{"status":"ok","message-type":"work-list","message-version":"1.0.0","message":{"facets":{},"total-results":3144,"items":[{"indexed":{"date-parts":[[2023,11,5]],"date-time":"2023-11-05T22:21:44Z","timestamp":1699222904227},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/s2213-8587(14)70078-6","type":"journal-article","created":{"date-parts":[[2014,7,23]],"date-time":"2014-07-23T23:43:15Z","timestamp":1406158995000},"page":"615","source":"Crossref","is-referenced-by-count":1,"title":["Research in brief"],"prefix":"10.1016","volume":"2","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T11:27:43Z","timestamp":1538393263000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700786"}},"issued":{"date-parts":[[2014,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S2213858714700786"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70078-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,8]]}},{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T05:41:08Z","timestamp":1783662068981,"version":"3.55.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/s2213-8587(23)00326-1","type":"journal-article","created":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T07:10:39Z","timestamp":1699945839000},"page":"879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diabetes: knowing your risk matters"],"prefix":"10.1016","volume":"11","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:20Z","timestamp":1761992000000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003261"}},"issued":{"date-parts":[[2023,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2213858723003261"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00326-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes: knowing your risk matters","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00326-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00223-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00351-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00141-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00194-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T23:11:14Z","timestamp":1724973074533},"reference-count":1,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/s2213-8587(15)00494-5","type":"journal-article","created":{"date-parts":[[2016,1,26]],"date-time":"2016-01-26T19:30:20Z","timestamp":1453836620000},"page":"98-99","source":"Crossref","is-referenced-by-count":7,"title":["Insulin patents and market exclusivities: unresolved issues \u2013 Authors' reply"],"prefix":"10.1016","volume":"4","author":[{"given":"Jing","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron S","family":"Kesselheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00494-5_bib2","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1377\/hlthaff.2009.0424","article-title":"State generic substitution laws can lower drug outlays under Medicaid","volume":"29","author":"Shrank","year":"2010","journal-title":"Health Aff (Millwood)"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004945?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004945?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T19:52:51Z","timestamp":1537041171000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004945"}},"issued":{"date-parts":[[2016,2]]},"references-count":1,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2213858715004945"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00494-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,2]]}},{"indexed":{"date-parts":[[2022,11,17]],"date-time":"2022-11-17T02:50:41Z","timestamp":1668653441614},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/s2213-8587(14)70129-9","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T19:16:07Z","timestamp":1409426167000},"page":"676","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Phaeochromocytoma revealed by a stellate neuroretinitis"],"prefix":"10.1016","volume":"2","author":[{"given":"Soufiane","family":"Berradi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zouheir","family":"Hafidi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajae","family":"Daoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T01:23:00Z","timestamp":1538270580000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701299"}},"issued":{"date-parts":[[2014,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S2213858714701299"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70129-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phaeochromocytoma revealed by a stellate neuroretinitis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70129-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T23:52:25Z","timestamp":1648684345499},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/s2213-8587(13)70121-9","type":"journal-article","created":{"date-parts":[[2013,10,27]],"date-time":"2013-10-27T21:02:02Z","timestamp":1382907722000},"page":"e16","source":"Crossref","is-referenced-by-count":0,"title":["A story of a golden boy"],"prefix":"10.1016","volume":"1","author":[{"given":"Hannah","family":"Cagney","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,11]],"date-time":"2020-03-11T11:25:32Z","timestamp":1583925932000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701219"}},"issued":{"date-parts":[[2013,12]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2213858713701219"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70121-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,12]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T21:41:24Z","timestamp":1648935684189},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/s2213-8587(14)70255-4","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T04:15:17Z","timestamp":1421900117000},"page":"158","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["History written on the heart"],"prefix":"10.1016","volume":"3","author":[{"given":"Julia","family":"Lowe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T05:00:18Z","timestamp":1537938018000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702554"}},"issued":{"date-parts":[[2015,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S2213858714702554"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70255-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"History written on the heart","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70255-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:56:15Z","timestamp":1648814175930},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/s2213-8587(15)00465-9","type":"journal-article","created":{"date-parts":[[2015,11,28]],"date-time":"2015-11-28T01:42:02Z","timestamp":1448674922000},"page":"14-15","source":"Crossref","is-referenced-by-count":0,"title":["China Diabetes Society 2016: a call for papers"],"prefix":"10.1016","volume":"4","author":[{"given":"Justine","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Helena","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00465-9_bib1","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/S0140-6736(13)61097-1","article-title":"Rapid health transition in China, 1990\u20132010: findings from the Global Burden of Disease Study 2010","volume":"381","author":"Yang","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00465-9_bib2","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.2337\/diacare.20.11.1664","article-title":"Prevalence of diabetes and its risk factors in China, 1994","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00465-9_bib3","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S2213-8587(14)70145-7","article-title":"Causes of type 2 diabetes in China","volume":"2","author":"Ma","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00465-9_bib4","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/S2213-8587(15)00382-4","article-title":"Diabetes prevention and continuing health-care reform in China","volume":"3","author":"Jia","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00465-9_bib5","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S2213-8587(14)70136-6","article-title":"Early therapy for type 2 diabetes in China","volume":"2","author":"Yang","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00465-9_bib6","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-8587(14)70144-5","article-title":"Diabetes in China: a societal solution for personal challenge","volume":"2","author":"Chan","year":"2014","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004659?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004659?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T10:28:27Z","timestamp":1537180107000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004659"}},"issued":{"date-parts":[[2016,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S2213858715004659"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00465-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,1]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T12:15:55Z","timestamp":1648901755327},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/s2213-8587(13)70043-3","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T20:46:15Z","timestamp":1379709975000},"page":"e11","source":"Crossref","is-referenced-by-count":0,"title":["Walk and talk like a man, eat like a caveman"],"prefix":"10.1016","volume":"1","author":[{"given":"Farhat","family":"Yaqub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T21:52:15Z","timestamp":1539381135000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700433"}},"issued":{"date-parts":[[2013,10]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S2213858713700433"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70043-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,10]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:53:55Z","timestamp":1649037235138},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/s2213-8587(18)30151-7","type":"journal-article","created":{"date-parts":[[2018,5,10]],"date-time":"2018-05-10T11:15:23Z","timestamp":1525950923000},"page":"e16","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2018; 6:627\u201336"],"prefix":"10.1016","volume":"6","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T08:40:07Z","timestamp":1548664807000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301517"}},"issued":{"date-parts":[[2018,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S2213858718301517"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30151-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,8]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:04:20Z","timestamp":1648670660752},"reference-count":12,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/s2213-8587(17)30140-7","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T02:47:32Z","timestamp":1493434052000},"page":"407-409","source":"Crossref","is-referenced-by-count":0,"title":["Can vitamin D prevent falls and fractures?"],"prefix":"10.1016","volume":"5","author":[{"given":"Roger","family":"Bouillon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30140-7_bib1","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1210\/er.2008-0004","article-title":"Vitamin D and human health: lessons from vitamin D receptor null mice","volume":"29","author":"Bouillon","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(17)30140-7_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(17)30103-1","article-title":"Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial","author":"Khaw","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30140-7_bib3","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2017.0175","article-title":"Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the Vitamin D Assessment Study: a randomized clinical trial","author":"Scragg","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(17)30140-7_bib4","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1210\/jc.2006-1404","article-title":"Need for additional calcium to reduce the risk of hip fracture with vitamin D supplementation: evidence from a comparative metaanalysis of randomized controlled trials","volume":"92","author":"Boonen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30140-7_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000227.pub4","article-title":"Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men","volume":"4","author":"Avenell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30140-7_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/nrendo.2017.31","article-title":"Comparative analysis of nutritional guidelines for vitamin D","author":"Bouillon","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(17)30140-7_bib7","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/S2213-8587(14)70068-3","article-title":"Vitamin D supplementation and falls: a trial sequential meta-analysis","volume":"2","author":"Bolland","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30140-7_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005465.pub3","article-title":"Interventions for preventing falls in older people in care facilities and hospitals","volume":"12","author":"Cameron","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30140-7_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007146.pub3","article-title":"Interventions for preventing falls in older people living in the community","volume":"9","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30140-7_bib10","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","article-title":"Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial","volume":"303","author":"Sanders","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30140-7_bib11","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamainternmed.2015.7148","article-title":"Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial","volume":"176","author":"Bischoff-Ferrari","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(17)30140-7_bib12","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1017\/S0007114513001840","article-title":"A systematic review of vitamin D status in populations worldwide","volume":"111","author":"Hilger","year":"2014","journal-title":"Br J Nutr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T07:31:20Z","timestamp":1535873480000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301407"}},"issued":{"date-parts":[[2017,6]]},"references-count":12,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2213858717301407"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30140-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,6]]}},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T18:08:13Z","timestamp":1648750093290},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/s2213-8587(17)30003-7","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T01:15:16Z","timestamp":1484010916000},"page":"95","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"5","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T05:54:30Z","timestamp":1536126870000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300037"}},"issued":{"date-parts":[[2017,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S2213858717300037"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30003-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,2]]}},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:45:49Z","timestamp":1648781149424},"reference-count":4,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/s2213-8587(15)00471-4","type":"journal-article","created":{"date-parts":[[2015,12,24]],"date-time":"2015-12-24T19:30:12Z","timestamp":1450985412000},"page":"18","source":"Crossref","is-referenced-by-count":1,"title":["Maternal thyroid function and child IQ \u2013 Authors' reply"],"prefix":"10.1016","volume":"4","author":[{"given":"Tim I M","family":"Korevaar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryan","family":"Muetzel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Henning","family":"Tiemeier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robin P","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00471-4_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-8587(15)00327-7","article-title":"Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study","volume":"4","author":"Korevaar","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00471-4_bib2","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1210\/jc.2008-2111","article-title":"Thyroid function in early pregnancy in Japanese healthy women: relation to urinary iodine excretion, emesis, and fetal and child development","volume":"94","author":"Orito","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00471-4_bib3","article-title":"Maternal and birth characteristics are determinants of offspring thyroid function","author":"Korevaar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00471-4_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.reprotox.2014.05.012","article-title":"The protective effects of nausea and vomiting of pregnancy against adverse fetal outcome\u2014a systematic review","volume":"47","author":"Koren","year":"2014","journal-title":"Reprod Toxicol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004714?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004714?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T11:54:25Z","timestamp":1537098865000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004714"}},"issued":{"date-parts":[[2016,1]]},"references-count":4,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S2213858715004714"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00471-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,1]]}},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T02:50:36Z","timestamp":1649127036753},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/s2213-8587(19)30144-5","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T18:36:18Z","timestamp":1556130978000},"page":"513-514","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetes, from 1500 BCE to 2000 CE"],"prefix":"10.1016","volume":"7","author":[{"given":"Peter H","family":"Bennett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301445?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301445?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T16:18:51Z","timestamp":1563207531000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301445"}},"issued":{"date-parts":[[2019,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S2213858719301445"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30144-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes, from 1500 BCE to 2000 CE","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30144-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"book-review","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:52:41Z","timestamp":1649098361014},"reference-count":8,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/s2213-8587(14)70053-1","type":"journal-article","created":{"date-parts":[[2014,3,24]],"date-time":"2014-03-24T13:51:02Z","timestamp":1395669062000},"page":"534-535","source":"Crossref","is-referenced-by-count":1,"title":["Surgery for diabetes in low and middle-income countries"],"prefix":"10.1016","volume":"2","author":[{"given":"Ainhoa","family":"Costas-Chavarri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rowan","family":"Gillies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70053-1_bib1","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.diabres.2011.10.018","article-title":"Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: The Diabcare Africa study","volume":"95","author":"Sobngwi","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(14)70053-1_bib2","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.jdiacomp.2013.08.008","article-title":"Physical activity, glycemic control, and diabetic peripheral neuropathy: a national sample","volume":"28","author":"Loprinzi","year":"2014","journal-title":"J Diabetes Complications"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70053-1_bib3","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1002\/dmrr.440","article-title":"Specific problems of the diabetic foot in developing countries","volume":"20","author":"Ramachandran","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(14)70053-1_bib4","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00125-008-1167-9","article-title":"A sub-Saharan African perspective of diabetes","volume":"52","author":"Gill","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70053-1_bib5","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1464-5491.2002.00740.x","article-title":"Clinical outcome of diabetes patients hospitalized with foot ulcers Dar es Salaam, Tanzania","volume":"19","author":"Gulam-Abbas","year":"2002","journal-title":"Diabet Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70053-1_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-7560(200009\/10)16:1+<::AID-DMRR105>3.0.CO;2-N","article-title":"The diabetic foot: a global view","volume":"16","author":"Boulton","year":"2000","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(14)70053-1_bib7","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1111\/j.1464-5491.2009.02781.x","article-title":"Magnitude of foot problems in diabetes in the developing world: a study of 1044 patients","volume":"26","author":"Jayaprakash","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(14)70053-1_bib8","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/(SICI)1528-252X(200003\/04)17:2<41::AID-PDI29>3.0.CO;2-S","article-title":"Pattern of hospital mortality among diabetic patients in Sudan","volume":"17","author":"Ahmed","year":"2000","journal-title":"Practical Diabetes Int"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T18:52:33Z","timestamp":1538765553000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700531"}},"issued":{"date-parts":[[2014,7]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S2213858714700531"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70053-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,7]]}},{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:15:57Z","timestamp":1762506957210},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30366-7","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T01:32:45Z","timestamp":1479432765000},"page":"S11","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S1","title":["1 year weight losses in the Tianjin Gestational Diabetes Mellitus Prevention Program: a randomised trial"],"prefix":"10.1016","volume":"4","author":[{"given":"Huikun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leishen","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shuang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junhong","family":"Leng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nan","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiqin","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Huiguang","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaakko","family":"Tuomilehto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xilin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhijie","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T11:56:56Z","timestamp":1536235016000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303667"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"alternative-id":["S2213858716303667"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30366-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T21:01:51Z","timestamp":1648674111596},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/s2213-8587(15)00516-1","type":"journal-article","created":{"date-parts":[[2016,2,24]],"date-time":"2016-02-24T23:59:50Z","timestamp":1456358390000},"page":"548","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["An active life is a sweet life"],"prefix":"10.1016","volume":"4","author":[{"given":"Elizabeth A","family":"McAninch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715005161?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715005161?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T18:29:54Z","timestamp":1536949794000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715005161"}},"issued":{"date-parts":[[2016,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S2213858715005161"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00516-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An active life is a sweet life","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00516-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,9,29]],"date-time":"2025-09-29T20:26:36Z","timestamp":1759177596558},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/s2213-8587(18)30004-4","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T15:05:23Z","timestamp":1517497523000},"page":"93","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Research digest: progress in microvascular complications"],"prefix":"10.1016","volume":"6","author":[{"given":"Naveed","family":"Sattar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Preiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T08:30:32Z","timestamp":1552984232000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300044"}},"issued":{"date-parts":[[2018,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S2213858718300044"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30004-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research digest: progress in microvascular complications","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30004-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:07:12Z","timestamp":1767150432356,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(23)00132-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/s2213-8587(23)00288-7","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T18:33:44Z","timestamp":1696444424000},"page":"e13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2023; 11: 567\u201377"],"prefix":"10.1016","volume":"11","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002887?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002887?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:26Z","timestamp":1761992006000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723002887"}},"issued":{"date-parts":[[2023,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2213858723002887"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00288-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2023; 11: 567\u201377","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00288-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00132-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,30]],"date-time":"2026-05-30T01:35:25Z","timestamp":1780104925761,"version":"3.54.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006520","name":"Edwards Lifesciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006520","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006775","name":"GE Healthcare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006775","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/s2213-8587(18)30257-2","type":"journal-article","created":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T18:34:51Z","timestamp":1535049291000},"page":"757-759","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Preoperative hyperglycaemia and risk of myocardial injury after non-cardiac surgery"],"prefix":"10.1016","volume":"6","author":[{"given":"Arnold C T","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen J","family":"Bax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30257-2_bib1","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/ALN.0000000000000113","article-title":"Myocardial injury after noncardiac surgery: a large, international, prospective cohort study establishing diagnostic criteria, characteristics, predictors, and 30-day outcomes","volume":"120","author":"Botto","year":"2014","journal-title":"Anesthesiology"},{"key":"10.1016\/S2213-8587(18)30257-2_bib2","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/CIRCULATIONAHA.113.002128","article-title":"Myocardial injury after noncardiac surgery and its association with short-term mortality","volume":"127","author":"van Waes","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30257-2_bib3","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.atherosclerosis.2012.02.021","article-title":"Coronary plaque rupture in patients with myocardial infarction after noncardiac surgery: frequent and dangerous","volume":"222","author":"Gualandro","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(18)30257-2_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.jacc.2004.03.073","article-title":"Cardiac troponin after major vascular surgery: the role of perioperative ischemia, preoperative thallium scanning, and coronary revascularization","volume":"44","author":"Landesberg","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(18)30257-2_bib5","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1001\/jama.2017.4360","article-title":"Association of postoperative high-sensitivity troponin levels with myocardial injury and 30-day mortality among patients undergoing noncardiac surgery","volume":"317","author":"Devereaux","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30257-2_bib6","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1001\/jama.2012.5502","article-title":"Association between postoperative troponin levels and 30-day mortality among patients undergoing noncardiac surgery","volume":"307","author":"Devereaux","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30257-2_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30205-5","article-title":"Association of preoperative glucose concentration with myocardial injury and death after non-cardiac surgery (GlucoVISION): a prospective cohort study","author":"Punthakee","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30257-2_bib8","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S0140-6736(99)08415-9","article-title":"Stress hyperglycaemia and increased risk of death after myocardial infarction in patients with and without diabetes: a systematic overview","volume":"355","author":"Capes","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30257-2_bib9","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1161\/01.CIR.100.10.1043","article-title":"Derivation and prospective validation of a simple index for prediction of cardiac risk of major noncardiac surgery","volume":"100","author":"Lee","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30257-2_bib10","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","author":"Finfer","year":"2009","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:19Z","timestamp":1761991579000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302572"}},"issued":{"date-parts":[[2018,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2213858718302572"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30257-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preoperative hyperglycaemia and risk of myocardial injury after non-cardiac surgery","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30257-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30205-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,4,10]],"date-time":"2025-04-10T07:48:55Z","timestamp":1744271335413},"reference-count":6,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/s2213-8587(18)30173-6","type":"journal-article","created":{"date-parts":[[2018,7,25]],"date-time":"2018-07-25T00:13:08Z","timestamp":1532477588000},"page":"599-600","source":"Crossref","is-referenced-by-count":2,"title":["Investigation of primary aldosteronism in patients with resistant hypertension"],"prefix":"10.1016","volume":"6","author":[{"given":"Kay Weng","family":"Choy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30173-6_bib1","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-8587(18)30071-8","article-title":"Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies","volume":"6","author":"Williams","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30173-6_bib2","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1210\/er.2017-00054","article-title":"Screening for endocrine hypertension: an Endocrine Society scientific statement","volume":"38","author":"Young","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(18)30173-6_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/j.clinbiochem.2015.01.003","article-title":"Laboratory challenges in primary aldosteronism screening and diagnosis","volume":"48","author":"Rehan","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/S2213-8587(18)30173-6_bib4","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30173-6_bib5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1177\/0004563216645364","article-title":"2016 Endocrine Society guidelines update for the diagnosis of primary aldosteronism: are the proposed aldosterone-to-renin ratio cut-off values relevant in the era of fully automated immunoassays?","volume":"53","author":"Denimal","year":"2016","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/S2213-8587(18)30173-6_bib6","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T04:04:37Z","timestamp":1534824277000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301736"}},"issued":{"date-parts":[[2018,8]]},"references-count":6,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S2213858718301736"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30173-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,8]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:03Z","timestamp":1761991983065,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/s2213-8587(21)00175-3","type":"journal-article","created":{"date-parts":[[2021,6,25]],"date-time":"2021-06-25T18:29:20Z","timestamp":1624645760000},"page":"652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Mark Atkinson: bringing two worlds together"],"prefix":"10.1016","volume":"9","author":[{"given":"Carl","family":"Power","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001753?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001753?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:45Z","timestamp":1761991785000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001753"}},"issued":{"date-parts":[[2021,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2213858721001753"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00175-3","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mark Atkinson: bringing two worlds together","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00175-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:20:09Z","timestamp":1758673209239,"version":"3.44.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/s2213-8587(25)00194-9","type":"journal-article","created":{"date-parts":[[2025,7,16]],"date-time":"2025-07-16T01:47:04Z","timestamp":1752630424000},"page":"649-650","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Policies on ultra-processed diets: feasible and urgent"],"prefix":"10.1016","volume":"13","author":[{"given":"Phillip","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carlos","family":"Monteiro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00194-9_bib1","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/S2213-8587(25)00139-1","article-title":"Ultra-processed foods: yet another wake-up call","volume":"13","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00194-9_bib2","article-title":"Ultra-processed foods and cardiometabolic health: public health policies to reduce consumption cannot wait","volume":"383","author":"Touvier","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00194-9_bib3","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s43016-022-00599-4","article-title":"From ultra-processed foods to ultra-processed dietary patterns","volume":"3","author":"Scrinis","year":"2022","journal-title":"Nat Food"},{"key":"10.1016\/S2213-8587(25)00194-9_bib4","article-title":"A policy approach to identifying food and beverage products that are ultra-processed and high in added salt, sugar and saturated fat in the United States: a cross-sectional analysis of packaged foods","volume":"32","author":"Popkin","year":"2024","journal-title":"Lancet Reg Health Am"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001949?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001949?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T23:45:25Z","timestamp":1758671125000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725001949"}},"issued":{"date-parts":[[2025,8]]},"references-count":4,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2213858725001949"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00194-9","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Policies on ultra-processed diets: feasible and urgent","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00194-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00139-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,2]],"date-time":"2025-11-02T16:57:26Z","timestamp":1762102646921,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/s2213-8587(21)00146-7","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T18:38:29Z","timestamp":1623868709000},"page":"417","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["First, do no harm"],"prefix":"10.1016","volume":"9","author":[{"given":"Jennifer","family":"Thorley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001467?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001467?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:09Z","timestamp":1761991749000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001467"}},"issued":{"date-parts":[[2021,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2213858721001467"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00146-7","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"First, do no harm","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00146-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:29:36Z","timestamp":1715041776738},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/s2213-8587(24)00099-8","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T22:32:54Z","timestamp":1713911574000},"page":"304","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Anand Hardikar: a scientific nomad searching for the truth"],"prefix":"10.1016","volume":"12","author":[{"given":"Susan","family":"Rahimi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Koch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:46:19Z","timestamp":1715039179000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000998"}},"issued":{"date-parts":[[2024,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2213858724000998"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00099-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anand Hardikar: a scientific nomad searching for the truth","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00099-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:11Z","timestamp":1761991991715,"version":"build-2065373602"},"reference-count":2,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["2P30DK111024-06"],"award-info":[{"award-number":["2P30DK111024-06"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/s2213-8587(22)00071-7","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T18:29:34Z","timestamp":1646418574000},"page":"238-240","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Creating diabetes guidelines for the individual not just the illness"],"prefix":"10.1016","volume":"10","author":[{"given":"Nuha Ali","family":"El Sayed","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Gabbay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo E","family":"Umpierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/S2213-8587(22)00071-7_bib1","first-page":"S1","article-title":"Standards of medical care in diabetes\u20142022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00071-7_bib2","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2021.11165","article-title":"Trends in prevalence of type 1 and type 2 diabetes in children and adolescents in the US, 2001\u20132017","volume":"326","author":"Lawrence","year":"2021","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:09Z","timestamp":1761991809000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000717"}},"issued":{"date-parts":[[2022,4]]},"references-count":2,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2213858722000717"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00071-7","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Creating diabetes guidelines for the individual not just the illness","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00071-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,10]],"date-time":"2025-11-10T21:13:17Z","timestamp":1762809197366,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/s2213-8587(22)00009-2","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T18:31:37Z","timestamp":1644258697000},"page":"151-152","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Prevention of diabetes mortality at ages younger than 25 years: access to medications and high-quality health care"],"prefix":"10.1016","volume":"10","author":[{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00009-2_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107843","article-title":"Global and regional diabetes prevalence estimates for 2019 and projections for 2030 and 2045: results from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"157","author":"Saeedi","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(22)00009-2_bib2","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fendo.2018.00070","article-title":"Understanding pre-type 1 diabetes: the key to prevention","volume":"9","author":"Jacobsen","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(22)00009-2_bib3","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","article-title":"Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank","volume":"6","author":"Thomas","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"journal-title":"Lancet Diabetes Endocrinol","article-title":"Diabetes mortality and trends before 25 years of age: an analysis of the Global Burden of Disease Study 2019","year":"2022","key":"10.1016\/S2213-8587(22)00009-2_bib4"},{"key":"10.1016\/S2213-8587(22)00009-2_bib5","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1126\/science.abi4742","article-title":"Preventing type 1 diabetes in childhood","volume":"373","author":"Dayan","year":"2021","journal-title":"Science"},{"key":"10.1016\/S2213-8587(22)00009-2_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00009-2_bib7","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(22)00009-2_bib8","doi-asserted-by":"crossref","first-page":"R59","DOI":"10.1530\/JOE-20-0596","article-title":"Towards improved precision and a new classification of diabetes mellitus","volume":"252","author":"Ahlqvist","year":"2021","journal-title":"J Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000092?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000092?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:49Z","timestamp":1761991849000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000092"}},"issued":{"date-parts":[[2022,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2213858722000092"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00009-2","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevention of diabetes mortality at ages younger than 25 years: access to medications and high-quality health care","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00009-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00349-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:27Z","timestamp":1761992187839,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/s2213-8587(21)00319-3","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T19:20:35Z","timestamp":1640200835000},"page":"86-87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["How do clinicians integrate oral octreotide into their treatment plan for acromegaly?"],"prefix":"10.1016","volume":"10","author":[{"given":"Maya B","family":"Lodish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00319-3_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21051682","article-title":"Somatostatin analogs in clinical practice: a review","volume":"21","author":"Gomes-Porras","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(21)00319-3_bib2","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1038\/s41574-018-0058-5","article-title":"A consensus statement on acromegaly therapeutic outcomes","volume":"14","author":"Melmed","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00319-3_bib3","doi-asserted-by":"crossref","first-page":"e3785","DOI":"10.1210\/clinem\/dgaa526","article-title":"Maintenance of acromegaly control in patients switching from injectable somatostatin receptor ligands to oral octreotide","volume":"105","author":"Samson","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00319-3_bib4","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1210\/jc.2014-4113","article-title":"Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial","volume":"100","author":"Melmed","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00319-3_bib5","article-title":"Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00319-3_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"A Pituitary Society update to acromegaly management guidelines","volume":"24","author":"Fleseriu","year":"2021","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(21)00319-3_bib7","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s12020-015-0766-8","article-title":"Quantitative analyses of T2-weighted MRI as a potential marker for response to somatostatin analogs in newly diagnosed acromegaly","volume":"52","author":"Heck","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(21)00319-3_bib8","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.677919","article-title":"Clinical and radiological predictors of biochemical response to first-line treatment with somatostatin receptor ligands in acromegaly: a real-life perspective","volume":"12","author":"Nista","year":"2021","journal-title":"Front Endocrinol (Lausanne)"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:41Z","timestamp":1761991901000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721003193"}},"issued":{"date-parts":[[2022,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2213858721003193"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00319-3","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How do clinicians integrate oral octreotide into their treatment plan for acromegaly?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00319-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00296-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:24Z","timestamp":1761992004322,"version":"build-2065373602"},"reference-count":2,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/s2213-8587(22)00014-6","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:52:59Z","timestamp":1647892379000},"page":"241-242","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Data processing in the DMagic cluster randomised controlled trial"],"prefix":"10.1016","volume":"10","author":[{"given":"Edward","family":"Fottrell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carina","family":"King","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kishwar","family":"Azad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00014-6_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S2213-8587(19)30001-4","article-title":"Community groups or mobile phone messaging to prevent and control type 2 diabetes and intermediate hyperglycaemia in Bangladesh (DMagic): a cluster-randomised controlled trial","volume":"7","author":"Fottrell","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"year":"2016","series-title":"Global report on diabetes","key":"10.1016\/S2213-8587(22)00014-6_bib2"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:40Z","timestamp":1761991840000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000146"}},"issued":{"date-parts":[[2022,4]]},"references-count":2,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2213858722000146"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00014-6","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Data processing in the DMagic cluster randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00014-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30001-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:49:40Z","timestamp":1762004980959,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/s2213-8587(18)30002-0","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T18:35:20Z","timestamp":1517250920000},"page":"761-763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Personalised blood pressure ranges in type 2 diabetes?"],"prefix":"10.1016","volume":"6","author":[{"given":"Martin K","family":"Rutter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30002-0_bib1","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30002-0_bib2","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrendo.2016.209","article-title":"Blood pressure reduction in diabetes: lessons from ACCORD, SPRINT and EMPA-REG OUTCOME","volume":"13","author":"Sarafidis","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(18)30002-0_bib3","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2337\/dc13-2334","article-title":"Outcomes of combined cardiovascular risk factor management strategies in type 2 diabetes: the ACCORD randomized trial","volume":"37","author":"Margolis","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30002-0_bib4","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.2337\/dci17-0026","article-title":"Diabetes and hypertension: a position statement by the American Diabetes Association","volume":"40","author":"de Boer","year":"2017","journal-title":"Diabetes Care"},{"year":"2017","series-title":"Type 2 diabetes in adults: management, NICE guideline 28","key":"10.1016\/S2213-8587(18)30002-0_bib5"},{"key":"10.1016\/S2213-8587(18)30002-0_bib6","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/HYPERTENSIONAHA.115.07020","article-title":"An expert opinion from the European Society of Hypertension-European Union Geriatric Medicine Society Working Group on the management of hypertension in very old, frail subjects","volume":"67","author":"Benetos","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(18)30002-0_bib7","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1161\/CIRCULATIONAHA.116.022536","article-title":"The implications of blood pressure measurement methods on treatment targets for blood pressure","volume":"134","author":"Bakris","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30002-0_bib8","first-page":"2293","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"374","author":"Bangalore","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30002-0_bib9","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.2337\/dc17-1366","article-title":"Intensive versus standard blood pressure control in SPRINT-eligible participants of the ACCORD-BP trial","volume":"40","author":"Buckley","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30002-0_bib10","doi-asserted-by":"crossref","first-page":"e003624","DOI":"10.1161\/CIRCOUTCOMES.117.003624","article-title":"Personalizing the intensity of blood pressure control: modeling the heterogeneity of risks and benefits from SPRINT (Systolic Blood Pressure Intervention Trial)","volume":"10","author":"Patel","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:29Z","timestamp":1761991589000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300020"}},"issued":{"date-parts":[[2018,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2213858718300020"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30002-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalised blood pressure ranges in type 2 diabetes?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30002-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:44Z","timestamp":1761992204406,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/s2213-8587(23)00148-1","type":"journal-article","created":{"date-parts":[[2023,5,22]],"date-time":"2023-05-22T18:37:18Z","timestamp":1684780638000},"page":"453","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Improving health equity through data collection"],"prefix":"10.1016","volume":"11","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001481?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001481?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:13Z","timestamp":1761991933000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001481"}},"issued":{"date-parts":[[2023,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2213858723001481"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00148-1","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving health equity through data collection","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00148-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:08Z","timestamp":1761991928640,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/s2213-8587(20)30279-5","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T18:38:49Z","timestamp":1597775929000},"page":"743-744","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bariatric and metabolic surgery during and after the COVID-19 pandemic \u2013 Authors' reply"],"prefix":"10.1016","volume":"8","author":[{"given":"David E","family":"Cummings","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Philip R","family":"Schauer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ricardo V","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30279-5_bib1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S2213-8587(20)30157-1","article-title":"Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery","volume":"8","author":"Rubino","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30279-5_bib2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose conrol in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30279-5_bib3","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00125-017-4513-y","article-title":"Metabolic surgery for the treatment of type 2 diabetes in obese individuals","volume":"61","author":"Cummings","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30279-5_bib4","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.2337\/dci20-0006","article-title":"Success (but unfinished) story of metabolic surgery","volume":"43","author":"Aminian","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30279-5_bib5","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/dom.13765","article-title":"Bariatric surgery is associated with a lower rate of death after myocardial infarction and stroke: a nationwide study","volume":"21","author":"Aminian","year":"2019","journal-title":"Diabetes Obes Metab"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(20)30279-5_bib6","first-page":"S89","article-title":"8. Obesity management for the treatment of type 2 diabetes: standards of medical care in diabetes\u20142020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30279-5_bib7","doi-asserted-by":"crossref","first-page":"924","DOI":"10.2337\/dc16-0350","article-title":"Metabolic surgery to treat type 2 diabetes in patients with a BMI <35 kg\/m2","volume":"39","author":"Cummings","year":"2016","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302795?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302795?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:15Z","timestamp":1761991695000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720302795"}},"issued":{"date-parts":[[2020,9]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2213858720302795"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30279-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bariatric and metabolic surgery during and after the COVID-19 pandemic \u2013 Authors' reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30279-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30157-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30278-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30276-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30277-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:34Z","timestamp":1761991954811,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/s2213-8587(20)30193-5","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T18:51:32Z","timestamp":1592333492000},"page":"569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Relating to transgender issues"],"prefix":"10.1016","volume":"8","author":[{"given":"Robert","family":"Stirrups","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:52Z","timestamp":1761991732000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301935"}},"issued":{"date-parts":[[2020,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2213858720301935"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30193-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Relating to transgender issues","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30193-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"book-review","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:33:10Z","timestamp":1761895990230},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/s2213-8587(14)70195-0","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T19:30:36Z","timestamp":1417030236000},"page":"2-3","source":"Crossref","is-referenced-by-count":1,"title":["When you come to a fork in the road, take it!"],"prefix":"10.1016","volume":"3","author":[{"given":"Steven J","family":"Russell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70195-0_bib1","doi-asserted-by":"crossref","first-page":"4383","DOI":"10.1210\/jc.2012-1561","article-title":"The T1D exchange clinic registry","volume":"97","author":"Beck","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70195-0_bib2","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/nyas.12431","article-title":"The artificial pancreas: current status and future prospects in the management of diabetes","volume":"1311","author":"Peyser","year":"2014","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/S2213-8587(14)70195-0_bib3","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1177\/193229681300700610","article-title":"Pharmacokinetics of insulin aspart and glucagon in type 1 diabetes during closed-loop operation","volume":"7","author":"Haidar","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(14)70195-0_bib4","doi-asserted-by":"crossref","first-page":"27ra27","DOI":"10.1126\/scitranslmed.3000619","article-title":"A bi-hormonal closed-loop blood glucose control device for type 1 diabetes","volume":"2","author":"El-Khatib","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(14)70195-0_bib5","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.1210\/en.2011-1499","article-title":"Minireview: Glucagon in the pathogenesis of hypoglycemia and hyperglycemia in diabetes","volume":"153","author":"Cryer","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(14)70195-0_bib6","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2337\/dc09-2254","article-title":"Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes. Castle JR","volume":"33","author":"Engle","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70195-0_bib7","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1503\/cmaj.121265","article-title":"Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial","volume":"185","author":"Haidar","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(14)70195-0_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJMoa1314474","article-title":"Outpatient glycemic control with a bionic pancreas in type 1 diabetes","volume":"371","author":"Russell","year":"2014","journal-title":"New Engl J Med"},{"key":"10.1016\/S2213-8587(14)70195-0_bib9","article-title":"Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial","author":"Haidar","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 1A","key":"10.1016\/S2213-8587(14)70195-0_bib10","first-page":"1","article-title":"A phase 2 comparative safety PK\/PD study of stable nonaqueous glucagon (G-Pen) vs. Lilly glucagon for treatment of severe hypo-glycemia","volume":"63","author":"Cersosima","year":"2014","journal-title":"Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T07:51:39Z","timestamp":1538034699000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701950"}},"issued":{"date-parts":[[2015,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S2213858714701950"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70195-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,1]]}},{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T23:12:10Z","timestamp":1761174730731},"reference-count":13,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/s2213-8587(18)30258-4","type":"journal-article","created":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T12:26:08Z","timestamp":1535545568000},"page":"759-761","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Availability and affordability of medicines: towards an evidence base for routine assessment"],"prefix":"10.1016","volume":"6","author":[{"given":"Alessandra","family":"Ferrario","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30258-4_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S0140-6736(16)31599-9","article-title":"Essential medicines for universal health coverage","volume":"389","author":"Wirtz","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30258-4_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30233-X","article-title":"Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries","author":"Chow","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30258-4_bib3","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2468-2667(17)30141-X","article-title":"Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data","volume":"2","author":"Attaei","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(18)30258-4_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(15)00469-9","article-title":"Availability and affordability of cardiovascular disease medicines and their effect on use in high-income, middle-income, and low-income countries: an analysis of the PURE study data","volume":"387","author":"Khatib","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30258-4_bib5","doi-asserted-by":"crossref","first-page":"e390","DOI":"10.1016\/S2468-2667(17)30168-8","article-title":"Beyond availability and affordability: how access to medicines affects non-communicable disease outcomes","volume":"2","author":"Wirtz","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(18)30258-4_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S0140-6736(15)00552-8","article-title":"Universal access to medicines","volume":"387","author":"Niessen","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30258-4_bib7","doi-asserted-by":"crossref","first-page":"e296","DOI":"10.1016\/S2214-109X(16)00066-8","article-title":"How the MDGs gave up on measuring access to medicines","volume":"4","author":"Gotham","year":"2016","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(18)30258-4_bib8","series-title":"Insulin prices profile, April 2016","author":"Ewen","year":"2016"},{"key":"10.1016\/S2213-8587(18)30258-4_bib9","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1093\/heapol\/czv136","article-title":"Progress in increasing affordability of medicines for non-communicable diseases since the introduction of mandatory health insurance in the Republic of Moldova","volume":"31","author":"Ferrario","year":"2016","journal-title":"Health Policy Plan"},{"key":"10.1016\/S2213-8587(18)30258-4_bib10","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1478-4505-11-45","article-title":"Promoting universal financial protection: health insurance for the poor in Georgia\u2014a case study","volume":"11","author":"Zoidze","year":"2013","journal-title":"Health Res Policy Syst"},{"key":"10.1016\/S2213-8587(18)30258-4_bib11","series-title":"Informality in the process of development and growth. Policy research working paper no WPS 7858","author":"Loayza","year":"2016"},{"key":"10.1016\/S2213-8587(18)30258-4_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/s40545-014-0020-4","article-title":"Uptake of new antidiabetic medications in three emerging markets: a comparison between Brazil, China and Thailand","volume":"8","author":"Lu","year":"2015","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/S2213-8587(18)30258-4_bib13","doi-asserted-by":"crossref","first-page":"e001686","DOI":"10.1136\/bmjopen-2012-001686","article-title":"Impact of universal health insurance coverage in Thailand on sales and market share of medicines for non-communicable diseases: an interrupted time series study","volume":"2","author":"Garabedian","year":"2012","journal-title":"BMJ Open"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T19:35:51Z","timestamp":1537904151000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302584"}},"issued":{"date-parts":[[2018,10]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2213858718302584"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30258-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Availability and affordability of medicines: towards an evidence base for routine assessment","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30258-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30233-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2023,11,8]],"date-time":"2023-11-08T07:27:47Z","timestamp":1699428467291},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/s2213-8587(16)30288-1","type":"journal-article","created":{"date-parts":[[2016,10,9]],"date-time":"2016-10-09T17:26:50Z","timestamp":1476034010000},"page":"96","source":"Crossref","is-referenced-by-count":1,"title":["Growing a billion dollar industry"],"prefix":"10.1016","volume":"5","author":[{"given":"Fiona","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T20:24:25Z","timestamp":1536351865000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302881"}},"issued":{"date-parts":[[2017,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S2213858716302881"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30288-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,2]]}},{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T20:32:50Z","timestamp":1715718770382},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/s2213-8587(17)30036-0","type":"journal-article","created":{"date-parts":[[2017,2,22]],"date-time":"2017-02-22T14:16:09Z","timestamp":1487772969000},"page":"162","source":"Crossref","is-referenced-by-count":3,"title":["Challenges of monitoring global diabetes prevalence"],"prefix":"10.1016","volume":"5","author":[{"given":"Majid","family":"Ezzati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leanne","family":"Riley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gretchen A","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaveh","family":"Hajifathalian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goodarz","family":"Danaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30036-0_bib1","doi-asserted-by":"publisher","first-page":"815","DOI":"10.1016\/S2213-8587(16)30220-0","article-title":"Liberating non-communicable disease data","volume":"4","author":"Bennett","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30036-0_bib2","doi-asserted-by":"publisher","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2\u00b77 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30036-0_bib3","doi-asserted-by":"publisher","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30036-0_bib4","doi-asserted-by":"publisher","first-page":"e1","DOI":"10.1373\/clinchem.2010.161596","article-title":"Guidelines and recommendations for laboratory analysis in the diagnosis and management of diabetes mellitus","volume":"57","author":"Sacks","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(17)30036-0_bib5","doi-asserted-by":"publisher","first-page":"140","DOI":"10.1258\/acb.2007.006212","article-title":"Measurement of blood glucose: comparison between different types of specimens","volume":"45","author":"Carstensen","year":"2008","journal-title":"Ann Clin Biochem"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T00:20:33Z","timestamp":1536020433000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300360"}},"issued":{"date-parts":[[2017,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2213858717300360"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30036-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,3]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:07Z","timestamp":1761991927912,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/s2213-8587(20)30120-0","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:34:40Z","timestamp":1587580480000},"page":"370-371","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["\u03b2-cell secretory dysfunction: a key cause of type 2 diabetes \u2013 Authors' reply"],"prefix":"10.1016","volume":"8","author":[{"given":"Gordon C","family":"Weir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Gaglia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Susan","family":"Bonner-Weir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30120-0_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S2213-8587(20)30022-X","article-title":"Inadequate \u03b2-cell mass is essential for the pathogenesis of type 2 diabetes","volume":"8","author":"Weir","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30120-0_bib2","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1210\/jcem-42-2-222","article-title":"Relationships between fasting plasma glucose levels and insulin secretion during intravenous glucose tolerance tests","volume":"42","author":"Brunzell","year":"1976","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30120-0_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/BF00500379","article-title":"Predictive value of intravenous glucose tolerance test insulin secretion less than or greater than the first percentile in islet cell antibody positive relatives of type 1 (insulin-dependent) diabetic patients","volume":"34","author":"Vardi","year":"1991","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30120-0_bib4","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.2337\/db07-0416","article-title":"Screening for insulitis in adult autoantibody-positive organ donors","volume":"56","author":"In't Veld","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30120-0_bib5","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1172\/JCI110910","article-title":"Partial pancreatectomy in the rat and subsequent defect in glucose-induced insulin release","volume":"71","author":"Bonner-Weir","year":"1983","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(20)30120-0_bib6","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2337\/diab.43.2.173","article-title":"Diazoxide causes recovery of beta-cell glucose responsiveness in 90% pancreatectomized diabetic rats","volume":"43","author":"Leahy","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30120-0_bib7","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1074\/jbc.M210581200","article-title":"Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaptation with impaired glucose tolerance or decompensated diabetes","volume":"278","author":"Laybutt","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(20)30120-0_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.02.002","article-title":"Beta cell identity changes with mild hyperglycemia: implications for function, growth, and vulnerability","author":"Ebrahimi","year":"2020","journal-title":"Mol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:13Z","timestamp":1761991693000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301200"}},"issued":{"date-parts":[[2020,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213858720301200"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30120-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-cell secretory dysfunction: a key cause of type 2 diabetes \u2013 Authors' reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30120-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30119-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30022-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T02:37:56Z","timestamp":1767839876884,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/s2213-8587(21)00211-4","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:38:56Z","timestamp":1630607936000},"page":"641-643","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Health disparities in transgender people"],"prefix":"10.1016","volume":"9","author":[{"given":"Vin","family":"Tangpricha","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00211-4_bib1","doi-asserted-by":"crossref","first-page":"3869","DOI":"10.1210\/jc.2017-01658","article-title":"Endocrine treatment of gender-dysphoric\/gender-incongruent persons: an endocrine society clinical practice guideline","volume":"102","author":"Hembree","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00211-4_bib2","first-page":"55","article-title":"Hormone therapy in transgender adults is safe with provider supervision; A review of hormone therapy sequelae for transgender individuals","volume":"2","author":"Weinand","year":"2015","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/S2213-8587(21)00211-4_bib3","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1111\/jsm.12571","article-title":"Cross-sex hormone therapy in trans persons is safe and effective at short-time follow-up: results from the European network for the investigation of gender incongruence","volume":"11","author":"Wierckx","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/S2213-8587(21)00211-4_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00185-6","article-title":"Mortality trends over five decades in adult transgender people receiving hormone treatment: a report from the Amsterdam cohort of gender dysphoria","author":"de Blok","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00211-4_bib5","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.jsxm.2016.09.012","article-title":"Differential effects of cyproterone acetate vs spironolactone on serum high-density lipoprotein and prolactin concentrations in the hormonal treatment of transgender women","volume":"13","author":"Fung","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/S2213-8587(21)00211-4_bib6","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1093\/brain\/awy108","article-title":"The occurrence of benign brain tumours in transgender individuals during cross-sex hormone treatment","volume":"141","author":"Nota","year":"2018","journal-title":"Brain"},{"key":"10.1016\/S2213-8587(21)00211-4_bib7","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-1725","article-title":"Pubertal suppression for transgender youth and risk of suicidal ideation","volume":"145","author":"Turban","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(21)00211-4_bib8","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1210\/jc.2018-02138","article-title":"cardiometabolic effects of testosterone in transmen and estrogen plus cyproterone acetate in transwomen","volume":"104","author":"van Velzen","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00211-4_bib9","doi-asserted-by":"crossref","first-page":"205","DOI":"10.7326\/M17-2785","article-title":"Cross-sex hormones and acute cardiovascular events in transgender persons: a cohort study","volume":"169","author":"Getahun","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(21)00211-4_bib10","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.jadohealth.2020.07.033","article-title":"Psychosocial characteristics of transgender youth seeking gender-affirming medical treatment: baseline findings from the trans youth care study","volume":"68","author":"Chen","year":"2021","journal-title":"J Adolesc Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002114?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002114?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:53Z","timestamp":1761991793000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002114"}},"issued":{"date-parts":[[2021,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2213858721002114"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00211-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health disparities in transgender people","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00211-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00185-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:49:39Z","timestamp":1773834579765,"version":"3.50.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009881","name":"Breakthrough T1D Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009881","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/s2213-8587(26)00028-8","type":"journal-article","created":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T23:42:31Z","timestamp":1773790951000},"page":"288-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Causal inference in perinatal epidemiology: big data's false promises"],"prefix":"10.1016","volume":"14","author":[{"given":"Jonathan","family":"McGavock","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00028-8_bib1","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2213-8587(25)00127-5","article-title":"Parental preconception BMI and risk of adverse birth outcomes in 8 million parent-child triads: a nationwide population-based cohort study in China","volume":"13","author":"Liu","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00028-8_bib2","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s10654-016-0149-3","article-title":"Statistical tests, P values, confidence intervals, and power: a guide to misinterpretations","volume":"31","author":"Greenland","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(26)00028-8_bib3","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2202\/1557-4679.1203","article-title":"An introduction to causal inference","volume":"6","author":"Pearl","year":"2010","journal-title":"Int J Biostat"},{"key":"10.1016\/S2213-8587(26)00028-8_bib4","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/S2213-8587(25)00036-1","article-title":"Association between maternal diabetes and neurodevelopmental outcomes in children: a systematic review and meta-analysis of 202 observational studies comprising 56\u00b71 million pregnancies","volume":"13","author":"Ye","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00028-8_bib5","first-page":"1866","article-title":"Triangulation in aetiological epidemiology","volume":"45","author":"Lawlor","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(26)00028-8_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-19257-z","article-title":"Mendelian randomization study of maternal influences on birthweight and future cardiometabolic risk in the HUNT cohort","volume":"11","author":"Moen","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(26)00028-8_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.socscimed.2018.07.035","article-title":"It's the mother!: how assumptions about the causal primacy of maternal effects influence research on the developmental origins of health and disease","volume":"213","author":"Sharp","year":"2018","journal-title":"Soc Sci Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000288?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000288?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:46:43Z","timestamp":1773823603000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000288"}},"issued":{"date-parts":[[2026,4]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2213858726000288"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00028-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Causal inference in perinatal epidemiology: big data's false promises","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00028-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T03:40:05Z","timestamp":1773286805405,"version":"3.50.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/s2213-8587(16)30397-7","type":"journal-article","created":{"date-parts":[[2016,11,30]],"date-time":"2016-11-30T05:53:33Z","timestamp":1480485213000},"page":"332","source":"Crossref","is-referenced-by-count":28,"title":["Hacking diabetes: DIY artificial pancreas systems"],"prefix":"10.1016","volume":"5","author":[{"given":"Conor","family":"Farrington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T08:59:45Z","timestamp":1536224385000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303977"}},"issued":{"date-parts":[[2017,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2213858716303977"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30397-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,5]]}},{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:47:41Z","timestamp":1766162861153,"version":"3.48.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/s2213-8587(24)00034-2","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T19:25:02Z","timestamp":1706556302000},"page":"160-161","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["TB Joshua and his megachurch: fake medical miracles and abuse in Nigeria"],"prefix":"10.1016","volume":"12","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:42:52Z","timestamp":1766162572000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000342"}},"issued":{"date-parts":[[2024,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2213858724000342"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00034-2","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TB Joshua and his megachurch: fake medical miracles and abuse in Nigeria","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00034-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T10:47:52Z","timestamp":1760784472651},"reference-count":9,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/s2213-8587(18)30178-5","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T18:47:56Z","timestamp":1528224476000},"page":"680-681","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["The earlier the better: preconception vitamin D and protection against pregnancy loss"],"prefix":"10.1016","volume":"6","author":[{"given":"Martin","family":"Hewison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30178-5_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/nyas.12129","article-title":"Vitamin D: beyond bone","volume":"1287","author":"Christakos","year":"2013","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/S2213-8587(18)30178-5_bib2","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1017\/S0007114510002436","article-title":"Avoidance of vitamin D deficiency in pregnancy in the United Kingdom: the case for a unified approach in National policy","volume":"104","author":"Hypponen","year":"2010","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(18)30178-5_bib3","doi-asserted-by":"crossref","first-page":"3517","DOI":"10.1210\/jc.2007-0718","article-title":"Maternal vitamin D deficiency increases the risk of preeclampsia","volume":"92","author":"Bodnar","year":"2007","journal-title":"J Clin Endrocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30178-5_bib4","doi-asserted-by":"crossref","first-page":"889","DOI":"10.3109\/14767058.2013.765849","article-title":"Maternal vitamin D status and adverse pregnancy outcomes: a systematic review and meta-analysis","volume":"26","author":"Wei","year":"2013","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/S2213-8587(18)30178-5_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30153-0","article-title":"Association of preconception serum 25-hydroxyvitamin D concentrations with livebirth and pregnancy loss: a prospective cohort study","author":"Mumford","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30178-5_bib6","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(14)60157-4","article-title":"Preconception low-dose aspirin and pregnancy outcomes: results from the EAGeR randomised trial","volume":"384","author":"Schisterman","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30178-5_bib7","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1210\/jc.2011-0385","article-title":"Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline","volume":"96","author":"Holick","year":"2011","journal-title":"J Clin Endrocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30178-5_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endrocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30178-5_bib9","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.abb.2011.11.018","article-title":"Vitamin D, the placenta and pregnancy","volume":"523","author":"Liu","year":"2012","journal-title":"Arch Biochem Biophys"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301785?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301785?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T23:20:26Z","timestamp":1534893626000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301785"}},"issued":{"date-parts":[[2018,9]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2213858718301785"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30178-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The earlier the better: preconception vitamin D and protection against pregnancy loss","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30178-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30153-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T11:51:15Z","timestamp":1773834675186,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/s2213-8587(25)00425-5","type":"journal-article","created":{"date-parts":[[2026,3,2]],"date-time":"2026-03-02T23:53:05Z","timestamp":1772495585000},"page":"280-281","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["USP8 genotype and tumour size as predictors for recurrence in Cushing's disease"],"prefix":"10.1016","volume":"14","author":[{"given":"Maya Beth","family":"Lodish","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00425-5_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00396-1","article-title":"Risk of recurrence after successful surgery for Cushing's disease is associated with USP8 genotype and tumour size: an international, retrospective, longitudinal cohort study","author":"Zhang","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00425-5_bib2","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s12020-025-04234-7","article-title":"The prevalence and predictors of Cushing disease recurrence: a 10-year experience of a pituitary tumor center of excellence","volume":"89","author":"Lamback","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(25)00425-5_bib3","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1227\/neu.0000000000003042","article-title":"Predictors of durable remission after successful surgery for Cushing disease: results from the multicenter RAPID Registry","volume":"95","author":"Findlay","year":"2024","journal-title":"Neurosurgery"},{"key":"10.1016\/S2213-8587(25)00425-5_bib4","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1093\/ejendo\/lvaf097","article-title":"Prevalence and clinical associations of USP8 variants in corticotroph tumours: a systematic review and aggregate data meta-analysis of 2171 cases","volume":"192","author":"Perez-Rivas","year":"2025","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00425-5_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/cen.13802","article-title":"The USP8 mutational status may predict long-term remission in patients with Cushing's disease","author":"Albani","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(25)00425-5_bib6","doi-asserted-by":"crossref","first-page":"e156","DOI":"10.1210\/clinem\/dgaf269","article-title":"The USP8 mutational status in combination with postsurgical cortisol levels for predicting recurrence of Cushing disease","volume":"111","author":"Zhou","year":"2025","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725004255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725004255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:47:41Z","timestamp":1773823661000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725004255"}},"issued":{"date-parts":[[2026,4]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2213858725004255"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00425-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"USP8 genotype and tumour size as predictors for recurrence in Cushing's disease","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00425-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00396-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:33:42Z","timestamp":1648812822467},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/s2213-8587(17)30009-8","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T23:15:51Z","timestamp":1485299751000},"page":"93","source":"Crossref","is-referenced-by-count":0,"title":["Prediabetes definitions and clinical outcomes"],"prefix":"10.1016","volume":"5","author":[{"given":"Yuli","family":"Huang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meijun","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30009-8_bib1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S2213-8587(16)30321-7","article-title":"Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study","volume":"5","author":"Warren","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30009-8_bib2","doi-asserted-by":"publisher","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30009-8_bib3","doi-asserted-by":"publisher","first-page":"293","DOI":"10.1016\/j.jacc.2006.03.043","volume":"48","author":"Kim","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30009-8_bib4","doi-asserted-by":"publisher","first-page":"1159","DOI":"10.1093\/eurheartj\/ehp589","article-title":"Impaired fasting plasma glucose and long-term cardiovascular risk: still a foggy relationship","volume":"31","author":"De Caterina","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(17)30009-8_bib5","doi-asserted-by":"publisher","first-page":"i5953","DOI":"10.1136\/bmj.i5953","article-title":"Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis","volume":"355","author":"Huang","year":"2016","journal-title":"BMJ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T18:20:32Z","timestamp":1536085232000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300098"}},"issued":{"date-parts":[[2017,2]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S2213858717300098"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30009-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,2]]}},{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:53:34Z","timestamp":1781585614038,"version":"3.54.5"},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/s2213-8587(16)30244-3","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T20:00:34Z","timestamp":1474401634000},"page":"817","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Research digest: weight loss to prevent and treat diabetes"],"prefix":"10.1016","volume":"4","author":[{"given":"Naveed","family":"Sattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Logue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Preiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:11:56Z","timestamp":1781583116000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302443"}},"issued":{"date-parts":[[2016,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2213858716302443"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30244-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research digest: weight loss to prevent and treat diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30244-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T13:33:56Z","timestamp":1775136836834,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/s2213-8587(24)00057-3","type":"journal-article","created":{"date-parts":[[2024,2,16]],"date-time":"2024-02-16T23:30:02Z","timestamp":1708126202000},"page":"225-227","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Denosumab in the treatment of osteoporosis associated with chronic kidney disease"],"prefix":"10.1016","volume":"12","author":[{"given":"Adrian","family":"Covic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mugurel","family":"Apetrii","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00057-3_bib1","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1093\/ndt\/gfaa192","article-title":"European Consensus Statement on the diagnosis and management of osteoporosis in chronic kidney disease stages G4\u2013G5D","volume":"36","author":"Evenepoel","year":"2021","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(24)00057-3_bib2","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S2213-8587(17)30310-8","article-title":"Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population","volume":"6","author":"Covic","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00057-3_bib3","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.2215\/CJN.0000000000000213","article-title":"Long-term effect of denosumab on bone disease in patients with CKD","volume":"18","author":"Iseri","year":"2023","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(24)00057-3_bib4","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1002\/jbmr.4804","article-title":"Hypocalcemia risk of denosumab across the spectrum of kidney disease: a population-based cohort study","volume":"38","author":"Cowan","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00057-3_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2023.28239","article-title":"Severe hypocalcemia with denosumab among older female dialysis-dependent patients","author":"Bird","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00057-3_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-12029-3","article-title":"Effects of bone turnover status on the efficacy and safety of denosumab among haemodialysis patients","volume":"12","author":"Hori","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(24)00057-3_bib8","doi-asserted-by":"crossref","first-page":"48868","DOI":"10.1074\/jbc.M208494200","article-title":"Parathyroid hormone stimulates receptor activator of NFkappa B ligand and inhibits osteoprotegerin expression via protein kinase A activation of cAMP-response element-binding protein","volume":"277","author":"Fu","year":"2002","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(24)00057-3_bib9","article-title":"Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS","author":"Tsourdi","year":"2020","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000573?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000573?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:46:04Z","timestamp":1715039164000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000573"}},"issued":{"date-parts":[[2024,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2213858724000573"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00057-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Denosumab in the treatment of osteoporosis associated with chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00057-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,15]],"date-time":"2026-06-15T22:39:51Z","timestamp":1781563191532,"version":"3.54.5"},"reference-count":5,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/s2213-8587(16)30098-5","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T07:55:13Z","timestamp":1476604513000},"page":"966-967","source":"Crossref","is-referenced-by-count":42,"title":["Obesity and the health of future generations"],"prefix":"10.1016","volume":"4","author":[{"given":"Mark","family":"Hanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Gluckman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavia","family":"Bustreo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30098-5_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)30217-0","article-title":"Preconceptional and maternal obesity: epidemiology and health consequences","author":"Poston","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30098-5_bib3","article-title":"Influence of maternal obesity on the long-term health of offspring","author":"Godfrey","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30098-5_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)30278-9","article-title":"Clinical management of pregnancy in the obese mother: before conception, during pregnancy, and post partum","author":"Ma","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30098-5_bib6","series-title":"The global strategy for women's, children's and adolescents' health (2016\u20132030)","year":"2015"},{"key":"10.1016\/S2213-8587(16)30098-5_bib7","article-title":"Interventions to prevent maternal obesity before conception, during pregnancy, and post partum","author":"Hanson","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T15:58:32Z","timestamp":1536335912000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716300985"}},"issued":{"date-parts":[[2016,12]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2213858716300985"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30098-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,12]]}},{"indexed":{"date-parts":[[2026,6,29]],"date-time":"2026-06-29T11:31:38Z","timestamp":1782732698640,"version":"3.54.5"},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/s2213-8587(24)00282-1","type":"journal-article","created":{"date-parts":[[2024,10,23]],"date-time":"2024-10-23T22:33:25Z","timestamp":1729722805000},"page":"869-870","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Young adult-onset type 2 diabetes heralds a poor prognosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Soon H","family":"Song","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian M","family":"Frier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00282-1_bib2","series-title":"Reverse the trend report: reducing type 2 diabetes in young people","year":"2024"},{"key":"10.1016\/S2213-8587(24)00282-1_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00242-0","article-title":"Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92)","author":"Lin","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00282-1_bib4","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003316","article-title":"Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: a population-based observational study","volume":"17","author":"Ke","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(24)00282-1_bib5","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.1007\/s00125-022-05764-9","article-title":"Temporal trends in the prevalence and incidenc0e of depression and the interplay of comorbidities in patients with young- and usual-onset type 2 diabetes from the USA and the UK","volume":"65","author":"Dibato","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00282-1_bib6","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15349","article-title":"Evaluating the incidence of complications among people with diabetes according to age of onset: findings from the UK Biobank","volume":"41","author":"Sajjadi","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00282-1_bib7","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s12916-022-02234-2","article-title":"Lifetime risk of cardiovascular-renal disease in type 2 diabetes: a population-based study in 473,399 individuals","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(24)00282-1_bib8","doi-asserted-by":"crossref","first-page":"o775","DOI":"10.1136\/bmj.o775","article-title":"Type 2 diabetes: summary of updated NICE guidance","volume":"377","author":"Moran","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00282-1_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.7705","article-title":"Potential gains in life expectancy associated with achieving treatment goals in US adults with type 2 diabetes","volume":"5","author":"Kianmehr","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(24)00282-1_bib10","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-8587(21)00207-2","article-title":"Identifying adults at high-risk for change in weight and BMI in England: a longitudinal, large-scale, population-based cohort study using electronic health records","volume":"9","author":"Katsoulis","year":"2021","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T04:07:55Z","timestamp":1732680475000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002821"}},"issued":{"date-parts":[[2024,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2213858724002821"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00282-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Young adult-onset type 2 diabetes heralds a poor prognosis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00282-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00242-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:00:45Z","timestamp":1771473645321,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/s2213-8587(24)00240-7","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:43:10Z","timestamp":1724398990000},"page":"782-784","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Closed-loop systems: a bridge to cell therapy for type 1 diabetes?"],"prefix":"10.1016","volume":"12","author":[{"given":"Sufyan","family":"Hussain","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katarina","family":"Braune","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shareen","family":"Forbes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter A","family":"Senior","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00240-7_bib1","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s13300-023-01394-5","article-title":"A systematic review of commercial hybrid closed-loop automated insulin delivery systems","volume":"14","author":"Peacock","year":"2023","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(24)00240-7_bib2","doi-asserted-by":"crossref","first-page":"q102","DOI":"10.1136\/bmj.q102","article-title":"Artificial pancreases for type 1 diabetes: better access is \u201cwatershed moment\u201d\u2014but delivery is key","volume":"384","author":"Iacobucci","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00240-7_bib3","doi-asserted-by":"crossref","first-page":"941","DOI":"10.2337\/dc23-1765","article-title":"Severe hypoglycemia and impaired awareness of hypoglycemia persist in people with type 1 diabetes despite use of diabetes technology: results from a cross-sectional survey","volume":"47","author":"Sherr","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00240-7_bib5","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1097\/SLA.0000000000005783","article-title":"Pancreas and islet transplantation: comparative outcome analysis of a single-centre cohort over 20-years","volume":"277","author":"Marfil-Garza","year":"2023","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(24)00240-7_bib6","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.2337\/dc17-1779","article-title":"Improved health-related quality of life in a phase 3 islet transplantation trial in type 1 diabetes complicated by severe hypoglycemia","volume":"41","author":"Foster","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00240-7_bib7","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/01.tp.0000280550.01028.89","article-title":"Quality of life after islet transplant: impact of the number of islet infusions and metabolic outcome","volume":"84","author":"Toso","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/S2213-8587(24)00240-7_bib8","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1007\/s11892-020-01339-3","article-title":"Assessment of risks and benefits of beta cell replacement versus automated insulin delivery systems for type 1 diabetes","volume":"20","author":"Senior","year":"2020","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(24)00240-7_bib9","doi-asserted-by":"crossref","DOI":"10.3390\/cells12202423","article-title":"The current status of allogenic islet cell transplantation","volume":"12","author":"Czarnecka","year":"2023","journal-title":"Cells"},{"key":"10.1016\/S2213-8587(24)00240-7_bib10","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1111\/ajt.13807","article-title":"Validation of the BETA-2 score: an improved tool to estimate beta cell function after clinical islet transplantation using a single fasting blood sample","volume":"16","author":"Forbes","year":"2016","journal-title":"Am J Transplant"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T22:59:19Z","timestamp":1729637959000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002407"}},"issued":{"date-parts":[[2024,11]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2213858724002407"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00240-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Closed-loop systems: a bridge to cell therapy for type 1 diabetes?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00240-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T07:22:24Z","timestamp":1774509744862,"version":"3.50.1"},"update-to":[{"DOI":"10.1016\/s2213-8587(24)00283-3","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/s2213-8587(24)00368-1","type":"journal-article","created":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T00:12:30Z","timestamp":1732666350000},"page":"e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Correction to Lancet Diabetes Endocrinol 2024; published online Nov 12. https:\/\/doi.org\/10.1016\/S2213-8587(24)00283-3"],"prefix":"10.1016","volume":"13","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:51:36Z","timestamp":1739839896000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003681"}},"issued":{"date-parts":[[2025,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2213858724003681"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00368-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2024; published online Nov 12. https:\/\/doi.org\/10.1016\/S2213-8587(24)00283-3","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00368-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00283-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:59Z","timestamp":1761992039875,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/s2213-8587(21)00117-0","type":"journal-article","created":{"date-parts":[[2021,5,27]],"date-time":"2021-05-27T18:38:08Z","timestamp":1622140688000},"page":"411-412","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Cognitive decline in longstanding type 1 diabetes: a role for severe hypoglycaemia"],"prefix":"10.1016","volume":"9","author":[{"given":"Brian M","family":"Frier","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00117-0_bib1","doi-asserted-by":"crossref","first-page":"99","DOI":"10.2337\/diacare.22.1.99","article-title":"Epidemiology of Diabetes Interventions and Complications (EDIC). Design, implementation, and preliminary results of a long-term follow-up of the Diabetes Control and Complications Trial cohort","volume":"22","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00117-0_bib2","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa066397","article-title":"Long-term effect of diabetes and its treatment on cognitive function","volume":"356","author":"Jacobson","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00117-0_bib3","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1007\/s00125-010-1883-9","article-title":"Biomedical risk factors for decreased cognitive functioning in type 1 diabetes: an 18 year follow-up of the Diabetes Control and Complications Trial (DCCT) cohort","volume":"54","author":"Jacobson","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00117-0_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00086-3","article-title":"Cognitive performance declines in older adults with type 1 diabetes: results from 32 years of follow-up in the DCCT\/EDIC Study","author":"Jacobson","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00117-0_bib5","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrendo.2014.170","article-title":"Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications","volume":"10","author":"Frier","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00117-0_bib6","doi-asserted-by":"crossref","first-page":"305","DOI":"10.2337\/diacare.23.3.305","article-title":"Recovery of cognitive function and mood after severe hypoglycemia in adults with insulin-treated diabetes","volume":"23","author":"Strachan","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00117-0_bib7","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1136\/bmj.313.7060.767","article-title":"Severe hypoglycaemia and cognitive impairment in diabetes","volume":"313","author":"Deary","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00117-0_bib8","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1007\/s00125-017-4233-3","article-title":"Cognitive deficits associated with impaired awareness of hypoglycaemia in type 1 diabetes","volume":"60","author":"Hansen","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00117-0_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S1474-4422(08)70021-8","article-title":"Cognition and diabetes: a lifespan perspective","volume":"7","author":"Biessels","year":"2008","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(21)00117-0_bib10","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.2337\/dc10-0621","article-title":"Cognitive function in type 1 diabetic adults with early exposure to severe hypoglycemia: a 16-year follow-up study","volume":"33","author":"\u00c5svold","year":"2010","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:37Z","timestamp":1761991777000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001170"}},"issued":{"date-parts":[[2021,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2213858721001170"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00117-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cognitive decline in longstanding type 1 diabetes: a role for severe hypoglycaemia","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00117-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00086-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T12:51:02Z","timestamp":1792587062049,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T00:00:00Z","timestamp":1375142400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/s2213-8587(13)70051-2","type":"journal-article","created":{"date-parts":[[2013,7,30]],"date-time":"2013-07-30T01:16:14Z","timestamp":1375146974000},"page":"97-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":131,"title":["Dynamics of childhood growth and obesity: development and validation of a quantitative mathematical model"],"prefix":"10.1016","volume":"1","author":[{"given":"Kevin D","family":"Hall","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy F","family":"Butte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boyd A","family":"Swinburn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carson C","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70051-2_bib1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","article-title":"The global obesity pandemic: shaped by global drivers and local environments","volume":"378","author":"Swinburn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70051-2_bib2","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1161\/CIRCULATIONAHA.111.047738","article-title":"Childhood obesity","volume":"126","author":"Lakshman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70051-2_bib3","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(11)60814-3","article-title":"Health and economic burden of the projected obesity trends in the USA and the UK","volume":"378","author":"Wang","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70051-2_bib4","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(11)60815-5","article-title":"Changing the future of obesity: science, policy, and action","volume":"378","author":"Gortmaker","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70051-2_bib5","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1210\/er.2006-0032","article-title":"Understanding and addressing the epidemic of obesity: an energy balance perspective","volume":"27","author":"Hill","year":"2006","journal-title":"Endocrine Rev"},{"key":"10.1016\/S2213-8587(13)70051-2_bib6","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/S0140-6736(11)60812-X","article-title":"Quantification of the effect of energy imbalance on bodyweight","volume":"378","author":"Hall","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70051-2_bib7","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ehb.2011.08.007","article-title":"Measuring weight outcomes for obesity intervention strategies: the case of a sugar-sweetened beverage tax","volume":"9","author":"Lin","year":"2011","journal-title":"Econ Hum Biol"},{"key":"10.1016\/S2213-8587(13)70051-2_bib8","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1146\/annurev-nutr-071811-150705","article-title":"Modeling metabolic adaptations and energy regulation in humans","volume":"32","author":"Hall","year":"2012","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/S2213-8587(13)70051-2_bib9","doi-asserted-by":"crossref","first-page":"3056","DOI":"10.1038\/oby.2007.364","article-title":"Energy imbalance underlying the development of childhood obesity","volume":"15","author":"Butte","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(13)70051-2_bib10","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1126\/science.1085985","article-title":"Comment on \u201cObesity and the environment: where do we go from here?\u201d","volume":"301","author":"Butte","year":"2003","journal-title":"Science"},{"key":"10.1016\/S2213-8587(13)70051-2_bib11","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1038\/oby.2008.5","article-title":"Energy gain and energy gap in normal-weight children: longitudinal data of the KOPS","volume":"16","author":"Plachta-Danielzik","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(13)70051-2_bib12","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1093\/ajcn\/83.4.859","article-title":"Estimating the effects of energy imbalance on changes in body weight in children","volume":"83","author":"Swinburn","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70051-2_bib13","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1471-2458-11-326","article-title":"Quantification of the energy gap in young overweight children. The PIAMA birth cohort study","volume":"11","author":"Van den Berg","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(13)70051-2_bib14","doi-asserted-by":"crossref","first-page":"e1721","DOI":"10.1542\/peds.2006-0682","article-title":"Estimating the energy gap among US children: a counterfactual approach","volume":"118","author":"Wang","year":"2006","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(13)70051-2_bib15","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.amepre.2012.01.018","article-title":"Reaching the healthy people goals for reducing childhood obesity: closing the energy gap","volume":"42","author":"Wang","year":"2012","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(13)70051-2_bib16","doi-asserted-by":"crossref","first-page":"e7940","DOI":"10.1371\/journal.pone.0007940","article-title":"The progressive increase of food waste in America and its environmental impact","volume":"4","author":"Hall","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70051-2_bib17","doi-asserted-by":"crossref","first-page":"e1000045","DOI":"10.1371\/journal.pcbi.1000045","article-title":"The dynamics of human body weight change","volume":"4","author":"Chow","year":"2008","journal-title":"PLoS Comp Biol"},{"key":"10.1016\/S2213-8587(13)70051-2_bib18","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3945\/ajcn.2008.26333","article-title":"Modeling weight-loss maintenance to help prevent body weight regain","volume":"88","author":"Hall","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70051-2_bib19","series-title":"Energy metabolism: tissue determinants and cellular corollaries","first-page":"61","article-title":"Organ and tissue contribution to metabolic rate","author":"Elia","year":"1992"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(13)70051-2_bib20","first-page":"169","article-title":"Metabolic rate and organ size during growth from infancy to maturity and during late gestation and early infancy","volume":"47","author":"Holliday","year":"1971","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(13)70051-2_bib21","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1002\/ajhb.22246","article-title":"High ratio of resting energy expenditure to body mass in childhood and adolescence: a mechanistic model","volume":"24","author":"Wang","year":"2012","journal-title":"Am J Hum Biol"},{"key":"10.1016\/S2213-8587(13)70051-2_bib22","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1249\/MSS.0b013e31823fb254","article-title":"Disparities in youth physical activity in the United States: 2003\u20132006","volume":"44","author":"Gortmaker","year":"2012","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(13)70051-2_bib23","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1097\/00005768-200009000-00012","article-title":"Age-related decline in physical activity: a synthesis of human and animal studies","volume":"32","author":"Sallis","year":"2000","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(13)70051-2_bib24","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/00005768-200009000-00013","article-title":"Changes in physical activity patterns in the United States, by sex and cross-sectional age","volume":"32","author":"Caspersen","year":"2000","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(13)70051-2_bib25","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1249\/mss.0b013e31815a51b3","article-title":"Physical activity in the United States measured by accelerometer","volume":"40","author":"Troiano","year":"2008","journal-title":"Med Sci Sports Exerc"},{"issue":"suppl","key":"10.1016\/S2213-8587(13)70051-2_bib26","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1093\/ajcn\/35.5.1169","article-title":"Body composition of reference children from birth to age 10 years","volume":"35","author":"Fomon","year":"1982","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70051-2_bib27","series-title":"Body composition measurements in infants and children","first-page":"76","article-title":"Body composition during adolescence","author":"Hashke","year":"1989"},{"key":"10.1016\/S2213-8587(13)70051-2_bib28","series-title":"Human body composition: growth, aging, nutrition, and activity","author":"Forbes","year":"1987"},{"key":"10.1016\/S2213-8587(13)70051-2_bib29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1749-6632.2000.tb06486.x","article-title":"The reference child and adolescent models of body composition. A contemporary comparison","volume":"904","author":"Ellis","year":"2000","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/S2213-8587(13)70051-2_bib30","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1093\/ajcn\/81.5.1102","article-title":"Longitudinal changes in energy expenditure in girls from late childhood through midadolescence","volume":"81","author":"Spadano","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70051-2_bib31","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1542\/peds.110.2.307","article-title":"Assessing risk factors for obesity between childhood and adolescence: II. Energy metabolism and physical activity","volume":"110","author":"Salbe","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(13)70051-2_bib32","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1038\/sj.ijo.0803402","article-title":"Body composition in normal weight, overweight and obese children: matched case-control analyses of total and regional tissue masses, and body composition trends in relation to relative weight","volume":"30","author":"Wells","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(13)70051-2_bib33","author":"McDowell"},{"key":"10.1016\/S2213-8587(13)70051-2_bib34","author":"Ogden"},{"key":"10.1016\/S2213-8587(13)70051-2_bib35","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1093\/ajcn\/48.1.91","article-title":"One-year follow-up of weight, total body potassium, and total body nitrogen in obese adolescents treated with the protein-sparing modified fast","volume":"48","author":"Stallings","year":"1988","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70051-2_bib36","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1038\/sj.ijo.0802845","article-title":"Longitudinal changes in activity patterns, physical capacities, energy expenditure, and body composition in severely obese adolescents during a multidisciplinary weight-reduction program","volume":"29","author":"Lazzer","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(13)70051-2_bib37","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1017\/S0007114510000206","article-title":"Mathematical modelling of energy expenditure during tissue deposition","volume":"104","author":"Hall","year":"2010","journal-title":"Br J Nutr"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(13)70093-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,19]],"date-time":"2019-07-19T19:44:56Z","timestamp":1563565496000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700512"}},"issued":{"date-parts":[[2013,10]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S2213858713700512"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70051-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dynamics of childhood growth and obesity: development and validation of a quantitative mathematical model","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70051-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70063-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T06:28:44Z","timestamp":1792132124056,"version":"4.4.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/s2213-8587(13)70067-6","type":"journal-article","created":{"date-parts":[[2013,9,11]],"date-time":"2013-09-11T03:32:37Z","timestamp":1378870357000},"page":"191-198","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":299,"title":["Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial"],"prefix":"10.1016","volume":"1","author":[{"given":"Ambady","family":"Ramachandran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chamukuttan","family":"Snehalatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagannathan","family":"Ram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundaram","family":"Selvam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arun","family":"Nanditha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananth Samith","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian F","family":"Godsland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nish","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azeem","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christofer","family":"Toumazou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K George","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desmond G","family":"Johnston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70067-6_bib1","series-title":"International Diabetes Federation (IDF) Diabetes Atlas","year":"2011"},{"key":"10.1016\/S2213-8587(13)70067-6_bib2","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70067-6_bib3","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70067-6_bib4","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70067-6_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70067-6_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.diabres.2004.06.010","article-title":"Prevention of type 2 diabetes by lifestyle intervention: a Japanese trial in IGT males","volume":"67","author":"Kosaka","year":"2005","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(13)70067-6_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","article-title":"Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis","volume":"334","author":"Gillies","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70067-6_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/tmj.2011.0119","article-title":"Diabetes management via mobile phones: a systematic review","volume":"18","author":"Holtz","year":"2012","journal-title":"Telemed J E Health"},{"key":"10.1016\/S2213-8587(13)70067-6_bib9","first-page":"711","article-title":"Reinforcement of adherence to prescription recommendations in Asian Indian diabetes patients using short message service (SMS)\u2014a pilot study","volume":"59","author":"Shetty","year":"2011","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(13)70067-6_bib10","doi-asserted-by":"crossref","first-page":"1934","DOI":"10.2337\/dc11-0366","article-title":"Cluster-randomized trial of a mobile phone personalized behavioral intervention for blood glucose control","volume":"34","author":"Quinn","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70067-6_bib11","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.amepre.2008.09.040","article-title":"Behavior change interventions delivered by mobile telephone short-message service","volume":"36","author":"Fjeldsoe","year":"2009","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(13)70067-6_bib12","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007457.pub2","article-title":"Mobile phone messaging for preventive health care","volume":"12","author":"Vodopivec-Jamsek","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(13)70067-6_bib13","first-page":"2012","article-title":"Mobile phone messaging for facilitating self-management of long-term illnesses","volume":"12","author":"de Jongh","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(13)70067-6_bib14","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1093\/epirev\/mxq004","article-title":"Text messaging as a tool for behavior change in disease prevention and management","volume":"32","author":"Cole-Lewis","year":"2010","journal-title":"Epidemiol Rev"},{"key":"10.1016\/S2213-8587(13)70067-6_bib16","doi-asserted-by":"crossref","first-page":"e1001362","DOI":"10.1371\/journal.pmed.1001362","article-title":"A systematic review of mobile technologies for health: health promotion and self management of diseases","volume":"10","author":"Free","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(13)70067-6_bib17","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1177\/193229681200600214","article-title":"Mobile phone-based video messages for diabetes self-care support","volume":"6","author":"Bell","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(13)70067-6_bib18","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1111\/j.1365-2702.2011.03951.x","article-title":"The impact of nurse short message services and telephone follow-ups on diabetic adherence: which one is more effective?","volume":"21","author":"Zolfaghari","year":"2012","journal-title":"J Clin Nurs"},{"key":"10.1016\/S2213-8587(13)70067-6_bib19","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0140-6736(10)61997-6","article-title":"Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial","volume":"376","author":"Lester","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70067-6_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(11)60701-0","article-title":"Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial","volume":"378","author":"Free","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70067-6_bib21","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1214\/aoap\/1177005878","article-title":"A new class of random numbers generator","volume":"1","author":"Marsaglia","year":"1991","journal-title":"Ann Applied Probability"},{"key":"10.1016\/S2213-8587(13)70067-6_bib22","doi-asserted-by":"crossref","first-page":"38","DOI":"10.4278\/0890-1171-12.1.38","article-title":"The transtheoretical model of health behavior change","volume":"12","author":"Prochaska","year":"1997","journal-title":"Am J Health Promot"},{"key":"10.1016\/S2213-8587(13)70067-6_bib23","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008066.pub2","article-title":"Transtheoretical model for dietary and physical exercise modification in weight loss management for overweight and obese adults","volume":"5","author":"Tuah","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(13)70067-6_bib24","series-title":"Definition, diagnosis and classification of diabetes mellitus and its complications.report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus","year":"1999"},{"key":"10.1016\/S2213-8587(13)70067-6_bib25","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70067-6_bib26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1111\/j.1464-5491.1995.tb00399.x","article-title":"The 30 minute insulin incremental response in an oral glucose tolerance test as a measure of insulin secretion","volume":"12","author":"Wareham","year":"1995","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70067-6_bib27","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0140-6736(91)91164-P","article-title":"Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in South Asians","volume":"337","author":"McKeigue","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70067-6_bib28","series-title":"Nutritive value of Indian foods","author":"Gopalan","year":"1989"},{"key":"10.1016\/S2213-8587(13)70067-6_bib29","doi-asserted-by":"crossref","first-page":"888","DOI":"10.2337\/diacare.28.4.888","article-title":"Impact of intensive lifestyle and metformin therapy on cardiovascular disease risk factors in the diabetes prevention program","volume":"28","author":"Ratner","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70067-6_bib30","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","article-title":"The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study","volume":"371","author":"Li","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70067-6_bib31","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70067-6_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1007\/s00125-012-2752-5","article-title":"Improved lifestyle and decreased diabetes risk over 13 years: long-term follow-up of the randomised Finnish Diabetes Prevention Study (DPS)","volume":"56","author":"Lindstr\u00f6m","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70067-6_bib33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11892-012-0254-y","article-title":"Translation of the Diabetes Prevention Program's lifestyle intervention: role of community health workers","volume":"12","author":"Ruggiero","year":"2012","journal-title":"Curr Diab Rep"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T05:28:16Z","timestamp":1539408496000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700676"}},"issued":{"date-parts":[[2013,11]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S2213858713700676"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70067-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70067-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70101-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:37:38Z","timestamp":1794281858727,"version":"4.9.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/s2213-8587(18)30240-7","type":"journal-article","created":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T23:56:28Z","timestamp":1537401388000},"page":"870-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":136,"title":["LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Frances","family":"Game","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Jeffcoate","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise","family":"Tarnow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith L","family":"Jacobsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane J","family":"Whitham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor F","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon J","family":"Ellender","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Fitzsimmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"L\u00f6ndahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ketan","family":"Dhatariya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harvey","family":"Chant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gill","family":"Spyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mollie","family":"Donohoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Uchegbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald","family":"Whitelaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Nayar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morton","family":"Michelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Marie","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Houlind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eskild","family":"Henneberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"J\u00f8rgensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kilimangalam","family":"Narayanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-France","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ammar","family":"Tarik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Hariman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor","family":"Oguntolu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Rayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haroon","family":"Siddique","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"D'Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deidre","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theingi","family":"Aung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Holmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergiu-Bogdan","family":"Catrina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arthur","family":"Ogunko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satyan","family":"Rajbhandari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30240-7_bib1","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","article-title":"The global burden of diabetic foot disease","volume":"366","author":"Boulton","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30240-7_bib2","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30240-7_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/dmrr.2707","article-title":"Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review","volume":"32","author":"Game","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(18)30240-7_bib4","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2213-8587(16)30012-2","article-title":"Reporting standards of studies and papers on the prevention and management of foot ulcers in diabetes: required details and markers of good quality","volume":"4","author":"Jeffcoate","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30240-7_bib5","first-page":"68","article-title":"A prospective, randomized, controlled trial of autologous platelet-rich plasma gel for the treatment of diabetic foot ulcers","volume":"52","author":"Driver","year":"2006","journal-title":"Ostomy Wound Manage"},{"key":"10.1016\/S2213-8587(18)30240-7_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1097\/00000658-198210000-00001","article-title":"Role of platelets and fibrin in the healing sequence: an in vivo study of angiogenesis and collagen synthesis","volume":"196","author":"Knighton","year":"1982","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(18)30240-7_bib7","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/08977190903468185","article-title":"Evidence on the use of platelet-rich plasma for diabetic ulcer: a systematic review","volume":"28","author":"Villela","year":"2010","journal-title":"Growth Factors"},{"key":"10.1016\/S2213-8587(18)30240-7_bib8","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.avsg.2016.04.023","article-title":"Platelet-rich plasma for the treatment of clean diabetic foot ulcers","volume":"38","author":"Ahmed","year":"2017","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/S2213-8587(18)30240-7_bib9","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1111\/wrr.12317","article-title":"The growing evidence for the use of platelet-rich plasma on diabetic chronic wounds: a review and a proposal for a new standard care","volume":"23","author":"Picard","year":"2015","journal-title":"Wound Repair Regen"},{"key":"10.1016\/S2213-8587(18)30240-7_bib10","first-page":"245","article-title":"Efficacy of autologous platelet-rich plasma for the treatment of muscle rupture with haematoma: a multicentre, randomised, double-blind, placebo-controlled clinical trial","volume":"14","author":"Martinez-Zapata","year":"2016","journal-title":"Blood Transfus"},{"key":"10.1016\/S2213-8587(18)30240-7_bib11","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1524-475X.2012.00870.x","article-title":"Characteristics of an autologous leukocyte and platelet-rich fibrin patch intended for the treatment of recalcitrant wounds","volume":"21","author":"Lundquist","year":"2013","journal-title":"Wound Repair Regen"},{"key":"10.1016\/S2213-8587(18)30240-7_bib12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1111\/cei.12773","article-title":"The phagocytic fitness of leucopatches may impact the healing of chronic wounds","volume":"184","author":"Thomsen","year":"2016","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S2213-8587(18)30240-7_bib13","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1177\/1534734611426755","article-title":"A pilot study to evaluate the safety and clinical performance of Leucopatch, an autologous, additive-free, platelet-rich fibrin for the treatment of recalcitrant chronic wounds","volume":"10","author":"Jorgensen","year":"2011","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/S2213-8587(18)30240-7_bib14","doi-asserted-by":"crossref","first-page":"172","DOI":"10.12968\/jowc.2015.24.4.172","article-title":"Use of an autologous leucocyte and platelet-rich fibrin patch on hard-to-heal DFUs: a pilot study","volume":"24","author":"Londahl","year":"2015","journal-title":"J Wound Care"},{"key":"10.1016\/S2213-8587(18)30240-7_bib15","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1186\/s13063-017-2216-9","article-title":"The LeucoPatch\u00ae system in the management of hard-to-heal diabetic foot ulcers: study protocol for a randomised controlled trial","volume":"18","author":"Game","year":"2017","journal-title":"Trials"},{"key":"10.1016\/S2213-8587(18)30240-7_bib16","first-page":"44","article-title":"A post-hoc analysis of reduction in diabetic foot ulcer size at 4 weeks as a predictor of healing at 21 weeks","volume":"55","author":"Snyder","year":"2010","journal-title":"Ostomy Wound Manage"},{"key":"10.1016\/S2213-8587(18)30240-7_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.jdiacomp.2008.02.001","article-title":"Fifty percent area reduction after 4 weeks of treatment is a reliable indicator for healing\u2014analysis of a single centre cohort of 704 diabetic patients","volume":"23","author":"Coerper","year":"2009","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(18)30240-7_bib18","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1093\/cid\/cis346","article-title":"2012 Infectious Diseases Society of America clinical practice guideline for the diagnosis and treatment of diabetic foot infections","volume":"54","author":"Lipsky","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(18)30240-7_bib19","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1111\/iwj.12496","article-title":"The 2015 IWGDF guidance on the prevention and management of foot problems in diabetes","volume":"13","author":"Bakker","year":"2016","journal-title":"Int Wound J"},{"key":"10.1016\/S2213-8587(18)30240-7_bib20","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1111\/iwj.12769","article-title":"Using image J to document healing in ulcers of the foot in diabetes","volume":"14","author":"Jeffcoate","year":"2017","journal-title":"Int Wound J"},{"key":"10.1016\/S2213-8587(18)30240-7_bib21","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S2213-8587(17)30438-2","article-title":"Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial","volume":"6","author":"Edmonds","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30240-7_bib22","doi-asserted-by":"crossref","DOI":"10.1111\/wrr.12630","article-title":"Multicenter, randomized controlled, observer-blinded study of a nitric oxide generating treatment in foot ulcers of patients with diabetes\u2014ProNOx1 study","author":"Edmonds","year":"2018","journal-title":"Wound Repair Regen"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302407?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302407?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T18:13:53Z","timestamp":1540404833000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302407"}},"issued":{"date-parts":[[2018,11]]},"references-count":22,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S2213858718302407"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30240-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LeucoPatch system for the management of hard-to-heal diabetic foot ulcers in the UK, Denmark, and Sweden: an observer-masked, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30240-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30262-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:27:40Z","timestamp":1794360460622,"version":"4.9.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30180-2","type":"journal-article","created":{"date-parts":[[2016,8,22]],"date-time":"2016-08-22T22:36:36Z","timestamp":1471905396000},"page":"933-942","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":196,"title":["Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?"],"prefix":"10.1016","volume":"4","author":[{"given":"Sophie","family":"Leboulleux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Michael","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furio","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schlumberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30180-2_bib1","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1002\/1097-0142(197412)34:6<2072::AID-CNCR2820340629>3.0.CO;2-#","article-title":"Occult thyroid carcinoma in Olmsted County, Minnesota: prevalence at autopsy compared with that in Hiroshima and Nagasaki, Japan","volume":"34","author":"Sampson","year":"1974","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30180-2_bib2","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1002\/1097-0142(197905)43:5<1702::AID-CNCR2820430521>3.0.CO;2-S","article-title":"Latent thyroid carcinoma at autopsy: a study from Oporto, Portugal","volume":"43","author":"Sobrinho-Simoes","year":"1979","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30180-2_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/1097-0142(19810115)47:2<319::AID-CNCR2820470218>3.0.CO;2-A","article-title":"Occult thyroid carcinoma at autopsy in Malmo, Sweden","volume":"47","author":"Bondeson","year":"1981","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30180-2_bib4","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1002\/1097-0142(19850801)56:3<531::AID-CNCR2820560321>3.0.CO;2-3","article-title":"Occult papillary carcinoma of the thyroid. A \u201cnormal\u201d finding in Finland. A systematic autopsy study","volume":"56","author":"Harach","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30180-2_bib5","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1093\/ajcp\/90.1.72","article-title":"Occult carcinomas of the thyroid. Evaluation of 1,020 sequential autopsies","volume":"90","author":"Lang","year":"1988","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib6","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1002\/1097-0142(19890715)64:2<547::AID-CNCR2820640232>3.0.CO;2-N","article-title":"Occult papillary thyroid carcinoma at autopsy in La Plata, Argentina","volume":"64","author":"Ottino","year":"1989","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30180-2_bib7","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1002\/1097-0142(19900301)65:5<1173::AID-CNCR2820650524>3.0.CO;2-2","article-title":"Occult papillary carcinoma of the thyroid. A study of 408 autopsy cases","volume":"65","author":"Yamamoto","year":"1990","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30180-2_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2559.1993.tb01214.x","article-title":"Occult thyroid carcinomas in the region of Minsk, Belarus. An autopsy study of 215 patients","volume":"23","author":"Furmanchuk","year":"1993","journal-title":"Histopathology"},{"key":"10.1016\/S2213-8587(16)30180-2_bib9","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1002\/1097-0142(19930615)71:12<4022::AID-CNCR2820711236>3.0.CO;2-O","article-title":"Occult carcinoma of the thyroid. A systematic autopsy study from Spain of two series performed with two different methods","volume":"71","author":"Martinez-Tello","year":"1993","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30180-2_bib10","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1089\/thy.2005.15.152","article-title":"Epidemiology of thyroid microcarcinoma found in autopsy series conducted in areas of different iodine intake","volume":"15","author":"Kovacs","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib11","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1385\/EP:12:1:23","article-title":"Latent carcinoma of the thyroid in Austria: a systematic autopsy study","volume":"12","author":"Neuhold","year":"2001","journal-title":"Endocr Pathol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib12","doi-asserted-by":"crossref","first-page":"676","DOI":"10.3346\/jkms.2014.29.5.676","article-title":"Papillary thyroid microcarcinomas are different from latent papillary thyroid carcinomas at autopsy","volume":"29","author":"Lee","year":"2014","journal-title":"J Korean Med Sci"},{"key":"10.1016\/S2213-8587(16)30180-2_bib13","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1089\/thy.2004.14.1056","article-title":"Increased incidence of thyroid carcinoma in France: a true epidemic or thyroid nodule management effects? Report from the French Thyroid Cancer Committee","volume":"14","author":"Leenhardt","year":"2004","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib14","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1016\/S0140-6736(12)62205-3","article-title":"Controversies in primary treatment of low-risk papillary thyroid cancer","volume":"381","author":"McLeod","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30180-2_bib15","doi-asserted-by":"crossref","first-page":"2369","DOI":"10.1158\/1055-9965.EPI-11-0596","article-title":"Thyroid cancer incidence among active duty US military personnel, 1990\u20132004","volume":"20","author":"Enewold","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(16)30180-2_bib16","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1089\/thy.2008.0210","article-title":"Time trends for thyroid cancer in northwestern Spain: true rise in the incidence of micro and larger forms of papillary thyroid carcinoma","volume":"19","author":"Rego-Iraeta","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib17","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973\u20132002","volume":"295","author":"Davies","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30180-2_bib18","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/thy.2010.0137","article-title":"The most commonly occurring papillary thyroid cancer in the United States is now a microcarcinoma in a patient older than 45 years","volume":"21","author":"Hughes","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib19","doi-asserted-by":"crossref","first-page":"e009843","DOI":"10.1136\/bmjopen-2015-009843","article-title":"Do US thyroid cancer incidence rates increase with socioeconomic status among people with health insurance? An observational study using SEER population-based data","volume":"5","author":"Altekruse","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(16)30180-2_bib20","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1089\/thy.2014.0594","article-title":"The impact of subclinical disease and mechanism of detection on the rise in thyroid cancer incidence: a population-based study in Olmsted County, Minnesota during 1935 through 2012","volume":"25","author":"Brito","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib21","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1089\/thy.2015.0116","article-title":"The impact of diagnostic changes on the rise in thyroid cancer incidence: a population-based study in selected high-resource countries","volume":"25","author":"Vaccarella","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib22","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1056\/NEJMp1409841","article-title":"Korea's thyroid-cancer \u201cepidemic\u201d\u2014screening and overdiagnosis","volume":"371","author":"Ahn","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30180-2_bib23","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMc1507622","article-title":"South Korea's thyroid-cancer \u201cepidemic\u201d\u2014turning the tide","volume":"373","author":"Ahn","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30180-2_bib24","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1097\/EDE.0000000000000385","article-title":"Thyroid cancer detection by ultrasound among residents ages 18 years and younger in Fukushima, Japan: 2011 to 2014","volume":"27","author":"Tsuda","year":"2016","journal-title":"Epidemiology"},{"key":"10.1016\/S2213-8587(16)30180-2_bib25","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1089\/thy.2013.0045","article-title":"The increasing incidence of thyroid cancer: the influence of access to care","volume":"23","author":"Morris","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib26","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1530\/EJE-08-0624","article-title":"Thyroid cancer: is the incidence rise abating?","volume":"160","author":"Sassolas","year":"2009","journal-title":"Eur J Endocrinol"},{"issue":"1 suppl 2","key":"10.1016\/S2213-8587(16)30180-2_bib27","first-page":"1","article-title":"Italian cancer figures\u2014report 2015: the burden of rare cancers in Italy","volume":"40","author":"Busco","year":"2016","journal-title":"Epidemiol Prev"},{"key":"10.1016\/S2213-8587(16)30180-2_bib28","doi-asserted-by":"crossref","first-page":"e234","DOI":"10.1016\/S1470-2045(13)70598-9","article-title":"Addressing overdiagnosis and overtreatment in cancer: a prescription for change","volume":"15","author":"Esserman","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib29","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1148\/radiol.2473072233","article-title":"Thyroid nodules: is it time to turn off the US machines?","volume":"247","author":"Cronan","year":"2008","journal-title":"Radiology"},{"key":"10.1016\/S2213-8587(16)30180-2_bib30","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.7863\/jum.2007.26.10.1367","article-title":"The thyroid incidentaloma\u2014ignore or investigate?","volume":"26","author":"Howlett","year":"2007","journal-title":"J Ultrasound Med"},{"key":"10.1016\/S2213-8587(16)30180-2_bib31","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1002\/(SICI)1097-0142(19980801)83:3<553::AID-CNCR25>3.0.CO;2-U","article-title":"Microcarcinoma of the thyroid gland: the Gustave-Roussy Institute experience","volume":"83","author":"Baudin","year":"1998","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30180-2_bib32","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1002\/(SICI)1097-0142(19990901)86:5<842::AID-CNCR21>3.0.CO;2-X","article-title":"Extracapsular invasion of lymph node metastasis. A good indicator of disease recurrence and poor prognosis in patients with thyroid microcarcinoma","volume":"86","author":"Yamashita","year":"1999","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30180-2_bib33","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/01.SLA.0000055273.58908.19","article-title":"Lymph node metastasis from 259 papillary thyroid microcarcinomas: frequency, pattern of occurrence and recurrence, and optimal strategy for neck dissection","volume":"237","author":"Wada","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(16)30180-2_bib34","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1016\/j.ejso.2006.07.001","article-title":"Papillary thyroid microcarcinoma (PTMC): prognostic factors, management and outcome in 403 patients","volume":"32","author":"Pelizzo","year":"2006","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib35","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1007\/s00268-007-9131-2","article-title":"Prognosis of patients with benign thyroid diseases accompanied by incidental papillary carcinoma undetectable on preoperative imaging tests","volume":"31","author":"Ito","year":"2007","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(16)30180-2_bib36","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.surg.2008.08.035","article-title":"Papillary thyroid microcarcinoma: a study of 900 cases observed in a 60-year period","volume":"144","author":"Hay","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(16)30180-2_bib37","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1007\/s00268-007-9453-0","article-title":"Papillary microcarcinoma","volume":"32","author":"Noguchi","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(16)30180-2_bib38","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1245\/s10434-009-0332-9","article-title":"Extent of thyroidectomy and lymphadenectomy in 254 patients with papillary thyroid microcarcinoma: a single-institution experience","volume":"16","author":"Besic","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib39","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1245\/s10434-011-1556-z","article-title":"Minimal extrathyroidal extension in patients with papillary thyroid microcarcinoma: is it a real prognostic factor?","volume":"18","author":"Moon","year":"2011","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib40","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/EJE-12-0105","article-title":"Scoring system for predicting recurrences in patients with papillary thyroid microcarcinoma","volume":"167","author":"Buffet","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib41","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1210\/jc.2011-1546","article-title":"Risk factors for neck nodal metastasis in papillary thyroid microcarcinoma: a study of 1066 patients","volume":"97","author":"Zhang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30180-2_bib42","doi-asserted-by":"crossref","first-page":"2834","DOI":"10.1210\/jc.2013-2118","article-title":"Differences in the recurrence and mortality outcomes rates of incidental and nonincidental papillary thyroid microcarcinoma: a systematic review and meta-analysis of 21 329 person-years of follow-up","volume":"99","author":"Mehanna","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30180-2_bib43","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00268-015-3392-y","article-title":"Clinical trials of active surveillance of papillary microcarcinoma of the thyroid","volume":"40","author":"Miyauchi","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(16)30180-2_bib44","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/cncr.11442","article-title":"Papillary microcarcinoma of the thyroid-\u2014prognostic significance of lymph node metastasis and multifocality","volume":"98","author":"Chow","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30180-2_bib45","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1749-4486.2010.02085.x","article-title":"Treatment and prognostic factors of papillary thyroid microcarcinoma","volume":"35","author":"Giordano","year":"2010","journal-title":"Clin Otolaryngol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib46","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1002\/cncr.26425","article-title":"A combined molecular-pathologic score improves risk stratification of thyroid papillary microcarcinoma","volume":"118","author":"Niemeier","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30180-2_bib47","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/s00268-005-7789-x","article-title":"Ultrasonographically and anatomopathologically detectable node metastases in the lateral compartment as indicators of worse relapse-free survival in patients with papillary thyroid carcinoma","volume":"29","author":"Ito","year":"2005","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(16)30180-2_bib48","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1245\/s10434-008-0044-6","article-title":"Central cervical nodal metastasis from papillary thyroid microcarcinoma: pattern and factors predictive of nodal metastasis","volume":"15","author":"Roh","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib49","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1245\/s10434-012-2654-2","article-title":"Multifocality and total tumor diameter predict central neck lymph node metastases in papillary thyroid microcarcinoma","volume":"20","author":"Zhao","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib50","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00268-012-1826-3","article-title":"Preoperative prediction of central lymph node metastasis in thyroid papillary microcarcinoma using clinicopathologic and sonographic features","volume":"37","author":"Kim","year":"2013","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(16)30180-2_bib51","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1097\/RLU.0b013e318279bc65","article-title":"Aggressive papillary thyroid microcarcinoma: prognostic factors and therapeutic strategy","volume":"38","author":"Ardito","year":"2013","journal-title":"Clin Nucl Med"},{"key":"10.1016\/S2213-8587(16)30180-2_bib52","doi-asserted-by":"crossref","first-page":"281","DOI":"10.4174\/jkss.2012.82.5.281","article-title":"Clinical features and prognostic factors in papillary thyroid microcarcinoma depends on age","volume":"82","author":"Cho","year":"2012","journal-title":"J Korean Surg Soc"},{"key":"10.1016\/S2213-8587(16)30180-2_bib53","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1530\/EJE-07-0896","article-title":"Thyroid papillary microcarcinoma: a descriptive and meta-analysis study","volume":"159","author":"Roti","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib54","doi-asserted-by":"crossref","first-page":"5723","DOI":"10.1210\/jc.2005-0285","article-title":"Prognostic factors for persistent or recurrent disease of papillary thyroid carcinoma with neck lymph node metastases and\/or tumor extension beyond the thyroid capsule at initial diagnosis","volume":"90","author":"Leboulleux","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30180-2_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib56","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1089\/thy.2012.0043","article-title":"The prognostic significance of nodal metastases from papillary thyroid carcinoma can be stratified based on the size and number of metastatic lymph nodes, as well as the presence of extranodal extension","volume":"22","author":"Randolph","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib57","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1089\/thy.2009.0110","article-title":"Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer","volume":"19","author":"Cooper","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib58","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1111\/j.1365-2559.2011.03791.x","article-title":"Desmoplastic stromal reaction in papillary thyroid microcarcinoma","volume":"58","author":"Koperek","year":"2011","journal-title":"Histopathology"},{"key":"10.1016\/S2213-8587(16)30180-2_bib59","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1111\/his.12025","article-title":"Histomorphological factors in the risk prediction of lymph node metastasis in papillary thyroid carcinoma","volume":"62","author":"Chung","year":"2013","journal-title":"Histopathology"},{"key":"10.1016\/S2213-8587(16)30180-2_bib60","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1002\/hed.21822","article-title":"Correlation of lymphatic vessel density and vascular endothelial growth factor with nodal metastasis in papillary thyroid microcarcinoma","volume":"34","author":"Chung","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/S2213-8587(16)30180-2_bib61","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s12149-012-0594-3","article-title":"Prediction of central lymph node metastasis from papillary thyroid microcarcinoma by 18F-fluorodeoxyglucose PET\/CT and ultrasonography","volume":"26","author":"Byun","year":"2012","journal-title":"Ann Nucl Med"},{"key":"10.1016\/S2213-8587(16)30180-2_bib62","doi-asserted-by":"crossref","first-page":"e2063","DOI":"10.1097\/MD.0000000000002063","article-title":"Relation between F-18 FDG uptake of PET\/CT and BRAFV600E mutation in papillary thyroid cancer","volume":"94","author":"Yoon","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S2213-8587(16)30180-2_bib63","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1097\/SLA.0b013e318230036d","article-title":"Should all papillary thyroid microcarcinomas be aggressively treated? An analysis of 18,445 cases","volume":"254","author":"Yu","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(16)30180-2_bib64","first-page":"1454","article-title":"High prevalence of BRAF mutations in thyroid cancer: genetic evidence for constitutive activation of the RET\/PTC-RAS-BRAF signaling pathway in papillary thyroid carcinoma","volume":"63","author":"Kimura","year":"2003","journal-title":"Cancer Res"},{"key":"10.1016\/S2213-8587(16)30180-2_bib65","doi-asserted-by":"crossref","first-page":"5399","DOI":"10.1210\/jc.2003-030838","article-title":"BRAF mutations in thyroid tumors are restricted to papillary carcinomas and anaplastic or poorly differentiated carcinomas arising from papillary carcinomas","volume":"88","author":"Nikiforova","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30180-2_bib66","doi-asserted-by":"crossref","first-page":"6373","DOI":"10.1210\/jc.2005-0987","article-title":"BRAF mutation predicts a poorer clinical prognosis for papillary thyroid cancer","volume":"90","author":"Xing","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30180-2_bib67","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/j.1365-2265.2006.02605.x","article-title":"The BRAF mutation is useful for prediction of clinical recurrence in low-risk patients with conventional papillary thyroid carcinoma","volume":"65","author":"Kim","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(16)30180-2_bib68","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1148\/radiol.2533090471","article-title":"Association of BRAFV600E mutation with poor clinical prognostic factors and US features in Korean patients with papillary thyroid microcarcinoma","volume":"253","author":"Kwak","year":"2009","journal-title":"Radiology"},{"key":"10.1016\/S2213-8587(16)30180-2_bib69","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1245\/s10434-008-0298-z","article-title":"BRAF mutation in papillary thyroid microcarcinoma: the promise of better risk management","volume":"16","author":"Xing","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib70","doi-asserted-by":"crossref","first-page":"3294","DOI":"10.1245\/s10434-010-1129-6","article-title":"The BRAF mutation is predictive of aggressive clinicopathological characteristics in papillary thyroid microcarcinoma","volume":"17","author":"Lin","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib71","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1002\/hed.21142","article-title":"Papillary microcarcinoma in comparison with larger papillary thyroid carcinoma in BRAFV600E mutation, clinicopathological features, and immunohistochemical findings","volume":"32","author":"Park","year":"2010","journal-title":"Head Neck"},{"key":"10.1016\/S2213-8587(16)30180-2_bib72","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.1245\/s10434-012-2851-z","article-title":"Papillary microcarcinoma of the thyroid: clinical characteristics and BRAFV600E mutational status of 977 cases","volume":"20","author":"Zheng","year":"2013","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib73","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1530\/EJE-15-0254","article-title":"BRAF V600E and decreased NIS and TPO expression are associated with aggressiveness of a subgroup of papillary thyroid microcarcinoma","volume":"173","author":"Bastos","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib74","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/ERC-14-0531","article-title":"BRAFV600E mutation in papillary thyroid microcarcinoma: a meta-analysis","volume":"22","author":"Li","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(16)30180-2_bib75","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1038\/modpathol.2015.92","article-title":"BRAF V600E and risk stratification of thyroid microcarcinoma: a multicenter pathological and clinical study","volume":"28","author":"Tallini","year":"2015","journal-title":"Mod Pathol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib76","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1245\/s10434-008-0233-3","article-title":"Analysis of differential BRAFV600E mutational status in high aggressive papillary thyroid microcarcinoma","volume":"16","author":"Lee","year":"2009","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib77","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1002\/cncy.21258","article-title":"BRAF (V600E) mutation analysis on liquid-based cytology-processed aspiration biopsies predicts bilaterality and lymph node involvement in papillary thyroid microcarcinoma","volume":"121","author":"Rossi","year":"2013","journal-title":"Cancer Cytopathol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib78","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1089\/thy.2015.0391","article-title":"BRAFV600E is correlated with recurrence of papillary thyroid microcarcinoma: a systematic review, multi-institutional primary data analysis, and meta-analysis","volume":"26","author":"Chen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib79","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1089\/thy.2015.0101","article-title":"TERT promoter mutations in papillary thyroid microcarcinomas","volume":"25","author":"de Biase","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib80","doi-asserted-by":"crossref","DOI":"10.18632\/oncotarget.7811","article-title":"BRAF and TERT promoter mutations in the aggressiveness of papillary thyroid carcinoma: a study of 653 patients","author":"Jin","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/S2213-8587(16)30180-2_bib81","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1089\/thy.2015.0278","article-title":"Multiple mutations detected preoperatively may predict aggressive behavior of papillary thyroid cancer and guide management\u2014a case report","volume":"25","author":"Shrestha","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib82","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1007\/s00268-009-0303-0","article-title":"An observational trial for papillary thyroid microcarcinoma in Japanese patients","volume":"34","author":"Ito","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(16)30180-2_bib83","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.jacr.2014.09.038","article-title":"Managing incidental thyroid nodules detected on imaging: white paper of the ACR Incidental Thyroid Findings Committee","volume":"12","author":"Hoang","year":"2015","journal-title":"J Am Coll Radiol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib84","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.surg.2013.04.068","article-title":"The impact of surgical volume on patient outcomes following thyroid surgery","volume":"154","author":"Kandil","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(16)30180-2_bib85","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1097\/00000658-199809000-00005","article-title":"The importance of surgeon experience for clinical and economic outcomes from thyroidectomy","volume":"228","author":"Sosa","year":"1998","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(16)30180-2_bib86","series-title":"Thyroid surgery: preventing and managing complications","first-page":"19","article-title":"Extent of thyroidectomy and incidence of morbidity: risk-appropriate treatment","author":"Hartl","year":"2013"},{"key":"10.1016\/S2213-8587(16)30180-2_bib87","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1210\/jc.2012-1063","article-title":"Risk of hypothyroidism following hemithyroidectomy: systematic review and meta-analysis of prognostic studies","volume":"97","author":"Verloop","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30180-2_bib88","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1210\/jc.2011-3399","article-title":"Combination treatment with T4 and T3: toward personalized replacement therapy in hypothyroidism?","volume":"97","author":"Biondi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30180-2_bib89","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1210\/jc.2015-4290","article-title":"Dynamic risk stratification in differentiated thyroid cancer patients treated without radioactive iodine","volume":"101","author":"Momesso","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30180-2_bib90","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1530\/eje.1.02158","article-title":"European consensus for the management of patients with differentiated thyroid carcinoma of the follicular epithelium","volume":"154","author":"Pacini","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib91","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1210\/jc.2012-1123","article-title":"Long-term surveillance of papillary thyroid cancer patients who do not undergo postoperative radioiodine remnant ablation: is there a role for serum thyroglobulin measurement?","volume":"97","author":"Durante","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30180-2_bib92","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1530\/EJE-13-0386","article-title":"Ultrasensitive serum thyroglobulin measurement is useful for the follow-up of patients treated with total thyroidectomy without radioactive iodine ablation","volume":"169","author":"Nascimento","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib93","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1200\/JCO.2015.65.7759","article-title":"Active surveillance for the management of localized prostate cancer (Cancer Care Ontario Guideline): American Society of Clinical Oncology Clinical Practice Guideline Endorsement","volume":"34","author":"Chen","year":"2016","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib94","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.urology.2010.10.039","article-title":"Factors that influence patient enrollment in active surveillance for low-risk prostate cancer","volume":"77","author":"Gorin","year":"2011","journal-title":"Urology"},{"key":"10.1016\/S2213-8587(16)30180-2_bib95","doi-asserted-by":"crossref","DOI":"10.1016\/j.juro.2016.02.2972","article-title":"Prospective quality of life in men choosing active surveillance compared to those biopsied but not diagnosed with prostate cancer","author":"Pham","year":"2016","journal-title":"J Urol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib96","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1089\/thy.2015.0178","article-title":"A clinical framework to facilitate risk stratification when considering an active surveillance alternative to immediate biopsy and surgery in papillary microcarcinoma","volume":"26","author":"Brito","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib97","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1007\/s00268-009-0359-x","article-title":"Three distinctly different kinds of papillary thyroid microcarcinoma should be recognized: our treatment strategies and outcomes","volume":"34","author":"Sugitani","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(16)30180-2_bib98","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/105072503321669875","article-title":"An observation trial without surgical treatment in patients with papillary microcarcinoma of the thyroid","volume":"13","author":"Ito","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib100","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib101","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1089\/thy.2013.0527","article-title":"Papillary thyroid microcarcinoma might progress during pregnancy","volume":"24","author":"Shindo","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib102","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1089\/thy.2015.0393","article-title":"Effects of pregnancy on papillary microcarcinomas of the thyroid re-evaluated in the entire patient series at Kuma Hospital","volume":"26","author":"Ito","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib103","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s00268-015-3349-1","article-title":"Natural history of asymptomatic papillary thyroid microcarcinoma: time-dependent changes in calcification and vascularity during active surveillance","volume":"40","author":"Fukuoka","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(16)30180-2_bib104","doi-asserted-by":"crossref","first-page":"117","DOI":"10.3348\/kjr.2012.13.2.117","article-title":"Radiofrequency ablation of benign thyroid nodules and recurrent thyroid cancers: consensus statement and recommendations","volume":"13","author":"Na","year":"2012","journal-title":"Korean J Radiol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib105","doi-asserted-by":"crossref","first-page":"699","DOI":"10.2214\/ajr.178.3.1780699","article-title":"Percutaneous ethanol injection for treatment of cervical lymph node metastases in patients with papillary thyroid carcinoma","volume":"178","author":"Lewis","year":"2002","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib106","doi-asserted-by":"crossref","first-page":"310","DOI":"10.4103\/0973-1482.73328","article-title":"Primary papillary thyroid carcinoma previously treated incompletely with radiofrequency ablation","volume":"6","author":"Kim","year":"2010","journal-title":"J Cancer Res Ther"},{"key":"10.1016\/S2213-8587(16)30180-2_bib107","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1007\/s11604-014-0350-9","article-title":"Needle track tumor seeding after radiofrequency ablation of a thyroid tumor","volume":"32","author":"Lee","year":"2014","journal-title":"Jpn J Radiol"},{"key":"10.1016\/S2213-8587(16)30180-2_bib108","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1089\/thy.2013.0279","article-title":"Ultrasound-guided percutaneous laser ablation of papillary thyroid microcarcinoma: a feasibility study on three cases with pathological and immunohistochemical evaluation","volume":"23","author":"Valcavi","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30180-2_bib99","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0039-6060(03)00384-2","article-title":"A novel classification system for patients with PTC: addition of the new variables of large (3 cm or greater) nodal metastases and reclassification during the follow-up period","volume":"135","author":"Sugitani","year":"2004","journal-title":"Surgery"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,18]],"date-time":"2024-06-18T20:40:38Z","timestamp":1718743238000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301802"}},"issued":{"date-parts":[[2016,11]]},"references-count":108,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2213858716301802"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30180-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Papillary thyroid microcarcinoma: time to shift from surgery to active surveillance?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30180-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T06:01:52Z","timestamp":1794290512201,"version":"4.9.0"},"reference-count":111,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T00:00:00Z","timestamp":1713916800000},"content-version":"am","delay-in-days":175,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["282510"],"award-info":[{"award-number":["282510"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R01 DK124395"],"award-info":[{"award-number":["R01 DK124395"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["30-DK116073"],"award-info":[{"award-number":["30-DK116073"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["R01 DK053456"],"award-info":[{"award-number":["R01 DK053456"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"NIDDK","doi-asserted-by":"publisher","award":["U54 DK118638"],"award-info":[{"award-number":["U54 DK118638"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["HL145076-01"],"award-info":[{"award-number":["HL145076-01"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK121843"],"award-info":[{"award-number":["R01 DK121843"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005847","name":"Health and Medical Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005847","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001692","name":"Croucher Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001692","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Union","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/s2213-8587(23)00159-6","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T18:27:10Z","timestamp":1696444030000},"page":"848-860","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes"],"prefix":"10.1016","volume":"11","author":[{"given":"Richard David","family":"Leslie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald Ching Wan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W","family":"Franks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristen J","family":"Nadeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan R","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Jose","family":"Redondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00159-6_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF diabetes atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00159-6_bib2","series-title":"IDF diabetes atlas","author":"Magliano","year":"2021"},{"key":"10.1016\/S2213-8587(23)00159-6_bib3","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s00125-021-05571-8","article-title":"Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults","volume":"64","author":"Green","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib4","article-title":"Prevalence of diagnosed type 1 and type 2 diabetes among US adults in 2016 and 2017: population based study","volume":"362","author":"Xu","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00159-6_bib5","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/j.pcd.2022.09.007","article-title":"Ethnic differences between Asians and non-Asians in clustering-based phenotype classification of adult-onset diabetes mellitus: a systematic narrative review","volume":"16","author":"Varghese","year":"2022","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/S2213-8587(23)00159-6_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/nyas.12098","article-title":"Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States","volume":"1281","author":"Ma","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(23)00159-6_bib7","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.2337\/dci20-0022","article-title":"Precision medicine in diabetes: a consensus report from the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"43","author":"Chung","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib8","series-title":"Classification of diabetes mellitus 2019","year":"2019"},{"key":"10.1016\/S2213-8587(23)00159-6_bib9","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1007\/s00125-022-05769-4","article-title":"Phenotypic and genetic classification of diabetes","volume":"65","author":"Deutsch","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib10","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.2337\/dbi21-0012","article-title":"Diabetes: concepts of \u03b2-cell organ dysfunction and failure would lead to earlier diagnoses and prevention","volume":"70","author":"Charles","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00159-6_bib11","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1007\/s00125-020-05211-7","article-title":"The clinical consequences of heterogeneity within and between different diabetes types","volume":"63","author":"Redondo","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib12","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.2337\/dc19-0102","article-title":"The influence of type 2 diabetes-associated factors on type 1 diabetes","volume":"42","author":"Redondo","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib13","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2337\/dc17-0961","article-title":"TCF7L2 Genetic variants contribute to phenotypic heterogeneity of type 1 diabetes","volume":"41","author":"Redondo","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib14","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1210\/clinem\/dgz296","article-title":"Single islet autoantibody at diagnosis of clinical type 1 diabetes is associated With older age and insulin resistance","volume":"105","author":"Redondo","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00159-6_bib15","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s00125-022-05818-y","article-title":"Milder loss of insulin-containing islets in individuals with type 1 diabetes and type 2 diabetes-associated TCF7L2 genetic variants","volume":"66","author":"Redondo","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib16","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2337\/dc19-1167","article-title":"Excess BMI accelerates islet autoimmunity in older children and adolescents","volume":"43","author":"Ferrara-Cook","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib17","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.2337\/dc18-0861","article-title":"Transcription factor 7-like 2 (TCF7L2) gene polymorphism and progression from single to multiple autoantibody positivity in individuals at risk for type 1 diabetes","volume":"41","author":"Redondo","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(23)00165-1","article-title":"Precision medicine for cardiometabolic disease: a framework for clinical translation","author":"Franks","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00159-6_bib19","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2337\/dc07-2417","article-title":"Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study","volume":"31","author":"Dabelea","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib20","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1001\/jama.2018.11628","article-title":"Association of gestational diabetes with maternal disorders of glucose metabolism and childhood adiposity","volume":"320","author":"Lowe","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00159-6_bib21","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/j.diabres.2018.07.039","article-title":"Offspring of mothers with hyperglycaemia in pregnancy: the short term and long-term impact. What is new?","volume":"145","author":"Armengaud","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00159-6_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of Type 2 diabetes","volume":"46","author":"Kahn","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib23","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s00125-009-1614-2","article-title":"Determinants of glucose tolerance in impaired glucose tolerance at baseline in the Actos Now for Prevention of Diabetes (ACT NOW) study","volume":"53","author":"DeFronzo","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib24","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(23)00159-6_bib25","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.cmet.2018.07.003","article-title":"Remission of human type 2 diabetes requires decrease in liver and pancreas fat content but is dependent upon capacity for \u03b2 cell recovery","volume":"28","author":"Taylor","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(23)00159-6_bib26","doi-asserted-by":"crossref","first-page":"4682","DOI":"10.1002\/sim.9532","article-title":"Capturing the pool dilution effect in group testing regression: A Bayesian approach","volume":"41","author":"Self","year":"2022","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib27","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.2337\/dc21-0770","article-title":"Adult-onset type 1 diabetes: current understanding and challenges","volume":"44","author":"Leslie","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib28","article-title":"Incidence of type 1 diabetes in China, 2010\u201313: population based study","volume":"360","author":"Weng","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00159-6_bib29","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","article-title":"Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank","volume":"6","author":"Thomas","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00159-6_bib30","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s001250051626","article-title":"Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States","volume":"44","author":"Redondo","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib31","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1007\/s00125-004-1608-z","article-title":"High frequency of abnormal glucose tolerance in DQA1*0102\/DQB1*0602 relatives identified as part of the Diabetes Prevention Trial--Type 1 Diabetes","volume":"48","author":"Greenbaum","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib32","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1210\/jc.2017-01490","article-title":"The role of age and excess body mass index in progression to type 1 diabetes in at-risk adults","volume":"102","author":"Ferrara","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00159-6_bib33","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2337\/dc16-2331","article-title":"Excess BMI in childhood: a modifiable risk factor for type 1 diabetes development?","volume":"40","author":"Ferrara","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib34","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s00125-011-2244-z","article-title":"The threshold hypothesis: solving the equation of nurture vs nature in type 1 diabetes","volume":"54","author":"Wasserfall","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib35","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dc19-0880","article-title":"Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes","volume":"43","author":"Battaglia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib36","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/db15-1615","article-title":"Differential insulitic profiles determine the extent of \u03b2-cell destruction and the age at onset of type 1 diabetes","volume":"65","author":"Leete","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00159-6_bib37","doi-asserted-by":"crossref","first-page":"390","DOI":"10.2337\/dc20-0567","article-title":"Clinical impact of residual C-peptide secretion in type 1 diabetes on glycemia and microvascular complications","volume":"44","author":"Jeyam","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib38","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1172\/JCI134057","article-title":"High residual C-peptide likely contributes to glycemic control in type 1 diabetes","volume":"130","author":"Rickels","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(23)00159-6_bib39","doi-asserted-by":"crossref","first-page":"418","DOI":"10.2337\/dc19-0986","article-title":"Genetic discrimination between LADA and childhood-onset type 1 diabetes within the MHC","volume":"43","author":"Mishra","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib40","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00125-018-4660-9","article-title":"Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk","volume":"61","author":"Tosur","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib41","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(22)00159-0","article-title":"Type 1 diabetes in diverse ancestries and the use of genetic risk scores","volume":"10","author":"Redondo","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00159-6_bib42","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2337\/dc20-2872","article-title":"Utility of diabetes type-specific genetic risk scores for the classification of diabetes type among multiethnic youth","volume":"45","author":"Oram","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib43","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1007\/s00125-020-05229-x","article-title":"Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia","volume":"63","author":"Balcha","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib44","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib45","doi-asserted-by":"crossref","first-page":"2644","DOI":"10.1210\/clinem\/dgac343","article-title":"Intralymphatic GAD-alum (Diamyd\u00ae) improves glycemic control in type 1 diabetes with HLA DR3-DQ2","volume":"107","author":"Nowak","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00159-6_bib46","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","article-title":"Verapamil and beta cell function in adults with recent-onset type 1 diabetes","volume":"24","author":"Ovalle","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib47","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1001\/jama.2023.2064","article-title":"Effect of verapamil on pancreatic beta cell function in newly diagnosed pediatric type 1 diabetes: a randomized clinical trial","volume":"329","author":"Forlenza","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00159-6_bib48","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1007\/s00125-021-05492-6","article-title":"Improving clinical utility of GAD65 autoantibodies by electrochemiluminescence assay and clinical phenotype when identifying autoimmune adult-onset diabetes","volume":"64","author":"Gu","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib49","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2337\/dc20-2834","article-title":"Latent autoimmune diabetes of adults (LADA) is likely to represent a mixed population of autoimmune (type 1) and nonautoimmune (type 2) diabetes","volume":"44","author":"Jones","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib50","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2337\/dc06-0749","article-title":"Accuracy and predictive value of classification schemes for ketosis-prone diabetes","volume":"29","author":"Balasubramanyam","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib51","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa205","article-title":"Decline pattern of beta-cell function in adult-onset latent autoimmune diabetes: an 8-year prospective study","volume":"105","author":"Li","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00159-6_bib52","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.2337\/dc22-0623","article-title":"Routine islet autoantibody testing in clinically diagnosed adult-onset type 1 diabetes can help identify misclassification and the possibility of successful insulin cessation","volume":"45","author":"Eason","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib53","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.1007\/s00125-020-05227-z","article-title":"Efficacy of GAD-alum immunotherapy associated with HLA-DR3-DQ2 in recently diagnosed type 1 diabetes","volume":"63","author":"Hannelius","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib54","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2337\/dbi20-0017","article-title":"Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel","volume":"69","author":"Buzzetti","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00159-6_bib55","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/dc17-2625","article-title":"proinsulin secretion is a persistent feature of type 1 diabetes","volume":"42","author":"Sims","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib56","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Davies","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib57","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00159-6_bib58","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00159-6_bib59","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41588-021-00948-2","article-title":"Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes","volume":"53","author":"Mansour Aly","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(23)00159-6_bib60","doi-asserted-by":"crossref","first-page":"2161","DOI":"10.2337\/dc20-0329","article-title":"Role of patatin-like phospholipase domain-containing 3 gene for hepatic lipid content and insulin resistance in diabetes","volume":"43","author":"Zaharia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib61","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S2213-8587(18)30316-4","article-title":"Novel subgroups of patients with adult-onset diabetes in Chinese and US populations","volume":"7","author":"Zou","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00159-6_bib62","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-001506","article-title":"Novel subgroups of type 2 diabetes and their association with microvascular outcomes in an Asian Indian population: a data-driven cluster analysis: the INSPIRED study","volume":"8","author":"Anjana","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib63","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00125-017-4210-x","article-title":"Painting a new picture of personalised medicine for diabetes","volume":"60","author":"McCarthy","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib64","series-title":"Cluster analysis","author":"Everitt","year":"2011"},{"key":"10.1016\/S2213-8587(23)00159-6_bib65","article-title":"Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: an IMI DIRECT study","volume":"3","author":"Wesolowska-Andersen","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib66","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41591-022-01790-7","article-title":"Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes","volume":"28","author":"Nair","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002654","article-title":"Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis","volume":"15","author":"Udler","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib68","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2337\/dc21-1395","article-title":"Type 2 diabetes partitioned polygenic scores associate with disease outcomes in 454,193 individuals across 13 cohorts","volume":"45","author":"DiCorpo","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib69","article-title":"Multi-ancestry genome-wide study in >2.5 million individuals reveals heterogeneity in mechanistic pathways of type 2 diabetes and complications","author":"Suzuki","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(23)00159-6_bib70","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2337\/dc13-1995","article-title":"Clinical and genetic determinants of progression of type 2 diabetes: a DIRECT study","volume":"37","author":"Zhou","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib71","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003209","article-title":"Obesity, clinical, and genetic predictors for glycemic progression in Chinese patients with type 2 diabetes: a cohort study using the Hong Kong Diabetes Register and Hong Kong Diabetes Biobank","volume":"17","author":"Jiang","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib72","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2337\/dc22-2301","article-title":"Differential associations of GAD antibodies (GADA) and C-peptide with insulin initiation, glycemic responses, and severe hypoglycemia in patients diagnosed with type 2 diabetes","volume":"46","author":"Fan","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib73","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/dc18-0344","article-title":"Sex and BMI alter the benefits and risks of sulfonylureas and thiazolidinediones in type 2 diabetes: a framework for evaluating stratification using routine clinical and individual trial data","volume":"41","author":"Dennis","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib74","doi-asserted-by":"crossref","first-page":"e873","DOI":"10.1016\/S2589-7500(22)00174-1","article-title":"Development of a treatment selection algorithm for SGLT2 and DPP-4 inhibitor therapies in people with type 2 diabetes: a retrospective cohort study","volume":"4","author":"Dennis","year":"2022","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(23)00159-6_bib75","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/s41591-022-02120-7","article-title":"Patient stratification for determining optimal second-line and third-line therapy for type 2 diabetes: the TriMaster study","volume":"29","author":"Shields","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib76","first-page":"17","article-title":"Pharmacogenetics in type 2 diabetes: influence on response to oral hypoglycemic agents","volume":"9","author":"Dawed","year":"2016","journal-title":"Pharm Genomics Pers Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib77","first-page":"7","article-title":"Incidence of type 1 and type 2 diabetes, between 2012\u20132016, among children and adolescents in Qatar","volume":"89","author":"Alyafei","year":"2018","journal-title":"Acta Biomed"},{"key":"10.1016\/S2213-8587(23)00159-6_bib78","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJMc1706291","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012","volume":"377","author":"Mayer-Davis","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib79","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/dme.13609","article-title":"Continuing rise of type 2 diabetes incidence in children and young people in the UK","volume":"35","author":"Candler","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib80","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1111\/pedi.12631","article-title":"Incidence and prevalence trends of youth-onset type 2 diabetes in a cohort of Canadian youth: 2002\u20132013","volume":"19","author":"Amed","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00159-6_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003052","article-title":"Secular trends in incidence of type 1 and type 2 diabetes in Hong Kong: a retrospective cohort study","volume":"17","author":"Luk","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib82","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","article-title":"A clinical trial to maintain glycemic control in youth with type 2 diabetes","volume":"366","author":"Zeitler","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib83","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00125-019-05075-6","article-title":"The changing face of paediatric diabetes","volume":"63","author":"Shah","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib84","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1111\/pedi.13254","article-title":"Type 2 diabetes in prepubertal children","volume":"22","author":"Astudillo","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00159-6_bib85","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1007\/s00125-010-1911-9","article-title":"Development, validation and use of an insulin sensitivity score in youths with diabetes: the SEARCH for Diabetes in Youth study","volume":"54","author":"Dabelea","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib86","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.2337\/dc13-0568","article-title":"Albuminuria according to status of autoimmunity and insulin sensitivity among youth with type 1 and type 2 diabetes","volume":"36","author":"Mottl","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib87","doi-asserted-by":"crossref","first-page":"4055","DOI":"10.1210\/jc.2013-1279","article-title":"Prevalence, characteristics and clinical diagnosis of maturity onset diabetes of the young due to mutations in HNF1A, HNF4A, and glucokinase: results from the SEARCH for Diabetes in Youth","volume":"98","author":"Pihoker","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00159-6_bib88","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/pedi.12998","article-title":"Beta cell function and insulin sensitivity in obese youth with maturity onset diabetes of youth mutations vs type 2 diabetes in TODAY: Longitudinal observations and glycemic failure","volume":"21","author":"Arslanian","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00159-6_bib89","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1210\/jc.2009-1756","article-title":"Insulin resistance in adolescents with type 1 diabetes and its relationship to cardiovascular function","volume":"95","author":"Nadeau","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00159-6_bib90","doi-asserted-by":"crossref","first-page":"2895","DOI":"10.1161\/CIRCULATIONAHA.118.035525","article-title":"Metformin improves insulin sensitivity and vascular health in youth with type 1 diabetes mellitus","volume":"138","author":"Bjornstad","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00159-6_bib91","doi-asserted-by":"crossref","first-page":"3265","DOI":"10.1210\/jc.2019-00129","article-title":"metformin improves peripheral insulin sensitivity in youth with type 1 diabetes","volume":"104","author":"Cree-Green","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00159-6_bib92","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1111\/dom.14800","article-title":"Bromocriptine quick-release as adjunct therapy in youth and adults with type 1 diabetes: a randomized, placebo-controlled crossover study","volume":"24","author":"Tell","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00159-6_bib93","doi-asserted-by":"crossref","first-page":"2833","DOI":"10.2337\/diabetes.52.11.2833","article-title":"Effect of type 1 diabetes on the gender difference in coronary artery calcification: a role for insulin resistance? The Coronary Artery Calcification in Type 1 Diabetes (CACTI) Study","volume":"52","author":"Dabelea","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00159-6_bib94","article-title":"Diabetes of unclear type in an adolescent boy with multiple islet-cell autoantibody positivity successfully managed with glucagon-like peptide-1 receptor agonist alone: a case report","author":"Ginnard","year":"2022","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(23)00159-6_bib95","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2337\/dc18-0787","article-title":"Impact of insulin and metformin versus metformin alone on \u03b2-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes","volume":"41","author":"Nadeau","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib96","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1007\/s00125-013-2915-z","article-title":"Global trends in the incidence and prevalence of type 2 diabetes in children and adolescents: a systematic review and evaluation of methodological approaches","volume":"56","author":"Fazeli Farsani","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00159-6_bib97","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/dc16-1066","article-title":"Youth-onset type 2 diabetes consensus report: current status, challenges, and priorities","volume":"39","author":"Nadeau","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib98","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108948","article-title":"Differential loss of \u03b2-cell function in youth vs. adults following treatment withdrawal in the Restoring Insulin Secretion (RISE) study","volume":"178","author":"Utzschneider","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00159-6_bib100","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.0686","article-title":"Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood","volume":"317","author":"Dabelea","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00159-6_bib101","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.2337\/dc12-2420","article-title":"Rapid rise in hypertension and nephropathy in youth with type 2 diabetes: the TODAY clinical trial","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib102","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/j.jdiacomp.2018.09.018","article-title":"The early natural history of albuminuria in young adults with youth-onset type 1 and type 2 diabetes","volume":"32","author":"Kahkoska","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(23)00159-6_bib103","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/j.jpeds.2006.04.065","article-title":"Lipid abnormalities are prevalent in youth with type 1 and type 2 diabetes: the SEARCH for Diabetes in Youth Study","volume":"149","author":"Kershnar","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(23)00159-6_bib104","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/pedi.12119","article-title":"Alterations in left ventricular, left atrial, and right ventricular structure and function to cardiovascular risk factors in adolescents with type 2 diabetes participating in the TODAY clinical trial","volume":"16","author":"Levitt Katz","year":"2015","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00159-6_bib105","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41591-020-0930-4","article-title":"A combined risk score enhances prediction of type 1 diabetes among susceptible children","volume":"26","author":"Ferrat","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib106","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2337\/dc18-0087","article-title":"A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk","volume":"41","author":"Redondo","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib107","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Defronzo","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00159-6_bib108","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1038\/s41591-022-02055-z","article-title":"Proteomic signatures for identification of impaired glucose tolerance","volume":"28","author":"Carrasco-Zanini","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(23)00159-6_bib109","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/dc18-2023","article-title":"Identification of novel T1D risk loci and their association with age and islet function at diagnosis in autoantibody-positive T1D individuals: based on a two-stage genome-wide association study","volume":"42","author":"Zhu","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib110","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.2337\/dc18-1032","article-title":"First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes","volume":"41","author":"Cousminer","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00159-6_bib111","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-031586","article-title":"Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18\u201350 years","volume":"9","author":"Lynam","year":"2019","journal-title":"BMJ Open"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:54Z","timestamp":1778858754000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001596"}},"issued":{"date-parts":[[2023,11]]},"references-count":111,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2213858723001596"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00159-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00159-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T23:16:48Z","timestamp":1794266208297,"version":"4.9.0"},"reference-count":46,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001003","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001003","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000769","name":"University of Oxford","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/s2213-8587(19)30256-6","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T18:38:52Z","timestamp":1567708732000},"page":"845-854","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":817,"title":["SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"7","author":[{"given":"Brendon L","family":"Neuen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamara","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiddo J L","family":"Heerspink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Billot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W","family":"Mahaffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Charytan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Arnott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Severine","family":"Bompoint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeera","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg J","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30256-6_bib1","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30256-6_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nrneph.2015.173","article-title":"Changing epidemiology of type 2 diabetes mellitus and associated chronic kidney disease","volume":"12","author":"Thomas","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S2213-8587(19)30256-6_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2017-000380","article-title":"Chronic kidney disease and the global NCDs agenda","volume":"2","author":"Neuen","year":"2017","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S2213-8587(19)30256-6_bib4","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30256-6_bib5","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30256-6_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30256-6_bib7","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/diacare.28.1.164","article-title":"Diabetic nephropathy: diagnosis, prevention, and treatment","volume":"28","author":"Gross","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30256-6_bib8","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1016\/S0140-6736(16)32064-5","article-title":"Chronic kidney disease","volume":"389","author":"Webster","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30256-6_bib9","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30256-6_bib10","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-8587(18)30141-4","article-title":"Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials","volume":"6","author":"Perkovic","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30256-6_bib11","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30256-6_bib12","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.118.035901","article-title":"Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function: data from the CANVAS program","volume":"138","author":"Neuen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30256-6_bib13","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1161\/CIRCULATIONAHA.117.028268","article-title":"Empagliflozin and clinical outcomes in patients with type 2 diabetes mellitus, established cardiovascular disease, and chronic kidney disease","volume":"137","author":"Wanner","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30256-6_bib14","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30256-6_bib15","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S2213-8587(19)30180-9","article-title":"Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE\u2013TIMI 58 randomised trial","volume":"7","author":"Mosenzon","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30256-6_bib16","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1111\/dom.13754","article-title":"Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: a meta-analysis of cardiovascular outcome trials","volume":"21","author":"Gilbert","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30256-6_bib17","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30256-6_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30256-6_bib19","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1053\/j.ajkd.2014.08.018","article-title":"GFR decline and subsequent risk of established kidney outcomes: a meta-analysis of 37 randomized controlled trials","volume":"64","author":"Heerspink","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(19)30256-6_bib20","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1111\/dom.12924","article-title":"Optimizing the analysis strategy for the CANVAS Program: a prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials","volume":"19","author":"Neal","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30256-6_bib21","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes\u2014authors reply","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30256-6_bib22","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.1681\/ASN.2018010103","article-title":"Empagliflozin and kidney function decline in patients with type 2 diabetes: a slope analysis from the EMPA-REG OUTCOME trial","volume":"29","author":"Wanner","year":"2018","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(19)30256-6_bib23","doi-asserted-by":"crossref","DOI":"10.1016\/j.kint.2019.02.033","article-title":"Analysis from the EMPA-REG OUTCOME trial indicates empagliflozin may assist in preventing the progression of chronic kidney disease in patients with type 2 diabetes irrespective of medications that alter intrarenal hemodynamics","author":"Mayer","year":"2019","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(19)30256-6_bib24","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ckj\/sfy090","article-title":"The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study","volume":"11","author":"Herrington","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/S2213-8587(19)30256-6_bib25","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30256-6_bib26","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30256-6_bib27","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30256-6_bib28","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.12.027","article-title":"Renoprotective effects of sodium-glucose cotransporter-2 inhibitors","volume":"94","author":"Heerspink","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(19)30256-6_bib29","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1111\/dom.13648","article-title":"Effect of SGLT2 inhibitors on cardiovascular, renal and safety outcomes in patients with type 2 diabetes mellitus and chronic kidney disease: a systematic review and meta-analysis","volume":"21","author":"Toyama","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30256-6_bib30","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/ki.2010.531","article-title":"Lower estimated GFR and higher albuminuria are associated with adverse kidney outcomes. A collaborative meta-analysis of general and high-risk population cohorts","volume":"80","author":"Gansevoort","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(19)30256-6_bib31","doi-asserted-by":"crossref","first-page":"73","DOI":"10.7326\/0003-4819-135-2-200107170-00007","article-title":"Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease: a meta-analysis of patient-level data","volume":"135","author":"Jafar","year":"2001","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(19)30256-6_bib32","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1681\/ASN.2006101081","article-title":"Progression risk, urinary protein excretion, and treatment effects of angiotensin-converting enzyme inhibitors in nondiabetic kidney disease","volume":"18","author":"Kent","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(19)30256-6_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ki.2014.128","article-title":"Diabetic kidney disease: a clinical update from Kidney Disease: Improving Global Outcomes","volume":"87","author":"Molitch","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(19)30256-6_bib34","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(19)30256-6_bib35","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1681\/ASN.2016060666","article-title":"Glomerular hyperfiltration in diabetes: mechanisms, clinical significance, and treatment","volume":"28","author":"Tonneijck","year":"2017","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(19)30256-6_bib36","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30256-6_bib37","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/dom.13413","article-title":"Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3a): the DERIVE Study","volume":"20","author":"Fioretto","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30256-6_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2337\/dbi16-0056","article-title":"Back to the future: glomerular hyperfiltration and the diabetic kidney","volume":"66","author":"Tuttle","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30256-6_bib39","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.118.037418","article-title":"Evaluation of glomerular hemodynamic function by empagliflozin in diabetic mice using in vivo imaging","volume":"140","author":"Kidokoro","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30256-6_bib40","doi-asserted-by":"crossref","DOI":"10.1093\/ndt\/gfz033","article-title":"Sodium glucose co-transporter 2 inhibition: a new avenue to protect the kidney","author":"Heerspink","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(19)30256-6_bib41","article-title":"Dapagliflozin, SGLT2 inhibitor, attenuates renal ischemia-reperfusion injury","volume":"11","author":"Chang","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30256-6_bib42","doi-asserted-by":"crossref","first-page":"F227","DOI":"10.1152\/ajprenal.00689.2014","article-title":"Acute SGLT inhibition normalizes O2 tension in the renal cortex but causes hypoxia in the renal medulla in anaesthetized control and diabetic rats","volume":"309","author":"O'Neill","year":"2015","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/S2213-8587(19)30256-6_bib43","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1001\/jama.2016.2628","article-title":"Interpretation of clinical trials that stopped early","volume":"15","author":"Viele","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30256-6_bib44","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30256-6_bib45","doi-asserted-by":"crossref","first-page":"318","DOI":"10.2215\/CJN.07680717","article-title":"Are SGLT2 inhibitors ready for prime time for CKD?","volume":"13","author":"Pecoits-Filho","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(19)30256-6_bib46","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1007\/s13300-018-0420-6","article-title":"Combination treatment of SGLT2 inhibitors and GLP-1 receptor agonists: symbiotic effects on metabolism and cardiorenal risk","volume":"9","author":"Goncalves","year":"2018","journal-title":"Diabetes Ther"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:50Z","timestamp":1761991670000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719302566"}},"issued":{"date-parts":[[2019,11]]},"references-count":46,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2213858719302566"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30256-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30256-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30253-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T16:48:56Z","timestamp":1794502136325,"version":"4.9.1"},"reference-count":49,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/s2213-8587(22)00044-4","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:56:37Z","timestamp":1647892597000},"page":"311-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":534,"title":["Risks and burdens of incident diabetes in long COVID: a cohort study"],"prefix":"10.1016","volume":"10","author":[{"given":"Yan","family":"Xie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-2600-0434","authenticated-orcid":false,"given":"Ziyad","family":"Al-Aly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00044-4_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(22)00044-4_bib2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"3","author":"Montefusco","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(22)00044-4_bib3","article-title":"Comparative evaluation of clinical manifestations and risk of death in patients admitted to hospital with COVID-19 and seasonal influenza: cohort study","volume":"371","author":"Xie","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00044-4_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s42255-020-00339-7","article-title":"Can COVID-19 cause diabetes?","volume":"3","author":"Accili","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(22)00044-4_bib5","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/dom.14269","article-title":"Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis","volume":"23","author":"Sathish","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(22)00044-4_bib6","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMc2018688","article-title":"New-onset diabetes in COVID-19","volume":"383","author":"Rubino","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00044-4_bib7","doi-asserted-by":"crossref","first-page":"n693","DOI":"10.1136\/bmj.n693","article-title":"Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study","volume":"372","author":"Ayoubkhani","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00044-4_bib8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S2213-8587(21)00244-8","article-title":"COVID-19 and metabolic disease: mechanisms and clinical management","volume":"9","author":"Steenblock","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00044-4_bib9","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.2337\/dc21-1318","article-title":"COVID-19, hyperglycemia, and new-onset diabetes","volume":"44","author":"Khunti","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00044-4_bib10","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.ekir.2016.08.016","article-title":"Geographic variation and US County characteristics associated with rapid kidney function decline","volume":"2","author":"Bowe","year":"2016","journal-title":"Kidney Int Rep"},{"key":"10.1016\/S2213-8587(22)00044-4_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/j.kint.2017.08.033","article-title":"Higher blood urea nitrogen is associated with increased risk of incident diabetes mellitus","volume":"93","author":"Xie","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(22)00044-4_bib12","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.15834","article-title":"Burden of cause-specific mortality associated with PM2.5 air pollution in the United States","volume":"2","author":"Bowe","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(22)00044-4_bib13","article-title":"Estimates of all cause mortality and cause specific mortality associated with proton pump inhibitors among US veterans: cohort study","volume":"365","author":"Xie","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00044-4_bib14","doi-asserted-by":"crossref","first-page":"603","DOI":"10.2215\/CJN.09710916","article-title":"Association between monocyte count and risk of incident CKD and progression to ESRD","volume":"12","author":"Bowe","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(22)00044-4_bib15","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.2337\/dc20-1231","article-title":"Comparative effectiveness of the sodium-glucose co-transporter-2 inhibitor empagliflozin vs. other antihyperglycemics on risk of major adverse kidney events","volume":"43","author":"Xie","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00044-4_bib16","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1001\/jamainternmed.2021.2488","article-title":"Comparative effectiveness of sodium-glucose cotransporter 2 inhibitors vs sulfonylureas in patients with type 2 diabetes","volume":"181","author":"Xie","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(22)00044-4_bib17","doi-asserted-by":"crossref","first-page":"14","DOI":"10.2215\/CJN.09610620","article-title":"Acute kidney injury in a national cohort of hospitalized US veterans with COVID-19","volume":"16","author":"Bowe","year":"2020","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(22)00044-4_bib18","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.2337\/dc20-1890","article-title":"Comparative effectiveness of SGLT2 Inhibitors, GLP-1 receptor agonists, DPP-4 inhibitors, and sulfonylureas on risk of kidney outcomes: emulation of a target trial using health care databases","volume":"43","author":"Xie","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00044-4_bib19","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020237","article-title":"Clinical implications of estimated glomerular filtration rate dip following sodium-glucose cotransporter-2 inhibitor initiation on cardiovascular and kidney outcomes","volume":"10","author":"Xie","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(22)00044-4_bib21","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.1056\/NEJMp1802313","article-title":"Making neighborhood-disadvantage metrics accessible\u2014the Neighborhood Atlas","volume":"378","author":"Kind","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00044-4_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-26513-3","article-title":"Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status","volume":"12","author":"Xie","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(22)00044-4_bib23","doi-asserted-by":"crossref","first-page":"2851","DOI":"10.1681\/ASN.2021060734","article-title":"Kidney outcomes in long COVID","volume":"32","author":"Bowe","year":"2021","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(22)00044-4_bib24","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","author":"Xie","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(22)00044-4_bib25","article-title":"Risks of mental health outcomes in people with COVID-19: cohort study","volume":"377","author":"Xie","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00044-4_bib26","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/EDE.0b013e3181a663cc","article-title":"High-dimensional propensity score adjustment in studies of treatment effects using health care claims data","volume":"20","author":"Schneeweiss","year":"2009","journal-title":"Epidemiology"},{"key":"10.1016\/S2213-8587(22)00044-4_bib27","article-title":"Short term exposure to fine particulate matter and hospital admission risks and costs in the Medicare population: time stratified, case crossover study","volume":"367","author":"Wei","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00044-4_bib28","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.mayocpiqo.2019.09.002","article-title":"Best definitions of multimorbidity to identify patients with high health care resource utilization","volume":"4","author":"Aubert","year":"2020","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/S2213-8587(22)00044-4_bib30","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1038\/clpt.2009.198","article-title":"Comparison of critical drug-drug interaction listings: the Department of Veterans Affairs medical system and standard reference compendia","volume":"87","author":"Olvey","year":"2010","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S2213-8587(22)00044-4_bib31","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1111\/jgs.12695","article-title":"Polypharmacy, drug-drug interactions, and potentially inappropriate medications in older adults with human immunodeficiency virus infection","volume":"62","author":"Greene","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(22)00044-4_bib32","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1080\/00273171.2011.568786","article-title":"An introduction to propensity score methods for reducing the effects of confounding in observational studies","volume":"46","author":"Austin","year":"2011","journal-title":"Multivariate Behav Res"},{"key":"10.1016\/S2213-8587(22)00044-4_bib33","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2020.7819","article-title":"Overlap weighting: a propensity score method that mimics attributes of a randomized clinical trial","volume":"323","author":"Thomas","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00044-4_bib34","first-page":"250","article-title":"Addressing extreme propensity scores via the overlap weights","volume":"188","author":"Li","year":"2019","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(22)00044-4_bib35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1177\/0962280206074463","article-title":"Multiple imputation of discrete and continuous data by fully conditional specification","volume":"16","author":"van Buuren","year":"2007","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/S2213-8587(22)00044-4_bib36","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1097\/EDE.0b013e3181d61eeb","article-title":"Negative controls: a tool for detecting confounding and bias in observational studies","volume":"21","author":"Lipsitch","year":"2010","journal-title":"Epidemiology"},{"key":"10.1016\/S2213-8587(22)00044-4_bib37","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1007\/s40471-020-00243-4","article-title":"A selective review of negative control methods in epidemiology","volume":"7","author":"Shi","year":"2020","journal-title":"Curr Epidemiol Rep"},{"key":"10.1016\/S2213-8587(22)00044-4_bib39","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15585\/mmwr.mm7102e2","article-title":"Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years\u2014United States, March 1, 2020\u2013June 28, 2021","volume":"71","author":"Barrett","year":"2022","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/S2213-8587(22)00044-4_bib40","article-title":"Relation of incident type 1 diabetes to recent COVID-19 infection: cohort study using e-health record linkage in Scotland","author":"McKeigue","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(22)00044-4_bib41","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/dom.14269","article-title":"Proportion of newly diagnosed diabetes in COVID-19 patients: a systematic review and meta-analysis","volume":"23","author":"Sathish","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(22)00044-4_bib42","doi-asserted-by":"crossref","first-page":"n693","DOI":"10.1136\/bmj.n693","article-title":"Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study","volume":"372","author":"Ayoubkhani","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00044-4_bib43","article-title":"Rates of serious clinical outcomes in survivors of hospitalisation with COVID-19: a descriptive cohort study within the OpenSAFELY platform","author":"Collaborative","year":"2021","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(22)00044-4_bib44","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1016\/j.cell.2020.04.035","article-title":"SARS-CoV-2 receptor ACE2 is an interferon \u2013 stimulated gene in human airway epithelial cells and is detected in specific cell subsets across tissues","volume":"181","author":"Ziegler","year":"2020","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(22)00044-4_bib45","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s42255-021-00347-1","article-title":"SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas","volume":"3","author":"M\u00fcller","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(22)00044-4_bib46","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","article-title":"A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/S2213-8587(22)00044-4_bib47","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.cmet.2021.05.013","article-title":"SARS-CoV-2 infects human pancreatic \u03b2 cells and elicits \u03b2 cell impairment","volume":"33","author":"Wu","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(22)00044-4_bib48","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.cmet.2021.05.015","article-title":"SARS-CoV-2 infection induces beta cell transdifferentiation","volume":"33","author":"Tang","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(22)00044-4_bib49","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110508","article-title":"Limited extent and consequences of pancreatic SARS-CoV-2 infection","volume":"38","author":"van der Heide","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/S2213-8587(22)00044-4_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2021.106564","article-title":"Ambient fine particulate matter air pollution and the risk of hospitalization among COVID-19 positive individuals: cohort study","volume":"154","author":"Bowe","year":"2021","journal-title":"Environ Int"},{"key":"10.1016\/S2213-8587(22)00044-4_bib51","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.mayocp.2020.04.043","article-title":"County-level contextual characteristics and disparities in life expectancy","volume":"96","author":"Xie","year":"2021","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/S2213-8587(22)00044-4_bib52","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-047369","article-title":"Temporal trends of COVID-19 mortality and hospitalisation rates: an observational cohort study from the US Department of Veterans Affairs","volume":"11","author":"Cai","year":"2021","journal-title":"BMJ Open"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:54Z","timestamp":1761991914000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000444"}},"issued":{"date-parts":[[2022,5]]},"references-count":49,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2213858722000444"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00044-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks and burdens of incident diabetes in long COVID: a cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00044-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00078-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T12:13:26Z","timestamp":1793189606157,"version":"4.5.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/s2213-8587(13)70214-6","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T20:30:19Z","timestamp":1391632219000},"page":"289-297","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":291,"title":["Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study"],"prefix":"10.1016","volume":"2","author":[{"given":"Richard E","family":"Pratley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Nauck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark N","family":"Feinglos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Ovalle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Illana","family":"Harman-Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"June","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rhona","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70214-6_bib1","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(13)70214-6_bib2","doi-asserted-by":"crossref","first-page":"S279","DOI":"10.2337\/dc11-s231","article-title":"Long-acting glucagon-like peptide 1 receptor agonists: a review of their efficacy and tolerability","volume":"34","author":"Garber","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70214-6_bib4","doi-asserted-by":"crossref","first-page":"4810","DOI":"10.1210\/jc.2008-1518","article-title":"Pharmacodynamics, pharmacokinetics, safety, and tolerability of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in patients with type 2 diabetes","volume":"93","author":"Matthews","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70214-6_bib5","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.2337\/dc09-0366","article-title":"Potential of albiglutide, a long-acting GLP-1 receptor agonist, in type 2 diabetes: a randomized controlled trial exploring weekly, biweekly, and monthly dosing","volume":"32","author":"Rosenstock","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70214-6_bib6","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1358\/dof.2010.35.9.1516042","article-title":"Albiglutide","volume":"35","author":"Rosenstock","year":"2010","journal-title":"Drugs Fut"},{"key":"10.1016\/S2213-8587(13)70214-6_bib7","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1463-1326.2008.00992.x","article-title":"Safety, tolerability, pharmacodynamics and pharmacokinetics of albiglutide, a long-acting glucagon-like peptide-1 mimetic, in healthy subjects","volume":"11","author":"Bush","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70214-6_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11136-005-1624-6","article-title":"Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience","volume":"15","author":"Brod","year":"2006","journal-title":"Qual Life Res"},{"key":"10.1016\/S2213-8587(13)70214-6_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1210\/jc.2010-2081","article-title":"DURATION-5: exenatide once weekly resulted in greater improvements in glycemic control compared with exenatide twice daily in patients with type 2 diabetes","volume":"96","author":"Blevins","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70214-6_bib11","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(08)61206-4","article-title":"Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study","volume":"372","author":"Drucker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70214-6_bib12","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(12)61267-7","article-title":"Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study","volume":"381","author":"Buse","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70214-6_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(09)60659-0","article-title":"Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26-week randomised, parallel-group, multinational, open-label trial (LEAD-6)","volume":"374","author":"Buse","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70214-6_bib14","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(08)61246-5","article-title":"Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial","volume":"373","author":"Garber","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70214-6_bib15","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/j.1464-5491.2009.02666.x","article-title":"Liraglutide, a once-daily human GLP-1 analogue, added to a sulphonylurea over 26 weeks produces greater improvements in glycaemic and weight control compared with adding rosiglitazone or placebo in subjects with type 2 diabetes (LEAD-1 SU)","volume":"26","author":"Marre","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70214-6_bib16","doi-asserted-by":"crossref","first-page":"84","DOI":"10.2337\/dc08-1355","article-title":"Efficacy and safety comparison of liraglutide, glimepiride, and placebo, all in combination with metformin, in type 2 diabetes: the LEAD (Liraglutide Effect and Action in Diabetes)-2 study","volume":"32","author":"Nauck","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70214-6_bib17","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1007\/s00125-009-1472-y","article-title":"Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial","volume":"52","author":"Russell-Jones","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70214-6_bib18","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc08-2124","article-title":"Efficacy and safety of the human glucagon-like peptide-1 analog liraglutide in combination with metformin and thiazolidinedione in patients with type 2 diabetes (LEAD-4 Met+TZD)","volume":"32","author":"Zinman","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70214-6_bib19","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/j.1742-1241.2011.02656.x","article-title":"One year of liraglutide treatment offers sustained and more effective glycaemic control and weight reduction compared with sitagliptin, both in combination with metformin, in patients with type 2 diabetes: a randomised, parallel-group, open-label trial","volume":"65","author":"Pratley","year":"2011","journal-title":"Int J Clin Pract"},{"key":"10.1016\/S2213-8587(13)70214-6_bib20","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1177\/1479164112441526","article-title":"GLP-1 receptor agonists: a clinical perspective on cardiovascular effects","volume":"9","author":"Mundil","year":"2012","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/S2213-8587(13)70214-6_bib21","first-page":"419","article-title":"Increased variability and abnormalities in pancreatic enzyme concentrations in otherwise asymptomatic subjects with type 2 diabetes","volume":"5","author":"Malloy","year":"2012","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/S2213-8587(13)70214-6_bib22","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/j.physbeh.2012.02.017","article-title":"Neuronal and intracellular signaling pathways mediating GLP-1 energy balance and glycemic effects","volume":"106","author":"Hayes","year":"2012","journal-title":"Physiol Behav"},{"key":"10.1016\/S2213-8587(13)70214-6_bib23","doi-asserted-by":"crossref","first-page":"2577","DOI":"10.2337\/db08-0121","article-title":"Brain glucagon-like peptide-1 regulates arterial blood flow, heart rate, and insulin sensitivity","volume":"57","author":"Cabou","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70214-6_bib25","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"55","author":"Inzucchi","year":"2012","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713702146?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713702146?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:34Z","timestamp":1761991534000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713702146"}},"issued":{"date-parts":[[2014,4]]},"references-count":22,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S2213858713702146"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70214-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70214-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70014-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T03:50:04Z","timestamp":1793418604953,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004628","name":"MedImmune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018465","name":"Regado Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["ZE 1109\/1\u20131"],"award-info":[{"award-number":["ZE 1109\/1\u20131"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006279","name":"St. Jude Medical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006279","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016619","name":"MyoKardia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016619","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006513","name":"Duke Clinical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008682","name":"Boston VA Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008682","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005205","name":"Janssen Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005205","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014384","name":"Amarin Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014384","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014736","name":"Society for Academic Continuing Medical Education","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/s2213-8587(19)30180-9","type":"journal-article","created":{"date-parts":[[2019,6,10]],"date-time":"2019-06-10T06:53:46Z","timestamp":1560149626000},"page":"606-617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":617,"title":["Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE\u2013TIMI 58 randomised trial"],"prefix":"10.1016","volume":"7","author":[{"given":"Ofri","family":"Mosenzon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D","family":"Wiviott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avivit","family":"Cahn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliza","family":"Rozenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Yanuv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L","family":"Goodrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina A","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiddo J L","family":"Heerspink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A","family":"Zelniker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie P","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren K","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P H","family":"Wilding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eri T","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid A M","family":"Gause-Nilsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fredriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Langkilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S","family":"Sabatine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Itamar","family":"Raz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30180-9_bib1","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/nrneph.2013.251","article-title":"The effect of RAAS blockade on the progression of diabetic nephropathy","volume":"10","author":"Roscioni","year":"2014","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S2213-8587(19)30180-9_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ki.2014.128","article-title":"Diabetic kidney disease: a clinical update from kidney disease: improving global outcomes","volume":"87","author":"Molitch","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(19)30180-9_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/dom.12583","article-title":"Early renin-angiotensin system intervention is more beneficial than late intervention in delaying end-stage renal disease in patients with type 2 diabetes","volume":"18","author":"Schievink","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30180-9_bib4","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1001\/jama.2011.861","article-title":"Temporal trends in the prevalence of diabetic kidney disease in the United States","volume":"305","author":"de Boer","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30180-9_bib5","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1681\/ASN.2012070718","article-title":"Kidney disease and increased mortality risk in type 2 diabetes","volume":"24","author":"Afkarian","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(19)30180-9_bib6","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1016\/S0140-6736(14)61601-9","article-title":"Worldwide access to treatment for end-stage kidney disease: a systematic review","volume":"385","author":"Liyanage","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30180-9_bib7","series-title":"2016 USRDS annual data report: epidemiology of kidney disease in the United States","year":"2016"},{"key":"10.1016\/S2213-8587(19)30180-9_bib8","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30180-9_bib9","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1016\/S2213-8587(17)30182-1","article-title":"Effects of empagliflozin on the urinary albumin-to-creatinine ratio in patients with type 2 diabetes and established cardiovascular disease: an exploratory analysis from the EMPA-REG OUTCOME randomised, placebo-controlled trial","volume":"5","author":"Cherney","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30180-9_bib10","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30180-9_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/S2213-8587(18)30141-4","article-title":"Canagliflozin and renal outcomes in type 2 diabetes: results from the CANVAS Program randomised clinical trials","volume":"6","author":"Perkovic","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30180-9_bib12","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1161\/CIRCULATIONAHA.118.035901","article-title":"Cardiovascular and renal outcomes with canagliflozin according to baseline kidney function","volume":"138","author":"Neuen","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30180-9_bib13","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30180-9_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30180-9_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ahj.2018.01.012","article-title":"The design and rationale for the Dapagliflozin Effect on Cardiovascular Events (DECLARE)\u2013TIMI 58 Trial","volume":"200","author":"Wiviott","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(19)30180-9_bib16","doi-asserted-by":"crossref","first-page":"1102","DOI":"10.1111\/dom.13217","article-title":"DECLARE-TIMI 58: participants\u2018 baseline characteristics","volume":"20","author":"Raz","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30180-9_bib17","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1016\/j.jdiacomp.2017.06.016","article-title":"Comparison of MDRD, CKD-EPI, and Cockcroft-Gault equation in relation to measured glomerular filtration rate among a large cohort with diabetes","volume":"31","author":"Schwandt","year":"2017","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(19)30180-9_bib18","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(19)30180-9_bib19","doi-asserted-by":"crossref","first-page":"1813","DOI":"10.1681\/ASN.2008121270","article-title":"Albuminuria and kidney function independently predict cardiovascular and renal outcomes in diabetes","volume":"20","author":"Ninomiya","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(19)30180-9_bib20","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30180-9_bib21","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30180-9_bib22","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1001\/jamacardio.2017.4228","article-title":"Cardiovascular outcomes according to urinary albumin and kidney disease in patients with type 2 diabetes at high cardiovascular risk","volume":"3","author":"Scirica","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(19)30180-9_bib23","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.12.027","article-title":"Renoprotective effects of sodium-glucose cotransporter-2 inhibitors","volume":"94","author":"Heerspink","year":"2018","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(19)30180-9_bib24","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1177\/1479164118783756","article-title":"Effects of sodium glucose co-transporter 2 inhibitors on the kidney","volume":"15","author":"de Albuquerque Rocha","year":"2018","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/S2213-8587(19)30180-9_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1038\/nrneph.2016.170","article-title":"Renal, metabolic and cardiovascular considerations of SGLT2 inhibition","volume":"13","author":"DeFronzo","year":"2017","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S2213-8587(19)30180-9_bib26","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(19)30180-9_bib27","doi-asserted-by":"crossref","first-page":"S165","DOI":"10.2337\/dcS15-3006","article-title":"SGLT2 inhibitors and the diabetic kidney","volume":"39","author":"Fioretto","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30180-9_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/dom.13508","article-title":"Effectiveness of dapagliflozin versus comparators on renal endpoints in the real world: a multicentre retrospective study","volume":"21","author":"Fadini","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30180-9_bib30","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1111\/dom.13532","article-title":"Acute renal outcomes with sodium-glucose co-transporter-2 inhibitors: real-world data analysis","volume":"21","author":"Cahn","year":"2019","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301809?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301809?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:49Z","timestamp":1761991609000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301809"}},"issued":{"date-parts":[[2019,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S2213858719301809"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30180-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of dapagliflozin on development and progression of kidney disease in patients with type 2 diabetes: an analysis from the DECLARE\u2013TIMI 58 randomised trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30180-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30183-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T02:01:02Z","timestamp":1785290462196,"version":"3.55.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/s2213-8587(19)30289-x","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T18:28:26Z","timestamp":1567794506000},"page":"737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Empowering women with PCOS"],"prefix":"10.1016","volume":"7","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930289X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930289X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:51Z","timestamp":1761991671000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871930289X"}},"issued":{"date-parts":[[2019,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S221385871930289X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30289-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empowering women with PCOS","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30289-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:42:45Z","timestamp":1786999365275,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/s2213-8587(24)00180-3","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T18:33:03Z","timestamp":1721759583000},"page":"508-510","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The enduring effect of the COVID-19 pandemic on diabetes"],"prefix":"10.1016","volume":"12","author":[{"given":"Ziyad","family":"Al-Aly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00180-3_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00180-3_bib2","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1126\/science.adl0867","article-title":"Solving the puzzle of long COVID","volume":"383","author":"Al-Aly","year":"2024","journal-title":"Science"},{"key":"10.1016\/S2213-8587(24)00180-3_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S2213-8587(22)00044-4","article-title":"Risks and burdens of incident diabetes in long COVID: a cohort study","volume":"10","author":"Xie","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00180-3_bib4","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1016\/S2213-8587(24)00159-1","article-title":"Incidence of diabetes after SARS-CoV-2 infection in England and the implications of COVID-19 vaccination: a retrospective cohort study of 16 million people","volume":"12","author":"Taylor","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00180-3_bib5","series-title":"Causal inference: what if","author":"Hern\u00e1n","year":"2020"},{"key":"10.1016\/S2213-8587(24)00180-3_bib6","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1038\/s41591-023-02521-2","article-title":"Postacute sequelae of COVID-19 at 2 years","volume":"29","author":"Bowe","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00180-3_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-02987-8","article-title":"Three-year outcomes of post-acute sequelae of COVID-19","author":"Cai","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00180-3_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S1473-3099(24)00171-3","article-title":"The persistence of SARS-CoV-2 in tissues and its association with long COVID symptoms: a cross-sectional cohort study in China","author":"Zuo","year":"2024","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S2213-8587(24)00180-3_bib9","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection","volume":"28","author":"Al-Aly","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00180-3_bib10","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1038\/s41591-022-02051-3","article-title":"Acute and postacute sequelae associated with SARS-CoV-2 reinfection","volume":"28","author":"Bowe","year":"2022","journal-title":"Nat Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001803?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001803?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:26:06Z","timestamp":1778858766000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001803"}},"issued":{"date-parts":[[2024,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2213858724001803"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00180-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The enduring effect of the COVID-19 pandemic on diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00180-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00159-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T13:59:38Z","timestamp":1787061578455,"version":"build-2736575974"},"reference-count":7,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/s2213-8587(24)00188-8","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T18:33:09Z","timestamp":1721759589000},"page":"516-518","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality \u2013 Authors' reply"],"prefix":"10.1016","volume":"12","author":[{"given":"David J A","family":"Jenkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korbua","family":"Srichaikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tauseef Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L","family":"Sievenpiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00188-8_bib1","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1001\/jama.2010.1691","article-title":"The evolution of population science: advent of the mega cohort","volume":"304","author":"Gaziano","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00188-8_bib2","series-title":"Causal inference: what if","author":"Hern\u00e1n","year":"2020"},{"key":"10.1016\/S2213-8587(24)00188-8_bib3","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1093\/ije\/dyr002","article-title":"When size matters","volume":"40","author":"Hense","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(24)00188-8_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/ijc.23110","article-title":"Dietary glycemic load, glycemic index and colorectal cancer risk: results from the Netherlands Cohort Study","volume":"122","author":"Weijenberg","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(24)00188-8_bib5","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1471-2288-8-79","article-title":"Undue reliance on I(2) in assessing heterogeneity may mislead","volume":"8","author":"R\u00fccker","year":"2008","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/S2213-8587(24)00188-8_bib6","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(18)31809-9","article-title":"Carbohydrate quality and human health: a series of systematic reviews and meta-analyses","volume":"393","author":"Reynolds","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00188-8_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0059202","article-title":"The impact of study size on meta-analyses: examination of underpowered studies in Cochrane reviews","volume":"8","author":"Turner","year":"2013","journal-title":"PLoS One"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:54Z","timestamp":1778858754000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001888"}},"issued":{"date-parts":[[2024,8]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2213858724001888"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00188-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality \u2013 Authors' reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00188-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00344-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:21:47Z","timestamp":1790400107494,"version":"4.1.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/s2213-8587(16)30006-7","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T09:39:49Z","timestamp":1462095589000},"page":"476-479","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["The role of glucagon in the artificial pancreas"],"prefix":"10.1016","volume":"4","author":[{"given":"Ahmad","family":"Haidar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed Raef","family":"Smaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Legault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Rabasa-Lhoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30006-7_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.4158\/EP13090.RA","article-title":"Insulin stacking versus therapeutic accumulation: understanding the differences","volume":"20","author":"Heise","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(16)30006-7_bib2","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.2337\/diabetes.54.4.1100","article-title":"The role of amylin and glucagon in the dampening of glycemic excursions in children with type 1 diabetes","volume":"54","author":"Heptulla","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)30006-7_bib3","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.2337\/dc13-0485","article-title":"Pharmacokinetics of insulin aspart in pump-treated subjects with type 1 diabetes: reproducibility and effect of age, weight, and duration of diabetes","volume":"36","author":"Haidar","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30006-7_bib4","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.2337\/dc14-0803","article-title":"Quantification of the glycemic response to microdoses of subcutaneous glucagon at varying insulin levels","volume":"37","author":"El Youssef","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30006-7_bib5","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa1509351","article-title":"Home use of an artificial beta cell in type 1 diabetes","volume":"373","author":"Thabit","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30006-7_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2213-8587(14)70226-8","article-title":"Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial","volume":"3","author":"Haidar","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30006-7_bib7","doi-asserted-by":"crossref","first-page":"27ra","DOI":"10.1126\/scitranslmed.3000619","article-title":"A bihormonal closed-loop artificial pancreas for type 1 diabetes","volume":"2","author":"El-Khatib","year":"2010","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(16)30006-7_bib8","doi-asserted-by":"crossref","first-page":"3344","DOI":"10.2337\/db06-0419","article-title":"Feasibility of automating insulin delivery for the treatment of type 1 diabetes","volume":"55","author":"Steil","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)30006-7_bib9","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2337\/dc12-0816","article-title":"Closed-loop basal insulin delivery over 36 hours in adolescents with type 1 diabetes: randomized clinical trial","volume":"36","author":"Elleri","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30006-7_bib10","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/BF00281818","article-title":"Influence of glucagon on plasma levels of potassium in man","volume":"19","author":"Massara","year":"1980","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(16)30006-7_bib11","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1056\/NEJM196807042790103","article-title":"Cardiovascular effects of glucagon in man","volume":"279","author":"Parmley","year":"1968","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30006-7_bib12","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3181\/00379727-87-21302","article-title":"Effect of chronic administration of glucagon to rats and rabbits","volume":"87","author":"Root","year":"1954","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/S2213-8587(16)30006-7_bib13","first-page":"384","article-title":"Changes in liver, pancreatic and stomach morphology following chronic glucagon administration in guinea-pigs","volume":"43","author":"Cameron","year":"1962","journal-title":"Br J Exp Pathol"},{"key":"10.1016\/S2213-8587(16)30006-7_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1210\/endo-59-3-340","article-title":"Effect of glucagon on glycogen in rats and rabbits","volume":"59","author":"Root","year":"1956","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(16)30006-7_bib15","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/diab.6.3.248","article-title":"The pathologic effects of large amounts of glucagon","volume":"6","author":"Salter","year":"1957","journal-title":"Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T09:06:19Z","timestamp":1658307979000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716300067"}},"issued":{"date-parts":[[2016,6]]},"references-count":15,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S2213858716300067"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30006-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of glucagon in the artificial pancreas","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30006-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:00:25Z","timestamp":1790456425971,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Government of Italy Ministry of Education University and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/s2213-8587(23)00094-3","type":"journal-article","created":{"date-parts":[[2023,4,28]],"date-time":"2023-04-28T18:40:06Z","timestamp":1682707206000},"page":"402-413","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study"],"prefix":"10.1016","volume":"11","author":[{"given":"Fabio","family":"Medas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Dobrinja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebtesam Abdullah","family":"Al-Suhaimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Altmeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Said","family":"Anajar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akif Enes","family":"Arikan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Azaryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lovenish","family":"Bains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giancarlo","family":"Basili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakan","family":"Bolukbasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Bononi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzad","family":"Borumandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mehmet Bu\u011fra","family":"Bozan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriela","family":"Brenta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Brunaud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maximilian","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Buemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luigi","family":"Canu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Cappellacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara Burchfield","family":"Cartwright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignasi","family":"Castells Fust\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Cavalheiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Cavallaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Chala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun Yan Bryant","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chaplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mustafa Sajjad","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Chiapponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Grazia","family":"Chiofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Chrysos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"D'Amore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"de Cillia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmela","family":"De Crea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicol\u00f2","family":"de Manzini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leandro Luongo","family":"de Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"De Pasquale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Del Rio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco Stefano","family":"Demarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthuswamy","family":"Dhiwakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluca","family":"Donatini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Miguel","family":"Dora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valerio","family":"D'Orazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viyey Kishore","family":"Doulatram Gamgaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vitalijus","family":"Eismontas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El Hassane","family":"Kabiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadj Omar","family":"El Malki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Islam","family":"Elzahaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Octavian","family":"Enciu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Eskander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Feroci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Figueroa-Bohorquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Filis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Gorostidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Fr\u00edas-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Gamboa-Dominguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volkan","family":"Genc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"G\u00f3mez-Pedraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppa","family":"Graceffa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia Cuco","family":"Guerreiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keshav Kumar","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Gurrado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiannis","family":"Hajiioannou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommi","family":"Hakala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wirsma Arif","family":"Harahap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay","family":"Hargitai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Hartl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Hellmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Hlozek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Van Trung","family":"Hoang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Iacobone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Innaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orestis","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J H Isabelle","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose Candido","family":"Xavier-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Jovanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reto Martin","family":"Kaderli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahmi","family":"Kakamad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krzysztof","family":"Kaliszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Karamanliev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Katoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andro","family":"Ko\u0161ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bozidar","family":"Kovacevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luiz Paulo","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Kr\u00e1lik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay Kumar","family":"Yadav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri\u00e1na","family":"Kumorov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Savvas","family":"Lampridis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Lasithiotakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Christophe","family":"Leclere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene Kwong Fei","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melvin Khee-Shing","family":"Leow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James Y","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo S","family":"Lino-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shirley Yuk Wah","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N\u00faria Perucho","family":"Llorach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestino Pio","family":"Lombardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"L\u00f3pez-G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Lori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Quintanilla-Dieck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Lucchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amin","family":"Madani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios","family":"Manatakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Markovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Materazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haggi","family":"Mazeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Mercante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goswin Yason","family":"Meyer-Rochow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olgica","family":"Mihaljevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Minuto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Monacelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesk","family":"Mulita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Mullineris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"Mu\u00f1oz-de-Nova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F\u00e1bio","family":"Murad\u00e1s Girardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saki","family":"Nader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tangjaturonrasme","family":"Napadon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantinos","family":"Nastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Offi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohad","family":"Ronen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Oragano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aida","family":"Orois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongqin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanouil","family":"Panagiotidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakanth Bhargav","family":"Panchangam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodosios","family":"Papavramidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pradipta Kumar","family":"Parida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Paspala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00d2scar Vidal","family":"P\u00e9rez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Petrovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Raffaelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constanza Fernanda","family":"Ramacciotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Ratia Gimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1ngel","family":"Rivo V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jong-Lyel","family":"Roh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leonardo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Sanabria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Santeerapharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arseny","family":"Semenov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjeewa","family":"Seneviratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Altinay","family":"Serdar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Sheahan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean C","family":"Sheppard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L","family":"Slotcavage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Constantin","family":"Smaxwil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Sorrenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftherios","family":"Spartalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chutintorn","family":"Sriphrapradang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Testini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yigit","family":"Turk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tzikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Vabalayte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Vargas-Osorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael Sebasti\u00e1n","family":"V\u00e1zquez Renter\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Vel\u00e1zquez-Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanura Malinda Pallegoda","family":"Vithana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Levent","family":"Y\u00fccel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin Danil","family":"Yulian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Zahradnikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Zarogoulidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evgeniia","family":"Ziablitskaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Zolotoukho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro Giorgio","family":"Cal\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Abdallah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AL","family":"Abentroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Acheimastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Agunaoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HM","family":"Al Bisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Al Ghuzlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Alakus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Alkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MC","family":"Almaraz Almaraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Amram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Anesidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Anestiadou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Angelucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GL","family":"Ansaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MI","family":"Antonopoulou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Arciniegas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Armellin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Arredondo Salda\u00f1a","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Astl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Athanasakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Avenia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Ayd\u0131n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Baba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Babala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MV","family":"Ban\u00fas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LA","family":"Barba-Valadez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SV","family":"Barcons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Battafarano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bayat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RMC","family":"Bella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Benariba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bernardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EG","family":"Bignami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bitenc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bitsianis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JDD","family":"Bola\u00f1os de la Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Bonati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Bonetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FA","family":"Borges","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Bouchagier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Boudina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bourial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Breuskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Brock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bruns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MC","family":"Burlacu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Buta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Buzanakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Caliseo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Callanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Calu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"Cameselle-Teijeiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DJ","family":"Camilo-Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Canberk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Candalise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Candanedo-Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LJ","family":"Carrillo Lizarazo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GB","family":"Carvalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Casallas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Casolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Castellani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Castillo Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Chambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Chatzipavlidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Chernikov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Chorti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TCM","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Chrisoulidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Chrysos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Conrado-Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Cordova Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Corigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Crocco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cuesta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"\u010cukman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LS","family":"Curto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RA","family":"Damilano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"D'Anna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"De","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"De Virgilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Dellaportas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Demarquet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Devresse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Di Meo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Diaz Pedrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Dmitry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Dom\u00ednguez Garijo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Dulgeroglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AC","family":"Dural","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Eksi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"El Hammoumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"El Kaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Eleni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Elliyanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u015e","family":"Ers\u00f6z","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Escobar-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Fedorova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Feeley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Fern\u00e1ndez Rodr\u00edguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Ferreli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Filoia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fingeret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Francescato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Gaino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Galiandro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JF","family":"Gallegos-Hern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Garas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Garc\u00eda Lorenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JP","family":"Garc\u00eda-Ch\u00e1vez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gaudiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gerasimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gerek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Gervasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Gjeloshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Gock\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Golubinskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gonz\u00e1lez Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Gonz\u00e1lez-M\u00ednguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Goran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gosman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Granados Garcia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Greco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gr\u00fcnbart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Gr\u00fctzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Guerlain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XG","family":"Guirao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Guzey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hajjij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Hamdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MS","family":"Hameed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LA","family":"Hauth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JD","family":"Hern\u00e1ndez-Acevedo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JF","family":"Hernandez-Carrillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Hevilla S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Hoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Hongkwon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Hu Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Hyeung Kyoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Ignjatovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ioannidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Iossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"I\u015f\u0131k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Jung Hoon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Karajovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kartini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Khambri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Kholov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kisiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kne\u017eevi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YQ","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Konca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Kosmidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Kotsovolis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LP","family":"Kowalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kralik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Kuczma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BG","family":"Kuravi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kurnia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Kyriaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CM","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Lallemant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AA","family":"Lardhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Leboulleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JW","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Lelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Leutner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MY","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CM","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Llanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Lo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Loderer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"L\u00f3pez-Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FF","family":"Magnabosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Maheo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AL","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Makay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Maksimova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mallouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Mamani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Manthey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Manyalich Blasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Marincola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Marulanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mavromati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mayilvaganan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Metso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Micalizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Michalopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Min-Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Miron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AK","family":"Mishra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Misso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mittermair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Moros\u00e1n Allo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mourad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Moysidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Nabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Nasiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Nastos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KY","family":"Ngiam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Nomine-Criqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AM","family":"Ntziovara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"Nu\u00f1o V\u00e1zquez-Garza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Nutautiene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Obtulovi\u010dov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"O'Keeffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NO","family":"Okudur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ossola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Ovejero Merino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ozdemir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pangonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SS","family":"Panigoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Panuzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Papaconstantinou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Pardo Matamoros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SA","family":"Paschou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pasculli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Paterakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Peiris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Pennestr\u00ec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Peppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Perdikaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Perdikaris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RH","family":"P\u00e9rez-Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Piana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Piccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Pietrasanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Placentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Pliakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Polistena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pongtippan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Potard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Rahul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rankin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ratnayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Reuto-Castillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ridolfo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Rios-Valencia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Riss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Rival","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Rivillas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Roi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EM","family":"Rollo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Romanchishen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Romito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Rotnagl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Rovcanin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sabol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Saki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Saleh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Salih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Saltiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Salvador-Camarmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DK","family":"Samal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"S\u00e1nchez-Flores","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Sapalidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Sarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Savkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RS","family":"Scheffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AL","family":"Scheinpflug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Scheuba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Scheyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Senashova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Serafini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ML","family":"Serrano Ar\u00e9valo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Shank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ML","family":"Shindo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Shoshkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Shvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Si\u010d\u00e1k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TG","family":"Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Sim\u00f3 Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Skuletic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Slijepcevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Slovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Soares","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Somova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Soto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Spiezia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Stankovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KJ","family":"Stephenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Straub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Summa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Surani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AA","family":"Syed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Symeonidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Taciak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tarallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tarle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Tasis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Tausanovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Tchabashvili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Tokarczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EA","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Topuz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Torresan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Uras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Vaccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c1","family":"Vald\u00e9s de Anca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Valentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Varaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JG","family":"Vartanian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GI","family":"Verras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Vithanage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Wijayalathge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Wiriyaamornchai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YLC","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Wongwattana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Xenaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"YF","family":"Y\u0131lmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yotsov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MT","family":"Zahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Zielke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00094-3_bib1","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1002\/bjs.11670","article-title":"Immediate and long-term impact of the COVID-19 pandemic on delivery of surgical services","volume":"107","author":"S\u00f8reide","year":"2020","journal-title":"Br J Surg"},{"key":"10.1016\/S2213-8587(23)00094-3_bib2","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2468-1253(21)00005-4","article-title":"Impact of the COVID-19 pandemic on the detection and management of colorectal cancer in England: a population-based study","volume":"6","author":"Morris","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(23)00094-3_bib3","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.cgh.2020.09.008","article-title":"Impact of SARS-CoV-2 pandemic on colorectal cancer screening delay: effect on stage shift and increased mortality","volume":"19","author":"Ricciardiello","year":"2021","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(23)00094-3_bib4","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1177\/09691413221101807","article-title":"Assessing the impact of the COVID-19 pandemic on breast cancer screening and diagnosis rates: a rapid review and meta-analysis","volume":"29","author":"Ng","year":"2022","journal-title":"J Med Screen"},{"key":"10.1016\/S2213-8587(23)00094-3_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0274918","article-title":"Diagnosis and treatment of digestive cancers during COVID-19 in Japan: a cancer registry-based study on the impact of COVID-19 on cancer care in Osaka (CanReCO)","volume":"17","author":"Kajiwara Saito","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(23)00094-3_bib6","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/jso.26581","article-title":"Delay in breast cancer diagnosis and its clinical consequences during the coronavirus disease pandemic","volume":"124","author":"Koca","year":"2021","journal-title":"J Surg Oncol"},{"key":"10.1016\/S2213-8587(23)00094-3_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.26334","article-title":"Gastrointestinal cancer stage at diagnosis before and during the COVID-19 pandemic in Japan","volume":"4","author":"Kuzuu","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(23)00094-3_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.ejca.2022.01.040","article-title":"Impact of the COVID-19 pandemic on disease stage and treatment for patients with pancreatic adenocarcinoma: a French comprehensive multicentre ambispective observational cohort study (CAPANCOVID)","volume":"166","author":"Brugel","year":"2022","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2213-8587(23)00094-3_bib9","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1016\/S1470-2045(21)00493-9","article-title":"Effect of COVID-19 pandemic lockdowns on planned cancer surgery for 15 tumour types in 61 countries: an international, prospective, cohort study","volume":"22","author":"Glasbey","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(23)00094-3_bib10","doi-asserted-by":"crossref","first-page":"3493","DOI":"10.1002\/hed.26858","article-title":"Treatment delay and tumor size in patients with oral cancer during the first year of the COVID-19 pandemic","volume":"43","author":"Metzger","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/S2213-8587(23)00094-3_bib11","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1002\/hed.26665","article-title":"The impact of COVID-19 on head and neck cancer diagnosis and disease extent","volume":"43","author":"Kiong","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/S2213-8587(23)00094-3_bib12","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1093\/bjs\/znab012","article-title":"Impact of the COVID-19 pandemic on surgery for thyroid cancer in Italy: nationwide retrospective study","volume":"108","author":"Medas","year":"2021","journal-title":"Br J Surg"},{"key":"10.1016\/S2213-8587(23)00094-3_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s13304-021-00979-8","article-title":"Management of endocrine surgical disorders during COVID-19 pandemic: expert opinion for non-surgical options","volume":"74","author":"Agcaoglu","year":"2022","journal-title":"Updates Surg"},{"key":"10.1016\/S2213-8587(23)00094-3_bib14","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1089\/thy.2017.0500","article-title":"The 2017 Bethesda system for reporting thyroid cytopathology","volume":"27","author":"Cibas","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(23)00094-3_bib15","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3390\/endocrines2030029","article-title":"Reporting thyroid cytology in a globalized world","volume":"2","author":"Pizzimenti","year":"2021","journal-title":"Endocrines"},{"key":"10.1016\/S2213-8587(23)00094-3_bib16","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(23)00094-3_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s12020-022-03131-7","article-title":"The COVID-19 outbreak and de-escalation of thyroid cancer diagnosis and treatment","volume":"78","author":"Grani","year":"2022","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(23)00094-3_bib18","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s13304-021-01051-1","article-title":"The THYCOVIT (thyroid surgery during COVID-19 pandemic in Italy) study: results from a nationwide, multicentric, case-controlled study","volume":"73","author":"Medas","year":"2021","journal-title":"Updates Surg"},{"key":"10.1016\/S2213-8587(23)00094-3_bib19","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1007\/s00595-021-02406-2","article-title":"The impact of COVID-19 on surgical procedures in Japan: analysis of data from the National Clinical Database","volume":"52","author":"Ikeda","year":"2022","journal-title":"Surg Today"},{"key":"10.1016\/S2213-8587(23)00094-3_bib20","doi-asserted-by":"crossref","first-page":"7197","DOI":"10.2147\/IJGM.S339998","article-title":"More aggressive cancer behaviour in thyroid cancer patients in the post-COVID-19 pandemic era: a retrospective study","volume":"14","author":"Liu","year":"2021","journal-title":"Int J Gen Med"},{"key":"10.1016\/S2213-8587(23)00094-3_bib21","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.amjsurg.2009.11.008","article-title":"Improved detection does not fully explain the rising incidence of well-differentiated thyroid cancer: a population-based analysis","volume":"200","author":"Morris","year":"2010","journal-title":"Am J Surg"},{"key":"10.1016\/S2213-8587(23)00094-3_bib22","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.amjsurg.2020.12.015","article-title":"A systematic review and meta-analysis of surgery delays and survival in breast, lung and colon cancers: implication for surgical triage during the COVID-19 pandemic","volume":"222","author":"Johnson","year":"2021","journal-title":"Am J Surg"},{"key":"10.1016\/S2213-8587(23)00094-3_bib23","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1007\/s00384-022-04270-z","article-title":"A delay in the diagnosis of colorectal cancer screened by fecal immunochemical tests during the COVID-19 pandemic: a longitudinal cohort study","volume":"37","author":"Ishibashi","year":"2022","journal-title":"Int J Colorectal Dis"},{"key":"10.1016\/S2213-8587(23)00094-3_bib24","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1097\/XCS.0000000000000326","article-title":"Impact of surgical delay on tumor upstaging and outcomes in estrogen receptor-negative ductal carcinoma in situ patients","volume":"235","author":"Deliere","year":"2022","journal-title":"J Am Coll Surg"},{"key":"10.1016\/S2213-8587(23)00094-3_bib25","doi-asserted-by":"crossref","first-page":"6189","DOI":"10.1245\/s10434-022-12139-2","article-title":"Impact of COVID-19 restrictions on stage of breast cancer at presentation and time to treatment at an urban safety-net hospital","volume":"29","author":"Kapp","year":"2022","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S2213-8587(23)00094-3_bib26","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/j.jaad.2022.05.018","article-title":"The association between COVID-19 lockdowns and melanoma diagnosis and thickness: a multicenter retrospective study from Europe","volume":"87","author":"Scharf","year":"2022","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S2213-8587(23)00094-3_bib27","article-title":"Evaluation of COVID-19 impact on delaying diagnostic-therapeutic pathways of lung cancer patients in Italy (COVID-DELAY study): fewer cases and higher stages from a real-world scenario","volume":"7","author":"Cantini","year":"2022","journal-title":"ESMO Open"},{"key":"10.1016\/S2213-8587(23)00094-3_bib28","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1007\/s10147-022-02142-8","article-title":"Impact of the first era of the coronavirus disease 2019 pandemic on gastric cancer patients: a single-institutional analysis in Japan","volume":"27","author":"Fujita","year":"2022","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/S2213-8587(23)00094-3_bib29","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s40336-021-00419-y","article-title":"Prevalence of thyroid dysfunction in patients with COVID-19: a systematic review","volume":"9","author":"Giovanella","year":"2021","journal-title":"Clin Transl Imaging"},{"key":"10.1016\/S2213-8587(23)00094-3_bib30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(20)30266-7","article-title":"SARS-CoV-2-related atypical thyroiditis","volume":"8","author":"Muller","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00094-3_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.707726","article-title":"COVID-19-associated subacute thyroiditis: evidence-based data from a systematic review","volume":"12","author":"Trimboli","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(23)00094-3_bib32","article-title":"Delayed follow-up visits and thyrotropin among patients with levothyroxine during the COVID-19 pandemic","volume":"6","author":"Inoue","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(23)00094-3_bib33","doi-asserted-by":"crossref","first-page":"e73","DOI":"10.1055\/s-0039-1692406","article-title":"The difference in thyroid stimulating hormone levels between differentiated carcinoma and benign enlargement","volume":"24","author":"Rianto","year":"2020","journal-title":"Int Arch Otorhinolaryngol"},{"key":"10.1016\/S2213-8587(23)00094-3_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/jitc-2021-004049","article-title":"TSH-TSHR axis promotes tumor immune evasion","volume":"10","author":"Wu","year":"2022","journal-title":"J Immunother Cancer"},{"key":"10.1016\/S2213-8587(23)00094-3_bib35","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.jss.2019.07.025","article-title":"Increased incidental thyroid cancer in patients with subclinical chronic lymphocytic thyroiditis","volume":"245","author":"Jackson","year":"2020","journal-title":"J Surg Res"},{"key":"10.1016\/S2213-8587(23)00094-3_bib36","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1007\/s12022-022-09729-x","article-title":"Thyroid nodules with indeterminate FNAC according to the Italian classification system: prevalence, rate of operation, and impact on risk of malignancy. An updated systematic review and meta-analysis","volume":"33","author":"Trimboli","year":"2022","journal-title":"Endocr Pathol"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(23)00229-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000}},{"DOI":"10.1016\/s2213-8587(26)00254-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T00:00:00Z","timestamp":1790294400000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:29:47Z","timestamp":1790454587000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000943"}},"issued":{"date-parts":[[2023,6]]},"references-count":36,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2213858723000943"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00094-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the COVID-19 pandemic on surgery for indeterminate thyroid nodules (THYCOVID): a retrospective, international, multicentre, cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00094-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00089-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:01:02Z","timestamp":1790452862648,"version":"4.1.0"},"reference-count":202,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004836","name":"Independent Research Fund Denmark","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004836","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007438","name":"Hede Nielsen Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007438","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015223","name":"Danish Diabetes and Endocrine Academy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/s2213-8587(26)00192-0","type":"journal-article","created":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T22:39:37Z","timestamp":1790375977000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["New genomic understanding and challenges in clinical care of Turner syndrome"],"prefix":"10.1016","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5924-1720","authenticated-orcid":false,"given":"Claus H","family":"Gravholt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7890-8201","authenticated-orcid":false,"given":"Camilla M","family":"Balle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1017-7702","authenticated-orcid":false,"given":"Emma B","family":"Hasselholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-5784-8065","authenticated-orcid":false,"given":"Line B","family":"Valsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-5752-5372","authenticated-orcid":false,"given":"Etki","family":"Hartogsohn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7688-5357","authenticated-orcid":false,"given":"Ivonne","family":"Bedei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-3825-0000","authenticated-orcid":false,"given":"Jesper","family":"Just","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2398-9520","authenticated-orcid":false,"given":"Philippe","family":"Backeljauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4408-3413","authenticated-orcid":false,"given":"Kirstine","family":"Stochholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00192-0_bib1","doi-asserted-by":"crossref","first-page":"G53","DOI":"10.1093\/ejendo\/lvae050","article-title":"Clinical practice guidelines for the care of girls and women with Turner syndrome","volume":"190","author":"Gravholt","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib2","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1136\/bmj.312.7022.16","article-title":"Prenatal and postnatal prevalence of Turner's syndrome: a registry study","volume":"312","author":"Gravholt","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(26)00192-0_bib3","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF00289473","article-title":"The distribution of chromosomal genotypes associated with Turner's syndrome: livebirth prevalence rates and evidence for diminished fetal mortality and severity in genotypes associated with structural X abnormalities or mosaicism","volume":"64","author":"Hook","year":"1983","journal-title":"Hum Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib4","doi-asserted-by":"crossref","first-page":"2419","DOI":"10.1093\/humrep\/dev192","article-title":"Only a minority of sex chromosome abnormalities are detected by the Danish national prenatal screening program for Down syndrome","volume":"30","author":"Viuff","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(26)00192-0_bib5","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/gim.0b013e31822e57a7","article-title":"Decision to abort after a prenatal diagnosis of sex chromosome abnormality: a systematic review of the literature","volume":"14","author":"Jeon","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(26)00192-0_bib6","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/pd.4439","article-title":"Pregnancy outcomes of prenatally diagnosed Turner syndrome: a French multicenter retrospective study including a series of 975 cases","volume":"34","author":"Gruchy","year":"2014","journal-title":"Prenat Diagn"},{"key":"10.1016\/S2213-8587(26)00192-0_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2025.102002","article-title":"The epidemiology of disorders of sex development","volume":"39","author":"Berglund","year":"2025","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib8","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1002\/ijc.30126","article-title":"Risk of solid tumors and hematological malignancy in persons with Turner and Klinefelter syndromes: a national cohort study","volume":"139","author":"Ji","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(26)00192-0_bib9","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/s13023-018-0976-2","article-title":"Changes in the cohort composition of turner syndrome and severe non-diagnosis of Klinefelter, 47,XXX and 47,XYY syndrome: a nationwide cohort study","volume":"14","author":"Berglund","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(26)00192-0_bib10","doi-asserted-by":"crossref","first-page":"4735","DOI":"10.1210\/jc.2008-1049","article-title":"Mortality in women with turner syndrome in Great Britain: a national cohort study","volume":"93","author":"Schoemaker","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib11","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/s41436-018-0271-6","article-title":"Mosaic Turner syndrome shows reduced penetrance in an adult population study","volume":"21","author":"Tuke","year":"2019","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(26)00192-0_bib12","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/clinem\/dgz039","article-title":"Sex hormone replacement therapy in Turner Syndrome\u2014impact on morbidity and mortality","volume":"105","author":"Viuff","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib13","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/ajmg.a.30092","article-title":"Turner syndrome: evaluation of prenatal diagnosis in 19 European registries","volume":"129A","author":"Baena","year":"2004","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(26)00192-0_bib14","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1067\/mob.2003.230","article-title":"A characteristic cluster of fetal sonographic markers that are predictive of fetal Turner syndrome in early pregnancy","volume":"188","author":"Bronshtein","year":"2003","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib15","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1002\/pd.6320","article-title":"Multicenter clinical experience with non-invasive cell-free DNA screening for monosomy X and related X-chromosome variants","volume":"43","author":"Bedei","year":"2023","journal-title":"Prenat Diagn"},{"key":"10.1016\/S2213-8587(26)00192-0_bib16","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1002\/ajmg.c.32136","article-title":"Non-invasive prenatal testing by cell-free DNA (cfNIPT) for detecting turner syndrome with mosaicism and structural variants-prenatal findings and postnatal outcomes","volume":"199","author":"Bedei","year":"2025","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100879","article-title":"Performance of prenatal cfDNA screening for sex chromosomes","volume":"25","author":"Martin","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(26)00192-0_bib18","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1002\/pd.5138","article-title":"Implications of fetoplacental mosaicism on cell-free DNA testing for sex chromosome aneuploidies","volume":"37","author":"Grati","year":"2017","journal-title":"Prenat Diagn"},{"key":"10.1016\/S2213-8587(26)00192-0_bib19","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1373\/clinchem.2013.215145","article-title":"Maternal mosaicism is a significant contributor to discordant sex chromosomal aneuploidies associated with noninvasive prenatal testing","volume":"60","author":"Wang","year":"2014","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(26)00192-0_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1002\/ajmg.c.32140","article-title":"Parental decision-making following a prenatal diagnosis of Turner syndrome: a systematic review","volume":"199","author":"Dorf","year":"2025","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib21","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1002\/pd.5814","article-title":"Confirmation rate of cell free DNA screening for sex chromosomal abnormalities according to the method of confirmatory testing","volume":"41","author":"L\u00fcthgens","year":"2021","journal-title":"Prenat Diagn"},{"key":"10.1016\/S2213-8587(26)00192-0_bib22","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1210\/jc.2006-0558","article-title":"Prevalence, incidence, diagnostic delay, and mortality in Turner syndrome","volume":"91","author":"Stochholm","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib24","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.1002\/ajmg.a.62459","article-title":"Age at and indication for diagnosis of Turner syndrome in the pediatric population","volume":"185","author":"Swauger","year":"2021","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(26)00192-0_bib25","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/S2215-0366(23)00004-4","article-title":"Associations of psychiatric disorders with sex chromosome aneuploidies in the Danish iPSYCH2015 dataset: a case-cohort study","volume":"10","author":"S\u00e1nchez","year":"2023","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/S2213-8587(26)00192-0_bib26","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1515\/cclm-2024-1400","article-title":"Reliable detection of sex chromosome abnormalities by quantitative fluorescence polymerase chain reaction","volume":"63","author":"Balle","year":"2025","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/S2213-8587(26)00192-0_bib27","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1089\/gtmb.2019.0226","article-title":"Gene copy number quantification of SHOX, VAMP7, and SRY for the detection of sex chromosome aneuploidies in neonates","volume":"24","author":"Ibarra-Ram\u00edrez","year":"2020","journal-title":"Genet Test Mol Biomarkers"},{"key":"10.1016\/S2213-8587(26)00192-0_bib28","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1210\/jc.2016-3414","article-title":"Whole-exome sequencing for diagnosis of Turner syndrome: towards next generation sequencing and newborn screening","volume":"102","author":"Murdock","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib29","doi-asserted-by":"crossref","DOI":"10.1093\/bioinformatics\/btag104","article-title":"Identification of autosomal and sex chromosome aneuploidies using next generation sequencing","volume":"42","author":"Barco-Armengol","year":"2026","journal-title":"Bioinformatics"},{"key":"10.1016\/S2213-8587(26)00192-0_bib30","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0895-4356(97)00237-0","article-title":"Morbidity in Turner syndrome","volume":"51","author":"Gravholt","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ahj.2024.11.007","article-title":"All-cause mortality and death by aortic dissection in women with Turner syndrome: a national clinical cohort study","volume":"281","author":"Thunstr\u00f6m","year":"2025","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(26)00192-0_bib32","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1111\/apt.16277","article-title":"Increased occurrence of liver and gastrointestinal diseases and anaemia in women with Turner syndrome\u2014a nationwide cohort study","volume":"53","author":"Viuff","year":"2021","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S2213-8587(26)00192-0_bib33","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41431-021-00989-5","article-title":"Disorders of the eye, ear, skin, and nervous system in women with Turner syndrome\u2014a nationwide cohort study","volume":"30","author":"Viuff","year":"2022","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib34","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.pedneo.2025.06.009","article-title":"Incidence and multisystem preadolescent complications of Turner syndrome: a nationwide study","volume":"67","author":"Cha","year":"2026","journal-title":"Pediatr Neonatol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib35","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1002\/bdr2.2222","article-title":"The burden of disease for children born alive with Turner syndrome-A European cohort study","volume":"115","author":"Andersen","year":"2023","journal-title":"Birth Defects Res"},{"key":"10.1016\/S2213-8587(26)00192-0_bib36","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.a.63819","article-title":"Prevalence, diagnostic features, and medical outcomes of females with Turner syndrome with a trisomy X cell line (45,X\/47,XXX): results from the InsighTS Registry","volume":"194","author":"Klamut","year":"2024","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(26)00192-0_bib37","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/cen.13394","article-title":"The Turner syndrome life course project: karyotype-phenotype analyses across the lifespan","volume":"87","author":"Cameron-Pimblett","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib38","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1530\/EJE-18-0878","article-title":"X chromosome gene dosage as a determinant of congenital malformations and of age-related comorbidity risk in patients with Turner syndrome, from childhood to early adulthood","volume":"180","author":"Fiot","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib39","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1210\/endrev\/bnac016","article-title":"The changing face of Turner syndrome","volume":"44","author":"Gravholt","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(26)00192-0_bib40","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1530\/EJE-20-0702","article-title":"Cancer occurrence in Turner syndrome and the effect of sex hormone substitution therapy","volume":"184","author":"Viuff","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib41","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/S1470-2045(08)70033-0","article-title":"Cancer incidence in women with Turner syndrome in Great Britain: a national cohort study","volume":"9","author":"Schoemaker","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib42","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.118.011501","article-title":"Long-term outcomes in patients with Turner syndrome: a 68-year follow-up","volume":"8","author":"Fuchs","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(26)00192-0_bib43","doi-asserted-by":"crossref","first-page":"991","DOI":"10.3349\/ymj.2022.0143","article-title":"Population prevalence, cancer risk, and mortality risk of turner syndrome in South Korean women based on National Health Insurance Service data","volume":"63","author":"Kim","year":"2022","journal-title":"Yonsei Med J"},{"key":"10.1016\/S2213-8587(26)00192-0_bib44","doi-asserted-by":"crossref","first-page":"4864","DOI":"10.1073\/pnas.1910003117","article-title":"Integrated functional genomic analyses of Klinefelter and Turner syndromes reveal global network effects of altered X chromosome dosage","volume":"117","author":"Zhang","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(26)00192-0_bib45","doi-asserted-by":"crossref","first-page":"7398","DOI":"10.1073\/pnas.1802889115","article-title":"Sex-chromosome dosage effects on gene expression in humans","volume":"115","author":"Raznahan","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(26)00192-0_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13073-023-01169-4","article-title":"X chromosome dosage and the genetic impact across human tissues","volume":"15","author":"Viuff","year":"2023","journal-title":"Genome Med"},{"key":"10.1016\/S2213-8587(26)00192-0_bib47","doi-asserted-by":"crossref","DOI":"10.1038\/srep34220","article-title":"Widespread DNA hypomethylation and differential gene expression in Turner syndrome","volume":"6","author":"Trolle","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(26)00192-0_bib48","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41525-025-00467-7","article-title":"Elevated levels of neutrophils with a pro-inflammatory profile in Turner syndrome across karyotypes","volume":"10","author":"Just","year":"2025","journal-title":"NPJ Genom Med"},{"key":"10.1016\/S2213-8587(26)00192-0_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.872750","article-title":"DNA methylation analysis of Turner syndrome BAV","volume":"13","author":"Gutierrez","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib50","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1186\/s13148-025-01963-4","article-title":"Epigenetic age acceleration in Turner and Klinefelter syndrome: correlations with clinical aging markers","volume":"17","author":"Hasselholm","year":"2025","journal-title":"Clin Epigenetics"},{"key":"10.1016\/S2213-8587(26)00192-0_bib51","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.cell.2023.11.033","article-title":"XIST directly regulates X-linked and autosomal genes in naive human pluripotent cells","volume":"187","author":"Dror","year":"2024","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(26)00192-0_bib52","doi-asserted-by":"crossref","first-page":"975","DOI":"10.3390\/ijms26030975","article-title":"Expression patterns of escape genes in Turner syndrome fibroblasts and induced pluripotent stem cells","volume":"26","author":"Byun","year":"2025","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(26)00192-0_bib53","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/s11882-016-0612-y","article-title":"Epigenetic dysfunction in Turner syndrome immune cells","volume":"16","author":"Thrasher","year":"2016","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/S2213-8587(26)00192-0_bib54","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1024244","article-title":"Bioinformatic analysis identifies the immunological profile of turner syndrome with different X chromosome origins","volume":"14","author":"Qi","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib55","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.12354","article-title":"Origin of the X-chromosome influences the development and treatment outcomes of Turner syndrome","volume":"9","author":"Zhang","year":"2021","journal-title":"PeerJ"},{"key":"10.1016\/S2213-8587(26)00192-0_bib56","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-025-89843-y","article-title":"Cytogenomic characterization of mosaic X-ring chromosomes in seventeen patients with Turner syndrome (TS)-42 years of experience at a single-site institution","volume":"15","author":"Madison","year":"2025","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(26)00192-0_bib57","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmg.39.3.217","article-title":"Phenotypic effects of mosaicism for a 47,XXX cell line in Turner syndrome","volume":"39","author":"Sybert","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib58","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/BF00193192","article-title":"The similarity of phenotypic effects caused by Xp and Xq deletions in the human female: a hypothesis","volume":"85","author":"Therman","year":"1990","journal-title":"Hum Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib59","doi-asserted-by":"crossref","DOI":"10.1038\/s41390-026-04797-9","article-title":"Ultra-performance liquid chromatography-mass spectrometry-based metabolic profiling of prepubertal children with Turner syndrome","author":"Zhou","year":"2026","journal-title":"Pediatr Res"},{"key":"10.1016\/S2213-8587(26)00192-0_bib60","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3390\/jcm9030664","article-title":"Metabolic fingerprint of Turner syndrome","volume":"9","author":"Bugajska","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/S2213-8587(26)00192-0_bib61","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf059","article-title":"Elevated liver enzymes in Turner syndrome: the role of low-grade inflammation and hormonal imbalances","volume":"9","author":"Ridder","year":"2025","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(26)00192-0_bib62","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae099","article-title":"Systemic inflammatory indices and liver dysfunction in Turner syndrome patients: a retrospective case-control study","volume":"8","author":"Zaegel","year":"2024","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(26)00192-0_bib63","doi-asserted-by":"crossref","first-page":"e602","DOI":"10.1210\/clinem\/dgad566","article-title":"Autoimmune disease in Turner syndrome in Sweden: an up to 25 years' controlled follow-up study","volume":"109","author":"Naess\u00e9n","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib64","doi-asserted-by":"crossref","first-page":"560","DOI":"10.3345\/cep.2024.00430","article-title":"Lifelong medical challenges and immunogenetics of Turner syndrome","volume":"67","author":"Cho","year":"2024","journal-title":"Clin Exp Pediatr"},{"key":"10.1016\/S2213-8587(26)00192-0_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.humimm.2024.111164","article-title":"Investigating the influence of inflammasome complex genes on Turner syndrome","volume":"85","author":"Samanta Moraes Laranjeira","year":"2024","journal-title":"Hum Immunol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib66","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1111\/iji.12323","article-title":"Analysis of PTPN22, ZFAT and MYO9B polymorphisms in Turner syndrome and risk of autoimmune disease","volume":"44","author":"Villanueva-Ortega","year":"2017","journal-title":"Int J Immunogenet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib67","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ng0597-54","article-title":"Pseudoautosomal deletions encompassing a novel homeobox gene cause growth failure in idiopathic short stature and Turner syndrome","volume":"16","author":"Rao","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib68","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1068128","article-title":"Growth in girls with Turner syndrome","volume":"13","author":"Isojima","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib69","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1210\/jcem.87.5.8477","article-title":"Growth hormone and low dose estrogen in Turner syndrome: results of a United States multi-center trial to near-final height","volume":"87","author":"Quigley","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib70","doi-asserted-by":"crossref","first-page":"3360","DOI":"10.1210\/jc.2004-2187","article-title":"Impact of growth hormone supplementation on adult height in turner syndrome: results of the Canadian randomized controlled trial","volume":"90","author":"Stephure","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib71","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1210\/jc.2002-021171","article-title":"Final height in girls with turner syndrome after long-term growth hormone treatment in three dosages and low dose estrogens","volume":"88","author":"van Pareren","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib72","doi-asserted-by":"crossref","first-page":"3406","DOI":"10.1210\/jc.2006-2874","article-title":"Growth hormone treatment of early growth failure in toddlers with Turner syndrome: a randomized, controlled, multicenter trial","volume":"92","author":"Davenport","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib73","first-page":"1936","article-title":"Early initiation of growth hormone treatment allows age-appropriate estrogen use in Turner's syndrome","volume":"86","author":"Reiter","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib74","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1203\/01.pdr.0000250039.42000.c9","article-title":"Major determinants of height development in Turner syndrome (TS) patients treated with GH: analysis of 987 patients from KIGS","volume":"61","author":"Ranke","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/S2213-8587(26)00192-0_bib75","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1210\/jc.2009-0178","article-title":"Long-term safety of recombinant human growth hormone in children","volume":"95","author":"Bell","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 5","key":"10.1016\/S2213-8587(26)00192-0_bib76","first-page":"41","article-title":"Headache, idiopathic intracranial hypertension and slipped capital femoral epiphysis during growth hormone treatment: a safety update from the KIGS database","volume":"68","author":"Darendeliler","year":"2007","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(26)00192-0_bib77","doi-asserted-by":"crossref","DOI":"10.1159\/000550211","article-title":"Real-world evidence of treatment patterns and costs of Turner syndrome and Noonan syndrome in the United States","author":"Dauber","year":"2025","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(26)00192-0_bib78","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1210\/er.2016-1036","article-title":"A track record on SHOX: from basic research to complex models and therapy","volume":"37","author":"Marchini","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(26)00192-0_bib79","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgag309","article-title":"Once-weekly somapacitan enhances linear growth in girls with Turner syndrome: a randomized controlled phase 3 study","author":"Mauras","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib80","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1210\/clinem\/dgag093","article-title":"Long-acting growth hormone for treating growth hormone deficiency in children: a meta-analysis of randomized controlled trials focusing on changes in body mass index","volume":"111","author":"Levaillant","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib81","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1210\/jc.2017-02183","article-title":"Estrogen replacement in Turner syndrome: literature review and practical considerations","volume":"103","author":"Klein","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib82","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000500050","article-title":"Optimal pubertal induction in girls with Turner syndrome using either oral or transdermal estradiol: a proposed modern strategy","volume":"91","author":"Donaldson","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(26)00192-0_bib83","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1530\/EC-19-0025","article-title":"Estradiol matrix patches for pubertal induction: stability of cut pieces at different temperatures","volume":"8","author":"Ankarberg-Lindgren","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(26)00192-0_bib84","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1056\/NEJMoa1005669","article-title":"Growth hormone plus childhood low-dose estrogen in Turner's syndrome","volume":"364","author":"Ross","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00192-0_bib85","doi-asserted-by":"crossref","DOI":"10.1172\/JCI197932","article-title":"Estrogen deficiency and risk of hearing loss in pediatric Turner syndrome","volume":"136","author":"Huang","year":"2026","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(26)00192-0_bib86","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1210\/clinem\/dgz196","article-title":"Sex-specific estrogen levels and reference intervals from infancy to late adulthood determined by LC-MS\/MS","volume":"105","author":"Frederiksen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib87","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1530\/EC-21-0134","article-title":"Female-dominant estrogen production in healthy children before adrenarche","volume":"10","author":"Igarashi","year":"2021","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(26)00192-0_bib88","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1210\/clinem\/dgac167","article-title":"Women with Turner syndrome are both estrogen and androgen deficient\u2014the impact of hormone replacement therapy","volume":"107","author":"Viuff","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib89","doi-asserted-by":"crossref","first-page":"4820","DOI":"10.1210\/jc.2009-0514","article-title":"Androgen replacement therapy in Turner syndrome: a pilot study","volume":"94","author":"Zuckerman-Levin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib90","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1515\/jpem-2020-0155","article-title":"Readiness for transition to adult care in adolescents and young adults with Turner syndrome","volume":"33","author":"Sheanon","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib91","doi-asserted-by":"crossref","DOI":"10.1002\/ajmg.c.32131","article-title":"Transition to adult care in Turner syndrome: research gaps and strategies for achieving success","volume":"199","author":"Nahata","year":"2025","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib92","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvag020","article-title":"European Society for Paediatric Endocrinology (ESPE) and European Society of Endocrinology (ESE) joint clinical practice guidance for healthcare transition from paediatric to adult endocrine care","volume":"194","author":"Le Roux","year":"2026","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib93","doi-asserted-by":"crossref","first-page":"3157","DOI":"10.1002\/ajmg.a.37953","article-title":"Autosomal and X chromosome structural variants are associated with congenital heart defects in Turner syndrome: the NHLBI GenTAC registry","volume":"170","author":"Prakash","year":"2016","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(26)00192-0_bib94","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1017\/S1047951106000928","article-title":"Clinical and epidemiological description of aortic dissection in Turner's syndrome","volume":"16","author":"Gravholt","year":"2006","journal-title":"Cardiol Young"},{"key":"10.1016\/S2213-8587(26)00192-0_bib95","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1097\/HJH.0000000000000599","article-title":"Arterial hypertension in Turner syndrome: a review of the literature and a practical approach for diagnosis and treatment","volume":"33","author":"De Groote","year":"2015","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(26)00192-0_bib96","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/01.hjh.0000200509.17947.0f","article-title":"Nocturnal hypertension and impaired sympathovagal tone in Turner syndrome","volume":"24","author":"Gravholt","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(26)00192-0_bib97","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1530\/eje.1.02267","article-title":"Body composition is distinctly altered in Turner syndrome: relations to glucose metabolism, circulating adipokines, and endothelial adhesion molecules","volume":"155","author":"Gravholt","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib98","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.eprac.2023.11.013","article-title":"Abnormal body composition increases the cardiometabolic risk in adolescents and young adults with Turner syndrome","volume":"30","author":"Mondal","year":"2024","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(26)00192-0_bib99","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad124","article-title":"A prospective study of lipids in adult women with Turner syndrome","volume":"7","author":"Sandahl","year":"2023","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(26)00192-0_bib100","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.78263","article-title":"Age acquired skewed X chromosome inactivation is associated with adverse health outcomes in humans","volume":"11","author":"Roberts","year":"2022","journal-title":"eLife"},{"key":"10.1016\/S2213-8587(26)00192-0_bib101","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0477","article-title":"Prevalence and management of hypertension in Turner syndrome: data from the International Turner syndrome (I-TS) registry","volume":"14","author":"Mathara Diddhenipothage","year":"2025","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(26)00192-0_bib102","article-title":"Lifelong aortic risk in Turner syndrome: unexpected aortic events in asymptomatic patients","volume":"11","author":"Jaiswal","year":"2025","journal-title":"J Vasc Surg Cases Innov Tech"},{"key":"10.1016\/S2213-8587(26)00192-0_bib103","first-page":"124","article-title":"Heart and aorta anomalies in Turner syndrome and relation with karyotype","volume":"17","author":"Kardelen Al","year":"2021","journal-title":"Acta Endocrinol (Bucur)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib104","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1002\/ajmg.c.32139","article-title":"Management of cardiovascular health issues in Turner syndrome: expert insights and expanded recommendations from the 2024 guideline development team","volume":"199","author":"de Groote","year":"2025","journal-title":"Am J Med Genet C Semin Med Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2025.1622222","article-title":"Diagnostic value of cardiac magnetic resonance imaging during transition care in adolescents with Turner syndrome","volume":"13","author":"Wi\u0119cek","year":"2025","journal-title":"Front Pediatr"},{"key":"10.1016\/S2213-8587(26)00192-0_bib106","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s10237-024-01892-w","article-title":"Unraveling aortic hemodynamics using fluid structure interaction: biomechanical insights into bicuspid aortic valve dynamics with multiple aortic lesions","volume":"24","author":"Govindarajan","year":"2025","journal-title":"Biomech Model Mechanobiol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib107","doi-asserted-by":"crossref","first-page":"569","DOI":"10.21037\/acs-2023-adw-0083","article-title":"Outcomes of cardiothoracic surgery in women with Turner syndrome","volume":"12","author":"Rib\u00e9","year":"2023","journal-title":"Ann Cardiothorac Surg"},{"key":"10.1016\/S2213-8587(26)00192-0_bib108","doi-asserted-by":"crossref","first-page":"97","DOI":"10.4330\/wjc.v12.i3.97","article-title":"Cardiovascular surgery in Turner syndrome\u2014early outcome and long-term follow-up","volume":"12","author":"Fuchs","year":"2020","journal-title":"World J Cardiol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib109","first-page":"69","article-title":"Insulin resistance is an intrinsic defect independent of fat mass in women with Turner's syndrome","volume":"65","author":"Salgin","year":"2006","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(26)00192-0_bib110","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1472-6823-11-6","article-title":"Delayed \u03b2-cell response and glucose intolerance in young women with Turner syndrome","volume":"11","author":"Hjerrild","year":"2011","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(26)00192-0_bib111","doi-asserted-by":"crossref","first-page":"3289","DOI":"10.1210\/jc.2009-0384","article-title":"X-chromosome gene dosage and the risk of diabetes in Turner syndrome","volume":"94","author":"Bakalov","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib112","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/diacare.21.7.1062","article-title":"Glucose metabolism, lipid metabolism, and cardiovascular risk factors in adult Turner's syndrome. The impact of sex hormone replacement","volume":"21","author":"Gravholt","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00192-0_bib113","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s12020-017-1336-z","article-title":"New insights on diabetes in Turner syndrome: results from an observational study in adulthood","volume":"59","author":"Ibarra-Gasparini","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(26)00192-0_bib114","article-title":"Characterization of Turner syndrome\u2014associated diabetes mellitus","author":"Cameron-Pimblett","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib115","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/j.1365-2249.2009.03895.x","article-title":"Increased prevalence of autoimmunity in Turner syndrome\u2014influence of age","volume":"156","author":"Mortensen","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib116","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1046\/j.1365-2265.1999.00841.x","article-title":"Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy","volume":"51","author":"Landin-Wilhelmsen","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib117","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1046\/j.1365-2265.2003.01807.x","article-title":"Increased fracture rates in Turner's syndrome: a nationwide questionnaire survey","volume":"59","author":"Gravholt","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib118","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0002-9343(03)00364-4","article-title":"Bone mineral density and fractures in Turner syndrome","volume":"115","author":"Bakalov","year":"2003","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(26)00192-0_bib119","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1530\/EJE-09-0020","article-title":"Long-term hormone replacement therapy preserves bone mineral density in Turner syndrome","volume":"161","author":"Cleemann","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib120","doi-asserted-by":"crossref","first-page":"3792","DOI":"10.1210\/jc.2018-00854","article-title":"A cross-sectional and longitudinal analysis of trabecular bone score in adults with Turner syndrome","volume":"103","author":"Nguyen","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib121","doi-asserted-by":"crossref","first-page":"e9","DOI":"10.3346\/jkms.2024.39.e9","article-title":"Effects of hormone replacement therapy on bone mineral density in korean adults with Turner syndrome","volume":"39","author":"Kim","year":"2024","journal-title":"J Korean Med Sci"},{"key":"10.1016\/S2213-8587(26)00192-0_bib122","doi-asserted-by":"crossref","first-page":"1794","DOI":"10.1002\/jbmr.1624","article-title":"Compromised trabecular microarchitecture and lower finite element estimates of radius and tibia bone strength in adults with turner syndrome: a cross-sectional study using high-resolution-pQCT","volume":"27","author":"Hansen","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00192-0_bib123","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1210\/jc.2017-02381","article-title":"A 6-year follow-up of fracture incidence and volumetric bone mineral density development in girls with Turner syndrome","volume":"103","author":"Soucek","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib124","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/cen.14484","article-title":"Starting age of oestrogen-progestin therapy is negatively associated with bone mineral density in young adults with Turner syndrome independent of age and body mass index","volume":"95","author":"Nishigaki","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib125","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-16-0582","article-title":"Dosage of estradiol, bone and body composition in Turner syndrome: a 5-year randomized controlled clinical trial","volume":"176","author":"Cleemann","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib126","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1359\/jbmr.2000.15.10.2005","article-title":"Spontaneous, but not induced, puberty permits adequate bone mass acquisition in adolescent Turner syndrome patients","volume":"15","author":"Carrascosa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00192-0_bib127","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1080\/13697137.2017.1325461","article-title":"Delay in estrogen commencement is associated with lower bone mineral density in Turner syndrome","volume":"20","author":"Nguyen","year":"2017","journal-title":"Climacteric"},{"key":"10.1016\/S2213-8587(26)00192-0_bib128","doi-asserted-by":"crossref","DOI":"10.1016\/j.jocd.2025.101635","article-title":"Low bone mass is common and associated with delayed estrogen replacement therapy in adult Brazilian women with Turner syndrome","volume":"29","author":"Vieira","year":"2026","journal-title":"J Clin Densitom"},{"key":"10.1016\/S2213-8587(26)00192-0_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.jaut.2007.05.002","article-title":"Epidemiology of autoimmune diseases in Denmark","volume":"29","author":"Eaton","year":"2007","journal-title":"J Autoimmun"},{"key":"10.1016\/S2213-8587(26)00192-0_bib130","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/j.yfrne.2014.04.004","article-title":"Gender differences in autoimmune disease","volume":"35","author":"Ngo","year":"2014","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib131","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1002\/art.27270","article-title":"Autoimmune diseases in women with Turner's syndrome","volume":"62","author":"J\u00f8rgensen","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(26)00192-0_bib132","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1547430","article-title":"Analysis of influencing factors on Turner syndrome combined with autoimmune thyroid disease","volume":"16","author":"Cen","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib133","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1186\/s13104-018-3950-0","article-title":"Prevalence of autoimmune thyroid diseases among the Turner Syndrome patients: meta-analysis of cross sectional studies","volume":"11","author":"Mohamed","year":"2018","journal-title":"BMC Res Notes"},{"key":"10.1016\/S2213-8587(26)00192-0_bib134","article-title":"Prevalence of celiac disease in patients with Turner syndrome: systematic review and meta-analysis","volume":"8","author":"Al-Bluwi","year":"2021","journal-title":"Front Med (Lausanne)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib135","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/ecco-jcc\/jjac103","article-title":"Chromosomal numerical aberrations and rare copy number variation in patients with inflammatory bowel disease","volume":"17","author":"Dirvanskyte","year":"2023","journal-title":"J Crohns Colitis"},{"key":"10.1016\/S2213-8587(26)00192-0_bib136","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/humrep\/det436","article-title":"Gene dosage as a relevant mechanism contributing to the determination of ovarian function in Turner syndrome","volume":"29","author":"Castronovo","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(26)00192-0_bib137","doi-asserted-by":"crossref","first-page":"307","DOI":"10.3389\/fendo.2018.00307","article-title":"Immunological profile and predisposition to autoimmunity in girls with Turner syndrome","volume":"9","author":"Gawlik","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib138","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jaut.2012.01.015","article-title":"Autoimmune disorders in women with turner syndrome and women with karyotypically normal primary ovarian insufficiency","volume":"38","author":"Bakalov","year":"2012","journal-title":"J Autoimmun"},{"key":"10.1016\/S2213-8587(26)00192-0_bib139","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1046\/j.1365-2265.2001.01296.x","article-title":"Autoimmune thyroid syndrome in women with Turner's syndrome\u2014the association with karyotype","volume":"55","author":"Elsheikh","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib140","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1530\/EC-13-0067","article-title":"The macrophage low-grade inflammation marker sCD163 is modulated by exogenous sex steroids","volume":"2","author":"Thomsen","year":"2013","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(26)00192-0_bib141","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1097\/MAO.0000000000003118","article-title":"Prevalence of otological disease in Turner syndrome: a systematic review","volume":"42","author":"Geerardyn","year":"2021","journal-title":"Otol Neurotol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib142","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.3109\/00016480902741962","article-title":"A longitudinal study of hearing decline in women with Turner syndrome","volume":"129","author":"Hederstierna","year":"2009","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib143","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/TACG.S229828","article-title":"Metabolic syndrome as a risk factor for sensorineural hearing loss in adult patients with Turner syndrome","volume":"13","author":"\u00c1lvarez-Nava","year":"2020","journal-title":"Appl Clin Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib144","doi-asserted-by":"crossref","first-page":"111","DOI":"10.3109\/09513590.2013.856002","article-title":"Hearing loss in adult women with Turner's syndrome and other congenital hypogonadisms","volume":"30","author":"Ros","year":"2014","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib145","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.heares.2008.11.006","article-title":"Estrogen and hearing from a clinical point of view; characteristics of auditory function in women with Turner syndrome","volume":"252","author":"Hederstierna","year":"2009","journal-title":"Hear Res"},{"key":"10.1016\/S2213-8587(26)00192-0_bib146","doi-asserted-by":"crossref","DOI":"10.1016\/j.bjorl.2025.101713","article-title":"High frequency of balance abnormalities in Turner syndrome","volume":"92","author":"Rocha","year":"2026","journal-title":"Braz J Otorhinolaryngol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib147","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0378-5955(01)00280-5","article-title":"Estrogen receptors in the normal adult and developing human inner ear and in Turner's syndrome","volume":"157","author":"Stenberg","year":"2001","journal-title":"Hear Res"},{"key":"10.1016\/S2213-8587(26)00192-0_bib148","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1080\/00016480310001097","article-title":"Ear and hearing problems in Turner's syndrome","volume":"123","author":"Hultcrantz","year":"2003","journal-title":"Acta Otolaryngol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib149","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1111\/j.1365-2265.2009.03715.x","article-title":"Health status in women with Turner syndrome: a questionnaire study on health status, education, work participation and aspects of sexual functioning","volume":"72","author":"Naess","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib150","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1159\/000502902","article-title":"Turner syndrome systematic review: spontaneous thelarche and menarche stratified by karyotype","volume":"92","author":"Dabrowski","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(26)00192-0_bib151","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1093\/humrep\/deab210","article-title":"Accelerated loss of oogonia and impaired folliculogenesis in females with Turner syndrome start during early fetal development","volume":"36","author":"Lundgaard Riis","year":"2021","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(26)00192-0_bib152","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/j.fertnstert.2003.12.011","article-title":"Number of ovarian follicles in human fetuses with the 45,X karyotype","volume":"81","author":"Reynaud","year":"2004","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(26)00192-0_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1640583","article-title":"Anti-M\u00fcllerian hormone as a biomarker of ovarian function and spontaneous puberty in Turner syndrome: a systematic review","volume":"16","author":"Bin-Abbas","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib154","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1016\/j.fertnstert.2025.07.003","article-title":"Minipuberty in girls with Turner syndrome provides insight into reproductive potential-a prospective cohort study","volume":"124","author":"van der Coelen","year":"2025","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(26)00192-0_bib155","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoae065","article-title":"Evidence-based guideline: premature ovarian insufficiency","volume":"2024","author":"Panay","year":"2024","journal-title":"Hum Reprod Open"},{"key":"10.1016\/S2213-8587(26)00192-0_bib156","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1093\/humrep\/deaf249","article-title":"Fertility preservation and counselling in prepubertal and pubertal girls with Turner syndrome","volume":"41","author":"Sage","year":"2026","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(26)00192-0_bib157","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1186\/s12884-024-06801-8","article-title":"Live birth rate after oocyte donation in females diagnosed with turner syndrome: a systematic review and meta-analysis","volume":"24","author":"Rashidian","year":"2024","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(26)00192-0_bib158","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1111\/cen.15078","article-title":"Fertility and pregnancy outcomes in women with Turner syndrome: a single centre experience","volume":"101","author":"Burt","year":"2024","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib159","doi-asserted-by":"crossref","DOI":"10.1093\/eurjpc\/zwaf574","article-title":"Cardiovascular outcomes and aortic growth in pregnant women with Turner syndrome: data from the ESC EORP Registry of Pregnancy and Cardiac Disease (ROPAC) III","author":"Van Der Zande","year":"2025","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib160","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.1093\/humrep\/det082","article-title":"Obstetric and neonatal outcome after oocyte donation in 106 women with Turner syndrome: a Nordic cohort study","volume":"28","author":"Hagman","year":"2013","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(26)00192-0_bib161","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/j.fertnstert.2025.12.001","article-title":"Fertility preservation in patients with medical indications: a committee opinion","volume":"125","author":"Gracia","year":"2026","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(26)00192-0_bib162","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1007\/s10815-022-02420-4","article-title":"First live birth after fertility preservation using vitrification of oocytes in a woman with mosaic Turner syndrome","volume":"39","author":"Strypstein","year":"2022","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib163","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/j.molmed.2020.11.003","article-title":"Fertility preservation: the challenge of freezing and transplanting ovarian tissue","volume":"27","author":"Dolmans","year":"2021","journal-title":"Trends Mol Med"},{"key":"10.1016\/S2213-8587(26)00192-0_bib164","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1007\/s10815-021-02127-y","article-title":"Reproductive outcomes after preimplantation genetic testing in mosaic Turner syndrome: a retrospective cohort study of 100 cycles","volume":"38","author":"Liao","year":"2021","journal-title":"J Assist Reprod Genet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib165","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1186\/s13023-025-04104-5","article-title":"The Danish Turner Syndrome Cryopreservation study: PROTOCOL for a prospective cohort study on reproductive outcomes after ovarian tissue cryopreservation in girls with Turner syndrome","volume":"20","author":"Balle","year":"2025","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(26)00192-0_bib166","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/j.fertnstert.2023.08.004","article-title":"TurnerFertility trial: fertility preservation in young girls with Turner syndrome by freezing ovarian cortex tissue\u2014a prospective intervention study","volume":"120","author":"Nadesapillai","year":"2023","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(26)00192-0_bib167","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1210\/jc.2008-0708","article-title":"Fertility preservation in girls with Turner syndrome: prognostic signs of the presence of ovarian follicles","volume":"94","author":"Borgstr\u00f6m","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib168","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1093\/humrep\/dez135","article-title":"Ovarian follicles of young patients with Turner's syndrome contain normal oocytes but monosomic 45,X granulosa cells","volume":"34","author":"Peek","year":"2019","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(26)00192-0_bib169","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1038\/s41398-024-02937-5","article-title":"Psychiatric disorders and comorbidity in women with Turner syndrome: a retrospective national cohort study","volume":"14","author":"Thunstr\u00f6m","year":"2024","journal-title":"Transl Psychiatry"},{"key":"10.1016\/S2213-8587(26)00192-0_bib170","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1055\/s-0044-100920","article-title":"Estradiol: a steroid with multiple facets","volume":"50","author":"Kumar","year":"2018","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(26)00192-0_bib171","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz061","article-title":"Effect of dosage of 17\u00df-estradiol on uterine growth in Turner syndrome\u2014a randomized controlled clinical pilot trial","volume":"105","author":"Cleemann","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib172","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1002\/hep.20026","article-title":"Vascular involvement of the liver in Turner's syndrome","volume":"39","author":"Roulot","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(26)00192-0_bib173","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1210\/jc.2004-1939","article-title":"Excess visceral and hepatic adipose tissue in Turner syndrome determined by magnetic resonance imaging: estrogen deficiency associated with hepatic adipose content","volume":"90","author":"Ostberg","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib174","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2265.2001.01321.x","article-title":"Hormone replacement therapy may improve hepatic function in women with Turner's syndrome","volume":"55","author":"Elsheikh","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib175","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/EJE-07-0070","article-title":"Quantitative liver functions in Turner syndrome with and without hormone replacement therapy","volume":"156","author":"Gravholt","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib176","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1210\/jc.2012-4243","article-title":"Metabolic effects of oral versus transdermal 17\u03b2-estradiol (E2): a randomized clinical trial in girls with Turner syndrome","volume":"98","author":"Torres-Santiago","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib177","doi-asserted-by":"crossref","first-page":"3502","DOI":"10.1210\/jc.2011-1449","article-title":"Pharmacokinetics and pharmacodynamics of oral and transdermal 17\u03b2 estradiol in girls with Turner syndrome","volume":"96","author":"Taboada","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib178","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1111\/cen.13869","article-title":"Impact of route of administration on genotoxic oestrogens concentrations using oral vs transdermal oestradiol in girls with Turner syndrome","volume":"90","author":"Mauras","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib179","doi-asserted-by":"crossref","first-page":"4012","DOI":"10.1210\/jc.2015-2237","article-title":"Oral vs transdermal estrogen therapy and vascular events: a systematic review and meta-analysis","volume":"100","author":"Mohammed","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib180","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/STROKEAHA.116.013052","article-title":"Postmenopausal hormone therapy and risk of stroke: impact of the route of estrogen administration and type of progestogen","volume":"47","author":"Canonico","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(26)00192-0_bib181","doi-asserted-by":"crossref","first-page":"408","DOI":"10.4158\/EP161622.OR","article-title":"Oral versus transdermal estrogen in Turner syndrome: a systematic review and meta-analysis","volume":"23","author":"Zaiem","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(26)00192-0_bib182","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1007\/s12020-016-1046-y","article-title":"Effect of estrogen replacement therapy on bone and cardiovascular outcomes in women with turner syndrome: a systematic review and meta-analysis","volume":"55","author":"Cintron","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(26)00192-0_bib183","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s11689-021-09399-6","article-title":"Neurodevelopmental and psychiatric disorders in females with Turner syndrome: a population-based study","volume":"13","author":"Bj\u00f6rlin Avdic","year":"2021","journal-title":"J Neurodev Disord"},{"key":"10.1016\/S2213-8587(26)00192-0_bib184","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/13546805.2023.2209312","article-title":"Cognitive profile in adult women with turner syndrome: IQ split and associations with ADHD and ASD","volume":"28","author":"Bj\u00f6rlin Avdic","year":"2023","journal-title":"Cogn Neuropsychiatry"},{"key":"10.1016\/S2213-8587(26)00192-0_bib185","article-title":"How does Turner syndrome affect quality of life? A systematic review","volume":"61","author":"Stoynova","year":"2025","journal-title":"Medicina (Kaunas)"},{"key":"10.1016\/S2213-8587(26)00192-0_bib186","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1507\/endocrj.EJ20-0617","article-title":"The current status of 492 adult women with Turner syndrome: a questionnaire survey by the Foundation for Growth Science","volume":"68","author":"Hanew","year":"2021","journal-title":"Endocr J"},{"key":"10.1016\/S2213-8587(26)00192-0_bib187","doi-asserted-by":"crossref","DOI":"10.1016\/j.cpnec.2021.100030","article-title":"Socioeconomic status in patients with Turner syndrome","volume":"5","author":"Noordman","year":"2021","journal-title":"Compr Psychoneuroendocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib188","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1530\/EJE-11-1066","article-title":"Socioeconomic parameters and mortality in Turner syndrome","volume":"166","author":"Stochholm","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib189","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1002\/ddrr.79","article-title":"Cognitive profile of Turner syndrome","volume":"15","author":"Hong","year":"2009","journal-title":"Dev Disabil Res Rev"},{"key":"10.1016\/S2213-8587(26)00192-0_bib190","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.jpsychires.2015.06.021","article-title":"Elucidating X chromosome influences on attention deficit hyperactivity disorder and executive function","volume":"68","author":"Green","year":"2015","journal-title":"J Psychiatr Res"},{"key":"10.1016\/S2213-8587(26)00192-0_bib191","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.ics.2006.06.016","article-title":"The cognitive phenotype of Turner syndrome: specific learning disabilities","volume":"1298","author":"Mazzocco","year":"2006","journal-title":"Int Congr Ser"},{"key":"10.1016\/S2213-8587(26)00192-0_bib192","doi-asserted-by":"crossref","first-page":"5073","DOI":"10.1210\/jc.2019-00340","article-title":"Health-related quality of life in Turner syndrome and the influence of growth hormone therapy: a 20-year follow-up","volume":"104","author":"Krantz","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib193","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1016\/j.bandl.2011.12.001","article-title":"Exceptional lexical skills but executive language deficits in school starters and young adults with Turners syndrome: implications for X chromosome effects on brain function","volume":"120","author":"Temple","year":"2012","journal-title":"Brain Lang"},{"key":"10.1016\/S2213-8587(26)00192-0_bib194","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1097\/00004703-200112000-00003","article-title":"Psychosocial development in adolescents with Turner syndrome","volume":"22","author":"McCauley","year":"2001","journal-title":"J Dev Behav Pediatr"},{"key":"10.1016\/S2213-8587(26)00192-0_bib195","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4158\/EP11059.OR","article-title":"Medical care of girls with Turner syndrome: where are we lacking?","volume":"17","author":"Nabhan","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(26)00192-0_bib196","doi-asserted-by":"crossref","first-page":"3408","DOI":"10.1210\/jc.2009-0495","article-title":"Determinants of medical care for young women with Turner syndrome","volume":"94","author":"Devernay","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib197","doi-asserted-by":"crossref","first-page":"E1517","DOI":"10.1210\/jc.2011-0346","article-title":"Standardized multidisciplinary evaluation yields significant previously undiagnosed morbidity in adult women with Turner syndrome","volume":"96","author":"Freriks","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib198","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1530\/EC-18-0053","article-title":"Health status, quality of life and medical care in adult women with Turner syndrome","volume":"7","author":"Ertl","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(26)00192-0_bib199","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1530\/EC-19-0418","article-title":"Deficient knowledge in adult care as an incentives for founding Turner centers in Germany","volume":"8","author":"Kahlert","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(26)00192-0_bib200","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/clinem\/dgaf517","article-title":"Approach to the patient with Turner syndrome","volume":"111","author":"Turner","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00192-0_bib201","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Ferrari","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00192-0_bib202","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11255-025-04677-x","article-title":"Global burden and health inequalities of sex chromosomal DSDs (1990\u20132021): a GBD 2021 analysis","volume":"58","author":"Su","year":"2025","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/S2213-8587(26)00192-0_bib203","doi-asserted-by":"crossref","DOI":"10.1002\/ijgo.71217","article-title":"Hormone therapy (HT) in women with premature ovarian insufficiency or early menopause: time to think of a new paradigm for healthy aging\u2014a joint FIGO and IMS position paper","author":"Benedetto","year":"2026","journal-title":"Int J Gynaecol Obstet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T19:53:50Z","timestamp":1790452430000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726001920"}},"issued":{"date-parts":[[2026,9]]},"references-count":202,"alternative-id":["S2213858726001920"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00192-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New genomic understanding and challenges in clinical care of Turner syndrome","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00192-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T18:37:47Z","timestamp":1789497467787,"version":"build-2803163510"},"reference-count":32,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/s2213-8587(19)30001-4","type":"journal-article","created":{"date-parts":[[2019,2,4]],"date-time":"2019-02-04T20:25:15Z","timestamp":1549311915000},"page":"200-212","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":122,"title":["Community groups or mobile phone messaging to prevent and control type 2 diabetes and intermediate hyperglycaemia in Bangladesh (DMagic): a cluster-randomised controlled trial"],"prefix":"10.1016","volume":"7","author":[{"given":"Edward","family":"Fottrell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Morrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Kuddus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjit Kumer","family":"Shaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carina","family":"King","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah","family":"Jennings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohenour","family":"Akter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tasmin","family":"Nahar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hassan","family":"Haghparast-Bidgoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A K Azad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Costello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kishwar","family":"Azad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30001-4_bib1","series-title":"Global report on diabetes","year":"2016"},{"key":"10.1016\/S2213-8587(19)30001-4_bib2","series-title":"Bangladesh demographic and health survey 2011","year":"2013"},{"key":"10.1016\/S2213-8587(19)30001-4_bib3","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1186\/1471-2458-12-434","article-title":"Cardiovascular diseases and type 2 diabetes in Bangladesh: a systematic review and meta-analysis of studies between 1995 and 2010","volume":"12","author":"Saquib","year":"2012","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(19)30001-4_bib4","doi-asserted-by":"crossref","first-page":"46","DOI":"10.4093\/dmj.2013.37.1.46","article-title":"Increasing prevalence of type 2 diabetes in a rural Bangladeshi population: a population based study for 10 years","volume":"37","author":"Bhowmik","year":"2013","journal-title":"Diabetes Metab J"},{"key":"10.1016\/S2213-8587(19)30001-4_bib5","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.diabres.2017.01.008","article-title":"Trend, projection, and appropriate body mass index cut-off point for diabetes and hypertension in Bangladesh","volume":"126","author":"Rahman","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(19)30001-4_bib6","doi-asserted-by":"crossref","first-page":"e000891","DOI":"10.1136\/bmjgh-2018-000891","article-title":"Diabetes knowledge and care practices among adults in rural Bangladesh: a cross-sectional survey","volume":"3","author":"Fottrell","year":"2018","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S2213-8587(19)30001-4_bib7","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1007\/s12529-011-9162-9","article-title":"Prevention of type 2 diabetes and its complications in developing countries: a review","volume":"19","author":"Rawal","year":"2012","journal-title":"Int J Behav Med"},{"key":"10.1016\/S2213-8587(19)30001-4_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2213-8587(13)70067-6","article-title":"Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial","volume":"1","author":"Ramachandran","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30001-4_bib9","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0145721712459890","article-title":"A community-based participatory diabetes prevention and management intervention in rural India using community health workers","volume":"38","author":"Balagopal","year":"2012","journal-title":"The Diabetes Educ"},{"key":"10.1016\/S2213-8587(19)30001-4_bib10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/dme.12720","article-title":"Community-based peer support significantly improves metabolic control in people with type 2 diabetes in Yaound\u00e9, Cameroon","volume":"32","author":"Assah","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30001-4_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1007\/s12529-014-9412-8","article-title":"A demonstration of peer support for Ugandan adults with type 2 diabetes","volume":"22","author":"Baumann","year":"2015","journal-title":"Int J Behav Med"},{"key":"10.1016\/S2213-8587(19)30001-4_bib12","doi-asserted-by":"crossref","first-page":"e1002575","DOI":"10.1371\/journal.pmed.1002575","article-title":"A peer-support lifestyle intervention for preventing type 2 diabetes in India: a cluster-randomized controlled trial of the Kerala Diabetes Prevention Program","volume":"15","author":"Thankappan","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(19)30001-4_bib13","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(13)60685-6","article-title":"Women's groups practising participatory learning and action to improve maternal and newborn health in low-resource settings: a systematic review and meta-analysis","volume":"381","author":"Prost","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30001-4_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/jech-2014-204271","article-title":"The effect of participatory women's groups on infant feeding and child health knowledge, behaviour and outcomes in rural Bangladesh: a controlled before-and-after study","volume":"69","author":"Younes","year":"2015","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(19)30001-4_bib15","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1136\/jech-2017-210134","article-title":"Growth and body composition of children aged 2\u20134 years after exposure to community mobilisation women's groups in Bangladesh","volume":"72","author":"Fottrell","year":"2018","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(19)30001-4_bib16","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1136\/jech-2015-205855","article-title":"Formative evaluation of a participatory women's group intervention to improve reproductive and women's health outcomes in rural Bangladesh: a controlled before and after study","volume":"70","author":"Harris-Fry","year":"2016","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(19)30001-4_bib17","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1186\/s13063-016-1738-x","article-title":"The effect of community groups and mobile phone messages on the prevention and control of diabetes in rural Bangladesh: study protocol for a three-arm cluster randomised controlled trial","volume":"17","author":"Fottrell","year":"2016","journal-title":"Trials"},{"key":"10.1016\/S2213-8587(19)30001-4_bib18","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/1748-5908-6-42","article-title":"The behaviour change wheel: a new method for characterising and designing behaviour change interventions","volume":"6","author":"Michie","year":"2011","journal-title":"Implement Sci"},{"key":"10.1016\/S2213-8587(19)30001-4_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/16549716.2018.1550736","article-title":"Developing a theory-driven contextually relevant mHealth intervention","volume":"12","author":"Jennings","year":"2019","journal-title":"Glob Health Action"},{"key":"10.1016\/S2213-8587(19)30001-4_bib20","doi-asserted-by":"crossref","first-page":"e54978","DOI":"10.1371\/journal.pone.0054978","article-title":"What is the role of informal healthcare providers in developing countries? A systematic review","volume":"8","author":"Sudhinaraset","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30001-4_bib21","series-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation","year":"2006"},{"key":"10.1016\/S2213-8587(19)30001-4_bib22","doi-asserted-by":"crossref","first-page":"e000787","DOI":"10.1136\/bmjgh-2018-000787","article-title":"Age, sex, and wealth distribution of diabetes, hypertension and non-communicable disease risk factors among adults in rural Bangladesh: a cross-sectional epidemiological survey","volume":"3","author":"Fottrell","year":"2018","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S2213-8587(19)30001-4_bib23","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30001-4_bib25","doi-asserted-by":"crossref","first-page":"e022035","DOI":"10.1136\/bmjopen-2018-022035","article-title":"Protocol of economic evaluation and equity impact analysis of mHealth and community groups for prevention and control of diabetes in rural Bangladesh in a three-arm cluster randomised controlled trial","volume":"8","author":"Haghparast-Bidgoli","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(19)30001-4_bib26","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/pubmed\/fdv009","article-title":"Mobile phone use and willingness to pay for SMS for diabetes in Bangladesh","volume":"38","author":"Shariful Islam","year":"2016","journal-title":"J Public Health (Oxf)"},{"key":"10.1016\/S2213-8587(19)30001-4_bib27","doi-asserted-by":"crossref","first-page":"25606","DOI":"10.3402\/gha.v7.25606","article-title":"Assessing the impact of mHealth interventions in low- and middle-income countries\u2014what has been shown to work?","volume":"7","author":"Hall","year":"2014","journal-title":"Glob Health Action"},{"key":"10.1016\/S2213-8587(19)30001-4_bib28","doi-asserted-by":"crossref","first-page":"e52","DOI":"10.2196\/jmir.3951","article-title":"Impact of mHealth chronic disease management on treatment adherence and patient outcomes: a systematic review","volume":"17","author":"Hamine","year":"2015","journal-title":"J Med Internet Res"},{"key":"10.1016\/S2213-8587(19)30001-4_bib29","doi-asserted-by":"crossref","first-page":"e112","DOI":"10.2337\/dc15-0505","article-title":"Effects of mobile phone SMS to improve glycemic control among patients with type 2 diabetes in Bangladesh: a prospective, parallel-group, randomized controlled trial","volume":"38","author":"Shariful Islam","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30001-4_bib30","doi-asserted-by":"crossref","first-page":"e238","DOI":"10.1016\/S2214-109X(18)30035-4","article-title":"Making waves: can radio reduce child mortality?","volume":"6","author":"Colbourn","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(19)30001-4_bib31","series-title":"Global Burden of Disease Study 2016 (GBD 2016) disability weights","year":"2017"},{"key":"10.1016\/S2213-8587(19)30001-4_bib32","series-title":"Making choices in health: WHO guide to cost-effectiveness analysis","author":"Tan-Torres Edejer","year":"2003"},{"key":"10.1016\/S2213-8587(19)30001-4_bib33","doi-asserted-by":"crossref","first-page":"e000033","DOI":"10.1136\/bmjgh-2016-000033","article-title":"Healthcare use and expenditure for diabetes in Bangladesh","volume":"2","author":"Shariful Islam","year":"2017","journal-title":"BMJ Glob Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300014?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300014?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T18:52:02Z","timestamp":1550602322000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300014"}},"issued":{"date-parts":[[2019,3]]},"references-count":32,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2213858719300014"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30001-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Community groups or mobile phone messaging to prevent and control type 2 diabetes and intermediate hyperglycaemia in Bangladesh (DMagic): a cluster-randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30001-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30027-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:52:31Z","timestamp":1791291151017,"version":"4.3.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/s2213-8587(26)00193-2","type":"journal-article","created":{"date-parts":[[2026,8,3]],"date-time":"2026-08-03T22:50:37Z","timestamp":1785797437000},"page":"799-801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Less can be more: the 2026 Endocrine Society Guideline for precision care in central precocious puberty"],"prefix":"10.1016","volume":"14","author":[{"given":"Sasha R","family":"Howard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00193-2_bib1","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1515\/jpem-2023-0507","article-title":"Effects of the COVID-19 pandemic on the incidence of central precocious puberty; a narrative review","volume":"37","author":"Hoskyns","year":"2023","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00193-2_bib2","doi-asserted-by":"crossref","first-page":"213","DOI":"10.3389\/fendo.2017.00213","article-title":"Precocious puberty or premature thelarche: analysis of a large patient series in a single tertiary center with special emphasis on 6- to 8-year-old girls","volume":"8","author":"Varimo","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(26)00193-2_bib3","doi-asserted-by":"crossref","first-page":"2101","DOI":"10.1210\/clinem\/dgag168","article-title":"Central precocious puberty: an Endocrine Society clinical practice guideline","volume":"111","author":"Latronico","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00193-2_bib4","doi-asserted-by":"crossref","first-page":"e752","DOI":"10.1542\/peds.2008-1783","article-title":"Consensus statement on the use of gonadotropin-releasing hormone analogs in children","volume":"123","author":"Carel","year":"2009","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(26)00193-2_bib5","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/ejendo\/lvae021","article-title":"Central precocious puberty in boys: secular trend and clinical features","volume":"190","author":"Huttunen","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00193-2_bib6","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae228","article-title":"Genetics and epigenetics of human pubertal timing: the contribution of genes associated with central precocious puberty","volume":"9","author":"Canton","year":"2025","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(26)00193-2_bib7","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1210\/clinem\/dgag169","article-title":"A systematic review supporting the Endocrine Society clinical practice guidelines on central precocious puberty","volume":"111","author":"Firwana","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00193-2_bib8","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1159\/000501336","article-title":"Use of Gonadotropin-releasing hormone analogs in children: update by an international consortium","volume":"91","author":"Bangalore Krishna","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(26)00193-2_bib9","doi-asserted-by":"crossref","first-page":"e1973","DOI":"10.1210\/clinem\/dgag096","article-title":"Efficacy of 24-weekly vs 12-weekly decapeptyl SR treatment in central precocious puberty: a UK multicentre retrospective cohort study","volume":"111","author":"Varughese","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00193-2_bib10","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaf224","article-title":"Long-term safety, efficacy, and PROs: phase 3 study of leuprolide acetate 6-month IM depot in central precocious puberty","volume":"10","author":"Klein","year":"2026","journal-title":"J Endocr Soc"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:06:08Z","timestamp":1791288368000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726001932"}},"issued":{"date-parts":[[2026,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2213858726001932"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00193-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Less can be more: the 2026 Endocrine Society Guideline for precision care in central precocious puberty","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00193-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T19:43:23Z","timestamp":1791229403556,"version":"4.1.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["322900939"],"award-info":[{"award-number":["322900939"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["TRR 219"],"award-info":[{"award-number":["TRR 219"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005565","name":"Janssen Biotech","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005565","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/s2213-8587(20)30343-0","type":"journal-article","created":{"date-parts":[[2020,11,5]],"date-time":"2020-11-05T13:09:30Z","timestamp":1604581770000},"page":"46-52","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":141,"title":["Guideline recommendations and the positioning of newer drugs in type 2 diabetes care"],"prefix":"10.1016","volume":"9","author":[{"given":"Nikolaus","family":"Marx","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Grant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B","family":"Buse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30343-0_bib1","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00125-008-1076-y","article-title":"Risk of myocardial infarction in men and women with type 2 diabetes in the UK: a cohort study using the General Practice Research Database","volume":"51","author":"Mulnier","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30343-0_bib2","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1093\/qjmed\/hcu170","article-title":"End-stage renal disease and survival in people with diabetes: a national database linkage study","volume":"108","author":"Bell","year":"2015","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(20)30343-0_bib3","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1161\/CIRCULATIONAHA.118.034986","article-title":"Incidence of hospitalization for heart failure and case-fatality among 3\u00b725 million people with and without diabetes mellitus","volume":"138","author":"McAllister","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(20)30343-0_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30343-0_bib5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib6","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2213-8587(15)00044-3","article-title":"Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials","volume":"3","author":"Udell","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30343-0_bib7","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30343-0_bib8","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2337\/dci19-0066","article-title":"2019 update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"43","author":"Buse","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30343-0_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(20)30343-0_bib10","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/dom.13687","article-title":"Time trends in prescribing of type 2 diabetes drugs, glycaemic response and risk factors: a retrospective analysis of primary care data, 2010\u20132017","volume":"21","author":"Dennis","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30343-0_bib11","doi-asserted-by":"crossref","first-page":"921","DOI":"10.2337\/dc19-1943","article-title":"Trends in clinical characteristics and prescribing preferences for SGLT2 inhibitors and GLP-1 receptor agonists, 2013\u20132018","volume":"43","author":"Dave","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30343-0_bib12","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib14","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib16","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa2004967","article-title":"Cardiovascular outcomes with ertugliflozin in type 2 diabetes","volume":"383","author":"Cannon","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib17","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib18","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib19","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney kisease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib22","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30343-0_bib23","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30343-0_bib24","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib25","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib26","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30343-0_bib27","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30343-0_bib28","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1093\/eurheartj\/ehaa082","article-title":"Effects of glucagon-like peptide-1 receptor agonists on major cardiovascular events in patients with type 2 diabetes mellitus with or without established cardiovascular disease: a meta-analysis of randomized controlled trials","volume":"41","author":"Marsico","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(20)30343-0_bib29","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1093\/eurheartj\/ehw106","volume":"37","author":"Piepoli","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(20)30343-0_bib30","doi-asserted-by":"crossref","first-page":"2034","DOI":"10.2337\/dc20-0120","volume":"43","author":"Caparrotta","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30343-0_bib31","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/dom.13938","article-title":"Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy?","volume":"22","author":"Inzucchi","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30343-0_bib32","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1089\/dia.2019.0213","article-title":"Adoption of new glucose-lowering medications in the US\u2014the case of SGLT2 inhibitors: nationwide cohort study","volume":"21","author":"McCoy","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(20)30343-0_bib33","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1016\/j.jacc.2019.01.029","article-title":"Prescription of glucagon-like peptide-1 receptor agonists by cardiologists","volume":"73","author":"Vaduganathan","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(20)30343-0_bib34","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1001\/jama.1971.03190220020005","article-title":"Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. III. Clinical implications of UGDP results","volume":"218","author":"Goldner","year":"1971","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(20)30407-1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303430?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303430?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:44Z","timestamp":1761991724000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303430"}},"issued":{"date-parts":[[2021,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2213858720303430"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30343-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Guideline recommendations and the positioning of newer drugs in type 2 diabetes care","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30343-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T11:38:38Z","timestamp":1790854718432,"version":"4.1.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/s2213-8587(23)00383-2","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T18:28:27Z","timestamp":1706034507000},"page":"90-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Anti-obesity drugs, eating disorders, and thinness among Japanese young women"],"prefix":"10.1016","volume":"12","author":[{"given":"Shotaro","family":"Kinoshita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taishiro","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00383-2_bib3","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12884-022-04418-3","article-title":"Severity of low pre-pregnancy body mass index and perinatal outcomes: the Japan Environment and Children's Study","volume":"22","author":"Nakanishi","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(23)00383-2_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/j.appet.2009.11.008","article-title":"Body image and eating disorders amongst Japanese adolescents. A review of the literature","volume":"54","author":"Chisuwa","year":"2010","journal-title":"Appetite"},{"key":"10.1016\/S2213-8587(23)00383-2_bib5","doi-asserted-by":"crossref","first-page":"333","DOI":"10.3200\/MONO.130.4.333-364","article-title":"When ideals are too \u201cfar off\u2019: physical self-ideal discrepancy and body dissatisfaction in Japan","volume":"130","author":"Kowner","year":"2004","journal-title":"Genet Soc Gen Psychol Monogr"},{"key":"10.1016\/S2213-8587(23)00383-2_bib6","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-41265-4","article-title":"Desire for thinness among young Japanese women from the perspective of objective and subjective ideal body shape","volume":"13","author":"Yasuda","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(23)00383-2_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1002\/eat.23439","article-title":"The changing profile of eating disorders and related sociocultural factors in Japan between 1700 and 2020: a systematic scoping review","volume":"54","author":"Nakai","year":"2021","journal-title":"Int J Eat Disord"},{"key":"10.1016\/S2213-8587(23)00383-2_bib8","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1016\/j.bodyim.2021.05.001","article-title":"Beauty ideals, social media, and body positivity: a qualitative investigation of influences on body image among young women in Japan","volume":"38","author":"Ando","year":"2021","journal-title":"Body Image"},{"key":"10.1016\/S2213-8587(23)00383-2_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/eat.24061","article-title":"The effectiveness and cultural adaptations of psychological interventions for eating disorders in East Asia: a systematic scoping review","author":"Yim","year":"2023","journal-title":"Int J Eat Disord"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:33Z","timestamp":1761992013000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003832"}},"issued":{"date-parts":[[2024,2]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2213858723003832"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00383-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-obesity drugs, eating disorders, and thinness among Japanese young women","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00383-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T19:49:36Z","timestamp":1792093776145,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/s2213-8587(21)00296-5","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T19:22:26Z","timestamp":1640200946000},"page":"102-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial"],"prefix":"10.1016","volume":"10","author":[{"given":"Maria","family":"Fleseriu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Dreval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bondar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gulnar","family":"Vagapova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Djuro","family":"Macut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yulia G","family":"Pokramovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E","family":"Molitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Leonova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Grineva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yury E","family":"Poteshkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yossi","family":"Gilgun-Sherki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H","family":"Ludlam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Patou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asi","family":"Haviv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray B","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke R","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Melmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian J","family":"Strasburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00296-5_bib1","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","article-title":"Multidisciplinary management of acromegaly: a consensus","volume":"21","author":"Giustina","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/S2213-8587(21)00296-5_bib2","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"New Eng J Med"},{"key":"10.1016\/S2213-8587(21)00296-5_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11102-020-01091-7","article-title":"A Pituitary Society update to acromegaly management guidelines","volume":"24","author":"Fleseriu","year":"2021","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(21)00296-5_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.101309","article-title":"The burden of disease for pituitary patients","volume":"33","author":"Biermasz","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00296-5_bib5","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1210\/clinem\/dgaa868","article-title":"Improvement in symptoms and health-related quality of life in acromegaly patients: a systematic review and meta-analysis","volume":"106","author":"Broersen","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00296-5_bib6","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1111\/cen.14309","article-title":"Effects of growth hormone receptor antagonism and somatostatin analog administration on quality of life in acromegaly","volume":"94","author":"Dichtel","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(21)00296-5_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.627711","article-title":"Disease and treatment-related burden in patients with acromegaly who are biochemically controlled on injectable somatostatin receptor ligands","volume":"12","author":"Fleseriu","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(21)00296-5_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1186\/s12902-020-00595-4","article-title":"Patient reported outcome data from acromegaly patients treated with injectable somatostatin receptor ligands (SRLs) in routine clinical practice","volume":"20","author":"Geer","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(21)00296-5_bib9","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1136\/jim-2017-000570","article-title":"Patient-centered assessment on disease burden, quality of life, and treatment satisfaction associated with acromegaly","volume":"66","author":"Liu","year":"2018","journal-title":"J Investig Med"},{"key":"10.1016\/S2213-8587(21)00296-5_bib10","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1530\/EJE-15-1042","article-title":"Patient-reported outcomes of parenteral somatostatin analogue injections in 195 patients with acromegaly","volume":"174","author":"Strasburger","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00296-5_bib11","doi-asserted-by":"crossref","first-page":"R13","DOI":"10.1530\/EJE-17-0041","article-title":"Management of endocrine disease: quality of life tools for the management of pituitary disease","volume":"177","author":"Webb","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00296-5_bib12","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1210\/jc.2014-4113","article-title":"Safety and efficacy of oral octreotide in acromegaly: results of a multicenter phase III trial","volume":"100","author":"Melmed","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00296-5_bib13","doi-asserted-by":"crossref","first-page":"e3785","DOI":"10.1210\/clinem\/dgaa526","article-title":"Maintenance of acromegaly control in patients switching from injectable somatostatin receptor ligands to oral octreotide","volume":"105","author":"Samson","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00296-5_bib14","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11102-020-01038-y","article-title":"An evaluation of the Acromegaly Treatment Satisfaction Questionnaire (Acro-TSQ) in adult patients with acromegaly, including correlations with other patient-reported outcome measures: data from two large multicenter international studies","volume":"23","author":"Fleseriu","year":"2020","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(21)00296-5_bib15","doi-asserted-by":"crossref","first-page":"353","DOI":"10.2165\/00019053-199304050-00006","article-title":"The validity and reproducibility of a work productivity and activity impairment instrument","volume":"4","author":"Reilly","year":"1993","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/S2213-8587(21)00296-5_bib16","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s40618-019-01138-y","article-title":"Association between biochemical control and comorbidities in patients with acromegaly: an Italian longitudinal retrospective chart review study","volume":"43","author":"Colao","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(21)00296-5_bib17","doi-asserted-by":"crossref","unstructured":"Fleseriu M, Melmed S, Mangal B, Strasburger C, Biermasz N. Longitudinal assessment of response to treatment with oral octreotide capsules in patients with acromegaly: post hoc analysis of a phase 3 trial. European Congress of Endocrinology, Munich, Germany; May 28\u201331, 2016 (poster).","DOI":"10.1530\/endoabs.41.GP151"},{"key":"10.1016\/S2213-8587(21)00296-5_bib18","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1210\/er.2018-00115","article-title":"Systemic complications of acromegaly and the impact of the current treatment landscape: an update","volume":"40","author":"Gadelha","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(21)00296-5_bib19","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1016\/S0306-4530(02)00108-7","article-title":"Two formulas for computation of the area under the curve represent measures of total hormone concentration versus time-dependent change","volume":"28","author":"Pruessner","year":"2003","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(21)00296-5_bib20","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1530\/EJE-11-0098","article-title":"Clinical and metabolic characteristics of acromegalic patients with high IGF1\/normal GH levels during somatostatin analog treatment","volume":"164","author":"Matta","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00296-5_bib21","doi-asserted-by":"crossref","first-page":"2271","DOI":"10.1210\/jc.2003-032150","article-title":"Variability and reliability of single serum IGF-I measurements: impact on determining predictability of risk ratios in disease development","volume":"89","author":"Milani","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00296-5_bib22","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1046\/j.1365-2265.2000.00876.x","article-title":"Circadian variation in serum free and total insulin-like growth factor (IGF)-I and IGF-II in untreated and treated acromegaly and growth hormone deficiency","volume":"52","author":"Skjaerbaek","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(21)00296-5_bib23","first-page":"4099","article-title":"Two-year follow-up of acromegalic patients treated with slow release lanreotide (30 mg)","volume":"85","author":"Baldelli","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00296-5_bib24","doi-asserted-by":"crossref","first-page":"4047","DOI":"10.1210\/jc.2013-2262","article-title":"Efficacy and safety of an octreotide implant in the treatment of patients with acromegaly","volume":"98","author":"Chieffo","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00296-5_bib25","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s11102-014-0585-6","article-title":"Pasireotide LAR maintains inhibition of GH and IGF-1 in patients with acromegaly for up to 25 months: results from the blinded extension phase of a randomized, double-blind, multicenter, phase III study","volume":"18","author":"Sheppard","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(21)00296-5_bib26","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s11102-011-0335-y","article-title":"Comparison of octreotide LAR and lanreotide autogel as post-operative medical treatment in acromegaly","volume":"15","author":"Tutuncu","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(21)00296-5_bib27","doi-asserted-by":"crossref","first-page":"2968","DOI":"10.1002\/sim.6122","article-title":"A new and improved confidence interval for the Mantel-Haenszel risk difference","volume":"33","author":"Klingenberg","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(21)00296-5_bib28","author":"Nurminen"},{"key":"10.1016\/S2213-8587(21)00296-5_bib29","doi-asserted-by":"crossref","first-page":"4554","DOI":"10.1210\/jc.2001-012012","article-title":"Primary medical therapy for acromegaly: an open, prospective, multicenter study of the effects of subcutaneous and intramuscular slow-release octreotide on growth hormone, insulin-like growth factor-I, and tumor size","volume":"87","author":"Bevan","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00296-5_bib30","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1210\/jc.2013-3757","article-title":"Acromegaly clinical trial methodology impact on reported biochemical efficacy rates of somatostatin receptor ligand treatments: a meta-analysis","volume":"99","author":"Carmichael","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00296-5_bib31","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.2165\/00003495-200363220-00014","article-title":"Octreotide long-acting release (LAR): a review of its use in the management of acromegaly","volume":"63","author":"McKeage","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/S2213-8587(21)00296-5_bib32","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1007\/s11102-016-0785-3","article-title":"New medical therapies on the horizon: oral octreotide","volume":"20","author":"Biermasz","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(21)00296-5_bib33","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s11102-019-01013-2","article-title":"Observed discordance between outcomes reported by acromegaly patients and their treating endocrinology medical provider","volume":"23","author":"Geer","year":"2020","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(21)00296-5_bib34","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.1210\/jc.2012-1179","article-title":"Oral octreotide absorption in human subjects: comparable pharmacokinetics to parenteral octreotide and effective growth hormone suppression","volume":"97","author":"Tuvia","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(22)00051-1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:48Z","timestamp":1761991848000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002965"}},"issued":{"date-parts":[[2022,2]]},"references-count":34,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2213858721002965"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00296-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maintenance of response to oral octreotide compared with injectable somatostatin receptor ligands in patients with acromegaly: a phase 3, multicentre, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00296-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00319-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:15Z","timestamp":1792097295476,"version":"4.4.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/s2213-8587(26)00247-0","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:50:10Z","timestamp":1791931810000},"page":"877-878","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone mineral density as a surrogate endpoint in osteoporosis trials \u2013 Author's reply"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6021-5458","authenticated-orcid":false,"given":"Ian R","family":"Reid","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00247-0_bib1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S2213-8587(26)00123-3","article-title":"Goal-directed osteoporosis treatment: are bone mineral density targets valid?","volume":"14","author":"Reid","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00247-0_bib2","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1016\/S2213-8587(20)30232-1","article-title":"No more fracture trials in osteoporosis?","volume":"8","author":"Reid","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00247-0_bib3","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1093\/jbmr\/zjae119","article-title":"Goal-directed osteoporosis treatment: ASBMR\/BHOF task force position statement 2024","volume":"39","author":"Cosman","year":"2024","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00247-0_bib4","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S2213-8587(20)30159-5","article-title":"Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials","volume":"8","author":"Black","year":"2020","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:40:50Z","timestamp":1792096850000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726002470"}},"issued":{"date-parts":[[2026,11]]},"references-count":4,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2213858726002470"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00247-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone mineral density as a surrogate endpoint in osteoporosis trials \u2013 Author's reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00247-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00123-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00246-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T06:52:05Z","timestamp":1792047125760,"version":"4.4.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000156","name":"Fonds de Recherche du Qu\u00e9bec - Sant\u00e9","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000156","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007476","name":"Canadian Diabetes Association","doi-asserted-by":"publisher","award":["OG-3-14-4500-RR"],"award-info":[{"award-number":["OG-3-14-4500-RR"]}],"id":[{"id":"10.13039\/100007476","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/s2213-8587(15)00141-2","type":"journal-article","created":{"date-parts":[[2015,6,13]],"date-time":"2015-06-13T03:39:58Z","timestamp":1434166798000},"page":"595-604","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial"],"prefix":"10.1016","volume":"3","author":[{"given":"Ahmad","family":"Haidar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Legault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Matteau-Pelletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Messier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryse","family":"Dallaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ladouceur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Rabasa-Lhoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00141-2_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","article-title":"Epidemiology of type 1 diabetes","volume":"39","author":"Maahs","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(15)00141-2_bib2","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1067\/mpd.2001.118887","article-title":"Beneficial effects of intensive therapy of diabetes during adolescence: outcomes after the conclusion of the Diabetes Control and Complications Trial (DCCT)","volume":"139","author":"White","year":"2001","journal-title":"J Pediatr"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00141-2_bib3","first-page":"117","article-title":"Findings from the Hvidore Study Group on Childhood Diabetes: metabolic control and quality of life","volume":"57","author":"Mortensen","year":"2002","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(15)00141-2_bib4","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.2337\/dc12-1959","article-title":"Most youth with type 1 diabetes in the T1D Exchange Clinic Registry do not meet American Diabetes Association or International Society for Pediatric and Adolescent Diabetes clinical guidelines","volume":"36","author":"Wood","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00141-2_bib5","doi-asserted-by":"crossref","first-page":"22","DOI":"10.2337\/diacare.20.1.22","article-title":"Hypoglycemia: incidence and clinical predictors in a large population-based sample of children and adolescents with IDDM","volume":"20","author":"Davis","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00141-2_bib6","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2337\/dc09-2081","article-title":"Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00141-2_bib7","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1037\/a0014770","article-title":"Nighttime caregiving behaviors among parents of young children with Type 1 diabetes: associations with illness characteristics and parent functioning","volume":"27","author":"Monaghan","year":"2009","journal-title":"Fam Syst Health"},{"key":"10.1016\/S2213-8587(15)00141-2_bib8","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1056\/NEJMoa0805017","article-title":"Continuous glucose monitoring and intensive treatment of type 1 diabetes","volume":"359","author":"Tamborlane","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00141-2_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1002853","article-title":"Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes","volume":"363","author":"Bergenstal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00141-2_bib10","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1001\/jama.2013.277818","article-title":"Effect of sensor-augmented insulin pump therapy and automated insulin suspension vs standard insulin pump therapy on hypoglycemia in patients with type 1 diabetes: a randomized clinical trial","volume":"310","author":"Ly","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00141-2_bib11","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrendo.2011.32","article-title":"Closed-loop insulin delivery: from bench to clinical practice","volume":"7","author":"Hovorka","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(15)00141-2_bib12","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2337\/dc13-2644","article-title":"Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial","volume":"37","author":"Hovorka","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00141-2_bib13","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2337\/dc14-0835","article-title":"MD-Logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial","volume":"37","author":"Nimri","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00141-2_bib14","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJMoa1206881","article-title":"Nocturnal glucose control with an artificial pancreas at a diabetes camp","volume":"368","author":"Phillip","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00141-2_bib15","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.2337\/dc14-0147","article-title":"Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes cAMP","volume":"37","author":"Ly","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00141-2_bib16","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2337\/dc09-2254","article-title":"Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes","volume":"33","author":"Castle","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00141-2_bib17","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1503\/cmaj.121265","article-title":"Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial","volume":"185","author":"Haidar","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(15)00141-2_bib18","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJMoa1314474","article-title":"Outpatient glycemic control with a bionic pancreas in type 1 diabetes","volume":"371","author":"Russell","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00141-2_bib19","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2213-8587(14)70226-8","article-title":"Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial","volume":"1","author":"Haidar","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00141-2_bib20","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1016\/j.diabres.2014.09.015","article-title":"Association between post-dinner dietary intakes and nocturnal hypoglycemic risk in adult patients with type 1 diabetes","volume":"106","author":"Desjardins","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00141-2_bib21","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2174\/1872214808666140714112644","article-title":"Ultra-fast acting insulin analogues","volume":"8","author":"Kalra","year":"2014","journal-title":"Recent Pat Endocr Metab Immune Drug Discov"},{"key":"10.1016\/S2213-8587(15)00141-2_bib22","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/pedi.12071","article-title":"Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis","volume":"15","author":"Nimri","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(15)00141-2_bib23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S2213-8587(14)70114-7","article-title":"Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study","volume":"2","author":"Thabit","year":"2014","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:55Z","timestamp":1761991555000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715001412"}},"issued":{"date-parts":[[2015,8]]},"references-count":23,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S2213858715001412"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00141-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outpatient overnight glucose control with dual-hormone artificial pancreas, single-hormone artificial pancreas, or conventional insulin pump therapy in children and adolescents with type 1 diabetes: an open-label, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00141-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00210-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:43:12Z","timestamp":1792449792808,"version":"4.5.0"},"reference-count":129,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/s2213-8587(26)00234-2","type":"journal-article","created":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:37:49Z","timestamp":1792449469000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["The development of obesity pharmacotherapy: from early challenges and setbacks to recognition by WHO"],"prefix":"10.1016","author":[{"given":"Bruno","family":"Halpern","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise A","family":"Baur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Bl\u00fcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Jackson-Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Ralston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00234-2_bib1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980-2013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00234-2_bib2","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"Phelps","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00234-2_bib3","series-title":"World obesity atlas 2025","year":"2025"},{"key":"10.1016\/S2213-8587(26)00234-2_bib4","first-page":"868","article-title":"Obesity stigma and its impact on health: a narrative review","volume":"69","author":"S\u00e1nchez-Carracedo","year":"2022","journal-title":"Endocrinol Diabetes Nutr (Engl Ed)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib6","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1038\/s41591-020-0803-x","article-title":"Joint international consensus statement for ending stigma of obesity","volume":"26","author":"Rubino","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/er.2017-00111","article-title":"Obesity pathogenesis: an Endocrine Society scientific statement","volume":"38","author":"Schwartz","year":"2017","journal-title":"Endocr Rev"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(26)00234-2_bib8","first-page":"S9","article-title":"Describing the weight-reduced state: physiology, behavior, and interventions","volume":"29","author":"Aronne","year":"2021","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib9","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S2213-8587(25)00254-2","article-title":"Rethinking obesity through the lens of genetics, environment and differential life circumstances","volume":"13","author":"Sattar","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl","key":"10.1016\/S2213-8587(26)00234-2_bib10","first-page":"S271","article-title":"Increasing clinical awareness of obesity as a serious, chronic, relapsing, and treatable disease","volume":"28","author":"Lazarus","year":"2022","journal-title":"Am J Manag Care"},{"key":"10.1016\/S2213-8587(26)00234-2_bib11","doi-asserted-by":"crossref","first-page":"e252","DOI":"10.1161\/CIR.0000000000001395","article-title":"Socioeconomic and structural barriers to addressing obesity in communities: a scientific statement from the American Heart Association","volume":"153","author":"Chung","year":"2026","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(26)00234-2_bib12","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1517\/14740338.2015.995088","article-title":"Why are anti-obesity drugs stigmatized?","volume":"14","author":"Halpern","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/S2213-8587(26)00234-2_bib13","doi-asserted-by":"crossref","first-page":"e1659","DOI":"10.1016\/S2214-109X(25)00275-X","article-title":"Obesity is a disease: global health policy must catch up","volume":"13","author":"Chandiwana","year":"2025","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(26)00234-2_bib14","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1038\/s41366-019-0453-6","article-title":"Obesity education in medical schools, residencies, and fellowships throughout the world: a systematic review","volume":"44","author":"Mastrocola","year":"2020","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.7326\/0003-4819-155-7-201110040-00006","article-title":"Effectiveness of primary care-relevant treatments for obesity in adults: a systematic evidence review for the US Preventive Services Task Force","volume":"155","author":"Leblanc","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib16","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1001\/jama.2025.13665","article-title":"Current and future medications for obesity treatment","volume":"334","author":"Kushner","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00234-2_bib17","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(16)00271-3","article-title":"Management of obesity","volume":"387","author":"Bray","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00234-2_bib18","doi-asserted-by":"crossref","first-page":"e071027","DOI":"10.1136\/bmj-2022-071027","article-title":"Long term outcomes of metabolic\/bariatric surgery in adults","volume":"383","author":"Courcoulas","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(26)00234-2_bib19","doi-asserted-by":"crossref","first-page":"2874","DOI":"10.1007\/s11695-023-06761-6","article-title":"Barriers to bariatric surgery: a mixed methods study investigating obstacles between clinic contact and surgery","volume":"33","author":"Hlavin","year":"2023","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(26)00234-2_bib20","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1007\/s11695-019-04243-2","article-title":"Insurance coverage criteria for bariatric surgery: a survey of policies","volume":"30","author":"Gebran","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(26)00234-2_bib21","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1007\/s11695-024-07118-3","article-title":"IFSO Worldwide Survey 2020-2021: current trends for bariatric and metabolic procedures","volume":"34","author":"Angrisani","year":"2024","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(26)00234-2_bib22","doi-asserted-by":"crossref","first-page":"e488","DOI":"10.1016\/S2214-109X(26)00009-4","article-title":"Therapies based on GLP-1 receptor agonists: significance, challenges, and opportunities","volume":"14","author":"Jackson-Morris","year":"2026","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(26)00234-2_bib23","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1001\/jama.2025.24288","article-title":"World Health Organization Guideline on the use and indications of glucagon-like peptide-1 therapies for the treatment of obesity in adults","volume":"335","author":"Celletti","year":"2026","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00234-2_bib24","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41366-024-01473-y","article-title":"What is the pipeline for future medications for obesity?","volume":"49","author":"Melson","year":"2025","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib25","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S2213-8587(24)00319-X","article-title":"Medications for obesity as preventatives: a public and patient safety issue","volume":"12","author":"Flint","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00234-2_bib26","unstructured":"Bray GA, Purnell JQ. An historical review of steps and missteps in the discovery of anti-obesity drugs. In: Feingold KR, Ahmed SF, Anawalt B, et al, eds. Endotext. South Dartmouth (MA): MDText.com, 2000."},{"key":"10.1016\/S2213-8587(26)00234-2_bib27","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.bpg.2014.07.015","article-title":"Medical treatment of obesity: the past, the present and the future","volume":"28","author":"Bray","year":"2014","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/S2213-8587(26)00234-2_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","article-title":"Anti-obesity drug discovery: advances and challenges","volume":"21","author":"M\u00fcller","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S2213-8587(26)00234-2_bib29","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/S0002-9343(97)89464-8","article-title":"Current views on obesity","volume":"100","author":"Stunkard","year":"1996","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib30","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19\u00b72 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00234-2_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/372425a0","article-title":"Positional cloning of the mouse obese gene and its human homologue","volume":"372","author":"Zhang","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(26)00234-2_bib32","doi-asserted-by":"crossref","first-page":"e174595","DOI":"10.1172\/JCI174595","article-title":"Leptin physiology and pathophysiology: knowns and unknowns 30 years after its discovery","volume":"134","author":"Flier","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(26)00234-2_bib33","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1056\/NEJM199909163411204","article-title":"Effects of recombinant leptin therapy in a child with congenital leptin deficiency","volume":"341","author":"Farooqi","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib34","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.282.16.1568","article-title":"Recombinant leptin for weight loss in obese and lean adults: a randomized, controlled, dose-escalation trial","volume":"282","author":"Heymsfield","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00234-2_bib35","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1056\/NEJM199708283370901","article-title":"Valvular heart disease associated with fenfluramine-phentermine","volume":"337","author":"Connolly","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib36","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1517\/14740338.2015.994502","article-title":"Safety assessment of FDA-approved (orlistat and lorcaserin) anti-obesity medications","volume":"14","author":"Halpern","year":"2015","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/S2213-8587(26)00234-2_bib37","doi-asserted-by":"crossref","first-page":"155","DOI":"10.2337\/diacare.27.1.155","article-title":"XENical in the prevention of diabetes in obese subjects (XENDOS) study: a randomized study of orlistat as an adjunct to lifestyle changes for the prevention of type 2 diabetes in obese patients","volume":"27","author":"Torgerson","year":"2004","journal-title":"Diabetes Care"},{"issue":"suppl 4","key":"10.1016\/S2213-8587(26)00234-2_bib38","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.ijo.0801931","article-title":"How does sibutramine work?","volume":"25","author":"Lean","year":"2001","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib39","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1001\/archinte.161.15.1814","article-title":"Long-term pharmacotherapy of obesity 2000: a review of efficacy and safety","volume":"161","author":"Glazer","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib40","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMoa1003114","article-title":"Effect of sibutramine on cardiovascular outcomes in overweight and obese subjects","volume":"363","author":"James","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib41","doi-asserted-by":"crossref","first-page":"2156","DOI":"10.1161\/CIRCULATIONAHA.111.028381","article-title":"Food and Drug Administration's obesity drug guidance document: a short history","volume":"125","author":"Colman","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(26)00234-2_bib42","doi-asserted-by":"crossref","first-page":"e240422","DOI":"10.20945\/2359-4292-2024-0422","volume":"68","author":"Moreira","year":"2024","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00234-2_bib43","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1056\/NEJMoa044537","article-title":"Effects of rimonabant on metabolic risk factors in overweight patients with dyslipidemia","volume":"353","author":"Despr\u00e9s","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib44","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1002\/oby.24019","article-title":"Seventeen years since rimonabant's downfall: reassessing its suicidality risk profile","volume":"32","author":"Cohen","year":"2024","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib45","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/obr.12299","article-title":"Clinical trial success rates of anti-obesity agents: the importance of combination therapies","volume":"16","author":"Hussain","year":"2015","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(26)00234-2_bib46","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1111\/dom.15515","article-title":"Pharmacological treatment of obesity in adults in Norway 2004\u20132022","volume":"26","author":"Ruiz","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00234-2_bib47","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2213-8587(21)00047-4","article-title":"Clinical management and treatment of obesity in China","volume":"9","author":"Zeng","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00234-2_bib48","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMp1211277","article-title":"The FDA's assessment of two drugs for chronic weight management","volume":"367","author":"Colman","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib49","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1080\/14740338.2017.1247807","article-title":"Safety assessment of combination therapies in the treatment of obesity: focus on naltrexone\/bupropion extended release and phentermine-topiramate extended release","volume":"16","author":"Halpern","year":"2017","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/S2213-8587(26)00234-2_bib50","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1001\/jama.2024.18000","article-title":"GLP-1 for treating obesity-origin, history, and evolution: 2024 Lasker-DeBakey Clinical Medical Research Award","volume":"332","author":"Knudsen","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00234-2_bib51","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1002\/oby.21533","article-title":"Low adoption of weight loss medications: a comparison of prescribing patterns of antiobesity pharmacotherapies and SGLT2s","volume":"24","author":"Thomas","year":"2016","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib52","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1001\/jama.2016.1461","article-title":"Evaluation of the cardiovascular risk of naltrexone-bupropion: a study interrupted","volume":"315","author":"Sharfstein","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00234-2_bib53","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1056\/NEJMoa1808721","article-title":"Cardiovascular safety of lorcaserin in overweight or obese patients","volume":"379","author":"Bohula","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib54","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1056\/NEJMp2003873","article-title":"Cancer risk associated with lorcaserin\u2014the FDA's review of the CAMELLIA-TIMI 61 Trial","volume":"383","author":"Sharretts","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib55","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1002\/oby.22810","article-title":"Should the same safety scrutiny of antiobesity medications be applied to other chronic usage drugs?","volume":"28","author":"Halpern","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib56","doi-asserted-by":"crossref","first-page":"100280","DOI":"10.1016\/j.obpill.2026.100280","article-title":"Design of INFORMUS, a pragmatic, randomized, double-blind, placebo-controlled study of cardiovascular outcomes with the extended-release, fixed-dose combination of naltrexone and bupropion","volume":"19","author":"Kyle","year":"2026","journal-title":"Obes Pillars"},{"key":"10.1016\/S2213-8587(26)00234-2_bib57","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1159\/000445192","article-title":"Obesity management in Europe: current status and objectives for the future","volume":"9","author":"Uerlich","year":"2016","journal-title":"Obes Facts"},{"key":"10.1016\/S2213-8587(26)00234-2_bib58","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1177\/003335491012500415","article-title":"Coverage of obesity treatment: a state-by-state analysis of Medicaid and state insurance laws","volume":"125","author":"Lee","year":"2010","journal-title":"Public Health Rep"},{"key":"10.1016\/S2213-8587(26)00234-2_bib59","doi-asserted-by":"crossref","first-page":"e13333","DOI":"10.1111\/obr.13333","article-title":"Weight stigma and obesity-related policies: a systematic review of the state of the literature","volume":"22","author":"Hill","year":"2021","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(26)00234-2_bib60","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1016\/j.gtc.2023.02.002","article-title":"Weight stigma and barriers to effective obesity care","volume":"52","author":"Puhl","year":"2023","journal-title":"Gastroenterol Clin North Am"},{"key":"10.1016\/S2213-8587(26)00234-2_bib61","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/dom.13752","article-title":"Gaps to bridge: misalignment between perception, reality and actions in obesity","volume":"21","author":"Caterson","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00234-2_bib62","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s13098-025-01660-5","article-title":"Exploring the perceptions of obesity, health habits, stigma, and eating behaviors in Brazil","volume":"17","author":"Viola","year":"2025","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/S2213-8587(26)00234-2_bib63","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.ecl.2020.02.007","article-title":"Barriers and solutions for prescribing obesity pharmacotherapy","volume":"49","author":"Fujioka","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(26)00234-2_bib64","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.1002\/oby.22581","article-title":"Antiobesity medication use in 2.2 million adults across eight large health care organizations: 2009\u20132015","volume":"27","author":"Saxon","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib65","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13679-017-0262-y","article-title":"Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over","volume":"6","author":"Ryan","year":"2017","journal-title":"Curr Obes Rep"},{"key":"10.1016\/S2213-8587(26)00234-2_bib66","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1002\/oby.22503","article-title":"Patient characteristics associated with receipt of prescription weight-management medications among veterans participating in MOVE!","volume":"27","author":"Thomas","year":"2019","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib67","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/MLR.0000000000002113","article-title":"Trends in obesity care among US adults, 2010-2021","volume":"63","author":"Podolsky","year":"2025","journal-title":"Med Care"},{"key":"10.1016\/S2213-8587(26)00234-2_bib68","series-title":"La s\u00e9cr\u00e9tine: son r\u00f4le physiologique, ses propri\u00e9t\u00e9s th\u00e9rapeutiques","author":"La Barre","year":"1936"},{"key":"10.1016\/S2213-8587(26)00234-2_bib69","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S0140-6736(64)90011-X","article-title":"New interpretation of oral glucose tolerance","volume":"2","author":"McIntyre","year":"1964","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00234-2_bib70","doi-asserted-by":"crossref","first-page":"387","DOI":"10.3389\/fendo.2018.00387","article-title":"The origin and understanding of the incretin concept","volume":"9","author":"Rehfeld","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib71","doi-asserted-by":"crossref","first-page":"102118","DOI":"10.1016\/j.molmet.2025.102118","article-title":"Glucose-dependent insulinotropic polypeptide (GIP)","volume":"95","author":"M\u00fcller","year":"2025","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(26)00234-2_bib72","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1016\/S0140-6736(87)91194-9","article-title":"Glucagon-like peptide-1 7-36: a physiological incretin in man","volume":"2","author":"Kreymann","year":"1987","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00234-2_bib73","doi-asserted-by":"crossref","first-page":"3829","DOI":"10.1016\/j.cell.2024.06.003","article-title":"Transforming obesity: the advancement of multi-receptor drugs","volume":"187","author":"Kusminski","year":"2024","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(26)00234-2_bib74","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1172\/JCI990","article-title":"Glucagon-like peptide 1 promotes satiety and suppresses energy intake in humans","volume":"101","author":"Flint","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(26)00234-2_bib75","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.molmet.2019.09.010","article-title":"Glucagon-like peptide 1 (GLP-1)","volume":"30","author":"M\u00fcller","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(26)00234-2_bib76","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s13098-023-01233-4","article-title":"Pharmacotherapy for obesity: moving towards efficacy improvement","volume":"16","author":"Coutinho","year":"2024","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/S2213-8587(26)00234-2_bib77","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib78","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib79","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib80","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1056\/NEJMoa2500969","article-title":"Oral semaglutide at a dose of 25 mg in adults with overweight or obesity","volume":"393","author":"Wharton","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib81","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1056\/NEJMoa2511774","article-title":"Orforglipron, an oral small-molecule GLP-1 receptor agonist for obesity treatment","volume":"393","author":"Wharton","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib82","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib83","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib84","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1002\/oby.24332","article-title":"Tirzepatide for reduction of morbidity and mortality in adults with obesity: rationale and design of the SURMOUNT-MMO trial","volume":"33","author":"Lam","year":"2025","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib85","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.adn4128","article-title":"The benefits of GLP-1 drugs beyond obesity","volume":"385","author":"Drucker","year":"2024","journal-title":"Science"},{"key":"10.1016\/S2213-8587(26)00234-2_bib86","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.clinthera.2023.12.014","article-title":"Use of dulaglutide, semaglutide, and tirzepatide in diabetes and weight management","volume":"46","author":"Powell","year":"2024","journal-title":"Clin Ther"},{"key":"10.1016\/S2213-8587(26)00234-2_bib87","doi-asserted-by":"crossref","first-page":"3732","DOI":"10.1111\/dom.70555","article-title":"Sex-specific changes in GLP-1RA trends (2019\u20132024): impact of FDA approval of semaglutide (Wegovy) for chronic weight management in the United States","volume":"28","author":"Daggolu","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00234-2_bib88","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1111\/dom.70609","article-title":"GLP-1 receptor agonists in Brazil: landscape of consumption, safety and regulation","volume":"28","author":"Hurtado","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00234-2_bib89","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(22)00318-7","article-title":"Social media and misinformation in diabetes and obesity","volume":"10","author":"Burki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00234-2_bib90","author":"Diabetes"},{"key":"10.1016\/S2213-8587(26)00234-2_bib91","doi-asserted-by":"crossref","first-page":"103082","DOI":"10.1016\/j.japh.2026.103082","article-title":"TikTokfluence: the rise of GLP-1 receptor agonists in the age of social media health trends","volume":"66","author":"G\u00fcnaltay","year":"2026","journal-title":"J Am Pharm Assoc"},{"key":"10.1016\/S2213-8587(26)00234-2_bib92","doi-asserted-by":"crossref","DOI":"10.17269\/s41997-026-01197-8","article-title":"Widespread exposure to GLP-1RAs and weight loss-related discourse: considering potential public health implications","author":"C\u00f4t\u00e9","year":"2026","journal-title":"Can J Public Health"},{"key":"10.1016\/S2213-8587(26)00234-2_bib93","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1093\/asj\/sjad211","article-title":"Public interest in the off-label use of glucagon-like peptide 1 agonists (ozempic) for cosmetic weight loss: a Google trends analysis","volume":"44","author":"Han","year":"2023","journal-title":"Aesthet Surg J"},{"key":"10.1016\/S2213-8587(26)00234-2_bib94","doi-asserted-by":"crossref","first-page":"e2457232","DOI":"10.1001\/jamanetworkopen.2024.57232","article-title":"Longitudinal analysis of obesity drug use and public awareness","volume":"8","author":"Berning","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(26)00234-2_bib95","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/S0140-6736(25)01375-3","article-title":"Semaglutide and cardiovascular outcomes by baseline and changes in adiposity measurements: a prespecified analysis of the SELECT trial","volume":"406","author":"Deanfield","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00234-2_bib96","doi-asserted-by":"crossref","first-page":"846","DOI":"10.2337\/dc24-1533","article-title":"Cardiovascular and kidney outcomes and mortality with long-acting injectable and oral glucagon-like peptide 1 receptor agonists in individuals with type 2 diabetes: a systematic review and meta-analysis of randomized trials","volume":"48","author":"Lee","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00234-2_bib97","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib98","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib99","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJMoa2410027","article-title":"Tirzepatide for heart failure with preserved ejection fraction and obesity","volume":"392","author":"Packer","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib100","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 Trial of semaglutide in metabolic dysfunction-associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib101","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib103","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1038\/s41591-024-03015-5","article-title":"Long-term kidney outcomes of semaglutide in obesity and cardiovascular disease in the SELECT trial","volume":"30","author":"Colhoun","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib104","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib105","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1038\/s41591-024-03133-0","article-title":"Effects of semaglutide with and without concomitant SGLT2 inhibitor use in participants with type 2 diabetes and chronic kidney disease in the FLOW trial","volume":"30","author":"Mann","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib106","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(25)02105-1","article-title":"GLP-1 receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits","volume":"407","author":"Nauck","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00234-2_bib107","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/S0140-6736(21)01919-X","article-title":"Obesity management as a primary treatment goal for type 2 diabetes: time to reframe the conversation","volume":"399","author":"Lingvay","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00234-2_bib108","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S2213-8587(24)00363-2","article-title":"Estimating direct tissue effects versus weight loss effects of incretin-based drugs for obesity on various chronic conditions","volume":"13","author":"Sattar","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00234-2_bib109","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity","volume":"387","author":"Weghuber","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib110","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","article-title":"A randomized, controlled trial of liraglutide for adolescents with obesity","volume":"382","author":"Kelly","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib111","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1016\/S0140-6736(25)01774-X","article-title":"Efficacy and safety of tirzepatide in children and adolescents with type 2 diabetes (SURPASS-PEDS): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"406","author":"Hannon","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00234-2_bib112","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2213-8587(22)00047-X","article-title":"Obesity in children and adolescents: epidemiology, causes, assessment, and management","volume":"10","author":"Jebeile","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00234-2_bib113","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1002\/oby.23808","article-title":"Reducing BMI below the obesity threshold in adolescents treated with once-weekly subcutaneous semaglutide 2.4 mg","volume":"31","author":"Kelly","year":"2023","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib114","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","article-title":"The cardiovascular biology of glucagon-like peptide-1","volume":"24","author":"Drucker","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(26)00234-2_bib115","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1210\/jc.2019-00004","article-title":"Extracellular fluid volume expansion uncovers a natriuretic action of GLP-1: a functional GLP-1\u2013renal axis in man","volume":"104","author":"Asmar","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00234-2_bib116","doi-asserted-by":"crossref","first-page":"F1010","DOI":"10.1152\/ajprenal.00028.2019","article-title":"Does glucagon-like peptide-1 induce diuresis and natriuresis by modulating afferent renal nerve activity?","volume":"317","author":"Katsurada","year":"2019","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/S2213-8587(26)00234-2_bib117","doi-asserted-by":"crossref","first-page":"106320","DOI":"10.1016\/j.phrs.2022.106320","article-title":"The anti-inflammatory and immunological properties of GLP-1 receptor agonists","volume":"182","author":"Bendotti","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/S2213-8587(26)00234-2_bib118","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1016\/j.cmet.2022.08.003","article-title":"Divergent roles for the gut intraepithelial lymphocyte GLP-1R in control of metabolism, microbiota, and T cell-induced inflammation","volume":"34","author":"Wong","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(26)00234-2_bib119","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib120","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMoa2504214","article-title":"Once-monthly maridebart cafraglutide for the treatment of obesity\u2014a phase 2 trial","volume":"393","author":"Jastreboff","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib121","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1007\/s00125-023-05947-y","article-title":"100 years of glucagon and 100 more","volume":"66","author":"Wewer Albrechtsen","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00234-2_bib122","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/dom.12585","article-title":"Glucagon increases energy expenditure independently of brown adipose tissue activation in humans","volume":"18","author":"Salem","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00234-2_bib123","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S2213-8587(23)00356-X","article-title":"Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial","volume":"12","author":"le Roux","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00234-2_bib124","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-hormone-receptor agonist retatrutide for obesity\u2014a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00234-2_bib125","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s42255-026-01465-4","article-title":"The story of amylin: from physiology to therapy","volume":"8","author":"Secher","year":"2026","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(26)00234-2_bib126","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1002\/oby.23374","article-title":"Beyond appetite regulation: targeting energy expenditure, fat oxidation, and lean mass preservation for sustainable weight loss","volume":"30","author":"Christoffersen","year":"2022","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(26)00234-2_bib127","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1126\/science.adn4691","article-title":"Obesity meets its match","volume":"382","author":"Couzin-Frankel","year":"2023","journal-title":"Science"},{"key":"10.1016\/S2213-8587(26)00234-2_bib128","doi-asserted-by":"crossref","first-page":"e186225","DOI":"10.1172\/JCI186225","article-title":"Joel Habener, Svetlana Mojsov, and Lotte Bjerre Knudsen awarded Lasker prize for pioneering work on GLP-1","volume":"134","author":"Ardehali","year":"2024","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(26)00234-2_bib129","series-title":"WHO Model List of Essential Medicines, 24th list","year":"2025"},{"key":"10.1016\/S2213-8587(26)00234-2_bib130","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1080\/14740338.2024.2430306","article-title":"Increased reporting of accidental overdose with glucagon-like peptide-1 receptor agonists: a population-based study","volume":"25","author":"McIntyre","year":"2026","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/S2213-8587(26)00234-2_bib131","doi-asserted-by":"crossref","first-page":"177","DOI":"10.2337\/dci24-0091","article-title":"Compounded GLP-1 and dual GIP\/GLP-1 receptor agonists: a statement from the American Diabetes Association","volume":"48","author":"Neumiller","year":"2025","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002342?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002342?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T22:38:01Z","timestamp":1792449481000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726002342"}},"issued":{"date-parts":[[2026,10]]},"references-count":129,"alternative-id":["S2213858726002342"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00234-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The development of obesity pharmacotherapy: from early challenges and setbacks to recognition by WHO","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00234-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:24:25Z","timestamp":1792167865623,"version":"4.4.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/s2213-8587(22)00078-x","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:56:14Z","timestamp":1647892574000},"page":"298-299","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Rising diabetes diagnosis in long COVID"],"prefix":"10.1016","volume":"10","author":[{"given":"K M Venkat","family":"Narayan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R","family":"Staimez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00078-X_bib1","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15585\/mmwr.mm7102e2","article-title":"Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 Years\u2014United States, March 1, 2020\u2013June 28, 2021","volume":"71","author":"Barrett","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S2213-8587(22)00078-X_bib2","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"3","author":"Montefusco","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(22)00078-X_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(22)00044-4","article-title":"Risks and burdens of incident diabetes in long COVID: a cohort study","author":"Xie","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00078-X_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.cell.2022.01.014","article-title":"Multiple early factors anticipate post-acute COVID-19 sequelae","author":"Su","year":"2022","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(22)00078-X_bib5","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-022-01689-3","article-title":"Long-term cardiovascular outcomes of COVID-19","author":"Xie","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(22)00078-X_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s42255-021-00347-1","article-title":"SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas","volume":"3","author":"M\u00fcller","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(22)00078-X_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2022.110508","article-title":"Limited extent and consequences of pancreatic SARS-CoV-2 infection","volume":"38","author":"van der Heide","year":"2022","journal-title":"Cell Rep"},{"key":"10.1016\/S2213-8587(22)00078-X_bib8","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.cmet.2021.05.015","article-title":"SARS-CoV-2 infection induces beta cell transdifferentiation","volume":"33","author":"Tang","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(22)00078-X_bib9","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.2337\/dc21-1318","article-title":"COVID-19, hyperglycemia, and new-onset diabetes","volume":"44","author":"Khunti","year":"2021","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872200078X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872200078X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:50Z","timestamp":1761991850000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872200078X"}},"issued":{"date-parts":[[2022,5]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S221385872200078X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00078-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rising diabetes diagnosis in long COVID","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00078-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00044-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T08:46:15Z","timestamp":1793090775495,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/s2213-8587(20)30271-0","type":"journal-article","created":{"date-parts":[[2020,8,13]],"date-time":"2020-08-13T18:40:20Z","timestamp":1597344020000},"page":"823-833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":741,"title":["Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study"],"prefix":"10.1016","volume":"8","author":[{"given":"Naomi","family":"Holman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Knighton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"O'Keefe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Curley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"Weaver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Bakhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Valabhji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30271-0_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30271-0_bib4","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.ijid.2016.06.015","article-title":"Prevalence of comorbidities in the Middle East respiratory syndrome coronavirus (MERS-CoV): a systematic review and meta-analysis","volume":"49","author":"Badawi","year":"2016","journal-title":"Int J Infect Dis"},{"key":"10.1016\/S2213-8587(20)30271-0_bib5","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(20)30271-0_bib6","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1007\/s00392-020-01626-9","article-title":"Prevalence and impact of cardiovascular metabolic diseases on COVID-19 in China","volume":"109","author":"Li","year":"2020","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/S2213-8587(20)30271-0_bib7","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1016\/S0140-6736(20)30566-3","article-title":"Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study","volume":"395","author":"Zhou","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30271-0_bib9","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(20)30271-0_bib10","author":"Perez-Guzman"},{"key":"10.1016\/S2213-8587(20)30271-0_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1177\/1932296820924469","article-title":"Glycemic characteristics and clinical outcomes of COVID-19 patients hospitalized in the United States","volume":"14","author":"Bode","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(20)30271-0_bib12","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(20)30271-0_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108138","article-title":"Commentary: COVID-19 and diabetes","volume":"162","author":"Villabona","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(20)30271-0_bib14","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.2337\/dc20-0660","article-title":"Clinical characteristics and outcomes of patients with diabetes and COVID-19 in association with glucose-lowering medication","volume":"43","author":"Chen","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30271-0_bib15","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.dsx.2020.04.018","article-title":"Diabetes mellitus is associated with increased mortality and severity of disease in COVID-19 pneumonia\u2014a systematic review, meta-analysis, and meta-regression","volume":"14","author":"Huang","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(20)30271-0_bib16","doi-asserted-by":"crossref","first-page":"513","DOI":"10.2337\/dc17-2131","article-title":"Risk of infection in type 1 and type 2 diabetes compared with the general population: a matched cohort study","volume":"41","author":"Carey","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30271-0_bib17","doi-asserted-by":"crossref","first-page":"2127","DOI":"10.2337\/dc18-0287","article-title":"Glycemic control and risk of infections among people with type 1 or type 2 diabetes in a large primary care cohort study","volume":"41","author":"Critchley","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30271-0_bib18","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2521-4","article-title":"OpenSAFELY: factors associated with COVID-19 death in 17 million patients","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(20)30271-0_bib19","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s00125-020-05180-x","article-title":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","volume":"63","author":"Cariou","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30271-0_bib20","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1161\/CIRCULATIONAHA.120.047659","article-title":"Obesity is a risk factor for severe COVID-19 infection: multiple potential mechanisms","volume":"142","author":"Sattar","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(20)30271-0_bib25","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2337\/dc16-1616","article-title":"Life expectancy and cause-specific mortality in type 2 diabetes: a population-based cohort study quantifying relationships in ethnic subgroups","volume":"40","author":"Wright","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30271-0_bib26","doi-asserted-by":"crossref","first-page":"20","DOI":"10.18332\/tid\/119324","article-title":"COVID-19 and smoking: a systematic review of the evidence","volume":"18","author":"Vardavas","year":"2020","journal-title":"Tob Induc Dis"},{"key":"10.1016\/S2213-8587(20)30271-0_bib27","doi-asserted-by":"crossref","DOI":"10.1093\/ntr\/ntaa082","article-title":"Smoking is associated With COVID-19 progression: a meta-analysis","author":"Patanavanich","year":"2020","journal-title":"Nicotine Tob Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302710?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302710?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:46Z","timestamp":1761991726000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720302710"}},"issued":{"date-parts":[[2020,10]]},"references-count":20,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2213858720302710"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30271-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30271-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T12:16:04Z","timestamp":1792844164888,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/s2213-8587(13)70048-2","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T04:26:30Z","timestamp":1376972790000},"page":"183-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":224,"title":["Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study"],"prefix":"10.1016","volume":"1","author":[{"given":"Lieza G","family":"Exalto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geert Jan","family":"Biessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Karter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elbert S","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne J","family":"Katon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome R","family":"Minkoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel A","family":"Whitmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70048-2_bib1","doi-asserted-by":"crossref","first-page":"e6817","DOI":"10.1371\/journal.pone.0006817","article-title":"Life expectancy in a large cohort of type 2 diabetes patients treated in primary care (ZODIAC-10)","volume":"4","author":"Lutgers","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70048-2_bib2","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1038\/nrendo.2010.228","article-title":"Cognitive function, dementia and type 2 diabetes mellitus in the elderly","volume":"7","author":"Strachan","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(13)70048-2_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S1474-4422(05)70284-2","article-title":"Risk of dementia in diabetes mellitus: a systematic review","volume":"5","author":"Biessels","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(13)70048-2_bib4","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.jalz.2012.12.004","article-title":"Can we prevent Alzheimer's disease? Secondary \u201cprevention\u201d trials in Alzheimer's disease","volume":"9","author":"Carrillo","year":"2013","journal-title":"Alzheimers Dement"},{"key":"10.1016\/S2213-8587(13)70048-2_bib5","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/S1474-4422(13)70030-9","article-title":"The European dementia prevention initiative","volume":"12","author":"Dehnel","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(13)70048-2_bib6","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1161\/01.CIR.97.18.1837","article-title":"Prediction of coronary heart disease using risk factor categories","volume":"97","author":"Wilson","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70048-2_bib7","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1161\/01.CIR.0000145172.55640.93","article-title":"Selecting patients with atrial fibrillation for anticoagulation: stroke risk stratification in patients taking aspirin","volume":"110","author":"Gage","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70048-2_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1212\/WNL.0b013e3181a81636","article-title":"Predicting risk of dementia in older adults: The late-life dementia risk index","volume":"73","author":"Barnes","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/S2213-8587(13)70048-2_bib9","doi-asserted-by":"crossref","first-page":"e16852","DOI":"10.1371\/journal.pone.0016852","article-title":"Prediction of dementia in primary care patients","volume":"6","author":"Jessen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70048-2_bib10","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1001\/archneurol.2010.136","article-title":"A summary risk score for the prediction of Alzheimer disease in elderly persons","volume":"67","author":"Reitz","year":"2010","journal-title":"Arch Neurol"},{"key":"10.1016\/S2213-8587(13)70048-2_bib11","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S1474-4422(06)70537-3","article-title":"Risk score for the prediction of dementia risk in 20 years among middle aged people: a longitudinal, population-based study","volume":"5","author":"Kivipelto","year":"2006","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(13)70048-2_bib12","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.2337\/dc08-0562","article-title":"Predictors of cognitive decline in older individuals with diabetes","volume":"31","author":"Bruce","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70048-2_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.3233\/JAD-2011-101524","article-title":"Incidence of dementia is increased in type 2 diabetes and reduced by the use of sulfonylureas and metformin","volume":"24","author":"Hsu","year":"2011","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/S2213-8587(13)70048-2_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1001\/archneurol.2007.29","article-title":"Enhanced risk for Alzheimer disease in persons with type 2 diabetes and APOE epsilon4: the Cardiovascular Health Study Cognition Study","volume":"65","author":"Irie","year":"2008","journal-title":"Arch Neurol"},{"key":"10.1016\/S2213-8587(13)70048-2_bib15","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11606-009-1248-6","article-title":"Comorbid depression is associated with an increased risk of dementia diagnosis in patients with diabetes: a prospective cohort study","volume":"25","author":"Katon","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S2213-8587(13)70048-2_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/joim.12000","article-title":"Hypoglycaemic episodes and risk of dementia in diabetes mellitus: 7-year follow-up study","volume":"273","author":"Lin","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(13)70048-2_bib17","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/gps.2604","article-title":"Risk factors for dementia in patients over 65 with diabetes","volume":"26","author":"Parikh","year":"2011","journal-title":"Int J Geriatr Psychiatry"},{"key":"10.1016\/S2213-8587(13)70048-2_bib18","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2009.460","article-title":"Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus","volume":"301","author":"Whitmer","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70048-2_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(01)00742-2","article-title":"Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry","volume":"111","author":"Karter","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(13)70048-2_bib20","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/ije\/dyn040","article-title":"Cohort Profile: The Diabetes Study of Northern California (DISTANCE)\u2014objectives and design of a survey follow-up study of social health disparities in a managed care population","volume":"38","author":"Moffet","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(13)70048-2_bib21","doi-asserted-by":"crossref","first-page":"719","DOI":"10.7326\/0003-4819-127-8_Part_2-199710151-00056","article-title":"Linking automated databases for research in managed care settings","volume":"127","author":"Selby","year":"1997","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(13)70048-2_bib22","doi-asserted-by":"crossref","first-page":"703","DOI":"10.2105\/AJPH.82.5.703","article-title":"Overcoming the absence of socioeconomic data in medical records: validation and application of a census-based methodology","volume":"82","author":"Krieger","year":"1992","journal-title":"Am J Public Health"},{"key":"10.1016\/S2213-8587(13)70048-2_bib23","first-page":"7","article-title":"Large-scale collection of family history data and recruitment of informative families for genetic analysis","volume":"25","author":"Karter","year":"1998","journal-title":"J Registry Manag"},{"key":"10.1016\/S2213-8587(13)70048-2_bib24","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11606-009-1179-2","article-title":"The association between the number of prescription medications and incident falls in a multi-ethnic population of adult type-2 diabetes patients: the diabetes and aging study","volume":"25","author":"Huang","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S2213-8587(13)70048-2_bib25","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1002\/sim.4026","article-title":"Several methods to assess improvement in risk prediction models: extension to survival analysis","volume":"30","author":"Chambless","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(13)70048-2_bib26","doi-asserted-by":"crossref","first-page":"264","DOI":"10.2337\/dc09-1068","article-title":"Depression and advanced complications of diabetes: a prospective cohort study","volume":"33","author":"Lin","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70048-2_bib27","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1373\/clinchem.2007.096529","article-title":"Statistical evaluation of prognostic versus diagnostic models: beyond the ROC curve","volume":"54","author":"Cook","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(13)70048-2_bib28","doi-asserted-by":"crossref","first-page":"b606","DOI":"10.1136\/bmj.b606","article-title":"Prognosis and prognostic research: application and impact of prognostic models in clinical practice","volume":"338","author":"Moons","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70048-2_bib29","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1002\/sim.5525","article-title":"Standardizing the power of the Hosmer-Lemeshow goodness of fit test in large data sets","volume":"32","author":"Paul","year":"2013","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(13)70048-2_bib30","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S1474-4422(11)70199-5","article-title":"Intensive glucose lowering and cognition in type 2 diabetes","volume":"10","author":"Biessels","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(13)70048-2_bib31","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(11)70188-0","article-title":"Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy","volume":"10","author":"Launer","year":"2011","journal-title":"Lancet Neurol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,21]],"date-time":"2019-07-21T11:43:18Z","timestamp":1563709398000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700482"}},"issued":{"date-parts":[[2013,11]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S2213858713700482"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70048-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70048-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70091-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T17:06:57Z","timestamp":1793639217654,"version":"4.5.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/s2213-8587(23)00170-5","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T18:35:06Z","timestamp":1687890906000},"page":"532-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Sleep and cardiometabolic health\u2014not so strange bedfellows"],"prefix":"10.1016","volume":"11","author":[{"given":"Shahrad","family":"Taheri","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00170-5_bib2","doi-asserted-by":"crossref","DOI":"10.1093\/gerona\/glad108","article-title":"Joint associations of device-measured sleep duration and efficiency with all-cause and cause-specific mortality: a prospective cohort study of 90\u2008398 UK Biobank participants","author":"Liang","year":"2023","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(23)00170-5_bib3","doi-asserted-by":"crossref","first-page":"e62","DOI":"10.1371\/journal.pmed.0010062","article-title":"Short sleep duration is associated with reduced leptin, elevated ghrelin, and increased body mass index","volume":"1","author":"Taheri","year":"2004","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(23)00170-5_bib4","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3945\/ajcn.113.069427","article-title":"Experimental sleep curtailment causes wake-dependent increases in 24-h energy expenditure as measured by whole-room indirect calorimetry","volume":"98","author":"Shechter","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00170-5_bib5","doi-asserted-by":"crossref","DOI":"10.1007\/s11325-023-02841-0","article-title":"Meta-analysis of correlation between sleep duration and gender difference in adults with type 2 diabetes","author":"Wang","year":"2023","journal-title":"Sleep Breath"},{"key":"10.1016\/S2213-8587(23)00170-5_bib6","article-title":"Association of accelerometer-measured sleep duration and different intensities of physical activity with incident type 2 diabetes in a population-based cohort study","author":"Jin","year":"2023","journal-title":"J Sport Health Sci"},{"key":"10.1016\/S2213-8587(23)00170-5_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2022.101594","article-title":"Effects of sleep manipulation on markers of insulin sensitivity: a systematic review and meta-analysis of randomized controlled trials","volume":"62","author":"Sondrup","year":"2022","journal-title":"Sleep Med Rev"},{"key":"10.1016\/S2213-8587(23)00170-5_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1001\/jamainternmed.2021.8098","article-title":"Effect of sleep extension on objectively assessed energy intake among adults with overweight in real-life settings: a randomized clinical trial","volume":"182","author":"Tasali","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(23)00170-5_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108532","article-title":"Systematic review of clinical practice guidelines to identify recommendations for sleep in type 2 diabetes mellitus management","volume":"170","author":"Smyth","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00170-5_bib10","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.smrv.2008.04.003","article-title":"Is sleep duration associated with obesity\u2014where do U stand?","volume":"12","author":"Taheri","year":"2008","journal-title":"Sleep Med Rev"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001705?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001705?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:45Z","timestamp":1761992025000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001705"}},"issued":{"date-parts":[[2023,8]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2213858723001705"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00170-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sleep and cardiometabolic health\u2014not so strange bedfellows","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00170-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T07:16:29Z","timestamp":1793949389206,"version":"4.8.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/s2213-8587(14)70112-3","type":"journal-article","created":{"date-parts":[[2014,6,8]],"date-time":"2014-06-08T19:15:12Z","timestamp":1402254912000},"page":"539","source":"Crossref","is-referenced-by-count":3,"title":["SGLT inhibition in patients with type 1 diabetes"],"prefix":"10.1016","volume":"2","author":[{"given":"Clayton A","family":"Dehn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70112-3_bib1","unstructured":"Henry RR, Rosenstock J, Chalamandris A-G, Kasichayanula S, Bogle A, Griffen SC. Exploring the potential of dapagliflozin in type 1 diabetes: phase 2a pilot study. 73rd American Diabetes Association Scientific Sessions; Chicago, IL, USA; June 21\u201325, 2013; 70-LB."},{"key":"10.1016\/S2213-8587(14)70112-3_bib2","unstructured":"Perkins BA, Cherney DZ, Partridge H, et al. The sodium glucose cotransporter 2 (SGLT2) inhibitor empagliflozin improves glycemic control in patients with type 1 diabetes: a single-arm clinical trial. 73rd American Diabetes Association Scientific Sessions; Chicago, IL, USA; June 21\u201325, 2013; 1074-P."},{"key":"10.1016\/S2213-8587(14)70112-3_bib4","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1172\/JCI72227","article-title":"Metabolic response to sodium\u2013glucose cotransporter 2 inhibition in type 2 diabetic patients","volume":"124","author":"Ferrannini","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(14)70112-3_bib5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI70704","article-title":"Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production","volume":"124","author":"Mervoci","year":"2014","journal-title":"J Clin Invest"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T10:25:58Z","timestamp":1538562358000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701123"}},"issued":{"date-parts":[[2014,7]]},"references-count":4,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S2213858714701123"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70112-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,7]]}},{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:06:28Z","timestamp":1793829988577,"version":"4.6.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["304985"],"award-info":[{"award-number":["304985"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012990","name":"Universit\u00e0 degli Studi di Siena","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012990","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/s2213-8587(20)30228-x","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T18:38:15Z","timestamp":1597775895000},"page":"762-772","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":125,"title":["Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Lakshminarayan R","family":"Ranganath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eftychia Eirini","family":"Psarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Baptiste","family":"Arnoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Braconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Br\u00f6ijers\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Loftus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Bygott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor F","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S","family":"Davison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane P","family":"Dillon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"FitzGerald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Glasova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony K","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliette H","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Imrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan C","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milad","family":"Khedr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dinny","family":"Laan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim-Hanh","family":"Le Quan Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Luangrath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ol'ga","family":"Luk\u00e1\u010dov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna M","family":"Milan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpesh","family":"Mistry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanda","family":"Mlyn\u00e1rikov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan P","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitta","family":"Olsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas P","family":"Rhodes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jozef","family":"Rovensk\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Rudebeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Santucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ella","family":"Shweihdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciar\u00e1n","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Sedl\u00e1kov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Sireau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Stan\u010d\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Szamosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa","family":"van Kan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sobhan","family":"Vinjamuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Vrt\u00edkov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Z\u00e1\u0148ov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Zatkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Gallagher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30228-X_bib1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0002-9343(63)90089-5","article-title":"Biochemical, pathologic and clinical aspects of alcaptonuria, ochronosis and ochronotic arthropathy: review of world literature (1584\u20131962)","volume":"34","author":"O'Brien","year":"1963","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(20)30228-X_bib2","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1056\/NEJMoa021736","article-title":"Natural history of alkaptonuria","volume":"347","author":"Phornphutkul","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30228-X_bib3","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1016\/S0140-6736(01)41972-6","article-title":"The incidence of alkaptonuria: a study in chemical individuality","volume":"2","author":"Garrod","year":"1902","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30228-X_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/0304-4165(69)90068-3","article-title":"Oxidation of homogentisic acid to ochronotic pigment in connective tissue","volume":"177","author":"Zannoni","year":"1969","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S2213-8587(20)30228-X_bib5","doi-asserted-by":"crossref","first-page":"3887","DOI":"10.1002\/art.30606","article-title":"The role of calcified cartilage and subchondral bone in the initiation and progression of ochronotic arthropathy in alkaptonuria","volume":"63","author":"Taylor","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(20)30228-X_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S0021-9258(18)70560-7","article-title":"The nature of the defect in tyrosine metabolism in alcaptonuria","volume":"230","author":"La Du","year":"1958","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(20)30228-X_bib7","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1111\/j.1365-2559.2008.03000.x","article-title":"Alkaptonuria\u2014a review of surgical and autopsy pathology","volume":"53","author":"Helliwell","year":"2008","journal-title":"Histopathology"},{"key":"10.1016\/S2213-8587(20)30228-X_bib8","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/0140-6736(92)92685-9","article-title":"Treatment of hereditary tyrosinaemia type I by inhibition of 4-hydroxyphenylpyruvate dioxygenase","volume":"340","author":"Lindstedt","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30228-X_bib9","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1517\/21678707.2013.800807","article-title":"Nitisinone for the treatment of hereditary tyrosinemia type I","volume":"1","author":"McKiernan","year":"2013","journal-title":"Expert Opin Orphan Drugs"},{"key":"10.1016\/S2213-8587(20)30228-X_bib10","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1086\/302027","article-title":"NTBC and alkaptonuria","volume":"63","author":"Anikster","year":"1998","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(20)30228-X_bib11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/j.metabol.2004.12.017","article-title":"Use of nitisinone in patients with alkaptonuria","volume":"54","author":"Suwannarat","year":"2005","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(20)30228-X_bib12","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.ymgme.2011.04.016","article-title":"A 3-year randomized therapeutic trial of nitisinone in alkaptonuria","volume":"103","author":"Introne","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(20)30228-X_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.ymgme.2018.07.011","article-title":"Nitisinone arrests ochronosis and decreases rate of progression of alkaptonuria: evaluation of the effect of nitisinone in the United Kingdom National Alkaptonuria Centre","volume":"125","author":"Ranganath","year":"2018","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(20)30228-X_bib14","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1016\/j.dib.2018.09.021","article-title":"Data on items of AKUSSI in alkaptonuria collected over three years from the United Kingdom National Alkaptonuria Centre and the impact of nitisinone","volume":"20","author":"Griffin","year":"2018","journal-title":"Data Brief"},{"key":"10.1016\/S2213-8587(20)30228-X_bib15","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1007\/s10545-011-9282-z","article-title":"Identification of alkaptonuria in the general population: a United Kingdom experience describing the challenges, possible solutions and persistent barriers","volume":"34","author":"Ranganath","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(20)30228-X_bib16","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1016\/j.joca.2012.04.013","article-title":"Ochronosis in a murine model of alkaptonuria is synonymous to that in the human condition","volume":"20","author":"Taylor","year":"2012","journal-title":"Osteoarthritis Cartilage"},{"key":"10.1016\/S2213-8587(20)30228-X_bib17","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1136\/annrheumdis-2012-202878","article-title":"Ochronotic osteoarthropathy in a mouse model of alkaptonuria, and its inhibition by nitisinone","volume":"73","author":"Preston","year":"2014","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S2213-8587(20)30228-X_bib18","first-page":"45","article-title":"Nitisinone arrests but does not reverse ochronosis in alkaptonuric mice","volume":"24","author":"Keenan","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/S2213-8587(20)30228-X_bib19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s10545-011-9374-9","article-title":"Natural history of alkaptonuria revisited: analyses based on scoring systems","volume":"34","author":"Ranganath","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(20)30228-X_bib20","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s10545-011-9367-8","article-title":"A quantitative assessment of alkaptonuria: testing the reliability of two disease severity scoring systems","volume":"34","author":"Cox","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(20)30228-X_bib21","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/annrheumdis-2014-206033","volume":"75","author":"Ranganath","year":"2016","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S2213-8587(20)30228-X_bib22","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/jimd.12152","article-title":"Ochronotic pigmentation is caused by homogentisic acid and is the key event in alkaptonuria leading to the destructive consequences of the disease\u2014a review","volume":"42","author":"Ranganath","year":"2019","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(20)30228-X_bib23","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1210\/jc.2008-1122","article-title":"Prediction of changes in bone mineral density in postmenopausal women treated with once-weekly bisphosphonates","volume":"94","author":"Burnett-Bowie","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30228-X_bib24","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.4065\/83.9.1032","article-title":"Bisphosphonates: mechanism of action and role in clinical practice","volume":"83","author":"Drake","year":"2008","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/S2213-8587(20)30228-X_bib25","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1359\/jbmr.2002.17.1.11","article-title":"Bone turnover matters: the raloxifene treatment paradox of dramatic decreases in vertebral fractures without commensurate increases in bone density","volume":"17","author":"Riggs","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(20)30228-X_bib26","first-page":"21","article-title":"Relationship between serum concentrations of nitisinone and its effect on homogentisic acid and tyrosine in patients with alkaptonuria","volume":"24","author":"Olsson","year":"2015","journal-title":"JIMD Rep"},{"key":"10.1016\/S2213-8587(20)30228-X_bib27","doi-asserted-by":"crossref","first-page":"4118","DOI":"10.1210\/jcem.85.11.6953","article-title":"Fracture risk reduction with alendronate in women with osteoporosis: the fracture intervention trial","volume":"85","author":"Black","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872030228X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872030228X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:13Z","timestamp":1761991693000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872030228X"}},"issued":{"date-parts":[[2020,9]]},"references-count":27,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S221385872030228X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30228-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of once-daily nitisinone for patients with alkaptonuria (SONIA 2): an international, multicentre, open-label, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30228-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30222-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T11:39:10Z","timestamp":1794051550923,"version":"4.8.0"},"reference-count":44,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","award":["14CRP20380886"],"award-info":[{"award-number":["14CRP20380886"]}],"id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001259","name":"National Kidney Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001259","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004095","name":"Kyowa Hakko Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK100446-01"],"award-info":[{"award-number":["R01DK100446-01"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/s2213-8587(17)30183-3","type":"journal-article","created":{"date-parts":[[2017,7,15]],"date-time":"2017-07-15T04:58:42Z","timestamp":1500094722000},"page":"718-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data"],"prefix":"10.1016","volume":"5","author":[{"given":"Kunihiro","family":"Matsushita","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoshana H","family":"Ballew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josef","family":"Coresh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatomi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"\u00c4rnl\u00f6v","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cirillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade S","family":"Hiramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heejin","family":"Kimm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael G","family":"Shlipak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank L J","family":"Visseren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron T","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Csaba P","family":"Kovesdy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varda","family":"Shalev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kronenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisatomi","family":"Arima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Schaeffner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Martus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adeera","family":"Levin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ognjenka","family":"Djurdjev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mila","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnar","family":"Heine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Seiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Zawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Insa","family":"Emrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sarnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hermann","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben","family":"Sch\u00f6ttker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dietrich","family":"Rothenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Saum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"K\u00f6ttgen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus","family":"Schneider","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai-Uwe","family":"Eckardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamie","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Lester","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex R","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corri","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angharad","family":"Marks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Fluck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sun Ha","family":"Jee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yejin","family":"Mok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Chodick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varda","family":"Shalev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jack F.M.","family":"Wetzels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Blankestijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan D","family":"van Zuilen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Peralta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Hiromoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronit","family":"Katz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sarnak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin","family":"Bottinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish N","family":"Nadkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen B","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajiv","family":"Nadukuru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy","family":"Kenealy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C Raina","family":"Elley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John F","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul L","family":"Drury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan JL","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiddo J Lambers","family":"Heerspink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simerjot K","family":"Jassal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaclyn","family":"Bergstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim H","family":"Ix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Barrett-Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamyar","family":"Kalantar-Zadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan J","family":"Carrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Gasparini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul Rashid","family":"Qureshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Barany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ale","family":"Algra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda","family":"van der Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00e5rten","family":"Segelmark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Stendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Staffan","family":"Sch\u00f6n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Navdeep","family":"Tangri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maneesh","family":"Sud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Naimark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lannfelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stein","family":"Hallan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S","family":"Levey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingsha","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan E.","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingying","family":"Sang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30183-3_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","article-title":"Executive summary: heart disease and stroke statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30183-3_bib2","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30183-3_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1001\/jama.300.2.197","article-title":"Ankle brachial index combined with Framingham risk score to predict cardiovascular events and mortality: a meta-analysis","volume":"300","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30183-3_bib4","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1016\/j.jvs.2014.03.290","article-title":"Epidemiology of peripheral arterial disease and critical limb ischemia in an insured national population","volume":"60","author":"Nehler","year":"2014","journal-title":"J Vasc Surg"},{"key":"10.1016\/S2213-8587(17)30183-3_bib5","doi-asserted-by":"crossref","first-page":"e000257","DOI":"10.1161\/JAHA.113.000257","article-title":"Ankle brachial index values, leg symptoms, and functional performance among community-dwelling older men and women in the lifestyle interventions and independence for elders study","volume":"2","author":"McDermott","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(17)30183-3_bib7","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1016\/j.amjcard.2009.06.068","article-title":"Combined role of reduced estimated glomerular filtration rate and microalbuminuria on the prevalence of peripheral arterial disease","volume":"104","author":"Baber","year":"2009","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(17)30183-3_bib8","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amjcard.2012.02.061","article-title":"Risk factors for peripheral arterial disease among patients with chronic kidney disease","volume":"110","author":"Chen","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(17)30183-3_bib9","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1093\/eurheartj\/ehp195","article-title":"Kidney function estimated from serum creatinine and cystatin C and peripheral arterial disease in NHANES 1999\u20132002","volume":"30","author":"Selvin","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(17)30183-3_bib10","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/j.atherosclerosis.2007.12.044","article-title":"Albuminuria and peripheral arterial disease: results from the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"201","author":"Wattanakit","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(17)30183-3_bib11","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1681\/ASN.2005111204","article-title":"Kidney function and risk of peripheral arterial disease: results from the Atherosclerosis Risk in Communities (ARIC) Study","volume":"18","author":"Wattanakit","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30183-3_bib12","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.atherosclerosis.2004.11.024","article-title":"Risk factors for peripheral arterial disease incidence in persons with diabetes: the Atherosclerosis Risk in Communities (ARIC) Study","volume":"180","author":"Wattanakit","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(17)30183-3_bib13","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.2215\/CJN.09741110","article-title":"Associations among estimated glomerular filtration rate, proteinuria, and adverse cardiovascular outcomes","volume":"6","author":"Bello","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30183-3_bib14","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1053\/j.ajkd.2014.05.014","article-title":"Association of albumin-creatinine ratio and cystatin C with change in ankle-brachial index: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"65","author":"Garimella","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(17)30183-3_bib15","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1016\/j.jacc.2016.11.008","article-title":"2016 AHA\/ACC guideline on the management of patients with lower extremity peripheral artery disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"69","author":"Gerhard-Herman","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30183-3_bib16","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1093\/ije\/dys173","article-title":"Cohort profile: The Chronic Kidney Disease Prognosis Consortium","volume":"42","author":"Matsushita","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30183-3_bib17","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.1001\/jama.2012.3954","article-title":"Comparison of risk prediction using the CKD-EPI equation and the MDRD study equation for estimated glomerular filtration rate","volume":"307","author":"Matsushita","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30183-3_bib18","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis of individual participant data","volume":"3","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30183-3_bib19","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1053\/j.ajkd.2010.02.337","article-title":"Estimating GFR using the CKD Epidemiology Collaboration (CKD-EPI) creatinine equation: more accurate GFR estimates, lower CKD prevalence estimates, and better risk predictions","volume":"55","author":"Levey","year":"2010","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(17)30183-3_bib20","doi-asserted-by":"crossref","first-page":"932","DOI":"10.1056\/NEJMoa1214234","article-title":"Cystatin C versus creatinine in determining risk based on kidney function","volume":"369","author":"Shlipak","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30183-3_bib21","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Intern Suppl"},{"key":"10.1016\/S2213-8587(17)30183-3_bib22","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30183-3_bib23","first-page":"S11","article-title":"Standards of medical care in diabetes\u20142012","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30183-3_bib24","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1161\/01.CIR.96.1.44","article-title":"Intermittent claudication. A risk profile from The Framingham Heart Study","volume":"96","author":"Murabito","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30183-3_bib25","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1161\/HYPERTENSIONAHA.113.01925","article-title":"Metabolic syndrome and risk of incident peripheral artery disease: the Cardiovascular Health Study","volume":"63","author":"Garg","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30183-3_bib26","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1001\/jama.2012.13415","article-title":"Associations between conventional cardiovascular risk factors and risk of peripheral artery disease in men","volume":"308","author":"Joosten","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30183-3_bib27","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1056\/NEJMoa1107477","article-title":"C-reactive protein, fibrinogen, and cardiovascular disease prediction","volume":"367","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30183-3_bib28","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/S0140-6736(10)60674-5","article-title":"Association of estimated glomerular filtration rate and albuminuria with all-cause and cardiovascular mortality in general population cohorts: a collaborative meta-analysis","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30183-3_bib29","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1080\/01621459.1962.10480664","article-title":"An efficient method of estimating seemingly unrelated regressions and tests for aggregation bias","volume":"57","author":"Zellner","year":"1962","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/S2213-8587(17)30183-3_bib30","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1038\/ki.2010.550","article-title":"Lower estimated glomerular filtration rate and higher albuminuria are associated with mortality and end-stage renal disease. A collaborative meta-analysis of kidney disease population cohorts","volume":"79","author":"Astor","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30183-3_bib31","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30183-3_bib32","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1002\/sim.1802","article-title":"Overall C as a measure of discrimination in survival analysis: model specific population value and confidence interval estimation","volume":"23","author":"Pencina","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(17)30183-3_bib33","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30183-3_bib34","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2009"},{"key":"10.1016\/S2213-8587(17)30183-3_bib35","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1161\/CIRCULATIONAHA.106.678342","article-title":"Chronic kidney disease: effects on the cardiovascular system","volume":"116","author":"Schiffrin","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30183-3_bib36","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1038\/ki.2010.123","article-title":"Cardio-kidney-damage: a unifying concept","volume":"78","author":"El Nahas","year":"2010","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30183-3_bib37","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jvs.2009.08.073","article-title":"Critical limb ischemia","volume":"51","author":"Varu","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/S2213-8587(17)30183-3_bib38","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1177\/145749691210100207","article-title":"Why critical limb ischemia criteria are not applicable to diabetic foot and what the consequences are","volume":"101","author":"Jorneskog","year":"2012","journal-title":"Scand J Surg"},{"key":"10.1016\/S2213-8587(17)30183-3_bib39","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1016\/j.amjhyper.2005.12.018","article-title":"Microalbuminuria and cardiovascular risk assessment in primary hypertension: should threshold levels be revised?","volume":"19","author":"Ratto","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/S2213-8587(17)30183-3_bib40","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30183-3_bib41","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1093\/aje\/kwh101","article-title":"Limitations of the odds ratio in gauging the performance of a diagnostic, prognostic, or screening marker","volume":"159","author":"Pepe","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30183-3_bib42","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.2337\/diacare.26.11.3160","article-title":"Follow-up report on the diagnosis of diabetes mellitus","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30183-3_bib43","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30183-3_bib44","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s12913-014-0669-z","article-title":"Guideline adherence and health outcomes in diabetes mellitus type 2 patients: a cross-sectional study","volume":"15","author":"Wesselink","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(17)30183-3_bib45","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1001\/jama.289.19.2560","article-title":"The seventh report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure: the JNC 7 report","volume":"289","author":"Chobanian","year":"2003","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301833?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301833?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:47Z","timestamp":1761991547000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301833"}},"issued":{"date-parts":[[2017,9]]},"references-count":44,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2213858717301833"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30183-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measures of chronic kidney disease and risk of incident peripheral artery disease: a collaborative meta-analysis of individual participant data","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30183-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30256-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:15:51Z","timestamp":1794107751851,"version":"4.8.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/s2213-8587(20)30074-7","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:34:26Z","timestamp":1587580466000},"page":"392-406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":191,"title":["Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Daisuke","family":"Yabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiro","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Kaneto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Deenadayalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Navarria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Gislum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Arisaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Asakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Azuma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Fukuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Fukushima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Harada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Ishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Jinnouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kaneko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kiyosue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Miho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nakamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nakanishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Numata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ohama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Okuguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Osonoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Sasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Seino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Shiraiwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Sugiura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30074-7_bib1","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1007\/s00125-018-4729-5","article-title":"Management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"61","author":"Davies","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30074-7_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1111\/jdi.12810","article-title":"Japanese Clinical Practice Guideline for Diabetes 2016","volume":"9","author":"Haneda","year":"2018","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(20)30074-7_bib3","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.diabet.2018.12.001","article-title":"Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: insights from the SUSTAIN 1\u20137 trials","volume":"45","author":"Aroda","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(20)30074-7_bib4","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/dom.13218","article-title":"Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: a randomized trial","volume":"20","author":"Kaku","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30074-7_bib5","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1111\/dom.13082","article-title":"Safety and efficacy of semaglutide once weekly vs sitagliptin once daily, both as monotherapy in Japanese people with type 2 diabetes","volume":"20","author":"Seino","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30074-7_bib7","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aar7047","article-title":"Transcellular stomach absorption of a derivatized glucagon-like peptide-1 receptor agonist","volume":"10","author":"Buckley","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(20)30074-7_bib8","first-page":"539","article-title":"Oral GLP-1 analog for type 2 diabetes on the horizon","volume":"320","author":"Abbasi","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30074-7_bib9","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2337\/dc19-0749","article-title":"PIONEER 1: randomized clinical trial of the efficacy and safety of oral semaglutide monotherapy in comparison with placebo in patients with type 2 diabetes","volume":"42","author":"Aroda","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30074-7_bib10","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1001\/jama.2019.2942","article-title":"Effect of additional oral semaglutide vs sitagliptin on glycated hemoglobin in adults with type 2 diabetes uncontrolled with metformin alone or with sulfonylurea: the PIONEER 3 randomized clinical trial","volume":"321","author":"Rosenstock","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30074-7_bib11","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S2213-8587(19)30192-5","article-title":"Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial","volume":"7","author":"Mosenzon","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30074-7_bib12","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S2213-8587(19)30194-9","article-title":"Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial","volume":"7","author":"Pieber","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30074-7_bib14","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s11892-015-0602-9","article-title":"\u03b2 cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in east Asians","volume":"15","author":"Yabe","year":"2015","journal-title":"Curr Diab Rep"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(20)30074-7_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/jdi.12490","article-title":"Incretin-based drugs for type 2 diabetes: focus on east Asian perspectives","volume":"7","author":"Seino","year":"2016","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(20)30074-7_bib16","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/S2213-8587(15)00389-7","article-title":"Type 2 diabetes via \u03b2-cell dysfunction in east Asian people","volume":"4","author":"Yabe","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30074-7_bib18","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1507\/endocrj.EJ15-0401","article-title":"A 1-year safety study of dulaglutide in Japanese patients with type 2 diabetes on a single oral hypoglycemic agent: an open-label, nonrandomized, phase 3 trial","volume":"62","author":"Emoto","year":"2015","journal-title":"Endocrine J"},{"key":"10.1016\/S2213-8587(20)30074-7_bib19","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1111\/dom.13218","article-title":"Safety and efficacy of once-weekly semaglutide vs additional oral antidiabetic drugs in Japanese people with inadequately controlled type 2 diabetes: a randomized trial","volume":"20","author":"Kaku","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30074-7_bib21","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00125-014-3460-0","article-title":"Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"58","author":"Inzucchi","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30074-7_bib22","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc12-2480","article-title":"Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society","volume":"36","author":"Seaquist","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30074-7_bib23","series-title":"Statistical analysis with missing data","author":"Little","year":"1987"},{"key":"10.1016\/S2213-8587(20)30074-7_bib26","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/dom.12534","article-title":"Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide is non-inferior to once-daily liraglutide and superior to placebo in Japanese patients with type 2 diabetes: a 26-week randomized phase III study","volume":"17","author":"Miyagawa","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30074-7_bib27","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1111\/dom.12602","article-title":"Once-weekly glucagon-like peptide-1 receptor agonist dulaglutide significantly decreases glycated haemoglobin compared with once-daily liraglutide in Japanese patients with type 2 diabetes: 52 weeks of treatment in a randomized phase III study","volume":"18","author":"Odawara","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30074-7_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0198160","article-title":"Clinical inertia in basal insulin-treated patients with type 2 diabetes\u2014results from a retrospective database study in Japan (JDDM 43)","volume":"13","author":"Satoh","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(20)30074-7_bib29","unstructured":"Maegawa H, Ishigaki Y, Andersen M, et al. Clinical inertia in patients with type 2 diabetes treated with oral antidiabetic drugs: a Japanese cohort study. Annual Meeting of the Japanese Diabetes Society; Sendai, Japan; May 24\u201326, 2019 (abstr III-P-167)."},{"key":"10.1016\/S2213-8587(20)30074-7_bib30","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1185\/03007991003672551","article-title":"Efficacy and safety of the once-daily human GLP-1 analogue, liraglutide, vs glibenclamide monotherapy in Japanese patients with type 2 diabetes","volume":"26","author":"Seino","year":"2010","journal-title":"Curr Med Res Opin"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(20)30074-7_bib31","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1111\/j.1463-1326.2009.01075.x","article-title":"The safety and efficacy of liraglutide with or without oral antidiabetic drug therapy in type 2 diabetes: an overview of the LEAD 1\u20135 studies","volume":"11","author":"Blonde","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30074-7_bib32","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/dmrr.2810","article-title":"Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program","volume":"32","author":"Jendle","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(20)30074-7_bib33","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S2213-8587(20)30075-9","article-title":"Dose-response, efficacy, and safety of oral semaglutide monotherapy in Japanese patients with type 2 diabetes (PIONEER 9): a 52-week, phase 2\/3a, randomised, controlled trial","volume":"8","author":"Yamada","year":"2020","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:20Z","timestamp":1761991700000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300747"}},"issued":{"date-parts":[[2020,5]]},"references-count":27,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213858720300747"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30074-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and efficacy of oral semaglutide versus dulaglutide in Japanese patients with type 2 diabetes (PIONEER 10): an open-label, randomised, active-controlled, phase 3a trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30074-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30079-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:30:50Z","timestamp":1794565850525,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,20]],"date-time":"2025-09-20T00:00:00Z","timestamp":1758326400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004937","name":"Bundesministerium f\u00fcr Forschung und Technologie","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004937","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005890","name":"Ministry of Health of the People's Republic of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000016","name":"U.S. Department of Health and Human Services","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000016","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100031584","name":"Deutsches Zentrum f\u00fcr Diabetesforschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100031584","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK2816"],"award-info":[{"award-number":["GRK2816"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","award":["01GI0925"],"award-info":[{"award-number":["01GI0925"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003542","name":"Ministerium f\u00fcr Wissenschaft, Forschung und Kunst Baden-W\u00fcrttemberg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003542","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000071","name":"National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000071","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000124","name":"Office of Research on Women's Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000124","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0531505"],"award-info":[{"award-number":["2024ZD0531505"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018537","name":"National Science and Technology Major Project","doi-asserted-by":"publisher","award":["2024ZD0531500"],"award-info":[{"award-number":["2024ZD0531500"]}],"id":[{"id":"10.13039\/501100018537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2024-GSP-GG-5"],"award-info":[{"award-number":["2024-GSP-GG-5"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005150","name":"Chinese Academy of Medical Sciences","doi-asserted-by":"publisher","award":["2025-GSP-GG-6"],"award-info":[{"award-number":["2025-GSP-GG-6"]}],"id":[{"id":"10.13039\/501100005150","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/s2213-8587(25)00295-5","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T23:35:22Z","timestamp":1765582522000},"page":"137-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study"],"prefix":"10.1016","volume":"14","author":[{"given":"Elsa","family":"Vazquez Arreola","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert L","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinping","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leontine","family":"Sandforth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siyao","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvid","family":"Sandforth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Qian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Giacca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Stefan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hubert","family":"Preissl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaus","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiner","family":"Jumpertz-von Schwartzenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas L","family":"Birkenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00295-5_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00125-024-06315-0","article-title":"Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes","volume":"68","author":"Rooney","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00295-5_bib2","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/j.tem.2025.01.004","article-title":"Prediabetes remission to reduce the global burden of type 2 diabetes","volume":"36","author":"Sandforth","year":"2025","journal-title":"Trends Endocrinol Metab"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00295-5_bib3","first-page":"S50","article-title":"Prevention or delay of diabetes and associated comorbidities: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00295-5_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111589","article-title":"International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes","volume":"209","author":"Bergman","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00295-5_bib5","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00295-5_bib6","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","author":"Knowler","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00295-5_bib7","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","article-title":"The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study","volume":"371","author":"Li","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00295-5_bib8","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.2337\/diacare.26.12.3230","article-title":"The Finnish Diabetes Prevention Study (DPS): Lifestyle intervention and 3-year results on diet and physical activity","volume":"26","author":"Lindstr\u00f6m","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00295-5_bib9","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00295-5_bib10","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.2337\/db21-0526","article-title":"Different effects of lifestyle intervention in high- and low-risk prediabetes: results of the randomized controlled Prediabetes Lifestyle Intervention Study (PLIS)","volume":"70","author":"Fritsche","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(25)00295-5_bib11","doi-asserted-by":"crossref","first-page":"677","DOI":"10.26719\/2014.20.11.677","article-title":"Prevention of type 2 diabetes - where is the evidence?","volume":"20","author":"Tuomilehto","year":"2014","journal-title":"East Mediterr Health J"},{"key":"10.1016\/S2213-8587(25)00295-5_bib12","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1007\/s00125-018-4582-6","article-title":"Fibre supplementation for the prevention of type 2 diabetes and improvement of glucose metabolism: the randomised controlled Optimal Fibre Trial (OptiFiT)","volume":"61","author":"Honsek","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00295-5_bib13","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2337\/dc11-1468","article-title":"The 10-year cost-effectiveness of lifestyle intervention or metformin for diabetes prevention: an intent-to-treat analysis of the DPP\/DPPOS","volume":"35","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00295-5_bib15","first-page":"11","article-title":"An expert group consensus statement on \u201capproach and management of prediabetes in India\u201d","volume":"70","author":"Das","year":"2022","journal-title":"J Assoc Physicians India"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00295-5_bib16","article-title":"1. Detection of diabetes and intermediate hyperglycaemia, and prevention of type 2 diabetes","volume":"222","author":"Colagiuri","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00295-5_bib17","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","article-title":"Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study","volume":"2","author":"Li","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00295-5_bib18","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1007\/s00125-010-1948-9","article-title":"Long-term effects of a randomised trial of a 6-year lifestyle intervention in impaired glucose tolerance on diabetes-related microvascular complications: the China Da Qing Diabetes Prevention Outcome Study","volume":"54","author":"Gong","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00295-5_bib19","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2213-8587(19)30093-2","article-title":"Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study","volume":"7","author":"Gong","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00295-5_bib20","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1161\/CIRCULATIONAHA.121.056756","article-title":"Effects of long-term metformin and lifestyle interventions on cardiovascular events in the Diabetes Prevention Program and its outcome study","volume":"145","author":"Goldberg","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(25)00295-5_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0005656","article-title":"Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study\u2014secondary analysis of the randomized trial","volume":"4","author":"Uusitupa","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(25)00295-5_bib22","doi-asserted-by":"crossref","first-page":"3455","DOI":"10.1038\/s41591-024-03373-0","article-title":"Lifestyle interventions for cardiometabolic health","volume":"30","author":"Rutters","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00295-5_bib23","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S2213-8587(23)00235-8","article-title":"Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)","volume":"11","author":"Sandforth","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00295-5_bib24","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","article-title":"Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study","volume":"379","author":"Perreault","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00295-5_bib25","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1038\/s41574-024-00996-8","article-title":"Prediabetes remission for type 2 diabetes mellitus prevention","volume":"20","author":"Birkenfeld","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(25)00295-5_bib26","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2337\/dc25-0160","article-title":"Subphenotype-dependent benefits of bariatric surgery for individuals at risk for type 2 diabetes","volume":"48","author":"Sandforth","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00295-5_bib27","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s00125-024-06178-5","article-title":"Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention","volume":"67","author":"Jumpertz von Schwartzenberg","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00295-5_bib28","doi-asserted-by":"crossref","first-page":"3330","DOI":"10.1038\/s41591-025-03944-9","article-title":"Prevention of type 2 diabetes through prediabetes remission without weight loss","volume":"31","author":"Sandforth","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00295-5_bib29","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(25)00295-5_bib30","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00295-5_bib31","first-page":"543","article-title":"Global Diabetes F. Copenhagen Declaration: a transformative vision for global diabetes","volume":"13","author":"Narayan","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00295-5_bib32","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-023-06048-6","article-title":"Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study","volume":"67","author":"Gregg","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00295-5_bib33","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.019045","article-title":"Reversion from pre-diabetes mellitus to normoglycemia and risk of cardiovascular disease and all-cause mortality in a Chinese population: a prospective cohort study","volume":"10","author":"Liu","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(25)00295-5_bib34","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2213-8587(25)00163-9","article-title":"The central role of recovery of \u03b2-cell function in the remission of prediabetes: a prospective cohort study in Canada","volume":"13","author":"Retnakaran","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00295-5_bib35","doi-asserted-by":"crossref","first-page":"1949","DOI":"10.2337\/dc23-0602","article-title":"Prediction of cardiometabolic health through changes in plasma proteins with intentional weight loss in the DiRECT and DIADEM-I randomized clinical trials of type 2 diabetes remission","volume":"46","author":"Sattar","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00295-5_bib36","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2337\/dc09-0523","article-title":"Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program","volume":"32","author":"Perreault","year":"2009","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:49:44Z","timestamp":1789073384000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002955"}},"issued":{"date-parts":[[2026,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2213858725002955"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00295-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediabetes remission and cardiovascular morbidity and mortality: post-hoc analyses from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00295-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00360-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00366-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:23:52Z","timestamp":1794590632838,"version":"4.9.1"},"reference-count":38,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010113","name":"Wilhelm och Else Stockmanns Stiftelse","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010113","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010116","name":"Medicinska Underst\u00f6dsf\u00f6reningen Liv och H\u00e4lsa rf","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010116","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/s2213-8587(21)00172-8","type":"journal-article","created":{"date-parts":[[2021,7,22]],"date-time":"2021-07-22T19:46:55Z","timestamp":1626983215000},"page":"575-585","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Long-term population-based trends in the incidence of cardiovascular disease in individuals with type 1 diabetes from Finland: a retrospective, nationwide, cohort study"],"prefix":"10.1016","volume":"9","author":[{"given":"Valma","family":"Harjutsalo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drazenka","family":"Pongrac Barlovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Henrik","family":"Groop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00172-8_bib1","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.2337\/db08-1543","article-title":"The presence and severity of chronic kidney disease predicts all-cause mortality in type 1 diabetes","volume":"58","author":"Groop","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00172-8_bib2","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1007\/s001250050988","article-title":"Incidence of cardiovascular disease in type 1 (insulin-dependent) diabetic subjects with and without diabetic nephropathy in Finland","volume":"41","author":"Tuomilehto","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00172-8_bib3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1136\/heartjnl-2014-307310","article-title":"Twenty-five-year trends in myocardial infarction attack and mortality rates, and case-fatality, in six European populations","volume":"101","author":"Degano","year":"2015","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(21)00172-8_bib4","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00172-8_bib5","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.2337\/db05-1423","article-title":"The 30-year natural history of type 1 diabetes complications: the Pittsburgh Epidemiology of Diabetes Complications Study experience","volume":"55","author":"Pambianco","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00172-8_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/XCE.0000000000000164","article-title":"Recent trends over time in vascular disease in type 1 diabetes: insights from the Pittsburgh Epidemiology of Diabetes Complications Study","volume":"8","author":"Costacou","year":"2019","journal-title":"Cardiovasc Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00172-8_bib7","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00172-8_bib8","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.2013.8399","article-title":"Incidence of type 1 diabetes in Finland","volume":"310","author":"Harjutsalo","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00172-8_bib9","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1464-5491.2006.01925.x","article-title":"Incidence and trends of childhood type 1 diabetes worldwide 1990\u20131999","volume":"23","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00172-8_bib10","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.2337\/diab.37.8.1113","article-title":"Geographic patterns of childhood insulin-dependent diabetes mellitus","volume":"37","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00172-8_bib11","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/S0140-6736(08)60765-5","article-title":"Time trends in the incidence of type 1 diabetes in Finnish children: a cohort study","volume":"371","author":"Harjutsalo","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00172-8_bib12","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1177\/1403494812456637","article-title":"quality of the Finnish hospital discharge register: a systematic review","volume":"40","author":"Sund","year":"2012","journal-title":"Scand J Public Health"},{"key":"10.1016\/S2213-8587(21)00172-8_bib13","doi-asserted-by":"crossref","first-page":"5195","DOI":"10.1210\/jc.2019-00042","article-title":"Body mass index and mortality in individuals with type 1 diabetes","volume":"104","author":"Dahlstr\u00f6m","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00172-8_bib14","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/S2213-8587(21)00172-8_bib15","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1161\/CIRCULATIONAHA.115.017719","article-title":"Introduction to the analysis of survival data in the presence of competing risks","volume":"133","author":"Austin","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00172-8_bib16","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1023\/A:1007306110822","article-title":"The validity of hospital discharge register data on coronary heart disease in Finland","volume":"13","author":"M\u00e4h\u00f6nen","year":"1997","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00172-8_bib17","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1023\/A:1007697720131","article-title":"The feasibility of combining data from routine hospital discharge and causes-of-death registers for epidemiological studies on stroke","volume":"16","author":"M\u00e4h\u00f6nen","year":"2000","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00172-8_bib18","doi-asserted-by":"crossref","first-page":"3018","DOI":"10.1002\/sim.2764","article-title":"Age-period-cohort models for the Lexis diagram","volume":"26","author":"Carstensen","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(21)00172-8_bib19","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S2213-8587(16)30010-9","article-title":"The changing face of diabetes complications","volume":"4","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00172-8_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/diacare.29.01.06.dc05-0776","article-title":"Recent trends in cardiovascular complications among men and women with and without diabetes","volume":"29","author":"Booth","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00172-8_bib21","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00172-8_bib22","doi-asserted-by":"crossref","first-page":"2759","DOI":"10.1111\/dom.13456","article-title":"Risk of coronary artery disease and stroke according to sex and presence of diabetic nephropathy in type 1 diabetes","volume":"20","author":"Harjutsalo","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00172-8_bib23","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.2019.3471","article-title":"Resurgence in diabetes-related complications","volume":"321","author":"Gregg","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00172-8_bib24","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/dc17-2364","article-title":"Incidence of end-stage renal disease in patients with type 1 diabetes","volume":"41","author":"Helve","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00172-8_bib25","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1016\/S2213-8587(15)00292-2","article-title":"Long-term excess risk of heart failure in people with type 1 diabetes: a prospective case-control study","volume":"3","author":"Rosengren","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00172-8_bib26","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1161\/CIRCULATIONAHA.118.034986","article-title":"Incidence of hospitalization for heart failure and case-fatality among 3.25 million people with and without diabetes mellitus","volume":"138","author":"McAllister","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00172-8_bib27","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1136\/bmj.294.6588.1651","article-title":"Proteinuria: value as predictor of cardiovascular mortality in insulin dependent diabetes mellitus","volume":"294","author":"Borch-Johnsen","year":"1987","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00172-8_bib28","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.gheart.2016.04.005","article-title":"Changes in CVD incidence and mortality rates, and life expectancy: north Karelia and national","volume":"11","author":"Salomaa","year":"2016","journal-title":"Glob Heart"},{"key":"10.1016\/S2213-8587(21)00172-8_bib29","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1093\/eurpub\/cku174","article-title":"Forty-year trends in cardiovascular risk factors in Finland","volume":"25","author":"Borodulin","year":"2015","journal-title":"Eur J Public Health"},{"key":"10.1016\/S2213-8587(21)00172-8_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1038\/ki.2014.206","article-title":"Improved prognosis of diabetic nephropathy in type 1 diabetes","volume":"87","author":"Andresdottir","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(21)00172-8_bib31","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.diabres.2003.11.017","article-title":"ACE inhibitors and calcium channel blockers: patterns of use and associations with mortality in type 1 diabetes","volume":"65","author":"Sobolewski","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(21)00172-8_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11892-015-0598-1","article-title":"Cardiac autoimmunity as a novel biomarker, mediator, and therapeutic target of heart disease in type 1 diabetes","volume":"15","author":"Lipes","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(21)00172-8_bib34","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1161\/CIRCULATIONAHA.118.036068","article-title":"Glycemic control, cardiac autoimmunity, and long-term risk of cardiovascular disease in type 1 diabetes mellitus","volume":"139","author":"Sousa","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00172-8_bib35","series-title":"Glycaemic control in patients with diabetes in Finland in 2009\u20132010","author":"Valle","year":"2010"},{"key":"10.1016\/S2213-8587(21)00172-8_bib36","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0140-6736(18)33047-2","article-title":"Excess mortality and cardiovascular disease risk in type 1 diabetes","volume":"393","author":"Costacou","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00172-8_bib37","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00172-8_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1177\/1403494819847051","article-title":"The validity of heart failure diagnoses in the Finnish hospital discharge register","volume":"48","author":"Vuori","year":"2020","journal-title":"Scand J Public Health"},{"key":"10.1016\/S2213-8587(21)00172-8_bib32","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2337\/dc15-2308","article-title":"Age-specific trends from 2000\u20132011 in all-cause and cause-specific mortality in type 1 and type 2 diabetes: a cohort study of more than one million people","volume":"39","author":"Harding","year":"2016","journal-title":"Diabetes Care"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(22)00350-3","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001728?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001728?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:50Z","timestamp":1761991790000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001728"}},"issued":{"date-parts":[[2021,9]]},"references-count":38,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2213858721001728"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00172-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term population-based trends in the incidence of cardiovascular disease in individuals with type 1 diabetes from Finland: a retrospective, nationwide, cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00172-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00190-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T22:32:10Z","timestamp":1794609130360,"version":"4.9.1"},"reference-count":69,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["grants P01 AG004875, AG048792, AR027065, and AR068275"],"award-info":[{"award-number":["grants P01 AG004875, AG048792, AR027065, and AR068275"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/s2213-8587(17)30188-2","type":"journal-article","created":{"date-parts":[[2017,7,7]],"date-time":"2017-07-07T13:15:20Z","timestamp":1499433320000},"page":"898-907","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":957,"title":["Osteoporosis treatment: recent developments and ongoing challenges"],"prefix":"10.1016","volume":"5","author":[{"given":"Sundeep","family":"Khosla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenz C","family":"Hofbauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30188-2_bib1","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1056\/NEJMra022219","article-title":"Selective estrogen-receptor modulators\u2014mechanisms of action and application to clinical practice","volume":"348","author":"Riggs","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib2","doi-asserted-by":"crossref","first-page":"2272","DOI":"10.1210\/jc.2012-1027","article-title":"Benefits and risks of bisphosphonate therapy for osteoporosis","volume":"97","author":"Khosla","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30188-2_bib3","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1210\/er.2007-0014","article-title":"Receptor activator of nuclear factor \u03baB ligand and osteoprotegerin regulation of bone remodeling in health and disease","volume":"29","author":"Kearns","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(17)30188-2_bib4","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib5","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30188-2_bib6","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib7","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1038\/nrd.2016.207","article-title":"Merck & Co. drops osteoporosis drug odanacatib","volume":"15","author":"Mullard","year":"2016","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S2213-8587(17)30188-2_bib8","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1002\/jbmr.2832","article-title":"Impact of the US Food and Drug Administration's safety-related announcements on the use of bisphosphonates after hip fracture","volume":"31","author":"Kim","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib9","first-page":"298","article-title":"Post-menopausal osteoporosis","volume":"55","author":"Albright","year":"1940","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/S2213-8587(17)30188-2_bib10","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/er.2008-0002","article-title":"Osteoporosis in men","volume":"29","author":"Khosla","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(17)30188-2_bib11","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1016\/S0140-6736(76)92217-0","article-title":"Long-term prevention of postmenopausal osteoporosis by oestrogen","volume":"i","author":"Lindsay","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30188-2_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-117-1-1","article-title":"Treatment of postmenopausal osteoporosis with transdermal estrogen","volume":"117","author":"Lufkin","year":"1992","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib13","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1001\/jama.290.13.1729","article-title":"Effect of estrogen plus progestin on risk of fracture and bone mineral density: the Women's Health Initiative randomized trial","volume":"290","author":"Cauley","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30188-2_bib14","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30188-2_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1097\/01.AOG.0000137833.43248.79","article-title":"Effects of ultralow-dose transdermal estradiol on bone mineral density: a randomized clinical trial","volume":"104","author":"Ettinger","year":"2004","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(17)30188-2_bib16","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene results from a 3-year randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30188-2_bib17","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1001\/jama.295.23.joc60074","article-title":"Effects of tamoxifen vs raloxifene on the risk of developing invasive breast cancer and other disease outcomes: the NSABP Study of Tamoxifen and Raloxifene (STAR) P-2 trial","volume":"295","author":"Vogel","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30188-2_bib18","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1016\/j.fertnstert.2009.02.093","article-title":"Efficacy of tissue-selective estrogen complex of bazedoxifene\/conjugated estrogens for osteoporosis prevention in at-risk postmenopausal women","volume":"92","author":"Lindsay","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(17)30188-2_bib19","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1056\/NEJM198101293040505","article-title":"Calcitonin: physiology and pathophysiology","volume":"304","author":"Austin","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S0002-9343(00)00490-3","article-title":"A randomized trial of nasal spray salmon calcitonin in postmenopausal women with established osteoporosis: the Prevent Recurrence Of Osteoporotic Fractures study","volume":"109","author":"Chesnut","year":"2000","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib22","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.bone.2011.04.022","article-title":"Bisphosphonates: the first 40 years","volume":"49","author":"Russell","year":"2011","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(17)30188-2_bib23","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-007-0540-8","article-title":"Mechanisms of action of bisphosphonates: similarities and differences and their potential influences on clinical efficacy","volume":"19","author":"Russell","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(17)30188-2_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1998","article-title":"Atypical subtrochanteric and diaphyseal femoral fractures: second report of a task force of the American Society for Bone Mineral Research","volume":"29","author":"Shane","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib25","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1359\/jbmr.0707onj","article-title":"Bisphosphonate-associated osteonecrosis of the jaw: report of a task force of the American Society for Bone and Mineral Research","volume":"22","author":"Khosla","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib26","doi-asserted-by":"crossref","first-page":"2048","DOI":"10.1056\/NEJMp1202619","article-title":"Bisphosphonates for osteoporosis\u2014where do we go from here?","volume":"366","author":"Whitaker","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib27","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1001\/jama.1934.02750160010003","article-title":"Hyperparathyroidism. A common and polymorphic condition as illustrated by seventeen proved cases from one clinic","volume":"102","author":"Albright","year":"1934","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30188-2_bib28","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/S0140-6736(76)92216-9","article-title":"Anabolic effect of low doses of a fragment of human parathyroid hormone on the skeleton in postmenopausal osteoporosis","volume":"1","author":"Reeve","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30188-2_bib29","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1080\/01926230490462138","article-title":"Bone neoplasms in F344 rats given teriparatide [rhPTH(1-34)] are dependent on duration of treatment and dose","volume":"32","author":"Vahle","year":"2004","journal-title":"Toxicol Pathol"},{"key":"10.1016\/S2213-8587(17)30188-2_bib30","doi-asserted-by":"crossref","first-page":"2429","DOI":"10.1002\/jbmr.1768","article-title":"The US postmarketing surveillance study of adult osteosarcoma and teriparatide: study design and findings from the last 7 years","volume":"27","author":"Andrews","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib32","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/S0092-8674(00)80209-3","article-title":"Osteoprotegerin: a novel secreted protein involved in the regulation of bone density","volume":"89","author":"Simonet","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(17)30188-2_bib33","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1101\/gad.12.9.1260","article-title":"Osteoprotegerin-deficient mice develop early onset osteoporosis and arterial calcification","volume":"12","author":"Bucay","year":"1998","journal-title":"Genes Dev"},{"key":"10.1016\/S2213-8587(17)30188-2_bib34","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0092-8674(00)81569-X","article-title":"Osteoprotegerin ligand is a cytokine that regulates osteoclast differentiation and activation","volume":"93","author":"Lacey","year":"1998","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(17)30188-2_bib35","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib37","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1056\/NEJMoa022436","article-title":"The effects of strontium ranelate on the risk of vertebral fracture in women with postmenopausal osteoporosis","volume":"350","author":"Meunier","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib39","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrd3705","article-title":"Bench to bedside: elucidation of the OPG-RANK-RANKL pathway and the development of denosumab","volume":"11","author":"Lacey","year":"2012","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S2213-8587(17)30188-2_bib40","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1034\/j.1399-0004.2003.00036.x","article-title":"The natural history of sclerostosis","volume":"63","author":"Hamersma","year":"2003","journal-title":"Clin Genet"},{"key":"10.1016\/S2213-8587(17)30188-2_bib41","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1002\/jbmr.1794","article-title":"Van Buchem disease: clinical, biochemical, and densitometric features of patients and disease carriers","volume":"28","author":"van Lierop","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib42","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1038\/nm.3074","article-title":"WNT signaling in bone homeostasis and disease: from human mutations to treatments","volume":"19","author":"Baron","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib43","doi-asserted-by":"crossref","first-page":"427","DOI":"10.2353\/ajpath.2007.060834","article-title":"Osteoclasts: what do they do and how do they do it?","volume":"170","author":"Teitelbaum","year":"2007","journal-title":"Am J Pathol"},{"key":"10.1016\/S2213-8587(17)30188-2_bib44","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1126\/science.273.5279.1236","article-title":"Pycnodysostosis, a lysosomal storage disease caused by cathepsin K deficiency","volume":"273","author":"Gelb","year":"1996","journal-title":"Science"},{"key":"10.1016\/S2213-8587(17)30188-2_bib45","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1359\/jbmr.1999.14.10.1654","article-title":"Cathepsin K knockout mice develop osteopetrosis due to a deficit in matrix degradation but not demineralization","volume":"14","author":"Gowen","year":"1999","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib46","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1007\/s00198-014-2944-6","article-title":"Odanacatib for the treatment of postmenopausal osteoporosis: development history and design and participant characteristics of LOFT, the Long-Term Odanacatib Fracture Trial","volume":"26","author":"Bone","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(17)30188-2_bib47","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra067395","article-title":"Mechanisms of anabolic therapies for osteoporosis","volume":"357","author":"Canalis","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib48","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1210\/en.2015-1726","article-title":"Binding selectivity of abaloparatide for PTH-type-1-receptor conformations and effects on downstream signaling","volume":"157","author":"Hattersley","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(17)30188-2_bib49","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/jc.2014-3718","article-title":"Effects of abaloparatide, a human parathyroid hormone-related peptide analog, on bone mineral density in postmenopausal women with osteoporosis","volume":"100","author":"Leder","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30188-2_bib50","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1210\/jc.2011-2332","article-title":"Update on bone anabolics in osteoporosis treatment: rationale, current status, and perspectives","volume":"97","author":"Baron","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30188-2_bib51","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1210\/en.2007-0270","article-title":"Targeting the Wnt\/\u03b2-catenin pathway to regulate bone formation in the adult skeleton","volume":"148","author":"Baron","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(17)30188-2_bib52","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1359\/jbmr.080216","article-title":"Targeted deletion of the sclerostin gene in mice results in increased bone formation and bone strength","volume":"23","author":"Li","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib53","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.2147\/DDDT.S127568","article-title":"Profile of romosozumab and its potential in the management of osteoporosis","volume":"11","author":"Lim","year":"2017","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/S2213-8587(17)30188-2_bib54","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1759720X13510479","article-title":"Role of sclerostin in bone and cartilage and its potential as a therapeutic target in bone diseases","volume":"6","author":"Lewiecki","year":"2014","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/S2213-8587(17)30188-2_bib55","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/nrd4233","article-title":"Can we safely target the WNT pathway?","volume":"13","author":"Kahn","year":"2014","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S2213-8587(17)30188-2_bib58","doi-asserted-by":"crossref","first-page":"11505","DOI":"10.1038\/ncomms11505","article-title":"A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair","volume":"7","author":"Florio","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(17)30188-2_bib59","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1002\/jbmr.1541","article-title":"Odanacatib: location and timing are everying","volume":"27","author":"Khosla","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib60","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1038\/nrrheum.2011.77","article-title":"Cathepsin K: its skeletal actions and role as a therapeutic target in osteoporosis","volume":"7","author":"Costa","year":"2011","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/S2213-8587(17)30188-2_bib61","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.1002\/jbmr.1695","article-title":"Odanacatib in the treatment of postmenopausal women with low bone mineral density: five years of continued therapy in a phase 2 study","volume":"27","author":"Langdah","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib62","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/jbmr.2888","article-title":"A crisis in the treatment of osteoporosis","volume":"31","author":"Khosla","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib63","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/jbmr.1698","article-title":"Making the first fracture the last fracture: ASBMR Task Force on Secondary Fracture Prevention","volume":"27","author":"Eisman","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib64","author":"Kolata"},{"key":"10.1016\/S2213-8587(17)30188-2_bib65","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1056\/NEJMcp1513724","article-title":"Clinical practice. Postmenopausal osteoporosis","volume":"374","author":"Black","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30188-2_bib66","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jbmr.3074","article-title":"Addressing the crisis in the treatment of osteoporosis: a path forward","volume":"32","author":"Khosla","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib67","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1016\/j.jocd.2013.06.004","article-title":"Incomplete atypical femoral fractures: assessing the diagnostic utility of DXA by extending femur length","volume":"16","author":"McKenna","year":"2013","journal-title":"J Clin Densitom"},{"key":"10.1016\/S2213-8587(17)30188-2_bib68","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1002\/jbmr.2748","article-title":"Incidence and characteristics of atypical femoral fractures: clinical and geometrical data","volume":"31","author":"Mahjoub","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib69","doi-asserted-by":"crossref","first-page":"2927","DOI":"10.1001\/jama.296.24.2927","article-title":"Effects of continuing or stopping alendronate after 5 years of treatment. The Fracture Intervention Trial Long-Term Extension (FLEX): a randomized trial","volume":"296","author":"Black","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30188-2_bib70","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jbmr.1494","article-title":"The effect of 3 versus 6 years of zoledronic acid treatment of osteoporosis: a randomized extension to the HORIZON-Pivotal Fracture Trial (PFT)","volume":"27","author":"Black","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib71","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a Task Force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30188-2_bib72","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30188-2_bib73","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","article-title":"Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial","volume":"386","author":"Leder","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30188-2_bib74","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00223-016-0148-0","article-title":"Does activin receptor blockade by bimagrumab (BYM338) pose detrimental effects on bone healing in a rat fibula osteotomy model?","volume":"99","author":"Tank\u00f3","year":"2016","journal-title":"Calcif Tissue Int"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:03:32Z","timestamp":1555373012000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301882"}},"issued":{"date-parts":[[2017,11]]},"references-count":69,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S2213858717301882"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30188-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoporosis treatment: recent developments and ongoing challenges","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30188-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:49:20Z","timestamp":1794649760019,"version":"4.9.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004323","name":"Amylin Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004323","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/s2213-8587(17)30412-6","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T22:12:41Z","timestamp":1512511961000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":555,"title":["Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis"],"prefix":"10.1016","volume":"6","author":[{"given":"M Angelyn","family":"Bethel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rishi A","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Merrill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuliya","family":"Lokhnygina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John B","family":"Buse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert J","family":"Mentz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neha J","family":"Pagidipati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie M","family":"Gustavson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nayyar","family":"Iqbal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"\u00d6hman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil R","family":"Poulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambady","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Zinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian F","family":"Hernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rury R","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30412-6_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/dom.12591","article-title":"Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"18","author":"Nauck","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(17)30412-6_bib2","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1161\/CIRCULATIONAHA.117.028136","article-title":"Cardiovascular actions and clinical outcomes with glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"136","author":"Nauck","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30412-6_bib3","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30412-6_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30412-6_bib5","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30412-6_bib6","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30412-6_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0197-2456(95)00134-4","article-title":"Assessing the quality of reports of randomized clinical trials: is blinding necessary?","volume":"17","author":"Jadad","year":"1996","journal-title":"Control Clin Trials"},{"key":"10.1016\/S2213-8587(17)30412-6_bib8","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1037\/1082-989X.11.2.193","article-title":"Assessing heterogeneity in meta-analysis: Q statistic or I2 index?","volume":"11","author":"Huedo-Medina","year":"2006","journal-title":"Psychol Methods"},{"key":"10.1016\/S2213-8587(17)30412-6_bib12","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.2337\/dc12-2709","article-title":"Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X)","volume":"36","author":"Rosenstock","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30412-6_bib13","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.2337\/dc09-1914","article-title":"DURATION-1: exenatide once weekly produces sustained glycemic control and weight loss over 52 weeks","volume":"33","author":"Buse","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30412-6_bib14","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(12)61267-7","article-title":"Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study","volume":"381","author":"Buse","year":"2013","journal-title":"Lancet"},{"issue":"suppl","key":"10.1016\/S2213-8587(17)30412-6_bib15","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1016\/j.jcjd.2016.08.114","article-title":"Efficacy and safety of once-weekly semaglutide vs exenatide ER after 56 weeks in subjects with type 2 diabetes (SUSTAIN 3)","volume":"40","author":"Hramiak","year":"2016","journal-title":"Can J Diabetes"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(17)30412-6_bib16","doi-asserted-by":"crossref","first-page":"S245","DOI":"10.2337\/dcS13-2004","article-title":"Do GLP-1-based therapies increase cancer risk?","volume":"36","author":"Nauck","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30412-6_bib17","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/jc.2011-2407","article-title":"Glucagon like peptide-1 receptor expression in the human thyroid gland","volume":"97","author":"Gier","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30412-6_bib18","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000330447","article-title":"Incretin receptors in non-neoplastic and neoplastic thyroid C cells in rodents and humans: relevance for incretin-based diabetes therapy","volume":"94","author":"Waser","year":"2011","journal-title":"Neuroendocrinology"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:13Z","timestamp":1761991573000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717304126"}},"issued":{"date-parts":[[2018,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S2213858717304126"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30412-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.732267672.793558327","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.732267672.793553180","asserted-by":"object"},{"id-type":"doi","id":"10.3410\/f.732267672.793559020","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30412-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30413-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:19:13Z","timestamp":1767151153969,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(20)30162-5","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/s2213-8587(20)30217-5","type":"journal-article","created":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T18:31:43Z","timestamp":1593109903000},"page":"e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correction to Lancet Diabetes Endocrinol 2020; 8: 582\u201393"],"prefix":"10.1016","volume":"8","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:16Z","timestamp":1761991756000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720302175"}},"issued":{"date-parts":[[2020,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2213858720302175"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30217-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2020; 8: 582\u201393","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30217-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30162-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:08:35Z","timestamp":1784070515059,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/s2213-8587(26)00129-4","type":"journal-article","created":{"date-parts":[[2026,6,7]],"date-time":"2026-06-07T22:09:03Z","timestamp":1780870143000},"page":"621-624","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Cagrilintide\u2013semaglutide: a new option for patients with type 2 diabetes"],"prefix":"10.1016","volume":"14","author":[{"given":"Andr\u00e9 J","family":"Scheen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00129-4_bib1","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1016\/S0140-6736(25)02105-1","article-title":"Glucagon-like receptor agonists and next-generation incretin-based medications: metabolic, cardiovascular, and renal benefits","volume":"407","author":"Nauck","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00129-4_bib2","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S0140-6736(23)01163-7","article-title":"Efficacy and safety of co-administered once-weekly cagrilintide 2\u00b74 mg with once-weekly semaglutide 2\u00b74 mg in type 2 diabetes: a multicentre, randomised, double-blind, active-controlled, phase 2 trial","volume":"402","author":"Frias","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00129-4_bib3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1056\/NEJMoa2502082","article-title":"Cagrilintide\u2013semaglutide in adults with overweight or obesity and type 2 diabetes","volume":"393","author":"Davies","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00129-4_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(26)00126-9","article-title":"Efficacy and safety of once-weekly cagrilintide\u2013semaglutide (CagriSema) in adults with type 2 diabetes inadequately controlled on diet and exercise (REIMAGINE 1): a randomised, double-blind, placebo-controlled, phase 3a study","author":"Aroda","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00129-4_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(26)00125-7","article-title":"Cagrilintide\u2013semaglutide (CagriSema) versus semaglutide or cagrilintide in people with type 2 diabetes (REIMAGINE 2): a double-blind, randomised, controlled, phase 3 study","author":"Buse","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00129-4_bib6","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S2213-8587(17)30013-X","article-title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","volume":"5","author":"Sorli","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00129-4_bib7","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","article-title":"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial","volume":"398","author":"Rosenstock","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00129-4_bib8","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(21)01443-4","article-title":"Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial","volume":"398","author":"Ludvik","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00129-4_bib9","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00129-4_bib10","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:48:48Z","timestamp":1784069328000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726001294"}},"issued":{"date-parts":[[2026,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2213858726001294"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00129-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cagrilintide\u2013semaglutide: a new option for patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00129-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00126-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00125-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T19:57:42Z","timestamp":1769111862871,"version":"3.49.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010377","name":"National Institute for Health and Care Excellence","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010377","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/s2213-8587(19)30407-3","type":"journal-article","created":{"date-parts":[[2020,1,20]],"date-time":"2020-01-20T19:41:15Z","timestamp":1579549275000},"page":"181-183","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Estimands in diabetes clinical trials"],"prefix":"10.1016","volume":"8","author":[{"given":"Thinzar","family":"Min","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen C","family":"Bain","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30407-3_bib2","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1136\/bmj.325.7365.652","article-title":"Post-randomisation exclusions: the intention to treat principle and excluding patients from analysis","volume":"325","author":"Fergusson","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30407-3_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1002\/pst.1705","article-title":"Choice of estimand and analysis methods in diabetes trials with rescue medication","volume":"14","author":"Holzhauer","year":"2015","journal-title":"Pharm Stat"},{"key":"10.1016\/S2213-8587(19)30407-3_bib6","series-title":"National Research Council (US) panel on handling missing data in clinical trials. the prevention and treatment of missing data in clinical trials","year":"2010"},{"key":"10.1016\/S2213-8587(19)30407-3_bib8","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/S2213-8587(19)30194-9","article-title":"Efficacy and safety of oral semaglutide with flexible dose adjustment versus sitagliptin in type 2 diabetes (PIONEER 7): a multicentre, open-label, randomised, phase 3a trial","volume":"7","author":"Pieber","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30407-3_bib9","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/S2213-8587(19)30192-5","article-title":"Efficacy and safety of oral semaglutide in patients with type 2 diabetes and moderate renal impairment (PIONEER 5): a placebo-controlled, randomised, phase 3a trial","volume":"7","author":"Mosenzon","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30407-3_bib10","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S2213-8587(19)30311-0","article-title":"Efficacy and safety of once-weekly semaglutide versus daily canagliflozin as add-on to metformin in patients with type 2 diabetes (SUSTAIN 8): a double-blind, phase 3b, randomised controlled trial","volume":"7","author":"Lingvay","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:27Z","timestamp":1761991647000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719304073"}},"issued":{"date-parts":[[2020,3]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2213858719304073"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30407-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Estimands in diabetes clinical trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30407-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:02:49Z","timestamp":1767150169881,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(16)30085-7","type":"correction","label":"Correction","source":"retraction-watch","updated":{"date-parts":[[2016,6,15]],"date-time":"2016-06-15T00:00:00Z","timestamp":1465948800000},"record-id":"19007"}],"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/s2213-8587(16)30140-1","type":"journal-article","created":{"date-parts":[[2016,6,17]],"date-time":"2016-06-17T01:46:36Z","timestamp":1466127996000},"page":"e8","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2016; published online June 6. http:\/\/dx.doi.org\/10.1016\/S2213-8587(16)30085-7"],"prefix":"10.1016","volume":"4","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:02:52Z","timestamp":1555372972000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301401"}},"issued":{"date-parts":[[2016,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S2213858716301401"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30140-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,8]]}},{"indexed":{"date-parts":[[2025,12,7]],"date-time":"2025-12-07T03:47:36Z","timestamp":1765079256342},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/s2213-8587(14)70189-5","type":"journal-article","created":{"date-parts":[[2014,9,10]],"date-time":"2014-09-10T23:30:16Z","timestamp":1410391816000},"page":"923","source":"Crossref","is-referenced-by-count":17,"title":["Diabetes in China: mapping the road ahead"],"prefix":"10.1016","volume":"2","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T22:57:37Z","timestamp":1538261857000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701895"}},"issued":{"date-parts":[[2014,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S2213858714701895"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70189-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,12]]}},{"indexed":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:28:33Z","timestamp":1738733313541,"version":"3.37.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/s2213-8587(24)00375-9","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T23:37:42Z","timestamp":1734478662000},"page":"83-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Barriers to care for refugees and migrants with diabetes"],"prefix":"10.1016","volume":"13","author":[{"given":"Kiran","family":"Jobanputra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gabriel","family":"Fabreau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"\u00c9imh\u00edn","family":"Ansbro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00375-9_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1016\/S0140-6736(20)31907-3","article-title":"The Lancet NCDI Poverty Commission: bridging a gap in universal health coverage for the poorest billion","volume":"396","author":"Bukhman","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00375-9_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002180","article-title":"Three steps to improve management of noncommunicable diseases in humanitarian crises","volume":"13","author":"Jobanputra","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(24)00375-9_bib4","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2213-8587(19)30083-X","article-title":"Challenges associated with providing diabetes care in humanitarian settings","volume":"7","author":"Boulle","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00375-9_bib5","article-title":"Chronic NCD care in crises: a qualitative study of global experts' perspectives on models of care for hypertension and diabetes in humanitarian settings","volume":"5","author":"Ansbro","year":"2022","journal-title":"J Migr Health"},{"key":"10.1016\/S2213-8587(24)00375-9_bib9","article-title":"Analysis of health overseas development aid for internally displaced persons in low- and middle-income countries","volume":"5","author":"Roberts","year":"2022","journal-title":"J Migr Health"},{"key":"10.1016\/S2213-8587(24)00375-9_bib10","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1016\/S2352-3026(22)00259-9","article-title":"Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war","volume":"9","author":"Agulnik","year":"2022","journal-title":"Lancet Haematol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003759?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003759?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:10:35Z","timestamp":1738703435000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003759"}},"issued":{"date-parts":[[2025,2]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2213858724003759"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00375-9","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Barriers to care for refugees and migrants with diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00375-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T02:38:41Z","timestamp":1761964721614},"reference-count":4,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/s2213-8587(15)00483-0","type":"journal-article","created":{"date-parts":[[2016,1,6]],"date-time":"2016-01-06T19:30:55Z","timestamp":1452108655000},"page":"86-87","source":"Crossref","is-referenced-by-count":5,"title":["Sugar: a shove to industry rather than a nudge to consumers?"],"prefix":"10.1016","volume":"4","author":[{"given":"Tim","family":"Lobstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00483-0_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00477-5","article-title":"Gradual reduction of sugar in soft drinks without substitution as a strategy to reduce overweight, obesity, and type 2 diabetes: a modelling study","author":"Ma","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00483-0_bib5","series-title":"UK salt reduction initiatives","year":"2009"},{"key":"10.1016\/S2213-8587(15)00483-0_bib6","series-title":"Sugar reduction: from evidence to action","year":"2015"},{"key":"10.1016\/S2213-8587(15)00483-0_bib8","author":"Oliver"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004830?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004830?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T05:53:22Z","timestamp":1537077202000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004830"}},"issued":{"date-parts":[[2016,2]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2213858715004830"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00483-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,2]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:20Z","timestamp":1761991940819,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/s2213-8587(20)30187-x","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T18:51:21Z","timestamp":1592333481000},"page":"557-558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient data from routinely collected medical records complement evidence from SGLT2 inhibitor outcome trials"],"prefix":"10.1016","volume":"8","author":[{"given":"Hertzel C","family":"Gerstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30187-X_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30187-X_bib3","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30187-X_bib4","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30187-X_bib5","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/S2213-8587(20)30130-3","article-title":"Risk of cardiovascular events and death associated with initiation of SGLT2 inhibitors compared with DPP-4 inhibitors: an analysis from the CVD-REAL 2 multinational cohort study","volume":"8","author":"Kohsaka","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30187-X_bib6","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S2213-8587(20)30038-3","article-title":"Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials","volume":"8","author":"Ghosh-Swaby","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30187-X_bib7","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/S0140-6736(18)32840-X","article-title":"Real-world studies no substitute for RCTs in establishing efficacy","volume":"393","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30187-X_bib8","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2018374","article-title":"How many patients with type 2 diabetes meet the inclusion criteria of the cardiovascular outcome trials with SGLT2 inhibitors? Estimations from a population database in a Mediterranean area","volume":"2019","author":"Canivell","year":"2019","journal-title":"J Diabetes Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872030187X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872030187X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:30Z","timestamp":1761991710000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872030187X"}},"issued":{"date-parts":[[2020,7]]},"references-count":7,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S221385872030187X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30187-x","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient data from routinely collected medical records complement evidence from SGLT2 inhibitor outcome trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30187-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30130-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:20:12Z","timestamp":1736918412018,"version":"3.33.0"},"reference-count":2,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/s2213-8587(24)00226-2","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:42:57Z","timestamp":1724398977000},"page":"615-616","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Food additive emulsifiers and risk of type 2 diabetes \u2013 Authors' reply"],"prefix":"10.1016","volume":"12","author":[{"given":"Bernard","family":"Srour","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Clara","family":"Salame","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mathilde","family":"Touvier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00226-2_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S2213-8587(24)00086-X","article-title":"Food additive emulsifiers and the risk of type 2 diabetes: analysis of data from the NutriNet-Sant\u00e9 prospective cohort study","volume":"12","author":"Salame","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00226-2_bib2","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1093\/aje\/kwy126","article-title":"Combining a food frequency questionnaire with 24-hour recalls to increase the precision of estimation of usual dietary intakes-evidence from the Validation Studies Pooling Project","volume":"187","author":"Freedman","year":"2018","journal-title":"Am J Epidemiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:09:16Z","timestamp":1736860156000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002262"}},"issued":{"date-parts":[[2024,9]]},"references-count":2,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213858724002262"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00226-2","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Food additive emulsifiers and risk of type 2 diabetes \u2013 Authors' reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00226-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00227-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00086-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00229-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00228-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,4,19]],"date-time":"2024-04-19T14:47:15Z","timestamp":1713538035425},"reference-count":2,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/s2213-8587(14)70097-x","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T20:30:17Z","timestamp":1401309017000},"page":"448","source":"Crossref","is-referenced-by-count":2,"title":["Bariatric surgery"],"prefix":"10.1016","volume":"2","author":[{"given":"Luca","family":"Busetto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Dixon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maurizio","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Pories","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott","family":"Shikora","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Angrisani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70097-X_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S2213-8587(13)70198-0","article-title":"Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery","volume":"2","author":"Cummings","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70097-X_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1007\/s11695-014-1214-1","article-title":"Bariatric surgery in class I obesity","volume":"24","author":"Busetto","year":"2014","journal-title":"Obes Surg"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871470097X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871470097X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T16:26:37Z","timestamp":1538583997000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871470097X"}},"issued":{"date-parts":[[2014,6]]},"references-count":2,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S221385871470097X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70097-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,6]]}},{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T09:17:16Z","timestamp":1715591836722},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/s2213-8587(15)00329-0","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T14:14:11Z","timestamp":1442585651000},"page":"832-834","source":"Crossref","is-referenced-by-count":3,"title":["Heart failure: fatal, forgotten, and frequent in type 1 diabetes too"],"prefix":"10.1016","volume":"3","author":[{"given":"Richard E","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00329-0_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/S0140-6736(06)68967-8","article-title":"Relation between age and cardiovascular disease in men and women with diabetes compared with non-diabetic people: a population-based retrospective cohort study","volume":"368","author":"Booth","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00329-0_bib2","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.2337\/diacare.26.8.2433","article-title":"Heart failure: the frequent, forgotten, and often fatal complication of diabetes","volume":"26","author":"Bell","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00329-0_bib3","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.2337\/diacare.27.8.1879","article-title":"The incidence of congestive heart failure in type 2 diabetes: an update","volume":"27","author":"Nichols","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00329-0_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00329-0_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.286.4.421","article-title":"Albuminuria and risk of cardiovascular events, death, and heart failure in diabetic and nondiabetic individuals","volume":"286","author":"Gerstein","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00329-0_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diacare.24.1.5","article-title":"Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy","volume":"24","author":"Poirier","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00329-0_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00292-2","article-title":"Long-term excess risk of heart failure in type 1 diabetes: a prospective case-control study","author":"Rosengren","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00329-0_bib8","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1007\/s00125-014-3164-5","article-title":"Prevalence of systolic and diastolic dysfunction in patients with type 1 diabetes without known heart disease: the Thousand & 1 Study","volume":"57","author":"Jensen","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00329-0_bib9","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1016\/S0140-6736(14)61402-1","article-title":"Heart failure in diabetes: effects of anti-hyperglycaemic drug therapy","volume":"385","author":"Gilbert","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00329-0_bib10","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S2213-8587(14)70031-2","article-title":"Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored","volume":"2","author":"McMurray","year":"2014","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T09:50:36Z","timestamp":1537350636000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003290"}},"issued":{"date-parts":[[2015,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S2213858715003290"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00329-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,11]]}},{"indexed":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T20:29:22Z","timestamp":1721680162895},"reference-count":5,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/s2213-8587(15)00214-4","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T19:38:23Z","timestamp":1435606703000},"page":"499","source":"Crossref","is-referenced-by-count":3,"title":["Does midlife obesity really lower dementia risk?"],"prefix":"10.1016","volume":"3","author":[{"given":"Helios","family":"Pareja-Galeano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fabian","family":"Sanchis-Gomar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rafael","family":"Alis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda","family":"Mor\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandro","family":"Lucia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00214-4_bib1","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(15)00033-9","article-title":"BMI and risk of dementia in two million people over two decades: a retrospective cohort study","volume":"3","author":"Qizilbash","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00214-4_bib2","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1136\/bmj.38446.466238.E0","article-title":"Obesity in middle age and future risk of dementia: a 27 year longitudinal population based study","volume":"330","author":"Whitmer","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00214-4_bib3","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3233\/JAD-141086","article-title":"2003\u20132013: a decade of body mass index, Alzheimer's disease, and dementia","volume":"43","author":"Emmerzaal","year":"2015","journal-title":"J Alzheimers Dis"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(15)00214-4_bib4","doi-asserted-by":"crossref","first-page":"S276","DOI":"10.2337\/dcS13-2023","article-title":"Obesity paradox does exist","volume":"36","author":"Hainer","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00214-4_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ijcard.2011.01.076","article-title":"Obesity paradox in elderly patients with cardiovascular diseases","volume":"155","author":"Dorner","year":"2012","journal-title":"Int J Cardiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T16:45:04Z","timestamp":1566924304000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002144"}},"issued":{"date-parts":[[2015,7]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2213858715002144"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00214-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,7]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T00:14:11Z","timestamp":1648512851945},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30293-5","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T08:02:37Z","timestamp":1476604957000},"page":"890","source":"Crossref","is-referenced-by-count":2,"title":["Research digest: cardiac biomarkers for risk prediction"],"prefix":"10.1016","volume":"4","author":[{"given":"David","family":"Preiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302935?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302935?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T15:58:30Z","timestamp":1536335910000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302935"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2213858716302935"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30293-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T06:30:12Z","timestamp":1648535412748},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/s2213-8587(16)00012-7","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:30:15Z","timestamp":1453854615000},"page":"103","source":"Crossref","is-referenced-by-count":0,"title":["Dr Mike: Sharing health leads to better health"],"prefix":"10.1016","volume":"4","author":[{"given":"Jules","family":"Morgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000127?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000127?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T23:52:53Z","timestamp":1537055573000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716000127"}},"issued":{"date-parts":[[2016,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2213858716000127"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)00012-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,2]]}},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T01:49:49Z","timestamp":1648691389952},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/s2213-8587(14)70215-3","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T20:30:21Z","timestamp":1412195421000},"page":"765","source":"Crossref","is-referenced-by-count":1,"title":["Healthy lifestyle guidelines\u2014are they good enough?"],"prefix":"10.1016","volume":"2","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702153?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702153?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T18:23:43Z","timestamp":1538159023000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702153"}},"issued":{"date-parts":[[2014,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S2213858714702153"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70215-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,10]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:17:47Z","timestamp":1649035067058},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/s2213-8587(16)30049-3","type":"journal-article","created":{"date-parts":[[2016,4,27]],"date-time":"2016-04-27T23:35:05Z","timestamp":1461800105000},"page":"e6","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2015; 3: 339\u201355"],"prefix":"10.1016","volume":"4","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T08:38:49Z","timestamp":1548664729000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716300493"}},"issued":{"date-parts":[[2016,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S2213858716300493"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30049-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,6]]}},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T09:23:33Z","timestamp":1648718613911},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/s2213-8587(14)70123-8","type":"journal-article","created":{"date-parts":[[2014,6,8]],"date-time":"2014-06-08T19:15:10Z","timestamp":1402254910000},"page":"e13","source":"Crossref","is-referenced-by-count":1,"title":["Fed Up"],"prefix":"10.1016","volume":"2","author":[{"given":"Aaron","family":"van Dorn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701238?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701238?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T10:25:58Z","timestamp":1538562358000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701238"}},"issued":{"date-parts":[[2014,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S2213858714701238"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70123-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,8]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T12:22:00Z","timestamp":1648902120495},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/s2213-8587(16)30312-6","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T20:01:07Z","timestamp":1478030467000},"page":"772","source":"Crossref","is-referenced-by-count":0,"title":["Alafia Samuels: fast-food watchdog in the Caribbean"],"prefix":"10.1016","volume":"5","author":[{"given":"Ray","family":"Cavanaugh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T09:39:59Z","timestamp":1539077999000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303126"}},"issued":{"date-parts":[[2017,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2213858716303126"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30312-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,10]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T15:04:54Z","timestamp":1649084694776},"reference-count":3,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,21]],"date-time":"2017-08-21T00:00:00Z","timestamp":1503273600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/s2213-8587(17)30284-x","type":"journal-article","created":{"date-parts":[[2017,8,23]],"date-time":"2017-08-23T03:15:21Z","timestamp":1503458121000},"page":"770-771","source":"Crossref","is-referenced-by-count":0,"title":["Research misconduct and the INTERGROWTH-21st study"],"prefix":"10.1016","volume":"5","author":[{"given":"Lawrence D","family":"Platt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Torvid","family":"Kiserud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marshall","family":"Lindheimer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30284-X_bib1","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/S0140-6736(17)30321-5","article-title":"Research misconduct and the INTERGROWTH-21st study","volume":"389","author":"Horton","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30284-X_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S2213-8587(17)30040-2","article-title":"Research misconduct and the INTERGROWTH-21st study","volume":"5","author":"Horton","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30284-X_bib3","doi-asserted-by":"crossref","first-page":"e385","DOI":"10.1016\/S2214-109X(17)30071-2","article-title":"Research misconduct and the INTERGROWTH-21st study","volume":"5","author":"Horton","year":"2017","journal-title":"Lancet Glob Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730284X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730284X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T13:40:57Z","timestamp":1539092457000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871730284X"}},"issued":{"date-parts":[[2017,10]]},"references-count":3,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S221385871730284X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30284-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,10]]}},{"indexed":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T17:48:53Z","timestamp":1653328133262},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70099-8","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T14:31:01Z","timestamp":1377009061000},"page":"14","source":"Crossref","is-referenced-by-count":2,"title":["Nutrition education: the way to reduce childhood obesity?"],"prefix":"10.1016","volume":"1","author":[{"given":"Susan","family":"Mayor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T20:59:40Z","timestamp":1539464380000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700998"}},"issued":{"date-parts":[[2013,9]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2213858713700998"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70099-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T09:29:44Z","timestamp":1648978184572},"reference-count":3,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/s2213-8587(16)30271-6","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T21:39:11Z","timestamp":1479850751000},"page":"971","source":"Crossref","is-referenced-by-count":0,"title":["Are statins useful in patients with advanced chronic kidney disease?"],"prefix":"10.1016","volume":"4","author":[{"given":"Luca","family":"Mascitelli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark R","family":"Goldstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30271-6_bib1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","article-title":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials","volume":"4","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30271-6_bib2","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1136\/bmj.39136.682083.AE","article-title":"Problems with use of composite end points in cardiovascular trials: systematic review of randomised controlled trials","volume":"334","author":"Ferreira-Gonzalez","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)30271-6_bib3","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2016.01.016","article-title":"Protocol for analyses of adverse event data from randomized controlled trials of statin therapy","volume":"176","year":"2016","journal-title":"Am Heart J"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T09:24:32Z","timestamp":1536225872000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302716"}},"issued":{"date-parts":[[2016,12]]},"references-count":3,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2213858716302716"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30271-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,12]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T14:59:34Z","timestamp":1648997974246},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/s2213-8587(18)30242-0","type":"journal-article","created":{"date-parts":[[2018,8,8]],"date-time":"2018-08-08T18:44:17Z","timestamp":1533753857000},"page":"770","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Type 1 cast: from pricks to pups at the Edinburgh Fringe"],"prefix":"10.1016","volume":"6","author":[{"given":"Peter","family":"Ranscombe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T19:35:46Z","timestamp":1537904146000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302420"}},"issued":{"date-parts":[[2018,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2213858718302420"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30242-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 cast: from pricks to pups at the Edinburgh Fringe","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30242-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T19:40:57Z","timestamp":1648582857901},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/s2213-8587(13)70022-6","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T15:07:43Z","timestamp":1366297663000},"page":"e12","source":"Crossref","is-referenced-by-count":0,"title":["Anna Peeters: President of ANZOS"],"prefix":"10.1016","volume":"1","author":[{"given":"Tony","family":"Kirby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700226?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700226?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T21:23:31Z","timestamp":1539725011000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700226"}},"issued":{"date-parts":[[2013,10]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S2213858713700226"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70022-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,10]]}},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:32:34Z","timestamp":1648762354074},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/s2213-8587(19)30008-7","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T06:29:49Z","timestamp":1548570589000},"page":"92","source":"Crossref","is-referenced-by-count":0,"title":["Food companies and nutrition: beyond mere disclosure"],"prefix":"10.1016","volume":"7","author":[{"given":"Robert","family":"Stirrups","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T06:29:50Z","timestamp":1548570590000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300087"}},"issued":{"date-parts":[[2019,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2213858719300087"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30008-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,2]]}},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T14:41:51Z","timestamp":1649169711950},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/s2213-8587(14)70247-5","type":"journal-article","created":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T19:15:56Z","timestamp":1419966956000},"page":"11-12","source":"Crossref","is-referenced-by-count":1,"title":["Association between 25-hydroxyvitamin D and type 2 diabetes \u2013 Authors' reply"],"prefix":"10.1016","volume":"3","author":[{"given":"Nita G","family":"Forouhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen J","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Ye","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70247-5_bib1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S2213-8587(14)70113-5","article-title":"Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study","volume":"2","author":"Vimaleswaran","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70247-5_bib2","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/ije\/dyh132","article-title":"Mendelian randomization: prospects, potentials, and limitations","volume":"33","author":"Davey Smith","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(14)70247-5_bib3","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1161\/ATVBAHA.109.201020","article-title":"Genetic variants influencing circulating lipid levels and risk of coronary artery disease","volume":"30","author":"Waterworth","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(14)70247-5_bib4","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009217.pub2","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"1","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(14)70247-5_bib5","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJMoa0804381","article-title":"Sex hormone-binding globulin and risk of type 2 diabetes in women and men","volume":"361","author":"Ding","year":"2009","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,18]],"date-time":"2019-08-18T23:17:10Z","timestamp":1566170230000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702475"}},"issued":{"date-parts":[[2015,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S2213858714702475"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70247-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,1]]}},{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T02:29:26Z","timestamp":1649212166164},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/s2213-8587(19)30357-2","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T20:59:48Z","timestamp":1574197188000},"page":"896","source":"Crossref","is-referenced-by-count":0,"title":["ENDO 2020: a call for papers"],"prefix":"10.1016","volume":"7","author":[{"given":"Marta","family":"Koch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neil","family":"Bennet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T20:59:48Z","timestamp":1574197188000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719303572"}},"issued":{"date-parts":[[2019,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S2213858719303572"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30357-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,12]]}},{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:10:37Z","timestamp":1778861437718,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/s2213-8587(24)00160-8","type":"journal-article","created":{"date-parts":[[2024,6,24]],"date-time":"2024-06-24T06:52:27Z","timestamp":1719211947000},"page":"505-507","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Value of early pregnancy HbA1c to predict gestational diabetes"],"prefix":"10.1016","volume":"12","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-4345-717X","authenticated-orcid":false,"given":"Yashdeep","family":"Gupta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00160-8_bib1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/obr.12442","article-title":"Lifestyle intervention can reduce the risk of gestational diabetes: a meta-analysis of randomized controlled trials","volume":"17","author":"Song","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(24)00160-8_bib2","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2214956","article-title":"Treatment of gestational diabetes mellitus diagnosed early in pregnancy","volume":"388","author":"Simmons","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00160-8_bib3","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/joim.12200","article-title":"More evidence of the problems of using HbA1c for diagnosing diabetes? The known knowns, the known unknowns and the unknown unknowns","volume":"276","author":"Church","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(24)00160-8_bib4","doi-asserted-by":"crossref","DOI":"10.2337\/dci23-0040","article-title":"Point-of-care HbA1c in clinical practice: caveats and considerations for optimal use","author":"Sacks","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00160-8_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00151-7","article-title":"Early pregnancy HbA1c as the first screening test for gestational diabetes: results from three prospective cohorts","author":"Saravanan","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00160-8_bib6","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/dc15-1887","article-title":"Issues with the diagnosis and classification of hyperglycemia in early pregnancy","volume":"39","author":"McIntyre","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00160-8_bib7","doi-asserted-by":"crossref","DOI":"10.2337\/dc23-2215","article-title":"Regression From early GDM to normal glucose tolerance and adverse pregnancy outcomes in the Treatment of Booking Gestational Diabetes Mellitus Study","author":"Simmons","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00160-8_bib8","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2337\/dc11-1641","article-title":"Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study","volume":"35","author":"Sacks","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00160-8_bib9","doi-asserted-by":"crossref","DOI":"10.2337\/dc23-2149","article-title":"Continuous glucose monitoring profiles in pregnancies with and without gestational diabetes mellitus","author":"Durnwald","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00160-8_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(24)00826-2","article-title":"Gestational diabetes 3: call to action for a life course approach","author":"Simmons","year":"2024","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:48Z","timestamp":1778858748000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001608"}},"issued":{"date-parts":[[2024,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2213858724001608"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00160-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Value of early pregnancy HbA1c to predict gestational diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00160-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00151-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,12,3]],"date-time":"2022-12-03T19:08:51Z","timestamp":1670094531423},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/s2213-8587(15)00339-3","type":"journal-article","created":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T20:06:01Z","timestamp":1442520361000},"page":"747","source":"Crossref","is-referenced-by-count":1,"title":["Tackling childhood obesity at its maternal roots"],"prefix":"10.1016","volume":"3","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003393?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003393?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T09:53:38Z","timestamp":1537350818000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003393"}},"issued":{"date-parts":[[2015,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2213858715003393"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00339-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,10]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T11:16:21Z","timestamp":1648638981737},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/s2213-8587(16)30008-0","type":"journal-article","created":{"date-parts":[[2016,5,8]],"date-time":"2016-05-08T12:48:18Z","timestamp":1462711698000},"page":"471-473","source":"Crossref","is-referenced-by-count":1,"title":["Testosterone replacement therapy: intent matters"],"prefix":"10.1016","volume":"4","author":[{"given":"Michael S","family":"Lauer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30008-0_bib1","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1093\/ije\/30.5.1156","article-title":"Comparing like with like: some historical milestones in the evolution of methods to create unbiased comparison groups in therapeutic experiments","volume":"30","author":"Chalmers","year":"2001","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(16)30008-0_bib2","unstructured":"Van Helmont J. Oriatrike, or physick refined: the common errors therein refuted and the whole art reformed and rectified. London: Lodowick-Loyd, 1662."},{"key":"10.1016\/S2213-8587(16)30008-0_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)00112-1","article-title":"Survival and cardiovascular events in men treated with testosterone replacement therapy: an intention-to-treat observational cohort study","author":"Wallis","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30008-0_bib4","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1097\/EDE.0b013e3181875e61","article-title":"Observational studies analyzed like randomized experiments: an application to postmenopausal hormone therapy and coronary heart disease","volume":"19","author":"Hern\u00e1n","year":"2008","journal-title":"Epidemiology"},{"key":"10.1016\/S2213-8587(16)30008-0_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1001\/jama.288.3.321","article-title":"Risks and benefits of estrogen plus progestin in healthy postmenopausal women: principal results from the Women's Health Initiative randomized controlled trial","volume":"288","author":"Rossouw","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30008-0_bib6","article-title":"Hormone studies: what went wrong?","author":"Kolata","year":"2003","journal-title":"New York Times (New York)"},{"key":"10.1016\/S2213-8587(16)30008-0_bib7","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1056\/NEJM199608153350701","article-title":"Postmenopausal estrogen and progestin use and the risk of cardiovascular disease","volume":"335","author":"Grodstein","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30008-0_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.7326\/0003-4819-137-4-200208200-00012","article-title":"Postmenopausal hormone replacement therapy and the primary prevention of cardiovascular disease","volume":"137","author":"Humphrey","year":"2002","journal-title":"Ann Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T06:51:01Z","timestamp":1536735061000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716300080"}},"issued":{"date-parts":[[2016,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S2213858716300080"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30008-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,6]]}},{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T18:36:54Z","timestamp":1775587014468,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/s2213-8587(17)30179-1","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T15:03:05Z","timestamp":1498057385000},"page":"496","source":"Crossref","is-referenced-by-count":1,"title":["Sacubitril\/valsartan in PARADIGM-HF \u2013 Authors' reply"],"prefix":"10.1016","volume":"5","author":[{"given":"Jelena P","family":"Seferovic","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Claggett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Scott D","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30179-1_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S2213-8587(17)30087-6","article-title":"Effect of sacubitril\/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial","volume":"5","author":"Seferovic","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30179-1_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1755-5922.2008.00053.x","article-title":"Insulin resistance: a potential new target for therapy in patients with heart failure","volume":"26","author":"Wong","year":"2008","journal-title":"Cardiovasc Ther"},{"key":"10.1016\/S2213-8587(17)30179-1_bib3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/01.CIR.0000054611.89228.92","article-title":"Enalapril reduces the incidence of diabetes in patients with chronic heart failure: insight from the Studies Of Left Ventricular Dysfunction (SOLVD)","volume":"107","author":"Vermes","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30179-1_bib4","doi-asserted-by":"crossref","first-page":"1882","DOI":"10.1007\/s00125-005-1847-7","article-title":"Neutral endopeptidase 24.11 and dipeptidyl peptidase IV are both mediators of the degradation of glucagon-like peptide 1 in the anaesthetised pig","volume":"48","author":"Plamboeck","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30179-1_bib5","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1007\/s00125-016-4172-4","article-title":"Improved glycaemia in high-fat-fed neprilysin-deficient mice is associated with reduced DPP-4 activity and increased active GLP-1 levels","volume":"60","author":"Willard","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30179-1_bib6","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/1755-5922.12183","article-title":"Pharmacodynamic and pharmacokinetic profiles of sacubitril\/valsartan (LCZ696) in patients with heart failure and reduced ejection fraction","volume":"34","author":"Kobalava","year":"2016","journal-title":"Cardiovasc Ther"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T04:15:57Z","timestamp":1560831357000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301791"}},"issued":{"date-parts":[[2017,7]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2213858717301791"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30179-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,7]]}},{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T13:46:28Z","timestamp":1782913588928,"version":"3.54.5"},"reference-count":14,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/s2213-8587(19)30072-5","type":"journal-article","created":{"date-parts":[[2019,3,15]],"date-time":"2019-03-15T23:38:00Z","timestamp":1552693080000},"page":"421-423","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome"],"prefix":"10.1016","volume":"7","author":[{"given":"Ana Luisa","family":"Perdigoto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Quandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevan C","family":"Herold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30072-5_bib1","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1126\/science.aar4060","article-title":"Cancer immunotherapy using checkpoint blockade","volume":"359","author":"Ribas","year":"2018","journal-title":"Science"},{"key":"10.1016\/S2213-8587(19)30072-5_bib2","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/S2213-8587(19)30072-5_bib3","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1056\/NEJMra1703481","article-title":"Immune-related adverse events associated with immune checkpoint blockade","volume":"378","author":"Postow","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30072-5_bib4","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1038\/nrendo.2016.205","article-title":"Cancer immunotherapy\u2014immune checkpoint blockade and associated endocrinopathies","volume":"13","author":"Byun","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(19)30072-5_bib5","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","article-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis","volume":"4","author":"Barroso-Sousa","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/S2213-8587(19)30072-5_bib6","doi-asserted-by":"crossref","first-page":"e150","DOI":"10.2337\/dc18-1465","article-title":"Increased reporting of immune checkpoint inhibitor-associated diabetes","volume":"41","author":"Wright","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30072-5_bib7","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00280-015-2873-x","article-title":"Phase 2 study of ipilimumab monotherapy in Japanese patients with advanced melanoma","volume":"76","author":"Yamazaki","year":"2015","journal-title":"Cancer Chemother Pharmacol"},{"key":"10.1016\/S2213-8587(19)30072-5_bib8","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.2337\/db07-1260","article-title":"Protective role of programmed death 1 ligand 1 (PD-L1) in nonobese diabetic mice: the paradox in transgenic models","volume":"57","author":"Wang","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30072-5_bib9","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.2337\/dbi18-0002","article-title":"Collateral damage: insulin-dependent diabetes induced with checkpoint inhibitors","volume":"67","author":"Stamatouli","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30072-5_bib10","doi-asserted-by":"crossref","first-page":"3144","DOI":"10.1210\/jc.2018-00728","article-title":"Programmed cell death-1 inhibitor-induced type 1 diabetes mellitus","volume":"103","author":"Clotman","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30072-5_bib11","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/db07-1331","article-title":"HLA DR-DQ haplotypes and genotypes and type 1 diabetes risk: analysis of the type 1 Diabetes Genetics Consortium families","volume":"57","author":"Erlich","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30072-5_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-217454","article-title":"Glucocorticoids did not reverse type 1 diabetes mellitus secondary to pembrolizumab in a patient with metastatic melanoma","volume":"2016","author":"Aleksova","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/S2213-8587(19)30072-5_bib13","doi-asserted-by":"crossref","first-page":"883","DOI":"10.4172\/2165-7920.1000883","article-title":"A case of nivolumab-induced fulminant type 1 diabetes with steroids and glucagon-like peptide 1 administration during the early onset","volume":"6","author":"Fukui","year":"2016","journal-title":"J Clin Case Rep"},{"key":"10.1016\/S2213-8587(19)30072-5_bib14","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s00262-016-1835-4","article-title":"A case report of insulin-dependent diabetes as immune-related toxicity of pembrolizumab: presentation, management and outcome","volume":"65","author":"Hansen","year":"2016","journal-title":"Cancer Immunol Immunother"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300725?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300725?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:18Z","timestamp":1761991578000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300725"}},"issued":{"date-parts":[[2019,6]]},"references-count":14,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2213858719300725"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30072-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Checkpoint inhibitor-induced insulin-dependent diabetes: an emerging syndrome","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30072-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T20:36:10Z","timestamp":1781642170349,"version":"3.54.5"},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/s2213-8587(16)30189-9","type":"journal-article","created":{"date-parts":[[2016,8,17]],"date-time":"2016-08-17T13:31:45Z","timestamp":1471440705000},"page":"737-738","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Country in focus: Gulf region states face major health challenges from obesity and diabetes"],"prefix":"10.1016","volume":"4","author":[{"given":"Talha Khan","family":"Burki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301899?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301899?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:17Z","timestamp":1761991577000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301899"}},"issued":{"date-parts":[[2016,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2213858716301899"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30189-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Country in focus: Gulf region states face major health challenges from obesity and diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30189-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:48:03Z","timestamp":1771631283295,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/s2213-8587(21)00142-x","type":"journal-article","created":{"date-parts":[[2021,6,18]],"date-time":"2021-06-18T19:49:49Z","timestamp":1624045789000},"page":"472-473","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Dulaglutide for erectile dysfunction in type 2 diabetes"],"prefix":"10.1016","volume":"9","author":[{"given":"Sten","family":"Madsbad","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00142-X_bib1","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.1111\/j.1743-6109.2008.01168.x","article-title":"Erectile dysfunction in diabetes mellitus","volume":"6","author":"Malavige","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/S2213-8587(21)00142-X_bib2","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1111\/dme.13403","article-title":"High prevalence of erectile dysfunction in diabetes: a systematic review and meta-analysis of 145 studies","volume":"34","author":"Kouidrat","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00142-X_bib3","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1111\/andr.12099","article-title":"Adding liraglutide to lifestyle changes, metformin and testosterone therapy boosts erectile function in diabetic obese men with overt hypogonadism","volume":"3","author":"Giagulli","year":"2015","journal-title":"Andrology"},{"key":"10.1016\/S2213-8587(21)00142-X_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00115-7","article-title":"Erectile function in men with type 2 diabetes treated with dulaglutide: an exploratory analysis of the REWIND placebo-controlled randomised trial","author":"Bajaj","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00142-X_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00142-X_bib6","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1111\/dme.13977","article-title":"Testosterone deficiency in men with type 2 diabetes: pathophysiology and treatment","volume":"37","author":"Gianatti","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00142-X_bib7","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","article-title":"The cardiovascular biology of glucagon-like peptide-1","volume":"24","author":"Drucker","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00142-X_bib8","first-page":"212","article-title":"Regulatory effect of liraglutide on the expression of eNOS in the corpus cavernosum of diabetic rats","volume":"22","author":"Yue","year":"2016","journal-title":"Zhonghua Nan Ke Xue"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872100142X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872100142X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:39Z","timestamp":1761991839000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872100142X"}},"issued":{"date-parts":[[2021,8]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S221385872100142X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00142-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dulaglutide for erectile dysfunction in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00142-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00115-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T03:30:28Z","timestamp":1771903828167,"version":"3.50.1"},"reference-count":11,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/s2213-8587(21)00081-4","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T11:23:54Z","timestamp":1618485834000},"page":"252-254","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Semaglutide for obesity: four STEPs forward, but more to come"],"prefix":"10.1016","volume":"9","author":[{"given":"Donna H","family":"Ryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00081-4_bib1","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/oby.22794","article-title":"Semaglutide 2.4 mg for the treatment of obesity: key elements of the step trials 1 to 5","volume":"28","author":"Kushner","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00081-4_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00081-4_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2.4 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomized, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00081-4_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","author":"Wadden","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00081-4_bib5","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00081-4_bib6","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1016\/j.metabol.2018.10.010","article-title":"Pharmacotherapy of obesity: available medications and drugs under investigation","volume":"92","author":"Pilitsi","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(21)00081-4_bib7","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.ahj.2020.07.008","article-title":"Semaglutide effects on cardiovascular outcomes in people with overweight or obesity (SELECT) rationale and design","volume":"229","author":"Ryan","year":"2020","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(21)00081-4_bib8","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s13679-017-0262-y","article-title":"Weight loss and improvement in comorbidity: differences at 5%, 10%, 15%, and over","volume":"6","author":"Ryan","year":"2017","journal-title":"Curr Obes Rep"},{"key":"10.1016\/S2213-8587(21)00081-4_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmet.2016.02.005","article-title":"Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity","volume":"23","author":"Magkos","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00081-4_bib10","unstructured":"Wing RR, for the Look AHEAD Research Group. Does lifestyle intervention improve health of adults with overweight\/obesity and type 2 diabetes: findings from the LOOK AHEAD randomized trial. Obesity (in press)."},{"key":"10.1016\/S2213-8587(21)00081-4_bib11","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1111\/dom.14280","article-title":"The effect of semaglutide 2.4 mg once weekly on energy intake, appetite, control of eating, and gastric emptying in adults with obesity","volume":"23","author":"Friedrichsen","year":"2021","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000814?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000814?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:25Z","timestamp":1761991765000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000814"}},"issued":{"date-parts":[[2021,5]]},"references-count":11,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2213858721000814"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00081-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semaglutide for obesity: four STEPs forward, but more to come","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00081-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:12:54Z","timestamp":1778764374631,"version":"3.51.4"},"reference-count":22,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/s2213-8587(26)00013-6","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T22:55:14Z","timestamp":1777071314000},"page":"475-484","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised study"],"prefix":"10.1016","volume":"14","author":[{"given":"Agn\u00e8s","family":"Linglart","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Emma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine","family":"Bacchetta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francisco","family":"de la Cerda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wesley","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Moira","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Cocca","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wolfgang","family":"H\u00f6gler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raja","family":"Padidela","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alina","family":"Tudor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emilia","family":"Quattrocchi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00013-6_bib1","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-019-1014-8","article-title":"FGF23 and its role in X-linked hypophosphatemia-related morbidity","volume":"14","author":"Beck-Nielsen","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(26)00013-6_bib2","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/s41581-024-00926-x","article-title":"Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia","volume":"21","author":"Haffner","year":"2025","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S2213-8587(26)00013-6_bib3","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1002\/jbmr.340","article-title":"A clinician's guide to X-linked hypophosphatemia","volume":"26","author":"Carpenter","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00013-6_bib4","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1186\/s13023-023-02882-4","article-title":"The International X-Linked Hypophosphatemia (XLH) Registry: first interim analysis of baseline demographic, genetic and clinical data","volume":"18","author":"Ariceta","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(26)00013-6_bib5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1007\/s004310050962","article-title":"Calcium metabolism and growth during early treatment of children with X-linked hypophosphataemic rickets","volume":"157","author":"Kruse","year":"1998","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(26)00013-6_bib6","doi-asserted-by":"crossref","first-page":"3591","DOI":"10.1210\/jc.2003-030036","article-title":"Early treatment improves growth and biochemical and radiographic outcome in X-linked hypophosphatemic rickets","volume":"88","author":"M\u00e4kitie","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00013-6_bib8","doi-asserted-by":"crossref","DOI":"10.1177\/20406223241247643","article-title":"Real-world non-interventional post-authorization safety study of long-term use of burosumab in children and adolescents with X-linked hypophosphatemia: first interim analysis","volume":"15","author":"Boot","year":"2024","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/S2213-8587(26)00013-6_bib9","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1056\/NEJMoa1714641","article-title":"Burosumab therapy in children with X-linked hypophosphatemia","volume":"378","author":"Carpenter","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00013-6_bib10","doi-asserted-by":"crossref","first-page":"2416","DOI":"10.1016\/S0140-6736(19)30654-3","article-title":"Burosumab versus conventional therapy in children with X-linked hypophosphataemia: a randomised, active-controlled, open-label, phase 3 trial","volume":"393","author":"Imel","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00013-6_bib11","doi-asserted-by":"crossref","first-page":"e3241","DOI":"10.1210\/clinem\/dgac296","article-title":"Effect of burosumab compared with conventional therapy on younger vs older children with X-linked hypophosphatemia","volume":"107","author":"Ward","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00013-6_bib12","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S2213-8587(18)30338-3","article-title":"Efficacy and safety of burosumab in children aged 1-4 years with X-linked hypophosphataemia: a multicentre, open-label, phase 2 trial","volume":"7","author":"Whyte","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00013-6_bib13","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s00467-011-2046-z","article-title":"Growth in PHEX-associated X-linked hypophosphatemic rickets: the importance of early treatment","volume":"27","author":"Quinlan","year":"2012","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/S2213-8587(26)00013-6_bib15","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10728","article-title":"Craniosynostosis in patients with X-linked hypophosphatemia: a review","volume":"7","author":"Munns","year":"2023","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(26)00013-6_bib16","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1210\/clinem\/dgab729","article-title":"Sustained efficacy and safety of burosumab, a monoclonal antibody to FGF23, in children with X-linked hypophosphatemia","volume":"107","author":"Linglart","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00013-6_bib17","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziad001","article-title":"Burosumab vs conventional therapy in children with X-linked hypophosphatemia: results of the open-label, phase 3 extension period","volume":"8","author":"Ward","year":"2024","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(26)00013-6_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s004670050669","article-title":"PHEX expression in parathyroid gland and parathyroid hormone dysregulation in X-linked hypophosphatemia","volume":"13","author":"Blydt-Hansen","year":"1999","journal-title":"Pediatr Nephrol"},{"key":"10.1016\/S2213-8587(26)00013-6_bib19","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1172\/JCI72829","article-title":"Randomized trial of the anti-FGF23 antibody KRN23 in X-linked hypophosphatemia","volume":"124","author":"Carpenter","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(26)00013-6_bib20","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1210\/jc.2015-1551","article-title":"Prolonged correction of serum phosphorus in adults with X-linked hypophosphatemia using monthly doses of KRN23","volume":"100","author":"Imel","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00013-6_bib21","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/s00223-019-00568-3","article-title":"Continued beneficial effects of burosumab in adults with X-linked hypophosphatemia: results from a 24-week treatment continuation period after a 24-week double-blind placebo-controlled period","volume":"105","author":"Portale","year":"2019","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(26)00013-6_bib22","article-title":"First-in-Asian phase I study of the anti-fibroblast growth factor 23 monoclonal antibody, burosumab: safety and pharmacodynamics in adults with X-linked hypophosphatemia","volume":"3","author":"Cheong","year":"2018","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(26)00013-6_bib23","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1002\/jcph.570","article-title":"Pharmacokinetics and pharmacodynamics of a human monoclonal anti-FGF23 antibody (KRN23) in the first multiple ascending-dose trial treating adults with X-linked hypophosphatemia","volume":"56","author":"Zhang","year":"2016","journal-title":"J Clin Pharmacol"},{"key":"10.1016\/S2213-8587(26)00013-6_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s00223-025-01374-w","article-title":"The diagnosis and therapy of XLH","volume":"116","author":"B\u00f6ckmann","year":"2025","journal-title":"Calcif Tissue Int"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000136?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000136?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:53:35Z","timestamp":1778763215000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000136"}},"issued":{"date-parts":[[2026,6]]},"references-count":22,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2213858726000136"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00013-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety, tolerability, pharmacokinetics, and efficacy of burosumab in infants with X-linked hypophosphataemia: an open-label, multicentre, non-randomised study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00013-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00073-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:51:17Z","timestamp":1778889077878,"version":"3.51.4"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/s2213-8587(21)00001-2","type":"journal-article","created":{"date-parts":[[2021,1,10]],"date-time":"2021-01-10T04:00:38Z","timestamp":1610251238000},"page":"61-63","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Public health emergency or opportunity to profit? The two faces of the COVID-19 pandemic"],"prefix":"10.1016","volume":"9","author":[{"given":"May CI","family":"van Schalkwyk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nason","family":"Maani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"McKee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00001-2_bib1","first-page":"50","article-title":"Capitalism after the pandemic: getting the recovery right","volume":"99","author":"Mazzucato","year":"2020","journal-title":"Foreign Aff"},{"key":"10.1016\/S2213-8587(21)00001-2_bib2","series-title":"Golden holocaust: origins of the cigarette catastrophe and the case for abolition","author":"Proctor","year":"2011"},{"key":"10.1016\/S2213-8587(21)00001-2_bib3","series-title":"The shock doctrine: the rise of disaster capitalism","author":"Klein","year":"2014"},{"key":"10.1016\/S2213-8587(21)00001-2_bib4","article-title":"Waste, negligence and cronyism: inside Britain's pandemic spending","author":"Bradley","year":"2020","journal-title":"The New York Times"},{"key":"10.1016\/S2213-8587(21)00001-2_bib5","series-title":"Signalling virtue, promoting harm: unhealthy commodity industries and COVID-19","author":"Collin","year":"2020"},{"key":"10.1016\/S2213-8587(21)00001-2_bib6","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s10551-012-1250-5","article-title":"The limits of corporate social responsibility: techniques of neutralization, stakeholder management and political CSR","volume":"112","author":"Fooks","year":"2013","journal-title":"J Bus Ethics"},{"key":"10.1016\/S2213-8587(21)00001-2_bib7","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/1468-0009.12368","article-title":"Public Meets Private: Conversations Between Coca-Cola and the CDC","volume":"97","author":"Maani Hessari","year":"2019","journal-title":"Milbank Q"},{"key":"10.1016\/S2213-8587(21)00001-2_bib9","article-title":"A new year's resolution for health workers","volume":"371","author":"McKee","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00001-2_bib10","series-title":"The role of health professionals in tobacco control","year":"2005"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:21Z","timestamp":1761991701000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000012"}},"issued":{"date-parts":[[2021,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2213858721000012"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00001-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Public health emergency or opportunity to profit? The two faces of the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00001-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T15:18:32Z","timestamp":1759331912390},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/s2213-8587(14)70080-4","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T15:35:14Z","timestamp":1399304114000},"page":"361","source":"Crossref","is-referenced-by-count":7,"title":["Subclinical Cushing's syndrome and cardiovascular disease"],"prefix":"10.1016","volume":"2","author":[{"given":"Panagiotis","family":"Anagnostis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Spyridon N","family":"Karras","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vasilios G","family":"Athyros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dimitri P","family":"Mikhailidis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Asterios","family":"Karagiannis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70080-4_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70080-4_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.14310\/horm.2002.1233","article-title":"Adrenal incidentaloma: a diagnostic challenge","volume":"8","author":"Anagnostis","year":"2009","journal-title":"Hormones (Athens)"},{"key":"10.1016\/S2213-8587(14)70080-4_bib3","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.1210\/jc.2009-0370","article-title":"Clinical review: The pathogenetic role of cortisol in the metabolic syndrome: a hypothesis","volume":"94","author":"Anagnostis","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70080-4_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/j.1365-2265.2011.04253.x","article-title":"Subclinical Cushing's syndrome: definition and management","volume":"76","author":"Terzolo","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70080-4_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1097\/SLA.0b013e31819a47d2","article-title":"Surgical versus conservative management for subclinical Cushing syndrome in adrenal incidentalomas: a prospective randomized study","volume":"249","author":"Toniato","year":"2009","journal-title":"Ann Surg"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700804?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700804?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T10:23:00Z","timestamp":1538648580000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700804"}},"issued":{"date-parts":[[2014,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S2213858714700804"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70080-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,5]]}},{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T01:04:19Z","timestamp":1792458259176,"version":"4.5.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/s2213-8587(21)00285-0","type":"journal-article","created":{"date-parts":[[2021,12,22]],"date-time":"2021-12-22T19:21:28Z","timestamp":1640200888000},"page":"129-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Subclinical hypothyroidism in older individuals"],"prefix":"10.1016","volume":"10","author":[{"given":"Bernadette","family":"Biondi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne R","family":"Cappola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00285-0_bib1","doi-asserted-by":"crossref","first-page":"ITC1","DOI":"10.7326\/AITC202007070","article-title":"Hypothyroidism","volume":"173","author":"McDermott","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(21)00285-0_bib2","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1001\/jama.2019.9052","article-title":"Subclinical hypothyroidism","volume":"322","author":"Biondi","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00285-0_bib3","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1056\/NEJMcp1611144","article-title":"Subclinical hypothyroidism","volume":"376","author":"Peeters","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00285-0_bib4","doi-asserted-by":"crossref","first-page":"4575","DOI":"10.1210\/jc.2007-1499","article-title":"Age-specific distribution of serum thyrotropin and antithyroid antibodies in the US population: implications for the prevalence of subclinical hypothyroidism","volume":"92","author":"Surks","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1089\/thy.2010.0092","article-title":"An approach for development of age-, gender-, and ethnicity-specific thyrotropin reference limits","volume":"21","author":"Boucai","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00285-0_bib6","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S2213-8587(18)30371-1","article-title":"Reference intervals in the diagnosis of thyroid dysfunction: treating patients not numbers","volume":"7","author":"Jonklaas","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00285-0_bib7","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1001\/jama.2019.14728","article-title":"The thyrotropin reference range should be changed in older patients","volume":"322","author":"Cappola","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00285-0_bib8","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S2213-8587(18)30028-7","article-title":"Clinical aspects of thyroid function during ageing","volume":"6","author":"Chaker","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00285-0_bib9","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/nrendo.2013.30","article-title":"Thyroid dysfunction in the elderly","volume":"9","author":"Boelaert","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00285-0_bib10","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1089\/thy.2014.0028","article-title":"Guidelines for the treatment of hypothyroidism: prepared by the american thyroid association task force on thyroid hormone replacement","volume":"24","author":"Jonklaas","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00285-0_bib11","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000356507","article-title":"2013 ETA guideline: management of subclinical hypothyroidism","volume":"2","author":"Pearce","year":"2013","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(21)00285-0_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1590\/S0004-27302013000400003","article-title":"Clinical practice guidelines for the management of hypothyroidism","volume":"57","author":"Brenta","year":"2013","journal-title":"Arq Bras Endocrinol Metabol"},{"key":"10.1016\/S2213-8587(21)00285-0_bib13","article-title":"Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline","volume":"365","author":"Bekkering","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00285-0_bib14","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1093\/gerona\/glr063","article-title":"Predictors of thyroid hormone initiation in older adults: results from the cardiovascular health study","volume":"66","author":"Somwaru","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(21)00285-0_bib15","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrendo.2018.18","article-title":"Global epidemiology of hyperthyroidism and hypothyroidism","volume":"14","author":"Taylor","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00285-0_bib16","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1111\/jgs.17015","article-title":"Thyroid hormone supplementation and all-cause mortality in community-dwelling older adults: results from the Baltimore Longitudinal Study of Aging","volume":"69","author":"Abbey","year":"2021","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(21)00285-0_bib17","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1089\/thy.2017.0715","article-title":"An age-specific serum thyrotropin reference range for the diagnosis of thyroid diseases in older adults: a cross-sectional survey in China","volume":"28","author":"Zhai","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00285-0_bib18","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1111\/ijcp.12619","article-title":"Subclinical hypothyroidism: a historical view and shifting prevalence","volume":"69","author":"Hennessey","year":"2015","journal-title":"Int J Clin Pract"},{"key":"10.1016\/S2213-8587(21)00285-0_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2016.12.008","article-title":"Prevalence of thyroid dysfunction and autoimmunity in the older population and implications of age-specific reference ranges","volume":"465","author":"Veltri","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2213-8587(21)00285-0_bib20","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1111\/j.1365-2265.1995.tb01894.x","article-title":"The incidence of thyroid disorders in the community: a twenty-year follow-up of the Whickham Survey","volume":"43","author":"Vanderpump","year":"1995","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(21)00285-0_bib21","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.beem.2011.12.004","article-title":"Natural history, diagnosis and management of subclinical thyroid dysfunction","volume":"26","author":"Biondi","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib22","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1210\/jc.2011-3020","article-title":"Age-related changes in thyroid function: a longitudinal study of a community-based cohort","volume":"97","author":"Bremner","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib23","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1089\/thy.2016.0133","article-title":"Thyroid function characteristics and determinants: The Rotterdam Study","volume":"26","author":"Chaker","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00285-0_bib24","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1210\/jc.2012-2481","article-title":"Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study","volume":"97","author":"Waring","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib25","doi-asserted-by":"crossref","first-page":"4890","DOI":"10.1210\/jc.2003-032061","article-title":"Spontaneous subclinical hypothyroidism in patients older than 55 years: an analysis of natural course and risk factors for the development of overt thyroid failure","volume":"89","author":"D\u00edez","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib26","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","article-title":"Subclinical thyroid disease","volume":"379","author":"Cooper","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00285-0_bib27","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1001\/jama.2015.5161","article-title":"Subclinical thyroid dysfunction and fracture risk: a meta-analysis","volume":"313","author":"Blum","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00285-0_bib28","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00285-0_bib29","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.096024","article-title":"Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts","volume":"126","author":"Gencer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00285-0_bib30","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1210\/jc.2015-1438","article-title":"Subclinical hypothyroidism and the risk of stroke events and fatal stroke: an individual participant data analysis","volume":"100","author":"Chaker","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib31","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1056\/NEJMoa1603825","article-title":"Thyroid hormone therapy for older adults with subclinical hypothyroidism","volume":"376","author":"Stott","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00285-0_bib32","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1001\/jama.2019.17274","article-title":"Association between levothyroxine treatment and thyroid-related symptoms among adults aged 80 years and older with subclinical hypothyroidism","volume":"322","author":"Mooijaart","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00285-0_bib33","doi-asserted-by":"crossref","first-page":"709","DOI":"10.7326\/M19-3193","article-title":"Subclinical hypothyroidism and hypothyroid symptoms: secondary analysis of a randomized trial","volume":"172","author":"de Montmollin","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(21)00285-0_bib34","doi-asserted-by":"crossref","first-page":"e89","DOI":"10.1093\/gerona\/glaa123","article-title":"Effect of thyroid hormone therapy on fatigability in older adults with subclinical hypothyroidism: a nested study within a randomized placebo-controlled trial","volume":"75","author":"Stuber","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(21)00285-0_bib35","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.36645","article-title":"Effect of levothyroxine therapy on the development of depressive symptoms in older adults with subclinical hypothyroidism: an ancillary study of a randomized clinical trial","volume":"4","author":"Wildisen","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(21)00285-0_bib36","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/clinem\/dgz058","article-title":"Skeletal effects of levothyroxine for subclinical hypothyroidism in older adults: a TRUST Randomized Trial Nested Study","volume":"105","author":"Gonzalez Rodriguez","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib37","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/j.amjmed.2020.01.018","article-title":"The impact of levothyroxine on cardiac function in older adults with mild subclinical hypothyroidism: a randomized clinical trial","volume":"133","author":"Gencer","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(21)00285-0_bib38","doi-asserted-by":"crossref","first-page":"2988","DOI":"10.1210\/jc.2018-00279","article-title":"Impact of thyroid hormone therapy on atherosclerosis in the elderly with subclinical hypothyroidism: a randomized trial","volume":"103","author":"Blum","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib39","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1001\/jama.2020.9389","article-title":"Effect of levothyroxine on left ventricular ejection fraction in patients with subclinical hypothyroidism and acute myocardial infarction: a randomized clinical trial","volume":"324","author":"Jabbar","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00285-0_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.674841","article-title":"Levothyroxine treatment and cardiovascular outcomes in older people with subclinical hypothyroidism: pooled individual results of two randomised controlled trials","volume":"12","author":"Zijlstra","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(21)00285-0_bib41","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1016\/j.amjmed.2016.06.013","article-title":"Hypothyroid symptoms fail to predict thyroid insufficiency in old people: a population-based case-control study","volume":"129","author":"Carl\u00e9","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(21)00285-0_bib42","doi-asserted-by":"crossref","first-page":"e208","DOI":"10.3399\/bjgp20X708065","article-title":"Subclinical thyroid dysfunction symptoms in older adults: cross-sectional study in UK primary care","volume":"70","author":"McCahon","year":"2020","journal-title":"Br J Gen Pract"},{"key":"10.1016\/S2213-8587(21)00285-0_bib43","doi-asserted-by":"crossref","first-page":"3658","DOI":"10.1210\/jc.2018-00481","article-title":"The relation between thyroid function and anemia: a pooled analysis of individual participant data","volume":"103","author":"Wopereis","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib44","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1001\/jama.2018.13770","article-title":"Association of thyroid hormone therapy with quality of life and thyroid-related symptoms in patients with subclinical hypothyroidism: a systematic review and meta-analysis","volume":"320","author":"Feller","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00285-0_bib45","doi-asserted-by":"crossref","first-page":"150","DOI":"10.3389\/fnagi.2015.00150","article-title":"Subclinical hypothyroidism and cognitive function in people over 60 years: a systematic review and meta-analysis","volume":"7","author":"Akintola","year":"2015","journal-title":"Front Aging Neurosci"},{"key":"10.1016\/S2213-8587(21)00285-0_bib46","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.1210\/jc.2015-2046","article-title":"Subclinical hypothyroidism and cognitive impairment: systematic review and meta-analysis","volume":"100","author":"Pasqualetti","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib47","doi-asserted-by":"crossref","first-page":"4945","DOI":"10.1210\/jc.2016-2129","article-title":"Subclinical thyroid dysfunction and the risk of cognitive decline: a systematic review and meta-analysis","volume":"101","author":"Rieben","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib48","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1530\/EC-21-0047","article-title":"Spectrum of thyroid dysfunction and dementia: a dose-response meta-analysis of 344, 248 individuals from cohort studies","volume":"10","author":"Tang","year":"2021","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(21)00285-0_bib49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000437387","article-title":"Subclinical thyroid dysfunction and depressive symptoms among the elderly: a prospective cohort study","volume":"103","author":"Blum","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(21)00285-0_bib50","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1038\/s41398-018-0283-7","article-title":"Subclinical hypothyroidism and depression: a meta-analysis","volume":"8","author":"Zhao","year":"2018","journal-title":"Transl Psychiatry"},{"key":"10.1016\/S2213-8587(21)00285-0_bib51","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12888-018-2006-2","article-title":"Association between subclinical hypothyroidism and depression: an updated systematic review and meta-analysis","volume":"19","author":"Loh","year":"2019","journal-title":"BMC Psychiatry"},{"key":"10.1016\/S2213-8587(21)00285-0_bib52","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1089\/thy.2013.0071","article-title":"Subclinical thyroid dysfunction and functional capacity among elderly","volume":"24","author":"Virgini","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00285-0_bib53","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1210\/jc.2009-1991","article-title":"Thyroid autoantibodies are associated with a reduced prevalence of frailty in community-dwelling older women","volume":"95","author":"Wang","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib54","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1111\/j.1365-2265.2011.04290.x","article-title":"Higher free thyroxine levels are associated with frailty in older men: the Health In Men Study","volume":"76","author":"Yeap","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(21)00285-0_bib55","doi-asserted-by":"crossref","first-page":"4524","DOI":"10.1210\/jc.2015-3191","article-title":"Subclinical thyroid dysfunction and frailty among older men","volume":"100","author":"Virgini","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib56","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1111\/joim.12688","article-title":"Association between subclinical thyroid dysfunction and change in bone mineral density in prospective cohorts","volume":"283","author":"Segna","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(21)00285-0_bib57","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12916-017-0777-9","article-title":"What is the association of hypothyroidism with risks of cardiovascular events and mortality? A meta-analysis of 55 cohort studies involving 1\u2008898\u2008314 participants","volume":"15","author":"Ning","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(21)00285-0_bib58","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.118.005266","article-title":"Thyroid dysfunction in heart failure and cardiovascular outcomes","volume":"11","author":"Kannan","year":"2018","journal-title":"Circ Heart Fail"},{"key":"10.1016\/S2213-8587(21)00285-0_bib59","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1210\/jc.2013-1039","article-title":"Subclinical hypothyroidism and survival: the effects of heart failure and race","volume":"98","author":"Rhee","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib60","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/s12872-019-1055-x","article-title":"Subclinical thyroid dysfunction is associated with adverse prognosis in heart failure patients with reduced ejection fraction","volume":"19","author":"Yang","year":"2019","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/S2213-8587(21)00285-0_bib61","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000001159","article-title":"Prognostic role of hypothyroidism in heart failure: a meta-analysis","volume":"94","author":"Ning","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S2213-8587(21)00285-0_bib62","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.1210\/jc.2014-1250","article-title":"Thyroid antibody status, subclinical hypothyroidism, and the risk of coronary heart disease: an individual participant data analysis","volume":"99","author":"Collet","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib63","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1210\/jc.2012-2180","article-title":"Persistent subclinical hypothyroidism and cardiovascular risk in the elderly: the cardiovascular health study","volume":"98","author":"Hyland","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib64","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1210\/jc.2010-1382","article-title":"Innate immune activity in plaque of patients with untreated and L-thyroxine-treated subclinical hypothyroidism","volume":"96","author":"Marfella","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib65","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1093\/eurheartj\/ehv737","article-title":"Clinical outcomes of patients with hypothyroidism undergoing percutaneous coronary intervention","volume":"37","author":"Zhang","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00285-0_bib66","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1089\/thy.2010.0298","article-title":"Hypothyroidism and moderate subclinical hypothyroidism are associated with increased all-cause mortality independent of coronary heart disease risk factors: a PreCIS database study","volume":"21","author":"McQuade","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00285-0_bib67","doi-asserted-by":"crossref","first-page":"4170","DOI":"10.1210\/jc.2016-2226","article-title":"Long-term outcome in levothyroxine treated patients with subclinical hypothyroidism and concomitant heart disease","volume":"101","author":"Andersen","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib68","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archinternmed.2012.1159","article-title":"Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality","volume":"172","author":"Razvi","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(21)00285-0_bib69","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10654-014-9946-8","article-title":"Subclinical thyroid dysfunction and the risk of stroke: a systematic review and meta-analysis","volume":"29","author":"Chaker","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00285-0_bib70","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/ndt\/gfy071","article-title":"Low thyroid function is not associated with an accelerated deterioration in renal function","volume":"34","author":"Meuwese","year":"2019","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(21)00285-0_bib71","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1089\/thy.2017.0414","article-title":"Subclinical hypothyroidism and the risk of cardiovascular disease and all-cause mortality: a meta-analysis of prospective cohort studies","volume":"28","author":"Moon","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00285-0_bib72","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/clinem\/dgz186","article-title":"Association of hypothyroidism and mortality in the elderly population: a systematic review and meta-analysis","volume":"105","author":"Tsai","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.amjmed.2015.11.027","article-title":"Subclinical thyroid disease and mortality in the elderly: a retrospective cohort study","volume":"129","author":"Grossman","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(21)00285-0_bib74","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1210\/clinem\/dgaa777","article-title":"Association of thyroid hormone therapy with mortality in subclinical hypothyroidism: a systematic review and meta-analysis","volume":"106","author":"Peng","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib75","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1001\/jama.292.21.2591","article-title":"Thyroid status, disability and cognitive function, and survival in old age","volume":"292","author":"Gussekloo","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00285-0_bib76","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1089\/thy.2020.0567","article-title":"Outcome of thyroid dysfunction in people aged eighty years and older: an individual patient data meta-analysis of four prospective studies (towards understanding longitudinal international older people studies consortium)","volume":"31","author":"Du Puy","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00285-0_bib77","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1210\/jc.2014-3586","article-title":"Thyroid function in the euthyroid range and adverse outcomes in older adults","volume":"100","author":"Cappola","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib78","doi-asserted-by":"crossref","first-page":"6403","DOI":"10.1210\/jc.2005-0872","article-title":"Thyroid hormone concentrations, disease, physical function, and mortality in elderly men","volume":"90","author":"van den Beld","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib79","first-page":"554","article-title":"Thyroid status and mortality risk in older adults with normal thyrotropin: sex differences in the Milan Geriatrics 75+ Cohort Study","volume":"72","author":"Ogliari","year":"2017","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(21)00285-0_bib80","doi-asserted-by":"crossref","first-page":"4385","DOI":"10.1210\/jc.2016-1935","article-title":"Serum thyroid function, mortality and disability in advanced old age: the Newcastle 85+ study","volume":"101","author":"Pearce","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib81","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1089\/thy.2019.0129","article-title":"Associations of elevated anti-thyroperoxidase antibodies with thyroid survival, functioning, and depressive symptoms in the oldest old: the Leiden 85-plus study","volume":"29","author":"Du Puy","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00285-0_bib82","doi-asserted-by":"crossref","first-page":"641","DOI":"10.7326\/M15-0483","article-title":"Screening for thyroid dysfunction: U.S. Preventive Services Task Force recommendation statement","volume":"162","author":"LeFevre","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(21)00285-0_bib83","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on practice guidelines","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00285-0_bib84","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S2213-8587(16)30276-5","article-title":"Levothyroxine overuse: time for an about face?","volume":"5","author":"Rodriguez-Gutierrez","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00285-0_bib85","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-019003","article-title":"Prevalence of potentially inappropriate prescribing in a subpopulation of older European clinical trial participants: a cross-sectional study","volume":"8","author":"Riordan","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(21)00285-0_bib86","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1210\/jc.2008-1696","article-title":"High frequency of and factors associated with thyroid hormone over-replacement and under-replacement in men and women aged 65 and over","volume":"94","author":"Somwaru","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib87","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1089\/thy.2015.0180","article-title":"Thyroid hormone therapy and risk of thyrotoxicosis in community-resident older adults: findings from the Baltimore Longitudinal Study of Aging","volume":"25","author":"Mammen","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00285-0_bib88","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1111\/cen.13519","article-title":"Long-term cardiovascular morbidity and mortality in patients treated for differentiated thyroid cancer","volume":"88","author":"Pajam\u00e4ki","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(21)00285-0_bib89","doi-asserted-by":"crossref","first-page":"4046","DOI":"10.1200\/JCO.2013.49.1043","article-title":"Long-term cardiovascular mortality in patients with differentiated thyroid carcinoma: an observational study","volume":"31","author":"Klein Hesselink","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(21)00285-0_bib90","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2238","article-title":"Levothyroxine dose and risk of fractures in older adults: nested case-control study","volume":"342","author":"Turner","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00285-0_bib91","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/jgs.14029","article-title":"Relationship between circulating thyroid-stimulating hormone, free thyroxine, and free triiodothyronine concentrations and 9-year mortality in euthyroid elderly adults","volume":"64","author":"Ceresini","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(21)00285-0_bib92","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1530\/EJE-13-0306","article-title":"Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: the Health In Men Study","volume":"169","author":"Yeap","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00285-0_bib93","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1210\/jc.2017-01854","article-title":"High circulating free thyroxine levels may increase the risk of frailty: the Rotterdam Study","volume":"103","author":"Bano","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib94","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1161\/CIRCULATIONAHA.117.028753","article-title":"Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation","volume":"136","author":"Baumgartner","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00285-0_bib95","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1210\/jc.2017-00294","article-title":"Thyroid function tests in the reference range and fracture: individual participant analysis of prospective cohorts","volume":"102","author":"Aubert","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib96","doi-asserted-by":"crossref","first-page":"R199","DOI":"10.1530\/EJE-17-0321","article-title":"Management of endocrine disease: l-thyroxine replacement therapy in the frail elderly: x\u00a7zllenge in clinical practice","volume":"177","author":"Ruggeri","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00285-0_bib97","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCULATIONAHA.115.020789","article-title":"Thyroid function and sudden cardiac death: a prospective population-based cohort study","volume":"134","author":"Chaker","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00285-0_bib98","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1159\/000504047","article-title":"Age-related serum thyroid-stimulating hormone reference range in older patients treated with levothyroxine: a randomized controlled feasibility trial (SORTED 1)","volume":"9","author":"Razvi","year":"2020","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(21)00285-0_bib99","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1210\/jc.2017-00410","article-title":"Defining optimal health range for thyroid function based on the risk of cardiovascular disease","volume":"102","author":"Chaker","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00285-0_bib100","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1089\/thy.2018.0416","article-title":"Thyroid and cardiovascular disease: research agenda for enhancing knowledge, prevention, and treatment","volume":"29","author":"Cappola","year":"2019","journal-title":"Thyroid"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002850?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002850?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:07Z","timestamp":1761991867000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002850"}},"issued":{"date-parts":[[2022,2]]},"references-count":100,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2213858721002850"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00285-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Subclinical hypothyroidism in older individuals","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00285-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T23:15:36Z","timestamp":1793661336486,"version":"4.5.1"},"reference-count":128,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T00:00:00Z","timestamp":1697587200000},"content-version":"am","delay-in-days":170,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"NIH","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/s2213-8587(23)00038-4","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T18:39:28Z","timestamp":1680287968000},"page":"345-361","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants"],"prefix":"10.1016","volume":"11","author":[{"given":"David","family":"Ta\u00efeb","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George B","family":"Wanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maleeha","family":"Ahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Lussey-Lepoutre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy D","family":"Perrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"N\u00f6lting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henri J L M","family":"Timmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zachary G","family":"Schwam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony L","family":"Estrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erqi Liu","family":"Pollom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucas","family":"Vitzthum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bourdeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth T","family":"Casey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Castinetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roderick","family":"Clifton-Bligh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora P M","family":"Corssmit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald R","family":"de Krijger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaydira","family":"Del Rivero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Eisenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans K","family":"Ghayee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Paule","family":"Gimenez-Roqueplo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Grossman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Imperiale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeroen C","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abhishek","family":"Jha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel N","family":"Kerstens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henricus P M","family":"Kunst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James K","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eamonn R","family":"Maher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Marchioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leilani B","family":"Mercado-Asis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozgur","family":"Mete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhide","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naris","family":"Nilubol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neeta","family":"Pandit-Taskar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fr\u00e9d\u00e9ric","family":"Sebag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akiyo","family":"Tanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiri","family":"Widimsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leah","family":"Meuter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques W M","family":"Lenders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karel","family":"Pacak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00038-4_bib1","doi-asserted-by":"crossref","first-page":"R11","DOI":"10.1530\/EJE-17-0523","article-title":"DIAGNOSIS of ENDOCRINE DISEASE: SDHx mutations: beyond pheochromocytomas and paragangliomas","volume":"178","author":"Mannelli","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib2","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1136\/jmedgenet-2016-104297","article-title":"Risk assessment of maternally inherited SDHD paraganglioma and phaeochromocytoma","volume":"54","author":"Burnichon","year":"2017","journal-title":"J Med Genet"},{"key":"10.1016\/S2213-8587(23)00038-4_bib3","article-title":"Grading quality of evidence and strength of recommendations","volume":"328","author":"Atkins","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00038-4_bib4","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/HJH.0000000000002438","article-title":"Genetics, diagnosis, management and future directions of research of phaeochromocytoma and paraganglioma: a position statement and consensus of the Working Group on Endocrine Hypertension of the European Society of Hypertension","volume":"38","author":"Lenders","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(23)00038-4_bib5","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an endocrine society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib6","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1530\/ERC-21-0359","article-title":"Head\/neck paragangliomas: focus on tumor location, mutational status and plasma methoxytyramine","volume":"29","author":"Richter","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib7","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/cen.12327","article-title":"Biochemical diagnosis of phaeochromocytoma using plasma-free normetanephrine, metanephrine and methoxytyramine: importance of supine sampling under fasting conditions","volume":"80","author":"D\u00e4rr","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/EJE-17-0077","article-title":"Plasma methoxytyramine: clinical utility with metanephrines for diagnosis of pheochromocytoma and paraganglioma","volume":"177","author":"Rao","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib9","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1373\/clinchem.2018.291369","article-title":"Biochemical diagnosis of chromaffin cell tumors in patients at high and low risk of disease: plasma versus urinary free or deconjugated o-methylated catecholamine metabolites","volume":"64","author":"Eisenhofer","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(23)00038-4_bib10","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1136\/jmedgenet-2017-105127","article-title":"Tumour risks and genotype-phenotype correlations associated with germline variants in succinate dehydrogenase subunit genes SDHB, SDHC and SDHD","volume":"55","author":"Andrews","year":"2018","journal-title":"J Med Genet"},{"key":"10.1016\/S2213-8587(23)00038-4_bib11","doi-asserted-by":"crossref","first-page":"E162","DOI":"10.1210\/jc.2012-2975","article-title":"Imaging work-up for screening of paraganglioma and pheochromocytoma in SDHx mutation carriers: a multicenter prospective study from the PGL","volume":"98","author":"Gimenez-Roqueplo","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib12","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1007\/s00330-015-4024-5","article-title":"The value of a rapid contrast-enhanced angio-MRI protocol in the detection of head and neck paragangliomas in SDHx mutations carriers: a retrospective study on behalf of the PGL. EVA investigators","volume":"26","author":"Gravel","year":"2016","journal-title":"Eur Radiol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib13","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.ejrad.2003.12.002","article-title":"The value of MR angiography techniques in the detection of head and neck paragangliomas","volume":"52","author":"van den Berg","year":"2004","journal-title":"Eur J Radiol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib14","doi-asserted-by":"crossref","first-page":"883","DOI":"10.3174\/ajnr.A0948","article-title":"Head and neck paragangliomas: value of contrast-enhanced 3D MR angiography","volume":"29","author":"Neves","year":"2008","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib15","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1007\/s00259-017-3896-9","article-title":"Superiority of 68Ga-DOTATATE over 18F-FDG and anatomic imaging in the detection of succinate dehydrogenase mutation (SDHx)-related pheochromocytoma and paraganglioma in the pediatric population","volume":"45","author":"Jha","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/S2213-8587(23)00038-4_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.2967\/jnumed.115.161018","article-title":"68Ga-DOTATATE PET\/CT in the localization of head and neck paragangliomas compared with other functional imaging modalities and CT\/MRI","volume":"57","author":"Janssen","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(23)00038-4_bib17","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s00259-015-3268-2","article-title":"Prospective comparison of (68)Ga-DOTATATE and (18)F-FDOPA PET\/CT in patients with various pheochromocytomas and paragangliomas with emphasis on sporadic cases","volume":"43","author":"Archier","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/S2213-8587(23)00038-4_bib18","doi-asserted-by":"crossref","first-page":"369","DOI":"10.2967\/jnumed.118.211706","article-title":"Performance of 68Ga-DOTA-conjugated somatostatin receptor-targeting peptide PET in detection of pheochromocytoma and paraganglioma: a systematic review and metaanalysis","volume":"60","author":"Han","year":"2019","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(23)00038-4_bib19","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1111\/cen.13737","article-title":"Role of DOTATATE-PET\/CT in preoperative assessment of phaeochromocytoma and paragangliomas","volume":"89","author":"Gild","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib20","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1210\/jc.2011-0333","article-title":"Functional imaging of SDHx-related head and neck paragangliomas: comparison of 18F-fluorodihydroxyphenylalanine, 18F-fluorodopamine, 18F-fluoro-2-deoxy-D-glucose PET, 123I-metaiodobenzylguanidine scintigraphy, and 111In-pentetreotide scintigraphy","volume":"96","author":"King","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib21","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1002\/hed.25604","article-title":"Tumor multifocality with vagus nerve involvement as a phenotypic marker of SDHD mutation in patients with head and neck paragangliomas: a 18F-FDOPA PET\/CT study","volume":"41","author":"Amodru","year":"2019","journal-title":"Head Neck"},{"key":"10.1016\/S2213-8587(23)00038-4_bib22","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00259-019-04398-1","article-title":"European Association of Nuclear Medicine practice guideline\/Society of Nuclear Medicine and Molecular Imaging procedure standard 2019 for radionuclide imaging of phaeochromocytoma and paraganglioma","volume":"46","author":"Ta\u00efeb","year":"2019","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/S2213-8587(23)00038-4_bib23","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1111\/cen.12126","article-title":"Functional characterization of nonmetastatic paraganglioma and pheochromocytoma by (18)F-FDOPA PET: focus on missed lesions","volume":"79","author":"Gabriel","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib24","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1007\/s00259-013-2346-6","article-title":"High incidence of extraadrenal paraganglioma in families with SDHx syndromes detected by functional imaging with [18F]fluorodihydroxyphenylalanine PET","volume":"40","author":"Miederer","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/S2213-8587(23)00038-4_bib25","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1111\/eci.12239","article-title":"18F-FDG PET\/CT as a predictor of hereditary head and neck paragangliomas","volume":"44","author":"Blanchet","year":"2014","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S2213-8587(23)00038-4_bib26","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1093\/jnci\/djs188","article-title":"Staging and functional characterization of pheochromocytoma and paraganglioma by 18F-fluorodeoxyglucose (18F-FDG) positron emission tomography","volume":"104","author":"Timmers","year":"2012","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(23)00038-4_bib27","doi-asserted-by":"crossref","first-page":"4757","DOI":"10.1210\/jc.2009-1248","article-title":"Comparison of 18F-fluoro-L-DOPA, 18F-fluoro-deoxyglucose, and 18F-fluorodopamine PET and 123I-MIBG scintigraphy in the localization of pheochromocytoma and paraganglioma","volume":"94","author":"Timmers","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib28","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1200\/JCO.2006.09.6297","article-title":"Superiority of fluorodeoxyglucose positron emission tomography to other functional imaging techniques in the evaluation of metastatic SDHB-associated pheochromocytoma and paraganglioma","volume":"25","author":"Timmers","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1002\/hed.23894","article-title":"Management of multicentric paragangliomas: review of 24 patients with 60 tumors","volume":"38","author":"\u00c1lvarez-Morujo","year":"2016","journal-title":"Head Neck"},{"key":"10.1016\/S2213-8587(23)00038-4_bib30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1177\/0194599815627667","article-title":"Head and neck paragangliomas: an update on evaluation and management","volume":"154","author":"Moore","year":"2016","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib31","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1016\/S0030-6665(05)70355-8","article-title":"Vagal paragangliomas","volume":"34","author":"Sniezek","year":"2001","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/S2213-8587(23)00038-4_bib32","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1177\/0194599814552060","article-title":"Subtotal resection for management of large jugular paragangliomas with functional lower cranial nerves","volume":"151","author":"Wanna","year":"2014","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib33","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.otc.2014.12.007","article-title":"Contemporary management of jugular paragangliomas","volume":"48","author":"Wanna","year":"2015","journal-title":"Otolaryngol Clin North Am"},{"key":"10.1016\/S2213-8587(23)00038-4_bib34","doi-asserted-by":"crossref","first-page":"400","DOI":"10.1177\/0194599820915490","article-title":"British Skull Base Society clinical consensus document on management of head and neck paragangliomas","volume":"163","author":"Lloyd","year":"2020","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib35","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1001\/archotol.124.10.1133","article-title":"Vagal paraganglioma: a review of 46 patients treated during a 20-year period","volume":"124","author":"Netterville","year":"1998","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib36","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1177\/0194599814555839","article-title":"Natural history of glomus jugulare: a review of 16 tumors managed with primary observation","volume":"152","author":"Carlson","year":"2015","journal-title":"Otolaryngol Head Neck Surg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib37","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1002\/1097-0142(20000615)88:12<2811::AID-CNCR21>3.0.CO;2-7","article-title":"Estimation of growth rate in patients with head and neck paragangliomas influences the treatment proposal","volume":"88","author":"Jansen","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib38","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/archoto.2012.37","article-title":"Natural history of cervical paragangliomas: outcomes of observation of 43 patients","volume":"138","author":"Langerman","year":"2012","journal-title":"Arch Otolaryngol Head Neck Surg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib39","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1210\/er.2014-1026","article-title":"Current approaches and recent developments in the management of head and neck paragangliomas","volume":"35","author":"Ta\u00efeb","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(23)00038-4_bib40","first-page":"983","article-title":"Multidisciplinary management of paragangliomas of the head and neck, part 1","volume":"17","author":"Hu","year":"2003","journal-title":"Oncology"},{"key":"10.1016\/S2213-8587(23)00038-4_bib41","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/hed.21790","article-title":"Head and neck paragangliomas: report of 175 patients (1989\u20132010)","volume":"34","author":"Papaspyrou","year":"2012","journal-title":"Head Neck"},{"key":"10.1016\/S2213-8587(23)00038-4_bib42","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1097\/MAO.0000000000000386","article-title":"The role of wait-and-scan and the efficacy of radiotherapy in the treatment of temporal bone paragangliomas","volume":"35","author":"Prasad","year":"2014","journal-title":"Otol Neurotol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib43","series-title":"Microsurgery of the skull base","first-page":"148","author":"Fisch","year":"1988"},{"key":"10.1016\/S2213-8587(23)00038-4_bib44","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1001\/archotol.1982.00790550005002","article-title":"Glomus tumors. Diagnosis, classification, and management of large lesions","volume":"108","author":"Jackson","year":"1982","journal-title":"Arch Otolaryngol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib45","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1177\/1538574406290254","article-title":"A multidisciplinary approach to carotid paragangliomas","volume":"40","author":"Kasper","year":"2006","journal-title":"Vasc Endovascular Surg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib46","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1288\/00005537-198912000-00007","article-title":"Effects of preoperative embolization on glomus jugulare tumors","volume":"99","author":"Murphy","year":"1989","journal-title":"Laryngoscope"},{"key":"10.1016\/S2213-8587(23)00038-4_bib47","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1097\/MAO.0b013e3181be6495","article-title":"Jugular foramen tumors: clinical characteristics and treatment outcomes","volume":"31","author":"Fayad","year":"2010","journal-title":"Otol Neurotol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib48","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1097\/00129492-200105000-00018","article-title":"Lateral skull base surgery for glomus tumors: long-term control","volume":"22","author":"Jackson","year":"2001","journal-title":"Otol Neurotol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib49","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1055\/s-2008-1058145","article-title":"An update on the surgical treatment of temporal bone paraganglioma","volume":"9","author":"Moe","year":"1999","journal-title":"Skull Base Surg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib50","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/jc.2005-1862","article-title":"Clinical presentation and penetrance of pheochromocytoma\/paraganglioma syndromes","volume":"91","author":"Benn","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib51","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1136\/jmedgenet-2019-106324","article-title":"Risk of metastatic pheochromocytoma and paraganglioma in SDHx mutation carriers: a systematic review and updated meta-analysis","volume":"57","author":"Lee","year":"2020","journal-title":"J Med Genet"},{"key":"10.1016\/S2213-8587(23)00038-4_bib52","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1136\/jmedgenet-2012-101192","article-title":"Risk of malignant paraganglioma in SDHB-mutation and SDHD-mutation carriers: a systematic review and meta-analysis","volume":"49","author":"van Hulsteijn","year":"2012","journal-title":"J Med Genet"},{"key":"10.1016\/S2213-8587(23)00038-4_bib53","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1186\/1471-2407-14-523","article-title":"The size of the primary tumor and age at initial diagnosis are independent predictors of the metastatic behavior and survival of patients with SDHB-related pheochromocytoma and paraganglioma: a retrospective cohort study","volume":"14","author":"Schovanek","year":"2014","journal-title":"BMC Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib54","doi-asserted-by":"crossref","first-page":"3296","DOI":"10.1210\/jc.2017-00992","article-title":"Malignant pheochromocytoma and paraganglioma: 272 patients over 55 years","volume":"102","author":"Hamidi","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib55","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1007\/s00268-016-3846-x","article-title":"En bloc resection with major blood vessel reconstruction for locally invasive retroperitoneal paragangliomas: a 15-year experience with literature review","volume":"41","author":"Hu","year":"2017","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib56","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1097\/SLE.0b013e318059b9d4","article-title":"Laparoscopic resection of an extra-adrenal pheochromocytoma","volume":"17","author":"Castillo","year":"2007","journal-title":"Surg Laparosc Endosc Percutan Tech"},{"key":"10.1016\/S2213-8587(23)00038-4_bib57","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1016\/j.athoracsur.2012.02.040","article-title":"Contemporary surgical management of cardiac paragangliomas","volume":"93","author":"Ramlawi","year":"2012","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib58","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jamcollsurg.2013.04.027","article-title":"Response after surgical resection of metastatic pheochromocytoma and paraganglioma: can postoperative biochemical remission be predicted?","volume":"217","author":"Ellis","year":"2013","journal-title":"J Am Coll Surg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib59","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.wneu.2011.03.026","article-title":"Stereotactic radiosurgery as the primary treatment for new and recurrent paragangliomas: is open surgical resection still the treatment of choice?","volume":"77","author":"Lieberson","year":"2012","journal-title":"World Neurosurg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib60","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1227\/01.NEU.0000245596.46581.B2","article-title":"Gamma Knife radiosurgery for glomus jugulare tumors: volumetric analysis in 17 patients","volume":"59","author":"Varma","year":"2006","journal-title":"Neurosurgery"},{"key":"10.1016\/S2213-8587(23)00038-4_bib61","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/hed.22976","article-title":"Jugular and vagal paragangliomas: systematic study of management with surgery and radiotherapy","volume":"35","author":"Su\u00e1rez","year":"2013","journal-title":"Head Neck"},{"key":"10.1016\/S2213-8587(23)00038-4_bib62","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1002\/cncr.11118","article-title":"Stereotactic linear accelerater-based radiosurgery for the treatment of patients with glomus jugulare tumors","volume":"97","author":"Maarouf","year":"2003","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib63","first-page":"228","article-title":"Treatment of head and neck paragangliomas","volume":"23","author":"Hu","year":"2016","journal-title":"Cancer Contr"},{"key":"10.1016\/S2213-8587(23)00038-4_bib64","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s12094-010-0467-y","article-title":"Successful treatment of glomus jugulare tumours with Gamma Knife radiosurgery: clinical and physical aspects of management and review of the literature","volume":"12","author":"Navarro Mart\u00edn","year":"2010","journal-title":"Clin Transl Oncol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib65","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.3171\/2014.5.JNS131880","article-title":"Jugulotympanic paragangliomas treated with Gamma Knife radiosurgery: a single-center review of 58 cases","volume":"121","author":"Gand\u00eda-Gonz\u00e1lez","year":"2014","journal-title":"J Neurosurg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib66","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.ijrobp.2014.02.010","article-title":"Treatment of head and neck paragangliomas with external beam radiation therapy","volume":"89","author":"Dupin","year":"2014","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S2213-8587(23)00038-4_bib67","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MAO.0000000000002461","article-title":"Long-term outcomes for the treatment of paragangliomas in the upfront, adjuvant, and salvage settings with stereotactic radiosurgery and intensity-modulated radiotherapy","volume":"41","author":"Anderson","year":"2020","journal-title":"Otol Neurotol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib68","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.ccr.2005.07.014","article-title":"Engaging the vascular component of the tumor response","volume":"8","author":"Fuks","year":"2005","journal-title":"Cancer Cell"},{"key":"10.1016\/S2213-8587(23)00038-4_bib69","doi-asserted-by":"crossref","first-page":"E10","DOI":"10.3171\/foc.2004.17.2.10","article-title":"Stereotactic radiosurgery in patients with glomus jugulare tumors","volume":"17","author":"Pollock","year":"2004","journal-title":"Neurosurg Focus"},{"key":"10.1016\/S2213-8587(23)00038-4_bib70","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1007\/s10143-020-01292-5","article-title":"Stereotactic radiosurgery for head and neck paragangliomas: a systematic review and meta-analysis","volume":"44","author":"Fatima","year":"2021","journal-title":"Neurosurg Rev"},{"key":"10.1016\/S2213-8587(23)00038-4_bib71","doi-asserted-by":"crossref","first-page":"e497","DOI":"10.1016\/j.ijrobp.2011.05.006","article-title":"Radiosurgery of glomus jugulare tumors: a meta-analysis","volume":"81","author":"Guss","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S2213-8587(23)00038-4_bib72","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/MAO.0000000000001957","article-title":"Outcomes of primary radiosurgery treatment of glomus jugulare tumors: systematic review with meta-analysis","volume":"39","author":"Shapiro","year":"2018","journal-title":"Otol Neurotol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib73","doi-asserted-by":"crossref","first-page":"246","DOI":"10.3171\/2012.4.JNS11214","article-title":"Gamma knife surgery for the management of glomus tumors: a multicenter study","volume":"117","author":"Sheehan","year":"2012","journal-title":"J Neurosurg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib74","first-page":"91","article-title":"The role of Gamma Knife radiosurgery in the management of glomus jugular tumours","volume":"84","author":"Eustacchio","year":"2002","journal-title":"Acta Neurochir Suppl"},{"issue":"suppl","key":"10.1016\/S2213-8587(23)00038-4_bib75","doi-asserted-by":"crossref","first-page":"241","DOI":"10.3171\/jns.2005.102.s_supplement.0241","article-title":"Gamma Knife surgery for glomus jugulare tumors: an intermediate report on efficacy and safety","volume":"102","author":"Sheehan","year":"2005","journal-title":"J Neurosurg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib76","doi-asserted-by":"crossref","first-page":"57","DOI":"10.4103\/0028-3886.33299","article-title":"Gamma Knife radiosurgery for glomus jugulare tumors: therapeutic advantages of minimalism in the skull base","volume":"56","author":"Sharma","year":"2008","journal-title":"Neurol India"},{"key":"10.1016\/S2213-8587(23)00038-4_bib77","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00701-020-04251-7","article-title":"LINAC radiosurgery for glomus jugulare tumors: retrospective\u2014cohort study of 23 patients","volume":"162","author":"Lior","year":"2020","journal-title":"Acta Neurochir"},{"key":"10.1016\/S2213-8587(23)00038-4_bib78","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1016\/j.radonc.2010.09.004","article-title":"Linac-based stereotactic body radiation therapy for treatment of glomus jugulare tumors","volume":"97","author":"Wegner","year":"2010","journal-title":"Radiother Oncol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib79","doi-asserted-by":"crossref","first-page":"109","DOI":"10.7785\/tcrt.2012.500303","article-title":"Robotic stereotactic radiosurgery in patients with unresectable glomus jugulare tumors","volume":"12","author":"Hurmuz","year":"2013","journal-title":"Technol Cancer Res Treat"},{"key":"10.1016\/S2213-8587(23)00038-4_bib80","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1002\/hed.26497","article-title":"Long term outcomes with linear accelerator stereotactic radiosurgery for treatment of jugulotympanic paragangliomas","volume":"43","author":"Patel","year":"2021","journal-title":"Head Neck"},{"key":"10.1016\/S2213-8587(23)00038-4_bib81","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1007\/s00405-013-2384-5","article-title":"Carotid body paragangliomas: a systematic study on management with surgery and radiotherapy","volume":"271","author":"Su\u00e1rez","year":"2014","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib82","doi-asserted-by":"crossref","first-page":"R291","DOI":"10.1530\/ERC-13-0223","article-title":"The management of head-and-neck paragangliomas","volume":"20","author":"Capatina","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib83","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1016\/j.ijrobp.2006.02.020","article-title":"Long-term results of irradiation for paraganglioma","volume":"65","author":"Krych","year":"2006","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S2213-8587(23)00038-4_bib84","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/hed.2880120405","article-title":"Radiation or surgery for chemodectoma of the temporal bone: a review of local control and complications","volume":"12","author":"Springate","year":"1990","journal-title":"Head Neck"},{"key":"10.1016\/S2213-8587(23)00038-4_bib85","doi-asserted-by":"crossref","first-page":"e66","DOI":"10.1055\/s-0040-1718408","article-title":"Radiation-induced malignant peripheral nerve sheath tumor of the vagus nerve following radiation treatment of cervical paraganglioma","volume":"81","author":"Lekovic","year":"2020","journal-title":"J Neurol Surg Rep"},{"key":"10.1016\/S2213-8587(23)00038-4_bib86","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.adro.2017.11.002","article-title":"External beam radiation therapy for advanced\/unresectable malignant paraganglioma and pheochromocytoma","volume":"3","author":"Breen","year":"2017","journal-title":"Adv Radiat Oncol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib87","doi-asserted-by":"crossref","first-page":"166","DOI":"10.3389\/fonc.2014.00166","article-title":"External beam radiation therapy in treatment of malignant pheochromocytoma and paraganglioma","volume":"4","author":"Vogel","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib88","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1055\/s-0032-1308992","article-title":"External beam radiation therapy (EBRT) for patients with malignant pheochromocytoma and non-head and -neck paraganglioma: combination with 131I-MIBG","volume":"44","author":"Fishbein","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(23)00038-4_bib89","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/cen.13284","article-title":"Preoperative alpha-blockade in phaeochromocytoma and paraganglioma: is it always necessary?","volume":"86","author":"Isaacs","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib90","first-page":"5153","article-title":"Dopamine excess in patients with head and neck paragangliomas","volume":"30","author":"van der Horst-Schrivers","year":"2010","journal-title":"Anticancer Res"},{"key":"10.1016\/S2213-8587(23)00038-4_bib91","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.anchir.2006.05.004","article-title":"Malignant hereditary paraganglioma: problems raised by non-functional forms management","volume":"131","author":"Bonnet","year":"2006","journal-title":"Ann Chir"},{"key":"10.1016\/S2213-8587(23)00038-4_bib92","doi-asserted-by":"crossref","first-page":"2068","DOI":"10.1210\/jc.2004-2025","article-title":"Biochemical and clinical manifestations of dopamine-producing paragangliomas: utility of plasma methoxytyramine","volume":"90","author":"Eisenhofer","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib93","first-page":"e89","article-title":"Dopamine-secreting phaeochromocytomas and paragangliomas: clinical features and management","volume":"51","author":"Foo","year":"2010","journal-title":"Singapore Med J"},{"key":"10.1016\/S2213-8587(23)00038-4_bib94","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.256","article-title":"Re-evaluating the prevalence and factors characteristic of catecholamine secreting head and neck paragangliomas","volume":"4","author":"Smith","year":"2021","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib95","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1002\/hed.24857","article-title":"Baroreceptor reflex failure: review of the literature and the potential impact on patients with head and neck cancer","volume":"39","author":"Shah-Becker","year":"2017","journal-title":"Head Neck"},{"key":"10.1016\/S2213-8587(23)00038-4_bib96","doi-asserted-by":"crossref","first-page":"3088","DOI":"10.1210\/clinem\/dgaa441","article-title":"Approach to the patient: perioperative management of the patient with pheochromocytoma or sympathetic paraganglioma","volume":"105","author":"Berends","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib97","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.1210\/clinem\/dgz188","article-title":"Efficacy of \u03b1-blockers on hemodynamic control during pheochromocytoma resection: a randomized controlled trial","volume":"105","author":"Buitenwerf","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib98","doi-asserted-by":"crossref","first-page":"4069","DOI":"10.1210\/jc.2007-1720","article-title":"Preoperative management of the pheochromocytoma patient","volume":"92","author":"Pacak","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib99","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1016\/j.jvs.2019.08.232","article-title":"Tumor-specific prognosis of mutation-positive patients with head and neck paragangliomas","volume":"71","author":"Sen","year":"2020","journal-title":"J Vasc Surg"},{"key":"10.1016\/S2213-8587(23)00038-4_bib100","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1021420","article-title":"Silent pheochromocytoma and paraganglioma: systematic review and proposed definitions for standardized terminology","volume":"13","author":"Constantinescu","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib101","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0033","article-title":"European Society of Endocrinology Clinical Practice guideline for long-term follow-up of patients operated on for a phaeochromocytoma or a paraganglioma","volume":"174","author":"Plouin","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib102","doi-asserted-by":"crossref","first-page":"342","DOI":"10.4158\/EP161377.OR","article-title":"Growth rate of paragangliomas related to germline mutations of the SDHx genes","volume":"23","author":"Micha\u0142owska","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(23)00038-4_bib103","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1055\/s-0037-1604347","article-title":"Age and tumor volume predict growth of carotid and vagal body paragangliomas","volume":"78","author":"Heesterman","year":"2017","journal-title":"J Neurol Surg B Skull Base"},{"key":"10.1016\/S2213-8587(23)00038-4_bib104","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1038\/ejhg.2015.36","article-title":"No evidence for increased mortality in SDHD variant carriers compared with the general population","volume":"23","author":"van Hulsteijn","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S2213-8587(23)00038-4_bib105","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/cen.12223","article-title":"No difference in phenotype of the main Dutch SDHD founder mutations","volume":"79","author":"van Hulsteijn","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib106","doi-asserted-by":"crossref","first-page":"e1301","DOI":"10.1210\/clinem\/dgaa888","article-title":"Screening of a large cohort of asymptomatic SDHx mutation carriers in routine practice","volume":"106","author":"Saie","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib107","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1677\/ERC-09-0024","article-title":"Pheochromocytomas and extra-adrenal paragangliomas detected by screening in patients with SDHD-associated head-and-neck paragangliomas","volume":"16","author":"Havekes","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib108","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1038\/s41431-018-0116-4","article-title":"Clinical progression and metachronous paragangliomas in a large cohort of SDHD germline variant carriers","volume":"26","author":"Heesterman","year":"2018","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S2213-8587(23)00038-4_bib109","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1038\/s41574-021-00492-3","article-title":"International consensus on initial screening and follow-up of asymptomatic SDHx mutation carriers","volume":"17","author":"Amar","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib110","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1210\/js.2017-00230","article-title":"Radiological surveillance screening in asymptomatic succinate dehydrogenase mutation carriers","volume":"1","author":"Tufton","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(23)00038-4_bib111","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/cen.13877","article-title":"Can subunit-specific phenotypes guide surveillance imaging decisions in asymptomatic SDH mutation carriers?","volume":"90","author":"Tufton","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib112","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.ejca.2021.01.008","article-title":"Consensus on molecular imaging and theranostics in neuroendocrine neoplasms","volume":"146","author":"Ambrosini","year":"2021","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib113","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/jc.2013-1907","article-title":"One-year progression-free survival of therapy-I patients with malignant pheochromocytoma and paraganglioma","volume":"98","author":"Hescot","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00038-4_bib114","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.1158\/1078-0432.CCR-20-3703","article-title":"High-specific-activity-131I-MIBG versus 177Lu-DOTATATE targeted radionuclide therapy for metastatic pheochromocytoma and paraganglioma","volume":"27","author":"Jha","year":"2021","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(23)00038-4_bib115","doi-asserted-by":"crossref","first-page":"R627","DOI":"10.1530\/ERC-19-0165","article-title":"Molecular imaging and radionuclide therapy of pheochromocytoma and paraganglioma in the era of genomic characterization of disease subgroups","volume":"26","author":"Ta\u00efeb","year":"2019","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib116","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1111\/cen.14106","article-title":"Peptide receptor radionuclide therapy in the management of advanced pheochromocytoma and paraganglioma: a systematic review and meta-analysis","volume":"91","author":"Satapathy","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib117","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1002\/cncr.23812","article-title":"Treatment of malignant pheochromocytoma\/paraganglioma with cyclophosphamide, vincristine, and dacarbazine: recommendation from a 22-year follow-up of 18 patients","volume":"113","author":"Huang","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib118","doi-asserted-by":"crossref","first-page":"267","DOI":"10.7326\/0003-4819-109-4-267","article-title":"Malignant pheochromocytoma: effective treatment with a combination of cyclophosphamide, vincristine, and dacarbazine","volume":"109","author":"Averbuch","year":"1988","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(23)00038-4_bib119","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/cen.12542","article-title":"Chemotherapy with cyclophosphamide, vincristine and dacarbazine for malignant paraganglioma and pheochromocytoma: systematic review and meta-analysis","volume":"81","author":"Niemeijer","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib120","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1007\/s12672-017-0284-7","article-title":"Controlling tumor progression with cyclophosphamide, vincristine, and dacarbazine treatment improves survival in patients with metastatic and unresectable malignant pheochromocytomas\/paragangliomas","volume":"8","author":"Asai","year":"2017","journal-title":"Horm Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib121","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/cen.12590","article-title":"Treatment of malignant phaeochromocytoma with a combination of cyclophosphamide, vincristine and dacarbazine: own experience and overview of the contemporary literature","volume":"82","author":"Deutschbein","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib122","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s12672-013-0133-2","article-title":"Combination chemotherapy with cyclophosphamide, vincristine, and dacarbazine in patients with malignant pheochromocytoma and paraganglioma","volume":"4","author":"Tanabe","year":"2013","journal-title":"Horm Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib123","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1007\/s10571-018-0579-4","article-title":"Continued tumor reduction of metastatic pheochromocytoma\/paraganglioma harboring succinate dehydrogenase subunit B mutations with cyclical chemotherapy","volume":"38","author":"Jawed","year":"2018","journal-title":"Cell Mol Neurobiol"},{"issue":"suppl 5","key":"10.1016\/S2213-8587(23)00038-4_bib124","doi-asserted-by":"crossref","first-page":"S621","DOI":"10.1016\/j.annonc.2021.08.702","article-title":"First International Randomized Study in Malignant Progressive Pheochromocytoma and Paragangliomas (FIRSTMAPPP): an academic double-blind trial investigating sunitinib","volume":"32","author":"Baudin","year":"2021","journal-title":"Ann Oncol"},{"key":"10.1016\/S2213-8587(23)00038-4_bib125","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1038\/s41416-019-0474-x","article-title":"A phase 2 trial of sunitinib in patients with progressive paraganglioma or pheochromocytoma: the SNIPP trial","volume":"120","author":"O'Kane","year":"2019","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib126","doi-asserted-by":"crossref","first-page":"2711","DOI":"10.1002\/ijc.28913","article-title":"SDHB mutations are associated with response to temozolomide in patients with metastatic pheochromocytoma or paraganglioma","volume":"135","author":"Hadoux","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib127","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1530\/ERC-21-0392","article-title":"SDHx mutations and temozolomide in malignant pheochromocytoma and paraganglioma","volume":"29","author":"Perez","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(23)00038-4_bib128","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1210\/jc.2012-4231","article-title":"Bone metastases and skeletal-related events in patients with malignant pheochromocytoma and sympathetic paraganglioma","volume":"98","author":"Ayala-Ramirez","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:07Z","timestamp":1761991927000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000384"}},"issued":{"date-parts":[[2023,5]]},"references-count":128,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2213858723000384"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00038-4","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742598842.793600842","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical consensus guideline on the management of phaeochromocytoma and paraganglioma in patients harbouring germline SDHD pathogenic variants","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00038-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T11:34:16Z","timestamp":1793446456803,"version":"4.5.0"},"reference-count":48,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging (NIA)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","doi-asserted-by":"publisher","award":["U01AG022132"],"award-info":[{"award-number":["U01AG022132"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","doi-asserted-by":"publisher","award":["U01AG020478"],"award-info":[{"award-number":["U01AG020478"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","doi-asserted-by":"publisher","award":["U01AG020487"],"award-info":[{"award-number":["U01AG020487"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)","doi-asserted-by":"publisher","award":["U01AG020480"],"award-info":[{"award-number":["U01AG020480"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"name":"NIH General Clinical Research Center","award":["RR00036"],"award-info":[{"award-number":["RR00036"]}]},{"name":"Diabetes Research Training Center","award":["DK20579"],"award-info":[{"award-number":["DK20579"]}]},{"name":"NIH Clinical Nutrition Research Unit","award":["DK56341"],"award-info":[{"award-number":["DK56341"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/s2213-8587(19)30151-2","type":"journal-article","created":{"date-parts":[[2019,7,11]],"date-time":"2019-07-11T18:44:42Z","timestamp":1562870682000},"page":"673-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":408,"title":["2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial"],"prefix":"10.1016","volume":"7","author":[{"given":"William E","family":"Kraus","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjushri","family":"Bhapkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim M","family":"Huffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl F","family":"Pieper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sai","family":"Krupa Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne M","family":"Redman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis T","family":"Villareal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Rochon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan B","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Ravussin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John O","family":"Holloszy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30151-2_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1161\/CIR.0000000000000366","article-title":"Executive summary: heart disease and stroke statistics\u20142016 update: a report from the American Heart Association","volume":"133","author":"Mozaffarian","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30151-2_bib2","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1126\/science.1173635","article-title":"Calorie restriction delays disease onset and mortality in rhesus monkeys","volume":"325","author":"Colman","year":"2009","journal-title":"Science"},{"key":"10.1016\/S2213-8587(19)30151-2_bib3","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms4557","article-title":"Calorie restriction reduces age-related and all-cause mortality in rhesus monkeys","volume":"5","author":"Colman","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(19)30151-2_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms14063","article-title":"Calorie restriction improves health and survival of rhesus monkeys","volume":"8","author":"Mattison","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(19)30151-2_bib5","doi-asserted-by":"crossref","first-page":"6659","DOI":"10.1073\/pnas.0308291101","article-title":"Long-term calorie restriction is highly effective in reducing the risk for atherosclerosis in humans","volume":"101","author":"Fontana","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(19)30151-2_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1016\/j.jacc.2005.08.069","article-title":"Long-term calorie restriction ameliorates the decline in diastolic function in humans","volume":"47","author":"Meyer","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30151-2_bib7","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1111\/j.1474-9726.2012.00825.x","article-title":"Calorie restriction may reverse age-related autonomic decline in humans","volume":"11","author":"Stein","year":"2012","journal-title":"Aging Cell"},{"key":"10.1016\/S2213-8587(19)30151-2_bib8","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJMoa064278","article-title":"HDL cholesterol, very low levels of LDL cholesterol, and cardiovascular events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30151-2_bib9","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1056\/NEJM199910073411501","article-title":"Body-mass index and mortality in a prospective cohort of U.S. adults","volume":"341","author":"Calle","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30151-2_bib10","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30151-2_bib11","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1056\/NEJMoa042000","article-title":"Statin therapy, LDL cholesterol, C-reactive protein, and coronary artery disease","volume":"352","author":"Nissen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30151-2_bib12","doi-asserted-by":"crossref","first-page":"2142","DOI":"10.1016\/j.jacc.2004.03.046","article-title":"Optimal low-density lipoprotein is 50 to 70 mg\/dl: lower is better and physiologically normal","volume":"43","author":"O'Keefe","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30151-2_bib13","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJMoa050080","article-title":"Normal fasting plasma glucose levels and type 2 diabetes in young men","volume":"353","author":"Tirosh","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30151-2_bib14","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1161\/CIRCULATIONAHA.105.548206","article-title":"Prediction of lifetime risk for cardiovascular disease by risk factor burden at 50 years of age","volume":"113","author":"Lloyd-Jones","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30151-2_bib15","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1093\/gerona\/glv057","article-title":"A 2-year randomized controlled trial of human calorie restriction: feasibility and effects on predictors of health span and longevity","volume":"70","author":"Ravussin","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(19)30151-2_bib16","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/gerona\/glq168","article-title":"Design and conduct of the CALERIE study: comprehensive assessment of the long-term effects of reducing intake of energy","volume":"66","author":"Rochon","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(19)30151-2_bib17","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.cct.2011.07.002","article-title":"The CALERIE study: design and methods of an innovative 25% calorie restriction intervention","volume":"32","author":"Rickman","year":"2011","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/S2213-8587(19)30151-2_bib18","doi-asserted-by":"crossref","first-page":"E441","DOI":"10.1152\/ajpendo.00290.2011","article-title":"Approaches for quantifying energy intake and %calorie restriction during calorie restriction interventions in humans: the multicenter CALERIE study","volume":"302","author":"Racette","year":"2012","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30151-2_bib19","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clinical Chem"},{"key":"10.1016\/S2213-8587(19)30151-2_bib20","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30151-2_bib21","doi-asserted-by":"crossref","first-page":"245","DOI":"10.2337\/diacare.18.2.245","article-title":"The use of areas under curves in diabetes research","volume":"18","author":"Allison","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30151-2_bib22","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1210\/en.2010-1164","article-title":"Comparison between surrogate indexes of insulin sensitivity\/resistance and hyperinsulinemic euglycemic glucose clamps in rhesus monkeys","volume":"152","author":"Lee","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(19)30151-2_bib23","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1111\/pedi.12303","article-title":"Triglyceride glucose index as a surrogate measure of insulin sensitivity in obese adolescents with normoglycemia, prediabetes, and type 2 diabetes mellitus: comparison with the hyperinsulinemic-euglycemic clamp","volume":"17","author":"Mohd Nor","year":"2016","journal-title":"Pediatric Diabetes"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(19)30151-2_bib24","doi-asserted-by":"crossref","first-page":"S212","DOI":"10.2337\/diabetes.51.2007.S212","article-title":"Accurate assessment of beta-cell function: the hyperbolic correction","volume":"51","author":"Bergman","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30151-2_bib25","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2337\/dc08-1478","article-title":"Oral disposition index predicts the development of future diabetes above and beyond fasting and 2-h glucose levels","volume":"32","author":"Utzschneider","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30151-2_bib26","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/j.amjcard.2011.04.037","article-title":"Comparison of aerobic versus resistance exercise training effects on metabolic syndrome (from the Studies of a Targeted Risk Reduction Intervention Through Defined Exercise-STRRIDE-AT\/RT)","volume":"108","author":"Bateman","year":"2011","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(19)30151-2_bib27","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1016\/j.amjcard.2007.07.027","article-title":"Exercise training amount and intensity effects on metabolic syndrome (from Studies of a Targeted Risk Reduction Intervention through Defined Exercise)","volume":"100","author":"Johnson","year":"2007","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(19)30151-2_bib28","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1002\/bimj.201100036","article-title":"Development of gatekeeping strategies in confirmatory clinical trials","volume":"53","author":"Dmitrienko","year":"2011","journal-title":"Biom J"},{"key":"10.1016\/S2213-8587(19)30151-2_bib29","doi-asserted-by":"crossref","first-page":"963","DOI":"10.2307\/2529876","article-title":"Random-effects models for longitudinal data","volume":"38","author":"Laird","year":"1982","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(19)30151-2_bib30","first-page":"1905","article-title":"Statistical principles for clinical trials: ICH harmonized tripartite guideline","volume":"18","author":"Group","year":"1999","journal-title":"Stats in Med"},{"key":"10.1016\/S2213-8587(19)30151-2_bib31","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/j.conctc.2016.10.005","article-title":"Application of the marginal structural model to account for suboptimal adherence in a randomized controlled trial","volume":"4","author":"Rochon","year":"2016","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/S2213-8587(19)30151-2_bib32","doi-asserted-by":"crossref","first-page":"913","DOI":"10.3945\/ajcn.116.137232","article-title":"Body-composition changes in the Comprehensive Assessment of Long-term Effects of Reducing Intake of Energy (CALERIE)-2 study: a 2-y randomized controlled trial of calorie restriction in nonobese humans","volume":"105","author":"Das","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(19)30151-2_bib33","doi-asserted-by":"crossref","first-page":"19124","DOI":"10.18632\/oncotarget.8093","article-title":"Safety of two-year calorie restriction in non-obese healthy individuals","volume":"7","author":"Romashkan","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/S2213-8587(19)30151-2_bib34","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.cell.2015.01.036","article-title":"A century of cholesterol and coronaries: from plaques to genes to statins","volume":"161","author":"Goldstein","year":"2015","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(19)30151-2_bib35","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1161\/CIRCULATIONAHA.107.717033","article-title":"Preventing heart disease in the 21st century: implications of the Pathobiological Determinants of Atherosclerosis in Youth (PDAY) study","volume":"117","author":"McGill","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30151-2_bib36","doi-asserted-by":"crossref","first-page":"137","DOI":"10.7326\/0003-4819-153-3-201008030-00004","article-title":"Nonoptimal lipids commonly present in young adults and coronary calcium later in life: the CARDIA (Coronary Artery Risk Development in Young Adults) study","volume":"153","author":"Pletcher","year":"2010","journal-title":"Annals Intern Med"},{"key":"10.1016\/S2213-8587(19)30151-2_bib37","doi-asserted-by":"crossref","first-page":"3143","DOI":"10.1161\/circ.106.25.3143","article-title":"Third Report of the National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, and Treatment of High Blood Cholesterol in Adults (Adult Treatment Panel III) final report","volume":"106","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30151-2_bib38","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1001\/archinte.161.3.361","article-title":"Low triglycerides-high high-density lipoprotein cholesterol and risk of ischemic heart disease","volume":"161","author":"Jeppesen","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(19)30151-2_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.7326\/0003-4819-147-6-200709180-00007","article-title":"Changes in triglyceride levels and risk for coronary heart disease in young men","volume":"147","author":"Tirosh","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(19)30151-2_bib40","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(19)30151-2_bib41","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1111\/acel.12103","article-title":"Life-long calorie restriction reduces oxidative stress and preserves nitric oxide bioavailability and function in arteries of old mice","volume":"12","author":"Donato","year":"2013","journal-title":"Aging Cell"},{"key":"10.1016\/S2213-8587(19)30151-2_bib42","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.2337\/dc13-2668","article-title":"Demonstration of the central role of insulin resistance in type 2 diabetes and cardiovascular disease","volume":"37","author":"Kraemer","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30151-2_bib43","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tabak","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30151-2_bib44","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s10549-014-3076-6","article-title":"Metabolic syndrome and breast cancer prognosis","volume":"147","author":"Berrino","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S2213-8587(19)30151-2_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/189384","article-title":"Metabolic syndrome is associated with increased breast cancer risk: a systematic review with meta-analysis","volume":"2014","author":"Bhandari","year":"2014","journal-title":"Int J Breast Cancer"},{"key":"10.1016\/S2213-8587(19)30151-2_bib46","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCRESAHA.116.301313","article-title":"Inflammation and immunity in diseases of the arterial tree: players and layers","volume":"116","author":"Libby","year":"2015","journal-title":"Circulation Res"},{"key":"10.1016\/S2213-8587(19)30151-2_bib47","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1126\/science.1230720","article-title":"Anti-inflammatory therapy in chronic disease: challenges and opportunities","volume":"339","author":"Tabas","year":"2013","journal-title":"Science"},{"key":"10.1016\/S2213-8587(19)30151-2_bib48","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1161\/01.CIR.0000052939.59093.45","article-title":"Markers of inflammation and cardiovascular disease: application to clinical and public health practice: a statement for healthcare professionals from the Centers for Disease Control and Prevention and the American Heart Association","volume":"107","author":"Pearson","year":"2003","journal-title":"Circulation"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301512?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301512?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:25Z","timestamp":1761991645000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301512"}},"issued":{"date-parts":[[2019,9]]},"references-count":48,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S2213858719301512"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30151-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"2 years of calorie restriction and cardiometabolic risk (CALERIE): exploratory outcomes of a multicentre, phase 2, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30151-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30196-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T22:50:14Z","timestamp":1793832614344,"version":"4.6.1"},"reference-count":86,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/s2213-8587(14)70142-1","type":"journal-article","created":{"date-parts":[[2014,8,3]],"date-time":"2014-08-03T23:15:15Z","timestamp":1407107715000},"page":"216-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":396,"title":["Diagnosis and management of adrenal insufficiency"],"prefix":"10.1016","volume":"3","author":[{"given":"Irina","family":"Bancos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70142-1_bib1","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2265.1994.tb02790.x","article-title":"Eighty-six cases of Addison's disease","volume":"41","author":"Kong","year":"1994","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib2","first-page":"1762","article-title":"Is the prevalence of Addison's disease underestimated?","volume":"84","author":"Laureti","year":"1999","journal-title":"J Clin Endocrinol Med"},{"key":"10.1016\/S2213-8587(14)70142-1_bib3","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1046\/j.1365-2265.2002.t01-1-01552.x","article-title":"High prevalence and increasing incidence of Addison's disease in western Norway","volume":"56","author":"Lovas","year":"2002","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib4","doi-asserted-by":"crossref","first-page":"4882","DOI":"10.1210\/jc.2009-1368","article-title":"Clinical, immunological, and genetic features of autoimmune primary adrenal insufficiency: observations from a Norwegian registry","volume":"94","author":"Erichsen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib5","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitairism","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70142-1_bib6","series-title":"On the constitutional and local effects of disease of the suprarenal capsules","author":"Addison","year":"1855"},{"key":"10.1016\/S2213-8587(14)70142-1_bib7","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(00)82745-2","article-title":"The use of synthetic desoxycorticosterone acetate in Addison's disease","volume":"232","author":"Simpson","year":"1938","journal-title":"Lancet"},{"issue":"suppl 68","key":"10.1016\/S2213-8587(14)70142-1_bib8","first-page":"S5","article-title":"History of the development of corticosteroid therapy","volume":"29","author":"Benedek","year":"2011","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib9","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(03)13492-7","article-title":"Adrenal insufficiency","volume":"361","author":"Arlt","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70142-1_bib10","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1210\/edrv.23.3.0466","article-title":"Autoimmune adrenal insufficiency and autoimmune polyendocrine syndromes: autoantibodies, autoantigens, and their applicability in diagnosis and disease prediction","volume":"23","author":"Betterle","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(14)70142-1_bib11","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nrendo.2011.245","article-title":"Autoimmune Addison disease: pathophysiology and genetic complexity","volume":"8","author":"Mitchell","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib12","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1210\/jcem.87.2.8192","article-title":"Autoimmune adrenocortical failure in Norway autoantibodies and human antigen class II associations related to clinical features","volume":"87","author":"Myhre","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain","volume":"55","author":"Regal","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70142-1_bib14","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1056\/NEJM199201233260403","article-title":"The effect of long-term glucocorticoid therapy on pituitary-adrenal responses to exogenous corticotropin-releasing hormone","volume":"326","author":"Schlaghecke","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70142-1_bib15","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0140-6736(99)06290-X","article-title":"Suppression and recovery of adrenal response after short-term, high-dose glucocorticoid treatment","volume":"355","author":"Henzen","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70142-1_bib16","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1210\/jc.2012-2851","article-title":"Mitotane therapy in adrenocortical cancer induces CYP3A4 and inhibits 5alpha-reductase, explaining the need for personalized glucocorticoid and androgen replacement","volume":"98","author":"Chortis","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib17","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1097\/MAJ.0b013e3181db6b7a","article-title":"Delayed diagnosis of adrenal insufficiency is common: a cross-sectional study in 216 patients","volume":"339","author":"Bleicken","year":"2010","journal-title":"Am J Med Sci"},{"key":"10.1016\/S2213-8587(14)70142-1_bib18","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1210\/jcem.83.5.4831","article-title":"Comparison of low and high dose corticotropin stimulation tests in patients with pituitary disease","volume":"83","author":"Mayenknecht","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib19","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1210\/jc.2008-2380","article-title":"Modified-release hydrocortisone to provide circadian cortisol profiles","volume":"94","author":"Debono","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib20","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1111\/j.1365-2265.2010.03807.x","article-title":"Autoimmunity predominates in a large South African cohort with Addison's disease of mainly European descent despite long-standing disease and is associated with HLA DQB*0201","volume":"73","author":"Ross","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib21","doi-asserted-by":"crossref","first-page":"528","DOI":"10.7326\/0003-4819-91-4-528","article-title":"The polyglandular failure syndrome: disease inheritance, HLA type, and immune function","volume":"91","author":"Eisenbarth","year":"1979","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(14)70142-1_bib22","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1530\/eje.0.1480609","article-title":"Severe hyponatremia due to hypopituitarism with adrenal insufficiency: report on 28 cases","volume":"148","author":"Diederich","year":"2003","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib23","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/eje.1.01911","article-title":"Evaluation of adrenal function in patients with growth hormone deficiency and hypothalamic-pituitary disorders: comparison between insulin-induced hypoglycemia, low-dose ACTH, standard ACTH and CRH stimulation tests","volume":"152","author":"Maghnie","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib24","doi-asserted-by":"crossref","first-page":"194","DOI":"10.7326\/0003-4819-139-3-200308050-00017","article-title":"Diagnosis of adrenal insufficiency","volume":"139","author":"Dorin","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(14)70142-1_bib25","first-page":"259","article-title":"Diagnosis and therapy surveillance in Addison's disease: rapid adenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone","volume":"75","author":"Oelkers","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib26","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.1988.03720050044021","article-title":"Rapid assessment of corticotropin reserve after pituitary surgery","volume":"259","author":"Watts","year":"1988","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70142-1_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1046\/j.1365-2265.1997.d01-1748.x","article-title":"Which patients benefit from provocative adrenal testing after transsphenoidal pituitary surgery?","volume":"46","author":"Auchus","year":"1997","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70142-1_bib28","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1210\/jc.2005-1131","article-title":"The long\u2013term predictive accuracy of the short synacthen (corticotropin) stimulation test for assessment of the hypothalamic-pituitary-adrenal axis","volume":"91","author":"Agha","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1365-2265.2008.03466.x","article-title":"Factors determining inadequate hypoglycemia during insulin tolerance testing (ITT) after pituitary surgery","volume":"71","author":"Lee","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70142-1_bib30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1530\/EJE-09-0997","article-title":"Recovery of pituitary function in the late-postoperative phase after pituitary surgery: results of dynamic testing in patients with pituitary disease by insulin tolerance test 3 and 12 months after surgery","volume":"162","author":"Berg","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib31","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1016\/0140-6736(92)91829-W","article-title":"21-Hydroxylase, a major autoantigen in idiopathic Addison's disease","volume":"339","author":"Winqvist","year":"1992","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70142-1_bib32","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/1097-0142(1950)3:1<74::AID-CNCR2820030111>3.0.CO;2-7","article-title":"Metastases in carcinoma; analysis of 1000 autopsied cases","volume":"3","author":"Abrams","year":"1950","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(14)70142-1_bib33","first-page":"49","article-title":"The apparent free cortisol concentration and the free cortisol index: a comparative study","volume":"25","author":"Brien","year":"1981","journal-title":"J Nucl Med Allied Sci"},{"key":"10.1016\/S2213-8587(14)70142-1_bib34","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1111\/j.1365-2265.2006.02451.x","article-title":"Low-dose ACTH (1microg) salivary test: a potential alternative to the classical blood test","volume":"64","author":"Marcus-Perlman","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib35","doi-asserted-by":"crossref","first-page":"3866","DOI":"10.1210\/jc.2006-1049","article-title":"Assessment of adrenal reserve in pregnancy: defining the normal response to the adrenocorticotropin stimulation test","volume":"91","author":"Suri","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib36","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1177\/0004563213509793","article-title":"Assessment of endogenous, oral and inhaled steroid cross-reactivity in the Roche cortisol immunoassay","volume":"51","author":"Stokes","year":"2013","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/S2213-8587(14)70142-1_bib37","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.ejim.2013.05.014","article-title":"Why glucocorticoid withdrawal may sometimes be as dangerous as the treatment itself","volume":"24","author":"Dinsen","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/S2213-8587(14)70142-1_bib38","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1183\/09031936.00016908","article-title":"Adrenal suppression in bronchiectasis and the impact of inhaled corticosteroids","volume":"32","author":"Holme","year":"2008","journal-title":"Eur Respir J"},{"key":"10.1016\/S2213-8587(14)70142-1_bib39","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1136\/adc.2005.087247","article-title":"Adrenal responses to low dose synthetic ACTH (Synacthen) in children receiving high dose inhaled fluticasone","volume":"91","author":"Paton","year":"2006","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(14)70142-1_bib40","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1159\/000094645","article-title":"Adrenal function improves in asthmatic children on inhaled steroids: a longitudinal study","volume":"13","author":"Priftis","year":"2006","journal-title":"Neuroimmunomodulation"},{"key":"10.1016\/S2213-8587(14)70142-1_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry","volume":"72","author":"Esteban","year":"1991","journal-title":"JCEM"},{"key":"10.1016\/S2213-8587(14)70142-1_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.2004.02106.x","article-title":"Weight-related dosing, timing and monitoring hydrocortisone replacement therapy in patients with adrenal insufficiency","volume":"61","author":"Mah","year":"2004","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib43","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1111\/j.1365-2265.2006.02473.x","article-title":"Quality of glucocorticoid replacement in adrenal insufficiency: clinical assessment vs. timed serum cortisol measurements","volume":"64","author":"Arlt","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib44","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1472-6823-12-8","article-title":"Current practice of glucocorticoid replacement therapy and patient-perceived health outcomes in adrenal insufficiency \u2013 a worldwide patient survey","volume":"12","author":"Forss","year":"2012","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(14)70142-1_bib45","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1365-2265.2006.02544.x","article-title":"Circadian hydrocortisone infusions in patients with adrenal insufficiency and congenital adrenal hyperplasia","volume":"65","author":"Merza","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70142-1_bib46","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/cen.12316","article-title":"An oral multiparticulate, modified-release, hydrocortisone replacement therapy that provides physiological cortisol exposure","volume":"80","author":"Whitaker","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70142-1_bib47","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1210\/jc.2009-1752","article-title":"High-calorie glucose-rich food attenuates neuroglycopenic symptoms in patients with Addison's disease","volume":"95","author":"Klement","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib48","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1111\/joim.12162","article-title":"Consensus statement on the diagnosis, treatment and follow-up of patients with primary adrenal insufficiency","volume":"275","author":"Husebye","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(14)70142-1_bib49","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1210\/jcem-59-3-551","article-title":"Age changes and sex differences in serum dehydroepiandrosterone sulfate concentrations throughout adulthood","volume":"59","author":"Orentreich","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib50","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3109\/07435800009048561","article-title":"DHEA replacement in women with adrenal insufficiency\u2013\u2013pharmacokinetics, bioconversion and clinical effects on well-being, sexuality and cognition","volume":"26","author":"Arlt","year":"2000","journal-title":"Endocr Res"},{"key":"10.1016\/S2213-8587(14)70142-1_bib51","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1515\/JPEM.2005.18.4.355","article-title":"Androgen replacement in adolescents and young women with hypopituitarism","volume":"18","author":"Bilger","year":"2005","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib52","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/j.1365-2265.2006.02648.x","article-title":"Dehydroepiandrosterone (DHEA) replacement reduces growth hormone (GH) dose requirement in female hypopituitary patients on GH replacement","volume":"65","author":"Brooke","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70142-1_bib53","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1210\/jc.2008-1982","article-title":"Effects of dehydroepiandrosterone therapy on pubic hair growth and psychological well-being in adolescent girls and young women with central adrenal insufficiency: a double-blind, randomized, placebo-controlled phase III trial","volume":"94","author":"Binder","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib54","first-page":"4650","article-title":"Improvement in mood and fatigue after dehydroepiandrosterone replacement in Addison's disease in a randomized, double blind trial","volume":"85","author":"Hunt","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib55","doi-asserted-by":"crossref","first-page":"E1927","DOI":"10.1210\/jc.2012-1680","article-title":"Adrenal steroidogenesis after B lymphocyte depletion therapy in new\u2013onset Addison's disease","volume":"97","author":"Pearce","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib56","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/ajt.12296","article-title":"The first simultaneous kidney\u2013adrenal gland\u2013pancreas transplantation: outcome at 1 year","volume":"13","author":"Vouillarmet","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(14)70142-1_bib57","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1210\/jc.2013-2449","article-title":"Residual adrenal function in autoimmune addison's disease: improvement after tetracosactide (ACTH1\u201324) treatment","volume":"99","author":"Gan","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib58","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-09-0559","article-title":"Adrenal crisis in treated Addison's disease: a predictable but under-managed event","volume":"162","author":"White","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib59","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1530\/EJE-09-0884","article-title":"Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies","volume":"162","author":"Hahner","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib60","doi-asserted-by":"crossref","first-page":"e6333","DOI":"10.1136\/bmj.e6333","article-title":"How to avoid precipitating an acute adrenal crisis","volume":"345","author":"Wass","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70142-1_bib61","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1530\/EJE-12-1057","article-title":"Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency","volume":"169","author":"Hahner","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib62","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/0140-6736(90)90289-H","article-title":"Self-management of adrenal insufficiency by rectal hydrocortisone","volume":"335","author":"Newrick","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70142-1_bib63","doi-asserted-by":"crossref","first-page":"4354","DOI":"10.1210\/jc.2010-0445","article-title":"Sexuality and fertility in women with Addison's disease","volume":"95","author":"Erichsen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib64","doi-asserted-by":"crossref","first-page":"5249","DOI":"10.1210\/jc.2010-0108","article-title":"Addison's disease in women is a risk factor for an adverse pregnancy outcome","volume":"95","author":"Bjornsdottir","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib65","doi-asserted-by":"crossref","first-page":"1533","DOI":"10.1210\/jc.2010-2395","article-title":"A longitudinal study of plasma and urinary cortisol in pregnancy and postpartum","volume":"96","author":"Jung","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib66","doi-asserted-by":"crossref","unstructured":"Demey-Ponsart E, Foidart J, Sulon J, Sodoyez J. Serum CBG, free and total cortisol and circadian patterns of adrenal function in normal pregnancy. J Steroid Biochem 982; 16: 165\u201369.","DOI":"10.1016\/0022-4731(82)90163-7"},{"key":"10.1016\/S2213-8587(14)70142-1_bib67","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1196\/annals.1290.016","article-title":"Maternal and fetal hypothalamic\u2013pituitary\u2013adrenal axes during pregnancy and postpartum","volume":"997","author":"Mastorakos","year":"2003","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(14)70142-1_bib68","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1111\/cen.12097","article-title":"What is the best diagnostic and therapeutic management strategy for an Addison patient during pregnancy?","volume":"78","author":"Lebbe","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70142-1_bib69","doi-asserted-by":"crossref","first-page":"207","DOI":"10.7326\/0003-4819-120-3-199402010-00005","article-title":"Effect of glucocorticoid replacement therapy on bone mineral density in patients with Addison disease","volume":"120","author":"Zelissen","year":"1994","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(14)70142-1_bib70","first-page":"212","article-title":"Therapeutic strategies in adrenal insufficiency","volume":"62","author":"Oelkers","year":"2001","journal-title":"Ann Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib71","doi-asserted-by":"crossref","first-page":"3912","DOI":"10.1210\/jc.2007-0685","article-title":"Impaired subjective health status in 256 patients with adrenal insufficiency on standard therapy based on cross\u2013sectional analysis","volume":"92","author":"Hahner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib72","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/nrn2914","article-title":"The crucial role of pulsatile activity of the HPA axis for continuous dynamic equilibration","volume":"11","author":"Lightman","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/S2213-8587(14)70142-1_bib73","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1038\/ncb1922","article-title":"Ultradian hormone stimulation induces glucocorticoid receptor-mediated pulses of gene transcription","volume":"11","author":"Stavreva","year":"2009","journal-title":"Nat Cell Biol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib74","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1530\/EJE-12-0351","article-title":"Effects of standard glucocorticoid replacement therapies on subjective well-being: a randomized, double-blind, crossover study in patients with secondary adrenal insufficiency","volume":"167","author":"Benson","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib75","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/EJE-07-0052","article-title":"Continuous subcutaneous hydrocortisone infusion in Addison's disease","volume":"157","author":"Lovas","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib76","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-08-0550","article-title":"Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death","volume":"160","author":"Erichsen","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70142-1_bib77","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","article-title":"Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency","volume":"69","author":"Bensing","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70142-1_bib78","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison's disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib79","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitairism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib80","first-page":"1247","article-title":"The daily cortisol production reinvestigated in healthy men. The serum and urinary cortisol production rates are not significantly different","volume":"83","author":"Kraan","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib81","doi-asserted-by":"crossref","first-page":"E1938","DOI":"10.1210\/jc.2012-2432","article-title":"Glucocorticoid replacement and mortality in patients with nonfunctioning pituitary adenoma","volume":"97","author":"Zueger","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib82","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact ofglucocorticoid replacement regimenson metabolic outcome and comorbidity in hypopituitary patients","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib83","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1007\/BF03345773","article-title":"Metabolic and cardiovascular profile in patients with Addison's disease under conventional glucocorticoid replacement","volume":"32","author":"Giordano","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(14)70142-1_bib84","first-page":"3082","article-title":"Metabolic effects of short-term elevations of plasma cortisol are more pronounced in the evening than in the morning","volume":"84","author":"Plat","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70142-1_bib85","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2796.2011.02352.x","article-title":"Risk of hip fracture in Addison's disease: a population-based cohort study","volume":"270","author":"Bjornsdottir","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(14)70142-1_bib86","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1210\/jc.2011-2036","article-title":"Bone mineral density is not significantly reduced in adult patients onlow-dose glucocorticoid replacement therapy","volume":"97","author":"Koetz","year":"2012","journal-title":"JCEM"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,31]],"date-time":"2024-05-31T21:13:38Z","timestamp":1717190018000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701421"}},"issued":{"date-parts":[[2015,3]]},"references-count":86,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S2213858714701421"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70142-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diagnosis and management of adrenal insufficiency","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70142-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T06:54:43Z","timestamp":1792220083530,"version":"4.4.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/s2213-8587(15)00216-8","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T21:11:03Z","timestamp":1435612263000},"page":"498","source":"Crossref","is-referenced-by-count":15,"title":["Does midlife obesity really lower dementia risk?"],"prefix":"10.1016","volume":"3","author":[{"given":"Mika","family":"Kivim\u00e4ki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archana","family":"Singh-Manoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin J","family":"Shipley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexis","family":"Elbaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00216-8_bib1","doi-asserted-by":"crossref","first-page":"176","DOI":"10.7326\/0003-4819-153-3-201008030-00260","article-title":"National Institutes of Health State-of-the-Science Conference statement: preventing Alzheimer disease and cognitive decline","volume":"153","author":"Daviglus","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(15)00216-8_bib2","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(15)00033-9","article-title":"BMI and risk of dementia in two million people over two decades: a retrospective cohort study","volume":"3","author":"Qizilbash","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00216-8_bib3","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/S0140-6736(74)92783-4","article-title":"Cardiorespiratory disease and diabetes among middle-aged male civil servants","volume":"303","author":"Reid","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00216-8_bib4","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.neurobiolaging.2013.07.022","article-title":"Abdominal obesity and lower gray matter volume: a Mendelian randomization study","volume":"35","author":"Debette","year":"2014","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S2213-8587(15)00216-8_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3233\/JAD-2010-101068","article-title":"The obesity related gene, FTO, interacts with APOE, and is associated with Alzheimer's disease risk: a prospective cohort study","volume":"23","author":"Keller","year":"2011","journal-title":"J Alzheimers Dis"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,27]],"date-time":"2019-08-27T16:48:08Z","timestamp":1566924488000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002168"}},"issued":{"date-parts":[[2015,7]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2213858715002168"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00216-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,7]]}},{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T05:10:05Z","timestamp":1792300205846,"version":"4.4.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004562","name":"Minist\u00e8re de l&apos;Education Nationale, de l&apos;Enseignement Superieur et de la Recherche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004562","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/s2213-8587(13)70059-7","type":"journal-article","created":{"date-parts":[[2013,9,5]],"date-time":"2013-09-05T22:03:10Z","timestamp":1378418590000},"page":"199-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":103,"title":["Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study"],"prefix":"10.1016","volume":"1","author":[{"given":"Kanetee","family":"Busiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00e9verine","family":"Drunat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Vaivre-Douret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Bonnefond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albane","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Flechtner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"G\u00e9rard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nathalie","family":"Pouvreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Elie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revital","family":"Nimri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liat De","family":"Vries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Tubiana-Rufi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Metz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne-Marie","family":"Bertrand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvie","family":"Nivot-Adamiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"de Kerdanet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Stuckens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farida","family":"Jennane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierre-Fran\u00e7ois","family":"Souchon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claire Le","family":"Tallec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"D\u00e9sir\u00e9e","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aur\u00e9lie","family":"Dechaume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Jacques","family":"Robert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Phillip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rapha\u00ebl","family":"Scharfmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Czernichow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Froguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martine","family":"Vaxillaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Cav\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70059-7_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s00592-011-0331-8","article-title":"Minimal incidence of neonatal\/infancy onset diabetes in Italy is 1:90,000 live births","volume":"49","author":"Iafusco","year":"2012","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(13)70059-7_bib2","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1007\/s00125-009-1416-6","article-title":"Referral rates for diagnostic testing support an incidence of permanent neonatal diabetes in three European countries of at least 1 in 260,000 live births","volume":"52","author":"Slingerland","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70059-7_bib3","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/1750-1172-2-12","article-title":"Neonatal diabetes mellitus: a disease linked to multiple mechanisms","volume":"2","author":"Polak","year":"2007","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(13)70059-7_bib4","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s11154-010-9150-4","article-title":"6q24 transient neonatal diabetes","volume":"11","author":"Temple","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/S2213-8587(13)70059-7_bib5","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes","volume":"350","author":"Gloyn","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70059-7_bib6","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.2337\/diabetes.53.10.2719","article-title":"Kir6.2 mutations are a common cause of permanent neonatal diabetes in a large cohort of French patients","volume":"53","author":"Vaxillaire","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70059-7_bib7","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","article-title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus","volume":"355","author":"Babenko","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70059-7_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70059-7_bib9","doi-asserted-by":"crossref","first-page":"28414","DOI":"10.1074\/jbc.M110.215822","article-title":"Disruption of a novel Kruppel-like transcription factor p300-regulated pathway for insulin biosynthesis revealed by studies of the c.-331 INS mutation found in neonatal diabetes mellitus","volume":"286","author":"Bonnefond","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(13)70059-7_bib10","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1073\/pnas.0707291104","article-title":"Insulin gene mutations as a cause of permanent neonatal diabetes","volume":"104","author":"Stoy","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(13)70059-7_bib11","doi-asserted-by":"crossref","first-page":"3105","DOI":"10.1073\/pnas.0910533107","article-title":"Recessive mutations in the INS gene result in neonatal diabetes through reduced insulin biosynthesis","volume":"107","author":"Garin","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(13)70059-7_bib12","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.2337\/db07-1358","article-title":"Heterozygous missense mutations in the insulin gene are linked to permanent diabetes appearing in the neonatal period or in early-infancy: a report from the French ND Study Group","volume":"57","author":"Polak","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70059-7_bib13","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/j.tem.2010.03.004","article-title":"Neonatal diabetes mellitus: a model for personalized medicine","volume":"21","author":"Greeley","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70059-7_bib14","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.2337\/diabetes.49.8.1359","article-title":"Transient neonatal diabetes: widening the understanding of the etiopathogenesis of diabetes","volume":"49","author":"Temple","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70059-7_bib15","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1007\/s00125-013-2832-1","article-title":"Clinical presentation of 6q24 transient neonatal diabetes mellitus (6q24 TNDM) and genotype-phenotype correlation in an international cohort of patients","volume":"56","author":"Docherty","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70059-7_bib16","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1111\/j.1464-5491.2007.02373.x","article-title":"Sulphonylurea therapy improves cognition in a patient with the V59M KCNJ11 mutation","volume":"25","author":"Slingerland","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70059-7_bib17","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2337\/diabetes.54.9.2503","article-title":"Activating mutations in Kir6.2 and neonatal diabetes: new clinical syndromes, new scientific insights, and new therapy","volume":"54","author":"Hattersley","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70059-7_bib18","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1080\/87565641.2011.560696","article-title":"Subtypes of developmental coordination disorder: research on their nature and etiology","volume":"36","author":"Vaivre-Douret","year":"2011","journal-title":"Dev Neuropsychol"},{"key":"10.1016\/S2213-8587(13)70059-7_bib19","first-page":"61","article-title":"Fetal growth from the AUDIPOG study. I. Establishment of reference curves","volume":"25","author":"Mamelle","year":"1996","journal-title":"J Gynecol Obstet Biol Reprod (Paris)"},{"key":"10.1016\/S2213-8587(13)70059-7_bib20","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/db09-1091","article-title":"Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention","volume":"59","author":"Meur","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70059-7_bib21","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1002\/humu.20838","article-title":"Update of mutations in the genes encoding the pancreatic beta-cell K(ATP) channel subunits Kir6.2 (KCNJ11) and sulfonylurea receptor 1 (ABCC8) in diabetes mellitus and hyperinsulinism","volume":"30","author":"Flanagan","year":"2009","journal-title":"Hum Mutat"},{"key":"10.1016\/S2213-8587(13)70059-7_bib22","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2337\/db07-0043","article-title":"Mutations in ATP-sensitive K+ channel genes cause transient neonatal diabetes and permanent diabetes in childhood or adulthood","volume":"56","author":"Flanagan","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70059-7_bib23","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1007\/s00125-006-0246-z","article-title":"Mutations in KCNJ11, which encodes Kir6.2, are a common cause of diabetes diagnosed in the first 6 months of life, with the phenotype determined by genotype","volume":"49","author":"Flanagan","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70059-7_bib24","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1111\/j.1464-5491.2007.02140.x","article-title":"The majority of cases of neonatal diabetes in Spain can be explained by known genetic abnormalities","volume":"24","author":"Rica","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70059-7_bib25","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1111\/j.1399-5448.2008.00433.x","article-title":"Diagnosis and treatment of neonatal diabetes: a United States experience","volume":"9","author":"Stoy","year":"2008","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(13)70059-7_bib26","doi-asserted-by":"crossref","first-page":"3979","DOI":"10.1210\/jc.2007-0486","article-title":"Molecular basis of neonatal diabetes in Japanese patients","volume":"92","author":"Suzuki","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70059-7_bib27","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ng.187","article-title":"Hypomethylation of multiple imprinted loci in individuals with transient neonatal diabetes is associated with mutations in ZFP57","volume":"40","author":"Mackay","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(13)70059-7_bib28","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1056\/NEJM199509143331105","article-title":"Long-term course of neonatal diabetes","volume":"333","author":"von Muhlendahl","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70059-7_bib29","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0140-6736(12)60360-2","article-title":"Diabetes and cognitive dysfunction","volume":"379","author":"McCrimmon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70059-7_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.2337\/dc11-1469","article-title":"Clinical and metabolic features of adult-onset diabetes caused by ABCC8 mutations","volume":"35","author":"Riveline","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70059-7_bib31","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1126\/science.1186146","article-title":"Muscle dysfunction caused by a KATP channel mutation in neonatal diabetes is neuronal in origin","volume":"329","author":"Clark","year":"2010","journal-title":"Science"},{"key":"10.1016\/S2213-8587(13)70059-7_bib32","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/S0169-328X(03)00125-6","article-title":"Distribution of glucokinase, glucose transporter GLUT2, sulfonylurea receptor-1, glucagon-like peptide-1 receptor and neuropeptide Y messenger RNAs in rat brain by quantitative real time RT-PCR","volume":"113","author":"Li","year":"2003","journal-title":"Brain Res Mol Brain Res"},{"key":"10.1016\/S2213-8587(13)70059-7_bib33","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/cne.20469","article-title":"Pore-forming subunits of K-ATP channels, Kir6.1 and Kir6.2, display prominent differences in regional and cellular distribution in the rat brain","volume":"484","author":"Thomzig","year":"2005","journal-title":"J Comp Neurol"},{"key":"10.1016\/S2213-8587(13)70059-7_bib34","first-page":"32","article-title":"Distribution of single organ malformations in European populations","volume":"38","author":"Stoll","year":"1995","journal-title":"Ann Genet"},{"key":"10.1016\/S2213-8587(13)70059-7_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ejmg.2007.03.003","article-title":"A 2.6 Mb deletion of 6q24.3-25.1 in a patient with growth failure, cardiac septal defect, thin upperlip and asymmetric dysmorphic ears","volume":"50","author":"Caselli","year":"2007","journal-title":"Eur J Med Genet"},{"key":"10.1016\/S2213-8587(13)70059-7_bib36","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00431-009-1008-y","article-title":"DNA hypomethylation, transient neonatal diabetes, and prune belly sequence in one of two identical twins","volume":"169","author":"Laborie","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(13)70059-7_bib37","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1002\/ajh.20868","article-title":"Evidence for linkage of red blood cell size and count: genome-wide scans in the Framingham Heart Study","volume":"82","author":"Lin","year":"2007","journal-title":"Am J Hematol"},{"key":"10.1016\/S2213-8587(13)70059-7_bib38","doi-asserted-by":"crossref","first-page":"1091","DOI":"10.1016\/0002-9378(89)90167-1","article-title":"Plasma insulin in appropriate- and small-for-gestational-age fetuses","volume":"160","author":"Economides","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(13)70059-7_bib39","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1172\/JCI200419876","article-title":"Impaired glucose homeostasis in transgenic mice expressing the human transient neonatal diabetes mellitus locus, TNDM","volume":"114","author":"Ma","year":"2004","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70059-7_bib40","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.siny.2006.10.008","article-title":"Energy requirements","volume":"12","author":"Hulzebos","year":"2007","journal-title":"Semin Fetal Neonatal Med"},{"key":"10.1016\/S2213-8587(13)70059-7_bib41","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1210\/jcem-72-2-277","article-title":"Insulin resistance of puberty: a defect restricted to peripheral glucose metabolism","volume":"72","author":"Amiel","year":"1991","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:04:49Z","timestamp":1761991489000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700597"}},"issued":{"date-parts":[[2013,11]]},"references-count":41,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S2213858713700597"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70059-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70059-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70094-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:40:43Z","timestamp":1792784443982,"version":"4.5.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100003092","name":"Dutch Diabetes Research Foundation","doi-asserted-by":"crossref","award":["grant 2012.11.1500"],"award-info":[{"award-number":["grant 2012.11.1500"]}],"id":[{"id":"10.13039\/501100003092","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Netherlands Heart Foundation","award":["grant 2009T038"],"award-info":[{"award-number":["grant 2009T038"]}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/s2213-8587(13)70156-6","type":"journal-article","created":{"date-parts":[[2013,11,11]],"date-time":"2013-11-11T20:46:33Z","timestamp":1384202793000},"page":"210-217","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":139,"title":["Brown adipose tissue volume in healthy lean south Asian adults compared with white Caucasians: a prospective, case-controlled observational study"],"prefix":"10.1016","volume":"2","author":[{"given":"Leontine E H","family":"Bakker","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00ebtte R","family":"Boon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianne A D","family":"van der Linden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenka Pereira","family":"Arias-Bouda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan B","family":"van Klinken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frits","family":"Smit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hein J","family":"Verberne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jouke T","family":"Tamsma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louis M","family":"Havekes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter D","family":"van Marken Lichtenbelt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M","family":"Jazet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick C N","family":"Rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70156-6_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(13)70156-6_bib2","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1186\/1471-2458-8-271","article-title":"Prevalence of diabetes mellitus and the performance of a risk score among Hindustani Surinamese, African Surinamese and ethnic Dutch: a cross-sectional population-based study","volume":"8","author":"Bindraban","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(13)70156-6_bib3","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.2337\/dc10-2300","article-title":"Deriving ethnic-specific BMI cutoff points for assessing diabetes risk","volume":"34","author":"Chiu","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70156-6_bib4","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2337\/dc06-0003","article-title":"South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients","volume":"29","author":"Chandie Shaw","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70156-6_bib5","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1136\/jech.50.2.137","article-title":"Ethnic differences in mortality from cardiovascular disease in the UK: do they persist in people with diabetes?","volume":"50","author":"Chaturvedi","year":"1996","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(13)70156-6_bib6","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/0140-6736(91)91164-P","article-title":"Relation of central obesity and insulin resistance with high diabetes prevalence and cardiovascular risk in south Asians","volume":"337","author":"McKeigue","year":"1991","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70156-6_bib7","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.jpeds.2011.11.025","article-title":"E-Selectin is elevated in cord blood of south Asian neonates compared with Caucasian neonates","volume":"160","author":"Boon","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(13)70156-6_bib8","doi-asserted-by":"crossref","first-page":"e14197","DOI":"10.1371\/journal.pone.0014197","article-title":"Fat oxidation, fitness and skeletal muscle expression of oxidative\/lipid metabolism genes in south Asians: implications for insulin resistance?","volume":"5","author":"Hall","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70156-6_bib9","doi-asserted-by":"crossref","first-page":"10001","DOI":"10.1073\/pnas.1207911109","article-title":"Cold but not sympathomimetics activates human brown adipose tissue in vivo","volume":"109","author":"Cypess","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(13)70156-6_bib10","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1172\/JCI60433","article-title":"Brown adipose tissue oxidative metabolism contributes to energy expenditure during acute cold exposure in humans","volume":"122","author":"Ouellet","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70156-6_bib11","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa0808718","article-title":"Cold-activated brown adipose tissue in healthy men","volume":"360","author":"Van Marken Lichtenbelt","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70156-6_bib12","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/oby.2010.105","article-title":"Brown adipose tissue, whole-body energy expenditure, and thermogenesis in healthy adult men","volume":"19","author":"Yoneshiro","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(13)70156-6_bib13","doi-asserted-by":"crossref","first-page":"R285","DOI":"10.1152\/ajpregu.00652.2010","article-title":"Implications of nonshivering thermogenesis for energy balance regulation in humans","volume":"301","author":"Van Marken Lichtenbelt","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/S2213-8587(13)70156-6_bib14","doi-asserted-by":"crossref","first-page":"3395","DOI":"10.1172\/JCI68993","article-title":"Cold acclimation recruits brown fat and increases nonshivering thermogenesis","volume":"123","author":"Van der Lans","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70156-6_bib15","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa0810780","article-title":"Identification and importance of brown adipose tissue in adult humans","volume":"360","author":"Cypess","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70156-6_bib16","doi-asserted-by":"crossref","first-page":"e17247","DOI":"10.1371\/journal.pone.0017247","article-title":"Brown adipose tissue in morbidly obese subjects","volume":"6","author":"Vijgen","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70156-6_bib17","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1038\/nm.2297","article-title":"Brown adipose tissue controls triglyceride clearance","volume":"17","author":"Bartelt","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(13)70156-6_bib18","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1172\/JCI62308","article-title":"Brown adipose tissue regulates glucose homeostasis and insulin sensitivity","volume":"123","author":"Stanford","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70156-6_bib19","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.physbeh.2006.04.026","article-title":"Evaluation of wireless determination of skin temperature using iButtons","volume":"88","author":"van Marken Lichtenbelt","year":"2006","journal-title":"Physiol Behav"},{"key":"10.1016\/S2213-8587(13)70156-6_bib20","first-page":"E399","article-title":"Indirect calorimetry: methodological and interpretative problems","volume":"258","author":"Simonson","year":"1990","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(13)70156-6_bib21","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1177\/088453368600100106","article-title":"Beside measurement of resting energy expenditure and respiratory quotient via indirect calorimetry","volume":"1","author":"Feurer","year":"1986","journal-title":"Nutr Clin Prac"},{"key":"10.1016\/S2213-8587(13)70156-6_bib22","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1007\/s00125-013-2938-5","article-title":"Cold-induced activity of brown adipose tissue in young lean men of South-Asian and European origin","volume":"56","author":"Admiraal","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70156-6_bib23","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3945\/ajcn.113.059022","article-title":"Brown adipose tissue activity after a high-calorie meal in humans","volume":"98","author":"Vosselman","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70156-6_bib24","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.cmet.2011.06.012","article-title":"Different metabolic responses of human brown adipose tissue to activation by cold and insulin","volume":"14","author":"Orava","year":"2011","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(13)70156-6_bib25","doi-asserted-by":"crossref","first-page":"3106","DOI":"10.2337\/db12-0288","article-title":"Systemic beta-adrenergic stimulation of thermogenesis is not accompanied by brown adipose tissue activity in humans","volume":"6","author":"Vosselman","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70156-6_bib26","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.jchemneu.2009.06.001","article-title":"Anatomy of synaptic circuits controlling the activity of sympathetic preganglionic neurons","volume":"38","author":"Llewellyn-Smith","year":"2009","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/S2213-8587(13)70156-6_bib27","doi-asserted-by":"crossref","unstructured":"Bakker LEH, van Schinkel LD, Guigas B, et al. A 5-day high fat high calorie diet impairs insulin sensitivity in healthy, young south Asian men but not in Caucasian men. Diabetes (in press).","DOI":"10.2337\/db13-0696"},{"key":"10.1016\/S2213-8587(13)70156-6_bib28","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1242\/jeb.050989","article-title":"Nonshivering thermogenesis and its adequate measurement in metabolic studies","volume":"214","author":"Cannon","year":"2011","journal-title":"J Exp Biol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T09:30:36Z","timestamp":1564651836000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701566"}},"issued":{"date-parts":[[2014,3]]},"references-count":28,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S2213858713701566"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70156-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Brown adipose tissue volume in healthy lean south Asian adults compared with white Caucasians: a prospective, case-controlled observational study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70156-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70177-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:37:02Z","timestamp":1760985422116},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(15)00520-3","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T05:02:30Z","timestamp":1456376550000},"page":"958","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Perivascular fat in human muscle"],"prefix":"10.1016","volume":"4","author":[{"given":"Rick I","family":"Meijer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erik H","family":"Serne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S","family":"Yudkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Victor WM","family":"van Hinsbergh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yvo M","family":"Smulders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Etto C","family":"Eringa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715005203?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715005203?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T22:29:52Z","timestamp":1536964192000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715005203"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2213858715005203"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00520-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perivascular fat in human muscle","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00520-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T03:20:18Z","timestamp":1775186418701,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/s2213-8587(16)30329-1","type":"journal-article","created":{"date-parts":[[2016,12,6]],"date-time":"2016-12-06T19:46:37Z","timestamp":1481053597000},"page":"411-412","source":"Crossref","is-referenced-by-count":7,"title":["The challenges of harmonising the iodine supply across Europe"],"prefix":"10.1016","volume":"5","author":[{"given":"Sarah C","family":"Bath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30329-1_bib1","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10653-015-9682-3","article-title":"A review of the iodine status of UK pregnant women and its implications for the offspring","volume":"37","author":"Bath","year":"2015","journal-title":"Environ Geochem Health"},{"key":"10.1016\/S2213-8587(16)30329-1_bib2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(15)00212-0","article-title":"Costs and benefits of iodine supplementation for pregnant women in a mildly to moderately iodine-deficient population: a modelling analysis","volume":"3","author":"Monahan","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30329-1_bib3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S2213-8587(15)00263-6","article-title":"Iodine deficiency in pregnant women in Europe","volume":"9","author":"Zimmermann","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30329-1_bib4","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1089\/thy.2015.0543","article-title":"Ensuring effective prevention of iodine deficiency disorders","volume":"26","author":"Volzke","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30329-1_bib6","series-title":"Assessment of iodine deficiency disorders and monitoring their elimination","year":"2007"},{"key":"10.1016\/S2213-8587(16)30329-1_bib7","doi-asserted-by":"crossref","first-page":"29829","DOI":"10.3402\/fnr.v59.29829","article-title":"A model to secure a stable iodine concentration in milk","volume":"59","author":"Troan","year":"2015","journal-title":"Food Nutr Res"},{"key":"10.1016\/S2213-8587(16)30329-1_bib9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1753-4887.2012.00528.x","article-title":"Assessment of iodine nutrition in populations: past, present, and future","volume":"70","author":"Zimmermann","year":"2012","journal-title":"Nutr Rev"},{"key":"10.1016\/S2213-8587(16)30329-1_bib10","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3945\/ajcn.113.065854","article-title":"Effect of iodine supplementation in pregnancy on child development and other clinical outcomes: a systematic review of randomized controlled trials","volume":"98","author":"Zhou","year":"2013","journal-title":"Am J Clin Nutr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303291?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303291?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T01:20:52Z","timestamp":1536196852000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303291"}},"issued":{"date-parts":[[2017,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2213858716303291"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30329-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,6]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:17:20Z","timestamp":1761992240070,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/s2213-8587(23)00366-2","type":"journal-article","created":{"date-parts":[[2024,1,3]],"date-time":"2024-01-03T18:29:20Z","timestamp":1704306560000},"page":"92-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of medical students in humanitarian responses to armed conflict"],"prefix":"10.1016","volume":"12","author":[{"given":"Ji Won Susie","family":"Yoo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rahul D","family":"Barmanray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00366-2_bib2","doi-asserted-by":"crossref","first-page":"15","DOI":"10.5195\/ijms.2022.1468","article-title":"War on Ukraine: impact on Ukrainian medical students","volume":"10","author":"Srichawla","year":"2022","journal-title":"Int J Med Stud"},{"key":"10.1016\/S2213-8587(23)00366-2_bib3","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2213-8587(19)30083-X","article-title":"Challenges associated with providing diabetes care in humanitarian settings","volume":"7","author":"Boulle","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00366-2_bib4","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1097\/00001888-200101000-00022","article-title":"Curricular and extracurricular activities of medical students during war, Zagreb University School of Medicine, 1991-1995","volume":"76","author":"Glunci\u0107","year":"2001","journal-title":"Acad Med"},{"key":"10.1016\/S2213-8587(23)00366-2_bib5","doi-asserted-by":"crossref","first-page":"312","DOI":"10.5195\/ijms.2021.1165","article-title":"A medical student's volunteering experience during the second Nagorno-Karabakh War","volume":"9","author":"Ibrahimli","year":"2021","journal-title":"Int J Med Stud"},{"key":"10.1016\/S2213-8587(23)00366-2_bib6","article-title":"Noncommunicable diseases prevention in low- and middle-income countries: an overview of health in all policies (HiAP)","volume":"58","author":"Ndubuisi","year":"2021","journal-title":"Inquiry"},{"key":"10.1016\/S2213-8587(23)00366-2_bib7","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/ACM.0000000000001328","article-title":"The impact of project ECHO on participant and patient outcomes: a systematic review","volume":"91","author":"Zhou","year":"2016","journal-title":"Acad Med"},{"key":"10.1016\/S2213-8587(23)00366-2_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s41256-020-00182-z","article-title":"Community health workers for non-communicable diseases prevention and control in Bangladesh: a qualitative study","volume":"6","author":"Rawal","year":"2020","journal-title":"Glob Health Res Policy"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:30Z","timestamp":1761992010000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003662"}},"issued":{"date-parts":[[2024,2]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2213858723003662"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00366-2","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of medical students in humanitarian responses to armed conflict","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00366-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:46:24Z","timestamp":1767149184298,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(25)00029-4","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/s2213-8587(25)00065-8","type":"journal-article","created":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T12:55:50Z","timestamp":1741438550000},"page":"e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2025; 13: 175\u201376"],"prefix":"10.1016","volume":"13","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T16:14:38Z","timestamp":1747412078000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000658"}},"issued":{"date-parts":[[2025,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2213858725000658"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00065-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2025; 13: 175\u201376","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00065-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00029-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:48:12Z","timestamp":1767149292139,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(23)00093-1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/s2213-8587(23)00158-4","type":"journal-article","created":{"date-parts":[[2023,5,29]],"date-time":"2023-05-29T18:33:08Z","timestamp":1685385188000},"page":"e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2023; 11: 414\u201325"],"prefix":"10.1016","volume":"11","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:16Z","timestamp":1761991936000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001584"}},"issued":{"date-parts":[[2023,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2213858723001584"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00158-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2023; 11: 414\u201325","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00158-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00093-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:46:23Z","timestamp":1767149183997,"version":"build-2238731810"},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,24]],"date-time":"2017-11-24T00:00:00Z","timestamp":1511481600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/s2213-8587(17)30396-0","type":"journal-article","created":{"date-parts":[[2017,11,29]],"date-time":"2017-11-29T05:19:02Z","timestamp":1511932742000},"page":"82-83","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Diabetes and adiposity: a heavy load for cancer"],"prefix":"10.1016","volume":"6","author":[{"given":"Yikyung","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham A","family":"Colditz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30396-0_bib1","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1016\/S0140-6736(17)32152-9","article-title":"Global, regional, and national age-sex specific mortality for 264 causes of death, 1980-2016: a systematic analysis for the Global Burden of Disease Study 2016","volume":"390","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30396-0_bib2","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1001\/jamaoncol.2016.5688","article-title":"Global, regional, and national cancer incidence, mortality, years of life lost, years lived with disability, and disability-adjusted life-years for 32 cancer groups, 1990 to 2015: a systematic analysis for the Global Burden of Disease Study","volume":"3","author":"Fitzmaurice","year":"2017","journal-title":"JAMA Oncol"},{"key":"10.1016\/S2213-8587(17)30396-0_bib3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128.9 million children, adolescents, and adults","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30396-0_bib4","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30396-0_bib5","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S2213-8587(18)30150-5","article-title":"Worldwide burden of cancer attributable to diabetes and high body-mass index: a comparative risk assessment","volume":"6","author":"Pearson-Stuttard","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30396-0_bib6","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1093\/annonc\/mdv355","article-title":"Central adiposity, obesity during early adulthood, and pancreatic cancer mortality in a pooled analysis of cohort studies","volume":"26","author":"Genkinger","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/S2213-8587(17)30396-0_bib7","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1089\/thy.2015.0319","article-title":"Anthropometric factors and thyroid cancer risk by histological subtype: pooled analysis of 22 prospective studies","volume":"26","author":"Kitahara","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(17)30396-0_bib8","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/bjh.12935","article-title":"Body size and multiple myeloma mortality: a pooled analysis of 20 prospective studies","volume":"166","author":"Teras","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/S2213-8587(17)30396-0_bib9","article-title":"Body fatness at an early age and risk of colorectal cancer","author":"Hidayat","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(17)30396-0_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/cncr.30819","article-title":"Body mass index at adolescence and risk of noncardia gastric cancer in a cohort of 1.79 million men and women","author":"Levi","year":"2017","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(17)30396-0_bib11","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/nature09515","article-title":"Distant metastasis occurs late during the genetic evolution of pancreatic cancer","volume":"467","author":"Yachida","year":"2010","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(17)30396-0_bib12","doi-asserted-by":"crossref","first-page":"g7607","DOI":"10.1136\/bmj.g7607","article-title":"Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies","volume":"350","author":"Tsilidis","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30396-0_bib13","doi-asserted-by":"crossref","first-page":"g7707","DOI":"10.1136\/bmj.g7707","article-title":"Type 2 diabetes and risk of cancer","volume":"350","author":"Satija","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30396-0_bib14","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1038\/bjc.2016.37","article-title":"From obesity to diabetes and cancer: epidemiological links and role of therapies","volume":"114","author":"Garcia-Jimenez","year":"2016","journal-title":"Br J Cancer"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(18)30135-9","type":"correction","label":"Correction","source":"retraction-watch","updated":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T00:00:00Z","timestamp":1527033600000},"record-id":"41929"},{"DOI":"10.1016\/s2213-8587(17)30366-2","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303960?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303960?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T04:30:07Z","timestamp":1552969807000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303960"}},"issued":{"date-parts":[[2018,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S2213858717303960"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30396-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and adiposity: a heavy load for cancer","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30396-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30366-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:50Z","timestamp":1761991910508,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/s2213-8587(20)30165-0","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T20:33:20Z","timestamp":1590006800000},"page":"476","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Chantal Mathieu: coordinating networks to tackle type 1 diabetes"],"prefix":"10.1016","volume":"8","author":[{"given":"Jennifer","family":"Thorley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301650?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301650?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:32Z","timestamp":1761991652000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301650"}},"issued":{"date-parts":[[2020,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2213858720301650"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30165-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Chantal Mathieu: coordinating networks to tackle type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30165-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:48:22Z","timestamp":1767149302417,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(25)00067-1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/s2213-8587(25)00129-9","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:02:04Z","timestamp":1746061324000},"page":"e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2025; published online April 25. https:\/\/doi.org\/10.1016\/S2213-8587(25)00067-1"],"prefix":"10.1016","volume":"13","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T16:13:42Z","timestamp":1748016822000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725001299"}},"issued":{"date-parts":[[2025,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2213858725001299"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00129-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2025; published online April 25. https:\/\/doi.org\/10.1016\/S2213-8587(25)00067-1","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00129-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00067-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:47:26Z","timestamp":1762004846384},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/s2213-8587(17)30012-8","type":"journal-article","created":{"date-parts":[[2017,1,16]],"date-time":"2017-01-16T21:03:23Z","timestamp":1484600603000},"page":"236-238","source":"Crossref","is-referenced-by-count":15,"title":["Semaglutide: a promising new glucagon-like peptide-1 receptor agonist"],"prefix":"10.1016","volume":"5","author":[{"given":"Andr\u00e9 J","family":"Scheen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30012-8_bib1","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1038\/nrendo.2012.140","article-title":"GLP-1 receptor agonists for individualized treatment of type 2 diabetes mellitus","volume":"8","author":"Meier","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(17)30012-8_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(17)30013-X","article-title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre, phase 3a trial","author":"Sorli","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30012-8_bib3","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30012-8_bib4","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1016\/j.clinthera.2008.08.006","article-title":"Efficacy and tolerability of exenatide monotherapy over 24 weeks in antidiabetic drug-naive patients with type 2 diabetes: a randomized, double-blind, placebo-controlled, parallel-group study","volume":"30","author":"Moretto","year":"2008","journal-title":"Clin Ther"},{"key":"10.1016\/S2213-8587(17)30012-8_bib5","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(08)61246-5","article-title":"Liraglutide versus glimepiride monotherapy for type 2 diabetes (LEAD-3 Mono): a randomised, 52-week, phase III, double-blind, parallel-treatment trial","volume":"373","author":"Garber","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30012-8_bib6","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.2337\/dc11-1935","article-title":"Efficacy and safety of the once-daily GLP-1 receptor agonist lixisenatide in monotherapy: a randomized, double-blind, placebo-controlled trial in patients with type 2 diabetes (GetGoal-Mono)","volume":"35","author":"Fonseca","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30012-8_bib7","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2337\/dc11-1107","article-title":"Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study","volume":"35","author":"Russell-Jones","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30012-8_bib8","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1007\/s00125-015-3795-1","article-title":"Efficacy and safety of once-weekly GLP-1 receptor agonist albiglutide (HARMONY 2): 52 week primary endpoint results from a randomised, placebo-controlled trial in patients with type 2 diabetes mellitus inadequately controlled with diet and exercise","volume":"59","author":"Nauck","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30012-8_bib9","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.2337\/dc13-2759","article-title":"Efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes in a randomized controlled trial (AWARD-3)","volume":"37","author":"Umpierrez","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30012-8_bib10","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1016\/S0140-6736(14)61097-7","article-title":"Which incretin-based therapy for type 2 diabetes?","volume":"384","author":"Scheen","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30012-8_bib11","unstructured":"Davies M, Pieber TR, Jabbour S, Hartoft-Nielsen M-L, H\u00f8jbjerg Hansen OK, Rosenstock J. Dose-dependent glucose lowering and body weight reductions with the novel oral formulation of semaglutide in patients with early type 2 diabetes. Oral presentation at the 52nd annual meeting of the European Association for the Study of Diabetes, Munich, Germany; Sept 15, 2016, abstract 149."}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T22:27:26Z","timestamp":1536100046000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300128"}},"issued":{"date-parts":[[2017,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S2213858717300128"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30012-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,4]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:10Z","timestamp":1761991930759,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011725","name":"Servier","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011725","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/s2213-8587(20)30044-9","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:34:17Z","timestamp":1587580457000},"page":"353-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cardiovascular and heart failure outcomes with type 2 diabetes therapies: how important is weight loss?"],"prefix":"10.1016","volume":"8","author":[{"given":"Angelo","family":"Avogaro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gian Paolo","family":"Fadini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30044-9_bib1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30044-9_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30044-9_bib3","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1016\/S2213-8587(20)30038-3","article-title":"Glucose-lowering drugs or strategies, atherosclerotic cardiovascular events, and heart failure in people with or at risk of type 2 diabetes: an updated systematic review and meta-analysis of randomised cardiovascular outcome trials","volume":"8","author":"Ghosh-Swaby","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30044-9_bib4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1016\/j.jacc.2003.11.039","article-title":"Reverse epidemiology of conventional cardiovascular risk factors in patients with chronic heart failure","volume":"43","author":"Kalantar-Zadeh","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(20)30044-9_bib5","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1016\/j.jacc.2018.01.047","article-title":"Prevalent and incident heart failure in cardiovascular outcome trials of patients with type 2 diabetes","volume":"71","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(20)30044-9_bib6","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30044-9_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12933-017-0529-3","article-title":"Effects of the SGLT2 inhibitor dapagliflozin on HDL cholesterol, particle size, and cholesterol efflux capacity in patients with type 2 diabetes: a randomized placebo-controlled trial","volume":"16","author":"Fadini","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(20)30044-9_bib8","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/sim.1187","article-title":"How should meta-regression analyses be undertaken and interpreted?","volume":"21","author":"Thompson","year":"2002","journal-title":"Stat Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:17Z","timestamp":1761991697000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300449"}},"issued":{"date-parts":[[2020,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213858720300449"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30044-9","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular and heart failure outcomes with type 2 diabetes therapies: how important is weight loss?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30044-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30038-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T03:23:38Z","timestamp":1771557818063,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/s2213-8587(22)00315-1","type":"journal-article","created":{"date-parts":[[2022,12,10]],"date-time":"2022-12-10T18:32:04Z","timestamp":1670697124000},"page":"2-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Long-term bone health in childhood cancer survivors: underappreciated and undertreated?"],"prefix":"10.1016","volume":"11","author":[{"given":"Cornelia S","family":"Link-Rachner","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tilman D","family":"Rachner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00315-1_bib1","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1016\/S2213-8587(13)70203-1","article-title":"Endocrine aspects of bone metastases","volume":"2","author":"Hofbauer","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00315-1_bib2","doi-asserted-by":"crossref","first-page":"2916","DOI":"10.1200\/JCO.19.01696","article-title":"Management of osteoporosis in survivors of adult cancers with nonmetastatic disease: ASCO clinical practice guideline","volume":"37","author":"Shapiro","year":"2019","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(22)00315-1_bib3","article-title":"Risk and determinants of low and very low bone mineral density and fractures in a national cohort of Dutch adult childhood cancer survivors (DCCSS-LATER): a cross-sectional study","author":"van Atteveld","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00315-1_bib4","series-title":"Long term follow up of survivors of childhood cancer (SIGN publication 132)","year":"2013"},{"key":"10.1016\/S2213-8587(22)00315-1_bib5","series-title":"Richtlijn follow-up na kinderkanker meer dan 5 jar na diagnose","year":"2010"},{"key":"10.1016\/S2213-8587(22)00315-1_bib6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-8587(21)00173-X","article-title":"Bone mineral density surveillance for childhood, adolescent, and young adult cancer survivors: evidence-based recommendations from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"9","author":"van Atteveld","year":"2021","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:17Z","timestamp":1761991937000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003151"}},"issued":{"date-parts":[[2023,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213858722003151"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00315-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term bone health in childhood cancer survivors: underappreciated and undertreated?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00315-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00286-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:48Z","timestamp":1761991908635,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/s2213-8587(19)30389-4","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T20:31:52Z","timestamp":1576614712000},"page":"5-7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["LDL cholesterol: lower, faster, younger?"],"prefix":"10.1016","volume":"8","author":[{"given":"Amanda J","family":"Berberich","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert A","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30389-4_bib1","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S2213-8587(19)30388-2","article-title":"Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327 037 participants","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30389-4_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174 000 participants in 27 randomised trials","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30389-4_bib3","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jacc.2015.10.077","article-title":"Reduction in total cardiovascular events with ezetimibe\/simvastatin post-acute coronary syndrome: the IMPROVE-IT trial","volume":"67","author":"Murphy","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30389-4_bib4","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30389-4_bib5","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1016\/j.jacc.2019.03.513","article-title":"Efficacy and safety of evolocumab in chronic kidney disease in the FOURIER trial","volume":"73","author":"Charytan","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30389-4_bib6","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S2213-8587(17)30313-3","article-title":"Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial","volume":"5","author":"Sabatine","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30389-4_bib7","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30389-4_bib8","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1161\/CIRCULATIONAHA.118.034309","article-title":"Clinical benefit of evolocumab by severity and extent of coronary artery disease","volume":"138","author":"Sabatine","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30389-4_bib9","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S2213-8587(19)30264-5","article-title":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30389-4_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2019.3502","article-title":"Effect of 1 or 2 doses of inclisiran on low-density lipoprotein cholesterol levels: one-year follow-up of the ORION-1 randomized clinical trial","author":"Ray","year":"2019","journal-title":"JAMA Cardiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:29Z","timestamp":1761991649000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719303894"}},"issued":{"date-parts":[[2020,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2213858719303894"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30389-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"LDL cholesterol: lower, faster, younger?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30389-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30388-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:08:40Z","timestamp":1762459720379,"version":"build-2065373602"},"reference-count":11,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health grant","doi-asserted-by":"crossref","award":["NIDDK 32333"],"award-info":[{"award-number":["NIDDK 32333"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/s2213-8587(19)30188-3","type":"journal-article","created":{"date-parts":[[2019,6,3]],"date-time":"2019-06-03T19:37:06Z","timestamp":1559590626000},"page":"745-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Three generational phenotypes of sporadic primary hyperparathyroidism: evolution defined by technology"],"prefix":"10.1016","volume":"7","author":[{"given":"Cristiana","family":"Cipriani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John P","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30188-3_bib1","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1073\/pnas.49.5.613","article-title":"Immunoassay of bovine and human parathyroid hormone","volume":"49","author":"Berson","year":"1963","journal-title":"PNAS"},{"key":"10.1016\/S2213-8587(19)30188-3_bib2","first-page":"603","article-title":"Serum multichannel autoanalyzers in the detection of hypercalcemia and hyperparathyroidism","volume":"133","author":"Mays","year":"1971","journal-title":"Surg Gynecol Obstet"},{"key":"10.1016\/S2213-8587(19)30188-3_bib3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.1093\/clinchem\/33.8.1364","article-title":"Highly sensitive two-site immunoradiometric assay of parathyrin, and its clinical utility in evaluating patients with hypercalcemia","volume":"33","author":"Nussbaum","year":"1987","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(19)30188-3_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1359\/jbmr.2001.16.4.605","article-title":"Development of a novel immunoradiometric assay exclusively for biologically active whole parathyroid hormone 1\u201384: implications for improvement of accurate assessment of parathyroid function","volume":"16","author":"Gao","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30188-3_bib5","first-page":"158","article-title":"Primary hyperparathyroidism in women: a tale of two cities\u2014New York and Beijing","volume":"45","author":"Bilezikian","year":"2000","journal-title":"Int J Fertil Womens Med"},{"key":"10.1016\/S2213-8587(19)30188-3_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/jbmr.5650030104","article-title":"Bone density of the radius, spine, and proximal femur in osteoporosis","volume":"3","author":"Mazess","year":"1988","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30188-3_bib7","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1210\/jc.2008-2006","article-title":"Morphometric vertebral fractures in postmenopausal women with primary hyperparathyroidism","volume":"94","author":"Vignali","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30188-3_bib8","doi-asserted-by":"crossref","first-page":"1963","DOI":"10.1210\/jc.2012-4255","article-title":"Trabecular bone score (TBS)\u2014a novel method to evaluate bone microarchitectural texture in patients with primary hyperparathyroidism","volume":"98","author":"Silva","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30188-3_bib9","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1210\/jc.2014-3708","article-title":"Prevalence of kidney stones and vertebral fractures in primary hyperparathyroidism using imaging technology","volume":"100","author":"Cipriani","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30188-3_bib10","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/0002-9343(74)90812-2","article-title":"Parathyroid function in human vitamin D deficiency and vitamin D deficiency in primary hyperparathyroidism","volume":"56","author":"Lumb","year":"1974","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(19)30188-3_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/j.beem.2018.09.009","article-title":"Management of normocalcemic primary hyperparathyroidism","volume":"32","author":"Cusano","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301883?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301883?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:30Z","timestamp":1761991650000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301883"}},"issued":{"date-parts":[[2019,10]]},"references-count":11,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2213858719301883"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30188-3","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Three generational phenotypes of sporadic primary hyperparathyroidism: evolution defined by technology","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30188-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T22:36:18Z","timestamp":1789079778527,"version":"build-2803163510"},"reference-count":56,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/s2213-8587(13)70155-4","type":"journal-article","created":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T08:46:04Z","timestamp":1385109964000},"page":"197-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":71,"title":["Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double-blind, randomised, placebo-controlled trial"],"prefix":"10.1016","volume":"2","author":[{"given":"Raschida R","family":"Bouhouch","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabir","family":"Bouhouch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Cherkaoui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdelmounaim","family":"Aboussad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Stinca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Haldimann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael B","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70155-4_bib1","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.1056\/NEJM199412293312603","article-title":"Timing of vulnerability of the brain to iodine deficiency in endemic cretinism","volume":"331","author":"Cao","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70155-4_bib2","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/S0140-6736(96)12365-5","article-title":"Effect on infant mortality of iodination of irrigation water in a severely iodine-deficient area of China","volume":"350","author":"DeLong","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70155-4_bib3","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1089\/thy.1998.8.1185","article-title":"Screening for congenital hypothyroidism used as an indicator of the degree of iodine deficiency and of its control","volume":"8","author":"Delange","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70155-4_bib4","author":"Brown"},{"key":"10.1016\/S2213-8587(13)70155-4_bib5","doi-asserted-by":"crossref","first-page":"5217","DOI":"10.1210\/jc.2010-0975","article-title":"The Swiss iodized salt program provides adequate iodine for school children and pregnant women, but weaning infants not receiving iodine-containing complementary foods as well as their mothers are iodine deficient","volume":"95","author":"Andersson","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70155-4_bib6","series-title":"Assessment of iodine deficiency disorders and monitoring their elimination: a guide for programme managers","year":"2007"},{"key":"10.1016\/S2213-8587(13)70155-4_bib7","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1017\/S1368980007361004","article-title":"Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2-years-old: conclusions and recommendations of the Technical Consultation","volume":"10","author":"Andersson","year":"2007","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(13)70155-4_bib8","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1530\/eje.0.1300547","article-title":"Prevention of iodine deficiency disorders by oral administration of lipiodol during pregnancy","volume":"130","author":"Chaouki","year":"1994","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70155-4_bib9","series-title":"The prevention and control of iodine deficiency disorders","article-title":"Iodized oil in the treatment and prophylaxis of IDD","author":"Dunn","year":"1987"},{"key":"10.1016\/S2213-8587(13)70155-4_bib10","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/00005792-200101000-00003","article-title":"Physiology and pharmacology of iodized oil in goiter prophylaxis","volume":"80","author":"Wolff","year":"2001","journal-title":"Medicine"},{"key":"10.1016\/S2213-8587(13)70155-4_bib11","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1056\/NEJM199201233260405","article-title":"Efficacy of low oral doses of iodized oil in the control of iodine deficiency in Zaire","volume":"326","author":"Tonglet","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70155-4_bib12","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1093\/jn\/127.4.574","article-title":"Infant survival is improved by oral iodine supplementation","volume":"127","author":"Cobra","year":"1997","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(13)70155-4_bib13","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1440-1754.2010.01972.x","article-title":"Iodine-induced neonatal hypothyroidism secondary to maternal seaweed consumption: a common practice in some Asian cultures to promote breast milk supply","volume":"47","author":"Emder","year":"2011","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/S2213-8587(13)70155-4_bib14","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1097\/MED.0b013e3283565bb2","article-title":"Iodine-induced thyroid dysfunction","volume":"19","author":"Leung","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(13)70155-4_bib15","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/thy.2007.0279","article-title":"Reference values for spot urinary iodine concentrations in iodine-sufficient newborns using a new pad collection method","volume":"18","author":"Dorey","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70155-4_bib16","first-page":"2","article-title":"Etude de pr\u00e9valence des troubles dus a la carence iod\u00e9e chez les enfants ag\u00e9s de 6 a 12 ans au Maroc","volume":"7","author":"Chaouki","year":"1996","journal-title":"Bull Epid\u00e9miol"},{"key":"10.1016\/S2213-8587(13)70155-4_bib17","doi-asserted-by":"crossref","first-page":"744","DOI":"10.3945\/jn.111.149393","article-title":"Global iodine status in 2011 and trends over the past decade","volume":"142","author":"Andersson","year":"2012","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(13)70155-4_bib18","series-title":"WHO child growth standards. Head circumference-for-age, arm circumference-forage, triceps skinfold-for-age and subscapular skinfold-for-age: methods and development","year":"2007"},{"key":"10.1016\/S2213-8587(13)70155-4_bib19","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/0022-4405(94)90011-6","article-title":"Review of the Bayley Scales of Infant Development\u2014second edition","volume":"32","author":"Nellis","year":"1994","journal-title":"J Sch Psychol"},{"key":"10.1016\/S2213-8587(13)70155-4_bib20","series-title":"Encyclopedia of infant and early childhood development","article-title":"Bayley Scales of Infant Development","author":"Lennon","year":"2008"},{"key":"10.1016\/S2213-8587(13)70155-4_bib21","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1192\/bjp.150.6.782","article-title":"Detection of postnatal depression. Development of the 10-item Edinburgh Postnatal Depression Scale","volume":"150","author":"Cox","year":"1987","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S2213-8587(13)70155-4_bib22","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s00737-005-0069-9","article-title":"Prevalence of postpartum depression in a Moroccan sample","volume":"8","author":"Agoub","year":"2005","journal-title":"Arch Womens Ment Health"},{"key":"10.1016\/S2213-8587(13)70155-4_bib23","doi-asserted-by":"crossref","first-page":"a3166","DOI":"10.1136\/bmj.a3166","article-title":"Analysis of continuous data from small samples","volume":"33","author":"Bland","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70155-4_bib24","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/clinchem\/42.2.239","article-title":"Ammonium persulfate: a safe alternative oxidizing reagent for measuring urinary iodine","volume":"42","author":"Pino","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(13)70155-4_bib25","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/clinchem\/44.4.817","article-title":"Direct determination of urinary iodine by inductively coupled plasma mass spectrometry using isotope dilution with iodine-129","volume":"44","author":"Haldimann","year":"1998","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(13)70155-4_bib26","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1093\/clinchem\/32.6.1013","article-title":"Thyroid screening of neonates without use of radioactivity: evaluation of time-resolved fluoroimmunoassay of thyrotropin","volume":"32","author":"Torresani","year":"1986","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(13)70155-4_bib27","series-title":"Anthro for personal computers, version 2. Software for assessing growth and development of the world's children","year":"2007"},{"key":"10.1016\/S2213-8587(13)70155-4_bib28","series-title":"Research in congenital hypothyroidism","article-title":"Iodine nutrition and congenital hypothyroidism","author":"Delange","year":"1989"},{"key":"10.1016\/S2213-8587(13)70155-4_bib29","series-title":"Manual for the Bayley scales of infant development","author":"Bayley","year":"1993"},{"key":"10.1016\/S2213-8587(13)70155-4_bib30","unstructured":"Pinheiro J, Bates D, DebRoy S, Saikat D, Deepayan S, the R Development Core Team. nlme: linear and nonlinear mixed effects models, 2013."},{"key":"10.1016\/S2213-8587(13)70155-4_bib31","unstructured":"Bates D, Maechler M, Bolder BS. Lme4: linear mixed-effects models using S4 classes, 2013."},{"key":"10.1016\/S2213-8587(13)70155-4_bib32","series-title":"R: a language and environment for statistical computing","year":"2012"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(13)70155-4_bib33","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1365-3016.2012.01275.x","article-title":"The effects of iodine deficiency in pregnancy and infancy","volume":"26","author":"Zimmermann","year":"2012","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/S2213-8587(13)70155-4_bib34","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.3390\/nu5041384","article-title":"Iodine and mental development of children 5 years old and under: a systematic review and meta-analysis","volume":"5","author":"Bougma","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(13)70155-4_bib35","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.3945\/ajcn.113.065854","article-title":"Effect of iodine supplementation in pregnancy on child development and other clinical outcomes: a systematic review of randomized controlled trials","volume":"98","author":"Zhou","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70155-4_bib36","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1016\/S0140-6736(71)91040-3","article-title":"Neurological damage to the fetus resulting from severe iodine deficiency during pregnancy","volume":"297","author":"Pharoah","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70155-4_bib37","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(13)60436-5","article-title":"Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC)","volume":"382","author":"Bath","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70155-4_bib38","series-title":"Dietary reference intakes for vitamin A, vitamin K, arsenic, boron, chromium, copper, iodine, iron, manganese, molybdenum, nickel, silicon, vanadium, and zinc","year":"2001"},{"key":"10.1016\/S2213-8587(13)70155-4_bib39","series-title":"Basic medical laboratory techniques","author":"Estridge","year":"2000"},{"key":"10.1016\/S2213-8587(13)70155-4_bib40","series-title":"Recommended dietary allowances","year":"1989"},{"key":"10.1016\/S2213-8587(13)70155-4_bib41","doi-asserted-by":"crossref","first-page":"8115","DOI":"10.1021\/es801549w","article-title":"Intake of iodine and perchlorate and excretion in human milk","volume":"42","author":"Dasgupta","year":"2008","journal-title":"Environ Sci Technol"},{"key":"10.1016\/S2213-8587(13)70155-4_bib42","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1089\/thy.2012.0058","article-title":"Environmental perchlorate and thiocyanate exposures and infant serum thyroid function","volume":"22","author":"Leung","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70155-4_bib43","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1038\/78630","article-title":"The mammary gland iodide transporter is expressed during lactation and in breast cancer","volume":"6","author":"Tazebay","year":"2000","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(13)70155-4_bib44","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/j.1365-2265.2008.03442.x","article-title":"Breastfeeding and maternal and infant iodine nutrition","volume":"70","author":"Azizi","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(13)70155-4_bib45","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/sj.ejcn.1600992","article-title":"Changes in iodine metabolism during late pregnancy and lactation: a longitudinal study among Sudanese women","volume":"54","author":"Eltom","year":"2000","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70155-4_bib46","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3945\/ajcn.2010.29630","article-title":"Breast-milk iodine concentration declines over the first 6 mo postpartum in iodine-deficient women","volume":"92","author":"Mulrine","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70155-4_bib47","first-page":"484","article-title":"Oral iodine supplementation does not reduce neutralizing antibody responses to oral poliovirus vaccine","volume":"77","author":"Taffs","year":"1999","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(13)70155-4_bib48","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003819.pub2","article-title":"Iodine supplementation for preventing iodine deficiency disorders in children","volume":"2","author":"Angermayr","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(13)70155-4_bib49","first-page":"20","article-title":"Oral iodized oil for correcting iodine deficiency: optimal dosing and outcome indicator selection","volume":"79","author":"Benmiloud","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70155-4_bib50","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1093\/ajcn\/84.5.1208","article-title":"Efficacy of oral iodized peanut oil is greater than that of iodized poppy seed oil among Indonesian schoolchildren","volume":"84","author":"Untoro","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70155-4_bib51","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1038\/sj.ejcn.1600921","article-title":"Effect of oral iodized oil on thyroid size and thyroid hormone metabolism in children with concurrent selenium and iodine deficiency","volume":"54","author":"Zimmermann","year":"2000","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70155-4_bib52","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1093\/ajcn\/61.6.1257","article-title":"New model for describing urinary iodine excretion: its use for comparing different oral preparations of iodized oil","volume":"61","author":"Furnee","year":"1995","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70155-4_bib53","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70155-4_bib54","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/er.2009-0011","article-title":"Iodine deficiency","volume":"30","author":"Zimmermann","year":"2009","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(13)70155-4_bib55","doi-asserted-by":"crossref","first-page":"U25","DOI":"10.1530\/eje.0.151U025","article-title":"Role of thyroid hormone during early brain development","volume":"3","author":"Morreale de Escobar","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70155-4_bib56","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.jfca.2004.06.003","article-title":"Iodine content of food groups","volume":"18","author":"Haldimann","year":"2005","journal-title":"J Food Comp Anal"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,10]],"date-time":"2020-08-10T12:09:19Z","timestamp":1597061359000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701554"}},"issued":{"date-parts":[[2014,3]]},"references-count":56,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S2213858713701554"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70155-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double-blind, randomised, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70155-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70185-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:19:42Z","timestamp":1788023982248,"version":"build-2784847793"},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/s2213-8587(17)30439-4","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T23:43:15Z","timestamp":1513813395000},"page":"159-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["Treatment strategies for neuroischaemic diabetic foot ulcers"],"prefix":"10.1016","volume":"6","author":[{"given":"Fran","family":"Game","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30439-4_bib1","author":"Kerr"},{"key":"10.1016\/S2213-8587(17)30439-4_bib2","article-title":"Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial","author":"Edmonds","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30439-4_bib3","doi-asserted-by":"crossref","first-page":"S119","DOI":"10.1002\/dmrr.825","article-title":"A systematic review of the effectiveness of interventions to enhance the healing of chronic ulcers of the foot in diabetes","volume":"24","author":"Hinchliffe","year":"2008","journal-title":"Diabetes Metab Res Rev"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30439-4_bib4","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/dmrr.2246","article-title":"A systematic review of interventions to enhance the healing of chronic ulcers of the foot in diabetes","volume":"28","author":"Game","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30439-4_bib5","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/dmrr.2707","article-title":"International Working Group on the Diabetic Foot (IWGDF). Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review","volume":"32","author":"Game","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(17)30439-4_bib6","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2213-8587(16)30012-2","article-title":"Reporting standards of studies and papers on the prevention and management of foot ulcers in diabetes: required details and markers of good quality","volume":"4","author":"Jeffcoate","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30439-4_bib7","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00125-006-0491-1","article-title":"High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe: baseline results from the Eurodiale study","volume":"50","author":"Prompers","year":"2007","journal-title":"Diabetologia"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30439-4_bib9","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/dmrr.2694","article-title":"The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus","volume":"32","author":"Bakker","year":"2016","journal-title":"Diabetes Metab Res Rev"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T04:59:25Z","timestamp":1535173165000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717304394"}},"issued":{"date-parts":[[2018,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2213858717304394"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30439-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment strategies for neuroischaemic diabetic foot ulcers","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30439-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30438-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:05:22Z","timestamp":1787508322963,"version":"build-2736575974"},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/s2213-8587(22)00142-5","type":"journal-article","created":{"date-parts":[[2022,5,5]],"date-time":"2022-05-05T18:31:24Z","timestamp":1651775484000},"page":"373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Menopause: a turning point for women's health"],"prefix":"10.1016","volume":"10","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:30Z","timestamp":1761991890000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001425"}},"issued":{"date-parts":[[2022,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2213858722001425"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00142-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menopause: a turning point for women's health","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00142-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T01:45:57Z","timestamp":1785894357376,"version":"3.56.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009131","name":"Direktion f\u00fcr Entwicklung und Zusammenarbeit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022690","name":"Breakthrough T1D","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018939","name":"World Diabetes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100032559","name":"Breakthrough T1D","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100032559","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/s2213-8587(26)00002-1","type":"journal-article","created":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T23:52:28Z","timestamp":1778889148000},"page":"570-580","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Type 1 diabetes intervention clusters in resource-limited settings: a systematic review and economic evaluation"],"prefix":"10.1016","volume":"14","author":[{"given":"Sanjay","family":"Basu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica Hanae","family":"Zafra-Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00002-1_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00002-1_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.34172\/hpp.2020.18","article-title":"Prevalence and incidence of type 1 diabetes in the world: a systematic review and meta-analysis","volume":"10","author":"Mobasseri","year":"2020","journal-title":"Health Promot Perspect"},{"key":"10.1016\/S2213-8587(26)00002-1_bib3","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1007\/s00125-008-1167-9","article-title":"A sub-Saharan African perspective of diabetes","volume":"52","author":"Gill","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00002-1_bib4","series-title":"Global type 1 diabetes prevalence, incidence, and mortality estimates 2025","year":"2024"},{"key":"10.1016\/S2213-8587(26)00002-1_bib5","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1080\/17441692.2019.1611897","article-title":"Healthcare delivery for paediatric and adolescent diabetes in low resource settings: type 1 diabetes clinics in Uganda","volume":"14","author":"Bahendeka","year":"2019","journal-title":"Glob Public Health"},{"key":"10.1016\/S2213-8587(26)00002-1_bib6","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00002-1_bib7","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S2213-8587(17)30239-5","article-title":"Diabetes structured self-management education programmes: a narrative review and current innovations","volume":"6","author":"Chatterjee","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00002-1_bib8","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1016\/j.pec.2015.11.003","article-title":"Diabetes self-management education for adults with type 2 diabetes mellitus: a systematic review of the effect on glycemic control","volume":"99","author":"Chrvala","year":"2016","journal-title":"Patient Educ Couns"},{"key":"10.1016\/S2213-8587(26)00002-1_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1377\/hlthaff.20.6.64","article-title":"Improving chronic illness care: translating evidence into action","volume":"20","author":"Wagner","year":"2001","journal-title":"Health Aff"},{"key":"10.1016\/S2213-8587(26)00002-1_bib10","series-title":"Making choices in health: WHO guide to cost-effectiveness analysis","author":"Tan-Torres Edejer","year":"2003"},{"key":"10.1016\/S2213-8587(26)00002-1_bib11","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(26)00002-1_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-067975","article-title":"Consolidated health economic evaluation reporting standards 2022 (CHEERS 2022) statement: updated reporting guidance for health economic evaluations","volume":"376","author":"Husereau","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(26)00002-1_bib13","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(26)00002-1_bib14","article-title":"ROBINS-I: a tool for assessing risk of bias in non-randomised studies of interventions","volume":"355","author":"Sterne","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(26)00002-1_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D Exchange in 2016\u20132018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(26)00002-1_bib16","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2337\/dc12-1770","article-title":"Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D exchange clinic registry participants","volume":"36","author":"Miller","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00002-1_bib17","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1007\/BF00398055","article-title":"Microvascular and acute complications in IDDM patients: the EURODIAB IDDM complications study","volume":"37","year":"1994","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00002-1_bib18","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00002-1_bib19","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00002-1_bib20","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00002-1_bib21","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bmj.325.7367.746","article-title":"Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial","volume":"325","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(26)00002-1_bib22","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.2020.6940","article-title":"Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Laffel","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00002-1_bib23","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2009.12.026","article-title":"Nurse diabetes case management interventions and blood glucose control: results of a meta-analysis","volume":"88","author":"Welch","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(26)00002-1_bib24","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.2337\/dc16-0346","article-title":"Do mobile phone applications improve glycemic control (HbA1c) in the self-management of diabetes? A systematic review, meta-analysis, and GRADE of 14 randomized trials","volume":"39","author":"Hou","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00002-1_bib25","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.diabres.2012.03.015","article-title":"Diabetes Australia position statement. A new language for diabetes: improving communications with and about people with diabetes","volume":"97","author":"Speight","year":"2012","journal-title":"Diabetes Res Clin Pract"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000021?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000021?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T00:58:54Z","timestamp":1785891534000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000021"}},"issued":{"date-parts":[[2026,7]]},"references-count":25,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2213858726000021"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00002-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes intervention clusters in resource-limited settings: a systematic review and economic evaluation","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00002-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,7]],"date-time":"2026-07-07T10:46:03Z","timestamp":1783421163404,"version":"3.54.6"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/s2213-8587(19)30111-1","type":"journal-article","created":{"date-parts":[[2019,3,22]],"date-time":"2019-03-22T19:45:20Z","timestamp":1553283920000},"page":"338","source":"Crossref","is-referenced-by-count":11,"title":["Analogue insulin as an essential medicine: the need for more evidence and lower prices"],"prefix":"10.1016","volume":"7","author":[{"given":"David","family":"Beran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Hemmingsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S","family":"Yudkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30111-1_bib1","series-title":"Essential medicines and health products","year":"2017"},{"key":"10.1016\/S2213-8587(19)30111-1_bib2","series-title":"Comparative efficacy and safety of intermediate-acting, long-acting and biosimilar insulins for type 1 diabetes mellitus: application to the WHO Model List of Essential Medicines","author":"Tricco","year":"2018"},{"key":"10.1016\/S2213-8587(19)30111-1_bib3","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(15)00521-5","article-title":"Constraints and challenges in access to insulin: a global perspective","volume":"4","author":"Beran","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30111-1_bib4","series-title":"Insulin prices profile, April 2016","author":"Ewen","year":"2016"},{"key":"10.1016\/S2213-8587(19)30111-1_bib5","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00125-010-1897-3","article-title":"The insulin dilemma in resource-limited countries. A way forward?","volume":"54","author":"Gill","year":"2011","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:09:59Z","timestamp":1571098199000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301111"}},"issued":{"date-parts":[[2019,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2213858719301111"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30111-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,5]]}},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:41:37Z","timestamp":1786999297869,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/s2213-8587(20)30219-9","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T18:35:57Z","timestamp":1595356557000},"page":"656-658","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Type 1 diabetes and fasting in Ramadan: time to rethink classification of risk?"],"prefix":"10.1016","volume":"8","author":[{"given":"Sufyan","family":"Hussain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30219-9_bib1","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(19)31142-0","article-title":"Advances in technology for management of type 1 diabetes","volume":"394","author":"Beck","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30219-9_bib2","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.2337\/diacare.27.10.2306","article-title":"A population-based study of diabetes and its characteristics during the fasting month of Ramadan in 13 countries: results of the epidemiology of diabetes and Ramadan 1422\/2001 (EPIDIAR) study","volume":"27","author":"Salti","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30219-9_bib3","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.diabres.2017.03.003","article-title":"Diabetes and Ramadan: practical guidelines","volume":"126","author":"Hassanein","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(20)30219-9_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmjdrc-2020-001248","article-title":"Recommendations for management of diabetes during Ramadan: update 2020, applying the principles of the ADA\/EASD consensus","volume":"8","author":"Ibrahim","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(20)30219-9_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/pedi.12920","article-title":"ISPAD Clinical Practice Consensus Guidelines: fasting during Ramadan by young people with diabetes","volume":"21","author":"Deeb","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(20)30219-9_bib6","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.diabet.2014.11.004","article-title":"Glucose excursions and glycaemic control during Ramadan fasting in diabetic patients: insights from continuous glucose monitoring (CGM)","volume":"41","author":"Lessan","year":"2015","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(20)30219-9_bib7","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.diabres.2019.02.027","article-title":"Risk of diabetic ketoacidosis during Ramadan fasting: a critical reappraisal","volume":"151","author":"Beshyah","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(20)30219-9_bib8","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/dc11-1579","article-title":"Improved biomedical and psychological outcomes 1 year after structured education in flexible insulin therapy for people with type 1 diabetes: the U.K. DAFNE experience","volume":"35","author":"Hopkins","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30219-9_bib9","doi-asserted-by":"crossref","first-page":"849","DOI":"10.3389\/fendo.2019.00849","article-title":"Intermittent fasting could be safely achieved in people with type 1 diabetes undergoing structured education and advanced glucose monitoring","volume":"10","author":"Al-Ozairi","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(20)30219-9_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00592-019-01414-6","article-title":"Glucose control during Ramadan fasting in a teenager with type 1 diabetes on MiniMed 670G hybrid closed-loop system","volume":"57","author":"Petrovski","year":"2020","journal-title":"Acta Diabetol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:55Z","timestamp":1761991735000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720302199"}},"issued":{"date-parts":[[2020,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2213858720302199"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30219-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes and fasting in Ramadan: time to rethink classification of risk?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30219-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:41:37Z","timestamp":1786999297916,"version":"build-2736575974"},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/s2213-8587(25)00296-7","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:02:32Z","timestamp":1758952952000},"page":"897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["World Heart Day: diabetes and cardiovascular risk"],"prefix":"10.1016","volume":"13","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:10:53Z","timestamp":1774987853000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002967"}},"issued":{"date-parts":[[2025,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2213858725002967"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00296-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"World Heart Day: diabetes and cardiovascular risk","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00296-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00165-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00022-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00217-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:42:45Z","timestamp":1786999365244,"version":"build-2736575974"},"update-to":[{"DOI":"10.1016\/s2213-8587(22)00277-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/s2213-8587(22)00360-6","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T08:25:30Z","timestamp":1674635130000},"page":"e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Correction to Lancet Diabetes Endocrinol 2022; 10: 859\u201368"],"prefix":"10.1016","volume":"11","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003606?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003606?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:42Z","timestamp":1761991902000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003606"}},"issued":{"date-parts":[[2023,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2213858722003606"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00360-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2022; 10: 859\u201368","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00360-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00277-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:39:56Z","timestamp":1786999196003,"version":"build-2736575974"},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/s2213-8587(18)30347-4","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T06:29:29Z","timestamp":1548570569000},"page":"85","source":"Crossref","is-referenced-by-count":32,"title":["Vitamin D supplementation and musculoskeletal health"],"prefix":"10.1016","volume":"7","author":[{"given":"Heike A","family":"Bischoff-Ferrari","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E John","family":"Orav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Abderhalden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bess","family":"Dawson-Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30347-4_bib1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(18)30265-1","article-title":"Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis","volume":"6","author":"Bolland","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30347-4_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1007\/s00198-015-3386-5","article-title":"Calcium plus vitamin D supplementation and risk of fractures: an updated meta-analysis from the National Osteoporosis Foundation","volume":"27","author":"Weaver","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(18)30347-4_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa1109617","article-title":"A pooled analysis of vitamin D dose requirements for fracture prevention","volume":"367","author":"Bischoff-Ferrari","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30347-4_bib4","author":"Foundation"},{"key":"10.1016\/S2213-8587(18)30347-4_bib5","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","article-title":"Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial","volume":"303","author":"Sanders","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30347-4_bib6","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/rheumatology\/kem240","article-title":"Effect of annual intramuscular vitamin D on fracture risk in elderly men and women\u2014a population-based, randomized, double-blind, placebo-controlled trial","volume":"46","author":"Smith","year":"2007","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/S2213-8587(18)30347-4_bib7","article-title":"Vitamin D supplements and prevention of cancer and cardiovascular disease","author":"Manson","year":"2018","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T06:29:30Z","timestamp":1548570570000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303474"}},"issued":{"date-parts":[[2019,2]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2213858718303474"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30347-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,2]]}},{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T17:13:11Z","timestamp":1790356391968,"version":"4.1.0"},"reference-count":3,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/s2213-8587(19)30260-8","type":"journal-article","created":{"date-parts":[[2019,9,17]],"date-time":"2019-09-17T18:33:14Z","timestamp":1568745194000},"page":"748","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Unaffordable insulin: patients pay the price"],"prefix":"10.1016","volume":"7","author":[{"given":"Fiona","family":"Conner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Pfiester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anbreen","family":"Slama-Chaudhry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30260-8_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(15)00521-5","article-title":"Constraints and challenges in access to insulin: a global perspective","volume":"4","author":"Beran","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30260-8_bib2","article-title":"Eli Lilly will sell half-price version of Humalog, its popular insulin","author":"Thomas","year":"2019","journal-title":"New York Times"},{"key":"10.1016\/S2213-8587(19)30260-8_bib4","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S2213-8587(19)30197-4","article-title":"Diabetes in humanitarian crises: the Boston Declaration","volume":"7","author":"Kehlenbrink","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:59Z","timestamp":1761991619000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719302608"}},"issued":{"date-parts":[[2019,10]]},"references-count":3,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2213858719302608"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30260-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Unaffordable insulin: patients pay the price","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30260-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00521-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T05:45:10Z","timestamp":1790401510206,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9lius Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/s2213-8587(21)00074-7","type":"journal-article","created":{"date-parts":[[2021,3,14]],"date-time":"2021-03-14T01:52:50Z","timestamp":1615686770000},"page":"259-260","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Type 1 diabetes in Finland: past, present, and future"],"prefix":"10.1016","volume":"9","author":[{"given":"Mikael","family":"Knip","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00074-7_bib1","doi-asserted-by":"crossref","first-page":"2953","DOI":"10.2337\/dc20-0604","article-title":"Decreased incidence of type 1 diabetes in young Finnish children","volume":"43","author":"Parviainen","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00074-7_bib2","first-page":"239","article-title":"Studies of childhood diabetes I: incidence in Finland","volume":"1","author":"Somersalo","year":"1955","journal-title":"Ann Paediatr Fenn"},{"key":"10.1016\/S2213-8587(21)00074-7_bib3","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jama.2013.8399","article-title":"Incidence of type 1 diabetes in Finland","volume":"310","author":"Harjutsalo","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00074-7_bib4","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00125-008-0952-9","article-title":"Marked temporal increase in the incidence of type 1 and type 2 diabetes among young adults in Finland","volume":"51","author":"Lammi","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00074-7_bib5","author":"Arffman"},{"key":"10.1016\/S2213-8587(21)00074-7_bib6","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1111\/pedi.12541","article-title":"Ketoacidosis at diagnosis of type 1 diabetes: effect of prospective studies with newborn genetic screening and follow-up of risk children","volume":"19","author":"Hekkala","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(21)00074-7_bib7","author":"Valle"},{"key":"10.1016\/S2213-8587(21)00074-7_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-020-05363-6","article-title":"Association of diabetes type and chronic diabetes complications with early exit from the labour force: register-based study of people with diabetes in Finland","author":"Kurkela","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00074-7_bib9","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2337\/db13-0619","article-title":"Coxsackievirus B1 induces beta-cell autoimmunity that portends type 1 diabetes","volume":"63","author":"Laitinen","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00074-7_bib10","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/joim.13138","article-title":"The association between bacterial infections and the risk of coronary heart disease in type 1 diabetes","volume":"288","author":"Simonsen","year":"2020","journal-title":"J Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000747?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000747?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:29Z","timestamp":1761991769000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000747"}},"issued":{"date-parts":[[2021,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2213858721000747"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00074-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes in Finland: past, present, and future","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00074-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T18:28:42Z","timestamp":1790015322903,"version":"4.0.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/s2213-8587(18)30020-2","type":"journal-article","created":{"date-parts":[[2018,1,31]],"date-time":"2018-01-31T00:21:29Z","timestamp":1517358089000},"page":"287-298","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":203,"title":["Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial"],"prefix":"10.1016","volume":"6","author":[{"given":"George J","family":"Kahaly","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Riedl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochem","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Pitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Ponto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja","family":"Diana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Kampmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Kolbe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars C","family":"Moeller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"F\u00fchrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Curro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Campi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danila","family":"Covelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marenza","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Marin\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Menconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Bartalena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petros","family":"Perros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilmar M","family":"Wiersinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00f6ksun","family":"Ayvaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lelio","family":"Baldeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kostas","family":"Boborides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Boschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas H","family":"Brix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Daumerie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Jane","family":"Dickinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Fichter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laszlo","family":"Heged\u00fcs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onur","family":"Konuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerassimos E","family":"Krassas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Lane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan S","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maarten.","family":"Mourits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Neoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Orgiazzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon H S","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georg","family":"von Arx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milos","family":"Zarkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30020-2_bib1","series-title":"Graves' orbitopathy: a multidisciplinary approach","year":"2017"},{"key":"10.1016\/S2213-8587(18)30020-2_bib2","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13023-017-0625-1","article-title":"Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement","volume":"12","author":"Perros","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(18)30020-2_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves' Orbitopathy guidelines for the management of Graves' orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(18)30020-2_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/EJE-07-0666","article-title":"Consensus statement of the European Group on Graves' orbitopathy (EUGOGO) on management of GO","volume":"158","author":"Bartalena","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(18)30020-2_bib5","doi-asserted-by":"crossref","first-page":"90","DOI":"10.2174\/187152211795495689","article-title":"Steroids and the immune response in Graves orbitopathy","volume":"11","author":"Zang","year":"2011","journal-title":"Immunol Endocr Metab Agents Med Chem"},{"key":"10.1016\/S2213-8587(18)30020-2_bib6","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1016\/j.jaci.2003.09.028","article-title":"High-dose intravenous glucocorticoid therapy abrogates circulating dendritic cells","volume":"112","author":"Suda","year":"2003","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S2213-8587(18)30020-2_bib7","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","article-title":"Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy","volume":"90","author":"Kahaly","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30020-2_bib8","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","article-title":"Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy","volume":"97","author":"Bartalena","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30020-2_bib9","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0162-3109(00)00188-0","article-title":"Mycophenolate mofetil and its mechanisms of action","volume":"47","author":"Allison","year":"2000","journal-title":"Immunopharmacology"},{"key":"10.1016\/S2213-8587(18)30020-2_bib10","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1016\/S0041-1345(02)03538-8","article-title":"Mechanisms of action of mycophenolate mofetil in preventing chronic rejection","volume":"34","author":"Allison","year":"2002","journal-title":"Transplant Proc"},{"key":"10.1016\/S2213-8587(18)30020-2_bib11","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1749-6632.1993.tb35881.x","article-title":"Immunosuppressive activity of mycophenolate mofetil","volume":"685","author":"Eugui","year":"1993","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(18)30020-2_bib12","doi-asserted-by":"crossref","first-page":"e195","DOI":"10.1016\/j.jaad.2010.06.017","article-title":"Cutaneous lupus erythematosus: update of therapeutic options part II","volume":"65","author":"Kuhn","year":"2011","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S2213-8587(18)30020-2_bib13","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1345\/aph.1D063","article-title":"Enteric-coated mycophenolate sodium","volume":"37","author":"Gabardi","year":"2003","journal-title":"Ann Pharmacother"},{"key":"10.1016\/S2213-8587(18)30020-2_bib14","doi-asserted-by":"crossref","first-page":"3238","DOI":"10.1016\/S0041-1345(01)02377-6","article-title":"Enteric coating of mycophenolate sodium: a rational approach to limit topical gastrointestinal lesions and extend the therapeutic index of mycophenolate","volume":"33","author":"Bjarnason","year":"2001","journal-title":"Transplant Proc"},{"key":"10.1016\/S2213-8587(18)30020-2_bib15","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/eje.1.02230","article-title":"Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers","volume":"155","author":"Wiersinga","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(18)30020-2_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.ajo.2011.02.018","article-title":"Quality of life in a German Graves orbitopathy population","volume":"152","author":"Ponto","year":"2011","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S2213-8587(18)30020-2_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40618-014-0227-x","article-title":"Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy","volume":"38","author":"Riedl","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(18)30020-2_bib18","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1007\/s40618-016-0441-9","article-title":"Prospective, systematically recorded mycophenolate safety data in Graves' orbitopathy","volume":"39","author":"Riedl","year":"2016","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(18)30020-2_bib19","series-title":"MedDRA Term selection: points to consider. Release 4.6; based on MedDRA version 16.1","year":"2013"},{"key":"10.1016\/S2213-8587(18)30020-2_bib20","series-title":"Data elements for transmission of individual case safety reports E2B","year":"2001"},{"key":"10.1016\/S2213-8587(18)30020-2_bib21","series-title":"Guideline for good clinical practice E6 (R1)","year":"1996"},{"key":"10.1016\/S2213-8587(18)30020-2_bib22","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1007\/s40618-017-0608-z","article-title":"Does early response to intravenous glucocorticoids predict the final outcome in patients with moderate-to-severe and active Graves' orbitopathy?","volume":"40","author":"Bartalena","year":"2017","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(18)30020-2_bib23","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1432-2277.2004.tb00394.x","article-title":"Long-term outcome of gastrointestinal complications in renal transplant patients treated with mycophenolate mofetil","volume":"17","author":"Hardinger","year":"2004","journal-title":"Transpl Int"},{"key":"10.1016\/S2213-8587(18)30020-2_bib24","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/S0140-6736(95)92534-1","article-title":"Placebo-controlled study of mycophenolate mofetil combined with cyclosporin and corticosteroids for prevention of acute rejection","volume":"345","year":"1995","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30020-2_bib25","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/cen.13170","article-title":"Efficacy and safety of mycophenolate mofetil in patients with active moderate-to-severe Graves' orbitopathy","volume":"86","author":"Ye","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(18)30020-2_bib26","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/jc.2009-2470","article-title":"A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy","volume":"95","author":"Lytton","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30020-2_bib27","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/j.ophtha.2011.03.030","article-title":"Clinical relevance of thyroid-stimulating immunoglobulins in Graves' ophthalmopathy","volume":"118","author":"Ponto","year":"2011","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(18)30020-2_bib28","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s40618-015-0254-2","article-title":"Thyroid-stimulating immunoglobulins indicate the onset of dysthyroid optic neuropathy","volume":"38","author":"Ponto","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(18)30020-2_bib29","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1056\/NEJMc1614624","article-title":"Graves' disease","volume":"376","author":"Kahaly","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30020-2_bib30","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:17Z","timestamp":1761991577000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300202"}},"issued":{"date-parts":[[2018,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2213858718300202"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30020-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30020-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30022-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T12:08:27Z","timestamp":1789646907628,"version":"4.0.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/s2213-8587(17)30171-7","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T01:45:30Z","timestamp":1500428730000},"page":"580-581","source":"Crossref","is-referenced-by-count":10,"title":["Oldest case of gigantism? Assessment of the alleged remains of Sa-Nakht, king of ancient Egypt"],"prefix":"10.1016","volume":"5","author":[{"given":"Francesco M","family":"Galassi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maciej","family":"Henneberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter","family":"de Herder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"R\u00fchli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"Habicht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30171-7_bib1","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000371808","article-title":"The history of acromegaly","volume":"103","author":"De Herder","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(17)30171-7_bib2","series-title":"Mah\u00e2sna B\u00eat Khall\u00e2f","author":"Garstang","year":"1903"},{"key":"10.1016\/S2213-8587(17)30171-7_bib3","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2307\/2839307","article-title":"The bones of Hen Nekht, an Egyptian king of the Thrid Dynasty","volume":"1","author":"Myers","year":"1901","journal-title":"Man"},{"key":"10.1016\/S2213-8587(17)30171-7_bib4","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1002\/ajpa.10223","article-title":"Variation in ancient Egyptian stature and body proportions","volume":"121","author":"Zakrzewski","year":"2003","journal-title":"Am J Phys Anthropol"},{"key":"10.1016\/S2213-8587(17)30171-7_bib5","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1002\/ajpa.22728","article-title":"Body height of mummified pharaohs supports historical suggestions of sibling marriages","volume":"157","author":"Habicht","year":"2015","journal-title":"Am J Phys Anthropol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301717?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301717?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T04:52:17Z","timestamp":1535604737000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301717"}},"issued":{"date-parts":[[2017,8]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S2213858717301717"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30171-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,8]]}},{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T18:00:00Z","timestamp":1791309600344,"version":"4.3.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/s2213-8587(14)70064-6","type":"journal-article","created":{"date-parts":[[2014,3,21]],"date-time":"2014-03-21T17:01:23Z","timestamp":1395421283000},"page":"442-444","source":"Crossref","is-referenced-by-count":8,"title":["Personalising metformin therapy: a clinician's perspective"],"prefix":"10.1016","volume":"2","author":[{"given":"Andr\u00e9 J","family":"Scheen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70064-6_bib1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"55","author":"Inzucchi","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70064-6_bib2","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.diabet.2013.02.006","article-title":"Metformin revisited: a critical review of the benefit-risk balance in at-risk patients with type 2 diabetes","volume":"39","author":"Scheen","year":"2013","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(14)70064-6_bib3","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2337\/dc13-1276","article-title":"The pharmacogenetics of type 2 diabetes: a systematic review","volume":"37","author":"Maruthur","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70064-6_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70050-6","article-title":"Heritability of variation in glycaemic response to metformin: a genome-wide complex trait analysis","author":"Zhou","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70064-6_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70004-X","article-title":"Combatting the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes","author":"Scheen","year":"2014","journal-title":"Lancet Diabetes Encocrinol"},{"key":"10.1016\/S2213-8587(14)70064-6_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2337\/dc11-1465","article-title":"Quantifying the effect of metformin treatment and dose on glycemic control","volume":"35","author":"Hirst","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70064-6_bib7","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2165\/11534750-000000000-00000","article-title":"Clinical pharmacokinetics of metformin","volume":"50","author":"Graham","year":"2011","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/S2213-8587(14)70064-6_bib8","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/FPC.0b013e32834c0010","article-title":"The pharmacogenetics of metformin and its impact on plasma metformin steady-state levels and glycosylated hemoglobin A1c","volume":"21","author":"Christensen","year":"2011","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/S2213-8587(14)70064-6_bib9","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/clpt.2012.210","article-title":"The effect of novel promoter variants in MATE1 and MATE2 on the pharmacokinetics and pharmacodynamics of metformin","volume":"93","author":"Stocker","year":"2013","journal-title":"Clin Pharmacol Ther"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T18:31:34Z","timestamp":1538764294000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700646"}},"issued":{"date-parts":[[2014,6]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S2213858714700646"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70064-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,6]]}},{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T19:41:15Z","timestamp":1791402075944,"version":"4.3.3"},"reference-count":85,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/s2213-8587(13)70173-6","type":"journal-article","created":{"date-parts":[[2013,12,12]],"date-time":"2013-12-12T22:17:12Z","timestamp":1386886632000},"page":"321-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":335,"title":["Childhood and adolescent overweight and obesity in Latin America: a systematic review"],"prefix":"10.1016","volume":"2","author":[{"given":"Juan \u00c1ngel","family":"Rivera","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresita Gonz\u00e1lez","family":"de Coss\u00edo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilia Susana","family":"Pedraza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania Cony","family":"Aburto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania Georgina","family":"S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reynaldo","family":"Martorell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70173-6_bib1","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","article-title":"The global obesity pandemic: shaped by global drivers and local environments","volume":"378","author":"Swinburn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70173-6_bib2","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/j.1467-789X.2010.00810.x","article-title":"The levelling off of the obesity epidemic since the year 1999\u2014a review of evidence and perspectives","volume":"11","author":"Rokholm","year":"2010","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(13)70173-6_bib3","series-title":"Epidemiology of obesity in children and adolescents","first-page":"95","article-title":"Epidemiology of obesity in children in South America","author":"Albala","year":"2011"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(13)70173-6_bib4","doi-asserted-by":"crossref","first-page":"S2","DOI":"10.1038\/sj.ijo.0800852","article-title":"Risks and consequences of childhood and adolescent obesity","volume":"23","author":"Must","year":"1999","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(13)70173-6_bib5","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1542\/peds.101.S2.518","article-title":"Health consequences of obesity in youth: childhood predictors of adult disease","volume":"101","author":"Dietz","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(13)70173-6_bib6","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1037\/0033-2909.133.4.557","article-title":"Stigma, obesity, and the health of the nation's children","volume":"133","author":"Puhl","year":"2007","journal-title":"Psychol Bull"},{"key":"10.1016\/S2213-8587(13)70173-6_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1006\/pmed.1993.1014","article-title":"Do obese children become obese adults? A review of the literature","volume":"22","author":"Serdula","year":"1993","journal-title":"Prev Med"},{"key":"10.1016\/S2213-8587(13)70173-6_bib8","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1353\/foc.2006.0004","article-title":"The consequences of childhood overweight and obesity","volume":"16","author":"Daniels","year":"2006","journal-title":"Future Child"},{"key":"10.1016\/S2213-8587(13)70173-6_bib9","series-title":"Joint WHO\/FAO expert consultation on diet, nutrition and the prevention of chronic disease 2002. WHO Technical Report Series 916","year":"2003"},{"key":"10.1016\/S2213-8587(13)70173-6_bib10","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1079\/PHN2003592","article-title":"The joint WHO\/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications","volume":"7","author":"Nishida","year":"2004","journal-title":"Public Health Nutr"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(13)70173-6_bib11","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1467-789X.2004.00133.x","article-title":"Obesity in children and young people: a crisis in public health","volume":"5","author":"Lobstein","year":"2004","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(13)70173-6_bib12","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.1542\/peds.109.5.e81","article-title":"Economic burden of obesity in youths aged 6 to 17 years: 1979\u20131999","volume":"109","author":"Wang","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(13)70173-6_bib13","series-title":"Obesity and the economics of prevention: Fit not fat","author":"Sassi","year":"2010"},{"key":"10.1016\/S2213-8587(13)70173-6_bib15","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1093\/ajcn\/72.4.1032","article-title":"Prevalence and trends of overweight among preschool children in developing countries","volume":"72","author":"de Onis","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib16","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3945\/ajcn.2010.29786","article-title":"Global prevalence and trends of overweight and obesity among preschool children","volume":"92","author":"de Onis","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib17","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S0140-6736(13)60937-X","article-title":"Maternal and child undernutrition and overweight in low-income and middle-income countries","volume":"382","author":"Black","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70173-6_bib18","series-title":"Measurement of nutritional impact","year":"1979"},{"key":"10.1016\/S2213-8587(13)70173-6_bib19","series-title":"WHO Child Growth Standards: Length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development","year":"2006"},{"key":"10.1016\/S2213-8587(13)70173-6_bib20","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","article-title":"Establishing a standard definition for child overweight and obesity worldwide: international survey","volume":"320","author":"Cole","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70173-6_bib21","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"de Onis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(13)70173-6_bib22","first-page":"1","article-title":"2000 CDC Growth Charts for the United States: methods and development","volume":"246","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat 11"},{"key":"10.1016\/S2213-8587(13)70173-6_bib23","first-page":"397","article-title":"Nutrition status in Argentinean children 6 to 72 months old: results from the National Nutrition and Health Survey (ENNyS)","volume":"107","author":"Dur\u00e1n","year":"2009","journal-title":"Arch Argent Pediatr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib24","series-title":"Childhood obesity prevention: international research, controversies, and interventions","first-page":"144","article-title":"Secular changes in overweight and obesity among Brazilian adolescents from 1974\/75 to 2002\/03","author":"Conde","year":"2010"},{"key":"10.1016\/S2213-8587(13)70173-6_bib25","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1590\/S0103-05822010000300006","article-title":"Overweight and obesity in seven to nine-year-old Brazilian students: data from the Brazilian Sports Project","volume":"28","author":"Pelegrini","year":"2010","journal-title":"Rev Paul Pediatr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib26","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1017\/S1368980011003582","article-title":"Severe food insecurity is associated with obesity among Brazilian adolescent females","volume":"15","author":"Kac","year":"2012","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib27","series-title":"Pesquisa de Or\u00e7amentos Familiares 2008\u20132009 Antropometria e Estado nutricional de Crian\u00e7as, Adolescentes e Adultos no Brasil","year":"2009"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(13)70173-6_bib28","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1590\/S1413-81232010000800012","article-title":"Nutritional status of adolescents and its relation with socio-demographics variables: National Adolescent School-based Health Survey (PeNSE), 2009","volume":"15","author":"Ara\u00fajo","year":"2010","journal-title":"Cien Saude Colet"},{"key":"10.1016\/S2213-8587(13)70173-6_bib29","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S136898000700050X","article-title":"Nutrition transition in Chile revisited: mid-term evaluation of obesity goals for the period 2000\u20132010","volume":"11","author":"Vio","year":"2008","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib30","first-page":"1","article-title":"Nutritional status in Chilean school children according to NCHS and WHO 2007 reference","volume":"27","author":"Atalah Samur","year":"2012","journal-title":"Nutr Hosp"},{"key":"10.1016\/S2213-8587(13)70173-6_bib31","series-title":"National Survey of the Nutritional Situation in Colombia 2010","year":"2010"},{"issue":"suppl 4","key":"10.1016\/S2213-8587(13)70173-6_bib32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1590\/S0036-36342009001000013","article-title":"Overweight and obesity trends in Mexican children 2 to 18 years of age from 1988 to 2006","volume":"51","author":"Bonvecchio","year":"2009","journal-title":"Salud Publica Mex"},{"issue":"suppl 4","key":"10.1016\/S2213-8587(13)70173-6_bib33","first-page":"494","article-title":"Child malnutrition in Mexico in the last two decades: prevalence using the new WHO 2006 growth standards","volume":"51","author":"Gonz\u00e1lez-de Coss\u00edo","year":"2009","journal-title":"Salud Publica Mex"},{"key":"10.1016\/S2213-8587(13)70173-6_bib34","series-title":"Epidemiology of obesity in children and adolescents","first-page":"69","article-title":"The epidemiology of childhood obesity in Canada, M\u00e9xico and the United States","author":"Ogden","year":"2011"},{"key":"10.1016\/S2213-8587(13)70173-6_bib35","series-title":"Obesity in Mexico: recommendations for a State Policy","article-title":"Epidemiology of obesity in Mexico: magnitude, distribution, trends and risk factors","author":"Rivera-Dommarco","year":"2012"},{"key":"10.1016\/S2213-8587(13)70173-6_bib36","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1590\/S1726-46342011000200008","article-title":"Prevalence of overwight and obesity among children under five years in Peru 2007\u20132010","volume":"28","author":"Pajuelo-Ram\u00edrez","year":"2011","journal-title":"Rev Peru Med Exp Salud Publica"},{"key":"10.1016\/S2213-8587(13)70173-6_bib37","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1093\/pubmed\/fdq079","article-title":"Nutritional status of school-aged children of Buenos Aires, Argentina: data using three references","volume":"33","author":"Kovalskys","year":"2011","journal-title":"J Public Health (Oxf)"},{"key":"10.1016\/S2213-8587(13)70173-6_bib38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1186\/1471-2458-11-585","article-title":"Modifiable risk factors for overweight and obesity in children and adolescents from S\u00e3o Paulo, Brazil","volume":"11","author":"Duncan","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(13)70173-6_bib39","first-page":"231","article-title":"Prevalence and determinants of overweight in preschool children","volume":"87","author":"Menezes","year":"2011","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/S2213-8587(13)70173-6_bib40","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1590\/S0102-311X2012000600016","article-title":"[Overweight in children and adolescents in Pernambuco State, Brazil: prevalence and determinants]","volume":"28","author":"Leal","year":"2012","journal-title":"Cad Saude Publica"},{"key":"10.1016\/S2213-8587(13)70173-6_bib41","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1590\/S0102-311X2009001200011","article-title":"[Prevalence of overweight and obesity and associated factors among public high school students in Pernambuco State, Brazil]","volume":"25","author":"Tassitano","year":"2009","journal-title":"Cad Saude Publica"},{"key":"10.1016\/S2213-8587(13)70173-6_bib42","first-page":"1","article-title":"Prevalence of extreme anthropometric measurements in children from Alagoas, Northeastern Brazil","volume":"44","author":"Ferreira","year":"2010","journal-title":"Rev Saude Publica"},{"key":"10.1016\/S2213-8587(13)70173-6_bib43","doi-asserted-by":"crossref","first-page":"347","DOI":"10.2223\/JPED.2203","article-title":"Overweight and associated factors in children from northeastern Brazil","volume":"88","author":"Moreira","year":"2012","journal-title":"J Pediatr (Rio J)"},{"key":"10.1016\/S2213-8587(13)70173-6_bib44","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1590\/S0102-311X2010000900006","article-title":"[Prevalence of overweight and abdominal obesity according to anthropometric parameters and the association with sexual maturation in adolescent schoolchildren]","volume":"26","author":"Pinto","year":"2010","journal-title":"Cad Saude Publica"},{"key":"10.1016\/S2213-8587(13)70173-6_bib45","first-page":"295","article-title":"Effects of social and environmental determinants on overweight and obesity among Brazilian schoolchildren from a developing region","volume":"30","author":"Guedes","year":"2011","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/S2213-8587(13)70173-6_bib46","first-page":"674","article-title":"Obesity and cardiovascular risk factors in school children from Sorocaba, SP","volume":"57","author":"Mazaro","year":"2011","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/S2213-8587(13)70173-6_bib47","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1017\/S1368980010003666","article-title":"Blood pressure and BMI in adolescents in Aracaju, Brazil","volume":"14","author":"Polderman","year":"2011","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib48","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1590\/S0102-311X2009000800021","article-title":"Influence of different body mass index cut-off values in assessing the nutritional status of adolescents in a household survey","volume":"25","author":"Gomes","year":"2009","journal-title":"Cad Saude Publica"},{"key":"10.1016\/S2213-8587(13)70173-6_bib49","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1590\/S0102-311X2012000200008","article-title":"Association of parents' nutritional status, and sociodemographic and dietary factors with overweight\/obesity in schoolchildren 7 to 14 years old","volume":"28","author":"Bernardo","year":"2012","journal-title":"Cad Saude Publica"},{"key":"10.1016\/S2213-8587(13)70173-6_bib50","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1590\/S0102-311X2008000700021","article-title":"[Nutritional status of first to fourth-grade students of urban schools in Pelotas, Rio Grande do Sul State, Brazil]","volume":"24","author":"Vieira","year":"2008","journal-title":"Cad Saude Publica"},{"key":"10.1016\/S2213-8587(13)70173-6_bib51","doi-asserted-by":"crossref","first-page":"4465","DOI":"10.1590\/S1413-81232011001200019","article-title":"[Overweight and obesity in prepubertal schoolchildren: the association with low birth weight and family antecedents of cardiovascular disease. Embu\u2014metropolitan region of S\u00e3o Paulo, 2006]","volume":"16","author":"Strufaldi","year":"2011","journal-title":"Cien Saude Colet"},{"key":"10.1016\/S2213-8587(13)70173-6_bib52","first-page":"767","article-title":"Risk factors associated with overweight among adolescents from Western S\u00e3o Paulo state","volume":"43","author":"Fernandes","year":"2009","journal-title":"Rev Esc Enferm USP"},{"key":"10.1016\/S2213-8587(13)70173-6_bib54","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1007\/s00431-009-0940-1","article-title":"Cardiovascular risk factors in children and adolescents living in an urban area of Southeast of Brazil: Ouro Preto Study","volume":"168","author":"C\u00e2ndido","year":"2009","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib55","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10900-011-9512-1","article-title":"Prevalence and factors associated with high body fat in adolescents from a region of Brazil","volume":"37","author":"Silva","year":"2012","journal-title":"J Community Health"},{"key":"10.1016\/S2213-8587(13)70173-6_bib56","first-page":"30","article-title":"[Nutritional status of preschool children attending the Chilean National Nursery Schools Council Programs (JUNJI): assessment of the agreement among anthropometric indicators of obesity and central obesity]","volume":"59","author":"Guti\u00e9rrez","year":"2009","journal-title":"Arch Latinoam Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib58","doi-asserted-by":"crossref","first-page":"872","DOI":"10.4067\/S0034-98872011000700007","article-title":"[Prevalence of hypertension in school age children and its association with obesity]","volume":"139","author":"Bancalari","year":"2011","journal-title":"Rev Med Chil"},{"key":"10.1016\/S2213-8587(13)70173-6_bib59","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1017\/S1368980010001540","article-title":"Nutritional profile of schoolchildren from different socio-economic levels in Santiago, Chile","volume":"14","author":"Liberona","year":"2011","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib60","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3945\/jn.108.098111","article-title":"Overweight is more prevalent than stunting and is associated with socioeconomic status, maternal obesity, and a snacking dietary pattern in school children from Bogota, Colombia","volume":"139","author":"McDonald","year":"2009","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib62","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.2047-6310.2012.00061.x","article-title":"Prevalence and socioeconomic differences of risk factors of cardiovascular disease in Ecuadorian adolescents","volume":"7","author":"Ochoa-Avil\u00e9s","year":"2012","journal-title":"Pediatr Obes"},{"key":"10.1016\/S2213-8587(13)70173-6_bib63","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1080\/03670240902794507","article-title":"Trends of overweight and obesity among children in Tijuana, Mexico","volume":"48","author":"Bacardi-Gasc\u00f3n","year":"2009","journal-title":"Ecol Food Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib64","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/j.earlhumdev.2012.04.002","article-title":"Stunting, overweight and child development impairment go hand in hand as key problems of early infancy: Uruguayan case","volume":"88","author":"Bove","year":"2012","journal-title":"Early Hum Dev"},{"key":"10.1016\/S2213-8587(13)70173-6_bib65","series-title":"National Health and Nutrition Survey 2006","article-title":"Nutritional Status","author":"Rivera-Dommarco","year":"2006"},{"key":"10.1016\/S2213-8587(13)70173-6_bib67","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1038\/oby.2008.351","article-title":"Will all Americans become overweight or obese? Estimating the progression and cost of the US obesity epidemic","volume":"16","author":"Wang","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(13)70173-6_bib68","author":"Finkelstein"},{"key":"10.1016\/S2213-8587(13)70173-6_bib69","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1377\/hlthaff.21.2.245","article-title":"The effects of obesity, smoking, and drinking on medical problems and costs","volume":"21","author":"Sturm","year":"2002","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/S2213-8587(13)70173-6_bib70","series-title":"Obesity in Mexico: Recommendations for a State Policy","article-title":"Cost of obesity: market failure and public policies for prevention and control of obesity in Mexico","author":"Alvarez del Rio","year":"2012"},{"key":"10.1016\/S2213-8587(13)70173-6_bib71","series-title":"The State of food and agriculture 2013","year":"2013"},{"key":"10.1016\/S2213-8587(13)70173-6_bib72","series-title":"Epidemiology of obesity in children and adolescents","first-page":"95","article-title":"Childhood obesity: prevalence worldwide\u2013synthesis part I. Chapter 13","author":"Ahrens","year":"2011"},{"key":"10.1016\/S2213-8587(13)70173-6_bib73","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0140-6736(07)61692-4","article-title":"Maternal and child undernutrition: consequences for adult health and human capital","volume":"371","author":"Victora","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70173-6_bib74","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/S0140-6736(13)60103-8","article-title":"Associations of linear growth and relative weight gain during early life with adult health and human capital in countries of low and middle income: findings from five birth cohort studies","volume":"382","author":"Adair","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70173-6_bib75","series-title":"Global strategy on diet, physical activity and health","year":"2004"},{"key":"10.1016\/S2213-8587(13)70173-6_bib76","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1377\/hlthaff.2009.0739","article-title":"Personal responsibility and obesity: a constructive approach to a controversial issue","volume":"29","author":"Brownell","year":"2010","journal-title":"Health Aff"},{"key":"10.1016\/S2213-8587(13)70173-6_bib77","series-title":"Obesity in Mexico: Recommendations for a State Policy","first-page":"11","article-title":"Obesity in Mexico: recommendations for a state policy. Position paper","author":"Rivera-Dommarco","year":"2012"},{"key":"10.1016\/S2213-8587(13)70173-6_bib78","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1161\/CIR.0b013e318260a20b","article-title":"Population approaches to improve diet, physical activity, and smoking habits: a scientific statement from the American Heart Association","volume":"126","author":"Mozaffarian","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70173-6_bib79","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1093\/ajcn\/72.4.929","article-title":"Consumption of energy-dense, nutrient-poor foods by adult Americans: nutritional and health implications. The Third National Health and Nutrition Examination Survey, 1988\u20131994","volume":"72","author":"Kant","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib80","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1038\/sj.ijo.0802224","article-title":"Greater prevalence of iron deficiency in overweight and obese children and adolescents","volume":"27","author":"Pinhas-Hamiel","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(13)70173-6_bib81","series-title":"Anemia in Latin America and the Caribbean, 2009: Situation analysis, trends, and implications for public health programming","author":"Mora","year":"2010"},{"key":"10.1016\/S2213-8587(13)70173-6_bib82","first-page":"483","article-title":"Legislation. Children. Obesity. Standing up for children's rights in Latin America [commentary]","volume":"3","author":"Jacoby","year":"2012","journal-title":"World Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib83","series-title":"National agreement for healthy eating. Strategy against overweight and obesity","year":"2010"},{"key":"10.1016\/S2213-8587(13)70173-6_bib84","series-title":"National agreement for healthy eating. Strategy against overweight and obesity. Program of action in the school context","year":"2010"},{"key":"10.1016\/S2213-8587(13)70173-6_bib85","series-title":"Economic aspects related to a soda tax in Mexico","author":"Colchero","year":"2013"},{"key":"10.1016\/S2213-8587(13)70173-6_bib86","doi-asserted-by":"crossref","first-page":"900","DOI":"10.1093\/jn\/135.4.900","article-title":"Food choices and diet costs: an economic analysis","volume":"135","author":"Drewnowski","year":"2005","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib87","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1079\/PHN2003585","article-title":"Diet, nutrition and the prevention of excess weight gain and obesity","volume":"7","author":"Swinburn","year":"2004","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(13)70173-6_bib53","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1016\/j.puhe.2007.08.002","article-title":"Prevalence of overweight and associated factors in southern Brazilian adolescents","volume":"122","author":"Campagnolo","year":"2008","journal-title":"Public Health"},{"key":"10.1016\/S2213-8587(13)70173-6_bib57","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1097\/MPG.0b013e31816eb448","article-title":"Secular and seasonal trends in obesity in Chilean preschool children, 1996-2004","volume":"47","author":"Stanojevic","year":"2008","journal-title":"J Pediatr Gastroenterol Nutr"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(13)70173-6_bib61","doi-asserted-by":"crossref","first-page":"S171","DOI":"10.1123\/jpah.8.s2.s171","article-title":"Walking or bicycling to school and weight status among adolescents from Monter\u00eda, Colombia","volume":"8","author":"Arango","year":"2011","journal-title":"J Phys Act Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:04:56Z","timestamp":1761991496000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701736"}},"issued":{"date-parts":[[2014,4]]},"references-count":85,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S2213858713701736"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70173-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Childhood and adolescent overweight and obesity in Latin America: a systematic review","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70173-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:53:41Z","timestamp":1791291221284,"version":"4.3.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/s2213-8587(26)00217-2","type":"journal-article","created":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:54:26Z","timestamp":1787784866000},"page":"793","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetes in a warming world"],"prefix":"10.1016","volume":"14","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002172?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002172?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:06:10Z","timestamp":1791288370000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726002172"}},"issued":{"date-parts":[[2026,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2213858726002172"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00217-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes in a warming world","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00217-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2468-2667(26)00025-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T19:25:03Z","timestamp":1791314703950,"version":"4.3.1"},"reference-count":20,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,5,21]],"date-time":"2015-05-21T00:00:00Z","timestamp":1432166400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/s2213-8587(15)00126-6","type":"journal-article","created":{"date-parts":[[2015,5,26]],"date-time":"2015-05-26T21:39:35Z","timestamp":1432676375000},"page":"507-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":437,"title":["Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study"],"prefix":"10.1016","volume":"3","author":[{"given":"Danish","family":"Saleheen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundas","family":"Javad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amrith","family":"Rodrigues","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Picataggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniya","family":"Lukmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan L","family":"Mucksavage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Luben","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffery","family":"Billheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J P","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Matthijs","family":"Boekholdt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kay-Tee","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Rader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00126-6_bib1","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/S0140-6736(07)61778-4","article-title":"Blood cholesterol and vascular mortality by age, sex, and blood pressure: a meta-analysis of individual data from 61 prospective studies with 55\u2008000 vascular deaths","volume":"370","author":"Lewington","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00126-6_bib2","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00126-6_bib3","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1172\/JCI114558","article-title":"Regression of atherosclerotic lesions by high density lipoprotein plasma fraction in the cholesterol-fed rabbit","volume":"85","author":"Badimon","year":"1990","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(15)00126-6_bib4","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1161\/01.CIR.100.17.1816","article-title":"Regression of atherosclerosis induced by liver-directed gene transfer of apolipoprotein A-I in mice","volume":"100","author":"Tangirala","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(15)00126-6_bib5","doi-asserted-by":"crossref","first-page":"2109","DOI":"10.1056\/NEJMoa0706628","article-title":"Effects of torcetrapib in patients at high risk for coronary events","volume":"357","author":"Barter","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00126-6_bib6","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa1206797","article-title":"Effects of dalcetrapib in patients with a recent acute coronary syndrome","volume":"367","author":"Schwartz","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00126-6_bib7","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00126-6_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1056\/NEJMoa1300955","article-title":"Effects of extended-release niacin with laropiprant in high-risk patients","volume":"371","author":"Landray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00126-6_bib9","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00126-6_bib10","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00126-6_bib11","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0022-2275(20)32113-1","article-title":"Cell cholesterol efflux: integration of old and new observations provides new insights","volume":"40","author":"Rothblat","year":"1999","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(15)00126-6_bib12","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1056\/NEJMoa1001689","article-title":"Cholesterol efflux capacity, high-density lipoprotein function, and atherosclerosis","volume":"364","author":"Khera","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00126-6_bib13","doi-asserted-by":"crossref","first-page":"2137","DOI":"10.1093\/eurheartj\/ehp221","article-title":"The joint effects of apolipoprotein B, apolipoprotein A1, LDL cholesterol, and HDL cholesterol on risk: 3510 cases of acute myocardial infarction and 9805 controls","volume":"30","author":"Parish","year":"2009","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(15)00126-6_bib14","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1161\/ATVBAHA.113.301373","article-title":"Paradoxical association of enhanced cholesterol efflux with increased incident cardiovascular risks","volume":"33","author":"Li","year":"2013","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(15)00126-6_bib15","doi-asserted-by":"crossref","first-page":"2383","DOI":"10.1056\/NEJMoa1409065","article-title":"HDL Cholesterol efflux capacity and incident cardiovascular events","volume":"371","author":"Rohatgi","year":"2014","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00126-6_bib16","first-page":"95","article-title":"EPIC-Norfolk: study design and characteristics of the cohort. European Prospective Investigation of Cancer","volume":"80","author":"Day","year":"1999","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(15)00126-6_bib17","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1161\/01.CIR.0000141730.65972.95","article-title":"Plasma levels of cholesteryl ester transfer protein and the risk of future coronary artery disease in apparently healthy men and women: the prospective EPIC (European Prospective Investigation into Cancer and nutrition)-Norfolk population study","volume":"110","author":"Boekholdt","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(15)00126-6_bib19","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1161\/ATVBAHA.109.199158","article-title":"The ability to promote efflux via ABCA1 determines the capacity of serum specimens with similar high-density lipoprotein cholesterol to remove cholesterol from macrophages","volume":"30","author":"de la Llera-Moya","year":"2010","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(15)00126-6_bib20","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1002\/sim.4780100703","article-title":"Floating absolute risk: an alternative to relative risk in survival and case-control analysis avoiding an arbitrary reference group","volume":"10","author":"Easton","year":"1991","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(15)00126-6_bib21","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1194\/jlr.D018051","article-title":"A sensitive assay for ABCA1-mediated cholesterol efflux using BODIPY-cholesterol","volume":"52","author":"Sankaranarayanan","year":"2011","journal-title":"J Lipid Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,9]],"date-time":"2022-05-09T09:33:03Z","timestamp":1652088783000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715001266"}},"issued":{"date-parts":[[2015,7]]},"references-count":20,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2213858715001266"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00126-6","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725525798.793528330","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of HDL cholesterol efflux capacity with incident coronary heart disease events: a prospective case-control study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00126-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00205-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Saleheen et al. Open Acess article disrtibuted under the terms of CC BY-NC-ND. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:55:10Z","timestamp":1792821310839,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100014653","name":"Manchester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014653","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0001164"],"award-info":[{"award-number":["G0001164"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12015\/1"],"award-info":[{"award-number":["MC_UU_12015\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_12015\/4"],"award-info":[{"award-number":["MC_UU_12015\/4"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["RP-PG-0606\u20131272"],"award-info":[{"award-number":["RP-PG-0606\u20131272"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007602","name":"Programme Grants for Applied Research","doi-asserted-by":"publisher","award":["RP-PG-0606\u20131259"],"award-info":[{"award-number":["RP-PG-0606\u20131259"]}],"id":[{"id":"10.13039\/501100007602","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["G061895"],"award-info":[{"award-number":["G061895"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003103","name":"Bundesamt f\u00fcr Strassen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003103","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007398","name":"Strategiske Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007398","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008392","name":"Sundhed og Sygdom, Det Frie Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008392","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000664","name":"Health Technology Assessment Programme","doi-asserted-by":"publisher","award":["08\/116\/300"],"award-info":[{"award-number":["08\/116\/300"]}],"id":[{"id":"10.13039\/501100000664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001732","name":"Danmarks Grundforskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001732","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002739","name":"Aarhus Universitets Forskningsfond","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002739","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/s2213-8587(19)30349-3","type":"journal-article","created":{"date-parts":[[2019,11,19]],"date-time":"2019-11-19T20:59:38Z","timestamp":1574197178000},"page":"925-937","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial"],"prefix":"10.1016","volume":"7","author":[{"given":"Simon J","family":"Griffin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy E H M","family":"Rutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel R","family":"Witte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torsten","family":"Lauritzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen J","family":"Sharp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Else-Marie","family":"Dalsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greg J","family":"Irving","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimke C","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelli","family":"Sandb\u00e6k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30349-3_bib1","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"G\u00e6de","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30349-3_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"G\u00e6de","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30349-3_bib3","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S2213-8587(17)30327-3","article-title":"Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial","volume":"5","author":"Ueki","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(19)30349-3_bib4","doi-asserted-by":"crossref","first-page":"S6","DOI":"10.1038\/sj.ijo.0801420","article-title":"The ADDITION study: proposed trial of the cost-effectiveness of an intensive multifactorial intervention on morbidity and mortality among people with type 2 diabetes detected by screening","volume":"24","author":"Lauritzen","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(19)30349-3_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1186\/1471-2458-9-136","article-title":"The ADDITION-Cambridge trial protocol: a cluster-randomised controlled trial of screening for type 2 diabetes and intensive treatment for screen-detected patients","volume":"9","author":"Echouffo-Tcheugui","year":"2009","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(19)30349-3_bib6","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1186\/1745-6215-11-16","article-title":"Rationale and design of the ADDITION-Leicester study, a systematic screening programme and randomised controlled trial of multi-factorial cardiovascular risk intervention in people with type 2 diabetes mellitus detected by screening","volume":"11","author":"Webb","year":"2010","journal-title":"Trials"},{"key":"10.1016\/S2213-8587(19)30349-3_bib7","doi-asserted-by":"crossref","first-page":"43","DOI":"10.3399\/bjgp09X394851","article-title":"Randomised controlled trial of intensive multifactorial treatment for cardiovascular risk in patients with screen-detected type 2 diabetes: 1-year data from the ADDITION Netherlands study","volume":"59","author":"Janssen","year":"2009","journal-title":"Br J Gen Pract"},{"key":"10.1016\/S2213-8587(19)30349-3_bib8","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(11)60698-3","article-title":"Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial","volume":"378","author":"Griffin","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30349-3_bib9","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1007\/s00125-008-1013-0","article-title":"Stepwise screening for diabetes identifies people with high but modifiable coronary heart disease risk. The ADDITION study","volume":"51","author":"Sandbaek","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30349-3_bib10","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.1111\/j.1464-5491.2008.02600.x","article-title":"How much might cardiovascular disease risk be reduced by intensive therapy in people with screen-detected diabetes?","volume":"25","author":"Echouffo-Tcheugui","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30349-3_bib11","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1111\/j.1464-5491.2011.03365.x","article-title":"Screening for type 2 diabetes. Lessons from the ADDITION-Europe study","volume":"28","author":"van den Donk","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30349-3_bib12","series-title":"Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation","year":"1999"},{"key":"10.1016\/S2213-8587(19)30349-3_bib13","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1136\/bmj.39474.922025.BE","article-title":"Effectiveness of the diabetes education and self management for ongoing and newly diagnosed (DESMOND) programme for people with newly diagnosed type 2 diabetes: cluster randomised controlled trial","volume":"336","author":"Davies","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30349-3_bib14","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30349-3_bib15","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30349-3_bib16","series-title":"Type 2 diabetes in general practice: diagnosis and treatment","year":"1999"},{"key":"10.1016\/S2213-8587(19)30349-3_bib17","series-title":"Clinical guidelines and evidence review for type 2 diabetes: blood glucose management","author":"McIntosh","year":"2001"},{"key":"10.1016\/S2213-8587(19)30349-3_bib18","first-page":"67","article-title":"Dutch College of General Practitioners. Practice guideline diabetes mellitus type 2","volume":"42","author":"Rutten","year":"1999","journal-title":"Huisarts Wetensch"},{"key":"10.1016\/S2213-8587(19)30349-3_bib19","series-title":"Type 2 diabetes: national clinical guideline for management in primary and secondary care","year":"2002"},{"key":"10.1016\/S2213-8587(19)30349-3_bib20","doi-asserted-by":"crossref","first-page":"247","DOI":"10.7326\/0003-4819-145-4-200608150-00004","article-title":"Using standardized serum creatinine values in the modification of diet in renal disease study equation for estimating glomerular filtration rate","volume":"145","author":"Levey","year":"2006","journal-title":"Ann Int Med"},{"key":"10.1016\/S2213-8587(19)30349-3_bib21","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1136\/hrt.2009.192328","article-title":"The Myocardial Ischaemia National Audit Project (MINAP)","volume":"96","author":"Herrett","year":"2010","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(19)30349-3_bib22","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/(SICI)1097-0258(19990330)18:6<695::AID-SIM60>3.0.CO;2-O","article-title":"Estimation of failure probabilities in the presence of competing risks: new representations of old estimators","volume":"18","author":"Gooley","year":"1999","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(19)30349-3_bib23","first-page":"19","article-title":"Regression standard errors in clustered samples","volume":"13","author":"Rogers","year":"1993","journal-title":"Stata Tech Bull"},{"key":"10.1016\/S2213-8587(19)30349-3_bib24","doi-asserted-by":"crossref","first-page":"4681","DOI":"10.1002\/sim.6274","article-title":"Relaxing the independent censoring assumption in the Cox proportional hazards model using multiple imputation","volume":"33","author":"Jackson","year":"2014","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(19)30349-3_bib25","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/sim.1981","article-title":"Adjusting for partially missing baseline measurements in randomized trials","volume":"24","author":"White","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(19)30349-3_bib26","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/1740774512450098","article-title":"Including all individuals is not enough: lessons for intention-to-treat analysis","volume":"9","author":"White","year":"2012","journal-title":"Clin Trials"},{"key":"10.1016\/S2213-8587(19)30349-3_bib27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1111\/dme.12410","article-title":"Does early intensive multifactorial therapy reduce modelled cardiovascular risk in individuals with screen-detected diabetes? Results from the ADDITION-Europe cluster randomized trial","volume":"31","author":"Black","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30349-3_bib28","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30349-3_bib29","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(09)61969-3","article-title":"Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study","volume":"375","author":"Currie","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30349-3_bib30","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30349-3_bib31","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1056\/NEJMoa0806359","article-title":"Long-term follow-up after tight control of blood pressure in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30349-3_bib32","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30349-3_bib33","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1007\/s00125-017-4299-y","article-title":"Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009","volume":"60","author":"Simmons","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30349-3_bib34","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.2337\/dc14-2459","article-title":"Early detection and treatment of type 2 diabetes reduce cardiovascular morbidity and mortality: a simulation of the results of the Anglo-Danish-Dutch Study of Intensive Treatment in People with Screen-Detected Diabetes in Primary Care (ADDITION-Europe)","volume":"38","author":"Herman","year":"2015","journal-title":"Diab Care"},{"key":"10.1016\/S2213-8587(19)30349-3_bib35","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1007\/s00125-018-4594-2","article-title":"Effect of screening for type 2 diabetes on healthcare costs: a register-based study among 139\u2008075 individuals diagnosed with diabetes in Denmark between 2001 and 2009","volume":"61","author":"Sorts\u00f8","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30349-3_bib36","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(12)61422-6","article-title":"Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial","volume":"380","author":"Simmons","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30349-3_bib37","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1007\/s00125-017-4323-2","article-title":"Effect of population screening for type 2 diabetes and cardiovascular risk factors on mortality rate and cardiovascular events: a controlled trial among 1,912,392 Danish adults","volume":"60","author":"Simmons","year":"2017","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:11Z","timestamp":1761991631000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719303493"}},"issued":{"date-parts":[[2019,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S2213858719303493"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30349-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term effects of intensive multifactorial therapy in individuals with screen-detected type 2 diabetes in primary care: 10-year follow-up of the ADDITION-Europe cluster-randomised trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30349-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30347-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:11:06Z","timestamp":1793261466155,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/s2213-8587(18)30100-1","type":"journal-article","created":{"date-parts":[[2018,4,13]],"date-time":"2018-04-13T18:36:49Z","timestamp":1523644609000},"page":"547-554","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Milton","family":"Packer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Claggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin P","family":"Lefkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J V","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean L","family":"Rouleau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael R","family":"Zile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30100-1_bib1","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1016\/S0140-6736(16)30969-2","article-title":"Importance of endogenous compensatory vasoactive peptides in broadening the effects of inhibitors of the renin-angiotensin system for the treatment of heart failure","volume":"389","author":"Packer","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30100-1_bib2","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1046\/j.1523-1747.2002.19618.x","article-title":"Neutral endopeptidase activity is increased in the skin of subjects with diabetic ulcers","volume":"119","author":"Antezana","year":"2002","journal-title":"J Invest Dermatol"},{"key":"10.1016\/S2213-8587(18)30100-1_bib3","first-page":"977","article-title":"Elevated neprilysin activity in vitreous of patients with proliferative diabetic retinopathy","volume":"12","author":"Hara","year":"2006","journal-title":"Mol Vis"},{"key":"10.1016\/S2213-8587(18)30100-1_bib4","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1002\/(SICI)1096-9136(199805)15:5<375::AID-DIA585>3.0.CO;2-N","article-title":"Atrial natriuretic peptide in type 2 diabetes mellitus: response to a physiological mixed meal and relationship to renal function","volume":"15","author":"Chattington","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30100-1_bib5","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1093\/oxfordjournals.ndt.a027401","article-title":"The renal response to exogenous insulin in non-insulin-dependent diabetes mellitus in relation to blood pressure and cardiovascular hormonal status","volume":"11","author":"Gans","year":"1996","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(18)30100-1_bib6","doi-asserted-by":"crossref","first-page":"5841","DOI":"10.1210\/en.2010-0655","article-title":"Targeted disruption of guanylyl cyclase-A\/natriuretic peptide receptor-A gene provokes renal fibrosis and remodeling in null mutant mice: role of proinflammatory cytokines","volume":"151","author":"Das","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(18)30100-1_bib7","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.1097\/01.hjh.0000179765.48324.b4","article-title":"Vascular and renal effects of vasopeptidase inhibition and angiotensin-converting enzyme blockade in spontaneously diabetic Goto-Kakizaki rats","volume":"23","author":"Cheng","year":"2005","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(18)30100-1_bib8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin-neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30100-1_bib9","doi-asserted-by":"crossref","first-page":"e002560","DOI":"10.1161\/CIRCHEARTFAILURE.115.002560","article-title":"Risk related to pre-diabetes mellitus and diabetes mellitus in heart failure with reduced ejection fraction: insights From Prospective Comparison of ARNI With ACEI to Determine Impact on Global Mortality and Morbidity in Heart Failure Trial","volume":"9","author":"Kristensen","year":"2016","journal-title":"Circ Heart Fail"},{"key":"10.1016\/S2213-8587(18)30100-1_bib10","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30100-1_bib11","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1038\/ki.2008.200","article-title":"Gender differences in predictors of the decline of renal function in the general population","volume":"74","author":"Halbesma","year":"2008","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(18)30100-1_bib12","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1016\/j.clinthera.2015.05.508","article-title":"Spironolactone add-on for preventing or slowing the progression of diabetic nephropathy: a meta-analysis","volume":"37","author":"Hou","year":"2015","journal-title":"Clin Ther"},{"key":"10.1016\/S2213-8587(18)30100-1_bib13","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30100-1_bib14","doi-asserted-by":"crossref","first-page":"2304","DOI":"10.2337\/dc16-1415","article-title":"Effect of sitagliptin on kidney function and respective cardiovascular outcomes in type 2 diabetes: outcomes from TECOS","volume":"39","author":"Cornel","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30100-1_bib15","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30100-1_bib16","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1016\/0002-9343(87)90213-0","article-title":"Influence of diabetes mellitus on changes in left ventricular performance and renal function produced by converting enzyme inhibition in patients with severe chronic heart failure","volume":"82","author":"Packer","year":"1987","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(18)30100-1_bib17","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1161\/CIRCHEARTFAILURE.113.000792","volume":"7","author":"Rossignol","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/S2213-8587(18)30100-1_bib18","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1161\/01.CIR.0000029801.86489.50","article-title":"Comparison of omapatrilat and enalapril in patients with chronic heart failure: the Omapatrilat Versus Enalapril Randomized Trial of Utility in Reducing Events (OVERTURE)","volume":"106","author":"Packer","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30100-1_bib19","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S2213-8587(17)30087-6","article-title":"Effect of sacubitril\/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial","volume":"5","author":"Seferovic","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30100-1_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/nrneph.2012.19","article-title":"Glomerular hyperfiltration: definitions, mechanisms and clinical implications","volume":"8","author":"Helal","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S2213-8587(18)30100-1_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/BF00400721","article-title":"Prevention of glomerular hyperfiltration in rats with streptozotocin-induced diabetes by an atrial natriuretic peptide receptor antagonist","volume":"38","author":"Sakamoto","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30100-1_bib22","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1046\/j.1365-2362.1999.00422.x","article-title":"Atrial natriuretic peptide increases albuminuria in type I diabetic patients: evidence for blockade of tubular protein reabsorption","volume":"29","author":"Jacobs","year":"1999","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S2213-8587(18)30100-1_bib23","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.1016\/S0024-3205(02)01990-2","article-title":"Increased expression of renal neutral endopeptidase in severe heart failure","volume":"71","author":"Knecht","year":"2002","journal-title":"Life Sci"},{"key":"10.1016\/S2213-8587(18)30100-1_bib24","doi-asserted-by":"crossref","first-page":"1548","DOI":"10.1161\/CIRCULATIONAHA.117.030418","article-title":"Activation and inhibition of sodium-hydrogen exchange is a mechanism that links the pathophysiology and treatment of diabetes with that of heart failure","volume":"136","author":"Packer","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30100-1_bib25","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jsbmb.2011.11.011","article-title":"Action of ANP on the nongenomic dose-dependent biphasic effect of aldosterone on NHE1 in proximal S3 segment","volume":"128","author":"Braga-Sobrinho","year":"2012","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S2213-8587(18)30100-1_bib26","doi-asserted-by":"crossref","first-page":"F1399","DOI":"10.1152\/ajprenal.00385.2011","article-title":"Mechanisms underlying the inhibitory effects of uroguanylin on NHE3 transport activity in renal proximal tubule","volume":"303","author":"Lessa","year":"2012","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/S2213-8587(18)30100-1_bib27","doi-asserted-by":"crossref","first-page":"F819","DOI":"10.1152\/ajprenal.00497.2016","article-title":"Primary proximal tubule hyperreabsorption and impaired tubular transport counterregulation determine glomerular hyperfiltration in diabetes: a modeling analysis","volume":"312","author":"Hallow","year":"2017","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/S2213-8587(18)30100-1_bib28","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000069766","article-title":"Cyclic GMP mediates influence of macula densa nitric oxide over tubuloglomerular feedback","volume":"26","author":"Thomson","year":"2003","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/S2213-8587(18)30100-1_bib29","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.ijcard.2015.03.116","article-title":"Combined angiotensin receptor blockade and neprilysin inhibition attenuates angiotensin-II mediated renal cellular collagen synthesis","volume":"186","author":"Wang","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/S2213-8587(18)30100-1_bib30","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1053\/j.ajkd.2015.10.025","article-title":"Prediabetes and risk of glomerular hyperfiltration and albuminuria in the general nondiabetic population: a prospective cohort study","volume":"67","author":"Melsom","year":"2016","journal-title":"Am J Kidney Dis"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T05:08:41Z","timestamp":1658293721000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301001"}},"issued":{"date-parts":[[2018,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2213858718301001"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30100-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733069310.793545026","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of neprilysin inhibition on renal function in patients with type 2 diabetes and chronic heart failure who are receiving target doses of inhibitors of the renin-angiotensin system: a secondary analysis of the PARADIGM-HF trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30100-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30142-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T04:38:43Z","timestamp":1794026323970,"version":"4.8.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008069","name":"University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008069","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/s2213-8587(21)00240-0","type":"journal-article","created":{"date-parts":[[2021,10,16]],"date-time":"2021-10-16T00:46:39Z","timestamp":1634345199000},"page":"825-836","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis"],"prefix":"10.1016","volume":"9","member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00240-0_bib1","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00240-0_bib4","doi-asserted-by":"crossref","first-page":"m4573","DOI":"10.1136\/bmj.m4573","article-title":"Sodium-glucose cotransporter protein-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"372","author":"Palmer","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00240-0_bib5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/M20-0864","article-title":"Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis","volume":"173","author":"Tsapas","year":"2020","journal-title":"Ann Intern Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00240-0_bib6","first-page":"S111","article-title":"9. Pharmacologic Approaches to Glycemic Treatment: Standards of Medical Care in Diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00240-0_bib7","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1007\/s00125-019-05039-w","article-title":"2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"63","author":"Buse","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00240-0_bib10","doi-asserted-by":"crossref","first-page":"e3158","DOI":"10.1002\/dmrr.3158","article-title":"Standards of medical care for type 2 diabetes in China 2019","volume":"35","author":"Jia","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(21)00240-0_bib11","first-page":"CD005613","article-title":"Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus","volume":"2","author":"Horvath","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(21)00240-0_bib12","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1007\/s00592-014-0698-4","article-title":"Systematic review and meta-analysis of randomized clinical trials comparing efficacy and safety outcomes of insulin glargine with NPH insulin, premixed insulin preparations or with insulin detemir in type 2 diabetes mellitus","volume":"52","author":"Rys","year":"2015","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(21)00240-0_bib13","first-page":"CD013228","article-title":"Short-acting insulin analogues versus regular human insulin for adult, non-pregnant persons with type 2 diabetes mellitus","volume":"12","author":"Fullerton","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(21)00240-0_bib14","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jama.2018.21364","article-title":"Implementation of a health plan program for switching from analogue to human insulin and glycemic control among Medicare beneficiaries with type 2 diabetes","volume":"321","author":"Luo","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00240-0_bib15","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1001\/jama.2018.21356","article-title":"Insulin analogues for type 2 diabetes","volume":"321","author":"Lipska","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00240-0_bib16","doi-asserted-by":"crossref","first-page":"520","DOI":"10.2471\/BLT.08.058925","article-title":"Global strategies to reduce the price of antiretroviral medicines: evidence from transactional databases","volume":"87","author":"Waning","year":"2009","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(21)00240-0_bib17","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1093\/heapol\/czl039","article-title":"Negotiating antiretroviral drug prices: the experience of the Andean countries","volume":"22","author":"Seoane-Vazquez","year":"2007","journal-title":"Health Policy Plan"},{"key":"10.1016\/S2213-8587(21)00240-0_bib18","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1126\/science.1061861","article-title":"Public health. Responding to market failures in tuberculosis control","volume":"293","author":"Gupta","year":"2001","journal-title":"Science"},{"key":"10.1016\/S2213-8587(21)00240-0_bib19","first-page":"815","article-title":"Has the implementation of the TRIPS Agreement in Latin America and the Caribbean produced intellectual property legislation that favours public health?","volume":"82","author":"Oliveira","year":"2004","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(21)00240-0_bib20","doi-asserted-by":"crossref","first-page":"925","DOI":"10.2471\/BLT.15.164418","article-title":"Cost-effectiveness thresholds: pros and cons","volume":"94","author":"Bertram","year":"2016","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(21)00240-0_bib21","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1478-7547-1-8","article-title":"Generalized cost-effectiveness analysis for national-level priority-setting in the health sector","volume":"1","author":"Hutubessy","year":"2003","journal-title":"Cost Eff Resour Alloc"},{"key":"10.1016\/S2213-8587(21)00240-0_bib23","author":"Bonita"},{"key":"10.1016\/S2213-8587(21)00240-0_bib24","doi-asserted-by":"crossref","first-page":"e1332","DOI":"10.1016\/S2214-109X(19)30318-3","article-title":"World Health Organization cardiovascular disease risk charts: revised models to estimate risk in 21 global regions","volume":"7","author":"Kaptoge","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(21)00240-0_bib25","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1016\/S2213-8587(17)30221-8","article-title":"Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials","volume":"5","author":"Basu","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00240-0_bib26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2337\/dc17-2002","article-title":"Validation of risk equations for complications of type 2 diabetes (RECODe) using individual participant data from diverse longitudinal cohorts in the U.S","volume":"41","author":"Basu","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00240-0_bib27","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/S2213-8587(18)30303-6","article-title":"Estimation of global insulin use for type 2 diabetes, 2018\u201330: a microsimulation analysis","volume":"7","author":"Basu","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00240-0_bib29","first-page":"S14","article-title":"2. Classification and Diagnosis of Diabetes: Standards of Medical Care in Diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00240-0_bib30","first-page":"1","article-title":"mice: multivariate imputation by chained equations in R","volume":"45","author":"van Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/S2213-8587(21)00240-0_bib32","doi-asserted-by":"crossref","first-page":"107839","DOI":"10.1016\/j.jdiacomp.2020.107839","article-title":"Estimates of insulin needs and dispensation given wastage, alternative glycemic targets, and non-insulin therapies in US populations with type 2 diabetes mellitus: a microsimulation study","volume":"35","author":"Basu","year":"2021","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(21)00240-0_bib33","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1016\/S0140-6736(12)61680-8","article-title":"Common values in assessing health outcomes from disease and injury: disability weights measurement study for the Global Burden of Disease Study 2010","volume":"380","author":"Salomon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00240-0_bib34","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1038\/s41574-018-0001-9","article-title":"Does lower limb amputation concern all SGLT2 inhibitors?","volume":"14","author":"Scheen","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00240-0_bib35","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1056\/NEJMc1711899","article-title":"Prices of generic drugs associated with numbers of manufacturers","volume":"377","author":"Dave","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00240-0_bib38","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-020-05375-2","article-title":"A global perspective on the issue of access to insulin","volume":"64","author":"Beran","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00240-0_bib39","doi-asserted-by":"crossref","first-page":"e001410","DOI":"10.1136\/bmjgh-2019-001410","article-title":"Insulin prices, availability and affordability in 13 low-income and middle-income countries","volume":"4","author":"Ewen","year":"2019","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S2213-8587(21)00240-0_bib40","doi-asserted-by":"crossref","first-page":"e000112","DOI":"10.1136\/bmjgh-2016-000112","article-title":"Challenges constraining access to insulin in the private-sector market of Delhi, India","volume":"1","author":"Sharma","year":"2016","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S2213-8587(21)00240-0_bib41","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1932296813515132","article-title":"Patient perspectives on biosimilar insulin","volume":"8","author":"Wilkins","year":"2014","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(21)00240-0_bib42","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1007\/s40273-014-0162-x","article-title":"Are current cost-effectiveness thresholds for low- and middle-income countries useful? Examples from the world of vaccines","volume":"32","author":"Newall","year":"2014","journal-title":"PharmacoEconomics"},{"key":"10.1016\/S2213-8587(21)00240-0_bib43","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2471\/BLT.14.138206","article-title":"Thresholds for the cost-effectiveness of interventions: alternative approaches","volume":"93","author":"Marseille","year":"2015","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(21)00240-0_bib44","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.jval.2016.02.017","article-title":"Country-level cost-effectiveness thresholds: initial estimates and the need for further research","volume":"19","author":"Woods","year":"2016","journal-title":"Value Health"},{"key":"10.1016\/S2213-8587(21)00240-0_bib45","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1016\/j.jval.2017.12.016","article-title":"Use and misuse of cost-effectiveness analysis thresholds in low- and middle-income countries: trends in cost-per-DALY studies","volume":"21","author":"Leech","year":"2018","journal-title":"Value Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:31Z","timestamp":1761991831000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002400"}},"issued":{"date-parts":[[2021,12]]},"references-count":36,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2213858721002400"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00240-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00240-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00264-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:26:02Z","timestamp":1794061562893,"version":"4.8.0"},"reference-count":136,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/s2213-8587(19)30081-6","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T18:39:47Z","timestamp":1571078387000},"page":"938-948","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":518,"title":["Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention"],"prefix":"10.1016","volume":"7","author":[{"given":"Dinesh","family":"Selvarajah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debasish","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian R","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Solomon","family":"Tesfaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30081-6_bib1","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/dc16-2042","article-title":"Diabetic neuropathy: a position statement by the American Diabetes Association","volume":"40","author":"Pop-Busui","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib2","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/diacare.22.9.1479","article-title":"Risk factors for severity of diabetic polyneuropathy: intensive longitudinal assessment of the Rochester Diabetic Neuropathy Study cohort","volume":"22","author":"Dyck","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib3","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1001\/jama.293.2.217","article-title":"Preventing foot ulcers in patients with diabetes","volume":"293","author":"Singh","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30081-6_bib4","series-title":"Diagnosis and Management of Diabetic Foot Complications","author":"Boulton","year":"2018"},{"key":"10.1016\/S2213-8587(19)30081-6_bib5","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1016\/j.gaitpost.2011.12.021","article-title":"Relation between risk of falling and postural sway complexity in diabetes","volume":"35","author":"Morrison","year":"2012","journal-title":"Gait Posture"},{"key":"10.1016\/S2213-8587(19)30081-6_bib6","doi-asserted-by":"crossref","first-page":"2456","DOI":"10.2337\/dc12-1964","article-title":"Mechanisms and management of diabetic painful distal symmetrical polyneuropathy","volume":"36","author":"Tesfaye","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib7","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1002\/dmrr.1226","article-title":"Diabetic polyneuropathies: update on research definition, diagnostic criteria and estimation of severity","volume":"27","author":"Dyck","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(19)30081-6_bib8","series-title":"Diabetes and foot care: time to act","year":"2005"},{"key":"10.1016\/S2213-8587(19)30081-6_bib9","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.mcna.2013.03.008","article-title":"Epidemiology of foot ulceration and amputation: can global variation be explained?","volume":"97","author":"Margolis","year":"2013","journal-title":"Med Clin North Am"},{"key":"10.1016\/S2213-8587(19)30081-6_bib10","doi-asserted-by":"crossref","first-page":"18525","DOI":"10.2337\/dc15-0536","article-title":"Diabetes, lower-extremity amputation, and death","volume":"38","author":"Hoffstad","year":"2015","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(19)30081-6_bib12","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/dmrr.2694","article-title":"The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus","volume":"32","author":"Bakker","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(19)30081-6_bib13","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.2337\/diacare.26.6.1790","article-title":"The health care costs of diabetic peripheral neuropathy in the US","volume":"26","author":"Gordois","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib14","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3390\/ijerph15010089","article-title":"Annual direct medical costs of diabetic foot disease in Brazil: a cost of illness study","volume":"15","author":"Toscano","year":"2018","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(19)30081-6_bib15","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.ando.2017.11.005","article-title":"Cost of diabetic foot in France, Spain, Italy, Germany and United Kingdom: a systematic review","volume":"79","author":"Tchero","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/S2213-8587(19)30081-6_bib16","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.2337\/dc10-2341","article-title":"Time-dependent impact of diabetes on mortality in patients after major lower extremity amputation: survival in a population-based 5-year cohort in Germany","volume":"34","author":"Icks","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib17","doi-asserted-by":"crossref","first-page":"1598","DOI":"10.2337\/diacare.27.7.1598","article-title":"Mortality in diabetic and nondiabetic patients after amputations performed from 1990 to 1995: a 5-year follow-up study","volume":"27","author":"Tentolouris","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib18","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.2337\/dc12-0200","article-title":"Long-term prognosis of diabetic foot patients and their limbs: amputation and death over the course of a decade","volume":"35","author":"Morbach","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib19","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1177\/1479164115579005","article-title":"Survival of diabetes patients with major amputation is comparable to malignant disease","volume":"12","author":"Hoffmann","year":"2015","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/S2213-8587(19)30081-6_bib20","doi-asserted-by":"crossref","first-page":"2193","DOI":"10.2337\/dc09-0651","article-title":"History of foot ulcer increases mortality among individuals with diabetes: ten-year follow-up of the Nord-Tr\u00f8ndelag Health Study, Norway","volume":"32","author":"Iversen","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib21","doi-asserted-by":"crossref","first-page":"2590","DOI":"10.1007\/s00125-018-4723-y","article-title":"Amputation-free survival in 17,353 people at high risk for foot ulceration in diabetes: a national observational study","volume":"61","author":"Vadiveloo","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30081-6_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.apmr.2004.09.011","article-title":"Distal symmetrical polyneuropathy: a definition for clinical research. A report of the American Academy of Neurology, the American Association of Electrodiagnostic Medicine, and the American Academy of Physical Medicine and Rehabilitation","volume":"86","author":"England","year":"2005","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/S2213-8587(19)30081-6_bib23","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.2337\/diacare.25.11.2010","article-title":"Can motor nerve conduction velocity predict foot problems in diabetic subjects over a 6-year outcome period?","volume":"25","author":"Carrington","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib24","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1111\/j.1464-5491.2012.03644.x","article-title":"Use of the Michigan Neuropathy Screening Instrument as a measure of distal symmetrical peripheral neuropathy in type 1 diabetes","volume":"29","author":"Herman","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1111\/j.1464-5491.2009.02667.x","article-title":"Reliability and validity of the modified Toronto Clinical Neuropathy Score in diabetic sensorimotor polyneuropathy","volume":"26","author":"Bril","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib26","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1007\/BF00400697","article-title":"A multicentre study of the prevalence of diabetic peripheral neuropathy in the United Kingdom hospital clinic population","volume":"36","author":"Young","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30081-6_bib27","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archneurol.2012.1481","article-title":"\u201cUnequivocally abnormal\u201d vs \u201cusual\u201d signs and symptoms for proficient diagnosis of diabetic polyneuropathy: Cl vs N Phys Trial","volume":"69","author":"Dyck","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib28","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jvs.2009.05.017","article-title":"The Semmes Weinstein monofilament examination as a screening tool for diabetic peripheral neuropathy","volume":"50","author":"Feng","year":"2009","journal-title":"J Vasc Surg"},{"key":"10.1016\/S2213-8587(19)30081-6_bib29","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2337\/dc11-0156","article-title":"The Ipswich Touch Test: a simple and novel method to identify inpatients with diabetes at risk of foot ulceration","volume":"34","author":"Rayman","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib30","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1111\/j.1464-5491.2012.03730.x","article-title":"A pocket-sized disposable device for testing the integrity of sensation in the outpatient setting","volume":"29","author":"Bowling","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib31","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1742-481X.2012.01051.x","article-title":"Screening patients at risk for diabetic foot ulceration: a comparison between measurement of vibration perception threshold and 10-g monofilament test","volume":"11","author":"Richard","year":"2014","journal-title":"Int Wound J"},{"key":"10.1016\/S2213-8587(19)30081-6_bib32","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1016\/j.jdiacomp.2018.05.010","article-title":"Usefulness of the vibration perception thresholds measurement as a diagnostic method for diabetic peripheral neuropathy: Results from the Rio de Janeiro type 2 diabetes cohort study","volume":"32","author":"Santos","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(19)30081-6_bib33","first-page":"449","article-title":"Measurement of current perception thresholds using the Neurometer\u2014applicability in diabetic neuropathy","volume":"88","author":"Inceu","year":"2015","journal-title":"Clujul Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib34","doi-asserted-by":"crossref","first-page":"519","DOI":"10.4093\/dmj.2018.0068","article-title":"Patterns of nerve conduction abnormalities in patients with type 2 diabetes mellitus according to the clinical phenotype determined by the current perception threshold","volume":"42","author":"Park","year":"2018","journal-title":"Diabetes Metab J"},{"key":"10.1016\/S2213-8587(19)30081-6_bib35","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.pcd.2017.09.004","article-title":"Hidden dangers revealed by misdiagnosed diabetic neuropathy: a comparison of simple clinical tests for the screening of vibration perception threshold at primary care level","volume":"12","author":"Azzopardi","year":"2018","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/S2213-8587(19)30081-6_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2010.06.021","article-title":"The clinical use of the 10g monofilament and its limitations: a review","volume":"90","author":"Tan","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(19)30081-6_bib37","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0058783","article-title":"Identification and prediction of diabetic sensorimotor polyneuropathy using individual and simple combinations of nerve conduction study parameters","volume":"8","author":"Weisman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30081-6_bib38","series-title":"The Diabetic Retinopathy Barometer Report: global findings","year":"2017"},{"key":"10.1016\/S2213-8587(19)30081-6_bib39","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004015","article-title":"A comparison of the causes of blindness certifications in England and Wales in working age adults (16\u201364 years), 1999\u20132000 with 2009\u20132010","volume":"4","author":"Liew","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(19)30081-6_bib40","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1007\/s00125-012-2606-1","article-title":"Diabetic nephropathy in type 1 diabetes: has the outlook improved since the 1980s?","volume":"55","author":"Marshall","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30081-6_bib41","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/j.jdiacomp.2015.09.008","article-title":"High prevalence of diagnosed and undiagnosed polyneuropathy in subjects with and without diabetes participating in a nationwide educational initiative (PROTECT study)","volume":"29","author":"Ziegler","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(19)30081-6_bib42","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s12020-014-0285-z","article-title":"New vistas in the diagnosis of diabetic polyneuropathy","volume":"47","author":"Papanas","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(19)30081-6_bib43","article-title":"Reliability and validity of a point-of-care sural nerve conduction device for identification of diabetic neuropathy","volume":"9","author":"Lee","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30081-6_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1177\/1932296814551044","article-title":"Assessment of diabetic neuropathy using a point-of-care nerve conduction device shows significant associations with the LDIFLARE method and clinical neuropathy scoring","volume":"9","author":"Sharma","year":"2014","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib45","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1055\/s-2005-872912","article-title":"Reproducibility of a new indicator test for sudomotor function (Neuropad) in patients with type 2 diabetes mellitus","volume":"113","author":"Papanas","year":"2005","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/S2213-8587(19)30081-6_bib46","series-title":"Neuropad for detecting preclinical diabetic peripheral neuropathy","year":"2018"},{"key":"10.1016\/S2213-8587(19)30081-6_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138224","article-title":"SUDOSCAN: a simple, rapid, and objective method with potential for screening for diabetic peripheral neuropathy","volume":"10","author":"Selvarajah","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30081-6_bib48","first-page":"7","article-title":"Accuracy of a rapid and non-invasive method for the assessment of small fiber neuropathy based on measurement of electrochemical skin conductances","volume":"29","author":"Bordier","year":"2016","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(19)30081-6_bib49","doi-asserted-by":"crossref","first-page":"390","DOI":"10.5114\/aoms.2016.59265","article-title":"Evaluation of sural nerve automated nerve conduction study in the diagnosis of peripheral neuropathy in patients with type 2 diabetes mellitus","volume":"12","author":"Chatzikosma","year":"2016","journal-title":"Arch Med Sci"},{"key":"10.1016\/S2213-8587(19)30081-6_bib50","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1089\/dia.2006.8.654","article-title":"Diabetic nerve conduction abnormalities in the primary care setting","volume":"8","author":"Vinik","year":"2006","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(19)30081-6_bib51","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1016\/j.jdiacomp.2006.08.003","article-title":"Sensitivity and specificity of a new indicator test (Neuropad) for the diagnosis of peripheral neuropathy in type 2 diabetes patients: a comparison with clinical examination and nerve conduction study","volume":"21","author":"Papanas","year":"2007","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(19)30081-6_bib52","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jdi.12575","article-title":"Sudoscan is an effective screening method for asymptomatic diabetic neuropathy in Chinese type 2 diabetes mellitus patients","volume":"8","author":"Mao","year":"2017","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(19)30081-6_bib53","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1002\/mus.20732","article-title":"Intraepidermal nerve fiber density as a marker of early diabetic neuropathy","volume":"35","author":"Umapathi","year":"2007","journal-title":"Muscle Nerve"},{"key":"10.1016\/S2213-8587(19)30081-6_bib54","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.2337\/db07-0285","article-title":"Surrogate markers of small fiber damage in human diabetic neuropathy","volume":"56","author":"Quattrini","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30081-6_bib55","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1002\/dmrr.1222","article-title":"Small fibre neuropathy: role in the diagnosis of diabetic sensorimotor polyneuropathy","volume":"27","author":"Malik","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(19)30081-6_bib56","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1111\/j.1468-1331.2010.03023.x","volume":"17","author":"Lauria","year":"2010","journal-title":"Eur J Neurol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib57","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1111\/j.1464-5491.2011.03345.x","article-title":"Neuropad: evaluation of three cut-off points of sudomotor dysfunction for early detection of polyneuropathy in recently diagnosed diabetes","volume":"28","author":"Ziegler","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib58","doi-asserted-by":"crossref","first-page":"236","DOI":"10.2337\/dc07-1942","article-title":"Evaluation of the self-administered indicator plaster Neuropad for the diagnosis of neuropathy in diabetes","volume":"31","author":"Tentolouris","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib59","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1111\/j.1464-5491.2009.02760.x","article-title":"Neuropad as a diagnostic tool for diabetic autonomic and sensorimotor neuropathy","volume":"26","author":"Spallone","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib60","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/dme.12536","article-title":"The diagnostic accuracy of Neuropad for assessing large and small fibre diabetic neuropathy","volume":"31","author":"Ponirakis","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib61","article-title":"Validation of Neuropad in the assessment of peripheral diabetic neuropathy in patients with Diabetes Mellitus versus the Michigan Neuropathy Screening Instrument, 10 g Monofilament application and Biothesiometer measurement","author":"Didangelos","year":"2019","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib62","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.diabet.2010.05.004","article-title":"A new simple method for assessing sudomotor function: relevance in type 2 diabetes","volume":"36","author":"Mayaudon","year":"2010","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(19)30081-6_bib63","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1089\/dia.2013.0129","article-title":"Sudoscan, a noninvasive tool for detecting diabetic small fiber neuropathy and autonomic dysfunction","volume":"15","author":"Casellini","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(19)30081-6_bib64","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/jms.5.4.169","article-title":"The first report of the National Screening Committee","volume":"5","author":"Gray","year":"1998","journal-title":"J Med Screen"},{"key":"10.1016\/S2213-8587(19)30081-6_bib66","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1111\/dme.13630","article-title":"One-stop microvascular screening service: an effective model for the early detection of diabetic peripheral neuropathy and the high-risk foot","volume":"35","author":"Binns-Hall","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib67","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MED.0000000000000320","article-title":"Mediators of diabetic neuropathy: is hyperglycemia the only culprit?","volume":"24","author":"Grisold","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(19)30081-6_bib68","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa032782","article-title":"Vascular risk factors and diabetic neuropathy","volume":"352","author":"Tesfaye","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib69","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.2337\/dc17-2062","article-title":"Risk factors for incident diabetic polyneuropathy in a cohort with screen-detected type 2 diabetes followed for 13 years: ADDITION-Denmark","volume":"41","author":"Andersen","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1056\/NEJM199507133330203","article-title":"Natural history of peripheral neuropathy in patients with non-insulin-dependent diabetes mellitus","volume":"333","author":"Partanen","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib71","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1001\/jama.295.14.1707","article-title":"Glycemic variability: a hemoglobin A1c-independent risk factor for diabetic complications","volume":"295","author":"Brownlee","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30081-6_bib72","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2011.137","article-title":"Diabetic neuropathy: cellular mechanisms as therapeutic targets","volume":"7","author":"Vincent","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib73","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1007\/BF00505180","article-title":"Microangiopathy in human diabetic neuropathy: relationship between capillary abnormalities and the severity of neuropathy","volume":"32","author":"Malik","year":"1989","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30081-6_bib74","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1007\/BF00400804","article-title":"Impaired blood flow and arterio-venous shunting in human diabetic neuropathy: a novel technique of nerve photography and fluorescein angiography","volume":"36","author":"Tesfaye","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30081-6_bib75","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1002\/ana.410380607","article-title":"Effect of intensive diabetes treatment on nerve conduction in the Diabetes Control and Complications Trial","volume":"38","year":"1995","journal-title":"Ann Neurol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib76","doi-asserted-by":"crossref","first-page":"31","DOI":"10.2337\/dc13-2114","article-title":"Neuropathy and related findings in the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Martin","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib77","article-title":"Enhanced glucose control for preventing and treating diabetic neuropathy","volume":"6","author":"Callaghan","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(19)30081-6_bib78","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30081-6_bib79","doi-asserted-by":"crossref","first-page":"721","DOI":"10.2337\/dc09-1471","article-title":"Effect of intensive compared with standard glycemia treatment strategies on mortality by baseline subgroup characteristics: the Action to Control Cardiovascular Risk in Diabetes (ACCORD) trial","volume":"33","author":"Calles-Escandon","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib80","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1001\/jama.2009.476","article-title":"Cardiac outcomes after screening for asymptomatic coronary artery disease in patients with type 2 diabetes: the DIAD study: a randomized controlled trial","volume":"301","author":"Young","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30081-6_bib81","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib82","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s00125-012-2744-5","article-title":"Impact of early detection and treatment of diabetes on the 6-year prevalence of cardiac autonomic neuropathy in people with screen-detected diabetes: ADDITION-Denmark, a cluster-randomised study","volume":"56","author":"Charles","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30081-6_bib83","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/dc11-0903","article-title":"Prevalence of neuropathy and peripheral arterial disease and the impact of treatment in people with screen-detected type 2 diabetes: the ADDITION-Denmark study","volume":"34","author":"Charles","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib84","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib85","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(19)30081-6_bib86","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/S0140-6736(71)92415-9","article-title":"Improvement in nerve conduction following treatment in newly diagnosed diabetics","volume":"297","author":"Ward","year":"1971","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30081-6_bib87","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/dc13-0012","article-title":"Impact of glycemic control strategies on the progression of diabetic peripheral neuropathy in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) cohort","volume":"36","author":"Pop-Busui","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib88","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1111\/j.1529-8027.2009.00237.x","article-title":"Hyperlipidemia: a new therapeutic target for diabetic neuropathy","volume":"14","author":"Vincent","year":"2009","journal-title":"J Peripher Nerv Syst"},{"key":"10.1016\/S2213-8587(19)30081-6_bib89","doi-asserted-by":"crossref","first-page":"635","DOI":"10.2337\/dc10-0878","article-title":"Triglycerides and amputation risk in patients with diabetes: ten-year follow-up in the DISTANCE study","volume":"34","author":"Callaghan","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib90","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.2337\/db08-1771","article-title":"Elevated triglycerides correlate with progression of diabetic neuropathy","volume":"58","author":"Wiggin","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30081-6_bib91","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc16-0081","article-title":"Metabolic syndrome components are associated with symptomatic polyneuropathy independent of glycemic status","volume":"39","author":"Callaghan","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib92","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/dc05-2415","article-title":"Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)","volume":"29","author":"Knopp","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib93","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1016\/S0140-6736(03)13636-7","article-title":"MRC\/BHF Heart Protection Study of cholesterol-lowering with simvastatin in 5963 people with diabetes: a randomised placebo-controlled trial","volume":"361","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30081-6_bib94","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30081-6_bib95","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s00125-007-0919-2","article-title":"Lipid-lowering therapy and peripheral sensory neuropathy in type 2 diabetes: the Fremantle Diabetes Study","volume":"51","author":"Davis","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30081-6_bib96","first-page":"195","article-title":"Atorvastatin treatment improves diabetic polyneuropathy electrophysiological changes in non-insulin dependent diabetic patients: a double blind, randomized clinical trial","volume":"37","author":"Zangiabadi","year":"2012","journal-title":"Minerva Endocrinol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib97","first-page":"401","article-title":"Effect of rosuvastatin on diabetic polyneuropathy: a randomized, double-blind, placebo-controlled phase IIa study","volume":"7","author":"Hern\u00e1ndez-Ojeda","year":"2014","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/S2213-8587(19)30081-6_bib98","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2174\/138161209787315701","article-title":"Fibrates and microvascular complications in diabetes\u2014insight from the FIELD study","volume":"15","author":"Ansquer","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/S2213-8587(19)30081-6_bib99","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1016\/S2213-8587(14)70173-1","article-title":"Statin use before diabetes diagnosis and risk of microvascular disease: a nationwide nested matched study","volume":"2","author":"Nielsen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib100","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamaophthalmol.2018.6399","article-title":"Association of statin therapy with prevention of vision-threatening diabetic retinopathy","volume":"137","author":"Kang","year":"2019","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib101","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1159\/000098058","article-title":"Hypertension and sensorimotor peripheral neuropathy in type 2 diabetes","volume":"57","author":"Jarmuzewska","year":"2007","journal-title":"Eur Neurol"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(19)30081-6_bib102","first-page":"B54","article-title":"Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes","volume":"23","author":"Estacio","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib103","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2337\/diab.46.4.665","article-title":"Hypertension as a risk factor for diabetic neuropathy: a prospective study","volume":"46","author":"Forrest","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30081-6_bib104","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/S0140-6736(98)02478-7","article-title":"Effect of angiotensin-converting-enzyme (ACE) inhibitor trandolapril on human diabetic neuropathy: randomised double-blind controlled trial","volume":"352","author":"Malik","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30081-6_bib105","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.111.174474","article-title":"Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the Delapril and Manidipine for Nephroprotection in Diabetes (DEMAND) randomized clinical trial","volume":"58","author":"Ruggenenti","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(19)30081-6_bib106","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1464-5491.2004.01124.x","article-title":"Aggregation of features of the metabolic syndrome is associated with increased prevalence of chronic complications in type 2 diabetes","volume":"21","author":"Costa","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib107","doi-asserted-by":"crossref","first-page":"2701","DOI":"10.2337\/dc06-0942","article-title":"The metabolic syndrome is a risk indicator of microvascular and macrovascular complications in diabetes: results from Metascreen, a multicenter diabetes clinic-based survey","volume":"29","author":"Bonadonna","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib108","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.2337\/dc10-2150","article-title":"Peripheral vascular disease and peripheral neuropathy in individuals with cardiometabolic clustering and obesity: National Health and Nutrition Examination Survey 2001\u20132004","volume":"34","author":"Ylitalo","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib109","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jamaneurol.2016.3745","article-title":"Association between metabolic syndrome components and polyneuropathy in an obese population","volume":"73","author":"Callaghan","year":"2016","journal-title":"JAMA Neurol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib110","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13098-015-0010-y","article-title":"Peripheral neuropathy is associated with insulin resistance independent of metabolic syndrome","volume":"7","author":"Han","year":"2015","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/S2213-8587(19)30081-6_bib111","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1136\/jnnp-2016-314171","article-title":"Metabolic syndrome is related to polyneuropathy and impaired peripheral nerve function: a prospective population-based cohort study","volume":"87","author":"Hanewinckel","year":"2016","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S2213-8587(19)30081-6_bib112","doi-asserted-by":"crossref","first-page":"464","DOI":"10.2337\/dc07-1796","article-title":"Prevalence of polyneuropathy in pre-diabetes and diabetes is associated with abdominal obesity and macroangiopathy: the MONICA\/KORA Augsburg Surveys S2 and S3","volume":"31","author":"Ziegler","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib113","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.2337\/dc06-0224","article-title":"Lifestyle intervention for pre-diabetic neuropathy","volume":"29","author":"Smith","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib114","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.jdiacomp.2012.05.007","article-title":"The effect of exercise on neuropathic symptoms, nerve function, and cutaneous innervation in people with diabetic peripheral neuropathy","volume":"26","author":"Kluding","year":"2012","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(19)30081-6_bib115","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jdiacomp.2005.07.005","article-title":"Exercise training can modify the natural history of diabetic peripheral neuropathy","volume":"20","author":"Balducci","year":"2006","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(19)30081-6_bib116","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/ana.24310","article-title":"Supervised exercise improves cutaneous reinnervation capacity in metabolic syndrome patients","volume":"77","author":"Singleton","year":"2015","journal-title":"Ann Neurol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib117","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1016\/j.jdiacomp.2017.03.008","article-title":"Structured lifestyle intervention in patients with the metabolic syndrome mitigates oxidative stress but fails to improve measures of cardiovascular autonomic neuropathy","volume":"31","author":"Pennathur","year":"2017","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(19)30081-6_bib118","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30081-6_bib119","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/S0140-6736(98)07368-1","article-title":"Intensified multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: the Steno type 2 randomised study","volume":"353","author":"G\u00e6de","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30081-6_bib120","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2337\/dc13-1544","article-title":"Effect of early multifactorial therapy compared with routine care on microvascular outcomes at 5 years in people with screen-detected diabetes: a randomised controlled trial: the ADDITION-Europe study","volume":"37","author":"Sandb\u00e6k","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib121","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1007\/s00125-016-4065-6","article-title":"Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial","volume":"59","author":"G\u00e6de","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30081-6_bib123","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1001\/jama.291.3.335","article-title":"Poor control of risk factors for vascular disease among adults with previously diagnosed diabetes","volume":"291","author":"Saydah","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30081-6_bib124","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1002\/dmrr.2397","article-title":"Whither pathogenetic treatments for diabetic polyneuropathy?","volume":"29","author":"Boulton","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(19)30081-6_bib125","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/s41572-019-0092-1","article-title":"Diabetic neuropathy","volume":"5","author":"Feldman","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(19)30081-6_bib126","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/nrneurol.2011.137","article-title":"Diabetic neuropathy: cellular mechanisms as therapeutic targets","volume":"7","author":"Vincent","year":"2011","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib127","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/S1474-4422(14)70251-0","article-title":"Pharmacotherapy for neuropathic pain in adults: a systematic review and meta-analysis","volume":"14","author":"Finnerup","year":"2015","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(19)30081-6_bib128","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3099","article-title":"Aerobic exercise training may improve nerve function in type 2 diabetes and pre-diabetes: a systematic review","volume":"35","author":"Gu","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(19)30081-6_bib129","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib131","author":"Kerr"},{"key":"10.1016\/S2213-8587(19)30081-6_bib133","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/dme.13512","article-title":"Diabetes-related major lower limb amputation incidence is strongly related to diabetic foot service provision and improves with enhancement of services: peer review of the South-West of England","volume":"35","author":"Paisey","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30081-6_bib134","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0180175","article-title":"Diagnostic utility of corneal confocal microscopy and intra-epidermal nerve fibre density in diabetic neuropathy","volume":"12","author":"Alam","year":"2017","journal-title":"PloS One"},{"key":"10.1016\/S2213-8587(19)30081-6_bib135","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1016\/j.jcjd.2015.02.006","article-title":"In vivo corneal confocal microscopy and prediction of future-incident neuropathy in type 1 diabetes: a preliminary longitudinal analysis","volume":"39","author":"Lovblom","year":"2015","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(19)30081-6_bib136","doi-asserted-by":"crossref","first-page":"255","DOI":"10.4093\/dmj.2018.0056","article-title":"Diagnosing diabetic neuropathy: something old, something new","volume":"42","author":"Petropoulos","year":"2018","journal-title":"Diabetes Metab J"},{"key":"10.1016\/S2213-8587(19)30081-6_bib137","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2337\/dc14-2114","article-title":"Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes","volume":"38","author":"Pritchard","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30081-6_bib138","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1097\/ICO.0b013e3182749419","article-title":"Repeatability of in vivo corneal confocal microscopy to quantify corneal nerve morphology","volume":"32","author":"Petropoulos","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/S2213-8587(19)30081-6_bib139","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183040","article-title":"Corneal confocal microscopy is a rapid reproducible ophthalmic technique for quantifying corneal nerve abnormalities","volume":"12","author":"Kalteniece","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30081-6_bib140","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1167\/iovs.13-13787","article-title":"Rapid automated diagnosis of diabetic peripheral neuropathy with in vivo corneal confocal microscopy","volume":"55","author":"Petropoulos","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"5 suppl","key":"10.1016\/S2213-8587(19)30081-6_bib141","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1016\/j.jcjd.2016.08.062","article-title":"Results of an International Corneal Confocal Microscopy (CCM) Consortium: a pooled multicentre analysis of the concurrent diagnostic validity of CCM to identify diabetic polyneuropathy in type 1 diabetes mellitus","volume":"40","author":"Perkins","year":"2016","journal-title":"Can J Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300816?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300816?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:27Z","timestamp":1761991647000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300816"}},"issued":{"date-parts":[[2019,12]]},"references-count":136,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S2213858719300816"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30081-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic peripheral neuropathy: advances in diagnosis and strategies for screening and early intervention","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30081-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T17:56:29Z","timestamp":1793987789278,"version":"4.8.0"},"reference-count":102,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/s2213-8587(17)30358-3","type":"journal-article","created":{"date-parts":[[2017,10,23]],"date-time":"2017-10-23T11:49:49Z","timestamp":1508759389000},"page":"332-346","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":364,"title":["Interventions to prevent global childhood overweight and obesity: a systematic review"],"prefix":"10.1016","volume":"6","author":[{"given":"Sara N","family":"Bleich","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelsey A","family":"Vercammen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Y","family":"Zatz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannah M","family":"Frelier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara B","family":"Ebbeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30358-3_bib1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30358-3_bib2","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/obr.12360","article-title":"Trends in child and adolescent obesity prevalence in economically advanced countries according to socioeconomic position: a systematic review","volume":"17","author":"Chung","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30358-3_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/ije\/dyi272","article-title":"The emerging epidemic of obesity in developing countries","volume":"35","author":"Prentice","year":"2005","journal-title":"Int J Epidemiol"},{"issue":"suppl 4","key":"10.1016\/S2213-8587(17)30358-3_bib4","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1542\/peds.2007-2329C","article-title":"Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report","volume":"120","author":"Barlow","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(17)30358-3_bib5","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1016\/j.jaci.2004.11.050","article-title":"The epidemiology of obesity and asthma","volume":"115","author":"Ford","year":"2005","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S2213-8587(17)30358-3_bib6","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1136\/adc.88.12.1043","article-title":"A controlled study of sleep related disordered breathing in obese children","volume":"88","author":"Wing","year":"2003","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(17)30358-3_bib7","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1210\/jc.2002-021442","article-title":"Obesity and risk of type 2 diabetes and cardiovascular disease in children and adolescents","volume":"88","author":"Goran","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30358-3_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.jpeds.2006.08.042","article-title":"Cardiovascular risk factors and excess adiposity among overweight children and adolescents: the Bogalusa Heart Study","volume":"150","author":"Freedman","year":"2007","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(17)30358-3_bib9","doi-asserted-by":"crossref","first-page":"282","DOI":"10.3109\/17477160903473697","article-title":"Self-esteem and quality of life in obese children and adolescents: a systematic review","volume":"5","author":"Griffiths","year":"2010","journal-title":"Int J Pediatr Obes"},{"key":"10.1016\/S2213-8587(17)30358-3_bib10","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1038\/ijo.2014.117","article-title":"Are overweight and obese youths more often bullied by their peers? A meta-analysis on the relation between weight status and bullying","volume":"38","author":"Van Geel","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(17)30358-3_bib11","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1467-789X.2008.00475.x","article-title":"Tracking of childhood overweight into adulthood: a systematic review of the literature","volume":"9","author":"Singh","year":"2008","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30358-3_bib12","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1038\/ijo.2010.222","article-title":"Long-term impact of overweight and obesity in childhood and adolescence on morbidity and premature mortality in adulthood: systematic review","volume":"35","author":"Reilly","year":"2011","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(17)30358-3_bib13","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1016\/S0140-6736(12)61728-0","article-title":"Global and regional mortality from 235 causes of death for 20 age groups in 1990 and 2010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lozano","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30358-3_bib14","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30358-3_bib15","first-page":"2042","article-title":"Association of adolescent obesity with risk of severe obesity in adulthood","volume":"304","author":"Suchindran","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30358-3_bib16","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1467-789X.2009.00712.x","article-title":"The economic burden of obesity worldwide: a systematic review of the direct costs of obesity","volume":"12","author":"Withrow","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30358-3_bib17","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1111\/j.1467-789X.2009.00708.x","article-title":"Direct medical cost of overweight and obesity in the USA: a quantitative systematic review","volume":"12","author":"Tsai","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30358-3_bib18","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1542\/peds.2014-0063","article-title":"Lifetime direct medical costs of childhood obesity","volume":"133","author":"Finkelstein","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(17)30358-3_bib19","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1111\/obr.12446","article-title":"The effects of school-based lifestyle interventions on body mass index and blood pressure: a multivariate multilevel meta-analysis of randomized controlled trials","volume":"17","author":"Oosterhoff","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30358-3_bib20","doi-asserted-by":"crossref","first-page":"8940","DOI":"10.3390\/ijerph110908940","article-title":"Global school-based childhood obesity interventions: a review","volume":"11","author":"Ickes","year":"2014","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(17)30358-3_bib21","doi-asserted-by":"crossref","first-page":"4902714","DOI":"10.1155\/2016\/4902714","article-title":"A systematised review of primary school whole class child obesity interventions: effectiveness, characteristics, and strategies","volume":"2016","author":"Brown","year":"2016","journal-title":"Biomed Res Int"},{"key":"10.1016\/S2213-8587(17)30358-3_bib22","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/josh.12396","article-title":"Systematic review of school-based interventions to modify dietary behavior: does intervention intensity impact effectiveness?","volume":"86","author":"Racey","year":"2016","journal-title":"J Sch Health"},{"key":"10.1016\/S2213-8587(17)30358-3_bib23","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1467-789X.2008.00515.x","article-title":"Systematic review of school-based interventions that focus on changing dietary intake and physical activity levels to prevent childhood obesity: an update to the obesity guidance produced by the National Institute for Health and Clinical Excellence","volume":"10","author":"Brown","year":"2009","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30358-3_bib24","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1016\/j.ijnurstu.2015.10.017","article-title":"Interventions to prevent and manage overweight or obesity in preschool children: a systematic review","volume":"53","author":"Ling","year":"2016","journal-title":"Int J Nurs Stud"},{"key":"10.1016\/S2213-8587(17)30358-3_bib25","doi-asserted-by":"crossref","first-page":"e201","DOI":"10.1542\/peds.2013-0886","article-title":"Systematic review of community-based childhood obesity prevention studies","volume":"132","author":"Bleich","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(17)30358-3_bib26","doi-asserted-by":"crossref","first-page":"e193","DOI":"10.1542\/peds.2013-0786","article-title":"A systematic review of home-based childhood obesity prevention studies","volume":"132","author":"Showell","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(17)30358-3_bib27","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1111\/j.1467-789X.2011.00976.x","article-title":"Systematic review of family and home-based interventions targeting paediatric overweight and obesity","volume":"13","author":"Knowlden","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30358-3_bib28","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1467-789X.2010.00751.x","article-title":"Parental influence and obesity prevention in pre-schoolers: a systematic review of interventions","volume":"12","author":"Skouteris","year":"2011","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30358-3_bib29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1111\/obr.12277","article-title":"What childhood obesity prevention programmes work? A systematic review and meta-analysis","volume":"16","author":"Wang","year":"2015","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30358-3_bib30","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1097\/00003727-200601000-00005","article-title":"Public health perspectives on the family: an ecological approach to promoting health in the family and community","volume":"29","author":"Novilla","year":"2006","journal-title":"Fam Community Health"},{"key":"10.1016\/S2213-8587(17)30358-3_bib31","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1186\/s12966-016-0420-8","article-title":"Assessing the sustained impact of a school-based obesity prevention program for adolescent boys: the ATLAS cluster randomized controlled trial","volume":"13","author":"Lubans","year":"2016","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(17)30358-3_bib32","doi-asserted-by":"crossref","first-page":"e723","DOI":"10.1542\/peds.2014-1012","article-title":"Smart-phone obesity prevention trial for adolescent boys in low-income communities: the ATLAS RCT","volume":"134","author":"Smith","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(17)30358-3_bib33","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.amepre.2012.09.055","article-title":"Overweight and obesity prevention for adolescents: a cluster randomized controlled trial in a school setting","volume":"44","author":"Bonsergent","year":"2013","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(17)30358-3_bib34","doi-asserted-by":"crossref","first-page":"e77971","DOI":"10.1371\/journal.pone.0077971","article-title":"The costs and cost-effectiveness of a school-based comprehensive intervention study on childhood obesity in China","volume":"8","author":"Meng","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30358-3_bib35","doi-asserted-by":"crossref","first-page":"e20152493","DOI":"10.1542\/peds.2015-2493","article-title":"Two-year BMI outcomes from a school-based intervention for nutrition and exercise: a randomized trial","volume":"137","author":"Bogart","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(17)30358-3_bib36","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1186\/1471-2458-13-626","article-title":"Promoting healthy weight in primary school children through physical activity and nutrition education: a pragmatic evaluation of the CHANGE! randomised intervention study","volume":"13","author":"Fairclough","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(17)30358-3_bib37","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1111\/jan.13217","article-title":"The effectiveness of the COPE healthy lifestyles TEEN program: a school-based intervention in middle school adolescents with 12-month follow-up","volume":"73","author":"Ardic","year":"2017","journal-title":"J Adv Nurs"},{"key":"10.1016\/S2213-8587(17)30358-3_bib38","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1123\/pes.2015-0011","article-title":"Effectiveness of a school-based fitness program on youths' physical and psychosocial health outcomes","volume":"27","author":"Weiss","year":"2015","journal-title":"Pediatr Exerc Sci"},{"key":"10.1016\/S2213-8587(17)30358-3_bib39","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1136\/jech.52.6.377","article-title":"The feasibility of creating a checklist for the assessment of the methodological quality both of randomised and non-randomised studies of health care interventions","volume":"52","author":"Downs","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(17)30358-3_bib40","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/j.jmpt.2008.06.009","article-title":"Chiropractic treatment of pregnancy-related low back pain: a systematic review of the evidence","volume":"31","author":"Stuber","year":"2008","journal-title":"J Manipulative Physiol Ther"},{"key":"10.1016\/S2213-8587(17)30358-3_bib41","doi-asserted-by":"crossref","first-page":"180","DOI":"10.3129\/i08-001","article-title":"Age-related macular degeneration and low-vision rehabilitation: a systematic review","volume":"43","author":"Hooper","year":"2008","journal-title":"Can J Ophthalmol"},{"key":"10.1016\/S2213-8587(17)30358-3_bib42","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.2196\/jmir.1286","article-title":"Effectiveness of web-based interventions on patient empowerment: a systematic review and meta-analysis","volume":"12","author":"Samoocha","year":"2010","journal-title":"J Med Internet Res"},{"key":"10.1016\/S2213-8587(17)30358-3_bib43","doi-asserted-by":"crossref","first-page":"iii","DOI":"10.3310\/hta7270","article-title":"Evaluating non-randomised intervention studies","volume":"7","author":"Deeks","year":"2003","journal-title":"Health Technol Assess"},{"key":"10.1016\/S2213-8587(17)30358-3_bib44","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1111\/jpc.13447","article-title":"Effects of the Youth Fit 4 Life physical activity\/nutrition protocol on body mass index, fitness and targeted social cognitive theory variables in 9- to 12-year-olds during after-school care","volume":"53","author":"Annesi","year":"2017","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/S2213-8587(17)30358-3_bib45","doi-asserted-by":"crossref","first-page":"618293","DOI":"10.1155\/2014\/618293","article-title":"School-based obesity prevention intervention in Chilean children: effective in controlling, but not reducing obesity","volume":"2014","author":"Kain","year":"2014","journal-title":"J Obes"},{"key":"10.1016\/S2213-8587(17)30358-3_bib46","first-page":"42","article-title":"Four-year outcomes of an educational intervention in healthy habits in schoolchildren: the Avall 3 Trial","volume":"27","author":"Llargu\u00e9s","year":"2017","journal-title":"Eur J Public Health"},{"key":"10.1016\/S2213-8587(17)30358-3_bib47","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/1471-2431-13-45","article-title":"Long term effects of a health promotion intervention in low socioeconomic Arab- Israeli kindergartens","volume":"13","author":"Nemet","year":"2013","journal-title":"BMC Pediatrics"},{"key":"10.1016\/S2213-8587(17)30358-3_bib48","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/j.amepre.2014.12.014","article-title":"A randomized trial of multiple interventions for childhood obesity in China","volume":"48","author":"Cao","year":"2015","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(17)30358-3_bib49","doi-asserted-by":"crossref","first-page":"e57498","DOI":"10.1371\/journal.pone.0057498","article-title":"Effectiveness of a randomized school-based intervention involving families and teachers to prevent excessive weight gain among adolescents in Brazil","volume":"8","author":"Cunha","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30358-3_bib50","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.amepre.2013.04.014","article-title":"The nutrition and enjoyable activity for teen girls study: a cluster randomized controlled trial","volume":"45","author":"Dewar","year":"2013","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(17)30358-3_bib51","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.ypmed.2016.01.020","article-title":"Preventing obesity among Brazilian adolescent girls: six-month outcomes of the Healthy Habits, Healthy Girls-Brazil school-based randomized controlled trial","volume":"86","author":"Leme","year":"2016","journal-title":"Prev Med"},{"key":"10.1016\/S2213-8587(17)30358-3_bib52","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12966-014-0154-4","article-title":"Gender differences on effectiveness of a school-based physical activity intervention for reducing cardiometabolic risk: a cluster randomized trial","volume":"11","author":"Martinez-Vizcaino","year":"2014","journal-title":"Int J Behav Nutr Phys Act"},{"issue":"Suppl 3","key":"10.1016\/S2213-8587(17)30358-3_bib53","first-page":"374","article-title":"Impact of a school-based intervention program on obesity risk factors in Mexican children","volume":"55","author":"Safdie","year":"2013","journal-title":"Salud Publica Mex"},{"key":"10.1016\/S2213-8587(17)30358-3_bib54","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1001\/jamapediatrics.2013.3688","article-title":"Effectiveness of peer-based healthy living lesson plans on anthropometric measures and physical activity in elementary school students: a cluster randomized trial","volume":"168","author":"Santos","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(17)30358-3_bib55","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1038\/ijo.2014.23","article-title":"A socio-ecological approach promoting physical activity and limiting sedentary behavior in adolescence showed weight benefits maintained 2\u00b75 years after intervention cessation","volume":"38","author":"Simon","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(17)30358-3_bib56","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/1745-6215-15-58","article-title":"A primary-school-based study to reduce the prevalence of childhood obesity\u2014the EdAl (Educacio en Alimentacio) study: a randomized controlled trial","volume":"15","author":"Tarro","year":"2014","journal-title":"Trials"},{"key":"10.1016\/S2213-8587(17)30358-3_bib57","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.ehb.2015.03.005","article-title":"Evaluating the impact of a school-based health intervention using a randomized field experiment","volume":"18","author":"Greve","year":"2015","journal-title":"Econ Hum Biol"},{"key":"10.1016\/S2213-8587(17)30358-3_bib58","doi-asserted-by":"crossref","first-page":"e005496","DOI":"10.1136\/bmjopen-2014-005496","article-title":"EdAl-2 (Educaci\u00f3 en Alimentaci\u00f3) programme: reproducibility of a cluster randomised, interventional, primaryschool-based study to induce healthier lifestyle activities in children","volume":"4","author":"Llaurad\u00f3","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(17)30358-3_bib59","doi-asserted-by":"crossref","first-page":"e87929","DOI":"10.1371\/journal.pone.0087929","article-title":"Long-term effect of a school-based physical activity program (KISS) on fitness and adiposity in children: a cluster-randomized controlled trial","volume":"9","author":"Meyer","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30358-3_bib60","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/ijo.2012.126","article-title":"Using routinely collected growth data to assess a school-based obesity prevention strategy","volume":"37","author":"Rappaport","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(17)30358-3_bib61","first-page":"75","article-title":"Gender differences and a school-based obesity prevention program in Argentina: a randomized trial","volume":"34","author":"Rausch Herscovici","year":"2013","journal-title":"Rev Panam Salud Publica"},{"key":"10.1016\/S2213-8587(17)30358-3_bib62","first-page":"236","article-title":"The effectiveness of a cluster-randomized controlled childhood obesity prevention study among Chinese primary school students: CLICK-obesity","volume":"15","author":"Xu","year":"2014","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30358-3_bib63","doi-asserted-by":"crossref","first-page":"E163","DOI":"10.5888\/pcd13.150495","article-title":"A physical activity intervention and changes in body mass index at a middle school with a large American Indian population, Oklahoma, 2004\u20132009","volume":"13","author":"Eichner","year":"2016","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/S2213-8587(17)30358-3_bib64","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1002\/oby.21365","article-title":"Association between a school-based intervention and adiposity outcomes in adolescents: the Italian \u201cEAT\u201d project","volume":"24","author":"Ermetici","year":"2016","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(17)30358-3_bib65","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1089\/chi.2015.0073","article-title":"The MATCH program: long-term obesity prevention through a middle school based intervention","volume":"12","author":"Lazorick","year":"2016","journal-title":"Child Obes"},{"issue":"2 suppl","key":"10.1016\/S2213-8587(17)30358-3_bib66","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1353\/hpu.2013.0111","article-title":"Improving overweight among at-risk minority youth: results of a pilot intervention in after-school programs","volume":"24","author":"Slusser","year":"2013","journal-title":"J Health Care Poor Underserved"},{"key":"10.1016\/S2213-8587(17)30358-3_bib67","doi-asserted-by":"crossref","first-page":"e004579","DOI":"10.1136\/bmjopen-2013-004579","article-title":"Preventing childhood obesity, phase II feasibility study focusing on south Asians: BEACHeS","volume":"4","author":"Adab","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(17)30358-3_bib68","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1136\/archdischild-2015-308673","article-title":"Effectiveness of a 5-year school-based intervention programme to reduce adiposity and improve fitness and lifestyle in Indian children; the SYM-KEM study","volume":"101","author":"Bhave","year":"2016","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(17)30358-3_bib69","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1186\/1471-2431-13-170","article-title":"Effect of four additional physical education lessons on body composition in children aged 8\u201313 years\u2014a prospective study during two school years","volume":"13","author":"Klakk","year":"2013","journal-title":"BMC Pediatr"},{"key":"10.1016\/S2213-8587(17)30358-3_bib70","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1123\/jpah.10.2.185","article-title":"Examining the impact of 45 minutes of daily physical education on cognitive ability, fitness performance, and body composition of African American youth","volume":"10","author":"Reed","year":"2013","journal-title":"J Phys Act Health"},{"key":"10.1016\/S2213-8587(17)30358-3_bib71","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/josh.12072","article-title":"Healthy Buddies reduces body mass index z-score and waist circumference in Aboriginal children living in remote coastal communities","volume":"83","author":"Ronsley","year":"2013","journal-title":"J Sch Health"},{"key":"10.1016\/S2213-8587(17)30358-3_bib72","first-page":"14","article-title":"Effect of an obesity prevention program focused on motivating environments in childhood: a school-based prospective study","volume":"14","author":"Yang","year":"2017","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(17)30358-3_bib73","doi-asserted-by":"crossref","first-page":"37","DOI":"10.3109\/01460862.2013.777818","article-title":"Do swimming exercises induce anthropometric changes in adolescents?","volume":"36","author":"Bielec","year":"2013","journal-title":"Issues Compr Pediatr Nurs"},{"key":"10.1016\/S2213-8587(17)30358-3_bib74","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1111\/josh.12217","article-title":"Effects of daily physical education on physical fitness and weight status in middle school adolescents","volume":"85","author":"Erfle","year":"2015","journal-title":"J Sch Health"},{"key":"10.1016\/S2213-8587(17)30358-3_bib75","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1111\/josh.12433","article-title":"The role of ethnicity in school-based obesity intervention for school-aged children: a pilot evaluation","volume":"86","author":"Karczewski","year":"2016","journal-title":"J Sch Health"},{"key":"10.1016\/S2213-8587(17)30358-3_bib76","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4278\/ajhp.140820-QUAN-413","article-title":"Advancing school and community engagement now for disease prevention (ASCEND): a quasi-experimental trial of school-based interventions to prevent childhood obesity","volume":"31","author":"Treu","year":"2017","journal-title":"Am J Health Promot"},{"key":"10.1016\/S2213-8587(17)30358-3_bib77","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/jamapediatrics.2015.3778","article-title":"Effect of a school-based water intervention on child body mass index and obesity","volume":"170","author":"Schwartz","year":"2016","journal-title":"JAMA Pediatrics"},{"key":"10.1016\/S2213-8587(17)30358-3_bib78","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1007\/s12529-013-9361-7","article-title":"Effects of a cognitive-behaviorally based physical activity treatment for 4- and 5-year-old children attending US preschools","volume":"20","author":"Annesi","year":"2013","journal-title":"Int J Behav Med"},{"key":"10.1016\/S2213-8587(17)30358-3_bib79","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1097\/SMJ.0b013e3182a05bef","article-title":"Reducing high BMI in African American preschoolers: effects of a behavior-based physical activity intervention on caloric expenditure","volume":"106","author":"Annesi","year":"2013","journal-title":"South Med J"},{"key":"10.1016\/S2213-8587(17)30358-3_bib80","first-page":"13","article-title":"Obesity prevention program in childcare centers: two-year follow-up","volume":"13","author":"Natale","year":"2016","journal-title":"Am J Health Promot"},{"key":"10.1016\/S2213-8587(17)30358-3_bib81","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1002\/oby.20269","article-title":"Family-based hip-hop to health: outcome results","volume":"21","author":"Fitzgibbon","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(17)30358-3_bib82","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amepre.2015.07.008","article-title":"Hip-Hop to Health Jr randomized effectiveness trial: 1-year follow-up results","volume":"50","author":"Kong","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(17)30358-3_bib83","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/1471-2431-14-118","article-title":"A policy-driven multifaceted approach for early childhood physical fitness promotion: impacts on body composition and physical fitness in young Chinese children","volume":"14","author":"Zhou","year":"2014","journal-title":"BMC Pediatr"},{"key":"10.1016\/S2213-8587(17)30358-3_bib84","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1111\/j.2047-6310.2013.00164.x","article-title":"Childhood obesity prevention and control in city recreation centres and family homes: the MOVE\/me Muevo Project","volume":"9","author":"Elder","year":"2014","journal-title":"Pediatr Obes"},{"key":"10.1016\/S2213-8587(17)30358-3_bib85","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ypmed.2013.06.001","article-title":"Shape Up Somerville two-year results: a community-based environmental change intervention sustains weight reduction in children","volume":"57","author":"Economos","year":"2013","journal-title":"Prev Med"},{"key":"10.1016\/S2213-8587(17)30358-3_bib86","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/ijpo.12135","article-title":"Multifaceted community-based intervention reduces rate of BMI growth in obese Mexican-origin boys","volume":"12","author":"Sadeghi","year":"2017","journal-title":"Pediatr Obes"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(17)30358-3_bib87","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/obr.12368","article-title":"Impact of a community based health-promotion programme in 2- to 9-year-old children in Europe on markers of the metabolic syndrome, the IDEFICS study","volume":"16","author":"Marild","year":"2015","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30358-3_bib88","first-page":"25","article-title":"The outcomes of health-promoting communities: being active eating well initiative-a community-based obesity prevention intervention in Victoria, Australia","volume":"25","author":"Bolton","year":"2017","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(17)30358-3_bib89","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.2047-6310.2013.00201.x","article-title":"Large reductions in child overweight and obesity in intervention and comparison communities 3 years after a community project","volume":"9","author":"Swinburn","year":"2014","journal-title":"Pediatr Obes"},{"key":"10.1016\/S2213-8587(17)30358-3_bib90","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1111\/ijpo.12022","article-title":"Downward trends in the prevalence of childhood overweight in two pilot towns taking part in the VIASANO community-based programme in Belgium: data from a national school health monitoring system","volume":"11","author":"Vinck","year":"2016","journal-title":"Pediatr Obes"},{"key":"10.1016\/S2213-8587(17)30358-3_bib91","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s12966-015-0320-3","article-title":"Promoting healthful family meals to prevent obesity: HOME Plus, a randomized controlled trial","volume":"12","author":"Fulkerson","year":"2015","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(17)30358-3_bib92","first-page":"24","article-title":"Childhood obesity prevention cluster randomized trial for Hispanic families: outcomes of the healthy families study","volume":"24","author":"Hull","year":"2016","journal-title":"Pediatr Obes"},{"key":"10.1016\/S2213-8587(17)30358-3_bib93","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1016\/j.jand.2013.08.004","article-title":"Position of the Academy of Nutrition and Dietetics: interventions for the prevention and treatment of pediatric overweight and obesity","volume":"113","author":"Hoelscher","year":"2013","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/S2213-8587(17)30358-3_bib94","series-title":"Accelerating progress in obesity prevention: solving the weight of the nation","year":"2012"},{"key":"10.1016\/S2213-8587(17)30358-3_bib95","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Collaborators","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30358-3_bib96","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.1016\/S0140-6736(14)61744-X","article-title":"Patchy progress on obesity prevention: emerging examples, entrenched barriers, and new thinking","volume":"385","author":"Roberto","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30358-3_bib97","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1016\/S0140-6736(14)61746-3","article-title":"Child and adolescent obesity: part of a bigger picture","volume":"385","author":"Lobstein","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30358-3_bib98","series-title":"Childhood obesity prevention programs: comparative effectiveness review and meta-analysis","author":"Wang","year":"2013"},{"key":"10.1016\/S2213-8587(17)30358-3_bib99","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S0140-6736(11)60815-5","article-title":"Changing the future of obesity: science, policy, and action","volume":"378","author":"Gortmaker","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30358-3_bib100","series-title":"Report of the commission on ending childhood obesity","year":"2016"},{"key":"10.1016\/S2213-8587(17)30358-3_bib101","doi-asserted-by":"crossref","first-page":"68","DOI":"10.4103\/2008-7802.162059","article-title":"Effect of school-based interventions to control childhood obesity: a review of reviews","volume":"6","author":"Amini","year":"2015","journal-title":"Int J Prev Med"},{"key":"10.1016\/S2213-8587(17)30358-3_bib102","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1038\/sj.ijo.0801401","article-title":"Waist circumference and waist-to-height ratio are better predictors of cardiovascular disease risk factors in children than body mass index","volume":"24","author":"Savva","year":"2000","journal-title":"Int J Obes Relat Metab Disord"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303583?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303583?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:27Z","timestamp":1761991587000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303583"}},"issued":{"date-parts":[[2018,4]]},"references-count":102,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2213858717303583"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30358-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Interventions to prevent global childhood overweight and obesity: a systematic review","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30358-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T19:38:45Z","timestamp":1793993925289,"version":"4.8.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006939","name":"EMORY UNIVERSITY","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006939","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/s2213-8587(25)00162-7","type":"journal-article","created":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T18:33:31Z","timestamp":1749062011000},"page":"538-539","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["IcoSema and the evolution of fixed-ratio insulin\u2013GLP-1 receptor agonist therapies"],"prefix":"10.1016","volume":"13","author":[{"given":"Guillermo","family":"Umpierrez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thaer","family":"Idrees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00162-7_bib1","doi-asserted-by":"crossref","first-page":"253","DOI":"10.2337\/ds22-0064","article-title":"Initiation of iGlarLixi versus basal-bolus insulin in adults with type 2 diabetes advancing from basal insulin therapy: the SoliComplex real-world study","volume":"36","author":"Pantalone","year":"2023","journal-title":"Diabetes Spectr"},{"key":"10.1016\/S2213-8587(25)00162-7_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s13300-019-00735-7","article-title":"Efficacy and safety of iGlarLixi, fixed-ratio combination of insulin glargine and lixisenatide, compared with basal-bolus regimen in patients with type 2 diabetes: propensity score matched analysis","volume":"11","author":"Tab\u00e1k","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(25)00162-7_bib3","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/dom.13343","article-title":"Free and fixed-ratio combinations of basal insulin and GLP-1 receptor agonists versus basal insulin intensification in type 2 diabetes: a systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Maiorino","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(25)00162-7_bib4","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.2337\/dc17-1114","article-title":"Efficacy and safety of IDegLira versus basal-bolus insulin therapy in patients with type 2 diabetes uncontrolled on metformin and basal insulin: the Dual VII randomized clinical trial","volume":"41","author":"Billings","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00162-7_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00096-8","article-title":"Once-weekly IcoSema versus once-weekly insulin icodec in type 2 diabetes management (COMBINE 1): an open-label, multicentre, treat-to-target, randomised, phase 3a trial","author":"Mathieu","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00162-7_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00052-X","article-title":"Once-weekly IcoSema versus multiple daily insulin injections in type 2 diabetes management (COMBINE 3): an open-label, multicentre, treat-to-target, non-inferiority, randomised, phase 3a trial","author":"Billings","year":"2025","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001627?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001627?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:25:48Z","timestamp":1766525148000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725001627"}},"issued":{"date-parts":[[2025,7]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2213858725001627"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00162-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"IcoSema and the evolution of fixed-ratio insulin\u2013GLP-1 receptor agonist therapies","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00162-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00052-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00096-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:15:35Z","timestamp":1794107735507,"version":"4.8.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/s2213-8587(24)00304-8","type":"journal-article","created":{"date-parts":[[2025,1,20]],"date-time":"2025-01-20T18:31:01Z","timestamp":1737397861000},"page":"196-209","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial"],"prefix":"10.1016","volume":"13","author":[{"given":"Melanie J","family":"Davies","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subodh","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shachi","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaja M","family":"Chinnakondepalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry A","family":"Borlaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dalane W","family":"Kitzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv J","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe","family":"Harring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afshin","family":"Salsali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren","family":"Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"von Lewinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter","family":"Abhayaratna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail N","family":"Kosiborod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00304-8_bib1","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.15420\/cfr.2023.03","article-title":"Epidemiology, clinical characteristics and cause-specific outcomes in heart failure with preserved ejection fraction","volume":"9","author":"Kapelios","year":"2023","journal-title":"Card Fail Rev"},{"key":"10.1016\/S2213-8587(24)00304-8_bib2","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/s41467-019-13690-5","article-title":"Genome-wide association and Mendelian randomisation analysis provide insights into the pathogenesis of heart failure","volume":"11","author":"Shah","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00304-8_bib3","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1016\/j.jchf.2018.08.007","article-title":"Pivotal role of excess intra-abdominal adipose in the pathogenesis of metabolic\/obese HFpEF","volume":"6","author":"Kitzman","year":"2018","journal-title":"JACC Heart Fail"},{"key":"10.1016\/S2213-8587(24)00304-8_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ejhf.2403","article-title":"Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction","volume":"24","author":"Jackson","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(24)00304-8_bib5","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.amjcard.2009.09.041","article-title":"Comparison of patients with heart failure and preserved left ventricular ejection fraction among those with versus without diabetes mellitus","volume":"105","author":"Aguilar","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(24)00304-8_bib6","doi-asserted-by":"crossref","DOI":"10.1093\/jmcb\/mjac028","article-title":"Heart failure with preserved ejection fraction (HFpEF) in type 2 diabetes mellitus: from pathophysiology to therapeutics","volume":"14","author":"Abudureyimu","year":"2022","journal-title":"J Mol Cell Biol"},{"key":"10.1016\/S2213-8587(24)00304-8_bib7","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1016\/j.jchf.2023.05.010","article-title":"Design and baseline characteristics of STEP-HFpEF program evaluating semaglutide in patients with obesity HFpEF phenotype","volume":"11","author":"Kosiborod","year":"2023","journal-title":"JACC Heart Fail"},{"key":"10.1016\/S2213-8587(24)00304-8_bib8","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00304-8_bib9","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1056\/NEJMoa2313917","article-title":"Semaglutide in patients with obesity-related heart failure and type 2 diabetes","volume":"390","author":"Kosiborod","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00304-8_bib10","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of Hyperglycemia in Type 2 Diabetes, 2022. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00304-8_bib11","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1016\/S0735-1097(00)00531-3","article-title":"Development and evaluation of the Kansas City Cardiomyopathy Questionnaire: a new health status measure for heart failure","volume":"35","author":"Green","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(24)00304-8_bib12","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1016\/j.jacc.2020.09.542","article-title":"Interpreting the Kansas City Cardiomyopathy Questionnaire in clinical trials and clinical care: JACC state-of-the-art review","volume":"76","author":"Spertus","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(24)00304-8_bib13","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1016\/S0140-6736(24)00469-0","article-title":"Semaglutide versus placebo in people with obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF DM randomised trials","volume":"403","author":"Butler","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00304-8_bib14","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/1467-9868.00259","article-title":"Semiparametric regression for the mean and rate functions of recurrent events","volume":"62","author":"Lin","year":"2000","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/S2213-8587(24)00304-8_bib15","first-page":"141","article-title":"An empirical transition matrix for non-homogeneous Markov chains based on censored observations","volume":"5","author":"Aalen","year":"1978","journal-title":"Scand J Stat"},{"key":"10.1016\/S2213-8587(24)00304-8_bib16","doi-asserted-by":"crossref","first-page":"R1101","DOI":"10.1152\/ajpregu.00390.2012","article-title":"Sodium-retaining effect of insulin in diabetes","volume":"303","author":"Brands","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/S2213-8587(24)00304-8_bib17","doi-asserted-by":"crossref","first-page":"2358","DOI":"10.1038\/s41591-023-02526-x","article-title":"Semaglutide in HFpEF across obesity class and by body weight reduction: a prespecified analysis of the STEP-HFpEF trial","volume":"29","author":"Borlaug","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00304-8_bib18","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/j.jacc.2024.04.022","article-title":"Semaglutide and NT-proBNP in obesity-related HFpEF: insights from the STEP-HFpEF program","volume":"84","author":"Petrie","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(24)00304-8_bib19","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00304-8_bib20","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00304-8_bib21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00304-8_bib22","doi-asserted-by":"crossref","first-page":"3254","DOI":"10.1093\/eurheartj\/ehae322","article-title":"Semaglutide and diuretic use in obesity-related heart failure with preserved ejection fraction: a pooled analysis of the STEP-HFpEF and STEP-HFpEF-DM trials","volume":"45","author":"Shah","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(24)00304-8_bib23","article-title":"Sparse data bias: a problem hiding in plain sight","volume":"352","author":"Greenland","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00304-8_bib24","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T15:45:14Z","timestamp":1741448714000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003048"}},"issued":{"date-parts":[[2025,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213858724003048"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00304-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semaglutide in obesity-related heart failure with preserved ejection fraction and type 2 diabetes across baseline HbA1c levels (STEP-HFpEF DM): a prespecified analysis of heart failure and metabolic outcomes from a randomised, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00304-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00335-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T22:46:03Z","timestamp":1794264363421,"version":"4.9.0"},"reference-count":90,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/s2213-8587(17)30357-1","type":"journal-article","created":{"date-parts":[[2017,11,5]],"date-time":"2017-11-05T23:57:09Z","timestamp":1509926229000},"page":"986-1004","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":291,"title":["Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials"],"prefix":"10.1016","volume":"5","author":[{"given":"Philippe","family":"Autier","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Mullie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alina","family":"Macacu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miruna","family":"Dragomir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magali","family":"Boniol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kim","family":"Coppens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9cile","family":"Pizot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathieu","family":"Boniol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30357-1_bib1","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1210\/jc.2010-2704","article-title":"The 2011 report on dietary reference intakes for calcium and vitamin D from the Institute of Medicine: what clinicians need to know","volume":"96","author":"Ross","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30357-1_bib2","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.jsbmb.2015.01.021","article-title":"Vitamin D and health: the need for more randomized controlled trials","volume":"148","author":"Jorde","year":"2015","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S2213-8587(17)30357-1_bib3","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/nure.12090","article-title":"Guidelines for optimizing design and analysis of clinical studies of nutrient effects","volume":"72","author":"Heaney","year":"2014","journal-title":"Nutr Rev"},{"key":"10.1016\/S2213-8587(17)30357-1_bib4","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S2213-8587(13)70165-7","article-title":"Vitamin D status and ill health: a systematic review","volume":"2","author":"Autier","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30357-1_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2213-8587(13)70212-2","article-title":"The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis","volume":"2","author":"Bolland","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30357-1_bib6","doi-asserted-by":"crossref","first-page":"g2035","DOI":"10.1136\/bmj.g2035","article-title":"Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials","volume":"348","author":"Theodoratou","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30357-1_bib7","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30357-1_bib8","doi-asserted-by":"crossref","first-page":"d2040","DOI":"10.1136\/bmj.d2040","article-title":"Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis","volume":"342","author":"Bolland","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30357-1_bib9","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1111\/j.1742-1241.2009.02312.x","article-title":"Effect of a high-calcium energy-reduced diet on abdominal obesity and cardiometabolic risk factors in obese Brazilian subjects","volume":"64","author":"Torres","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/S2213-8587(17)30357-1_bib10","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1471-2288-7-10","article-title":"Development of AMSTAR: a measurement tool to assess the methodological quality of systematic reviews","volume":"7","author":"Shea","year":"2007","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/S2213-8587(17)30357-1_bib11","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1001\/jama.1995.03520290060030","article-title":"Empirical evidence of bias. Dimensions of methodological quality associated with estimates of treatment effects in controlled trials","volume":"273","author":"Schulz","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30357-1_bib12","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30357-1_bib13","series-title":"Agency for Healthcare Research Quality. Methods guide for comparative effectiveness reviews","article-title":"Handling continuous outcomes in quantitative synthesis","author":"Fu","year":"2013"},{"key":"10.1016\/S2213-8587(17)30357-1_bib14","article-title":"Vitamin D supplementation for prevention of mortality in adults","volume":"1","author":"Bjelakovic","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30357-1_bib15","doi-asserted-by":"crossref","first-page":"746","DOI":"10.3945\/ajcn.113.082602","article-title":"Cardiovascular disease and vitamin D supplementation: trial analysis, systematic review, and meta-analysis","volume":"100","author":"Ford","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30357-1_bib16","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00394-016-1159-3","article-title":"Effects of vitamin D supplementation on endothelial function: a systematic review and meta-analysis of randomised clinical trials","volume":"56","author":"Hussin","year":"2017","journal-title":"Eur J Nutr"},{"key":"10.1016\/S2213-8587(17)30357-1_bib17","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1001\/jamainternmed.2015.0237","article-title":"Effect of vitamin D supplementation on blood pressure: a systematic review and meta-analysis incorporating individual patient data","volume":"175","author":"Beveridge","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(17)30357-1_bib18","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1111\/eci.12510","article-title":"Vitamin D and cardiovascular risk among adults with obesity: a systematic review and meta-analysis","volume":"45","author":"Manousopoulou","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S2213-8587(17)30357-1_bib19","article-title":"Vitamin D supplementation for prevention of cancer in adults","volume":"6","author":"Bjelakovic","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30357-1_bib20","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1038\/bjc.2014.294","article-title":"Vitamin D supplements and cancer incidence and mortality: a meta-analysis","volume":"111","author":"Keum","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(17)30357-1_bib21","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1093\/nutrit\/nuv012","article-title":"Effect of vitamin D supplementation alone or with calcium on adiposity measures: a systematic review and meta-analysis of randomized controlled trials","volume":"73","author":"Chandler","year":"2015","journal-title":"Nutr Rev"},{"key":"10.1016\/S2213-8587(17)30357-1_bib22","doi-asserted-by":"crossref","first-page":"3551","DOI":"10.1210\/jc.2014-2136","article-title":"Effect of vitamin D3 supplementation on improving glucose homeostasis and preventing diabetes: a systematic review and meta-analysis","volume":"99","author":"Seida","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30357-1_bib23","doi-asserted-by":"crossref","first-page":"16142","DOI":"10.1038\/srep16142","article-title":"The effect of vitamin D supplementation on insulin and glucose metabolism in overweight and obese individuals: systematic review with meta-analysis","volume":"5","author":"Jamka","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(17)30357-1_bib24","doi-asserted-by":"crossref","first-page":"i6583","DOI":"10.1136\/bmj.i6583","article-title":"Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data","volume":"356","author":"Martineau","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30357-1_bib25","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008824.pub2","article-title":"Vitamin D supplementation for preventing infections in children under five years of age","volume":"11","author":"Yakoob","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30357-1_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40001-016-0208-y","article-title":"Vitamin D and airway infections: a European perspective","volume":"21","author":"Zittermann","year":"2016","journal-title":"Eur J Med Res"},{"key":"10.1016\/S2213-8587(17)30357-1_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006086.pub4","article-title":"Nutritional supplements for people being treated for active tuberculosis","volume":"6","author":"Grobler","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30357-1_bib28","article-title":"Vitamin D for the management of asthma","volume":"9","author":"Martineau","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30357-1_bib29","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1016\/j.jaip.2016.09.024","article-title":"Prenatal intake of vitamins and allergic outcomes in the offspring: a systematic review and meta-analysis","volume":"5","author":"Vahdaninia","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/S2213-8587(17)30357-1_bib30","doi-asserted-by":"crossref","first-page":"4336","DOI":"10.1210\/jc.2014-1742","article-title":"The effects of vitamin D on skeletal muscle strength, muscle mass, and muscle power: a systematic review and meta-analysis of randomized controlled trials","volume":"99","author":"Beaudart","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30357-1_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/jhn.12394","article-title":"Vitamin D supplementation and its influence on muscle strength and mobility in community-dwelling older persons: a systematic review and meta-analysis","volume":"30","author":"Rosendahl-Riise","year":"2017","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/S2213-8587(17)30357-1_bib32","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1177\/1352458513489756","article-title":"The effect of vitamin D-related interventions on multiple sclerosis relapses: a meta-analysis","volume":"19","author":"James","year":"2013","journal-title":"Mult Scler"},{"key":"10.1016\/S2213-8587(17)30357-1_bib33","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1177\/1352458517690271","article-title":"A systematic review of the effects of modifiable risk factor interventions on the progression of multiple sclerosis","volume":"23","author":"Hempel","year":"2017","journal-title":"Mult Scler"},{"key":"10.1016\/S2213-8587(17)30357-1_bib34","first-page":"415","article-title":"Effect of vitamin D supplementation on pain: a systematic review and meta-analysis","volume":"19","author":"Wu","year":"2016","journal-title":"Pain Physician"},{"key":"10.1016\/S2213-8587(17)30357-1_bib35","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.nut.2014.06.017","article-title":"Vitamin D supplementation to reduce depression in adults: meta-analysis of randomized controlled trials","volume":"31","author":"Gowda","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/S2213-8587(17)30357-1_bib36","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1097\/PSY.0000000000000044","article-title":"Vitamin D supplementation for depressive symptoms: a systematic review and meta-analysis of randomized controlled trials","volume":"76","author":"Shaffer","year":"2014","journal-title":"Psychosom Med"},{"key":"10.1016\/S2213-8587(17)30357-1_bib37","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1210\/jc.2013-3450","article-title":"Efficacy of vitamin D supplementation in depression in adults: a systematic review","volume":"99","author":"Li","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30357-1_bib38","doi-asserted-by":"crossref","first-page":"e7024","DOI":"10.1097\/MD.0000000000007024","article-title":"Vitamin D supplementation and disease activity in patients with immune-mediated rheumatic diseases: a systematic review and meta-analysis","volume":"96","author":"Franco","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S2213-8587(17)30357-1_bib39","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1007\/s00394-015-1089-5","article-title":"The effect of vitamin D supplementation on selected inflammatory biomarkers in obese and overweight subjects: a systematic review with meta-analysis","volume":"55","author":"Jamka","year":"2016","journal-title":"Eur J Nutr"},{"key":"10.1016\/S2213-8587(17)30357-1_bib40","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.ejim.2013.03.005","article-title":"Effects of vitamin D supplementation on body fat accumulation, inflammation, and metabolic risk factors in obese adults with low vitamin D levels\u2014results from a randomized trial","volume":"24","author":"Wamberg","year":"2013","journal-title":"Eur J Intern Med"},{"key":"10.1016\/S2213-8587(17)30357-1_bib41","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1093\/gerona\/glp006","article-title":"Calcium plus vitamin D supplementation and mortality in postmenopausal women: the Women's Health Initiative calcium\u2013vitamin D randomized controlled trial","volume":"64","author":"LaCroix","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(17)30357-1_bib42","doi-asserted-by":"crossref","first-page":"764","DOI":"10.3945\/ajcn.110.007336","article-title":"Daily consumption of vitamin D- or vitamin D + calcium-fortified yogurt drink improved glycemic control in patients with type 2 diabetes: a randomized clinical trial","volume":"93","author":"Nikooyeh","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30357-1_bib43","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1741-7015-9-125","article-title":"Regular consumption of vitamin D-fortified yogurt drink (Doogh) improved endothelial biomarkers in subjects with type 2 diabetes: a randomized double-blind clinical trial","volume":"9","author":"Shab-Bidar","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(17)30357-1_bib44","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007470.pub2","article-title":"Vitamin D supplementation for prevention of mortality in adults","volume":"7","author":"Bjelakovic","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30357-1_bib45","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1001\/jama.2014.13204","article-title":"Effect of high-dose vitamin D3 on hospital length of stay in critically ill patients with vitamin D deficiency: the VITdAL-ICU randomized clinical trial","volume":"312","author":"Amrein","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30357-1_bib46","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1001\/jamacardio.2017.0175","article-title":"Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the Vitamin D Assessment Study: a randomized clinical trial","volume":"2","author":"Scragg","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(17)30357-1_bib47","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1161\/CIRCHEARTFAILURE.114.001738","article-title":"Risk of heart failure among postmenopausal women: a secondary analysis of the randomized trial of vitamin D plus calcium of the Women's Health Initiative","volume":"8","author":"Donneyong","year":"2015","journal-title":"Circ Heart Fail"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30357-1_bib48","first-page":"3","article-title":"Arterial stiffness: recommendations and standardization","volume":"4","author":"Townsend","year":"2017","journal-title":"Pulse (Basel)"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(17)30357-1_bib49","doi-asserted-by":"crossref","first-page":"S314","DOI":"10.2337\/dc09-S330","article-title":"Endothelial dysfunction as a target for prevention of cardiovascular disease","volume":"32","author":"Versari","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30357-1_bib50","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1056\/NEJMoa055222","article-title":"Calcium plus vitamin D supplementation and the risk of colorectal cancer","volume":"354","author":"Wactawski-Wende","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30357-1_bib51","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.326.7387.469","article-title":"Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial","volume":"326","author":"Trivedi","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30357-1_bib52","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/jc.2011-1309","article-title":"Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D3 and\/or calcium (RECORD trial)","volume":"97","author":"Avenell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30357-1_bib53","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1001\/jama.2017.2115","article-title":"Effect of vitamin D and calcium supplementation on cancer incidence in older women: a randomized clinical trial","volume":"317","author":"Lappe","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30357-1_bib54","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1500409","article-title":"A trial of calcium and vitamin D for the prevention of colorectal adenomas","volume":"373","author":"Baron","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30357-1_bib55","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1210\/jc.2015-4013","article-title":"Vitamin D 20\u2008000 IU per week for five years does not prevent progression from prediabetes to diabetes","volume":"101","author":"Jorde","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30357-1_bib56","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1080\/23744235.2016.1201853","article-title":"Prevention of urinary tract infections with vitamin D supplementation 20,000 IU per week for five years. Results from an RCT including 511 subjects","volume":"48","author":"Jorde","year":"2016","journal-title":"Infect Dis (Lond)"},{"key":"10.1016\/S2213-8587(17)30357-1_bib57","doi-asserted-by":"crossref","first-page":"d2975","DOI":"10.1136\/bmj.d2975","article-title":"Effect of weekly vitamin D supplements on mortality, morbidity, and growth of low birthweight term infants in India up to age 6 months: randomised controlled trial","volume":"342","author":"Kumar","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30357-1_bib58","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1164\/rccm.200804-567OC","article-title":"Vitamin D as supplementary treatment for tuberculosis: a double-blind, randomized, placebo-controlled trial","volume":"179","author":"Wejse","year":"2009","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S2213-8587(17)30357-1_bib59","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1590\/1516-3180.20161343T2","article-title":"Vitamin D supplementation for women during pregnancy","volume":"134","author":"De-Regil","year":"2016","journal-title":"Sao Paulo Med J"},{"key":"10.1016\/S2213-8587(17)30357-1_bib60","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.fertnstert.2015.02.019","article-title":"Effect of vitamin D supplementation during pregnancy on maternal and neonatal outcomes: a systematic review and meta-analysis of randomized controlled trials","volume":"103","author":"P\u00e9rez-L\u00f3pez","year":"2015","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(17)30357-1_bib61","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000358338","article-title":"Vitamin D and pre-eclampsia: original data, systematic review and meta-analysis","volume":"63","author":"Hypp\u00f6nen","year":"2013","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/S2213-8587(17)30357-1_bib62","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1111\/jog.13239","article-title":"Vitamin D and risk of preterm birth: up-to-date meta-analysis of randomized controlled trials and observational studies","volume":"43","author":"Zhou","year":"2017","journal-title":"J Obstet Gynaecol Res"},{"key":"10.1016\/S2213-8587(17)30357-1_bib63","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1111\/j.1471-0528.1946.tb05778.x","article-title":"The nutrition of expectant and nursing mothers in relation to maternal and infant mortality and morbidity","volume":"53","year":"1946","journal-title":"J Obstet Gynaecol Br Emp"},{"key":"10.1016\/S2213-8587(17)30357-1_bib64","first-page":"151","article-title":"Prevention of preeclampsia with low-dose aspirin or calcium supplementation","volume":"5","author":"Taherian","year":"2002","journal-title":"Arch Iran Med"},{"key":"10.1016\/S2213-8587(17)30357-1_bib65","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1111\/cen.12751","article-title":"Supplementation of vitamin D in pregnancy and its correlation with feto-maternal outcome","volume":"83","author":"Sablok","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(17)30357-1_bib66","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1001\/jama.2015.18318","article-title":"Effect of vitamin D3 supplementation during pregnancy on risk of persistent wheeze in the offspring: a randomized clinical trial","volume":"315","author":"Chawes","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30357-1_bib67","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1001\/jama.2015.18589","article-title":"Effect of prenatal supplementation with vitamin D on asthma or recurrent wheezing in offspring by age 3 years: the VDAART randomized clinical trial","volume":"315","author":"Litonjua","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30357-1_bib68","first-page":"687","article-title":"The effects of vitamin D supplementation on maternal and neonatal outcome: a randomized clinical trial","volume":"13","author":"Mojibian","year":"2015","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/S2213-8587(17)30357-1_bib70","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30357-1_bib71","doi-asserted-by":"crossref","first-page":"e66627","DOI":"10.1371\/journal.pone.0066627","article-title":"Prenatal vitamin D supplementation and child respiratory health: a randomised controlled trial","volume":"8","author":"Goldring","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30357-1_bib72","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/bmj.332.7547.969","article-title":"Reporting attrition in randomised controlled trials","volume":"332","author":"Dumville","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30357-1_bib73","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S0140-6736(02)07882-0","article-title":"Sample size slippages in randomised trials: exclusions and the lost and wayward","volume":"359","author":"Schulz","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30357-1_bib74","first-page":"430","article-title":"Data extraction errors in meta-analyses that use standardized mean differences","volume":"298","author":"Gotzsche","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30357-1_bib75","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.jclinepi.2005.11.010","article-title":"Single data extraction generated more errors than double data extraction in systematic reviews","volume":"59","author":"Buscemi","year":"2006","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(17)30357-1_bib76","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1002\/jrsm.1092","article-title":"A tool to assess the quality of a meta-analysis","volume":"4","author":"Higgins","year":"2013","journal-title":"Res Synth Methods"},{"key":"10.1016\/S2213-8587(17)30357-1_bib77","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1200\/JCO.2014.59.2386","article-title":"Plasma vitamin D concentration and survival in colorectal cancer: potential confounding by the systemic inflammatory response","volume":"33","author":"Conway","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(17)30357-1_bib78","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1038\/bjc.2013.418","article-title":"Cancer and systemic inflammation: stage the tumour and stage the host","volume":"109","author":"McMillan","year":"2013","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(17)30357-1_bib79","doi-asserted-by":"crossref","first-page":"e0170791","DOI":"10.1371\/journal.pone.0170791","article-title":"Vitamin D and mortality: individual participant data meta-analysis of standardized 25-hydroxyvitamin D in 26\u2008916 individuals from a European consortium","volume":"12","author":"Gaksch","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30357-1_bib80","doi-asserted-by":"crossref","first-page":"e92614","DOI":"10.1371\/journal.pone.0092614","article-title":"The effect of the systemic inflammatory response on plasma vitamin 25 (OH) D concentrations adjusted for albumin","volume":"9","author":"Ghashut","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30357-1_bib81","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.clinbiochem.2016.01.002","article-title":"The association between vitamin D and C-reactive protein levels in patients with inflammatory and non-inflammatory diseases","volume":"49","author":"Kruit","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/S2213-8587(17)30357-1_bib82","doi-asserted-by":"crossref","first-page":"e0141770","DOI":"10.1371\/journal.pone.0141770","article-title":"The impact of vitamin D levels on inflammatory status: a systematic review of immune cell studies","volume":"10","author":"Calton","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30357-1_bib83","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1093\/infdis\/jit355","article-title":"Immunomodulatory effects of vitamin D on innate and adaptive immune responses to Streptococcus pneumoniae","volume":"208","author":"Olliver","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/S2213-8587(17)30357-1_bib84","doi-asserted-by":"crossref","first-page":"4240","DOI":"10.3390\/nu7064240","article-title":"Modulation of the immune response to respiratory viruses by vitamin D","volume":"7","author":"Greiller","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(17)30357-1_bib85","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nrendo.2010.226","article-title":"Antibacterial effects of vitamin D","volume":"7","author":"Hewison","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(17)30357-1_bib86","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1158\/1055-9965.EPI-15-0601","article-title":"Vitamin D, inflammation, and colorectal cancer progression: a review of mechanistic studies and future directions for epidemiological studies","volume":"24","author":"van Harten-Gerritsen","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(17)30357-1_bib87","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/j.ijcard.2016.11.154","article-title":"Modes of death in patients with heart failure and preserved ejection fraction","volume":"228","author":"Aschauer","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/S2213-8587(17)30357-1_bib88","first-page":"1185","article-title":"Sepsis-associated outcomes in critically ill patients with malignancies","volume":"12","author":"Torres","year":"2015","journal-title":"Ann Am Thorac Soc"},{"key":"10.1016\/S2213-8587(17)30357-1_bib89","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jcrc.2014.01.014","article-title":"Prognostic factors in critically ill cancer patients admitted to the intensive care unit","volume":"29","author":"Aygencel","year":"2014","journal-title":"J Crit Care"},{"key":"10.1016\/S2213-8587(17)30357-1_bib90","doi-asserted-by":"crossref","first-page":"f6698","DOI":"10.1136\/bmj.f6698","article-title":"Implausible results in human nutrition research","volume":"347","author":"Ioannidis","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30357-1_bib91","doi-asserted-by":"crossref","first-page":"g7089","DOI":"10.1136\/bmj.g7089","article-title":"Clinical trials: what a waste","volume":"349","author":"Ioannidis","year":"2014","journal-title":"BMJ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T08:20:19Z","timestamp":1535271619000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303571"}},"issued":{"date-parts":[[2017,12]]},"references-count":90,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2213858717303571"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30357-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of vitamin D supplementation on non-skeletal disorders: a systematic review of meta-analyses and randomised trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30357-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T22:49:57Z","timestamp":1794350997888,"version":"4.9.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,2,29]],"date-time":"2016-02-29T00:00:00Z","timestamp":1456704000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"MRC","award":["programme code U105960371"],"award-info":[{"award-number":["programme code U105960371"]}]},{"name":"European Union's Seventh Framework Programme","award":["FP7\/2007\u20132013"],"award-info":[{"award-number":["FP7\/2007\u20132013"]}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/s2213-8587(16)00044-9","type":"journal-article","created":{"date-parts":[[2016,3,2]],"date-time":"2016-03-02T00:37:55Z","timestamp":1456879075000},"page":"393-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":222,"title":["Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial"],"prefix":"10.1016","volume":"4","author":[{"given":"Cyrus","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas C","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aris T","family":"Papageorghiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Inez","family":"Schoenmakers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Fraser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saurabh V","family":"Gandhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah R","family":"Crozier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca J","family":"Moon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel K","family":"Arden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine M","family":"Dennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith M","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hazel M","family":"Inskip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Prentice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Zulf","family":"Mughal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Eastell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Kassim","family":"Javaid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)00044-9_bib1","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1002\/jbmr.2286","article-title":"Osteoporosis: a lifecourse approach","volume":"29","author":"Harvey","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(16)00044-9_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1359\/jbmr.090701","article-title":"Low maternal vitamin D status and fetal bone development: cohort study","volume":"25","author":"Mahon","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(16)00044-9_bib3","doi-asserted-by":"crossref","first-page":"E2070","DOI":"10.1210\/jc.2012-2538","article-title":"The effect of maternal vitamin D concentration on fetal bone","volume":"97","author":"Ioannou","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)00044-9_bib4","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.1210\/jc.2009-1391","article-title":"Maternal vitamin D status determines bone variables in the newborn","volume":"95","author":"Viljakainen","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)00044-9_bib5","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1007\/s00198-010-1499-4","article-title":"Maternal vitamin D status affects bone growth in early childhood\u2014a prospective cohort study","volume":"22","author":"Viljakainen","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(16)00044-9_bib6","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/S0140-6736(06)67922-1","article-title":"Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study","volume":"367","author":"Javaid","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00044-9_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta18450","article-title":"Vitamin D supplementation in pregnancy: a systematic review","volume":"18","author":"Harvey","year":"2014","journal-title":"Health Technol Assess"},{"key":"10.1016\/S2213-8587(16)00044-9_bib8","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1002\/jbmr.2138","article-title":"Maternal vitamin D status during pregnancy and bone mass in offspring at 20 years of age: a prospective cohort study","volume":"29","author":"Zhu","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(16)00044-9_bib9","series-title":"Primer on the metabolic bone diseases and mineral metabolism","first-page":"106","article-title":"Vitamin D: photobiology, metabolism, mechanisms of action, and clinical applications","author":"Holick","year":"2006"},{"key":"10.1016\/S2213-8587(16)00044-9_bib10","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/S0022-3476(98)70013-7","article-title":"Low total body bone mineral content and high bone resorption in Korean winter-born versus summer-born newborn infants","volume":"132","author":"Namgung","year":"1998","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(16)00044-9_bib11","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/ajcn\/69.1.159","article-title":"Seasonal vitamin D in African American and white infants","volume":"69","author":"Tsang","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)00044-9_bib12","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1210\/jc.2008-2146","article-title":"Estimated maternal ultraviolet B exposure levels in pregnancy influence skeletal development of the child","volume":"94","author":"Sayers","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)00044-9_bib13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(13)61827-9","article-title":"Maternal vitamin D status during pregnancy and bone-mineral content in offspring","volume":"382","author":"Harvey","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00044-9_bib14","doi-asserted-by":"crossref","first-page":"e4695","DOI":"10.1136\/bmj.e4695","article-title":"Vitamin D: some perspective please","volume":"345","author":"Harvey","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)00044-9_bib15","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1016\/S0140-6736(12)62203-X","article-title":"Association of maternal vitamin D status during pregnancy with bone-mineral content in offspring: a prospective cohort study","volume":"381","author":"Lawlor","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00044-9_bib16","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","article-title":"Dual-energy x-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions","volume":"17","author":"Crabtree","year":"2014","journal-title":"J Clin Densitom"},{"key":"10.1016\/S2213-8587(16)00044-9_bib17","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1017\/S2040174409990055","article-title":"Maternal predictors of neonatal bone size and geometry: the Southampton Women's Survey","volume":"1","author":"Harvey","year":"2010","journal-title":"J Dev Orig Health Dis"},{"key":"10.1016\/S2213-8587(16)00044-9_bib18","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1359\/jbmr.2001.16.9.1694","article-title":"Neonatal bone mass: influence of parental birthweight, maternal smoking, body composition, and activity during pregnancy","volume":"16","author":"Godfrey","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(16)00044-9_bib19","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1359\/jbmr.0301211","article-title":"Umbilical venous IGF-1 concentration, neonatal bone mass, and body composition","volume":"19","author":"Javaid","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(16)00044-9_bib20","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1365-2265.2010.03918.x","article-title":"Foetal and postnatal growth and bone mass at 6 months: the Generation R Study","volume":"74","author":"Ay","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(16)00044-9_bib21","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1067\/mpd.2001.116297","article-title":"Bone mineral density and body composition in boys with distal forearm fractures: a dual-energy x-ray absorptiometry study","volume":"139","author":"Goulding","year":"2001","journal-title":"J Pediatr"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)00044-9_bib22","first-page":"i83","article-title":"Skeletal growth tracks through childhood","volume":"45","author":"Harvey","year":"2006","journal-title":"Rheumatology"},{"key":"10.1016\/S2213-8587(16)00044-9_bib23","doi-asserted-by":"crossref","first-page":"1690","DOI":"10.1210\/jc.2009-2319","article-title":"Tracking of bone mass and density during childhood and adolescence","volume":"95","author":"Kalkwarf","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)00044-9_bib24","doi-asserted-by":"crossref","first-page":"3160","DOI":"10.1210\/jc.2011-1111","article-title":"Revised reference curves for bone mineral content and areal bone mineral density according to age and sex for black and non-black children: results of the bone mineral density in childhood study","volume":"96","author":"Zemel","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)00044-9_bib25","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/j.jpeds.2013.12.040","article-title":"Longitudinal tracking of dual-energy x-ray absorptiometry bone measures over 6 years in children and adolescents: persistence of low bone mass to maturity","volume":"164","author":"Wren","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(16)00044-9_bib26","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s00198-003-1454-8","article-title":"A theoretical analysis of the relative influences of peak BMD, age-related bone loss and menopause on the development of osteoporosis","volume":"14","author":"Hernandez","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(16)00044-9_bib27","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/1745-6215-13-13","article-title":"MAVIDOS Maternal Vitamin D Osteoporosis Study: study protocol for a randomized controlled trial","volume":"13","author":"Harvey","year":"2012","journal-title":"Trials"},{"key":"10.1016\/S2213-8587(16)00044-9_bib28","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1007\/s00198-014-2926-8","article-title":"Ethnic differences in urinary calcium and phosphate excretion between Gambian and British older adults","volume":"26","author":"Redmond","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(16)00044-9_bib29","first-page":"32","article-title":"Vitamin D status as an international issue: national surveys and the problem of standardization","volume":"243","author":"Sempos","year":"2012","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1016\/S2213-8587(16)00044-9_bib30","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1203\/00006450-199704000-00022","article-title":"Improvement in the accuracy of dual energy x-ray absorptiometry for whole body and regional analysis of body composition: validation using piglets and methodologic considerations in infants","volume":"41","author":"Brunton","year":"1997","journal-title":"Pediatr Res"},{"key":"10.1016\/S2213-8587(16)00044-9_bib31","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1136\/bmj.286.6373.1233","article-title":"Mineral content of the forearms of babies born to Asian and white mothers","volume":"286","author":"Congdon","year":"1983","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)00044-9_bib32","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1210\/jc.2007-0279","article-title":"Paternal skeletal size predicts intrauterine bone mineral accrual","volume":"93","author":"Harvey","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)00044-9_bib33","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1503\/cmaj.1040508","article-title":"Vitamin D deficiency and whole-body and femur bone mass relative to weight in healthy newborns","volume":"172","author":"Weiler","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(16)00044-9_bib34","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1179\/146532806X152782","article-title":"The relationship between birthweight, 25-hydroxyvitamin D concentrations and bone mineral status in neonates","volume":"26","author":"Akcakus","year":"2006","journal-title":"Ann Trop Paediatr"},{"key":"10.1016\/S2213-8587(16)00044-9_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3390\/nu4020068","article-title":"Evidence of associations between feto-maternal vitamin D status, cord parathyroid hormone and bone-specific alkaline phosphatase, and newborn whole body bone mineral content","volume":"4","author":"Dror","year":"2012","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(16)00044-9_bib36","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1111\/j.1651-2227.2009.01352.x","article-title":"Maternal plasma 25-hydroxyvitamin D concentration and birthweight, growth and bone mineral accretion of Gambian infants","volume":"98","author":"Prentice","year":"2009","journal-title":"Acta Paediatr"},{"key":"10.1016\/S2213-8587(16)00044-9_bib37","doi-asserted-by":"crossref","first-page":"57","DOI":"10.3945\/ajcn.112.037473","article-title":"Maternal vitamin D status in pregnancy is associated with adiposity in the offspring: findings from the Southampton Women's Survey","volume":"96","author":"Crozier","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)00044-9_bib38","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.jsbmb.2010.03.038","article-title":"Seasonal 25-hydroxyvitamin D changes in British postmenopausal women at 57 degrees N and 51 degrees N: a longitudinal study","volume":"121","author":"Mavroeidi","year":"2010","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S2213-8587(16)00044-9_bib39","doi-asserted-by":"crossref","first-page":"1449","DOI":"10.1007\/s00198-014-2976-y","article-title":"Vitamin D and bone development","volume":"26","author":"Moon","year":"2015","journal-title":"Osteoporos Int"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T05:53:28Z","timestamp":1668837208000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716000449"}},"issued":{"date-parts":[[2016,5]]},"references-count":39,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S2213858716000449"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)00044-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)00044-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)00079-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Cooper et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:17:53Z","timestamp":1794071873312,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/s2213-8587(18)30234-1","type":"journal-article","created":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T20:02:28Z","timestamp":1537041748000},"page":"781-789","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES)"],"prefix":"10.1016","volume":"6","author":[{"given":"John P","family":"Armato","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A","family":"DeFronzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Abdul-Ghani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ron J","family":"Ruby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30234-1_bib2","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1046\/j.1464-5491.2002.00835.x","article-title":"Impaired glucose tolerance and impaired fasting glycaemia: the current status on definition and intervention","volume":"19","author":"Unwin","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30234-1_bib3","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2337\/dc05-2179","article-title":"Contribution of \u03b2 cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose","volume":"29","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30234-1_bib4","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2337\/db05-1200","article-title":"Insulin secretion and insulin action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study (VEGAS)","volume":"55","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30234-1_bib5","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.2337\/dc08-0225","article-title":"One hour plasma glucose concentration and the metabolic syndrome identify subjects at high risk for future type 2 diabetes","volume":"31","author":"Abdul-Ghani","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30234-1_bib6","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.2337\/dc05-1711","article-title":"Risk of progression to type 2 diabetes based upon relationship between post-load plasma glucose and fasting plasma glucose","volume":"29","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30234-1_bib7","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/dc08-1264","article-title":"Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study","volume":"32","author":"Abdul-Ghani","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30234-1_bib8","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2337\/dc17-1351","article-title":"Enhanced predictive capability of a 1-hour oral glucose tolerance test: a prospective population-based cohort study","volume":"41","author":"Pareek","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30234-1_bib9","doi-asserted-by":"crossref","first-page":"3744","DOI":"10.1210\/jc.2015-2573","article-title":"One-hour postload hyperglycemia is a stronger predictor of type 2 diabetes than impaired fasting glucose","volume":"100","author":"Fiorentino","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30234-1_bib10","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00125-014-3390-x","article-title":"Modelling of OGTT curve identifies 1 h plasma glucose level as a strong predictor of incident type 2 diabetes: results from two prospective cohorts","volume":"58","author":"Alyass","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30234-1_bib11","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"DeFronzo","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30234-1_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/dom.12417","volume":"17","author":"Abdul-Ghani","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30234-1_bib13","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2337\/dc16-1738","article-title":"Combination therapy with exenatide plus pioglitazone versus basal\/bolus insulin in poorly controlled T2DM patients on sulfonylurea plus metformin: the QATAR Study","volume":"40","author":"Abdul-Ghani","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30234-1_bib14","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30234-1_bib15","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance","volume":"364","author":"DeFronzo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30234-1_bib16","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial","volume":"368","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30234-1_bib17","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s13679-015-0155-x","article-title":"Weight loss and the prevention and treatment of type 2 diabetes using lifestyle therapy, pharmacotherapy, and bariatric surgery: mechanisms of action","volume":"4","author":"Grams","year":"2015","journal-title":"Curr Obes Rep"},{"key":"10.1016\/S2213-8587(18)30234-1_bib18","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30234-1_bib19","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s00125-003-1263-9","article-title":"B-cell dysfunction and glucose intolerance: results from the San Antonio Metabolism (SAM) study","volume":"47","author":"Gastaldelli","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30234-1_bib20","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1056\/NEJMra041001","article-title":"Thiazolidinediones","volume":"351","author":"Yki-Jarvinen","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30234-1_bib21","doi-asserted-by":"crossref","first-page":"e871","DOI":"10.1152\/ajpendo.00551.2006","article-title":"Thiazolidinediones improve \u03b2-cell function in type 2 diabetic patients","volume":"292","author":"Gastaldelli","year":"2007","journal-title":"Am J Phyisol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30234-1_bib22","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.2337\/db13-0265","article-title":"Prevention of diabetes with pioglitazone in ACT NOW: physiologic correlates","volume":"62","author":"DeFronzo","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30234-1_bib23","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1007\/s00125-017-4289-0","article-title":"Effects of semaglutide on \u03b2 cell function and glycaemic control in participants with type 2 diabetes: a randomised, double-blind, placebo-controlled trial","volume":"60","author":"Kapitza","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30234-1_bib24","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2337\/dc11-0291","article-title":"Effects of exenatide on measures of \u03b2-cell function after 3 years in metformin-treated patients with type 2 diabetes","volume":"34","author":"Bunck","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30234-1_bib25","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/S0140-6736(10)60746-5","article-title":"Low-dose combination therapy with rosiglitazone and metformin to prevent type 2 diabetes mellitus (CANOE trial): a double-blind randomised controlled study","volume":"376","author":"Zinman","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30234-1_bib26","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1161\/CIRCULATIONAHA.117.029190","volume":"136","author":"Kosiborod","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30234-1_bib27","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1016\/S2213-8587(17)30258-9","article-title":"Cardiovascular mortality and morbidity in patients with type 2 diabetes following initiation of sodium-glucose co-transporter-2 inhibitors versus other glucose-lowering drugs (CVD-REAL Nordic): a multinational observational analysis","volume":"5","author":"Birkeland","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30234-1_bib28","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30234-1_bib29","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2147\/CEOR.S69981","article-title":"Estimating the real world daily usage and cost for exenatide twice daily and liraglutide in Germany, the Netherlands, and the UK based on volumes dispensed by pharmacies","volume":"7","author":"McDonell","year":"2015","journal-title":"Clinicoecon Outcomes Res"},{"key":"10.1016\/S2213-8587(18)30234-1_bib30","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1210\/jc.2015-4202","article-title":"Diabetes incidence and glucose tolerance after termination of pioglitazone therapy: results from ACT NOW","volume":"101","author":"Tripathy","year":"2016","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302341?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302341?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T19:35:50Z","timestamp":1537904150000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302341"}},"issued":{"date-parts":[[2018,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2213858718302341"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30234-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES)","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30234-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30267-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:24:30Z","timestamp":1794565470670,"version":"4.9.1"},"reference-count":114,"publisher":"Elsevier BV","issue":"3","content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/s2213-8587(13)70086-x","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T11:35:23Z","timestamp":1382096123000},"page":"238-249","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":254,"title":["Hyperthyroidism in pregnancy"],"prefix":"10.1016","volume":"1","author":[{"given":"David S","family":"Cooper","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Laurberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70086-X_bib1","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.beem.2004.03.001","article-title":"The regulation of thyroid function during normal pregnancy: importance of the iodine nutrition status","volume":"18","author":"Glinoer","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib2","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1210\/jc.2002-021291","article-title":"Type 3 iodothyronine deiodinase is highly expressed in the human uteroplacental unit and in fetal epithelium","volume":"88","author":"Huang","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/cen.12232","article-title":"Screening for overt thyroid disease in early pregnancy may be preferable to searching for small aberrations in thyroid function tests","volume":"79","author":"Laurberg","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(13)70086-X_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/S0889-8529(05)70187-0","article-title":"Free thyroid hormone measurement. A critical appraisal","volume":"30","author":"Stockigt","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(13)70086-X_bib5","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2008.10.042","article-title":"Free T4 immunoassays are flawed during pregnancy","volume":"200","author":"Lee","year":"2009","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1097\/01.AOG.0000175836.41390.73","article-title":"Thyroid-stimulating hormone in singleton and twin pregnancy: importance of gestational age-specific reference ranges","volume":"106","author":"Dashe","year":"2005","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib7","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ajog.2007.12.003","article-title":"First- and second-trimester thyroid hormone reference data in pregnant women: a FaSTER (First- and Second-Trimester Evaluation of Risk for aneuploidy) Research Consortium study","volume":"199","author":"Lambert-Messerlian","year":"2008","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib8","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1016\/0002-9378(89)90195-6","article-title":"Ultrasonographically determined thyroid size in pregnancy and post partum: the goitrogenic effect of pregnancy","volume":"160","author":"Rasmussen","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib9","first-page":"888","article-title":"Thyroid gland size in pregnancy. An ultrasound and clinical study","volume":"32","author":"Nelson","year":"1987","journal-title":"J Reprod Med"},{"key":"10.1016\/S2213-8587(13)70086-X_bib10","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70086-X_bib11","doi-asserted-by":"crossref","first-page":"2543","DOI":"10.1210\/jc.2011-2803","article-title":"Management of thyroid dysfunction during pregnancy and postpartum: an Endocrine Society clinical practice guideline","volume":"97","author":"De Groot","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib12","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1530\/EJE-10-1155","article-title":"Epidemiology of subtypes of hyperthyroidism in Denmark: a population-based study","volume":"164","author":"Carl\u00e9","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib13","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-11-0548","article-title":"Incidence of hyperthyroidism in Sweden","volume":"165","author":"Abraham-Nordling","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib14","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.beem.2009.08.013","article-title":"Iodine intake as a determinant of thyroid disorders in populations","volume":"24","author":"Laurberg","year":"2010","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib15","first-page":"30","article-title":"Changes of serum anti-thyroid antibodies during and after pregnancy in autoimmune thyroid diseases","volume":"31","author":"Amino","year":"1978","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib16","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1210\/jcem-55-1-108","article-title":"Aggravation of thyrotoxicosis in early pregnancy and after delivery in Graves' disease","volume":"55","author":"Amino","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib17","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.beem.2004.03.010","article-title":"Physiological and pathological aspects of the effect of human chorionic gonadotropin on the thyroid","volume":"18","author":"Hershman","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib18","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1056\/NEJM199812173392505","article-title":"Familial gestational hyperthyroidism caused by a mutant thyrotropin receptor hypersensitive to human chorionic gonadotropin","volume":"339","author":"Rodien","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70086-X_bib19","first-page":"362","article-title":"TSH secreting adenoma of pituitary gland (TSHom)\u2014rare cause of hyperthyroidism in pregnancy","volume":"138","author":"Bolz","year":"2013","journal-title":"Dtsch Med Wochenschr"},{"key":"10.1016\/S2213-8587(13)70086-X_bib20","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1159\/000342982","article-title":"2012 European Thyroid Association guidelines for the management of familial and persistent sporadic non-autoimmune hyperthyroidism caused by thyroid-stimulating hormone receptor germline mutations","volume":"1","author":"Paschke","year":"2012","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(13)70086-X_bib21","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1210\/jc.2012-1275","article-title":"Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt","volume":"97","author":"Laurberg","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib22","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1210\/jc.2007-0178","article-title":"Sources of circulating 3,5,3\u2032-triiodothyronine in hyperthyroidism estimated after blocking of type 1 and type 2 iodothyronine deiodinases","volume":"92","author":"Laurberg","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib23","doi-asserted-by":"crossref","first-page":"142413","DOI":"10.4061\/2011\/142413","article-title":"Transient non-autoimmune hyperthyroidism of early pregnancy","volume":"2011","author":"Goldman","year":"2011","journal-title":"J Thyroid Res"},{"key":"10.1016\/S2213-8587(13)70086-X_bib24","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.AOG.0000197991.64246.9a","article-title":"Subclinical hyperthyroidism and pregnancy outcomes","volume":"107","author":"Casey","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/0002-9378(89)90088-4","article-title":"Thyrotoxicosis complicating pregnancy","volume":"160","author":"Davis","year":"1989","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib26","first-page":"946","article-title":"Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism","volume":"84","author":"Millar","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib27","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s00404-009-1105-1","article-title":"Overt and subclinical thyroid dysfunction among Indian pregnant women and its effect on maternal and fetal outcome","volume":"281","author":"Sahu","year":"2010","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/S2213-8587(13)70086-X_bib28","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00404-010-1362-z","article-title":"Outcomes of pregnancy complicated with hyperthyroidism: a cohort study","volume":"283","author":"Luewan","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/S2213-8587(13)70086-X_bib29","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0002-9378(03)00944-X","article-title":"Thyrotoxicosis and heart failure that complicate pregnancy","volume":"190","author":"Sheffield","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib30","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/0028-2243(94)90276-3","article-title":"Maternal and perinatal outcome in thyrotoxicosis complicating pregnancy","volume":"54","author":"Kriplani","year":"1994","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib31","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1089\/thy.1992.2.219","article-title":"Diagnosis and management of Graves' disease in pregnancy","volume":"2","author":"Hamburger","year":"1992","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70086-X_bib32","first-page":"127","article-title":"Use of anti-thyroid drugs in euthyroid pregnant women with previous Graves' disease","volume":"28","author":"McNab","year":"2005","journal-title":"Clin Invest Med"},{"key":"10.1016\/S2213-8587(13)70086-X_bib33","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1046\/j.1365-2265.2001.01173.x","article-title":"Congenital thyrotoxicosis in premature infants","volume":"54","author":"Smith","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(13)70086-X_bib34","doi-asserted-by":"crossref","first-page":"6093","DOI":"10.1210\/jc.2004-2555","article-title":"Management of Graves' disease during pregnancy: the key role of fetal thyroid gland monitoring","volume":"90","author":"Luton","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib35","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-08-0663","article-title":"Management of Graves' hyperthyroidism in pregnancy: focus on both maternal and foetal thyroid function, and caution against surgical thyroidectomy in pregnancy","volume":"160","author":"Laurberg","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib36","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/105072503321086962","article-title":"Laboratory medicine practice guidelines. Laboratory support for the diagnosis and monitoring of thyroid disease","volume":"13","author":"Baloch","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70086-X_bib37","doi-asserted-by":"crossref","first-page":"3341","DOI":"10.1210\/jc.2008-0568","article-title":"Variability in thyroid-stimulating hormone suppression by human chorionic [corrected] gonadotropin during early pregnancy","volume":"93","author":"Haddow","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/jcem-71-2-276","article-title":"Regulation of maternal thyroid during pregnancy","volume":"71","author":"Glinoer","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib39","first-page":"436","article-title":"Evaluation of the thyroid function of healthy pregnant women by five different hormone assays","volume":"65","author":"Berta","year":"2010","journal-title":"Pharmazie"},{"key":"10.1016\/S2213-8587(13)70086-X_bib40","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1530\/acta.0.1010531","article-title":"A longitudinal study of serum TSH, and total and free iodothyronines during normal pregnancy","volume":"101","author":"Weeke","year":"1982","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/S2213-8587(13)70086-X_bib41","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1210\/jc.2012-4309","article-title":"Clinical utility of TSH receptor antibodies","volume":"98","author":"Barbesino","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib42","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1530\/eje.0.1390584","article-title":"Guidelines for TSH-receptor antibody measurements in pregnancy: results of an evidence-based symposium organized by the European Thyroid Association","volume":"139","author":"Laurberg","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib43","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2010.0417","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"21","author":"Bahn Chair","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70086-X_bib44","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1089\/thy.2011.0056","article-title":"Similar clinical performance of a novel chimeric thyroid-stimulating hormone receptor bioassay and an automated thyroid-stimulating hormone receptor binding assay in Graves' disease","volume":"21","author":"Kamijo","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70086-X_bib45","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S0140-6736(00)82433-2","article-title":"Pregnancy complicating simple goiter and Graves' disease","volume":"213","author":"Gardiner-Hill","year":"1952","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70086-X_bib46","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1210\/jcem-8-9-717","article-title":"The collection of radioactive iodine by the human fetal thyroid","volume":"8","author":"Chapman","year":"1948","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib47","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1210\/jcem-11-10-1045","article-title":"The use of antithyroid drugs during pregnancy","volume":"11","author":"Astwood","year":"1951","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib48","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70086-X_bib49","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1056\/NEJM198008073030603","article-title":"Carbimazole and the autoimmune response in Graves' disease","volume":"303","author":"McGregor","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70086-X_bib50","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1530\/eje.1.02295","article-title":"Remission of Graves' disease during anti-thyroid drug therapy. Time to reconsider the mechanism?","volume":"155","author":"Laurberg","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib51","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1210\/jcem-45-6-1187","article-title":"The placental transfer of propylthiouracil, methimazole and carbimazole","volume":"45","author":"Marchant","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib52","doi-asserted-by":"crossref","first-page":"3099","DOI":"10.1210\/jc.82.9.3099","article-title":"Methimazole and propylthiouracil equally cross the perfused human term placental lobule","volume":"82","author":"Mortimer","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1210\/jcem-62-1-217","article-title":"Pharmacology of propylthiouracil (PTU) in pregnant hyperthyroid women: correlation of maternal PTU concentrations with cord serum thyroid function tests","volume":"62","author":"Gardner","year":"1986","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib54","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1210\/jc.82.11.3633","article-title":"Effects of propylthiouracil and methimazole on fetal thyroid status in mothers with Graves' hyperthyroidism","volume":"82","author":"Momotani","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib55","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/S0002-9378(94)70390-6","article-title":"A comparison of propylthiouracil versus methimazole in the treatment of hyperthyroidism in pregnancy","volume":"170","author":"Wing","year":"1994","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib56","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1046\/j.1365-2265.2001.01239.x","article-title":"Efficacy of single daily dosage of methimazole vs. propylthiouracil in the induction of euthyroidism","volume":"54","author":"Homsanit","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(13)70086-X_bib57","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1056\/NEJM198607033150104","article-title":"Antithyroid drug therapy for Graves' disease during pregnancy. Optimal regimen for fetal thyroid status","volume":"315","author":"Momotani","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70086-X_bib58","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nrendo.2011.34","article-title":"Antithyroid drug-induced fetal goitrous hypothyroidism","volume":"7","author":"Bliddal","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib59","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1530\/acta.0.1230311","article-title":"Antithyroid drug treatment of Graves' disease in pregnancy: long-term effects on somatic growth, intellectual development and thyroid function of the offspring","volume":"123","author":"Messer","year":"1990","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/S2213-8587(13)70086-X_bib60","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1007\/BF01957719","article-title":"Intellectual capacity of subjects exposed to methimazole or propylthiouracil in utero","volume":"151","author":"Eisenstein","year":"1992","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(13)70086-X_bib61","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1159\/000342920","article-title":"Side effects of anti-thyroid drugs and their impact on the choice of treatment for thyrotoxicosis in pregnancy","volume":"1","author":"Taylor","year":"2012","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(13)70086-X_bib62","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1089\/thy.2008.0364","article-title":"Methimazole-induced agranulocytosis in patients with Graves' disease is more frequent with an initial dose of 30 mg daily than with 15 mg daily","volume":"19","author":"Takata","year":"2009","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70086-X_bib63","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1097\/MED.0b013e3283565b49","article-title":"The propylthiouracil dilemma","volume":"19","author":"Glinoer","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(13)70086-X_bib64","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1210\/jc.2009-0850","article-title":"Putting propylthiouracil in perspective","volume":"94","author":"Cooper","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib65","doi-asserted-by":"crossref","first-page":"4549","DOI":"10.1210\/jc.2012-2802","article-title":"A 2011 survey of clinical practice patterns in the management of Graves' disease","volume":"97","author":"Burch","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib66","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1210\/jc.2009-2752","article-title":"Shifts in propylthiouracil and methimazole prescribing practices: antithyroid drug use in the United States from 1991 to 2008","volume":"95","author":"Emiliano","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib67","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajmg.a.30418","article-title":"Carbimazole embryopathy: an emerging phenotype","volume":"132A","author":"Foulds","year":"2005","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(13)70086-X_bib68","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jc.2011-2860","article-title":"Treatment of graves' disease with antithyroid drugs in the first trimester of pregnancy and the prevalence of congenital malformation","volume":"97","author":"Yoshihara","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib69","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1089\/thy.2012.0488","article-title":"Prevalence of thyrotoxicosis, anti-thyroid medication use, and complications among pregnant women in the United States","volume":"23","author":"Korelitz","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70086-X_bib70","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/j.1471-0528.2011.03019.x","article-title":"Risk of adverse perinatal outcomes with antithyroid treatment during pregnancy: a nationwide population-based study","volume":"118","author":"Chen","year":"2011","journal-title":"BJOG"},{"key":"10.1016\/S2213-8587(13)70086-X_bib72","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/BF03347071","article-title":"Hyperthyroidism and pregnancy. An Italian Thyroid Association (AIT) and Italian Association of Clinical Endocrinologists (AME) joint statement for clinical practice","volume":"34","author":"Negro","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(13)70086-X_bib73","first-page":"235","article-title":"Thyroid failure after potassium iodide treatment of diffuse toxic goiter","volume":"88","author":"Wood","year":"1975","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/S2213-8587(13)70086-X_bib74","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.jpeds.2012.05.057","article-title":"Congenital hypothyroidism caused by excess prenatal maternal iodine ingestion","volume":"161","author":"Connelly","year":"2012","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(13)70086-X_bib75","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1210\/jc.75.3.738","article-title":"Effects of iodine on thyroid status of fetus versus mother in treatment of Graves' disease complicated by pregnancy","volume":"75","author":"Momotani","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002863","article-title":"Oral beta-blockers for mild to moderate hypertension during pregnancy","volume":"3","author":"Magee","year":"2003","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(13)70086-X_bib77","doi-asserted-by":"crossref","first-page":"e001185","DOI":"10.1136\/bmjopen-2012-001185","article-title":"\u03b2-Blocker treatment during pregnancy and adverse pregnancy outcomes: a nationwide population-based cohort study","volume":"2","author":"Meidahl Petersen","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(13)70086-X_bib78","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1056\/NEJM198111263052205","article-title":"Current concepts: beta-blockers in pregnancy","volume":"305","author":"Rubin","year":"1981","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70086-X_bib79","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/0002-8703(88)90530-3","article-title":"Beta-adrenergic blockers in pregnancy","volume":"115","author":"Frishman","year":"1988","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(13)70086-X_bib80","doi-asserted-by":"crossref","first-page":"461","DOI":"10.3109\/00016349109007160","article-title":"Treatment of hyperthyroidism in pregnancy","volume":"70","author":"Sherif","year":"1991","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S2213-8587(13)70086-X_bib81","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1089\/thy.1998.8.795","article-title":"Intrapartum labetalol for the treatment of maternal and fetal thyrotoxicosis","volume":"8","author":"Bowman","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70086-X_bib82","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1001\/archsurg.2009.48","article-title":"Outcomes following thyroid and parathyroid surgery in pregnant women","volume":"144","author":"Kuy","year":"2009","journal-title":"Arch Surg"},{"key":"10.1016\/S2213-8587(13)70086-X_bib83","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1210\/jc.2007-0229","article-title":"Effect of lugol solution on thyroid gland blood flow and microvessel density in the patients with Graves' disease","volume":"92","author":"Erbil","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib84","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1038\/ncpendmet0508","article-title":"Therapy insight: management of Graves' disease during pregnancy","volume":"3","author":"Chan","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib85","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/j.beem.2004.03.005","article-title":"Hyperthyroidism in pregnancy","volume":"18","author":"Mestman","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib86","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.0954-6820.1977.tb16790.x","article-title":"Effects of dexamethasone, desoxycorticosterone, and ACTH on serum concentrations of thyroxine, 3,5,3\u2032-triiodothyronine and 3,3\u2032,5\u2032-triiodothyronine","volume":"202","author":"Westgren","year":"1977","journal-title":"Acta Med Scand"},{"key":"10.1016\/S2213-8587(13)70086-X_bib87","doi-asserted-by":"crossref","first-page":"3985","DOI":"10.1210\/jc.2008-0966","article-title":"The effect of pregnancy on subsequent relapse from Graves' disease after a successful course of antithyroid drug therapy","volume":"93","author":"Rotondi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib88","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1530\/acta.0.1160321","article-title":"The postpartum period constitutes an important risk for the development of clinical Graves' disease in young women","volume":"116","author":"Jansson","year":"1987","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/S2213-8587(13)70086-X_bib89","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1507\/endocrj.41.325","article-title":"Prevalence of postpartum onset of disease within patients with Graves' disease of child-bearing age","volume":"41","author":"Tada","year":"1994","journal-title":"Endocr J"},{"key":"10.1016\/S2213-8587(13)70086-X_bib90","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1089\/thy.2005.15.1287","article-title":"Increased risk of Graves' disease after pregnancy","volume":"15","author":"Benhaim Rochester","year":"2005","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70086-X_bib91","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1530\/EJE-08-0236","article-title":"The post partum period and the onset of Graves' disease: an overestimated risk factor","volume":"159","author":"Rotondi","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib92","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1046\/j.1365-2265.2002.01615.x","article-title":"Postpartum recurrence of Graves' hyperthyroidism can be prevented by the continuation of antithyroid drugs during pregnancy","volume":"57","author":"Nakagawa","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(13)70086-X_bib93","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/BF00613617","article-title":"Excretion of methimazole in human milk","volume":"23","author":"Johansen","year":"1982","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib94","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1210\/jcem-58-3-473","article-title":"Methimazole pharmacology in man: studies using a newly developed radioimmunoassay for methimazole","volume":"58","author":"Cooper","year":"1984","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib95","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1046\/j.1365-2265.2000.01078.x","article-title":"Thyroid function in wholly breast-feeding infants whose mothers take high doses of propylthiouracil","volume":"53","author":"Momotani","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(13)70086-X_bib96","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.1210\/jc.85.9.3233","article-title":"Thyroid function and intellectual development of infants nursed by mothers taking methimazole","volume":"85","author":"Azizi","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib97","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1542\/peds.108.3.776","article-title":"Transfer of drugs and other chemicals into human milk","volume":"108","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(13)70086-X_bib98","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1111\/j.1365-2265.1990.tb00850.x","article-title":"Graves' disease in pregnancy: TSH receptor binding inhibiting immunoglobulins and maternal and neonatal thyroid function","volume":"32","author":"Mortimer","year":"1990","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(13)70086-X_bib99","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S0140-6736(85)91148-1","article-title":"Fetal hyperthyroidism: experience of treatment in four siblings","volume":"1","author":"Cove","year":"1985","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70086-X_bib100","first-page":"1018","article-title":"Thyroid-stimulating immunoglobulin as a cause of recurrent intrauterine fetal death","volume":"71","author":"Houck","year":"1988","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib101","first-page":"838","article-title":"Successful treatment of recurrent non-immune hydrops secondary to fetal hyperthyroidism","volume":"87","author":"Treadwell","year":"1996","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(13)70086-X_bib102","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1089\/thy.1999.9.727","article-title":"Fetal and neonatal hyperthyroidism","volume":"9","author":"Zimmerman","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70086-X_bib103","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000297595","article-title":"Therapeutic approach of fetal thyroid disorders","volume":"74","author":"Polak","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(13)70086-X_bib104","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1089\/thy.1992.2.207","article-title":"Fetal thyroid function","volume":"2","author":"Thorpe-Beeston","year":"1992","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70086-X_bib105","doi-asserted-by":"crossref","first-page":"4097","DOI":"10.1210\/jc.2004-0573","article-title":"Human fetal and cord serum thyroid hormones: developmental trends and interrelationships","volume":"89","author":"Hume","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib106","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.1210\/jc.2010-0409","article-title":"Approach to the patient with resistance to thyroid hormone and pregnancy","volume":"95","author":"Weiss","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib107","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1001\/jama.292.6.691","article-title":"Fetal loss associated with excess thyroid hormone exposure","volume":"292","author":"Anselmo","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70086-X_bib108","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1203\/00006450-199708000-00014","article-title":"The mechanisms of transient hypothyroxinemia in infants born to mothers with Graves' disease","volume":"42","author":"Matsuura","year":"1997","journal-title":"Pediatr Res"},{"key":"10.1016\/S2213-8587(13)70086-X_bib109","doi-asserted-by":"crossref","first-page":"2984","DOI":"10.1210\/jc.2006-2042","article-title":"Loss of integrity of thyroid morphology and function in children born to mothers with inadequately treated Graves' disease","volume":"92","author":"Kempers","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib110","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/thy.1999.9.705","article-title":"Postpartum autoimmune thyroid syndrome: a model of aggravation of autoimmune disease","volume":"9","author":"Amino","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70086-X_bib111","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.beem.2004.03.008","article-title":"Postpartum thyroiditis","volume":"18","author":"Stagnaro-Green","year":"2004","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib112","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1080\/08916930290031667","article-title":"Postpartum thyroiditis","volume":"35","author":"Lazarus","year":"2002","journal-title":"Autoimmunity"},{"key":"10.1016\/S2213-8587(13)70086-X_bib113","doi-asserted-by":"crossref","first-page":"3191","DOI":"10.1210\/jc.85.9.3191","article-title":"Postpartum thyroid dysfunction in pregnant thyroid peroxidase antibody-positive women living in an area with mild to moderate iodine deficiency: is iodine supplementation safe?","volume":"85","author":"N\u00f8hr","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib114","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1210\/jc.2010-1980","article-title":"High rate of persistent hypothyroidism in a large-scale prospective study of postpartum thyroiditis in southern Italy","volume":"96","author":"Stagnaro-Green","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70086-X_bib115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1210\/jc.85.1.71","article-title":"Postpartum thyroiditis and long-term thyroid status: prognostic influence of thyroid peroxidase antibodies and ultrasound echogenicity","volume":"85","author":"Premawardhana","year":"2000","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871370086X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871370086X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,30]],"date-time":"2019-07-30T20:17:04Z","timestamp":1564517824000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871370086X"}},"issued":{"date-parts":[[2013,11]]},"references-count":114,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S221385871370086X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70086-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hyperthyroidism in pregnancy","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70086-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70109-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70166-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70151-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:57:55Z","timestamp":1794628675103,"version":"4.9.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004628","name":"MedImmune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012679","name":"Institut de Cardiologie de Montr\u00e9al","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009857","name":"Regeneron Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018679","name":"HLS Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018679","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013394","name":"REGENXBIO","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013394","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007190","name":"Unilever","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016405","name":"European Atherosclerosis Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020141","name":"Akebia Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013669","name":"Ionis Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013669","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100022030","name":"Silence Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/s2213-8587(19)30264-5","type":"journal-article","created":{"date-parts":[[2019,9,30]],"date-time":"2019-09-30T18:52:27Z","timestamp":1569869547000},"page":"50-67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":203,"title":["Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement"],"prefix":"10.1016","volume":"8","author":[{"given":"Robert A","family":"Hegele","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Bor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry N","family":"Ginsberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Arca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Averna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph J","family":"Binder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Calabresi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M John","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Cuchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnold","family":"von Eckardstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"Frikke-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Kees","family":"Hovingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian","family":"Kronenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dieter","family":"L\u00fctjohann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus G","family":"Parhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick J","family":"Raal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik K","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan T","family":"Remaley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane K","family":"Stock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik S","family":"Stroes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lale","family":"Tokg\u00f6zo\u011flu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberico L","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30264-5_bib1","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jval.2015.05.008","article-title":"Rare disease terminology and definitions\u2014a systematic global review: report of the ISPOR rare disease special interest group","volume":"18","author":"Richter","year":"2015","journal-title":"Value Health"},{"key":"10.1016\/S2213-8587(19)30264-5_bib5","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.cell.2019.02.040","article-title":"A diagnosis for all rare genetic diseases: the horizon and the next frontiers","volume":"177","author":"Boycott","year":"2019","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(19)30264-5_bib6","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1097\/MOL.0000000000000482","article-title":"Polygenic influences on dyslipidemias","volume":"29","author":"Dron","year":"2018","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1097\/MOL.0000000000000163","article-title":"Targeted next-generation sequencing in monogenic dyslipidemias","volume":"26","author":"Hegele","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib8","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1038\/nrg2481","article-title":"Plasma lipoproteins: genetic influences and clinical implications","volume":"10","author":"Hegele","year":"2009","journal-title":"Nat Rev Genet"},{"key":"10.1016\/S2213-8587(19)30264-5_bib9","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30264-5_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.93","article-title":"Familial hypercholesterolaemia","volume":"3","author":"Defesche","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(19)30264-5_bib11","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the consensus panel on familial hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30264-5_bib12","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S0140-6736(02)07955-2","article-title":"Autosomal recessive hypercholesterolaemia in Sardinia, Italy, and mutations in ARH: a clinical and molecular genetic analysis","volume":"359","author":"Arca","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30264-5_bib13","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1002\/humu.23634","article-title":"ClinVar database of global familial hypercholesterolemia-associated DNA variants","volume":"39","author":"Iacocca","year":"2018","journal-title":"Hum Mutat"},{"key":"10.1016\/S2213-8587(19)30264-5_bib14","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/j.jacl.2016.09.009","article-title":"Familial defective apolipoprotein B-100: a review","volume":"10","author":"Andersen","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib15","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MOL.0000000000000386","article-title":"Complexity of mechanisms among human proprotein convertase subtilisin-kexin type 9 variants","volume":"28","author":"Dron","year":"2017","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib16","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1161\/ATVBAHA.116.308027","article-title":"Polygenic versus monogenic causes of hypercholesterolemia ascertained clinically","volume":"36","author":"Wang","year":"2016","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib17","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"16","author":"Berberich","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib18","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.atherosclerosis.2014.04.003","article-title":"Lysosomal acid lipase deficiency\u2014an under-recognized cause of dyslipidaemia and liver dysfunction","volume":"235","author":"Reiner","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(19)30264-5_bib19","first-page":"e27","article-title":"Current role of lipoprotein apheresis in the treatment of high-risk patients","volume":"5","author":"Julius","year":"2018","journal-title":"J Cardiovasc Dev Dis"},{"key":"10.1016\/S2213-8587(19)30264-5_bib20","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S2213-8587(17)30044-X","article-title":"Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study","volume":"5","author":"Raal","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib21","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1161\/CIRCULATIONAHA.117.028208","article-title":"Long-term efficacy and safety of the microsomal triglyceride transfer protein inhibitor lomitapide in patients with homozygous familial hypercholesterolemia","volume":"136","author":"Blom","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30264-5_bib22","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1161\/CIRCRESAHA.118.313171","article-title":"Lipid-lowering agents","volume":"124","author":"Hegele","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(19)30264-5_bib23","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1056\/NEJMc1705994","article-title":"ANGPTL3 inhibition in homozygous familial hypercholesterolemia","volume":"377","author":"Gaudet","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30264-5_bib24","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/jcp.2007.049775","article-title":"Sitosterolaemia: pathophysiology, clinical presentation and laboratory diagnosis","volume":"61","author":"Kidambi","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib25","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1056\/NEJMoa1501365","article-title":"A phase 3 trial of sebelipase alfa in lysosomal acid lipase deficiency","volume":"373","author":"Burton","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30264-5_bib26","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11883-014-0423-3","article-title":"Update on primary hypobetalipoproteinemia","volume":"16","author":"Hooper","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/S2213-8587(19)30264-5_bib27","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1080\/10408360500295113","article-title":"Monogenic hypocholesterolaemic lipid disorders and apolipoprotein B metabolism","volume":"42","author":"Hooper","year":"2005","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/S2213-8587(19)30264-5_bib28","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1007\/s10545-013-9665-4","article-title":"Abetalipoproteinemia and homozygous hypobetalipoproteinemia: a framework for diagnosis and management","volume":"37","author":"Lee","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(19)30264-5_bib29","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/MOL.0000000000000072","article-title":"Hypobetalipoproteinemia and abetalipoproteinemia","volume":"25","author":"Welty","year":"2014","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib30","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1172\/JCI115799","article-title":"Lipoproteins containing the truncated apolipoprotein, Apo B-89, are cleared from human plasma more rapidly than Apo B-100-containing lipoproteins in vivo","volume":"89","author":"Parhofer","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(19)30264-5_bib31","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1161\/01.ATV.17.5.881","article-title":"Decreased production and increased catabolism of apolipoprotein B-100 in apolipoprotein B-67\/B-100 heterozygotes","volume":"17","author":"Welty","year":"1997","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib32","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/S0022-2275(20)37582-9","article-title":"Positive linear correlation between the length of truncated apolipoprotein B and its secretion rate: in vivo studies in human apoB-89, apoB-75, apoB-54.8, and apoB-31 heterozygotes","volume":"37","author":"Parhofer","year":"1996","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(19)30264-5_bib33","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1097\/MOL.0000000000000578","article-title":"Chylomicron retention disease: genetics, biochemistry, and clinical spectrum","volume":"30","author":"Levy","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib34","doi-asserted-by":"crossref","first-page":"e1266","DOI":"10.1210\/jc.2012-1298","article-title":"Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization","volume":"97","author":"Minicocci","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30264-5_bib35","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa1002926","article-title":"Exome sequencing, ANGPTL3 mutations, and familial combined hypolipidemia","volume":"363","author":"Musunuru","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30264-5_bib36","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1086\/507488","article-title":"Molecular characterization of loss-of-function mutations in PCSK9 and identification of a compound heterozygote","volume":"79","author":"Zhao","year":"2006","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(19)30264-5_bib37","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1016\/j.jacl.2017.06.013","article-title":"Clinical and biochemical characteristics of individuals with low cholesterol syndromes: a comparison between familial hypobetalipoproteinemia and familial combined hypolipidemia","volume":"11","author":"Di Costanzo","year":"2017","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib38","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1038\/nrendo.2015.26","article-title":"Chylomicronaemia\u2014current diagnosis and future therapies","volume":"11","author":"Brahm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib39","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.jacl.2018.10.006","article-title":"Severe hypertriglyceridemia is primarily polygenic","volume":"13","author":"Dron","year":"2019","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s11883-017-0667-9","article-title":"Genetics of triglycerides and the risk of atherosclerosis","volume":"19","author":"Dron","year":"2017","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/S2213-8587(19)30264-5_bib41","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1016\/j.jacl.2018.03.093","article-title":"Clinical and biochemical features of different molecular etiologies of familial chylomicronemia","volume":"12","author":"Hegele","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib42","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.bbalip.2011.10.006","article-title":"Lipase maturation factor 1: a lipase chaperone involved in lipid metabolism","volume":"1821","author":"P\u00e9terfy","year":"2012","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S2213-8587(19)30264-5_bib43","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/j.tem.2016.04.013","article-title":"GPIHBP1 and plasma triglyceride metabolism","volume":"27","author":"Fong","year":"2016","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30264-5_bib44","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1097\/MOL.0000000000000581","article-title":"Progress in finding pathogenic DNA copy number variations in dyslipidemia","volume":"30","author":"Iacocca","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib45","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/j.ajhg.2011.11.028","article-title":"Transient infantile hypertriglyceridemia, fatty liver, and hepatic fibrosis caused by mutated GPD1, encoding glycerol-3-phosphate dehydrogenase 1","volume":"90","author":"Basel-Vanagaite","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(19)30264-5_bib46","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1038\/nm.2347","article-title":"The transcription factor cyclic AMP-responsive element-binding protein H regulates triglyceride metabolism","volume":"17","author":"Lee","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(19)30264-5_bib47","doi-asserted-by":"crossref","first-page":"5570","DOI":"10.1093\/hmg\/ddu269","article-title":"Inheritance of rare functional GCKR variants and their contribution to triglyceride levels in families","volume":"23","author":"Rees","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(19)30264-5_bib48","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.atherosclerosis.2018.12.019","article-title":"Chylomicronemia\u2014differences between familial chylomicronemia syndrome and multifactorial chylomicronemia","volume":"283","author":"Paquette","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(19)30264-5_bib49","doi-asserted-by":"crossref","DOI":"10.1111\/joim.12925","article-title":"Conservative management in hypertriglyceridemia-associated pancreatitis","author":"Berberich","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(19)30264-5_bib50","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1210\/jc.2012-1250","article-title":"Severe hypertriglyceridemia in pregnancy","volume":"97","author":"Goldberg","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30264-5_bib51","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehz209","article-title":"N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels","author":"Alexander","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30264-5_bib52","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.pathol.2018.11.002","article-title":"Apolipoprotein E in lipoprotein metabolism, health and cardiovascular disease","volume":"51","author":"Marais","year":"2019","journal-title":"Pathology"},{"key":"10.1016\/S2213-8587(19)30264-5_bib53","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1016\/j.jacl.2018.09.006","article-title":"The spectrum of type III hyperlipoproteinemia","volume":"12","author":"Sniderman","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib54","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1126\/science.1161524","article-title":"A null mutation in human APOC3 confers a favorable plasma lipid profile and apparent cardioprotection","volume":"322","author":"Pollin","year":"2008","journal-title":"Science"},{"key":"10.1016\/S2213-8587(19)30264-5_bib55","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1373\/clinchem.2018.287037","article-title":"Quantifying atherogenic lipoproteins: current and future challenges in the era of personalized medicine and very low concentrations of LDL cholesterol. A consensus statement from EAS and EFLM","volume":"64","author":"Langlois","year":"2018","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(19)30264-5_bib56","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS Guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30264-5_bib57","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00392-017-1106-1","article-title":"HDL cholesterol: reappraisal of its clinical relevance","volume":"106","author":"M\u00e4rz","year":"2017","journal-title":"Clin Res Cardiol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib58","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1253\/circj.CJ-13-1025","article-title":"High-density lipoproteins. Multifunctional but vulnerable protections from atherosclerosis","volume":"77","author":"Annema","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/S2213-8587(19)30264-5_bib59","doi-asserted-by":"crossref","first-page":"2524","DOI":"10.1001\/jama.299.21.2524","article-title":"Association of loss-of-function mutations in the ABCA1 gene with high-density lipoprotein cholesterol levels and risk of ischemic heart disease","volume":"299","author":"Frikke-Schmidt","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30264-5_bib60","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S0140-6736(12)60312-2","article-title":"Plasma HDL cholesterol and risk of myocardial infarction: a mendelian randomisation study","volume":"380","author":"Voight","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30264-5_bib61","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.2215\/CJN.00730116","article-title":"High density lipoprotein cholesterol and the risk of all-cause mortality among US veterans","volume":"11","author":"Bowe","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib62","doi-asserted-by":"crossref","first-page":"2073","DOI":"10.1016\/j.jacc.2016.08.038","article-title":"High-density lipoprotein cholesterol and cause-specific mortality in individuals without previous cardiovascular conditions: the CANHEART Study","volume":"68","author":"Ko","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib63","doi-asserted-by":"crossref","first-page":"2478","DOI":"10.1093\/eurheartj\/ehx163","article-title":"Extreme high high-density lipoprotein cholesterol is paradoxically associated with high mortality in men and women: two prospective cohort studies","volume":"38","author":"Madsen","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30264-5_bib64","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1093\/eurheartj\/ehx665","article-title":"U-shaped relationship of HDL and risk of infectious disease: two prospective population-based cohort studies","volume":"39","author":"Madsen","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30264-5_bib65","doi-asserted-by":"crossref","first-page":"2162","DOI":"10.1194\/jlr.M079822","article-title":"Polygenic determinants in extremes of high-density lipoprotein cholesterol","volume":"58","author":"Dron","year":"2017","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(19)30264-5_bib66","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1194\/jlr.M088203","article-title":"Genetic and secondary causes of severe HDL deficiency and cardiovascular disease","volume":"59","author":"Geller","year":"2018","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(19)30264-5_bib67","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1172\/JCI200523915","article-title":"Targeted inactivation of hepatic ABCA1 causes profound hypoalphalipoproteinemia and kidney hypercatabolism of ApoA-I","volume":"115","author":"Timmins","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(19)30264-5_bib68","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI27352","article-title":"Intestinal ABCA1 directly contributes to HDL biogenesis in vivo","volume":"116","author":"Brunham","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(19)30264-5_bib69","doi-asserted-by":"crossref","first-page":"22930","DOI":"10.1074\/jbc.M801408200","article-title":"Increased cellular free cholesterol in macrophage-specific Abca1 knock-out mice enhances pro-inflammatory response of macrophages","volume":"283","author":"Zhu","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(19)30264-5_bib70","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1161\/CIRCULATIONAHA.111.066589","article-title":"Cholesterol efflux and atheroprotection: advancing the concept of reverse cholesterol transport","volume":"125","author":"Rosenson","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30264-5_bib71","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.numecd.2018.09.006","article-title":"Lipoprotein-X fifty years after its original discovery","volume":"29","author":"Fellin","year":"2019","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(19)30264-5_bib72","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.atherosclerosis.2011.11.034","article-title":"Genetic lecithin: cholesterol acyltransferase deficiency and cardiovascular disease","volume":"222","author":"Calabresi","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(19)30264-5_bib73","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0150083","article-title":"Lipoprotein X causes renal disease in LCAT deficiency","volume":"11","author":"Ossoli","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30264-5_bib74","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000167056","article-title":"Renal lesions in familial lecithin-cholesterol acyltransferase deficiency. Ultrastructural heterogeneity of glomerular changes","volume":"6","author":"Imbasciati","year":"1986","journal-title":"Am J Nephrol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib75","doi-asserted-by":"crossref","first-page":"1000","DOI":"10.1161\/CIRCULATIONAHA.118.034706","article-title":"Complete and partial LCAT deficiency are differentially associated with atherosclerosis","volume":"138","author":"Oldoni","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30264-5_bib76","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000008148","article-title":"Apolipoprotein A-1-related amyloidosis: 2 case reports and review of the literature","volume":"96","author":"Lu","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S2213-8587(19)30264-5_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003063","article-title":"Population-based resequencing of APOA1 in 10,330 individuals: spectrum of genetic variation, phenotype, and comparison with extreme phenotype approach","volume":"8","author":"Haase","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(19)30264-5_bib78","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/j.jmb.2015.10.029","article-title":"Structural stability and local dynamics in disease-causing mutants of human apolipoprotein A-I: what makes the protein amyloidogenic?","volume":"428","author":"Das","year":"2016","journal-title":"J Mol Biol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib79","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/j.jacl.2008.06.002","article-title":"Clinical presentation, laboratory values, and coronary heart disease risk in marked high-density lipoprotein-deficiency states","volume":"2","author":"Santos","year":"2008","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib80","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jacl.2017.12.012","article-title":"A case of apolipoprotein A-I deficiency due to carboxyl-terminal truncation","volume":"12","author":"Tanaka","year":"2018","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib81","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.pcad.2016.08.006","article-title":"Diagnosis and treatment of high density lipoprotein deficiency","volume":"59","author":"Schaefer","year":"2016","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(19)30264-5_bib82","doi-asserted-by":"crossref","DOI":"10.1038\/ejhg.2016.187","article-title":"Clinical utility gene card for: Tangier disease","author":"Hooper","year":"2017","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S2213-8587(19)30264-5_bib83","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.5551\/jat.43257","article-title":"Accelerated atherogenicity in Tangier Disease","volume":"25","author":"Muratsu","year":"2018","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/S2213-8587(19)30264-5_bib84","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/0021-9150(94)90144-9","article-title":"Homozygous Tangier disease and cardiovascular disease","volume":"107","author":"Serfaty-Lacrosniere","year":"1994","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(19)30264-5_bib85","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/j.clinbiochem.2014.08.014","article-title":"A review on lecithin: cholesterol acyltransferase deficiency","volume":"48","author":"Saeedi","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/S2213-8587(19)30264-5_bib86","first-page":"245","article-title":"Lecithin cholesterol acyltransferase","volume":"1529","author":"Jonas","year":"2000","journal-title":"Biochem Biophys Acta"},{"key":"10.1016\/S2213-8587(19)30264-5_bib87","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.atherosclerosis.2011.01.025","article-title":"Proteinuria in early childhood due to familial LCAT deficiency caused by loss of a disulfide bond in lecithin:cholesterol acyl transferase","volume":"216","author":"Holleboom","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(19)30264-5_bib88","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/j.amjcard.2008.07.010","article-title":"Comparison of treatment of severe high-density lipoprotein cholesterol deficiency in men with daily atorvastatin (20 mg) versus fenofibrate (200 mg) versus extended-release niacin (2 g)","volume":"102","author":"Alrasadi","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib89","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1194\/jlr.M055665","article-title":"Effect of open-label infusion of an apoA-I-containing particle (CER-001) on RCT and artery wall thickness in patients with FHA","volume":"56","author":"Kootte","year":"2015","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(19)30264-5_bib90","doi-asserted-by":"crossref","first-page":"213","DOI":"10.5414\/CNP69213","article-title":"Therapeutic management of a new case of LCAT deficiency with a multifactorial long-term approach based on high doses of angiotensin II receptor blockers (ARBs)","volume":"69","author":"Aranda","year":"2008","journal-title":"Clin Nephrol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib91","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/01913123.2010.551578","article-title":"Lecithin: cholesterol acyltransferase (LCAT) deficiency: renal lesions with early graft recurrence","volume":"35","author":"Strom","year":"2011","journal-title":"Ultrastruct Pathol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib92","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1161\/CIRCRESAHA.115.306223","article-title":"Safety and tolerability of ACP-501, a recombinant human lecithin: cholesterol acyltransferase, in a phase 1 single-dose escalation study","volume":"118","author":"Shamburek","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(19)30264-5_bib93","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1124\/jpet.117.240457","article-title":"Lecithin: cholesterol acyltransferase activation by sulfhydryl-reactive small molecules: role of cysteine-31","volume":"362","author":"Freeman","year":"2017","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S2213-8587(19)30264-5_bib94","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.jacl.2015.12.007","article-title":"Familial lecithin: cholesterol acyltransferase deficiency: first-in-human treatment with enzyme replacement","volume":"10","author":"Shamburek","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib95","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1056\/NEJM199011013231803","article-title":"Increased high-density lipoprotein levels caused by a common cholesteryl-ester transfer protein gene mutation","volume":"323","author":"Inazu","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30264-5_bib96","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1056\/NEJMoa0907687","article-title":"Genetic variant of the scavenger receptor BI in humans","volume":"364","author":"Vergeer","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30264-5_bib97","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1111\/j.1399-0004.2011.01682.x","article-title":"Novel mutations in scavenger receptor BI associated with high HDL cholesterol in humans","volume":"79","author":"Brunham","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/S2213-8587(19)30264-5_bib98","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1126\/science.aad3517","article-title":"Rare variant in scavenger receptor BI raises HDL cholesterol and increases risk of coronary heart disease","volume":"351","author":"Zanoni","year":"2016","journal-title":"Science"},{"key":"10.1016\/S2213-8587(19)30264-5_bib99","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1161\/CIRCRESAHA.117.311978","article-title":"Trials and tribulations of CETP Inhibitors","volume":"122","author":"Tall","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(19)30264-5_bib100","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1161\/01.ATV.13.5.720","article-title":"Hepatic lipase deficiency. Clinical, biochemical, and molecular genetic characteristics","volume":"13","author":"Hegele","year":"1995","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S2213-8587(19)30264-5_bib101","series-title":"Primary hyperlipidemias","author":"Davignon","year":"2007"},{"key":"10.1016\/S2213-8587(19)30264-5_bib102","first-page":"1471","article-title":"Canadian Cardiovascular Society position statement on familial hypercholesterolemia","volume":"30","author":"Genest","year":"2014","journal-title":"Can J Cardiol"},{"key":"10.1016\/S2213-8587(19)30264-5_bib103","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/1750-1172-1-40","article-title":"Retinitis pigmentosa","volume":"1","author":"Hamel","year":"2006","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(19)30264-5_bib104","series-title":"Anderson's disease\/chylomicron retention disease and mutations in the SAR1B gene, mutations in human genetic disease","author":"Sassolas","year":"2012"},{"key":"10.1016\/S2213-8587(19)30264-5_bib105","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1503\/cmaj.060963","article-title":"Hypertriglyceridemia: its etiology, effects and treatment","volume":"176","author":"Yuan","year":"2007","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(19)30264-5_bib106","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1016\/j.ijporl.2014.09.011","article-title":"The curious case of the orange coloured tonsils","volume":"78","author":"Ravesloot","year":"2014","journal-title":"Int J Ped Otorhinolaryngology"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:53Z","timestamp":1761991673000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719302645"}},"issued":{"date-parts":[[2020,1]]},"references-count":103,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2213858719302645"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30264-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rare dyslipidaemias, from phenotype to genotype to management: a European Atherosclerosis Society task force consensus statement","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30264-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:17:04Z","timestamp":1794647824600,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100020963","name":"Department of Epidemiology and Biostatistics, University of California, San Francisco","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007334","name":"Ministry of Health and Family Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009104","name":"Department of Health Research, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009104","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/s2213-8587(23)00119-5","type":"journal-article","created":{"date-parts":[[2023,6,7]],"date-time":"2023-06-07T20:06:51Z","timestamp":1686168411000},"page":"474-489","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":774,"title":["Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)"],"prefix":"10.1016","volume":"11","author":[{"given":"Ranjit Mohan","family":"Anjana","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Deepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Pradeepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puthiyaveettil Kottayam","family":"Jabbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiranya Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay Kumar","family":"Dhandhania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Bhansali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paturi Vishnupriya","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankush","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishnan","family":"Lakshmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Venkata","family":"Madhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal","family":"Elangovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhankar","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulagamathesan","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhakrishnan","family":"Subashini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupinder Singh","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit Mohan","family":"Anjana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rajendra","family":"Pradeepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohan","family":"Deepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasudevan","family":"Sudha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elangovan","family":"Nirmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radhakrishnan","family":"Subashini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulagamathesan","family":"Venkatesan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L M","family":"Nath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramakrishnan","family":"Lakshmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jagadish","family":"Mahanta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sri Venkata","family":"Madhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashok Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rupinder Singh","family":"Dhaliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanvir","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paturi Vishnupriya","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Modugu Nageswara","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lobsang","family":"Jampa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiranya Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prasanta Kumar","family":"Borah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Smita","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Bhansali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpana","family":"Dash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vijay Kumar","family":"Shrivas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Krishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankush","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amit","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jayendrasinh M","family":"Padhiyar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bharti","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jatinder Kumar","family":"Mokta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ramesh","family":"Gulepa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vinay Kumar","family":"Dhandhania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabha","family":"Adhikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Puthiyaveettil Kottayam","family":"Jabbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Jayakumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunil M","family":"Jain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaurav","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shashank","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chittaranjan S","family":"Yajnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prashant P","family":"Joshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Somorjit","family":"Ningombam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T B","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R O","family":"Budnah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M R","family":"Basaiawmoit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"family":"Rosangluaia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P C","family":"Lalramenga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vizolie","family":"Suokhrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sao","family":"Tunyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saroj Kumar","family":"Tripathy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirmal Chandra","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil Jacob","family":"Purty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"John","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arvind","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B Lal","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandeep K","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karma Jigme","family":"Tobgay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tempo Tsewang","family":"Kaleon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taranga","family":"Reang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapan Kumar","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarita","family":"Bajaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manoj Kumar","family":"Mathur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sagar","family":"Modi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakesh","family":"Kakkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Subhankar","family":"Chowdhury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sujoy","family":"Ghosh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00119-5_bib1","series-title":"The global burden of disease: generating evidence, guiding policy\u2014south Asia regional edition","year":"2013"},{"key":"10.1016\/S2213-8587(23)00119-5_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1093\/bmb\/ldu018","article-title":"Non-communicable diseases in South Asia: contemporary perspectives","volume":"111","author":"Siegel","year":"2014","journal-title":"Br Med Bull"},{"key":"10.1016\/S2213-8587(23)00119-5_bib3","doi-asserted-by":"crossref","first-page":"e1352","DOI":"10.1016\/S2214-109X(18)30387-5","article-title":"The increasing burden of diabetes and variations among the states of India: the Global Burden of Disease Study 1990\u20132016","volume":"6","author":"Tandon","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(23)00119-5_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112514","article-title":"The interaction between district-level development and individual-level socioeconomic gradients of cardiovascular disease risk factors in India: a cross-sectional study of 2.4 million adults","volume":"239","author":"Jung","year":"2019","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(23)00119-5_bib5","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1177\/1741826711424567","article-title":"Twenty-year trends in cardiovascular risk factors in India and influence of educational status","volume":"19","author":"Gupta","year":"2012","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/S2213-8587(23)00119-5_bib6","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamainternmed.2017.8094","article-title":"Diabetes and hypertension in india: a nationally representative study of 1.3 million adults","volume":"178","author":"Geldsetzer","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(23)00119-5_bib7","doi-asserted-by":"crossref","first-page":"3094","DOI":"10.2337\/dc20-0886","article-title":"Contrasting associations between diabetes and cardiovascular mortality rates in low-, middle-, and high-income countries: cohort study data from 143,567 individuals in 21 countries in the PURE Study","volume":"43","author":"Anjana","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00119-5_bib8","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1177\/193229681100500413","article-title":"The Indian Council of Medical Research-India Diabetes (ICMR-INDIAB) study: methodological details","volume":"5","author":"Anjana","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(23)00119-5_bib9","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1007\/s00125-011-2291-5","article-title":"Prevalence of diabetes and prediabetes (impaired fasting glucose and\/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study","volume":"54","author":"Anjana","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00119-5_bib10","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2213-8587(17)30174-2","article-title":"Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR-INDIAB population-based cross-sectional study","volume":"5","author":"Anjana","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00119-5_bib11","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1038\/jhh.2014.57","article-title":"Prevalence of and risk factors for hypertension in urban and rural India: the ICMR-INDIAB study","volume":"29","author":"Bhansali","year":"2015","journal-title":"J Hum Hypertens"},{"key":"10.1016\/S2213-8587(23)00119-5_bib12","doi-asserted-by":"crossref","first-page":"139","DOI":"10.4103\/0971-5916.164234","article-title":"Prevalence of generalized & abdominal obesity in urban & rural India\u2014the ICMR-INDIAB Study (Phase-I) [ICMR-INDIAB-3]","volume":"142","author":"Pradeepa","year":"2015","journal-title":"Indian J Med Res"},{"key":"10.1016\/S2213-8587(23)00119-5_bib13","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096808","article-title":"Prevalence of dyslipidemia in urban and rural India: the ICMR-INDIAB study","volume":"9","author":"Joshi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(23)00119-5_bib14","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1479-5868-11-26","article-title":"Physical activity and inactivity patterns in India - results from the ICMR-INDIAB study (Phase-1) [ICMR-INDIAB-5]. [ICMR-INDIAB-5]","volume":"11","author":"Anjana","year":"2014","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(23)00119-5_bib15","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1016\/S2213-8587(22)00072-9","article-title":"Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national cross-sectional study","volume":"10","author":"Anjana","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00119-5_bib17","series-title":"Anthropometric standardization reference manual","first-page":"55","article-title":"Skinfold thickness and measurement technique","author":"Harrison","year":"1988"},{"key":"10.1016\/S2213-8587(23)00119-5_bib19","series-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation","year":"2006"},{"key":"10.1016\/S2213-8587(23)00119-5_bib20","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.2337\/diacare.20.7.1183","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"20","year":"1997","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00119-5_bib21","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00119-5_bib22","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/j.diabres.2011.03.012","article-title":"Report of a World Health Organization Consultation: use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus","volume":"93","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00119-5_bib24","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00119-5_bib25","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1001\/jama.285.19.2486","article-title":"Executive Summary of The Third Report of The National Cholesterol Education Program (NCEP) Expert Panel on Detection, Evaluation, And Treatment of High Blood Cholesterol In Adults (Adult Treatment Panel III)","volume":"285","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00119-5_bib26","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(23)00119-5_bib27","series-title":"Practical methods for design and analysis of complex surveys","author":"Lehtonen","year":"2003"},{"key":"10.1016\/S2213-8587(23)00119-5_bib28","series-title":"National Family Health Survey (NFHS-5), 2019\u201321: India: Volume I","year":"2021"},{"key":"10.1016\/S2213-8587(23)00119-5_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: Global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00119-5_bib31","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(23)00119-5_bib32","series-title":"IDF Diabetes Atlas","first-page":"37","year":"2021"},{"key":"10.1016\/S2213-8587(23)00119-5_bib33","doi-asserted-by":"crossref","first-page":"797","DOI":"10.2337\/dc11-1321","article-title":"Spuriously high prevalence of prediabetes diagnosed by HbA(1c) in young indians partly explained by hematological factors and iron deficiency anemia","volume":"35","author":"Hardikar","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00119-5_bib34","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cca.2016.10.003","article-title":"Effect of iron deficiency anemia and iron supplementation on HbA1c levels\u2014implications for diagnosis of prediabetes and diabetes mellitus in Asian Indians","volume":"468","author":"Madhu","year":"2017","journal-title":"Clin Chim Acta"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00119-5_bib35","first-page":"1","article-title":"RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2022","volume":"42","author":"Makkar","year":"2022","journal-title":"Int J Diabetes Dev Ctries"},{"key":"10.1016\/S2213-8587(23)00119-5_bib36","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.1210\/jc.2016-1370","article-title":"A reappraisal of prediabetes","volume":"101","author":"Davidson","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00119-5_bib37","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11892-018-1002-8","article-title":"Diabetes in south Asians: phenotype, clinical presentation, and natural history","volume":"18","author":"Unnikrishnan","year":"2018","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(23)00119-5_bib38","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/j.ihj.2015.03.020","article-title":"Consensus statement on the management of dyslipidemia in Indian subjects: a different perspective","volume":"67","author":"Enas","year":"2015","journal-title":"Indian Heart J"},{"key":"10.1016\/S2213-8587(23)00119-5_bib39","doi-asserted-by":"crossref","first-page":"247","DOI":"10.4330\/wjc.v8.i3.247","article-title":"Lipoprotein abnormalities in South Asians and its association with cardiovascular disease: current state and future directions","volume":"8","author":"Bilen","year":"2016","journal-title":"World J Cardiol"},{"key":"10.1016\/S2213-8587(23)00119-5_bib40","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1016\/j.ihj.2017.02.020","article-title":"Recent trends in epidemiology of dyslipidemias in India","volume":"69","author":"Gupta","year":"2017","journal-title":"Indian Heart J"},{"key":"10.1016\/S2213-8587(23)00119-5_bib41","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1016\/j.jacc.2008.09.041","article-title":"Lipid profile, plasma apolipoproteins, and risk of a first myocardial infarction among Asians: an analysis from the INTERHEART Study","volume":"53","author":"Karthikeyan","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(23)00119-5_bib42","article-title":"Diabetes diagnosis, treatment, and control in India: results from a national survey of 1.65 million adults aged 18 years and older, 2019-2021","author":"Varghese","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(23)00119-5_bib43","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1097\/HJH.0000000000000146","article-title":"Hypertension in India: a systematic review and meta-analysis of prevalence, awareness, and control of hypertension","volume":"32","author":"Anchala","year":"2014","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(23)00119-5_bib44","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1038\/s41371-022-00692-y","article-title":"Hypertension treatment cascade in India: results from National Noncommunicable Disease Monitoring Survey","volume":"37","author":"Amarchand","year":"2022","journal-title":"J Hum Hypertens"},{"key":"10.1016\/S2213-8587(23)00119-5_bib45","first-page":"11","article-title":"Persistent high prevalence of cardiovascular risk factors in the urban middle class in India: Jaipur Heart Watch-5","volume":"60","author":"Gupta","year":"2012","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(23)00119-5_bib46","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-006-0219-2","article-title":"Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India\u2014the Chennai Urban Rural Epidemiology Study (CURES-17)","volume":"49","author":"Mohan","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00119-5_bib47","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14424","article-title":"Temporal changes in diabetes prevalence and achievement of care goals in urban South Asia from 2010 to 2016\u2014the Center for Cardio-metabolic Risk Reduction in South Asia Study","volume":"38","author":"Anjana","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00119-5_bib48","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00125-020-05132-5","article-title":"Why are South Asians prone to type 2 diabetes? A hypothesis based on underexplored pathways","volume":"63","author":"Narayan","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00119-5_bib49","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.2337\/dc14-2814","article-title":"Incidence of diabetes and prediabetes and predictors of progression among asian indians: 10-year follow-up of the Chennai Urban Rural Epidemiology Study (CURES)","volume":"38","author":"Anjana","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00119-5_bib51","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1089\/dia.2010.0218","article-title":"Comparison of capillary whole blood versus venous plasma glucose estimations in screening for diabetes mellitus in epidemiological studies in developing countries","volume":"13","author":"Priya","year":"2011","journal-title":"Diabetes Technol Ther"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:12Z","timestamp":1761991932000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001195"}},"issued":{"date-parts":[[2023,7]]},"references-count":46,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2213858723001195"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00119-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic non-communicable disease health report of India: the ICMR-INDIAB national cross-sectional study (ICMR-INDIAB-17)","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00119-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00163-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:46:45Z","timestamp":1794674805449,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T00:00:00Z","timestamp":1654732800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000883","name":"University of Bristol","doi-asserted-by":"publisher","award":["MC_UU_00011\/1"],"award-info":[{"award-number":["MC_UU_00011\/1"]}],"id":[{"id":"10.13039\/501100000883","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1149987"],"award-info":[{"award-number":["APP1149987"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1174120"],"award-info":[{"award-number":["APP1174120"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["RE\/18\/6\/34217"],"award-info":[{"award-number":["RE\/18\/6\/34217"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004211","name":"Oxford Martin School, University of Oxford","doi-asserted-by":"publisher","award":["ES\/P011055\/1"],"award-info":[{"award-number":["ES\/P011055\/1"]}],"id":[{"id":"10.13039\/501100004211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["FS\/19\/36\/34346"],"award-info":[{"award-number":["FS\/19\/36\/34346"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/18\/65\/33872"],"award-info":[{"award-number":["PG\/18\/65\/33872"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000850","name":"National Heart and Lung Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/s2213-8587(22)00172-3","type":"journal-article","created":{"date-parts":[[2022,7,22]],"date-time":"2022-07-22T18:34:29Z","timestamp":1658514869000},"page":"645-654","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":111,"title":["Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis"],"prefix":"10.1016","volume":"10","author":[{"given":"Milad","family":"Nazarzadeh","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeinab","family":"Bidel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dexter","family":"Canoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Copland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derrick A","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Davey Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rury R","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda I","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Wamil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard J","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koon","family":"Teo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry R","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl J","family":"Pepine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazem","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Agodoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Algra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F W","family":"Asselbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Beckett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Berge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F P J","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C J","family":"Bulpitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Byington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Cutler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R B","family":"Devereaux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Dwyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Estacio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Fagard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ishii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Julius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kanno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S E","family":"Kjeldsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kostis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kuramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lanke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lievre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L H","family":"Lindholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lueders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"MacMahon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Mancia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Matsuzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M H","family":"Mehlum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nissen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ogihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ohkubo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pfeffer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N R","family":"Poulter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Rakugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Reboldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Remuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ruggenenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Saruta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Schrader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Schrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Sleight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J A","family":"Staessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Thijs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ueshima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Umemoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W H","family":"van Gilst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Verdecchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Wachtell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Whelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Wing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Zanchetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z Y","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Baigent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BM","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"de Zeeuw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lubsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Malacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Perkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Rothwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Salimi-Khorshidi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Turnbull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Viberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00172-3_bib1","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(22)00172-3_bib2","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b79 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00172-3_bib3","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","author":"Cushman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00172-3_bib4","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00172-3_bib5","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00172-3_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028698","volume":"9","author":"Rahimi","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(22)00172-3_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2021-320171","article-title":"Antihypertensive drug effects on long-term blood pressure: an individual-level data meta-analysis of randomised clinical trials","author":"Canoy","year":"2022","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(22)00172-3_bib8","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0140-6736(21)01921-8","article-title":"Age-stratified and blood-pressure-stratified effects of blood-pressure-lowering pharmacotherapy for the prevention of cardiovascular disease and death: an individual participant-level data meta-analysis","volume":"398","author":"Rahimi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00172-3_bib9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(21)00590-0","article-title":"Pharmacological blood pressure lowering for primary and secondary prevention of cardiovascular disease across different levels of blood pressure: an individual participant-level data meta-analysis","volume":"397","author":"Rahimi","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00172-3_bib10","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/1740774507085276","article-title":"A comparison of methods for fixed effects meta-analysis of individual patient data with time to event outcomes","volume":"4","author":"Tudur Smith","year":"2007","journal-title":"Clin Trials"},{"key":"10.1016\/S2213-8587(22)00172-3_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003599","article-title":"Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: an individual participant data meta-analysis","volume":"18","author":"Pinho-Gomes","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(22)00172-3_bib12","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1093\/biomet\/75.2.383","article-title":"A stagewise rejective multiple test procedure based on a modified Bonferroni test","volume":"75","author":"Hommel","year":"1988","journal-title":"Biometrika"},{"key":"10.1016\/S2213-8587(22)00172-3_bib13","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1056\/NEJMsr077003","article-title":"Statistics in medicine\u2014reporting of subgroup analyses in clinical trials","volume":"357","author":"Wang","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00172-3_bib14","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jrsm.1054","article-title":"Automating network meta-analysis","volume":"3","author":"van Valkenhoef","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/S2213-8587(22)00172-3_bib15","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(21)01920-6","article-title":"Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis","volume":"398","author":"Nazarzadeh","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00172-3_bib16","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1291\/hypres.28.307","article-title":"Effects of candesartan on cardiovascular outcomes in Japanese hypertensive patients","volume":"28","author":"Suzuki","year":"2005","journal-title":"Hypertens Res"},{"key":"10.1016\/S2213-8587(22)00172-3_bib17","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","author":"Turner","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00172-3_bib18","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1161\/HYPERTENSIONAHA.118.12414","article-title":"Effects of blood pressure lowering on clinical outcomes according to baseline blood pressure and cardiovascular risk in patients with type 2 diabetes mellitus","volume":"73","author":"Rahman","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(22)00172-3_bib19","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archinte.165.12.1410","article-title":"Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials","volume":"165","author":"Turnbull","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(22)00172-3_bib20","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1161\/HYPERTENSIONAHA.120.15026","article-title":"2020 International Society of Hypertension global hypertension practice guidelines","volume":"75","author":"Unger","year":"2020","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(22)00172-3_bib21","doi-asserted-by":"crossref","first-page":"e127","DOI":"10.1016\/j.jacc.2017.11.006","volume":"71","author":"Whelton","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(22)00172-3_bib22","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/eurheartj\/ehy339","article-title":"2018 ESC\/ESH Guidelines for the management of arterial hypertension","volume":"39","author":"Williams","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(22)00172-3_bib23","doi-asserted-by":"crossref","first-page":"i717","DOI":"10.1136\/bmj.i717","article-title":"Effect of antihypertensive treatment at different blood pressure levels in patients with diabetes mellitus: systematic review and meta-analyses","volume":"352","author":"Brunstr\u00f6m","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00172-3_bib24","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/jrsm.4","article-title":"Meta-analysis of a binary outcome using individual participant data and aggregate data","volume":"1","author":"Riley","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/S2213-8587(22)00172-3_bib25","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00172-3_bib26","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1016\/S0140-6736(21)00572-9","article-title":"Cardiovascular risk prediction in type 2 diabetes before and after widespread screening: a derivation and validation study","volume":"397","author":"Pylypchuk","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00172-3_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002538","article-title":"Blood pressure-lowering treatment strategies based on cardiovascular risk versus blood pressure: a meta-analysis of individual participant data","volume":"15","author":"Karmali","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(22)00172-3_bib28","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.2337\/dc17-0885","article-title":"Effect of intensive versus standard blood pressure treatment according to baseline prediabetes status: a post hoc analysis of a randomized trial","volume":"40","author":"Bress","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00172-3_bib29","doi-asserted-by":"crossref","first-page":"440","DOI":"10.2337\/dc19-1683","article-title":"glycated hemoglobin, prediabetes, and the links to cardiovascular disease: data from UK Biobank","volume":"43","author":"Welsh","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00172-3_bib30","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1159\/000446122","article-title":"cardiovascular outcomes in action to control cardiovascular risk in diabetes: impact of blood pressure level and presence of kidney disease","volume":"43","author":"Papademetriou","year":"2016","journal-title":"Am J Nephrol"},{"key":"10.1016\/S2213-8587(22)00172-3_bib31","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/j.diabres.2016.09.016","article-title":"Effects of reducing blood pressure on cardiovascular outcomes and mortality in patients with type 2 diabetes: focus on SGLT2 inhibitors and EMPA-REG OUTCOME","volume":"121","author":"Scheen","year":"2016","journal-title":"Diabetes Res Clin Pract"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:25Z","timestamp":1761991885000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001723"}},"issued":{"date-parts":[[2022,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2213858722001723"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00172-3","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742248324.793595336","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00172-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00191-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T16:32:35Z","timestamp":1688401955029},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Heart and Stroke Foundation of Ontario","award":["T-000353"],"award-info":[{"award-number":["T-000353"]}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/s2213-8587(17)30150-x","type":"journal-article","created":{"date-parts":[[2017,5,6]],"date-time":"2017-05-06T00:49:04Z","timestamp":1494031744000},"page":"490-492","source":"Crossref","is-referenced-by-count":1,"title":["PCSK9 inhibitors: smooth sailing or a little turbulence ahead?"],"prefix":"10.1016","volume":"5","author":[{"given":"Robert A","family":"Hegele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30150-X_bib1","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30150-X_bib2","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1056\/NEJMoa1614062","article-title":"Lipid-reduction variability and antidrug-antibody formation with bococizumab","volume":"376","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30150-X_bib3","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa1701488","article-title":"Cardiovascular efficacy and safety of bococizumab in high-risk patients","volume":"376","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30150-X_bib4","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1056\/NEJMoa1615758","article-title":"Inclisiran in patients at high cardiovascular risk with elevated LDL cholesterol","volume":"376","author":"Ray","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30150-X_bib5","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30150-X_bib6","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30150-X_bib7","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30150-X_bib8","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1016\/j.ahj.2014.07.028","article-title":"Effect of alirocumab, a monoclonal antibody to PCSK9, on long-term cardiovascular outcomes following acute coronary syndromes: rationale and design of the ODYSSEY outcomes trial","volume":"168","author":"Schwartz","year":"2014","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(17)30150-X_bib9","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1056\/NEJMc1616623","article-title":"Antidrug antibodies in patients treated with alirocumab","volume":"376","author":"Roth","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30150-X_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2017.0747","article-title":"Long-term low-density lipoprotein cholesterol-lowering efficacy, persistence, and safety of evolocumab in treatment of hypercholesterolemia: results up to 4 years from the open-label OSLER-1 extension study","author":"Koren","year":"2017","journal-title":"JAMA Cardiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730150X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730150X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T04:15:58Z","timestamp":1560831358000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871730150X"}},"issued":{"date-parts":[[2017,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S221385871730150X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30150-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,7]]}},{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T16:21:40Z","timestamp":1768407700314,"version":"3.49.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/s2213-8587(24)00398-x","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T23:39:26Z","timestamp":1740181166000},"page":"267-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Vitamin D and acute respiratory infections: a definitive answer?"],"prefix":"10.1016","volume":"13","author":[{"given":"Chris","family":"Gallagher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00398-X_bib1","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1001\/archinternmed.2008.560","article-title":"Association between serum 25-hydroxyvitamin D level and upper respiratory tract infection in the Third National Health and Nutrition Examination Survey","volume":"169","author":"Ginde","year":"2009","journal-title":"Arch Intern Med"},{"issue":"suppl","key":"10.1016\/S2213-8587(24)00398-X_bib2","doi-asserted-by":"crossref","first-page":"33S","DOI":"10.1016\/8756-3282(95)00205-R","article-title":"New understanding of the molecular mechanism of receptor-mediated genomic actions of the vitamin D hormone","volume":"17","author":"Haussler","year":"1995","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(24)00398-X_bib3","doi-asserted-by":"crossref","first-page":"911","DOI":"10.3390\/ijms23020911","article-title":"Time-resolved gene expression analysis monitors the regulation of inflammatory mediators and attenuation of adaptive immune response by vitamin D","volume":"23","author":"Hanel","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(24)00398-X_bib4","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.4049\/jimmunol.170.11.5382","article-title":"Differential regulation of vitamin D receptor and its ligand in human monocyte-derived dendritic cells","volume":"170","author":"Hewison","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(24)00398-X_bib5","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1126\/science.1123933","article-title":"Toll-like receptor triggering of a vitamin D-mediated human antimicrobial response","volume":"311","author":"Liu","year":"2006","journal-title":"Science"},{"key":"10.1016\/S2213-8587(24)00398-X_bib6","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/eji.200425995","article-title":"Vitamin D3 down-regulates monocyte TLR expression and triggers hyporesponsiveness to pathogen-associated molecular patterns","volume":"36","author":"Sadeghi","year":"2006","journal-title":"Eur J Immunol"},{"key":"10.1016\/S2213-8587(24)00398-X_bib7","doi-asserted-by":"crossref","first-page":"1634","DOI":"10.4049\/jimmunol.179.3.1634","article-title":"Modulatory effects of 1,25-dihydroxyvitamin D3 on human B cell differentiation","volume":"179","author":"Chen","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(24)00398-X_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00348-6","article-title":"Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of stratified aggregate data","author":"Joliffe","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00398-X_bib9","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7326\/M20-3812","article-title":"The effects of four doses of vitamin D supplements on falls in older adults: a response-adaptive, randomized clinical trial","volume":"174","author":"Appel","year":"2021","journal-title":"Ann Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872400398X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872400398X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T20:14:07Z","timestamp":1747426447000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872400398X"}},"issued":{"date-parts":[[2025,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S221385872400398X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00398-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D and acute respiratory infections: a definitive answer?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00398-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00348-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:32:56Z","timestamp":1775176376704,"version":"3.50.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/s2213-8587(18)30368-1","type":"journal-article","created":{"date-parts":[[2019,1,15]],"date-time":"2019-01-15T22:24:37Z","timestamp":1547591077000},"page":"331-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Low-carbohydrate diets in type 2 diabetes"],"prefix":"10.1016","volume":"7","author":[{"given":"Jeannie","family":"Tay","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin I","family":"de Bock","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth J","family":"Mayer-Davis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30368-1_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/dc11-2216","article-title":"Macronutrients, food groups, ng patterns in the management of diabetes: a systematic review of the literature, 2010","volume":"35","author":"Wheeler","year":"2012","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30368-1_bib2","first-page":"S38","article-title":"4. Lifestyle management: standards of medical care in diabetes\u20142018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30368-1_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/dme.13603","article-title":"Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes","volume":"35","author":"Dyson","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30368-1_bib4","doi-asserted-by":"crossref","first-page":"S64","DOI":"10.1016\/j.jcjd.2017.10.009","article-title":"Nutrition therapy","volume":"42","author":"Sievenpiper","year":"2018","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(18)30368-1_bib5","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.diabres.2018.02.026","article-title":"Effect of dietary carbohydrate restriction on glycemic control in adults with diabetes: a systematic review and meta-analysis","volume":"139","author":"Sainsbury","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30368-1_bib6","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/ajcn\/nqy096","article-title":"Effects of low-carbohydrate- compared with low-fat-diet interventions on metabolic control in people with type 2 diabetes: a systematic review including GRADE assessments","volume":"108","author":"van Zuuren","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(18)30368-1_bib7","doi-asserted-by":"crossref","first-page":"e000354","DOI":"10.1136\/bmjdrc-2016-000354","article-title":"Systematic review and meta-analysis of dietary carbohydrate restriction in patients with type 2 diabetes","volume":"5","author":"Snorgaard","year":"2017","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(18)30368-1_bib8","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1111\/dom.13164","article-title":"Effects of an energy-restricted low-carbohydrate, high unsaturated fat\/low saturated fat diet versus a high-carbohydrate, low-fat diet in type 2 diabetes: a 2-year randomized clinical trial","volume":"20","author":"Tay","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30368-1_bib9","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.2337\/dc15-1380","article-title":"Euglycemic diabetic ketoacidosis: a predictable, detectable, and preventable safety concern with SGLT2 inhibitors","volume":"38","author":"Rosenstock","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30368-1_bib10","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1017\/S0007114513000548","article-title":"Very-low-carbohydrate ketogenic diet v. low-fat diet for long-term weight loss: a meta-analysis of randomised controlled trials","volume":"110","author":"Bueno","year":"2013","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(18)30368-1_bib11","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.jacc.2007.08.050","article-title":"Metabolic effects of weight loss on a very-low-carbohydrate diet compared with an isocaloric high-carbohydrate diet in abdominally obese subjects","volume":"51","author":"Tay","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(18)30368-1_bib13","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s11745-010-3467-3","article-title":"Limited effect of dietary saturated fat on plasma saturated fat in the context of a low carbohydrate diet","volume":"45","author":"Forsythe","year":"2010","journal-title":"Lipids"},{"key":"10.1016\/S2213-8587(18)30368-1_bib12","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S2213-8587(15)00208-9","article-title":"Diverging global trends in heart disease and type 2 diabetes: the role of carbohydrates and saturated fats","volume":"3","author":"Mozaffarian","year":"2015","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303681?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303681?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:09:25Z","timestamp":1571098165000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303681"}},"issued":{"date-parts":[[2019,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2213858718303681"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30368-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Low-carbohydrate diets in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30368-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:14:16Z","timestamp":1761992056460,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/s2213-8587(21)00216-3","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T05:54:32Z","timestamp":1628229272000},"page":"545","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Type 1 diabetes: one size does not fit all"],"prefix":"10.1016","volume":"9","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:21Z","timestamp":1761991821000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002163"}},"issued":{"date-parts":[[2021,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2213858721002163"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00216-3","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes: one size does not fit all","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00216-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:19:13Z","timestamp":1767151153944,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(22)00307-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/s2213-8587(23)00096-7","type":"journal-article","created":{"date-parts":[[2023,4,18]],"date-time":"2023-04-18T18:30:36Z","timestamp":1681842636000},"page":"e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2023; 11: 86\u201395"],"prefix":"10.1016","volume":"11","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:19Z","timestamp":1761991939000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000967"}},"issued":{"date-parts":[[2023,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2213858723000967"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00096-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2023; 11: 86\u201395","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00096-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00307-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:14:00Z","timestamp":1761992040446,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/s2213-8587(21)00124-8","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T19:19:07Z","timestamp":1620415147000},"page":"483","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vanita Aroda: the accidental role model\u2026 by no accident"],"prefix":"10.1016","volume":"9","author":[{"given":"Priya","family":"Venkatesan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001248?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001248?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:38Z","timestamp":1761991778000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001248"}},"issued":{"date-parts":[[2021,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2213858721001248"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00124-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vanita Aroda: the accidental role model\u2026 by no accident","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00124-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T21:18:53Z","timestamp":1775078333529,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/s2213-8587(20)30428-9","type":"journal-article","created":{"date-parts":[[2020,12,22]],"date-time":"2020-12-22T18:47:06Z","timestamp":1608662826000},"page":"59-61","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["SGLT2 inhibitors: expanding their Empire beyond diabetes"],"prefix":"10.1016","volume":"9","author":[{"given":"Marcel H A","family":"Muskiet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiddo J L","family":"Heerspink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dani\u00ebl H","family":"van Raalte","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30428-9_bib1","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.2337\/dc15-0642","article-title":"Sodium-glucose cotransporter inhibitors: effects on renal and intestinal glucose transport: from bench to bedside","volume":"38","author":"Mudaliar","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30428-9_bib2","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30428-9_bib3","article-title":"Effects of SGLT2 inhibitors on kidney and cardiovascular function","author":"Vallon","year":"2020","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/S2213-8587(20)30428-9_bib4","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30428-9_bib5","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30428-9_bib6","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30428-9_bib7","article-title":"Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial","author":"Jensen","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30428-9_bib8","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1161\/CIRCULATIONAHA.120.045691","article-title":"Empagliflozin in heart failure: diuretic and cardiorenal effects","volume":"142","author":"Griffin","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(20)30428-9_bib9","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2337\/dc17-1096","article-title":"How does empagliflozin reduce cardiovascular mortality? Insights from a mediation analysis of the EMPA-REG OUTCOME trial","volume":"41","author":"Inzucchi","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30428-9_bib10","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/dom.13126","article-title":"Why do SGLT2 inhibitors reduce heart failure hospitalization? A differential volume regulation hypothesis","volume":"20","author":"Hallow","year":"2018","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720304289?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720304289?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:25Z","timestamp":1761991705000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720304289"}},"issued":{"date-parts":[[2021,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2213858720304289"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30428-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT2 inhibitors: expanding their Empire beyond diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30428-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30382-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:46Z","timestamp":1761991906688,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/s2213-8587(19)30272-4","type":"journal-article","created":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T18:32:42Z","timestamp":1565289162000},"page":"753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Treading one's own path"],"prefix":"10.1016","volume":"7","author":[{"given":"Fiona","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:25Z","timestamp":1761991645000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719302724"}},"issued":{"date-parts":[[2019,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2213858719302724"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30272-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treading one's own path","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30272-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,20]],"date-time":"2025-10-20T18:38:46Z","timestamp":1760985526375},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/s2213-8587(16)30425-9","type":"journal-article","created":{"date-parts":[[2017,1,6]],"date-time":"2017-01-06T15:06:56Z","timestamp":1483715216000},"page":"152-154","source":"Crossref","is-referenced-by-count":8,"title":["Pros and cons of bariatric surgery in adolescents"],"prefix":"10.1016","volume":"5","author":[{"given":"Geltrude","family":"Mingrone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30425-9_bib1","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30425-9_bib2","first-page":"392747","article-title":"Prevalence of overweight and obesity in adolescents: a systematic review","volume":"2013","author":"Bibiloni Mdel","year":"2013","journal-title":"ISRN Obes"},{"key":"10.1016\/S2213-8587(16)30425-9_bib3","doi-asserted-by":"publisher","first-page":"1307","DOI":"10.1056\/NEJMoa1502821","article-title":"Cardiometabolic risks and severity of obesity in children and young adults","volume":"373","author":"Skinner","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30425-9_bib4","doi-asserted-by":"publisher","first-page":"S161","DOI":"10.2337\/dc11-s212","article-title":"Type 2 diabetes in youth: epidemiology and pathophysiology","volume":"34","author":"D'Adamo","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30425-9_bib5","doi-asserted-by":"publisher","first-page":"624","DOI":"10.1016\/j.jpeds.2010.09.049","article-title":"Smaller weight changes in standardized body mass index in response to treatment as weight classification increases","volume":"158","author":"Johnston","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(16)30425-9_bib6","doi-asserted-by":"publisher","first-page":"2873","DOI":"10.1001\/jama.293.23.2873","article-title":"Effect of orlistat on weight and body composition in obese adolescents: a randomized controlled trial","volume":"293","author":"Chanoine","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30425-9_bib7","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1001\/jamapediatrics.2013.1045","article-title":"The effect of glucagon-like peptide-1 receptor agonist therapy on body mass index in adolescents with severe obesity: a randomized, placebo-controlled, clinical trial","volume":"167","author":"Kelly","year":"2013","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(16)30425-9_bib8","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30315-1","article-title":"Long-term outcomes of bariatric surgery in adolescents with severe obesity (FABS-5+): a prospective follow-up analysis","author":"Inge","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30425-9_bib9","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(16)30424-7","article-title":"Laparoscopic Roux-en-Y gastric bypass in adolescents with severe obesity (AMOS): a prospective, 5-year, Swedish nationwide study","author":"Olbers","year":"2017","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716304259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716304259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T08:22:11Z","timestamp":1536135731000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716304259"}},"issued":{"date-parts":[[2017,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2213858716304259"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30425-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,3]]}},{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:36:55Z","timestamp":1761896215097},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/s2213-8587(15)00476-3","type":"journal-article","created":{"date-parts":[[2015,12,25]],"date-time":"2015-12-25T00:30:27Z","timestamp":1451003427000},"page":"19-20","source":"Crossref","is-referenced-by-count":2,"title":["Drug approvals in India"],"prefix":"10.1016","volume":"4","author":[{"given":"Anil","family":"Pareek","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nitin","family":"Chandurkar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00476-3_bib1","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/S2213-8587(15)00328-9","article-title":"The marketing of unproven drugs for diabetes and dyslipidaemia in India","volume":"3","author":"Luthra","year":"2015","journal-title":"Lancet Diabetes & Endocrinol"},{"key":"10.1016\/S2213-8587(15)00476-3_bib2","article-title":"Indians face risk from unproven drugs: Lancet","author":"Mukherjee","year":"2015","journal-title":"Times of India (Mumbai)"},{"key":"10.1016\/S2213-8587(15)00476-3_bib3","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1185\/03007995.2014.909393","article-title":"Efficacy and safety of hydroxychloroquine in the treatment of type 2 diabetes: a double-blind randomized comparison with pioglitazone","volume":"30","author":"Pareek","year":"2014","journal-title":"Current Med Res Opin"},{"key":"10.1016\/S2213-8587(15)00476-3_bib4","doi-asserted-by":"crossref","first-page":"678","DOI":"10.7326\/0003-4819-112-9-678","article-title":"Hydroxychloroquine in decompensated, treatment-refractory noninsulin-dependent diabetes mellitus. A new job for an old drug?","volume":"112","author":"Quatraro","year":"1990","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(15)00476-3_bib5","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/S0168-8227(01)00325-4","article-title":"The effectiveness of hydroxychloroquine in patients with type 2 diabetes mellitus who are refractory to sulfonylureas\u2014a randomized trial","volume":"55","author":"Gerstein","year":"2002","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00476-3_bib6","doi-asserted-by":"crossref","first-page":"3569","DOI":"10.1002\/art.27703","article-title":"Changes in glycosylated hemoglobin after initiation of hydroxychloroquine or methotrexate treatment in diabetes patients with rheumatic diseases","volume":"62","author":"Rekedal","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(15)00476-3_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.semarthrit.2013.01.001","article-title":"Multifaceted effects of hydroxychloroquine in human disease","volume":"43","author":"Olsen","year":"2013","journal-title":"Semin Arthritis Rheum"},{"key":"10.1016\/S2213-8587(15)00476-3_bib8","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1007\/s00125-015-3689-2","article-title":"Antidiabetogenic effects of hydroxychloroquine on insulin sensitivity and beta cell function: a randomised trial","volume":"58","author":"Wasko","year":"2015","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004763?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004763?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T15:54:23Z","timestamp":1537113263000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004763"}},"issued":{"date-parts":[[2016,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S2213858715004763"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00476-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,1]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T13:00:47Z","timestamp":1648558847886},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70002-0","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T12:32:37Z","timestamp":1359981157000},"page":"e9","source":"Crossref","is-referenced-by-count":0,"title":["Jean-Pierre Chanoine: taking paediatric endocrinology global"],"prefix":"10.1016","volume":"1","author":[{"given":"David","family":"Holmes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700020?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700020?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T21:25:41Z","timestamp":1539897941000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700020"}},"issued":{"date-parts":[[2013,9]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2213858713700020"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70002-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]}},{"indexed":{"date-parts":[[2024,9,16]],"date-time":"2024-09-16T22:21:10Z","timestamp":1726525270101},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/s2213-8587(16)30395-3","type":"journal-article","created":{"date-parts":[[2016,11,25]],"date-time":"2016-11-25T01:30:18Z","timestamp":1480037418000},"page":"688","source":"Crossref","is-referenced-by-count":1,"title":["Nizar Albache: championing the cause of Syrian refugees with diabetes"],"prefix":"10.1016","volume":"5","author":[{"given":"Jennifer","family":"Thorley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T13:31:31Z","timestamp":1574775091000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303953"}},"issued":{"date-parts":[[2017,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2213858716303953"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30395-3","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2017,9]]}},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:10Z","timestamp":1720746730568},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/s2213-8587(13)70042-1","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T02:18:11Z","timestamp":1371089891000},"page":"s16","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Research in brief"],"prefix":"10.1016","volume":"1","author":[{"given":"Iley","family":"Ozerlat-Gunduz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T09:53:19Z","timestamp":1539597199000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700421"}},"issued":{"date-parts":[[2013,8]]},"references-count":0,"alternative-id":["S2213858713700421"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70042-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,8]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T20:39:18Z","timestamp":1649104758810},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/s2213-8587(17)30141-9","type":"journal-article","created":{"date-parts":[[2017,5,9]],"date-time":"2017-05-09T21:15:34Z","timestamp":1494364534000},"page":"421","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"5","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T21:29:37Z","timestamp":1535837377000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301419"}},"issued":{"date-parts":[[2017,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2213858717301419"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30141-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,6]]}},{"indexed":{"date-parts":[[2024,5,7]],"date-time":"2024-05-07T00:27:19Z","timestamp":1715041639911},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/s2213-8587(24)00066-4","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T23:30:43Z","timestamp":1709595043000},"page":"221-222","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Long-term trial outcomes of Roux-en-Y gastric bypass and one anastomosis gastric bypass: tipping the scale"],"prefix":"10.1016","volume":"12","author":[{"given":"Paulina","family":"Salminen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00066-4_bib1","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.2019.14231","article-title":"Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity","volume":"322","author":"Aminian","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00066-4_bib2","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jama.2017.20313","article-title":"Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial","volume":"319","author":"Salminen","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00066-4_bib3","doi-asserted-by":"crossref","first-page":"1937","DOI":"10.1007\/s11695-020-05207-7","article-title":"Bariatric Surgery Survey 2018: similarities and disparities among the 5 IFSO CHAPTERS","volume":"31","author":"Angrisani","year":"2021","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(24)00066-4_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00035-4","article-title":"Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass at 5 years (YOMEGA): a prospective, open-label, non-inferiority, randomised extension study","author":"Robert","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00066-4_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11695-023-06913-8","article-title":"IFSO Consensus on Definitions and Clinical Practice Guidelines for Obesity Management\u2014an International Delphi Study","volume":"34","author":"Salminen","year":"2024","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(24)00066-4_bib6","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1016\/S0140-6736(19)30475-1","article-title":"Efficacy and safety of one anastomosis gastric bypass versus Roux-en-Y gastric bypass for obesity (YOMEGA): a multicentre, randomised, open-label, non-inferiority trial","volume":"393","author":"Robert","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00066-4_bib7","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1002\/oby.23852","article-title":"Roux-en-Y versus one-anastomosis gastric bypass (RYSA study): weight loss, metabolic improvements, and nutrition at 1 year after surgery, a multicenter randomized controlled trial","volume":"31","author":"Heinonen","year":"2023","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(24)00066-4_bib8","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1097\/01.sla.0000167762.46568.98","article-title":"Laparoscopic Roux-en-Y versus mini-gastric bypass for the treatment of morbid obesity: a prospective randomized controlled clinical trial","volume":"242","author":"Lee","year":"2005","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(24)00066-4_bib9","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jamasurg.2022.2229","article-title":"Effect of laparoscopic sleeve gastrectomy vs Roux-en-Y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS randomized clinical trial","volume":"157","author":"Salminen","year":"2022","journal-title":"JAMA Surg"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:45:59Z","timestamp":1715039159000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000664"}},"issued":{"date-parts":[[2024,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2213858724000664"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00066-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term trial outcomes of Roux-en-Y gastric bypass and one anastomosis gastric bypass: tipping the scale","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00066-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00035-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T21:42:42Z","timestamp":1648590162275},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/s2213-8587(14)70209-8","type":"journal-article","created":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T20:30:14Z","timestamp":1412195414000},"page":"e16","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Encrinol 2014; 2: 730\u201339"],"prefix":"10.1016","volume":"2","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702098?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702098?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T03:37:15Z","timestamp":1548646635000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702098"}},"issued":{"date-parts":[[2014,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S2213858714702098"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70209-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,10]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T07:47:58Z","timestamp":1648972078636},"reference-count":2,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/s2213-8587(19)30148-2","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T20:53:07Z","timestamp":1557953587000},"page":"424-425","source":"Crossref","is-referenced-by-count":0,"title":["Insulin resistance underlying type 2 diabetes \u2013 Authors' reply"],"prefix":"10.1016","volume":"7","author":[{"given":"Maria I","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paula A","family":"Bracco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bruce B","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30148-2_bib1","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-8587(19)30058-0","article-title":"Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil","volume":"7","author":"Schmidt","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30148-2_bib2","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","article-title":"Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study","volume":"373","author":"Tab\u00e1k","year":"2009","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T17:04:00Z","timestamp":1560791040000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301482"}},"issued":{"date-parts":[[2019,6]]},"references-count":2,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2213858719301482"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30148-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,6]]}},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:13Z","timestamp":1720746733376},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/s2213-8587(13)70040-8","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T02:41:06Z","timestamp":1371091266000},"page":"s14","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S1","title":["FDA declines approval of testosterone drug for third time"],"prefix":"10.1016","volume":"1","author":[{"given":"Leslie Harris","family":"O'Hanlon","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T09:53:12Z","timestamp":1539597192000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700408"}},"issued":{"date-parts":[[2013,8]]},"references-count":0,"alternative-id":["S2213858713700408"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70040-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,8]]}},{"indexed":{"date-parts":[[2022,6,21]],"date-time":"2022-06-21T18:18:29Z","timestamp":1655835509392},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/s2213-8587(13)70213-4","type":"journal-article","created":{"date-parts":[[2014,3,5]],"date-time":"2014-03-05T09:46:03Z","timestamp":1394012763000},"page":"351-352","source":"Crossref","is-referenced-by-count":5,"title":["Salt, hypertension, and proteinuria in diabetic nephropathy"],"prefix":"10.1016","volume":"2","author":[{"given":"Matthew R","family":"Weir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70213-4_bib1","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(13)70213-4_bib2","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1161\/01.CIR.0000139860.33974.28","article-title":"Albuminuria, a therapeutic target for cardiovascular protection in type 2 diabetic patients with nephropathy","volume":"110","author":"de Zeeuw","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70213-4_bib3","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1681\/ASN.2006050445","article-title":"Albuminuria is a target for renoprotective therapy independent from blood pressure in patients with type 2 diabetic nephropathy: post hoc analysis from the Reduction of Endpoints in NIDDM with the Angiotensin II Antagonist Losartan (RENAAL) trial","volume":"18","author":"Eijkelkamp","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(13)70213-4_bib4","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1093\/eurheartj\/ehr017","article-title":"Albuminuria and blood pressure, independent targets for cardioprotective therapy in patients with diabetes and nephropathy: a post hoc analysis of the combined RENAAL and IDNT trials","volume":"32","author":"Holtkamp","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(13)70213-4_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70030-0","article-title":"Effects of sodium restriction and hydrochlorothiazide added to RAAS blockade efficacy in diabetic nephropathy: a randomised clinical trial","author":"Kwakernaak","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70213-4_bib6","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/ki.2012.74","article-title":"Moderation of dietary sodium potentiates the renal and cardiovascular protective effects of angiotensin receptor blockers","volume":"82","author":"Lambers Heerspink","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(13)70213-4_bib7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1681\/ASN.2007060693","article-title":"Effects of dietary sodium and hydrochlorothiazide on the antiproteinuric efficacy of losartan","volume":"19","author":"Vogt","year":"2008","journal-title":"J Am Soc Nephrol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713702134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713702134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T06:53:10Z","timestamp":1538808790000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713702134"}},"issued":{"date-parts":[[2014,5]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S2213858713702134"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70213-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,5]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T18:38:25Z","timestamp":1649011105868},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/s2213-8587(18)30259-6","type":"journal-article","created":{"date-parts":[[2018,8,20]],"date-time":"2018-08-20T22:41:35Z","timestamp":1534804895000},"page":"845","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Illustrating issues around gender"],"prefix":"10.1016","volume":"6","author":[{"given":"Fiona","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302596?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302596?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T22:13:51Z","timestamp":1540419231000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302596"}},"issued":{"date-parts":[[2018,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S2213858718302596"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30259-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Illustrating issues around gender","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30259-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"book-review","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:15Z","timestamp":1720746735576},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/s2213-8587(13)70020-2","type":"journal-article","created":{"date-parts":[[2013,7,4]],"date-time":"2013-07-04T01:33:16Z","timestamp":1372901596000},"page":"s17","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Research in brief"],"prefix":"10.1016","volume":"1","author":[{"given":"Iley","family":"Ozerlat-Gunduz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T21:25:40Z","timestamp":1539552340000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700202"}},"issued":{"date-parts":[[2013,8]]},"references-count":0,"alternative-id":["S2213858713700202"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70020-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,8]]}},{"indexed":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T14:04:59Z","timestamp":1692367499689},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/s2213-8587(13)70060-3","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T23:01:12Z","timestamp":1374706872000},"page":"82-84","source":"Crossref","is-referenced-by-count":2,"title":["The nuclear option for insulinomas"],"prefix":"10.1016","volume":"1","author":[{"given":"Ashley","family":"Grossman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70060-3_bib1","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70060-3_bib2","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1038\/nrendo.2009.198","article-title":"Diagnosis of insulinoma in a patient with hypoglycemia without obvious hyperinsulinemia","volume":"5","author":"Coelho","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(13)70060-3_bib3","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1530\/EJE-10-0056","article-title":"Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation","volume":"162","author":"Druce","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70060-3_bib4","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1007\/s00330-009-1444-0","article-title":"The role of arterial stimulation and simultaneous venous sampling in addition to cross-sectional imaging for localisation of biochemically proven insulinoma","volume":"19","author":"Morganstein","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/S2213-8587(13)70060-3_bib5","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1210\/jc.2008-1986","article-title":"Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience","volume":"94","author":"Guettier","year":"2009","journal-title":"J Clinical Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70060-3_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70049-4","article-title":"Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study","author":"Christ","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70060-3_bib7","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1210\/jc.2009-1082","article-title":"Glucagon-like peptide-1 receptor imaging for localization of insulinomas","volume":"94","author":"Christ","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70060-3_bib8","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2967\/jnumed.110.085142","article-title":"Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas","volume":"52","author":"Wild","year":"2011","journal-title":"J Nucl Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T06:30:34Z","timestamp":1539498634000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700603"}},"issued":{"date-parts":[[2013,10]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S2213858713700603"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70060-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,10]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T10:46:10Z","timestamp":1648637170811},"reference-count":14,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/s2213-8587(18)30202-x","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T23:06:43Z","timestamp":1540336003000},"page":"839-840","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Testosterone therapy and physical function"],"prefix":"10.1016","volume":"6","author":[{"given":"Bradley D","family":"Anawalt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie T","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30202-X_bib1","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone treatment in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30202-X_bib2","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1001\/jamainternmed.2016.9540","article-title":"Association of testosterone levels with anemia in older men","volume":"177","author":"Roy","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(18)30202-X_bib3","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamainternmed.2016.9539","article-title":"Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone","volume":"177","author":"Snyder","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(18)30202-X_bib4","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30202-X_bib5","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1001\/jama.2016.21044","article-title":"Testosterone treatment and cognitive function in older men with low testosterone and age-associated memory impairment","volume":"317","author":"Resnick","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30202-X_bib6","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1056\/NEJMe1600196","article-title":"Establishing a framework\u2014does testosterone supplementation help older men?","volume":"374","author":"Orwoll","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30202-X_bib7","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1001\/jama.2017.0129","article-title":"Testosterone and male aging: faltering hope for rejuvenation","volume":"317","author":"Handelsman","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30202-X_bib8","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1016\/S2213-8587(18)30171-2","article-title":"Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials","volume":"6","author":"Bhasin","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30202-X_bib9","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/jc.2004-1184","article-title":"Older men are as responsive as young men to the anabolic effects of graded doses of testosterone on the skeletal muscle","volume":"90","author":"Bhasin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30202-X_bib10","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2015-4333","article-title":"Testosterone attenuates age-related fall in aerobic function in mobility limited older men with low testosterone","volume":"10","author":"Storer","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30202-X_bib11","doi-asserted-by":"crossref","first-page":"1891","DOI":"10.1210\/jc.2012-3695","article-title":"Effects of testosterone and progressive resistance exercise in healthy, highly functioning older men with low-normal testosterone levels","volume":"98","author":"Hildreth","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30202-X_bib12","first-page":"583","article-title":"Effects of testosterone supplementation for 3 years on muscle performance and physical function in older men","volume":"102","author":"Storer","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30202-X_bib13","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/0898264314525665","article-title":"Association between 6-minute walk test and all-cause mortality, coronary heart disease-specific mortality, and incident coronary heart disease","volume":"26","author":"Yazdanyar","year":"2014","journal-title":"J Aging Health"},{"key":"10.1016\/S2213-8587(18)30202-X_bib14","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1001\/jama.2014.5616","article-title":"Effect of structured physical activity on prevention of major mobility disability in older adults: the LIFE study randomized clinical trial","volume":"311","author":"Pahor","year":"2014","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871830202X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871830202X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T22:13:48Z","timestamp":1540419228000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871830202X"}},"issued":{"date-parts":[[2018,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S221385871830202X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30202-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone therapy and physical function","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30202-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30171-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T22:58:40Z","timestamp":1649199520958},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/s2213-8587(15)00412-x","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T01:42:43Z","timestamp":1445910163000},"page":"915","source":"Crossref","is-referenced-by-count":4,"title":["An INDEPTH look at global data collection"],"prefix":"10.1016","volume":"3","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500412X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500412X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T07:25:41Z","timestamp":1537255541000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871500412X"}},"issued":{"date-parts":[[2015,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S221385871500412X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00412-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,12]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T00:17:16Z","timestamp":1648945036115},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,2,8]],"date-time":"2017-02-08T00:00:00Z","timestamp":1486512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/s2213-8587(17)30040-2","type":"journal-article","created":{"date-parts":[[2017,2,10]],"date-time":"2017-02-10T01:45:19Z","timestamp":1486691119000},"page":"160-161","source":"Crossref","is-referenced-by-count":3,"title":["Research misconduct and the INTERGROWTH-21st study"],"prefix":"10.1016","volume":"5","author":[{"given":"Richard","family":"Horton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sabine","family":"Kleinert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Linklater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zo\u00eb","family":"Mullan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30040-2_bib2","doi-asserted-by":"publisher","first-page":"857","DOI":"10.1016\/S0140-6736(14)60932-6","article-title":"International standards for newborn weight, length, and head circumference by gestational age and sex: the Newborn Cross-Sectional Study of the INTERGROWTH-21st Project","volume":"384","author":"Villar","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30040-2_bib3","doi-asserted-by":"publisher","first-page":"869","DOI":"10.1016\/S0140-6736(14)61490-2","article-title":"International standards for fetal growth based on serial ultrasound measurements: the Fetal Growth Longitudinal Study of the INTERGROWTH-21st Project","volume":"384","author":"Papageorghiou","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30040-2_bib4","doi-asserted-by":"publisher","first-page":"781","DOI":"10.1016\/S2213-8587(14)70121-4","article-title":"The likeness of fetal growth and newborn size across non-isolated populations in the INTERGROWTH-21st Project: the Fetal Growth Longitudinal Study and Newborn Cross-Sectional Study","volume":"2","author":"Villar","year":"2014","journal-title":"Lancet Diabet Endocrinol"},{"key":"10.1016\/S2213-8587(17)30040-2_bib5","doi-asserted-by":"publisher","first-page":"e681","DOI":"10.1016\/S2214-109X(15)00163-1","article-title":"Postnatal growth standards for preterm infants: the Preterm Postnatal Follow-up Study of the INTERGROWTH-21st Project","volume":"3","author":"Villar","year":"2015","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(17)30040-2_bib6","series-title":"Physical status: the use and interpretation of anthropometry","year":"1995"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30040-2_bib7","doi-asserted-by":"publisher","first-page":"S15","DOI":"10.1177\/15648265040251S103","article-title":"The WHO Multicentre Growth Reference Study: planning, study design, and methodology","volume":"25","author":"De Onis","year":"2004","journal-title":"Food Nutr Bull"},{"key":"10.1016\/S2213-8587(17)30040-2_bib8","doi-asserted-by":"publisher","first-page":"e1002220","DOI":"10.1371\/journal.pmed.1002220","article-title":"The World Health Organization Fetal Growth Charts: a multinational longitudinal study of ultrasound biometric measurements and estimated fetal weight","volume":"14","author":"Kiserud","year":"2017","journal-title":"PLoS Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300402?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300402?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T11:57:28Z","timestamp":1536062248000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300402"}},"issued":{"date-parts":[[2017,3]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2213858717300402"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30040-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,3]]}},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T22:58:24Z","timestamp":1648853904230},"reference-count":4,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/s2213-8587(17)30408-4","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T04:35:19Z","timestamp":1513744519000},"page":"10","source":"Crossref","is-referenced-by-count":1,"title":["Iodine supplementation in pregnant women and child neurodevelopment"],"prefix":"10.1016","volume":"6","author":[{"given":"Song","family":"Mao","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liangxia","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30408-4_bib1","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1016\/S2213-8587(17)30332-7","article-title":"Effect of iodine supplementation in pregnant women on child neurodevelopment: a randomised, double-blind, placebo-controlled trial","volume":"5","author":"Gowachirapant","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30408-4_bib2","doi-asserted-by":"crossref","first-page":"961","DOI":"10.3390\/nu9090961","article-title":"Iodine intakes of Victorian schoolchildren measured using 24-h urinary iodine excretion","volume":"9","author":"Beckford","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(17)30408-4_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.neuro.2011.11.006","article-title":"Fetal exposure to propoxur and abnormal child neurodevelopment at 2 years of age","volume":"33","author":"Ostrea","year":"2012","journal-title":"Neurotoxicology"},{"key":"10.1016\/S2213-8587(17)30408-4_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1111\/dmcn.12282","article-title":"A cohort study on full breastfeeding and child neuropsychological development: the role of maternal social, psychological, and nutritional factors","volume":"56","author":"Julvez","year":"2014","journal-title":"Dev Med Child Neurol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304084?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304084?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T05:27:50Z","timestamp":1535174870000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717304084"}},"issued":{"date-parts":[[2018,1]]},"references-count":4,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2213858717304084"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30408-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,1]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T07:43:56Z","timestamp":1648885436434},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/s2213-8587(16)30313-8","type":"journal-article","created":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T20:01:04Z","timestamp":1478030464000},"page":"964-966","source":"Crossref","is-referenced-by-count":0,"title":["Excessive gains in BMI during adolescence increase risks of cardiovascular mortality in men"],"prefix":"10.1016","volume":"4","author":[{"given":"Jennifer L","family":"Baker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30313-8_bib1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30313-8_bib2","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.1016\/S0140-6736(16)31012-1","article-title":"Global, regional, and national life expectancy, all-cause mortality, and cause-specific mortality for 249 causes of death, 1980\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","author":"Wang","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30313-8_bib3","doi-asserted-by":"crossref","first-page":"2329","DOI":"10.1056\/NEJMoa072515","article-title":"Childhood body-mass index and the risk of coronary heart disease in adulthood","volume":"357","author":"Baker","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30313-8_bib4","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1056\/NEJMoa1503840","article-title":"Body-mass index in 2\u00b73 million adolescents and cardiovascular death in adulthood","volume":"374","author":"Twig","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30313-8_bib5","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa1006992","article-title":"Adolescent BMI trajectory and risk of diabetes versus coronary disease","volume":"364","author":"Tirosh","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30313-8_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)30273-X","article-title":"Association between excessive body-mass index increase during puberty and risk of cardiovascular mortality in adult men: a population-based cohort study","author":"Ohlsson","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30313-8_bib7","series-title":"CDC Growth Charts: United States. Advance data from vital and health statistics; no 314","author":"Kuczmarski","year":"2000"},{"key":"10.1016\/S2213-8587(16)30313-8_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2307\/4594149","article-title":"Relationship of childhood weight status to morbidity in adults","volume":"86","author":"Abraham","year":"1971","journal-title":"HSMHA Health Rep"},{"key":"10.1016\/S2213-8587(16)30313-8_bib9","doi-asserted-by":"crossref","first-page":"11208","DOI":"10.1038\/srep11208","article-title":"Puberty timing associated with diabetes, cardiovascular disease and also diverse health outcomes in men and women: the UK Biobank study","volume":"5","author":"Day","year":"2015","journal-title":"Sci Rep"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T22:20:41Z","timestamp":1536272441000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303138"}},"issued":{"date-parts":[[2016,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2213858716303138"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30313-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,12]]}},{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T16:09:37Z","timestamp":1784909377876,"version":"3.55.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/s2213-8587(15)00364-2","type":"journal-article","created":{"date-parts":[[2015,10,13]],"date-time":"2015-10-13T06:26:56Z","timestamp":1444717616000},"page":"835-837","source":"Crossref","is-referenced-by-count":25,"title":["Evolution of insulin patents and market exclusivities in the USA"],"prefix":"10.1016","volume":"3","author":[{"given":"Jing","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron S","family":"Kesselheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00364-2_bib1","series-title":"IDF Diabetes Atlas","year":"2014"},{"key":"10.1016\/S2213-8587(15)00364-2_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2337\/dc14-1687","article-title":"Change in medical spending attributable to diabetes: national data from 1987 to 2011","volume":"38","author":"Zhuo","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00364-2_bib3","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2014.6316","article-title":"Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010","volume":"311","author":"Lipska","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00364-2_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamainternmed.2015.4338","article-title":"Trends in Medicaid reimbursements for insulin from 1991 through 2014","author":"Luo","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(15)00364-2_bib6","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1056\/NEJMms1411398","article-title":"Why is there no generic insulin? Historical origins of a modern problem","volume":"372","author":"Greene","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00364-2_bib7","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1162\/105864097567039","article-title":"Generic entry and the pricing of pharmaceuticals","volume":"6","author":"Frank","year":"1997","journal-title":"J Econ Manag Strat"},{"key":"10.1016\/S2213-8587(15)00364-2_bib8","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1177\/000992280404300109","article-title":"Accuracy and precision of low-dose insulin administration using syringes, pen injectors, and a pump","volume":"43","author":"Keith","year":"2004","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/S2213-8587(15)00364-2_bib9","doi-asserted-by":"crossref","first-page":"1009","DOI":"10.1517\/14712598.2012.688024","article-title":"Biosimilar insulins","volume":"12","author":"Heinemann","year":"2012","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/S2213-8587(15)00364-2_bib10","series-title":"Guideline on non-clinical and clinical development of similar biological medicinal products containing recombinant human insulin and insulin analogues","year":"2015"},{"key":"10.1016\/S2213-8587(15)00364-2_bib11","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1126\/science.aab1684","article-title":"Are trade secrets delaying biosimilars?","volume":"348","author":"Price","year":"2015","journal-title":"Science"},{"key":"10.1016\/S2213-8587(15)00364-2_bib12","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1056\/NEJMp0908496","article-title":"Balancing innovation, access, and profits\u2014market exclusivity for biologics","volume":"361","author":"Engelberg","year":"2009","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003642?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003642?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,22]],"date-time":"2022-05-22T21:45:36Z","timestamp":1653255936000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003642"}},"issued":{"date-parts":[[2015,11]]},"references-count":11,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S2213858715003642"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00364-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,11]]}},{"indexed":{"date-parts":[[2026,5,12]],"date-time":"2026-05-12T10:44:10Z","timestamp":1778582650239,"version":"3.51.4"},"reference-count":2,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/s2213-8587(16)30114-0","type":"journal-article","created":{"date-parts":[[2016,6,26]],"date-time":"2016-06-26T23:01:08Z","timestamp":1466982068000},"page":"648-649","source":"Crossref","is-referenced-by-count":4,"title":["Liberating data: the WHO response \u2013 Authors' reply"],"prefix":"10.1016","volume":"4","author":[{"given":"Justine","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John S","family":"Yudkin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rifat","family":"Atun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30114-0_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S2213-8587(16)00037-1","article-title":"Liberating data: the crucial weapon in the fight against NCDs. 2016","volume":"4","author":"Davies","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30114-0_bib2","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants","volume":"387","year":"2016","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T04:02:50Z","timestamp":1555387370000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301140"}},"issued":{"date-parts":[[2016,8]]},"references-count":2,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S2213858716301140"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30114-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,8]]}},{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T18:42:37Z","timestamp":1784832157882,"version":"3.55.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/s2213-8587(19)30323-7","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T22:30:03Z","timestamp":1571178603000},"page":"e22","source":"Crossref","is-referenced-by-count":1,"title":["Correction to Lancet Diabetes Endocrinol 2019; 7: 356\u201367"],"prefix":"10.1016","volume":"7","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T20:21:41Z","timestamp":1572034901000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719303237"}},"issued":{"date-parts":[[2019,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2213858719303237"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30323-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,11]]}},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:41:37Z","timestamp":1786999297871,"version":"build-2736575974"},"reference-count":3,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/s2213-8587(22)00342-4","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T18:30:04Z","timestamp":1671129004000},"page":"14-15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Mendelian randomisation and vitamin D: the importance of model assumptions"],"prefix":"10.1016","volume":"11","author":[{"given":"Guillaume","family":"Butler-Laporte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Brent","family":"Richards","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00342-4_bib1","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S2213-8587(21)00282-5","article-title":"Targeting of vitamin D supplementation to individuals with deficiency","volume":"9","author":"Butler-Laporte","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00342-4_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2213-8587(21)00263-1","article-title":"Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses","volume":"9","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00342-4_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1809944","article-title":"Vitamin D supplements and prevention of cancer and cardiovascular disease","volume":"380","author":"Manson","year":"2019","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003424?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003424?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:37Z","timestamp":1761991897000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003424"}},"issued":{"date-parts":[[2023,1]]},"references-count":3,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213858722003424"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00342-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mendelian randomisation and vitamin D: the importance of model assumptions","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00342-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00263-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:42:44Z","timestamp":1786999364026,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/s2213-8587(24)00268-7","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T18:39:05Z","timestamp":1724956745000},"page":"682-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Why does visceral adiposity not explain higher type 2 diabetes prevalence in Asian Indians?"],"prefix":"10.1016","volume":"12","author":[{"given":"Viswanathan","family":"Mohan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit Mohan","family":"Anjana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00268-7_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00195-5","article-title":"Adiposity and metabolic health in Asian populations: an epidemiological study using dual-energy x-ray absorptiometry in Singapore","author":"Mina","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00268-7_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2023-003385","article-title":"Differences in type 2 diabetes risk between East, South, and Southeast Asians living in Singapore: the multi-ethnic cohort","volume":"11","author":"Seah","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(24)00268-7_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3192","article-title":"Tale of two Indians: heterogeneity in type 2 diabetes pathophysiology","volume":"35","author":"Staimez","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(24)00268-7_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1007\/BF00454882","article-title":"Serum immunoreactive insulin responses to a glucose load in Asian Indian and European type 2 (non-insulin-dependent) diabetic patients and control subjects","volume":"29","author":"Mohan","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00268-7_bib5","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1210\/jc.2002-020434","article-title":"Adiposity and hyperinsulinemia in Indians are present at birth","volume":"87","author":"Yajnik","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00268-7_bib6","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.2337\/dc12-2290","article-title":"Evidence of reduced \u03b2-cell function in Asian Indians with mild dysglycemia","volume":"36","author":"Staimez","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00268-7_bib7","doi-asserted-by":"crossref","first-page":"7","DOI":"10.2337\/dci23-0068","article-title":"Diabetes in South Asians: uncovering novel risk factors with longitudinal epidemiologic data: Kelly West Award Lecture 2023","volume":"47","author":"Kanaya","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00268-7_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00125-022-05803-5","article-title":"Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data","volume":"66","author":"liodromiti","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00268-7_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s42255-024-01101-z","article-title":"Weight gain leads to greater adverse metabolic responses in South Asian compared with white European men: the GlasVEGAS study","author":"McLaren","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(24)00268-7_bib10","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2337\/dc19-2335","article-title":"White rice intake and incident diabetes: a study of 132,373 participants in 21 countries","volume":"43","author":"Bhavadharini","year":"2020","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T19:11:33Z","timestamp":1727205093000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002687"}},"issued":{"date-parts":[[2024,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2213858724002687"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00268-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why does visceral adiposity not explain higher type 2 diabetes prevalence in Asian Indians?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00268-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00195-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:39:56Z","timestamp":1786999196002,"version":"build-2736575974"},"reference-count":7,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/s2213-8587(15)00424-6","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T20:00:54Z","timestamp":1447876854000},"page":"928-929","source":"Crossref","is-referenced-by-count":67,"title":["Understanding EMPA-REG OUTCOME"],"prefix":"10.1016","volume":"3","author":[{"given":"Marcel H A","family":"Muskiet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dani\u00ebl H","family":"van Raalte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik JM","family":"van Bommel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark M","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lennart","family":"Tonneijck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00424-6_bib1","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00424-6_bib2","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S2213-8587(15)00384-8","article-title":"Getting to the heart of the matter in type 2 diabetes","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00424-6_bib3","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/dom.12127","article-title":"Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes","volume":"15","author":"Lambers Heerspink","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00424-6_bib4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1038\/ki.2014.246","article-title":"Sodium glucose cotransport-2 inhibition and intrarenal RAS activity in people with type 1 diabetes","volume":"86","author":"Cherney","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(15)00424-6_bib5","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/nrcardio.2014.59","article-title":"Angiotensin-converting enzyme 2 and angiotensin 1\u20137: novel therapeutic targets","volume":"11","author":"Jiang","year":"2014","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(15)00424-6_bib6","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S0140-6736(02)08090-X","article-title":"Cardiovascular morbidity and mortality in patients with diabetes in the Losartan Intervention For Endpoint reduction in hypertension study (LIFE): a randomised trial against atenolol","volume":"359","author":"Lindholm","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00424-6_bib7","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1056\/NEJMoa0806182","article-title":"Benazepril plus amlodipine or hydrochlorothiazide for hypertension in high-risk patients","volume":"359","author":"Jamerson","year":"2008","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004246?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004246?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T12:22:09Z","timestamp":1537186929000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004246"}},"issued":{"date-parts":[[2015,12]]},"references-count":7,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S2213858715004246"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00424-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,12]]}},{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T14:25:13Z","timestamp":1787235913938,"version":"build-2736575974"},"reference-count":111,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100018822","name":"Western Sydney University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018822","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M. and Harry B. Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018562","name":"Steno Diabetes Center Copenhagen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001067","name":"Juvenile Diabetes Research Foundation Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/s2213-8587(24)00103-7","type":"journal-article","created":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T18:37:12Z","timestamp":1716489432000},"page":"483-492","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores"],"prefix":"10.1016","volume":"12","author":[{"given":"Mugdha V","family":"Joglekar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simranjeet","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flemming","family":"Pociot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anandwardhan A","family":"Hardikar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00103-7_bib1","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00103-7_bib2","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","article-title":"Heterogeneity and endotypes in type 1 diabetes mellitus","volume":"19","author":"Redondo","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00103-7_bib3","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2337\/dbi18-0034","article-title":"Etiology of autoimmune islet disease: timing is everything","volume":"70","author":"Lernmark","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib4","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/dbi20-0054","article-title":"Screening for type 1 diabetes in the general population: a status report and perspective","volume":"71","author":"Sims","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib5","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00103-7_bib6","doi-asserted-by":"crossref","first-page":"2605","DOI":"10.1007\/s00125-020-05276-4","article-title":"Type 1 diabetes can present before the age of 6 months and is characterised by autoimmunity and rapid loss of beta cells","volume":"63","author":"Johnson","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib7","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1038\/nrd.2016.233","article-title":"Dynamic versus static biomarkers in cancer immune checkpoint blockade: unravelling complexity","volume":"16","author":"Lesterhuis","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S2213-8587(24)00103-7_bib8","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/pedi.12597","article-title":"Genetics of type 1 diabetes","volume":"19","author":"Redondo","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib9","doi-asserted-by":"crossref","first-page":"989","DOI":"10.2337\/dc15-0101","article-title":"Predicting type 1 diabetes using biomarkers","volume":"38","author":"Bonifacio","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00103-7_bib10","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","article-title":"Genetic risk factors for type 1 diabetes","volume":"387","author":"Pociot","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00103-7_bib11","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41591-020-0930-4","article-title":"A combined risk score enhances prediction of type 1 diabetes among susceptible children","volume":"26","author":"Ferrat","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00103-7_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/pedi.12066","article-title":"Children followed in the TEDDY study are diagnosed with type 1 diabetes at an early stage of disease","volume":"15","author":"Elding Larsson","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib13","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1373\/clinchem.2010.148221","article-title":"Genetics of type 1 diabetes","volume":"57","author":"Steck","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(24)00103-7_bib14","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Robertson","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00103-7_bib15","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/pedi.12092","article-title":"Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers","volume":"15","author":"Steck","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib16","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-22574-5","article-title":"application of a genetic risk score to racially diverse type 1 diabetes populations demonstrates the need for diversity in risk-modeling","volume":"8","author":"Perry","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(24)00103-7_bib17","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dc19-0880","article-title":"Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes","volume":"43","author":"Battaglia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00103-7_bib18","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s00125-015-3789-z","article-title":"Diabetes at the crossroads: relevance of disease classification to pathophysiology and treatment","volume":"59","author":"Leslie","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib19","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1007\/s00125-021-05513-4","article-title":"DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life","volume":"64","author":"Thomas","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib20","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.2337\/db08-0605","article-title":"Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening","volume":"57","author":"Barker","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/dc15-1111","article-title":"A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults","volume":"39","author":"Oram","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00103-7_bib22","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12916-017-0846-0","article-title":"Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes","volume":"15","author":"Mishra","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(24)00103-7_bib23","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/db15-1690","article-title":"Type 1 diabetes genetic risk score: a novel tool to discriminate monogenic and type 1 diabetes","volume":"65","author":"Patel","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib24","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s00125-014-3362-1","article-title":"Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes","volume":"57","author":"Winkler","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib25","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/dc18-1785","article-title":"Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis","volume":"42","author":"Sharp","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00103-7_bib26","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002548","article-title":"Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: a prospective study in children","volume":"15","author":"Bonifacio","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(24)00103-7_bib27","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.1093\/nar\/gkad373","article-title":"Deep integrative models for large-scale human genomics","volume":"51","author":"Sigurdsson","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S2213-8587(24)00103-7_bib28","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1093\/hmg\/ddy443","article-title":"Construction and benchmarking of a multi-ethnic reference panel for the imputation of HLA class I and II alleles","volume":"28","author":"Degenhardt","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(24)00103-7_bib29","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pcbi.1002877","article-title":"Multi-population classical HLA type imputation","volume":"9","author":"Dilthey","year":"2013","journal-title":"PLoS Comput Biol"},{"key":"10.1016\/S2213-8587(24)00103-7_bib30","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2337\/dc20-2872","article-title":"Utility of diabetes type-specific genetic risk scores for the classification of diabetes type among multiethnic youth","volume":"45","author":"Oram","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00103-7_bib31","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41591-020-0930-4","article-title":"A combined risk score enhances prediction of type 1 diabetes among susceptible children","volume":"26","author":"Ferrat","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00103-7_bib32","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(22)00159-0","article-title":"Type 1 diabetes in diverse ancestries and the use of genetic risk scores","volume":"10","author":"Redondo","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00103-7_bib33","article-title":"Population-specific causal disease effect sizes in functionally important regions impacted by selection","volume":"12","author":"Shi","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00103-7_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2022.906965","article-title":"Multiethnic polygenic risk prediction in diverse populations through transfer learning","volume":"13","author":"Tian","year":"2022","journal-title":"Front Genet"},{"key":"10.1016\/S2213-8587(24)00103-7_bib35","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2337\/diabetes.48.9.1677","article-title":"Onset of type 1 diabetes: a dynamical instability","volume":"48","author":"Freiesleben De Blasio","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib36","doi-asserted-by":"crossref","first-page":"2232","DOI":"10.1007\/s00125-011-2244-z","article-title":"The threshold hypothesis: solving the equation of nurture vs nature in type 1 diabetes","volume":"54","author":"Wasserfall","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib37","doi-asserted-by":"crossref","first-page":"753","DOI":"10.3934\/mbe.2009.6.753","article-title":"Modeling dynamic changes in type 1 diabetes progression: quantifying beta-cell variation after the appearance of islet-specific autoimmune responses","volume":"6","author":"Nelson","year":"2009","journal-title":"Math Biosci Eng"},{"key":"10.1016\/S2213-8587(24)00103-7_bib38","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00103-7_bib39","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1080\/14789450.2019.1634548","article-title":"The role of proteomics in assessing beta-cell dysfunction and death in type 1 diabetes","volume":"16","author":"Nakayasu","year":"2019","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/S2213-8587(24)00103-7_bib40","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/S2213-8587(21)00139-X","article-title":"Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"Gitelman","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00103-7_bib41","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/db20-3-LB","article-title":"3-LB: golimumab (GLM) preserves \u00df-cell function and reduces insulin use and hypoglycemia in children and young adults with recently diagnosed type 1 diabetes (T1D): the phase 2 T1GER study","volume":"69","author":"Quattrin","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib42","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2306691","article-title":"Baricitinib and \u03b2-cell function in patients with new-onset type 1 diabetes","volume":"389","author":"Waibel","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00103-7_bib43","doi-asserted-by":"crossref","first-page":"2121","DOI":"10.1007\/s00125-022-05780-9","article-title":"Progression likelihood score identifies substages of presymptomatic type 1 diabetes in childhood public health screening","volume":"65","author":"Weiss","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib44","doi-asserted-by":"crossref","first-page":"528","DOI":"10.2337\/dc07-1459","article-title":"A risk score for type 1 diabetes derived from autoantibody-positive participants in the diabetes prevention trial-type 1","volume":"31","author":"Sosenko","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00103-7_bib45","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2337\/db15-0956","article-title":"Coxsackievirus B5 infection induces dysregulation of microRNAs predicted to target known type 1 diabetes risk genes in human pancreatic islets","volume":"65","author":"Kim","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib46","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41574-022-00688-1","article-title":"Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus","volume":"18","author":"Nekoua","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00103-7_bib47","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2213-8587(23)00122-5","article-title":"Enteroviruses and risk of islet autoimmunity or type 1 diabetes: systematic review and meta-analysis of controlled observational studies detecting viral nucleic acids and proteins","volume":"11","author":"Isaacs","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00103-7_bib48","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/dc17-1983","article-title":"Early infant diet and islet autoimmunity in the TEDDY study","volume":"41","author":"Uusitalo","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00103-7_bib49","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2337\/dc17-0238","article-title":"Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the TEDDY study","volume":"40","author":"Krischer","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00103-7_bib50","doi-asserted-by":"crossref","DOI":"10.1080\/07853890.2023.2198255","article-title":"Protocol for a nested case-control study design for omics investigations in the environmental determinants of islet autoimmunity cohort","volume":"55","author":"Oakey","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/S2213-8587(24)00103-7_bib51","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.molmet.2016.02.003","article-title":"Primary prevention of beta-cell autoimmunity and type 1 diabetes\u2014The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives","volume":"5","author":"Ziegler","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(24)00103-7_bib52","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1186\/1471-2431-13-124","article-title":"Environmental determinants of islet autoimmunity (ENDIA): a pregnancy to early life cohort study in children at-risk of type 1 diabetes","volume":"13","author":"Penno","year":"2013","journal-title":"BMC Pediatr"},{"key":"10.1016\/S2213-8587(24)00103-7_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1447.062","article-title":"The environmental determinants of diabetes in the young (TEDDY) study","volume":"1150","author":"Group","year":"2008","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(24)00103-7_bib54","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2337\/db14-1208","article-title":"The streetlight effect in type 1 diabetes","volume":"64","author":"Battaglia","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib55","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.2337\/db15-0011","article-title":"The streetlight effect\u2014is there light at the end of the tunnel?","volume":"64","author":"Lernmark","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib56","doi-asserted-by":"crossref","DOI":"10.1172\/JCI162123","article-title":"Elevations in blood glucose before and after the appearance of islet autoantibodies in children","volume":"132","author":"Warncke","year":"2022","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(24)00103-7_bib57","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1007\/s00125-015-3621-9","article-title":"OGTT and random plasma glucose in the prediction of type 1 diabetes and time to diagnosis","volume":"58","author":"Helminen","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib58","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.2337\/db14-0497","article-title":"HbA1c predicts time to diagnosis of type 1 diabetes in children at risk","volume":"64","author":"Helminen","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib59","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1111\/pedi.13413","article-title":"HbA1c as a time predictive biomarker for an additional islet autoantibody and type 1 diabetes in seroconverted TEDDY children","volume":"23","author":"Salami","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib60","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/978-3-031-50624-6_11","article-title":"Omics to unveil diabetes mellitus pathogenesis and biomarkers: focus on proteomics, lipidomics, and metabolomics","volume":"1443","author":"Soares","year":"2024","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/S2213-8587(24)00103-7_bib61","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1158278","article-title":"The importance of biomarker development for monitoring type 1 diabetes progression rate and therapeutic responsiveness","volume":"14","author":"Fyvie","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/S2213-8587(24)00103-7_bib62","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1117076","article-title":"Circulating biomarkers during progression to type 1 diabetes: a systematic review","volume":"14","author":"Brenu","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(24)00103-7_bib63","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1007\/s00125-018-4726-8","article-title":"Immunological biomarkers for the development and progression of type 1 diabetes","volume":"61","author":"Mathieu","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib64","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.ebiom.2019.06.031","article-title":"Microbiome and type 1 diabetes","volume":"46","author":"Siljander","year":"2019","journal-title":"EBioMedicine"},{"key":"10.1016\/S2213-8587(24)00103-7_bib65","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1016\/j.chom.2015.01.001","article-title":"The dynamics of the human infant gut microbiome in development and in progression toward type 1 diabetes","volume":"17","author":"Kostic","year":"2015","journal-title":"Cell Host Microbe"},{"key":"10.1016\/S2213-8587(24)00103-7_bib66","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-43039-4","article-title":"Serum APOC1 levels are decreased in young autoantibody positive children who rapidly progress to type 1 diabetes","volume":"13","author":"Hirvonen","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(24)00103-7_bib67","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12014-023-09429-6","article-title":"Systematic review of type 1 diabetes biomarkers reveals regulation in circulating proteins related to complement, lipid metabolism, and immune response","volume":"20","author":"Sarkar","year":"2023","journal-title":"Clin Proteomics"},{"key":"10.1016\/S2213-8587(24)00103-7_bib68","doi-asserted-by":"crossref","first-page":"1983","DOI":"10.1007\/s00125-023-05974-9","article-title":"Targeted serum proteomics of longitudinal samples from newly diagnosed youth with type 1 diabetes distinguishes markers of disease and C-peptide trajectory","volume":"66","author":"Moulder","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib69","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00125-018-4712-1","article-title":"Biomarkers of islet beta cell stress and death in type 1 diabetes","volume":"61","author":"Sims","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib70","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1080\/14789450.2017.1265449","article-title":"The progress and potential of proteomic biomarkers for type 1 diabetes in children","volume":"14","author":"Moulder","year":"2017","journal-title":"Expert Rev Proteomics"},{"key":"10.1016\/S2213-8587(24)00103-7_bib71","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1210\/jc.2016-2773","article-title":"Measurement of pro-islet amyloid polypeptide (1\u201348) in diabetes and islet transplants","volume":"102","author":"Courtade","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00103-7_bib72","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2337\/dc15-2849","article-title":"Elevations in the fasting serum proinsulin-to-c-peptide ratio precede the onset of type 1 diabetes","volume":"39","author":"Sims","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00103-7_bib73","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.trsl.2019.08.001","article-title":"Abnormalities in proinsulin processing in islets from individuals with longstanding type 1 diabetes","volume":"213","author":"Sims","year":"2019","journal-title":"Transl Res"},{"key":"10.1016\/S2213-8587(24)00103-7_bib74","article-title":"Plasma protein biomarkers predict the development of persistent autoantibodies and type 1 diabetes 6 months prior to the onset of autoimmunity","volume":"4","author":"Nakayasu","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/S2213-8587(24)00103-7_bib75","doi-asserted-by":"crossref","first-page":"2975","DOI":"10.1084\/jem.20081800","article-title":"Dysregulation of lipid and amino acid metabolism precedes islet autoimmunity in children who later progress to type 1 diabetes","volume":"205","author":"Oresic","year":"2008","journal-title":"J Exp Med"},{"key":"10.1016\/S2213-8587(24)00103-7_bib76","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1211015","article-title":"Circulating metabolic signatures of rapid and slow progression to type 1 diabetes in islet autoantibody-positive children","volume":"14","author":"Lamichhane","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(24)00103-7_bib77","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1007\/s11892-016-0820-9","article-title":"Metabolomic biomarkers in the progression to type 1 diabetes","volume":"16","author":"Overgaard","year":"2016","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(24)00103-7_bib78","doi-asserted-by":"crossref","first-page":"19018","DOI":"10.1073\/pnas.1111008108","article-title":"Detection of \u03b2-cell death in diabetes using differentially methylated circulating DNA","volume":"108","author":"Akirav","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(24)00103-7_bib79","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.2337\/db15-0430","article-title":"Elevations in circulating methylated and unmethylated preproinsulin DNA in new-onset type 1 diabetes","volume":"64","author":"Fisher","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib80","doi-asserted-by":"crossref","first-page":"E1826","DOI":"10.1073\/pnas.1519286113","article-title":"Identification of tissue-specific cell death using methylation patterns of circulating DNA","volume":"113","author":"Lehmann-Werman","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(24)00103-7_bib81","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/s13148-020-00906-5","article-title":"Circulating unmethylated CHTOP and INS DNA fragments provide evidence of possible islet cell death in youth with obesity and diabetes","volume":"12","author":"Syed","year":"2020","journal-title":"Clin Epigenetics"},{"key":"10.1016\/S2213-8587(24)00103-7_bib82","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136579","article-title":"Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic \u03b2 cells","volume":"5","author":"Neiman","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(24)00103-7_bib83","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1210\/clinem\/dgaa008","article-title":"Circulating unmethylated insulin DNA as a biomarker of human beta cell death: a multi-laboratory assay comparison","volume":"105","author":"Speake","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00103-7_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104625","article-title":"Gene expression signature predicts rate of type 1 diabetes progression","volume":"92","author":"Suomi","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/S2213-8587(24)00103-7_bib85","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.gene.2013.01.038","article-title":"Dynamic expression of microRNAs during the differentiation of human embryonic stem cells into insulin-producing cells","volume":"518","author":"Wei","year":"2013","journal-title":"Gene"},{"key":"10.1016\/S2213-8587(24)00103-7_bib86","doi-asserted-by":"crossref","first-page":"806","DOI":"10.1017\/S2040174422000137","article-title":"Circulating microRNAs from early childhood and adolescence are associated with pre-diabetes at 18 years of age in women from the PMNS cohort","volume":"13","author":"Joglekar","year":"2022","journal-title":"J Dev Orig Health Dis"},{"key":"10.1016\/S2213-8587(24)00103-7_bib87","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/nature06253","article-title":"Roquin represses autoimmunity by limiting inducible T-cell co-stimulator messenger RNA","volume":"450","author":"Yu","year":"2007","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00103-7_bib88","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1016\/j.molimm.2007.10.035","article-title":"MicroRNA targets in immune genes and the Dicer\/Argonaute and ARE machinery components","volume":"45","author":"Asirvatham","year":"2008","journal-title":"Mol Immunol"},{"key":"10.1016\/S2213-8587(24)00103-7_bib89","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1038\/nrg1555","article-title":"Induction and suppression of RNA silencing: insights from viral infections","volume":"6","author":"Voinnet","year":"2005","journal-title":"Nat Rev Genet"},{"key":"10.1016\/S2213-8587(24)00103-7_bib90","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.tem.2007.10.001","article-title":"New pancreas from old: microregulators of pancreas regeneration","volume":"18","author":"Joglekar","year":"2007","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00103-7_bib91","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2021.102379","article-title":"Machine learning workflows identify a microRNA signature of insulin transcription in human tissues","volume":"24","author":"Wong","year":"2021","journal-title":"iScience"},{"key":"10.1016\/S2213-8587(24)00103-7_bib92","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.gep.2008.10.001","article-title":"Expression of islet-specific microRNAs during human pancreatic development","volume":"9","author":"Joglekar","year":"2009","journal-title":"Gene Expr Patterns"},{"key":"10.1016\/S2213-8587(24)00103-7_bib93","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1038\/nature03076","article-title":"A pancreatic islet-specific microRNA regulates insulin secretion","volume":"432","author":"Poy","year":"2004","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00103-7_bib94","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s00125-016-4156-4","article-title":"Circulating microRNA levels predict residual beta cell function and glycaemic control in children with type 1 diabetes mellitus","volume":"60","author":"Samandari","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib95","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1007\/s00125-017-4294-3","article-title":"Association of serum microRNAs with islet autoimmunity, disease progression and metabolic impairment in relatives at risk of type 1 diabetes","volume":"60","author":"Snowhite","year":"2017","journal-title":"Diabetologia"},{"issue":"suppl","key":"10.1016\/S2213-8587(24)00103-7_bib96","doi-asserted-by":"crossref","first-page":"S122","DOI":"10.1016\/j.molmet.2019.06.009","article-title":"The role of T cell miRNAs for regulatory T cell induction in islet autoimmunity","volume":"27S","author":"Scherm","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(24)00103-7_bib97","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1097\/MED.0000000000000420","article-title":"MicroRNAs: markers of \u03b2-cell stress and autoimmunity","volume":"25","author":"Dotta","year":"2018","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib98","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1097\/MED.0000000000000261","article-title":"Nucleic acid biomarkers of \u03b2 cell stress and death in type 1 diabetes","volume":"23","author":"Syed","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib99","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1007\/s00125-021-05429-z","article-title":"Postpartum circulating microRNA enhances prediction of future type 2 diabetes in women with previous gestational diabetes","volume":"64","author":"Joglekar","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib100","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/pedi.12521","article-title":"DNA methylation and its role in the pathogenesis of diabetes","volume":"18","author":"Bansal","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004735","article-title":"Genome-wide associations between genetic and epigenetic variation influence mRNA expression and insulin secretion in human pancreatic islets","volume":"10","author":"Olsson","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(24)00103-7_bib102","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jaut.2013.10.001","article-title":"DNA methylation profiles in type 1 diabetes twins point to strong epigenetic effects on etiology","volume":"50","author":"Stefan","year":"2014","journal-title":"J Autoimmun"},{"key":"10.1016\/S2213-8587(24)00103-7_bib103","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s11892-017-0916-x","article-title":"The Role of Epigenetics in Type 1 Diabetes","volume":"17","author":"Jerram","year":"2017","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(24)00103-7_bib104","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.2337\/db17-0261","article-title":"The influence of type 1 diabetes genetic susceptibility regions, age, sex, and family history on the progression from multiple autoantibodies to type 1 diabetes: a TEDDY study report","volume":"66","author":"Krischer","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00103-7_bib105","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.2337\/dc09-2344","article-title":"Age-related differences in the frequency of ketoacidosis at diagnosis of type 1 diabetes in children and adolescents","volume":"33","author":"Hekkala","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00103-7_bib106","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.diabres.2007.04.002","article-title":"Ethnicity and young age influence the frequency of diabetic ketoacidosis at the onset of type 1 diabetes","volume":"78","author":"Rodacki","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(24)00103-7_bib107","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1007\/s00125-022-05836-w","article-title":"The effect of age on longitudinal measures of beta cell function and insulin sensitivity during the progression of early stage type 1 diabetes","volume":"66","author":"Ferrannini","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00103-7_bib108","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s11892-018-1083-4","article-title":"The effect of age on the progression and severity of type 1 diabetes: potential effects on disease mechanisms","volume":"18","author":"Leete","year":"2018","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(24)00103-7_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0000116","article-title":"Development of a dynamic prediction model for unplanned ICU admission and mortality in hospitalized patients","volume":"2","author":"Placido","year":"2023","journal-title":"PLoS Digit Health"},{"key":"10.1016\/S2213-8587(24)00103-7_bib110","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00103-7_bib111","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/oxfordjournals.aje.a112335","article-title":"Causes","volume":"104","author":"Rothman","year":"1976","journal-title":"Am J Epidemiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T05:29:01Z","timestamp":1718774941000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001037"}},"issued":{"date-parts":[[2024,7]]},"references-count":111,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2213858724001037"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00103-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prediction of progression to type 1 diabetes with dynamic biomarkers and risk scores","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00103-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,4,22]],"date-time":"2025-04-22T05:03:26Z","timestamp":1745298206524},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/s2213-8587(19)30142-1","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T19:21:06Z","timestamp":1555615266000},"page":"595","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["How neoliberalism ruins traditional diets and health"],"prefix":"10.1016","volume":"7","author":[{"given":"Marion","family":"Nestle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301421?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301421?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T08:03:44Z","timestamp":1564387424000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301421"}},"issued":{"date-parts":[[2019,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S2213858719301421"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30142-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How neoliberalism ruins traditional diets and health","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30142-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"book-review","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:49:42Z","timestamp":1785883782526,"version":"3.56.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002918","name":"Gentofte Hospital","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002918","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001734","name":"K\u00f8benhavns Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001734","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/s2213-8587(26)00075-6","type":"journal-article","created":{"date-parts":[[2026,5,22]],"date-time":"2026-05-22T22:58:02Z","timestamp":1779490682000},"page":"581-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trial"],"prefix":"10.1016","volume":"14","author":[{"given":"Mads M","family":"Helsted","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Fonnesbech-Wulff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina L","family":"Schaltz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid W","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casper K","family":"Nielsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Englund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bolette","family":"Hartmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Vilsb\u00f8ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens J","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asger B","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikkel B","family":"Christensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip K","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L\u00e6rke S","family":"Gasbjerg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00075-6_bib1","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes\u2014global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/S2213-8587(26)00075-6_bib2","doi-asserted-by":"crossref","first-page":"3212","DOI":"10.1210\/jc.2015-3777","article-title":"Components of the metabolic syndrome and risk of type 2 diabetes","volume":"101","author":"Marott","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00075-6_bib3","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/BF02427280","article-title":"Reduced incretin effect in type 2 (non-insulin-dependent) diabetes","volume":"29","author":"Nauck","year":"1986","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00075-6_bib4","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1007\/BF01225454","article-title":"The incretin concept today","volume":"16","author":"Creutzfeldt","year":"1979","journal-title":"Diabetologia"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(26)00075-6_bib5","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/dom.14496","article-title":"The evolving story of incretins (GIP and GLP-1) in metabolic and cardiovascular disease: a pathophysiological update","volume":"23","author":"Nauck","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00075-6_bib6","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1038\/s42255-024-01113-9","article-title":"GLP-1 physiology in obesity and development of incretin-based drugs for chronic weight management","volume":"6","author":"Holst","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(26)00075-6_bib7","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.2337\/diab.44.9.1126","article-title":"Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects","volume":"44","author":"Deacon","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(26)00075-6_bib8","first-page":"3575","article-title":"Degradation of endogenous and exogenous gastric inhibitory polypeptide in healthy and in type 2 diabetic subjects as revealed using a new assay for the intact peptide","volume":"85","author":"Deacon","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00075-6_bib9","doi-asserted-by":"crossref","first-page":"2210","DOI":"10.1111\/dom.13353","article-title":"Semaglutide induces weight loss in subjects with type 2 diabetes regardless of baseline BMI or gastrointestinal adverse events in the SUSTAIN 1 to 5 trials","volume":"20","author":"Ahr\u00e9n","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00075-6_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.regpep.2007.07.002","article-title":"The insulinotropic effect of GIP is impaired in patients with chronic pancreatitis and secondary diabetes mellitus as compared to patients with chronic pancreatitis and normal glucose tolerance","volume":"144","author":"Knop","year":"2007","journal-title":"Regul Pept"},{"key":"10.1016\/S2213-8587(26)00075-6_bib11","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1007\/s00125-008-1195-5","article-title":"Four weeks of near-normalisation of blood glucose improves the insulin response to glucagon-like peptide-1 and glucose-dependent insulinotropic polypeptide in patients with type 2 diabetes","volume":"52","author":"H\u00f8jberg","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00075-6_bib12","doi-asserted-by":"crossref","first-page":"209ra151","DOI":"10.1126\/scitranslmed.3007218","article-title":"Unimolecular dual incretins maximize metabolic benefits in rodents, monkeys, and humans","volume":"5","author":"Finan","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(26)00075-6_bib13","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S0140-6736(21)01324-6","article-title":"Efficacy and safety of a novel dual GIP and GLP-1 receptor agonist tirzepatide in patients with type 2 diabetes (SURPASS-1): a double-blind, randomised, phase 3 trial","volume":"398","author":"Rosenstock","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00075-6_bib14","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.1111\/dom.15216","article-title":"The importance of glucose-dependent insulinotropic polypeptide receptor activation for the effects of tirzepatide","volume":"25","author":"Gasbjerg","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00075-6_bib15","doi-asserted-by":"crossref","first-page":"e065736","DOI":"10.1136\/bmjopen-2022-065736","article-title":"Separate and combined effects of long-term GIP and GLP-1 receptor activation in patients with type 2 diabetes: a structured summary of a study protocol for a double-blind, randomised, placebo-controlled clinical trial","volume":"13","author":"Helsted","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00075-6_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2337\/diab.43.4.535","article-title":"Tissue and plasma concentrations of amidated and glycine-extended glucagon-like peptide I in humans","volume":"43","author":"\u00d8rskov","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(26)00075-6_bib17","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","volume":"11","author":"Battelino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00075-6_bib18","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1016\/S0140-6736(18)32260-8","article-title":"Efficacy and safety of LY3298176, a novel dual GIP and GLP-1 receptor agonist, in patients with type 2 diabetes: a randomised, placebo-controlled and active comparator-controlled phase 2 trial","volume":"392","author":"Frias","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00075-6_bib19","doi-asserted-by":"crossref","first-page":"e013096","DOI":"10.1136\/bmjopen-2016-013096","article-title":"To condition or not condition? Analysing \u2018change\u2019 in longitudinal randomised controlled trials","volume":"6","author":"Coffman","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00075-6_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/S2213-8587(26)00075-6_bib21","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00075-6_bib22","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1172\/JCI116186","article-title":"Preserved incretin activity of glucagon-like peptide 1 [7-36 amide] but not of synthetic human gastric inhibitory polypeptide in patients with type-2 diabetes mellitus","volume":"91","author":"Nauck","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(26)00075-6_bib23","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s00125-002-0878-6","article-title":"Defective amplification of the late phase insulin response to glucose by GIP in obese type II diabetic patients","volume":"45","author":"Vilsb\u00f8ll","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00075-6_bib24","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1007\/s00125-021-05547-8","article-title":"The effect of 6-day subcutaneous glucose-dependent insulinotropic polypeptide infusion on time in glycaemic range in patients with type 1 diabetes: a randomised, double-blind, placebo-controlled crossover trial","volume":"64","author":"Heimb\u00fcrger","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00075-6_bib25","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.2337\/db10-1332","article-title":"GIP does not potentiate the antidiabetic effects of GLP-1 in hyperglycemic patients with type 2 diabetes","volume":"60","author":"Mentis","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(26)00075-6_bib26","doi-asserted-by":"crossref","first-page":"171214","DOI":"10.1016\/j.peptides.2024.171214","article-title":"Safety of native glucose-dependent insulinotropic polypeptide in humans","volume":"177","author":"Helsted","year":"2024","journal-title":"Peptides"},{"key":"10.1016\/S2213-8587(26)00075-6_bib27","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.1111\/dom.15736","article-title":"Randomised comparison of intravenous and subcutaneous routes of glucagon-like peptide-1 administration for lowering plasma glucose in hyperglycaemic subjects with type 2 diabetes","volume":"26","author":"Quast","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00075-6_bib28","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 siabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00075-6_bib29","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1002\/psp4.13099","article-title":"Population pharmacokinetics of the GIP\/GLP receptor agonist tirzepatide","volume":"13","author":"Schneck","year":"2024","journal-title":"CPT Pharmacometrics Syst Pharmacol"},{"key":"10.1016\/S2213-8587(26)00075-6_bib30","doi-asserted-by":"crossref","first-page":"e140532","DOI":"10.1172\/jci.insight.140532","article-title":"Tirzepatide is an imbalanced and biased dual GIP and GLP-1 receptor agonist","volume":"5","author":"Willard","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(26)00075-6_bib31","doi-asserted-by":"crossref","first-page":"5474","DOI":"10.1111\/dom.15875","article-title":"A long-acting glucose-dependent insulinotropic polypeptide receptor agonist improves the gastrointestinal tolerability of glucagon-like peptide-1 receptor agonist therapy","volume":"26","author":"Knop","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00075-6_bib32","doi-asserted-by":"crossref","first-page":"3618","DOI":"10.1128\/MCB.00256-14","article-title":"A naturally occurring GIP receptor variant undergoes enhanced agonist-induced desensitization, which impairs GIP control of adipose insulin sensitivity","volume":"34","author":"Mohammad","year":"2014","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S2213-8587(26)00075-6_bib33","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1056\/NEJMoa2504214","article-title":"Once-monthly maridebart cafraglutide for the treatment of obesity\u2014a phase 2 trial","volume":"393","author":"Jastreboff","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00075-6_bib34","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/s42255-025-01299-6","article-title":"Unravelling the GIPR agonist versus antagonist paradox","volume":"7","author":"Adriaenssens","year":"2025","journal-title":"Nat Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000756?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000756?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T22:11:07Z","timestamp":1785881467000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000756"}},"issued":{"date-parts":[[2026,7]]},"references-count":34,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S2213858726000756"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00075-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of a 6-week subcutaneous infusion of native GIP alone or as add-on to semaglutide in people with type 2 diabetes: a single-centre, double-blind, parallel-group, randomised, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00075-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T00:46:21Z","timestamp":1787791581412,"version":"build-2784847793"},"reference-count":25,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016016","name":"Gilead UK and Ireland Corporate Contributions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016016","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/s2213-8587(20)30405-8","type":"journal-article","created":{"date-parts":[[2020,12,23]],"date-time":"2020-12-23T19:34:41Z","timestamp":1608752081000},"page":"82-93","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":275,"title":["Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland"],"prefix":"10.1016","volume":"9","author":[{"given":"Stuart J","family":"McGurnaghan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Weir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jen","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Kennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A K","family":"Blackbourn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"McAllister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Hutchinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M","family":"Caparrotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Mellor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Jeyam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph E","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hatam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"H\u00f6hn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazir","family":"Lone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Butterly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian","family":"Kennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"McCrimmon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ewan","family":"Pearson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Philip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jim","family":"McMenamin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Smith-Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"McKeigue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M","family":"Colhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Whettlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Gasiorowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Merrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy","family":"McAuley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"April","family":"Went","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calum","family":"Purdie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Fischbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Ramsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eisin","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genna","family":"Drennan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Gowans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heather","family":"Murdoch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jade","family":"Carruthers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josie","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Heatlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Donaldson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Paton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Llano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Murphy-Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Cameron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Brownlie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Gaffney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aynsley","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"McArdle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Glass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jodie","family":"McCoubrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30405-8_bib1","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","volume":"36","author":"Guo","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(20)30405-8_bib2","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1002\/jmv.25783","article-title":"Clinical features and treatment of COVID-19 patients in northeast Chongqing","volume":"92","author":"Wan","year":"2020","journal-title":"J Med Virol"},{"key":"10.1016\/S2213-8587(20)30405-8_bib3","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30405-8_bib4","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis","volume":"94","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/S2213-8587(20)30405-8_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0238281","article-title":"Characteristics and outcomes of a cohort of COVID-19 patients in the province of Reggio Emilia, Italy","volume":"15","author":"Giorgi Rossi","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(20)30405-8_bib6","doi-asserted-by":"crossref","first-page":"2052","DOI":"10.1001\/jama.2020.6775","article-title":"Presenting characteristics, comorbidities, and outcomes among 5700 patients hospitalized with COVID-19 in the New York City area","volume":"323","author":"Richardson","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30405-8_bib7","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/jama.2020.4326","article-title":"Characteristics and outcomes of 21 critically ill patients with COVID-19 in Washington State","volume":"323","author":"Arentz","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30405-8_bib9","article-title":"Features of 20\u2008133 UK patients in hospital with COVID-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(20)30405-8_bib10","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19","volume":"382","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30405-8_bib11","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(20)30405-8_bib12","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa346","article-title":"Predicting mortality due to SARS-CoV-2: a mechanistic score relating obesity and diabetes to COVID-19 outcomes in Mexico","volume":"105","author":"Bello-Chavolla","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30405-8_bib13","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Type 1 and type 2 diabetes and COVID-19 related mortality in England: a cohort study in people with diabetes","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30405-8_bib14","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30405-8_bib16","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s00125-020-05180-x","article-title":"Phenotypic characteristics and prognosis of inpatients with COVID-19 and diabetes: the CORONADO study","volume":"63","author":"Cariou","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30405-8_bib17","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2014.16425","article-title":"Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008\u20132010","volume":"313","author":"Livingstone","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30405-8_bib18","doi-asserted-by":"crossref","first-page":"2774","DOI":"10.1161\/CIRCULATIONAHA.118.034986","article-title":"Incidence of hospitalization for heart failure and case-fatality among 3\u00b725 million people with and without diabetes mellitus","volume":"138","author":"McAllister","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(20)30405-8_bib22","doi-asserted-by":"crossref","DOI":"10.18637\/jss.v045.i07","article-title":"Amelia II: a program for missing data","volume":"45","author":"Honaker","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/S2213-8587(20)30405-8_bib24","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ije\/28.5.964","article-title":"The use of fractional polynomials to model continuous risk variables in epidemiology","volume":"28","author":"Royston","year":"1999","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(20)30405-8_bib25","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1177\/0962280218776989","article-title":"Quantifying performance of a diagnostic test as the expected information for discrimination: relation to the C-statistic","volume":"28","author":"McKeigue","year":"2018","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/S2213-8587(20)30405-8_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154344","article-title":"Diabetes, glycaemic control, and risk of COVID-19 hospitalisation: population-based, prospective cohort study","volume":"112","author":"Hamer","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(20)30405-8_bib27","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003374","article-title":"Rapid epidemiological analysis of comorbidities and treatments as risk factors for COVID-19 in Scotland (REACT-SCOT): a population-based case-control study","volume":"17","author":"McKeigue","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(20)30405-8_bib28","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1016\/j.mayocp.2020.07.024","article-title":"COVID-19 and sex differences: mechanisms and biomarkers","volume":"95","author":"Haitao","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/S2213-8587(20)30405-8_bib29","series-title":"Causal inference: what if","author":"Hern\u00e1n","year":"2020"},{"key":"10.1016\/S2213-8587(20)30405-8_bib30","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1016\/S0140-6736(20)30567-5","article-title":"How will country-based mitigation measures influence the course of the COVID-19 epidemic?","volume":"395","author":"Anderson","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30405-8_bib31","article-title":"Living risk prediction algorithm (QCOVID) for risk of hospital admission and mortality from coronavirus 19 in adults: national derivation and validation cohort study","volume":"371","author":"Clift","year":"2020","journal-title":"BMJ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720304058?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720304058?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:24Z","timestamp":1761991704000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720304058"}},"issued":{"date-parts":[[2021,2]]},"references-count":25,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2213858720304058"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30405-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30405-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30432-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:06:24Z","timestamp":1785362784779,"version":"3.55.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/s2213-8587(17)30116-x","type":"journal-article","created":{"date-parts":[[2017,4,5]],"date-time":"2017-04-05T20:15:39Z","timestamp":1491423339000},"page":"313","source":"Crossref","is-referenced-by-count":25,"title":["Urbanisation, inequality, and non-communicable disease risk"],"prefix":"10.1016","volume":"5","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730116X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730116X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T19:22:00Z","timestamp":1535916120000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871730116X"}},"issued":{"date-parts":[[2017,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S221385871730116X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30116-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,5]]}},{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T17:23:03Z","timestamp":1791307383537,"version":"4.3.1"},"update-to":[{"DOI":"10.1016\/s2213-8587(22)00218-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/s2213-8587(22)00280-7","type":"journal-article","created":{"date-parts":[[2022,10,7]],"date-time":"2022-10-07T18:34:00Z","timestamp":1665167640000},"page":"e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Correction to Lancet Diabetes Endocrinol 2022; 10: 741\u201360"],"prefix":"10.1016","volume":"10","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:56Z","timestamp":1761991856000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722002807"}},"issued":{"date-parts":[[2022,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2213858722002807"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00280-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2022; 10: 741\u201360","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00280-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00218-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T16:07:51Z","timestamp":1791216471906,"version":"4.1.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/s2213-8587(24)00153-0","type":"journal-article","created":{"date-parts":[[2024,6,25]],"date-time":"2024-06-25T18:33:53Z","timestamp":1719340433000},"page":"596-600","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["The potential role for artificial intelligence in fracture risk prediction"],"prefix":"10.1016","volume":"12","author":[{"given":"Namki","family":"Hong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle E","family":"Whittier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claus-C","family":"Gl\u00fcer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00153-0_bib1","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s00198-023-06907-3","article-title":"Global burden of hip fracture: the Global Burden of Disease study","volume":"35","author":"Feng","year":"2024","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(24)00153-0_bib2","doi-asserted-by":"crossref","first-page":"882241","DOI":"10.3389\/fendo.2022.882241","article-title":"The global burden of osteoporosis, low bone mass, and its related fracture in 204 countries and territories, 1990\u20132019","volume":"13","author":"Shen","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(24)00153-0_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1186\/s13643-023-02181-w","article-title":"Screening for the primary prevention of fragility fractures among adults aged 40 years and older in primary care: systematic reviews of the effects and acceptability of screening and treatment, and the accuracy of risk prediction tools","volume":"12","author":"Gates","year":"2023","journal-title":"Syst Rev"},{"key":"10.1016\/S2213-8587(24)00153-0_bib4","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00198-019-04919-6","article-title":"Performance of predictive tools to identify individuals at risk of non-traumatic fracture: a systematic review, meta-analysis, and meta-regression","volume":"30","author":"Beaudoin","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(24)00153-0_bib5","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1056\/NEJMra2301725","article-title":"The current and future state of AI interpretation of medical images","volume":"388","author":"Rajpurkar","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00153-0_bib6","doi-asserted-by":"crossref","first-page":"1806","DOI":"10.1001\/jama.2019.16489","article-title":"How to read articles that use machine learning: users' guides to the medical literature","volume":"322","author":"Liu","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00153-0_bib7","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1056\/NEJMra2302038","article-title":"Artificial intelligence and machine learning in clinical medicine, 2023","volume":"388","author":"Haug","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00153-0_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1038\/s41591-018-0300-7","article-title":"High-performance medicine: the convergence of human and artificial intelligence","volume":"25","author":"Topol","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00153-0_bib9","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1002\/jbmr.4814","article-title":"Deep-learning-based detection of vertebral fracture and osteoporosis using lateral spine x-ray radiography","volume":"38","author":"Hong","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00153-0_bib10","doi-asserted-by":"crossref","DOI":"10.1177\/1759720X211024029","article-title":"Opportunistic diagnosis of osteoporosis, fragile bone strength and vertebral fractures from routine CT scans; a review of approved technology systems and pathways to implementation","volume":"13","author":"Aggarwal","year":"2021","journal-title":"Ther Adv Musculoskelet Dis"},{"key":"10.1016\/S2213-8587(24)00153-0_bib11","doi-asserted-by":"crossref","first-page":"e22550","DOI":"10.2196\/22550","article-title":"Deep learning with electronic health records for short-term fracture risk identification: crystal bone algorithm development and validation","volume":"22","author":"Almog","year":"2020","journal-title":"J Med Internet Res"},{"key":"10.1016\/S2213-8587(24)00153-0_bib12","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1016\/S2589-7500(22)00111-X","article-title":"Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses","volume":"4","author":"Ferguson","year":"2022","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(24)00153-0_bib13","doi-asserted-by":"crossref","first-page":"4713","DOI":"10.1007\/s00330-020-06845-2","article-title":"Radiology reporting of osteoporotic vertebral fragility fractures on computed tomography studies: results of a UK national audit","volume":"30","author":"Howlett","year":"2020","journal-title":"Eur Radiol"},{"key":"10.1016\/S2213-8587(24)00153-0_bib14","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1007\/s00198-020-05710-8","article-title":"Integration of a vertebral fracture identification service into a fracture liaison service: a quality improvement project","volume":"32","author":"Ong","year":"2021","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(24)00153-0_bib15","doi-asserted-by":"crossref","first-page":"101876","DOI":"10.1016\/j.eclinm.2023.101876","article-title":"Development and validation of sex-specific hip fracture prediction models using electronic health records: a retrospective, population-based cohort study","volume":"58","author":"Li","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/S2213-8587(24)00153-0_bib16","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/s41746-022-00583-z","article-title":"Digital biomarkers: convergence of digital health technologies and biomarkers","volume":"5","author":"Vasudevan","year":"2022","journal-title":"NPJ Digit Med"},{"key":"10.1016\/S2213-8587(24)00153-0_bib17","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1056\/NEJMoa1901183","article-title":"Large-scale assessment of a smartwatch to identify atrial fibrillation","volume":"381","author":"Perez","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00153-0_bib18","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/s41746-019-0217-7","article-title":"Development of digital biomarkers for resting tremor and bradykinesia using a wrist-worn wearable device","volume":"3","author":"Mahadevan","year":"2020","journal-title":"NPJ Digit Med"},{"key":"10.1016\/S2213-8587(24)00153-0_bib19","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1109\/JBHI.2019.2930091","article-title":"Smartphone-based assessment of gait during straight walking, turning, and walking speed modulation in laboratory and free-living environments","volume":"24","author":"Silsupadol","year":"2020","journal-title":"IEEE J Biomed Health Inform"},{"key":"10.1016\/S2213-8587(24)00153-0_bib20","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.future.2017.04.036","article-title":"Towards fog-driven IoT eHealth: promises and challenges of IoT in medicine and healthcare","volume":"78","author":"Farahani","year":"2018","journal-title":"Future Gener Comput Syst"},{"key":"10.1016\/S2213-8587(24)00153-0_bib21","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1002\/jbmr.3619","article-title":"Characteristics of self-reported sleep and the risk of falls and fractures: the Women's Health Initiative (WHI)","volume":"34","author":"Cauley","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00153-0_bib22","first-page":"24","article-title":"Bone health: biology and nutrition","volume":"27","author":"Rizzoli","year":"2024","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/S2213-8587(24)00153-0_bib23","first-page":"7740","article-title":"Wearable technology and ECG processing for fall risk assessment, prevention and detection","volume":"2015","author":"Melillo","year":"2015","journal-title":"Annu Int Conf IEEE Eng Med Biol Soc"},{"key":"10.1016\/S2213-8587(24)00153-0_bib24","doi-asserted-by":"crossref","first-page":"1257676","DOI":"10.3389\/fbioe.2023.1257676","article-title":"IoT-blockchain empowered Trinet: optimized fall detection system for elderly safety","volume":"11","author":"Alfayez","year":"2023","journal-title":"Front Bioeng Biotechnol"},{"key":"10.1016\/S2213-8587(24)00153-0_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1038\/s41746-020-0302-y","article-title":"Digitizing clinical trials","volume":"3","author":"Inan","year":"2020","journal-title":"NPJ Digit Med"},{"key":"10.1016\/S2213-8587(24)00153-0_bib26","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1111\/jce.15866","article-title":"\u201cPill-in-Pocket\u201d anticoagulation for stroke prevention in atrial fibrillation","volume":"34","author":"Peigh","year":"2023","journal-title":"J Cardiovasc Electrophysiol"},{"key":"10.1016\/S2213-8587(24)00153-0_bib27","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1038\/s41746-023-00966-w","article-title":"Prediction of atrial fibrillation from at-home single-lead ECG signals without arrhythmias","volume":"6","author":"Gadaleta","year":"2023","journal-title":"NPJ Digit Med"},{"key":"10.1016\/S2213-8587(24)00153-0_bib28","doi-asserted-by":"crossref","first-page":"114186","DOI":"10.1016\/j.measurement.2024.114186","article-title":"A comprehensive review of elderly fall detection using wireless communication and artificial intelligence techniques","volume":"226","author":"Gharghan","year":"2024","journal-title":"Measurement"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(24)00153-0_bib29","doi-asserted-by":"crossref","first-page":"S407","DOI":"10.1007\/s00198-010-1253-y","article-title":"Development and use of FRAX in osteoporosis","volume":"21","author":"Kanis","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(24)00153-0_bib30","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1002\/jbmr.4808","article-title":"A fracture risk assessment tool for high resolution peripheral quantitative computed tomography","volume":"38","author":"Whittier","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00153-0_bib31","doi-asserted-by":"crossref","first-page":"876","DOI":"10.1002\/jbmr.4805","article-title":"Hip fracture risk assessment in elderly and diabetic patients: combining autonomous finite element analysis and machine learning","volume":"38","author":"Yosibash","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00153-0_bib32","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1002\/jbmr.4342","article-title":"Bone radiomics score derived from DXA hip images enhances hip fracture prediction in older women","volume":"36","author":"Hong","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00153-0_bib33","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1002\/jbmr.4494","article-title":"Bone microarchitecture phenotypes identified in older adults are associated with different levels of osteoporotic fracture risk","volume":"37","author":"Whittier","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00153-0_bib34","doi-asserted-by":"crossref","first-page":"310","DOI":"10.3390\/fi15090310","article-title":"Exploring homomorphic encryption and differential privacy techniques towards secure federated learning paradigm","volume":"15","author":"Aziz","year":"2023","journal-title":"Future Internet"},{"key":"10.1016\/S2213-8587(24)00153-0_bib35","doi-asserted-by":"crossref","first-page":"104658","DOI":"10.1016\/j.ijmedinf.2021.104658","article-title":"Detecting model misconducts in decentralized healthcare federated learning","volume":"158","author":"Kuo","year":"2021","journal-title":"Int J Med Inform"},{"key":"10.1016\/S2213-8587(24)00153-0_bib36","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1038\/s41591-022-01981-2","article-title":"Multimodal biomedical AI","volume":"28","author":"Acosta","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00153-0_bib37","first-page":"1181","article-title":"AI-based opportunistic CT screening of incidental cardiovascular disease, osteoporosis, and sarcopenia: cost-effectiveness analysis","volume":"48","author":"Pickhardt","year":"2023","journal-title":"Abdom Radiol"},{"key":"10.1016\/S2213-8587(24)00153-0_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1007\/s11657-020-00871-9","article-title":"SCOPE 2021: a new scorecard for osteoporosis in Europe","volume":"16","author":"Kanis","year":"2021","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(24)00153-0_bib39","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S1470-2045(23)00298-X","volume":"24","author":"L\u00e5ng","year":"2023","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(24)00153-0_bib40","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.1002\/jbmr.3528","article-title":"A new fracture risk assessment tool (FREM) based on public health registries","volume":"33","author":"Rubin","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00153-0_bib41","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1001\/jama.2023.22295","article-title":"Measuring the impact of AI in the diagnosis of hospitalized patients: a randomized clinical vignette survey study","volume":"330","author":"Jabbour","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00153-0_bib42","article-title":"Generalized out-of-distribution detection: a survey","author":"Yang","year":"2021","journal-title":"arXiv"},{"key":"10.1016\/S2213-8587(24)00153-0_bib43","doi-asserted-by":"crossref","first-page":"116017","DOI":"10.1016\/j.bone.2021.116017","article-title":"Feasibility of a generalized convolutional neural network for automated identification of vertebral compression fractures: the Manitoba Bone Mineral Density Registry","volume":"150","author":"Monchka","year":"2021","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(24)00153-0_bib44","doi-asserted-by":"crossref","first-page":"e22456","DOI":"10.1016\/j.heliyon.2023.e22456","article-title":"A decision support system for osteoporosis risk prediction using machine learning and explainable artificial intelligence","volume":"9","author":"Khanna","year":"2023","journal-title":"Heliyon"},{"key":"10.1016\/S2213-8587(24)00153-0_bib45","series-title":"Interpretable and annotation-efficient learning for medical image computing","first-page":"3","article-title":"Assessing attribution maps for explaining CNN-based vertebral fracture classifiers","author":"Yilmaz","year":"2020"},{"key":"10.1016\/S2213-8587(24)00153-0_bib46","doi-asserted-by":"crossref","first-page":"e2345050","DOI":"10.1001\/jamanetworkopen.2023.45050","article-title":"Guiding principles to address the impact of algorithm bias on racial and ethnic disparities in health and health care","volume":"6","author":"Chin","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(24)00153-0_bib47","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1038\/s41591-020-1041-y","article-title":"Minimum information about clinical artificial intelligence modeling: the MI-CLAIM checklist","volume":"26","author":"Norgeot","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00153-0_bib48","doi-asserted-by":"crossref","first-page":"e200029","DOI":"10.1148\/ryai.2020200029","article-title":"Checklist for artificial intelligence in medical imaging (CLAIM): a guide for authors and reviewers","volume":"2","author":"Mongan","year":"2020","journal-title":"Radiol Artif Intell"},{"key":"10.1016\/S2213-8587(24)00153-0_bib49","doi-asserted-by":"crossref","first-page":"101369","DOI":"10.1016\/j.jocd.2023.101369","article-title":"Positions of the International Society for Clinical Densitometry and their etiology: a scoping review","volume":"26","author":"Shepherd","year":"2023","journal-title":"J Clin Densitom"},{"key":"10.1016\/S2213-8587(24)00153-0_bib50","article-title":"Characterizing the clinical adoption of medical AI devices through U.S. insurance claims","volume":"1","author":"Wu","year":"2023","journal-title":"NEJM AI"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:26:12Z","timestamp":1778858772000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001530"}},"issued":{"date-parts":[[2024,8]]},"references-count":50,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2213858724001530"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00153-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The potential role for artificial intelligence in fracture risk prediction","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00153-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:49:22Z","timestamp":1791251362770,"version":"4.1.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/s2213-8587(24)00161-x","type":"journal-article","created":{"date-parts":[[2024,6,6]],"date-time":"2024-06-06T19:35:54Z","timestamp":1717702554000},"page":"433","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Alarming rise in young-onset type 2 diabetes"],"prefix":"10.1016","volume":"12","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872400161X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872400161X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T03:19:51Z","timestamp":1718767191000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872400161X"}},"issued":{"date-parts":[[2024,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S221385872400161X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00161-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Alarming rise in young-onset type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00161-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,4,15]],"date-time":"2025-04-15T04:56:21Z","timestamp":1744692981654},"reference-count":7,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/s2213-8587(14)70165-2","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T23:16:22Z","timestamp":1409440582000},"page":"614","source":"Crossref","is-referenced-by-count":1,"title":["High serum cholesterol: a missed risk factor for chronic kidney disease mortality\u2013Authors' reply"],"prefix":"10.1016","volume":"2","author":[{"given":"Majid","family":"Ezzati","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Goodarz","family":"Danaei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70165-2_bib1","article-title":"Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70165-2_bib2","doi-asserted-by":"crossref","first-page":"e65174","DOI":"10.1371\/journal.pone.0065174","article-title":"The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(14)70165-2_bib3","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.pcad.2009.09.001","article-title":"Epidemiology and natural history of atherosclerotic renovascular disease","volume":"52","author":"Chrysochou","year":"2009","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(14)70165-2_bib4","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.2215\/CJN.09320913","article-title":"Relation of Serum Lipids and Lipoproteins with Progression of CKD: The CRIC Study","volume":"9","author":"Rahman","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(14)70165-2_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/joim.12081","article-title":"High density lipoprotein cholesterol levels are an independent predictor of the progression of chronic kidney disease","volume":"274","author":"Baragetti","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(14)70165-2_bib6","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1111\/jch.12139","article-title":"Long-term follow-up of moderately hypercholesterolemic hypertensive patients following randomization to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)","volume":"15","author":"Margolis","year":"2013","journal-title":"J Clin Hypertens"},{"key":"10.1016\/S2213-8587(14)70165-2_bib7","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T05:22:58Z","timestamp":1538284978000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701652"}},"issued":{"date-parts":[[2014,8]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S2213858714701652"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70165-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,8]]}},{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T18:11:16Z","timestamp":1775499076653,"version":"3.50.1"},"reference-count":135,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012358","name":"Collaboration for Leadership in Applied Health Research and Care - Greater Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/s2213-8587(18)30203-1","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T19:03:23Z","timestamp":1538420603000},"page":"992-1002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":57,"title":["Public health and health systems: implications for the prevention and management of type 2 diabetes in south Asia"],"prefix":"10.1016","volume":"6","author":[{"given":"Andrew P","family":"Hills","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anoop","family":"Misra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason M R","family":"Gill","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nuala M","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mario J","family":"Soares","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ambady","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Latha","family":"Palaniappan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steven J","family":"Street","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ranil","family":"Jayawardena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ross","family":"Arena","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30203-1_bib1","series-title":"Global action plan for the prevention and control of noncommunicable diseases 2013\u20132020","year":"2013"},{"key":"10.1016\/S2213-8587(18)30203-1_bib2","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1001\/jamainternmed.2017.3140","article-title":"Outcomes in south Asia matter for the world","volume":"177","author":"Feachem","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib3","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-8587(17)30181-X","article-title":"Diabetes in sub-Saharan Africa: from clinical care to health policy","volume":"5","author":"Atun","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30203-1_bib4","doi-asserted-by":"crossref","first-page":"359S","DOI":"10.3945\/ajcn.113.071571","article-title":"Global epidemiology of obesity, vegetarian dietary patterns, and noncommunicable disease in Asian Indians","volume":"100","author":"Singh","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(18)30203-1_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30204-3","article-title":"Epidemiology and determinants of type 2 diabetes in south Asia","author":"Hills","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30203-1_bib6","series-title":"Capitalizing on the demographic transition: tackling noncommunicable diseases in South Asia","author":"Engelgau","year":"2011"},{"key":"10.1016\/S2213-8587(18)30203-1_bib7","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1186\/s12889-017-4986-0","article-title":"Cultural adaptation of a peer-led lifestyle intervention program for diabetes prevention in India: the Kerala Diabetes Prevention Program (K-DPP)","volume":"17","author":"Mathews","year":"2017","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(18)30203-1_bib8","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/nrendo.2017.151","article-title":"Global aetiology and epidemiology of type 2 diabetes mellitus and its complications","volume":"14","author":"Zheng","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(18)30203-1_bib9","series-title":"National programme for prevention and control of cancer, diabetes, cardiovascular diseases and stroke (NPCDCS). Operational guidelines","year":"2013"},{"key":"10.1016\/S2213-8587(18)30203-1_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30199-2","article-title":"Clinical management of type 2 diabetes in south Asia","author":"Misra","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30203-1_bib11","doi-asserted-by":"crossref","first-page":"e000057","DOI":"10.1136\/bmjgh-2016-000057","article-title":"Primary healthcare policy implementation in south Asia","volume":"1","author":"van Weel","year":"2016","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S2213-8587(18)30203-1_bib12","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1016\/S2213-8587(16)30331-X","article-title":"Country in Focus: confronting the challenge of NCDs in Nepal","volume":"4","author":"Mishra","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30203-1_bib13","doi-asserted-by":"crossref","first-page":"79","DOI":"10.4103\/2224-3151.122935","article-title":"Chronic disease management in SE Asia Region: a need to do more","volume":"2","author":"Sharma","year":"2013","journal-title":"WHO South East Asia J Public Health"},{"key":"10.1016\/S2213-8587(18)30203-1_bib14","series-title":"Country profile","year":"2016"},{"key":"10.1016\/S2213-8587(18)30203-1_bib15","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13098-017-0207-3","article-title":"Prevalence and risk factors of diabetes in a large community-based study in North India: results from a STEPS survey in Punjab, India","volume":"9","author":"Tripathy","year":"2017","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/S2213-8587(18)30203-1_bib16","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/S2213-8587(17)30190-0","article-title":"The need for improved diabetes care in India","volume":"5","author":"Viswanathan","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30203-1_bib17","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2213-8587(17)30174-2","article-title":"Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR\u2013INDIAB population-based cross-sectional study","volume":"5","author":"Anjana","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30203-1_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.4038\/gmj.v16i2.3749","article-title":"Sri Lanka's approach to primary health care: a success story in south Asia","volume":"16","author":"Hewa","year":"2011","journal-title":"Galle Med J"},{"key":"10.1016\/S2213-8587(18)30203-1_bib19","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12913-015-1026-6","article-title":"A first country-wide review of diabetes mellitus care in Bhutan: time to do better","volume":"15","author":"Zam","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(18)30203-1_bib20","doi-asserted-by":"crossref","first-page":"44","DOI":"10.4103\/2224-3151.206552","article-title":"An approach to diabetes prevention and management: the Bhutan experience","volume":"5","author":"Tandin","year":"2016","journal-title":"WHO South East Asia J Public Health"},{"key":"10.1016\/S2213-8587(18)30203-1_bib21","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.3402\/gha.v9.31704","article-title":"Challenges in diabetes mellitus type 2 management in Nepal: a literature review","volume":"9","author":"Gyawali","year":"2016","journal-title":"Glob Health Action"},{"key":"10.1016\/S2213-8587(18)30203-1_bib22","first-page":"44","article-title":"Dealing with the burden of hyptertension in Nepal: current status, challenges and health system issues","volume":"17","author":"Dhital","year":"2013","journal-title":"WHO South East Asia J Public Health"},{"key":"10.1016\/S2213-8587(18)30203-1_bib23","doi-asserted-by":"crossref","first-page":"40","DOI":"10.4103\/2224-3151.206551","article-title":"Strengthening policy and governance to address the growing burden of diabetes in Nepal","volume":"5","author":"Upreti","year":"2016","journal-title":"WHO South East Asia J Public Health"},{"key":"10.1016\/S2213-8587(18)30203-1_bib24","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1002\/hec.1209","article-title":"Catastrophic payments for health care in Asia","volume":"16","author":"van Doorslaer","year":"2007","journal-title":"Health Econ"},{"key":"10.1016\/S2213-8587(18)30203-1_bib25","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1016\/j.socscimed.2005.07.001","article-title":"What are the economic consequences for households of illness and of paying for health care in low- and middle-income country contexts?","volume":"62","author":"McIntyre","year":"2006","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S2213-8587(16)30010-9","article-title":"The changing face of diabetes complications","volume":"4","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30203-1_bib27","series-title":"Success factors for women's and children's health: Nepal","year":"2015"},{"key":"10.1016\/S2213-8587(18)30203-1_bib28","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1001\/jamainternmed.2017.3133","article-title":"Progress toward universal health coverage: a comparative analysis in 5 south Asian countries","volume":"177","author":"Rahman","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib29","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.1016\/S2214-109X(17)30413-8","article-title":"Trends in, and projections of, indicators of universal health coverage in Bangladesh, 1995\u20132030: a Bayesian analysis of population-based household data","volume":"6","author":"Rahman","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(18)30203-1_bib30","doi-asserted-by":"crossref","first-page":"e1001728","DOI":"10.1371\/journal.pmed.1001728","article-title":"Monitoring intervention coverage in the context of universal health coverage","volume":"11","author":"Boerma","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib31","series-title":"Health at a glance: Asia\/Pacific 2016: measuring progress towards universal health coverage","first-page":"82","article-title":"Health expenditure per capita and in relation to GDP","year":"2016"},{"key":"10.1016\/S2213-8587(18)30203-1_bib32","series-title":"Regional strategy for universal health coverage","year":"2015"},{"key":"10.1016\/S2213-8587(18)30203-1_bib33","doi-asserted-by":"crossref","first-page":"j1420","DOI":"10.1136\/bmj.j1420","article-title":"Diabetes, cardiovascular disease, and chronic kidney disease in south Asia: current status and future directions","volume":"357","author":"Misra","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30203-1_bib34","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1038\/ejcn.2017.93","article-title":"Mysteries of type 2 diabetes: the Indian Elephant meets the Chinese Dragon","volume":"71","author":"Rhodes","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(18)30203-1_bib35","first-page":"224","article-title":"Diabetes scenario in a backward rural district population of India and need for restructuring of health care delivery services","volume":"6","author":"Kanungo","year":"2016","journal-title":"Epidemiology"},{"key":"10.1016\/S2213-8587(18)30203-1_bib36","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s40545-015-0041-7","article-title":"Access to and quality use of non-communicable diseases medicines in Nepal","volume":"8","author":"Bhuvan","year":"2015","journal-title":"J Pharm Policy Pract"},{"key":"10.1016\/S2213-8587(18)30203-1_bib37","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2471\/BLT.06.033647","article-title":"The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries","volume":"85","author":"Mendis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(18)30203-1_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/0976-0105.121653","article-title":"Evaluation of antidiabetic prescriptions, cost and adherence to treatment guidelines: a prospective, cross-sectional study at a tertiary care teaching hospital","volume":"4","author":"Acharya","year":"2013","journal-title":"J Basic Clin Pharm"},{"key":"10.1016\/S2213-8587(18)30203-1_bib39","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1038\/ejcn.2017.53","article-title":"Novel approaches for the promotion of physical activity and exercise for prevention and management of type 2 diabetes","volume":"71","author":"Arena","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(18)30203-1_bib40","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0140-6736(08)61404-X","article-title":"Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care","volume":"372","author":"Beaglehole","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30203-1_bib41","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1136\/bjsports-2015-094895","article-title":"Exercise prescription for patients with type 2 diabetes\u2014a synthesis of international recommendations: narrative review","volume":"50","author":"Mendes","year":"2016","journal-title":"Br J Sports Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib42","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s40279-012-0004-y","article-title":"Exercise prescription in the treatment of type 2 diabetes mellitus current practices, existing guidelines and future directions","volume":"43","author":"O'Hagan","year":"2013","journal-title":"Sports Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib43","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.pec.2011.08.013","article-title":"The reporting of previous lifestyle counseling by persons at high risk of type 2 diabetes","volume":"87","author":"Salmela","year":"2012","journal-title":"Patient Educ Couns"},{"key":"10.1016\/S2213-8587(18)30203-1_bib44","doi-asserted-by":"crossref","first-page":"2692","DOI":"10.2337\/dc10-1548","article-title":"Exercise and type 2 diabetes: the American College of Sports Medicine and the American Diabetes Association: joint position statement executive summary","volume":"33","author":"Colberg","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30203-1_bib45","doi-asserted-by":"crossref","first-page":"e55580","DOI":"10.1371\/journal.pone.0055580","article-title":"Joint prevalence of diabetes, impaired glucose regulation, cardiovascular disease risk and chronic kidney disease in south Asians and white Europeans","volume":"8","author":"Khunti","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30203-1_bib46","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/dme.12592","article-title":"Acknowledging and allocating responsibility for clinical inertia in the management of type 2 diabetes in primary care: a qualitative study","volume":"32","author":"Zafar","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib47","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/dc11-1116","article-title":"Perceiving need for lifestyle counseling: findings from Finnish individuals at high risk of type 2 diabetes","volume":"35","author":"Salmela","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30203-1_bib48","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/1753-0407.12316","article-title":"Socioeconomic factors relating to diabetes and its management in India","volume":"8","author":"Shrivastava","year":"2016","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(18)30203-1_bib49","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1186\/1479-5868-10-116","article-title":"Physical activity patterns among south-Asian adults: a systematic review","volume":"10","author":"Ranasinghe","year":"2013","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(18)30203-1_bib50","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/fampra\/cml066","article-title":"Promoting physical activity among south Asian women with coronary heart disease and diabetes: what might help?","volume":"24","author":"Sriskantharajah","year":"2007","journal-title":"Fam Pract"},{"key":"10.1016\/S2213-8587(18)30203-1_bib51","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2165\/00007256-200838100-00002","article-title":"Physical activity and prevention of type 2 diabetes mellitus","volume":"38","author":"Gill","year":"2008","journal-title":"Sports Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib52","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dme.12018","article-title":"Can diabetes prevention programmes be translated effectively into real-world settings and still deliver improved outcomes? A synthesis of evidence","volume":"30","author":"Johnson","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib53","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1177\/1559827615619341","article-title":"Prescribing a healthy lifestyle polypill with high therapeutic efficacy in many shapes and sizes","volume":"11","author":"Arena","year":"2015","journal-title":"Am J Lifestyle Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib55","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.healthpol.2009.02.003","article-title":"Capacity to control noncommunicable diseases in the countries of South-East Asia","volume":"92","author":"Leowski","year":"2009","journal-title":"Health Policy"},{"key":"10.1016\/S2213-8587(18)30203-1_bib56","first-page":"39","article-title":"An integrated approach to preventing cardiovascular disease: community-based approaches, health system initiatives, and public health policy","volume":"3","author":"Karwalajtys","year":"2010","journal-title":"Risk Manag Healthc Policy"},{"key":"10.1016\/S2213-8587(18)30203-1_bib57","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJM199504273321701","article-title":"Association of young maternal age with adverse reproductive outcomes","volume":"332","author":"Fraser","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib58","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1089\/met.2005.3.8","article-title":"Stress and metabolism","volume":"3","author":"Seematter","year":"2005","journal-title":"Metab Syndr Relat Disord"},{"key":"10.1016\/S2213-8587(18)30203-1_bib59","doi-asserted-by":"crossref","first-page":"5955","DOI":"10.3390\/nu6125955","article-title":"Sugar intake, obesity, and diabetes in India","volume":"6","author":"Gulati","year":"2014","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(18)30203-1_bib60","article-title":"In a first, Kerala imposes 14.5% \u2018fat tax\u2019 on junk food","author":"Bhushan","year":"2016","journal-title":"Economic Times"},{"key":"10.1016\/S2213-8587(18)30203-1_bib61","doi-asserted-by":"crossref","first-page":"e1001582","DOI":"10.1371\/journal.pmed.1001582","article-title":"Averting obesity and type 2 diabetes in India through sugar-sweetened beverage taxation: an economic-epidemiologic modeling study","volume":"11","author":"Basu","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib62","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1210\/er.2010-0028","article-title":"Childhood obesity in developing countries: epidemiology, determinants, and prevention","volume":"33","author":"Gupta","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(18)30203-1_bib63","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/dia.2011.0111","article-title":"Consensus physical activity guidelines for Asian Indians","volume":"14","author":"Misra","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(18)30203-1_bib64","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0140-6736(06)69703-1","article-title":"Epidemic obesity and type 2 diabetes in Asia","volume":"368","author":"Yoon","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30203-1_bib65","doi-asserted-by":"crossref","first-page":"505","DOI":"10.3945\/ajcn.112.042457","article-title":"Systematic review and meta-analysis of different dietary approaches to the management of type 2 diabetes","volume":"97","author":"Ajala","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(18)30203-1_bib66","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nut.2014.06.011","article-title":"Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base","volume":"31","author":"Feinman","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/S2213-8587(18)30203-1_bib67","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2013.08.005","article-title":"Effects of pistachio nuts on body composition, metabolic, inflammatory and oxidative stress parameters in Asian Indians with metabolic syndrome: a 24-wk, randomized control trial","volume":"30","author":"Gulati","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/S2213-8587(18)30203-1_bib68","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.diabres.2009.10.004","article-title":"The Kathmandu Declaration:\u201cLife Circle\u201d approach to prevention and care of diabetes mellitus","volume":"87","author":"Wijesuriya","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30203-1_bib69","series-title":"WHO child growth standards and the identification of severe acute malnutrition in infants and children","year":"2009"},{"key":"10.1016\/S2213-8587(18)30203-1_bib70","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1093\/eurheartj\/ehv207","volume":"36","author":"Arena","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(18)30203-1_bib71","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1080\/14779072.2016.1227703","article-title":"Creating a pro-active health care system to combat chronic diseases in Sri Lanka: the central role of preventive medicine and healthy lifestyle behaviors: an official policy statement of the European Society of Preventive Medicine","volume":"14","author":"Sagner","year":"2016","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/S2213-8587(18)30203-1_bib72","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1186\/s12889-015-2518-3","article-title":"Knowledge and perceptions about diet and physical activity among Sri Lankan adults with diabetes mellitus: a qualitative study","volume":"15","author":"Ranasinghe","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(18)30203-1_bib73","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1038\/ejcn.2009.150","article-title":"Effects of controlled school-based multi-component model of nutrition and lifestyle interventions on behavior modification, anthropometry and metabolic risk profile of urban Asian Indian adolescents in North India","volume":"64","author":"Singhal","year":"2010","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(18)30203-1_bib74","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S0007114510000681","article-title":"Improvement in nutrition-related knowledge and behaviour of urban Asian Indian school children: findings from the \u2018Medical education for children\/Adolescents for Realistic prevention of obesity and diabetes and for healthy aGeing\u2019 (MARG) intervention study","volume":"104","author":"Shah","year":"2010","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(18)30203-1_bib75","doi-asserted-by":"crossref","first-page":"e44098","DOI":"10.1371\/journal.pone.0044098","article-title":"Association of educational, occupational and socioeconomic status with cardiovascular risk factors in Asian Indians: a cross-sectional study","volume":"7","author":"Gupta","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30203-1_bib76","doi-asserted-by":"crossref","first-page":"2422","DOI":"10.2337\/diabetes.48.12.2422","article-title":"Insulin resistance syndrome in 8-year-old Indian children: small at birth, big at 8 years, or both?","volume":"48","author":"Bavdekar","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30203-1_bib77","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/dc11-0442","article-title":"Globalization of diabetes: the role of diet, lifestyle, and genes","volume":"34","author":"Hu","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30203-1_bib78","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/j.diabres.2012.04.024","article-title":"Gestational diabetes: the public health relevance and approach","volume":"97","author":"Veeraswamy","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30203-1_bib79","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11892-014-0489-x","article-title":"Long-term health outcomes in offspring born to women with diabetes in pregnancy","volume":"14","author":"Fraser","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(18)30203-1_bib80","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4103\/2230-8210.113720","article-title":"South Asian women with diabetes: psychosocial challenges and management: consensus statement","volume":"17","author":"Bajaj","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30203-1_bib81","doi-asserted-by":"crossref","first-page":"1830","DOI":"10.1016\/S0140-6736(18)30311-8","article-title":"Before the beginning: nutrition and lifestyle in the preconception period and its importance for future health","volume":"391","author":"Stephenson","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30203-1_bib82","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11892-018-1002-8","article-title":"Diabetes in south Asians: phenotype, clinical presentation, and natural history","volume":"18","author":"Unnikrishnan","year":"2018","journal-title":"Curr Diab Rep"},{"issue":"12 suppl 3","key":"10.1016\/S2213-8587(18)30203-1_bib83","first-page":"S9","article-title":"The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan\u2014common action area","volume":"54","author":"Nishtar","year":"2004","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/S2213-8587(18)30203-1_bib84","first-page":"1","article-title":"National diabetes action plan of Pakistan: need and challenges","volume":"7","author":"Sherin","year":"2015","journal-title":"Khyber Med Univ J"},{"key":"10.1016\/S2213-8587(18)30203-1_bib86","series-title":"Nepal Health Facility Survey 2015","year":"2017"},{"key":"10.1016\/S2213-8587(18)30203-1_bib87","series-title":"Type 2 diabetes: prevention in people at high risk","year":"2012"},{"key":"10.1016\/S2213-8587(18)30203-1_bib88","series-title":"Global recommendations on physical activity for health","year":"2010"},{"key":"10.1016\/S2213-8587(18)30203-1_bib89","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1111\/j.1753-0407.2011.00139.x","article-title":"Nutrition transition in India: secular trends in dietary intake and their relationship to diet-related non-communicable diseases","volume":"3","author":"Misra","year":"2011","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(18)30203-1_bib90","doi-asserted-by":"crossref","first-page":"3244","DOI":"10.1161\/CIRCULATIONAHA.109.192521","article-title":"Exercise training for type 2 diabetes mellitus: impact on cardiovascular risk: a scientific statement from the American Heart Association","volume":"119","author":"Marwick","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30203-1_bib91","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1186\/1471-2458-14-789","article-title":"High-intensity compared to moderate-intensity training for exercise initiation, enjoyment, adherence, and intentions: an intervention study","volume":"14","author":"Heinrich","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(18)30203-1_bib92","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1479-5868-11-26","article-title":"Physical activity and inactivity patterns in India\u2014results from the ICMR\u2013INDIAB study (phase-1) [ICMR-INDIAB-5]","volume":"11","author":"Anjana","year":"2014","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(18)30203-1_bib93","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1017\/S1368980014001086","article-title":"Risk perception is not associated with attendance at a preventive intervention for type 2 diabetes mellitus among south Asians at risk of diabetes","volume":"18","author":"Vlaar","year":"2015","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(18)30203-1_bib94","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/dme.12540","article-title":"Diabetes in south Asians","volume":"31","author":"Misra","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib95","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1007\/s00125-013-2969-y","article-title":"Lower cardiorespiratory fitness contributes to increased insulin resistance and fasting glycaemia in middle-aged south Asian compared with European men living in the UK","volume":"56","author":"Ghouri","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30203-1_bib96","first-page":"6","article-title":"Effects of exercise on insulin resistance in south Asians and Europeans","volume":"3","author":"Davey","year":"2000","journal-title":"J Exerc Physiol"},{"issue":"3 suppl","key":"10.1016\/S2213-8587(18)30203-1_bib97","doi-asserted-by":"crossref","first-page":"289S","DOI":"10.1080\/07315724.2010.10719844","article-title":"Obesity, the metabolic syndrome, and type 2 diabetes in developing countries: role of dietary fats and oils","volume":"29","author":"Misra","year":"2010","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/S2213-8587(18)30203-1_bib98","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/ejcn.2017.92","article-title":"Abdominal obesity and type 2 diabetes in Asian Indians: dietary strategies including edible oils, cooking practices and sugar intake","volume":"71","author":"Gulati","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(18)30203-1_bib99","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1161\/CIRCULATIONAHA.114.008729","article-title":"Cardiovascular diseases in India: current epidemiology and future directions","volume":"133","author":"Prabhakaran","year":"2016","journal-title":"Circulation"},{"issue":"12 suppl 3","key":"10.1016\/S2213-8587(18)30203-1_bib100","first-page":"S1","article-title":"The National Action Plan for the Prevention and Control of Non-communicable Diseases and Health Promotion in Pakistan\u2014prelude and finale","volume":"54","author":"Nishtar","year":"2004","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/S2213-8587(18)30203-1_bib101","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-006-0219-2","article-title":"Secular trends in the prevalence of diabetes and impaired glucose tolerance in urban South India\u2014the Chennai Urban Rural Epidemiology Study (CURES-17)","volume":"49","author":"Mohan","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30203-1_bib103","series-title":"Multisectoral Action Plan for the Prevention and Control of Non-Communicable Diseases (2014\u20132020)","year":"2014"},{"key":"10.1016\/S2213-8587(18)30203-1_bib104","series-title":"National Policy and Strategic Frame-Work on Prevention and Control of Non-Communicable Diseases","year":"2009"},{"key":"10.1016\/S2213-8587(18)30203-1_bib105","doi-asserted-by":"crossref","first-page":"e0118365","DOI":"10.1371\/journal.pone.0118365","article-title":"Awareness, treatment, and control of diabetes in Bangladesh: a nationwide population-based study","volume":"10","author":"Rahman","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30203-1_bib106","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.healthpol.2010.09.004","article-title":"Noncommunicable chronic disease in Bangladesh: overview of existing programs and priorities going forward","volume":"100","author":"Bleich","year":"2011","journal-title":"Health Policy"},{"key":"10.1016\/S2213-8587(18)30203-1_bib108","first-page":"225","article-title":"Non-communicable diseases in Nepal: challenges and opportunities","volume":"11","author":"Neupane","year":"2013","journal-title":"J Nepal Health Res Counc"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30203-1_bib109","doi-asserted-by":"crossref","first-page":"S67","DOI":"10.4103\/0970-0218.94712","article-title":"Integrating services for noncommunicable diseases prevention and control: use of primary health care approach","volume":"36","author":"Narain","year":"2011","journal-title":"Indian J Community Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib110","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrendo.2016.53","article-title":"Diabetes mellitus and its complications in India","volume":"12","author":"Unnikrishnan","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(18)30203-1_bib111","doi-asserted-by":"crossref","first-page":"2708","DOI":"10.3390\/nu5072708","article-title":"Obesity and dyslipidemia in south Asians","volume":"5","author":"Misra","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(18)30203-1_bib112","doi-asserted-by":"crossref","first-page":"140421","DOI":"10.5888\/pcd12.140421","article-title":"Use of culturally focused theoretical frameworks for adapting diabetes prevention programs: a qualitative review","volume":"12","author":"Thompson","year":"2015","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/S2213-8587(18)30203-1_bib113","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1080\/17437199.2014.941997","article-title":"Quantifying the strength of the associations of prototype perceptions with behaviour, behavioural willingness and intentions: a meta-analysis","volume":"10","author":"van Lettow","year":"2016","journal-title":"Health Psychol Rev"},{"key":"10.1016\/S2213-8587(18)30203-1_bib114","doi-asserted-by":"crossref","first-page":"e000126","DOI":"10.1136\/bmjdrc-2015-000126","article-title":"Engaging south Asian women with type 2 diabetes in a culturally relevant exercise intervention: a randomized controlled trial","volume":"3","author":"Natesan","year":"2015","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(18)30203-1_bib115","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1249\/MSS.0000000000000906","article-title":"Effectiveness of exercise on visceral adipose tissue in older south Asian women","volume":"48","author":"Lesser","year":"2016","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(18)30203-1_bib116","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1161\/CIRCULATIONAHA.115.015373","article-title":"A cluster-randomized, controlled trial of a simplified multifaceted management program for individuals at high cardiovascular risk (SimCard trial) in rural Tibet, China, and Haryana, India","volume":"132","author":"Tian","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30203-1_bib117","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.diabres.2012.09.023","article-title":"Improving diabetes care: multi-component cardiovascular disease risk reduction strategies for people with diabetes in south Asia\u2014the CARRS multi-center translation trial","volume":"98","author":"Shah","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30203-1_bib118","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.114.010636","article-title":"Estimated global, regional, and national disease burdens related to sugar-sweetened beverage consumption in 2010","volume":"132","author":"Singh","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30203-1_bib119","doi-asserted-by":"crossref","first-page":"399","DOI":"10.7326\/M15-2807","article-title":"Effectiveness of a multicomponent quality improvement strategy to improve achievement of diabetes care goals: a randomized, controlled trial","volume":"165","author":"Ali","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib120","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/fampra\/cmi069","article-title":"Empowering patients with diabetes: a qualitative primary care study focusing on south Asians in Leicester, UK","volume":"22","author":"Stone","year":"2005","journal-title":"Fam Pract"},{"key":"10.1016\/S2213-8587(18)30203-1_bib121","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1016\/j.amjcard.2013.05.064","article-title":"Cardiovascular risk factor control and adherence to recommended lifestyle and medical therapies in persons with coronary heart disease (from the National Health and Nutrition Examination Survey 2007\u20132010)","volume":"112","author":"Tang","year":"2013","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(18)30203-1_bib122","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.diabres.2017.01.004","article-title":"Health education on diabetes and other non-communicable diseases imparted to teachers shows a cascading effect. A study from southern India","volume":"125","author":"Selvam","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30203-1_bib123","doi-asserted-by":"crossref","first-page":"82","DOI":"10.4103\/2224-3151.206170","article-title":"Motivating and demotivating factors for community health workers: a qualitative study in urban slums of Delhi, India","volume":"6","author":"George","year":"2017","journal-title":"WHO South East Asia J Public Health"},{"key":"10.1016\/S2213-8587(18)30203-1_bib124","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s12960-016-0163-2","article-title":"The global pendulum swing towards community health workers in low- and middle-income countries: a scoping review of trends, geographical distribution and programmatic orientations, 2005 to 2014","volume":"14","author":"Schneider","year":"2016","journal-title":"Hum Resour Health"},{"key":"10.1016\/S2213-8587(18)30203-1_bib125","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1177\/0145721712459890","article-title":"A community-based participatory diabetes prevention and management intervention in rural India using community health workers","volume":"38","author":"Balagopal","year":"2012","journal-title":"Diabetes Educ"},{"key":"10.1016\/S2213-8587(18)30203-1_bib126","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1177\/175797590701400103","article-title":"The Heartfile Lodhran CVD prevention project\u2014end of project evaluation","volume":"14","author":"Nishtar","year":"2007","journal-title":"Promot Educ"},{"key":"10.1016\/S2213-8587(18)30203-1_bib127","doi-asserted-by":"crossref","first-page":"c2641","DOI":"10.1136\/bmj.c2641","article-title":"Community based lifestyle intervention for blood pressure reduction in children and young adults in developing country: cluster randomised controlled trial","volume":"340","author":"Jafar","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30203-1_bib128","doi-asserted-by":"crossref","first-page":"2096","DOI":"10.1016\/j.socscimed.2008.01.046","article-title":"Producing effective knowledge agents in a pluralistic environment: what future for community health workers?","volume":"66","author":"Standing","year":"2008","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(18)30203-1_bib129","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1093\/heapol\/czu126","article-title":"Which intervention design factors influence performance of community health workers in low- and middle-income countries? A systematic review","volume":"30","author":"Kok","year":"2015","journal-title":"Health Policy Plan"},{"key":"10.1016\/S2213-8587(18)30203-1_bib130","series-title":"Multisectoral preventive health services in Sri Lanka: lessons for developing countries in providing public goods in health. World Bank Policy Research Working Paper","author":"Das Gupta","year":"2013"},{"key":"10.1016\/S2213-8587(18)30203-1_bib131","series-title":"Package of essential noncommunicable (PEN) disease interventions for primary health care in low-resource settings","year":"2010"},{"key":"10.1016\/S2213-8587(18)30203-1_bib132","doi-asserted-by":"crossref","first-page":"154","DOI":"10.4103\/2224-3151.206731","article-title":"Package of essential noncommunicable disease (PEN) interventions in primary health-care settings of Bhutan: a performance assessment study","volume":"3","author":"Wangchuk","year":"2014","journal-title":"WHO South East Asia J Public Health"},{"key":"10.1016\/S2213-8587(18)30203-1_bib133","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2337\/dc16-1241","article-title":"The stepwise approach to diabetes prevention: results from the D-CLIP randomized controlled trial","volume":"39","author":"Weber","year":"2016","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30203-1_bib134","first-page":"S90","article-title":"The two levels of care for diabetes in a developing country: mechanisms for improved intermediate health outcomes","volume":"10","author":"Vitale","year":"2015","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(18)30203-1_bib135","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1377\/hlthaff.2015.0403","article-title":"Innovations in diabetes care around the world: case studies of care transformation through accountable care reforms","volume":"34","author":"Thoumi","year":"2015","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/S2213-8587(18)30203-1_bib136","first-page":"759","article-title":"A simplified Indian Diabetes Risk Score for screening for undiagnosed diabetic subjects","volume":"53","author":"Mohan","year":"2005","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(18)30203-1_bib137","doi-asserted-by":"crossref","first-page":"29088","DOI":"10.3402\/gha.v8.29088","article-title":"Prevalence of type 2 diabetes in Nepal: a systematic review and meta-analysis from 2000 to 2014","volume":"8","author":"Gyawali","year":"2015","journal-title":"Glob Health Action"},{"key":"10.1016\/S2213-8587(18)30203-1_bib138","first-page":"163","article-title":"Consensus statement for diagnosis of obesity, abdominal obesity and the metabolic syndrome for Asian Indians and recommendations for physical activity, medical and surgical management","volume":"57","author":"Misra","year":"2009","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(18)30203-1_bib139","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1464-5491.2012.03669.x","article-title":"Insulin initiation and management in people with type 2 diabetes in an ethnically diverse population: the healthcare provider perspective","volume":"29","author":"Patel","year":"2012","journal-title":"Diabet Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:21Z","timestamp":1761991641000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302031"}},"issued":{"date-parts":[[2018,12]]},"references-count":135,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2213858718302031"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30203-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Public health and health systems: implications for the prevention and management of type 2 diabetes in south Asia","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30203-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30199-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30204-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:12:52Z","timestamp":1778764372005,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/s2213-8587(26)00012-4","type":"journal-article","created":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T22:40:19Z","timestamp":1776465619000},"page":"438-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["What REDEFINE 5 signals for obesity trials in Asia and beyond"],"prefix":"10.1016","volume":"14","author":[{"given":"Yu Mi","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanita R","family":"Aroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00012-4_bib1","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00012-4_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7570\/jomes23031","article-title":"Diagnosis of obesity: 2022 update of Clinical Practice Guidelines for Obesity by the Korean Society for the Study of Obesity","volume":"32","author":"Haam","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/S2213-8587(26)00012-4_bib3","doi-asserted-by":"crossref","first-page":"102989","DOI":"10.1016\/j.dsx.2024.102989","article-title":"Revised definition of obesity in Asian Indians living in India","volume":"19","author":"Misra","year":"2025","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(26)00012-4_bib4","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1507\/endocrj.EJ23-0593","article-title":"Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan","volume":"71","author":"Ogawa","year":"2024","journal-title":"Endocr J"},{"key":"10.1016\/S2213-8587(26)00012-4_bib5","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00012-4_bib6","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00012-4_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00402-4","article-title":"Efficacy and safety of co-administered cagrilintide and semaglutide versus semaglutide alone in adults with overweight or obesity with or without type 2 diabetes in Japan and Taiwan (REDEFINE 5): a multicentre, randomised, active-controlled, phase 3a trial","author":"Yamauchi","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00012-4_bib8","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa2502081","article-title":"Coadministered cagrilintide and semaglutide in adults with overweight or obesity","volume":"393","author":"Garvey","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00012-4_bib9","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000580","article-title":"Atherosclerotic cardiovascular disease in south Asians in the United States: epidemiology, risk factors, and treatments: a scientific statement from the American Heart Association","volume":"138","author":"Volgman","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(26)00012-4_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S2213-8587(22)00008-0","article-title":"Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial","volume":"10","author":"Kadowaki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00012-4_bib11","doi-asserted-by":"crossref","first-page":"838","DOI":"10.1016\/S2213-8587(25)00164-0","article-title":"Once-weekly semaglutide 2\u00b74 mg in an Asian population with obesity, defined as BMI \u226525 kg\/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"13","author":"Lim","year":"2025","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000124?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000124?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:53:03Z","timestamp":1778763183000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000124"}},"issued":{"date-parts":[[2026,6]]},"references-count":11,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2213858726000124"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00012-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What REDEFINE 5 signals for obesity trials in Asia and beyond","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00012-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00402-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:46:24Z","timestamp":1767149184198,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(20)30153-4","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/s2213-8587(22)00082-1","type":"journal-article","created":{"date-parts":[[2022,3,21]],"date-time":"2022-03-21T19:53:48Z","timestamp":1647892428000},"page":"e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2020; 8: 594\u2013605"],"prefix":"10.1016","volume":"10","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:08Z","timestamp":1761991808000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000821"}},"issued":{"date-parts":[[2022,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2213858722000821"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00082-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2020; 8: 594\u2013605","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00082-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30153-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,6]],"date-time":"2026-06-06T19:16:31Z","timestamp":1780773391178,"version":"3.54.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/s2213-8587(19)30065-8","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T18:48:53Z","timestamp":1551984533000},"page":"337","source":"Crossref","is-referenced-by-count":12,"title":["GLP-1 and the renin\u2013angiotensin\u2013aldosterone system"],"prefix":"10.1016","volume":"7","author":[{"given":"David Le\u00f3n","family":"Jim\u00e9nez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel Camafort","family":"Babkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Pablo","family":"Miramontes Gonz\u00e1lez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30065-8_bib1","article-title":"New pharmacological strategies for protecting kidney function in type 2 diabetes","author":"Muskiet","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30065-8_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.12651","article-title":"Short-term effects of liraglutide on kidney function and vasoactive hormones in type 2 diabetes: a randomized clinical trial","volume":"18","author":"Skov","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30065-8_bib3","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2014.00023","article-title":"Tissue renin\u2013angiotensin systems: a unifying hypothesis of metabolic disease","volume":"5","author":"Skov","year":"2014","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(19)30065-8_bib4","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2337\/dc16-1371","article-title":"Renal effects of DPP-4 inhibitor sitagliptin or GLP-1 receptor agonist liraglutide in overweight patients with type 2 diabetes: a 12-week, randomized, double-blind, placebo-controlled trial","volume":"39","author":"Tonneijck","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30065-8_bib5","doi-asserted-by":"crossref","first-page":"E664","DOI":"10.1210\/jc.2012-3855","article-title":"Glucagon-like peptide-1 (GLP-1): effect on kidney hemodynamics and renin\u2013angiotensin\u2013aldosterone system in healthy men","volume":"98","author":"Skov","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T00:09:32Z","timestamp":1571098172000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300658"}},"issued":{"date-parts":[[2019,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2213858719300658"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30065-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,5]]}},{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T17:54:42Z","timestamp":1767894882614,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/s2213-8587(19)30060-9","type":"journal-article","created":{"date-parts":[[2019,2,18]],"date-time":"2019-02-18T23:35:22Z","timestamp":1550532922000},"page":"242-243","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Exploring the use of metformin in pregnant women with polycystic ovary syndrome: new evidence, new wisdom"],"prefix":"10.1016","volume":"7","author":[{"given":"Lourdes","family":"Ib\u00e1\u00f1ez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francis","family":"de Zegher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30060-9_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/j.fertnstert.2017.06.015","article-title":"Increased rates of complications in singleton pregnancies of women previously diagnosed with polycystic ovary syndrome predominantly in the hyperandrogenic phenotype","volume":"108","author":"de Wilde","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(19)30060-9_bib2","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1210\/jc.2018-01787","article-title":"Pre-conception characteristics predict obstetrical and neonatal outcomes in women with polycystic ovary syndrome","volume":"104","author":"Christ","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30060-9_bib3","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1093\/humrep\/deh109","volume":"19","author":"Glueck","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(19)30060-9_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1210\/jcem.87.2.8207","article-title":"Effects of metformin on early pregnancy loss in the polycystic ovary syndrome","volume":"87","author":"Jakubowicz","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30060-9_bib5","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1093\/humrep\/deh347","article-title":"Metformin reduces pregnancy complications without affecting androgen levels in pregnant polycystic ovary syndrome women: results of a randomized study","volume":"19","author":"Vanky","year":"2004","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(19)30060-9_bib6","doi-asserted-by":"crossref","first-page":"E448","DOI":"10.1210\/jc.2010-0853","article-title":"Metformin versus placebo from first trimester to delivery in polycystic ovary syndrome: a randomized, controlled multicenter study","volume":"95","author":"Vanky","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30060-9_bib7","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1111\/aogs.12015","article-title":"On the potential of metformin to prevent preterm delivery in women with polycystic ovary syndrome\u2014an epi-analysis","volume":"91","author":"Vanky","year":"2012","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S2213-8587(19)30060-9_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30002-6","article-title":"Use of metformin to treat pregnant women with polycystic ovary syndrome (PregMet2): a randomised, double-blind, placebo-controlled trial","author":"L\u00f8vvik","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30060-9_bib9","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.tem.2018.09.005","article-title":"Central obesity, faster maturation, and \u2018PCOS\u2019 in girls","volume":"29","author":"de Zegher","year":"2018","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30060-9_bib10","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1001\/jama.287.19.2534","article-title":"Association of a woman's own birth weight with subsequent risk for gestational diabetes","volume":"287","author":"Innes","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30060-9_bib11","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1530\/EC-18-0076","article-title":"Polycystic ovary syndrome and risk factors for gestational diabetes","volume":"7","author":"Mustaniemi","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(19)30060-9_bib12","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1210\/js.2018-00200","article-title":"A pre-pregnancy biomarker risk score improves prediction of future gestational diabetes","volume":"2","author":"Badon","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(19)30060-9_bib13","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1007\/s00125-018-4779-8","article-title":"Non-alcoholic fatty liver disease in the first trimester and subsequent development of gestational diabetes mellitus","volume":"62","author":"Lee","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30060-9_bib14","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.jadohealth.2017.04.010","article-title":"Normalizing ovulation rate by preferential reduction of hepato-visceral fat in adolescent girls with polycystic ovary syndrome","volume":"61","author":"Ib\u00e1\u00f1ez","year":"2017","journal-title":"J Adolesc Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300609?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300609?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T15:21:41Z","timestamp":1553095301000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300609"}},"issued":{"date-parts":[[2019,4]]},"references-count":14,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S2213858719300609"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30060-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the use of metformin in pregnant women with polycystic ovary syndrome: new evidence, new wisdom","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30060-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30002-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:38Z","timestamp":1761991958525,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,3,1]],"date-time":"2021-03-01T00:00:00Z","timestamp":1614556800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,3]]},"DOI":"10.1016\/s2213-8587(21)00021-8","type":"journal-article","created":{"date-parts":[[2021,2,17]],"date-time":"2021-02-17T13:50:17Z","timestamp":1613569817000},"page":"139-140","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Positioning newer drugs in the management of type 2 diabetes"],"prefix":"10.1016","volume":"9","author":[{"given":"Nikolaus","family":"Marx","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie J","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter J","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John R","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Cosentino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John B","family":"Buse","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00021-8_bib1","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2213-8587(20)30343-0","article-title":"Guideline recommendations and the positioning of newer drugs in type 2 diabetes care","volume":"9","author":"Marx","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00021-8_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2337\/dci19-0066","article-title":"2019 update to: Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"43","author":"Buse","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00021-8_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00021-8_bib4","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1016\/S0140-6736(20)32523-X","article-title":"First-line treatment for type 2 diabetes: is it too early to abandon metformin?","volume":"396","author":"Zaccardi","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00021-8_bib5","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1111\/dom.13938","article-title":"Are the cardiovascular and kidney benefits of empagliflozin influenced by baseline glucose-lowering therapy?","volume":"22","author":"Inzucchi","year":"2020","journal-title":"Diabetes Obes Metab"},{"author":"Neuen","key":"10.1016\/S2213-8587(21)00021-8_bib6"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:57Z","timestamp":1761991737000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000218"}},"issued":{"date-parts":[[2021,3]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2021,3]]}},"alternative-id":["S2213858721000218"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00021-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Positioning newer drugs in the management of type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00021-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30343-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00022-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,25]],"date-time":"2026-01-25T03:37:17Z","timestamp":1769312237683,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000738","name":"US Department of Veterans Affairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000738","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/s2213-8587(22)00324-2","type":"journal-article","created":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T21:20:25Z","timestamp":1669929625000},"page":"11-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Diabetes after SARS-CoV-2 infection"],"prefix":"10.1016","volume":"11","author":[{"given":"Ziyad","family":"Al-Aly","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00324-2_bib1","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(22)00324-2_bib2","doi-asserted-by":"crossref","first-page":"6571","DOI":"10.1038\/s41467-021-26513-3","article-title":"Burdens of post-acute sequelae of COVID-19 by severity of acute infection, demographics and health status","volume":"12","author":"Xie","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(22)00324-2_bib3","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S2213-8587(22)00044-4","article-title":"Risks and burdens of incident diabetes in long COVID: a cohort study","volume":"10","author":"Xie","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00324-2_bib4","doi-asserted-by":"crossref","first-page":"713","DOI":"10.15585\/mmwr.mm7121e1","article-title":"Post\u2013COVID conditions among adult COVID-19 survivors aged 18\u201364 and \u226565 years \u2014 United States, March 2020\u2013November 2021","volume":"71","author":"Bull-Otterson","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S2213-8587(22)00324-2_bib5","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00125-022-05670-0","article-title":"Incidence of newly diagnosed diabetes after Covid-19","volume":"65","author":"Rathmann","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00324-2_bib6","doi-asserted-by":"crossref","first-page":"59","DOI":"10.15585\/mmwr.mm7102e2","article-title":"Risk for newly diagnosed diabetes >30 days after SARS-CoV-2 infection among persons aged <18 years - United States, March 1, 2020-June 28, 2021","volume":"71","author":"Barrett","year":"2022","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S2213-8587(22)00324-2_bib7","article-title":"Relation of Incident Type 1 Diabetes to Recent COVID-19 Infection: Cohort Study Using e-Health Record Linkage in Scotland","author":"McKeigue","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00324-2_bib8","doi-asserted-by":"crossref","first-page":"e1004052","DOI":"10.1371\/journal.pmed.1004052","article-title":"Cardiometabolic outcomes up to 12 months after COVID-19 infection. A matched cohort study in the UK","volume":"19","author":"Rezel-Potts","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(22)00324-2_bib9","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-01840-0","article-title":"Long COVID after breakthrough SARS-CoV-2 infection","volume":"28","author":"Al-Aly","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(22)00324-2_bib10","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/s41591-022-02051-3","article-title":"Acute and postacute sequelae associated with SARS-CoV-2 reinfection","volume":"28","author":"Bowe","year":"2022","journal-title":"Nat Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003242?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003242?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:59Z","timestamp":1761991919000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003242"}},"issued":{"date-parts":[[2023,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213858722003242"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00324-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes after SARS-CoV-2 infection","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00324-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T11:54:57Z","timestamp":1771588497662,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,4]]},"DOI":"10.1016\/s2213-8587(19)30064-6","type":"journal-article","created":{"date-parts":[[2019,2,23]],"date-time":"2019-02-23T18:26:22Z","timestamp":1550946382000},"page":"243-245","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Definitions of intermediate hyperglycaemia and progression to type 2 diabetes"],"prefix":"10.1016","volume":"7","author":[{"given":"Jaakko","family":"Tuomilehto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30064-6_bib1","series-title":"Second report. Technical report Series 646","year":"1980"},{"key":"10.1016\/S2213-8587(19)30064-6_bib2","series-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consulation","year":"2006"},{"key":"10.1016\/S2213-8587(19)30064-6_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30058-0","article-title":"Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil","author":"Schmidt","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30064-6_bib4","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jamainternmed.2017.6040","article-title":"Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials","volume":"177","author":"Haw","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(19)30064-6_bib5","doi-asserted-by":"crossref","first-page":"1352","DOI":"10.1001\/archinternmed.2011.275","article-title":"Lifestyle modification and prevention of type 2 diabetes in overweight Japanese with impaired fasting glucose levels: a randomized controlled trial","volume":"171","author":"Saito","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(19)30064-6_bib6","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2337\/dc09-1524","article-title":"Prevalence of diabetes and high risk for diabetes using A1C criteria in the US population in 1988\u20132006","volume":"33","author":"Cowie","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30064-6_bib7","series-title":"Abbreviated report of a WHO consultation. Use of glycated hemoglobin (HbA1c) in the diagnosis if diabetes mellitus","year":"2011"},{"key":"10.1016\/S2213-8587(19)30064-6_bib8","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.2337\/dc17-0245","article-title":"The prognostic value of fasting plasma glucose, two-hour postload glucose, and HbA1c in patients with coronary artery disease: a report from EUROASPIRE IV: a survey from the European Society of Cardiology","volume":"40","author":"Shahim","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30064-6_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1055\/s-0028-1087203","article-title":"Tools for predicting the risk of type 2 diabetes in daily practice","volume":"41","author":"Schwarz","year":"2009","journal-title":"Horm Metab Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,20]],"date-time":"2019-03-20T15:21:57Z","timestamp":1553095317000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300646"}},"issued":{"date-parts":[[2019,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2019,4]]}},"alternative-id":["S2213858719300646"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30064-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Definitions of intermediate hyperglycaemia and progression to type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30064-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30058-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T00:59:31Z","timestamp":1775091571778,"version":"3.50.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/s2213-8587(20)30181-9","type":"journal-article","created":{"date-parts":[[2020,5,15]],"date-time":"2020-05-15T21:25:55Z","timestamp":1589577955000},"page":"571","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":21,"title":["How diabetes management is adapting amid the COVID-19 pandemic"],"prefix":"10.1016","volume":"8","author":[{"given":"Peter","family":"Ranscombe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:22Z","timestamp":1761991702000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301819"}},"issued":{"date-parts":[[2020,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2213858720301819"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30181-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How diabetes management is adapting amid the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30181-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:24Z","timestamp":1761991944716,"version":"build-2065373602"},"reference-count":4,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/s2213-8587(20)30154-6","type":"journal-article","created":{"date-parts":[[2020,4,28]],"date-time":"2020-04-28T18:32:30Z","timestamp":1588098750000},"page":"473-474","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Managing diabetes in Qatar during the COVID-19 pandemic"],"prefix":"10.1016","volume":"8","author":[{"given":"Shahrad","family":"Taheri","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Odette","family":"Chagoury","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Tourette","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ioanna","family":"Skaroni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Manal","family":"Othman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Bashir","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Khaled","family":"Dukhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dabia","family":"Al Mohannadi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dahlia","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wissam","family":"Ghadban","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mahmoud","family":"Zirie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Samya","family":"Al-Abdulla","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdul B","family":"Abou-Samra","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30154-6_bib1","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/S0140-6736(20)30183-5","article-title":"Clinical features of patients infected with 2019 novel coronavirus in Wuhan, China","volume":"395","author":"Huang","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30154-6_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14300","article-title":"COVID-19 and diabetes","author":"Ma","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(20)30154-6_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2020.03.017","article-title":"Prevalence of comorbidities in the novel Wuhan coronavirus (COVID-19) infection: a systematic review and meta-analysis","author":"Yang","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/S2213-8587(20)30154-6_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta23020","article-title":"Vitamin D supplementation to prevent acute respiratory infections: individual participant data meta-analysis","volume":"23","author":"Martineau","year":"2019","journal-title":"Health Technol Assess"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:39Z","timestamp":1761991719000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301546"}},"issued":{"date-parts":[[2020,6]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2213858720301546"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30154-6","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing diabetes in Qatar during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30154-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T08:18:51Z","timestamp":1771575531782,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/s2213-8587(24)00071-8","type":"journal-article","created":{"date-parts":[[2024,4,23]],"date-time":"2024-04-23T22:32:25Z","timestamp":1713911545000},"page":"301-302","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Rethinking the label anti-obesity medication"],"prefix":"10.1016","volume":"12","author":[{"given":"Stuart W","family":"Flint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00071-8_bib1","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00071-8_bib2","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00071-8_bib3","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00071-8_bib4","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00071-8_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12470","article-title":"Preferences and emotional response to weight-related terminology used by healthcare professionals to describe body weight in people living with overweight and obesity","volume":"11","author":"Brown","year":"2021","journal-title":"Clin Obes"},{"key":"10.1016\/S2213-8587(24)00071-8_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101408","article-title":"Pervasiveness, impact and implications of weight stigma","volume":"47","author":"Brown","year":"2022","journal-title":"EClinicalMedicine"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(24)00131-1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:46:08Z","timestamp":1715039168000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000718"}},"issued":{"date-parts":[[2024,5]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2213858724000718"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00071-8","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/S2213-8587(24)00131-1","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rethinking the label anti-obesity medication","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00071-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,21]],"date-time":"2026-04-21T04:09:58Z","timestamp":1776744598493,"version":"3.51.2"},"reference-count":13,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/s2213-8587(17)30405-9","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T18:34:38Z","timestamp":1516386878000},"page":"681-683","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Keeping it off: the challenge of weight-loss maintenance"],"prefix":"10.1016","volume":"6","author":[{"given":"Michael","family":"Lean","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Hankey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30405-9_bib1","series-title":"Management of obesity","year":"2010"},{"key":"10.1016\/S2213-8587(17)30405-9_bib2","doi-asserted-by":"crossref","first-page":"1188","DOI":"10.1038\/ijo.2015.59","article-title":"Physiological adaptions to weight loss and factors favouring weight regain","volume":"39","author":"Greenaway","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(17)30405-9_bib3","doi-asserted-by":"crossref","first-page":"g2646","DOI":"10.1136\/bmj.g2646","article-title":"Long term maintenance of weight loss with non-surgical interventions in obese adults: systematic review and meta-analyses of randomised controlled trials","volume":"348","author":"Dombrowski","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30405-9_bib4","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1080\/10408398.2014.922044","article-title":"Weighing the evidence of common beliefs in obesity research","volume":"55","author":"Casazza","year":"2015","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/S2213-8587(17)30405-9_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/17437199.2017.1299583","article-title":"Understanding the challenge of weight loss maintenance: a systematic review and synthesis of qualitative research on weight loss maintenance","volume":"11","author":"Greaves","year":"2017","journal-title":"Health Psychol Rev"},{"key":"10.1016\/S2213-8587(17)30405-9_bib6","series-title":"Type 2 diabetes in adults: management. NICE guideline [NG28]","year":"2017"},{"key":"10.1016\/S2213-8587(17)30405-9_bib7","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1007\/s11695-013-0892-4","article-title":"Weight loss and weight regain\u20145-year follow-up for circular- vs. linear-stapled gastrojejunostomy in laparoscopic Roux-en-Y gastric bypass","volume":"23","author":"Langer","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30405-9_bib8","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/cob.12131","article-title":"Interest, views and perceived barriers to bariatric surgery in patients with morbid obesity","volume":"6","author":"Wharton","year":"2016","journal-title":"Clin Obes"},{"key":"10.1016\/S2213-8587(17)30405-9_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1111\/j.1758-8111.2011.00006.x","article-title":"Comparison of a low-energy diet and a very low-energy diet in sedentary obese individuals: a pragmatic randomized controlled trial","volume":"1","author":"Christensen","year":"2011","journal-title":"Clin Obes"},{"key":"10.1016\/S2213-8587(17)30405-9_bib10","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1046\/j.1467-789x.2000.00004.x","article-title":"Lessons from obesity management programmes: greater initial weight loss improves long-term maintenance","volume":"1","author":"Astrup","year":"2000","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30405-9_bib11","doi-asserted-by":"crossref","first-page":"3957","DOI":"10.2903\/j.efsa.2015.3957","article-title":"Scientific opinion on the essential composition of total diet replacements for weight control","volume":"13","year":"2015","journal-title":"EFSA Journal"},{"key":"10.1016\/S2213-8587(17)30405-9_bib12","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3945\/ajcn.113.070052","article-title":"Effects of anti-obesity drugs, diet, and exercise on weight-loss maintenance after a very-low-calorie diet or low-calorie diet: a systematic review and meta-analysis of randomized controlled trials","volume":"99","author":"Johansson","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30405-9_bib13","doi-asserted-by":"crossref","DOI":"10.3945\/ajcn.117.157446","article-title":"Comparison among criteria to define successful weight-loss maintainersand regainers in the Action for Health in Diabetes (Look AHEAD) and Diabetes Prevention Program trials","author":"Berger","year":"2017","journal-title":"Am J Clin Nutr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:06Z","timestamp":1761991566000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717304059"}},"issued":{"date-parts":[[2018,9]]},"references-count":13,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2213858717304059"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30405-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Keeping it off: the challenge of weight-loss maintenance","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30405-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,7]],"date-time":"2026-04-07T00:57:13Z","timestamp":1775523433907,"version":"3.50.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/s2213-8587(13)70206-7","type":"journal-article","created":{"date-parts":[[2013,12,5]],"date-time":"2013-12-05T10:00:49Z","timestamp":1386237649000},"page":"e3","source":"Crossref","is-referenced-by-count":1,"title":["Correction to Lancet Diabetes Endocrinol 2013; 1: 275\u201383"],"prefix":"10.1016","volume":"2","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713702067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713702067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T03:35:54Z","timestamp":1548646554000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713702067"}},"issued":{"date-parts":[[2014,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S2213858713702067"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70206-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,1]]}},{"indexed":{"date-parts":[[2026,2,14]],"date-time":"2026-02-14T05:58:30Z","timestamp":1771048710467,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"crossref","award":["2017YFC0907504"],"award-info":[{"award-number":["2017YFC0907504"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001809","name":"National Nature Science Foundation of China","doi-asserted-by":"crossref","award":["no. 81773517"],"award-info":[{"award-number":["no. 81773517"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Hubei Province Science Fund for Distinguished Young Scholars","award":["2018CFA033"],"award-info":[{"award-number":["2018CFA033"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/s2213-8587(19)30159-7","type":"journal-article","created":{"date-parts":[[2019,5,10]],"date-time":"2019-05-10T18:29:05Z","timestamp":1557512945000},"page":"502-503","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Dietary transitions and cardiometabolic health in China"],"prefix":"10.1016","volume":"7","author":[{"given":"Xiong-Fei","family":"Pan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"An","family":"Pan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"Suppl 1","key":"10.1016\/S2213-8587(19)30159-7_bib1","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/obr.12120","article-title":"Synthesis and implications: China's nutrition transition in the context of changes across other low- and middle-income countries","volume":"15","author":"Popkin","year":"2014","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(19)30159-7_bib2","article-title":"Health effects of dietary risks in 195 countries, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30159-7_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30152-4","article-title":"The dietary transition and its association with cardiometabolic mortality among Chinese adults, 1982\u20132012: a cross-sectional population-based study","author":"He","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30159-7_bib4","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.jacc.2016.06.011","article-title":"Potential impact of time trend of life-style factors on cardiovascular disease burden in China","volume":"68","author":"Li","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30159-7_bib5","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.2337\/dc17-0571","article-title":"Time trends of dietary and lifestyle factors and their potential impact on diabetes burden in China","volume":"40","author":"Li","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30159-7_bib6","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1161\/CIRCULATIONAHA.115.008728","article-title":"Prevention and control of cardiovascular disease in the rapidly changing economy of China","volume":"133","author":"Wu","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30159-7_bib7","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1001\/jama.2017.7596","article-title":"Prevalence and ethnic pattern of diabetes and prediabetes in China in 2013","volume":"317","author":"Wang","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30159-7_bib8","series-title":"Healthy China 2030 Plan","year":"2016"},{"key":"10.1016\/S2213-8587(19)30159-7_bib9","series-title":"The National Nutrition Plan (Year 2017\u20132030)","year":"2017"},{"key":"10.1016\/S2213-8587(19)30159-7_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0140-6736(18)31788-4","article-title":"Food in the Anthropocene: the EAT\u2013Lancet Commission on healthy diets from sustainable food systems","volume":"393","author":"Willett","year":"2019","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T16:18:58Z","timestamp":1563207538000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301597"}},"issued":{"date-parts":[[2019,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S2213858719301597"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30159-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dietary transitions and cardiometabolic health in China","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30159-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30152-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T04:51:29Z","timestamp":1783486289133,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/s2213-8587(19)30185-8","type":"journal-article","created":{"date-parts":[[2019,6,28]],"date-time":"2019-06-28T18:31:29Z","timestamp":1561746689000},"page":"589-590","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Maternal thyroid function and brain development: time for preconception screening?"],"prefix":"10.1016","volume":"7","author":[{"given":"Francesco","family":"Vermiglio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariacarla","family":"Moleti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 3","key":"10.1016\/S2213-8587(19)30185-8_bib1","doi-asserted-by":"crossref","first-page":"U25","DOI":"10.1530\/eje.0.151u025","article-title":"Role of thyroid hormone during early brain development","volume":"151","author":"Morreale de Escobar","year":"2004","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(19)30185-8_bib2","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1111\/cen.13724","article-title":"Clinical associations of maternal thyroid function with foetal brain development: epidemiological interpretation and overview of available evidence","volume":"89","author":"Korevaar","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(19)30185-8_bib3","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1106104","article-title":"Antenatal thyroid screening and childhood cognitive function","volume":"366","author":"Lazarus","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30185-8_bib4","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJMoa1606205","article-title":"Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy","volume":"376","author":"Casey","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30185-8_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30153-6","article-title":"Maternal thyroid function during pregnancy and child brain morphology: a time window-specific analysis of a prospective cohort","author":"Jansen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30185-8_bib6","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1089\/thy.2015.0336","article-title":"Effects of maternal iodine nutrition and thyroid status on cognitive development in offspring: a pilot study","volume":"26","author":"Moleti","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(19)30185-8_bib7","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/nrn2793","article-title":"The neuroscience of human intelligence differences","volume":"11","author":"Deary","year":"2010","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/S2213-8587(19)30185-8_bib8","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1111\/1471-0528.12681","article-title":"Attention deficit hyperactivity disorder and autism spectrum disorder in children born to mothers with thyroid dysfunction: a Danish nationwide cohort study","volume":"121","author":"Andersen","year":"2014","journal-title":"BJOG"},{"key":"10.1016\/S2213-8587(19)30185-8_bib9","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 Guidelines of the American Thyroid Association for the Diagnosis and Management of Thyroid Disease During Pregnancy and the Postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(19)30185-8_bib10","doi-asserted-by":"crossref","first-page":"3234","DOI":"10.1210\/jc.2010-0013","article-title":"Thyroid hormone early adjustment in pregnancy (the THERAPY) trial","volume":"95","author":"Yassa","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301858?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301858?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:59Z","timestamp":1761991619000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301858"}},"issued":{"date-parts":[[2019,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S2213858719301858"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30185-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal thyroid function and brain development: time for preconception screening?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30185-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30153-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T14:49:33Z","timestamp":1782917373575,"version":"3.54.5"},"reference-count":15,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007277","name":"Icahn School of Medicine at Mount Sinai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007277","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005035","name":"Biotronik","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005035","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007311","name":"Cleveland Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007311","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000871","name":"Mayo Clinic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008497","name":"Boston Scientific Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008497","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006513","name":"Duke Clinical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006513","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018465","name":"Regado Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018465","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019361","name":"Belvoir Media Group","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005485","name":"American College of Cardiology Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005485","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014384","name":"Amarin Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014384","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015237","name":"Medicines Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015237","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/s2213-8587(18)30311-5","type":"journal-article","created":{"date-parts":[[2018,11,2]],"date-time":"2018-11-02T19:34:21Z","timestamp":1541187261000},"page":"914-916","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The perils of polyvascular disease in type 2 diabetes"],"prefix":"10.1016","volume":"6","author":[{"given":"Subodh","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C David","family":"Mazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30311-5_bib1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S2213-8587(18)30079-2","article-title":"Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980\u2008793 adults from 68 prospective studies","volume":"6","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30311-5_bib2","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30311-5_bib3","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/S2213-8587(13)70089-5","article-title":"Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials","volume":"1","author":"Verma","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30311-5_bib4","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30311-5_bib5","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1001\/jama.2010.1322","article-title":"Comparative determinants of 4-year cardiovascular event rates in stable outpatients at risk of or with atherothrombosis","volume":"304","author":"Bhatt","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30311-5_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1161\/CIRCOUTCOMES.111.964379","article-title":"Polyvascular disease and long-term cardiovascular outcomes in older patients with non-ST-segment-elevation myocardial infarction","volume":"5","author":"Subherwal","year":"2012","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/S2213-8587(18)30311-5_bib7","author":"Gutierrez"},{"key":"10.1016\/S2213-8587(18)30311-5_bib8","doi-asserted-by":"crossref","first-page":"3211","DOI":"10.1093\/eurheartj\/ehx102","article-title":"Identification of vascular patients at very high risk for recurrent cardiovascular events: validation of the current ACC\/AHA very high risk criteria","volume":"38","author":"van den Berg","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(18)30311-5_bib9","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1161\/CIRCULATIONAHA.116.022194","article-title":"Clinical update: cardiovascular disease in diabetes mellitus: atherosclerotic cardiovascular disease and heart failure in type 2 diabetes mellitus\u2014mechanisms, management, and clinical considerations","volume":"133","author":"Low Wang","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30311-5_bib10","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(14)70219-0","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b79 million people","volume":"3","author":"Shah","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30311-5_bib11","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1161\/CIRCULATIONAHA.117.032031","article-title":"Cardiovascular outcomes and safety of empagliflozin in patients with type 2 diabetes mellitus and peripheral artery disease: a subanalysis of EMPA-REG OUTCOME","volume":"137","author":"Verma","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30311-5_bib12","doi-asserted-by":"crossref","first-page":"2306","DOI":"10.1016\/j.jacc.2018.03.008","article-title":"Major adverse limb events and mortality in patients with peripheral artery disease: the COMPASS trial","volume":"71","author":"Anand","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(18)30311-5_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30290-0","article-title":"Polyvascular disease, type 2 diabetes, and long-term vascular risk: a secondary analysis of the IMPROVE-IT trial","author":"Bonaca","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30311-5_bib14","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1161\/CIRCULATIONAHA.118.033898","article-title":"Effect of liraglutide on cardiovascular events in patients with type 2 diabetes mellitus and polyvascular disease: results of the LEADER trial","volume":"137","author":"Verma","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30311-5_bib15","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1161\/CIRCULATIONAHA.117.032235","article-title":"Low-density lipoprotein cholesterol lowering with evolocumab and outcomes in patients with peripheral artery disease: insights from the FOURIER trial (Further Cardiovascular Outcomes Research With PCSK9 Inhibition in Subjects With Elevated Risk)","volume":"137","author":"Bonaca","year":"2018","journal-title":"Circulation"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:17Z","timestamp":1761991577000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303115"}},"issued":{"date-parts":[[2018,12]]},"references-count":15,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2213858718303115"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30311-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The perils of polyvascular disease in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30311-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30290-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:12:55Z","timestamp":1778764375790,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/s2213-8587(26)00070-7","type":"journal-article","created":{"date-parts":[[2026,4,20]],"date-time":"2026-04-20T23:15:49Z","timestamp":1776726949000},"page":"444-446","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A conceptual framework for modernising and right-sizing global diabetes care"],"prefix":"10.1016","volume":"14","author":[{"given":"Mohammed K","family":"Ali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo M","family":"Carillo-Larco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Troels Krarup","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Ridderstr\u00e5le","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00070-7_bib1","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(23)00001-6","article-title":"Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact","volume":"401","author":"Gregg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00070-7_bib2","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2214-109X(25)00393-6","article-title":"Attainment of global diabetes targets in 2021: a pooled analysis of individual-level data from national surveys in 100 low-income, middle-income, and high-income countries","volume":"14","year":"2026","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(26)00070-7_bib3","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1016\/S0140-6736(12)60480-2","article-title":"Effectiveness of quality improvement strategies on the management of diabetes: a systematic review and meta-analysis","volume":"379","author":"Tricco","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00070-7_bib4","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1056\/NEJMoa2509958","article-title":"Home-based care for hypertension in rural South Africa","volume":"393","author":"Siedner","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00070-7_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00070-7_bib6","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-026-06687-5","article-title":"Subtypes of newly diagnosed type 2 diabetes and risk of complications: analysis of electronic health records in the USA","author":"Li","year":"2026","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00070-7_bib7","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1111\/aos.13936","article-title":"Evidence-based Danish guidelines for screening of diabetic retinopathy","volume":"96","author":"Grauslund","year":"2018","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/S2213-8587(26)00070-7_bib8","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1111\/dom.16200","article-title":"Cumulative risk of diabetic foot complications in risk groups of type 1 and type 2 diabetes: Real-world evidence from a 22-year follow-up study","volume":"27","author":"Akerkar","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00070-7_bib9","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2666-7568(21)00089-1","article-title":"The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680 102 adults","volume":"2","author":"Flood","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/S2213-8587(26)00070-7_bib10","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S2213-8587(18)30233-X","article-title":"Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study","volume":"6","author":"Chow","year":"2018","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000707?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000707?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:53:56Z","timestamp":1778763236000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000707"}},"issued":{"date-parts":[[2026,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2213858726000707"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00070-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A conceptual framework for modernising and right-sizing global diabetes care","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00070-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T09:21:05Z","timestamp":1772011265661,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/s2213-8587(20)30305-3","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T18:37:03Z","timestamp":1600195023000},"page":"808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Cortisol concentrations and mortality from COVID-19"],"prefix":"10.1016","volume":"8","author":[{"given":"Kay W","family":"Choy","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30305-3_bib1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S2213-8587(20)30216-3","article-title":"Association between high serum total cortisol concentrations and mortality from COVID-19","volume":"8","author":"Tan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30305-3_bib2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1210\/clinem\/dgz206","article-title":"Dynamic pituitary\u2013adrenal interactions in the critically ill after cardiac surgery","volume":"105","author":"Gibbison","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30305-3_bib3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1214969","article-title":"Reduced cortisol metabolism during critical illness","volume":"368","author":"Boonen","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30305-3_bib4","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1056\/NEJMoa020266","article-title":"Measurements of serum free cortisol in critically ill patients","volume":"350","author":"Hamrahian","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30305-3_bib5","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/0004563216687335","article-title":"Measuring cortisol in serum, urine and saliva\u2014are our assays good enough?","volume":"54","author":"El-Farhan","year":"2017","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/S2213-8587(20)30305-3_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0004563213514567","article-title":"The effect of serum matrix and gender on cortisol measurement by commonly used immunoassays","volume":"51","author":"Dodd","year":"2014","journal-title":"Ann Clin Biochem"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303053?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303053?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:26Z","timestamp":1761991706000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303053"}},"issued":{"date-parts":[[2020,10]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2213858720303053"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30305-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cortisol concentrations and mortality from COVID-19","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30305-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30216-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30304-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30306-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T05:20:10Z","timestamp":1784956810211,"version":"3.55.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-19-ICTS-068"],"award-info":[{"award-number":["1-19-ICTS-068"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000051","name":"National Human Genome Research Institute","doi-asserted-by":"publisher","award":["U01HG011723"],"award-info":[{"award-number":["U01HG011723"]}],"id":[{"id":"10.13039\/100000051","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK066358"],"award-info":[{"award-number":["R01DK066358"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK122586"],"award-info":[{"award-number":["R01DK122586"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["U01DK105556"],"award-info":[{"award-number":["U01DK105556"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/s2213-8587(21)00287-4","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T02:18:21Z","timestamp":1635387501000},"page":"808-810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Predicting diabetes risk in diverse populations: what next?"],"prefix":"10.1016","volume":"9","author":[{"given":"Josep M","family":"Mercader","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie C Y","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa K","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00287-4_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/s41591-020-0800-0","article-title":"Polygenic and clinical risk scores and their impact on age at onset and prediction of cardiometabolic diseases and common cancers","volume":"26","author":"Mars","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(21)00287-4_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.molmet.2016.02.003","article-title":"Primary prevention of beta-cell autoimmunity and type 1 diabetes\u2013The Global Platform for the Prevention of Autoimmune Diabetes (GPPAD) perspectives","volume":"5","author":"Ziegler","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(21)00287-4_bib4","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/dc15-1111","article-title":"A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults","volume":"39","author":"Oram","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00287-4_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002654","article-title":"Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis","volume":"15","author":"Udler","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(21)00287-4_bib6","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(21)00287-4_bib7","article-title":"Trans-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation","author":"Mahajan","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(21)00287-4_bib8","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2337\/dc18-1727","article-title":"Type 1 diabetes risk in African-Ancestry participants and utility of an ancestry-specific genetic risk score","volume":"42","author":"Onengut-Gumuscu","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00287-4_bib9","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Robertson","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(21)00287-4_bib10","article-title":"Improving polygenic prediction in ancestrally diverse populations","author":"Ruan","year":"2021","journal-title":"medRxiv"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:24Z","timestamp":1761991884000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002874"}},"issued":{"date-parts":[[2021,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2213858721002874"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00287-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Predicting diabetes risk in diverse populations: what next?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00287-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:42:49Z","timestamp":1794379369991,"version":"4.9.0"},"reference-count":49,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/s2213-8587(23)00382-0","type":"journal-article","created":{"date-parts":[[2024,1,29]],"date-time":"2024-01-29T19:25:04Z","timestamp":1706556304000},"page":"209-214","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":58,"title":["A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Ken K Y","family":"Ho","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Katznelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew S","family":"Little","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justo P","family":"Casta\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Beatriz","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ursula B","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Chanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f4nica","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shlomo","family":"Melmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00382-0_bib1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/endrev\/bnac010","article-title":"Clinical biology of the pituitary adenoma","volume":"43","author":"Melmed","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(23)00382-0_bib2","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvaa205","article-title":"Pituitary neoplasm nomenclature workshop: does adenoma stand the test of time?","volume":"5","author":"Ho","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(23)00382-0_bib3","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1007\/s11596-022-2673-6","article-title":"Overview of the 2022 WHO Classification of pituitary adenomas\/pituitary neuroendocrine tumors: clinical practices, controversies, and perspectives","volume":"42","author":"Wan","year":"2022","journal-title":"Curr Med Sci"},{"key":"10.1016\/S2213-8587(23)00382-0_bib4","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/s41574-023-00883-8","article-title":"Pituitary adenoma or neuroendocrine tumour: the need for an integrated prognostic classification","volume":"19","author":"Ho","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib5","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1353\/pbm.2011.0015","article-title":"Classification, disease, and diagnosis","volume":"54","author":"Jutel","year":"2011","journal-title":"Perspect Biol Med"},{"issue":"suppl 29","key":"10.1016\/S2213-8587(23)00382-0_bib7","first-page":"S42","article-title":"Assessment of disease severity and prognosis","volume":"21","author":"Medsger","year":"2003","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib8","series-title":"Principles of critical care","first-page":"83","article-title":"Assessment of severity of illness","author":"Russell","year":"2015"},{"key":"10.1016\/S2213-8587(23)00382-0_bib9","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib10","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1038\/s41574-023-00886-5","article-title":"Diagnosis and management of prolactin-secreting pituitary adenomas: a Pituitary Society international consensus statement","volume":"19","author":"Petersenn","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib11","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/gerona\/62.3.286","article-title":"Framework for evaluating disease severity measures in older adults with comorbidity","volume":"62","author":"Boyd","year":"2007","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(23)00382-0_bib12","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJMra1810772","article-title":"Pituitary-tumor endocrinopathies","volume":"382","author":"Melmed","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00382-0_bib13","doi-asserted-by":"crossref","first-page":"2651","DOI":"10.1210\/jc.2015-1475","article-title":"Excess mortality in women and young adults with non-functioning pituitary adenoma: a Swedish nationwide study","volume":"100","author":"Olsson","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1210\/jc.2010-1942","article-title":"Mortality and morbidity in Cushing's disease over 50 years in Stoke-on-Trent, UK: audit and meta-analysis of literature","volume":"96","author":"Clayton","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib15","doi-asserted-by":"crossref","first-page":"1022","DOI":"10.1210\/jc.2012-2893","article-title":"Predictors of mortality and long-term outcomes in treated Cushing's disease: a study of 346 patients","volume":"98","author":"Lambert","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib16","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in patients with Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib17","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/EJE-19-1023","article-title":"Management of endocrine disease: does gender matter in the management of acromegaly?","volume":"182","author":"Lenders","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib18","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1530\/EJE-18-0015","article-title":"Decreasing mortality and changes in treatment patterns in patients with acromegaly from a nationwide study","volume":"178","author":"Esposito","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1530\/EJE-16-0117","article-title":"Acromegaly incidence, prevalence, complications and long-term prognosis: a nationwide cohort study","volume":"175","author":"Dal","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib20","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1530\/EJE-09-0012","article-title":"Characterization of resistance to the prolactin-lowering effects of cabergoline in macroprolactinomas: a study in 122 patients","volume":"160","author":"Delgrange","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1210\/jc.2007-1191","article-title":"Mortality in acromegaly: a metaanalysis","volume":"93","author":"Dekkers","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib22","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S2213-8587(22)00244-3","article-title":"Acromegaly: pathogenesis, diagnosis, and management","volume":"10","author":"Fleseriu","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib23","first-page":"117","article-title":"Incidence and late prognosis of cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib24","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1210\/jc.2018-02524","article-title":"Overall and disease-specific mortality in patients with Cushing disease: a Swedish nationwide study","volume":"104","author":"Ragnarsson","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib25","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1210\/clinem\/dgac265","article-title":"The effect of endogenous Cushing syndrome on all-cause and cause-specific mortality","volume":"107","author":"Limumpornpetch","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1530\/EC-17-0171","article-title":"Morbidity and mortality in patients with hyperprolactinaemia: the PROLEARS study","volume":"6","author":"Soto-Pedre","year":"2017","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(23)00382-0_bib27","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1210\/jc.2010-1054","article-title":"Natural history of nonfunctioning pituitary adenomas and incidentalomas: a systematic review and metaanalysis","volume":"96","author":"Fern\u00e1ndez-Balsells","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib28","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1007\/s11154-020-09588-z","article-title":"Multidisciplinary management of acromegaly: a consensus","volume":"21","author":"Giustina","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/S2213-8587(23)00382-0_bib29","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1210\/jc.2014-3787","article-title":"Excess mortality associated with hypopituitarism in adults: a meta-analysis of observational studies","volume":"100","author":"Pappachan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib30","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1210\/er.2009-0033","article-title":"Mortality in patients with pituitary disease","volume":"31","author":"Sherlock","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(23)00382-0_bib31","doi-asserted-by":"crossref","first-page":"3888","DOI":"10.1210\/jc.2016-2118","article-title":"Hormonal replacement in hypopituitarism in adults: an Endocrine Society clinical practice guideline","volume":"101","author":"Fleseriu","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib32","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00382-0_bib33","doi-asserted-by":"crossref","first-page":"4216","DOI":"10.1210\/jc.2009-1097","article-title":"ACTH deficiency, higher doses of hydrocortisone replacement, and radiotherapy are independent predictors of mortality in patients with acromegaly","volume":"94","author":"Sherlock","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(21)00136-7","article-title":"Adrenal insufficiency","volume":"397","author":"Husebye","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00382-0_bib35","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s12020-016-1159-3","article-title":"Mortality in adults with hypopituitarism: a systematic review and meta-analysis","volume":"56","author":"Jasim","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(23)00382-0_bib36","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1001\/jama.2016.19699","article-title":"Diagnosis and treatment of pituitary adenomas: a review","volume":"317","author":"Molitch","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00382-0_bib37","doi-asserted-by":"crossref","first-page":"3368","DOI":"10.1210\/jc.2017-00773","article-title":"Risk of recurrence in pituitary neuroendocrine tumors: a prospective study using a five-tiered classification","volume":"102","author":"Raverot","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib38","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1530\/EJE-22-0812","article-title":"Real-life clinical impact of a five-tiered classification of pituitary tumor","volume":"187","author":"Sahakian","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib39","article-title":"Transsphenoidal surgery of giant pituitary adenoma: results and experience of 239 cases in a single center","volume":"13","author":"Chen","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib40","first-page":"610","article-title":"Pituitary adenomas with invasion of the cavernous sinus space: a magnetic resonance imaging classification compared with surgical findings","volume":"33","author":"Knosp","year":"1993","journal-title":"Neurosurgery"},{"key":"10.1016\/S2213-8587(23)00382-0_bib41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ando.2015.04.003","article-title":"Postsurgical management of non-functioning pituitary adenoma","volume":"76","author":"Cortet-Rudelli","year":"2015","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/S2213-8587(23)00382-0_bib42","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1210\/js.2019-00163","article-title":"Residual tumor confers a 10-fold increased risk of regrowth in clinically non-functioning pituitary tumors","volume":"3","author":"Maletkovic","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(23)00382-0_bib43","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s12022-022-09703-7","article-title":"Overview of the 2022 WHO classification of pituitary tumors","volume":"33","author":"Asa","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib44","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1530\/EJE-22-0440","article-title":"Aggressive pituitary tumours and carcinomas, characteristics, and management of 171 patients","volume":"187","author":"Burman","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib45","doi-asserted-by":"crossref","first-page":"R235","DOI":"10.1530\/EJE-19-0602","article-title":"Somatic and germline mutations in the pathogenesis of pituitary adenomas","volume":"181","author":"Vandeva","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib46","doi-asserted-by":"crossref","first-page":"R21","DOI":"10.1530\/JOE-18-0446","article-title":"Germline and mosaic mutations causing pituitary tumours: genetic and molecular aspects","volume":"240","author":"Pepe","year":"2019","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib47","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1530\/EJE-15-1064","article-title":"Landscape of somatic mutations in sporadic GH-secreting pituitary adenomas","volume":"174","author":"Ronchi","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00382-0_bib48","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(23)00382-0_bib49","doi-asserted-by":"crossref","first-page":"E997","DOI":"10.1210\/jc.2015-1453","article-title":"The gene of the ubiquitin-specific protease 8 is frequently mutated in adenomas causing Cushing's disease","volume":"100","author":"Perez-Rivas","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00382-0_bib50","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.ccell.2019.11.002","article-title":"Pangenomic classification of pituitary neuroendocrine tumors","volume":"37","author":"Neou","year":"2020","journal-title":"Cancer Cell"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:43:18Z","timestamp":1766162598000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003820"}},"issued":{"date-parts":[[2024,3]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2213858723003820"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00382-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A proposed clinical classification for pituitary neoplasms to guide therapy and prognosis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00382-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:29:32Z","timestamp":1794061772677,"version":"4.8.0"},"reference-count":82,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"NHMRC Senior Principal Research Fellowship","award":["ID GNT1137071"],"award-info":[{"award-number":["ID GNT1137071"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/s2213-8587(19)30388-2","type":"journal-article","created":{"date-parts":[[2019,12,17]],"date-time":"2019-12-17T20:31:54Z","timestamp":1576614714000},"page":"36-49","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":172,"title":["Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327\u2008037 participants"],"prefix":"10.1016","volume":"8","author":[{"given":"Nelson","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordan","family":"Fulcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishan","family":"Abeysuriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shejil","family":"Kumar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Luca","family":"Di Tanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Keech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Rodgers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sean","family":"Lal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30388-2_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170\u2008000 participants in 26 randomised trials","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib2","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1016\/S0140-6736(14)61368-4","article-title":"Efficacy and safety of LDL-lowering therapy among men and women: meta-analysis of individual data from 174\u2008000 participants in 27 randomised trials","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib3","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib4","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S0140-6736(18)31942-1","article-title":"Efficacy and safety of statin therapy in older people: a meta-analysis of individual participant data from 28 randomised controlled trials","volume":"393","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib5","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk: the Task Force for the Management of Dyslipidaemias of the European Society of Cardiology (ESC) and European Atherosclerosis Society (EAS)","author":"Mach","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30388-2_bib6","first-page":"e596","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30388-2_bib7","first-page":"e1082","article-title":"AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30388-2_bib8","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.2015.15629","article-title":"Statins for prevention of cardiovascular disease in adults: evidence report and systematic review for the US Preventive Services Task Force","volume":"316","author":"Chou","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30388-2_bib9","first-page":"1263","article-title":"2016 Canadian Cardiovascular Society guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in the adult","volume":"32","author":"Anderson","year":"2016","journal-title":"Can J Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib10","doi-asserted-by":"crossref","first-page":"291","DOI":"10.7326\/M15-0840","article-title":"Management of dyslipidemia for cardiovascular disease risk reduction: synopsis of the 2014 US Department of Veterans Affairs and US Department of Defense clinical practice guideline","volume":"163","author":"Downs","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30388-2_bib13","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib14","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1001\/jama.2018.2525","article-title":"Association between baseline LDL-C level and total and cardiovascular mortality after LDL-C lowering: a systematic review and meta-analysis","volume":"319","author":"Navarese","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30388-2_bib15","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1001\/jamacardio.2018.2258","article-title":"Efficacy and safety of further lowering of low-density lipoprotein cholesterol in patients starting with very low levels: a meta-analysis","volume":"3","author":"Sabatine","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib16","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","article-title":"2016 ESC\/EAS guidelines for the management of dyslipidaemias","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30388-2_bib17","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/j.jacc.2018.06.046","article-title":"Impact of lipids on cardiovascular health: JACC Health Promotion Series","volume":"72","author":"Ference","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib18","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1000 genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib19","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis","volume":"60","author":"Ference","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib20","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib21","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1001\/jama.295.13.jpc60002","article-title":"Effect of very high-intensity statin therapy on regression of coronary atherosclerosis: the ASTEROID trial","volume":"295","author":"Nissen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30388-2_bib22","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1056\/NEJMoa1110874","article-title":"Effect of two intensive statin regimens on progression of coronary disease","volume":"365","author":"Nicholls","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004201","article-title":"Plasma cholesterol-induced lesion networks activated before regression of early, mature, and advanced atherosclerosis","volume":"10","author":"Bj\u00f6rkegren","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib24","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.jacc.2013.03.058","article-title":"Changes in plaque lipid content after short-term intensive versus standard statin therapy: the YELLOW trial (Reduction in Yellow Plaque by Aggressive Lipid-Lowering Therapy)","volume":"62","author":"Kini","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib25","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1016\/j.jacc.2013.04.066","article-title":"Intensification of statin therapy results in a rapid reduction in atherosclerotic inflammation: results of a multicenter fluorodeoxyglucose-positron emission tomography\/computed tomography feasibility study","volume":"62","author":"Tawakol","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib26","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.amjcard.2011.12.016","article-title":"Comparison of arterial remodeling and changes in plaque composition between patients with progression versus regression of coronary atherosclerosis during statin therapy (from the TRUTH study)","volume":"109","author":"Nozue","year":"2012","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib27","doi-asserted-by":"crossref","first-page":"2779","DOI":"10.1016\/j.jacc.2014.04.009","article-title":"Curing atherosclerosis should be the next major cardiovascular prevention goal","volume":"63","author":"Robinson","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib28","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.jacc.2019.03.529","article-title":"Associations of blood pressure and cholesterol levels during young adulthood with later cardiovascular events","volume":"74","author":"Zhang","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib29","doi-asserted-by":"crossref","first-page":"1828","DOI":"10.1016\/j.jacc.2015.08.857","article-title":"Next steps in primary prevention of coronary heart disease: rationale for and design of the ECAD trial","volume":"66","author":"Domanski","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib30","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1161\/CIRCOUTCOMES.111.000071","article-title":"Comparative tolerability and harms of individual statins: a study-level network meta-analysis of 246\u2008955 participants from 135 randomized, controlled trials","volume":"6","author":"Naci","year":"2013","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/S2213-8587(19)30388-2_bib31","doi-asserted-by":"crossref","first-page":"77C","DOI":"10.1016\/j.amjcard.2005.12.014","article-title":"An assessment of statin safety by hepatologists","volume":"97","author":"Cohen","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib32","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/eurheartj\/ehy182","article-title":"Adverse effects of statin therapy: perception vs the evidence\u2014focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract","volume":"39","author":"Mach","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30388-2_bib33","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib34","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30388-2_bib35","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1161\/01.CIR.90.4.1679","article-title":"Effect of lovastatin on early carotid atherosclerosis and cardiovascular events","volume":"90","author":"Furberg","year":"1994","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30388-2_bib36","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30388-2_bib37","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib38","doi-asserted-by":"crossref","first-page":"2998","DOI":"10.1001\/jama.288.23.2998","article-title":"Major outcomes in moderately hypercholesterolemic, hypertensive patients randomized to pravastatin vs usual care: the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT-LLT)","volume":"288","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30388-2_bib39","first-page":"1772","article-title":"Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the alliance study","volume":"44","author":"Koren","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib40","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1253\/circj.CJ-14-0877","article-title":"Assessment of lipophilic vs hydrophilic statin therapy in acute myocardial infarction\u2014ALPS-AMI study","volume":"79","author":"Izawa","year":"2015","journal-title":"Circ J"},{"key":"10.1016\/S2213-8587(19)30388-2_bib41","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib42","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/dc05-2415","article-title":"Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)","volume":"29","author":"Knopp","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30388-2_bib43","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1161\/01.CIR.103.13.1721","article-title":"Low-dose metoprolol CR\/XL and fluvastatin slow progression of carotid intima-media thickness: main results from the \u03b2-Blocker Cholesterol-Lowering Asymptomatic Plaque Study (BCAPS)","volume":"103","author":"Hedblad","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30388-2_bib44","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib45","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib46","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib47","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.2337\/dc17-2224","article-title":"Intensive treat-to-target statin therapy in high-risk Japanese patients with hypercholesterolemia and diabetic retinopathy: report of a randomized study","volume":"41","author":"Itoh","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30388-2_bib48","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib49","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib50","first-page":"810","article-title":"Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge?","volume":"1","year":"2000","journal-title":"Ital Heart J"},{"key":"10.1016\/S2213-8587(19)30388-2_bib51","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1001\/jama.2016.16951","article-title":"Effect of evolocumab on progression of coronary disease in statin-treated patients: the GLAGOV randomized clinical trial","volume":"316","author":"Nicholls","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30388-2_bib52","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1185\/030079902125000787","article-title":"Treatment with atorvastatin to the National Cholesterol Educational Program goal versus \u2018usual\u2019 care in secondary coronary heart disease prevention. The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study","volume":"18","author":"Athyros","year":"2002","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/S2213-8587(19)30388-2_bib53","doi-asserted-by":"crossref","first-page":"2264","DOI":"10.1093\/eurheartj\/ehx162","article-title":"Low-density lipoprotein cholesterol targeting with pitavastatin + ezetimibe for patients with acute coronary syndrome and dyslipidaemia: the HIJ-PROPER study, a prospective, open-label, randomized trial","volume":"38","author":"Hagiwara","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30388-2_bib54","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1056\/NEJMoa1600176","article-title":"Cholesterol lowering in intermediate-risk persons without cardiovascular disease","volume":"374","author":"Yusuf","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib55","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20,536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib56","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.atherosclerosis.2004.08.033","article-title":"Fluvastatin and lifestyle modification for reduction of carotid intima-media thickness and left ventricular mass progression in drug-treated hypertensives","volume":"178","author":"Anderssen","year":"2005","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(19)30388-2_bib57","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction. The IDEAL study: a randomized controlled trial","volume":"294","author":"Pedersen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30388-2_bib58","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib59","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1016\/j.ebiom.2015.08.006","article-title":"The Japan Statin Treatment Against Recurrent Stroke (J-STARS): a multicenter, randomized, open-label, parallel-group study","volume":"2","author":"Hosomi","year":"2015","journal-title":"EBioMedicine"},{"key":"10.1016\/S2213-8587(19)30388-2_bib60","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib61","doi-asserted-by":"crossref","first-page":"34C","DOI":"10.1016\/S0002-9149(99)80468-8","article-title":"The Kuopio Atherosclerosis Prevention Study (KAPS): effect of pravastatin treatment on lipids, oxidation resistance of lipoproteins, and atherosclerotic progression","volume":"76","author":"Salonen","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib62","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib63","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30388-2_bib64","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/S0140-6736(94)92082-6","article-title":"Effect of simvastatin on coronary atheroma: the Multicentre Anti-Atheroma Study (MAAS)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib65","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(06)69472-5","article-title":"Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial","volume":"368","author":"Nakamura","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib66","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib67","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib68","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib69","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1253\/circj.CJ-12-1062","article-title":"Effects of pitavastatin in Japanese patients with chronic heart failure: the Pitavastatin Heart Failure Study (PEARL Study)","volume":"77","author":"Takano","year":"2013","journal-title":"Circ J"},{"key":"10.1016\/S2213-8587(19)30388-2_bib70","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/0735-1097(95)00301-0","article-title":"Pravastatin limitation of atherosclerosis in the coronary arteries (PLAC I): reduction in atherosclerosis progression and clinical events","volume":"26","author":"Pitt","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(19)30388-2_bib71","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib72","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib73","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib74","doi-asserted-by":"crossref","first-page":"1997","DOI":"10.1161\/CIRCULATIONAHA.117.032615","article-title":"High-dose versus low-dose pitavastatin in Japanese patients with stable coronary artery disease (REAL-CAD): a randomized superiority trial","volume":"137","author":"Taguchi","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30388-2_bib75","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1161\/01.CIR.96.2.429","article-title":"Functional evaluation of lipid-lowering therapy by pravastatin in the Regression Growth Evaluation Statin Study (REGRESS)","volume":"96","author":"Aengevaeren","year":"1997","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30388-2_bib76","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(10)60310-8","article-title":"Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12\u2008064 survivors of myocardial infarction: a double-blind randomised trial","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib77","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib78","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30388-2_bib79","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib80","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1056\/NEJMoa1701488","article-title":"Cardiovascular efficacy and safety of bococizumab in high-risk patients","volume":"376","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib81","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30388-2_bib82","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:07Z","timestamp":1761991627000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719303882"}},"issued":{"date-parts":[[2020,1]]},"references-count":82,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2213858719303882"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30388-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensive LDL cholesterol-lowering treatment beyond current recommendations for the prevention of major vascular events: a systematic review and meta-analysis of randomised trials including 327\u2008037 participants","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30388-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30389-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T19:29:21Z","timestamp":1793820561047,"version":"4.6.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/s2213-8587(23)00356-x","type":"journal-article","created":{"date-parts":[[2024,2,5]],"date-time":"2024-02-05T18:29:33Z","timestamp":1707157773000},"page":"162-173","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":232,"title":["Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial"],"prefix":"10.1016","volume":"12","author":[{"given":"Carel W","family":"le Roux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oren","family":"Steen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn J","family":"Lucas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Startseva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Unseld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita M","family":"Hennige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00356-X_bib1","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/obr.12551","article-title":"Obesity: a chronic relapsing progressive disease process. A position statement of the World Obesity Federation","volume":"18","author":"Bray","year":"2017","journal-title":"Obes Rev"},{"issue":"suppl","key":"10.1016\/S2213-8587(23)00356-X_bib2","first-page":"S288","article-title":"A review of current guidelines for the treatment of obesity","volume":"28","author":"Cornier","year":"2022","journal-title":"Am J Manag Care"},{"key":"10.1016\/S2213-8587(23)00356-X_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11695-022-06332-1","article-title":"2022 American Society of Metabolic and Bariatric Surgery (ASMBS) and International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO) indications for metabolic and bariatric surgery","volume":"33","author":"Eisenberg","year":"2023","journal-title":"Obes Surg"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00356-X_bib4","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/jdi.12464","article-title":"Neural effects of gut- and brain-derived glucagon-like peptide-1 and its receptor agonist","volume":"7","author":"Katsurada","year":"2016","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(23)00356-X_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2021.101351","article-title":"GLP-1 physiology informs the pharmacotherapy of obesity","volume":"57","author":"Drucker","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(23)00356-X_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3\u00b70 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00356-X_bib7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00356-X_bib8","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00356-X_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101090","article-title":"Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease","volume":"46","author":"Baggio","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(23)00356-X_bib10","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00356-X_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101633","article-title":"BI 456906: Discovery and preclinical pharmacology of a novel GCGR\/GLP-1R dual agonist with robust anti-obesity efficacy","volume":"66","author":"Zimmermann","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(23)00356-X_bib12","doi-asserted-by":"crossref","first-page":"E671","DOI":"10.1152\/ajpendo.00492.2002","article-title":"Glucagon and regulation of glucose metabolism","volume":"284","author":"Jiang","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00356-X_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2019.110696","article-title":"Direct effects of glucagon on glucose uptake and lipolysis in human adipocytes","volume":"503","author":"Pereira","year":"2020","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(23)00356-X_bib14","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/dom.12585","article-title":"Glucagon increases energy expenditure independently of brown adipose tissue activation in humans","volume":"18","author":"Salem","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00356-X_bib15","article-title":"Dose-response effects on HbA1c and bodyweight reductions with a dual glucagon\/GLP-1 receptor agonist, survodutide, compared with placebo and open-label semaglutide in people with type 2 diabetes: a randomised clinical trial","author":"Bl\u00fcher","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00356-X_bib16","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/dom.14948","article-title":"Phase I studies of the safety, tolerability, pharmacokinetics and pharmacodynamics of the dual glucagon receptor\/glucagon-like peptide-1 receptor agonist BI 456906","volume":"25","author":"Jungnik","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00356-X_bib17","series-title":"R: a language and environment for statistical computing. Version 3.6.1","year":"2020"},{"key":"10.1016\/S2213-8587(23)00356-X_bib18","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","article-title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial","volume":"392","author":"O'Neil","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00356-X_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1038\/sj.ijo.0803175","article-title":"The definition of weight maintenance","volume":"30","author":"Stevens","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(23)00356-X_bib20","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101801","article-title":"Results from three phase 1 trials of NNC9204-1177, a glucagon\/GLP-1 receptor co-agonist: effects on weight loss and safety in adults with overweight or obesity","volume":"78","author":"Friedrichsen","year":"2023","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(23)00356-X_bib21","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-hormone-receptor agonist retatrutide for obesity \u2013 A phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00356-X_bib22","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-022-05536-w","article-title":"Contribution of obesity and cardiometabolic risk factors in developing cardiovascular disease: a population-based cohort study","volume":"12","author":"Bakhtiyari","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(23)00356-X_bib23","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(23)00356-X_bib24","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00356-X_bib25","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00356-X_bib26","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00356-X_bib27","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00356-X_bib28","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1056\/NEJMoa2108269","article-title":"Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes","volume":"385","author":"Gerstein","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00356-X_bib29","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00356-X_bib30","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat Med"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(25)00399-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,17]],"date-time":"2025-12-17T00:00:00Z","timestamp":1765929600000}},{"DOI":"10.1016\/s2213-8587(25)00399-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872300356X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872300356X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:42:56Z","timestamp":1766162576000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872300356X"}},"issued":{"date-parts":[[2024,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S221385872300356X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00356-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon and GLP-1 receptor dual agonist survodutide for obesity: a randomised, double-blind, placebo-controlled, dose-finding phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00356-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00029-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T09:34:13Z","timestamp":1794562453255,"version":"4.9.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"MRC","award":["UD99999906"],"award-info":[{"award-number":["UD99999906"]}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"crossref","award":["Bb\/H013539\/2"],"award-info":[{"award-number":["Bb\/H013539\/2"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"crossref","award":["bb\/I000933\/I"],"award-info":[{"award-number":["bb\/I000933\/I"]}],"id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"crossref","award":["ES022186"],"award-info":[{"award-number":["ES022186"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/s2213-8587(13)70143-8","type":"journal-article","created":{"date-parts":[[2013,12,3]],"date-time":"2013-12-03T02:00:24Z","timestamp":1386036024000},"page":"65-75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":257,"title":["Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome"],"prefix":"10.1016","volume":"2","author":[{"given":"Lee D","family":"Roberts","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Koulman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian L","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70143-8_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S0167-7799(98)01214-1","article-title":"Systematic functional analysis of the yeast genome","volume":"16","author":"Oliver","year":"1998","journal-title":"Trends Biotechnol"},{"key":"10.1016\/S2213-8587(13)70143-8_bib2","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1002\/cfg.82","article-title":"Combining genomics, metabolome analysis, and biochemical modelling to understand metabolic networks","volume":"2","author":"Fiehn","year":"2001","journal-title":"Comp Funct Genomics"},{"key":"10.1016\/S2213-8587(13)70143-8_bib3","doi-asserted-by":"crossref","first-page":"1181","DOI":"10.1080\/004982599238047","article-title":"\u2018Metabonomics\u2019: understanding the metabolic responses of living systems to pathophysiological stimuli via multivariate statistical analysis of biological NMR spectroscopic data","volume":"29","author":"Nicholson","year":"1999","journal-title":"Xenobiotica"},{"key":"10.1016\/S2213-8587(13)70143-8_bib4","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.1038\/4551054a","article-title":"Systems biology: metabonomics","volume":"455","author":"Nicholson","year":"2008","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(13)70143-8_bib5","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00125-009-1637-8","article-title":"Insulin resistance is associated with a metabolic profile of altered protein metabolism in Chinese and Asian-Indian men","volume":"53","author":"Tai","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70143-8_bib6","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.2337\/db12-0754","article-title":"Metabolite profiles during oral glucose challenge","volume":"62","author":"Ho","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70143-8_bib7","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1002\/rcm.2854","article-title":"High-throughput direct-infusion ion trap mass spectrometry: a new method for metabolomics","volume":"21","author":"Koulman","year":"2007","journal-title":"Rapid Commun Mass Spectrom"},{"key":"10.1016\/S2213-8587(13)70143-8_bib8","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1038\/nbt823","article-title":"High-throughput classification of yeast mutants for functional genomics using metabolic footprinting","volume":"21","author":"Allen","year":"2003","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S2213-8587(13)70143-8_bib9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/db12-0495","article-title":"Identification of serum metabolites associated with risk of diabetes using a targeted metabolomic approach","volume":"62","author":"Floegel","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70143-8_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1186\/gm115","article-title":"Increased hepatic oxidative metabolism distinguishes the action of Peroxisome proliferator-activated receptor delta from Peroxisome proliferator-activated receptor gamma in the ob\/ob mouse","volume":"1","author":"Roberts","year":"2009","journal-title":"Genome Med"},{"key":"10.1016\/S2213-8587(13)70143-8_bib11","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1602\/neurorx.1.2.189","article-title":"Biomarkers and surrogate markers: an FDA perspective","volume":"1","author":"Katz","year":"2004","journal-title":"NeuroRx"},{"key":"10.1016\/S2213-8587(13)70143-8_bib12","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1007\/s12263-012-0284-8","article-title":"Genetic predisposition to diabetes is associated with impaired insulin secretion but does not modify insulin resistance or secretion in response to an intervention to lower dietary saturated fat","volume":"7","author":"Walker","year":"2012","journal-title":"Genes Nutr"},{"key":"10.1016\/S2213-8587(13)70143-8_bib13","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1177\/193229680900300413","article-title":"Genetic susceptibility to diabetes and implications for therapy","volume":"3","author":"Florez","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(13)70143-8_bib14","doi-asserted-by":"crossref","first-page":"542698","DOI":"10.1155\/2012\/542698","article-title":"Diet, inflammation, and glycemic control in diabetes: an integrative review of the literature","volume":"2012","author":"Nowlin","year":"2012","journal-title":"J Nutr Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib15","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S0140-6736(08)60147-6","article-title":"Environmental pollution and diabetes: a neglected association","volume":"371","author":"Jones","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70143-8_bib16","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.1016\/j.bcp.2010.07.029","article-title":"Nature or nurture: let food be your epigenetic medicine in chronic inflammatory disorders","volume":"80","author":"Szic","year":"2010","journal-title":"Biochem Pharmacol"},{"key":"10.1016\/S2213-8587(13)70143-8_bib17","doi-asserted-by":"crossref","first-page":"4293","DOI":"10.1210\/jc.2012-3487","article-title":"Year in diabetes 2012: the diabetes tsunami","volume":"97","author":"Sherwin","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib18","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jchromb.2008.04.002","article-title":"A matter of fat: an introduction to lipidomic profiling methods","volume":"871","author":"Roberts","year":"2008","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/S2213-8587(13)70143-8_bib19","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1039\/B906712B","article-title":"Systems level studies of mammalian metabolomes: the roles of mass spectrometry and nuclear magnetic resonance spectroscopy","volume":"40","author":"Dunn","year":"2011","journal-title":"Chem Soc Rev"},{"key":"10.1016\/S2213-8587(13)70143-8_bib20","doi-asserted-by":"crossref","first-page":"737","DOI":"10.4155\/fmc.09.54","article-title":"(1)H NMR-based metabonomics for investigating diabetes","volume":"1","author":"Maher","year":"2009","journal-title":"Future Med Chem"},{"key":"10.1016\/S2213-8587(13)70143-8_bib21","doi-asserted-by":"crossref","first-page":"2205","DOI":"10.4155\/bio.11.223","article-title":"Integration of metabolomics in heart disease and diabetes research: current achievements and future outlook","volume":"3","author":"Dunn","year":"2011","journal-title":"Bioanalysis"},{"key":"10.1016\/S2213-8587(13)70143-8_bib22","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1373\/clinchem.2011.169573","article-title":"Metabolomics and cardiovascular biomarker discovery","volume":"58","author":"Rhee","year":"2012","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(13)70143-8_bib23","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1172\/JCI101300","article-title":"The metabolism of amino acids in diabetes mellitus","volume":"21","author":"Luetscher","year":"1942","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70143-8_bib24","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1056\/NEJM196910092811503","article-title":"Plasma amino acid levels and insulin secretion in obesity","volume":"281","author":"Felig","year":"1969","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70143-8_bib25","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1172\/JCI105456","article-title":"Stimulation of insulin secretion by amino acids","volume":"45","author":"Floyd","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70143-8_bib26","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1210\/jcem-28-2-266","article-title":"Secretion of insulin induced by amino acids and glucose in diabetes mellitus","volume":"28","author":"Floyd","year":"1968","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib27","doi-asserted-by":"crossref","first-page":"599","DOI":"10.2337\/diabetes.51.3.599","article-title":"Mechanism of amino acid-induced skeletal muscle insulin resistance in humans","volume":"51","author":"Krebs","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70143-8_bib28","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1038\/nm0411-418","article-title":"An amino acid profile to predict diabetes?","volume":"17","author":"Langenberg","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(13)70143-8_bib29","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1172\/JCI1326","article-title":"Bidirectional modulation of insulin action by amino acids","volume":"101","author":"Patti","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70143-8_bib30","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/msb.2008.50","article-title":"Metabolic profiling of the human response to a glucose challenge reveals distinct axes of insulin sensitivity","volume":"4","author":"Shaham","year":"2008","journal-title":"Mol Syst Biol"},{"key":"10.1016\/S2213-8587(13)70143-8_bib31","doi-asserted-by":"crossref","first-page":"E384","DOI":"10.1152\/ajpendo.90748.2008","article-title":"Changes of the plasma metabolome during an oral glucose tolerance test: is there more than glucose to look at?","volume":"296","author":"Zhao","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib32","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1007\/s11306-009-0177-z","article-title":"Metabolomic analysis of a human oral glucose tolerance test reveals fatty acids as reliable indicators of regulated metabolism","volume":"6","author":"Spegel","year":"2010","journal-title":"Metabolomics"},{"key":"10.1016\/S2213-8587(13)70143-8_bib33","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1016\/j.chemphyslip.2011.05.003","article-title":"Bile acid signaling after an oral glucose tolerance test","volume":"164","author":"Matysik","year":"2011","journal-title":"Chem Phys Lipids"},{"key":"10.1016\/S2213-8587(13)70143-8_bib34","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1038\/nm.2307","article-title":"Metabolite profiles and the risk of developing diabetes","volume":"17","author":"Wang","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(13)70143-8_bib35","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/eurheartj\/ehs424","article-title":"A diabetes-predictive amino acid score and future cardiovascular disease","volume":"34","author":"Magnusson","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(13)70143-8_bib36","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.2337\/db11-1378","article-title":"Hyperglycemia and a common variant of GCKR are associated with the levels of eight amino acids in 9,369 Finnish men","volume":"61","author":"Stancakova","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70143-8_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.cmet.2009.02.002","article-title":"A branched-chain amino acid-related metabolic signature that differentiates obese and lean humans and contributes to insulin resistance","volume":"9","author":"Newgard","year":"2009","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib38","doi-asserted-by":"crossref","first-page":"1678","DOI":"10.2337\/dc08-2075","article-title":"Relationships between circulating metabolic intermediates and insulin action in overweight to obese, inactive men and women","volume":"32","author":"Huffman","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70143-8_bib39","doi-asserted-by":"crossref","first-page":"e13953","DOI":"10.1371\/journal.pone.0013953","article-title":"Metabolic footprint of diabetes: a multiplatform metabolomics study in an epidemiological setting","volume":"5","author":"Suhre","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70143-8_bib40","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1161\/CIRCULATIONAHA.111.067827","article-title":"Metabolite profiling identifies pathways associated with metabolic risk in humans","volume":"125","author":"Cheng","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70143-8_bib41","doi-asserted-by":"crossref","first-page":"e10538","DOI":"10.1371\/journal.pone.0010538","article-title":"Quantitative metabolomics by H-NMR and LC-MS\/MS confirms altered metabolic pathways in diabetes","volume":"5","author":"Lanza","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70143-8_bib42","doi-asserted-by":"crossref","first-page":"106","DOI":"10.3945\/ajcn.2008.26362","article-title":"Oral glutamine increases circulating glucagon-like peptide 1, glucagon, and insulin concentrations in lean, obese, and diabetic subjects","volume":"89","author":"Greenfield","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70143-8_bib43","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1097\/01.CCM.0000196829.30741.D4","article-title":"Parenterally administered dipeptide alanyl-glutamine prevents worsening of insulin sensitivity in multiple-trauma patients","volume":"34","author":"Bakalar","year":"2006","journal-title":"Crit Care Med"},{"key":"10.1016\/S2213-8587(13)70143-8_bib44","doi-asserted-by":"crossref","first-page":"13393","DOI":"10.1074\/jbc.M311502200","article-title":"A signaling role of glutamine in insulin secretion","volume":"279","author":"Li","year":"2004","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(13)70143-8_bib45","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1097\/00075197-199901000-00007","article-title":"The use of alpha-ketoglutarate salts in clinical nutrition and metabolic care","volume":"2","author":"Cynober","year":"1999","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/S2213-8587(13)70143-8_bib46","doi-asserted-by":"crossref","first-page":"e10883","DOI":"10.1371\/journal.pone.0010883","article-title":"\u03b1-hydroxybutyrate is an early biomarker of insulin resistance and glucose intolerance in a nondiabetic population","volume":"5","author":"Gall","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70143-8_bib47","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/db12-0707","article-title":"Early metabolic markers of the development of dysglycemia and diabetes and their physiological significance","volume":"62","author":"Ferrannini","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70143-8_bib48","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1038\/msb.2012.43","article-title":"Novel biomarkers for pre-diabetes identified by metabolomics","volume":"8","author":"Wang-Sattler","year":"2012","journal-title":"Mol Syst Biol"},{"key":"10.1016\/S2213-8587(13)70143-8_bib49","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.cmet.2008.08.012","article-title":"A sweet spot for the bariatric surgeon","volume":"8","author":"Perez-Tilve","year":"2008","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib50","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1126\/science.320.5875.438","article-title":"Medicine: bypassing medicine to treat diabetes","volume":"320","author":"Couzin","year":"2008","journal-title":"Science"},{"key":"10.1016\/S2213-8587(13)70143-8_bib51","doi-asserted-by":"crossref","first-page":"e7905","DOI":"10.1371\/journal.pone.0007905","article-title":"Metabolite profiling identifies candidate markers reflecting the clinical adaptations associated with Roux-en-Y gastric bypass surgery","volume":"4","author":"Mutch","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70143-8_bib52","doi-asserted-by":"crossref","first-page":"80re2","DOI":"10.1126\/scitranslmed.3002043","article-title":"Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss","volume":"3","author":"Laferrere","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(13)70143-8_bib53","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1016\/j.cmet.2012.01.024","article-title":"Interplay between lipids and branched-chain amino acids in development of insulin resistance","volume":"15","author":"Newgard","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib54","doi-asserted-by":"crossref","first-page":"11348","DOI":"10.1074\/jbc.M109.075184","article-title":"Adipose tissue branched chain amino acid (BCAA) metabolism modulates circulating BCAA levels","volume":"285","author":"Herman","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(13)70143-8_bib55","doi-asserted-by":"crossref","first-page":"E1552","DOI":"10.1152\/ajpendo.00134.2007","article-title":"Obesity-related elevations in plasma leucine are associated with alterations in enzymes involved in branched-chain amino acid metabolism","volume":"293","author":"She","year":"2007","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib56","doi-asserted-by":"crossref","first-page":"18745","DOI":"10.1073\/pnas.0903032106","article-title":"Mechanisms of human insulin resistance and thiazolidinedione-mediated insulin sensitization","volume":"106","author":"Sears","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(13)70143-8_bib57","doi-asserted-by":"crossref","first-page":"E164","DOI":"10.1152\/ajpendo.00219.2010","article-title":"Multi-tissue, selective PPAR gamma modulation of insulin sensitivity and metabolic pathways in obese rats","volume":"300","author":"Hsiao","year":"2011","journal-title":"Am J Physiol Endocrinol Med"},{"key":"10.1016\/S2213-8587(13)70143-8_bib58","doi-asserted-by":"crossref","first-page":"8126","DOI":"10.1016\/S0021-9258(17)34371-5","article-title":"Regulation of leucine and alpha-ketoisocaproate metabolism in skeletal muscle","volume":"253","author":"Hutson","year":"1978","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(13)70143-8_bib59","first-page":"E839","article-title":"Amino acids augment insulin's suppression of whole body proteolysis","volume":"257","author":"Flakoll","year":"1989","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(13)70143-8_bib60","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.cmet.2006.05.003","article-title":"Nutrient overload, insulin resistance, and ribosomal protein S6 kinase 1, S6K1","volume":"3","author":"Um","year":"2006","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib61","doi-asserted-by":"crossref","first-page":"E592","DOI":"10.1152\/ajpendo.90645.2008","article-title":"Amino acid regulation of TOR complex 1","volume":"296","author":"Avruch","year":"2009","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib62","doi-asserted-by":"crossref","first-page":"746","DOI":"10.2337\/db10-1246","article-title":"Leucine deprivation increases hepatic insulin sensitivity via GCN2\/mTOR\/S6K1 and AMPK pathways","volume":"60","author":"Xiao","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70143-8_bib63","doi-asserted-by":"crossref","first-page":"e21187","DOI":"10.1371\/journal.pone.0021187","article-title":"Dietary leucine: an environmental modifier of insulin resistance acting on multiple levels of metabolism","volume":"6","author":"Macotela","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70143-8_bib64","doi-asserted-by":"crossref","DOI":"10.2337\/db13-0570","article-title":"Biomarkers for type 2 diabetes and impaired fasting glucose using a non-targeted metabolomics approach","author":"Menni","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70143-8_bib65","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1038\/ng.507","article-title":"A genome-wide perspective of genetic variation in human metabolism","volume":"42","author":"Illig","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(13)70143-8_bib66","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1038\/ng.837","article-title":"A genome-wide association study of metabolic traits in human urine","volume":"43","author":"Suhre","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(13)70143-8_bib67","doi-asserted-by":"crossref","first-page":"e1000282","DOI":"10.1371\/journal.pgen.1000282","article-title":"Genetics meets metabolomics: a genome-wide association study of metabolite profiles in human serum","volume":"4","author":"Gieger","year":"2008","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(13)70143-8_bib68","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.cmet.2013.06.013","article-title":"A genome-wide association study of the human metabolome in a community-based cohort","volume":"18","author":"Rhee","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0022-2275(20)40442-0","article-title":"Chromatographic separation, identification, and analysis of phosphatides","volume":"3","author":"Marinetti","year":"1962","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(13)70143-8_bib70","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s11745-012-3661-6","article-title":"Automated high-throughput fatty acid analysis of umbilical cord serum and application to an epidemiological study","volume":"47","author":"Lin","year":"2012","journal-title":"Lipids"},{"key":"10.1016\/S2213-8587(13)70143-8_bib71","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1039\/C2AN15911B","article-title":"A microfluidic device for the automated derivatization of free fatty acids to fatty acid methyl esters","volume":"137","author":"Duong","year":"2012","journal-title":"Analyst"},{"key":"10.1016\/S2213-8587(13)70143-8_bib72","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.3945\/ajcn.110.003970","article-title":"Circulating palmitoleic acid and risk of metabolic abnormalities and new-onset diabetes","volume":"92","author":"Mozaffarian","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70143-8_bib73","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.3945\/ajcn.2010.29182","article-title":"Fatty acids measured in plasma and erythrocyte-membrane phospholipids and derived by food-frequency questionnaire and the risk of new-onset diabetes: a pilot study in the European Prospective Investigation into Cancer and Nutrition (EPIC)-Norfolk cohort","volume":"92","author":"Patel","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70143-8_bib74","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/ajcn\/86.1.189","article-title":"Plasma phospholipid and dietary fatty acids as predictors of diabetes: interpreting the role of linoleic acid","volume":"86","author":"Hodge","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70143-8_bib75","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.metabol.2012.06.004","article-title":"Estimated plasma stearoyl co-A desaturase-1 activity and risk of incident diabetes: the Atherosclerosis Risk in Communities (ARIC) study","volume":"62","author":"Chow","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(13)70143-8_bib76","doi-asserted-by":"crossref","first-page":"160","DOI":"10.7326\/0003-4819-155-3-201108020-00006","article-title":"Circulating long-chain \u03c9-3 fatty acids and incidence of congestive heart failure in older adults: the Cardiovascular Health Study\u2014a cohort study","volume":"155","author":"Mozaffarian","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(13)70143-8_bib77","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0022-2275(20)32553-0","article-title":"Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men","volume":"39","author":"Aarsland","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(13)70143-8_bib78","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ajcn\/87.4.817","article-title":"Parallel activation of de novo lipogenesis and stearoyl-CoA desaturase activity after 3 d of high-carbohydrate feeding","volume":"87","author":"Chong","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70143-8_bib79","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1210\/jc.2010-2007","article-title":"A dual sugar challenge test for lipogenic sensitivity to dietary fructose","volume":"96","author":"Hudgins","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib80","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/db08-1074","article-title":"Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver","volume":"58","author":"Kotronen","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70143-8_bib81","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3945\/ajcn.112.038695","article-title":"Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans","volume":"96","author":"Sevastianova","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70143-8_bib82","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1007\/BF02534421","article-title":"Altered fatty-acid desaturation and microsomal fatty-acid composition in the streptozotocin diabetic rat","volume":"15","author":"Faas","year":"1980","journal-title":"Lipids"},{"key":"10.1016\/S2213-8587(13)70143-8_bib83","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJM199301283280404","article-title":"The relation between insulin sensitivity and the fatty-acid composition of skeletal-muscle phospholipids","volume":"328","author":"Borkman","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70143-8_bib84","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1016\/0026-0495(89)90261-8","article-title":"Insulin secretion and insulin action related to the serum phospholipid fatty acid pattern in healthy men","volume":"38","author":"Pelik\u00e1nov\u00e1","year":"1989","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(13)70143-8_bib85","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1002\/(SICI)1096-8644(199905)109:1<9::AID-AJPA2>3.0.CO;2-M","article-title":"Plasma phospholipid fatty acids in the central Canadian Arctic: biocultural explanations for ethnic differences","volume":"109","author":"Young","year":"1999","journal-title":"Am J Phys Anthropol"},{"key":"10.1016\/S2213-8587(13)70143-8_bib86","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1152\/japplphysiol.01438.2005","article-title":"Saturated, but not n-6 polyunsaturated, fatty acids induce insulin resistance: role of intramuscular accumulation of lipid metabolites","volume":"100","author":"Lee","year":"2006","journal-title":"J Appl Physiol"},{"key":"10.1016\/S2213-8587(13)70143-8_bib87","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1194\/jlr.M200189-JLR200","article-title":"Relationship between stearoyl-CoA desaturase activity and plasma triglycerides in human and mouse hypertriglyceridemia","volume":"43","author":"Attie","year":"2002","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(13)70143-8_bib88","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/jn\/131.9.2260","article-title":"Targeted disruption of stearoyl-CoA desaturase 1 gene in mice causes atrophy of sebaceous and meibomian glands and depletion of wax esters in the eyelid","volume":"131","author":"Miyazaki","year":"2001","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(13)70143-8_bib89","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1016\/j.numecd.2007.11.002","article-title":"Effects of saturated and unsaturated fatty acids on estimated desaturase activities during a controlled dietary intervention","volume":"18","author":"Warensj\u00f6","year":"2008","journal-title":"Nutr Metab Cardiovas Dis"},{"key":"10.1016\/S2213-8587(13)70143-8_bib90","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1210\/jc.2009-1975","article-title":"Plasma fatty acids and desaturase activity are associated with circulating adiponectin in healthy adolescent girls","volume":"95","author":"Gallo","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70143-8_bib91","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1038\/ijo.2008.89","article-title":"Serum phospholipid and cholesteryl ester fatty acids and estimated desaturase activities are related to overweight and cardiovascular risk factors in adolescents","volume":"32","author":"Steffen","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(13)70143-8_bib92","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.ajhg.2012.03.014","article-title":"Genetic adaptation of fatty-acid metabolism: a human-specific haplotype increasing the biosynthesis of long-chain omega-3 and omega-6 fatty acids","volume":"90","author":"Ameur","year":"2012","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(13)70143-8_bib93","doi-asserted-by":"crossref","first-page":"e1000338","DOI":"10.1371\/journal.pgen.1000338","article-title":"Genome-wide association study of plasma polyunsaturated fatty acids in the InCHIANTI Study","volume":"5","author":"Tanaka","year":"2009","journal-title":"Plos Genet"},{"key":"10.1016\/S2213-8587(13)70143-8_bib94","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/ng.2274","article-title":"A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance","volume":"44","author":"Manning","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(13)70143-8_bib95","doi-asserted-by":"crossref","first-page":"e21198","DOI":"10.1371\/journal.pone.0021198","article-title":"ELOVL6 genetic variation is related to insulin sensitivity: a new candidate gene in energy metabolism","volume":"6","author":"Morcillo","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70143-8_bib96","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1007\/s00125-009-1282-2","article-title":"Serum saturated fatty acids containing triacylglycerols are better markers of insulin resistance than total serum triacylglycerol concentrations","volume":"52","author":"Kotronen","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70143-8_bib97","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1172\/JCI44442","article-title":"Lipid profiling identifies a triacylglycerol signature of insulin resistance and improves diabetes prediction in humans","volume":"121","author":"Rhee","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70143-8_bib98","first-page":"831","article-title":"Receptor and postreceptor effects of free fatty acids (FFA) on hepatocyte insulin dynamics","volume":"14","author":"Hennes","year":"1990","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(13)70143-8_bib99","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2337\/diabetes.52.5.1081","article-title":"Hepatic VLDL production in ob\/ob mice is not stimulated by massive de novo lipogenesis but is less sensitive to the suppressive effects of insulin","volume":"52","author":"Wiegman","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70143-8_bib100","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.2337\/db06-0200","article-title":"Liver-specific inhibition of ChREBP improves hepatic steatosis and insulin resistance in ob\/ob mice","volume":"55","author":"Dentin","year":"2006","journal-title":"Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701438?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701438?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,18]],"date-time":"2022-03-18T13:04:58Z","timestamp":1647608698000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701438"}},"issued":{"date-parts":[[2014,1]]},"references-count":100,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S2213858713701438"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70143-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Towards metabolic biomarkers of insulin resistance and type 2 diabetes: progress from the metabolome","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70143-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T15:30:12Z","timestamp":1794238212823,"version":"4.9.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/s2213-8587(21)00111-x","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T11:24:16Z","timestamp":1618485856000},"page":"325-327","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["The WHO Global Diabetes Compact: a new initiative to support people living with diabetes"],"prefix":"10.1016","volume":"9","author":[{"given":"Daniel","family":"Hunt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca","family":"Hemmingsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alena","family":"Matzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cherian","family":"Varghese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asmus","family":"Hammerich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Luciani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anselm","family":"Hennis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Branca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Bull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino","family":"Berdzuli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Marie","family":"Dangou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Razia","family":"Pendse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Pratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bente","family":"Mikkelsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00111-X_bib1","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/S0140-6736(20)31761-X","article-title":"NCD Countdown 2030: pathways to achieving Sustainable Development Goal target 3.4","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00111-X_bib2","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S2213-8587(18)30233-X","article-title":"Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study","volume":"6","author":"Chow","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00111-X_bib4","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(15)00521-5","article-title":"Constraints and challenges in access to insulin: a global perspective","volume":"4","author":"Beran","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00111-X_bib9","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S2213-8587(19)30083-X","article-title":"Challenges associated with providing diabetes care in humanitarian settings","volume":"7","author":"Boulle","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00111-X_bib10","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S2213-8587(19)30082-8","article-title":"The burden of diabetes and use of diabetes care in humanitarian crises in low-income and middle-income countries","volume":"7","author":"Kehlenbrink","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872100111X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872100111X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:05Z","timestamp":1761991745000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872100111X"}},"issued":{"date-parts":[[2021,6]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S221385872100111X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00111-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The WHO Global Diabetes Compact: a new initiative to support people living with diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00111-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 World Health Organization. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T03:47:03Z","timestamp":1794541623521,"version":"4.9.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100019081","name":"Science and Technology Program of Hunan Province","doi-asserted-by":"publisher","award":["2024RC3047"],"award-info":[{"award-number":["2024RC3047"]}],"id":[{"id":"10.13039\/501100019081","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82301349"],"award-info":[{"award-number":["82301349"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82172685"],"award-info":[{"award-number":["82172685"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/s2213-8587(25)00036-1","type":"journal-article","created":{"date-parts":[[2025,4,8]],"date-time":"2025-04-08T20:19:47Z","timestamp":1744143587000},"page":"494-504","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Association between maternal diabetes and neurodevelopmental outcomes in children: a systematic review and meta-analysis of 202 observational studies comprising 56\u00b71 million pregnancies"],"prefix":"10.1016","volume":"13","author":[{"given":"Wenrui","family":"Ye","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cong","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xisong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yinghua","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-0288-6306","authenticated-orcid":false,"given":"Zhixiong","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1703-8836","authenticated-orcid":false,"given":"Fangkun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00036-1_bib1","first-page":"S15","article-title":"2. Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00036-1_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11892-015-0699-x","article-title":"Prevalence of gestational diabetes and risk of progression to type 2 diabetes: a global perspective","volume":"16","author":"Zhu","year":"2016","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(25)00036-1_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109049","article-title":"IDF Diabetes Atlas: the prevalence of pre-existing diabetes in pregnancy\u2014a systematic reviewand meta-analysis of studies published during 2010\u20132020","volume":"183","author":"Chivese","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00036-1_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109050","article-title":"IDF Diabetes Atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group's Criteria","volume":"183","author":"Wang","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00036-1_bib5","article-title":"Gestational diabetes mellitus and adverse pregnancy outcomes: systematic review and meta-analysis","volume":"377","author":"Ye","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00036-1_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1038\/s41574-022-00717-z","article-title":"Fetoplacental oxygen homeostasis in pregnancies with maternal diabetes mellitus and obesity","volume":"18","author":"Desoye","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(25)00036-1_bib7","doi-asserted-by":"crossref","DOI":"10.3390\/ijms22062965","article-title":"Diabetes during pregnancy: a maternal disease complicating the course of pregnancy with long-term deleterious effects on the offspring: a clinical review","volume":"22","author":"Ornoy","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(25)00036-1_bib8","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"10.1016\/S2213-8587(25)00036-1_bib9","series-title":"Clinical descriptions and diagnostic requirements for ICD-11 mental, behavioural and neurodevelopmental disorders","year":"2024"},{"key":"10.1016\/S2213-8587(25)00036-1_bib10","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1038\/nature13394","article-title":"Genome sequencing identifies major causes of severe intellectual disability","volume":"511","author":"Gilissen","year":"2014","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00036-1_bib11","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.tins.2020.05.004","article-title":"Neurodevelopmental disorders: from genetics to functional pathways","volume":"43","author":"Parenti","year":"2020","journal-title":"Trends Neurosci"},{"key":"10.1016\/S2213-8587(25)00036-1_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1038\/s41586-018-0566-4","article-title":"Common genetic variants contribute to risk of rare severe neurodevelopmental disorders","volume":"562","author":"Niemi","year":"2018","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00036-1_bib13","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1038\/nature10945","article-title":"De novo mutations revealed by whole-exome sequencing are strongly associated with autism","volume":"485","author":"Sanders","year":"2012","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00036-1_bib14","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/s41583-021-00457-5","article-title":"Environmental influences on the pace of brain development","volume":"22","author":"Tooley","year":"2021","journal-title":"Nat Rev Neurosci"},{"key":"10.1016\/S2213-8587(25)00036-1_bib15","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1017\/S0954579420000620","article-title":"Early environmental risk factors for neurodevelopmental disorders \u2014 |a systematic review of twin and sibling studies","volume":"33","author":"Carlsson","year":"2021","journal-title":"Dev Psychopathol"},{"key":"10.1016\/S2213-8587(25)00036-1_bib16","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1176\/appi.ajp.2014.13101359","article-title":"Familial recurrence of autism spectrum disorder: evaluating genetic and environmental contributions","volume":"171","author":"Risch","year":"2014","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2213-8587(25)00036-1_bib17","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1007\/s10803-013-1928-2","article-title":"Maternal diabetes and the risk of autism spectrum disorders in the offspring: a systematic review and meta-analysis","volume":"44","author":"Xu","year":"2014","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/S2213-8587(25)00036-1_bib18","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2147\/NDT.S189200","article-title":"The association of maternal diabetes with attention deficit and hyperactivity disorder in offspring: a meta-analysis","volume":"15","author":"Zhao","year":"2019","journal-title":"Neuropsychiatr Dis Treat"},{"key":"10.1016\/S2213-8587(25)00036-1_bib19","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2015-2206","article-title":"The association of maternal obesity and diabetes with autism and other developmental disabilities","volume":"137","author":"Li","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(25)00036-1_bib20","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20787","article-title":"Associations of different types of maternal diabetes and body mass index with offspring psychiatric disorders","volume":"3","author":"Kong","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(25)00036-1_bib21","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1038\/s41591-024-02917-8","article-title":"Maternal diabetes and risk of attention-deficit\/hyperactivity disorder in offspring in a multinational cohort of 3.6 million mother-child pairs","volume":"30","author":"Chan","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00036-1_bib22","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.2337\/dc24-0108","article-title":"Long-term neurobehavioral and metabolic outcomes in offspring of mothers with diabetes during pregnancy: a large, population-based cohort study in Ontario, Canada","volume":"47","author":"Feig","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00036-1_bib23","doi-asserted-by":"crossref","first-page":"2976","DOI":"10.1017\/S0033291724001053","article-title":"Shared familial risk for type 2 diabetes mellitus and psychiatric disorders: a nationwide multigenerational genetics study","volume":"54","author":"Wimberley","year":"2024","journal-title":"Psychol Med"},{"key":"10.1016\/S2213-8587(25)00036-1_bib24","article-title":"Machine learning analysis with population data for prepregnancy and perinatal risk factors for the neurodevelopmental delay of offspring","volume":"14","author":"Yang","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(25)00036-1_bib25","series-title":"Cochrane handbook for systematic reviews of interventions: Cochrane book series","year":"2008"},{"key":"10.1016\/S2213-8587(25)00036-1_bib26","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00036-1_bib27","author":"Wells"},{"key":"10.1016\/S2213-8587(25)00036-1_bib28","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1136\/ebmental-2019-300117","article-title":"How to perform a meta-analysis with R: a practical tutorial","volume":"22","author":"Balduzzi","year":"2019","journal-title":"Evid Based Ment Health"},{"key":"10.1016\/S2213-8587(25)00036-1_bib29","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1002\/jrsm.12","article-title":"A basic introduction to fixed-effect and random-effects models for meta-analysis","volume":"1","author":"Borenstein","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/S2213-8587(25)00036-1_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f7450","article-title":"Converting an odds ratio to a range of plausible relative risks for better communication of research findings","volume":"348","author":"Grant","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00036-1_bib31","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(25)00036-1_bib32","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00036-1_bib33","series-title":"Meta-analysis with R","author":"Schwarzer","year":"2015"},{"key":"10.1016\/S2213-8587(25)00036-1_bib35","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1002\/jrsm.11","article-title":"Outlier and influence diagnostics for meta-analysis","volume":"1","author":"Viechtbauer","year":"2010","journal-title":"Res Synth Methods"},{"key":"10.1016\/S2213-8587(25)00036-1_bib36","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/jrsm.1053","article-title":"GOSH \u2014 a graphical display of study heterogeneity","volume":"3","author":"Olkin","year":"2012","journal-title":"Res Synth Methods"},{"key":"10.1016\/S2213-8587(25)00036-1_bib37","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00036-1_bib38","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1177\/1362361318772813","article-title":"Prenatal and perinatal risk factors and the clinical implications on autism spectrum disorder","volume":"23","author":"Chien","year":"2019","journal-title":"Autism"},{"key":"10.1016\/S2213-8587(25)00036-1_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.jped.2016.01.012","article-title":"Prenatal, perinatal and postnatal factors associated with autism spectrum disorder","volume":"92","author":"Hadjkacem","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(25)00036-1_bib40","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1089\/bfm.2012.0145","article-title":"Breastfeeding may protect from developing attention-deficit\/hyperactivity disorder","volume":"8","author":"Mimouni-Bloch","year":"2013","journal-title":"Breastfeed Med"},{"key":"10.1016\/S2213-8587(25)00036-1_bib41","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2019-3449","article-title":"Promoting optimal development: identifying infants and young children with developmental disorders through developmental surveillance and screening","volume":"145","author":"Lipkin","year":"2020","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(25)00036-1_bib42","series-title":"Early childhood developmental screening: a compendium of measures for children ages birth to five","author":"Moodie","year":"2014"},{"key":"10.1016\/S2213-8587(25)00036-1_bib43","article-title":"Evidence-informed milestones for developmental surveillance tools","volume":"149","author":"Zubler","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(25)00036-1_bib44","series-title":"Regional Office for Europe. Integrated care models: an overview: working document","year":"2016"},{"key":"10.1016\/S2213-8587(25)00036-1_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0269803","article-title":"Maternal and neonatal risk factors for autism spectrum disorder: a case-control study from Egypt","volume":"17","author":"Arafa","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(25)00036-1_bib46","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/s10995-021-03331-z","article-title":"Cognitive and motor development in 3- to 6-year-old children born to mothers with hyperglycaemia first detected in pregnancy in an urban African population","volume":"26","author":"Soepnel","year":"2022","journal-title":"Matern Child Health J"},{"key":"10.1016\/S2213-8587(25)00036-1_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.ejmhg.2011.02.011","article-title":"Risk factors for autism: an Egyptian study","volume":"12","author":"El-Baz","year":"2011","journal-title":"Egypt J Med Hum Genet"},{"key":"10.1016\/S2213-8587(25)00036-1_bib48","first-page":"141","article-title":"The association between gestational diabetes mellitus (GDM) in mothers and attention deficit\/hyperactivity disorder (ADHD) in their offspring","volume":"65","author":"Thongsookdee","year":"2020","journal-title":"J Psychiatr Assoc Thailand"},{"key":"10.1016\/S2213-8587(25)00036-1_bib49","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/0002-9378(69)90067-2","article-title":"Neuropsychological deficits in children of diabetic mothers. A report from the Collaborative Sdy of Cerebral Palsy","volume":"105","author":"Churchill","year":"1969","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(25)00036-1_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2023.101217","article-title":"Gestational diabetes mellitus and risk of neurodevelopmental disorders in young offspring: does the risk differ by race and ethnicity?","volume":"6","author":"Liu","year":"2024","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/S2213-8587(25)00036-1_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108269","article-title":"Association of maternal diabetes with attention deficit\/hyperactivity disorder (ADHD) in offspring: a meta-analysis and review","volume":"165","author":"Guo","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00036-1_bib52","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1111\/dmcn.15488","article-title":"Childhood neurodevelopmental disorders and maternal diabetes: a population-based cohort study","volume":"65","author":"Chen","year":"2023","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/S2213-8587(25)00036-1_bib53","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.2337\/dc18-0733","article-title":"Maternal gestational diabetes mellitus, type 1 diabetes, and type 2 diabetes during pregnancy and risk of ADHD in offspring","volume":"41","author":"Xiang","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00036-1_bib54","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1038\/s41582-021-00530-8","article-title":"Maternal immune activation and neuroinflammation in human neurodevelopmental disorders","volume":"17","author":"Han","year":"2021","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/S2213-8587(25)00036-1_bib55","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S2215-0366(19)30181-6","article-title":"Environmental risk factors and biomarkers for autism spectrum disorder: an umbrella review of the evidence","volume":"6","author":"Kim","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/S2213-8587(25)00036-1_bib56","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc09-1799","article-title":"Increased toll-like receptor (TLR) activation and TLR ligands in recently diagnosed type 2 diabetic subjects","volume":"33","author":"Dasu","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00036-1_bib57","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1038\/s41590-024-01797-x","article-title":"Prenatal and postnatal neuroimmune interactions in neurodevelopmental disorders","volume":"25","author":"Kim","year":"2024","journal-title":"Nat Immunol"},{"key":"10.1016\/S2213-8587(25)00036-1_bib58","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2020.5487","article-title":"Association of maternal autoimmune disease with attention-deficit\/hyperactivity disorder in children","volume":"175","author":"Nielsen","year":"2021","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(25)00036-1_bib59","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.neuint.2019.03.009","article-title":"Inflammatory domains modulate autism spectrum disorder susceptibility during maternal nutritional programming","volume":"126","author":"Maldonado-Ruiz","year":"2019","journal-title":"Neurochem Int"},{"key":"10.1016\/S2213-8587(25)00036-1_bib60","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1007\/s00125-013-3065-z","article-title":"Maternal diabetes in pregnancy and offspring cognitive ability: sibling study with 723,775 men from 579,857 families","volume":"57","author":"Fraser","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00036-1_bib61","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000009438","article-title":"Association of maternal diabetes with autism spectrum disorders in offspring: a systemic review and meta-analysis","volume":"97","author":"Wan","year":"2018","journal-title":"Medicine"},{"key":"10.1016\/S2213-8587(25)00036-1_bib62","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.neubiorev.2019.11.003","article-title":"Cumulative evidence for association of parental diabetes mellitus and attention-deficit\/hyperactivity disorder","volume":"117","author":"Zeng","year":"2020","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/S2213-8587(25)00036-1_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-84573-3","article-title":"The association between gestational diabetes and ASD and ADHD: a systematic review and meta-analysis","volume":"11","author":"Rowland","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(25)00036-1_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0142583","article-title":"Maternal diabetes and cognitive performance in the offspring: a systematic review and meta-analysis","volume":"10","author":"Camprubi Robles","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(25)00036-1_bib65","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1007\/s00125-019-4923-0","article-title":"Neurocognitive and behavioural outcomes in offspring exposed to maternal pre-existing diabetes: a systematic review and meta-analysis","volume":"62","author":"Yamamoto","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00036-1_bib66","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-011270","article-title":"early motor function of children with autism spectrum disorder: a systematic review","volume":"147","author":"Lim","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(25)00036-1_bib67","article-title":"Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up","volume":"367","author":"Yu","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00036-1_bib68","series-title":"Classification of diabetes mellitus","year":"2019"},{"key":"10.1016\/S2213-8587(25)00036-1_bib69","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.2337\/dc10-0719","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: response to Weinert","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00036-1_bib70","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/jama.2019.8584","article-title":"Hemoglobin A1c levels during pregnancy and risk of autism spectrum disorders in offspring","volume":"322","author":"Xiang","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00036-1_bib71","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1080\/J006v20n01_04","article-title":"Comparison of the motor development of school-age children born to mothers with and without diabetes mellitus","volume":"20","author":"Ratzon","year":"2000","journal-title":"Phys Occup Ther Pediatr"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00036-1_bib72","first-page":"681","article-title":"School-age children born to diabetic mothers and to mothers with gestational diabetes exhibit a high rate of inattention and fine and gross motor impairment","volume":"14","author":"Ornoy","year":"2001","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00036-1_bib73","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.5620","article-title":"Psychosocial factors and glycemic control in young adults with youth-onset type 2 diabetes","volume":"7","author":"Trief","year":"2024","journal-title":"JAMA Netw Open"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000361?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000361?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T20:13:40Z","timestamp":1748031220000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000361"}},"issued":{"date-parts":[[2025,6]]},"references-count":72,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2213858725000361"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00036-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between maternal diabetes and neurodevelopmental outcomes in children: a systematic review and meta-analysis of 202 observational studies comprising 56\u00b71 million pregnancies","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00036-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00087-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:36:30Z","timestamp":1789094190892,"version":"build-2803163510"},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009131","name":"Swiss Agency for Development and Cooperation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/s2213-8587(25)00029-4","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T23:33:52Z","timestamp":1740526432000},"page":"175-176","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Type 1 diabetes screening: need for ethical, equity, and health systems perspective"],"prefix":"10.1016","volume":"13","author":[{"given":"David","family":"Beran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Bandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuele","family":"Bosi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Boettcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Anne","family":"Burckhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Colange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Tousch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val\u00e9rie","family":"Schwitzgebel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00029-4_bib1","first-page":"1276","article-title":"Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes","volume":"47","author":"Phillip","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00029-4_bib2","first-page":"1","article-title":"ISPAD Clinical Practice Consensus Guidelines 2024: screening, staging, and strategies to preserve beta-cell function in children and adolescents with type 1 diabetes","volume":"11","author":"Haller","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(25)00029-4_bib3","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/dbi20-0054","article-title":"Screening for type 1 diabetes in the general population: a status report and perspective","volume":"71","author":"Sims","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(25)00029-4_bib4","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/S2213-8587(22)00384-9","article-title":"Teplizumab approval for type 1 diabetes in the USA","volume":"11","author":"Beran","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00029-4_bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00592-024-02245-w","article-title":"Use of teplizumab in children and adolescents at risk of type 1 diabetes: perspectives of parents and caregivers from an Italian pediatric diabetes center","volume":"61","author":"Bombaci","year":"2024","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(25)00029-4_bib6","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/S0140-6736(23)02295-X","article-title":"Population screening requires robust evidence-genomics is no exception","volume":"403","author":"Turnbull","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00029-4_bib7","series-title":"Principles and practice of screening for disease","author":"Wilson","year":"1968"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(25)00065-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000294?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000294?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T20:45:26Z","timestamp":1741466726000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000294"}},"issued":{"date-parts":[[2025,3]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213858725000294"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00029-4","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/S2213-8587(25)00065-8","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes screening: need for ethical, equity, and health systems perspective","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00029-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:00:32Z","timestamp":1788559232765,"version":"build-2803163510"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/s2213-8587(13)70149-9","type":"journal-article","created":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:43Z","timestamp":1383264043000},"page":"125-132","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"2","author":[{"given":"Nobuya","family":"Inagaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hitoshi","family":"Onouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuo","family":"Funao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shingo","family":"Kuroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70149-9_bib1","doi-asserted-by":"crossref","first-page":"S57","DOI":"10.1016\/S0895-4356(01)00457-7","article-title":"Treatment adherence in chronic disease","volume":"54","author":"Dunbar-Jacob","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(13)70149-9_bib2","article-title":"Interventions for enhancing medication adherence","volume":"2","author":"Haynes","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(13)70149-9_bib3","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.2337\/diacare.27.12.2800","article-title":"Clinical outcomes and adherence to medications measured by claims data in patients with diabetes","volume":"27","author":"Pladevall","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70149-9_bib4","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.2337\/diacare.27.5.1218","article-title":"A systematic review of adherence with medications for diabetes","volume":"27","author":"Cramer","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70149-9_bib5","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/01.mlr.0000114908.90348.f9","article-title":"Variations in patients'adherence to medical recommendations: a quantitative review of 50 years of research","volume":"42","author":"DiMatteo","year":"2004","journal-title":"Med Care"},{"key":"10.1016\/S2213-8587(13)70149-9_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.clinthera.2011.01.019","article-title":"A review of diabetes treatment adherence and the association with clinical and economic outcomes","volume":"33","author":"Asche","year":"2011","journal-title":"Clin Ther"},{"key":"10.1016\/S2213-8587(13)70149-9_bib7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70149-9_bib8","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70149-9_bib9","doi-asserted-by":"crossref","first-page":"S357","DOI":"10.2337\/dc09-S339","article-title":"A summary of the ADVANCE trial","volume":"32","author":"Hellar","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70149-9_bib10","first-page":"27","article-title":"Dosing frequency and medication adherence in chronic disease","volume":"18","author":"Coleman","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/S2213-8587(13)70149-9_bib11","doi-asserted-by":"crossref","first-page":"1696","DOI":"10.1016\/S0140-6736(06)69705-5","article-title":"The incretin system: glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors in type 2 diabetes","volume":"368","author":"Drucker","year":"2006","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(13)70149-9_bib12","doi-asserted-by":"crossref","first-page":"S16","DOI":"10.1331\/JAPhA.2009.09078","article-title":"Differential chemistry (structure), mechanism of action, and pharmacology of GLP-1 receptor agonists and DPP-4 inhibitors","volume":"49","author":"Neumiller","year":"2009","journal-title":"J Am Pharm Assoc"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(13)70149-9_bib13","first-page":"S-117","article-title":"[Title in Japanese]","volume":"55","author":"Matsuno","year":"2012","journal-title":"J Japan Diabetes Soc"},{"key":"10.1016\/S2213-8587(13)70149-9_bib14","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.2040-1124.2012.00207.x","article-title":"International clinical harmonization of glycated hemoglobin in Japan: from Japan Diabetes Society to National Glycohemoglobin Standardization Program values","volume":"3","author":"Kashiwagi","year":"2012","journal-title":"J Diab Invest"},{"key":"10.1016\/S2213-8587(13)70149-9_bib15","series-title":"Evidence-based Practice Guideline for the Treatment of Diabetes in Japan","year":"2007"},{"key":"10.1016\/S2213-8587(13)70149-9_bib16","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1185\/030079908X261069","article-title":"Sitagliptin, a DPP-4 inhibitor for the treatment of patients with type 2 diabetes: a review of recent clinical trials","volume":"24","author":"Karasik","year":"2008","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/S2213-8587(13)70149-9_bib17","doi-asserted-by":"crossref","first-page":"2614","DOI":"10.1016\/j.clinthera.2007.12.034","article-title":"Sitagliptin phosphate: a DPP-4 inhibitor for the treatment of type 2 diabetes mellitus","volume":"29","author":"Zerilli","year":"2007","journal-title":"Clin Ther"},{"key":"10.1016\/S2213-8587(13)70149-9_bib18","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1055\/s-2007-991172","article-title":"Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes","volume":"39","author":"Ahren","year":"2007","journal-title":"Horm Metab Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701499?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701499?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:22:56Z","timestamp":1539217376000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701499"}},"issued":{"date-parts":[[2014,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S2213858713701499"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70149-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SYR-472, a novel once-weekly dipeptidyl peptidase-4 (DPP-4) inhibitor, in type 2 diabetes mellitus: a phase 2, randomised, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70149-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70157-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T23:41:11Z","timestamp":1788392471359,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011541","name":"National Cancer Institute Division of Cancer Epidemiology and Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/s2213-8587(24)00269-9","type":"journal-article","created":{"date-parts":[[2024,10,7]],"date-time":"2024-10-07T18:37:40Z","timestamp":1728326260000},"page":"780-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["The growing global burden of thyroid cancer overdiagnosis"],"prefix":"10.1016","volume":"12","author":[{"given":"Cari M","family":"Kitahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00269-9_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00223-7","article-title":"Evolving epidemiological patterns of thyroid cancer and estimates of overdiagnosis in 2013\u201317 in 63 countries worldwide: a population-based study","author":"Li","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00269-9_bib2","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMp1604412","article-title":"Worldwide thyroid-cancer epidemic? The increasing impact of overdiagnosis","volume":"375","author":"Vaccarella","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00269-9_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-008696","article-title":"Overdiagnosis and overuse of diagnostic and screening tests in low-income and middle-income countries: a scoping review","volume":"7","author":"Albarqouni","year":"2022","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S2213-8587(24)00269-9_bib4","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1016\/j.eprac.2021.09.006","article-title":"Progress and challenges in thyroid cancer management","volume":"27","author":"Haymart","year":"2021","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(24)00269-9_bib5","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1200\/JCO.21.01841","article-title":"Association between radioactive iodine treatment for pediatric and young adulthood differentiated thyroid cancer and risk of second primary malignancies","volume":"40","author":"Pasqual","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(24)00269-9_bib6","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1089\/thy.2020.0321","article-title":"Reversal in thyroid cancer incidence trends in the United States, 2000\u20132017","volume":"30","author":"Lee","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(24)00269-9_bib7","doi-asserted-by":"crossref","first-page":"4087","DOI":"10.1002\/cam4.3926","article-title":"Decreasing trends in thyroid cancer incidence in South Korea: What happened in South Korea?","volume":"10","author":"Oh","year":"2021","journal-title":"Cancer Med"},{"key":"10.1016\/S2213-8587(24)00269-9_bib8","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1093\/jnci\/djz202","article-title":"Impact of overweight and obesity on US papillary thyroid cancer incidence trends (1995\u20132015)","volume":"112","author":"Kitahara","year":"2020","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(24)00269-9_bib9","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Murray","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00269-9_bib10","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/toxics9010014","article-title":"Endocrine disrupting chemicals and thyroid cancer: an overview","volume":"9","author":"Alsen","year":"2021","journal-title":"Toxics"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T18:59:29Z","timestamp":1729623569000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002699"}},"issued":{"date-parts":[[2024,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2213858724002699"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00269-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The growing global burden of thyroid cancer overdiagnosis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00269-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00223-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:11:53Z","timestamp":1789989113874,"version":"4.0.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/s2213-8587(19)30319-5","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T18:29:57Z","timestamp":1571164197000},"page":"828-829","source":"Crossref","is-referenced-by-count":11,"title":["Diabetes clusters and risk of diabetes-associated diseases \u2013 Authors' reply"],"prefix":"10.1016","volume":"7","author":[{"given":"Oana P","family":"Zaharia","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Kuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klaus","family":"Strassburger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Volker","family":"Burkart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Szendroedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30319-5_bib1","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30319-5_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30319-5_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s12933-016-0374-9","article-title":"Cohort profile: the German Diabetes Study (GDS)","volume":"15","author":"Szendroedi","year":"2016","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(19)30319-5_bib4","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.csda.2006.11.025","article-title":"Cluster-wise assessment of cluster stability","volume":"52","author":"Hennig","year":"2007","journal-title":"Comput Stat Data Anal"},{"key":"10.1016\/S2213-8587(19)30319-5_bib5","series-title":"International encyclopedia of statistical science","first-page":"206","article-title":"Categorical data analysis","author":"Agresti","year":"2011"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T16:21:37Z","timestamp":1572020497000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719303195"}},"issued":{"date-parts":[[2019,11]]},"references-count":5,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2213858719303195"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30319-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,11]]}},{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T08:55:04Z","timestamp":1790067304355,"version":"4.0.1"},"reference-count":95,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO 114"],"award-info":[{"award-number":["KFO 114"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STE 1096\/1-3"],"award-info":[{"award-number":["STE 1096\/1-3"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/s2213-8587(16)00082-6","type":"journal-article","created":{"date-parts":[[2016,5,14]],"date-time":"2016-05-14T00:21:34Z","timestamp":1463185294000},"page":"789-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"title":["Phenotypes of prediabetes and stratification of cardiometabolic risk"],"prefix":"10.1016","volume":"4","author":[{"given":"Norbert","family":"Stefan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Fritsche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz","family":"Schick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"H\u00e4ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)00082-6_bib1","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00082-6_bib2","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1001\/jama.2015.10029","article-title":"Prevalence of and trends in diabetes among adults in the United States, 1988\u20132012","volume":"314","author":"Menke","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)00082-6_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(16)00082-6_bib4","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S2213-8587(14)70144-5","article-title":"Diabetes in China: a societal solution for a personal challenge","volume":"2","author":"Chan","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib5","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(15)00508-2","article-title":"Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study","volume":"4","author":"Huo","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib6","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S2213-8587(13)70112-8","article-title":"Diabetes: a 21st century challenge","volume":"2","author":"Zimmet","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib7","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Seshasai","year":"2011","journal-title":"N Engl J Med"},{"issue":"suppl","key":"10.1016\/S2213-8587(16)00082-6_bib8","first-page":"S13","article-title":"Classification and diagnosis of diabetes","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib9","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1016\/S2213-8587(13)70175-X","article-title":"Definition of intervention points in prediabetes","volume":"2","author":"Ferrannini","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib10","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tab\u00e1k","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00082-6_bib11","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00082-6_bib12","doi-asserted-by":"crossref","first-page":"442","DOI":"10.2337\/dc09-0749","article-title":"Cardiovascular disease in type 2 diabetes from population to man to mechanisms: the Kelly West Award Lecture 2008","volume":"33","author":"Laakso","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib13","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture. From the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"Defronzo","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)00082-6_bib14","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/db08-1607","article-title":"Changes in insulin sensitivity and insulin release in relation to glycemia and glucose tolerance in 6,414 Finnish men","volume":"58","author":"Stanc\u00e1kov\u00e1","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)00082-6_bib15","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1056\/NEJMoa0801869","article-title":"Clinical risk factors, DNA variants, and the development of type 2 diabetes","volume":"359","author":"Lyssenko","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib16","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1007\/s00125-007-0899-2","article-title":"Insulin sensitivity, insulin release and glucagon-like peptide-1 levels in persons with impaired fasting glucose and\/or impaired glucose tolerance in the EUGENE2 study","volume":"51","author":"Laakso","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(16)00082-6_bib17","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI7231","article-title":"The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"104","author":"Weyer","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(16)00082-6_bib18","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diabres.2007.05.004","article-title":"Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies","volume":"78","author":"Gerstein","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(16)00082-6_bib19","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","author":"Knowler","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00082-6_bib20","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1007\/s00125-009-1289-8","article-title":"Plasma glucose levels as predictors of diabetes: the Mexico City diabetes study","volume":"52","author":"Ferrannini","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(16)00082-6_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2213-8587(15)00362-9","article-title":"Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study","volume":"4","author":"Ligthart","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib22","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/dc08-1264","article-title":"Fasting versus postload plasma glucose concentration and the risk for future type 2 diabetes: results from the Botnia Study","volume":"32","author":"Abdul-Ghani","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib23","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1573399811666150416122903","article-title":"Heterogeneity of pre-diabetes and type 2 diabetes: implications for prediction, prevention and treatment responsiveness","volume":"12","author":"Faerch","year":"2016","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/S2213-8587(16)00082-6_bib24","doi-asserted-by":"crossref","first-page":"439","DOI":"10.2337\/dc08-1195","article-title":"Natural history of insulin sensitivity and insulin secretion in the progression from normal glucose tolerance to impaired fasting glycemia and impaired glucose tolerance: the Inter99 study","volume":"32","author":"Faerch","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2213-8587(13)70008-1","article-title":"Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study","volume":"1","author":"Faerch","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib26","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1210\/jc.2014-2853","article-title":"Relationship between insulin resistance and \u03b2-cell dysfunction in subphenotypes of prediabetes and type 2 diabetes","volume":"100","author":"Faerch","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)00082-6_bib27","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF00418345","article-title":"Intra-individual variation of glucose, specific insulin and proinsulin concentrations measured by two oral glucose tolerance tests in a general Caucasian population: the Hoorn Study","volume":"39","author":"Mooy","year":"1996","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(16)00082-6_bib28","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.2014.1873","article-title":"Glycated hemoglobin measurement and prediction of cardiovascular disease","volume":"311","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)00082-6_bib29","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1007\/s00125-014-3238-4","article-title":"Basal insulin glargine and microvascular outcomes in dysglycaemic individuals: results of the Outcome Reduction with an Initial Glargine Intervention (ORIGIN) trial","volume":"57","author":"Gilbert","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(16)00082-6_bib30","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.2337\/dc12-2129","article-title":"Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE)","volume":"36","author":"Lonn","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib31","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib32","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/S2213-8587(14)70062-2","article-title":"Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial","volume":"2","author":"Cukierman-Yaffe","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib33","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)00082-6_bib34","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.2337\/dc08-0369","article-title":"Insulin sensitivity measured with euglycemic clamp is independently associated with glomerular filtration rate in a community-based cohort","volume":"31","author":"Nerpin","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib35","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)00082-6_bib36","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/nm.2627","article-title":"The cellular and signaling networks linking the immune system and metabolism in disease","volume":"18","author":"Osborn","year":"2012","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib37","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2013.12.012","article-title":"What we talk about when we talk about fat","volume":"156","author":"Rosen","year":"2014","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(16)00082-6_bib38","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib39","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S2213-8587(13)70192-X","article-title":"Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study","volume":"2","author":"Tuligenga","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib40","doi-asserted-by":"crossref","first-page":"785","DOI":"10.7326\/M14-0737","article-title":"Diabetes in midlife and cognitive change over 20 years: a cohort study","volume":"161","author":"Rawlings","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib41","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMoa1215740","article-title":"Glucose levels and risk of dementia","volume":"369","author":"Crane","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib42","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archneurol.2010.225","article-title":"Insulin resistance and Alzheimer-like reductions in regional cerebral glucose metabolism for cognitively normal adults with prediabetes or early type 2 diabetes","volume":"68","author":"Baker","year":"2011","journal-title":"Arch Neurol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib43","doi-asserted-by":"crossref","first-page":"2928","DOI":"10.2337\/db10-0539","article-title":"Accelerated progression from mild cognitive impairment to dementia in people with diabetes","volume":"59","author":"Xu","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)00082-6_bib44","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ncpendmet0427","article-title":"Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1","volume":"3","author":"LeRoith","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)00082-6_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/S2213-8587(16)00082-6_bib46","doi-asserted-by":"crossref","first-page":"g7371","DOI":"10.1136\/bmj.g7371","article-title":"Blood glucose concentration and risk of pancreatic cancer: systematic review and dose-response meta-analysis","volume":"349","author":"Liao","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)00082-6_bib47","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.1007\/s00125-014-3361-2","article-title":"Prediabetes and the risk of cancer: a meta-analysis","volume":"57","author":"Huang","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(16)00082-6_bib48","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.tem.2015.08.001","article-title":"The IL-1 pathway in type 2 diabetes and cardiovascular complications","volume":"26","author":"Herder","year":"2015","journal-title":"Trends Endocrinol Metab"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(16)00082-6_bib49","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.2337\/dcS13-2011","article-title":"Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes","volume":"36","author":"DeFronzo","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib50","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance","volume":"364","author":"DeFronzo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib51","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMoa1001122","article-title":"Effect of nateglinide on the incidence of diabetes and cardiovascular events","volume":"362","author":"Holman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib52","doi-asserted-by":"crossref","first-page":"pe7","DOI":"10.1126\/scisignal.3110pe7","article-title":"ER stress in pancreatic \u03b2 cells: the thin red line between adaptation and failure","volume":"3","author":"Eizirik","year":"2010","journal-title":"Sci Signal"},{"key":"10.1016\/S2213-8587(16)00082-6_bib53","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib54","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1016\/S0140-6736(06)69701-8","article-title":"Sustained reduction in the incidence of type 2 diabetes by lifestyle intervention: follow-up of the Finnish Diabetes Prevention Study","volume":"368","author":"Lindstr\u00f6m","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00082-6_bib55","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib56","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib57","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","article-title":"The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study","volume":"371","author":"Li","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00082-6_bib58","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","article-title":"Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study","volume":"2","author":"Li","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib59","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1161\/CIR.0b013e3181e8edf1","article-title":"Interventions to promote physical activity and dietary lifestyle changes for cardiovascular risk factor reduction in adults: a scientific statement from the American Heart Association","volume":"122","author":"Artinian","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)00082-6_bib60","doi-asserted-by":"crossref","first-page":"857","DOI":"10.2337\/dc07-2162","article-title":"Determinants for the effectiveness of lifestyle intervention in the Finnish Diabetes Prevention Study","volume":"31","author":"Lindstr\u00f6m","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib61","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","article-title":"Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study","volume":"379","author":"Perreault","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00082-6_bib62","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2337\/dc09-0523","article-title":"Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program","volume":"32","author":"Perreault","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib63","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1056\/NEJM199312303292703","article-title":"Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians","volume":"329","author":"Lillioja","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib64","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","article-title":"Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study","volume":"373","author":"Tab\u00e1k","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00082-6_bib65","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S2213-8587(15)00336-8","article-title":"10-year trajectory of \u03b2-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study","volume":"4","author":"Ohn","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib66","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/2012.jama.11132","article-title":"Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults","volume":"308","author":"Neeland","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)00082-6_bib67","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/liv.12200","article-title":"Non-alcoholic fatty liver disease independently predicts prediabetes during a 7-year prospective follow-up","volume":"33","author":"Zelber-Sagi","year":"2013","journal-title":"Liver Int"},{"key":"10.1016\/S2213-8587(16)00082-6_bib68","doi-asserted-by":"crossref","first-page":"2877","DOI":"10.1007\/s00125-015-3760-z","article-title":"A high-risk phenotype associates with reduced improvement in glycaemia during a lifestyle intervention in prediabetes","volume":"58","author":"Stefan","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(16)00082-6_bib69","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.2337\/db11-0231","article-title":"The metabolically benign and malignant fatty liver","volume":"60","author":"Stefan","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)00082-6_bib70","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archinte.168.15.1609","article-title":"Identification and characterization of metabolically benign obesity in humans","volume":"168","author":"Stefan","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib71","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S2213-8587(13)70170-0","article-title":"Inhibition of 11\u03b2-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"2","author":"Stefan","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib72","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","article-title":"Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications","volume":"1","author":"Stefan","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib73","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"The obese without cardiometabolic risk factor clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999\u20132004)","volume":"168","author":"Wildman","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib74","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/archinte.167.7.642","article-title":"Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity","volume":"167","author":"McLaughlin","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib75","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1210\/jc.2004-0165","article-title":"Metabolic and body composition factors in subgroups of obesity: what do we know?","volume":"89","author":"Karelis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)00082-6_bib76","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/obr.12199","article-title":"Metabolically healthy and unhealthy obese\u2014the 2013 Stock Conference report","volume":"15","author":"Samocha-Bonet","year":"2014","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(16)00082-6_bib77","doi-asserted-by":"crossref","first-page":"2177","DOI":"10.2337\/dc15-1218","article-title":"Definitions of metabolic health and risk of future type 2 diabetes in BMI categories: a systematic review and network meta-analysis","volume":"38","author":"Lotta","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib78","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.metabol.2015.10.019","article-title":"Metabolic health and weight: understanding metabolically unhealthy normal weight or metabolically healthy obese patients","volume":"65","author":"Mathew","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(16)00082-6_bib79","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1210\/er.2008-0009","article-title":"Causes and metabolic consequences of Fatty liver","volume":"29","author":"Stefan","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(16)00082-6_bib80","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1056\/NEJMra0912063","article-title":"Risk of cardiovascular disease in patients with nonalcoholic fatty liver disease","volume":"363","author":"Targher","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib81","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(16)00082-6_bib82","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1016\/S2213-8587(14)70032-4","article-title":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","volume":"2","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib83","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/dc10-0665","article-title":"Prevalence, metabolic features, and prognosis of metabolically healthy obese Italian individuals: the Cremona Study","volume":"34","author":"Calori","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib84","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","article-title":"Are metabolically healthy overweight and obesity benign conditions?: A systematic review and meta-analysis","volume":"159","author":"Kramer","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib85","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jacc.2014.09.077","article-title":"The natural course of healthy obesity over 20 years","volume":"65","author":"Bell","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib86","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.2337\/dc12-1971","article-title":"Diabetes and cardiovascular disease outcomes in the metabolically healthy obese phenotype: a cohort study","volume":"36","author":"Appleton","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00082-6_bib87","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.jacc.2015.06.014","article-title":"Incidence of metabolic risk factors among healthy obese adults: 20-year follow-up","volume":"66","author":"Bell","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib88","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00125-012-2598-x","article-title":"Adiponectin: mechanistic insights and clinical implications","volume":"55","author":"Turer","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(16)00082-6_bib89","doi-asserted-by":"crossref","first-page":"R209","DOI":"10.1530\/EJE-14-0540","article-title":"Are metabolically healthy obese individuals really healthy?","volume":"171","author":"Bl\u00fcher","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib90","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2012.258","article-title":"The role of hepatokines in metabolism","volume":"9","author":"Stefan","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(16)00082-6_bib91","doi-asserted-by":"crossref","first-page":"39495","DOI":"10.1038\/nm.3116","article-title":"Circulating fetuin-A and free fatty acids interact to predict insulin resistance in humans","volume":"19","author":"Stefan","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib92","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1056\/NEJMc1412427","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Stefan","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00082-6_bib93","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.2337\/db14-0319","article-title":"Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity","volume":"63","author":"Scott","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)00082-6_bib94","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.2337\/db09-1568","article-title":"Detailed physiologic characterization reveals diverse mechanisms for novel genetic loci regulating glucose and insulin metabolism in humans","volume":"59","author":"Ingelsson","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)00082-6_bib95","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.jhep.2009.05.023","article-title":"Non-invasive assessment and quantification of liver steatosis by ultrasound, computed tomography and magnetic resonance","volume":"51","author":"Schwenzer","year":"2009","journal-title":"J Hepatol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:38Z","timestamp":1761991598000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716000826"}},"issued":{"date-parts":[[2016,9]]},"references-count":95,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2213858716000826"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)00082-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Phenotypes of prediabetes and stratification of cardiometabolic risk","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)00082-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T16:53:31Z","timestamp":1790614411976,"version":"4.1.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T00:00:00Z","timestamp":1697673600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/s2213-8587(23)00317-0","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T23:31:56Z","timestamp":1701473516000},"page":"29-38","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trial"],"prefix":"10.1016","volume":"12","author":[{"given":"Davaasambuu","family":"Ganmaa","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polyna","family":"Khudyakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uyanga","family":"Buyanjargal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enkhtsetseg","family":"Tserenkhuu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumiya","family":"Erdenenbaatar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuluun-Erdene","family":"Achtai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Narankhuu","family":"Yansanjav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Baigal","family":"Delgererekh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munkhzaya","family":"Ankhbat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enkhjargal","family":"Tsendjav","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Batbayar","family":"Ochirbat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Badamtsetseg","family":"Jargalsaikhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davaasambuu","family":"Enkhmaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian R","family":"Martineau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00317-0_bib1","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1359\/jbmr.040902","article-title":"Epidemiology of childhood fractures in Britain: a study using the general practice research database","volume":"19","author":"Cooper","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(23)00317-0_bib2","doi-asserted-by":"crossref","first-page":"148","DOI":"10.3109\/17453671003628780","article-title":"Epidemiology of fractures in children and adolescents","volume":"81","author":"Hedstr\u00f6m","year":"2010","journal-title":"Acta Orthop"},{"key":"10.1016\/S2213-8587(23)00317-0_bib3","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1136\/ip.4.3.194","article-title":"Fractures among children: incidence and impact on daily activities","volume":"4","author":"Kopjar","year":"1998","journal-title":"Inj Prev"},{"key":"10.1016\/S2213-8587(23)00317-0_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1067\/mem.2001.115882","article-title":"Injury prevention and control in children","volume":"38","author":"Mace","year":"2001","journal-title":"Ann Emerg Med"},{"key":"10.1016\/S2213-8587(23)00317-0_bib5","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.704647","article-title":"The impact of diet and physical activity on bone health in children and adolescents","volume":"12","author":"Proia","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(23)00317-0_bib6","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00317-0_bib7","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1007\/s00198-014-2783-5","article-title":"Vitamin D and skeletal health in infancy and childhood","volume":"25","author":"Moon","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(23)00317-0_bib8","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ajcnut.2023.05.028","article-title":"Vitamin D supplementation for improving bone density in vitamin D-deficient children and adolescents: systematic review and individual participant data meta-analysis of randomized controlled trials","volume":"118","author":"Wu","year":"2023","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00317-0_bib9","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1016\/S2666-7568(21)00172-0","article-title":"Global, regional, and national burden of bone fractures in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"2","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/S2213-8587(23)00317-0_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/nu13114175","article-title":"Prevalence and determinants of vitamin D deficiency in 9595 Mongolian schoolchildren: a cross-sectional study","volume":"13","author":"Bater","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(23)00317-0_bib11","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1056\/NEJMoa1915176","article-title":"Vitamin D supplements for prevention of tuberculosis infection and disease","volume":"383","author":"Ganmaa","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00317-0_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamapediatrics.2022.4581","article-title":"Influence of vitamin D supplementation on growth, body composition, and pubertal development among school-aged children in an area with a high prevalence of vitamin D deficiency: a randomized clinical trial","volume":"177","author":"Ganmaa","year":"2023","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(23)00317-0_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/nu12051514","article-title":"Diet and nutrition status of Mongolian adults","volume":"12","author":"Bromage","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(23)00317-0_bib15","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1203\/PDR.0b013e318163a286","article-title":"Quantitative ultrasound methods to assess bone mineral status in children: technical characteristics, performance, and clinical application","volume":"63","author":"Baroncelli","year":"2008","journal-title":"Pediatr Res"},{"key":"10.1016\/S2213-8587(23)00317-0_bib16","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.5740\/jaoacint.17-0259","article-title":"General steps to standardize the laboratory measurement of serum total 25-hydroxyvitamin D","volume":"100","author":"Sempos","year":"2017","journal-title":"J AOAC Int"},{"key":"10.1016\/S2213-8587(23)00317-0_bib17","article-title":"Influence of vitamin D supplementation on bone mineral content, bone turnover markers and fracture risk in South African schoolchildren: multicentre double-blind randomised placebo-controlled trial (ViDiKids)","author":"Middelkoop","year":"2023","journal-title":"MedRxiv"},{"key":"10.1016\/S2213-8587(23)00317-0_bib18","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1210\/clinem\/dgab742","article-title":"Vitamin D supplementation and fractures in adults: a systematic umbrella review of meta-analyses of controlled trials","volume":"107","author":"Chakhtoura","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00317-0_bib19","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1210\/jc.2015-2175","article-title":"Global consensus recommendations on prevention and management of nutritional rickets","volume":"101","author":"Munns","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00317-0_bib20","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1007\/s00198-011-1817-5","article-title":"Quantitative ultrasound of the heel and fracture risk assessment: an updated meta-analysis","volume":"23","author":"Moayyeri","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(23)00317-0_bib21","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1359\/JBMR.040401","article-title":"Quantitative ultrasound assessment in children with fractures","volume":"19","author":"Schalamon","year":"2004","journal-title":"J Bone Miner Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T21:04:27Z","timestamp":1741208667000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003170"}},"issued":{"date-parts":[[2024,1]]},"references-count":20,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213858723003170"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00317-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00317-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00353-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T14:35:06Z","timestamp":1790778906306,"version":"4.1.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Heisenberg Professorship from the Deutsche Forschungsgemeinschaft","award":["DFG 1096\/3\u20131"],"award-info":[{"award-number":["DFG 1096\/3\u20131"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/s2213-8587(15)00474-x","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T08:30:40Z","timestamp":1453969840000},"page":"457-467","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":102,"title":["Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications"],"prefix":"10.1016","volume":"4","author":[{"given":"Norbert","family":"Stefan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans-Ulrich","family":"H\u00e4ring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank B","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias B","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00474-X_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1016\/S0140-6736(14)60648-6","article-title":"Prevention of chronic disease in the 21st century: elimination of the leading preventable causes of premature death and disability in the USA","volume":"384","author":"Bauer","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib3","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(15)00474-X_bib4","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1093\/ije\/dys086","article-title":"Adult height and the risk of cause-specific death and vascular morbidity in 1 million people: individual participant meta-analysis","volume":"41","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1136\/jech.57.2.141","article-title":"Associations of height, leg length, and lung function with cardiovascular risk factors in the Midspan Family Study","volume":"57","author":"Gunnell","year":"2003","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(15)00474-X_bib6","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1359\/jbmr.070814","article-title":"Risk factors for vertebral and nonvertebral fracture over 10 years: a population-based study in women","volume":"23","author":"Finigan","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(15)00474-X_bib7","doi-asserted-by":"crossref","first-page":"e41","DOI":"10.1371\/journal.pgen.0020041","article-title":"Assumption-free estimation of heritability from genome-wide identity-by-descent sharing between full siblings","volume":"2","author":"Visscher","year":"2006","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib8","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng.2477","article-title":"New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism","volume":"45","author":"Horikoshi","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib9","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1038\/ng.3097","article-title":"Defining the role of common variation in the genomic and biological architecture of adult human height","volume":"46","author":"Wood","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/j.ehb.2010.03.001","article-title":"Long run trends in the heights of European men, 19th\u201320th centuries","volume":"8","author":"Hatton","year":"2010","journal-title":"Econ Hum Biol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib11","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1080\/03014460601116803","article-title":"The mysterious trend in American heights in the 20th century","volume":"34","author":"Komlos","year":"2007","journal-title":"Ann Hum Biol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib12","first-page":"573","article-title":"Secular changes of stature in rural children and adolescents in China, 1985\u20132010","volume":"27","author":"Chen","year":"2014","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/S2213-8587(15)00474-X_bib13","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.ehb.2014.07.002","article-title":"The role of nutrition and genetics as key determinants of the positive height trend","volume":"15","author":"Grasgruber","year":"2014","journal-title":"Econ Hum Biol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib14","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1002\/ajhb.20770","article-title":"Secular changes in stature and body mass index for Chinese youth in sixteen major cities, 1950s\u20132005","volume":"20","author":"Ji","year":"2008","journal-title":"Am J Hum Biol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib15","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/156482651103200103","article-title":"Secular trends in height in different states of India in relation to socioeconomic characteristics and dietary intakes","volume":"32","author":"Mamidi","year":"2011","journal-title":"Food Nutr Bull"},{"key":"10.1016\/S2213-8587(15)00474-X_bib16","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1056\/NEJMra1109345","article-title":"Noncommunicable diseases","volume":"369","author":"Hunter","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00474-X_bib17","doi-asserted-by":"crossref","first-page":"2694","DOI":"10.1056\/NEJMoa042135","article-title":"Adiposity as compared with physical activity in predicting mortality among women","volume":"351","author":"Hu","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00474-X_bib18","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","article-title":"General and abdominal adiposity and risk of death in Europe","volume":"359","author":"Pischon","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00474-X_bib19","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1093\/annonc\/mdp363","article-title":"Adult height and cancer mortality in Asia: the Asia Pacific Cohort Studies Collaboration","volume":"21","author":"Batty","year":"2010","journal-title":"Ann Oncol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib20","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1093\/aje\/kwp107","article-title":"Competing risk regression models for epidemiologic data","volume":"170","author":"Lau","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.2307\/2532940","article-title":"Applying Cox regression to competing risks","volume":"51","author":"Lunn","year":"1995","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(15)00474-X_bib22","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1093\/aje\/kwq368","article-title":"Risk factors for mortality in the nurses' health study: a competing risks analysis","volume":"173","author":"Baer","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib23","doi-asserted-by":"crossref","first-page":"2546","DOI":"10.1001\/archinte.166.22.2546","article-title":"Height loss in older men\u2014associations with total mortality and incidence of cardiovascular disease","volume":"166","author":"Wannamethee","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(15)00474-X_bib24","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1093\/eurheartj\/ehq155","article-title":"Short stature is associated with coronary heart disease: a systematic review of the literature and a meta-analysis","volume":"31","author":"Paajanen","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(15)00474-X_bib25","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1007\/s10654-013-9867-y","article-title":"Adult height and risk of ischemic heart disease, atrial fibrillation, stroke, venous thromboembolism, and premature death: a population based 36-year follow-up study","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib26","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1093\/ije\/dyp150","article-title":"Adult height and the risks of cardiovascular disease and major causes of death in the Asia-Pacific region: 21,000 deaths in 510,000 men and women","volume":"38","author":"Lee","year":"2009","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib27","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1093\/aje\/155.8.683","article-title":"Height in young adulthood and risk of death from cardiorespiratory disease: a prospective study of male former students of Glasgow University, Scotland","volume":"155","author":"McCarron","year":"2002","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib28","doi-asserted-by":"crossref","first-page":"1172","DOI":"10.1111\/j.1467-789X.2012.01030.x","article-title":"Hip circumference, height and risk of type 2 diabetes: systematic review and meta-analysis","volume":"13","author":"Janghorbani","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(15)00474-X_bib29","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S1470-2045(11)70154-1","article-title":"Height and cancer incidence in the Million Women Study: prospective cohort, and meta-analysis of prospective studies of height and total cancer risk","volume":"12","author":"Green","year":"2011","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib30","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1007\/s10552-012-9983-0","article-title":"Height and pancreatic cancer risk: a systematic review and meta-analysis of cohort studies","volume":"23","author":"Aune","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(15)00474-X_bib31","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1007\/s00432-014-1870-5","article-title":"Height and kidney cancer risk: a meta-analysis of prospective studies","volume":"141","author":"Liang","year":"2014","journal-title":"J Cancer Res Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib32","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1158\/1055-9965.EPI-08-0342","article-title":"Height and prostate cancer risk: a large nested case-control study (ProtecT) and meta-analysis","volume":"17","author":"Zuccolo","year":"2008","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(15)00474-X_bib33","doi-asserted-by":"crossref","first-page":"e1003284","DOI":"10.1371\/journal.pgen.1003284","article-title":"Evidence of gene-environment interactions between common breast cancer susceptibility loci and established environmental risk factors","volume":"9","author":"Nickels","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib34","first-page":"107","article-title":"Height and breast cancer risk: evidence from prospective studies and Mendelian randomization","author":"Zhang","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(15)00474-X_bib35","doi-asserted-by":"crossref","first-page":"djt465","DOI":"10.1093\/jnci\/djt465","article-title":"Anthropometric and hormonal risk factors for male breast cancer: male breast cancer pooling project results","volume":"106","author":"Brinton","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(15)00474-X_bib36","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.ehb.2012.04.003","article-title":"Associations of mortality with own height using son's height as an instrumental variable","volume":"11","author":"Carslake","year":"2013","journal-title":"Econ Hum Biol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib37","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMoa1404881","article-title":"Genetically determined height and coronary artery disease","volume":"372","author":"Nelson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00474-X_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyv074","article-title":"Adult height, coronary heart disease and stroke: a multi-locus Mendelian randomization meta-analysis","author":"N\u00fcesch","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib39","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1093\/ije\/dyv082","article-title":"Mendelian randomization study of height and risk of colorectal cancer","volume":"44","author":"Thrift","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib40","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10552-015-0654-9","article-title":"The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium","volume":"26","author":"Davies","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(15)00474-X_bib41","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1136\/jech.52.3.142","article-title":"Childhood leg length and adult mortality: follow up of the Carnegie (Boyd Orr) Survey of Diet and Health in Pre-war Britain","volume":"52","author":"Gunnell","year":"1998","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(15)00474-X_bib42","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1136\/jech.2009.104216","article-title":"The association of childhood height, leg length and other measures of skeletal growth with adult cardiovascular disease: the Boyd-Orr cohort","volume":"66","author":"Whitley","year":"2012","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(15)00474-X_bib43","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1007\/s00125-002-0887-5","article-title":"The association between components of adult height and Type II diabetes and insulin resistance: British Women's Heart and Health Study","volume":"45","author":"Lawlor","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00474-X_bib44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1093\/oxfordjournals.epirev.a000809","article-title":"Height, leg length, and cancer risk: a systematic review","volume":"23","author":"Gunnell","year":"2001","journal-title":"Epidemiol Rev"},{"key":"10.1016\/S2213-8587(15)00474-X_bib45","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1038\/sj.bjc.6600972","article-title":"Associations of adult measures of childhood growth with breast cancer: findings from the British Women's Heart and Health Study","volume":"89","author":"Lawlor","year":"2003","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(15)00474-X_bib46","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s10552-008-9239-1","article-title":"Childhood stature and adult cancer risk: the Boyd Orr cohort","volume":"20","author":"Whitley","year":"2009","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(15)00474-X_bib47","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1056\/NEJMoa040576","article-title":"Growth patterns and the risk of breast cancer in women","volume":"351","author":"Ahlgren","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00474-X_bib48","series-title":"The changing body: health, nutrition, and human development in the western world since 1700","author":"Floud","year":"2011"},{"key":"10.1016\/S2213-8587(15)00474-X_bib49","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1093\/aje\/kwn187","article-title":"Adult height and the risk of mortality in South Korean women","volume":"168","author":"Song","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib50","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1093\/ije\/dyr173","article-title":"Associations of adult height and its components with mortality: a report from cohort studies of 135,000 Chinese women and men","volume":"40","author":"Wang","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib51","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1136\/jech.54.2.97","article-title":"Height and risk of death among men and women: aetiological implications of associations with cardiorespiratory disease and cancer mortality","volume":"54","author":"Davey Smith","year":"2000","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(15)00474-X_bib52","doi-asserted-by":"crossref","first-page":"1776","DOI":"10.1093\/ije\/dys149","article-title":"Parental height in relation to offspring coronary heart disease: examining transgenerational influences on health using the west of Scotland Midspan Family Study","volume":"41","author":"Gray","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib53","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.anbehav.2013.03.038","article-title":"The height of choosiness: mutual mate choice for stature results in suboptimal pair formation for both sexes","volume":"86","author":"Stulp","year":"2013","journal-title":"Anim Behav"},{"key":"10.1016\/S2213-8587(15)00474-X_bib54","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1378\/chest.127.6.1952","article-title":"The relationship between reduced lung function and cardiovascular mortality: a population-based study and a systematic review of the literature","volume":"127","author":"Sin","year":"2005","journal-title":"Chest"},{"key":"10.1016\/S2213-8587(15)00474-X_bib55","doi-asserted-by":"crossref","first-page":"R984","DOI":"10.1152\/ajpregu.00036.2011","article-title":"Body height and blood pressure regulation in humans during anti-orthostatic tilting","volume":"302","author":"Arvedsen","year":"2012","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib56","doi-asserted-by":"crossref","first-page":"756","DOI":"10.3389\/fpsyg.2014.00756","article-title":"Heart rate variability biofeedback: how and why does it work?","volume":"5","author":"Lehrer","year":"2014","journal-title":"Front Psychol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib57","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S0002-8703(97)70202-3","article-title":"Higher prevalence and greater severity of coronary disease in short versus tall men referred for coronary arteriography","volume":"133","author":"Nwasokwa","year":"1997","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(15)00474-X_bib58","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1126\/science.1230721","article-title":"Pleiotropic actions of insulin resistance and inflammation in metabolic homeostasis","volume":"339","author":"Odegaard","year":"2013","journal-title":"Science"},{"key":"10.1016\/S2213-8587(15)00474-X_bib59","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.2337\/dc05-1997","article-title":"Short stature and the risk of adiposity, insulin resistance, and type 2 diabetes in middle age: the Third National Health and Nutrition Examination Survey (NHANES III), 1988\u20131994","volume":"29","author":"Asao","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00474-X_bib60","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1046\/j.1365-2265.2003.01857.x","article-title":"An investigation of fetal, postnatal and childhood growth with insulin-like growth factor I and binding protein 3 in adulthood","volume":"59","author":"Ben-Shlomo","year":"2003","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(15)00474-X_bib61","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ncpendmet0427","article-title":"Mechanisms of disease: metabolic effects of growth hormone and insulin-like growth factor 1","volume":"3","author":"LeRoith","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00474-X_bib62","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00474-X_bib63","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archinte.168.15.1609","article-title":"Identification and characterization of metabolically benign obesity in humans","volume":"168","author":"Stefan","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(15)00474-X_bib64","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00474-X_bib65","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1038\/nrendo.2012.258","article-title":"The role of hepatokines in metabolism","volume":"9","author":"Stefan","year":"2013","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib66","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1038\/nrc3215","article-title":"The insulin and insulin-like growth factor receptor family in neoplasia: an update","volume":"12","author":"Pollak","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/S2213-8587(15)00474-X_bib67","doi-asserted-by":"crossref","first-page":"3686","DOI":"10.1210\/jcem.86.8.7722","article-title":"The role of IGF-binding proteins in mediating the effects of recombinant human IGF-I on insulin requirements in type 1 diabetes mellitus","volume":"86","author":"Crowne","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00474-X_bib68","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1126\/science.279.5350.563","article-title":"Plasma insulin-like growth factor-I and prostate cancer risk: a prospective study","volume":"279","author":"Chan","year":"1998","journal-title":"Science"},{"key":"10.1016\/S2213-8587(15)00474-X_bib69","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1016\/S0140-6736(97)10384-1","article-title":"Circulating concentrations of insulin-like growth factor-I and risk of breast cancer","volume":"351","author":"Hankinson","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib70","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/hmg\/ddu583","article-title":"Meta-analysis of genome-wide association studies of adult height in East Asians identifies 17 novel loci","volume":"24","author":"He","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib71","doi-asserted-by":"crossref","first-page":"70ra13","DOI":"10.1126\/scitranslmed.3001845","article-title":"Growth hormone receptor deficiency is associated with a major reduction in pro-aging signaling, cancer, and diabetes in humans","volume":"3","author":"Guevara-Aguirre","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(15)00474-X_bib72","doi-asserted-by":"crossref","first-page":"R321","DOI":"10.1530\/ERC-13-0231","article-title":"IGF2 and cancer","volume":"20","author":"Livingstone","year":"2013","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(15)00474-X_bib73","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/endo-124-6-3077","article-title":"Effects of insulin-like growth factors I and II on growth and differentiation of transplanted rat embryos and fetal tissues","volume":"124","author":"Liu","year":"1989","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(15)00474-X_bib74","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(15)00474-X_bib75","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s10911-013-9303-7","article-title":"Insulin and IGFs in obesity-related breast cancer","volume":"18","author":"Belardi","year":"2013","journal-title":"J Mammary Gland Biol Neoplasia"},{"key":"10.1016\/S2213-8587(15)00474-X_bib76","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1210\/er.2012-1033","article-title":"Tumors, IGF-2, and hypoglycemia: insights from the clinic, the laboratory, and the historical archive","volume":"34","author":"Dynkevich","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(15)00474-X_bib77","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/ng.125","article-title":"Identification of ten loci associated with height highlights new biological pathways in human growth","volume":"40","author":"Lettre","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib78","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1038\/ng.392","article-title":"Lin28 promotes transformation and is associated with advanced human malignancies","volume":"41","author":"Viswanathan","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib79","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.cell.2008.09.017","article-title":"Hmga2 promotes neural stem cell self-renewal in young but not old mice by reducing p16Ink4a and p19Arf expression","volume":"135","author":"Nishino","year":"2008","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(15)00474-X_bib80","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1038\/414768a","article-title":"c-Myc regulates mammalian body size by controlling cell number but not cell size","volume":"414","author":"Trumpp","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(15)00474-X_bib81","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1038\/ng2121","article-title":"A common variant of HMGA2 is associated with adult and childhood height in the general population","volume":"39","author":"Weedon","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib82","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/ng.593","article-title":"Lin28a transgenic mice manifest size and puberty phenotypes identified in human genetic association studies","volume":"42","author":"Zhu","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib83","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/j.cell.2011.08.033","article-title":"The Lin28\/let-7 axis regulates glucose metabolism","volume":"147","author":"Zhu","year":"2011","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(15)00474-X_bib84","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1126\/science.1160809","article-title":"Understanding the Warburg effect: the metabolic requirements of cell proliferation","volume":"324","author":"Vander Heiden","year":"2009","journal-title":"Science"},{"key":"10.1016\/S2213-8587(15)00474-X_bib85","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.tcb.2012.06.001","article-title":"How does Lin28 let-7 control development and disease?","volume":"22","author":"Thornton","year":"2012","journal-title":"Trends Cell Biol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib86","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1126\/science.1260825","article-title":"Cancer etiology. Variation in cancer risk among tissues can be explained by the number of stem cell divisions","volume":"347","author":"Tomasetti","year":"2015","journal-title":"Science"},{"key":"10.1016\/S2213-8587(15)00474-X_bib87","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1126\/science.347.6219.224","article-title":"Science Communication. Backlash greets \u2018bad luck\u2019 cancer study and coverage","volume":"347","author":"Couzin-Frankel","year":"2015","journal-title":"Science"},{"key":"10.1016\/S2213-8587(15)00474-X_bib88","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1093\/jnci\/80.10.772","article-title":"Are cell number and cell proliferation risk factors for cancer?","volume":"80","author":"Albanes","year":"1988","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(15)00474-X_bib89","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.cmet.2014.02.006","article-title":"Low protein intake is associated with a major reduction in IGF-1, cancer, and overall mortality in the 65 and younger but not older population","volume":"19","author":"Levine","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(15)00474-X_bib90","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.3945\/ajcn.2008.26838","article-title":"Meta-analysis of animal fat or animal protein intake and colorectal cancer","volume":"89","author":"Alexander","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00474-X_bib91","first-page":"84","article-title":"Nutritional predictors of insulin-like growth factor I and their relationships to cancer in men","volume":"12","author":"Giovannucci","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(15)00474-X_bib92","first-page":"852","article-title":"Dietary correlates of plasma insulin-like growth factor I and insulin-like growth factor binding protein 3 concentrations","volume":"11","author":"Holmes","year":"2002","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(15)00474-X_bib93","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1093\/ajcn\/81.5.1163","article-title":"Association of diet with serum insulin-like growth factor I in middle-aged and elderly men","volume":"81","author":"Larsson","year":"2005","journal-title":"Am J Clin Nutr"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00474-X_bib94","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000090640","article-title":"Overview of the IGF-I system","volume":"65","author":"Cohen","year":"2006","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(15)00474-X_bib95","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1136\/bmj.315.7118.1255","article-title":"Milk intake and bone mineral acquisition in adolescent girls: randomised, controlled intervention trial","volume":"315","author":"Cadogan","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00474-X_bib96","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1038\/sj.ejcn.1601948","article-title":"High intakes of skimmed milk, but not meat, increase serum IGF-I and IGFBP-3 in eight-year-old boys","volume":"58","author":"Hoppe","year":"2004","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00474-X_bib97","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1080\/03014460802680466","article-title":"Consumption of milk, but not other dairy products, is associated with height among US preschool children in NHANES 1999-2002","volume":"36","author":"Wiley","year":"2009","journal-title":"Ann Hum Biol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib99","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1038\/ng1607","article-title":"Demonstrating stratification in a European American population","volume":"37","author":"Campbell","year":"2005","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(15)00474-X_bib100","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/nbu.12086","article-title":"Dairy and cardiovascular health: friend or foe?","volume":"39","author":"Markey","year":"2014","journal-title":"Nutr Bull"},{"key":"10.1016\/S2213-8587(15)00474-X_bib101","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3945\/ajcn.113.059030","article-title":"Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies","volume":"98","author":"Aune","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00474-X_bib102","doi-asserted-by":"crossref","first-page":"87","DOI":"10.3945\/ajcn.113.067157","article-title":"Dairy products, calcium, and prostate cancer risk: a systematic review and meta-analysis of cohort studies","volume":"101","author":"Aune","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00474-X_bib103","doi-asserted-by":"crossref","first-page":"g6015","DOI":"10.1136\/bmj.g6015","article-title":"Milk intake and risk of mortality and fractures in women and men: cohort studies","volume":"349","author":"Micha\u00eblsson","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00474-X_bib104","doi-asserted-by":"crossref","first-page":"487","DOI":"10.3945\/ajcn.114.105049","article-title":"Milk intake is not associated with low risk of diabetes or overweight-obesity: a Mendelian randomization study in 97,811 Danish individuals","volume":"102","author":"Bergholdt","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00474-X_bib105","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1093\/ije\/dyv109","article-title":"Milk intake is not associated with ischaemic heart disease in observational or Mendelian randomization analyses in 98\u2008529 Danish adults","volume":"44","author":"Bergholdt","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib106","doi-asserted-by":"crossref","first-page":"1901","DOI":"10.1002\/ijc.27836","article-title":"Genetic variation in the lactase gene, dairy product intake and risk for prostate cancer in the European prospective investigation into cancer and nutrition","volume":"132","author":"Travis","year":"2013","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(15)00474-X_bib107","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1038\/ejcn.2009.34","article-title":"Differential effects of casein versus whey on fasting plasma levels of insulin, IGF-1 and IGF-1\/IGFBP-3: results from a randomized 7-day supplementation study in prepubertal boys","volume":"63","author":"Hoppe","year":"2009","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00474-X_bib108","doi-asserted-by":"crossref","first-page":"1250256","DOI":"10.1126\/science.1250256","article-title":"Cell biology. Metabolic control of cell death","volume":"345","author":"Green","year":"2014","journal-title":"Science"},{"key":"10.1016\/S2213-8587(15)00474-X_bib109","article-title":"Does milk and dairy consumption during pregnancy influence fetal growth and infant birthweight? A systematic literature review","volume":"56","author":"Brantsaeter","year":"2012","journal-title":"Food Nutr Res"},{"key":"10.1016\/S2213-8587(15)00474-X_bib110","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0899-9007(97)00193-7","article-title":"Maternal nutrition, fetal nutrition, and disease in later life","volume":"13","author":"Barker","year":"1997","journal-title":"Nutrition"},{"key":"10.1016\/S2213-8587(15)00474-X_bib111","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1073\/pnas.0806560105","article-title":"Persistent epigenetic differences associated with prenatal exposure to famine in humans","volume":"105","author":"Heijmans","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(15)00474-X_bib112","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/j.placenta.2013.07.063","article-title":"Placental programming of chronic diseases, cancer and lifespan: a review","volume":"34","author":"Barker","year":"2013","journal-title":"Placenta"},{"key":"10.1016\/S2213-8587(15)00474-X_bib113","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1056\/NEJMoa044160","article-title":"Trajectories of growth among children who have coronary events as adults","volume":"353","author":"Barker","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00474-X_bib114","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1002\/ajhb.22409","article-title":"The shape of the placental surface at birth and colorectal cancer in later life","volume":"25","author":"Barker","year":"2013","journal-title":"Am J Hum Biol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib115","doi-asserted-by":"crossref","first-page":"1722","DOI":"10.1093\/ajcn\/86.6.1722","article-title":"Childhood dairy intake and adult cancer risk: 65-y follow-up of the Boyd Orr cohort","volume":"86","author":"van der Pols","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00474-X_bib116","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1002\/ajhb.22201","article-title":"Cow milk consumption, insulin-like growth factor-I, and human biology: a life history approach","volume":"24","author":"Wiley","year":"2012","journal-title":"Am J Hum Biol"},{"key":"10.1016\/S2213-8587(15)00474-X_bib117","doi-asserted-by":"crossref","first-page":"e356","DOI":"10.1136\/bmj.e356","article-title":"25 year trends in first time hospitalisation for acute myocardial infarction, subsequent short and long term mortality, and the prognostic impact of sex and comorbidity: a Danish nationwide cohort study","volume":"344","author":"Schmidt","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00474-X_bib118","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/ijo.2012.201","article-title":"Optimal scaling of weight and waist circumference to height for maximal association with DXA-measured total body fat mass by sex, age and race\/ethnicity","volume":"37","author":"Heo","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(15)00474-X_bib119","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/ajpa.20107","article-title":"Weight-height relationships and body mass index: some observations from the Diverse Populations Collaboration","volume":"128","year":"2005","journal-title":"Am J Phys Anthropol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500474X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500474X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,4]],"date-time":"2019-09-04T02:30:29Z","timestamp":1567564229000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871500474X"}},"issued":{"date-parts":[[2016,5]]},"references-count":118,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S221385871500474X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00474-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00474-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:43Z","timestamp":1792097383842,"version":"4.4.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007687","name":"Swedish Society of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007687","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/s2213-8587(26)00162-2","type":"journal-article","created":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T22:53:37Z","timestamp":1788303217000},"page":"903-913","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case\u2013control study"],"prefix":"10.1016","volume":"14","author":[{"given":"Erik","family":"Kadesj\u00f6","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"S\u00f6derling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Hviid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor","family":"Wintzell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Svanstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Eliasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soffia","family":"Gudbj\u00f6rnsd\u00f3ttir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Melbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Hveem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jonasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel P","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00162-2_bib1","doi-asserted-by":"crossref","first-page":"2000","DOI":"10.1007\/s00125-022-05773-8","article-title":"SGLT2 inhibitors in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials balancing their risks and benefits","volume":"65","author":"Marilly","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00162-2_bib2","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.2337\/dc15-1251","article-title":"Diabetic ketoacidosis and related events in the canagliflozin type 2 Diabetes Clinical Program","volume":"38","author":"Erondu","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00162-2_bib3","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa2030186","article-title":"Sotagliflozin in patients with diabetes and chronic kidney disease","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00162-2_bib4","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00162-2_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00162-2_bib6","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa2004967","article-title":"Cardiovascular outcomes with ertugliflozin in type 2 diabetes","volume":"383","author":"Cannon","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00162-2_bib7","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00162-2_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107797","article-title":"Defining and characterising diabetic ketoacidosis in adults","volume":"155","author":"Dhatariya","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(26)00162-2_bib9","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcjd.2021.04.006","article-title":"Sodium-glucose cotransporter-2 inhibitors and risk of diabetic ketoacidosis among adults with type 2 diabetes: a systematic review and meta-analysis","volume":"46","author":"Colacci","year":"2022","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(26)00162-2_bib10","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1093\/ehjcvp\/pvae045","article-title":"Comparative cardiovascular and renal effectiveness of empagliflozin and dapagliflozin: Scandinavian cohort study","volume":"10","author":"Engstr\u00f6m","year":"2024","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/S2213-8587(26)00162-2_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.7326\/M20-0289","article-title":"sodium-glucose cotransporter-2 inhibitors and the risk for diabetic ketoacidosis: a multicenter cohort study","volume":"173","author":"Douros","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(26)00162-2_bib12","doi-asserted-by":"crossref","first-page":"919","DOI":"10.2337\/dc21-2177","article-title":"Comparative safety of sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors and sulfonylureas on the risk of diabetic ketoacidosis","volume":"45","author":"Dawwas","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00162-2_bib13","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s11606-020-06561-z","article-title":"Identifying risk factors for diabetic ketoacidosis associated with SGLT2 inhibitors: a nationwide cohort study in the USA","volume":"36","author":"Fralick","year":"2021","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S2213-8587(26)00162-2_bib14","doi-asserted-by":"crossref","first-page":"2750","DOI":"10.1111\/dom.16282","article-title":"A systematic literature review on the burden of diabetic ketoacidosis in type 2 diabetes mellitus","volume":"27","author":"Wysham","year":"2025","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00162-2_bib15","doi-asserted-by":"crossref","first-page":"1680","DOI":"10.1007\/s00125-025-06439-x","article-title":"Treatment discontinuation among users of GLP-1 receptor agonists and SGLT2 inhibitors in a national population of individuals with type 2 diabetes","volume":"68","author":"Lim","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00162-2_bib16","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.2337\/dci24-0032","article-title":"Hyperglycemic Crises in Adults With Diabetes: A Consensus Report","volume":"47","author":"Umpierrez","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00162-2_bib17","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/14740338.2023.2275704","article-title":"The risk factors of diabetic ketosis and diabetic ketoacidosis among patients with type 2 diabetes mellitus treated with SGLT2 inhibitors: a retrospective study","volume":"23","author":"Zhao","year":"2024","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/S2213-8587(26)00162-2_bib18","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-8587(19)30154-8","article-title":"SGLT2 inhibitors as adjunctive therapy for type 1 diabetes: balancing benefits and risks","volume":"7","author":"Taylor","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00162-2_bib19","doi-asserted-by":"crossref","first-page":"3077","DOI":"10.1210\/jc.2019-00139","article-title":"SGLT2 inhibitors increase the risk of diabetic ketoacidosis developing in the community and during hospital admission","volume":"104","author":"Hamblin","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00162-2_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1649270","article-title":"Severe euglycemic ketoacidosis following combined therapy with GLP-1 receptor agonist and SGLT-2 inhibitor, refractory to standard treatment: a case report","volume":"16","author":"Gandecka-Pempera","year":"2025","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(26)00162-2_bib21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.2337\/dc23-2394","article-title":"Trends in incidence of hospitalization for hypoglycemia and diabetic ketoacidosis in individuals with type 1 or type 2 diabetes with and without severe mental illness in Denmark from 1996 to 2020: a nationwide study","volume":"47","author":"Scheuer","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00162-2_bib22","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108588","article-title":"Factors affecting in-hospital mortality of diabetic ketoacidosis patients: a retrospective cohort study","volume":"171","author":"Sato","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(26)00162-2_bib23","doi-asserted-by":"crossref","DOI":"10.1177\/11795514231153717","article-title":"Clinical characteristics and outcomes of diabetic ketoacidosis in patients with type 2 diabetes using SGLT2 inhibitors","volume":"16","author":"Almazrouei","year":"2023","journal-title":"Clin Med Insights Endocrinol Diabetes"},{"key":"10.1016\/S2213-8587(26)00162-2_bib24","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.1002\/pds.4887","article-title":"Diabetic ketoacidosis in patients with type 2 diabetes treated with sodium glucose co-transporter 2 inhibitors versus other antihyperglycemic agents: an observational study of four US administrative claims databases","volume":"28","author":"Wang","year":"2019","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/S2213-8587(26)00162-2_bib25","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1007\/s10654-025-01221-0","article-title":"Diagnostic accuracy in the Swedish national patient register: a review including diagnoses in the outpatient register","volume":"40","author":"Everhov","year":"2025","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(26)00162-2_bib26","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1177\/1403494819859737","article-title":"The Norwegian Patient Registry and the Norwegian Registry for Primary Health Care: research potential of two nationwide health-care registries","volume":"48","author":"Bakken","year":"2020","journal-title":"Scand J Public Health"},{"key":"10.1016\/S2213-8587(26)00162-2_bib27","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/S2213-8587(26)00162-2_bib28","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.jcjd.2024.01.006","article-title":"Validation of the diagnostic accuracy levels of International Classification of Diseases, 10th revision codes for diabetic ketoacidosis: a multicentre, cross-sectional study of adults","volume":"48","author":"Hodzic-Santor","year":"2024","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(26)00162-2_bib29","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.2337\/diacare.25.9.1591","article-title":"Recent trends in hospitalization for diabetic ketoacidosis in Ontario children","volume":"25","author":"Curtis","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00162-2_bib30","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1186\/1471-2288-11-157","article-title":"Positive predictive value of automated database records for diabetic ketoacidosis (DKA) in children and youth exposed to antipsychotic drugs or control medications: a Tennessee Medicaid Study","volume":"11","author":"Bobo","year":"2011","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/S2213-8587(26)00162-2_bib31","doi-asserted-by":"crossref","first-page":"6999","DOI":"10.1111\/dom.70098","article-title":"Clinical characteristics and outcomes of diabetes-related ketoacidosis (DKA) in sodium-glucose co-transporter-2 inhibitor (SGLT2i) users with type 2 diabetes","volume":"27","author":"Sharma","year":"2025","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001622?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001622?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:15Z","timestamp":1792096875000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726001622"}},"issued":{"date-parts":[[2026,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2213858726001622"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00162-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ketoacidosis with SGLT2 inhibitors in routine clinical practice of type 2 diabetes: Scandinavian cohort and nested case\u2013control study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00162-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T09:38:58Z","timestamp":1792229938675,"version":"4.4.0"},"reference-count":217,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/s2213-8587(25)00397-3","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:40:53Z","timestamp":1771630853000},"page":"337-355","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Diabetes and mental health"],"prefix":"10.1016","volume":"14","author":[{"given":"Fran\u00e7ois","family":"Pouwer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominic","family":"Ehrmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ragnhild Bjark\u00f8y","family":"Strandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalida","family":"Ismail","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jori","family":"Aalders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Rutters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maartje","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Speight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjolein","family":"Iversen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard I G","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00397-3_bib1","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1192\/bjp.81.333.332","article-title":"The inter-relationships of mental disorders and diabetes mellitus","volume":"81","author":"Menninger","year":"1935","journal-title":"J Ment Sci"},{"key":"10.1016\/S2213-8587(25)00397-3_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/00005053-193501000-00001","article-title":"Psychological factors in the etiology of diabetes","volume":"81","author":"Menninger","year":"1935","journal-title":"J Nerv Ment Dis"},{"key":"10.1016\/S2213-8587(25)00397-3_bib3","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1651-2227.1963.tb03796.x","article-title":"Family background and state of mental health in a group of diabetic schoolchildren","volume":"52","author":"Sterky","year":"1963","journal-title":"Acta Paediatr"},{"key":"10.1016\/S2213-8587(25)00397-3_bib4","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/dme.14254","article-title":"How psychosocial and behavioural research has shaped our understanding of diabetes","volume":"37","author":"Nouwen","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib5","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1007\/s00125-024-06233-1","article-title":"The impact of hypoglycaemia on daily functioning among adults with diabetes: a prospective observational study using the Hypo-METRICS app","volume":"67","author":"S\u00f8holm","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00397-3_bib6","doi-asserted-by":"crossref","first-page":"e3504","DOI":"10.1210\/clinem\/dgac204","article-title":"Severe mental illness and the risk of diabetes complications: a nationwide, register-based cohort study","volume":"107","author":"Scheuer","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00397-3_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.pcd.2021.11.001","article-title":"A systematic review and meta-analysis to compare the prevalence of depression between people with and without type 1 and type 2 diabetes","volume":"16","author":"Farooqi","year":"2022","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/S2213-8587(25)00397-3_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108855","article-title":"Psychiatric disorders as risk factors for type 2 diabetes: an umbrella review of systematic reviews with and without meta-analyses","volume":"176","author":"Lindekilde","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00397-3_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107826","article-title":"Depression and risk of gestational diabetes: a meta-analysis of cohort studies","volume":"156","author":"Arafa","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00397-3_bib10","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/dme.14170","article-title":"Is there an increased risk of perinatal mental disorder in women with gestational diabetes? A systematic review and meta-analysis","volume":"37","author":"Wilson","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib11","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1192\/bjp.2021.222","article-title":"Risk factors of postpartum depression and depressive symptoms: umbrella review of current evidence from systematic reviews and meta-analyses of observational studies","volume":"221","author":"Gastaldon","year":"2022","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S2213-8587(25)00397-3_bib12","doi-asserted-by":"crossref","first-page":"e473","DOI":"10.1002\/edm2.473","article-title":"Association between type 1 diabetes mellitus and eating disorders: a systematic review and meta-analysis","volume":"7","author":"Dean","year":"2024","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/S2213-8587(25)00397-3_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.jpsychires.2022.03.013","article-title":"Systematic review and meta-analysis of risk of gestational diabetes in women with preconception mental disorders","volume":"149","author":"Wilson","year":"2022","journal-title":"J Psychiatr Res"},{"key":"10.1016\/S2213-8587(25)00397-3_bib14","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1111\/jdi.13793","article-title":"Obstructive sleep apnea, prediabetes and progression of type 2 diabetes: a systematic review and meta-analysis","volume":"13","author":"Wang","year":"2022","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(25)00397-3_bib15","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.sleep.2019.11.1246","article-title":"Sleep quality and gestational diabetes in pregnant women: a systematic review and meta-analysis","volume":"67","author":"Zhu","year":"2020","journal-title":"Sleep Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.smrv.2025.102122","article-title":"Sleep-related breathing disorders during pregnancy: a systematic review and meta-analysis","volume":"82","author":"Poletti","year":"2025","journal-title":"Sleep Med Rev"},{"key":"10.1016\/S2213-8587(25)00397-3_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108752","article-title":"The impact of hypoglycaemia on quality of life outcomes among adults with type 1 diabetes: a systematic review","volume":"174","author":"Chatwin","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00397-3_bib18","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15071","article-title":"Effectiveness of educational and behavioural interventions for reducing fear of hypoglycaemia among adults with type 1 diabetes: systematic review and meta-analyses","volume":"40","author":"Chatwin","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib19","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14706","article-title":"Changes in quality of life following hypoglycaemia in adults with type 2 diabetes: a systematic review of longitudinal studies","volume":"39","author":"Matlock","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib20","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1111\/dme.12245","article-title":"Diabetes Attitudes, Wishes and Needs second study (DAWN2\u2122): cross-national benchmarking of diabetes-related psychosocial outcomes for people with diabetes","volume":"30","author":"Nicolucci","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib21","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2023-003394","article-title":"Prevalence of fear of hypoglycemia in adults with type 1 diabetes using a newly developed screener and clinician's perspective on its implementation","volume":"11","author":"Peter","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib22","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/dc13-0971","article-title":"Toward defining a cutoff score for elevated fear of hypoglycemia on the hypoglycemia fear survey worry subscale in patients with type 2 diabetes","volume":"37","author":"Haj\u00f3s","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib23","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1016\/j.pcd.2022.11.009","article-title":"Fear of hypoglycemia and its predictive factors among diabetic pregnant women","volume":"17","author":"Salimi","year":"2023","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/S2213-8587(25)00397-3_bib24","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2174\/1573399810666141113115026","article-title":"Managing hypoglycemia in diabetes may be more fear management than glucose management: a practical guide for diabetes care providers","volume":"10","author":"Vallis","year":"2014","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/S2213-8587(25)00397-3_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2025.1563410","article-title":"Fear of hypoglycemia is linked to poorer glycemic control and reduced quality of life in adults with type 1 diabetes","volume":"16","author":"Mesa D\u00edaz","year":"2025","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(25)00397-3_bib26","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diabres.2018.01.014","article-title":"Fear of hypoglycaemia and its relation to hypoglycaemia awareness and symptom intensity in type 1 diabetes","volume":"137","author":"Hatle","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00397-3_bib27","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.13","article-title":"A longitudinal study of fear of hypoglycaemia in adults with type 1 diabetes","volume":"1","author":"Anderbro","year":"2018","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/S2213-8587(25)00397-3_bib28","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063586","article-title":"Metabolic control and incidence of hypoglycaemia, hospitalisation and complications among Saudi patients with type 2 diabetes initiating second-line therapy: an analysis of the Saudi Arabia data from the DISCOVER Observational Study programme","volume":"13","author":"Al Rubeaan","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(25)00397-3_bib29","first-page":"186","article-title":"Assessment of the impact of fear of hypoglycemic episodes on glycemic and hypoglycemia management","volume":"29","author":"Leiter","year":"2005","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(25)00397-3_bib30","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-038462","article-title":"Factors associated with fear of hypoglycaemia among the T1D Exchange Glu population in a cross-sectional online survey","volume":"10","author":"Liu","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(25)00397-3_bib31","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc10-1343","article-title":"Psychometric properties of the hypoglycemia fear survey-ii for adults with type 1 diabetes","volume":"34","author":"Gonder-Frederick","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib32","article-title":"Psychosocial burden of diabetes in Africa: a systematic review and meta-analysis","author":"Boakye","year":"2025","journal-title":"J Health Psychol"},{"key":"10.1016\/S2213-8587(25)00397-3_bib33","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2337\/diacare.18.6.754","article-title":"Assessment of diabetes-related distress","volume":"18","author":"Polonsky","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib34","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diacare.28.3.626","article-title":"Assessing psychosocial distress in diabetes: development of the diabetes distress scale","volume":"28","author":"Polonsky","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112014","article-title":"The role of depression and diabetes distress in glycemic control: a meta-analysis","volume":"221","author":"Wojujutari Ajele","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00397-3_bib36","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/S2213-8587(15)00135-7","article-title":"Constructs of depression and distress in diabetes: time for an appraisal","volume":"3","author":"Snoek","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00397-3_bib37","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1111\/dme.14157","article-title":"Twenty-five years of diabetes distress research","volume":"37","author":"Skinner","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib38","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1111\/dme.12861","article-title":"Longitudinal relationship of diabetes-related distress and depressive symptoms: analysing incidence and persistence","volume":"32","author":"Ehrmann","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib39","doi-asserted-by":"crossref","first-page":"126","DOI":"10.2337\/dc23-1001","article-title":"Diabetes distress and associations with demographic and clinical variables: a nationwide population-based registry study of 10\u2008186 adults with type 1 diabetes in Norway","volume":"47","author":"Hernar","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib40","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.jdiacomp.2015.01.012","article-title":"Understanding the sources of diabetes distress in adults with type 1 diabetes","volume":"29","author":"Fisher","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(25)00397-3_bib41","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/j.jdiacomp.2016.03.032","article-title":"Diabetes distress in adults with type 1 diabetes: Prevalence, incidence and change over time","volume":"30","author":"Fisher","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(25)00397-3_bib42","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15040","article-title":"Reduced heart rate variability in people with type 1 diabetes and elevated diabetes distress: results from the longitudinal observational DIA-LINK1 study","volume":"40","author":"Ehrmann","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib43","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1111\/dme.13381","article-title":"Diabetes distress is linked with worsening diabetes management over time in adults with type 1 diabetes","volume":"34","author":"Hessler","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib44","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/dme.13448","article-title":"The prevalence of diabetes-specific emotional distress in people with type 2 diabetes: a systematic review and meta-analysis","volume":"34","author":"Perrin","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib45","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1016\/j.jcjd.2020.06.007","article-title":"Depression and diabetes distress in South Asian adults living in low- and middle-income countries: a scoping review","volume":"44","author":"Kalra","year":"2020","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(25)00397-3_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2022.108256","article-title":"A new perspective on diabetes distress using the type 2 diabetes distress assessment system (T2-DDAS): Prevalence and change over time","volume":"36","author":"Fisher","year":"2022","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(25)00397-3_bib47","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jcjd.2023.04.018","article-title":"Diabetes distress is associated with future risk of progression of diabetic nephropathy in adults with type 2 diabetes: a prospective cohort study (Diabetes Distress and Care Registry at Tenri [DDCRT23])","volume":"47","author":"Hayashino","year":"2023","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(25)00397-3_bib48","article-title":"Impact of diabetes distress on glycemic control and diabetic complications in type 2 diabetes mellitus","volume":"14","author":"Park","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(25)00397-3_bib49","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.1007\/s00125-017-4367-3","article-title":"The association of depressive symptoms and diabetes distress with glycaemic control and diabetes complications over 2 years in newly diagnosed type 2 diabetes: a prospective cohort study","volume":"60","author":"Ismail","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00397-3_bib50","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1111\/dme.12860","article-title":"Cyclical relationship between depressive symptoms and diabetes distress in people with type 2 diabetes mellitus: results from the Montreal Evaluation of Diabetes Treatment Cohort Study","volume":"32","author":"Burns","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1186\/s12884-019-2376-6","article-title":"Diabetes distress is associated with adverse pregnancy outcomes in women with gestational diabetes: a prospective cohort study","volume":"19","author":"Schmidt","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(25)00397-3_bib52","series-title":"Structured Clinical Interview for DSM-5 Disorders, Clinical Trials Version (SCID-5-CT)","author":"First","year":"2015"},{"key":"10.1016\/S2213-8587(25)00397-3_bib53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1002\/wps.21227","article-title":"The WHO Flexible Interview for ICD-11 (FLII-11)","volume":"23","author":"Reed","year":"2024","journal-title":"World Psychiatry"},{"key":"10.1016\/S2213-8587(25)00397-3_bib54","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1046\/j.1525-1497.2001.016009606.x","article-title":"The PHQ-9: validity of a brief depression severity measure","volume":"16","author":"Kroenke","year":"2001","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib55","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1177\/014662167700100306","article-title":"The CES-D scale: a self-report depression scale for research in the general population","volume":"1","author":"Radloff","year":"1977","journal-title":"Appl Psychol Meas"},{"key":"10.1016\/S2213-8587(25)00397-3_bib56","series-title":"Manual for the Beck Depression Inventory-II","author":"Beck","year":"1996"},{"key":"10.1016\/S2213-8587(25)00397-3_bib57","doi-asserted-by":"crossref","first-page":"112","DOI":"10.2174\/157339909788166828","article-title":"Depression and quality of life in patients with diabetes: a systematic review from the European Depression in Diabetes (EDID) Research Consortium","volume":"5","author":"Schram","year":"2009","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/S2213-8587(25)00397-3_bib58","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.2337\/dc08-1341","article-title":"Depression and diabetes treatment nonadherence: a meta-analysis","volume":"31","author":"Gonzalez","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112275","article-title":"The impact of depression on healing outcomes in people with diabetes-related foot ulcers: a systematic review","volume":"225","author":"Al-Smadi","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00397-3_bib60","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14671","article-title":"The bidirectional longitudinal association between depressive symptoms and HbA1c: a systematic review and meta-analysis","volume":"39","author":"Beran","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib61","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/dme.14054","article-title":"Longitudinal associations between depression and diabetes complications: a systematic review and meta-analysis","volume":"36","author":"Nouwen","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib62","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0057058","article-title":"Depression and risk of mortality in people with diabetes mellitus: a systematic review and meta-analysis","volume":"8","author":"van Dooren","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(25)00397-3_bib63","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2022.11.004","article-title":"Prevalence of mental disorders in people living with type 1 diabetes: a systematic literature review and meta-analysis","volume":"80","author":"Benton","year":"2023","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/S2213-8587(25)00397-3_bib64","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1007\/s00281-019-00730-x","article-title":"Subclinical inflammation and depressive symptoms in patients with type 1 and type 2 diabetes","volume":"41","author":"Herder","year":"2019","journal-title":"Semin Immunopathol"},{"key":"10.1016\/S2213-8587(25)00397-3_bib65","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41398-024-03209-y","article-title":"Associations between biomarkers of inflammation and depressive symptoms-potential differences between diabetes types and symptom clusters of depression","volume":"15","author":"Herder","year":"2025","journal-title":"Transl Psychiatry"},{"key":"10.1016\/S2213-8587(25)00397-3_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.psyneuen.2021.105448","article-title":"Depression in type 2 diabetes: a systematic review and meta-analysis of blood inflammatory markers","volume":"134","author":"Nguyen","year":"2021","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(25)00397-3_bib67","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.1016\/j.pec.2016.03.020","article-title":"Biobehavioral determinants of glycemic control in type 2 diabetes: a systematic review and meta-analysis","volume":"99","author":"Brown","year":"2016","journal-title":"Patient Educ Couns"},{"key":"10.1016\/S2213-8587(25)00397-3_bib68","article-title":"The relationship between gestational diabetes and postpartum depression: a systematic review","volume":"16","author":"Saeed Alqahtani","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/S2213-8587(25)00397-3_bib69","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1600-0447.2009.01363.x","article-title":"A systematic review of studies validating the Edinburgh Postnatal Depression Scale in antepartum and postpartum women","volume":"119","author":"Gibson","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S2213-8587(25)00397-3_bib70","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.jpsychires.2017.12.001","article-title":"Depressive symptoms, impaired glucose metabolism, high visceral fat, and high systolic blood pressure in a subgroup of women with recent gestational diabetes","volume":"97","author":"Ferrari","year":"2018","journal-title":"J Psychiatr Res"},{"key":"10.1016\/S2213-8587(25)00397-3_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-051498","article-title":"Development of type 2 diabetes in women with comorbid gestational diabetes and common mental disorders in the Born in Bradford cohort","volume":"12","author":"Wilson","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(25)00397-3_bib72","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002382","article-title":"Adverse metabolic outcomes in the early and late postpartum after gestational diabetes are broader than glucose control","volume":"9","author":"Kosinski","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib73","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15400","article-title":"One-year postpartum weight retention and glucose intolerance in women with prediabetes after gestational diabetes","volume":"41","author":"Mievis","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.midw.2019.102586","article-title":"Neonatal outcomes and its association among gestational diabetes mellitus with and without depression, anxiety and stress symptoms in Malaysia: a cross-sectional study","volume":"81","author":"Lee","year":"2020","journal-title":"Midwifery"},{"key":"10.1016\/S2213-8587(25)00397-3_bib75","doi-asserted-by":"crossref","first-page":"3862","DOI":"10.1080\/14767058.2019.1701647","article-title":"Increased rates of adverse perinatal outcomes in women with gestational diabetes and depression","volume":"34","author":"Packer","year":"2021","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.jpsychores.2021.110489","article-title":"Mental health and its associations with weight in women with gestational diabetes mellitus. A prospective clinical cohort study","volume":"146","author":"Gilbert","year":"2021","journal-title":"J Psychosom Res"},{"key":"10.1016\/S2213-8587(25)00397-3_bib77","doi-asserted-by":"crossref","DOI":"10.3390\/nu13113823","article-title":"Obsessed with healthy eating: a systematic review of observational studies assessing orthorexia nervosa in patients with diabetes mellitus","volume":"13","author":"Grammatikopoulou","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(25)00397-3_bib78","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2337\/dc09-1890","article-title":"Brief screening tool for disordered eating in diabetes: internal consistency and external validity in a contemporary sample of pediatric patients with type 1 diabetes","volume":"33","author":"Markowitz","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib79","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1007\/s40200-022-00980-x","article-title":"Pathological eating behaviours and risk of retinopathy in diabetes: a systematic review and meta-analysis","volume":"21","author":"Trott","year":"2022","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/S2213-8587(25)00397-3_bib80","doi-asserted-by":"crossref","DOI":"10.2174\/1573399820666230822095939","article-title":"Associations between disordered eating behaviors and HbA1c in young people with type 1 diabetes: a systematic review and meta-analysis","volume":"20","author":"Marks","year":"2024","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/S2213-8587(25)00397-3_bib81","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.2337\/dc19-0445","article-title":"Disturbed eating behaviors in adolescents and emerging adults with type 1 diabetes: a one-year prospective study","volume":"42","author":"Luyckx","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib82","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40337-018-0223-1","article-title":"Binge eating disorder and night eating syndrome in adults with type 2 diabetes: a systematic review","volume":"6","author":"Abbott","year":"2018","journal-title":"J Eat Disord"},{"key":"10.1016\/S2213-8587(25)00397-3_bib83","doi-asserted-by":"crossref","first-page":"1818","DOI":"10.1002\/eat.23361","article-title":"Impact of binge eating during pregnancy on gestational weight gain and postpartum weight retention among women with gestational diabetes mellitus: LINDA-Brasil","volume":"53","author":"Silvani","year":"2020","journal-title":"Int J Eat Disord"},{"key":"10.1016\/S2213-8587(25)00397-3_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108035","article-title":"The association between sleep and diabetes outcomes\u2014a systematic review","volume":"161","author":"Khalil","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00397-3_bib85","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/0165-1781(89)90047-4","article-title":"The Pittsburgh Sleep Quality Index: a new instrument for psychiatric practice and research","volume":"28","author":"Buysse","year":"1989","journal-title":"Psychiatry Res"},{"key":"10.1016\/S2213-8587(25)00397-3_bib86","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.smrv.2013.08.002","article-title":"Evaluation of the measurement properties of the Epworth sleepiness scale: a systematic review","volume":"18","author":"Kendzerska","year":"2014","journal-title":"Sleep Med Rev"},{"key":"10.1016\/S2213-8587(25)00397-3_bib87","doi-asserted-by":"crossref","first-page":"665","DOI":"10.5664\/jcsm.6576","article-title":"AASM scoring manual updates for 2017 (version 2.4)","volume":"13","author":"Berry","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib88","doi-asserted-by":"crossref","DOI":"10.1093\/sleepadvances\/zpac001","article-title":"Comparing polysomnography, actigraphy, and sleep diary in the home environment: The Study of Women's Health Across the Nation (SWAN) Sleep Study","volume":"3","author":"Lehrer","year":"2022","journal-title":"Sleep Adv"},{"key":"10.1016\/S2213-8587(25)00397-3_bib89","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1007\/s11325-018-1661-3","article-title":"Monitoring healthy and disturbed sleep through smartphone applications: a review of experimental evidence","volume":"23","author":"Fino","year":"2019","journal-title":"Sleep Breath"},{"key":"10.1016\/S2213-8587(25)00397-3_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107967","article-title":"The associations of objectively measured sleep duration and sleep disturbances with diabetic retinopathy","volume":"159","author":"Chew","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00397-3_bib91","doi-asserted-by":"crossref","first-page":"3","DOI":"10.5664\/jcsm.11462","article-title":"Sleep-disordered breathing and diabetes mellitus: a deadly duo","volume":"21","author":"Engal","year":"2025","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib92","doi-asserted-by":"crossref","first-page":"1467","DOI":"10.1007\/s11325-020-02283-y","article-title":"Risk of mortality among patients with moderate to severe obstructive sleep apnea and diabetes mellitus: results from the SantOSA cohort","volume":"25","author":"Labarca","year":"2021","journal-title":"Sleep Breath"},{"key":"10.1016\/S2213-8587(25)00397-3_bib93","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.sleep.2016.03.019","article-title":"Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis","volume":"23","author":"Reutrakul","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib94","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/clinem\/dgz065","article-title":"Prevalence of insomnia (symptoms) in T2D and association with metabolic parameters and glycemic control: meta-analysis","volume":"105","author":"Koopman","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00397-3_bib95","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1016\/j.chest.2017.05.009","article-title":"Obstructive sleep apnea and diabetes: a state of the art review","volume":"152","author":"Reutrakul","year":"2017","journal-title":"Chest"},{"key":"10.1016\/S2213-8587(25)00397-3_bib96","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1097\/AOG.0000000000000959","article-title":"Sleep duration and blood glucose control in women with gestational diabetes mellitus","volume":"126","author":"Twedt","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(25)00397-3_bib97","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102119","article-title":"Effect of diabetes technologies on the fear of hypoglycaemia among people living with type 1 diabetes: a systematic review and meta-analysis","volume":"62","author":"Talbo","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/S2213-8587(25)00397-3_bib98","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2337\/diacare.18.6.754","article-title":"Assessment of diabetes-related distress","volume":"18","author":"Polonsky","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib99","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1186\/s12884-023-05949-z","article-title":"Experiences of stigma, psychological distress, and facilitative coping among pregnant people with gestational diabetes mellitus","volume":"23","author":"Sun","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(25)00397-3_bib100","doi-asserted-by":"crossref","DOI":"10.1111\/dme.70106","article-title":"Diabetes distress and sleep impairment in type 2 diabetes: a population-based cross-sectional study-The HUNT Study, Norway","volume":"42","author":"Riise","year":"2025","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib101","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1007\/s00125-020-05274-6","article-title":"The joint association of diabetes distress and depressive symptoms with all-cause mortality in Japanese individuals with type 2 diabetes: a prospective cohort study (Diabetes Distress and Care Registry in Tenri [DDCRT 20])","volume":"63","author":"Hayashino","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00397-3_bib102","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1007\/s00592-025-02549-5","article-title":"Effects of a health education intervention based on the behavior change wheel on fear of hypoglycemia behavior in type 2 diabetes mellitus patients: a randomized controlled pilot trial","volume":"62","author":"Zhao","year":"2025","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(25)00397-3_bib103","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1179\/2057332415Y.0000000004","article-title":"Effective interventions for reducing diabetes distress: systematic review and meta-analysis","volume":"12","author":"Sturt","year":"2015","journal-title":"International Diabetes Nursing"},{"key":"10.1016\/S2213-8587(25)00397-3_bib104","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.pcd.2019.04.001","article-title":"Effectiveness of psychoeducational interventions for the treatment of diabetes-specific emotional distress and glycaemic control in people with type 2 diabetes: a systematic review and meta-analysis","volume":"13","author":"Perrin","year":"2019","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/S2213-8587(25)00397-3_bib105","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/M15-1399","article-title":"Behavioral programs for type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"163","author":"Pillay","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib106","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/dme.14256","article-title":"Trends in diabetes self-management education: where are we coming from and where are we going? A narrative review","volume":"37","author":"Hermanns","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib107","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-20428-6","article-title":"Effectiveness of psychoeducation interventions for pregnant women with gestational diabetes mellitus: an integrative review","volume":"24","author":"Alshammari","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(25)00397-3_bib108","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1111\/dme.13509","article-title":"Systematic review and meta-analysis of the efficacy of interventions for people with type 1 diabetes mellitus and disordered eating","volume":"34","author":"Clery","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib109","doi-asserted-by":"crossref","DOI":"10.1016\/j.ajogmf.2022.100836","article-title":"Sleep intervention and glycemic control in gestational diabetes mellitus: a feasibility study","volume":"5","author":"Twedt","year":"2023","journal-title":"Am J Obstet Gynecol MFM"},{"key":"10.1016\/S2213-8587(25)00397-3_bib110","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14948","article-title":"The effectiveness of cognitive behavioural therapy and third-wave cognitive behavioural interventions on diabetes-related distress: a systematic review and meta-analysis","volume":"39","author":"Jenkinson","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib111","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1186\/s12888-024-06125-z","article-title":"The effectiveness of psychological interventions on diabetes distress and glycemic level in adults with type 2 diabetes: a systematic review and meta-analysis","volume":"24","author":"Zu","year":"2024","journal-title":"BMC Psychiatry"},{"key":"10.1016\/S2213-8587(25)00397-3_bib112","doi-asserted-by":"crossref","DOI":"10.1002\/brb3.1981","article-title":"Treatment for comorbid depressive disorder or subthreshold depression in diabetes mellitus: systematic review and meta-analysis","volume":"11","author":"van der Feltz-Cornelis","year":"2021","journal-title":"Brain Behav"},{"key":"10.1016\/S2213-8587(25)00397-3_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109965","article-title":"The efficacy of cognitive behavioral therapy-based intervention on patients with diabetes: a meta-analysis","volume":"189","author":"Li","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00397-3_bib114","article-title":"Safety of a co-designed cognitive behavioural therapy intervention for people with type 1 diabetes and eating disorders (STEADY): a feasibility randomised controlled trial","volume":"50","author":"Stadler","year":"2025","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/S2213-8587(25)00397-3_bib115","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1046\/j.1464-5491.2002.00679.x","article-title":"Group therapy for binge eating in type 2 diabetes: a randomized trial","volume":"19","author":"Kenardy","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib116","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.sleep.2020.11.035","article-title":"Sleep interventions and glucose metabolism: systematic review and meta-analysis","volume":"78","author":"Kothari","year":"2021","journal-title":"Sleep Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib117","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110854","article-title":"E-Health technologies for treatment of depression, anxiety and emotional distress in person with diabetes mellitus: a systematic review and meta-analysis","volume":"203","author":"Tavares Franquez","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00397-3_bib118","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-072061","article-title":"Impact of an acceptance and commitment therapy programme on HbA1c, self-management and psychosocial factors in adults with type 1 diabetes and elevated HbA1c levels: a randomised controlled trial","volume":"13","author":"Wijk","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(25)00397-3_bib119","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.1111\/jdi.13439","article-title":"Effects of mindfulness-based intervention on glycemic control and psychological outcomes in people with diabetes: a systematic review and meta-analysis","volume":"12","author":"Ni","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(25)00397-3_bib120","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14525","article-title":"Effects of mindfulness- and acceptance-based interventions on diabetes distress and glycaemic level in people with type 2 diabetes: systematic review and meta-analysis","volume":"38","author":"Ngan","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib121","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/jnu.12560","article-title":"Effects of mindfulness-based stress reduction and mindfulness-based cognitive therapy in people with diabetes: a systematic review and meta-analysis","volume":"52","author":"Ni","year":"2020","journal-title":"J Nurs Scholarsh"},{"key":"10.1016\/S2213-8587(25)00397-3_bib122","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/s40337-020-00357-6","article-title":"An open trial of app-assisted acceptance and commitment therapy (iACT) for eating disorders in type 1 diabetes","volume":"9","author":"Merwin","year":"2021","journal-title":"J Eat Disord"},{"key":"10.1016\/S2213-8587(25)00397-3_bib123","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3928\/02793695-20241029-01","article-title":"Effectiveness of nurse-led psychological interventions on diabetes distress, depression, and glycemic control in individuals with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"63","author":"Hu","year":"2025","journal-title":"J Psychosoc Nurs Ment Health Serv"},{"key":"10.1016\/S2213-8587(25)00397-3_bib124","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13033-022-00521-2","article-title":"Effectiveness of non-specialist delivered psychological interventions on glycemic control and mental health problems in individuals with type 2 diabetes: a systematic review and meta-analysis","volume":"16","author":"Oyedeji","year":"2022","journal-title":"Int J Ment Health Syst"},{"key":"10.1016\/S2213-8587(25)00397-3_bib125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s12884-025-07195-x","article-title":"Research on the application effect of self-transcendence nursing model in patients with gestational diabetes mellitus: a randomised controlled trial","volume":"25","author":"Xu","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(25)00397-3_bib126","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18178982","article-title":"Efficacy of eHealth interventions for adults with diabetes: a systematic review and meta-analysis","volume":"18","author":"Bassi","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(25)00397-3_bib127","doi-asserted-by":"crossref","first-page":"266","DOI":"10.12968\/bjon.2020.29.5.266","article-title":"The impact of online self-management interventions on midlife adults with type 2 diabetes: a systematic review","volume":"29","author":"Celik","year":"2020","journal-title":"Br J Nurs"},{"key":"10.1016\/S2213-8587(25)00397-3_bib128","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1177\/10547738241252885","article-title":"Influence of mHealth-based lifestyle interventions on symptoms of anxiety and depression of women with gestational diabetes: a meta-analysis","volume":"33","author":"Liao","year":"2024","journal-title":"Clin Nurs Res"},{"key":"10.1016\/S2213-8587(25)00397-3_bib129","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12884-025-07138-6","article-title":"Effect of stress management based self-care counseling on glycemic control in women with gestational diabetes mellitus: a randomized controlled trial study","volume":"25","author":"Bagheri-Tirtashi","year":"2025","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(25)00397-3_bib130","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1017\/S0007114524002599","article-title":"Providing online guided self-help for the management of binge eating in adults with type 2 diabetes: the POSE-D pilot study and process evaluation","volume":"132","author":"Traviss-Turner","year":"2024","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(25)00397-3_bib131","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/dc13-1928","article-title":"Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the Look AHEAD Trial","volume":"37","author":"Rubin","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib132","article-title":"Mothers after Gestational Diabetes in Australia (MAGDA): a randomised controlled trial of a postnatal diabetes prevention program","volume":"13","author":"O'Reilly","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib133","doi-asserted-by":"crossref","first-page":"65","DOI":"10.2337\/dc15-1254","article-title":"The comparative effectiveness of diabetes prevention strategies to reduce postpartum weight retention in women with gestational diabetes mellitus: the Gestational Diabetes' Effects on Moms (GEM) cluster randomized controlled trial","volume":"39","author":"Ferrara","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102523","article-title":"Effectiveness of a blended mobile-based lifestyle intervention in women with glucose intolerance after a recent history of gestational diabetes (MELINDA): a 1-year, prospective, multicentre, randomised controlled trial","volume":"70","author":"Minschart","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/S2213-8587(25)00397-3_bib135","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1148426","article-title":"Effect of the MySweetheart randomized controlled trial on birth, anthropometric and psychobehavioral outcomes in offspring of women with GDM","volume":"14","author":"Gilbert","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(25)00397-3_bib136","doi-asserted-by":"crossref","DOI":"10.1136\/bmjmed-2023-000588","volume":"3","author":"Quansah","year":"2024","journal-title":"BMJ Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib137","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/dom.13794","article-title":"A randomized trial comparing the efficacy and safety of treating patients with type 2 diabetes and highly elevated HbA1c levels with basal-bolus insulin or a glucagon-like peptide-1 receptor agonist plus basal insulin: the SIMPLE study","volume":"21","author":"Abreu","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(25)00397-3_bib138","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1001\/jamapsychiatry.2025.0679","article-title":"Glucagon-like peptide 1 receptor agonists and mental health: a systematic review and meta-analysis","volume":"82","author":"Pierret","year":"2025","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/S2213-8587(25)00397-3_bib139","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.jagp.2023.08.010","article-title":"The antidepressant effects of GLP-1 receptor agonists: a systematic review and meta-analysis","volume":"32","author":"Chen","year":"2024","journal-title":"Am J Geriatr Psychiatry"},{"key":"10.1016\/S2213-8587(25)00397-3_bib140","article-title":"GLP-1 receptor agonists: a novel pharmacotherapy for binge eating (binge eating disorder and bulimia nervosa)? A systematic review","volume":"35","author":"Aoun","year":"2024","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/S2213-8587(25)00397-3_bib141","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12967-025-06302-y","article-title":"Glucagon-like peptide-1 receptor agonists for obstructive sleep apnea in patients with obesity and type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"23","author":"Yang","year":"2025","journal-title":"J Transl Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib142","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1089\/dia.2018.0332","article-title":"The effects and effect sizes of real-time continuous glucose monitoring on patient-reported outcomes: a secondary analysis of the HypoDE study","volume":"21","author":"Ehrmann","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(25)00397-3_bib143","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2020.6928","article-title":"Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Pratley","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00397-3_bib144","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1089\/dia.2019.0345","article-title":"Systematic review of randomized controlled trials evaluating glycemic efficacy and patient satisfaction of intermittent-scanned continuous glucose monitoring in patients with diabetes","volume":"22","author":"Cowart","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(25)00397-3_bib145","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14944","article-title":"Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: a narrative review","volume":"40","author":"Speight","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib146","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14581","article-title":"Diabetes technologies in people with type 1 diabetes mellitus and disordered eating: a systematic review on continuous subcutaneous insulin infusion, continuous glucose monitoring and automated insulin delivery","volume":"38","author":"Priesterroth","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/nu17091507","article-title":"Effects of individualized nutrition therapy and continuous glucose monitoring on dietary and sleep quality in individuals with prediabetes and overweight or obesity","volume":"17","author":"Basiri","year":"2025","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(25)00397-3_bib148","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102852","article-title":"Effect of automated insulin delivery systems on person-reported outcomes in people with diabetes: a systematic review and meta-analysis","volume":"76","author":"Roos","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/S2213-8587(25)00397-3_bib149","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1111\/dom.15351","article-title":"Should people with type 2 diabetes treated by multiple daily insulin injections with home health care support be switched to hybrid closed-loop? The CLOSE AP+ randomized controlled trial","volume":"26","author":"Reznik","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(25)00397-3_bib150","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15503","article-title":"The effect of automated insulin delivery system use on diabetes distress in people with type 1 diabetes and their caregivers: a systematic review and meta-analysis","volume":"42","author":"Canha","year":"2025","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib151","doi-asserted-by":"crossref","first-page":"1801","DOI":"10.1056\/NEJMoa2415948","article-title":"A randomized trial of automated insulin delivery in type 2 diabetes","volume":"392","author":"Kudva","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib152","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.2337\/dc24-0623","article-title":"Closed-loop insulin therapy for people with type 2 diabetes treated with an insulin pump: a 12-week multicenter, open-label randomized, controlled, crossover trial","volume":"47","author":"Borel","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib153","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2022.846162","article-title":"The psychological implications of automated insulin delivery systems in type 1 diabetes care","volume":"3","author":"Nefs","year":"2022","journal-title":"Front Clin Diabetes Healthc"},{"key":"10.1016\/S2213-8587(25)00397-3_bib154","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/dc23-2452","article-title":"EMBARK: a randomized, controlled trial comparing three approaches to reducing diabetes distress and improving HbA1c in adults with type 1 diabetes","volume":"47","author":"Hessler","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib155","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1111\/wvn.12719","article-title":"Effectiveness of acceptance and commitment therapy in people with type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"21","author":"Wang","year":"2024","journal-title":"Worldviews Evid Based Nurs"},{"key":"10.1016\/S2213-8587(25)00397-3_bib156","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1089\/tmj.2023.0374","article-title":"Are e-health interventions effective in reducing diabetes-related distress and depression in patients with type 2 diabetes? A systematic review with meta-analysis","volume":"30","author":"Fern\u00e1ndez-Rodr\u00edguez","year":"2024","journal-title":"Telemed J e-Health"},{"key":"10.1016\/S2213-8587(25)00397-3_bib157","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1177\/1357633X211058329","article-title":"Effectiveness of technology-based psychosocial interventions on diabetes distress and health-relevant outcomes among type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"30","author":"Yap","year":"2024","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(25)00397-3_bib158","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15446","article-title":"Bringing the assessment and treatment of diabetes distress into the real world of clinical care: time for a shift in perspective","volume":"41","author":"Fisher","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib159","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.2337\/dci21-0043","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"44","author":"Holt","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib160","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.2337\/dc16-2053","article-title":"Psychosocial care for people with diabetes: a position statement of the American Diabetes Association","volume":"39","author":"Young-Hyman","year":"2016","journal-title":"Diabetes Care"},{"issue":"suppl","key":"10.1016\/S2213-8587(25)00397-3_bib161","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0165-0327(12)70004-6","article-title":"Epidemiology of depression and diabetes: a systematic review","volume":"142","author":"Roy","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/S2213-8587(25)00397-3_bib162","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2337\/dc10-1414","article-title":"Prevalence of depression in individuals with impaired glucose metabolism or undiagnosed diabetes: a systematic review and meta-analysis of the European Depression in Diabetes (EDID) Research Consortium","volume":"34","author":"Nouwen","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib163","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S2213-8587(15)00134-5","article-title":"The link between depression and diabetes: the search for shared mechanisms","volume":"3","author":"Moulton","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00397-3_bib164","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1007\/s11892-017-0923-y","article-title":"Shared dysregulation of homeostatic brain-body pathways in depression and type 2 diabetes","volume":"17","author":"Hoogendoorn","year":"2017","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(25)00397-3_bib165","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1111\/dme.14227","article-title":"How 25 years of psychosocial research has contributed to a better understanding of the links between depression and diabetes","volume":"37","author":"Pouwer","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib166","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1038\/mp.2013.20","article-title":"The vascular depression hypothesis: mechanisms linking vascular disease with depression","volume":"18","author":"Taylor","year":"2013","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S2213-8587(25)00397-3_bib167","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jamapsychiatry.2017.0984","article-title":"Association of microvascular dysfunction with late-life depression: a systematic review and meta-analysis","volume":"74","author":"van Agtmaal","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/S2213-8587(25)00397-3_bib168","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00125-025-06472-w","article-title":"Biomarkers of inflammation and improvement in depressive symptoms in type 1 and type 2 diabetes: differential associations with depressive symptom clusters","volume":"68","author":"Herder","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00397-3_bib169","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1177\/1359105315620293","article-title":"Effectiveness of mindfulness-based interventions on physiological and psychological complications in adults with diabetes: a systematic review","volume":"22","author":"Noordali","year":"2017","journal-title":"J Health Psychol"},{"key":"10.1016\/S2213-8587(25)00397-3_bib170","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-8587(24)00123-2","article-title":"An integrated diabetes and mental health intervention for people with type 1 diabetes and severe disordered eating: a prospective proof-of-concept cohort study","volume":"12","author":"Ismail","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00397-3_bib171","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15025","article-title":"A thematic analysis of YouTube comments on a television documentary titled \u2018Diabulimia: The World's Most Dangerous Eating Disorder\u2019","volume":"40","author":"Ferrey","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib172","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2337\/dc24-1599","article-title":"Diabetes Body Project: acute effects of an eating disorder prevention program for young women with type 1 diabetes. A multinational randomized controlled trial","volume":"48","author":"Hennekes","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib173","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1007\/s00125-021-05541-0","article-title":"Sleep disorders in people with type 2 diabetes and associated health outcomes: a review of the literature","volume":"64","author":"Schipper","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00397-3_bib174","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s12020-023-03537-x","article-title":"Sleep disorders during pregnancy: an underestimated risk factor for gestational diabetes mellitus","volume":"83","author":"Eleftheriou","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(25)00397-3_bib175","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/nyas.12355","article-title":"Interactions between sleep, circadian function, and glucose metabolism: implications for risk and severity of diabetes","volume":"1311","author":"Reutrakul","year":"2014","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(25)00397-3_bib176","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1177\/0145721712467683","article-title":"Effect of poor sleep quality and excessive daytime sleepiness on factors associated with diabetes self-management","volume":"39","author":"Chasens","year":"2013","journal-title":"Diabetes Educ"},{"key":"10.1016\/S2213-8587(25)00397-3_bib177","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.diabet.2014.12.004","article-title":"Sleep habits and diabetes","volume":"41","author":"Larcher","year":"2015","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(25)00397-3_bib178","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/sleep\/23.3.1i","article-title":"Factors predicting sleep disruption in type II diabetes","volume":"23","author":"Lamond","year":"2000","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(25)00397-3_bib179","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.sleep.2010.08.005","article-title":"Randomized trial of pramipexole for patients with restless legs syndrome (RLS) and RLS-related impairment of mood","volume":"12","author":"Montagna","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib180","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib181","doi-asserted-by":"crossref","first-page":"327","DOI":"10.5664\/jcsm.6972","article-title":"Continuous positive airway pressure therapy in gestational diabetes with obstructive sleep apnea: a randomized controlled trial","volume":"14","author":"Chirakalwasan","year":"2018","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib182","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1111\/crj.12915","article-title":"CPAP in patients with obstructive sleep apnea and type 2 diabetes mellitus: systematic review and meta-analysis","volume":"12","author":"Labarca","year":"2018","journal-title":"Clin Respir J"},{"key":"10.1016\/S2213-8587(25)00397-3_bib183","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.sleep.2024.05.029","article-title":"The effect of cognitive behavioral therapy for insomnia on sleep and glycemic outcomes in people with type 2 diabetes: a randomized controlled trial","volume":"120","author":"Groeneveld","year":"2024","journal-title":"Sleep Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib184","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1007\/s00125-021-05609-x","article-title":"Prevalence of type 2 diabetes in psychiatric disorders: an umbrella review with meta-analysis of 245 observational studies from 32 systematic reviews","volume":"65","author":"Lindekilde","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00397-3_bib185","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s11892-024-01564-0","article-title":"Mind in metabolism\u2014a comprehensive literature review on diabetes and its connections to obsessive compulsive disorder, schizophrenia, and bipolar disorder","volume":"25","author":"Cannon","year":"2024","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(25)00397-3_bib186","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s11892-016-0740-8","article-title":"The link between adverse childhood experiences and diabetes","volume":"16","author":"Huffhines","year":"2016","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(25)00397-3_bib187","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-28373-x","article-title":"Posttraumatic stress disorder and diabetes-related outcomes in patients with type 1 diabetes","volume":"13","author":"Lunkenheimer","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(25)00397-3_bib188","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2023.1107144","article-title":"Prevalence and incidence of post-traumatic stress disorder and symptoms in people with chronic somatic diseases: a systematic review and meta-analysis","volume":"14","author":"Lunkenheimer","year":"2023","journal-title":"Front Psychiatry"},{"key":"10.1016\/S2213-8587(25)00397-3_bib189","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.27569","article-title":"Posttraumatic stress disorder and type 2 diabetes outcomes in veterans","volume":"7","author":"Scherrer","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(25)00397-3_bib190","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.euroneuro.2024.11.002","article-title":"Risk of mortality and complications in patients with severe mental illness and co-occurring diabetes mellitus: a systematic review and meta-analysis","volume":"91","author":"Ho","year":"2025","journal-title":"Eur Neuropsychopharmacol"},{"key":"10.1016\/S2213-8587(25)00397-3_bib191","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.jad.2019.07.025","article-title":"Risk of hyperglycemic crisis episode in diabetic patients with bipolar disorder: a nationwide population-based cohort study","volume":"257","author":"Tsai","year":"2019","journal-title":"J Affect Disord"},{"key":"10.1016\/S2213-8587(25)00397-3_bib192","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyt.2022.825678","article-title":"Depression mediates the association between childhood emotional abuse and the onset of type 2 diabetes: findings from German multi-cohort prospective studies","volume":"13","author":"Atasoy","year":"2022","journal-title":"Front Psychiatry"},{"key":"10.1016\/S2213-8587(25)00397-3_bib193","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1111\/acps.13760","article-title":"The risk of diabetes and HbA1c deterioration during antipsychotic drug treatment: a Danish two-cohort study among patients with first-episode schizophrenia","volume":"151","author":"Madsen","year":"2025","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S2213-8587(25)00397-3_bib194","doi-asserted-by":"crossref","first-page":"423","DOI":"10.3390\/ijerph21040423","article-title":"Non-pharmacological interventions for type 2 diabetes in people living with severe mental illness: results of a systematic review and meta-analysis","volume":"21","author":"Ojo","year":"2024","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(25)00397-3_bib195","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/dme.12428","article-title":"The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision","volume":"31","author":"Fisher","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib196","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/j.1600-0447.2011.01744.x","article-title":"The heterogeneity of the depressive syndrome: when numbers get serious","volume":"124","author":"Ostergaard","year":"2011","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S2213-8587(25)00397-3_bib197","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15332","article-title":"Towards the standardisation of adult person-reported outcome domains in diabetes research: a consensus statement development panel","volume":"41","author":"Barnard-Kelly","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib198","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.pec.2005.01.009","article-title":"Nurses' recognition and registration of depression, anxiety and diabetes-specific emotional problems in outpatients with diabetes mellitus","volume":"60","author":"Pouwer","year":"2006","journal-title":"Patient Educ Couns"},{"key":"10.1016\/S2213-8587(25)00397-3_bib199","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1089\/heq.2020.0104","article-title":"Primary care physician recognition and documentation of depressive symptoms among Chinese and Latinx patients during routine visits: a cross-sectional study","volume":"5","author":"Garcia","year":"2021","journal-title":"Health Equity"},{"key":"10.1016\/S2213-8587(25)00397-3_bib200","first-page":"344","article-title":"Differences in the clinical recognition of depression in diabetes patients: the Diabetes Study of Northern California (DISTANCE)","volume":"19","author":"Hudson","year":"2013","journal-title":"Am J Manag Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00397-3_bib201","first-page":"S86","article-title":"5. Facilitating positive health behaviors and well-being to improve health outcomes: Standards of Care in Diabetes\u20132025","volume":"48","author":"ElSayed","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib202","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/dme.12242","article-title":"Diabetes Attitudes, Wishes and Needs second study (DAWN2\u2122): cross-national comparisons on barriers and resources for optimal care\u2013healthcare professional perspective","volume":"30","author":"Holt","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib203","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15442","article-title":"Effectiveness of the MyDiaMate application in reducing diabetes distress in adults with type 1 diabetes: study protocol of the multi-national, randomised-controlled MyREMEDY trial","volume":"42","author":"Mohr","year":"2025","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib204","author":"Hendrieckx"},{"key":"10.1016\/S2213-8587(25)00397-3_bib205","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15312","article-title":"Roles and competencies of the clinical psychologist in adult diabetes care\u2014a consensus report","volume":"41","author":"Snoek","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib206","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s10880-009-9158-7","article-title":"Medical psychology services in Dutch general hospitals: state of the art developments and recommendations for the future","volume":"16","author":"Soons","year":"2009","journal-title":"J Clin Psychol Med Settings"},{"key":"10.1016\/S2213-8587(25)00397-3_bib207","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0283148","article-title":"Psychometric properties of an innovative smartphone application to investigate the daily impact of hypoglycemia in people with type 1 or type 2 diabetes: the Hypo-METRICS app","volume":"18","author":"S\u00f8holm","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(25)00397-3_bib208","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108745","article-title":"Ecological momentary assessment for health behaviors and contextual factors in persons with diabetes: a systematic review","volume":"174","author":"Nam","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00397-3_bib209","doi-asserted-by":"crossref","first-page":"2433","DOI":"10.1007\/s00125-024-06239-9","article-title":"Perceived glucose levels matter more than CGM-based data in predicting diabetes distress in type 1 or type 2 diabetes: a precision mental health approach using n-of-1 analyses","volume":"67","author":"Ehrmann","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00397-3_bib210","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1186\/s40337-025-01329-4","article-title":"Ecological momentary interventions for eating disorders: a systematic review of the nascent science and recommendations for future research","volume":"13","author":"Kruger","year":"2025","journal-title":"J Eat Disord"},{"key":"10.1016\/S2213-8587(25)00397-3_bib211","doi-asserted-by":"crossref","first-page":"465","DOI":"10.3390\/jcm8040465","article-title":"Current state and future directions of technology-based ecological momentary assessment and intervention for major depressive disorder: a systematic review","volume":"8","author":"Colombo","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib212","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2024-004524","article-title":"Clinical phenotyping of people living with type 1 diabetes according to their levels of diabetes-related distress: results from the SFDT1 cohort","volume":"13","author":"Canha","year":"2025","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(25)00397-3_bib213","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-080053","article-title":"Associations between use of diabetes technology and diabetes distress: a Danish cross-sectional survey of adults with type 1 diabetes","volume":"14","author":"Lorenzen","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(25)00397-3_bib214","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15338","article-title":"Identifying the deficiencies of currently available CGM to improve uptake and benefit","volume":"41","author":"Barnard-Kelly","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib215","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.1111\/dme.13255","article-title":"Review of research grant allocation to psychosocial studies in diabetes research","volume":"33","author":"Jones","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib216","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15514","article-title":"The missing piece: the clinical translation of precision diabetes medicine requires precision mental health care: A call to action from the international PsychoSocial Aspects of Diabetes (PSAD) Study Group","volume":"42","author":"Pouwer","year":"2025","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00397-3_bib217","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S2213-8587(23)00347-9","article-title":"Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations","volume":"12","author":"Speight","year":"2024","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:47:30Z","timestamp":1773823650000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003973"}},"issued":{"date-parts":[[2026,4]]},"references-count":217,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2213858725003973"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00397-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and mental health","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00397-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,17]],"date-time":"2026-10-17T21:00:42Z","timestamp":1792270842594,"version":"4.4.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/s2213-8587(15)00008-x","type":"journal-article","created":{"date-parts":[[2015,4,12]],"date-time":"2015-04-12T00:30:13Z","timestamp":1428798613000},"page":"568-576","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":73,"title":["Effect of cancer treatment on hypothalamic\u2013pituitary function"],"prefix":"10.1016","volume":"3","author":[{"given":"Elizabeth","family":"Crowne","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helena","family":"Gleeson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Benghiat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Sanghera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Toogood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00008-X_bib1","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.ejca.2005.11.003","article-title":"Caring for survivors of childhood cancers: the size of the problem","volume":"42","author":"Curry","year":"2006","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2213-8587(15)00008-X_bib2","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00008-X_bib3","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/pbc.20612","article-title":"Long-term follow-up of pediatric cancer survivors: education, surveillance, and screening","volume":"46","author":"Landier","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00008-X_bib4","unstructured":"Skinner R, Wallace WH, Levitt G, eds. Therapy Based Long Term Follow Up: Practice Statement. 2nd edn; 2006."},{"key":"10.1016\/S2213-8587(15)00008-X_bib5","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/bmj.323.7307.271","article-title":"Developing strategies for long term follow up of survivors of childhood cancer","volume":"323","author":"Wallace","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00008-X_bib6","doi-asserted-by":"crossref","first-page":"f1190","DOI":"10.1136\/bmj.f1190","article-title":"Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance","volume":"346","author":"Wallace","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00008-X_bib7","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.pcl.2014.09.011","article-title":"Brain tumors","volume":"62","author":"Chintagumpala","year":"2015","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/S2213-8587(15)00008-X_bib8","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1053\/j.seminoncol.2014.06.010","article-title":"Medical management of high-grade astrocytoma: current and emerging therapies","volume":"41","author":"Johnson","year":"2014","journal-title":"Semin Oncol"},{"key":"10.1016\/S2213-8587(15)00008-X_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD006678.pub2","article-title":"Chemotherapy for children with medulloblastoma","volume":"1","author":"Michiels","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(15)00008-X_bib10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1016\/j.hoc.2009.07.003","article-title":"Long-term outcomes in survivors of childhood acute lymphoblastic leukemia","volume":"23","author":"Nathan","year":"2009","journal-title":"Hematol Oncol Clin North Am"},{"key":"10.1016\/S2213-8587(15)00008-X_bib11","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1016\/0360-3016(87)90227-6","article-title":"Symptomatic hypothalamic-pituitary dysfunction in nasopharyngeal carcinoma patients following radiation therapy: a retrospective study","volume":"13","author":"Lam","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S2213-8587(15)00008-X_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.ecl.2007.10.004","article-title":"Hypopituitarism: clinical features, diagnosis, and management","volume":"37","author":"Toogood","year":"2008","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(15)00008-X_bib13","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1038\/ncpendmet1051","article-title":"Radiation-induced hypopituitarism after cancer therapy: who, how and when to test","volume":"5","author":"Darzy","year":"2009","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib14","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1677\/erc.1.00779","article-title":"The impact of cancer therapy on the endocrine system in survivors of childhood brain tumours","volume":"11","author":"Gleeson","year":"2004","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(15)00008-X_bib15","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.radonc.2014.08.018","article-title":"Pituitary dysfunction in adult patients after cranial irradiation for head and nasopharyngeal tumours","volume":"113","author":"Appelman-Dijkstra","year":"2014","journal-title":"Radiother Oncol"},{"key":"10.1016\/S2213-8587(15)00008-X_bib16","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1111\/j.1365-2265.1976.tb01955.x","article-title":"The effect of varying doses of cerebral irradiation on growth hormone production in childhood","volume":"5","author":"Shalet","year":"1976","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(15)00008-X_bib17","doi-asserted-by":"crossref","first-page":"2189","DOI":"10.1002\/1097-0142(19851101)56:9<2189::AID-CNCR2820560909>3.0.CO;2-I","article-title":"Long-term effects of cranial irradiation on endocrine function in children with brain tumors. A prospective study","volume":"56","author":"Duffner","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00008-X_bib18","first-page":"165","article-title":"Effects of cranial irradiation on hypothalamic-pituitary function\u2014a 5-year longitudinal study in patients with nasopharyngeal carcinoma","volume":"78","author":"Lam","year":"1991","journal-title":"Q J Med"},{"key":"10.1016\/S2213-8587(15)00008-X_bib19","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S0022-3476(05)80487-1","article-title":"Dose dependency of time of onset of radiation-induced growth hormone deficiency","volume":"118","author":"Clayton","year":"1991","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(15)00008-X_bib20","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1056\/NEJM199301143280203","article-title":"Hypothalamic-pituitary dysfunction after radiation for brain tumors","volume":"328","author":"Constine","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00008-X_bib21","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1046\/j.1365-2265.2000.01079.x","article-title":"Cranial radiotherapy of childhood brain tumours: growth hormone deficiency and its relation to the biological effective dose of irradiation in a large population based study","volume":"53","author":"Schmiegelow","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(15)00008-X_bib22","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1038\/sj.bmt.1701769","article-title":"Nutritional status and growth after bone marrow transplantation (BMT) during childhood: EBMT Late-Effects Working Party retrospective data","volume":"23","author":"Cohen","year":"1999","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S2213-8587(15)00008-X_bib23","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1507\/endocrj.48.133","article-title":"Final height and growth hormone secretion after bone marrow transplantation in children","volume":"48","author":"Shinagawa","year":"2001","journal-title":"Endocr J"},{"key":"10.1016\/S2213-8587(15)00008-X_bib24","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1182\/blood.V86.2.819.bloodjournal862819","article-title":"Growth in children after bone marrow transplantation for acute leukemia","volume":"86","author":"Huma","year":"1995","journal-title":"Blood"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00008-X_bib25","first-page":"86","article-title":"Growth and growth hormone status after a bone marrow transplant","volume":"58","author":"Shalet","year":"2002","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(15)00008-X_bib27","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/j.1365-2265.1989.tb01260.x","article-title":"Radiation-induced hypopituitarism is dose-dependent","volume":"31","author":"Littley","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(15)00008-X_bib28","doi-asserted-by":"crossref","first-page":"771","DOI":"10.7326\/0003-4819-83-6-771","article-title":"Hypopituitarism after external irradiation. Evidence for both hypothalamic and pituitary origin","volume":"83","author":"Samaan","year":"1975","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(15)00008-X_bib29","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1210\/jcem-54-6-1135","article-title":"Effects of cranial radiation on hypothalamic-adenohypophyseal function: abnormal growth hormone secretory dynamics","volume":"54","author":"Chrousos","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib30","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1111\/j.1651-2227.1986.tb10195.x","article-title":"The effects of cranial irradiation on growth hormone secretion","volume":"75","author":"Ahmed","year":"1986","journal-title":"Acta Paediatr Scand"},{"key":"10.1016\/S2213-8587(15)00008-X_bib31","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000180772","article-title":"Growth hormone release in children after cranial irradiation","volume":"27","author":"Lannering","year":"1987","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(15)00008-X_bib32","first-page":"847","article-title":"Effects of low-dose cranial radiation on growth hormone secretory dynamics and hypothalamic-pituitary function","volume":"142","author":"Costin","year":"1988","journal-title":"Am J Dis Child"},{"key":"10.1016\/S2213-8587(15)00008-X_bib33","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/0360-3016(82)90442-4","article-title":"Hypothalamic, pituitary and thyroid dysfunction after radiotherapy to the head and neck","volume":"8","author":"Samaan","year":"1982","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S2213-8587(15)00008-X_bib34","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1677\/joe.0.1500329","article-title":"Evolution of growth hormone neurosecretory disturbance after cranial irradiation for childhood brain tumours: a prospective study","volume":"150","author":"Spoudeas","year":"1996","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(15)00008-X_bib35","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S0022-3476(86)81027-7","article-title":"Greater susceptibility to hypothalamopituitary irradiation in younger children with acute lymphoblastic leukemia","volume":"108","author":"Brauner","year":"1986","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(15)00008-X_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1365-2265.1999.00839.x","article-title":"The relative roles of continuous growth hormone-releasing hormone (GHRH(1-29)NH2) and intermittent somatostatin(1-14)(SS) in growth hormone (GH) pulse generation: studies in normal and post cranial irradiated individuals","volume":"51","author":"Achermann","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(15)00008-X_bib37","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1210\/jc.2003-031224","article-title":"Reassessment of growth hormone status is required at final height in children treated with growth hormone replacement after radiation therapy","volume":"89","author":"Gleeson","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib38","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1136\/adc.68.4.458","article-title":"Growth and growth hormone secretion after bone marrow transplantation","volume":"68","author":"Brauner","year":"1993","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(15)00008-X_bib39","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/adc.67.9.1107","article-title":"Endocrine deficit after fractionated total body irradiation","volume":"67","author":"Ogilvy-Stuart","year":"1992","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(15)00008-X_bib40","doi-asserted-by":"crossref","first-page":"5245","DOI":"10.1210\/jcem.86.11.8056","article-title":"GH deficiency caused by cranial irradiation during childhood: factors and markers in young adults","volume":"86","author":"Adan","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib41","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/j.1365-2265.1992.tb02903.x","article-title":"A novel variant of growth hormone (GH) insufficiency following low dose cranial irradiation","volume":"36","author":"Crowne","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(15)00008-X_bib42","doi-asserted-by":"crossref","first-page":"2794","DOI":"10.1210\/jc.2004-2002","volume":"90","author":"Darzy","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib43","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1007\/BF01957523","article-title":"Growth following single fraction and fractionated total body irradiation for bone marrow transplantation","volume":"152","author":"Thomas","year":"1993","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(15)00008-X_bib44","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1182\/blood.V86.2.825.bloodjournal862825","article-title":"Role of busulfan and total body irradiation on growth of prepubertal children receiving bone marrow transplantation and results of treatment with recombinant human growth hormone","volume":"86","author":"Giorgiani","year":"1995","journal-title":"Blood"},{"key":"10.1016\/S2213-8587(15)00008-X_bib45","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1038\/sj.bmt.1704324","article-title":"Pubertal development and final height after autologous bone marrow transplantation for acute lymphoblastic leukemia","volume":"33","author":"Frisk","year":"2004","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S2213-8587(15)00008-X_bib46","doi-asserted-by":"crossref","first-page":"1348","DOI":"10.1182\/blood-2004-07-2528","article-title":"Final adult height of patients who received hematopoietic cell transplantation in childhood","volume":"105","author":"Sanders","year":"2005","journal-title":"Blood"},{"key":"10.1016\/S2213-8587(15)00008-X_bib47","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1007\/s004310050006","article-title":"Pubertal development and growth after total-body irradiation and bone marrow transplantation for haematological malignancies","volume":"159","author":"Bakker","year":"2000","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(15)00008-X_bib48","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/00043426-198721000-00004","article-title":"Evaluation of gonadal function following long-term treatment for acute lymphoblastic leukemia in girls","volume":"9","author":"Pasqualini","year":"1987","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/S2213-8587(15)00008-X_bib49","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1097\/00007890-198309000-00005","article-title":"Late effects on gonadal function of cyclophosphamide, total-body irradiation, and marrow transplantation","volume":"36","author":"Sanders","year":"1983","journal-title":"Transplantation"},{"key":"10.1016\/S2213-8587(15)00008-X_bib50","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1136\/adc.62.11.1107","article-title":"Precocious and premature puberty associated with treatment of acute lymphoblastic leukaemia","volume":"62","author":"Leiper","year":"1987","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(15)00008-X_bib51","first-page":"1282","article-title":"Cranial irradiation and early puberty","volume":"78","author":"Ogilvy-Stuart","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib52","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1002\/(SICI)1096-911X(199710)29:4<280::AID-MPO8>3.0.CO;2-I","article-title":"Increased LH and FSH secretion after cranial irradiation in boys","volume":"29","author":"Lannering","year":"1997","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/S2213-8587(15)00008-X_bib53","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1093\/humrep\/16.9.1838","article-title":"Hypothalamic-pituitary-ovarian dysfunction after prepubertal chemotherapy and cranial irradiation for acute leukaemia","volume":"16","author":"Bath","year":"2001","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(15)00008-X_bib54","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1210\/jcem-54-6-1164","article-title":"Effect of hypothalamic and pituitary irradiation on pubertal development in children with cranial tumors","volume":"54","author":"Rappaport","year":"1982","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib55","first-page":"2446","article-title":"Gonadal status in male survivors following childhood brain tumors","volume":"86","author":"Schmiegelow","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib56","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1038\/bjc.1990.138","article-title":"Endocrine disorders following treatment of childhood brain tumours","volume":"61","author":"Livesey","year":"1990","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(15)00008-X_bib57","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1002\/mpo.10267","article-title":"Hypothalamo-pituitary-adrenal axis integrity after cranial irradiation for childhood posterior fossa tumours","volume":"40","author":"Spoudeas","year":"2003","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/S2213-8587(15)00008-X_bib58","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000185357","article-title":"Hypothalamic-pituitary-adrenal function following cranial irradiation","volume":"47","author":"Oberfield","year":"1997","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(15)00008-X_bib59","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1210\/jc.2002-021994","article-title":"Assessment of the hypothalamo-pituitary-adrenal axis in patients treated with radiotherapy and chemotherapy for childhood brain tumor","volume":"88","author":"Schmiegelow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib60","first-page":"307","article-title":"Growth and development of long-term survivors of childhood acute lymphoblastic leukemia treated with and without prophylactic radiation of the central nervous system","volume":"8","author":"Drinnan","year":"1985","journal-title":"Clin Invest Med"},{"key":"10.1016\/S2213-8587(15)00008-X_bib61","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/1097-0142(19860401)57:7<1287::AID-CNCR2820570706>3.0.CO;2-O","article-title":"Hypothalamic-pituitary function of children with acute lymphocytic leukemia after three forms of central nervous system prophylaxis. A retrospective study","volume":"57","author":"Voorhess","year":"1986","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00008-X_bib62","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1365-2265.1993.tb02369.x","article-title":"Adrenocorticotrophin and cortisol secretion in children after low dose cranial irradiation","volume":"39","author":"Crowne","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(15)00008-X_bib63","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1210\/jc.2002-020380","article-title":"A population-based study of thyroid function after radiotherapy and chemotherapy for a childhood brain tumor","volume":"88","author":"Schmiegelow","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib64","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/pbc.22082","article-title":"Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study","volume":"53","author":"Chow","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00008-X_bib65","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1515\/JPEM.2004.17.1.55","article-title":"Hypothalamic dysfunction after chemotherapy","volume":"17","author":"Rose","year":"2004","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib66","doi-asserted-by":"crossref","first-page":"2013","DOI":"10.1002\/1097-0142(19921001)70:7<2013::AID-CNCR2820700734>3.0.CO;2-J","article-title":"The effects of adjuvant chemotherapy on growth in children with medulloblastoma","volume":"70","author":"Olshan","year":"1992","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00008-X_bib67","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1651-2227.1995.tb13864.x","article-title":"Effect of chemotherapy on growth","volume":"411","author":"Ogilvy-Stuart","year":"1995","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/S2213-8587(15)00008-X_bib68","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF01972968","article-title":"Prolonged intrathecal chemotherapy replacing cranial irradiation in high-risk acute lymphatic leukaemia: long-term follow up with cerebral computed tomography scans and endocrinological studies","volume":"154","author":"Hasle","year":"1995","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(15)00008-X_bib69","doi-asserted-by":"crossref","first-page":"3926","DOI":"10.1210\/jc.2013-2435","article-title":"Central diabetes insipidus: a previously unreported side effect of temozolomide","volume":"98","author":"Faje","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib70","doi-asserted-by":"crossref","first-page":"3111","DOI":"10.1210\/jcem.82.9.4238","article-title":"Effects of chemotherapy-induced testicular damage on inhibin, gonadotropin, and testosterone secretion: a prospective longitudinal study","volume":"82","author":"Wallace","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib71","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00039-X","article-title":"Cancer treatment and gonadal function: experimental and established strategies for fertility preservation in children and young adults","author":"Anderson","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00008-X_bib72","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/S0022-3476(04)00233-1","article-title":"Suppression of adrenal function in children with acute lymphoblastic leukemia following induction therapy with corticosteroid and other cytotoxic agents","volume":"144","author":"Mahachoklertwattana","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(15)00008-X_bib73","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jpeds.2005.06.006","article-title":"Clinical impact of corticosteroid-induced adrenal suppression during treatment for acute lymphoblastic leukemia in children: a prospective observational study using the low-dose adrenocorticotropin test","volume":"147","author":"Rix","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(15)00008-X_bib74","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1016\/S0140-6736(03)13492-7","article-title":"Adrenal insufficiency","volume":"361","author":"Arlt","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00008-X_bib75","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1097\/PPO.0b013e31823261db","article-title":"Beyond cancer vaccines: a reason for future optimism with immunomodulatory therapy","volume":"17","author":"Postow","year":"2011","journal-title":"Cancer J"},{"key":"10.1016\/S2213-8587(15)00008-X_bib76","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1210\/jc.2012-4075","article-title":"Endocrine side effects induced by immune checkpoint inhibitors","volume":"98","author":"Corsello","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib77","doi-asserted-by":"crossref","first-page":"4078","DOI":"10.1210\/jc.2014-2306","article-title":"Ipilimumab-induced hypophysitis: a detailed longitudinal analysis in a large cohort of patients with metastatic melanoma","volume":"99","author":"Faje","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib78","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1634\/theoncologist.2011-0404","article-title":"Hypophysitis induced by monoclonal antibodies to cytotoxic T lymphocyte antigen 4: challenges from a new cause of a rare disease","volume":"17","author":"Torino","year":"2012","journal-title":"Oncologist"},{"key":"10.1016\/S2213-8587(15)00008-X_bib79","doi-asserted-by":"crossref","first-page":"8968","DOI":"10.1200\/JCO.2005.01.109","article-title":"Antitumor activity in melanoma and anti-self responses in a phase I trial with the anti-cytotoxic T lymphocyte-associated antigen 4 monoclonal antibody CP-675,206","volume":"23","author":"Ribas","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00008-X_bib80","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/edrv.19.2.0329","article-title":"The diagnosis of growth hormone deficiency in children and adults","volume":"19","author":"Shalet","year":"1998","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(15)00008-X_bib81","first-page":"3323","article-title":"Reliability of provocative tests to assess growth hormone secretory status. Study in 472 normally growing children","volume":"81","author":"Ghigo","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib82","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1046\/j.1365-2265.1996.00855.x","article-title":"The assessment of growth hormone status in normal young adult males using a variety of provocative agents","volume":"45","author":"Rahim","year":"1996","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(15)00008-X_bib83","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1210\/jcem-71-6-1481","article-title":"Growth hormone (GH) responsiveness to combined administration of arginine and GH-releasing hormone does not vary with age in man","volume":"71","author":"Ghigo","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib84","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/eje.1.01967","article-title":"The cut-off limits of the GH response to GH-releasing hormone-arginine test related to body mass index","volume":"153","author":"Corneli","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(15)00008-X_bib85","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1530\/EJE-07-0631","volume":"157","author":"Ho","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(15)00008-X_bib86","first-page":"379","article-title":"Consensus guidelines for the diagnosis and treatment of adults with growth hormone deficiency: summary statement of the Growth Hormone Research Society Workshop on Adult Growth Hormone Deficiency","volume":"83","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib87","doi-asserted-by":"crossref","first-page":"4124","DOI":"10.1210\/jc.2003-030126","article-title":"Effect of growth hormone (GH) treatment on bone in postpubertal GH-deficient patients: a 2-year randomized, controlled, dose-ranging study","volume":"88","author":"Shalet","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.beem.2014.09.006","article-title":"Growth hormone replacement in adults - current standards and new perspectives","volume":"29","author":"H\u00f6ybye","year":"2015","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib89","doi-asserted-by":"crossref","first-page":"2030","DOI":"10.1210\/jc.2013-4159","article-title":"Growth hormone exposure as a risk factor for the development of subsequent neoplasms of the central nervous system: a report from the childhood cancer survivor study","volume":"99","author":"Patterson","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib90","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1016\/j.jocn.2014.04.016","article-title":"Growth hormone treatment and risk of recurrence or development of secondary neoplasms in survivors of pediatric brain tumors","volume":"21","author":"Wang","year":"2014","journal-title":"J Clin Neurosci"},{"key":"10.1016\/S2213-8587(15)00008-X_bib91","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2265.2005.02338.x","article-title":"Tumour surveillance imaging in patients with extrapituitary tumours receiving growth hormone replacement","volume":"63","author":"Chung","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(15)00008-X_bib92","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/(SICI)1096-911X(200001)34:1<14::AID-MPO3>3.0.CO;2-W","article-title":"Adult height after growth hormone (GH) treatment for GH deficiency due to cranial irradiation","volume":"34","author":"Adan","year":"2000","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/S2213-8587(15)00008-X_bib93","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1210\/jc.2003-030366","article-title":"Improvements in final height over 25 years in growth hormone (GH)-deficient childhood survivors of brain tumors receiving GH replacement","volume":"88","author":"Gleeson","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00008-X_bib94","doi-asserted-by":"crossref","first-page":"R229","DOI":"10.1530\/EJE-13-0894","article-title":"Transition in endocrinology: induction of puberty","volume":"170","author":"Dunkel","year":"2014","journal-title":"Eur J Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500008X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500008X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T20:11:35Z","timestamp":1598904695000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871500008X"}},"issued":{"date-parts":[[2015,7]]},"references-count":93,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S221385871500008X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00008-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of cancer treatment on hypothalamic\u2013pituitary function","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00008-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00031-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00029-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00038-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00039-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T16:00:39Z","timestamp":1792512039110,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/s2213-8587(21)00284-9","type":"journal-article","created":{"date-parts":[[2021,12,16]],"date-time":"2021-12-16T18:34:53Z","timestamp":1639679693000},"page":"142-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia"],"prefix":"10.1016","volume":"10","author":[{"given":"Gary F","family":"Lewis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00284-9_bib1","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/CIR.0b013e3182160726","article-title":"Triglycerides and cardiovascular disease: a scientific statement from the American Heart Association","volume":"123","author":"Miller","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00284-9_bib2","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1001\/jama.294.14.1773","article-title":"Trends in serum lipids and lipoproteins of adults, 1960\u20132002","volume":"294","author":"Carroll","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00284-9_bib3","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1001\/jama.2015.4260","article-title":"Prevalence of the metabolic syndrome in the United States, 2003\u20132012","volume":"313","author":"Aguilar","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00284-9_bib4","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1017\/S1368980019004166","article-title":"Prevalence and determinants of metabolic syndrome based on three definitions in rural northeast China","volume":"23","author":"Du","year":"2020","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(21)00284-9_bib5","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1001\/jamacardio.2019.3780","article-title":"Apolipoprotein B particles and cardiovascular disease: a narrative review","volume":"4","author":"Sniderman","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib6","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00284-9_bib7","doi-asserted-by":"crossref","first-page":"616","DOI":"10.3389\/fendo.2020.00616","article-title":"Hypertriglyceridemia-causes, significance, and approaches to therapy","volume":"11","author":"Santos-Baez","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(21)00284-9_bib8","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1093\/eurheartj\/ehz785","article-title":"Clinical review on triglycerides","volume":"41","author":"Laufs","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00284-9_bib9","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2337\/db16-0046","article-title":"Pharmacological targeting of the atherogenic dyslipidemia complex: the next frontier in CVD prevention beyond lowering LDL cholesterol","volume":"65","author":"Xiao","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00284-9_bib10","first-page":"595","article-title":"The atherogenic dyslipidemia complex and novel approaches to cardiovascular disease prevention in diabetes","volume":"34","author":"Stahel","year":"2018","journal-title":"Can J Cardiol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib11","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.CIR.102.2.179","article-title":"Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?","volume":"102","author":"Lemieux","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00284-9_bib12","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab551","article-title":"Triglyceride-rich lipoproteins and their remnants: metabolic insights, role in atherosclerotic cardiovascular disease, and emerging therapeutic strategies-a consensus statement from the European Atherosclerosis Society","author":"Ginsberg","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00284-9_bib13","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1161\/CIRCRESAHA.119.312617","article-title":"HDL and reverse cholesterol transport","volume":"124","author":"Ouimet","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(21)00284-9_bib14","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1016\/j.jacc.2020.02.059","article-title":"Triglyceride-rich lipoprotein cholesterol, small dense LDL cholesterol, and incident cardiovascular disease","volume":"75","author":"Duran","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0241993","article-title":"Association of small, dense LDL-cholesterol concentration and lipoprotein particle characteristics with coronary heart disease: a systematic review and meta-analysis","volume":"15","author":"Liou","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00284-9_bib16","article-title":"Mechanisms of atherosclerosis induced by postprandial lipemia","volume":"8","author":"Zhao","year":"2021","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/S2213-8587(21)00284-9_bib17","first-page":"1129","article-title":"2021 Canadian Cardiovascular Society Guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib18","doi-asserted-by":"crossref","first-page":"3046","DOI":"10.1161\/hc5001.100624","article-title":"Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S","volume":"104","author":"Ballantyne","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00284-9_bib19","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1016\/j.ahj.2018.09.011","article-title":"Rationale and design of the Pemafibrate to Reduce Cardiovascular Outcomes by Reducing Triglycerides in Patients with Diabetes (PROMINENT) study","volume":"206","author":"Pradhan","year":"2018","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(21)00284-9_bib20","doi-asserted-by":"crossref","first-page":"213","DOI":"10.4093\/dmj.2020.0001","article-title":"Fibrates revisited: potential role in cardiovascular risk reduction","volume":"44","author":"Kim","year":"2020","journal-title":"Diabetes Metab J"},{"key":"10.1016\/S2213-8587(21)00284-9_bib21","series-title":"Endotext","article-title":"Metabolic syndrome","author":"Lam","year":"2000"},{"key":"10.1016\/S2213-8587(21)00284-9_bib22","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1007\/s11892-019-1173-y","article-title":"The genetic epidemiology of type 2 diabetes: opportunities for health translation","volume":"19","author":"Meigs","year":"2019","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(21)00284-9_bib23","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.3714","article-title":"Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance","volume":"49","author":"Lotta","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(21)00284-9_bib24","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2020.00455","article-title":"Genetics of hypertriglyceridemia","volume":"11","author":"Dron","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(21)00284-9_bib25","doi-asserted-by":"crossref","first-page":"S139","DOI":"10.1016\/j.molmet.2019.06.016","article-title":"Biomarkers for type 2 diabetes","volume":"27S","author":"Laakso","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(21)00284-9_bib26","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1038\/nrcardio.2017.31","article-title":"Hypertriglyceridaemia and risk of coronary artery disease","volume":"14","author":"Reiner","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib27","doi-asserted-by":"crossref","DOI":"10.3390\/nu11123000","article-title":"Human postprandial nutrient metabolism and low-grade inflammation: a narrative review","volume":"11","author":"Meessen","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(21)00284-9_bib28","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/mnfr.201300104","article-title":"High-fat meal induced postprandial inflammation","volume":"58","author":"Herieka","year":"2014","journal-title":"Mol Nutr Food Res"},{"key":"10.1016\/S2213-8587(21)00284-9_bib29","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.tcm.2019.01.004","article-title":"Inflammation, infection and atherosclerosis","volume":"29","author":"Shah","year":"2019","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/S2213-8587(21)00284-9_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-45005-5","article-title":"Oxylipins in triglyceride-rich lipoproteins of dyslipidemic subjects promote endothelial inflammation following a high fat meal","volume":"9","author":"Rajamani","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(21)00284-9_bib31","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1016\/j.tcm.2015.10.004","article-title":"Metabolic syndrome update","volume":"26","author":"Grundy","year":"2016","journal-title":"Trends Cardiovasc Med"},{"key":"10.1016\/S2213-8587(21)00284-9_bib32","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1210\/er.2014-1062","article-title":"Hypertriglyceridemia in the genomic era: a new paradigm","volume":"36","author":"Lewis","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(21)00284-9_bib33","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s11883-999-0038-2","article-title":"Impact of body weight and weight loss on cardiovascular risk factors","volume":"1","author":"Hecker","year":"1999","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/S2213-8587(21)00284-9_bib34","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(21)00284-9_bib35","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.plipres.2013.06.001","article-title":"Postprandial lipoproteins and the molecular regulation of vascular homeostasis","volume":"52","author":"Botham","year":"2013","journal-title":"Prog Lipid Res"},{"key":"10.1016\/S2213-8587(21)00284-9_bib36","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/JOE-16-0237","article-title":"Very low-density lipoprotein (VLDL)-induced signals mediating aldosterone production","volume":"232","author":"Tsai","year":"2017","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib37","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.freeradbiomed.2019.04.030","article-title":"Repositioning of niclosamide ethanolamine (NEN), an anthelmintic drug, for the treatment of lipotoxicity","volume":"137","author":"Park","year":"2019","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/S2213-8587(21)00284-9_bib38","article-title":"Relationship Between Autophagy and Metabolic Syndrome Characteristics in the Pathogenesis of Atherosclerosis","volume":"9","author":"Xu","year":"2021","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib39","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1161\/CIRCRESAHA.117.309419","article-title":"Extracellular Vesicles in Metabolic Syndrome","volume":"120","author":"Mart\u00ednez","year":"2017","journal-title":"Circ Res"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00284-9_bib40","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.1016\/S0049-3848(01)00293-6","article-title":"Plasminogen activator inhibitor type-1 in cardiovascular disease. Status report 2001","volume":"103","author":"Huber","year":"2001","journal-title":"Thromb Res"},{"key":"10.1016\/S2213-8587(21)00284-9_bib41","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12933-014-0159-y","article-title":"Hypertriglyceridemia: a too long unfairly neglected major cardiovascular risk factor","volume":"13","author":"Tenenbaum","year":"2014","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib42","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1111\/ijlh.12773","article-title":"VIIaAT complexes, procoagulant phospholipids, and thrombin generation during postprandial lipemia","volume":"40","author":"Silveira","year":"2018","journal-title":"Int J Lab Hematol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib43","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.thromres.2020.04.035","article-title":"Arterial and venous thrombosis: what's the link? A narrative review","volume":"191","author":"Delluc","year":"2020","journal-title":"Thromb Res"},{"key":"10.1016\/S2213-8587(21)00284-9_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101097","article-title":"Moderate SIRT1 overexpression protects against brown adipose tissue inflammation","volume":"42","author":"Escalona-Garrido","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(21)00284-9_bib45","doi-asserted-by":"crossref","first-page":"2439","DOI":"10.1111\/liv.14597","article-title":"NAFLD is related to post-prandial triglyceride-enrichment of HDL particles in association with endothelial and HDL dysfunction","volume":"40","author":"Verwer","year":"2020","journal-title":"Liver Int"},{"key":"10.1016\/S2213-8587(21)00284-9_bib46","first-page":"401","article-title":"Benefits of sustained moderate weight loss in obesity","volume":"11","author":"Pasanisi","year":"2001","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(21)00284-9_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1467-789X.2004.00127.x","article-title":"Effects of weight loss in overweight\/obese individuals and long-term lipid outcomes\u2014 a systematic review","volume":"5","author":"Poobalan","year":"2004","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00284-9_bib48","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(21)00284-9_bib49","first-page":"S102","article-title":"2013 AHA\/ACC\/TOS guideline for the management of overweight and obesity in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines and The Obesity Society","volume":"129","author":"Jensen","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00284-9_bib50","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/oby.22676","article-title":"History of cardiovascular disease, intensive lifestyle intervention, and cardiovascular outcomes in the look AHEAD Trial","volume":"28","author":"Lewis","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00284-9_bib51","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000510","article-title":"Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association","volume":"136","author":"Sacks","year":"2017","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00284-9_bib52","doi-asserted-by":"crossref","first-page":"S15","DOI":"10.3949\/ccjm.84.s1.03","article-title":"The essential role of exercise in the management of type 2 diabetes","volume":"84","author":"Kirwan","year":"2017","journal-title":"Cleve Clin J Med"},{"key":"10.1016\/S2213-8587(21)00284-9_bib53","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/j.amjmed.2006.02.031","article-title":"Metabolic syndrome and risk of cardiovascular disease: a meta-analysis","volume":"119","author":"Galassi","year":"2006","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(21)00284-9_bib54","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12933-020-01166-6","article-title":"Risk for cardiovascular disease associated with metabolic syndrome and its components: a 13-year prospective study in the RIVANA cohort","volume":"19","author":"Guembe","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib55","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00284-9_bib56","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.atherosclerosis.2019.08.014","article-title":"2019 ESC\/EAS guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"290","author":"Mach","year":"2019","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(21)00284-9_bib57","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.jacc.2021.06.011","article-title":"2021 ACC expert consensus decision pathway on the management of ASCVD risk reduction in patients with persistent hypertriglyceridemia: a report of the American College of Cardiology Solution Set Oversight Committee","volume":"78","author":"Virani","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib58","first-page":"12","article-title":"Hypertension in metabolic syndrome: novel insights","volume":"16","author":"Katsimardou","year":"2020","journal-title":"Curr Hypertens Rev"},{"key":"10.1016\/S2213-8587(21)00284-9_bib59","first-page":"596","article-title":"Hypertension Canada's 2020 comprehensive guidelines for the prevention, diagnosis, risk assessment, and treatment of hypertension in adults and children","volume":"36","author":"Rabi","year":"2020","journal-title":"Can J Cardiol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib60","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1812792","article-title":"Cardiovascular risk reduction with icosapent ethyl for hypertriglyceridemia","volume":"380","author":"Bhatt","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00284-9_bib61","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1097\/HCO.0000000000000678","article-title":"Cardiovascular risk reduction with icosapent ethyl","volume":"34","author":"Patel","year":"2019","journal-title":"Curr Opin Cardiol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib62","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00284-9_bib63","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00284-9_bib64","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib65","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00284-9_bib66","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00284-9_bib67","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1161\/CIR.0000000000000450","article-title":"Contributory risk and management of comorbidities of hypertension, obesity, diabetes mellitus, hyperlipidemia, and metabolic syndrome in chronic heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Bozkurt","year":"2016","journal-title":"Circulation"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00284-9_bib68","first-page":"S98","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes-2020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00284-9_bib69","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.2337\/db14-1706","article-title":"Gut peptides are novel regulators of intestinal lipoprotein secretion: experimental and pharmacological manipulation of lipoprotein metabolism","volume":"64","author":"Xiao","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00284-9_bib70","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1161\/ATVBAHA.112.246207","article-title":"Exenatide, a glucagon-like peptide-1 receptor agonist, acutely inhibits intestinal lipoprotein production in healthy humans","volume":"32","author":"Xiao","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib71","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.jacc.2021.04.083","article-title":"Mortality benefit of rivaroxaban plus aspirin in patients with chronic coronary or peripheral artery disease","volume":"78","author":"Eikelboom","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib72","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41569-019-0314-y","article-title":"Dual-pathway inhibition for secondary and tertiary antithrombotic prevention in cardiovascular disease","volume":"17","author":"Capodanno","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib73","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1161\/CIRCRESAHA.118.313155","article-title":"Antithrombotic agents","volume":"124","author":"Chan","year":"2019","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(21)00284-9_bib74","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1097\/MOL.0000000000000640","article-title":"SPPARM alpha: the Lazarus effect","volume":"30","author":"Fruchart","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib75","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1161\/CIRCRESAHA.116.307591","article-title":"Treatment of obesity: weight loss and bariatric surgery","volume":"118","author":"Wolfe","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(21)00284-9_bib76","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0140-6736(18)31773-2","article-title":"Efficacy and safety of semaglutide compared with liraglutide and placebo for weight loss in patients with obesity: a randomised, double-blind, placebo and active controlled, dose-ranging, phase 2 trial","volume":"392","author":"O'Neil","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00284-9_bib77","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1002\/oby.22794","article-title":"Semaglutide 2.4 mg for the treatment of obesity: key elements of the STEP trials 1 to 5","volume":"28","author":"Kushner","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00284-9_bib78","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00284-9_bib79","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1097\/MOL.0000000000000676","article-title":"Regulation of lipoprotein lipase-mediated lipolysis of triglycerides","volume":"31","author":"Basu","year":"2020","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib80","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1097\/MOL.0000000000000679","article-title":"The next generation of triglyceride-lowering drugs: will reducing apolipoprotein C-III or angiopoietin like protein 3 reduce cardiovascular disease?","volume":"31","author":"Reeskamp","year":"2020","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib81","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1080\/14779072.2021.1955348","article-title":"Volanesorsen for treatment of familial chylomicronemia syndrome","volume":"19","author":"Lazarte","year":"2021","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/S2213-8587(21)00284-9_bib82","doi-asserted-by":"crossref","first-page":"2785","DOI":"10.1093\/eurheartj\/ehz209","article-title":"N-acetyl galactosamine-conjugated antisense drug to APOC3 mRNA, triglycerides and atherogenic lipoprotein levels","volume":"40","author":"Alexander","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00284-9_bib83","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1097\/MOL.0000000000000755","article-title":"Inhibition of angiopoietin-like 3 for the management of severe hypercholesterolemia","volume":"32","author":"Mohamed","year":"2021","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(21)00284-9_bib84","doi-asserted-by":"crossref","first-page":"3936","DOI":"10.1093\/eurheartj\/ehaa689","article-title":"Vupanorsen, an N-acetyl galactosamine-conjugated antisense drug to ANGPTL3 mRNA, lowers triglycerides and atherogenic lipoproteins in patients with diabetes, hepatic steatosis, and hypertriglyceridaemia","volume":"41","author":"Gaudet","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00284-9_bib85","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1161\/CIRCRESAHA.121.319077","article-title":"Interleukin-6 signaling and anti-interleukin-6 therapeutics in cardiovascular disease","volume":"128","author":"Ridker","year":"2021","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(21)00284-9_bib86","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.121.021198","article-title":"Colchicine in patients with coronary artery disease: a systematic review and meta-analysis of randomized trials","volume":"10","author":"Kofler","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(21)00284-9_bib87","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.arcmed.2020.11.010","article-title":"Epidemiology, pathogenesis, diagnosis and emerging treatment of nonalcoholic fatty liver disease","volume":"52","author":"Makri","year":"2021","journal-title":"Arch Med Res"},{"key":"10.1016\/S2213-8587(21)00284-9_bib88","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1080\/14728214.2020.1796968","article-title":"Emerging drugs for the treatment of non-alcoholic steatohepatitis: a focused review of farnesoid X receptor agonists","volume":"25","author":"Shah","year":"2020","journal-title":"Expert Opin Emerg Drugs"},{"key":"10.1016\/S2213-8587(21)00284-9_bib89","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.1016\/S0140-6736(19)32517-6","article-title":"Resmetirom (MGL-3196) for the treatment of non-alcoholic steatohepatitis: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","volume":"394","author":"Harrison","year":"2019","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(22)00011-0","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002849?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002849?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:24Z","timestamp":1761991884000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002849"}},"issued":{"date-parts":[[2022,2]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2213858721002849"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00284-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effective, disease-modifying, clinical approaches to patients with mild-to-moderate hypertriglyceridaemia","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00284-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:53:56Z","timestamp":1792803236740,"version":"4.5.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,3]],"date-time":"2023-08-03T00:00:00Z","timestamp":1691020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271"],"award-info":[{"award-number":["314061271"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004571","name":"Minist\u00e8re des Affaires Sociales et de la Sant\u00e9","doi-asserted-by":"publisher","award":["2010-P100139"],"award-info":[{"award-number":["2010-P100139"]}],"id":[{"id":"10.13039\/501100004571","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/s2213-8587(23)00193-6","type":"journal-article","created":{"date-parts":[[2023,8,21]],"date-time":"2023-08-21T18:29:31Z","timestamp":1692642571000},"page":"720-730","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study"],"prefix":"10.1016","volume":"11","author":[{"given":"Massimo","family":"Terzolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Perotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Lib\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darko","family":"Kastelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm Reinout","family":"Haak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Loli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9n\u00e9dicte","family":"Decoudier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helene","family":"Lasolle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Quinkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Haissaguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Stigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Zatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Candida Barisson Villares","family":"Fragoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Canu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michaela","family":"Luconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Reimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kroiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Megerle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otilia","family":"Kimpel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Dusek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"N\u00f6lting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bourdeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Chortis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine Hester","family":"Ettaieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Cosentini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Grisanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Berchialla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bovis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pia","family":"Sormani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Bruzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome","family":"Bertherat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfredo","family":"Berruti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00193-6_bib1","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology Clinical Practice Guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00193-6_bib2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1210\/jc.2014-3182","article-title":"Major prognostic role of Ki67 in localized adrenocortical carcinoma after complete resection","volume":"100","author":"Beuschlein","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00193-6_bib3","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.surg.2018.04.068","article-title":"Longitudinal patterns of recurrence in patients with adrenocortical carcinoma","volume":"165","author":"Glenn","year":"2019","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(23)00193-6_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s12020-019-02141-2","article-title":"The clinical utility of \u2018GRAS\u2019 parameters in stage I\u2013III adrenocortical carcinomas: long-term data from a high-volume institution","volume":"67","author":"Liang","year":"2020","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(23)00193-6_bib5","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1530\/EJE-21-0510","article-title":"S-GRAS score for prognostic classification of adrenocortical carcinoma: an international, multicenter ENSAT study","volume":"186","author":"Elhassan","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00193-6_bib6","doi-asserted-by":"crossref","first-page":"R27","DOI":"10.1530\/EJE-22-0260","article-title":"ENDOCRINE TUMOURS: our experience with the management of patients with non-metastatic adrenocortical carcinoma","volume":"187","author":"Terzolo","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00193-6_bib7","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1001\/archsurg.1982.01380330010004","article-title":"Treatment of adrenal carcinomas","volume":"117","author":"Schteingart","year":"1982","journal-title":"Arch Surg"},{"key":"10.1016\/S2213-8587(23)00193-6_bib8","doi-asserted-by":"crossref","first-page":"2372","DOI":"10.1056\/NEJMoa063360","article-title":"Adjuvant mitotane treatment for adrenocortical carcinoma","volume":"356","author":"Terzolo","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00193-6_bib9","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/j.annonc.2020.08.2099","article-title":"Adrenocortical carcinomas and malignant phaeochromocytomas: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up","volume":"31","author":"Fassnacht","year":"2020","journal-title":"Ann Oncol"},{"key":"10.1016\/S2213-8587(23)00193-6_bib10","doi-asserted-by":"crossref","first-page":"3730","DOI":"10.1210\/jc.2008-0579","article-title":"Adjuvant mitotane for adrenocortical cancer\u2014a recurring controversy","volume":"93","author":"Huang","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00193-6_bib11","doi-asserted-by":"crossref","first-page":"1879","DOI":"10.1210\/jc.2009-0120","article-title":"Adjuvant mitotane for adrenocortical cancer\u2014working through uncertainty","volume":"94","author":"Terzolo","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00193-6_bib12","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1002\/1097-0142(19950515)75:10<2587::AID-CNCR2820751028>3.0.CO;2-5","article-title":"Adrenocortical carcinoma. A clinical study and treatment results of 52 patients","volume":"75","author":"Kasperlik-Za\u0142uska","year":"1995","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(23)00193-6_bib13","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1200\/JCO.2002.20.4.941","article-title":"Adrenocortical carcinoma: clinical, morphologic, and molecular characterization","volume":"20","author":"Stojadinovic","year":"2002","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(23)00193-6_bib14","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2559.2009.03423.x","article-title":"Clinicopathological study of a series of 92 adrenocortical carcinomas: from a proposal of simplified diagnostic algorithm to prognostic stratification","volume":"55","author":"Volante","year":"2009","journal-title":"Histopathology"},{"key":"10.1016\/S2213-8587(23)00193-6_bib15","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1200\/JCO.2009.27.5958","article-title":"Adjuvant therapy in patients with adrenocortical carcinoma: a position of an international panel","volume":"28","author":"Berruti","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(23)00193-6_bib16","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/cncr.24030","article-title":"Limited prognostic value of the 2004 International Union Against Cancer staging classification for adrenocortical carcinoma: proposal for a Revised TNM Classification","volume":"115","author":"Fassnacht","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(23)00193-6_bib17","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.1210\/jc.2010-2676","article-title":"Plasma concentrations of o,p'DDD, o,p'DDA, and o,p'DDE as predictors of tumor response to mitotane in adrenocortical carcinoma: results of a retrospective ENS@T multicenter study","volume":"96","author":"Hermsen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00193-6_bib18","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1530\/EJE-13-0242","article-title":"Mitotane levels predict the outcome of patients with adrenocortical carcinoma treated adjuvantly following radical resection","volume":"169","author":"Terzolo","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00193-6_bib20","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1016\/S0959-8049(01)00127-7","article-title":"Interpreting quality of life data: population-based reference data for the EORTC QLQ-C30","volume":"37","author":"Fayers","year":"2001","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2213-8587(23)00193-6_bib21","doi-asserted-by":"crossref","first-page":"1256","DOI":"10.1056\/NEJMc076267","article-title":"Adjuvant mitotane in adrenocortical carcinoma","volume":"357","author":"Bertherat","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00193-6_bib22","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1245\/s10434-009-0716-x","article-title":"Recurrence of adrenal cortical carcinoma following resection: surgery alone can achieve results equal to surgery plus mitotane","volume":"17","author":"Grubbs","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S2213-8587(23)00193-6_bib23","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1210\/jc.2013-2856","article-title":"Adjuvant therapies and patient and tumor characteristics associated with survival of adult patients with adrenocortical carcinoma","volume":"99","author":"Else","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00193-6_bib24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1016\/j.jamcollsurg.2015.12.013","article-title":"Outcomes of adjuvant mitotane after resection of adrenocortical carcinoma: a 13-institution study by the US Adrenocortical Carcinoma Group","volume":"222","author":"Postlewait","year":"2016","journal-title":"J Am Coll Surg"},{"key":"10.1016\/S2213-8587(23)00193-6_bib25","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1210\/jc.2016-2894","article-title":"Long-term outcomes of adjuvant mitotane therapy in patients with radically resected adrenocortical carcinoma","volume":"102","author":"Berruti","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00193-6_bib26","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1054\/bjoc.2000.1142","article-title":"Reasons for accepting or declining to participate in randomized clinical trials for cancer therapy","volume":"82","author":"Jenkins","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(23)00193-6_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/EJE-18-0923","article-title":"Adjuvant mitotane therapy is beneficial in non-metastatic adrenocortical carcinoma at high risk of recurrence","volume":"180","author":"Calabrese","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00193-6_bib28","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1016\/S0140-6736(02)09088-8","article-title":"Anastrozole alone or in combination with tamoxifen versus tamoxifen alone for adjuvant treatment of postmenopausal women with early breast cancer: first results of the ATAC randomised trial","volume":"359","author":"Baum","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00193-6_bib29","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1200\/JCO.2008.18.5678","article-title":"Gene expression profiling reveals a new classification of adrenocortical tumors and identifies molecular predictors of malignancy and survival","volume":"27","author":"de Reyni\u00e8s","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(23)00193-6_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1530\/EJE-11-0806","article-title":"Combined expression of BUB1B, DLGAP5, and PINK1 as predictors of poor outcome in adrenocortical tumors: validation in a Brazilian cohort of adult and pediatric patients","volume":"166","author":"Fragoso","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00193-6_bib31","first-page":"923","article-title":"DNA methylation is an independent prognostic marker of survival in adrenocortical cancer","volume":"102","author":"Jouinot","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00193-6_bib32","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/clinem\/dgac470","article-title":"Prognostic role of targeted methylation analysis in paraffin-embedded samples of adrenocortical carcinoma","volume":"107","author":"Lippert","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00193-6_bib33","doi-asserted-by":"crossref","first-page":"3276","DOI":"10.1158\/1078-0432.CCR-18-2693","article-title":"Targeted assessment of G0S2 methylation identifies a rapidly recurrent, routinely fatal molecular subtype of adrenocortical carcinoma","volume":"25","author":"Mohan","year":"2019","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(23)00193-6_bib34","doi-asserted-by":"crossref","first-page":"3452","DOI":"10.1158\/1078-0432.CCR-11-2692","article-title":"Ribonucleotide reductase large subunit (RRM1) gene expression may predict efficacy of adjuvant mitotane in adrenocortical cancer","volume":"18","author":"Volante","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(23)00193-6_bib35","doi-asserted-by":"crossref","first-page":"4759","DOI":"10.1210\/jc.2013-2281","article-title":"Comparison of two mitotane starting dose regimens in patients with advanced adrenocortical carcinoma","volume":"98","author":"Kerkhofs","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00193-6_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/jcm8111850","article-title":"Mitotane concentrations influence the risk of recurrence in adrenocortical carcinoma patients on adjuvant treatment","volume":"8","author":"Puglisi","year":"2019","journal-title":"J Clin Med"},{"key":"10.1016\/S2213-8587(23)00193-6_bib37","doi-asserted-by":"crossref","first-page":"269","DOI":"10.3390\/jpm11040269","article-title":"What is the optimal duration of adjuvant mitotane therapy in adrenocortical carcinoma? An unanswered question","volume":"11","author":"Basile","year":"2021","journal-title":"J Pers Med"},{"key":"10.1016\/S2213-8587(23)00193-6_bib38","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.ccell.2016.07.013","article-title":"Comprehensive pan-genomic characterization of adrenocortical carcinoma","volume":"30","author":"Zheng","year":"2016","journal-title":"Cancer Cell"},{"key":"10.1016\/S2213-8587(23)00193-6_bib39","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1001\/jamaoncol.2019.1558","article-title":"Value of molecular classification for prognostic assessment of adrenocortical carcinoma","volume":"5","author":"Assi\u00e9","year":"2019","journal-title":"JAMA Oncol"},{"key":"10.1016\/S2213-8587(23)00193-6_bib40","doi-asserted-by":"crossref","first-page":"3300","DOI":"10.1210\/jc.2011-1397","article-title":"(18)F-FDG-PET\/CT imaging of ACTH-independent macronodular adrenocortical hyperplasia (AIMAH) demonstrating increased (18)F-FDG uptake","volume":"96","author":"Alencar","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(23)00319-4","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001936?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001936?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:10Z","timestamp":1761991990000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001936"}},"issued":{"date-parts":[[2023,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2213858723001936"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00193-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adjuvant mitotane versus surveillance in low-grade, localised adrenocortical carcinoma (ADIUVO): an international, multicentre, open-label, randomised, phase 3 trial and observational study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00193-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00231-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T02:02:18Z","timestamp":1793671338819,"version":"4.5.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012331","name":"LEO Fondet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012331","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013235","name":"NIHR Greater Manchester Patient Safety Translational Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013235","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/s2213-8587(21)00116-9","type":"journal-article","created":{"date-parts":[[2021,5,11]],"date-time":"2021-05-11T20:21:42Z","timestamp":1620764502000},"page":"413-415","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":100,"title":["Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK"],"prefix":"10.1016","volume":"9","author":[{"given":"Matthew J","family":"Carr","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison K","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lalantha","family":"Leelarathna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hood","family":"Thabit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Milne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh","family":"Kanumilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren M","family":"Ashcroft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin K","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00116-9_bib1","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00116-9_bib2","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00116-9_bib3","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(21)00116-9_bib4","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1016\/S2468-2667(20)30201-2","article-title":"Diagnosis of physical and mental health conditions in primary care during the COVID-19 pandemic: a retrospective cohort study","volume":"5","author":"Williams","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(21)00116-9_bib6","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1002\/osp4.442","article-title":"Weight-related lifestyle behaviours and the COVID-19 crisis: an online survey study of UK adults during social lockdown","volume":"6","author":"Robinson","year":"2020","journal-title":"Obes Sci Pract"},{"key":"10.1016\/S2213-8587(21)00116-9_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.appet.2020.104853","article-title":"Obesity, eating behavior and physical activity during COVID-19 lockdown: a study of UK adults","volume":"156","author":"Robinson","year":"2021","journal-title":"Appetite"},{"key":"10.1016\/S2213-8587(21)00116-9_bib8","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1007\/s00125-017-4299-y","article-title":"Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139\u2008075 individuals diagnosed with diabetes in Denmark between 2001 and 2009","volume":"60","author":"Simmons","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00116-9_bib9","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1111\/dom.13243","article-title":"Legacy benefits of blood glucose, blood pressure and lipid control in individuals with diabetes and cardiovascular disease: time to overcome multifactorial therapeutic inertia?","volume":"20","author":"Khunti","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00116-9_bib10","doi-asserted-by":"crossref","first-page":"G67","DOI":"10.1530\/EJE-20-0377","article-title":"Endocrinology in the time of COVID-19: remodelling diabetes services and emerging innovation","volume":"183","author":"Wake","year":"2020","journal-title":"Eur J Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001169?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001169?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:14Z","timestamp":1761991754000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001169"}},"issued":{"date-parts":[[2021,7]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2213858721001169"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00116-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00116-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30271-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T04:00:56Z","timestamp":1793419256484,"version":"4.5.0"},"reference-count":72,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/s2213-8587(15)00379-4","type":"journal-article","created":{"date-parts":[[2015,12,4]],"date-time":"2015-12-04T06:52:32Z","timestamp":1449211952000},"page":"148-158","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":270,"title":["Diabetes and infection: assessing the association with glycaemic control in population-based studies"],"prefix":"10.1016","volume":"4","author":[{"given":"Jonathan","family":"Pearson-Stuttard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samkeliso","family":"Blundell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tess","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek G","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Critchley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00379-4_bib2","doi-asserted-by":"crossref","first-page":"2690","DOI":"10.2337\/dc12-2074","article-title":"Secular changes in the age-specific prevalence of diabetes among U.S. adults: 1988\u20132010","volume":"36","author":"Cheng","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00379-4_bib3","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2337\/diacare.24.6.1066","article-title":"Prevalence of diabetes in care home residents","volume":"24","author":"Sinclair","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00379-4_bib4","series-title":"Textbook of Diabetes","article-title":"Diabetes and Infections","author":"Cockram","year":"2010"},{"key":"10.1016\/S2213-8587(15)00379-4_bib5","series-title":"Type 2 Diabetes Mellitus: an Evidence Based Approach to Practical Management","article-title":"Type 2 diabetes and concomitant illness","author":"Dungan","year":"2008"},{"key":"10.1016\/S2213-8587(15)00379-4_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/431587","article-title":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus","volume":"41","author":"Muller","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(15)00379-4_bib7","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1016\/j.idc.2007.07.003","article-title":"Infections in diabetes mellitus and hyperglycemia","volume":"21","author":"Gupta","year":"2007","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/S2213-8587(15)00379-4_bib8","first-page":"2239","article-title":"Clinical epidemiology of fungal infection in diabetes","volume":"66","author":"Higa","year":"2008","journal-title":"Nihon Rinsho"},{"key":"10.1016\/S2213-8587(15)00379-4_bib9","first-page":"309","article-title":"Necrotizing (malignant) external otitis","volume":"68","author":"Handzel","year":"2003","journal-title":"Am Fam Physician"},{"key":"10.1016\/S2213-8587(15)00379-4_bib10","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1001\/archinte.159.12.1301","article-title":"Pulmonary mucormycosis: the last 30 years","volume":"159","author":"Lee","year":"1999","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib11","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jdiacomp.2014.11.005","article-title":"Diabetes mellitus and infection: an evaluation of hospital utilization and management costs in the United States","volume":"29","author":"Korbel","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(15)00379-4_bib12","doi-asserted-by":"crossref","first-page":"510","DOI":"10.2337\/diacare.26.2.510","article-title":"Quantifying the risk of infectious diseases for people with diabetes","volume":"26","author":"Shah","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00379-4_bib13","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1111\/dme.12384","article-title":"New estimates of the burden of acute community-acquired infections among older people with diabetes mellitus: a retrospective cohort study using linked electronic health records","volume":"31","author":"McDonald","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib14","doi-asserted-by":"crossref","first-page":"e68008","DOI":"10.1371\/journal.pone.0068008","article-title":"Recent HbA1c values and mortality risk in type 2 diabetes. population-based case-control study","volume":"8","author":"Nicholas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(15)00379-4_bib15","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/jamainternmed.2014.2894","article-title":"Effect of patients\u2019 risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus","volume":"174","author":"Vijan","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib16","doi-asserted-by":"crossref","first-page":"h3293","DOI":"10.1136\/bmj.h3293","article-title":"Diabetes is rising in OECD countries, report warns","volume":"350","author":"Wise","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00379-4_bib18","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jamda.2012.04.012","article-title":"Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes","volume":"13","author":"Sinclair","year":"2012","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/S2213-8587(15)00379-4_bib19","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib20","doi-asserted-by":"crossref","first-page":"d6898","DOI":"10.1136\/bmj.d6898","article-title":"Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials","volume":"343","author":"Hemmingsen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00379-4_bib21","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.2337\/diacare.18.11.1415","article-title":"Adverse events and their association with treatment regimens in the diabetes control and complications trial","volume":"18","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00379-4_bib23","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jdiacomp.2012.06.008","article-title":"Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD)","volume":"26","author":"Hirji","year":"2012","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(15)00379-4_bib24","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2217\/ahe.10.86","article-title":"Optimal glycaemic control in the elderly: where is the evidence and who should be targeted?","volume":"7","author":"Tessier","year":"2011","journal-title":"Aging Health"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00379-4_bib26","first-page":"S28","article-title":"Implications of the United kingdom prospective diabetes study","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00379-4_bib27","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib28","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S2213-8587(13)70025-1","article-title":"Dysglycaemia, vasculopenia, and the chronic consequences of diabetes","volume":"1","author":"Gerstein","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00379-4_bib29","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib30","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib31","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib32","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1016\/S0140-6736(14)60884-9","article-title":"Glycaemic control, cardiovascular disease, and mortality in type 2 diabetes","volume":"384","author":"Chiasson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00379-4_bib33","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2337\/dc06-2417","article-title":"Type 2 diabetes and pneumonia outcomes: a population-based cohort study","volume":"30","author":"Kornum","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00379-4_bib34","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1002\/(SICI)1096-9136(199605)13:5<457::AID-DIA83>3.0.CO;2-T","article-title":"Influence of diabetes mellitus and glycaemic control on the characteristics and outcome of common infections","volume":"13","author":"Leibovici","year":"1996","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1097\/SLA.0b013e3181f4e499","article-title":"Acute glucose elevation is highly predictive of infection and outcome in critically injured trauma patients","volume":"252","author":"Bochicchio","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(15)00379-4_bib36","doi-asserted-by":"crossref","first-page":"3001","DOI":"10.1097\/CCM.0b013e3181b083f7","article-title":"Hyperglycemia-related mortality in critically ill patients varies with admission diagnosis","volume":"37","author":"Falciglia","year":"2009","journal-title":"Crit Care Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib37","doi-asserted-by":"crossref","first-page":"2772","DOI":"10.1097\/01.CCM.0000189741.44071.25","article-title":"Impact of admission hyperglycemia on hospital mortality in various intensive care unit populations","volume":"33","author":"Whitcomb","year":"2005","journal-title":"Crit Care Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib38","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1182\/blood-2007-11-121723","article-title":"Hyperglycemia enhances coagulation and reduces neutrophil degranulation, whereas hyperinsulinemia inhibits fibrinolysis during human endotoxemia","volume":"112","author":"Stegenga","year":"2008","journal-title":"Blood"},{"key":"10.1016\/S2213-8587(15)00379-4_bib39","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1464-5491.2007.02348.x","article-title":"Effect of acute hyperglycaemia and\/or hyperinsulinaemia on proinflammatory gene expression, cytokine production and neutrophil function in humans","volume":"25","author":"Stegenga","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib40","doi-asserted-by":"crossref","first-page":"e92977","DOI":"10.1371\/journal.pone.0092977","article-title":"Phagocytosis via complement or Fc-gamma receptors is compromised in monocytes from type 2 diabetes patients with chronic hyperglycemia","volume":"9","author":"Restrepo","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(15)00379-4_bib41","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1479-5876-10-35","article-title":"Hyperglycemic conditions inhibit C3-mediated immunologic control of Staphylococcus aureus","volume":"10","author":"Hair","year":"2012","journal-title":"J Transl Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib42","doi-asserted-by":"crossref","first-page":"1974","DOI":"10.1016\/j.molimm.2010.04.018","article-title":"Impaired phagocytosis by alveolar macrophages from diabetic rats is related to the deficient coupling of LTs to the Fc gamma R signaling cascade","volume":"47","author":"Ferracini","year":"2010","journal-title":"Mol Immunol"},{"key":"10.1016\/S2213-8587(15)00379-4_bib43","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1007\/s00125-006-0570-3","article-title":"Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome","volume":"50","author":"Benfield","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00379-4_bib44","first-page":"512","article-title":"The role of diabetes mellitus in patients with bloodstream infections","volume":"138","author":"Stoeckle","year":"2008","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/S2213-8587(15)00379-4_bib45","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1089\/sur.2005.6.427","article-title":"The impact of diabetes in patients with necrotizing soft tissue infections","volume":"6","author":"Kao","year":"2005","journal-title":"Surg Infect (Larchmt)"},{"key":"10.1016\/S2213-8587(15)00379-4_bib46","doi-asserted-by":"crossref","first-page":"e60057","DOI":"10.1371\/journal.pone.0060057","article-title":"Skin and soft tissue infections and associated complications among commercially insured patients aged 0-64 years with and without diabetes in the U.S","volume":"8","author":"Suaya","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(15)00379-4_bib47","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/1742-2094-11-80","article-title":"Reduced immune cell infiltration and increased pro-inflammatory mediators in the brain of Type 2 diabetic mouse model infected with West Nile virus","volume":"11","author":"Kumar","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/S2213-8587(15)00379-4_bib48","doi-asserted-by":"crossref","first-page":"e62418","DOI":"10.1371\/journal.pone.0062418","article-title":"Natural killer cell function, an important target for infection and tumor protection, is impaired in type 2 diabetes","volume":"8","author":"Berrou","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(15)00379-4_bib49","doi-asserted-by":"crossref","first-page":"2688","DOI":"10.4049\/jimmunol.178.5.2688","article-title":"NKp46 and NKG2D recognition of infected dendritic cells is necessary for NK cell activation in the human response to influenza infection","volume":"178","author":"Draghi","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(15)00379-4_bib50","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2337\/dc09-2215","article-title":"Diabetes and the severity of pandemic influenza A (H1N1) infection","volume":"33","author":"Allard","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00379-4_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1159\/000345107","article-title":"Diabetes and infection: is there a link?\u2014A mini-review","volume":"59","author":"Knapp","year":"2013","journal-title":"Gerontology"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00379-4_bib52","first-page":"S27","article-title":"Infections in patients with diabetes mellitus: a review of pathogenesis","volume":"16","author":"Casqueiro","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00379-4_bib53","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0168-8227(98)00023-0","article-title":"Infections in patients with type 2 diabetes in general practice","volume":"40","author":"Bartelink","year":"1998","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00379-4_bib54","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.2337\/diacare.25.10.1778","article-title":"Diabetes and the risk of acute urinary tract infection among postmenopausal women","volume":"25","author":"Boyko","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00379-4_bib55","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1093\/oxfordjournals.aje.a000181","article-title":"Risk of urinary tract infection and asymptomatic bacteriuria among diabetic and nondiabetic postmenopausal women","volume":"161","author":"Boyko","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00379-4_bib56","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.juro.2008.11.021","article-title":"Urinary tract infections in women with type 1 diabetes mellitus: survey of female participants in the epidemiology of diabetes interventions and complications study cohort","volume":"181","author":"Czaja","year":"2009","journal-title":"J Urol"},{"key":"10.1016\/S2213-8587(15)00379-4_bib57","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0168-8227(00)00245-X","article-title":"Effect of insulin therapy on quality of life in type 2 diabetes mellitus: the Fremantle Diabetes Study","volume":"52","author":"Davis","year":"2001","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00379-4_bib58","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1093\/fampra\/cmq026","article-title":"Risk of recurrent acute lower urinary tract infections and prescription pattern of antibiotics in women with and without diabetes in primary care","volume":"27","author":"Gorter","year":"2010","journal-title":"Fam Pract"},{"key":"10.1016\/S2213-8587(15)00379-4_bib59","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1002\/pds.2043","article-title":"Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials","volume":"19","author":"Hammar","year":"2010","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/S2213-8587(15)00379-4_bib60","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.2337\/dc08-0138","article-title":"Diabetes, glycemic control, and risk of hospitalization with pneumonia: a population-based case-control study","volume":"31","author":"Kornum","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00379-4_bib61","first-page":"267","article-title":"Impact of diabetes mellitus on pneumonia mortality in a senior population: results from the NHANES III follow-up study","volume":"10","author":"Liu","year":"2013","journal-title":"J Geriatr Cardiol"},{"key":"10.1016\/S2213-8587(15)00379-4_bib62","doi-asserted-by":"crossref","first-page":"e000067","DOI":"10.1136\/bmjdrc-2014-000067","article-title":"Bacterial infections in patients with type 1 diabetes: a 14-year follow-up study","volume":"3","author":"Simonsen","year":"2015","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(15)00379-4_bib63","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jinf.2011.05.013","article-title":"Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G","volume":"63","author":"Thomsen","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/S2213-8587(15)00379-4_bib64","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1097\/01.CCM.0000119424.31648.1E","article-title":"Severe bloodstream infections: a population-based assessment","volume":"32","author":"Laupland","year":"2004","journal-title":"Crit Care Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib65","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1007\/s00345-012-0934-x","article-title":"Prevalence of urinary tract infection and risk factors among Saudi patients with diabetes","volume":"31","author":"Al-Rubeaan","year":"2013","journal-title":"World J Urol"},{"key":"10.1016\/S2213-8587(15)00379-4_bib66","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2213-8587(14)70164-0","article-title":"The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets","volume":"2","author":"Odone","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00379-4_bib68","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1093\/fampra\/cml025","article-title":"The use of primary care databases: case-control and case-only designs","volume":"23","author":"Smeeth","year":"2006","journal-title":"Fam Pract"},{"key":"10.1016\/S2213-8587(15)00379-4_bib69","series-title":"Introduction to Meta-Analysis","article-title":"Publication Bias","author":"Borenstein","year":"2009"},{"key":"10.1016\/S2213-8587(15)00379-4_bib70","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.diabres.2011.10.018","article-title":"Type 2 diabetes control and complications in specialised diabetes care centres of six sub-Saharan African countries: the Diabcare Africa study","volume":"95","author":"Sobngwi","year":"2012","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00379-4_bib71","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7861\/clinmedicine.13-1-27","article-title":"Management of diabetes in resource-poor settings","volume":"13","author":"Grant","year":"2013","journal-title":"Clin Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib72","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1744-8603-5-9","article-title":"A review of co-morbidity between infectious and chronic disease in Sub Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization","volume":"5","author":"Young","year":"2009","journal-title":"Global Health"},{"key":"10.1016\/S2213-8587(15)00379-4_bib73","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1016\/S0140-6736(12)60360-2","article-title":"Diabetes and cognitive dysfunction","volume":"379","author":"McCrimmon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00379-4_bib74","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/jama.2010.1553","article-title":"Long-term cognitive impairment and functional disability among survivors of severe sepsis","volume":"304","author":"Iwashyna","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00379-4_bib75","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1164\/rccm.201212-2154OC","article-title":"Bidirectional relationship between cognitive function and pneumonia","volume":"188","author":"Shah","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S2213-8587(15)00379-4_bib76","doi-asserted-by":"crossref","first-page":"1170","DOI":"10.1001\/archneurol.2012.1117","article-title":"Diabetes, glucose control, and 9-year cognitive decline among older adults without dementia","volume":"69","author":"Yaffe","year":"2012","journal-title":"Arch Neurol"},{"key":"10.1016\/S2213-8587(15)00379-4_bib77","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S2213-8587(13)70192-X","article-title":"Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study","volume":"2","author":"Tuligenga","year":"2014","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003794?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003794?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,28]],"date-time":"2022-05-28T07:18:22Z","timestamp":1653722302000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003794"}},"issued":{"date-parts":[[2016,2]]},"references-count":72,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2213858715003794"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00379-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and infection: assessing the association with glycaemic control in population-based studies","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00379-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T08:02:08Z","timestamp":1793520128770,"version":"4.5.0"},"update-to":[{"DOI":"10.1016\/s2213-8587(25)00299-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/s2213-8587(26)00238-x","type":"journal-article","created":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T22:36:09Z","timestamp":1788993369000},"page":"e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correction to Lancet Diabetes Endocrinol 2026; 14: 149\u201356"],"prefix":"10.1016","volume":"14","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872600238X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872600238X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:40:50Z","timestamp":1792096850000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872600238X"}},"issued":{"date-parts":[[2026,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S221385872600238X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00238-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2026; 14: 149\u201356","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00238-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00299-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:13:34Z","timestamp":1793459614883,"version":"4.5.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003395","name":"Shanghai Education Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003395","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017950","name":"Shanghai Municipal Health Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017950","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/s2213-8587(25)00423-1","type":"journal-article","created":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T23:39:40Z","timestamp":1772149180000},"page":"285-288","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Autologous and allogeneic stem cell-derived islet therapy in three recipients with type 1 diabetes and complete loss of endogenous pancreatic \u03b2-cell function pretransplant"],"prefix":"10.1016","volume":"14","author":[{"given":"Yongquan","family":"Shi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifan","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuo","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaying","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Ling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tianlong","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tengfei","family":"Nie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junsong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoxi","family":"Meng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqiang","family":"Liao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tongkun","family":"Wei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Da","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyu","family":"Mou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoliang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Junfeng","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duowen","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xue","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Dai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhijia","family":"Ni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqi","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiren","family":"Fu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guoshan","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaokang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxian","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ming","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M James","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xin","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00423-1_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrendo.2014.170","article-title":"Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications","volume":"10","author":"Frier","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(25)00423-1_bib2","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa2506549","article-title":"Stem cell-derived, fully differentiated islets for type 1 diabetes","volume":"393","author":"Reichman","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00423-1_bib3","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41421-024-00662-3","article-title":"Treating a type 2 diabetic patient with impaired pancreatic islet function by personalized endoderm stem cell-derived islet tissue","volume":"10","author":"Wu","year":"2024","journal-title":"Cell Discov"},{"key":"10.1016\/S2213-8587(25)00423-1_bib4","doi-asserted-by":"crossref","first-page":"6152","DOI":"10.1016\/j.cell.2024.09.004","article-title":"Transplantation of chemically induced pluripotent stem-cell-derived islets under abdominal anterior rectus sheath in a type 1 diabetes patient","volume":"187","author":"Wang","year":"2024","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(25)00423-1_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00423-1_bib6","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1001\/jama.293.7.830","article-title":"Single-donor, marginal-dose islet transplantation in patients with type 1 diabetes","volume":"293","author":"Hering","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00423-1_bib7","first-page":"132","article-title":"Recurrent diabetes mellitus in the pancreas iso- and allograft. A light and electron microscopic and immunohistochemical analysis of four cases","volume":"53","author":"Sibley","year":"1985","journal-title":"Lab Invest"},{"key":"10.1016\/S2213-8587(25)00423-1_bib8","doi-asserted-by":"crossref","first-page":"2657","DOI":"10.1038\/s41591-024-03115-2","article-title":"Ustekinumab for type 1 diabetes in adolescents: a multicenter, double-blind, randomized phase 2 trial","volume":"30","author":"Tatovic","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00423-1_bib9","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1056\/NEJMoa1902226","article-title":"An anti-CD3 antibody, teplizumab, in relatives at risk for type 1 diabetes","volume":"381","author":"Herold","year":"2019","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725004231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725004231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:47:43Z","timestamp":1773823663000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725004231"}},"issued":{"date-parts":[[2026,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2213858725004231"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00423-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Autologous and allogeneic stem cell-derived islet therapy in three recipients with type 1 diabetes and complete loss of endogenous pancreatic \u03b2-cell function pretransplant","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00423-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T08:28:31Z","timestamp":1793262511655,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/s2213-8587(20)30039-5","type":"journal-article","created":{"date-parts":[[2020,2,14]],"date-time":"2020-02-14T18:47:54Z","timestamp":1581706074000},"page":"266-268","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Pyrethroid exposure: not so harmless after all"],"prefix":"10.1016","volume":"8","author":[{"given":"Barbara","family":"Demeneix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Leemans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Couderq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30039-5_bib1","article-title":"Association between exposure to pyrethroid insecticides and risk of all-cause and cause-specific mortality in the general US adult population","author":"Bao","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(20)30039-5_bib2","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1016\/j.chemosphere.2017.10.115","article-title":"Pyrethroid pesticide residues in the global environment: An overview","volume":"191","author":"Tang","year":"2018","journal-title":"Chemosphere"},{"key":"10.1016\/S2213-8587(20)30039-5_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s00204-011-0726-x","article-title":"Molecular mechanisms of pyrethroid insecticide neurotoxicity: recent advances","volume":"86","author":"Soderlund","year":"2012","journal-title":"Arch Toxicol"},{"key":"10.1016\/S2213-8587(20)30039-5_bib4","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/j.envpol.2018.11.031","article-title":"Effects of pyrethroid insecticides on hypothalamic-pituitary-gonadal axis: a reproductive health perspective","volume":"245","author":"Ye","year":"2019","journal-title":"Environ Pollut"},{"key":"10.1016\/S2213-8587(20)30039-5_bib5","doi-asserted-by":"crossref","first-page":"8977","DOI":"10.1021\/acs.est.6b02253","article-title":"Pyrethroid pesticides as endocrine disruptors: molecular mechanisms in vertebrates with a focus on fishes","volume":"50","author":"Brander","year":"2016","journal-title":"Environ Sci Technol"},{"key":"10.1016\/S2213-8587(20)30039-5_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.ijheh.2015.01.002","article-title":"Pyrethroids: exposure and health effects\u2014an update","volume":"218","author":"Saillenfait","year":"2015","journal-title":"Int J Hyg Environ Health"},{"key":"10.1016\/S2213-8587(20)30039-5_bib7","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/j.chemosphere.2019.06.098","article-title":"Environmental pyrethroid exposure and thyroid hormones of pregnant women in Shandong, China","volume":"234","author":"Hu","year":"2019","journal-title":"Chemosphere"},{"key":"10.1016\/S2213-8587(20)30039-5_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.envint.2019.104958","article-title":"Sex and poverty modify associations between maternal peripartum concentrations of DDT\/E and pyrethroid metabolites and thyroid hormone levels in neonates participating in the VHEMBE study, South Africa","volume":"131","author":"Chevrier","year":"2019","journal-title":"Environ Int"},{"key":"10.1016\/S2213-8587(20)30039-5_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2019.133920","article-title":"Urinary 3-phenoxybenzoic acid levels and the association with thyroid hormones in adults: Korean National Environmental Health Survey 2012\u20132014","volume":"696","author":"Hwang","year":"2019","journal-title":"Sci Total Environ"},{"key":"10.1016\/S2213-8587(20)30039-5_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1093\/toxsci\/kfs165","article-title":"The insecticide synergist piperonyl butoxide inhibits hedgehog signaling: assessing chemical risks","volume":"128","author":"Wang","year":"2012","journal-title":"Toxicol Sci"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:38Z","timestamp":1761991658000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300395"}},"issued":{"date-parts":[[2020,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2213858720300395"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30039-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pyrethroid exposure: not so harmless after all","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30039-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:18:40Z","timestamp":1793038720180,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,7]],"date-time":"2026-01-07T00:00:00Z","timestamp":1767744000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000329","name":"Novo Nordisk Haemophilia Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart Lung and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,7]]},"DOI":"10.1016\/s2213-8587(25)00405-x","type":"journal-article","created":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T22:59:18Z","timestamp":1777330758000},"page":"558-569","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries"],"prefix":"10.1016","volume":"14","author":[{"given":"Alicia","family":"Huerta-Chagoya","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joohyun","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Mandla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingchang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren E","family":"Petty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Kiat","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaewon","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madhusmita","family":"Rout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kuang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A","family":"Aguilar-Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lourdes","family":"Garc\u00eda-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clicerio","family":"Gonz\u00e1lez-Villalpando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher A","family":"Haiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Young Jin","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo Heon","family":"Kwak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Leong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth J F","family":"Loos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andres","family":"Moreno-Estrada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Orozco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerome I","family":"Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dharambir","family":"Sanghera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Tusie-Luna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin F","family":"Voight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijana","family":"Vujkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin G","family":"Walters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Ge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa K","family":"Manning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer E","family":"Below","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueling","family":"Sim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josep M","family":"Mercader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maggie C Y","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda S.","family":"Adair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adebowale","family":"Adeyemo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Habibul","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Akiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonia S.","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane M.","family":"Becker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alain G.","family":"Bertoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zheng","family":"Bian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence F.","family":"Bielak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Blangero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Boehnke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erwin P.","family":"Bottinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald W.","family":"Bowden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Bragg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Brody","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas A.","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian E.","family":"Cade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jin-Fang","family":"Chai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C.","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giriraj R.","family":"Chandak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li-Ching","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong-Mi","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miao-Li","family":"Chee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chien-Hsiun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan-Tsong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yii-Der I.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ji","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guanjie","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shyh-Huei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei-Min","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Yu","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoon Shin","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyeok Sun","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Ming","family":"Chuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miguel","family":"Cruz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swapan K.","family":"Das","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph A.","family":"DeFronzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Janaka","family":"deSilva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Latchezar","family":"Dimitrov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayo P.","family":"Doumatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shufa","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravindranath","family":"Duggirala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie S.","family":"Emery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James C.","family":"Engert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel S.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele K.","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Finer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C.","family":"Florez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Floyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myriam","family":"Fornage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth G.","family":"Frankel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barry I.","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pauline","family":"Genter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hertzel C.","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark O.","family":"Goodarzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penny","family":"Gordon-Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariaelisa","family":"Graff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myron","family":"Gross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuqing","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yang","family":"Hai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig L.","family":"Hanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MGeoffrey","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Momoko","family":"Horikoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie-Green","family":"Howard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willa","family":"Hsueh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mengna","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yi-Jen","family":"Hung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mi Yeong","family":"Hwang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chii-Min","family":"Hwu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sahoko","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiya","family":"Igase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eli","family":"Ipp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad T.","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Isono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hye-Mi","family":"Jang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farzana","family":"Jasmine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jost B.","family":"Jonas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoonjung Y.","family":"Joo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edmond","family":"Kabagambe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichiro","family":"Kamatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fouad R.","family":"Kandeel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon L.R.","family":"Kardia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth W.","family":"Karlson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anuradhani","family":"Kasturiratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norihiro","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomohiro","family":"Katsuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Varinderpal","family":"Kaur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Kawaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob M.","family":"Keaton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel N.","family":"Kho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiea-Chuen","family":"Khor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad","family":"Kibriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bong-Jo","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Woon-Puay","family":"Koh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuhiko","family":"Kohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaspal S.","family":"Kooner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Kooperberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raymond J.","family":"Kreienkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amel","family":"Lamri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A.","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanette R.","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Myung-Shik","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jung-Jin","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"Lehman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor JY.","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongmei","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jirong","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tin","family":"Louie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xi","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Lv","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie A.","family":"Lynch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiro","family":"Maeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubha","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisa M.","family":"Maruthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark I.","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"McKean-Cowdin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B.","family":"Meigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iona Y.","family":"Millwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen L.","family":"Mohlke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha A.","family":"Motala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Girish N.","family":"Nadkarni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jerry L.","family":"Nadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Nakatochi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike A.","family":"Nalls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uma","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aude","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari E.","family":"North","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darryl","family":"Nousome","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukinori","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumit","family":"Paliwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S.","family":"Pankow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Par\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaehyun","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyong Soo","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esteban J.","family":"Parra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay R.","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark A.","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A.","family":"Peyser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser J.","family":"Pirie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Preuss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A.","family":"Province","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce M.","family":"Psaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PSKDB","family":"PunyaSri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie J.","family":"Raffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura M.","family":"Raffield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura J.","family":"Rasmussen-Torvik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Redline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander P.","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S.","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Rohde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Roll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashedeh","family":"Roshani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles N.","family":"Rotimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charumathi","family":"Sabanayagam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danish","family":"Saleheen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Sandow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Schurmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Shahriar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas M.","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne H-H.","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinxiu","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ou","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M.","family":"Shuey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moneeza K.","family":"Siddiqui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer A.","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamar","family":"Sofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cassandra N.","family":"Spracklen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrienne M.","family":"Stilp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuharu","family":"Tabara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E-Shyong","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman M.","family":"Tajuddin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumihiko","family":"Takeuchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jingyi","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent D.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farook","family":"Thameem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fuu-Jen","family":"Tsai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip S.","family":"Tsao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam S.","family":"Udler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adan","family":"Valladares-Salgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A.","family":"van Heel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rob M.","family":"vanDam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rohit","family":"Varma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maheak","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Wacher-Rodarte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya-Xing","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric A.","family":"Whitsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ananda R.","family":"Wickremasinghe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Genevieve L.","family":"Wojcik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tien Y.","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jer-Yuarn","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yong-Bing","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anny H.","family":"Xiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chittaranjan S.","family":"Yajnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa R.","family":"Yanek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiro","family":"Yokota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Canqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian-Min","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleftheria","family":"Zeggini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weihua","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan B.","family":"Zonderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00405-X_bib1","series-title":"IDF Diabetes Atlas","year":"2025"},{"key":"10.1016\/S2213-8587(25)00405-X_bib2","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/S2213-8587(21)00287-4","article-title":"Predicting diabetes risk in diverse populations: what next?","volume":"9","author":"Mercader","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00405-X_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","article-title":"Genetic drivers of heterogeneity in type 2 diabetes pathophysiology","volume":"627","author":"Suzuki","year":"2024","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00405-X_bib4","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1210\/er.2019-00088","article-title":"Genetic risk scores for diabetes diagnosis and precision medicine","volume":"40","author":"Udler","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(25)00405-X_bib5","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","author":"Knowler","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00405-X_bib6","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1038\/s41591-024-02796-z","article-title":"Selection, optimization and validation of ten chronic disease polygenic risk scores for clinical implementation in diverse US populations","volume":"30","author":"Lennon","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00405-X_bib7","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1016\/j.ajhg.2023.10.001","article-title":"The GenoVA study: equitable implementation of a pragmatic randomized trial of polygenic-risk scoring in primary care","volume":"110","author":"Vassy","year":"2023","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(25)00405-X_bib8","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13073-024-01337-0","article-title":"Polygenic scores for longitudinal prediction of incident type 2 diabetes in an ancestrally and medically diverse primary care physician network: a patient cohort study","volume":"16","author":"Mandla","year":"2024","journal-title":"Genome Med"},{"key":"10.1016\/S2213-8587(25)00405-X_bib9","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/ds19-0006","article-title":"Innovative diabetes interventions in the U.S. Hispanic population","volume":"32","author":"Fortmann","year":"2019","journal-title":"Diabetes Spectr"},{"key":"10.1016\/S2213-8587(25)00405-X_bib10","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(25)00405-X_bib11","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/s41576-023-00637-2","article-title":"Principles and methods for transferring polygenic risk scores across global populations","volume":"25","author":"Kachuri","year":"2024","journal-title":"Nat Rev Genet"},{"key":"10.1016\/S2213-8587(25)00405-X_bib12","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1016\/j.ajhg.2024.10.010","article-title":"The PRIMED Consortium: reducing disparities in polygenic risk assessment","volume":"111","author":"Kullo","year":"2024","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(25)00405-X_bib13","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1038\/s43856-024-00647-z","article-title":"Inclusiveness of the All of Us Research Program improves polygenic risk scores and fosters genomic medicine for all","volume":"4","author":"Kidenya","year":"2024","journal-title":"Commun Med (Lond)"},{"key":"10.1016\/S2213-8587(25)00405-X_bib14","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1038\/s41586-023-06957-x","article-title":"Genomic data in the All of Us Research Program","volume":"627","author":"Bick","year":"2024","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00405-X_bib15","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","article-title":"Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation","volume":"54","author":"Mahajan","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(25)00405-X_bib16","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1038\/s41588-020-0637-y","article-title":"Discovery of 318 new risk loci for type 2 diabetes and related vascular outcomes among 1.4 million participants in a multi-ancestry meta-analysis","volume":"52","author":"Vujkovic","year":"2020","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(25)00405-X_bib17","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1038\/s41586-022-05473-8","article-title":"FinnGen provides genetic insights from a well-phenotyped isolated population","volume":"613","author":"Kurki","year":"2023","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00405-X_bib18","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/nature15393","article-title":"A global reference for human genetic variation","volume":"526","year":"2015","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00405-X_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09718-5","article-title":"Polygenic prediction via Bayesian regression and continuous shrinkage priors","volume":"10","author":"Ge","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(25)00405-X_bib20","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/s41588-022-01054-7","article-title":"Improving polygenic prediction in ancestrally diverse populations","volume":"54","author":"Ruan","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(25)00405-X_bib21","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1534\/g3.118.200502","article-title":"Imputation-aware tag SNP selection to improve power for large-scale, multi-ethnic association studies","volume":"8","author":"Wojcik","year":"2018","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/S2213-8587(25)00405-X_bib22","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/s41588-024-01937-x","article-title":"Enhancing the Polygenic Score Catalog with tools for score calculation and ancestry normalization","volume":"56","author":"Lambert","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(25)00405-X_bib23","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2174\/1573403X1604201229115531","article-title":"Complications of the type 2 diabetes mellitus","volume":"16","author":"Farmaki","year":"2020","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/S2213-8587(25)00405-X_bib24","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1038\/s42003-022-03248-5","article-title":"Identification of genetic effects underlying type 2 diabetes in South Asian and European populations","volume":"5","author":"Loh","year":"2022","journal-title":"Commun Biol"},{"key":"10.1016\/S2213-8587(25)00405-X_bib25","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41586-020-2263-3","article-title":"Identification of type 2 diabetes loci in 433,540 East Asian individuals","volume":"582","author":"Spracklen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00405-X_bib26","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s41586-023-06079-4","article-title":"Polygenic scoring accuracy varies across the genetic ancestry continuum","volume":"618","author":"Ding","year":"2023","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00405-X_bib27","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/s41591-024-03317-8","article-title":"Genetic basis of early onset and progression of type 2 diabetes in South Asians","volume":"31","author":"Hodgson","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00405-X_bib28","doi-asserted-by":"crossref","first-page":"212","DOI":"10.2337\/dc24-1537","article-title":"Additive value of polygenic risk score to family history for type 2 diabetes prediction: results from the All of Us research database","volume":"48","author":"Drzymalla","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00405-X_bib29","doi-asserted-by":"crossref","DOI":"10.1016\/j.gim.2023.100006","article-title":"Returning integrated genomic risk and clinical recommendations: the eMERGE study","volume":"25","author":"Linder","year":"2023","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(25)00405-X_bib30","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1186\/s13073-022-01074-2","article-title":"Development and validation of a trans-ancestry polygenic risk score for type 2 diabetes in diverse populations","volume":"14","author":"Ge","year":"2022","journal-title":"Genome Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872500405X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872500405X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T21:06:17Z","timestamp":1783112777000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872500405X"}},"issued":{"date-parts":[[2026,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2026,7]]}},"alternative-id":["S221385872500405X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00405-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multi-ancestry polygenic risk scores for the prediction of type 2 diabetes and complications in diverse ancestries","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00405-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T14:35:22Z","timestamp":1793370922513,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021697","name":"Sykehuset i Vestfold","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021697","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006095","name":"South-Eastern Norway Regional Health Authority","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006095","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/s2213-8587(24)00396-6","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T18:45:39Z","timestamp":1743792339000},"page":"397-409","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial"],"prefix":"10.1016","volume":"13","author":[{"given":"Jostein","family":"W\u00e5gen Hauge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Borgeraas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e5re Inge","family":"Birkeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line Kristin","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens Kristoffer","family":"Hertel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milada","family":"Hagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne L\u00f8vdal","family":"Gulseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Lorentzen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birgitte","family":"Seip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronette L","family":"Kolotkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Svanevik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone Gretland","family":"Valderhaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rune","family":"Sandbu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8ran","family":"Hjelmes\u00e6th","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dag","family":"Hofs\u00f8","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00396-6_bib1","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.2337\/dc21-2498","article-title":"Effect of banded Roux-en-Y gastric bypass versus sleeve gastrectomy on diabetes remission at 5 years among patients with obesity and type 2 diabetes: a blinded randomized clinical trial","volume":"45","author":"Murphy","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00396-6_bib2","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes\u20145-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00396-6_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s11695-018-3525-0","article-title":"Long-term outcomes after bariatric surgery: a systematic review and meta-analysis of weight loss at 10 or more years for all bariatric procedures and a single-centre review of 20-year outcomes after adjustable gastric banding","volume":"29","author":"O\u2019Brien","year":"2019","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(24)00396-6_bib4","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1016\/j.amjmed.2016.02.004","article-title":"Changes in lipid profile of obese patients following contemporary bariatric surgery: a meta-analysis","volume":"129","author":"Heffron","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(24)00396-6_bib5","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.jacc.2023.11.032","article-title":"Randomized Trial of effect of bariatric surgery on blood pressure after 5 years","volume":"83","author":"Schiavon","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(24)00396-6_bib6","doi-asserted-by":"crossref","first-page":"2552","DOI":"10.2337\/dc20-3023","article-title":"Cardiovascular outcomes in patients with type 2 diabetes and obesity: comparison of gastric bypass, sleeve gastrectomy, and usual care","volume":"44","author":"Aminian","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00396-6_bib7","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1002\/oby.21322","article-title":"Long-term health-related quality of life in bariatric surgery patients: a systematic review and meta-analysis","volume":"24","author":"Driscoll","year":"2016","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(24)00396-6_bib8","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S2213-8587(23)00127-4","article-title":"Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg): a single-centre, randomised controlled trial","volume":"11","author":"Svanevik","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00396-6_bib9","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jama.2020.12567","article-title":"Benefits and risks of bariatric surgery in adults: a review","volume":"324","author":"Arterburn","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00396-6_bib10","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2468-1253(20)30331-9","article-title":"Prevention and treatment of nutritional complications after bariatric surgery","volume":"6","author":"Nuzzo","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00396-6_bib11","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022: a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Davies","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00396-6_bib12","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC Guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(24)00396-6_bib14","doi-asserted-by":"crossref","first-page":"100836","DOI":"10.1016\/j.lanepe.2024.100836","article-title":"Long-term effect of sleeve gastrectomy vs Roux-en-Y gastric bypass in people living with severe obesity: a phase III multicentre randomised controlled trial (SleeveBypass)","volume":"38","author":"Biter","year":"2024","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/S2213-8587(24)00396-6_bib15","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jama.2017.20897","article-title":"Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y Gastric bypass on weight loss in patients with morbid obesity: the SM-BOSS randomized clinical trial","volume":"319","author":"Peterli","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00396-6_bib16","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1001\/jama.2017.20313","article-title":"Effect of laparoscopic sleeve gastrectomy vs laparoscopic Roux-en-Y Gastric bypass on weight loss at 5 years among patients with morbid obesity: the SLEEVEPASS randomized clinical trial","volume":"319","author":"Salminen","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00396-6_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1093\/bjs\/znaa011","article-title":"Laparoscopic Roux-en-Y gastric bypass versus laparoscopic sleeve gastrectomy: 5-year outcomes of merged data from two randomized clinical trials (SLEEVEPASS and SM-BOSS)","volume":"108","author":"W\u00f6lnerhanssen","year":"2021","journal-title":"Br J Surg"},{"key":"10.1016\/S2213-8587(24)00396-6_bib18","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S2213-8587(19)30344-4","article-title":"Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial","volume":"7","author":"Hofs\u00f8","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00396-6_bib19","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1053\/j.gastro.2021.08.021","article-title":"Sleeve gastrectomy confers higher risk of gastroesophageal reflux disease than gastric bypass: a randomized controlled trial from the Oseberg Reflux Working Group","volume":"161","author":"Lorentzen","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(24)00396-6_bib20","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1136\/gutjnl-2023-330616","article-title":"Updates to the modern diagnosis of GERD: Lyon consensus 2.0","volume":"73","author":"Gyawali","year":"2024","journal-title":"Gut"},{"key":"10.1016\/S2213-8587(24)00396-6_bib21","doi-asserted-by":"crossref","first-page":"2667","DOI":"10.1007\/s11695-020-04545-w","article-title":"Erosive esophagitis and symptoms of gastroesophageal reflux disease in patients with morbid obesity with and without type 2 diabetes: a cross-sectional study","volume":"30","author":"Lorentzen","year":"2020","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(24)00396-6_bib22","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.cgh.2008.11.025","article-title":"Efficacy of the long-acting repeatable formulation of the somatostatin analogue octreotide in postoperative dumping","volume":"7","author":"Arts","year":"2009","journal-title":"Clin Gastroenterol Hepatol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00396-6_bib23","first-page":"S111","article-title":"Glycemic goals and hypoglycemia: standards of care in diabetes\u20142024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00396-6_bib24","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.2337\/dc15-2481","article-title":"Durability of addition of Roux-en-Y gastric bypass to lifestyle intervention and medical management in achieving primary treatment goals for uncontrolled type 2 diabetes in mild to moderate obesity: a randomized control trial","volume":"39","author":"Ikramuddin","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00396-6_bib25","doi-asserted-by":"crossref","first-page":"e076316","DOI":"10.1136\/bmj-2023-076316","article-title":"The estimands framework: a primer on the ICH E9(R1) addendum","volume":"384","author":"Kahan","year":"2024","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00396-6_bib26","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00396-6_bib27","doi-asserted-by":"crossref","first-page":"e756","DOI":"10.1210\/clinem\/dgab643","article-title":"Gastrointestinal hormones and \u03b2-cell function after gastric bypass and sleeve gastrectomy: a randomized controlled trial (Oseberg)","volume":"107","author":"Fatima","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00396-6_bib28","doi-asserted-by":"crossref","first-page":"15154","DOI":"10.1038\/s41598-019-51516-y","article-title":"Sustained improvements in glucose metabolism late after Roux-En-Y gastric bypass surgery in patients with and without preoperative diabetes","volume":"9","author":"J\u00f8rgensen","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(24)00396-6_bib29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s11695-021-05856-2","article-title":"Validation of Ad-DiaRem and ABCD diabetes remission prediction scores at 1-year after Roux-en-Y gastric bypass and sleeve gastrectomy in the randomized controlled Oseberg trial","volume":"32","author":"Fatima","year":"2022","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(24)00396-6_bib30","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1001\/jamasurg.2024.2162","article-title":"Gastric bypass vs diet and cardiovascular risk factors: a nonrandomized controlled trial","volume":"159","author":"Karlsson","year":"2024","journal-title":"JAMA Surg"},{"key":"10.1016\/S2213-8587(24)00396-6_bib31","doi-asserted-by":"crossref","first-page":"bvaa049","DOI":"10.1210\/jendso\/bvaa049","article-title":"Bariatric surgery: remission of inflammation, cardiometabolic benefits, and common adverse effects","volume":"4","author":"Biobaku","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(24)00396-6_bib32","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1016\/j.gassur.2024.06.014","article-title":"Significant and distinct impacts of sleeve gastrectomy and Roux-en-Y gastric bypass on esophageal acid exposure, esophageal motility, and endoscopic findings: a systematic review and meta-analysis","volume":"28","author":"Valentini","year":"2024","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/S2213-8587(24)00396-6_bib33","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.numecd.2021.08.047","article-title":"Rate of post-bariatric hypoglycemia using continuous glucose monitoring: a meta-analysis of literature studies","volume":"32","author":"Lupoli","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(24)00396-6_bib34","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/S0140-6736(23)01200-X","article-title":"Tirzepatide once weekly for the treatment of obesity in people with type 2 diabetes (SURMOUNT-2): a double-blind, randomised, multicentre, placebo-controlled, phase 3 trial","volume":"402","author":"Garvey","year":"2023","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:02:03Z","timestamp":1762610523000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003966"}},"issued":{"date-parts":[[2025,5]]},"references-count":33,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2213858724003966"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00396-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of gastric bypass versus sleeve gastrectomy on the remission of type 2 diabetes, weight loss, and cardiovascular risk factors at 5 years (Oseberg): secondary outcomes of a single-centre, triple-blind, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00396-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00026-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:05:17Z","timestamp":1794488717033,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2017,3,13]],"date-time":"2017-03-13T00:00:00Z","timestamp":1489363200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["084711\/Z\/08\/Z"],"award-info":[{"award-number":["084711\/Z\/08\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RC1TW008485"],"award-info":[{"award-number":["RC1TW008485"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["RC2HL101834"],"award-info":[{"award-number":["RC2HL101834"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/L003120\/1"],"award-info":[{"award-number":["MR\/L003120\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["RG\/13\/13\/30194"],"award-info":[{"award-number":["RG\/13\/13\/30194"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000061","name":"Fogarty International Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000061","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["PG\/09\/035\/27378"],"award-info":[{"award-number":["PG\/09\/035\/27378"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000690","name":"Research Councils UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000690","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008898","name":"National Space Biomedical Research Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008898","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/s2213-8587(17)30088-8","type":"journal-article","created":{"date-parts":[[2017,4,10]],"date-time":"2017-04-10T20:06:11Z","timestamp":1491854771000},"page":"524-533","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":229,"title":["Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis"],"prefix":"10.1016","volume":"5","author":[{"given":"Danish","family":"Saleheen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip C","family":"Haycock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asif","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Taleb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atif","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shahid","family":"Abbas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faisal","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saba","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem","family":"Qamar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khan Shah","family":"Zaman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zia","family":"Yaqoob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tahir","family":"Saghir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Nadeem Hasan","family":"Rizvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anis","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadeem Hayyat","family":"Mallick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohammad","family":"Ishaq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Zahed","family":"Rasheed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fazal-ur-Rehman","family":"Memon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Mahmood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveeduddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Frossard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph L","family":"Witztum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santica","family":"Marcovina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manjinder","family":"Sandhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Rader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Danesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30088-8_bib1","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30088-8_bib2","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30088-8_bib3","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/j.jacc.2009.10.080","article-title":"Apolipoprotein(a) isoforms and the risk of vascular disease: systematic review of 40 studies involving 58,000 participants","volume":"55","author":"Erqou","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30088-8_bib4","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30088-8_bib5","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa1109034","article-title":"Genetic associations with valvular calcification and aortic stenosis","volume":"368","author":"Thanassoulis","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30088-8_bib6","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1016\/j.cll.2006.07.002","article-title":"Lipoprotein(a): a unique risk factor for cardiovascular disease","volume":"26","author":"Anuurad","year":"2006","journal-title":"Clin Lab Med"},{"key":"10.1016\/S2213-8587(17)30088-8_bib7","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein(a): resurrected by genetics","volume":"273","author":"Kronenberg","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(17)30088-8_bib8","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0140-6736(15)61252-1","article-title":"Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study","volume":"386","author":"Tsimikas","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30088-8_bib9","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1016\/S0140-6736(16)31009-1","article-title":"Antisense oligonucleotides targeting apolipoprotein(a) in people with raised lipoprotein(a): two randomised, double-blind, placebo-controlled, dose-ranging trials","volume":"388","author":"Viney","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30088-8_bib10","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1194\/jlr.M040733","article-title":"Determinants of binding of oxidized phospholipids on apolipoprotein (a) and lipoprotein (a)","volume":"54","author":"Leibundgut","year":"2013","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(17)30088-8_bib11","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s10654-009-9334-y","article-title":"The Pakistan Risk of Myocardial Infarction Study: a resource for the study of genetic, lifestyle and other determinants of myocardial infarction in South Asia","volume":"24","author":"Saleheen","year":"2009","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30088-8_bib12","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/ng.3396","article-title":"A comprehensive 1,000 Genomes-based genome-wide association meta-analysis of coronary artery disease","volume":"47","author":"Nikpay","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30088-8_bib13","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1038\/ng.922","article-title":"Genome-wide association study identifies six new loci influencing pulse pressure and mean arterial pressure","volume":"43","author":"Wain","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30088-8_bib14","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","author":"Willer","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30088-8_bib15","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1038\/ng.2606","article-title":"Genome-wide meta-analysis identifies 11 new loci for anthropometric traits and provides insights into genetic architecture","volume":"45","author":"Berndt","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30088-8_bib16","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.2385","article-title":"Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways","volume":"44","author":"Scott","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30088-8_bib17","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1093\/clinchem\/42.3.436","article-title":"Relation between number of apolipoprotein(a) kringle 4 repeats and mobility of isoforms in agarose gel: basis for a standardized isoform nomenclature","volume":"42","author":"Marcovina","year":"1996","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(17)30088-8_bib18","doi-asserted-by":"crossref","first-page":"1956","DOI":"10.1093\/clinchem\/46.12.1956","article-title":"Use of a reference material proposed by the International Federation of Clinical Chemistry and Laboratory Medicine to evaluate analytical methods for the determination of plasma lipoprotein(a)","volume":"46","author":"Marcovina","year":"2000","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(17)30088-8_bib19","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.jacc.2015.01.050","article-title":"Relationship of oxidized phospholipids on apolipoprotein B-100 to cardiovascular outcomes in patients treated with intensive versus moderate atorvastatin therapy: the TNT trial","volume":"65","author":"Byun","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30088-8_bib20","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1038\/nature09534","article-title":"A map of human genome variation from population-scale sequencing","volume":"467","author":"Abecasis","year":"2010","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(17)30088-8_bib21","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1177\/0962280210394459","article-title":"Using multiple genetic variants as instrumental variables for modifiable risk factors","volume":"21","author":"Palmer","year":"2012","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/S2213-8587(17)30088-8_bib22","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.cmet.2010.09.010","article-title":"Atherogenic lipids and lipoproteins trigger CD36-TLR2-dependent apoptosis in macrophages undergoing endoplasmic reticulum stress","volume":"12","author":"Seimon","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(17)30088-8_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.carrev.2011.08.001","article-title":"The role of oxidized phospholipids, lipoprotein (a) and biomarkers of oxidized lipoproteins in chronically occluded coronary arteries in sudden cardiac death and following successful percutaneous revascularization","volume":"13","author":"Fefer","year":"2012","journal-title":"Cardiovasc Revasc Med"},{"key":"10.1016\/S2213-8587(17)30088-8_bib24","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1161\/01.ATV.14.5.770","article-title":"Binding and degradation of lipoprotein(a) and LDL by primary cultures of human hepatocytes. Comparison with cultured human monocyte-macrophages and fibroblasts","volume":"14","author":"Snyder","year":"1994","journal-title":"Arterioscler Thromb"},{"key":"10.1016\/S2213-8587(17)30088-8_bib25","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1002\/clc.4960180507","article-title":"Effect of simvastatin on Lp(a) concentrations","volume":"18","author":"Haffner","year":"1995","journal-title":"Clin Cardiol"},{"key":"10.1016\/S2213-8587(17)30088-8_bib26","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1093\/eurheartj\/ehs023","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, lowers low-density lipoprotein cholesterol in high-risk statin-intolerant patients: a randomized, double-blind, placebo-controlled trial","volume":"33","author":"Visser","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(17)30088-8_bib27","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2014.01.006","article-title":"Reduction in lipoprotein(a) with PCSK9 monoclonal antibody evolocumab (AMG 145): a pooled analysis of more than 1,300 patients in 4 phase II trials","volume":"63","author":"Raal","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30088-8_bib28","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/j.jacl.2015.11.014","article-title":"Evacetrapib alone or in combination with statins lowers lipoprotein(a) and total and small LDL particle concentrations in mildly hypercholesterolemic patients","volume":"10","author":"Nicholls","year":"2016","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(17)30088-8_bib29","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1194\/jlr.D800050-JLR200","article-title":"Determination of lipoprotein(a) kringle repeat number from genomic DNA: copy number variation genotyping using qPCR","volume":"50","author":"Lanktree","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(17)30088-8_bib30","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1161\/ATVBAHA.114.303462","article-title":"A common LPA null allele associates with lower lipoprotein(a) levels and coronary artery disease risk","volume":"34","author":"Kyriakou","year":"2014","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:52Z","timestamp":1761991552000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300888"}},"issued":{"date-parts":[[2017,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2213858717300888"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30088-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.727506878.793532931","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Apolipoprotein(a) isoform size, lipoprotein(a) concentration, and coronary artery disease: a mendelian randomisation analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30088-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30063-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T09:11:01Z","timestamp":1794474661790,"version":"4.9.1"},"reference-count":124,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,19]],"date-time":"2023-01-19T00:00:00Z","timestamp":1674086400000},"content-version":"am","delay-in-days":171,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP3 DK111906"],"award-info":[{"award-number":["DP3 DK111906"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK121843"],"award-info":[{"award-number":["R01 DK121843"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK122586"],"award-info":[{"award-number":["R01 DK122586"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK124395"],"award-info":[{"award-number":["R01 DK124395"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HG010297"],"award-info":[{"award-number":["R01 HG010297"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HG011345"],"award-info":[{"award-number":["R01 HG011345"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HL151152"],"award-info":[{"award-number":["R01 HL151152"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 HG011723"],"award-info":[{"award-number":["U01 HG011723"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015241","name":"Society for the Study of Reproduction","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015241","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/s2213-8587(22)00159-0","type":"journal-article","created":{"date-parts":[[2022,6,17]],"date-time":"2022-06-17T18:57:31Z","timestamp":1655492251000},"page":"597-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["Type 1 diabetes in diverse ancestries and the use of genetic risk scores"],"prefix":"10.1016","volume":"10","author":[{"given":"Maria J","family":"Redondo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher R","family":"Gignoux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Dabelea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William A","family":"Hagopian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suna","family":"Onengut-Gumuscu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Oram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen S","family":"Rich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00159-0_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dc19-0880","article-title":"Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes","volume":"43","author":"Battaglia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib2","doi-asserted-by":"crossref","first-page":"17758","DOI":"10.1073\/pnas.1212380109","article-title":"The great human expansion","volume":"109","author":"Henn","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(22)00159-0_bib3","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1038\/475163a","article-title":"Genomics for the world","volume":"475","author":"Bustamante","year":"2011","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(22)00159-0_bib4","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1038\/538161a","article-title":"Genomics is failing on diversity","volume":"538","author":"Popejoy","year":"2016","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(22)00159-0_bib5","doi-asserted-by":"crossref","first-page":"16057","DOI":"10.1073\/pnas.0903341106","article-title":"Out of Africa: modern human origins special feature: explaining worldwide patterns of human genetic variation using a coalescent-based serial founder model of migration outward from Africa","volume":"106","author":"DeGiorgio","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(22)00159-0_bib6","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1038\/s41431-021-00873-2","article-title":"Genetic drift from the out-of-Africa bottleneck leads to biased estimation of genetic architecture and selection","volume":"29","author":"Ashraf","year":"2021","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib7","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S0959-437X(00)00245-8","article-title":"Genome-wide variation in the human and fruitfly: a comparison","volume":"11","author":"Aquadro","year":"2001","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/S2213-8587(22)00159-0_bib8","doi-asserted-by":"crossref","first-page":"11983","DOI":"10.1073\/pnas.1019276108","article-title":"Demographic history and rare allele sharing among human populations","volume":"108","author":"Gravel","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(22)00159-0_bib9","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s00251-017-1017-3","article-title":"A genomic perspective on HLA evolution","volume":"70","author":"Meyer","year":"2018","journal-title":"Immunogenetics"},{"key":"10.1016\/S2213-8587(22)00159-0_bib10","doi-asserted-by":"crossref","first-page":"e1005693","DOI":"10.1371\/journal.pcbi.1005693","article-title":"HLA class I haplotype diversity is consistent with selection for frequent existing haplotypes","volume":"13","author":"Alter","year":"2017","journal-title":"PLOS Comput Biol"},{"key":"10.1016\/S2213-8587(22)00159-0_bib11","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1093\/molbev\/msab147","article-title":"Analysis of genomic DNA from medieval plague victims suggests long-term effect of Yersinia pestis on human immunity genes","volume":"38","author":"Immel","year":"2021","journal-title":"Mol Biol Evol"},{"key":"10.1016\/S2213-8587(22)00159-0_bib12","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1464-5491.2006.01925.x","article-title":"Incidence and trends of childhood type 1 diabetes worldwide 1990-1999","volume":"23","author":"Group","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib13","doi-asserted-by":"crossref","first-page":"12522","DOI":"10.1038\/ncomms12522","article-title":"A continuum of admixture in the western hemisphere revealed by the African Diaspora genome","volume":"7","author":"Mathias","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(22)00159-0_bib14","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/j.ajhg.2021.10.008","article-title":"Evolving use of ancestry, ethnicity, and race in genetics research\u2014a survey spanning seven decades","volume":"108","author":"Byeon","year":"2021","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib15","doi-asserted-by":"crossref","first-page":"402","DOI":"10.2337\/dc13-1838","article-title":"Prevalence of diabetes in US youth in 2009: the SEARCH for diabetes in youth study","volume":"37","author":"Pettitt","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib16","doi-asserted-by":"crossref","first-page":"e3075","DOI":"10.1002\/dmrr.3075","article-title":"Incidence and trend of type 1 diabetes and the underlying environmental determinants","volume":"35","author":"Xia","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(22)00159-0_bib17","doi-asserted-by":"crossref","first-page":"161","DOI":"10.15585\/mmwr.mm6906a3","article-title":"Trends in incidence of type 1 and type 2 diabetes among youths - selected counties and Indian reservations, United States, 2002\u20132015","volume":"69","author":"Divers","year":"2020","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S2213-8587(22)00159-0_bib18","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012","volume":"376","author":"Mayer-Davis","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib19","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1111\/nyas.14573","article-title":"Twenty years of pediatric diabetes surveillance: what do we know and why it matters","volume":"1495","author":"Dabelea","year":"2021","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(22)00159-0_bib20","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.2337\/dc21-0342","article-title":"Incidence of type 1 diabetes may be underestimated in the Chinese population: evidence from 21.7 million people between 2007 and 2017","volume":"44","author":"Liu","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib21","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1111\/pedi.12480","article-title":"Incidence of type 1 diabetes has doubled in Kuwaiti children 0\u201314 years over the last 20 years","volume":"18","author":"Shaltout","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib22","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1111\/j.1399-5448.2011.00765.x","article-title":"High incidence of childhood type 1 diabetes in Al-Madinah, north west Saudi Arabia (2004-2009)","volume":"12","author":"Habeb","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib23","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1111\/dme.13408","article-title":"Racial and ethnic differences among children with new-onset autoimmune type 1 diabetes","volume":"34","author":"Gandhi","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib24","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2337\/dc17-2335","article-title":"Racial\/ethnic minority youth with recent-onset type 1 diabetes have poor prognostic factors","volume":"41","author":"Redondo","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib25","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1542\/peds.2014-1774","article-title":"Racial\u2013ethnic disparities in management and outcomes among children with type 1 diabetes","volume":"135","author":"Willi","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(22)00159-0_bib26","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.jpeds.2009.05.025","article-title":"Glycemic control in youth with diabetes: the SEARCH for diabetes in youth study","volume":"155","author":"Petitti","year":"2009","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(22)00159-0_bib27","doi-asserted-by":"crossref","first-page":"e938","DOI":"10.1542\/peds.2013-2795","article-title":"Trends in the prevalence of ketoacidosis at diabetes diagnosis: the SEARCH for diabetes in youth study","volume":"133","author":"Dabelea","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(22)00159-0_bib28","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1056\/NEJM200002033420501","article-title":"A novel subtype of type 1 diabetes mellitus characterized by a rapid onset and an ab-sence of diabetes-related antibodies","volume":"342","author":"Imagawa","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib29","doi-asserted-by":"crossref","first-page":"1858202","DOI":"10.1155\/2016\/1858202","article-title":"Immunological aspects of fulminant type 1 diabetes in Chinese","volume":"2016","author":"Wang","year":"2016","journal-title":"J Immunol Res"},{"key":"10.1016\/S2213-8587(22)00159-0_bib30","doi-asserted-by":"crossref","first-page":"e3501","DOI":"10.1002\/dmrr.3501","article-title":"The fulminant index: a method of rapidly differentiating fulminant type 1 diabetes from diabetic ketoacidosis","volume":"38","author":"Qiu","year":"2022","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(22)00159-0_bib31","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1007\/s00125-009-1539-9","article-title":"Differential association of HLA with three subtypes of type 1 diabetes: fulminant, slowly progressive and acute-onset","volume":"52","author":"Kawabata","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00159-0_bib32","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1210\/er.2007-0026","article-title":"Syndromes of ketosis-prone diabetes mellitus","volume":"29","author":"Balasubramanyam","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(22)00159-0_bib33","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1007\/s00125-017-4256-9","article-title":"Late-onset islet autoimmunity in childhood: the Diabetes Autoimmunity Study in the Young (DAISY)","volume":"60","author":"Frohnert","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00159-0_bib34","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1007\/s00125-018-4660-9","article-title":"Ethnic differences in progression of islet autoimmunity and type 1 diabetes in relatives at risk","volume":"61","author":"Tosur","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00159-0_bib35","doi-asserted-by":"crossref","first-page":"4596","DOI":"10.1210\/jc.2017-01490","article-title":"The role of age and excess body mass index in progression to type 1 diabetes in at-risk adults","volume":"102","author":"Ferrara","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00159-0_bib36","doi-asserted-by":"crossref","first-page":"698","DOI":"10.2337\/dc16-2331","article-title":"Excess BMI in childhood: a modifiable risk factor for type 1 diabetes development?","volume":"40","author":"Ferrara","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib37","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1080\/07853890410018952","article-title":"A six-fold gradient in the incidence of type 1 diabetes at the eastern border of Finland","volume":"37","author":"Kondrashova","year":"2005","journal-title":"Ann Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib38","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1007\/s00125-018-4704-1","article-title":"Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells","volume":"61","author":"Ifie","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00159-0_bib39","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","article-title":"Prospective virome analyses in young children at increased genetic risk for type 1 diabetes","volume":"25","author":"Vehik","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib40","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1001\/jamapediatrics.2015.2757","article-title":"Association of early exposure of probiotics and islet autoimmunity in the TEDDY study","volume":"170","author":"Uusitalo","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(22)00159-0_bib41","doi-asserted-by":"crossref","first-page":"e052449","DOI":"10.1136\/bmjopen-2021-052449","article-title":"Supplementation with Bifidobacterium longum subspecies infantis EVC001 for mitigation of type 1 diabetes autoimmunity: the GPPAD-SINT1A randomised controlled trial protocol","volume":"11","author":"Ziegler","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(22)00159-0_bib42","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1056\/NEJMc0805398","article-title":"Concordance for islet autoimmunity among monozygotic twins","volume":"359","author":"Redondo","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib43","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2337\/diab.22.6.429","article-title":"Histocompatibility (HL-A) antigens, lymphocytotoxic antibodies and tissue antibodies in patients with diabetes mellitus","volume":"22","author":"Singal","year":"1973","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib44","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0140-6736(74)91201-X","article-title":"HL-A antigens and diabetes mellitus","volume":"2","author":"Nerup","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib45","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1399-0004.1982.tb02075.x","article-title":"Genetic heterogeneity of diabetes and HLA","volume":"21","author":"Barbosa","year":"1982","journal-title":"Clin Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib46","first-page":"1015","article-title":"Genetic heterogeneity of insulin-dependent (type I) diabetes mellitus: evidence from a study of extended haplotypes","volume":"36","author":"Rich","year":"1984","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib47","doi-asserted-by":"crossref","first-page":"176","DOI":"10.2337\/diab.33.2.176","article-title":"A polymorphic locus near the human insulin gene is associated with insulin-dependent diabetes mellitus","volume":"33","author":"Bell","year":"1984","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib48","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/ng0397-289","article-title":"Insulin expression in human thymus is modulated by INS VNTR alleles at the IDDM2 locus","volume":"15","author":"Vafiadis","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib49","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1038\/ng0397-293","article-title":"The insulin gene is transcribed in the human thymus and transcription levels correlated with allelic variation at the INS VNTR-IDDM2 susceptibility locus for type 1 diabetes","volume":"15","author":"Pugliese","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib50","doi-asserted-by":"crossref","first-page":"1075","DOI":"10.1093\/hmg\/5.7.1075","article-title":"The CTLA-4 gene region of chromosome 2q33 is linked to, and associated with, type 1 diabetes","volume":"5","author":"Nistic\u00f2","year":"1996","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib51","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/ng1323","article-title":"A functional variant of lymphoid tyrosine phosphatase is associated with type I diabetes","volume":"36","author":"Bottini","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib52","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1086\/429843","article-title":"Localization of a type 1 diabetes locus in the IL2RA\/CD25 region by use of tag single-nucleotide polymorphisms","volume":"76","author":"Vella","year":"2005","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib53","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1196\/annals.1375.001","article-title":"The Type 1 Diabetes Genetics Consortium","volume":"1079","author":"Rich","year":"2006","journal-title":"Ann N Y Acad Sci"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(22)00159-0_bib54","doi-asserted-by":"crossref","first-page":"S121","DOI":"10.1038\/gene.2009.99","article-title":"The Type I Diabetes Genetics Consortium \u2018rapid response\u2019 family-based candidate gene study: strategy, genes selection, and main outcome","volume":"10","author":"Julier","year":"2009","journal-title":"Genes Immun"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(22)00159-0_bib55","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1111\/j.1463-1326.2008.01011.x","article-title":"Results of the MHC fine mapping workshop","volume":"11","author":"Rich","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(22)00159-0_bib56","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.2337\/db10-1195","article-title":"Tests for genetic interactions in type 1 diabetes: linkage and stratification analyses of 4,422 affected sib-pairs","volume":"60","author":"Morahan","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib57","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib58","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1007\/s00125-012-2450-3","article-title":"Confirmation of novel type 1 diabetes risk loci in families","volume":"55","author":"Cooper","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00159-0_bib59","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2337\/dc18-1727","article-title":"Type 1 diabetes risk in African-ancestry participants and utility of an ancestry-specific genetic risk score","volume":"42","author":"Onengut-Gumuscu","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib60","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Robertson","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib61","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1038\/ng.3245","article-title":"Fine mapping of type 1 diabetes susceptibility loci and evidence for colocalization of causal variants with lymphoid gene enhancers","volume":"47","author":"Onengut-Gumuscu","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib62","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41586-021-03552-w","article-title":"Interpreting type 1 diabetes risk with genetics and single-cell epigenomics","volume":"594","author":"Chiou","year":"2021","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(22)00159-0_bib63","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1007\/s00125-020-05248-8","article-title":"Next steps in the identification of gene targets for type 1 diabetes","volume":"63","author":"Grant","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00159-0_bib64","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1038\/s41588-021-00945-5","article-title":"An open approach to systematically prioritize causal variants and genes at all published human GWAS trait-associated loci","volume":"53","author":"Mountjoy","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib65","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2337\/dc19-0803","article-title":"Genetic variants predisposing most strongly to type 1 diabetes diagnosed under age 7 years lie near candidate genes that function in the immune system and in pancreatic \u03b2-cells","volume":"43","author":"Inshaw","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib66","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/s12916-019-1392-8","article-title":"Persistent C-peptide secretion in type 1 diabetes and its relationship to the genetic architecture of diabetes","volume":"17","author":"McKeigue","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib67","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2337\/db12-0207","article-title":"Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study","volume":"62","author":"Zhou","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib68","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","article-title":"Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank","volume":"6","author":"Thomas","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00159-0_bib69","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12916-017-0958-6","article-title":"Fluctuations in the incidence of type 1 diabetes in the United States from 2001 to 2015: a longitudinal study","volume":"15","author":"Rogers","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib70","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.2337\/dc18-1032","article-title":"First genome-wide association study of latent autoimmune diabetes in adults reveals novel insights linking immune and metabolic diabetes","volume":"41","author":"Cousminer","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib71","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12916-017-0846-0","article-title":"Relative contribution of type 1 and type 2 diabetes loci to the genetic etiology of adult-onset, non-insulin-requiring autoimmune diabetes","volume":"15","author":"Mishra","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib72","doi-asserted-by":"crossref","first-page":"311","DOI":"10.2337\/dc17-0961","article-title":"TCF7L2 genetic variants contribute to phenotypic heterogeneity of type 1 diabetes","volume":"41","author":"Redondo","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib73","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.2337\/dc18-0861","article-title":"Transcription factor 7-like 2 (TCF7L2) gene polymorphism and progression from single to multiple autoantibody positivity in individuals at risk for type 1 diabetes","volume":"41","author":"Redondo","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib74","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41588-019-0379-x","article-title":"Clinical use of current polygenic risk scores may exacerbate health disparities","volume":"51","author":"Martin","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib75","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s42003-018-0261-x","article-title":"A scientometric review of genome-wide association studies","volume":"2","author":"Mills","year":"2019","journal-title":"Commun Biol"},{"key":"10.1016\/S2213-8587(22)00159-0_bib76","doi-asserted-by":"crossref","first-page":"3255","DOI":"10.1534\/g3.118.200502","article-title":"Imputation-aware tag SNP selection to improve power for large-scale, multi-ethnic association studies","volume":"8","author":"Wojcik","year":"2018","journal-title":"G3 (Bethesda)"},{"key":"10.1016\/S2213-8587(22)00159-0_bib77","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1038\/s41586-019-1310-4","article-title":"Genetic analyses of diverse populations improves discovery for complex traits","volume":"570","author":"Wojcik","year":"2019","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(22)00159-0_bib78","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1007\/s00125-006-0213-8","article-title":"Type 1 diabetes in Japan","volume":"49","author":"Kawasaki","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00159-0_bib79","doi-asserted-by":"crossref","first-page":"608","DOI":"10.2337\/diab.44.6.608","article-title":"HLA-DQB1*0602 is associated with dominant protection from diabetes even among islet cell antibody-positive first-degree relatives of patients with IDDM","volume":"44","author":"Pugliese","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib80","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.1007\/s00125-021-05513-4","article-title":"DR15-DQ6 remains dominantly protective against type 1 diabetes throughout the first five decades of life","volume":"64","author":"Thomas","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00159-0_bib81","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/1520-7560(2000)9999:9999<::AID-DMRR164>3.0.CO;2-M","article-title":"Genetic susceptibility factors of type 1 diabetes in Asians","volume":"17","author":"Park","year":"2001","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(22)00159-0_bib82","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/ncpendmet0351","article-title":"Fulminant type 1 diabetes: a novel clinical entity requiring special attention by all medical practitioners","volume":"3","author":"Hanafusa","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00159-0_bib83","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1002\/dmrr.1234","article-title":"Analysis of the HLA and non-HLA susceptibility loci in Japanese type 1 diabetes","volume":"27","author":"Yamashita","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(22)00159-0_bib84","doi-asserted-by":"crossref","first-page":"665","DOI":"10.2337\/db18-0314","article-title":"Genome-wide association study confirming a strong effect of HLA and identifying variants in CSAD\/lnc-ITGB7-1 on chromosome 12q13.13 associated with susceptibility to fulminant type 1 diabetes","volume":"68","author":"Kawabata","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib85","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/dc18-2023","article-title":"Identification of novel T1D risk loci and their association with age and islet function at diagnosis in autoantibody-positive T1D individuals: based on a two-stage genome-wide association study","volume":"42","author":"Zhu","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib86","doi-asserted-by":"crossref","first-page":"9450","DOI":"10.1038\/s41598-020-65317-1","article-title":"Type 1 diabetes genetic risk score is discriminative of diabetes in non-Europeans: evidence from a study in India","volume":"10","author":"Harrison","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(22)00159-0_bib87","doi-asserted-by":"crossref","first-page":"107894","DOI":"10.1016\/j.diabres.2019.107894","article-title":"Clinical features, biochemistry and HLA-DRB1 status in children and adolescents with diabetes in Dhaka, Bangladesh","volume":"158","author":"Zabeen","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(22)00159-0_bib88","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/j.diabres.2019.01.023","article-title":"Clinical features, biochemistry and HLA-DRB1 status in youth-onset type 1 diabetes in Pakistan","volume":"149","author":"Fawwad","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(22)00159-0_bib89","doi-asserted-by":"crossref","first-page":"3292","DOI":"10.2337\/db13-0094","article-title":"HLA class II genotyping of African American type 1 diabetic patients reveals associations unique to African haplotypes","volume":"62","author":"Noble","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib90","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/pedi.12369","article-title":"Predominance of DR3 in Somali children with type 1 diabetes in the twin cities, Minnesota","volume":"18","author":"Sunni","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib91","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1007\/s00125-020-05229-x","article-title":"Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia","volume":"63","author":"Balcha","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00159-0_bib92","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1111\/dme.12148","article-title":"HLA class II gene associations in African American type 1 diabetes reveal a protective HLA-DRB1*03 haplotype","volume":"30","author":"Howson","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib93","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1016\/j.jaut.2015.07.014","article-title":"Immunogenetics of type 1 diabetes: a comprehensive review","volume":"64","author":"Noble","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/S2213-8587(22)00159-0_bib94","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1111\/j.1399-543X.2005.00117.x","article-title":"Newborn HLA-DR,DQ genotype screening: age- and ethnicity-specific type 1 diabetes risk estimates","volume":"6","author":"Emery","year":"2005","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib95","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.gde.2018.07.006","article-title":"Genetic diversity in populations across Latin America: implications for population and medical genetic studies","volume":"53","author":"Belbin","year":"2018","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/S2213-8587(22)00159-0_bib96","doi-asserted-by":"crossref","first-page":"14157","DOI":"10.1038\/s41598-021-93691-x","article-title":"Genetic ancestry inferred from autosomal and Y chromosome markers and HLA genotypes in Type 1 diabetes from an admixed Brazilian population","volume":"11","author":"Azulay","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(22)00159-0_bib98","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1038\/ng0493-358","article-title":"HLA class II alleles and susceptibility and resistance to insulin dependent diabetes mellitus in Mexican-American families","volume":"3","author":"Erlich","year":"1993","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib99","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1086\/375655","article-title":"Association and interaction of the IL4R, IL4, and IL13 loci with type 1 diabetes among Filipinos","volume":"72","author":"Bugawan","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(22)00159-0_bib100","first-page":"133","article-title":"HLA-DQ A1, -DQB1 and -DRB1 gene polymorphism--in Malay type 1 diabetes mellitus patients and their use for risk prediction","volume":"66","author":"Rohana","year":"2011","journal-title":"Med J Malaysia"},{"key":"10.1016\/S2213-8587(22)00159-0_bib101","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.2337\/db08-0605","article-title":"Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening","volume":"57","author":"Barker","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib102","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/dc15-1111","article-title":"A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults","volume":"39","author":"Oram","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib103","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/db15-1690","article-title":"Type 1 diabetes genetic risk score: a novel tool to discriminate monogenic and type 1 diabetes","volume":"65","author":"Patel","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib104","doi-asserted-by":"crossref","first-page":"e031586","DOI":"10.1136\/bmjopen-2019-031586","article-title":"Development and validation of multivariable clinical diagnostic models to identify type 1 diabetes requiring rapid insulin therapy in adults aged 18-50 years","volume":"9","author":"Lynam","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(22)00159-0_bib105","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1111\/dme.14361","article-title":"Histological validation of a type 1 diabetes clinical diagnostic model for classification of diabetes","volume":"37","author":"Carr","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib106","doi-asserted-by":"crossref","first-page":"208","DOI":"10.2337\/dc18-0431","article-title":"A type 1 diabetes genetic risk score can identify patients with GAD65 autoantibody-positive type 2 diabetes who rapidly progress to insulin therapy","volume":"42","author":"Grubb","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib107","doi-asserted-by":"crossref","first-page":"14074","DOI":"10.1073\/pnas.0606349103","article-title":"Extreme genetic risk for type 1A diabetes","volume":"103","author":"Aly","year":"2006","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S2213-8587(22)00159-0_bib108","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1111\/pedi.12092","article-title":"Improving prediction of type 1 diabetes by testing non-HLA genetic variants in addition to HLA markers","volume":"15","author":"Steck","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib109","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1038\/gene.2012.36","article-title":"A strategy for combining minor genetic susceptibility genes to improve prediction of disease in type 1 diabetes","volume":"13","author":"Winkler","year":"2012","journal-title":"Genes Immun"},{"key":"10.1016\/S2213-8587(22)00159-0_bib110","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s00125-014-3362-1","article-title":"Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes","volume":"57","author":"Winkler","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00159-0_bib111","doi-asserted-by":"crossref","first-page":"e1002548","DOI":"10.1371\/journal.pmed.1002548","article-title":"Genetic scores to stratify risk of developing multiple islet autoantibodies and type 1 diabetes: a prospective study in children","volume":"15","author":"Bonifacio","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib112","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2337\/dc18-0087","article-title":"A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk","volume":"41","author":"Redondo","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib113","doi-asserted-by":"crossref","first-page":"4529","DOI":"10.1038\/s41598-018-22574-5","article-title":"Application of a genetic risk score to racially diverse type 1 diabetes populations demonstrates the need for diversity in risk-modeling","volume":"8","author":"Perry","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(22)00159-0_bib114","doi-asserted-by":"crossref","first-page":"1694","DOI":"10.1111\/dme.14071","article-title":"Type 1 diabetes genetic risk score discriminates between monogenic and type 1 diabetes in children diagnosed at the age of <5 years in the Iranian population","volume":"36","author":"Yaghootkar","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib115","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1038\/s41591-020-0930-4","article-title":"A combined risk score enhances prediction of type 1 diabetes among susceptible children","volume":"26","author":"Ferrat","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(22)00159-0_bib116","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1111\/pedi.13310","article-title":"Improved genetic risk scoring algorithm for type 1 diabetes prediction","volume":"23","author":"Qu","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(22)00159-0_bib117","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/dc18-1785","article-title":"Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis","volume":"42","author":"Sharp","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib118","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s11892-017-0961-5","article-title":"Genetic risk scores for type 1 diabetes prediction and diagnosis","volume":"17","author":"Redondo","year":"2017","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(22)00159-0_bib119","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2337\/dc20-2872","article-title":"Utility of diabetes type-specific genetic risk scores for the classification of diabetes type among multiethnic youth","volume":"45","author":"Oram","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00159-0_bib120","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1002\/gepi.22083","article-title":"Multiethnic polygenic risk scores improve risk prediction in diverse populations","volume":"41","author":"M\u00e1rquez-Luna","year":"2017","journal-title":"Genet Epidemiol"},{"key":"10.1016\/S2213-8587(22)00159-0_bib121","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1016\/j.jclinepi.2015.09.016","article-title":"Million Veteran Program: a mega-biobank to study genetic influences on health and disease","volume":"70","author":"Gaziano","year":"2016","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(22)00159-0_bib122","doi-asserted-by":"crossref","first-page":"19193","DOI":"10.1038\/s41598-020-75690-6","article-title":"Novel genetic risk factors influence progression of islet autoimmunity to type 1 diabetes","volume":"10","author":"Onengut-Gumuscu","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(22)00159-0_bib123","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s00125-014-3362-1","article-title":"Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes","volume":"57","author":"Winkler","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00159-0_bib124","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1038\/s41467-021-21975-x","article-title":"A deep learning method for HLA imputation and trans-ethnic MHC fine-mapping of type 1 diabetes","volume":"12","author":"Naito","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(22)00159-0_bib97","doi-asserted-by":"crossref","first-page":"534","DOI":"10.4239\/wjd.v10.i11.534","article-title":"Type 1 diabetes loci display a variety of native American and African ancestries in diseased individuals from northwest Colombia","volume":"10","author":"Gomez-Lopera","year":"2019","journal-title":"World J Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:29Z","timestamp":1761991889000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001590"}},"issued":{"date-parts":[[2022,8]]},"references-count":124,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2213858722001590"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00159-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes in diverse ancestries and the use of genetic risk scores","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00159-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:58:08Z","timestamp":1794650288647,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["279277"],"award-info":[{"award-number":["279277"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["FP7\/20072-013"],"award-info":[{"award-number":["FP7\/20072-013"]}],"id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/s2213-8587(20)30026-7","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T18:54:32Z","timestamp":1583175272000},"page":"301-312","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":250,"title":["Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Nete","family":"Tofte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Lindhardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Adamova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan J L","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joachim","family":"Beige","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joline W J","family":"Beulens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas L","family":"Birkenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Delles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingo","family":"Dimos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidmila","family":"Francov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Frimodt-M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Girman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"G\u00f6ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tereza","family":"Havrdova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiddo J L","family":"Heerspink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan","family":"Kooy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gozewijn D","family":"Laverman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harald","family":"Mischak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerjan","family":"Navis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giel","family":"Nijpels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina","family":"Noutsou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Ortiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aneliya","family":"Parvanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederik","family":"Persson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John R","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piero L","family":"Ruggenenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke","family":"Rutters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivan","family":"Rychl\u00edk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justyna","family":"Siwy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goce","family":"Spasovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijn","family":"Speeckaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Trillini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Z\u00fcrbig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"von der Leyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silke","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brit","family":"R\u00e4disch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anika","family":"H\u00e4vemeier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Busmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Wittkop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Neuhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regina","family":"Ax-Smolarski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veit","family":"Zieglschmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Bollweber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun","family":"W\u00f6lk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viktor R.","family":"Curovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninna H.","family":"Tougaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mie K.","family":"Eickhoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sascha","family":"Pilemann-Lyberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe A.","family":"Winther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Signe V.","family":"Rosenlund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tine W.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernt J.","family":"von Scholten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian S.","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie H.","family":"Zobel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens C.","family":"Laursen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simone","family":"Theilade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lone","family":"Jelstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina R.","family":"Juhl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorthe","family":"Riis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessie A.","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne G.","family":"Lundgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maja L.D.","family":"Halkj\u00e6r","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Aabo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Frost Lerche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Lajer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rikke J.","family":"Stefansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria A.","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Durban","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Raad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Prigge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Schiemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robbie","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Kean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Surtees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Gant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stanley M.H.","family":"Yeung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilse","family":"Hagedoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Flynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joe","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katriona","family":"Brooksbank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolina","family":"Aparicio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilian P.","family":"Iliev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Nones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Lo Bue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Melacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Cugini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Prandini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verusca","family":"Lecchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svitlana","family":"Yakymchuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Gherardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Gaspari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio N.","family":"Cannata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Stucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u0160\u00e1rka","family":"Albrechtov\u00e1","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Eldeik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Amanaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatriz","family":"Fernandez-Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinny","family":"Sanchez-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clotilde","family":"V\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana B.","family":"Sanz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria D.","family":"Sanchez-Ni\u00f1o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian M.","family":"Ramos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria \u00c1.","family":"Gonzalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gjulsen","family":"Selim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatjana","family":"Gjorgovski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slavica S.","family":"Stratrova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivera","family":"Stojceva-Taneva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petra","family":"Schutten-Westerneng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brenda","family":"Wierbos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Huvers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anneke K.","family":"De Bruin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Lapauw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elsie","family":"de Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Rokegem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabien","family":"Inion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Kreutzmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Dewettinck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Boukens-de Graaf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ferrina","family":"Clerc-de Jong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannet","family":"Entius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Nannings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzy","family":"van Steenderen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Friedrich W.","family":"Petry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ceyda","family":"Kilic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30026-7_bib1","series-title":"IDF diabetes atlas","year":"2019"},{"key":"10.1016\/S2213-8587(20)30026-7_bib2","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30026-7_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2014.10.014","article-title":"Microalbuminuria: a parameter that has changed diabetes care","volume":"107","author":"Parving","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(20)30026-7_bib4","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/dc13-2036","article-title":"Improved survival and renal prognosis of patients with type 2 diabetes and nephropathy with improved control of risk factors","volume":"37","author":"Andr\u00e9sd\u00f3ttir","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30026-7_bib5","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30026-7_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/0003-4819-151-1-200907070-00120","article-title":"Effect of candesartan on microalbuminuria and albumin excretion rate in diabetes: three randomized trials","volume":"151","author":"Bilous","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(20)30026-7_bib7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJMoa1007994","article-title":"Olmesartan for the delay or prevention of microalbuminuria in type 2 diabetes","volume":"364","author":"Haller","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30026-7_bib8","doi-asserted-by":"crossref","first-page":"2424","DOI":"10.1074\/mcp.M110.001917","article-title":"Naturally occurring human urinary peptides for use in diagnosis of chronic kidney disease","volume":"9","author":"Good","year":"2010","journal-title":"Mol Cell Proteomics"},{"key":"10.1016\/S2213-8587(20)30026-7_bib9","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1093\/ndt\/gfw239","article-title":"A urinary proteome-based classifier for the early detection of decline in glomerular filtration","volume":"32","author":"Pontillo","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(20)30026-7_bib10","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1093\/ndt\/gfw292","article-title":"Urinary proteomics predict onset of microalbuminuria in normoalbuminuric type 2 diabetic patients, a sub-study of the DIRECT-Protect 2 study","volume":"32","author":"Lindhardt","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(20)30026-7_bib11","doi-asserted-by":"crossref","first-page":"3304","DOI":"10.2337\/db12-0348","article-title":"Urinary proteomics for early diagnosis in diabetic nephropathy","volume":"61","author":"Z\u00fcrbig","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30026-7_bib12","doi-asserted-by":"crossref","first-page":"2106","DOI":"10.2337\/diacare.28.9.2106","article-title":"Beneficial effects of adding spironolactone to recommended antihypertensive treatment in diabetic nephropathy: a randomized, double-masked, cross-over study","volume":"28","author":"Rossing","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30026-7_bib13","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1186\/s12882-016-0337-0","article-title":"Effect of mineralocorticoid receptor antagonists on proteinuria and progression of chronic kidney disease: a systematic review and meta-analysis","volume":"17","author":"Currie","year":"2016","journal-title":"BMC Nephrol"},{"key":"10.1016\/S2213-8587(20)30026-7_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010310","article-title":"Proteomic prediction and renin angiotensin aldosterone system inhibition prevention of early diabetic nephropathy in type 2 diabetic patients with normoalbuminuria (PRIORITY): essential study design and rationale of a randomised clinical multicentre trial","volume":"6","author":"Lindhardt","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(20)30026-7_bib15","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.clinbiochem.2012.09.025","article-title":"Technical aspects and inter-laboratory variability in native peptide profiling: the CE-MS experience","volume":"46","author":"Mischak","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/S2213-8587(20)30026-7_bib16","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1093\/ndt\/gfu039","article-title":"Multicentre prospective validation of a urinary peptidome-based classifier for the diagnosis of type 2 diabetic nephropathy","volume":"29","author":"Siwy","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(20)30026-7_bib17","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1111\/dme.13669","article-title":"Characteristics of high- and low-risk individuals in the PRIORITY study: urinary proteomics and mineralocorticoid receptor antagonism for prevention of diabetic nephropathy in type 2 diabetes","volume":"35","author":"Tofte","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(20)30026-7_bib18","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1056\/NEJMoa011489","article-title":"The effect of irbesartan on the development of diabetic nephropathy in patients with type 2 diabetes","volume":"345","author":"Parving","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30026-7_bib19","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1007\/s00125-016-4065-6","article-title":"Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial","volume":"59","author":"G\u00e6de","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30026-7_bib20","first-page":"S40","article-title":"Renal structure and function in non-insulin dependent diabetic patients with microalbuminuria","volume":"63","author":"Brocco","year":"1997","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/S2213-8587(20)30026-7_bib21","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1007\/s00125-016-4021-5","article-title":"JAK inhibition in the treatment of diabetic kidney disease","volume":"59","author":"Brosius","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30026-7_bib22","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/S2213-8587(18)30314-0","article-title":"Change in albuminuria as a surrogate endpoint for progression of kidney disease: a meta-analysis of treatment effects in randomised clinical trials","volume":"7","author":"Heerspink","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30026-7_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0062837","article-title":"CKD273, a new proteomics classifier assessing CKD and its prognosis","volume":"8","author":"Argil\u00e9s","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(20)30026-7_bib24","doi-asserted-by":"crossref","first-page":"2260","DOI":"10.1093\/ndt\/gfu234","article-title":"The urinary proteome as correlate and predictor of renal function in a population study","volume":"29","author":"Gu","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(20)30026-7_bib25","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1681\/ASN.2014050423","article-title":"Diagnosis and prediction of CKD progression by assessment of urinary peptides","volume":"26","author":"Schanstra","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(20)30026-7_bib26","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1093\/ndt\/gfx068","article-title":"Cost-effectiveness of screening type 2 diabetes patients for chronic kidney disease progression with the CKD273 urinary peptide classifier as compared to urinary albumin excretion","volume":"33","author":"Critselis","year":"2018","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(20)30026-7_bib27","doi-asserted-by":"crossref","first-page":"2829","DOI":"10.1111\/j.1523-1755.2005.00756.x","article-title":"Beneficial impact of spironolactone in diabetic nephropathy","volume":"68","author":"Schjoedt","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(20)30026-7_bib28","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1681\/ASN.2009070737","article-title":"Addition of angiotensin receptor blockade or mineralocorticoid antagonism to maximal angiotensin-converting enzyme inhibition in diabetic nephropathy","volume":"20","author":"Mehdi","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(20)30026-7_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-17083-w","article-title":"Association of kidney fibrosis with urinary peptides: a path towards non-invasive liquid biopsies?","volume":"7","author":"Magalh\u00e3es","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(20)30026-7_bib30","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1001\/jama.2015.10081","article-title":"Effect of finerenone on albuminuria in patients with diabetic nephropathy: a randomized clinical trial","volume":"314","author":"Bakris","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30026-7_bib31","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1016\/S2213-8587(19)30080-4","article-title":"Change in albuminuria as a surrogate endpoint in chronic kidney disease\u2014authors' reply","volume":"7","author":"Heerspink","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:36Z","timestamp":1761991656000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300267"}},"issued":{"date-parts":[[2020,4]]},"references-count":31,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2213858720300267"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30026-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early detection of diabetic kidney disease by urinary proteomics and subsequent intervention with spironolactone to delay progression (PRIORITY): a prospective observational study and embedded randomised placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30026-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30067-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:46:24Z","timestamp":1767149184186,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(24)00071-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/s2213-8587(24)00131-1","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T18:33:42Z","timestamp":1715020422000},"page":"e17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2024; 12: 301\u201302"],"prefix":"10.1016","volume":"12","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,21]],"date-time":"2024-05-21T21:59:29Z","timestamp":1716328769000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001311"}},"issued":{"date-parts":[[2024,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2213858724001311"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00131-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2024; 12: 301\u201302","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00131-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00071-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:11Z","timestamp":1761991871336,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/s2213-8587(16)30187-5","type":"journal-article","created":{"date-parts":[[2016,7,30]],"date-time":"2016-07-30T15:23:25Z","timestamp":1469892205000},"page":"735","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Research digest: NAFLD in the spotlight"],"prefix":"10.1016","volume":"4","author":[{"given":"David","family":"Preiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301875?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301875?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:17Z","timestamp":1761991577000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301875"}},"issued":{"date-parts":[[2016,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2213858716301875"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30187-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research digest: NAFLD in the spotlight","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30187-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:46:24Z","timestamp":1767149184017,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(21)00296-5","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/s2213-8587(22)00051-1","type":"journal-article","created":{"date-parts":[[2022,2,21]],"date-time":"2022-02-21T18:30:17Z","timestamp":1645468217000},"page":"e3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2022; 10: 102\u201311"],"prefix":"10.1016","volume":"10","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:47Z","timestamp":1761991847000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000511"}},"issued":{"date-parts":[[2022,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2213858722000511"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00051-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2022; 10: 102\u201311","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00051-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00296-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T01:30:16Z","timestamp":1769045416330,"version":"3.49.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/s2213-8587(19)30143-3","type":"journal-article","created":{"date-parts":[[2019,4,24]],"date-time":"2019-04-24T22:36:17Z","timestamp":1556145377000},"page":"833","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The complexity of obesity"],"prefix":"10.1016","volume":"7","author":[{"given":"Stuart W","family":"Flint","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T20:21:03Z","timestamp":1572034863000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301433"}},"issued":{"date-parts":[[2019,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2213858719301433"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30143-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The complexity of obesity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30143-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,2]],"date-time":"2026-01-02T17:16:58Z","timestamp":1767374218244,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/s2213-8587(19)30380-8","type":"journal-article","created":{"date-parts":[[2019,11,27]],"date-time":"2019-11-27T18:35:21Z","timestamp":1574879721000},"page":"9-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Iodine and folate\u2014essential for mothers to be"],"prefix":"10.1016","volume":"8","author":[{"given":"Malcolm","family":"Prentice","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Janis","family":"Hickey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Vanderpump","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter N","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John H","family":"Lazarus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30380-8_bib2","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1017\/S0007114513004030","article-title":"Iodine deficiency in pregnant women living in the South-East of the UK: the influence of diet and nutritional supplements on iodine status","volume":"111","author":"Bath","year":"2014","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(19)30380-8_bib3","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1111\/j.1365-2826.2008.01733.x","article-title":"Neurodevelopmental and neurophysiological actions of thyroid hormone","volume":"20","author":"Williams","year":"2008","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/S2213-8587(19)30380-8_bib4","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(13)60436-5","article-title":"Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC)","volume":"382","author":"Bath","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30380-8_bib7","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1017\/S0007114515001464","article-title":"Iodine and pregnancy\u2014a UK cross-sectional survey of dietary intake, knowledge and awareness","volume":"114","author":"Combet","year":"2015","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(19)30380-8_bib8","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1136\/bmj.l1087","article-title":"Tackling salt consumption outside the home","volume":"364","author":"Caraher","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30380-8_bib9","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1006\/enrs.1994.1020","article-title":"Low-level lead exposure and children's IQ: a meta-analysis and search for a threshold","volume":"65","author":"Schwartz","year":"1994","journal-title":"Environ Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:57Z","timestamp":1761991617000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719303808"}},"issued":{"date-parts":[[2020,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2213858719303808"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30380-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Iodine and folate\u2014essential for mothers to be","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30380-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,28]],"date-time":"2026-04-28T11:57:15Z","timestamp":1777377435293,"version":"3.51.4"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/s2213-8587(19)30424-3","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T20:58:17Z","timestamp":1578430697000},"page":"93-95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Smoking cessation, weight gain, and cardiovascular risk"],"prefix":"10.1016","volume":"8","author":[{"given":"Katarina","family":"Kos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30424-3_bib1","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1038\/ijo.2015.127","article-title":"Ten-year weight gain in smokers who quit, smokers who continued smoking and never smokers in the United States, NHANES 2003\u20132012","volume":"39","author":"Veldheer","year":"2015","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(19)30424-3_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1093\/ajcn\/87.4.801","article-title":"Consequences of smoking for body weight, body fat distribution, and insulin resistance","volume":"87","author":"Chiolero","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(19)30424-3_bib3","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1001\/jama.2013.1644","article-title":"Association of smoking cessation and weight change with cardiovascular disease among adults with and without diabetes","volume":"309","author":"Clair","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30424-3_bib4","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1001\/jama.2013.6871","article-title":"Smoking cessation, weight change, and coronary heart disease among postmenopausal women with and without diabetes","volume":"310","author":"Luo","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30424-3_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30413-9","article-title":"Smoking cessation and weight change in relation to cardiovascular disease incidence and mortality in people with type 2 diabetes: a population-based cohort study","author":"Liu","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30424-3_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(19)32679-0","article-title":"Clinical presentation, treatment, and short-term outcomes of lung injury associated with e-cigarettes or vaping: a prospective observational cohort study","author":"Blagev","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30424-3_bib7","article-title":"What are the respiratory effects of e-cigarettes?","volume":"366","author":"Gotts","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30424-3_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1038\/nm.3826","article-title":"Activation of AMPK\u03b12 in adipocytes is essential for nicotine-induced insulin resistance in vivo","volume":"21","author":"Wu","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(19)30424-3_bib9","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S2213-8587(15)00316-2","article-title":"Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis","volume":"3","author":"Pan","year":"2015","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304243?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304243?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:41Z","timestamp":1761991661000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719304243"}},"issued":{"date-parts":[[2020,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2213858719304243"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30424-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Smoking cessation, weight gain, and cardiovascular risk","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30424-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30413-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T08:11:22Z","timestamp":1768637482752,"version":"3.49.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/s2213-8587(23)00064-5","type":"journal-article","created":{"date-parts":[[2023,3,21]],"date-time":"2023-03-21T19:39:31Z","timestamp":1679427571000},"page":"220-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Biodiversity and its double-edged role in the pathogenesis of type 1 diabetes"],"prefix":"10.1016","volume":"11","author":[{"given":"Daniel","family":"Chan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jan Hau","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00064-5_bib1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-021-01418-2","article-title":"100 years of insulin: celebrating the past, present and future of diabetes therapy","volume":"27","author":"Sims","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(23)00064-5_bib2","doi-asserted-by":"crossref","first-page":"1839","DOI":"10.1007\/s00125-017-4377-1","article-title":"Regulatory T cell dysfunction in type 1 diabetes: what's broken and how can we fix it?","volume":"60","author":"Hull","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00064-5_bib3","doi-asserted-by":"crossref","first-page":"1445","DOI":"10.1111\/all.13763","article-title":"A biodiversity hypothesis","volume":"74","author":"Haahtela","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/S2213-8587(23)00064-5_bib4","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S2213-8587(23)00041-4","article-title":"SARS-CoV-2 and type 1 diabetes in children in Finland: an observational study","volume":"11","author":"Knip","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00064-5_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3043","article-title":"Gut microbiome in type 1 diabetes: a comprehensive review","volume":"34","author":"Zheng","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(23)00064-5_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fmicb.2022.803121","article-title":"A two-time point analysis of gut microbiota in the general population of buenos aires and its variation due to preventive and compulsory social isolation during the COVID-19 pandemic","volume":"13","author":"Aguilera","year":"2022","journal-title":"Front Microbiol"},{"key":"10.1016\/S2213-8587(23)00064-5_bib7","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/j.stem.2020.06.015","article-title":"A human pluripotent stem cell-based platform to study SARS-CoV-2 tropism and model virus infection in human cells and organoids","volume":"27","author":"Yang","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/S2213-8587(23)00064-5_bib8","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/MPG.0000000000002860","article-title":"COVID-19-associated multisystem inflammatory syndrome in children presenting as acute pancreatitis","volume":"71","author":"Stevens","year":"2020","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/S2213-8587(23)00064-5_bib9","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.633184","article-title":"Antibody responses in COVID-19: a review","volume":"12","author":"Chvatal-Medina","year":"2021","journal-title":"Front Immunol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:30Z","timestamp":1761992010000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000645"}},"issued":{"date-parts":[[2023,4]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2213858723000645"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00064-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Biodiversity and its double-edged role in the pathogenesis of type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00064-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00041-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T14:53:49Z","timestamp":1777560829109,"version":"3.51.4"},"update-to":[{"DOI":"10.1016\/s2213-8587(25)00062-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/s2213-8587(25)00195-0","type":"journal-article","created":{"date-parts":[[2025,6,23]],"date-time":"2025-06-23T18:34:09Z","timestamp":1750703649000},"page":"e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correction to Lancet Diabetes Endocrinol 2025; 13: 580\u201390"],"prefix":"10.1016","volume":"13","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T23:45:37Z","timestamp":1758671137000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725001950"}},"issued":{"date-parts":[[2025,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2213858725001950"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00195-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2025; 13: 580\u201390","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00195-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00062-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T12:28:26Z","timestamp":1765888106086},"reference-count":13,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/s2213-8587(18)30370-x","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T11:29:50Z","timestamp":1548588590000},"page":"88-89","source":"Crossref","is-referenced-by-count":3,"title":["Vitamin D supplementation and musculoskeletal health \u2013 Authors' reply"],"prefix":"10.1016","volume":"7","author":[{"given":"Mark J","family":"Bolland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Grey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alison","family":"Avenell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30370-X_bib1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(18)30265-1","article-title":"Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis","volume":"6","author":"Bolland","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30370-X_bib2","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1093\/oxfordjournals.epirev.a036281","article-title":"Epidemiology of osteoporosis and osteoporotic fractures","volume":"7","author":"Cummings","year":"1985","journal-title":"Epidemiol Rev"},{"key":"10.1016\/S2213-8587(18)30370-X_bib3","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30370-X_bib4","doi-asserted-by":"crossref","first-page":"d2040","DOI":"10.1136\/bmj.d2040","article-title":"Calcium supplements with or without vitamin D and risk of cardiovascular events: reanalysis of the Women's Health Initiative limited access dataset and meta-analysis","volume":"342","author":"Bolland","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30370-X_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1002\/jbmr.1484","article-title":"Adverse events from calcium supplementation: relationship to errors in myocardial infarction self-reporting in randomized controlled trials of calcium supplementation","volume":"27","author":"Lewis","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30370-X_bib6","doi-asserted-by":"crossref","first-page":"h4580","DOI":"10.1136\/bmj.h4580","article-title":"Calcium intake and risk of fracture: systematic review","volume":"351","author":"Bolland","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30370-X_bib7","doi-asserted-by":"crossref","first-page":"h4183","DOI":"10.1136\/bmj.h4183","article-title":"Calcium intake and bone mineral density: systematic review and meta-analysis","volume":"351","author":"Tai","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30370-X_bib8","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","article-title":"Vitamin D3 and calcium to prevent hip fractures in the elderly women","volume":"327","author":"Chapuy","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30370-X_bib9","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1007\/s00198-016-3765-6","article-title":"Further major uncorrected errors in National Osteoporosis Foundation meta-analyses of calcium and vitamin D supplementation in fracture prevention","volume":"28","author":"Avenell","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(18)30370-X_bib10","doi-asserted-by":"crossref","first-page":"2637","DOI":"10.1007\/s00198-015-3466-6","article-title":"Errors in NOF meta-analyses of calcium and vitamin D supplements","volume":"27","author":"Bolland","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(18)30370-X_bib11","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1186\/s12874-018-0555-1","article-title":"Assessment of research waste part 2: wrong study populations- an exemplar of baseline vitamin D status of participants in trials of vitamin D supplementation","volume":"18","author":"Bolland","year":"2018","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/S2213-8587(18)30370-X_bib12","article-title":"Vitamin D supplements and prevention of cancer and cardiovascular disease","author":"Manson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30370-X_bib13","first-page":"1052","article-title":"Prevention of bone loss by vitamin D supplementation in elderly women: a randomized double-blind trial","volume":"80","author":"Ooms","year":"1995","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871830370X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871830370X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T11:29:52Z","timestamp":1548588592000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871830370X"}},"issued":{"date-parts":[[2019,2]]},"references-count":13,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S221385871830370X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30370-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,2]]}},{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T06:08:45Z","timestamp":1768802925377,"version":"3.49.0"},"update-to":[{"DOI":"10.1016\/s2213-8587(22)00188-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014422","name":"Eli Lilly Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014422","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/s2213-8587(25)00325-0","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T22:45:52Z","timestamp":1760568352000},"page":"e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2022; 10: 623\u201333"],"prefix":"10.1016","volume":"13","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T16:54:20Z","timestamp":1768755260000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003250"}},"issued":{"date-parts":[[2025,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2213858725003250"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00325-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2022; 10: 623\u201333","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00325-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00188-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T01:03:43Z","timestamp":1765328623148,"version":"3.46.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/s2213-8587(25)00358-4","type":"journal-article","created":{"date-parts":[[2025,11,22]],"date-time":"2025-11-22T00:02:59Z","timestamp":1763769779000},"page":"19","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Getting smart about the food we eat"],"prefix":"10.1016","volume":"14","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:36:30Z","timestamp":1765326990000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003584"}},"issued":{"date-parts":[[2026,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2213858725003584"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00358-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Getting smart about the food we eat","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00358-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"book-review","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:48:12Z","timestamp":1767149292146,"version":"build-2238731810"},"reference-count":2,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/s2213-8587(16)30153-x","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T04:26:18Z","timestamp":1469247978000},"page":"733-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Young people have a new vision for essential medicines"],"prefix":"10.1016","volume":"4","author":[{"given":"Shiva Raj","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sam Wing Sum","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine H.","family":"Onarheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Lander","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melissa J","family":"Barber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abhishek","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jorge","family":"Browne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan D","family":"Jarvis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30153-X_bib2","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s11948-009-9168-8","article-title":"Patenting and licensing of university research: promoting innovation or undermining academic values?","volume":"17","author":"Sterckx","year":"2011","journal-title":"Sci Eng Ethics"},{"key":"10.1016\/S2213-8587(16)30153-X_bib6","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1016\/S0140-6736(03)13375-2","article-title":"25 years of the WHO essential medicines lists: progress and challenges","volume":"361","author":"Laing","year":"2003","journal-title":"Lancet"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(16)30195-4","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630153X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630153X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:22Z","timestamp":1761991582000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871630153X"}},"issued":{"date-parts":[[2016,9]]},"references-count":2,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S221385871630153X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30153-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Young people have a new vision for essential medicines","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30153-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:39Z","timestamp":1761991959673,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"crossref","award":["2017T013"],"award-info":[{"award-number":["2017T013"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Dutch Diabetes Foundation","award":["2017.81.002"],"award-info":[{"award-number":["2017.81.002"]}]},{"DOI":"10.13039\/501100001826","name":"Netherlands Organization for Health Research and Development","doi-asserted-by":"crossref","award":["543003109"],"award-info":[{"award-number":["543003109"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/s2213-8587(20)30184-4","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T18:51:13Z","timestamp":1592333473000},"page":"552-553","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is maternal obesity a risk factor for rare childhood cardiovascular diseases?"],"prefix":"10.1016","volume":"8","author":[{"given":"Romy","family":"Gaillard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30184-4_bib1","doi-asserted-by":"crossref","first-page":"j1","DOI":"10.1136\/bmj.j1","article-title":"Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child","volume":"356","author":"Catalano","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(20)30184-4_bib2","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jama.2019.3820","article-title":"Association of gestational weight gain with adverse maternal and infant outcomes","volume":"321","author":"Voerman","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30184-4_bib3","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s10654-015-0085-7","article-title":"Maternal obesity during pregnancy and cardiovascular development and disease in the offspring","volume":"30","author":"Gaillard","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(20)30184-4_bib4","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/S2213-8587(20)30151-0","article-title":"Maternal obesity and risk of cardiovascular diseases in offspring: a population-based cohort and sibling-controlled study","volume":"8","author":"Razaz","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30184-4_bib5","article-title":"Risk of major congenital malformations in relation to maternal overweight and obesity severity: cohort study of 1\u00b72 million singletons","volume":"357","author":"Persson","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(20)30184-4_bib6","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1093\/cvr\/cvy082","article-title":"Maternal diet-induced obesity programmes cardiac dysfunction in male mice independently of post-weaning diet","volume":"114","author":"Loche","year":"2018","journal-title":"Cardiovasc Res"},{"key":"10.1016\/S2213-8587(20)30184-4_bib7","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/REP-10-0077","article-title":"Impact of maternal obesity on offspring obesity and cardiometabolic disease risk","volume":"140","author":"Drake","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/S2213-8587(20)30184-4_bib8","article-title":"Effect of diet and physical activity based interventions in pregnancy on gestational weight gain and pregnancy outcomes: meta-analysis of individual participant data from randomised trials","volume":"358","year":"2017","journal-title":"BMJ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:59Z","timestamp":1761991739000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301844"}},"issued":{"date-parts":[[2020,7]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2213858720301844"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30184-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is maternal obesity a risk factor for rare childhood cardiovascular diseases?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30184-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30151-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:06Z","timestamp":1761991986235,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/s2213-8587(21)00212-6","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T18:38:35Z","timestamp":1629484715000},"page":"640-641","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs"],"prefix":"10.1016","volume":"9","author":[{"given":"Darren K","family":"McGuire","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Neha J","family":"Pagidipati","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00212-6_bib1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00212-6_bib2","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-8587(20)30344-2","article-title":"Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial","volume":"8","author":"McGuire","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00212-6_bib3","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00212-6_bib4","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2337\/dci19-0066","article-title":"2019 Update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A Consensus Report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"43","author":"Buse","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00212-6_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00212-6_bib6","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2108269","article-title":"Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes","author":"Gerstein","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00212-6_bib7","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ejhf.657","article-title":"Effect of liraglutide, a glucagon-like peptide-1 analogue, on left ventricular function in stable chronic heart failure patients with and without diabetes (LIVE)\u2014a multicentre, double-blind, randomised, placebo-controlled trial","volume":"19","author":"Jorsal","year":"2017","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(21)00212-6_bib8","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1001\/jama.2016.10260","article-title":"Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial","volume":"316","author":"Margulies","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00212-6_bib9","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1161\/CIRCULATIONAHA.120.045888","article-title":"Glucagon-like peptide 1 receptor agonists and heart failure: the need for further evidence generation and practice guidelines optimization","volume":"142","author":"Khan","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00212-6_bib10","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.016835","article-title":"Gaps in evidence-based therapy use in insured patients in the united states with type 2 diabetes mellitus and atherosclerotic cardiovascular disease","volume":"10","author":"Nelson","year":"2021","journal-title":"J Am Heart Assoc"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002126?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002126?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:52Z","timestamp":1761991792000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002126"}},"issued":{"date-parts":[[2021,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2213858721002126"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00212-6","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP1 receptor agonists: from antihyperglycaemic to cardiovascular drugs","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00212-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00203-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:43Z","timestamp":1761991903486,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/s2213-8587(19)30404-8","type":"journal-article","created":{"date-parts":[[2019,12,12]],"date-time":"2019-12-12T18:39:42Z","timestamp":1576175982000},"page":"104","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Helena Teede: driving collaboration and impact"],"prefix":"10.1016","volume":"8","author":[{"given":"Tony","family":"Kirby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304048?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304048?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:19Z","timestamp":1761991639000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719304048"}},"issued":{"date-parts":[[2020,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2213858719304048"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30404-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Helena Teede: driving collaboration and impact","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30404-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T21:10:50Z","timestamp":1649020250504},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/s2213-8587(19)30259-1","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T22:33:34Z","timestamp":1564439614000},"page":"e21","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2019; 7: 618\u201328"],"prefix":"10.1016","volume":"7","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T23:31:39Z","timestamp":1566343899000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719302591"}},"issued":{"date-parts":[[2019,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S2213858719302591"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30259-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,9]]}},{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T18:17:39Z","timestamp":1769019459991,"version":"3.49.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DK DK113241-A1"],"award-info":[{"award-number":["K23DK DK113241-A1"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/s2213-8587(21)00241-2","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:39:06Z","timestamp":1630607946000},"page":"643-644","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":20,"title":["Diabetic ketoacidosis risk during the COVID-19 pandemic"],"prefix":"10.1016","volume":"9","author":[{"given":"Priyathama","family":"Vellanki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guillermo E","family":"Umpierrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00241-2_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41572-020-0165-1","article-title":"Diabetic ketoacidosis","volume":"6","author":"Dhatariya","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(21)00241-2_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.1091","article-title":"Characteristics of and mortality associated with diabetic ketoacidosis among US patients hospitalized with or without COVID-19","volume":"4","author":"Pasquel","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(21)00241-2_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00208-4","article-title":"Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study","author":"Misra","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00241-2_bib4","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2337\/dc17-1583","article-title":"Trends in hospital admission for diabetic ketoacidosis in adults with type 1 and type 2 diabetes in England, 1998\u20132013: a retrospective cohort study","volume":"41","author":"Zhong","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00241-2_bib5","doi-asserted-by":"crossref","first-page":"971","DOI":"10.4158\/EP161679.RA","article-title":"Diabetic ketoacidosis: a common debut of diabetes among African Americans with type 2 diabetes","volume":"23","author":"Vellanki","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(21)00241-2_bib6","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1007\/s00125-019-4942-x","article-title":"Early-life factors contributing to type 1 diabetes","volume":"62","author":"Craig","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00241-2_bib7","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23886-3","article-title":"Viral infiltration of pancreatic islets in patients with COVID-19","volume":"12","author":"Steenblock","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(21)00241-2_bib8","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.cmet.2021.05.013","article-title":"SARS-CoV-2 infects human pancreatic \u03b2 cells and elicits \u03b2 cell impairment","volume":"33","author":"Wu","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00241-2_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/2914275","article-title":"Inflammatory-related clinical and metabolic outcomes in COVID-19 patients","volume":"2020","author":"Martinez-Urbistondo","year":"2020","journal-title":"Mediators Inflamm"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002412?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002412?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:46Z","timestamp":1761991786000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002412"}},"issued":{"date-parts":[[2021,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2213858721002412"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00241-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic ketoacidosis risk during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00241-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00208-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T05:28:25Z","timestamp":1648877305298},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/s2213-8587(18)30177-3","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T22:33:50Z","timestamp":1529447630000},"page":"526","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"6","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301773?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301773?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T02:00:15Z","timestamp":1529460015000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301773"}},"issued":{"date-parts":[[2018,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2213858718301773"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30177-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research in brief","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30177-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T22:43:47Z","timestamp":1648853027400},"reference-count":3,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/s2213-8587(15)00084-4","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T23:30:52Z","timestamp":1429745452000},"page":"316","source":"Crossref","is-referenced-by-count":0,"title":["Effects of RAS inhibitors on diabetic retinopathy \u2013 Authors' reply"],"prefix":"10.1016","volume":"3","author":[{"given":"Thomas T","family":"van Sloten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Coen D A","family":"Stehouwer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00084-4_bib1","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0140-6736(08)61412-9","article-title":"Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials","volume":"372","author":"Chaturvedi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00084-4_bib2","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(08)61411-7","article-title":"Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial","volume":"372","author":"Sjolie","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00084-4_bib3","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/S2213-8587(14)70256-6","article-title":"Beneficial effect of renin-angiotensin system inhibitors on diabetic retinopathy: a systematic review and meta-analysis","volume":"3","author":"Wang","year":"2015","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T07:58:02Z","timestamp":1537689482000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000844"}},"issued":{"date-parts":[[2015,5]]},"references-count":3,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S2213858715000844"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00084-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,5]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T08:37:33Z","timestamp":1648629453909},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/s2213-8587(15)00132-1","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T23:45:35Z","timestamp":1432165535000},"page":"406-407","source":"Crossref","is-referenced-by-count":0,"title":["In defence of NICE draft type 2 diabetes guidelines \u2013 Author's reply"],"prefix":"10.1016","volume":"3","author":[{"given":"Anthony H","family":"Barnett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00132-1_bib1","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/S2213-8587(15)00053-4","article-title":"NICE draft type 2 diabetes guidelines: a cause for concern","volume":"3","author":"Barnett","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00132-1_bib3","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1463-1326.2008.00882.x","article-title":"Hypoglycaemic symptoms, treatment satisfaction, adherence and their associations with glycaemic goal in patients with type 2 diabetes mellitus: findings from the Real-Life Effectiveness and Care Patterns of Diabetes Management (RECAP-DM) Study","volume":"10","author":"Alvarez-Guisasola","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00132-1_bib4","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1177\/0145721714529608","article-title":"The impact of nocturnal hypoglycemia on clinical and cost-related issues in patients with type 1 and type 2 diabetes","volume":"40","author":"Edelman","year":"2014","journal-title":"Diabetes Educ"},{"key":"10.1016\/S2213-8587(15)00132-1_bib5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00125-007-0599-y","article-title":"Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration","volume":"50","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00132-1_bib6","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMsa1103053","article-title":"Emergency hospitalizations for adverse drug events in older Americans","volume":"365","author":"Budnitz","year":"2011","journal-title":"N Eng J Med"},{"key":"10.1016\/S2213-8587(15)00132-1_bib7","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1464-5491.2012.03698.x","article-title":"Estimating the current and future costs of Type 1 and Type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs","volume":"29","author":"Hex","year":"2012","journal-title":"Diabet Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T13:20:20Z","timestamp":1537622420000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715001321"}},"issued":{"date-parts":[[2015,6]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S2213858715001321"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00132-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,6]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T18:13:42Z","timestamp":1649096022351},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/s2213-8587(14)70182-2","type":"journal-article","created":{"date-parts":[[2014,11,3]],"date-time":"2014-11-03T00:45:57Z","timestamp":1414975557000},"page":"934","source":"Crossref","is-referenced-by-count":1,"title":["New diabetes screening recommendations in the USA"],"prefix":"10.1016","volume":"2","author":[{"given":"Patricia","family":"Lobo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701822?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701822?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T02:21:40Z","timestamp":1538101300000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701822"}},"issued":{"date-parts":[[2014,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S2213858714701822"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70182-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,12]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T07:20:20Z","timestamp":1648538420023},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/s2213-8587(15)00251-x","type":"journal-article","created":{"date-parts":[[2015,7,2]],"date-time":"2015-07-02T09:23:06Z","timestamp":1435828986000},"page":"590-591","source":"Crossref","is-referenced-by-count":0,"title":["Judging journals' impact"],"prefix":"10.1016","volume":"3","author":[{"given":"Justine","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Linklater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500251X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500251X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:07:29Z","timestamp":1563322049000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871500251X"}},"issued":{"date-parts":[[2015,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S221385871500251X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00251-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,8]]}},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:26Z","timestamp":1720746746591},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30361-8","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T06:32:58Z","timestamp":1479450778000},"page":"S6","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Multiple organ-specific autoantibodies in patients with phenotypic type 2 diabetes in China: a post-hoc analysis of the China National Diabetes and Metabolic Disorders Study"],"prefix":"10.1016","volume":"4","author":[{"given":"Yufei","family":"Xiang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gan","family":"Huang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yaxi","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiong","family":"Feng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xia","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tubao","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhenqi","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhongyan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Haoming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuhe","family":"Ji","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dalong","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jiapu","family":"Ge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lixiang","family":"Lin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Li","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhigang","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiang","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xuan","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xinyuan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wenying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303618?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303618?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T15:56:54Z","timestamp":1536249414000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303618"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"alternative-id":["S2213858716303618"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30361-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T18:19:53Z","timestamp":1648750793181},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/s2213-8587(15)00333-2","type":"journal-article","created":{"date-parts":[[2015,9,9]],"date-time":"2015-09-09T01:08:55Z","timestamp":1441760935000},"page":"764","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"3","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003332?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003332?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T16:23:32Z","timestamp":1537374212000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003332"}},"issued":{"date-parts":[[2015,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2213858715003332"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00333-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,10]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T06:05:12Z","timestamp":1649052312874},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/s2213-8587(19)30095-6","type":"journal-article","created":{"date-parts":[[2019,3,7]],"date-time":"2019-03-07T18:48:55Z","timestamp":1551984535000},"page":"e19","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2019; 7: 560\u201374"],"prefix":"10.1016","volume":"7","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300956?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300956?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T16:18:50Z","timestamp":1563207530000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300956"}},"issued":{"date-parts":[[2019,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S2213858719300956"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30095-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,7]]}},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T04:32:22Z","timestamp":1648787542173},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/s2213-8587(15)00259-4","type":"journal-article","created":{"date-parts":[[2015,7,12]],"date-time":"2015-07-12T19:46:23Z","timestamp":1436730383000},"page":"593","source":"Crossref","is-referenced-by-count":0,"title":["John Yudkin: a global health fanatic"],"prefix":"10.1016","volume":"3","author":[{"given":"Dara","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002594?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002594?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:07:38Z","timestamp":1563322058000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002594"}},"issued":{"date-parts":[[2015,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S2213858715002594"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00259-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,8]]}},{"indexed":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T08:08:19Z","timestamp":1706774899173},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/s2213-8587(18)30147-5","type":"journal-article","created":{"date-parts":[[2018,5,23]],"date-time":"2018-05-23T20:16:28Z","timestamp":1527106588000},"page":"444","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Changing the conversation"],"prefix":"10.1016","volume":"6","author":[{"given":"Jules","family":"Morgan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T08:32:39Z","timestamp":1574757159000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301475"}},"issued":{"date-parts":[[2018,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S2213858718301475"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30147-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Changing the conversation","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30147-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,6,5]],"date-time":"2024-06-05T10:58:46Z","timestamp":1717585126167},"reference-count":9,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/s2213-8587(17)30216-4","type":"journal-article","created":{"date-parts":[[2017,6,11]],"date-time":"2017-06-11T21:31:09Z","timestamp":1497216669000},"page":"567-569","source":"Crossref","is-referenced-by-count":6,"title":["Metformin in type 1 diabetes"],"prefix":"10.1016","volume":"5","author":[{"given":"Eberhard","family":"Standl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30216-4_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(17)30194-8","article-title":"Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial","author":"Petrie","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30216-4_bib2","series-title":"NICE guideline NG17","article-title":"Type 1 diabetes in adults: diagnosis and management","year":"2015"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30216-4_bib3","first-page":"S1","article-title":"Standards of medical care in diabetes\u20142017","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30216-4_bib4","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00125-009-1636-9","article-title":"The use of metformin in type 1 diabetes: a systematic review of efficacy","volume":"53","author":"Vella","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30216-4_bib5","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1001\/jama.2015.16174","article-title":"Effect of metformin added to insulin on glycemic control among overweight\/obese adolescents with type 1 diabetes: a randomized clinical trial","volume":"314","author":"Libman","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30216-4_bib6","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1016\/j.cmet.2014.09.018","article-title":"Metformin: from mechanisms of action to therapies","volume":"20","author":"Foretz","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(17)30216-4_bib7","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dci15-0013","article-title":"Mechanism of metformin: a tale of two sites","volume":"39","author":"Song","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30216-4_bib8","doi-asserted-by":"crossref","first-page":"198","DOI":"10.2337\/dc15-0488","article-title":"The primary glucose-lowering effect of metformin resides in the gut, not the circulation: results from short-term pharmacokinetic and 12-week dose-ranging studies","volume":"39","author":"Buse","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30216-4_bib9","doi-asserted-by":"crossref","first-page":"4610","DOI":"10.1210\/en.2011-1485","article-title":"Mechanisms underlying metformin-induced secretion of glucagon-like peptide-1 from the intestinal L cell","volume":"152","author":"Mulherin","year":"2011","journal-title":"Endocrinology"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,29]],"date-time":"2022-07-29T14:22:49Z","timestamp":1659104569000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717302164"}},"issued":{"date-parts":[[2017,8]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S2213858717302164"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30216-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,8]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T00:48:47Z","timestamp":1648946927535},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30283-2","type":"journal-article","created":{"date-parts":[[2016,9,30]],"date-time":"2016-09-30T18:29:19Z","timestamp":1475260159000},"page":"e11","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2016; 4: 812\u201314"],"prefix":"10.1016","volume":"4","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302832?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302832?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T03:38:20Z","timestamp":1548646700000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302832"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2213858716302832"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30283-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T08:26:47Z","timestamp":1648974407063},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/s2213-8587(19)30112-3","type":"journal-article","created":{"date-parts":[[2019,3,27]],"date-time":"2019-03-27T05:14:54Z","timestamp":1553663694000},"page":"428","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Psychological support for bariatric surgery"],"prefix":"10.1016","volume":"7","author":[{"given":"Samantha","family":"Scholtz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carel W","family":"le Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301123?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301123?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T21:03:51Z","timestamp":1560805431000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301123"}},"issued":{"date-parts":[[2019,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2213858719301123"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30112-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Psychological support for bariatric surgery","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30112-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"book-review","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T07:37:57Z","timestamp":1648712277396},"reference-count":6,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/s2213-8587(15)00287-9","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T23:50:11Z","timestamp":1440028211000},"page":"681","source":"Crossref","is-referenced-by-count":1,"title":["Mortality and metformin use in patients with advanced chronic kidney disease \u2013 Authors' reply"],"prefix":"10.1016","volume":"3","author":[{"given":"Szu-Chun","family":"Hung","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu-Kang","family":"Chang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia-Sin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chih-Cheng","family":"Hsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Der-Cherng","family":"Tarng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00287-9_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(15)00123-0","article-title":"Metformin use and mortality in patients with advanced chronic kidney disease: national, retrospective, observational, cohort study","volume":"3","author":"Hung","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00287-9_bib2","doi-asserted-by":"crossref","first-page":"e001076","DOI":"10.1136\/bmjopen-2012-001076","article-title":"Effectiveness and safety of metformin in 51675 patients with type 2 diabetes and different levels of renal function: a cohort study from the Swedish National Diabetes Register","volume":"2","author":"Ekstr\u00f6m","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(15)00287-9_bib3","doi-asserted-by":"crossref","first-page":"2668","DOI":"10.1001\/jama.2014.15298","article-title":"Metformin in patients with type 2 diabetes and kidney disease: a systematic review","volume":"312","author":"Inzucchi","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00287-9_bib4","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1016\/S0168-8227(00)00179-0","article-title":"Epidemiologic study of type 2 diabetes in Taiwan","volume":"50","author":"Chang","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00287-9_bib5","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1001\/jamainternmed.2014.6936","article-title":"Metformin use reduction in mild to moderate renal impairment: possible inappropriate curbing of use based on Food and Drug Administration contraindications","volume":"175","author":"Flory","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(15)00287-9_bib6","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1056\/NEJMoa1414266","article-title":"Follow-up of glycemic control and cardiovascular outcomes in type 2 diabetes","volume":"372","author":"Hayward","year":"2015","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002879?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002879?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:22:27Z","timestamp":1549844547000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002879"}},"issued":{"date-parts":[[2015,9]]},"references-count":6,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S2213858715002879"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00287-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,9]]}},{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T11:54:33Z","timestamp":1723031673083},"reference-count":13,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/s2213-8587(15)00050-9","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T22:10:33Z","timestamp":1426716633000},"page":"236-238","source":"Crossref","is-referenced-by-count":7,"title":["Diagnostic criteria for osteoporosis should not be expanded"],"prefix":"10.1016","volume":"3","author":[{"given":"John T","family":"Schousboe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristine E","family":"Ensrud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00050-9_bib1","first-page":"1","article-title":"Report of a WHO Study Group","volume":"843","year":"1994","journal-title":"World Health Organ Tech Rep Ser"},{"key":"10.1016\/S2213-8587(15)00050-9_bib3","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1001\/jama.286.22.2815","article-title":"Identification and fracture outcomes of undiagnosed low bone mineral density in postmenopausal women: results from the National Osteoporosis Risk Assessment","volume":"286","author":"Siris","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00050-9_bib4","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s00198-014-2655-z","article-title":"The clinical diagnosis of osteoporosis: a position statement from the National Bone Health Alliance Working Group","volume":"25","author":"Siris","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(15)00050-9_bib5","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1359\/jbmr.081203","article-title":"Estimates of the proportion of older white women who would be recommended for pharmacologic treatment by the new U.S. National Osteoporosis Foundation Guidelines","volume":"24","author":"Donaldson","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(15)00050-9_bib6","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1002\/jbmr.55","article-title":"Estimates of the proportion of older white men who would be recommended for pharmacologic treatment by the new US National Osteoporosis Foundation guidelines","volume":"25","author":"Donaldson","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(15)00050-9_bib7","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-148-3-200802050-00198","article-title":"Systematic review: comparative effectiveness of treatments to prevent fractures in men and women with low bone density or osteoporosis","volume":"148","author":"MacLean","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(15)00050-9_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jbmr.536","article-title":"Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis","volume":"27","author":"McClung","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(15)00050-9_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1359\/jbmr.061008","article-title":"Clodronate reduces the incidence of fractures in community-dwelling elderly women unselected for osteoporosis: results of a double-blind, placebo-controlled randomized study","volume":"22","author":"McCloskey","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(15)00050-9_bib10","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.jbspin.2006.06.004","article-title":"Effects of osteoporosis medications on bone quality","volume":"74","author":"Benhamou","year":"2007","journal-title":"Joint Bone Spine"},{"key":"10.1016\/S2213-8587(15)00050-9_bib11","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s00198-007-0550-6","article-title":"Cost-effective osteoporosis treatment thresholds: the United States perspective","volume":"19","author":"Tosteson","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(15)00050-9_bib12","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1007\/s00198-007-0343-y","article-title":"The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women","volume":"18","author":"Kanis","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(15)00050-9_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1370\/afm.310","article-title":"Is there time for management of patients with chronic diseases in primary care?","volume":"3","author":"Ostbye","year":"2005","journal-title":"Ann Fam Med"},{"key":"10.1016\/S2213-8587(15)00050-9_bib14","doi-asserted-by":"crossref","first-page":"2720","DOI":"10.1016\/j.socscimed.2005.11.009","article-title":"Making the invisible body visible. Bone scans, osteoporosis and women's bodily experiences","volume":"62","author":"Reventlow","year":"2006","journal-title":"Soc Sci Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000509?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000509?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T04:24:07Z","timestamp":1537763047000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000509"}},"issued":{"date-parts":[[2015,4]]},"references-count":13,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S2213858715000509"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00050-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,4]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T21:31:25Z","timestamp":1649107885699},"reference-count":5,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/s2213-8587(18)30200-6","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T20:13:09Z","timestamp":1532463189000},"page":"602","source":"Crossref","is-referenced-by-count":0,"title":["Risk\u2013benefit profile of intensive blood pressure treatment \u2013 Authors' reply"],"prefix":"10.1016","volume":"6","author":[{"given":"Srinivasan","family":"Beddhu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Boucher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William C","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Guo","family":"Wei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alfred K","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul K","family":"Whelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn M","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30200-6_bib1","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S2213-8587(18)30099-8","article-title":"Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials","volume":"6","author":"Beddhu","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30200-6_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2215\/CJN.05510517","article-title":"BP reduction, kidney function decline, and cardiovascular events in patients without CKD","volume":"13","author":"Magrico","year":"2018","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(18)30200-6_bib3","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1007\/s10742-008-0028-9","article-title":"Causal mediation analyses for randomized trials","volume":"8","author":"Lynch","year":"2008","journal-title":"Health Serv Outcomes Res Methodol"},{"key":"10.1016\/S2213-8587(18)30200-6_bib4","series-title":"Computation, causation, and discovery","first-page":"349","article-title":"Testing and estimation of direct effects by reparameterizing directed acyclic graphs with structural nested models","author":"Robins","year":"1999"},{"key":"10.1016\/S2213-8587(18)30200-6_bib5","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1161\/CIRCULATIONAHA.117.030848","article-title":"Influence of baseline diastolic blood pressure on effects of intensive compared to standard blood pressure control","volume":"137","author":"Beddhu","year":"2018","journal-title":"Circulation"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:04:37Z","timestamp":1534809877000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302006"}},"issued":{"date-parts":[[2018,8]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S2213858718302006"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30200-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,8]]}},{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T06:25:38Z","timestamp":1777962338707,"version":"3.51.4"},"reference-count":5,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/s2213-8587(25)00221-9","type":"journal-article","created":{"date-parts":[[2025,7,25]],"date-time":"2025-07-25T22:33:11Z","timestamp":1753482791000},"page":"742-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Fluids in paediatric diabetic ketoacidosis: the choice is not solely academic"],"prefix":"10.1016","volume":"13","author":[{"given":"Ivana","family":"Rabbone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Bonfanti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentino","family":"Cherubini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Iafusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marco","family":"Marigliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Riccardo","family":"Schiaffini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sonia","family":"Toni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrea","family":"Scaramuzza","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Bassi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Di Candia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulio","family":"Frontino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maddalena","family":"Macedoni","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Mancioppi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariangela","family":"Martino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valentina","family":"Tiberi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Davide","family":"Tinti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleonora","family":"Chiarle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fortunato","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00221-9_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1111\/pedi.13406","article-title":"ISPAD clinical practice consensus guidelines 2022: diabetic ketoacidosis and hyperglycemic hyperosmolar state","volume":"23","author":"Glaser","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(25)00221-9_bib2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1056\/NEJM200101253440404","article-title":"Risk factors for cerebral edema in children with diabetic ketoacidosis","volume":"344","author":"Glaser","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00221-9_bib3","series-title":"Handbook on injectable drugs","author":"Trissel","year":"2021"},{"key":"10.1016\/S2213-8587(25)00221-9_bib4","series-title":"Comprehensive clinical nephrology","first-page":"109","article-title":"Management of severe symptomatic hyponatremia and hypokalemia","author":"Kamel","year":"2019"},{"key":"10.1016\/S2213-8587(25)00221-9_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1711584","article-title":"Balanced crystalloids versus saline in critically ill adults","volume":"378","author":"Semler","year":"2018","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T20:06:37Z","timestamp":1756757197000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002219"}},"issued":{"date-parts":[[2025,9]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2213858725002219"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00221-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluids in paediatric diabetic ketoacidosis: the choice is not solely academic","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00221-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,20]],"date-time":"2026-07-20T12:18:05Z","timestamp":1784549885697,"version":"3.55.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/s2213-8587(18)30351-6","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T11:29:50Z","timestamp":1548588590000},"page":"89-90","source":"Crossref","is-referenced-by-count":24,"title":["GLP-1 receptor agonists and cardiovascular disease: drug-specific or class effects?"],"prefix":"10.1016","volume":"7","author":[{"given":"Elric","family":"Zweck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30351-6_bib1","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(17)30412-6","article-title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"Bethel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30351-6_bib2","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30351-6_bib3","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S2213-8587(17)30413-8","article-title":"GLP-1 receptor agonists: differentiation within the class","volume":"6","author":"Taylor","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30351-6_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S2213-8587(13)70214-6","article-title":"Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study","volume":"2","author":"Pratley","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30351-6_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.cmet.2016.06.009","article-title":"The cardiovascular biology of glucagon-like peptide-1","volume":"24","author":"Drucker","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(18)30351-6_bib6","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1097\/MOL.0b013e328321b3a8","article-title":"Ectopic lipids and organ function","volume":"20","author":"Szendroedi","year":"2009","journal-title":"Curr Opin Lipidol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303516?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303516?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T11:29:52Z","timestamp":1548588592000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303516"}},"issued":{"date-parts":[[2019,2]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2213858718303516"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30351-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,2]]}},{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T00:07:01Z","timestamp":1782778021868,"version":"3.54.5"},"reference-count":99,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/s2213-8587(17)30233-4","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T07:00:42Z","timestamp":1503644442000},"page":"60-68","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Aiding sleep in type 2 diabetes: therapeutic considerations"],"prefix":"10.1016","volume":"6","author":[{"given":"Xiao","family":"Tan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lieve","family":"van Egmond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin D","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Cedernaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Benedict","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30233-4_bib1","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.dsx.2016.06.009","article-title":"Predictors of sleep disorders among patients with type 2 diabetes mellitus","volume":"10","author":"Gupta","year":"2016","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(17)30233-4_bib2","series-title":"International classification of sleep disorders","year":"2014"},{"key":"10.1016\/S2213-8587(17)30233-4_bib3","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1073\/pnas.0706446105","article-title":"Slow-wave sleep and the risk of type 2 diabetes in humans","volume":"105","author":"Tasali","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(17)30233-4_bib4","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1016\/j.psyneuen.2013.03.018","article-title":"Selective slow wave sleep but not rapid eye movement sleep suppression impairs morning glucose tolerance in healthy men","volume":"38","author":"Herzog","year":"2013","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(17)30233-4_bib5","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/sleep\/34.3.371","article-title":"Disturbed glucoregulatory response to food intake after moderate sleep restriction","volume":"34","author":"Schmid","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jsr.12340","article-title":"A single night of partial sleep loss impairs fasting insulin sensitivity but does not affect cephalic phase insulin release in young men","volume":"25","author":"Cedernaes","year":"2016","journal-title":"J Sleep Res"},{"key":"10.1016\/S2213-8587(17)30233-4_bib7","doi-asserted-by":"crossref","first-page":"1664","DOI":"10.1210\/jc.2014-3911","article-title":"Subchronic sleep restriction causes tissue-specific insulin resistance","volume":"100","author":"Rao","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30233-4_bib8","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1378\/chest.11-1945","article-title":"Prevalence of diagnosed sleep apnea among patients with type 2 diabetes in primary care","volume":"141","author":"Heffner","year":"2012","journal-title":"Chest"},{"key":"10.1016\/S2213-8587(17)30233-4_bib9","doi-asserted-by":"crossref","first-page":"355","DOI":"10.4158\/EP.13.4.355","article-title":"Prevalence of sleep apnea in a population of adults with type 2 diabetes mellitus","volume":"13","author":"Einhorn","year":"2007","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(17)30233-4_bib10","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.2337\/dc08-1776","article-title":"Obstructive sleep apnea among obese patients with type 2 diabetes","volume":"32","author":"Foster","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30233-4_bib11","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1164\/rccm.200909-1423OC","article-title":"Impact of untreated obstructive sleep apnea on glucose control in type 2 diabetes","volume":"181","author":"Aronsohn","year":"2010","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib12","series-title":"The AASM manual for the scoring of sleep and associated events: rules, terminology and technical specifications. Version 2.3","author":"Berry","year":"2016"},{"key":"10.1016\/S2213-8587(17)30233-4_bib13","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth Sleepiness Scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib14","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/aje\/kws342","article-title":"Increased prevalence of sleep-disordered breathing in adults","volume":"177","author":"Peppard","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30233-4_bib15","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.smrv.2015.03.002","article-title":"Effects of continuous positive airway pressure treatment on glucose metabolism in patients with obstructive sleep apnea","volume":"25","author":"Mart\u00ednez-Ceron","year":"2016","journal-title":"Sleep Med Rev"},{"key":"10.1016\/S2213-8587(17)30233-4_bib16","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.smrv.2016.02.001","article-title":"The impact of sleep amount and sleep quality on glycemic control in type 2 diabetes: a systematic review and meta-analysis","volume":"31","author":"Lee","year":"2017","journal-title":"Sleep Med Rev"},{"key":"10.1016\/S2213-8587(17)30233-4_bib17","doi-asserted-by":"crossref","first-page":"e104176","DOI":"10.1371\/journal.pone.0104176","article-title":"Hawthorne effect with transient behavioral and biochemical changes in a randomized controlled sleep extension trial of chronically short-sleeping obese adults: implications for the design and interpretation of clinical studies","volume":"9","author":"Cizza","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30233-4_bib18","doi-asserted-by":"crossref","first-page":"707","DOI":"10.5665\/sleep.4660","article-title":"Beneficial impact of sleep extension on fasting insulin sensitivity in adults with habitual sleep restriction","volume":"38","author":"Leproult","year":"2015","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.psyneuen.2015.02.010","article-title":"Improved sleep quality in older adults with insomnia reduces biomarkers of disease risk: pilot results from a randomized controlled comparative efficacy trial","volume":"55","author":"Carroll","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(17)30233-4_bib20","doi-asserted-by":"crossref","first-page":"e8343","DOI":"10.1136\/bmj.e8343","article-title":"Effectiveness of non-benzodiazepine hypnotics in treatment of adult insomnia: meta-analysis of data submitted to the Food and Drug Administration","volume":"345","author":"Huedo-Medina","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30233-4_bib21","first-page":"225","article-title":"Meta-analysis of benzodiazepine use in the treatment of insomnia","volume":"162","author":"Holbrook","year":"2000","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(17)30233-4_bib22","doi-asserted-by":"crossref","first-page":"261","DOI":"10.2165\/00002018-200326040-00004","article-title":"New drugs for insomnia: comparative tolerability of zopiclone, zolpidem and zaleplon","volume":"26","author":"Terzano","year":"2003","journal-title":"Drug Saf"},{"key":"10.1016\/S2213-8587(17)30233-4_bib23","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1192\/apt.bp.111.009209","article-title":"Why benzodiazepines are not going away","volume":"18","author":"Tyrer","year":"2012","journal-title":"Advan Psychiatr Treat"},{"key":"10.1016\/S2213-8587(17)30233-4_bib24","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0022-3999(02)00417-8","article-title":"Prevalence of anxiety in adults with diabetes: a systematic review","volume":"53","author":"Grigsby","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/S2213-8587(17)30233-4_bib25","first-page":"E76","article-title":"Prevalence of self-reported sleep problems among people with diabetes in the United States, 2005\u20132008","volume":"9","author":"Plantinga","year":"2012","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/S2213-8587(17)30233-4_bib26","doi-asserted-by":"crossref","first-page":"859","DOI":"10.5665\/SLEEP.1114","article-title":"Prevalence and polysomnographic correlates of insomnia comorbid with medical disorders","volume":"34","author":"Budhiraja","year":"2011","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib27","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/5134602","article-title":"The use of antidepressants, anxiolytics, and hypnotics in people with type 2 diabetes and patterns associated with use: the hoorn diabetes care system cohort","author":"Mast","year":"2017","journal-title":"BioMed Research International"},{"key":"10.1016\/S2213-8587(17)30233-4_bib28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1002\/pds.3825","article-title":"Exposure to benzodiazepines (anxiolytics, hypnotics and related drugs) in seven European electronic healthcare databases: a cross-national descriptive study from the PROTECT-EU Project","volume":"25","author":"Huerta","year":"2016","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/S2213-8587(17)30233-4_bib29","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s40618-013-0016-y","article-title":"Impact of short-term treatment with benzodiazepines and imidazopyridines on glucose metabolism in healthy subjects","volume":"37","author":"Gramaglia","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(17)30233-4_bib30","doi-asserted-by":"crossref","first-page":"e1621","DOI":"10.1097\/MD.0000000000001621","article-title":"Risk of type 2 diabetes in patients with nonapnea sleep disorders in using different types of hypnotics: a population-based retrospective cohort study","volume":"94","author":"Lin","year":"2015","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S2213-8587(17)30233-4_bib31","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.5665\/sleep.4068","article-title":"Electroencephalographic power spectral density profile of the orexin receptor antagonist suvorexant in patients with primary insomnia and healthy subjects","volume":"37","author":"Ma","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib32","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/j.sleep.2012.11.012","article-title":"A preliminary study of slow-wave EEG activity and insulin sensitivity in adolescents","volume":"14","author":"Armitage","year":"2013","journal-title":"Sleep Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.smrv.2004.05.002","article-title":"Melatonin as a chronobiotic","volume":"9","author":"Arendt","year":"2005","journal-title":"Sleep Med Rev"},{"key":"10.1016\/S2213-8587(17)30233-4_bib34","first-page":"CD001520","article-title":"Melatonin for the prevention and treatment of jet lag","volume":"2","author":"Herxheimer","year":"2002","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30233-4_bib35","first-page":"1","article-title":"Trends in the use of complementary health approaches among adults: United States, 2002\u20132012","volume":"79","author":"Clarke","year":"2015","journal-title":"Natl Health Stat Report"},{"key":"10.1016\/S2213-8587(17)30233-4_bib36","doi-asserted-by":"crossref","first-page":"e63773","DOI":"10.1371\/journal.pone.0063773","article-title":"Meta-analysis: melatonin for the treatment of primary sleep disorders","volume":"8","author":"Ferracioli-Oda","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30233-4_bib37","first-page":"550","article-title":"Does melatonin improve sleep? Efficacy of melatonin","volume":"332","author":"Arendt","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30233-4_bib38","doi-asserted-by":"crossref","first-page":"307","DOI":"10.5664\/jcsm.6470","article-title":"Clinical practice guideline for the pharmacologic treatment of chronic insomnia in adults: an American Academy of Sleep Medicine Clinical Practice Guideline","volume":"13","author":"Sateia","year":"2017","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib39","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.5665\/sleep.3110","article-title":"Combination of light and melatonin time cues for phase advancing the human circadian clock","volume":"36","author":"Burke","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib40","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1093\/sleep\/33.12.1605","article-title":"The use of exogenous melatonin in delayed sleep phase disorder: a meta-analysis","volume":"33","author":"van Geijlswijk","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib41","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1080\/07420528.2017.1279624","article-title":"Later chronotype is associated with higher hemoglobin A1c in prediabetes patients","volume":"34","author":"Anothaisintawee","year":"2017","journal-title":"Chronobiol Int"},{"key":"10.1016\/S2213-8587(17)30233-4_bib42","doi-asserted-by":"crossref","first-page":"1388","DOI":"10.1001\/jama.2013.2710","article-title":"Melatonin secretion and the incidence of type 2 diabetes","volume":"309","author":"McMullan","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30233-4_bib43","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.5665\/sleep.4088","article-title":"Acute melatonin administration in humans impairs glucose tolerance in both the morning and evening","volume":"37","author":"Rubio-Sastre","year":"2014","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib44","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.cmet.2016.04.009","article-title":"Increased melatonin signaling is a risk factor for type 2 diabetes","volume":"23","author":"Tuomi","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(17)30233-4_bib45","doi-asserted-by":"crossref","first-page":"15924","DOI":"10.3390\/ijms150915924","article-title":"Therapeutic effects of melatonin receptor agonists on sleep and comorbid disorders","volume":"15","author":"Laudon","year":"2014","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(17)30233-4_bib46","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.sleep.2013.11.788","article-title":"Ramelteon for the treatment of insomnia in adults: a systematic review and meta-analysis","volume":"15","author":"Kuriyama","year":"2014","journal-title":"Sleep Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib47","doi-asserted-by":"crossref","first-page":"878","DOI":"10.14740\/jocmr2754w","article-title":"The effects of ramelteon on glucose metabolism and sleep quality in type 2 diabetic patients with insomnia: a pilot prospective randomized controlled trial","volume":"8","author":"Tsunoda","year":"2016","journal-title":"J Clin Med Res"},{"key":"10.1016\/S2213-8587(17)30233-4_bib48","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1212\/WNL.0b013e31827688ee","article-title":"Orexin receptor antagonism for treatment of insomnia: a randomized clinical trial of suvorexant","volume":"79","author":"Herring","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/S2213-8587(17)30233-4_bib49","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S1474-4422(14)70053-5","article-title":"Safety and efficacy of suvorexant during 1-year treatment of insomnia with subsequent abrupt treatment discontinuation: a phase 3 randomised, double-blind, placebo-controlled trial","volume":"13","author":"Michelson","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(17)30233-4_bib50","doi-asserted-by":"crossref","first-page":"456","DOI":"10.12688\/f1000research.6845.1","article-title":"Is suvorexant a better choice than alternative hypnotics?","volume":"4","author":"Kripke","year":"2015","journal-title":"F1000Res"},{"key":"10.1016\/S2213-8587(17)30233-4_bib51","doi-asserted-by":"crossref","first-page":"4146","DOI":"10.1210\/en.2016-1404","article-title":"Timed inhibition of orexin system by suvorexant improved sleep and glucose metabolism in type 2 diabetic db\/db mice","volume":"157","author":"Tsuneki","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(17)30233-4_bib52","doi-asserted-by":"crossref","first-page":"191","DOI":"10.7326\/M14-2841","article-title":"Cognitive behavioral therapy for chronic insomnia: a systematic review and meta-analysis","volume":"163","author":"Trauer","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib53","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.2009.682","article-title":"Cognitive behavioral therapy, singly and combined with medication, for persistent insomnia: a randomized controlled trial","volume":"301","author":"Morin","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30233-4_bib54","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.smrv.2014.06.010","article-title":"Self-help cognitive-behavioral therapy for insomnia: a meta-analysis of randomized controlled trials","volume":"19","author":"Ho","year":"2015","journal-title":"Sleep Med Rev"},{"key":"10.1016\/S2213-8587(17)30233-4_bib55","doi-asserted-by":"crossref","first-page":"e41218","DOI":"10.1371\/journal.pone.0041218","article-title":"Impact of five nights of sleep restriction on glucose metabolism, leptin and testosterone in young adult men","volume":"7","author":"Reynolds","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30233-4_bib56","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S2213-8587(14)70012-9","article-title":"The metabolic burden of sleep loss","volume":"3","author":"Schmid","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30233-4_bib57","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1093\/sleep\/33.5.669","article-title":"Sleep EEG predictors and correlates of the response to cognitive behavioral therapy for insomnia","volume":"33","author":"Krystal","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib58","doi-asserted-by":"crossref","first-page":"769","DOI":"10.5665\/sleep.1872","article-title":"A randomized, placebo-controlled trial of online cognitive behavioral therapy for chronic insomnia disorder delivered via an automated media-rich web application","volume":"35","author":"Espie","year":"2012","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib59","first-page":"CD001106","article-title":"Continuous positive airways pressure for obstructive sleep apnoea in adults","volume":"3","author":"Giles","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30233-4_bib60","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1007\/s11325-012-0680-8","article-title":"Effects of continuous positive airway pressure on glycemic control and insulin resistance in patients with obstructive sleep apnea: a meta-analysis","volume":"17","author":"Yang","year":"2013","journal-title":"Sleep Breath"},{"key":"10.1016\/S2213-8587(17)30233-4_bib61","doi-asserted-by":"crossref","first-page":"31","DOI":"10.3810\/hp.2014.04.1101","article-title":"Effect of continuous positive airway pressure on type 2 diabetes mellitus and glucose metabolism","volume":"42","author":"Gallegos","year":"2014","journal-title":"Hosp Pract (1995)"},{"key":"10.1016\/S2213-8587(17)30233-4_bib62","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1164\/rccm.201510-1942OC","article-title":"Effect of continuous positive airway pressure on glycemic control in patients with obstructive sleep apnea and type 2 diabetes. A randomized clinical trial","volume":"194","author":"Mart\u00ednez-Cer\u00f3n","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib63","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2165\/00003495-200565030-00005","article-title":"Oral antidiabetic agents: current role in type 2 diabetes mellitus","volume":"65","author":"Krentz","year":"2005","journal-title":"Drugs"},{"issue":"204","key":"10.1016\/S2213-8587(17)30233-4_bib64","first-page":"207","article-title":"Long-term effects of nocturnal continuous positive airway pressure therapy in patients with resistant hypertension and obstructive sleep apnea","volume":"63","author":"Fren\u0163","year":"2014","journal-title":"Pneumologia"},{"key":"10.1016\/S2213-8587(17)30233-4_bib65","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2337\/dc13-0933","article-title":"Association of obstructive sleep apnea in rapid eye movement sleep with reduced glycemic control in type 2 diabetes: therapeutic implications","volume":"37","author":"Grimaldi","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30233-4_bib66","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1164\/rccm.201408-1564OC","article-title":"Eight hours of nightly continuous positive airway pressure treatment of obstructive sleep apnea improves glucose metabolism in patients with prediabetes. A randomized controlled trial","volume":"192","author":"Pamidi","year":"2015","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib67","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1164\/rccm.201602-0396LE","article-title":"Effect of one week of 8-hour nightly Continuous positive airway pressure treatment of obstructive sleep apnea on glycemic control in type 2 diabetes: a proof-of-concept study","volume":"194","author":"Mokhlesi","year":"2016","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib68","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1136\/thx.2006.074351","article-title":"Effect of CPAP on insulin resistance and HbA1c in men with obstructive sleep apnoea and type 2 diabetes","volume":"62","author":"West","year":"2007","journal-title":"Thorax"},{"key":"10.1016\/S2213-8587(17)30233-4_bib69","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1155\/2008\/534372","article-title":"Long-term compliance with continuous positive airway pressure in patients with obstructive sleep apnea","volume":"15","author":"Wolkove","year":"2008","journal-title":"Can Respir J"},{"key":"10.1016\/S2213-8587(17)30233-4_bib70","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5665\/sleep.2460","article-title":"Response to CPAP withdrawal in patients with mild versus severe obstructive sleep apnea\/hypopnea syndrome","volume":"36","author":"Young","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib71","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/sleep\/30.5.635","article-title":"Increased adherence to CPAP with a group cognitive behavioral treatment intervention: a randomized trial","volume":"30","author":"Richards","year":"2007","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib72","doi-asserted-by":"crossref","first-page":"773","DOI":"10.5664\/jcsm.4858","article-title":"Clinical practice guideline for the treatment of obstructive sleep apnea and snoring with oral appliance therapy: an update for 2015","volume":"11","author":"Ramar","year":"2015","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib73","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1164\/rccm.201212-2223OC","article-title":"Health outcomes of continuous positive airway pressure versus oral appliance treatment for obstructive sleep apnea: a randomized controlled trial","volume":"187","author":"Phillips","year":"2013","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib74","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1093\/sleep\/33.10.1396","article-title":"Surgical modifications of the upper airway for obstructive sleep apnea in adults: a systematic review and meta-analysis","volume":"33","author":"Caples","year":"2010","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib75","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1056\/NEJMoa1308659","article-title":"Upper-airway stimulation for obstructive sleep apnea","volume":"370","author":"Strollo","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib76","doi-asserted-by":"crossref","first-page":"i2123","DOI":"10.1136\/bmj.i2123","article-title":"Advances in the management of chronic insomnia","volume":"354","author":"Kay-Stacey","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30233-4_bib77","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1093\/gerona\/63.9.997","article-title":"Effects of moderate-intensity exercise on polysomnographic and subjective sleep quality in older adults with mild to moderate sleep complaints","volume":"63","author":"King","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(17)30233-4_bib78","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.sleep.2011.02.007","article-title":"Effects of moderate aerobic exercise training on chronic primary insomnia","volume":"12","author":"Passos","year":"2011","journal-title":"Sleep Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib79","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.sleep.2016.02.010","article-title":"Effects of aerobic exercise on home-based sleep among overweight and obese men with chronic insomnia symptoms: a randomized controlled trial","volume":"25","author":"Tan","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib80","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s00408-013-9511-3","article-title":"Effects of exercise training on sleep apnea: a meta-analysis","volume":"192","author":"Iftikhar","year":"2014","journal-title":"Lung"},{"key":"10.1016\/S2213-8587(17)30233-4_bib81","doi-asserted-by":"crossref","first-page":"1790","DOI":"10.1001\/jama.2011.576","article-title":"Physical activity advice only or structured exercise training and association with HbA1c levels in type 2 diabetes: a systematic review and meta-analysis","volume":"305","author":"Umpierre","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30233-4_bib82","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S1836-9553(12)70106-6","article-title":"Exercise training improves sleep quality in middle-aged and older adults with sleep problems: a systematic review","volume":"58","author":"Yang","year":"2012","journal-title":"J Physiother"},{"key":"10.1016\/S2213-8587(17)30233-4_bib83","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s11154-012-9234-4","article-title":"Reusch JE, Bridenstine M, Regensteiner JG. Type 2 diabetes mellitus and exercise impairment","volume":"14","author":"Reusch","year":"2013","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/S2213-8587(17)30233-4_bib84","doi-asserted-by":"crossref","first-page":"S149","DOI":"10.2337\/dcS13-2024","article-title":"Is physical exercise a core therapeutical element for most patients with type 2 diabetes?","volume":"36","author":"De Feo","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30233-4_bib85","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(75)90718-7","article-title":"Isocaloric diet changes and electroencephalographic sleep","volume":"306","author":"Phillips","year":"1975","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30233-4_bib86","doi-asserted-by":"crossref","first-page":"938","DOI":"10.3945\/an.116.012336","article-title":"Effects of diet on sleep quality","volume":"7","author":"St-Onge","year":"2016","journal-title":"Adv Nutr"},{"key":"10.1016\/S2213-8587(17)30233-4_bib87","doi-asserted-by":"crossref","first-page":"19","DOI":"10.5664\/jcsm.5384","article-title":"Fiber and saturated fat are associated with sleep arousals and slow wave sleep","volume":"12","author":"St-Onge","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/S2213-8587(17)30233-4_bib88","doi-asserted-by":"crossref","first-page":"E751","DOI":"10.3390\/nu8110751","article-title":"Effect of six-month diet intervention on sleep among overweight and obese men with chronic insomnia symptoms: a randomized controlled trial","volume":"8","author":"Tan","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(17)30233-4_bib89","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.5665\/sleep.3056","article-title":"Effectiveness of lifestyle interventions on obstructive sleep apnea (OSA): systematic review and meta-analysis","volume":"36","author":"Araghi","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(17)30233-4_bib90","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1001\/archinternmed.2009.266","article-title":"A randomized study on the effect of weight loss on obstructive sleep apnea among obese patients with type 2 diabetes: the Sleep AHEAD study","volume":"169","author":"Foster","year":"2009","journal-title":"Arch Intern Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30233-4_bib91","first-page":"S36","article-title":"Nutrition principles and recommendations in diabetes","volume":"27","author":"Franz","year":"2004","journal-title":"Diabetes Care"},{"issue":"supp l","key":"10.1016\/S2213-8587(17)30233-4_bib92","first-page":"S47","article-title":"6. Obesity management for the treatment of type 2 diabetes","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30233-4_bib93","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.2337\/dc12-2697","article-title":"Chronotype is independently associated with glycemic control in type 2 diabetes","volume":"36","author":"Reutrakul","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30233-4_bib94","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00424-011-1053-z","article-title":"Sleep and metabolic function","volume":"463","author":"Morselli","year":"2012","journal-title":"Pflugers Arch"},{"key":"10.1016\/S2213-8587(17)30233-4_bib95","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.smrv.2015.10.002","article-title":"Sleep disturbances compared to traditional risk factors for diabetes development: systematic review and meta-analysis","volume":"30","author":"Anothaisintawee","year":"2016","journal-title":"Sleep Med Rev"},{"key":"10.1016\/S2213-8587(17)30233-4_bib96","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jsr.12340","article-title":"A single night of partial sleep loss impairs fasting insulin sensitivity but does not affect cephalic phase insulin release in young men","volume":"25","author":"Cedernaes","year":"2016","journal-title":"J Sleep Res"},{"key":"10.1016\/S2213-8587(17)30233-4_bib97","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2337\/db14-1475","article-title":"Determinants of shortened, disrupted, and mistimed sleep and associated metabolic health consequences in healthy humans","volume":"64","author":"Cedernaes","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30233-4_bib98","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0145721711400663","article-title":"Sleep quality and quality of life in adults with type 2 diabetes","volume":"37","author":"Luyster","year":"2011","journal-title":"Diabetes Educ"},{"key":"10.1016\/S2213-8587(17)30233-4_bib99","doi-asserted-by":"crossref","first-page":"e0157579","DOI":"10.1371\/journal.pone.0157579","article-title":"Global assessment of the impact of type 2 diabetes on sleep through specific questionnaires. A case-control study","volume":"11","author":"Lecube","year":"2016","journal-title":"PLoS One"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302334?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302334?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T09:08:00Z","timestamp":1658308080000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717302334"}},"issued":{"date-parts":[[2018,1]]},"references-count":99,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2213858717302334"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30233-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aiding sleep in type 2 diabetes: therapeutic considerations","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30233-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:36:09Z","timestamp":1785825369713,"version":"3.56.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/s2213-8587(19)30197-4","type":"journal-article","created":{"date-parts":[[2019,6,7]],"date-time":"2019-06-07T10:02:14Z","timestamp":1559901734000},"page":"590-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Diabetes in humanitarian crises: the Boston Declaration"],"prefix":"10.1016","volume":"7","author":[{"given":"Sylvia","family":"Kehlenbrink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M","family":"Jaacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigiriya","family":"Aebischer Perone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9imh\u00edn","family":"Ansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Ashbourne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rifat","family":"Atun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"St\u00e9phane","family":"Besan\u00e7on","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Boulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Bygrave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrique","family":"Caballero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Cristello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Digovich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Doocy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Senan","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Ewen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dina","family":"Goodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena","family":"Hamvas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saria","family":"Hassan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meredith A.","family":"Hawkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arjan","family":"Hehenkamp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth F.","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lindsay M.","family":"Jaacks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dlorah","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Jobanputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Kayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Kehlenbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Farah","family":"Kidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Klatman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydje","family":"Lahens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Laing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Leaning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Le Feuvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Lontchi-Yimagou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Luo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gemma","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie E.","family":"McDonnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Meigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joy","family":"Moy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham","family":"Ogle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelli","family":"O'Laughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Pfiester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwan","family":"Ratnayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amulya","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayard","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khrist","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisreen","family":"Salti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacqueline","family":"Seiglie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Seita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Siesj\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Slim","family":"Slama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine J.","family":"Souris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bram","family":"Wispelwey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sydney","family":"Yovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ossama","family":"Zaqqout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30197-4_bib1","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","author":"Roth","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30197-4_bib2","series-title":"Disease control priorities, 3rd edn. Cardiovascular, respiratory, and related disorders","first-page":"209","article-title":"Diabetes: an update on the pandemic and potential solutions","author":"Ali","year":"2017"},{"key":"10.1016\/S2213-8587(19)30197-4_bib4","series-title":"The human cost of natural disasters 2015: a global perspective","year":"2015"},{"key":"10.1016\/S2213-8587(19)30197-4_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30082-8","article-title":"The burden of diabetes and use of diabetes care in humanitarian crises in low-income and middle-income countries","author":"Kehlenbrink","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30197-4_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30083-X","article-title":"Challenges associated with providing diabetes care in humanitarian settings","author":"Boulle","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30197-4_bib7","series-title":"International Conference on Refugees and Diabetes","article-title":"Conference Summary Report","year":"2017"},{"key":"10.1016\/S2213-8587(19)30197-4_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002751","article-title":"Health system performance for people with diabetes in 28 low- and middle-income countries: a cross-sectional study of nationally representative surveys","volume":"16","author":"Manne-Goehler","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(19)30197-4_bib9","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13031-017-0119-8","article-title":"Non-communicable diseases in humanitarian settings: ten essential questions","volume":"11","author":"Aebischer Perone","year":"2017","journal-title":"Confl Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301974?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301974?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:17Z","timestamp":1761991637000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301974"}},"issued":{"date-parts":[[2019,8]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S2213858719301974"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30197-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes in humanitarian crises: the Boston Declaration","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30197-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30082-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30083-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,9]],"date-time":"2026-07-09T04:24:51Z","timestamp":1783571091894,"version":"3.55.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/s2213-8587(16)00077-2","type":"journal-article","created":{"date-parts":[[2016,3,17]],"date-time":"2016-03-17T01:17:03Z","timestamp":1458177423000},"page":"381-382","source":"Crossref","is-referenced-by-count":14,"title":["Active commuting: an easy and effective way to improve health"],"prefix":"10.1016","volume":"4","author":[{"given":"Lars Bo","family":"Andersen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)00077-2_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)00053-X","article-title":"Active commuting and obesity in mid-life: cross-sectional, observational evidence from UK Biobank","author":"Flint","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00077-2_bib2","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/j.1600-0838.2011.01299.x","article-title":"Health benefits of cycling: a systematic review","volume":"21","author":"Oja","year":"2011","journal-title":"Scand J Med Sci Sports"},{"key":"10.1016\/S2213-8587(16)00077-2_bib3","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1001\/archinte.160.11.1621","article-title":"All-cause mortality associated with physical activity during leisure time, work, sports, and cycling to work","volume":"160","author":"Andersen","year":"2000","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(16)00077-2_bib4","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1136\/bmjopen-2012-001307","article-title":"Bicycling to school improves the cardiometabolic risk factor profile: a randomised controlled trial","volume":"2","author":"Ostergaard","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(16)00077-2_bib5","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1123\/jpah.8.8.1025","article-title":"Cycling to school and cardiovascular risk factors: a longitudinal study","volume":"8","author":"Andersen","year":"2011","journal-title":"J Phys Act Health"},{"key":"10.1016\/S2213-8587(16)00077-2_bib6","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1111\/j.1600-0838.1991.tb00288.x","article-title":"Physiological effects of walking and cycling to work","volume":"1","author":"Oja","year":"1991","journal-title":"Scand J Med Sci Sports"},{"key":"10.1016\/S2213-8587(16)00077-2_bib7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1056\/NEJMoa021067","article-title":"Walking compared with vigorous exercise for the prevention of cardiovascular events in women","volume":"347","author":"Manson","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00077-2_bib8","doi-asserted-by":"crossref","first-page":"1397","DOI":"10.1001\/archinte.163.12.1397","article-title":"Walking: the best medicine for diabetes?","volume":"163","author":"Hu","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(16)00077-2_bib9","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1001\/jama.292.12.1454","article-title":"Physical activity, including walking, and cognitive function in older women","volume":"292","author":"Weuve","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)00077-2_bib10","doi-asserted-by":"crossref","unstructured":"Sallis JF, Cerin E, Conway TL, et al. Physical activity in relation to urban environments in 14 cities worldwide: a cross-sectional study. Lancet (in press).","DOI":"10.1016\/S0140-6736(15)01284-2"},{"key":"10.1016\/S2213-8587(16)00077-2_bib11","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1136\/bmj.39198.722720.BE","article-title":"Interventions to promote walking: systematic review","volume":"334","author":"Ogilvie","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)00077-2_bib12","first-page":"1164","article-title":"Transportation and health. Odense\u2014The National Cycling City of Denmark, 1999\u20132002]","volume":"167","author":"Troelsen","year":"2005","journal-title":"Ugeskr Laeger"},{"key":"10.1016\/S2213-8587(16)00077-2_bib13","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0140-6736(12)60646-1","article-title":"Global physical activity levels: surveillance progress, pitfalls, and prospects","volume":"380","author":"Hallal","year":"2012","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T08:26:21Z","timestamp":1536913581000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716000772"}},"issued":{"date-parts":[[2016,5]]},"references-count":13,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S2213858716000772"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)00077-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,5]]}},{"indexed":{"date-parts":[[2026,3,19]],"date-time":"2026-03-19T12:23:41Z","timestamp":1773923021318,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/s2213-8587(16)30423-5","type":"journal-article","created":{"date-parts":[[2016,12,20]],"date-time":"2016-12-20T21:45:26Z","timestamp":1482270326000},"page":"79-81","source":"Crossref","is-referenced-by-count":1,"title":["How concerned should we be over the long-term safety of growth hormone therapy?"],"prefix":"10.1016","volume":"5","author":[{"given":"Nicholas A","family":"Tritos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30423-5_bib1","doi-asserted-by":"publisher","first-page":"544","DOI":"10.1038\/281544a0","article-title":"Direct expression in Escherichia coli of a DNA sequence coding for human growth hormone","volume":"281","author":"Goeddel","year":"1979","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)30423-5_bib2","doi-asserted-by":"publisher","first-page":"804","DOI":"10.1210\/jc.2006-2017","article-title":"Management of the child born small for gestational age through to adulthood: a consensus statement of the International Societies of Pediatric Endocrinology and the Growth Hormone Research Society","volume":"92","author":"Clayton","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30423-5_bib3","article-title":"Metabolic health of young adults who were born small for gestational age and treated with growth hormone, after cessation of growth hormone treatment: a 5-year longitudinal study","author":"van der Steen","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30423-5_bib4","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1210\/jc.2015-3019","article-title":"Adiposity in children born small for gestational age is associated with \u03b2-cell function, genetic variants for insulin resistance, and response to growth hormone treatment","volume":"101","author":"Thankamony","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30423-5_bib5","doi-asserted-by":"publisher","first-page":"P1","DOI":"10.1530\/EJE-15-0873","article-title":"GH safety workshop position paper: a critical appraisal of recombinant human GH therapy in children and adults","volume":"174","author":"Allen","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(16)30423-5_bib6","doi-asserted-by":"publisher","first-page":"880","DOI":"10.1001\/jama.1991.03460070062043","article-title":"Creutzfeldt-Jakob disease in pituitary growth hormone recipients in the United States","volume":"265","author":"Fradkin","year":"1991","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30423-5_bib7","doi-asserted-by":"publisher","first-page":"3494","DOI":"10.1210\/jc.2006-0656","article-title":"Growth hormone treatment and risk of second neoplasms in the childhood cancer survivor","volume":"91","author":"Ergun-Longmire","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30423-5_bib8","doi-asserted-by":"publisher","first-page":"980","DOI":"10.1210\/jc.2012-2684","article-title":"Prospective safety surveillance of GH-deficient adults: comparison of GH-treated vs untreated patients","volume":"98","author":"Hartman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30423-5_bib9","doi-asserted-by":"publisher","first-page":"416","DOI":"10.1210\/jc.2011-1995","article-title":"Long-term mortality after recombinant growth hormone treatment for isolated growth hormone deficiency or childhood short stature: preliminary report of the French SAGhE study","volume":"97","author":"Carel","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30423-5_bib10","doi-asserted-by":"publisher","first-page":"E213","DOI":"10.1210\/jc.2011-2882","article-title":"Long-term mortality and causes of death in isolated GHD, ISS, and SGA patients treated with recombinant growth hormone during childhood in Belgium, The Netherlands, and Sweden: preliminary report of 3 countries participating in the EU SAGhE study","volume":"97","author":"S\u00e4vendahl","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716304235?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716304235?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T14:52:26Z","timestamp":1536159146000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716304235"}},"issued":{"date-parts":[[2017,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S2213858716304235"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30423-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,2]]}},{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T11:45:55Z","timestamp":1778154355710,"version":"3.51.4"},"reference-count":15,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23 DK094866"],"award-info":[{"award-number":["K23 DK094866"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK104942"],"award-info":[{"award-number":["R01 DK104942"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/s2213-8587(18)30138-4","type":"journal-article","created":{"date-parts":[[2018,6,4]],"date-time":"2018-06-04T18:39:48Z","timestamp":1528137588000},"page":"594-595","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Precision medicine in KCNJ11 permanent neonatal diabetes"],"prefix":"10.1016","volume":"6","author":[{"given":"Siri Atma W","family":"Greeley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lisa R","family":"Letourneau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louis H","family":"Philipson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30138-4_bib1","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes","volume":"350","author":"Gloyn","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30138-4_bib2","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2337\/dc10-1616","article-title":"The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes","volume":"34","author":"Greeley","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30138-4_bib3","doi-asserted-by":"crossref","first-page":"17539","DOI":"10.1073\/pnas.0404756101","article-title":"Molecular basis of Kir6.2 mutations associated with neonatal diabetes or neonatal diabetes plus neurological features","volume":"101","author":"Proks","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(18)30138-4_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30106-2","article-title":"Effectiveness and safety of long-term treatment with sulfonylureas in patients with neonatal diabetes due to KCNJ11 mutations: an international cohort study","author":"Bowman","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30138-4_bib5","doi-asserted-by":"crossref","first-page":"629","DOI":"10.2337\/dci17-0003","article-title":"Modern sulfonylureas: dangerous or wrongly accused?","volume":"40","author":"Riddle","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30138-4_bib6","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2337\/dc16-1943","article-title":"Sulfonylureas and the risks of cardiovascular events and death: a methodological meta-regression analysis of the observational studies","volume":"40","author":"Azoulay","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30138-4_bib7","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.2337\/dc15-1358","article-title":"The use of glyburide compared with other sulfonylureas and the risk of cancer in patients with type 2 diabetes","volume":"38","author":"Tuccori","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30138-4_bib8","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30138-4_bib9","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1007\/s00125-015-3593-9","article-title":"Age at the time of sulfonylurea initiation influences treatment outcomes in KCNJ11-related neonatal diabetes","volume":"58","author":"Thurber","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30138-4_bib10","first-page":"405","article-title":"Hypoglycemia in sulfonylurea-treated KCNJ11-neonatal diabetes: mild-moderate symptomatic episodes occur infrequently but none involving unconsciousness or seizures","volume":"49","author":"Lanning","year":"2017","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(18)30138-4_bib11","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.2337\/dc11-2225","article-title":"Visuomotor performance in KCNJ11-related neonatal diabetes is impaired in children with DEND-associated mutations and may be improved by early treatment with sulfonylureas","volume":"35","author":"Shah","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30138-4_bib12","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ncpneuro0640","article-title":"Sulfonylurea improves CNS function in a case of intermediate DEND syndrome caused by a mutation in KCNJ11","volume":"3","author":"Mlynarski","year":"2007","journal-title":"Nat Clin Pract Neurol"},{"key":"10.1016\/S2213-8587(18)30138-4_bib13","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.2337\/dc12-2166","article-title":"Switching to sulphonylureas in children with iDEND syndrome caused by KCNJ11 mutations results in improved cerebellar perfusion","volume":"36","author":"Fendler","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30138-4_bib14","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2213-8587(13)70059-7","article-title":"Neuropsychological dysfunction and developmental defects associated with genetic changes in infants with neonatal diabetes mellitus: a prospective cohort study","volume":"1","author":"Busiah","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30138-4_bib15","doi-asserted-by":"crossref","first-page":"e0134476","DOI":"10.1371\/journal.pone.0134476","article-title":"Systemic administration of glibenclamide fails to achieve therapeutic levels in the brain and cerebrospinal fluid of rodents","volume":"10","author":"Lahmann","year":"2015","journal-title":"PLoS One"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301384?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301384?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:55Z","timestamp":1761991555000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301384"}},"issued":{"date-parts":[[2018,8]]},"references-count":15,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S2213858718301384"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30138-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision medicine in KCNJ11 permanent neonatal diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30138-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30106-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:11:21Z","timestamp":1778861481280,"version":"3.51.4"},"reference-count":4,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/s2213-8587(24)00190-6","type":"journal-article","created":{"date-parts":[[2024,7,23]],"date-time":"2024-07-23T18:33:10Z","timestamp":1721759590000},"page":"519","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Association of glycaemic index and glycaemic load with type 2 diabetes in the PURE study \u2013 Authors' reply"],"prefix":"10.1016","volume":"12","author":[{"given":"Victoria","family":"Miller","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David A","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00190-6_bib1","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/S2213-8587(24)00069-X","article-title":"Associations of the glycaemic index and the glycaemic load with risk of type 2 diabetes in 127\u2008594 people from 20 countries (PURE): a prospective cohort study","volume":"12","author":"Miller","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00190-6_bib2","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(18)31809-9","article-title":"Carbohydrate quality and human health: a series of systematic reviews and meta-analyses","volume":"393","author":"Reynolds","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00190-6_bib3","article-title":"Dietary Glycemic Index and Load and the Risk of Type 2 Diabetes: Assessment of Causal Relations","volume":"11","author":"Livesey","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(24)00190-6_bib4","doi-asserted-by":"crossref","first-page":"258S","DOI":"10.1093\/ajcn\/87.1.258S","article-title":"Glycemic response and health--a systematic review and meta-analysis: relations between dietary glycemic properties and health outcomes","volume":"87","author":"Livesey","year":"2008","journal-title":"Am J Clin Nutr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:49Z","timestamp":1778858749000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001906"}},"issued":{"date-parts":[[2024,8]]},"references-count":4,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2213858724001906"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00190-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of glycaemic index and glycaemic load with type 2 diabetes in the PURE study \u2013 Authors' reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00190-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00189-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00069-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:09:36Z","timestamp":1784070576931,"version":"3.55.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/s2213-8587(26)00152-x","type":"journal-article","created":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T22:53:34Z","timestamp":1781132014000},"page":"629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ethical eating: food choices that make a difference"],"prefix":"10.1016","volume":"14","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872600152X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872600152X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:48:55Z","timestamp":1784069335000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872600152X"}},"issued":{"date-parts":[[2026,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S221385872600152X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00152-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ethical eating: food choices that make a difference","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00152-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"book-review","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,16]],"date-time":"2026-04-16T17:46:37Z","timestamp":1776361597918,"version":"3.51.2"},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/s2213-8587(23)00258-9","type":"journal-article","created":{"date-parts":[[2023,9,25]],"date-time":"2023-09-25T18:53:33Z","timestamp":1695668013000},"page":"784-785","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Remission of prediabetes via lifestyle intervention"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2589-2976","authenticated-orcid":false,"given":"Michael","family":"Bergman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brenda","family":"Dorcely","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00258-9_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(23)00235-8","article-title":"Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)","author":"Sandforth","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00258-9_bib2","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"Erratum. 2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00258-9_bib3","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/s41574-019-0227-1","article-title":"Prevention begets prevention\u2014lessons from the Da Qing Study","volume":"15","author":"Dagogo-Jack","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00258-9_bib4","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","article-title":"Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study","volume":"379","author":"Perreault","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00258-9_bib5","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJMoa050080","article-title":"Normal fasting plasma glucose levels and type 2 diabetes in young men","volume":"353","author":"Tirosh","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00258-9_bib6","doi-asserted-by":"crossref","first-page":"R590","DOI":"10.1152\/ajpregu.00325.2014","article-title":"Identifying glucose thresholds for incident diabetes by physiological analysis: a mathematical solution","volume":"308","author":"Ferrannini","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/S2213-8587(23)00258-9_bib7","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/S2213-8587(23)00039-6","article-title":"Current diagnostic criteria identify risk for type 2 diabetes too late","volume":"11","author":"Bergman","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00258-9_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110839","article-title":"One-hour glucose is an earlier marker of dysglycemia than two-hour glucose","volume":"203","author":"Ha","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00258-9_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109977","article-title":"One-hour post-load glucose is associated with severity of hepatic fibrosis risk","volume":"189","author":"Jagannathan","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00258-9_bib10","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1007\/s12020-022-03109-5","article-title":"Continuous glucose monitoring and 1-h plasma glucose identifies glycemic variability and dysglycemia in high-risk individuals with HbA1c\u2008<5\u00b77%: a pilot study","volume":"77","author":"Dorcely","year":"2022","journal-title":"Endocrine"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002589?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002589?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:14Z","timestamp":1761991994000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723002589"}},"issued":{"date-parts":[[2023,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2213858723002589"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00258-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Remission of prediabetes via lifestyle intervention","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00258-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00235-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:09:47Z","timestamp":1767150587088,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(23)00256-5","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/s2213-8587(23)00362-5","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T18:59:48Z","timestamp":1701197988000},"page":"e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2023; 11: 942\u201354"],"prefix":"10.1016","volume":"12","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:04:33Z","timestamp":1741190673000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003625"}},"issued":{"date-parts":[[2024,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213858723003625"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00362-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2023; 11: 942\u201354","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00362-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00256-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T15:50:06Z","timestamp":1792684206272,"version":"4.5.0"},"reference-count":50,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2016YFC100307"],"award-info":[{"award-number":["2016YFC100307"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003995","name":"Natural Science Foundation of Anhui Province","doi-asserted-by":"publisher","award":["2308085MH287"],"award-info":[{"award-number":["2308085MH287"]}],"id":[{"id":"10.13039\/501100003995","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473722"],"award-info":[{"award-number":["82473722"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82204059"],"award-info":[{"award-number":["82204059"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/s2213-8587(25)00127-5","type":"journal-article","created":{"date-parts":[[2025,7,15]],"date-time":"2025-07-15T20:40:37Z","timestamp":1752612037000},"page":"754-764","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Parental preconception BMI and risk of adverse birth outcomes in 8 million parent\u2013child triads: a nationwide population-based cohort study in China"],"prefix":"10.1016","volume":"13","author":[{"given":"Buyun","family":"Liu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanyu","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaxin","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuxiao","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Conghui","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huaqun","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guifeng","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyi","family":"Lyu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanbin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jueming","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiyao","family":"Jin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsomo","family":"Tenzin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jihong","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuanyuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zuoqi","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ya","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongguang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiaomei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiping","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haiping","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghai","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00127-5_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","article-title":"Epidemiology and determinants of obesity in China","volume":"9","author":"Pan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib2","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S2213-8587(16)30107-3","article-title":"Influence of maternal obesity on the long-term health of offspring","volume":"5","author":"Godfrey","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib3","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2213-8587(19)30193-7","article-title":"Association between maternal pre-pregnancy obesity and preterm birth according to maternal age and race or ethnicity: a population-based study","volume":"7","author":"Liu","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S2213-8587(16)30217-0","article-title":"Preconceptional and maternal obesity: epidemiology and health consequences","volume":"4","author":"Poston","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib5","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1111\/aogs.14786","article-title":"Maternal pre-pregnancy overweight or obesity and risk of birth defects in offspring: population-based cohort study","volume":"103","author":"Liu","year":"2024","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S2213-8587(25)00127-5_bib6","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/aje\/kws134","article-title":"Parent-offspring body mass index associations in the Norwegian Mother and Child Cohort Study: a family-based approach to studying the role of the intrauterine environment in childhood adiposity","volume":"176","author":"Fleten","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(21)00798-4","article-title":"Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004\u201318","volume":"398","author":"Wang","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00127-5_bib8","doi-asserted-by":"crossref","first-page":"3390","DOI":"10.1111\/dom.15238","article-title":"Prevalence of obesity and associated complications in China: a cross-sectional, real-world study in 15.8 million adults","volume":"25","author":"Chen","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(25)00127-5_bib9","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/mrd.23660","article-title":"Paternal obesity induces epigenetic aberrations and gene expression changes in placenta and fetus","volume":"90","author":"Deshpande","year":"2023","journal-title":"Mol Reprod Dev"},{"key":"10.1016\/S2213-8587(25)00127-5_bib10","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/j.fertnstert.2010.09.038","article-title":"Paternal diet-induced obesity impairs embryo development and implantation in the mouse","volume":"95","author":"Mitchell","year":"2011","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(25)00127-5_bib11","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1186\/s12884-021-04261-y","article-title":"Association of parental pre-pregnancy BMI with neonatal outcomes and birth defect in fresh embryo transfer cycles: a retrospective cohort study","volume":"21","author":"Chen","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(25)00127-5_bib12","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.arcped.2023.01.003","article-title":"Father's weight could contribute to large babies in overweight and obese mothers with and without gestational diabetes","volume":"30","author":"Bedani","year":"2023","journal-title":"Arch Pediatr"},{"key":"10.1016\/S2213-8587(25)00127-5_bib13","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1111\/ppe.12213","article-title":"Parental body mass index, gestational weight gain, and risk of macrosomia: a population-based case-control study in China","volume":"29","author":"Yang","year":"2015","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2022.1036689","article-title":"Parental pre-pregnancy body mass index and risk of low birth weight in offspring: a prospective cohort study in central China","volume":"10","author":"Wei","year":"2022","journal-title":"Front Public Health"},{"key":"10.1016\/S2213-8587(25)00127-5_bib15","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1080\/01443615.2021.1945558","article-title":"Paternal body mass index before conception associated with offspring's birth weight in Chinese population: a prospective study","volume":"42","author":"Xu","year":"2022","journal-title":"J Obstet Gynaecol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib16","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1093\/aje\/kwk030","article-title":"Epidemiologic evidence for the fetal overnutrition hypothesis: findings from the mater-university study of pregnancy and its outcomes","volume":"165","author":"Lawlor","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib17","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11845-023-03409-3","article-title":"Association of maternal and paternal risk factors with risk of congenital heart disease in infants: a case-control study","volume":"193","author":"Dong","year":"2024","journal-title":"Ir J Med Sci"},{"key":"10.1016\/S2213-8587(25)00127-5_bib18","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.020051","article-title":"Effect of maternal pre-pregnancy\/early-pregnancy body mass index and pregnancy smoking and alcohol on congenital heart diseases: a parental negative control study","volume":"10","author":"Taylor","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(25)00127-5_bib19","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1017\/S000711452200054X","article-title":"Preconception paternal\/maternal BMI and risk of small\/large for gestational age infant in over 4\u00b77 million Chinese women aged 20\u201349 years: a population-based cohort study in China","volume":"129","author":"Guo","year":"2022","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(25)00127-5_bib20","first-page":"162","article-title":"Design of the national free proception health examination project in China","volume":"95","author":"Zhang","year":"2015","journal-title":"Zhonghua Yi Xue Za Zhi"},{"key":"10.1016\/S2213-8587(25)00127-5_bib21","doi-asserted-by":"crossref","first-page":"e624","DOI":"10.1016\/S2214-109X(17)30142-0","article-title":"Maternal pre-pregnancy infection with hepatitis B virus and the risk of preterm birth: a population-based cohort study","volume":"5","author":"Liu","year":"2017","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(25)00127-5_bib22","first-page":"83","article-title":"Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2014study on optimal cut-off points of body mass index and waist circumference in Chinese adults","volume":"15","author":"Zhou","year":"2002","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/S2213-8587(25)00127-5_bib23","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1093\/aje\/kwh090","article-title":"A modified poisson regression approach to prospective studies with binary data","volume":"159","author":"Zou","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib24","first-page":"90","article-title":"Chinese Guidelines for the Clinical Management of Obesity (2024 Edition)","volume":"16","year":"2025","journal-title":"Medical J Peking Union Medical College Hospital"},{"key":"10.1016\/S2213-8587(25)00127-5_bib25","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ije\/dyq195","article-title":"Maternal underweight and the risk of preterm birth and low birth weight: a systematic review and meta-analyses","volume":"40","author":"Han","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib26","article-title":"Assessing the relationship between pregravid body mass index and risk of adverse maternal pregnancy and neonatal outcomes: prospective data in Southwest China","volume":"11","author":"Chen","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(25)00127-5_bib27","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.ejogrb.2016.10.012","article-title":"Systematic review and meta-analysis on the association of prepregnancy underweight and miscarriage","volume":"207","author":"Balsells","year":"2016","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib28","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.ajog.2014.03.028","article-title":"Association between maternal body mass index and congenital heart defects in offspring: a systematic review","volume":"211","author":"Cai","year":"2014","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib29","first-page":"190","article-title":"Maternal underweight and obesity and risk of orofacial clefts in a large international consortium of population-based studies","volume":"46","author":"Kutbi","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib30","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.jacc.2018.10.050","article-title":"Maternal overweight and obesity and risk of congenital heart defects","volume":"73","author":"Persson","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib31","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.955544","article-title":"Association between paternal pre-pregnancy body mass index with preterm birth and low birth weight","volume":"10","author":"Sun","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/S2213-8587(25)00127-5_bib32","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1186\/s12884-020-03492-9","article-title":"Paternal factors and adverse birth outcomes in Lanzhou, China","volume":"21","author":"Li","year":"2021","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(25)00127-5_bib33","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1017\/S2040174418001162","article-title":"Paternal height has an impact on birth weight of their offspring in a Japanese population: the Japan Environment and Children's Study","volume":"10","author":"Takagi","year":"2019","journal-title":"J Dev Orig Health Dis"},{"key":"10.1016\/S2213-8587(25)00127-5_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1114250","article-title":"Effects of paternal obesity on maternal-neonatal outcomes and long-term prognosis in adolescents","volume":"14","author":"Lin","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(25)00127-5_bib35","article-title":"Effects of paternal obesity on fetal development and pregnancy complications: a prospective clinical cohort study","volume":"13","author":"Lin","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(25)00127-5_bib36","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.36157","article-title":"Preconception and early-pregnancy body mass index in women and men, time to pregnancy, and risk of miscarriage","volume":"7","author":"Boxem","year":"2024","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(25)00127-5_bib37","article-title":"Preconceptional paternal obesity may increase the risk of congenital urogenital anomalies in offspring: a case-control study","author":"Achkar","year":"2024","journal-title":"Andrology"},{"key":"10.1016\/S2213-8587(25)00127-5_bib38","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1038\/s41387-021-00172-1","article-title":"Paternal weight prior to conception and infant birthweight: a prospective cohort study","volume":"11","author":"Retnakaran","year":"2021","journal-title":"Nutr Diabetes"},{"key":"10.1016\/S2213-8587(25)00127-5_bib39","first-page":"405","article-title":"Birthweight associations with parental obesity: retrospective analysis of 1,778 singleton term births following assisted reproductive treatment","volume":"2","author":"McPherson","year":"2021","journal-title":"F S Rep"},{"key":"10.1016\/S2213-8587(25)00127-5_bib40","doi-asserted-by":"crossref","first-page":"j1","DOI":"10.1136\/bmj.j1","article-title":"Obesity and pregnancy: mechanisms of short term and long term adverse consequences for mother and child","volume":"356","author":"Catalano","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00127-5_bib41","doi-asserted-by":"crossref","first-page":"4067","DOI":"10.1093\/hmg\/ddx290","article-title":"Maternal BMI at the start of pregnancy and offspring epigenome-wide DNA methylation: findings from the pregnancy and childhood epigenetics (PACE) consortium","volume":"26","author":"Sharp","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(25)00127-5_bib42","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/AOG.0000000000000739","article-title":"Prevalence and characteristics associated with gestational weight gain adequacy","volume":"125","author":"Deputy","year":"2015","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(25)00127-5_bib43","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1111\/1471-0528.15661","article-title":"Impact of maternal body mass index and gestational weight gain on pregnancy complications: an individual participant data meta-analysis of European, North American and Australian cohorts","volume":"126","author":"Santos","year":"2019","journal-title":"BJOG"},{"key":"10.1016\/S2213-8587(25)00127-5_bib44","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.1001\/jama.2019.3820","article-title":"Association of gestational weight gain with adverse maternal and infant outcomes","volume":"321","author":"Voerman","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00127-5_bib45","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/3152173","article-title":"Epigenetic remodeling in male germline development","volume":"2016","author":"Li","year":"2016","journal-title":"Stem Cells Int"},{"key":"10.1016\/S2213-8587(25)00127-5_bib46","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1741-7015-11-29","article-title":"Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort","volume":"11","author":"Soubry","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(25)00127-5_bib47","doi-asserted-by":"crossref","first-page":"E441","DOI":"10.1152\/ajpendo.00239.2024","article-title":"Paternal obesity decreases infant MSC mitochondrial functional capacity","volume":"327","author":"Jevtovic","year":"2024","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00127-5_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2022.101463","article-title":"Sperm histone H3 lysine 4 tri-methylation serves as a metabolic sensor of paternal obesity and is associated with the inheritance of metabolic dysfunction","volume":"59","author":"Pepin","year":"2022","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(25)00127-5_bib49","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1097\/EDE.0000000000000660","article-title":"Long-term recall of pregnancy-related events","volume":"28","author":"Chin","year":"2017","journal-title":"Epidemiology"},{"key":"10.1016\/S2213-8587(25)00127-5_bib50","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1001\/jama.2021.4788","article-title":"Diagnosis and management of infertility: a review","volume":"326","author":"Carson","year":"2021","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:02:36Z","timestamp":1762610556000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725001275"}},"issued":{"date-parts":[[2025,9]]},"references-count":50,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2213858725001275"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00127-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Parental preconception BMI and risk of adverse birth outcomes in 8 million parent\u2013child triads: a nationwide population-based cohort study in China","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00127-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00170-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T22:49:07Z","timestamp":1792190947303,"version":"4.4.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/s2213-8587(13)70054-8","type":"journal-article","created":{"date-parts":[[2013,7,24]],"date-time":"2013-07-24T03:47:14Z","timestamp":1374637634000},"page":"81-82","source":"Crossref","is-referenced-by-count":20,"title":["Diabetes-related disability as a target for prevention"],"prefix":"10.1016","volume":"1","author":[{"given":"Edward W","family":"Gregg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70054-8_bib1","article-title":"Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study","author":"Lind","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70054-8_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70046-9","article-title":"Diabetes and risk of physical disability in adults: a systematic review and meta-analysis","author":"Wong","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70054-8_bib3","author":"Statistics"},{"key":"10.1016\/S2213-8587(13)70054-8_bib4","doi-asserted-by":"crossref","first-page":"e4144","DOI":"10.1371\/journal.pone.0004144","article-title":"Diabetes and the risk of multi-system aging phenotypes: a systematic review and meta-analysis","volume":"4","author":"Lu","year":"2009","journal-title":"PloS one"},{"key":"10.1016\/S2213-8587(13)70054-8_bib5","doi-asserted-by":"crossref","DOI":"10.2337\/dc12-2074","article-title":"Secular changes in the age-specific prevalence of diabetes among US adults: 1988\u20132010","author":"Cheng","year":"2013","journal-title":"Diabetes care"},{"key":"10.1016\/S2213-8587(13)70054-8_bib6","doi-asserted-by":"crossref","first-page":"554","DOI":"10.7326\/0003-4819-154-8-201104190-00007","article-title":"Individualizing glycemic targets in type 2 diabetes mellitus: implications of recent clinical trials","volume":"154","author":"Ismail-Beigi","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(13)70054-8_bib7","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa1110294","article-title":"Lifestyle change and mobility in obese adults with type 2 diabetes","volume":"366","author":"Rejeski","year":"2012","journal-title":"NEJM"},{"key":"10.1016\/S2213-8587(13)70054-8_bib9","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2337\/diacare.25.1.61","article-title":"Diabetes and incidence of functional disability in older women","volume":"25","author":"Gregg","year":"2002","journal-title":"Diabetes care"},{"key":"10.1016\/S2213-8587(13)70054-8_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700548?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700548?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T07:22:27Z","timestamp":1539501747000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700548"}},"issued":{"date-parts":[[2013,10]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S2213858713700548"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70054-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,10]]}},{"indexed":{"date-parts":[[2026,10,19]],"date-time":"2026-10-19T11:33:35Z","timestamp":1792409615772,"version":"4.4.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,25]],"date-time":"2021-10-25T00:00:00Z","timestamp":1635120000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MR\/V034057\/1"],"award-info":[{"award-number":["MR\/V034057\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000761","name":"Imperial College London","doi-asserted-by":"publisher","award":["203928\/Z\/16\/Z"],"award-info":[{"award-number":["203928\/Z\/16\/Z"]}],"id":[{"id":"10.13039\/501100000761","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000762","name":"Imperial College Healthcare NHS Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000762","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/s2213-8587(21)00288-6","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T22:02:50Z","timestamp":1638309770000},"page":"46-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records"],"prefix":"10.1016","volume":"10","author":[{"given":"Jonathan","family":"Pearson-Stuttard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling J","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Bennett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eszter P","family":"Vamos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Valabhji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda J","family":"Cross","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Majid","family":"Ezzati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00288-6_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/s41572-020-0165-1","article-title":"Diabetic ketoacidosis","volume":"6","author":"Dhatariya","year":"2020","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(21)00288-6_bib2","article-title":"The age-specific quantitative effects of metabolic risk factors on cardiovascular diseases and diabetes: a pooled analysis","volume":"8","author":"Singh","year":"2013","journal-title":"PLoS One"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00288-6_bib3","first-page":"S28","article-title":"Implications of the United Kingdom prospective diabetes study","volume":"26","author":"Genuth","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00288-6_bib4","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00288-6_bib5","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00288-6_bib6","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/S0140-6736(18)30314-3","article-title":"Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data","volume":"391","author":"Gregg","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00288-6_bib7","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2337\/dc15-2308","article-title":"Age-specific trends from 2000\u20132011 in all-cause and cause-specific mortality in type 1 and type 2 diabetes: a cohort study of more than one million people","volume":"39","author":"Harding","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00288-6_bib8","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S2213-8587(20)30431-9","article-title":"Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records","volume":"9","author":"Pearson-Stuttard","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00288-6_bib9","article-title":"Diabetic kidney disease","volume":"1","author":"Thomas","year":"2015","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(21)00288-6_bib10","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2213-8587(15)00379-4","article-title":"Diabetes and infection: assessing the association with glycaemic control in population-based studies","volume":"4","author":"Pearson-Stuttard","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00288-6_bib11","doi-asserted-by":"crossref","first-page":"734","DOI":"10.2337\/dc06-1539","article-title":"Spectrum of liver disease in type 2 diabetes and management of patients with diabetes and liver disease","volume":"30","author":"Tolman","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00288-6_bib12","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1001\/jamaneurol.2017.1658","article-title":"Associations between midlife vascular risk factors and 25-year incident dementia in the atherosclerosis risk in communities (ARIC) cohort","volume":"74","author":"Gottesman","year":"2017","journal-title":"JAMA Neurol"},{"key":"10.1016\/S2213-8587(21)00288-6_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S2213-8587(13)70192-X","article-title":"Midlife type 2 diabetes and poor glycaemic control as risk factors for cognitive decline in early old age: a post-hoc analysis of the Whitehall II cohort study","volume":"2","author":"Tuligenga","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00288-6_bib14","first-page":"350","article-title":"Type 2 diabetes and cancer: umbrella review of meta-analyses of observational studies","volume":"350","author":"Tsilidis","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00288-6_bib15","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1158\/1055-9965.EPI-20-1245","article-title":"Type 2 diabetes and cancer: an umbrella review of observational and Mendelian randomisation studies","volume":"30","author":"Pearson-Stuttard","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(21)00288-6_bib16","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: clinical practice research datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00288-6_bib17","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.3399\/bjgp10X483562","article-title":"Validity of diagnostic coding within the general practice research database: a systematic review","volume":"60","author":"Khan","year":"2010","journal-title":"Br J Gen Pract"},{"key":"10.1016\/S2213-8587(21)00288-6_bib18","doi-asserted-by":"crossref","first-page":"e191","DOI":"10.1016\/S2468-2667(17)30032-4","article-title":"Acute myocardial infarction hospital admissions and deaths in England: a national follow-back and follow-forward record-linkage study","volume":"2","author":"Asaria","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(21)00288-6_bib19","article-title":"Counting hospital activity: spells or episodes?","volume":"329","author":"Aylin","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00288-6_bib20","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.2337\/dc14-0096","article-title":"Mortality trends among people with type 1 and type 2 diabetes in Australia: 1997\u20132010","volume":"37","author":"Harding","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00288-6_bib23","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1177\/01410768211005109","article-title":"Associations between attainment of incentivised primary care indicators and emergency hospital admissions among type 2 diabetes patients: a population-based historical cohort study","volume":"114","author":"Gunn","year":"2021","journal-title":"J R Soc Med"},{"key":"10.1016\/S2213-8587(21)00288-6_bib25","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.2019.3471","article-title":"Resurgence in diabetes-related complications","volume":"321","author":"Gregg","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00288-6_bib26","doi-asserted-by":"crossref","first-page":"537","DOI":"10.7861\/clinmedicine.17-6-537","article-title":"Harveian Oration 2017: triumphs and challenges in a world shaped by medicine","volume":"17","author":"Whitty","year":"2017","journal-title":"Clin Med (Lond)"},{"key":"10.1016\/S2213-8587(21)00288-6_bib27","author":"Steventon"},{"key":"10.1016\/S2213-8587(21)00288-6_bib28","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1016\/S2468-2667(19)30222-1","article-title":"Multimorbidity-a defining challenge for health systems","volume":"4","author":"Pearson-Stuttard","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(21)00288-6_bib29","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1093\/pubmed\/fdr054","article-title":"Systematic review of discharge coding accuracy","volume":"34","author":"Burns","year":"2012","journal-title":"J Public Health (Oxf)"},{"key":"10.1016\/S2213-8587(21)00288-6_bib30","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.2337\/dc17-1583","article-title":"Trends in hospital admission for diabetic ketoacidosis in adults with type 1 and type 2 diabetes in England, 1998\u20132013: a retrospective cohort study","volume":"41","author":"Zhong","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00288-6_bib31","doi-asserted-by":"crossref","first-page":"106","DOI":"10.2337\/dc19-0653","article-title":"Trends in rates of infections requiring hospitalization among adults with versus without diabetes in the US, 2000\u20132015","volume":"43","author":"Harding","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00288-6_bib32","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d8059","article-title":"Determinants of the decline in mortality from acute myocardial infarction in England between 2002 and 2010: linked national database study","volume":"344","author":"Smolina","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00288-6_bib33","doi-asserted-by":"crossref","first-page":"265","DOI":"10.2337\/dc11-1682","article-title":"Nationwide study on trends in hospital admissions for major cardiovascular events and procedures among people with and without diabetes in England, 2004\u20132009","volume":"35","author":"Vamos","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00288-6_bib34","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1464-5491.2011.03419.x","article-title":"Miscoding, misclassification and misdiagnosis of diabetes in primary care","volume":"29","author":"de Lusignan","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00288-6_bib35","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.326.7399.1130","article-title":"Use of Read codes in diabetes management in a south London primary care group: implications for establishing disease registers","volume":"326","author":"Gray","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00288-6_bib36","author":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00288-6_bib37","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","volume":"390","year":"2017","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002886?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002886?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:03Z","timestamp":1761991803000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002886"}},"issued":{"date-parts":[[2022,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2213858721002886"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00288-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00288-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00313-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:30:08Z","timestamp":1794022208623,"version":"4.8.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/s2213-8587(14)70135-4","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T17:27:03Z","timestamp":1402939623000},"page":"678-679","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["SGLT-2 inhibitors as second-line therapy in type 2 diabetes"],"prefix":"10.1016","volume":"2","author":[{"given":"Abd A","family":"Tahrani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70135-4_bib1","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1016\/S0140-6736(11)60207-9","article-title":"Management of type 2 diabetes: new and future developments in treatment","volume":"378","author":"Tahrani","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70135-4_bib2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S2213-8587(13)70050-0","article-title":"SGLT inhibitors in management of diabetes","volume":"1","author":"Tahrani","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70135-4_bib3","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position Statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70135-4_bib4","doi-asserted-by":"crossref","first-page":"262","DOI":"10.7326\/0003-4819-159-4-201308200-00007","article-title":"Sodium-Glucose Cotransporter 2 Inhibitors for Type 2 DiabetesA Systematic Review and Meta-analysis","volume":"159","author":"Vasilakou","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(14)70135-4_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70120-2","article-title":"Comparison of empagliflozin and glimepiride as add-on to metformin in patients with type 2 diabetes: a 104-week randomised, active-controlled, double-blind, phase 3 trial","author":"Ridderstr\u00e5le","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70135-4_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1111\/dom.12189","article-title":"Dapagliflozin maintains glycaemic control while reducing weight and body fat mass over 2 years in patients with type 2 diabetes mellitus inadequately controlled on metformin","volume":"16","author":"Bolinder","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(14)70135-4_bib7","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2337\/dc11-0606","article-title":"Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial","volume":"34","author":"Nauck","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70135-4_bib8","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(13)60683-2","article-title":"Efficacy and safety of canagliflozin versus glimepiride in patients with type 2 diabetes inadequately controlled with metformin (CANTATA-SU): 52 week results from a randomised, double-blind, phase 3 non-inferiority trial","volume":"382","author":"Cefalu","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70135-4_bib9","doi-asserted-by":"crossref","first-page":"1232","DOI":"10.2337\/dc11-1926","article-title":"Dose-ranging effects of canagliflozin, a sodium-glucose cotransporter 2 inhibitor, as add-on to metformin in subjects with type 2 diabetes","volume":"35","author":"Rosenstock","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70135-4_bib10","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1111\/dom.12185","article-title":"Efficacy and safety of empagliflozin, a sodium glucose cotransporter 2 (SGLT2) inhibitor, as add-on to metformin in type 2 diabetes with mild hyperglycaemia","volume":"15","author":"Rosenstock","year":"2013","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701354?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701354?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:16Z","timestamp":1761991516000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701354"}},"issued":{"date-parts":[[2014,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S2213858714701354"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70135-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT-2 inhibitors as second-line therapy in type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70135-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70120-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T22:51:52Z","timestamp":1794005512037,"version":"4.8.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/s2213-8587(16)30042-0","type":"journal-article","created":{"date-parts":[[2016,5,12]],"date-time":"2016-05-12T22:03:00Z","timestamp":1463090580000},"page":"577-587","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":270,"title":["High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study"],"prefix":"10.1016","volume":"4","author":[{"given":"Anne","family":"Langsted","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia R","family":"Kamstrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne","family":"Benn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Tybj\u00e6rg-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f8rge G","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30042-0_bib1","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30042-0_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30042-0_bib3","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30042-0_bib4","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30042-0_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/j.1365-2796.2012.02592.x","article-title":"Lipoprotein(a): resurrected by genetics","volume":"273","author":"Kronenberg","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(16)30042-0_bib6","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30042-0_bib7","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30042-0_bib8","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1016\/0140-6736(90)91242-3","article-title":"Apolipoprotein(a) and ischaemic heart disease in familial hypercholesterolaemia","volume":"335","author":"Wiklund","year":"1990","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30042-0_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0021-9150(91)90100-H","article-title":"Lipoprotein Lp(a) in homozygous familial hypercholesterolemia: density profile, particle heterogeneity and apolipoprotein(a) phenotype","volume":"86","author":"Guo","year":"1991","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30042-0_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/sj.ejhg.5200152","article-title":"Concentrations of the atherogenic Lp(a) are elevated in FH","volume":"6","author":"Lingenhel","year":"1998","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S2213-8587(16)30042-0_bib11","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/eurheartj\/ehu085","article-title":"Efficacy and safety of evolocumab (AMG 145), a fully human monoclonal antibody to PCSK9, in hyperlipidaemic patients on various background lipid therapies: pooled analysis of 1359 patients in four phase 2 trials","volume":"35","author":"Stein","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30042-0_bib12","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30042-0_bib13","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.jacc.2013.09.038","article-title":"Elevated lipoprotein(a) and risk of aortic valve stenosis in the general population","volume":"63","author":"Kamstrup","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30042-0_bib14","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S0002-9149(03)00530-7","article-title":"Comparison of the efficacy and safety of rosuvastatin versus atorvastatin, simvastatin, and pravastatin across doses (STELLAR* Trial)","volume":"92","author":"Jones","year":"2003","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(16)30042-0_bib15","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.cca.2011.05.036","article-title":"Lipoprotein(a)-cholesterol: a significant component of serum cholesterol","volume":"412","author":"Kinpara","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2213-8587(16)30042-0_bib16","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30042-0_bib17","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/j.atherosclerosissup.2011.06.001","article-title":"Familial hypercholesterolaemia: a model of care for Australasia","volume":"12","author":"Watts","year":"2011","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/S2213-8587(16)30042-0_bib18","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","volume":"303","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)30042-0_bib19","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/0002-9149(93)90155-6","article-title":"Diagnosing heterozygous familial hypercholesterolemia using new practical criteria validated by molecular genetics","volume":"72","author":"Williams","year":"1993","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(16)30042-0_bib20","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1093\/eurheartj\/ehw028","article-title":"Mutations causative of familial hypercholesterolaemia: screening of 98\u2008098 individuals from the Copenhagen General Population Study estimated a prevalence of 1 in 217","volume":"37","author":"Benn","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30042-0_bib21","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30042-0_bib22","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1097\/MOL.0b013e3283598d81","article-title":"Emerging therapeutic agents to lower lipoprotein (a) levels","volume":"23","author":"Kolski","year":"2012","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(16)30042-0_bib23","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1172\/JCI117794","article-title":"The low density lipoprotein receptor is not required for normal catabolism of Lp(a) in humans","volume":"95","author":"Rader","year":"1995","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(16)30042-0_bib24","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30042-0_bib25","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1161\/01.ATV.0000149380.94984.f0","article-title":"Phenotype of heterozygotes for low-density lipoprotein receptor mutations identified in different background populations","volume":"25","author":"Tybjaerg-Hansen","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(16)30042-0_bib26","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1074\/jbc.M114.611988","article-title":"Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin\/kexin type 9 through the low density lipoprotein receptor","volume":"290","author":"Romagnuolo","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(16)30042-0_bib27","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM199005243222104","article-title":"Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia","volume":"322","author":"Seed","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30042-0_bib28","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients","volume":"256","author":"Jansen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(16)30042-0_bib29","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1373\/clinchem.2005.055228","article-title":"Lipoprotein(a) is an independent risk factor for cardiovascular disease in heterozygous familial hypercholesterolemia","volume":"51","author":"Holmes","year":"2005","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(16)30042-0_bib30","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1016\/S0140-6736(15)61252-1","article-title":"Antisense therapy targeting apolipoprotein(a): a randomised, double-blind, placebo-controlled phase 1 study","volume":"386","author":"Tsimikas","year":"2015","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T12:07:11Z","timestamp":1567858031000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716300420"}},"issued":{"date-parts":[[2016,7]]},"references-count":30,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S2213858716300420"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30042-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30042-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30082-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T05:06:30Z","timestamp":1794200790277,"version":"4.8.0"},"reference-count":107,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70045-7","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T23:06:28Z","timestamp":1372374388000},"page":"59-70","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":202,"title":["Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives"],"prefix":"10.1016","volume":"1","author":[{"given":"Markus J","family":"Seibel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark S","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70045-7_bib1","first-page":"181","article-title":"The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis","volume":"24","author":"Hench","year":"1949","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/S2213-8587(13)70045-7_bib2","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1136\/bmj.313.7053.344","article-title":"Use of oral corticosteroids in the community and the prevention of secondary osteoporosis: a cross sectional study","volume":"313","author":"Walsh","year":"1996","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70045-7_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/qjmed\/93.2.105","article-title":"Use of oral corticosteroids in the United Kingdom","volume":"93","author":"van Staa","year":"2000","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(13)70045-7_bib4","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.bone.2011.05.007","article-title":"Regional differences in treatment for osteoporosis","volume":"49","author":"Diez-Perez","year":"2011","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(13)70045-7_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/art.30070","article-title":"Exogenous and endogenous glucocorticoids in rheumatic diseases","volume":"63","author":"Buttgereit","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(13)70045-7_bib6","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1097\/00002281-199607000-00015","article-title":"Relationship between osteoporosis and arthritis and effect of corticosteroids and other drugs on bone","volume":"8","author":"Henderson","year":"1996","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/S2213-8587(13)70045-7_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0606","article-title":"Mechanisms of glucocorticoid-induced myopathy","volume":"197","author":"Schakman","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70045-7_bib8","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1007\/s12020-011-9580-0","article-title":"Glucocorticoid-induced osteonecrosis","volume":"41","author":"Weinstein","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(13)70045-7_bib9","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1056\/NEJM199708073370603","article-title":"Intermittent etidronate therapy to prevent corticosteroid-induced osteoporosis","volume":"337","author":"Adachi","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70045-7_bib10","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","article-title":"Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"42","author":"Cohen","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(13)70045-7_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1136\/thx.54.4.296","article-title":"Morbidity from asthma in relation to regular treatment: a community based study","volume":"54","author":"Walsh","year":"1999","journal-title":"Thorax"},{"key":"10.1016\/S2213-8587(13)70045-7_bib12","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1164\/rccm.2110047","article-title":"The impact of oral corticosteroid use on bone mineral density and vertebral fracture","volume":"166","author":"Walsh","year":"2002","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S2213-8587(13)70045-7_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s001980200108","article-title":"The epidemiology of corticosteroid-induced osteoporosis: a meta-analysis","volume":"13","author":"van Staa","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(13)70045-7_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses","volume":"39","author":"van Staa","year":"2000","journal-title":"Rheumatology (Oxford)"},{"key":"10.1016\/S2213-8587(13)70045-7_bib15","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(00)02138-3","article-title":"Inhaled corticosteroid use and bone-mineral density in patients with asthma","volume":"355","author":"Wong","year":"2000","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70045-7_bib16","doi-asserted-by":"crossref","first-page":"2485","DOI":"10.1002\/art.21194","article-title":"Longitudinal patterns in the prevention of osteoporosis in glucocorticoid-treated patients","volume":"52","author":"Curtis","year":"2005","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(13)70045-7_bib17","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1002\/jbmr.1698","article-title":"Making the first fracture the last fracture: ASBMR task force report on secondary fracture prevention","volume":"27","author":"Eisman","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib18","doi-asserted-by":"crossref","first-page":"2238","DOI":"10.1002\/jbmr.1753","article-title":"Selective glucocorticoid receptor agonists: glucocorticoid therapy with no regrets?","volume":"27","author":"Cooper","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib19","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S0083-6729(08)60646-9","article-title":"11 beta-hydroxysteroid dehydrogenase","volume":"57","author":"Stewart","year":"1999","journal-title":"Vitam Horm"},{"key":"10.1016\/S2213-8587(13)70045-7_bib20","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1359\/jbmr.2001.16.6.1037","article-title":"Modulation of 11beta-hydroxysteroid dehydrogenase isozymes by proinflammatory cytokines in osteoblasts: an autocrine switch from glucocorticoid inactivation to activation","volume":"16","author":"Cooper","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib21","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","article-title":"Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor","volume":"11","author":"Rauch","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(13)70045-7_bib22","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s00223-005-0297-z","article-title":"Impaired cortical bone acquisition and osteoblast differentiation in mice with osteoblast-targeted disruption of glucocorticoid signaling","volume":"79","author":"Sher","year":"2006","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(13)70045-7_bib23","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1210\/en.2003-0655","article-title":"Transgenic expression of 11beta-hydroxysteroid dehydrogenase type 2 in osteoblasts reveals an anabolic role for endogenous glucocorticoids in bone","volume":"145","author":"Sher","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(13)70045-7_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1242\/dev.027706","article-title":"Glucocorticoid-dependent Wnt signaling by mature osteoblasts is a key regulator of cranial skeletal development in mice","volume":"136","author":"Zhou","year":"2009","journal-title":"Development"},{"key":"10.1016\/S2213-8587(13)70045-7_bib25","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1074\/jbc.M702687200","article-title":"Osteoblasts directly control lineage commitment of mesenchymal progenitor cells through Wnt signaling","volume":"283","author":"Zhou","year":"2008","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(13)70045-7_bib26","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.bone.2009.03.673","article-title":"Endogenous glucocorticoid signaling in osteoblasts is necessary to maintain normal bone structure in mice","volume":"45","author":"Kalak","year":"2009","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(13)70045-7_bib27","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.bone.2010.06.002","article-title":"Col3.6-HSD2 transgenic mice: a glucocorticoid loss-of-function model spanning early and late osteoblast differentiation","volume":"47","author":"Yang","year":"2010","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(13)70045-7_bib28","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1016\/8756-3282(92)90364-3","article-title":"Characterization of cells with osteogenic potential from human marrow","volume":"13","author":"Haynesworth","year":"1992","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(13)70045-7_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1002\/jbmr.5650100216","article-title":"Dexamethasone alters the subpopulation make-up of rat bone marrow stromal cell cultures","volume":"10","author":"Herbertson","year":"1995","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib30","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00223-009-9303-1","article-title":"Biphasic glucocorticoid-dependent regulation of Wnt expression and its inhibitors in mature osteoblastic cells","volume":"85","author":"Mak","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(13)70045-7_bib31","doi-asserted-by":"crossref","first-page":"e63578","DOI":"10.1371\/journal.pone.0063578","article-title":"Deletion of mesenchymal glucocorticoid receptor attenuates embryonic lung development and abdominal wall closure","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70045-7_bib32","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/j.devcel.2005.03.016","article-title":"Wnt\/beta-catenin signaling in mesenchymal progenitors controls osteoblast and chondrocyte differentiation during vertebrate skeletogenesis","volume":"8","author":"Day","year":"2005","journal-title":"Dev Cell"},{"key":"10.1016\/S2213-8587(13)70045-7_bib33","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/S8756-3282(00)00344-6","article-title":"Expression and functional consequences of 11beta-hydroxysteroid dehydrogenase activity in human bone","volume":"27","author":"Cooper","year":"2000","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(13)70045-7_bib34","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1474-9726.2009.00545.x","article-title":"Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice","volume":"9","author":"Weinstein","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/S2213-8587(13)70045-7_bib35","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1359\/jbmr.2002.17.6.979","article-title":"Osteoblastic 11beta-hydroxysteroid dehydrogenase type 1 activity increases with age and glucocorticoid exposure","volume":"17","author":"Cooper","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib36","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1210\/en.2003-1427","article-title":"Mice deficient in 11beta-hydroxysteroid dehydrogenase type 1 lack bone marrow adipocytes, but maintain normal bone formation","volume":"145","author":"Justesen","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(13)70045-7_bib37","doi-asserted-by":"crossref","first-page":"692","DOI":"10.1111\/j.1365-2265.2005.02281.x","article-title":"Circulating cortisone levels are associated with biochemical markers of bone formation and lumbar spine BMD: the Hertfordshire Cohort Study","volume":"62","author":"Cooper","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(13)70045-7_bib38","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1016\/j.bone.2009.07.080","article-title":"HSD11B1 polymorphisms predicted bone mineral density and fracture risk in postmenopausal women without a clinically apparent hypercortisolemia","volume":"45","author":"Hwang","year":"2009","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(13)70045-7_bib39","doi-asserted-by":"crossref","DOI":"10.1172\/JCI64162","article-title":"11beta-hydroxysteroid dehydrogenase blockade prevents age-induced skin structure and function defects","author":"Tiganescu","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70045-7_bib40","doi-asserted-by":"crossref","first-page":"19317","DOI":"10.1073\/pnas.1105857108","article-title":"Glucocorticoid therapy of antigen-induced arthritis depends on the dimerized glucocorticoid receptor in T cells","volume":"108","author":"Baschant","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(13)70045-7_bib41","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70045-7_bib42","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O'Brien","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(13)70045-7_bib43","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1359\/JBMR.0301242","article-title":"Prevention of glucocorticoid-induced apoptosis in osteocytes and osteoblasts by calbindin-D28k","volume":"19","author":"Liu","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib44","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1002\/(SICI)1097-4644(20000301)76:3<518::AID-JCB18>3.0.CO;2-M","article-title":"Tandem repeat of C\/EBP binding sites mediates PPARgamma2 gene transcription in glucocorticoid-induced adipocyte differentiation","volume":"76","author":"Shi","year":"2000","journal-title":"J Cell Biochem"},{"key":"10.1016\/S2213-8587(13)70045-7_bib45","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1002\/jbmr.120","article-title":"Regulation of human bone marrow stromal cell proliferation and differentiation capacity by glucocorticoid receptor and AP-1 crosstalk","volume":"25","author":"Carcamo-Orive","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib46","doi-asserted-by":"crossref","first-page":"E1953","DOI":"10.1210\/jc.2012-2218","article-title":"Circulating sclerostin levels are decreased in patients with endogenous hypercortisolism and increase after treatment","volume":"97","author":"van Lierop","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70045-7_bib47","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1210\/en.2007-0910","article-title":"Modulation of Dickkopf-1 attenuates glucocorticoid induction of osteoblast apoptosis, adipocytic differentiation, and bone mass loss","volume":"149","author":"Wang","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(13)70045-7_bib48","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1007\/BF03349028","article-title":"The effect of long-term prednisone treatment on growth hormone and insulin-like growth factor-1","volume":"19","author":"Prummel","year":"1996","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(13)70045-7_bib49","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/er.20.3.345","article-title":"Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families","volume":"20","author":"Suda","year":"1999","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(13)70045-7_bib50","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1038\/nm.2448","article-title":"Matrix-embedded cells control osteoclast formation","volume":"17","author":"Xiong","year":"2011","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(13)70045-7_bib51","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/en.140.10.4382","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(13)70045-7_bib52","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/jcb.21414","article-title":"Dexamethasone promotes osteoclastogenesis by inhibiting osteoprotegerin through multiple levels","volume":"103","author":"Kondo","year":"2008","journal-title":"J Cell Biochem"},{"key":"10.1016\/S2213-8587(13)70045-7_bib53","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1210\/en.139.3.1006","article-title":"Dexamethasone promotes expression of membrane-bound macrophage colony-stimulating factor in murine osteoblast-like cells","volume":"139","author":"Rubin","year":"1998","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(13)70045-7_bib54","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","article-title":"Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density","volume":"147","author":"Jia","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(13)70045-7_bib55","doi-asserted-by":"crossref","first-page":"3874","DOI":"10.1210\/jc.2003-022025","article-title":"11beta-hydroxysteroid dehydrogenase type 1 activity predicts the effects of glucocorticoids on bone","volume":"88","author":"Cooper","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70045-7_bib56","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1136\/ard.2009.107466","article-title":"Synergistic induction of local glucocorticoid generation by inflammatory cytokines and glucocorticoids: implications for inflammation associated bone loss","volume":"69","author":"Kaur","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S2213-8587(13)70045-7_bib57","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/en.2011-1398","article-title":"11beta-hydroxysteroid dehydrogenase type 1, but not type 2, deficiency worsens acute inflammation and experimental arthritis in mice","volume":"153","author":"Coutinho","year":"2012","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(13)70045-7_bib58","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s00223-011-9512-2","article-title":"Can 11beta-hydroxysteroid dehydrogenase activity predict the sensitivity of bone to therapeutic glucocorticoids in inflammatory bowel disease?","volume":"89","author":"Cooper","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(13)70045-7_bib59","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1016\/j.cell.2007.05.047","article-title":"Endocrine regulation of energy metabolism by the skeleton","volume":"130","author":"Lee","year":"2007","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(13)70045-7_bib60","doi-asserted-by":"crossref","first-page":"4172","DOI":"10.1172\/JCI63377","article-title":"Osteoblasts mediate the adverse effects of glucocorticoids on fuel metabolism","volume":"122","author":"Brennan-Speranza","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70045-7_bib61","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1159\/000116623","article-title":"Minireview on regulation of intestinal calcium absorption. Emphasis on molecular mechanisms of transcellular pathway","volume":"77","author":"Perez","year":"2008","journal-title":"Digestion"},{"key":"10.1016\/S2213-8587(13)70045-7_bib62","first-page":"381","article-title":"Effects of glucocorticoids on calcium and phosphate excretion","volume":"171","author":"Ritz","year":"1984","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/S2213-8587(13)70045-7_bib63","doi-asserted-by":"crossref","first-page":"229","DOI":"10.7326\/0003-4819-129-3-199808010-00012","article-title":"Interactions between the hypothalamic\u2013pituitary\u2013adrenal axis and the female reproductive system: clinical implications","volume":"129","author":"Chrousos","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(13)70045-7_bib64","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.jbspin.2010.02.025","article-title":"Glucocorticoid-induced myopathy","volume":"78","author":"Pereira","year":"2011","journal-title":"Joint Bone Spine"},{"key":"10.1016\/S2213-8587(13)70045-7_bib65","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1007\/s00198-012-2073-z","article-title":"Are changes in bone mineral density different between groups of early rheumatoid arthritis patients treated according to a tight control strategy with or without prednisone if osteoporosis prophylaxis is applied?","volume":"24","author":"van der Goes","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(13)70045-7_bib66","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1136\/ard.2007.073817","article-title":"Changes in bone mineral density in patients with recent onset, active rheumatoid arthritis","volume":"67","author":"Guler-Yuksel","year":"2008","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S2213-8587(13)70045-7_bib67","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/01.RHU.0000073586.28977.31","article-title":"Incidence of nonvertebral fractures in relation to time on treatment and bone density in glucocorticoid-treated patients: a retrospective approach","volume":"9","author":"Goemaere","year":"2003","journal-title":"J Clin Rheumatol"},{"key":"10.1016\/S2213-8587(13)70045-7_bib68","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1210\/jc.2008-1578","article-title":"Age dependence of early symptomatic vertebral fracture with high-dose glucocorticoid treatment for collagen vascular diseases","volume":"94","author":"Tatsuno","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70045-7_bib69","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","article-title":"Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy","volume":"48","author":"Van Staa","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(13)70045-7_bib70","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","article-title":"A meta-analysis of prior corticosteroid use and fracture risk","volume":"19","author":"Kanis","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib71","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s001980050138","article-title":"Number and type of vertebral deformities: epidemiological characteristics and relation to back pain and height loss","volume":"9","author":"Ismail","year":"1999","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(13)70045-7_bib72","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00774-004-0596-x","article-title":"Guidelines on the management and treatment of glucocorticoid-induced osteoporosis of the Japanese Society for Bone and Mineral Research (2004)","volume":"23","author":"Nawata","year":"2005","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/S2213-8587(13)70045-7_bib73","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00198-012-1958-1","article-title":"A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis","volume":"23","author":"Lekamwasam","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(13)70045-7_bib74","doi-asserted-by":"crossref","first-page":"1515","DOI":"10.1002\/acr.20295","article-title":"American College of Rheumatology 2010 recommendations for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"62","author":"Grossman","year":"2010","journal-title":"Arthritis Care Res (Hoboken)"},{"key":"10.1016\/S2213-8587(13)70045-7_bib75","doi-asserted-by":"crossref","first-page":"5804","DOI":"10.1210\/jc.2005-0646","article-title":"Two polymorphisms in the glucocorticoid receptor gene directly affect glucocorticoid-regulated gene expression","volume":"90","author":"Russcher","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70045-7_bib76","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007146.pub2","article-title":"Interventions for preventing falls in older people living in the community","volume":"2","author":"Gillespie","year":"2009","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(13)70045-7_bib77","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/S0889-8529(05)70017-7","article-title":"The science and therapy of glucocorticoid-induced bone loss","volume":"27","author":"Lane","year":"1998","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(13)70045-7_bib78","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1002\/1529-0131(199908)42:8<1740::AID-ANR25>3.0.CO;2-E","article-title":"The role of vitamin D in corticosteroid-induced osteoporosis: a meta-analytic approach","volume":"42","author":"Amin","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(13)70045-7_bib79","doi-asserted-by":"crossref","first-page":"961","DOI":"10.7326\/0003-4819-125-12-199612150-00004","article-title":"Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial","volume":"125","author":"Buckley","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(13)70045-7_bib80","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1172\/JCI0214538","article-title":"Promotion of osteoclast survival and antagonism of bisphosphonate-induced osteoclast apoptosis by glucocorticoids","volume":"109","author":"Weinstein","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70045-7_bib81","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1172\/JCI6800","article-title":"Prevention of osteocyte and osteoblast apoptosis by bisphosphonates and calcitonin","volume":"104","author":"Plotkin","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70045-7_bib82","doi-asserted-by":"crossref","first-page":"2907","DOI":"10.1210\/jc.85.8.2907","article-title":"Apoptosis of osteocytes in glucocorticoid-induced osteonecrosis of the hip","volume":"85","author":"Weinstein","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70045-7_bib83","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1038\/ncponc0688","article-title":"Therapy insight: the risks and benefits of bisphosphonates for the treatment of tumor-induced bone disease","volume":"4","author":"Dunstan","year":"2007","journal-title":"Nat Clin Pract Oncol"},{"key":"10.1016\/S2213-8587(13)70045-7_bib84","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"373","author":"Reid","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70045-7_bib85","doi-asserted-by":"crossref","first-page":"e154","DOI":"10.1161\/CIRCULATIONAHA.105.167586","volume":"112","author":"Hunt","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70045-7_bib86","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1016\/S0140-6736(07)61342-7","article-title":"Use of calcium or calcium in combination with vitamin D supplementation to prevent fractures and bone loss in people aged 50 years and older: a meta-analysis","volume":"370","author":"Tang","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70045-7_bib87","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1359\/jbmr.2000.15.9.1645","article-title":"Corticosteroid osteoporosis: practical implications of recent trials","volume":"15","author":"Sambrook","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib88","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1056\/NEJM199306173282404","article-title":"Prevention of corticosteroid osteoporosis. A comparison of calcium, calcitriol, and calcitonin","volume":"328","author":"Sambrook","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70045-7_bib89","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1359\/jbmr.2003.18.5.919","article-title":"Prevention and treatment of glucocorticoid-induced osteoporosis: a comparison of calcitriol, vitamin D plus calcium, and alendronate plus calcium","volume":"18","author":"Sambrook","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib90","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/er.23.1.16","article-title":"Antiresorptive treatment of postmenopausal osteoporosis: comparison of study designs and outcomes in large clinical trials with fracture as an endpoint","volume":"23","author":"Marcus","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(13)70045-7_bib91","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.bone.2011.10.024","article-title":"Bisphosphonates and glucocorticoid osteoporosis in men: results of a randomized controlled trial comparing zoledronic acid with risedronate","volume":"50","author":"Sambrook","year":"2012","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(13)70045-7_bib92","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"339","author":"Saag","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70045-7_bib93","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1359\/jbmr.090216","article-title":"Ibandronate prevents bone loss and reduces vertebral fracture risk in male cardiac transplant patients: a randomized double-blind, placebo-controlled trial","volume":"24","author":"Fahrleitner-Pammer","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib94","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1007\/s00198-003-1425-0","article-title":"Intermittent intravenous ibandronate injections reduce vertebral fracture risk in corticosteroid-induced osteoporosis: results from a long-term comparative study","volume":"14","author":"Ringe","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(13)70045-7_bib95","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1-34) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70045-7_bib96","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1210\/en.2009-1488","article-title":"Intermittent parathyroid hormone administration counteracts the adverse effects of glucocorticoids on osteoblast and osteocyte viability, bone formation, and strength in mice","volume":"151","author":"Weinstein","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(13)70045-7_bib97","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1172\/JCI3914","article-title":"Parathyroid hormone treatment can reverse corticosteroid-induced osteoporosis. Results of a randomized controlled clinical trial","volume":"102","author":"Lane","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70045-7_bib98","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70045-7_bib99","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1359\/jbmr.2000.15.5.944","article-title":"Bone mass continues to increase at the hip after parathyroid hormone treatment is discontinued in glucocorticoid-induced osteoporosis: results of a randomized controlled clinical trial","volume":"15","author":"Lane","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib100","doi-asserted-by":"crossref","first-page":"141","DOI":"10.3899\/jrheum.090411","article-title":"Baseline glucocorticoid dose and bone mineral density response with teriparatide or alendronate therapy in patients with glucocorticoid-induced osteoporosis","volume":"37","author":"Devogelaer","year":"2010","journal-title":"J Rheumatol"},{"key":"10.1016\/S2213-8587(13)70045-7_bib101","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1210\/jc.83.3.801","article-title":"Corticosteroid-induced bone loss in men","volume":"83","author":"Pearce","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70045-7_bib102","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1001\/jama.282.7.637","article-title":"Reduction of vertebral fracture risk in postmenopausal women with osteoporosis treated with raloxifene: results from a 3-year randomized clinical trial","volume":"282","author":"Ettinger","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70045-7_bib103","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/ard.2010.143453","article-title":"Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial","volume":"70","author":"Mok","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S2213-8587(13)70045-7_bib104","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1136\/ard.2009.112920","article-title":"Effects of denosumab on bone mineral density and bone turnover in patients with rheumatoid arthritis receiving concurrent glucocorticoids or bisphosphonates","volume":"69","author":"Dore","year":"2010","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S2213-8587(13)70045-7_bib105","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.1074\/jbc.M109.037309","article-title":"Glucocorticoid regulation of mouse and human dual specificity phosphatase 1 (DUSP1) genes: unusual cis-acting elements and unexpected evolutionary divergence","volume":"285","author":"Tchen","year":"2010","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(13)70045-7_bib106","doi-asserted-by":"crossref","first-page":"2242","DOI":"10.1002\/jbmr.1688","article-title":"Selective glucocorticoid receptor modulation maintains bone mineral density in mice","volume":"27","author":"Thiele","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70045-7_bib107","doi-asserted-by":"crossref","first-page":"3854","DOI":"10.1172\/JCI66180","article-title":"New mechanisms of glucocorticoid-induced insulin resistance: make no bones about it","volume":"122","author":"Ferris","year":"2012","journal-title":"J Clin Invest"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700457?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700457?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,16]],"date-time":"2019-07-16T12:17:54Z","timestamp":1563279474000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700457"}},"issued":{"date-parts":[[2013,9]]},"references-count":107,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2213858713700457"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70045-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid-induced osteoporosis: mechanisms, management, and future perspectives","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70045-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T13:25:13Z","timestamp":1794230713992,"version":"4.9.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,26]],"date-time":"2018-10-26T00:00:00Z","timestamp":1540512000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"Wellcome Trust and the Royal Society","award":["grant number 107731\/Z\/15\/Z"],"award-info":[{"award-number":["grant number 107731\/Z\/15\/Z"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/s2213-8587(18)30288-2","type":"journal-article","created":{"date-parts":[[2018,10,30]],"date-time":"2018-10-30T23:32:22Z","timestamp":1540942342000},"page":"944-953","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1133,"title":["Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3\u00b76 million adults in the UK"],"prefix":"10.1016","volume":"6","author":[{"given":"Krishnan","family":"Bhaskaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"dos-Santos-Silva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Leon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian J","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Smeeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30288-2_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30288-2_bib2","doi-asserted-by":"crossref","first-page":"i2156","DOI":"10.1136\/bmj.i2156","article-title":"BMI and all cause mortality: systematic review and non-linear dose-response meta-analysis of 230 cohort studies with 3\u00b774 million deaths among 30\u00b73 million participants","volume":"353","author":"Aune","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30288-2_bib3","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1056\/NEJMoa1000367","article-title":"Body-mass index and mortality among 1\u00b746 million white adults","volume":"363","author":"Berrington de Gonzalez","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30288-2_bib4","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","article-title":"Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30288-2_bib5","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900\u2008000 adults: collaborative analyses of 57 prospective studies","volume":"373","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30288-2_bib6","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2012.113905","article-title":"Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis","volume":"309","author":"Flegal","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30288-2_bib7","first-page":"428","article-title":"The big fat truth","volume":"497","author":"Hughes","year":"2013","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(18)30288-2_bib8","doi-asserted-by":"crossref","first-page":"b5043","DOI":"10.1136\/bmj.b5043","article-title":"The association between BMI and mortality using offspring BMI as an indicator of own BMI: large intergenerational mortality study","volume":"339","author":"Davey Smith","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30288-2_bib9","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s10654-012-9758-7","article-title":"Body mass index, smoking, and risk of death between 40 and 70 years of age in a Norwegian cohort of 32,727 women and 33,475 men","volume":"28","author":"Hjellvik","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(18)30288-2_bib10","doi-asserted-by":"crossref","first-page":"d3785","DOI":"10.1136\/bmj.d3785","article-title":"Cause specific mortality, social position, and obesity among women who had never smoked: 28 year cohort study","volume":"342","author":"Hart","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30288-2_bib11","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S1470-2045(10)70141-8","article-title":"Body-mass index and cancer mortality in the Asia-Pacific Cohort Studies Collaboration: pooled analyses of 424,519 participants","volume":"11","author":"Parr","year":"2010","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(18)30288-2_bib12","doi-asserted-by":"crossref","first-page":"e003389","DOI":"10.1136\/bmjopen-2013-003389","article-title":"Representativeness and optimal use of body mass index (BMI) in the UK Clinical Practice Research Datalink (CPRD)","volume":"3","author":"Bhaskaran","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(18)30288-2_bib13","first-page":"S230","article-title":"Linkage of the General Practice Research Database (GPRD) with other data sources","volume":"20","author":"Gallagher","year":"2011","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/S2213-8587(18)30288-2_bib14","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data Resource Profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(18)30288-2_bib15","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/pubmed\/fdt116","article-title":"Completeness and usability of ethnicity data in UK-based primary care and hospital databases","volume":"36","author":"Mathur","year":"2014","journal-title":"J Public Health"},{"key":"10.1016\/S2213-8587(18)30288-2_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age-sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30288-2_bib17","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1016\/S0140-6736(15)00195-6","article-title":"Changes in health in England, with analysis by English regions and areas of deprivation, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","author":"Newton","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30288-2_bib18","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1093\/ije\/dyr213","article-title":"Competing risks in epidemiology: possibilities and pitfalls","volume":"41","author":"Andersen","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(18)30288-2_bib19","series-title":"WHO technical report series 894: Obesity\u2014preventing and managing the global epidemic\u2014report of a WHO consultation","year":"2000"},{"key":"10.1016\/S2213-8587(18)30288-2_bib21","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/j.annepidem.2014.11.010","article-title":"Estimating population attributable fractions to quantify the health burden of obesity","volume":"25","author":"Flegal","year":"2015","journal-title":"Ann Epidemiol"},{"key":"10.1016\/S2213-8587(18)30288-2_bib22","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1093\/ije\/28.5.964","article-title":"The use of fractional polynomials to model continuous risk variables in epidemiology","volume":"28","author":"Royston","year":"1999","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(18)30288-2_bib24","doi-asserted-by":"crossref","first-page":"1450","DOI":"10.1038\/ijo.2011.268","article-title":"Body mass index versus waist circumference as predictors of mortality in Canadian adults","volume":"36","author":"Staiano","year":"2012","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(18)30288-2_bib25","doi-asserted-by":"crossref","first-page":"e0180818","DOI":"10.1371\/journal.pone.0180818","article-title":"Age-dependent relationships between body mass index and mortality: Singapore longitudinal ageing study","volume":"12","author":"Ng","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30288-2_bib26","doi-asserted-by":"crossref","first-page":"2920","DOI":"10.1002\/sim.3944","article-title":"Bias and efficiency of multiple imputation compared with complete-case analysis for missing covariate values","volume":"29","author":"White","year":"2010","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(18)30288-2_bib27","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1093\/ije\/dyu080","article-title":"What is the difference between missing completely at random and missing at random?","volume":"43","author":"Bhaskaran","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(18)30288-2_bib28","series-title":"Guidance for doctors completing medical certificates of cause of death in England and Wales","year":"2010"},{"key":"10.1016\/S2213-8587(18)30288-2_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.pcad.2017.03.001","article-title":"Impact of cardiorespiratory fitness on all-cause and disease-specific mortality: advances since 2009","volume":"60","author":"Harber","year":"2017","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(18)30288-2_bib30","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.pcad.2017.01.004","article-title":"Epidemiology of physical activity and exercise training in the United States","volume":"60","author":"Katzmarzyk","year":"2017","journal-title":"Prog Cardiovasc Dis"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302882?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302882?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T05:12:34Z","timestamp":1550553154000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302882"}},"issued":{"date-parts":[[2018,12]]},"references-count":28,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2213858718302882"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30288-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3\u00b76 million adults in the UK","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30288-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30309-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T12:55:57Z","timestamp":1793105757577,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/s2213-8587(17)30438-2","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T18:43:16Z","timestamp":1513795396000},"page":"186-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":242,"title":["Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Michael","family":"Edmonds","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 Luis","family":"L\u00e1zaro-Mart\u00ednez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus Manuel","family":"Alfayate-Garc\u00eda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Martini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Michel","family":"Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Rayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Lobmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Uccioli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Sauvadet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Bohbot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Charles","family":"Kerihuel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Piaggesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30438-2_bib1","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.1056\/NEJMra1615439","article-title":"Diabetic foot ulcers and their recurrence","volume":"376","author":"Armstrong","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30438-2_bib3","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/14737167.2017.1305891","article-title":"Losing a foot versus losing a dollar; a systematic review of cost studies in diabetic foot complications","volume":"17","author":"Petrakis","year":"2017","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30438-2_bib4","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/dmrr.2694","article-title":"The 2015 IWGDF guidance documents on prevention and management of foot problems in diabetes: development of an evidence-based global consensus","volume":"32","author":"Bakker","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(17)30438-2_bib5","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1111\/dme.13054","article-title":"Association of diabetic foot ulcer and death in a population-based cohort from the United Kingdom","volume":"33","author":"Walsh","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(17)30438-2_bib7","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1111\/wrr.12391","article-title":"WHS guidelines update: diabetic foot ulcer treatment guidelines","volume":"24","author":"Lavery","year":"2016","journal-title":"Wound Repair Regen"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30438-2_bib8","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1002\/dmrr.2695","article-title":"Prevention and management of foot problems in diabetes: a summary guidance for daily practice 2015 based on the IWGDF Guidance Documents","volume":"32","author":"Schaper","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(17)30438-2_bib9","article-title":"Dressings for treating foot ulcers in people with diabetes: an overview of systematic reviews","volume":"7","author":"Wu","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(17)30438-2_bib10","doi-asserted-by":"crossref","first-page":"158S","DOI":"10.1097\/PRS.0000000000002681","article-title":"Dressing and diabetic foot ulcers: a current review of the evidence","volume":"138","author":"Game","year":"2016","journal-title":"Plast Reconstr Surg"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30438-2_bib11","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1002\/dmrr.2707","article-title":"Effectiveness of interventions to enhance healing of chronic ulcers of the foot in diabetes: a systematic review","volume":"32","author":"Game","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(17)30438-2_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s00125-006-0491-1","article-title":"High prevalence of ischaemia, infection and serious comorbidity in patients with diabetic foot disease in Europe: baseline results from the Eurodiale study","volume":"50","author":"Prompers","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30438-2_bib13","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1007\/s00125-008-1226-2","article-title":"Complexity of factors related to outcome of neuropathic and neuroischaemic\/ischaemic diabetic foot ulcers: a cohort study","volume":"52","author":"Gershater","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30438-2_bib14","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1177\/193229681100500636","article-title":"Diabetic foot ulcers and vascular insufficiency: our population has changed, but our methods have not","volume":"5","author":"Armstrong","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(17)30438-2_bib15","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1177\/2042018813489719","article-title":"Improving major amputation rates in the multicomplex diabetic foot patient: focus on the severity of peripheral arterial disease","volume":"4","author":"Brechow","year":"2013","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30438-2_bib16","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1111\/j.1365-2796.2004.01431.x","article-title":"Abnormal circulating levels of metalloprotease 9 and its tissue inhibitor 1 in angiographically proven peripheral arterial disease: relationship to disease severity","volume":"257","author":"Tayebjee","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(17)30438-2_bib17","doi-asserted-by":"crossref","first-page":"277","DOI":"10.12968\/jowc.2016.25.5.277","article-title":"Elevated levels of matrix metalloproteinases and chronic wound healing: an updated review of clinical evidence","volume":"25","author":"Lazaro","year":"2016","journal-title":"J Wound Care"},{"key":"10.1016\/S2213-8587(17)30438-2_bib18","doi-asserted-by":"crossref","first-page":"2937","DOI":"10.2337\/db12-0227","article-title":"Mechanisms involved in the development and healing of diabetic foot ulceration","volume":"61","author":"Dinh","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30438-2_bib19","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.3760\/cma.j.issn.0366-6999.20131179","article-title":"Role of matrix metalloproteinases in chronic wound healing: diagnostic and therapeutic implications","volume":"127","author":"Ren","year":"2014","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/S2213-8587(17)30438-2_bib20","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2337\/dc08-0763","article-title":"Increased matrix metalloproteinase-9 predicts poor wound healing in diabetic foot ulcers","volume":"32","author":"Liu","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30438-2_bib21","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1007\/s00592-013-0478-6","article-title":"Expression of tissue inhibitor of metalloprotease 3 is reduced in ischemic but not neuropathic ulcers from patients with type 2 diabetes mellitus","volume":"50","author":"Menghini","year":"2013","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(17)30438-2_bib22","series-title":"Supporting evidence-based practice: a clinical review of TLC healing matrix","author":"White","year":"2015"},{"key":"10.1016\/S2213-8587(17)30438-2_bib23","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/0167-4838(93)90031-L","article-title":"Sucralfate and soluble sucrose octasulfate bind and stabilize acidic fibroblast growth factor","volume":"1203","author":"Volkin","year":"1993","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S2213-8587(17)30438-2_bib24","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1107\/S174430910801066X","article-title":"Dimerization effect of sucrose octasulfate on rat FGF1","volume":"64","author":"Kulahin","year":"2008","journal-title":"Acta Crystallogr Sect F Struct Biol Cryst Commun"},{"key":"10.1016\/S2213-8587(17)30438-2_bib25","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/j.1524-475X.2012.00797.x","article-title":"A randomized, controlled, double-blind prospective trial with a lipido-colloid technology-nano-oligosaccharide factor wound dressing in the local management of venous leg ulcers","volume":"20","author":"Meaume","year":"2012","journal-title":"Wound Repair Regen"},{"key":"10.1016\/S2213-8587(17)30438-2_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1111\/j.1742-481X.2008.00453.x","article-title":"Evaluation of the nano-oligosaccharide factor lipido-colloid matrix in the local management of venous leg ulcers: results of a randomised, controlled trial","volume":"5","author":"Schmutz","year":"2008","journal-title":"Int Wound J"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(17)30438-2_bib27","doi-asserted-by":"crossref","first-page":"4","DOI":"10.12968\/jowc.2017.26.Sup2.S4","article-title":"The reality of routine practice: a pooled data analysis on chronic wounds treated with TLC-NOSF wound dressings","volume":"26","author":"M\u00fcnter","year":"2017","journal-title":"J Wound Care"},{"key":"10.1016\/S2213-8587(17)30438-2_bib28","doi-asserted-by":"crossref","first-page":"78","DOI":"10.12968\/jowc.2013.22.2.78","article-title":"The Explorer study: the first double-blind RCT to assess the efficacy of TLC-NOSF on DFUs","volume":"22","author":"Shanahan","year":"2013","journal-title":"J Wound Care"},{"key":"10.1016\/S2213-8587(17)30438-2_bib29","doi-asserted-by":"crossref","first-page":"855","DOI":"10.2337\/diacare.21.5.855","article-title":"Validation of a diabetic wound classification system. The contribution of depth, infection, and ischemia to risk of amputation","volume":"21","author":"Armstrong","year":"1998","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30438-2_bib30","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1002\/dmrr.2251","article-title":"Specific guidelines for the treatment of diabetic foot infections 2011","volume":"28","author":"Lipsky","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(17)30438-2_bib31","first-page":"349","article-title":"Role of endovascular intervention in patients with diabetic foot ulcer and concomitant peripheral arterial disease","volume":"30","author":"Claesson","year":"2011","journal-title":"Int Angiol"},{"key":"10.1016\/S2213-8587(17)30438-2_bib33","doi-asserted-by":"crossref","first-page":"e0177176","DOI":"10.1371\/journal.pone.0177176","article-title":"Severity and duration of diabetic foot ulcer (DFU) before seeking care as predictors of healing time: a retrospective cohort study","volume":"12","author":"Smith-Str\u00f8m","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30438-2_bib34","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2213-8587(16)30012-2","article-title":"Reporting standards of studies and papers on the prevention and management of foot ulcers in diabetes: required details and markers of good quality","volume":"4","author":"Jeffcoate","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30438-2_bib35","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1089\/wound.2014.0571","article-title":"Quality randomized clinical trials of topical diabetic foot ulcer healing agents","volume":"5","author":"Bolton","year":"2016","journal-title":"Adv Wound Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30438-2_bib36","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1002\/dmrr.2700","article-title":"IWGDF guidance on use of interventions to enhance the healing of chronic ulcers of the foot in diabetes","volume":"32","author":"Game","year":"2016","journal-title":"Diabetes Metab Res Rev"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(18)30082-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,29]],"date-time":"2024-06-29T19:11:02Z","timestamp":1719688262000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717304382"}},"issued":{"date-parts":[[2018,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2213858717304382"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30438-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sucrose octasulfate dressing versus control dressing in patients with neuroischaemic diabetic foot ulcers (Explorer): an international, multicentre, double-blind, randomised, controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30438-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30439-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:43:19Z","timestamp":1793299399929,"version":"4.5.0"},"reference-count":101,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/s2213-8587(17)30434-5","type":"journal-article","created":{"date-parts":[[2018,1,29]],"date-time":"2018-01-29T18:35:23Z","timestamp":1517250923000},"page":"487-499","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":54,"title":["Optimisation of follow-up after metabolic surgery"],"prefix":"10.1016","volume":"6","author":[{"given":"Geltrude","family":"Mingrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carel W","family":"Le Roux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30434-5_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S2213-8587(16)30162-0","article-title":"Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial","volume":"4","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30434-5_bib2","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s11695-015-1657-z","article-title":"Bariatric surgery worldwide 2013","volume":"25","author":"Angrisani","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib3","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1007\/s11695-017-2666-x","article-title":"Bariatric surgery and endoluminal procedures: IFSO worldwide survey 2014","volume":"27","author":"Angrisani","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sj\u00f6str\u00f6m","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30434-5_bib5","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-term mortality after gastric bypass surgery","volume":"357","author":"Adams","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30434-5_bib6","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMoa035622","article-title":"Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery","volume":"351","author":"Sj\u00f6str\u00f6m","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30434-5_bib7","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1001\/jamasurg.2015.1250","article-title":"Patient and referring practitioner characteristics associated with the likelihood of undergoing bariatric surgery: a systematic review","volume":"150","author":"Funk","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib8","article-title":"Effects of bariatric surgery in obese patients with hypertension: the GATEWAY randomized trial (gastric bypass to treat obese patients with steady hypertension)","author":"Schiavon","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30434-5_bib9","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.metabol.2015.12.013","article-title":"Guidelines on vitamin D replacement in bariatric surgery: identification and systematic appraisal","volume":"65","author":"Chakhtoura","year":"2016","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(17)30434-5_bib10","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamasurg.2013.3654","article-title":"The effectiveness and risks of bariatric surgery: an updated systematic review and meta-analysis, 2003\u20132012","volume":"149","author":"Chang","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib11","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.soard.2016.12.005","article-title":"ASMBS position statement on postprandial hyperinsulinemic hypoglycemia after bariatric surgery","volume":"13","author":"Eisenberg","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(17)30434-5_bib12","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/SLA.0000000000001622","article-title":"Long-term (>10 yrs) outcome of the laparoscopic biliopancreatic diversion with duodenal switch","volume":"264","author":"Bolckmans","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib13","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1097\/SLA.0000000000001775","article-title":"Increased esophageal exposure to weakly acidic reflux 5 years after laparoscopic-en-Y gastric bypass","volume":"264","author":"Rebecchi","year":"2016","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib14","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/j.amjsurg.2010.05.007","article-title":"Abdominal pain after gastric bypass: suspects and solutions","volume":"201","author":"Greenstein","year":"2011","journal-title":"Am J Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib15","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","article-title":"Bariatric surgery versus intensive medical therapy in obese patients with diabetes","volume":"366","author":"Schauer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30434-5_bib16","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa1401329","article-title":"Bariatric surgery versus intensive medical therapy for diabetes\u20143-year outcomes","volume":"370","author":"Schauer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30434-5_bib17","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes\u20145-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30434-5_bib18","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1200111","article-title":"Bariatric surgery versus conventional medical therapy for type 2 diabetes","volume":"366","author":"Mingrone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30434-5_bib19","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0140-6736(15)00075-6","article-title":"Bariatric-metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial","volume":"386","author":"Mingrone","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30434-5_bib20","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/jama.2013.5835","article-title":"Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial","volume":"309","author":"Ikramuddin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30434-5_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S2213-8587(15)00089-3","article-title":"Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial","volume":"3","author":"Ikramuddin","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30434-5_bib22","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1001\/jamasurg.2014.467","article-title":"Surgical vs medical treatments for type 2 diabetes mellitus: a randomized clinical trial","volume":"149","author":"Courcoulas","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib23","first-page":"80","article-title":"Protein malnutrition incidence comparison after gastric bypass versus biliopancreatic diversion","volume":"32","author":"Su\u00e1rez Llanos","year":"2015","journal-title":"Nutr Hosp"},{"key":"10.1016\/S2213-8587(17)30434-5_bib24","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1007\/s11695-015-1676-9","article-title":"Risk of malnutrition, trace metal, and vitamin deficiency post Roux-en-Y gastric bypass\u2014a prospective study of 20 patients with BMI < 35 kg\/m2","volume":"25","author":"Billeter","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib25","doi-asserted-by":"crossref","first-page":"506","DOI":"10.3945\/an.113.004341","article-title":"Mineral malnutrition following bariatric surgery","volume":"4","author":"Gletsu-Miller","year":"2013","journal-title":"Adv Nutr"},{"key":"10.1016\/S2213-8587(17)30434-5_bib26","doi-asserted-by":"crossref","first-page":"2316","DOI":"10.1007\/s11695-016-2098-z","article-title":"Medium-term results of combined laparoscopic sleeve gastrectomy and modified jejuno-ileal bypass in bariatric surgery","volume":"26","author":"Hassn","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib27","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.1007\/s11695-010-0237-5","article-title":"Zinc deficiency: a frequent and underestimated complication after bariatric surgery","volume":"20","author":"Sall\u00e9","year":"2010","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib28","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1177\/0884533615570376","article-title":"Zinc: physiology, deficiency, and parenteral nutrition","volume":"30","author":"Livingstone","year":"2015","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/S2213-8587(17)30434-5_bib29","first-page":"G376","article-title":"Regional specificity of iron uptake by small intestinal brush-border membranes from normal and iron-deficient mice","volume":"248","author":"Muir","year":"1985","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(17)30434-5_bib30","doi-asserted-by":"crossref","first-page":"810","DOI":"10.3945\/ajcn.112.039255","article-title":"Heme- and nonheme-iron absorption and iron status 12 mo after sleeve gastrectomy and Roux-en-Y gastric bypass in morbidly obese women","volume":"96","author":"Ruz","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30434-5_bib31","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.3390\/nu5051595","article-title":"Iron deficiency and bariatric surgery","volume":"5","author":"J\u00e1uregui-Lobera","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(17)30434-5_bib32","doi-asserted-by":"crossref","first-page":"f5934","DOI":"10.1136\/bmj.f5934","article-title":"Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials","volume":"347","author":"Gloy","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30434-5_bib33","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1159\/000366012","article-title":"Beriberi, a severe complication after metabolic surgery\u2014review of the literature","volume":"7","author":"Stroh","year":"2014","journal-title":"Obes Facts"},{"key":"10.1016\/S2213-8587(17)30434-5_bib34","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1146\/annurev-physiol-020911-153251","article-title":"The intestinal absorption of folates","volume":"76","author":"Visentin","year":"2014","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/S2213-8587(17)30434-5_bib35","first-page":"489","article-title":"The role of the pancreas in cobalamin (vitamin B12) absorption","volume":"79","author":"Herzlich","year":"1984","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(17)30434-5_bib36","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1002\/pd.4023","article-title":"Fetal neural tube defects in pregnant women previously submitted to bariatric surgery: more attention to a new emerging entity","volume":"33","author":"Pelizzo","year":"2013","journal-title":"Prenat Diagn"},{"key":"10.1016\/S2213-8587(17)30434-5_bib37","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00431-009-1005-1","article-title":"Maternal bariatric surgery: adverse outcomes in neonates","volume":"169","author":"Eerdekens","year":"2010","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(17)30434-5_bib38","first-page":"1114","article-title":"Bile salt deficiency and the absorption of vitamin D metabolites. In vivo study in the rat","volume":"23","author":"Maislos","year":"1987","journal-title":"Isr J Med Sci"},{"key":"10.1016\/S2213-8587(17)30434-5_bib39","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1007\/s11695-017-2557-1","article-title":"Evaluation of vitamin and trace element requirements after sleeve gastrectomy at long term","volume":"27","author":"Pellitero","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib40","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1177\/0884533614546888","article-title":"Vitamin D status following bariatric surgery: implications and recommendations","volume":"29","author":"Cole","year":"2014","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/S2213-8587(17)30434-5_bib41","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.jsbmb.2016.12.012","article-title":"Vitamin D and intestinal calcium transport after bariatric surgery","volume":"173","author":"Schafer","year":"2017","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S2213-8587(17)30434-5_bib42","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s11695-009-0028-z","article-title":"Chronic increase of bone turnover markers after biliopancreatic diversion is related to secondary hyperparathyroidism and weight loss. Relation with bone mineral density","volume":"20","author":"Balsa","year":"2010","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib43","doi-asserted-by":"crossref","first-page":"420","DOI":"10.3945\/an.114.008086","article-title":"Maternal micronutrient deficiencies and related adverse neonatal outcomes after bariatric surgery: a systematic review","volume":"6","author":"Jans","year":"2015","journal-title":"Adv Nutr"},{"key":"10.1016\/S2213-8587(17)30434-5_bib44","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/AOG.0b013e3181649e7b","article-title":"Fetal cerebral hemorrhage caused by vitamin K deficiency after complicated bariatric surgery","volume":"112","author":"Van Mieghem","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(17)30434-5_bib45","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1530\/EJE-17-0014","article-title":"Bone structural changes after gastric bypass surgery evaluated by HR-pQCT: a two-year longitudinal study","volume":"176","author":"Shanbhogue","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(17)30434-5_bib46","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s00198-013-2463-x","article-title":"Fracture risk following bariatric surgery: a population-based study","volume":"25","author":"Nakamura","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(17)30434-5_bib47","doi-asserted-by":"crossref","first-page":"i3794","DOI":"10.1136\/bmj.i3794","article-title":"Change in fracture risk and fracture pattern after bariatric surgery: nested case-control study","volume":"354","author":"Rousseau","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30434-5_bib48","doi-asserted-by":"crossref","first-page":"e5085","DOI":"10.1136\/bmj.e5085","article-title":"Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study","volume":"345","author":"Lalmohamed","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30434-5_bib49","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1111\/obr.12467","article-title":"Dumping syndrome after esophageal, gastric or bariatric surgery: pathophysiology, diagnosis, and management","volume":"18","author":"van Beek","year":"2017","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30434-5_bib50","doi-asserted-by":"crossref","first-page":"3600","DOI":"10.1210\/jc.2016-1143","article-title":"Risk factors for spontaneously self-reported postprandial hypoglycemia after bariatric surgery","volume":"101","author":"Nannipieri","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30434-5_bib51","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.soard.2011.11.023","article-title":"Abnormal glucose tolerance testing after gastric bypass","volume":"9","author":"Roslin","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(17)30434-5_bib52","doi-asserted-by":"crossref","first-page":"1600","DOI":"10.1007\/s11695-012-0711-3","article-title":"Dumping symptoms and incidence of hypoglycaemia after provocation test at 6 and 12 months after laparoscopic sleeve gastrectomy","volume":"22","author":"Papamargaritis","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib53","doi-asserted-by":"crossref","first-page":"1220","DOI":"10.1016\/j.soard.2014.01.010","article-title":"Postprandial hyperinsulinemic hypoglycemia after gastric bypass surgical treatment","volume":"10","author":"Mala","year":"2014","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(17)30434-5_bib54","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1038\/ki.2014.352","article-title":"Kidney stones are common after bariatric surgery","volume":"87","author":"Lieske","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30434-5_bib55","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1053\/j.gastro.2017.01.004","article-title":"Steatorrhea and hyperoxaluria in severely obese patients before and after Roux-en-Y gastric bypass","volume":"152","author":"Moreland","year":"2017","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(17)30434-5_bib56","doi-asserted-by":"crossref","first-page":"424","DOI":"10.3109\/0886022X.2015.1137186","article-title":"The risk of kidney stones following bariatric surgery: a systematic review and meta-analysis","volume":"38","author":"Thongprayoon","year":"2016","journal-title":"Ren Fail"},{"key":"10.1016\/S2213-8587(17)30434-5_bib57","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/obr.12052","article-title":"A systematic review of variables associated with the relationship between obesity and depression","volume":"14","author":"Preiss","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30434-5_bib58","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.amjmed.2010.06.016","article-title":"Risk of suicide after long-term follow-up from bariatric surgery","volume":"123","author":"Tindle","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(17)30434-5_bib59","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1001\/jama.2015.18118","article-title":"Mental health conditions among patients seeking and undergoing bariatric surgery: a meta-analysis","volume":"315","author":"Dawes","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30434-5_bib60","first-page":"348","article-title":"Developing clinical guidelines","volume":"170","author":"Shekelle","year":"1999","journal-title":"West J Med"},{"key":"10.1016\/S2213-8587(17)30434-5_bib61","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.soard.2009.01.010","article-title":"SAGES guideline for clinical application of laparoscopic bariatric surgery","volume":"5","year":"2009","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(17)30434-5_bib62","doi-asserted-by":"crossref","first-page":"g6608","DOI":"10.1136\/bmj.g6608","article-title":"Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance","volume":"349","author":"Stegenga","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30434-5_bib63","first-page":"487S","article-title":"Proceedings of a National Institutes of Health consensus development conference. March 25\u201327, 1991, Bethesda, MD","volume":"55","year":"1992","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30434-5_bib64","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1097\/01.MIB.0000165113.33557.3a","article-title":"Crohn's disease after gastric bypass surgery for morbid obesity: is there an association?","volume":"11","author":"Ahn","year":"2005","journal-title":"Inflamm Bowel Dis"},{"key":"10.1016\/S2213-8587(17)30434-5_bib65","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1007\/s11695-010-0201-4","article-title":"Bariatric surgery outcomes in patients aged 65 years and older at an American Society for Metabolic and Bariatric Surgery Center of Excellence","volume":"20","author":"O'Keefe","year":"2010","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib66","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1111\/obr.12425","article-title":"Changes in problematic and disordered eating after gastric bypass, adjustable gastric banding and vertical sleeve gastrectomy: a systematic review of pre-post studies","volume":"17","author":"Opozda","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30434-5_bib67","doi-asserted-by":"crossref","first-page":"23","DOI":"10.3389\/fendo.2012.00023","article-title":"Bariatric surgery in hypothalamic obesity","volume":"3","author":"Bingham","year":"2012","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(17)30434-5_bib68","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1038\/ajg.2012.444","article-title":"Guidelines for the diagnosis and management of gastroesophageal reflux disease","volume":"108","author":"Katz","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(17)30434-5_bib69","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1111\/j.1572-0241.1999.01360.x","article-title":"Association of Helicobacter pylori infection with gastric carcinoma: a meta-analysis","volume":"94","author":"Eslick","year":"1999","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(17)30434-5_bib70","first-page":"e418","volume":"116","author":"Fleisher","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30434-5_bib71","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1503\/cmaj.050011","article-title":"Perioperative cardiac events in patients undergoing noncardiac surgery: a review of the magnitude of the problem, the pathophysiology of the events and methods to estimate and communicate risk","volume":"173","author":"Devereaux","year":"2005","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(17)30434-5_bib72","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/S0735-1097(01)01788-0","volume":"39","author":"Eagle","year":"2002","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30434-5_bib73","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.5664\/jcsm.5948","article-title":"Patient partnerships transforming sleep medicine research and clinical care: perspectives from the Sleep Apnea Patient-Centered Outcomes Network","volume":"12","author":"Redline","year":"2016","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/S2213-8587(17)30434-5_bib74","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1001\/jama.2016.19635","article-title":"Screening for obstructive sleep apnea in adults: evidence report and systematic review for the US Preventive Services Task Force","volume":"317","author":"Jonas","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30434-5_bib75","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1001\/jama.2016.18630","article-title":"Screening for obstructive sleep apnea. Implications for the sleep health of the population","volume":"317","author":"Redline","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30434-5_bib76","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1016\/j.soard.2017.03.022","article-title":"Perioperative management of obstructive sleep apnea in bariatric surgery: a consensus guideline","volume":"13","author":"de Raaff","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(17)30434-5_bib77","doi-asserted-by":"crossref","first-page":"479","DOI":"10.5664\/jcsm.6506","article-title":"Clinical practice guideline for diagnostic testing for adult obstructive sleep apnea: an American Academy of Sleep Medicine clinical practice guideline","volume":"13","author":"Kapur","year":"2017","journal-title":"J Clin Sleep Med"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(17)30434-5_bib79","doi-asserted-by":"crossref","first-page":"S157","DOI":"10.2337\/dc09-S302","article-title":"Skeletal muscle insulin resistance is the primary defect in type 2 diabetes","volume":"32","author":"DeFronzo","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30434-5_bib80","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00125-014-3460-0","article-title":"Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"58","author":"Inzucchi","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30434-5_bib81","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4158\/EP161682.CS","article-title":"Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm\u20142017 executive summary","volume":"23","author":"Garber","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(17)30434-5_bib82","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.2337\/dci15-0012","article-title":"Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"38","author":"Fox","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30434-5_bib83","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.1007\/s11695-017-2697-3","article-title":"Preoperative weight loss and operative outcome after laparoscopic sleeve gastrectomy","volume":"27","author":"Watanabe","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib84","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.soard.2015.08.519","article-title":"Weight loss before gastric bypass and postoperative weight change: data from the Scandinavian Obesity Registry (SOReg)","volume":"12","author":"Gerber","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(17)30434-5_bib85","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/archsurg.2011.273","article-title":"Preoperative very low-calorie diet and operative outcome after laparoscopic gastric bypass: a randomized multicenter study","volume":"146","author":"Van Nieuwenhove","year":"2011","journal-title":"Arch Surg"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30434-5_bib86","first-page":"S99","article-title":"13. Diabetes care in the hospital","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30434-5_bib87","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/dc16-0236","article-title":"Metabolic surgery in the treatment algorithm for type 2 diabetes: a joint statement by international diabetes organizations","volume":"39","author":"Rubino","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30434-5_bib88","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0002-8223(02)90346-9","article-title":"Dietary reference intakes for energy, carbohydrate, fiber, fat, fatty acids, cholesterol, protein and amino acids","volume":"102","author":"Trumbo","year":"2002","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/S2213-8587(17)30434-5_bib89","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1159\/000481825","article-title":"Practical recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the Post-Bariatric Surgery Medical Management","volume":"10","author":"Busetto","year":"2017","journal-title":"Obes Facts"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30434-5_bib90","first-page":"S1","volume":"21","author":"Mechanick","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(17)30434-5_bib91","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1111\/obr.12525","article-title":"Long-term hypovitaminosis D and secondary hyperparathyroidism outcomes of the Roux-en-Y gastric bypass: a systematic review","volume":"18","author":"Switzer","year":"2017","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30434-5_bib92","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.soard.2016.01.001","article-title":"Vitamin D status and supplementation before and after bariatric surgery: a comprehensive literature review","volume":"12","author":"Peterson","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(17)30434-5_bib93","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1007\/s11695-016-2273-2","article-title":"Low educational status and childhood obesity associated with insufficient mid-term weight loss after sleeve gastrectomy: a retrospective observational cohort study","volume":"27","author":"Dilektasli","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib94","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1007\/s11695-015-1830-4","article-title":"Predictive factors for insufficient weight loss after bariatric surgery: does obstructive sleep apnea influence weight loss?","volume":"26","author":"de Raaff","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30434-5_bib95","doi-asserted-by":"crossref","first-page":"379564","DOI":"10.1155\/2013\/379564","article-title":"The economic impact of weight regain","volume":"2013","author":"Sheppard","year":"2013","journal-title":"Gastroenterol Res Pract"},{"key":"10.1016\/S2213-8587(17)30434-5_bib96","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.soard.2006.07.012","article-title":"Endoscopy and upper gastrointestinal contrast studies are complementary in evaluation of weight regain after bariatric surgery","volume":"2","author":"Brethauer","year":"2006","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(17)30434-5_bib97","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/j.soard.2011.09.010","article-title":"Influence of pouch and stoma size on weight loss after gastric bypass","volume":"8","author":"Heneghan","year":"2012","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(17)30434-5_bib98","doi-asserted-by":"crossref","first-page":"3922","DOI":"10.1007\/s00464-015-4699-3","article-title":"Endoscopic revision of gastric bypass: holy grail or epic fail?","volume":"30","author":"Gallo","year":"2016","journal-title":"Surg Endosc"},{"key":"10.1016\/S2213-8587(17)30434-5_bib99","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.soard.2016.10.018","article-title":"The utility of weight loss medications after bariatric surgery for weight regain or inadequate weight loss: a multi-center study","volume":"13","author":"Stanford","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(17)30434-5_bib100","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","volume":"389","author":"Le Roux","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30434-5_bib101","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.soard.2015.01.015","article-title":"Revision and reversal after biliopancreatic diversion for excessive side effects or ineffective weight loss: a review of the current literature on indications and procedures","volume":"11","author":"Topart","year":"2015","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(17)30434-5_bib102","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1016\/j.soard.2016.02.023","article-title":"Roux-en-Y gastric bypass reversal: a systematic review","volume":"12","author":"Shoar","year":"2016","journal-title":"Surg Obes Relat Dis"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304345?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304345?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:09Z","timestamp":1761991569000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717304345"}},"issued":{"date-parts":[[2018,6]]},"references-count":101,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S2213858717304345"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30434-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Optimisation of follow-up after metabolic surgery","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30434-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T16:33:39Z","timestamp":1793205219788,"version":"4.5.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk A\/S","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/s2213-8587(25)00164-0","type":"journal-article","created":{"date-parts":[[2025,8,18]],"date-time":"2025-08-18T08:56:29Z","timestamp":1755507389000},"page":"838-847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Once-weekly semaglutide 2\u00b74 mg in an Asian population with obesity, defined as BMI \u226525 kg\/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial"],"prefix":"10.1016","volume":"13","author":[{"given":"Soo","family":"Lim","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Supawan","family":"Buranapin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaolei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar\u00eda","family":"Quiroga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyung Hee","family":"Park","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jee-Hyun","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders Rasmussen","family":"Rinnov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arisara","family":"Suwanagool","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00164-0_bib1","doi-asserted-by":"crossref","first-page":"169","DOI":"10.7570\/jomes22024","article-title":"Obesity fact sheet in Korea, 2021: trends in obesity prevalence and obesity-related comorbidity incidence stratified by age from 2009 to 2019","volume":"31","author":"Yang","year":"2022","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/S2213-8587(25)00164-0_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.7570\/jomes23031","article-title":"Diagnosis of obesity: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity","volume":"32","author":"Haam","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/S2213-8587(25)00164-0_bib3","article-title":"Obesity and hypertension in Asia: current status and challenges","volume":"15","author":"Chu","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/S2213-8587(25)00164-0_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155217","article-title":"A 2022 update on the epidemiology of obesity and a call to action: as its twin COVID-19 pandemic appears to be receding, the obesity and dysmetabolism pandemic continues to rage on","volume":"133","author":"Boutari","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(25)00164-0_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13520","article-title":"Obesity in South and southeast Asia\u2014a new consensus on care and management","volume":"24","author":"Tham","year":"2023","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(25)00164-0_bib7","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1016\/S0140-6736(06)69703-1","article-title":"Epidemic obesity and type 2 diabetes in Asia","volume":"368","author":"Yoon","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00164-0_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7570\/jomes23016","article-title":"Evaluation and treatment of obesity and its comorbidities: 2022 update of clinical practice guidelines for obesity by the Korean Society for the Study of Obesity","volume":"32","author":"Kim","year":"2023","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/S2213-8587(25)00164-0_bib11","doi-asserted-by":"crossref","first-page":"2821","DOI":"10.1007\/s12325-021-01710-0","article-title":"Weight loss and maintenance related to the mechanism of action of glucagon-like peptide 1 receptor agonists","volume":"38","author":"Ard","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/S2213-8587(25)00164-0_bib14","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00164-0_bib15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00164-0_bib16","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00164-0_bib17","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00164-0_bib18","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00164-0_bib19","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1038\/s41591-022-02026-4","article-title":"Two-year effects of semaglutide in adults with overweight or obesity: the STEP 5 trial","volume":"28","author":"Garvey","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00164-0_bib20","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S2213-8587(22)00008-0","article-title":"Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial","volume":"10","author":"Kadowaki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00164-0_bib21","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1001\/jama.2021.23619","article-title":"Effect of weekly subcutaneous semaglutide vs daily liraglutide on body weight in adults with overweight or obesity without diabetes: the STEP 8 randomized clinical trial","volume":"327","author":"Rubino","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00164-0_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S2213-8587(23)00388-1","article-title":"Efficacy and safety of once weekly semaglutide 2\u00b74 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial","volume":"12","author":"Mu","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00164-0_bib24","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00164-0_bib25","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-8587(24)00182-7","article-title":"Efficacy and safety of once-weekly semaglutide 2\u00b74 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial","volume":"12","author":"McGowan","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00164-0_bib26","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.2337\/dc21-1785","article-title":"Changes in glucose metabolism and glycemic status with once-weekly subcutaneous semaglutide 2\u00b74 mg among participants with prediabetes in the STEP program","volume":"45","author":"Perreault","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00164-0_bib27","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/dom.12824","article-title":"Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: a systematic analysis of published clinical trials","volume":"19","author":"Bettge","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(25)00164-0_bib28","doi-asserted-by":"crossref","first-page":"1632","DOI":"10.1016\/j.jacc.2024.08.007","article-title":"The effect of semaglutide on mortality and COVID-19\u2013related deaths: an analysis from the SELECT trial","volume":"84","author":"Scirica","year":"2024","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(25)00164-0_bib29","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001640?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001640?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:02:45Z","timestamp":1762610565000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725001640"}},"issued":{"date-parts":[[2025,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2213858725001640"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00164-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Once-weekly semaglutide 2\u00b74 mg in an Asian population with obesity, defined as BMI \u226525 kg\/m2, in South Korea and Thailand (STEP 11): a randomised, double-blind, placebo-controlled, phase 3 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00164-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00201-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T15:06:44Z","timestamp":1793286404298,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010663","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010663","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/s2213-8587(23)00153-5","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T18:26:45Z","timestamp":1692728805000},"page":"637-640","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Tuning of cellular insulin release by music for real-time diabetes control"],"prefix":"10.1016","volume":"11","author":[{"given":"Haijie","family":"Zhao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuai","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Didi\u00e9e","family":"Hussherr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Buchmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Palma","family":"Teixeira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fussenegger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00153-5_bib1","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.neuron.2018.07.033","article-title":"TMC1 forms the pore of mechanosensory transduction channels in vertebrate inner ear hair cells","volume":"99","author":"Pan","year":"2018","journal-title":"Neuron"},{"key":"10.1016\/S2213-8587(23)00153-5_bib2","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1038\/s41467-022-28205-y","article-title":"Sonogenetic control of mammalian cells using exogenous Transient Receptor Potential A1 channels","volume":"13","author":"Duque","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(23)00153-5_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1126\/science.1193270","article-title":"Piezo1 and Piezo2 are essential components of distinct mechanically activated cation channels","volume":"330","author":"Coste","year":"2010","journal-title":"Science"},{"key":"10.1016\/S2213-8587(23)00153-5_bib4","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1038\/368265a0","article-title":"A large-conductance mechanosensitive channel in E. coli encoded by mscL alone","volume":"368","author":"Sukharev","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(23)00153-5_bib5","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1038\/ncomms1999","article-title":"Controlled delivery of bioactive molecules into live cells using the bacterial mechanosensitive channel MscL","volume":"3","author":"Doerner","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(23)00153-5_bib6","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1126\/science.aau7187","article-title":"Electrogenetic cellular insulin release for real-time glycemic control in type 1 diabetic mice","volume":"368","author":"Krawczyk","year":"2020","journal-title":"Science"},{"key":"10.1016\/S2213-8587(23)00153-5_bib7","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1038\/nature12354","article-title":"Ultrasensitive fluorescent proteins for imaging neuronal activity","volume":"499","author":"Chen","year":"2013","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(23)00153-5_bib8","doi-asserted-by":"crossref","first-page":"4751","DOI":"10.1002\/bit.27939","article-title":"Control of gene expression in engineered mammalian cells with a programmable shear-stress inducer","volume":"118","author":"Strittmatter","year":"2021","journal-title":"Biotechnol Bioeng"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00153-5_bib9","doi-asserted-by":"crossref","first-page":"S53","DOI":"10.2337\/diabetes.51.2007.S53","article-title":"Modeling phasic insulin release: immediate and time-dependent effects of glucose","volume":"51","author":"Nesher","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00153-5_bib10","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1016\/S0140-6736(08)60485-7","article-title":"Once-daily basal insulin glargine versus thrice-daily prandial insulin lispro in people with type 2 diabetes on oral hypoglycaemic agents (APOLLO): an open randomised controlled trial","volume":"371","author":"Bretzel","year":"2008","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:02Z","timestamp":1761991982000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001535"}},"issued":{"date-parts":[[2023,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2213858723001535"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00153-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tuning of cellular insulin release by music for real-time diabetes control","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00153-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,8]],"date-time":"2026-11-08T03:45:39Z","timestamp":1794109539967,"version":"4.8.0"},"reference-count":142,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/s2213-8587(17)30186-9","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T20:34:35Z","timestamp":1503693275000},"page":"69-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":765,"title":["Type 2 diabetes in adolescents and young adults"],"prefix":"10.1016","volume":"6","author":[{"given":"Nadia","family":"Lascar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Pattison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford J","family":"Bailey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srikanth","family":"Bellary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30186-9_bib1","series-title":"IDF Diabetes Atlas","year":"2015"},{"key":"10.1016\/S2213-8587(17)30186-9_bib2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1542\/peds.2012-3494","article-title":"Management of newly diagnosed type 2 diabetes mellitus (T2DM) in children and adolescents","volume":"131","author":"Copeland","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(17)30186-9_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/diaclin.34.1.3","article-title":"Standards of medical care in diabetes\u20142016 abridged for primary care providers","volume":"34","year":"2016","journal-title":"Clin Diabetes"},{"key":"10.1016\/S2213-8587(17)30186-9_bib4","series-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation","year":"2006"},{"key":"10.1016\/S2213-8587(17)30186-9_bib5","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1001\/jama.2014.3201","article-title":"Prevalence of type 1 and type 2 diabetes among children and adolescents from 2001 to 2009","volume":"311","author":"Dabelea","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30186-9_bib6","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012","volume":"376","author":"Mayer-Davis","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30186-9_bib7","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.jpeds.2004.12.042","article-title":"The global spread of type 2 diabetes mellitus in children and adolescents","volume":"146","author":"Pinhas-Hamiel","year":"2005","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(17)30186-9_bib8","series-title":"Diabetes Atlas 2000","year":"2000"},{"key":"10.1016\/S2213-8587(17)30186-9_bib9","series-title":"Diabetes Atlas","year":"2003"},{"key":"10.1016\/S2213-8587(17)30186-9_bib10","series-title":"Diabetes Atlas","year":"2006"},{"key":"10.1016\/S2213-8587(17)30186-9_bib11","series-title":"IDF Diabetes Atlas","year":"2013"},{"key":"10.1016\/S2213-8587(17)30186-9_bib12","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/dom.12123","article-title":"The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010","volume":"15","author":"Holden","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(17)30186-9_bib13","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2337\/dc06-1813","article-title":"Rising incidence of type 2 diabetes in children in the UK","volume":"30","author":"Haines","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib14","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","article-title":"Lifetime risk for diabetes mellitus in the United States","volume":"290","author":"Narayan","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30186-9_bib15","doi-asserted-by":"crossref","first-page":"119","DOI":"10.4093\/kdj.2010.34.2.119","article-title":"The clinical characteristics of the newly diagnosed early onset (<40 years old) diabetes in outpatients' clinic","volume":"34","author":"Kim","year":"2010","journal-title":"Korean Diabetes J"},{"key":"10.1016\/S2213-8587(17)30186-9_bib16","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.diabres.2005.05.007","article-title":"Comparisons of the outcomes on control, type of management and complications status in early onset and late onset type 2 diabetes in Asia","volume":"71","author":"Chuang","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30186-9_bib17","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1590\/S0036-36342010000700006","article-title":"Early-onset type 2 diabetes in a Mexican survey: results from the National Health and Nutrition Survey 2006","volume":"52","author":"Jimenez-Corona","year":"2010","journal-title":"Salud Publica Mex"},{"key":"10.1016\/S2213-8587(17)30186-9_bib18","doi-asserted-by":"crossref","first-page":"638","DOI":"10.2337\/diacare.28.3.638","article-title":"Youth type 2 diabetes: insulin resistance, \u03b2-cell failure, or both?","volume":"28","author":"Gungor","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib19","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/jc.2005-1672","article-title":"Characterization of insulin secretion and resistance in type 2 diabetes of adolescents","volume":"91","author":"Druet","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30186-9_bib20","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1515\/JPEM.2006.19.2.135","article-title":"Type 2 diabetes mellitus in African-American adolescents: impaired beta-cell function in the face of severe insulin resistance","volume":"19","author":"Taha","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30186-9_bib21","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1093\/qjmed\/hcg040","article-title":"Deteriorating beta\u2013cell function in type 2 diabetes: a long\u2013term model","volume":"96","author":"Bagust","year":"2003","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(17)30186-9_bib22","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-002-1009-0","article-title":"The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes","volume":"46","author":"Kahn","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30186-9_bib23","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/dc12-2393","article-title":"Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and \u03b2-cell function in TODAY","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib24","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1111\/j.1399-5448.2012.00915.x","article-title":"Progressive deterioration of \u03b2-cell function in obese youth with type 2 diabetes","volume":"14","author":"Bacha","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(17)30186-9_bib25","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/dia.2012.0259","article-title":"Associations of \u03b2-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians","volume":"15","author":"Mohan","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(17)30186-9_bib26","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1177\/2040622314548679","article-title":"Early onset type 2 diabetes: risk factors, clinical impact and management","volume":"5","author":"Wilmot","year":"2014","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/S2213-8587(17)30186-9_bib27","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.2337\/diacare.24.9.1522","article-title":"Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset","volume":"24","author":"Hillier","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib28","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/nature05482","article-title":"Mechanisms linking obesity to insulin resistance and type 2 diabetes","volume":"444","author":"Kahn","year":"2006","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(17)30186-9_bib29","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s11892-012-0341-0","article-title":"Etiology of insulin resistance in youth with type 2 diabetes","volume":"13","author":"Cree-Green","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(17)30186-9_bib30","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1172\/JCI57132","article-title":"Inflammatory links between obesity and metabolic disease","volume":"121","author":"Lumeng","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(17)30186-9_bib31","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jpeds.2016.02.055","article-title":"Inflammatory markers in obese adolescents with type 2 diabetes and their relationship to hepatokines and adipokines","volume":"173","author":"Reinehr","year":"2016","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(17)30186-9_bib32","doi-asserted-by":"crossref","first-page":"538474","DOI":"10.1155\/2012\/538474","article-title":"Impact of maternal diabetes on epigenetic modifications leading to diseases in the offspring","volume":"2012","author":"Vrachnis","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/S2213-8587(17)30186-9_bib33","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.2337\/dc08-0769","article-title":"Association between maternal diabetes in utero and age at offspring's diagnosis of type 2 diabetes","volume":"31","author":"Pettitt","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib34","doi-asserted-by":"crossref","first-page":"485082","DOI":"10.1155\/2013\/485082","article-title":"Early life factors and type 2 diabetes mellitus","volume":"2013","author":"Jiang","year":"2013","journal-title":"J Diabetes Res"},{"key":"10.1016\/S2213-8587(17)30186-9_bib35","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1542\/peds.109.2.194","article-title":"Infant weight gain and childhood overweight status in a multicenter, cohort study","volume":"109","author":"Stettler","year":"2002","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(17)30186-9_bib36","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1016\/j.socscimed.2011.04.005","article-title":"Early life undernutrition and chronic diseases at older ages: the effects of the Dutch famine on cardiovascular diseases and diabetes","volume":"73","author":"Portrait","year":"2011","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(17)30186-9_bib37","doi-asserted-by":"crossref","first-page":"218598","DOI":"10.1155\/2011\/218598","article-title":"Maternal diabetes in pregnancy: early and long-term outcomes on the offspring and the concept of \u201cmetabolic memory\u201d","volume":"2011","author":"Yessoufou","year":"2011","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/S2213-8587(17)30186-9_bib38","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30186-9_bib39","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1079\/PHN2003586","article-title":"Diet, nutrition and the prevention of type 2 diabetes","volume":"7","author":"Steyn","year":"2004","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(17)30186-9_bib40","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0140-6736(02)09678-2","article-title":"Childhood obesity: public-health crisis, common sense cure","volume":"360","author":"Ebbeling","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30186-9_bib41","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","article-title":"The global obesity pandemic: shaped by global drivers and local environments","volume":"378","author":"Swinburn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30186-9_bib42","doi-asserted-by":"crossref","first-page":"486","DOI":"10.3390\/nu8080486","article-title":"The effectiveness of different diet strategies to reduce type 2 diabetes risk in youth","volume":"8","author":"Gow","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(17)30186-9_bib43","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ajcn\/79.4.537","article-title":"Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity","volume":"79","author":"Bray","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30186-9_bib44","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.physbeh.2010.01.036","article-title":"Sugar-sweetened beverages and risk of obesity and type 2 diabetes: epidemiologic evidence","volume":"100","author":"Hu","year":"2010","journal-title":"Physiol Behav"},{"key":"10.1016\/S2213-8587(17)30186-9_bib45","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.jada.2006.02.002","article-title":"Dietary intake among youth with diabetes: the SEARCH for Diabetes in Youth Study","volume":"106","author":"Mayer-Davis","year":"2006","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/S2213-8587(17)30186-9_bib46","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1136\/bjsm.2004.016675","article-title":"Evidence for secular trends in children's physical activity behaviour","volume":"39","author":"Dollman","year":"2005","journal-title":"Br J Sports Med"},{"key":"10.1016\/S2213-8587(17)30186-9_bib47","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1038\/sj.ijo.0802994","article-title":"Use of information and communication technology and prevalence of overweight and obesity among adolescents","volume":"29","author":"Kautiainen","year":"2005","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(17)30186-9_bib48","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0140-6736(12)60646-1","article-title":"Global physical activity levels: surveillance progress, pitfalls, and prospects","volume":"380","author":"Hallal","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30186-9_bib49","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1097\/00005768-200009000-00013","article-title":"Changes in physical activity patterns in the United States, by sex and cross-sectional age","volume":"32","author":"Caspersen","year":"2000","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(17)30186-9_bib50","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1249\/mss.0b013e31815a51b3","article-title":"Physical activity in the United States measured by accelerometer","volume":"40","author":"Troiano","year":"2008","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(17)30186-9_bib51","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1249\/01.MSS.0000106174.43932.92","article-title":"Physical activity levels and patterns of 9- and 15-yr-old European children","volume":"36","author":"Riddoch","year":"2004","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(17)30186-9_bib52","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/S0895-4356(02)00427-4","article-title":"Relation of self-rated measures of physical activity to multiple risk factors of insulin resistance syndrome in young adults: the Bogalusa Heart Study","volume":"55","author":"Gustat","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(17)30186-9_bib53","doi-asserted-by":"crossref","first-page":"3092","DOI":"10.1001\/jama.290.23.3092","article-title":"Cardiorespiratory fitness in young adulthood and the development of cardiovascular disease risk factors","volume":"290","author":"Carnethon","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30186-9_bib54","doi-asserted-by":"crossref","first-page":"305","DOI":"10.3132\/dvdr.2007.057","article-title":"Physical activity for the prevention and management of youth-onset type 2 diabetes mellitus: focus on cardiovascular complications","volume":"4","author":"McGavock","year":"2007","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/S2213-8587(17)30186-9_bib55","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1038\/sj.ejcn.1601503","article-title":"Socio-economic status, dietary intake and 10 y trends: the Dutch National Food Consumption Survey","volume":"57","author":"Hulshof","year":"2003","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30186-9_bib56","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1186\/1471-2458-13-252","article-title":"Type 2 diabetes prevalence varies by socio-economic status within and between migrant groups: analysis and implications for Australia","volume":"13","author":"Abouzeid","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(17)30186-9_bib57","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1006\/pmed.2002.1115","article-title":"Socioeconomic status differences in recreational physical activity levels and real and perceived access to a supportive physical environment","volume":"35","author":"Giles-Corti","year":"2002","journal-title":"Prev Med"},{"key":"10.1016\/S2213-8587(17)30186-9_bib58","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/1471-2458-13-458","article-title":"Acculturation and obesity among migrant populations in high income countries\u2014a systematic review","volume":"13","author":"Delavari","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(17)30186-9_bib59","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1001\/jamainternmed.2016.2952","article-title":"What we don't talk about when we talk about preventing type 2 diabetes\u2014addressing socioeconomic disadvantage","volume":"176","author":"Spencer Bonilla","year":"2016","journal-title":"JAMA Internal Med"},{"key":"10.1016\/S2213-8587(17)30186-9_bib60","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMsa1103216","article-title":"Neighborhoods, obesity, and diabetes\u2014a randomized social experiment","volume":"365","author":"Ludwig","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30186-9_bib61","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4239\/wjd.v4.i6.270","article-title":"Type 2 diabetes mellitus in children and adolescents","volume":"4","author":"Reinehr","year":"2013","journal-title":"World J Diabetes"},{"key":"10.1016\/S2213-8587(17)30186-9_bib62","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1034\/j.1399-5448.2003.00022.x","article-title":"Prevention of type 2 diabetes in young people: a theoretical perspective","volume":"4","author":"Huang","year":"2003","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(17)30186-9_bib63","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1462-8902.2004.00330.x","article-title":"Strong family history predicts a younger age of onset for subjects diagnosed with type 2 diabetes","volume":"6","author":"Molyneaux","year":"2004","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(17)30186-9_bib64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/diacare.24.4.663","article-title":"Familial early-onset type 2 diabetes in Chinese patients: obesity and genetics have more significant roles than autoimmunity","volume":"24","author":"Ng","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib65","first-page":"377","article-title":"Familial early onset of type-2 diabetes mellitus and its complications","volume":"1","author":"Jali","year":"2009","journal-title":"N Am J Med Sci"},{"key":"10.1016\/S2213-8587(17)30186-9_bib66","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.2337\/diabetes.52.7.1857","article-title":"Young-onset type 2 diabetes families are the major contributors to genetic loci in the Diabetes UK Warren 2 genome scan and identify putative novel loci on chromosomes 8q21, 21q22, and 22q11","volume":"52","author":"Frayling","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30186-9_bib67","doi-asserted-by":"crossref","first-page":"718","DOI":"10.2337\/dc13-1995","article-title":"Clinical and genetic determinants of progression of type 2 diabetes: a DIRECT study","volume":"37","author":"Zhou","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib68","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1093\/aje\/kwp443","article-title":"Socioeconomic status and incidence of type 2 diabetes: results from the Black Women's Health Study","volume":"171","author":"Krishnan","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30186-9_bib69","doi-asserted-by":"crossref","first-page":"e27670","DOI":"10.1371\/journal.pone.0027670","article-title":"Socioeconomic status and incident type 2 diabetes mellitus: data from the Women's Health Study","volume":"6","author":"Lee","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30186-9_bib70","doi-asserted-by":"crossref","first-page":"512914","DOI":"10.1155\/2013\/512914","article-title":"Sociocultural and socioeconomic influences on type 2 diabetes risk in overweight\/obese African-American and Latino-American children and adolescents","volume":"2013","author":"Hasson","year":"2013","journal-title":"J Obes"},{"key":"10.1016\/S2213-8587(17)30186-9_bib71","first-page":"220","article-title":"Early-onset type 2 diabetes: metabolic and genetic characterization in the Mexican population","volume":"86","author":"Aguilar-Salinas","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30186-9_bib72","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1399-0004.2010.01577.x","article-title":"Association of novel variants in the hepatocyte nuclear factor 4A gene with maturity onset diabetes of the young and early onset type 2 diabetes","volume":"80","author":"Anuradha","year":"2011","journal-title":"Clin Genet"},{"key":"10.1016\/S2213-8587(17)30186-9_bib73","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/j.metabol.2004.03.003","article-title":"Triple genetic variation in the HNF-4\u03b1 gene is associated with early-onset type 2 diabetes mellitus in a Philippino family","volume":"53","author":"Gragnoli","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(17)30186-9_bib74","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1055\/s-2007-978656","article-title":"A novel dominant-negative mutation of the hepatocyte nuclear factor-1\u03b1 gene in Japanese early-onset type 2 diabetes","volume":"32","author":"Tanaka","year":"2000","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(17)30186-9_bib75","first-page":"149","article-title":"Incidence of young onset insulin-requiring diabetes mellitus among 18- to 30-year-olds in Dhaka, Bangladesh (1994\u20132003)","volume":"74","author":"Nizam","year":"2012","journal-title":"Nagoya J Med Sci"},{"key":"10.1016\/S2213-8587(17)30186-9_bib76","first-page":"131","article-title":"Clinical and laboratory features of youth onset type 2 diabetes in Jamaica","volume":"59","author":"Tulloch-Reid","year":"2010","journal-title":"West Indian Med J"},{"key":"10.1016\/S2213-8587(17)30186-9_bib77","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1210\/jc.2013-2007","article-title":"Gestational diabetes and type 2 diabetes in reproductive-aged women with polycystic ovary syndrome","volume":"99","author":"Joham","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30186-9_bib78","doi-asserted-by":"crossref","first-page":"33","DOI":"10.4239\/wjd.v2.i3.33","article-title":"Assessing and treating insulin resistance in women with polycystic ovarian syndrome","volume":"2","author":"Traub","year":"2011","journal-title":"World J Diabetes"},{"key":"10.1016\/S2213-8587(17)30186-9_bib79","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1089\/jwh.2006.0098","article-title":"Polycystic ovarian syndrome (PCOS): a significant contributor to the overall burden of type 2 diabetes in women","volume":"16","author":"Talbott","year":"2007","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/S2213-8587(17)30186-9_bib80","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1007\/s11892-013-0448-y","article-title":"Nonalcoholic fatty liver disease and type 2 diabetes in obese children","volume":"14","author":"Hecht","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(17)30186-9_bib81","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.2337\/dc07-zb06","article-title":"Nonalcoholic fatty liver disease and insulin resistance in youth","volume":"30","author":"Bloomgarden","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib82","first-page":"448","article-title":"Study of prevalence of nonalcoholic fatty liver disease (NAFLD) in type 2 diabetes patients in India (SPRINT)","volume":"61","author":"Kalra","year":"2013","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(17)30186-9_bib83","doi-asserted-by":"crossref","first-page":"e161971","DOI":"10.1001\/jamapediatrics.2016.1971","article-title":"Prevalence of prediabetes and type 2 diabetes in children with nonalcoholic fatty liver disease","volume":"170","author":"Newton","year":"2016","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(17)30186-9_bib84","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1111\/pedi.12281","article-title":"Presentation of youth with type 2 diabetes in the Pediatric Diabetes Consortium","volume":"17","author":"Klingensmith","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(17)30186-9_bib85","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1111\/pedi.12264","article-title":"Presentation and effectiveness of early treatment of type 2 diabetes in youth: lessons from the TODAY study","volume":"17","author":"Kelsey","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(17)30186-9_bib86","doi-asserted-by":"crossref","first-page":"e84","DOI":"10.2337\/dc15-0157","article-title":"Trends and characteristics of self-reported case presentation of diabetes diagnosis among youth from 2002 to 2010: findings from the SEARCH for Diabetes in Youth Study","volume":"38","author":"Saydah","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib87","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2337\/dc05-2470","article-title":"Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes","volume":"29","author":"Eppens","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib88","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0140-6736(07)60821-6","article-title":"Acute and chronic complications of type 2 diabetes mellitus in children and adolescents","volume":"369","author":"Pinhas-Hamiel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30186-9_bib89","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/jc.2010-1642","article-title":"Characteristics of adolescents and youth with recent-onset type 2 diabetes: the TODAY cohort at baseline","volume":"96","author":"Copeland","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30186-9_bib90","doi-asserted-by":"crossref","first-page":"e000044","DOI":"10.1136\/bmjdrc-2014-000044","article-title":"Complication characteristics between young-onset type 2 versus type 1 diabetes in a UK population","volume":"3","author":"Song","year":"2015","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib91","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1530\/EJE-15-1149","article-title":"Time to insulin initiation and long-term effects of initiating insulin in people with type 2 diabetes mellitus: the Hoorn Diabetes Care System Cohort Study","volume":"174","author":"Mast","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(17)30186-9_bib92","first-page":"2319","article-title":"Prevalence of metabolic syndrome in young adults","volume":"4","author":"Adam","year":"2015","journal-title":"Int J Sci Res"},{"key":"10.1016\/S2213-8587(17)30186-9_bib93","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/qjmed\/hcp121","article-title":"Early onset type 2 diabetes mellitus: a harbinger for complications in later years\u2014clinical observation from a secondary care cohort","volume":"102","author":"Song","year":"2009","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(17)30186-9_bib94","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/qjmed\/hcq135","article-title":"Cardiovascular and metabolic risk profiles in young and old patients with type 2 diabetes","volume":"103","author":"Gunathilake","year":"2010","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(17)30186-9_bib95","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1258\/acb.2009.009080","article-title":"Apolipoproteins in diabetes dyslipidaemia in South Asians with young adult-onset diabetes: distribution, associations and patterns","volume":"47","author":"Katulanda","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/S2213-8587(17)30186-9_bib96","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1177\/14746514080080020201","article-title":"Early-onset type 2 diabetes mellitus: a condition with elevated cardiovascular risk?","volume":"8","author":"Song","year":"2008","journal-title":"Br J Diabetes Vasc Dis"},{"key":"10.1016\/S2213-8587(17)30186-9_bib97","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1093\/qjmed\/hcs113","article-title":"Early-onset type 2 diabetes: higher burden of atherogenic apolipoprotein particles during statin treatment","volume":"105","author":"Song","year":"2012","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(17)30186-9_bib98","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(15)00508-2","article-title":"Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study","volume":"4","author":"Huo","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30186-9_bib99","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1464-5491.2011.03542.x","article-title":"Estimated morbidity and mortality in adolescents and young adults diagnosed with type 2 diabetes mellitus","volume":"29","author":"Rhodes","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(17)30186-9_bib100","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.0686","article-title":"Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood","volume":"317","author":"Dabelea","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30186-9_bib101","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1007\/s11892-013-0456-y","article-title":"Nephropathy in youth and young adults with type 2 diabetes","volume":"14","author":"Solis-Herrera","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(17)30186-9_bib102","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2337\/dc11-2312","article-title":"High burden of kidney disease in youth-onset type 2 diabetes","volume":"35","author":"Dart","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib103","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.diabres.2011.07.030","article-title":"Early-onset type 2 diabetes: high risk for premature diabetic retinopathy","volume":"94","author":"Song","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(17)30186-9_bib104","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/ijcp.12789","article-title":"Significant retinopathy in young-onset type 2 vs type 1 diabetes: a clinical observation","volume":"70","author":"Song","year":"2016","journal-title":"Int J Clin Pract"},{"key":"10.1016\/S2213-8587(17)30186-9_bib105","doi-asserted-by":"crossref","first-page":"3903","DOI":"10.2337\/dc13-1213","article-title":"Peripheral neuropathy in adolescents and young adults with type 1 and type 2 diabetes from the SEARCH for Diabetes in Youth follow-up cohort: a pilot study","volume":"36","author":"Jaiswal","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib106","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2337\/diacare.26.11.2999","article-title":"Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth","volume":"26","author":"Hillier","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib107","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.amjmed.2014.03.018","article-title":"Premature mortality and comorbidities in young-onset diabetes: a 7-year prospective analysis","volume":"127","author":"Chan","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(17)30186-9_bib108","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2337\/dc13-1336","article-title":"Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetes","volume":"37","author":"Luk","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib109","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1111\/dme.12335","article-title":"Adolescents and young adults with newly diagnosed type 2 diabetes demonstrate greater carotid intima-media thickness than those with type 1 diabetes","volume":"31","author":"Gu","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(17)30186-9_bib110","doi-asserted-by":"crossref","first-page":"3740","DOI":"10.1210\/jc.2008-2039","article-title":"Influence of duration of diabetes, glycemic control, and traditional cardiovascular risk factors on early atherosclerotic vascular changes in adolescents and young adults with type 2 diabetes mellitus","volume":"94","author":"Shah","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30186-9_bib111","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.2337\/dc12-2455","article-title":"Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes","volume":"36","author":"Constantino","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib112","doi-asserted-by":"crossref","first-page":"549","DOI":"10.4158\/EP11389.OR","article-title":"Sensorineural hearing loss\u2014a common finding in early-onset type 2 diabetes mellitus","volume":"18","author":"Lerman-Garber","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(17)30186-9_bib113","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.arcmed.2008.10.003","article-title":"Hearing loss in middle-aged subjects with type 2 diabetes mellitus","volume":"40","author":"Ren","year":"2009","journal-title":"Arch Med Res"},{"key":"10.1016\/S2213-8587(17)30186-9_bib114","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1007\/s11255-009-9565-6","article-title":"Is male fertility associated with type 2 diabetes mellitus?","volume":"41","author":"Bener","year":"2009","journal-title":"Int Urol Nephrol"},{"key":"10.1016\/S2213-8587(17)30186-9_bib115","doi-asserted-by":"crossref","first-page":"2273","DOI":"10.1007\/s00125-010-1890-x","article-title":"Ageing brain abnormalities in young obese patients with type 2 diabetes: a cause for concern","volume":"53","author":"Nolan","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30186-9_bib116","doi-asserted-by":"crossref","first-page":"443","DOI":"10.2337\/dc12-0922","article-title":"Insulin resistance, brain atrophy, and cognitive performance in late middle-aged adults","volume":"36","author":"Willette","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib117","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.2337\/dc16-1066","article-title":"Youth-onset type 2 diabetes consensus report: current status, challenges, and priorities","volume":"39","author":"Nadeau","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib118","doi-asserted-by":"crossref","first-page":"84","DOI":"10.4158\/EP151126.CS","article-title":"Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm\u20142016 executive summary","volume":"22","author":"Garber","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(17)30186-9_bib119","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1093\/pch\/17.3.129","article-title":"Success with lifestyle monotherapy in youth with new-onset type 2 diabetes","volume":"17","author":"Wittmeier","year":"2012","journal-title":"Paediatr Child Health"},{"key":"10.1016\/S2213-8587(17)30186-9_bib120","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2337\/diacare.27.2.348","article-title":"Treatment of type 2 diabetes in childhood using a very-low-calorie diet","volume":"27","author":"Willi","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib121","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1007\/s00125-007-0655-7","article-title":"Early-onset type 2 diabetes in obese white subjects is characterised by a marked defect in beta cell insulin secretion, severe insulin resistance and a lack of response to aerobic exercise training","volume":"50","author":"Burns","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30186-9_bib122","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1007\/s11892-014-0568-z","article-title":"Lifestyle therapy for the treatment of youth with type 2 diabetes","volume":"15","author":"McGavock","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(17)30186-9_bib123","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2337\/diacare.25.1.89","article-title":"Effect of metformin in pediatric patients with type 2 diabetes: a randomized controlled trial","volume":"25","author":"Jones","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib124","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1592\/phco.24.9.871.36099","article-title":"Type 2 diabetes mellitus in the pediatric population","volume":"24","author":"Gaylor","year":"2004","journal-title":"Pharmacotherapy"},{"key":"10.1016\/S2213-8587(17)30186-9_bib125","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1007\/s11892-012-0334-z","article-title":"Current treatment options for type 2 diabetes mellitus in youth: today's realities and lessons from the TODAY study","volume":"13","author":"George","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(17)30186-9_bib126","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","article-title":"A clinical trial to maintain glycemic control in youth with type 2 diabetes","volume":"366","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30186-9_bib127","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S2213-8587(14)70137-8","article-title":"Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort","volume":"2","author":"Yeung","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30186-9_bib128","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.diabres.2004.01.005","article-title":"Glycaemic control and microvascular complication among patients with youth onset diabetes in India using differing types of insulin and methods of glucose monitoring","volume":"65","author":"Miglani","year":"2004","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(17)30186-9_bib129","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2147\/DMSO.S13791","article-title":"Achievement of cardiovascular risk factor targets in young adults with diabetes mellitus","volume":"3","author":"Donovan","year":"2010","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/S2213-8587(17)30186-9_bib130","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1016\/j.pcd.2011.06.003","article-title":"Characteristics, complications and management of a large multiethnic cohort of younger adults with type 2 diabetes","volume":"5","author":"Benhalima","year":"2011","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/S2213-8587(17)30186-9_bib131","first-page":"107","article-title":"Type 2 diabetes in children and adolescents in a 2-year follow-up: insufficient adherence to diabetes centers","volume":"69","author":"Reinehr","year":"2008","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(17)30186-9_bib132","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1038\/nrendo.2016.86","article-title":"Pharmacology and therapeutic implications of current drugs for type 2 diabetes mellitus","volume":"12","author":"Tahrani","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(17)30186-9_bib133","doi-asserted-by":"crossref","first-page":"2300","DOI":"10.1016\/S0140-6736(12)60401-2","article-title":"Bariatric surgery for type 2 diabetes","volume":"379","author":"Dixon","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30186-9_bib134","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2213-8587(16)30425-9","article-title":"Pros and cons of bariatric surgery in adolescents","volume":"5","author":"Mingrone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30186-9_bib135","doi-asserted-by":"crossref","first-page":"5015","DOI":"10.1007\/s00464-016-4849-2","article-title":"Outcomes of bariatric surgery in the young: a single-institution experience caring for patients under 21 years old","volume":"30","author":"Serrano","year":"2016","journal-title":"Surg Endosc"},{"key":"10.1016\/S2213-8587(17)30186-9_bib136","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2337\/dc12-0354","article-title":"Burden of diabetes on the ability to work: a systematic review","volume":"36","author":"Breton","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib137","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/dme.12566","article-title":"Depression, anxiety and self-care behaviours of young adults with type 2 diabetes: results from the International Diabetes Management and Impact for Long-term Empowerment and Success (MILES) Study","volume":"32","author":"Browne","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(17)30186-9_bib138","doi-asserted-by":"crossref","first-page":"122","DOI":"10.2337\/dc15-1206","article-title":"Pregnancy outcomes in youth with type 2 diabetes: the TODAY study experience","volume":"39","author":"Klingensmith","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30186-9_bib139","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1177\/1474651411431590","article-title":"The policy puzzle: the diabetes maze in Europe","volume":"11","author":"Day","year":"2011","journal-title":"Br J Diabetes Vasc Dis"},{"key":"10.1016\/S2213-8587(17)30186-9_bib140","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1111\/dom.12270","article-title":"Prevention of type 2 diabetes; a systematic review and meta-analysis of different intervention strategies","volume":"16","author":"Merlotti","year":"2014","journal-title":"Diab Obes Metab"},{"key":"10.1016\/S2213-8587(17)30186-9_bib141","first-page":"22","article-title":"Prevention and treatment of type 2 diabetes in youth","volume":"67","author":"Libman","year":"2007","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(17)30186-9_bib142","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1177\/193229681100500334","article-title":"DIAMAP: a road map for diabetes research in Europe","volume":"5","author":"Hills","year":"2011","journal-title":"J Diabetes Sci Technol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,2]],"date-time":"2019-10-02T16:43:09Z","timestamp":1570034589000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301869"}},"issued":{"date-parts":[[2018,1]]},"references-count":142,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2213858717301869"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30186-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes in adolescents and young adults","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30186-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T04:40:37Z","timestamp":1775018437209,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/s2213-8587(24)00274-2","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T23:03:12Z","timestamp":1725663792000},"page":"683-685","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Islet transplantation in kidney transplant recipients with type 1 diabetes"],"prefix":"10.1016","volume":"12","author":[{"given":"Shareen","family":"Forbes","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas W H","family":"Kay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00274-2_bib1","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1016\/S2213-8587(18)30078-0","article-title":"Islet transplantation versus insulin therapy in patients with type 1 diabetes with severe hypoglycaemia or poorly controlled glycaemia after kidney transplantation (TRIMECO): a multicentre, randomised controlled trial","volume":"6","author":"Lablanche","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00274-2_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00241-9","article-title":"Islet-after-kidney transplantation versus kdney alone in kidney transplant recipients with type 1 diabetes (KAIAK): a population-based target trial emulation in France","author":"Maanaoui","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00274-2_bib4","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dbi23-0012","article-title":"Evidence for C-peptide as a validated surrogate to predict clinical benefits in trials of disease-modifying therapies for type 1 diabetes","volume":"73","author":"Latres","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00274-2_bib5","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1056\/NEJMoa2306691","article-title":"Baricitinib and \u03b2-Cell function in patients with new-onset type 1 diabetes","volume":"389","author":"Waibel","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00274-2_bib6","article-title":"Islet transplantation outcomes in type 1 diabetes and transplantation of HLA-DQ8\/DR4: results of a single-centre retrospective cohort in Canada","volume":"67","author":"Forbes","year":"2023","journal-title":"EClinicalMedicine"},{"key":"10.1016\/S2213-8587(24)00274-2_bib7","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1111\/ajt.13407","article-title":"De novo donor-specific HLA antibodies are associated with rapid loss of graft function following islet transplantation in type 1 diabetes","volume":"15","author":"Brooks","year":"2015","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(24)00274-2_bib8","doi-asserted-by":"crossref","first-page":"3006","DOI":"10.1016\/S0140-6736(16)32187-0","article-title":"Rabbit-ATG or basiliximab induction for rapid steroid withdrawal after renal transplantation (Harmony): an open-label, multicentre, randomised controlled trial","volume":"388","author":"Thomusch","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00274-2_bib9","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1111\/ajt.14619","article-title":"Campath, calcineurin inhibitor reduction, and chronic allograft nephropathy (the 3C study)\u2014results of a randomized controlled clinical trial","volume":"18","author":"Haynes","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(24)00274-2_bib10","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00125-022-05804-4","article-title":"Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry","volume":"66","author":"Hering","year":"2023","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002742?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002742?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T23:11:31Z","timestamp":1727219491000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002742"}},"issued":{"date-parts":[[2024,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2213858724002742"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00274-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Islet transplantation in kidney transplant recipients with type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00274-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00241-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:17:17Z","timestamp":1761992237303,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/s2213-8587(23)00260-7","type":"journal-article","created":{"date-parts":[[2023,9,5]],"date-time":"2023-09-05T22:42:54Z","timestamp":1693953774000},"page":"717-718","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Craniopharyngioma: medico-social support for optimised care"],"prefix":"10.1016","volume":"11","author":[{"given":"Thomas","family":"Cuny","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Reynaud","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pascal","family":"Barat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Blandine","family":"Gatta-Cherifi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00260-7_bib1","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1038\/s41572-019-0125-9","article-title":"Craniopharyngioma","volume":"5","author":"M\u00fcller","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(23)00260-7_bib2","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1210\/endrev\/bnac035","article-title":"Contemporary biological insights and clinical management of craniopharyngioma","volume":"44","author":"Apps","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(23)00260-7_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/cancers14153831","article-title":"The challenging management of craniopharyngiomas in adults: time for a reappraisal?","volume":"14","author":"Cuny","year":"2022","journal-title":"Cancers (Basel)"},{"key":"10.1016\/S2213-8587(23)00260-7_bib4","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/S2213-8587(23)00162-6","article-title":"National UK guidelines for the management of paediatric craniopharyngioma","volume":"11","author":"Gan","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00260-7_bib5","doi-asserted-by":"crossref","DOI":"10.1093\/ejendo\/lvad027","article-title":"Outcome after pediatric craniopharyngioma: the role of age at diagnosis and hypothalamic damage","volume":"188","author":"Beckhaus","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00260-7_bib6","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ecl.2020.05.010","article-title":"Pituitary tumors centers of excellence","volume":"49","author":"Frara","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(23)00260-7_bib7","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1530\/EJE-20-0652","article-title":"Evaluation of an individualized education program in pituitary diseases: a pilot study","volume":"183","author":"Albarel","year":"2020","journal-title":"Eur J Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:05Z","timestamp":1761991985000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723002607"}},"issued":{"date-parts":[[2023,10]]},"references-count":7,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2213858723002607"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00260-7","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Craniopharyngioma: medico-social support for optimised care","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00260-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T12:40:06Z","timestamp":1746189606115,"version":"3.40.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/s2213-8587(25)00024-5","type":"journal-article","created":{"date-parts":[[2025,2,28]],"date-time":"2025-02-28T23:31:32Z","timestamp":1740785492000},"page":"357-358","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Promising treatment options with tirzepatide for Japanese individuals with obesity disease"],"prefix":"10.1016","volume":"13","author":[{"given":"Michael A","family":"Nauck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Soo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00024-5_bib1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00024-5_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00024-5_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00024-5_bib4","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00024-5_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00377-2","article-title":"Efficacy and safety of once-weekly tirzepatide in Japanese patients with obesity disease (SURMOUNT-J): a multicentre, randomised, double-blind, placebo-controlled phase 3 trial","author":"Kadowaki","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00024-5_bib6","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1507\/endocrj.EJ23-0593","article-title":"Definition, criteria, and core concepts of guidelines for the management of obesity disease in Japan","volume":"71","author":"Ogawa","year":"2024","journal-title":"Endocr J"},{"key":"10.1016\/S2213-8587(25)00024-5_bib7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1016\/j.metabol.2009.03.021","article-title":"Higher liver fat content among Japanese in Japan compared with non-Hispanic whites in the United States","volume":"58","author":"Azuma","year":"2009","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(25)00024-5_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1111\/jdi.12305","article-title":"Incretin physiology and pathophysiology from an Asian perspective","volume":"6","author":"Cho","year":"2015","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(25)00024-5_bib9","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00024-5_bib10","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1056\/NEJMoa2404881","article-title":"Tirzepatide for the treatment of obstructive sleep apnea and obesity","volume":"391","author":"Malhotra","year":"2024","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000245?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000245?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T14:49:39Z","timestamp":1746110979000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000245"}},"issued":{"date-parts":[[2025,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2213858725000245"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00024-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Promising treatment options with tirzepatide for Japanese individuals with obesity disease","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00024-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00377-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:16Z","timestamp":1761992176037,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/s2213-8587(22)00217-0","type":"journal-article","created":{"date-parts":[[2022,7,28]],"date-time":"2022-07-28T18:42:31Z","timestamp":1659033751000},"page":"697","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Paisan Ruamviboonsuk: saving sight in Thailand"],"prefix":"10.1016","volume":"10","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:25Z","timestamp":1761991885000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722002170"}},"issued":{"date-parts":[[2022,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2213858722002170"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00217-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Paisan Ruamviboonsuk: saving sight in Thailand","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00217-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2589-7500(22)00017-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T10:28:23Z","timestamp":1758709703368},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T00:00:00Z","timestamp":1383696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/s2213-8587(13)70171-2","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T02:00:15Z","timestamp":1383789615000},"page":"94-95","source":"Crossref","is-referenced-by-count":4,"title":["Metformin for cardiovascular disease: promise still unproven"],"prefix":"10.1016","volume":"2","author":[{"given":"Chris P H","family":"Lexis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iwan C C","family":"van der Horst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70171-2_bib1","article-title":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial","author":"Preiss","year":"2013","journal-title":"Lancet Diabet & Endocrinol"},{"key":"10.1016\/S2213-8587(13)70171-2_bib2","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1440-1681.2008.04920.x","article-title":"Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study","volume":"35","author":"Meaney","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/S2213-8587(13)70171-2_bib3","doi-asserted-by":"crossref","first-page":"1906","DOI":"10.1007\/s00125-004-1547-8","article-title":"Metformin or gliclazide, rather than glibenclamide, attenuate progression of carotid intima-media thickness in subjects with type 2 diabetes","volume":"47","author":"Katakami","year":"2004","journal-title":"Diabetalogia"},{"key":"10.1016\/S2213-8587(13)70171-2_bib4","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1111\/j.1463-1326.2008.00959.x","article-title":"Study rationale and design of the CIMT trial: the Copenhagen Insulin and Metformin Therapy trial","volume":"11","author":"Lundby Christensen","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70171-2_bib5","doi-asserted-by":"crossref","first-page":"445.e1","DOI":"10.1016\/j.ahj.2006.11.005","article-title":"A randomized trial of the effects of rosiglitazone and metformin on inflammation and subclinical atherosclerosis in patients with type 2 diabetes","volume":"153","author":"Stocker","year":"2007","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(13)70171-2_bib6","doi-asserted-by":"crossref","first-page":"H459","DOI":"10.1152\/ajpheart.00054.2011","article-title":"Metformin improves cardiac function in a nondiabetic rat model of post-MI heart failure","volume":"301","author":"Yin","year":"2011","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/S2213-8587(13)70171-2_bib7","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s10557-008-6092-0","article-title":"Metformin: effects on micro and macrovascular complications in type 2 diabetes","volume":"22","author":"Bailey","year":"2008","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/S2213-8587(13)70171-2_bib8","doi-asserted-by":"crossref","first-page":"944","DOI":"10.2337\/db11-1132","article-title":"Metformin prevents the development of chronic heart failure in the SHHF rat model","volume":"61","author":"Cittadini","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70171-2_bib9","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1016\/j.amjcard.2004.02.028","article-title":"Relation of metformin treatment to clinical events in diabetic patient undergoing percutaneous intervention","volume":"93","author":"Kao","year":"2004","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(13)70171-2_bib10","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1001\/archinternmed.2010.409","article-title":"Metformin use and mortality among patients with diabetes and atherothrombosis","volume":"170","author":"Roussel","year":"2010","journal-title":"Arch Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T00:56:55Z","timestamp":1539219415000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701712"}},"issued":{"date-parts":[[2014,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S2213858713701712"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70171-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,2]]}},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T20:28:07Z","timestamp":1649190487677},"reference-count":8,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/s2213-8587(15)00209-0","type":"journal-article","created":{"date-parts":[[2015,7,12]],"date-time":"2015-07-12T23:46:04Z","timestamp":1436744764000},"page":"581-582","source":"Crossref","is-referenced-by-count":0,"title":["Metformin in cardiac surgery: high expectations"],"prefix":"10.1016","volume":"3","author":[{"given":"Iwan CC","family":"van der Horst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maarten WN","family":"Nijsten","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00209-0_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00121-7","article-title":"Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial","author":"El Messaoudi","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00209-0_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1136\/bmj.3.5672.683","article-title":"Triple Starr valve replacement","volume":"3","author":"Braimbridge","year":"1969","journal-title":"Br Med J"},{"key":"10.1016\/S2213-8587(15)00209-0_bib3","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.ejcts.2010.10.007","article-title":"Glucose-insulin-potassium therapy in adult patients undergoing cardiac surgery: a meta-analysis","volume":"40","author":"Fan","year":"2011","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/S2213-8587(15)00209-0_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10557-012-6413-1","article-title":"Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial","volume":"26","author":"Lexis","year":"2012","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/S2213-8587(15)00209-0_bib5","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s13054-015-0736-9","article-title":"Effect of high-dose dexamethasone on perioperative lactate levels and glucose control: a randomized controlled trial","volume":"19","author":"Ottens","year":"2015","journal-title":"Crit Care"},{"key":"10.1016\/S2213-8587(15)00209-0_bib6","first-page":"206","article-title":"Comparison of metformin and insulin in the control of hyperglycaemia in non-diabetic critically ill patients","volume":"63","author":"Mojtahedzadeh","year":"2012","journal-title":"Endokrynol Pol"},{"key":"10.1016\/S2213-8587(15)00209-0_bib7","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S2213-8587(13)70152-9","article-title":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial","volume":"2","author":"Preiss","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00209-0_bib8","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.2014.3315","article-title":"Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial","volume":"311","author":"Lexis","year":"2014","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T04:07:28Z","timestamp":1563336448000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002090"}},"issued":{"date-parts":[[2015,8]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S2213858715002090"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00209-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,8]]}},{"indexed":{"date-parts":[[2024,3,13]],"date-time":"2024-03-13T02:43:59Z","timestamp":1710297839288},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/s2213-8587(18)30341-3","type":"journal-article","created":{"date-parts":[[2018,12,6]],"date-time":"2018-12-06T23:42:43Z","timestamp":1544139763000},"page":"1","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Type 1 diabetes research: poised for progress"],"prefix":"10.1016","volume":"7","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T20:26:55Z","timestamp":1555532815000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303413"}},"issued":{"date-parts":[[2019,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2213858718303413"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30341-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes research: poised for progress","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30341-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30112-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30109-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:17:21Z","timestamp":1761992241875,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/s2213-8587(23)00386-8","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T18:28:46Z","timestamp":1706034526000},"page":"95","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Rafik Jacob: Caring for the most vulnerable"],"prefix":"10.1016","volume":"12","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003868?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003868?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:33Z","timestamp":1761992013000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003868"}},"issued":{"date-parts":[[2024,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2213858723003868"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00386-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rafik Jacob: Caring for the most vulnerable","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00386-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,3]],"date-time":"2025-11-03T23:03:44Z","timestamp":1762211024065,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/s2213-8587(22)00106-1","type":"journal-article","created":{"date-parts":[[2022,4,21]],"date-time":"2022-04-21T18:34:41Z","timestamp":1650566081000},"page":"378-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The ABC targets of diabetes in India"],"prefix":"10.1016","volume":"10","author":[{"given":"Jennifer","family":"Manne-Goehler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"author":"Gregg","key":"10.1016\/S2213-8587(22)00106-1_bib2"},{"key":"10.1016\/S2213-8587(22)00106-1_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(22)00072-9","article-title":"Achievement of guideline recommended diabetes treatment targets and health habits in people with self-reported diabetes in India (ICMR-INDIAB-13): a national cross-sectional study","author":"Anjana","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00106-1_bib4","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/nrendo.2016.53","article-title":"Diabetes mellitus and its complications in India","volume":"12","author":"Unnikrishnan","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(22)00106-1_bib5","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1001\/jamainternmed.2017.8094","article-title":"Diabetes and hypertension in India: a nationally representative study of 1\u00b73 million adults","volume":"178","author":"Geldsetzer","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(22)00106-1_bib6","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2666-7568(21)00089-1","article-title":"The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680\u2008102 adults","volume":"2","author":"Flood","year":"2021","journal-title":"Lancet Healthy Longevity"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:38Z","timestamp":1761991898000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001061"}},"issued":{"date-parts":[[2022,6]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2213858722001061"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00106-1","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ABC targets of diabetes in India","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00106-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00072-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:45Z","timestamp":1761991965009,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/s2213-8587(21)00114-5","type":"journal-article","created":{"date-parts":[[2021,4,20]],"date-time":"2021-04-20T18:30:50Z","timestamp":1618943450000},"page":"334","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Elizabeth Pearce: maintaining the fight against iodine deficiency"],"prefix":"10.1016","volume":"9","author":[{"given":"Ray","family":"Cavanaugh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:08Z","timestamp":1761991748000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001145"}},"issued":{"date-parts":[[2021,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213858721001145"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00114-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Elizabeth Pearce: maintaining the fight against iodine deficiency","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00114-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,25]],"date-time":"2026-07-25T04:38:10Z","timestamp":1784954290084,"version":"3.55.0"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008018","name":"Victorian Cancer Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008018","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01AG029824"],"award-info":[{"award-number":["U01AG029824"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1127060"],"award-info":[{"award-number":["1127060"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["334047"],"award-info":[{"award-number":["334047"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/s2213-8587(23)00327-3","type":"journal-article","created":{"date-parts":[[2023,12,21]],"date-time":"2023-12-21T18:32:39Z","timestamp":1703183559000},"page":"98-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial"],"prefix":"10.1016","volume":"12","author":[{"given":"Sophia","family":"Zoungas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhen","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice J","family":"Owen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara E","family":"Espinoza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"Ernst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robyn L","family":"Woods","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne G","family":"Orchard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"McNeil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne M","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher M","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Ryan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Wolfe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00327-3_bib2","doi-asserted-by":"crossref","first-page":"2114","DOI":"10.2337\/dc06-1136","article-title":"Impact of recent increase in incidence on future diabetes burden: US, 2005\u20132050","volume":"29","author":"Narayan","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00327-3_bib3","doi-asserted-by":"crossref","first-page":"M5","DOI":"10.1093\/gerona\/56.1.M5","article-title":"Diabetes in elderly adults","volume":"56","author":"Meneilly","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(23)00327-3_bib4","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2337\/dc16-1732","article-title":"The pathophysiology of hyperglycemia in older adults: clinical considerations","volume":"40","author":"Lee","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00327-3_bib5","doi-asserted-by":"crossref","first-page":"195","DOI":"10.2174\/157339906776818532","article-title":"Relationship between inflammation, insulin resistance and type 2 diabetes: \u2018cause or effect\u2019?","volume":"2","author":"Greenfield","year":"2006","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/S2213-8587(23)00327-3_bib6","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1053\/meta.2002.32804","article-title":"Subclinical inflammation is strongly related to insulin resistance but not to impaired insulin secretion in a high risk population for diabetes","volume":"51","author":"Temelkova-Kurktschiev","year":"2002","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(23)00327-3_bib7","first-page":"45","article-title":"Type 2 diabetes mellitus, oxidative stress and inflammation: examining the links","volume":"11","author":"Oguntibeju","year":"2019","journal-title":"Int J Physiol Pathophysiol Pharmacol"},{"key":"10.1016\/S2213-8587(23)00327-3_bib8","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1016\/S0002-9343(99)00066-2","article-title":"Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly","volume":"106","author":"Harris","year":"1999","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(23)00327-3_bib9","first-page":"1799","article-title":"Plasma fibrinogen level and the risk of major cardiovascular diseases and nonvascular mortality: an individual participant meta-analysis","volume":"294","author":"Danesh","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00327-3_bib10","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1016\/S0140-6736(09)61717-7","article-title":"C-reactive protein concentration and risk of coronary heart disease, stroke, and mortality: an individual participant meta-analysis","volume":"375","author":"Kaptoge","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00327-3_bib11","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1345\/aph.1M483","article-title":"Potential role of salicylates in type 2 diabetes","volume":"44","author":"Rumore","year":"2010","journal-title":"Ann Pharmacother"},{"key":"10.1016\/S2213-8587(23)00327-3_bib12","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.amjmed.2008.09.044","article-title":"Aspirin use and risk of type 2 diabetes in apparently healthy men","volume":"122","author":"Hayashino","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(23)00327-3_bib13","doi-asserted-by":"crossref","first-page":"1944","DOI":"10.2337\/dc13-2977","article-title":"Effect of salsalate on insulin action, secretion, and clearance in nondiabetic, insulin-resistant individuals: a randomized, placebo-controlled study","volume":"37","author":"Kim","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00327-3_bib14","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1007\/BF00291974","article-title":"Acetyl-salicylic acid impairs insulin-mediated glucose utilization and reduces insulin clearance in healthy and non-insulin-dependent diabetic man","volume":"28","author":"Bratusch-Marrain","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00327-3_bib15","doi-asserted-by":"crossref","first-page":"3","DOI":"10.2337\/dc08-1206","article-title":"A randomized trial of low-dose aspirin in the prevention of clinical type 2 diabetes in women","volume":"32","author":"Pradhan","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00327-3_bib16","first-page":"204","article-title":"The importance and strategy of diabetes prevention","volume":"2","author":"Shi","year":"2016","journal-title":"Chronic Dis Transl Med"},{"key":"10.1016\/S2213-8587(23)00327-3_bib17","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.amjcard.2018.10.032","article-title":"Prevention of diabetes mellitus in patients with prediabetes","volume":"123","author":"Carris","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(23)00327-3_bib18","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1056\/NEJMoa1803955","article-title":"Effect of aspirin on all-cause mortality in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00327-3_bib19","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1056\/NEJMoa1805819","article-title":"Effect of aspirin on cardiovascular events and bleeding in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00327-3_bib20","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1056\/NEJMoa1800722","article-title":"Effect of aspirin on disability-free survival in the healthy elderly","volume":"379","author":"McNeil","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00327-3_bib21","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/j.cct.2013.09.014","article-title":"Study design of Aspirin in Reducing Events in the Elderly (ASPREE): a randomized, controlled trial","volume":"36","year":"2013","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/S2213-8587(23)00327-3_bib22","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1080\/13854046.2018.1488996","article-title":"Normative performance of healthy older individuals on the Modified Mini-Mental State (3MS) examination according to ethno-racial group, gender, age, and education level","volume":"33","author":"Ryan","year":"2019","journal-title":"Clin Neuropsychol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00327-3_bib23","first-page":"S15","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes\u20142021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00327-3_bib25","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1093\/gerona\/glab340","article-title":"The effect of low-dose aspirin on frailty phenotype and frailty index in community-dwelling older adults in the Aspirin in Reducing Events in the Elderly study","volume":"77","author":"Espinoza","year":"2022","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(23)00327-3_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/S2213-8587(23)00327-3_bib27","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1111\/j.1538-7836.2010.03997.x","article-title":"The role of weight and enteric coating on aspirin response in cardiovascular patients","volume":"8","author":"Peace","year":"2010","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2213-8587(23)00327-3_bib28","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1093\/eurheartj\/ehy066","article-title":"Antithrombotic therapy and body mass: an expert position paper of the ESC Working Group on Thrombosis","volume":"39","author":"Rocca","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(23)00327-3_bib29","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S0140-6736(18)31133-4","article-title":"Effects of aspirin on risks of vascular events and cancer according to bodyweight and dose: analysis of individual patient data from randomised trials","volume":"392","author":"Rothwell","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00327-3_bib30","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.4049\/jimmunol.0900477","article-title":"Effects of low-dose aspirin on acute inflammatory responses in humans","volume":"183","author":"Morris","year":"2009","journal-title":"J Immunol"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(23)00327-3_bib31","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1038\/sj.ijo.0802501","article-title":"Inflammation and the IKK beta\/I kappa B\/NF-kappa B axis in obesity- and diet-induced insulin resistance","volume":"27","author":"Shoelson","year":"2003","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(23)00327-3_bib32","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1177\/1753944707088185","article-title":"Aspirin and diabetes mellitus: revisiting an old player","volume":"2","author":"Manrique","year":"2008","journal-title":"Ther Adv Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(23)00327-3_bib33","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1038\/nrendo.2009.109","article-title":"Diabetes: aspirin and prevention of diabetes still a topic of debate","volume":"5","author":"Lastra","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00327-3_bib34","doi-asserted-by":"crossref","first-page":"826","DOI":"10.4158\/EP12064.OR","article-title":"Reduction of insulin resistance and plasma glucose level by salsalate treatment in persons with prediabetes","volume":"18","author":"Faghihimani","year":"2012","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(23)00327-3_bib35","doi-asserted-by":"crossref","first-page":"289","DOI":"10.2337\/dc07-1338","article-title":"Salsalate improves glycemia and inflammatory parameters in obese young adults","volume":"31","author":"Fleischman","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00327-3_bib36","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1007\/s00125-012-2819-3","article-title":"A randomised trial of salsalate for insulin resistance and cardiovascular risk factors in persons with abnormal glucose tolerance","volume":"56","author":"Goldfine","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00327-3_bib37","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1161\/CIRCRESAHA.118.312806","article-title":"Age-related changes in glucose metabolism, hyperglycemia, and cardiovascular risk","volume":"123","author":"Chia","year":"2018","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(23)00327-3_bib38","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.2337\/dc08-0577","article-title":"Effect of aging on A1C levels in individuals without diabetes: evidence from the Framingham Offspring Study and the National Health and Nutrition Examination Survey 2001\u20132004","volume":"31","author":"Pani","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00327-3_bib39","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1804988","article-title":"Effects of aspirin for primary prevention in persons with diabetes mellitus","volume":"379","author":"Bowman","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00327-3_bib40","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/S0140-6736(18)31924-X","article-title":"Use of aspirin to reduce risk of initial vascular events in patients at moderate risk of cardiovascular disease (ARRIVE): a randomised, double-blind, placebo-controlled trial","volume":"392","author":"Gaziano","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00327-3_bib41","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1136\/gutjnl-2020-321585","article-title":"Major GI bleeding in older persons using aspirin: incidence and risk factors in the ASPREE randomised controlled trial","volume":"70","author":"Mahady","year":"2021","journal-title":"Gut"},{"key":"10.1016\/S2213-8587(23)00327-3_bib42","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.25803","article-title":"Low-dose aspirin and the risk of stroke and intracerebral bleeding in healthy older people: secondary analysis of a randomized clinical trial","volume":"6","author":"Cloud","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(23)00327-3_bib43","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1038\/ajg.2010.436","article-title":"Low-dose aspirin-induced ulceration is attenuated by aspirin-phosphatidylcholine: a randomized clinical trial","volume":"106","author":"Cryer","year":"2011","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(23)00327-3_bib44","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1007\/s11239-020-02051-5","article-title":"Bioavailability of aspirin in fasted and fed states of a novel pharmaceutical lipid aspirin complex formulation","volume":"49","author":"Angiolillo","year":"2020","journal-title":"J Thromb Thrombolysis"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:47Z","timestamp":1761991967000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003273"}},"issued":{"date-parts":[[2024,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2213858723003273"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00327-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Daily low-dose aspirin and incident type 2 diabetes in community-dwelling healthy older adults: a post-hoc analysis of efficacy and safety in the ASPREE randomised placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00327-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00363-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:41:37Z","timestamp":1786999297861,"version":"build-2736575974"},"reference-count":7,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/s2213-8587(22)00036-5","type":"journal-article","created":{"date-parts":[[2022,2,7]],"date-time":"2022-02-07T18:31:46Z","timestamp":1644258706000},"page":"159-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["An inter-humanitarian agency study of diabetes care and surveillance in humanitarian settings"],"prefix":"10.1016","volume":"10","author":[{"given":"Sylvia","family":"Kehlenbrink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Omar","family":"Mahboob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Al-Zubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Boulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigiriya","family":"Aebischer Perone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmad Hecham","family":"Alani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Kiapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Hering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Donelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Kayden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bianca C","family":"Porneala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Rosner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James B","family":"Meigs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00036-5_bib2","series-title":"Global trends: forced displacement in 2020","year":"2021"},{"key":"10.1016\/S2213-8587(22)00036-5_bib3","doi-asserted-by":"crossref","first-page":"590","DOI":"10.1016\/S2213-8587(19)30197-4","article-title":"Diabetes in humanitarian crises: the Boston Declaration","volume":"7","author":"Kehlenbrink","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00036-5_bib4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S2213-8587(19)30082-8","article-title":"The burden of diabetes and use of diabetes care in humanitarian crises in low-income and middle-income countries","volume":"7","author":"Kehlenbrink","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00036-5_bib5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1093\/heapol\/czab007","article-title":"Models of care for patients with hypertension and diabetes in humanitarian crises: a systematic review","volume":"36","author":"Jaung","year":"2021","journal-title":"Health Policy Plan"},{"key":"10.1016\/S2213-8587(22)00036-5_bib6","series-title":"Global Report on Internal Displacement 2021","year":"2021"},{"key":"10.1016\/S2213-8587(22)00036-5_bib7","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(22)00036-5_bib8","series-title":"WHO Discussion Paper: draft recommendations to strengthen and monitor diabetes responses within national noncommunicable disease programmes, including potential targets","year":"2021"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:40Z","timestamp":1761991840000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000365"}},"issued":{"date-parts":[[2022,3]]},"references-count":7,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2213858722000365"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00036-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An inter-humanitarian agency study of diabetes care and surveillance in humanitarian settings","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00036-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30197-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:43:05Z","timestamp":1786999385535,"version":"build-2736575974"},"reference-count":23,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/s2213-8587(25)00223-2","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T16:14:59Z","timestamp":1757520899000},"page":"891-896","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Strengthening non-communicable disease care in all-hazards emergencies"],"prefix":"10.1016","volume":"13","author":[{"given":"Kiran","family":"Jobanputra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sigiriya Aebischer","family":"Perone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9imh\u00edn","family":"Ansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saeed","family":"Baraiah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sadhana","family":"Bhagwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Boulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hicham","family":"El-Berri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibtihal","family":"Fadhil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Kehlenbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lilian","family":"Kiapi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars Bruun","family":"Larsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelheid","family":"Marschang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iryna","family":"Vlasenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Woodman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00223-2_bib7","author":"Pierce"},{"key":"10.1016\/S2213-8587(25)00223-2_bib8","series-title":"Noncommunicable diseases\u2014a compendium","first-page":"285","article-title":"Financing and allocating resources for NCD prevention and control","author":"Banatvala","year":"2023"},{"key":"10.1016\/S2213-8587(25)00223-2_bib10","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(16)31404-0","article-title":"Care of non-communicable diseases in emergencies","volume":"389","author":"Slama","year":"2017","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00223-2_bib17","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5365\/wpsar.2015.6.3.HYN_024","article-title":"Use of the WHO package of essential noncommunicable disease interventions after typhoon Haiyan","volume":"6","author":"Martinez","year":"2015","journal-title":"Western Pac Surveill Response J"},{"key":"10.1016\/S2213-8587(25)00223-2_bib19","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.1980","article-title":"Sudan's healthcare crisis: the struggle of kidney patients amidst conflict","volume":"7","author":"Konozy","year":"2024","journal-title":"Health Sci Rep"},{"key":"10.1016\/S2213-8587(25)00223-2_bib20","doi-asserted-by":"crossref","first-page":"72","DOI":"10.4274\/balkanmedj.galenos.2023.27022023","article-title":"Management of crush-related acute kidney injury after disasters","volume":"40","author":"Kandemir","year":"2023","journal-title":"Balkan Med J"},{"key":"10.1016\/S2213-8587(25)00223-2_bib23","author":"Enea"},{"key":"10.1016\/S2213-8587(25)00223-2_bib25","doi-asserted-by":"crossref","first-page":"e3553","DOI":"10.1210\/clinem\/dgac331","article-title":"Strengthening diabetes care in humanitarian crises in low- and middle-income settings","volume":"107","author":"Kehlenbrink","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00223-2_bib31","author":"Beart"},{"key":"10.1016\/S2213-8587(25)00223-2_bib38","doi-asserted-by":"crossref","first-page":"20","DOI":"10.32352\/0367-3057.4.22.03","article-title":"Elements of good pharmaceutical practice in the implementation of pharmaceutical care for patients with diabetes during the martial law","volume":"4","author":"Vlasenko","year":"2022","journal-title":"Farm Zh"},{"key":"10.1016\/S2213-8587(25)00223-2_bib39","doi-asserted-by":"crossref","first-page":"22","DOI":"10.32352\/0367-3057.3.22.03","article-title":"Study of the needs and pharmaceutical provision of patients with diabetes during time of state of martial law","volume":"3","author":"Vlasenko","year":"2022","journal-title":"Farm Zh"},{"key":"10.1016\/S2213-8587(25)00223-2_bib40","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/S0140-6736(24)00230-7","article-title":"UNRWA at the frontlines: managing health care in Gaza during catastrophe","volume":"403","author":"Al-Jadba","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00223-2_bib41","article-title":"Thermal stability and storage of human insulin","volume":"11","author":"Richter","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(25)00223-2_bib42","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/S1470-2045(23)00577-6","article-title":"Strategies to promote sustainable care for children with cancer in Ukraine","volume":"25","author":"Agulnik","year":"2024","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(25)00223-2_bib43","doi-asserted-by":"crossref","first-page":"250","DOI":"10.26719\/2025.31.4.250","article-title":"Experiences of children with kidney failure in Gaza","volume":"31","author":"Ankah","year":"2025","journal-title":"East Mediterr Health J"},{"key":"10.1016\/S2213-8587(25)00223-2_bib44","doi-asserted-by":"crossref","first-page":"e645","DOI":"10.1016\/S2352-3026(22)00259-9","article-title":"Global effort to evacuate Ukrainian children with cancer and blood disorders who have been affected by war","volume":"9","author":"Agulnik","year":"2022","journal-title":"Lancet Haematol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00223-2_bib45","doi-asserted-by":"crossref","first-page":"21","DOI":"10.5365\/wpsar.2015.6.3.HYN_020","article-title":"Surveillance for and issues relating to noncommunicable diseases post-Haiyan in region 8","volume":"6","author":"Martinez","year":"2015","journal-title":"Western Pac Surveill Response J"},{"key":"10.1016\/S2213-8587(25)00223-2_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2023-012998","article-title":"Recovery of health systems during protracted humanitarian crises: a case for bridging the humanitarian-development divide within the health sector","volume":"8","author":"Olu","year":"2023","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S2213-8587(25)00223-2_bib48","author":"Schmid"},{"key":"10.1016\/S2213-8587(25)00223-2_bib50","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/S2213-8587(22)00168-1","article-title":"Diabetes in humanitarian crises","volume":"10","author":"Burki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00223-2_bib51","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13031-021-00345-w","article-title":"Operational considerations for the management of non-communicable diseases in humanitarian emergencies","volume":"15","author":"Bausch","year":"2021","journal-title":"Confl Health"},{"key":"10.1016\/S2213-8587(25)00223-2_bib52","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/j.semnephrol.2020.06.007","article-title":"Role of the international and national renal organizations in natural disasters: strategies for renal rescue","volume":"40","author":"Lameire","year":"2020","journal-title":"Semin Nephrol"},{"key":"10.1016\/S2213-8587(25)00223-2_bib53","author":"Schmid"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T16:15:49Z","timestamp":1757520949000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002232"}},"issued":{"date-parts":[[2025,10]]},"references-count":23,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2213858725002232"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00223-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strengthening non-communicable disease care in all-hazards emergencies","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00223-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T18:00:25Z","timestamp":1787508025473,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/s2213-8587(25)00200-1","type":"journal-article","created":{"date-parts":[[2025,8,25]],"date-time":"2025-08-25T22:38:33Z","timestamp":1756161513000},"page":"816-818","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cardiovascular risk in type 1 versus type 2 diabetes"],"prefix":"10.1016","volume":"13","author":[{"given":"Anna","family":"Solini","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00200-1_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107833","article-title":"Meta-analysis of type 1 diabetes mellitus and risk of cardiovascular disease","volume":"35","author":"Cai","year":"2021","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(25)00200-1_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc22-1744","article-title":"Relationships between the cumulative incidences of long-term complications in type 1 diabetes: the DCCT\/EDIC study","volume":"46","author":"Bebu","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00200-1_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108591","article-title":"Moderation of the effect of glycemia on the risk of cardiovascular disease in type 1 diabetes: the DCCT\/EDIC study","volume":"171","author":"Bebu","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00200-1_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00165-2","article-title":"Risk differences and underlying factors of cardiovascular events and mortality in patients with type 2 diabetes versus type 1 diabetes: a longitudinal cohort study of Swedish nationwide register data","author":"Patsoukaki","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00200-1_bib5","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1186\/s12933-025-02803-8","article-title":"Cumulative exposures to glycaemia and lipids are associated with coronary artery disease in type 1 diabetes: a call for action","volume":"24","author":"Bergdal","year":"2025","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(25)00200-1_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1186\/s12933-019-0961-7","article-title":"Microvascular complications burden (nephropathy, retinopathy and peripheral polyneuropathy) affects risk of major vascular events and all-cause mortality in type 1 diabetes: a 10-year follow-up study","volume":"18","author":"Garofolo","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(25)00200-1_bib7","doi-asserted-by":"crossref","first-page":"804","DOI":"10.3390\/ijms25020804","article-title":"Diabetic vasculopathy: molecular mechanisms and clinical Insights","volume":"25","author":"Jia","year":"2024","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(25)00200-1_bib8","doi-asserted-by":"crossref","first-page":"2266","DOI":"10.2337\/dc24-0475","article-title":"Association of insulin resistance with cardiovascular disease and all-cause mortality in type 1 diabetes: systematic review and meta-analysis","volume":"47","author":"Sun","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00200-1_bib9","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1007\/s00125-023-05975-8","article-title":"SGLT2i and GLP-1 RA therapy in type 1 diabetes and reno-vascular outcomes: a real-world study","volume":"66","author":"Anson","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00200-1_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110908","article-title":"Rationale and design of a randomised phase III registration trial investigating finerenone in participants with type 1 diabetes and chronic kidney disease: The FINE-ONE trial","volume":"204","author":"Heerspink","year":"2023","journal-title":"Diabetes Res Clin Pract"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T16:15:36Z","timestamp":1757520936000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002001"}},"issued":{"date-parts":[[2025,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2213858725002001"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00200-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular risk in type 1 versus type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00200-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00165-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T10:05:51Z","timestamp":1782900351849,"version":"3.54.5"},"reference-count":7,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/s2213-8587(22)00257-1","type":"journal-article","created":{"date-parts":[[2022,9,13]],"date-time":"2022-09-13T18:48:38Z","timestamp":1663094918000},"page":"688-689","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Growing global burden of type 1 diabetes needs multitiered precision public health interventions"],"prefix":"10.1016","volume":"10","author":[{"given":"Serena Jingchuan","family":"Guo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00257-1_bib1","article-title":"Global, regional, and national burden and trend of diabetes in 195 countries and territories: an analysis from 1990 to 2025","volume":"10","author":"Lin","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(22)00257-1_bib2","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes\u2014Global Burden of Disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/S2213-8587(22)00257-1_bib3","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1007\/s00125-019-4863-8","article-title":"Type 1 diabetes defined by severe insulin deficiency occurs after 30 years of age and is commonly treated as type 2 diabetes","volume":"62","author":"Thomas","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00257-1_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00257-1_bib5","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1111\/pedi.12565","article-title":"Systematic review of publicity interventions to increase awareness amongst healthcare professionals and the public to promote earlier diagnosis of type 1 diabetes in children and young people","volume":"19","author":"Deylami","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(22)00257-1_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2019-001410","article-title":"Insulin prices, availability and affordability in 13 low-income and middle-income countries","volume":"4","author":"Ewen","year":"2019","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S2213-8587(22)00257-1_bib7","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-020-05375-2","article-title":"A global perspective on the issue of access to insulin","volume":"64","author":"Beran","year":"2021","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002571?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002571?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:20Z","timestamp":1761991880000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722002571"}},"issued":{"date-parts":[[2022,10]]},"references-count":7,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2213858722002571"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00257-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Growing global burden of type 1 diabetes needs multitiered precision public health interventions","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00257-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00218-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T19:36:16Z","timestamp":1791920176634,"version":"4.3.4"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003748","name":"Svenska S\u00e4llskapet f\u00f6r Medicinsk Forskning","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003748","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/s2213-8587(18)30320-6","type":"journal-article","created":{"date-parts":[[2018,12,5]],"date-time":"2018-12-05T18:36:48Z","timestamp":1544035008000},"page":"106-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden"],"prefix":"10.1016","volume":"7","author":[{"given":"Henrik","family":"Svanstr\u00f6m","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mads","family":"Melbye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Eliasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann-Marie","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Franz\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soffia","family":"Gudbj\u00f6rnsdottir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristian","family":"Hveem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Jonasson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Pasternak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30320-6_bib1","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","article-title":"ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(18)30320-6_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30320-6_bib3","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30320-6_bib4","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30320-6_bib5","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30320-6_bib6","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30320-6_bib7","first-page":"S73","article-title":"8. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes\u20142018","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30320-6_bib8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1111\/dom.12665","article-title":"Comparative cardiovascular safety of glucagon-like peptide-1 receptor agonists versus other antidiabetic drugs in routine care: a cohort study","volume":"18","author":"Patorno","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30320-6_bib9","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30320-6_bib10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30320-6_bib11","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30320-6_bib12","article-title":"Effect of linagliptin vs placebo on major cardiovascular events in adults with type 2 diabetes and high cardiovascular and renal risk: the CARMELINA randomized clinical trial","author":"Rosenstock","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30320-6_bib13","first-page":"798","article-title":"Data resource profile: the Danish National Prescription Registry","volume":"46","author":"Potteg\u00e5rd","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(18)30320-6_bib14","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/S2213-8587(18)30320-6_bib15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1007\/s10654-017-0316-1","article-title":"The Swedish cause of death register","volume":"32","author":"Brooke","year":"2017","journal-title":"Eur J Epidemiol"},{"issue":"7 suppl","key":"10.1016\/S2213-8587(18)30320-6_bib16","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1177\/1403494811399958","article-title":"The Danish Register of Causes of Death","volume":"39","author":"Helweg-Larsen","year":"2011","journal-title":"Scand J Public Health"},{"key":"10.1016\/S2213-8587(18)30320-6_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(18)30320-6_bib18","doi-asserted-by":"crossref","first-page":"449","DOI":"10.2147\/CLEP.S91125","article-title":"The Danish National Patient Registry: a review of content, data quality, and research potential","volume":"7","author":"Schmidt","year":"2015","journal-title":"Clin Epidemiol"},{"key":"10.1016\/S2213-8587(18)30320-6_bib19","doi-asserted-by":"crossref","first-page":"e012817","DOI":"10.1136\/bmjopen-2016-012817","article-title":"Positive predictive value of cardiac examination, procedure and surgery codes in the Danish National Patient Registry: a population-based validation study","volume":"6","author":"Adelborg","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(18)30320-6_bib20","doi-asserted-by":"crossref","first-page":"e012832","DOI":"10.1136\/bmjopen-2016-012832","article-title":"Positive predictive value of cardiovascular diagnoses in the Danish National Patient Registry: a validation study","volume":"6","author":"Sundb\u00f8ll","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(18)30320-6_bib21","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s10654-016-0117-y","article-title":"Registers of the Swedish total population and their use in medical research","volume":"31","author":"Ludvigsson","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(18)30320-6_bib22","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s10654-014-9930-3","article-title":"The Danish Civil Registration System as a tool in epidemiology","volume":"29","author":"Schmidt","year":"2014","journal-title":"Eur J Epidemiol"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(18)30320-6_bib23","doi-asserted-by":"crossref","first-page":"S291","DOI":"10.1016\/S0168-8227(14)70732-6","article-title":"Diabetes care\u2014improvement through measurement","volume":"106","author":"Eliasson","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30320-6_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1002\/bimj.200810488","article-title":"Some methods of propensity-score matching had superior performance to others: results of an empirical investigation and Monte Carlo simulations","volume":"51","author":"Austin","year":"2009","journal-title":"Biom J"},{"key":"10.1016\/S2213-8587(18)30320-6_bib25","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1080\/01621459.2000.10474263","article-title":"Estimating and using propensity scores with partially missing data","volume":"95","author":"D'Agostino","year":"2000","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/S2213-8587(18)30320-6_bib26","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1002\/sim.2787","article-title":"Multiple imputation: review of theory, implementation and software","volume":"26","author":"Harel","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(18)30320-6_bib27","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2337\/dc17-1223","article-title":"Lower risk of death with SGLT2 inhibitors in observational studies: real or bias?","volume":"41","author":"Suissa","year":"2018","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:29Z","timestamp":1761991589000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303206"}},"issued":{"date-parts":[[2019,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2213858718303206"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30320-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Use of liraglutide and risk of major cardiovascular events: a register-based cohort study in Denmark and Sweden","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30320-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30340-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T11:42:00Z","timestamp":1790077320155,"version":"4.0.1"},"reference-count":95,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/s2213-8587(17)30099-2","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T00:45:19Z","timestamp":1495500319000},"page":"816-826","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":104,"title":["Puberty suppression in transgender children and adolescents"],"prefix":"10.1016","volume":"5","author":[{"given":"Simone","family":"Mahfouda","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia K","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aris","family":"Siafarikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Florian D","family":"Zepf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashleigh","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30099-2_bib1","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s10912-013-9228-6","article-title":"The endocrinologist's office\u2014puberty suppression: saving children from a natural disaster?","volume":"34","author":"Sadjadi","year":"2013","journal-title":"J Med Humanit"},{"key":"10.1016\/S2213-8587(17)30099-2_bib2","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1038\/nrurol.2016.128","article-title":"To treat or not to treat: puberty suppression in childhood-onset gender dysphoria","volume":"13","author":"Costa","year":"2016","journal-title":"Nat Rev Urol"},{"key":"10.1016\/S2213-8587(17)30099-2_bib3","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.jadohealth.2015.04.004","article-title":"Early medical treatment of children and adolescents with gender dysphoria: an empirical ethical study","volume":"57","author":"Vrouenraets","year":"2015","journal-title":"J Adolesc Health"},{"key":"10.1016\/S2213-8587(17)30099-2_bib4","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.chc.2011.08.001","article-title":"Treatment of adolescents with gender dysphoria in the Netherlands","volume":"20","author":"Cohen-Kettenis","year":"2011","journal-title":"Child Adolesc Psychiatr Clin N Am"},{"key":"10.1016\/S2213-8587(17)30099-2_bib5","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1007\/s007870050073","article-title":"Pubertal delay as an aid in diagnosis and treatment of a transsexual adolescent","volume":"7","author":"Cohen-Kettenis","year":"1998","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1080\/15532739.2011.700873","article-title":"Standards of care for the health of transsexual, transgender, and gender-nonconforming people, version 7","volume":"13","author":"Coleman","year":"2012","journal-title":"Int J Transgend"},{"key":"10.1016\/S2213-8587(17)30099-2_bib7","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.jadohealth.2015.11.010","article-title":"Characteristics of referrals for gender dysphoria over a 13-year period","volume":"58","author":"Chen","year":"2016","journal-title":"J Adolesc Health"},{"key":"10.1016\/S2213-8587(17)30099-2_bib8","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1542\/peds.2011-0907","article-title":"Children and adolescents with gender identity disorder referred to a pediatric medical center","volume":"129","author":"Spack","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(17)30099-2_bib9","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jpeds.2013.10.068","article-title":"Clinical management of youth with gender dysphoria in Vancouver","volume":"164","author":"Khatchadourian","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(17)30099-2_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1080\/00918369.2012.653300","article-title":"Clinical management of gender dysphoria in children and adolescents: the Dutch approach","volume":"59","author":"de Vries","year":"2012","journal-title":"J Homosex"},{"key":"10.1016\/S2213-8587(17)30099-2_bib11","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S2215-0366(15)00586-6","article-title":"Gender incongruence of childhood in the ICD-11: controversies, proposal and rationale","volume":"3","author":"Drescher","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib12","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/S2215-0366(16)30042-6","article-title":"The psycho-medical case against a gender incongruence of childhood diagnosis","volume":"3","author":"Winter","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib13","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1016\/S2215-0366(16)30043-8","article-title":"Removal of gender incongruence of childhood diagnostic category: a human rights perspective","volume":"3","author":"Cabral","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib14","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S2215-0366(16)30038-4","article-title":"Removal of gender incongruence of childhood diagnostic category: a human rights perspective\u2014Authors' reply","volume":"3","author":"Drescher","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib15","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"10.1016\/S2213-8587(17)30099-2_bib16","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/wps.20354","article-title":"Disorders related to sexuality and gender identity in the ICD-11: revising the ICD-10 classification based on current scientific evidence, best clinical practices, and human rights considerations","volume":"15","author":"Reed","year":"2016","journal-title":"World Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib17","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1093\/jpepsy\/4.1.29","article-title":"Homosexual outcome of discordant gender identity\/role in childhood: longitudinal follow-up","volume":"4","author":"Money","year":"1979","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/S2213-8587(17)30099-2_bib18","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/CHI.0b013e31818956b9","article-title":"Psychosexual outcome of gender-dysphoric children","volume":"47","author":"Wallien","year":"2008","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib19","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1037\/0012-1649.44.1.34","article-title":"A follow-up study of girls with gender identity disorder","volume":"44","author":"Drummond","year":"2008","journal-title":"Dev Psychol"},{"key":"10.1016\/S2213-8587(17)30099-2_bib20","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jaac.2013.03.016","article-title":"Factors associated with desistence and persistence of childhood gender dysphoria: a quantitative follow-up study","volume":"52","author":"Steensma","year":"2013","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib21","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/1359104514558431","article-title":"Young people with features of gender dysphoria: demographics and associated difficulties","volume":"21","author":"Holt","year":"2016","journal-title":"Clin Child Psychol Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib22","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrendo.2011.78","article-title":"Puberty suppression in gender identity disorder: the Amsterdam experience","volume":"7","author":"Kreukels","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(17)30099-2_bib23","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1007\/s10508-011-9758-9","article-title":"Puberty suppression in a gender-dysphoric adolescent: a 22-year follow-up","volume":"40","author":"Cohen-Kettenis","year":"2011","journal-title":"Arch Sex Behav"},{"key":"10.1016\/S2213-8587(17)30099-2_bib24","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/BF01543120","article-title":"Effects of adequacy of gender reassignment surgery on psychological adjustment: a follow-up of fourteen male-to-female patients","volume":"18","author":"Ross","year":"1989","journal-title":"Arch Sex Behav"},{"key":"10.1016\/S2213-8587(17)30099-2_bib25","doi-asserted-by":"crossref","first-page":"3132","DOI":"10.1210\/jc.2009-0345","article-title":"Endocrine treatment of transsexual persons: an Endocrine Society clinical practice guideline","volume":"94","author":"Hembree","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30099-2_bib27","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/00918369.2012.653302","article-title":"Psychological evaluation and medical treatment of transgender youth in an interdisciplinary \u201cGender Management Service\u201d (GeMS) in a major pediatric center","volume":"59","author":"Edwards-Leeper","year":"2012","journal-title":"J Homosex"},{"key":"10.1016\/S2213-8587(17)30099-2_bib28","doi-asserted-by":"crossref","first-page":"578","DOI":"10.5694\/mja12.10222","article-title":"Hormone treatment of gender identity disorder in a cohort of children and adolescents","volume":"196","author":"Hewitt","year":"2012","journal-title":"Med J Aust"},{"key":"10.1016\/S2213-8587(17)30099-2_bib29","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1080\/0092623X.2013.772550","article-title":"Sexual behavior of gender-dysphoric individuals before gender-confirming interventions: a European multicenter study","volume":"40","author":"Cerwenka","year":"2014","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/S2213-8587(17)30099-2_bib30","first-page":"316","article-title":"Puberty-delaying hormone therapy in adolescents with gender identity disorder","volume":"115","author":"Nakatsuka","year":"2012","journal-title":"Seishin Shinkeigaku Zasshi"},{"key":"10.1016\/S2213-8587(17)30099-2_bib31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/s13034-015-0042-y","article-title":"Two years of gender identity service for minors: overrepresentation of natal girls with severe problems in adolescent development","volume":"9","author":"Kaltiala-Heino","year":"2015","journal-title":"Child Adolesc Psychiatry Ment Health"},{"key":"10.1016\/S2213-8587(17)30099-2_bib32","doi-asserted-by":"crossref","first-page":"2206","DOI":"10.1111\/jsm.13034","article-title":"Psychological support, puberty suppression, and psychosocial functioning in adolescents with gender dysphoria","volume":"12","author":"Costa","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/S2213-8587(17)30099-2_bib33","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1056\/NEJM199101103240205","article-title":"Gonadotropin-releasing hormone and its analogues","volume":"324","author":"Conn","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30099-2_bib34","series-title":"Williams textbook of endocrinology","author":"Melmed","year":"2011"},{"key":"10.1016\/S2213-8587(17)30099-2_bib35","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1515\/jpem-2013-0286","article-title":"Age of thelarche and menarche in contemporary US females: a cross-sectional analysis","volume":"27","author":"Cabrera","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30099-2_bib36","doi-asserted-by":"crossref","first-page":"e1058","DOI":"10.1542\/peds.2011-3291","article-title":"Secondary sexual characteristics in boys: data from the Pediatric Research in Office Settings Network","volume":"130","author":"Herman-Giddens","year":"2012","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(17)30099-2_bib37","first-page":"306","article-title":"Review of outcomes after cessation of gonadotropin-releasing hormone agonist treatment of girls with precocious puberty","volume":"11","author":"Thornton","year":"2014","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/S2213-8587(17)30099-2_bib38","first-page":"890","article-title":"Ovulation and menstrual function of adolescent girls with central precocious puberty after therapy with gonadotropin-releasing hormone agonists","volume":"75","author":"Jay","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30099-2_bib39","first-page":"4480","article-title":"Is obesity an outcome of gonadotropin-releasing hormone agonist administration? Analysis of growth and body composition in 110 patients with central precocious puberty","volume":"84","author":"Palmert","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30099-2_bib40","doi-asserted-by":"crossref","first-page":"4536","DOI":"10.1210\/jcem.86.9.7863","article-title":"The longitudinal study of adrenal maturation during gonadal suppression: evidence that adrenarche is a gradual process","volume":"86","author":"Palmert","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30099-2_bib41","doi-asserted-by":"crossref","first-page":"S131","DOI":"10.1530\/eje.1.02231","article-title":"Clinical management of gender identity disorder in adolescents: a protocol on psychological and paediatric endocrinology aspects","volume":"155","author":"Delemarre-van de Waal","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(17)30099-2_bib42","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/01.med.0000436193.33470.1f","article-title":"Management of juvenile gender dysphoria","volume":"20","author":"Hembree","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(17)30099-2_bib43","doi-asserted-by":"crossref","first-page":"463","DOI":"10.2165\/00003495-200363050-00003","article-title":"Progestogens with antiandrogenic properties","volume":"63","author":"Raudrant","year":"2003","journal-title":"Drugs"},{"key":"10.1016\/S2213-8587(17)30099-2_bib44","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s13293-016-0067-9","article-title":"Consecutive lynestrenol and cross-sex hormone treatment in biological female adolescents with gender dysphoria: a retrospective analysis","volume":"7","author":"Tack","year":"2016","journal-title":"Biol Sex Differ"},{"key":"10.1016\/S2213-8587(17)30099-2_bib45","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1097\/MED.0b013e32835c711e","article-title":"Current management of gender identity disorder in childhood and adolescence: guidelines, barriers and areas of controversy","volume":"20","author":"Shumer","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(17)30099-2_bib46","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.1210\/jc.2013-1024","article-title":"Treatment and outcomes of precocious puberty: an update","volume":"98","author":"Fuqua","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30099-2_bib47","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/S0140-6736(16)00682-6","article-title":"Serving transgender people: clinical care considerations and service delivery models in transgender health","volume":"388","author":"Wylie","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30099-2_bib48","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1001\/jama.2012.165234","article-title":"Management of transgenderism","volume":"309","author":"Spack","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30099-2_bib49","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.med.0000436188.95351.4d","article-title":"Progress on the road to better medical care for transgender patients","volume":"20","author":"Gardner","year":"2013","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(17)30099-2_bib50","doi-asserted-by":"crossref","first-page":"3470","DOI":"10.1210\/jc.2007-0746","article-title":"Long-term administration of testosterone undecanoate every 3 months for testosterone supplementation in female-to-male transsexuals","volume":"92","author":"Mueller","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30099-2_bib51","author":"Kelly"},{"key":"10.1016\/S2213-8587(17)30099-2_bib52","doi-asserted-by":"crossref","first-page":"4379","DOI":"10.1210\/jc.2014-1919","article-title":"Approach to the patient: transgender youth: endocrine considerations","volume":"99","author":"Rosenthal","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30099-2_bib53","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1111\/j.1743-6109.2010.01943.x","article-title":"Puberty suppression in adolescents with gender identity disorder: a prospective follow-up study","volume":"8","author":"de Vries","year":"2011","journal-title":"J Sex Med"},{"key":"10.1016\/S2213-8587(17)30099-2_bib54","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/0092623X.2011.611219","article-title":"Demographics, behavior problems, and psychosexual characteristics of adolescents with gender identity disorder or transvestic fetishism","volume":"38","author":"Zucker","year":"2012","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/S2213-8587(17)30099-2_bib55","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s00787-015-0764-7","article-title":"Poor peer relations predict parent-and self-reported behavioral and emotional problems of adolescents with gender dysphoria: a cross-national, cross-clinic comparative analysis","volume":"25","author":"de Vries","year":"2016","journal-title":"Eur Child Adolesc Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.jadohealth.2015.04.027","article-title":"Baseline physiologic and psychosocial characteristics of transgender youth seeking care for gender dysphoria","volume":"57","author":"Olson","year":"2015","journal-title":"J Adolesc Health"},{"key":"10.1016\/S2213-8587(17)30099-2_bib57","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.psychres.2010.07.033","article-title":"Comparing adult and adolescent transsexuals: an MMPI-2 and MMPI-A study","volume":"186","author":"de Vries","year":"2011","journal-title":"Psychiatry Res"},{"key":"10.1016\/S2213-8587(17)30099-2_bib58","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1111\/j.1469-7610.2011.02426.x","article-title":"Psychiatric comorbidity in gender dysphoric adolescents","volume":"52","author":"de Vries","year":"2011","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib59","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jaac.2016.04.001","article-title":"Self-harm and suicidality in children referred for gender dysphoria","volume":"55","author":"Aitken","year":"2016","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib60","article-title":"Suicidality, self-harm, and body dissatisfaction in transgender adolescents and emerging adults with gender dysphoria","author":"Peterson","year":"2016","journal-title":"Suicide Life Threat Behav"},{"key":"10.1016\/S2213-8587(17)30099-2_bib61","article-title":"Psychosocial and psychological vulnerability in adolescents with gender dysphoria: a \u201cproof of principle\u201d study","author":"Bechard","year":"2016","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/S2213-8587(17)30099-2_bib62","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/S2215-0366(16)30165-1","article-title":"Removing transgender identity from the classification of mental disorders: a Mexican field study for ICD-11","volume":"3","author":"Robles","year":"2016","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib63","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1037\/sgd0000152","article-title":"Behavioral and emotional problems as a function of peer relationships in adolescents with gender dysphoria: a comparison with clinical and nonclinical controls","volume":"3","author":"Shiffman","year":"2016","journal-title":"Psychol Sex Orientat Gend Divers"},{"key":"10.1016\/S2213-8587(17)30099-2_bib64","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1037\/sgd0000029","article-title":"Employment, mental health, internalized stigma, and coping with transphobia among transgender individuals","volume":"1","author":"Mizock","year":"2014","journal-title":"Psychol Sex Orientat Gend Divers"},{"key":"10.1016\/S2213-8587(17)30099-2_bib65","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1097\/00004583-200104000-00017","article-title":"Adolescents with gender identity disorder who were accepted or rejected for sex reassignment surgery: a prospective follow-up study","volume":"40","author":"Smith","year":"2001","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib66","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1097\/00004583-199702000-00017","article-title":"Sex reassignment of adolescent transsexuals: a follow-up study","volume":"36","author":"Cohen-Kettenis","year":"1997","journal-title":"J Am Acad Child Adolesc Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib67","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1111\/j.1365-2265.2009.03625.x","article-title":"Hormonal therapy and sex reassignment: a systematic review and meta-analysis of quality of life and psychosocial outcomes","volume":"72","author":"Murad","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(17)30099-2_bib68","series-title":"BDI-II-NL: manual for the Dutch version of the Beck Depression Inventory","author":"van der Does","year":"2002"},{"key":"10.1016\/S2213-8587(17)30099-2_bib69","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1001\/archpsyc.1983.01790100074010","article-title":"A children's global assessment scale (CGAS)","volume":"40","author":"Shaffer","year":"1983","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S2213-8587(17)30099-2_bib70","series-title":"Handleiding voor de youth self report (Manual for the youth self report)","author":"Verhulst","year":"1997"},{"key":"10.1016\/S2213-8587(17)30099-2_bib71","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1542\/peds.2013-2958","article-title":"Young adult psychological outcome after puberty suppression and gender reassignment","volume":"134","author":"de Vries","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(17)30099-2_bib72","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1023\/B:QURE.0000018486.91360.00","article-title":"The World Health Organization's WHOQOL-BREF quality of life assessment: psychometric properties and results of the international field trial. A report from the WHOQOL group","volume":"13","author":"Skevington","year":"2004","journal-title":"Qual Life Res"},{"key":"10.1016\/S2213-8587(17)30099-2_bib73","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1023\/A:1006824100041","article-title":"A measure of subjective happiness: preliminary reliability and construct validation","volume":"46","author":"Lyubomirsky","year":"1999","journal-title":"Soc Indic Res"},{"key":"10.1016\/S2213-8587(17)30099-2_bib74","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0191-8869(98)00180-9","article-title":"The satisfaction with life scale (SWLS): appraisal with 1700 healthy young adults in the Netherlands","volume":"26","author":"Arrindell","year":"1999","journal-title":"Pers Individ Dif"},{"key":"10.1016\/S2213-8587(17)30099-2_bib75","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.psyneuen.2015.03.007","article-title":"Puberty suppression and executive functioning: an fMRI-study in adolescents with gender dysphoria","volume":"56","author":"Staphorsius","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(17)30099-2_bib76","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1016\/j.neuroimage.2006.07.022","article-title":"The effect of gender on planning: an fMRI study using the Tower of London task","volume":"33","author":"Boghi","year":"2006","journal-title":"Neuroimage"},{"key":"10.1016\/S2213-8587(17)30099-2_bib77","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1467-7687.2005.00456.x","article-title":"Brain development during puberty: state of the science","volume":"9","author":"Blakemore","year":"2006","journal-title":"Dev Sci"},{"key":"10.1016\/S2213-8587(17)30099-2_bib78","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.3389\/fpsyg.2016.01053","article-title":"Cognitive, emotional, and psychosocial functioning of girls treated with pharmacological puberty blockage for idiopathic central precocious puberty","volume":"7","author":"Wojniusz","year":"2016","journal-title":"Front Psychol"},{"key":"10.1016\/S2213-8587(17)30099-2_bib79","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nn1173","article-title":"Prefrontal cortical function and anxiety: controlling attention to threat-related stimuli","volume":"7","author":"Bishop","year":"2004","journal-title":"Nat Neurosci"},{"key":"10.1016\/S2213-8587(17)30099-2_bib80","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.bone.2009.10.005","article-title":"Maximizing bone mineral mass gain during growth for the prevention of fractures in the adolescents and the elderly","volume":"46","author":"Rizzoli","year":"2010","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(17)30099-2_bib81","series-title":"Gender identity disorders in children and adolescents: guidelines for management","author":"Di Ceglie","year":"1998"},{"issue":"suppl 367","key":"10.1016\/S2213-8587(17)30099-2_bib82","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1111\/j.1651-2227.1990.tb11630.x","article-title":"Gonadotrophin-releasing hormone agonist treatment of central precocious puberty: an analysis of growth data in a developmental context","volume":"79","author":"Boepple","year":"1990","journal-title":"Acta Paediatrica"},{"key":"10.1016\/S2213-8587(17)30099-2_bib83","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1210\/jc.2007-1216","article-title":"Long-term observation of 87 girls with idiopathic central precocious puberty treated with gonadotropin-releasing hormone analogs: impact on adult height, body mass index, bone mineral content, and reproductive function","volume":"93","author":"Pasquino","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30099-2_bib84","first-page":"653","article-title":"Long-term effectiveness of depot gonadotropin-releasing hormone analogue in the treatment of children with central precocious puberty","volume":"147","author":"Clemons","year":"1993","journal-title":"Am J Dis Child"},{"key":"10.1016\/S2213-8587(17)30099-2_bib85","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1159\/000441497","article-title":"Central precocious puberty: adult height in girls treated with quarterly or monthly gonadotropin-releasing hormone analog triptorelin","volume":"84","author":"Bertelloni","year":"2015","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(17)30099-2_bib86","doi-asserted-by":"crossref","first-page":"1697","DOI":"10.1007\/s10508-016-0764-9","article-title":"Perceptions of sex, gender, and puberty suppression: a qualitative analysis of transgender youth","volume":"45","author":"Vrouenraets","year":"2016","journal-title":"Arch Sex Behav"},{"key":"10.1016\/S2213-8587(17)30099-2_bib87","doi-asserted-by":"crossref","first-page":"8","DOI":"10.15406\/emij.2015.02.00008","article-title":"Arterial hypertension as a complication of triptorelin treatment in adolescents with gender dysphoria","volume":"2","author":"Klink","year":"2015","journal-title":"Endocrinol Metab Int J"},{"key":"10.1016\/S2213-8587(17)30099-2_bib88","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/S0378-5122(99)00086-9","article-title":"Effects of combined sex hormone replacement therapy on small artery biomechanics in pharmacologically ovariectomized rats","volume":"34","author":"Acs","year":"2000","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(17)30099-2_bib89","doi-asserted-by":"crossref","first-page":"E270","DOI":"10.1210\/jc.2014-2439","article-title":"Bone mass in young adulthood following gonadotropin-releasing hormone analog treatment and cross-sex hormone treatment in adolescents with gender dysphoria","volume":"100","author":"Klink","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30099-2_bib90","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.bone.2016.11.008","article-title":"Effect of pubertal suppression and cross-sex hormone therapy on bone turnover markers and bone mineral apparent density (BMAD) in transgender adolescents","volume":"95","author":"Vlot","year":"2017","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(17)30099-2_bib91","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1016\/j.jsxm.2016.05.004","article-title":"Efficacy and safety of gonadotropin-releasing hormone agonist treatment to suppress puberty in gender dysphoric adolescents","volume":"13","author":"Schagen","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/S2213-8587(17)30099-2_bib92","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1530\/eje.1.02056","article-title":"Three-month sustained-release triptorelin (11.25 mg) in the treatment of central precocious puberty","volume":"154","author":"Carel","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(17)30099-2_bib93","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.ejogrb.2014.03.021","article-title":"Influence of an oral contraceptive containing drospirenone on insulin sensitivity of healthy women","volume":"178","author":"Cagnacci","year":"2014","journal-title":"Eur J Obstet Gynecol Reprod Biol"},{"key":"10.1016\/S2213-8587(17)30099-2_bib94","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.sxmr.2016.08.001","article-title":"An update on the surgical treatment for transgender patients","volume":"5","author":"Colebunders","year":"2017","journal-title":"Sex Med Rev"},{"key":"10.1016\/S2213-8587(17)30099-2_bib95","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.jsxm.2016.06.009","article-title":"Patient-reported esthetic and functional outcomes of primary total laparoscopic intestinal vaginoplasty in transgender women with penoscrotal hypoplasia","volume":"13","author":"Bouman","year":"2016","journal-title":"J Sex Med"},{"key":"10.1016\/S2213-8587(17)30099-2_bib96","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1097\/MED.0000000000000229","article-title":"Advancing methods for US transgender health research","volume":"23","author":"Reisner","year":"2016","journal-title":"Curr Opin Endocrinol Diabetes Obes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,18]],"date-time":"2025-06-18T19:01:40Z","timestamp":1750273300000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300992"}},"issued":{"date-parts":[[2017,10]]},"references-count":95,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2213858717300992"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30099-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Puberty suppression in transgender children and adolescents","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30099-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T02:18:18Z","timestamp":1788315498352,"version":"build-2803163510"},"reference-count":40,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/s2213-8587(24)00245-6","type":"journal-article","created":{"date-parts":[[2024,10,14]],"date-time":"2024-10-14T18:40:35Z","timestamp":1728931235000},"page":"934-938","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Continuous glucose sensor accuracy: beyond the headline metric"],"prefix":"10.1016","volume":"12","author":[{"given":"Nick","family":"Oliver","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monika","family":"Reddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lala","family":"Leelarathna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00245-6_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14854","article-title":"Effect of divergent continuous glucose monitoring technologies on glycaemic control in type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials","volume":"39","author":"Elbalshy","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00245-6_bib2","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1016\/S0140-6736(18)30297-6","article-title":"Real-time continuous glucose monitoring in adults with type 1 diabetes and impaired hypoglycaemia awareness or severe hypoglycaemia treated with multiple daily insulin injections (HypoDE): a multicentre, randomised controlled trial","volume":"391","author":"Heinemann","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00245-6_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14944","article-title":"Impact of glycaemic technologies on quality of life and related outcomes in adults with type 1 diabetes: a narrative review","volume":"40","author":"Speight","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00245-6_bib4","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1001\/jama.2020.6928","article-title":"Effect of continuous glucose monitoring on hypoglycemia in older adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Pratley","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00245-6_bib5","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1001\/jama.2020.6940","article-title":"Effect of continuous glucose monitoring on glycemic control in adolescents and young adults with type 1 diabetes: a randomized clinical trial","volume":"323","author":"Laffel","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00245-6_bib6","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.2337\/dc20-0736","article-title":"Use of factory-calibrated real-time continuous glucose monitoring improves time in target and HbA1c in a multiethnic cohort of adolescents and young adults with type 1 diabetes: the MILLENNIALS study","volume":"43","author":"Thabit","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00245-6_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/dc19-0977","article-title":"Continuous glucose monitoring in people with type 1 diabetes on multiple-dose injection therapy: the relationship between glycemic control and hypoglycemia","volume":"43","author":"Oliver","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00245-6_bib8","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1089\/dia.2023.0057","article-title":"Continuous glucose monitoring impact and implications of real-world evidence: past, present, and future","volume":"25","author":"Gavin","year":"2023","journal-title":"Diabetes Technol Ther"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00245-6_bib9","first-page":"S126","article-title":"7. Diabetes technology: standards of care in diabetes\u20142024","volume":"47","author":"Technology","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00245-6_bib10","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/dme.13942","article-title":"Is it possible to constantly and accurately monitor blood sugar levels, in people with type 1 diabetes, with a discrete device (non-invasive or invasive)?","volume":"37","author":"Avari","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00245-6_bib11","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1111\/dom.14962","article-title":"CGM accuracy: contrasting CE marking with the governmental controls of the USA (FDA) and Australia (TGA): a narrative review","volume":"25","author":"Pemberton","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00245-6_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/dia.2014.0272","article-title":"Assessing sensor accuracy for non-adjunct use of continuous glucose monitoring","volume":"17","author":"Kovatchev","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(24)00245-6_bib13","doi-asserted-by":"crossref","first-page":"1805","DOI":"10.2337\/dc06-0079","article-title":"A critical appraisal of the continuous glucose-error grid analysis","volume":"29","author":"Wentholt","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00245-6_bib14","doi-asserted-by":"crossref","DOI":"10.1177\/19322968241250357","article-title":"Importance of FDA-integrated continuous glucose monitors to ensure accuracy of continuous glucose monitoring","author":"Klonoff","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(24)00245-6_bib15","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2337\/dc18-1581","article-title":"Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring","volume":"41","author":"Bergenstal","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00245-6_bib16","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00245-6_bib17","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1373\/clinchem.2007.097402","article-title":"The IFCC reference measurement system for HbA1c: a 6-year progress report","volume":"54","author":"Weykamp","year":"2008","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(24)00245-6_bib18","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1089\/dia.2023.0013","article-title":"The accuracy of continuous glucose sensors in people with diabetes undergoing hemodialysis (ALPHA Study)","volume":"25","author":"Avari","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(24)00245-6_bib19","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2337\/dc23-0635","article-title":"Hybrid closed-loop therapy in adults with type 1 diabetes and above-target HbA1c: a real-world observational study","volume":"46","author":"Crabtree","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00245-6_bib20","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","volume":"11","author":"Battelino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00245-6_bib21","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1089\/dia.2022.0093","article-title":"Impact of different types of data loss on optimal continuous glucose monitoring sampling duration","volume":"24","author":"Akturk","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(24)00245-6_bib22","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/dia.2020.0387","article-title":"Robust determination of the optimal continuous glucose monitoring length of intervention to evaluate long-term glycaemic control","volume":"23","author":"Herrero","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(24)00245-6_bib23","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1089\/dia.2023.0476","article-title":"Limitations of 14-day continuous glucose monitoring sampling for assessment of hypoglycemia and glycemic variability in type 1 diabetes","volume":"26","author":"Akturk","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(24)00245-6_bib24","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1210\/jc.2011-1894","article-title":"Racial and ethnic differences in the relationship between HbA1c and blood glucose: implications for the diagnosis of diabetes","volume":"97","author":"Herman","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00245-6_bib25","doi-asserted-by":"crossref","first-page":"e2221","DOI":"10.1210\/clinem\/dgac034","article-title":"Complications of diabetes and metrics of glycemic management derived from continuous glucose monitoring","volume":"107","author":"Yapanis","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00245-6_bib26","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14616","article-title":"Cohort profile: national diabetes audit for England and Wales","volume":"38","author":"Holman","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00245-6_bib27","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41572-023-00421-w","article-title":"Monogenic diabetes","volume":"9","author":"Bonnefond","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(24)00245-6_bib28","article-title":"CGM patterns in adults with cystic fibrosis-related diabetes before and after elexacaftor-tezacaftor-ivacaftor therapy","volume":"30","author":"Crow","year":"2022","journal-title":"J Clin Transl Endocrinol"},{"key":"10.1016\/S2213-8587(24)00245-6_bib29","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1265076","article-title":"Accuracy and impact on quality of life of real-time continuous glucose monitoring in children with hyperinsulinaemic hypoglycaemia","volume":"14","author":"Sivasubramanian","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(24)00245-6_bib30","doi-asserted-by":"crossref","first-page":"e3612","DOI":"10.1210\/clinem\/dgac411","article-title":"A prospective study on continuous glucose monitoring in glycogen storage disease type ia: toward glycemic targets","volume":"107","author":"Rossi","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00245-6_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001017","article-title":"Effective diabetes complication management is a step toward a carbon-efficient planet: an economic modeling study","volume":"8","author":"Fordham","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(24)00245-6_bib32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11892-022-01470-3","article-title":"The use of diabetes technology to address inequity in health outcomes: limitations and opportunities","volume":"22","author":"Agarwal","year":"2022","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(24)00245-6_bib33","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14906","article-title":"The impact of socio-economic deprivation on access to diabetes technology in adults with type 1 diabetes","volume":"39","author":"Fallon","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00245-6_bib34","author":"Kar"},{"key":"10.1016\/S2213-8587(24)00245-6_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.jclinepi.2024.111428","article-title":"Panel stacking is a threat to consensus statement validity","volume":"173","author":"Kepp","year":"2024","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(24)00245-6_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-081723","article-title":"Health professionals implicit bias of patients with low socioeconomic status (SES) and its effects on clinical decision-making: a scoping review","volume":"14","author":"Job","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(24)00245-6_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijmedinf.2023.105124","article-title":"Sociodemographic determinants of digital health literacy: a systematic review and meta-analysis","volume":"177","author":"Estrela","year":"2023","journal-title":"Int J Med Inform"},{"key":"10.1016\/S2213-8587(24)00245-6_bib38","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15338","article-title":"Identifying the deficiencies of currently available CGM to improve uptake and benefit","volume":"41","author":"Barnard-Kelly","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00245-6_bib39","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2337\/dsi23-0002","article-title":"Roadmap to achieving continuous glucose monitoring equity: insights from the T1D exchange quality improvement collaborative","volume":"36","author":"Ebekozien","year":"2023","journal-title":"Diabetes Spectr"},{"key":"10.1016\/S2213-8587(24)00245-6_bib40","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2337\/dc17-2123","article-title":"Why are we failing to address the issue of access to insulin? A national and global perspective","volume":"41","author":"Beran","year":"2018","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,26]],"date-time":"2024-11-26T23:08:34Z","timestamp":1732662514000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002456"}},"issued":{"date-parts":[[2024,12]]},"references-count":40,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2213858724002456"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00245-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous glucose sensor accuracy: beyond the headline metric","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00245-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T17:03:32Z","timestamp":1789578212850,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/s2213-8587(21)00238-2","type":"journal-article","created":{"date-parts":[[2021,9,27]],"date-time":"2021-09-27T20:02:59Z","timestamp":1632772979000},"page":"733-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial"],"prefix":"10.1016","volume":"9","author":[{"given":"Giulia","family":"Lanzolla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Sabini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marenza","family":"Leo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Menconi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Rocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Sframeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Piaggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Nardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Marcocci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Marin\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00238-2_bib1","first-page":"444","article-title":"Prevalence and natural history of Graves' orbitopathy in the XXI century","volume":"36","author":"Piantanida","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(21)00238-2_bib2","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1007\/s40618-014-0097-2","article-title":"Extrathyroidal manifestations of Graves' disease: a 2014 update","volume":"37","author":"Bartalena","year":"2014","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(21)00238-2_bib3","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1055\/s-0035-1555762","article-title":"Current insights into the pathogenesis of Graves' ophthalmopathy","volume":"47","author":"Bahn","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(21)00238-2_bib4","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves' Orbitopathy guidelines for the management of Graves' orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(21)00238-2_bib5","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jc.2010-1962","article-title":"Clinical review: intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity","volume":"96","author":"Zang","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00238-2_bib6","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3389\/fendo.2019.00933","article-title":"Cholesterol serum levels and use of statins in Graves' Orbitopathy: a new starting point for the therapy","volume":"22","author":"Lanzolla","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(21)00238-2_bib7","doi-asserted-by":"crossref","first-page":"e2819","DOI":"10.1210\/clinem\/dgab184","article-title":"Statins: a new hope on the horizon of Graves' orbitopathy?","volume":"106","author":"Marin\u00f2","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00238-2_bib8","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamaophthalmol.2014.5103","article-title":"Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease","volume":"133","author":"Stein","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/S2213-8587(21)00238-2_bib9","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1210\/clinem\/dgab070","article-title":"Statins decrease the risk of orbitopathy in newly diagnosed patients with Graves disease","volume":"106","author":"Nilsson","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00238-2_bib10","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/thy.2017.0430","article-title":"High serum cholesterol is a novel risk factor for Graves' orbitopathy: results of a cross-sectional study","volume":"28","author":"Sabini","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00238-2_bib11","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s40618-018-0915-z","article-title":"Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory study","volume":"41","author":"Lanzolla","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(21)00238-2_bib12","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1080\/13814788.2017.1398320","article-title":"Main messages for primary care from the 2016 European Guidelines on cardiovascular disease prevention in clinical practice","volume":"24","author":"Piepoli","year":"2018","journal-title":"Eur J Gen Pract"},{"key":"10.1016\/S2213-8587(21)00238-2_bib13","doi-asserted-by":"crossref","first-page":"2889","DOI":"10.1016\/j.jacc.2013.11.002","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Stone","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00238-2_bib14","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","article-title":"Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy","volume":"90","author":"Kahaly","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00238-2_bib15","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(21)00238-2_bib16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1136\/bjo.82.7.773","article-title":"Development of a disease specific quality of life questionnaire for patients with Graves' ophthalmopathy: the GO-QOL","volume":"82","author":"Terwee","year":"1998","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(21)00238-2_bib17","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/s40618-014-0227-x","article-title":"Prospectively recorded and MedDRA-coded safety data of intravenous methylprednisolone therapy in Graves' orbitopathy","volume":"38","author":"Riedl","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(21)00238-2_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.609895","article-title":"Evidence that baseline levels of low-density lipoproteins cholesterol affect the clinical response of Graves' ophthalmopathy to parenteral corticosteroids","volume":"11","author":"Naselli","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(21)00238-2_bib19","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.jaapos.2018.04.009","article-title":"The effect of oral statin therapy on strabismus in patients with thyroid eye disease","volume":"22","author":"Reynolds","year":"2018","journal-title":"J AAPOS"},{"issue":"Suppl 1","key":"10.1016\/S2213-8587(21)00238-2_bib20","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000510700","article-title":"Proposal for standardization of primary and secondary outcomes in patients with active, moderate-to-severe Graves' orbitopathy","volume":"9","author":"Bartalena","year":"2020","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(21)00238-2_bib21","doi-asserted-by":"crossref","first-page":"2292","DOI":"10.1161\/01.CIR.0000100688.17280.E6","article-title":"Rosuvastatin in the primary prevention of cardiovascular disease among patients with low levels of low-density lipoprotein cholesterol and elevated high-sensitivity C-reactive protein: rationale and design of the JUPITER trial","volume":"108","author":"Ridker","year":"2003","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00238-2_bib22","first-page":"204","article-title":"C-Reactive protein: how has JUPITER impacted clinical practice?","volume":"9","author":"Verma","year":"2009","journal-title":"Ochsner J"},{"key":"10.1016\/S2213-8587(21)00238-2_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1038\/nri3793","article-title":"Cholesterol, inflammation, and innate immunity","volume":"15","author":"Tall","year":"2015","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/S2213-8587(21)00238-2_bib24","doi-asserted-by":"crossref","first-page":"e2176","DOI":"10.1210\/clinem\/dgab035","article-title":"Genetic Profiling of orbital fibroblasts from patients with Graves' ORBITOPATHY","volume":"106","author":"Rotondo Dottore","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00238-2_bib25","doi-asserted-by":"crossref","first-page":"e330","DOI":"10.1038\/cddis.2012.61","article-title":"Apoptosis, autophagy and ER stress in mevalonate cascade inhibition-induced cell death of human atrial fibroblasts","volume":"3","author":"Ghavami","year":"2012","journal-title":"Cell Death Dis"},{"key":"10.1016\/S2213-8587(21)00238-2_bib26","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/j.mcn.2015.08.010","article-title":"Statin-modified dendritic cells regulate humoral immunity in experimental autoimmune myasthenia gravis","volume":"68","author":"Li","year":"2015","journal-title":"Mol Cell Neurosci"},{"key":"10.1016\/S2213-8587(21)00238-2_bib27","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1530\/EC-19-0319","article-title":"Simvastatin downregulates adipogenesis in 3T3-L1 preadipocytes and orbital fibroblasts from Graves' ophthalmopathy patients","volume":"8","author":"Shahida","year":"2019","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(21)00238-2_bib28","article-title":"Simvastatin and rock inhibitor Y-27632 inhibit myofibroblast differentiation of Graves' ophthalmopathy-derived orbital fibroblasts via rhoa-mediated ERK and p38 signaling pathways","volume":"11","author":"Wei","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(21)00238-2_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1111\/j.1742-1241.2006.01004.x","article-title":"Comparison of intravenous methylprednisolone therapy vs. oral methylprednisolone therapy in patients with Graves' ophthalmopathy","volume":"61","author":"Aktaran","year":"2007","journal-title":"Int J Clin Pract"},{"key":"10.1016\/S2213-8587(21)00238-2_bib30","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","article-title":"Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy","volume":"97","author":"Bartalena","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002382?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002382?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:48Z","timestamp":1761991848000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002382"}},"issued":{"date-parts":[[2021,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2213858721002382"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00238-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00238-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00268-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T18:10:12Z","timestamp":1790791812293,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023560","name":"Bioplatforms Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023560","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/s2213-8587(23)00063-3","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T18:39:20Z","timestamp":1680287960000},"page":"324-332","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":41,"title":["The effect of monthly vitamin D supplementation on fractures: a tertiary outcome from the population-based, double-blind, randomised, placebo-controlled D-Health trial"],"prefix":"10.1016","volume":"11","author":[{"given":"Mary","family":"Waterhouse","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter R","family":"Ebeling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald S A","family":"McLeod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dallas","family":"English","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Briony Duarte","family":"Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Baxter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce K","family":"Armstrong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunter","family":"Hartel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Kimlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel L","family":"O'Connell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolieke C","family":"van der Pols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison J","family":"Venn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Penelope M","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Whiteman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel E","family":"Neale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00063-3_bib1","doi-asserted-by":"crossref","first-page":"e580","DOI":"10.1016\/S2666-7568(21)00172-0","article-title":"Global, regional, and national burden of bone fractures in 204 countries and territories, 1990\u20132019: a systematic analysis from the Global Burden of Disease Study 2019","volume":"2","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/S2213-8587(23)00063-3_bib2","doi-asserted-by":"crossref","first-page":"1236","DOI":"10.1093\/gerona\/glt092","article-title":"Epidemiology of fracture risk with advancing age","volume":"68","author":"Ensrud","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(23)00063-3_bib3","doi-asserted-by":"crossref","first-page":"1641","DOI":"10.1007\/s00198-017-3955-x","article-title":"The associations between serum 25-hydroxyvitamin D level and the risk of total fracture and hip fracture","volume":"28","author":"Feng","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(23)00063-3_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.17789","article-title":"Vitamin D and calcium for the prevention of fracture: a systematic review and meta-analysis","volume":"2","author":"Yao","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(23)00063-3_bib5","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1007\/s00774-022-01333-7","article-title":"Relationship between serum vitamin D and hip fracture in the elderly: a systematic review and meta-analysis","volume":"40","author":"Habibi Ghahfarrokhi","year":"2022","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/S2213-8587(23)00063-3_bib6","doi-asserted-by":"crossref","first-page":"39849","DOI":"10.18632\/oncotarget.16337","article-title":"The serum 25-hydroxyvitamin D levels and hip fracture risk: a meta-analysis of prospective cohort studies","volume":"8","author":"Lv","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/S2213-8587(23)00063-3_bib7","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/gepi.22357","article-title":"A comprehensive genetic and epidemiological association analysis of vitamin D with common diseases\/traits in the UK Biobank","volume":"45","author":"Ye","year":"2021","journal-title":"Genet Epidemiol"},{"key":"10.1016\/S2213-8587(23)00063-3_bib8","article-title":"Assessment of the genetic and clinical determinants of fracture risk: genome wide association and mendelian randomisation study","volume":"362","author":"Trajanoska","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00063-3_bib9","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1093\/ije\/dyz182","article-title":"Phenome-wide Mendelian-randomization study of genetically determined vitamin D on multiple health outcomes using the UK Biobank study","volume":"48","author":"Meng","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00063-3_bib10","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1210\/clinem\/dgab742","article-title":"Vitamin D supplementation and fractures in adults: a systematic umbrella review of meta-analyses of controlled trials","volume":"107","author":"Chakhtoura","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00063-3_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.g2035","article-title":"Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials","volume":"348","author":"Theodoratou","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00063-3_bib12","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2202106","article-title":"Supplemental vitamin D and incident fractures in midlife and older adults","volume":"387","author":"LeBoff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00063-3_bib13","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.2019.11889","article-title":"Effect of high-dose vitamin D supplementation on volumetric bone density and bone strength: a randomized clinical trial","volume":"322","author":"Burt","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00063-3_bib14","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.1001\/jama.2017.19344","article-title":"Association between calcium or vitamin D supplementation and fracture incidence in community-dwelling older adults: a systematic review and meta-analysis","volume":"318","author":"Zhao","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00063-3_bib15","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","article-title":"Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial","volume":"303","author":"Sanders","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00063-3_bib16","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/S2213-8587(17)30103-1","article-title":"Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial","volume":"5","author":"Khaw","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00063-3_bib17","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cct.2016.04.005","article-title":"The D-Health Trial: a randomized trial of vitamin D for prevention of mortality and cancer","volume":"48","author":"Neale","year":"2016","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/S2213-8587(23)00063-3_bib18","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2019.100333","article-title":"A randomized placebo-controlled trial of vitamin D supplementation for reduction of mortality and cancer: statistical analysis plan for the D-Health Trial","volume":"14","author":"Waterhouse","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/S2213-8587(23)00063-3_bib19","first-page":"32","article-title":"Vitamin D status as an international issue: national surveys and the problem of standardization","volume":"243","author":"Sempos","year":"2012","journal-title":"Scand J Clin Lab Invest Suppl"},{"key":"10.1016\/S2213-8587(23)00063-3_bib20","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1007\/s11306-013-0518-9","article-title":"Optimized 25-hydroxyvitamin D analysis using liquid\u2013liquid extraction with 2D separation with LC\/MS\/MS detection provides superior precision compared to conventional assays","volume":"9","author":"Clarke","year":"2013","journal-title":"Metabolomics"},{"key":"10.1016\/S2213-8587(23)00063-3_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106347","article-title":"Predicting deseasonalised serum 25 hydroxy vitamin D concentrations in the D-Health Trial: an analysis using boosted regression trees","volume":"104","author":"Waterhouse","year":"2021","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/S2213-8587(23)00063-3_bib22","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S2213-8587(21)00345-4","article-title":"The D-Health Trial: a randomised controlled trial of the effect of vitamin D on mortality","volume":"10","author":"Neale","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00063-3_bib23","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1097\/00001648-199001000-00010","article-title":"No adjustments are needed for multiple comparisons","volume":"1","author":"Rothman","year":"1990","journal-title":"Epidemiology"},{"key":"10.1016\/S2213-8587(23)00063-3_bib24","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1809944","article-title":"Vitamin D Supplements and prevention of cancer and cardiovascular disease","volume":"380","author":"Manson","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00063-3_bib25","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamainternmed.2015.7148","article-title":"Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial","volume":"176","author":"Bischoff-Ferrari","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(23)00063-3_bib26","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jgs.14679","article-title":"High-dose monthly vitamin D for prevention of acute respiratory infection in older long-term care residents: a randomized clinical trial","volume":"65","author":"Ginde","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(23)00063-3_bib27","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1002\/jcsm.12759","article-title":"Vitamin D supplementation and risk of falling: outcomes from the randomized, placebo-controlled D-Health Trial","volume":"12","author":"Waterhouse","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/S2213-8587(23)00063-3_bib28","doi-asserted-by":"crossref","first-page":"387","DOI":"10.5694\/j.1326-5377.2010.tb03964.x","article-title":"Prevalence and treatment of osteoporosis in older Australian men: findings from the CHAMP study","volume":"193","author":"Bleicher","year":"2010","journal-title":"Med J Aust"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:17Z","timestamp":1761991937000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000633"}},"issued":{"date-parts":[[2023,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2213858723000633"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00063-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of monthly vitamin D supplementation on fractures: a tertiary outcome from the population-based, double-blind, randomised, placebo-controlled D-Health trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00063-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00087-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T17:07:02Z","timestamp":1790874422078,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/s2213-8587(18)30048-2","type":"journal-article","created":{"date-parts":[[2018,4,16]],"date-time":"2018-04-16T18:47:07Z","timestamp":1523904427000},"page":"476-486","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":179,"title":["Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study"],"prefix":"10.1016","volume":"6","author":[{"given":"Angus","family":"Forbes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor","family":"Murrells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrietta","family":"Mulnier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30048-2_bib1","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.1001\/jama.2015.8345","article-title":"Glycemic control in older adults with diabetes mellitus","volume":"314","author":"Huang","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30048-2_bib2","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(09)61969-3","article-title":"Survival as a function of HbA1c in people with type 2 diabetes: a retrospective cohort study","volume":"375","author":"Currie","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30048-2_bib3","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.2337\/dc10-2377","article-title":"Glycemic control, complications, and death in older diabetic patients: the Diabetes and Aging Study","volume":"34","author":"Huang","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30048-2_bib4","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.diabres.2014.07.017","article-title":"Hemoglobin A1c, comorbid conditions and all-cause mortality in older patients with DM: a retrospective 9-year cohort study","volume":"106","author":"Grembowski","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30048-2_bib5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30048-2_bib6","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30048-2_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30048-2_bib8","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.jacc.2008.10.008","volume":"53","author":"Skyler","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(18)30048-2_bib9","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.2337\/dc12-1801","article-title":"Diabetes in older adults","volume":"35","author":"Kirkman","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30048-2_bib10","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.jamda.2012.04.012","article-title":"Diabetes mellitus in older people: position statement on behalf of the International Association of Gerontology and Geriatrics (IAGG), the European Diabetes Working Party for Older People (EDWPOP), and the International Task Force of Experts in Diabetes","volume":"13","author":"Sinclair","year":"2012","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/S2213-8587(18)30048-2_bib11","doi-asserted-by":"crossref","first-page":"2354","DOI":"10.2337\/dc15-1188","article-title":"Long-term glycemic variability and risk of adverse outcomes: a systematic review and meta-analysis","volume":"38","author":"Gorst","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30048-2_bib12","first-page":"251","article-title":"Generalisability of The Health Improvement Network (THIN) database: demographics, chronic disease prevalence and mortality rates","volume":"19","author":"Blak","year":"2011","journal-title":"Inform Prim Care"},{"key":"10.1016\/S2213-8587(18)30048-2_bib13","doi-asserted-by":"crossref","first-page":"639","DOI":"10.3399\/bjgp15X686881","article-title":"Nursing consultations and control of diabetes in general practice: a retrospective observational study","volume":"65","author":"Murrells","year":"2015","journal-title":"Br J Gen Pract"},{"key":"10.1016\/S2213-8587(18)30048-2_bib15","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1471-2296-11-1","article-title":"Adaptation and validation of the Charlson Index for Read\/OXMIS coded databases","volume":"11","author":"Khan","year":"2010","journal-title":"BMC Fam Pract"},{"key":"10.1016\/S2213-8587(18)30048-2_bib16","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1080\/01621459.1989.10478874","article-title":"The robust inference for the proportional hazards model","volume":"84","author":"Lin","year":"1989","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/S2213-8587(18)30048-2_bib17","doi-asserted-by":"crossref","first-page":"2198","DOI":"10.2337\/dc08-0864","article-title":"A1c variability and the risk of microvascular complications in type 1 diabetes: data from the Diabetes Control and Complications Trial","volume":"31","author":"Kilpatrick","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30048-2_bib18","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1136\/jcp.2007.054304","article-title":"Haemoglobin A1c in the diagnosis and monitoring of diabetes mellitus","volume":"61","author":"Kilpatrick","year":"2008","journal-title":"J Clin Pathol"},{"key":"10.1016\/S2213-8587(18)30048-2_bib19","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1007\/s00125-017-4423-z","article-title":"Day-to-day fasting glycaemic variability in DEVOTE: associations with severe hypoglycaemia and cardiovascular outcomes (DEVOTE 2)","volume":"61","author":"Zinman","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30048-2_bib20","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.2337\/dc14-0199","article-title":"Impact of visit-to-visit glycemic variability on the risks of macrovascular and microvascular events and all-cause mortality in type 2 diabetes: the ADVANCE trial","volume":"37","author":"Hirakawa","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30048-2_bib21","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30048-2_bib22","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/j.jamda.2016.07.013","article-title":"Frailty as a major factor in the increased risk of death and disability in older people with diabetes","volume":"17","author":"Castro-Rodr\u00edguez","year":"2016","journal-title":"Am Med Dir Assoc"},{"key":"10.1016\/S2213-8587(18)30048-2_bib23","doi-asserted-by":"crossref","first-page":"652","DOI":"10.4172\/2155-6156.1000652","article-title":"Glycemic variability among older adults with type 2 diabetes","volume":"7","author":"Tong","year":"2016","journal-title":"J Diabetes Metab"},{"key":"10.1016\/S2213-8587(18)30048-2_bib24","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/dci16-0042","article-title":"Hemoglobin A1c and mortality in older adults with and without diabetes: results from the National Health and Nutrition Examination Surveys (1988\u20132011)","volume":"40","author":"Palta","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30048-2_bib25","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/dc14-1787","article-title":"Association between hemoglobin A1c and all-cause mortality: results of the mortality follow-up of the German National Health Interview and Examination Survey 1998","volume":"38","author":"Paprott","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30048-2_bib26","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1161\/CIRCOUTCOMES.110.957936","article-title":"Low hemoglobin A1c and risk of all-cause mortality among US adults without diabetes","volume":"3","author":"Carson","year":"2010","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/S2213-8587(18)30048-2_bib27","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1093\/gerona\/glw024","article-title":"Glucose levels and risk of frailty","volume":"71","author":"Zaslavsky","year":"2016","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(18)30048-2_bib28","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.diabres.2014.03.005","article-title":"IDF guideline for managing type 2 diabetes in older people","volume":"103","author":"Dunning","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"suppl 5","key":"10.1016\/S2213-8587(18)30048-2_bib29","first-page":"265","article-title":"Guidelines for improving the care of the older person with diabetes mellitus","volume":"51","year":"2003","journal-title":"J Am Geriatr Soc"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300482?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300482?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T08:32:12Z","timestamp":1574757132000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300482"}},"issued":{"date-parts":[[2018,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S2213858718300482"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30048-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30048-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30069-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T10:27:01Z","timestamp":1790504821268,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/s2213-8587(20)30073-5","type":"journal-article","created":{"date-parts":[[2020,3,3]],"date-time":"2020-03-03T18:33:52Z","timestamp":1583260432000},"page":"363-365","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Knowledge gaps and weight stigma shape attitudes toward obesity"],"prefix":"10.1016","volume":"8","author":[{"given":"Majella","family":"O'Keeffe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart W","family":"Flint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30073-5_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s40608-015-0064-2","article-title":"UK adults' implicit and explicit attitudes towards obesity: a cross-sectional study","volume":"2","author":"Flint","year":"2015","journal-title":"BMC Obes"},{"key":"10.1016\/S2213-8587(20)30073-5_bib2","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1002\/oby.20789","article-title":"Perceived weight discrimination and C-reactive protein","volume":"22","author":"Sutin","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(20)30073-5_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0048448","article-title":"Implicit and explicit anti-fat bias among a large sample of medical doctors by BMI, race\/ethnicity and gender","volume":"7","author":"Sabin","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(20)30073-5_bib4","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1016\/S0104-4230(12)70189-6","article-title":"Beliefs and practices of healthcare providers regarding obesity: a systematic review","volume":"58","author":"Teixeira","year":"2012","journal-title":"Rev Assoc Med Bras"},{"key":"10.1016\/S2213-8587(20)30073-5_bib5","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/sj.ijo.0801537","article-title":"Fat phobia scale revisited: the short form","volume":"25","author":"Bacon","year":"2001","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(20)30073-5_bib6","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1016\/S1091-255X(03)00047-7","article-title":"Body weight regulation and obesity","volume":"7","author":"Kaplan","year":"2003","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/S2213-8587(20)30073-5_bib7","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1093\/bmb\/ldx022","article-title":"The contribution of genetics and environment to obesity","volume":"123","author":"Albuquerque","year":"2017","journal-title":"Br Med Bull"},{"key":"10.1016\/S2213-8587(20)30073-5_bib8","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1007\/s00125-017-4513-y","article-title":"Metabolic surgery for the treatment of type 2 diabetes in obese individuals","volume":"61","author":"Cummings","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30073-5_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0803-x","article-title":"Joint international consensus statement for ending stigma of obesity","author":"Rubino","year":"2020","journal-title":"Nat Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:52Z","timestamp":1761991672000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300735"}},"issued":{"date-parts":[[2020,5]]},"references-count":9,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213858720300735"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30073-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knowledge gaps and weight stigma shape attitudes toward obesity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30073-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T20:50:00Z","timestamp":1790369400908,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/s2213-8587(25)00023-3","type":"journal-article","created":{"date-parts":[[2025,2,6]],"date-time":"2025-02-06T23:38:50Z","timestamp":1738885130000},"page":"172-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["What is a normal glucose value?"],"prefix":"10.1016","volume":"13","author":[{"given":"Viral N","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00023-3_bib1","first-page":"S146","article-title":"7 Diabetes technology: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00023-3_bib2","first-page":"S27","article-title":"2 Diagnosis and classification of diabetes: standards of care in diabetes-2025","volume":"48","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00023-3_bib3","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1177\/19322968241242487","article-title":"Continuous glucose monitoring for prediabetes: what are the best metrics?","volume":"18","author":"Zahalka","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(25)00023-3_bib4","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1210\/jc.2018-02763","article-title":"Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study","volume":"104","author":"Shah","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00023-3_bib5","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.2337\/dc23-2332","article-title":"Relationship between sensor-detected hypoglycemia and patient-reported hypoglycemia in people with type 1 and insulin-treated type 2 diabetes: the Hypo-METRICS study","volume":"47","author":"Divilly","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00023-3_bib6","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.2337\/diacare.26.4.1026","article-title":"Assessing the shape of the glucose curve during an oral glucose tolerance test","volume":"26","author":"Tschritter","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00023-3_bib7","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/1932296820905904","article-title":"Effect of exercise and meals on continuous glucose monitor data in healthy individuals without diabetes","volume":"15","author":"DuBose","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(25)00023-3_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-58703-6","article-title":"Leveraging continuous glucose monitoring for personalized modeling of insulin-regulated glucose metabolism","volume":"14","author":"Erd\u0151s","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(25)00023-3_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-72837-7","article-title":"Evaluating HbA1c-to-average glucose conversion with patient-specific kinetic models for diverse populations","volume":"14","author":"Sato Imuro","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(25)00023-3_bib10","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1056\/NEJM197410242911713","article-title":"Non-hypoglycemia is an epidemic condition","volume":"291","author":"Yager","year":"1974","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000233?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000233?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T20:45:29Z","timestamp":1741466729000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000233"}},"issued":{"date-parts":[[2025,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213858725000233"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00023-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What is a normal glucose value?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00023-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:28:30Z","timestamp":1790720910558,"version":"4.1.0"},"reference-count":13,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30218-2","type":"journal-article","created":{"date-parts":[[2016,8,20]],"date-time":"2016-08-20T05:51:33Z","timestamp":1471672293000},"page":"882-883","source":"Crossref","is-referenced-by-count":6,"title":["Use and misuse of hormones in sport"],"prefix":"10.1016","volume":"4","author":[{"given":"Peter H","family":"Sonksen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard I G","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30218-2_bib2","author":"Harvey"},{"key":"10.1016\/S2213-8587(16)30218-2_bib3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1016\/S0140-6736(89)92328-3","article-title":"Beneficial effects of growth hormone treatment in GH-deficient adults","volume":"1","author":"Jorgensen","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30218-2_bib4","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomon","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30218-2_bib5","doi-asserted-by":"crossref","first-page":"568","DOI":"10.7326\/0003-4819-152-9-201005040-00007","article-title":"The effects of growth hormone on body composition and physical performance in recreational athletes: a randomized trial","volume":"152","author":"Meinhardt","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)30218-2_bib6","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1677\/joe.0.1700013","article-title":"Insulin, growth hormone and sport","volume":"170","author":"Sonksen","year":"2001","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(16)30218-2_bib7","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.ghir.2009.04.015","article-title":"The International Olympic Committee (IOC) and GH-2000","volume":"19","author":"Sonksen","year":"2009","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/S2213-8587(16)30218-2_bib8","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/S0140-6736(99)00775-8","article-title":"Detection of doping with human growth hormone","volume":"353","author":"Wu","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30218-2_bib9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/dta.1562","article-title":"Biochemical markers of recombinant human insulin-like growth factor-I (rhIGF-I)\/rhIGF binding protein-3 (rhIGFBP-3) misuse in athletes","volume":"5","author":"Guha","year":"2013","journal-title":"Drug Test Anal"},{"key":"10.1016\/S2213-8587(16)30218-2_bib10","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1007\/s00216-011-4702-3","article-title":"Determination of growth hormone releasing peptides (GHRP) and their major metabolites in human urine for doping controls by means of liquid chromatography mass spectrometry","volume":"401","author":"Thomas","year":"2011","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/S2213-8587(16)30218-2_bib11","author":"Sygall"},{"key":"10.1016\/S2213-8587(16)30218-2_bib12","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1001\/jama.288.18.2282","article-title":"Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial","volume":"288","author":"Blackman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30218-2_bib13","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jc.2005-0957","article-title":"The effects of growth hormone and\/or testosterone in healthy elderly men: a randomized controlled trial","volume":"91","author":"Giannoulis","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30218-2_bib14","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1365-2265.2003.01700.x","article-title":"Recombinant human growth hormone treatment in elderly patients undergoing elective total hip replacement","volume":"58","author":"Weissberger","year":"2003","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,9]],"date-time":"2018-09-09T00:57:20Z","timestamp":1536454640000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302182"}},"issued":{"date-parts":[[2016,11]]},"references-count":13,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2213858716302182"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30218-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T03:33:24Z","timestamp":1793504004865,"version":"4.5.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/s2213-8587(24)00232-8","type":"journal-article","created":{"date-parts":[[2024,8,6]],"date-time":"2024-08-06T22:35:29Z","timestamp":1722983729000},"page":"606-608","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Implementing type 2 diabetes remission interventions in the real world: what have we learnt?"],"prefix":"10.1016","volume":"12","author":[{"given":"Srikanth","family":"Bellary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00232-8_bib1","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1001\/jama.2014.5988","article-title":"Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications","volume":"311","author":"Sjostrom","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00232-8_bib2","doi-asserted-by":"crossref","first-page":"k3760","DOI":"10.1136\/bmj.k3760","article-title":"Doctor Referral of Overweight People to Low Energy total diet replacement Treatment (DROPLET): pragmatic randomised controlled trial","volume":"362","author":"Astbury","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00232-8_bib3","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00232-8_bib4","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2213-8587(20)30117-0","article-title":"Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial","volume":"8","author":"Taheri","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00232-8_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00194-3","article-title":"Early findings from the NHS Type 2 Diabetes Path to Remission Programme: a prospective evaluation of real-world implementation","author":"Valabhji","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00232-8_bib7","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-023-06048-6","article-title":"Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study","volume":"67","author":"Gregg","year":"2024","journal-title":"Diabetologia"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00232-8_bib8","first-page":"S145","article-title":"8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes\u20132024","volume":"47","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:09:20Z","timestamp":1736860160000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002328"}},"issued":{"date-parts":[[2024,9]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213858724002328"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00232-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Implementing type 2 diabetes remission interventions in the real world: what have we learnt?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00232-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00194-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T00:46:04Z","timestamp":1794357964820,"version":"4.9.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/s2213-8587(20)30369-7","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T02:04:04Z","timestamp":1608170644000},"page":"22-31","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":525,"title":["Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial"],"prefix":"10.1016","volume":"9","author":[{"given":"David C","family":"Wheeler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bergur V","family":"Stef\u00e1nsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Jongs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan Fan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J V","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Correa-Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Toto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C David","family":"Sj\u00f6str\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Langkilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiddo J L","family":"Heerspink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30369-7_bib1","doi-asserted-by":"crossref","first-page":"2757","DOI":"10.1007\/s13300-020-00930-x","article-title":"SGLT2 inhibitors: slowing of chronic kidney disease progression in type 2 diabetes","volume":"11","author":"Wheeler","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(20)30369-7_bib2","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30369-7_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30369-7_bib4","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(20)30369-7_bib5","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S2213-8587(20)30162-5","article-title":"Effects of the SGLT2 inhibitor dapagliflozin on proteinuria in non-diabetic patients with chronic kidney disease (DIAMOND): a randomised, double-blind, crossover trial","volume":"8","author":"Cherney","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30369-7_bib6","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(20)30369-7_bib7","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1016\/j.kint.2019.09.013","article-title":"The renal hemodynamic effects of the SGLT2 inhibitor dapagliflozin are caused by post-glomerular vasodilatation rather than pre-glomerular vasoconstriction in metformin-treated patients with type 2 diabetes in the randomized, double-blind RED trial","volume":"97","author":"van Bommel","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(20)30369-7_bib8","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1016\/S0140-6736(96)11445-8","article-title":"Randomised placebo-controlled trial of effect of ramipril on decline in glomerular filtration rate and risk of terminal renal failure in proteinuric, non-diabetic nephropathy","volume":"349","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30369-7_bib9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1056\/NEJM199604113341502","article-title":"Effect of the angiotensin-converting-enzyme inhibitor benazepril on the progression of chronic renal insufficiency","volume":"334","author":"Maschio","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30369-7_bib10","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1056\/NEJMoa053107","article-title":"Efficacy and safety of benazepril for advanced chronic renal insufficiency","volume":"354","author":"Hou","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30369-7_bib11","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1056\/NEJMoa011161","article-title":"Effects of losartan on renal and cardiovascular outcomes in patients with type 2 diabetes and nephropathy","volume":"345","author":"Brenner","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30369-7_bib12","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30369-7_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/ndt\/gfz290","article-title":"Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial","volume":"35","author":"Heerspink","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(20)30369-7_bib14","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/ndt\/gfaa234","article-title":"The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics","volume":"35","author":"Wheeler","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(20)30369-7_bib15","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.007197","article-title":"Cardioprotective effects of sirtuin-1 and its downstream effectors potential role in mediating the heart failure benefits of SGLT2 (sodium-glucose cotransporter 2) inhibitors","author":"Packer","year":"2020","journal-title":"Circ Heart Fail"},{"key":"10.1016\/S2213-8587(20)30369-7_bib16","article-title":"Organ protection by SGLT2 inhibitors: role of metabolic energy and water conservation","author":"Marton","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S2213-8587(20)30369-7_bib17","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1111\/dom.13301","article-title":"Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers","volume":"20","author":"Dekkers","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30369-7_bib18","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1159\/000499597","article-title":"Canagliflozin prevents intrarenal angiotensinogen augmentation and mitigates kidney injury and hypertension in mouse model of type 2 diabetes mellitus","volume":"49","author":"Woods","year":"2019","journal-title":"Am J Nephrol"},{"key":"10.1016\/S2213-8587(20)30369-7_bib19","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30369-7_bib20","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2020.1906","article-title":"Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes","volume":"323","author":"Petrie","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30369-7_bib21","article-title":"Efficacy of dapagliflozin on renal function and outcomes in patients with heart failure with reduced ejection fraction: results of DAPA-HF","author":"Jhund","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(20)30369-7_bib22","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30369-7_bib23","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1093\/ckj\/sfy090","article-title":"The potential for improving cardio-renal outcomes by sodium-glucose co-transporter-2 inhibition in people with chronic kidney disease: a rationale for the EMPA-KIDNEY study","volume":"11","author":"Herrington","year":"2018","journal-title":"Clin Kidney J"},{"key":"10.1016\/S2213-8587(20)30369-7_bib24","series-title":"Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation","year":"2011"},{"key":"10.1016\/S2213-8587(20)30369-7_bib25","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1111\/dom.13413","article-title":"Efficacy and safety of dapagliflozin in patients with type 2 diabetes and moderate renal impairment (chronic kidney disease stage 3A): the DERIVE study","volume":"20","author":"Fioretto","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30369-7_bib26","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S2213-8587(19)30086-5","volume":"7","author":"Pollock","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303697?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303697?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:38Z","timestamp":1761991718000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303697"}},"issued":{"date-parts":[[2021,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2213858720303697"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30369-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of dapagliflozin on major adverse kidney and cardiovascular events in patients with diabetic and non-diabetic chronic kidney disease: a prespecified analysis from the DAPA-CKD trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30369-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30374-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T10:03:33Z","timestamp":1794218613688,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/s2213-8587(22)00008-0","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T19:08:58Z","timestamp":1644001738000},"page":"193-206","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":322,"title":["Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial"],"prefix":"10.1016","volume":"10","author":[{"given":"Takashi","family":"Kadowaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joakim","family":"Isendahl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usman","family":"Khalid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sang Yeoup","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Nishida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wataru","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Tobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soo","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00008-0_bib2","series-title":"Guidelines for the management of obesity disease","year":"2016"},{"key":"10.1016\/S2213-8587(22)00008-0_bib3","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7570\/jomes.2019.28.1.40","article-title":"2018 Korean Society for the Study of Obesity Guideline for the Management of Obesity in Korea","volume":"28","author":"Seo","year":"2019","journal-title":"J Obes Metab Syndr"},{"key":"10.1016\/S2213-8587(22)00008-0_bib4","first-page":"1","article-title":"Criteria and classification of obesity in Japan and Asia-Oceania","volume":"94","author":"Kanazawa","year":"2005","journal-title":"World Rev Nutr Diet"},{"key":"10.1016\/S2213-8587(22)00008-0_bib5","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2018.3788","article-title":"Association between obesity and cardiovascular outcomes: a systematic review and meta-analysis of Mendelian randomization studies","volume":"1","author":"Riaz","year":"2018","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(22)00008-0_bib6","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1002\/ijc.31553","article-title":"Quantitative association between body mass index and the risk of cancer: a global meta-analysis of prospective cohort studies","volume":"143","author":"Fang","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(22)00008-0_bib7","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1038\/s41586-020-2263-3","article-title":"Identification of type 2 diabetes loci in 433,540 East Asian individuals","volume":"582","author":"Spracklen","year":"2020","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(22)00008-0_bib8","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3945\/ajcn.112.035758","volume":"96","author":"Nazare","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(22)00008-0_bib9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/sj.ijo.0803248","article-title":"Japanese men have larger areas of visceral adipose tissue than Caucasian men in the same levels of waist circumference in a population-based study","volume":"30","author":"Kadowaki","year":"2006","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(22)00008-0_bib10","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.2337\/dc07-0218","article-title":"Reduction of visceral fat is associated with decrease in the number of metabolic risk factors in Japanese men","volume":"30","author":"Okauchi","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00008-0_bib11","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.34","article-title":"Obesity","volume":"3","author":"Gonz\u00e1lez-Muniesa","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(22)00008-0_bib12","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.arcmed.2006.10.014","article-title":"High frequency of cardiovascular risk factors in overweight adult Japanese subjects","volume":"38","author":"Yang","year":"2007","journal-title":"Arch Med Res"},{"key":"10.1016\/S2213-8587(22)00008-0_bib13","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/01.STR.0000169925.57251.4e","article-title":"Body mass index and mortality from cardiovascular disease among Japanese men and women: the JACC study","volume":"36","author":"Cui","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(22)00008-0_bib14","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa1010679","article-title":"Association between body-mass index and risk of death in more than 1 million Asians","volume":"364","author":"Zheng","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00008-0_bib15","doi-asserted-by":"crossref","first-page":"e466","DOI":"10.1016\/j.orcp.2013.10.003","article-title":"Three percent weight reduction is the minimum requirement to improve health hazards in obese and overweight people in Japan","volume":"8","author":"Muramoto","year":"2014","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/S2213-8587(22)00008-0_bib16","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","article-title":"Long-term persistence of hormonal adaptations to weight loss","volume":"365","author":"Sumithran","year":"2011","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(22)00008-0_bib17","first-page":"S100","article-title":"8. Obesity Management for the Treatment of Type 2 Diabetes: Standards of Medical Care in Diabetes-2021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00008-0_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.2337\/dci19-0066","article-title":"2019 update to: Management of Hyperglycemia in Type 2 Diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"43","author":"Buse","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00008-0_bib20","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00008-0_bib21","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00008-0_bib22","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00008-0_bib23","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.1001\/jama.2021.3224","article-title":"Effect of continued weekly subcutaneous semaglutide vs placebo on weight loss maintenance in adults with overweight or obesity: the STEP 4 randomized clinical trial","volume":"325","author":"Rubino","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00008-0_bib24","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1001\/jama.2013.281053","article-title":"World Medical Association Declaration of Helsinki: ethical principles for medical research involving human subjects","volume":"310","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00008-0_bib27","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1038\/s41366-020-00733-x","article-title":"Estimating and reporting treatment effects in clinical trials for weight management: using estimands to interpret effects of intercurrent events and missing data","volume":"45","author":"Wharton","year":"2021","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(22)00008-0_bib28","series-title":"Statistical analysis with missing data","author":"Little","year":"1987"},{"key":"10.1016\/S2213-8587(22)00008-0_bib29","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00008-0_bib30","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1016\/S2213-8587(17)30236-X","article-title":"Progress and challenges in anti-obesity pharmacotherapy","volume":"6","author":"Bessesen","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(22)00008-0_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP161365.GL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology comprehensive clinical practice guidelines for medical care of patients with obesity","volume":"22","author":"Garvey","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(22)00008-0_bib32","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.diabet.2018.12.001","article-title":"Comparative efficacy, safety, and cardiovascular outcomes with once-weekly subcutaneous semaglutide in the treatment of type 2 diabetes: Insights from the SUSTAIN 1-7 trials","volume":"45","author":"Aroda","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(22)00008-0_bib33","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1111\/dom.12824","article-title":"Occurrence of nausea, vomiting and diarrhoea reported as adverse events in clinical trials studying glucagon-like peptide-1 receptor agonists: a systematic analysis of published clinical trials","volume":"19","author":"Bettge","year":"2017","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:52Z","timestamp":1761991852000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000080"}},"issued":{"date-parts":[[2022,3]]},"references-count":29,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2213858722000080"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00008-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00008-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00038-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T06:33:27Z","timestamp":1794465207690,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/s2213-8587(21)00292-8","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T22:02:51Z","timestamp":1638309771000},"page":"35-45","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial"],"prefix":"10.1016","volume":"10","author":[{"given":"Subodh","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nitish K","family":"Dhingra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joao Pedro","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerasimos","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James L","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S P","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Peil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matias","family":"Nordaby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Brueckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart J","family":"Pocock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Filippatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pocock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JP","family":"Ferreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Brueckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Jamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FK","family":"Welty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Clayton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KG","family":"Parhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TR","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"Konstam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KR","family":"Lees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Carson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Doehner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Haas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pehrson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Komajda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Anand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Teerlink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rabinstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Steiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Kamel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Tsivgoulis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Freston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kaplowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Petrie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nicholls","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Bocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Giannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Spinar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-F","family":"Seronde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Senni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Taddi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D-J","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Chuquiure","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HPB","family":"La Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JRG","family":"Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Squire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Pina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bernstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Januzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Lip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Scirica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Tsutsui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Aizenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Cartasegna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Colombo Berra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Colombo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fernandez Moutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Glenny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Alvarez Lorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Anauch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Facta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fernandez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ahuad Guerrero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lobo M\u00e1rquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RA","family":"Leon de la Fuente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mansilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hominal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Hasbani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Najenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Moises Azize","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Luquez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Guzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Sessa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Amuch\u00e1stegui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Salomone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Perna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Piskorz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Perez de Arenaza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Zaidman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Poy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Resk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Villarreal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Majul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Smith Casabella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sassone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Liberman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Carnero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Caccavo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Berli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Budassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Bono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Alvarisqueta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Amerena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kostner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Begg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Beltrame","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Colquhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sverdlov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Vaddadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Coller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Prior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Friart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Leone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Janssens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Vervoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Timmermans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Troisfontaines","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Franssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Sarens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Vandekerckhove","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Van De Borne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Chenot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"De Sutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"De Vuyst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Debonnaire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dupont","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Pereira Dutra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LH","family":"Canani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MdC","family":"Vieira Moreira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LM","family":"Backes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"De Souza Paolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ER","family":"Manenti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Saporito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Villa\u00e7a Guimar\u00e3es Filho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Franco Hirakawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LA","family":"Saliba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FC","family":"Neuenschwander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CA","family":"de Freitas Zerbini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Gon\u00e7alves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Gon\u00e7alves Mello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ascen\u00e7\u00e3o de Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Beck da Silva Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EA","family":"Bocchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Da Silveira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JB","family":"de Moura Xavier Moraes Junior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JD","family":"de Souza Neto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HC","family":"Finimundi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CR","family":"Sampaio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Vasconcellos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FJ","family":"Neves Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MM","family":"Noya Rabelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rodrigues Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Santos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Vidotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MV","family":"Sim\u00f5es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FL","family":"Gomes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Vieira Nascimento","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Precoma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FA","family":"Helfenstein Fonseca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JA","family":"Ribas Fortes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PE","family":"Le\u00e3es","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Campos de Albuquerque","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JF","family":"Kerr Saraiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Rassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FA","family":"Alves da Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Reis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Zieroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Dion","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Savard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bourgeois","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Constance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Verma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-H","family":"Leblanc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Yung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Swiggum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Pliamm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Pesant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Tyrrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Huynh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Spiegelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Giannetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-P","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hartleib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bhargava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Straatman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Virani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Costa-Vitali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Heffernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Khaykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Senaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Zhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Lubelsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Toma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"McKelvie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Noronha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Babapulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Curnew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lavoie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Berlingieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kouz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Lonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Chehayeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Cui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Fan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Tang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Kong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Yao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Peng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Jerabek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Burianova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Fiala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hubac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Ludka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Monhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Vodnansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Zeman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Foldyna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Krupicka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Podpera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Busak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Radvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Vomacka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Prosecky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Cifkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Durdil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Vesely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Vaclavik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Cervinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Linhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Brabec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Miklik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Bourhaial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-G","family":"Olbrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Genth-Zotz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Kemala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Lemke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"B\u00f6hm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Schellong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Rieker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Heitzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Ince","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Faghih","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Birkenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Begemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ghanem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ujeyl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"von Haehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Dorsel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Bauersachs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Prull","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Weidemann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Darius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Nickenig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Wilke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sauter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Rauch-Kroehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Frey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CP","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"K\u00f6nig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Maier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Menzel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Proskynitopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-H","family":"Ebert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-E","family":"Sarnighausen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-D","family":"D\u00fcngen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Licka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Marx","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Stellbrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Winkelmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Menck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JL","family":"L\u00f3pez-Send\u00f3n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"de la Fuente Gal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JF","family":"Delgado Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Manito Lorite","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"P\u00e9rez de Juan Romero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Galve Basilio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Cereto Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JR","family":"Gonz\u00e1lez Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JJ","family":"G\u00f3mez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sanmart\u00edn Fern\u00e1ndez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Garcia-Moll Marimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Pascual Figal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Bover Freire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Bonnefoy Cudraz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Jobbe Duval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Tomasevic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Habib","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Isnard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Picard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Khanoyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-L","family":"Dubois-Rande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Galinier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Roubille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Alexandre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Babuty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Delarche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-F","family":"Seronde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-B","family":"Berneau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Girerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Rosano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Yousef","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Arden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bakhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Squire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Boos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Travill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Koenyves","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Lakatos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Matoltsy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Noori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Zilahi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Andrassy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kancz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Simon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Sydo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Vorobcsuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Merkely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RG","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Szakal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Barany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Nagy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Szolnoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"VK","family":"Chopra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mandal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Rastogi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Mullasari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Shankar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Oomman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Kaul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Komarlu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kahali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bhagwat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Vijan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NK","family":"Ghaisas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kashyap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kothari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"TaddeI","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Scherillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Zac\u00e0","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Salvioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Fucili","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Cosmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Volpe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Senni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Mazzone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Esposito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Doi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Sakagami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Oishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yasaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Tsuboi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Fujino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Himi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ichikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kijima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Koga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Yuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Fukui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kubota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Manita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Fujinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Matsumura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Fukumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kawai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Hiasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Kazatani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Ogimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Inoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Oguri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kinoshita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Okuhara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Otomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Matsunaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Takaishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Miyagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Uehara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Takaishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Urata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kataoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Matsubara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Imamaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Yoshitama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Sekino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Furutani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Koda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Matsuoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Shinozaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Tsunoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Yonezawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Hori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Yagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Arikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hashizume","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ishiki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Koizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Taguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nanasato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Yoshida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Tsujiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Nakamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Oku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Suwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Momiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kadokami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Maeno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kawamitsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Maruyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Nakata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Wada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-J","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JO","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B-S","family":"Yoo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-O","family":"Choi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SK","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-H","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M-C","family":"Cho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SH","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-O","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J-J","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SM","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D-S","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MH","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Llamas Esperon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Illescas D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Fajardo Campos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Almeida Alvarado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bazzoni Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Echeverri Rico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Lopez Alcocer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Valle Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Hernandez Herrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Calvo Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FG","family":"Padilla Padilla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Rodriguez Briones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EJJR","family":"Chuquiure Valenzuela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ME","family":"Aguilera Real","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Carrillo Calvillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Alpizar Salazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JL","family":"Cervantes Esc\u00e1rcega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Velasco Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Al - Windy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"van Heerebeek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Bellersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-P","family":"Brunner-La Rocca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GCM","family":"Linssen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"van de Wetering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"van Stralen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Groutars","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Smits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Yilmaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WEM","family":"Kok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Van der Meer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Dijkmans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Troquay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AP","family":"van Alem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Van de Wal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Handoko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ICD","family":"Westendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PFMM","family":"van Bergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BJWM","family":"Rensing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Hoogslag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Kietselaer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JA","family":"Kragten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FR","family":"den Hartog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Alings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Danilowicz-Szymanowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Raczak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Piesiewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Zmuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Kus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Podolec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Musial","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Drelich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Kania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Miekus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mazur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Janik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Spyra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Peruga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Balsam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Krakowiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Szachniewicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ginel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Grzybowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Chrustowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Wojewoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kalinka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Zurakowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Koc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Debinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Fil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kujawiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Forys","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kasprzak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Krol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Michalski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Mirek-Bryniarska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Radwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Skonieczny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Stania","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Skoczylas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Madej","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Jurowiecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Firek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Wozakowska-Kaplon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Cymerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Neutel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Adams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Balfour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Deswal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Djamson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Rinde-Hoffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Woodhouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"MacNevin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Rama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Broome-Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kindsvater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Abramov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Barettella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pinney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Herre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Vora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Challappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Cox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Jani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Karim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Akhtar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Paukman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Bhatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Budoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Bush","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Potler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Delgado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Dy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Fialkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Sangrigoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Ferdinand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"East","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Falkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Donahoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Ebrahimi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Kline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Khouzam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Jaffrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Jarmukli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Kazemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Koren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Friedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Herzog","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Greenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Silva Enciso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Grover-McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Hauptman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Mikhalkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Hegde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hodsden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Khouri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"McGrew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Littlefield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"McLaurin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lupovitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Labin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Rao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Leithe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Lesko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Lombardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mahal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Dauber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Banerjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Needell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Paladino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Munuswamy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"McMillan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mumma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Adlakha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Onwuanyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Serota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Schmedtje","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Paraschos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Potu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Sai-Sudhakar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Saltzberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Skopicki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Bui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Carr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Stevens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Tahirkheli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Tallaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Yousuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Trichon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Welker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Tolerico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Vest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Vivo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"X","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Abadier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Dunlap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Kotha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Zaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Uriel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Greene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Salacata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Arora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Gazmuri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kobayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Iteld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Vijayakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Dab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Mirza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Marques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Nallasivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Bensimhon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Peart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Saint-Jacques","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Barringhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Contreras","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Koneru","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00292-8_bib1","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.jacc.2018.04.070","article-title":"Medical therapy for heart failure with reduced ejection fraction: the CHAMP-HF registry","volume":"72","author":"Greene","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00292-8_bib2","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1001\/jamacardio.2020.0640","article-title":"Assessment of limitations to optimization of guideline-directed medical therapy in heart failure from the GUIDE-IT trial: a secondary analysis of a randomized clinical trial","volume":"5","author":"Fiuzat","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(21)00292-8_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1016\/j.jchf.2020.10.002","article-title":"Standardized definitions for evaluation of heart failure therapies: scientific expert panel from the heart failure collaboratory and academic research consortium","volume":"8","author":"Abraham","year":"2020","journal-title":"JACC Heart Fail"},{"key":"10.1016\/S2213-8587(21)00292-8_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00292-8_bib5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1161\/CIRCULATIONAHA.120.051824","article-title":"Effect of empagliflozin on cardiovascular and renal outcomes in patients with heart failure by baseline diabetes status: results from the EMPEROR-Reduced trial","volume":"143","author":"Anker","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00292-8_bib6","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1161\/CIRCULATIONAHA.120.051685","article-title":"Cardiac and kidney benefits of empagliflozin in heart failure across the spectrum of kidney function: insights from EMPEROR-Reduced","volume":"143","author":"Zannad","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00292-8_bib7","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/ehab360","article-title":"Regional and ethnic influences on the response to empagliflozin in patients with heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial","author":"Lam","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00292-8_bib8","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00292-8_bib9","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/eurheartj\/ehaa183","article-title":"Effects of dapagliflozin in DAPA-HF according to background heart failure therapy","volume":"41","author":"Docherty","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00292-8_bib10","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/ejhf.1536","article-title":"Evaluation of the effect of sodium-glucose co-transporter 2 inhibition with empagliflozin on morbidity and mortality of patients with chronic heart failure and a reduced ejection fraction: rationale for and design of the EMPEROR-Reduced trial","volume":"21","author":"Packer","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(21)00292-8_bib11","doi-asserted-by":"crossref","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/AHA guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00292-8_bib12","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00292-8_bib13","doi-asserted-by":"crossref","first-page":"508","DOI":"10.2337\/dci19-0074","article-title":"SGLT2 inhibitors produce cardiorenal benefits by promoting adaptive cellular reprogramming to induce a state of fasting mimicry: a paradigm shift in understanding their mechanism of action","volume":"43","author":"Packer","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00292-8_bib14","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1093\/cvr\/cvaa064","article-title":"Critical examination of mechanisms underlying the reduction in heart failure events with SGLT2 inhibitors: identification of a molecular link between their actions to stimulate erythrocytosis and to alleviate cellular stress","volume":"117","author":"Packer","year":"2021","journal-title":"Cardiovasc Res"},{"key":"10.1016\/S2213-8587(21)00292-8_bib15","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1161\/CIRCULATIONAHA.119.040909","article-title":"Reconceptualization of the molecular mechanism by which sodium-glucose cotransporter 2 inhibitors reduce the risk of heart failure events","volume":"140","author":"Packer","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00292-8_bib16","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1001\/jamacardio.2017.2275","article-title":"Effects of sodium-glucose cotransporter 2 inhibitors for the treatment of patients with heart failure: proposal of a novel mechanism of action","volume":"2","author":"Packer","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(21)00292-8_bib17","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1002\/ejhf.1732","article-title":"Autophagy stimulation and intracellular sodium reduction as mediators of the cardioprotective effect of sodium-glucose cotransporter 2 inhibitors","volume":"22","author":"Packer","year":"2020","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(21)00292-8_bib18","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/S2213-8587(21)00292-8_bib19","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1146\/annurev-physiol-031620-095920","article-title":"Effects of SGLT2 Inhibitors on Kidney and Cardiovascular Function","volume":"83","author":"Vallon","year":"2021","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/S2213-8587(21)00292-8_bib20","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00292-8_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2213-8587(20)30382-X","article-title":"Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial","volume":"9","author":"Jensen","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00292-8_bib22","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1161\/CIRCULATIONAHA.119.042375","article-title":"Effect of empagliflozin on left ventricular mass in patients with type 2 diabetes mellitus and coronary artery disease: the EMPA-HEART cardiolink-6 randomized clinical trial","volume":"140","author":"Verma","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00292-8_bib23","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/CIRCULATIONAHA.120.052186","article-title":"Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)","volume":"143","author":"Lee","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00292-8_bib24","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.jacc.2020.11.008","article-title":"Randomized trial of empagliflozin in nondiabetic patients with heart failure and reduced ejection fraction","volume":"77","author":"Santos-Gallego","year":"2021","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00292-8_bib25","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1001\/jamacardio.2020.6827","article-title":"Associations of empagliflozin with left ventricular volumes, mass, and function in patients with heart failure and reduced ejection fraction: a substudy of the Empire HF randomized clinical trial","volume":"6","author":"Omar","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(21)00292-8_bib26","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1002\/ejhf.2149","article-title":"Rapid evidence-based sequencing of foundational drugs for heart failure and a reduced ejection fraction","volume":"23","author":"Packer","year":"2021","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(21)00292-8_bib27","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2337\/dc19-1410","article-title":"Reinterpreting cardiorenal protection of renal sodium\u2013 glucose cotransporter 2 inhibitors via cellular life history programming","volume":"43","author":"Avogaro","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00292-8_bib28","doi-asserted-by":"crossref","first-page":"2312","DOI":"10.1161\/01.CIR.100.23.2312","article-title":"Comparative effects of low and high doses of the angiotensin-converting enzyme inhibitor, lisinopril, on morbidity and mortality in chronic heart failure","volume":"100","author":"Packer","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00292-8_bib29","doi-asserted-by":"crossref","first-page":"e25","DOI":"10.1016\/j.amjmed.2019.06.053","article-title":"Early effects of starting doses of enalapril in patients with chronic heart failure in the SOLVD Treatment trial","volume":"133","author":"Lam","year":"2020","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(21)00292-8_bib30","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1001\/jama.289.6.712","article-title":"Effects of initiating carvedilol in patients with severe chronic heart failure: results from the COPERNICUS Study","volume":"289","author":"Krum","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00292-8_bib31","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.jacc.2005.04.038","article-title":"Eplerenone reduces mortality 30 days after randomization following acute myocardial infarction in patients with left ventricular systolic dysfunction and heart failure","volume":"46","author":"Pitt","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00292-8_bib32","doi-asserted-by":"crossref","first-page":"1840","DOI":"10.1016\/S0140-6736(09)61913-9","article-title":"Effects of high-dose versus low-dose losartan on clinical outcomes in patients with heart failure (HEAAL study): a randomised, double-blind trial","volume":"374","author":"Konstam","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00292-8_bib33","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ejhf.1400","article-title":"Renal function stratified dose comparisons of eplerenone versus placebo in the EMPHASIS-HF trial","volume":"21","author":"Ferreira","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(21)00292-8_bib34","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1161\/01.CIR.94.11.2807","article-title":"Carvedilol produces dose-related improvements in left ventricular function and survival in subjects with chronic heart failure","volume":"94","author":"Bristow","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00292-8_bib35","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1002\/ejhf.580","article-title":"Efficacy of sacubitril\/valsartan vs. enalapril at lower than target doses in heart failure with reduced ejection fraction: the PARADIGM-HF trial","volume":"18","author":"Vardeny","year":"2016","journal-title":"Eur J Heart Fail"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002928?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002928?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:39Z","timestamp":1761991839000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002928"}},"issued":{"date-parts":[[2022,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2213858721002928"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00292-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00292-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00311-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:36:11Z","timestamp":1794584171337,"version":"4.9.1"},"reference-count":98,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/s2213-8587(15)00135-7","type":"journal-article","created":{"date-parts":[[2015,5,17]],"date-time":"2015-05-17T19:45:57Z","timestamp":1431891957000},"page":"450-460","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":387,"title":["Constructs of depression and distress in diabetes: time for an appraisal"],"prefix":"10.1016","volume":"3","author":[{"given":"Frank J","family":"Snoek","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marijke A","family":"Bremmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norbert","family":"Hermanns","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/S2213-8587(15)00135-7_bib1","doi-asserted-by":"crossref","first-page":"S56","DOI":"10.1016\/S0165-0327(12)70009-5","article-title":"Co-occurrence of diabetes and depression: conceptual considerations for an emerging global health challenge","volume":"142","author":"Fisher","year":"2012","journal-title":"J Affect Disord"},{"issue":"suppl","key":"10.1016\/S2213-8587(15)00135-7_bib2","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1016\/S0165-0327(12)70004-6","article-title":"Epidemiology of depression and diabetes: a systematic review","volume":"142","author":"Roy","year":"2012","journal-title":"J Affect Disord"},{"key":"10.1016\/S2213-8587(15)00135-7_bib3","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1016\/S0022-3999(02)00417-8","article-title":"Prevalence of anxiety in adults with diabetes: a systematic review","volume":"53","author":"Grigsby","year":"2002","journal-title":"J Psychosom Res"},{"key":"10.1016\/S2213-8587(15)00135-7_bib4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1111\/j.1464-5491.2005.01414.x","article-title":"Affective and anxiety disorders in a German sample of diabetic patients: prevalence, comorbidity and risk factors","volume":"22","author":"Hermanns","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib5","doi-asserted-by":"crossref","first-page":"970","DOI":"10.2337\/dc13-1832","article-title":"Recurrent subthreshold depression in type 2 diabetes: an important risk factor for poor health outcomes","volume":"37","author":"Schmitz","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.2190\/KLGD-4H8D-4RYL-TWQ8","article-title":"Anxiety and poor glycemic control: a meta-analytic review of the literature","volume":"32","author":"Anderson","year":"2002","journal-title":"Int J Psychiatry Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib7","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.2337\/dc08-1341","article-title":"Depression and diabetes treatment nonadherence: a meta-analysis","volume":"31","author":"Gonzalez","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib8","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1007\/s11606-008-0731-9","article-title":"Depression and diabetes: a potentially lethal combination","volume":"23","author":"Katon","year":"2008","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib9","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/S2213-8587(13)70139-6","article-title":"Depression and type 2 diabetes: a causal association?","volume":"2","author":"Tab\u00e1k","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00135-7_bib10","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008381.pub2","article-title":"Psychological and pharmacological interventions for depression in patients with diabetes mellitus and depression","volume":"12","author":"Baumeister","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(15)00135-7_bib11","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1001\/archpsyc.61.10.1042","article-title":"The Pathways Study: a randomized trial of collaborative care in patients with diabetes and depression","volume":"61","author":"Katon","year":"2004","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib12","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/j.genhosppsych.2010.03.011","article-title":"Effect of interventions for major depressive disorder and significant depressive symptoms in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"32","author":"van der Feltz-Cornelis","year":"2010","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib13","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.2337\/dc13-2134","article-title":"NIDDK international conference report on diabetes and depression: current understanding and future directions","volume":"37","author":"Holt","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib14","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1111\/dme.12428","article-title":"The confusing tale of depression and distress in patients with diabetes: a call for greater clarity and precision","volume":"31","author":"Fisher","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib15","series-title":"Saving normal: an insider's revolt against out-of-control psychiatric diagnosis, DSM-5, big pharma and the medicalization of life","author":"Allen","year":"2013"},{"key":"10.1016\/S2213-8587(15)00135-7_bib17","series-title":"Diagnostic and Statistical Manual of Mental Disorders, Fifth Edition, DSM-5","year":"2013"},{"key":"10.1016\/S2213-8587(15)00135-7_bib19","series-title":"Screening for depression and other psychological problems in diabetes","author":"Lloyd","year":"2012"},{"key":"10.1016\/S2213-8587(15)00135-7_bib20","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1001\/jama.291.21.2581","article-title":"Prevalence, severity, and unmet need for treatment of mental disorders in the World Health Organization World Mental Health Surveys","volume":"291","author":"Demyttenaere","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00135-7_bib21","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1001\/archpsyc.62.6.617","article-title":"Prevalence, severity, and comorbidity of 12-month DSM-IV disorders in the National Comorbidity Survey Replication","volume":"62","author":"Kessler","year":"2005","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib22","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1176\/appi.ajp.157.12.1925","article-title":"Affective disorders and suicide risk: a reexamination","volume":"157","author":"Bostwick","year":"2000","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib23","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1186\/1741-7015-9-90","article-title":"Cross-national epidemiology of DSM-IV major depressive episode","volume":"9","author":"Bromet","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib24","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1159\/000362563","article-title":"The four-year course of major depressive disorder: the role of staging and risk factor determination","volume":"83","author":"Boschloo","year":"2014","journal-title":"Psychother Psychosom"},{"key":"10.1016\/S2213-8587(15)00135-7_bib25","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/archpsyc.65.5.513","article-title":"Population-based study of first onset and chronicity in major depressive disorder","volume":"65","author":"Eaton","year":"2008","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib26","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1192\/bjp.181.3.208","article-title":"Duration of major depressive episodes in the general population: results from The Netherlands Mental Health Survey and Incidence Study (NEMESIS)","volume":"181","author":"Spijker","year":"2002","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib27","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1037\/a0021659","article-title":"Severe and nonsevere events in first onsets versus recurrences of depression: evidence for stress sensitization","volume":"120","author":"Stroud","year":"2011","journal-title":"J Abnorm Psychol"},{"key":"10.1016\/S2213-8587(15)00135-7_bib28","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.genhosppsych.2007.06.002","article-title":"Major depression in individuals with chronic medical disorders: prevalence, correlates and association with health resource utilization, lost productivity and functional disability","volume":"29","author":"Egede","year":"2007","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib29","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S0140-6736(07)61415-9","article-title":"Depression, chronic diseases, and decrements in health: results from the World Health Surveys","volume":"370","author":"Moussavi","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00135-7_bib30","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1097\/00006842-199209000-00007","article-title":"Similarity of depression in diabetic and psychiatric patients","volume":"54","author":"Lustman","year":"1992","journal-title":"Psychosom Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib31","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/1472-6963-10-235","article-title":"Validation of the PHQ-9 as a screening instrument for depression in diabetes patients in specialized outpatient clinics","volume":"10","author":"van Steenbergen-Weijenburg","year":"2010","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(15)00135-7_bib32","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1111\/j.1464-5491.2010.03028.x","article-title":"Depressive symptoms in the first year from diagnosis of Type 2 diabetes: results from the DESMOND trial","volume":"27","author":"Skinner","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib33","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.2337\/dc06-0617","article-title":"Psychological outcomes of patients with screen-detected type 2 diabetes: the influence of time since diagnosis and treatment intensity","volume":"29","author":"Thoolen","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib34","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1007\/s00125-003-1124-6","article-title":"Rates and risks for co-morbid depression in patients with Type 2 diabetes mellitus: results from a community-based study","volume":"46","author":"Pouwer","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00135-7_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.jad.2012.07.018","article-title":"Self-rated health: a predictor for the three year incidence of major depression in individuals with Type II diabetes","volume":"145","author":"Badawi","year":"2013","journal-title":"J Affect Disord"},{"key":"10.1016\/S2213-8587(15)00135-7_bib36","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0277-9536(94)90294-1","article-title":"The disablement process","volume":"38","author":"Verbrugge","year":"1994","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib37","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1177\/014572170202800211","article-title":"Beliefs and attitudes of African Americans with type 2 diabetes toward depression","volume":"28","author":"Egede","year":"2002","journal-title":"Diabetes Educ"},{"key":"10.1016\/S2213-8587(15)00135-7_bib38","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.diabres.2014.01.001","article-title":"Depression and type 2 diabetes in low- and middle-income countries: a systematic review","volume":"103","author":"Mendenhall","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00135-7_bib39","series-title":"Stress without distress","author":"Selye","year":"1974"},{"key":"10.1016\/S2213-8587(15)00135-7_bib40","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1046\/j.1365-2648.2003.02938.x","article-title":"Psychological distress: concept analysis","volume":"45","author":"Ridner","year":"2004","journal-title":"J Adv Nurs"},{"key":"10.1016\/S2213-8587(15)00135-7_bib41","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1037\/0022-006X.51.5.730","article-title":"The structure of psychological distress and well-being in general populations","volume":"51","author":"Veit","year":"1983","journal-title":"J Consult Clin Psychol"},{"key":"10.1016\/S2213-8587(15)00135-7_bib42","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S0140-6736(08)61078-8","article-title":"Psychological adjustment to chronic disease","volume":"372","author":"de Ridder","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00135-7_bib43","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1093\/eurpub\/ckt017","article-title":"The association between self-reported history of physical diseases and psychological distress in a community-dwelling Japanese population: the Ohsaki Cohort 2006 Study","volume":"24","author":"Nakaya","year":"2014","journal-title":"Eur J Public Health"},{"key":"10.1016\/S2213-8587(15)00135-7_bib44","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1017\/S0033291702006074","article-title":"Short screening scales to monitor population prevalences and trends in non-specific psychological distress","volume":"32","author":"Kessler","year":"2002","journal-title":"Psychol Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib45","doi-asserted-by":"crossref","first-page":"754","DOI":"10.2337\/diacare.18.6.754","article-title":"Assessment of diabetes-related distress","volume":"18","author":"Polonsky","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib46","doi-asserted-by":"crossref","first-page":"480","DOI":"10.2337\/diacare.9.5.480","article-title":"Measurement of emotional adjustment in diabetic patients: validity and reliability of ATT39","volume":"9","author":"Dunn","year":"1986","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib47","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diacare.28.3.626","article-title":"Assessing psychosocial distress in diabetes: development of the diabetes distress scale","volume":"28","author":"Polonsky","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib48","doi-asserted-by":"crossref","first-page":"760","DOI":"10.2337\/diacare.20.5.760","article-title":"The Problem Areas in Diabetes Scale. An evaluation of its clinical utility","volume":"20","author":"Welch","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib49","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.2337\/diacare.23.9.1305","article-title":"Diabetes-related emotional distress in Dutch and U.S. diabetic patients: cross-cultural validity of the problem areas in diabetes scale","volume":"23","author":"Snoek","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib50","doi-asserted-by":"crossref","first-page":"601","DOI":"10.2337\/dc10-1552","article-title":"Monitoring of Individual Needs in Diabetes (MIND): baseline data from the Cross-National Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study","volume":"34","author":"Snoek","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib51","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.1111\/dme.12472","article-title":"Diabetes-specific emotional distress in people with Type 2 diabetes: a comparison between primary and secondary care","volume":"31","author":"Stoop","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib52","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jpsychores.2014.06.015","article-title":"Relationships of diabetes-specific emotional distress, depression, anxiety, and overall well-being with HbA1c in adult persons with type 1 diabetes","volume":"77","author":"Strandberg","year":"2014","journal-title":"J Psychosom Res"},{"key":"10.1016\/S2213-8587(15)00135-7_bib53","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1111\/j.1464-5491.2008.02533.x","article-title":"A longitudinal study of affective and anxiety disorders, depressive affect and diabetes distress in adults with Type 2 diabetes","volume":"25","author":"Fisher","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib54","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1007\/s10865-013-9505-x","article-title":"The differential associations of depression and diabetes distress with quality of life domains in type 2 diabetes","volume":"37","author":"Carper","year":"2014","journal-title":"J Behav Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib55","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.2337\/dc09-2175","article-title":"The relationship between diabetes distress and clinical depression with glycemic control among patients with type 2 diabetes","volume":"33","author":"Fisher","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib56","doi-asserted-by":"crossref","first-page":"23","DOI":"10.2337\/dc09-1238","article-title":"Diabetes distress but not clinical depression or depressive symptoms is associated with glycemic control in both cross-sectional and longitudinal analyses","volume":"33","author":"Fisher","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib57","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.psym.2012.08.004","article-title":"Putting PAID to diabetes-related distress: the potential utility of the problem areas in diabetes (PAID) scale in patients with diabetes","volume":"54","author":"Reddy","year":"2013","journal-title":"Psychosomatics"},{"key":"10.1016\/S2213-8587(15)00135-7_bib58","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1111\/j.1464-5491.2010.03025.x","article-title":"Diabetes-specific emotional distress mediates the association between depressive symptoms and glycaemic control in Type 1 and Type 2 diabetes","volume":"27","author":"van Bastelaar","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib59","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1111\/dme.12553","article-title":"Assessment of diabetes acceptance can help identify patients with ineffective diabetes self-care and poor diabetes control","volume":"31","author":"Schmitt","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib60","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s00125-005-0094-2","article-title":"How to screen for depression and emotional problems in patients with diabetes: comparison of screening characteristics of depression questionnaires, measurement of diabetes-specific emotional problems and standard clinical assessment","volume":"49","author":"Hermanns","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00135-7_bib61","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.2337\/dc11-1326","article-title":"Monitoring of Individual Needs in Diabetes (MIND)-2: follow-up data from the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) MIND study","volume":"35","author":"Snoek","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib62","doi-asserted-by":"crossref","first-page":"542","DOI":"10.2337\/dc06-1614","article-title":"Clinical depression versus distress among patients with type 2 diabetes: not just a question of semantics","volume":"30","author":"Fisher","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib63","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s00125-008-1113-x","article-title":"Differentiating symptoms of depression from diabetes-specific distress: relationships with self-care in type 2 diabetes","volume":"51","author":"Gonzalez","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00135-7_bib64","doi-asserted-by":"crossref","first-page":"934","DOI":"10.2337\/diacare.23.7.934","article-title":"Depression and poor glycemic control: a meta-analytic review of the literature","volume":"23","author":"Lustman","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib65","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1046\/j.1464-5491.2001.00499.x","article-title":"Association between symptoms of depression and glycaemic control may be unstable across gender","volume":"18","author":"Pouwer","year":"2001","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib66","article-title":"Negative association between depression and diabetes control only when accompanied by diabetes-specific distress","author":"Schmitt","year":"2014","journal-title":"J Behavioral Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib67","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.jpsychires.2012.01.013","article-title":"Suboptimal glycemic control in type 2 diabetes: a key role for anhedonia?","volume":"46","author":"Nefs","year":"2012","journal-title":"J Psychiatr Res"},{"key":"10.1016\/S2213-8587(15)00135-7_bib68","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1111\/dme.12082","article-title":"Differential associations between depressive symptoms and glycaemic control in outpatients with diabetes","volume":"30","author":"Bot","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib69","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2337\/diacare.25.1.30","article-title":"Stress management improves long-term glycemic control in type 2 diabetes","volume":"25","author":"Surwit","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib70","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1017\/S0033291704004210","article-title":"Beyond major depression","volume":"35","author":"Parker","year":"2005","journal-title":"Psychol Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib71","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.biopsych.2011.08.022","article-title":"High dimensional endophenotype ranking in the search for major depression risk genes","volume":"71","author":"Glahn","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib72","doi-asserted-by":"crossref","first-page":"1582","DOI":"10.4088\/JCP.09m05398blu","article-title":"Identifying depressive subtypes in a large cohort study: results from the Netherlands Study of Depression and Anxiety (NESDA)","volume":"71","author":"Lamers","year":"2010","journal-title":"J Clin Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib73","doi-asserted-by":"crossref","first-page":"2083","DOI":"10.1017\/S0033291712000141","article-title":"Stability and transitions of depressive subtypes over a 2-year follow-up","volume":"42","author":"Lamers","year":"2012","journal-title":"Psychol Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib74","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/da.22233","article-title":"Major depressive disorder subtypes to predict long-term course","volume":"31","author":"van Loo","year":"2014","journal-title":"Depress Anxiety"},{"key":"10.1016\/S2213-8587(15)00135-7_bib75","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.genhosppsych.2007.12.008","article-title":"The association of depression and anxiety with obesity and unhealthy behaviors among community-dwelling US adults","volume":"30","author":"Strine","year":"2008","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib76","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.psychres.2009.04.015","article-title":"Depression and obesity: a meta-analysis of community-based studies","volume":"178","author":"de Wit","year":"2010","journal-title":"Psychiatry Res"},{"key":"10.1016\/S2213-8587(15)00135-7_bib77","doi-asserted-by":"crossref","first-page":"e267","DOI":"10.1016\/j.orcp.2011.04.007","article-title":"The relationship between abdominal obesity and depression in the general population: A systematic review and meta-analysis","volume":"5","author":"Xu","year":"2011","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00135-7_bib78","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1600-0447.2008.01315.x","article-title":"No association of depression and anxiety with the metabolic syndrome: the Norwegian HUNT study","volume":"120","author":"Hildrum","year":"2009","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S2213-8587(15)00135-7_bib79","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.biopsych.2007.01.012","article-title":"Associations between anxiety, depression, and the metabolic syndrome","volume":"62","author":"Skilton","year":"2007","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib80","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1375\/twin.13.4.347","article-title":"Major depression and the metabolic syndrome","volume":"13","author":"Foley","year":"2010","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/S2213-8587(15)00135-7_bib81","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1600-0447.2007.00965.x","article-title":"Melancholia and atypical depression in the Zurich study: epidemiology, clinical characteristics, course, comorbidity and personality","volume":"433","author":"Angst","year":"2007","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/S2213-8587(15)00135-7_bib82","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1001\/archgenpsychiatry.2010.2","article-title":"Overweight, obesity, and depression: a systematic review and meta-analysis of longitudinal studies","volume":"67","author":"Luppino","year":"2010","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib83","doi-asserted-by":"crossref","first-page":"2762","DOI":"10.2337\/diacare.28.11.2762","article-title":"High incidence of diabetes in men with sleep complaints or short sleep duration: a 12-year follow-up study of a middle-aged population","volume":"28","author":"Mallon","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib84","doi-asserted-by":"crossref","first-page":"657","DOI":"10.2337\/diacare.29.03.06.dc05-0879","article-title":"Sleep duration as a risk factor for the development of type 2 diabetes","volume":"29","author":"Yaggi","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib85","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/dc09-2317","article-title":"Partial sleep restriction decreases insulin sensitivity in type 1 diabetes","volume":"33","author":"Donga","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib86","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.2337\/dc10-1962","article-title":"Cross-sectional associations between measures of sleep and markers of glucose metabolism among subjects with and without diabetes: the Coronary Artery Risk Development in Young Adults (CARDIA) Sleep Study","volume":"34","author":"Knutson","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib87","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1126\/science.1195027","article-title":"Circadian integration of metabolism and energetics","volume":"330","author":"Bass","year":"2010","journal-title":"Science"},{"key":"10.1016\/S2213-8587(15)00135-7_bib88","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/archpsyc.1994.03950010008002","article-title":"Lifetime and 12-month prevalence of DSM-III-R psychiatric disorders in the United States. Results from the National Comorbidity Survey","volume":"51","author":"Kessler","year":"1994","journal-title":"Arch Gen Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib89","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1176\/appi.ajp.162.6.1179","article-title":"Influence of psychiatric comorbidity on recovery and recurrence in generalized anxiety disorder, social phobia, and panic disorder: a 12-year prospective study","volume":"162","author":"Bruce","year":"2005","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib90","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1192\/bjp.176.3.229","article-title":"Lifetime panic-depression comorbidity in the National Comorbidity Survey. Association with symptoms, impairment, course and help-seeking","volume":"176","author":"Roy-Byrne","year":"2000","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib91","unstructured":"Kelly SJ, Ismail M. Stress and type 2 diabetes: a review of how stress contributes to the development of T2D. Annu Rev Public Health (in press)."},{"key":"10.1016\/S2213-8587(15)00135-7_bib92","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2337\/diacare.27.5.1066","article-title":"Diabetes, depression, and quality of life: a population study","volume":"27","author":"Goldney","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib93","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1586\/erp.12.86","article-title":"Effect of comorbid depression on quality of life in adults with Type 2 diabetes","volume":"13","author":"Egede","year":"2013","journal-title":"Expert Rev Pharmacoecon Outcomes Res"},{"key":"10.1016\/S2213-8587(15)00135-7_bib94","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/0165-0327(91)90012-H","article-title":"Models of stress, vulnerability and affective disorder","volume":"21","author":"Rodgers","year":"1991","journal-title":"J Affect Disord"},{"key":"10.1016\/S2213-8587(15)00135-7_bib95","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa1003955","article-title":"Collaborative care for patients with depression and chronic illnesses","volume":"363","author":"Katon","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00135-7_bib96","doi-asserted-by":"crossref","first-page":"320","DOI":"10.2337\/dc10-1248","article-title":"Web-based depression treatment for type 1 and type 2 diabetic patients: a randomized, controlled trial","volume":"34","author":"van Bastelaar","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib97","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1186\/1471-244X-13-206","volume":"13","author":"Petrak","year":"2013","journal-title":"BMC Psychiatry"},{"key":"10.1016\/S2213-8587(15)00135-7_bib98","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2337\/diacare.6.4.409","article-title":"Coping with predictable crises of diabetes","volume":"6","author":"Hamburg","year":"1983","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00135-7_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2012.10.001","article-title":"Global Guideline for Type 2 Diabetes","volume":"104","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"suppl 12","key":"10.1016\/S2213-8587(15)00135-7_bib100","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/j.1399-5448.2009.00580.x","article-title":"Psychological care of children and adolescents with diabetes","volume":"10","author":"Delamater","year":"2009","journal-title":"Pediatr Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T10:27:41Z","timestamp":1537612061000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715001357"}},"issued":{"date-parts":[[2015,6]]},"references-count":98,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S2213858715001357"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00135-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Constructs of depression and distress in diabetes: time for an appraisal","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00135-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:54:55Z","timestamp":1794556495275,"version":"4.9.1"},"update-to":[{"DOI":"10.1016\/s2213-8587(20)30343-0","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/s2213-8587(20)30407-1","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T02:04:23Z","timestamp":1608170663000},"page":"e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correction to Lancet Diabetes Endocrinol 2021; 9: 46\u201352"],"prefix":"10.1016","volume":"9","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720304071?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720304071?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:51Z","timestamp":1761991731000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720304071"}},"issued":{"date-parts":[[2021,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2213858720304071"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30407-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2021; 9: 46\u201352","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30407-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30343-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:39:17Z","timestamp":1794566357580,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T00:00:00Z","timestamp":1415664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["RP-PG-0407-10314, PI HH"],"award-info":[{"award-number":["RP-PG-0407-10314, PI HH"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome Trust","award":["WT 086091\/Z\/08\/Z, PI HH"],"award-info":[{"award-number":["WT 086091\/Z\/08\/Z, PI HH"]}]},{"name":"Medical Research Prognosis Research Strategy Partnership","award":["G0902393\/99558, PI HH"],"award-info":[{"award-number":["G0902393\/99558, PI HH"]}]},{"DOI":"10.13039\/501100000265","name":"The Medical Research Council","doi-asserted-by":"crossref","award":["K006584\/1, PI HH"],"award-info":[{"award-number":["K006584\/1, PI HH"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome Trust","award":["098504"],"award-info":[{"award-number":["098504"]}]},{"name":"Wellcome Trust clinical research training fellowship","award":["0938\/30\/Z\/10\/Z"],"award-info":[{"award-number":["0938\/30\/Z\/10\/Z"]}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"crossref","award":["NIHR\/CS\/009\/004"],"award-info":[{"award-number":["NIHR\/CS\/009\/004"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/s2213-8587(14)70219-0","type":"journal-article","created":{"date-parts":[[2014,11,10]],"date-time":"2014-11-10T20:03:31Z","timestamp":1415649811000},"page":"105-113","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1045,"title":["Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b79 million people"],"prefix":"10.1016","volume":"3","author":[{"given":"Anoop Dinesh","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Langenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleni","family":"Rapsomaniki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Denaxas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mar","family":"Pujades-Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris P","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Deanfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Smeeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adam","family":"Timmis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harry","family":"Hemingway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70219-0_bib1","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(14)70219-0_bib2","doi-asserted-by":"crossref","first-page":"s3","DOI":"10.1097\/01.hjr.0000368191.86614.5a","article-title":"The global burden of diabetes and its complications: an emerging pandemic","volume":"17","author":"van Dieren","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/S2213-8587(14)70219-0_bib3","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70219-0_bib4","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70219-0_bib5","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1001\/jama.1979.03290450033020","article-title":"Diabetes and cardiovascular disease: the Framingham study","volume":"241","author":"Kannel","year":"1979","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70219-0_bib6","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1038\/nrcardio.2010.180","article-title":"Pathophysiology and epidemiology of abdominal aortic aneurysms","volume":"8","author":"Nordon","year":"2011","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(14)70219-0_bib7","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-014-3260-6","article-title":"Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858,507 individuals and 28,203 coronary events","volume":"57","author":"Peters","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70219-0_bib8","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1016\/S0140-6736(14)60685-1","article-title":"Blood pressure and incidence of twelve cardiovascular diseases: lifetime risks, healthy life-years lost, and age-specific associations in 1\u00b725 million people","volume":"383","author":"Rapsomaniki","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70219-0_bib9","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/ije\/dys188","article-title":"Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)","volume":"41","author":"Denaxas","year":"2012","journal-title":"Int J Epidemiol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70219-0_bib11","first-page":"S81","article-title":"Diagnosis and classification of diabetes mellitus","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70219-0_bib12","series-title":"Type 2 diabetes: national clinical guideline for management in primary and secondary care (update)","year":"2008"},{"key":"10.1016\/S2213-8587(14)70219-0_bib14","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1016\/S0140-6736(13)61249-0","article-title":"Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysis","volume":"382","author":"Fowkes","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70219-0_bib15","doi-asserted-by":"crossref","first-page":"f2350","DOI":"10.1136\/bmj.f2350","article-title":"Completeness and diagnostic validity of recording acute myocardial infarction events in primary care, hospital care, disease registry, and national mortality records: cohort study","volume":"346","author":"Herrett","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70219-0_bib16","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1016\/j.jvs.2010.05.090","article-title":"Analysis of risk factors for abdominal aortic aneurysm in a cohort of more than 3 million individuals","volume":"52","author":"Kent","year":"2010","journal-title":"J Vasc Surg"},{"key":"10.1016\/S2213-8587(14)70219-0_bib17","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.ejvs.2013.12.007","article-title":"Diabetes and abdominal aortic aneurysms","volume":"47","author":"De Rango","year":"2014","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/S2213-8587(14)70219-0_bib18","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.avsg.2011.08.003","article-title":"Socioeconomic position, comorbidity, and mortality in aortic aneurysms: a 13-year prospective cohort study","volume":"26","author":"Ohrlander","year":"2012","journal-title":"Ann Vasc Surg"},{"key":"10.1016\/S2213-8587(14)70219-0_bib19","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1016\/j.annepidem.2007.02.004","article-title":"Traditional and novel risk factors for clinically diagnosed abdominal aortic aneurysm: the Kaiser multiphasic health checkup cohort study","volume":"17","author":"Iribarren","year":"2007","journal-title":"Ann Epidemiol"},{"key":"10.1016\/S2213-8587(14)70219-0_bib20","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1161\/01.STR.0000190838.02954.e8","article-title":"Risk factors for subarachnoid hemorrhage: an updated systematic review of epidemiological studies","volume":"36","author":"Feigin","year":"2005","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(14)70219-0_bib21","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ejvs.2009.10.014","article-title":"Diabetes and the abdominal aortic aneurysm","volume":"39","author":"Shantikumar","year":"2010","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/S2213-8587(14)70219-0_bib22","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1007\/s11154-010-9133-5","article-title":"Type 2 diabetes mellitus and the risk of sudden cardiac arrest in the community","volume":"11","author":"Siscovick","year":"2010","journal-title":"Rev Endocr Metab Disord"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70219-0_bib23","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s00592-009-0157-9","article-title":"Diabetes and the risk of sudden cardiac death, the Atherosclerosis Risk in Communities study","volume":"47","author":"Kucharska-Newton","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(14)70219-0_bib24","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.numecd.2010.01.008","article-title":"Cardiovascular risk in women with diabetes","volume":"20","author":"Rivellese","year":"2010","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(14)70219-0_bib25","doi-asserted-by":"crossref","first-page":"962","DOI":"10.2337\/diacare.23.7.962","article-title":"Impact of diabetes on coronary artery disease in women and men: a meta-analysis of prospective studies","volume":"23","author":"Lee","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70219-0_bib26","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1001\/archinte.162.15.1737","article-title":"Explaining the sex difference in coronary heart disease mortality among patients with type 2 diabetes mellitus: a meta-analysis","volume":"162","author":"Kanaya","year":"2002","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(14)70219-0_bib27","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(14)60040-4","article-title":"Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775\u2008385 individuals and 12\u2008539 strokes","volume":"383","author":"Peters","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70219-0_bib28","doi-asserted-by":"crossref","first-page":"2859","DOI":"10.1007\/s00125-006-0493-z","article-title":"Risk of stroke in people with type 2 diabetes in the UK: a study using the General Practice Research Database","volume":"49","author":"Mulnier","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70219-0_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1111\/j.1464-5491.2011.03419.x","article-title":"Miscoding, misclassification and misdiagnosis of diabetes in primary care","volume":"29","author":"de Lusignan","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(14)70219-0_bib30","series-title":"Health Survey for England 2003, volume 2: risk factors for cardiovascular disease","article-title":"Diabetes","author":"Shelton","year":"2004"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702190?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702190?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T08:32:47Z","timestamp":1589272367000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702190"}},"issued":{"date-parts":[[2015,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S2213858714702190"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70219-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b79 million people","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70219-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70237-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Shah et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:00:54Z","timestamp":1794582054870,"version":"4.9.1"},"reference-count":94,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["P01 AI42288"],"award-info":[{"award-number":["P01 AI42288"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]},{"name":"JDRF","award":["SRA-2014-236"],"award-info":[{"award-number":["SRA-2014-236"]}]},{"name":"JDRF","award":["SRA-2015-35"],"award-info":[{"award-number":["SRA-2015-35"]}]},{"name":"Wellcome Trust","award":["WT096920"],"award-info":[{"award-number":["WT096920"]}]},{"name":"UK National Institute for Health Research Biomedical Research Centre at Guy's & St Thomas' Hospital and King's College London","award":["IS-BRC-1215-20006"],"award-info":[{"award-number":["IS-BRC-1215-20006"]}]},{"name":"JDRF","award":["3-SRA-2014-314-M-R"],"award-info":[{"award-number":["3-SRA-2014-314-M-R"]}]},{"name":"JDRF","award":["2-SRA-2014-295-Q-R"],"award-info":[{"award-number":["2-SRA-2014-295-Q-R"]}]},{"name":"JDRF","award":["1-SRA-2015-114-S-B"],"award-info":[{"award-number":["1-SRA-2015-114-S-B"]}]},{"name":"JDRF","award":["2-SRA-2016-148-Q-R"],"award-info":[{"award-number":["2-SRA-2016-148-Q-R"]}]},{"name":"JDRF","award":["2-SRA-2016-311-S-B"],"award-info":[{"award-number":["2-SRA-2016-311-S-B"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/s2213-8587(18)30112-8","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T18:51:16Z","timestamp":1540407076000},"page":"52-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":160,"title":["The challenge of modulating \u03b2-cell autoimmunity in type 1 diabetes"],"prefix":"10.1016","volume":"7","author":[{"given":"Mark A","family":"Atkinson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart O","family":"Roep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Posgai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel C S","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Peakman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30112-8_bib1","doi-asserted-by":"crossref","first-page":"3233","DOI":"10.2337\/db16-0687","article-title":"Type 1 diabetes prevention: a goal dependent on accepting a diagnosis of an asymptomatic disease","volume":"65","author":"Ziegler","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib2","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1016\/S0022-3476(87)80058-6","article-title":"Effects of cyclosporine in recent-onset juvenile type 1 diabetes: impact of age and duration of disease","volume":"111","author":"Stiller","year":"1987","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(18)30112-8_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1542\/peds.85.3.241","article-title":"Cyclosporine A for the treatment of new-onset insulin-dependent diabetes mellitus","volume":"85","author":"Chase","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(18)30112-8_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2337\/diab.38.6.779","article-title":"Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes","volume":"38","author":"Cook","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib5","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00592-010-0188-2","article-title":"Cyclosporin and methotrexate therapy induces remission in type 1 diabetes mellitus","volume":"47","author":"Sobel","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib6","article-title":"Antigen-based immune modulation therapy for type 1 diabetes: the era of precision medicine","author":"Roep","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib7","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1056\/NEJMoa012864","article-title":"Anti-CD3 monoclonal antibody in new-onset type 1 diabetes","volume":"346","author":"Herold","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib8","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib9","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib10","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI81722","article-title":"Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients","volume":"125","author":"Rigby","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(18)30112-8_bib11","doi-asserted-by":"crossref","first-page":"3449","DOI":"10.2337\/db14-0047","article-title":"Reduction in CD4 central memory T-cell subset in costimulation modulator abatacept-treated patients with recent-onset type 1 diabetes is associated with slower C-peptide decline","volume":"63","author":"Orban","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib12","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1007\/s00125-016-3917-4","article-title":"Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: 2 year results of a randomised trial","volume":"59","author":"Gitelman","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30112-8_bib13","doi-asserted-by":"crossref","first-page":"826","DOI":"10.2337\/dc09-1349","article-title":"Failure to preserve \u03b2-cell function with mycophenolate mofetil and daclizumab combined therapy in patients with new-onset type 1 diabetes","volume":"33","author":"Gottlieb","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30112-8_bib14","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/db12-0049","article-title":"Rapamycin\/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs \u03b2-cell function","volume":"61","author":"Long","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib15","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/S2213-8587(13)70113-X","article-title":"Low-dose interleukin 2 in patients with type 1 diabetes: a phase 1\/2 randomised, double-blind, placebo-controlled trial","volume":"1","author":"Hartemann","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib16","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.jaut.2015.01.001","article-title":"Low-dose interleukin-2 fosters a dose-dependent regulatory T cell tuned milieu in T1D patients","volume":"58","author":"Rosenzwajg","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/S2213-8587(18)30112-8_bib17","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.2337\/db14-1322","article-title":"Selective IL-2 responsiveness of regulatory T cells through multiple intrinsic mechanisms supports the use of low-dose IL-2 therapy in type 1 diabetes","volume":"64","author":"Yu","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib18","doi-asserted-by":"crossref","first-page":"e009799","DOI":"10.1136\/bmjopen-2015-009799","article-title":"Protocol of the adaptive study of IL-2 dose frequency on regulatory T cells in type 1 diabetes (DILfrequency): a mechanistic, non-randomised, repeat dose, open-label, response-adaptive study","volume":"5","author":"Truman","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(18)30112-8_bib19","doi-asserted-by":"crossref","first-page":"e1002139","DOI":"10.1371\/journal.pmed.1002139","article-title":"Regulatory T cell responses in participants with type 1 diabetes after a single dose of interleukin-2: a non-randomised, open label, adaptive dose-finding trial","volume":"13","author":"Todd","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib20","doi-asserted-by":"crossref","first-page":"eaai7793","DOI":"10.1126\/sciimmunol.aai7793","article-title":"Partial exhaustion of CD8 T cells and clinical response to teplizumab in new-onset type 1 diabetes","volume":"1","author":"Long","year":"2016","journal-title":"Sci Immunol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib21","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30112-8_bib22","doi-asserted-by":"crossref","DOI":"10.1080\/09546634.2018.1430301","article-title":"Safety of biologic agents for psoriasis in patients with viral hepatitis","author":"AlMutairi","year":"2018","journal-title":"J Dermatolog Treat"},{"key":"10.1016\/S2213-8587(18)30112-8_bib23","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s40259-017-0256-z","article-title":"Biosimilarity and interchangeability: principles and evidence: a systematic review","volume":"32","author":"McKinnon","year":"2018","journal-title":"BioDrugs"},{"key":"10.1016\/S2213-8587(18)30112-8_bib24","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.tibtech.2017.12.004","article-title":"A regulatory perspective on testing of biological activity of complex biologics","volume":"36","author":"Saldanha","year":"2018","journal-title":"Trends Biotechnol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib25","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000478072","article-title":"Adverse reactions to biologics in psoriasis","volume":"53","author":"Lockwood","year":"2018","journal-title":"Curr Probl Dermatol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib26","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1084\/jem.20111187","article-title":"Demonstration of islet-autoreactive CD8 T cells in insulitic lesions from recent onset and long-term type 1 diabetes patients","volume":"209","author":"Coppieters","year":"2012","journal-title":"J Exp Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib27","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/db15-1615","article-title":"Differential insulitic profiles determine the extent of \u03b2-cell destruction and the age at onset of type 1 diabetes","volume":"65","author":"Leete","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib28","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/7651_2015_287","article-title":"Histology of type 1 diabetes pancreas","volume":"1433","author":"Willcox","year":"2016","journal-title":"Methods Mol Biol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib29","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1007\/s00125-010-1817-6","article-title":"Evidence of increased islet cell proliferation in patients with recent-onset type 1 diabetes","volume":"53","author":"Willcox","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30112-8_bib30","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1365-2249.2008.03860.x","article-title":"Analysis of islet inflammation in human type 1 diabetes","volume":"155","author":"Willcox","year":"2009","journal-title":"Clin Exp Immunol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib31","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1038\/9442","article-title":"The NOD mouse model of type 1 diabetes: as good as it gets?","volume":"5","author":"Atkinson","year":"1999","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib32","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1038\/nri1502","article-title":"Satisfaction (not) guaranteed: re-evaluating the use of animal models of type 1 diabetes","volume":"4","author":"Roep","year":"2004","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib33","doi-asserted-by":"crossref","first-page":"96cm22","DOI":"10.1126\/scitranslmed.3002757","article-title":"Evaluating preclinical efficacy","volume":"3","author":"Atkinson","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib34","doi-asserted-by":"crossref","first-page":"e54712","DOI":"10.1371\/journal.pone.0054712","article-title":"Transient B-cell depletion with anti-CD20 in combination with proinsulin DNA vaccine or oral insulin: immunologic effects and efficacy in NOD mice","volume":"8","author":"Sarikonda","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30112-8_bib35","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2337\/db15-0492","article-title":"A preclinical consortium approach for assessing the efficacy of combined anti-CD3 plus IL-1 blockade in reversing new-onset autoimmune diabetes in NOD mice","volume":"65","author":"Gill","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib36","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1073\/pnas.91.1.123","article-title":"Anti-CD3 antibody induces long-term remission of overt autoimmunity in nonobese diabetic mice","volume":"91","author":"Chatenoud","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(18)30112-8_bib37","doi-asserted-by":"crossref","first-page":"2947","DOI":"10.4049\/jimmunol.158.6.2947","article-title":"CD3 antibody-induced dominant self tolerance in overtly diabetic NOD mice","volume":"158","author":"Chatenoud","year":"1997","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib38","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1002\/dmrr.1273","article-title":"Preservation of recall immunity in anti-CD3-treated recent onset type 1 diabetes patients","volume":"27","author":"Alkemade","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(18)30112-8_bib40","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejphar.2015.03.047","article-title":"Animal models of rheumatoid arthritis: how informative are they?","volume":"759","author":"McNamee","year":"2015","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.3389\/fendo.2017.00276","article-title":"Isogenic cellular systems model the impact of genetic risk variants in the pathogenesis of type 1 diabetes","volume":"8","author":"Wallet","year":"2017","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(18)30112-8_bib42","doi-asserted-by":"crossref","first-page":"10954","DOI":"10.1073\/pnas.1710415114","article-title":"Type 1 diabetes induction in humanized mice","volume":"114","author":"Tan","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(18)30112-8_bib43","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012","volume":"376","author":"Mayer-Davis","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","article-title":"Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank","volume":"6","author":"Thomas","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30112-8_bib45","first-page":"A413","article-title":"Analysis of diabetes incidence against type 1 diabetes genetic risk score in 150,000 shows autoimmune diabetes presents as often between 30\u201360 years as before 30 years","volume":"65","author":"Oram","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib46","doi-asserted-by":"crossref","first-page":"e011144","DOI":"10.1136\/bmjopen-2016-011144","article-title":"Capillary blood islet autoantibody screening for identifying pre-type 1 diabetes in the general population: design and initial results of the Fr1da study","volume":"6","author":"Raab","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(18)30112-8_bib47","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1111\/j.1399-5448.2011.00799.x","article-title":"Prediction model for the incidence and prevalence of type 1 diabetes in childhood and adolescence: evidence for a cohort-dependent increase within the next two decades in Germany","volume":"13","author":"Ehehalt","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib48","doi-asserted-by":"crossref","first-page":"2746","DOI":"10.2337\/dc13-0327","article-title":"Low-dose otelixizumab anti-CD3 monoclonal antibody DEFEND-1 study: results of the randomized phase III study in recent-onset human type 1 diabetes","volume":"37","author":"Aronson","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30112-8_bib49","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1111\/dme.12361","article-title":"Efficacy and safety of low-dose otelixizumab anti-CD3 monoclonal antibody in preserving C-peptide secretion in adolescent type 1 diabetes: DEFEND-2, a randomized, placebo-controlled, double-blind, multi-centre study","volume":"31","author":"Ambery","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib50","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1007\/s00125-009-1644-9","article-title":"Four-year metabolic outcome of a randomised controlled CD3-antibody trial in recent-onset type 1 diabetic patients depends on their age and baseline residual beta cell mass","volume":"53","author":"Keymeulen","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30112-8_bib51","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/j.clim.2013.05.001","article-title":"Anti-CD3 clinical trials in type 1 diabetes mellitus","volume":"149","author":"Daifotis","year":"2013","journal-title":"Clin Immunol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib53","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(13)70111-6","article-title":"Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial","volume":"1","author":"Rigby","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib54","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1900\/RDS.2012.9.201","article-title":"From markers to molecular mechanisms: type 1 diabetes in the post-GWAS era","volume":"9","author":"Baxter","year":"2012","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/S2213-8587(18)30112-8_bib55","doi-asserted-by":"crossref","first-page":"4179","DOI":"10.2337\/db13-0656","article-title":"Acceleration of the loss of the first-phase insulin response during the progression to type 1 diabetes in Diabetes Prevention Trial\u2013Type 1 participants","volume":"62","author":"Sosenko","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib56","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2337\/db11-1538","article-title":"Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data","volume":"61","author":"Greenbaum","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib57","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI78142","article-title":"\u03b2 cell death and dysfunction during type 1 diabetes development in at-risk individuals","volume":"125","author":"Herold","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(18)30112-8_bib58","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s11892-016-0783-x","article-title":"Biomarkers of \u03b2-cell stress and death in type 1 diabetes","volume":"16","author":"Mirmira","year":"2016","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/S2213-8587(18)30112-8_bib59","doi-asserted-by":"crossref","first-page":"E1826","DOI":"10.1073\/pnas.1519286113","article-title":"Identification of tissue-specific cell death using methylation patterns of circulating DNA","volume":"113","author":"Lehmann-Werman","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(18)30112-8_bib60","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1007\/BF02629258","article-title":"Abnormal proinsulin\/C-peptide ratio in juvenile diabetes","volume":"19","author":"Ludvigsson","year":"1982","journal-title":"Acta Diabetol Lat"},{"key":"10.1016\/S2213-8587(18)30112-8_bib61","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/dme.13153","article-title":"\u03b2-cell specific T-lymphocyte response has a distinct inflammatory phenotype in children with type 1 diabetes compared with adults","volume":"34","author":"Arif","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib62","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa1107096","article-title":"GAD65 antigen therapy in recently diagnosed type 1 diabetes mellitus","volume":"366","author":"Ludvigsson","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib63","doi-asserted-by":"crossref","first-page":"163","DOI":"10.2217\/imt.14.104","article-title":"Impact of disease heterogeneity on treatment efficacy of immunotherapy in type 1 diabetes: different shades of gray","volume":"7","author":"Woittiez","year":"2015","journal-title":"Immunotherapy"},{"key":"10.1016\/S2213-8587(18)30112-8_bib64","doi-asserted-by":"crossref","first-page":"1975","DOI":"10.2337\/dc15-1429","article-title":"Defining pathways for development of disease-modifying therapies in children with type 1 diabetes: a consensus report","volume":"38","author":"Wherrett","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30112-8_bib65","doi-asserted-by":"crossref","first-page":"177","DOI":"10.3892\/br.2012.42","article-title":"TNF inhibitor therapy for rheumatoid arthritis","volume":"2013","author":"Ma","year":"2013","journal-title":"Biomed Rep Eng"},{"key":"10.1016\/S2213-8587(18)30112-8_bib66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1464-5491.1986.tb00722.x","article-title":"Lawrence lecture. Death of a beta cell: homicide or suicide?","volume":"3","author":"Bottazzo","year":"1986","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib67","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db10-1797","article-title":"How does type 1 diabetes develop? The notion of homicide or \u03b2-cell suicide revisited","volume":"60","author":"Atkinson","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib68","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2337\/db15-0779","article-title":"Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes","volume":"65","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib69","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s00125-013-3067-x","article-title":"The majority of patients with long-duration type 1 diabetes are insulin microsecretors and have functioning beta cells","volume":"57","author":"Oram","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30112-8_bib70","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/j.cmet.2017.08.013","article-title":"Persistence of pancreatic insulin mRNA expression and proinsulin protein in type 1 diabetes pancreata","volume":"26","author":"Wasserfall","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(18)30112-8_bib71","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cmet.2017.01.005","article-title":"\u03b2 cells that resist immunological attack develop during progression of autoimmune diabetes in NOD mice","volume":"25","author":"Rui","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(18)30112-8_bib72","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1007\/s00125-016-4144-8","article-title":"Rebranding asymptomatic type 1 diabetes: the case for autoimmune beta cell disorder as a pathological and diagnostic entity","volume":"60","author":"Bonifacio","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30112-8_bib73","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2337\/db15-0779","article-title":"Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes","volume":"65","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib74","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1172\/JCI120555","article-title":"Autoreactive T effector memory differentiation mirrors \u03b2 cell function in type 1 diabetes","volume":"128","author":"Yeo","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(18)30112-8_bib75","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1006\/jaut.1999.0312","article-title":"Autoreactive T cell responses in insulin-dependent (type 1) diabetes mellitus. Report of the First International Workshop for Standardization of T Cell Assays","volume":"13","author":"Roep","year":"1999","journal-title":"J Autoimmun"},{"key":"10.1016\/S2213-8587(18)30112-8_bib76","doi-asserted-by":"crossref","first-page":"172","DOI":"10.2337\/db14-0858","article-title":"Proinsulin-specific, HLA-DQ8, and HLA-DQ8-transdimer-restricted CD4+ T cells infiltrate islets in type 1 diabetes","volume":"64","author":"Pathiraja","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib77","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.1038\/nm.4203","article-title":"Analysis of self-antigen specificity of islet-infiltrating T cells from human donors with type 1 diabetes","volume":"22","author":"Babon","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(18)30112-8_bib78","doi-asserted-by":"crossref","first-page":"722","DOI":"10.2337\/db16-1025","article-title":"Islet-derived CD4 T cells targeting proinsulin in human autoimmune diabetes","volume":"66","author":"Michels","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib79","doi-asserted-by":"crossref","first-page":"e88242","DOI":"10.1172\/jci.insight.88242","article-title":"Tissue distribution and clonal diversity of the T and B cell repertoire in type 1 diabetes","volume":"1","author":"Seay","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(18)30112-8_bib80","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1038\/s41467-017-01925-2","article-title":"T cell receptor \u03b2-chains display abnormal shortening and repertoire sharing in type 1 diabetes","volume":"8","author":"Gomez-Tourino","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(18)30112-8_bib81","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1038\/s41598-017-01454-4","article-title":"High throughput single cell counting in droplet-based microfluidics","volume":"7","author":"Lu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(18)30112-8_bib82","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1007\/s11892-017-0946-4","article-title":"T cell receptor profiling in type 1 diabetes","volume":"17","author":"Jacobsen","year":"2017","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/S2213-8587(18)30112-8_bib83","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.2337\/db09-0160","article-title":"Differences in baseline lymphocyte counts and autoreactivity are associated with differences in outcome of islet cell transplantation in type 1 diabetic patients","volume":"58","author":"Hilbrands","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib84","doi-asserted-by":"crossref","first-page":"e2435","DOI":"10.1371\/journal.pone.0002435","article-title":"Cellular islet autoimmunity associates with clinical outcome of islet cell transplantation","volume":"3","author":"Huurman","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30112-8_bib85","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2337\/db09-1486","article-title":"Simultaneous detection of circulating autoreactive CD8+ T-cells specific for different islet cell-associated epitopes using combinatorial MHC multimers","volume":"59","author":"Velthuis","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib86","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2017.00167","article-title":"Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes","volume":"8","author":"Malmegrim","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib87","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s00125-016-4122-1","article-title":"GAD vaccine reduces insulin loss in recently diagnosed type 1 diabetes: findings from a Bayesian meta-analysis","volume":"60","author":"Beam","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30112-8_bib88","doi-asserted-by":"crossref","first-page":"3120","DOI":"10.2337\/db14-0095","article-title":"Recommendations for the definition of clinical responder in insulin preservation studies","volume":"63","author":"Beam","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib89","doi-asserted-by":"crossref","first-page":"3835","DOI":"10.2337\/db14-0365","article-title":"Blood and islet phenotypes indicate immunological heterogeneity in type 1 diabetes","volume":"63","author":"Arif","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30112-8_bib90","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1111\/dom.13063","article-title":"Beyond glycaemic control: a crossover, double-blinded, 24-week intervention with liraglutide in type 1 diabetes","volume":"20","author":"Dub\u00e9","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30112-8_bib91","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1177\/1932296817699847","article-title":"Use of sitagliptin with closed-loop technology to decrease postprandial blood glucose in type 1 diabetes","volume":"11","author":"Underland","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib92","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1111\/dom.12924","article-title":"Optimizing the analysis strategy for the CANVAS Program: a prespecified plan for the integrated analyses of the CANVAS and CANVAS-R trials","volume":"19","author":"Neal","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30112-8_bib93","doi-asserted-by":"crossref","first-page":"67","DOI":"10.3389\/fcell.2015.00067","article-title":"\u03b2 cell ER stress and the implications for immunogenicity in type 1 diabetes","volume":"3","author":"Marr\u00e9","year":"2015","journal-title":"Front Cell Dev Biol"},{"key":"10.1016\/S2213-8587(18)30112-8_bib94","first-page":"4588","article-title":"Carbamazepine, a beta-cell protecting drug, reduces type 1 diabetes incidence in NOD mice","volume":"8","author":"Lee","year":"2018","journal-title":"Nat Sci Rep"},{"key":"10.1016\/S2213-8587(18)30112-8_bib95","doi-asserted-by":"crossref","first-page":"971","DOI":"10.2337\/dc15-0078","article-title":"Current state of type 1 diabetes treatment in the US: updated data from the T1D Exchange clinic registry","volume":"38","author":"Miller","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30112-8_bib39","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.cellimm.2017.07.007","article-title":"Remodeling T cell compartments during anti-CD3 immunotherapy of type 1 diabetes","volume":"319","author":"Long","year":"2017","journal-title":"Cell Immunol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301128?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301128?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:35Z","timestamp":1761991595000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301128"}},"issued":{"date-parts":[[2019,1]]},"references-count":94,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2213858718301128"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30112-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The challenge of modulating \u03b2-cell autoimmunity in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30112-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30109-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T05:14:03Z","timestamp":1794633243309,"version":"4.9.1"},"reference-count":185,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/s2213-8587(25)00394-8","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T23:39:22Z","timestamp":1769643562000},"page":"259-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Menopausal hormone treatment and breast cancer"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-9614-6968","authenticated-orcid":false,"given":"Anne","family":"Gompel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-9828-4114","authenticated-orcid":false,"given":"Richard","family":"Simcock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00394-8_bib1","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/s41591-025-03502-3","article-title":"Global patterns and trends in breast cancer incidence and mortality across 185 countries","volume":"31","author":"Kim","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib3","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.jsbmb.2013.05.008","article-title":"Effects of menopausal hormonal therapy on occult breast tumors","volume":"137","author":"Santen","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib4","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1016\/S1470-2045(12)70425-4","article-title":"Menarche, menopause, and breast cancer risk: individual participant meta-analysis, including 118 964 women with breast cancer from 117 epidemiological studies","volume":"13","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib5","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1016\/j.maturitas.2015.06.040","article-title":"Hormone therapy and risk of venous thromboembolism among postmenopausal women","volume":"82","author":"Canonico","year":"2015","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(25)00394-8_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1001\/jamainternmed.2013.11074","article-title":"Lower risk of cardiovascular events in postmenopausal women taking oral estradiol compared with oral conjugated equine estrogens","volume":"174","author":"Smith","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib7","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/jth.12560","article-title":"Differential associations of oral estradiol and conjugated equine estrogen with hemostatic biomarkers","volume":"12","author":"Blondon","year":"2014","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2213-8587(25)00394-8_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c2519","article-title":"Transdermal and oral hormone replacement therapy and the risk of stroke: a nested case-control study","volume":"340","author":"Renoux","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00394-8_bib9","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/STROKEAHA.116.013052","article-title":"Postmenopausal hormone therapy and risk of stroke: impact of the route of estrogen administration and type of progestogen","volume":"47","author":"Canonico","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(25)00394-8_bib10","first-page":"1","article-title":"Major adverse cardiovascular events risk in menopausal women treated with oral estradiol\/micronized progesterone versus conjugated estrogens\/medroxyprogesterone: a claims data analysis in the USA","volume":"7","author":"Stevenson","year":"2025","journal-title":"Climacteric"},{"key":"10.1016\/S2213-8587(25)00394-8_bib11","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.2337\/diacare.21.10.1589","article-title":"Effect of postmenopausal hormone therapy on glucose and insulin concentrations","volume":"21","author":"Espeland","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00394-8_bib12","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1001\/jama.1995.03520270033028","article-title":"Effects of estrogen or estrogen\/progestin regimens on heart disease risk factors in postmenopausal women. The Postmenopausal Estrogen\/Progestin Interventions (PEPI) Trial","volume":"273","author":"Miller","year":"1995","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00394-8_bib13","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.maturitas.2022.01.012","article-title":"Impact of micronised progesterone and medroxyprogesterone acetate in combination with transdermal oestradiol on cardiovascular markers in women diagnosed with premature ovarian insufficiency or an early menopause: a randomised pilot trial","volume":"161","author":"Mittal","year":"2022","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(25)00394-8_bib14","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/03630242.2020.1824956","article-title":"Micronized progesterone, progestins, and menopause hormone therapy","volume":"61","author":"Hipolito Rodrigues","year":"2021","journal-title":"Women Health"},{"key":"10.1016\/S2213-8587(25)00394-8_bib15","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1056\/NEJM198908033210505","article-title":"The risk of breast cancer after estrogen and estrogen-progestin replacement","volume":"321","author":"Bergkvist","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s10549-014-2934-6","article-title":"Risk of breast cancer after stopping menopausal hormone therapy in the E3N cohort","volume":"145","author":"Fournier","year":"2014","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S2213-8587(25)00394-8_bib17","article-title":"Use of hormone replacement therapy and risk of breast cancer: nested case-control studies using the QResearch and CPRD databases","volume":"371","author":"Vinogradova","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00394-8_bib18","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1016\/S0140-6736(19)31709-X","article-title":"Type and timing of menopausal hormone therapy and breast cancer risk: individual participant meta-analysis of the worldwide epidemiological evidence","volume":"394","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00394-8_bib19","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1001\/jama.2020.9482","article-title":"Association of menopausal hormone therapy with breast cancer incidence and mortality during long-term follow-up of the women's health initiative randomized clinical trials","volume":"324","author":"Chlebowski","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00394-8_bib20","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s10549-007-9523-x","article-title":"Unequal risks for breast cancer associated with different hormone replacement therapies: results from the E3N cohort study","volume":"107","author":"Fournier","year":"2008","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S2213-8587(25)00394-8_bib21","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/09513590701382104","article-title":"Breast cancer incidence and hormone replacement therapy: results from the MISSION study, prospective phase","volume":"23","author":"Espi\u00e9","year":"2007","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib22","doi-asserted-by":"crossref","first-page":"514","DOI":"10.3109\/13697130903075352","article-title":"Risk of gynecological cancers in users of estradiol\/dydrogesterone or other HRT preparations","volume":"12","author":"Schneider","year":"2009","journal-title":"Climacteric"},{"key":"10.1016\/S2213-8587(25)00394-8_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1097\/AOG.0b013e31818e8cd6","article-title":"Breast cancer risk in postmenopausal women using estradiol-progestogen therapy","volume":"113","author":"Lyytinen","year":"2009","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib24","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0078016","article-title":"Risk of breast cancer by type of menopausal hormone therapy: a case-control study among post-menopausal women in France","volume":"8","author":"Cordina-Duverger","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(25)00394-8_bib25","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1097\/AOG.0000000000004723","article-title":"Menopausal hormone therapy formulation and breast cancer risk","volume":"139","author":"Abenhaim","year":"2022","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib26","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1001\/archinternmed.2007.123","article-title":"Estrogen plus progestin and breast cancer detection by means of mammography and breast biopsy","volume":"168","author":"Chlebowski","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib27","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1080\/13697137.2018.1476483","article-title":"Progesterone, progestins and the breast in menopause treatment","volume":"21","author":"Gompel","year":"2018","journal-title":"Climacteric"},{"key":"10.1016\/S2213-8587(25)00394-8_bib28","doi-asserted-by":"crossref","first-page":"406","DOI":"10.7326\/M19-0274","article-title":"Menopausal estrogen-alone therapy and health outcomes in women with and without bilateral oophorectomy: a randomized trial","volume":"171","author":"Manson","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib29","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1093\/aje\/kwn090","article-title":"Conjugated equine estrogens and breast cancer risk in the Women's Health Initiative clinical trial and observational study","volume":"167","author":"Prentice","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib31","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.jsbmb.2013.10.011","article-title":"Pharmacology of conjugated equine estrogens: efficacy, safety and mechanism of action","volume":"142","author":"Bhavnani","year":"2014","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1093\/aje\/kwaa210","article-title":"Randomized trial evaluation of the benefits and risks of menopausal hormone therapy among women 50\u201359 years of age","volume":"190","author":"Prentice","year":"2021","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib33","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa073","article-title":"Underlying breast cancer risk and menopausal hormone therapy","volume":"105","author":"Santen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00394-8_bib34","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1210\/er.2012-1008","article-title":"Progestogens used in postmenopausal hormone therapy: differences in their pharmacological properties, intracellular actions, and clinical effects","volume":"34","author":"Stanczyk","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib35","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/978-3-031-70875-6_15","article-title":"Hormone signaling in breast development and cancer","volume":"1464","author":"Agnoletto","year":"2025","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib36","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1007\/s10549-011-1394-5","article-title":"Glucocorticoid receptor activity discriminates between progesterone and medroxyprogesterone acetate effects in breast cells","volume":"131","author":"Courtin","year":"2012","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S2213-8587(25)00394-8_bib37","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1002\/ijc.20710","article-title":"Breast cancer risk in relation to different types of hormone replacement therapy in the E3N-EPIC cohort","volume":"114","author":"Fournier","year":"2005","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib38","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/09513590.2016.1248932","article-title":"Estradiol therapy and breast cancer risk in perimenopausal and postmenopausal women: a systematic review and meta-analysis","volume":"33","author":"Yang","year":"2017","journal-title":"Gynecological Endocrinology"},{"key":"10.1016\/S2213-8587(25)00394-8_bib39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S1470-2045(25)00211-6","article-title":"Hormone therapy use and young-onset breast cancer: a pooled analysis of prospective cohorts included in the Premenopausal Breast Cancer Collaborative Group","volume":"26","author":"O'Brien","year":"2025","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib40","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1097\/GME.0000000000001115","article-title":"Estrogen-alone therapy and invasive breast cancer incidence by dose, formulation, and route of delivery: findings from the WHI observational study","volume":"25","author":"Shufelt","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(25)00394-8_bib41","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1002\/ijc.29810","article-title":"Postmenopausal hormone therapy and the risk of breast cancer in Norway","volume":"138","author":"Rom\u00e1n","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib42","doi-asserted-by":"crossref","first-page":"126","DOI":"10.1038\/s41416-024-02590-1","article-title":"Menopausal hormone therapy and breast cancer risk: a population-based cohort study of 1\u00b73 million women in Norway","volume":"131","author":"Stoer","year":"2024","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib43","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1245\/s10434-008-0019-7","article-title":"Menopausal hormone therapy and breast cancer phenotype: does dose matter?","volume":"15","author":"Garwood","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib44","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(03)14596-5","article-title":"Breast cancer and hormone-replacement therapy in the Million Women Study","volume":"362","author":"Beral","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00394-8_bib45","doi-asserted-by":"crossref","first-page":"5138","DOI":"10.1200\/JCO.2008.21.6432","article-title":"Estrogen-progestagen menopausal hormone therapy and breast cancer: does delay from menopause onset to treatment initiation influence risks?","volume":"27","author":"Fournier","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib46","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1158\/1940-6207.CAPR-11-0185","article-title":"Paradoxical clinical effect of estrogen on breast cancer risk: a \u201cnew\u201d biology of estrogen-induced apoptosis","volume":"4","author":"Jordan","year":"2011","journal-title":"Cancer Prev Res"},{"key":"10.1016\/S2213-8587(25)00394-8_bib47","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1111\/aogs.14110","article-title":"Thirty years of mirena: a story of innovation and change in women's healthcare","volume":"100","author":"Gemzell-Danielsson","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S2213-8587(25)00394-8_bib48","doi-asserted-by":"crossref","first-page":"470","DOI":"10.3109\/13697137.2014.991302","article-title":"The levonorgestrel-releasing intrauterine system for endometrial protection during estrogen replacement therapy: a clinical review","volume":"18","author":"Depypere","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/S2213-8587(25)00394-8_bib49","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1089\/jwh.2013.4544","article-title":"Contraception and hormonal management in the perimenopause","volume":"24","author":"Long","year":"2015","journal-title":"J Womens Health"},{"key":"10.1016\/S2213-8587(25)00394-8_bib50","doi-asserted-by":"crossref","first-page":"821.e1","DOI":"10.1016\/j.ajog.2021.12.022","article-title":"Oral contraceptive use by formulation and breast cancer risk by subtype in the Nurses' Health Study II: a prospective cohort study","volume":"226","author":"Burchardt","year":"2022","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib51","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1111\/aogs.13817","article-title":"Levonorgestrel-releasing intrauterine system and breast cancer risk: a systematic review and meta-analysis","volume":"99","author":"Conz","year":"2020","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S2213-8587(25)00394-8_bib52","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/jama.2024.18575","article-title":"Breast cancer in users of levonorgestrel-releasing intrauterine systems","volume":"332","author":"M\u00f8rch","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00394-8_bib53","doi-asserted-by":"crossref","first-page":"450.e1","DOI":"10.1016\/j.ajog.2024.05.011","article-title":"Association of levonorgestrel-releasing intrauterine device with gynecologic and breast cancers: a national cohort study in Sweden","volume":"231","author":"Yi","year":"2024","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib54","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1093\/jnci\/djae282","article-title":"Long-acting, progestin-based contraceptives and risk of breast, gynecological, and other cancers","volume":"117","author":"Tuesley","year":"2025","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(25)00394-8_bib55","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00404-022-06640-y","article-title":"Influence of the levonorgestrel-releasing intrauterine system on the risk of breast cancer: a systematic review","volume":"307","author":"Z\u00fcrcher","year":"2023","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/S2213-8587(25)00394-8_bib56","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1186\/s12885-023-11049-0","article-title":"Association of reproductive risk factors and breast cancer molecular subtypes: a systematic review and meta-analysis","volume":"23","author":"Mao","year":"2023","journal-title":"BMC Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13058-015-0546-7","article-title":"Lobular breast cancer: incidence and genetic and non-genetic risk factors","volume":"17","author":"Dossus","year":"2015","journal-title":"Breast Cancer Res"},{"key":"10.1016\/S2213-8587(25)00394-8_bib58","doi-asserted-by":"crossref","first-page":"81109","DOI":"10.18632\/oncotarget.20154","article-title":"Change in risk of breast cancer after receiving hormone replacement therapy by considering effect-modifiers: a systematic review and dose-response meta-analysis of prospective studies","volume":"8","author":"Wang","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/S2213-8587(25)00394-8_bib59","doi-asserted-by":"crossref","first-page":"495EP","DOI":"10.1007\/s10549-022-06571-x","article-title":"Multivariate analysis of independent roles of socioeconomic status, occupational physical activity, reproductive factors, and postmenopausal hormonal therapy in risk of breast cancer","volume":"193","author":"Katuwal","year":"2022","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S2213-8587(25)00394-8_bib60","doi-asserted-by":"crossref","first-page":"363EP","DOI":"10.1007\/s10549-017-4171-2","article-title":"Estrogen-progestin use and breast cancer characteristics in lean and overweight postmenopausal women","volume":"163","author":"Kjartansdottir","year":"2017","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S2213-8587(25)00394-8_bib61","doi-asserted-by":"crossref","first-page":"80","DOI":"10.3389\/fonc.2020.00080","article-title":"Prognostic impact of menopausal hormone therapy in breast cancer differs according to tumor characteristics and treatment","volume":"10","author":"Godina","year":"2020","journal-title":"Front Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib62","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/j.1471-0528.2008.01690.x","article-title":"Differential impact of conventional and low-dose oral hormone therapy, tibolone and raloxifene on mammographic breast density, assessed by an automated quantitative method","volume":"115","author":"Eilertsen","year":"2008","journal-title":"BJOG"},{"key":"10.1016\/S2213-8587(25)00394-8_bib63","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1016\/j.maturitas.2003.08.009","article-title":"Mammographic breast density changes after 1 year of tibolone use","volume":"48","author":"Kutlu","year":"2004","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(25)00394-8_bib64","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1056\/NEJMoa0800743","article-title":"The effects of tibolone in older postmenopausal women","volume":"359","author":"Cummings","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib65","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S1470-2045(08)70341-3","article-title":"Safety and efficacy of tibolone in breast-cancer patients with vasomotor symptoms: a double-blind, randomised, non-inferiority trial","volume":"10","author":"Kenemans","year":"2009","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib66","article-title":"Short-term and long-term effects of tibolone in postmenopausal women","volume":"10","author":"Formoso","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ejendo\/lvad168","article-title":"Breast cancer risk association with postmenopausal hormone therapy: health insurance database in South Korea-based cohort study","volume":"190","author":"Yuk","year":"2024","journal-title":"Euro J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib68","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1097\/GME.0b013e318271f5e7","article-title":"Breast density changes in a randomized controlled trial evaluating bazedoxifene\/conjugated estrogens","volume":"20","author":"Harvey","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(25)00394-8_bib69","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1097\/GME.0000000000002537","article-title":"The rediscovery of estetrol and its implications for estrogen treatment","volume":"32","author":"Coelingh Bennink","year":"2025","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(25)00394-8_bib70","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1080\/17512433.2022.2054413","article-title":"Profile of estetrol, a promising native estrogen for oral contraception and the relief of climacteric symptoms of menopause","volume":"15","author":"G\u00e9rard","year":"2022","journal-title":"Expert Rev Clin Pharmacol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib71","doi-asserted-by":"crossref","first-page":"17621","DOI":"10.18632\/oncotarget.4184","article-title":"Combined estrogenic and anti-estrogenic properties of estetrol on breast cancer may provide a safe therapeutic window for the treatment of menopausal symptoms","volume":"6","author":"G\u00e9rard","year":"2015","journal-title":"Oncotarget"},{"key":"10.1016\/S2213-8587(25)00394-8_bib72","doi-asserted-by":"crossref","DOI":"10.3390\/cancers13102486","article-title":"Estetrol combined to progestogen for menopause or contraception indication is neutral on breast cancer","volume":"13","author":"Gallez","year":"2021","journal-title":"Cancers"},{"key":"10.1016\/S2213-8587(25)00394-8_bib73","doi-asserted-by":"crossref","first-page":"358","DOI":"10.3390\/molecules25020358","article-title":"Androgen receptor in breast cancer-clinical and preclinical research insights","volume":"25","author":"Anestis","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/S2213-8587(25)00394-8_bib74","doi-asserted-by":"crossref","first-page":"4660","DOI":"10.1210\/jc.2019-01603","article-title":"Global consensus position statement on the use of testosterone therapy for women","volume":"104","author":"Davis","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00394-8_bib75","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1093\/jsxmed\/qdae013","article-title":"Characteristics of systemic testosterone therapy for female hypoactive sexual desire disorder\u2014a claims database analysis","volume":"21","author":"Agrawal","year":"2024","journal-title":"J Sex Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib76","doi-asserted-by":"crossref","first-page":"150","DOI":"10.4274\/ejbh.galenos.2021.6213","article-title":"Breast cancer incidence reduction in women treated with subcutaneous testosterone: testosterone therapy and breast cancer incidence study","volume":"17","author":"Donovitz","year":"2021","journal-title":"Eur J Breast Health"},{"key":"10.1016\/S2213-8587(25)00394-8_bib77","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1097\/01.GME.0000119983.48235.D3","article-title":"Breast cancer incidence in postmenopausal women using testosterone in addition to usual hormone therapy","volume":"11","author":"Dimitrakakis","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(25)00394-8_bib78","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.maturitas.2013.08.002","article-title":"Reduced breast cancer incidence in women treated with subcutaneous testosterone, or testosterone with anastrozole: a prospective, observational study","volume":"76","author":"Glaser","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(25)00394-8_bib79","doi-asserted-by":"crossref","DOI":"10.1186\/s12885-019-6457-8","article-title":"Incidence of invasive breast cancer in women treated with testosterone implants: a prospective 10-year cohort study","volume":"19","author":"Glaser","year":"2019","journal-title":"BMC Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib80","doi-asserted-by":"crossref","first-page":"817","DOI":"10.1093\/ije\/dyac238","article-title":"Lifestyle, genetic risk and incidence of cancer: a prospective cohort study of 13 cancer types","volume":"52","author":"Byrne","year":"2023","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib81","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1007\/s10654-023-01005-4","article-title":"The association of a combined healthy lifestyle with the risk of postmenopausal breast cancer subtypes in the Netherlands Cohort Study","volume":"38","author":"van den Brandt","year":"2023","journal-title":"Euro J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib82","doi-asserted-by":"crossref","DOI":"10.34172\/jrhs.2021.57","article-title":"Factors for the primary prevention of breast cancer: a meta-analysis of prospective cohort studies","volume":"21","author":"Poorolajal","year":"2021","journal-title":"J Res Health Sci"},{"key":"10.1016\/S2213-8587(25)00394-8_bib83","doi-asserted-by":"crossref","first-page":"607","DOI":"10.3390\/nu12030607","article-title":"Adherence to the world cancer research fund\/American Institute For Cancer Research recommendations and the risk of breast cancer","volume":"12","author":"Turati","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(25)00394-8_bib84","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17134731","article-title":"Breast cancer primary prevention and diet: an umbrella review","volume":"17","author":"Buja","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(25)00394-8_bib85","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1097\/GRF.0000000000000239","article-title":"Breast cancer epidemiology and risk factors","volume":"59","author":"Rojas","year":"2016","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib86","doi-asserted-by":"crossref","first-page":"1295","DOI":"10.1001\/jamaoncol.2016.1025","article-title":"Breast Cancer Risk from modifiable and nonmodifiable risk factors among white women in the United States","volume":"2","author":"Maas","year":"2016","journal-title":"JAMA Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib87","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1002\/ijc.33680","article-title":"Can breast cancer be stopped? Modifiable risk factors of breast cancer among women with a prior benign or premalignant lesion","volume":"149","author":"Lilleborge","year":"2021","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib88","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1186\/s12885-024-12641-8","article-title":"Non-genetic factors and breast cancer: an umbrella review of meta-analyses","volume":"24","author":"Yiallourou","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib89","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kww145","article-title":"Population attributable risk of modifiable and nonmodifiable breast cancer risk factors in postmenopausal breast cancer","volume":"184","author":"Tamimi","year":"2016","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib90","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1158\/1055-9965.EPI-23-0923","article-title":"Abbreviated score to assess adherence to the 2018 WCRF\/AICR cancer prevention recommendations and risk of cancer in the UK Biobank","volume":"33","author":"Malcomson","year":"2024","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib91","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1158\/1055-9965.EPI-21-0765","article-title":"Association of a healthy lifestyle index with risk of breast cancer among women with normal body mass index in the UK Biobank","volume":"31","author":"Peila","year":"2022","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib92","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.3760","article-title":"Association of Nongenetic Factors with Breast Cancer Risk in Genetically Predisposed Groups of Women in the UK Biobank Cohort","volume":"3","author":"Al Ajmi","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(25)00394-8_bib93","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1093\/jnci\/djr172","article-title":"Risk factor modification and projections of absolute breast cancer risk","volume":"103","author":"Petracci","year":"2011","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(25)00394-8_bib94","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1186\/s13058-024-01890-x","article-title":"Reproductive factors and mammographic density within the International Consortium of Mammographic Density: a cross-sectional study","volume":"26","author":"O'Driscoll","year":"2024","journal-title":"Breast Cancer Res"},{"key":"10.1016\/S2213-8587(25)00394-8_bib95","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1002\/cam4.4434","article-title":"Adiposity and breast, endometrial, and colorectal cancer risk in postmenopausal women: quantification of the mediating effects of leptin, C-reactive protein, fasting insulin, and estradiol","volume":"11","author":"Dashti","year":"2022","journal-title":"Cancer Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib96","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.nut.2018.04.018","article-title":"Associations between dietary inflammatory index and incidence of breast and prostate cancer: A systematic review and meta-analysis","volume":"56","author":"Moradi","year":"2018","journal-title":"Nutrition"},{"key":"10.1016\/S2213-8587(25)00394-8_bib97","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1038\/s41430-021-01039-5","article-title":"Dietary inflammatory index and breast cancer risk: an updated meta-analysis of observational studies","volume":"76","author":"Hayati","year":"2022","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(25)00394-8_bib98","doi-asserted-by":"crossref","first-page":"13039","DOI":"10.18632\/aging.202985","article-title":"Strong association between the dietary inflammatory index(DII) and breast cancer: a systematic review and meta-analysis","volume":"13","author":"Chen","year":"2021","journal-title":"Aging"},{"key":"10.1016\/S2213-8587(25)00394-8_bib99","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1038\/s41430-018-0196-9","article-title":"Meta-analysis of the association between the dietary inflammatory index (DII) and breast cancer risk","volume":"73","author":"Wang","year":"2019","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(25)00394-8_bib100","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1080\/15592294.2022.2107841","article-title":"Weight loss reduces circulating micro-RNA related to obesity and breast cancer in postmenopausal women","volume":"17","author":"Duggan","year":"2022","journal-title":"Epigenetics"},{"key":"10.1016\/S2213-8587(25)00394-8_bib101","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1158\/1940-6207.CAPR-20-0181","article-title":"Changes in dietary inflammatory index patterns with weight loss in women: a randomized controlled trial","volume":"14","author":"Duggan","year":"2021","journal-title":"Cancer Prev Res"},{"key":"10.1016\/S2213-8587(25)00394-8_bib102","first-page":"1183","article-title":"World Cancer Research Fund International: continuous update project\u2014systematic literature review and meta-analysis of observational cohort studies on physical activity, sedentary behavior, adiposity, and weight change and breast cancer risk","volume":"30","author":"Chan","year":"2019","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(25)00394-8_bib103","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1007\/s10549-018-5016-3","article-title":"Adult weight change and the risk of pre- and postmenopausal breast cancer in the Chinese Wuxi Exposure and Breast Cancer Study","volume":"173","author":"Cao","year":"2019","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S2213-8587(25)00394-8_bib104","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1136\/jech-2023-220706","article-title":"Burden of postmenopausal breast cancer attributable to excess body weight: comparative study of body mass index and CUN-BAE in MCC-Spain study","volume":"79","author":"Cubelos-Fernandez","year":"2024","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(25)00394-8_bib105","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1093\/ije\/dyab032","article-title":"Long-term weight change and risk of breast cancer in the European Prospective Investigation into Cancer and Nutrition (EPIC) study","volume":"50","author":"Ellingjord-Dale","year":"2022","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib106","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/j.orcp.2021.08.004","article-title":"Effect of long-term weight gain on the risk of breast cancer across women's whole adulthood as well as hormone-changed menopause stages: a systematic review and dose-response meta-analysis","volume":"15","author":"Hao","year":"2021","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00394-8_bib107","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s12905-023-02162-0","article-title":"Obesity at age 20 and weight gain during adulthood increase risk of total and premature all-cause mortality: findings from women attending breast screening in Manchester","volume":"23","author":"Pegington","year":"2023","journal-title":"BMC Womens Health"},{"key":"10.1016\/S2213-8587(25)00394-8_bib108","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.14.04067","article-title":"Role of body mass index and weight change in the risk of cancer: a systematic review and meta-analysis of 66 cohort studies","volume":"14","author":"Shi","year":"2024","journal-title":"J Glob Health"},{"key":"10.1016\/S2213-8587(25)00394-8_bib109","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1001\/jama.296.2.193","article-title":"Adult weight change and risk of postmenopausal breast cancer","volume":"296","author":"Eliassen","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00394-8_bib110","doi-asserted-by":"crossref","first-page":"779","DOI":"10.1158\/1055-9965.EPI-16-0611","article-title":"Weight fluctuation and cancer risk in postmenopausal women: the Women's Health Initiative","volume":"26","author":"Welti","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib111","doi-asserted-by":"crossref","first-page":"2003","DOI":"10.1002\/ijc.30627","article-title":"Weight and weight changes in early adulthood and later breast cancer risk","volume":"140","author":"Rosner","year":"2017","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib112","doi-asserted-by":"crossref","first-page":"2154","DOI":"10.1210\/clinem\/dgac241","article-title":"Obesity and Breast Cancer Risk: The Oncogenic Implications of Metabolic Dysregulation","volume":"107","author":"Naaman","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00394-8_bib113","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djv088","article-title":"Adult weight gain and adiposity-related cancers: a dose-response meta-analysis of prospective observational studies","volume":"107","author":"Keum","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(25)00394-8_bib114","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1186\/s12885-016-2793-0","article-title":"Weight and weight changes throughout life and postmenopausal breast cancer risk: a case-control study in France","volume":"16","author":"Cordina-Duverger","year":"2016","journal-title":"BMC Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib115","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-138-1-200301070-00005","article-title":"Glycemic effects of postmenopausal hormone therapy: the Heart and Estrogen\/progestin Replacement Study. A randomized, double-blind, placebo-controlled trial","volume":"138","author":"Kanaya","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib116","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1007\/s00125-004-1448-x","article-title":"Effect of oestrogen plus progestin on the incidence of diabetes in postmenopausal women: results from the Women's Health Initiative Hormone Trial","volume":"47","author":"Margolis","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00394-8_bib117","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1210\/er.2016-1146","article-title":"Menopausal hormone therapy and type 2 diabetes prevention: evidence, mechanisms, and clinical implications","volume":"38","author":"Mauvais-Jarvis","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib118","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-024-65916-2","article-title":"The association of breast cancer patients survival and prior menopausal hormone therapy in women with type 2 diabetes","volume":"14","author":"Hosio","year":"2024","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(25)00394-8_bib119","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/jnci\/dji056","article-title":"Are breast density and bone mineral density independent risk factors for breast cancer?","volume":"97","author":"Kerlikowske","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(25)00394-8_bib120","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1002\/cncr.23674","article-title":"Hip bone density predicts breast cancer risk independently of Gail score: results from the Women's Health Initiative","volume":"113","author":"Chen","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/annotation\/2811f3e3-8efe-4183-bcd7-e4a11401fb89","article-title":"Association between bone mineral density and incidence of breast cancer","volume":"8","author":"Fraenkel","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(25)00394-8_bib122","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1007\/s10549-010-1138-y","article-title":"Bone mineral density and risk of postmenopausal breast cancer","volume":"126","author":"Grenier","year":"2011","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S2213-8587(25)00394-8_bib123","doi-asserted-by":"crossref","first-page":"2768","DOI":"10.1002\/cncr.34252","article-title":"Bone mineral density and risk of breast cancer: a cohort study and Mendelian randomization analysis","volume":"128","author":"Zhang","year":"2022","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib124","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1186\/s12885-024-12908-0","article-title":"A causal relationship between bone mineral density and breast cancer risk: a mendelian randomization study based on east Asian population","volume":"24","author":"Cheng","year":"2024","journal-title":"BMC Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib125","first-page":"1333","article-title":"Menopausal vasomotor symptoms and incident breast cancer risk in the Study of Women's Health Across the Nation","volume":"27","author":"Hart","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(25)00394-8_bib126","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1158\/1055-9965.EPI-10-0998","article-title":"Relationship between menopausal symptoms and risk of postmenopausal breast cancer","volume":"20","author":"Huang","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib127","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1097\/GME.0000000000001283","article-title":"Persistent vasomotor symptoms and breast cancer in the Women's Health Initiative","volume":"26","author":"Chlebowski","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(25)00394-8_bib128","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1007\/s10549-020-05744-w","article-title":"Hormone replacement therapy and mammographic density: a systematic literature review","volume":"182","author":"Azam","year":"2020","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S2213-8587(25)00394-8_bib129","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1016\/j.breast.2022.09.007","article-title":"Mammographic breast density and the risk of breast cancer: a systematic review and meta-analysis","volume":"66","author":"Bodewes","year":"2022","journal-title":"Breast"},{"key":"10.1016\/S2213-8587(25)00394-8_bib130","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24044123","article-title":"Effects of estradiol\/micronized progesterone vs. conjugated equine estrogens\/medroxyprogesterone acetate on breast cancer gene expression in healthy postmenopausal women","volume":"24","author":"Lalitkumar","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(25)00394-8_bib131","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1097\/GME.0000000000001844","article-title":"The effect of hormone therapy on breast density following risk-reducing salpingo-oophorectomy in women with an increased risk for breast and ovarian cancer","volume":"28","author":"van Barele","year":"2021","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(25)00394-8_bib132","doi-asserted-by":"crossref","DOI":"10.1093\/jnci\/djx001","article-title":"Mammographic density change with estrogen and progestin therapy and breast cancer risk","volume":"109","author":"Byrne","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(25)00394-8_bib133","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s10549-018-4735-9","article-title":"Does mammographic density mediate risk factor associations with breast cancer? An analysis by tumor characteristics","volume":"170","author":"Rice","year":"2018","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S2213-8587(25)00394-8_bib134","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1158\/1055-9965.EPI-20-0038","article-title":"Hormone replacement therapy, breast cancer risk factors, and breast cancer risk: a nationwide population-based cohort","volume":"29","author":"Yoo","year":"2020","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib135","first-page":"495","article-title":"Hormone replacement therapy, mammographic density, and breast cancer risk: a cohort study","volume":"29","author":"Azam","year":"2018","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(25)00394-8_bib136","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1200\/JCO.2009.26.4770","article-title":"Breast cancer risk by breast density, menopause, and postmenopausal hormone therapy use","volume":"28","author":"Kerlikowske","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib137","doi-asserted-by":"crossref","first-page":"279","DOI":"10.7326\/M15-2886","article-title":"Screening for breast cancer: US Preventive Services Task Force Recommendation Statement","volume":"164","author":"Siu","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib138","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.cpet.2023.04.003","article-title":"Breast cancer screening and diagnosis: recent advances in imaging and current limitations","volume":"18","author":"Gegios","year":"2023","journal-title":"PET Clin"},{"key":"10.1016\/S2213-8587(25)00394-8_bib139","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jama.2020.0572","article-title":"Comparison of abbreviated breast mri vs digital breast tomosynthesis for breast cancer detection among women with dense breasts undergoing screening","volume":"323","author":"Comstock","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00394-8_bib140","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.1001\/jamainternmed.2024.4224","article-title":"Breast cancer screening using mammography, digital breast tomosynthesis, and magnetic resonance imaging by breast density","volume":"184","author":"Stout","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib141","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.1001\/archinternmed.2009.303","article-title":"New-onset breast tenderness after initiation of estrogen plus progestin therapy and breast cancer risk","volume":"169","author":"Crandall","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib142","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1001\/archinte.166.15.1578","article-title":"Association of new-onset breast discomfort with an increase in mammographic density during hormone therapy","volume":"166","author":"Crandall","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib143","doi-asserted-by":"crossref","DOI":"10.4178\/epih.e2023092","article-title":"Cancer risk based on alcohol consumption levels: a comprehensive systematic review and meta-analysis","volume":"45","author":"Jun","year":"2023","journal-title":"Epidemiol Health"},{"key":"10.1016\/S2213-8587(25)00394-8_bib144","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/ije\/dyv156","article-title":"Alcohol consumption and breast cancer risk by estrogen receptor status: In a pooled analysis of 20 studies","volume":"45","author":"Jung","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib145","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1097\/EDE.0000000000000261","article-title":"Risk of breast cancer in relation to combined effects of hormone therapy, body mass index, and alcohol use, by hormone-receptor status","volume":"26","author":"Hvidtfeldt","year":"2015","journal-title":"Epidemiology"},{"key":"10.1016\/S2213-8587(25)00394-8_bib146","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.1002\/ijc.23184","article-title":"Alcohol intake and risk of breast cancer defined by estrogen and progesterone receptor status\u2013a meta-analysis of epidemiological studies","volume":"122","author":"Suzuki","year":"2008","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib147","doi-asserted-by":"crossref","first-page":"2006","DOI":"10.1158\/1055-9965.EPI-12-0418","article-title":"Alcohol consumption and breast cancer risk among postmenopausal women following the cessation of hormone therapy use: the California Teachers Study","volume":"21","author":"Horn-Ross","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib148","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1007\/s12672-018-0338-5","article-title":"The influence of menopausal hormone therapy and potential lifestyle interactions in female cancer development\u2014a population-based prospective study","volume":"9","author":"Holm","year":"2018","journal-title":"Horm Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib149","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1158\/1055-9965.EPI-21-0789","article-title":"Alcohol intake and endogenous hormones in pre- and postmenopausal women: findings from the UK biobank","volume":"30","author":"Tin","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib150","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1002\/ijc.32324","article-title":"Mediation analysis of the alcohol-postmenopausal breast cancer relationship by sex hormones in the EPIC cohort","volume":"146","author":"Assi","year":"2020","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib151","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1080\/13697137.2025.2585487","article-title":"International Menopause Society (IMS) recommendations and key messages on women's midlife health and menopause","volume":"28","author":"Panay","year":"2025","journal-title":"Climacteric"},{"key":"10.1016\/S2213-8587(25)00394-8_bib152","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1200\/JCO.19.02407","article-title":"Amount and intensity of leisure-time physical activity and lower cancer risk","volume":"38","author":"Matthews","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib153","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1136\/bjsports-2024-109360","article-title":"Amount and intensity of daily total physical activity, step count and risk of incident cancer in the UK Biobank","volume":"59","author":"Shreves","year":"2025","journal-title":"Br J Sports Med"},{"key":"10.1016\/S2213-8587(25)00394-8_bib154","doi-asserted-by":"crossref","first-page":"635","DOI":"10.3109\/0284186X.2014.998275","article-title":"Physical activity, risk of death and recurrence in breast cancer survivors: a systematic review and meta-analysis of epidemiological studies","volume":"54","author":"Lahart","year":"2015","journal-title":"Acta Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib156","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ajcnut.2024.10.003","article-title":"Adulthood dietary and lifestyle patterns and risk of breast cancer: Global Cancer Update Programme (CUP Global) systematic literature review","volume":"121","author":"Konieczna","year":"2025","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(25)00394-8_bib157","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ijc.31387","article-title":"A dietary pattern based on estrogen metabolism is associated with breast cancer risk in a prospective cohort of postmenopausal women","volume":"143","author":"Guinter","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib158","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.1158\/1055-9965.EPI-20-1803","article-title":"Cigarette smoking and estrogen-related cancer","volume":"30","author":"Baron","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib159","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/sj.bjc.6600596","article-title":"Alcohol, tobacco and breast cancer\u2014collaborative reanalysis of individual data from 53 epidemiological studies, including 58,515 women with breast cancer and 95,067 women without the disease","volume":"87","author":"Hamajima","year":"2002","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib160","doi-asserted-by":"crossref","first-page":"640","DOI":"10.2188\/jea.JE20220206","article-title":"Dose-response relationships between cigarette smoking and breast cancer risk: a systematic review and meta-analysis","volume":"33","author":"Scala","year":"2023","journal-title":"J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib161","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10549-015-3628-4","article-title":"Active and passive smoking and risk of breast cancer: a meta-analysis","volume":"154","author":"Macacu","year":"2015","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S2213-8587(25)00394-8_bib162","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2022.961970","article-title":"The relationship between tobacco and breast cancer incidence: a systematic review and meta-analysis of observational studies","volume":"12","author":"He","year":"2022","journal-title":"Front Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib163","doi-asserted-by":"crossref","first-page":"573","DOI":"10.3390\/nu16050573","article-title":"The impact of vitamin D and its dietary supplementation in breast cancer prevention: an integrative review","volume":"16","author":"Torres","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(25)00394-8_bib164","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1002\/cncr.33767","article-title":"Performance of the IBIS\/Tyrer-Cuzick model of breast cancer risk by race and ethnicity in the Women's Health Initiative","volume":"127","author":"Kurian","year":"2021","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib171","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa623","article-title":"Approach to managing a postmenopausal patient","volume":"105","author":"Santen","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00394-8_bib172","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1097\/GME.0000000000002028","article-title":"The 2022 hormone therapy position statement of The North American Menopause Society","volume":"29","author":"Faubion","year":"2022","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(25)00394-8_bib173","doi-asserted-by":"crossref","first-page":"1268","DOI":"10.1016\/j.mayocp.2020.04.017","article-title":"Breast cancer risk assessment: a step-wise approach for primary care providers on the front lines of shared decision making","volume":"95","author":"McClintock","year":"2020","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/S2213-8587(25)00394-8_bib174","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1038\/s41416-023-02145-w","article-title":"Proactive breast cancer risk assessment in primary care: a review based on the principles of screening","volume":"128","author":"Usher-Smith","year":"2023","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib175","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1111\/tbj.13967","article-title":"Breast cancer risk assessment and management programs: A practical guide","volume":"26","author":"Sciaraffa","year":"2020","journal-title":"Breast J"},{"key":"10.1016\/S2213-8587(25)00394-8_bib176","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoae065","article-title":"Evidence-based guideline: premature ovarian insufficiency","volume":"2024","author":"Panay","year":"2024","journal-title":"Hum Reprod Open"},{"key":"10.1016\/S2213-8587(25)00394-8_bib177","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1001\/jamaoncol.2018.0211","article-title":"Hormone replacement therapy after oophorectomy and breast cancer risk among BRCA1 mutation carriers","volume":"4","author":"Kotsopoulos","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib178","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.critrevonc.2018.09.018","article-title":"Hormone replacement therapy after prophylactic risk-reducing salpingo-oophorectomy and breast cancer risk in BRCA1 and BRCA2 mutation carriers: a meta-analysis","volume":"132","author":"Marchetti","year":"2018","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib179","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.1093\/jnci\/djn313","article-title":"Hormone therapy and the risk of breast cancer in BRCA1 mutation carriers","volume":"100","author":"Eisen","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(25)00394-8_bib180","doi-asserted-by":"crossref","first-page":"7804","DOI":"10.1200\/JCO.2004.00.8151","article-title":"Effect of short-term hormone replacement therapy on breast cancer risk reduction after bilateral prophylactic oophorectomy in BRCA1 and BRCA2 mutation carriers: the PROSE Study Group","volume":"23","author":"Rebbeck","year":"2005","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib181","doi-asserted-by":"crossref","first-page":"143","DOI":"10.4143\/crt.2023.653","article-title":"Short-term impact of hormone replacement therapy on risk of breast cancer in BRCA mutation carriers: a nationwide study in South Korea","volume":"56","author":"Kim","year":"2024","journal-title":"Cancer Res Treat"},{"key":"10.1016\/S2213-8587(25)00394-8_bib182","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/j.ejca.2012.07.003","article-title":"Hormone replacement therapy after breast cancer: 10 year follow up of the Stockholm randomised trial","volume":"49","author":"Fahl\u00e9n","year":"2013","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2213-8587(25)00394-8_bib183","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1093\/jnci\/djn058","article-title":"Increased risk of recurrence after hormone replacement therapy in breast cancer survivors","volume":"100","author":"Holmberg","year":"2008","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(25)00394-8_bib184","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1177\/2053369118824920","article-title":"British Menopause Society consensus statement on the management of estrogen deficiency symptoms, arthralgia and menopause diagnosis in women treated for early breast cancer","volume":"25","author":"Marsden","year":"2019","journal-title":"Post Reprod Health"},{"key":"10.1016\/S2213-8587(25)00394-8_bib185","doi-asserted-by":"crossref","first-page":"3647","DOI":"10.1210\/jc.2017-01138","article-title":"Managing menopausal symptoms and associated clinical issues in breast cancer survivors","volume":"102","author":"Santen","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00394-8_bib186","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1001\/jamaoncol.2023.4508","article-title":"Vaginal Estrogen Therapy Use and Survival in Females With Breast Cancer","volume":"10","author":"McVicker","year":"2024","journal-title":"JAMA Oncol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib187","doi-asserted-by":"crossref","first-page":"1347","DOI":"10.1093\/jnci\/djac112","article-title":"Systemic or vaginal hormone therapy after early breast cancer: a Danish observational cohort study","volume":"114","author":"Cold","year":"2022","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(25)00394-8_bib188","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.maturitas.2017.04.013","article-title":"Managing menopausal symptoms after breast cancer\u2014a multidisciplinary approach","volume":"105","author":"Cohen","year":"2017","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(25)00394-8_bib189","article-title":"Genitourinary syndrome of menopause","author":"Danan","year":"2024","journal-title":"Syst Rev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib190","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1097\/GME.0000000000001138","article-title":"The role of androgens in the treatment of genitourinary syndrome of menopause (GSM): International Society for the Study of Women's Sexual Health (ISSWSH) expert consensus panel review","volume":"25","author":"Simon","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(25)00394-8_bib191","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1097\/AOG.0000000000005294","article-title":"Safety of vaginal estrogen therapy for genitourinary syndrome of menopause in women with a history of breast cancer","volume":"142","author":"Agrawal","year":"2023","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(25)00394-8_bib192","article-title":"Genitourinary syndrome of menopause (GSM): recommendations from the Fifth International Consultation on Sexual Medicine (ICSM 2024)","volume":"22","author":"Simon","year":"2025","journal-title":"Sex Med Rev"},{"key":"10.1016\/S2213-8587(25)00394-8_bib193","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1097\/GME.0000000000000956","article-title":"Breast cancer, endometrial cancer, and cardiovascular events in participants who used vaginal estrogen in the Women's Health Initiative observational study","volume":"25","author":"Crandall","year":"2018","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(25)00394-8_bib194","first-page":"1335","article-title":"Systemic and local effects of vaginal dehydroepiandrosterone (DHEA): NCCTG N10C1 (Alliance)","volume":"26","author":"Barton","year":"2018","journal-title":"Support Care Cancer"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(26)00139-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T00:00:00Z","timestamp":1780531200000}},{"DOI":"10.1016\/s2213-8587(26)00139-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:22:25Z","timestamp":1782858145000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003948"}},"issued":{"date-parts":[[2026,3]]},"references-count":185,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2213858725003948"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00394-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Menopausal hormone treatment and breast cancer","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00394-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T15:33:34Z","timestamp":1794670414088,"version":"4.9.1"},"reference-count":166,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,15]],"date-time":"2025-08-15T00:00:00Z","timestamp":1755216000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001659","name":"German Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/s2213-8587(25)00251-7","type":"journal-article","created":{"date-parts":[[2025,9,27]],"date-time":"2025-09-27T06:02:49Z","timestamp":1758952969000},"page":"964-979","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Glucocorticoid-induced osteoporosis: novel concepts and clinical implications"],"prefix":"10.1016","volume":"13","author":[{"given":"Lorenz C","family":"Hofbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet E","family":"Compston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth G","family":"Saag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tsourdi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00251-7_bib1","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1002\/j.1550-8528.1994.tb00097.x","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism). 1932","volume":"2","author":"Cushing","year":"1994","journal-title":"Obes Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib2","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0025-6196(24)00526-3","article-title":"The effect of a hormone of the adrenal cortex (17-hydroxy-11-dehydrocorticosterone; compound E) and of pituitary adrenocorticotropic hormone on rheumatoid arthritis","volume":"24","author":"Hench","year":"1949","journal-title":"Proc Staff Meet Mayo Clin"},{"key":"10.1016\/S2213-8587(25)00251-7_bib3","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1001\/jama.2023.11305","article-title":"Cushing syndrome: a review","volume":"330","author":"Reincke","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00251-7_bib4","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1359\/jbmr.2000.15.6.993","article-title":"Use of oral corticosteroids and risk of fractures","volume":"15","author":"van Staa","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2023.116958","article-title":"Risk of fracture in women with glucocorticoid requiring diseases is independent from glucocorticoid use: an analysis on a nation-wide database","volume":"179","author":"Adami","year":"2024","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(25)00251-7_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsbmb.2021.105952","article-title":"The clinical significance of the glucocorticoid receptors: genetics and epigenetics","volume":"213","author":"Motavalli","year":"2021","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.908727","article-title":"Prevention and treatment of glucocorticoid-induced osteoporosis in adults: consensus recommendations from the Belgian Bone Club","volume":"13","author":"Laurent","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib8","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.14309\/ajg.0000000000001774","article-title":"Budesonide maintenance in microscopic colitis: clinical outcomes and safety profile from a population-based study","volume":"117","author":"Tome","year":"2022","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib9","doi-asserted-by":"crossref","first-page":"R46","DOI":"10.1093\/ejendo\/lvad029","article-title":"Extensive expertise in endocrinology: advances in the management of glucocorticoid-induced osteoporosis","volume":"188","author":"Compston","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib10","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1007\/s40265-019-01145-6","article-title":"Current treatments and new developments in the management of glucocorticoid-induced osteoporosis","volume":"79","author":"Raterman","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/S2213-8587(25)00251-7_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/20503121241235056","article-title":"Nationwide prevalence of glucocorticoid prescriptions over 17 years and osteoporosis prevention among long-term users","volume":"12","author":"Bjornsdottir","year":"2024","journal-title":"SAGE Open Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib12","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1080\/17446651.2020.1772051","article-title":"Updates in epidemiology, pathophysiology and management strategies of glucocorticoid-induced osteoporosis","volume":"15","author":"Chiodini","year":"2020","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00251-7_bib13","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1007\/s00774-022-01325-7","article-title":"Fracture risk associated with glucocorticoid-induced osteoporosis in Japan","volume":"40","author":"Soen","year":"2022","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/S2213-8587(25)00251-7_bib14","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1093\/rheumatology\/39.12.1383","article-title":"Oral corticosteroids and fracture risk: relationship to daily and cumulative doses","volume":"39","author":"van Staa","year":"2000","journal-title":"Rheumatology"},{"key":"10.1016\/S2213-8587(25)00251-7_bib15","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1210\/endrev\/bnab028","article-title":"Secondary osteoporosis","volume":"43","author":"Ebeling","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(25)00251-7_bib16","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1007\/s00198-024-07284-1","article-title":"Rapid reduction in fracture risk after the discontinuation of long-term oral glucocorticoid therapy: a retrospective cohort study using a nationwide health insurance claims database in Japan","volume":"36","author":"Iki","year":"2025","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib17","doi-asserted-by":"crossref","first-page":"3239","DOI":"10.1007\/s00198-016-3646-z","article-title":"Glucocorticoid exposure and fracture risk in patients with new-onset rheumatoid arthritis","volume":"27","author":"Balasubramanian","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib18","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s11657-018-0424-x","article-title":"Impact of cumulative exposure to high-dose oral glucocorticoids on fracture risk in Denmark: a population-based case-control study","volume":"13","author":"Amiche","year":"2018","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(25)00251-7_bib19","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1007\/s00198-015-3455-9","article-title":"Fracture risk in oral glucocorticoid users: a Bayesian meta-regression leveraging control arms of osteoporosis clinical trials","volume":"27","author":"Amiche","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib20","doi-asserted-by":"crossref","first-page":"1881","DOI":"10.1002\/jbmr.3523","article-title":"Glucocorticoid exposure and fracture risk in a cohort of US patients with selected conditions","volume":"33","author":"Balasubramanian","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib21","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1007\/s00198-024-07023-6","volume":"35","author":"Iki","year":"2024","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib22","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s11657-015-0244-1","article-title":"The risk factors for fractures and trabecular bone score value in patients with endogenous Cushing's syndrome","volume":"10","author":"Belaya","year":"2015","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(25)00251-7_bib23","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1093\/jbmr\/zjae067","article-title":"Fracture risk and bone health in adrenal adenomas with mild autonomous cortisol secretion\/subclinical hypercortisolism: a systematic review, meta-analysis and meta-regression","volume":"39","author":"Pal","year":"2024","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib24","doi-asserted-by":"crossref","first-page":"3224","DOI":"10.1002\/art.11283","article-title":"Bone density threshold and other predictors of vertebral fracture in patients receiving oral glucocorticoid therapy","volume":"48","author":"van Staa","year":"2003","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(25)00251-7_bib25","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1056\/NEJMcp1012926","article-title":"Clinical practice. Glucocorticoid-induced bone disease","volume":"365","author":"Weinstein","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib26","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1097\/00042737-200012080-00013","article-title":"Incidence of vertebral fractures in the first three months after orthotopic liver transplantation","volume":"12","author":"Ninkovic","year":"2000","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2023.105604","article-title":"Risk and management of osteoporosis due to inhaled, epidural, intra-articular or topical glucocorticoids","volume":"90","author":"Anastasilakis","year":"2023","journal-title":"Joint Bone Spine"},{"key":"10.1016\/S2213-8587(25)00251-7_bib28","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1111\/j.1365-2222.2008.03029.x","article-title":"Dose-response relationship for risk of non-vertebral fracture with inhaled corticosteroids","volume":"38","author":"Weatherall","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/S2213-8587(25)00251-7_bib29","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/j.1365-2796.2005.01467.x","article-title":"Fracture risk associated with systemic and topical corticosteroids","volume":"257","author":"Vestergaard","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib30","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1093\/jbmr\/zjae162","article-title":"Epidural steroid injections and fracture incidence among older individuals with radiculopathy","volume":"40","author":"Yun","year":"2025","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib31","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1001\/jamadermatol.2020.4968","article-title":"Association of potent and very potent topical corticosteroids and the risk of osteoporosis and major osteoporotic fractures","volume":"157","author":"Egeberg","year":"2021","journal-title":"JAMA Dermatol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib32","doi-asserted-by":"crossref","first-page":"4394","DOI":"10.1210\/jc.2005-0036","article-title":"Iatrogenic Cushing's syndrome with osteoporosis and secondary adrenal failure in human immunodeficiency virus-infected patients receiving inhaled corticosteroids and ritonavir-boosted protease inhibitors: six cases","volume":"90","author":"Samaras","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00251-7_bib33","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/2325957413488187","article-title":"Iatrogenic Cushing syndrome and secondary adrenal insufficiency related to concomitant triamcinolone and ritonavir administration: a case report and review","volume":"13","author":"Song","year":"2014","journal-title":"J Int Assoc Provid AIDS Care"},{"key":"10.1016\/S2213-8587(25)00251-7_bib34","doi-asserted-by":"crossref","first-page":"3628","DOI":"10.7150\/ijbs.82933","article-title":"11\u03b2-hydroxysteroid dehydrogenase type 1 facilitates osteoporosis by turning on osteoclastogenesis through Hippo signaling","volume":"19","author":"Li","year":"2023","journal-title":"Int J Biol Sci"},{"key":"10.1016\/S2213-8587(25)00251-7_bib35","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1186\/s13075-019-1972-1","article-title":"11\u03b2-HSD1 plays a critical role in trabecular bone loss associated with systemic glucocorticoid therapy","volume":"21","author":"Fenton","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/S2213-8587(25)00251-7_bib36","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1016\/0092-8674(90)90396-V","article-title":"Transcriptional interference between c-Jun and the glucocorticoid receptor: mutual inhibition of DNA binding due to direct protein-protein interaction","volume":"62","author":"Yang-Yen","year":"1990","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(25)00251-7_bib37","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/0092-8674(90)90395-U","article-title":"Antitumor promotion and antiinflammation: down-modulation of AP-1 (Fos\/Jun) activity by glucocorticoid hormone","volume":"62","author":"Jonat","year":"1990","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(25)00251-7_bib38","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/308513a0","article-title":"Characterization of DNA sequences through which cadmium and glucocorticoid hormones induce human metallothionein-IIA gene","volume":"308","author":"Karin","year":"1984","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00251-7_bib39","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mce.2007.05.014","article-title":"Selective glucocorticoid receptor agonists (SEGRAs): novel ligands with an improved therapeutic index","volume":"275","author":"Sch\u00e4cke","year":"2007","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib40","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1515\/hsz-2015-0106","article-title":"The glucocorticoid receptor in inflammatory processes: transrepression is not enough","volume":"396","author":"H\u00fcbner","year":"2015","journal-title":"Biol Chem"},{"key":"10.1016\/S2213-8587(25)00251-7_bib41","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.cmet.2010.05.005","article-title":"Glucocorticoids suppress bone formation by attenuating osteoblast differentiation via the monomeric glucocorticoid receptor","volume":"11","author":"Rauch","year":"2010","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(25)00251-7_bib42","doi-asserted-by":"crossref","DOI":"10.1212\/WNL.0000000000208112","article-title":"Efficacy and safety of vamorolone over 48 weeks in boys with Duchenne muscular dystrophy: a randomized controlled trial","volume":"102","author":"Dang","year":"2024","journal-title":"Neurology"},{"key":"10.1016\/S2213-8587(25)00251-7_bib43","doi-asserted-by":"crossref","first-page":"4382","DOI":"10.1210\/endo.140.10.7034","article-title":"Stimulation of osteoprotegerin ligand and inhibition of osteoprotegerin production by glucocorticoids in human osteoblastic lineage cells: potential paracrine mechanisms of glucocorticoid-induced osteoporosis","volume":"140","author":"Hofbauer","year":"1999","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(25)00251-7_bib44","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1210\/en.2006-0459","article-title":"Glucocorticoids act directly on osteoclasts to increase their life span and reduce bone density","volume":"147","author":"Jia","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(25)00251-7_bib45","doi-asserted-by":"crossref","first-page":"162","DOI":"10.3181\/00379727-217-44218","article-title":"Prevention of corticosteroid-induced bone loss with alendronate","volume":"217","author":"Wimalawansa","year":"1998","journal-title":"Proc Soc Exp Biol Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib46","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1002\/art.24445","article-title":"Prevention of glucocorticoid-induced bone loss in mice by inhibition of RANKL","volume":"60","author":"Hofbauer","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(25)00251-7_bib47","doi-asserted-by":"crossref","first-page":"3323","DOI":"10.1210\/en.2011-0170","article-title":"Osteoprotegerin prevents glucocorticoid-induced osteocyte apoptosis in mice","volume":"152","author":"Weinstein","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(25)00251-7_bib48","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1359\/JBMR.041125","article-title":"Effects of low-dose prednisone on bone metabolism","volume":"20","author":"Ton","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib49","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/S8756-3282(98)00097-0","article-title":"Effects of short-term treatment with prednisolone and calcitriol on bone and mineral metabolism in normal men","volume":"23","author":"Gram","year":"1998","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(25)00251-7_bib50","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1002\/jbmr.5650110516","article-title":"Altered trabecular architecture induced by corticosteroids: a bone histomorphometric study","volume":"11","author":"Chappard","year":"1996","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib51","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1359\/JBMR.051103","article-title":"Glucocorticoid-treated mice have localized changes in trabecular bone material properties and osteocyte lacunar size that are not observed in placebo-treated or estrogen-deficient mice","volume":"21","author":"Lane","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib52","doi-asserted-by":"crossref","DOI":"10.1038\/srep30186","article-title":"Mesenchymal progenitors in osteopenias of diverse pathologies: differential characteristics in the common shift from osteoblastogenesis to adipogenesis","volume":"6","author":"Sui","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(25)00251-7_bib53","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/S1096-6374(02)00117-X","article-title":"Expression of insulin-like growth factor system constituents in differentiating rat osteoblastic cell populations","volume":"12","author":"Jia","year":"2002","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib54","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1007\/s00223-009-9303-1","article-title":"Biphasic glucocorticoid-dependent regulation of Wnt expression and its inhibitors in mature osteoblastic cells","volume":"85","author":"Mak","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib55","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/j.bbrc.2008.12.035","article-title":"BMP\/Wnt antagonists are upregulated by dexamethasone in osteoblasts and reversed by alendronate and PTH: potential therapeutic targets for glucocorticoid-induced osteoporosis","volume":"379","author":"Hayashi","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(25)00251-7_bib56","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1002\/jbmr.3702","article-title":"Osteogenic Dkk1 mediates glucocorticoid-Induced but not arthritis-induced bone loss","volume":"34","author":"Colditz","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib57","doi-asserted-by":"crossref","DOI":"10.1038\/boneres.2017.13","article-title":"Sclerostin activity plays a key role in the negative effect of glucocorticoid signaling on osteoblast function in mice","volume":"5","author":"Beier","year":"2017","journal-title":"Bone Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib58","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/s41392-021-00528-0","article-title":"Targeting cellular senescence prevents glucocorticoid-induced bone loss through modulation of the DPP4-GLP-1 axis","volume":"6","author":"Wang","year":"2021","journal-title":"Signal Transduct Target Ther"},{"key":"10.1016\/S2213-8587(25)00251-7_bib59","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bbrc.2022.02.112","article-title":"Dexamethasone induces ferroptosis via P53\/SLC7A11\/GPX4 pathway in glucocorticoid-induced osteonecrosis of the femoral head","volume":"602","author":"Sun","year":"2022","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(25)00251-7_bib60","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1172\/JCI2799","article-title":"Inhibition of osteoblastogenesis and promotion of apoptosis of osteoblasts and osteocytes by glucocorticoids. Potential mechanisms of their deleterious effects on bone","volume":"102","author":"Weinstein","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(25)00251-7_bib61","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/en.2003-0990","article-title":"Glucocorticoids act directly on osteoblasts and osteocytes to induce their apoptosis and reduce bone formation and strength","volume":"145","author":"O'Brien","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(25)00251-7_bib62","doi-asserted-by":"crossref","DOI":"10.1038\/srep44618","article-title":"Glucocorticoid suppression of osteocyte perilacunar remodeling is associated with subchondral bone degeneration in osteonecrosis","volume":"7","author":"Fowler","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(25)00251-7_bib63","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1111\/j.1474-9726.2009.00545.x","article-title":"Endogenous glucocorticoids decrease skeletal angiogenesis, vascularity, hydration, and strength in aged mice","volume":"9","author":"Weinstein","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/S2213-8587(25)00251-7_bib64","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bone.2018.05.025","article-title":"Preservation of type H vessels and osteoblasts by enhanced preosteoclast platelet-derived growth factor type BB attenuates glucocorticoid-induced osteoporosis in growing mice","volume":"114","author":"Yang","year":"2018","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(25)00251-7_bib65","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s00198-005-1923-3","article-title":"High-dose glucocorticoid treatment induces rapid loss of trabecular bone mineral density and lean body mass","volume":"17","author":"Natsui","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib66","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1210\/en.2006-0539","article-title":"Myostatin gene deletion prevents glucocorticoid-induced muscle atrophy","volume":"148","author":"Gilson","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(25)00251-7_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0166468","article-title":"The association between systemic glucocorticoid use and the risk of cataract and glaucoma in patients with rheumatoid arthritis: a systematic review and meta-analysis","volume":"11","author":"Black","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(25)00251-7_bib68","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1159\/000061083","article-title":"Growth hormone in glucocorticoid-induced osteoporosis","volume":"30","author":"Manelli","year":"2002","journal-title":"Front Horm Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib69","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1530\/JOE-21-0388","article-title":"Combined growth hormone and insulin-like growth factor-1 rescues growth retardation in glucocorticoid-treated mdxmice but does not prevent osteopenia","volume":"253","author":"Wood","year":"2022","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib70","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00198-023-06951-z","article-title":"Growth hormone and testosterone delay vertebral fractures in boys with muscular dystrophy on chronic glucocorticoids","volume":"35","author":"Loscalzo","year":"2024","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/rmdopen-2020-001355","article-title":"Vertebral fracture risk in glucocorticoid-induced osteoporosis: the role of hypogonadism and corticosteroid boluses","volume":"6","author":"Florez","year":"2020","journal-title":"RMD Open"},{"key":"10.1016\/S2213-8587(25)00251-7_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2023.104733","article-title":"Adrenal steroid metabolites and bone status in patients with adrenal incidentalomas and hypercortisolism","volume":"95","author":"Nakao","year":"2023","journal-title":"EBioMedicine"},{"key":"10.1016\/S2213-8587(25)00251-7_bib73","doi-asserted-by":"crossref","first-page":"E299","DOI":"10.1152\/ajpendo.00232.2005","article-title":"Glucocorticoids differentially regulate expression of duodenal and renal calbindin-D9k through glucocorticoid receptor-mediated pathway in mouse model","volume":"290","author":"Lee","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00251-7_bib74","doi-asserted-by":"crossref","first-page":"375","DOI":"10.14245\/ns.2448140.070","article-title":"Pharmacological treatment of degenerative cervical myelopathy: a critical review of current evidence","volume":"21","author":"Levett","year":"2024","journal-title":"Neurospine"},{"key":"10.1016\/S2213-8587(25)00251-7_bib75","doi-asserted-by":"crossref","first-page":"E449","DOI":"10.36076\/ppj.2023.26.E449","article-title":"Intradiscal glucocorticoid injection in discogenic back pain and influence on modic changes: a systematic review and meta-analysis of RCTs","volume":"26","author":"Riegger","year":"2023","journal-title":"Pain Physician"},{"key":"10.1016\/S2213-8587(25)00251-7_bib76","doi-asserted-by":"crossref","first-page":"2088","DOI":"10.1002\/art.42646","article-title":"2022 American College of Rheumatology Guideline for the prevention and treatment of glucocorticoid-induced osteoporosis","volume":"75","author":"Humphrey","year":"2023","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib77","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvae146","article-title":"Prevention and treatment of glucocorticoid-induced osteoporosis in adults: recommendations from the European Calcified Tissue Society","volume":"191","author":"Paccou","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib78","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s11657-022-01061-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"17","author":"Gregson","year":"2022","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(25)00251-7_bib79","doi-asserted-by":"crossref","first-page":"2591","DOI":"10.1007\/s40520-022-02261-2","article-title":"Evidence based Latin American Guidelines of clinical practice on prevention, diagnosis, management and treatment of glucocorticoid induced osteoporosis","volume":"34","author":"Messina","year":"2022","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib80","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00198-019-04906-x","article-title":"Glucocorticoid-induced osteoporosis: 2019 concise clinical review","volume":"30","author":"Adami","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib81","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1359\/JBMR.040134","article-title":"A meta-analysis of prior corticosteroid use and fracture risk","volume":"19","author":"Kanis","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib82","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1007\/s00198-015-3078-1","article-title":"The impact of glucocorticoid therapy on trabecular bone score in older women","volume":"26","author":"Paggiosi","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib83","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1111\/1756-185X.14164","article-title":"Discriminative ability of trabecular bone score over bone mineral density for vertebral and fragility fracture in patients treated with long-term and low-dose glucocorticoid","volume":"24","author":"Lee","year":"2021","journal-title":"Int J Rheum Dis"},{"key":"10.1016\/S2213-8587(25)00251-7_bib84","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1055\/a-1528-7261","article-title":"Clinical utility of trabecular bone score (TBS) in fracture risk assessment of patients with rheumatic diseases treated with glucocorticoids","volume":"53","author":"Nowakowska-P\u0142aza","year":"2021","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib85","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/4210217","article-title":"Trabecular bone score reflects trabecular microarchitecture deterioration and fragility fracture in female adult patients receiving glucocorticoid therapy: a pre-post controlled study","volume":"2017","author":"Chuang","year":"2017","journal-title":"Biomed Res Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib86","doi-asserted-by":"crossref","DOI":"10.3390\/jcm12237399","article-title":"Trabecular bone score (TBS) in individuals with type 2 diabetes mellitus: an updated review","volume":"12","author":"Trandafir","year":"2023","journal-title":"J Clin Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib87","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1002\/jbmr.3851","article-title":"Clinical performance of the updated trabecular bone score (TBS) algorithm, which accounts for the soft tissue thickness: the OsteoLaus study","volume":"34","author":"Shevroja","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib88","first-page":"329","article-title":"Bone microarchitecture assessed by 3D high-resolution peripheral quantitative computed tomography (HR-pQCT) as predictor of fracture risk in patients with glucocorticoid-induced osteoporosis","volume":"51","author":"So","year":"2025","journal-title":"J Orthop Transl"},{"key":"10.1016\/S2213-8587(25)00251-7_bib89","doi-asserted-by":"crossref","first-page":"4231","DOI":"10.1210\/jc.2014-2177","article-title":"Abnormalities in cortical bone, trabecular plates, and stiffness in postmenopausal women treated with glucocorticoids","volume":"99","author":"Sutter","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00251-7_bib90","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00198-020-05641-4","article-title":"Trabecular and cortical bone involvement in rheumatoid arthritis by DXA and DXA-based 3D modelling","volume":"32","author":"Brance","year":"2021","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib91","doi-asserted-by":"crossref","first-page":"3340","DOI":"10.1210\/jc.2018-00490","article-title":"Bone mass, microstructure, and strength can discriminate vertebral fracture in patients on long-term steroid treatment","volume":"103","author":"Shen","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00251-7_bib92","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1002\/jbmr.2497","article-title":"Bone tissue properties measurement by reference point indentation in glucocorticoid-induced osteoporosis","volume":"30","author":"Mellibovsky","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib93","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1186\/s12891-015-0733-9","article-title":"Prevalence of fractures in women with rheumatoid arthritis and\/or systemic lupus erythematosus on chronic glucocorticoid therapy","volume":"16","author":"Rentero","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/S2213-8587(25)00251-7_bib94","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1007\/s00198-020-05804-3","article-title":"Vertebral fracture: epidemiology, impact and use of DXA vertebral fracture assessment in fracture liaison services","volume":"32","author":"Lems","year":"2021","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib95","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00198-010-1524-7","article-title":"Guidance for the adjustment of FRAX according to the dose of glucocorticoids","volume":"22","author":"Kanis","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib96","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s00198-010-1461-5","article-title":"Spine-hip discordance and fracture risk assessment: a physician-friendly FRAX enhancement","volume":"22","author":"Leslie","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib97","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1007\/s00223-014-9911-2","article-title":"Impact of femoral neck and lumbar spine BMD discordances on FRAX probabilities in women: a meta-analysis of international cohorts","volume":"95","author":"Johansson","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib98","first-page":"363","article-title":"Assessment of fracture risk with FRAX and FRAXplus","volume":"160","author":"Tan","year":"2024","journal-title":"Gac Med Mex"},{"key":"10.1016\/S2213-8587(25)00251-7_bib99","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1016\/j.cca.2016.06.036","article-title":"Clinical usefulness of bone turnover marker concentrations in osteoporosis","volume":"467","author":"Morris","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2213-8587(25)00251-7_bib100","series-title":"Primer on the metabolic bone diseases and disorders of mineral metabolism","first-page":"266","article-title":"Biochemical markers of bone turnover in osteoporosis","author":"Szulc","year":"2025"},{"key":"10.1016\/S2213-8587(25)00251-7_bib101","series-title":"Biomarkers in bone disease","first-page":"905","article-title":"Bone turnover markers and glucocorticoid treatments","author":"Devogelaer","year":"2017"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(25)00251-7_bib102","doi-asserted-by":"crossref","first-page":"ii11","DOI":"10.1093\/rheumatology\/kex459","article-title":"Prevention of glucocorticoid morbidity in giant cell arteritis","volume":"57","author":"Buttgereit","year":"2018","journal-title":"Rheumatology"},{"key":"10.1016\/S2213-8587(25)00251-7_bib103","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/bjh.15735","article-title":"The prevention of glucocorticoid-induced osteoporosis in patients with immune thrombocytopenia receiving steroids: a British Society for Haematology Good Practice Paper","volume":"185","author":"Hill","year":"2019","journal-title":"Br J Haematol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib104","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1177\/1076029609350889","article-title":"Effects of bisphosphonate administration on the bone mass in immune thrombocytopenic purpura patients under treatment with steroids","volume":"16","author":"Nomura","year":"2010","journal-title":"Clin Appl Thromb Hemost"},{"key":"10.1016\/S2213-8587(25)00251-7_bib105","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/bjh.18104","article-title":"Bone health and glucocorticoid-containing lymphoma therapy\u2014a review of risk factors and preventative measures","volume":"198","author":"Eyre","year":"2022","journal-title":"Br J Haematol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib106","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1056\/NEJMra2314942","article-title":"Primary central nervous system vasculitis","volume":"391","author":"Salvarani","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib107","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1046\/j.1365-2265.2003.01761.x","article-title":"Long-term follow-up of bone mineral density in Addison's disease","volume":"58","author":"Jodar","year":"2003","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib108","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s12020-021-02723-z","article-title":"Rate of fracture in patients with glucocorticoid replacement therapy: a systematic review and meta-analysis","volume":"74","author":"Li","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(25)00251-7_bib109","article-title":"Exercise effects on glucocorticoid-induced bone loss in adults: a systematic review and meta-analysis","volume":"7","author":"Kast","year":"2023","journal-title":"Rheumatol Adv Pract"},{"key":"10.1016\/S2213-8587(25)00251-7_bib110","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1007\/s00198-023-06682-1","article-title":"Exercise training and bone mineral density in postmenopausal women: an updated systematic review and meta-analysis of intervention studies with emphasis on potential moderators","volume":"34","author":"Mohebbi","year":"2023","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib111","article-title":"The multi-faceted nature of age-associated osteoporosis","volume":"20","author":"Smit","year":"2024","journal-title":"Bone Rep"},{"key":"10.1016\/S2213-8587(25)00251-7_bib112","doi-asserted-by":"crossref","first-page":"961","DOI":"10.7326\/0003-4819-125-12-199612150-00004","article-title":"Calcium and vitamin D3 supplementation prevents bone loss in the spine secondary to low-dose corticosteroids in patients with rheumatoid arthritis. A randomized, double-blind, placebo-controlled trial","volume":"125","author":"Buckley","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib113","first-page":"995","article-title":"Vitamin D and calcium in the prevention of corticosteroid induced osteoporosis: a 3 year follow-up","volume":"23","author":"Adachi","year":"1996","journal-title":"J Rheumatol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib114","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10067-020-05294-y","article-title":"The effect of calcium and vitamin D compounds on bone mineral density in patients undergoing glucocorticoid therapies: a network meta-analysis","volume":"40","author":"Deng","year":"2021","journal-title":"Clin Rheumatol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib115","doi-asserted-by":"crossref","first-page":"2257","DOI":"10.1007\/s00198-012-1958-1","article-title":"A framework for the development of guidelines for the management of glucocorticoid-induced osteoporosis","volume":"23","author":"Lekamwasam","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib116","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1056\/NEJM199807303390502","article-title":"Alendronate for the prevention and treatment of glucocorticoid-induced osteoporosis. Glucocorticoid-Induced Osteoporosis Intervention Study Group","volume":"339","author":"Saag","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib117","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1002\/1529-0131(200101)44:1<202::AID-ANR27>3.0.CO;2-W","article-title":"Two-year effects of alendronate on bone mineral density and vertebral fracture in patients receiving glucocorticoids: a randomized, double-blind, placebo-controlled extension trial","volume":"44","author":"Adachi","year":"2001","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(25)00251-7_bib118","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.3899\/jrheum.081207","article-title":"Once-weekly oral alendronate 70 mg in patients with glucocorticoid-induced bone loss: a 12-month randomized, placebo-controlled clinical trial","volume":"36","author":"Stoch","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib119","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1002\/1529-0131(199911)42:11<2309::AID-ANR8>3.0.CO;2-K","article-title":"Risedronate therapy prevents corticosteroid-induced bone loss: a twelve-month, multicenter, randomized, double-blind, placebo-controlled, parallel-group study","volume":"42","author":"Cohen","year":"1999","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(25)00251-7_bib120","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1359\/jbmr.2000.15.6.1006","article-title":"Efficacy and safety of daily risedronate in the treatment of corticosteroid-induced osteoporosis in men and women: a randomized trial. European Corticosteroid-Induced Osteoporosis Treatment Study","volume":"15","author":"Reid","year":"2000","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib121","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s002230001146","article-title":"Effects of risedronate treatment on bone density and vertebral fracture in patients on corticosteroid therapy","volume":"67","author":"Wallach","year":"2000","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib122","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/S0140-6736(09)60250-6","article-title":"Zoledronic acid and risedronate in the prevention and treatment of glucocorticoid-induced osteoporosis (HORIZON): a multicentre, double-blind, double-dummy, randomised controlled trial","volume":"373","author":"Reid","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00251-7_bib123","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1093\/rheumatology\/keaa228","article-title":"Pharmacological prevention of fractures in patients undergoing glucocorticoid therapies: a systematic review and network meta-analysis","volume":"60","author":"Deng","year":"2021","journal-title":"Rheumatology"},{"key":"10.1016\/S2213-8587(25)00251-7_bib124","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz023","article-title":"Efficacy and safety of first- and second-line drugs to prevent glucocorticoid-induced fractures","volume":"105","author":"Ding","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00251-7_bib125","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1001\/jama.2017.8040","article-title":"Association between alendronate use and hip fracture risk in older patients using oral prednisolone","volume":"318","author":"Axelsson","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00251-7_bib126","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jbmr.3318","article-title":"Effectiveness of oral bisphosphonates in reducing fracture risk among oral glucocorticoid users: three matched cohort analyses","volume":"33","author":"Amiche","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib127","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1210\/jc.2017-01912","article-title":"Alendronate use and the risk of nonvertebral fracture during glucocorticoid therapy: a retrospective cohort study","volume":"103","author":"Bergman","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00251-7_bib128","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s11914-020-00612-4","article-title":"Benefits of bisphosphonate therapy: beyond the skeleton","volume":"18","author":"Billington","year":"2020","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/S2213-8587(25)00251-7_bib129","article-title":"Increased cardiovascular risk in rheumatoid arthritis: mechanisms and implications","volume":"361","author":"England","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00251-7_bib130","doi-asserted-by":"crossref","first-page":"483","DOI":"10.2217\/fon-2019-0722","article-title":"Molecular mechanisms underlying rheumatoid arthritis and cancer development and treatment","volume":"16","author":"Morand","year":"2020","journal-title":"Future Oncol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib131","article-title":"Bisphosphonates for steroid-induced osteoporosis","volume":"10","author":"Allen","year":"2016","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(25)00251-7_bib132","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/S2213-8587(18)30075-5","article-title":"Denosumab versus risedronate in glucocorticoid-induced osteoporosis: a multicentre, randomised, double-blind, active-controlled, double-dummy, non-inferiority study","volume":"6","author":"Saag","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib133","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1002\/art.40874","article-title":"Denosumab versus risedronate in glucocorticoid-induced osteoporosis: final results of a twenty-four-month randomized, double-blind, double-dummy trial","volume":"71","author":"Saag","year":"2019","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib134","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1002\/jbmr.4551","article-title":"Effect of denosumab compared with risedronate on bone strength in patients initiating or continuing glucocorticoid treatment","volume":"37","author":"Geusens","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib135","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1002\/art.39075","article-title":"Risk of hospitalized infection among rheumatoid arthritis patients concurrently treated with a biologic agent and denosumab","volume":"67","author":"Curtis","year":"2015","journal-title":"Arthritis Rheumatol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib136","doi-asserted-by":"crossref","first-page":"29","DOI":"10.7326\/M24-0013","article-title":"The effect of denosumab on risk for emergently treated hypocalcemia by stage of chronic kidney disease: a target trial emulation","volume":"178","author":"Bird","year":"2025","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib137","article-title":"Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS","volume":"106","author":"Tsourdi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00251-7_bib138","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1056\/NEJMoa1916525","article-title":"Atypical femur fracture risk versus fragility fracture prevention with bisphosphonates","volume":"383","author":"Black","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib139","doi-asserted-by":"crossref","first-page":"100","DOI":"10.3109\/17453674.2015.1004149","article-title":"Risk of atypical femoral fracture during and after bisphosphonate use","volume":"86","author":"Schilcher","year":"2015","journal-title":"Acta Orthop"},{"key":"10.1016\/S2213-8587(25)00251-7_bib140","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/S2213-8587(17)30138-9","article-title":"10 years of denosumab treatment in postmenopausal women with osteoporosis: results from the phase 3 randomised FREEDOM trial and open-label extension","volume":"5","author":"Bone","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib141","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1210\/clinem\/dgab888","article-title":"Osteonecrosis of the jaw and antiresorptive agents in benign and malignant diseases: a critical review organized by the ECTS","volume":"107","author":"Anastasilakis","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00251-7_bib142","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1258\/rsmsmj.54.1.21","article-title":"Hormone replacement therapy (HRT) or etidronate for osteoporosis in postmenopausal asthmatics on glucocorticoids: a randomised factorial trial","volume":"54","author":"Campbell","year":"2009","journal-title":"Scott Med J"},{"key":"10.1016\/S2213-8587(25)00251-7_bib143","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1136\/ard.2010.143453","article-title":"Raloxifene for prevention of glucocorticoid-induced bone loss: a 12-month randomised double-blinded placebo-controlled trial","volume":"70","author":"Mok","year":"2011","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S2213-8587(25)00251-7_bib144","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13075-021-02564-1","article-title":"Effectiveness of bazedoxifene in preventing glucocorticoid-induced bone loss in rheumatoid arthritis patients","volume":"23","author":"Cho","year":"2021","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/S2213-8587(25)00251-7_bib145","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1056\/NEJMoa071408","article-title":"Teriparatide or alendronate in glucocorticoid-induced osteoporosis","volume":"357","author":"Saag","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib146","doi-asserted-by":"crossref","first-page":"3346","DOI":"10.1002\/art.24879","article-title":"Effects of teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: thirty-six-month results of a randomized, double-blind, controlled trial","volume":"60","author":"Saag","year":"2009","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(25)00251-7_bib147","doi-asserted-by":"crossref","first-page":"1355","DOI":"10.1002\/jbmr.1870","article-title":"Comparative effects of teriparatide and risedronate in glucocorticoid-induced osteoporosis in men: 18-month results of the EuroGIOPs trial","volume":"28","author":"Gl\u00fcer","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib148","doi-asserted-by":"crossref","first-page":"2095","DOI":"10.1007\/s00198-009-0917-y","article-title":"Teriparatide versus alendronate for treating glucocorticoid-induced osteoporosis: an analysis by gender and menopausal status","volume":"20","author":"Langdahl","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib149","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1007\/s00198-019-04999-4","article-title":"Abaloparatide increases bone mineral density and bone strength in ovariectomized rabbits with glucocorticoid-induced osteopenia","volume":"30","author":"Chandler","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib150","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1002\/jbmr.2869","article-title":"Protection from glucocorticoid-induced osteoporosis by anti-catabolic signaling in the absence of Sost\/sclerostin","volume":"31","author":"Sato","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib151","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1038\/s41574-020-0341-0","article-title":"Pathogenesis of glucocorticoid-induced osteoporosis and options for treatment","volume":"16","author":"Chotiyarnwong","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib152","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/joim.20017","article-title":"Romosozumab versus denosumab in long-term users of glucocorticoids: a pilot randomized controlled trial","volume":"296","author":"Mok","year":"2024","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib153","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1093\/mr\/roac014","article-title":"Comparable efficacy of denosumab and romosozumab in patients with rheumatoid arthritis receiving glucocorticoid administration","volume":"33","author":"Kobayakawa","year":"2023","journal-title":"Mod Rheumatol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib154","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1056\/NEJMoa053569","article-title":"Alendronate or alfacalcidol in glucocorticoid induced osteoporosis","volume":"355","author":"de Nijs","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00251-7_bib155","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00198-011-1800-1","article-title":"Post hoc analysis of a single IV infusion of zoledronic acid versus daily oral risedronate on lumbar spine bone mineral density in different subgroups with glucocorticoid-induced osteoporosis","volume":"23","author":"Roux","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(25)00251-7_bib156","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/BOR.0000000000000934","article-title":"Glucocorticoid-induced osteoporosis in premenopausal women: management for the rheumatologist","volume":"35","author":"Chakrabarti","year":"2023","journal-title":"Curr Opin Rheumatol"},{"key":"10.1016\/S2213-8587(25)00251-7_bib157","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11505","article-title":"A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair","volume":"7","author":"Florio","year":"2016","journal-title":"Nat Commun"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00251-7_bib158","first-page":"4","article-title":"AGA2118, a bispecific monoclonal antibody neutralizing both sclerostin and DKK1, increased bone Formation, decreased bone resorption, and led to rapid BMD gains in a first in human, single- and multiple-dose, placebo-controlled, randomized study","volume":"39","author":"Drake","year":"2024","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib159","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/s41586-024-07634-3","article-title":"A maternal brain hormone that builds bone","volume":"632","author":"Babey","year":"2024","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00251-7_bib160","doi-asserted-by":"crossref","DOI":"10.3390\/ijms20225768","article-title":"Exploring the interface between inflammatory and therapeutic glucocorticoid induced bone and muscle loss","volume":"20","author":"Webster","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(25)00251-7_bib161","doi-asserted-by":"crossref","first-page":"925","DOI":"10.1136\/annrheumdis-2021-221957","article-title":"Low dose, add-on prednisolone in patients with rheumatoid arthritis aged 65+: the pragmatic randomised, double-blind placebo-controlled GLORIA trial","volume":"81","author":"Boers","year":"2022","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S2213-8587(25)00251-7_bib162","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.metabol.2017.12.002","article-title":"The importance of the circadian system & sleep for bone health","volume":"84","author":"Swanson","year":"2018","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(25)00251-7_bib163","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1002\/art.1780240705","article-title":"Bone loss in adults receiving alternate day glucocorticoid therapy. A comparison with daily therapy","volume":"24","author":"Gluck","year":"1981","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(25)00251-7_bib164","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12902-020-00633-1","article-title":"The contribution of serum cortisone and glucocorticoid metabolites to detrimental bone health in patients receiving hydrocortisone therapy","volume":"20","author":"Dineen","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(25)00251-7_bib165","first-page":"53","article-title":"Trends in systemic glucocorticoid utilization in the United Kingdom from 1990 to 2019: a population-based, serial cross-sectional analysis","volume":"15","author":"Menzies-Gow","year":"2024","journal-title":"Pragmat Obs Res"},{"key":"10.1016\/S2213-8587(25)00251-7_bib166","doi-asserted-by":"crossref","first-page":"E6301","DOI":"10.1073\/pnas.1515386112","article-title":"JAK inhibition alleviates the cellular senescence-associated secretory phenotype and frailty in old age","volume":"112","author":"Xu","year":"2015","journal-title":"Proc Natl Acad Sci USA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002517?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002517?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:11:16Z","timestamp":1774987876000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002517"}},"issued":{"date-parts":[[2025,11]]},"references-count":166,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2213858725002517"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00251-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucocorticoid-induced osteoporosis: novel concepts and clinical implications","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00251-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T04:07:16Z","timestamp":1649218036850},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/s2213-8587(16)30058-4","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T21:48:35Z","timestamp":1462312115000},"page":"484","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"4","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300584?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300584?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T09:56:09Z","timestamp":1536746169000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716300584"}},"issued":{"date-parts":[[2016,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S2213858716300584"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30058-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,6]]}},{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T03:12:18Z","timestamp":1649214738791},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/s2213-8587(17)30338-8","type":"journal-article","created":{"date-parts":[[2017,10,11]],"date-time":"2017-10-11T00:45:13Z","timestamp":1507682713000},"page":"16","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sugar: the prime suspect in poor health"],"prefix":"10.1016","volume":"6","author":[{"given":"Talha Khan","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T03:57:40Z","timestamp":1535342260000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303388"}},"issued":{"date-parts":[[2018,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2213858717303388"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30338-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sugar: the prime suspect in poor health","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30338-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"book-review","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,8,25]],"date-time":"2024-08-25T06:26:28Z","timestamp":1724567188269},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/s2213-8587(15)00092-3","type":"journal-article","created":{"date-parts":[[2015,5,29]],"date-time":"2015-05-29T06:49:12Z","timestamp":1432882152000},"page":"489-491","source":"Crossref","is-referenced-by-count":15,"title":["Humble kidneys predict mighty heart troubles"],"prefix":"10.1016","volume":"3","author":[{"given":"Alberto","family":"Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatriz","family":"Fernandez-Fernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl","key":"10.1016\/S2213-8587(15)00092-3_bib1","first-page":"1","article-title":"KDIGO 2012 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int"},{"issue":"suppl","key":"10.1016\/S2213-8587(15)00092-3_bib2","first-page":"259","article-title":"KDIGO clinical practice guideline for lipid management in chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(15)00092-3_bib3","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1056\/NEJMc1405680","article-title":"Application of the new cholesterol guidelines","volume":"371","author":"Gallegos-Villalobos","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00092-3_bib4","doi-asserted-by":"crossref","first-page":"1635","DOI":"10.1093\/eurheartj\/ehs092","volume":"33","author":"Perk","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(15)00092-3_bib5","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00092-3_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00040-6","article-title":"Estimated glomerular filtration rate and albuminuria for prediction of cardiovascular outcomes: a collaborative meta-analysis","author":"Matsushita","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00092-3_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.jacc.2008.10.036","article-title":"The sudden demise of dual renin-angiotensin system blockade or the soft science of the surrogate end point","volume":"53","author":"Messerli","year":"2009","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(15)00092-3_bib8","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1681\/ASN.2010101073","article-title":"The inflammatory cytokines TWEAK and TNF\u03b1 reduce renal klotho expression through NF\u03baB","volume":"22","author":"Moreno","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(15)00092-3_bib9","article-title":"Proteinuria increases plasma phosphate by altering its tubular handling","author":"de Seigneux","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(15)00092-3_bib10","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.cmet.2014.06.011","article-title":"A switch from white to brown fat increases energy expenditure in cancer-associated cachexia","volume":"20","author":"Petruzzelli","year":"2014","journal-title":"Cell Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000923?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000923?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T08:20:00Z","timestamp":1537604400000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000923"}},"issued":{"date-parts":[[2015,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2213858715000923"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00092-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,7]]}},{"indexed":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T01:02:25Z","timestamp":1722387745816},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/s2213-8587(14)70028-2","type":"journal-article","created":{"date-parts":[[2014,2,17]],"date-time":"2014-02-17T12:45:18Z","timestamp":1392641118000},"page":"354-356","source":"Crossref","is-referenced-by-count":3,"title":["Targeting non-alcoholic fatty liver disease through 11-\u03b2HSD1 inhibition"],"prefix":"10.1016","volume":"2","author":[{"given":"Vlad","family":"Ratziu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70028-2_bib1","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1053\/j.gastro.2012.02.003","article-title":"Role of obesity and lipotoxicity in the development of nonalcoholic steatohepatitis: pathophysiology and clinical implications","volume":"142","author":"Cusi","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(14)70028-2_bib2","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1056\/NEJMoa0907929","article-title":"Pioglitazone, vitamin E, or placebo for nonalcoholic steatohepatitis","volume":"362","author":"Sanyal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70028-2_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70170-0","article-title":"Inhibition of 11\u03b2-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double blind, placebo-controlled trial","author":"Stefan","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70028-2_bib4","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2012-1050","article-title":"11beta-hydroxysteroid dehydrogenase 1: translational and therapeutic aspects","volume":"34","author":"Gathercole","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(14)70028-2_bib5","doi-asserted-by":"crossref","first-page":"41293","DOI":"10.1074\/jbc.M103676200","article-title":"Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice","volume":"276","author":"Morton","year":"2001","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(14)70028-2_bib6","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1194\/jlr.M013748","article-title":"Effects of antisense-mediated inhibition of 11beta-hydroxysteroid dehydrogenase type 1 on hepatic lipid metabolism","volume":"52","author":"Li","year":"2011","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(14)70028-2_bib7","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/dc09-2315","article-title":"The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor INCB13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy","volume":"33","author":"Rosenstock","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70028-2_bib8","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1053\/j.gastro.2008.03.078","article-title":"Rosiglitazone for nonalcoholic steatohepatitis: one-year results of the randomized placebo-controlled Fatty Liver Improvement with Rosiglitazone Therapy (FLIRT) trial","volume":"135","author":"Ratziu","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(14)70028-2_bib9","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1365-2265.2008.03358.x","article-title":"Hepatic 11beta-HSD1 mRNA expression in fatty liver and nonalcoholic steatohepatitis","volume":"70","author":"Konopelska","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70028-2_bib10","doi-asserted-by":"crossref","first-page":"4924","DOI":"10.1210\/jc.2003-030596","article-title":"Body fat distribution and cortisol metabolism in healthy men: enhanced 5beta-reductase and lower cortisol\/cortisone metabolite ratios in men with fatty liver","volume":"88","author":"Westerbacka","year":"2003","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T15:57:12Z","timestamp":1538841432000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700282"}},"issued":{"date-parts":[[2014,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S2213858714700282"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70028-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,5]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T14:41:06Z","timestamp":1648996866952},"reference-count":4,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/s2213-8587(17)30145-6","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T21:00:25Z","timestamp":1495573225000},"page":"416-417","source":"Crossref","is-referenced-by-count":0,"title":["Bariatric surgery, glycaemic status, and microvascular complications \u2013 Authors' reply"],"prefix":"10.1016","volume":"5","author":[{"given":"Lena M S","family":"Carlsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kajsa","family":"Sj\u00f6holm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bj\u00f6rn","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Markku","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30145-6_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-8587(17)30061-X","article-title":"Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study","volume":"5","author":"Carlsson","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30145-6_bib2","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/2012.jama.11792","article-title":"Health care use during 20 years following bariatric surgery","volume":"308","author":"Neovius","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30145-6_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.mce.2015.05.033","article-title":"Neuroendocrine adaptations to bariatric surgery","volume":"418","author":"Dixon","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(17)30145-6_bib4","doi-asserted-by":"crossref","DOI":"10.1053\/j.gastro.2017.01.045","article-title":"Intensive lifestyle intervention for obesity: principles, practices, and results","author":"Webb","year":"2017","journal-title":"Gastroenterology"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T10:21:37Z","timestamp":1535797297000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301456"}},"issued":{"date-parts":[[2017,6]]},"references-count":4,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2213858717301456"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30145-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,6]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T10:58:09Z","timestamp":1648551489446},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/s2213-8587(18)30344-9","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T23:32:43Z","timestamp":1545175963000},"page":"e1","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2019; 7: 25\u201333"],"prefix":"10.1016","volume":"7","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303449?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303449?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T20:27:01Z","timestamp":1555532821000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303449"}},"issued":{"date-parts":[[2019,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2213858718303449"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30344-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,1]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T22:43:52Z","timestamp":1648593832032},"reference-count":3,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30236-4","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T23:45:21Z","timestamp":1477439121000},"page":"886-887","source":"Crossref","is-referenced-by-count":0,"title":["Adrenal vein sampling versus CT scanning in primary aldosteronism \u2013 Authors' reply"],"prefix":"10.1016","volume":"4","author":[{"given":"Gert-Jan","family":"van der Wilt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tanja","family":"Dekkers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacques W W","family":"Lenders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaap","family":"Deinum","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30236-4_bib1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30236-4_bib2","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1210\/jc.2011-2830","article-title":"The Adrenal Vein Sampling International Study (AVIS) for identifying the major subtypes of primary aldosteronism","volume":"97","author":"Rossi","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30236-4_bib3","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1136\/bmj.39500.677199.AE","article-title":"Grading quality of evidence and strength of recommendations for diagnostic tests and strategies","volume":"336","author":"Schunemann","year":"2008","journal-title":"BMJ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T07:54:06Z","timestamp":1536306846000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302364"}},"issued":{"date-parts":[[2016,11]]},"references-count":3,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2213858716302364"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30236-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T22:43:17Z","timestamp":1648680197714},"reference-count":5,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/s2213-8587(17)30172-9","type":"journal-article","created":{"date-parts":[[2017,6,21]],"date-time":"2017-06-21T15:03:13Z","timestamp":1498057393000},"page":"495","source":"Crossref","is-referenced-by-count":1,"title":["Sacubitril\/valsartan in PARADIGM-HF"],"prefix":"10.1016","volume":"5","author":[{"given":"Dayana","family":"Flores","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zaid","family":"Sabti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikola","family":"Kozhuharov","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christian","family":"Mueller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30172-9_bib1","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S2213-8587(17)30087-6","article-title":"Effect of sacubitril\/valsartan versus enalapril on glycaemic control in patients with heart failure and diabetes: a post-hoc analysis from the PARADIGM-HF trial","volume":"5","author":"Seferovic","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30172-9_bib2","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1161\/CIRCULATIONAHA.114.013748","article-title":"Angiotensin receptor neprilysin inhibition compared with enalapril on the risk of clinical progression in surviving patients with heart failure","volume":"131","author":"Packer","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30172-9_bib3","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1210\/jc.2004-1953","article-title":"Lipid mobilization with physiological atrial natriuretic peptide concentrations in humans","volume":"90","author":"Birkenfeld","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30172-9_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1080\/15438600303728","article-title":"Omapatrilat, an angiotensin-converting enzyme and neutral endopeptidase inhibitor, attenuates early atherosclerosis in diabetic and in nondiabetic low-density lipoprotein receptor-deficient mice","volume":"4","author":"Levy","year":"2003","journal-title":"Int J Exp Diabesity Res"},{"key":"10.1016\/S2213-8587(17)30172-9_bib5","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1016\/S0021-9150(00)00565-7","article-title":"Omapatrilat, a dual angiotensin-converting enzyme and neutral endopeptidase inhibitor, prevents fatty streak deposit in apolipoprotein E-deficient mice","volume":"155","author":"Arnal","year":"2001","journal-title":"Atherosclerosis"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T04:15:55Z","timestamp":1560831355000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301729"}},"issued":{"date-parts":[[2017,7]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2213858717301729"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30172-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,7]]}},{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T02:36:23Z","timestamp":1649212583575},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/s2213-8587(17)30108-0","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T01:01:02Z","timestamp":1492736462000},"page":"e3","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2017: 5: 125\u201333"],"prefix":"10.1016","volume":"5","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T08:39:14Z","timestamp":1548664754000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301080"}},"issued":{"date-parts":[[2017,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2213858717301080"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30108-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,5]]}},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T04:35:39Z","timestamp":1649133339918},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/s2213-8587(14)70037-3","type":"journal-article","created":{"date-parts":[[2014,4,11]],"date-time":"2014-04-11T20:15:22Z","timestamp":1397247322000},"page":"e12","source":"Crossref","is-referenced-by-count":0,"title":["Correction for Lancet Diabetes Endocrinol 2014; published online March 25"],"prefix":"10.1016","volume":"2","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T08:36:44Z","timestamp":1548664604000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700373"}},"issued":{"date-parts":[[2014,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S2213858714700373"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70037-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,5]]}},{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:47:08Z","timestamp":1762508828368,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/s2213-8587(22)00195-4","type":"journal-article","created":{"date-parts":[[2022,7,7]],"date-time":"2022-07-07T18:28:18Z","timestamp":1657218498000},"page":"549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["What's preventing us from curbing the obesity crisis?"],"prefix":"10.1016","volume":"10","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:49Z","timestamp":1761991849000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001954"}},"issued":{"date-parts":[[2022,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2213858722001954"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00195-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What's preventing us from curbing the obesity crisis?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00195-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T12:29:06Z","timestamp":1777552146385,"version":"3.51.4"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/s2213-8587(22)00108-5","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T18:35:23Z","timestamp":1650652523000},"page":"375-376","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["SURPASSing the current dogma: is our framework shifting?"],"prefix":"10.1016","volume":"10","author":[{"given":"Natasha P","family":"Malkani","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vanita R","family":"Aroda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00108-5_bib1","author":"Battelino","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00108-5_bib2","doi-asserted-by":"crossref","unstructured":"Ludvik B, Giorgino F, J\u00f3dar E, et al. Once-weekly tirzepatide versus once-daily insulin degludec as add-on to metformin with or without SGLT2 inhibitors in patients with type 2 diabetes (SURPASS-3): a randomised, open-label, parallel-group, phase 3 trial. Lancet; 398: 583\u201398.","DOI":"10.1016\/S0140-6736(21)01443-4"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(22)00108-5_bib3","first-page":"S83","article-title":"Glycemic targets: standards of medical care in diabetes\u20142022","volume":"45","author":"Draznin","year":"2022","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(22)00108-5_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/dom.13162","article-title":"A review of GLP-1 receptor agonists: evolution and advancement, through the lens of randomised controlled trials","volume":"20","author":"Aroda","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(22)00108-5_bib5","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1080\/17446651.2020.1830759","article-title":"Tirzepatide: a glucose-dependent insulinotropic polypeptide (GIP) and glucagon-like peptide-1 (GLP-1) dual agonist in development for the treatment of type 2 diabetes","volume":"15","author":"Fr\u00edas","year":"2020","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00108-5_bib6","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00108-5_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes\u2014state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(22)00108-5_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101090","article-title":"Glucagon-like peptide-1 receptor co-agonists for treating metabolic disease","volume":"46","author":"Baggio","year":"2021","journal-title":"Mol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:42Z","timestamp":1761991902000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001085"}},"issued":{"date-parts":[[2022,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2213858722001085"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00108-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SURPASSing the current dogma: is our framework shifting?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00108-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00077-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:41:28Z","timestamp":1761993688465,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30376-x","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T06:33:01Z","timestamp":1479450781000},"page":"S21","source":"Crossref","is-referenced-by-count":4,"special_numbering":"S1","title":["Tea consumption and risk of type 2 diabetes: a longitudinal study with data from the Chinese Health and Nutrition Survey"],"prefix":"10.1016","volume":"4","author":[{"given":"Paul H","family":"Lee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hairong","family":"Nan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630376X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630376X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T15:56:52Z","timestamp":1536249412000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871630376X"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"alternative-id":["S221385871630376X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30376-x","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:19:15Z","timestamp":1767151155932,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(21)00267-9","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/s2213-8587(21)00324-7","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T18:31:53Z","timestamp":1639506713000},"page":"e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2022; 10: 58\u201374"],"prefix":"10.1016","volume":"10","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003247?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003247?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:30Z","timestamp":1761991830000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721003247"}},"issued":{"date-parts":[[2022,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2213858721003247"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00324-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2022; 10: 58\u201374","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00324-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00267-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:18Z","timestamp":1761991818949,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/s2213-8587(18)30076-7","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T20:40:29Z","timestamp":1521578429000},"page":"272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Research digest: updates on diabetes in pregnancy"],"prefix":"10.1016","volume":"6","author":[{"given":"Naveed","family":"Sattar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Preiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300767?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300767?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:01Z","timestamp":1761991561000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300767"}},"issued":{"date-parts":[[2018,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2213858718300767"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30076-7","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research digest: updates on diabetes in pregnancy","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30076-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:17Z","timestamp":1761991937824,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271-TRR 205"],"award-info":[{"award-number":["314061271-TRR 205"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2012_A103","2015_A228"],"award-info":[{"award-number":["2012_A103","2015_A228"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/s2213-8587(20)30040-1","type":"journal-article","created":{"date-parts":[[2020,2,25]],"date-time":"2020-02-25T18:36:46Z","timestamp":1582655806000},"page":"258-259","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Metformin: the white knight fighting corticosteroid side-effects"],"prefix":"10.1016","volume":"8","author":[{"given":"Martin","family":"Reincke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30040-1_bib1","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/S2213-8587(20)30040-1_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/EJE-19-0305","article-title":"Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark","volume":"181","author":"Laugesen","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30040-1_bib3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1111\/all.13874","article-title":"Oral corticosteroid use, morbidity and mortality in asthma: a nationwide prospective cohort study in Sweden","volume":"74","author":"Ekstr\u00f6m","year":"2019","journal-title":"Allergy"},{"key":"10.1016\/S2213-8587(20)30040-1_bib4","article-title":"Time to diagnosis in Cushing's syndrome: a meta-analysis based on 5367 patients","author":"Rubinstein","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30040-1_bib5","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S2213-8587(19)30343-2","article-title":"Cushing's disease\u2014from Minnie G to key issues in the early 21st century","volume":"7","author":"Kelsall","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30040-1_bib6","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jconrel.2014.05.039","article-title":"Liposomal corticosteroids for the treatment of inflammatory disorders and cancer","volume":"190","author":"Ozbakir","year":"2014","journal-title":"J Control Release"},{"key":"10.1016\/S2213-8587(20)30040-1_bib7","doi-asserted-by":"crossref","first-page":"C23","DOI":"10.1530\/EJE-19-0555","article-title":"Three percent annually on systemic glucocorticoids: facts, worries and perspectives","volume":"181","author":"Meijer","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30040-1_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(20)30021-8","article-title":"The use of metformin to reduce metabolic complications and inflammation in patients on systemic glucocorticoid therapy: a randomised, double-blind, placebo-controlled, proof-of-concept, phase 2 trial","author":"Pernicova","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30040-1_bib9","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1038\/nrm.2017.95","article-title":"AMPK: guardian of metabolism and mitochondrial homeostasis","volume":"19","author":"Herzig","year":"2018","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/S2213-8587(20)30040-1_bib10","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.1096\/fj.07-094144","article-title":"AMP-activated protein kinase mediates glucocorticoid-induced metabolic changes: a novel mechanism in Cushing's syndrome","volume":"22","author":"Christ-Crain","year":"2008","journal-title":"FASEB J"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:27Z","timestamp":1761991707000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300401"}},"issued":{"date-parts":[[2020,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2213858720300401"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30040-1","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin: the white knight fighting corticosteroid side-effects","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30040-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30021-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:15Z","timestamp":1761991935457,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/s2213-8587(20)30306-5","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T18:37:03Z","timestamp":1600195023000},"page":"809-810","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Cortisol concentrations and mortality from COVID-19 \u2013 Authors' reply"],"prefix":"10.1016","volume":"8","author":[{"given":"Tricia","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Edouard G","family":"Mills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Phylactou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bijal","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei C","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Layla","family":"Thurston","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Muzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Karim","family":"Meeran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"A Toby","family":"Prevost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alexander N","family":"Comninos","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ali","family":"Abbara","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Waljit S","family":"Dhillo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30306-5_bib1","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/S2213-8587(20)30216-3","article-title":"Association between high serum total cortisol concentrations and mortality from COVID-19","volume":"8","author":"Tan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30306-5_bib2","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1210\/clinem\/dgz206","article-title":"Dynamic pituitary\u2013adrenal interactions in the critically ill after cardiac surgery","volume":"105","author":"Gibbison","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30306-5_bib3","doi-asserted-by":"crossref","first-page":"1751","DOI":"10.1007\/s00134-017-4919-5","article-title":"Guidelines for the diagnosis and management of critical illness-related corticosteroid insufficiency (CIRCI) in critically ill patients (part I): Society of Critical Care Medicine (SCCM) and European Society of Intensive Care Medicine (ESICM) 2017","volume":"43","author":"Annane","year":"2017","journal-title":"Intensive Care Med"},{"key":"10.1016\/S2213-8587(20)30306-5_bib4","article-title":"Dexamethasone in hospitalized patients with Covid-19\u2014preliminary report","author":"Horby","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30306-5_bib5","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/cen.13439","article-title":"Redefining the stress cortisol response to surgery","volume":"87","author":"Khoo","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30306-5_bib6","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1177\/0004563213514567","article-title":"The effect of serum matrix and gender on cortisol measurement by commonly used immunoassays","volume":"51","author":"Dodd","year":"2014","journal-title":"Ann Clin Biochem"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303065?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303065?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:23Z","timestamp":1761991703000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303065"}},"issued":{"date-parts":[[2020,10]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2213858720303065"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30306-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cortisol concentrations and mortality from COVID-19 \u2013 Authors' reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30306-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30305-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30304-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30216-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,6,11]],"date-time":"2025-06-11T23:32:14Z","timestamp":1749684734438},"reference-count":3,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/s2213-8587(18)30213-4","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T23:20:36Z","timestamp":1534893636000},"page":"686-687","source":"Crossref","is-referenced-by-count":3,"title":["Radioactive iodine ablation in low-risk thyroid cancer \u2013 Authors' reply"],"prefix":"10.1016","volume":"6","author":[{"given":"Sophie","family":"Leboulleux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Isabelle","family":"Borget","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schlumberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30213-4_bib1","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/S2213-8587(18)30113-X","article-title":"Outcome after ablation in patients with low-risk thyroid cancer (ESTIMABL1): 5-year follow-up results of a randomised, phase 3, equivalence trial","volume":"6","author":"Schlumberger","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30213-4_bib2","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1056\/NEJMoa1108586","article-title":"Strategies of radioiodine ablation in low-risk thyroid cancer patients","volume":"366","author":"Schlumberger","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30213-4_bib3","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1056\/NEJMoa1109589","article-title":"Ablation with low-dose radioiodine and thyrotropin alfa in thyroid cancer","volume":"366","author":"Mallick","year":"2012","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T23:20:38Z","timestamp":1534893638000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302134"}},"issued":{"date-parts":[[2018,9]]},"references-count":3,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2213858718302134"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30213-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,9]]}},{"indexed":{"date-parts":[[2026,2,5]],"date-time":"2026-02-05T12:57:59Z","timestamp":1770296279999,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/s2213-8587(24)00347-4","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T23:31:49Z","timestamp":1737761509000},"page":"166-167","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Protein-binding therapy: a new approach to lower cholesterol"],"prefix":"10.1016","volume":"13","author":[{"given":"Robert A","family":"Hegele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00347-4_bib1","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(21)02001-8","article-title":"Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study","volume":"399","author":"Tromp","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00347-4_bib2","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 Update on European Atherosclerosis Society consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(24)00347-4_bib3","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/ATVBAHA.123.320268","article-title":"Evolocumab treatment in pediatric patients with homozygous familial hypercholesterolemia: pooled data from three open-label studies","volume":"44","author":"Raal","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(24)00347-4_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1097\/MOL.0000000000000919","article-title":"PCSK9-directed therapies: an update","volume":"35","author":"Katzmann","year":"2024","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(24)00347-4_bib5","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1093\/eurheartj\/ehad596","article-title":"Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial","volume":"44","author":"Raal","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(24)00347-4_bib6","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1001\/jamacardio.2024.1659","article-title":"Efficacy and safety of lerodalcibep in patients with or at high risk of cardiovascular disease: a randomized clinical trial","volume":"9","author":"Klug","year":"2024","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(24)00347-4_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00313-9","article-title":"Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial","author":"Raal","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00347-4_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00233-X","article-title":"Lomitapide for the treatment of paediatric patients with homozygous familial hypercholesterolaemia: results from the efficacy phase of APH-19, a phase 3, open-label study","author":"Masana","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00347-4_bib9","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1161\/CIRCULATIONAHA.123.065529","article-title":"Evinacumab for pediatric patients with homozygous familial hypercholesterolemia","volume":"149","author":"Wiegman","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00347-4_bib10","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/eurheartj\/ehx317","article-title":"Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol","volume":"39","author":"Thompson","year":"2018","journal-title":"Eur Heart J"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003474?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003474?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T20:45:09Z","timestamp":1741466709000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003474"}},"issued":{"date-parts":[[2025,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213858724003474"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00347-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Protein-binding therapy: a new approach to lower cholesterol","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00347-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00313-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:08Z","timestamp":1761991988271,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/s2213-8587(21)00187-x","type":"journal-article","created":{"date-parts":[[2021,8,17]],"date-time":"2021-08-17T18:33:14Z","timestamp":1629225194000},"page":"638","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Black oesophagus in an adolescent with type 2 diabetes"],"prefix":"10.1016","volume":"9","author":[{"given":"Paolo","family":"Quitadamo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Flora","family":"Caruso","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristina","family":"Bucci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Casimiro","family":"Del Monaco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessandra","family":"Verde","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Angela","family":"Zanfardino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Caterina","family":"Strisciuglio","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alessia","family":"Piscopo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dario","family":"Iafusco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Augusto","family":"Mastrominico","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mariano","family":"Caldore","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872100187X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872100187X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:57Z","timestamp":1761991797000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872100187X"}},"issued":{"date-parts":[[2021,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S221385872100187X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00187-x","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Black oesophagus in an adolescent with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00187-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:10Z","timestamp":1761991870738,"version":"build-2065373602"},"reference-count":3,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016469","name":"Takeda Pharmaceuticals International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016469","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017012","name":"Roche Diabetes Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017012","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/s2213-8587(17)30440-0","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T10:05:10Z","timestamp":1517479510000},"page":"91-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Technology and chronic disease management \u2013 Authors' reply"],"prefix":"10.1016","volume":"6","author":[{"given":"Sudesna","family":"Chatterjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie J","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"Heller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jane","family":"Speight","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frank J","family":"Snoek","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30440-0_bib1","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/S2213-8587(17)30239-5","article-title":"Diabetes structured self-management education programmes: a narrative review and current innovations","volume":"6","author":"Chatterjee","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30440-0_bib2","doi-asserted-by":"crossref","first-page":"1015","DOI":"10.1177\/1932296817713506","article-title":"A systematic review of reviews evaluating technology-enabled diabetes self-management education and support","volume":"11","author":"Greenwood","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(17)30440-0_bib3","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/1745-6215-14-146","article-title":"Active ingredients are reported more often for pharmacologic than non-pharmacologic interventions: an illustrative review of reporting practices in titles and abstracts","volume":"14","author":"McCleary","year":"2013","journal-title":"Trials"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:15Z","timestamp":1761991575000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717304400"}},"issued":{"date-parts":[[2018,2]]},"references-count":3,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S2213858717304400"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30440-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Technology and chronic disease management \u2013 Authors' reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30440-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30441-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30239-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T09:20:54Z","timestamp":1648804854901},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/s2213-8587(15)00054-6","type":"journal-article","created":{"date-parts":[[2015,3,18]],"date-time":"2015-03-18T22:10:53Z","timestamp":1426716653000},"page":"e3","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2013; 1: 140\u201351"],"prefix":"10.1016","volume":"3","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T03:37:01Z","timestamp":1548646621000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000546"}},"issued":{"date-parts":[[2015,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S2213858715000546"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00054-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,4]]}},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:46:24Z","timestamp":1767149184109,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(21)00263-1","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000}}],"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100005614","name":"Biogen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005614","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004330","name":"GlaxoSmithKline","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004330","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/s2213-8587(21)00282-5","type":"journal-article","created":{"date-parts":[[2021,10,28]],"date-time":"2021-10-28T02:18:05Z","timestamp":1635387485000},"page":"803-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["RETRACTED: Targeting of vitamin D supplementation to individuals with deficiency"],"prefix":"10.1016","volume":"9","author":[{"given":"Guillaume","family":"Butler-Laporte","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Brent","family":"Richards","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00282-5_bib1","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.1001\/jama.2017.4392","article-title":"Trends in use of high-dose vitamin D supplements exceeding 1000 or 4000 International Units daily, 1999\u20132014","volume":"317","author":"Rooney","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00282-5_bib2","article-title":"Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomization analyses","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00282-5_bib3","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1056\/NEJMoa1809944","article-title":"Vitamin D supplements and prevention of cancer and cardiovascular disease","volume":"380","author":"Manson","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00282-5_bib4","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1001\/jama.2019.11889","article-title":"Effect of high-dose vitamin D supplementation on volumetric bone density and bone strength: a randomized clinical trial","volume":"322","author":"Burt","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00282-5_bib5","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1093\/ije\/dyz183","article-title":"Commentary: role of vitamin D in disease through the lens of Mendelian randomisation\u2014evidence from Mendelian randomization challenges the benefits of vitamin D supplementation for disease prevention","volume":"48","author":"Manousaki","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00282-5_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001866","article-title":"Vitamin D and risk of multiple sclerosis: a Mendelian randomization study","volume":"12","author":"Mokry","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(21)00282-5_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.nutres.2010.12.001","article-title":"Prevalence and correlates of vitamin D deficiency in US adults","volume":"31","author":"Forrest","year":"2011","journal-title":"Nutr Res"},{"key":"10.1016\/S2213-8587(21)00282-5_bib8","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00282-5_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002711","article-title":"Genetic determinants of lipids and cardiovascular disease outcomes","volume":"12","author":"Allara","year":"2019","journal-title":"Circ Genomic Precis Med"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(21)00263-1","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000}},{"DOI":"10.1016\/s2213-8587(23)00364-9","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002825?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002825?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:29Z","timestamp":1761991889000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002825"}},"issued":{"date-parts":[[2021,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2213858721002825"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00282-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RETRACTED: Targeting of vitamin D supplementation to individuals with deficiency","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00282-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00263-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T18:08:44Z","timestamp":1779905324734,"version":"3.53.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/s2213-8587(18)30144-x","type":"journal-article","created":{"date-parts":[[2018,5,24]],"date-time":"2018-05-24T00:16:30Z","timestamp":1527120990000},"page":"427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Transgender health: access to care under threat"],"prefix":"10.1016","volume":"6","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871830144X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871830144X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T13:32:36Z","timestamp":1574775156000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871830144X"}},"issued":{"date-parts":[[2018,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S221385871830144X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30144-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Transgender health: access to care under threat","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30144-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(16)00682-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(16)00683-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(16)00684-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30148-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:53:02Z","timestamp":1781585582724,"version":"3.54.5"},"reference-count":2,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/s2213-8587(16)30101-2","type":"journal-article","created":{"date-parts":[[2016,7,26]],"date-time":"2016-07-26T13:27:10Z","timestamp":1469539630000},"page":"812","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Type 1 diabetes: the need for culture-appropriate nutritional information for carbohydrate counting"],"prefix":"10.1016","volume":"4","author":[{"given":"Hamza","family":"Nasir","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumana","family":"Narasimhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30101-2_bib2","series-title":"The complete guide to carb counting","author":"Warshaw","year":"2011"},{"key":"10.1016\/S2213-8587(16)30101-2_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1111\/j.1747-0080.2008.01313.x","article-title":"Developing a food exchange list for Middle Eastern appetizers and desserts commonly consumed in Jordan","volume":"66","author":"Bawadi","year":"2009","journal-title":"Nutr Diet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:11:22Z","timestamp":1781583082000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301012"}},"issued":{"date-parts":[[2016,10]]},"references-count":2,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2213858716301012"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30101-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes: the need for culture-appropriate nutritional information for carbohydrate counting","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30101-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:44Z","timestamp":1761992204425,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/s2213-8587(23)00003-7","type":"journal-article","created":{"date-parts":[[2023,1,25]],"date-time":"2023-01-25T08:25:50Z","timestamp":1674635150000},"page":"81","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["May Ng: a lifetime commitment to children"],"prefix":"10.1016","volume":"11","author":[{"given":"Carl","family":"Power","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000037?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000037?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:14Z","timestamp":1761991934000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000037"}},"issued":{"date-parts":[[2023,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2213858723000037"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00003-7","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"May Ng: a lifetime commitment to children","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00003-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:19:31Z","timestamp":1767151171508,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(24)00150-5","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK121619"],"award-info":[{"award-number":["R01DK121619"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/s2213-8587(25)00051-8","type":"journal-article","created":{"date-parts":[[2025,2,21]],"date-time":"2025-02-21T18:39:46Z","timestamp":1740163186000},"page":"e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2024; 12: 523\u201334"],"prefix":"10.1016","volume":"13","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000518?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000518?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:01:54Z","timestamp":1762610514000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000518"}},"issued":{"date-parts":[[2025,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2213858725000518"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00051-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2024; 12: 523\u201334","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00051-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00150-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:19:13Z","timestamp":1767151153843,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(13)70212-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/s2213-8587(20)30316-8","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T18:37:17Z","timestamp":1600195037000},"page":"e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2014; 2: 307\u201320"],"prefix":"10.1016","volume":"8","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:21Z","timestamp":1761991701000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303168"}},"issued":{"date-parts":[[2020,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2213858720303168"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30316-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2014; 2: 307\u201320","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30316-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70212-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:45Z","timestamp":1761991965143,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/s2213-8587(21)00076-0","type":"journal-article","created":{"date-parts":[[2021,4,16]],"date-time":"2021-04-16T09:19:45Z","timestamp":1618564785000},"page":"323-325","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The knowns and unknowns of teprotumumab for thyroid eye disease"],"prefix":"10.1016","volume":"9","author":[{"given":"Tomasz","family":"Bednarczuk","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon H","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00076-0_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1159\/000443828","article-title":"The 2016 European Thyroid Association\/European Group on Graves' Orbitopathy guidelines for the management of Graves' orbitopathy","volume":"5","author":"Bartalena","year":"2016","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(21)00076-0_bib2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.3109\/08916939309014643","article-title":"Autoantibodies to IGF-1 binding sites in thyroid associated ophthalmopathy","volume":"16","author":"Weightman","year":"1993","journal-title":"Autoimmunity"},{"key":"10.1016\/S2213-8587(21)00076-0_bib3","doi-asserted-by":"crossref","first-page":"1748","DOI":"10.1056\/NEJMoa1614949","article-title":"Teprotumumab for thyroid-associated ophthalmopathy","volume":"376","author":"Smith","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00076-0_bib4","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00076-0_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00056-5","article-title":"Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials","author":"Kahaly","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00076-0_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/01676830.2021.1886311","article-title":"Teprotumumab and hearing loss: hear the warnings","author":"Chern","year":"2021","journal-title":"Orbit"},{"key":"10.1016\/S2213-8587(21)00076-0_bib7","doi-asserted-by":"crossref","first-page":"4541","DOI":"10.1200\/JCO.2010.34.0000","article-title":"R1507, a monoclonal antibody to the insulin-like growth factor 1 receptor, in patients with recurrent or refractory Ewing sarcoma family of tumors: results of a phase II Sarcoma Alliance for Research through Collaboration study","volume":"29","author":"Pappo","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(21)00076-0_bib8","article-title":"Early experience with teprotumumab for chronic thyroid eye disease","volume":"19","author":"Ozzello","year":"2020","journal-title":"Am J Ophthalmol Case Rep"},{"key":"10.1016\/S2213-8587(21)00076-0_bib9","article-title":"Teprotumumab for dysthyroid optic neuropathy: early response to therapy","author":"Sears","year":"2020","journal-title":"Ophthalmic Plast Reconstr Surg"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00076-0_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000510700","article-title":"Proposal for standardization of primary and secondary outcomes in patients with active, moderate-to-severe Graves' orbitopathy","volume":"9","author":"Bartalena","year":"2020","journal-title":"Eur Thyroid J"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000760?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000760?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:08Z","timestamp":1761991748000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000760"}},"issued":{"date-parts":[[2021,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213858721000760"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00076-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The knowns and unknowns of teprotumumab for thyroid eye disease","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00076-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00056-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:28Z","timestamp":1761992008635,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/s2213-8587(21)00215-1","type":"journal-article","created":{"date-parts":[[2021,8,6]],"date-time":"2021-08-06T05:54:25Z","timestamp":1628229265000},"page":"732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Sherita Hill Golden: tackling the source of health disparities"],"prefix":"10.1016","volume":"9","author":[{"given":"Ray","family":"Cavanaugh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002151?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002151?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:48Z","timestamp":1761991848000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002151"}},"issued":{"date-parts":[[2021,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2213858721002151"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00215-1","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sherita Hill Golden: tackling the source of health disparities","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00215-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,4]],"date-time":"2026-01-04T04:09:42Z","timestamp":1767499782530,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/s2213-8587(20)30226-6","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T18:35:59Z","timestamp":1595356559000},"page":"666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Management of diabetes in patients with COVID-19"],"prefix":"10.1016","volume":"8","author":[{"given":"Jagat J","family":"Mukherjee","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kalyan K","family":"Gangopadhyay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Subir","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30226-6_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30226-6_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-022768","article-title":"Changing use of antidiabetic drugs in the UK: trends in prescribing 2000\u20132017","volume":"8","author":"Wilkinson","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(20)30226-6_bib3","article-title":"Pioglitazone upregulates angiotensin converting enzyme 2 expression in insulin-sensitive tissues in rats with high-fat diet-induced nonalcoholic steatohepatitis","volume":"2014","author":"Zhang","year":"2014","journal-title":"ScientificWorldJournal"},{"key":"10.1016\/S2213-8587(20)30226-6_bib4","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/j.apsb.2020.02.008","article-title":"Analysis of therapeutic targets for SARS-CoV-2 and discovery of potential drugs by computational methods","volume":"10","author":"Wu","year":"2020","journal-title":"Acta Pharm Sini B"},{"key":"10.1016\/S2213-8587(20)30226-6_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3319","article-title":"Diabetes is a risk factor for the progression and prognosis of COVID-19","author":"Guo","year":"2020","journal-title":"Diabetes Metab Res Rev"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:20Z","timestamp":1761991700000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720302266"}},"issued":{"date-parts":[[2020,8]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2213858720302266"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30226-6","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of diabetes in patients with COVID-19","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30226-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30223-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30227-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30152-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30234-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30235-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30231-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T22:23:49Z","timestamp":1775168629094,"version":"3.50.1"},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30383-7","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T01:33:07Z","timestamp":1479432787000},"page":"S28","source":"Crossref","is-referenced-by-count":2,"special_numbering":"S1","title":["Adherence to a healthy lifestyle and the risk of type 2 diabetes in Chinese adults: a prospective, longitudinal cohort study"],"prefix":"10.1016","volume":"4","author":[{"given":"Jun","family":"Lv","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Canqing","family":"Yu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yu","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zheng","family":"Bian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yiping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Junshi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhengming","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lu","family":"Qi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Liming","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303837?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303837?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T11:56:50Z","timestamp":1536235010000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303837"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"alternative-id":["S2213858716303837"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30383-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2026,5,13]],"date-time":"2026-05-13T07:29:04Z","timestamp":1778657344484,"version":"3.51.4"},"reference-count":9,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"name":"Australian National Health and Medical Research Council","award":["1078477"],"award-info":[{"award-number":["1078477"]}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["107833"],"award-info":[{"award-number":["107833"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["1092968"],"award-info":[{"award-number":["1092968"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100000925","name":"NHMRC","doi-asserted-by":"crossref","award":["1156726"],"award-info":[{"award-number":["1156726"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/s2213-8587(20)30188-1","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T18:51:27Z","timestamp":1592333487000},"page":"559-560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Walking the path together: incorporating Indigenous knowledge in diabetes research"],"prefix":"10.1016","volume":"8","author":[{"given":"Louise J","family":"Maple-Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sian","family":"Graham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jackie","family":"McKee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brandy","family":"Wicklow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30188-1_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(09)60914-4","article-title":"Indigenous health part 1: determinants and disease patterns","volume":"374","author":"Gracey","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30188-1_bib2","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.diabres.2011.06.012","article-title":"Diabetes prevalence and determinants in Indigenous Australian populations: a systematic review","volume":"93","author":"Minges","year":"2011","journal-title":"Diabetes Res Clin Prac"},{"key":"10.1016\/S2213-8587(20)30188-1_bib3","doi-asserted-by":"crossref","first-page":"e128","DOI":"10.1503\/cmaj.190836","article-title":"Diabetes prevalence, incidence and mortality in First Nations and other people in Ontario, 1995\u20132014: a population-based study using linked administrative data","volume":"192","author":"Walker","year":"2020","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(20)30188-1_bib4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamapediatrics.2018.1201","article-title":"Association of Gestational Diabetes and type 2 diabetes exposure in utero with the development of type 2 diabetes in First Nations and non-First Nations offspring","volume":"172","author":"Wicklow","year":"2018","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(20)30188-1_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.5694\/mja2.13002","article-title":"Emerging diabetes and metabolic conditions among Aboriginal and Torres Strait Islander young people","volume":"210","author":"Titmuss","year":"2019","journal-title":"Med J Aust"},{"key":"10.1016\/S2213-8587(20)30188-1_bib6","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s12519-019-00247-1","article-title":"Progress in understanding youth-onset type 2 diabetes in the United States: recent lessons from clinical trials","volume":"15","author":"Zeitler","year":"2019","journal-title":"World J Pediatr"},{"key":"10.1016\/S2213-8587(20)30188-1_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)32461-3","article-title":"Type 2 diabetes in youth is a disease of poverty","volume":"390","author":"McGavock","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30188-1_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1139\/h11-128","article-title":"A socioecological framework to understand weight-related issues in Aboriginal children in Canada","volume":"37","author":"Willows","year":"2012","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/S2213-8587(20)30188-1_bib9","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1186\/s12913-017-2478-7","article-title":"Health service changes to address diabetes in pregnancy in a complex setting: perspectives of health professionals","volume":"17","author":"Kirkham","year":"2017","journal-title":"BMC Health Serv Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301881?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301881?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:53Z","timestamp":1761991673000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301881"}},"issued":{"date-parts":[[2020,7]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2213858720301881"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30188-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Walking the path together: incorporating Indigenous knowledge in diabetes research","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30188-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:53:06Z","timestamp":1781585586273,"version":"3.54.5"},"reference-count":9,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T00:00:00Z","timestamp":1469577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/s2213-8587(16)30192-9","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T20:10:40Z","timestamp":1469823040000},"page":"801-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Knowing what we do not know: statin therapy in advanced chronic kidney disease"],"prefix":"10.1016","volume":"4","author":[{"given":"Muh Geot","family":"Wong","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30192-9_bib1","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1093\/eurheartj\/ehu107","article-title":"The ACC\/AHA 2013 guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular disease risk in adults: the good the bad and the uncertain\u2014a comparison with ESC\/EAS guidelines for the management of dyslipidaemias 2011","volume":"35","author":"Ray","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30192-9_bib2","first-page":"259","article-title":"Clinical practice guideline for lipid management in chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(16)30192-9_bib3","article-title":"HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis","volume":"5","author":"Palmer","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(16)30192-9_bib4","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/eht065","article-title":"Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"34","author":"Hou","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30192-9_bib5","article-title":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30192-9_bib6","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30192-9_bib7","doi-asserted-by":"crossref","first-page":"40","DOI":"10.7326\/M14-2957","article-title":"Effects of proprotein convertase subtilisin\/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis","volume":"163","author":"Navarese","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)30192-9_bib8","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S2213-8587(14)70246-3","article-title":"Renal effects of atorvastatin and rosuvastatin in patients with diabetes who have progressive renal disease (PLANET I): a randomised clinical trial","volume":"3","author":"de Zeeuw","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30192-9_bib9","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.2215\/CJN.04371206","article-title":"Effect of intensive lipid lowering with atorvastatin on renal function in patients with coronary heart disease: the Treating to New Targets (TNT) study","volume":"2","author":"Shepherd","year":"2007","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301929?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301929?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:12:53Z","timestamp":1781583173000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301929"}},"issued":{"date-parts":[[2016,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2213858716301929"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30192-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Knowing what we do not know: statin therapy in advanced chronic kidney disease","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30192-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30156-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,23]],"date-time":"2026-06-23T13:59:07Z","timestamp":1782223147398,"version":"3.54.5"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/s2213-8587(15)00514-8","type":"journal-article","created":{"date-parts":[[2016,1,20]],"date-time":"2016-01-20T00:30:22Z","timestamp":1453249822000},"page":"200-202","source":"Crossref","is-referenced-by-count":9,"title":["Innovation in capacity building of primary-care physicians in diabetes management in India: a new slant in medical education"],"prefix":"10.1016","volume":"4","author":[{"given":"Sandeep","family":"Bhalla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ranjit","family":"Unnikrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rahul","family":"Srivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorairaj","family":"Prabhakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00514-8_bib1","series-title":"IDF Diabetes Atlas","year":"2015"},{"key":"10.1016\/S2213-8587(15)00514-8_bib2","first-page":"632","article-title":"Doctor population ratio for India\u2014the reality","volume":"137","author":"Deo","year":"2013","journal-title":"Indian J Med Res"},{"key":"10.1016\/S2213-8587(15)00514-8_bib3","author":"Ghosh"},{"key":"10.1016\/S2213-8587(15)00514-8_bib4","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.socscimed.2013.02.018","article-title":"Which doctor for primary health care? Quality of care and non-physician clinicians in India","volume":"84","author":"Rao","year":"2013","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(15)00514-8_bib5","series-title":"Quality and accountability in healthcare delivery: audit evidence from primary care providers in India","author":"Das","year":"2015"},{"key":"10.1016\/S2213-8587(15)00514-8_bib6","series-title":"Evidence scan: quality improvement training for healthcare professionals","year":"2012"},{"key":"10.1016\/S2213-8587(15)00514-8_bib7","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.diabres.2008.11.005","article-title":"Immediate impact of a diabetes training programme for primary care physicians\u2014an endeavor for national capacity building for diabetes management in India","volume":"83","author":"Murugesan","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00514-8_bib8","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1002\/pdi.1953","article-title":"Improving the effectiveness of short-term courses for multidisciplinary health care professionals","volume":"32","author":"Kapur","year":"2015","journal-title":"Practical Diabetes"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(15)00514-8_bib9","first-page":"A93","article-title":"An Innovative approach to continuing professional diabetes education evaluation of a problem-based program implemented in diabetes care in India","volume":"46","author":"Kelkar","year":"2003","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715005148?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715005148?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T03:25:20Z","timestamp":1537068320000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715005148"}},"issued":{"date-parts":[[2016,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S2213858715005148"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00514-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,3]]}},{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T18:17:13Z","timestamp":1769105833376,"version":"3.49.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000769","name":"Oxford University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/s2213-8587(18)30212-2","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T20:13:12Z","timestamp":1532463192000},"page":"603","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Research digest: heart failure in diabetes comes into focus"],"prefix":"10.1016","volume":"6","author":[{"given":"Naveed","family":"Sattar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Preiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:50Z","timestamp":1761991550000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302122"}},"issued":{"date-parts":[[2018,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S2213858718302122"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30212-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research digest: heart failure in diabetes comes into focus","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30212-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:12Z","timestamp":1761991752042,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/s2213-8587(16)30118-8","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T12:49:01Z","timestamp":1468068541000},"page":"727-729","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Why sex?"],"prefix":"10.1016","volume":"4","author":[{"given":"Jennifer A Marshall","family":"Graves","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30118-8_bib1","doi-asserted-by":"crossref","first-page":"8867","DOI":"10.1073\/pnas.1501820112","article-title":"Evolutionary perspectives on clonal reproduction in vertebrate animals","volume":"112","author":"Avise","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(16)30118-8_bib2","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1126\/science.201.4361.1155","article-title":"Parthenogenetic lizards","volume":"201","author":"Cuellar","year":"1978","journal-title":"Science"},{"key":"10.1016\/S2213-8587(16)30118-8_bib3","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1420-9101.2011.02438.x","article-title":"Physiological implications of genomic state in parthenogenetic lizards of reciprocal hybrid origin","volume":"25","author":"Roberts","year":"2012","journal-title":"J Evol Biol"},{"key":"10.1016\/S2213-8587(16)30118-8_bib4","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a002592","article-title":"Mammalian genomic imprinting","author":"Bartolomei","year":"2011","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/S2213-8587(16)30118-8_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev-genom-082908-150026","article-title":"Evolution of Genomic Imprinting: insights from marsupials and monotremes","volume":"10","author":"Renfree","year":"2009","journal-title":"Ann Rev Genomics Human Genet"},{"key":"10.1016\/S2213-8587(16)30118-8_bib6","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1038\/ng0306-271","article-title":"An earlier formulation of the genetic conflict hypothesis of genomic imprinting","volume":"38","author":"Haig","year":"2006","journal-title":"Nat Genet"},{"year":"1978","author":"Maynard Smith","series-title":"The evolution of sex","key":"10.1016\/S2213-8587(16)30118-8_bib7"},{"key":"10.1016\/S2213-8587(16)30118-8_bib8","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1002\/dvg.1020150303","article-title":"Advantages of sexual reproduction","volume":"15","author":"Crow","year":"1994","journal-title":"Dev Genet"},{"year":"1971","author":"Kimura","series-title":"Theoretical aspects of population genetics","key":"10.1016\/S2213-8587(16)30118-8_bib10"},{"key":"10.1016\/S2213-8587(16)30118-8_bib11","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1111\/j.1420-9101.2004.00866.x","article-title":"Lower fecundity in parthenogenetic geckos than sexual relatives in the Australian arid zone","volume":"18","author":"Kearney","year":"2005","journal-title":"J Evol Biol"},{"key":"10.1016\/S2213-8587(16)30118-8_bib12","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1126\/science.2983425","article-title":"Genetic basis for species vulnerability in the cheetah","volume":"227","author":"O'Brien","year":"1985","journal-title":"Science"},{"key":"10.1016\/S2213-8587(16)30118-8_bib13","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1146\/annurev-animal-022513-114204","article-title":"Pathogenesis and molecular biology of a transmissible tumor in the Tasmanian devil","volume":"2","author":"Bender","year":"2014","journal-title":"Annu Rev Anim Biosci"},{"key":"10.1016\/S2213-8587(16)30118-8_bib14","doi-asserted-by":"crossref","first-page":"R233","DOI":"10.1016\/j.cub.2016.01.034","article-title":"The end of an ancient asexual scandal","volume":"26","author":"Schwander","year":"2016","journal-title":"Curr Biol"},{"key":"10.1016\/S2213-8587(16)30118-8_bib9","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1017\/S0016672300026392","article-title":"Deleterious mutations as an evolutionary factor. 1. The advantage of recombination","volume":"44","author":"Kondrashov","year":"1984","journal-title":"Genet Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:48Z","timestamp":1761991548000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301188"}},"issued":{"date-parts":[[2016,9]]},"references-count":14,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2213858716301188"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30118-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Why sex?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30118-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,2]],"date-time":"2026-05-02T14:22:34Z","timestamp":1777731754598,"version":"3.51.4"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/s2213-8587(21)00052-8","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T19:40:54Z","timestamp":1616528454000},"page":"255","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exposure to endocrine-disrupting chemicals in utero and thyroid cancer risk in offspring"],"prefix":"10.1016","volume":"9","author":[{"given":"Ankan Mukherjee","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhudev C","family":"Das","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00052-8_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2213-8587(20)30399-5","article-title":"Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study","volume":"9","author":"Kitahara","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00052-8_bib2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S2213-8587(20)30129-7","article-title":"Endocrine-disrupting chemicals: implications for human health","volume":"8","author":"Kahn","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00052-8_bib3","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1089\/105072503770867192","article-title":"Polychlorinated biphenyls and thyroid status in humans: a review","volume":"13","author":"Hagmar","year":"2003","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00052-8_bib4","doi-asserted-by":"crossref","first-page":"281","DOI":"10.3121\/cmr.1.4.281","article-title":"Polybrominated diphenyl ethers (PBDEs): new pollutants-old diseases","volume":"1","author":"Siddiqi","year":"2003","journal-title":"Clin Med Res"},{"key":"10.1016\/S2213-8587(21)00052-8_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijms18122583","article-title":"Thyroid disrupting chemicals","volume":"18","author":"Calsolaro","year":"2017","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(21)00052-8_bib6","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/j.envint.2010.12.005","article-title":"Effects of pre and postnatal exposure to low levels of polybromodiphenyl ethers on neurodevelopment and thyroid hormone levels at 4 years of age","volume":"37","author":"Gascon","year":"2011","journal-title":"Environ Int"},{"key":"10.1016\/S2213-8587(21)00052-8_bib7","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1210\/jc.2014-4324","article-title":"Estimating burden and disease costs of exposure to endocrine-disrupting chemicals in the European union","volume":"100","author":"Trasande","year":"2015","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000528?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000528?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:27Z","timestamp":1761991767000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000528"}},"issued":{"date-parts":[[2021,5]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2213858721000528"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00052-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure to endocrine-disrupting chemicals in utero and thyroid cancer risk in offspring","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00052-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30399-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00073-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,5]],"date-time":"2026-05-05T01:02:36Z","timestamp":1777942956362,"version":"3.51.4"},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/s2213-8587(17)30107-9","type":"journal-article","created":{"date-parts":[[2017,4,20]],"date-time":"2017-04-20T21:00:52Z","timestamp":1492722052000},"page":"e3","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2017; 5: 240\u201341"],"prefix":"10.1016","volume":"5","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T03:38:55Z","timestamp":1548646735000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301079"}},"issued":{"date-parts":[[2017,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2213858717301079"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30107-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,5]]}},{"indexed":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:20:35Z","timestamp":1771629635682,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/s2213-8587(18)30133-5","type":"journal-article","created":{"date-parts":[[2018,5,4]],"date-time":"2018-05-04T18:34:02Z","timestamp":1525458842000},"page":"591-593","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["New hope for glucokinase activators in type 2 diabetes?"],"prefix":"10.1016","volume":"6","author":[{"given":"Andr\u00e9 J","family":"Scheen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30133-5_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1517\/13543784.2016.1152260","article-title":"Investigational insulin secretagogues for type 2 diabetes","volume":"25","author":"Scheen","year":"2016","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/S2213-8587(18)30133-5_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/978-3-642-17214-4_15","article-title":"Research and development of glucokinase activators for diabetes therapy: theoretical and practical aspects","volume":"203","author":"Matschinsky","year":"2011","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/S2213-8587(18)30133-5_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.2174\/1389557514666140722082713","article-title":"Recent updates on glucokinase activators for the treatment of type 2 diabetes mellitus","volume":"14","author":"Grewal","year":"2014","journal-title":"Mini Rev Med Chem"},{"key":"10.1016\/S2213-8587(18)30133-5_bib4","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1016\/j.bmcl.2016.10.085","article-title":"Novel, highly potent systemic glucokinase activators for the treatment of type 2 diabetes mellitus","volume":"27","author":"Xu","year":"2017","journal-title":"Bioorg Med Chem Lett"},{"key":"10.1016\/S2213-8587(18)30133-5_bib5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.2337\/dc11-1200","article-title":"Effects of MK-0941, a novel glucokinase activator, on glycemic control in insulin-treated patients with type 2 diabetes","volume":"34","author":"Meininger","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30133-5_bib6","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/dom.12100","article-title":"Dose-ranging study with the glucokinase activator AZD1656 as monotherapy in Japanese patients with type 2 diabetes mellitus","volume":"15","author":"Kiyosue","year":"2013","journal-title":"Diabetes Obesity Metab"},{"key":"10.1016\/S2213-8587(18)30133-5_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30105-0","article-title":"Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study","author":"Zhu","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30133-5_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1111\/dom.12474","article-title":"Two dose-ranging studies with PF-04937319, a systemic partial activator of glucokinase, as add-on therapy to metformin in adults with type 2 diabetes","volume":"17","author":"Amin","year":"2015","journal-title":"Diabetes Obesity Metab"},{"key":"10.1016\/S2213-8587(18)30133-5_bib9","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/dom.12586","article-title":"AMG 151 (ARRY-403), a novel glucokinase activator, decreases fasting and postprandial glycaemia in patients with type 2 diabetes","volume":"18","author":"Katz","year":"2016","journal-title":"Diabetes Obesity Metab"},{"key":"10.1016\/S2213-8587(18)30133-5_bib10","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1002\/cpdd.261","article-title":"Glycemic effect and safety of a systemic, partial glucokinase activator, PF-04937319, in patients with type 2 diabetes mellitus inadequately controlled on metformin\u2014a randomized, crossover, active-controlled study","volume":"5","author":"Denney","year":"2016","journal-title":"Clin Pharmacol Drug Dev"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:04:35Z","timestamp":1534809875000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301335"}},"issued":{"date-parts":[[2018,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S2213858718301335"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30133-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New hope for glucokinase activators in type 2 diabetes?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30133-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30105-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:08:53Z","timestamp":1780664933838,"version":"3.54.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/s2213-8587(26)00008-2","type":"journal-article","created":{"date-parts":[[2026,2,17]],"date-time":"2026-02-17T23:47:20Z","timestamp":1771372040000},"page":"194-196","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prioritising nutrition alongside paediatric obesity management medications"],"prefix":"10.1016","volume":"14","author":[{"given":"Cara F","family":"Ruggiero","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Spreckley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikki","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrian","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00008-2_bib2","author":"Refsum"},{"key":"10.1016\/S2213-8587(26)00008-2_bib3","doi-asserted-by":"crossref","first-page":"2245","DOI":"10.1056\/NEJMoa2208601","article-title":"Once-weekly semaglutide in adolescents with obesity","volume":"387","author":"Weghuber","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00008-2_bib4","doi-asserted-by":"crossref","first-page":"3141","DOI":"10.1038\/s41591-025-03774-9","article-title":"Tirzepatide on ingestive behavior in adults with overweight or obesity: a randomized 6-week phase 1 trial","volume":"31","author":"Martin","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00008-2_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00008-2_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1210\/clinem\/dgaa836","article-title":"Bone metabolism in adolescents undergoing bariatric surgery","volume":"106","author":"Misra","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00008-2_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3109\/09513599209081006","article-title":"Weight loss and menstrual cycle: clinical and endocrinological evaluation","volume":"6","author":"Falsetti","year":"1992","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/S2213-8587(26)00008-2_bib8","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-1649","article-title":"Preventing obesity and eating disorders in adolescents","volume":"138","author":"Golden","year":"2016","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(26)00008-2_bib9","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/oby.24336","article-title":"Nutritional priorities to support GLP-1 therapy for obesity: a joint Advisory from the American College of Lifestyle Medicine, the American Society for Nutrition, the Obesity Medicine Association, and The Obesity Society","volume":"33","author":"Mozaffarian","year":"2025","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(26)00008-2_bib10","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2024-067858","article-title":"Pediatric obesity pharmacotherapy: state of the science, research gaps, and opportunities","volume":"154","author":"Armstrong","year":"2024","journal-title":"Pediatrics"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:30:24Z","timestamp":1780662624000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000082"}},"issued":{"date-parts":[[2026,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2213858726000082"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00008-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prioritising nutrition alongside paediatric obesity management medications","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00008-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T19:57:39Z","timestamp":1792612659557,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/s2213-8587(18)30027-5","type":"journal-article","created":{"date-parts":[[2018,2,27]],"date-time":"2018-02-27T18:36:37Z","timestamp":1519756597000},"page":"392-403","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"title":["Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988\u20132014"],"prefix":"10.1016","volume":"6","author":[{"given":"Mohammed K","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kai McKeever","family":"Bullard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Saydah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"Imperatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30027-5_bib1","doi-asserted-by":"crossref","first-page":"g4485","DOI":"10.1136\/bmj.g4485","article-title":"The epidemic of pre-diabetes: the medicine and the politics","volume":"349","author":"Yudkin","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30027-5_bib2","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/j.diabres.2007.05.004","article-title":"Annual incidence and relative risk of diabetes in people with various categories of dysglycemia: a systematic overview and meta-analysis of prospective studies","volume":"78","author":"Gerstein","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30027-5_bib3","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00125-013-2902-4","article-title":"Progression rates from HbA1c 6.0\u20136.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis","volume":"56","author":"Morris","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30027-5_bib4","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30027-5_bib5","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30027-5_bib6","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.2014.1873","article-title":"Glycated hemoglobin measurement and prediction of cardiovascular disease","volume":"311","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30027-5_bib7","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30027-5_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18\u2008686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30027-5_bib9","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/archinte.165.12.1410","article-title":"Effects of different blood pressure-lowering regimens on major cardiovascular events in individuals with and without diabetes mellitus: results of prospectively designed overviews of randomized trials","volume":"165","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(18)30027-5_bib10","doi-asserted-by":"crossref","first-page":"565","DOI":"10.7326\/0003-4819-136-8-200204160-00005","article-title":"A diabetes report card for the United States: quality of care in the 1990s","volume":"136","author":"Saaddine","year":"2002","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(18)30027-5_bib11","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMsa1213829","article-title":"Achievement of goals in US diabetes care, 1999\u20132010","volume":"368","author":"Ali","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30027-5_bib14","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1097\/EDE.0b013e31829ef01a","article-title":"The prevalence of type 1 diabetes in the United States","volume":"4","author":"Menke","year":"2013","journal-title":"Epidemiol"},{"key":"10.1016\/S2213-8587(18)30027-5_bib16","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1161\/01.HYP.0000107251.49515.c2","article-title":"Seventh Report of the Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure","volume":"42","author":"Chobanian","year":"2003","journal-title":"Hypertension"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30027-5_bib17","first-page":"S60","article-title":"(8) Cardiovascular disease and risk management","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30027-5_bib18","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1161\/CIRCULATIONAHA.107.699579","article-title":"General cardiovascular risk profile for use in primary care: the Framingham Heart Study","volume":"117","author":"D'Agostino","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30027-5_bib19","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs1010671","article-title":"The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56)","volume":"101","author":"Stevens","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/S2213-8587(18)30027-5_bib20","doi-asserted-by":"crossref","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk. A report of the American College of Cardiology\/American Heart Association task force on practice guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(18)30027-5_bib21","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(18)30027-5_bib22","doi-asserted-by":"crossref","first-page":"382","DOI":"10.2215\/CJN.03080314","article-title":"A systematic review of glomerular hyperfiltration assessment and definition in the medical literature","volume":"10","author":"Cachat","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(18)30027-5_bib23","doi-asserted-by":"crossref","first-page":"i5953","DOI":"10.1136\/bmj.i5953","article-title":"Association between prediabetes and risk of cardiovascular disease and all cause mortality: systematic review and meta-analysis","volume":"355","author":"Huang","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30027-5_bib24","doi-asserted-by":"crossref","first-page":"673","DOI":"10.2215\/CJN.07891109","article-title":"Prevalence of chronic kidney disease in US adults with undiagnosed diabetes or prediabetes","volume":"5","author":"Plantinga","year":"2010","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(18)30027-5_bib25","doi-asserted-by":"crossref","first-page":"3172","DOI":"10.2337\/dc14-1036","article-title":"The economic burden of elevated blood glucose levels in 2012: diagnosed and undiagnosed diabetes, gestational diabetes mellitus, and prediabetes","volume":"37","author":"Dall","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30027-5_bib26","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30027-5_bib27","doi-asserted-by":"crossref","first-page":"g280","DOI":"10.1136\/bmj.g280","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"348","author":"Ebrahim","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30027-5_bib29","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30027-5_bib30","first-page":"209","article-title":"Awareness of prediabetes\u2013United States, 2005\u20132010","volume":"62","author":"Li","year":"2013","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/S2213-8587(18)30027-5_bib31","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30027-5_bib32","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/S2213-8587(14)70057-9","article-title":"Cardiovascular mortality, all-cause mortality, and diabetes incidence after lifestyle intervention for people with impaired glucose tolerance in the Da Qing Diabetes Prevention Study: a 23-year follow-up study","volume":"2","author":"Li","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30027-5_bib33","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2337\/dc09-0523","article-title":"Regression from pre-diabetes to normal glucose regulation in the diabetes prevention program","volume":"32","author":"Perreault","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30027-5_bib34","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1464-5491.2012.03750.x","article-title":"Long-term effects of the Diabetes Prevention Program interventions on cardiovascular risk factors: a report from the DPP Outcomes Study","volume":"30","author":"Orchard","year":"2013","journal-title":"Diabetic Med"},{"key":"10.1016\/S2213-8587(18)30027-5_bib35","doi-asserted-by":"crossref","first-page":"385","DOI":"10.2337\/diacare.29.02.06.dc05-1781","article-title":"Lifestyle intervention is associated with lower prevalence of urinary incontinence","volume":"29","author":"Brown","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30027-5_bib36","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1001\/jamainternmed.2017.6040","article-title":"Long-term sustainability of diabetes prevention approaches: a systematic review and meta-analysis of randomized clinical trials","volume":"177","author":"Haw","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(18)30027-5_bib37","doi-asserted-by":"crossref","first-page":"e1002095","DOI":"10.1371\/journal.pmed.1002095","article-title":"Cardiometabolic risk factor changes observed in diabetes prevention programs in US settings: a systematic review and meta-analysis","volume":"13","author":"Mudaliar","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(18)30027-5_bib38","doi-asserted-by":"crossref","first-page":"e5656","DOI":"10.1371\/journal.pone.0005656","article-title":"Ten-year mortality and cardiovascular morbidity in the Finnish Diabetes Prevention Study\u2014secondary analysis of the randomized trial","volume":"4","author":"Uusitupa","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30027-5_bib39","doi-asserted-by":"crossref","first-page":"437","DOI":"10.7326\/M15-0452","article-title":"Combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the Community Preventive Services Task Force","volume":"163","author":"Balk","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(18)30027-5_bib40","doi-asserted-by":"crossref","first-page":"1222","DOI":"10.2337\/dc15-1095","article-title":"Disability-free life-years lost among adults aged \u226550 years with and without diabetes","volume":"39","author":"Bardenheier","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30027-5_bib41","doi-asserted-by":"crossref","first-page":"861","DOI":"10.7326\/M15-2345","article-title":"Screening for abnormal blood glucose and type 2 diabetes mellitus: US Preventive Services Task Force recommendation statement screening for abnormal blood glucose and type 2 diabetes mellitus","volume":"163","author":"Siu","year":"2015","journal-title":"Ann Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T15:59:51Z","timestamp":1535039991000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300275"}},"issued":{"date-parts":[[2018,5]]},"references-count":37,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2213858718300275"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30027-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular and renal burdens of prediabetes in the USA: analysis of data from serial cross-sectional surveys, 1988\u20132014","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30027-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30030-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T08:27:32Z","timestamp":1792744052716,"version":"4.5.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/s2213-8587(20)30373-9","type":"journal-article","created":{"date-parts":[[2020,12,17]],"date-time":"2020-12-17T02:04:19Z","timestamp":1608170659000},"page":"5-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Testosterone replacement to prevent type 2 diabetes? Not just yet"],"prefix":"10.1016","volume":"9","author":[{"given":"Naveed","family":"Sattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James G","family":"Boyle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ebaa","family":"Al-Ozairi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30373-9_bib1","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30373-9_bib2","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/S2213-8587(20)30367-3","article-title":"Testosterone treatment to prevent or revert type 2 diabetes in men enrolled in a lifestyle programme (T4DM): a randomised, double-blind, placebo-controlled, 2-year, phase 3b trial","volume":"9","author":"Wittert","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30373-9_bib3","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00125-020-05253-x","article-title":"An atlas on risk factors for type 2 diabetes: a wide-angled Mendelian randomisation study","volume":"63","author":"Yuan","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30373-9_bib4","doi-asserted-by":"crossref","first-page":"2341","DOI":"10.1210\/jc.2011-0118","article-title":"Low testosterone in men with type 2 diabetes: significance and treatment","volume":"96","author":"Grossmann","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30373-9_bib5","doi-asserted-by":"crossref","first-page":"105","DOI":"10.7326\/M19-0830","article-title":"Efficacy and safety of testosterone treatment in men: an evidence report for a clinical practice guideline by the American College of Physicians","volume":"172","author":"Diem","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(20)30373-9_bib6","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1055\/s-2002-36771","article-title":"Hemostatic and rheological variables and risk of cardiovascular disease","volume":"2","author":"Lowe","year":"2002","journal-title":"Semin Vasc Med"},{"key":"10.1016\/S2213-8587(20)30373-9_bib7","doi-asserted-by":"crossref","first-page":"708","DOI":"10.1001\/jama.2016.21043","article-title":"Testosterone treatment and coronary artery plaque volume in older men with low testosterone","volume":"317","author":"Budoff","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30373-9_bib9","series-title":"Hormone therapy for the primary prevention of chronic conditions in postmenopausal women: an evidence review for the US Preventive Services Task Force. Evidence Synthesis No 155. Report No 15-05227-EF-1","author":"Gartlehner","year":"2017"},{"key":"10.1016\/S2213-8587(20)30373-9_bib10","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2213-8587(19)30093-2","article-title":"Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study","volume":"7","author":"Gong","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303739?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303739?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:53Z","timestamp":1761991733000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303739"}},"issued":{"date-parts":[[2021,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2213858720303739"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30373-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Testosterone replacement to prevent type 2 diabetes? Not just yet","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30373-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30367-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T20:54:05Z","timestamp":1792356845158,"version":"4.4.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/s2213-8587(18)30317-6","type":"journal-article","created":{"date-parts":[[2018,11,14]],"date-time":"2018-11-14T00:44:31Z","timestamp":1542156271000},"page":"911","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Family matters in diabetes care"],"prefix":"10.1016","volume":"6","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T05:12:19Z","timestamp":1550553139000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303176"}},"issued":{"date-parts":[[2018,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2213858718303176"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30317-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Family matters in diabetes care","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30317-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:22:00Z","timestamp":1792153320354,"version":"4.4.0"},"reference-count":24,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,31]],"date-time":"2024-10-31T00:00:00Z","timestamp":1730332800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100027211","name":"Diabetes Research Wellness Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100027211","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001922","name":"Efficacy and Mechanism Evaluation Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001922","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100022690","name":"JDRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100022690","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/s2213-8587(24)00340-1","type":"journal-article","created":{"date-parts":[[2025,1,27]],"date-time":"2025-01-27T23:33:20Z","timestamp":1738020800000},"page":"210-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Automated insulin delivery during the first 6 months postpartum (AiDAPT): a prespecified extension study"],"prefix":"10.1016","volume":"13","author":[{"given":"Tara T M","family":"Lee","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Collett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"Bergford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hartnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor M","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine F","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"McCance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata E","family":"Wilinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judy","family":"Sibayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Craig","family":"Kollman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Hovorka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen R","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharine F","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Rogers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duncan","family":"Fowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Rosier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zeenat","family":"Banu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Barker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Rayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Gurnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katy","family":"Davenport","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannie","family":"Grisoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Savine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen R","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara T M","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tara","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"McKelvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nina","family":"Willer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Collett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mei-See","family":"Man","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Flanagan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee","family":"Shepstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Brackenridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Reid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olanike","family":"Okolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleanor","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Del","family":"Endersby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Dover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frances","family":"Dougherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M","family":"Reynolsd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Carty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharon","family":"Mackin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isobel","family":"Crawford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Buchan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"McCance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Quinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cains","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goher","family":"Ayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00340-1_bib1","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/0002-9378(74)90337-8","article-title":"Sharp temporary drop in insulin requirement after cesarean section in diabetic patients","volume":"120","author":"Lev-Ran","year":"1974","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(24)00340-1_bib2","doi-asserted-by":"crossref","first-page":"364","DOI":"10.2337\/dc13-1348","article-title":"Peripartum management of glycemia in women with type 1 diabetes","volume":"37","author":"Achong","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00340-1_bib3","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/nrendo.2012.154","article-title":"Managing type 1 diabetes mellitus in pregnancy\u2013from planning to breastfeeding","volume":"8","author":"Ringholm","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00340-1_bib4","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1111\/dme.13674","article-title":"Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes","volume":"35","author":"Dashora","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00340-1_bib5","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/dia.2019.0280","article-title":"Insulin pump settings during breastfeeding in women with type 1 diabetes","volume":"22","author":"N\u00f8rgaard","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(24)00340-1_bib6","doi-asserted-by":"crossref","DOI":"10.1080\/17482631.2019.1698496","article-title":"The lived experiences of healthcare during pregnancy, birth, and three months after in women with type 1 diabetes mellitus","volume":"15","author":"Dahlberg","year":"2020","journal-title":"Int J Qual Stud Health Well-being"},{"key":"10.1016\/S2213-8587(24)00340-1_bib7","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s13300-023-01394-5","article-title":"A Systematic review of commercial hybrid closed-loop automated insulin delivery systems","volume":"14","author":"Peacock","year":"2023","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(24)00340-1_bib8","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus recommendations for the use of automated insulin delivery technologies in clinical practice","volume":"44","author":"Phillip","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(24)00340-1_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15099","article-title":"A systematic review on the impact of commercially available hybrid closed loop systems on psychological outcomes in youths with type 1 diabetes and their parents","volume":"40","author":"Franceschi","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00340-1_bib10","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1056\/NEJMoa2303911","article-title":"Automated insulin delivery in women with pregnancy complicated by type 1 diabetes","volume":"389","author":"Lee","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00340-1_bib11","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1089\/dia.2023.0323","article-title":"Listening to women: experiences of using closed-loop in type 1 diabetes pregnancy","volume":"25","author":"Lawton","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(24)00340-1_bib13","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1602494","article-title":"Closed-loop insulin delivery during pregnancy in women with type 1 diabetes","volume":"375","author":"Stewart","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00340-1_bib14","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2337\/dc17-2534","article-title":"Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial","volume":"41","author":"Stewart","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00340-1_bib15","doi-asserted-by":"crossref","DOI":"10.1089\/dia.2024.0012","article-title":"Randomized Trial of assisted hybrid closed-loop therapy versus sensor-augmented pump therapy in pregnancy","author":"Polsky","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(24)00340-1_bib16","doi-asserted-by":"crossref","first-page":"2258","DOI":"10.2337\/dc23-0882","article-title":"A randomized trial of closed-loop insulin delivery postpartum in type 1 diabetes","volume":"46","author":"Donovan","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00340-1_bib17","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/dia.2018.0060","article-title":"Adaptability of closed loop during labor, delivery, and postpartum: a secondary analysis of data from two randomized crossover trials in type 1 diabetes pregnancy","volume":"20","author":"Stewart","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(24)00340-1_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12884-022-04543-z","article-title":"AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial - study protocol","volume":"22","author":"Lee","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(24)00340-1_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14576","article-title":"2020 NICE guideline update: good news for pregnant women with type 1 diabetes and past or current gestational diabetes","volume":"38","author":"Murphy","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00340-1_bib21","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1016\/S2213-8587(24)00039-1","article-title":"CONCEPTT to care: the science of implementation in diabetes care","volume":"12","author":"Scott","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00340-1_bib22","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.2337\/dc13-0485","article-title":"Pharmacokinetics of insulin as part in pump-treated subjects with type 1 diabetes: reproducibility and effect of age, weight, and duration of diabetes","volume":"36","author":"Haidar","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00340-1_bib23","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00340-1_bib24","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1016\/S0140-6736(24)01298-4","article-title":"Non-communicable diseases in reproductive care","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00340-1_bib25","author":"McAndrew"},{"key":"10.1016\/S2213-8587(24)00340-1_bib27","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1097\/MOP.0000000000000647","article-title":"Breastfeeding: uncovering barriers and offering solutions","volume":"30","author":"Sayres","year":"2018","journal-title":"Curr Opin Pediatr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003401?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003401?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T20:45:26Z","timestamp":1741466726000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003401"}},"issued":{"date-parts":[[2025,3]]},"references-count":24,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213858724003401"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00340-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Automated insulin delivery during the first 6 months postpartum (AiDAPT): a prespecified extension study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00340-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00374-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T18:32:53Z","timestamp":1792175573163,"version":"4.4.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012358","name":"Collaboration for Leadership in Applied Health Research and Care - Greater Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019434","name":"NIHR Exeter Clinical Research Facility","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/s2213-8587(20)30102-9","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:34:31Z","timestamp":1587580471000},"page":"447-455","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":142,"title":["The importance of language in engagement between health-care professionals and people living with obesity: a joint consensus statement"],"prefix":"10.1016","volume":"8","author":[{"given":"Charlotte","family":"Albury","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W David","family":"Strain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah Le","family":"Brocq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Logue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cathy","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abd","family":"Tahrani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30102-9_bib2","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/S0140-6736(18)32203-7","article-title":"Global, regional, and national age-sex-specific mortality for 282 causes of death in 195 countries and territories, 1980-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"392","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30102-9_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1242\/dmm.010553","article-title":"Fat: an evolving issue","volume":"5","author":"Speakman","year":"2012","journal-title":"Dis Model Mech"},{"key":"10.1016\/S2213-8587(20)30102-9_bib6","doi-asserted-by":"crossref","first-page":"52","DOI":"10.3109\/10408363.2015.1084990","article-title":"Sugar consumption, metabolic disease and obesity: the state of the controversy","volume":"53","author":"Stanhope","year":"2016","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/S2213-8587(20)30102-9_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5844","article-title":"Are the causes of obesity primarily environmental? No","volume":"345","author":"Frayling","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(20)30102-9_bib8","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1038\/sj.ijo.0802211","article-title":"Understanding the physiology of obesity: review of recent developments in obesity research","volume":"26","author":"Woods","year":"2002","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(20)30102-9_bib9","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1001\/jama.2014.4133","article-title":"Increasing adiposity: consequence or cause of overeating?","volume":"311","author":"Ludwig","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30102-9_bib10","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ng.686","article-title":"Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index","volume":"42","author":"Speliotes","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(20)30102-9_bib11","doi-asserted-by":"crossref","first-page":"977","DOI":"10.4158\/EP14280.PS","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology position statement on the 2014 advanced framework for a new diagnosis of obesity as a chronic disease","volume":"20","author":"Garvey","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(20)30102-9_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/nyas.12328","article-title":"Update on obesity pharmacotherapy","volume":"1311","author":"Bray","year":"2014","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/S2213-8587(20)30102-9_bib13","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1210\/jc.2011-2525","article-title":"Clinical review: regulation of food intake, energy balance, and body fat mass: implications for the pathogenesis and treatment of obesity","volume":"97","author":"Guyenet","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30102-9_bib14","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(20)30102-9_bib15","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e5843","article-title":"Are the causes of obesity primarily environmental? Yes","volume":"345","author":"Wilding","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(20)30102-9_bib16","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.fertnstert.2017.02.104","article-title":"Obesity pandemic: causes, consequences, and solutions-but do we have the will?","volume":"107","author":"Meldrum","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(20)30102-9_bib17","doi-asserted-by":"crossref","DOI":"10.1590\/0102-311x00048619","article-title":"Is the local food environment associated with excess body weight in adolescents in S\u00e3o Paulo, Brazil?","volume":"36","author":"Nogueira","year":"2020","journal-title":"Cad Saude Publica"},{"key":"10.1016\/S2213-8587(20)30102-9_bib18","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","article-title":"The global obesity pandemic: shaped by global drivers and local environments","volume":"378","author":"Swinburn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30102-9_bib19","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17041321","article-title":"Food retail environments in Greater Melbourne 2008\u20132016: longitudinal analysis of intra-city variation in density and healthiness of food outlets","volume":"17","author":"Needham","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(20)30102-9_bib20","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1038\/oby.2001.108","article-title":"Bias, discrimination, and obesity","volume":"9","author":"Puhl","year":"2001","journal-title":"Obes Res"},{"key":"10.1016\/S2213-8587(20)30102-9_bib21","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s13679-015-0153-z","article-title":"Health consequences of weight stigma: implications for obesity prevention and treatment","volume":"4","author":"Puhl","year":"2015","journal-title":"Curr Obes Rep"},{"key":"10.1016\/S2213-8587(20)30102-9_bib24","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1038\/oby.2008.636","article-title":"The stigma of obesity: a review and update","volume":"17","author":"Puhl","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30102-9_bib25","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/jhg.2015.148","article-title":"Gene-environment interactions in obesity: implication for future applications in preventive medicine","volume":"61","author":"Nakamura","year":"2016","journal-title":"J Hum Genet"},{"key":"10.1016\/S2213-8587(20)30102-9_bib26","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa1203039","article-title":"Sugar-sweetened beverages and genetic risk of obesity","volume":"367","author":"Qi","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30102-9_bib27","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1002\/oby.21538","article-title":"Persistent metabolic adaptation 6 years after \u201cThe Biggest Loser\u201d competition","volume":"24","author":"Fothergill","year":"2016","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30102-9_bib28","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1210\/er.2017-00111","article-title":"Obesity pathogenesis: an endocrine society scientific statement","volume":"38","author":"Schwartz","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(20)30102-9_bib29","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.2105\/AJPH.2009.159491","article-title":"Obesity stigma: important considerations for public health","volume":"100","author":"Puhl","year":"2010","journal-title":"Am J Public Health"},{"key":"10.1016\/S2213-8587(20)30102-9_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-020-0803-x","article-title":"Joint international consensus statement for ending stigma of obesity","author":"Rubino","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(20)30102-9_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(20)30073-5","article-title":"Knowledge gaps and weight stigma shape attitudes toward obesity","author":"O'Keeffe","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30102-9_bib32","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1007\/s13679-015-0153-z","article-title":"Health consequences of weight stigma: implications for obesity prevention and treatment","volume":"4","author":"Puhl","year":"2015","journal-title":"Curr Obes Rep"},{"key":"10.1016\/S2213-8587(20)30102-9_bib33","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s12916-018-1116-5","article-title":"How and why weight stigma drives the obesity \u2018epidemic\u2019 and harms health","volume":"16","author":"Tomiyama","year":"2018","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(20)30102-9_bib34","doi-asserted-by":"crossref","first-page":"2033","DOI":"10.1038\/oby.2009.131","article-title":"Associations between perceived weight discrimination and the prevalence of psychiatric disorders in the general population","volume":"17","author":"Hatzenbuehler","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30102-9_bib35","doi-asserted-by":"crossref","first-page":"1957","DOI":"10.1038\/oby.2011.204","article-title":"The impact of weight stigma on caloric consumption","volume":"19","author":"Schvey","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30102-9_bib36","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1359105307084318","article-title":"Effects of weight stigma on exercise motivation and behavior: a preliminary investigation among college-aged females","volume":"13","author":"Vartanian","year":"2008","journal-title":"J Health Psychol"},{"key":"10.1016\/S2213-8587(20)30102-9_bib37","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1177\/0956797615601103","article-title":"Weight discrimination and risk of mortality","volume":"26","author":"Sutin","year":"2015","journal-title":"Psychol Sci"},{"key":"10.1016\/S2213-8587(20)30102-9_bib38","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.appet.2016.02.027","article-title":"The relative stigmatization of eating disorders and obesity in males and females","volume":"102","author":"Murakami","year":"2016","journal-title":"Appetite"},{"key":"10.1016\/S2213-8587(20)30102-9_bib39","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1016\/j.amepre.2017.04.003","article-title":"Intersectionality: an understudied framework for addressing weight stigma","volume":"53","author":"Himmelstein","year":"2017","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(20)30102-9_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-023389","article-title":"Social deprivation, gender and obesity: multiple stigma? Results of a population survey from Germany","volume":"9","author":"Makowski","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(20)30102-9_bib41","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1038\/oby.2008.35","article-title":"Changes in perceived weight discrimination among Americans, 1995-1996 through 2004-2006","volume":"16","author":"Andreyeva","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30102-9_bib42","series-title":"Language matters: language and diabetes","author":"Kar","year":"2018"},{"key":"10.1016\/S2213-8587(20)30102-9_bib43","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ypmed.2019.04.015","article-title":"Person-first language and addiction: a means to an end, not an end in itself","volume":"124","author":"Pollack","year":"2019","journal-title":"Prev Med"},{"key":"10.1016\/S2213-8587(20)30102-9_bib44","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1080\/01612840.2018.1522400","article-title":"Identifying language for people on the autism spectrum: a scoping review","volume":"40","author":"Shakes","year":"2019","journal-title":"Issues Ment Health Nurs"},{"key":"10.1016\/S2213-8587(20)30102-9_bib45","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.yebeh.2016.10.034","article-title":"\u2018Epileptic\u2019, \u2018epileptic person\u2019 or \u2018person with epilepsy\u2019? Bringing quantitative and qualitative evidence on the views of UK patients and carers to the terminology debate","volume":"67","author":"Noble","year":"2017","journal-title":"Epilepsy Behav"},{"key":"10.1016\/S2213-8587(20)30102-9_bib46","doi-asserted-by":"crossref","first-page":"21","DOI":"10.3810\/pgm.2009.11.2074","article-title":"The medical risks of obesity","volume":"121","author":"Pi-Sunyer","year":"2009","journal-title":"Postgrad Med"},{"key":"10.1016\/S2213-8587(20)30102-9_bib47","doi-asserted-by":"crossref","first-page":"j477","DOI":"10.1136\/bmj.j477","article-title":"Adiposity and cancer at major anatomical sites: umbrella review of the literature","volume":"356","author":"Kyrgiou","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(20)30102-9_bib48","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.metabol.2018.11.005","article-title":"Obesity and dyslipidemia","volume":"92","author":"Vekic","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(20)30102-9_bib49","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.3892\/etm.2016.3667","article-title":"Obesity and hypertension","volume":"12","author":"Jiang","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/S2213-8587(20)30102-9_bib50","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S2213-8587(14)70229-3","article-title":"Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study","volume":"3","author":"Grover","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30102-9_bib51","doi-asserted-by":"crossref","first-page":"1914","DOI":"10.1111\/dom.13752","article-title":"Gaps to bridge: misalignment between perception, reality and actions in obesity","volume":"21","author":"Caterson","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30102-9_bib52","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/oby.2008.638","article-title":"Neurobehavioral inhibition of reward-driven feeding: implications for dieting and obesity","volume":"17","author":"Appelhans","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30102-9_bib53","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.neuron.2011.02.016","article-title":"Reward mechanisms in obesity: new insights and future directions","volume":"69","author":"Kenny","year":"2011","journal-title":"Neuron"},{"key":"10.1016\/S2213-8587(20)30102-9_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1210\/en.2005-0972","article-title":"Attenuated peptide YY release in obese subjects is associated with reduced satiety","volume":"147","author":"le Roux","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(20)30102-9_bib55","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1038\/oby.2007.355","article-title":"Influence of BMI and gender on postprandial hormone responses","volume":"15","author":"Carroll","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30102-9_bib56","series-title":"Foresight \u2018Tackling Obesities: Future Choices\u2019 project","author":"Butland","year":"2007"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(20)30102-9_bib57","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/obr.12093","article-title":"The evolution of policy and actions to tackle obesity in England","volume":"14","author":"Jebb","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(20)30102-9_bib58","doi-asserted-by":"crossref","first-page":"R581","DOI":"10.1152\/ajpregu.00755.2010","article-title":"Biology's response to dieting: the impetus for weight regain","volume":"301","author":"Maclean","year":"2011","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/S2213-8587(20)30102-9_bib59","doi-asserted-by":"crossref","first-page":"R1117","DOI":"10.1152\/ajpregu.00808.2007","article-title":"Weight regain after sustained weight reduction is accompanied by suppressed oxidation of dietary fat and adipocyte hyperplasia","volume":"294","author":"Jackman","year":"2008","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/S2213-8587(20)30102-9_bib60","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/1476-511X-10-99","article-title":"Analysis of time-dependent adaptations in whole-body energy balance in obesity induced by high-fat diet in rats","volume":"10","author":"So","year":"2011","journal-title":"Lipids Health Dis"},{"key":"10.1016\/S2213-8587(20)30102-9_bib61","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","article-title":"Long-term persistence of hormonal adaptations to weight loss","volume":"365","author":"Sumithran","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30102-9_bib62","series-title":"Fat","author":"Lupton","year":"2013"},{"key":"10.1016\/S2213-8587(20)30102-9_bib63","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/j.eatbeh.2014.08.014","article-title":"Weight and health-related quality of life: the moderating role of weight discrimination and internalized weight bias","volume":"15","author":"Latner","year":"2014","journal-title":"Eat Behav"},{"key":"10.1016\/S2213-8587(20)30102-9_bib64","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1111\/j.1745-7599.2002.tb00089.x","article-title":"Exploring the association between body weight, stigma of obesity, and health care avoidance","volume":"14","author":"Drury","year":"2002","journal-title":"J Am Acad Nurse Pract"},{"key":"10.1016\/S2213-8587(20)30102-9_bib65","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1007\/s11606-009-0922-z","article-title":"African Americans' perceptions of physician attempts to address obesity in the primary care setting","volume":"24","author":"Ward","year":"2009","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S2213-8587(20)30102-9_bib66","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1186\/1471-2458-11-513","article-title":"Words matter: a qualitative investigation of which weight status terms are acceptable and motivate weight loss when used by health professionals","volume":"11","author":"Gray","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(20)30102-9_bib67","doi-asserted-by":"crossref","first-page":"421","DOI":"10.3122\/jabfm.2013.04.120350","article-title":"Women weigh in: obese African American and White women's perspectives on physicians' roles in weight management","volume":"26","author":"Chugh","year":"2013","journal-title":"J Am Board Fam Med"},{"key":"10.1016\/S2213-8587(20)30102-9_bib68","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/1471-2296-10-59","article-title":"Attitudes, norms and controls influencing lifestyle risk factor management in general practice","volume":"10","author":"Ampt","year":"2009","journal-title":"BMC Fam Pract"},{"key":"10.1016\/S2213-8587(20)30102-9_bib69","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1177\/1524839916658025","article-title":"Primary care resident training for obesity, nutrition, and physical activity counseling: a mixed-methods study","volume":"18","author":"Antognoli","year":"2017","journal-title":"Health Promot Pract"},{"key":"10.1016\/S2213-8587(20)30102-9_bib70","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1071\/HC14212","article-title":"General practitioner opinion of weight management interventions in New Zealand","volume":"6","author":"Claridge","year":"2014","journal-title":"J Prim Health Care"},{"key":"10.1016\/S2213-8587(20)30102-9_bib71","first-page":"750","article-title":"A qualitative study of GPs' views of treating obesity","volume":"55","author":"Epstein","year":"2005","journal-title":"Br J Gen Pract"},{"key":"10.1016\/S2213-8587(20)30102-9_bib72","first-page":"769","article-title":"Barriers to effective conversations regarding overweight and obesity in regional Victoria","volume":"46","author":"Glenister","year":"2017","journal-title":"Aust Fam Physician"},{"key":"10.1016\/S2213-8587(20)30102-9_bib73","first-page":"93","article-title":"Barriers and enablers to managing obesity in general practice: a practical approach for use in implementation activities","volume":"20","author":"Gunther","year":"2012","journal-title":"Qual Prim Care"},{"key":"10.1016\/S2213-8587(20)30102-9_bib74","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1471-2296-12-7","article-title":"General practitioners' and district nurses' conceptions of the encounter with obese patients in primary health care","volume":"12","author":"Hansson","year":"2011","journal-title":"BMC Fam Pract"},{"key":"10.1016\/S2213-8587(20)30102-9_bib75","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1093\/fampra\/cmr051","article-title":"A qualitative study on patients' and physicians' visions for the future management of overweight or obesity","volume":"29","author":"Heintze","year":"2012","journal-title":"Fam Pract"},{"key":"10.1016\/S2213-8587(20)30102-9_bib76","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.amepre.2006.12.008","article-title":"Obesity counseling and guidelines in primary care: a qualitative study","volume":"32","author":"Leverence","year":"2007","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(20)30102-9_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1155\/2016\/8212837","article-title":"Exploring self-efficacy in Australian general practitioners managing patient obesity: a qualitative survey study","volume":"2016","author":"Ashman","year":"2016","journal-title":"Int J Family Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(20)30102-9_bib78","doi-asserted-by":"crossref","first-page":"i177","DOI":"10.1093\/fampra\/cmr072","article-title":"A local consensus process making use of focus groups to enhance the implementation of a national integrated health care standard on obesity care","volume":"29","author":"Derksen","year":"2012","journal-title":"Fam Pract"},{"key":"10.1016\/S2213-8587(20)30102-9_bib79","doi-asserted-by":"crossref","first-page":"498","DOI":"10.4278\/0890-1171-21.6.498","article-title":"Physicians' beliefs about discussing obesity: results from focus groups","volume":"21","author":"Alexander","year":"2007","journal-title":"Am J Health Promot"},{"key":"10.1016\/S2213-8587(20)30102-9_bib80","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/1471-2296-7-35","article-title":"Barriers to obesity management: a pilot study of primary care clinicians","volume":"7","author":"Forman-Hoffman","year":"2006","journal-title":"BMC Fam Pract"},{"key":"10.1016\/S2213-8587(20)30102-9_bib81","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.pec.2012.06.033","article-title":"Primary care providers' communication with patients during weight counseling: a focus group study","volume":"89","author":"Gudzune","year":"2012","journal-title":"Patient Educ Couns"},{"key":"10.1016\/S2213-8587(20)30102-9_bib82","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1093\/fampra\/cmq110","article-title":"Attitudes towards obesity treatment in GP training practices: a focus group study","volume":"28","author":"Jochemsen-van der Leeuw","year":"2011","journal-title":"Fam Pract"},{"key":"10.1016\/S2213-8587(20)30102-9_bib83","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1017\/S1463423612000059","article-title":"Practice nurses and obesity: professional and practice-based factors affecting role adequacy and role legitimacy","volume":"13","author":"Nolan","year":"2012","journal-title":"Prim Health Care Res Dev"},{"key":"10.1016\/S2213-8587(20)30102-9_bib84","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1080\/13548500701203441","article-title":"Talking to primary care patients about weight: a study of GPs and practice nurses in the UK","volume":"12","author":"Michie","year":"2007","journal-title":"Psychol Health Med"},{"key":"10.1016\/S2213-8587(20)30102-9_bib85","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-008546","article-title":"Raising the topic of weight in general practice: perspectives of GPs and primary care nurses","volume":"5","author":"Blackburn","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(20)30102-9_bib86","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/1472-6920-14-53","article-title":"An obesity educational intervention for medical students addressing weight bias and communication skills using standardized patients","volume":"14","author":"Kushner","year":"2014","journal-title":"BMC Med Educ"},{"key":"10.1016\/S2213-8587(20)30102-9_bib87","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00127-005-0994-y","article-title":"Does stigma concerning mental disorders differ through medical education? A survey among medical students in Istanbul","volume":"41","author":"Ay","year":"2006","journal-title":"Soc Psychiatry Psychiatr Epidemiol"},{"key":"10.1016\/S2213-8587(20)30102-9_bib88","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12347","article-title":"Clinical encounters about obesity: systematic review of patients' perspectives","volume":"10","author":"Ananthakumar","year":"2020","journal-title":"Clin Obes"},{"key":"10.1016\/S2213-8587(20)30102-9_bib89","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1186\/s12875-019-0992-x","article-title":"Communication practices for delivering health behaviour change conversations in primary care: a systematic review and thematic synthesis","volume":"20","author":"Albury","year":"2019","journal-title":"BMC Fam Pract"},{"key":"10.1016\/S2213-8587(20)30102-9_bib90","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1111\/j.1365-2929.2004.02037.x","article-title":"Conversation analysis: a practical resource in the health care setting","volume":"39","author":"Barnes","year":"2005","journal-title":"Med Educ"},{"key":"10.1016\/S2213-8587(20)30102-9_bib91","doi-asserted-by":"crossref","first-page":"e779","DOI":"10.3399\/bjgp16X686653","article-title":"Calling the GP surgery: patient burden, patient satisfaction, and implications for training","volume":"66","author":"Stokoe","year":"2016","journal-title":"Br J Gen Pract"},{"key":"10.1016\/S2213-8587(20)30102-9_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0156174","article-title":"Engaging terminally ill patients in end of life talk: how experienced palliative medicine doctors navigate the dilemma of promoting discussions about dying","volume":"11","author":"Pino","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(20)30102-9_bib93","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/1753-0407.12814","article-title":"Tackling clinical inertia: use of coproduction to improve patient engagement","volume":"10","author":"Soto","year":"2018","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(20)30102-9_bib94","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.appet.2012.11.005","article-title":"\u201cFat is your fault\u201d. Gatekeepers to health, attributions of responsibility and the portrayal of gender in the Irish media representation of obesity","volume":"62","author":"De Br\u00fan","year":"2013","journal-title":"Appetite"},{"key":"10.1016\/S2213-8587(20)30102-9_bib95","doi-asserted-by":"crossref","first-page":"712","DOI":"10.1038\/oby.2007.635","article-title":"Fat stigmatization in television shows and movies: a content analysis","volume":"15","author":"Himes","year":"2007","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30102-9_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222543","article-title":"\u201c\u2026or else I close my ears\u201d How women with obesity want to be approached and treated regarding gestational weight management: a qualitative interview study","volume":"14","author":"Christenson","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(20)30102-9_bib97","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1016\/S0140-6736(16)31893-1","article-title":"Screening and brief intervention for obesity in primary care: a parallel, two-arm, randomised trial","volume":"388","author":"Aveyard","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30102-9_bib99","doi-asserted-by":"crossref","DOI":"10.1007\/s13679-020-00367-0","article-title":"The association between weight-based teasing from peers and family in childhood and depressive symptoms in childhood and adulthood: a systematic review","author":"Szwimer","year":"2020","journal-title":"Curr Obes Rep"},{"key":"10.1016\/S2213-8587(20)30102-9_bib100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.socscimed.2018.10.015","article-title":"Distribution and disavowal: managing the parental stigma of children's weight and weight loss","volume":"219","author":"Davis","year":"2018","journal-title":"Soc Sci Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301029?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301029?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:11Z","timestamp":1761991691000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301029"}},"issued":{"date-parts":[[2020,5]]},"references-count":94,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213858720301029"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30102-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The importance of language in engagement between health-care professionals and people living with obesity: a joint consensus statement","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30102-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T08:12:59Z","timestamp":1791879179922,"version":"4.3.4"},"reference-count":6,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/s2213-8587(14)70014-2","type":"journal-article","created":{"date-parts":[[2014,2,5]],"date-time":"2014-02-05T20:31:46Z","timestamp":1391632306000},"page":"266-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["GLP-1 receptor agonists: why is once weekly inferior to once daily?"],"prefix":"10.1016","volume":"2","author":[{"given":"Alan J","family":"Garber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70014-2_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70214-6","article-title":"Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study","author":"Pratley","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70014-2_bib2","doi-asserted-by":"crossref","first-page":"1880","DOI":"10.2337\/dc09-0366","article-title":"Potential of albiglutide, a long acting GLP-1 receptor agonist, in type 2 diabetes","volume":"32","author":"Rosenstock","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70014-2_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(12)61267-7","article-title":"Exenatide once weekly versus liraglutide once daily for patients with type 2 diabetes (DURATION-6): a randomized open label study","volume":"381","author":"Buse","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70014-2_bib4","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S0140-6736(09)60659-0","article-title":"Liraglutide once a day versus exenatide twice a day for type 2 diabetes: a 26 week randomized, multinational parallel group open label trial (LEAD 6)","volume":"374","author":"Buse","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70014-2_bib5","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(08)61206-4","article-title":"Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomized open label non inferiority study","volume":"372","author":"Drucker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70014-2_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1177\/0145721708317869","article-title":"Measuring physiological insulin resistance: barriers to insulin use","volume":"34","author":"Larkin","year":"2008","journal-title":"Diabetes Educ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700142?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700142?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:02Z","timestamp":1761991502000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700142"}},"issued":{"date-parts":[[2014,4]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S2213858714700142"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70014-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonists: why is once weekly inferior to once daily?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70014-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70214-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T23:40:12Z","timestamp":1792021212134,"version":"4.4.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009131","name":"Direktion f\u00fcr Entwicklung und Zusammenarbeit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009131","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016304","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016304","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K23DK129827"],"award-info":[{"award-number":["K23DK129827"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["2T32DK063688"],"award-info":[{"award-number":["2T32DK063688"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000897","name":"Cystic Fibrosis Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018939","name":"World Diabetes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018939","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/s2213-8587(25)00253-0","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:14:27Z","timestamp":1758086067000},"page":"908-909","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Improving type 1 diabetes care globally: the importance of medical education"],"prefix":"10.1016","volume":"13","author":[{"given":"Brynn E","family":"Marks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaisree R","family":"Iyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valla","family":"Tantayotai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"de Beaufort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00253-0_bib1","series-title":"Curriculum development for medical education: a six step approach","author":"Thomas","year":"2022"},{"issue":"suppl 9","key":"10.1016\/S2213-8587(25)00253-0_bib2","doi-asserted-by":"crossref","first-page":"S63","DOI":"10.1097\/00001888-199009000-00045","article-title":"The assessment of clinical skills\/competence\/performance","volume":"65","author":"Miller","year":"1990","journal-title":"Acad Med"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(25)00253-0_bib3","article-title":"Child health needs and the pediatric endocrinology workforce: 2020\u20132040","volume":"153","author":"Aye","year":"2024","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(25)00253-0_bib4","doi-asserted-by":"crossref","DOI":"10.1159\/000547140","article-title":"IDEAL: a comprehensive virtual training program for pediatric diabetes educators in low-resource settings\u2014structure, strengths, and challenges","author":"Virmani","year":"2025","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(25)00253-0_bib5","first-page":"1","article-title":"Development and implementation of a pediatric endocrinology education program in Francophone Africa","volume":"97","author":"Niang","year":"2023","journal-title":"Horm Res Pediatr"},{"key":"10.1016\/S2213-8587(25)00253-0_bib6","doi-asserted-by":"crossref","first-page":"243","DOI":"10.2337\/dc24-2100","article-title":"Project ECHO diabetes trial improves outcomes for medically underserved people","volume":"48","author":"Walker","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00253-0_bib7","doi-asserted-by":"crossref","DOI":"10.1159\/000546936","article-title":"ADECA: a novel course for training paediatric diabetes nurse educators in sub-Saharan Africa","author":"Agwu","year":"2025","journal-title":"Horm Res Paediatr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:11:34Z","timestamp":1774987894000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002530"}},"issued":{"date-parts":[[2025,11]]},"references-count":7,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2213858725002530"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00253-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving type 1 diabetes care globally: the importance of medical education","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00253-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T23:02:43Z","timestamp":1791241363674,"version":"4.1.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/s2213-8587(18)30307-3","type":"journal-article","created":{"date-parts":[[2018,12,15]],"date-time":"2018-12-15T01:22:12Z","timestamp":1544836932000},"page":"93-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial"],"prefix":"10.1016","volume":"7","author":[{"given":"Michael P","family":"Whyte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill H","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott","family":"Moseley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji P","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Bishop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nada J","family":"Salman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dawn","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mairead","family":"McGinn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William H","family":"McAlister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30307-3_bib1","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/nrendo.2016.14","article-title":"Hypophosphatasia\u2014aetiology, nosology, pathogenesis, diagnosis and treatment","volume":"12","author":"Whyte","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(18)30307-3_bib2","doi-asserted-by":"crossref","first-page":"7666","DOI":"10.1073\/pnas.85.20.7666","article-title":"A missense mutation in the human liver\/bone\/kidney alkaline phosphatase gene causing a lethal form of hypophosphatasia","volume":"85","author":"Weiss","year":"1988","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(18)30307-3_bib3","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/j.1749-6632.2010.05387.x","article-title":"Physiological role of alkaline phosphatase explored in hypophosphatasia","volume":"1192","author":"Whyte","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/S2213-8587(18)30307-3_bib4","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1172\/JCI112031","article-title":"Markedly increased circulating pyridoxal-5\u2032-phosphate levels in hypophosphatasia. Alkaline phosphatase acts in vitamin B6 metabolism","volume":"76","author":"Whyte","year":"1985","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(18)30307-3_bib5","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S0140-6736(65)91422-4","article-title":"Excretion of inorganic pyrophosphate in hypophosphatasia","volume":"286","author":"Russell","year":"1965","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30307-3_bib6","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1038\/212901a0","article-title":"Effect of pyrophosphate on hydroxyapatite and its implications in calcium homeostasis","volume":"212","author":"Fleisch","year":"1966","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(18)30307-3_bib7","series-title":"Genetics of bone biology and skeletal disease","first-page":"481","article-title":"Hypophosphatasia and how alkaline phosphatase promotes mineralization","author":"Whyte","year":"2018"},{"key":"10.1016\/S2213-8587(18)30307-3_bib8","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1016\/j.bone.2007.01.020","article-title":"Pyridoxine-responsive seizures as the first symptom of infantile hypophosphatasia caused by two novel missense mutations (c.677T>C, p.M226T; c.1112C>T, p.T371I) of the tissue-nonspecific alkaline phosphatase gene","volume":"40","author":"Baumgartner-Sigl","year":"2007","journal-title":"Bone"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(18)30307-3_bib9","doi-asserted-by":"crossref","first-page":"S25","DOI":"10.1007\/s10545-009-9012-y","article-title":"Perinatal hypophosphatasia presenting as neonatal epileptic encephalopathy with abnormal neurotransmitter metabolism secondary to reduced co-factor pyridoxal-5\u2032-phosphate availability","volume":"33","author":"Balasubramaniam","year":"2010","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(18)30307-3_bib10","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/BF00975316","article-title":"Hypophosphatasia. Review of 24 cases","volume":"5","author":"Kozlowski","year":"1976","journal-title":"Pediatr Radiol"},{"key":"10.1016\/S2213-8587(18)30307-3_bib11","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s00381-008-0708-3","article-title":"Neurosurgical aspects of childhood hypophosphatasia","volume":"25","author":"Collmann","year":"2009","journal-title":"Childs Nerv Syst"},{"key":"10.1016\/S2213-8587(18)30307-3_bib12","doi-asserted-by":"crossref","first-page":"483","DOI":"10.3109\/15513818809022304","article-title":"Pulmonary hypoplasia in neonatal hypophosphatasia","volume":"8","author":"Silver","year":"1988","journal-title":"Pediatr Pathol"},{"key":"10.1016\/S2213-8587(18)30307-3_bib13","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/8904_2013_224","article-title":"Outcome of perinatal hypophosphatasia in Manitoba Mennonites: a retrospective cohort analysis","volume":"11","author":"Leung","year":"2013","journal-title":"JIMD Rep"},{"key":"10.1016\/S2213-8587(18)30307-3_bib14","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1297\/cpe.19.7","article-title":"Clinical characteristics of perinatal lethal hypophosphatasia: a report of 6 cases","volume":"19","author":"Nakamura-Utsunomiya","year":"2010","journal-title":"Clin Pediatr Endocrinol"},{"key":"10.1016\/S2213-8587(18)30307-3_bib15","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1210\/jc.2015-3462","article-title":"Asfotase alfa treatment improves survival for perinatal and infantile hypophosphatasia","volume":"101","author":"Whyte","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30307-3_bib17","series-title":"Package insert","year":"2018"},{"key":"10.1016\/S2213-8587(18)30307-3_bib18","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1056\/NEJMoa1106173","article-title":"Enzyme-replacement therapy in life-threatening hypophosphatasia","volume":"366","author":"Whyte","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30307-3_bib19","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1002\/ppul.22527","article-title":"Respiratory mechanics in an infant with perinatal lethal hypophosphatasia treated with human recombinant enzyme replacement therapy","volume":"47","author":"Rodriguez","year":"2012","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/S2213-8587(18)30307-3_bib20","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/jbmr.3377","article-title":"Validation of a novel scoring system for changes in skeletal manifestations of hypophosphatasia in newborns, infants, and children: the Radiographic Global Impression of Change scale","volume":"33","author":"Whyte","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30307-3_bib21","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1093\/tropej\/46.3.132","article-title":"Radiographic scoring method for the assessment of the severity of nutritional rickets","volume":"46","author":"Thacher","year":"2000","journal-title":"J Trop Pediatr"},{"key":"10.1016\/S2213-8587(18)30307-3_bib22","first-page":"1","article-title":"2000 CDC growth charts for the United States: methods and development","volume":"246","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat 11"},{"key":"10.1016\/S2213-8587(18)30307-3_bib24","series-title":"Bayley Scales of Infant and Toddler Development. Administration manual","author":"Bayley","year":"2006"},{"key":"10.1016\/S2213-8587(18)30307-3_bib25","series-title":"Peabody Developmental Motor Scales","author":"Folio","year":"2000"},{"key":"10.1016\/S2213-8587(18)30307-3_bib26","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1080\/J006v27n04_06","article-title":"Review of the Bruininks-Oseretsky Test of Motor Proficiency, Second Edition (BOT-2)","volume":"27","author":"Deitz","year":"2007","journal-title":"Phys Occup Ther Pediatr"},{"key":"10.1016\/S2213-8587(18)30307-3_bib27","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/BF01800216","article-title":"Increased plasma pyridoxal-5\u2032-phosphate levels before and after pyridoxine loading in carriers of perinatal\/infantile hypophosphatasia","volume":"13","author":"Chodirker","year":"1990","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(18)30307-3_bib28","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1093\/ndt\/gfp362","article-title":"Plasma pyrophosphate and vascular calcification in chronic kidney disease","volume":"25","author":"O'Neill","year":"2010","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(18)30307-3_bib29","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1002\/jbmr.1752","article-title":"Severe skeletal toxicity from protracted etidronate therapy for generalized arterial calcification of infancy","volume":"28","author":"Otero","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30307-3_bib30","doi-asserted-by":"crossref","first-page":"20206","DOI":"10.1073\/pnas.1319582110","article-title":"ABCC6 prevents ectopic mineralization seen in pseudoxanthoma elasticum by inducing cellular nucleotide release","volume":"110","author":"Jansen","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(18)30307-3_bib31","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/cen.13343","article-title":"Safety and efficacy of treatment with asfotase alfa in patients with hypophosphatasia: results from a Japanese clinical trial","volume":"87","author":"Kitaoka","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(18)30307-3_bib32","doi-asserted-by":"crossref","first-page":"e85971","DOI":"10.1172\/jci.insight.85971","article-title":"Asfotase alfa therapy for children with hypophosphatasia","volume":"1","author":"Whyte","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(18)30307-3_bib33","doi-asserted-by":"crossref","unstructured":"Whyte MP, Leung E, Wilcox WR, et al. Hypophosphatasia: a retrospective natural history study of the severe perinatal and infantile forms. Pediatric Academic Societies and Asian Society for Pediatric Research Joint Meeting; Vancouver; May 3\u20136, 2014. Abstract 752416.","DOI":"10.1530\/boneabs.3.PP364"},{"key":"10.1016\/S2213-8587(18)30307-3_bib34","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.ymgme.2017.07.010","article-title":"Monitoring guidance for patients with hypophosphatasia treated with asfotase alfa","volume":"122","author":"Kishnani","year":"2017","journal-title":"Mol Genet Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,8]],"date-time":"2019-11-08T01:02:40Z","timestamp":1573174960000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303073"}},"issued":{"date-parts":[[2019,2]]},"references-count":32,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2213858718303073"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30307-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Asfotase alfa for infants and young children with hypophosphatasia: 7 year outcomes of a single-arm, open-label, phase 2 extension trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30307-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30321-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T22:25:43Z","timestamp":1793053543007,"version":"4.5.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001349","name":"National Medical Research Council","doi-asserted-by":"publisher","award":["CM24\/00080"],"award-info":[{"award-number":["CM24\/00080"]}],"id":[{"id":"10.13039\/501100001349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["MOH-00092900"],"award-info":[{"award-number":["MOH-00092900"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","award":["CA20122"],"award-info":[{"award-number":["CA20122"]}],"id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271-TRR 205"],"award-info":[{"award-number":["314061271-TRR 205"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2012_A103"],"award-info":[{"award-number":["2012_A103"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003042","name":"Else Kr\u00f6ner-Fresenius-Stiftung","doi-asserted-by":"publisher","award":["2015_A228"],"award-info":[{"award-number":["2015_A228"]}],"id":[{"id":"10.13039\/501100003042","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011727","name":"Stockholm l\u00e4ns landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011727","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100014434","name":"Narodowa Agencja Wymiany Akademickiej","doi-asserted-by":"publisher","award":["BPN\/WAL\/2023\/1\/00107\/U\/00001"],"award-info":[{"award-number":["BPN\/WAL\/2023\/1\/00107\/U\/00001"]}],"id":[{"id":"10.13039\/501100014434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007952","name":"Eva Luise und Horst K\u00f6hler Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007952","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/s2213-8587(25)00302-x","type":"journal-article","created":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T00:03:34Z","timestamp":1769040214000},"page":"202-215","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Effect of surgical versus conservative management on cardiovascular outcomes in patients with bilateral adrenal tumours and cortisol excess: an international, retrospective cohort study"],"prefix":"10.1016","volume":"14","author":[{"given":"Elisabeth","family":"Nowak","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte L","family":"Vi\u00ebtor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Feelders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Araujo-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C\u00e9sar Mingu\u00e9z","family":"Ojeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eider","family":"Pascual-Corrales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bahaa","family":"Salama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashi","family":"Sandooja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Altieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Detomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Bobrowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Ambroziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adrianna","family":"Gladka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Bioletto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirko","family":"Parasiliti-Caprino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edelmiro Men\u00e9ndez","family":"Torre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diego","family":"Rivas-Otero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom\u00e1s","family":"Gonz\u00e1lez-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Ceccato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Tizianel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianna","family":"Torchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serena","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Mangone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Mantovani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iacopo","family":"Chiodini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Favero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Onnicha","family":"Suntornlohanakul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Morelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Chiodaroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u0142gorzata","family":"Trofimiuk-M\u00fcldner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicja","family":"Hubalewska-Dydejczyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Puglisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Reimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krystallenia I","family":"Alexandraki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadni","family":"Spyroglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"K\u0142osowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Chrisoulidou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Loli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Angelousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Duarte","family":"Pignatelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicia","family":"Hanzu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sybille","family":"Fuld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Pamporaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shobana","family":"Athimulam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Quinkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athina","family":"Markou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy","family":"Puar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Deutschbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Verena S","family":"Hoffmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00302-X_bib1","doi-asserted-by":"crossref","first-page":"3331","DOI":"10.1210\/clinem\/dgab512","article-title":"Approach to the patient with adrenal incidentaloma","volume":"106","author":"Bancos","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00302-X_bib2","doi-asserted-by":"crossref","first-page":"S88","DOI":"10.1093\/ejendo\/lvad134","article-title":"Comorbidities in mild autonomous cortisol secretion and the effect of treatment: systematic review and meta-analysis","volume":"189","author":"Pelsma","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00302-X_bib3","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/S2213-8587(22)00100-0","article-title":"Age-dependent and sex-dependent disparity in mortality in patients with adrenal incidentalomas and autonomous cortisol secretion: an international, retrospective, cohort study","volume":"10","author":"Deutschbein","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00302-X_bib4","doi-asserted-by":"crossref","first-page":"325","DOI":"10.7326\/M21-1737","article-title":"Cardiometabolic disease burden and steroid excretion in benign adrenal tumors: a cross-sectional multicenter study","volume":"175","author":"Prete","year":"2022","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00302-X_bib5","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1016\/S0140-6736(23)01961-X","article-title":"Cushing's syndrome","volume":"402","author":"Gadelha","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00302-X_bib6","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an endocrine society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00302-X_bib7","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1093\/ejendo\/lvad066","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenal incidentalomas, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"189","author":"Fassnacht","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00302-X_bib8","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1007\/s00268-007-9408-5","article-title":"The role of unilateral adrenalectomy in ACTH-independent macronodular adrenal hyperplasia (AIMAH)","volume":"32","author":"Iacobone","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(25)00302-X_bib9","doi-asserted-by":"crossref","first-page":"4417","DOI":"10.1210\/jc.2015-2662","article-title":"Unilateral adrenalectomy as a first-line treatment of Cushing's syndrome in patients with primary bilateral macronodular adrenal hyperplasia","volume":"100","author":"Debillon","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00302-X_bib10","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1210\/jc.2018-02204","article-title":"Long-term outcome of primary bilateral macronodular adrenocortical hyperplasia after unilateral adrenalectomy","volume":"104","author":"Osswald","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00302-X_bib11","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1530\/EJE-15-0566","article-title":"Biochemical and clinical benefits of unilateral adrenalectomy in patients with subclinical hypercortisolism and bilateral adrenal incidentalomas","volume":"173","author":"Perogamvros","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00302-X_bib12","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-14-0824","article-title":"Extensive expertise in endocrinology. Adrenal crisis","volume":"172","author":"Allolio","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00302-X_bib13","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00302-X_bib14","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00302-X_bib15","first-page":"e563","article-title":"2019 ACC\/AHA guideline on the primary prevention of cardiovascular disease: executive summary: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"140","author":"Arnett","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(25)00302-X_bib16","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(25)00302-X_bib17","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1016\/S2213-8587(13)70211-0","article-title":"Cardiovascular events and mortality in patients with adrenal incidentalomas that are either non-secreting or associated with intermediate phenotype or subclinical Cushing's syndrome: a 15-year retrospective study","volume":"2","author":"Di Dalmazi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00302-X_bib18","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa2415879","article-title":"Global effect of cardiovascular risk factors on lifetime estimates","volume":"393","author":"Magnussen","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00302-X_bib19","doi-asserted-by":"crossref","first-page":"107","DOI":"10.7326\/M18-3630","article-title":"Natural history of adrenal incidentalomas with and without mild autonomous cortisol excess: a systematic review and meta-analysis","volume":"171","author":"Elhassan","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00302-X_bib20","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1093\/ejendo\/lvae127","article-title":"Frequency of clinical signs in patients with Cushing's syndrome and mild autonomous cortisol secretion: overlap is common","volume":"191","author":"Braun","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00302-X_bib21","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1016\/S2213-8587(25)00062-2","article-title":"Surgery for the treatment of arterial hypertension in patients with unilateral adrenal incidentalomas and mild autonomous cortisol secretion (CHIRACIC): a multicentre, open-label, superiority randomised controlled trial","volume":"13","author":"Tabarin","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00302-X_bib22","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/endrev\/bnac034","article-title":"Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia","volume":"44","author":"Bertherat","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(25)00302-X_bib23","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00302-X_bib24","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1007\/s00268-007-9332-8","article-title":"The clinical conundrum of corticotropin-independent autonomous cortisol secretion in patients with bilateral adrenal masses","volume":"32","author":"Young","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(25)00302-X_bib25","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/cen.14833","article-title":"Adrenal venous sampling for lateralization of cortisol hypersecretion in patients with bilateral adrenal masses","volume":"98","author":"Johnson","year":"2023","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00302-X_bib26","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s00268-018-4788-2","article-title":"Outcomes of adrenal venous sampling in patients with bilateral adrenal masses and ACTH-independent Cushing's syndrome","volume":"43","author":"Acharya","year":"2019","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(25)00302-X_bib27","doi-asserted-by":"crossref","first-page":"4553","DOI":"10.1210\/jc.2018-01198","article-title":"Adrenal venous sampling for assessment of autonomous cortisol secretion","volume":"103","author":"Ueland","year":"2018","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872500302X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872500302X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:30:03Z","timestamp":1780662603000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872500302X"}},"issued":{"date-parts":[[2026,3]]},"references-count":27,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S221385872500302X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00302-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of surgical versus conservative management on cardiovascular outcomes in patients with bilateral adrenal tumours and cortisol excess: an international, retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00302-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00354-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T00:39:00Z","timestamp":1793234340931,"version":"4.5.0"},"reference-count":26,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2017\u201301707"],"award-info":[{"award-number":["2017\u201301707"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["2020\u201301303"],"award-info":[{"award-number":["2020\u201301303"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008546","name":"Diabetesf\u00f6rbundet","doi-asserted-by":"publisher","award":["2019- 417"],"award-info":[{"award-number":["2019- 417"]}],"id":[{"id":"10.13039\/501100008546","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["19OC0057184"],"award-info":[{"award-number":["19OC0057184"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Hj\u00e4rt-Lungfonden","doi-asserted-by":"publisher","award":["20180410"],"award-info":[{"award-number":["20180410"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/s2213-8587(21)00141-8","type":"journal-article","created":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T18:46:03Z","timestamp":1625165163000},"page":"515-524","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Long-term risk of anaemia after bariatric surgery: results from the Swedish Obese Subjects study"],"prefix":"10.1016","volume":"9","author":[{"given":"Kari","family":"Johansson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Arne","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"S\u00f6derling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Neovius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M S","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajsa","family":"Sj\u00f6holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00141-8_bib1","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1001\/jama.2014.5988","article-title":"Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications","volume":"311","author":"Sj\u00f6str\u00f6m","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00141-8_bib2","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1111\/joim.12012","article-title":"Review of the key results from the Swedish Obese Subjects (SOS) trial\u2014a prospective controlled intervention study of bariatric surgery","volume":"273","author":"Sj\u00f6str\u00f6m","year":"2013","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(21)00141-8_bib3","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa2002449","article-title":"Life expectancy after bariatric surgery in the Swedish Obese Subjects Study","volume":"383","author":"Carlsson","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00141-8_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1381\/0960892053268264","article-title":"Nutritional deficiencies following bariatric surgery: what have we learned?","volume":"15","author":"Bloomberg","year":"2005","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(21)00141-8_bib5","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.2174\/138920012803341339","article-title":"Vitamin, mineral, and drug absorption following bariatric surgery","volume":"13","author":"Sawaya","year":"2012","journal-title":"Curr Drug Metab"},{"key":"10.1016\/S2213-8587(21)00141-8_bib6","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1111\/apt.12872","article-title":"Review article: the nutritional and pharmacological consequences of obesity surgery","volume":"40","author":"Stein","year":"2014","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S2213-8587(21)00141-8_bib7","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev-nutr-071812-161225","article-title":"Nutrient deficiencies after gastric bypass surgery","volume":"33","author":"Saltzman","year":"2013","journal-title":"Annu Rev Nutr"},{"key":"10.1016\/S2213-8587(21)00141-8_bib9","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1200111","article-title":"Bariatric surgery versus conventional medical therapy for type 2 diabetes","volume":"366","author":"Mingrone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00141-8_bib10","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa1401329","article-title":"Bariatric surgery versus intensive medical therapy for diabetes\u20143-year outcomes","volume":"370","author":"Schauer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00141-8_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-006964","article-title":"Anaemia and related nutrient deficiencies after Roux-en-Y gastric bypass surgery: a systematic review and meta-analysis","volume":"5","author":"Weng","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(21)00141-8_bib12","doi-asserted-by":"crossref","first-page":"3002","DOI":"10.1007\/s00464-019-07092-3","article-title":"The incidence of iron deficiency anemia post-Roux-en-Y gastric bypass and sleeve gastrectomy: a systematic review","volume":"34","author":"Enani","year":"2020","journal-title":"Surg Endosc"},{"key":"10.1016\/S2213-8587(21)00141-8_bib13","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1007\/s11695-014-1500-y","article-title":"Prevalence of anemia and related deficiencies 10 years after gastric bypass\u2014a retrospective study","volume":"25","author":"Karefylakis","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(21)00141-8_bib14","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1007\/s11695-017-2582-0","article-title":"Status of iron metabolism 10 years after Roux-en-Y gastric bypass","volume":"27","author":"Monaco-Ferreira","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(21)00141-8_bib15","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.jamcollsurg.2013.10.023","article-title":"Incidence, treatment, and outcomes of iron deficiency after laparoscopic Roux-en-Y gastric bypass: a 10-year analysis","volume":"218","author":"Obinwanne","year":"2014","journal-title":"J Am Coll Surg"},{"key":"10.1016\/S2213-8587(21)00141-8_bib16","first-page":"465","article-title":"Swedish obese subjects (SOS). Recruitment for an intervention study and a selected description of the obese state","volume":"16","author":"Sj\u00f6str\u00f6m","year":"1992","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(21)00141-8_bib17","doi-asserted-by":"crossref","first-page":"2683","DOI":"10.1056\/NEJMoa035622","article-title":"Lifestyle, diabetes, and cardiovascular risk factors 10 years after bariatric surgery","volume":"351","author":"Sj\u00f6str\u00f6m","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00141-8_bib18","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/oby.20397","article-title":"Alcohol consumption and alcohol problems after bariatric surgery in the Swedish obese subjects study","volume":"21","author":"Svensson","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00141-8_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41366-018-0097-y","article-title":"Long-term incidence of serious fall-related injuries after bariatric surgery in Swedish obese subjects","volume":"43","author":"Carlsson","year":"2019","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(21)00141-8_bib20","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.clnu.2017.01.022","article-title":"Long-term nutritional status in patients following Roux-en-Y gastric bypass surgery","volume":"37","author":"Dogan","year":"2018","journal-title":"Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00141-8_bib21","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.soard.2016.12.018","article-title":"American Society for Metabolic and Bariatric Surgery integrated health nutritional guidelines for the surgical weight loss patient 2016 update: micronutrients","volume":"13","author":"Parrott","year":"2017","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(21)00141-8_bib22","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1016\/S0140-6736(15)60865-0","article-title":"Iron deficiency anaemia","volume":"387","author":"Lopez","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00141-8_bib23","article-title":"Nordiska riktlinjer f\u00f6r kosttillskott och uppf\u00f6ljning efter obesitaskirurgi\u2014monitorering och supplementering med vitaminer och mineraler","volume":"115","author":"Laurenius","year":"2018","journal-title":"Lakartidningen"},{"key":"10.1016\/S2213-8587(21)00141-8_bib24","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1080\/14767058.2018.1555811","article-title":"The relationship between maternal anemia during pregnancy with preterm birth: a systematic review and meta-analysis","volume":"33","author":"Rahmati","year":"2020","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/S2213-8587(21)00141-8_bib25","doi-asserted-by":"crossref","first-page":"1728","DOI":"10.1080\/14767058.2017.1411477","article-title":"Maternal anemia during pregnancy and small for gestational age: a systematic review and meta-analysis","volume":"32","author":"Badfar","year":"2019","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/S2213-8587(21)00141-8_bib26","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1056\/NEJMoa1405789","article-title":"Outcomes of pregnancy after bariatric surgery","volume":"372","author":"Johansson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00141-8_bib27","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1056\/NEJMc1516566","article-title":"Bariatric surgery and preterm birth","volume":"375","author":"Stephansson","year":"2016","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:43Z","timestamp":1761991843000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001418"}},"issued":{"date-parts":[[2021,8]]},"references-count":26,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2213858721001418"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00141-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term risk of anaemia after bariatric surgery: results from the Swedish Obese Subjects study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00141-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00143-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T18:42:05Z","timestamp":1784659325137,"version":"3.55.0"},"reference-count":177,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100005242","name":"Universit\u00e9 de Montr\u00e9al","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005242","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/s2213-8587(24)00200-6","type":"journal-article","created":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T22:45:53Z","timestamp":1727131553000},"page":"837-855","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Aberrant hormone receptors regulate a wide spectrum of endocrine tumors"],"prefix":"10.1016","volume":"12","author":[{"given":"Andr\u00e9","family":"Lacroix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Bourdeau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fanny","family":"Chasseloup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kamenick\u00fd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine-Guy","family":"Lopez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estelle","family":"Louiset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Herv\u00e9","family":"Lefebvre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00200-6_bib1","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1210\/jcem-34-3-447","article-title":"Adenyl cyclase hormone responses of certain human endocrine tumors","volume":"34","author":"Schorr","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.beem.2018.01.003","article-title":"Aberrant G-protein coupled hormone receptor in adrenal diseases","volume":"32","author":"St-Jean","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1210\/endrev\/bnac034","article-title":"Clinical, pathophysiologic, genetic, and therapeutic progress in primary bilateral macronodular adrenal hyperplasia","volume":"44","author":"Bertherat","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(24)00200-6_bib4","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-13-0308","article-title":"Autocrine\/paracrine regulatory mechanisms in adrenocortical neoplasms responsible for primary adrenal hypercorticism","volume":"169","author":"Lefebvre","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib5","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1111\/cen.13496","article-title":"Gain-of-function mutations in G-protein-coupled receptor genes associated with human endocrine disorders","volume":"88","author":"Fukami","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib6","doi-asserted-by":"crossref","first-page":"1038","DOI":"10.1210\/endrev\/bnac011","article-title":"Peptidergic G protein-coupled receptor regulation of adrenal function: bench to bedside and back","volume":"43","author":"Lenzini","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(24)00200-6_bib7","doi-asserted-by":"crossref","first-page":"111258","DOI":"10.1016\/j.mce.2021.111258","article-title":"Adrenal medulla development and medullary-cortical interactions","volume":"528","author":"Bechmann","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib8","doi-asserted-by":"crossref","first-page":"111377","DOI":"10.1016\/j.mce.2021.111377","article-title":"Steroidogenic cell microenvironment and adrenal function in physiological and pathophysiological conditions","volume":"535","author":"Lopez","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib9","doi-asserted-by":"crossref","first-page":"4967","DOI":"10.1210\/jc.2019-00425","article-title":"Illicit upregulation of serotonin signaling pathway in adrenals of patients with high plasma or intra-adrenal ACTH levels","volume":"104","author":"Le Mestre","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib10","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1210\/jcem.87.6.8571","article-title":"Expression and function of vasoactive intestinal peptide, pituitary adenylate cyclase-activating polypeptide, and their receptors in the human adrenal gland","volume":"87","author":"Mazzocchi","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib11","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1038\/s41467-020-16470-8","article-title":"The neuropeptide substance P regulates aldosterone secretion in human adrenals","volume":"11","author":"Wils","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00200-6_bib12","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1007\/s10571-010-9594-9","article-title":"Expression of trophic peptides and their receptors in chromaffin cells and pheochromocytoma","volume":"30","author":"Thouennon","year":"2010","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib13","first-page":"2195","article-title":"Vasopressin receptors in human adrenal medulla and pheochromocytoma","volume":"84","author":"Grazzini","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib14","doi-asserted-by":"crossref","first-page":"34","DOI":"10.3389\/fendo.2015.00034","article-title":"Cell-to-cell communication in bilateral macronodular adrenal hyperplasia causing hypercortisolism","volume":"6","author":"Lefebvre","year":"2015","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib15","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJM199911183412104","article-title":"Leuprolide acetate therapy in luteinizing hormone-dependent Cushing's syndrome","volume":"341","author":"Lacroix","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib16","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.mce.2014.11.013","article-title":"Paracrine control of steroidogenesis by serotonin in adrenocortical neoplasms","volume":"408","author":"Lefebvre","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib17","doi-asserted-by":"crossref","first-page":"e87958","DOI":"10.1172\/jci.insight.87958","article-title":"PKA regulatory subunit 1A inactivating mutation induces serotonin signaling in primary pigmented nodular adrenal disease","volume":"1","author":"Bram","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(24)00200-6_bib18","doi-asserted-by":"crossref","first-page":"R56","DOI":"10.1093\/ejendo\/lvad026","article-title":"Extensive expertise in endocrinology: glucose-dependent insulinotropic peptide-dependent Cushing's syndrome","volume":"188","author":"Lacroix","year":"2023","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib19","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(21)00236-9","article-title":"Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study","volume":"9","author":"Chasseloup","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib20","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1016\/j.gim.2021.09.018","article-title":"KDM1A inactivation causes hereditary food-dependent Cushing syndrome","volume":"24","author":"Vaczlavik","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib21","doi-asserted-by":"crossref","first-page":"e92184","DOI":"10.1172\/jci.insight.92184","article-title":"Adrenal GIPR expression and chromosome 19q13 microduplications in GIP-dependent Cushing's syndrome","volume":"2","author":"Lecoq","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(24)00200-6_bib22","doi-asserted-by":"crossref","first-page":"585","DOI":"10.7326\/0003-4819-131-8-199910190-00006","article-title":"Paradoxical response to dexamethasone in the diagnosis of primary pigmented nodular adrenocortical disease","volume":"131","author":"Stratakis","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib23","doi-asserted-by":"crossref","first-page":"3931","DOI":"10.1210\/jc.2002-022001","article-title":"Primary pigmented nodular adrenocortical disease: paradoxical responses of cortisol secretion to dexamethasone occur in vitro and are associated with increased expression of the glucocorticoid receptor","volume":"88","author":"Bourdeau","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib24","doi-asserted-by":"crossref","first-page":"2406","DOI":"10.1210\/jc.2009-0031","article-title":"The paradoxical increase in cortisol secretion induced by dexamethasone in primary pigmented nodular adrenocortical disease involves a glucocorticoid receptor-mediated effect of dexamethasone on protein kinase A catalytic subunits","volume":"94","author":"Louiset","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib25","doi-asserted-by":"crossref","first-page":"72","DOI":"10.3389\/fendo.2016.00072","article-title":"Role of ACTH and other hormones in the regulation of aldosterone production in primary aldosteronism","volume":"7","author":"El Ghorayeb","year":"2016","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib26","doi-asserted-by":"crossref","first-page":"e3969","DOI":"10.1210\/clinem\/dgab420","article-title":"ACTH stimulation maximizes the accuracy of peripheral steroid profiling in primary aldosteronism subtyping","volume":"106","author":"Tezuka","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib27","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1530\/EJE-08-0711","article-title":"Screening for membrane hormone receptor expression in primary aldosteronism","volume":"160","author":"Zwermann","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib28","doi-asserted-by":"crossref","first-page":"2771","DOI":"10.1210\/jc.2011-0573","article-title":"Significance of adrenocorticotropin stimulation test in the diagnosis of an aldosterone-producing adenoma","volume":"96","author":"Sonoyama","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib29","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1210\/jc.2014-3551","article-title":"Diagnostic value of ACTH stimulation test in determining the subtypes of primary aldosteronism","volume":"100","author":"Jiang","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib30","doi-asserted-by":"crossref","first-page":"5867","DOI":"10.1210\/jc.2019-01182","article-title":"Three discrete patterns of primary aldosteronism lateralization in response to cosyntropin during adrenal vein sampling","volume":"104","author":"Wannachalee","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib31","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1016\/j.surg.2017.09.032","article-title":"Subtyping of primary aldosteronism with adrenal vein sampling: hormone- and side-specific effects of cosyntropin and metoclopramide","volume":"163","author":"Rossitto","year":"2018","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(24)00200-6_bib32","doi-asserted-by":"crossref","first-page":"E550","DOI":"10.1210\/jc.2014-3660","article-title":"Mast cell hyperplasia is associated with aldosterone hypersecretion in a subset of aldosterone-producing adenomas","volume":"100","author":"Duparc","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib33","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1530\/eje.1.02051","article-title":"Expression profile of serotonin4 (5-HT4) receptors in adrenocortical aldosterone-producing adenomas","volume":"153","author":"Cartier","year":"2005","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib34","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.mce.2016.06.015","article-title":"Temporal and spatial distribution of mast cells and steroidogenic enzymes in the human fetal adrenal","volume":"434","author":"Naccache","year":"2016","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib35","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1210\/jc.2008-1340","article-title":"Regulation of aldosterone secretion by several aberrant receptors including for glucose-dependent insulinotropic peptide in a patient with an aldosteronoma","volume":"94","author":"Lampron","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib36","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1016\/j.mce.2017.08.019","article-title":"Aberrant G protein-receptor expression is associated with DNA methylation in aldosterone-producing adenoma","volume":"461","author":"Itcho","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib37","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1210\/jcem.87.3.8327","article-title":"Characterization of serotonin(4) receptors in adrenocortical aldosterone-producing adenomas: in vivo and in vitro studies","volume":"87","author":"Lefebvre","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib38","doi-asserted-by":"crossref","first-page":"e45","DOI":"10.1210\/clinem\/dgaa703","article-title":"Aldosterone is aberrantly regulated by various stimuli in a high proportion of patients with primary aldosteronism","volume":"106","author":"St-Jean","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib39","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1210\/jc.2005-1453","article-title":"Evidence for a role of vasopressin in the control of aldosterone secretion in primary aldosteronism: in vitro and in vivo studies","volume":"91","author":"Perraudin","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib40","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1677\/JOE-07-0037","article-title":"G-protein-coupled receptors in aldosterone-producing adenomas: a potential cause of hyperaldosteronism","volume":"195","author":"Ye","year":"2007","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib41","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1210\/jc.2005-1298","article-title":"Elevated expression of luteinizing hormone receptor in aldosterone-producing adenomas","volume":"91","author":"Saner-Amigh","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib42","first-page":"318","article-title":"LH, progesterone, and TSH can stimulate aldosterone in vitro: a study on normal adrenal cortex and aldosterone producing adenoma","volume":"46","author":"Nicolini","year":"2014","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(24)00200-6_bib43","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.mce.2014.01.016","article-title":"Aberrant gonadotropin-releasing hormone receptor (GnRHR) expression and its regulation of CYP11B2 expression and aldosterone production in adrenal aldosterone-producing adenoma (APA)","volume":"384","author":"Nakamura","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib44","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1530\/EJE-10-0879","article-title":"A case of primary aldosteronism in pregnancy: do LH and GNRH receptors have a potential role in regulating aldosterone secretion?","volume":"164","author":"Albiger","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib45","doi-asserted-by":"crossref","first-page":"1153374","DOI":"10.3389\/fendo.2023.1153374","article-title":"HCG-responsive aldosteronoma with transient secretion during pregnancy confirmed through HCG-stimulated adrenal venous sampling","volume":"14","author":"Castinetti","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib46","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.1210\/jc.2018-00087","article-title":"Genetic characterization of GnRH\/LH-responsive primary aldosteronism","volume":"103","author":"Gagnon","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib47","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1038\/s41588-021-00906-y","article-title":"Somatic mutations of GNA11 and GNAQ in CTNNB1-mutant aldosterone-producing adenomas presenting in puberty, pregnancy or menopause","volume":"53","author":"Zhou","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00200-6_bib48","first-page":"1494","article-title":"Pregnancy, primary aldosteronism, and somatic CTNNB1 mutations","volume":"374","author":"Teo","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib49","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1210\/jcem-40-4-720","article-title":"Characterization of the glucagon receptor in a pheochromocytoma","volume":"40","author":"Levey","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib50","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0196-9781(01)00369-2","article-title":"Human pheochromocytomas, but not adrenal medulla, express glucagon-receptor gene and possess an in vitro secretory response to glucagon","volume":"22","author":"Albertin","year":"2001","journal-title":"Peptides"},{"key":"10.1016\/S2213-8587(24)00200-6_bib51","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1161\/01.HYP.17.6.733","article-title":"Glucagon and clonidine testing in the diagnosis of pheochromocytoma","volume":"17","author":"Grossman","year":"1991","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(24)00200-6_bib52","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1210\/jc.2009-1850","article-title":"Low sensitivity of glucagon provocative testing for diagnosis of pheochromocytoma","volume":"95","author":"Lenders","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib53","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1161\/HYPERTENSIONAHA.121.18864","article-title":"Expression of LHCGR in pheochromocytomas unveils an endocrine mechanism connecting pregnancy and epinephrine overproduction","volume":"79","author":"Lopez","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(24)00200-6_bib54","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1016\/S0140-6736(76)92008-0","article-title":"Hypertensive crisis in patient with phaeochromocytoma given metoclopramide","volume":"2","author":"Plouin","year":"1976","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00200-6_bib55","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1097\/00004872-198404000-00002","article-title":"Metoclopramide increases the release of catecholamines from isolated human phaeochromocytomas","volume":"2","author":"Adler-Graschinsky","year":"1984","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(24)00200-6_bib56","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1677\/ERC-08-0190","article-title":"Metoclopramide stimulates catecholamine- and granin-derived peptide secretion from pheochromocytoma cells through activation of serotonin type 4 (5-HT4) receptors","volume":"16","author":"Guillemot","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(24)00200-6_bib57","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00031","article-title":"Secretion of vasopressin from a human pheochromocytoma","volume":"128","author":"Boccara","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib58","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib59","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1056\/NEJMoa1215245","article-title":"Intraadrenal corticotropin in bilateral macronodular adrenal hyperplasia","volume":"369","author":"Louiset","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib60","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1530\/ERC-21-0298","article-title":"\u03b2-catenin activation and illicit receptor expression in adrenocortical cells","volume":"29","author":"Le Mestre","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(24)00200-6_bib61","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/clinchem\/hvac191","article-title":"In situ metabolomics of cortisol-producing adenomas","volume":"69","author":"Murakami","year":"2023","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(24)00200-6_bib62","doi-asserted-by":"crossref","first-page":"E687","DOI":"10.1210\/jc.2011-3000","article-title":"Activation of cyclic AMP signaling leads to different pathway alterations in lesions of the adrenal cortex caused by germline PRKAR1A defects versus those due to somatic GNAS mutations","volume":"97","author":"Almeida","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib63","doi-asserted-by":"crossref","first-page":"101386","DOI":"10.1016\/j.beem.2020.101386","article-title":"Adrenocortical hyperplasia: a multifaceted disease","volume":"34","author":"Bourdeau","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib64","first-page":"494","article-title":"Estradiol stimulates cortisol production by adrenal cells in estrogen-dependent primary adrenocortical nodular dysplasia","volume":"77","author":"Caticha","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib65","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1677\/ERC-07-0081","article-title":"Expression of progesterone and estradiol receptors in normal adrenal cortex, adrenocortical tumors, and primary pigmented nodular adrenocortical disease","volume":"15","author":"de Cremoux","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(24)00200-6_bib66","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1210\/er.2010-0001","article-title":"Development and function of the human fetal adrenal cortex: a key component in the feto-placental unit","volume":"32","author":"Ishimoto","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(24)00200-6_bib67","doi-asserted-by":"crossref","first-page":"19546","DOI":"10.1038\/srep19546","article-title":"Activating mutations in CTNNB1 in aldosterone producing adenomas","volume":"6","author":"\u00c5kerstr\u00f6m","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(24)00200-6_bib68","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1093\/hmg\/ddt484","article-title":"WNT\/\u03b2-catenin signalling is activated in aldosterone-producing adenomas and controls aldosterone production","volume":"23","author":"Berthon","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(24)00200-6_bib69","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1530\/eje.0.1370262","article-title":"Absence of angiotensin II type 1 receptor gene mutations in human adrenal tumors","volume":"137","author":"Sachse","year":"1997","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib70","doi-asserted-by":"crossref","first-page":"e865","DOI":"10.1210\/clinem\/dgab611","article-title":"Reassessment of postural stimulation testing as a simple tool to identify a subgroup of patients with unilateral primary aldosteronism","volume":"107","author":"Teresa Fuss","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib71","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1111\/j.1365-2265.2011.04202.x","article-title":"A prospective evaluation of postural stimulation testing, computed tomography and adrenal vein sampling in the differential diagnosis of primary aldosteronism","volume":"76","author":"Lau","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib72","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism \u2013 a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib73","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1055\/a-2106-4663","article-title":"Role of adrenal vein sampling in guiding surgical decision in primary aldosteronism","volume":"131","author":"Younes","year":"2023","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/S2213-8587(24)00200-6_bib74","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/clinem\/dgac679","article-title":"Intra-individual variability of serum aldosterone and implications for primary aldosteronism screening","volume":"108","author":"Maciel","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib75","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1161\/HYPERTENSIONAHA.120.16429","article-title":"Intraindividual variability of aldosterone concentrations in primary aldosteronism: implications for case detection","volume":"77","author":"Yozamp","year":"2021","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(24)00200-6_bib76","doi-asserted-by":"crossref","first-page":"5153","DOI":"10.3390\/ijms24065153","article-title":"Pathophysiology and management of glycemic alterations before and after surgery for pheochromocytoma and paraganglioma","volume":"24","author":"Lopez","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(24)00200-6_bib77","doi-asserted-by":"crossref","first-page":"5956","DOI":"10.1210\/jcem.86.12.8091","article-title":"NPY regulates catecholamine secretion from human adrenal chromaffin cells","volume":"86","author":"Cavadas","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib78","first-page":"446","article-title":"Preproenkephalin B-derived opioid peptides in human phaeochromocytomas","volume":"114","author":"Yanase","year":"1987","journal-title":"Acta Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib79","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0014-2999(98)00834-6","article-title":"Kappa1-opioid binding sites are the dominant opioid binding sites in surgical specimens of human pheochromocytomas and in a human pheochromocytoma (KAT45) cell line","volume":"364","author":"Kampa","year":"1999","journal-title":"Eur J Pharmacol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib80","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1056\/NEJM198303173081113","article-title":"Naloxone administration releases catecholamines","volume":"308","author":"Mannelli","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib81","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/j.1365-2265.1986.tb03273.x","article-title":"Naloxone provokes catecholamine release in phaeochromocytomas and paragangliomas","volume":"24","author":"Bouloux","year":"1986","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib82","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.tem.2009.12.003","article-title":"Pituitary somatostatin receptor signaling","volume":"21","author":"Ben-Shlomo","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib83","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s41572-019-0071-6","article-title":"Acromegaly","volume":"5","author":"Colao","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(24)00200-6_bib84","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1038\/s41574-018-0114-1","article-title":"The causes and consequences of pituitary gigantism","volume":"14","author":"Beckers","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib85","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1055\/s-2007-1013580","article-title":"Correlative studies between the presence of thyrotropin-releasing hormone (TRH) receptors and the in vitro stimulation of growth-hormone (GH) secretion in human GH-secreting adenomas","volume":"17","author":"Le Dafniet","year":"1985","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(24)00200-6_bib86","first-page":"1974","article-title":"Gonadotropin-releasing hormone and gonadotropin-releasing hormone receptor messenger ribonucleic acids expression in nontumorous and neoplastic pituitaries","volume":"82","author":"Sanno","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib87","first-page":"443","article-title":"Paradoxical growth hormone response to thyrotropin-releasing hormone in acromegaly. Clinical correlations and prognostic value","volume":"122","author":"De Marinis","year":"1990","journal-title":"Acta Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib88","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1055\/s-2007-1002096","article-title":"TRH\/GnRH test in acromegaly. Long-term follow-up experience with successfully treated patients","volume":"25","author":"Brockmeier","year":"1993","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(24)00200-6_bib89","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1111\/cen.12336","article-title":"Gsp mutation in acromegaly and its influence on TRH-induced paradoxical GH response","volume":"80","author":"Goto","year":"2014","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib90","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1210\/jcem-44-3-465","article-title":"Effect of dopamine on plasma growth hormone and prolactin levels in normal and acromegalic subjects","volume":"44","author":"Camanni","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib91","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1210\/jcem-49-5-737","article-title":"In vitro effect of dopamine and L-dopa on prolactin and growth hormone release from human pituitary adenomas","volume":"49","author":"Peillon","year":"1979","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib92","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1210\/er.2015-1042","article-title":"Pituitary apoplexy","volume":"36","author":"Briet","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(24)00200-6_bib93","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1507\/endocrj.50.643","article-title":"Glucose-dependent insulinotropic polypeptide induced growth hormone secretion in acromegaly","volume":"50","author":"Umahara","year":"2003","journal-title":"Endocr J"},{"key":"10.1016\/S2213-8587(24)00200-6_bib94","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1111\/j.1365-2826.2011.02155.x","article-title":"The glucose-dependent insulinotropic polypeptide receptor is overexpressed amongst GNAS1 mutation-negative somatotropinomas and drives growth hormone (GH)-promoter activity in GH3 cells","volume":"23","author":"Occhi","year":"2011","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib95","doi-asserted-by":"crossref","first-page":"244","DOI":"10.1159\/000497214","article-title":"Growth hormone response to oral glucose load: from normal to pathological conditions","volume":"108","author":"Hage","year":"2019","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(24)00200-6_bib96","doi-asserted-by":"crossref","first-page":"R261","DOI":"10.1530\/EJE-20-1448","article-title":"Management of endocrine disease: etiology and outcome of acromegaly in patients with a paradoxical GH response to glucose","volume":"184","author":"Hage","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib97","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1530\/EJE-16-0831","article-title":"The GIP\/GIPR axis is functionally linked to GH-secretion increase in a significant proportion of gsp- somatotropinomas","volume":"176","author":"Regazzo","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib98","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1210\/jc.2018-01504","article-title":"Hypermethylator phenotype and ectopic GIP receptor in GNAS mutation-negative somatotropinomas","volume":"104","author":"Hage","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib99","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1007\/s11102-022-01272-6","article-title":"Characterization of sporadic somatotropinomas with high GIP receptor expression","volume":"25","author":"Faria","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(24)00200-6_bib100","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1093\/ejendo\/lvae013","article-title":"KDM1A genotyping and expression in 146 sporadic somatotroph pituitary adenomas","volume":"190","author":"Chasseloup","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib101","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.1210\/jc.2017-02287","article-title":"Genomic alterations and complex subclonal architecture in sporadic GH-secreting pituitary adenomas","volume":"103","author":"Hage","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib102","doi-asserted-by":"crossref","first-page":"9264","DOI":"10.3390\/ijms24119264","article-title":"The methylation analysis of the glucose-dependent insulinotropic polypeptide receptor (GIPR) locus in GH-secreting pituitary adenomas","volume":"24","author":"Dalle Nogare","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(24)00200-6_bib103","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1038\/nrg3230","article-title":"Functions of DNA methylation: islands, start sites, gene bodies and beyond","volume":"13","author":"Jones","year":"2012","journal-title":"Nat Rev Genet"},{"key":"10.1016\/S2213-8587(24)00200-6_bib104","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s11154-019-09536-6","article-title":"The pathogenic role of the GIP\/GIPR axis in human endocrine tumors: emerging clinical mechanisms beyond diabetes","volume":"21","author":"Regazzo","year":"2020","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/S2213-8587(24)00200-6_bib105","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1210\/jc.2018-01360","article-title":"Paradoxical GH increase during OGTT is associated with first-generation somatostatin analog responsiveness in acromegaly","volume":"104","author":"Scaroni","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib106","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1210\/jc.2018-00975","article-title":"Clinical characteristics of acromegalic patients with paradoxical GH response to oral glucose load","volume":"104","author":"Mukai","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib107","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1530\/EJE-21-0324","article-title":"Characteristics and treatment responsiveness of patients with acromegaly and a paradoxical GH increase to oral glucose load","volume":"185","author":"Atquet","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib108","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1007\/s00125-017-4447-4","article-title":"GIP(3-30)NH2 is an efficacious GIP receptor antagonist in humans: a randomised, double-blinded, placebo-controlled, crossover study","volume":"61","author":"Gasbjerg","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00200-6_bib109","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1056\/NEJMoa1408028","article-title":"Gigantism and acromegaly due to Xq26 microduplications and GPR101 mutation","volume":"371","author":"Trivellin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib110","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1016\/j.ajhg.2022.02.002","article-title":"Duplications disrupt chromatin architecture and rewire GPR101-enhancer communication in X-linked acrogigantism","volume":"109","author":"Franke","year":"2022","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(24)00200-6_bib111","doi-asserted-by":"crossref","first-page":"111091","DOI":"10.1016\/j.mce.2020.111091","article-title":"The X-linked acrogigantism-associated gene gpr101 is a regulator of early embryonic development and growth in zebrafish","volume":"520","author":"Trivellin","year":"2021","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib112","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1530\/ERC-16-0082","article-title":"Somatic mosaicism underlies X-linked acrogigantism syndrome in sporadic male subjects","volume":"23","author":"Daly","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(24)00200-6_bib113","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S0928-4257(00)00212-6","article-title":"Localization of five somatostatin receptors in the rat central nervous system using subtype-specific antibodies","volume":"94","author":"Schulz","year":"2000","journal-title":"J Physiol Paris"},{"key":"10.1016\/S2213-8587(24)00200-6_bib114","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/0024-3205(94)00956-2","article-title":"Expression of mRNA for all five human somatostatin receptors (hSSTR1-5) in pituitary tumors","volume":"56","author":"Panetta","year":"1995","journal-title":"Life Sci"},{"key":"10.1016\/S2213-8587(24)00200-6_bib115","first-page":"1386","article-title":"Somatostatin receptor subtype gene expression in pituitary adenomas","volume":"80","author":"Miller","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib116","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1530\/EJE-15-0832","article-title":"Factors predicting pasireotide responsiveness in somatotroph pituitary adenomas resistant to first-generation somatostatin analogues: an immunohistochemical study","volume":"174","author":"Iacovazzo","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib117","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1038\/ng.3166","article-title":"Mutations in the deubiquitinase gene USP8 cause Cushing's disease","volume":"47","author":"Reincke","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00200-6_bib118","doi-asserted-by":"crossref","first-page":"e13148","DOI":"10.1111\/jne.13148","article-title":"Genetics of Cushing's disease","volume":"34","author":"Simon","year":"2022","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib119","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1007\/s11102-022-01253-9","article-title":"Genetics of Cushing's disease: from the lab to clinical practice","volume":"25","author":"Theodoropoulou","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(24)00200-6_bib120","doi-asserted-by":"crossref","first-page":"9132","DOI":"10.3390\/ijms21239132","article-title":"The mechanisms underlying autonomous adrenocorticotropic hormone secretion in Cushing's disease","volume":"21","author":"Fukuoka","year":"2020","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(24)00200-6_bib121","doi-asserted-by":"crossref","first-page":"4712","DOI":"10.1172\/JCI60417","article-title":"EGFR as a therapeutic target for human, canine, and mouse ACTH-secreting pituitary adenomas","volume":"121","author":"Fukuoka","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(24)00200-6_bib122","doi-asserted-by":"crossref","first-page":"2452","DOI":"10.1210\/jc.2003-030837","article-title":"Dopamine receptor expression and function in corticotroph pituitary tumors","volume":"89","author":"Pivonello","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib123","doi-asserted-by":"crossref","first-page":"1118","DOI":"10.1210\/jc.2008-2101","article-title":"Coexpression of dopamine and somatostatin receptor subtypes in corticotroph adenomas","volume":"94","author":"de Bruin","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00200-6_bib124","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000314296","article-title":"Role of somatostatin receptors in normal and tumoral pituitary corticotropic cells","volume":"92","author":"Hofland","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(24)00200-6_bib125","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S2213-8587(18)30155-4","article-title":"Advances in the medical treatment of Cushing's syndrome","volume":"7","author":"Feelders","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib126","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib127","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1530\/EJE-16-0662","article-title":"Cabergoline for Cushing's disease: a large retrospective multicenter study","volume":"176","author":"Ferriere","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib128","doi-asserted-by":"crossref","first-page":"1165681","DOI":"10.3389\/fendo.2023.1165681","article-title":"Long-term efficacy and safety of subcutaneous pasireotide alone or in combination with cabergoline in Cushing's disease","volume":"14","author":"Feelders","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib129","first-page":"1768","article-title":"Vasopressin receptor expression and mutation analysis in corticotropin-secreting tumors","volume":"81","author":"Dahia","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib130","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/jc.2013-1992","article-title":"A cellular and molecular basis for the selective desmopressin-induced ACTH release in Cushing disease patients: key role of AVPR1b receptor and potential therapeutic implications","volume":"98","author":"Luque","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib131","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1677\/joe.0.1770373","article-title":"Corticotrophin-releasing activity of desmopressin in Cushing's disease: lack of correlation between in vivo and in vitro responsiveness","volume":"177","author":"Pecori Giraldi","year":"2003","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib132","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1172\/JCI118547","article-title":"The pituitary V3 vasopressin receptor and the corticotroph phenotype in ectopic ACTH syndrome","volume":"97","author":"de Keyzer","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(24)00200-6_bib133","doi-asserted-by":"crossref","first-page":"R29","DOI":"10.1530\/EJE-19-0877","article-title":"Management of endocrine disease: Cushing's syndrome due to ectopic ACTH secretion: an expert operational opinion","volume":"182","author":"Young","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib134","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1007\/s11102-022-01220-4","article-title":"Responsiveness to DDAVP in Cushing's disease is associated with USP8 mutations through enhancing AVPR1B promoter activity","volume":"25","author":"Shichi","year":"2022","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(24)00200-6_bib135","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.yfrne.2013.07.005","article-title":"Somatostatin receptors: from signaling to clinical practice","volume":"34","author":"Theodoropoulou","year":"2013","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib136","doi-asserted-by":"crossref","first-page":"924168","DOI":"10.1155\/2012\/924168","article-title":"A review on the association between glucagon-like peptide-1 receptor agonists and thyroid cancer","volume":"2012","author":"Chiu","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/S2213-8587(24)00200-6_bib137","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2967\/jnumed.106.038679","article-title":"GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting","volume":"48","author":"K\u00f6rner","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib138","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1210\/jc.2011-2407","article-title":"Glucagon like peptide-1 receptor expression in the human thyroid gland","volume":"97","author":"Gier","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib139","doi-asserted-by":"crossref","first-page":"384","DOI":"10.2337\/dc22-1148","article-title":"GLP-1 receptor agonists and the risk of thyroid cancer","volume":"46","author":"Bezin","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00200-6_bib140","doi-asserted-by":"crossref","first-page":"249","DOI":"10.2337\/dci22-0052","article-title":"Putting GLP-1 RAs and thyroid cancer in context: additional evidence and remaining doubts","volume":"46","author":"Thompson","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00200-6_bib141","first-page":"403","article-title":"Glucagon-like peptide-1 receptor agonists and thyroid cancer: a narrative review","volume":"34","author":"Espinosa De Ycaza","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(24)00200-6_bib142","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1159\/000330447","article-title":"Incretin receptors in non-neoplastic and neoplastic thyroid C cells in rodents and humans: relevance for incretin-based diabetes therapy","volume":"94","author":"Waser","year":"2011","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(24)00200-6_bib143","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1530\/ERC-21-0258","article-title":"The GIP\/GIPR axis in medullary thyroid cancer: clinical and molecular findings","volume":"29","author":"Regazzo","year":"2022","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(24)00200-6_bib144","doi-asserted-by":"crossref","first-page":"170229","DOI":"10.1016\/j.peptides.2019.170229","article-title":"GIP receptor: expression in neuroendocrine tumours, internalization, signalling from endosomes and structure-function relationship studies","volume":"125","author":"Reubi","year":"2020","journal-title":"Peptides"},{"key":"10.1016\/S2213-8587(24)00200-6_bib145","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1111\/iep.12024","article-title":"Somatostatin receptor expression in thyroid disease","volume":"94","author":"Atkinson","year":"2013","journal-title":"Int J Exp Pathol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib146","first-page":"2417","article-title":"Somatostatin and somatostatin receptor subtype gene expression in medullary thyroid carcinoma","volume":"83","author":"Mato","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib147","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1111\/apm.12584","article-title":"Expression of somatostatin receptor 2A in medullary thyroid carcinoma is associated with lymph node metastasis","volume":"124","author":"Herac","year":"2016","journal-title":"APMIS"},{"key":"10.1016\/S2213-8587(24)00200-6_bib148","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1007\/s12020-017-1424-0","article-title":"Somatostatin receptor subtype 1 might be a predictor of better response to therapy in medullary thyroid carcinoma","volume":"58","author":"Kendler","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(24)00200-6_bib149","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/j.1365-2265.1992.tb00955.x","article-title":"Results of long-term continuous subcutaneous octreotide administration in 14 patients with medullary thyroid carcinoma","volume":"36","author":"Modigliani","year":"1992","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib150","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1007\/s12020-018-1583-7","article-title":"The antiproliferative effect of pasireotide LAR alone and in combination with everolimus in patients with medullary thyroid cancer: a single-center, open-label, phase II, proof-of-concept study","volume":"62","author":"Faggiano","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(24)00200-6_bib151","first-page":"e4903","article-title":"Metastatic medullary thyroid cancer: the role of 68Gallium-DOTA-somatostatin analogue PET\/CT and peptide receptor radionuclide therapy","volume":"106","author":"Hayes","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib152","first-page":"3455","article-title":"Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization","volume":"54","author":"Reubi","year":"1994","journal-title":"Cancer Res"},{"key":"10.1016\/S2213-8587(24)00200-6_bib153","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00428-002-0609-x","article-title":"Expression of somatostatin receptor types 1-5 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis","volume":"440","author":"Papotti","year":"2002","journal-title":"Virchows Arch"},{"key":"10.1016\/S2213-8587(24)00200-6_bib154","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1677\/erc.0.0100451","article-title":"Somatostatin receptors in gastroentero-pancreatic neuroendocrine tumours","volume":"10","author":"de Herder","year":"2003","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(24)00200-6_bib155","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1056\/NEJM198609113151102","article-title":"Treatment of the malignant carcinoid syndrome. Evaluation of a long-acting somatostatin analogue","volume":"315","author":"Kvols","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib156","doi-asserted-by":"crossref","first-page":"162","DOI":"10.7326\/0003-4819-107-2-162","article-title":"Treatment of metastatic islet cell carcinoma with a somatostatin analogue (SMS 201-995)","volume":"107","author":"Kvols","year":"1987","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib157","doi-asserted-by":"crossref","first-page":"4656","DOI":"10.1200\/JCO.2009.22.8510","article-title":"Placebo-controlled, double-blind, prospective, randomized study on the effect of octreotide LAR in the control of tumor growth in patients with metastatic neuroendocrine midgut tumors: a report from the PROMID Study Group","volume":"27","author":"Rinke","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib158","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1316158","article-title":"Lanreotide in metastatic enteropancreatic neuroendocrine tumors","volume":"371","author":"Caplin","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib159","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S0140-6736(89)91258-0","article-title":"Localisation of endocrine-related tumours with radioiodinated analogue of somatostatin","volume":"1","author":"Krenning","year":"1989","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00200-6_bib160","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1056\/NEJM199011013231805","article-title":"Somatostatin-receptor imaging in the localization of endocrine tumors","volume":"323","author":"Lamberts","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib161","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1056\/NEJMoa1607427","article-title":"Phase 3 trial of 177Lu-dotatate for midgut neuroendocrine tumors","volume":"376","author":"Strosberg","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib162","doi-asserted-by":"crossref","first-page":"1386","DOI":"10.1097\/MPA.0000000000000700","article-title":"Association between somatostatin receptor expression and clinical outcomes in neuroendocrine tumors","volume":"45","author":"Qian","year":"2016","journal-title":"Pancreas"},{"key":"10.1016\/S2213-8587(24)00200-6_bib163","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1002\/cncr.28341","article-title":"Clinicopathologic characteristics of pancreatic neuroendocrine tumors and relation of somatostatin receptor type 2A to outcomes","volume":"119","author":"Okuwaki","year":"2013","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(24)00200-6_bib164","doi-asserted-by":"crossref","first-page":"e230257","DOI":"10.1530\/EC-23-0257","article-title":"Glucagon-like peptide 1 receptor agonists and thyroid cancer: is it the time to be concerned?","volume":"12","author":"Lisco","year":"2023","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(24)00200-6_bib165","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1056\/NEJMc0802045","article-title":"Glucagon-like peptide 1-receptor scans to localize occult insulinomas","volume":"359","author":"Wild","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib166","doi-asserted-by":"crossref","first-page":"2318","DOI":"10.1007\/s00259-018-4101-5","article-title":"Comparison of glucagon-like peptide-1 receptor (GLP-1R) PET\/CT, SPECT\/CT and 3T MRI for the localisation of occult insulinomas: evaluation of diagnostic accuracy in a prospective crossover imaging study","volume":"45","author":"Antwi","year":"2018","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/S2213-8587(24)00200-6_bib167","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/nrendo.2011.120","article-title":"Neuroendocrine neoplasms of the gut and pancreas: new insights","volume":"8","author":"Rindi","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib168","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1007\/s12022-022-09708-2","article-title":"Overview of the 2022 WHO Classification of Neuroendocrine Neoplasms","volume":"33","author":"Rindi","year":"2022","journal-title":"Endocr Pathol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib169","doi-asserted-by":"crossref","first-page":"927859","DOI":"10.3389\/fendo.2022.927859","article-title":"Use of GLP-1 receptor agonists and occurrence of thyroid disorders: a meta-analysis of randomized controlled trials","volume":"13","author":"Hu","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(24)00200-6_bib170","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00259-003-1184-3","article-title":"Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting","volume":"30","author":"Reubi","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/S2213-8587(24)00200-6_bib171","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s002590100541","article-title":"Somatostatin receptor sst1-sst5 expression in normal and neoplastic human tissues using receptor autoradiography with subtype-selective ligands","volume":"28","author":"Reubi","year":"2001","journal-title":"Eur J Nucl Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib172","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1002\/jlcr.3750","article-title":"Exendin-4 analogs in insulinoma theranostics","volume":"62","author":"Jansen","year":"2019","journal-title":"J Labelled Comp Radiopharm"},{"key":"10.1016\/S2213-8587(24)00200-6_bib173","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1210\/jc.2011-2454","article-title":"Glucose-dependent insulinotropic polypeptide receptors in most gastroenteropancreatic and bronchial neuroendocrine tumors","volume":"97","author":"Waser","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00200-6_bib174","doi-asserted-by":"crossref","first-page":"1206","DOI":"10.1016\/j.surg.2013.04.052","article-title":"Gastric inhibitory polypeptide receptor (GIPR) is a promising target for imaging and therapy in neuroendocrine tumors","volume":"154","author":"Sherman","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(24)00200-6_bib175","doi-asserted-by":"crossref","first-page":"976","DOI":"10.2967\/jnumed.113.133744","article-title":"The glucose-dependent insulinotropic polypeptide receptor: a novel target for neuroendocrine tumor imaging\u2014first preclinical studies","volume":"55","author":"Gourni","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(24)00200-6_bib176","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1749-6632.2000.tb06946.x","article-title":"In vitro evaluation of VIP\/PACAP receptors in healthy and diseased human tissues. Clinical implications","volume":"921","author":"Reubi","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(24)00200-6_bib177","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.2967\/jnumed.118.224048","article-title":"Combination of 5-Fluorouracil with epigenetic modifiers induces radiosensitization, somatostatin receptor 2 expression, and radioligand binding in neuroendocrine tumor cells in vitro","volume":"60","author":"Jin","year":"2019","journal-title":"J Nucl Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T23:00:22Z","timestamp":1729638022000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002006"}},"issued":{"date-parts":[[2024,11]]},"references-count":177,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2213858724002006"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00200-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Aberrant hormone receptors regulate a wide spectrum of endocrine tumors","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00200-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:32:06Z","timestamp":1784309526919,"version":"3.55.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/s2213-8587(17)30133-x","type":"journal-article","created":{"date-parts":[[2017,4,25]],"date-time":"2017-04-25T01:01:01Z","timestamp":1493082061000},"page":"89-90","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Has the UK really become iodine sufficient?"],"prefix":"10.1016","volume":"6","author":[{"given":"Sarah C","family":"Bath","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret P","family":"Rayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30133-X_bib2","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1016\/S0140-6736(11)60693-4","article-title":"Iodine status of UK schoolgirls: a cross-sectional survey","volume":"377","author":"Vanderpump","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30133-X_bib3","series-title":"National Diet and Nutrition Survey results from years 5 and 6 (combined) of the rolling programme (2012\/2013\u20132013\/2014)","year":"2016"},{"key":"10.1016\/S2213-8587(17)30133-X_bib4","series-title":"Assessment of iodine deficiency disorders and monitoring their elimination","year":"2007"},{"key":"10.1016\/S2213-8587(17)30133-X_bib5","series-title":"National Diet and Nutrition Survey: results from years 1, 2, 3 and 4 (combined) of the rolling programme (2008\/2009\u20132011\/2012)","year":"2014"},{"key":"10.1016\/S2213-8587(17)30133-X_bib6","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1177\/156482651103200304","article-title":"Comparison of median urinary iodine concentration as an indicator of iodine status among pregnant women, school-age children, and nonpregnant women","volume":"32","author":"Wong","year":"2011","journal-title":"Food Nutr Bull"},{"key":"10.1016\/S2213-8587(17)30133-X_bib8","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1007\/s10653-015-9682-3","article-title":"A review of the iodine status of UK pregnant women and its implications for the offspring","volume":"37","author":"Bath","year":"2015","journal-title":"Environ Geochem Health"},{"key":"10.1016\/S2213-8587(17)30133-X_bib9","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/j.1753-4887.2012.00528.x","article-title":"Assessment of iodine nutrition in populations: past, present, and future","volume":"70","author":"Zimmermann","year":"2012","journal-title":"Nutr Rev"},{"key":"10.1016\/S2213-8587(17)30133-X_bib10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.3945\/jn.115.229005","article-title":"Estimation of the prevalence of inadequate and excessive iodine intakes in school-age children from the adjusted distribution of urinary iodine concentrations from population surveys","volume":"146","author":"Zimmermann","year":"2016","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(17)30133-X_bib11","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(13)60436-5","article-title":"Effect of inadequate iodine status in UK pregnant women on cognitive outcomes in their children: results from the Avon Longitudinal Study of Parents and Children (ALSPAC)","volume":"382","author":"Bath","year":"2013","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T08:29:56Z","timestamp":1552984196000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871730133X"}},"issued":{"date-parts":[[2018,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S221385871730133X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30133-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Has the UK really become iodine sufficient?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30133-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:30:22Z","timestamp":1786491022986,"version":"build-2736575974"},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/s2213-8587(26)00161-0","type":"journal-article","created":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T22:47:30Z","timestamp":1782859650000},"page":"710-712","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["ADA Scientific Sessions 2026: a line crossed"],"prefix":"10.1016","volume":"14","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:07:11Z","timestamp":1786489631000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726001610"}},"issued":{"date-parts":[[2026,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2213858726001610"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00161-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"ADA Scientific Sessions 2026: a line crossed","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00161-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:30:24Z","timestamp":1786491024517,"version":"build-2736575974"},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/s2213-8587(26)00194-4","type":"journal-article","created":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T22:50:05Z","timestamp":1785365405000},"page":"703","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Soaring GLP-1 receptor agonist use"],"prefix":"10.1016","volume":"14","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001944?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001944?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:07:06Z","timestamp":1786489626000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726001944"}},"issued":{"date-parts":[[2026,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2213858726001944"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00194-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Soaring GLP-1 receptor agonist use","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00194-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00356-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T02:41:58Z","timestamp":1782873718962,"version":"3.54.5"},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010676","name":"EU Framework Programme for Research and Innovation Societal Challenges","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010676","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/s2213-8587(24)00286-9","type":"journal-article","created":{"date-parts":[[2024,11,11]],"date-time":"2024-11-11T23:34:31Z","timestamp":1731368071000},"page":"870-872","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Global diabetes incidence trends in young adults"],"prefix":"10.1016","volume":"12","author":[{"given":"Lars C","family":"Stene","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00286-9_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00286-9_bib2","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S2213-8587(22)00276-5","article-title":"Estimating the total incidence of type 1 diabetes in children and adolescents aged 0\u201319 years from 1990 to 2050: a global simulation-based analysis","volume":"10","author":"Ward","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00286-9_bib3","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00286-9_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00243-2","article-title":"Trends in the incidence of young-adult-onset diabetes by diabetes type: a multi-national population-based study from an international diabetes consortium","author":"Magliano","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00286-9_bib5","article-title":"Trends in incidence of total or type 2 diabetes: systematic review","volume":"366","author":"Magliano","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00286-9_bib6","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00125-018-4763-3","article-title":"Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989\u20132013: a multicentre prospective registration study","volume":"62","author":"Patterson","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00286-9_bib7","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archinte.167.14.1545","article-title":"Short-term variability in measures of glycemia and implications for the classification of diabetes","volume":"167","author":"Selvin","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(24)00286-9_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2024.101567","article-title":"Trends in the incidence of type 1 diabetes and type 2 diabetes in children and adolescents in North Rhine-Westphalia, Germany, from 2002 to 2022","volume":"50","author":"Stahl-Pehe","year":"2024","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(24)00286-9_bib9","doi-asserted-by":"crossref","first-page":"e26","DOI":"10.2337\/dc23-2068","article-title":"Incidence of type 1 diabetes in children has fallen to pre-COVID-19 pandemic levels: a population-wide analysis from Scotland","volume":"47","author":"Berthon","year":"2024","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T04:08:23Z","timestamp":1732680503000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002869"}},"issued":{"date-parts":[[2024,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2213858724002869"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00286-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global diabetes incidence trends in young adults","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00286-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00243-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T23:35:35Z","timestamp":1794008135793,"version":"4.8.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/s2213-8587(24)00246-8","type":"journal-article","created":{"date-parts":[[2024,8,8]],"date-time":"2024-08-08T18:40:23Z","timestamp":1723142423000},"page":"601","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"title":["Diabetes-related complications: a toll too high"],"prefix":"10.1016","volume":"12","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002468?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002468?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T08:09:29Z","timestamp":1736842169000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002468"}},"issued":{"date-parts":[[2024,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213858724002468"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00246-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes-related complications: a toll too high","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00246-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T23:54:25Z","timestamp":1789430065628,"version":"build-2803163510"},"reference-count":33,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"The Ukraine State Diabetes Mellitus Program","award":["project number 0106U000844"],"award-info":[{"award-number":["project number 0106U000844"]}]},{"name":"National Institute of Aging, National Institutes of Health","award":["number RO1 AG028593"],"award-info":[{"award-number":["number RO1 AG028593"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/s2213-8587(15)00279-x","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T10:23:53Z","timestamp":1441275833000},"page":"787-794","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"title":["Association between type 2 diabetes and prenatal exposure to the Ukraine famine of 1932\u201333: a retrospective cohort study"],"prefix":"10.1016","volume":"3","author":[{"given":"L H","family":"Lumey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mykola D","family":"Khalangot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander M","family":"Vaiserman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00279-X_bib1","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/S0140-6736(00)92530-3","article-title":"Death-rates in Great Britain and Sweden. Some general regularities and their significance","volume":"223","author":"Kermack","year":"1934","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00279-X_bib2","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF00400248","article-title":"Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis","volume":"35","author":"Hales","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00279-X_bib3","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2008.06.020","article-title":"Fetal programming of glucose-insulin metabolism","volume":"297","author":"Jones","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(15)00279-X_bib4","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1001\/jama.2008.886","article-title":"Birth weight and risk of type 2 diabetes: a systematic review","volume":"300","author":"Whincup","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00279-X_bib5","doi-asserted-by":"crossref","first-page":"1848","DOI":"10.1056\/NEJMe058187","article-title":"Developmental origins of health and disease","volume":"353","author":"Gillman","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00279-X_bib6","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1093\/ije\/dyh083","article-title":"Intrauterine famine exposure and body proportions at birth: the Dutch Hunger Winter","volume":"33","author":"Stein","year":"2004","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00279-X_bib7","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/ng.2477","article-title":"New loci associated with birth weight identify genetic links between intrauterine growth and adult height and metabolism","volume":"45","author":"Horikoshi","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(15)00279-X_bib8","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1093\/oxfordjournals.epirev.a017923","article-title":"Review of the evidence on fetal and early childhood antecedents of adult chronic disease","volume":"18","author":"Joseph","year":"1996","journal-title":"Epidemiol Rev"},{"key":"10.1016\/S2213-8587(15)00279-X_bib9","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-publhealth-031210-101230","article-title":"Prenatal famine and adult health","volume":"32","author":"Lumey","year":"2011","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/S2213-8587(15)00279-X_bib10","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(97)07244-9","article-title":"Glucose tolerance in adults after prenatal exposure to famine","volume":"351","author":"Ravelli","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00279-X_bib11","first-page":"S164","article-title":"Food restriction during gestation and impaired fasting glucose or glucose tolerance and type 2 diabetes mellitus in adulthood: evidence from the Dutch Hunger Winter Families Study","volume":"1","author":"Lumey","year":"2009","journal-title":"J Dev Orig Health Dis"},{"key":"10.1016\/S2213-8587(15)00279-X_bib12","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.2337\/db10-0385","article-title":"Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood","volume":"59","author":"Li","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(15)00279-X_bib13","doi-asserted-by":"crossref","first-page":"4703","DOI":"10.1073\/pnas.1215626110","article-title":"Quantification of excess risk for diabetes for those born in times of hunger, in an entire population of a nation, across a century","volume":"110","author":"Thurner","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(15)00279-X_bib14","doi-asserted-by":"crossref","first-page":"1342","DOI":"10.1136\/bmj.315.7119.1342","article-title":"Does malnutrition in utero determine diabetes and coronary heart disease in adulthood? Results from the Leningrad siege study, a cross sectional study","volume":"315","author":"Stanner","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00279-X_bib15","doi-asserted-by":"crossref","first-page":"53","DOI":"10.25336\/P6FC7G","article-title":"Demography of a man-made human catastrophe: the case of massive famine in Ukraine 1932\u20131933","volume":"42","author":"Rudnytskyi","year":"2015","journal-title":"Can Stud Popul"},{"key":"10.1016\/S2213-8587(15)00279-X_bib16","series-title":"The Foreign Office and the famine. British documents on Ukraine and the great famine of 1932\u20131933","author":"Carynnyk","year":"1988"},{"key":"10.1016\/S2213-8587(15)00279-X_bib17","series-title":"The years of hunger: Soviet agriculture, 1931\u20131933","author":"Davies","year":"2010"},{"key":"10.1016\/S2213-8587(15)00279-X_bib19","unstructured":"European Parliament. Commemoration of the Holodomor, the artificial famine in Ukraine (1932\u20131933). 2008."},{"key":"10.1016\/S2213-8587(15)00279-X_bib20","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/00324720215934","article-title":"A new estimate of Ukrainian population losses during the crises of the 1930s and 1940s","volume":"56","author":"Vallin","year":"2002","journal-title":"Popul Stud"},{"key":"10.1016\/S2213-8587(15)00279-X_bib21","series-title":"Definition, diagnosis, and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus","year":"1999"},{"key":"10.1016\/S2213-8587(15)00279-X_bib22","series-title":"Modern epidemiology","author":"Rothman","year":"2008"},{"key":"10.1016\/S2213-8587(15)00279-X_bib23","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1007\/s00125-009-1519-0","article-title":"Seasonality of birth in adult type 2 diabetic patients in three Ukrainian regions","volume":"52","author":"Vaiserman","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00279-X_bib24","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/j.socscimed.2013.10.027","article-title":"Independent and additive association of prenatal famine exposure and intermediary life conditions with adult mortality between age 18\u201363 years","volume":"119","author":"Ekamper","year":"2014","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(15)00279-X_bib25","first-page":"588","article-title":"Predisposition to type II diabetes in Ukraine residents exposed to famine 1932\u20131933 during prenatal development","volume":"23","author":"Vaiserman","year":"2010","journal-title":"Adv Gerontol"},{"key":"10.1016\/S2213-8587(15)00279-X_bib26","series-title":"Early life nutrition and adult health and development","first-page":"145","article-title":"Early-life exposure to the Ukraine famine of 1933 and type 2 diabetes in adulthood","author":"Vaiserman","year":"2013"},{"key":"10.1016\/S2213-8587(15)00279-X_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biochi.2013.10.003","article-title":"Early environmental factors, alteration of epigenetic marks and metabolic disease susceptibility","volume":"97","author":"Portha","year":"2014","journal-title":"Biochimie"},{"key":"10.1016\/S2213-8587(15)00279-X_bib28","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/er.2009-0039","article-title":"Child health, developmental plasticity, and epigenetic programming","volume":"32","author":"Hochberg","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(15)00279-X_bib29","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s00018-013-1297-1","article-title":"Developmental and environmental epigenetic programming of the endocrine pancreas: consequences for type 2 diabetes","volume":"70","author":"Sandovici","year":"2013","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/S2213-8587(15)00279-X_bib30","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/emboj.2011.503","article-title":"DNA methylation profiling identifies epigenetic dysregulation in pancreatic islets from type 2 diabetic patients","volume":"31","author":"Volkmar","year":"2012","journal-title":"EMBO J"},{"key":"10.1016\/S2213-8587(15)00279-X_bib31","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyv043","article-title":"Early gestation as the critical time-window for changes in the prenatal environment to affect the adult human blood methylome","author":"Tobi","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00279-X_bib32","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1073\/pnas.0806560105","article-title":"Persistent epigenetic differences associated with prenatal exposure to famine in humans","volume":"105","author":"Heijmans","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(15)00279-X_bib33","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1016\/j.socscimed.2009.01.027","article-title":"Famine, death, and madness: schizophrenia in early adulthood after prenatal exposure to the Chinese Great Leap Forward Famine","volume":"68","author":"Song","year":"2009","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(15)00279-X_bib34","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/aogs.12494","article-title":"Genetic, nongenetic and epigenetic risk determinants in developmental programming of type 2 diabetes","volume":"93","author":"Vaag","year":"2014","journal-title":"Acta Obstet Gynecol Scand"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500279X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500279X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,30]],"date-time":"2019-08-30T00:35:17Z","timestamp":1567125317000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871500279X"}},"issued":{"date-parts":[[2015,10]]},"references-count":33,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S221385871500279X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00279-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between type 2 diabetes and prenatal exposure to the Ukraine famine of 1932\u201333: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00279-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00323-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T10:31:51Z","timestamp":1788949911432,"version":"build-2803163510"},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,1,1]],"date-time":"2021-01-01T00:00:00Z","timestamp":1609459200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,1]]},"DOI":"10.1016\/s2213-8587(20)30408-3","type":"journal-article","created":{"date-parts":[[2020,12,4]],"date-time":"2020-12-04T19:00:15Z","timestamp":1607108415000},"page":"1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":38,"title":["Osteoporosis: overlooked in men for too long"],"prefix":"10.1016","volume":"9","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720304083?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720304083?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:51Z","timestamp":1761991731000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720304083"}},"issued":{"date-parts":[[2021,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2021,1]]}},"alternative-id":["S2213858720304083"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30408-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoporosis: overlooked in men for too long","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30408-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T02:36:25Z","timestamp":1789094185974,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["FKZ01KX1818"],"award-info":[{"award-number":["FKZ01KX1818"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M and Harry B Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010571","name":"Federal Ministry of Education and Research Berlin Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010571","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["3-SRA-2015\\u201372-M-R"],"award-info":[{"award-number":["3-SRA-2015\\u201372-M-R"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["3-SRA-2019\\u2013718-Q-R"],"award-info":[{"award-number":["3-SRA-2019\\u2013718-Q-R"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation United States of America","doi-asserted-by":"publisher","award":["1-SRA-2014\\u2013310-M-R"],"award-info":[{"award-number":["1-SRA-2014\\u2013310-M-R"]}],"id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/s2213-8587(24)00101-3","type":"journal-article","created":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T18:33:02Z","timestamp":1715020382000},"page":"376-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Effect of population-wide screening for presymptomatic early-stage type 1 diabetes on paediatric clinical care"],"prefix":"10.1016","volume":"12","author":[{"given":"Ezio","family":"Bonifacio","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christiane","family":"Winkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anette-Gabriele","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00101-3_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jama.2019.21565","article-title":"Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany","volume":"323","author":"Ziegler","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00101-3_bib2","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/dc19-2003","article-title":"Cost and cost-effectiveness of large-scale screening for type 1 diabetes in Colorado","volume":"43","author":"McQueen","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00101-3_bib3","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1007\/s00125-023-05953-0","article-title":"Children diagnosed with presymptomatic type 1 diabetes through public health screening have milder diabetes at clinical manifestation","volume":"66","author":"Hummel","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00101-3_bib4","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S2213-8587(23)00354-6","article-title":"Screening type 1 diabetes and celiac disease by law","volume":"12","author":"Bosi","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00101-3_bib5","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1016\/S2213-8587(22)00141-3","article-title":"Two-age islet-autoantibody screening for childhood type 1 diabetes: a prospective cohort study","volume":"10","author":"Ghalwash","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00101-3_bib6","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.2337\/dc21-0969","article-title":"Incidence of type 1 diabetes in children and adolescents during the COVID-19 pandemic in Germany: Results From the DPV Registry","volume":"45","author":"Kamrath","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00101-3_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3777","article-title":"Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes","volume":"40","author":"Hendriks","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(24)00101-3_bib8","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S2213-8587(22)00246-7","article-title":"Impact of the COVID-19 pandemic on long-term trends in the prevalence of diabetic ketoacidosis at diagnosis of paediatric type 1 diabetes: an international multicentre study based on data from 13 national diabetes registries","volume":"10","author":"Birkebaek","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00101-3_bib9","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1007\/s00125-023-06017-z","article-title":"Presymptomatic type 1 diabetes and disease severity at onset. Reply to Schneider J, Gemulla G, Kiess W et al","volume":"66","author":"Hummel","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00101-3_bib10","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/dc17-0558","article-title":"Diabetic ketoacidosis at diagnosis of type 1 diabetes predicts poor long-term glycemic control","volume":"40","author":"Duca","year":"2017","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:40:20Z","timestamp":1779306020000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001013"}},"issued":{"date-parts":[[2024,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2213858724001013"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00101-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of population-wide screening for presymptomatic early-stage type 1 diabetes on paediatric clinical care","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00101-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:01:29Z","timestamp":1790456489976,"version":"4.1.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/s2213-8587(23)00130-4","type":"journal-article","created":{"date-parts":[[2023,5,11]],"date-time":"2023-05-11T19:28:12Z","timestamp":1683833292000},"page":"375","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Schooling and diabetes: not a level playing field"],"prefix":"10.1016","volume":"11","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:29:40Z","timestamp":1790454580000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001304"}},"issued":{"date-parts":[[2023,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2213858723001304"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00130-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Schooling and diabetes: not a level playing field","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00130-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T11:48:51Z","timestamp":1789904931678,"version":"4.0.1"},"reference-count":1,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/s2213-8587(14)70186-x","type":"journal-article","created":{"date-parts":[[2014,9,22]],"date-time":"2014-09-22T19:15:25Z","timestamp":1411413325000},"page":"773","source":"Crossref","is-referenced-by-count":15,"title":["Fetal growth and ethnic variation"],"prefix":"10.1016","volume":"2","author":[{"given":"Paul S","family":"Albert","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine L","family":"Grantz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70186-X_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70121-4","article-title":"The likeness of fetal growth and newborn size across non-isolated populations in the INTERGROWTH-21st Project: the Fetal Growth Longitudinal Study and Newborn Cross-Sectional Study","author":"Villar","year":"2014","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871470186X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871470186X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T09:56:52Z","timestamp":1538215012000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871470186X"}},"issued":{"date-parts":[[2014,10]]},"references-count":1,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S221385871470186X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70186-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,10]]}},{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T03:41:48Z","timestamp":1789789308221,"version":"4.0.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T00:00:00Z","timestamp":1407196800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/s2213-8587(14)70166-4","type":"journal-article","created":{"date-parts":[[2014,8,5]],"date-time":"2014-08-05T23:15:20Z","timestamp":1407280520000},"page":"770-772","source":"Crossref","is-referenced-by-count":33,"title":["Saturated fatty acids and type 2 diabetes: more evidence to re-invent dietary guidelines"],"prefix":"10.1016","volume":"2","author":[{"given":"Dariush","family":"Mozaffarian","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70166-4_bib1","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ajcn\/77.5.1146","article-title":"Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials","volume":"77","author":"Mensink","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70166-4_bib2","doi-asserted-by":"crossref","first-page":"A003","DOI":"10.1161\/circ.127.suppl_12.A003","article-title":"Effects of saturated, polyunsaturated, and monounsaturated fat on blood glucose, insulin sensitivity, and beta cell function: a systematic review and meta-analysis of 84 randomized controlled feeding trials","volume":"127","author":"Imamura","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(14)70166-4_bib3","doi-asserted-by":"crossref","first-page":"e1000252","DOI":"10.1371\/journal.pmed.1000252","article-title":"Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Mozaffarian","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(14)70166-4_bib4","doi-asserted-by":"crossref","first-page":"398","DOI":"10.7326\/M13-1788","article-title":"Association of dietary, circulating, and supplement fatty acids with coronary risk: a systematic review and meta-analysis","volume":"160","author":"Chowdhury","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(14)70166-4_bib5","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1007\/s11745-010-3393-4","article-title":"Saturated fat and cardiometabolic risk factors, coronary heart disease, stroke, and diabetes: a fresh look at the evidence","volume":"45","author":"Micha","year":"2010","journal-title":"Lipids"},{"key":"10.1016\/S2213-8587(14)70166-4_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70146-9","article-title":"Differences in the prospective association between individual plasma phospholipid saturated fatty acids and incident type 2 diabetes: the EPIC-InterAct case-cohort study","author":"Forouhi","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70166-4_bib7","doi-asserted-by":"crossref","first-page":"854","DOI":"10.3945\/ajcn.112.045468","article-title":"trans-Palmitoleic acid, other dairy fat biomarkers, and incident diabetes: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"97","author":"Mozaffarian","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70166-4_bib8","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.3945\/ajcn.113.059030","article-title":"Dairy products and the risk of type 2 diabetes: a systematic review and dose-response meta-analysis of cohort studies","volume":"98","author":"Aune","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70166-4_bib9","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1161\/CIRCGENETICS.112.964619","article-title":"Genome-wide association study identifies novel loci associated with concentrations of four plasma phospholipid fatty acids in the de novo lipogenesis pathway: results from the CHARGE consortium","volume":"6","author":"Wu","year":"2013","journal-title":"Circ Cardiovasc Genet"},{"key":"10.1016\/S2213-8587(14)70166-4_bib10","doi-asserted-by":"crossref","first-page":"e1001255","DOI":"10.1371\/journal.pmed.1001255","article-title":"Plasma phospholipid fatty acid concentration and incident coronary heart disease in men and women: the EPIC-Norfolk prospective study","volume":"9","author":"Khaw","year":"2012","journal-title":"PLoS Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701664?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701664?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,13]],"date-time":"2022-04-13T18:38:02Z","timestamp":1649875082000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701664"}},"issued":{"date-parts":[[2014,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S2213858714701664"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70166-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,10]]}},{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:55:51Z","timestamp":1793652951039,"version":"4.5.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/s2213-8587(25)00091-9","type":"journal-article","created":{"date-parts":[[2025,6,19]],"date-time":"2025-06-19T18:32:11Z","timestamp":1750357931000},"page":"662-673","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Efficacy and safety of automated insulin delivery in children aged 2\u20136 years (LENNY): an open-label, multicentre, randomised, crossover trial"],"prefix":"10.1016","volume":"13","author":[{"given":"Tadej","family":"Battelino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salla","family":"Kuusela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambika","family":"Shetty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana","family":"Rabbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentino","family":"Cherubini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ritva","family":"Ahom\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna-Kaisa","family":"Tuomaala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Peters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Iafusco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Premkumar","family":"Sundaram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Schiaffini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Cellot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Gulotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Di Piazza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ohad","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"van den Heuvel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"Vorrink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shannon","family":"Edd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Berangere","family":"Julian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Castaneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari-Anne","family":"Pulkkinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rea","family":"Jussila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Kauppi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"Viikari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johanna","family":"Hunttila","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidi","family":"Alanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sauli","family":"Palmu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Pohjanp\u00e4\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henna","family":"Jylh\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanna","family":"V\u00e4\u00e4r\u00e4l\u00e4","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari","family":"Koski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ninni","family":"Ker\u00e4nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"Pozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Cammarata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Boggio Sola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Savastio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Chiarle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessio","family":"Battioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Dimarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Tiberi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Iannilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Capogna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Zanfardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentina","family":"Pampanini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Novella","family":"Rapini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Bratina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klemen","family":"Dovc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darja","family":"Smigoc Schweiger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Murn Berkopec","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadeja","family":"Logar Dolin\u0161ek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie","family":"Fay Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Yong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Kelleher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Mullier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jenny","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Kinghorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Josephine","family":"Byatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasmin","family":"Khanagha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melani","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Trentham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Yendle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgina","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bethan","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"de Carteret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Rees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Margetts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucie","family":"Wellings","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sally","family":"Amor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Potts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Besine","family":"Laszczych","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Badham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Greening","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aan","family":"Mayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00091-9_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2352-4642(19)30055-0","article-title":"The effect of type 1 diabetes on the developing brain","volume":"3","author":"Cameron","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/S2213-8587(25)00091-9_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/20406223241229855","article-title":"Brain functional and structural changes in diabetic children. How can intellectual development be optimized in type 1 diabetes?","volume":"15","author":"Stanis\u0142awska-Kubiak","year":"2024","journal-title":"Ther Adv Chronic Dis"},{"key":"10.1016\/S2213-8587(25)00091-9_bib3","doi-asserted-by":"crossref","first-page":"476","DOI":"10.2337\/db15-1242","article-title":"Variations in brain volume and growth in young children with type 1 diabetes","volume":"65","author":"Mazaika","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(25)00091-9_bib4","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.2337\/dc07-2132","article-title":"Cognitive function in children with type 1 diabetes: a meta-analysis","volume":"31","author":"Gaudieri","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00091-9_bib5","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00091-9_bib6","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1089\/dia.2023.0141","article-title":"The association of time in range and diabetic complications: the evidence is strong","volume":"25","author":"Beck","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(25)00091-9_bib7","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/dia.2023.0320","article-title":"Longitudinal trends in glycemic outcomes and technology use for over 48,000 people with type 1 diabetes (2016-2022) from the T1D Exchange Quality Improvement Collaborative","volume":"25","author":"Ebekozien","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(25)00091-9_bib8","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/dia.2020.0618","article-title":"The SWEET project 10-year benchmarking in 19 countries worldwide is associated with improved HbA1c and increased use of diabetes technology in youth with type 1 diabetes","volume":"23","author":"Gerhardsson","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00091-9_bib9","first-page":"S73","article-title":"6. Glycemic targets: standards of medical care in diabetes\u20142021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00091-9_bib10","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1089\/dia.2023.0433","article-title":"Celebrating the data from 100,000 real-world users of the MiniMed 780G system in Europe, Middle East, and Africa collected over 3 years: from data to clinical evidence","volume":"26","author":"Choudhary","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(25)00091-9_bib11","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00091-9_bib13","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1056\/NEJMoa2111673","article-title":"Randomized trial of closed-loop control in very young children with type 1 diabetes","volume":"386","author":"Ware","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00091-9_bib14","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/s00592-022-01851-w","article-title":"Successful transitioning children and adolescents with type 1 diabetes from multiple daily injections to advanced hybrid closed-loop system in 10 days: a prospective intervention study on MiniMed 780G system","volume":"59","author":"Petrovski","year":"2022","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(25)00091-9_bib15","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1111\/dom.15562","article-title":"During an 18-month course of automated insulin delivery treatment, children aged 2 to 6\u2008years achieve and maintain a higher time in tight range","volume":"26","author":"Pulkkinen","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(25)00091-9_bib16","series-title":"ISO 14155:2020. Clinical investigation of medical devices for human subjects\u2014good clinical practice","year":"2020"},{"key":"10.1016\/S2213-8587(25)00091-9_bib17","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(25)00091-9_bib19","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.2337\/dc24-0162","article-title":"Associations between glucose metabolism measures and amyloid-\u03b2 and tau load on PET 14 years later: findings from the Framingham Heart Study","volume":"47","author":"van Gils","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00091-9_bib20","doi-asserted-by":"crossref","first-page":"1941","DOI":"10.2337\/dc20-0171","article-title":"Acute hyperglycemia and spatial working memory in adolescents with type 1 diabetes","volume":"43","author":"\u0160uput Omladi\u010d","year":"2020","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00091-9_bib21","first-page":"S125","article-title":"10. Cardiovascular disease and risk management: standards of medical care in diabetes\u20142021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00091-9_bib22","first-page":"S151","article-title":"11. Microvascular complications and foot care: standards of medical care in diabetes\u20142021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00091-9_bib23","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00125-024-06171-y","article-title":"The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study","volume":"67","author":"De Meulemeester","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00091-9_bib24","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1089\/dia.2022.0313","article-title":"MiniMed 780G in 2- to 6-year-old children: safety and clinical outcomes after the first 12 weeks","volume":"25","author":"Pulkkinen","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(25)00091-9_bib25","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1089\/dia.2023.0508","article-title":"Clinical outcomes with MiniMed 780G advanced hybrid closed-loop therapy in 2- to 6-year-old children with type 1 diabetes","volume":"26","author":"Abraham","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(25)00091-9_bib26","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1283181","article-title":"Are all HCL systems the same? Long term outcomes of three HCL systems in children with type 1 diabetes: real-life registry-based study","volume":"14","author":"Santova","year":"2023","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(25)00091-9_bib27","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.2337\/dc22-2046","article-title":"Safety of real-life usage of advanced hybrid closed-loop system MiniMed 780G in children with type 1 diabetes younger than 7 years old","volume":"46","author":"Tornese","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00091-9_bib28","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2337\/dc23-1317","article-title":"Demographic, clinical, management, and outcome characteristics of 8004 young children with type 1 diabetes","volume":"47","author":"Sandy","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00091-9_bib29","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.2337\/dc21-2359","article-title":"Safety and glycemic outcomes with a tubeless automated insulin delivery system in very young children with type 1 diabetes: a single-arm multicenter clinical trial","volume":"45","author":"Sherr","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00091-9_bib30","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1111\/pedi.13428","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: psychological care of children, adolescents and young adults with diabetes","volume":"23","author":"de Wit","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(25)00091-9_bib31","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1111\/dom.14807","article-title":"Predictors of time in target glucose range in real-world users of the MiniMed 780G system","volume":"24","author":"Casta\u00f1eda","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(25)00091-9_bib32","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/cod.14166","article-title":"Contact dermatitis in children caused by diabetes devices","volume":"87","author":"Alves da Silva","year":"2022","journal-title":"Contact Dermatitis"},{"key":"10.1016\/S2213-8587(25)00091-9_bib33","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1089\/dia.2021.0540","article-title":"Evaluation of extended infusion set performance in adults with type 1 diabetes: infusion set survival rate and glycemic outcomes from a pivotal trial","volume":"24","author":"Brazg","year":"2022","journal-title":"Diabetes Technol Ther"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000919?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000919?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T23:45:52Z","timestamp":1758671152000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000919"}},"issued":{"date-parts":[[2025,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2213858725000919"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00091-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of automated insulin delivery in children aged 2\u20136 years (LENNY): an open-label, multicentre, randomised, crossover trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00091-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00116-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:17:50Z","timestamp":1794071870556,"version":"4.8.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/s2213-8587(16)30328-x","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T13:09:45Z","timestamp":1479301785000},"page":"5-7","source":"Crossref","is-referenced-by-count":55,"title":["The need for international consensus on prediabetes"],"prefix":"10.1016","volume":"5","author":[{"given":"Lydia E","family":"Makaroff","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30328-X_bib1","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tab\u00e1k","year":"2012","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)30328-X_bib2","first-page":"S4","article-title":"Standards of medical care in diabetes\u20142016: summary of revisions","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30328-X_bib3","series-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation","year":"2006"},{"key":"10.1016\/S2213-8587(16)30328-X_bib4","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30328-X_bib5","doi-asserted-by":"crossref","first-page":"g4485","DOI":"10.1136\/bmj.g4485","article-title":"The epidemic of pre-diabetes: the medicine and the politics","volume":"349","author":"Yudkin","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)30328-X_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.2174\/1573399811666150416122903","article-title":"Heterogeneity of pre-diabetes and type 2 diabetes: implications for prediction, prevention and treatment responsiveness","volume":"12","author":"Faerch","year":"2016","journal-title":"Curr Diabetes Rev"},{"key":"10.1016\/S2213-8587(16)30328-X_bib7","article-title":"Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study","author":"Warren","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30328-X_bib8","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.2337\/dc16-1143","article-title":"\u201cPrediabetes\u201d: are there problems with this label? No, we need heightened awareness of this condition!","volume":"39","author":"Cefalu","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30328-X_bib9","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.2337\/dc15-2113","article-title":"\u201cPrediabetes\u201d: are there problems with this label? Yes, the label creates further problems!","volume":"39","author":"Yudkin","year":"2016","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630328X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630328X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T17:55:15Z","timestamp":1536256515000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871630328X"}},"issued":{"date-parts":[[2017,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S221385871630328X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30328-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,1]]}},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T17:17:53Z","timestamp":1794071873121,"version":"4.8.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/s2213-8587(23)00039-6","type":"journal-article","created":{"date-parts":[[2023,2,16]],"date-time":"2023-02-16T18:34:17Z","timestamp":1676572457000},"page":"224-226","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Current diagnostic criteria identify risk for type 2 diabetes too late"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0003-2589-2976","authenticated-orcid":false,"given":"Michael","family":"Bergman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Buysschaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akhtar","family":"Hussain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Sesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaakko","family":"Tuomilehto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00039-6_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S2213-8587(16)30328-X","article-title":"The need for international consensus on prediabetes","volume":"5","author":"Makaroff","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00039-6_bib2","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"2. Classification and diagnosis of diabetes: standards of care in diabetes\u20142023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00039-6_bib3","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.diabres.2018.09.017","article-title":"Petition to replace current OGTT criteria for diagnosing prediabetes with the 1-hour post-load plasma glucose \u2265155 mg\/dL (8\u00b76 mmol\/L)","volume":"146","author":"Bergman","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00039-6_bib4","doi-asserted-by":"crossref","first-page":"R590","DOI":"10.1152\/ajpregu.00325.2014","article-title":"Identifying glucose thresholds for incident diabetes by physiological analysis: a mathematical solution","volume":"308","author":"Ferrannini","year":"2015","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/S2213-8587(23)00039-6_bib5","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1056\/NEJMoa050080","article-title":"Normal fasting plasma glucose levels and type 2 diabetes in young men","volume":"353","author":"Tirosh","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00039-6_bib6","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","article-title":"Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study","volume":"373","author":"Tab\u00e1k","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00039-6_bib7","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.2337\/dc19-0244","article-title":"Regression from prediabetes to normal glucose regulation and prevalence of microvascular disease in the Diabetes Prevention Program Outcomes Study (DPPOS)","volume":"42","author":"Perreault","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00039-6_bib8","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1016\/S2213-8587(18)30234-1","article-title":"Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES)","volume":"6","author":"Armato","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00039-6_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109977","article-title":"One-hour post-load glucose is associated with severity of hepatic fibrosis risk","volume":"189","author":"Jagannathan","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00039-6_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1007\/s00592-022-01963-3","article-title":"A simulation model estimates lifetime health and economic outcomes of screening prediabetes using the 1-h plasma glucose","volume":"60","author":"Andellini","year":"2023","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(23)00039-6_bib11","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.2337\/dc20-1688","article-title":"Accuracy of 1-hour plasma glucose during the oral glucose tolerance test in diagnosis of type 2 diabetes in adults: a meta-analysis","volume":"44","author":"Ahuja","year":"2021","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:33Z","timestamp":1761991953000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000396"}},"issued":{"date-parts":[[2023,4]]},"references-count":11,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2213858723000396"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00039-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current diagnostic criteria identify risk for type 2 diabetes too late","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00039-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:14:36Z","timestamp":1794503676622,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,4,26]],"date-time":"2019-04-26T00:00:00Z","timestamp":1556236800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Medical Research Council","doi-asserted-by":"crossref","award":["MRC [MR\/N00633X\/1]"],"award-info":[{"award-number":["MRC [MR\/N00633X\/1]"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"crossref"}]},{"name":"NIHR Clinician Scientist award","award":["CS-2015-15-018"],"award-info":[{"award-number":["CS-2015-15-018"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/s2213-8587(19)30087-7","type":"journal-article","created":{"date-parts":[[2019,4,29]],"date-time":"2019-04-29T23:29:46Z","timestamp":1556580586000},"page":"442-451","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":435,"title":["Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data"],"prefix":"10.1016","volume":"7","author":[{"given":"John M","family":"Dennis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley M","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E","family":"Henley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus G","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T","family":"Hattersley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30087-7_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/nyas.13588","article-title":"Precision medicine in diabetes: an opportunity for clinical translation","volume":"1411","author":"Merino","year":"2018","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(19)30087-7_bib2","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/S2213-8587(18)30052-4","article-title":"Precision medicine in the management of type 2 diabetes","volume":"6","author":"Gloyn","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30087-7_bib3","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00125-017-4210-x","article-title":"Painting a new picture of personalised medicine for diabetes","volume":"60","author":"McCarthy","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30087-7_bib4","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30087-7_bib5","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S2213-8587(18)30126-8","article-title":"Novel diabetes subgroups","volume":"6","author":"Feher","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30087-7_bib6","doi-asserted-by":"crossref","first-page":"1844","DOI":"10.2337\/dc18-0344","article-title":"Sex and BMI alter the benefits and risks of sulfonylureas and thiazolidinediones in type 2 diabetes: a framework for evaluating stratification using routine clinical and individual trial data","volume":"41","author":"Dennis","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30087-7_bib7","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1016\/S2213-8587(18)30124-4","article-title":"Novel diabetes subgroups","volume":"6","author":"van Smeden","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30087-7_bib8","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30087-7_bib9","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","article-title":"Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial","volume":"373","author":"Home","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30087-7_bib10","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","article-title":"Correct homeostasis model assessment (HOMA) evaluation uses the computer program","volume":"21","author":"Levy","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30087-7_bib11","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.2337\/diabetes.53.12.3193","article-title":"Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe","volume":"53","author":"Zinman","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30087-7_bib12","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(19)30087-7_bib13","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1373\/clinchem.2006.077180","article-title":"Expressing the modification of diet in renal disease study equation for estimating glomerular filtration rate with standardized serum creatinine values","volume":"53","author":"Levey","year":"2007","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(19)30087-7_bib14","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30087-7_bib15","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.csda.2006.11.025","article-title":"Cluster-wise assessment of cluster stability","volume":"52","author":"Hennig","year":"2007","journal-title":"Comput Stat Data Anal"},{"key":"10.1016\/S2213-8587(19)30087-7_bib16","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/j.2041-210x.2012.00261.x","article-title":"A general and simple method for obtaining R2 from generalized linear mixed-effects models","volume":"4","author":"Nakagawa","year":"2013","journal-title":"Methods Ecol Evol"},{"key":"10.1016\/S2213-8587(19)30087-7_bib17","series-title":"Regression modeling strategies","author":"Frank","year":"2006"},{"key":"10.1016\/S2213-8587(19)30087-7_bib18","first-page":"63","article-title":"Evaluating biomarkers for guiding treatment decisions","volume":"26","author":"Bossuyt","year":"2015","journal-title":"EJIFCC"},{"key":"10.1016\/S2213-8587(19)30087-7_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.7326\/0003-4819-154-4-201102150-00006","article-title":"Measuring the performance of markers for guiding treatment decisions","volume":"154","author":"Janes","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(19)30087-7_bib21","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S2213-8587(18)30316-4","article-title":"Novel subgroups of patients with adult-onset diabetes in Chinese and US populations","volume":"7","author":"Zou","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30087-7_bib22","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00125-017-4519-5","article-title":"Rates of glycaemic deterioration in a real-world population with type 2 diabetes","volume":"61","author":"Donnelly","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30087-7_bib23","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1007\/s00125-017-4226-2","article-title":"Precision diabetes: learning from monogenic diabetes","volume":"60","author":"Hattersley","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30087-7_bib24","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/S0140-6736(03)14571-0","article-title":"Genetic cause of hyperglycaemia and response to treatment in diabetes","volume":"362","author":"Pearson","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30087-7_bib25","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1056\/NEJMoa061759","article-title":"Switching from insulin to oral sulfonylureas in patients with diabetes due to Kir6.2 mutations","volume":"355","author":"Pearson","year":"2006","journal-title":"New Eng J Med"},{"key":"10.1016\/S2213-8587(19)30087-7_bib26","doi-asserted-by":"crossref","first-page":"311ra174","DOI":"10.1126\/scitranslmed.aaa9364","article-title":"Identification of type 2 diabetes subgroups through topological analysis of patient similarity","volume":"7","author":"Li","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(19)30087-7_bib27","doi-asserted-by":"crossref","first-page":"e1002654","DOI":"10.1371\/journal.pmed.1002654","article-title":"Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis","volume":"15","author":"Udler","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(19)30087-7_bib28","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/dc15-0258","article-title":"Markers of beta-cell failure predict poor glycemic response to glp-1 receptor agonist therapy in type 2 diabetes","volume":"39","author":"Jones","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30087-7_bib29","doi-asserted-by":"crossref","first-page":"e00016","DOI":"10.1002\/edm2.16","article-title":"Slope of change in HbA1c from baseline with empagliflozin compared with sitagliptin or glimepiride in patients with type 2 diabetes","volume":"1","author":"DeFronzo","year":"2018","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/S2213-8587(19)30087-7_bib30","doi-asserted-by":"crossref","first-page":"705","DOI":"10.2337\/dc17-1827","article-title":"Precision medicine in type 2 diabetes: clinical markers of insulin resistance are associated with altered short- and long-term glycemic response to DPP-4 inhibitor therapy","volume":"41","author":"Dennis","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30087-7_bib31","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1056\/NEJMp1610336","article-title":"Data sharing\u2014is the juice worth the squeeze?","volume":"375","author":"Strom","year":"2016","journal-title":"N Eng J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300877?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300877?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:51Z","timestamp":1761991611000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300877"}},"issued":{"date-parts":[[2019,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2213858719300877"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30087-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30087-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30118-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T08:52:52Z","timestamp":1794473572042,"version":"4.9.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/s2213-8587(23)00354-6","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T18:32:36Z","timestamp":1701455556000},"page":"12-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Screening type 1 diabetes and celiac disease by law"],"prefix":"10.1016","volume":"12","author":[{"given":"Emanuele","family":"Bosi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Catassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00354-6_bib1","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(23)00223-4","article-title":"Type 1 diabetes","volume":"401","author":"Quattrin","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00354-6_bib2","doi-asserted-by":"crossref","first-page":"2413","DOI":"10.1016\/S0140-6736(22)00794-2","article-title":"Coeliac disease","volume":"399","author":"Catassi","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00354-6_bib3","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00354-6_bib4","doi-asserted-by":"crossref","first-page":"59","DOI":"10.14309\/ajg.0000000000002075","article-title":"American College of Gastroenterology Guidelines Update: diagnosis and management of celiac disease","volume":"118","author":"Rubio-Tapia","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(23)00354-6_bib5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/dbi20-0054","article-title":"Screening for Type 1 diabetes in the general population: a status report and perspective","volume":"71","author":"Sims","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00354-6_bib6","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jama.2019.21565","article-title":"Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany","volume":"323","author":"Ziegler","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00354-6_bib7","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/j.dld.2022.12.023","article-title":"Prevalence and detection rate of celiac disease in Italy: results of a SIGENP multicenter screening in school-age children","volume":"55","author":"Lionetti","year":"2023","journal-title":"Dig Liver Dis"},{"key":"10.1016\/S2213-8587(23)00354-6_bib8","doi-asserted-by":"crossref","first-page":"539","DOI":"10.14309\/ajg.0000000000002056","article-title":"Incidence of pediatric celiac disease varies by region","volume":"118","author":"Stahl","year":"2023","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(23)00354-6_bib9","series-title":"Principles and practice of screening for disease","author":"Wilson","year":"1968"},{"key":"10.1016\/S2213-8587(23)00354-6_bib10","doi-asserted-by":"crossref","first-page":"837","DOI":"10.2337\/dc21-1648","article-title":"Costs of public health screening of children for presymptomatic type 1 diabetes in Bavaria, Germany","volume":"45","author":"Karl","year":"2022","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003546?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003546?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:04:35Z","timestamp":1741190675000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003546"}},"issued":{"date-parts":[[2024,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213858723003546"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00354-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening type 1 diabetes and celiac disease by law","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00354-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:07:47Z","timestamp":1793394467361,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/s2213-8587(21)00295-3","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T18:47:06Z","timestamp":1638211626000},"page":"24-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials"],"prefix":"10.1016","volume":"10","author":[{"given":"Peter","family":"Rossing","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio E","family":"Inzucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Vart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Jongs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kieran F","family":"Docherty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep S","family":"Jhund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"K\u00f8ber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail N","family":"Kosiborod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felipe A","family":"Martinez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piotr","family":"Ponikowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S","family":"Sabatine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David L","family":"DeMets","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olof","family":"Bengtsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magnus","family":"Lindberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Maria","family":"Langkilde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikaela","family":"Sj\u00f6strand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bergur V","family":"Stefansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Karlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn M","family":"Chertow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fan Fan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ricardo","family":"Correa-Rotter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert D","family":"Toto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J V","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiddo J L","family":"Heerspink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00295-3_bib2","first-page":"S34","article-title":"Prevention or Delay of Type 2 Diabetes: Standards of Medical Care in Diabetes\u20142021","volume":"44","year":"2021","journal-title":"Am Diab Assoc Diabet Care"},{"key":"10.1016\/S2213-8587(21)00295-3_bib3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in Patients with Chronic Kidney Disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00295-3_bib4","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and Renal Outcomes with Empagliflozin in Heart Failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00295-3_bib5","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00295-3_bib6","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1093\/ndt\/gfz290","article-title":"Rationale and protocol of the Dapagliflozin And Prevention of Adverse outcomes in Chronic Kidney Disease (DAPA-CKD) randomized controlled trial","volume":"35","author":"Heerspink","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(21)00295-3_bib7","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/ejhf.1432","article-title":"A trial to evaluate the effect of the sodium-glucose co-transporter 2 inhibitor dapagliflozin on morbidity and mortality in patients with heart failure and reduced left ventricular ejection fraction (DAPA-HF)","volume":"21","author":"McMurray","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(21)00295-3_bib8","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/S2213-8587(21)00295-3_bib9","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/ndt\/gfaa234","article-title":"The dapagliflozin and prevention of adverse outcomes in chronic kidney disease (DAPA-CKD) trial: baseline characteristics","volume":"35","author":"Wheeler","year":"2020","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(21)00295-3_bib10","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1002\/ejhf.1548","article-title":"The dapagliflozin and prevention of adverse-outcomes in heart Failure (DAPA-HF) trial: baseline characteristics","volume":"21","author":"McMurray","year":"2019","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(21)00295-3_bib11","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/hrt.2006.092379","article-title":"Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)","volume":"93","author":"Torp-Pedersen","year":"2007","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(21)00295-3_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.104.528166","article-title":"Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure","volume":"112","author":"Yusuf","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00295-3_bib13","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ejhf.896","article-title":"Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial","volume":"20","author":"Kristensen","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(21)00295-3_bib14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in Heart Failure with a Preserved Ejection Fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00295-3_bib15","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1053\/j.ajkd.2018.06.017","article-title":"Incident type 2 diabetes among individuals with CKD: findings from the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"73","author":"Jepson","year":"2019","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(21)00295-3_bib16","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1001\/archinte.166.7.797","article-title":"Differing effects of antihypertensive drugs on the incidence of diabetes mellitus among patients with hypertensive kidney disease","volume":"166","author":"Thornley-Brown","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(21)00295-3_bib17","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, Cardiovascular Outcomes, and Mortality in Type 2 Diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00295-3_bib18","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and Renal Outcomes in Type 2 Diabetes and Nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00295-3_bib19","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00295-3_bib20","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and Cardiovascular Outcomes in Type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00295-3_bib21","doi-asserted-by":"crossref","DOI":"10.2337\/diacare.26.9.2701","article-title":"Preventing, delaying, or masking type 2 diabetes with metformin in the diabetes prevention program?","volume":"26","author":"Scheen","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00295-3_bib22","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1111\/dom.13584","article-title":"Effect of canagliflozin treatment on hepatic triglyceride content and glucose metabolism in patients with type 2 diabetes","volume":"21","author":"Cusi","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00295-3_bib23","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1210\/jc.2014-3472","article-title":"Dapagliflozin lowers plasma glucose concentration and improves \u03b2-cell function","volume":"100","author":"Merovci","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00295-3_bib24","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1172\/JCI70704","article-title":"Dapagliflozin improves muscle insulin sensitivity but enhances endogenous glucose production","volume":"124","author":"Merovci","year":"2014","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(21)00295-3_bib25","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1007\/s00125-020-05306-1","article-title":"The effects of dapagliflozin, metformin or exercise on glycaemic variability in overweight or obese individuals with prediabetes (the PRE-D Trial): a multi-arm, randomised, controlled trial","volume":"64","author":"F\u00e6rch","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00295-3_bib26","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2337\/dc20-1675","article-title":"Dapagliflozin and the incidence of type 2 diabetes in patients with heart failure and reduced ejection fraction: an exploratory analysis from DAPA-HF","volume":"44","author":"Inzucchi","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00295-3_bib27","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00295-3_bib28","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial","volume":"368","author":"Gerstein","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00295-3_bib29","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00295-3_bib30","doi-asserted-by":"crossref","first-page":"1399","DOI":"10.1016\/S0140-6736(17)30069-7","article-title":"3 years of liraglutide versus placebo for type 2 diabetes risk reduction and weight management in individuals with prediabetes: a randomised, double-blind trial","volume":"389","author":"le Roux","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00295-3_bib31","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2213-8587(19)30093-2","article-title":"Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study","volume":"7","author":"Gong","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002953?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002953?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:07Z","timestamp":1761991807000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002953"}},"issued":{"date-parts":[[2022,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2213858721002953"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00295-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00295-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00310-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T17:04:21Z","timestamp":1794330261817,"version":"4.9.0"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004348","name":"Stockholms L\u00e4ns Landsting","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004348","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","award":["12198"],"award-info":[{"award-number":["12198"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004047","name":"Karolinska Institutet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004047","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70007-x","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T14:55:03Z","timestamp":1361890503000},"page":"35-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":163,"title":["One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study"],"prefix":"10.1016","volume":"1","author":[{"given":"Sebastian","family":"Gidl\u00f6f","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Astrid","family":"Thil\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrika","family":"von D\u00f6beln","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Ritz\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Wedell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Nordenstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70007-X_bib1","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.pcl.2011.07.012","article-title":"Steroid 21 hydroxylase deficiency congenital adrenal hyperplasia","volume":"58","author":"Nimkarn","year":"2011","journal-title":"Pediatr Clin North Am"},{"key":"10.1016\/S2213-8587(13)70007-X_bib2","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1097\/MED.0b013e328346938c","article-title":"Congenital adrenal hyperplasia: an update in children","volume":"18","author":"Trapp","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(13)70007-X_bib3","first-page":"245","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"21","author":"White","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(13)70007-X_bib4","first-page":"797","article-title":"Congenital adrenal hyperplasia associated with the adrenogenital syndrome: an attempt to correct its disordered hormonal pattern","volume":"29","author":"Bartter","year":"1950","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70007-X_bib5","first-page":"249","article-title":"The suppression of androgen secretion by cortisone in a case of congenital adrenal hyperplasia","volume":"86","author":"Wilkins","year":"1950","journal-title":"Bull Johns Hopkins Hosp"},{"key":"10.1016\/S2213-8587(13)70007-X_bib6","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1210\/jcem-17-2-272","article-title":"9-alpha-Fluorohydrocortisone-induced hypertension in a male infant with adrenogenitalism, and in 6 adults with Addison's disease","volume":"17","author":"Engel","year":"1957","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70007-X_bib7","first-page":"1145","article-title":"Mutational spectrum of the steroid 21-hydroxylase gene in Sweden: implications for genetic diagnosis and association with disease manifestation","volume":"78","author":"Wedell","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70007-X_bib8","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1172\/JCI115897","article-title":"Disease expression and molecular genotype in congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"90","author":"Speiser","year":"1992","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70007-X_bib9","first-page":"160","article-title":"Fetal androgens and female gender identity in the early-treated adrenogenital syndrome","volume":"122","author":"Ehrhardt","year":"1968","journal-title":"Johns Hopkins Med J"},{"key":"10.1016\/S2213-8587(13)70007-X_bib10","first-page":"727","article-title":"Behavioral effects of prenatal versus postnatal androgen excess in children with 21-hydroxylase-deficient congenital adrenal hyperplasia","volume":"85","author":"Berenbaum","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70007-X_bib11","doi-asserted-by":"crossref","first-page":"5119","DOI":"10.1210\/jc.2001-011531","article-title":"Sex-typed toy play behavior correlates with the degree of prenatal androgen exposure assessed by CYP21 genotype in girls with congenital adrenal hyperplasia","volume":"87","author":"Nordenstrom","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70007-X_bib12","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/j.yhbeh.2007.05.015","article-title":"Increased aggression and activity level in 3- to 11-year-old girls with congenital adrenal hyperplasia (CAH)","volume":"52","author":"Pasterski","year":"2007","journal-title":"Horm Behav"},{"key":"10.1016\/S2213-8587(13)70007-X_bib13","doi-asserted-by":"crossref","first-page":"3432","DOI":"10.1210\/jc.2009-0636","article-title":"Gender role behavior, sexuality, and psychosocial adaptation in women with congenital adrenal hyperplasia due to CYP21A2 deficiency","volume":"94","author":"Frisen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70007-X_bib14","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1007\/s10508-007-9265-1","article-title":"Sexual orientation in women with classical or non-classical congenital adrenal hyperplasia as a function of degree of prenatal androgen excess","volume":"37","author":"Meyer-Bahlburg","year":"2008","journal-title":"Arch Sex Behav"},{"key":"10.1016\/S2213-8587(13)70007-X_bib15","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1055\/s-0029-1233490","article-title":"Congenital adrenal hyperplasia: a critical appraisal of the evolution of feminizing genitoplasty and the controversies surrounding gender reassignment","volume":"19","author":"Braga","year":"2009","journal-title":"Eur J Pediatr Surg"},{"key":"10.1016\/S2213-8587(13)70007-X_bib16","first-page":"73","article-title":"Sexual function and fertility in adult females and males with congenital adrenal hyperplasia","volume":"56","author":"Jaaskelainen","year":"2001","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(13)70007-X_bib17","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1530\/eje.1.02294","article-title":"Quality of life in 70 women with disorders of sex development","volume":"155","author":"Johannsen","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70007-X_bib18","doi-asserted-by":"crossref","first-page":"5110","DOI":"10.1210\/jc.2010-0917","article-title":"Health status of adults with congenital adrenal hyperplasia: a cohort study of 203 patients","volume":"95","author":"Arlt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70007-X_bib19","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1530\/EJE-10-0284","article-title":"Subjective health status in men and women with congenital adrenal hyperplasia: a population-based survey in Norway","volume":"163","author":"Nermoen","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70007-X_bib20","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1210\/jcem-45-5-1003","article-title":"Microfilter paper method for 17 alpha-hydroxyprogesterone radioimmunoassay: its application for rapid screening for congenital adrenal hyperplasia","volume":"45","author":"Pang","year":"1977","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70007-X_bib21","doi-asserted-by":"crossref","first-page":"494173","DOI":"10.1186\/1687-9856-2010-494173","article-title":"A summary of the endocrine society clinical practice guidelines on congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency","volume":"2010","author":"Speiser","year":"2010","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.1016\/S2213-8587(13)70007-X_bib22","first-page":"22","article-title":"Female preponderance in congenital adrenal hyperplasia due to CYP21 deficiency in England: implications for neonatal screening","volume":"63","author":"Nordenstrom","year":"2005","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(13)70007-X_bib23","doi-asserted-by":"crossref","first-page":"3243","DOI":"10.1210\/jc.2004-0016","article-title":"Primary adrenal insufficiency in children: twenty years experience at the Sainte-Justine Hospital, Montreal","volume":"90","author":"Perry","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70007-X_bib24","doi-asserted-by":"crossref","first-page":"E11","DOI":"10.1542\/peds.101.4.e11","article-title":"Benefits of neonatal screening for congenital adrenal hyperplasia (21-hydroxylase deficiency) in Sweden","volume":"101","author":"Thil'en","year":"1998","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(13)70007-X_bib25","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1210\/jcem.85.3.6441","article-title":"Predicting phenotype in steroid 21-hydroxylase deficiency? Comprehensive genotyping in 155 unrelated, well defined patients from southern Germany","volume":"85","author":"Krone","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70007-X_bib28","doi-asserted-by":"crossref","first-page":"1309","DOI":"10.1016\/S0140-6736(77)90362-2","article-title":"Close genetic linkage between HLA and congenital adrenal hyperplasia (21-hydroxylase deficiency)","volume":"2","author":"Dupont","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70007-X_bib29","doi-asserted-by":"crossref","first-page":"7232","DOI":"10.1073\/pnas.89.15.7232","article-title":"Steroid 21-hydroxylase deficiency: three additional mutated alleles and establishment of phenotype-genotype relationships of common mutations","volume":"89","author":"Wedell","year":"1992","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(13)70007-X_bib30","author":"Sim"},{"key":"10.1016\/S2213-8587(13)70007-X_bib31","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1159\/000321223","article-title":"Molecular genetics of 21-hydroxylase deficiency","volume":"20","author":"Wedell","year":"2011","journal-title":"Endocr Dev"},{"key":"10.1016\/S2213-8587(13)70007-X_bib32","first-page":"2322","article-title":"Steroid 21-hydroxylase deficiency: genotype may not predict phenotype","volume":"80","author":"Wilson","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70007-X_bib33","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1210\/jcem-22-10-953","article-title":"Performance control of preparations which could be used as reference material for the estimation of urinary gonadotropins in the mouse uterine weight method","volume":"22","author":"Rosemberg","year":"1962","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70007-X_bib34","doi-asserted-by":"crossref","first-page":"3633","DOI":"10.1210\/jc.2009-2639","article-title":"Sexual function and surgical outcome in women with congenital adrenal hyperplasia due to CYP21A2 deficiency: clinical perspective and the patients' perception","volume":"95","author":"Nordenstrom","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70007-X_bib35","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-12-0161","article-title":"Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency","volume":"167","author":"Reisch","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70007-X_bib36","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/163676a0","article-title":"A morphological distinction between neurones of the male and female, and the behaviour of the nucleolar satellite during accelerated nucleoprotein synthesis","volume":"163","author":"Barr","year":"1949","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(13)70007-X_bib37","doi-asserted-by":"crossref","first-page":"982025","DOI":"10.1186\/1687-9856-2010-982025","article-title":"Review of outcome information in 46,XX patients with congenital adrenal hyperplasia assigned\/reared male: what does it say about gender assignment","volume":"2010","author":"Lee","year":"2010","journal-title":"Int J Pediatr Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871370007X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871370007X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:04:57Z","timestamp":1761991497000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871370007X"}},"issued":{"date-parts":[[2013,9]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S221385871370007X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70007-x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725663179.793508333","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70007-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70009-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T19:04:57Z","timestamp":1794251097409,"version":"4.9.0"},"reference-count":12,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000265","name":"UK Research and Innovation Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019418","name":"National Institute for Health Research Maudsley Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019418","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023232","name":"National Institute for Health and Care Research Applied Research Collaboration South London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023232","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000659","name":"NIHR Trainees Coordinating Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/s2213-8587(24)00184-0","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T03:41:44Z","timestamp":1724384504000},"page":"608-610","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["A roadmap for integrating mental health and diabetes services"],"prefix":"10.1016","volume":"12","author":[{"given":"Khalida","family":"Ismail","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marietta","family":"Stadler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Holloway","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Valabhji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00184-0_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03123-2","article-title":"The burden of diabetes-associated multiple long-term conditions on years of life spent and lost","author":"Gregg","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00184-0_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.genhosppsych.2022.11.004","article-title":"Prevalence of mental disorders in people living with type 1 diabetes: a systematic literature review and meta-analysis","volume":"80","author":"Benton","year":"2023","journal-title":"Gen Hosp Psychiatry"},{"key":"10.1016\/S2213-8587(24)00184-0_bib3","doi-asserted-by":"crossref","first-page":"1508","DOI":"10.1111\/dme.13448","article-title":"The prevalence of diabetes-specific emotional distress in people with type 2 diabetes: A systematic review and meta-analysis","volume":"34","author":"Perrin","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00184-0_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s11892-015-0660-z","article-title":"The detection and management of diabetes distress in people with type 1 diabetes","volume":"15","author":"Sturt","year":"2015","journal-title":"Curr Diabetes Rep"},{"key":"10.1016\/S2213-8587(24)00184-0_bib5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1111\/dme.14170","article-title":"Is there an increased risk of perinatal mental disorder in women with gestational diabetes? A systematic review and meta-analysis","volume":"37","author":"Wilson","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00184-0_bib6","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/jamapsychiatry.2015.0082","article-title":"Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study","volume":"72","author":"Katon","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/S2213-8587(24)00184-0_bib7","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40337-018-0223-1","article-title":"Binge eating disorder and night eating syndrome in adults with type 2 diabetes: a systematic review","volume":"6","author":"Abbott","year":"2018","journal-title":"J Eat Disord"},{"key":"10.1016\/S2213-8587(24)00184-0_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hsdr09100","article-title":"Identifying determinants of diabetes risk and outcomes for people with severe mental illness: a mixed-methods study","volume":"9","author":"Lister","year":"2021","journal-title":"Health Serv Deliv Res"},{"key":"10.1016\/S2213-8587(24)00184-0_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta24280","article-title":"Psychological interventions to improve self-management of type 1 and type 2 diabetes: a systematic review","volume":"24","author":"Winkley","year":"2020","journal-title":"Health Technol Assess"},{"key":"10.1016\/S2213-8587(24)00184-0_bib10","doi-asserted-by":"crossref","first-page":"2611","DOI":"10.1056\/NEJMoa1003955","article-title":"Collaborative care for patients with depression and chronic illnesses","volume":"363","author":"Katon","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00184-0_bib11","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-8587(24)00123-2","article-title":"An integrated medical and mental health intervention for people with type 1 diabetes and severe disordered eating","volume":"12","author":"Ismail","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00184-0_bib12","doi-asserted-by":"crossref","first-page":"e114","DOI":"10.1192\/bjo.2023.505","article-title":"The Goldberg\u2013Huxley model of the pathway to psychiatric care: 21st-century systematic review","volume":"9","author":"Huxley","year":"2023","journal-title":"BJPsych Open"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001840?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001840?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T08:09:06Z","timestamp":1736842146000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001840"}},"issued":{"date-parts":[[2024,9]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213858724001840"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00184-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A roadmap for integrating mental health and diabetes services","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00184-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2024 Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T08:25:32Z","timestamp":1794644732587,"version":"4.9.1"},"reference-count":154,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"European Union's Seventh Framework Programme","award":["FP7\/2007-2013"],"award-info":[{"award-number":["FP7\/2007-2013"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/s2213-8587(16)30081-x","type":"journal-article","created":{"date-parts":[[2016,8,5]],"date-time":"2016-08-05T19:28:02Z","timestamp":1470425282000},"page":"457-468","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":138,"title":["The global diabetes epidemic: what does it mean for infectious diseases in tropical countries?"],"prefix":"10.1016","volume":"5","author":[{"given":"Reinout","family":"van Crevel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"van de Vijver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A J","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30081-X_bib1","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S2213-8587(14)70110-X","article-title":"Clinical management of concurrent diabetes and tuberculosis and the implications for patient services","volume":"2","author":"Riza","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib2","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/dmrr.682","article-title":"Common infections in diabetes: pathogenesis, management and relationship to glycaemic control","volume":"23","author":"Peleg","year":"2006","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(16)30081-X_bib3","series-title":"IDF diabetes","year":"2015"},{"key":"10.1016\/S2213-8587(16)30081-X_bib4","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/S2213-8587(14)70145-7","article-title":"Causes of type 2 diabetes in China","volume":"2","author":"Ma","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib5","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2213-8587(14)70109-3","article-title":"Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice","volume":"2","author":"Lonnroth","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib6","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2213-8587(14)70164-0","article-title":"The effect of diabetes and undernutrition trends on reaching 2035 global tuberculosis targets","volume":"2","author":"Odone","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib7","doi-asserted-by":"crossref","first-page":"e2865","DOI":"10.1371\/journal.pntd.0002865","article-title":"The global burden of disease study 2010: interpretation and implications for the neglected tropical diseases","volume":"8","author":"Hotez","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(14)61682-2","article-title":"Global, regional, and national age\u2013sex specific all-cause and cause-specific mortality for 240 causes of death, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"385","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30081-X_bib9","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30081-X_bib10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1016\/j.joms.2011.06.209","article-title":"Rhinocerebral mucormycosis: a diagnostic challenge and therapeutic dilemma in immunocompetent host","volume":"70","author":"Singh","year":"2012","journal-title":"J Oral Maxillofac Surg"},{"key":"10.1016\/S2213-8587(16)30081-X_bib11","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1016\/S1473-3099(12)70205-0","article-title":"Klebsiella pneumoniae liver abscess: a new invasive syndrome","volume":"12","author":"Siu","year":"2012","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1016\/j.jdiacomp.2012.06.008","article-title":"Incidence of urinary tract infection among patients with type 2 diabetes in the UK General Practice Research Database (GPRD)","volume":"26","author":"Hirji","year":"2012","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(16)30081-X_bib13","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2337\/dc06-2417","article-title":"Type 2 diabetes and pneumonia outcomes: a population-based cohort study","volume":"30","author":"Kornum","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30081-X_bib14","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.jinf.2011.05.013","article-title":"Impact of diabetes and poor glycaemic control on risk of bacteraemia with haemolytic streptococci groups A, B, and G","volume":"63","author":"Thomsen","year":"2011","journal-title":"J Infect"},{"key":"10.1016\/S2213-8587(16)30081-X_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2337\/diacare.27.1.70","article-title":"Diabetes and outcome of community-acquired pneumococcal bacteremia: a 10-year population-based cohort study","volume":"27","author":"Thomsen","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30081-X_bib16","doi-asserted-by":"crossref","first-page":"1488","DOI":"10.1001\/jama.2015.12160","article-title":"Association between hospitalization with community-acquired laboratory-confirmed influenza pneumonia and prior receipt of influenza vaccination","volume":"314","author":"Grijalva","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30081-X_bib17","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1302\/0301-620X.96B11.34888","article-title":"Necrotising soft-tissue infections of the upper limb: risk factors for amputation and death","volume":"96-B","author":"Uehara","year":"2014","journal-title":"Bone Joint J"},{"key":"10.1016\/S2213-8587(16)30081-X_bib18","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ajo.2014.11.032","article-title":"Risk factors predictive of endogenous endophthalmitis among hospitalized patients with hematogenous infections in the United States","volume":"159","author":"Vaziri","year":"2015","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib19","doi-asserted-by":"crossref","first-page":"e69581","DOI":"10.1371\/journal.pone.0069581","article-title":"Risk factors for community-acquired urinary tract infections caused by ESBL-producing enterobacteriaceae\u2014a case-control study in a low prevalence country","volume":"8","author":"S\u00f8raas","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30081-X_bib20","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.jmii.2012.09.001","article-title":"Risk factors and clinical impact of levofloxacin or cefazolin nonsusceptibility or ESBL production among uropathogens in adults with community-onset urinary tract infections","volume":"47","author":"Wu","year":"2014","journal-title":"J Microbiol Immunol Infect"},{"key":"10.1016\/S2213-8587(16)30081-X_bib21","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.1001\/jama.2015.12480","article-title":"Epidemiology of carbapenem-resistant Enterobacteriaceae in 7 US Communities, 2012\u20132013","volume":"314","author":"Guh","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30081-X_bib22","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1093\/cid\/cit194","article-title":"Influenza vaccine effectiveness in preventing outpatient, inpatient, and severe cases of laboratory-confirmed influenza","volume":"57","author":"Castilla","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib23","doi-asserted-by":"crossref","first-page":"e1003794","DOI":"10.1371\/journal.ppat.1003794","article-title":"Host susceptibility factors to bacterial infections in type 2 diabetes","volume":"9","author":"Gan","year":"2013","journal-title":"PLoS Pathog"},{"key":"10.1016\/S2213-8587(16)30081-X_bib24","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1111\/imm.12394","article-title":"Immunological mechanisms contributing to the double burden of diabetes and intracellular bacterial infections","volume":"144","author":"Hodgson","year":"2015","journal-title":"Immunology"},{"key":"10.1016\/S2213-8587(16)30081-X_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/imr.12257","article-title":"Acquired immunodeficiencies and tuberculosis: focus on HIV\/AIDS and diabetes mellitus","volume":"264","author":"Ronacher","year":"2015","journal-title":"Immunol Rev"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)30081-X_bib26","first-page":"S27","article-title":"Infections in patients with diabetes mellitus: a review of pathogenesis","volume":"16","author":"Casqueiro","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30081-X_bib27","doi-asserted-by":"crossref","first-page":"263ra159","DOI":"10.1126\/scitranslmed.3009885","article-title":"Metformin as adjunct antituberculosis therapy","volume":"6","author":"Singhal","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib28","doi-asserted-by":"crossref","first-page":"e2795","DOI":"10.1371\/journal.pntd.0002795","article-title":"Sulphonylurea usage in melioidosis is associated with severe disease and suppressed immune response","volume":"8","author":"Liu","year":"2014","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib29","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/S0140-6736(10)61458-4","article-title":"Burden of endemic health-care-associated infection in developing countries: systematic review and meta-analysis","volume":"377","author":"Allegranzi","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30081-X_bib30","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2213-8587(15)00379-4","article-title":"Diabetes and infection: assessing the association with glycaemic control in population-based studies","volume":"4","author":"Pearson-Stuttard","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib31","unstructured":"Manne-Goehler J, Atun R, Stokes A, et al. Unmet need for diabetes care in sub-Saharan Africa: individual pooled analysis in 12 countries. Lancet Diabetes Endocrinol (in press)."},{"key":"10.1016\/S2213-8587(16)30081-X_bib32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(15)00521-5","article-title":"Constraints and challenges in access to insulin: a global perspective","volume":"4","author":"Beran","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib33","doi-asserted-by":"crossref","first-page":"27","DOI":"10.7861\/clinmedicine.13-1-27","article-title":"Management of diabetes in resource-poor settings","volume":"13","author":"Grant","year":"2013","journal-title":"Clin Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib34","doi-asserted-by":"crossref","first-page":"e1001513","DOI":"10.1371\/journal.pmed.1001513","article-title":"Physician emigration from sub-Saharan Africa to the United States: analysis of the 2011 AMA physician masterfile","volume":"10","author":"Tankwanchi","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib35","doi-asserted-by":"crossref","first-page":"E398","DOI":"10.1111\/1469-0691.12199","article-title":"Molecular epidemiology of Staphylococcus aureus strains isolated from inpatients with infected diabetic foot ulcers in an Algerian University Hospital","volume":"19","author":"Djahmi","year":"2013","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/S2213-8587(16)30081-X_bib36","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1177\/193229680900300208","article-title":"Eliminating the blood: ongoing outbreaks of hepatitis B virus infection and the need for innovative glucose monitoring technologies","volume":"3","author":"Thompson","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib37","doi-asserted-by":"crossref","first-page":"74","DOI":"10.5588\/pha.14.0107","article-title":"Diabetes mellitus in Addis Ababa, Ethiopia: admissions, complications and outcomes in a large referral hospital","volume":"5","author":"Gizaw","year":"2015","journal-title":"Public Health Action"},{"key":"10.1016\/S2213-8587(16)30081-X_bib38","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1111\/j.1742-481X.2007.00376.x","article-title":"Challenges for management of the diabetic foot in Africa: doing more with less","volume":"4","author":"Abbas","year":"2007","journal-title":"Int Wound J"},{"key":"10.1016\/S2213-8587(16)30081-X_bib39","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1177\/1534734610380025","article-title":"Clinical profile of diabetic foot in India","volume":"9","author":"Pendsey","year":"2010","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/S2213-8587(16)30081-X_bib40","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1016\/S0140-6736(03)13169-8","article-title":"Diabetic foot ulcers","volume":"361","author":"Jeffcoate","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30081-X_bib41","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1111\/j.1464-5491.2010.03012.x","article-title":"A clinical analysis of diabetic patients with hand ulcer in a diabetic foot centre","volume":"27","author":"Wang","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib42","doi-asserted-by":"crossref","first-page":"199","DOI":"10.11604\/pamj.2014.18.199.3593","article-title":"Tropical diabetes hand syndrome with autoamputation of the digits: case report and review of literature","volume":"18","author":"Raimi","year":"2014","journal-title":"Pan Afr Med J"},{"key":"10.1016\/S2213-8587(16)30081-X_bib43","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2165\/00128071-200506010-00003","article-title":"Tropical diabetic hand syndrome. Epidemiology, pathogenesis, and management","volume":"6","author":"Abbas","year":"2005","journal-title":"Am J Clin Dermatol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib44","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1016\/S0140-6736(05)67698-2","article-title":"The global burden of diabetic foot disease","volume":"366","author":"Boulton","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30081-X_bib45","first-page":"408","article-title":"Clinical profile and management outcome of diabetic foot ulcers in a tertiary care hospital","volume":"18","author":"Mehmood","year":"2008","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/S2213-8587(16)30081-X_bib46","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1046\/j.1464-5491.2002.00740.x","article-title":"Clinical outcome of diabetes patients hospitalized with foot ulcers, Dar es Salaam, Tanzania","volume":"19","author":"Gulam-Abbas","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib47","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1111\/j.1742-481X.2010.00764.x","article-title":"The \u2018Step by Step\u2019 Diabetic Foot Project in Tanzania: a model for improving patient outcomes in less-developed countries","volume":"8","author":"Abbas","year":"2011","journal-title":"Int Wound J"},{"key":"10.1016\/S2213-8587(16)30081-X_bib48","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S1473-3099(10)70316-9","article-title":"Mucormycosis: its contemporary face and management strategies","volume":"11","author":"Sun","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib49","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.3201\/eid1509.090334","article-title":"Increasing incidence of zygomycosis (mucormycosis), France, 1997\u20132006","volume":"15","author":"Bitar","year":"2009","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib50","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1136\/pgmj.2003.016030","article-title":"Presentation and outcome of rhino-orbital-cerebral mucormycosis in patients with diabetes","volume":"80","author":"Bhansali","year":"2004","journal-title":"Postgrad Med J"},{"key":"10.1016\/S2213-8587(16)30081-X_bib51","article-title":"Rhino-orbital mucormycosis in a patient with diabetes","author":"Bakshi","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 5","key":"10.1016\/S2213-8587(16)30081-X_bib52","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/j.1469-0691.2009.02973.x","article-title":"Changing epidemiology of an emerging infection: zygomycosis","volume":"15","author":"Meis","year":"2009","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/S2213-8587(16)30081-X_bib53","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1136\/pgmj.2008.076463","article-title":"Invasive zygomycosis in India: experience in a tertiary care hospital","volume":"85","author":"Chakrabarti","year":"2009","journal-title":"Postgrad Med J"},{"key":"10.1016\/S2213-8587(16)30081-X_bib54","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1097\/QCO.0b013e32834ab21e","article-title":"The emerging epidemiology of mould infections in developing countries","volume":"24","author":"Chakrabarti","year":"2011","journal-title":"Curr Opin Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib55","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib56","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s40200-014-0123-0","article-title":"Changes in glycosylated haemoglobin and treatment outcomes in patients with tuberculosis in Iran: a cohort study","volume":"13","author":"Tabarsi","year":"2014","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/S2213-8587(16)30081-X_bib57","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1741-7015-9-81","article-title":"The impact of diabetes on tuberculosis treatment outcomes: a systematic review","volume":"9","author":"Baker","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib58","doi-asserted-by":"crossref","first-page":"e0134410","DOI":"10.1371\/journal.pone.0134410","article-title":"Glucose metabolism disorders, HIV and antiretroviral therapy among Tanzanian adults","volume":"10","author":"Maganga","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30081-X_bib59","doi-asserted-by":"crossref","first-page":"197","DOI":"10.2147\/DMSO.S80084","article-title":"Diabetes mellitus and risk factors in human immunodeficiency virus-infected individuals at Jimma University Specialized Hospital, Southwest Ethiopia","volume":"8","author":"Mohammed","year":"2015","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/S2213-8587(16)30081-X_bib60","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1186\/s12981-015-0065-8","article-title":"Changes in blood pressure, glucose levels, insulin secretion and anthropometry after long term exposure to antiretroviral therapy in South African women","volume":"12","author":"Abrahams","year":"2015","journal-title":"AIDS Res Ther"},{"key":"10.1016\/S2213-8587(16)30081-X_bib61","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/QAD.0b013e32834e8776","article-title":"Ten-year diabetes incidence in 1046 HIV-infected patients started on a combination antiretroviral treatment","volume":"26","author":"Capeau","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(16)30081-X_bib62","doi-asserted-by":"crossref","first-page":"e44575","DOI":"10.1371\/journal.pone.0044575","article-title":"Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study","volume":"7","author":"Rasmussen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30081-X_bib63","doi-asserted-by":"crossref","first-page":"e2844","DOI":"10.1097\/MD.0000000000002844","article-title":"Risk factors for incident diabetes in a cohort taking first-line nonnucleoside reverse transcriptase inhibitor-based antiretroviral therapy","volume":"95","author":"Karamchand","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S2213-8587(16)30081-X_bib64","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S2213-8587(15)00363-0","article-title":"The prevalence of type 2 diabetes among older people in Africa: a systematic review","volume":"4","author":"Werfalli","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib65","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1086\/315167","article-title":"Epidemic transmission of human immunodeficiency virus in renal dialysis centers in Egypt","volume":"181","author":"El Sayed","year":"1999","journal-title":"J Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib66","doi-asserted-by":"crossref","first-page":"471","DOI":"10.5301\/ijao.5000437","article-title":"Transmission of hepatitis C virus in dialysis units: a systematic review of reports on outbreaks","volume":"38","author":"Fabrizi","year":"2015","journal-title":"Int J Artif Organs"},{"key":"10.1016\/S2213-8587(16)30081-X_bib67","doi-asserted-by":"crossref","first-page":"1005","DOI":"10.1016\/S0140-6736(14)60844-8","article-title":"Global, regional, and national incidence and mortality for HIV, tuberculosis, and malaria during 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Murray","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30081-X_bib68","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.3201\/eid1610.100399","article-title":"Type 2 diabetes mellitus and increased risk for malaria infection","volume":"16","author":"Danquah","year":"2010","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib69","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/S1473-3099(07)70021-X","article-title":"Epidemiology and burden of malaria in pregnancy","volume":"7","author":"Desai","year":"2007","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib70","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.diabres.2013.11.003","article-title":"Global estimates of the prevalence of hyperglycaemia in pregnancy","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(16)30081-X_bib71","first-page":"489","article-title":"Frequency of diabetes mellitus and hyperglycemia in chagasic and non-chagasic women","volume":"32","author":"Santos dos","year":"1999","journal-title":"Rev Soc Bras Med Trop"},{"key":"10.1016\/S2213-8587(16)30081-X_bib72","doi-asserted-by":"crossref","first-page":"3820","DOI":"10.3390\/ijms16023820","article-title":"Diabetes mellitus increases severity of thrombocytopenia in dengue-infected patients","volume":"16","author":"Chen","year":"2015","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(16)30081-X_bib73","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1186\/s12879-015-1141-3","article-title":"Clinico-laboratory spectrum of dengue viral infection and risk factors associated with dengue hemorrhagic fever: a retrospective study","volume":"15","author":"Mallhi","year":"2015","journal-title":"BMC Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib74","doi-asserted-by":"crossref","first-page":"e1641","DOI":"10.1371\/journal.pntd.0001641","article-title":"Diabetes with hypertension as risk factors for adult dengue hemorrhagic fever in a predominantly dengue serotype 2 epidemic: a case control study","volume":"6","author":"Pang","year":"2012","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib75","doi-asserted-by":"crossref","first-page":"e0003741","DOI":"10.1371\/journal.pntd.0003741","article-title":"Is diabetes a risk factor for a severe clinical presentation of dengue? Review and meta-analysis","volume":"9","author":"Htun","year":"2015","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib76","doi-asserted-by":"crossref","first-page":"e699","DOI":"10.1371\/journal.pntd.0000699","article-title":"Allergies and diabetes as risk factors for dengue hemorrhagic fever: results of a case control study","volume":"4","author":"Figueiredo","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib77","doi-asserted-by":"crossref","first-page":"e0138465","DOI":"10.1371\/journal.pone.0138465","article-title":"Incidence, characteristics and risk factors of acute kidney injury among dengue patients: a retrospective analysis","volume":"10","author":"Mallhi","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30081-X_bib78","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1186\/s12879-014-0649-2","article-title":"Early clinical and laboratory risk factors of intensive care unit requirement during 2004\u20132008 dengue epidemics in Singapore: a matched case-control study","volume":"14","author":"Pang","year":"2014","journal-title":"BMC Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib79","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/0035-9203(84)90289-X","article-title":"Pentamidine-induced diabetes mellitus","volume":"78","author":"Jha","year":"1984","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S2213-8587(16)30081-X_bib80","doi-asserted-by":"crossref","first-page":"47","DOI":"10.2337\/diacare.18.1.47","article-title":"Pentamidine-induced derangements of glucose homeostasis. Determinant roles of renal failure and drug accumulation. A study of 128 patients","volume":"18","author":"Assan","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30081-X_bib81","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1016\/S0140-6736(82)92468-0","article-title":"Diabetes mellitus associated with pentamidine mesylate","volume":"1","author":"Belehu","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30081-X_bib82","doi-asserted-by":"crossref","first-page":"7","DOI":"10.47878\/hi.1979.v4.35626","article-title":"Diabetic status in leprosy","volume":"4","author":"Nigam","year":"1979","journal-title":"Hansenol Int"},{"key":"10.1016\/S2213-8587(16)30081-X_bib83","doi-asserted-by":"crossref","first-page":"e2338","DOI":"10.1371\/journal.pntd.0002338","article-title":"CD4+ Th17 cells discriminate clinical types and constitute a third subset of non-Th1, non-Th2 T cells in human leprosy","volume":"7","author":"Saini","year":"2013","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib84","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.4269\/ajtmh.2010.10-0410","article-title":"Decreased prevalence of lymphatic filariasis among subjects with type-1 diabetes","volume":"83","author":"Aravindhan","year":"2010","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/S2213-8587(16)30081-X_bib85","doi-asserted-by":"crossref","first-page":"e707","DOI":"10.1371\/journal.pntd.0000707","article-title":"Decreased prevalence of lymphatic filariasis among diabetic subjects associated with a diminished pro-inflammatory cytokine response (CURES 83)","volume":"4","author":"Aravindhan","year":"2010","journal-title":"PLoS Negl Trop Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib86","doi-asserted-by":"crossref","first-page":"E283","DOI":"10.1210\/jc.2012-2517","article-title":"Association of previous schistosome infection with diabetes and metabolic syndrome: a cross-sectional study in rural China","volume":"98","author":"Chen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30081-X_bib87","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1046\/j.1365-3024.1999.00213.x","article-title":"Infection with Schistosoma mansoni prevents insulin dependent diabetes mellitus in non-obese diabetic mice","volume":"21","author":"Cooke","year":"1999","journal-title":"Parasite Immunol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib88","doi-asserted-by":"crossref","first-page":"795210","DOI":"10.1155\/2010\/795210","article-title":"Immune modulation by Schistosoma mansoni antigens in NOD mice: effects on both innate and adaptive immune systems","volume":"2010","author":"Zaccone","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib89","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.exppara.2011.05.017","article-title":"Parasitological and morphological study of Schistosoma mansoni and diabetes mellitus in mice","volume":"129","author":"Hulstijn","year":"2011","journal-title":"Exp Parasitol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib90","doi-asserted-by":"crossref","first-page":"3027","DOI":"10.1096\/fj.14-266239","article-title":"Chronic helminth infection and helminth-derived egg antigens promote adipose tissue M2 macrophages and improve insulin sensitivity in obese mice","volume":"29","author":"Hussaarts","year":"2015","journal-title":"FASEB J"},{"key":"10.1016\/S2213-8587(16)30081-X_bib91","doi-asserted-by":"crossref","first-page":"e0127746","DOI":"10.1371\/journal.pone.0127746","article-title":"Infection with soil-transmitted helminths is associated with increased insulin sensitivity","volume":"10","author":"Wiria","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30081-X_bib92","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.diabres.2015.01.012","article-title":"Does Strongyloides stercoralis infection protect against type 2 diabetes in humans? Evidence from Australian Aboriginal adults","volume":"107","author":"Hays","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(16)30081-X_bib93","doi-asserted-by":"crossref","first-page":"e86289","DOI":"10.1371\/journal.pone.0086289","article-title":"Secreted proteins from the helminth Fasciola hepatica inhibit the initiation of autoreactive T cell responses and prevent diabetes in the NOD mouse","volume":"9","author":"Lund","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30081-X_bib94","doi-asserted-by":"crossref","first-page":"850541","DOI":"10.1155\/2010\/850541","article-title":"Taenia crassiceps infection attenuates multiple low-dose streptozotocin-induced diabetes","volume":"2010","author":"Espinoza-Jim\u00e9nez","year":"2010","journal-title":"J Biomed Biotechnol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib95","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jiph.2012.08.001","article-title":"Diabetic status of patients with leprosy in Kuwait","volume":"5","author":"Saraya","year":"2012","journal-title":"J Infect Public Health"},{"key":"10.1016\/S2213-8587(16)30081-X_bib96","first-page":"236","article-title":"Screening for diabetes mellitus in leprosy patients with complicated ulcers","volume":"51","author":"Smith","year":"1979","journal-title":"Lepr India"},{"key":"10.1016\/S2213-8587(16)30081-X_bib97","first-page":"125","article-title":"A study of steroid-induced diabetes mellitus in leprosy","volume":"81","author":"Papang","year":"2009","journal-title":"Indian J Lepr"},{"key":"10.1016\/S2213-8587(16)30081-X_bib98","series-title":"Infectious diseases","first-page":"1213","article-title":"Melioidosis","author":"Peacock","year":"2010"},{"key":"10.1016\/S2213-8587(16)30081-X_bib99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1055\/s-0034-1398389","article-title":"Melioidosis: evolving concepts in epidemiology, pathogenesis, and treatment","volume":"36","author":"Currie","year":"2015","journal-title":"Semin Respir Crit Care Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib100","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/cid\/cir808","article-title":"Clinical features and epidemiology of melioidosis pneumonia: results from a 21-year study and review of the literature","volume":"54","author":"Meumann","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib101","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1186\/1471-2334-10-302","article-title":"Incidence, risk factors and clinical epidemiology of melioidosis: a complex socio-ecological emerging infectious disease in the Alor Setar region of Kedah, Malaysia","volume":"10","author":"Hassan","year":"2010","journal-title":"BMC Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib102","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1128\/IAI.00212-12","article-title":"Burkholderia pseudomallei triggers altered inflammatory profiles in a whole-blood model of type 2 diabetes-melioidosis comorbidity","volume":"80","author":"Morris","year":"2012","journal-title":"Infect Immun"},{"key":"10.1016\/S2213-8587(16)30081-X_bib103","doi-asserted-by":"crossref","first-page":"2289","DOI":"10.1172\/JCI57817","article-title":"Glutathione deficiency in type 2 diabetes impairs cytokine responses and control of intracellular bacteria","volume":"122","author":"Tan","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(16)30081-X_bib104","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1093\/cid\/ciq192","article-title":"Glyburide is anti-inflammatory and associated with reduced mortality in melioidosis","volume":"52","author":"Koh","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib105","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1038\/nature12060","article-title":"The global distribution and burden of dengue","volume":"496","author":"Bhatt","year":"2013","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)30081-X_bib106","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.3201\/eid1312.061265","article-title":"Risk factors for West Nile virus neuroinvasive disease, California, 2005","volume":"13","author":"Jean","year":"2007","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib107","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1464-5491.2006.01861.x","article-title":"Plasma glucose levels and diabetes are independent predictors for mortality and morbidity in patients with SARS","volume":"23","author":"Yang","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib108","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1016\/S1473-3099(13)70204-4","article-title":"Epidemiological, demographic, and clinical characteristics of 47 cases of Middle East respiratory syndrome coronavirus disease from Saudi Arabia: a descriptive study","volume":"13","author":"Assiri","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib109","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/j.medmal.2014.09.009","article-title":"Ebola outbreak in Conakry, Guinea: epidemiological, clinical, and outcome features","volume":"44","author":"Barry","year":"2014","journal-title":"Med Mal Infect"},{"key":"10.1016\/S2213-8587(16)30081-X_bib110","first-page":"546","article-title":"Fatal rabies encephalitis despite post-exposure vaccination in a diabetic patient: a need for use of rabies immune globulin in all post-exposure cases","volume":"47","author":"Deshmukh","year":"1999","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(16)30081-X_bib111","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.annder.2012.05.013","article-title":"Unusual clinical presentation of cutaneous leishmaniasis in three diabetic patients","volume":"139","author":"Chiheb","year":"2012","journal-title":"Ann Dermatol Venereol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib112","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1684\/ejd.2009.0732","article-title":"Unusual multifocal cutaneous leishmaniasis in a diabetic patient","volume":"19","author":"Ceyhan","year":"2009","journal-title":"Eur J Dermatol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib113","first-page":"464","article-title":"Reinfestation in cutaneous leishmaniasis: a new look at predisposing conditions","volume":"21","author":"Sharquie","year":"2000","journal-title":"Saudi Med J"},{"key":"10.1016\/S2213-8587(16)30081-X_bib114","first-page":"127","article-title":"Pancreatic anatomopathologic changes in chronic chagasic women. Preliminary data","volume":"36","author":"dos Santos","year":"1999","journal-title":"Arq Gastroenterol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib115","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/0035-9203(88)90272-6","article-title":"Trypanosoma cruzi infection in diabetic mice","volume":"82","author":"Tanowitz","year":"1988","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S2213-8587(16)30081-X_bib116","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1089\/jir.1986.6.499","article-title":"Trypanosoma brucei rhodesiense infection in mice prevents virus-induced diabetes: possible role of interferon and immunological mechanisms","volume":"6","author":"Gould","year":"1986","journal-title":"J Interferon Res"},{"key":"10.1016\/S2213-8587(16)30081-X_bib117","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.actatropica.2006.06.006","article-title":"Is there an association between positive Strongyloides stercoralis serology and diabetes mellitus?","volume":"99","author":"Mendon\u00e7a","year":"2006","journal-title":"Acta Trop"},{"key":"10.1016\/S2213-8587(16)30081-X_bib118","doi-asserted-by":"crossref","first-page":"407","DOI":"10.4103\/0255-0857.71854","article-title":"Disseminated infection with Strongyloides stercoralis in a diabetic patient","volume":"28","author":"Murali","year":"2010","journal-title":"Indian J Med Microbiol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib119","first-page":"294","article-title":"Overwhelming strongyloidiasis in a diabetic patient following ACTH treatment and keto-acidosis","volume":"14","author":"Debussche","year":"1988","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(16)30081-X_bib120","first-page":"179","article-title":"Disseminated strongyloidiasis in a diabetic patient","volume":"45","author":"Coovadia","year":"1993","journal-title":"Trop Geogr Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib121","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1097\/00006676-199205000-00019","article-title":"Distal pancreatic atrophy and diabetes associated with an intrapancreatic hydatid cyst","volume":"7","author":"Arnaud","year":"1992","journal-title":"Pancreas"},{"key":"10.1016\/S2213-8587(16)30081-X_bib122","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1016\/S1473-3099(14)70771-6","article-title":"Helminth therapy or elimination: epidemiological, immunological, and clinical considerations","volume":"14","author":"Wammes","year":"2014","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib123","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.1126\/science.1223466","article-title":"Double burden of noncommunicable and infectious diseases in developing countries","volume":"337","author":"Bygbjerg","year":"2012","journal-title":"Science"},{"key":"10.1016\/S2213-8587(16)30081-X_bib124","doi-asserted-by":"crossref","first-page":"23611","DOI":"10.3402\/gha.v7.23611","article-title":"The workforce for health in a globalized context\u2014global shortages and international migration","volume":"7","author":"Aluttis","year":"2014","journal-title":"Glob Health Action"},{"key":"10.1016\/S2213-8587(16)30081-X_bib125","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0140-6736(10)61353-0","article-title":"Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries","volume":"376","author":"Samb","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30081-X_bib126","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30081-X_bib127","doi-asserted-by":"crossref","first-page":"23574","DOI":"10.3402\/gha.v7.23574","article-title":"The development and experience of epidemiological transition theory over four decades: a systematic review","volume":"7","author":"Santosa","year":"2014","journal-title":"Glob Health Action"},{"key":"10.1016\/S2213-8587(16)30081-X_bib128","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.4269\/ajtmh.15-0715","article-title":"An emerging epidemic of noncommunicable diseases in developing populations due to a triple evolutionary mismatch","volume":"94","author":"Koopman","year":"2016","journal-title":"Am J Trop Med Hyg"},{"key":"10.1016\/S2213-8587(16)30081-X_bib129","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/j.pcad.2013.09.004","article-title":"Innovative business approaches for incenting health promotion in sub-Saharan Africa: progress and persisting challenges","volume":"56","author":"Patel","year":"2013","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib130","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1093\/trstmh\/trv038","article-title":"HIV with non-communicable diseases in primary care in Kibera, Nairobi, Kenya: characteristics and outcomes 2010\u20132013","volume":"109","author":"Edwards","year":"2015","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S2213-8587(16)30081-X_bib131","doi-asserted-by":"crossref","first-page":"273re1","DOI":"10.1126\/scitranslmed.aaa0056","article-title":"A smartphone dongle for diagnosis of infectious diseases at the point of care","volume":"7","author":"Laksanasopin","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib132","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12936-015-0674-7","article-title":"Evaluation of a protocol for remote identification of mosquito vector species reveals BG-Sentinel trap as an efficient tool for Anopheles gambiae outdoor collection in Burkina Faso","volume":"14","author":"Pombi","year":"2015","journal-title":"Malar J"},{"key":"10.1016\/S2213-8587(16)30081-X_bib133","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0140-6736(10)61997-6","article-title":"Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial","volume":"376","author":"Lester","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30081-X_bib134","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/s12977-014-0133-5","article-title":"Opposing regulation of endolysosomal pathways by long-acting nanoformulated antiretroviral therapy and HIV-1 in human macrophages","volume":"12","author":"Ara\u00ednga","year":"2015","journal-title":"Retrovirology"},{"key":"10.1016\/S2213-8587(16)30081-X_bib135","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/1472-6963-10-339","article-title":"Task shifting to non-physician clinicians for integrated management of hypertension and diabetes in rural Cameroon: a programme assessment at two years","volume":"10","author":"Labhardt","year":"2010","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(16)30081-X_bib136","doi-asserted-by":"crossref","first-page":"e0145634","DOI":"10.1371\/journal.pone.0145634","article-title":"Task shifting the management of non-communicable diseases to nurses in Kibera, Kenya: does it work?","volume":"11","author":"Some","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30081-X_bib137","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1377\/hlthaff.2011.0914","article-title":"Peer support for self-management of diabetes improved outcomes in international settings","volume":"31","author":"Fisher","year":"2012","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/S2213-8587(16)30081-X_bib138","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/j.1365-3156.2011.02827.x","article-title":"Improved retention rates with low-cost interventions in hypertension and diabetes management in a rural African environment of nurse-led care: a cluster-randomised trial","volume":"16","author":"Labhardt","year":"2011","journal-title":"Trop Med Int Health"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)30081-X_bib139","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1467-789X.2007.00456.x","article-title":"Hypertension and cardiovascular diseases intervention in the capital steel and iron company and Beijing Fangshan community","volume":"9","author":"Chen","year":"2008","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(16)30081-X_bib140","first-page":"A12","article-title":"Pausa para tu Salud: reduction of weight and waistlines by integrating exercise breaks into workplace organizational routine","volume":"5","author":"Lara","year":"2008","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/S2213-8587(16)30081-X_bib141","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/S0140-6736(12)62128-X","article-title":"Promotion of access to essential medicines for non-communicable diseases: practical implications of the UN political declaration","volume":"381","author":"Hogerzeil","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30081-X_bib142","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.amepre.2013.03.020","article-title":"Lifestyle interventions in patients with coronary heart disease: a systematic review","volume":"45","author":"de Waure","year":"2013","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib143","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD011163.pub2","article-title":"Multiple risk factor interventions for primary prevention of cardiovascular disease in low- and middle-income countries","volume":"8","author":"Uthman","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(16)30081-X_bib144","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1744-8603-8-9","article-title":"The economic impact of non-communicable diseases on households in India","volume":"8","author":"Engelgau","year":"2012","journal-title":"Global Health"},{"key":"10.1016\/S2213-8587(16)30081-X_bib145","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1080\/13557858.2012.754409","article-title":"Review of community-based interventions for prevention of cardiovascular diseases in low- and middle-income countries","volume":"17","author":"van de Vijver","year":"2012","journal-title":"Ethn Health"},{"key":"10.1016\/S2213-8587(16)30081-X_bib146","doi-asserted-by":"crossref","first-page":"137460","DOI":"10.1155\/2012\/137460","article-title":"Strengthening health systems for chronic care: leveraging HIV programs to support diabetes services in Ethiopia and Swaziland","volume":"2012","author":"Rabkin","year":"2012","journal-title":"J Trop Med"},{"key":"10.1016\/S2213-8587(16)30081-X_bib147","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1016\/S2213-8587(15)00381-2","article-title":"Effectiveness of an mHealth intervention to improve the cardiometabolic profile of people with prehypertension in low-resource urban settings in Latin America: a randomised controlled trial","volume":"4","author":"Rubinstein","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib148","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2213-8587(13)70067-6","article-title":"Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial","volume":"1","author":"Ramachandran","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib149","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2213-8587(16)30001-8","article-title":"mHealth plus community health worker interventions: the future research agenda","volume":"4","author":"Mishra","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30081-X_bib150","doi-asserted-by":"crossref","first-page":"e339","DOI":"10.1016\/S2214-109X(13)70113-X","article-title":"Causes of vision loss worldwide, 1990\u20132010: a systematic analysis","volume":"1","author":"Bourne","year":"2013","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(16)30081-X_bib151","doi-asserted-by":"crossref","first-page":"S37","DOI":"10.1111\/j.1523-1755.2005.09807.x","article-title":"Preventive strategies of renal failure in the Arab world","volume":"98","author":"Shaheen","year":"2005","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/S2213-8587(16)30081-X_bib152","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1177\/039139889501800503","article-title":"Serious renal disease in Egypt","volume":"18","author":"Essamie","year":"1995","journal-title":"Int J Artif Organs"},{"key":"10.1016\/S2213-8587(16)30081-X_bib153","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1186\/1744-8603-9-62","article-title":"Epidemiology, management, complications and costs associated with type 2 diabetes in Brazil: a comprehensive literature review","volume":"9","author":"Bertoldi","year":"2013","journal-title":"Global Health"},{"key":"10.1016\/S2213-8587(16)30081-X_bib154","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1002\/eji.201344301","article-title":"Diabetes and immunity to tuberculosis","volume":"44","author":"Martinez","year":"2014","journal-title":"Eur J Immunol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630081X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630081X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,4]],"date-time":"2025-06-04T15:31:00Z","timestamp":1749051060000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871630081X"}},"issued":{"date-parts":[[2017,6]]},"references-count":154,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S221385871630081X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30081-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The global diabetes epidemic: what does it mean for infectious diseases in tropical countries?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30081-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T10:26:27Z","timestamp":1794565587819,"version":"4.9.1"},"reference-count":40,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,1,18]],"date-time":"2018-01-18T00:00:00Z","timestamp":1516233600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/s2213-8587(17)30432-1","type":"journal-article","created":{"date-parts":[[2018,1,19]],"date-time":"2018-01-19T23:34:46Z","timestamp":1516404886000},"page":"208-222","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":312,"title":["Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi"],"prefix":"10.1016","volume":"6","author":[{"given":"Alison J","family":"Price","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amelia C","family":"Crampin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alemayehu","family":"Amberbir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ndoliwe","family":"Kayuni-Chihana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Crispin","family":"Musicha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terence","family":"Tafatatha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Branson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie A","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elenaus","family":"Mwaiyeghele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence","family":"Nkhwazi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liam","family":"Smeeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Munthali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice M","family":"Mwagomba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Mwansambo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith R","family":"Glynn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shabbar","family":"Jaffar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moffat","family":"Nyirenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30432-1_bib1","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.1001\/jama.291.21.2616","article-title":"The global burden of chronic diseases: overcoming impediments to prevention and control","volume":"291","author":"Yach","year":"2004","journal-title":"J Am Med Assoc"},{"key":"10.1016\/S2213-8587(17)30432-1_bib2","doi-asserted-by":"crossref","first-page":"2011","DOI":"10.1371\/journal.pmed.0030442","article-title":"Projections of global mortality and burden of disease from 2002 to 2030","volume":"3","author":"Mathers","year":"2006","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30432-1_bib3","doi-asserted-by":"crossref","first-page":"2287","DOI":"10.1016\/S0140-6736(15)00128-2","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990\u20132013: a systematic analysis for the global burden of disease study 2013","volume":"386","author":"Forouzanfar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30432-1_bib4","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1016\/S0140-6736(12)61766-8","article-title":"A comparative risk assessment of burden of disease and injury attributable to 67 risk factors and risk factor clusters in 21 regions, 1990\u20132010: A systematic analysis for the global burden of disease study 2010","volume":"380","author":"Lim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30432-1_bib5","doi-asserted-by":"crossref","first-page":"e132","DOI":"10.1016\/S2214-109X(14)70381-X","article-title":"Dietary quality among men and women in 187 countries in 1990 and 2010: a systematic assessment","volume":"3","author":"Imamura","year":"2015","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(17)30432-1_bib6","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1016\/S0140-6736(15)01284-2","article-title":"Physical activity in relation to urban environments in 14 cities worldwide: a cross-sectional study","volume":"387","author":"Sallis","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30432-1_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1744-8603-5-9","article-title":"A review of co-morbidity between infectious and chronic disease in sub-Saharan Africa: TB and diabetes mellitus, HIV and metabolic syndrome, and the impact of globalization","volume":"5","author":"Young","year":"2009","journal-title":"Global Health"},{"key":"10.1016\/S2213-8587(17)30432-1_bib8","doi-asserted-by":"crossref","first-page":"e29","DOI":"10.1161\/CIRCULATIONAHA.107.189624","article-title":"Epidemiological evidence for cardiovascular disease in HIV-infected patients and relationship to highly active antiretroviral therapy","volume":"118","author":"Currier","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30432-1_bib9","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.trstmh.2008.05.028","article-title":"Indoor air pollution from biomass fuel smoke is a major health concern in the developing world","volume":"102","author":"Fullerton","year":"2008","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S2213-8587(17)30432-1_bib10","doi-asserted-by":"crossref","first-page":"e13582","DOI":"10.1371\/journal.pone.0013582","article-title":"Hypertension, diabetes and overweight: looming legacies of the Biafran famine","volume":"5","author":"Hult","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30432-1_bib11","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/ije\/dyx078","article-title":"Trends in obesity and diabetes across africa from 1980 to 2014: an analysis of pooled population-based studies","volume":"46","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30432-1_bib12","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(16)31919-5","article-title":"Worldwide trends in blood pressure from 1975 to 2015: a pooled analysis of 1479 population-based measurement studies with 19\u00b71 million participants","volume":"389","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30432-1_bib13","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30432-1_bib14","doi-asserted-by":"crossref","first-page":"e20316","DOI":"10.1371\/journal.pone.0020316","article-title":"The burden of selected chronic non-communicable diseases and their risk factors in Malawi: nationwide STEPS survey","volume":"6","author":"Msyamboza","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30432-1_bib15","series-title":"Global action plan for the prevention and control of NCDs 2013\u20132020","year":"2013"},{"key":"10.1016\/S2213-8587(17)30432-1_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12982-015-0039-2","article-title":"Hypertension and diabetes in Africa: design and implementation of a large population-based study of burden and risk factors in rural and urban Malawi","volume":"13","author":"Crampin","year":"2016","journal-title":"Emerg Themes Epidemiol"},{"key":"10.1016\/S2213-8587(17)30432-1_bib17","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1093\/ije\/dys088","article-title":"Profile: the Karonga health and demographic surveillance system","volume":"41","author":"Crampin","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30432-1_bib19","series-title":"Malawi demographic and health survey 2015\u201316","year":"2017"},{"key":"10.1016\/S2213-8587(17)30432-1_bib20","series-title":"Malawi 2008 population and housing census results","year":"2008"},{"key":"10.1016\/S2213-8587(17)30432-1_bib21","doi-asserted-by":"crossref","first-page":"461","DOI":"10.2471\/BLT.05.027037","article-title":"Methods for establishing a surveillance system for cardiovascular diseases in Indian industrial populations","volume":"84","author":"Reddy","year":"2006","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(17)30432-1_bib22","author":"Thistle"},{"key":"10.1016\/S2213-8587(17)30432-1_bib24","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1186\/1471-2458-13-1161","article-title":"Multimorbidity prevalence in the general population: the role of obesity in chronic disease clustering","volume":"13","author":"Agborsangaya","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(17)30432-1_bib26","series-title":"Guideline: sugars intake for adults and children","year":"2015"},{"key":"10.1016\/S2213-8587(17)30432-1_bib27","doi-asserted-by":"crossref","first-page":"2172","DOI":"10.1097\/HJH.0000000000001070","article-title":"Accessing clinical services and retention in care following screening for hypertension and diabetes among Malawian adults: an urban\/rural comparison","volume":"34","author":"Musicha","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(17)30432-1_bib28","series-title":"Age standardization of rates: a new world standard. GPE Discussion Paper Series: No. 31","author":"Ahmad","year":"2001"},{"key":"10.1016\/S2213-8587(17)30432-1_bib29","series-title":"Screening for high blood pressure in adults: a systematic evidence review for the US Preventive Services task force","first-page":"1","author":"Piper","year":"2014"},{"key":"10.1016\/S2213-8587(17)30432-1_bib31","first-page":"479","article-title":"Sustained 10-year gain in adult life expectancy following antiretroviral therapy roll-out in rural Malawi: July 2005 to June 2014","volume":"46","author":"Price","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30432-1_bib34","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ije\/dyv343","article-title":"Data resource profile: Network for analysing longitudinal population-based HIV\/AIDS data on Africa (ALPHA network)","volume":"45","author":"Reniers","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30432-1_bib35","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S0140-6736(12)60861-7","article-title":"Hypertension in developing countries","volume":"380","author":"Ibrahim","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30432-1_bib36","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(10)60550-8","article-title":"Diabetes in sub-Saharan Africa","volume":"375","author":"Mbanya","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30432-1_bib37","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1161\/HYPERTENSIONAHA.114.04394","article-title":"Burden of undiagnosed hypertension in sub-Saharan africa: a systematic review and meta-analysis","volume":"65","author":"Ataklte","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30432-1_bib38","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/1471-2458-11-365","article-title":"Prevalence of obesity and associated risk factors among adults in Kinondoni municipal district, Dar es Salaam Tanzania","volume":"11","author":"Shayo","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(17)30432-1_bib39","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1186\/1745-6215-14-409","article-title":"A community-based intervention for primary prevention of cardiovascular diseases in the slums of Nairobi: the SCALE UP study protocol for a prospective quasi-experimental community-based trial","volume":"14","author":"Oti","year":"2013","journal-title":"Trials"},{"key":"10.1016\/S2213-8587(17)30432-1_bib40","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the global burden of disease study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30432-1_bib41","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1253\/circj.CJ-14-0850","article-title":"Global trend in overweight and obesity and its association with cardiovascular disease incidence","volume":"78","author":"Yatsuya","year":"2014","journal-title":"Circ J"},{"key":"10.1016\/S2213-8587(17)30432-1_bib42","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1001\/jama.289.1.76","article-title":"Prevalence of obesity, diabetes, and obesity-related health risk factors, 2001","volume":"289","author":"Mokdad","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30432-1_bib43","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1152\/physrev.00053.2003","article-title":"Developmental origins of the metabolic syndrome: Prediction, plasticity, and programming","volume":"85","author":"McMillen","year":"2005","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(17)30432-1_bib44","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.bpobgyn.2014.06.007","article-title":"Developmental origins of health and disease\u2014global public health implications","volume":"29","author":"Hanson","year":"2015","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/S2213-8587(17)30432-1_bib45","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/S0140-6736(17)30402-6","article-title":"Non-communicable disease syndemics: poverty, depression, and diabetes among low-income populations","volume":"389","author":"Mendenhall","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30432-1_bib46","doi-asserted-by":"crossref","first-page":"e27917","DOI":"10.1371\/journal.pone.0027917","article-title":"Combining qualitative and quantitative evidence to determine factors leading to late presentation for antiretroviral therapy in Malawi","volume":"6","author":"Parrott","year":"2011","journal-title":"PLoS One"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304321?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304321?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,24]],"date-time":"2018-08-24T17:20:57Z","timestamp":1535131257000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717304321"}},"issued":{"date-parts":[[2018,3]]},"references-count":40,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2213858717304321"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30432-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30432-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30433-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:19:29Z","timestamp":1794651569332,"version":"4.9.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T00:00:00Z","timestamp":1478563200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"crossref","award":["#14\/0004878"],"award-info":[{"award-number":["#14\/0004878"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/s2213-8587(16)30280-7","type":"journal-article","created":{"date-parts":[[2016,11,8]],"date-time":"2016-11-08T20:15:14Z","timestamp":1478636114000},"page":"117-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":126,"title":["Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial"],"prefix":"10.1016","volume":"5","author":[{"given":"Hood","family":"Thabit","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hartnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet M","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Lake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata E","family":"Wilinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Ruan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Hovorka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30280-7_bib2","doi-asserted-by":"crossref","first-page":"367","DOI":"10.2337\/dc06-1715","article-title":"Prevalence of hyper- and hypoglycemia among inpatients with diabetes: a national survey of 44 U.S. hospitals","volume":"30","author":"Wexler","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30280-7_bib3","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1210\/jcem.87.3.8341","article-title":"Hyperglycemia: an independent marker of in-hospital mortality in patients with undiagnosed diabetes","volume":"87","author":"Umpierrez","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30280-7_bib4","doi-asserted-by":"crossref","first-page":"f134","DOI":"10.1136\/bmj.f134","article-title":"Should inpatient hyperglycaemia be treated?","volume":"346","author":"Dhatariya","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)30280-7_bib5","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30280-7_bib6","doi-asserted-by":"crossref","first-page":"500","DOI":"10.1111\/dom.12228","article-title":"Glucose control in non-critically ill inpatients with diabetes: towards closed-loop","volume":"16","author":"Thabit","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(16)30280-7_bib7","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrendo.2011.32","article-title":"Closed-loop insulin delivery: from bench to clinical practice","volume":"7","author":"Hovorka","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(16)30280-7_bib8","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa1509351","article-title":"Home use of an artificial beta cell in type 1 diabetes","volume":"373","author":"Thabit","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30280-7_bib9","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S2213-8587(15)00335-6","article-title":"2 month evening and night closed-loop glucose control in patients with type 1 diabetes under free-living conditions: a randomised crossover trial","volume":"3","author":"Kropff","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30280-7_bib10","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/dc13-1030","article-title":"Feasibility of closed-loop insulin delivery in type 2 diabetes: a randomized controlled study","volume":"37","author":"Kumareswaran","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30280-7_bib11","author":"Evans"},{"key":"10.1016\/S2213-8587(16)30280-7_bib12","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(09)61998-X","article-title":"Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial","volume":"375","author":"Hovorka","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30280-7_bib13","doi-asserted-by":"crossref","first-page":"d1855","DOI":"10.1136\/bmj.d1855","article-title":"Overnight closed loop insulin delivery (artificial pancreas) in adults with type 1 diabetes: crossover randomised controlled studies","volume":"342","author":"Hovorka","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)30280-7_bib14","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1089\/dia.2012.0185","article-title":"Assessing performance of closed-loop insulin delivery systems by continuous glucose monitoring: drawbacks and way forward","volume":"15","author":"Hovorka","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(16)30280-7_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1002\/jhm.390","article-title":"Evaluation of hospital glycemic control at US academic medical centers","volume":"4","author":"Boord","year":"2009","journal-title":"J Hosp Med"},{"key":"10.1016\/S2213-8587(16)30280-7_bib16","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1177\/193229681300700217","article-title":"Failure to control hyperglycemia in noncritically ill diabetes patients despite standard glycemic management in a hospital setting","volume":"7","author":"Neubauer","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(16)30280-7_bib17","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.2337\/dc08-2127","article-title":"Hypoglycemia and clinical outcomes in patients with diabetes hospitalized in the general ward","volume":"32","author":"Turchin","year":"2009","journal-title":"Diabetes Care"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(16)30280-7_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.4158\/EP.10.S2.53","article-title":"Reduction of hospital costs and length of stay by good control of blood glucose levels","volume":"10","author":"Ahmann","year":"2004","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(16)30280-7_bib19","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/db08-0063","article-title":"Oscillating glucose is more deleterious to endothelial function and oxidative stress than mean glucose in normal and type 2 diabetic patients","volume":"57","author":"Ceriello","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)30280-7_bib20","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1097\/CCM.0b013e31818b38d2","article-title":"Glycemic variability: a strong independent predictor of mortality in critically ill patients","volume":"36","author":"Krinsley","year":"2008","journal-title":"Crit Care Med"},{"key":"10.1016\/S2213-8587(16)30280-7_bib21","doi-asserted-by":"crossref","first-page":"2225","DOI":"10.1210\/jc.2013-4519","article-title":"Glucose turnover after replacement of usual therapy by insulin in insulin-naive type 2 diabetes subjects","volume":"99","author":"Thabit","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30280-7_bib22","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/cc12838","article-title":"Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial","volume":"17","author":"Leelarathna","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/S2213-8587(16)30280-7_bib23","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.2337\/dc08-2107","article-title":"Effect of intensive insulin therapy using a closed-loop glycemic control system in hepatic resection patients: a prospective randomized clinical trial","volume":"32","author":"Okabayashi","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30280-7_bib24","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/dc13-1771","article-title":"Intensive versus intermediate glucose control in surgical intensive care unit patients","volume":"37","author":"Okabayashi","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30280-7_bib25","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/dom.12186","article-title":"Efficacy, usability and sequence of operations of a workflow-integrated algorithm for basal-bolus insulin therapy in hospitalized type 2 diabetes patients","volume":"16","author":"Mader","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(16)30280-7_bib26","doi-asserted-by":"crossref","first-page":"81","DOI":"10.4158\/EP12196.OR","article-title":"Management of hyperglycemia with the administration of intravenous exenatide to patients in the cardiac intensive care unit","volume":"19","author":"Abuannadi","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(16)30280-7_bib27","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.2337\/dc12-2233","article-title":"Is incretin-based therapy ready for the care of hospitalized patients with type 2 diabetes?: Insulin therapy has proven itself and is considered the mainstay of treatment","volume":"36","author":"Umpierrez","year":"2013","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,3,12]],"date-time":"2020-03-12T11:53:19Z","timestamp":1584013999000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302807"}},"issued":{"date-parts":[[2017,2]]},"references-count":26,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S2213858716302807"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30280-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30280-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30327-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:21:29Z","timestamp":1794666089722,"version":"4.9.1"},"reference-count":111,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"(EMS)","award":["K23 DK084337"],"award-info":[{"award-number":["K23 DK084337"]}]},{"name":"(SJS)","award":["K24 DK074457"],"award-info":[{"award-number":["K24 DK074457"]}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/s2213-8587(13)70183-9","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T13:45:29Z","timestamp":1391435129000},"page":"165-174","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":180,"title":["Bone loss after bariatric surgery: causes, consequences, and management"],"prefix":"10.1016","volume":"2","author":[{"given":"Emily M","family":"Stein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shonni J","family":"Silverberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70183-9_bib1","doi-asserted-by":"crossref","first-page":"337","DOI":"10.4158\/EP12437.GL","volume":"19","author":"Mechanick","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(13)70183-9_bib2","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s11695-009-0014-5","article-title":"Metabolic\/bariatric surgery worldwide 2008","volume":"19","author":"Buchwald","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib3","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1001\/jama.288.22.2793","article-title":"Bariatric surgery and long-term control of morbid obesity","volume":"288","author":"Brolin","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70183-9_bib4","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","article-title":"Bariatric surgery versus intensive medical therapy in obese patients with diabetes","volume":"366","author":"Schauer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70183-9_bib5","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1200111","article-title":"Bariatric surgery versus conventional medical therapy for type 2 diabetes","volume":"366","author":"Mingrone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70183-9_bib6","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sj\u00f6str\u00f6m","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70183-9_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-term mortality after gastric bypass surgery","volume":"357","author":"Adams","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70183-9_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1210\/jc.2012-2394","article-title":"Bariatric surgery results in cortical bone loss","volume":"98","author":"Stein","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70183-9_bib9","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1210\/jc.2008-0481","article-title":"The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss","volume":"93","author":"Fleischer","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70183-9_bib10","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1210\/jc.2003-031756","article-title":"Gastric bypass surgery for morbid obesity leads to an increase in bone turnover and a decrease in bone mass","volume":"89","author":"Coates","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70183-9_bib11","series-title":"Atlas of metabolic and weight loss surgery","author":"Jones","year":"2010"},{"key":"10.1016\/S2213-8587(13)70183-9_bib12","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/j.1365-2265.2008.03470.x","article-title":"Vitamin D insufficiency prior to bariatric surgery: risk factors and a pilot treatment study","volume":"71","author":"Stein","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(13)70183-9_bib13","first-page":"284516","article-title":"Vitamin D Deficiency is prevalent in morbidly obese adolescents prior to bariatric surgery","volume":"2013","author":"Censani","year":"2013","journal-title":"ISRN Obes"},{"key":"10.1016\/S2213-8587(13)70183-9_bib14","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1093\/ajcn\/85.3.860","article-title":"Hypovitaminosis D in British adults at age 45 y: nationwide cohort study of dietary and lifestyle predictors","volume":"85","author":"Hypp\u00f6nen","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70183-9_bib15","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1093\/ajcn\/34.11.2359","article-title":"Vitamin D status and bone histomorphometry in gross obesity","volume":"34","author":"Compston","year":"1981","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70183-9_bib16","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1093\/ajcn\/72.3.690","article-title":"Decreased bioavailability of vitamin D in obesity","volume":"72","author":"Wortsman","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70183-9_bib17","doi-asserted-by":"crossref","first-page":"1655","DOI":"10.1210\/jc.2011-2280","article-title":"Serum leptin, parathyroid hormone, 1,25-dihydroxyvitamin D, fibroblast growth factor 23, bone alkaline phosphatase, and sclerostin relationships in obesity","volume":"97","author":"Grethen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70183-9_bib18","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1007\/s11695-010-0138-7","article-title":"Calcium and vitamin D supplementation after gastric bypass should be individualized to improve or avoid hyperparathyroidism","volume":"20","author":"Flores","year":"2010","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/s00198-007-0492-z","article-title":"Relationships between fat and bone","volume":"19","author":"Reid","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(13)70183-9_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/jbmr.1486","article-title":"Obesity and fracture in men and women: an epidemiologic perspective","volume":"27","author":"Nielson","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib21","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1093\/ajcn\/83.1.146","article-title":"Relation of body composition, fat mass, and serum lipids to osteoporotic fractures and bone mineral density in Chinese men and women","volume":"83","author":"Hsu","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70183-9_bib22","doi-asserted-by":"crossref","first-page":"1761","DOI":"10.2214\/ajr.183.6.01831761","article-title":"Bone marrow fat and bone mineral density on proton MR spectroscopy and dual-energy X-ray absorptiometry: their ratio as a new indicator of bone weakening","volume":"183","author":"Schellinger","year":"2004","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/S2213-8587(13)70183-9_bib23","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1210\/jc.2008-2422","article-title":"Reciprocal relations of subcutaneous and visceral fat to bone structure and strength","volume":"94","author":"Gilsanz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70183-9_bib24","doi-asserted-by":"crossref","first-page":"2562","DOI":"10.1210\/jc.2013-1047","article-title":"Abdominal fat is associated with lower bone formation and inferior bone quality in healthy premenopausal women: a transiliac bone biopsy study","volume":"98","author":"Cohen","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70183-9_bib25","article-title":"A meta-analysis of the association of fracture risk and body mass index in women","author":"Johansson","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib26","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/jbmr.1880","article-title":"In obese postmenopausal women, bone microarchitecture and strength are not commensurate to greater body weight: the Os des Femmes de Lyon (OFELY) study","volume":"28","author":"Sornay-Rendu","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib27","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.amjmed.2011.06.013","article-title":"Obesity is not protective against fracture in postmenopausal women: GLOW","volume":"124","author":"Compston","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(13)70183-9_bib28","doi-asserted-by":"crossref","first-page":"2090","DOI":"10.1359\/JBMR.050820","article-title":"Bone and body composition of children and adolescents with repeated forearm fractures","volume":"20","author":"Goulding","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib29","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1359\/jbmr.091004","article-title":"Obesity and fractures in postmenopausal women","volume":"25","author":"Premaor","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib30","article-title":"Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the global longitudinal study of osteoporosis in women (GLOW)","author":"Compston","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib31","doi-asserted-by":"crossref","first-page":"629637","DOI":"10.1155\/2012\/629637","article-title":"Intramuscular adipose tissue, sarcopenia, and mobility function in older individuals","volume":"2012","author":"Marcus","year":"2012","journal-title":"J Aging Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib32","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/jbmr.1878","article-title":"The association between fracture site and obesity in men: a population-based cohort study","volume":"28","author":"Premaor","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1385\/JCD:6:3:199","article-title":"An overlying fat panniculus affects femur bone mass measurement","volume":"6","author":"Binkley","year":"2003","journal-title":"J Clin Densitom"},{"key":"10.1016\/S2213-8587(13)70183-9_bib34","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jbmr.506","article-title":"Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT","volume":"27","author":"Yu","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib35","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.jocd.2012.01.002","article-title":"Obesity increases precision errors in dual-energy X-ray absorptiometry measurements","volume":"15","author":"Knapp","year":"2012","journal-title":"J Clin Densitom"},{"key":"10.1016\/S2213-8587(13)70183-9_bib36","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s004210050204","article-title":"Validation of a dual energy X-ray absorptiometer: measurement of bone mass and soft tissue composition","volume":"75","author":"Madsen","year":"1997","journal-title":"Eur J Appl Physiol Occup Physiol"},{"key":"10.1016\/S2213-8587(13)70183-9_bib37","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jbmr.506","article-title":"Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT","volume":"27","author":"Yu","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib38","author":"Colt"},{"key":"10.1016\/S2213-8587(13)70183-9_bib39","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1038\/nrgastro.2011.112","article-title":"Surgical approaches to the treatment of obesity","volume":"8","author":"Dixon","year":"2011","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(13)70183-9_bib40","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1001\/jama.292.14.1724","article-title":"Bariatric surgery: a systematic review and meta-analysis","volume":"292","author":"Buchwald","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70183-9_bib41","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1001\/archsurg.2011.1708","article-title":"Roux-en-Y gastric bypass vs gastric banding for morbid obesity: a case-matched study of 442 patients","volume":"147","author":"Romy","year":"2012","journal-title":"Arch Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib42","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1381\/096089206777822359","article-title":"A 10-year experience with laparoscopic gastric banding for morbid obesity: high long-term complication and failure rates","volume":"16","author":"Suter","year":"2006","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib43","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1038\/sj.ijo.0803040","article-title":"Gastric banding induces negative bone remodelling in the absence of secondary hyperparathyroidism: potential role of serum C telopeptides for follow-up","volume":"29","author":"Giusti","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(13)70183-9_bib44","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1038\/sj.ijo.0802177","article-title":"Bone metabolism and risk of secondary hyperparathyroidism 12 months after gastric banding in obese pre-menopausal women","volume":"27","author":"Pugnale","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(13)70183-9_bib45","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1210\/jcem.87.3.8351","article-title":"IL-1 receptor antagonist serum levels are increased in human obesity: a possible link to the resistance to leptin?","volume":"87","author":"Meier","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70183-9_bib46","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1381\/096089203765887705","article-title":"Effect of weight loss on bone metabolism: comparison of vertical banded gastroplasty and medical intervention","volume":"13","author":"Guney","year":"2003","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib47","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1016\/j.metabol.2004.01.015","article-title":"Changes in bone mineral content after surgical treatment of morbid obesity","volume":"53","author":"von Mach","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(13)70183-9_bib48","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1002\/bjs.1800831046","article-title":"Effects of vertical-banded gastroplasty on bone and mineral metabolism in obese patients","volume":"83","author":"Cundy","year":"1996","journal-title":"Br J Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib49","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1007\/s11695-013-0866-6","article-title":"Short- and mid-term changes in bone mineral density after laparoscopic sleeve gastrectomy","volume":"23","author":"Ruiz-Tovar","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib50","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1111\/j.1467-789X.2012.01050.x","article-title":"Bariatric surgery, bone loss, obesity and possible mechanisms","volume":"14","author":"Brzozowska","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(13)70183-9_bib51","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.ciresp.2010.04.008","article-title":"Bone mass loss after sleeve gastrectomy: a prospective comparative study with gastric bypass","volume":"88","author":"Nogu\u00e9s","year":"2010","journal-title":"Cir Esp"},{"key":"10.1016\/S2213-8587(13)70183-9_bib52","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1097\/SLA.0b013e31822c9dac","article-title":"First report from the American College of Surgeons Bariatric Surgery Center Network: laparoscopic sleeve gastrectomy has morbidity and effectiveness positioned between the band and the bypass","volume":"254","author":"Hutter","year":"2011","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib53","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1097\/SLA.0b013e3181f2aed0","article-title":"Early postoperative outcomes of metabolic surgery to treat diabetes from sites participating in the ASMBS bariatric surgery center of excellence program as reported in the Bariatric Outcomes Longitudinal Database","volume":"252","author":"Demaria","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib54","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1007\/s11695-012-0654-8","article-title":"Bone mineral changes in spine and proximal femur in individual obese women after laparoscopic sleeve gastrectomy: a short-term study","volume":"22","author":"Pluskiewicz","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib55","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1097\/SLA.0b013e3181b92480","article-title":"A prospective randomized trial of laparoscopic gastric bypass versus laparoscopic adjustable gastric banding for the treatment of morbid obesity: outcomes, quality of life, and costs","volume":"250","author":"Nguyen","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib56","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00464-011-2125-z","article-title":"Long-term outcomes of laparoscopic adjustable gastric banding and laparoscopic Roux-en-Y gastric bypass in the United States","volume":"26","author":"Spivak","year":"2012","journal-title":"Surg Endosc"},{"key":"10.1016\/S2213-8587(13)70183-9_bib57","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1038\/oby.2006.226","article-title":"True fractional calcium absorption is decreased after Roux-en-Y gastric bypass surgery","volume":"14","author":"Riedt","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(13)70183-9_bib58","doi-asserted-by":"crossref","first-page":"1287","DOI":"10.1007\/s11695-012-0687-z","article-title":"Changes in bone mineral density in women following 1-year gastric bypass surgery","volume":"22","author":"Casagrande","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib59","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00464-007-9228-6","article-title":"Risk of secondary hyperparathyroidism after laparoscopic gastric bypass surgery in obese women","volume":"21","author":"Youssef","year":"2007","journal-title":"Surg Endosc"},{"key":"10.1016\/S2213-8587(13)70183-9_bib60","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1097\/00000441-200502000-00001","article-title":"Metabolic bone disease after gastric bypass surgery for obesity","volume":"329","author":"De Prisco","year":"2005","journal-title":"Am J Med Sci"},{"key":"10.1016\/S2213-8587(13)70183-9_bib61","doi-asserted-by":"crossref","first-page":"1062","DOI":"10.1381\/0960892041975505","article-title":"Calcium metabolism in pre- and postmenopausal morbidly obese women at baseline and after laparoscopic Roux-en-Y gastric bypass","volume":"14","author":"El-Kadre","year":"2004","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib62","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11695-010-0338-1","article-title":"Evaluation of bone mineral density loss in morbidly obese women after gastric bypass: 3-year follow-up","volume":"21","author":"Vilarrasa","year":"2011","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib63","article-title":"Bone loss after bariatric surgery: discordant results between DXA and QCT bone density","author":"Yu","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib64","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1210\/jc.2009-0265","article-title":"Serum markers of bone turnover are increased at six and 18 months after Roux-en-Y bariatric surgery: correlation with the reduction in leptin","volume":"95","author":"Bruno","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70183-9_bib65","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1381\/096089292765559936","article-title":"Biochemical evidence of metabolic bone disease in women following Roux-Y gastric bypass for morbid obesity","volume":"2","author":"Ott","year":"1992","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib66","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1038\/oby.2004.7","article-title":"Bone and gastric bypass surgery: effects of dietary calcium and vitamin D","volume":"12","author":"Goode","year":"2004","journal-title":"Obes Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib67","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1007\/s11695-008-9638-0","article-title":"Changes in bone mineral density, body composition and adiponectin levels in morbidly obese patients after bariatric surgery","volume":"19","author":"Carrasco","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib68","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1007\/s11695-009-9843-5","article-title":"Evaluation of bone disease in morbidly obese women after gastric bypass and risk factors implicated in bone loss","volume":"19","author":"Vilarrasa","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib69","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1590\/S0100-879X2007000400009","article-title":"Impact of marked weight loss induced by bariatric surgery on bone mineral density and remodeling","volume":"40","author":"Pereira","year":"2007","journal-title":"Braz J Med Biol Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib70","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1038\/oby.2011.133","article-title":"Increased PTH and 1.25(OH)(2)D levels associated with increased markers of bone turnover following bariatric surgery","volume":"19","author":"Sinha","year":"2011","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(13)70183-9_bib71","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.gassur.2005.07.012","article-title":"Effects of gastric bypass procedures on bone mineral density, calcium, parathyroid hormone, and vitamin D","volume":"9","author":"Johnson","year":"2005","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib72","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1097\/01.sla.0000218085.25902.f8","article-title":"Body composition, dietary intake, and energy expenditure after laparoscopic Roux-en-Y gastric bypass and laparoscopic vertical banded gastroplasty: a randomized clinical trial","volume":"244","author":"Olbers","year":"2006","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib73","doi-asserted-by":"crossref","first-page":"2086","DOI":"10.1007\/s11695-013-1016-x","article-title":"Effect of bariatric surgery on bone mineral density: comparison of gastric bypass and sleeve gastrectomy","volume":"23","author":"Vilarrasa","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib74","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1007\/s11695-009-9938-z","article-title":"Bone mass decreases in morbidly obese women after long limb-biliopancreatic diversion and marked weight loss without secondary hyperparathyroidism. A physiological adaptation to weight loss?","volume":"19","author":"Tsiftsis","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib75","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1007\/s11695-012-0772-3","article-title":"Secondary hyperparathyroidism, vitamin D sufficiency, and serum calcium 5 years after gastric bypass and duodenal switch","volume":"23","author":"Hewitt","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib76","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1053\/slas.2002.126332","article-title":"Laparoscopic biliopancreatic diversion with duodenal switch","volume":"9","author":"Feng","year":"2002","journal-title":"Semin Laparosc Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib77","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1381\/096089203322618722","article-title":"Calcium and vitamin D depletion and elevated parathyroid hormone following biliopancreatic diversion","volume":"13","author":"Newbury","year":"2003","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib78","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1016\/j.gassur.2003.09.020","article-title":"Serum fat-soluble vitamin deficiency and abnormal calcium metabolism after malabsorptive bariatric surgery","volume":"8","author":"Slater","year":"2004","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib79","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1007\/s11695-007-9063-9","article-title":"Parathyroid hormone and bone marker levels in patients with morbid obesity before and after biliopancreatic diversion","volume":"17","author":"Moreiro","year":"2007","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib80","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S1091-255X(01)00086-5","article-title":"Does bone change after biliopancreatic diversion?","volume":"6","author":"Marceau","year":"2002","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib81","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1365-2265.2009.03611.x","article-title":"Vitamin supplements after bariatric surgery","volume":"72","author":"Aasheim","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(13)70183-9_bib82","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/0016-5085(84)90712-1","article-title":"Bone histomorphometry and vitamin D status after biliopancreatic bypass for obesity","volume":"87","author":"Compston","year":"1984","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(13)70183-9_bib83","doi-asserted-by":"crossref","first-page":"1468","DOI":"10.1001\/jama.299.12.1468","article-title":"Osteoporosis and fractures: missing the bridge?","volume":"299","author":"Cheung","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70183-9_bib84","doi-asserted-by":"crossref","first-page":"e5085","DOI":"10.1136\/bmj.e5085","article-title":"Risk of fracture after bariatric surgery in the United Kingdom: population based, retrospective cohort study","volume":"345","author":"Lalmohamed","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70183-9_bib85","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/ar.1092190104","article-title":"Bone \u201cmass\u201d and the \u201cmechanostat\u201d: a proposal","volume":"219","author":"Frost","year":"1987","journal-title":"Anat Rec"},{"key":"10.1016\/S2213-8587(13)70183-9_bib86","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1038\/sj.sc.3101832","article-title":"Bone loss in spinal cord-injured patients: from physiopathology to therapy","volume":"44","author":"Ma\u00efmoun","year":"2006","journal-title":"Spinal Cord"},{"key":"10.1016\/S2213-8587(13)70183-9_bib87","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1359\/jbmr.1998.13.10.1594","article-title":"The effects of twelve weeks of bed rest on bone histology, biochemical markers of bone turnover, and calcium homeostasis in eleven normal subjects","volume":"13","author":"Zerwekh","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib88","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1093\/ajcn\/70.1.97","article-title":"Effect of a lifestyle intervention on bone mineral density in premenopausal women: a randomized trial","volume":"70","author":"Salamone","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70183-9_bib89","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1359\/JBMR.041132","article-title":"Overweight postmenopausal women lose bone with moderate weight reduction and 1 g\/day calcium intake","volume":"20","author":"Riedt","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib90","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jbmr.1483","article-title":"Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial","volume":"27","author":"Schwartz","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib91","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1359\/jbmr.2001.16.1.141","article-title":"Bone minerals changes in obese women during a moderate weight loss with and without calcium supplementation","volume":"16","author":"Jensen","year":"2001","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib92","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1359\/jbmr.1998.13.6.1045","article-title":"Calcium supplementation suppresses bone turnover during weight reduction in postmenopausal women","volume":"13","author":"Ricci","year":"1998","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib93","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0021-9290(01)00040-9","article-title":"Hip contact forces and gait patterns from routine activities","volume":"34","author":"Bergmann","year":"2001","journal-title":"J Biomech"},{"key":"10.1016\/S2213-8587(13)70183-9_bib94","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1007\/BF01625450","article-title":"Secondary hyperparathyroidism and osteopenia in women following gastric exclusion surgery for obesity","volume":"1","author":"Shaker","year":"1991","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(13)70183-9_bib95","doi-asserted-by":"crossref","first-page":"1373","DOI":"10.1038\/ijo.2012.115","article-title":"Bariatric surgery and bone disease: from clinical perspective to molecular insights","volume":"36","author":"Folli","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(13)70183-9_bib96","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/j.soard.2010.04.002","article-title":"Bariatric surgery, proton pump inhibitors, and possibility of osteoporosis","volume":"6","author":"Deitel","year":"2010","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(13)70183-9_bib97","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1093\/ajcn\/77.1.204","article-title":"Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol","volume":"77","author":"Heaney","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70183-9_bib98","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.soard.2008.08.004","article-title":"Treatment of vitamin D depletion after Roux-en-Y gastric bypass: a randomized prospective clinical trial","volume":"5","author":"Carlin","year":"2009","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(13)70183-9_bib99","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1002\/jbmr.5650040302","article-title":"Skeletal disease in primary hyperparathyroidism","volume":"4","author":"Silverberg","year":"1989","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib100","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1007\/s11695-012-0698-9","article-title":"Gut hormones and leptin: impact on energy control and changes after bariatric surgery\u2014what the future holds","volume":"22","author":"Michalakis","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib101","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ijo.2009.79","article-title":"Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass","volume":"33","author":"Korner","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(13)70183-9_bib102","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S8756-3282(02)00864-5","article-title":"Relationships among body mass, its components, and bone","volume":"31","author":"Reid","year":"2002","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(13)70183-9_bib103","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1016\/j.bbrc.2005.03.210","article-title":"Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast","volume":"331","author":"Oshima","year":"2005","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(13)70183-9_bib104","doi-asserted-by":"crossref","first-page":"e40038","DOI":"10.1371\/journal.pone.0040038","article-title":"Peptide YY regulates bone remodeling in mice: a link between gut and skeletal biology","volume":"7","author":"Wong","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70183-9_bib105","doi-asserted-by":"crossref","first-page":"2737","DOI":"10.1210\/jc.2007-1972","article-title":"Hypothalamic-pituitary-testicular axis disruptions in older men are differentially linked to age and modifiable risk factors: the European Male Aging Study","volume":"93","author":"Wu","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70183-9_bib106","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1530\/EJE-12-0955","article-title":"Body weight loss reverts obesity-associated hypogonadotropic hypogonadism: a systematic review and meta-analysis","volume":"168","author":"Corona","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70183-9_bib107","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.apnr.2007.03.004","article-title":"Incidence of bone loss, falls, and fractures after Roux-en-Y gastric bypass for morbid obesity","volume":"22","author":"Berarducci","year":"2009","journal-title":"Appl Nurs Res"},{"key":"10.1016\/S2213-8587(13)70183-9_bib108","article-title":"Fracture risk following bariatric surgery: a population-based study","author":"Nakamura","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(13)70183-9_bib109","first-page":"169","article-title":"Routine supplementation does not warrant the nutritional status of vitamin D adequate after gastric bypass Roux-en-Y","volume":"28","author":"da Rosa","year":"2013","journal-title":"Nutr Hosp"},{"key":"10.1016\/S2213-8587(13)70183-9_bib110","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s11695-008-9680-y","article-title":"Finding the optimal dose of vitamin D following Roux-en-Y gastric bypass: a prospective, randomized pilot clinical trial","volume":"19","author":"Goldner","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70183-9_bib111","doi-asserted-by":"crossref","first-page":"4823","DOI":"10.1210\/jc.2009-2128","article-title":"Endocrine and nutritional management of the post-bariatric surgery patient: an Endocrine Society Clinical Practice Guideline","volume":"95","author":"Heber","year":"2010","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T04:43:04Z","timestamp":1648183384000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701839"}},"issued":{"date-parts":[[2014,2]]},"references-count":111,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S2213858713701839"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70183-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone loss after bariatric surgery: causes, consequences, and management","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70183-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T17:08:28Z","timestamp":1794589708260,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/s2213-8587(15)00508-2","type":"journal-article","created":{"date-parts":[[2015,12,18]],"date-time":"2015-12-18T07:09:35Z","timestamp":1450422575000},"page":"115-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":211,"title":["Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study"],"prefix":"10.1016","volume":"4","author":[{"given":"Xiaoxu","family":"Huo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leili","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lixin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinyue","family":"Zhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanfeng","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiuying","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhe","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xingwu","family":"Ran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benli","family":"Su","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanming","family":"Hao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Guo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanjing","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Changyu","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dayi","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00508-2_bib1","first-page":"S3","article-title":"The global burden of diabetes and its complications: an emerging pandemic","volume":"17","author":"van Dieren","year":"2010","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/S2213-8587(15)00508-2_bib2","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1586\/14779072.6.3.315","article-title":"Early-onset type 2 diabetes mellitus: an increasing phenomenon of elevated cardiovascular risk","volume":"6","author":"Song","year":"2008","journal-title":"Expert Rev Cardiovasc Ther"},{"key":"10.1016\/S2213-8587(15)00508-2_bib3","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1093\/qjmed\/95.4.241","article-title":"Complications and cardiovascular risk factors in South Asians and Europeans with early-onset type 2 diabetes","volume":"95","author":"Chowdhury","year":"2002","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(15)00508-2_bib4","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2337\/diacare.26.11.2999","article-title":"Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth","volume":"26","author":"Hillier","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00508-2_bib5","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.296.4.421","article-title":"Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians","volume":"296","author":"Pavkov","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00508-2_bib6","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.2337\/dc12-2455","article-title":"Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes","volume":"36","author":"Constantino","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00508-2_bib7","doi-asserted-by":"crossref","first-page":"436","DOI":"10.2337\/dc13-0954","article-title":"Earlier onset of complications in youth with type 2 diabetes","volume":"37","author":"Dart","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00508-2_bib8","doi-asserted-by":"crossref","first-page":"149","DOI":"10.2337\/dc13-1336","article-title":"Prospective study on the incidences of cardiovascular-renal complications in Chinese patients with young-onset type 1 and type 2 diabetes","volume":"37","author":"Luk","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00508-2_bib9","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00508-2_bib10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2013.168118","article-title":"2010 China Noncommunicable Disease Surveillance Group. Prevalence and control of diabetes in Chinese adults","volume":"310","author":"Xu","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00508-2_bib11","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.amjmed.2014.03.018","article-title":"Premature mortality and comorbidities in young-onset diabetes: a 7-year prospective analysis","volume":"127","author":"Chan","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(15)00508-2_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.jdiacomp.2014.08.010","article-title":"Prevalence of microvascular diseases among tertiary care Chinese with early versus late onset of type 2 diabetes","volume":"29","author":"Li","year":"2015","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(15)00508-2_bib13","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1002\/(SICI)1096-9136(199807)15:7<539::AID-DIA668>3.0.CO;2-S","article-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Part 1: diagnosis and classification of diabetes mellitus provisional report of a WHO consultation","volume":"15","author":"Alberti","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00508-2_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(15)00508-2_bib15","series-title":"China statistical yearbook 2011","year":"2011"},{"key":"10.1016\/S2213-8587(15)00508-2_bib16","doi-asserted-by":"crossref","first-page":"652","DOI":"10.2337\/dc10-1512","article-title":"Rising rates of all types of diabetes in south Asian and non-south Asian children and young people aged 0\u201329 years in West Yorkshire, UK, 1991\u20132006","volume":"34","author":"Harron","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00508-2_bib17","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1007\/s00125-007-0690-4","article-title":"A high incidence of type 1 diabetes and an alarming increase in the incidence of type 2 diabetes among young adults in Finland between 1992 and 1996","volume":"50","author":"Lammi","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00508-2_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1177\/000992289803700208","article-title":"Increased incidence of non-insulin dependent diabetes mellitus among Japanese school children correlates with an increased intake of animal protein and fat","volume":"37","author":"Kitagawa","year":"1998","journal-title":"Clin Pediatr (Phila)"},{"key":"10.1016\/S2213-8587(15)00508-2_bib19","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"Prevalence of diabetes among men and women in China","volume":"362","author":"Yang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00508-2_bib20","first-page":"282","article-title":"Study on the epidemiological characteristics of diabetes mellitus and IGT in China","volume":"19","author":"Wang","year":"1998","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/S2213-8587(15)00508-2_bib21","doi-asserted-by":"crossref","first-page":"73","DOI":"10.3132\/dvdr.2005.012","article-title":"Contrasting clinical and cardiovascular risk status between early and later onset type 2 diabetes","volume":"2","author":"Hatunic","year":"2005","journal-title":"Diabetes Vasc Dis Res"},{"key":"10.1016\/S2213-8587(15)00508-2_bib22","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/qjmed\/hcp121","article-title":"Early onset type 2 diabetes mellitus: a harbinger for complications in later years\u2014clinical observation from a secondary care cohort","volume":"102","author":"Song","year":"2009","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(15)00508-2_bib23","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1093\/qjmed\/hcq135","article-title":"Cardiovascular and metabolic risk profiles in young and old patients with type 2 diabetes","volume":"103","author":"Gunathilake","year":"2010","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(15)00508-2_bib24","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1053\/euhj.2001.2655","article-title":"Effect of glycaemic control and age on low-density lipoprotein susceptibility to oxidation in diabetes mellitus type 1","volume":"22","author":"Liguori","year":"2001","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(15)00508-2_bib25","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s11906-006-0010-2","article-title":"Interaction of oxidized low-density lipoprotein and the renin-angiotensin system in coronary artery disease","volume":"8","author":"Chen","year":"2006","journal-title":"Curr Hypertens Rep"},{"key":"10.1016\/S2213-8587(15)00508-2_bib26","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/S2213-8587(14)70137-8","article-title":"Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort","volume":"2","author":"Yeung","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00508-2_bib27","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1038\/nrendo.2015.37","article-title":"Drug-subphenotype interactions for cancer in type 2 diabetes","volume":"11","author":"Yang","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(15)00508-2_bib28","doi-asserted-by":"crossref","first-page":"13656","DOI":"10.1073\/pnas.96.24.13656","article-title":"Insulin selectively increases SREBP-1c mRNA in the livers of rats with streptozotocin-induced diabetes","volume":"96","author":"Shimomura","year":"1999","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(15)00508-2_bib29","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2337\/dc12-0421","article-title":"\u03b2-cell mass and turnover in humans: effects of obesity and aging","volume":"36","author":"Saisho","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00508-2_bib30","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00508-2_bib31","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00508-2_bib32","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00508-2_bib33","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00508-2_bib34","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00125-014-3369-7","article-title":"Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes","volume":"57","author":"Zoungas","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00508-2_bib35","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2337\/db12-0207","article-title":"Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study","volume":"62","author":"Zhou","year":"2013","journal-title":"Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715005082?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715005082?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T05:06:21Z","timestamp":1658293581000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715005082"}},"issued":{"date-parts":[[2016,2]]},"references-count":35,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2213858715005082"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00508-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726040074.793514750","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00508-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00390-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T08:39:49Z","timestamp":1794559189207,"version":"4.9.1"},"reference-count":123,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003473","name":"Harbin University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003473","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001547","name":"China Medical Board","doi-asserted-by":"publisher","award":["16\\u2013262"],"award-info":[{"award-number":["16\\u2013262"]}],"id":[{"id":"10.13039\/100001547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001547","name":"China Medical Board","doi-asserted-by":"publisher","award":["262"],"award-info":[{"award-number":["262"]}],"id":[{"id":"10.13039\/100001547","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003347","name":"Fudan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001537","name":"University of Auckland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001537","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015862","name":"Chinese Nutrition Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015862","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002412","name":"Xi\u2019an Jiaotong University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002412","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017605","name":"Shaanxi University of Chinese Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017605","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2017YFC0907201"],"award-info":[{"award-number":["2017YFC0907201"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013290","name":"National Key Research and Development Program of China Stem Cell and Translational Research","doi-asserted-by":"publisher","award":["2017YFC0907200"],"award-info":[{"award-number":["2017YFC0907200"]}],"id":[{"id":"10.13039\/501100013290","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000835","name":"University of Bath","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000835","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005595","name":"University of California","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005595","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54 HD070725"],"award-info":[{"award-number":["U54 HD070725"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006641","name":"United Nations Childrens Fund","doi-asserted-by":"publisher","award":["2018-Nutrition-2.1.2.3"],"award-info":[{"award-number":["2018-Nutrition-2.1.2.3"]}],"id":[{"id":"10.13039\/100006641","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/s2213-8587(21)00118-2","type":"journal-article","created":{"date-parts":[[2021,6,4]],"date-time":"2021-06-04T20:48:35Z","timestamp":1622839715000},"page":"446-461","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":513,"title":["Health policy and public health implications of obesity in China"],"prefix":"10.1016","volume":"9","author":[{"given":"Youfa","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liwang","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Xue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00118-2_bib1","first-page":"504","article-title":"The impact of urbanization on the community food environment in China","volume":"26","author":"Wu","year":"2017","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/ejcn.2016.171","article-title":"New national data show alarming increase in obesity and noncommunicable chronic diseases in China","volume":"71","author":"Wang","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib3","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(21)00118-2_bib4","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/obr.12106","article-title":"Programme and policy options for preventing obesity in China","volume":"14","author":"Wang","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00118-2_bib6","series-title":"Blue paper on obesity prevention and control in China","author":"Wang","year":"2019"},{"key":"10.1016\/S2213-8587(21)00118-2_bib7","doi-asserted-by":"crossref","first-page":"e1166","DOI":"10.1016\/S2214-109X(19)30276-1","article-title":"Prevention and control of obesity in China","volume":"7","author":"Wang","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(21)00118-2_bib8","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","article-title":"Epidemiology and determinants of obesity in China","volume":"9","author":"Pan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00118-2_bib9","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2213-8587(21)00047-4","article-title":"Clinical management and treatment of obesity in China","volume":"9","author":"Zeng","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00118-2_bib10","first-page":"227","article-title":"Prevalence of metabolically healthy obesity and its impacts on incidences of hypertension, diabetes and the metabolic syndrome in Taiwan","volume":"21","author":"Hwang","year":"2012","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1038\/jhh.2014.124","article-title":"Hypertension outcomes in metabolically unhealthy normal-weight and metabolically healthy obese children and adolescents","volume":"29","author":"Ding","year":"2015","journal-title":"J Hum Hypertens"},{"key":"10.1016\/S2213-8587(21)00118-2_bib12","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1017\/S0007114519003143","article-title":"Metabolically healthy general and abdominal obesity are associated with increased risk of hypertension","volume":"123","author":"Zhao","year":"2020","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib13","first-page":"586","article-title":"Comparison of anthropometric indices of obesity in predicting subsequent risk of hyperglycemia among Chinese men and women in Mainland China","volume":"19","author":"Xu","year":"2010","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib14","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s12020-015-0560-7","article-title":"Childhood obesity affects adult metabolic syndrome and diabetes","volume":"50","author":"Liang","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(21)00118-2_bib15","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2337\/dc17-1852","article-title":"Associations of general and central adiposity with incident diabetes in Chinese men and women","volume":"41","author":"Bragg","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00118-2_bib16","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.orcp.2017.10.005","article-title":"Dynamic status of metabolically healthy overweight\/obesity and metabolically unhealthy and normal weight and the risk of type 2 diabetes mellitus: a cohort study of a rural adult Chinese population","volume":"12","author":"Wang","year":"2018","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/S2213-8587(21)00118-2_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107828","article-title":"Effects of obesity and a history of gestational diabetes on the risk of postpartum diabetes and hyperglycemia in Chinese women: obesity, GDM and diabetes risk","volume":"156","author":"Fan","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(21)00118-2_bib18","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3202","article-title":"Metabolically healthy obesity increased diabetes incidence in a middle-aged and elderly Chinese population","volume":"36","author":"Wei","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(21)00118-2_bib19","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1002\/oby.22800","article-title":"The diabetes risk and determinants of transition from metabolically healthy to unhealthy phenotypes in 49,702 older adults: 4-year cohort study","volume":"28","author":"Feng","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00118-2_bib20","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.ijo.0802634","article-title":"Anthropometric predictors of coronary heart disease in Chinese women","volume":"28","author":"Zhang","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(21)00118-2_bib21","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/STROKEAHA.108.539692","article-title":"General and abdominal adiposity and risk of stroke in Chinese women","volume":"40","author":"Zhang","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(21)00118-2_bib22","first-page":"1172","article-title":"[Association between central obesity and risk for heart disease in adults in China: a prospective study]","volume":"39","author":"Tian","year":"2018","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00118-2_bib23","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1016\/S2214-109X(18)30216-X","article-title":"Adiposity and risk of ischaemic and haemorrhagic stroke in 0\u00b75 million Chinese men and women: a prospective cohort study","volume":"6","author":"Chen","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(21)00118-2_bib24","article-title":"Cardiovascular disease outcomes in metabolically healthy obesity in communities of Beijing cohort study","author":"Li","year":"2018","journal-title":"Int J Clin Pract"},{"key":"10.1016\/S2213-8587(21)00118-2_bib25","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1530\/EJE-18-0356","article-title":"Association between the metabolically healthy obese phenotype and the risk of myocardial infarction: results from the Kailuan study","volume":"179","author":"Xu","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00118-2_bib26","first-page":"1541","article-title":"[Association of body mass index and waist circumference with major chronic diseases in Chinese adults]","volume":"40","author":"Li","year":"2019","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00118-2_bib27","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.archger.2019.01.004","article-title":"Metabolically healthy obese phenotype and risk of cardiovascular disease: results from the China Health and Retirement Longitudinal Study","volume":"82","author":"Li","year":"2019","journal-title":"Arch Gerontol Geriatr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib28","article-title":"The effects of transitions in metabolic health and obesity status on incident cardiovascular disease: insights from a general Chinese population","author":"Guo","year":"2020","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/S2213-8587(21)00118-2_bib29","first-page":"231","article-title":"[Body mass index and cancer incidence:a prospective cohort study in northern China]","volume":"35","author":"Guo","year":"2014","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00118-2_bib30","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41416-018-0124-8","article-title":"Adiposity and risks of colorectal and small intestine cancer in Chinese adults: a prospective study of 0.5 million people","volume":"119","author":"Pang","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(21)00118-2_bib31","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/ijc.30187","article-title":"Prospective cohort study of general and central obesity, weight change trajectory and risk of major cancers among Chinese women","volume":"139","author":"Liu","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(21)00118-2_bib32","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/ijc.32148","article-title":"Central adiposity in relation to risk of liver cancer in Chinese adults: A prospective study of 0.5 million people","volume":"145","author":"Pang","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(21)00118-2_bib33","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/jech-2017-208895","article-title":"Young adulthood and adulthood adiposity in relation to incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis","volume":"71","author":"Pang","year":"2017","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(21)00118-2_bib34","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/ije\/27.5.824","article-title":"Body weight and mortality: a prospective evaluation in a cohort of middle-aged men in Shanghai, China","volume":"27","author":"Yuan","year":"1998","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00118-2_bib35","first-page":"245","article-title":"Effect of body mass index on all-cause mortality and incidence of cardiovascular diseases--report for meta-analysis of prospective studies open optimal cut-off points of body mass index in Chinese adults","volume":"15","author":"Zhou","year":"2002","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/S2213-8587(21)00118-2_bib36","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/archinte.166.14.1498","article-title":"Obesity, physical activity, and mortality in a prospective chinese elderly cohort","volume":"166","author":"Schooling","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(21)00118-2_bib37","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.295.7.776","article-title":"Body weight and mortality among men and women in China","volume":"295","author":"Gu","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00118-2_bib38","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.167.9.886","article-title":"Abdominal adiposity and mortality in Chinese women","volume":"167","author":"Zhang","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(21)00118-2_bib39","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1056\/NEJMoa1010679","article-title":"Association between body-mass index and risk of death in more than 1 million Asians","volume":"364","author":"Zheng","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00118-2_bib40","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1503\/cmaj.100303","article-title":"Body mass index and all-cause mortality in a large Chinese cohort","volume":"183","author":"Lin","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(21)00118-2_bib41","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138429","article-title":"Prospective cohort study of central adiposity and risk of death in middle aged and elderly Chinese","volume":"10","author":"Warren Andersen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00118-2_bib42","doi-asserted-by":"crossref","DOI":"10.1097\/MD.0000000000004327","article-title":"Association between body mass index and mortality in a prospective cohort of Chinese adults","volume":"95","author":"Sun","year":"2016","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S2213-8587(21)00118-2_bib43","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.17371","article-title":"Association of adult weight gain with major health outcomes among middle-aged Chinese persons with low body weight in early adulthood","volume":"2","author":"Jia","year":"2019","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(21)00118-2_bib44","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1016\/j.orcp.2019.08.004","article-title":"Joint association of body mass index and central obesity with cardiovascular events and all-cause mortality in prediabetic population: a prospective cohort study","volume":"13","author":"Liu","year":"2019","journal-title":"Obes Res Clin Pract"},{"key":"10.1016\/S2213-8587(21)00118-2_bib45","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1038\/sj.ijo.0802263","article-title":"Rates of weight change for black and white Americans over a twenty year period","volume":"27","author":"Sheehan","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(21)00118-2_bib46","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.2337\/dc17-2336","article-title":"Obesity progression between young adulthood and midlife and incident diabetes: a retrospective cohort study of U.S. adults","volume":"41","author":"Stokes","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00118-2_bib47","article-title":"Weight change across adulthood in relation to all cause and cause specific mortality: prospective cohort study","volume":"367","author":"Chen","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00118-2_bib48","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jama.2017.7092","article-title":"Associations of weight gain from early to middle adulthood with major health outcomes later in life","volume":"318","author":"Zheng","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00118-2_bib51","series-title":"National chronic disease and risk factor surveillance","year":"2013"},{"key":"10.1016\/S2213-8587(21)00118-2_bib52","series-title":"Report on the status of nutrition and chronic diseases of Chinese residents","year":"2015"},{"key":"10.1016\/S2213-8587(21)00118-2_bib53","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S2213-8587(19)30075-0","article-title":"Economic development and the nutritional status of Chinese school-aged children and adolescents from 1995 to 2014: an analysis of five successive national surveys","volume":"7","author":"Dong","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00118-2_bib54","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/j.1467-789X.2006.00230.x","article-title":"Measuring the full economic costs of diet, physical activity and obesity-related chronic diseases","volume":"7","author":"Popkin","year":"2006","journal-title":"Obes Rev"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00118-2_bib55","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1467-789X.2007.00440.x","article-title":"Economic burden of obesity-related chronic diseases in Mainland China","volume":"9","author":"Zhao","year":"2008","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00118-2_bib56","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hec.3217","article-title":"The medical cost attributable to obesity and overweight in China: estimation based on longitudinal surveys","volume":"25","author":"Qin","year":"2016","journal-title":"Health Econ"},{"key":"10.1016\/S2213-8587(21)00118-2_bib57","first-page":"598","article-title":"[Economic costs of both overweight and obesity among Chinese urban and rural residents, in 2010]","volume":"34","author":"Zhang","year":"2013","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00118-2_bib58","first-page":"22","article-title":"Out-of-pocket care expenditures due to excess of body weight in the Chinese population aged 45 and older","volume":"36","author":"Yan","year":"2019","journal-title":"Chin J Heal Stat"},{"key":"10.1016\/S2213-8587(21)00118-2_bib59","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1016\/j.jdiacomp.2016.11.007","article-title":"Direct health care costs associated with obesity in Chinese population in 2011","volume":"31","author":"Shi","year":"2017","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(21)00118-2_bib62","doi-asserted-by":"crossref","first-page":"574","DOI":"10.3945\/an.114.006650","article-title":"Applications of complex systems science in obesity and noncommunicable chronic disease research","volume":"5","author":"Wang","year":"2014","journal-title":"Adv Nutr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib63","series-title":"Bridging the evidence gap in obesity prevention: a framework to inform decision making","year":"2010"},{"key":"10.1016\/S2213-8587(21)00118-2_bib64","series-title":"Accelerating progress in obesity prevention: solving the weight of the nation","year":"2010"},{"key":"10.1016\/S2213-8587(21)00118-2_bib65","doi-asserted-by":"crossref","first-page":"88","DOI":"10.3945\/an.114.007203","article-title":"Applications of systems science in biomedical research regarding obesity and noncommunicable chronic diseases: opportunities, promise, and challenges","volume":"6","author":"Wang","year":"2015","journal-title":"Adv Nutr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib66","author":"Shekar"},{"key":"10.1016\/S2213-8587(21)00118-2_bib68","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.1016\/S0140-6736(10)61514-0","article-title":"Tackling of unhealthy diets, physical inactivity, and obesity: health effects and cost-effectiveness","volume":"376","author":"Cecchini","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00118-2_bib69","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1017\/S1368980017000234","article-title":"The UN Decade of Nutrition, the NOVA food classification and the trouble with ultra-processing","volume":"21","author":"Monteiro","year":"2018","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib70","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/obr.12879","article-title":"A comparison of the healthiness of packaged foods and beverages from 12 countries using the Health Star Rating nutrient profiling system, 2013\u20132018","volume":"20","author":"Dunford","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00118-2_bib71","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cmet.2019.05.008","article-title":"Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake","volume":"30","author":"Hall","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00118-2_bib72","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13146","article-title":"Ultraprocessed food and chronic noncommunicable diseases: a systematic review and meta-analysis of 43 observational studies","volume":"22","author":"Lane","year":"2021","journal-title":"Obes Rev"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(21)00118-2_bib73","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1111\/obr.12099","article-title":"Structural responses to the obesity and non-communicable diseases epidemic: the Chilean Law of Food Labeling and Advertising","volume":"14","author":"Corval\u00e1n","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00118-2_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003015","article-title":"An evaluation of Chile's Law of Food Labeling and Advertising on sugar-sweetened beverage purchases from 2015 to 2017: a before-and-after study","volume":"17","author":"Taillie","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(21)00118-2_bib75","doi-asserted-by":"crossref","first-page":"1054","DOI":"10.2105\/AJPH.2020.305658","article-title":"Food advertising on television before and after a national unhealthy food marketing regulation in Chile, 2016-2017","volume":"110","author":"Correa","year":"2020","journal-title":"Am J Public Health"},{"key":"10.1016\/S2213-8587(21)00118-2_bib76","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1017\/S1368980019003355","article-title":"Evaluating the impact of Chile's marketing regulation of unhealthy foods and beverages: pre-school and adolescent children's changes in exposure to food advertising on television","volume":"23","author":"Dillman Carpentier","year":"2020","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib77","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.puhe.2020.06.035","article-title":"Effect of front-of-package nutrition labeling on food purchases: a systematic review","volume":"191","author":"An","year":"2021","journal-title":"Public Health"},{"key":"10.1016\/S2213-8587(21)00118-2_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/foods9121796","article-title":"Analysis of factors influencing food nutritional labels use in Nanjing, China","volume":"9","author":"Zhang","year":"2020","journal-title":"Foods"},{"key":"10.1016\/S2213-8587(21)00118-2_bib79","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1017\/S1368980018000332","article-title":"A cross-sectional survey of nutrition labelling use and its associated factors on parents of school students in Shanghai, China","volume":"21","author":"Ma","year":"2018","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib81","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/j.appet.2012.04.017","article-title":"Systematic reviews of the evidence on the nature, extent and effects of food marketing to children. A retrospective summary","volume":"62","author":"Cairns","year":"2013","journal-title":"Appetite"},{"key":"10.1016\/S2213-8587(21)00118-2_bib82","series-title":"Stakeholder involvement. Background paper prepared for the WHO\/WEF Joint Event on Preventing Noncommunicable Diseases in the Workplace (Dalian\/China, September 2007)","author":"Griffiths","year":"2007"},{"key":"10.1016\/S2213-8587(21)00118-2_bib83","series-title":"Taking action on childhood obesity","year":"2018"},{"key":"10.1016\/S2213-8587(21)00118-2_bib84","author":"Thavorncharoensap"},{"key":"10.1016\/S2213-8587(21)00118-2_bib85","series-title":"Measures registry user guide: food environment","author":"Lytle","year":"2017"},{"key":"10.1016\/S2213-8587(21)00118-2_bib86","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/oby.22073","article-title":"Did the food environment cause the obesity epidemic?","volume":"26","author":"Hall","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00118-2_bib87","doi-asserted-by":"crossref","first-page":"S89","DOI":"10.1016\/S0140-6736(16)32325-X","article-title":"Association of the food environment with obesity: a systematic review of geographical and statistical methods","volume":"388","author":"Pineda","year":"2016","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00118-2_bib88","article-title":"Association between access to convenience stores and childhood obesity: a systematic review","volume":"22","author":"Xin","year":"2021","journal-title":"Obes Rev"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00118-2_bib89","article-title":"Neighborhood supermarket access and childhood obesity: a systematic review","volume":"22","author":"Zhou","year":"2021","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00118-2_bib90","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1177\/1757913916679860","article-title":"Obesogenic environments: current evidence of the built and food environments","volume":"137","author":"Townshend","year":"2017","journal-title":"Perspect Public Health"},{"key":"10.1016\/S2213-8587(21)00118-2_bib91","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1186\/1479-5868-8-125","article-title":"In search of causality: a systematic review of the relationship between the built environment and physical activity among adults","volume":"8","author":"McCormack","year":"2011","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(21)00118-2_bib92","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1093\/abm\/kax043","article-title":"The built environment as a determinant of physical activity: a systematic review of longitudinal studies and natural experiments","volume":"52","author":"K\u00e4rmeniemi","year":"2018","journal-title":"Ann Behav Med"},{"key":"10.1016\/S2213-8587(21)00118-2_bib93","series-title":"Physical activity: moving toward obesity solutions","year":"2015"},{"key":"10.1016\/S2213-8587(21)00118-2_bib94","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1467-789X.2008.00547.x","article-title":"Long-term effectiveness of diet-plus-exercise interventions vs. diet-only interventions for weight loss: a meta-analysis","volume":"10","author":"Wu","year":"2009","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00118-2_bib95","doi-asserted-by":"crossref","first-page":"1226","DOI":"10.1111\/obr.12460","article-title":"Physical activity and obesity: what we know and what we need to know","volume":"17","author":"Chin","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00118-2_bib96","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1007\/s11524-015-0017-6","article-title":"Why the neighborhood social environment is critical in obesity prevention","volume":"93","author":"Suglia","year":"2016","journal-title":"J Urban Health"},{"key":"10.1016\/S2213-8587(21)00118-2_bib97","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/j.amepre.2011.06.036","article-title":"Neighborhood environment and physical activity among youth a review","volume":"41","author":"Ding","year":"2011","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(21)00118-2_bib98","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1080\/07315724.2005.10719448","article-title":"A review of family and social determinants of children's eating patterns and diet quality","volume":"24","author":"Patrick","year":"2005","journal-title":"J Am Coll Nutr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib99","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJMsa066082","article-title":"The spread of obesity in a large social network over 32 years","volume":"357","author":"Christakis","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00118-2_bib100","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1038\/oby.2008.615","article-title":"Exploiting social networks to mitigate the obesity epidemic","volume":"17","author":"Bahr","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00118-2_bib101","series-title":"2008\u20132013 action plan for the global strategy for the prevention and control of noncommunicable diseases","year":"2009"},{"key":"10.1016\/S2213-8587(21)00118-2_bib102","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1111\/j.1467-3010.2012.01962.x","article-title":"Financial penalties on foods: the fat tax in Denmark","volume":"37","author":"Smed","year":"2012","journal-title":"Nutr Bull"},{"key":"10.1016\/S2213-8587(21)00118-2_bib103","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1002\/pam.21960","article-title":"The pass-through of taxes on sugar-sweetened beverages to retail prices: the case of Berkeley, California","volume":"36","author":"Cawley","year":"2017","journal-title":"J Policy Anal Manage"},{"key":"10.1016\/S2213-8587(21)00118-2_bib104","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1093\/ajae\/aax024","article-title":"Soda taxes and the prices of sodas and other drinks: evidence from Mexico","volume":"99","author":"Grogger","year":"2017","journal-title":"Am J Agric Econ"},{"key":"10.1016\/S2213-8587(21)00118-2_bib105","article-title":"Beverage purchases from stores in Mexico under the excise tax on sugar sweetened beverages: observational study","volume":"352","author":"Colchero","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00118-2_bib106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002283","article-title":"Changes in prices, sales, consumer spending, and beverage consumption one year after a tax on sugar-sweetened beverages in Berkeley, California, US: a before-and-after study","volume":"14","author":"Silver","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(21)00118-2_bib107","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f6189","article-title":"Overall and income specific effect on prevalence of overweight and obesity of 20% sugar sweetened drink tax in UK: econometric and comparative risk assessment modelling study","volume":"347","author":"Briggs","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00118-2_bib108","doi-asserted-by":"crossref","first-page":"1187","DOI":"10.1111\/obr.12868","article-title":"Impact of sugar-sweetened beverage taxes on purchases and dietary intake: Systematic review and meta-analysis","volume":"20","author":"Teng","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00118-2_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003412","article-title":"Sugar-sweetened beverage taxes: lessons to date and the future of taxation","volume":"18","author":"Popkin","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(21)00118-2_bib110","series-title":"Report on sugar sweetened beverage consumption in Chinese children","author":"Ma","year":"2018"},{"key":"10.1016\/S2213-8587(21)00118-2_bib111","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1111\/j.1468-0009.2009.00554.x","article-title":"Food prices and obesity: evidence and policy implications for taxes and subsidies","volume":"87","author":"Powell","year":"2009","journal-title":"Milbank Q"},{"issue":"suppl","key":"10.1016\/S2213-8587(21)00118-2_bib112","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.amepre.2004.06.015","article-title":"Economic interventions to promote physical activity: application of the SLOTH model","volume":"27","author":"Pratt","year":"2004","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(21)00118-2_bib113","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.2105\/AJPH.2011.300201","article-title":"Using the tax system to promote physical activity: critical analysis of Canadian initiatives","volume":"101","author":"von Tigerstrom","year":"2011","journal-title":"Am J Public Health"},{"key":"10.1016\/S2213-8587(21)00118-2_bib114","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.11124\/JBISRIR-2017-003695","article-title":"Effectiveness of family-based weight management interventions for children with overweight and obesity: an umbrella review","volume":"17","author":"Chai","year":"2019","journal-title":"JBI Database Syst Rev Implement Reports"},{"key":"10.1016\/S2213-8587(21)00118-2_bib115","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1111\/j.1468-0009.2009.00548.x","article-title":"Schools and obesity prevention: creating school environments and policies to promote healthy eating and physical activity","volume":"87","author":"Story","year":"2009","journal-title":"Milbank Q"},{"key":"10.1016\/S2213-8587(21)00118-2_bib116","series-title":"Prevention of overweight and obesity in children and adolescents: UNICEF advocacy strategy guidance","year":"2020"},{"key":"10.1016\/S2213-8587(21)00118-2_bib117","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13176","article-title":"Improving the school food environment for the prevention of childhood obesity: what works and what doesn't","volume":"22","author":"Pineda","year":"2021","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00118-2_bib118","first-page":"1139","article-title":"Comprehensive school-based intervention to control overweight and obesity in China: a cluster randomized controlled trial","volume":"26","author":"Xu","year":"2017","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00118-2_bib119","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1089\/chi.2018.0251","article-title":"A school-based comprehensive intervention for childhood obesity in China: a cluster randomized controlled trial","volume":"15","author":"Liu","year":"2019","journal-title":"Child Obes"},{"key":"10.1016\/S2213-8587(21)00118-2_bib120","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/ijo.2017.243","article-title":"Childhood obesity prevention through a community-based cluster randomized controlled physical activity intervention among schools in china: the health legacy project of the 2nd world summer youth olympic Games (YOG-Obesity study)","volume":"42","author":"Wang","year":"2018","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(21)00118-2_bib121","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002971","article-title":"The CHIRPY DRAGON intervention in preventing obesity in Chinese primary-school--aged children: a cluster-randomised controlled trial","volume":"16","author":"Li","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(21)00118-2_bib122","series-title":"Childhood obesity prevention programs: comparative effectiveness review and meta-analysis","author":"Wang","year":"2013"},{"key":"10.1016\/S2213-8587(21)00118-2_bib123","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s13679-016-0226-7","article-title":"\u201cWhole-of-Community\u201d obesity prevention: a review of challenges and opportunities in multilevel, multicomponent interventions","volume":"5","author":"Ewart-Pierce","year":"2016","journal-title":"Curr Obes Rep"},{"key":"10.1016\/S2213-8587(21)00118-2_bib124","doi-asserted-by":"crossref","first-page":"5866","DOI":"10.3390\/ijerph110605866","article-title":"What works in community-based interventions promoting physical activity and healthy eating? A review of reviews","volume":"11","author":"Brand","year":"2014","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(21)00118-2_bib125","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1111\/obr.12821","article-title":"Efficacy of population-wide diabetes and obesity prevention programs: an overview of systematic reviews on proximal, intermediate, and distal outcomes and a meta-analysis of impact on BMI","volume":"20","author":"Roberts","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00118-2_bib126","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1007\/s10900-012-9542-3","article-title":"Fifty communities putting prevention to work: accelerating chronic disease prevention through policy, systems and environmental change","volume":"37","author":"Bunnell","year":"2012","journal-title":"J Community Health"},{"key":"10.1016\/S2213-8587(21)00118-2_bib127","doi-asserted-by":"crossref","DOI":"10.5888\/pcd13.150272","article-title":"Community-based interventions to decrease obesity and tobacco exposure and reduce health care costs: outcome estimates from Communities Putting Prevention to Work for 2010\u20132020","volume":"13","author":"Soler","year":"2016","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/S2213-8587(21)00118-2_bib128","article-title":"Community wide interventions for increasing physical activity","volume":"1","author":"Baker","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(21)00118-2_bib129","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/j.amepre.2009.07.003","article-title":"The effectiveness of worksite nutrition and physical activity interventions for controlling employee overweight and obesity: a systematic review","volume":"37","author":"Anderson","year":"2009","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(21)00118-2_bib130","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/j.ypmed.2017.11.011","article-title":"A systematic review of the long-term effectiveness of work-based lifestyle interventions to tackle overweight and obesity","volume":"107","author":"Tam","year":"2018","journal-title":"Prev Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001182?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001182?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:34Z","timestamp":1778858734000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001182"}},"issued":{"date-parts":[[2021,7]]},"references-count":123,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2213858721001182"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00118-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health policy and public health implications of obesity in China","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00118-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:34Z","timestamp":1720746754848},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30387-4","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T01:33:36Z","timestamp":1479432816000},"page":"S32","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S1","title":["Impaired pancreatic \u03b2-cell compensatory function in Chinese patients with type 2 diabetes and high genetic risk: a 9-year prospective cohort study"],"prefix":"10.1016","volume":"4","author":[{"given":"Jing","family":"Yan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danfeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303874?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303874?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T11:56:42Z","timestamp":1536235002000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303874"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"alternative-id":["S2213858716303874"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30387-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2022,3,28]],"date-time":"2022-03-28T22:12:33Z","timestamp":1648505553745},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/s2213-8587(19)30115-9","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T01:53:32Z","timestamp":1555466012000},"page":"342","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"7","author":[{"given":"Kate V","family":"McIntosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301159?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301159?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T04:10:03Z","timestamp":1571112603000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301159"}},"issued":{"date-parts":[[2019,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2213858719301159"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30115-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research in brief","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30115-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T15:31:01Z","timestamp":1777563061744,"version":"3.51.4"},"reference-count":5,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/s2213-8587(22)00251-0","type":"journal-article","created":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T18:33:35Z","timestamp":1662057215000},"page":"695","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Insulin pricing in the USA: the saga continues"],"prefix":"10.1016","volume":"10","author":[{"given":"Irl B","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00251-0_bib1","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2337\/dci18-0019","article-title":"Insulin Access and Affordability Working Group: conclusions and recommendations","volume":"41","author":"Cefalu","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00251-0_bib2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1001\/jama.2020.1012","article-title":"Changes in list prices, net prices, and discounts for branded drugs in the US, 2007\u20132018","volume":"323","author":"Hernandez","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00251-0_bib3","author":"Seeley"},{"key":"10.1016\/S2213-8587(22)00251-0_bib4","author":"Chung"},{"key":"10.1016\/S2213-8587(22)00251-0_bib5","doi-asserted-by":"crossref","first-page":"2157","DOI":"10.1056\/NEJMp2203001","article-title":"A radical treatment for insulin pricing","volume":"386","author":"Dafny","year":"2022","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002510?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002510?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:17Z","timestamp":1761991877000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722002510"}},"issued":{"date-parts":[[2022,10]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2213858722002510"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00251-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin pricing in the USA: the saga continues","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00251-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T09:20:13Z","timestamp":1648632013763},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/s2213-8587(16)30111-5","type":"journal-article","created":{"date-parts":[[2016,6,7]],"date-time":"2016-06-07T01:51:14Z","timestamp":1465264274000},"page":"565","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"4","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301115?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301115?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2016,6,27]],"date-time":"2016-06-27T03:15:52Z","timestamp":1466997352000},"score":0.0,"resource":{"primary":{"URL":"http:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301115"}},"issued":{"date-parts":[[2016,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S2213858716301115"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30111-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,7]]}},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T14:40:12Z","timestamp":1649169612585},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/s2213-8587(15)00383-6","type":"journal-article","created":{"date-parts":[[2015,10,16]],"date-time":"2015-10-16T22:58:50Z","timestamp":1445036330000},"page":"26","source":"Crossref","is-referenced-by-count":0,"title":["Amy Tenderich: a trailblazer for diabetes innovation"],"prefix":"10.1016","volume":"4","author":[{"given":"Patricia","family":"Lobo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003836?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003836?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T19:24:25Z","timestamp":1537298665000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003836"}},"issued":{"date-parts":[[2016,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S2213858715003836"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00383-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,1]]}},{"indexed":{"date-parts":[[2023,11,14]],"date-time":"2023-11-14T16:42:17Z","timestamp":1699980137138},"reference-count":8,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T00:00:00Z","timestamp":1409702400000},"content-version":"vor","delay-in-days":2,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/s2213-8587(14)70119-6","type":"journal-article","created":{"date-parts":[[2014,6,25]],"date-time":"2014-06-25T23:15:39Z","timestamp":1403738139000},"page":"682-684","source":"Crossref","is-referenced-by-count":7,"title":["Low vitamin D and hypertension: a causal association?"],"prefix":"10.1016","volume":"2","author":[{"given":"Shoaib","family":"Afzal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"B\u00f8rge G","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70119-6_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70113-5","article-title":"Association of vitamin D status with arterial blood pressure and hypertension risk: a mendelian randomisation study","author":"Vimaleswaran","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70119-6_bib2","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1210\/jc.2011-0398","article-title":"Vitamin D and cardiovascular outcomes: a systematic review and meta-analysis","volume":"96","author":"Elamin","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70119-6_bib3","doi-asserted-by":"crossref","first-page":"g2035","DOI":"10.1136\/bmj.g2035","article-title":"Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials","volume":"348","author":"Theodoratou","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70119-6_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-8587(13)70200-6","article-title":"Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study","volume":"2","author":"Afzal","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70119-6_bib5","doi-asserted-by":"crossref","first-page":"e1001383","DOI":"10.1371\/journal.pmed.1001383","article-title":"Causal relationship between obesity and vitamin D status: bi-directional Mendelian randomization analysis of multiple cohorts","volume":"10","author":"Vimaleswaran","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(14)70119-6_bib6","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/HYPERTENSIONAHA.109.130005","article-title":"Does greater adiposity increase blood pressure and hypertension risk? Mendelian randomization using the FTO\/MC4R genotype","volume":"54","author":"Timpson","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(14)70119-6_bib7","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1002\/sim.3034","article-title":"Mendelian randomization: using genes as instruments for making causal inferences in epidemiology","volume":"27","author":"Lawlor","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(14)70119-6_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Davey Smith","year":"2003","journal-title":"Int J Epidemiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701196?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701196?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T03:52:11Z","timestamp":1538538731000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701196"}},"issued":{"date-parts":[[2014,9]]},"references-count":8,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S2213858714701196"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70119-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,9]]}},{"indexed":{"date-parts":[[2023,3,22]],"date-time":"2023-03-22T06:11:18Z","timestamp":1679465478924},"reference-count":0,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70005-6","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T17:36:40Z","timestamp":1359999400000},"page":"e10","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Androgen-secreting adrenocortical carcinoma"],"prefix":"10.1016","volume":"1","author":[{"given":"Kamal P","family":"Galketiya","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumathi","family":"Ranjikumar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Usama","family":"Majeed","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T01:25:24Z","timestamp":1539912324000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700056"}},"issued":{"date-parts":[[2013,9]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2213858713700056"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70005-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Androgen-secreting adrenocortical carcinoma","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70005-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T08:43:42Z","timestamp":1649061822679},"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/s2213-8587(19)30032-4","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T23:36:48Z","timestamp":1550619408000},"page":"177","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"7","author":[{"given":"Kate V","family":"McIntosh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T23:52:47Z","timestamp":1550620367000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300324"}},"issued":{"date-parts":[[2019,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2213858719300324"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30032-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research in brief","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30032-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T02:23:06Z","timestamp":1648693386470},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/s2213-8587(15)00166-7","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T17:52:21Z","timestamp":1433613141000},"page":"e10","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2014; published online Nov 14"],"prefix":"10.1016","volume":"3","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T08:36:51Z","timestamp":1548664611000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715001667"}},"issued":{"date-parts":[[2015,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S2213858715001667"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00166-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,11]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T04:28:53Z","timestamp":1648528133570},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/s2213-8587(17)30282-6","type":"journal-article","created":{"date-parts":[[2017,8,30]],"date-time":"2017-08-30T11:33:34Z","timestamp":1504092814000},"page":"761-762","source":"Crossref","is-referenced-by-count":1,"title":["Is atrial fibrillation another manifestation of organ damage in diabetes?"],"prefix":"10.1016","volume":"5","author":[{"given":"Kazuo","family":"Miyazawa","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory Y H","family":"Lip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30282-6_bib1","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.ijcard.2005.02.050","article-title":"Diabetes mellitus is a strong, independent risk for atrial fibrillation and flutter in addition to other cardiovascular disease","volume":"105","author":"Movahed","year":"2005","journal-title":"Int J Cardiol"},{"key":"10.1016\/S2213-8587(17)30282-6_bib2","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1080\/14656566.2017.1350647","article-title":"Considerations and treatment options for patients with comorbid atrial fibrillation and diabetes mellitus","volume":"18","author":"Moss","year":"2017","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/S2213-8587(17)30282-6_bib3","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1161\/STROKEAHA.115.009371","article-title":"Duration of diabetes mellitus and risk of thromboembolism and bleeding in atrial fibrillation: nationwide cohort study","volume":"46","author":"Overvad","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(17)30282-6_bib4","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.jacc.2015.10.080","article-title":"Effect of diabetes and glycemic control on ischemic stroke risk in af patients: ATRIA study","volume":"67","author":"Ashburner","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30282-6_bib5","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30282-6_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(17)30262-0","article-title":"Risk of atrial fibrillation in people with type 1 diabetes compared with matched controls from the general population: a prospective case-control study","author":"Dahlqvist","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30282-6_bib7","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30282-6_bib8","doi-asserted-by":"crossref","first-page":"1972","DOI":"10.1056\/NEJMoa1408214","article-title":"Glycemic control and excess mortality in type 1 diabetes","volume":"371","author":"Lind","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30282-6_bib9","doi-asserted-by":"crossref","first-page":"1217","DOI":"10.1016\/j.amjcard.2014.07.045","article-title":"Impact of intensive glycemic control on the incidence of atrial fibrillation and associated cardiovascular outcomes in patients with type 2 diabetes mellitus (from the Action to Control Cardiovascular Risk in Diabetes Study)","volume":"114","author":"Fatemi","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(17)30282-6_bib10","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.1160\/TH16-11-0876","article-title":"Stroke prevention in atrial fibrillation: past, present and future. Comparing the guidelines and practical decision-making","volume":"117","author":"Lip","year":"2017","journal-title":"Thromb Haemost"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302826?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302826?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T13:40:46Z","timestamp":1539092446000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717302826"}},"issued":{"date-parts":[[2017,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2213858717302826"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30282-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,10]]}},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T10:02:30Z","timestamp":1648720950191},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/s2213-8587(19)30316-x","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T18:29:51Z","timestamp":1571164191000},"page":"831","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["55th Annual Meeting of the European Association for the Study of Diabetes"],"prefix":"10.1016","volume":"7","author":[{"given":"Neil","family":"Bennet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930316X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930316X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T16:21:30Z","timestamp":1572020490000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871930316X"}},"issued":{"date-parts":[[2019,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S221385871930316X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30316-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"55th Annual Meeting of the European Association for the Study of Diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30316-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2023,1,30]],"date-time":"2023-01-30T11:15:34Z","timestamp":1675077334797},"reference-count":14,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/s2213-8587(16)30145-0","type":"journal-article","created":{"date-parts":[[2016,8,2]],"date-time":"2016-08-02T18:18:37Z","timestamp":1470161917000},"page":"88-90","source":"Crossref","is-referenced-by-count":3,"title":["De-evolution of diagnostic testing for adrenal insufficiency"],"prefix":"10.1016","volume":"5","author":[{"given":"Gregory A","family":"Kline","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Daniel T","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30145-0_bib1","doi-asserted-by":"publisher","first-page":"993","DOI":"10.1530\/EJE-08-0880","article-title":"Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone","volume":"160","author":"Lovas","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(16)30145-0_bib2","doi-asserted-by":"publisher","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30145-0_bib3","doi-asserted-by":"publisher","first-page":"117","DOI":"10.1001\/jama.1938.02790280007002","article-title":"Concentrations of chloride, sodium and potassium in urine and blood: their diagnostic significance in the diagnosis of Addison's disease","volume":"111","author":"Cutler","year":"1938","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30145-0_bib4","doi-asserted-by":"publisher","first-page":"1005","DOI":"10.1001\/jama.1948.02890460001001","article-title":"A test for adrenal cortical insufficiency; the response to pituitary adrenocorticotropic hormone","volume":"137","author":"Thorn","year":"1948","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30145-0_bib5","doi-asserted-by":"publisher","first-page":"79","DOI":"10.1210\/jcem-7-2-79","article-title":"Excretion of glycogenic corticoids and of 17-ketosteroids in various endocrine and other disorders","volume":"7","author":"Venning","year":"1947","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30145-0_bib6","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1172\/JCI105357","article-title":"The plasma sugar, free fatty acid, cortisol and growth hormone response to insulin. I. In control subjects","volume":"45","author":"Greenwood","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(16)30145-0_bib7","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.1056\/NEJM198206173062405","article-title":"Discordant cortisol response to exogenous ACTH and insulin-induced hypoglycaemia in patients with pituitary disease","volume":"306","author":"Borst","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30145-0_bib8","doi-asserted-by":"publisher","first-page":"1651","DOI":"10.1056\/NEJM199406093302306","article-title":"Hypopituitarism","volume":"330","author":"Vance","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30145-0_bib9","doi-asserted-by":"publisher","first-page":"473","DOI":"10.1046\/j.1365-2265.1996.712533.x","article-title":"A comparison between short ACTH and insulin stress tests for assessing hypothalamo-pituitary-adrenal function","volume":"44","author":"Ammari","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(16)30145-0_bib10","doi-asserted-by":"publisher","first-page":"194","DOI":"10.7326\/0003-4819-139-3-200308050-00017","article-title":"Diagnosis of adrenal insufficiency","volume":"139","author":"Dorin","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)30145-0_bib11","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1016\/j.beem.2013.10.008","article-title":"Determination of cortisol in serum, saliva and urine","volume":"27","author":"Turpeinen","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30145-0_bib12","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1093\/clinchem\/29.5.862","article-title":"External quality assessment of assays for cortisol in plasma: use of target data obtained by gas chromatography\/mass spectrometry","volume":"29","author":"Gaskell","year":"1983","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(16)30145-0_bib13","doi-asserted-by":"publisher","first-page":"673","DOI":"10.1111\/cen.12039","article-title":"Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography-mass spectrometry and five automated immunoassays","volume":"78","author":"El-Farhan","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(16)30145-0_bib14","doi-asserted-by":"publisher","first-page":"357","DOI":"10.1016\/j.clinbiochem.2004.01.005","article-title":"Cortisol and cortisone analysis in serum and plasma by atmospheric pressure photoionization tandem mass spectrometry","volume":"37","author":"Kushnir","year":"2004","journal-title":"Clin Biochem"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,4]],"date-time":"2022-07-04T19:23:37Z","timestamp":1656962617000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301450"}},"issued":{"date-parts":[[2017,2]]},"references-count":14,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S2213858716301450"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30145-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,2]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T16:33:17Z","timestamp":1649089997558},"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/s2213-8587(15)00011-x","type":"journal-article","created":{"date-parts":[[2015,2,18]],"date-time":"2015-02-18T19:30:11Z","timestamp":1424287811000},"page":"172","source":"Crossref","is-referenced-by-count":0,"title":["Breaking through the binary"],"prefix":"10.1016","volume":"3","author":[{"given":"Luke","family":"Worley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500011X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500011X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T21:53:53Z","timestamp":1537826033000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871500011X"}},"issued":{"date-parts":[[2015,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S221385871500011X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00011-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,3]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T04:16:50Z","timestamp":1648613810321},"reference-count":6,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/s2213-8587(15)00496-9","type":"journal-article","created":{"date-parts":[[2016,1,27]],"date-time":"2016-01-27T00:30:20Z","timestamp":1453854620000},"page":"98","source":"Crossref","is-referenced-by-count":0,"title":["Insulin patents and market exclusivities: unresolved issues"],"prefix":"10.1016","volume":"4","author":[{"given":"Warren","family":"Kaplan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard","family":"Laing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marg","family":"Ewen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Beran","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00496-9_bib1","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1016\/S2213-8587(15)00364-2","article-title":"Evolution of insulin patents and market exclusivities in the USA","volume":"3","author":"Luo","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00496-9_bib2","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/s00125-010-1897-3","article-title":"The insulin dilemma in resource-limited countries. A way forward?","volume":"54","author":"Gill","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00496-9_bib3","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1185\/03007995.2015.1020366","article-title":"Incidence, prevalence, and trend analysis of the use of insulin delivery systems in the United States (2005 to 2011)","volume":"31","author":"Perez-Nieves","year":"2015","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/S2213-8587(15)00496-9_bib4","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/dom.12260","article-title":"How many people inject insulin? UK estimates from 1991 to 2010","volume":"16","author":"Holden","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00496-9_bib5","doi-asserted-by":"crossref","first-page":"1648","DOI":"10.1016\/S0140-6736(12)61950-3","article-title":"On the road to the insulin centenary","volume":"380","author":"Beran","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00496-9_bib6","author":"Nainggolan"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004969?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004969?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T23:52:51Z","timestamp":1537055571000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004969"}},"issued":{"date-parts":[[2016,2]]},"references-count":6,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2213858715004969"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00496-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,2]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T20:48:20Z","timestamp":1648586900548},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/s2213-8587(16)30260-1","type":"journal-article","created":{"date-parts":[[2016,9,14]],"date-time":"2016-09-14T21:51:28Z","timestamp":1473889888000},"page":"582","source":"Crossref","is-referenced-by-count":0,"title":["Mich\u00e8le Ramsay: working collaboratively to improve African health"],"prefix":"10.1016","volume":"5","author":[{"given":"Fiona","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T12:23:55Z","timestamp":1536409435000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302601"}},"issued":{"date-parts":[[2017,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S2213858716302601"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30260-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,8]]}},{"indexed":{"date-parts":[[2022,7,6]],"date-time":"2022-07-06T02:30:34Z","timestamp":1657074634482},"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/s2213-8587(14)70016-6","type":"journal-article","created":{"date-parts":[[2014,2,24]],"date-time":"2014-02-24T04:15:17Z","timestamp":1393215317000},"page":"193","source":"Crossref","is-referenced-by-count":1,"title":["Research in brief"],"prefix":"10.1016","volume":"2","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700166?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700166?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T11:50:14Z","timestamp":1538826614000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700166"}},"issued":{"date-parts":[[2014,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S2213858714700166"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70016-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,3]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:42:42Z","timestamp":1762004562846},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/s2213-8587(13)70164-5","type":"journal-article","created":{"date-parts":[[2013,12,6]],"date-time":"2013-12-06T01:45:16Z","timestamp":1386294316000},"page":"1","source":"Crossref","is-referenced-by-count":14,"title":["Vitamin D: chasing a myth?"],"prefix":"10.1016","volume":"2","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T13:25:29Z","timestamp":1539005129000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701645"}},"issued":{"date-parts":[[2014,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S2213858713701645"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70164-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,1]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:57Z","timestamp":1761991917032,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/s2213-8587(19)30379-1","type":"journal-article","created":{"date-parts":[[2019,11,25]],"date-time":"2019-11-25T18:31:30Z","timestamp":1574706690000},"page":"95-97","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Liberalisation, deintensification, and simplification in diabetes management: words matter"],"prefix":"10.1016","volume":"8","author":[{"given":"Medha","family":"Munshi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joshua J","family":"Neumiller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30379-1_bib1","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(14)70176-7","article-title":"Diabetes in older people: new insights and remaining challenges","volume":"3","author":"Sinclair","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30379-1_bib2","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/jc.2019-00198","article-title":"Treatment of diabetes in older adults: an endocrine society* clinical practice guideline","volume":"104","author":"LeRoith","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"year":"2013","series-title":"IDF global guideline for managing older people with type 2 diabetes","key":"10.1016\/S2213-8587(19)30379-1_bib3"},{"key":"10.1016\/S2213-8587(19)30379-1_bib4","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.2337\/dc12-1801","article-title":"Diabetes in older adults","volume":"35","author":"Kirkman","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30379-1_bib5","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1001\/jamainternmed.2016.2288","article-title":"Simplification of insulin regimen in older adults and risk of hypoglycemia","volume":"176","author":"Munshi","year":"2016","journal-title":"JAMA Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:43Z","timestamp":1761991663000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719303791"}},"issued":{"date-parts":[[2020,2]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2213858719303791"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30379-1","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Liberalisation, deintensification, and simplification in diabetes management: words matter","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30379-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:35Z","timestamp":1720746755943},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30386-2","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T01:33:47Z","timestamp":1479432827000},"page":"S31","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Overall and abdominal obesity with insulin sensitivity and secretion in a Han Chinese population: a Mendelian randomisation study"],"prefix":"10.1016","volume":"4","author":[{"given":"Tao","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojing","family":"Ma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danfeng","family":"Peng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Miao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuqian","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheng","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303862?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303862?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T11:56:42Z","timestamp":1536235002000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303862"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"alternative-id":["S2213858716303862"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30386-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:14:26Z","timestamp":1761992066708,"version":"build-2065373602"},"reference-count":3,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/s2213-8587(21)00317-x","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T18:31:50Z","timestamp":1639506710000},"page":"21","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Diabetes and the WHO Model List of Essential Medicines"],"prefix":"10.1016","volume":"10","author":[{"given":"Carissa F","family":"Etienne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00317-X_bib1","first-page":"971","article-title":"Insulin's centenary: the birth of an idea","volume":"8","author":"Hegele","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00317-X_bib2","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00317-X_bib3","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2337\/dci18-0019","article-title":"Insulin Access and Affordability Working Group: conclusions and recommendations","volume":"41","author":"Cefalu","year":"2018","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872100317X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872100317X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:43Z","timestamp":1761991843000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872100317X"}},"issued":{"date-parts":[[2022,1]]},"references-count":3,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S221385872100317X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00317-x","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes and the WHO Model List of Essential Medicines","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00317-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00320-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00318-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00321-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00323-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00322-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Pan American Health Organization. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:45Z","timestamp":1761992025248,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/s2213-8587(22)00167-x","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T18:34:26Z","timestamp":1654108466000},"page":"478-480","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["How should endocrinologists diagnose and treat non-alcoholic fatty liver disease?"],"prefix":"10.1016","volume":"10","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6322-7753","authenticated-orcid":false,"given":"Christopher D","family":"Byrne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giovanni","family":"Targher","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00167-X_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","article-title":"Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease","volume":"55","author":"Ludwig","year":"1980","journal-title":"Mayo Clin Proc"},{"issue":"suppl","key":"10.1016\/S2213-8587(22)00167-X_bib2","doi-asserted-by":"crossref","first-page":"S47","DOI":"10.1016\/j.jhep.2014.12.012","article-title":"NAFLD: a multisystem disease","volume":"62","author":"Byrne","year":"2015","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(22)00167-X_bib3","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2468-1253(21)00020-0","article-title":"Non-alcoholic fatty liver disease: a multisystem disease requiring a multidisciplinary and holistic approach","volume":"6","author":"Targher","year":"2021","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(22)00167-X_bib4","doi-asserted-by":"crossref","first-page":"528","DOI":"10.1016\/j.eprac.2022.03.010","volume":"28","author":"Cusi","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(22)00167-X_bib5","doi-asserted-by":"crossref","first-page":"341","DOI":"10.2337\/dc17-1590","article-title":"Cardiovascular disease, cancer, and mortality among people with type 2 diabetes and alcoholic or nonalcoholic fatty liver disease hospital admission","volume":"41","author":"Wild","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00167-X_bib6","article-title":"Non-alcoholic fatty liver disease (NAFLD): summary of NICE guidance","volume":"354","author":"Glen","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00167-X_bib7","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1002\/hep.30254","article-title":"Burden of illness and economic model for patients with nonalcoholic steatohepatitis in the United States","volume":"69","author":"Younossi","year":"2019","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(22)00167-X_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S2468-1253(22)00061-9","article-title":"Quality standards for the management of non-alcoholic fatty liver disease (NAFLD): consensus recommendations from the British Association for the Study of the Liver and British Society of Gastroenterology NAFLD Special Interest Group","author":"McPherson","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(22)00167-X_bib9","doi-asserted-by":"crossref","DOI":"10.1161\/ATV.0000000000000153","article-title":"Nonalcoholic fatty liver disease and cardiovascular risk: a scientific statement from the American Heart Association","author":"Duell","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(22)00167-X_bib10","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.numecd.2021.04.028","article-title":"Non-alcoholic fatty liver disease in adults 2021: A clinical practice guideline of the Italian Association for the Study of the Liver (AISF), the Italian Society of Diabetology (SID) and the Italian Society of Obesity (SIO)","volume":"32","author":"Marchesini","year":"2022","journal-title":"Nutr Metab Cardiovasc Dis"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872200167X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872200167X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:04Z","timestamp":1761991864000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872200167X"}},"issued":{"date-parts":[[2022,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S221385872200167X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00167-x","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How should endocrinologists diagnose and treat non-alcoholic fatty liver disease?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00167-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:35Z","timestamp":1761992195196,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/s2213-8587(22)00321-7","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T20:10:18Z","timestamp":1667592618000},"page":"844","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Lorenz Hofbauer: connecting the unexpected"],"prefix":"10.1016","volume":"10","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:56Z","timestamp":1761991916000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003217"}},"issued":{"date-parts":[[2022,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2213858722003217"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00321-7","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lorenz Hofbauer: connecting the unexpected","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00321-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,19]],"date-time":"2026-04-19T12:13:06Z","timestamp":1776600786240,"version":"3.51.2"},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/s2213-8587(17)30373-x","type":"journal-article","created":{"date-parts":[[2017,11,22]],"date-time":"2017-11-22T20:48:47Z","timestamp":1511383727000},"page":"925","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Good value care: when less is more"],"prefix":"10.1016","volume":"5","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730373X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730373X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T22:21:33Z","timestamp":1535235693000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871730373X"}},"issued":{"date-parts":[[2017,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S221385871730373X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30373-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Good value care: when less is more","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30373-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,5,13]],"date-time":"2024-05-13T08:37:23Z","timestamp":1715589443867},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/s2213-8587(16)00009-7","type":"journal-article","created":{"date-parts":[[2016,1,13]],"date-time":"2016-01-13T08:57:59Z","timestamp":1452675479000},"page":"85","source":"Crossref","is-referenced-by-count":0,"title":["Sugar: pushing forward on cutting back"],"prefix":"10.1016","volume":"4","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T06:52:38Z","timestamp":1537080758000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716000097"}},"issued":{"date-parts":[[2016,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2213858716000097"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)00009-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,2]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:52Z","timestamp":1761991912092,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/s2213-8587(20)30077-2","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T18:54:33Z","timestamp":1583175273000},"page":"276","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Can a low-cost, highly effective approach to diabetes find sufficient funding in the USA?"],"prefix":"10.1016","volume":"8","author":[{"given":"Mary Beth","family":"Nierengarten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300772?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300772?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:36Z","timestamp":1761991656000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300772"}},"issued":{"date-parts":[[2020,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2213858720300772"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30077-2","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can a low-cost, highly effective approach to diabetes find sufficient funding in the USA?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30077-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:13Z","timestamp":1761991873634,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/s2213-8587(16)30184-x","type":"journal-article","created":{"date-parts":[[2016,7,23]],"date-time":"2016-07-23T04:26:19Z","timestamp":1469247979000},"page":"725-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Collaborative funding for NCDs\u2014a model of research funding"],"prefix":"10.1016","volume":"4","author":[{"given":"Justine","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30184-X_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(15)60692-4","article-title":"Global, regional, and national incidence, prevalence, and years lived with disability for 301 acute and chronic diseases and injuries in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"386","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30184-X_bib2","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1016\/S0140-6736(16)30167-2","article-title":"National spending on health by source for 184 countries between 2013 and 2040","volume":"387","author":"Dieleman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30184-X_bib3","doi-asserted-by":"crossref","first-page":"2536","DOI":"10.1016\/S0140-6736(16)30168-4","article-title":"Development assistance for health: past trends, associations, and the future of international financial flows for health","volume":"387","author":"Dieleman","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30184-X_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/S2213-8587(15)00005-4","article-title":"Monitoring progress in NCDs: key to accountability","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30184-X_bib5","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S2213-8587(16)00037-1","article-title":"Liberating data: the crucial weapon in the fight against NCDs","volume":"4","author":"Davies","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30184-X_bib6","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-8587(16)30110-3","article-title":"HIV and NCDs: the need to build stronger health systems","volume":"4","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30184-X_bib7","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1001\/jama.2014.15939","article-title":"The anatomy of medical research: US and international comparisons","volume":"313","author":"Moses","year":"2015","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630184X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630184X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:21Z","timestamp":1761991581000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871630184X"}},"issued":{"date-parts":[[2016,9]]},"references-count":7,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S221385871630184X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30184-x","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Collaborative funding for NCDs\u2014a model of research funding","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30184-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:53Z","timestamp":1761992033153,"version":"build-2065373602"},"reference-count":3,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/s2213-8587(20)30220-5","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T18:35:57Z","timestamp":1595356557000},"page":"665-666","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Metabolic health and COVID-19: a call for greater medical nutrition education"],"prefix":"10.1016","volume":"8","author":[{"given":"Juliet","family":"Burridge","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Bradfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ally","family":"Jaffee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Iain","family":"Broadley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sumantra","family":"Ray","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30220-5_bib1","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-8587(20)30164-9","article-title":"COVID-19: underlying metabolic health in the spotlight","volume":"8","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30220-5_bib2","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.cmi.2017.02.013","article-title":"Body mass index and the risk of infection - from underweight to obesity","volume":"24","author":"Dobner","year":"2018","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/S2213-8587(20)30220-5_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjnph-2019-000049","article-title":"Time for nutrition in medical education","author":"Macaninch","year":"2020","journal-title":"BMJ Nutr Prev Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:27Z","timestamp":1761991767000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720302205"}},"issued":{"date-parts":[[2020,8]]},"references-count":3,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2213858720302205"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30220-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic health and COVID-19: a call for greater medical nutrition education","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30220-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30164-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,3,6]],"date-time":"2025-03-06T05:30:43Z","timestamp":1741239043054,"version":"3.38.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004411","name":"Heart and Stroke Foundation of Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004411","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/s2213-8587(23)00352-2","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T23:33:45Z","timestamp":1701732825000},"page":"2-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["New clarity for managing statin intolerance in diabetes"],"prefix":"10.1016","volume":"12","author":[{"given":"Robert A","family":"Hegele","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00352-2_bib1","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1016\/j.cjca.2021.03.016","article-title":"2021 Canadian Cardiovascular Society Guidelines for the management of dyslipidemia for the prevention of cardiovascular disease in adults","volume":"37","author":"Pearson","year":"2021","journal-title":"Can J Cardiol"},{"key":"10.1016\/S2213-8587(23)00352-2_bib2","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(08)60104-X","article-title":"Efficacy of cholesterol-lowering therapy in 18,686 people with diabetes in 14 randomised trials of statins: a meta-analysis","volume":"371","author":"Kearney","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00352-2_bib3","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41569-023-00877-z","article-title":"Cardiovascular risk in diabetes mellitus: epidemiology, assessment and prevention","volume":"20","author":"Wong","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(23)00352-2_bib4","doi-asserted-by":"crossref","first-page":"2526","DOI":"10.1093\/eurheartj\/ehy182","article-title":"Adverse effects of statin therapy: perception vs. the evidence - focus on glucose homeostasis, cognitive, renal and hepatic function, haemorrhagic stroke and cataract","volume":"39","author":"Mach","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(23)00352-2_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1097\/MOL.0000000000000565","article-title":"Bempedoic acid: effects on lipoprotein metabolism and atherosclerosis","volume":"30","author":"Burke","year":"2019","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(23)00352-2_bib6","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJMoa2215024","article-title":"Bempedoic acid and cardiovascular outcomes in statin-intolerant patients","volume":"388","author":"Nissen","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00352-2_bib7","article-title":"Efficacy and safety of bempedoic acid among patients with and without diabetes: prespecified analysis of the CLEAR Outcomes randomised trial","author":"Ray","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00352-2_bib8","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1161\/CIRCULATIONAHA.117.030950","article-title":"Benefit of adding ezetimibe to statin therapy on cardiovascular outcomes and safety in patients with versus without diabetes mellitus: results from IMPROVE-IT (Improved Reduction of Outcomes: Vytorin Efficacy International Trial)","volume":"137","author":"Giugliano","year":"2018","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00352-2_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2023.101749","article-title":"Statins and diabetes: what are the connections?","volume":"37","author":"Sattar","year":"2023","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00352-2_bib10","doi-asserted-by":"crossref","first-page":"301","DOI":"10.7326\/M13-1921","article-title":"N-of-1 (single-patient) trials for statin-related myalgia","volume":"160","author":"Joy","year":"2014","journal-title":"Ann Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T21:04:32Z","timestamp":1741208672000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003522"}},"issued":{"date-parts":[[2024,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213858723003522"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00352-2","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New clarity for managing statin intolerance in diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00352-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00316-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:42:44Z","timestamp":1786999364048,"version":"build-2736575974"},"reference-count":25,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007476","name":"Canadian Diabetes Association","doi-asserted-by":"publisher","award":["OG-2-12-3868-RR"],"award-info":[{"award-number":["OG-2-12-3868-RR"]}],"id":[{"id":"10.13039\/100007476","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/s2213-8587(14)70226-8","type":"journal-article","created":{"date-parts":[[2014,11,26]],"date-time":"2014-11-26T19:30:32Z","timestamp":1417030232000},"page":"17-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":190,"title":["Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial"],"prefix":"10.1016","volume":"3","author":[{"given":"Ahmad","family":"Haidar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Legault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginie","family":"Messier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina Maria","family":"Mitre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Leroux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00e9mi","family":"Rabasa-Lhoret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70226-8_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70226-8_bib2","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70226-8_bib3","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1111\/j.1464-5491.2010.03006.x","article-title":"Frequency of biochemical hypoglycaemia in adults with Type 1 diabetes with and without impaired awareness of hypoglycaemia: no identifiable differences using continuous glucose monitoring","volume":"27","author":"Choudhary","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(14)70226-8_bib4","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/dmrr.482","article-title":"Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection","volume":"20","author":"Pedersen-Bjergaard","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(14)70226-8_bib5","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1007\/s00125-002-0822-9","article-title":"Hypoglycaemia: the limiting factor in the glycaemic management of type I and type II diabetes","volume":"45","author":"Cryer","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70226-8_bib6","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1001\/jama.290.16.2159","volume":"290","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70226-8_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1002853","article-title":"Effectiveness of sensor-augmented insulin-pump therapy in type 1 diabetes","volume":"363","author":"Bergenstal","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70226-8_bib8","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1056\/NEJMoa1303576","article-title":"Threshold-based insulin-pump interruption for reduction of hypoglycemia","volume":"369","author":"Bergenstal","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70226-8_bib9","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrendo.2011.32","article-title":"Closed-loop insulin delivery: from bench to clinical practice","volume":"7","author":"Hovorka","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(14)70226-8_bib10","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2337\/dc13-2644","article-title":"Overnight closed-loop insulin delivery in young people with type 1 diabetes: a free-living, randomized clinical trial","volume":"37","author":"Hovorka","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70226-8_bib11","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.2337\/dc13-2911","article-title":"Day and night home closed-loop insulin delivery in adults with type 1 diabetes: three-center randomized crossover study","volume":"37","author":"Leelarathna","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70226-8_bib12","doi-asserted-by":"crossref","first-page":"3025","DOI":"10.2337\/dc14-0835","article-title":"MD-logic overnight control for 6 weeks of home use in patients with type 1 diabetes: randomized crossover trial","volume":"37","author":"Nimri","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70226-8_bib13","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1016\/S2213-8587(14)70114-7","article-title":"Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study","volume":"2","author":"Thabit","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70226-8_bib14","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.2337\/dc14-0147","article-title":"Overnight glucose control with an automated, unified safety system in children and adolescents with type 1 diabetes at diabetes camp","volume":"37","author":"Ly","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70226-8_bib15","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJMoa1206881","article-title":"Nocturnal glucose control with an artificial pancreas at a diabetes camp","volume":"368","author":"Phillip","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70226-8_bib16","first-page":"363","article-title":"Automation control of blood sugar a servomechanism for glucose monitoring and control","volume":"9","author":"Kadish","year":"1963","journal-title":"Trans Am Soc Artif Intern Organs"},{"key":"10.1016\/S2213-8587(14)70226-8_bib17","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2337\/dc09-2254","article-title":"Novel use of glucagon in a closed-loop system for prevention of hypoglycemia in type 1 diabetes","volume":"33","author":"Castle","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70226-8_bib18","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1503\/cmaj.121265","article-title":"Glucose-responsive insulin and glucagon delivery (dual-hormone artificial pancreas) in adults with type 1 diabetes: a randomized crossover controlled trial","volume":"185","author":"Haidar","year":"2013","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(14)70226-8_bib19","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1056\/NEJMoa1314474","article-title":"Outpatient glycemic control with a bionic pancreas in type 1 diabetes","volume":"371","author":"Russell","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70226-8_bib20","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S1499-2671(06)01010-0","article-title":"Type 1 diabetes and vigorous exercise: applications of exercise physiology to patient management","volume":"30","author":"Riddell","year":"2006","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(14)70226-8_bib21","doi-asserted-by":"crossref","first-page":"2493","DOI":"10.2337\/dc11-2381","article-title":"The effect of walking on postprandial glycemic excursion in patients with type 1 diabetes and healthy people","volume":"35","author":"Manohar","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70226-8_bib22","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.2337\/dc09-2081","article-title":"Prolonged nocturnal hypoglycemia is common during 12 months of continuous glucose monitoring in children and adults with type 1 diabetes","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70226-8_bib23","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1037\/a0014770","article-title":"Nighttime caregiving behaviors among parents of young children with Type 1 diabetes: associations with illness characteristics and parent functioning","volume":"27","author":"Monaghan","year":"2009","journal-title":"Fam Syst Health"},{"key":"10.1016\/S2213-8587(14)70226-8_bib24","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1089\/dia.2013.0166","article-title":"Feasibility of a portable bihormonal closed-loop system to control glucose excursions at home under free-living conditions for 48 hours","volume":"16","author":"van Bon","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(14)70226-8_bib25","doi-asserted-by":"crossref","first-page":"e000025","DOI":"10.1136\/bmjdrc-2014-000025","article-title":"Closing the loop overnight at home setting: psychosocial impact for adolescents with type 1 diabetes and their parents","volume":"2","author":"Barnard","year":"2014","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702268?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702268?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:37Z","timestamp":1761991537000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702268"}},"issued":{"date-parts":[[2015,1]]},"references-count":25,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S2213858714702268"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70226-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70226-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70195-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,18]],"date-time":"2026-08-18T14:02:56Z","timestamp":1787061776414,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/s2213-8587(20)30018-8","type":"journal-article","created":{"date-parts":[[2020,1,28]],"date-time":"2020-01-28T18:31:07Z","timestamp":1580236267000},"page":"264-266","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Variation in the classification of hyperglycaemia in pregnancy and its implication"],"prefix":"10.1016","volume":"8","author":[{"given":"Yashdeep","family":"Gupta","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpesh","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Kalra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30018-8_bib1","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1097\/00006250-195706000-00008","article-title":"Evaluation of the prediabetic state during pregnancy","volume":"9","author":"Carrington","year":"1957","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(20)30018-8_bib2","doi-asserted-by":"crossref","first-page":"1039","DOI":"10.2337\/diab.28.12.1039","article-title":"Classification and diagnosis of diabetes mellitus and other categories of glucose intolerance","volume":"28","year":"1979","journal-title":"Diabetes"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(20)30018-8_bib3","first-page":"B161","article-title":"Summary and recommendations of the Fourth International Workshop-Conference on gestational diabetes mellitus","volume":"21","author":"Metzger","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30018-8_bib4","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc10-0719","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30018-8_bib5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2337\/dc12-1157","article-title":"Evaluation of the value of fasting plasma glucose in the first prenatal visit to diagnose gestational diabetes mellitus in China","volume":"36","author":"Zhu","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30018-8_bib6","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.diabet.2012.03.006","article-title":"Correspondence between first-trimester fasting glycaemia and oral glucose tolerance test in gestational diabetes diagnosis","volume":"38","author":"Corrado","year":"2012","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(20)30018-8_bib7","doi-asserted-by":"crossref","first-page":"53","DOI":"10.2337\/dc15-1887","article-title":"Issues with the diagnosis and classification of hyperglycemia in early pregnancy","volume":"39","author":"McIntyre","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30018-8_bib8","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.diabres.2013.10.012","article-title":"Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy: a World Health Organization guideline","volume":"103","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(20)30018-8_bib9","first-page":"S13","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(20)30018-8_bib10","first-page":"S14","article-title":"Classification and diagnosis of diabetes: standards of medical care in diabetes","volume":"43","year":"2020","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:25Z","timestamp":1761991645000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300188"}},"issued":{"date-parts":[[2020,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2213858720300188"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30018-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Variation in the classification of hyperglycaemia in pregnancy and its implication","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30018-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,15]],"date-time":"2026-08-15T05:02:42Z","timestamp":1786770162828,"version":"build-2736575974"},"reference-count":42,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/s2213-8587(15)00477-5","type":"journal-article","created":{"date-parts":[[2016,1,7]],"date-time":"2016-01-07T00:43:47Z","timestamp":1452127427000},"page":"105-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Gradual reduction of sugar in soft drinks without substitution as a strategy to reduce overweight, obesity, and type 2 diabetes: a modelling study"],"prefix":"10.1016","volume":"4","author":[{"given":"Yuan","family":"Ma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng J","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunjian","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kawther M","family":"Hashem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham A","family":"MacGregor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00477-5_bib1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00477-5_bib3","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1475-2891-10-103","article-title":"Beverage patterns and trends among school-aged children in the US, 1989\u20132008","volume":"10","author":"Lasater","year":"2011","journal-title":"Nutr J"},{"key":"10.1016\/S2213-8587(15)00477-5_bib4","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2105\/AJPH.2012.300974","article-title":"Relationship of soft drink consumption to global overweight, obesity, and diabetes: a cross-national analysis of 75 countries","volume":"103","author":"Basu","year":"2013","journal-title":"Am J Public Health"},{"key":"10.1016\/S2213-8587(15)00477-5_bib6","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1097\/MCO.0b013e328346df36","article-title":"Effects of carbohydrates on satiety: differences between liquid and solid food","volume":"14","author":"Pan","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/S2213-8587(15)00477-5_bib7","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1038\/ijo.2012.225","article-title":"Changes in water and beverage intake and long-term weight changes: results from three prospective cohort studies","volume":"37","author":"Pan","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(15)00477-5_bib8","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.3945\/ajcn.2008.27240","article-title":"Reduction in consumption of sugar-sweetened beverages is associated with weight loss: the PREMIER trial","volume":"89","author":"Chen","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00477-5_bib9","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1017\/S0007114514001329","article-title":"Association between sugar-sweetened and artificially sweetened soft drinks and type 2 diabetes: systematic review and dose-response meta-analysis of prospective studies","volume":"112","author":"Greenwood","year":"2014","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(15)00477-5_bib10","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.114.010636","article-title":"Estimated global, regional, and national disease burdens related to sugar-sweetened beverage consumption in 2010","volume":"132","author":"Singh","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(15)00477-5_bib11","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/jhh.2013.105","article-title":"Salt reduction in the United Kingdom: a successful experiment in public health","volume":"28","author":"He","year":"2014","journal-title":"J Hum Hypertens"},{"key":"10.1016\/S2213-8587(15)00477-5_bib12","doi-asserted-by":"crossref","first-page":"e004549","DOI":"10.1136\/bmjopen-2013-004549","article-title":"Salt reduction in England from 2003 to 2011: its relationship to blood pressure, stroke and ischaemic heart disease mortality","volume":"4","author":"He","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(15)00477-5_bib13","series-title":"Carbohydrates and health 2015","year":"2015"},{"key":"10.1016\/S2213-8587(15)00477-5_bib14","series-title":"Childhood obesity action plan","year":"2015"},{"key":"10.1016\/S2213-8587(15)00477-5_bib15","series-title":"Guideline: sugars intake for adults and children","year":"2015"},{"key":"10.1016\/S2213-8587(15)00477-5_bib16","year":"2015"},{"key":"10.1016\/S2213-8587(15)00477-5_bib17","series-title":"Obesity: the prevention, identification, assessment and management of overweight and obesity in adults and children","author":"NICE","year":"2006"},{"key":"10.1016\/S2213-8587(15)00477-5_bib19","series-title":"National Diet and Nutrition Survey: results from years 1 to 4 (combined) of the rolling programme for 2008 and 2009 to 2011 and 2012","year":"2014"},{"key":"10.1016\/S2213-8587(15)00477-5_bib20","series-title":"Methods used for household food and drink waste in the UK 2012","year":"2013"},{"key":"10.1016\/S2213-8587(15)00477-5_bib21","series-title":"Overview of the UK population","year":"2015"},{"key":"10.1016\/S2213-8587(15)00477-5_bib22","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1093\/jn\/129.10.1765","article-title":"Recent advances from application of doubly labeled water to measurement of human energy expenditure","volume":"129","author":"Schoeller","year":"1999","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(15)00477-5_bib23","doi-asserted-by":"crossref","first-page":"e76632","DOI":"10.1371\/journal.pone.0076632","article-title":"Validity of US nutritional surveillance: National Health and Nutrition Examination Survey caloric energy intake data, 1971\u20132010","volume":"8","author":"Archer","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(15)00477-5_bib24","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/S0002-8223(03)01074-5","article-title":"Selective underreporting of energy intake in women: magnitude, determinants, and effect of training","volume":"103","author":"Scagliusi","year":"2003","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/S2213-8587(15)00477-5_bib25","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1136\/bmj.311.7011.986","article-title":"Dietary underreporting by obese individuals\u2014is it specific or non-specific?","volume":"311","author":"Heitmann","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00477-5_bib26","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.3945\/ajcn.2008.26333","article-title":"Modeling weight-loss maintenance to help prevent body weight regain","volume":"88","author":"Hall","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00477-5_bib27","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(11)60814-3","article-title":"Health and economic burden of the projected obesity trends in the USA and the UK","volume":"378","author":"Wang","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00477-5_bib28","doi-asserted-by":"crossref","first-page":"h2622","DOI":"10.1136\/bmj.h2622","article-title":"Statistics notes: bootstrap resampling methods","volume":"350","author":"Bland","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00477-5_bib29","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1038\/sj.ijo.0803720","article-title":"What is the required energy deficit per unit weight loss?","volume":"32","author":"Hall","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(15)00477-5_bib30","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1046\/j.1365-2362.2002.01036.x","article-title":"Prediction of body weight changes caused by changes in energy balance","volume":"32","author":"Christiansen","year":"2002","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S2213-8587(15)00477-5_bib31","doi-asserted-by":"crossref","first-page":"f6189","DOI":"10.1136\/bmj.f6189","article-title":"Overall and income specific effect on prevalence of overweight and obesity of 20% sugar sweetened drink tax in UK: econometric and comparative risk assessment modelling study","volume":"347","author":"Briggs","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00477-5_bib32","series-title":"Global action plan for the prevention and control of noncommunicable diseases 2013\u20132020","year":"2013"},{"key":"10.1016\/S2213-8587(15)00477-5_bib33","doi-asserted-by":"crossref","first-page":"477","DOI":"10.3945\/ajcn.2008.26566","article-title":"Can a small-changes approach help address the obesity epidemic? A report of the Joint Task Force of the American Society for Nutrition, Institute of Food Technologists, and International Food Information Council","volume":"89","author":"Hill","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00477-5_bib34","doi-asserted-by":"crossref","first-page":"81","DOI":"10.7812\/TPP\/14-229","article-title":"Does consuming sugar and artificial sweeteners change taste preferences?","volume":"19","author":"Bartolotto","year":"2015","journal-title":"Perm J"},{"key":"10.1016\/S2213-8587(15)00477-5_bib35","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.jhealeco.2012.10.005","article-title":"Implications of a sugar-sweetened beverage (SSB) tax when substitutions to non-beverage items are considered","volume":"32","author":"Finkelstein","year":"2013","journal-title":"J Health Econ"},{"key":"10.1016\/S2213-8587(15)00477-5_bib36","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1017\/S0007114512005430","article-title":"Fewer adults add salt at the table after initiation of a national salt campaign in the UK: a repeated cross-sectional analysis","volume":"110","author":"Sutherland","year":"2013","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(15)00477-5_bib37","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1038\/507150a","article-title":"Storm brewing over WHO sugar proposal. Industry backlash expected over suggested cut in intake","volume":"507","author":"Owens","year":"2014","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(15)00477-5_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1007\/s11894-014-0423-z","article-title":"The paradox of artificial sweeteners in managing obesity","volume":"17","author":"Roberts","year":"2015","journal-title":"Curr Gastroenterol Rep"},{"key":"10.1016\/S2213-8587(15)00477-5_bib44","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1038\/nature13793","article-title":"Artificial sweeteners induce glucose intolerance by altering the gut microbiota","volume":"514","author":"Suez","year":"2014","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(15)00477-5_bib45","doi-asserted-by":"crossref","first-page":"1798","DOI":"10.2337\/dc12-9002","article-title":"Nonnutritive sweeteners: current use and health perspectives: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"35","author":"Gardner","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00477-5_bib46","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.appet.2015.03.027","article-title":"Artificial sweeteners are not the answer to childhood obesity","volume":"93","author":"Swithers","year":"2015","journal-title":"Appetite"},{"key":"10.1016\/S2213-8587(15)00477-5_bib47","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1016\/j.physbeh.2012.05.006","article-title":"Altered processing of sweet taste in the brain of diet soda drinkers","volume":"107","author":"Green","year":"2012","journal-title":"Physiol Behav"},{"key":"10.1016\/S2213-8587(15)00477-5_bib48","series-title":"Health-related taxes on food and beverages","author":"Cornelsen","year":"2015"},{"key":"10.1016\/S2213-8587(15)00477-5_bib49","doi-asserted-by":"crossref","first-page":"1072","DOI":"10.1186\/1471-2458-13-1072","article-title":"Evidence that a tax on sugar sweetened beverages reduces the obesity rate: a meta-analysis","volume":"13","author":"Cabrera Escobar","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(15)00477-5_bib50","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.ehb.2011.08.007","article-title":"Measuring weight outcomes for obesity intervention strategies: the case of a sugar-sweetened beverage tax","volume":"9","author":"Lin","year":"2011","journal-title":"Econ Hum Biol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004775?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004775?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,13]],"date-time":"2024-06-13T17:24:56Z","timestamp":1718299496000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004775"}},"issued":{"date-parts":[[2016,2]]},"references-count":42,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2213858715004775"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00477-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gradual reduction of sugar in soft drinks without substitution as a strategy to reduce overweight, obesity, and type 2 diabetes: a modelling study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00477-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00483-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T02:43:40Z","timestamp":1785811420212,"version":"3.56.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/s2213-8587(16)30399-0","type":"journal-article","created":{"date-parts":[[2016,12,7]],"date-time":"2016-12-07T00:46:40Z","timestamp":1481071600000},"page":"14-15","source":"Crossref","is-referenced-by-count":6,"title":["The ecological cost of continued use of endocrine-disrupting chemicals"],"prefix":"10.1016","volume":"5","author":[{"given":"Lindsay M","family":"Jaacks","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soumya","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30399-0_bib1","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1016\/S2213-8587(16)30275-3","article-title":"Exposure to endocrine-disrupting chemicals in the USA: a population-based disease burden and cost analysis","volume":"4","author":"Attina","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30399-0_bib2","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.ocecoaman.2011.05.007","article-title":"The economic cost and control of marine debris damage in the Asia-Pacific region","volume":"54","author":"McIlgorm","year":"2011","journal-title":"Ocean Coast Manag"},{"key":"10.1016\/S2213-8587(16)30399-0_bib3","doi-asserted-by":"crossref","first-page":"2047","DOI":"10.1098\/rstb.2008.0242","article-title":"A critical analysis of the biological impacts of plasticizers on wildlife","volume":"364","author":"Oehlmann","year":"2009","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/S2213-8587(16)30399-0_bib5","first-page":"629","article-title":"Foreign body rumen impaction with indigestible materials in ruminants in Nigeria: a review","volume":"61","author":"Akinrinmade","year":"2013","journal-title":"Anim Health Prodn"},{"key":"10.1016\/S2213-8587(16)30399-0_bib6","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1017\/S1751731110000595","article-title":"Effects of environmental pollutants on the reproduction and welfare of ruminants","volume":"4","author":"Rhind","year":"2010","journal-title":"Animal"},{"key":"10.1016\/S2213-8587(16)30399-0_bib7","author":"Alexandratos"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303990?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303990?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T05:20:51Z","timestamp":1536211251000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303990"}},"issued":{"date-parts":[[2017,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S2213858716303990"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30399-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,1]]}},{"indexed":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T03:36:07Z","timestamp":1773200167272,"version":"3.50.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/s2213-8587(16)30110-3","type":"journal-article","created":{"date-parts":[[2016,6,11]],"date-time":"2016-06-11T14:36:11Z","timestamp":1465655771000},"page":"549-550","source":"Crossref","is-referenced-by-count":13,"title":["HIV and NCDs: the need to build stronger health systems"],"prefix":"10.1016","volume":"4","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301103?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301103?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T08:01:42Z","timestamp":1536652902000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301103"}},"issued":{"date-parts":[[2016,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S2213858716301103"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30110-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,7]]}},{"indexed":{"date-parts":[[2026,8,25]],"date-time":"2026-08-25T04:31:08Z","timestamp":1787632268392,"version":"build-2736575974"},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/s2213-8587(17)30414-x","type":"journal-article","created":{"date-parts":[[2017,12,20]],"date-time":"2017-12-20T04:35:28Z","timestamp":1513744528000},"page":"1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Diabetes: mapping the titanic struggle ahead"],"prefix":"10.1016","volume":"6","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730414X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730414X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T05:27:46Z","timestamp":1535174866000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871730414X"}},"issued":{"date-parts":[[2018,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S221385871730414X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30414-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes: mapping the titanic struggle ahead","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30414-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:36:12Z","timestamp":1785825372624,"version":"3.56.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009131","name":"Swiss Agency for Development and Cooperation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009131","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/s2213-8587(24)00156-6","type":"journal-article","created":{"date-parts":[[2024,5,30]],"date-time":"2024-05-30T22:42:15Z","timestamp":1717108935000},"page":"444-445","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lack of access to insulin: undermining the Rights of the Child"],"prefix":"10.1016","volume":"12","author":[{"given":"Olivia","family":"Heller","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Duperrex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip D","family":"Jaff\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Goldhagen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol A","family":"Abidha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann","family":"Skelton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Otani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvon","family":"Heller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Dominique","family":"Vassalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Beran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00156-6_bib1","series-title":"Geneva Declaration of the Rights of the Child","year":"1924"},{"key":"10.1016\/S2213-8587(24)00156-6_bib4","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s00125-021-05571-8","article-title":"Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults","volume":"64","author":"Green","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00156-6_bib5","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1007\/s00125-020-05375-2","article-title":"A global perspective on the issue of access to insulin","volume":"64","author":"Beran","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00156-6_bib6","series-title":"Reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes","year":"2021"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T07:19:50Z","timestamp":1718781590000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001566"}},"issued":{"date-parts":[[2024,7]]},"references-count":4,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2213858724001566"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00156-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lack of access to insulin: undermining the Rights of the Child","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00156-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T20:49:45Z","timestamp":1791924585064,"version":"4.3.4"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/s2213-8587(24)00313-9","type":"journal-article","created":{"date-parts":[[2025,1,24]],"date-time":"2025-01-24T23:31:27Z","timestamp":1737761487000},"page":"178-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial"],"prefix":"10.1016","volume":"13","author":[{"given":"Frederick J","family":"Raal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vimal","family":"Mehta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meral","family":"Kayikcioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Blom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Preeti","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishay","family":"Elis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Vest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kate","family":"Caldwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"El Mustapha","family":"Bahassi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Kallend","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan A","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00313-9_bib1","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 Update on European Atherosclerosis Society consensus statement on homozygous familial hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(24)00313-9_bib2","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(21)02001-8","article-title":"Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study","volume":"399","author":"Tromp","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00313-9_bib3","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1038\/s41569-018-0052-6","article-title":"The complex molecular genetics of familial hypercholesterolaemia","volume":"16","author":"Berberich","year":"2019","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(24)00313-9_bib4","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0140-6736(93)90815-X","article-title":"Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia","volume":"341","author":"Moorjani","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00313-9_bib5","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1016\/j.jacc.2017.06.058","article-title":"Efficacy of rosuvastatin in children with homozygous familial hypercholesterolemia and association with underlying genetic mutations","volume":"70","author":"Stein","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(24)00313-9_bib6","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1161\/CIRCULATIONAHA.113.004678","article-title":"Effect of the proprotein convertase subtilisin\/kexin 9 monoclonal antibody, AMG 145, in homozygous familial hypercholesterolemia","volume":"128","author":"Stein","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00313-9_bib7","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1161\/ATVBAHA.117.310217","article-title":"Homozygous familial hypercholesterolemia patients with identical mutations variably express the LDLR (low-density lipoprotein receptor): implications for the efficacy of evolocumab","volume":"38","author":"Thedrez","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(24)00313-9_bib8","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1161\/ATVBAHA.117.310675","article-title":"Expression of LDLRs (low-density lipoprotein receptors), dyslipidemia severity, and response to PCSK9 (proprotein convertase subtilisin kexin type 9) inhibition in homozygous familial hypercholesterolemia: connecting the dots","volume":"38","author":"Santos","year":"2018","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(24)00313-9_bib9","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ihj.2021.11.185","article-title":"Shortcomings on genetic testing of familial hypercholesterolemia (FH) in India: can we collaborate to establish Indian FH registry?","volume":"74","author":"Reddy","year":"2022","journal-title":"Indian Heart J"},{"key":"10.1016\/S2213-8587(24)00313-9_bib10","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.atherosclerosis.2018.08.012","article-title":"What have we learned from Turkish familial hypercholesterolemia registries (A-HIT1 and A-HIT2)?","volume":"277","author":"Kayikcioglu","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(24)00313-9_bib11","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00313-9_bib12","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1016\/j.jacl.2021.10.003","article-title":"Evolocumab in patients with homozygous familial hypercholesterolemia in India","volume":"15","author":"Bansal","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(24)00313-9_bib13","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1161\/ATVBAHA.122.317793","article-title":"Efficacy and safety of alirocumab in children and adolescents with homozygous familial hypercholesterolemia: phase 3, multinational open-label study","volume":"42","author":"Bruckert","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(24)00313-9_bib14","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/CIRCULATIONAHA.122.063460","article-title":"Efficacy, safety, and tolerability of inclisiran in patients with homozygous familial hypercholesterolemia: results from the ORION-5 randomized clinical trial","volume":"149","author":"Raal","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00313-9_bib15","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.1161\/ATVBAHA.123.320268","article-title":"Evolocumab treatment in pediatric patients with homozygous familial hypercholesterolemia: pooled data from three open-label studies","volume":"44","author":"Raal","year":"2024","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(24)00313-9_bib16","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1093\/eurheartj\/ehad596","article-title":"Long-term efficacy and safety of lerodalcibep in heterozygous familial hypercholesterolaemia: the LIBerate-HeFH trial","volume":"44","author":"Raal","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(24)00313-9_bib17","article-title":"CONSORT 2010 statement: extension to randomised crossover trials","volume":"366","author":"Dwan","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00313-9_bib18","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/gim.2017.151","article-title":"Analysis of publicly available LDLR, APOB, and PCSK9 variants associated with familial hypercholesterolemia: application of ACMG guidelines and implications for familial hypercholesterolemia diagnosis","volume":"20","author":"Chora","year":"2018","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(24)00313-9_bib19","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.gim.2021.09.012","article-title":"The Clinical Genome Resource (ClinGen) Familial Hypercholesterolemia Variant Curation Expert Panel consensus guidelines for LDLR variant classification","volume":"24","author":"Chora","year":"2022","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(24)00313-9_bib20","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1161\/ATVBAHA.119.313051","article-title":"Functional analysis of LDLR (low-density lipoprotein receptor) variants in patient lymphocytes to assess the effect of evinacumab in homozygous familial hypercholesterolemia patients with a spectrum of LDLR activity","volume":"39","author":"Banerjee","year":"2019","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(24)00313-9_bib21","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0002-9149(97)00298-1","article-title":"The rule of 5 and the rule of 7 in lipid lowering by statin drugs","volume":"80","author":"Roberts","year":"1997","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(24)00313-9_bib22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.amjcard.2009.08.651","article-title":"Meta-analysis of comparative efficacy of increasing dose of atorvastatin versus rosuvastatin versus simvastatin on lowering levels of atherogenic lipids (from VOYAGER)","volume":"105","author":"Nicholls","year":"2010","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(24)00313-9_bib24","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 5.1.0","year":"2011"},{"key":"10.1016\/S2213-8587(24)00313-9_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/S2213-8587(17)30044-X","article-title":"Long-term treatment with evolocumab added to conventional drug therapy, with or without apheresis, in patients with homozygous familial hypercholesterolaemia: an interim subset analysis of the open-label TAUSSIG study","volume":"5","author":"Raal","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00313-9_bib26","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1161\/CIRCULATIONAHA.119.044431","article-title":"Inclisiran durably lowers low-density lipoprotein cholesterol and proprotein convertase subtilisin\/kexin type 9 expression in homozygous familial hypercholesterolemia: the ORION-2 pilot study","volume":"141","author":"Hoving","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00313-9_bib27","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/j.jacc.2020.05.027","article-title":"Efficacy and safety of alirocumab in adults with homozygous familial hypercholesterolemia: the ODYSSEY HoFH trial","volume":"76","author":"Blom","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(24)00313-9_bib28","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1093\/eurheartj\/ehx144","article-title":"Low-density lipoproteins cause atherosclerotic cardiovascular disease. 1. Evidence from genetic, epidemiologic, and clinical studies. A consensus statement from the European Atherosclerosis Society Consensus Panel","volume":"38","author":"Ference","year":"2017","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(24)00313-9_bib29","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00313-9_bib30","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00313-9_bib31","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.3390\/ijms19061676","article-title":"Validation of LDLr activity as a tool to improve genetic diagnosis of familial hypercholesterolemia: a retrospective on functional characterization of LDLr variants","volume":"19","author":"Benito-Vicente","year":"2018","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(24)00313-9_bib32","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1038\/s41569-021-00549-w","article-title":"Pharmacogenetics to guide cardiovascular drug therapy","volume":"18","author":"Duarte","year":"2021","journal-title":"Nat Rev Cardiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003139?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003139?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T20:45:06Z","timestamp":1741466706000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003139"}},"issued":{"date-parts":[[2025,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213858724003139"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00313-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lerodalcibep and evolocumab for the treatment of homozygous familial hypercholesterolaemia with PCSK9 inhibition (LIBerate-HoFH): a phase 3, randomised, open-label, crossover, non-inferiority trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00313-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00347-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T20:27:46Z","timestamp":1791491266663,"version":"4.3.4"},"reference-count":6,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/s2213-8587(24)00191-8","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:42:24Z","timestamp":1724398944000},"page":"698-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Sociodemographic and health-related differences in non-diabetic hyperglycaemia and undiagnosed type 2 diabetes in England during 2013\u201319: a cross-sectional study"],"prefix":"10.1016","volume":"12","author":[{"given":"Emma","family":"Campbell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ellie","family":"Macey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caitlin","family":"Kneebone-Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Shine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vah\u00e9","family":"Nafilyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ross","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Finning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00191-8_bib1","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S2213-8587(23)00223-1","article-title":"Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation","volume":"11","author":"Kaptoge","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00191-8_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2015-010155","article-title":"Social inequalities in prevalence of diagnosed and undiagnosed diabetes and impaired glucose regulation in participants in the Health Surveys for England series","volume":"6","author":"Moody","year":"2016","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(24)00191-8_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14829","article-title":"Undiagnosed diabetes: prevalence and cardiovascular risk profile in a population-based study of 52 856 individuals. The HUNT Study, Norway","volume":"39","author":"Bjark\u00f8","year":"2022","journal-title":"Diabetic Med"},{"key":"10.1016\/S2213-8587(24)00191-8_bib5","doi-asserted-by":"crossref","first-page":"3424","DOI":"10.1111\/dom.15223","article-title":"Impact of the COVID-19 pandemic on new diagnoses of type 2 diabetes in England","volume":"25","author":"Barron","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00191-8_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2014-005002","article-title":"Prevalence of prediabetes in England from 2003 to 2011: population-based, cross-sectional study","volume":"4","author":"Mainous","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(24)00191-8_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2023.102275","article-title":"Sociodemographic and health-related differences in undiagnosed hypertension in the health survey for England 2015\u20132019: a cross-sectional cohort study","volume":"65","author":"Campbell","year":"2023","journal-title":"EClinicalMedicine"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T23:11:09Z","timestamp":1727219469000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001918"}},"issued":{"date-parts":[[2024,10]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2213858724001918"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00191-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sociodemographic and health-related differences in non-diabetic hyperglycaemia and undiagnosed type 2 diabetes in England during 2013\u201319: a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00191-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T06:19:57Z","timestamp":1791353997994,"version":"4.3.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/s2213-8587(26)00048-3","type":"journal-article","created":{"date-parts":[[2026,3,11]],"date-time":"2026-03-11T23:39:43Z","timestamp":1773272383000},"page":"379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Europe's school food policy gap"],"prefix":"10.1016","volume":"14","author":[{"given":"Vijay Shankar","family":"Balakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000483?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000483?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:44:04Z","timestamp":1776206644000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000483"}},"issued":{"date-parts":[[2026,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2213858726000483"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00048-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Europe's school food policy gap","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00048-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T10:09:47Z","timestamp":1784023787522,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Federal Ministry of Education and Research Bonn Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019771","name":"European Union's Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019771","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/s2213-8587(25)00054-3","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T05:02:00Z","timestamp":1746075720000},"page":"455-457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Does tirzepatide treatment improve skeletal muscle composition?"],"prefix":"10.1016","volume":"13","author":[{"given":"Norbert","family":"Stefan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00054-3_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00054-3_bib2","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S2213-8587(23)00086-4","article-title":"Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment","volume":"11","author":"Stefan","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00054-3_bib3","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00054-3_bib4","doi-asserted-by":"crossref","first-page":"260","DOI":"10.3389\/fphys.2012.00260","article-title":"Sarcopenia, dynapenia, and the impact of advancing age on human skeletal muscle size and strength; a quantitative review","volume":"3","author":"Mitchell","year":"2012","journal-title":"Front Physiol"},{"key":"10.1016\/S2213-8587(25)00054-3_bib5","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1159\/000530241","article-title":"Higher risk of sarcopenia in older adults with type 2 diabetes: NHANES 1999\u20132018","volume":"16","author":"Dai","year":"2023","journal-title":"Obes Facts"},{"key":"10.1016\/S2213-8587(25)00054-3_bib6","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1002\/jcsm.12834","article-title":"Adverse muscle composition predicts all-cause mortality in the UK Biobank imaging study","volume":"12","author":"Linge","year":"2021","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/S2213-8587(25)00054-3_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jama.2024.6586","article-title":"Is weight loss-induced muscle mass loss clinically relevant?","volume":"332","author":"Conte","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00054-3_bib8","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S2213-8587(24)00272-9","article-title":"Muscle matters: the effects of medically induced weight loss on skeletal muscle","volume":"12","author":"Prado","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00054-3_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00027-0","article-title":"Tirzepatide and muscle composition changes in people with type 2 diabetes (SURPASS-3 MRI): a post-hoc analysis of a randomised, open-label, parallel-group, phase 3 trial","author":"Sattar","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00054-3_bib10","doi-asserted-by":"crossref","first-page":"5503","DOI":"10.1111\/dom.15913","article-title":"Glucagon-like peptide-1 receptor agonist-based agents and weight loss composition: filling the gaps","volume":"26","author":"Dubin","year":"2024","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000543?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000543?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T20:13:23Z","timestamp":1748031203000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000543"}},"issued":{"date-parts":[[2025,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2213858725000543"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00054-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Does tirzepatide treatment improve skeletal muscle composition?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00054-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00027-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,27]],"date-time":"2026-05-27T19:32:30Z","timestamp":1779910350628,"version":"3.53.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["DP3 DK 101055"],"award-info":[{"award-number":["DP3 DK 101055"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["RO1 DK 085623"],"award-info":[{"award-number":["RO1 DK 085623"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004331","name":"Johnson and Johnson","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004331","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/s2213-8587(14)70126-3","type":"journal-article","created":{"date-parts":[[2014,6,16]],"date-time":"2014-06-16T16:37:13Z","timestamp":1402936633000},"page":"679-681","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":16,"title":["The artificial pancreas: a digital-age treatment for diabetes"],"prefix":"10.1016","volume":"2","author":[{"given":"Claudio","family":"Cobelli","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Kovatchev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70126-3_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70114-7","article-title":"Home use of closed-loop insulin delivery for overnight glucose control in adults with type 1 diabetes: a 4-week, multicentre, randomised crossover study","author":"Thabit","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70126-3_bib2","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S0140-6736(09)61998-X","article-title":"Manual closed-loop insulin delivery in children and adolescents with type 1 diabetes: a phase 2 randomised crossover trial","volume":"375","author":"Hovorka","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70126-3_bib3","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.2337\/dc12-1965","article-title":"Feasibility of outpatient fully integrated closed-loop control: first studies of wearable artificial pancreas","volume":"36","author":"Kovatchev","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70126-3_bib4","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1056\/NEJMoa1206881","article-title":"Nocturnal glucose control with an artificial pancreas at a diabetes camp","volume":"368","author":"Phillip","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70126-3_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/pedi.12071","article-title":"Night glucose control with MD-Logic artificial pancreas in home setting: a single blind, randomized crossover trial-interim analysis","volume":"15","author":"Nimri","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(14)70126-3_bib6","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.2337\/dc13-2644","article-title":"Overnight closed-loop insulin delivery in young people with type 1 diabetes: A free-living randomized clinical trial","volume":"37","author":"Hovorka","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70126-3_bib7","doi-asserted-by":"crossref","first-page":"2986","DOI":"10.1109\/TBME.2012.2192930","article-title":"Modular closed-loop control of diabetes","volume":"29","author":"Patek","year":"2012","journal-title":"Trans Biomed Eng"},{"key":"10.1016\/S2213-8587(14)70126-3_bib8","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.2337\/dc12-0660","article-title":"Pilot studies of wearable outpatient artificial pancreas in type 1 diabetes","volume":"37","author":"Cobelli","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70126-3_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.diabres.2013.09.009","article-title":"Closed loop developments to improve glucose control at home","volume":"102","author":"Renard","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(14)70126-3_bib10","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.2337\/dc13-1631","article-title":"First use of model predictive control in outpatient wearable artificial pancreas","volume":"37","author":"Del Favero","year":"2014","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701263?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701263?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:04Z","timestamp":1761991504000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701263"}},"issued":{"date-parts":[[2014,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S2213858714701263"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70126-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The artificial pancreas: a digital-age treatment for diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70126-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70114-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T09:26:05Z","timestamp":1768814765349,"version":"3.49.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30235-2","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T19:45:23Z","timestamp":1477424723000},"page":"885-886","source":"Crossref","is-referenced-by-count":2,"title":["Adrenal vein sampling versus CT scanning in primary aldosteronism"],"prefix":"10.1016","volume":"4","author":[{"given":"Troy H","family":"Puar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joan J","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keng S","family":"Ng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jia W","family":"Kam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kuo W","family":"Wang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30235-2_bib1","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","volume":"4","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30235-2_bib2","doi-asserted-by":"crossref","first-page":"329","DOI":"10.7326\/0003-4819-151-5-200909010-00007","article-title":"Systematic review: diagnostic procedures to differentiate unilateral from bilateral adrenal abnormality in primary aldosteronism","volume":"151","author":"Kempers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)30235-2_bib3","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1210\/jc.2014-3676","article-title":"Does contralateral suppression at adrenal venous sampling predict outcome following unilateral adrenalectomy for primary aldosteronism? A retrospective study","volume":"100","author":"Wolley","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30235-2_bib4","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1161\/HYPERTENSIONAHA.110.158543","article-title":"Adrenal cortex remodeling and functional zona glomerulosa hyperplasia in primary aldosteronism","volume":"56","author":"Boulkroun","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(16)30235-2_bib5","doi-asserted-by":"crossref","first-page":"e819","DOI":"10.1210\/jc.2011-2965","article-title":"Microarray, qPCR, and KCNJ5 sequencing of aldosterone-producing adenomas reveal differences in genotype and phenotype between zona glomerulosa- and zona fasciculata-like tumors","volume":"97","author":"Azizan","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302352?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302352?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T03:54:05Z","timestamp":1536292445000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302352"}},"issued":{"date-parts":[[2016,11]]},"references-count":5,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2213858716302352"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30235-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T04:25:07Z","timestamp":1780460707420,"version":"3.54.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/s2213-8587(18)30267-5","type":"journal-article","created":{"date-parts":[[2018,9,16]],"date-time":"2018-09-16T00:02:29Z","timestamp":1537056149000},"page":"756-757","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Real-world diabetes prevention: from theory to practice"],"prefix":"10.1016","volume":"6","author":[{"given":"Robert E J","family":"Ryder","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30267-5_bib1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/db09-9028","article-title":"Banting Lecture: from the triumvirate to the ominous octet: a new paradigm for the treatment of type 2 diabetes mellitus","volume":"58","author":"DeFronzo","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30267-5_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.15277\/bjdvd.2015.021","article-title":"Rehabilitation of pioglitazone","volume":"15","author":"Ryder","year":"2015","journal-title":"Br J Diabetes Vasc Dis"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(18)30267-5_bib3","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.2337\/dcS13-2011","article-title":"Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes mellitus","volume":"36","author":"DeFronzo","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30267-5_bib4","doi-asserted-by":"crossref","first-page":"3920","DOI":"10.2337\/db13-0265","article-title":"Prevention of diabetes with pioglitazone in ACT NOW: Physiologic correlates","volume":"62","author":"DeFronzo","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30267-5_bib5","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.2337\/db05-1200","article-title":"Insulin secretion and action in subjects with impaired fasting glucose and impaired glucose tolerance: results from the Veterans Administration Genetic Epidemiology Study","volume":"55","author":"Abdul-Ghani","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30267-5_bib6","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance","volume":"364","author":"DeFronzo","year":"2011","journal-title":"NEJM"},{"key":"10.1016\/S2213-8587(18)30267-5_bib7","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/dom.12417","volume":"17","author":"Abdul-Ghani","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30267-5_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30234-1","article-title":"SSuccessful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES)","author":"Armato","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30267-5_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302675?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302675?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T23:35:54Z","timestamp":1537918554000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302675"}},"issued":{"date-parts":[[2018,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2213858718302675"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30267-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Real-world diabetes prevention: from theory to practice","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30267-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30234-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:39:42Z","timestamp":1761863982194},"reference-count":11,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2019,7,1]],"date-time":"2019-07-01T00:00:00Z","timestamp":1561939200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,7]]},"DOI":"10.1016\/s2213-8587(19)30195-0","type":"journal-article","created":{"date-parts":[[2019,6,4]],"date-time":"2019-06-04T18:44:25Z","timestamp":1559673865000},"page":"504-505","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Treatment of persistent or recurrent type 2 diabetes after metabolic surgery"],"prefix":"10.1016","volume":"7","author":[{"given":"Geltrude","family":"Mingrone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30195-0_bib1","doi-asserted-by":"crossref","first-page":"3783","DOI":"10.1007\/s11695-018-3450-2","article-title":"IFSO Worldwide Survey 2016: primary, endoluminal, and revisional procedures","volume":"28","author":"Angrisani","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(19)30195-0_bib2","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1016\/S0140-6736(15)00075-6","article-title":"Bariatric\u2013metabolic surgery versus conventional medical treatment in obese patients with type 2 diabetes: 5 year follow-up of an open-label, single-centre, randomised controlled trial","volume":"386","author":"Mingrone","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30195-0_bib3","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1056\/NEJMoa1600869","article-title":"Bariatric surgery versus intensive medical therapy for diabetes\u20145-year outcomes","volume":"376","author":"Schauer","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30195-0_bib4","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1001\/jama.2017.20813","article-title":"Lifestyle intervention and medical management with vs without Roux-en-Y gastric bypass and control of hemoglobin A1c, LDL cholesterol, and systolic blood pressure at 5 years in the Diabetes Surgery Study","volume":"319","author":"Ikramuddin","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30195-0_bib5","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1053\/j.gastro.2007.03.057","article-title":"Bariatric surgery: a review of procedures and outcomes","volume":"132","author":"Elder","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(19)30195-0_bib6","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/obr.12013","article-title":"Post-operative behavioural management in bariatric surgery: a systematic review and meta-analysis of randomized controlled trials","volume":"14","author":"Rudolph","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(19)30195-0_bib7","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1097\/SLA.0b013e3180caa3e3","article-title":"Gut hormones as mediators of appetite and weight loss after Roux-en-Y gastric bypass","volume":"246","author":"le Roux","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(19)30195-0_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30157-3","article-title":"Adjunctive liraglutide treatment in patients with persistent or recurrent type 2 diabetes after metabolic surgery (GRAVITAS): a randomised, double-blind, placebo-controlled trial","author":"Miras","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30195-0_bib9","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.cgh.2010.11.004","article-title":"Gastrojejunal stoma diameter predicts weight regain after Roux-en-Y gastric bypass","volume":"9","author":"Abu Dayyeh","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(19)30195-0_bib10","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1053\/j.gastro.2013.04.002","article-title":"Endoscopic suturing for transoral outlet reduction increases weight loss after Roux-en-Y gastric bypass surgery","volume":"145","author":"Thompson","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(19)30195-0_bib11","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1001\/jama.2015.9676","article-title":"Efficacy of liraglutide for weight loss among patients with type 2 diabetes: the SCALE Diabetes randomized clinical trial","volume":"314","author":"Davies","year":"2015","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301950?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301950?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,15]],"date-time":"2019-07-15T16:19:04Z","timestamp":1563207544000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301950"}},"issued":{"date-parts":[[2019,7]]},"references-count":11,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2019,7]]}},"alternative-id":["S2213858719301950"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30195-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of persistent or recurrent type 2 diabetes after metabolic surgery","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30195-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30157-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,10]],"date-time":"2025-10-10T12:53:46Z","timestamp":1760100826107},"reference-count":14,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/s2213-8587(15)00331-9","type":"journal-article","created":{"date-parts":[[2015,9,13]],"date-time":"2015-09-13T23:30:53Z","timestamp":1442187053000},"page":"831-832","source":"Crossref","is-referenced-by-count":4,"title":["Prevention of diabetes: more answers, more questions"],"prefix":"10.1016","volume":"3","author":[{"given":"Anoop","family":"Misra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00331-9_bib1","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00331-9_bib2","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00331-9_bib3","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/ejcn.2013.70","article-title":"Overweight, obesity and related non-communicable diseases in Asian Indian girls and women","volume":"67","author":"Chopra","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00331-9_bib4","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1210\/jc.2014-3761","article-title":"The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the Diabetes Prevention Program outcomes study 10-year follow-up","volume":"100","author":"Aroda","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00331-9_bib5","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.3945\/ajcn.113.058099","article-title":"Insulin resistance and inflammation predict kinetic body weight changes in response to dietary weight loss and maintenance in overweight and obese subjects by using a Bayesian network approach","volume":"98","author":"Kong","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00331-9_bib6","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/ijo.2013.54","article-title":"FTO predicts weight regain in the Look AHEAD clinical trial","volume":"37","author":"McCaffery","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(15)00331-9_bib7","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3945\/ajcn.111.012369","article-title":"Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans","volume":"94","author":"Sevastianova","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00331-9_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/M13-1725","article-title":"Prevention of diabetes with Mediterranean diets: a subgroup analysis of a randomized trial","volume":"160","author":"Salas-Salvado","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(15)00331-9_bib9","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ejcn.2013.177","article-title":"Relation of the Mediterranean diet with the incidence of gestational diabetes","volume":"68","author":"Karamanos","year":"2014","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(15)00331-9_bib10","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1111\/dme.12500","article-title":"Long-term changes in dietary and food intake behaviour in the Diabetes Prevention Program Outcomes Study","volume":"31","author":"Jaacks","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00331-9_bib11","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","article-title":"Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study","volume":"379","author":"Perreault","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00331-9_bib12","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1016\/j.jand.2013.07.003","article-title":"Predictors of sustained reduction in energy and fat intake in the Diabetes Prevention Program Outcomes Study intensive lifestyle intervention","volume":"113","author":"Davis","year":"2013","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/S2213-8587(15)00331-9_bib13","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1097\/AOG.0000000000000420","article-title":"A web-based lifestyle intervention for women with recent gestational diabetes mellitus: a randomized controlled trial","volume":"124","author":"Nicklas","year":"2014","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(15)00331-9_bib14","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S2213-8587(13)70067-6","article-title":"Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial","volume":"1","author":"Ramachandran","year":"2013","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003319?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003319?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T12:26:53Z","timestamp":1537360013000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003319"}},"issued":{"date-parts":[[2015,11]]},"references-count":14,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S2213858715003319"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00331-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,11]]}},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:48:10Z","timestamp":1767149290425,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(22)00191-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/s2213-8587(22)00222-4","type":"journal-article","created":{"date-parts":[[2022,8,23]],"date-time":"2022-08-23T18:42:34Z","timestamp":1661280154000},"page":"e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2022; 10: 612\u201313"],"prefix":"10.1016","volume":"10","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:54Z","timestamp":1761991914000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722002224"}},"issued":{"date-parts":[[2022,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2213858722002224"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00222-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2022; 10: 612\u201313","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00222-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00191-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:19:15Z","timestamp":1767151155938,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(20)30303-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/s2213-8587(20)30378-8","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T21:49:33Z","timestamp":1605736173000},"page":"e7","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2020; 8: 939\u201348"],"prefix":"10.1016","volume":"8","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303788?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303788?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:10Z","timestamp":1761991750000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303788"}},"issued":{"date-parts":[[2020,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2213858720303788"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30378-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2020; 8: 939\u201348","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30378-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30303-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:43Z","timestamp":1761991903891,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/s2213-8587(19)30427-9","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T20:58:19Z","timestamp":1578430699000},"page":"90-92","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["REWIND to fast forward: time to revisit stroke prevention in type 2 diabetes?"],"prefix":"10.1016","volume":"8","author":[{"given":"Vanita","family":"Aroda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30427-9_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30423-1","article-title":"The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial","author":"Gerstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30427-9_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30427-9_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(17)30412-6","article-title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"Bethel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30427-9_bib4","article-title":"Glucagon-like peptide-1 receptor agonists and prevention of stroke systematic review of cardiovascular outcome trials with meta-analysis","author":"Bellastella","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(19)30427-9_bib5","article-title":"2019 update to: management of hyperglycaemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","author":"Buse","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30427-9_bib6","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30427-9_bib7","doi-asserted-by":"crossref","first-page":"1165","DOI":"10.1007\/s40618-019-01047-0","article-title":"Cardiovascular outcome trials and major cardiovascular events: does glucose matter? A systematic review with meta-analysis","volume":"42","author":"Giugliano","year":"2019","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(19)30427-9_bib8","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/bcpt.12974","article-title":"Neuroprotective mechanisms of glucagon-like peptide-1-based therapies in ischaemic stroke: a systematic review based on pre-clinical studies","volume":"122","author":"Marlet","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/S2213-8587(19)30427-9_bib9","doi-asserted-by":"crossref","DOI":"10.1007\/s10557-019-06915-8","article-title":"Neuroprotection in rats following ischaemia-reperfusion injury by GLP-1 analogues-liraglutide and semaglutide","author":"Basalay","year":"2019","journal-title":"Cardiovasc Drugs Ther"},{"year":"1910","series-title":"Harvard Classics: Sacred Writings 1","author":"Eliot","key":"10.1016\/S2213-8587(19)30427-9_bib10"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:20Z","timestamp":1761991640000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719304279"}},"issued":{"date-parts":[[2020,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2213858719304279"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30427-9","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"REWIND to fast forward: time to revisit stroke prevention in type 2 diabetes?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30427-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30423-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T06:01:41Z","timestamp":1759384901237},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/s2213-8587(14)70100-7","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T11:35:05Z","timestamp":1399289705000},"page":"364-365","source":"Crossref","is-referenced-by-count":9,"title":["The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes \u2013 Authors' reply"],"prefix":"10.1016","volume":"2","author":[{"given":"Mark J","family":"Bolland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Grey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Greg D","family":"Gamble","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian R","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70100-7_bib1","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1001\/archinte.168.15.1629","article-title":"25-hydroxyvitamin D levels and the risk of mortality in the general population","volume":"168","author":"Melamed","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(14)70100-7_bib2","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3945\/ajcn.2010.29749","article-title":"Plasma vitamin D and mortality in older men: a community-based prospective cohort study","volume":"92","author":"Michaelsson","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70100-7_bib3","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S2213-8587(13)70165-7","article-title":"Vitamin D status and ill health: a systematic review","volume":"2","author":"Autier","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70100-7_bib4","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","article-title":"Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial","volume":"303","author":"Sanders","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70100-7_bib5","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2011.1960","article-title":"Reversals of established medical practices: evidence to abandon ship","volume":"307","author":"Prasad","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70100-7_bib6","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.cct.2011.09.009","article-title":"The VITamin D and OmegA-3 TriaL (VITAL): rationale and design of a large randomized controlled trial of vitamin D and marine omega-3 fatty acid supplements for the primary prevention of cancer and cardiovascular disease","volume":"33","author":"Manson","year":"2012","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/S2213-8587(14)70100-7_bib7","doi-asserted-by":"crossref","DOI":"10.1002\/jbmr.2235","article-title":"Benefits of calcium supplements are too small for clinical equipoise to exist","author":"Bolland","year":"2014","journal-title":"J Bone Miner Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701007?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701007?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T06:23:01Z","timestamp":1538634181000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701007"}},"issued":{"date-parts":[[2014,5]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S2213858714701007"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70100-7","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2014,5]]}},{"indexed":{"date-parts":[[2026,1,14]],"date-time":"2026-01-14T19:26:32Z","timestamp":1768418792491,"version":"3.49.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,4,1]],"date-time":"2024-04-01T00:00:00Z","timestamp":1711929600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,4]]},"DOI":"10.1016\/s2213-8587(24)00070-6","type":"journal-article","created":{"date-parts":[[2024,3,4]],"date-time":"2024-03-04T23:30:44Z","timestamp":1709595044000},"page":"231-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Bariatric tourism"],"prefix":"10.1016","volume":"12","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000706?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000706?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:46:02Z","timestamp":1715039162000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000706"}},"issued":{"date-parts":[[2024,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2024,4]]}},"alternative-id":["S2213858724000706"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00070-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bariatric tourism","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00070-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:47:38Z","timestamp":1766162858838,"version":"3.48.0"},"reference-count":2,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/s2213-8587(24)00037-8","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T18:28:55Z","timestamp":1708453735000},"page":"158-159","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Milestone achievement for global access to blood glucose meters and test strips"],"prefix":"10.1016","volume":"12","author":[{"given":"Emma","family":"Klatman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beatrice","family":"Vetter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cathy","family":"Haldane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Graham","family":"Ogle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00037-8_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2019.107859","article-title":"Documenting and visualising progress towards universal health coverage of insulin and blood glucose test strips for people with diabetes","volume":"157","author":"Klatman","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(24)00037-8_bib4","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(23)00001-6","article-title":"Improving health outcomes of people with diabetes mellitus: global target setting to reduce the burden of diabetes mellitus by 2030","volume":"401","author":"Gregg","year":"2023","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000378?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000378?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:42:46Z","timestamp":1766162566000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000378"}},"issued":{"date-parts":[[2024,3]]},"references-count":2,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2213858724000378"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00037-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Milestone achievement for global access to blood glucose meters and test strips","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00037-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T04:17:28Z","timestamp":1773289048898,"version":"3.50.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/s2213-8587(19)30417-6","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T18:29:28Z","timestamp":1582050568000},"page":"186-187","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":22,"title":["Health-care professional opinions of DIY artificial pancreas systems in the UK"],"prefix":"10.1016","volume":"8","author":[{"given":"Thomas S J","family":"Crabtree","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pratik","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Hammond","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alistair","family":"Lumb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alasdair","family":"McLay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma G","family":"Wilmot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30417-6_bib2","doi-asserted-by":"crossref","DOI":"10.1177\/1932296816665635","article-title":"Real-world use of open source artificial pancreas systems","volume":"10","author":"Lewis","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(19)30417-6_bib3","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1932296818795705","article-title":"Twitter analysis of #OpenAPS DIY artificial pancreas technology use suggests improved A1C and quality of life","volume":"13","author":"Litchman","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(19)30417-6_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/pdi.2216","article-title":"DIY artificial pancreas systems: here to stay?","volume":"36","author":"Crabtree","year":"2019","journal-title":"Pract Diabetes"},{"key":"10.1016\/S2213-8587(19)30417-6_bib5","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S2213-8587(19)30416-4","article-title":"DIY artificial pancreas systems: the clinician perspective","volume":"8","author":"Wilmot","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30417-6_bib6","author":"Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304176?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304176?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:43Z","timestamp":1761991663000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719304176"}},"issued":{"date-parts":[[2020,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2213858719304176"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30417-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health-care professional opinions of DIY artificial pancreas systems in the UK","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30417-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30416-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,13]],"date-time":"2026-07-13T22:59:35Z","timestamp":1783983575844,"version":"3.55.0"},"reference-count":16,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/s2213-8587(16)30154-1","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:01:29Z","timestamp":1469664089000},"page":"805-807","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Splitting atoms: the Endocrine Society guideline for the management of primary aldosteronism"],"prefix":"10.1016","volume":"4","author":[{"given":"Morris J","family":"Brown","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30154-1_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.7326\/0003-4819-44-1-1","article-title":"Primary aldosteronism, a new clinical entity","volume":"44","author":"Conn","year":"1956","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)30154-1_bib2","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30154-1_bib3","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1001\/jama.1966.03100010077019","article-title":"Normokalemic primary aldosteronism. Its masquerade as primary aldosteronism","volume":"195","author":"Conn","year":"1966","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30154-1_bib4","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30154-1_bib5","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1161\/01.HYP.0000040261.30455.B6","article-title":"Hyperaldosteronism among black and white subjects with resistant hypertension","volume":"40","author":"Calhoun","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(16)30154-1_bib7","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30154-1_bib8","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double-blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30154-1_bib9","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1126\/science.1198785","article-title":"K+ channel mutations in adrenal aldosterone-producing adenomas and hereditary hypertension","volume":"331","author":"Choi","year":"2011","journal-title":"Science"},{"key":"10.1016\/S2213-8587(16)30154-1_bib10","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(16)30154-1_bib11","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.mce.2013.11.022","article-title":"Development of monoclonal antibodies against human CYP11B1 and CYP11B2","volume":"383","author":"Gomez-Sanchez","year":"2014","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(16)30154-1_bib12","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","article-title":"Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas","volume":"411","author":"Monticone","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(16)30154-1_bib13","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/ERC-15-0321","article-title":"Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas","volume":"22","author":"Akerstrom","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(16)30154-1_bib14","doi-asserted-by":"crossref","first-page":"1393","DOI":"10.1056\/NEJMoa1402670","article-title":"A controlled trial of renal denervation for resistant hypertension","volume":"370","author":"Bhatt","year":"2014","journal-title":"N Engl J Med"},{"issue":"5 pt 1","key":"10.1016\/S2213-8587(16)30154-1_bib15","first-page":"e566","article-title":"Role of Ca2+ in response of aldosterone to stimulation by angiotensin II in vivo","volume":"254","author":"Johnson","year":"1988","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(16)30154-1_bib16","doi-asserted-by":"crossref","first-page":"e1341","DOI":"10.1210\/jc.2013-4255","article-title":"Adrenal nodularity and somatic mutations in primary aldosteronism: one node is the culprit?","volume":"99","author":"Dekkers","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30154-1_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)30100-0","article-title":"Adrenal vein sampling versus CT scan to determine treatment in primary aldosteronism: an outcome-based randomised diagnostic trial","author":"Dekkers","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:11:53Z","timestamp":1781583113000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301541"}},"issued":{"date-parts":[[2016,10]]},"references-count":16,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2213858716301541"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30154-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Splitting atoms: the Endocrine Society guideline for the management of primary aldosteronism","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30154-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T02:37:28Z","timestamp":1783478248031,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70027-5","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T22:18:12Z","timestamp":1371075492000},"page":"9-10","source":"Crossref","is-referenced-by-count":30,"title":["Intensive insulin for type 2 diabetes: the risk of causing harm"],"prefix":"10.1016","volume":"1","author":[{"given":"Christopher J","family":"Nolan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil B","family":"Ruderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Prentki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70027-5_bib1","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70027-5_bib2","doi-asserted-by":"crossref","first-page":"b4909","DOI":"10.1136\/bmj.b4909","article-title":"The association between symptomatic, severe hypoglycaemia and mortality in type 2 diabetes: retrospective epidemiological analysis of the ACCORD study","volume":"340","author":"Bonds","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70027-5_bib3","doi-asserted-by":"crossref","first-page":"983","DOI":"10.2337\/dc09-1278","article-title":"Epidemiologic relationships between A1C and all-cause mortality during a median 3\u00b74-year follow-up of glycemic treatment in the ACCORD trial","volume":"33","author":"Riddle","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70027-5_bib4","doi-asserted-by":"crossref","first-page":"E471","DOI":"10.1152\/ajpendo.00316.2005","article-title":"Increased malonyl-CoA and diacylglycerol content and reduced AMPK activity accompany insulin resistance induced by glucose infusion in muscle and liver of rats","volume":"290","author":"Kraegen","year":"2006","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70027-5_bib5","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(11)60614-4","article-title":"Type 2 diabetes across generations: from pathophysiology to prevention and management","volume":"378","author":"Nolan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70027-5_bib6","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.yjmcc.2010.09.014","article-title":"Too much or not enough of a good thing? Cardiac glucolipotoxicity versus lipoprotection","volume":"50","author":"Taegtmeyer","year":"2010","journal-title":"J Mol Cell Cardiol"},{"key":"10.1016\/S2213-8587(13)70027-5_bib7","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1161\/01.CIR.103.13.1734","article-title":"Effect of non-insulin-dependent diabetes mellitus on myocardial insulin responsiveness in patients with ischemic heart disease","volume":"103","author":"Jagasia","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70027-5_bib8","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70027-5_bib9","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s00125-011-2084-x","article-title":"Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study","volume":"54","author":"Mellbin","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70027-5_bib10","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/jc.2012-3042","article-title":"Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in Type 2 Diabetes","volume":"98","author":"Currie","year":"2013","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700275?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700275?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T05:53:19Z","timestamp":1539582799000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700275"}},"issued":{"date-parts":[[2013,9]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2213858713700275"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70027-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]}},{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T09:05:36Z","timestamp":1783760736783,"version":"3.55.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1135843"],"award-info":[{"award-number":["1135843"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/s2213-8587(20)30239-4","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T18:36:08Z","timestamp":1595356568000},"page":"693-702","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Associations between androgens and sexual function in premenopausal women: a cross-sectional study"],"prefix":"10.1016","volume":"8","author":[{"given":"Jia","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rakibul M","family":"Islam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A","family":"Skiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin J","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30239-4_bib1","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1001\/jama.1943.02840010019004","article-title":"Testosterone proprionate pellet implanation in gyneic disorders","volume":"121","author":"Greenblatt","year":"1943","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30239-4_bib2","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2213-8587(19)30189-5","article-title":"Safety and efficacy of testosterone therapy for women: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Islam","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30239-4_bib3","doi-asserted-by":"crossref","first-page":"5382","DOI":"10.1210\/jc.2019-01357","article-title":"Androgens during the reproductive years: what is normal for women?","volume":"104","author":"Skiba","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30239-4_bib4","doi-asserted-by":"crossref","first-page":"4542","DOI":"10.1210\/jc.2010-1314","article-title":"Toward excellence in testosterone testing: a consensus statement","volume":"95","author":"Rosner","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30239-4_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.rbmo.2018.10.006","article-title":"Steroid profiles by liquid chromatography-mass spectrometry of matched serum and single dominant ovarian follicular fluid from women undergoing IVF","volume":"38","author":"Walters","year":"2019","journal-title":"Reprod Biomed Online"},{"key":"10.1016\/S2213-8587(20)30239-4_bib6","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1192\/bjp.148.1.74","article-title":"Hormones, mood and sexuality in lactating women","volume":"148","author":"Alder","year":"1986","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S2213-8587(20)30239-4_bib7","first-page":"143","article-title":"The psychoendocrinology of female sexuality: a research project","volume":"10","author":"Appelt","year":"1986","journal-title":"German Journal Psychology"},{"key":"10.1016\/S2213-8587(20)30239-4_bib8","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1080\/00926230050084669","article-title":"Controlled studies on women presenting with sexual drive disorder: I. Endocrine status","volume":"26","author":"Riley","year":"2000","journal-title":"J Sex Marital Ther"},{"key":"10.1016\/S2213-8587(20)30239-4_bib9","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1001\/jama.294.1.91","article-title":"Circulating androgen levels and self-reported sexual function in women","volume":"294","author":"Davis","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30239-4_bib10","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1111\/jsm.12774","article-title":"Is there a correlation between androgens and sexual desire in women?","volume":"12","author":"W\u00e5hlin-Jacobsen","year":"2015","journal-title":"J Sex Med"},{"key":"10.1016\/S2213-8587(20)30239-4_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1080\/09513590.2016.1226793","article-title":"Sexual dysfunction in premenopausal women could be related to hormonal profile","volume":"33","author":"Vale","year":"2017","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/S2213-8587(20)30239-4_bib12","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.maturitas.2012.11.004","article-title":"Testosterone implants in women: pharmacological dosing for a physiologic effect","volume":"74","author":"Glaser","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(20)30239-4_bib13","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.maturitas.2010.12.001","article-title":"Beneficial effects of testosterone therapy in women measured by the validated Menopause Rating Scale (MRS)","volume":"68","author":"Glaser","year":"2011","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(20)30239-4_bib14","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1007\/s12020-018-1781-3","article-title":"Effects of dehydroepiandrosterone (DHEA) supplementation on sexual function in premenopausal infertile women","volume":"63","author":"Kushnir","year":"2019","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(20)30239-4_bib15","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/1753-6405.12868","article-title":"Challenges in recruitment to an epidemiological study of young Australian women: the Grollo-Ruzzene Foundation Young Women's Health Study","volume":"43","author":"Skiba","year":"2019","journal-title":"Aust N Z J Public Health"},{"key":"10.1016\/S2213-8587(20)30239-4_bib16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1097\/01.GME.0000109316.11228.77","article-title":"Profile of Female Sexual Function: a patient-based, international, psychometric instrument for the assessment of hypoactive sexual desire in oophorectomized women","volume":"11","author":"McHorney","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(20)30239-4_bib17","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/j.jclinepi.2014.12.014","article-title":"The number of subjects per variable required in linear regression analyses","volume":"68","author":"Austin","year":"2015","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(20)30239-4_bib18","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.fertnstert.2019.09.027","article-title":"The prevalence of sexual dysfunctions and sexually related distress in young women: a cross-sectional survey","volume":"113","author":"Zheng","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(20)30239-4_bib19","doi-asserted-by":"crossref","first-page":"3847","DOI":"10.1210\/jc.2005-0212","article-title":"Androgen levels in adult females: changes with age, menopause, and oophorectomy","volume":"90","author":"Davison","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30239-4_bib20","doi-asserted-by":"crossref","first-page":"1817","DOI":"10.1016\/S0140-6736(13)62366-1","article-title":"Sexual function in Britain: findings from the third National Survey of Sexual Attitudes and Lifestyles (Natsal-3)","volume":"382","author":"Mitchell","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30239-4_bib21","doi-asserted-by":"crossref","first-page":"C113","DOI":"10.1016\/0303-7207(91)90116-A","article-title":"Intracrinology","volume":"78","author":"Labrie","year":"1991","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(20)30239-4_bib22","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.mce.2017.08.016","article-title":"Intracrine androgen biosynthesis, metabolism and action revisited","volume":"465","author":"Schiffer","year":"2018","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(20)30239-4_bib23","doi-asserted-by":"crossref","first-page":"390","DOI":"10.1097\/01.GME.0000060256.03945.20","article-title":"Transdermal testosterone therapy improves well-being, mood, and sexual function in premenopausal women","volume":"10","author":"Goldstat","year":"2003","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(20)30239-4_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7326\/0003-4819-148-8-200804150-00001","article-title":"Safety and efficacy of a testosterone metered-dose transdermal spray for treatment of decreased sexual satisfaction in premenopausal women: a randomized trial","volume":"148","author":"Davis","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(20)30239-4_bib25","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/jsm.12426","article-title":"Testosterone improves antidepressant-emergent loss of libido in women: findings from a randomized, double-blind, placebo-controlled trial","volume":"11","author":"Fooladi","year":"2014","journal-title":"J Sex Med"},{"key":"10.1016\/S2213-8587(20)30239-4_bib26","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.maturitas.2009.12.017","article-title":"DHEA for postmenopausal women: a review of the evidence","volume":"66","author":"Panjari","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(20)30239-4_bib27","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1111\/j.1743-6109.2009.01381.x","article-title":"A randomized trial of oral DHEA treatment for sexual function, well-being, and menopausal symptoms in postmenopausal women with low libido","volume":"6","author":"Panjari","year":"2009","journal-title":"J Sex Med"},{"key":"10.1016\/S2213-8587(20)30239-4_bib28","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.1210\/jcem-69-5-1047","article-title":"Metabolic clearance rate (MCR) of dehydroepiandrosterone sulfate (DS), its metabolism to dehydroepiandrosterone, androstenedione, testosterone, and dihydrotestosterone, and the effect of increased plasma DS concentration on DS MCR in normal women","volume":"69","author":"Haning","year":"1989","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30239-4_bib29","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1210\/jcem-73-6-1210","article-title":"Metabolism of dehydroepiandrosterone sulfate (DS) in normal women and women with high DS concentrations","volume":"73","author":"Haning","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 4","key":"10.1016\/S2213-8587(20)30239-4_bib30","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/S0015-0282(02)02985-0","article-title":"Androgen production in women","volume":"77","author":"Burger","year":"2002","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(20)30239-4_bib31","doi-asserted-by":"crossref","first-page":"3676","DOI":"10.1210\/jc.2009-0672","article-title":"A systematic review and meta-analysis of randomized placebo-controlled trials of DHEA treatment effects on quality of life in women with adrenal insufficiency","volume":"94","author":"Alkatib","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30239-4_bib32","doi-asserted-by":"crossref","first-page":"3536","DOI":"10.1210\/jc.2014-2261","article-title":"Clinical review: the benefits and harms of systemic dehydroepiandrosterone (DHEA) in postmenopausal women with normal adrenal function: a systematic review and meta-analysis","volume":"99","author":"Elraiyah","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30239-4_bib33","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1530\/EJE-15-1181","article-title":"Adrenal-derived 11-oxygenated 19-carbon steroids are the dominant androgens in classic 21-hydroxylase deficiency","volume":"174","author":"Turcu","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30239-4_bib34","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/er.2017-00171","article-title":"Free testosterone: pumping up the tires or ending the free ride?","volume":"38","author":"Handelsman","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(20)30239-4_bib35","doi-asserted-by":"crossref","first-page":"3941","DOI":"10.3892\/mmr.2014.3117","article-title":"Association between serum levels and pentanucleotide polymorphism in the sex hormone binding globulin gene and cardiovascular risk factors in females with polycystic ovary syndrome","volume":"11","author":"Baldani","year":"2015","journal-title":"Mol Med Rep"},{"key":"10.1016\/S2213-8587(20)30239-4_bib36","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1002805","article-title":"A genome-wide association meta-analysis of circulating sex hormone-binding globulin reveals multiple Loci implicated in sex steroid hormone regulation","volume":"8","author":"Coviello","year":"2012","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(20)30239-4_bib37","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2265.2011.04301.x","article-title":"The contribution of SHBG to the variation in HOMA-IR is not dependent on endogenous oestrogen or androgen levels in postmenopausal women","volume":"77","author":"Davis","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30239-4_bib38","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1056\/NEJMoa0804381","article-title":"Sex hormone-binding globulin and risk of type 2 diabetes in women and men","volume":"361","author":"Ding","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30239-4_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.mayocp.2017.11.002","article-title":"The International Society for the Study of Women's Sexual Health process of care for management of hypoactive sexual desire disorder in women","volume":"93","author":"Clayton","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/S2213-8587(20)30239-4_bib40","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1210\/jc.2011-2134","article-title":"Age-specific reference ranges for serum testosterone and androstenedione concentrations in women measured by liquid chromatography-tandem mass spectrometry","volume":"97","author":"Haring","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:59Z","timestamp":1761991739000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720302394"}},"issued":{"date-parts":[[2020,8]]},"references-count":40,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2213858720302394"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30239-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between androgens and sexual function in premenopausal women: a cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30239-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,13]],"date-time":"2026-03-13T15:25:12Z","timestamp":1773415512719,"version":"3.50.1"},"reference-count":115,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/s2213-8587(13)70181-5","type":"journal-article","created":{"date-parts":[[2014,2,26]],"date-time":"2014-02-26T05:36:54Z","timestamp":1393393014000},"page":"63-74","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":37,"title":["Skeletal health in adults with HIV infection"],"prefix":"10.1016","volume":"3","author":[{"given":"Mark J","family":"Bolland","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Grey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian R","family":"Reid","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70181-5_bib1","doi-asserted-by":"crossref","first-page":"1497","DOI":"10.1001\/jama.280.17.1497","article-title":"Effectiveness of potent antiretroviral therapy on time to AIDS and death in men with known HIV infection duration","volume":"280","author":"Detels","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70181-5_bib2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1097\/00002030-199905070-00016","article-title":"Quality of life outcomes of combination zalcitabine-zidovudine, saquinavir-zidovudine, and saquinavir-zalcitabine-zidovudine therapy for HIV-infected adults with CD4 cell counts between 50 and 350 per cubic millimeter. PISCES (SV14604) Study Group","volume":"13","author":"Revicki","year":"1999","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib3","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1046\/j.1468-1293.2000.00033.x","article-title":"Changes in the uptake of antiretroviral therapy and survival in people with known duration of HIV infection in Europe: results from CASCADE","volume":"1","year":"2000","journal-title":"HIV Med"},{"key":"10.1016\/S2213-8587(13)70181-5_bib4","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1097\/QAD.0b013e32833a3946","article-title":"Life expectancy of recently diagnosed asymptomatic HIV-infected patients approaches that of uninfected individuals","volume":"24","author":"van Sighem","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib5","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1007\/BF01728893","article-title":"Alterations in bone turnover in HIV-positive patients","volume":"21","author":"Hern\u00e1ndez Quero","year":"1993","journal-title":"Infection"},{"key":"10.1016\/S2213-8587(13)70181-5_bib6","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/8756-3282(94)00028-X","article-title":"Bone remodelling in human immunodeficiency virus-1-infected patients. A histomorphometric study","volume":"16","author":"Serrano","year":"1995","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(13)70181-5_bib7","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1007\/s002239900288","article-title":"Bone mineral density in patients with human immunodeficiency virus infection","volume":"61","author":"Paton","year":"1997","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(13)70181-5_bib8","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1053\/meta.2000.8609","article-title":"Changes in calciotropic hormones and biochemical markers of bone metabolism in patients with human immunodeficiency virus infection","volume":"49","author":"Teichmann","year":"2000","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(13)70181-5_bib9","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1053\/jinf.2002.1109","article-title":"Osteopenia in HIV-infected women prior to highly active antiretroviral therapy","volume":"46","author":"Teichmann","year":"2003","journal-title":"J Infect"},{"key":"10.1016\/S2213-8587(13)70181-5_bib10","doi-asserted-by":"crossref","first-page":"F63","DOI":"10.1097\/00002030-200003100-00005","article-title":"Accelerated bone mineral loss in HIV-infected patients receiving potent antiretroviral therapy","volume":"14","author":"Tebas","year":"2000","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib11","doi-asserted-by":"crossref","first-page":"2165","DOI":"10.1097\/QAD.0b013e32801022eb","article-title":"Antiretroviral therapy and the prevalence of osteopenia and osteoporosis: a meta-analytic review","volume":"20","author":"Brown","year":"2006","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib12","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2265.2006.02572.x","article-title":"Bone mineral density is not reduced in HIV-infected Caucasian men treated with highly active antiretroviral therapy","volume":"65","author":"Bolland","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(13)70181-5_bib13","doi-asserted-by":"crossref","first-page":"4522","DOI":"10.1210\/jc.2007-1660","article-title":"Low body weight mediates the relationship between HIV infection and low bone mineral density: a meta-analysis","volume":"92","author":"Bolland","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib14","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/2047-783X-14-2-59","article-title":"Bone mineral density in human immunodeficiency virus-1 infected men with hypogonadism prior to highly-active-antiretroviral-therapy (HAART)","volume":"14","author":"Teichmann","year":"2009","journal-title":"Eur J Med Res"},{"key":"10.1016\/S2213-8587(13)70181-5_bib15","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1210\/jc.2009-0708","article-title":"Low bone mass and high bone turnover in postmenopausal human immunodeficiency virus-infected women","volume":"95","author":"Yin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib16","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1097\/QAI.0b013e3181bf6471","article-title":"Short-term bone loss in HIV-infected premenopausal women","volume":"53","author":"Yin","year":"2010","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(13)70181-5_bib17","first-page":"460","article-title":"Evaluation of bone mineral density in Iranian HIV\/AIDS patients","volume":"49","author":"Badie","year":"2011","journal-title":"Acta Med Iran"},{"key":"10.1016\/S2213-8587(13)70181-5_bib18","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1093\/cid\/cis455","article-title":"Low bone mass in behaviorally HIV-infected young men on antiretroviral therapy: Adolescent Trials Network Study 021B","volume":"55","author":"Mulligan","year":"2012","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib19","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1111\/j.1365-2265.2012.04452.x","article-title":"The combination of FRAX and Ageing Male Symptoms scale better identifies treated HIV males at risk for major fracture","volume":"77","author":"Pepe","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(13)70181-5_bib20","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1093\/infdis\/jis687","article-title":"Low bone mineral density, regardless of HIV status, in men who have sex with men","volume":"207","author":"Grijsen","year":"2013","journal-title":"J Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib21","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1097\/00002030-200104130-00022","article-title":"Osteopenia in HIV-infected patients: is it the disease or is it the treatment?","volume":"15","author":"Knobel","year":"2001","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib23","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1359\/JBMR.0301246","article-title":"BMD is reduced in HIV-infected men irrespective of treatment","volume":"19","author":"Amiel","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70181-5_bib27","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1097\/QAD.0b013e3280148c05","article-title":"Decreased bone mineral density and increased fracture risk in aging men with or at risk for HIV infection","volume":"21","author":"Arnsten","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib28","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1007\/s00198-007-0428-7","article-title":"Fragility fractures and bone mineral density in HIV positive women: a case-control population-based study","volume":"18","author":"Prior","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(13)70181-5_bib29","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/S8756-3282(02)00864-5","article-title":"Relationships among body mass, its components, and bone","volume":"31","author":"Reid","year":"2002","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(13)70181-5_bib30","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1016\/j.jocd.2006.02.005","article-title":"Body mass index is not a good predictor of bone density: results from WHI, CHS, and EPIDOS","volume":"9","author":"Robbins","year":"2006","journal-title":"J Clin Densitom"},{"key":"10.1016\/S2213-8587(13)70181-5_bib31","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.jocd.2007.07.006","article-title":"Impact of HIV infection on total body composition in treatment-naive men evaluated by dual-energy X-ray absorptiometry comparison of 90 untreated HIV-infected men to 241 controls","volume":"10","author":"Delpierre","year":"2007","journal-title":"J Clin Densitom"},{"key":"10.1016\/S2213-8587(13)70181-5_bib32","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1097\/QAI.0b013e31804a7f4d","article-title":"Effects of weight, body composition, and testosterone on bone mineral density in HIV-infected women","volume":"45","author":"Dolan","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(13)70181-5_bib33","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1097\/QAI.0b013e31826cba6c","article-title":"Association of regional body composition with bone mineral density in HIV-infected and HIV-uninfected women: women's interagency HIV study","volume":"61","author":"Sharma","year":"2012","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(13)70181-5_bib34","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1097\/QAI.0b013e318295eb1d","article-title":"Body composition, soluble markers of inflammation, and bone mineral density in antiretroviral therapy-naive HIV-1-infected individuals","volume":"63","author":"Brown","year":"2013","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(13)70181-5_bib35","unstructured":"Mulligan K, Glidden DV, Gonzales P, et al. Effects of FTC\/TDF on bone mineral density in seronegative men from 4 continents: DEXA results of the global iPrEx study. 18th Conference of Retrovirus and Opportunistic Infections; Boston, MA, USA; Feb 27\u2013March 3, 2011. Abstract 94LB."},{"key":"10.1016\/S2213-8587(13)70181-5_bib36","doi-asserted-by":"crossref","first-page":"e23688","DOI":"10.1371\/journal.pone.0023688","article-title":"Bone mineral density in HIV-negative men participating in a tenofovir pre-exposure prophylaxis randomized clinical trial in San Francisco","volume":"6","author":"Liu","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70181-5_bib37","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1056\/NEJMoa1110711","article-title":"Antiretroviral preexposure prophylaxis for heterosexual HIV transmission in Botswana","volume":"367","author":"Thigpen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70181-5_bib38","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1097\/QAD.0b013e32833c93fe","article-title":"High prevalence of reduced bone mineral density in primary HIV-1-infected men","volume":"24","author":"Grijsen","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib39","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1097\/00126334-200307010-00001","article-title":"HIV infection\u2014a risk factor for osteoporosis","volume":"33","author":"Thomas","year":"2003","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(13)70181-5_bib40","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1097\/QAD.0b013e32832ce85a","article-title":"Metabolic bone disease in HIV infection","volume":"23","author":"Borderi","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib41","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1093\/cid\/cit056","article-title":"Physiologic frailty and fragility fracture in HIV-infected male veterans","volume":"56","author":"Womack","year":"2013","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib42","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1210\/jc.2011-0591","article-title":"Stable bone density in HAART-treated individuals with HIV: a meta-analysis","volume":"96","author":"Bolland","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib43","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1210\/jc.2006-0127","article-title":"Longitudinal analysis of bone density in human immunodeficiency virus-infected women","volume":"91","author":"Dolan","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib44","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1111\/j.1365-2265.2007.02875.x","article-title":"Bone mineral density remains stable in HAART-treated HIV-infected men over 2 years","volume":"67","author":"Bolland","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(13)70181-5_bib48","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1310\/hct0803-164","article-title":"The safety and efficacy of tenofovir DF in combination with lamivudine and efavirenz through 6 years in antiretroviral-na\u00efve HIV-1-infected patients","volume":"8","author":"Cassetti","year":"2007","journal-title":"HIV Clin Trials"},{"key":"10.1016\/S2213-8587(13)70181-5_bib49","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/j.1365-2265.2011.04274.x","article-title":"Stable bone mineral density over 6 years in HIV-infected men treated with highly active antiretroviral therapy (HAART)","volume":"76","author":"Bolland","year":"2012","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(13)70181-5_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1001\/jama.292.2.191","article-title":"Efficacy and safety of tenofovir DF vs stavudine in combination therapy in antiretroviral-naive patients: a 3-year randomized trial","volume":"292","author":"Gallant","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70181-5_bib51","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1097\/QAI.0b013e3181adce44","article-title":"Loss of bone mineral density after antiretroviral therapy initiation, independent of antiretroviral regimen","volume":"51","author":"Brown","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(13)70181-5_bib52","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1097\/QAD.0b013e32832c4947","article-title":"First line zidovudine\/lamivudine\/lopinavir\/ritonavir leads to greater bone loss compared to nevirapine\/lopinavir\/ritonavir","volume":"23","author":"van Vonderen","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib53","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1086\/656417","article-title":"Comparison of changes in bone density and turnover with abacavir-lamivudine versus tenofovir-emtricitabine in HIV-infected adults: 48-week results from the ASSERT study","volume":"51","author":"Stellbrink","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib54","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.bone.2011.01.015","article-title":"Prospective one-year bone loss in treatment-na\u00efve HIV+ men and women on single or multiple drug HIV therapies","volume":"48","author":"Briot","year":"2011","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(13)70181-5_bib55","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1111\/j.1468-1293.2010.00864.x","article-title":"Bone mineral density changes in protease inhibitor-sparing vs. nucleoside reverse transcriptase inhibitor-sparing highly active antiretroviral therapy: data from a randomized trial","volume":"12","author":"Hansen","year":"2011","journal-title":"HIV Med"},{"key":"10.1016\/S2213-8587(13)70181-5_bib56","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1093\/infdis\/jir188","volume":"203","author":"McComsey","year":"2011","journal-title":"J Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib57","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1097\/00002030-200404300-00011","article-title":"Reversibility of lipoatrophy in HIV-infected patients 2 years after switching from a thymidine analogue to abacavir: the MITOX Extension Study","volume":"18","author":"Martin","year":"2004","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib58","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1086\/380790","article-title":"Improvement in lipoatrophy associated with highly active antiretroviral therapy in human immunodeficiency virus-infected patients switched from stavudine to abacavir or zidovudine: the results of the TARHEEL study","volume":"38","author":"McComsey","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib59","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1097\/QAI.0b013e318042e204","article-title":"Switching to a protease inhibitor-containing, nucleoside-sparing regimen (lopinavir\/ritonavir plus efavirenz) increases limb fat but raises serum lipid levels: results of a prospective randomized trial (AIDS clinical trial group 5125s)","volume":"45","author":"Tebas","year":"2007","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(13)70181-5_bib60","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1086\/529384","article-title":"Effect of reducing the dose of stavudine on body composition, bone density, and markers of mitochondrial toxicity in HIV-infected subjects: a randomized, controlled study","volume":"46","author":"McComsey","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib61","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1097\/QAI.0b013e3181aa12d5","article-title":"A simplification trial switching from nucleoside reverse transcriptase inhibitors to once-daily fixed-dose abacavir\/lamivudine or tenofovir\/emtricitabine in HIV-1-infected patients with virological suppression","volume":"51","author":"Mart\u00ednez","year":"2009","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(13)70181-5_bib62","doi-asserted-by":"crossref","first-page":"1591","DOI":"10.1086\/644769","article-title":"Simplification of antiretroviral therapy with tenofovir-emtricitabine or abacavir-lamivudine: a randomized, 96-week trial","volume":"49","author":"Martin","year":"2009","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib63","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1097\/QAD.0b013e32834f3507","article-title":"Body composition changes after switching from protease inhibitors to raltegravir: SPIRAL-LIP substudy","volume":"26","author":"Curran","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib64","doi-asserted-by":"crossref","first-page":"347","DOI":"10.3851\/IMP1928","article-title":"Mitochondrial function, inflammation, fat and bone in HIV lipoatrophy: randomized study of uridine supplementation or switch to tenofovir","volume":"17","author":"McComsey","year":"2012","journal-title":"Antivir Ther"},{"key":"10.1016\/S2213-8587(13)70181-5_bib65","doi-asserted-by":"crossref","first-page":"1196","DOI":"10.1089\/aid.2011.0336","article-title":"A switch in therapy to a reverse transcriptase inhibitor sparing combination of lopinavir\/ritonavir and raltegravir in virologically suppressed HIV-infected patients: a pilot randomized trial to assess efficacy and safety profile: the KITE study","volume":"28","author":"Ofotokun","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/S2213-8587(13)70181-5_bib66","doi-asserted-by":"crossref","first-page":"e32445","DOI":"10.1371\/journal.pone.0032445","article-title":"Comparison of bone and renal effects in HIV-infected adults switching to abacavir or tenofovir based therapy in a randomized trial","volume":"7","author":"Rasmussen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70181-5_bib67","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1210\/jc.2012-3686","article-title":"Impact of switching from zidovudine to tenofovir disoproxil fumarate on bone mineral density and markers of bone metabolism in virologically suppressed HIV-1 infected patients; a substudy of the PREPARE study","volume":"98","author":"Cotter","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib68","doi-asserted-by":"crossref","DOI":"10.1111\/hiv.12011","article-title":"Impact of switching from zidovudine\/lamivudine to tenofovir\/emtricitabine on lipoatrophy: the RECOMB study","author":"Ribera","year":"2013","journal-title":"HIV Med"},{"key":"10.1016\/S2213-8587(13)70181-5_bib69","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJMc1210464","article-title":"Antiretroviral preexposure prophylaxis for HIV prevention","volume":"368","author":"Bolland","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70181-5_bib70","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1056\/NEJMc1210464","article-title":"Antiretroviral preexposure prophylaxis for HIV prevention","volume":"368","author":"Thigpen","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70181-5_bib71","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1359\/jbmr.2004.19.5.714","article-title":"Fanconi's syndrome in HIV+ adults: report of three cases and literature review","volume":"19","author":"Earle","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70181-5_bib72","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1097\/QAD.0b013e32832c1792","article-title":"Continuous antiretroviral therapy decreases bone mineral density","volume":"23","author":"Grund","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib73","first-page":"145","article-title":"Decreased bone formative and enhanced resorptive markers in human immunodeficiency virus infection: indication of normalization of the bone-remodeling process during highly active antiretroviral therapy","volume":"84","author":"Aukrust","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib74","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1002\/jbmr.1861","article-title":"Interruption or deferral of antiretroviral therapy reduces markers of bone turnover compared with continuous therapy: The SMART Body Composition substudy","volume":"28","author":"Hoy","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70181-5_bib75","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/1471-2334-12-38","article-title":"Prospective evaluation of bone markers, parathormone and 1,25-(OH)2 vitamin D in HIV-positive patients after the initiation of tenofovir\/emtricitabine with atazanavir\/ritonavir or efavirenz","volume":"12","author":"Foc\u00e0","year":"2012","journal-title":"BMC Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib76","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1086\/367569","article-title":"Longitudinal evolution of bone mineral density and bone markers in human immunodeficiency virus-infected individuals","volume":"36","author":"Mondy","year":"2003","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib77","doi-asserted-by":"crossref","first-page":"e38377","DOI":"10.1371\/journal.pone.0038377","article-title":"Changes in bone turnover and bone loss in HIV-infected patients changing treatment to tenofovir-emtricitabine or abacavir-lamivudine","volume":"7","author":"Haskelberg","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70181-5_bib78","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1086\/498511","article-title":"Bone disease and HIV infection","volume":"42","author":"Amorosa","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib79","doi-asserted-by":"crossref","first-page":"13848","DOI":"10.1073\/pnas.1003020107","article-title":"Alterations in the immuno-skeletal interface drive bone destruction in HIV-1 transgenic rats","volume":"107","author":"Vikulina","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(13)70181-5_bib80","doi-asserted-by":"crossref","first-page":"9271","DOI":"10.1073\/pnas.161290298","article-title":"An HIV-1 transgenic rat that develops HIV-related pathology and immunologic dysfunction","volume":"98","author":"Reid","year":"2001","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(13)70181-5_bib81","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1097\/QAD.0b013e32833f6294","article-title":"Fracture incidence in HIV-infected women: results from the Women's Interagency HIV Study","volume":"24","author":"Yin","year":"2010","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib82","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1097\/QAD.0b013e3283292195","article-title":"Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults","volume":"23","author":"Collin","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib83","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1093\/cid\/ciq242","article-title":"Increased rates of bone fracture among HIV-infected persons in the HIV Outpatient Study (HOPS) compared with the US general population, 2000\u20132006","volume":"52","author":"Young","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib84","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1097\/QAD.0b013e328359a8ca","article-title":"Fractures after antiretroviral initiation","volume":"26","author":"Yin","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib85","doi-asserted-by":"crossref","first-page":"3499","DOI":"10.1210\/jc.2008-0828","article-title":"Fracture prevalence among human immunodeficiency virus (HIV)-infected versus non-HIV-infected patients in a large U.S. healthcare system","volume":"93","author":"Triant","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib86","doi-asserted-by":"crossref","first-page":"e17217","DOI":"10.1371\/journal.pone.0017217","article-title":"Increased risk of fragility fractures among HIV infected compared to uninfected male veterans","volume":"6","author":"Womack","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70181-5_bib87","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1097\/QAD.0b013e32834ed8a7","article-title":"Incidence of low and high-energy fractures in persons with and without HIV infection: a Danish population-based cohort study","volume":"26","author":"Hansen","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib88","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1002\/hep.25866","article-title":"Risk of hip fracture associated with hepatitis C virus infection and hepatitis C\/human immunodeficiency virus coinfection","volume":"56","author":"Lo Re","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(13)70181-5_bib89","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1002\/jbmr.1874","article-title":"HIV infection is strongly associated with hip fracture risk, independently of age, gender and co-morbidities: a population-based cohort study","volume":"28","author":"Guerri-Fernandez","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70181-5_bib90","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1016\/0895-4356(95)00048-8","article-title":"Importance of events per independent variable in proportional hazards regression analysis. II. Accuracy and precision of regression estimates","volume":"48","author":"Peduzzi","year":"1995","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(13)70181-5_bib91","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1097\/QAD.0b013e32835192ae","article-title":"Osteoporotic fracture risk associated with cumulative exposure to tenofovir and other antiretroviral agents","volume":"26","author":"Bedimo","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib92","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1097\/QAI.0b013e31821ecf4c","article-title":"Low CD4 count is associated with an increased risk of fragility fracture in HIV-infected patients","volume":"57","author":"Yong","year":"2011","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(13)70181-5_bib93","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1097\/QAD.0b013e328351997f","article-title":"Overall benefit of antiretroviral treatment on the risk of fracture in HIV: nested case-control analysis in a health-insured population","volume":"26","author":"Mundy","year":"2012","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib94","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/BF02437839","article-title":"Biodemographic comparisons of homosexual and heterosexual men in the Kinsey Interview Data","volume":"25","author":"Blanchard","year":"1996","journal-title":"Arch Sex Behav"},{"key":"10.1016\/S2213-8587(13)70181-5_bib95","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1002\/(SICI)1098-108X(199609)20:2<135::AID-EAT3>3.0.CO;2-H","article-title":"The influence of sexual orientation on body dissatisfaction in adult men and women","volume":"20","author":"Beren","year":"1996","journal-title":"Int J Eat Disord"},{"key":"10.1016\/S2213-8587(13)70181-5_bib96","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/S0749-3797(01)00331-2","article-title":"Smoking among lesbians, gays, and bisexuals: a review of the literature","volume":"21","author":"Ryan","year":"2001","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(13)70181-5_bib97","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.drugalcdep.2007.12.004","article-title":"Drug use and other risk factors related to lower body mass index among HIV-infected individuals","volume":"95","author":"Quach","year":"2008","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/S2213-8587(13)70181-5_bib98","first-page":"200","article-title":"The relationship between bone turnover and body weight, serum insulin-like growth factor (IGF) I, and serum IGF-binding protein levels in patients with anorexia nervosa","volume":"85","author":"Hotta","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib99","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1210\/jc.2007-2325","article-title":"Circulating levels of inflammatory markers predict change in bone mineral density and resorption in older adults: a longitudinal study","volume":"93","author":"Ding","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib100","doi-asserted-by":"crossref","first-page":"544","DOI":"10.4158\/EP.9.6.544","article-title":"American Association of Clinical Endocrinologists medical guidelines for clinical practice for the prevention and treatment of postmenopausal osteoporosis: 2001 edition, with selected updates for 2003","volume":"9","author":"Hodgson","year":"2003","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(13)70181-5_bib101","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1210\/jc.2008-0926","article-title":"A revised clinician's guide to the prevention and treatment of osteoporosis","volume":"93","author":"Dawson-Hughes","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib102","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s00198-008-0712-1","article-title":"Case finding for the management of osteoporosis with FRAX\u2014assessment and intervention thresholds for the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(13)70181-5_bib103","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1007\/s00198-010-1445-5","article-title":"Construction and validation of a simplified fracture risk assessment tool for Canadian women and men: results from the CaMos and Manitoba cohorts","volume":"22","author":"Leslie","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(13)70181-5_bib104","doi-asserted-by":"crossref","first-page":"2135","DOI":"10.1007\/s00198-011-1823-7","article-title":"Differing perceptions of intervention thresholds for fracture risk: a survey of patients and doctors","volume":"23","author":"Douglas","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(13)70181-5_bib105","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1056\/NEJMoa1107142","article-title":"Bone-density testing interval and transition to osteoporosis in older women","volume":"366","author":"Gourlay","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70181-5_bib106","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1086\/656412","article-title":"Bone disease in HIV infection: a practical review and recommendations for HIV care providers","volume":"51","author":"McComsey","year":"2010","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib107","doi-asserted-by":"crossref","first-page":"2051","DOI":"10.1056\/NEJMp1202623","article-title":"Continuing bisphosphonate treatment for osteoporosis\u2014for whom and for how long?","volume":"366","author":"Black","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70181-5_bib108","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1310\/MD8V-5DLG-EN3T-BRHX","article-title":"Alendronate reduces bone resorption in HIV-associated osteopenia\/osteoporosis","volume":"5","author":"Guaraldi","year":"2004","journal-title":"HIV Clin Trials"},{"key":"10.1016\/S2213-8587(13)70181-5_bib109","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1097\/01.qai.0000145352.04440.1e","article-title":"Alendronate, vitamin D, and calcium for the treatment of osteopenia\/osteoporosis associated with HIV infection","volume":"38","author":"Mondy","year":"2005","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(13)70181-5_bib110","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1097\/QAD.0b013e3282ef961d","article-title":"Alendronate with calcium and vitamin D supplementation is safe and effective for the treatment of decreased bone mineral density in HIV","volume":"21","author":"McComsey","year":"2007","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib111","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1089\/aid.2011.0224","article-title":"Effect of alendronate on HIV-associated osteoporosis: a randomized, double-blind, placebo-controlled, 96-week trial (ANRS 120)","volume":"28","author":"Rozenberg","year":"2012","journal-title":"AIDS Res Hum Retroviruses"},{"key":"10.1016\/S2213-8587(13)70181-5_bib112","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1210\/jc.2006-2216","article-title":"Annual zoledronate increases bone density in highly active antiretroviral therapy-treated human immunodeficiency virus-infected men: a randomized controlled trial","volume":"92","author":"Bolland","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib113","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1097\/QAD.0b013e32831c8adc","article-title":"A double-blinded, randomized controlled trial of zoledronate therapy for HIV-associated osteopenia and osteoporosis","volume":"23","author":"Huang","year":"2009","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib114","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.1359\/jbmr.080312","article-title":"Effects of intravenous zoledronate on bone turnover and BMD persist for at least 24 months","volume":"23","author":"Bolland","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70181-5_bib115","doi-asserted-by":"crossref","first-page":"1922","DOI":"10.1210\/jc.2012-1424","article-title":"Effects of intravenous zoledronate on bone turnover and bone density persist for at least five years in HIV-infected men","volume":"97","author":"Bolland","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib22","doi-asserted-by":"crossref","first-page":"1917","DOI":"10.1097\/00002030-200309050-00010","article-title":"Decreased bone mineral density in HIV-infected patients is independent of antiretroviral therapy","volume":"17","author":"Bruera","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(13)70181-5_bib24","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1210\/jc.2003-031506","article-title":"Reduced bone mineral density in human immunodeficiency virus-infected patients and its association with increased central adiposity and postload hyperglycemia","volume":"89","author":"Brown","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70181-5_bib25","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1385\/JCD:8:3:287","article-title":"Total body composition by DXA of 241 HIV-negative men and 162 HIV-infected men: proposal of reference values for defining lipodystrophy","volume":"8","author":"Bonnet","year":"2005","journal-title":"J Clin Densitom"},{"key":"10.1016\/S2213-8587(13)70181-5_bib26","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1086\/501015","article-title":"HIV infection and bone mineral density in middle-aged women","volume":"42","author":"Arnsten","year":"2006","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(13)70181-5_bib45","unstructured":"Sharma A, Cohen H, Freeman R, Santoro N, Schoenbaum E. Prospective evaluation of bone mineral density among middle-aged HIV-infected and -uninfected women. 16th Conference on Retroviruses and Opportunistic Infections; Montr\u00e9al, Canada; Feb 8\u201311, 2009. Abstr 757."},{"key":"10.1016\/S2213-8587(13)70181-5_bib46","first-page":"S362","article-title":"Determinants of bone loss in HIV+ postmenopausal women","volume":"24","author":"Yin","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(13)70181-5_bib47","doi-asserted-by":"crossref","first-page":"2337","DOI":"10.1097\/QAD.0b013e32833d7da7","article-title":"Prospective study of bone mineral density changes in aging men with or at risk for HIV infection","volume":"24","author":"Sharma","year":"2010","journal-title":"AIDS"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701815?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701815?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,27]],"date-time":"2022-03-27T19:15:35Z","timestamp":1648408535000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701815"}},"issued":{"date-parts":[[2015,1]]},"references-count":115,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S2213858713701815"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70181-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal health in adults with HIV infection","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70181-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,17]],"date-time":"2026-06-17T14:22:30Z","timestamp":1781706150762,"version":"3.54.5"},"reference-count":9,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/s2213-8587(18)30348-6","type":"journal-article","created":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T06:29:45Z","timestamp":1548570585000},"page":"85-86","source":"Crossref","is-referenced-by-count":21,"title":["Vitamin D supplementation and musculoskeletal health"],"prefix":"10.1016","volume":"7","author":[{"given":"Roger","family":"Bouillon","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Lips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Bilezikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30348-6_bib1","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(18)30265-1","article-title":"Effects of vitamin D supplementation on musculoskeletal health: a systematic review, meta-analysis, and trial sequential analysis","volume":"6","author":"Bolland","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30348-6_bib2","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1001\/jama.2014.5559","article-title":"How to read a systematic review and meta-analysis and apply the results to patient care: users' guides to the medical literature","volume":"312","author":"Murad","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30348-6_bib3","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1210\/jc.2006-1404","article-title":"Need for additional calcium to reduce the risk of hip fracture with vitamin d supplementation: evidence from a comparative metaanalysis of randomized controlled trials","volume":"92","author":"Boonen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30348-6_bib4","article-title":"Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men","volume":"4","author":"Avenell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(18)30348-6_bib5","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S2213-8587(13)70212-2","article-title":"The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis","volume":"2","author":"Bolland","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30348-6_bib6","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1038\/nrendo.2017.31","article-title":"Comparative analysis of nutritional guidelines for vitamin D","volume":"13","author":"Bouillon","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(18)30348-6_bib7","doi-asserted-by":"crossref","first-page":"i6583","DOI":"10.1136\/bmj.i6583","article-title":"Vitamin D supplementation to prevent acute respiratory tract infections: systematic review and meta-analysis of individual participant data","volume":"356","author":"Martineau","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30348-6_bib8","doi-asserted-by":"crossref","first-page":"12","DOI":"10.3390\/nu9121353","article-title":"Effect of monthly, high-dose, long-term vitamin D on lung function: a randomised controlled trial","volume":"9","author":"Sluyter","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(18)30348-6_bib9","doi-asserted-by":"crossref","first-page":"g1903","DOI":"10.1136\/bmj.g1903","article-title":"Vitamin D and risk of cause specific death: systematic review and meta-analysis of observational cohort and randomised intervention studies","volume":"348","author":"Chowdhury","year":"2014","journal-title":"BMJ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,27]],"date-time":"2019-01-27T06:29:48Z","timestamp":1548570588000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303486"}},"issued":{"date-parts":[[2019,2]]},"references-count":9,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2213858718303486"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30348-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,2]]}},{"indexed":{"date-parts":[[2026,3,5]],"date-time":"2026-03-05T08:34:19Z","timestamp":1772699659025,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/s2213-8587(13)70110-4","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T20:46:45Z","timestamp":1379710005000},"page":"86-87","source":"Crossref","is-referenced-by-count":1,"title":["Molecular nutrition: the good, the bad, and the uncertain"],"prefix":"10.1016","volume":"1","author":[{"given":"Jeffrey I","family":"Mechanick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/S2213-8587(13)70110-4_bib1","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1007\/s11739-013-0918-x","article-title":"Molecular and transcultural nutrition","volume":"8","author":"Mechanick","year":"2013","journal-title":"Intern Emerg Med"},{"key":"10.1016\/S2213-8587(13)70110-4_bib2","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1017\/S0007114509220836","article-title":"Cross-sectional association of dietary patterns with insulin-resistant phenotypes among adults without diabetes in the Framingham Offspring Study","volume":"102","author":"Liu","year":"2009","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(13)70110-4_bib3","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.phrs.2011.07.004","article-title":"Dietary phytochemicals and their potential effects on obesity: a review","volume":"64","author":"Gonzalez-Castejon","year":"2011","journal-title":"Pharmacol Res"},{"key":"10.1016\/S2213-8587(13)70110-4_bib4","doi-asserted-by":"crossref","first-page":"417","DOI":"10.4158\/EP.9.5.417","article-title":"American Association of Clinical Endocrinologists medical guidelines for the clinical use of dietary supplements and nutraceuticals","volume":"9","author":"Mechanick","year":"2003","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(13)70110-4_bib5","first-page":"713696","article-title":"Endocrine disrupting chemicals: associated disorders and mechanisms of action","volume":"2012","author":"De Coster","year":"2012","journal-title":"J Environm Publ Health"},{"key":"10.1016\/S2213-8587(13)70110-4_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.talanta.2012.07.078","article-title":"Analysis of synthetic endocrine-disrupting chemicals in food: a review","volume":"100","author":"Mezcua","year":"2012","journal-title":"Talanta"},{"key":"10.1016\/S2213-8587(13)70110-4_bib7","doi-asserted-by":"crossref","first-page":"3057","DOI":"10.1007\/s00216-012-5905-y","article-title":"Validation and application of reporter gene assays for the determination of estrogenic and androgenic endocrine disruptor activity in sport supplements","volume":"403","author":"Plotan","year":"2012","journal-title":"Anal Bioanal Chem"},{"key":"10.1016\/S2213-8587(13)70110-4_bib8","doi-asserted-by":"crossref","DOI":"10.1007\/s12672-013-0150-1","article-title":"Endocrine disrupting activities of the flavonoid nutraceuticals luteolin and quercetin","author":"Nordeen","year":"2013","journal-title":"Horm Canc"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701104?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701104?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T21:52:13Z","timestamp":1539381133000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701104"}},"issued":{"date-parts":[[2013,10]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S2213858713701104"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70110-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,10]]}},{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:10:41Z","timestamp":1778861441444,"version":"3.51.4"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/s2213-8587(26)00034-3","type":"journal-article","created":{"date-parts":[[2026,3,28]],"date-time":"2026-03-28T00:04:08Z","timestamp":1774656248000},"page":"371-373","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prevalence of early-stage type 1 diabetes in young adults: a population-based cohort study"],"prefix":"10.1016","volume":"14","author":[{"given":"Marie","family":"Standl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marlon","family":"Scholz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elisabeth","family":"Thiering","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Monika","family":"Gappa","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tamara","family":"Schikowski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Achenbach","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anette-G","family":"Ziegler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00034-3_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00034-3_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1001\/jama.2019.21565","article-title":"Yield of a public health screening of children for islet autoantibodies in Bavaria, Germany","volume":"323","author":"Ziegler","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00034-3_bib3","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.2337\/dc19-2003","article-title":"Cost and cost-effectiveness of large-scale screening for type 1 diabetes in Colorado","volume":"43","author":"McQueen","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00034-3_bib4","doi-asserted-by":"crossref","first-page":"994","DOI":"10.2337\/dc21-1752","article-title":"The incidence of adult-onset type 1 diabetes: a systematic review from 32 countries and regions","volume":"45","author":"Harding","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00034-3_bib5","doi-asserted-by":"crossref","first-page":"85","DOI":"10.5414\/ALX01455E","article-title":"GINIplus and LISAplus - Design and selected results of two German birth cohorts about natural course of atopic diseases and their determinants","volume":"1","author":"Heinrich","year":"2017","journal-title":"Allergol Select"},{"key":"10.1016\/S2213-8587(26)00034-3_bib6","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1089\/dia.2016.0199","article-title":"3 Screen ELISA for high-throughput detection of beta cell autoantibodies in capillary blood","volume":"18","author":"Ziegler","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(26)00034-3_bib7","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.metabol.2010.07.025","article-title":"Clinical and genetic characteristics of patients with autoimmune thyroid disease with anti-islet autoimmunity","volume":"60","author":"Moriguchi","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(26)00034-3_bib8","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2337\/dc24-2886","article-title":"Unfolding the mystery of autoimmunity: the environmental determinants of diabetes in the young (TEDDY) study","volume":"48","author":"Rewers","year":"2025","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000343?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000343?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:59Z","timestamp":1778858759000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000343"}},"issued":{"date-parts":[[2026,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2213858726000343"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00034-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prevalence of early-stage type 1 diabetes in young adults: a population-based cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00034-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,22]],"date-time":"2025-12-22T22:08:13Z","timestamp":1766441293020},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/s2213-8587(17)30070-0","type":"journal-article","created":{"date-parts":[[2017,3,22]],"date-time":"2017-03-22T00:39:45Z","timestamp":1490143185000},"page":"235","source":"Crossref","is-referenced-by-count":23,"title":["Sweet success: will sugar taxes improve health?"],"prefix":"10.1016","volume":"5","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300700?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300700?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T09:28:41Z","timestamp":1535966921000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300700"}},"issued":{"date-parts":[[2017,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S2213858717300700"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30070-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,4]]}},{"indexed":{"date-parts":[[2026,2,10]],"date-time":"2026-02-10T05:28:36Z","timestamp":1770701316748,"version":"3.49.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/s2213-8587(14)70025-7","type":"journal-article","created":{"date-parts":[[2014,3,2]],"date-time":"2014-03-02T22:31:15Z","timestamp":1393799475000},"page":"535-537","source":"Crossref","is-referenced-by-count":6,"title":["Diabetes in the United Arab Emirates: the need for valid datasets for health service planning"],"prefix":"10.1016","volume":"2","author":[{"given":"Sharon","family":"Brownie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lyndal","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Rossiter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew P","family":"Hills","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter","family":"Robb","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammed","family":"Hag-Ali","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70025-7_bib1","series-title":"IDF Diabetes Atlas","year":"2013"},{"key":"10.1016\/S2213-8587(14)70025-7_bib2","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/1744-8603-8-18","article-title":"A profile and approach to chronic disease in Abu Dhabi","volume":"8","author":"Hajat","year":"2012","journal-title":"Global Health"},{"key":"10.1016\/S2213-8587(14)70025-7_bib3","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ijo.2012.131","article-title":"The prevalence and potential determinants of obesity among school children and adolescents in Abu Dhabi, United Arab Emirates","volume":"37","author":"Al Junaibi","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(14)70025-7_bib4","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1038\/ejcn.2011.135","article-title":"Nutrition transition in the United Arab Emirates","volume":"65","author":"Ng","year":"2011","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70025-7_bib5","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1186\/1742-7622-6-6","article-title":"Seven mistakes and potential solutions in epidemiology, including a call for a World Council of Epidemiology and Causality","volume":"6","author":"Bhopal","year":"2009","journal-title":"Emerg Themes Epidemiol"},{"key":"10.1016\/S2213-8587(14)70025-7_bib6","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/1476-072X-5-61","article-title":"Health indicators and human development in the Arab region","volume":"5","author":"Boutayeb","year":"2006","journal-title":"Int J Health Geogr"},{"key":"10.1016\/S2213-8587(14)70025-7_bib7","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1007\/s00038-009-0065-3","article-title":"Commentary: mosaic Arab world, health and development","volume":"54","author":"Mandil","year":"2009","journal-title":"Int J Public Health"},{"key":"10.1016\/S2213-8587(14)70025-7_bib8","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1177\/1010539510390673","article-title":"Mortality trends and the epidemiological transition in Nauru","volume":"23","author":"Carter","year":"2011","journal-title":"Asia Pac J Public Health"},{"key":"10.1016\/S2213-8587(14)70025-7_bib9","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1742-7622-8-2","article-title":"Conceptualising population health: from mechanistic thinking to complexity science","volume":"8","author":"Jayasinghe","year":"2011","journal-title":"Emerg Themes Epidemiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700257?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700257?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T03:54:48Z","timestamp":1538798088000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700257"}},"issued":{"date-parts":[[2014,7]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S2213858714700257"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70025-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,7]]}},{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T16:00:42Z","timestamp":1792684842909,"version":"4.5.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/s2213-8587(16)30219-4","type":"journal-article","created":{"date-parts":[[2016,9,20]],"date-time":"2016-09-20T20:00:34Z","timestamp":1474401634000},"page":"815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Strengthening of information systems and research to tackle HIV and non-communicable diseases"],"prefix":"10.1016","volume":"4","author":[{"given":"Pratik","family":"Khanal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anu","family":"Khanal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30219-4_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-8587(16)30110-3","article-title":"HIV and NCDs: the need to build stronger health systems","volume":"4","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30219-4_bib2","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1016\/S0140-6736(10)61353-0","article-title":"Prevention and management of chronic disease: a litmus test for health-systems strengthening in low-income and middle-income countries","volume":"376","author":"Samb","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30219-4_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S2213-8587(16)00037-1","article-title":"Liberating data: the crucial weapon in the fight against NCDs","volume":"4","author":"Davies","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30219-4_bib4","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/S2213-8587(16)30054-7","article-title":"Liberating data to combat NCDs","volume":"4","author":"Mishra","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30219-4_bib5","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1186\/1472-6963-14-295","article-title":"Practicalities and challenges in re-orienting the health system in Zambia for treating chronic conditions","volume":"14","author":"Aantjes","year":"2014","journal-title":"BMC Health Serv Res"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)30219-4_bib6","doi-asserted-by":"crossref","first-page":"S8","DOI":"10.1097\/QAI.0000000000000253","article-title":"Observational research on NCDs in HIV-positive populations: conceptual and methodological considerations","volume":"67","author":"Petersen","year":"2014","journal-title":"J Acquir Immune Def Syndr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:13:04Z","timestamp":1781583184000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302194"}},"issued":{"date-parts":[[2016,10]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2213858716302194"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30219-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strengthening of information systems and research to tackle HIV and non-communicable diseases","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30219-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30110-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:14:32Z","timestamp":1793862872406,"version":"4.6.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/s2213-8587(22)00318-7","type":"journal-article","created":{"date-parts":[[2022,11,3]],"date-time":"2022-11-03T20:07:24Z","timestamp":1667506044000},"page":"845","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Social media and misinformation in diabetes and obesity"],"prefix":"10.1016","volume":"10","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:18Z","timestamp":1761991938000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003187"}},"issued":{"date-parts":[[2022,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2213858722003187"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00318-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Social media and misinformation in diabetes and obesity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00318-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:12:27Z","timestamp":1793873547208,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/s2213-8587(13)70021-4","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T01:46:34Z","timestamp":1382060794000},"page":"46-55","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":143,"title":["Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial"],"prefix":"10.1016","volume":"2","author":[{"given":"Wenying","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haoming","family":"Tian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiguang","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhe","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianping","family":"Weng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juming","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhaojun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70021-4_bib1","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"55","author":"Inzucchi","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70021-4_bib2","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70021-4_bib3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70021-4_bib4","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/j.diabres.2006.06.023","article-title":"Role of metformin in the initiation of pharmacotherapy for type 2 diabetes: an Asian-Pacific perspective","volume":"75","author":"Chan","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(13)70021-4_bib5","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70021-4_bib6","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"Prevalence of diabetes among men and women in China","volume":"362","author":"Yang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70021-4_bib7","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1002\/dmrr.1149","article-title":"Contribution of postprandial glucose to excess hyperglycaemia in Asian type 2 diabetic patients using continuous glucose monitoring","volume":"27","author":"Wang","year":"2011","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(13)70021-4_bib8","first-page":"131","article-title":"The preventive effect of acarbose and metformin on the IGT population from becoming diabetes mellitus: a 3-year multicentral prospective study","volume":"17","author":"Yang","year":"2001","journal-title":"Chin J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70021-4_bib9","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/S0002-9343(97)00252-0","article-title":"Efficacy of 24-week monotherapy with acarbose, metformin, or placebo in dietary-treated NIDDM patients: the Essen-II Study","volume":"103","author":"Hoffmann","year":"1997","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(13)70021-4_bib10","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1111\/j.1464-5491.2009.02748.x","article-title":"Investigation of the effect of oral metformin on dipeptidylpeptidase-4 (DPP-4) activity in type 2 diabetes","volume":"26","author":"Cuthbertson","year":"2009","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70021-4_bib11","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1007\/s00125-010-1986-3","article-title":"New aspects of an old drug: metformin as a glucagon-like peptide 1 (GLP-1) enhancer and sensitiser","volume":"54","author":"Cho","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70021-4_bib12","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00125-010-1937-z","article-title":"Metformin regulates the incretin receptor axis via a pathway dependent on peroxisome proliferator-activated receptor-\u03b1 in mice","volume":"54","author":"Maida","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70021-4_bib13","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/(SICI)1096-9136(199806)15:6<485::AID-DIA610>3.0.CO;2-Y","article-title":"Prolonged and enhanced secretion of glucagon-like peptide 1 (7-36 amide) after oral sucrose due to alpha-glucosidase inhibition (acarbose) in type 2 diabetic patients","volume":"15","author":"Seifarth","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70021-4_bib14","doi-asserted-by":"crossref","first-page":"G752","DOI":"10.1152\/ajpgi.2001.281.3.G752","article-title":"Inhibition of gastric emptying by acarbose is correlated with GLP-1 response and accompanied by CCK release","volume":"281","author":"En\u00e7","year":"2001","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.1016\/S2213-8587(13)70021-4_bib15","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1002\/(SICI)1096-9136(199802)15:2<120::AID-DIA529>3.0.CO;2-I","article-title":"Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect","volume":"15","author":"Ranganath","year":"1998","journal-title":"Diabet Med"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(13)70021-4_bib16","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1111\/j.1365-2362.1994.tb02252.x","article-title":"Intestinal effects of alpha-glucosidase inhibitors: absorption of nutrients and enterohormonal changes","volume":"24","author":"G\u00f6ke","year":"1994","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70021-4_bib17","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1159\/000201282","article-title":"Voglibose (AO-128) is an efficient alpha-glucosidase inhibitor and mobilizes the endogenous GLP-1 reserve","volume":"56","author":"G\u00f6ke","year":"1995","journal-title":"Digestion"},{"key":"10.1016\/S2213-8587(13)70021-4_bib18","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1046\/j.1463-1326.2002.00219.x","article-title":"The effects of miglitol on glucagon-like peptide-1 secretion and appetite sensations in obese type 2 diabetics","volume":"4","author":"Lee","year":"2002","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70021-4_bib19","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1463-1326.2011.01512.x","article-title":"Proportion of patients at HbA1c target 7% with eight classes of antidiabetic drugs in type 2 diabetes: systematic review of 218 randomized controlled trials with 78,945 patients","volume":"14","author":"Esposito","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70021-4_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003639.pub2","article-title":"Alpha-glucosidase inhibitors for type 2 diabetes mellitus","volume":"2","author":"Van de Laar","year":"2005","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(13)70021-4_bib21","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1111\/j.1464-5491.2008.02391.x","article-title":"Comparison of vildagliptin and acarbose monotherapy in patients with Type 2 diabetes: a 24-week, double-blind, randomized trial","volume":"25","author":"Pan","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70021-4_bib22","first-page":"386","article-title":"Comparison of vildagliptin and acarbose monotherapy in patients with type 2 diabetes: a 24-week, multi-center, double-blind, double dummy controlled, randomized trial","volume":"25","author":"Pan","year":"2009","journal-title":"Chin J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70021-4_bib23","doi-asserted-by":"crossref","first-page":"960","DOI":"10.2337\/diacare.22.6.960","article-title":"A randomized double-blind trial of acarbose in type 2 diabetes shows improved glycemic control over 3 years (U.K. Prospective Diabetes Study 44)","volume":"22","author":"Holman","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70021-4_bib24","unstructured":"Ministry of Health of The People's Republic of China. Dietary Guidelines for Chinese (2007)."},{"key":"10.1016\/S2213-8587(13)70021-4_bib25","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s11892-012-0252-0","article-title":"Transculturalization of a diabetes-specific nutrition algorithm: Asian application","volume":"12","author":"Su","year":"2012","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(13)70021-4_bib26","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1111\/j.1464-5491.2011.03371.x","article-title":"Diabetes UK evidence-based nutrition guidelines for the prevention and management of diabetes","volume":"28","author":"Dyson","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70021-4_bib27","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1079\/PHN2003592","article-title":"The joint WHO\/FAO expert consultation on diet, nutrition and the prevention of chronic diseases: process, product and policy implications","volume":"7","author":"Nishida","year":"2004","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(13)70021-4_bib28","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/j.1464-5491.2005.01451.x","article-title":"alpha-Glucosidase inhibition (acarbose) fails to enhance secretion of glucagon-like peptide 1 (7-36 amide) and to delay gastric emptying in type 2 diabetic patients","volume":"22","author":"H\u00fccking","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70021-4_bib29","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1016\/j.tem.2010.01.006","article-title":"Mechanisms facilitating weight loss and resolution of type 2 diabetes following bariatric surgery","volume":"21","author":"Karra","year":"2010","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70021-4_bib30","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1016\/S0026-0495(96)90020-7","article-title":"Effects of acarbose on fecal nutrients, colonic pH, and short-chain fatty acids and rectal proliferative indices","volume":"45","author":"Holt","year":"1996","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(13)70021-4_bib31","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1017\/S0007114500001239","article-title":"Acarbose raises serum butyrate in human subjects with impaired glucose tolerance","volume":"84","author":"Wolever","year":"2000","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(13)70021-4_bib32","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1079\/BJN20031063","article-title":"Starch digestion, large-bowel fermentation and intestinal mucosal cell proliferation in rats treated with the alpha-glucosidase inhibitor acarbose","volume":"91","author":"Dehghan-Kooshkghazi","year":"2004","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(13)70021-4_bib33","first-page":"557","article-title":"Influence of acarbose on blood glucose and breath hydrogen after carbohydrate load with sucrose or starch","volume":"59","author":"Koytchev","year":"2009","journal-title":"Arzneimittelforschung"},{"key":"10.1016\/S2213-8587(13)70021-4_bib34","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1007\/s00125-013-2991-0","article-title":"Molecular mechanism of action of metformin: old or new insights?","volume":"56","author":"Rena","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70021-4_bib35","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1177\/1479164112441524","article-title":"Alpha-glucosidase inhibitors 2012\u2014cardiovascular considerations and trial evaluation","volume":"9","author":"Standl","year":"2012","journal-title":"DiabVasc Dis Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700214?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700214?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T19:17:12Z","timestamp":1716059832000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700214"}},"issued":{"date-parts":[[2014,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S2213858713700214"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70021-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Acarbose compared with metformin as initial therapy in patients with newly diagnosed type 2 diabetes: an open-label, non-inferiority randomised trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70021-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70107-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:11:09Z","timestamp":1793761869371,"version":"4.6.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,12]],"date-time":"2021-05-12T00:00:00Z","timestamp":1620777600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UM1AI109565"],"award-info":[{"award-number":["UM1AI109565"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"Juvenile Diabetes Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014247","name":"Immune Tolerance Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["1UL1TR001108"],"award-info":[{"award-number":["1UL1TR001108"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["P30DK036836"],"award-info":[{"award-number":["P30DK036836"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1TR000004"],"award-info":[{"award-number":["UL1TR000004"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1TR001878"],"award-info":[{"award-number":["UL1TR001878"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000097","name":"National Center for Research Resources","doi-asserted-by":"publisher","award":["UL1TR002537"],"award-info":[{"award-number":["UL1TR002537"]}],"id":[{"id":"10.13039\/100000097","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/s2213-8587(21)00139-x","type":"journal-article","created":{"date-parts":[[2021,6,29]],"date-time":"2021-06-29T18:45:40Z","timestamp":1624992340000},"page":"502-514","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":130,"title":["Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial"],"prefix":"10.1016","volume":"9","author":[{"given":"Stephen E","family":"Gitelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian N","family":"Bundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ele","family":"Ferrannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Lori","family":"Blanchfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A","family":"DiMeglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric I","family":"Felner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L","family":"Gaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Alice","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra G","family":"Mirmira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinath","family":"Sanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Tsalikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M","family":"Wentworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M","family":"Willi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P","family":"Krischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A","family":"Bluestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mayalin","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Lori","family":"Blanchfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A","family":"Bluestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanne","family":"Buchanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian N","family":"Bundy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Cabbage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Coleman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"De La Vega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A","family":"DiMeglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmella","family":"Evans-Molina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric I","family":"Felner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ele","family":"Ferrannini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Ferrara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason L","family":"Gaglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E","family":"Gitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felicity","family":"Healy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurie","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Hildinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margaret","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nora","family":"Kayton Bryant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Kinderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Koshy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brianne","family":"Kost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey P","family":"Krischer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Krishfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olena","family":"Kucheruk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Lindsley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S Alice","family":"Long","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manasa","family":"Mantravadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Mari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shelley","family":"Mesfin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron","family":"Michels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary Ellen","family":"Migre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pantea","family":"Minnock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raghavendra G","family":"Mirmira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elham","family":"Mohammed-Nur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashvin","family":"Nursing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryan","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Olivos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Parker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Redl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Reed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brittany","family":"Resnick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinath","family":"Sanda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sayre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisavet","family":"Serti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Sims","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol","family":"Soppe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Szubowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Tansey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Terrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Tersey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Torok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Tsalikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John M","family":"Wentworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Wesch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Willi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Woerner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00139-X_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00139-X_bib2","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1089\/dia.2018.0384","article-title":"State of type 1 diabetes management and outcomes from the T1D Exchange in 2016\u20132018","volume":"21","author":"Foster","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(21)00139-X_bib3","doi-asserted-by":"crossref","first-page":"3766","DOI":"10.2337\/db13-0345","article-title":"Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders","volume":"62","author":"Herold","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00139-X_bib4","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00139-X_bib5","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.2337\/db19-0057","article-title":"Low-dose anti-thymocyte globulin preserves C-peptide, reduces HbA1c, and increases regulatory to conventional T-cell ratios in new-onset type 1 diabetes: two-year clinical trial data","volume":"68","author":"Haller","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00139-X_bib6","doi-asserted-by":"crossref","first-page":"3285","DOI":"10.1172\/JCI81722","article-title":"Alefacept provides sustained clinical and immunological effects in new-onset type 1 diabetes patients","volume":"125","author":"Rigby","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(21)00139-X_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","article-title":"Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial","volume":"378","author":"Orban","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00139-X_bib8","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1056\/NEJMoa2006136","article-title":"Golimumab and beta-cell function in youth with new-onset type 1 diabetes","volume":"383","author":"Quattrin","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00139-X_bib9","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1182\/blood-2004-08-3097","article-title":"The development of imatinib as a therapeutic agent for chronic myeloid leukemia","volume":"105","author":"Deininger","year":"2005","journal-title":"Blood"},{"key":"10.1016\/S2213-8587(21)00139-X_bib10","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1096\/fj.06-6910com","article-title":"Amelioration of diabetes by imatinib mesylate (Gleevec): role of \u03b2-cell NF-\u03baB activation and anti-apoptotic preconditioning","volume":"21","author":"H\u00e4gerkvist","year":"2007","journal-title":"FASEB J"},{"key":"10.1016\/S2213-8587(21)00139-X_bib11","doi-asserted-by":"crossref","first-page":"18895","DOI":"10.1073\/pnas.0810246105","article-title":"Tyrosine kinase inhibitors reverse type 1 diabetes in nonobese diabetic mice","volume":"105","author":"Louvet","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(21)00139-X_bib12","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.cmet.2017.03.018","article-title":"Targeting ABL-IRE1\u03b1 signaling spares ER-stressed pancreatic \u03b2 cells to reverse autoimmune diabetes","volume":"25","author":"Morita","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00139-X_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1042\/CS20070122","article-title":"Imatinib mesylate improves insulin sensitivity and glucose disposal rates in rats fed a high-fat diet","volume":"114","author":"H\u00e4gerkvist","year":"2008","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/S2213-8587(21)00139-X_bib14","doi-asserted-by":"crossref","first-page":"329","DOI":"10.2337\/db08-0080","article-title":"Imatinib mesylate reduces endoplasmic reticulum stress and induces remission of diabetes in db\/db mice","volume":"58","author":"Han","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00139-X_bib15","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1038\/nrrheum.2009.82","article-title":"Tyrosine kinases as targets for the treatment of rheumatoid arthritis","volume":"5","author":"D'Aura Swanson","year":"2009","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/S2213-8587(21)00139-X_bib16","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1016\/j.tem.2015.09.003","article-title":"Tyrosine kinase inhibitors and diabetes: a novel treatment paradigm?","volume":"26","author":"Fountas","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00139-X_bib17","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2174\/1872213X113079990021","article-title":"Imatinib mesylate: an innovation in treatment of autoimmune diseases","volume":"7","author":"Azizi","year":"2013","journal-title":"Recent Pat Inflamm Allergy Drug Discov"},{"key":"10.1016\/S2213-8587(21)00139-X_bib18","doi-asserted-by":"crossref","first-page":"3867","DOI":"10.2337\/db15-0430","article-title":"Elevations in circulating methylated and unmethylated preproinsulin DNA in new-onset type 1 diabetes","volume":"64","author":"Fisher","year":"2015","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00139-X_bib19","doi-asserted-by":"crossref","first-page":"S221","DOI":"10.2337\/diabetes.51.2007.S221","article-title":"Assessing insulin secretion by modeling in multiple-meal tests: role of potentiation","volume":"51","author":"Mari","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00139-X_bib20","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2337\/diacare.23.3.295","article-title":"Use of the oral glucose tolerance test to assess insulin release and insulin sensitivity","volume":"23","author":"Stumvoll","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00139-X_bib21","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.143","article-title":"A quantitative measure of treatment response in recent-onset type 1 diabetes","volume":"3","author":"Bundy","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/S2213-8587(21)00139-X_bib22","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1038\/nrclinonc.2016.41","article-title":"Immunological off-target effects of imatinib","volume":"13","author":"Zitvogel","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/S2213-8587(21)00139-X_bib23","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa086","article-title":"RIPK2 dictates insulin responses to tyrosine kinase inhibitors in obese male mice","volume":"161","author":"Duggan","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(21)00139-X_bib24","doi-asserted-by":"crossref","first-page":"679","DOI":"10.2337\/db09-1378","article-title":"Progression to diabetes in relatives of type 1 diabetic patients: mechanisms and mode of onset","volume":"59","author":"Ferrannini","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00139-X_bib25","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1007\/BF00586459","article-title":"Proinsulin and C-peptide at onset and during 12 months cyclosporin treatment of type 1 (insulin-dependent) diabetes mellitus","volume":"33","author":"Snorgaard","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00139-X_bib26","doi-asserted-by":"crossref","first-page":"2259","DOI":"10.1007\/s00125-018-4712-1","article-title":"Biomarkers of islet beta cell stress and death in type 1 diabetes","volume":"61","author":"Sims","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00139-X_bib27","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/j.beem.2013.11.003","article-title":"Regulation of glucose and lipid homeostasis by adiponectin: effects on hepatocytes, pancreatic \u03b2 cells and adipocytes","volume":"28","author":"Tao","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00139-X_bib28","doi-asserted-by":"crossref","first-page":"829","DOI":"10.2337\/db15-1382","article-title":"PPAR\u03b3 antagonist Gleevec improves insulin sensitivity and promotes the browning of white adipose tissue","volume":"65","author":"Choi","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00139-X_bib29","doi-asserted-by":"crossref","first-page":"3763","DOI":"10.1210\/jc.2010-0086","article-title":"Plasma adiponectin levels are markedly elevated in imatinib-treated chronic myeloid leukemia (CML) patients: a mechanism for improved insulin sensitivity in type 2 diabetic CML patients?","volume":"95","author":"Fitter","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00139-X_bib30","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1200\/JCO.2003.11.143","article-title":"Practical management of patients with chronic myeloid leukemia receiving imatinib","volume":"21","author":"Deininger","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(21)00139-X_bib31","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1089\/dia.2020.0305","article-title":"Comparing beta cell preservation across clinical trials in recent-onset type 1 diabetes","volume":"22","author":"Jacobsen","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(21)00139-X_bib32","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2337\/db11-1538","article-title":"Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite type 1 diabetes TrialNet data","volume":"61","author":"Greenbaum","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00139-X_bib33","doi-asserted-by":"crossref","first-page":"1836","DOI":"10.2337\/dc19-2288","article-title":"C-peptide levels in subjects followed longitudinally before and after type 1 diabetes diagnosis in TrialNet","volume":"43","author":"Bogun","year":"2020","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872100139X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872100139X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:52Z","timestamp":1761991792000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872100139X"}},"issued":{"date-parts":[[2021,8]]},"references-count":33,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S221385872100139X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00139-x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.740412722.793587361","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Imatinib therapy for patients with recent-onset type 1 diabetes: a multicentre, randomised, double-blind, placebo-controlled, phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00139-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00169-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T21:09:20Z","timestamp":1793394560812,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/s2213-8587(16)30281-9","type":"journal-article","created":{"date-parts":[[2016,11,2]],"date-time":"2016-11-02T00:01:11Z","timestamp":1478044871000},"page":"18-25","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":86,"title":["Infection and antibiotic use in infancy and risk of childhood obesity: a longitudinal birth cohort study"],"prefix":"10.1016","volume":"5","author":[{"given":"De-Kun","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeannette","family":"Ferber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxana","family":"Odouli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30281-9_bib1","doi-asserted-by":"crossref","first-page":"16498","DOI":"10.3748\/wjg.v20.i44.16498","article-title":"Mechanistic links between gut microbial community dynamics, microbial functions and metabolic health","volume":"20","author":"Ha","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/S2213-8587(16)30281-9_bib2","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1038\/pr.2015.51","article-title":"A possible link between early probiotic intervention and the risk of neuropsychiatric disorders later in childhood: a randomized trial","volume":"77","author":"Partty","year":"2015","journal-title":"Pediatr Res"},{"key":"10.1016\/S2213-8587(16)30281-9_bib3","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1097\/MOP.0000000000000234","article-title":"Influence of the human intestinal microbiome on obesity and metabolic dysfunction","volume":"26","author":"Tilg","year":"2015","journal-title":"Curr Opin Pediatr"},{"key":"10.1016\/S2213-8587(16)30281-9_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1007\/s00281-013-0399-z","article-title":"Gut microbiome and metabolic diseases","volume":"36","author":"Fukuda","year":"2014","journal-title":"Semin Immunopathol"},{"issue":"suppl 4","key":"10.1016\/S2213-8587(16)30281-9_bib5","doi-asserted-by":"crossref","first-page":"S164","DOI":"10.1542\/peds.2007-2329C","article-title":"Expert committee recommendations regarding the prevention, assessment, and treatment of child and adolescent overweight and obesity: summary report","volume":"120","author":"Barlow","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)30281-9_bib6","series-title":"Population-based approaches to childhood obesity prevention. 2012","year":"2012"},{"key":"10.1016\/S2213-8587(16)30281-9_bib7","series-title":"Accelerating progress in obesity prevention: solving the weight of the nation","year":"2012"},{"key":"10.1016\/S2213-8587(16)30281-9_bib8","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.cell.2014.05.052","article-title":"Altering the intestinal microbiota during a critical developmental window has lasting metabolic consequences","volume":"158","author":"Cox","year":"2014","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(16)30281-9_bib9","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/ijo.2011.27","article-title":"Childhood overweight after establishment of the gut microbiota: the role of delivery mode, pre-pregnancy weight and early administration of antibiotics","volume":"35","author":"Ajslev","year":"2011","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(16)30281-9_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/ijo.2012.132","article-title":"Infant antibiotic exposures and early-life body mass","volume":"37","author":"Trasande","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(16)30281-9_bib11","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1001\/jamapediatrics.2014.1539","article-title":"Association of antibiotics in infancy with early childhood obesity","volume":"168","author":"Bailey","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(16)30281-9_bib12","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1542\/peds.2014-3407","article-title":"Antibiotic exposure in infancy and risk of being overweight in the first 24 months of life","volume":"135","author":"Saari","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)30281-9_bib13","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1038\/ijo.2013.218","article-title":"Antibiotic treatment during infancy and increased body mass index in boys: an international cross-sectional study","volume":"38","author":"Murphy","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(16)30281-9_bib14","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1038\/ijo.2014.119","article-title":"Infant antibiotic exposure and the development of childhood overweight and central adiposity","volume":"38","author":"Azad","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(16)30281-9_bib15","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1001\/jama.2016.2395","article-title":"Antibiotic exposure during the first 6 months of life and weight gain during childhood","volume":"315","author":"Gerber","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30281-9_bib16","doi-asserted-by":"crossref","first-page":"109","DOI":"10.3389\/fped.2014.00109","article-title":"External influence of early childhood establishment of gut microbiota and subsequent health implications","volume":"2","author":"Munyaka","year":"2014","journal-title":"Front Pediatr"},{"key":"10.1016\/S2213-8587(16)30281-9_bib17","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1016\/S1473-3099(11)70274-2","article-title":"A framework for identification of infections that contribute to human obesity","volume":"11","author":"Dhurandhar","year":"2011","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S2213-8587(16)30281-9_bib18","doi-asserted-by":"crossref","first-page":"e1005572","DOI":"10.1371\/journal.ppat.1005572","article-title":"Influenza virus affects intestinal microbiota and secondary Salmonella infection in the gut through type I interferons","volume":"12","author":"Deriu","year":"2016","journal-title":"PLoS Pathog"},{"key":"10.1016\/S2213-8587(16)30281-9_bib19","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cytogfr.2016.03.002","article-title":"The emerging role of interferon regulatory factor 9 in the antiviral host response and beyond","volume":"29","author":"Suprunenko","year":"2016","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/S2213-8587(16)30281-9_bib20","doi-asserted-by":"crossref","first-page":"2397","DOI":"10.1084\/jem.20140625","article-title":"Respiratory influenza virus infection induces intestinal immune injury via microbiota-mediated Th17 cell-dependent inflammation","volume":"211","author":"Wang","year":"2014","journal-title":"J Exp Med"},{"key":"10.1016\/S2213-8587(16)30281-9_bib21","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1136\/gutjnl-2015-309990","article-title":"The gut microbiota and host health: a new clinical frontier","volume":"65","author":"Marchesi","year":"2016","journal-title":"Gut"},{"key":"10.1016\/S2213-8587(16)30281-9_bib22","doi-asserted-by":"crossref","first-page":"17737","DOI":"10.3748\/wjg.v20.i47.17737","article-title":"Intestinal microbiota and type 2 diabetes: from mechanism insights to therapeutic perspective","volume":"20","author":"Han","year":"2014","journal-title":"World J Gastroenterol"},{"key":"10.1016\/S2213-8587(16)30281-9_bib23","series-title":"Similarity of the adult Kaiser Permanente Membership in Northern California to the insured and general population in Northern California: statistics from the 2011\u201312 California Health Interview Survey","author":"Gordon","year":"2015"},{"key":"10.1016\/S2213-8587(16)30281-9_bib24","series-title":"A comparison of sociodemographic and health characteristics of the Kaiser Permanente Northern California membership derived from two data sources: the 2008 Member Health Survey and the 2007 California Health Interview Survey","author":"Gordon","year":"2012"},{"key":"10.1016\/S2213-8587(16)30281-9_bib26","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1093\/cid\/cit750","article-title":"Effectiveness of seasonal trivalent influenza vaccine for preventing influenza virus illness among pregnant women: a population-based case-control study during the 2010\u20132011 and 2011\u20132012 influenza seasons","volume":"58","author":"Thompson","year":"2014","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(16)30281-9_bib27","doi-asserted-by":"crossref","first-page":"202.e1","DOI":"10.1016\/j.ajog.2014.08.004","article-title":"Severity of influenza and noninfluenza acute respiratory illness among pregnant women, 2010\u20132012","volume":"212","author":"Sokolow","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(16)30281-9_bib28","doi-asserted-by":"crossref","first-page":"14771","DOI":"10.1038\/srep14771","article-title":"Influence of H7N9 virus infection and associated treatment on human gut microbiota","volume":"5","author":"Qin","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(16)30281-9_bib29","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1016\/j.cell.2013.10.034","article-title":"Temporal response of the human virome to immunosuppression and antiviral therapy","volume":"155","author":"De Vlaminck","year":"2013","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(16)30281-9_bib30","doi-asserted-by":"crossref","first-page":"3182","DOI":"10.1002\/eji.201344405","article-title":"The bacteriome\u2013mycobiome interaction and antifungal host defense","volume":"44","author":"Oever","year":"2014","journal-title":"Eur J Immunol"},{"key":"10.1016\/S2213-8587(16)30281-9_bib31","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1126\/science.1187703","article-title":"Exploitation of the intestinal microflora by the parasitic nematode Trichuris muris","volume":"328","author":"Hayes","year":"2010","journal-title":"Science"},{"key":"10.1016\/S2213-8587(16)30281-9_bib32","first-page":"1","article-title":"2000 CDC growth charts for the United States: methods and development","volume":"246","author":"Kuczmarski","year":"2002","journal-title":"Vital Health Stat"},{"key":"10.1016\/S2213-8587(16)30281-9_bib33","series-title":"Logistic regression","author":"Hosmer","year":"2000"},{"key":"10.1016\/S2213-8587(16)30281-9_bib34","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1111\/j.1742-7843.2006.pto_293.x","article-title":"Indications for propensity scores and review of their use in pharmacoepidemiology","volume":"98","author":"Glynn","year":"2006","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/S2213-8587(16)30281-9_bib35","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.jclinepi.2005.07.004","article-title":"A review of the application of propensity score methods yielded increasing use, advantages in specific settings, but not substantially different estimates compared with conventional multivariable methods","volume":"59","author":"Sturmer","year":"2006","journal-title":"J Clin Epidemiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T06:07:41Z","timestamp":1568527661000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302819"}},"issued":{"date-parts":[[2017,1]]},"references-count":34,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S2213858716302819"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30281-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Infection and antibiotic use in infancy and risk of childhood obesity: a longitudinal birth cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30281-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30314-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T18:46:23Z","timestamp":1793213183679,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/s2213-8587(14)70161-5","type":"journal-article","created":{"date-parts":[[2014,8,12]],"date-time":"2014-08-12T19:16:05Z","timestamp":1407870965000},"page":"867-874","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":271,"title":["Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985\u20132011: a modelling study"],"prefix":"10.1016","volume":"2","author":[{"given":"Edward W","family":"Gregg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaohui","family":"Zhuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling J","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann L","family":"Albright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K M Venkat","family":"Narayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore J","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70161-5_bib1","doi-asserted-by":"crossref","unstructured":"Narayan KM, Boyle JP, Thompson TJ, Sorensen SW, Williamson DF. Lifetime risk for diabetes mellitus in the United States. JAMA; 290: 1884\u201390.","DOI":"10.1001\/jama.290.14.1884"},{"key":"10.1016\/S2213-8587(14)70161-5_bib2","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00125-008-1150-5","article-title":"Lifetime risk and projected population prevalence of diabetes","volume":"51","author":"Magliano","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70161-5_bib4","first-page":"1","article-title":"Deaths: final data for 2010","volume":"61","author":"Murphy","year":"2013","journal-title":"Natl Vital Stat Rep"},{"key":"10.1016\/S2213-8587(14)70161-5_bib5","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2337\/dc11-1162","article-title":"Trends in death rates among US adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey","volume":"35","author":"Gregg","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70161-5_bib6","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1007\/s00125-006-0585-9","article-title":"Increasing prevalence of type 2 diabetes in a Scottish population: effect of increasing incidence or decreasing mortality?","volume":"50","author":"Evans","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70161-5_bib7","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(07)60361-4","article-title":"Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995\u20132005: a population-based study","volume":"369","author":"Lipscombe","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70161-5_bib8","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00125-013-3063-1","article-title":"Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study","volume":"56","author":"Lind","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70161-5_bib9","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2\u00b77 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70161-5_bib10","first-page":"1","article-title":"Design and estimation for the National Health Interview Survey, 1995\u20132004","volume":"130","author":"Botman","year":"2000","journal-title":"Vital Health Stat 2"},{"key":"10.1016\/S2213-8587(14)70161-5_bib12","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/jnci\/85.11.892","article-title":"The lifetime risk of developing breast cancer","volume":"85","author":"Feuer","year":"1993","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(14)70161-5_bib14","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.amepre.2005.12.009","article-title":"Changes in incidence of diabetes in US adults, 1997\u20132003","volume":"30","author":"Geiss","year":"2006","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(14)70161-5_bib15","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2337\/dc12-0669","article-title":"Projections of type 1 and type 2 diabetes burden in the US population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth","volume":"35","author":"Imperatore","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70161-5_bib16","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1093\/oxfordjournals.aje.a009903","article-title":"Standardized lifetime risk","volume":"149","author":"Sasieni","year":"1999","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(14)70161-5_bib17","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1001\/jama.2012.67929","article-title":"Association of an intensive lifestyle intervention with remission of type 2 diabetes","volume":"308","author":"Gregg","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70161-5_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1478-7954-8-29","article-title":"Projection of the year 2050 burden of diabetes in the US adult population: dynamic modeling of incidence, mortality, and prediabetes prevalence","volume":"8","author":"Boyle","year":"2010","journal-title":"Popul Health Metr"},{"key":"10.1016\/S2213-8587(14)70161-5_bib19","doi-asserted-by":"crossref","first-page":"1613","DOI":"10.1056\/NEJMsa1213829","article-title":"Achievement of goals in U.S. diabetes care, 1999\u20132010","volume":"368","author":"Ali","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70161-5_bib21","doi-asserted-by":"crossref","first-page":"149","DOI":"10.7326\/0003-4819-147-3-200708070-00167","article-title":"Mortality trends in men and women with diabetes, 1971 to 2000","volume":"147","author":"Gregg","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(14)70161-5_bib22","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1038\/oby.2003.179","article-title":"The sweetening of the world's diet","volume":"11","author":"Popkin","year":"2003","journal-title":"Obes Res"},{"key":"10.1016\/S2213-8587(14)70161-5_bib23","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the decrease in U.S. deaths from coronary disease, 1980\u20132000","volume":"356","author":"Ford","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70161-5_bib24","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.2337\/diacare.20.12.1859","article-title":"Comparison of diabetes diagnostic categories in the US population according to the 1997 American Diabetes Association and 1980\u20131985 World Health Organization diagnostic criteria","volume":"20","author":"Harris","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70161-5_bib25","doi-asserted-by":"crossref","first-page":"562","DOI":"10.2337\/dc09-1524","article-title":"Prevalence of diabetes and high risk for diabetes using A1C criteria in the U.S. population in 1988\u20132006","volume":"33","author":"Cowie","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70161-5_bib27","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1111\/j.1464-5491.2008.02541.x","article-title":"Prevalence and incidence of Type 2 diabetes and its complications 1996\u20132003\u2014estimates from a Swedish population-based study","volume":"25","author":"Ringborg","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(14)70161-5_bib28","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1007\/s00125-008-1156-z","article-title":"The Danish National Diabetes Register: trends in incidence, prevalence and mortality","volume":"51","author":"Carstensen","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70161-5_bib29","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"issue":"4 suppl 4","key":"10.1016\/S2213-8587(14)70161-5_bib30","doi-asserted-by":"crossref","first-page":"S346","DOI":"10.1016\/j.amepre.2012.12.009","article-title":"Preventing type 2 diabetes in communities across the US: the National Diabetes Prevention Program","volume":"44","author":"Albright","year":"2013","journal-title":"Am J Prev Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T20:53:48Z","timestamp":1538340828000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701615"}},"issued":{"date-parts":[[2014,11]]},"references-count":25,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S2213858714701615"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70161-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985\u20132011: a modelling study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70161-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70172-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T19:40:43Z","timestamp":1792784443971,"version":"4.5.0"},"reference-count":122,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"NIH","award":["R01CA187397; K05CA160724"],"award-info":[{"award-number":["R01CA187397; K05CA160724"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/s2213-8587(15)00038-8","type":"journal-article","created":{"date-parts":[[2015,4,11]],"date-time":"2015-04-11T20:30:12Z","timestamp":1428784212000},"page":"545-555","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":40,"title":["Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer"],"prefix":"10.1016","volume":"3","author":[{"given":"Emily S","family":"Tonorezos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa M","family":"Hudson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela B","family":"Edgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leontien C","family":"Kremer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles A","family":"Sklar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Hamish B","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin C","family":"Oeffinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00038-8_bib1","author":"Howlader"},{"key":"10.1016\/S2213-8587(15)00038-8_bib3","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1038\/sj.bjc.6604460","article-title":"Survival from cancer in teenagers and young adults in England, 1979\u20132003","volume":"99","author":"Birch","year":"2008","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib4","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/nrc3634","article-title":"Survivors of childhood and adolescent cancer: life-long risks and responsibilities","volume":"14","author":"Robison","year":"2014","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib5","doi-asserted-by":"crossref","first-page":"1778","DOI":"10.1016\/j.ejca.2007.04.015","article-title":"Long term survivors of childhood cancer: cure and care. The Erice statement","volume":"43","author":"Haupt","year":"2007","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib6","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2013.6296","article-title":"Clinical ascertainment of health outcomes among adults treated for childhood cancer","volume":"309","author":"Hudson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00038-8_bib7","doi-asserted-by":"crossref","first-page":"1572","DOI":"10.1056\/NEJMsa060185","article-title":"Chronic health conditions in adult survivors of childhood cancer","volume":"355","author":"Oeffinger","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00038-8_bib8","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1001\/jama.2011.747","article-title":"Long-term risks of subsequent primary neoplasms among survivors of childhood cancer","volume":"305","author":"Reulen","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00038-8_bib9","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1200\/JCO.2013.51.1055","article-title":"Aging and risk of severe, disabling, life-threatening, and fatal events in the childhood cancer survivor study","volume":"32","author":"Armstrong","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib10","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.1016\/S0140-6736(13)62564-7","article-title":"Hospital contacts for endocrine disorders in Adult Life after Childhood Cancer in Scandinavia (ALiCCS): a population-based cohort study","volume":"383","author":"De Fine Licht","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00038-8_bib11","doi-asserted-by":"crossref","first-page":"3126","DOI":"10.1200\/JCO.2013.54.1086","article-title":"Psychosexual functioning among adult female survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"32","author":"Ford","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib12","doi-asserted-by":"crossref","first-page":"208","DOI":"10.3322\/canjclin.54.4.208","article-title":"Long-term complications following childhood and adolescent cancer: foundations for providing risk-based health care for survivors","volume":"54","author":"Oeffinger","year":"2004","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/S2213-8587(15)00038-8_bib13","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1097\/SPC.0b013e328363a607","article-title":"Developing international consensus for late effects screening and guidance","volume":"7","author":"Skinner","year":"2013","journal-title":"Curr Opin Support Palliat Care"},{"key":"10.1016\/S2213-8587(15)00038-8_bib14","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1093\/annonc\/mdr595","article-title":"The Dutch Childhood Oncology Group guideline for follow-up of asymptomatic cardiac dysfunction in childhood cancer survivors","volume":"23","author":"Sieswerda","year":"2012","journal-title":"Ann Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib16","series-title":"Long term follow up of survivors of childhood cancer (SIGN publication no. 132)","year":"2013"},{"key":"10.1016\/S2213-8587(15)00038-8_bib17","series-title":"Long term follow up therapy based guidelines","author":"Skinner","year":"2005"},{"key":"10.1016\/S2213-8587(15)00038-8_bib18","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1002\/pbc.24445","article-title":"A worldwide collaboration to harmonize guidelines for the long-term follow-up of childhood and young adult cancer survivors: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"60","author":"Kremer","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib19","unstructured":"Anderson RA, Mitchell RT, Kelsey TW, Spears N, Telfer EE, Wallace WHB. Cancer treatment and fertility: strategies for fertility preservation in children and young adults. Lancet Diabetes Endocrinol (in press)."},{"key":"10.1016\/S2213-8587(15)00038-8_bib20","unstructured":"Toogood A, Crowne E, Gleeson H, Benghiat H, Sanghera P. Effect of cancer treatment on hypothalamic\u2013pituitary function. Lancet Diabetes Endocrinol (in press)."},{"key":"10.1016\/S2213-8587(15)00038-8_bib21","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/pbc.23385","article-title":"Lessons from the past: opportunities to improve childhood cancer survivor care through outcomes investigations of historical therapeutic approaches for pediatric hematological malignancies","volume":"58","author":"Hudson","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib22","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1007\/s11102-006-6042-4","article-title":"Hypopituitarism as a consequence of brain tumours and radiotherapy","volume":"8","author":"Darzy","year":"2005","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(15)00038-8_bib23","doi-asserted-by":"crossref","first-page":"4743","DOI":"10.1200\/JCO.2011.38.9833","article-title":"Therapy for pediatric brain tumors and the risk of growth hormone deficiency","volume":"29","author":"Sklar","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib24","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.ctrv.2009.06.004","article-title":"Prevalence and risk factors of radiation-induced growth hormone deficiency in childhood cancer survivors: a systematic review","volume":"35","author":"Mulder","year":"2009","journal-title":"Cancer Treat Rev"},{"key":"10.1016\/S2213-8587(15)00038-8_bib25","doi-asserted-by":"crossref","first-page":"3726","DOI":"10.1210\/jc.2010-0117","article-title":"Cardiovascular risk, cardiac function, physical activity, and quality of life with and without long-term growth hormone therapy in adult survivors of childhood acute lymphoblastic leukemia","volume":"95","author":"Follin","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00038-8_bib26","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1093\/jncimonographs\/lgi018","article-title":"Maintenance of ovarian function and risk of premature menopause related to cancer treatment","volume":"2005","author":"Sklar","year":"2005","journal-title":"J Natl Cancer Inst Monogr"},{"key":"10.1016\/S2213-8587(15)00038-8_bib27","doi-asserted-by":"crossref","first-page":"R141","DOI":"10.1677\/ERC-10-0002","article-title":"Endocrine complications in long-term survivors of childhood cancers","volume":"17","author":"Chemaitilly","year":"2010","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib28","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1001\/archinternmed.2009.209","article-title":"Diabetes mellitus in long-term survivors of childhood cancer. Increased risk associated with radiation therapy: a report for the childhood cancer survivor study","volume":"169","author":"Meacham","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(15)00038-8_bib29","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1002\/cncr.22120","article-title":"Metabolic syndrome and growth hormone deficiency in adult survivors of childhood acute lymphoblastic leukemia","volume":"107","author":"Gurney","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib30","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1200\/JCO.2003.06.131","article-title":"Obesity in adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study","volume":"21","author":"Oeffinger","year":"2003","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib31","doi-asserted-by":"crossref","first-page":"4639","DOI":"10.1200\/JCO.2008.16.3527","article-title":"Longitudinal changes in obesity and body mass index among adult survivors of childhood acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study","volume":"26","author":"Garmey","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib32","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1158\/1055-9965.EPI-09-0555","article-title":"Cardiovascular risk factors in adult survivors of pediatric cancer\u2014a report from the childhood cancer survivor study","volume":"19","author":"Meacham","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(15)00038-8_bib33","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1111\/bjh.12754","article-title":"Metabolic syndrome and cardiovascular risk among long-term survivors of acute lymphoblastic leukaemia\u2014from the St. Jude Lifetime Cohort","volume":"165","author":"Nottage","year":"2014","journal-title":"Br J Haematol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib34","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/S0022-3476(95)70258-X","article-title":"High incidence of obesity in young adults after treatment of acute lymphoblastic leukemia in childhood","volume":"127","author":"Didi","year":"1995","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(15)00038-8_bib35","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1203\/00006450-199507000-00015","article-title":"Obesity after successful treatment of acute lymphoblastic leukemia in childhood","volume":"38","author":"Van Dongen-Melman","year":"1995","journal-title":"Pediatr Res"},{"key":"10.1016\/S2213-8587(15)00038-8_bib36","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1097\/00043426-198624000-00005","article-title":"Prevalence of obesity in children after therapy for acute lymphoblastic leukemia","volume":"8","author":"Zee","year":"1986","journal-title":"Am J Pediatr Hematol Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib37","doi-asserted-by":"crossref","first-page":"3742","DOI":"10.1210\/jcem.86.8.7764","article-title":"Effect of glucocorticoid therapy on energy intake in children treated for acute lymphoblastic leukemia","volume":"86","author":"Reilly","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00038-8_bib38","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1038\/sj.ijo.0801403","article-title":"Risk factors for excess weight gain in children treated for acute lymphoblastic leukaemia","volume":"24","author":"Reilly","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(15)00038-8_bib39","doi-asserted-by":"crossref","first-page":"3698","DOI":"10.1200\/JCO.2008.19.7251","article-title":"Insulin resistance and risk factors for cardiovascular disease in young adult survivors of childhood acute lymphoblastic leukemia","volume":"27","author":"Oeffinger","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib40","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1002\/pbc.22964","article-title":"Adipokines, body fatness, and insulin resistance among survivors of childhood leukemia","volume":"58","author":"Tonorezos","year":"2012","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib41","first-page":"1","article-title":"Skeletal, neuromuscular and fitness impairments among children with newly diagnosed acute lymphoblastic leukemia","volume":"20","author":"Ness","year":"2014","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/S2213-8587(15)00038-8_bib42","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/pbc.24492","article-title":"Reduced cardiorespiratory fitness in adult survivors of childhood acute lymphoblastic leukemia","volume":"60","author":"Tonorezos","year":"2013","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib43","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/ncpendmet0579","article-title":"Gastric bypass surgery for treatment of hypothalamic obesity after craniopharyngioma therapy","volume":"3","author":"Inge","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00038-8_bib44","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1007\/s10552-012-0116-6","article-title":"Contribution of diet and physical activity to metabolic parameters among survivors of childhood leukemia","volume":"24","author":"Tonorezos","year":"2013","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(15)00038-8_bib45","doi-asserted-by":"crossref","first-page":"2742","DOI":"10.1002\/cncr.28670","article-title":"Lifestyle and metabolic syndrome in adult survivors of childhood cancer: a report from the St. Jude Lifetime Cohort Study","volume":"120","author":"Smith","year":"2014","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib46","doi-asserted-by":"crossref","first-page":"3643","DOI":"10.1200\/JCO.2014.56.7511","article-title":"Exercise and risk of major cardiovascular events in adult survivors of childhood Hodgkin lymphoma: a report from the childhood cancer survivor study","volume":"32","author":"Jones","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib47","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/pbc.25276","article-title":"Physical activity and cardiovascular risk factors in childhood cancer survivors","volume":"62","author":"Slater","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib48","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00038-8_bib49","doi-asserted-by":"crossref","first-page":"e787","DOI":"10.1016\/j.ijrobp.2010.10.037","article-title":"Hypothyroidism after head-and-neck radiotherapy in children and adolescents: preliminary results of the \u201cRegistry for the Evaluation of Side Effects After Radiotherapy in Childhood and Adolescence\u201d (RiSK)","volume":"81","author":"B\u00f6lling","year":"2011","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S2213-8587(15)00038-8_bib50","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1002\/pbc.22082","article-title":"Risk of thyroid dysfunction and subsequent thyroid cancer among survivors of acute lymphoblastic leukemia: a report from the Childhood Cancer Survivor Study","volume":"53","author":"Chow","year":"2009","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib51","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJM199108293250902","article-title":"Thyroid diseases after treatment of Hodgkin's disease","volume":"325","author":"Hancock","year":"1991","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00038-8_bib52","first-page":"3227","article-title":"Abnormalities of the thyroid in survivors of Hodgkin's disease: data from the Childhood Cancer Survivor Study","volume":"85","author":"Sklar","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00038-8_bib53","doi-asserted-by":"crossref","first-page":"5250","DOI":"10.1002\/cncr.26186","article-title":"Risk factors for radiation-induced hypothyroidism: a literature-based meta-analysis","volume":"117","author":"Vogelius","year":"2011","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib54","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1200\/JCO.2005.05.0195","article-title":"White race as a risk factor for hypothyroidism after treatment for pediatric Hodgkin's lymphoma","volume":"24","author":"Metzger","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib55","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1667\/RR2240.1","article-title":"Risk of second primary thyroid cancer after radiotherapy for a childhood cancer in a large cohort study: an update from the childhood cancer survivor study","volume":"174","author":"Bhatti","year":"2010","journal-title":"Radiat Res"},{"key":"10.1016\/S2213-8587(15)00038-8_bib56","doi-asserted-by":"crossref","first-page":"e209","DOI":"10.1016\/j.ijrobp.2012.03.044","article-title":"Thyroid adenomas after solid cancer in childhood","volume":"84","author":"Haddy","year":"2012","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S2213-8587(15)00038-8_bib57","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1002\/pbc.20541","article-title":"Natural history of thyroid nodules in survivors of pediatric Hodgkin lymphoma","volume":"46","author":"Metzger","year":"2006","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib58","doi-asserted-by":"crossref","first-page":"2014","DOI":"10.1016\/S0140-6736(05)66695-0","article-title":"Primary thyroid cancer after a first tumour in childhood (the Childhood Cancer Survivor Study): a nested case-control study","volume":"365","author":"Sigurdson","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00038-8_bib59","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1667\/RR2889.1","article-title":"A pooled analysis of thyroid cancer incidence following radiotherapy for childhood cancer","volume":"178","author":"Veiga","year":"2012","journal-title":"Radiat Res"},{"key":"10.1016\/S2213-8587(15)00038-8_bib60","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1089\/thy.2011.0464","article-title":"Differentiated thyroid carcinoma after 131I-MIBG treatment for neuroblastoma during childhood: description of the first two cases","volume":"22","author":"Van Santen","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(15)00038-8_bib61","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1016\/j.ejca.2014.01.014","article-title":"Adult life after childhood cancer in Scandinavia: diabetes mellitus following treatment for cancer in childhood","volume":"50","author":"Holmqvist","year":"2014","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib62","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.1016\/S1470-2045(12)70323-6","article-title":"Radiation dose to the pancreas and risk of diabetes mellitus in childhood cancer survivors: a retrospective cohort study","volume":"13","author":"De Vathaire","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib63","doi-asserted-by":"crossref","first-page":"3257","DOI":"10.1200\/JCO.2013.54.4379","article-title":"Risk of diabetes mellitus in long-term survivors of Hodgkin lymphoma","volume":"32","author":"Van Nimwegen","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib64","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/0167-8140(91)90011-5","article-title":"Effects of single dose irradiation on pancreatic beta-cell function","volume":"22","author":"Sarri","year":"1991","journal-title":"Radiother Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib65","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s004310050617","article-title":"Abnormal insulin response to glucose following treatment for Wilms' tumor in childhood","volume":"156","author":"Cicognani","year":"1997","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(15)00038-8_bib66","doi-asserted-by":"crossref","first-page":"1933","DOI":"10.1002\/cncr.26403","article-title":"Acute ovarian failure underestimates age-specific reproductive impairment for young women undergoing chemotherapy for cancer","volume":"118","author":"Letourneau","year":"2012","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib67","doi-asserted-by":"crossref","first-page":"2374","DOI":"10.1200\/JCO.2008.21.1839","article-title":"Ovarian failure and reproductive outcomes after childhood cancer treatment: results from the Childhood Cancer Survivor Study","volume":"27","author":"Green","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib68","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1093\/humupd\/dms022","article-title":"How do chemotherapeutic agents damage the ovary?","volume":"18","author":"Morgan","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/S2213-8587(15)00038-8_bib69","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1093\/molehr\/gau057","article-title":"Docetaxel induces moderate ovarian toxicity in mice, primarily affecting granulosa cells of early growing follicles","volume":"20","author":"Lopes","year":"2014","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/S2213-8587(15)00038-8_bib70","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1016\/j.fertnstert.2013.03.014","article-title":"Antim\u00fcllerian hormone, the assessment of the ovarian reserve, and the reproductive outcome of the young patient with cancer","volume":"99","author":"Anderson","year":"2013","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(15)00038-8_bib71","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1002\/1097-0142(20010201)91:3<613::AID-CNCR1042>3.0.CO;2-R","article-title":"High risk of infertility and long term gonadal damage in males treated with high dose cyclophosphamide for sarcoma during childhood","volume":"91","author":"Kenney","year":"2001","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib72","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1002\/(SICI)1096-911X(199907)33:1<2::AID-MPO2>3.0.CO;2-7","article-title":"Reproductive physiology and treatment-related loss of sex hormone production","volume":"33","author":"Sklar","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib73","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1002\/(SICI)1096-911X(199905)32:5<366::AID-MPO10>3.0.CO;2-7","article-title":"Gonadal function in young patients successfully treated for Hodgkin disease","volume":"32","author":"Papadakis","year":"1999","journal-title":"Med Pediatr Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib74","doi-asserted-by":"crossref","first-page":"4180","DOI":"10.1210\/jc.2009-0337","article-title":"Hypogonadism risk in men treated for childhood cancer","volume":"94","author":"Romerius","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00038-8_bib75","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/sj.bmt.1704481","article-title":"Disturbances of growth and endocrine function after busulphan-based conditioning for haematopoietic stem cell transplantation during infancy and childhood","volume":"33","author":"Bakker","year":"2004","journal-title":"Bone Marrow Transplant"},{"issue":"suppl 5","key":"10.1016\/S2213-8587(15)00038-8_bib76","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1398-2265.2004.00165.x","article-title":"Endocrine complications of high-dose therapy with stem cell transplantation","volume":"8","author":"Sanders","year":"2004","journal-title":"Pediatr Transplant"},{"key":"10.1016\/S2213-8587(15)00038-8_bib77","doi-asserted-by":"crossref","first-page":"4505","DOI":"10.1182\/blood-2012-06-437178","article-title":"Cardiovascular risk factors in hematopoietic cell transplantation survivors: role in development of subsequent cardiovascular disease","volume":"120","author":"Armenian","year":"2012","journal-title":"Blood"},{"key":"10.1016\/S2213-8587(15)00038-8_bib78","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1038\/leu.2010.210","article-title":"Late effects in survivors of acute leukemia treated with hematopoietic cell transplantation: a report from the Bone Marrow Transplant Survivor Study","volume":"24","author":"Baker","year":"2010","journal-title":"Leukemia"},{"key":"10.1016\/S2213-8587(15)00038-8_bib79","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1038\/bmt.2009.40","article-title":"Disorders of glucose homeostasis in young adults treated with total body irradiation during childhood: a pilot study","volume":"44","author":"Chemaitilly","year":"2009","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S2213-8587(15)00038-8_bib80","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1016\/j.bbmt.2010.05.016","article-title":"Increased cardiometabolic traits in pediatric survivors of acute lymphoblastic leukemia treated with total body irradiation","volume":"16","author":"Chow","year":"2010","journal-title":"Biol Blood and Marrow Transplant"},{"key":"10.1016\/S2213-8587(15)00038-8_bib81","doi-asserted-by":"crossref","first-page":"4442","DOI":"10.1182\/blood-2010-09-304899","article-title":"Prevalence and risk factors of the metabolic syndrome in adult survivors of childhood leukemia","volume":"117","author":"Oudin","year":"2011","journal-title":"Blood"},{"key":"10.1016\/S2213-8587(15)00038-8_bib82","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1016\/j.bbmt.2009.05.010","article-title":"Hypertension and diabetes mellitus in adult and pediatric survivors of allogeneic hematopoietic cell transplantation","volume":"15","author":"Majhail","year":"2009","journal-title":"Biol Blood Marrow Transplant"},{"key":"10.1016\/S2213-8587(15)00038-8_bib83","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1182\/blood-2008-08-173005","article-title":"Thyroid function following hematopoietic cell transplantation in children: 30 years' experience","volume":"113","author":"Sanders","year":"2009","journal-title":"Blood"},{"key":"10.1016\/S2213-8587(15)00038-8_bib84","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.ijrobp.2004.11.038","article-title":"Predicting age of ovarian failure after radiation to a field that includes the ovaries","volume":"62","author":"Wallace","year":"2005","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/S2213-8587(15)00038-8_bib85","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1097\/GRF.0b013e3181f96b54","article-title":"Toxicity of chemotherapy and radiation on female reproduction","volume":"53","author":"Meirow","year":"2010","journal-title":"Clin Obstet Gynecol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib86","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.3324\/haematol.2012.081265","article-title":"Symptomatic osteonecrosis in childhood leukemia survivors: prevalence, risk factors and impact on quality of life in adulthood","volume":"98","author":"Girard","year":"2013","journal-title":"Haematologica"},{"key":"10.1016\/S2213-8587(15)00038-8_bib87","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/pbc.21281","article-title":"Bone mineral density deficits in pediatric patients treated for sarcoma","volume":"50","author":"Kaste","year":"2008","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib88","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2265.2005.02263.x","article-title":"Skeletal morbidity in childhood acute lymphoblastic leukaemia","volume":"63","author":"Davies","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(15)00038-8_bib89","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1136\/adc.2009.172528","article-title":"Skeletal morbidity in children receiving chemotherapy for acute lymphoblastic leukaemia","volume":"95","author":"Elmantaser","year":"2010","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(15)00038-8_bib90","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1200\/JCO.2004.04.199","article-title":"Skeletal morbidity in childhood acute lymphoblastic leukemia","volume":"22","author":"Mandel","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib91","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1530\/EJE-12-0702","article-title":"Long-term skeletal consequences of childhood acute lymphoblastic leukemia in adult males: a cohort study","volume":"168","author":"Makitie","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib92","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1002\/pbc.25010","article-title":"Bone mineral density among long-term survivors of childhood acute lymphoblastic leukemia: results from the St. Jude Lifetime Cohort Study","volume":"61","author":"Gurney","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib93","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1067\/mpd.2001.113102","article-title":"Normal bone mineral density after treatment for childhood acute lymphoblastic leukemia diagnosed between 1991 and 1998","volume":"138","author":"Kadan-Lottick","year":"2001","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(15)00038-8_bib94","first-page":"747","article-title":"Osteonecrosis: an emerging complication of intensive chemotherapy for childhood acute lymphoblastic leukemia","volume":"88","author":"Aric\u00f2","year":"2003","journal-title":"Haematologica"},{"key":"10.1016\/S2213-8587(15)00038-8_bib95","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1002\/pbc.20244","article-title":"Osteonecrosis: a treatment related toxicity in childhood acute lymphoblastic leukemia (ALL)\u2014experiences from trial ALL-BFM 95","volume":"44","author":"B\u00fcrger","year":"2005","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib96","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1038\/bmt.2011.234","article-title":"Osteonecrosis in children after allogeneic hematopoietic cell transplantation: study of prevalence, risk factors and longitudinal changes using MR imaging","volume":"47","author":"Sharma","year":"2012","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S2213-8587(15)00038-8_bib97","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1200\/JCO.2011.37.3217","article-title":"Prospective study on incidence, risk factors, and long-term outcome of osteonecrosis in pediatric acute lymphoblastic leukemia","volume":"29","author":"te Winkel","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib98","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/S1470-2045(12)70274-7","article-title":"Effect of alternate-week versus continuous dexamethasone scheduling on the risk of osteonecrosis in paediatric patients with acute lymphoblastic leukaemia: results from the CCG-1961 randomised cohort trial","volume":"13","author":"Mattano","year":"2012","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib99","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1200\/JCO.2012.43.2070","volume":"31","author":"Vrooman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib100","doi-asserted-by":"crossref","first-page":"3262","DOI":"10.1200\/JCO.2000.18.18.3262","article-title":"Osteonecrosis as a complication of treating acute lymphoblastic leukemia in children: a report from the Children's Cancer Group","volume":"18","author":"Mattano","year":"2000","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib101","doi-asserted-by":"crossref","first-page":"3930","DOI":"10.1200\/JCO.2004.11.020","article-title":"Pharmacogenetic risk factors for osteonecrosis of the hip among children with leukemia","volume":"22","author":"Relling","year":"2004","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib102","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.1182\/blood-2010-10-311969","article-title":"Pharmacokinetic, pharmacodynamic, and pharmacogenetic determinants of osteonecrosis in children with acute lymphoblastic leukemia","volume":"117","author":"Kawedia","year":"2011","journal-title":"Blood"},{"key":"10.1016\/S2213-8587(15)00038-8_bib103","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1111\/j.1365-2265.2007.02813.x","article-title":"Thyroid function in paediatric and young adult patients after sarcoma therapy: a report from the Late Effects Surveillance System","volume":"66","author":"Paulides","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(15)00038-8_bib104","doi-asserted-by":"crossref","first-page":"f1190","DOI":"10.1136\/bmj.f1190","article-title":"Long term follow-up of survivors of childhood cancer: summary of updated SIGN guidance","volume":"346","author":"Wallace","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00038-8_bib105","doi-asserted-by":"crossref","DOI":"10.1002\/pbc.25310","article-title":"The views of European clinicians on guidelines for long-term follow-up of childhood cancer survivors","author":"Brown","year":"2014","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib106","doi-asserted-by":"crossref","first-page":"e621","DOI":"10.1016\/S1470-2045(13)70303-6","article-title":"Recommendations for breast cancer surveillance for female survivors of childhood, adolescent, and young adult cancer given chest radiation: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"14","author":"Mulder","year":"2013","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib107","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/S1470-2045(14)70409-7","article-title":"Recommendations for cardiomyopathy surveillance for survivors of childhood cancer: a report from the International Late Effects of Childhood Cancer Guideline Harmonization Group","volume":"16","author":"Armenian","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib108","doi-asserted-by":"crossref","first-page":"4401","DOI":"10.1200\/JCO.2008.16.9607","article-title":"Medical care in long-term survivors of childhood cancer: a report from the childhood cancer survivor study","volume":"26","author":"Nathan","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib109","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s11764-013-0291-9","article-title":"Attendance at a survivorship clinic: impact on knowledge and psychosocial adjustment","volume":"7","author":"Ford","year":"2013","journal-title":"J Cancer Surviv"},{"key":"10.1016\/S2213-8587(15)00038-8_bib110","doi-asserted-by":"crossref","first-page":"227","DOI":"10.3390\/children1020227","article-title":"Clinical guidelines for the care of childhood cancer survivors","volume":"1","author":"Tonorezos","year":"2014","journal-title":"Children"},{"key":"10.1016\/S2213-8587(15)00038-8_bib111","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1007\/s00520-014-2130-6","article-title":"Childhood cancer survivors' primary care and follow-up experiences","volume":"22","author":"Kirchhoff","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib112","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7326\/M13-1941","article-title":"General internists' preferences and knowledge about the care of adult survivors of childhood cancer: a cross-sectional survey","volume":"160","author":"Suh","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(15)00038-8_bib113","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s11764-013-0271-0","article-title":"Family physician preferences and knowledge gaps regarding the care of adolescent and young adult survivors of childhood cancer","volume":"7","author":"Nathan","year":"2013","journal-title":"J Cancer Surviv"},{"issue":"suppl","key":"10.1016\/S2213-8587(15)00038-8_bib114","doi-asserted-by":"crossref","first-page":"4409","DOI":"10.1002\/cncr.24590","article-title":"Caring for cancer survivors: a survey of primary care physicians","volume":"115","author":"Bober","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib115","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1200\/JCO.2006.07.0474","article-title":"Models for delivering survivorship care","volume":"24","author":"Oeffinger","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib116","doi-asserted-by":"crossref","first-page":"232","DOI":"10.1016\/S1470-2045(08)70034-2","article-title":"Shared care by paediatric oncologists and family doctors for long-term follow-up of adult childhood cancer survivors: a pilot study","volume":"9","author":"Blaauwbroek","year":"2008","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib117","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s11764-011-0207-5","article-title":"Family doctor-driven follow-up for adult childhood cancer survivors supported by a web-based survivor care plan","volume":"6","author":"Blaauwbroek","year":"2012","journal-title":"J Cancer Surviv"},{"key":"10.1016\/S2213-8587(15)00038-8_bib118","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1200\/JOP.2011.000345","article-title":"Response to a treatment summary and care plan among adult survivors of pediatric and young adult cancer","volume":"8","author":"Spain","year":"2012","journal-title":"J Oncol Pract"},{"key":"10.1016\/S2213-8587(15)00038-8_bib119","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/bjc.2014.505","article-title":"Survivorship care plans in cancer: a systematic review of care plan outcomes","volume":"111","author":"Brennan","year":"2014","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib121","doi-asserted-by":"crossref","first-page":"3974","DOI":"10.1200\/JCO.2014.57.3493","article-title":"Increasing cardiomyopathy screening in at-risk adult survivors of pediatric malignancies: a randomized controlled trial","volume":"32","author":"Hudson","year":"2014","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib122","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1002\/pbc.22696","article-title":"Increasing rates of breast cancer and cardiac surveillance among high-risk survivors of childhood Hodgkin lymphoma following a mailed, one-page survivorship care plan","volume":"56","author":"Oeffinger","year":"2011","journal-title":"Pediatr Blood Cancer"},{"key":"10.1016\/S2213-8587(15)00038-8_bib123","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.2217\/fon.13.107","article-title":"Health problems in survivors of childhood cancer: the need for international collaboration in long-term follow-up care","volume":"9","author":"Mulder","year":"2013","journal-title":"Future Oncol"},{"key":"10.1016\/S2213-8587(15)00038-8_bib124","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/bmj.323.7307.271","article-title":"Developing strategies for long term follow up of survivors of childhood cancer","volume":"323","author":"Wallace","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00038-8_bib125","doi-asserted-by":"crossref","first-page":"e002451","DOI":"10.1136\/bmjopen-2012-002451","article-title":"Can intensity of long-term follow-up for survivors of childhood and teenage cancer be determined by therapy-based risk stratification?","volume":"3","author":"Edgar","year":"2013","journal-title":"BMJ Open"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000388?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000388?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,31]],"date-time":"2020-08-31T16:11:37Z","timestamp":1598890297000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000388"}},"issued":{"date-parts":[[2015,7]]},"references-count":122,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2213858715000388"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00038-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Screening and management of adverse endocrine outcomes in adult survivors of childhood and adolescent cancer","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00038-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00039-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00008-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00029-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00031-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:19:30Z","timestamp":1793038770612,"version":"4.5.0"},"reference-count":184,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,28]],"date-time":"2025-07-28T00:00:00Z","timestamp":1753660800000},"content-version":"am","delay-in-days":177,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100019180","name":"HORIZON EUROPE European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019180","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/s2213-8587(24)00339-5","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T18:33:42Z","timestamp":1736793222000},"page":"149-164","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":45,"title":["Dissection of type 2 diabetes: a genetic perspective"],"prefix":"10.1016","volume":"13","author":[{"given":"Am\u00e9lie","family":"Bonnefond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C","family":"Florez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth J F","family":"Loos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Froguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00339-5_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib2","series-title":"IDF diabetes atlas","author":"Magliano","year":"2021"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00339-5_bib3","doi-asserted-by":"crossref","first-page":"S19","DOI":"10.2337\/dc23-S002","article-title":"Classification and diagnosis of diabetes: standards of care in diabetes\u20132023","volume":"46","author":"ElSayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00339-5_bib4","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1017\/thg.2015.83","article-title":"The concordance and heritability of type 2 diabetes in 34,166 twin pairs from international twin registers: the Discordant Twin (DISCOTWIN) Consortium","volume":"18","author":"Willemsen","year":"2015","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib5","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00125-011-2267-5","article-title":"Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study","volume":"54","author":"Almgren","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00339-5_bib6","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1017\/thg.2019.11","article-title":"Heritability of type 2 diabetes in the Washington state twin registry","volume":"22","author":"Avery","year":"2019","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib7","series-title":"Diabetes mellitus. WHO technical report series 727","author":"Vftter","year":"1985"},{"key":"10.1016\/S2213-8587(24)00339-5_bib8","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1038\/356162a0","article-title":"Close linkage of glucokinase locus on chromosome 7p to early-onset non-insulin-dependent diabetes mellitus","volume":"356","author":"Froguel","year":"1992","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00339-5_bib9","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1038\/356721a0","article-title":"Nonsense mutation in the glucokinase gene causes early-onset non-insulin-dependent diabetes mellitus","volume":"356","author":"Vionnet","year":"1992","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00339-5_bib10","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00125-011-2319-x","article-title":"Heterozygous ABCC8 mutations are a cause of MODY","volume":"55","author":"Bowman","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00339-5_bib11","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1056\/NEJMoa055068","article-title":"Activating mutations in the ABCC8 gene in neonatal diabetes mellitus","volume":"355","author":"Babenko","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ajhg.2015.05.011","article-title":"Loss-of-function mutations in APPL1 in familial diabetes mellitus","volume":"97","author":"Prudente","year":"2015","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib13","doi-asserted-by":"crossref","first-page":"E2117","DOI":"10.1210\/jc.2014-1949","article-title":"A novel variant in CDKN1C is associated with intrauterine growth restriction, short stature, and early-adulthood-onset diabetes","volume":"99","author":"Kerns","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib14","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/ng1708","article-title":"Mutations in the CEL VNTR cause a syndrome of diabetes and pancreatic exocrine dysfunction","volume":"38","author":"Raeder","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib15","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1086\/520961","article-title":"A homozygous mutation in a novel zinc-finger protein, ERIS, is responsible for Wolfram syndrome 2","volume":"81","author":"Amr","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib16","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/j.ajhg.2019.03.018","article-title":"A specific CNOT1 mutation results in a novel syndrome of pancreatic agenesis and holoprosencephaly through impaired pancreatic and neurological development","volume":"104","author":"De Franco","year":"2019","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib17","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/j.ajhg.2014.10.013","article-title":"Absence of BiP co-chaperone DNAJC3 causes diabetes mellitus and multisystemic neurodegeneration","volume":"95","author":"Synofzik","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib18","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2337\/db19-1029","article-title":"De novo mutations in EIF2B1 affecting eIF2 signaling cause neonatal\/early onset diabetes and transient hepatic dysfunction","volume":"69","author":"De Franco","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib19","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/78085","article-title":"EIF2AK3, encoding translation initiation factor 2-alpha kinase 3, is mutated in patients with Wolcott\u2013Rallison syndrome","volume":"25","author":"Del\u00e9pine","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib20","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/pedi.12814","article-title":"Exome sequencing identifies a de novo FOXA2 variant in a patient with syndromic diabetes","volume":"20","author":"Stekelenburg","year":"2019","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib21","doi-asserted-by":"crossref","first-page":"2888","DOI":"10.2337\/db14-0061","article-title":"GATA4 mutations are a cause of neonatal and childhood-onset diabetes","volume":"63","author":"Shaw-Smith","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib22","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/ng.1035","article-title":"GATA6 haploinsufficiency causes pancreatic agenesis in humans","volume":"44","author":"Allen","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib23","doi-asserted-by":"crossref","first-page":"1588","DOI":"10.1056\/NEJM200105243442104","article-title":"Neonatal diabetes mellitus due to complete glucokinase deficiency","volume":"344","author":"Nj\u00f8lstad","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib24","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1038\/ng1802","article-title":"Mutations in GLIS3 are responsible for a rare syndrome with neonatal diabetes mellitus and congenital hypothyroidism","volume":"38","author":"Sen\u00e9e","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib25","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1038\/384455a0","article-title":"Mutations in the hepatocyte nuclear factor-1alpha gene in maturity-onset diabetes of the young (MODY3)","volume":"384","author":"Yamagata","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00339-5_bib26","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1210\/jc.2003-031552","article-title":"Hepatocyte nuclear factor-1 alpha gene inactivation: cosegregation between liver adenomatosis and diabetes phenotypes in two maturity-onset diabetes of the young (MODY)3 families","volume":"89","author":"Reznik","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib27","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1038\/ng1297-384","article-title":"Mutation in hepatocyte nuclear factor-1 beta gene (TCF2) associated with MODY","volume":"17","author":"Horikawa","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib28","doi-asserted-by":"crossref","first-page":"2905","DOI":"10.1210\/jc.2003-031828","article-title":"Neonatal diabetes mellitus and neonatal polycystic, dysplastic kidneys: phenotypically discordant recurrence of a mutation in the hepatocyte nuclear factor-1beta gene due to germline mosaicism","volume":"89","author":"Yorifuji","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib29","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/384458a0","article-title":"Mutations in the hepatocyte nuclear factor-4alpha gene in maturity-onset diabetes of the young (MODY1)","volume":"384","author":"Yamagata","year":"1996","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00339-5_bib30","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1016\/j.ajhg.2011.07.006","article-title":"Microcephaly with simplified gyration, epilepsy, and infantile diabetes linked to inappropriate apoptosis of neural progenitors","volume":"89","author":"Poulton","year":"2011","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib31","doi-asserted-by":"crossref","first-page":"653","DOI":"10.2337\/db09-1091","article-title":"Insulin gene mutations resulting in early-onset diabetes: marked differences in clinical presentation, metabolic status, and pathogenic effect through endoplasmic reticulum retention","volume":"59","author":"Meur","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib32","doi-asserted-by":"crossref","first-page":"15040","DOI":"10.1073\/pnas.0707291104","article-title":"Insulin gene mutations as a cause of permanent neonatal diabetes","volume":"104","author":"St\u00f8y","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(24)00339-5_bib33","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0037423","article-title":"Whole-exome sequencing and high throughput genotyping identified KCNJ11 as the thirteenth MODY gene","volume":"7","author":"Bonnefond","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(24)00339-5_bib34","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1056\/NEJMoa032922","article-title":"Activating mutations in the gene encoding the ATP-sensitive potassium-channel subunit Kir6.2 and permanent neonatal diabetes","volume":"350","author":"Gloyn","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib35","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.138057","article-title":"A KCNK16 mutation causing TALK-1 gain-of-function is associated with maturity-onset diabetes of the young","volume":"6","author":"Graff","year":"2021","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(24)00339-5_bib36","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2337\/db21-0520","article-title":"Gene panel sequencing of patients with monogenic diabetes brings to light genes typically associated with syndromic presentations","volume":"71","author":"Saint-Martin","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib37","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1038\/ng0892-368","article-title":"Mutation in mitochondrial tRNA(Leu)(UUR) gene in a large pedigree with maternally transmitted type II diabetes mellitus and deafness","volume":"1","author":"van den Ouweland","year":"1992","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib38","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1073\/pnas.1712262115","article-title":"MAFA missense mutation causes familial insulinomatosis and diabetes mellitus","volume":"115","author":"Iacovazzo","year":"2018","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S2213-8587(24)00339-5_bib39","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.2337\/db20-1174","article-title":"Loss of MANF causes childhood-onset syndromic diabetes due to increased endoplasmic reticulum stress","volume":"70","author":"Montaser","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib40","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.51319","article-title":"Biallelic TANGO1 mutations cause a novel syndromal disease due to hampered cellular collagen secretion","volume":"9","author":"Lekszas","year":"2020","journal-title":"eLife"},{"key":"10.1016\/S2213-8587(24)00339-5_bib41","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/j.diabet.2013.02.007","article-title":"Transcription factor gene MNX1 is a novel cause of permanent neonatal diabetes in a consanguineous family","volume":"39","author":"Bonnefond","year":"2013","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib42","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/15500","article-title":"Mutations in NEUROD1 are associated with the development of type 2 diabetes mellitus","volume":"23","author":"Malecki","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib43","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.2337\/db10-0011","article-title":"Homozygous mutations in NEUROD1 are responsible for a novel syndrome of permanent neonatal diabetes and neurological abnormalities","volume":"59","author":"Rubio-Cabezas","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib44","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/db10-1008","article-title":"Permanent neonatal diabetes and enteric anendocrinosis associated with biallelic mutations in NEUROG3","volume":"60","author":"Rubio-Cabezas","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib45","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.cmet.2013.11.021","article-title":"Analysis of transcription factors key for mouse pancreatic development establishes NKX2-2 and MNX1 mutations as causes of neonatal diabetes in man","volume":"19","author":"Flanagan","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib46","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1038\/s41591-021-01502-7","article-title":"Mutations and variants of ONECUT1 in diabetes","volume":"27","author":"Philippi","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib47","doi-asserted-by":"crossref","first-page":"224","DOI":"10.2337\/diabetes.51.1.224","article-title":"PAX6 mutation as a genetic factor common to aniridia and glucose intolerance","volume":"51","author":"Yasuda","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib48","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.2337\/db13-1784","article-title":"Recessive mutations in PCBD1 cause a new type of early-onset diabetes","volume":"63","author":"Simaite","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib49","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1111\/cge.13930","article-title":"Biallelic loss of function variant in the unfolded protein response gene PDIA6 is associated with asphyxiating thoracic dystrophy and neonatal-onset diabetes","volume":"99","author":"Al-Fadhli","year":"2021","journal-title":"Clin Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib50","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabet.2023.101507","article-title":"Dominant PDX1 deficiency causes highly penetrant diabetes at different ages, associated with obesity and exocrine pancreatic deficiency: lessons for precision medicine","volume":"50","author":"Kouidrat","year":"2024","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib51","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/ng0197-106","article-title":"Pancreatic agenesis attributable to a single nucleotide deletion in the human IPF1 gene coding sequence","volume":"15","author":"Stoffers","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib52","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/ng1097-138","article-title":"Early-onset type-II diabetes mellitus (MODY4) linked to IPF1","volume":"17","author":"Stoffers","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib53","doi-asserted-by":"crossref","first-page":"3951","DOI":"10.2337\/db15-0477","article-title":"A missense mutation in PPP1R15B causes a syndrome including diabetes, short stature and microcephaly","volume":"64","author":"Abdulkarim","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib54","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1038\/ng1475","article-title":"Mutations in PTF1A cause pancreatic and cerebellar agenesis","volume":"36","author":"Sellick","year":"2004","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1038\/ng.2826","article-title":"Recessive mutations in a distal PTF1A enhancer cause isolated pancreatic agenesis","volume":"46","author":"Weedon","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib56","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1038\/nature08748","article-title":"Rfx6 directs islet formation and insulin production in mice and humans","volume":"463","author":"Smith","year":"2010","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00339-5_bib57","doi-asserted-by":"crossref","first-page":"888","DOI":"10.1038\/s41467-017-00895-9","article-title":"Heterozygous RFX6 protein truncating variants are associated with MODY with reduced penetrance","volume":"8","author":"Patel","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00339-5_bib58","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.2337\/db17-0821","article-title":"Loss-of-function mutation in thiamine transporter 1 in a family with autosomal dominant diabetes","volume":"68","author":"Jungtrakoon","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib59","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/10372","article-title":"Mutations in SLC19A2 cause thiamine-responsive megaloblastic anaemia associated with diabetes mellitus and deafness","volume":"22","author":"Labay","year":"1999","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib60","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ng1197-324","article-title":"Mutations in GLUT2, the gene for the liver-type glucose transporter, in patients with Fanconi\u2013Bickel syndrome","volume":"17","author":"Santer","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib61","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1003888","article-title":"tRNA methyltransferase homolog gene TRMT10A mutation in young onset diabetes and primary microcephaly in humans","volume":"9","author":"Igoillo-Esteve","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib62","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1038\/2441","article-title":"A gene encoding a transmembrane protein is mutated in patients with diabetes mellitus and optic atrophy (Wolfram syndrome)","volume":"20","author":"Inoue","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib63","doi-asserted-by":"crossref","first-page":"3943","DOI":"10.2337\/db13-0571","article-title":"Autosomal dominant diabetes arising from a Wolfram syndrome 1 mutation","volume":"62","author":"Bonnycastle","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib64","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.2337\/db16-1296","article-title":"Dominant ER stress-inducing WFS1 mutations underlie a genetic syndrome of neonatal\/infancy-onset diabetes, congenital sensorineural deafness, and congenital cataracts","volume":"66","author":"De Franco","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib65","doi-asserted-by":"crossref","first-page":"6338","DOI":"10.1172\/JCI141455","article-title":"YIPF5 mutations cause neonatal diabetes and microcephaly through endoplasmic reticulum stress","volume":"130","author":"De Franco","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(24)00339-5_bib66","doi-asserted-by":"crossref","first-page":"505","DOI":"10.2337\/dc12-0700","article-title":"Transient neonatal diabetes, ZFP57, and hypomethylation of multiple imprinted loci: a detailed follow-up","volume":"36","author":"Boonen","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00339-5_bib67","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1038\/s41588-023-01565-x","article-title":"Primate-specific ZNF808 is essential for pancreatic development in humans","volume":"55","author":"De Franco","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib68","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1038\/s41572-023-00421-w","article-title":"Monogenic diabetes","volume":"9","author":"Bonnefond","year":"2023","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(24)00339-5_bib69","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2020.540718","article-title":"Neonatal diabetes mellitus","volume":"8","author":"Beltrand","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/S2213-8587(24)00339-5_bib70","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1001\/jama.2013.283980","article-title":"Prevalence of vascular complications among patients with glucokinase mutations and prolonged, mild hyperglycemia","volume":"311","author":"Steele","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00339-5_bib71","first-page":"726","article-title":"High sensitivity to sulphonylurea treatment in 2 patients with maturity-onset diabetes of the young type 3","volume":"146","author":"Bosselaar","year":"2002","journal-title":"Ned Tijdschr Geneeskd"},{"key":"10.1016\/S2213-8587(24)00339-5_bib72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/1753-0407.12959","article-title":"Liver adenomatosis in patients with hepatocyte nuclear factor-1 alpha maturity onset diabetes of the young (HNF1A-MODY): clinical, radiological and pathological characteristics in a French series","volume":"12","author":"Haddouche","year":"2020","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib73","doi-asserted-by":"crossref","first-page":"202","DOI":"10.2337\/dc13-0410","article-title":"Cost-effectiveness of MODY genetic testing: translating genomic advances into practical health applications","volume":"37","author":"Naylor","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00339-5_bib74","doi-asserted-by":"crossref","first-page":"622","DOI":"10.2337\/dc10-1616","article-title":"The cost-effectiveness of personalized genetic medicine: the case of genetic testing in neonatal diabetes","volume":"34","author":"Greeley","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00339-5_bib75","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1750-1172-5-29","article-title":"Wolcott\u2013Rallison syndrome","volume":"5","author":"Julier","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(24)00339-5_bib76","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1038\/79216","article-title":"The common PPARgamma Pro12Ala polymorphism is associated with decreased risk of type 2 diabetes","volume":"26","author":"Altshuler","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib77","doi-asserted-by":"crossref","first-page":"568","DOI":"10.2337\/diabetes.52.2.568","article-title":"Large-scale association studies of variants in genes encoding the pancreatic beta-cell KATP channel subunits Kir6.2 (KCNJ11) and SUR1 (ABCC8) confirm that the KCNJ11 E23K variant is associated with type 2 diabetes","volume":"52","author":"Gloyn","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib78","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.2337\/diabetes.53.5.1360","article-title":"Haplotype structure and genotype-phenotype correlations of the sulfonylurea receptor and the islet ATP-sensitive potassium channel gene region","volume":"53","author":"Florez","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib79","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1086\/377139","article-title":"Localization of a susceptibility gene for type 2 diabetes to chromosome 5q34-q35.2","volume":"73","author":"Reynisdottir","year":"2003","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib80","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1038\/ng1732","article-title":"Variant of transcription factor 7-like 2 (TCF7L2) gene confers risk of type 2 diabetes","volume":"38","author":"Grant","year":"2006","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib81","doi-asserted-by":"crossref","first-page":"D977","DOI":"10.1093\/nar\/gkac1010","article-title":"The NHGRI-EBI GWAS catalog: knowledgebase and deposition resource","volume":"51","author":"Sollis","year":"2023","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S2213-8587(24)00339-5_bib82","doi-asserted-by":"crossref","DOI":"10.1002\/pld3.91","article-title":"ShinyAIM: shiny-based application of interactive Manhattan plots for longitudinal genome-wide association studies","volume":"2","author":"Hussain","year":"2018","journal-title":"Plant Direct"},{"key":"10.1016\/S2213-8587(24)00339-5_bib83","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05616","article-title":"A genome-wide association study identifies novel risk loci for type 2 diabetes","volume":"445","author":"Sladek","year":"2007","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00339-5_bib84","doi-asserted-by":"crossref","first-page":"1331","DOI":"10.1126\/science.1142358","article-title":"Genome-wide association analysis identifies loci for type 2 diabetes and triglyceride levels","volume":"316","author":"Saxena","year":"2007","journal-title":"Science"},{"key":"10.1016\/S2213-8587(24)00339-5_bib85","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1126\/science.1142382","article-title":"A genome-wide association study of type 2 diabetes in Finns detects multiple susceptibility variants","volume":"316","author":"Scott","year":"2007","journal-title":"Science"},{"key":"10.1016\/S2213-8587(24)00339-5_bib86","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1126\/science.1142364","article-title":"Replication of genome-wide association signals in UK samples reveals risk loci for type 2 diabetes","volume":"316","author":"Zeggini","year":"2007","journal-title":"Science"},{"key":"10.1016\/S2213-8587(24)00339-5_bib87","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/ng2043","article-title":"A variant in CDKAL1 influences insulin response and risk of type 2 diabetes","volume":"39","author":"Steinthorsdottir","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib88","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","author":"Burton","year":"2007","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00339-5_bib89","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1086\/520599","article-title":"Type 2 diabetes whole-genome association study in four populations: the DiaGen consortium","volume":"81","author":"Salonen","year":"2007","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib90","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1038\/ng.208","article-title":"SNPs in KCNQ1 are associated with susceptibility to type 2 diabetes in East Asian and European populations","volume":"40","author":"Unoki","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib91","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001300","article-title":"Genome-wide association study of coronary heart disease and its risk factors in 8,090 African Americans: the NHLBI CARe Project","volume":"7","author":"Lettre","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib92","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1001363","article-title":"Transferability of type 2 diabetes implicated loci in multi-ethnic cohorts from Southeast Asia","volume":"7","author":"Sim","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib93","doi-asserted-by":"crossref","first-page":"2038","DOI":"10.1007\/s00125-011-2172-y","article-title":"Genome-wide association study of type 2 diabetes in a sample from Mexico City and a meta-analysis of a Mexican\u2013American sample from Starr County, Texas","volume":"54","author":"Parra","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00339-5_bib94","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/ng.120","article-title":"Meta-analysis of genome-wide association data and large-scale replication identifies additional susceptibility loci for type 2 diabetes","volume":"40","author":"Zeggini","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib95","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ng.1019","article-title":"Meta-analysis of genome-wide association studies identifies eight new loci for type 2 diabetes in east Asians","volume":"44","author":"Cho","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib96","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1004517","article-title":"Meta-analysis of genome-wide association studies in African Americans provides insights into the genetic architecture of type 2 diabetes","volume":"10","author":"Ng","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib97","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1038\/ng.2897","article-title":"Genome-wide trans-ancestry meta-analysis provides insight into the genetic architecture of type 2 diabetes susceptibility","volume":"46","author":"Mahajan","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib98","doi-asserted-by":"crossref","first-page":"1505","DOI":"10.1038\/s41588-018-0241-6","article-title":"Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps","volume":"50","author":"Mahajan","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib99","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","article-title":"Genetic drivers of heterogeneity in type 2 diabetes pathophysiology","volume":"627","author":"Suzuki","year":"2024","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00339-5_bib100","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1038\/ng.2794","article-title":"Assessing the phenotypic effects in the general population of rare variants in genes for a dominant Mendelian form of diabetes","volume":"45","author":"Flannick","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib101","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/s12916-017-0977-3","article-title":"Spectrum of mutations in monogenic diabetes genes identified from high-throughput DNA sequencing of 6888 individuals","volume":"15","author":"Bansal","year":"2017","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib102","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s42255-020-00294-3","article-title":"Pathogenic variants in actionable MODY genes are associated with type 2 diabetes","volume":"2","author":"Bonnefond","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib103","doi-asserted-by":"crossref","first-page":"2845","DOI":"10.1007\/s00125-012-2645-7","article-title":"GATA6 inactivating mutations are associated with heart defects and, inconsistently, with pancreatic agenesis and diabetes","volume":"55","author":"Bonnefond","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00339-5_bib104","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.cmet.2014.12.020","article-title":"Rare and common genetic events in type 2 diabetes: what should biologists know?","volume":"21","author":"Bonnefond","year":"2015","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib105","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1038\/s41588-018-0183-z","article-title":"Genome-wide polygenic scores for common diseases identify individuals with risk equivalent to monogenic mutations","volume":"50","author":"Khera","year":"2018","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib106","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1038\/s41588-022-01058-3","article-title":"Multi-ancestry genetic study of type 2 diabetes highlights the power of diverse populations for discovery and translation","volume":"54","author":"Mahajan","year":"2022","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib107","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/ng.1053","article-title":"Rare MTNR1B variants impairing melatonin receptor 1B function contribute to type 2 diabetes","volume":"44","author":"Bonnefond","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib108","doi-asserted-by":"crossref","first-page":"13127","DOI":"10.1073\/pnas.1410428111","article-title":"Rare variants in PPARG with decreased activity in adipocyte differentiation are associated with increased risk of type 2 diabetes","volume":"111","author":"Majithia","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(24)00339-5_bib109","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00125-023-06035-x","article-title":"Pathogenic monoallelic variants in GLIS3 increase type 2 diabetes risk and identify a subgroup of patients sensitive to sulfonylureas","volume":"67","author":"Meulebrouck","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00339-5_bib110","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2023.101867","article-title":"Exploring the role of purinergic receptor P2RY1 in type 2 diabetes risk and pathophysiology: insights from human functional genomics","volume":"79","author":"Dance","year":"2024","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib111","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-51004-6","article-title":"Functional genetics reveals the contribution of delta opioid receptor to type 2 diabetes and beta-cell function","volume":"15","author":"Meulebrouck","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00339-5_bib112","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1038\/ng.2915","article-title":"Loss-of-function mutations in SLC30A8 protect against type 2 diabetes","volume":"46","author":"Flannick","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib113","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1038\/ng.2882","article-title":"Identification of low-frequency and rare sequence variants associated with elevated or reduced risk of type 2 diabetes","volume":"46","author":"Steinthorsdottir","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib114","doi-asserted-by":"crossref","first-page":"2305","DOI":"10.1001\/jama.2014.6511","article-title":"Association of a low-frequency variant in HNF1A with type 2 diabetes in a Latino population","volume":"311","author":"Estrada","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00339-5_bib115","doi-asserted-by":"crossref","first-page":"1726","DOI":"10.2337\/dc18-0384","article-title":"Mexican carriers of the HNF1A p.E508K variant do not experience an enhanced response to sulfonylureas","volume":"41","author":"Martag\u00f3n","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00339-5_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003196","article-title":"The role of polygenic susceptibility to obesity among carriers of pathogenic mutations in MC4R in the UK Biobank population","volume":"17","author":"Chami","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib117","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1007\/s00125-022-05806-2","article-title":"The contribution of functional HNF1A variants and polygenic susceptibility to risk of type 2 diabetes in ancestrally diverse populations","volume":"66","author":"Stalbow","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00339-5_bib118","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1007\/s00125-008-1025-9","article-title":"Newly identified loci highlight beta cell dysfunction as a key cause of type 2 diabetes: where are the insulin resistance genes?","volume":"51","author":"Florez","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00339-5_bib119","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1007\/s11892-010-0143-1","article-title":"The genetics of insulin resistance: Where's Waldo?","volume":"10","author":"Watanabe","year":"2010","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(24)00339-5_bib120","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.1002\/oby.22301","article-title":"The fat mass- and obesity-associated (FTO) gene to obesity: lessons from mouse models","volume":"26","author":"Chang","year":"2018","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(24)00339-5_bib121","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1038\/nature11082","article-title":"Topological domains in mammalian genomes identified by analysis of chromatin interactions","volume":"485","author":"Dixon","year":"2012","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00339-5_bib122","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1502214","article-title":"FTO obesity variant circuitry and adipocyte browning in humans","volume":"373","author":"Claussnitzer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib123","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature13138","article-title":"Obesity-associated variants within FTO form long-range functional connections with IRX3","volume":"507","author":"Smemo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00339-5_bib124","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI85526","article-title":"Hypomorphism of Fto and Rpgrip1l causes obesity in mice","volume":"126","author":"Stratigopoulos","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(24)00339-5_bib125","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1038\/ng.2870","article-title":"Pancreatic islet enhancer clusters enriched in type 2 diabetes risk-associated variants","volume":"46","author":"Pasquali","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib126","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1038\/ng.3437","article-title":"Genetic fine mapping and genomic annotation defines causal mechanisms at type 2 diabetes susceptibility loci","volume":"47","author":"Gaulton","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib127","doi-asserted-by":"crossref","first-page":"13924","DOI":"10.1073\/pnas.1402665111","article-title":"Global genomic and transcriptomic analysis of human pancreatic islets reveals novel genes influencing glucose metabolism","volume":"111","author":"Fadista","year":"2014","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(24)00339-5_bib128","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.molmet.2019.03.004","article-title":"Laser capture microdissection of human pancreatic islets reveals novel eQTLs associated with type 2 diabetes","volume":"24","author":"Khamis","year":"2019","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib129","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1005694","article-title":"Transcript expression data from human islets links regulatory signals from genome-wide association studies for type 2 diabetes and glycemic traits to their downstream effectors","volume":"11","author":"van de Bunt","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.celrep.2021.109807","article-title":"TIGER: the gene expression regulatory variation landscape of human pancreatic islets","volume":"37","author":"Alonso","year":"2021","journal-title":"Cell Rep"},{"key":"10.1016\/S2213-8587(24)00339-5_bib131","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.2337\/db14-0957","article-title":"Targeted allelic expression profiling in human islets identifies cis-regulatory effects for multiple variants identified by type 2 diabetes genome-wide association studies","volume":"64","author":"Locke","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib132","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.molmet.2017.03.011","article-title":"Expression and functional assessment of candidate type 2 diabetes susceptibility genes identify four new genes contributing to human insulin secretion","volume":"6","author":"Ndiaye","year":"2017","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib133","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002654","article-title":"Type 2 diabetes genetic loci informed by multi-trait associations point to disease mechanisms and subtypes: a soft clustering analysis","volume":"15","author":"Udler","year":"2018","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib134","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41591-024-02865-3","article-title":"Multi-ancestry polygenic mechanisms of type 2 diabetes","volume":"30","author":"Smith","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib135","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.2337\/dc06-0513","article-title":"Association of Pro12Ala polymorphism in peroxisome proliferator-activated receptor gamma with pre-diabetic phenotypes: meta-analysis of 57 studies on nondiabetic individuals","volume":"29","author":"T\u00f6njes","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00339-5_bib136","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/j.1368-504X.2004.00389.x","article-title":"Dysfunctional fat cells, lipotoxicity and type 2 diabetes","volume":"58","author":"DeFronzo","year":"2004","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1016\/S2213-8587(24)00339-5_bib137","doi-asserted-by":"crossref","first-page":"E1135","DOI":"10.1152\/ajpendo.0327.2001","article-title":"Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus","volume":"283","author":"Miyazaki","year":"2002","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib138","doi-asserted-by":"crossref","first-page":"288","DOI":"10.2337\/diacare.22.2.288","article-title":"Effects of a thiazolidinedione compound on body fat and fat distribution of patients with type 2 diabetes","volume":"22","author":"Kelly","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00339-5_bib139","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMoa072366","article-title":"Genomewide association analysis of coronary artery disease","volume":"357","author":"Samani","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib140","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1038\/ng.443","article-title":"Genetic variant near IRS1 is associated with type 2 diabetes, insulin resistance and hyperinsulinemia","volume":"41","author":"Rung","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib141","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1038\/ng.866","article-title":"Genetic variation near IRS1 associates with reduced adiposity and an impaired metabolic profile","volume":"43","author":"Kilpel\u00e4inen","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib142","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/372186a0","article-title":"Alternative pathway of insulin signalling in mice with targeted disruption of the IRS-1 gene","volume":"372","author":"Araki","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00339-5_bib143","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/372182a0","article-title":"Insulin resistance and growth retardation in mice lacking insulin receptor substrate-1","volume":"372","author":"Tamemoto","year":"1994","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00339-5_bib144","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1128\/MCB.21.7.2521-2532.2001","article-title":"Essential role of insulin receptor substrate 1 (IRS-1) and IRS-2 in adipocyte differentiation","volume":"21","author":"Miki","year":"2001","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S2213-8587(24)00339-5_bib145","doi-asserted-by":"crossref","first-page":"1918","DOI":"10.1128\/MCB.24.5.1918-1929.2004","article-title":"Differential roles of insulin receptor substrates in brown adipocyte differentiation","volume":"24","author":"Tseng","year":"2004","journal-title":"Mol Cell Biol"},{"key":"10.1016\/S2213-8587(24)00339-5_bib146","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1038\/ng.685","article-title":"Meta-analysis identifies 13 new loci associated with waist-hip ratio and reveals sexual dimorphism in the genetic basis of fat distribution","volume":"42","author":"Heid","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib147","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10495","article-title":"New loci for body fat percentage reveal link between adiposity and cardiometabolic disease risk","volume":"7","author":"Lu","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00339-5_bib148","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1038\/s42255-023-00807-w","article-title":"A non-coding variant linked to metabolic obesity with normal weight affects actin remodelling in subcutaneous adipocytes","volume":"5","author":"Glunk","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib149","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1038\/ng.3620","article-title":"A thrifty variant in CREBRF strongly influences body mass index in Samoans","volume":"48","author":"Minster","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib150","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1002\/oby.23559","article-title":"The protective effect of rs373863828 on type 2 diabetes does not operate through a body composition pathway in adult Samoans","volume":"30","author":"Hawley","year":"2022","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(24)00339-5_bib151","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41366-020-00659-4","article-title":"A missense variant in CREBRF, rs373863828, is associated with fat-free mass, not fat mass in Samoan infants","volume":"45","author":"Arslanian","year":"2021","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib152","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-40595-1","article-title":"REPTOR and CREBRF encode key regulators of muscle energy metabolism","volume":"14","author":"Saavedra","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00339-5_bib153","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1038\/s42255-021-00346-2","article-title":"Genome-wide discovery of genetic loci that uncouple excess adiposity from its comorbidities","volume":"3","author":"Huang","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(24)00339-5_bib154","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2337\/db18-0708","article-title":"Genome-wide and abdominal MRI data provide evidence that a genetically determined favorable adiposity phenotype is characterized by lower ectopic liver fat and lower risk of type 2 diabetes, heart disease, and hypertension","volume":"68","author":"Ji","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib155","doi-asserted-by":"crossref","first-page":"1843","DOI":"10.2337\/db21-0129","article-title":"Genetic evidence for different adiposity phenotypes and their opposing influences on ectopic fat and risk of cardiometabolic disease","volume":"70","author":"Martin","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib156","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14531","article-title":"Genetically defined favourable adiposity is not associated with a clinically meaningful difference in clinical course in people with type 2 diabetes but does associate with a favourable metabolic profile","volume":"38","author":"Heald","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib157","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15213","article-title":"Genetic scores associated with favourable and unfavourable adiposity have consistent effect on metabolic profile and disease risk across diverse ethnic groups","volume":"40","author":"Ahmed","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib158","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1038\/ng.2700","article-title":"Association between large detectable clonal mosaicism and type 2 diabetes with vascular complications","volume":"45","author":"Bonnefond","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00339-5_bib159","doi-asserted-by":"crossref","first-page":"2488","DOI":"10.1056\/NEJMoa1408617","article-title":"Age-related clonal hematopoiesis associated with adverse outcomes","volume":"371","author":"Jaiswal","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib160","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1038\/s41574-022-00671-w","article-title":"Epigenetics of type 2 diabetes mellitus and weight change \u2013 a tool for precision medicine?","volume":"18","author":"Ling","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00339-5_bib161","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/S2213-8587(15)00127-8","article-title":"Epigenome-wide association of DNA methylation markers in peripheral blood from Indian Asians and Europeans with incident type 2 diabetes: a nested case-control study","volume":"3","author":"Chambers","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00339-5_bib162","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.2337\/db18-0290","article-title":"Epigenome-wide association study of incident type 2 diabetes in a British population: EPIC\u2013Norfolk study","volume":"68","author":"Cardona","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib163","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1080\/15592294.2016.1178418","article-title":"DNA methylation of loci within ABCG1 and PHOSPHO1 in blood DNA is associated with future type 2 diabetes risk","volume":"11","author":"Dayeh","year":"2016","journal-title":"Epigenetics"},{"key":"10.1016\/S2213-8587(24)00339-5_bib164","first-page":"142","article-title":"The implication of adipocyte ATP-binding cassette A1 and G1 transporters in metabolic complications of obesity","volume":"70","author":"Choromanska","year":"2019","journal-title":"J Physiol Pharmacol"},{"key":"10.1016\/S2213-8587(24)00339-5_bib165","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/bcp.13898","article-title":"Associations of statin use with glycaemic traits and incident type 2 diabetes","volume":"85","author":"Ahmadizar","year":"2019","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/S2213-8587(24)00339-5_bib166","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCGEN.119.002766","article-title":"Whole blood DNA methylation signatures of diet are associated with cardiovascular disease risk factors and all-cause mortality","volume":"13","author":"Ma","year":"2020","journal-title":"Circ Genom Precis Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib167","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3390\/antiox12020458","article-title":"CHIP haploinsufficiency exacerbates hepatic steatosis via enhanced TXNIP expression and endoplasmic reticulum stress responses","volume":"12","author":"Han","year":"2023","journal-title":"Antioxidants"},{"key":"10.1016\/S2213-8587(24)00339-5_bib168","first-page":"243","article-title":"TXNIP inhibition in the treatment of diabetes. Verapamil as a novel therapeutic modality in diabetic patients","volume":"95","author":"Borowiec","year":"2022","journal-title":"Med Pharm Rep"},{"key":"10.1016\/S2213-8587(24)00339-5_bib169","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11089","article-title":"Blood-based biomarkers of age-associated epigenetic changes in human islets associate with insulin secretion and diabetes","volume":"7","author":"Bacos","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00339-5_bib170","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.2337\/db17-1539","article-title":"Increased hepatic PDGF-AA signaling mediates liver insulin resistance in obesity-associated type 2 diabetes","volume":"67","author":"Abderrahmani","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00339-5_bib171","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-023-43719-9","article-title":"Genes with epigenetic alterations in human pancreatic islets impact mitochondrial function, insulin secretion, and type 2 diabetes","volume":"14","author":"R\u00f6nn","year":"2023","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00339-5_bib172","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.2337\/dc16-0586","article-title":"Precision medicine in diabetes: is it time?","volume":"39","author":"Florez","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00339-5_bib173","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s11892-019-1169-7","article-title":"Type 2 diabetes: multiple genes, multiple diseases","volume":"19","author":"Udler","year":"2019","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(24)00339-5_bib174","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00339-5_bib175","article-title":"Four groups of type 2 diabetes contribute to the etiological and clinical heterogeneity in newly diagnosed individuals: an IMI DIRECT study","volume":"3","author":"Wesolowska-Andersen","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib176","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41591-020-1116-9","article-title":"Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes","volume":"27","author":"Wagner","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib177","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41591-022-01790-7","article-title":"Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes","volume":"28","author":"Nair","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00339-5_bib178","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.1210\/er.2019-00088","article-title":"Genetic risk scores for diabetes diagnosis and precision medicine","volume":"40","author":"Udler","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(24)00339-5_bib179","doi-asserted-by":"crossref","first-page":"674","DOI":"10.2337\/dc21-1395","article-title":"Type 2 diabetes partitioned polygenic scores associate with disease outcomes in 454,193 individuals across 13 cohorts","volume":"45","author":"DiCorpo","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00339-5_bib180","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","article-title":"Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data","volume":"7","author":"Dennis","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00339-5_bib181","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1007\/s00125-017-4210-x","article-title":"Painting a new picture of personalised medicine for diabetes","volume":"60","author":"McCarthy","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00339-5_bib182","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S2213-8587(22)00340-0","article-title":"Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials","volume":"11","author":"Dawed","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00339-5_bib183","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1007\/s00125-015-3588-6","article-title":"Genomic medicine at the heart of diabetes management","volume":"58","author":"McCarthy","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00339-5_bib184","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1007\/s00125-022-05769-4","article-title":"Phenotypic and genetic classification of diabetes","volume":"65","author":"Deutsch","year":"2022","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003395?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003395?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T16:14:44Z","timestamp":1738685684000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003395"}},"issued":{"date-parts":[[2025,2]]},"references-count":184,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2213858724003395"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00339-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dissection of type 2 diabetes: a genetic perspective","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00339-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,3]],"date-time":"2026-09-03T04:17:10Z","timestamp":1788409030848,"version":"build-2803163510"},"reference-count":8,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100007265","name":"BUSM","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA043418-04"],"award-info":[{"award-number":["K23DA043418-04"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["1K01HL151902-01A1"],"award-info":[{"award-number":["1K01HL151902-01A1"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000968","name":"American Heart Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000968","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002584","name":"AHA","doi-asserted-by":"publisher","award":["20CDA35320148"],"award-info":[{"award-number":["20CDA35320148"]}],"id":[{"id":"10.13039\/100002584","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/s2213-8587(21)00266-7","type":"journal-article","created":{"date-parts":[[2021,9,24]],"date-time":"2021-09-24T18:52:59Z","timestamp":1632509579000},"page":"729-731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Impact of the COVID-19 pandemic on transgender and gender diverse health care"],"prefix":"10.1016","volume":"9","author":[{"given":"Claire M","family":"Burgess","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abagail W","family":"Batchelder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colleen A","family":"Sloan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Ieong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Carl G","family":"Streed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00266-7_bib1","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1037\/sgd0000081","article-title":"Development of the gender minority stress and resilience measure","volume":"2","author":"Testa","year":"2015","journal-title":"Psychol Sex Orientat Gend Divers"},{"key":"10.1016\/S2213-8587(21)00266-7_bib2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/S2213-8587(20)30182-0","article-title":"Health care and mental health challenges for transgender individuals during the COVID-19 pandemic","volume":"8","author":"Wang","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00266-7_bib3","series-title":"The report of the 2015 U.S. Transgender Survey","author":"James","year":"2016"},{"key":"10.1016\/S2213-8587(21)00266-7_bib5","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1007\/s10508-020-01754-3","article-title":"\u201cYou have to wait a little longer\u201d: transgender (mental) health at risk as a consequence of deferring gender-affirming treatments during COVID-19","volume":"49","author":"van der Miesen","year":"2020","journal-title":"Arch Sex Behav"},{"key":"10.1016\/S2213-8587(21)00266-7_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0254215","article-title":"Gender-affirming care, mental health, and economic stability in the time of COVID-19: a multi-national, cross-sectional study of transgender and nonbinary people","volume":"16","author":"Jarrett","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00266-7_bib7","author":"Fowers"},{"key":"10.1016\/S2213-8587(21)00266-7_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0239570","article-title":"Residual clinical damage after COVID-19: a retrospective and prospective observational cohort study","volume":"15","author":"De Lorenzo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00266-7_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1056\/NEJMp2031608","article-title":"Telemedicine and medical licensure\u2014potential paths for reform","volume":"384","author":"Mehrotra","year":"2021","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002667?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002667?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:25Z","timestamp":1761991825000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002667"}},"issued":{"date-parts":[[2021,11]]},"references-count":8,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2213858721002667"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00266-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of the COVID-19 pandemic on transgender and gender diverse health care","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00266-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:09:11Z","timestamp":1790748551143,"version":"4.1.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/s2213-8587(17)30435-7","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T23:34:56Z","timestamp":1515540896000},"page":"161-163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Bariatric surgery: many benefits, but emerging risks"],"prefix":"10.1016","volume":"6","author":[{"given":"Matthew J","family":"Spittal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gema","family":"Fr\u00fchbeck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30435-7_bib1","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","author":"NCD Risk Factor Collaboration (NCD-RisC)","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30435-7_bib2","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1038\/nrendo.2015.84","article-title":"Bariatric and metabolic surgery: a shift in eligibility and success criteria","volume":"11","author":"Fr\u00fchbeck","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(17)30435-7_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2213-8587(16)00013-9","article-title":"Self-harm and suicide after bariatric surgery: time for action","volume":"4","author":"Dixon","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30435-7_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(17)30437-0","article-title":"Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies","author":"Neovius","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30435-7_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/acps.12669","article-title":"Risk of psychiatric disorders, self-harm behaviour and service use associated with bariatric surgery","volume":"135","author":"Kovacs","year":"2017","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S2213-8587(17)30435-7_bib6","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1192\/bjp.bp.116.182717","article-title":"Predicting suicidal behaviours using clinical instruments: systematic review and meta-analysis of positive predictive values for risk scales","volume":"210","author":"Carter","year":"2017","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S2213-8587(17)30435-7_bib7","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s11695-016-2271-4","article-title":"Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)","volume":"26","author":"De Luca","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30435-7_bib8","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/j.soard.2016.02.008","article-title":"Recommendations for the presurgical psychosocial evaluation of bariatric surgery patients","volume":"12","author":"Sogg","year":"2016","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(17)30435-7_bib9","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/oby.20066","article-title":"Possible risk factors for increased suicide following bariatric surgery","volume":"21","author":"Mitchell","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(17)30435-7_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.psyneuen.2014.08.016","article-title":"Suicidal patients are deficient in vitamin D, associated with a pro-inflammatory status in the blood","volume":"50","author":"Grudet","year":"2014","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(17)30435-7_bib11","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1176\/appi.ajp.2016.15111500","article-title":"Neurometabolic disorders: potentially treatable abnormalities in patients with treatment-refractory depression and suicidal behavior","volume":"174","author":"Pan","year":"2017","journal-title":"Am J Psychiatry"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304357?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304357?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T09:08:05Z","timestamp":1658308085000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717304357"}},"issued":{"date-parts":[[2018,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2213858717304357"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30435-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bariatric surgery: many benefits, but emerging risks","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30435-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30437-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,11]],"date-time":"2026-09-11T16:14:39Z","timestamp":1789143279832,"version":"build-2803163510"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/s2213-8587(23)00348-0","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T18:31:56Z","timestamp":1701455516000},"page":"14-17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Mendelian randomisation at 20 years: how can it avoid hubris, while achieving more?"],"prefix":"10.1016","volume":"12","author":[{"given":"George Davey","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shah","family":"Ebrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00348-0_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1093\/ije\/dyg070","article-title":"\u2018Mendelian randomization\u2019: can genetic epidemiology contribute to understanding environmental determinants of disease?","volume":"32","author":"Davey Smith","year":"2003","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00348-0_bib2","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s10654-020-00622-7","article-title":"Mendel's laws, Mendelian randomization and causal inference in observational data: substantive and nomenclatural issues","volume":"35","author":"Davey Smith","year":"2020","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00348-0_bib3","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"10.1016\/S2213-8587(23)00348-0_bib4","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/01.ATV.0000183937.65887.9c","article-title":"Does elevated plasma fibrinogen increase the risk of coronary heart disease?: evidence from a meta-analysis of genetic association studies","volume":"25","author":"Davey Smith","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(23)00348-0_bib5","doi-asserted-by":"crossref","first-page":"d548","DOI":"10.1136\/bmj.d548","article-title":"Association between C reactive protein and coronary heart disease: mendelian randomisation analysis based on individual participant data","volume":"342","author":"Wensley","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00348-0_bib6","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1194\/jlr.P066902","article-title":"Associations of genetic variants for adult lipid levels with lipid levels in children. The Generation R Study","volume":"57","author":"Latsuzbaia","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(23)00348-0_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/nrcardio.2017.156","article-title":"Dyslipidaemia: revealing the effect of CETP inhibition in cardiovascular disease","volume":"14","author":"Holmes","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(23)00348-0_bib8","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1093\/ije\/dyx028","article-title":"Two-sample Mendelian randomization: avoiding the downsides of a powerful, widely applicable but potentially fallible technique","volume":"45","author":"Hartwig","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00348-0_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/srep46947","article-title":"Retraction: a significant causal association between C-reactive protein levels and schizophrenia","volume":"8","author":"Inoshita","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(23)00348-0_bib10","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgad569","article-title":"Mendelian randomization studies in endocrinology: raising the quality bar for submissions and publications in The Journal of Clinical Endocrinology & Metabolism","author":"Kjaergaard","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00348-0_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S2213-8587(22)00345-X","article-title":"Mendelian randomisation and vitamin D: the importance of model assumptions","volume":"11","author":"Davey Smith","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00348-0_bib12","article-title":"Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00348-0_bib13","article-title":"Non-linear mendelian randomization: evaluation of biases using negative controls with a focus on BMI and vitamin D","author":"Hamilton","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(23)00348-0_bib14","first-page":"1866","article-title":"Triangulation in aetiological epidemiology","volume":"45","author":"Lawlor","year":"2016","journal-title":"Int J Epidemiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:04:33Z","timestamp":1741190673000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003480"}},"issued":{"date-parts":[[2024,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213858723003480"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00348-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mendelian randomisation at 20 years: how can it avoid hubris, while achieving more?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00348-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00287-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,8]],"date-time":"2026-09-08T12:38:51Z","timestamp":1788871131217,"version":"build-2803163510"},"reference-count":16,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/s2213-8587(13)70090-1","type":"journal-article","created":{"date-parts":[[2013,9,25]],"date-time":"2013-09-25T11:35:24Z","timestamp":1380108924000},"page":"30-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial"],"prefix":"10.1016","volume":"2","author":[{"given":"Helena W","family":"Rodbard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Virginia E","family":"Visco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Line C","family":"Hiort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David HW","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70090-1_bib2","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)","volume":"281","author":"Turner","year":"1999","journal-title":"J Am Med Assoc"},{"key":"10.1016\/S2213-8587(13)70090-1_bib3","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of longterm complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70090-1_bib4","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"Br Med J"},{"key":"10.1016\/S2213-8587(13)70090-1_bib5","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.amjmed.2009.12.004","article-title":"Glycemic control and complications in type 2 diabetes mellitus","volume":"123","author":"Stolar","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(13)70090-1_bib6","doi-asserted-by":"crossref","first-page":"540","DOI":"10.4158\/EP.15.6.540","article-title":"Statement by an American Association of Clinical Endocrinologists\/American College of Endocrinology consensus panel on type 2 diabetes mellitus: an algorithm for glycemic control","volume":"15","author":"Rodbard","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(13)70090-1_bib7","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70090-1_bib8","doi-asserted-by":"crossref","first-page":"727","DOI":"10.4158\/EP10367.OR","article-title":"Comparison of 2 intensification regimens with rapid acting insulin aspart in type 2 diabetes mellitus inadequately controlled by once-daily insulin detemir and oral antidiabetic drugs: the step-wise randomized study","volume":"17","author":"Meneghini","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(13)70090-1_bib9","unstructured":"World Medical Association. Declaration of Helsinki. Ethical principles for medical research involving human subjects. Last amended by the 59th WMA General Assembly, Seoul, October 2008."},{"key":"10.1016\/S2213-8587(13)70090-1_bib10","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1463-1326.2009.01060.x","article-title":"Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets\u2014the TITRATE study","volume":"11","author":"Blonde","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70090-1_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11136-005-1624-6","article-title":"Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience","volume":"15","author":"Brod","year":"2006","journal-title":"Qual Life Res"},{"key":"10.1016\/S2213-8587(13)70090-1_bib12","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1477-7525-7-83","article-title":"Understanding and assessing the impact of treatment in diabetes: the treatment-related impact measures for diabetes and devices (TRIM-Diabetes and TRIM-Diabetes Device)","volume":"7","author":"Brod","year":"2009","journal-title":"Health Qual Life Outcomes"},{"issue":"Suppl 5A","key":"10.1016\/S2213-8587(13)70090-1_bib14","doi-asserted-by":"crossref","first-page":"27S","DOI":"10.1016\/j.amjmed.2005.04.012","article-title":"Adherence to pharmacologic therapy in patients with type 2 diabetes mellitus","volume":"118","author":"Rubin","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(13)70090-1_bib15","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1530\/EJE-11-0022","article-title":"Insulin initiation in patients with type 2 diabetes mellitus: treatment guidelines, clinical evidence and patterns of use of basal vs premixed insulin analogues","volume":"166","author":"Vaag","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70090-1_bib16","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.diabet.2012.08.010","article-title":"Comparison of stepwise addition of prandial insulin to a basal-bolus regimen when basal insulin is insufficient for glycaemic control in type 2 diabetes: results of the OSIRIS study","volume":"38","author":"Raccah","year":"2012","journal-title":"Diabet Metab"},{"key":"10.1016\/S2213-8587(13)70090-1_bib17","doi-asserted-by":"crossref","first-page":"395","DOI":"10.4158\/EP10323.OR","article-title":"A stepwise approach to insulin therapy in patients with type 2 diabetes mellitus and basal insulin treatment failure","volume":"17","author":"Davidson","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(13)70090-1_bib18","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/dme.12019","article-title":"Stepwise intensification of insuliln therapy in type 2 diabetes management-exploring the concept of the basal-plus approach in clinical practice","volume":"30","author":"Owens","year":"2013","journal-title":"Diabet Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:04:53Z","timestamp":1761991493000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700901"}},"issued":{"date-parts":[[2014,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S2213858713700901"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70090-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment intensification with stepwise addition of prandial insulin aspart boluses compared with full basal-bolus therapy (FullSTEP Study): a randomised, treat-to-target clinical trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70090-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70056-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T21:10:29Z","timestamp":1793999429214,"version":"4.8.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["288034826"],"award-info":[{"award-number":["288034826"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271"],"award-info":[{"award-number":["314061271"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["324141047"],"award-info":[{"award-number":["324141047"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/s2213-8587(21)00244-8","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T21:03:06Z","timestamp":1633467786000},"page":"786-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":231,"title":["COVID-19 and metabolic disease: mechanisms and clinical management"],"prefix":"10.1016","volume":"9","author":[{"given":"Charlotte","family":"Steenblock","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter E H","family":"Schwarz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Linkermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Zimmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantin","family":"Kulebyakin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vsevolod A","family":"Tkachuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander G","family":"Markov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin Hrab\u011b","family":"de Angelis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannes","family":"Rietzsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman N","family":"Rodionov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Hopkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas L","family":"Birkenfeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernhard","family":"Boehm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard I G","family":"Holt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jay S","family":"Skyler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Hans","family":"DeVries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert H","family":"Eckel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K George M M","family":"Alberti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Geloneze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Mbanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry C","family":"Onyegbutulem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambady","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Hassanein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gavin","family":"Bewick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giatgen A","family":"Spinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00fcdiger","family":"Landgraf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geltrude","family":"Mingrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00244-8_bib1","doi-asserted-by":"crossref","first-page":"e1003","DOI":"10.1016\/S2214-109X(20)30264-3","article-title":"Global, regional, and national estimates of the population at increased risk of severe COVID-19 due to underlying health conditions in 2020: a modelling study","volume":"8","author":"Clark","year":"2020","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(21)00244-8_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-88130-w","article-title":"A systematic review and meta-analysis of geographic differences in comorbidities and associated severity and mortality among individuals with COVID-19","volume":"11","author":"Thakur","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(21)00244-8_bib3","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-8587(20)30238-2","article-title":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes","volume":"8","author":"Apicella","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib4","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1038\/s41366-021-00804-7","article-title":"Metabolic dysfunction and immunometabolism in COVID-19 pathophysiology and therapeutics","volume":"45","author":"Batabyal","year":"2021","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(21)00244-8_bib5","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1016\/j.dsx.2020.06.016","article-title":"Metabolic syndrome and COVID-19: An update on the associated comorbidities and proposed therapies","volume":"14","author":"Costa","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(21)00244-8_bib6","article-title":"Features of 20\u2008133 UK patients in hospital with covid-19 using the ISARIC WHO Clinical Characterisation Protocol: prospective observational cohort study","volume":"369","author":"Docherty","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00244-8_bib7","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/j.dsx.2021.03.019","article-title":"Non-alcoholic fatty liver disease and clinical outcomes in patients with COVID-19: a comprehensive systematic review and meta-analysis","volume":"15","author":"Singh","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(21)00244-8_bib8","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1111\/dom.14124","article-title":"Prevalence of co-morbidities and their association with mortality in patients with COVID-19: a systematic review and meta-analysis","volume":"22","author":"Singh","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib9","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1038\/s41574-020-00462-1","article-title":"Global pandemics interconnected \u2013 obesity, impaired metabolic health and COVID-19","volume":"17","author":"Stefan","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib10","doi-asserted-by":"crossref","first-page":"1578","DOI":"10.1016\/j.immuni.2021.05.002","article-title":"Distinct immunological signatures discriminate severe COVID-19 from non-SARS-CoV-2-driven critical pneumonia","volume":"54","author":"Kreutmair","year":"2021","journal-title":"Immunity"},{"key":"10.1016\/S2213-8587(21)00244-8_bib11","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1016\/S0140-6736(20)31024-2","article-title":"Obesity could shift severe COVID-19 disease to younger ages","volume":"395","author":"Kass","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00244-8_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1038\/s42255-021-00358-y","article-title":"Consequences of the COVID-19 pandemic for patients with metabolic diseases","volume":"3","author":"Bornstein","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib13","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2337\/dc20-2260","article-title":"COVID-19 severity is tripled in the diabetes community: a prospective analysis of the pandemic's impact in type 1 and type 2 diabetes","volume":"44","author":"Gregory","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00244-8_bib14","doi-asserted-by":"crossref","first-page":"e240","DOI":"10.1016\/S2468-2667(20)30085-2","article-title":"Why inequality could spread COVID-19","volume":"5","author":"Ahmed","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(21)00244-8_bib15","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.10.020389","article-title":"COVID-19: Obesity, deprivation and death","volume":"10","author":"Simpson","year":"2020","journal-title":"J Glob Health"},{"key":"10.1016\/S2213-8587(21)00244-8_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmi.2021.06.036","article-title":"BNT162b2 vaccine breakthrough: clinical characteristics of 152 fully vaccinated hospitalized COVID-19 patients in Israel","author":"Brosh-Nissimov","year":"2021","journal-title":"Clin Microbiol Infect"},{"key":"10.1016\/S2213-8587(21)00244-8_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/jcm10132945","article-title":"Long-term outcomes of patients with coronavirus disease 2019 at one year after hospital discharge","volume":"10","author":"Maestre-Mu\u00f1iz","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/S2213-8587(21)00244-8_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.686029","article-title":"Unraveling the mystery surrounding post-acute sequelae of COVID-19","volume":"12","author":"Ramakrishnan","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1111\/bph.12159","article-title":"ACE2, angiotensin-(1-7) and Mas receptor axis in inflammation and fibrosis","volume":"169","author":"Sim\u00f5es e Silva","year":"2013","journal-title":"Br J Pharmacol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib20","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1016\/j.phrs.2017.06.005","article-title":"The vasoprotective axes of the renin-angiotensin system: Physiological relevance and therapeutic implications in cardiovascular, hypertensive and kidney diseases","volume":"125","author":"Li","year":"2017","journal-title":"Pharmacol Res"},{"key":"10.1016\/S2213-8587(21)00244-8_bib21","doi-asserted-by":"crossref","first-page":"e07","DOI":"10.15420\/ecr.2020.30","article-title":"The renin-angiotensin-aldosterone system and coronavirus disease 2019","volume":"16","author":"Coto","year":"2021","journal-title":"Eur Cardiol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib22","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib23","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/978-94-024-1079-2_69","article-title":"Effects of taurine on ACE, ACE2 and HSP70 expression of hypothalamic-pituitary-adrenal axis in stress-induced hypertensive rats","volume":"975","author":"Lv","year":"2017","journal-title":"Adv Exp Med Biol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib24","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.cmet.2020.11.006","article-title":"SARS-CoV-2 cell entry factors ACE2 and TMPRSS2 are expressed in the microvasculature and ducts of human pancreas but are not enriched in \u03b2 cells","volume":"32","author":"Coate","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib25","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1016\/j.cmet.2020.11.005","article-title":"Expression of SARS-CoV-2 entry factors in the pancreas of normal organ donors and individuals with COVID-19","volume":"32","author":"Kusmartseva","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib26","doi-asserted-by":"crossref","first-page":"2128","DOI":"10.1016\/j.cgh.2020.04.040","article-title":"ACE2 expression in pancreas may cause pancreatic damage after SARS-CoV-2 infection","volume":"18","author":"Liu","year":"2020","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.596898","article-title":"SARS-CoV-2 receptor angiotensin I-converting enzyme type 2 (ACE2) is expressed in human pancreatic \u03b2-cells and in the human pancreas microvasculature","volume":"11","author":"Fignani","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(21)00244-8_bib28","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s42255-021-00347-1","article-title":"SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas","volume":"3","author":"M\u00fcller","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib29","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1016\/j.cmet.2021.05.013","article-title":"SARS-CoV-2 infects human pancreatic \u03b2 cells and elicits \u03b2 cell impairment","volume":"33","author":"Wu","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib30","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23886-3","article-title":"Viral infiltration of pancreatic islets in patients with COVID-19","volume":"12","author":"Steenblock","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(21)00244-8_bib31","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110271","article-title":"Relevance of SARS-CoV-2 related factors ACE2 and TMPRSS2 expressions in gastrointestinal tissue with pathogenesis of digestive symptoms, diabetes-associated mortality, and disease recurrence in COVID-19 patients","volume":"144","author":"Kumar","year":"2020","journal-title":"Med Hypotheses"},{"key":"10.1016\/S2213-8587(21)00244-8_bib32","doi-asserted-by":"crossref","first-page":"R45","DOI":"10.1530\/JOE-20-0260","article-title":"Endocrine aspects of ACE2 regulation: RAAS, steroid hormones and SARS-CoV-2","volume":"247","author":"Young","year":"2020","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib33","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/S2213-8587(21)00244-8_bib34","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1056\/NEJMoa2021436","article-title":"Dexamethasone in hospitalized patients with COVID-19","volume":"384","author":"Horby","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00244-8_bib35","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.molmet.2019.12.012","article-title":"Glucocorticoid induces human beta cell dysfunction by involving riborepressor GAS5 LincRNA","volume":"32","author":"Esguerra","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib36","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/ehjcvp\/pvaa064","article-title":"A systematic review and meta-analysis to evaluate the clinical outcomes in COVID-19 patients on angiotensin-converting enzyme inhibitors or angiotensin receptor blockers","volume":"7","author":"Grover","year":"2021","journal-title":"Eur Heart J Cardiovasc Pharmacother"},{"key":"10.1016\/S2213-8587(21)00244-8_bib37","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-16048-4","article-title":"Neutralization of SARS-CoV-2 spike pseudotyped virus by recombinant ACE2-Ig","volume":"11","author":"Lei","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(21)00244-8_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.therap.2021.01.051","article-title":"DPP-4 inhibitors and severe course of illness in patients with COVID-19","volume":"76","author":"Bouhanick","year":"2021","journal-title":"Therapie"},{"key":"10.1016\/S2213-8587(21)00244-8_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.tim.2021.03.004","article-title":"Therapeutic potential of metformin in COVID-19: reasoning for its protective role","author":"Samuel","year":"2021","journal-title":"Trends Microbiol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib40","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S2213-8587(21)00050-4","article-title":"Prescription of glucose-lowering therapies and risk of COVID-19 mortality in people with type 2 diabetes: a nationwide observational study in England","volume":"9","author":"Khunti","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2020.107723","article-title":"Anti-inflammatory properties of antidiabetic drugs: a \u201cpromised land\u201d in the COVID-19 era?","volume":"34","author":"Katsiki","year":"2020","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(21)00244-8_bib42","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/j.bbrc.2020.01.081","article-title":"Intratracheal GLP-1 receptor agonist treatment up-regulates mucin via p38 and exacerbates emphysematous phenotype in mucus hypersecretory obstructive lung diseases","volume":"524","author":"Nohara","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(21)00244-8_bib43","doi-asserted-by":"crossref","DOI":"10.1177\/2042018821996482","article-title":"Dipeptidyl peptidase-4 inhibitor use and mortality in COVID-19 patients with diabetes mellitus: an updated systematic review and meta-analysis","volume":"12","author":"Pal","year":"2021","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib44","doi-asserted-by":"crossref","first-page":"251","DOI":"10.4093\/dmj.2020.0206","article-title":"Effects of a DPP-4 inhibitor and RAS blockade on clinical outcomes of patients with diabetes and COVID-19","volume":"45","author":"Rhee","year":"2021","journal-title":"Diabetes Metab J"},{"key":"10.1016\/S2213-8587(21)00244-8_bib45","doi-asserted-by":"crossref","DOI":"10.1016\/j.lanepe.2021.100178","article-title":"Humoral and cellular immunity to SARS-CoV-2 vaccination in renal transplant versus dialysis patients: a prospective, multicenter observational study using mRNA-1273 or BNT162b2 mRNA vaccine","author":"Stumpf","year":"2021","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/S2213-8587(21)00244-8_bib46","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2337\/dci21-0003","article-title":"Diabetes, obesity, COVID-19, Insulin, and other antidiabetes drugs","volume":"44","author":"Dandona","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00244-8_bib47","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/j.cmet.2020.11.014","article-title":"Insulin treatment is associated with increased mortality in patients with COVID-19 and type 2 diabetes","volume":"33","author":"Yu","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib48","doi-asserted-by":"crossref","first-page":"2431","DOI":"10.1056\/NEJMoa2006923","article-title":"Renin-angiotensin-aldosterone system blockers and the risk of COVID-19","volume":"382","author":"Mancia","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00244-8_bib49","doi-asserted-by":"crossref","first-page":"1020","DOI":"10.1001\/jamacardio.2020.1855","article-title":"Association of use of angiotensin-converting enzyme inhibitors and angiotensin ii receptor blockers with testing positive for coronavirus disease 2019 (COVID-19)","volume":"5","author":"Mehta","year":"2020","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib50","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1161\/CIRCRESAHA.120.317134","article-title":"Association of inpatient use of angiotensin-converting enzyme inhibitors and angiotensin II receptor blockers with mortality among patients with hypertension hospitalized with COVID-19","volume":"126","author":"Zhang","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(21)00244-8_bib51","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9072315","article-title":"The plasmatic aldosterone and c-reactive protein levels, and the severity of COVID-19: the Dyhor-19 study","volume":"9","author":"Villard","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/S2213-8587(21)00244-8_bib52","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2020.02.052","article-title":"SARS-CoV-2 cell entry depends on ACE2 and TMPRSS2 and is blocked by a clinically proven protease inhibitor","volume":"181","author":"Hoffmann","year":"2020","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(21)00244-8_bib53","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.cell.2020.02.058","article-title":"Structure, function, and antigenicity of the SARS-CoV-2 spike glycoprotein","volume":"181","author":"Walls","year":"2020","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(21)00244-8_bib54","doi-asserted-by":"crossref","DOI":"10.1126\/science.abg3055","article-title":"Estimated transmissibility and impact of SARS-CoV-2 lineage B.1.1.7 in England","volume":"372","author":"Davies","year":"2021","journal-title":"Science"},{"key":"10.1016\/S2213-8587(21)00244-8_bib55","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1126\/science.abh2644","article-title":"Genomics and epidemiology of the P.1 SARS-CoV-2 lineage in Manaus, Brazil","volume":"372","author":"Faria","year":"2021","journal-title":"Science"},{"key":"10.1016\/S2213-8587(21)00244-8_bib56","doi-asserted-by":"crossref","DOI":"10.2807\/1560-7917.ES.2020.26.1.2002106","article-title":"Early transmissibility assessment of the N501Y mutant strains of SARS-CoV-2 in the United Kingdom, October to November 2020","volume":"26","author":"Leung","year":"2021","journal-title":"Euro Surveill"},{"key":"10.1016\/S2213-8587(21)00244-8_bib57","doi-asserted-by":"crossref","first-page":"7045","DOI":"10.1002\/jcp.30367","article-title":"Higher infectivity of the SARS-CoV-2 new variants is associated with K417N\/T, E484K, and N501Y mutants: an insight from structural data","volume":"236","author":"Khan","year":"2021","journal-title":"J Cell Physiol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e06564","article-title":"Pan-India novel coronavirus SARS-CoV-2 genomics and global diversity analysis in spike protein","volume":"7","author":"Alai","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/S2213-8587(21)00244-8_bib59","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/s41586-020-2180-5","article-title":"Structure of the SARS-CoV-2 spike receptor-binding domain bound to the ACE2 receptor","volume":"581","author":"Lan","year":"2020","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(21)00244-8_bib60","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1126\/science.abd2985","article-title":"Neuropilin-1 facilitates SARS-CoV-2 cell entry and infectivity","volume":"370","author":"Cantuti-Castelvetri","year":"2020","journal-title":"Science"},{"key":"10.1016\/S2213-8587(21)00244-8_bib61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/j.cell.2020.10.028","article-title":"Genome-wide CRISPR screens reveal host factors critical for SARS-CoV-2 infection","volume":"184","author":"Wei","year":"2021","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(21)00244-8_bib62","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cell.2020.11.025","article-title":"Synergism of TNF-\u03b1 and IFN-\u03b3 triggers inflammatory cell death, tissue damage, and mortality in SARS-CoV-2 infection and cytokine shock syndromes","volume":"184","author":"Karki","year":"2021","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(21)00244-8_bib63","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1186\/s13054-020-03209-6","article-title":"Serum levels of receptor-interacting protein kinase-3 in patients with COVID-19","volume":"24","author":"Nakamura","year":"2020","journal-title":"Crit Care"},{"key":"10.1016\/S2213-8587(21)00244-8_bib64","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/nri3743","article-title":"Regulated cell death and inflammation: an auto-amplification loop causes organ failure","volume":"14","author":"Linkermann","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.isci.2020.101400","article-title":"The MERS-CoV Receptor DPP4 as a candidate binding target of the SARS-CoV-2 spike","volume":"23","author":"Li","year":"2020","journal-title":"iScience"},{"key":"10.1016\/S2213-8587(21)00244-8_bib66","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/713609354","article-title":"Dipeptidyl-peptidase IV from bench to bedside: an update on structural properties, functions, and clinical aspects of the enzyme DPP IV","volume":"40","author":"Lambeir","year":"2003","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/S2213-8587(21)00244-8_bib67","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1210\/er.2014-1035","article-title":"Pharmacology, physiology, and mechanisms of action of dipeptidyl peptidase-4 inhibitors","volume":"35","author":"Mulvihill","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(21)00244-8_bib68","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa011","article-title":"Coronavirus Infections and type 2 diabetes-shared pathways with therapeutic implications","volume":"41","author":"Drucker","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(21)00244-8_bib69","article-title":"The impact of obesity on severe disease and mortality in people with SARS-CoV-2: a systematic review and meta-analysis","volume":"4","author":"Seidu","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib70","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1038\/s42255-020-0237-2","article-title":"A metabolic handbook for the COVID-19 pandemic","volume":"2","author":"Ayres","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib71","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S2213-8587(20)30110-8","article-title":"Causes, consequences, and treatment of metabolically unhealthy fat distribution","volume":"8","author":"Stefan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib72","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1161\/CIRCRESAHA.120.317055","article-title":"COVID-19 and the heart","volume":"126","author":"Akhmerov","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(21)00244-8_bib73","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bbi.2020.04.077","article-title":"COVID-19 presenting as stroke","volume":"87","author":"Avula","year":"2020","journal-title":"Brain Behav Immun"},{"key":"10.1016\/S2213-8587(21)00244-8_bib74","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a009191","article-title":"Insulin receptor signaling in normal and insulin-resistant states","volume":"6","author":"Boucher","year":"2014","journal-title":"Cold Spring Harb Perspect Biol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib75","doi-asserted-by":"crossref","first-page":"1213","DOI":"10.1016\/j.dsx.2019.01.041","article-title":"How the association between obesity and inflammation may lead to insulin resistance and cancer","volume":"13","author":"Amin","year":"2019","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(21)00244-8_bib76","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00424-017-1955-5","article-title":"Macrophage function in obesity-induced inflammation and insulin resistance","volume":"469","author":"Lauterbach","year":"2017","journal-title":"Pflugers Arch"},{"key":"10.1016\/S2213-8587(21)00244-8_bib77","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1186\/s13098-021-00639-2","article-title":"Diabetes, obesity, and insulin resistance in COVID-19: molecular interrelationship and therapeutic implications","volume":"13","author":"Santos","year":"2021","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/S2213-8587(21)00244-8_bib78","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0133494","article-title":"Obesity is a positive modulator of IL-6R and IL-6 expression in the subcutaneous adipose tissue: significance for metabolic inflammation","volume":"10","author":"Sindhu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00244-8_bib79","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.diabres.2014.04.006","article-title":"Inflammation as a link between obesity, metabolic syndrome and type 2 diabetes","volume":"105","author":"Esser","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(21)00244-8_bib80","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1016\/j.jacc.2018.07.081","article-title":"Blood sugar regulation for cardiovascular health promotion and disease prevention: JACC health promotion series","volume":"72","author":"Schwarz","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib81","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1055\/s-2007-978907","article-title":"Regulation of adrenocortical function by cytokines\u2013relevance for immune-endocrine interaction","volume":"30","author":"Marx","year":"1998","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(21)00244-8_bib82","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1038\/s41380-020-0758-9","article-title":"Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) and the neuroendocrine stress axis","volume":"25","author":"Steenblock","year":"2020","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S2213-8587(21)00244-8_bib83","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1016\/S2213-2600(21)00160-0","article-title":"Inhaled budesonide in the treatment of early COVID-19 (STOIC): a phase 2, open-label, randomised controlled trial","volume":"9","author":"Ramakrishnan","year":"2021","journal-title":"Lancet Respir Med"},{"key":"10.1016\/S2213-8587(21)00244-8_bib84","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1016\/S2213-8587(20)30149-2","article-title":"Use of glucocorticoids in patients with adrenal insufficiency and COVID-19 infection","volume":"8","author":"Isidori","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib85","first-page":"327","article-title":"Induction of pro-inflammatory cytokines (IL-1 and IL-6) and lung inflammation by Coronavirus-19 (COVI-19 or SARS-CoV-2): anti-inflammatory strategies","volume":"34","author":"Conti","year":"2020","journal-title":"J Biol Regul Homeost Agents"},{"key":"10.1016\/S2213-8587(21)00244-8_bib86","doi-asserted-by":"crossref","DOI":"10.1016\/j.curtheres.2020.100609","article-title":"Diabetic ketoacidosis precipitated by Coronavirus disease 2019 infection: case series","volume":"93","author":"Alsadhan","year":"2020","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/S2213-8587(21)00244-8_bib87","doi-asserted-by":"crossref","first-page":"2491e3","DOI":"10.1016\/j.ajem.2020.05.114","article-title":"Newly diagnosed diabetes and diabetic ketoacidosis precipitated by COVID-19 infection","volume":"38","author":"Heaney","year":"2020","journal-title":"Am J Emerg Med"},{"key":"10.1016\/S2213-8587(21)00244-8_bib88","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1038\/s42255-020-00281-8","article-title":"Autoantibody-negative insulin-dependent diabetes mellitus after SARS-CoV-2 infection: a case report","volume":"2","author":"Hollstein","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib89","doi-asserted-by":"crossref","first-page":"1935","DOI":"10.1111\/dom.14057","article-title":"COVID-19 infection may cause ketosis and ketoacidosis","volume":"22","author":"Li","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib90","doi-asserted-by":"crossref","first-page":"774","DOI":"10.1038\/s42255-021-00407-6","article-title":"Acute and long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"3","author":"Montefusco","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib91","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1515\/jpem-2020-0426","article-title":"New onset diabetes with diabetic ketoacidosis in a child with multisystem inflammatory syndrome due to COVID-19","volume":"34","author":"Naguib","year":"2020","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib92","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMc2018688","article-title":"New-onset diabetes in COVID-19","volume":"383","author":"Rubino","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00244-8_bib93","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2020.13445","article-title":"Ketoacidosis in children and adolescents with newly diagnosed type 1 diabetes during the COVID-19 pandemic in Germany","volume":"324","author":"Kamrath","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00244-8_bib94","article-title":"New-onset type 1 diabetes in Finnish children during the COVID-19 pandemic","author":"Salmi","year":"2021","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(21)00244-8_bib95","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2020-237903","article-title":"Coronavirus disease-19 (COVID-19) associated with acute necrotising pancreatitis (ANP)","volume":"13","author":"Kumaran","year":"2020","journal-title":"BMJ Case Rep"},{"key":"10.1016\/S2213-8587(21)00244-8_bib96","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1038\/s42255-020-00339-7","article-title":"Can COVID-19 cause diabetes?","volume":"3","author":"Accili","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib97","doi-asserted-by":"crossref","DOI":"10.1111\/aphw.12284","article-title":"Adhering to COVID-19 health guidelines: examining demographic and psychological predictors of adherence","author":"Bailey","year":"2021","journal-title":"Appl Psychol Health Well-Being"},{"key":"10.1016\/S2213-8587(21)00244-8_bib98","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.dsx.2021.02.026","article-title":"COVID-19 vaccination in patients with diabetes mellitus: current concepts, uncertainties and challenges","volume":"15","author":"Pal","year":"2021","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(21)00244-8_bib99","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00125-021-05404-8","article-title":"The disproportionate excess mortality risk of COVID-19 in younger people with diabetes warrants vaccination prioritisation","volume":"64","author":"McGovern","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00244-8_bib100","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1007\/BF03347104","article-title":"The European perspective of diabetes prevention: the need for individualization of diabetes prevention","volume":"36","author":"M\u00fcller","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(21)00244-8_bib102","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14469","article-title":"Use of MyDesmond digital education programme to support self-management in people with type 2 diabetes during the COVID-19 pandemic","volume":"38","author":"Quinn","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00244-8_bib103","article-title":"Diabetes-related amputations: a pandemic within a pandemic","author":"Rogers","year":"2020","journal-title":"J Am Podiatr Med Assoc"},{"key":"10.1016\/S2213-8587(21)00244-8_bib105","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.dsx.2020.06.042","article-title":"Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals","volume":"14","author":"Chudasama","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(21)00244-8_bib106","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14549","article-title":"The impact of COVID-19 restrictions on accelerometer-assessed physical activity and sleep in individuals with type 2 diabetes","author":"Rowlands","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00244-8_bib107","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.2337\/dci21-0001","article-title":"Diabetes and COVID-19: population impact 18 months into the pandemic","volume":"44","author":"Gregg","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00244-8_bib108","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S2213-8587(20)30405-8","article-title":"Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland","volume":"9","author":"McGurnaghan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib109","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14439","article-title":"A post COVID-19 \u2018Marshall Plan\u2019 for type 2 diabetes","volume":"38","author":"Petrie","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00244-8_bib110","doi-asserted-by":"crossref","DOI":"10.2196\/28097","article-title":"Psychological crisis intervention for COVID-19 lockdown stress in patients with type 1 diabetes mellitus: survey study and qualitative analysis","volume":"8","author":"Cyranka","year":"2021","journal-title":"JMIR Ment Health"},{"key":"10.1016\/S2213-8587(21)00244-8_bib111","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-002035","article-title":"Increased stress, weight gain and less exercise in relation to glycemic control in people with type 1 and type 2 diabetes during the COVID-19 pandemic","volume":"9","author":"Ruissen","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(21)00244-8_bib112","doi-asserted-by":"crossref","DOI":"10.2174\/1573403X17666210126103204","article-title":"Stress and physical inactivity: two explosive ingredients for the heart in COVID-19 pandemic times","author":"Ruberti","year":"2021","journal-title":"Curr Cardiol Rev"},{"key":"10.1016\/S2213-8587(21)00244-8_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.jdiacomp.2021.107927","article-title":"Pharmacological management of COVID-19 in type 2 diabetes","volume":"35","author":"Ceriello","year":"2021","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(21)00244-8_bib114","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S2213-8587(21)00180-7","article-title":"Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Kosiborod","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib115","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108695","article-title":"Phenotypic characteristics and prognosis of newly diagnosed diabetes in hospitalized patients with COVID-19: results from the CORONADO study","volume":"175","author":"Cariou","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(21)00244-8_bib116","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.2337\/dc20-1824","article-title":"Association between DPP-4 inhibitors and COVID-19-related outcomes among patients with type 2 diabetes","volume":"44","author":"Noh","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00244-8_bib117","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2337\/dc20-1521","article-title":"Sitagliptin treatment at the time of hospitalization was associated with reduced mortality in patients with type 2 diabetes and covid-19: a multicenter, case-control, retrospective, observational study","volume":"43","author":"Solerte","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00244-8_bib118","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1002\/jmv.26498","article-title":"Mortality risk with preadmission metformin use in patients with COVID-19 and diabetes: a meta-analysis","volume":"93","author":"Kow","year":"2021","journal-title":"J Med Virol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib119","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/j.diabet.2020.07.006","article-title":"Metformin and COVID-19: from cellular mechanisms to reduced mortality","volume":"46","author":"Scheen","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib120","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/j.cmet.2020.08.013","article-title":"Metformin is associated with higher incidence of acidosis, but not mortality, in individuals with COVID-19 and pre-existing type 2 diabetes","volume":"32","author":"Cheng","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib121","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1016\/S0140-6736(21)00676-0","article-title":"Tocilizumab in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"397","author":"Group","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00244-8_bib122","first-page":"465","article-title":"Rapid beneficial effect of the IL-6 receptor blockade on insulin resistance and insulin sensitivity in non-diabetic patients with rheumatoid arthritis","volume":"37","author":"Casta\u00f1eda","year":"2019","journal-title":"Clin Exp Rheumatol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib123","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.diabet.2020.05.005","article-title":"Negative impact of hyperglycaemia on tocilizumab therapy in COVID-19 patients","volume":"46","author":"Marfella","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib124","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1007\/s00125-020-05164-x","article-title":"Prevention and management of COVID-19 among patients with diabetes: an appraisal of the literature","volume":"63","author":"Katulanda","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00244-8_bib125","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: meta-analysis A","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00244-8_bib126","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1111\/1753-0407.12090","article-title":"Glucocorticoid-induced hyperglycemia","volume":"6","author":"Perez","year":"2014","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(21)00244-8_bib128","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","volume":"31","author":"Zhu","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib129","doi-asserted-by":"crossref","first-page":"578","DOI":"10.2337\/dc20-1857","article-title":"Association between achieving inpatient glycemic control and clinical outcomes in hospitalized patients with COVID-19: a multicenter, retrospective hospital-based analysis","volume":"44","author":"Klonoff","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00244-8_bib130","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/dc20-1862","article-title":"Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study","volume":"44","author":"Lu","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00244-8_bib131","article-title":"Altered lipid metabolism in recovered SARS patients twelve years after infection","volume":"7","author":"Wu","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(21)00244-8_bib132","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1007\/s00592-009-0109-4","article-title":"Binding of SARS coronavirus to its receptor damages islets and causes acute diabetes","volume":"47","author":"Yang","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib133","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/1471-2377-11-37","article-title":"Chronic widespread musculoskeletal pain, fatigue, depression and disordered sleep in chronic post-SARS syndrome; a case-controlled study","volume":"11","author":"Moldofsky","year":"2011","journal-title":"BMC Neurol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib134","doi-asserted-by":"crossref","DOI":"10.1016\/j.mehy.2020.110469","article-title":"COVID-19 and chronic fatigue syndrome: is the worst yet to come?","volume":"146","author":"Wostyn","year":"2021","journal-title":"Med Hypotheses"},{"key":"10.1016\/S2213-8587(21)00244-8_bib135","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(21)00244-8_bib136","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1136\/bjsports-2020-102596","article-title":"The Stanford Hall consensus statement for post-COVID-19 rehabilitation","volume":"54","author":"Barker-Davies","year":"2020","journal-title":"Br J Sports Med"},{"key":"10.1016\/S2213-8587(21)00244-8_bib137","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.jsbmb.2019.04.006","article-title":"The adrenal gland in stress \u2013 adaptation on a cellular level","volume":"190","author":"Berger","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.iccn.2021.103084","article-title":"Experiences, opinions and expectations of health care providers towards an intensive care unit follow-up clinic: Qualitative study and online survey","author":"Rohr","year":"2021","journal-title":"Intensive Crit Care Nurs"},{"key":"10.1016\/S2213-8587(21)00244-8_bib139","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.idc.2021.03.009","article-title":"Mucormycosis","volume":"35","author":"Steinbrink","year":"2021","journal-title":"Infect Dis Clin North Am"},{"key":"10.1016\/S2213-8587(21)00244-8_bib140","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1017\/S0022215121000992","article-title":"Post coronavirus disease mucormycosis: a deadly addition to the pandemic spectrum","volume":"135","author":"Sharma","year":"2021","journal-title":"J Laryngol Otol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib141","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41574-021-00495-0","article-title":"Long COVID \u2013 metabolic risk factors and novel therapeutic management","volume":"17","author":"Khunti","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib142","doi-asserted-by":"crossref","first-page":"n693","DOI":"10.1136\/bmj.n693","article-title":"Post-COVID syndrome in individuals admitted to hospital with COVID-19: retrospective cohort study","volume":"372","author":"Ayoubkhani","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00244-8_bib143","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1186\/s13098-020-00593-5","article-title":"Prevalence of people at risk of developing type 2 diabetes mellitus and the involvement of community pharmacies in a national screening campaign: a pioneer action in Brazil","volume":"12","author":"Correr","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/S2213-8587(21)00244-8_bib144","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0377-1237(09)80056-7","article-title":"Diabetes mellitus in India: the modern scourge","volume":"65","author":"Mehta","year":"2009","journal-title":"Med J Armed Forces India"},{"key":"10.1016\/S2213-8587(21)00244-8_bib145","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1007\/s10654-013-9771-5","article-title":"Twelve-year trends in the prevalence and risk factors of diabetes and prediabetes in Turkish adults","volume":"28","author":"Satman","year":"2013","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00244-8_bib146","author":"Soy"},{"key":"10.1016\/S2213-8587(21)00244-8_bib147","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1007\/s00125-019-4941-y","article-title":"What should governments be doing to prevent diabetes throughout the life course?","volume":"62","author":"Timpel","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00244-8_bib148","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.mayocpiqo.2020.12.004","article-title":"Digital health surveillance strategies for management of coronavirus disease 2019","volume":"5","author":"Jose","year":"2021","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/S2213-8587(21)00244-8_bib149","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/s13063-020-04982-z","article-title":"Effectiveness and cost-effectiveness of four different strategies for SARS-CoV-2 surveillance in the general population (CoV-Surv Study): a structured summary of a study protocol for a cluster-randomised, two-factorial controlled trial","volume":"22","author":"Deckert","year":"2021","journal-title":"Trials"},{"key":"10.1016\/S2213-8587(21)00244-8_bib150","first-page":"287","article-title":"A quantitative estimation of the pancreatic islet tissue1","volume":"6","author":"Ogilvie","year":"1937","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(21)00244-8_bib151","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/dom.14293","article-title":"Change in glucose-lowering medication regimens in individuals with type 2 diabetes mellitus during the COVID-19 pandemic in Germany","volume":"23","author":"Jacob","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00244-8_bib152","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002448?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002448?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:00Z","timestamp":1761991800000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002448"}},"issued":{"date-parts":[[2021,11]]},"references-count":149,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2213858721002448"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00244-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19 and metabolic disease: mechanisms and clinical management","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00244-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:01:23Z","timestamp":1794268883469,"version":"4.9.0"},"reference-count":60,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000865","name":"Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["304467\/2015\\u20134"],"award-info":[{"award-number":["304467\/2015\\u20134"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/s2213-8587(25)00217-7","type":"journal-article","created":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T16:10:53Z","timestamp":1757520653000},"page":"924-934","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["Global, regional, and national cascades of diabetes care, 2000\u201323: a systematic review and modelling analysis using findings from the Global Burden of Disease Study"],"prefix":"10.1016","volume":"13","author":[{"given":"Lauryn K","family":"Stafford","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Gage","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne Yiru","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madeleine","family":"Conrad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismael Barreras","family":"Beltran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J","family":"Boyko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce B","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon I","family":"Hay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hailey","family":"Lenox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Lozano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna J","family":"Magliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos A","family":"Aguilar Salinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Zitko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J L","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annie","family":"Haakenstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kanyin Liane","family":"Ong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00217-7_bib1","series-title":"10th edition scientific committee. IDF Diabetes Atlas","author":"Magliano","year":"2021"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00217-7_bib2","first-page":"S20","article-title":"Diagnosis and Classification of Diabetes: Standards of Care in Diabetes","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00217-7_bib5","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/S0140-6736(24)00757-8","volume":"403","author":"Ferrari","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"0","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib7","unstructured":"Hay SI, Ong LK. Burden of 375 diseases and injuries, risk-attributable burden of 88 risk factors, and healthy life expectancy in 204 countries and territories, including 660 subnational locations, 1990\u20132023: a systematic analysis for the Global Burden of Disease Study 2023. Lancet (in press)."},{"key":"10.1016\/S2213-8587(25)00217-7_bib8","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1016\/j.jand.2016.11.016","article-title":"The effectiveness and cost of lifestyle interventions including nutrition education for diabetes prevention: a systematic review and meta-analysis","volume":"117","author":"Sun","year":"2017","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib9","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.2337\/dci24-0063","article-title":"History of the diabetes control and complications trial and its follow-up epidemiology of diabetes interventions and complications study: studies that changed the treatment of type 1 diabetes","volume":"47","author":"Nathan","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00217-7_bib10","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib11","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00217-7_bib12","first-page":"S179","article-title":"Cardiovascular disease and risk management: standards of care in diabetes","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00217-7_bib13","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-001061","article-title":"Association between pre-diabetes and microvascular and macrovascular disease in newly diagnosed type 2 diabetes","volume":"8","author":"Palladino","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(25)00217-7_bib14","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1016\/S0140-6736(24)01439-9","article-title":"Global health 2050: the path to halving premature death by mid-century","volume":"404","author":"Jamison","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib15","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s12981-016-0120-0","article-title":"The HIV treatment cascade and care continuum: updates, goals, and recommendations for the future","volume":"13","author":"Kay","year":"2016","journal-title":"AIDS Res Ther"},{"key":"10.1016\/S2213-8587(25)00217-7_bib16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1016\/S1473-3099(16)30216-X","article-title":"The cascade of care in diagnosis and treatment of latent tuberculosis infection: a systematic review and meta-analysis","volume":"16","author":"Alsdurf","year":"2016","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S2213-8587(25)00217-7_bib17","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1001\/jamainternmed.2019.2396","article-title":"Evaluation of the cascade of diabetes care in the United States, 2005\u201316","volume":"179","author":"Kazemian","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(25)00217-7_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-069193","article-title":"Diabetes care cascade and associated factors in 10 700 middle-aged adults in four sub-Saharan African countries: a cross-sectional study","volume":"13","author":"Wade","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(25)00217-7_bib19","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"Zhou","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002751","article-title":"Health system performance for people with diabetes in 28 low- and middle-income countries: a cross-sectional study of nationally representative surveys","volume":"16","author":"Manne-Goehler","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(25)00217-7_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2024.1305304","article-title":"The worldwide trend in diabetes awareness, treatment, and control from 1985 to 2022: a systematic review and meta-analysis of 233 population-representative studies","volume":"12","author":"Shahrestanaki","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/S2213-8587(25)00217-7_bib22","first-page":"116","article-title":"Rule of halves: implications of increasing diagnosis and reducing dropout for future workload and prescribing costs in primary care","volume":"42","author":"Hart","year":"1992","journal-title":"Br J Gen Pract"},{"key":"10.1016\/S2213-8587(25)00217-7_bib23","doi-asserted-by":"crossref","first-page":"1250","DOI":"10.1016\/S0140-6736(20)30750-9","article-title":"Measuring universal health coverage based on an index of effective coverage of health services in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","author":"Lozano","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib25","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00217-7_bib26","first-page":"S111","article-title":"Glycemic goals and hypoglycemia: standards of care in diabetes","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00217-7_bib27","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1080\/10618600.2020.1868303","article-title":"Trimmed constrained mixed effects models: formulations and algorithms","volume":"30","author":"Zheng","year":"2021","journal-title":"J Comput Graph Stat"},{"key":"10.1016\/S2213-8587(25)00217-7_bib28","doi-asserted-by":"crossref","first-page":"2236","DOI":"10.1016\/S0140-6736(18)30994-2","article-title":"Measuring performance on the Healthcare Access and Quality Index for 195 countries and territories and selected subnational locations: a systematic analysis from the Global Burden of Disease Study 2016","volume":"391","author":"Fullman","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib29","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1016\/S0140-6736(23)00001-6","article-title":"Improving health outcomes of people with diabetes: target setting for the WHO Global Diabetes Compact","volume":"401","author":"Gregg","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib30","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s13300-013-0022-2","article-title":"Comparison of national\/regional diabetes guidelines for the management of blood glucose control in non-western countries","volume":"4","author":"Home","year":"2013","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(25)00217-7_bib31","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib32","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1136\/jech.2009.087304","article-title":"The effect of health promotion on diagnosis and management of diabetes","volume":"66","author":"Lee","year":"2012","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(25)00217-7_bib33","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1007\/s11892-015-0591-8","article-title":"The impact of health systems on diabetes care in low and lower middle income countries","volume":"15","author":"Beran","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(25)00217-7_bib34","article-title":"Readiness of sub-Saharan Africa healthcare systems for the new pandemic, diabetes: a systematic review","volume":"2018","author":"Nuche-Berenguer","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/S2213-8587(25)00217-7_bib35","doi-asserted-by":"crossref","first-page":"518","DOI":"10.3389\/fendo.2020.00518","article-title":"The challenges in the development of diabetes prevention and care models in low-income settings","volume":"11","author":"Karachaliou","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(25)00217-7_bib36","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2337\/dc17-1795","article-title":"Gaps in guidelines for the management of diabetes in low- and middle-income versus high-income countries-a systematic review","volume":"41","author":"Owolabi","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00217-7_bib37","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41574-020-0334-z","article-title":"Young-onset type 2 diabetes mellitus\u2014implications for morbidity and mortality","volume":"16","author":"Magliano","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(25)00217-7_bib38","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108948","article-title":"Differential loss of \u03b2-cell function in youth vs. adults following treatment withdrawal in the Restoring Insulin Secretion (RISE) study","volume":"178","author":"Utzschneider","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00217-7_bib39","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1177\/08982643231187104","article-title":"Age as a moderator of health outcomes and trust in physicians","volume":"36","author":"Katz","year":"2024","journal-title":"J Aging Health"},{"key":"10.1016\/S2213-8587(25)00217-7_bib40","doi-asserted-by":"crossref","first-page":"e733","DOI":"10.1002\/hsr2.733","article-title":"Barriers to accessing health care among young people in 30 low-middle income countries","volume":"5","author":"Nachiappan","year":"2022","journal-title":"Health Sci Rep"},{"key":"10.1016\/S2213-8587(25)00217-7_bib41","first-page":"e250","article-title":"Significant disparities exist in consumer health insurance literacy: implications for health care reform","volume":"3","author":"Edward","year":"2019","journal-title":"Health Lit Res Pract"},{"key":"10.1016\/S2213-8587(25)00217-7_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110572","article-title":"Impact of changes in diabetes screening guidelines on testing eligibility and potential yield among adults without diagnosed diabetes in the United States","volume":"197","author":"Ali","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00217-7_bib43","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s41745-023-00357-w","article-title":"The evolution of diabetes treatment through the ages: from starvation diets to insulin, incretins, SGLT2-inhibitors and beyond","volume":"103","author":"Mudaliar","year":"2023","journal-title":"J Indian Inst Sci"},{"key":"10.1016\/S2213-8587(25)00217-7_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155531","article-title":"Advances in physiology, design and development of novel medications changing the landscape of obesity pharmacotherapy","volume":"142","author":"Chakhtoura","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(25)00217-7_bib45","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1007\/s13300-020-00831-z","article-title":"Evolution of insulin delivery devices: from syringes, pens, and pumps to DIY artificial pancreas","volume":"11","author":"Kesavadev","year":"2020","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(25)00217-7_bib46","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S2213-8587(21)00240-0","article-title":"Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis","volume":"9","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00217-7_bib47","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.2337\/dc19-1173","article-title":"The impact of medicaid expansion on diabetes management","volume":"43","author":"Lee","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00217-7_bib48","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1186\/s13098-016-0150-8","article-title":"Access to medicines for diabetes treatment in Brazil: evaluation of \u201chealth has no price\u201d program","volume":"8","author":"Araujo","year":"2016","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/S2213-8587(25)00217-7_bib50","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11892-019-1146-1","article-title":"Economic impact of diabetes in south Asia: the magnitude of the problem","volume":"19","author":"Singh","year":"2019","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(25)00217-7_bib51","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1007\/s13300-019-0590-x","article-title":"Lack of treatment persistence and treatment nonadherence as barriers to glycaemic control in patients with type 2 diabetes","volume":"10","author":"Guerci","year":"2019","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(25)00217-7_bib52","doi-asserted-by":"crossref","first-page":"2092","DOI":"10.2337\/dci23-0035","article-title":"Diabetes and multiple long-term conditions: a review of our current global health challenge","volume":"46","author":"Khunti","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00217-7_bib53","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(25)00397-6","article-title":"Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","author":"Kerr","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib54","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","author":"Ng","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109118","article-title":"IDF diabetes atlas: global estimates of undiagnosed diabetes in adults for 2021","volume":"183","author":"Ogurtsova","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00217-7_bib56","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"0","author":"Zhou","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00217-7_bib57","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archinte.167.14.1545","article-title":"Short-term variability in measures of glycemia and implications for the classification of diabetes","volume":"167","author":"Selvin","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(25)00217-7_bib58","doi-asserted-by":"crossref","first-page":"156","DOI":"10.7326\/M18-0091","article-title":"Prognostic implications of single-sample confirmatory testing for undiagnosed diabetes: a prospective cohort study","volume":"169","author":"Selvin","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00217-7_bib59","doi-asserted-by":"crossref","first-page":"81","DOI":"10.2337\/dc20-2030","article-title":"Regression to the mean contributes to the apparent improvement in glycemia 3.8 years after screening: the ELSA-Brasil study","volume":"44","author":"Schmidt","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00217-7_bib60","doi-asserted-by":"crossref","first-page":"495","DOI":"10.2188\/jea.JE20200089","article-title":"Validity assessment of self-reported medication use for hypertension, diabetes, and dyslipidemia in a pharmacoepidemiologic study by comparison with health insurance claims","volume":"31","author":"Matsumoto","year":"2021","journal-title":"J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00217-7_bib61","article-title":"Factors influencing self-reported medication use in the survey of health aging and retirement in Europe (SHARE) dataset","volume":"9","author":"Sch\u00f6nenberg","year":"2021","journal-title":"Healthcare (Basel)"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(25)00217-7_bib63","doi-asserted-by":"crossref","first-page":"S184","DOI":"10.2337\/dc11-s216","article-title":"The pros and cons of diagnosing diabetes with A1C","volume":"34","author":"Bonora","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00217-7_bib64","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2213-8587(22)00278-9","article-title":"The impact of the COVID-19 pandemic on diabetes services: planning for a global recovery","volume":"10","author":"Khunti","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00217-7_bib65","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/j.pcd.2021.06.012","article-title":"Control of type 2 diabetes mellitus during the COVID-19 pandemic","volume":"15","author":"Felix","year":"2021","journal-title":"Prim Care Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:11:48Z","timestamp":1774987908000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002177"}},"issued":{"date-parts":[[2025,11]]},"references-count":60,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2213858725002177"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00217-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global, regional, and national cascades of diabetes care, 2000\u201323: a systematic review and modelling analysis using findings from the Global Burden of Disease Study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00217-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00250-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:38:56Z","timestamp":1794278336707,"version":"4.9.0"},"reference-count":23,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003142","name":"Fonds NutsOhra","doi-asserted-by":"publisher","award":["1104-002"],"award-info":[{"award-number":["1104-002"]}],"id":[{"id":"10.13039\/501100003142","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["836011012"],"award-info":[{"award-number":["836011012"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/s2213-8587(22)00045-6","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T20:39:44Z","timestamp":1647290384000},"page":"322-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial"],"prefix":"10.1016","volume":"10","author":[{"given":"Myrthe M","family":"van Dijk","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Vissenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Fliers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joris A M","family":"van der Post","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Louise P","family":"van der Hoorn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"de Weerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter K","family":"Kuchenbecker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Hoek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Marko","family":"Sikkema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold R","family":"Verhoeve","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimiko A","family":"Broeze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corry H","family":"de Koning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Willem","family":"Verpoest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ole B","family":"Christiansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolien","family":"Koks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan P","family":"de Bruin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitri N M","family":"Papatsonis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Torrance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Madelon","family":"van Wely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H","family":"Bisschop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mari\u00ebtte","family":"Goddijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00045-6_bib1","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(21)00681-4","article-title":"Recurrent miscarriage: evidence to accelerate action","volume":"397","author":"Coomarasamy","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00045-6_bib2","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00045-6_bib3","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/j.fertnstert.2019.11.003","article-title":"Subclinical hypothyroidism and thyroid autoimmunity in recurrent pregnancy loss: a systematic review and meta-analysis","volume":"113","author":"Dong","year":"2020","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(22)00045-6_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/humupd\/dmr024","article-title":"Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review","volume":"17","author":"van den Boogaard","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/S2213-8587(22)00045-6_bib5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrendo.2017.93","article-title":"Thyroid disease in pregnancy: new insights in diagnosis and clinical management","volume":"13","author":"Korevaar","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(22)00045-6_bib6","first-page":"69","article-title":"Thyroid autoimmunity impairs the thyroidal response to human chorionic gonadotropin: two population-based prospective cohort studies","volume":"102","author":"Korevaar","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00045-6_bib7","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1159\/000343759","article-title":"Reduction of miscarriages through universal screening and treatment of thyroid autoimmune diseases","volume":"74","author":"Lepoutre","year":"2012","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/S2213-8587(22)00045-6_bib8","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1530\/EJE-16-0548","article-title":"Effects of levothyroxine treatment on pregnancy outcomes in pregnant women with autoimmune thyroid disease","volume":"176","author":"Nazarpour","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(22)00045-6_bib9","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.1056\/NEJMoa1812537","article-title":"Levothyroxine in women with thyroid peroxidase antibodies before conception","volume":"380","author":"Dhillon-Smith","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00045-6_bib10","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.2017.18249","article-title":"Effect of levothyroxine on miscarriage among women with normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer: a randomized clinical trial","volume":"318","author":"Wang","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00045-6_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043751","article-title":"Impact of levothyroxine in women with positive thyroid antibodies on pregnancy outcomes: a systematic review and meta-analysis of randomised controlled trials","volume":"11","author":"Lau","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(22)00045-6_bib12","article-title":"ESHRE guideline: recurrent pregnancy loss","volume":"2018","author":"Bender Atik","year":"2018","journal-title":"Hum Reprod Open"},{"key":"10.1016\/S2213-8587(22)00045-6_bib13","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(22)00045-6_bib14","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1016\/j.fertnstert.2012.06.048","article-title":"Evaluation and treatment of recurrent pregnancy loss: a committee opinion","volume":"98","year":"2012","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(22)00045-6_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.cct.2015.08.005","article-title":"Effect of levothyroxine on live birth rate in euthyroid women with recurrent miscarriage and TPO antibodies (T4-LIFE study)","volume":"44","author":"Vissenberg","year":"2015","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/S2213-8587(22)00045-6_bib17","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1093\/humrep\/15.7.1637","article-title":"Prospective pregnancy outcome in untreated recurrent miscarriers with thyroid autoantibodies","volume":"15","author":"Rushworth","year":"2000","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(22)00045-6_bib18","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2616","article-title":"Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence","volume":"342","author":"Thangaratinam","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00045-6_bib19","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1093\/humupd\/dms007","article-title":"Treatment of thyroid disorders before conception and in early pregnancy: a systematic review","volume":"18","author":"Vissenberg","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/S2213-8587(22)00045-6_bib20","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1093\/oxfordjournals.humrep.a135823","article-title":"Thyroid autoantibodies in euthyroid non-pregnant women with recurrent spontaneous abortions","volume":"10","author":"Bussen","year":"1995","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(22)00045-6_bib21","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1530\/eje.0.1340084","article-title":"Recurrent miscarriage is associated with increased numbers of CD5\/20 positive lymphocytes and an increased incidence of thyroid antibodies","volume":"134","author":"Roberts","year":"1996","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(22)00045-6_bib22","doi-asserted-by":"crossref","first-page":"458","DOI":"10.4158\/EP.14.4.458","article-title":"Thyroid autoimmunity and recurrent spontaneous abortion in Iran: a case-control study","volume":"14","author":"Iravani","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(22)00045-6_bib23","doi-asserted-by":"crossref","first-page":"96","DOI":"10.3390\/medicina57020096","article-title":"Prevalence of thyroid autoimmunity in women with recurrent pregnancy loss","volume":"57","author":"Godines-Enriquez","year":"2021","journal-title":"Medicina"},{"key":"10.1016\/S2213-8587(22)00045-6_bib24","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1089\/thy.2019.0077","article-title":"Thyroid peroxidase antibodies and prospective live birth rate: a cohort study of women with recurrent pregnancy loss","volume":"29","author":"Bliddal","year":"2019","journal-title":"Thyroid"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000456?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000456?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:20Z","timestamp":1761991880000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000456"}},"issued":{"date-parts":[[2022,5]]},"references-count":23,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2213858722000456"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00045-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00045-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00079-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T02:09:30Z","timestamp":1794535770859,"version":"4.9.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/s2213-8587(23)00227-9","type":"journal-article","created":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T18:30:08Z","timestamp":1694197808000},"page":"743-754","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9240-2124","authenticated-orcid":false,"given":"Yanning","family":"Xu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Derakhshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Hysaj","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lea","family":"Wildisen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Till","family":"Ittermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Pingitore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nazanin","family":"Abolhassani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Medici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lambertus A L M","family":"Kiemeney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels P","family":"Riksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin P F","family":"Dullaart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Trompet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00f6rge","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagmar","family":"F\u00fchrer-Sakel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark P J","family":"Vanderpump","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Axel","family":"Muendlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heinz","family":"Drexel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Howard A","family":"Fink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Kamran","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maryam","family":"Kavousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Connie M","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabela M","family":"Bensenor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fereidoun","family":"Azizi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme J","family":"Hankey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Iacoviello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Misa","family":"Imaizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Ceresini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jos\u00e9 A","family":"Sgarbi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas C","family":"Bauer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristien","family":"Boelaert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan J L","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Wouter","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Vaes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Iervasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bu B","family":"Yeap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudi G J","family":"Westendorp","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim I M","family":"Korevaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salman","family":"Razvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobijn","family":"Gussekloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne R","family":"Cappola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolas","family":"Rodondi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin P","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-7855-5418","authenticated-orcid":false,"given":"Layal","family":"Chaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00227-9_bib1","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1080\/10408363.2018.1482256","article-title":"Distinguishing reference intervals and clinical decision limits \u2013 a review by the IFCC Committee on Reference Intervals and Decision Limits","volume":"55","author":"Ozarda","year":"2018","journal-title":"Crit Rev Clin Lab Sci"},{"key":"10.1016\/S2213-8587(23)00227-9_bib2","doi-asserted-by":"crossref","first-page":"2100","DOI":"10.1161\/CIRCULATIONAHA.117.028753","article-title":"Thyroid function within the normal range, subclinical hypothyroidism, and the risk of atrial fibrillation","volume":"136","author":"Baumgartner","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00227-9_bib3","doi-asserted-by":"crossref","first-page":"4270","DOI":"10.1210\/jc.2016-2255","article-title":"Thyroid function within the reference range and the risk of stroke: an individual participant data analysis","volume":"101","author":"Chaker","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00227-9_bib4","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.1210\/jc.2014-3586","article-title":"Thyroid function in the euthyroid range and adverse outcomes in older adults","volume":"100","author":"Cappola","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00227-9_bib5","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1056\/NEJM199908053410607","article-title":"Guidelines for healthy weight","volume":"341","author":"Willett","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00227-9_bib6","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00227-9_bib7","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1089\/thy.2012.0205","article-title":"Clinical practice guidelines for hypothyroidism in adults: cosponsored by the American Association of Clinical Endocrinologists and the American Thyroid Association","volume":"22","author":"Garber","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(23)00227-9_bib8","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1159\/000356507","article-title":"2013 ETA guideline: management of subclinical hypothyroidism","volume":"2","author":"Pearce","year":"2013","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(23)00227-9_bib9","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00227-9_bib10","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1161\/CIRCULATIONAHA.112.096024","article-title":"Subclinical thyroid dysfunction and the risk of heart failure events: an individual participant data analysis from 6 prospective cohorts","volume":"126","author":"Gencer","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00227-9_bib11","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1001\/jama.291.2.228","article-title":"Subclinical thyroid disease: scientific review and guidelines for diagnosis and management","volume":"291","author":"Surks","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00227-9_bib12","doi-asserted-by":"crossref","first-page":"1695","DOI":"10.1089\/thy.2019.0535","article-title":"Clinical parameters are more likely to be associated with thyroid hormone levels than with thyrotropin levels: a systematic review and meta-analysis","volume":"30","author":"Fitzgerald","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(23)00227-9_bib13","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s12020-020-02397-z","article-title":"Thyroid function and risk of all-cause and cardiovascular mortality: a prospective population-based cohort study","volume":"71","author":"Groothof","year":"2021","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(23)00227-9_bib14","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1530\/EJE-13-0306","article-title":"Higher free thyroxine levels are associated with all-cause mortality in euthyroid older men: the Health In Men Study","volume":"169","author":"Yeap","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00227-9_bib15","doi-asserted-by":"crossref","first-page":"2853","DOI":"10.1210\/jc.2017-00410","article-title":"Defining optimal health range for thyroid function based on the risk of cardiovascular disease","volume":"102","author":"Chaker","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00227-9_bib16","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.1001\/jamainternmed.2021.2686","article-title":"Levothyroxine use in the United States, 2008\u20132018","volume":"181","author":"Brito","year":"2021","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(23)00227-9_bib17","author":"Wells"},{"key":"10.1016\/S2213-8587(23)00227-9_bib18","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1002\/jrsm.1384","article-title":"Individual participant data meta-analysis of intervention studies with time-to-event outcomes: a review of the methodology and an applied example","volume":"11","author":"de Jong","year":"2020","journal-title":"Res Synth Methods"},{"key":"10.1016\/S2213-8587(23)00227-9_bib19","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/S2213-8587(23)00227-9_bib20","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(23)00227-9_bib21","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00227-9_bib22","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1002\/sim.6451","article-title":"Imputation of systematically missing predictors in an individual participant data meta-analysis: a generalized approach using MICE","volume":"34","author":"Jolani","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(23)00227-9_bib23","first-page":"160","article-title":"Multiple imputation for multilevel data with continuous and binary variables","volume":"33","author":"Vincent","year":"2018","journal-title":"Stat Sci"},{"key":"10.1016\/S2213-8587(23)00227-9_bib24","doi-asserted-by":"crossref","first-page":"2556","DOI":"10.1056\/NEJMcp1611144","article-title":"Subclinical hypothyroidism","volume":"376","author":"Peeters","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00227-9_bib26","doi-asserted-by":"crossref","first-page":"2686","DOI":"10.2174\/138161208786264142","article-title":"Prognostic role of sub-clinical hypothyroidism in chronic heart failure outpatients","volume":"14","author":"Iacoviello","year":"2008","journal-title":"Curr Pharm Des"},{"key":"10.1016\/S2213-8587(23)00227-9_bib27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/jgs.14029","article-title":"Relationship between circulating thyroid-stimulating hormone, free thyroxine, and free triiodothyronine concentrations and 9-year mortality in euthyroid elderly adults","volume":"64","author":"Ceresini","year":"2016","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(23)00227-9_bib28","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/archinte.167.14.1526","article-title":"Association between increased mortality and mild thyroid dysfunction in cardiac patients","volume":"167","author":"Iervasi","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(23)00227-9_bib29","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1186\/1471-2318-10-39","article-title":"The BELFRAIL (BFC80+) study: a population-based prospective cohort study of the very elderly in Belgium","volume":"10","author":"Vaes","year":"2010","journal-title":"BMC Geriatr"},{"key":"10.1016\/S2213-8587(23)00227-9_bib30","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1210\/jc.2013-3778","article-title":"Thyroid status and renal function in older persons in the general population","volume":"99","author":"Meuwese","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00227-9_bib31","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1530\/EJE-13-1070","article-title":"Associations between thyroid function and mortality: the influence of age","volume":"171","author":"van de Ven","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00227-9_bib32","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1210\/jc.2011-1978","article-title":"Subclinical thyroid dysfunction and the risk of heart failure in older persons at high cardiovascular risk","volume":"97","author":"Nanchen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00227-9_bib33","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1161\/CIRCRESAHA.117.311603","article-title":"Thyroid function and the risk of atherosclerotic cardiovascular morbidity and mortality: The Rotterdam Study","volume":"121","author":"Bano","year":"2017","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(23)00227-9_bib34","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/EJE-09-0566","article-title":"Decreased serum TSH levels are not associated with mortality in the adult northeast German population","volume":"162","author":"Ittermann","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00227-9_bib35","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1067\/mhj.2002.123579","volume":"144","author":"Schmermund","year":"2002","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(23)00227-9_bib36","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2265.2009.03640.x","article-title":"Initial thyroid status and cardiovascular risk factors: the EPIC-Norfolk prospective population study","volume":"72","author":"Boekholdt","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(23)00227-9_bib37","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/S0140-6736(01)06067-6","article-title":"Prediction of all-cause and cardiovascular mortality in elderly people from one low serum thyrotropin result: a 10-year cohort study","volume":"358","author":"Parle","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00227-9_bib38","doi-asserted-by":"crossref","first-page":"1734","DOI":"10.1210\/jc.2009-1749","article-title":"The incidence of ischemic heart disease and mortality in people with subclinical hypothyroidism: reanalysis of the Whickham Survey cohort","volume":"95","author":"Razvi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00227-9_bib39","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/j.atherosclerosis.2015.10.100","article-title":"High plasma omentin predicts cardiovascular events independently from the presence and extent of angiographically determined atherosclerosis","volume":"244","author":"Saely","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(23)00227-9_bib40","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1093\/aje\/kwr294","article-title":"Brazilian longitudinal study of adult health (ELSA-Brasil): objectives and design","volume":"175","author":"Aquino","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00227-9_bib41","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1530\/EJE-09-0845","article-title":"Subclinical thyroid dysfunctions are independent risk factors for mortality in a 7.5-year follow-up: the Japanese-Brazilian thyroid study","volume":"162","author":"Sgarbi","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00227-9_bib42","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1111\/j.1365-2265.2011.04328.x","article-title":"Thyroid function and prevalent and incident metabolic syndrome in older adults: the Health, Ageing and Body Composition Study","volume":"76","author":"Waring","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(23)00227-9_bib43","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/j.cct.2005.05.006","article-title":"Design and baseline characteristics of the osteoporotic fractures in men (MrOS) study--a large observational study of the determinants of fracture in older men","volume":"26","author":"Orwoll","year":"2005","journal-title":"Contemp Clin Trials"},{"key":"10.1016\/S2213-8587(23)00227-9_bib44","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1001\/jama.295.9.1033","article-title":"Thyroid status, cardiovascular risk, and mortality in older adults","volume":"295","author":"Cappola","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00227-9_bib45","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2019.20745","article-title":"Association of subclinical hypothyroidism and cardiovascular disease with mortality","volume":"3","author":"Inoue","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(23)00227-9_bib46","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1089\/thy.2016.0156","article-title":"Association between serum thyrotropin levels and mortality among euthyroid adults in the United States","volume":"26","author":"Inoue","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(23)00227-9_bib47","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1055\/s-0043-121031","article-title":"Thyroid dysfunction states and incident cardiovascular events: The Tehran Thyroid Study","volume":"50","author":"Tohidi","year":"2018","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(23)00227-9_bib48","doi-asserted-by":"crossref","first-page":"3365","DOI":"10.1210\/jc.2003-031089","article-title":"Risk for ischemic heart disease and all-cause mortality in subclinical hypothyroidism","volume":"89","author":"Imaizumi","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00227-9_bib49","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1001\/archinte.165.21.2467","article-title":"Subclinical thyroid dysfunction as a risk factor for cardiovascular disease","volume":"165","author":"Walsh","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(23)00227-9_bib50","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1161\/CIRCULATIONAHA.115.020789","article-title":"Thyroid function and sudden cardiac death: a prospective population-based cohort study","volume":"134","author":"Chaker","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00227-9_bib51","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1056\/NEJM198201073060107","article-title":"Thyroid-pituitary interaction: feedback regulation of thyrotropin secretion by thyroid hormones","volume":"306","author":"Larsen","year":"1982","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00227-9_bib52","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/nrcardio.2016.174","article-title":"Thyroid hormones and cardiovascular disease","volume":"14","author":"Jabbar","year":"2017","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(23)00227-9_bib53","doi-asserted-by":"crossref","first-page":"2936","DOI":"10.1210\/jc.2012-4223","article-title":"The relationship between TSH and free T4 in a large population is complex and nonlinear and differs by age and sex","volume":"98","author":"Hadlow","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00227-9_bib54","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"Collet","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(23)00227-9_bib55","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.cca.2022.01.006","article-title":"Hyperlipidemia and hypothyroidism","volume":"527","author":"Su","year":"2022","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2213-8587(23)00227-9_bib56","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/j.hfc.2011.08.011","article-title":"Aging-associated cardiovascular changes and their relationship to heart failure","volume":"8","author":"Strait","year":"2012","journal-title":"Heart Fail Clin"},{"key":"10.1016\/S2213-8587(23)00227-9_bib57","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1089\/thy.2016.0133","article-title":"Thyroid function characteristics and determinants: The Rotterdam Study","volume":"26","author":"Chaker","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(23)00227-9_bib58","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1136\/gutjnl-2021-324689","article-title":"Relative risk rather than absolute risk reduction should be preferred to sensitise the public to preventive actions","volume":"71","author":"Chapelle","year":"2022","journal-title":"Gut"},{"key":"10.1016\/S2213-8587(23)00227-9_bib59","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1136\/bmj.320.7236.659","article-title":"Guidelines on preventing cardiovascular disease in clinical practice","volume":"320","author":"Jackson","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00227-9_bib60","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1093\/eurheartj\/ehab312","article-title":"SCORE2-OP risk prediction algorithms: estimating incident cardiovascular event risk in older persons in four geographical risk regions","volume":"42","author":"de Vries","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(23)00227-9_bib61","doi-asserted-by":"crossref","first-page":"2719","DOI":"10.1210\/jc.2017-00294","article-title":"Thyroid function tests in the reference range and fracture: individual participant analysis of prospective cohorts","volume":"102","author":"Aubert","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00227-9_bib62","doi-asserted-by":"crossref","first-page":"5030","DOI":"10.1210\/jc.2016-2104","article-title":"Thyroid function and cancer risk: The Rotterdam Study","volume":"101","author":"Khan","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00227-9_bib63","doi-asserted-by":"crossref","first-page":"3204","DOI":"10.1210\/jc.2016-1300","article-title":"Thyroid function and the risk of nonalcoholic fatty liver disease: The Rotterdam Study","volume":"101","author":"Bano","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00227-9_bib66","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1001\/jamainternmed.2013.11312","article-title":"Falling threshold for treatment of borderline elevated thyrotropin levels-balancing benefits and risks: evidence from a large community-based study","volume":"174","author":"Taylor","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(23)00227-9_bib67","article-title":"Thyroid hormones treatment for subclinical hypothyroidism: a clinical practice guideline","volume":"365","author":"Bekkering","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00227-9_bib68","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1001\/jama.299.7.769","article-title":"Triiodothyronine levels in athyreotic individuals during levothyroxine therapy","volume":"299","author":"Jonklaas","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00227-9_bib69","doi-asserted-by":"crossref","first-page":"c221","DOI":"10.1136\/bmj.c221","article-title":"Meta-analysis of individual participant data: rationale, conduct, and reporting","volume":"340","author":"Riley","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00227-9_bib70","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jclinepi.2019.05.031","article-title":"Retrieval of individual patient data depended on study characteristics: a randomized controlled trial","volume":"113","author":"Veroniki","year":"2019","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(23)00227-9_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002279?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002279?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:52Z","timestamp":1761991972000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723002279"}},"issued":{"date-parts":[[2023,10]]},"references-count":68,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2213858723002279"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00227-9","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.742777839.793601809","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The optimal healthy ranges of thyroid function defined by the risk of cardiovascular disease and mortality: systematic review and individual participant data meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00227-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00257-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:03:39Z","timestamp":1794567819556,"version":"4.9.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006306","name":"Sigrid Jus\u00e9liuksen S\u00e4\u00e4ti\u00f6","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006306","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001729","name":"Swedish Foundation for Strategic Research","doi-asserted-by":"publisher","award":["IRC15-0067"],"award-info":[{"award-number":["IRC15-0067"]}],"id":[{"id":"10.13039\/501100001729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2017-02688"],"award-info":[{"award-number":["2017-02688"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Swedish Research Council","doi-asserted-by":"publisher","award":["2020-02191"],"award-info":[{"award-number":["2020-02191"]}],"id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011272","name":"European Commission Seventh Framework Programme for Research and Technological Development Health","doi-asserted-by":"publisher","award":["269045"],"award-info":[{"award-number":["269045"]}],"id":[{"id":"10.13039\/100011272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001858","name":"Sweden&apos;s Innovation Agency","doi-asserted-by":"publisher","award":["2023-04234"],"award-info":[{"award-number":["2023-04234"]}],"id":[{"id":"10.13039\/501100001858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["521-2010-3490"],"award-info":[{"award-number":["521-2010-3490"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["2014-6395"],"award-info":[{"award-number":["2014-6395"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["349-2006-237"],"award-info":[{"award-number":["349-2006-237"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["2009-1039"],"award-info":[{"award-number":["2009-1039"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["2012-5538"],"award-info":[{"award-number":["2012-5538"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["2010-5983"],"award-info":[{"award-number":["2010-5983"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","award":["2015-2558"],"award-info":[{"award-number":["2015-2558"]}],"id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004817","name":"Lund University Medical Faculty Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004817","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015736","name":"Folkh\u00e4lsan Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015736","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006189","name":"Director Albert Pahlsson Foundation for Research and Charity","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006189","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100020948","name":"AstraZeneca R&amp;D Gothenburg","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100020948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008550","name":"Swedish Diabetes Association Research Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008550","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["263401"],"award-info":[{"award-number":["263401"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002341","name":"Academy of Finland","doi-asserted-by":"publisher","award":["267882"],"award-info":[{"award-number":["267882"]}],"id":[{"id":"10.13039\/501100002341","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023754","name":"Bo and Kerstin Hjelt Diabetes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023754","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Heart and Lung Foundation","doi-asserted-by":"publisher","award":["20220606"],"award-info":[{"award-number":["20220606"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003793","name":"Heart and Lung Foundation","doi-asserted-by":"publisher","award":["20180640"],"award-info":[{"award-number":["20180640"]}],"id":[{"id":"10.13039\/501100003793","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008546","name":"Diabetesf\u00f6rbundet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008546","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003173","name":"Crafoord Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003173","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000781","name":"European Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000781","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012529","name":"Diabetes Wellness Foundation Network Sweden","doi-asserted-by":"publisher","award":["25-420 PG"],"award-info":[{"award-number":["25-420 PG"]}],"id":[{"id":"10.13039\/501100012529","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF18OC0034408"],"award-info":[{"award-number":["NNF18OC0034408"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Foundation","doi-asserted-by":"publisher","award":["NNF21OC0070457"],"award-info":[{"award-number":["NNF21OC0070457"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/s2213-8587(25)00283-9","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T20:24:55Z","timestamp":1763238295000},"page":"29-40","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":24,"title":["Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: a prospective cohort study in Sweden"],"prefix":"10.1016","volume":"14","author":[{"given":"Olof","family":"Asplund","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manonanthini","family":"Thangam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi B","family":"Prasad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Lejonberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Ekstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liisa","family":"Hakaste","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Gustav","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders H","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Oscarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiinamaija","family":"Tuomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ola","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Ahlqvist","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00283-9_bib1","first-page":"S20","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20142024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00283-9_bib2","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1038\/s41591-022-01790-7","article-title":"Heterogeneity in phenotype, disease progression and drug response in type 2 diabetes","volume":"28","author":"Nair","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00283-9_bib3","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1038\/s41588-021-00948-2","article-title":"Genome-wide association analyses highlight etiological differences underlying newly defined subtypes of diabetes","volume":"53","author":"Mansour Aly","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(25)00283-9_bib4","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/s41591-023-02502-5","article-title":"Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine","volume":"29","author":"Tobias","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00283-9_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.7326\/M17-0939","article-title":"Hemoglobin A1c targets for glycemic control with pharmacologic therapy for nonpregnant adults with type 2 diabetes mellitus: a guidance statement update from the American College of Physicians","volume":"168","author":"Qaseem","year":"2018","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00283-9_bib6","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1007\/s00125-022-05731-4","article-title":"Precision prognostics for the development of complications in diabetes","volume":"65","author":"Schiborn","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00283-9_bib7","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1038\/s41581-020-0278-5","article-title":"Genetics of diabetes mellitus and diabetes complications","volume":"16","author":"Cole","year":"2020","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S2213-8587(25)00283-9_bib8","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00283-9_bib9","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1038\/s43856-023-00360-3","article-title":"Precision subclassification of type 2 diabetes: a systematic review","volume":"3","author":"Misra","year":"2023","journal-title":"Commun Med"},{"key":"10.1016\/S2213-8587(25)00283-9_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00283-9_bib11","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00283-9_bib12","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022: a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00283-9_bib13","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.2337\/diacare.21.12.2191","article-title":"Correct homeostasis model assessment (HOMA) evaluation uses the computer program","volume":"21","author":"Levy","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00283-9_bib14","author":"Sj\u00f6berg"},{"key":"10.1016\/S2213-8587(25)00283-9_bib15","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/j.jdiacomp.2016.08.009","article-title":"Prevalence and risk factors for diabetic retinopathy at diagnosis (DRAD) in patients recently diagnosed with type 2 diabetes (T2D) or latent autoimmune diabetes in the adult (LADA)","volume":"30","author":"Martinell","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(25)00283-9_bib16","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00125-025-06407-5","article-title":"Macular perfusion alterations in people with recent-onset diabetes and novel diabetes subtypes","volume":"68","author":"Kaya","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00283-9_bib18","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41591-020-1116-9","article-title":"Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes","volume":"27","author":"Wagner","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00283-9_bib19","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/BF01219790","article-title":"Diabetes and atherosclerosis\u2014the role of insulin","volume":"16","author":"Stout","year":"1979","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00283-9_bib20","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1210\/er.2018-00141","article-title":"Insulin resistance and atherosclerosis: implications for insulin-sensitizing agents","volume":"40","author":"Di Pino","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(25)00283-9_bib21","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/dc12-1211","article-title":"C-peptide levels are associated with mortality and cardiovascular mortality in patients undergoing angiography: the LURIC study","volume":"36","author":"Marx","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00283-9_bib22","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.112.003152","article-title":"Fasting serum C-peptide levels predict cardiovascular and overall death in nondiabetic adults","volume":"1","author":"Patel","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(25)00283-9_bib23","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2337\/dc21-0429","article-title":"Increased risk of incident heart failure and death is associated with insulin resistance in people with newly diagnosed type 2 diabetes: UKPDS 89","volume":"44","author":"Wamil","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00283-9_bib24","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/0026-0495(91)90075-8","article-title":"Insulin resistance and hyperinsulinemia in patients with chronic congestive heart failure","volume":"40","author":"Paolisso","year":"1991","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(25)00283-9_bib25","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM199604113341504","article-title":"Hyperinsulinemia as an independent risk factor for ischemic heart disease","volume":"334","author":"Despr\u00e9s","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00283-9_bib26","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1007\/s00011-023-01845-6","article-title":"Inflammation in heart failure: pathophysiology and therapeutic strategies","volume":"73","author":"Boulet","year":"2024","journal-title":"Inflamm Res"},{"key":"10.1016\/S2213-8587(25)00283-9_bib27","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12933-023-01913-5","article-title":"Obesity and atrial fibrillation: a narrative review from arrhythmogenic mechanisms to clinical significance","volume":"22","author":"Shu","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(25)00283-9_bib28","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1212\/WNL.28.10.973","article-title":"Epidemiologic assessment of chronic atrial fibrillation and risk of stroke: the Framingham study","volume":"28","author":"Wolf","year":"1978","journal-title":"Neurology"},{"key":"10.1016\/S2213-8587(25)00283-9_bib29","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1161\/STROKEAHA.115.012004","article-title":"Atrial fibrillation and mechanisms of stroke: time for a new model","volume":"47","author":"Kamel","year":"2016","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(25)00283-9_bib30","article-title":"A machine learning-based classification of adult-onset diabetes identifies patients at risk of liver-related complications","volume":"5","author":"Otero Sanchez","year":"2023","journal-title":"JHEP Rep Innov Hepatol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T16:47:51Z","timestamp":1769014071000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002839"}},"issued":{"date-parts":[[2026,1]]},"references-count":29,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2213858725002839"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00283-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: a prospective cohort study in Sweden","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00283-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00303-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T13:41:49Z","timestamp":1794490909411,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/s2213-8587(16)00113-3","type":"journal-article","created":{"date-parts":[[2016,5,3]],"date-time":"2016-05-03T21:47:38Z","timestamp":1462312058000},"page":"507-516","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population"],"prefix":"10.1016","volume":"4","author":[{"given":"P\u00e4r","family":"Hallberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niclas","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luisa","family":"Iba\u00f1ez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuelle","family":"Bondon-Guitton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhold","family":"Kreutz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Carvajal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Isabel","family":"Lucena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther Sancho","family":"Ponce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariam","family":"Molokhia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javier","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Axelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qun-Ying","family":"Yue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik K E","family":"Magnusson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mia","family":"Wadelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)00113-3_bib1","doi-asserted-by":"crossref","first-page":"95","DOI":"10.21307\/immunohematology-2019-103","article-title":"Drug-induced immune neutropenia\/agranulocytosis","volume":"30","author":"Curtis","year":"2014","journal-title":"Immunohematology"},{"key":"10.1016\/S2213-8587(16)00113-3_bib2","doi-asserted-by":"crossref","first-page":"657","DOI":"10.7326\/0003-4819-146-9-200705010-00009","article-title":"Systematic review: agranulocytosis induced by nonchemotherapy drugs","volume":"146","author":"Andersohn","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)00113-3_bib3","doi-asserted-by":"crossref","first-page":"4776","DOI":"10.1210\/jc.2013-2569","article-title":"Analysis of 754 cases of antithyroid drug-induced agranulocytosis over 30 years in Japan","volume":"98","author":"Nakamura","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)00113-3_bib4","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1056\/NEJMra042972","article-title":"Antithyroid drugs","volume":"352","author":"Cooper","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00113-3_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MOH.0b013e3282f15fb9","article-title":"Idiosyncratic drug-induced agranulocytosis or acute neutropenia","volume":"15","author":"Andres","year":"2008","journal-title":"Curr Opin Hematol"},{"key":"10.1016\/S2213-8587(16)00113-3_bib6","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1517\/14740338.7.4.481","article-title":"Recognition and management of drug-induced blood cytopenias: the example of drug-induced acute neutropenia and agranulocytosis","volume":"7","author":"Andres","year":"2008","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/S2213-8587(16)00113-3_bib7","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1517\/17425255.2015.985649","article-title":"Current understanding of the mechanisms of idiosyncratic drug-induced agranulocytosis","volume":"11","author":"Johnston","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/S2213-8587(16)00113-3_bib8","doi-asserted-by":"crossref","first-page":"7633","DOI":"10.1038\/ncomms8633","article-title":"Genetic determinants of antithyroid drug-induced agranulocytosis by human leukocyte antigen genotyping and genome-wide association study","volume":"6","author":"Chen","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(16)00113-3_bib9","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1002\/cpt.309","article-title":"HLA-B*38:02:01 predicts carbimazole\/methimazole-induced agranulocytosis","volume":"99","author":"Cheung","year":"2016","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S2213-8587(16)00113-3_bib10","doi-asserted-by":"crossref","first-page":"490","DOI":"10.7326\/0003-4819-124-5-199603010-00005","article-title":"Association between the DRB1*08032 histocompatibility antigen and methimazole-induced agranulocytosis in Japanese patients with Graves disease","volume":"124","author":"Tamai","year":"1996","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)00113-3_bib11","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1007\/s00228-013-1618-1","article-title":"Drug-induced agranulocytosis in the Berlin case-control surveillance study","volume":"70","author":"Huber","year":"2014","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/S2213-8587(16)00113-3_bib12","series-title":"The use of the WHO-UMC system for standardised case causality assessment","year":"2015"},{"key":"10.1016\/S2213-8587(16)00113-3_bib13","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1017\/thg.2012.104","article-title":"The Swedish Twin Registry: establishment of a biobank and other recent developments","volume":"16","author":"Magnusson","year":"2013","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/S2213-8587(16)00113-3_bib14","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1097\/FPC.0000000000000186","article-title":"CYP2C9 variants as a risk modifier of NSAID-related gastrointestinal bleeding: a case-control study","volume":"26","author":"Figueiras","year":"2016","journal-title":"Pharmacogenet Genomics"},{"key":"10.1016\/S2213-8587(16)00113-3_bib16","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1038\/nmeth.2307","article-title":"Improved whole-chromosome phasing for disease and population genetic studies","volume":"10","author":"Delaneau","year":"2013","journal-title":"Nat Methods"},{"key":"10.1016\/S2213-8587(16)00113-3_bib17","doi-asserted-by":"crossref","first-page":"e1000529","DOI":"10.1371\/journal.pgen.1000529","article-title":"A flexible and accurate genotype imputation method for the next generation of genome-wide association studies","volume":"5","author":"Howie","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(16)00113-3_bib18","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1038\/nrg3706","article-title":"Statistical power and significance testing in large-scale genetic studies","volume":"15","author":"Sham","year":"2014","journal-title":"Nat Rev Genet"},{"key":"10.1016\/S2213-8587(16)00113-3_bib19","doi-asserted-by":"crossref","first-page":"e64683","DOI":"10.1371\/journal.pone.0064683","article-title":"Imputing amino acid polymorphisms in human leukocyte antigens","volume":"8","author":"Jia","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)00113-3_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1093\/bioinformatics\/19.1.149","article-title":"Genetic Power Calculator: design of linkage and association genetic mapping studies of complex traits","volume":"19","author":"Purcell","year":"2003","journal-title":"Bioinformatics"},{"key":"10.1016\/S2213-8587(16)00113-3_bib21","doi-asserted-by":"crossref","first-page":"196","DOI":"10.2174\/138920021502140327180733","article-title":"Human leukocyte antigen (HLA) pharmacogenomic tests: potential and pitfalls","volume":"15","author":"Daly","year":"2014","journal-title":"Curr Drug Metab"},{"key":"10.1016\/S2213-8587(16)00113-3_bib22","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1056\/NEJM200009073431006","article-title":"The HLA system. First of two parts","volume":"343","author":"Klein","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00113-3_bib23","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S1074-7613(01)00115-7","article-title":"HLA DNA typing and transplantation","volume":"14","author":"Erlich","year":"2001","journal-title":"Immunity"},{"key":"10.1016\/S2213-8587(16)00113-3_bib24","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1186\/s13104-015-1219-4","article-title":"Genetic determinants of cocaine-associated agranulocytosis","volume":"8","author":"Buxton","year":"2015","journal-title":"BMC Res Notes"},{"key":"10.1016\/S2213-8587(16)00113-3_bib25","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1056\/NEJMcp0801880","article-title":"Graves' disease","volume":"358","author":"Brent","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00113-3_bib26","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1093\/hmg\/ddm165","article-title":"A novel and major association of HLA-C in Graves' disease that eclipses the classical HLA-DRB1 effect","volume":"16","author":"Simmonds","year":"2007","journal-title":"Hum Mol Genet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)00113-3_bib27","doi-asserted-by":"crossref","first-page":"D913","DOI":"10.1093\/nar\/gkq1128","article-title":"Allele frequency net: a database and online repository for immune gene frequencies in worldwide populations","volume":"39","author":"Gonzalez-Galarza","year":"2011","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S2213-8587(16)00113-3_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1111\/j.1399-0039.2006.00529.x","article-title":"HLA-A, -B, and -DRB1 polymorphism defined by sequence-based typing of the Han population in Northern China","volume":"67","author":"Yang","year":"2006","journal-title":"Tissue Antigens"},{"key":"10.1016\/S2213-8587(16)00113-3_bib29","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1038\/nature05911","article-title":"Genome-wide association study of 14,000 cases of seven common diseases and 3,000 shared controls","volume":"447","year":"2007","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)00113-3_bib30","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1038\/nature15817","article-title":"Pharmacogenomics in the clinic","volume":"526","author":"Relling","year":"2015","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)00113-3_bib31","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.1001\/jama.2015.16535","article-title":"Management of Graves disease: a review","volume":"314","author":"Burch","year":"2015","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716001133?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716001133?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T14:57:40Z","timestamp":1655650660000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716001133"}},"issued":{"date-parts":[[2016,6]]},"references-count":30,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S2213858716001133"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)00113-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetic variants associated with antithyroid drug-induced agranulocytosis: a genome-wide association study in a European population","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)00113-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30013-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:15:34Z","timestamp":1794672934064,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,21]],"date-time":"2018-02-21T00:00:00Z","timestamp":1519171200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["SP\/08\/002"],"award-info":[{"award-number":["SP\/08\/002"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100023392","name":"NIHR Barts Biomedical Research Centre, Queen Mary University of London","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023392","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/s2213-8587(18)30071-8","type":"journal-article","created":{"date-parts":[[2018,4,11]],"date-time":"2018-04-11T18:32:25Z","timestamp":1523471545000},"page":"464-475","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":292,"title":["Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies"],"prefix":"10.1016","volume":"6","author":[{"given":"Bryan","family":"Williams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve V","family":"Morant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Sever","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gordon T","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Kennedy","family":"Cruickshank","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark J","family":"Caulfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandosh","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isla S","family":"Mackenzie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Salsbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris J","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Balakrishnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Cannon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Coughlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"D'Souza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Enobakhare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Findlay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Gardiner-Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Helmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Helmy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Hobbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Iles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kwok","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Lacy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"MacIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Markandu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"McCallum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"McCann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"McGinnis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Melville","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Muir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KS","family":"Myint","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Nazir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Palmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Papworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Rutkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Saxena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Schumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Soran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Stanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Thom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Zak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30071-8_bib1","doi-asserted-by":"crossref","first-page":"e7473","DOI":"10.1136\/bmj.e7473","article-title":"Resistant hypertension","volume":"345","author":"Myat","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30071-8_bib2","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1093\/ajh\/hpu151","article-title":"Systematic review and meta-analysis of the prevalence of resistant hypertension in treated hypertensive populations","volume":"28","author":"Achelrod","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/S2213-8587(18)30071-8_bib3","doi-asserted-by":"crossref","first-page":"2059","DOI":"10.1016\/S0140-6736(15)00257-3","article-title":"Spironolactone versus placebo, bisoprolol, and doxazosin to determine the optimal treatment for drug-resistant hypertension (PATHWAY-2): a randomised, double blind, crossover trial","volume":"386","author":"Williams","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30071-8_bib4","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(98)07614-4","article-title":"Optimisation of antihypertensive treatment by crossover rotation of four major classes","volume":"353","author":"Dickerson","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30071-8_bib5","doi-asserted-by":"crossref","first-page":"1376","DOI":"10.1093\/ajh\/hpv031","article-title":"The effects of aldosterone antagonists in patients with resistant hypertension: a meta-analysis of randomized and nonrandomized studies","volume":"28","author":"Dahal","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/S2213-8587(18)30071-8_bib6","doi-asserted-by":"crossref","first-page":"e008951","DOI":"10.1136\/bmjopen-2015-008951","article-title":"Prevention and treatment of hypertension with algorithm-based therapy (PATHWAY) number 2: protocol for a randomised crossover trial to determine optimal treatment for drug-resistant hypertension","volume":"5","author":"Williams","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(18)30071-8_bib7","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/S2213-8587(15)00377-0","article-title":"Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial","volume":"4","author":"Brown","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30071-8_bib8","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1136\/heartjnl-2013-305063","article-title":"High rates of non-adherence to antihypertensive treatment revealed by high-performance liquid chromatography-tandem mass spectrometry (HP LC-MS\/MS) urine analysis","volume":"100","author":"Tomaszewski","year":"2014","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(18)30071-8_bib9","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/j.cca.2015.01.028","article-title":"State of the art of aldosterone immunoassays. A multicenter collaborative study on the behalf of the Cardiovascular Biomarkers Study Group of the Italian Section of European Society of Ligand Assay (ELAS) and Societ\u00e0 Italiana di Biochimica Clinica (SIBIOC)","volume":"444","author":"Fortunato","year":"2015","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2213-8587(18)30071-8_bib10","doi-asserted-by":"crossref","first-page":"982","DOI":"10.1161\/01.HYP.0000016176.16042.2F","article-title":"Resistant hypertension: comparing hemodynamic management to specialist care","volume":"39","author":"Taler","year":"2002","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(18)30071-8_bib11","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1527-5299.2000.80140.x","article-title":"Reproducibility of impedance cardiography hemodynamic measures in clinically stable heart failure patients","volume":"6","author":"Greenberg","year":"2000","journal-title":"Congest Heart Fail"},{"key":"10.1016\/S2213-8587(18)30071-8_bib12","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1161\/HYPERTENSIONAHA.117.10197","article-title":"Confirmatory tests for the diagnosis of primary aldosteronism: a prospective diagnostic accuracy study","volume":"71","author":"Song","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(18)30071-8_bib13","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1365-2362.2008.02060.x","article-title":"The serum sodium to urinary sodium to (serum potassium)2 to urinary potassium (SUSPPUP) ratio in patients with primary aldosteronism","volume":"39","author":"Willenberg","year":"2009","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S2213-8587(18)30071-8_bib14","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1016\/S0140-6736(08)60834-X","article-title":"Prevalence of primary hyperaldosteronism in resistant hypertension: a retrospective observational study","volume":"371","author":"Douma","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30071-8_bib15","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1136\/hrt.2006.107706","article-title":"Renin: friend or foe?","volume":"93","author":"Brown","year":"2007","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(18)30071-8_bib16","doi-asserted-by":"crossref","first-page":"e006986","DOI":"10.1161\/JAHA.117.006986","article-title":"Combination therapy is superior to sequential monotherapy for the initial treatment of hypertension: a double-blind randomized controlled trial","volume":"6","author":"MacDonald","year":"2017","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(18)30071-8_bib17","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s40795-016-0075-5","article-title":"Sodium intake in Germany estimated from sodium excretion measured in spot urine samples","volume":"2","author":"Klenow","year":"2016","journal-title":"BMC Nutr"},{"key":"10.1016\/S2213-8587(18)30071-8_bib18","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.1172\/JCI107082","article-title":"Studies of the control of plasma aldosterone concentration in normal man. 3. Response to sodium chloride infusion","volume":"51","author":"Williams","year":"1972","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(18)30071-8_bib19","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1056\/NEJM197203022860901","article-title":"Essential hypertension: renin and aldosterone, heart attack and stroke","volume":"286","author":"Brunner","year":"1972","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30071-8_bib20","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1042\/cs0780049","article-title":"Mineralocorticoid activity of carbenoxolone: contrasting effects of carbenoxolone and liquorice on 11\u03b2-hydroxysteroid dehydrogenase activity in man","volume":"78","author":"Stewart","year":"1990","journal-title":"Clin Sci"},{"key":"10.1016\/S2213-8587(18)30071-8_bib21","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society clinical practice guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30071-8_bib22","author":"Brown"},{"key":"10.1016\/S2213-8587(18)30071-8_bib23","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(18)30071-8_bib24","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(18)30071-8_bib25","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1038\/ng.2716","article-title":"Somatic mutations in ATP1A1 and CACNA1D underlie a common subtype of adrenal hypertension","volume":"45","author":"Azizan","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(18)30071-8_bib26","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1161\/HYPERTENSIONAHA.114.03419","article-title":"Genetic spectrum and clinical correlates of somatic mutations in aldosterone-producing adenoma","volume":"64","author":"Fernandes-Rosa","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(18)30071-8_bib27","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1530\/ERC-15-0321","article-title":"Novel somatic mutations and distinct molecular signature in aldosterone-producing adenomas","volume":"22","author":"Akerstrom","year":"2015","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(18)30071-8_bib28","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/j.mce.2015.04.022","article-title":"Immunohistochemical, genetic and clinical characterization of sporadic aldosterone-producing adenomas","volume":"411","author":"Monticone","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(18)30071-8_bib29","doi-asserted-by":"crossref","first-page":"E4591","DOI":"10.1073\/pnas.1505529112","article-title":"Aldosterone-stimulating somatic gene mutations are common in normal adrenal glands","volume":"112","author":"Nishimoto","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(18)30071-8_bib30","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1161\/HYPERTENSIONAHA.116.07716","article-title":"Preclinical and early clinical profile of a highly selective and potent oral inhibitor of aldosterone synthase (CYP11B2)","volume":"69","author":"Bogman","year":"2017","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(18)30071-8_bib31","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1210\/jc.2015-1268","article-title":"Stress-induced aldosterone hyper-secretion in a substantial subset of patients with essential hypertension","volume":"100","author":"Markou","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30071-8_bib32","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.1365-2362.2010.02401.x","article-title":"Assessment of serum sodium to urinary sodium divided by (serum potassium)2 to urinary potassium as a screening tool for primary aldosteronism","volume":"41","author":"Steichen","year":"2011","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S2213-8587(18)30071-8_bib33","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1111\/bcp.13152","article-title":"Spironolactone use and risk of incident cancers: a retrospective, matched cohort study","volume":"83","author":"Mackenzie","year":"2017","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/S2213-8587(18)30071-8_bib34","doi-asserted-by":"crossref","first-page":"170","DOI":"10.1097\/HJH.0000000000001130","article-title":"Spironolactone and the risk of urinary tract cancer in patients with hypertension: a nationwide population-based retrospective case-control study","volume":"35","author":"Chuang","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(18)30071-8_bib35","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1002\/bjs.10219","article-title":"Radiofrequency ablation compared with laparoscopic adrenalectomy for aldosterone-producing adenoma","volume":"103","author":"Liu","year":"2016","journal-title":"Br J Surg"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300718?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300718?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:57Z","timestamp":1761991557000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300718"}},"issued":{"date-parts":[[2018,6]]},"references-count":35,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S2213858718300718"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30071-8","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.733048792.793571586","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine and haemodynamic changes in resistant hypertension, and blood pressure responses to spironolactone or amiloride: the PATHWAY-2 mechanisms substudies","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30071-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30080-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:20:12Z","timestamp":1736918412082,"version":"3.33.0"},"reference-count":2,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/s2213-8587(24)00216-x","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:42:48Z","timestamp":1724398968000},"page":"613-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reasons to not rethink the label anti-obesity medication"],"prefix":"10.1016","volume":"12","author":[{"given":"Richard","family":"Armitage","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00216-X_bib1","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S2213-8587(24)00071-8","article-title":"Rethinking the label anti-obesity medication","volume":"12","author":"Flint","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00216-X_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101408","article-title":"Pervasiveness, impact and implications of weight stigma","volume":"47","author":"Brown","year":"2022","journal-title":"eClinicalMedicine"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872400216X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872400216X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:09:12Z","timestamp":1736860152000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872400216X"}},"issued":{"date-parts":[[2024,9]]},"references-count":2,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S221385872400216X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00216-x","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reasons to not rethink the label anti-obesity medication","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00216-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,7,17]],"date-time":"2024-07-17T06:01:26Z","timestamp":1721196086010},"reference-count":7,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/s2213-8587(16)30326-6","type":"journal-article","created":{"date-parts":[[2016,11,22]],"date-time":"2016-11-22T21:39:25Z","timestamp":1479850765000},"page":"976-977","source":"Crossref","is-referenced-by-count":3,"title":["Papillary thyroid microcarcinoma and active surveillance \u2013 Authors' reply"],"prefix":"10.1016","volume":"4","author":[{"given":"Sophie","family":"Leboulleux","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R Michael","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Furio","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Schlumberger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30326-6_bib1","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1089\/thy.2013.0367","article-title":"Patient age is significantly related to the progression of papillary microcarcinoma of the thyroid under observation","volume":"24","author":"Ito","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30326-6_bib2","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1007\/s00268-015-3392-y","article-title":"Clinical trials of active surveillance of papillary microcarcinoma of the thyroid","volume":"40","author":"Miyauchi","year":"2016","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(16)30326-6_bib3","doi-asserted-by":"crossref","first-page":"2559","DOI":"10.3892\/ol.2015.3544","article-title":"Prediction of central lymph node metastasis in 392 patients with cervical lymph node-negative papillary thyroid carcinoma in Eastern China","volume":"10","author":"Xiang","year":"2015","journal-title":"Oncol Lett"},{"key":"10.1016\/S2213-8587(16)30326-6_bib4","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12957-015-0553-2","article-title":"The clinical prognosis of patients with cN0 papillary thyroid microcarcinoma by central neck dissection","volume":"13","author":"Zhang","year":"2015","journal-title":"World J Surg Oncol"},{"key":"10.1016\/S2213-8587(16)30326-6_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30326-6_bib6","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1016\/j.surg.2013.04.068","article-title":"The impact of surgical volume on patient outcomes following thyroid surgery","volume":"154","author":"Kandil","year":"2013","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(16)30326-6_bib7","article-title":"Successful implementation of an active surveillance management approach to low risk papillary thyroid cancer in the United States","volume":"26","author":"Tuttle","year":"2016","journal-title":"Thyroid"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303266?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303266?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T17:46:16Z","timestamp":1568569576000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303266"}},"issued":{"date-parts":[[2016,12]]},"references-count":7,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2213858716303266"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30326-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,12]]}},{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T00:31:27Z","timestamp":1649205087346},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/s2213-8587(14)70133-0","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T19:16:37Z","timestamp":1404846997000},"page":"689","source":"Crossref","is-referenced-by-count":0,"title":["Durhane Wong-Rieger: championing patients"],"prefix":"10.1016","volume":"2","author":[{"given":"Rebecca","family":"Heald","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T16:24:30Z","timestamp":1538411070000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701330"}},"issued":{"date-parts":[[2014,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S2213858714701330"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70133-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,9]]}},{"indexed":{"date-parts":[[2022,4,6]],"date-time":"2022-04-06T04:08:22Z","timestamp":1649218102650},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/s2213-8587(17)30328-5","type":"journal-article","created":{"date-parts":[[2017,9,23]],"date-time":"2017-09-23T05:31:57Z","timestamp":1506144717000},"page":"940","source":"Crossref","is-referenced-by-count":0,"title":["Fat: so much more than just fat"],"prefix":"10.1016","volume":"5","author":[{"given":"Robert","family":"Stirrups","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T10:51:06Z","timestamp":1535367066000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303285"}},"issued":{"date-parts":[[2017,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2213858717303285"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30328-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,12]]}},{"indexed":{"date-parts":[[2023,8,25]],"date-time":"2023-08-25T18:52:52Z","timestamp":1692989572330},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/s2213-8587(16)30404-1","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T02:45:33Z","timestamp":1482288333000},"page":"3-5","source":"Crossref","is-referenced-by-count":1,"title":["Type 2 diabetes: a two-headed snake in kidney transplant recipients?"],"prefix":"10.1016","volume":"5","author":[{"given":"Steven","family":"Van Laecke","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raymond","family":"Vanholder","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30404-1_bib1","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1056\/NEJM199912023412303","article-title":"Comparison of mortality in all patients on dialysis, patients on dialysis awaiting transplantation, and recipients of a first cadaveric transplant","volume":"341","author":"Wolfe","year":"1999","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30404-1_bib2","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2337\/dc11-1162","article-title":"Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006: findings from the National Health Interview Survey","volume":"35","author":"Gregg","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30404-1_bib3","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/aje\/kwn342","article-title":"Is relative mortality of type 2 diabetes mellitus decreasing?","volume":"169","author":"Gulliford","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(16)30404-1_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1016\/S2213-8587(16)30317-5","article-title":"Long-term outcomes of kidney transplantation in people with type 2 diabetes: a population cohort study","volume":"5","author":"Lim","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30404-1_bib5","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/ki.2014.70","article-title":"Enhanced posttransplant management of patients with diabetes improves patient outcomes","volume":"86","author":"Keddis","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(16)30404-1_bib6","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dc15-0991","article-title":"An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes","volume":"39","author":"Al-Saeed","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30404-1_bib7","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.2337\/dc12-2455","article-title":"Long-term complications and mortality in young-onset diabetes","volume":"36","author":"Constantino","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30404-1_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.296.4.421","article-title":"Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians","volume":"296","author":"Parkov","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30404-1_bib9","first-page":"230","article-title":"Preventing a cardiovascular disease epidemic among Indigenous populations through lifestyle changes","volume":"3","author":"Stoner","year":"2012","journal-title":"Int J Prev Med"},{"key":"10.1016\/S2213-8587(16)30404-1_bib10","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1016\/S0140-6736(09)60937-5","article-title":"Diabetes in Asia","volume":"375","author":"Ramachandran","year":"2010","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716304041?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716304041?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T18:52:24Z","timestamp":1536173544000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716304041"}},"issued":{"date-parts":[[2017,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S2213858716304041"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30404-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,1]]}},{"indexed":{"date-parts":[[2022,5,31]],"date-time":"2022-05-31T06:49:09Z","timestamp":1653979749544},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/s2213-8587(17)30341-8","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T10:32:21Z","timestamp":1507890741000},"page":"2-3","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Is the new treatment for Cushing's disease too sweet?"],"prefix":"10.1016","volume":"6","author":[{"given":"Ashley","family":"Grossman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30341-8_bib1","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1016\/S0140-6736(06)68699-6","article-title":"Cushing's syndrome","volume":"367","author":"Newell-Price","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30341-8_bib2","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society Clinical Practice Guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30341-8_bib3","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.1210\/jc.2007-2734","article-title":"Treatment of corticotropin-dependent Cushing's syndrome: a consensus statement","volume":"93","author":"Biller","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30341-8_bib4","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(16)30005-5","article-title":"Mortality in Cushing's disease more than 10 years after remission: a multicentre, multinational, retrospective cohort study","volume":"4","author":"Clayton","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30341-8_bib5","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/EJE-12-0921","article-title":"Long-term cure and recurrence rates in Cushing's disease: predictive factors in a single-center study","volume":"168","author":"Alexandraki","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(17)30341-8_bib6","doi-asserted-by":"crossref","first-page":"3939","DOI":"10.1210\/jc.2013-1470","article-title":"Clinical review: outcome of bilateral adrenalectomy in Cushing's syndrome: a systematic review","volume":"98","author":"Ritzel","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30341-8_bib7","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1007\/s11102-016-0742-1","article-title":"Updates on the role of adrenal steroidogenesis inhibitors in Cushing's syndrome: a focus on novel therapies","volume":"19","author":"Fleseriu","year":"2016","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(17)30341-8_bib8","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing's disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30341-8_bib9","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1159\/000314296","article-title":"Role of somatostatin receptors in normal and tumoral corticotropic cells","volume":"92","author":"Hofland","year":"2010","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(17)30341-8_bib10","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1210\/jc.2008-1008","article-title":"Treatment of pituitary-dependent Cushing's disease with the multireceptor ligand somatostatin analog pasireotide (SOM230): a multicenter, phase II trial","volume":"94","author":"Boscaro","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30341-8_bib11","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A 12-month phase 3 study of pasireotide in Cushing's disease","volume":"8","author":"Colao","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30341-8_bib12","article-title":"Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial","author":"Lacroix","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30341-8_bib13","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1530\/EJE-11-0738","article-title":"Suspension of octreotide LAR after long-term, successful treatment of patients with acromegaly: is it worth trying?","volume":"166","author":"Ram\u00edrez","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(17)30341-8_bib14","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1007\/s11102-014-0615-4","article-title":"Update on radiation therapy in patients with Cushing's disease","volume":"18","author":"Tritos","year":"2015","journal-title":"Pituitary"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303418?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303418?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T23:55:12Z","timestamp":1535327712000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303418"}},"issued":{"date-parts":[[2018,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2213858717303418"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30341-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the new treatment for Cushing's disease too sweet?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30341-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30326-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T13:30:55Z","timestamp":1648819855003},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/s2213-8587(14)70019-1","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T19:54:37Z","timestamp":1396900477000},"page":"528-529","source":"Crossref","is-referenced-by-count":0,"title":["Bariatric surgery for diabetes control in overweight people"],"prefix":"10.1016","volume":"2","author":[{"given":"Jacques","family":"Himpens","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70019-1_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70066-X","article-title":"Multidisciplinary diabetes care with and without bariatric surgery in overwight people: a randomised controlled trial","author":"Wentworth","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70019-1_bib2","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70019-1_bib3","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archsurg.2011.45","article-title":"Long-term outcomes of laparoscopic adjustable gastric banding","volume":"146","author":"Himpens","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/S2213-8587(14)70019-1_bib4","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1007\/s00464-011-2125-z","article-title":"Long-term outcomes of laparoscopic adjustable band and laparoscopic Roux-en-Y gastric bypass in the United States","volume":"26","author":"Spivak","year":"2012","journal-title":"Surg Endosc"},{"key":"10.1016\/S2213-8587(14)70019-1_bib5","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.soard.2009.09.019","article-title":"Re-emergence of diabetes after gastric bypass in patients with mid- to long-term follow-up","volume":"6","author":"DiGiorgi","year":"2010","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(14)70019-1_bib6","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/SLA.0b013e31827b6c02","article-title":"Long term outcomes after bariatric surgery: Fifteen year follow up after gastric banding and a systematic review of the literature","volume":"257","author":"O'Brien","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(14)70019-1_bib7","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/j.suc.2011.04.008","article-title":"The surgical treatment of type two diabetes mellitus","volume":"91","author":"Pories","year":"2011","journal-title":"Surg Clin North Am"},{"key":"10.1016\/S2213-8587(14)70019-1_bib8","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1097\/SLA.0b013e31813e8a56","article-title":"Predictive factors of outcome after gastric banding: a nationwide survey on the role of center activity and patients' behavior","volume":"246","author":"Chevallier","year":"2007","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(14)70019-1_bib9","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1016\/j.surg.2012.07.023","article-title":"Benefits and complications of the duodenal switch\/biliopancreatic diversion compared to the Roux-en-Y gastric bypass","volume":"152","author":"Dorman","year":"2012","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(14)70019-1_bib10","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1097\/SLA.0b013e318203ae44","article-title":"Effects of biliopancreatic diversion on type 2 diabetes with BMI 25 to 35","volume":"253","author":"Scopinaro","year":"2011","journal-title":"Ann Surg"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700191?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700191?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T23:25:09Z","timestamp":1538695509000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700191"}},"issued":{"date-parts":[[2014,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S2213858714700191"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70019-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,7]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T12:42:10Z","timestamp":1649076130856},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/s2213-8587(15)00140-0","type":"journal-article","created":{"date-parts":[[2015,5,10]],"date-time":"2015-05-10T19:45:13Z","timestamp":1431287113000},"page":"594","source":"Crossref","is-referenced-by-count":0,"title":["Growth in sales of custom-compounded menopause hormones"],"prefix":"10.1016","volume":"3","author":[{"given":"Peter","family":"Ranscombe","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001400?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001400?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:07:14Z","timestamp":1563322034000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715001400"}},"issued":{"date-parts":[[2015,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S2213858715001400"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00140-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,8]]}},{"indexed":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T14:09:28Z","timestamp":1696255768987},"reference-count":4,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70001-9","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T12:34:15Z","timestamp":1359981255000},"page":"3-4","source":"Crossref","is-referenced-by-count":5,"title":["Intensive insulin therapy for type 2 diabetes at diagnosis"],"prefix":"10.1016","volume":"1","author":[{"given":"J Hans","family":"DeVries","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70001-9_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70006-8","article-title":"Short-term intensive insulin therapy and its impact on type 2 diabetes: a systematic review and meta-analysis","author":"Kramer","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70001-9_bib2","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1002\/dmrr.405","article-title":"Improved glycaemic control in type 1 diabetes patients following participation per se in a clinical trial\u2014mechanisms and implications","volume":"19","author":"DeVries","year":"2003","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(13)70001-9_bib3","doi-asserted-by":"crossref","first-page":"2989","DOI":"10.2337\/dc07-0155","article-title":"Recruitment to a clinical trial improves glycemic control in patients with diabetes","volume":"30","author":"Gale","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70001-9_bib4","doi-asserted-by":"crossref","first-page":"e334","DOI":"10.1371\/journal.pmed.0020334","article-title":"Local literature bias in genetic epidemiology: an empirical evaluation of the Chinese literature","volume":"2","author":"Pan","year":"2005","journal-title":"PLoS Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700019?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700019?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T21:25:36Z","timestamp":1539897936000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700019"}},"issued":{"date-parts":[[2013,9]]},"references-count":4,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2213858713700019"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70001-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]}},{"indexed":{"date-parts":[[2024,5,14]],"date-time":"2024-05-14T20:37:52Z","timestamp":1715719072711},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/s2213-8587(13)70159-1","type":"journal-article","created":{"date-parts":[[2013,10,25]],"date-time":"2013-10-25T01:45:03Z","timestamp":1382665503000},"page":"97-98","source":"Crossref","is-referenced-by-count":2,"title":["The role of carbohydrate counting in type 1 diabetes"],"prefix":"10.1016","volume":"2","author":[{"given":"Judith","family":"Wylie-Rosett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70159-1_bib1","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1016\/j.jada.2007.05.009","article-title":"2006\u20132007 American Diabetes Association nutrition recommendations: issues for practice translation","volume":"107","author":"Wylie-Rosett","year":"2007","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/S2213-8587(13)70159-1_bib2","article-title":"Efficacy of carbohydrate counting in type 1 diabetes: a systematic review and meta-analysis","author":"Bell","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70159-1_bib3","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1016\/0002-8223(93)91750-K","article-title":"Nutrition interventions for intensive therapy in the Diabetes Control and Complications Trial. The DCCT Research Group","volume":"93","author":"Anderson","year":"1993","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/S2213-8587(13)70159-1_bib4","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1016\/j.jand.2012.07.033","article-title":"Medical nutrition therapy for youth with type 1 diabetes mellitus: more than carbohydrate counting","volume":"112","author":"Wylie-Rosett","year":"2012","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/S2213-8587(13)70159-1_bib5","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM199306103282306","article-title":"Long-term complications of diabetes mellitus","volume":"328","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70159-1_bib6","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bmj.325.7367.746","article-title":"Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial","volume":"325","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70159-1_bib7","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.2337\/diacare.24.7.1137","article-title":"The effect of flexible low glycemic index dietary advice versus measured carbohydrate exchange diets on glycemic control in children with type 1 diabetes","volume":"24","author":"Gilbertson","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70159-1_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.jneb.2013.06.003","article-title":"Correlates of medical nutrition therapy and cardiovascular outcomes in youth with type 1 diabetes","author":"The","year":"2013","journal-title":"J Nutr Educ Behav"},{"key":"10.1016\/S2213-8587(13)70159-1_bib9","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1016\/j.jand.2012.06.001","article-title":"Randomized nutrition education intervention to improve carbohydrate counting in adolescents with type 1 diabetes study: is more intensive education needed?","volume":"112","author":"Spiegel","year":"2012","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/S2213-8587(13)70159-1_bib10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2337\/dc11-2216","article-title":"Macronutrients, food groups, and eating patterns in the management of diabetes: a systematic review of the literature, 2010","volume":"35","author":"Wheeler","year":"2012","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701591?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701591?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T06:24:13Z","timestamp":1539239053000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701591"}},"issued":{"date-parts":[[2014,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S2213858713701591"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70159-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,2]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T14:08:33Z","timestamp":1649081313867},"reference-count":5,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/s2213-8587(18)30239-0","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T22:38:58Z","timestamp":1537915138000},"page":"765","source":"Crossref","is-referenced-by-count":0,"title":["GLP-1 receptor agonists, CKD, and eGFR trajectory \u2013 Authors' reply"],"prefix":"10.1016","volume":"6","author":[{"given":"Katherine R","family":"Tuttle","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark C","family":"Lakshmanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian","family":"Rayner","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert S","family":"Busch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alan G","family":"Zimmermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"D Bradley","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fady T","family":"Botros","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30239-0_bib1","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S2213-8587(18)30104-9","article-title":"Dulaglutide versus insulin glargine in patients with type 2 diabetes and moderate-to-severe chronic kidney disease (AWARD-7): a multicentre, open-label, randomised trial","volume":"6","author":"Tuttle","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30239-0_bib2","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/dom.12816","article-title":"Effects of once-weekly dulaglutide on kidney function in patients with type 2 diabetes in phase II and III clinical trials","volume":"19","author":"Tuttle","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30239-0_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1111\/dom.12808","article-title":"The effect of liraglutide on renal function: a randomized clinical trial","volume":"19","author":"von Scholten","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30239-0_bib4","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s00125-016-3938-z","article-title":"Acute renal effects of the GLP-1 receptor agonist exenatide in overweight type 2 diabetes patients: a randomised, double-blind, placebo-controlled trial","volume":"59","author":"Tonneijck","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30239-0_bib5","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302390?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302390?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T23:35:48Z","timestamp":1537918548000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302390"}},"issued":{"date-parts":[[2018,10]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2213858718302390"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30239-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,10]]}},{"indexed":{"date-parts":[[2024,8,7]],"date-time":"2024-08-07T12:31:12Z","timestamp":1723033872363},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T00:00:00Z","timestamp":1415664000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/s2213-8587(14)70237-2","type":"journal-article","created":{"date-parts":[[2014,11,11]],"date-time":"2014-11-11T01:03:30Z","timestamp":1415667810000},"page":"92-93","source":"Crossref","is-referenced-by-count":4,"title":["Use of national data sources in diabetes epidemiology"],"prefix":"10.1016","volume":"3","author":[{"given":"Mark","family":"Woodward","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70237-2_bib1","article-title":"Type 2 diabetes and incidence of cardiovascular diseases: a cohort study in 1\u00b79 million people","author":"Shah","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70237-2_bib2","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1093\/ije\/dys188","article-title":"Data resource profile: cardiovascular disease research using linked bespoke studies and electronic health records (CALIBER)","volume":"41","author":"Denaxas","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(14)70237-2_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.2337\/diacare.26.2.360","article-title":"The effects of diabetes on the risks of major cardiovascular diseases and death in the Asia-Pacific region","volume":"26","author":"Woodward","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70237-2_bib4","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70237-2_bib5","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(14)60040-4","article-title":"Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775 385 individuals and 12 539 strokes","volume":"383","author":"Peters","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70237-2_bib6","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-014-3260-6","article-title":"Diabetes as risk factor for incident coronary heart disease in women compared with men: a systematic review and meta-analysis of 64 cohorts including 858 507 individuals and 28\u2008203 coronary events","volume":"57","author":"Peters","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70237-2_bib8","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1136\/heartjnl-2011-300734","article-title":"Prediction models for the risk of cardiovascular disease in patients with type 2 diabetes: a systematic review","volume":"98","author":"van Dieren","year":"2012","journal-title":"Heart"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T21:53:18Z","timestamp":1538085198000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702372"}},"issued":{"date-parts":[[2015,2]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S2213858714702372"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70237-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,2]]}},{"indexed":{"date-parts":[[2023,9,23]],"date-time":"2023-09-23T14:53:52Z","timestamp":1695480832708},"reference-count":5,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/s2213-8587(14)70141-x","type":"journal-article","created":{"date-parts":[[2014,8,30]],"date-time":"2014-08-30T19:16:25Z","timestamp":1409426185000},"page":"612-613","source":"Crossref","is-referenced-by-count":4,"title":["Testosterone and cardiovascular disease"],"prefix":"10.1016","volume":"2","author":[{"given":"T Hugh","family":"Jones","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70141-X_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70082-8","article-title":"Testosterone, cardiovascular disease, and mortality in men: living in the dark","author":"Page","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70141-X_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1016\/j.maturitas.2013.04.012","article-title":"A J-shaped association between plasma testosterone and risk of ischemic arterial event in elderly men: the French 3C cohort study","volume":"75","author":"Soisson","year":"2013","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(14)70141-X_bib3","doi-asserted-by":"crossref","first-page":"E9","DOI":"10.1210\/jc.2013-3272","article-title":"In older men an optimal plasma testosterone is associated with reduced all-cause mortality and higher dihydrotestosterone with reduced ischemic heart disease mortality, while estradiol levels do not predict mortality","volume":"99","author":"Yeap","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70141-X_bib4","unstructured":"Tan R, Cook KR, Reilly WG. Testosterone therapy is not associated with higher risk of myocardial infarction or stroke: the low T experience. American Association of Clinical Endocrinologists Annual Meeting 2014; May 13\u201318, 2014; Las Vegas, NV, USA. Abstract 1353."},{"key":"10.1016\/S2213-8587(14)70141-X_bib5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-13-0321","article-title":"Testosterone deficiency is associated with increased risk of mortality and testosterone replacement improves survival in men with type 2 diabetes","volume":"169","author":"Muraleedharan","year":"2013","journal-title":"Eur J Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871470141X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871470141X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,30]],"date-time":"2018-09-30T01:22:58Z","timestamp":1538270578000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871470141X"}},"issued":{"date-parts":[[2014,8]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S221385871470141X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70141-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,8]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:29Z","timestamp":1761991949016,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/s2213-8587(20)30276-x","type":"journal-article","created":{"date-parts":[[2020,8,18]],"date-time":"2020-08-18T18:38:44Z","timestamp":1597775924000},"page":"741-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bariatric and metabolic surgery during and after the COVID-19 pandemic"],"prefix":"10.1016","volume":"8","author":[{"given":"Bruno","family":"Halpern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marcio C","family":"Mancini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30276-X_bib1","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1016\/S2213-8587(20)30157-1","article-title":"Bariatric and metabolic surgery during and after the COVID-19 pandemic: DSS recommendations for management of surgical candidates and postoperative patients and prioritisation of access to surgery","volume":"8","author":"Rubino","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30276-X_bib2","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1111\/obr.12837","article-title":"Metabolic surgery for the treatment of type 2 diabetes in patients with BMI lower than 35 kg\/m2: why caution is still needed","volume":"20","author":"Halpern","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(20)30276-X_bib3","doi-asserted-by":"crossref","DOI":"10.1155\/2010\/102341","article-title":"Feasibility of bariatric surgery as a strategy for secondary prevention in cardiovascular disease: a report from the Swedish Obese Subjects trial","volume":"2010","author":"Delling","year":"2010","journal-title":"J Obes"},{"key":"10.1016\/S2213-8587(20)30276-X_bib4","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.amjcard.2019.09.041","article-title":"Comparison of short and long term cardiovascular outcomes after bariatric surgery in patients with vs without coronary artery disease","volume":"125","author":"Pirlet","year":"2020","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(20)30276-X_bib5","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872030276X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872030276X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:44Z","timestamp":1761991724000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872030276X"}},"issued":{"date-parts":[[2020,9]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S221385872030276X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30276-x","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bariatric and metabolic surgery during and after the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30276-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30157-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30277-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30278-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30279-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:19:31Z","timestamp":1767151171326,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(21)00263-1","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T00:00:00Z","timestamp":1689206400000},"record-id":"49986"},{"DOI":"10.1016\/s2213-8587(21)00263-1","type":"expression_of_concern","label":"Expression of concern","source":"publisher","updated":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000}}],"reference-count":4,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/s2213-8587(23)00198-5","type":"journal-article","created":{"date-parts":[[2023,7,13]],"date-time":"2023-07-13T18:33:16Z","timestamp":1689273196000},"page":"634","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Expression of Concern\u2014Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses"],"prefix":"10.1016","volume":"11","member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00198-5_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2213-8587(21)00263-1","article-title":"Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses","volume":"9","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00198-5_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S2213-8587(22)00345-X","article-title":"Mendelian randomisation and vitamin D: the importance of model assumptions","volume":"11","author":"Smith","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00198-5_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S2213-8587(22)00342-4","article-title":"Mendelian randomisation and vitamin D: the importance of model assumptions","volume":"11","author":"Butler-Laporte","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00198-5_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(22)00344-8","article-title":"Mendelian randomisation and vitamin D: the importance of model assumptions\u2014Authors' reply","volume":"11","author":"Burgess","year":"2023","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001985?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001985?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:25Z","timestamp":1761991945000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001985"}},"issued":{"date-parts":[[2023,9]]},"references-count":4,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2213858723001985"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00198-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of Concern\u2014Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00198-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00263-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:07:27Z","timestamp":1765609647721},"reference-count":8,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,7,8]],"date-time":"2015-07-08T00:00:00Z","timestamp":1436313600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/s2213-8587(15)00234-x","type":"journal-article","created":{"date-parts":[[2015,7,10]],"date-time":"2015-07-10T11:21:52Z","timestamp":1436527312000},"page":"749-750","source":"Crossref","is-referenced-by-count":2,"title":["Metformin and pregnancy outcomes in obese women"],"prefix":"10.1016","volume":"3","author":[{"given":"Jerrie","family":"Refuerzo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00234-X_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00219-3","article-title":"Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controll trial","author":"Chiswick","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00234-X_bib2","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1136\/bmj.298.6673.564","article-title":"Growth in utero, blood pressure in childhood and adult life, and mortality from cardiovascular disease","volume":"298","author":"Barker","year":"1989","journal-title":"BMJ"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(15)00234-X_bib3","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1289\/ehp.00108s3545","article-title":"Fetal, infant, and childhood growth are predictors of coronary heart disease, diabetes, and hypertension in adult men and women","volume":"108","author":"Osmond","year":"2000","journal-title":"Environ Health Perspect"},{"key":"10.1016\/S2213-8587(15)00234-X_bib5","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.ajog.2006.11.027","article-title":"Gestational weight gain and child adiposity at age 3 years","volume":"196","author":"Oken","year":"2007","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 8","key":"10.1016\/S2213-8587(15)00234-X_bib6","first-page":"S1","article-title":"Childhood predictors of adult obesity: a systematic review","volume":"23","author":"Parsons","year":"1999","journal-title":"Int J Obes Relat Metab Dis"},{"key":"10.1016\/S2213-8587(15)00234-X_bib7","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1161\/01.CIR.94.6.1310","article-title":"Birth weight and adult hypertension and obesity in women","volume":"94","author":"Curhan","year":"1996","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(15)00234-X_bib8","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1093\/humupd\/dmn043","article-title":"Insulin sensitizing drugs for weight loss in women of reproductive age who are overweight or obese: systematic review and meta-analysis","volume":"15","author":"Nieuwenhuis-Ruifrok","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/S2213-8587(15)00234-X_bib9","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.2337\/dc11-0660","article-title":"Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition at 2 years of age","volume":"34","author":"Rowan","year":"2011","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500234X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500234X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T01:28:19Z","timestamp":1537493299000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871500234X"}},"issued":{"date-parts":[[2015,10]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S221385871500234X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00234-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,10]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:51:44Z","timestamp":1762005104707},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/s2213-8587(19)30224-4","type":"journal-article","created":{"date-parts":[[2019,7,3]],"date-time":"2019-07-03T22:38:33Z","timestamp":1562193513000},"page":"583","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Baby foods: time to get tough on sugars"],"prefix":"10.1016","volume":"7","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T12:04:06Z","timestamp":1564401846000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719302244"}},"issued":{"date-parts":[[2019,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S2213858719302244"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30224-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Baby foods: time to get tough on sugars","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30224-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:10Z","timestamp":1761991750241,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/s2213-8587(18)30077-9","type":"journal-article","created":{"date-parts":[[2018,3,20]],"date-time":"2018-03-20T20:40:28Z","timestamp":1521578428000},"page":"274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Juleen Zierath: in pursuit of curiosity"],"prefix":"10.1016","volume":"6","author":[{"given":"Fiona","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300779?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300779?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:46Z","timestamp":1761991546000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300779"}},"issued":{"date-parts":[[2018,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2213858718300779"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30077-9","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Juleen Zierath: in pursuit of curiosity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30077-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:36Z","timestamp":1761991956252,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007405","name":"Hjerteforeningen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007405","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005275","name":"Region Hovedstaden","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005275","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/s2213-8587(21)00079-6","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T11:23:44Z","timestamp":1618485824000},"page":"258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fluid volume regulation in patients with heart failure \u2013 Authors' reply"],"prefix":"10.1016","volume":"9","author":[{"given":"Jesper","family":"Jensen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Massar","family":"Omar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jacob Eifer","family":"M\u00f8ller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Schou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00079-6_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2213-8587(20)30382-X","article-title":"Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial","volume":"9","author":"Jensen","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00079-6_bib2","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00079-6_bib3","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00079-6_bib4","doi-asserted-by":"crossref","first-page":"2740","DOI":"10.1016\/j.jacc.2020.10.005","article-title":"Effect of empagliflozin on hemodynamics in patients with heart failure and reduced ejection fraction","volume":"76","author":"Omar","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00079-6_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCULATIONAHA.120.052503","article-title":"Empagliflozin effects on pulmonary artery pressure in patients with heart failure: results from EMpagliflozin Evaluation By MeasuRing ImpAct on HemodynamiCs in PatiEnts with Heart Failure (EMBRACE-HF) Trial","author":"Nassif","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00079-6_bib6","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1093\/eurjhf\/hft050","article-title":"EURObservational Research Programme: regional differences and 1-year follow-up results of the Heart Failure Pilot Survey (ESC-HF Pilot)","volume":"15","author":"Maggioni","year":"2013","journal-title":"Eur J Heart Fail"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000796?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000796?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:55Z","timestamp":1761991735000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000796"}},"issued":{"date-parts":[[2021,5]]},"references-count":6,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2213858721000796"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00079-6","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluid volume regulation in patients with heart failure \u2013 Authors' reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00079-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00080-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/2213-8587(21)00082-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30382-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:54Z","timestamp":1761991734768,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100017459","name":"Allergan Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017459","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/s2213-8587(14)70099-3","type":"journal-article","created":{"date-parts":[[2014,5,28]],"date-time":"2014-05-28T20:30:14Z","timestamp":1401309014000},"page":"448-449","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bariatric surgery"],"prefix":"10.1016","volume":"2","author":[{"given":"Catherine","family":"Keating","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anna","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martin","family":"Neovius","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70099-3_bib1","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S2213-8587(13)70198-0","article-title":"Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery","volume":"2","author":"Cummings","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70099-3_bib2","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2337\/dc08-1749","article-title":"Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis","volume":"32","author":"Keating","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70099-3_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta13410","article-title":"The clinical effectiveness and cost-effectiveness of bariatric (weight loss) surgery for obesity: a systematic review and economic evaluation","volume":"13","author":"Picot","year":"2009","journal-title":"Health Technol Assess"},{"key":"10.1016\/S2213-8587(14)70099-3_bib4","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/2012.jama.11792","article-title":"Health care use during 20 years following bariatric surgery","volume":"308","author":"Neovius","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70099-3_bib5","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1001\/jama.2013.276131","article-title":"Cost-effectiveness of bariatric surgery","volume":"310","author":"Maciejewski","year":"2013","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700993?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700993?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:12Z","timestamp":1761991512000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700993"}},"issued":{"date-parts":[[2014,6]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S2213858714700993"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70099-3","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2014,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bariatric surgery","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70099-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70198-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T10:28:01Z","timestamp":1762252081617},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/s2213-8587(14)70098-1","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T15:35:05Z","timestamp":1399304105000},"page":"364","source":"Crossref","is-referenced-by-count":5,"title":["The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes"],"prefix":"10.1016","volume":"2","author":[{"given":"William B","family":"Grant","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70098-1_bib1","article-title":"The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis","author":"Bolland","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70098-1_bib2","doi-asserted-by":"crossref","first-page":"1016","DOI":"10.1038\/ejcn.2011.68","article-title":"An estimate of the global reduction in mortality rates through doubling vitamin D levels","volume":"65","author":"Grant","year":"2011","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70098-1_bib3","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1016\/j.jphotobiol.2010.04.008","article-title":"Relation between prediagnostic serum 25-hydroxyvitamin D level and incidence of breast, colorectal, and other cancers","volume":"101","author":"Grant","year":"2010","journal-title":"J Photochem Photobiol B"},{"key":"10.1016\/S2213-8587(14)70098-1_bib4","first-page":"617","article-title":"Vitamin D supplement doses and serum 25-hydroxyvitamin D in the range associated with cancer prevention","volume":"31","author":"Garland","year":"2011","journal-title":"Anticancer Res"},{"key":"10.1016\/S2213-8587(14)70098-1_bib5","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/nure.12090","article-title":"Guidelines for optimizing design and analysis of clinical studies of nutrient effects","volume":"72","author":"Heaney","year":"2014","journal-title":"Nutr Rev"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700981?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700981?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T10:23:01Z","timestamp":1538648581000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700981"}},"issued":{"date-parts":[[2014,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S2213858714700981"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70098-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,5]]}},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:02:54Z","timestamp":1767150174751,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(16)00052-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/s2213-8587(16)30080-8","type":"journal-article","created":{"date-parts":[[2016,5,9]],"date-time":"2016-05-09T19:38:27Z","timestamp":1462822707000},"page":"e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correction to Lancet Diabetes Endocrinol 2016; 4: 411\u201319"],"prefix":"10.1016","volume":"4","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:39Z","timestamp":1761991599000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716300808"}},"issued":{"date-parts":[[2016,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2213858716300808"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30080-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2016; 4: 411\u201319","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30080-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)00052-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,13]],"date-time":"2025-11-13T02:06:57Z","timestamp":1762999617764,"version":"build-2065373602"},"reference-count":1,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/s2213-8587(20)30336-3","type":"journal-article","created":{"date-parts":[[2020,9,24]],"date-time":"2020-09-24T20:50:53Z","timestamp":1600980653000},"page":"878-879","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Tackling the COVID-19 pandemic in paradise: the Mauritian experience"],"prefix":"10.1016","volume":"8","author":[{"given":"Sudhirsen","family":"Kowlessur","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bhushan","family":"Ori","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Zimmet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaakko","family":"Tuomilehto","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pierrot","family":"Chitson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yogeshwaree","family":"Ramphul","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30336-3_bib2","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:12Z","timestamp":1761991752000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303363"}},"issued":{"date-parts":[[2020,11]]},"references-count":1,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2213858720303363"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30336-3","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tackling the COVID-19 pandemic in paradise: the Mauritian experience","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30336-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:22:00Z","timestamp":1761513720733},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/s2213-8587(15)00394-0","type":"journal-article","created":{"date-parts":[[2015,11,11]],"date-time":"2015-11-11T03:54:43Z","timestamp":1447214083000},"page":"5-6","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Type 2 diabetes: lifetime risk of advancing from prediabetes"],"prefix":"10.1016","volume":"4","author":[{"given":"Kamlesh","family":"Khunti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Danielle H","family":"Bodicoat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Melanie J","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00394-0_bib1","doi-asserted-by":"crossref","first-page":"922","DOI":"10.2337\/dc13-2195","article-title":"Diabetes prevention in the real world: effectiveness of pragmatic lifestyle interventions for the prevention of type 2 diabetes and of the impact of adherence to guideline recommendations: a systematic review and meta-analysis","volume":"37","author":"Dunkley","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00394-0_bib2","doi-asserted-by":"crossref","first-page":"239","DOI":"10.2337\/dc11-1116","article-title":"Perceiving need for lifestyle counseling: findings from Finnish individuals at high risk of type 2 diabetes","volume":"35","author":"Salmela","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00394-0_bib3","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/1472-6947-1-2","article-title":"Identifying patient preferences for communicating risk estimates: a descriptive pilot study","volume":"1","author":"Fortin","year":"2001","journal-title":"BMC Med Inform Decis Mak"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(15)00394-0_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/heartjnl-2014-305693","article-title":"Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)","volume":"100","year":"2014","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(15)00394-0_bib5","article-title":"Lifetime risk of progression from prediabetes to type 2 diabetes: a prospective cohort study","author":"Ligthart","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00394-0_bib6","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1007\/s00125-013-2902-4","article-title":"Progression rates from HbA1c 6.0\u20136.4% and other prediabetes definitions to type 2 diabetes: a meta-analysis","volume":"56","author":"Morris","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00394-0_bib7","series-title":"Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation","year":"2011"},{"key":"10.1016\/S2213-8587(15)00394-0_bib8","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1136\/pgmj.2009.091215","article-title":"Should glycated haemoglobin (HbA1c) be used to detect people with type 2 diabetes mellitus and impaired glucose regulation?","volume":"86","author":"Mostafa","year":"2010","journal-title":"Postgrad Med J"},{"key":"10.1016\/S2213-8587(15)00394-0_bib9","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1136\/pgmj.2004.029124","article-title":"Diabetes and ethnic minorities","volume":"81","author":"Oldroyd","year":"2005","journal-title":"Postgrad Med J"},{"key":"10.1016\/S2213-8587(15)00394-0_bib10","doi-asserted-by":"crossref","first-page":"e90813","DOI":"10.1371\/journal.pone.0090813","article-title":"Body mass index and waist circumference cut-points in multi-ethnic populations from the UK and India: the ADDITION-Leicester, Jaipur heart watch and New Delhi cross-sectional studies","volume":"9","author":"Bodicoat","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(15)00394-0_bib11","doi-asserted-by":"crossref","first-page":"3411","DOI":"10.2337\/dc13-0331","article-title":"Clinical inertia in people with type 2 diabetes: a retrospective cohort study of more than 80\u2008000 people","volume":"36","author":"Khunti","year":"2013","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003940?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003940?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T09:05:55Z","timestamp":1658307955000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003940"}},"issued":{"date-parts":[[2016,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S2213858715003940"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00394-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes: lifetime risk of advancing from prediabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00394-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00362-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,23]],"date-time":"2026-07-23T09:27:52Z","timestamp":1784798872796,"version":"3.55.0"},"update-to":[{"DOI":"10.1016\/s2213-8587(19)30249-9","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/s2213-8587(20)30037-1","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T18:29:49Z","timestamp":1582050589000},"page":"e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Correction to Lancet Diabetes Endocrinol 2019; 7: 776\u201385"],"prefix":"10.1016","volume":"8","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:26Z","timestamp":1761991646000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300371"}},"issued":{"date-parts":[[2020,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2213858720300371"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30037-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2019; 7: 776\u201385","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30037-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30249-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,6,10]],"date-time":"2024-06-10T01:33:41Z","timestamp":1717983221883},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/s2213-8587(13)70185-2","type":"journal-article","created":{"date-parts":[[2013,11,22]],"date-time":"2013-11-22T08:46:04Z","timestamp":1385109964000},"page":"184-185","source":"Crossref","is-referenced-by-count":1,"title":["Direct or indirect iodine supplementation of infants?"],"prefix":"10.1016","volume":"2","author":[{"given":"Sarah C","family":"Bath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70185-2_bib1","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1017\/S1368980007361004","article-title":"Prevention and control of iodine deficiency in pregnant and lactating women and in children less than 2-years-old: conclusions and recommendations of the Technical Consultation","volume":"10","author":"Andersson","year":"2007","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(13)70185-2_bib2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/j.1440-1754.2010.01972.x","article-title":"Iodine-induced neonatal hypothyroidism secondary to maternal seaweed consumption: a common practice in some Asian cultures to promote breast milk supply","volume":"47","author":"Emder","year":"2011","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/S2213-8587(13)70185-2_bib3","article-title":"Direct iodine supplementation of infants versus supplementation of their breastfeeding mothers: a double-blind, randomised, placebo-controlled trial","author":"Bouhouch","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70185-2_bib6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1089\/thy.2011.0087","article-title":"Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and postpartum","volume":"21","author":"Stagnaro-Green","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70185-2_bib8","doi-asserted-by":"crossref","first-page":"2463","DOI":"10.1001\/jama.2012.45423","article-title":"Iodine supplementation during pregnancy and lactation","volume":"308","author":"Stagnaro-Green","year":"2012","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701852?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701852?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,3]],"date-time":"2019-08-03T23:37:51Z","timestamp":1564875471000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701852"}},"issued":{"date-parts":[[2014,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S2213858713701852"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70185-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,3]]}},{"indexed":{"date-parts":[[2026,3,9]],"date-time":"2026-03-09T13:42:56Z","timestamp":1773063776305,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/s2213-8587(22)00348-5","type":"journal-article","created":{"date-parts":[[2022,11,25]],"date-time":"2022-11-25T20:50:00Z","timestamp":1669409400000},"page":"5-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Re-evaluating obesity in Mexico\u2014lessons for the global obesity epidemic"],"prefix":"10.1016","volume":"11","author":[{"given":"James Ren\u00e9","family":"Jolin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ver\u00f3nica","family":"V\u00e1zquez-Vel\u00e1zquez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fatima Cody","family":"Stanford","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00348-5_bib1","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1016\/S2213-8587(20)30269-2","article-title":"Obesity in Mexico: rapid epidemiological transition and food industry interference in health policies","volume":"8","author":"Barquera","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00348-5_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003221","article-title":"Predicting obesity reduction after implementing warning labels in Mexico: a modeling study","volume":"17","author":"Basto-Abreu","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(22)00348-5_bib3","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1377\/hlthaff.2018.05469","article-title":"Cost-effectiveness of the sugar-sweetened beverage excise tax in Mexico","volume":"38","author":"Basto-Abreu","year":"2019","journal-title":"Health Aff (Millwood)"},{"key":"10.1016\/S2213-8587(22)00348-5_bib4","doi-asserted-by":"crossref","first-page":"1667","DOI":"10.1038\/ijo.2015.191","article-title":"Why food policy and obesity policy are not synonymous: the need to establish clear obesity policy in the United States","volume":"39","author":"Stanford","year":"2015","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(22)00348-5_bib5","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1093\/heapol\/czz063","article-title":"Coca-Cola's political and policy influence in Mexico: understanding the role of institutions, interests and divided society","volume":"34","author":"G\u00f3mez","year":"2019","journal-title":"Health Policy Plan"},{"key":"10.1016\/S2213-8587(22)00348-5_bib6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.socscimed.2004.08.047","article-title":"Coca-colonization of diets in the Yucatan","volume":"61","author":"Leatherman","year":"2005","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(22)00348-5_bib7","article-title":"More to obesity than what meets the eye: a comprehensive approach to counteracting obesity stigma","author":"Jolin","year":"2022","journal-title":"Postgrad Med J"},{"key":"10.1016\/S2213-8587(22)00348-5_bib8","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.1016\/S0140-6736(18)32537-6","article-title":"Time for a new obesity narrative","volume":"392","author":"Ralston","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00348-5_bib9","doi-asserted-by":"crossref","first-page":"e449","DOI":"10.1371\/journal.pmed.0030449","article-title":"Structural violence and clinical medicine","volume":"3","author":"Farmer","year":"2006","journal-title":"PLoS Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003485?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003485?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:16Z","timestamp":1761991936000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003485"}},"issued":{"date-parts":[[2023,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213858722003485"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00348-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Re-evaluating obesity in Mexico\u2014lessons for the global obesity epidemic","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00348-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:56:29Z","timestamp":1761155789739},"reference-count":3,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/s2213-8587(14)70096-8","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T15:34:23Z","timestamp":1399304063000},"page":"363-364","source":"Crossref","is-referenced-by-count":14,"title":["The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes"],"prefix":"10.1016","volume":"2","author":[{"given":"Heike A","family":"Bischoff-Ferrari","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Endel J","family":"Orav","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Walter C","family":"Willett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bess","family":"Dawson-Hughes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70096-8_bib1","article-title":"The effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis","author":"Bolland","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70096-8_bib2","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1016\/S0140-6736(05)63013-9","article-title":"Oral vitamin D3 and calcium for secondary prevention of low-trauma fractures in elderly people (Randomised Evaluation of Calcium Or vitamin D, RECORD): a randomised placebo-controlled trial","volume":"365","author":"Grant","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70096-8_bib3","doi-asserted-by":"crossref","first-page":"1852","DOI":"10.1093\/rheumatology\/kem240","article-title":"Effect of annual intramuscular vitamin D on fracture risk in elderly men and women\u2013a population-based, randomized, double-blind, placebo-controlled trial","volume":"46","author":"Smith","year":"2007","journal-title":"Rheumatology (Oxford)"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700968?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700968?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T10:23:01Z","timestamp":1538648581000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700968"}},"issued":{"date-parts":[[2014,5]]},"references-count":3,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S2213858714700968"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70096-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,5]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:55Z","timestamp":1761991915839,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/s2213-8587(20)30121-2","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:34:39Z","timestamp":1587580479000},"page":"368-369","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Type 1 diabetes\u2014origins and epidemiology"],"prefix":"10.1016","volume":"8","author":[{"given":"Suvi M","family":"Virtanen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mikael","family":"Knip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30121-2_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2213-8587(19)30412-7","article-title":"Type 1 diabetes\u2014early life origins and changing epidemiology","volume":"8","author":"Norris","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30121-2_bib2","doi-asserted-by":"crossref","first-page":"3636","DOI":"10.2337\/db13-0300","article-title":"Patterns of autoantibody appearance and genetic associations reveal heterogeneous pathways of \u03b2-cell destruction","volume":"62","author":"Ilonen","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30121-2_bib3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1007\/s00125-018-4561-y","article-title":"Coxsackievirus B infections are associated with the initiation of insulin-driven autoimmunity that progresses to type 1 diabetes","volume":"61","author":"Sioofy-Khojine","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30121-2_bib4","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dc19-0880","article-title":"Introducing endotypes in type 1 diabetes to address the challenge of disease heterogeneity and move towards precision medicine approaches","volume":"43","author":"Battaglia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30121-2_bib5","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1007\/s00125-017-4280-9","article-title":"Fatty acid status in infancy is associated with the risk of type 1 diabetes associated autoimmunity","volume":"60","author":"Niinist\u00f6","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30121-2_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/jama.2017.19826","article-title":"Effect of hydrolyzed infant formula vs conventional formula on risk of type 1 diabetes: the TRIGR randomized clinical trial","volume":"319","author":"Knip","year":"2018","journal-title":"JAMA"},{"issue":"suppl 22","key":"10.1016\/S2213-8587(20)30121-2_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1111\/pedi.12341","article-title":"Dietary factors in the development of type 1 diabetes","volume":"17","author":"Virtanen","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(20)30121-2_bib8","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1001\/jamapediatrics.2014.296","article-title":"Microbial exposures in infancy and subsequent appearance of type 1 diabetes-associated autoantibodies: a cohort study","volume":"168","author":"Virtanen","year":"2014","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(20)30121-2_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1093\/ije\/dyx245","article-title":"The association between asthma and type 1 diabetes: a paediatric case-cohort study in Finland, years 1981\u20132009","volume":"47","author":"Mets\u00e4l\u00e4","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(20)30121-2_bib10","doi-asserted-by":"crossref","DOI":"10.1093\/aje\/kwaa002","article-title":"Use of antiasthmatic drugs and the risk of type 1 diabetes in children: a nationwide case-cohort study","author":"Mets\u00e4l\u00e4","year":"2020","journal-title":"Am J Epidemiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:41Z","timestamp":1761991661000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301212"}},"issued":{"date-parts":[[2020,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213858720301212"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30121-2","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes\u2014origins and epidemiology","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30121-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30412-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30106-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30109-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:50Z","timestamp":1761992210386,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/s2213-8587(23)00002-5","type":"journal-article","created":{"date-parts":[[2023,2,6]],"date-time":"2023-02-06T18:44:27Z","timestamp":1675709067000},"page":"140-141","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Making sense of weekly insulins"],"prefix":"10.1016","volume":"11","author":[{"given":"Philip","family":"Home","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00002-5_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(22)00388-6","article-title":"Safety and efficacy of once-weekly basal insulin Fc in people with type 2 diabetes previously treated with basal insulin: a multicentre, open-label, randomised, phase 2 study","author":"Frias","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00002-5_bib2","doi-asserted-by":"crossref","first-page":"2107","DOI":"10.1056\/NEJMoa2022474","article-title":"Once-weekly insulin for type 2 diabetes without previous insulin treatment","volume":"383","author":"Rosenstock","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00002-5_bib3","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-022-05787-2","article-title":"Management of hyperglycaemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"65","author":"Davies","year":"2022","journal-title":"Diabetologia"},{"author":"Holleman","key":"10.1016\/S2213-8587(23)00002-5_bib4"},{"key":"10.1016\/S2213-8587(23)00002-5_bib5","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1517\/17425255.2015.1058779","article-title":"Comparison of the pharmacokinetic and pharmacodynamic profiles of insulin degludec and insulin glargine","volume":"11","author":"Heise","year":"2015","journal-title":"Expert Opin Drug Metab Toxicol"},{"key":"10.1016\/S2213-8587(23)00002-5_bib6","article-title":"Pharmacokinetic and pharmacodynamic properties of the novel Basal Insulin Fc (BIF, insulin efsitora alfa), an insulin fusion protein in development for once-weekly dosing for the treatment of patients with diabetes mellitus","author":"Heise","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00002-5_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002301","article-title":"Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing","volume":"9","author":"Nishimura","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(23)00002-5_bib10","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1016\/S2213-8587(21)00182-0","article-title":"Insulin therapy development beyond 100 years","volume":"9","author":"Home","year":"2021","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000025?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000025?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:23Z","timestamp":1761991943000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000025"}},"issued":{"date-parts":[[2023,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2213858723000025"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00002-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Making sense of weekly insulins","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00002-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00388-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,18]],"date-time":"2026-05-18T03:20:04Z","timestamp":1779074404388,"version":"3.51.4"},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/s2213-8587(15)00294-6","type":"journal-article","created":{"date-parts":[[2015,8,19]],"date-time":"2015-08-19T19:50:16Z","timestamp":1440013816000},"page":"684-685","source":"Crossref","is-referenced-by-count":3,"title":["Country in Focus: economic transition and non-communicable diseases in Thailand"],"prefix":"10.1016","volume":"3","author":[{"given":"Dimitris","family":"Xanthos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002946?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002946?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,10]],"date-time":"2019-02-10T19:23:26Z","timestamp":1549826606000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002946"}},"issued":{"date-parts":[[2015,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S2213858715002946"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00294-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,9]]}},{"indexed":{"date-parts":[[2024,9,15]],"date-time":"2024-09-15T18:34:24Z","timestamp":1726425264262},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/s2213-8587(13)70030-5","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T21:26:04Z","timestamp":1369257964000},"page":"172-173","source":"Crossref","is-referenced-by-count":5,"title":["Subclinical thyroid disease: where is the evidence?"],"prefix":"10.1016","volume":"1","author":[{"given":"Jayne A","family":"Franklyn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kristien","family":"Boelaert","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70030-5_bib1","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1016\/S0140-6736(11)60276-6","article-title":"Subclinical thyroid disease","volume":"379","author":"Cooper","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70030-5_bib2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1001\/archinternmed.2012.402","article-title":"Subclinical hyperthyroidism and the risk of coronary heart disease and mortality","volume":"172","author":"Collet","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(13)70030-5_bib3","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1001\/archinte.167.9.928","article-title":"Association between serum free thyroxine concentration and atrial fibrillation","volume":"167","author":"Gammage","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(13)70030-5_bib4","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1089\/thy.2012.2208.com","article-title":"Subclinical thyroid disease: time to enter the age of evidence-based medicine","volume":"22","author":"Goichot","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(13)70030-5_bib5","doi-asserted-by":"crossref","first-page":"456","DOI":"10.4158\/EP.17.3.456","article-title":"Hyperthyroidism and other causes of thyrotoxicosis: management guidelines of the American Thyroid Association and American Association of Clinical Endocrinologists","volume":"17","author":"Bahn","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(13)70030-5_bib6","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1001\/jama.2010.1361","article-title":"Subclinical hypothyroidism and the risk of coronary heart disease and mortality","volume":"304","author":"Rodondi","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70030-5_bib7","doi-asserted-by":"crossref","first-page":"3944","DOI":"10.1210\/jc.2012-2481","article-title":"Longitudinal changes in thyroid function in the oldest old and survival: the cardiovascular health study all-stars study","volume":"97","author":"Waring","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70030-5_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003419.pub2","article-title":"Thyroid hormone replacement for subclinical hypothyroidism","volume":"3","author":"Villar","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(13)70030-5_bib9","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1001\/archinternmed.2012.1159","article-title":"Levothyroxine treatment of subclinical hypothyroidism, fatal and nonfatal cardiovascular events, and mortality","volume":"172","author":"Razvi","year":"2012","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(13)70030-5_bib10","doi-asserted-by":"crossref","first-page":"2732","DOI":"10.1210\/jc.2012-1663","article-title":"Preservation of renal function by thyroid hormone replacement therapy in chronic kidney disease patients with subclinical hypothyroidism","volume":"97","author":"Shin","year":"2012","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T17:22:27Z","timestamp":1539624147000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700305"}},"issued":{"date-parts":[[2013,11]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S2213858713700305"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70030-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2013,11]]}},{"indexed":{"date-parts":[[2024,7,29]],"date-time":"2024-07-29T17:12:51Z","timestamp":1722273171231},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/s2213-8587(17)30016-5","type":"journal-article","created":{"date-parts":[[2017,1,23]],"date-time":"2017-01-23T20:01:33Z","timestamp":1485201693000},"page":"155-157","source":"Crossref","is-referenced-by-count":3,"title":["New country-specific CVD risk charts: recalibrate and refine"],"prefix":"10.1016","volume":"5","author":[{"given":"Andrew Edward","family":"Moran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30016-5_bib1","article-title":"Laboratory-based and office-based risk scores and charts to predict 10-year risk of cardiovascular disease in 182 countries: a pooled analysis of prospective cohorts and health surveys","author":"Ueda","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30016-5_bib2","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1001\/jama.286.2.180","article-title":"Validation of the Framingham coronary heart disease prediction scores: results of a multiple ethnic groups investigation","volume":"286","author":"D'Agostino","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30016-5_bib3","doi-asserted-by":"publisher","first-page":"2591","DOI":"10.1001\/jama.291.21.2591","article-title":"Predictive value for the Chinese population of the Framingham CHD risk assessment tool compared with the Chinese Multi-Provincial Cohort Study","volume":"291","author":"Liu","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30016-5_bib4","doi-asserted-by":"publisher","first-page":"2217","DOI":"10.1161\/CIRCULATIONAHA.105.607499","article-title":"Estimation of 10-year risk of fatal and nonfatal ischemic cardiovascular diseases in Chinese adults","volume":"114","author":"Wu","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30016-5_bib5","doi-asserted-by":"publisher","first-page":"2935","DOI":"10.1016\/j.jacc.2013.11.005","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"63","author":"Goff","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30016-5_bib6","doi-asserted-by":"publisher","first-page":"786","DOI":"10.7326\/M16-1739","article-title":"Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update","volume":"165","author":"Cook","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30016-5_bib8","doi-asserted-by":"publisher","first-page":"1574","DOI":"10.1161\/CIRCULATIONAHA.115.018383","article-title":"Individualized statin benefit for determining statin eligibility in the primary prevention of cardiovascular disease","volume":"133","author":"Thanassoulis","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30016-5_bib9","unstructured":"Pletcher MJ, Pignone M, Jarmul JA, Moran AE, Vittinghoff E, Newman T. Population impact and efficiency of benefit-targeted vs. risk-targeted statin prescribing for primary prevention of cardiovascular disease. J Am Heart Assoc (in press)."},{"key":"10.1016\/S2213-8587(17)30016-5_bib10","doi-asserted-by":"publisher","first-page":"b1665","DOI":"10.1136\/bmj.b1665","article-title":"Use of blood pressure lowering drugs in the prevention of cardiovascular disease: meta-analysis of 147 randomised trials in the context of expectations from prospective epidemiological studies","volume":"338","author":"Law","year":"2009","journal-title":"BMJ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T18:29:04Z","timestamp":1536085744000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300165"}},"issued":{"date-parts":[[2017,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2213858717300165"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30016-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,3]]}},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:48:12Z","timestamp":1767149292179,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(23)00267-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,7]],"date-time":"2023-12-07T00:00:00Z","timestamp":1701907200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/s2213-8587(23)00381-9","type":"journal-article","created":{"date-parts":[[2023,12,11]],"date-time":"2023-12-11T18:32:31Z","timestamp":1702319551000},"page":"e12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2023; 11: 915\u201325"],"prefix":"10.1016","volume":"12","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003819?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003819?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:35Z","timestamp":1761992015000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003819"}},"issued":{"date-parts":[[2024,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2213858723003819"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00381-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2023; 11: 915\u201325","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00381-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00267-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,2]],"date-time":"2025-10-02T10:25:27Z","timestamp":1759400727386},"reference-count":5,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/s2213-8587(17)30147-x","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T21:00:26Z","timestamp":1495573226000},"page":"417-418","source":"Crossref","is-referenced-by-count":5,"title":["Gestational vitamin D and childhood bone health"],"prefix":"10.1016","volume":"5","author":[{"given":"Toshihiro","family":"Sugiyama","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30147-X_bib1","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2213-8587(17)30064-5","article-title":"25-hydroxyvitamin D concentrations during fetal life and bone health in children aged 6 years: a population-based prospective cohort study","volume":"5","author":"Garcia","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30147-X_bib2","doi-asserted-by":"crossref","first-page":"46","DOI":"10.3389\/fendo.2017.00046","article-title":"Osteoporosis therapy: bone modeling during growth and aging","volume":"8","author":"Sugiyama","year":"2017","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(17)30147-X_bib3","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1016\/S0140-6736(02)08147-3","article-title":"Adaptation of bone to mechanical loads","volume":"359","author":"Sugiyama","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30147-X_bib4","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1007\/s00198-014-2975-z","article-title":"An evidence-based perspective on vitamin D and the growing skeleton","volume":"26","author":"Sugiyama","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(17)30147-X_bib5","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.3945\/ajcn.116.143461","article-title":"Vitamin D status and bone health in obesity: another mechanistic point of view","volume":"104","author":"Sugiyama","year":"2016","journal-title":"Am J Clin Nutr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730147X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871730147X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T10:21:37Z","timestamp":1535797297000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871730147X"}},"issued":{"date-parts":[[2017,6]]},"references-count":5,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S221385871730147X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30147-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,6]]}},{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T14:10:37Z","timestamp":1770819037699,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/s2213-8587(15)00519-7","type":"journal-article","created":{"date-parts":[[2016,5,4]],"date-time":"2016-05-04T12:41:53Z","timestamp":1462365713000},"page":"479-480","source":"Crossref","is-referenced-by-count":30,"title":["The rising cost of diabetes care in the USA"],"prefix":"10.1016","volume":"4","author":[{"given":"Patricia","family":"Peter","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasia","family":"Lipska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00519-7_bib1","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2337\/dc12-2625","article-title":"Economic costs of diabetes in the US in 2012","volume":"36","author":"Yang","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00519-7_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2337\/dc14-1687","article-title":"Change in medical spending attributable to diabetes: national data from 1987 to 2011","volume":"38","author":"Zhuo","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00519-7_bib3","doi-asserted-by":"crossref","first-page":"985","DOI":"10.2337\/dc13-2097","article-title":"Ambulatory treatment of type 2 diabetes in the US, 1997\u20132012","volume":"37","author":"Turner","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00519-7_bib5","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1056\/NEJMc1306652","article-title":"Achievement of goals in US diabetes care, 1999\u20132010","volume":"369","author":"Ali","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00519-7_bib6","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00519-7_bib7","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1161\/CIRCULATIONAHA.113.007787","article-title":"Trends in hospitalizations and outcomes for acute cardiovascular disease and stroke, 1999\u20132011","volume":"130","author":"Krumholz","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(15)00519-7_bib8","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1001\/jamainternmed.2014.1824","article-title":"National trends in US hospital admissions for hyperglycemia and hypoglycemia among Medicare beneficiaries, 1999 to 2011","volume":"174","author":"Lipska","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(15)00519-7_bib9","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1056\/NEJMp1512009","article-title":"Measuring the value of prescription drugs","volume":"373","author":"Neumann","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00519-7_bib10","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1001\/jama.2015.16843","article-title":"Payer and policy maker steps to support value-based pricing for drugs","volume":"314","author":"Bach","year":"2015","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715005197?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715005197?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T20:34:41Z","timestamp":1655670881000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715005197"}},"issued":{"date-parts":[[2016,6]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S2213858715005197"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00519-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,6]]}},{"indexed":{"date-parts":[[2025,12,15]],"date-time":"2025-12-15T00:27:03Z","timestamp":1765758423664},"reference-count":6,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2016,3,1]],"date-time":"2016-03-01T00:00:00Z","timestamp":1456790400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,3]]},"DOI":"10.1016\/s2213-8587(16)00035-8","type":"journal-article","created":{"date-parts":[[2016,1,28]],"date-time":"2016-01-28T07:47:59Z","timestamp":1453967279000},"page":"204-205","source":"Crossref","is-referenced-by-count":7,"title":["Developing equity in capacity of paediatric endocrinology subspecialists worldwide"],"prefix":"10.1016","volume":"4","author":[{"given":"Gordon Otieno","family":"Odundo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Ngwiri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Olivia","family":"Otuoma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nadia Musimbi","family":"Chanzu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)00035-8_bib2","series-title":"IDF Diabetes Atlas","year":"2015"},{"key":"10.1016\/S2213-8587(16)00035-8_bib3","doi-asserted-by":"crossref","first-page":"105","DOI":"10.4274\/jcrpe.v3i3.22","article-title":"Current concepts in disorders of sexual development","volume":"3","author":"Ocal","year":"2011","journal-title":"J Clin Res Pediatr Endocrinol"},{"key":"10.1016\/S2213-8587(16)00035-8_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00514-8","article-title":"Innovation in capacity building of primary-care physicians in diabetes management in India: a new slant in medical education","author":"Bhalla","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00035-8_bib5","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1097\/ACM.0b013e3181f09112","article-title":"Factors related to retention of postgraduate trainees in obstetrics-gynecology at the Korle-Bu teaching hospital in Ghana","volume":"85","author":"Clinton","year":"2010","journal-title":"Acad Med"},{"key":"10.1016\/S2213-8587(16)00035-8_bib6","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1542\/peds.2012-0848","article-title":"Promoting excellence in the care of pediatric endocrine diseases in the developing world","volume":"121","author":"Zacharin","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)00035-8_bib8","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1038\/sj.clpt.6100106","article-title":"World Health Organization program for the selection and use of essential medicines","volume":"81","author":"Reidenberg","year":"2007","journal-title":"Clin Pharmacol Ther"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000358?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000358?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T23:22:06Z","timestamp":1537053726000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716000358"}},"issued":{"date-parts":[[2016,3]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2016,3]]}},"alternative-id":["S2213858716000358"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)00035-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,3]]}},{"indexed":{"date-parts":[[2025,10,13]],"date-time":"2025-10-13T19:59:01Z","timestamp":1760385541610},"reference-count":13,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/s2213-8587(17)30091-8","type":"journal-article","created":{"date-parts":[[2017,3,17]],"date-time":"2017-03-17T23:11:26Z","timestamp":1489792286000},"page":"7-9","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["What research is needed to address the co-epidemics of HIV and cardiometabolic disease in sub-Saharan Africa?"],"prefix":"10.1016","volume":"6","author":[{"given":"Pascal","family":"Geldsetzer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jennifer","family":"Manne-Goehler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Till","family":"B\u00e4rnighausen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justine Ina","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30091-8_bib1","article-title":"The HIV epidemic in sub-saharan africa is aging: evidence from the demographic and health surveys in sub-Saharan Africa","author":"Vollmer","year":"2016","journal-title":"AIDS Behav"},{"key":"10.1016\/S2213-8587(17)30091-8_bib2","doi-asserted-by":"crossref","first-page":"e361","DOI":"10.1016\/S2352-3018(16)30087-X","article-title":"Estimates of global, regional, and national incidence, prevalence, and mortality of HIV, 1980\u20132015: the Global Burden of Disease Study 2015","volume":"3","author":"Wang","year":"2016","journal-title":"Lancet HIV"},{"key":"10.1016\/S2213-8587(17)30091-8_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1126\/science.1230413","article-title":"Increases in adult life expectancy in rural South Africa: valuing the scale-up of HIV treatment","volume":"339","author":"Bor","year":"2013","journal-title":"Science"},{"key":"10.1016\/S2213-8587(17)30091-8_bib4","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/S0140-6736(16)31460-X","article-title":"Global, regional, and national disability-adjusted life-years (DALYs) for 315 diseases and injuries and healthy life expectancy (HALE), 1990\u20132015: a systematic analysis for the Global Burden of Disease Study 2015","volume":"388","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30091-8_bib5","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-8587(16)30291-1","article-title":"Diabetes and NCD research: meeting the needs of the patient","volume":"4","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30091-8_bib6","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1080\/03630242.2015.1101734","article-title":"Comparison of health behaviors among women brothel workers to those of the general population of women in Denmark","volume":"56","author":"Pedersen","year":"2016","journal-title":"Women Health"},{"key":"10.1016\/S2213-8587(17)30091-8_bib7","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1097\/COH.0b013e328354bcc8","article-title":"Barriers to HIV treatment among people who use injection drugs: implications for \u2018treatment as prevention\u2019","volume":"7","author":"Milloy","year":"2012","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/S2213-8587(17)30091-8_bib8","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S2213-8587(15)00388-5","article-title":"Pathophysiology and management of cardiovascular disease in patients with HIV","volume":"4","author":"Nou","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(17)30091-8_bib9","doi-asserted-by":"crossref","first-page":"S187","DOI":"10.1097\/QAD.0000000000000252","article-title":"Interventions to improve adherence to antiretroviral therapy: a rapid systematic review","volume":"28","author":"Chaiyachati","year":"2014","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(17)30091-8_bib10","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S2213-8587(16)30181-4","article-title":"Diabetes diagnosis and care in sub-Saharan Africa: pooled analysis of individual data from 12 countries","volume":"4","author":"Manne-Goehler","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30091-8_bib11","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1097\/QAI.0000000000000254","article-title":"HIV, tuberculosis, and noncommunicable diseases: what is known about the costs, effects, and cost-effectiveness of integrated care?","volume":"67","author":"Hyle","year":"2014","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(17)30091-8_bib12","doi-asserted-by":"crossref","first-page":"e0164634","DOI":"10.1371\/journal.pone.0164634","article-title":"\u201cThey just come, pick and go.\u201d The acceptability of integrated medication adherence clubs for HIV and non communicable disease (NCD) patients in Kibera, Kenya","volume":"11","author":"Venables","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30091-8_bib13","article-title":"Population-level decline in BMI and systolic blood pressure following mass HIV treatment: evidence from rural KwaZulu-Natal","author":"Geldsetzer","year":"2016","journal-title":"Obesity (Silver Spring)"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300918?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300918?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T08:23:14Z","timestamp":1535962994000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300918"}},"issued":{"date-parts":[[2018,1]]},"references-count":13,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2213858717300918"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30091-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What research is needed to address the co-epidemics of HIV and cardiometabolic disease in sub-Saharan Africa?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30091-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:52:00Z","timestamp":1767963120811,"version":"3.49.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/s2213-8587(17)30404-7","type":"journal-article","created":{"date-parts":[[2017,12,19]],"date-time":"2017-12-19T23:35:16Z","timestamp":1513726516000},"page":"12-13","source":"Crossref","is-referenced-by-count":19,"title":["Linoleic acid and diabetes prevention"],"prefix":"10.1016","volume":"6","author":[{"given":"George","family":"Henderson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catherine","family":"Crofts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Grant","family":"Schofield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30404-7_bib1","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S2213-8587(17)30307-8","article-title":"Omega-6 fatty acid biomarkers and incident type 2 diabetes: pooled analysis of individual-level data for 39\u2008740 adults from 20 prospective cohort studies","volume":"5","author":"Wu","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30404-7_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1093\/oxfordjournals.aje.a008933","article-title":"Relation of smoking and alcohol consumption to serum fatty acids","volume":"144","author":"Simon","year":"1996","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30404-7_bib3","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11745-007-3132-7","article-title":"Comparison of low fat and low carbohydrate diets on circulating fatty acid composition and markers of inflammation","volume":"43","author":"Forsythe","year":"2008","journal-title":"Lipids"},{"key":"10.1016\/S2213-8587(17)30404-7_bib4","doi-asserted-by":"crossref","first-page":"660","DOI":"10.3945\/an.115.009944","article-title":"Increase in adipose tissue linoleic acid of US adults in the last half century","volume":"6","author":"Guyenet","year":"2015","journal-title":"Adv Nutr"},{"key":"10.1016\/S2213-8587(17)30404-7_bib5","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/s12937-017-0254-5","article-title":"The effect of replacing saturated fat with mostly n-6 polyunsaturated fat on coronary heart disease: a meta-analysis of randomised controlled trials","volume":"16","author":"Hamley","year":"2017","journal-title":"Nutr J"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304047?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304047?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,25]],"date-time":"2018-08-25T01:27:51Z","timestamp":1535160471000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717304047"}},"issued":{"date-parts":[[2018,1]]},"references-count":5,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2213858717304047"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30404-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,1]]}},{"indexed":{"date-parts":[[2024,7,4]],"date-time":"2024-07-04T22:36:15Z","timestamp":1720132575343},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/s2213-8587(18)30005-6","type":"journal-article","created":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T15:05:21Z","timestamp":1517497521000},"page":"81","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tackling childhood obesity: a step in the right direction"],"prefix":"10.1016","volume":"6","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T08:30:33Z","timestamp":1552984233000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300056"}},"issued":{"date-parts":[[2018,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S2213858718300056"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30005-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tackling childhood obesity: a step in the right direction","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30005-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:07:12Z","timestamp":1767150432452,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(25)00053-1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,30]],"date-time":"2025-04-30T00:00:00Z","timestamp":1745971200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/s2213-8587(25)00133-0","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T18:37:51Z","timestamp":1746211071000},"page":"e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2025; published online April 25. https:\/\/doi.org\/10.1016\/S2213-8587(25)00053-1"],"prefix":"10.1016","volume":"13","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T16:13:47Z","timestamp":1748016827000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725001330"}},"issued":{"date-parts":[[2025,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2213858725001330"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00133-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2025; published online April 25. https:\/\/doi.org\/10.1016\/S2213-8587(25)00053-1","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00133-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00053-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T16:35:02Z","timestamp":1721061302676},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/s2213-8587(14)70273-6","type":"journal-article","created":{"date-parts":[[2014,12,30]],"date-time":"2014-12-30T19:15:56Z","timestamp":1419966956000},"page":"1","source":"Crossref","is-referenced-by-count":2,"title":["Dying for a good night's sleep"],"prefix":"10.1016","volume":"3","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702736?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702736?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T12:20:58Z","timestamp":1537964458000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702736"}},"issued":{"date-parts":[[2015,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S2213858714702736"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70273-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,1]]}},{"indexed":{"date-parts":[[2026,4,3]],"date-time":"2026-04-03T00:32:30Z","timestamp":1775176350492,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/s2213-8587(17)30285-1","type":"journal-article","created":{"date-parts":[[2017,8,29]],"date-time":"2017-08-29T05:15:16Z","timestamp":1503983716000},"page":"758-759","source":"Crossref","is-referenced-by-count":3,"title":["Macronutrients and cardiovascular risk in a global context"],"prefix":"10.1016","volume":"5","author":[{"given":"Nita G","family":"Forouhi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fumiaki","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30285-1_bib1","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1161\/CIR.0000000000000510","article-title":"Dietary fats and cardiovascular disease: a presidential advisory from the American Heart Association","volume":"136","author":"Sacks","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30285-1_bib2","doi-asserted-by":"crossref","first-page":"e1000252","DOI":"10.1371\/journal.pmed.1000252","article-title":"Effects on coronary heart disease of increasing polyunsaturated fat in place of saturated fat: a systematic review and meta-analysis of randomized controlled trials","volume":"7","author":"Mozaffarian","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30285-1_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(17)30283-8","article-title":"Association of dietary nutrients with blood lipids and blood pressure in 18 countries: a cross-sectional analysis from the PURE study","author":"Mente","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30285-1_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(17)32252-3","article-title":"Associations of fats and carbohydrate intake with cardiovascular disease and mortality in 18 countries from five continents (PURE): a prospective cohort study","author":"Dehghan","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30285-1_bib5","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30285-1_bib6","first-page":"2499","article-title":"Lipid-related markers and cardiovascular disease prediction","volume":"307","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30285-1_bib7","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1093\/aje\/154.12.1107","article-title":"Assessment of questionnaire validity for measuring total fat intake using plasma lipid levels as criteria","volume":"154","author":"Willett","year":"2001","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30285-1_bib8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1159\/000441085","article-title":"Update on the global burden of ischemic and hemorrhagic stroke in 1990\u20132013: the GBD 2013 Study","volume":"45","author":"Feigin","year":"2015","journal-title":"Neuroepidemiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T09:40:53Z","timestamp":1539078053000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717302851"}},"issued":{"date-parts":[[2017,10]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2213858717302851"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30285-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,10]]}},{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T14:42:09Z","timestamp":1778942529765,"version":"3.51.4"},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/s2213-8587(14)70224-4","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T00:15:30Z","timestamp":1414628130000},"page":"864","source":"Crossref","is-referenced-by-count":3,"title":["Leptin: 20 years later"],"prefix":"10.1016","volume":"2","author":[{"given":"Norra","family":"MacReady","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T04:51:13Z","timestamp":1538110273000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702244"}},"issued":{"date-parts":[[2014,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S2213858714702244"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70224-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,11]]}},{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:56:52Z","timestamp":1778860612455,"version":"3.51.4"},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/s2213-8587(21)00003-6","type":"journal-article","created":{"date-parts":[[2021,1,14]],"date-time":"2021-01-14T01:25:15Z","timestamp":1610587515000},"page":"53","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":32,"title":["Vitamin D and COVID-19: why the controversy?"],"prefix":"10.1016","volume":"9","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000036?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000036?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:29Z","timestamp":1761991709000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000036"}},"issued":{"date-parts":[[2021,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2213858721000036"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00003-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D and COVID-19: why the controversy?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00003-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,26]],"date-time":"2026-06-26T05:53:33Z","timestamp":1782453213728,"version":"3.54.5"},"reference-count":6,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/s2213-8587(20)30190-x","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T18:51:30Z","timestamp":1592333490000},"page":"566-567","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Oh sugar! How diabetes campaigns can be damaging to the cause they aim to serve"],"prefix":"10.1016","volume":"8","author":[{"given":"Jane","family":"Speight","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy C","family":"Skinner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyle Jacques","family":"Rose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renza","family":"Scibilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew J","family":"Boulton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30190-X_bib1","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1080\/17437199.2017.1415767","article-title":"Ignoring theory and misinterpreting evidence: the false belief in fear appeals","volume":"12","author":"Kok","year":"2018","journal-title":"Health Psychol Rev"},{"key":"10.1016\/S2213-8587(20)30190-X_bib2","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1080\/17437199.2018.1454846","article-title":"Towards consensus on fear appeals: a rejoinder to the commentaries on Kok, Peters, Kessels, ten Hoor, and Ruiter (2018)","volume":"12","author":"Peters","year":"2018","journal-title":"Health Psychol Rev"},{"key":"10.1016\/S2213-8587(20)30190-X_bib3","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11892-015-0636-z","article-title":"From individuals to international policy: achievements and ongoing needs in diabetes advocacy","volume":"15","author":"Hilliard","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(20)30190-X_bib4","doi-asserted-by":"crossref","DOI":"10.2337\/dc16-0117","article-title":"Measuring the stigma surrounding type 2 diabetes: development and validation of the Type 2 Diabetes Stigma Assessment Scale (DSAS-2)","volume":"39","author":"Browne","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30190-X_bib5","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1111\/dme.13507","article-title":"Measuring type 1 diabetes stigma: development and validation of the type 1 diabetes stigma assessment Scale (DSAS-1)","volume":"34","author":"Browne","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(20)30190-X_bib6","author":"Leonard"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872030190X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872030190X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:21Z","timestamp":1761991701000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872030190X"}},"issued":{"date-parts":[[2020,7]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S221385872030190X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30190-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Oh sugar! How diabetes campaigns can be damaging to the cause they aim to serve","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30190-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T06:29:43Z","timestamp":1782368983991,"version":"3.54.5"},"reference-count":4,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/s2213-8587(22)00363-1","type":"journal-article","created":{"date-parts":[[2022,12,19]],"date-time":"2022-12-19T18:32:32Z","timestamp":1671474752000},"page":"75","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Analysis of cluster randomised trials as if they were individually randomised"],"prefix":"10.1016","volume":"11","author":[{"given":"Mark J","family":"Bolland","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alison","family":"Avenell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Grey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00363-1_bib1","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1016\/S2213-8587(21)00051-6","article-title":"Vitamin D supplementation to prevent acute respiratory infections: a systematic review and meta-analysis of aggregate data from randomised controlled trials","volume":"9","author":"Jolliffe","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00363-1_bib2","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.2","article-title":"Chapter 23: Including variants on randomized trials","author":"Higgins","year":"2021"},{"key":"10.1016\/S2213-8587(22)00363-1_bib3","article-title":"Vitamin D and acute respiratory infection: secondary analysis of a previous randomised controlled trial and updated meta-analyses","author":"Bolland","year":"2022","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(22)00363-1_bib4","author":"Bolland"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003631?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003631?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:08Z","timestamp":1761991928000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003631"}},"issued":{"date-parts":[[2023,2]]},"references-count":4,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2213858722003631"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00363-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Analysis of cluster randomised trials as if they were individually randomised","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00363-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00051-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,26]],"date-time":"2026-07-26T04:54:05Z","timestamp":1785041645331,"version":"3.55.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021371","name":"Schmutzler Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021371","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["GRK 2576"],"award-info":[{"award-number":["GRK 2576"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Forschung, Technologie und Raumfahrt","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003107","name":"Bundesministerium f\u00fcr Gesundheit","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003107","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/s2213-8587(25)00303-1","type":"journal-article","created":{"date-parts":[[2025,11,15]],"date-time":"2025-11-15T20:24:56Z","timestamp":1763238296000},"page":"3-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The long and winding road to precision diabetology"],"prefix":"10.1016","volume":"14","author":[{"given":"Michael","family":"Roden","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00303-1_bib1","doi-asserted-by":"crossref","first-page":"1770","DOI":"10.1007\/s00125-021-05625-x","article-title":"A novel diabetes typology: towards precision diabetology from pathogenesis to treatment","volume":"65","author":"Herder","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00303-1_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00303-1_bib3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00303-1_bib4","article-title":"Comorbidities and mortality in subgroups of adults with diabetes with up to 14 years follow-up: a prospective cohort study in Swedeny","author":"Asplund","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00303-1_bib5","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00125-025-06407-5","article-title":"Macular perfusion alterations in people with recent-onset diabetes and novel diabetes subtypes","volume":"68","author":"Kaya","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00303-1_bib6","doi-asserted-by":"crossref","DOI":"10.2337\/dc24-2023","article-title":"Role of adipose tissue compartments for cardiovascular risk in diabetes endotypes","author":"Zaharia","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00303-1_bib7","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/s41574-025-01132-w","article-title":"Diabetes mellitus polygenic risk scores: heterogeneity and clinical translation","volume":"21","author":"Ortega","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(25)00303-1_bib8","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1016\/S2213-8587(24)00234-1","article-title":"Depression symptoms, wellbeing, health-related quality of life, and diabetes-related distress in novel subtypes of recent-onset diabetes in Germany: a 5-year observational follow-up study","volume":"12","author":"Sommer","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00303-1_bib9","doi-asserted-by":"crossref","first-page":"2139","DOI":"10.1007\/s00125-025-06486-4","article-title":"Recognising, quantifying and accounting for classification uncertainty in type 2 diabetes subtypes","volume":"68","author":"Mori","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00303-1_bib10","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1038\/s42255-023-00943-3","article-title":"Randomized open-label trial of semaglutide and dapagliflozin in patients with type 2 diabetes of different pathophysiology","volume":"6","author":"Dwibedi","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(25)00303-1_bib11","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.1038\/s41591-024-03032-4","article-title":"A global initiative to deliver precision health in diabetes","volume":"30","author":"Cefalu","year":"2024","journal-title":"Nat Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:05:05Z","timestamp":1769025905000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003031"}},"issued":{"date-parts":[[2026,1]]},"references-count":11,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2213858725003031"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00303-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The long and winding road to precision diabetology","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00303-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00283-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,10]],"date-time":"2026-06-10T06:19:46Z","timestamp":1781072386219,"version":"3.54.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/s2213-8587(22)00049-3","type":"journal-article","created":{"date-parts":[[2022,2,11]],"date-time":"2022-02-11T18:29:19Z","timestamp":1644604159000},"page":"149","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Homing in on the causes of male infertility"],"prefix":"10.1016","volume":"10","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000493?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000493?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:53Z","timestamp":1761991853000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000493"}},"issued":{"date-parts":[[2022,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2213858722000493"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00049-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Homing in on the causes of male infertility","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00049-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,17]],"date-time":"2026-07-17T17:31:44Z","timestamp":1784309504533,"version":"3.55.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/s2213-8587(16)30055-9","type":"journal-article","created":{"date-parts":[[2016,4,29]],"date-time":"2016-04-29T20:57:09Z","timestamp":1461963429000},"page":"469","source":"Crossref","is-referenced-by-count":7,"title":["Iodine deficiency in the UK: grabbing the low-hanging fruit"],"prefix":"10.1016","volume":"4","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,12]],"date-time":"2018-09-12T19:23:14Z","timestamp":1536780194000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716300559"}},"issued":{"date-parts":[[2016,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S2213858716300559"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30055-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,6]]}},{"indexed":{"date-parts":[[2026,7,30]],"date-time":"2026-07-30T01:52:18Z","timestamp":1785376338613,"version":"3.55.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008616","name":"Rush University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008616","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008199","name":"RTI International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008199","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/s2213-8587(21)00029-2","type":"journal-article","created":{"date-parts":[[2021,2,9]],"date-time":"2021-02-09T23:51:01Z","timestamp":1612914661000},"page":"199-200","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["National registries as a catalyst to development of diabetes care in low-income and middle-income countries"],"prefix":"10.1016","volume":"9","author":[{"given":"Angela Mary","family":"Jackson-Morris","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Sembajwe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Nugent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00029-2_bib1","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1001\/jama.2020.11787","article-title":"Excess deaths from COVID-19 and other causes, March\u2013April 2020","volume":"324","author":"Woolf","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00029-2_bib2","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1016\/S2213-8587(20)30238-2","article-title":"COVID-19 in people with diabetes: understanding the reasons for worse outcomes","volume":"8","author":"Apicella","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00029-2_bib3","article-title":"National diabetes registries: do they make a difference?","author":"Bak","year":"2020","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(21)00029-2_bib4","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00029-2_bib5","series-title":"World diabetes report","year":"2016"},{"key":"10.1016\/S2213-8587(21)00029-2_bib6","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.ijmedinf.2012.07.003","article-title":"Health information exchange interventions can enhance quality and continuity of HIV care","volume":"81","author":"Shade","year":"2012","journal-title":"Int J Med Inform"},{"key":"10.1016\/S2213-8587(21)00029-2_bib7","doi-asserted-by":"crossref","first-page":"52","DOI":"10.4103\/2224-3151.282997","article-title":"Why do many basic packages of health services stay on the shelf? A look at potential reasons in the WHO South-East Asia region","volume":"9","author":"Vinyals Torres","year":"2020","journal-title":"WHO South-East Asia J Public Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:40Z","timestamp":1761991780000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000292"}},"issued":{"date-parts":[[2021,4]]},"references-count":7,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2213858721000292"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00029-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"National registries as a catalyst to development of diabetes care in low-income and middle-income countries","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00029-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:36:12Z","timestamp":1785825372568,"version":"3.56.0"},"reference-count":2,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/s2213-8587(15)00236-3","type":"journal-article","created":{"date-parts":[[2015,7,19]],"date-time":"2015-07-19T23:45:35Z","timestamp":1437349535000},"page":"675-677","source":"Crossref","is-referenced-by-count":42,"title":["The challenge of diabetes in sub-Saharan Africa"],"prefix":"10.1016","volume":"3","author":[{"given":"Rifat","family":"Atun","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edwin A M","family":"Gale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00236-3_bib4","doi-asserted-by":"crossref","unstructured":"Lee JT, Hamid F, Pati S, Atun R, Millett C. Impact of noncommunicable disease multimorbidity on healthcare utilisation and out-of-pocket expenditures in middle-income countries: cross sectional analysis. PLoS One (in press).","DOI":"10.1371\/journal.pone.0127199"},{"key":"10.1016\/S2213-8587(15)00236-3_bib5","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/S0140-6736(13)60063-X","article-title":"Improving responsiveness of health systems to non-communicable diseases","volume":"381","author":"Atun","year":"2013","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002363?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002363?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:23:04Z","timestamp":1549844584000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002363"}},"issued":{"date-parts":[[2015,9]]},"references-count":2,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S2213858715002363"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00236-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,9]]}},{"indexed":{"date-parts":[[2026,8,26]],"date-time":"2026-08-26T22:41:03Z","timestamp":1787784063597,"version":"build-2784847793"},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,11]]},"DOI":"10.1016\/s2213-8587(23)00259-0","type":"journal-article","created":{"date-parts":[[2023,10,4]],"date-time":"2023-10-04T18:33:40Z","timestamp":1696444420000},"page":"785-787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Faster and faster: meeting the challenges of delayed insulin action during pregnancy"],"prefix":"10.1016","volume":"11","author":[{"given":"Denice S","family":"Feig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00259-0_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00259-0_bib2","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00125-011-2363-6","article-title":"Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy","volume":"55","author":"Murphy","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00259-0_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s40262-017-0514-8","article-title":"A pooled analysis of clinical pharmacology trials investigating the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in adults with type 1 diabetes","volume":"56","author":"Heise","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/S2213-8587(23)00259-0_bib4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/dc16-1771","article-title":"Fast-acting insulin aspart improves glycemic control in basal-bolus treatment for type 1 diabetes: results of a 26-week multicenter, active-controlled, treat-to-target, randomized, parallel-group trial (onset 1)","volume":"40","author":"Russell-Jones","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00259-0_bib5","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1111\/dom.13205","article-title":"Efficacy and safety of fast-acting insulin aspart in comparison with insulin aspart in type 1 diabetes (onset 1): A 52-week, randomized, treat-to-target, phase III trial","volume":"20","author":"Mathieu","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00259-0_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(23)00236-X","article-title":"Faster-acting insulin aspart versus insulin aspart in the treatement of type 1 or type 2 diabetes during pregnancy and post-delivery (CopenFast): an open-label, single-centre, randomised controlled trial","author":"N\u00f8rgaard","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00259-0_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.2337\/dc20-1017","article-title":"Pharmacokinetics and Pharmacodynamics of Three Different Formulations of Insulin Aspart: A randomized, double-blind, crossover study in men with type 1 diabetes","volume":"44","author":"Svehlikova","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00259-0_bib8","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1111\/dom.14563","article-title":"Ultra rapid lispro (URLi) shows accelerated pharmacokinetics and greater reduction in postprandial glucose versus Humalog\u00ae in patients with type 1 diabetes mellitus in a randomized, double-blind meal test early-phase study","volume":"24","author":"Kazda","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00259-0_bib9","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/dom.13610","article-title":"A randomized, multicentre trial evaluating the efficacy and safety of fast-acting insulin aspart in continuous subcutaneous insulin infusion in adults with type 1 diabetes (onset 5)","volume":"21","author":"Klonoff","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00259-0_bib10","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/dom.14355","article-title":"Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: a double-blind, multicentre, multinational, randomized, crossover study","volume":"23","author":"Boughton","year":"2021","journal-title":"Diabetes Obes Metab"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(23)00295-4","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002590?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002590?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:23Z","timestamp":1761991943000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723002590"}},"issued":{"date-parts":[[2023,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2023,11]]}},"alternative-id":["S2213858723002590"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00259-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Faster and faster: meeting the challenges of delayed insulin action during pregnancy","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00259-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00236-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,27]],"date-time":"2026-08-27T12:33:26Z","timestamp":1787834006162,"version":"build-2784847793"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/s2213-8587(21)00218-7","type":"journal-article","created":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T18:39:00Z","timestamp":1630607940000},"page":"649-651","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Effect of the COVID-19 pandemic on body weight in people at high risk of type 2 diabetes referred to the English NHS Diabetes Prevention Programme"],"prefix":"10.1016","volume":"9","author":[{"given":"Jonathan","family":"Valabhji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Bradley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Bakhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Jebb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00218-7_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2337\/dc19-1425","article-title":"Early outcomes from the English National Health Service Diabetes Prevention Programme","volume":"43","author":"Valabhji","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00218-7_bib2","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2213-8587(21)00089-9","article-title":"Associations between body-mass index and COVID-19 severity in 6\u00b79 million people in England: a prospective, community-based, cohort study","volume":"9","author":"Gao","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00218-7_bib3","doi-asserted-by":"crossref","first-page":"1510","DOI":"10.1111\/dme.14083","article-title":"The healthier you: NHS Diabetes Prevention Programme: digital modes of delivery engage younger people","volume":"36","author":"McGough","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00218-7_bib4","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1093\/aje\/kwq134","article-title":"Weight change and incident diabetes: addressing an unresolved issue","volume":"172","author":"Jacobs-van der Bruggen","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00218-7_bib5","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMc2018688","article-title":"New-onset diabetes in COVID-19","volume":"383","author":"Rubino","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00218-7_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00208-4","article-title":"Temporal trends in emergency admissions for diabetic ketoacidosis in people with diabetes in England before and during the COVID-19 pandemic: a population-based study","author":"Misra","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00218-7_bib7","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0231229","article-title":"Validation of self-reported height and weight in a large, nationwide cohort of U.S. adults","volume":"15","author":"Hodge","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00218-7_bib8","doi-asserted-by":"crossref","first-page":"671","DOI":"10.3390\/nu13020671","article-title":"Longitudinal weight gain and related risk behaviors during the COVID-19 pandemic in adults in the US","volume":"13","author":"Bhutani","year":"2021","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(21)00218-7_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12453","article-title":"Impact of the COVID-19 pandemic lockdown on weight status and factors associated with weight gain among adults in Massachusetts","volume":"11","author":"Mulugeta","year":"2021","journal-title":"Clin Obes"},{"key":"10.1016\/S2213-8587(21)00218-7_bib10","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18041876","article-title":"Global impact of COVID-19 on weight and weight-related behaviours in the adult population: a scoping review","volume":"18","author":"Chew","year":"2021","journal-title":"Int J Environ Res Public Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:34Z","timestamp":1761991834000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002187"}},"issued":{"date-parts":[[2021,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2213858721002187"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00218-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of the COVID-19 pandemic on body weight in people at high risk of type 2 diabetes referred to the English NHS Diabetes Prevention Programme","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00218-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,16]],"date-time":"2026-09-16T19:47:05Z","timestamp":1789588025844,"version":"build-2803163510"},"reference-count":30,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,11,1]],"date-time":"2018-11-01T00:00:00Z","timestamp":1541030400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,10,23]],"date-time":"2019-10-23T00:00:00Z","timestamp":1571788800000},"content-version":"am","delay-in-days":356,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000065","name":"National Institute of Neurological Disorders and Stroke","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["1UL1RR025771"],"award-info":[{"award-number":["1UL1RR025771"]}],"id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006975","name":"Indiana Clinical and Translational Sciences Institute","doi-asserted-by":"publisher","award":["K07AG3587"],"award-info":[{"award-number":["K07AG3587"]}],"id":[{"id":"10.13039\/100006975","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009633","name":"Eunice Kennedy Shriver National Institute of Child Health and Human Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009633","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018578","name":"Clinical and Translational Science Institute, Boston University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018578","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U01 AG030644"],"award-info":[{"award-number":["U01 AG030644"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,11]]},"DOI":"10.1016\/s2213-8587(18)30171-2","type":"journal-article","created":{"date-parts":[[2018,10,23]],"date-time":"2018-10-23T19:06:42Z","timestamp":1540321602000},"page":"879-890","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials"],"prefix":"10.1016","volume":"6","author":[{"given":"Shalender","family":"Bhasin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan S","family":"Ellenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas W","family":"Storer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shehzad","family":"Basaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Pahor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alisa J","family":"Stephens-Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane A","family":"Cauley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristine E","family":"Ensrud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John T","family":"Farrar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Cella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvin M","family":"Matsumoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Glenn R","family":"Cunningham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald S","family":"Swerdloff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cora E","family":"Lewis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark E","family":"Molitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Barrett-Connor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P","family":"Crandall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoling","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Preston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Cifelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M","family":"Gill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30171-2_bib1","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1210\/jc.2004-1184","article-title":"Older men are as responsive to the anabolic effects of testosterone as young men","volume":"90","author":"Bhasin","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30171-2_bib2","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1210\/jc.2002-021231","article-title":"Testosterone dose-dependently increases maximal voluntary strength and leg power, but does not affect fatigability or specific tension","volume":"88","author":"Storer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30171-2_bib3","first-page":"2647","article-title":"Effect of testosterone treatment on body composition and muscle strength in men over 65 years of age","volume":"84","author":"Snyder","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30171-2_bib4","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1210\/jc.2004-1933","article-title":"Exogenous testosterone (T) alone or with finasteride increases physical performance, grip strength, and lean body mass in older men with low serum T","volume":"90","author":"Page","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30171-2_bib5","doi-asserted-by":"crossref","first-page":"M266","DOI":"10.1093\/gerona\/56.5.M266","article-title":"Effects of transdermal testosterone on bone and muscle in older men with low bioavailable testosterone levels","volume":"56","author":"Kenny","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(18)30171-2_bib6","doi-asserted-by":"crossref","first-page":"2282","DOI":"10.1001\/jama.288.18.2282","article-title":"Growth hormone and sex steroid administration in healthy aged women and men: a randomized controlled trial","volume":"288","author":"Blackman","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30171-2_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30171-2_bib8","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/gerona\/glr100","article-title":"Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation","volume":"66","author":"Travison","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(18)30171-2_bib9","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1210\/jc.2009-1251","article-title":"Effects of testosterone on muscle strength, physical function, body composition, and quality of life in intermediate-frail and frail elderly men: a randomized, double-blind, placebo-controlled study","volume":"95","author":"Srinivas-Shankar","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30171-2_bib10","doi-asserted-by":"crossref","first-page":"M321","DOI":"10.1093\/gerona\/57.5.M321","article-title":"Effects of transdermal testosterone on cognitive function and health perception in older men with low bioavailable testosterone levels","volume":"57","author":"Kenny","year":"2002","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(18)30171-2_bib11","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1111\/j.1532-5415.2008.01927.x","article-title":"Changes in muscle mass, muscle strength and power, but not physical function are related to testosterone dose in healthy older men","volume":"56","author":"Storer","year":"2008","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(18)30171-2_bib12","doi-asserted-by":"crossref","first-page":"1647","DOI":"10.1056\/NEJMoa054629","article-title":"DHEA in elderly women and DHEA or testosterone in elderly men","volume":"355","author":"Nair","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30171-2_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2007.51","article-title":"Effect of testosterone supplementation on functional mobility, and other parameters in older men: a randomized controlled trial","volume":"299","author":"Emmelot-Vonk","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30171-2_bib14","first-page":"583","article-title":"Effects of testosterone supplementation for 3 years on muscle performance and physical function in older men","volume":"102","author":"Storer","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30171-2_bib15","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.2015.8881","article-title":"Effects of testosterone administration for 3 years on subclinical atherosclerosis progression in older men with low or low-normal testosterone levels: a randomized clinical trial","volume":"314","author":"Basaria","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30171-2_bib16","series-title":"Testosterone and aging: clinical research directions","author":"Liverman","year":"2004"},{"key":"10.1016\/S2213-8587(18)30171-2_bib17","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1177\/1740774514524032","article-title":"The testosterone trials: seven coordinated trials of testosterone treatment in elderly men","volume":"11","author":"Snyder","year":"2014","journal-title":"Clin Trials"},{"key":"10.1016\/S2213-8587(18)30171-2_bib18","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1093\/gerona\/glv031","article-title":"Recruitment and screening for the testosterone trials","volume":"70","author":"Cauley","year":"2015","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(18)30171-2_bib19","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1056\/NEJMoa1506119","article-title":"Effects of testosterone on sexual function, physical function and vitality in older men","volume":"374","author":"Snyder","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30171-2_bib20","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1001\/jama.2010.1923","article-title":"Gait speed and survival in older adults","volume":"305","author":"Studenski","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30171-2_bib21","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1002\/cpt1974155443","article-title":"Minimization: a new method of assigning patients to treatment and control groups","volume":"15","author":"Taves","year":"1974","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S2213-8587(18)30171-2_bib22","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1111\/j.1532-5415.1999.tb05209.x","article-title":"Walking speed and stride length predicts 36 months dependency, mortality, and institutionalization in Chinese aged 70 and older","volume":"47","author":"Woo","year":"1999","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(18)30171-2_bib23","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1111\/j.1532-5415.2005.53501.x","article-title":"Prognostic value of usual gait speed in well-functioning older people\u2014results from the Health, Aging and Body Composition Study","volume":"53","author":"Cesari","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(18)30171-2_bib24","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1093\/ageing\/afg107","article-title":"The predictive validity for mortality of the index of mobility-related limitation\u2014results from the EPESE study","volume":"32","author":"Melzer","year":"2003","journal-title":"Age Ageing"},{"key":"10.1016\/S2213-8587(18)30171-2_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1471-2474-6-3","article-title":"Assessing stability and change of four performing measures: a longitudinal study evaluating outcome following total hip and knee arthroplasty","volume":"6","author":"Kennedy","year":"2005","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/S2213-8587(18)30171-2_bib26","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1111\/j.1532-5415.2006.00701.x","article-title":"Meaningful change and responsiveness in common physical performance measures in older adults","volume":"54","author":"Perera","year":"2006","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(18)30171-2_bib27","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1164\/ajrccm.155.4.9105067","article-title":"Interpreting small differences in functional status: the six minute walk test in chronic lung disease patients","volume":"155","author":"Redelmeier","year":"1997","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S2213-8587(18)30171-2_bib28","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I: conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/S2213-8587(18)30171-2_bib29","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1111\/jgs.14804","article-title":"Effect of physical activity versus health education on physical function, grip strength and mobility","volume":"65","author":"Santanasto","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(18)30171-2_bib30","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199607043350101","article-title":"The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men","volume":"335","author":"Bhasin","year":"1996","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301712?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301712?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:10Z","timestamp":1761991570000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301712"}},"issued":{"date-parts":[[2018,11]]},"references-count":30,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2018,11]]}},"alternative-id":["S2213858718301712"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30171-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of testosterone replacement on measures of mobility in older men with mobility limitation and low testosterone concentrations: secondary analyses of the Testosterone Trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30171-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30202-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T00:40:23Z","timestamp":1789605623866,"version":"build-2803163510"},"reference-count":96,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011946","name":"Abbott Diabetes Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011946","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017012","name":"Roche Diabetes Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100017012","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/s2213-8587(17)30260-7","type":"journal-article","created":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T01:00:44Z","timestamp":1504227644000},"page":"143-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Distal technologies and type 1 diabetes management"],"prefix":"10.1016","volume":"6","author":[{"given":"Danny C","family":"Duke","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Barry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David V","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jane","family":"Speight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Harris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30260-7_bib1","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/diacare.23.10.1516","article-title":"Incidence of childhood type 1 diabetes worldwide: Diabetes Mondiale (DiaMond) Project Group","volume":"23","author":"Karvonen","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30260-7_bib2","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(09)60568-7","article-title":"Incidence trends for childhood type 1 diabetes in Europe during 1989\u20132003 and predicted new cases 2005\u201320: a multicentre prospective registration study","volume":"373","author":"Patterson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30260-7_bib3","doi-asserted-by":"crossref","first-page":"S102","DOI":"10.2337\/dc09-S202","article-title":"Diabetes in non-Hispanic white youth prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study","volume":"32","author":"Bell","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30260-7_bib4","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1056\/NEJM199306103282306","article-title":"Long-term complications of diabetes mellitus","volume":"328","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30260-7_bib5","author":"Kay"},{"key":"10.1016\/S2213-8587(17)30260-7_bib7","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1177\/1932296816650900","article-title":"Diabetes technology uptake, outcomes, barriers, and the intersection with distress","volume":"10","author":"Naranjo","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib8","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1037\/a0040383","article-title":"Psychology, technology, and diabetes management","volume":"71","author":"Gonder-Frederick","year":"2016","journal-title":"Am Psychol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib9","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1177\/1357633X13479701","article-title":"Effects of self-management health information technology on glycaemic control for patients with diabetes: a meta-analysis of randomized controlled trials","volume":"19","author":"Tao","year":"2013","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib10","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1177\/1357633X15605223","article-title":"Using mobile technology to motivate adolescents with type 1 diabetes mellitus: a systematic review of recent literature","volume":"21","author":"Deacon","year":"2015","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib11","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1089\/dia.2012.0291","article-title":"Text message interventions for children and adolescents with type 1 diabetes: a systematic review","volume":"15","author":"Herbert","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(17)30260-7_bib12","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1089\/tmj.2011.0119","article-title":"Diabetes management via mobile phones: a systematic review","volume":"18","author":"Holtz","year":"2012","journal-title":"Telemed J E Health"},{"key":"10.1016\/S2213-8587(17)30260-7_bib13","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1177\/1932296814529885","article-title":"Improving type 1 diabetes management with mobile tools a systematic review","volume":"8","author":"Peterson","year":"2014","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib14","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1258\/jtt.2011.110513","article-title":"A review of telephone coaching services for people with long-term conditions","volume":"17","author":"Hutchison","year":"2011","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib15","doi-asserted-by":"crossref","first-page":"371","DOI":"10.4239\/wjd.v6.i3.371","article-title":"Telehealth interventions to reduce management complications in type 1 diabetes: a review","volume":"6","author":"Balkhi","year":"2015","journal-title":"World J Diabetes"},{"key":"10.1016\/S2213-8587(17)30260-7_bib16","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1177\/193229681300700130","article-title":"Mobile applications for diabetes self-management: status and potential","volume":"7","author":"El-Gayar","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib17","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.2337\/dc14-2469","article-title":"Seeing is believing: using Skype to improve diabetes outcomes in youth","volume":"38","author":"Harris","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30260-7_bib18","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1177\/193229681300700318","article-title":"Behavioral health care for adolescents with poorly controlled diabetes via Skype: does working alliance remain intact?","volume":"7","author":"Freeman","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib19","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.2337\/dc14-2519","article-title":"Depressive symptoms in a trial Behavior Family Systems Therapy for diabetes: a post hoc analysis of change","volume":"38","author":"Riley","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30260-7_bib20","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1177\/193229681000400125","article-title":"Telehealth behavior therapy for the management of type 1 diabetes in adolescents","volume":"4","author":"Lehmkuhl","year":"2010","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib21","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1111\/j.1464-5491.2011.03302.x","article-title":"Mobile phone support is associated with reduced ketoacidosis in young adults","volume":"28","author":"Farrell","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(17)30260-7_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1089\/dia.2012.0243","article-title":"Impact of telemedicine assessment on glycemic variability in children with type 1 diabetes mellitus","volume":"15","author":"Pe\u00f1a","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(17)30260-7_bib23","doi-asserted-by":"crossref","first-page":"533","DOI":"10.2337\/dc10-1259","article-title":"The Diabeo software enabling individualized insulin dose adjustments combined with telemedicine support improves HbA1c in poorly controlled type 1 diabetic patients: a 6-month, randomized, open-label, parallel-group, multicenter trial (TeleDiab 1 study)","volume":"34","author":"Charpentier","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30260-7_bib24","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1258\/jtt.2012.120103","article-title":"Use of telemedicine in subjects with type 1 diabetes equipped with an insulin pump and real-time continuous glucose monitoring","volume":"18","author":"Gonzalez-Molero","year":"2012","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib25","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/j.jcjd.2014.10.005","article-title":"The effectiveness of internet intervention on 926 patients with diabetes mellitus for up to 30 months","volume":"39","author":"Tildesley","year":"2015","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(17)30260-7_bib26","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1089\/dia.2015.0425","article-title":"CoYoT1 clinic: innovative telemedicine care model for young adults with type 1 diabetes","volume":"18","author":"Raymond","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(17)30260-7_bib27","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1089\/dia.2012.0323","article-title":"Impact of remote management of diabetes via computer: the 360 study\u2014a proof-of-concept randomized trial","volume":"15","author":"Leichter","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(17)30260-7_bib28","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.diabet.2013.09.001","article-title":"Telemedicine and type 1 diabetes: is technology per se sufficient to improve glycaemic control?","volume":"40","author":"Franc","year":"2014","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(17)30260-7_bib29","doi-asserted-by":"crossref","first-page":"e235","DOI":"10.2196\/jmir.2588","article-title":"Diabetes self-management smartphone application for adults with type 1 diabetes: randomized controlled trial","volume":"15","author":"Kirwan","year":"2013","journal-title":"J Med Internet Res"},{"key":"10.1016\/S2213-8587(17)30260-7_bib30","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1089\/dia.2013.0021","article-title":"Impact of the \u201cDiabetes Interactive Diary\u201d telemedicine system on metabolic control, risk of hypoglycemia, and quality of life: a randomized clinical trial in type 1 diabetes","volume":"15","author":"Rossi","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(17)30260-7_bib31","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1258\/jtt.2011.111006","article-title":"A pilot test of a tailored mobile and web-based diabetes messaging system for adolescents","volume":"18","author":"Mulvaney","year":"2012","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1177\/1357633X14529244","article-title":"Effect of mobile phone short text messages on glycaemic control in children with type 1 diabetes","volume":"20","author":"Bin-Abbas","year":"2014","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib33","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1258\/jtt.2012.120506","article-title":"Telemedicine in paediatric patients with poorly controlled type 1 diabetes","volume":"19","author":"Choi","year":"2013","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib34","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1016\/j.pedn.2015.02.002","article-title":"A pilot randomized trial of text-messaging for symptom awareness and diabetes knowledge in adolescents with type 1 diabetes","volume":"30","author":"Han","year":"2015","journal-title":"J Pediatr Nurs"},{"key":"10.1016\/S2213-8587(17)30260-7_bib35","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1177\/1932296815576956","article-title":"Integrating visual dietary documentation in mobile-phone-based self-management application for adolescents with type 1 diabetes","volume":"9","author":"Fr\u00f8island","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib36","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.pec.2013.04.012","article-title":"Using a robot to personalise health education for children with diabetes type 1: a pilot study","volume":"92","author":"Henkemans","year":"2013","journal-title":"Patient Educ Couns"},{"key":"10.1016\/S2213-8587(17)30260-7_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dia.2015.0227","article-title":"Impact of a serious videogame designed for flexible insulin therapy on the knowledge and behaviors of children with type 1 diabetes: the LUDIDIAB pilot study","volume":"18","author":"Joubert","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(17)30260-7_bib38","doi-asserted-by":"crossref","first-page":"e427","DOI":"10.5812\/ijp.25(3)2015.427","article-title":"Effect of playing interactive computer game on distress of insulin injection among type 1 diabetic children","volume":"25","author":"Ebrahimpour","year":"2015","journal-title":"Iran J Pediatr"},{"key":"10.1016\/S2213-8587(17)30260-7_bib39","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.2337\/dc14-2487","article-title":"Social media and diabetes: can Facebook and Skype improve glucose control in patients with type 1 diabetes on pump therapy? One-year experience","volume":"38","author":"Petrovski","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30260-7_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1177\/1357633X13512069","article-title":"Pilot study of a web-based intervention for adolescents with type 1 diabetes","volume":"19","author":"Newton","year":"2013","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib41","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1080\/00981389.2012.699507","article-title":"Evaluation of an online education and support intervention for adolescents with diabetes","volume":"51","author":"Nicholas","year":"2012","journal-title":"Soc Work Health Care"},{"key":"10.1016\/S2213-8587(17)30260-7_bib42","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1097\/NNR.0b013e3182690a29","article-title":"An internet coping skills training program for youth with type 1 diabetes: six-month outcomes","volume":"61","author":"Whittemore","year":"2012","journal-title":"Nurs Res"},{"key":"10.1016\/S2213-8587(17)30260-7_bib43","doi-asserted-by":"crossref","first-page":"2475","DOI":"10.2337\/dc12-2199","article-title":"Internet psycho-education programs improve outcomes in youth with type 1 diabetes","volume":"36","author":"Grey","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30260-7_bib44","doi-asserted-by":"crossref","first-page":"602","DOI":"10.2337\/dc09-1881","article-title":"An internet-based program to improve self-management in adolescents with type 1 diabetes","volume":"33","author":"Mulvaney","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30260-7_bib45","first-page":"303","article-title":"Parental self-efficacy and online support among parents of children diagnosed with type 1 diabetes mellitus","volume":"38","author":"Merkel","year":"2012","journal-title":"Pediatr Nurs"},{"key":"10.1016\/S2213-8587(17)30260-7_bib46","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s13142-016-0397-5","article-title":"Internet-based incentives increase blood glucose testing with a non-adherent, diverse sample of teens with type 1 diabetes mellitus: a randomized controlled Trial","volume":"6","author":"Raiff","year":"2016","journal-title":"Transl Behav Med"},{"key":"10.1016\/S2213-8587(17)30260-7_bib47","doi-asserted-by":"crossref","first-page":"134","DOI":"10.4093\/dmj.2014.38.2.134","article-title":"A randomized controlled trial of an internet-based mentoring program for type 1 diabetes patients with inadequate glycemic control","volume":"38","author":"Suh","year":"2014","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(17)30260-7_bib48","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1089\/dia.2013.0313","article-title":"The efficiency of telemedicine to optimize metabolic control in patients with type 1 diabetes mellitus: Telemed study","volume":"16","author":"Esmatjes","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(17)30260-7_bib49","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1399-5448.2011.00800.x","article-title":"The effectiveness of internet-based blood glucose monitoring system on improving diabetes control in adolescents with type 1 diabetes","volume":"13","author":"Landau","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(17)30260-7_bib50","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1111\/pedi.12103","article-title":"Teaming up: feasibility of an online treatment environment for adolescents with type 1 diabetes","volume":"15","author":"Boogerd","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(17)30260-7_bib51","doi-asserted-by":"crossref","first-page":"200","DOI":"10.3390\/jpm4020200","article-title":"Impact of information technology on the therapy of type-1 diabetes: a case study of children and adolescents in Germany","volume":"4","author":"Berndt","year":"2014","journal-title":"J Pers Med"},{"key":"10.1016\/S2213-8587(17)30260-7_bib52","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1177\/1357633X15598425","article-title":"Impact of long-term use of eHealth systems in adolescents with type 1 diabetes treated with sensor-augmented pump therapy","volume":"22","author":"Schiaffini","year":"2015","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib53","doi-asserted-by":"crossref","first-page":"384","DOI":"10.1177\/1357633X0501100802","article-title":"Telemedicine in the future","volume":"11","author":"Heinzelman","year":"2005","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib54","doi-asserted-by":"crossref","first-page":"e79246","DOI":"10.1371\/journal.pone.0079246","article-title":"Telemedicine application in the care of diabetes patients: systematic review and meta-analysis","volume":"8","author":"Marcolino","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30260-7_bib55","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1111\/j.1463-1326.2012.01599.x","article-title":"Pumpers, Skypers, surfers and texters: technology to improve the management of diabetes in teenagers","volume":"14","author":"Harris","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(17)30260-7_bib56","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.pedn.2013.10.013","article-title":"Impact of telemedicine in managing type 1 diabetes among school-age children and adolescents: an integrative review","volume":"29","author":"Guljas","year":"2014","journal-title":"J Pediatr Nurs"},{"key":"10.1016\/S2213-8587(17)30260-7_bib57","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1177\/1932296816642577","article-title":"Videoconferencing for teens with diabetes: family matters","volume":"10","author":"Duke","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib58","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.diabres.2016.04.019","article-title":"Does telemedicine improve treatment outcomes for diabetes? A meta-analysis of results from 55 randomized controlled trials","volume":"116","author":"Su","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(17)30260-7_bib59","doi-asserted-by":"crossref","first-page":"1372","DOI":"10.1111\/j.1464-5491.2005.01627.x","article-title":"A systematic review of telemedicine interventions to support blood glucose self-monitoring in diabetes","volume":"22","author":"Farmer","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(17)30260-7_bib60","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1377\/hlthaff.2013.0589","article-title":"Mobile phone diabetes project led to improved glycemic control and net savings for Chicago plan participants","volume":"33","author":"Nundy","year":"2014","journal-title":"Health Aff"},{"key":"10.1016\/S2213-8587(17)30260-7_bib61","doi-asserted-by":"crossref","first-page":"1460","DOI":"10.1177\/193229680900300628","article-title":"Health technologies for monitoring and managing diabetes: a systematic review","volume":"3","author":"Russell-Minda","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib62","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.pedn.2014.04.009","article-title":"The role of mobile phones in adolescent T1DM: a review of the literature","volume":"29","author":"Barnaba","year":"2014","journal-title":"J Pediatr Nurs"},{"key":"10.1016\/S2213-8587(17)30260-7_bib63","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1177\/1932296816639610","article-title":"Texting adolescents in repeat DKA and their caregivers","volume":"10","author":"Wagner","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib64","doi-asserted-by":"crossref","first-page":"e1001382","DOI":"10.1371\/journal.pmed.1001382","article-title":"Scaling up mHealth: where is the evidence?","volume":"10","author":"Tomlinson","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30260-7_bib65","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1038\/scientificamerican0712-16","article-title":"How to fulfill the true promise of \u201cmHealth\u201d: mobile devices have the potential to become powerful medical tools","volume":"307","author":"Collins","year":"2012","journal-title":"Sci Am"},{"key":"10.1016\/S2213-8587(17)30260-7_bib66","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1007\/s10865-016-9765-3","article-title":"What do we know about mobile applications for diabetes self-management? A review of reviews","volume":"39","author":"Hood","year":"2016","journal-title":"J Behav Med"},{"key":"10.1016\/S2213-8587(17)30260-7_bib67","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12916-015-0314-7","article-title":"Smartphone apps for calculating insulin dose: a systematic assessment","volume":"13","author":"Huckvale","year":"2015","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(17)30260-7_bib68","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s13142-013-0205-4","article-title":"Adherence to evidence-based guidelines among diabetes self-management apps","volume":"3","author":"Breland","year":"2013","journal-title":"Transl Behav Med"},{"key":"10.1016\/S2213-8587(17)30260-7_bib69","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1089\/dia.2016.0233","article-title":"The use of mobile applications among adolescents with type 1 diabetes: results from diabetes MILES Youth\u2014Australia","volume":"18","author":"Trawley","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(17)30260-7_bib70","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1177\/1524839911405850","article-title":"Harnessing social media for health promotion and behavior change","volume":"14","author":"Korda","year":"2011","journal-title":"Health Promot Pract"},{"key":"10.1016\/S2213-8587(17)30260-7_bib71","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1399-5448.2011.00791.x","article-title":"Evaluation of a combined blood glucose monitoring and gaming system (Didget\u00ae) for motivation in children, adolescents, and young adults with type 1 diabetes","volume":"14","author":"Klingensmith","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(17)30260-7_bib72","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1093\/jpepsy\/jst081","article-title":"Mediators of 12-month outcomes of two internet interventions for youth with type 1 diabetes","volume":"39","author":"Jaser","year":"2014","journal-title":"J Pediatr Psychol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib73","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.pcd.2015.09.002","article-title":"Use of communication technologies by people with type 1 diabetes in the social networking era: a chance for improvement","volume":"10","author":"Gim\u00e9nez-P\u00e9rez","year":"2015","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/S2213-8587(17)30260-7_bib74","first-page":"38","article-title":"Social media use among individuals with diabetes","volume":"4","author":"Shaffer-Hudkins","year":"2014","journal-title":"Int J Commun Health"},{"key":"10.1016\/S2213-8587(17)30260-7_bib75","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1007\/s11606-010-1526-3","article-title":"Online social networking by patients with diabetes: a qualitative evaluation of communication with Facebook","volume":"26","author":"Greene","year":"2011","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S2213-8587(17)30260-7_bib76","doi-asserted-by":"crossref","first-page":"e18","DOI":"10.2337\/dc14-2461","article-title":"Paging Dr Google: parents' report of internet use for type 1 diabetes management","volume":"38","author":"Balkhi","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30260-7_bib77","doi-asserted-by":"crossref","first-page":"862","DOI":"10.1080\/00981389.2013.827144","article-title":"Examining preferences for website support to parents of adolescents with diabetes","volume":"52","author":"Nicholas","year":"2013","journal-title":"Soc Work Health Care"},{"key":"10.1016\/S2213-8587(17)30260-7_bib80","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2147\/PPA.S77730","article-title":"Design, construction, and implementation of an online platform for patients with type 1 diabetes: EncoDiab","volume":"9","author":"Alvarado-Martel","year":"2015","journal-title":"Patient Prefer Adherence"},{"key":"10.1016\/S2213-8587(17)30260-7_bib81","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1089\/dia.2014.0078","article-title":"A systematic review of electronic portal usage among patients with diabetes","volume":"16","author":"Amante","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(17)30260-7_bib82","doi-asserted-by":"crossref","first-page":"S7","DOI":"10.5334\/ijic.2551","article-title":"mHealth data-sharing system to improve communication during consultations: type 1 diabetes patients' perspective during the FI-STAR study","volume":"16","author":"Bradway","year":"2016","journal-title":"Int J Integr Care"},{"key":"10.1016\/S2213-8587(17)30260-7_bib83","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/S2213-8587(15)00414-3","article-title":"Mobile applications for diabetes management: efficacy issues and regulatory challenges","volume":"12","author":"Istepanian","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib84","doi-asserted-by":"crossref","first-page":"e15","DOI":"10.2196\/jmir.2170","article-title":"Type 1 diabetes eHealth psychoeducation: youth recruitment, participation, and satisfaction","volume":"15","author":"Whittemore","year":"2013","journal-title":"J Med Internet Res"},{"key":"10.1016\/S2213-8587(17)30260-7_bib85","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1177\/1357633X15617885","article-title":"Process evaluation of a mobile health intervention for people with diabetes in low income countries: the implementation of the TEXT4DSM study","volume":"23","author":"Van Olmen","year":"2017","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib86","doi-asserted-by":"crossref","first-page":"1178","DOI":"10.1089\/dia.2012.0139","article-title":"Factors affecting acceptability and usability of technological approaches to diabetes self-management: a case study","volume":"14","author":"Vuong","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(17)30260-7_bib87","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/1357633X0501100102","article-title":"Introduction to the practice of telemedicine","volume":"11","author":"Craig","year":"2005","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib88","first-page":"CD002098","article-title":"Telemedicine versus face to face patient care: effects on professional practice and health care outcomes","volume":"2","author":"Currell","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30260-7_bib90","series-title":"In: Information and communications for development 2012: maximizing mobile","article-title":"mHealth (ch 3)","author":"Friederici","year":"2012"},{"key":"10.1016\/S2213-8587(17)30260-7_bib91","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diabres.2010.03.029","article-title":"Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings","volume":"88","author":"Beran","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(17)30260-7_bib92","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1353\/hpu.2014.0037","article-title":"A systematic review of innovative diabetes care models in low- and middle-income countries (LMICs)","volume":"25","author":"Esterson","year":"2014","journal-title":"J Health Care Poor Underserved"},{"key":"10.1016\/S2213-8587(17)30260-7_bib93","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1345\/aph.1P779","article-title":"The evolution of diabetes care in the rural, resource-constrained setting of western Kenya","volume":"45","author":"Pastakia","year":"2011","journal-title":"Ann Pharmacother"},{"key":"10.1016\/S2213-8587(17)30260-7_bib94","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1089\/tmj.2012.0232","article-title":"The link between information and communication technologies and global public health: pushing forward","volume":"19","author":"Cabieses","year":"2013","journal-title":"Telemed J E Health"},{"key":"10.1016\/S2213-8587(17)30260-7_bib95","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1177\/1357633X15609853","article-title":"Challenges in conducting mHealth research with underserved populations: lessons learned","volume":"22","author":"Nelson","year":"2016","journal-title":"J Telemed Telecare"},{"key":"10.1016\/S2213-8587(17)30260-7_bib96","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1177\/193229681300700305","article-title":"Development and feasibility of a text messaging and interactive voice response intervention for low-income, diverse adults with type 2 diabetes mellitus","volume":"7","author":"Osborn","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(17)30260-7_bib97","doi-asserted-by":"crossref","first-page":"i1174","DOI":"10.1136\/bmj.i1174","article-title":"Guidelines for reporting of health interventions using mobile phones: mobile health (mHealth) evidence reporting and assessment (mERA) checklist","volume":"352","author":"Agarwal","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30260-7_bib98","series-title":"Telemedicine: opportunities and developments in member states\u2014report on the second global survey on eHealth","year":"2010"},{"key":"10.1016\/S2213-8587(17)30260-7_bib101","series-title":"Mobile applications for the health sector","author":"Qiang","year":"2011"},{"key":"10.1016\/S2213-8587(17)30260-7_bib102","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.2196\/ijmr.4504","article-title":"Use of commonly available technologies for diabetes information and self-management among adolescents with type 1 diabetes and their parents: a web-based survey study","volume":"4","author":"Vaala","year":"2015","journal-title":"Interact J Med Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302607?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302607?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:26Z","timestamp":1761991586000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717302607"}},"issued":{"date-parts":[[2018,2]]},"references-count":96,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S2213858717302607"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30260-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Distal technologies and type 1 diabetes management","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30260-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:32:19Z","timestamp":1794317539810,"version":"4.9.0"},"reference-count":58,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007885","name":"European Association for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001773","name":"University of New South Wales","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001773","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007028","name":"Leona M and Harry B Helmsley Charitable Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007028","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001067","name":"Juvenile Diabetes Research Foundation Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001067","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015539","name":"Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/s2213-8587(23)00122-5","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T18:34:31Z","timestamp":1687890871000},"page":"578-592","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Enteroviruses and risk of islet autoimmunity or type 1 diabetes: systematic review and meta-analysis of controlled observational studies detecting viral nucleic acids and proteins"],"prefix":"10.1016","volume":"11","author":[{"given":"Sonia R","family":"Isaacs","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anju","family":"Roy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brieana","family":"Dance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily J","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dylan B","family":"Foskett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna J","family":"Maxwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William D","family":"Rawlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ki Wook","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00122-5_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00122-5_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/pedi.13410","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: stages of type 1 diabetes in children and adolescents","volume":"23","author":"Besser","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00122-5_bib3","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1111\/pedi.12597","article-title":"Genetics of type 1 diabetes","volume":"19","author":"Redondo","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00122-5_bib4","article-title":"Localization of enteroviral RNA within the pancreas in donors with T1D and T1D-associated autoantibodies","volume":"2","author":"Geravandi","year":"2021","journal-title":"Cell Rep Med"},{"key":"10.1016\/S2213-8587(23)00122-5_bib5","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3390\/v13030434","article-title":"World-wide prevalence and genotype distribution of enteroviruses","volume":"13","author":"Brouwer","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/S2213-8587(23)00122-5_bib6","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41574-022-00688-1","article-title":"Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus","volume":"18","author":"Nekoua","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00122-5_bib7","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s00125-012-2591-4","article-title":"No evidence of enteroviruses in the intestine of patients with type 1 diabetes","volume":"55","author":"Mercalli","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00122-5_bib8","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1111\/j.1464-5491.2004.01182.x","article-title":"Coxsackie B virus serology and type 1 diabetes mellitus: a systematic review of published case-control studies","volume":"21","author":"Green","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00122-5_bib9","doi-asserted-by":"crossref","first-page":"d35","DOI":"10.1136\/bmj.d35","article-title":"Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies","volume":"342","author":"Yeung","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00122-5_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-018-30322-y","article-title":"Amplification and next generation sequencing of near full-length human enteroviruses for identification and characterisation from clinical samples","volume":"8","author":"Isaacs","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(23)00122-5_bib11","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1111\/pedi.12952","article-title":"Higher frequency of vertebrate-infecting viruses in the gut of infants born to mothers with type 1 diabetes","volume":"21","author":"Kim","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00122-5_bib12","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00122-5_bib13","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00122-5_bib14","series-title":"Cochrane Handbook for Systematic Reviews of Interventions version 6.3","year":"2022"},{"key":"10.1016\/S2213-8587(23)00122-5_bib15","article-title":"Higher abundance of enterovirus A species in the gut of children with islet autoimmunity","volume":"9","author":"Kim","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(23)00122-5_bib16","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1007\/s00592-011-0297-6","article-title":"First-degree relatives of persons with type 1 diabetes: insulin resistance and enterovirus infection are associated with different patterns of islet cell autoimmunity","volume":"50","author":"Cubas-Due\u00f1as","year":"2013","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(23)00122-5_bib17","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1080\/08916930701523429","article-title":"Occurrence of enterovirus RNA in serum of children with newly diagnosed type 1 diabetes and islet cell autoantibody-positive subjects in a population with a low incidence of type 1 diabetes","volume":"40","author":"Sarmiento","year":"2007","journal-title":"Autoimmunity"},{"key":"10.1016\/S2213-8587(23)00122-5_bib18","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/(SICI)1096-9071(200006)61:2<214::AID-JMV7>3.0.CO;2-9","article-title":"Enterovirus RNA in serum is a risk factor for beta-cell autoimmunity and clinical type 1 diabetes: a prospective study. Childhood Diabetes in Finland (DiMe) Study Group","volume":"61","author":"L\u00f6nnrot","year":"2000","journal-title":"J Med Virol"},{"key":"10.1016\/S2213-8587(23)00122-5_bib19","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1111\/pedi.12056","article-title":"Intrafamilial spread of enterovirus infections at the clinical onset of type 1 diabetes","volume":"14","author":"Salvatoni","year":"2013","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00122-5_bib20","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1046\/j.1464-5491.2002.00807_2.x","article-title":"Detection of enterovirus RNA sequences in serum samples from autoantibody-positive subjects at risk for diabetes","volume":"19","author":"Coutant","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00122-5_bib21","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0168-8227(02)00198-5","article-title":"Prospective study of enteroviral infections and development of beta-cell autoimmunity. Diabetes autoimmunity study in the young (DAISY)","volume":"59","author":"Graves","year":"2003","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00122-5_bib22","doi-asserted-by":"crossref","first-page":"E6166","DOI":"10.1073\/pnas.1706359114","article-title":"Intestinal virome changes precede autoimmunity in type I diabetes-susceptible children","volume":"114","author":"Zhao","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(23)00122-5_bib23","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1007\/s00125-016-4177-z","article-title":"Detection of enteroviruses in stools precedes islet autoimmunity by several months: possible evidence for slowly operating mechanisms in virus-induced autoimmunity","volume":"60","author":"Honkanen","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00122-5_bib24","doi-asserted-by":"crossref","first-page":"1865","DOI":"10.1038\/s41591-019-0667-0","article-title":"Prospective virome analyses in young children at increased genetic risk for type 1 diabetes","volume":"25","author":"Vehik","year":"2019","journal-title":"Nat Med"},{"issue":"suppl 14","key":"10.1016\/S2213-8587(23)00122-5_bib25","first-page":"90","article-title":"Newly diagnosed type 1 diabetes is associated to intrafamilial enterovirus infections","volume":"11","author":"Salvatoni","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00122-5_bib26","series-title":"Diabetes and Viruses","first-page":"143","article-title":"Enteroviruses in blood","author":"Toniolo","year":"2013"},{"key":"10.1016\/S2213-8587(23)00122-5_bib27","doi-asserted-by":"crossref","first-page":"285","DOI":"10.2337\/diacare.27.1.285","article-title":"Increased prevalence of enteroviral RNA in blood spots from newborn children who later developed type 1 diabetes: a population-based case-control study","volume":"27","author":"Dahlquist","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00122-5_bib28","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1002\/jmv.1890420217","article-title":"Failure to detect genomic viral sequences in pancreatic tissues from two children with acute-onset diabetes mellitus","volume":"42","author":"Buesa-Gomez","year":"1994","journal-title":"J Med Virol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00122-5_bib29","first-page":"167","article-title":"Enteroviruses in the pancreas of live adult patients with newly diagnosed type 1 diabetes: results from the DiViD study","volume":"60","author":"Krogvold","year":"2017","journal-title":"Diabetologia"},{"issue":"suppl 17","key":"10.1016\/S2213-8587(23)00122-5_bib30","first-page":"46","article-title":"Enterovirus infection and low Treg function: two possible biomarkers of progression to autoimmune T1D","volume":"13","author":"Musolino","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00122-5_bib31","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2337\/db11-1157","article-title":"Type 1 diabetes is associated with enterovirus infection in gut mucosa","volume":"61","author":"Oikarinen","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00122-5_bib32","doi-asserted-by":"crossref","first-page":"12620","DOI":"10.18632\/oncotarget.14896","article-title":"Detection and localization of viral infection in the pancreas of patients with type 1 diabetes using short fluorescently-labelled oligonucleotide probes","volume":"8","author":"Busse","year":"2017","journal-title":"Oncotarget"},{"key":"10.1016\/S2213-8587(23)00122-5_bib33","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/pedi.13207","article-title":"Eukaryotic viruses in the fecal virome at the onset of type 1 diabetes: a study from four geographically distant African and Asian countries","volume":"22","author":"Cinek","year":"2021","journal-title":"Pediatr Diabetes"},{"issue":"suppl 15","key":"10.1016\/S2213-8587(23)00122-5_bib34","first-page":"40","article-title":"Coxsackie virus (CV) RNA in peripheral blood mononuclear cells (PBMCs) in newly diagnosed type 1 diabetic children","volume":"12","author":"Sherif","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00122-5_bib35","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/eci.12485","article-title":"Monocytes of patients with type 1 diabetes harbour enterovirus RNA","volume":"45","author":"Alidjinou","year":"2015","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S2213-8587(23)00122-5_bib36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1016\/j.kjms.2017.12.010","article-title":"Alteration in CD8+ T cell subsets in enterovirus-infected patients: an alarming factor for type 1 diabetes mellitus","volume":"34","author":"Zargari Samani","year":"2018","journal-title":"Kaohsiung J Med Sci"},{"key":"10.1016\/S2213-8587(23)00122-5_bib37","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1111\/pedi.12673","article-title":"Vitamin D status, enterovirus infection, and type 1 diabetes in Italian children\/adolescents","volume":"19","author":"Federico","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00122-5_bib38","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-017-04993-y","article-title":"Revealing enterovirus infection in chronic human disorders: An integrated diagnostic approach","volume":"7","author":"Genoni","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(23)00122-5_bib39","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/vim.2009.0072","article-title":"Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection","volume":"23","author":"Schulte","year":"2010","journal-title":"Viral Immunol"},{"key":"10.1016\/S2213-8587(23)00122-5_bib40","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1002\/jmv.21008","article-title":"Recent enterovirus infection in type 1 diabetes: evidence with a novel IgM method","volume":"79","author":"Elfaitouri","year":"2007","journal-title":"J Med Virol"},{"key":"10.1016\/S2213-8587(23)00122-5_bib41","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1086\/374742","article-title":"Reduced frequency of HLA DRB1*03-DQB1*02 in children with type 1 diabetes associated with enterovirus RNA","volume":"187","author":"Craig","year":"2003","journal-title":"J Infect Dis"},{"key":"10.1016\/S2213-8587(23)00122-5_bib42","doi-asserted-by":"crossref","first-page":"2995","DOI":"10.1007\/s00125-011-2305-3","article-title":"Human enterovirus infections in children at increased risk for type 1 diabetes: the Babydiet study","volume":"54","author":"Simonen-Tikka","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00122-5_bib43","doi-asserted-by":"crossref","first-page":"151","DOI":"10.2337\/dc10-1413","article-title":"Human enterovirus RNA in monthly fecal samples and islet autoimmunity in Norwegian children with high genetic risk for type 1 diabetes: the MIDIA study","volume":"34","author":"Tapia","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00122-5_bib44","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abd6527","article-title":"Islet expression of type I interferon response sensors is associated with immune infiltration and viral infection in type 1 diabetes","volume":"7","author":"Apaolaza","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/S2213-8587(23)00122-5_bib45","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00125-009-1276-0","article-title":"The prevalence of enteroviral capsid protein VP1 immunostaining in pancreatic islets in human type 1 diabetes","volume":"52","author":"Richardson","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00122-5_bib46","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1017\/S0950268821002442","article-title":"Association between enterovirus infection and clinical type 1 diabetes mellitus: systematic review and meta-analysis of observational studies","volume":"150","author":"Yang","year":"2021","journal-title":"Epidemiol Infect"},{"key":"10.1016\/S2213-8587(23)00122-5_bib47","article-title":"Association between Enterovirus infection and type 1 diabetes risk: a meta-analysis of 38 case-control studies","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(23)00122-5_bib48","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/dbi20-0054","article-title":"Screening for type 1 diabetes in the general population: a status report and perspective","volume":"71","author":"Sims","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00122-5_bib49","doi-asserted-by":"crossref","first-page":"3427","DOI":"10.1128\/JCM.01589-12","article-title":"Nearly constant shedding of diverse enteric viruses by two healthy infants","volume":"50","author":"Kapusinszky","year":"2012","journal-title":"J Clin Microbiol"},{"key":"10.1016\/S2213-8587(23)00122-5_bib50","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1073\/pnas.0700442104","article-title":"Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients","volume":"104","author":"Dotta","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(23)00122-5_bib51","doi-asserted-by":"crossref","first-page":"2491","DOI":"10.1007\/s00125-021-05525-0","article-title":"Characterisation of enterovirus RNA detected in the pancreas and other specimens of live patients with newly diagnosed type 1 diabetes in the DiViD study","volume":"64","author":"Oikarinen","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00122-5_bib52","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/(SICI)1096-9136(199806)15:6<515::AID-DIA608>3.0.CO;2-F","article-title":"Simultaneous onset of type 1 diabetes mellitus in identical infant twins with enterovirus infection","volume":"15","author":"Smith","year":"1998","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00122-5_bib53","doi-asserted-by":"crossref","first-page":"358","DOI":"10.1007\/s10620-016-4403-z","article-title":"Circulating zonulin correlates with density of enteroviruses and tolerogenic dendritic cells in the small bowel mucosa of celiac disease patients","volume":"62","author":"Vorobjova","year":"2017","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S2213-8587(23)00122-5_bib54","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1007\/s00125-022-05753-y","article-title":"Detection of enterovirus RNA in peripheral blood mononuclear cells correlates with the presence of the predisposing allele of the type 1 diabetes risk gene IFIH1 and with disease stage","volume":"65","author":"Sioofy-Khojine","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00122-5_bib55","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-022-05779-2","article-title":"Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study","volume":"65","author":"Krogvold","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00122-5_bib56","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1080\/14760584.2018.1548281","article-title":"Developing a vaccine for type 1 diabetes by targeting coxsackievirus B","volume":"17","author":"Hy\u00f6ty","year":"2018","journal-title":"Expert Rev Vaccines"},{"key":"10.1016\/S2213-8587(23)00122-5_bib57","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aaz2433","article-title":"A hexavalent Coxsackievirus B vaccine is highly immunogenic and has a strong protective capacity in mice and nonhuman primates","volume":"6","author":"Stone","year":"2020","journal-title":"Sci Adv"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00122-5_bib58","first-page":"124","article-title":"Enterovirus infection and risk of islet autoimmunity and type 1 diabetes: systematic review and meta-analysis of molecular studies","volume":"65","author":"Isaacs","year":"2022","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T19:48:26Z","timestamp":1779306506000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001225"}},"issued":{"date-parts":[[2023,8]]},"references-count":58,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2213858723001225"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00122-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Enteroviruses and risk of islet autoimmunity or type 1 diabetes: systematic review and meta-analysis of controlled observational studies detecting viral nucleic acids and proteins","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00122-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00133-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:32:21Z","timestamp":1794317541480,"version":"4.9.0"},"reference-count":11,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/s2213-8587(23)00168-7","type":"journal-article","created":{"date-parts":[[2023,6,24]],"date-time":"2023-06-24T20:57:19Z","timestamp":1687640239000},"page":"536-540","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action"],"prefix":"10.1016","volume":"11","author":[{"given":"Hiddo JL","family":"Heerspink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David ZI","family":"Cherney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Per-Henrik","family":"Groop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Matthieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katherine R","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet B","family":"McGill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00168-7_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00168-7_bib2","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/S2213-8587(22)00099-7","article-title":"Incidence rate patterns, cumulative incidence, and time trends for moderate and severe albuminuria in individuals diagnosed with type 1 diabetes aged 0\u201314 years: a population-based retrospective cohort study","volume":"10","author":"Jansson Sigfrids","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00168-7_bib3","doi-asserted-by":"crossref","first-page":"883","DOI":"10.2337\/dc18-2062","article-title":"Risk factors for kidney disease in type 1 diabetes","volume":"42","author":"Perkins","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00168-7_bib4","doi-asserted-by":"crossref","first-page":"1969","DOI":"10.2215\/CJN.02870316","article-title":"Albuminuria changes and cardiovascular and renal outcomes in type 1 diabetes: the DCCT\/EDIC study","volume":"11","author":"de Boer","year":"2016","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(23)00168-7_bib5","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1056\/NEJM199311113292004","article-title":"The effect of angiotensin-converting-enzyme inhibition on diabetic nephropathy","volume":"329","author":"Lewis","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00168-7_bib6","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.2337\/dc19-0937","article-title":"The impact of sotagliflozin on renal function, albuminuria, blood pressure, and hematocrit in adults with type 1 diabetes","volume":"42","author":"Van Raalte","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00168-7_bib7","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1038\/ki.2014.143","article-title":"Endothelin and endothelin antagonists in chronic kidney disease","volume":"86","author":"Kohan","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(23)00168-7_bib8","series-title":"ABT-627, a selective ETA-receptor antagonist, reduce proteinuria in patients with diabetes mellitus","first-page":"90","author":"Honing","year":"1999"},{"key":"10.1016\/S2213-8587(23)00168-7_bib9","doi-asserted-by":"crossref","first-page":"1936","DOI":"10.1007\/s00125-004-1542-0","article-title":"Aldosterone escape during blockade of the renin-angiotensin-aldosterone system in diabetic nephropathy is associated with enhanced decline in glomerular filtration rate","volume":"47","author":"Schjoedt","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00168-7_bib10","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s43441-022-00445-6","article-title":"Innovations in pediatric therapeutics development: principles for the use of bridging biomarkers in pediatric extrapolation","volume":"57","author":"Fleming","year":"2023","journal-title":"Ther Innov Regul Sci"},{"key":"10.1016\/S2213-8587(23)00168-7_bib11","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001687?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001687?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:50Z","timestamp":1761991970000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001687"}},"issued":{"date-parts":[[2023,8]]},"references-count":11,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2213858723001687"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00168-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"People with type 1 diabetes and chronic kidney disease urgently need new therapies: a call for action","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00168-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T18:47:25Z","timestamp":1794336445893,"version":"4.9.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/s2213-8587(23)00132-8","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T19:14:57Z","timestamp":1688411697000},"page":"567-577","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial"],"prefix":"10.1016","volume":"11","author":[{"given":"Lihui","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng'ai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luling","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianling","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianling","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lihui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yunliang","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng'ai","family":"Shen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueying","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luling","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuyun","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weidong","family":"Ren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufeng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianling","family":"Bai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongyu","family":"Kuang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiang","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenli","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanjie","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuang","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donghong","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ningling","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guangwei","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Hou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yingju","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhixia","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xu","family":"Lian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianling","family":"Du","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ping","family":"Tu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Su","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinhua","family":"Yin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenjia","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"He","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhongyan","family":"Shan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xueqin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chang","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yun","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Binhong","family":"Duan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenbo","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhengnan","family":"Gao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lijuan","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huimin","family":"Han","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Li","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bo","family":"Feng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingling","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xinfang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoping","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tong","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qiuhong","family":"Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00132-8_bib1","doi-asserted-by":"crossref","first-page":"m997","DOI":"10.1136\/bmj.m997","article-title":"Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study","volume":"369","author":"Li","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00132-8_bib2","series-title":"Definition, diagnosis and classification of diabetes mellitus and its complications: report of a WHO consultation. Part 1, Diagnosis and classification of diabetes mellitus","year":"1999"},{"key":"10.1016\/S2213-8587(23)00132-8_bib3","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1464-5491.2007.02068.x","article-title":"Incidence of type 2 diabetes in England and its association with baseline impaired fasting glucose: the Ely study 1990\u20132000","volume":"24","author":"Forouhi","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00132-8_bib4","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00132-8_bib5","doi-asserted-by":"crossref","first-page":"2279","DOI":"10.1016\/S0140-6736(12)60283-9","article-title":"Prediabetes: a high-risk state for diabetes development","volume":"379","author":"Tab\u00e1k","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00132-8_bib6","doi-asserted-by":"crossref","first-page":"537","DOI":"10.2337\/diacare.20.4.537","article-title":"Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study","volume":"20","author":"Pan","year":"1997","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00132-8_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00132-8_bib8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00132-8_bib9","doi-asserted-by":"crossref","DOI":"10.1155\/2017\/8493145","article-title":"The effectiveness of lifestyle adaptation for the prevention of prediabetes in adults: a systematic review","volume":"2017","author":"Kerrison","year":"2017","journal-title":"J Diabetes Res"},{"key":"10.1016\/S2213-8587(23)00132-8_bib10","first-page":"131","article-title":"The preventive effect of acarbose and metformin on the IGT population from becoming diabetes mellitus: a 3-year multicentral prospective study","volume":"17","author":"Yang","year":"2001","journal-title":"Chin J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00132-8_bib11","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.2337\/diabetes.54.4.1150","article-title":"Prevention of type 2 diabetes with troglitazone in the Diabetes Prevention Program","volume":"54","author":"Knowler","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00132-8_bib12","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance","volume":"364","author":"DeFronzo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00132-8_bib13","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00132-8_bib14","first-page":"363","article-title":"Treating prediabetes with metformin: systematic review and meta-analysis","volume":"55","author":"Lily","year":"2009","journal-title":"Can Fam Physician"},{"key":"10.1016\/S2213-8587(23)00132-8_bib15","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/j.diabres.2005.10.005","article-title":"Insulinogenic indices from insulin and C-peptide: comparison of beta-cell function from OGTT and IVGTT","volume":"72","author":"Tura","year":"2006","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00132-8_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00132-8_bib17","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/dom.13884","article-title":"Efficacy of metformin in preventing progression to diabetes in a Chinese population with impaired glucose regulation: Protocol for a multicentre, open-label, randomized controlled clinical study","volume":"22","author":"Ji","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00132-8_bib18","doi-asserted-by":"crossref","first-page":"1760","DOI":"10.2337\/dc16-1241","article-title":"The stepwise approach to diabetes prevention: results from the D-CLIP randomized controlled trial","volume":"39","author":"Weber","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00132-8_bib19","first-page":"14","article-title":"Antihypertensive effect of metformin in essential hypertensive patients with hyperinsulinemia","volume":"49","author":"Xing","year":"2010","journal-title":"Zhonghua Nei Ke Za Zhi"},{"key":"10.1016\/S2213-8587(23)00132-8_bib20","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00132-8_bib21","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial","volume":"368","author":"Gerstein","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00132-8_bib22","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.1056\/NEJMoa1001122","article-title":"Effect of nateglinide on the incidence of diabetes and cardiovascular events","volume":"362","author":"Holman","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00132-8_bib23","doi-asserted-by":"crossref","first-page":"281","DOI":"10.7326\/0003-4819-131-4-199908170-00008","article-title":"Pharmacologic therapy for type 2 diabetes mellitus","volume":"131","author":"DeFronzo","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(23)00132-8_bib24","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/s41574-019-0242-2","article-title":"Understanding the glucoregulatory mechanisms of metformin in type 2 diabetes mellitus","volume":"15","author":"Foretz","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00132-8_bib25","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"Prevalence of diabetes among men and women in China","volume":"362","author":"Yang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00132-8_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1136\/postgradmedj-2015-133281","article-title":"Pathophysiology of type 1 and type 2 diabetes mellitus: a 90-year perspective","volume":"92","author":"Zaccardi","year":"2016","journal-title":"Postgrad Med J"},{"key":"10.1016\/S2213-8587(23)00132-8_bib27","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.2337\/diab.44.11.1249","article-title":"UK prospective diabetes study 16. Overview of 6 years' therapy of type II diabetes: a progressive disease","volume":"44","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00132-8_bib28","doi-asserted-by":"crossref","first-page":"1684","DOI":"10.2337\/dc16-0798","article-title":"Pioglitazone prevents diabetes in patients with insulin resistance and cerebrovascular disease","volume":"39","author":"Inzucchi","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00132-8_bib29","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00132-8_bib30","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110048","article-title":"Long-term influence of type 2 diabetes and metabolic syndrome on all-cause and cardiovascular death, and microvascular and macrovascular complications in Chinese adults\u2014a 30-year follow-up of the Da Qing diabetes study","volume":"191","author":"He","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00132-8_bib31","doi-asserted-by":"crossref","DOI":"10.2337\/diacare.26.9.2701","article-title":"Preventing, delaying, or masking type 2 diabetes with metformin in the diabetes prevention program?","volume":"26","author":"Scheen","year":"2003","journal-title":"Diabetes Care"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(23)00288-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,11,1]],"date-time":"2023-11-01T00:00:00Z","timestamp":1698796800000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:11Z","timestamp":1761991991000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001328"}},"issued":{"date-parts":[[2023,8]]},"references-count":31,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2213858723001328"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00132-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Safety and effectiveness of metformin plus lifestyle intervention compared with lifestyle intervention alone in preventing progression to diabetes in a Chinese population with impaired glucose regulation: a multicentre, open-label, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00132-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00152-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:39:21Z","timestamp":1794278361976,"version":"4.9.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/s2213-8587(22)00079-1","type":"journal-article","created":{"date-parts":[[2022,3,14]],"date-time":"2022-03-14T20:39:56Z","timestamp":1647290396000},"page":"299-301","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Levothyroxine treatment in euthyroid women positive for thyroid peroxidase antibodies and recurrent pregnancy loss"],"prefix":"10.1016","volume":"10","author":[{"given":"Tim I M","family":"Korevaar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rima","family":"Dhillon-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00079-1_bib1","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(21)00682-6","article-title":"Miscarriage matters: the epidemiological, physical, psychological, and economic costs of early pregnancy loss","volume":"397","author":"Quenby","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00079-1_bib2","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1016\/S0140-6736(21)00681-4","article-title":"Recurrent miscarriage: evidence to accelerate action","volume":"397","author":"Coomarasamy","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00079-1_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d2616","article-title":"Association between thyroid autoantibodies and miscarriage and preterm birth: meta-analysis of evidence","volume":"342","author":"Thangaratinam","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00079-1_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(22)00045-6","article-title":"Levothyroxine in euthyroid thyroid peroxidase antibody positive women with recurrent pregnancy loss (T4LIFE trial): a multicentre, randomised, double-blind, placebo-controlled, phase3 trial","author":"van Dijk","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00079-1_bib5","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1812537","article-title":"Levothyroxine in women with thyroid peroxidase antibodies before conception","author":"Dhillon-Smith","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00079-1_bib6","doi-asserted-by":"crossref","first-page":"2190","DOI":"10.1001\/jama.2017.18249","article-title":"Effect of levothyroxine on miscarriage among women with normal thyroid function and thyroid autoimmunity undergoing in vitro fertilization and embryo transfer: a randomized clinical trial","volume":"318","author":"Wang","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00079-1_bib7","article-title":"Aspirin or heparin or both for improving pregnancy outcomes in women with persistent antiphospholipid antibodies and recurrent pregnancy loss","volume":"5","author":"Hamuly\u00e1k","year":"2020","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(22)00079-1_bib8","first-page":"69","article-title":"Thyroid autoimmunity impairs the thyroidal response to human chorionic gonadotropin: two population-based prospective cohort studies","volume":"102","author":"Korevaar","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00079-1_bib9","doi-asserted-by":"crossref","first-page":"3808","DOI":"10.1210\/jc.2004-0105","article-title":"Impact of ovarian hyperstimulation on thyroid function in women with and without thyroid autoimmunity","volume":"89","author":"Poppe","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00079-1_bib10","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1089\/thy.2014.0029","article-title":"Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study","volume":"24","author":"Liu","year":"2014","journal-title":"Thyroid"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:06Z","timestamp":1761991866000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000791"}},"issued":{"date-parts":[[2022,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2213858722000791"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00079-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Levothyroxine treatment in euthyroid women positive for thyroid peroxidase antibodies and recurrent pregnancy loss","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00079-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00045-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2022 Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T05:54:16Z","timestamp":1794030856350,"version":"4.8.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/s2213-8587(18)30316-4","type":"journal-article","created":{"date-parts":[[2018,12,18]],"date-time":"2018-12-18T18:32:38Z","timestamp":1545157958000},"page":"9-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":254,"title":["Novel subgroups of patients with adult-onset diabetes in Chinese and US populations"],"prefix":"10.1016","volume":"7","author":[{"given":"Xiantong","family":"Zou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianghai","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhanxing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linong","family":"Ji","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30316-4_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30316-4_bib2","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"Prevalence of diabetes among men and women in China","volume":"362","author":"Yang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30316-4_bib3","first-page":"2579","article-title":"Visualizing data using t-SNE","volume":"9","author":"Maaten","year":"2008","journal-title":"J Mach Learn Res"},{"key":"10.1016\/S2213-8587(18)30316-4_bib4","doi-asserted-by":"crossref","first-page":"46534","DOI":"10.1038\/srep46534","article-title":"The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional study","volume":"7","author":"Zou","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(18)30316-4_bib5","doi-asserted-by":"crossref","first-page":"543","DOI":"10.2337\/db12-0207","article-title":"Frequency, immunogenetics, and clinical characteristics of latent autoimmune diabetes in China (LADA China study): a nationwide, multicenter, clinic-based cross-sectional study","volume":"62","author":"Zhou","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30316-4_bib6","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.2337\/diabetes.53.12.3193","article-title":"Phenotypic characteristics of GAD antibody-positive recently diagnosed patients with type 2 diabetes in North America and Europe","volume":"53","author":"Zinman","year":"2004","journal-title":"Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:50Z","timestamp":1761991610000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303164"}},"issued":{"date-parts":[[2019,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2213858718303164"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30316-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Novel subgroups of patients with adult-onset diabetes in Chinese and US populations","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30316-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30051-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T04:45:56Z","timestamp":1793853956934,"version":"4.6.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/s2213-8587(17)30437-0","type":"journal-article","created":{"date-parts":[[2018,1,9]],"date-time":"2018-01-09T18:35:12Z","timestamp":1515522912000},"page":"197-207","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":155,"title":["Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies"],"prefix":"10.1016","volume":"6","author":[{"given":"Martin","family":"Neovius","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gustaf","family":"Bruze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Jacobson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kajsa","family":"Sj\u00f6holm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kari","family":"Johansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fredrik","family":"Granath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingmar","family":"N\u00e4slund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claude","family":"Marcus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan","family":"Ottosson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markku","family":"Peltonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lena M S","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30437-0_bib1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19\u00b72 million participants","volume":"387","author":"NCD Risk Factor Collaboration","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30437-0_bib2","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-term mortality after gastric bypass surgery","volume":"357","author":"Adams","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30437-0_bib3","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sjostrom","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30437-0_bib4","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1001\/jama.2014.16968","article-title":"Association between bariatric surgery and long-term survival","volume":"313","author":"Arterburn","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30437-0_bib5","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sjostrom","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30437-0_bib6","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1161\/CIRCULATIONAHA.116.025629","article-title":"Weight loss and heart failure: a nationwide study of gastric bypass surgery versus intensive lifestyle treatment","volume":"135","author":"Sundstrom","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30437-0_bib7","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1001\/jama.2014.5988","article-title":"Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications","volume":"311","author":"Sjostrom","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30437-0_bib8","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-8587(17)30061-X","article-title":"Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study","volume":"5","author":"Carlsson","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30437-0_bib9","doi-asserted-by":"crossref","first-page":"g3961","DOI":"10.1136\/bmj.g3961","article-title":"Bariatric surgery for obesity and metabolic conditions in adults","volume":"349","author":"Arterburn","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30437-0_bib10","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1001\/jamasurg.2014.2440","article-title":"Long-term outcomes of bariatric surgery: a National Institutes of Health symposium","volume":"149","author":"Courcoulas","year":"2014","journal-title":"JAMA Surg"},{"key":"10.1016\/S2213-8587(17)30437-0_bib11","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1016\/j.amjmed.2010.06.016","article-title":"Risk of suicide after long-term follow-up from bariatric surgery","volume":"123","author":"Tindle","year":"2010","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(17)30437-0_bib12","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1097\/SLA.0000000000001884","article-title":"Suicide, self-harm, and depression after gastric bypass surgery: a nationwide cohort study","volume":"265","author":"Lagerros","year":"2017","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(17)30437-0_bib13","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.1002\/bjs.10258","article-title":"Alcohol and substance abuse, depression and suicide attempts after Roux-en-Y gastric bypass surgery","volume":"103","author":"Backman","year":"2016","journal-title":"Br J Surg"},{"key":"10.1016\/S2213-8587(17)30437-0_bib14","first-page":"225","article-title":"Self-harm emergencies after bariatric surgery: a population-based cohort study","volume":"151","author":"Bhatti","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/S2213-8587(17)30437-0_bib15","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1111\/acps.12669","article-title":"Risk of psychiatric disorders, self-harm behaviour and service use associated with bariatric surgery","volume":"135","author":"Kovacs","year":"2017","journal-title":"Acta Psychiatr Scand"},{"key":"10.1016\/S2213-8587(17)30437-0_bib16","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.1001\/2012.jama.11164","article-title":"Health benefits of gastric bypass surgery after 6 years","volume":"308","author":"Adams","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30437-0_bib17","doi-asserted-by":"crossref","first-page":"1893","DOI":"10.1007\/s11695-015-1619-5","article-title":"Formation of the Scandinavian Obesity Surgery Registry, SOReg","volume":"25","author":"Hedenbro","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30437-0_bib18","doi-asserted-by":"crossref","first-page":"1822","DOI":"10.1007\/s11695-015-1657-z","article-title":"Bariatric surgery worldwide 2013","volume":"25","author":"Angrisani","year":"2015","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30437-0_bib19","author":"OECD"},{"key":"10.1016\/S2213-8587(17)30437-0_bib20","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-8587(15)00290-9","article-title":"Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study","volume":"3","author":"Keating","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30437-0_bib21","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1177\/1536867X0900900402","article-title":"CEM: coarsened exact matching in Stata","volume":"9","author":"Blackwell","year":"2009","journal-title":"Stata J"},{"key":"10.1016\/S2213-8587(17)30437-0_bib22","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1001\/2012.jama.10156","article-title":"Surgical vs lifestyle treatment for type 2 diabetes","volume":"308","author":"Ludwig","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30437-0_bib23","doi-asserted-by":"crossref","first-page":"f5934","DOI":"10.1136\/bmj.f5934","article-title":"Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials","volume":"347","author":"Gloy","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30437-0_bib24","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/obr.12014","article-title":"Risk of completed suicide after bariatric surgery: a systematic review","volume":"14","author":"Peterhansel","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(17)30437-0_bib25","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1046\/j.1365-2125.2002.01698.x","article-title":"Faster absorption of ethanol and higher peak concentration in women after gastric bypass surgery","volume":"54","author":"Klockhoff","year":"2002","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/S2213-8587(17)30437-0_bib26","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1001\/jamasurg.2013.700","article-title":"Increased admission for alcohol dependence after gastric bypass surgery compared with restrictive bariatric surgery","volume":"148","author":"Ostlund","year":"2013","journal-title":"JAMA Surg"},{"key":"10.1016\/S2213-8587(17)30437-0_bib27","doi-asserted-by":"crossref","first-page":"2444","DOI":"10.1002\/oby.20397","article-title":"Alcohol consumption and alcohol problems after bariatric surgery in the Swedish obese subjects study","volume":"21","author":"Svensson","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(17)30437-0_bib28","doi-asserted-by":"crossref","first-page":"2516","DOI":"10.1001\/jama.2012.6147","article-title":"Prevalence of alcohol use disorders before and after bariatric surgery","volume":"307","author":"King","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30437-0_bib29","doi-asserted-by":"crossref","first-page":"1132","DOI":"10.1001\/2012.jama.11792","article-title":"Health care use during 20 years following bariatric surgery","volume":"308","author":"Neovius","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30437-0_bib30","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1002\/oby.21908","article-title":"Change in use of sleep medications after gastric bypass surgery or intensive lifestyle treatment in adults with obesity","volume":"25","author":"Ng","year":"2017","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(17)30437-0_bib31","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1002\/oby.20066","article-title":"Possible risk factors for increased suicide following bariatric surgery","volume":"21","author":"Mitchell","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(17)30437-0_bib32","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1038\/sj.ijo.0803573","article-title":"Ten-year trends in health-related quality of life after surgical and conventional treatment for severe obesity: the SOS intervention study","volume":"31","author":"Karlsson","year":"2007","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(17)30437-0_bib33","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/S2213-8587(16)00013-9","article-title":"Self-harm and suicide after bariatric surgery: time for action","volume":"4","author":"Dixon","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30437-0_bib34","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1007\/s11695-016-2271-4","article-title":"Indications for surgery for obesity and weight-related diseases: position statements from the International Federation for the Surgery of Obesity and Metabolic Disorders (IFSO)","volume":"26","author":"De Luca","year":"2016","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(17)30437-0_bib35","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1159\/000355480","article-title":"Interdisciplinary European guidelines on metabolic and bariatric surgery","volume":"6","author":"Fried","year":"2013","journal-title":"Obes Facts"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,9]],"date-time":"2019-10-09T01:25:12Z","timestamp":1570584312000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717304370"}},"issued":{"date-parts":[[2018,3]]},"references-count":35,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2213858717304370"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30437-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of suicide and non-fatal self-harm after bariatric surgery: results from two matched cohort studies","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30437-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30435-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T00:47:38Z","timestamp":1794271658538,"version":"4.9.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009647","name":"Ministry of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009647","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","award":["U18DP006133"],"award-info":[{"award-number":["U18DP006133"]}],"id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","award":["U18DP006139"],"award-info":[{"award-number":["U18DP006139"]}],"id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","award":["U18DP006138"],"award-info":[{"award-number":["U18DP006138"]}],"id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","award":["U18DP006136"],"award-info":[{"award-number":["U18DP006136"]}],"id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","award":["U18DP006134"],"award-info":[{"award-number":["U18DP006134"]}],"id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010753","name":"National Health Laboratory Service","doi-asserted-by":"publisher","award":["1U18DP006131"],"award-info":[{"award-number":["1U18DP006131"]}],"id":[{"id":"10.13039\/501100010753","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003921","name":"Department of Health and Aged Care, Australian Government","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001322","name":"South African Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019434","name":"NIHR Exeter Clinical Research Facility","doi-asserted-by":"publisher","award":["CS-2015\\u201315\\u2013018"],"award-info":[{"award-number":["CS-2015\\u201315\\u2013018"]}],"id":[{"id":"10.13039\/501100019434","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["156184"],"award-info":[{"award-number":["156184"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["17\/63\/131"],"award-info":[{"award-number":["17\/63\/131"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/s2213-8587(25)00120-2","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T22:40:47Z","timestamp":1753137647000},"page":"745-753","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study"],"prefix":"10.1016","volume":"13","author":[{"given":"Jean Claude","family":"Katte","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Squires","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mesmin Y","family":"Dehayem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priscilla A","family":"Balungi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn J","family":"Padoa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dhriti","family":"Sengupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Segun","family":"Fatumo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thereza","family":"Piloya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Nyangabyaki-Twesigye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silver","family":"Bahendeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edna","family":"Majaliwa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kandi C","family":"Muze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Ramaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne","family":"Sap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayesha A","family":"Motala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fraser J","family":"Pirie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Rheeder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacobus C","family":"Van Dyk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Mbanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley M","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amy S","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Pihoker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jasmin","family":"Divers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kashyap A","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Oram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Dabelea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T","family":"Hattersley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy J","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nigel J","family":"Crowther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moffat J","family":"Nyirenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugene","family":"Sobngwi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus G","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00120-2_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00120-2_bib2","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-015-3514-y","article-title":"The 6 year incidence of diabetes-associated autoantibodies in genetically at-risk children: the TEDDY study","volume":"58","author":"Krischer","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00120-2_bib3","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1016\/S0140-6736(16)30582-7","article-title":"Genetic risk factors for type 1 diabetes","volume":"387","author":"Pociot","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00120-2_bib4","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(23)00223-4","article-title":"Type 1 diabetes","volume":"401","author":"Quattrin","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00120-2_bib5","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0140-6736(13)60591-7","article-title":"Type 1 diabetes","volume":"383","author":"Atkinson","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00120-2_bib6","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-8587(17)30181-X","article-title":"Diabetes in sub-Saharan Africa: from clinical care to health policy","volume":"5","author":"Atun","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00120-2_bib7","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1014626","article-title":"The phenotype of type 1 diabetes in sub-Saharan Africa","volume":"11","author":"Katte","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/S2213-8587(25)00120-2_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/1740-2557-4-4","article-title":"Islet cell autoantibodies in African patients with type 1 and type 2 diabetes in Dar es Salaam Tanzania: a cross sectional study","volume":"4","author":"Lutale","year":"2007","journal-title":"J Autoimmune Dis"},{"key":"10.1016\/S2213-8587(25)00120-2_bib9","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/diacare.25.3.453","article-title":"Basal and postglucagon C-peptide levels in Ethiopians with diabetes","volume":"25","author":"Siraj","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00120-2_bib10","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1007\/s11892-018-1003-7","article-title":"Type 1 diabetes in a resource-poor setting: malnutrition related, malnutrition modified, or just diabetes?","volume":"18","author":"Balcha","year":"2018","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(25)00120-2_bib11","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/dme.14204","article-title":"Identification of a subgroup of black South Africans with type 1 diabetes who are older at diagnosis but have lower levels of glutamic acid decarboxylase and islet antigen 2 autoantibodies","volume":"37","author":"Padoa","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00120-2_bib12","article-title":"Uganda Genome Resource: a rich research database for genomic studies of communicable and non-communicable diseases in Africa","volume":"2","author":"Fatumo","year":"2022","journal-title":"Cell Genom"},{"key":"10.1016\/S2213-8587(25)00120-2_bib13","first-page":"2","article-title":"Seroprevalence of hepatitis C virus infection in patients with type 2 diabetes mellitus is associated with increased age in sub-Saharan Africa: results from a cross-sectional comparative analysis","volume":"2","author":"Feutseu","year":"2023","journal-title":"Front Gastroenterol (Lausanne)"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(25)00120-2_bib14","article-title":"Genomic and environmental risk factors for cardiometabolic diseases in Africa: methods used for phase 1 of the AWI-Gen population cross-sectional study","volume":"11","author":"Ali","year":"2018","journal-title":"Glob Health Action"},{"key":"10.1016\/S2213-8587(25)00120-2_bib15","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.2337\/dc14-0574","article-title":"The SEARCH for Diabetes in Youth study: rationale, findings, and future directions","volume":"37","author":"Hamman","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00120-2_bib16","doi-asserted-by":"crossref","first-page":"200","DOI":"10.2337\/dc18-1785","article-title":"Development and standardization of an improved type 1 diabetes genetic risk score for use in newborn screening and incident diagnosis","volume":"42","author":"Sharp","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00120-2_bib17","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2337\/dc21-0365","article-title":"Polygenic prediction of type 2 diabetes in Africa","volume":"45","author":"Chikowore","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00120-2_bib18","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/dme.12159","article-title":"The clinical utility of C-peptide measurement in the care of patients with diabetes","volume":"30","author":"Jones","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00120-2_bib19","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.diabres.2013.11.013","article-title":"Clinical and biological characteristics of diabetic patients under age 40 in Cameroon: relation to autoantibody status and comparison with Belgian patients","volume":"103","author":"Asanghanwa","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00120-2_bib20","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1007\/s00125-020-05229-x","article-title":"Type 1 diabetes in Africa: an immunogenetic study in the Amhara of North-West Ethiopia","volume":"63","author":"Balcha","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00120-2_bib21","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.815703","article-title":"The prevalence of islet autoantibodies in children and adolescents with type 1 diabetes mellitus: a global scoping review","volume":"13","author":"Ross","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(25)00120-2_bib22","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020904","article-title":"Relationship between islet autoantibody status and the clinical characteristics of children and adults with incident type 1 diabetes in a UK cohort","volume":"8","author":"Bravis","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(25)00120-2_bib23","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00125-022-05823-1","article-title":"The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes","volume":"66","author":"Thomas","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00120-2_bib24","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2907","article-title":"Clinical heterogeneity of type 1 diabetes (T1D) found in Asia","volume":"33","author":"Park","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(25)00120-2_bib25","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1007\/s00125-010-1921-7","article-title":"Immunological and C-peptide studies of patients with diabetes in northern Ethiopia: existence of an unusual subgroup possibly related to malnutrition","volume":"54","author":"Gill","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00120-2_bib26","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1373\/clinchem.2019.304196","article-title":"Islet Autoantibody Standardization Program 2018 Workshop: interlaboratory comparison of glutamic acid decarboxylase autoantibody assay performance","volume":"65","author":"Lampasona","year":"2019","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(25)00120-2_bib27","doi-asserted-by":"crossref","first-page":"82","DOI":"10.2337\/dc19-0747","article-title":"Absence of islet autoantibodies and modestly raised glucose values at diabetes diagnosis should lead to testing for MODY: lessons from a 5-year pediatric Swedish National Cohort Study","volume":"43","author":"Carlsson","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00120-2_bib28","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2337\/dc20-2872","article-title":"Utility of diabetes type-specific genetic risk scores for the classification of diabetes type among multiethnic youth","volume":"45","author":"Oram","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00120-2_bib29","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-65317-1","article-title":"Type 1 diabetes genetic risk score is discriminative of diabetes in non-Europeans: evidence from a study in India","volume":"10","author":"Harrison","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(25)00120-2_bib30","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14712","article-title":"Persistence of islet autoantibodies after diagnosis in type 1 diabetes","volume":"38","author":"Long","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00120-2_bib31","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1007\/s00125-016-3997-1","article-title":"Tetraspanin 7 autoantibodies in type 1 diabetes","volume":"59","author":"Walther","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00120-2_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14979","article-title":"The measurement of autoantibodies to insulin informs diagnosis of diabetes in a childhood population negative for other autoantibodies","volume":"39","author":"Williams","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00120-2_bib33","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00125-021-05644-8","article-title":"Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes","volume":"65","author":"Kibirige","year":"2022","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001202?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001202?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:58Z","timestamp":1778858758000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725001202"}},"issued":{"date-parts":[[2025,9]]},"references-count":33,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2213858725001202"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00120-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00120-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00167-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,23]],"date-time":"2026-10-23T14:26:23Z","timestamp":1792765583392,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/s2213-8587(16)30267-4","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T15:34:23Z","timestamp":1474040063000},"page":"1004-1016","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":364,"title":["Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial"],"prefix":"10.1016","volume":"4","author":[{"given":"Juan P","family":"Fr\u00edas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Guja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Azazuddin","family":"Ahmed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Dong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"\u00d6hman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge A","family":"Jabbour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)30267-4_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4158\/EP15672.GLSUPPL","article-title":"American Association of Clinical Endocrinologists and American College of Endocrinology\u2014clinical practice guidelines for developing a diabetes mellitus comprehensive care plan\u20142015","volume":"21","author":"Handelsman","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(16)30267-4_bib2","doi-asserted-by":"crossref","first-page":"S52","DOI":"10.2337\/dc16-S010","article-title":"7. Approaches to glycemic treatment","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30267-4_bib3","doi-asserted-by":"crossref","first-page":"740","DOI":"10.2337\/dc13-0467","article-title":"Dapagliflozin is effective as add-on therapy to sitagliptin with or without metformin: a 24-week, multicenter, randomized, double-blind, placebo-controlled study","volume":"37","author":"Jabbour","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30267-4_bib4","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.2337\/db10-0474","article-title":"Rapid tachyphylaxis of the glucagon-like peptide 1-induced deceleration of gastric emptying in humans","volume":"60","author":"Nauck","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)30267-4_bib5","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1080\/00325481.2015.1090295","article-title":"User's guide to mechanism of action and clinical use of GLP-1 receptor agonists","volume":"127","author":"Shaefer","year":"2015","journal-title":"Postgrad Med"},{"key":"10.1016\/S2213-8587(16)30267-4_bib6","doi-asserted-by":"crossref","first-page":"T1","DOI":"10.1530\/JOE-13-0414","article-title":"Effects of glucagon-like peptide 1 on appetite and body weight: focus on the CNS","volume":"221","author":"van Bloemendaal","year":"2014","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(16)30267-4_bib7","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30267-4_bib8","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/dc15-0355","article-title":"Energy balance after sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Ferrannini","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30267-4_bib9","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30267-4_bib10","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(16)30267-4_bib11","doi-asserted-by":"crossref","first-page":"S127","DOI":"10.2337\/dcS13-2011","article-title":"Pathophysiologic approach to therapy in patients with newly diagnosed type 2 diabetes","volume":"36","author":"DeFronzo","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30267-4_bib12","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1111\/dom.12417","volume":"17","author":"Abdul-Ghani","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(16)30267-4_bib13","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1210\/jc.2011-2243","article-title":"Efficacy and tolerability of the DPP-4 inhibitor alogliptin combined with pioglitazone, in metformin-treated patients with type 2 diabetes","volume":"97","author":"DeFronzo","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30267-4_bib14","doi-asserted-by":"crossref","first-page":"376","DOI":"10.2337\/dc14-1142","article-title":"Dual add-on therapy in type 2 diabetes poorly controlled with metformin monotherapy: a randomized double-blind trial of saxagliptin plus dapagliflozin addition versus single addition of saxagliptin or dapagliflozin to metformin","volume":"38","author":"Rosenstock","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30267-4_bib15","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1007\/s40265-014-0324-3","article-title":"Dapagliflozin: a review of its use in patients with type 2 diabetes","volume":"74","author":"Plosker","year":"2014","journal-title":"Drugs"},{"key":"10.1016\/S2213-8587(16)30267-4_bib16","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s40265-015-0420-z","article-title":"Exenatide extended-release: an updated review of its use in type 2 diabetes mellitus","volume":"75","author":"Syed","year":"2015","journal-title":"Drugs"},{"key":"10.1016\/S2213-8587(16)30267-4_bib17","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.12459","article-title":"Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data","volume":"17","author":"Del Prato","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(16)30267-4_bib18","doi-asserted-by":"crossref","first-page":"2234","DOI":"10.1016\/S0140-6736(10)60406-0","article-title":"Once weekly exenatide compared with insulin glargine titrated to target in patients with type 2 diabetes (DURATION-3): an open-label randomised trial","volume":"375","author":"Diamant","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30267-4_bib19","doi-asserted-by":"crossref","DOI":"10.1089\/dia.2016.0107","article-title":"Efficacy and tolerability of exenatide once weekly over 6 years in patients with type 2 diabetes: an uncontrolled open-label extension of the DURATION-1 study","author":"Henry","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(16)30267-4_bib20","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/dom.12589","article-title":"Efficacy and safety of canagliflozin when used in conjunction with incretin-mimetic therapy in patients with type 2 diabetes","volume":"18","author":"Fulcher","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(16)30267-4_bib21","article-title":"Dapagliflozin QD and exenatide QW dual therapy: a 24-week randomized, placebo-controlled, phase 2 study examining effects on bodyweight and prediabetes in obese nondiabetic adults","author":"Lundkvist","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(16)30267-4_bib22","first-page":"2","article-title":"Additive weight loss effect with a combination of an oral sodium-glucose cotransporter 2 (SGLT2) inhibitor and a glucagon-like peptide 1 (GLP-1) agonist in type 2 diabetes","volume":"32","author":"McGovern","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(16)30267-4_bib23","doi-asserted-by":"crossref","unstructured":"Garc\u00eda-Rubi E. Real life experience with the combination of exenatide LAR and dapagliflozin in obese type 2 diabetic patients in Mexico City. 26th American Association of Clinical Endocrinologists (AACE) Annual Scientific & Clinical Congress; Austin, TX, USA; May 3\u20137, 2016. 223 (abstr).","DOI":"10.1016\/S1530-891X(20)44931-6"},{"key":"10.1016\/S2213-8587(16)30267-4_bib24","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.4158\/EP15877.OR","article-title":"SGLT-2 inhibitor therapy added to GLP-1 agonist therapy in the management of T2DM","volume":"21","author":"Saroka","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(16)30267-4_bib25","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1464-5491.2010.02941.x","article-title":"Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials","volume":"27","author":"DeFronzo","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(16)30267-4_bib26","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1007\/s11892-014-0483-3","article-title":"Cardiovascular actions of GLP-1 and incretin-based pharmacotherapy","volume":"14","author":"Avogaro","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(16)30267-4_bib27","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30267-4_bib28","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S0140-6736(10)60590-9","article-title":"Efficacy and safety of exenatide once weekly versus sitagliptin or pioglitazone as an adjunct to metformin for treatment of type 2 diabetes (DURATION-2): a randomised trial","volume":"376","author":"Bergenstal","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30267-4_bib29","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2337\/dc11-1107","article-title":"Efficacy and safety of exenatide once weekly versus metformin, pioglitazone, and sitagliptin used as monotherapy in drug-naive patients with type 2 diabetes (DURATION-4): a 26-week double-blind study","volume":"35","author":"Russell-Jones","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30267-4_bib30","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2213-8587(14)70174-3","volume":"2","author":"Gough","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30267-4_bib31","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1007\/s40620-016-0261-1","article-title":"The effect of dapagliflozin on renal function in patients with type 2 diabetes","volume":"29","author":"Kohan","year":"2016","journal-title":"J Nephrol"},{"key":"10.1016\/S2213-8587(16)30267-4_bib34","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc12-2480","article-title":"Hypoglycemia and diabetes: a report of a workgroup of the American Diabetes Association and the Endocrine Society","volume":"36","author":"Seaquist","year":"2013","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302674?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302674?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:53:35Z","timestamp":1668819215000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302674"}},"issued":{"date-parts":[[2016,12]]},"references-count":32,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2213858716302674"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30267-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exenatide once weekly plus dapagliflozin once daily versus exenatide or dapagliflozin alone in patients with type 2 diabetes inadequately controlled with metformin monotherapy (DURATION-8): a 28 week, multicentre, double-blind, phase 3, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30267-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30263-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T05:32:06Z","timestamp":1792647126266,"version":"4.5.0"},"reference-count":149,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"US National Institutes of Health","doi-asserted-by":"crossref","award":["grants P30-DK063491 and R01-MD007867"],"award-info":[{"award-number":["grants P30-DK063491 and R01-MD007867"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/s2213-8587(17)30200-0","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T10:30:20Z","timestamp":1505471420000},"page":"223-236","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":423,"title":["Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications"],"prefix":"10.1016","volume":"6","author":[{"given":"Mark O","family":"Goodarzi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30200-0_bib1","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1016\/S0140-6736(16)30054-X","article-title":"Trends in adult body-mass index in 200 countries from 1975 to 2014: a pooled analysis of 1698 population-based measurement studies with 19\u00b72 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib2","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1023\/A:1025635913927","article-title":"Genetic and environmental factors in relative body weight and human adiposity","volume":"27","author":"Maes","year":"1997","journal-title":"Behav Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1007\/s00125-016-4187-x","article-title":"Genetics of obesity: can an old dog teach us new tricks?","volume":"60","author":"Yeo","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30200-0_bib4","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1042\/CS20160136","article-title":"Recent progress in genetics, epigenetics and metagenomics unveils the pathophysiology of human obesity","volume":"130","author":"Pigeyre","year":"2016","journal-title":"Clin Sci"},{"key":"10.1016\/S2213-8587(17)30200-0_bib5","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1159\/000093341","article-title":"BDNF Val66Met polymorphism is associated with body mass index in healthy adults","volume":"53","author":"Gunstad","year":"2006","journal-title":"Neuropsychobiology"},{"key":"10.1016\/S2213-8587(17)30200-0_bib6","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1093\/hmg\/ddm132","article-title":"Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene","volume":"16","author":"Stutzmann","year":"2007","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib7","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1038\/ng.686","article-title":"Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index","volume":"42","author":"Speliotes","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib8","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1038\/ng.274","article-title":"Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity","volume":"41","author":"Thorleifsson","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib9","doi-asserted-by":"crossref","first-page":"e115","DOI":"10.1371\/journal.pgen.0030115","article-title":"Genome-wide association scan shows genetic variants in the FTO gene are associated with obesity-related traits","volume":"3","author":"Scuteri","year":"2007","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib10","doi-asserted-by":"crossref","first-page":"e1361","DOI":"10.1371\/journal.pone.0001361","article-title":"Genome wide association (GWA) study for early onset extreme obesity supports the role of fat mass and obesity associated gene (FTO) variants","volume":"2","author":"Hinney","year":"2007","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30200-0_bib11","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1126\/science.1141634","article-title":"A common variant in the FTO gene is associated with body mass index and predisposes to childhood and adult obesity","volume":"316","author":"Frayling","year":"2007","journal-title":"Science"},{"key":"10.1016\/S2213-8587(17)30200-0_bib12","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/ng2048","article-title":"Variation in FTO contributes to childhood obesity and severe adult obesity","volume":"39","author":"Dina","year":"2007","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib13","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(17)30200-0_bib14","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1038\/ng.3390","article-title":"Genetic variance estimation with imputed variants finds negligible missing heritability for human height and body mass index","volume":"47","author":"Yang","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib15","first-page":"1018","article-title":"Quantifying the extent to which index event biases influence large genetic association studies","volume":"26","author":"Yaghootkar","year":"2017","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib16","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1038\/nature14132","article-title":"New genetic loci link adipose and insulin biology to body fat distribution","volume":"518","author":"Shungin","year":"2015","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(17)30200-0_bib17","doi-asserted-by":"crossref","first-page":"D1001","DOI":"10.1093\/nar\/gkt1229","article-title":"The NHGRI GWAS Catalog, a curated resource of SNP-trait associations","volume":"42","author":"Welter","year":"2014","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S2213-8587(17)30200-0_bib18","doi-asserted-by":"crossref","first-page":"e1004508","DOI":"10.1371\/journal.pgen.1004508","article-title":"Novel approach identifies SNPs in SLC2A10 and KCNK9 with evidence for parent-of-origin effect on body mass index","volume":"10","author":"Hoggart","year":"2014","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib19","doi-asserted-by":"crossref","first-page":"6849","DOI":"10.1093\/hmg\/ddv379","article-title":"Gene-based meta-analysis of genome-wide association studies implicates new loci involved in obesity","volume":"24","author":"Hagg","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib20","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/nature11401","article-title":"FTO genotype is associated with phenotypic variability of body mass index","volume":"490","author":"Yang","year":"2012","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(17)30200-0_bib21","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1038\/ijo.2016.207","article-title":"Generalization and fine mapping of European ancestry-based central adiposity variants in African ancestry populations","volume":"41","author":"Yoneyama","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib22","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1093\/hmg\/dds396","article-title":"Gene-centric meta-analyses of 108\u2008912 individuals confirm known body mass index loci and reveal three novel signals","volume":"22","author":"Guo","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib23","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.ajhg.2013.08.012","article-title":"Fine mapping and identification of BMI loci in African Americans","volume":"93","author":"Gong","year":"2013","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib24","doi-asserted-by":"crossref","first-page":"1469","DOI":"10.1126\/science.1151710","article-title":"The obesity-associated FTO gene encodes a 2-oxoglutarate-dependent nucleic acid demethylase","volume":"318","author":"Gerken","year":"2007","journal-title":"Science"},{"key":"10.1016\/S2213-8587(17)30200-0_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s13679-015-0143-1","article-title":"The \u2018Fat Mass and Obesity Related\u2019 (FTO) gene: mechanisms of impact on obesity and energy balance","volume":"4","author":"Speakman","year":"2015","journal-title":"Curr Obes Rep"},{"key":"10.1016\/S2213-8587(17)30200-0_bib26","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.cmet.2014.09.010","article-title":"Obesity and FTO: changing focus at a complex locus","volume":"20","author":"Tung","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(17)30200-0_bib27","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1038\/nature07848","article-title":"Inactivation of the Fto gene protects from obesity","volume":"458","author":"Fischer","year":"2009","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(17)30200-0_bib28","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ng.713","article-title":"Overexpression of Fto leads to increased food intake and results in obesity","volume":"42","author":"Church","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib29","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1038\/nature13138","article-title":"Obesity-associated variants within FTO form long-range functional connections with IRX3","volume":"507","author":"Smemo","year":"2014","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(17)30200-0_bib30","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa1502214","article-title":"FTO obesity variant circuitry and adipocyte browning in humans","volume":"373","author":"Claussnitzer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib31","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1073\/pnas.0911591107","article-title":"Long-range gene regulation links genomic type 2 diabetes and obesity risk regions to HHEX, SOX4, and IRX3","volume":"107","author":"Ragvin","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(17)30200-0_bib32","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1074\/jbc.M110.188482","article-title":"Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator-interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling","volume":"286","author":"Stratigopoulos","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(17)30200-0_bib33","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.1172\/JCI85526","article-title":"Hypomorphism of Fto and Rpgrip1l causes obesity in mice","volume":"126","author":"Stratigopoulos","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(17)30200-0_bib34","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.7717\/peerj.856","article-title":"Obesity genetics in mouse and human: back and forth, and back again","volume":"3","author":"Yazdi","year":"2015","journal-title":"PeerJ"},{"key":"10.1016\/S2213-8587(17)30200-0_bib35","doi-asserted-by":"crossref","first-page":"5890","DOI":"10.1038\/ncomms6890","article-title":"Biological interpretation of genome-wide association studies using predicted gene functions","volume":"6","author":"Pers","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(17)30200-0_bib36","doi-asserted-by":"crossref","first-page":"e139","DOI":"10.1093\/nar\/gks542","article-title":"FunciSNP: an R\/bioconductor tool integrating functional non-coding data sets with genetic association studies to identify candidate regulatory SNPs","volume":"40","author":"Coetzee","year":"2012","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S2213-8587(17)30200-0_bib37","doi-asserted-by":"crossref","first-page":"dyw337","DOI":"10.1093\/ije\/dyw337","article-title":"Gene-obesogenic environment interactions in the UK Biobank study","volume":"2017","author":"Tyrrell","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib38","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.1042\/CS20160221","article-title":"The importance of gene-environment interactions in human obesity","volume":"130","author":"Reddon","year":"2016","journal-title":"Clin Sci"},{"key":"10.1016\/S2213-8587(17)30200-0_bib39","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/j.beem.2011.11.003","article-title":"Genetic determinants of common obesity and their value in prediction","volume":"26","author":"Loos","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30200-0_bib40","doi-asserted-by":"crossref","first-page":"225","DOI":"10.3389\/fgene.2014.00225","article-title":"A simulation study of gene-by-environment interactions in GWAS implies ample hidden effects","volume":"5","author":"Marigorta","year":"2014","journal-title":"Front Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib41","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.2016.8729","article-title":"Association of a genetic risk score with body mass index across different birth cohorts","volume":"316","author":"Walter","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30200-0_bib42","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1073\/pnas.1411893111","article-title":"Cohort of birth modifies the association between FTO genotype and BMI","volume":"112","author":"Rosenquist","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(17)30200-0_bib43","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1159\/000351742","article-title":"The positive association of obesity variants with adulthood adiposity strengthens over an 80-year period: a gene-by-birth year interaction","volume":"75","author":"Demerath","year":"2013","journal-title":"Hum Hered"},{"key":"10.1016\/S2213-8587(17)30200-0_bib44","doi-asserted-by":"crossref","first-page":"2511","DOI":"10.2337\/db08-0153","article-title":"Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees","volume":"57","author":"Stutzmann","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib45","doi-asserted-by":"crossref","first-page":"e1005378","DOI":"10.1371\/journal.pgen.1005378","article-title":"The influence of age and sex on genetic associations with adult body size and shape: a large-scale genome-wide interaction study","volume":"11","author":"Winkler","year":"2015","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib46","doi-asserted-by":"crossref","first-page":"1651","DOI":"10.1007\/s13524-015-0421-2","article-title":"The genome-wide influence on human BMI depends on physical activity, life course, and historical period","volume":"52","author":"Guo","year":"2015","journal-title":"Demography"},{"key":"10.1016\/S2213-8587(17)30200-0_bib47","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.3945\/ajcn.111.027870","article-title":"Adult obesity susceptibility variants are associated with greater childhood weight gain and a faster tempo of growth: the 1946 British Birth Cohort Study","volume":"95","author":"Elks","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30200-0_bib48","doi-asserted-by":"crossref","first-page":"29","DOI":"10.3389\/fendo.2012.00029","article-title":"Variability in the heritability of body mass index: a systematic review and meta-regression","volume":"3","author":"Elks","year":"2012","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib49","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1038\/oby.2012.64","article-title":"Associations of variants in FTO and near MC4R with obesity traits in South Asian Indians","volume":"20","author":"Vasan","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(17)30200-0_bib50","doi-asserted-by":"crossref","first-page":"307542","DOI":"10.1155\/2011\/307542","article-title":"Associations of FTO and MC4R variants with obesity traits in Indians and the role of rural\/urban environment as a possible effect modifier","volume":"2011","author":"Taylor","year":"2011","journal-title":"J Obes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib51","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/1471-2156-15-18","article-title":"Genotype-environment interactions for quantitative traits in Korea Associated Resource (KARE) cohorts","volume":"15","author":"Kim","year":"2014","journal-title":"BMC Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib52","doi-asserted-by":"crossref","first-page":"12724","DOI":"10.1038\/ncomms12724","article-title":"Multiple novel gene-by-environment interactions modify the effect of FTO variants on body mass index","volume":"7","author":"Young","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(17)30200-0_bib53","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1093\/ije\/dyr077","article-title":"Genetic variation at CHRNA5-CHRNA3-CHRNB4 interacts with smoking status to influence body mass index","volume":"40","author":"Freathy","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib54","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1038\/ijo.2015.152","article-title":"A novel interaction between the FLJ33534 locus and smoking in obesity: a genome-wide study of 14\u2008131 Pakistani adults","volume":"40","author":"Ahmad","year":"2016","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib55","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1186\/s12863-015-0289-6","article-title":"Interaction of smoking and obesity susceptibility loci on adolescent BMI: the National Longitudinal Study of Adolescent to Adult Health","volume":"16","author":"Young","year":"2015","journal-title":"BMC Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib56","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1002\/oby.21582","article-title":"The effect of tobacco cessation on weight gain, obesity, and diabetes risk","volume":"24","author":"Bush","year":"2016","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(17)30200-0_bib57","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1186\/s12881-015-0259-x","article-title":"Physical activity, smoking, and genetic predisposition to obesity in people from Pakistan: the PROMIS study","volume":"16","author":"Ahmad","year":"2015","journal-title":"BMC Med Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib58","doi-asserted-by":"crossref","first-page":"14977","DOI":"10.1038\/ncomms14977","article-title":"Genome-wide meta-analysis of 241,258 adults accounting for smoking behaviour identifies novel loci for obesity traits","volume":"8","author":"Justice","year":"2017","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(17)30200-0_bib59","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/adb.12317","article-title":"Genome-wide association study of body mass index in subjects with alcohol dependence","volume":"22","author":"Polimanti","year":"2017","journal-title":"Addict Biol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib60","first-page":"769","article-title":"Population genetic studies on aldehyde dehydrogenase isozyme deficiency and alcohol sensitivity","volume":"35","author":"Goedde","year":"1983","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib61","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1253\/circj.CJ-10-0774","article-title":"Confirmation of ALDH2 as a major locus of drinking behavior and of its variants regulating multiple metabolic phenotypes in a Japanese population","volume":"75","author":"Takeuchi","year":"2011","journal-title":"Circ J"},{"key":"10.1016\/S2213-8587(17)30200-0_bib62","doi-asserted-by":"crossref","first-page":"20691","DOI":"10.1038\/srep20691","article-title":"Effects of obesity related genetic variations on visceral and subcutaneous fat distribution in a Chinese population","volume":"6","author":"Wang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(17)30200-0_bib63","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1177\/0003122415590627","article-title":"Lifetime socioeconomic status, historical context, and genetic inheritance in shaping body mass in middle and late adulthood","volume":"80","author":"Liu","year":"2015","journal-title":"Am Sociol Rev"},{"key":"10.1016\/S2213-8587(17)30200-0_bib64","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1038\/ejhg.2014.189","article-title":"Gene by stress genome-wide interaction analysis and path analysis identify EBF1 as a cardiovascular and metabolic risk gene","volume":"23","author":"Singh","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib65","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1002\/gepi.21910","article-title":"Computing a synthetic chronic psychosocial stress measurement in multiple datasets and its application in the replication of G x E interactions of the EBF1 gene","volume":"39","author":"Singh","year":"2015","journal-title":"Genet Epidemiol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib66","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s13524-013-0259-4","article-title":"Is the gene-environment interaction paradigm relevant to genome-wide studies? The case of education and body mass index","volume":"51","author":"Boardman","year":"2014","journal-title":"Demography"},{"key":"10.1016\/S2213-8587(17)30200-0_bib67","doi-asserted-by":"crossref","first-page":"e1003500","DOI":"10.1371\/journal.pgen.1003500","article-title":"Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits","volume":"9","author":"Randall","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib68","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1093\/hmg\/ddu248","article-title":"Meta-analysis of genome-wide association studies in East Asian-ancestry populations identifies four new loci for body mass index","volume":"23","author":"Wen","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib69","doi-asserted-by":"crossref","first-page":"e1006719","DOI":"10.1371\/journal.pgen.1006719","article-title":"Discovery and fine-mapping of adiposity loci using high density imputation of genome-wide association studies in individuals of African ancestry: African Ancestry Anthropometry Genetics Consortium","volume":"13","author":"Ng","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib70","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa1203039","article-title":"Sugar-sweetened beverages and genetic risk of obesity","volume":"367","author":"Qi","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib71","doi-asserted-by":"crossref","first-page":"g1610","DOI":"10.1136\/bmj.g1610","article-title":"Fried food consumption, genetic risk, and body mass index: gene-diet interaction analysis in three US cohort studies","volume":"348","author":"Qi","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30200-0_bib72","doi-asserted-by":"crossref","first-page":"4728","DOI":"10.1093\/hmg\/ddv186","article-title":"Gene x dietary pattern interactions in obesity: analysis of up to 68\u2008317 adults of European ancestry","volume":"24","author":"Nettleton","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib73","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1007\/s12263-013-0352-8","article-title":"Genetic susceptibility to obesity and diet intakes: association and interaction analyses in the Malmo Diet and Cancer Study","volume":"8","author":"Rukh","year":"2013","journal-title":"Genes Nutr"},{"key":"10.1016\/S2213-8587(17)30200-0_bib74","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.3945\/ajcn.2009.27958","article-title":"Fat and carbohydrate intake modify the association between genetic variation in the FTO genotype and obesity","volume":"90","author":"Sonestedt","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30200-0_bib75","doi-asserted-by":"crossref","first-page":"675","DOI":"10.2337\/dc10-0948","article-title":"Lifestyle interaction with fat mass and obesity-associated (FTO) genotype and risk of obesity in apparently healthy US women","volume":"34","author":"Ahmad","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30200-0_bib76","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.2337\/db14-1629","article-title":"Dietary intake, FTO genetic variants, and adiposity: a combined analysis of over 16,000 children and adolescents","volume":"64","author":"Qi","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib77","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.3945\/jn.111.143826","article-title":"A high intake of saturated fatty acids strengthens the association between the fat mass and obesity-associated gene and BMI","volume":"141","author":"Corella","year":"2011","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(17)30200-0_bib78","doi-asserted-by":"crossref","first-page":"824","DOI":"10.3945\/jn.111.153460","article-title":"High dietary saturated fat intake accentuates obesity risk associated with the fat mass and obesity-associated gene in adults","volume":"142","author":"Phillips","year":"2012","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(17)30200-0_bib79","doi-asserted-by":"crossref","first-page":"6961","DOI":"10.1093\/hmg\/ddu411","article-title":"FTO genetic variants, dietary intake and body mass index: insights from 177,330 individuals","volume":"23","author":"Qi","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib80","doi-asserted-by":"crossref","first-page":"e1000332","DOI":"10.1371\/journal.pmed.1000332","article-title":"Physical activity attenuates the genetic predisposition to obesity in 20,000 men and women from EPIC-Norfolk prospective population study","volume":"7","author":"Li","year":"2010","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib81","doi-asserted-by":"crossref","first-page":"e136","DOI":"10.1038\/nutd.2014.33","article-title":"Modification of genetic influences on adiposity between 36 and 63 years of age by physical activity and smoking in the 1946 British Birth Cohort Study","volume":"4","author":"Johnson","year":"2014","journal-title":"Nutr Diabetes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib82","doi-asserted-by":"crossref","first-page":"e1003607","DOI":"10.1371\/journal.pgen.1003607","article-title":"Gene x physical activity interactions in obesity: combined analysis of 111,421 individuals of European ancestry","volume":"9","author":"Ahmad","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib83","doi-asserted-by":"crossref","first-page":"e91442","DOI":"10.1371\/journal.pone.0091442","article-title":"Associations of genetic risk score with obesity and related traits and the modifying effect of physical activity in a Chinese Han population","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30200-0_bib84","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.112.098061","article-title":"Television watching, leisure time physical activity, and the genetic predisposition in relation to body mass index in women and men","volume":"126","author":"Qi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30200-0_bib85","doi-asserted-by":"crossref","first-page":"e1001116","DOI":"10.1371\/journal.pmed.1001116","article-title":"Physical activity attenuates the influence of FTO variants on obesity risk: a meta-analysis of 218,166 adults and 19,268 children","volume":"8","author":"Kilpelainen","year":"2011","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib86","doi-asserted-by":"crossref","first-page":"18672","DOI":"10.1038\/srep18672","article-title":"Physical activity and genetic predisposition to obesity in a multiethnic longitudinal study","volume":"6","author":"Reddon","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(17)30200-0_bib87","doi-asserted-by":"crossref","first-page":"e1006528","DOI":"10.1371\/journal.pgen.1006528","article-title":"Genome-wide physical activity interactions in adiposity\u2014a meta-analysis of 200,452 adults","volume":"13","author":"Graff","year":"2017","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib88","doi-asserted-by":"crossref","first-page":"i1102","DOI":"10.1136\/bmj.i1102","article-title":"The impact of communicating genetic risks of disease on risk-reducing health behaviour: systematic review with meta-analysis","volume":"352","author":"Hollands","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30200-0_bib89","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1002\/oby.20958","article-title":"Genetic susceptibility testing and readiness to control weight: Results from a randomized controlled trial","volume":"23","author":"Meisel","year":"2015","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(17)30200-0_bib90","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.jpsychores.2008.09.003","article-title":"A consultation with genetic information about obesity decreases self-blame about eating and leads to realistic weight loss goals in obese individuals","volume":"66","author":"Conradt","year":"2009","journal-title":"J Psychosom Res"},{"key":"10.1016\/S2213-8587(17)30200-0_bib91","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1007\/s11606-007-0353-7","article-title":"Is information on genetic determinants of obesity helpful or harmful for obese people?\u2014A randomized clinical trial","volume":"22","author":"Rief","year":"2007","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib92","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1056\/NEJMoa1011893","article-title":"Effect of direct-to-consumer genomewide profiling to assess disease risk","volume":"364","author":"Bloss","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib93","doi-asserted-by":"crossref","first-page":"i4707","DOI":"10.1136\/bmj.i4707","article-title":"FTO genotype and weight loss: systematic review and meta-analysis of 9563 individual participant data from eight randomised controlled trials","volume":"354","author":"Livingstone","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30200-0_bib94","doi-asserted-by":"crossref","first-page":"363","DOI":"10.2337\/dc11-1328","article-title":"Genetic predictors of weight loss and weight regain after intensive lifestyle modification, metformin treatment, or standard care in the Diabetes Prevention Program","volume":"35","author":"Delahanty","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30200-0_bib95","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1002\/oby.20540","article-title":"The effect of GWAS identified BMI loci on changes in body weight among middle-aged Danes during a five-year period","volume":"22","author":"Sandholt","year":"2014","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(17)30200-0_bib96","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1038\/ijo.2013.54","article-title":"FTO predicts weight regain in the Look AHEAD clinical trial","volume":"37","author":"McCaffery","year":"2013","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib97","doi-asserted-by":"crossref","first-page":"4312","DOI":"10.2337\/db15-0441","article-title":"Genetic predisposition to weight loss and regain with lifestyle intervention: analyses from the Diabetes Prevention Program and the Look AHEAD randomized controlled trials","volume":"64","author":"Papandonatos","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib98","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.3945\/ajcn.111.016543","article-title":"Analyses of single nucleotide polymorphisms in selected nutrient-sensitive genes in weight-regain prevention: the DIOGENES study","volume":"95","author":"Larsen","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30200-0_bib99","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1038\/ijo.2010.166","article-title":"Associations of markers in 11 obesity candidate genes with maximal weight loss and weight regain in the SOS bariatric surgery cases","volume":"35","author":"Sarzynski","year":"2011","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib100","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/oby.21554","article-title":"Body mass index: has epidemiology started to break down causal contributions to health and disease?","volume":"24","author":"Corbin","year":"2016","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(17)30200-0_bib101","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/aje\/kwr323","article-title":"Credible Mendelian randomization studies: approaches for evaluating the instrumental variable assumptions","volume":"175","author":"Glymour","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib102","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1161\/HYPERTENSIONAHA.109.130005","article-title":"Does greater adiposity increase blood pressure and hypertension risk? Mendelian randomization using the FTO\/MC4R genotype","volume":"54","author":"Timpson","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30200-0_bib103","doi-asserted-by":"crossref","first-page":"e1001474","DOI":"10.1371\/journal.pmed.1001474","article-title":"The role of adiposity in cardiometabolic traits: a Mendelian randomization analysis","volume":"10","author":"Fall","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib104","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-8587(13)70200-6","article-title":"Vitamin D concentration, obesity, and risk of diabetes: a mendelian randomisation study","volume":"2","author":"Afzal","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib105","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.ajhg.2013.12.014","article-title":"Causal effects of body mass index on cardiometabolic traits and events: a Mendelian randomization analysis","volume":"94","author":"Holmes","year":"2014","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib106","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.2337\/db14-0988","article-title":"Age- and sex-specific causal effects of adiposity on cardiovascular risk factors","volume":"64","author":"Fall","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib107","doi-asserted-by":"crossref","first-page":"16645","DOI":"10.1038\/srep16645","article-title":"MR-PheWAS: hypothesis prioritization among potential causal effects of body mass index on many outcomes, using Mendelian randomization","volume":"5","author":"Millard","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(17)30200-0_bib108","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1038\/ijo.2016.155","article-title":"Overall and central obesity with insulin sensitivity and secretion in a Han Chinese population: a Mendelian randomization analysis","volume":"40","author":"Wang","year":"2016","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib109","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1016\/j.jdiacomp.2016.06.006","article-title":"Genetic predisposition to obesity is associated with insulin secretion in Chinese adults: the Cardiometabolic Risk in Chinese (CRC) study","volume":"30","author":"Liang","year":"2016","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(17)30200-0_bib110","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1038\/ejhg.2015.162","article-title":"Increased genetic risk for obesity in premature coronary artery disease","volume":"24","author":"Cole","year":"2016","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib111","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/ije\/dyv094","article-title":"Adiposity as a cause of cardiovascular disease: a Mendelian randomization study","volume":"44","author":"Hagg","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib112","doi-asserted-by":"crossref","first-page":"e1001212","DOI":"10.1371\/journal.pmed.1001212","article-title":"The effect of elevated body mass index on ischemic heart disease risk: causal estimates from a Mendelian randomisation approach","volume":"9","author":"Nordestgaard","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib113","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1111\/joim.12299","article-title":"Obesity as a causal risk factor for deep venous thrombosis: a Mendelian randomization study","volume":"277","author":"Klovaite","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib114","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1161\/CIRCULATIONAHA.116.024921","article-title":"Genetic obesity and the risk of atrial fibrillation: causal estimates from Mendelian randomization","volume":"135","author":"Chatterjee","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30200-0_bib115","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2015.12.034","article-title":"Obesity and peripheral arterial disease: a Mendelian randomization analysis","volume":"247","author":"Huang","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(17)30200-0_bib116","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1161\/CIRCRESAHA.116.304846","article-title":"Remnant cholesterol, low-density lipoprotein cholesterol, and blood pressure as mediators from obesity to ischemic heart disease","volume":"116","author":"Varbo","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(17)30200-0_bib117","doi-asserted-by":"crossref","first-page":"e1002105","DOI":"10.1371\/journal.pmed.1002105","article-title":"Genetically predicted body mass index and breast cancer risk: Mendelian randomization analyses of data from 145,000 women of European descent","volume":"13","author":"Guo","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib118","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1093\/ije\/dyw129","article-title":"Mendelian randomization study of adiposity-related traits and risk of breast, ovarian, prostate, lung and colorectal cancer","volume":"45","author":"Gao","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib119","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1007\/s10654-016-0147-5","article-title":"High body mass index and cancer risk-a Mendelian randomisation study","volume":"31","author":"Benn","year":"2016","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib120","doi-asserted-by":"crossref","first-page":"31121","DOI":"10.1038\/srep31121","article-title":"The causal relevance of body mass index in different histological types of lung cancer: a Mendelian randomization study","volume":"6","author":"Carreras-Torres","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(17)30200-0_bib121","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1093\/ije\/dyw158","article-title":"Adult body mass index and risk of ovarian cancer by subtype: a Mendelian randomization study","volume":"45","author":"Dixon","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib122","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1038\/bjc.2016.188","article-title":"Mendelian randomisation analysis strongly implicates adiposity with risk of developing colorectal cancer","volume":"115","author":"Jarvis","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(17)30200-0_bib123","doi-asserted-by":"crossref","first-page":"1024","DOI":"10.1158\/1055-9965.EPI-14-1309","article-title":"Mendelian randomization study of body mass index and colorectal cancer risk","volume":"24","author":"Thrift","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(17)30200-0_bib124","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1007\/s10552-015-0654-9","article-title":"The effects of height and BMI on prostate cancer incidence and mortality: a Mendelian randomization study in 20,848 cases and 20,214 controls from the PRACTICAL consortium","volume":"26","author":"Davies","year":"2015","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(17)30200-0_bib125","doi-asserted-by":"crossref","first-page":"dju252","DOI":"10.1093\/jnci\/dju252","article-title":"Obesity and risk of esophageal adenocarcinoma and Barrett's esophagus: a Mendelian randomization study","volume":"106","author":"Thrift","year":"2014","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(17)30200-0_bib126","doi-asserted-by":"crossref","first-page":"djv178","DOI":"10.1093\/jnci\/djv178","article-title":"Evidence of a causal association between insulinemia and endometrial cancer: a Mendelian randomization analysis","volume":"107","author":"Nead","year":"2015","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(17)30200-0_bib127","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1158\/1055-9965.EPI-16-0147","article-title":"Genetic risk score Mendelian randomization shows that obesity measured as body mass index, but not waist:hip ratio, is causal for endometrial cancer","volume":"25","author":"Painter","year":"2016","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(17)30200-0_bib128","doi-asserted-by":"crossref","first-page":"djx012","DOI":"10.1093\/jnci\/djx012","article-title":"The role of obesity, type 2 diabetes, and metabolic factors in pancreatic cancer: a Mendelian randomization study","volume":"109","author":"Carreras-Torres","year":"2017","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(17)30200-0_bib129","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1111\/j.1365-2796.2011.02343.x","article-title":"Using genetic loci to understand the relationship between adiposity and psychological distress: a Mendelian Randomization study in the Copenhagen General Population Study of 53,221 adults","volume":"269","author":"Lawlor","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib130","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1159\/000438957","article-title":"Normal variation in pubertal timing: genetic determinants in relation to growth and adiposity","volume":"29","author":"Willemsen","year":"2016","journal-title":"Endocr Dev"},{"key":"10.1016\/S2213-8587(17)30200-0_bib131","doi-asserted-by":"crossref","first-page":"180729","DOI":"10.1155\/2011\/180729","article-title":"Mendelian randomisation study of childhood BMI and early menarche","volume":"2011","author":"Mumby","year":"2011","journal-title":"J Obes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib132","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1002\/ajpa.22121","article-title":"Genetic risk for earlier menarche also influences peripubertal body mass index","volume":"150","author":"Johnson","year":"2013","journal-title":"Am J Phys Anthropol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib133","doi-asserted-by":"crossref","first-page":"8464","DOI":"10.1038\/ncomms9464","article-title":"Causal mechanisms and balancing selection inferred from genetic associations with polycystic ovary syndrome","volume":"6","author":"Day","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(17)30200-0_bib134","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1007\/s13277-012-0372-9","article-title":"Association between FTO gene polymorphism and cancer risk: evidence from 16,277 cases and 31,153 controls","volume":"33","author":"Li","year":"2012","journal-title":"Tumour Biol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib135","doi-asserted-by":"crossref","first-page":"e1001765","DOI":"10.1371\/journal.pmed.1001765","article-title":"Metabolic signatures of adiposity in young adults: Mendelian randomization analysis and effects of weight change","volume":"11","author":"Wurtz","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib136","doi-asserted-by":"crossref","first-page":"e1006125","DOI":"10.1371\/journal.pgen.1006125","article-title":"Genome-wide association analyses in 128,266 individuals identifies new morningness and sleep duration loci","volume":"12","author":"Jones","year":"2016","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib137","doi-asserted-by":"crossref","first-page":"10448","DOI":"10.1038\/ncomms10448","article-title":"GWAS of 89,283 individuals identifies genetic variants associated with self-reporting of being a morning person","volume":"7","author":"Hu","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(17)30200-0_bib138","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1038\/ng.3749","article-title":"Genome-wide association analyses of sleep disturbance traits identify new loci and highlight shared genetics with neuropsychiatric and metabolic traits","volume":"49","author":"Lane","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30200-0_bib139","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1136\/thoraxjnl-2015-207379","article-title":"Obese individuals experience wheezing without asthma but not asthma without wheezing: a Mendelian randomisation study of 85,437 adults from the Copenhagen General Population Study","volume":"71","author":"Colak","year":"2016","journal-title":"Thorax"},{"key":"10.1016\/S2213-8587(17)30200-0_bib140","doi-asserted-by":"crossref","first-page":"e1001669","DOI":"10.1371\/journal.pmed.1001669","article-title":"Effects of BMI, fat mass, and lean mass on asthma in childhood: a Mendelian randomization study","volume":"11","author":"Granell","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib141","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.2337\/db15-0254","article-title":"Genetic evidence for a causal role of obesity in diabetic kidney disease","volume":"64","author":"Todd","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib142","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1038\/ijo.2010.137","article-title":"C-reactive protein levels and body mass index: elucidating direction of causation through reciprocal Mendelian randomization","volume":"35","author":"Timpson","year":"2011","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(17)30200-0_bib143","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/jc.2015-3640","article-title":"Genetics of common endocrine disease: the present and the future","volume":"101","author":"Goodarzi","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30200-0_bib144","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1038\/nrendo.2010.121","article-title":"Behavioral and pharmacologic therapies for obesity","volume":"6","author":"Vetter","year":"2010","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(17)30200-0_bib145","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1038\/43185","article-title":"Congenital leptin deficiency is associated with severe early-onset obesity in humans","volume":"387","author":"Montague","year":"1997","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(17)30200-0_bib146","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1172\/JCI0215693","article-title":"Beneficial effects of leptin on obesity, T cell hyporesponsiveness, and neuroendocrine\/metabolic dysfunction of human congenital leptin deficiency","volume":"110","author":"Farooqi","year":"2002","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(17)30200-0_bib147","doi-asserted-by":"crossref","first-page":"7257","DOI":"10.1073\/pnas.0706473105","article-title":"Leptin responsiveness restored by amylin agonism in diet-induced obesity: evidence from nonclinical and clinical studies","volume":"105","author":"Roth","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(17)30200-0_bib148","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1146\/annurev.med.56.062904.144924","article-title":"Monogenic obesity in humans","volume":"56","author":"Farooqi","year":"2005","journal-title":"Annu Rev Med"},{"key":"10.1016\/S2213-8587(17)30200-0_bib149","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa1512693","article-title":"Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist","volume":"375","author":"Kuhnen","year":"2016","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302000?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302000?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T13:25:34Z","timestamp":1535376334000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717302000"}},"issued":{"date-parts":[[2018,3]]},"references-count":149,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2213858717302000"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30200-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30200-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30312-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30236-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30292-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T18:24:45Z","timestamp":1794507885050,"version":"4.9.1"},"reference-count":56,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100015769","name":"Dexcom Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/s2213-8587(24)00372-3","type":"journal-article","created":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T18:34:37Z","timestamp":1739817277000},"page":"427-437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":39,"title":["Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies"],"prefix":"10.1016","volume":"13","author":[{"given":"Medha","family":"Munshi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna R","family":"Kahkoska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua J","family":"Neumiller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anastasia-Stefania","family":"Alexopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nancy A","family":"Allen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tali","family":"Cukierman-Yaffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elbert S","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sei J","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia J","family":"Lipska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa M","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graydon S","family":"Meneilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naushira","family":"Pandya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E","family":"Pratley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leocadio","family":"Rodriguez-Ma\u00f1as","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan J","family":"Sinclair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah L","family":"Sy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Toschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth S","family":"Weinstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00372-3_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108078","article-title":"Diabetes and global ageing among 65\u201399-year-old adults: findings from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"162","author":"Sinclair","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(24)00372-3_bib4","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1016\/S2213-8587(20)30230-8","article-title":"Diabetes in ageing: pathways for developing the evidence base for clinical guidance","volume":"8","author":"Munshi","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00372-3_bib5","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1056\/NEJMoa1003795","article-title":"Severe hypoglycemia and risks of vascular events and death","volume":"363","author":"Zoungas","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00372-3_bib6","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.f4533","article-title":"Severe hypoglycaemia and cardiovascular disease: systematic review and meta-analysis with bias analysis","volume":"347","author":"Goto","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00372-3_bib7","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2337\/dc11-2054","article-title":"Increased mortality of patients with diabetes reporting severe hypoglycemia","volume":"35","author":"McCoy","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00372-3_bib8","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1016\/j.amjmed.2011.08.008","article-title":"Death during intensive glycemic therapy of diabetes: mechanisms and implications","volume":"124","author":"Cryer","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(24)00372-3_bib9","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1111\/dom.12031","article-title":"Hypoglycaemia and accident risk in people with type 2 diabetes mellitus treated with non-insulin antidiabetes drugs","volume":"15","author":"Signorovitch","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00372-3_bib10","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00372-3_bib11","first-page":"S158","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00372-3_bib12","first-page":"S244","article-title":"13. Older adults: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00372-3_bib13","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1111\/jgs.12514","article-title":"Guidelines abstracted from the American Geriatrics Society Guidelines for improving the care of older adults with diabetes mellitus: 2013 update","volume":"61","author":"Moreno","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(24)00372-3_bib14","doi-asserted-by":"crossref","first-page":"1520","DOI":"10.1210\/jc.2019-00198","article-title":"Treatment of diabetes in older adults: an Endocrine Society* clinical practice guideline","volume":"104","author":"LeRoith","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00372-3_bib15","series-title":"IDF global guideline for managing older people with type 2 diabetes","author":"Cho","year":"2013"},{"key":"10.1016\/S2213-8587(24)00372-3_bib16","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/j.diabres.2014.03.005","article-title":"New IDF Guideline for managing type 2 diabetes in older people","volume":"103","author":"Dunning","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(24)00372-3_bib17","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/j.jamda.2017.02.009","article-title":"Polypharmacy is associated with higher frailty risk in older people: an 8-year longitudinal cohort study","volume":"18","author":"Veronese","year":"2017","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/S2213-8587(24)00372-3_bib18","article-title":"The association between polypharmacy and dementia: a nested case-control study based on a 12-year longitudinal cohort database in South Korea","volume":"12","author":"Park","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(24)00372-3_bib19","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.jamda.2019.10.022","article-title":"Adverse outcomes of polypharmacy in older people: systematic review of reviews","volume":"21","author":"Davies","year":"2020","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/S2213-8587(24)00372-3_bib20","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3047","article-title":"Glycemic variability in the development of cardiovascular complications in diabetes","volume":"34","author":"Nusca","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(24)00372-3_bib21","doi-asserted-by":"crossref","DOI":"10.3390\/nu12123906","article-title":"Glycemic variability and CNS inflammation: reviewing the connection","volume":"12","author":"Watt","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(24)00372-3_bib22","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/S2213-8587(18)30048-2","article-title":"Mean HbA1c, HbA1c variability, and mortality in people with diabetes aged 70 years and older: a retrospective cohort study","volume":"6","author":"Forbes","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00372-3_bib23","first-page":"S111","article-title":"6. Glycemic goals and hypoglycemia: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00372-3_bib24","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.2147\/DMSO.S421851","article-title":"Global prevalence of anemia among type 2 diabetic adult patients: a systematic review and meta-analysis","volume":"16","author":"Arkew","year":"2023","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/S2213-8587(24)00372-3_bib25","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1111\/jgs.17565","article-title":"Unexplained anemia of aging: etiology, health consequences, and diagnostic criteria","volume":"70","author":"Guralnik","year":"2022","journal-title":"J Am Geriatr Soc"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00372-3_bib26","first-page":"S126","article-title":"7. Diabetes technology: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00372-3_bib27","doi-asserted-by":"crossref","first-page":"429","DOI":"10.2337\/cd20-0043","article-title":"Using continuous glucose monitoring in clinical practice","volume":"38","author":"Miller","year":"2020","journal-title":"Clin Diabetes"},{"key":"10.1016\/S2213-8587(24)00372-3_bib28","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00372-3_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.23942","article-title":"Association of Continuous glucose monitoring use and hemoglobin A1c levels across the lifespan among individuals with type 1 diabetes in the US","volume":"5","author":"Weinstein","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(24)00372-3_bib30","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2337\/dci23-0021","article-title":"The growing role of technology in the care of older adults with diabetes","volume":"46","author":"Huang","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00372-3_bib31","series-title":"Diabetes in America","article-title":"Diabetes in older adults","author":"Laiteerapong","year":"2018"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00372-3_bib32","first-page":"S52","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00372-3_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1111\/jgs.15809","article-title":"Decision making for older adults with multiple chronic conditions: executive summary for the American Geriatrics Society guiding principles on the care of older adults with multimorbidity","volume":"67","author":"Boyd","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(24)00372-3_bib34","doi-asserted-by":"crossref","first-page":"e98","DOI":"10.1093\/geronb\/gbx138","article-title":"Decision-making preferences and deprescribing: perspectives of older adults and companions about their medicines","volume":"73","author":"Weir","year":"2018","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"10.1016\/S2213-8587(24)00372-3_bib35","doi-asserted-by":"crossref","first-page":"1008","DOI":"10.1007\/s11606-022-07828-3","article-title":"A Qualitative study of perspectives of older adults on deintensifying diabetes medications","volume":"38","author":"Pilla","year":"2023","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S2213-8587(24)00372-3_bib36","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1111\/jgs.16662","article-title":"Feasibility of clinicians aligning health care with patient priorities in geriatrics ambulatory care","volume":"68","author":"Freytag","year":"2020","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(24)00372-3_bib37","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.2633","article-title":"Assessment of patient-preferred language to achieve goal-aligned deprescribing in older adults","volume":"4","author":"Green","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(24)00372-3_bib38","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1001\/jamainternmed.2014.7345","article-title":"Potential overtreatment of diabetes mellitus in older adults with tight glycemic control","volume":"175","author":"Lipska","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(24)00372-3_bib39","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1111\/j.1532-5415.2011.03726.x","article-title":"Risk of hypoglycemia in older veterans with dementia and cognitive impairment: implications for practice and policy","volume":"59","author":"Feil","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(24)00372-3_bib40","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/dc14-0599","article-title":"Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia","volume":"38","author":"Thorpe","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00372-3_bib41","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s12603-017-0869-4","article-title":"Inadequate glycaemic control and therapeutic management of adults over 65 years old with type 2 diabetes mellitus in Spain","volume":"21","author":"Formiga","year":"2017","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/S2213-8587(24)00372-3_bib42","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1186\/s12877-020-01780-9","article-title":"Poor health status, inappropriate glucose-lowering therapy and high one-year mortality in geriatric patients with type 2 diabetes","volume":"20","author":"Christiaens","year":"2020","journal-title":"BMC Geriatr"},{"key":"10.1016\/S2213-8587(24)00372-3_bib43","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1016\/j.diabet.2018.05.003","article-title":"Haemoglobin A1c and 5-year all-cause mortality in French type 2 diabetic patients aged 70 years and older: the GERODIAB observational cohort","volume":"44","author":"Doucet","year":"2018","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(24)00372-3_bib44","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1016\/j.jdiacomp.2017.02.014","article-title":"Liberating A1C goals in older adults may not protect against the risk of hypoglycemia","volume":"31","author":"Munshi","year":"2017","journal-title":"J Diabetes Complications"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00372-3_bib45","first-page":"S244","article-title":"American Diabetes Association Professional Practice C. 13. Older adults: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00372-3_bib46","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCOUTCOMES.116.003514","article-title":"Treatment deintensification is uncommon in adults with type 2 diabetes mellitus: a retrospective cohort study","volume":"10","author":"McAlister","year":"2017","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/S2213-8587(24)00372-3_bib47","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.diabres.2014.04.012","article-title":"Nursing home patients with diabetes: prevalence, drug treatment and glycemic control","volume":"105","author":"Andreassen","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(24)00372-3_bib48","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1111\/jgs.15335","article-title":"Use of intensive glycemic management in older adults with diabetes mellitus","volume":"66","author":"Arnold","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(24)00372-3_bib49","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/j.jdiacomp.2017.11.011","article-title":"Deintensification of hypoglycaemic medications-use of a systematic review approach to highlight safety concerns in older people with type 2 diabetes","volume":"32","author":"Abdelhafiz","year":"2018","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(24)00372-3_bib50","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1080\/14656566.2021.1912735","article-title":"Careful use to minimize adverse events of oral antidiabetic medications in the elderly","volume":"22","author":"Scheen","year":"2021","journal-title":"Expert Opin Pharmacother"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00372-3_bib51","first-page":"S295","article-title":"16. Diabetes care in the hospital: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00372-3_bib52","author":"Joshi"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00372-3_bib53","first-page":"S179","article-title":"10. Cardiovascular disease and risk management: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00372-3_bib54","first-page":"S219","article-title":"11. Chronic kidney disease and risk management: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00372-3_bib55","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1111\/jgs.17735","article-title":"Glycemic treatment deintensification practices in nursing home residents with type 2 diabetes","volume":"70","author":"Lederle","year":"2022","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(24)00372-3_bib56","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.diabres.2008.08.014","article-title":"Can diabetes medication be reduced in elderly patients? An observational study of diabetes drug withdrawal in nursing home patients with tight glycaemic control","volume":"82","author":"Sj\u00f6blom","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(24)00372-3_bib57","doi-asserted-by":"crossref","first-page":"1558","DOI":"10.2337\/dc21-2116","article-title":"Effect of deintensifying diabetes medications on negative events in older veteran nursing home residents","volume":"45","author":"Niznik","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00372-3_bib58","doi-asserted-by":"crossref","first-page":"308","DOI":"10.2337\/dc15-2512","article-title":"Management of diabetes in long-term care and skilled nursing facilities: a position statement of the American Diabetes Association","volume":"39","author":"Munshi","year":"2016","journal-title":"Diabetes Care"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(25)00071-3","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:02:09Z","timestamp":1762610529000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003723"}},"issued":{"date-parts":[[2025,5]]},"references-count":56,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2213858724003723"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00372-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Realigning diabetes regimens in older adults: a 4S Pathway to guide simplification and deprescribing strategies","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00372-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T02:37:25Z","timestamp":1790476645376,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["32473B_162608"],"award-info":[{"award-number":["32473B_162608"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005688","name":"Gottfried und Julia Bangerter-Rhyner Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005688","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008485","name":"Schweizerische Akademie der Medizinischen Wissenschaften","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008485","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/s2213-8587(22)00219-4","type":"journal-article","created":{"date-parts":[[2022,8,22]],"date-time":"2022-08-22T18:45:40Z","timestamp":1661193940000},"page":"700-709","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":81,"title":["Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey"],"prefix":"10.1016","volume":"10","author":[{"given":"Cihan","family":"Atila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul Benjamin","family":"Loughrey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aoife","family":"Garrahy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Winzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Refardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Gildroy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malak","family":"Hamza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aparna","family":"Pal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph G","family":"Verbalis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher J","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars G","family":"Hemkens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven J","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sherlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles J","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Karavitaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Newell-Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John A H","family":"Wass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Christ-Crain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00219-4_bib1","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000336333","article-title":"Diabetes insipidus\u2014diagnosis and management","volume":"77","author":"Di Iorgi","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(22)00219-4_bib2","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S0889-8529(18)30031-8","article-title":"Diabetes insipidus","volume":"24","author":"Robertson","year":"1995","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(22)00219-4_bib3","doi-asserted-by":"crossref","first-page":"3958","DOI":"10.1210\/jc.2013-2326","article-title":"Clinical review: treatment of neurohypophyseal diabetes insipidus","volume":"98","author":"Oiso","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00219-4_bib5","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12020-015-0637-3","article-title":"Quality of life in the patients with central diabetes insipidus assessed by Nagasaki diabetes insipidus questionnaire","volume":"51","author":"Nozaki","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(22)00219-4_bib6","doi-asserted-by":"crossref","first-page":"3181","DOI":"10.1210\/jc.2018-02608","article-title":"Low plasma oxytocin levels and increased psychopathology in hypopituitary men with diabetes insipidus","volume":"104","author":"Aulinas","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00219-4_bib7","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJM200010053431403","article-title":"Central diabetes insipidus in children and young adults","volume":"343","author":"Maghnie","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00219-4_bib8","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1016\/0887-8994(94)90001-9","article-title":"Etiologies of central diabetes insipidus in children","volume":"11","author":"Wang","year":"1994","journal-title":"Pediatr Neurol"},{"key":"10.1016\/S2213-8587(22)00219-4_bib9","first-page":"191","article-title":"Primary or idiopathic diabetes insipidus: a system disease","volume":"7","author":"Blotner","year":"1958","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(22)00219-4_bib10","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1111\/j.1365-2265.2011.04270.x","article-title":"Anterior hypopituitarism is rare and autoimmune disease is common in adults with idiopathic central diabetes insipidus","volume":"76","author":"Hannon","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(22)00219-4_bib11","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/j.juro.2007.03.015","article-title":"The comparative safety of oral versus intranasal desmopressin for the treatment of children with nocturnal enuresis","volume":"178","author":"Robson","year":"2007","journal-title":"J Urol"},{"key":"10.1016\/S2213-8587(22)00219-4_bib12","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1507\/endocrj.EJ13-0165","article-title":"Efficacy and safety of desmopressin orally disintegrating tablet in patients with central diabetes insipidus: results of a multicenter open-label dose-titration study","volume":"60","author":"Arima","year":"2013","journal-title":"Endocr J"},{"key":"10.1016\/S2213-8587(22)00219-4_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.7326\/0003-4819-103-2-228","article-title":"Desmopressin","volume":"103","author":"Richardson","year":"1985","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(22)00219-4_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1530\/EJE-14-0719","article-title":"Abnormal plasma sodium concentrations in patients treated with desmopressin for cranial diabetes insipidus: results of a long-term retrospective study","volume":"172","author":"Behan","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(22)00219-4_bib15","series-title":"Williams textbook of endocrinology","author":"Melmed","year":"2019"},{"key":"10.1016\/S2213-8587(22)00219-4_bib16","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-022-02191-2","article-title":"Challenges and improvement needs in the care of patients with central diabetes insipidus","volume":"17","author":"Teare","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(22)00219-4_bib17","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1093\/ndt\/gfu263","article-title":"Desmopressin acetate (DDAVP)-associated hyponatremia and brain damage: a case series","volume":"29","author":"Achinger","year":"2014","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(22)00219-4_bib18","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa517","article-title":"Excess mortality among hospitalized patients with hypopituitarism-a population-based, matched-cohort study","volume":"105","author":"Ebrahimi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00219-4_bib19","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1111\/cen.13028","article-title":"Concerns about the safety of patients with diabetes insipidus admitted to hospital","volume":"84","author":"Gleeson","year":"2016","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(22)00219-4_bib20","doi-asserted-by":"crossref","first-page":"G8","DOI":"10.1530\/EC-18-0154","article-title":"Society for endocrinology clinical guidance: Inpatient management of cranial diabetes insipidus","volume":"7","author":"Baldeweg","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(22)00219-4_bib21","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/j.psyneuen.2017.11.006","article-title":"De-masking oxytocin-deficiency in craniopharyngioma and assessing its link with affective function","volume":"88","author":"Gebert","year":"2018","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(22)00219-4_bib22","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s11102-019-00936-0","article-title":"Oxytocin alterations and neurocognitive domains in patients with hypopituitarism","volume":"22","author":"Eisenberg","year":"2019","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(22)00219-4_bib23","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1530\/eje.1.02176","article-title":"Does long-term GH replacement therapy in hypopituitary adults with GH deficiency normalise quality of life?","volume":"155","author":"Koltowska-H\u00e4ggstr\u00f6m","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(22)00219-4_bib24","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.ecl.2014.10.013","article-title":"Health-related quality of life in pituitary diseases","volume":"44","author":"Crespo","year":"2015","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(22)00219-4_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044304","article-title":"Development and validation of a new questionnaire assessing quality of life in adults with hypopituitarism: adult hypopituitarism questionnaire (AHQ)","volume":"7","author":"Ishii","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(22)00219-4_bib26","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1016\/j.jpeds.2011.03.044","article-title":"Natural history of idiopathic diabetes insipidus","volume":"159","author":"Richards","year":"2011","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(22)00219-4_bib27","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s12020-017-1257-x","article-title":"First experiences with neuropsychological effects of oxytocin administration in childhood-onset craniopharyngioma","volume":"56","author":"Hoffmann","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(22)00219-4_bib28","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1111\/cen.13578","article-title":"Time for change: renaming diabetes insipidus to improve patient safety","volume":"88","author":"Prentice","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(22)00219-4_bib29","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1530\/EJE-22-0187","article-title":"Management of cranial diabetes insipidus \u2013 clinical outcomes and patient perception of care","volume":"187","author":"Dilrukshi","year":"2022","journal-title":"Euro J Endocrinol"},{"key":"10.1016\/S2213-8587(22)00219-4_bib30","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1038\/nrneph.2015.89","article-title":"Pathophysiology, diagnosis and management of nephrogenic diabetes insipidus","volume":"11","author":"Bockenhauer","year":"2015","journal-title":"Nat Rev Nephrol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:35Z","timestamp":1761991895000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722002194"}},"issued":{"date-parts":[[2022,10]]},"references-count":29,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S2213858722002194"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00219-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00219-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00225-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T23:04:32Z","timestamp":1790118272332,"version":"4.0.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/s2213-8587(13)70166-9","type":"journal-article","created":{"date-parts":[[2013,10,18]],"date-time":"2013-10-18T11:35:41Z","timestamp":1382096141000},"page":"163","source":"Crossref","is-referenced-by-count":23,"title":["The untapped potential of the thyroid axis"],"prefix":"10.1016","volume":"1","author":[{"name":"The Lancet Diabetes and Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T21:53:43Z","timestamp":1539294823000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701669"}},"issued":{"date-parts":[[2013,11]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S2213858713701669"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70166-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,11]]}},{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T21:11:17Z","timestamp":1789074677304,"version":"build-2803163510"},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/s2213-8587(25)00401-2","type":"journal-article","created":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T00:31:13Z","timestamp":1767918673000},"page":"110-111","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Integrating mental health and non-communicable disease care: from declarations to practice"],"prefix":"10.1016","volume":"14","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725004012?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725004012?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:50:34Z","timestamp":1789073434000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725004012"}},"issued":{"date-parts":[[2026,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2213858725004012"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00401-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integrating mental health and non-communicable disease care: from declarations to practice","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00401-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,19]],"date-time":"2026-09-19T04:23:56Z","timestamp":1789791836772,"version":"4.0.1"},"reference-count":29,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003197","name":"Agenzia Italiana del Farmaco, Ministero della Salute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003197","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/s2213-8587(17)30317-0","type":"journal-article","created":{"date-parts":[[2017,9,13]],"date-time":"2017-09-13T03:45:15Z","timestamp":1505274315000},"page":"887-897","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":259,"title":["Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial"],"prefix":"10.1016","volume":"5","author":[{"given":"Olga","family":"Vaccaro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Masulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Nicolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Del Prato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo P","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela A","family":"Rivellese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Squatrito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo B","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Sesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mocarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lucisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Signorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Perriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Carla","family":"Babini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunziata","family":"Lapolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Buzzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Di Cianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Iannarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Cordera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"La Macchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zamboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Scaranna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Boemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Iovine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Lauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Leotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Dall'Aglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Cannarsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tonutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio C","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Anichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Di Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Citro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Antenucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Gnasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Cosmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Zavaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Vedovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"di Bartolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fornengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga","family":"Vaccaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Masulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Nicolucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo Pietro","family":"Maggioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Sesti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mocarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lucisano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Sacco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Signorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"Cappellini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Riccardi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Boemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Giansanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tanase","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Lanari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivano","family":"Testa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Ricci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pancani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Ranchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Vagheggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Scatona","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Giorgino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Laviola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Tarantino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Gigantelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariangela","family":"Manicone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eleonora","family":"Conte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Trevisan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristiana","family":"Scaranna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Rota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro R.","family":"Dodesini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio Marchesini","family":"Reggiani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luca","family":"Montesi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalia","family":"Mazzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Forlani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Di Luzio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Mazzotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antimo","family":"Aiello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelina","family":"Barrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Musto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorentina","family":"D'Amico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastiano","family":"Squatrito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiziana","family":"Sinagra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Longhitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Trowpea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sparti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Italia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico","family":"Lisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Grasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Pezzino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Insalaco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Gnasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Carallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Scicchitano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Serena","family":"De Franceschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Costanza","family":"Santini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Mazzotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Calbucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Ripani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Cuneo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Corsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo B.","family":"Giorda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Romeo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Lesina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Comoglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Bonetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Robusto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Nada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Asprino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Cetraro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelina","family":"Impieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Lucchese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Donnarumma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Biagio","family":"Tizio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Clemente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lazzaro","family":"Lenza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pia","family":"Paraggio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Tomasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zamboni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicoletta","family":"Dozio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egle","family":"Scalambra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edoardo","family":"Mannucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Lamanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Cignarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olga La","family":"Macchia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Fariello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Rosaria","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivano","family":"Franzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Radin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renzo","family":"Cordera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Annunziata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Affinito","family":"Bonabello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Durante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mara","family":"Dolcino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenza","family":"Gallo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Mazzucchelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Aleo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pierluigi","family":"Melga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Briatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Maggi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Storace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Cecoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela","family":"Antenucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ercole","family":"D'Ugo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Pupillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Pompea Antonia","family":"Baldassarre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Salvati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Minnucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"De Luca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"Zugaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Livia","family":"Santarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Bosco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittorio","family":"Petrella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grazia Giovanna","family":"La Verghetta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Iannarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonella","family":"De Gregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Settimio","family":"D'Andrea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Elisa","family":"Giuliani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"w Lorella","family":"Polidoro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Sperandio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filomena","family":"Sciarretta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfonso","family":"Pezzella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Buzzetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Carlone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Potenziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Venditti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Foffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Carbone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Cipolloni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gaetano","family":"Leto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosalia","family":"Serra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Petrachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziano","family":"Di Cianni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilia","family":"Lacaria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Russo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Goretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Sannino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanna","family":"Gregori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Dolci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Bruselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L.","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Baccetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Del Freo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonino","family":"Di Benedetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Cucinotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loretta","family":"Giunta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Concetta","family":"Ruffo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Desiree","family":"Cannizzaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Basilio","family":"Pintaudi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Pata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Ragonese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Lettina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teresa","family":"Mancuso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Coppolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pier Marco","family":"Piatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Monti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michela","family":"Stuccillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Lucotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Setola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia Valentina","family":"Crippa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia","family":"Loi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Oldani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Luisa","family":"Bottalico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beatrice","family":"Pellegata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bonomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Silvia Maria","family":"Menicatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Resi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Bertuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eugenia Olga","family":"Disoteo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianluigi","family":"Pizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela Albarosa","family":"Rivellese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Annuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brunella","family":"Capaldo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Nappo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania Michela","family":"Auciello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Amelia","family":"Turco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucia","family":"Costagliola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ciro","family":"Iovine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina Della","family":"Corte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Vallefuoco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Nappi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilena","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Cocozza","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Ciano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Massimino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nadia","family":"Garofalo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelo","family":"Avogaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Vedovato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Guarneri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annunziata","family":"Lapolla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Domenico","family":"Fedele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Sartore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nino Cristiano","family":"Chilelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bonsembiante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Giordano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aldo","family":"Galluzzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Torregrossa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Dall'Aglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Mancastroppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leone","family":"Arsenio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico","family":"Cioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvana","family":"Caronna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Papi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimiliano","family":"Babini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriele","family":"Perriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fausto","family":"Santeusanio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gioia","family":"Calagreti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Timi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Tantucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Marino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agostino","family":"Consoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Ginestra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosamaria","family":"Di Biagio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merilda","family":"Taraborelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Del Prato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Miccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Bianchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monia","family":"Garofolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantina Savina","family":"Politi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Penno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donatella","family":"Zavaroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Livraga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabio","family":"Calzoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni Luigi Francesco","family":"Mancastroppa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Anichini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Corsini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Tedeschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Sole","family":"Gaglian\u00f2","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulio","family":"Ippolito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Salutini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Citro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cervellino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Natale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vita","family":"Salvatore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Armando","family":"Zampino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosa","family":"Sinisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Calabrese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adolfo","family":"Arcangeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Zogheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Guizzotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Longo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Di Bartolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Caselli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Pellicano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrizia","family":"Scolozzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Termine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Luberto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Ballardini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna Carla","family":"Babini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Ripani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Trojani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mazzuca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matteo","family":"Bruglia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Ciamei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvia","family":"Genghini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zannoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Pugliese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Vitale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziela","family":"Rangel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Salvi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandra","family":"Zappaterreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samantha","family":"Cordone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Simonelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marilla","family":"Meggiorini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurora","family":"Frasheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clelia","family":"Di Pippo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Maglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Mazzitelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Lauro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Elena","family":"Rinaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelica","family":"Galli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"D'Angelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Leotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Concetta","family":"Suraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"De Cosmo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Bacci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Pio","family":"Palena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Genovese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Mancino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maurizio","family":"Rondinelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filippo","family":"Capone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Calabretto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica","family":"Bulgheroni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Loredana","family":"Bucciarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Dotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Ceccarelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Fondelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clorinda","family":"Santacroce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Guarino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Nigi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlo","family":"Lalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Di Vizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maura","family":"Scarponi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Montani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Di Bernardino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Romagni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katia","family":"Dolcetti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Cannarsa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Forte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stella","family":"Potenziani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucilla","family":"Tamburo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Fornengo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo Cavallo","family":"Perin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tania","family":"Prinzis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Gruden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graziella","family":"Bruno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Zucco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Perotta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saverio","family":"Marena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simona","family":"Monsignore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Panero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fulvia","family":"Ponzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio Carlo","family":"Bossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Carpinteri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Linda","family":"Casagrande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Francesca","family":"Coletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura Silvia Maria","family":"Menicatti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annalisa","family":"Balini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello","family":"Filopanti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Madaschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Pulcina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Grimaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Tonutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Venturini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandra","family":"Agus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefania","family":"Pagnutti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Guidotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Cavarape","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Linda","family":"Casagrande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enzo","family":"Bonora","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Cigolini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabella","family":"Pichiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinna","family":"Brangani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giulia","family":"Fainelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Tomasetto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giacomo","family":"Zoppini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Galletti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominica","family":"Perrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Capra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Bianchini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Ceseri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Di Nardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Sasso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Bartolomei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Suliman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gianna","family":"Fabbri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geremia","family":"Romano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Maturo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Nunziata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Capobianco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppina","family":"De Simone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Villa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Rota","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmine","family":"Pentangelo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ornella","family":"Carbonara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gennaro","family":"Caiazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Cutolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tommasina","family":"Sorrentino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeria","family":"Mastrilli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Umberto","family":"Amelia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerardo","family":"Corigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iole","family":"Gaeta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Armentano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasqualino","family":"Calatola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gelsomina","family":"Capuano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruno","family":"Angiulli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pasquale","family":"Auletta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ettore","family":"Petraroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cinzia E.","family":"Iodice","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariano","family":"Agrusta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30317-0_bib1","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1001\/archinte.164.13.1438","article-title":"Impact of diabetes and previous myocardial infarction on long-term survival: 25-year mortality follow-up of primary screenees of the Multiple Risk Factor Intervention Trial","volume":"164","author":"Vaccaro","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(17)30317-0_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30317-0_bib3","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30317-0_bib4","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.1001\/jama.281.21.2005","article-title":"Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49)","volume":"281","author":"Turner","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30317-0_bib5","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00125-014-3460-0","article-title":"Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"58","author":"Inzucchi","year":"2015","journal-title":"Diabetologia"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30317-0_bib6","first-page":"S1","article-title":"Standards of medical care in diabetes\u20142017","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30317-0_bib7","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/dc16-0985","article-title":"Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006\u20132013","volume":"40","author":"Lipska","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30317-0_bib8","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.2016.9400","article-title":"Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis","volume":"316","author":"Palmer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30317-0_bib9","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/dom.12456","article-title":"Cardiovascular safety of sulphonylureas: over 40\u2008 years of continuous controversy without an answer","volume":"17","author":"Abdelmoneim","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(17)30317-0_bib10","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30317-0_bib11","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone after ischemic stroke or transient ischemic attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30317-0_bib12","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1001\/jama.2015.7996","article-title":"Pioglitazone use and risk of bladder cancer and other common cancers in persons with diabetes","volume":"314","author":"Lewis","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30317-0_bib13","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.bone.2014.08.010","article-title":"Risk of fracture with thiazolidinediones: an updated meta-analysis of randomized clinical trials","volume":"68","author":"Zhu","year":"2014","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(17)30317-0_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/1471-2261-14-129","article-title":"The risk of heart failure associated with the use of noninsulin blood glucose-lowering drugs: systematic review and meta-analysis of published observational studies","volume":"14","author":"Lorenzo","year":"2014","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/S2213-8587(17)30317-0_bib15","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.4158\/EP161409.CO","article-title":"Revisiting the use of pioglitazone in the treatment of type 2 diabetes","volume":"22","author":"Einhorn","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(17)30317-0_bib16","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.numecd.2012.09.003","article-title":"Addition of either pioglitazone or a sulfonylurea in type 2 diabetic patients inadequately controlled with metformin alone: impact on cardiovascular events. A randomized controlled trial","volume":"22","author":"Vaccaro","year":"2012","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(17)30317-0_bib17","series-title":"Standard Italiani per la cura del diabete mellito","year":"2016"},{"key":"10.1016\/S2213-8587(17)30317-0_bib19","doi-asserted-by":"crossref","first-page":"2747","DOI":"10.1002\/sim.2151","article-title":"A review of methods for futility stopping based on conditional power","volume":"24","author":"Lachin","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(17)30317-0_bib20","series-title":"Applied longitudinal data analysis: modeling change and event occurrence","author":"Singer","year":"2003"},{"key":"10.1016\/S2213-8587(17)30317-0_bib21","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","article-title":"Excess mortality in persons with type 2 diabetes","volume":"373","author":"Tancredi","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30317-0_bib22","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30317-0_bib23","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","article-title":"Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial","volume":"373","author":"Home","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30317-0_bib24","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30317-0_bib25","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2213-8587(14)70213-X","article-title":"Mortality risk among sulfonylureas: a systematic review and network meta-analysis","volume":"3","author":"Simpson","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30317-0_bib26","doi-asserted-by":"crossref","first-page":"1561","DOI":"10.1001\/jama.299.13.1561","article-title":"Comparison of pioglitazone vs glimepiride on progression of coronary atherosclerosis in patients with type 2 diabetes: the PERISCOPE randomized controlled trial","volume":"299","author":"Nissen","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30317-0_bib27","doi-asserted-by":"crossref","first-page":"E110","DOI":"10.1210\/jc.2011-1699","article-title":"Pioglitazone-mediated changes in lipoprotein particle composition are predicted by changes in adiponectin level in type 2 diabetes","volume":"97","author":"Sam","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30317-0_bib28","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"335","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30317-0_bib29","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1016\/S0140-6736(14)60794-7","article-title":"Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes","volume":"383","author":"Holman","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30317-0_bib30","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1177\/1479164115570301","article-title":"Design and baseline characteristics of the CARdiovascular Outcome Trial of LINAgliptin Versus Glimepiride in Type 2 Diabetes (CAROLINA)","volume":"12","author":"Marx","year":"2015","journal-title":"Diab Vasc Dis Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303170?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303170?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:55Z","timestamp":1761991555000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303170"}},"issued":{"date-parts":[[2017,11]]},"references-count":29,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S2213858717303170"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30317-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30317-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30320-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T05:39:47Z","timestamp":1789882787216,"version":"4.0.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/s2213-8587(17)30191-2","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T06:00:20Z","timestamp":1496901620000},"page":"483","source":"Crossref","is-referenced-by-count":25,"title":["Should we officially recognise obesity as a disease?"],"prefix":"10.1016","volume":"5","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301912?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301912?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T04:15:55Z","timestamp":1560831355000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301912"}},"issued":{"date-parts":[[2017,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2213858717301912"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30191-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,7]]}},{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T08:06:12Z","timestamp":1790841972069,"version":"4.1.0"},"reference-count":17,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/s2213-8587(17)30312-1","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T14:15:28Z","timestamp":1505484928000},"page":"164-166","source":"Crossref","is-referenced-by-count":54,"title":["Precision medicine: diagnosis and management of obesity"],"prefix":"10.1016","volume":"6","author":[{"given":"Gema","family":"Fr\u00fchbeck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitrios N","family":"Kiortsis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Catal\u00e1n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30312-1_bib1","doi-asserted-by":"crossref","first-page":"2229","DOI":"10.1056\/NEJMsb1503104","article-title":"Precision medicine\u2014personalized, problematic, and promising","volume":"372","author":"Jameson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30312-1_bib2","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.1016\/S0140-6736(16)00271-3","article-title":"Management of obesity","volume":"387","author":"Bray","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30312-1_bib3","series-title":"Fact sheet: obesity and overweight","year":"2016"},{"key":"10.1016\/S2213-8587(17)30312-1_bib4","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000368783","article-title":"Beyond BMI\u2014phenotyping the obesities","volume":"7","author":"Blundell","year":"2014","journal-title":"Obes Facts"},{"key":"10.1016\/S2213-8587(17)30312-1_bib5","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30312-1_bib6","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(17)30312-1_bib7","doi-asserted-by":"crossref","first-page":"4746","DOI":"10.1093\/hmg\/ddv194","article-title":"Dissecting the genetics of the human transcriptome identifies novel trait-related trans-eQTLs and corroborates the regulatory relevance of non-protein coding loci","volume":"24","author":"Kirsten","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(17)30312-1_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.mce.2017.04.009","article-title":"Small non coding RNAs in adipocyte biology and obesity","author":"Amri","year":"2017","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(17)30312-1_bib9","doi-asserted-by":"crossref","first-page":"572","DOI":"10.1016\/j.cmet.2017.02.002","article-title":"Systems biology of metabolism: a driver for developing personalized and precision medicine","volume":"25","author":"Nielsen","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(17)30312-1_bib10","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1038\/nchembio.462","article-title":"The challenges of integrating multi-omic data sets","volume":"6","author":"Palsson","year":"2010","journal-title":"Nat Chem Biol"},{"key":"10.1016\/S2213-8587(17)30312-1_bib11","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/oby.21381","article-title":"NIH working group report\u2014using genomic information to guide weight management: from universal to precision treatment","volume":"24","author":"Bray","year":"2016","journal-title":"Obesity (Silver Spring)"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30312-1_bib12","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1159\/000360506","article-title":"Developmental programming and transgenerational transmission of obesity","volume":"64","author":"Vickers","year":"2014","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/S2213-8587(17)30312-1_bib13","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1056\/NEJMcibr1414707","article-title":"Epigenetic signatures of obesity","volume":"372","author":"Ozanne","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30312-1_bib14","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2014.11.005","article-title":"Peri-conception parental obesity, reproductive health, and transgenerational impacts","volume":"26","author":"Lane","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30312-1_bib15","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1016\/j.cell.2015.11.001","article-title":"Personalized nutrition by prediction of glycemic responses","volume":"163","author":"Zeevi","year":"2015","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(17)30312-1_bib16","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1056\/NEJMsa066082","article-title":"The spread of obesity in a large social network over 32 years","volume":"357","author":"Christakis","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30312-1_bib17","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1016\/S0140-6736(17)30003-X","article-title":"Syndemics and the biosocial conception of health","volume":"389","author":"Singer","year":"2017","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T17:25:38Z","timestamp":1535390738000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303121"}},"issued":{"date-parts":[[2018,3]]},"references-count":17,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2213858717303121"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30312-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,3]]}},{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T23:41:35Z","timestamp":1791330095172,"version":"4.3.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/s2213-8587(13)70123-2","type":"journal-article","created":{"date-parts":[[2013,9,22]],"date-time":"2013-09-22T21:15:15Z","timestamp":1379884515000},"page":"261-263","source":"Crossref","is-referenced-by-count":7,"title":["Restoring immune balance in type 1 diabetes"],"prefix":"10.1016","volume":"1","author":[{"given":"Kevan C","family":"Herold","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70123-2_bib1","doi-asserted-by":"crossref","first-page":"1998","DOI":"10.4049\/jimmunol.1100539","article-title":"Increased T cell proliferative responses to islet antigens identify clinical responders to anti-CD20 monoclonal antibody (rituximab) therapy in type 1 diabetes","volume":"187","author":"Herold","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(13)70123-2_bib2","doi-asserted-by":"crossref","DOI":"10.2337\/db13-0345","article-title":"Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: Metabolic and immunologic features at baseline identify a subgroup of responders","author":"Herold","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70123-2_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70111-6","article-title":"Targeting of effector memory T cells with alefacept in new onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial","author":"Rigby","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70123-2_bib4","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2337\/diabetes.53.2.426","article-title":"Insulin secretion in type 1 diabetes","volume":"53","author":"Steele","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70123-2_bib5","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1001\/archderm.139.6.719","article-title":"An international, randomized, double-blind, placebo-controlled phase 3 trial of intramuscular alefacept in patients with chronic plaque psoriasis","volume":"139","author":"Lebwohl","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/S2213-8587(13)70123-2_bib6","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.4049\/jimmunol.1100713","article-title":"Anti-CD3 therapy promotes tolerance by selectively depleting pathogenic cells while preserving regulatory T cells","volume":"187","author":"Penaranda","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(13)70123-2_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70065-2","article-title":"Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial","author":"Gitelman","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70123-2_bib8","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/db12-0049","article-title":"Rapamycin\/IL-2 Combination therapy in patients with type 1 diabetes augments tregs yet transiently impairs beta-cell function","volume":"61","author":"Long","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70123-2_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nri3422","article-title":"Type 1 diabetes: translating mechanistic observations into effective clinical outcomes","volume":"13","author":"Herold","year":"2013","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/S2213-8587(13)70123-2_bib10","doi-asserted-by":"crossref","first-page":"5136","DOI":"10.1210\/en.2007-0358","article-title":"Exendin-4 improves reversal of diabetes in NOD mice treated with anti-CD3 monoclonal antibody by enhancing recovery of beta-cells","volume":"148","author":"Sherry","year":"2007","journal-title":"Endocrinology"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T15:52:33Z","timestamp":1539359553000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701232"}},"issued":{"date-parts":[[2013,12]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2213858713701232"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70123-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,12]]}},{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T16:23:27Z","timestamp":1792167807335,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,12,1]],"date-time":"2019-12-01T00:00:00Z","timestamp":1575158400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,12]]},"DOI":"10.1016\/s2213-8587(19)30353-5","type":"journal-article","created":{"date-parts":[[2019,11,3]],"date-time":"2019-11-03T09:47:48Z","timestamp":1572774468000},"page":"893-895","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Skeletal considerations in the medical treatment of transgender people"],"prefix":"10.1016","volume":"7","author":[{"given":"Sundeep","family":"Khosla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Davidge-Pitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30353-5_bib1","doi-asserted-by":"crossref","first-page":"Itc1","DOI":"10.7326\/AITC201907020","article-title":"Care of the transgender patient","volume":"171","author":"Safer","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(19)30353-5_bib2","doi-asserted-by":"crossref","first-page":"256","DOI":"10.7326\/M17-0577","article-title":"Cardiovascular disease among transgender adults receiving hormone therapy: a narrative review","volume":"167","author":"Streed","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(19)30353-5_bib3","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.maturitas.2019.05.002","article-title":"Transgender bone health","volume":"127","author":"Davidge-Pitts","year":"2019","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(19)30353-5_bib4","first-page":"298","article-title":"Post-menopausal osteoporosis","volume":"55","author":"Albright","year":"1940","journal-title":"Trans Assoc Am Physicians"},{"key":"10.1016\/S2213-8587(19)30353-5_bib5","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1002\/jbmr.2529","article-title":"New insights into androgen and estrogen receptor regulation of the male skeleton","volume":"30","author":"Khosla","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30353-5_bib6","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1002\/jbmr.2485","article-title":"The effects of androgens on murine cortical bone do not require AR or ERalpha signaling in osteoblasts and osteoclasts","volume":"30","author":"Ucer","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30353-5_bib7","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jor.1100080418","article-title":"Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats","volume":"8","author":"Turner","year":"1990","journal-title":"J Orthop Res"},{"key":"10.1016\/S2213-8587(19)30353-5_bib8","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1210\/edrv.23.3.0465","article-title":"Sex steroids and the construction and conservation of the adult skeleton","volume":"23","author":"Riggs","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(19)30353-5_bib9","article-title":"Fracture risk in trans women and trans men using long-term gender-affirming hormonal treatment: a nationwide cohort study","author":"Wiepjes","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30353-5_bib10","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1097\/GME.0000000000000921","article-title":"The 2017 hormone therapy position statement of The North American Menopause Society","volume":"24","year":"2017","journal-title":"Menopause"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303535?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303535?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:39Z","timestamp":1761991659000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719303535"}},"issued":{"date-parts":[[2019,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2019,12]]}},"alternative-id":["S2213858719303535"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30353-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal considerations in the medical treatment of transgender people","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30353-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T20:47:32Z","timestamp":1791578852258,"version":"4.3.4"},"reference-count":8,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/s2213-8587(16)30097-3","type":"journal-article","created":{"date-parts":[[2016,5,22]],"date-time":"2016-05-22T13:48:54Z","timestamp":1463924934000},"page":"555-556","source":"Crossref","is-referenced-by-count":5,"title":["Diabetic microvascular complications as simple indicators of risk for cardiovascular outcomes and heart failure"],"prefix":"10.1016","volume":"4","author":[{"given":"Naveed","family":"Sattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Preiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30097-3_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)30057-2","article-title":"Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study","author":"Brownrigg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30097-3_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/S2213-8587(13)70025-1","article-title":"Dysglycaemia, vasculopenia, and the chronic consequences of diabetes","volume":"1","author":"Gerstein","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30097-3_bib3","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"issue":"25 suppl 2","key":"10.1016\/S2213-8587(16)30097-3_bib5","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)30097-3_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/dom.12614","article-title":"Prediction of 10-year vascular risk in patients with diabetes: the AD-ON risk score","volume":"18","author":"Woodward","year":"2016","journal-title":"Diabetes Obes Metab"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(16)30097-3_bib7","doi-asserted-by":"crossref","first-page":"ii1","DOI":"10.1136\/heartjnl-2014-305693","article-title":"Joint British Societies' consensus recommendations for the prevention of cardiovascular disease (JBS3)","volume":"100","year":"2014","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(16)30097-3_bib8","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1016\/j.ahj.2010.10.019","article-title":"A systematic review of event rates in clinical trials in diabetes mellitus: the importance of quantifying baseline cardiovascular disease history and proteinuria and implications for clinical trial design","volume":"161","author":"Preiss","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(16)30097-3_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)30010-9","article-title":"The changing face of diabetes complications","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300973?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300973?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,11]],"date-time":"2018-09-11T18:24:00Z","timestamp":1536690240000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716300973"}},"issued":{"date-parts":[[2016,7]]},"references-count":8,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S2213858716300973"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30097-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,7]]}},{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:56Z","timestamp":1792097336376,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/s2213-8587(26)00250-0","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:50:10Z","timestamp":1791931810000},"page":"873-876","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Precision medicine in type 2 diabetes: should clustering be used?"],"prefix":"10.1016","volume":"14","author":[{"given":"Philippe","family":"Froguel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Bonnefond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00250-0_bib1","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/S2213-8587(24)00339-5","article-title":"Dissection of type 2 diabetes: a genetic perspective","volume":"13","author":"Bonnefond","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00250-0_bib2","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1038\/s42255-020-00294-3","article-title":"Pathogenic variants in actionable MODY genes are associated with type 2 diabetes","volume":"2","author":"Bonnefond","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(26)00250-0_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00250-0_bib4","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","article-title":"Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data","volume":"7","author":"Dennis","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00250-0_bib5","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1038\/s41591-020-1116-9","article-title":"Pathophysiology-based subphenotyping of individuals at elevated risk for type 2 diabetes","volume":"27","author":"Wagner","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00250-0_bib6","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","article-title":"Genetic drivers of heterogeneity in type 2 diabetes pathophysiology","volume":"627","author":"Suzuki","year":"2024","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(26)00250-0_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2025-106407","article-title":"Identification of comorbidity-based clusters and mortality risk in hospitalised patients with diabetes mellitus in Karachi, Pakistan: a machine learning analysis","volume":"16","author":"Aziz","year":"2026","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00250-0_bib8","doi-asserted-by":"crossref","first-page":"1458","DOI":"10.2337\/dc26-0118","article-title":"To cluster or not to cluster? A comparison of approaches to targeting type 2 diabetes glucose-lowering therapy in the TriMaster crossover trial","volume":"49","author":"G\u00fcdemann","year":"2026","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00250-0_bib9","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1038\/s42255-025-01413-8","article-title":"Inhibition of IRAK4 by microbial trimethylamine blunts metabolic inflammation and ameliorates glycemic control","volume":"7","author":"Chilloux","year":"2025","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(26)00250-0_bib10","doi-asserted-by":"crossref","first-page":"2265","DOI":"10.1038\/s41591-024-03067-7","article-title":"Strain-specific gut microbial signatures in type 2 diabetes identified in a cross-cohort analysis of 8,117 metagenomes","volume":"30","author":"Mei","year":"2024","journal-title":"Nat Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:11Z","timestamp":1792096871000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726002500"}},"issued":{"date-parts":[[2026,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2213858726002500"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00250-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Precision medicine in type 2 diabetes: should clustering be used?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00250-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T21:58:06Z","timestamp":1793656686548,"version":"4.5.1"},"reference-count":43,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,23]],"date-time":"2024-09-23T00:00:00Z","timestamp":1727049600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100009109","name":"Bayer Pharma AG","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009109","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/s2213-8587(24)00309-7","type":"journal-article","created":{"date-parts":[[2025,1,13]],"date-time":"2025-01-13T23:33:22Z","timestamp":1736811202000},"page":"107-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial"],"prefix":"10.1016","volume":"13","author":[{"given":"Jawad H","family":"Butt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pardeep S","family":"Jhund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alasdair D","family":"Henderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brian L","family":"Claggett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay S","family":"Desai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Prabhakar","family":"Viswanathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Kolkhof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick","family":"Schloemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flaviana","family":"Amarante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S P","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Senni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjiv J","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriaan A","family":"Voors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertram","family":"Pitt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J V","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00309-7_bib1","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.2337\/dci22-0014","article-title":"Heart failure: an underappreciated complication of diabetes. A consensus report of the American Diabetes Association","volume":"45","author":"Pop-Busui","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00309-7_bib2","doi-asserted-by":"crossref","DOI":"10.1161\/CIR.0000000000000691","article-title":"Type 2 diabetes mellitus and heart failure: a scientific statement from the American Heart Association and the Heart Failure Society of America: this statement does not represent an update of the 2017 ACC\/AHA\/HFSA heart failure guideline update","author":"Dunlay","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00309-7_bib3","doi-asserted-by":"crossref","first-page":"869","DOI":"10.1016\/S2213-8587(22)00308-4","volume":"10","author":"Inzucchi","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00309-7_bib4","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1002\/ejhf.2403","article-title":"Diabetes and pre-diabetes in patients with heart failure and preserved ejection fraction","volume":"24","author":"Jackson","year":"2022","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(24)00309-7_bib5","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/j.amjcard.2018.11.022","article-title":"Comparison of outcomes in patients with diabetes mellitus treated with versus without insulin + heart failure with preserved left ventricular ejection fraction (from the TOPCAT study)","volume":"123","author":"Huynh","year":"2019","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(24)00309-7_bib6","doi-asserted-by":"crossref","DOI":"10.1161\/CIRCHEARTFAILURE.120.008075","article-title":"Impact of insulin treatment on the effect of eplerenone: insights from the EMPHASIS-HF trial","author":"Ferreira","year":"2021","journal-title":"Circ Heart Fail"},{"key":"10.1016\/S2213-8587(24)00309-7_bib7","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1001\/jama.2020.1906","article-title":"Effect of dapagliflozin on worsening heart failure and cardiovascular death in patients with heart failure with and without diabetes","volume":"323","author":"Petrie","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00309-7_bib8","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.2337\/dc17-0697","article-title":"Prognostic impact of diabetes on long-term survival outcomes in patients with heart failure: a meta-analysis","volume":"40","author":"Dauriz","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00309-7_bib9","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1093\/eurheartj\/ehn153","article-title":"Impact of diabetes on outcomes in patients with low and preserved ejection fraction heart failure: an analysis of the candesartan in heart failure: assessment of reduction in mortality and morbidity (CHARM) programme","volume":"29","author":"MacDonald","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(24)00309-7_bib10","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1161\/CIRCULATIONAHA.107.702795","article-title":"Metabolic mechanisms in heart failure","volume":"116","author":"Ashrafian","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00309-7_bib11","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1161\/CIRCRESAHA.116.306206","article-title":"Insulin signaling and heart failure","volume":"118","author":"Riehle","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(24)00309-7_bib12","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1161\/CIRCULATIONAHA.104.528166","article-title":"Effects of candesartan on the development of a new diagnosis of diabetes mellitus in patients with heart failure","volume":"112","author":"Yusuf","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00309-7_bib13","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa1001121","article-title":"Effect of valsartan on the incidence of diabetes and cardiovascular events","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00309-7_bib14","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","article-title":"Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis","volume":"369","author":"Elliott","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00309-7_bib15","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1002\/ejhf.3266","article-title":"Baseline characteristics of patients with heart failure with mildly reduced or preserved ejection fraction: the FINEARTS-HF trial","volume":"26","author":"Solomon","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(24)00309-7_bib16","doi-asserted-by":"crossref","first-page":"1324","DOI":"10.1002\/ejhf.3253","article-title":"Finerenone in patients with heart failure with mildly reduced or preserved ejection fraction: rationale and design of the FINEARTS-HF trial","volume":"26","author":"Vaduganathan","year":"2024","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(24)00309-7_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/ijms23169243","article-title":"Nonsteroidal mineralocorticoid receptor antagonism by finerenone\u2014translational aspects and clinical perspectives across multiple organ systems","volume":"23","author":"Kolkhof","year":"2022","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(24)00309-7_bib18","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1093\/eurheartj\/ehaa736","article-title":"Steroidal and non-steroidal mineralocorticoid receptor antagonists in cardiorenal medicine","volume":"42","author":"Agarwal","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(24)00309-7_bib19","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1056\/NEJMoa2407107","article-title":"Finerenone in heart failure with mildly reduced or preserved ejection fraction","volume":"391","author":"Solomon","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00309-7_bib20","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes 2024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00309-7_bib21","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.4794","article-title":"A brief introduction to mixed effects modelling and multi-model inference in ecology","volume":"6","author":"Harrison","year":"2018","journal-title":"PeerJ"},{"key":"10.1016\/S2213-8587(24)00309-7_bib22","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.2517-6161.1972.tb00899.x","article-title":"Regression models and life-tables","volume":"34","author":"Cox","year":"1972","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/S2213-8587(24)00309-7_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1080\/01621459.1999.10474144","article-title":"A proportional hazards model for the subdistribution of a competing risk","volume":"94","author":"Fine","year":"1999","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/S2213-8587(24)00309-7_bib24","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1111\/1467-9868.00259","article-title":"Semiparametric regression for the mean and rate functions of recurrent events","volume":"62","author":"Lin","year":"2000","journal-title":"J R Stat Soc Series B Stat Methodol"},{"key":"10.1016\/S2213-8587(24)00309-7_bib25","doi-asserted-by":"crossref","first-page":"121","DOI":"10.21037\/atm.2018.02.12","article-title":"Time-varying covariates and coefficients in Cox regression models","volume":"6","author":"Zhang","year":"2018","journal-title":"Ann Transl Med"},{"key":"10.1016\/S2213-8587(24)00309-7_bib26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1093\/eurjhf\/hfs067","article-title":"Eplerenone and new-onset diabetes in patients with mild heart failure: results from the Eplerenone in Mild Patients Hospitalization and Survival Study in Heart Failure (EMPHASIS-HF)","volume":"14","author":"Preiss","year":"2012","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(24)00309-7_bib27","doi-asserted-by":"crossref","first-page":"968","DOI":"10.1136\/hrt.2006.092379","article-title":"Effects of metoprolol and carvedilol on pre-existing and new onset diabetes in patients with chronic heart failure: data from the Carvedilol Or Metoprolol European Trial (COMET)","volume":"93","author":"Torp-Pedersen","year":"2007","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(24)00309-7_bib28","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s12933-019-0883-4","article-title":"Heart failure and the prognostic impact and incidence of new-onset of diabetes mellitus: a nationwide cohort study","volume":"18","author":"Zareini","year":"2019","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(24)00309-7_bib29","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1016\/S2213-8587(21)00295-3","article-title":"Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials","volume":"10","author":"Rossing","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00309-7_bib30","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00309-7_bib31","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1002\/ejhf.896","article-title":"Aliskiren alone or in combination with enalapril vs. enalapril among patients with chronic heart failure with and without diabetes: a subgroup analysis from the ATMOSPHERE trial","volume":"20","author":"Kristensen","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(24)00309-7_bib32","doi-asserted-by":"crossref","first-page":"586","DOI":"10.2337\/dc20-1675","article-title":"Dapagliflozin and the incidence of type 2 diabetes in patients with heart failure and reduced ejection fraction: an exploratory analysis from DAPA-HF","volume":"44","author":"Inzucchi","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00309-7_bib33","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1016\/j.amepre.2023.07.009","article-title":"Diabetes prevalence and incidence inequality trends among U.S. adults, 2008\u20132021","volume":"65","author":"Saelee","year":"2023","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(24)00309-7_bib34","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/j.ahj.2010.04.024","article-title":"Effect of eplerenone versus spironolactone on cortisol and hemoglobin A1c levels in patients with chronic heart failure","volume":"160","author":"Yamaji","year":"2010","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(24)00309-7_bib35","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1007\/s00125-008-0972-5","article-title":"Spironolactone for poorly controlled hypertension in type 2 diabetes: conflicting effects on blood pressure, endothelial function, glycaemic control and hormonal profiles","volume":"51","author":"Swaminathan","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00309-7_bib36","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/j.metabol.2006.07.025","article-title":"The effect of spironolactone on circulating adipocytokines in patients with type 2 diabetes mellitus complicated by diabetic nephropathy","volume":"55","author":"Matsumoto","year":"2006","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(24)00309-7_bib37","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1007\/s00125-004-1510-8","article-title":"Spironolactone impairs endothelial function and heart rate variability in patients with type 2 diabetes","volume":"47","author":"Davies","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00309-7_bib38","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/dom.14999","article-title":"Effects of finerenone in people with chronic kidney disease and type 2 diabetes are independent of HbA1c at baseline, HbA1c variability, diabetes duration and insulin use at baseline","volume":"25","author":"McGill","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00309-7_bib39","doi-asserted-by":"crossref","first-page":"1986","DOI":"10.1210\/jc.2009-2521","article-title":"Aldosterone production and insulin resistance in healthy adults","volume":"95","author":"Garg","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00309-7_bib40","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1586\/eem.11.60","article-title":"Potassium and risk of type 2 diabetes","volume":"6","author":"Chatterjee","year":"2011","journal-title":"Expert Rev Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00309-7_bib41","doi-asserted-by":"crossref","first-page":"2252","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","volume":"385","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00309-7_bib42","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00309-7_bib43","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/s40618-021-01635-z","article-title":"Class-specific responses of brown adipose tissue to steroidal and nonsteroidal mineralocorticoid receptor antagonists","volume":"45","author":"Marzolla","year":"2022","journal-title":"J Endocrinol Invest"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003097?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003097?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:14:09Z","timestamp":1738703649000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003097"}},"issued":{"date-parts":[[2025,2]]},"references-count":43,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2213858724003097"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00309-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Finerenone and new-onset diabetes in heart failure: a prespecified analysis of the FINEARTS-HF trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00309-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00317-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T17:42:55Z","timestamp":1793468575472,"version":"4.5.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/s2213-8587(23)00353-4","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T23:32:15Z","timestamp":1701473535000},"page":"4-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The role of vitamin D in paediatric bone health"],"prefix":"10.1016","volume":"12","author":[{"given":"John M","family":"Pettifor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kebashni","family":"Thandrayen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00353-4_bib1","doi-asserted-by":"crossref","first-page":"1976","DOI":"10.1359\/jbmr.040902","article-title":"Epidemiology of childhood fractures in Britain: a study using the general practice research database","volume":"19","author":"Cooper","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(23)00353-4_bib2","article-title":"Vitamin D supplements for fracture prevention in schoolchildren in Mongolia: analysis of secondary outcomes from a multicentre, double-blind, randomised, placebo-controlled trial","author":"Ganmaa","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00353-4_bib4","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1017\/S1368980019005251","article-title":"25-hydroxyvitamin D assay standardisation and vitamin D guidelines paralysis","volume":"23","author":"Sempos","year":"2020","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(23)00353-4_bib5","article-title":"Influence of vitamin D supplementation on bone mineral content, bone turnover markers and fracture risk in South African schoolchildren: multicentre double-blind randomised placebo-controlled trial (ViDiKids)","author":"Middelkoop","year":"2023","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(23)00353-4_bib6","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/jbmr.5650090407","article-title":"Metabolic bone disease in black teenagers with genu valgum or varum without radiologic rickets: a bone histomorphometric study","volume":"9","author":"Schnitzler","year":"1994","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(23)00353-4_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.nut.2023.112151","article-title":"Supplementation of vitamin D isolated or calcium-associated with bone remodeling and fracture risk in postmenopausal women without osteoporosis: a systematic review of randomized clinical trials","volume":"116","author":"Reis","year":"2023","journal-title":"Nutrition"},{"key":"10.1016\/S2213-8587(23)00353-4_bib8","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1002\/jbmr.4888","article-title":"Health effects of vitamin D supplementation: lessons learned from randomized controlled trials and Mendelian randomization studies","volume":"38","author":"Bouillon","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(23)00353-4_bib9","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.ajcnut.2023.05.028","article-title":"Vitamin D supplementation for improving bone density in vitamin D-deficient children and adolescents: systematic review and individual participant data meta-analysis of randomized controlled trials","volume":"118","author":"Wu","year":"2023","journal-title":"Am J Clin Nutr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T21:04:34Z","timestamp":1741208674000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003534"}},"issued":{"date-parts":[[2024,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213858723003534"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00353-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The role of vitamin D in paediatric bone health","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00353-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00317-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T02:42:05Z","timestamp":1793414525636,"version":"4.5.0"},"reference-count":94,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/s2213-8587(16)30041-9","type":"journal-article","created":{"date-parts":[[2016,5,28]],"date-time":"2016-05-28T20:51:10Z","timestamp":1464468670000},"page":"850-861","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":381,"title":["Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel"],"prefix":"10.1016","volume":"4","author":[{"given":"Raul D","family":"Santos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel S","family":"Gidding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marina A","family":"Cuchel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip J","family":"Barter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth J","family":"Baum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberico L","family":"Catapano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M John","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joep C","family":"Defesche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emanuela","family":"Folco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Freiberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacques","family":"Genest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Kees","family":"Hovingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariko","family":"Harada-Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ann S","family":"Jackson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Mata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrick M","family":"Moriarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick J","family":"Raal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khalid","family":"Al-Rasadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kausik K","family":"Ray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zelijko","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric J G","family":"Sijbrands","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shizuya","family":"Yamashita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30041-9_bib1","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1161\/CIR.0000000000000297","article-title":"The agenda for familial hypercholesterolemia: a scientific statement from the American Heart Association","volume":"132","author":"Gidding","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)30041-9_bib2","doi-asserted-by":"crossref","first-page":"3956","DOI":"10.1210\/jc.2012-1563","article-title":"Familial hypercholesterolemia in the Danish general population: prevalence, coronary artery disease, and cholesterol-lowering medication","volume":"97","author":"Benn","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30041-9_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.jacl.2014.01.002","article-title":"Integrated guidance on the care of familial hypercholesterolemia from the International FH Foundation","volume":"8","author":"Watts","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib4","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management\u2014a position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30041-9_bib5","doi-asserted-by":"crossref","first-page":"3478","DOI":"10.1093\/eurheartj\/eht273","article-title":"Familial hypercholesterolaemia is underdiagnosed and undertreated in the general population: guidance for clinicians to prevent coronary heart disease: consensus statement of the European Atherosclerosis Society","volume":"34","author":"Nordestgaard","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30041-9_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.atherosclerosis.2014.11.015","article-title":"Prevalence and clinical correlates of familial hypercholesterolemia founder mutations in the general population","volume":"238","author":"Lahtinen","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30041-9_bib7","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1016\/j.atherosclerosis.2012.02.019","article-title":"Homozygous familial hypercholesterolemia: current perspectives on diagnosis and treatment","volume":"223","author":"Raal","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30041-9_bib8","doi-asserted-by":"crossref","first-page":"560","DOI":"10.1093\/eurheartj\/ehu058","article-title":"Homozygous autosomal dominant hypercholesterolaemia in the Netherlands: prevalence, genotype-phenotype relationship, and clinical outcome","volume":"36","author":"Sjouke","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30041-9_bib9","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1093\/aje\/kwh237","article-title":"Familial hypercholesterolemia and coronary heart disease: a HuGE association review","volume":"160","author":"Austin","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib10","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jacl.2014.09.005","article-title":"The doctor's dilemma: challenges in the diagnosis and care of homozygous familial hypercholesterolemia","volume":"8","author":"Baum","year":"2014","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib11","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1016\/j.atherosclerosis.2013.01.007","article-title":"Spectrum of mutations and phenotypic expression in patients with autosomal dominant hypercholesterolemia identified in Italy","volume":"227","author":"Bertolini","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30041-9_bib12","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1016\/S0140-6736(10)60284-X","article-title":"Mipomersen, an apolipoprotein B synthesis inhibitor, for lowering of LDL cholesterol concentrations in patients with homozygous familial hypercholesterolaemia: a randomised, double-blind, placebo-controlled trial","volume":"375","author":"Raal","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30041-9_bib13","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","article-title":"Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30041-9_bib14","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/S0140-6736(14)61399-4","article-title":"PCSK9 inhibition with evolocumab (AMG 145) in heterozygous familial hypercholesterolaemia (RUTHERFORD-2): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30041-9_bib15","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1016\/S0140-6736(12)62127-8","article-title":"Use of low-density lipoprotein cholesterol gene score to distinguish patients with polygenic and monogenic familial hypercholesterolaemia: a case-control study","volume":"381","author":"Talmud","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30041-9_bib16","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1373\/clinchem.2014.231365","article-title":"Refinement of variant selection for the LDL cholesterol genetic risk score in the diagnosis of the polygenic form of clinical familial hypercholesterolemia and replication in samples from 6 countries","volume":"61","author":"Futema","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(16)30041-9_bib17","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1093\/eurheartj\/ehl366","article-title":"Influence of LDL-receptor mutation type on age at first cardiovascular event in patients with familial hypercholesterolaemia","volume":"28","author":"Souverein","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30041-9_bib18","doi-asserted-by":"crossref","first-page":"2625","DOI":"10.1093\/eurheartj\/ehn422","article-title":"Reductions in all-cause, cancer, and coronary mortality in statin-treated patients with heterozygous familial hypercholesterolaemia: a prospective registry study","volume":"29","author":"Neil","year":"2008","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30041-9_bib19","doi-asserted-by":"crossref","first-page":"788","DOI":"10.1001\/jama.2012.9624","article-title":"Comparison of novel risk markers for improvement in cardiovascular risk assessment in intermediate-risk individuals","volume":"308","author":"Yeboah","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30041-9_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1093\/eurheartj\/ehu358","volume":"36","author":"Cho","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30041-9_bib21","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1016\/j.amjcard.2014.12.034","article-title":"Assessment of coronary atherosclerosis in patients with familial hypercholesterolemia by coronary computed tomography angiography","volume":"115","author":"Tada","year":"2015","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib22","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1016\/j.atherosclerosis.2013.12.020","article-title":"Severe heterozygous familial hypercholesterolemia and risk for cardiovascular disease: a study of a cohort of 14\u2008000 mutation carriers","volume":"233","author":"Besseling","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30041-9_bib23","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1161\/ATVBAHA.114.304549","article-title":"Mipomersen, an antisense oligonucleotide to apolipoprotein B-100, reduces lipoprotein(a) in various populations with hypercholesterolemia: results of 4 phase III trials","volume":"35","author":"Santos","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib24","first-page":"2996","article-title":"ODYSSEY FH I and FH II: 78 week results with alirocumab treatment in 735 patients with heterozygous familial hypercholesterolaemia","volume":"36","author":"Kastelein","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30041-9_bib25","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1007\/s40273-015-0355-y","article-title":"PCSK9 inhibitors: a technology worth paying for?","volume":"34","author":"Weintraub","year":"2016","journal-title":"PharmacoEconomics"},{"key":"10.1016\/S2213-8587(16)30041-9_bib26","doi-asserted-by":"crossref","first-page":"2185","DOI":"10.1016\/j.jacc.2013.07.083","article-title":"Lipid control in the modern era: an orphan's tale of rags to riches","volume":"62","author":"Milani","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib27","first-page":"2499","article-title":"Lipid-related markers and cardiovascular disease prediction","volume":"307","author":"Di Angelantonio","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30041-9_bib28","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1038\/nature09270","article-title":"Biological, clinical and population relevance of 95 loci for blood lipids","volume":"466","author":"Teslovich","year":"2010","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)30041-9_bib29","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30041-9_bib30","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/j.jacc.2012.09.017","article-title":"Effect of long-term exposure to lower low-density lipoprotein cholesterol beginning early in life on the risk of coronary heart disease: a Mendelian randomization analysis","volume":"60","author":"Ference","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib31","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170,000 participants in 26 randomised trials","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30041-9_bib32","first-page":"1476","article-title":"Ezetimibe plus a statin after acute coronary syndromes","volume":"373","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30041-9_bib33","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1210\/jc.2009-0141","article-title":"Genetic and metabolic determinants of plasma PCSK9 levels","volume":"94","author":"Lakoski","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl","key":"10.1016\/S2213-8587(16)30041-9_bib34","doi-asserted-by":"crossref","first-page":"S172","DOI":"10.1194\/jlr.R800091-JLR200","article-title":"PCSK9: a convertase that coordinates LDL catabolism","volume":"50","author":"Horton","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(16)30041-9_bib35","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/j.amjcard.2008.07.035","article-title":"Longitudinal evaluation and assessment of cardiovascular disease in patients with homozygous familial hypercholesterolemia","volume":"102","author":"Kolansky","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib36","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1016\/j.atherosclerosissup.2015.02.002","article-title":"Managing homozygous familial hypercholesterolaemia from cradle to grave","volume":"18","author":"Thompson","year":"2015","journal-title":"Atheroscler Suppl"},{"key":"10.1016\/S2213-8587(16)30041-9_bib37","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1136\/bmj.303.6807.893","article-title":"Risk of fatal coronary heart disease in familial hypercholesterolaemia","volume":"303","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)30041-9_bib38","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1038\/nature13917","article-title":"Exome sequencing identifies rare LDLR and APOA5 alleles conferring risk for myocardial infarction","volume":"518","author":"Do","year":"2015","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)30041-9_bib39","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1093\/eurheartj\/ehv289","article-title":"Prevalence and management of familial hypercholesterolaemia in patients with acute coronary syndromes","volume":"36","author":"Nanchen","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30041-9_bib40","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)30041-9_bib41","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.atherosclerosis.2015.09.029","article-title":"Improved cardiovascular outcomes following temporal advances in lipid-lowering therapy in a genetically-characterised cohort of familial hypercholesterolaemia homozygotes","volume":"243","author":"Thompson","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30041-9_bib42","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1007\/s11883-014-0465-6","article-title":"Lipoprotein apheresis in the management of familial hypercholesterolaemia: historical perspective and recent advances","volume":"17","author":"Stefanutti","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/S2213-8587(16)30041-9_bib43","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/j.atherosclerosis.2009.09.014","article-title":"Evaluation of cholesterol lowering treatment of patients with familial hypercholesterolemia: a large cross-sectional study in the Netherlands","volume":"209","author":"Pijlman","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30041-9_bib44","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.1016\/j.jacc.2016.01.008","article-title":"Attainment of LDL-cholesterol treatment goals in patients with familial hypercholesterolemia: 5-year SAFEHEART Registry follow-up","volume":"67","author":"Perez de Isla","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib45","doi-asserted-by":"crossref","first-page":"2425","DOI":"10.1093\/eurheartj\/ehv157","article-title":"Familial hypercholesterolaemia in children and adolescents: gaining decades of life by optimizing detection and treatment","volume":"36","author":"Wiegman","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30041-9_bib46","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s11883-015-0491-z","article-title":"Genetics of familial hypercholesterolemia","volume":"17","author":"Brautbar","year":"2015","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/S2213-8587(16)30041-9_bib47","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.1016\/0140-6736(93)90815-X","article-title":"Mutations of low-density-lipoprotein-receptor gene, variation in plasma cholesterol, and expression of coronary heart disease in homozygous familial hypercholesterolaemia","volume":"341","author":"Moorjani","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30041-9_bib48","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1161\/CIRCULATIONAHA.110.979450","article-title":"Molecular basis of autosomal dominant hypercholesterolemia: assessment in a large cohort of hypercholesterolemic children","volume":"123","author":"van der Graaf","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)30041-9_bib49","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1258\/acb.2010.010089","article-title":"A double heterozygote for familial hypercholesterolaemia and familial defective apolipoprotein B-100","volume":"47","author":"Taylor","year":"2010","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/S2213-8587(16)30041-9_bib50","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1161\/01.ATV.11.5.1137","article-title":"Type III dyslipoproteinemia in patients heterozygous for familial hypercholesterolemia and apolipoprotein E2: evidence for a gene-gene interaction","volume":"11","author":"Hopkins","year":"1991","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib51","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1161\/01.ATV.11.5.1349","article-title":"Effects of three genetic loci in a pedigree with multiple lipoprotein phenotypes","volume":"11","author":"Emi","year":"1991","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib52","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.atherosclerosis.2015.12.033","article-title":"Clinical phenotype in relation to the distance-to-index-patient in familial hypercholesterolemia","volume":"246","author":"Besseling","year":"2015","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30041-9_bib53","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1136\/bmj.322.7293.1019","article-title":"Mortality over two centuries in large pedigree with familial hypercholesterolaemia: family tree mortality study","volume":"322","author":"Sijbrands","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)30041-9_bib54","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1001\/jama.1986.03370020065029","article-title":"Evidence that men with familial hypercholesterolemia can avoid early coronary death: an analysis of 77 gene carriers in four Utah pedigrees","volume":"255","author":"Williams","year":"1986","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30041-9_bib55","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1258\/acb.2009.009004","article-title":"Hypobetalipoproteinaemia secondary to chronic hepatitis C virus infection in a patient with familial hypercholesterolaemia","volume":"46","author":"Bima","year":"2009","journal-title":"Ann Clin Biochem"},{"key":"10.1016\/S2213-8587(16)30041-9_bib56","doi-asserted-by":"crossref","first-page":"718","DOI":"10.4161\/epi.27981","article-title":"Epipolymorphisms within lipoprotein genes contribute independently to plasma lipid levels in familial hypercholesterolemia","volume":"9","author":"Guay","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/S2213-8587(16)30041-9_bib57","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1161\/01.ATV.18.6.1007","article-title":"Association of specific LDL receptor gene mutations with differential plasma lipoprotein response to simvastatin in young French Canadians with heterozygous familial hypercholesterolemia","volume":"18","author":"Couture","year":"1998","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib58","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1016\/j.atherosclerosis.2013.12.028","article-title":"Presence and type of low density lipoprotein receptor (LDLR) mutation influences the lipid profile and response to lipid-lowering therapy in Brazilian patients with heterozygous familial hypercholesterolemia","volume":"233","author":"Santos","year":"2014","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30041-9_bib59","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1038\/clpt.2014.82","article-title":"Pharmacogenomics, lipid disorders, and treatment options","volume":"96","author":"Gryn","year":"2014","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S2213-8587(16)30041-9_bib60","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(14)61374-X","article-title":"Inhibition of PCSK9 with evolocumab in homozygous familial hypercholesterolaemia (TESLA Part B): a randomised, double-blind, placebo-controlled trial","volume":"385","author":"Raal","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30041-9_bib61","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1161\/01.CIR.92.3.290","article-title":"Coronary artery disease in heterozygous familial hypercholesterolemia patients with the same LDL receptor gene mutation","volume":"92","author":"Ferrieres","year":"1995","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)30041-9_bib62","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib63","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1111\/j.1365-2796.2004.01405.x","article-title":"The contribution of classical risk factors to cardiovascular disease in familial hypercholesterolaemia: data in 2400 patients","volume":"256","author":"Jansen","year":"2004","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(16)30041-9_bib64","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1016\/j.ijcard.2015.08.146","article-title":"Elevated lipoprotein(a), hypertension and renal insufficiency as predictors of coronary artery disease in patients with genetically confirmed heterozygous familial hypercholesterolemia","volume":"201","author":"Chan","year":"2015","journal-title":"Int J Cardiol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib65","doi-asserted-by":"crossref","first-page":"1960","DOI":"10.1161\/01.ATV.0000177811.14176.2b","article-title":"Tendon xanthomas in familial hypercholesterolemia are associated with cardiovascular risk independently of the low-density lipoprotein receptor gene mutation","volume":"25","author":"Civeira","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib66","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1056\/NEJM199005243222104","article-title":"Relation of serum lipoprotein(a) concentration and apolipoprotein(a) phenotype to coronary heart disease in patients with familial hypercholesterolemia","volume":"322","author":"Seed","year":"1990","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30041-9_bib67","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)30042-0","article-title":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","author":"Langsted","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib68","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/jama.2009.1063","article-title":"Lipoprotein(a) concentration and the risk of coronary heart disease, stroke, and nonvascular mortality","volume":"302","author":"Erqou","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30041-9_bib69","doi-asserted-by":"crossref","first-page":"2518","DOI":"10.1056\/NEJMoa0902604","article-title":"Genetic variants associated with Lp(a) lipoprotein level and coronary disease","volume":"361","author":"Clarke","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30041-9_bib70","doi-asserted-by":"crossref","first-page":"2331","DOI":"10.1001\/jama.2009.801","article-title":"Genetically elevated lipoprotein(a) and increased risk of myocardial infarction","volume":"301","author":"Kamstrup","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30041-9_bib71","doi-asserted-by":"crossref","first-page":"2844","DOI":"10.1093\/eurheartj\/ehq386","article-title":"Lipoprotein(a) as a cardiovascular risk factor: current status","volume":"31","author":"Nordestgaard","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30041-9_bib72","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1016\/j.jacc.2013.12.049","article-title":"Lipoprotein(a) and cardiovascular disease in heterozygous familial hypercholesterolemia: should we also blame the LDL receptor?","volume":"63","author":"Santos","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib73","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1161\/01.ATV.20.2.522","article-title":"Lipoprotein(a) in homozygous familial hypercholesterolemia","volume":"20","author":"Kraft","year":"2000","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib74","doi-asserted-by":"crossref","first-page":"11649","DOI":"10.1074\/jbc.M114.611988","article-title":"Lipoprotein(a) catabolism is regulated by proprotein convertase subtilisin\/kexin type 9 through the low density lipoprotein receptor","volume":"290","author":"Romagnuolo","year":"2015","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(16)30041-9_bib75","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1111\/joim.12335","article-title":"Lipoprotein(a) levels are associated with aortic valve calcification in asymptomatic patients with familial hypercholesterolaemia","volume":"278","author":"Vongpromek","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(16)30041-9_bib76","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1097\/MOL.0000000000000249","article-title":"Cardiac computed tomography imaging in familial hypercholesterolaemia: implications for therapy and clinical trials","volume":"26","author":"Sijbrands","year":"2015","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib77","doi-asserted-by":"crossref","first-page":"1643","DOI":"10.1016\/j.jacc.2015.08.035","volume":"66","author":"McClelland","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib78","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S0735-1097(01)01364-X","article-title":"Screening patients with chest pain in the emergency department using electron beam tomography: a follow-up study","volume":"38","author":"Georgiou","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib79","doi-asserted-by":"crossref","first-page":"3277","DOI":"10.1093\/eurheartj\/eht293","article-title":"Prognostic value of coronary computed tomography angiography during 5 years of follow-up in patients with suspected coronary artery disease","volume":"34","author":"Hadamitzky","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30041-9_bib80","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1161\/ATVBAHA.114.304351","volume":"35","author":"Chow","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib81","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.jcct.2015.12.005","article-title":"Long term prognostic utility of coronary CT angiography in patients with no modifiable coronary artery disease risk factors: results from the 5 year follow-up of the CONFIRM International Multicenter Registry","volume":"10","author":"Cheruvu","year":"2016","journal-title":"J Cardiovasc Comput Tomogr"},{"key":"10.1016\/S2213-8587(16)30041-9_bib82","doi-asserted-by":"crossref","first-page":"2580","DOI":"10.1161\/01.CIR.98.23.2580","article-title":"Usefulness of electron beam tomography in adolescents and young adults with heterozygous familial hypercholesterolemia","volume":"98","author":"Gidding","year":"1998","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)30041-9_bib83","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1016\/j.atherosclerosis.2010.10.001","article-title":"Evaluation of subclinical atherosclerosis by computed tomography coronary angiography and its association with risk factors in familial hypercholesterolemia","volume":"213","author":"Miname","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30041-9_bib84","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.atherosclerosis.2011.09.052","article-title":"Accelerated subclinical coronary atherosclerosis in patients with familial hypercholesterolemia","volume":"219","author":"Neefjes","year":"2011","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30041-9_bib85","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1016\/j.atherosclerosis.2007.08.017","article-title":"Non-invasive detection of aortic and coronary atherosclerosis in homozygous familial hypercholesterolemia by 64 slice multi-detector row computed tomography angiography","volume":"197","author":"Santos","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30041-9_bib87","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1093\/eurheartj\/eht549","article-title":"Long-term efficacy and safety of mipomersen in patients with familial hypercholesterolaemia: 2-year interim results of an open-label extension","volume":"36","author":"Santos","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30041-9_bib88","doi-asserted-by":"crossref","first-page":"a2423","DOI":"10.1136\/bmj.a2423","article-title":"Efficacy of statins in familial hypercholesterolaemia: a long term cohort study","volume":"337","author":"Versmissen","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)30041-9_bib89","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1016\/j.jacl.2011.12.003","article-title":"The use of lipopheresis in the practice of clinical lipidology","volume":"6","author":"Brown","year":"2012","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib90","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/S0140-6736(14)61702-5","article-title":"Familial hypercholesterolaemia: PCSK9 inhibitors are coming","volume":"385","author":"Santos","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30041-9_bib91","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1016\/j.atherosclerosis.2009.06.010","article-title":"Efficacy criteria and cholesterol targets for LDL apheresis","volume":"208","author":"Thompson","year":"2010","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(16)30041-9_bib92","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/j.1537-2995.2009.02135.x","article-title":"Aorta and coronary angiographic follow-up of children with severe hypercholesterolemia treated with low-density lipoprotein apheresis","volume":"49","author":"Stefanutti","year":"2009","journal-title":"Transfusion"},{"key":"10.1016\/S2213-8587(16)30041-9_bib93","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0002-9149(98)00692-4","article-title":"Long-term efficacy of low-density lipoprotein apheresis on coronary heart disease in familial hypercholesterolemia","volume":"82","author":"Mabuchi","year":"1998","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(16)30041-9_bib94","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1161\/CIRCRESAHA.115.304008","article-title":"AAV vectors expressing LDLR gain-of-function variants demonstrate increased efficacy in mouse models of familial hypercholesterolemia","volume":"115","author":"Somanathan","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(16)30041-9_bib95","doi-asserted-by":"crossref","first-page":"13231","DOI":"10.1038\/srep13231","article-title":"Restoration of physiologically responsive low-density lipoprotein receptor-mediated endocytosis in genetically deficient induced pluripotent stem cells","volume":"5","author":"Ramakrishnan","year":"2015","journal-title":"Sci Rep"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(26)00135-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:12:27Z","timestamp":1781583147000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716300419"}},"issued":{"date-parts":[[2016,10]]},"references-count":94,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2213858716300419"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30041-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining severe familial hypercholesterolaemia and the implications for clinical management: a consensus statement from the International Atherosclerosis Society Severe Familial Hypercholesterolemia Panel","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30041-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T01:08:41Z","timestamp":1793840921769,"version":"4.6.1"},"update-to":[{"DOI":"10.1016\/s2213-8587(21)00263-1","type":"retraction","label":"Retraction","source":"retraction-watch","updated":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"record-id":"49985"},{"DOI":"10.1016\/s2213-8587(21)00263-1","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}},{"DOI":"10.1016\/s2213-8587(23)00287-5","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}},{"DOI":"10.1016\/s2213-8587(21)00282-5","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,27]],"date-time":"2023-11-27T00:00:00Z","timestamp":1701043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/s2213-8587(23)00364-9","type":"journal-article","created":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T23:32:55Z","timestamp":1701473575000},"page":"8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Retraction and republication\u2014Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses"],"prefix":"10.1016","volume":"12","author":[{"family":"The Editors of The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00364-9_bib1","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S2213-8587(21)00263-1","article-title":"Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses","volume":"9","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00364-9_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S2213-8587(22)00345-X","article-title":"Mendelian randomisation and vitamin D: the importance of model assumptions","volume":"11","author":"Smith","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00364-9_bib3","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/S2213-8587(22)00342-4","article-title":"Mendelian randomisation and vitamin D: the importance of model assumptions","volume":"11","author":"Butler-Laporte","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00364-9_bib4","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(22)00344-8","article-title":"Mendelian randomisation and vitamin D: the importance of model assumptions\u2014Authors' reply","volume":"11","author":"Burgess","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00364-9_bib5","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S2213-8587(23)00198-5","article-title":"Expression of Concern\u2014Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses","volume":"11","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00364-9_bib6","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1016\/S2213-8587(21)00282-5","article-title":"Targeting of vitamin D supplementation to individuals with deficiency","volume":"12","author":"Butler-Laporte","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00364-9_bib7","article-title":"Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses","year":"2023","journal-title":"Lancet Diabetes Endocrinol"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(21)00263-1","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T21:04:37Z","timestamp":1741208677000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003649"}},"issued":{"date-parts":[[2024,1]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213858723003649"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00364-9","relation":{"retraction":[{"id-type":"doi","id":"10.1016\/S2213-8587(21)00263-1","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Retraction and republication\u2014Estimating dose-response relationships for vitamin D with coronary heart disease, stroke, and all-cause mortality: observational and Mendelian randomisation analyses","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00364-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00263-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00287-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00282-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T00:36:54Z","timestamp":1792975014379,"version":"4.5.0"},"update-to":[{"DOI":"10.1016\/s2213-8587(22)00099-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/s2213-8587(22)00347-3","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T18:30:05Z","timestamp":1671129005000},"page":"e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Correction to Lancet Diabetes Endocrinol 2022; 10: 489\u201398"],"prefix":"10.1016","volume":"11","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003473?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003473?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:57Z","timestamp":1761991917000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003473"}},"issued":{"date-parts":[[2023,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213858722003473"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00347-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2022; 10: 489\u201398","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00347-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00099-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:30:24Z","timestamp":1793316624224,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100007885","name":"European Association for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001065","name":"Australian Diabetes Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001065","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001782","name":"The University of Melbourne","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001782","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015539","name":"Commonwealth of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015539","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/s2213-8587(25)00031-2","type":"journal-article","created":{"date-parts":[[2025,2,19]],"date-time":"2025-02-19T23:36:13Z","timestamp":1740008173000},"page":"270-272","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["When glucose time in range is not tight, is it lax? Considering new terminology for CGM targets"],"prefix":"10.1016","volume":"13","author":[{"given":"Ray","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mervyn","family":"Kyi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"O'Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerry","family":"Rayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spiros","family":"Fourlanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00031-2_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00031-2_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/S2213-8587(22)00319-9","article-title":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","volume":"11","author":"Battelino","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00031-2_bib3","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1007\/s00125-024-06171-y","article-title":"The association of chronic complications with time in tight range and time in range in people with type 1 diabetes: a retrospective cross-sectional real-world study","volume":"67","author":"De Meulemeester","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00031-2_bib4","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1089\/dia.2023.0380","article-title":"A comparison of continuous glucose monitoring-measured time-in-range 70\u2013180 mg\/dL versus time-in-tight-range 70-140\u2008mg\/dL","volume":"26","author":"Beck","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(25)00031-2_bib5","article-title":"What is the relationship between time in range, time in tight range, and HbA1c in youth and young adults with type 1 diabetes? Results from the German\/Austrian\/Luxembourgian\/Swiss Diabetes Prospective Follow-Up Registry","volume":"16","author":"Burckhardt","year":"2024","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(25)00031-2_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1089\/dia.2023.0565","article-title":"Is it time to move beyond TIR to TITR? Real-world data from over 20,000 users of continuous glucose monitoring in patients with type 1 and type 2 diabetes","volume":"26","author":"Dunn","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(25)00031-2_bib7","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1089\/dia.2023.0373","article-title":"Aiming for the best glycemic control beyond time in range: time in tight range as a new continuous glucose monitoring metric in children and adolescents with type 1 diabetes using different treatment modalities","volume":"26","author":"Passanisi","year":"2024","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(25)00031-2_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3826","article-title":"Time in tight range in children and adolescents with type 1 diabetes: a cross-sectional observational single centre study evaluating efficacy of new advanced technologies","volume":"40","author":"Schiaffini","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(25)00031-2_bib9","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15423","article-title":"'We're taught green is good\u2019: perspectives on time in range and time in tight range from youth with type 1 diabetes, and parents of youth with type 1 diabetes","volume":"41","author":"Tanenbaum","year":"2024","journal-title":"Diabet Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00031-2_bib10","first-page":"S295","article-title":"16. diabetes care in the hospital: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000312?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000312?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T20:14:17Z","timestamp":1747426457000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000312"}},"issued":{"date-parts":[[2025,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2213858725000312"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00031-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"When glucose time in range is not tight, is it lax? Considering new terminology for CGM targets","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00031-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:34:43Z","timestamp":1793295283384,"version":"4.5.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/s2213-8587(25)00161-5","type":"journal-article","created":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T18:34:46Z","timestamp":1748543686000},"page":"547-549","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["New drug approved for hyperphagia in Prader\u2013Willi syndrome"],"prefix":"10.1016","volume":"13","author":[{"given":"Merlin G","family":"Butler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00161-5_bib1","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24054271","article-title":"Prader-Willi syndrome and chromosome 15q11.2 BP1-BP2 region: a review","volume":"24","author":"Butler","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(25)00161-5_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ajmg.1320350306","article-title":"Prader-Willi syndrome: current understanding of cause and diagnosis","volume":"35","author":"Butler","year":"1990","journal-title":"Am J Med Genet"},{"key":"10.1016\/S2213-8587(25)00161-5_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(25)00161-5_bib5","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/gim.2016.178","article-title":"Causes of death in Prader-Willi syndrome: Prader-Willi Syndrome Association (USA) 40-year mortality survey","volume":"19","author":"Butler","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(25)00161-5_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jmedgenet-2018-105301","article-title":"Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study","volume":"56","author":"Butler","year":"2019","journal-title":"J Med Genet"},{"key":"10.1016\/S2213-8587(25)00161-5_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader-Willi syndrome\u2014clinical genetics, diagnosis and treatment approaches: an update","volume":"15","author":"Butler","year":"2019","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/S2213-8587(25)00161-5_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijms24032150","article-title":"Clinical trials in Prader-Willi syndrome: a review","volume":"24","author":"Mahmoud","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(25)00161-5_bib9","doi-asserted-by":"crossref","first-page":"1676","DOI":"10.1210\/clinem\/dgad014","article-title":"Diazoxide choline extended-release tablet in people with Prader-Willi syndrome: a double-blind, placebo-controlled trial","volume":"108","author":"Miller","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00161-5_bib10","doi-asserted-by":"crossref","first-page":"450","DOI":"10.3390\/genes11040450","article-title":"The potential role of activating the ATP-sensitive potassium channel in the treatment of hyperphagic obesity","volume":"11","author":"Cowen","year":"2020","journal-title":"Genes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001615?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001615?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:26:23Z","timestamp":1766525183000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725001615"}},"issued":{"date-parts":[[2025,7]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S2213858725001615"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00161-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New drug approved for hyperphagia in Prader\u2013Willi syndrome","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00161-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T19:45:40Z","timestamp":1794512740113,"version":"4.9.1"},"reference-count":46,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/s2213-8587(22)00317-5","type":"journal-article","created":{"date-parts":[[2022,11,30]],"date-time":"2022-11-30T02:05:19Z","timestamp":1669773919000},"page":"58-62","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":70,"title":["Treating chronic diseases without tackling excess adiposity promotes multimorbidity"],"prefix":"10.1016","volume":"11","author":[{"given":"Naveed","family":"Sattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J V","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iain B","family":"McInnes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanita R","family":"Aroda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mike E J","family":"Lean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00317-5_bib1","series-title":"Body weight modification interventions for chronic non-cancer pain: a review of clinical effectiveness","author":"Li","year":"2020"},{"key":"10.1016\/S2213-8587(22)00317-5_bib3","article-title":"Depression and metabolic syndrome: a narrative review","volume":"14","author":"Al-Khatib","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/S2213-8587(22)00317-5_bib4","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(19)32007-0","article-title":"Variations in common diseases, hospital admissions, and deaths in middle-aged adults in 21 countries from five continents (PURE): a prospective cohort study","volume":"395","author":"Dagenais","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00317-5_bib5","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/S2213-8587(21)00288-6","article-title":"Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records","volume":"10","author":"Pearson-Stuttard","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00317-5_bib6","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the decrease in U.S. deaths from coronary disease, 1980\u20132000","volume":"356","author":"Ford","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00317-5_bib7","doi-asserted-by":"crossref","first-page":"3227","DOI":"10.1093\/eurheartj\/ehab484","article-title":"2021 ESC Guidelines on cardiovascular disease prevention in clinical practice","volume":"42","author":"Visseren","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(22)00317-5_bib8","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00317-5_bib9","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1136\/annrheumdis-2019-216656","article-title":"Efficacy of pharmacological treatment in rheumatoid arthritis: a systematic literature research informing the 2019 update of the EULAR recommendations for management of rheumatoid arthritis","volume":"79","author":"Kerschbaumer","year":"2020","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S2213-8587(22)00317-5_bib10","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(20)30748-0","article-title":"Estimating lifetime benefits of comprehensive disease-modifying pharmacological therapies in patients with heart failure with reduced ejection fraction: a comparative analysis of three randomised controlled trials","volume":"396","author":"Vaduganathan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00317-5_bib11","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(07)60361-4","article-title":"Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995\u20132005: a population-based study","volume":"369","author":"Lipscombe","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00317-5_bib12","doi-asserted-by":"crossref","first-page":"c154","DOI":"10.1136\/bmj.c154","article-title":"Management of obesity: summary of SIGN guideline","volume":"340","author":"Logue","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00317-5_bib14","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/qjmed\/hcv201","article-title":"Changing guards: time to move beyond body mass index for population monitoring of excess adiposity","volume":"109","author":"Tanamas","year":"2016","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(22)00317-5_bib15","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.3945\/ajcn.113.070466","article-title":"Derivation and validation of simple equations to predict total muscle mass from simple anthropometric and demographic data","volume":"100","author":"Al-Gindan","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(22)00317-5_bib16","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s00592-019-01328-3","article-title":"Associations of BMI, waist circumference, body fat, and skeletal muscle with type 2 diabetes in adults","volume":"56","author":"Han","year":"2019","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(22)00317-5_bib17","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S0140-6736(16)30175-1","article-title":"Body-mass index and all-cause mortality: individual-participant-data meta-analysis of 239 prospective studies in four continents","volume":"388","author":"Di Angelantonio","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00317-5_bib18","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1093\/eurheartj\/ehz388","article-title":"Body mass index and body composition in relation to 14 cardiovascular conditions in UK Biobank: a Mendelian randomization study","volume":"41","author":"Larsson","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(22)00317-5_bib19","doi-asserted-by":"crossref","first-page":"4238","DOI":"10.2337\/db15-0254","article-title":"Genetic evidence for a causal role of obesity in diabetic kidney disease","volume":"64","author":"Todd","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00317-5_bib20","article-title":"Disease consequences of higher adiposity uncoupled from its adverse metabolic effects using Mendelian randomisation","volume":"11","author":"Martin","year":"2022","journal-title":"eLife"},{"key":"10.1016\/S2213-8587(22)00317-5_bib21","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12916-021-02188-x","article-title":"Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of Mendelian randomization studies","volume":"19","author":"Larsson","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(22)00317-5_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002739","article-title":"Evidence of a causal relationship between body mass index and psoriasis: a mendelian randomization study","volume":"16","author":"Budu-Aggrey","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(22)00317-5_bib23","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/ije\/dyw051","article-title":"High body mass index and risk of exacerbations and pneumonias in individuals with chronic obstructive pulmonary disease: observational and genetic risk estimates from the Copenhagen General Population Study","volume":"45","author":"\u00c7olak","year":"2016","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(22)00317-5_bib24","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","article-title":"Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5\u00b724 million UK adults","volume":"384","author":"Bhaskaran","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00317-5_bib25","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00317-5_bib26","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1001\/jama.2019.14231","article-title":"Association of metabolic surgery with major adverse cardiovascular outcomes in patients with type 2 diabetes and obesity","volume":"322","author":"Aminian","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00317-5_bib27","doi-asserted-by":"crossref","first-page":"3079","DOI":"10.2337\/dc20-0388","article-title":"Potential benefits and harms of gastric bypass surgery in obese individuals with type 1 diabetes: a nationwide, matched, observational cohort study","volume":"43","author":"H\u00f6skuldsd\u00f3ttir","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00317-5_bib28","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13075-019-1810-5","article-title":"Weight loss improves disease activity in patients with psoriatic arthritis and obesity: an interventional study","volume":"21","author":"Klingberg","year":"2019","journal-title":"Arthritis Res Ther"},{"key":"10.1016\/S2213-8587(22)00317-5_bib29","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1159\/000513664","article-title":"Effect of an intensive weight-loss lifestyle intervention on kidney function: a randomized controlled Trial","volume":"52","author":"D\u00edaz-L\u00f3pez","year":"2021","journal-title":"Am J Nephrol"},{"key":"10.1016\/S2213-8587(22)00317-5_bib30","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.6722","article-title":"Effect of bariatric surgery on risk of complications after total knee arthroplasty: a randomized clinical trial","volume":"5","author":"Dowsey","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(22)00317-5_bib31","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S2213-8587(22)00033-X","article-title":"Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study","volume":"10","author":"Kivim\u00e4ki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00317-5_bib32","doi-asserted-by":"crossref","first-page":"5531","DOI":"10.1002\/ehf2.13517","article-title":"The genomics of heart failure: design and rationale of the HERMES consortium","volume":"8","author":"Lumbers","year":"2021","journal-title":"ESC Heart Fail"},{"key":"10.1016\/S2213-8587(22)00317-5_bib33","first-page":"1","article-title":"Mean body weight, height, and body mass index, United States 1960-2002","volume":"347","author":"Ogden","year":"2004","journal-title":"Adv Data"},{"key":"10.1016\/S2213-8587(22)00317-5_bib34","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1038\/ijo.2013.216","article-title":"Changing distributions of body size and adiposity with age","volume":"38","author":"Vlassopoulos","year":"2014","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(22)00317-5_bib35","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1001\/jama.2012.113905","article-title":"Association of all-cause mortality with overweight and obesity using standard body mass index categories: a systematic review and meta-analysis","volume":"309","author":"Flegal","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00317-5_bib36","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa1703860","article-title":"Simulation of growth trajectories of childhood obesity into adulthood","volume":"377","author":"Ward","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00317-5_bib37","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2352-4642(19)30323-2","article-title":"Global trends in insufficient physical activity among adolescents: a pooled analysis of 298 population-based surveys with 1\u00b76 million participants","volume":"4","author":"Guthold","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/S2213-8587(22)00317-5_bib39","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1038\/s41574-019-0288-1","article-title":"Turning the tables on obesity: young people, IT and social movements","volume":"16","author":"Nikolaou","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(22)00317-5_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-069719","article-title":"Effectiveness of weight management interventions for adults delivered in primary care: systematic review and meta-analysis of randomised controlled trials","volume":"377","author":"Madigan","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00317-5_bib41","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1016\/S0140-6736(11)61344-5","article-title":"Primary care referral to a commercial provider for weight loss treatment versus standard care: a randomised controlled trial","volume":"378","author":"Jebb","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00317-5_bib42","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/jhn.12611","article-title":"Filling the intervention gap: service evaluation of an intensive nonsurgical weight management programme for severe and complex obesity","volume":"32","author":"McCombie","year":"2019","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/S2213-8587(22)00317-5_bib43","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1007\/s00125-020-05224-2","article-title":"Type 2 diabetes remission: 2 year within-trial and lifetime-horizon cost-effectiveness of the Diabetes Remission Clinical Trial (DiRECT)\/Counterweight-Plus weight management programme","volume":"63","author":"Xin","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00317-5_bib44","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1056\/NEJMoa2028198","article-title":"Healthy weight loss maintenance with exercise, liraglutide, or both combined","volume":"384","author":"Lundgren","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00317-5_bib45","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial","volume":"397","author":"Mingrone","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00317-5_bib46","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0140-6736(20)32649-0","article-title":"Metabolic surgery versus conventional medical therapy in patients with type 2 diabetes: 10-year follow-up of an open-label, single-centre, randomised controlled trial","volume":"397","author":"Mingrone","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00317-5_bib47","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1056\/NEJMoa2002449","article-title":"Life expectancy after bariatric surgery in the Swedish obese subjects study","volume":"383","author":"Carlsson","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00317-5_bib48","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00317-5_bib49","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003175?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003175?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:57Z","timestamp":1761991917000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003175"}},"issued":{"date-parts":[[2023,1]]},"references-count":46,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213858722003175"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00317-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treating chronic diseases without tackling excess adiposity promotes multimorbidity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00317-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:18:47Z","timestamp":1794583127382,"version":"4.9.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T00:00:00Z","timestamp":1508803200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/s2213-8587(17)30362-5","type":"journal-article","created":{"date-parts":[[2017,11,30]],"date-time":"2017-11-30T19:01:01Z","timestamp":1512068461000},"page":"122-129","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":400,"title":["Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank"],"prefix":"10.1016","volume":"6","author":[{"given":"Nicholas J","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel E","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael N","family":"Weedon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley M","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Oram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew T","family":"Hattersley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30362-5_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","article-title":"Epidemiology of type 1 diabetes","volume":"39","author":"Maahs","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(17)30362-5_bib2","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1186\/s12889-015-1591-y","article-title":"Global epidemiology of type 1 diabetes in young adults and adults: a systematic review","volume":"15","author":"Diaz-Valencia","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(17)30362-5_bib4","doi-asserted-by":"crossref","first-page":"E315","DOI":"10.3399\/bjgp16X684961","article-title":"Practical Classification Guidelines for Diabetes in patients treated with insulin: a cross-sectional study of the accuracy of diabetes diagnosis","volume":"66","author":"Hope","year":"2016","journal-title":"Br J Gen Pract"},{"key":"10.1016\/S2213-8587(17)30362-5_bib5","doi-asserted-by":"crossref","first-page":"d3319","DOI":"10.1136\/bmj.d3319","article-title":"Diagnosis, classification, and treatment of diabetes","volume":"342","author":"Farmer","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30362-5_bib6","author":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30362-5_bib7","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1111\/dme.12159","article-title":"The clinical utility of C-peptide measurement in the care of patients with diabetes","volume":"30","author":"Jones","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(17)30362-5_bib8","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.2337\/diacare.23.9.1326","article-title":"Genetic, autoimmune, and clinical characteristics of childhood- and adult-onset type 1 diabetes","volume":"23","author":"Sabbah","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30362-5_bib9","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/jc.2009-1365","article-title":"Clinical applications of diabetes antibody testing","volume":"95","author":"Bingley","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30362-5_bib10","doi-asserted-by":"crossref","first-page":"e1000540","DOI":"10.1371\/journal.pgen.1000540","article-title":"Prediction and interaction in complex disease genetics: experience in type 1 diabetes","volume":"5","author":"Clayton","year":"2009","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(17)30362-5_bib11","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1097\/MPG.0b013e31821a23d0","article-title":"European Society for Pediatric Gastroenterology, Hepatology, and Nutrition guidelines for the diagnosis of coeliac disease","volume":"54","author":"Husby","year":"2012","journal-title":"J Pediatr Gastroenterol Nutr"},{"key":"10.1016\/S2213-8587(17)30362-5_bib12","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1111\/j.1572-0241.2002.05471.x","article-title":"HLA-DQ typing in the diagnosis of celiac disease","volume":"97","author":"Kaukinen","year":"2002","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(17)30362-5_bib13","first-page":"1303","article-title":"Ankylosing spondylitis and axial spondyloarthritis","volume":"375","author":"Taurog","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30362-5_bib14","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30362-5_bib15","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ng.2383","article-title":"Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes","volume":"44","author":"Morris","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(17)30362-5_bib16","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/dc15-1111","article-title":"A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults","volume":"39","author":"Oram","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30362-5_bib17","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1007\/s00125-014-3362-1","article-title":"Feature ranking of type 1 diabetes susceptibility genes improves prediction of type 1 diabetes","volume":"57","author":"Winkler","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30362-5_bib18","doi-asserted-by":"crossref","first-page":"2094","DOI":"10.2337\/db15-1690","article-title":"Type 1 diabetes genetic risk score: a novel tool to discriminate monogenic and type 1 diabetes","volume":"65","author":"Patel","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30362-5_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1126\/scitranslmed.3008601","article-title":"UK Biobank data: come and get it","volume":"6","author":"Allen","year":"2014","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(17)30362-5_bib20","doi-asserted-by":"crossref","first-page":"i582","DOI":"10.1136\/bmj.i582","article-title":"Height, body mass index, and socioeconomic status: mendelian randomisation study in UK Biobank","volume":"352","author":"Tyrrell","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30362-5_bib21","doi-asserted-by":"crossref","first-page":"3152","DOI":"10.2337\/db08-0605","article-title":"Two single nucleotide polymorphisms identify the highest-risk diabetes HLA genotype: potential for rapid screening","volume":"57","author":"Barker","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30362-5_bib22","doi-asserted-by":"crossref","first-page":"e0162388","DOI":"10.1371\/journal.pone.0162388","article-title":"Algorithms for the capture and adjudication of prevalent and incident diabetes in UK Biobank","volume":"11","author":"Eastwood","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30362-5_bib23","first-page":"661","article-title":"Genome-wide association study of 14\u2008000 cases of seven common diseases and 3000 shared controls","volume":"447","year":"2007","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(17)30362-5_bib24","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(13)62219-9","article-title":"The many faces of diabetes: a disease with increasing heterogeneity","volume":"383","author":"Tuomi","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30362-5_bib25","doi-asserted-by":"crossref","first-page":"i1224","DOI":"10.1136\/bmj.i1224","article-title":"Can genetic evidence help us understand why height and weight relate to social position?","volume":"352","author":"Davey Smith","year":"2016","journal-title":"BMJ"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(17)30362-5_bib26","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.2337\/dc09-S201","article-title":"The many faces of diabetes in American youth: type 1 and type 2 diabetes in five race and ethnic populations: the SEARCH for Diabetes in Youth Study","volume":"32","author":"Mayer-Davis","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30362-5_bib27","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1016\/S0140-6736(04)17357-1","article-title":"The rising incidence of childhood type 1 diabetes and reduced contribution of high-risk HLA haplotypes","volume":"364","author":"Gillespie","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30362-5_bib28","doi-asserted-by":"crossref","first-page":"2645","DOI":"10.2337\/db11-0364","article-title":"Genetic analysis of adult-onset autoimmune diabetes","volume":"60","author":"Howson","year":"2011","journal-title":"Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303625?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303625?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T04:30:04Z","timestamp":1552969804000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303625"}},"issued":{"date-parts":[[2018,2]]},"references-count":27,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S2213858717303625"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30362-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30362-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30399-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T11:04:59Z","timestamp":1794567899701,"version":"4.9.1"},"reference-count":50,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,8]],"date-time":"2023-09-08T00:00:00Z","timestamp":1694131200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["BCDSA\\\\100005"],"award-info":[{"award-number":["BCDSA\\\\100005"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["NIHR203312"],"award-info":[{"award-number":["NIHR203312"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["116074"],"award-info":[{"award-number":["116074"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018956","name":"NIHR Cambridge Biomedical Research Centre","doi-asserted-by":"publisher","award":["BRC-1215-20014"],"award-info":[{"award-number":["BRC-1215-20014"]}],"id":[{"id":"10.13039\/501100018956","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000269","name":"Economic and Social Research Council","doi-asserted-by":"publisher","award":["ES\/T013192\/1"],"award-info":[{"award-number":["ES\/T013192\/1"]}],"id":[{"id":"10.13039\/501100000269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RG\/18\/13\/33946"],"award-info":[{"award-number":["RG\/18\/13\/33946"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["CH\/12\/2\/29428"],"award-info":[{"award-number":["CH\/12\/2\/29428"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/s2213-8587(23)00223-1","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T18:29:22Z","timestamp":1694456962000},"page":"731-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":235,"title":["Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation"],"prefix":"10.1016","volume":"11","author":[{"given":"S","family":"Kaptoge","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SRK","family":"Seshasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Bolton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Spackman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Ataklte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Willeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Burgess","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Pennells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Altay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Assmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Ben-Shlomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LG","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Bj\u00f6rkelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DG","family":"Blazer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EJ","family":"Brunner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GR","family":"Dagenais","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JA","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CJ","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Sr","given":"RB","family":"D'Agostino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Daimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LB","family":"Daniels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Danker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KW","family":"Davidson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RT","family":"de Jongh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Donfrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ducimetiere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PJM","family":"Elders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Engstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Gallacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SJL","family":"Bakker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"Goldbourt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"de La C\u00e1mara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Grimsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Gudnason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PO","family":"Hansson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Imano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JW","family":"Jukema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Kabrhel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kauhanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kavousi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kiechl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MW","family":"Knuiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kromhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HM","family":"Krumholz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LH","family":"Kuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Laatikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DA","family":"Lowler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HE","family":"Meyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Mukamal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PJ","family":"Nietert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ninomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Nitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BG","family":"Nordestgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JF","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PM","family":"Ridker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Q","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Roussel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Sakurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Salomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Sch\u00f6ttker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JE","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TE","family":"Strandberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Tolonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tverdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WMM","family":"Verschuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Wagenknecht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RB","family":"Wallace","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SG","family":"Wannamethee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"NJ","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Wassertheil-Smoller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BB","family":"Yeap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Harrison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Inouye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AS","family":"Butterworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AM","family":"Wood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SG","family":"Thompson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Danesh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Di Angelantonio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RW","family":"Tipping","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MP","family":"Bancks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Mongraw-Chaffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Magliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"ELM","family":"Barr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PZ","family":"Zimmet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MW","family":"Knuiman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PH","family":"Whincup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Willeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Willeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Leitner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DA","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Ben-Shlomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Elwood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SE","family":"Sutherland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KJ","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RM","family":"Selmer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LL","family":"Haheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Ariansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tybjaer-Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Frikkle-Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Langsted","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Donfrancesco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Lo Noce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Balkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Bonnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Fumeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DL","family":"Pablos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CR","family":"Ferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TG","family":"Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Mclachlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Guralnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"KT","family":"Khaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Brenner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Holleczek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Stocker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Nissinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Palmieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Vartiainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Jousilahti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Harald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JM","family":"Massaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pencina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Lyass","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Susa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Oizumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Kayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Chetrit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Roth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Orenstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Welin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Sv\u00e4rdsudd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Lissner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Hange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Mehlig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Salomaa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RS","family":"Tilvis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Dennison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Westbury","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PE","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"OP","family":"Almeida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"GJ","family":"Hankey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Shibata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MT","family":"Bom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Rutters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Muilwijk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Kraft","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lindstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Turman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Yamagishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Laatikainen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JT","family":"Salonen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LN","family":"van Schoor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"EM","family":"van Zutphen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"WMM","family":"Verschuren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Engstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Melander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"BM","family":"Psaty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Blaha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"IH","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RA","family":"Kronmal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Rosengren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Nitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Grandits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Tverdal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H-C","family":"Shin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JR","family":"Albertorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RF","family":"Gillum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"FB","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JA","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Hill- Briggs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Vrany","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JE","family":"Schwartz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Kitamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Iso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Amouyel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Arveiler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ferrieres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"RT","family":"Gansevoort","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"de Boer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Kieneker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"CJ","family":"Crespo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Assmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Trompet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Cantin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JP","family":"Despr\u00e9s","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Lamarche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Laughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"McEvoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Aspelund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Thorsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Sigurdsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MA","family":"Ikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Dorr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Schipf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AM","family":"Fretts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JG","family":"Umans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Shara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Davey-Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Can","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Y\u00fcksel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"U","family":"\u00d6zkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Nakagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y","family":"Morikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Ishizaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Nj\u00f8lstad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Wilsgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sundstr\u00f6m","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Buring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"V","family":"Arndt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Rothenbacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Manson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Tinker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Shipley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"AG","family":"Tabak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kivimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Packard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Feskens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Geleijnse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Kromhout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00223-1_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2\u00b77 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00223-1_bib2","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants","volume":"387","author":"Zhou","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00223-1_bib3","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jama.2014.11494","article-title":"Prevalence and incidence trends for diagnosed diabetes among adults aged 20 to 79 years, United States, 1980\u20132012","volume":"312","author":"Geiss","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00223-1_bib5","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00223-1_bib6","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S2213-8587(14)70161-5","article-title":"Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985\u20132011: a modelling study","volume":"2","author":"Gregg","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S2213-8587(22)00252-2","article-title":"Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study","volume":"10","author":"Tomic","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib8","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1001\/jama.296.4.421","article-title":"Effect of youth-onset type 2 diabetes mellitus on incidence of end-stage renal disease and mortality in young and middle-aged Pima Indians","volume":"296","author":"Pavkov","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00223-1_bib9","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1111\/j.1464-5491.2010.03075.x","article-title":"A 12-year follow-up study of all-cause and cardiovascular mortality among 10,532 people newly diagnosed with Type 2 diabetes in Tayside, Scotland","volume":"27","author":"Barnett","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00223-1_bib10","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1093\/aje\/kwn342","article-title":"Is relative mortality of type 2 diabetes mellitus decreasing?","volume":"169","author":"Gulliford","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib11","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1001\/jama.2015.7008","article-title":"Association of cardiometabolic multimorbidity with mortality","volume":"314","author":"Di Angelantonio","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00223-1_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.2337\/dc15-0991","article-title":"An inverse relationship between age of type 2 diabetes onset and complication risk and mortality: the impact of youth-onset type 2 diabetes","volume":"39","author":"Al-Saeed","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00223-1_bib13","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.2337\/diacare.23.8.1119","article-title":"Diabetes duration and cause-specific mortality in the Verona Diabetes Study","volume":"23","author":"Brun","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00223-1_bib14","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.atherosclerosis.2012.01.011","article-title":"Duration of type 2 diabetes strongly predicts all-cause and cardiovascular mortality in people referred for coronary angiography","volume":"221","author":"Silbernagel","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(23)00223-1_bib15","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1016\/S2213-8587(18)30050-0","article-title":"Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study","volume":"6","author":"Herrington","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib16","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/archinternmed.2011.2","article-title":"Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors","volume":"171","author":"Wannamethee","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(23)00223-1_bib17","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s00125-018-4544-z","article-title":"Impact of age at diagnosis and duration of type 2 diabetes on mortality in Australia 1997\u20132011","volume":"61","author":"Huo","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00223-1_bib18","doi-asserted-by":"crossref","first-page":"E642","DOI":"10.1210\/jc.2013-3210","article-title":"Improved survival among patients with complicated type 2 diabetes in Denmark: a prospective study (2002\u20132010)","volume":"99","author":"F\u00e6rch","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00223-1_bib19","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/oxfordjournals.aje.a116343","article-title":"An analysis of excess mortality rates for persons with non-insulin-dependent diabetes mellitus in Western Australia using the Cox proportional hazards regression model","volume":"135","author":"Knuiman","year":"1992","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib20","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/j.jfma.2012.09.013","article-title":"Mortality trends in patients with diabetes in Taiwan: a nationwide survey in 2000\u20132009","volume":"111","author":"Li","year":"2012","journal-title":"J Formos Med Assoc"},{"key":"10.1016\/S2213-8587(23)00223-1_bib21","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1111\/dom.12123","article-title":"The incidence of type 2 diabetes in the United Kingdom from 1991 to 2010","volume":"15","author":"Holden","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00223-1_bib22","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1001\/jama.290.14.1884","article-title":"Lifetime risk for diabetes mellitus in the United States","volume":"290","author":"Narayan","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00223-1_bib23","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1136\/postgradmedj-2012-130877","article-title":"Falling mortality rates in type 2 diabetes mellitus in the Wirral Peninsula: a longitudinal and retrospective cohort population-based study","volume":"88","author":"Nwaneri","year":"2012","journal-title":"Postgrad Med J"},{"key":"10.1016\/S2213-8587(23)00223-1_bib24","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(15)00508-2","article-title":"Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study","volume":"4","author":"Huo","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib25","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/CIRCULATIONAHA.118.037885","article-title":"Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks","volume":"139","author":"Sattar","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00223-1_bib26","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.annepidem.2018.08.015","article-title":"State-level diabetes-attributable mortality and years of life lost in the United States","volume":"28","author":"Alva","year":"2018","journal-title":"Ann Epidemiol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib27","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12963-021-00266-z","article-title":"Diabetes free life expectancy and years of life lost associated with type 2 diabetes: projected trends in Germany between 2015 and 2040","volume":"19","author":"T\u00f6nnies","year":"2021","journal-title":"Popul Health Metr"},{"key":"10.1016\/S2213-8587(23)00223-1_bib28","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0268805","article-title":"Trends in lifetime risk and years of potential life lost from diabetes in the United States, 1997\u20132018","volume":"17","author":"Koyama","year":"2022","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(23)00223-1_bib29","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/dc14-1453","article-title":"Life years lost and lifetime health care expenditures associated with diabetes in the U.S., National Health Interview Survey, 1997\u20132000","volume":"38","author":"Leung","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00223-1_bib30","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1007\/s10654-007-9165-7","article-title":"The Emerging Risk Factors Collaboration: analysis of individual data on lipid, inflammatory and other markers in over 1.1 million participants in 104 prospective studies of cardiovascular diseases","volume":"22","year":"2007","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(23)00223-1_bib32","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00223-1_bib33","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1002\/sim.2655","article-title":"Analysing and interpreting competing risk data","volume":"26","author":"Pintilie","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(23)00223-1_bib34","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1002\/sim.2054","article-title":"Testing treatment effects in the presence of competing risks","volume":"24","author":"Freidlin","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(23)00223-1_bib35","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1002\/sim.2944","article-title":"First-event or marginal estimation of cause-specific hazards for analysing correlated multivariate failure-time data?","volume":"27","author":"Tai","year":"2008","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(23)00223-1_bib36","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1093\/ije\/dyq063","article-title":"Statistical methods for the time-to-event analysis of individual participant data from multiple epidemiological studies","volume":"39","author":"Thompson","year":"2010","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib37","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1007\/s10654-019-00494-6","article-title":"Principles of confounder selection","volume":"34","author":"VanderWeele","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib38","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(23)00223-1_bib40","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00223-1_bib41","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di Angelantonio","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00223-1_bib42","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.2337\/diacare.24.9.1522","article-title":"Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset","volume":"24","author":"Hillier","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00223-1_bib43","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-020-05169-6","article-title":"Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes","volume":"63","author":"Wright","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00223-1_bib44","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00125-017-4532-8","article-title":"Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register","volume":"61","author":"Steinarsson","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00223-1_bib45","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00125-014-3369-7","article-title":"Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes","volume":"57","author":"Zoungas","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00223-1_bib46","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib47","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00223-1_bib48","doi-asserted-by":"crossref","first-page":"2192","DOI":"10.1007\/s00125-017-4299-y","article-title":"Effect of screening for type 2 diabetes on risk of cardiovascular disease and mortality: a controlled trial among 139,075 individuals diagnosed with diabetes in Denmark between 2001 and 2009","volume":"60","author":"Simmons","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00223-1_bib49","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2337\/dc13-2101","article-title":"Estimating the delay between onset and diagnosis of type 2 diabetes from the time course of retinopathy prevalence","volume":"37","author":"Porta","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00223-1_bib50","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/S2213-8587(17)30362-5","article-title":"Frequency and phenotype of type 1 diabetes in the first six decades of life: a cross-sectional, genetically stratified survival analysis from UK Biobank","volume":"6","author":"Thomas","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib51","article-title":"A practical guide to handling competing events in etiologic time-to-event studies","volume":"4","author":"Mansournia","year":"2022","journal-title":"Glob Epidemiol"},{"key":"10.1016\/S2213-8587(23)00223-1_bib52","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1097\/EDE.0b013e3181c1ea43","article-title":"The hazards of hazard ratios","volume":"21","author":"Hern\u00e1n","year":"2010","journal-title":"Epidemiology"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:18Z","timestamp":1778858718000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723002231"}},"issued":{"date-parts":[[2023,10]]},"references-count":50,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2213858723002231"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00223-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00223-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00255-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T04:42:16Z","timestamp":1794631336734,"version":"4.9.1"},"reference-count":110,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/s2213-8587(16)30107-3","type":"journal-article","created":{"date-parts":[[2016,10,16]],"date-time":"2016-10-16T03:52:24Z","timestamp":1476589944000},"page":"53-64","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":991,"title":["Influence of maternal obesity on the long-term health of offspring"],"prefix":"10.1016","volume":"5","author":[{"given":"Keith M","family":"Godfrey","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca M","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan L","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moffat","family":"Nyirenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent W V","family":"Jaddoe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johan G","family":"Eriksson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birit F P","family":"Broekman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30107-3_bib1","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1017\/S0029665111003077","article-title":"The consequences of obesity and excess weight gain in pregnancy","volume":"70","author":"Norman","year":"2011","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/S2213-8587(16)30107-3_bib2","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/REP-10-0077","article-title":"Impact of maternal obesity on offspring obesity and cardiometabolic disease risk","volume":"140","author":"Drake","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/S2213-8587(16)30107-3_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1038\/ijo.2009.250","article-title":"A nationally representative study of maternal obesity in England, UK: trends in incidence and demographic inequalities in 619\u2008323 births, 1989\u20132007","volume":"34","author":"Heslehurst","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(16)30107-3_bib4","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1113\/EP085132","article-title":"Determining the consequences of maternal obesity on offspring health","volume":"100","author":"Patel","year":"2015","journal-title":"Exp Physiol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib5","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/humupd\/dmp050","article-title":"Maternal metabolism and obesity: modifiable determinants of pregnancy outcome","volume":"16","author":"Nelson","year":"2010","journal-title":"Hum Reprod Update"},{"key":"10.1016\/S2213-8587(16)30107-3_bib6","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/j.psyneuen.2015.09.019","article-title":"Decreased maternal hypothalamic\u2013pituitary\u2013adrenal axis activity in very severely obese pregnancy: Associations with birthweight and gestation at delivery","volume":"63","author":"Stirrat","year":"2016","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(16)30107-3_bib7","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1159\/000355222","article-title":"The placental exposome: placental determinants of fetal adiposity and postnatal body composition","volume":"63","author":"Lewis","year":"2013","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/S2213-8587(16)30107-3_bib8","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1111\/aogs.12506","article-title":"Childhood consequences of maternal obesity and excessive weight gain during pregnancy","volume":"93","author":"Gaillard","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S2213-8587(16)30107-3_bib9","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1007\/s10654-015-0085-7","article-title":"Maternal obesity during pregnancy and cardiovascular development and disease in the offspring","volume":"30","author":"Gaillard","year":"2015","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib10","doi-asserted-by":"crossref","first-page":"e61627","DOI":"10.1371\/journal.pone.0061627","article-title":"Pre-pregnancy body mass index in relation to infant birth weight and offspring overweight\/obesity: a systematic review and meta-analysis","volume":"8","author":"Yu","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30107-3_bib11","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1007\/s00404-013-3053-z","article-title":"Risk of childhood overweight or obesity associated with excessive weight gain during pregnancy: a meta-analysis","volume":"289","author":"Tie","year":"2014","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/S2213-8587(16)30107-3_bib12","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1161\/HYPERTENSIONAHA.113.02671","article-title":"Childhood cardiometabolic outcomes of maternal obesity during pregnancy: the Generation R Study","volume":"63","author":"Gaillard","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(16)30107-3_bib13","doi-asserted-by":"crossref","first-page":"1303","DOI":"10.3945\/ajcn.2008.27416","article-title":"Perinatal risk factors for childhood obesity and metabolic dysregulation","volume":"90","author":"Catalano","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30107-3_bib14","doi-asserted-by":"crossref","first-page":"e33","DOI":"10.1371\/journal.pmed.0050033","article-title":"Exploring the developmental overnutrition hypothesis using parental\u2013offspring associations and FTO as an instrumental variable","volume":"5","author":"Lawlor","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(16)30107-3_bib15","doi-asserted-by":"crossref","first-page":"368","DOI":"10.3945\/ajcn.114.094268","article-title":"Modifiable early-life risk factors for childhood adiposity and overweight: an analysis of their combined impact and potential for prevention","volume":"101","author":"Robinson","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30107-3_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1038\/ijo.2014.175","article-title":"Maternal weight gain in different periods of pregnancy and childhood cardio-metabolic outcomes. The Generation R Study","volume":"39","author":"Gaillard","year":"2015","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(16)30107-3_bib17","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1161\/CIRCULATIONAHA.109.906081","article-title":"Association of maternal weight gain in pregnancy with offspring obesity and metabolic and vascular traits in childhood","volume":"121","author":"Fraser","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)30107-3_bib18","doi-asserted-by":"crossref","first-page":"1745","DOI":"10.3945\/ajcn.2009.29128","article-title":"Weight gain in pregnancy and childhood body composition: findings from the Southampton Women's Survey","volume":"91","author":"Crozier","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30107-3_bib19","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1097\/AOG.0b013e31818a5d50","article-title":"Maternal gestational weight gain and offspring weight in adolescence","volume":"112","author":"Oken","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib20","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1016\/j.annepidem.2014.08.002","article-title":"A prospective study of maternal prenatal weight and offspring cardiometabolic health in midchildhood","volume":"24","author":"Perng","year":"2014","journal-title":"Ann Epidemiol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib21","doi-asserted-by":"crossref","first-page":"3845","DOI":"10.1210\/jc.2014-1561","article-title":"Maternal prepregnancy BMI, offspring's early postnatal growth, and metabolic profile at age 5\u20136 years: the ABCD Study","volume":"99","author":"Oostvogels","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30107-3_bib22","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1471-0528.2012.03319.x","article-title":"Maternal weight gain during the first half of pregnancy and offspring obesity at 16 years: a prospective cohort study","volume":"119","author":"Laitinen","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/S2213-8587(16)30107-3_bib23","doi-asserted-by":"crossref","first-page":"1381","DOI":"10.1161\/CIRCULATIONAHA.111.070060","article-title":"Associations of maternal prepregnancy body mass index and gestational weight gain with adult offspring cardiometabolic risk factors: the Jerusalem Perinatal Family Follow-up Study","volume":"125","author":"Hochner","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)30107-3_bib24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.3945\/jn.108.100669","article-title":"Maternal anthropometry is associated with the body mass index and waist:height ratio of offspring at 23 years of age","volume":"139","author":"Tequeanes","year":"2009","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(16)30107-3_bib25","doi-asserted-by":"crossref","first-page":"5365","DOI":"10.1210\/jc.2010-0697","article-title":"Maternal BMI, parity and pregnancy weight gain: influences on offspring adiposity in young adulthood","volume":"95","author":"Reynolds","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30107-3_bib26","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1038\/ijo.2009.206","article-title":"Gestational weight gain in relation to offspring body mass index and obesity from infancy through adulthood","volume":"34","author":"Schack-Nielsen","year":"2010","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(16)30107-3_bib27","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1038\/ijo.2014.179","article-title":"Gestational weight gain in normal weight women and offspring cardio-metabolic risk factors at 20 years of age","volume":"39","author":"Hrolfsdottir","year":"2015","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(16)30107-3_bib28","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1007\/s10995-010-0689-1","article-title":"Predictors of obesity in childhood, adolescence, and adulthood in a birth cohort","volume":"15","author":"Rooney","year":"2011","journal-title":"Matern Child Health J"},{"key":"10.1016\/S2213-8587(16)30107-3_bib29","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1161\/CIRCULATIONAHA.108.813436","article-title":"Associations of gestational weight gain with offspring body mass index and blood pressure at 21 years of age: evidence from a birth cohort study","volume":"119","author":"Mamun","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)30107-3_bib30","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1136\/bmj.315.7112.837","article-title":"Mother's weight in pregnancy and coronary heart disease in a cohort of Finnish men: follow up study","volume":"315","author":"Fors\u00e9n","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)30107-3_bib31","doi-asserted-by":"crossref","first-page":"94","DOI":"10.3109\/07853890.2015.1004360","article-title":"Maternal weight in pregnancy and offspring body composition in late adulthood: findings from the Helsinki Birth Cohort Study (HBCS)","volume":"47","author":"Eriksson","year":"2015","journal-title":"Ann Med"},{"key":"10.1016\/S2213-8587(16)30107-3_bib32","doi-asserted-by":"crossref","first-page":"f4539","DOI":"10.1136\/bmj.f4539","article-title":"Maternal obesity during pregnancy and premature mortality from cardiovascular event in adult offspring: follow-up of 1\u2008323\u2008275 person years","volume":"347","author":"Reynolds","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)30107-3_bib33","doi-asserted-by":"crossref","first-page":"434","DOI":"10.3109\/07853890.2014.919728","article-title":"Long-term consequences of maternal overweight in pregnancy on offspring later health: findings from the Helsinki Birth Cohort Study","volume":"46","author":"Eriksson","year":"2014","journal-title":"Ann Med"},{"key":"10.1016\/S2213-8587(16)30107-3_bib34","doi-asserted-by":"crossref","first-page":"1456","DOI":"10.1016\/0002-9378(88)90574-1","article-title":"Maternal physiologic adaptations to early human pregnancy","volume":"159","author":"Clapp","year":"1988","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib35","doi-asserted-by":"crossref","DOI":"10.1111\/all.12876","article-title":"Longitudinal study of maternal body mass index, gestational weight gain, and offspring asthma","author":"Dumas","year":"2016","journal-title":"Allergy"},{"key":"10.1016\/S2213-8587(16)30107-3_bib36","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1136\/thoraxjnl-2012-202556","article-title":"The relationship between maTernal adiposity and infant weight gain, and childhood wheeze and atopy","volume":"68","author":"Pike","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/S2213-8587(16)30107-3_bib37","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/ppe.12013","article-title":"Maternal prepregnancy obesity is an independent risk factor for frequent wheezing in infants by age 14 months","volume":"27","author":"Guerra","year":"2013","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib38","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.jaci.2012.09.008","article-title":"Maternal obesity, gestational weight gain, and risk of asthma and atopic disease in offspring: a study within the Danish National Birth Cohort","volume":"131","author":"Harpsoe","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib39","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1007\/s10995-012-1124-6","article-title":"Subcutaneous body fat in pregnant New Zealand women: association with wheeze in their infants at 18 months","volume":"17","author":"Watson","year":"2013","journal-title":"Matern Child Health J"},{"key":"10.1016\/S2213-8587(16)30107-3_bib40","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1136\/jech.2011.133777","article-title":"Associations between pre-pregnancy obesity and asthma symptoms in adolescents","volume":"66","author":"Patel","year":"2012","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(16)30107-3_bib41","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.1016\/j.jaci.2011.08.025","article-title":"Maternal obesity during pregnancy as a risk for early-life asthma","volume":"128","author":"Lowe","year":"2011","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib42","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1038\/ijo.2009.194","article-title":"Maternal overweight before pregnancy and asthma in offspring followed for 8 years","volume":"34","author":"Scholtens","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(16)30107-3_bib43","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1089\/ped.2010.0032","article-title":"Maternal pre-pregnancy obesity and recurrent wheezing in early childhood","volume":"23","author":"Kumar","year":"2010","journal-title":"Pediatr Allergy Immunol Pulmonol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib44","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1111\/j.1365-3016.2009.01034.x","article-title":"Maternal obesity in pregnancy and respiratory health in early childhood","volume":"23","author":"H\u00e5berg","year":"2009","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib45","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s10995-007-0292-2","article-title":"Maternal pre-pregnancy obesity and diagnosis of asthma in offspring at age 3 years","volume":"12","author":"Reichman","year":"2008","journal-title":"Matern Child Health J"},{"key":"10.1016\/S2213-8587(16)30107-3_bib46","doi-asserted-by":"crossref","first-page":"e535","DOI":"10.1542\/peds.2014-0439","article-title":"Maternal obesity in pregnancy, gestational weight gain, and risk of childhood asthma","volume":"134","author":"Forno","year":"2014","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)30107-3_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.jaci.2014.11.012","article-title":"The gut microbiota and inflammatory noncommunicable diseases: associations and potentials for gut microbiota therapies","volume":"135","author":"West","year":"2015","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib48","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1378\/chest.10-1800","article-title":"Epigenetics and prenatal influences on asthma and allergic airways disease","volume":"139","author":"Martino","year":"2011","journal-title":"Chest"},{"key":"10.1016\/S2213-8587(16)30107-3_bib49","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1038\/pr.2014.169","article-title":"Of the bugs that shape us: maternal obesity, the gut microbiome, and long-term disease risk","volume":"77","author":"Gohir","year":"2015","journal-title":"Pediatr Res"},{"key":"10.1016\/S2213-8587(16)30107-3_bib50","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.immuni.2014.05.014","article-title":"Diet, metabolites, and \u201cwestern-lifestyle\u201d inflammatory diseases","volume":"40","author":"Thorburn","year":"2014","journal-title":"Immunity"},{"key":"10.1016\/S2213-8587(16)30107-3_bib51","doi-asserted-by":"crossref","first-page":"7320","DOI":"10.1038\/ncomms8320","article-title":"Evidence that asthma is a developmental origin disease influenced by maternal diet and bacterial metabolites","volume":"6","author":"Thorburn","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(16)30107-3_bib52","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1016\/j.nut.2014.02.015","article-title":"Does maternal diet during pregnancy and lactation affect outcomes in offspring? A systematic review of food-based approaches","volume":"30","author":"Netting","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/S2213-8587(16)30107-3_bib53","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.jaci.2012.11.019","article-title":"Early-life environmental determinants of allergic diseases and the wider pandemic of inflammatory noncommunicable diseases","volume":"131","author":"Prescott","year":"2013","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib54","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1159\/000375143","article-title":"The global burden of obesity and the challenges of prevention","volume":"66","author":"Seidell","year":"2015","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/S2213-8587(16)30107-3_bib55","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1097\/GCO.0b013e32835e0e82","article-title":"Sepsis and maternal mortality","volume":"2","author":"Acosta","year":"2013","journal-title":"Curr Opin Obstet Gynecol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib56","doi-asserted-by":"crossref","first-page":"1688","DOI":"10.1038\/oby.2009.513","article-title":"The influence of a high-fat dietary environment in the fetal period on postnatal metabolic and immune function","volume":"18","author":"Odaka","year":"2010","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(16)30107-3_bib57","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.4049\/jimmunol.1301057","article-title":"Parental dietary fat intake alters offspring microbiome and immunity","volume":"191","author":"Myles","year":"2013","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib58","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1111\/pai.12387","article-title":"Maternal obesity alters immune cells frequencies and responses in umbilical cord blood samples","volume":"26","author":"Wilson","year":"2015","journal-title":"Pediatr Allergy Immunol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib59","doi-asserted-by":"crossref","first-page":"1719","DOI":"10.1111\/j.1365-2222.2010.03629.x","article-title":"Neonatal immune function and inflammatory illnesses in later life: lessons to be learnt from the developing world?","volume":"40","author":"Lisciandro","year":"2010","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/S2213-8587(16)30107-3_bib60","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s11882-010-0148-5","article-title":"The hygiene hypothesis revisited: role of materno-fetal interactions","volume":"10","author":"Thornton","year":"2010","journal-title":"Curr Allergy Asthma Rep"},{"key":"10.1016\/S2213-8587(16)30107-3_bib61","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1136\/thoraxjnl-2012-203009","article-title":"Obesity and susceptibility to severe outcomes following respiratory viral infection","volume":"68","author":"Almond","year":"2013","journal-title":"Thorax"},{"key":"10.1016\/S2213-8587(16)30107-3_bib62","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1042\/CS20150045","article-title":"Perinatal inflammation: a common factor in the early origins of cardiovascular disease?","volume":"129","author":"Nguyen","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/S2213-8587(16)30107-3_bib63","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/j.cppeds.2015.06.008","article-title":"Association between prenatal exposure to maternal infection and offspring mood disorders: a review of the literature","volume":"45","author":"Simane","year":"2015","journal-title":"Curr Probl Pediatr Adolesc Health Care"},{"key":"10.1016\/S2213-8587(16)30107-3_bib64","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1097\/INF.0000000000000224","article-title":"Metabolic complications of in utero maternal HIV and antiretroviral exposure in HIV-exposed infants","volume":"33","author":"Jao","year":"2014","journal-title":"Pediatr Infect Dis J"},{"key":"10.1016\/S2213-8587(16)30107-3_bib65","doi-asserted-by":"crossref","first-page":"e202","DOI":"10.1542\/peds.2010-0651","article-title":"Intrauterine effects of maternal prepregnancy overweight on child cognition and behavior in 2 cohorts","volume":"127","author":"Brion","year":"2011","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)30107-3_bib66","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1093\/ije\/dyt152","article-title":"Maternal pre-pregnancy body mass index and offspring attention deficit hyperactivity disorder: a population-based cohort study using a sibling-comparison design","volume":"43","author":"Chen","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib67","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1016\/j.jpeds.2013.06.062","article-title":"Maternal diagnosis of obesity and risk of cerebral palsy in the child","volume":"163","author":"Crisham Janik","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(16)30107-3_bib68","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1093\/ije\/dyv081","article-title":"Maternal body mass index during early pregnancy, gestational weight gain, and risk of autism spectrum disorders: results from a Swedish total population and discordant sibling study","volume":"44","author":"Gardner","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib69","doi-asserted-by":"crossref","first-page":"e1198","DOI":"10.1542\/peds.2014-3058","article-title":"Maternal prepregnancy body mass index and child psychosocial development at 6 years of age","volume":"135","author":"Jo","year":"2015","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)30107-3_bib70","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1007\/s10803-015-2549-8","article-title":"Association between maternal obesity and autism spectrum disorder in offspring: a meta-analysis","volume":"46","author":"Li","year":"2016","journal-title":"J Autism Dev Disord"},{"key":"10.1016\/S2213-8587(16)30107-3_bib71","doi-asserted-by":"crossref","first-page":"NP196","DOI":"10.1177\/0883073813510971","article-title":"Is prepregnancy obesity associated with risk of cerebral palsy and epilepsy in children?","volume":"29","author":"Pan","year":"2014","journal-title":"J Child Neurol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib72","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1111\/j.1469-7610.2009.02133.x","article-title":"Maternal pre-pregnancy obesity and risk for inattention and negative emotionality in children","volume":"51","author":"Rodriguez","year":"2010","journal-title":"J Child Psychol Psychiatry"},{"key":"10.1016\/S2213-8587(16)30107-3_bib73","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1542\/peds.2012-0788","article-title":"Maternal prepregnancy BMI and child cognition: a longitudinal cohort study","volume":"131","author":"Basatemur","year":"2013","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)30107-3_bib74","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1093\/aje\/kws239","article-title":"Associations of maternal weight gain in pregnancy with offspring cognition in childhood and adolescence: findings from the Avon Longitudinal Study of Parents and Children","volume":"177","author":"Gage","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib75","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1016\/j.jpeds.2014.07.003","article-title":"The association between maternal obesity and neurodevelopmental outcomes of offspring","volume":"165","author":"Mehta","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(16)30107-3_bib76","doi-asserted-by":"crossref","first-page":"e0133010","DOI":"10.1371\/journal.pone.0133010","article-title":"Maternal obesity, overweight and gestational diabetes affect the offspring neurodevelopment at 6 and 18 months of age\u2014a follow up from the PREOBE cohort","volume":"10","author":"Torres-Espinola","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30107-3_bib77","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/j.1467-789X.2011.00971.x","article-title":"Does maternal body mass index during pregnancy influence risk of schizophrenia in the adult offspring?","volume":"13","author":"Khandaker","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(16)30107-3_bib78","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3389\/fnins.2015.00194","article-title":"The role of maternal obesity in the risk of neuropsychiatric disorders","volume":"9","author":"Rivera","year":"2015","journal-title":"Front Neurosci"},{"key":"10.1016\/S2213-8587(16)30107-3_bib79","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.physbeh.2012.07.014","article-title":"Maternal high fat diet consumption during the perinatal period programs offspring behavior","volume":"123","author":"Sullivan","year":"2014","journal-title":"Physiol Behav"},{"key":"10.1016\/S2213-8587(16)30107-3_bib80","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1186\/s12974-014-0156-9","article-title":"Dietary intervention rescues maternal obesity induced behavior deficits and neuroinflammation in offspring","volume":"11","author":"Kang","year":"2014","journal-title":"J Neuroinflammation"},{"key":"10.1016\/S2213-8587(16)30107-3_bib81","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1016\/j.tem.2014.11.005","article-title":"Peri-conception parental obesity, reproductive health, and transgenerational impacts","volume":"26","author":"Lane","year":"2015","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30107-3_bib82","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1017\/S204017441500121X","article-title":"The developmental environment, epigenetic biomarkers and long-term health","volume":"6","author":"Godfrey","year":"2015","journal-title":"J Dev Orig Health Dis"},{"key":"10.1016\/S2213-8587(16)30107-3_bib83","doi-asserted-by":"crossref","first-page":"E805","DOI":"10.1152\/ajpendo.00013.2015","article-title":"Preconception diet or exercise intervention in obese fathers normalizes sperm microRNA profile and metabolic syndrome in female offspring","volume":"308","author":"McPherson","year":"2015","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30107-3_bib84","doi-asserted-by":"crossref","first-page":"e25254","DOI":"10.1371\/journal.pone.0025254","article-title":"Birthweight, maternal weight trajectories and global DNA methylation of LINE-1 repetitive elements","volume":"6","author":"Michels","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30107-3_bib85","doi-asserted-by":"crossref","first-page":"e72824","DOI":"10.1371\/journal.pone.0072824","article-title":"Predictors and consequences of global DNA methylation in cord blood and at three years","volume":"8","author":"Herbstman","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30107-3_bib86","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1186\/1756-0500-7-278","article-title":"DNA methylation signatures in cord blood associated with maternal gestational weight gain: results from the ALSPAC cohort","volume":"7","author":"Morales","year":"2014","journal-title":"BMC Res Notes"},{"key":"10.1016\/S2213-8587(16)30107-3_bib87","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/em.21827","article-title":"Maternal preconception body mass index and offspring cord blood DNA methylation: exploration of early life origins of disease","volume":"55","author":"Liu","year":"2014","journal-title":"Environ Mol Mutagen"},{"key":"10.1016\/S2213-8587(16)30107-3_bib88","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.1093\/ije\/dyv042","article-title":"Maternal pre-pregnancy BMI and gestational weight gain, offspring DNA methylation and later offspring adiposity: findings from the Avon Longitudinal Study of Parents and Children","volume":"44","author":"Sharp","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(16)30107-3_bib89","first-page":"170","article-title":"Methylation and expression of immune and inflammatory genes in the offspring of bariatric bypass surgery patients","volume":"492","author":"Gu\u00e9nard","year":"2013","journal-title":"J Obes"},{"key":"10.1016\/S2213-8587(16)30107-3_bib90","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/oby.2008.605","article-title":"Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns","volume":"17","author":"Gemma","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(16)30107-3_bib91","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s10552-012-9932-y","article-title":"Association of cord blood methylation fractions at imprinted insulin-like growth factor 2 (IGF2), plasma IGF2, and birth weight","volume":"23","author":"Hoyo","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(16)30107-3_bib92","first-page":"11","article-title":"Paternal obesity is associated with IGF2 hypomethylation in newborns: results from a Newborn Epigenetics Study (NEST) cohort","volume":"6","author":"Soubry","year":"2013","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(16)30107-3_bib93","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/ijo.2013.193","article-title":"Newborns of obese parents have altered DNA methylation patterns at imprinted genes","volume":"39","author":"Soubry","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(16)30107-3_bib94","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1080\/15592294.2015.1078963","article-title":"Offspring DNA methylation of the aryl-hydrocarbon receptor repressor gene is associated with maternal BMI, gestational age, and birth weight","volume":"10","author":"Burris","year":"2015","journal-title":"Epigenetics"},{"key":"10.1016\/S2213-8587(16)30107-3_bib95","doi-asserted-by":"crossref","first-page":"492170","DOI":"10.1155\/2013\/492170","article-title":"Methylation and expression of immune and inflammatory genes in the offspring of bariatric bypass surgery patients","volume":"2013","author":"Gu\u00e9nard","year":"2013","journal-title":"J Obes"},{"key":"10.1016\/S2213-8587(16)30107-3_bib96","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/15592294.2015.1029700","article-title":"Mendelian randomization supports causality between maternal hyperglycemia and epigenetic regulation of leptin gene in newborns","volume":"10","author":"Allard","year":"2015","journal-title":"Epigenetics"},{"key":"10.1016\/S2213-8587(16)30107-3_bib97","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1017\/S0007114510003302","article-title":"Influences on the quality of young children's diets: the importance of maternal food choices","volume":"105","author":"Fisk","year":"2011","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(16)30107-3_bib98","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1080\/19490976.2015.1078051","article-title":"Rate of establishing the gut microbiota in infancy has consequences for future health","volume":"6","author":"Dogra","year":"2015","journal-title":"Gut Microbes"},{"key":"10.1016\/S2213-8587(16)30107-3_bib99","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.3945\/ajcn.115.108738","article-title":"Abdominal adipose tissue compartments vary with ethnicity in Asian neonates: Growing Up in Singapore Toward Healthy Outcomes birth cohort study","volume":"103","author":"Tint","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30107-3_bib100","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.2337\/db13-0671","article-title":"PGC1\u03b1 promoter methylation in blood at 5\u20137 years predicts adiposity from 9 to 14 years (EarlyBird 50)","volume":"63","author":"Clarke-Harris","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)30107-3_bib101","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-8935-2-7","article-title":"Tissue-specific variation in DNA methylation levels along human chromosome 1","volume":"2","author":"De Bustos","year":"2009","journal-title":"Epigenetics Chromatin"},{"key":"10.1016\/S2213-8587(16)30107-3_bib102","doi-asserted-by":"crossref","first-page":"3135","DOI":"10.1096\/fj.09-150490","article-title":"Variation, patterns, and temporal stability of DNA methylation: considerations for epigenetic epidemiology","volume":"24","author":"Talens","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/S2213-8587(16)30107-3_bib103","doi-asserted-by":"crossref","first-page":"e02419","DOI":"10.1128\/mBio.02419-14","article-title":"Dynamics of infant gut microbiota are influenced by delivery mode and gestational duration and are associated with subsequent adiposity","volume":"6","author":"Dogra","year":"2015","journal-title":"MBio"},{"key":"10.1016\/S2213-8587(16)30107-3_bib104","doi-asserted-by":"crossref","first-page":"144","DOI":"10.3389\/fnins.2013.00144","article-title":"Perinatal nutrition programs neuroimmune function long-term: mechanisms and implications","volume":"7","author":"Spencer","year":"2013","journal-title":"Front Neurosci"},{"key":"10.1016\/S2213-8587(16)30107-3_bib105","doi-asserted-by":"crossref","first-page":"984","DOI":"10.1016\/j.clinthera.2015.04.002","article-title":"Gut-microbiota-brain axis and its effect on neuropsychiatric disorders with suspected immune dysregulation","volume":"37","author":"Petra","year":"2015","journal-title":"Clin Ther"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)30107-3_bib106","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1016\/S0140-6736(15)60396-8","article-title":"Dynamics of DNA methylation at IGF2 in preterm and term infants during the first year of life: an observational study","volume":"385","author":"Piyasena","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30107-3_bib107","doi-asserted-by":"crossref","first-page":"1064","DOI":"10.1101\/gr.171439.113","article-title":"The effect of genotype and in utero environment on interindividual variation in neonate DNA methylomes","volume":"24","author":"Teh","year":"2014","journal-title":"Genome Res"},{"key":"10.1016\/S2213-8587(16)30107-3_bib108","doi-asserted-by":"crossref","first-page":"4275","DOI":"10.1210\/jc.2009-0709","article-title":"Effects of maternal surgical weight loss in mothers on intergenerational transmission of obesity","volume":"94","author":"Smit","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30107-3_bib109","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1007\/s00125-015-3708-3","article-title":"Convergence in insulin resistance between very severely obese and lean women at the end of pregnancy","volume":"58","author":"Forbes","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(16)30107-3_bib110","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1001\/jama.2012.39","article-title":"Prevalence of obesity and trends in the distribution of body mass index among US adults, 1999\u20132010","volume":"307","author":"Flegal","year":"2012","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T11:58:33Z","timestamp":1536321513000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301073"}},"issued":{"date-parts":[[2017,1]]},"references-count":110,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S2213858716301073"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30107-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Influence of maternal obesity on the long-term health of offspring","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30107-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30278-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30217-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30108-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30098-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T06:16:38Z","timestamp":1794636998117,"version":"4.9.1"},"reference-count":131,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T00:00:00Z","timestamp":1728604800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/s2213-8587(24)00318-8","type":"journal-article","created":{"date-parts":[[2024,12,13]],"date-time":"2024-12-13T18:36:22Z","timestamp":1734114982000},"page":"134-148","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":461,"title":["Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment"],"prefix":"10.1016","volume":"13","author":[{"given":"Norbert","family":"Stefan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannele","family":"Yki-J\u00e4rvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brent A","family":"Neuschwander-Tetri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00318-8_bib1","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1097\/HEP.0000000000000004","article-title":"The global epidemiology of nonalcoholic fatty liver disease (NAFLD) and nonalcoholic steatohepatitis (NASH): a systematic review","volume":"77","author":"Younossi","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib2","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib3","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/j.jceh.2022.12.005","article-title":"The growing economic and clinical burden of nonalcoholic steatohepatitis (NASH) in the United States","volume":"13","author":"Younossi","year":"2023","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib4","doi-asserted-by":"crossref","first-page":"1978","DOI":"10.1016\/j.cgh.2023.04.015","article-title":"The global burden of liver disease","volume":"21","author":"Younossi","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1001\/jama.2020.2298","article-title":"Nonalcoholic steatohepatitis: a review","volume":"323","author":"Sheka","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00318-8_bib6","doi-asserted-by":"crossref","first-page":"2212","DOI":"10.1016\/S0140-6736(20)32511-3","article-title":"Non-alcoholic fatty liver disease","volume":"397","author":"Powell","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00318-8_bib7","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1016\/S2213-8587(22)00003-1","article-title":"A global view of the interplay between nonalcoholic fatty liver disease and diabetes","volume":"10","author":"Stefan","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib8","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1038\/s41575-021-00448-y","article-title":"The complex link between NAFLD and type 2 diabetes mellitus\u2014mechanisms and treatments","volume":"18","author":"Targher","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib9","first-page":"691","article-title":"MASLD: a systemic metabolic disorder with cardiovascular and malignant complications","volume":"73","author":"Targher","year":"2024","journal-title":"Gut"},{"key":"10.1016\/S2213-8587(24)00318-8_bib10","doi-asserted-by":"crossref","first-page":"1369","DOI":"10.1053\/j.gastro.2008.01.075","article-title":"Liver, muscle, and adipose tissue insulin action is directly related to intrahepatic triglyceride content in obese subjects","volume":"134","author":"Korenblat","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib11","doi-asserted-by":"crossref","first-page":"2237","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib12","doi-asserted-by":"crossref","first-page":"908","DOI":"10.1038\/s41591-018-0104-9","article-title":"Mechanisms of NAFLD development and therapeutic strategies","volume":"24","author":"Friedman","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib13","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.jhepr.2019.07.002","article-title":"From NASH to diabetes and from diabetes to NASH: mechanisms and treatment options","volume":"1","author":"Gastaldelli","year":"2019","journal-title":"JHEP Rep Innov Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib14","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41586-019-1797-8","article-title":"The integrative biology of type 2 diabetes","volume":"576","author":"Roden","year":"2019","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00318-8_bib15","doi-asserted-by":"crossref","first-page":"2537","DOI":"10.1016\/j.cell.2021.04.015","article-title":"Mechanisms and disease consequences of nonalcoholic fatty liver disease","volume":"184","author":"Loomba","year":"2021","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(24)00318-8_bib16","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/S2468-1253(22)00317-X","article-title":"Global prevalence of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in the overweight and obese population: a systematic review and meta-analysis","volume":"8","author":"Quek","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib17","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1016\/j.cgh.2024.03.006","article-title":"The global epidemiology of nonalcoholic fatty liver disease and nonalcoholic steatohepatitis among patients with type 2 diabetes","volume":"22","author":"Younossi","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib18","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1053\/j.gastro.2019.11.312","article-title":"MAFLD: a consensus-driven proposed nomenclature for metabolic associated fatty liver disease","volume":"158","author":"Eslam","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib19","doi-asserted-by":"crossref","first-page":"1966","DOI":"10.1097\/HEP.0000000000000520","article-title":"A multisociety Delphi consensus statement on new fatty liver disease nomenclature","volume":"78","author":"Rinella","year":"2023","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib20","doi-asserted-by":"crossref","first-page":"e54","DOI":"10.1016\/j.jhep.2023.07.021","article-title":"Can we use old NAFLD data under the new MASLD definition?","volume":"80","author":"Song","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib21","doi-asserted-by":"crossref","first-page":"e76","DOI":"10.1016\/j.jhep.2023.08.026","article-title":"99% of patients with NAFLD meet MASLD criteria and natural history is therefore identical","volume":"80","author":"Hagstr\u00f6m","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib22","doi-asserted-by":"crossref","first-page":"e51","DOI":"10.1016\/j.jhep.2023.07.017","article-title":"Confirmatory biomarker diagnostic studies are not needed when transitioning from NAFLD to MASLD","volume":"80","author":"Ratziu","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib23","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1172\/JCI129186","article-title":"Metabolically healthy obesity: facts and fantasies","volume":"129","author":"Smith","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(24)00318-8_bib24","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s11154-023-09829-x","article-title":"Phenotyping the obesities: reality or utopia?","volume":"24","author":"Portincasa","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/S2213-8587(24)00318-8_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/S2213-8587(23)00086-4","article-title":"Metabolic health and cardiometabolic risk clusters: implications for prediction, prevention, and treatment","volume":"11","author":"Stefan","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib26","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.cmet.2024.03.002","article-title":"Cardiometabolic characteristics of people with metabolically healthy and unhealthy obesity","volume":"36","author":"Petersen","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib27","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/s41574-024-01008-5","article-title":"Metabolically healthy obesity: from epidemiology and mechanisms to clinical implications","volume":"20","author":"Schulze","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib28","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S2213-8587(23)00159-6","article-title":"Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes","volume":"11","author":"Leslie","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib29","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.1038\/s41591-023-02502-5","article-title":"Second international consensus report on gaps and opportunities for the clinical translation of precision diabetes medicine","volume":"29","author":"Tobias","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib30","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1161\/CIR.0000000000001186","article-title":"A synopsis of the evidence for the science and clinical management of cardiovascular-kidney-metabolic (CKM) syndrome: a scientific statement from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00318-8_bib31","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1007\/s11154-023-09820-6","article-title":"Towards precision medicine in non-alcoholic fatty liver disease","volume":"24","author":"Francque","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/S2213-8587(24)00318-8_bib32","doi-asserted-by":"crossref","first-page":"830","DOI":"10.3390\/jpm13050830","article-title":"Precision medicine in fatty liver disease\/non-alcoholic fatty liver disease","volume":"13","author":"Valenzuela-Vallejo","year":"2023","journal-title":"J Pers Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib33","article-title":"Metabolic dysfunction-associated steatotic liver disease heterogeneity: need of subtyping","volume":"15","author":"Habib","year":"2024","journal-title":"World J Gastrointest Pathophysiol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib34","doi-asserted-by":"crossref","first-page":"40","DOI":"10.3390\/metabo14010040","article-title":"Endpoints in NASH clinical trials: are we blind in one eye?","volume":"14","author":"Lonardo","year":"2024","journal-title":"Metabolites"},{"key":"10.1016\/S2213-8587(24)00318-8_bib35","doi-asserted-by":"crossref","first-page":"e0112","DOI":"10.1097\/HC9.0000000000000112","article-title":"Clustering NAFLD: phenotypes of nonalcoholic fatty liver disease and their differing trajectories","volume":"7","author":"Kantartzis","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/S2213-8587(24)00318-8_bib36","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/j.eprac.2023.06.012","article-title":"Identification of high-risk patients with nonalcoholic fatty liver disease in endocrinology clinics","volume":"29","author":"Younossi","year":"2023","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(24)00318-8_bib37","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1056\/NEJMoa2029349","article-title":"Prospective study of outcomes in adults with nonalcoholic fatty liver disease","volume":"385","author":"Sanyal","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib38","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2468-1253(23)00157-7","article-title":"Type 2 diabetes, hepatic decompensation, and hepatocellular carcinoma in patients with non-alcoholic fatty liver disease: an individual participant-level data meta-analysis","volume":"8","author":"Huang","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib39","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.1136\/gutjnl-2020-322786","article-title":"Mortality in biopsy-confirmed nonalcoholic fatty liver disease: results from a nationwide cohort","volume":"70","author":"Simon","year":"2021","journal-title":"Gut"},{"key":"10.1016\/S2213-8587(24)00318-8_bib40","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1053\/j.gastro.2015.04.043","article-title":"Liver fibrosis, but no other histologic features, is associated with long-term outcomes of patients with nonalcoholic fatty liver disease","volume":"149","author":"Angulo","year":"2015","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib41","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1172\/JCI134165","article-title":"Insulin resistance drives hepatic de novo lipogenesis in nonalcoholic fatty liver disease","volume":"130","author":"Smith","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(24)00318-8_bib42","doi-asserted-by":"crossref","first-page":"489","DOI":"10.2337\/dc20-1644","article-title":"Hepatic insulin resistance is not pathway selective in humans with nonalcoholic fatty liver disease","volume":"44","author":"Ter Horst","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00318-8_bib43","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1016\/j.cmet.2024.04.006","article-title":"Hepatic selective insulin resistance at the intersection of insulin signaling and metabolic dysfunction-associated steatotic liver disease","volume":"36","author":"Bo","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib44","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1038\/s41575-021-00472-y","article-title":"Dietary carbohydrates and fats in nonalcoholic fatty liver disease","volume":"18","author":"Yki-J\u00e4rvinen","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.cmet.2019.12.002","article-title":"Leveraging human genetics to identify potential new treatments for fatty liver disease","volume":"31","author":"Romeo","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib46","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1097\/MOG.0000000000000927","article-title":"Advances in the genetics of nonalcoholic fatty liver disease","volume":"39","author":"Ajmera","year":"2023","journal-title":"Curr Opin Gastroenterol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib47","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1038\/ng.3855","article-title":"Adiposity amplifies the genetic risk of fatty liver disease conferred by multiple loci","volume":"49","author":"Stender","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00318-8_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.21037\/tgh-23-31","article-title":"Genetic and epigenetic determinants of non-alcoholic fatty liver disease (NAFLD) in lean individuals: a systematic review","volume":"9","author":"Njei","year":"2023","journal-title":"Transl Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib49","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1007\/s00204-023-03498-0","article-title":"Pharmacogenetics in early drug development for non-alcoholic steatohepatitis: missed chances and future opportunities","volume":"97","author":"Boeckmans","year":"2023","journal-title":"Arch Toxicol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib50","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1016\/j.cmet.2023.10.008","article-title":"The PNPLA3 I148M variant increases ketogenesis and decreases hepatic de novo lipogenesis and mitochondrial function in humans","volume":"35","author":"Luukkonen","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib51","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1093\/eurheartj\/ehx662","article-title":"Liver fat content, non-alcoholic fatty liver disease, and ischaemic heart disease: Mendelian randomization and meta-analysis of 279\u2008013 individuals","volume":"39","author":"Lauridsen","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(24)00318-8_bib52","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.1038\/ng.3977","article-title":"Exome-wide association study of plasma lipids in >300,000 individuals","volume":"49","author":"Liu","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00318-8_bib53","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib54","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-024-49224-x","article-title":"PNPLA3 is a triglyceride lipase that mobilizes polyunsaturated fatty acids to facilitate hepatic secretion of large-sized very low-density lipoprotein","volume":"15","author":"Johnson","year":"2024","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00318-8_bib55","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1016\/j.jhep.2016.01.002","article-title":"Hepatic ceramides dissociate steatosis and insulin resistance in patients with non-alcoholic fatty liver disease","volume":"64","author":"Luukkonen","year":"2016","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib56","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.jhep.2021.10.013","article-title":"Distinct contributions of metabolic dysfunction and genetic risk factors in the pathogenesis of non-alcoholic fatty liver disease","volume":"76","author":"Luukkonen","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib57","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(24)00318-8_bib58","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1053\/j.gastro.2013.11.049","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","volume":"146","author":"Lambert","year":"2014","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2022.100250","article-title":"Elevated de novo lipogenesis, slow liver triglyceride turnover, and clinical correlations in nonalcoholic steatohepatitis patients","volume":"63","author":"Lawitz","year":"2022","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(24)00318-8_bib60","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2024.06.030","article-title":"Differing genetic variants associated with liver fat and their contrasting relationships with cardiovascular diseases and cancer","author":"Ahmed","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib61","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1172\/JCI129187","article-title":"Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome","volume":"129","author":"Kahn","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(24)00318-8_bib62","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","article-title":"Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans","volume":"26","author":"Stefan","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib63","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cmet.2013.03.008","article-title":"Mechanisms and metabolic implications of regional differences among fat depots","volume":"17","author":"Tchkonia","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib64","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrendo.2014.185","article-title":"Biology of upper-body and lower-body adipose tissue\u2013link to whole-body phenotypes","volume":"11","author":"Karpe","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib65","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41580-018-0093-z","article-title":"Adipogenesis and metabolic health","volume":"20","author":"Ghaben","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib66","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/S2213-8587(20)30110-8","article-title":"Causes, consequences, and treatment of metabolically unhealthy fat distribution","volume":"8","author":"Stefan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib67","first-page":"907","article-title":"Lipodistrophy: a paradigm for understanding the consequences of \u201coverloading\u201d adipose tissue","volume":"101","author":"Lim","year":"2021","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(24)00318-8_bib68","doi-asserted-by":"crossref","first-page":"836","DOI":"10.7326\/L19-0635","article-title":"Lipodystrophic nonalcoholic fatty liver disease induced by immune checkpoint blockade","volume":"172","author":"Eigentler","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib69","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1053\/j.gastro.2022.06.023","article-title":"AGA clinical practice update: diagnosis and management of nonalcoholic fatty liver disease in lean individuals: expert review","volume":"163","author":"Long","year":"2022","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.aohep.2024.101288","article-title":"Lean non-alcoholic fatty liver disease and the risk of all-cause mortality: an updated meta-analysis","volume":"29","author":"Wongtrakul","year":"2024","journal-title":"Ann Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib71","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1136\/gutjnl-2020-322564","article-title":"Caucasian lean subjects with non-alcoholic fatty liver disease share long-term prognosis of non-lean: time for reappraisal of BMI-driven approach?","volume":"71","author":"Younes","year":"2022","journal-title":"Gut"},{"key":"10.1016\/S2213-8587(24)00318-8_bib72","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/hep4.1124","article-title":"Risk for development of severe liver disease in lean patients with nonalcoholic fatty liver disease: a long-term follow-up study","volume":"2","author":"Hagstr\u00f6m","year":"2017","journal-title":"Hepatol Commun"},{"key":"10.1016\/S2213-8587(24)00318-8_bib73","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1002\/hep.32427","article-title":"Metabolic subtypes of patients with NAFLD exhibit distinctive cardiovascular risk profiles","volume":"76","author":"Mart\u00ednez-Arranz","year":"2022","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib74","doi-asserted-by":"crossref","first-page":"e0016","DOI":"10.1097\/HC9.0000000000000016","article-title":"Novel metabolic phenotypes for extrahepatic complication of nonalcoholic fatty liver disease","volume":"7","author":"Yi","year":"2023","journal-title":"Hepatol Commun"},{"key":"10.1016\/S2213-8587(24)00318-8_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155294","article-title":"Novel metabolic classification for extrahepatic complication of metabolic associated fatty liver disease: a data-driven cluster analysis with international validation","volume":"136","author":"Ye","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(24)00318-8_bib76","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1016\/j.cmet.2023.11.010","article-title":"ChREBP is activated by reductive stress and mediates GCKR-associated metabolic traits","volume":"36","author":"Singh","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib77","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1038\/s41588-023-01497-6","article-title":"Genome-wide association meta-analysis identifies 17 loci associated with nonalcoholic fatty liver disease","volume":"55","author":"Chen","year":"2023","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00318-8_bib78","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03283-1","article-title":"Data-driven cluster analysis identifies distinct types of metabolic dysfunction-associated steatotic liver disease","author":"Raverdy","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/s41591-024-03284-0","article-title":"Partitioned polygenic risk scores identify distinct types of metabolic dysfunction-associated steatotic liver disease","author":"Jamialahmadi","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib80","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1002\/hep.24376","article-title":"Endpoints and clinical trial design for nonalcoholic steatohepatitis","volume":"54","author":"Sanyal","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib82","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.1016\/j.jhep.2022.04.002","article-title":"Breakthroughs in therapies for NASH and remaining challenges","volume":"76","author":"Ratziu","year":"2022","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib83","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1136\/gutjnl-2021-326874","article-title":"Current therapies and new developments in NASH","volume":"71","author":"Dufour","year":"2022","journal-title":"Gut"},{"key":"10.1016\/S2213-8587(24)00318-8_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2024.03.011","article-title":"New and emerging treatments for metabolic dysfunction-associated steatohepatitis","volume":"36","author":"Tincopa","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib85","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S2213-8587(24)00102-5","article-title":"Effect of SGLT2 inhibitors on heart failure outcomes and cardiovascular death across the cardiometabolic disease spectrum: a systematic review and meta-analysis","volume":"12","author":"Usman","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib86","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib87","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1126\/science.adn4128","article-title":"The benefits of GLP-1 drugs beyond obesity","volume":"385","author":"Drucker","year":"2024","journal-title":"Science"},{"key":"10.1016\/S2213-8587(24)00318-8_bib88","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib89","doi-asserted-by":"crossref","first-page":"2064","DOI":"10.2337\/dc21-2049","article-title":"Comparison of tofogliflozin and glimepiride effects on nonalcoholic fatty liver disease in participants with type 2 diabetes: a randomized, 48-week, open-label, active-controlled trial","volume":"45","author":"Takeshita","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00318-8_bib90","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00318-8_bib91","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib92","unstructured":"Newsome P, Sanyal A, Kliers I, et al. Phase 3 ESSENCE trial: semaglutide in metabolic dysfunction-associated steatohepatitis (MASH). American Association for the Study of Liver Diseases, The Liver Meeting; Nov 7\u201311, 2024 (abstr 5018)."},{"key":"10.1016\/S2213-8587(24)00318-8_bib93","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2468-1253(23)00068-7","article-title":"Semaglutide 2\u00b74 mg once weekly in patients with non-alcoholic steatohepatitis-related cirrhosis: a randomised, placebo-controlled phase 2 trial","volume":"8","author":"Loomba","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib94","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1056\/NEJMoa2401943","article-title":"Tirzepatide for metabolic dysfunction-associated steatohepatitis with liver fibrosis","volume":"391","author":"Loomba","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib95","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa2401755","article-title":"A phase 2 randomized trial of survodutide in MASH and fibrosis","volume":"391","author":"Sanyal","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib96","doi-asserted-by":"crossref","first-page":"998","DOI":"10.1056\/NEJMoa2304286","article-title":"Randomized, controlled trial of the FGF21 analogue pegozafermin in NASH","volume":"389","author":"Loomba","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib97","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1056\/NEJMoa2309000","article-title":"A phase 3, randomized, controlled trial of resmetirom in NASH with liver fibrosis","volume":"390","author":"Harrison","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib98","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1001\/jamainternmed.2016.9607","article-title":"Thiazolidinediones and advanced liver fibrosis in nonalcoholic steatohepatitis: a meta-analysis","volume":"177","author":"Musso","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib99","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa2036205","article-title":"A randomized, controlled trial of the pan-PPAR agonist lanifibranor in NASH","volume":"385","author":"Francque","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib100","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/S2468-1253(21)00261-2","article-title":"Efficacy of peroxisome proliferator-activated receptor agonists, glucagon-like peptide-1 receptor agonists, or sodium-glucose cotransporter-2 inhibitors for treatment of non-alcoholic fatty liver disease: a systematic review","volume":"7","author":"Mantovani","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib101","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1001\/jamainternmed.2023.8029","article-title":"Outcomes of various classes of oral antidiabetic drugs on nonalcoholic fatty liver disease","volume":"184","author":"Jang","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib102","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/j.diabet.2019.01.008","article-title":"Beneficial effects of SGLT2 inhibitors on fatty liver in type 2 diabetes: a common comorbidity associated with severe complications","volume":"45","author":"Scheen","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib103","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1093\/cvr\/cvae047","article-title":"SGLT2 inhibitors: from glucose-lowering to cardiovascular benefits","volume":"120","author":"Preda","year":"2024","journal-title":"Cardiovasc Res"},{"key":"10.1016\/S2213-8587(24)00318-8_bib104","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/S2213-8587(22)00340-0","article-title":"Pharmacogenomics of GLP-1 receptor agonists: a genome-wide analysis of observational data and large randomised controlled trials","volume":"11","author":"Dawed","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib105","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/j.cmet.2023.07.010","article-title":"GIPR\/GLP-1R dual agonist therapies for diabetes and weight loss-chemistry, physiology, and clinical applications","volume":"35","author":"Campbell","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib106","doi-asserted-by":"crossref","first-page":"1898","DOI":"10.1016\/j.cmet.2024.06.012","article-title":"Tirzepatide modulates the regulation of adipocyte nutrient metabolism through long-acting activation of the GIP receptor","volume":"36","author":"Regmi","year":"2024","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib107","article-title":"Effect of pemvidutide, a GLP-1\/glucagon dual receptor agonist, on MASLD: a randomized, double-blind, placebo-controlled study","author":"Harrison","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib108","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1038\/s41591-024-03018-2","article-title":"Triple hormone receptor agonist retatrutide for metabolic dysfunction-associated steatotic liver disease: a randomized phase 2a trial","volume":"30","author":"Sanyal","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib109","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.cmet.2019.01.004","article-title":"A dozen years of discovery: insights into the physiology and pharmacology of FGF21","volume":"29","author":"Kliewer","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib110","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1016\/j.cmet.2023.01.006","article-title":"The role of hepatokines in NAFLD","volume":"35","author":"Stefan","year":"2023","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib111","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.cgh.2023.04.011","article-title":"Pegbelfermin in patients with nonalcoholic steatohepatitis and stage 3 fibrosis (FALCON 1): a randomized phase 2b study","volume":"22","author":"Loomba","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib112","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.cgh.2023.04.012","article-title":"Pegbelfermin in patients with nonalcoholic steatohepatitis and compensated cirrhosis (FALCON 2): a randomized phase 2b study","volume":"22","author":"Abdelmalek","year":"2024","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib113","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1016\/S2468-1253(23)00272-8","article-title":"Safety and efficacy of once-weekly efruxifermin versus placebo in non-alcoholic steatohepatitis (HARMONY): a multicentre, randomised, double-blind, placebo-controlled, phase 2b trial","volume":"8","author":"Harrison","year":"2023","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib114","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1136\/gutjnl-2023-331115","article-title":"FGF-21 analogues for treatment of non-alcoholic steatohepatitis and fibrosis: a meta-analysis with fragility index of phase 2 randomised placebo-controlled trials","volume":"73","author":"Mantovani","year":"2024","journal-title":"Gut"},{"key":"10.1016\/S2213-8587(24)00318-8_bib115","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1016\/j.jhep.2024.04.034","article-title":"FGF21 agonists: an emerging therapeutic for metabolic dysfunction-associated steatohepatitis and beyond","volume":"81","author":"Harrison","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib116","doi-asserted-by":"crossref","first-page":"1173","DOI":"10.1089\/thy.2018.0664","article-title":"Nonalcoholic fatty liver disease and hypercholesterolemia: roles of thyroid hormones, metabolites, and agonists","volume":"29","author":"Sinha","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(24)00318-8_bib118","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41575-020-00366-5","article-title":"Nonalcoholic steatohepatitis: the role of peroxisome proliferator-activated receptors","volume":"18","author":"Francque","year":"2021","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib119","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1210\/clinem\/dgac624","article-title":"Approach to the patient with nonalcoholic fatty liver disease","volume":"108","author":"Belfort-DeAguiar","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00318-8_bib120","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/hep.29367","article-title":"The diagnosis and management of nonalcoholic fatty liver disease: practice guidance from the American Association for the Study of Liver Diseases","volume":"67","author":"Chalasani","year":"2018","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib121","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1016\/j.jhep.2024.04.031","article-title":"EASL-EASD-EASO clinical practice guidelines on the management of metabolic dysfunction-associated steatotic liver disease (MASLD)","volume":"81","year":"2024","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib122","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1002\/hep.31843","article-title":"Saroglitazar, a PPAR-\u03b1\/\u03b3 agonist, for treatment of NAFLD: a randomized controlled double-blind phase 2 trial","volume":"74","author":"Gawrieh","year":"2021","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib123","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1053\/j.gastro.2020.11.051","article-title":"AGA clinical practice update on lifestyle modification using diet and exercise to achieve weight loss in the management of nonalcoholic fatty liver disease: expert review","volume":"160","author":"Younossi","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib124","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.aohep.2020.09.006","article-title":"Latin American Association for the study of the liver (ALEH) practice guidance for the diagnosis and treatment of non-alcoholic fatty liver disease","volume":"19","author":"Arab","year":"2020","journal-title":"Ann Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib125","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1111\/jgh.13857","article-title":"Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017\u2014part 1: definition, risk factors and assessment","volume":"33","author":"Wong","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib126","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/jgh.13856","article-title":"The Asia-Pacific Working Party on Non-alcoholic Fatty Liver Disease guidelines 2017\u2014part 2: management and special groups","volume":"33","author":"Chitturi","year":"2018","journal-title":"J Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib127","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(22)02403-5","article-title":"Contemporary medical, device, and surgical therapies for obesity in adults","volume":"401","author":"Perdomo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00318-8_bib128","doi-asserted-by":"crossref","first-page":"1290","DOI":"10.1053\/j.gastro.2020.06.006","article-title":"Bariatric surgery provides long-term resolution of nonalcoholic steatohepatitis and regression of fibrosis","volume":"159","author":"Lassailly","year":"2020","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(24)00318-8_bib130","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1001\/jama.2021.19569","article-title":"Association of bariatric surgery with major adverse liver and cardiovascular outcomes in patients with biopsy-proven nonalcoholic steatohepatitis","volume":"326","author":"Aminian","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00318-8_bib131","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","article-title":"A new framework for the diagnosis, staging and management of obesity in adults","volume":"30","author":"Busetto","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00318-8_bib132","article-title":"Advancements in pharmacological treatment of NAFLD\/MASLD: a focus on metabolic and liver-targeted interventions","volume":"12","author":"Ciardullo","year":"2024","journal-title":"Gastroenterol Rep"},{"key":"10.1016\/S2213-8587(24)00318-8_bib133","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1038\/s41575-024-00938-9","article-title":"Envisioning how to advance the MASH field","volume":"21","author":"Allen","year":"2024","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(24)00318-8_bib129","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial","volume":"401","author":"Verrastro","year":"2023","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003188?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003188?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,27]],"date-time":"2025-02-27T21:10:45Z","timestamp":1740690645000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003188"}},"issued":{"date-parts":[[2025,2]]},"references-count":131,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2213858724003188"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00318-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic dysfunction-associated steatotic liver disease: heterogeneous pathomechanisms and effectiveness of metabolism-based treatment","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00318-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T03:58:48Z","timestamp":1794628728825,"version":"4.9.1"},"reference-count":129,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["2 APP 2016668"],"award-info":[{"award-number":["2 APP 2016668"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DK120932"],"award-info":[{"award-number":["K23DK120932"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["223024\/Z\/21\/Z"],"award-info":[{"award-number":["223024\/Z\/21\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/s2213-8587(23)00225-5","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T18:29:47Z","timestamp":1694456987000},"page":"768-782","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":231,"title":["Current insights and emerging trends in early-onset type 2 diabetes"],"prefix":"10.1016","volume":"11","author":[{"given":"Shivani","family":"Misra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Ke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shylaja","family":"Srinivasan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpesh","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moffat J","family":"Nyriyenda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose C","family":"Florez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna J","family":"Magliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00225-5_bib1","series-title":"Diabetes Atlas","year":"2021"},{"key":"10.1016\/S2213-8587(23)00225-5_bib2","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-8587(17)30186-9","article-title":"Type 2 diabetes in adolescents and young adults","volume":"6","author":"Lascar","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib3","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2337\/dc20-0417","article-title":"Temporal trend in young-onset type 2 diabetes-macrovascular and mortality risk: study of U.K. primary care electronic medical records","volume":"43","author":"Koye","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib4","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.2337\/dc20-2375","article-title":"Associations of type 2 diabetes onset age with cardiovascular disease and mortality: the Kailuan Study","volume":"44","author":"Zhao","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib5","doi-asserted-by":"crossref","first-page":"2228","DOI":"10.1161\/CIRCULATIONAHA.118.037885","article-title":"Age at diagnosis of type 2 diabetes mellitus and associations with cardiovascular and mortality risks","volume":"139","author":"Sattar","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00225-5_bib6","doi-asserted-by":"crossref","first-page":"416","DOI":"10.1056\/NEJMoa2100165","article-title":"Long-term complications in youth-onset type 2 diabetes","volume":"385","author":"Bjornstad","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib7","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14940","article-title":"Characteristics and care of young people with type 2 diabetes included in the national diabetes audit datasets for England","volume":"40","author":"Misra","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib9","article-title":"Global burden of type 2 diabetes in adolescents and young adults, 1990-2019: systematic analysis of the Global Burden of Disease Study 2019","volume":"379","author":"Xie","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00225-5_bib10","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1109333","article-title":"A clinical trial to maintain glycemic control in youth with type 2 diabetes","volume":"366","author":"Zeitler","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib11","doi-asserted-by":"crossref","first-page":"2716","DOI":"10.1001\/jama.297.24.2716","article-title":"Incidence of diabetes in youth in the United States","volume":"297","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00225-5_bib12","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.1007\/s00125-020-05174-9","article-title":"Adults with early-onset type 2 diabetes (aged 18-39 years) are severely underrepresented in diabetes clinical research trials","volume":"63","author":"Sargeant","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib13","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/dom.13874","article-title":"Cardiovascular outcomes trials in type 2 diabetes: time to include young adults","volume":"22","author":"Ke","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00225-5_bib14","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1016\/S0022-3476(96)80124-7","article-title":"Increased incidence of non-insulin-dependent diabetes mellitus among adolescents","volume":"128","author":"Pinhas-Hamiel","year":"1996","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(23)00225-5_bib15","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1001\/jama.282.16.1519","article-title":"The spread of the obesity epidemic in the United States, 1991\u20131998","volume":"282","author":"Mokdad","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00225-5_bib16","doi-asserted-by":"crossref","first-page":"1278","DOI":"10.2337\/diacare.23.9.1278","article-title":"Diabetes trends in the US: 1990\u20131998","volume":"23","author":"Mokdad","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib17","doi-asserted-by":"crossref","first-page":"2999","DOI":"10.2337\/diacare.26.11.2999","article-title":"Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth","volume":"26","author":"Hillier","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib18","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1007\/s00125-017-4532-8","article-title":"Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register","volume":"61","author":"Steinarsson","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib19","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1001\/jama.2017.0686","article-title":"Association of type 1 diabetes vs type 2 diabetes diagnosed during childhood and adolescence with complications during teenage years and young adulthood","volume":"317","author":"Dabelea","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00225-5_bib20","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-020-05319-w","article-title":"Impact of age at type 2 diabetes mellitus diagnosis on mortality and vascular complications: systematic review and meta-analyses","volume":"64","author":"Nanayakkara","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib21","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/ajcn\/84.2.427","article-title":"Body mass index history and risk of type 2 diabetes: results from the European Prospective Investigation into Cancer and Nutrition (EPIC)-Potsdam Study","volume":"84","author":"Schienkiewitz","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00225-5_bib22","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1016\/S2213-8587(23)00025-6","article-title":"Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002-18: results from the population-based SEARCH for Diabetes in Youth study","volume":"11","author":"Wagenknecht","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib23","doi-asserted-by":"crossref","first-page":"1758","DOI":"10.2337\/dc06-2010","article-title":"Changing patterns of type 2 diabetes incidence among Pima Indians","volume":"30","author":"Pavkov","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-059716","article-title":"Prevalence and incidence of diabetes among Aboriginal people in remote communities of the Northern Territory, Australia: a retrospective, longitudinal data-linkage study","volume":"12","author":"Hare","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(23)00225-5_bib25","doi-asserted-by":"crossref","first-page":"E48","DOI":"10.9778\/cmajo.20190226","article-title":"Prevalence, incidence and outcomes of diabetes in Ontario First Nations children: a longitudinal population-based cohort study","volume":"8","author":"Shulman","year":"2020","journal-title":"CMAJ Open"},{"key":"10.1016\/S2213-8587(23)00225-5_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-046956","article-title":"Prevalence of and risk factors for diabetes mellitus in the school-attending adolescent population of the United Arab Emirates: a large cross-sectional study","volume":"11","author":"Barakat","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(23)00225-5_bib27","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1111\/dme.13609","article-title":"Continuing rise of type 2 diabetes incidence in children and young people in the UK","volume":"35","author":"Candler","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib28","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/pedi.13009","article-title":"Comparison of the incidence of diabetes in United States and Indian youth: An international harmonization of youth diabetes registries","volume":"22","author":"Jensen","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00225-5_bib29","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.2337\/dc06-0138","article-title":"Effects of traditional and western environments on prevalence of type 2 diabetes in Pima Indians in Mexico and the U.S","volume":"29","author":"Schulz","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib30","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1007\/s00125-020-05169-6","article-title":"Age-, sex- and ethnicity-related differences in body weight, blood pressure, HbA1c and lipid levels at the diagnosis of type 2 diabetes relative to people without diabetes","volume":"63","author":"Wright","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib31","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1136\/adc.2008.143313","article-title":"Management and 1 year outcome for UK children with type 2 diabetes","volume":"94","author":"Shield","year":"2009","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(23)00225-5_bib32","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/s00125-019-05058-7","article-title":"Age of obesity onset, cumulative obesity exposure over early adulthood and risk of type 2 diabetes","volume":"63","author":"Luo","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib33","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1056\/NEJMoa1713231","article-title":"Change in overweight from childhood to early adulthood and risk of type 2 diabetes","volume":"378","author":"Bjerregaard","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib35","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.1007\/s00125-019-4914-1","article-title":"Developmental overnutrition and obesity and type 2 diabetes in offspring","volume":"62","author":"Perng","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib36","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00125-010-1925-3","article-title":"Association of exposure to diabetes in utero with adiposity and fat distribution in a multiethnic population of youth: the Exploring Perinatal Outcomes among Children (EPOCH) Study","volume":"54","author":"Crume","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib37","doi-asserted-by":"crossref","first-page":"1422","DOI":"10.2337\/dc07-2417","article-title":"Association of intrauterine exposure to maternal diabetes and obesity with type 2 diabetes in youth: the SEARCH Case-Control Study","volume":"31","author":"Dabelea","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib38","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1210\/clinem\/dgac663","article-title":"Maternal diabetes in youth-onset type 2 diabetes is associated with progressive dysglycemia and risk of complications","volume":"108","author":"Shah","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00225-5_bib39","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/S2213-8587(20)30129-7","article-title":"Endocrine-disrupting chemicals: implications for human health","volume":"8","author":"Kahn","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib40","doi-asserted-by":"crossref","first-page":"164","DOI":"10.2337\/dc18-1122","article-title":"The shape of the glucose response curve during an oral glucose tolerance test: Forerunner of heightened glycemic failure rates and accelerated decline in B-cell function in today","volume":"42","author":"Arslanian","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib41","doi-asserted-by":"crossref","first-page":"3359","DOI":"10.1007\/s00125-012-2719-6","article-title":"Clinical evolution of beta cell function in youth with diabetes: the SEARCH for Diabetes in Youth study","volume":"55","author":"Dabelea","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib42","doi-asserted-by":"crossref","first-page":"1938","DOI":"10.2337\/dc21-0027","article-title":"Baseline predictors of glycemic worsening in youth and adults with impaired glucose tolerance or recently diagnosed type 2 diabetes in the Restoring Insulin Secretion (RISE) Study","volume":"44","author":"Sam","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib43","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/s41581-022-00645-1","article-title":"Youth-onset type 2 diabetes mellitus: an urgent challenge","volume":"19","author":"Bjornstad","year":"2023","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib44","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","article-title":"Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data","volume":"7","author":"Dennis","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib45","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s00125-017-4519-5","article-title":"Rates of glycaemic deterioration in a real-world population with type 2 diabetes","volume":"61","author":"Donnelly","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib46","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1016\/S2352-4642(18)30235-9","article-title":"Trajectories of changes in glucose tolerance in a multiethnic cohort of obese youths: an observational prospective analysis","volume":"2","author":"Galderisi","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/S2213-8587(23)00225-5_bib47","article-title":"The prevalence of obesity among children with type 2 diabetes: a systematic review and meta-analysis","volume":"5","author":"Cioana","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(23)00225-5_bib48","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/dc12-2393","article-title":"Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and \u03b2-cell function in TODAY","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib49","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003316","article-title":"Age at diagnosis, glycemic trajectories, and responses to oral glucose-lowering drugs in type 2 diabetes in Hong Kong: a population-based observational study","volume":"17","author":"Ke","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib50","doi-asserted-by":"crossref","first-page":"817","DOI":"10.2337\/dc20-2134","article-title":"OGTT glucose response curves, insulin sensitivity, and \u03b2-cell function in RISE: comparison between youth and adults at randomization and in response to interventions to preserve \u03b2-cell function","volume":"44","author":"Arslanian","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib51","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/pedi.12562","article-title":"Insulin sensitivity across the lifespan from obese adolescents to obese adults with impaired glucose tolerance: who is worse off?","volume":"19","author":"Arslanian","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00225-5_bib52","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41574-022-00669-4","article-title":"Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations","volume":"18","author":"Ke","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib53","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s00125-021-05543-y","article-title":"Subgroups of patients with young-onset type 2 diabetes in India reveal insulin deficiency as a major driver","volume":"65","author":"Prasad","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib55","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00125-022-05671-z","article-title":"Young-onset diabetes in Asian Indians is associated with lower measured and genetically determined beta cell function","volume":"65","author":"Siddiqui","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib56","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S2213-8587(18)30316-4","article-title":"Novel subgroups of patients with adult-onset diabetes in Chinese and US populations","volume":"7","author":"Zou","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib57","article-title":"The characteristics of newly diagnosed adult early-onset diabetes: a population-based cross-sectional study","volume":"7","author":"Zou","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(23)00225-5_bib58","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00125-011-2267-5","article-title":"Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study","volume":"54","author":"Almgren","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib59","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05616","article-title":"A genome-wide association study identifies novel risk loci for type 2 diabetes","volume":"445","author":"Sladek","year":"2007","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(23)00225-5_bib60","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1007\/s11892-022-01462-3","article-title":"Genetics of type 2 diabetes: implications from large-scale studies","volume":"22","author":"DeForest","year":"2022","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(23)00225-5_bib61","doi-asserted-by":"crossref","first-page":"996","DOI":"10.2337\/db20-0443","article-title":"The first genome-wide association study for type 2 diabetes in youth: the Progress in Diabetes Genetics in Youth (ProDiGY) consortium","volume":"70","author":"Srinivasan","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00225-5_bib62","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/S2213-8587(21)00327-2","article-title":"Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data","volume":"10","author":"Magliano","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib63","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s00125-019-05074-7","article-title":"Secular trends in all-cause and cause-specific mortality rates in people with diabetes in Hong Kong, 2001\u20132016: a retrospective cohort study","volume":"63","author":"Wu","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib64","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s12933-020-01039-y","article-title":"Trends in diabetes-related complications in Hong Kong, 2001\u20132016: a retrospective cohort study","volume":"19","author":"Wu","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib65","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib66","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/jama.2019.3471","article-title":"Resurgence in diabetes-related complications","volume":"321","author":"Gregg","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00225-5_bib67","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1016\/j.amjmed.2014.03.018","article-title":"Premature mortality and comorbidities in young-onset diabetes: a 7-year prospective analysis","volume":"127","author":"Chan","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib68","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/S2213-8587(15)00508-2","article-title":"Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study","volume":"4","author":"Huo","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib69","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.2337\/dc20-0352","article-title":"The association between age of onset of type 2 diabetes and the long-term risk of end-stage kidney disease: a national registry study","volume":"43","author":"Morton","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib70","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s00125-021-05494-4","article-title":"Young age at diabetes diagnosis amplifies the effect of diabetes duration on risk of chronic kidney disease: a prospective cohort study","volume":"64","author":"Wu","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib71","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.2337\/dc05-2470","article-title":"Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes","volume":"29","author":"Eppens","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib72","doi-asserted-by":"crossref","first-page":"231","DOI":"10.2337\/dc20-2045","article-title":"Association of cardiometabolic multimorbidity and depression with cardiovascular events in early-onset adult type 2 diabetes: a multiethnic study in the US","volume":"44","author":"Dibato","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib73","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7326\/M18-1900","article-title":"Excess burden of mental illness and hospitalization in young-onset type 2 diabetes: a population-based cohort study","volume":"170","author":"Ke","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib74","doi-asserted-by":"crossref","first-page":"2950","DOI":"10.2337\/dc22-1053","article-title":"Early-onset type 2 diabetes and mood, anxiety, and stress-related disorders: a genetically informative register-based cohort study","volume":"45","author":"Liu","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib75","doi-asserted-by":"crossref","first-page":"579","DOI":"10.2337\/dc22-1237","article-title":"Age at diagnosis of type 2 diabetes and depressive symptoms, diabetes-specific distress, and self-compassion","volume":"46","author":"Barker","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib76","doi-asserted-by":"crossref","first-page":"120","DOI":"10.2337\/dc22-1575","article-title":"Incident early- and later-onset type 2 diabetes and risk of early- and later-onset cancer: prospective cohort study","volume":"46","author":"Zhang","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib77","doi-asserted-by":"crossref","first-page":"616","DOI":"10.4158\/EP10357.RA","article-title":"Significantly increased risk of cancer in patients with diabetes mellitus: a systematic review and meta-analysis","volume":"17","author":"Noto","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(23)00225-5_bib78","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1093\/jnci\/djaa141","article-title":"Incident type 2 diabetes duration and cancer risk: a prospective study in two US cohorts","volume":"113","author":"Hu","year":"2021","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(23)00225-5_bib79","first-page":"1038","article-title":"Pregnancy outcomes in young women with youth-onset type 2 diabetes followed in the TODAY study","volume":"45","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib80","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1111\/dme.12051","article-title":"Prescribing in pregnancy for women with diabetes: use of potential teratogenic drugs and contraception","volume":"30","author":"Makda","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib81","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S2213-8587(19)30068-3","article-title":"Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial","volume":"7","author":"Lean","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib82","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2213-8587(20)30117-0","article-title":"Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial","volume":"8","author":"Taheri","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib83","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/S2213-8587(20)30147-9","article-title":"Remission of type 2 diabetes by weight loss in a non-white population","volume":"8","author":"Taylor","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib84","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2337\/diacare.27.2.348","article-title":"Treatment of type 2 diabetes in childhood using a very-low-calorie diet","volume":"27","author":"Willi","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib85","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/pedi.13409","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: type 2 diabetes in children and adolescents","volume":"23","author":"Shah","year":"2022","journal-title":"Pediatr Diabetes"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00225-5_bib86","doi-asserted-by":"crossref","first-page":"S230","DOI":"10.2337\/dc23-S014","article-title":"Children and adolescents: standards of care in diabetes","volume":"46","author":"El Sayed","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib87","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/dom.14192","article-title":"Early combination therapy delayed treatment escalation in newly diagnosed young-onset type 2 diabetes: a subanalysis of the VERIFY study","volume":"23","author":"Chan","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00225-5_bib88","doi-asserted-by":"crossref","first-page":"790","DOI":"10.2337\/dc06-1554","article-title":"Glimepiride versus metformin as monotherapy in pediatric patients with type 2 diabetes: a randomized, single-blind comparative study","volume":"30","author":"Gottschalk","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib89","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.2337\/dc18-0787","article-title":"Impact of insulin and metformin versus metformin alone on \u03b2-cell function in youth with impaired glucose tolerance or recently diagnosed type 2 diabetes","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib90","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1056\/NEJMoa1903822","article-title":"Liraglutide in children and adolescents with type 2 diabetes","volume":"381","author":"Tamborlane","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib91","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1056\/NEJMoa2204601","article-title":"Once-weekly dulaglutide for the treatment of youths with type 2 diabetes","volume":"387","author":"Arslanian","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib92","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.2337\/dc21-2275","article-title":"Once-weekly exenatide in youth with type 2 diabetes","volume":"45","author":"Tamborlane","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib93","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S2213-8587(22)00052-3","article-title":"Efficacy and safety of dapagliflozin in children and young adults with type 2 diabetes: a prospective, multicentre, randomised, parallel group, phase 3 study","volume":"10","author":"Tamborlane","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib94","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S2213-8587(22)00387-4","article-title":"Efficacy and safety of the SGLT2 inhibitor empagliflozin versus placebo and the DPP-4 inhibitor linagliptin versus placebo in young people with type 2 diabetes (DINAMO): a multicentre, randomised, double-blind, parallel group, phase 3 trial","volume":"11","author":"Laffel","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib95","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2017-000464","article-title":"Variables associated withHbA1c and weight reductions when adding liraglutide to multipledaily insulin injections in persons with type 2 diabetes (MDILiraglutide trial 3)","volume":"6","author":"Dahlqvist","year":"2018","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib96","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1001\/jama.2014.5988","article-title":"Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications","volume":"311","author":"Sj\u00f6str\u00f6m","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00225-5_bib97","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sj\u00f6str\u00f6m","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib98","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1506699","article-title":"Weight loss and health status 3 years after bariatric surgery in adolescents","volume":"374","author":"Inge","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib99","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1056\/NEJMoa1813909","article-title":"Five-year outcomes of gastric bypass in adolescents as compared with adults","volume":"380","author":"Inge","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib100","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14903","article-title":"Young-onset type 2 diabetes: a neglected group requiring urgent attention","volume":"39","author":"Song","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib101","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1177\/0145721708325156","article-title":"Development of a diabetes education program for youth with type 2 diabetes","volume":"35","author":"Grey","year":"2009","journal-title":"Diabetes Educ"},{"key":"10.1016\/S2213-8587(23)00225-5_bib102","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14927","article-title":"Developing services to support the delivery of care to people with early-onset type 2 diabetes","volume":"39","author":"Misra","year":"2022","journal-title":"Diabet Med"},{"issue":"suppl 27","key":"10.1016\/S2213-8587(23)00225-5_bib103","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1111\/pedi.12719","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: type 2 diabetes mellitus in youth","volume":"19","author":"Zeitler","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00225-5_bib104","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1007\/s00125-021-05568-3","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"64","author":"Holt","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00225-5_bib105","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110136","article-title":"Long-term outcomes of the pay-for-performance program for patients with young-onset (20\u201340 years of age) type 2 diabetes","volume":"193","author":"Yen","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00225-5_bib106","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00225-5_bib107","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2337\/dc22-0387","article-title":"Ten-year effectiveness of the multidisciplinary Risk Assessment and Management Programme-Diabetes Mellitus (RAMP-DM) on macrovascular and microvascular complications and all-cause mortality: a population-based cohort study","volume":"45","author":"Tang","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib108","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1007\/s11892-017-0905-0","article-title":"Use of continuous glucose monitoring in youth-onset type 2 diabetes","volume":"17","author":"Chan","year":"2017","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(23)00225-5_bib109","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1186\/s12875-022-01662-6","article-title":"Influence of synchronous primary care telemedicine versus in-person visits on diabetes, hypertension, and hyperlipidemia outcomes: a systematic review","volume":"23","author":"Mabeza","year":"2022","journal-title":"BMC Prim Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib110","doi-asserted-by":"crossref","first-page":"66","DOI":"10.2337\/ds18-0082","article-title":"Secular trends in information communications technology: access, use, and attitudes of young and older patients with diabetes","volume":"33","author":"Middleton","year":"2020","journal-title":"Diabetes Spectr"},{"key":"10.1016\/S2213-8587(23)00225-5_bib111","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/dme.13589","article-title":"Transfer from paediatric to adult care for young adults with Type 2 diabetes: the SEARCH for Diabetes in Youth Study","volume":"35","author":"Agarwal","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib112","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1016\/j.jcjd.2021.03.001","article-title":"Transition of youth with type 2 diabetes: predictors of health-care utilization after transition to adult care from population-based administrative data","volume":"45","author":"Pundyk","year":"2021","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(23)00225-5_bib113","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.jcjd.2018.10.007","article-title":"Transition to adult diabetes care: a description of practice in the Ontario Pediatric Diabetes Network","volume":"43","author":"Shulman","year":"2019","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(23)00225-5_bib114","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1111\/dme.12566","article-title":"Depression, anxiety and self-care behaviours of young adults with Type 2 diabetes: results from the International Diabetes Management and Impact for Long-term Empowerment and Success (MILES) study","volume":"32","author":"Browne","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib115","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/dme.12078","article-title":"The needs, concerns, and characteristics of younger Australian adults with type 2 diabetes","volume":"30","author":"Browne","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib116","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dc08-9026","volume":"32","author":"Skyler","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib117","series-title":"Type 2 diabetes in adults: management. NICE guideline","year":"2015"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00225-5_bib119","first-page":"S208","article-title":"14. Children and adolescents: standards of medical care in diabetes","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib120","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib121","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1016\/S0140-6736(17)32129-3","article-title":"Worldwide trends in body-mass index, underweight, overweight, and obesity from 1975 to 2016: a pooled analysis of 2416 population-based measurement studies in 128\u00b79 million children, adolescents, and adults","volume":"390","author":"Bentham","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00225-5_bib122","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1001\/jama.2022.14543","article-title":"Screening for prediabetes and type 2 diabetes in children and adolescents: US preventive services task force recommendation statement","volume":"328","author":"Mangione","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00225-5_bib123","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003981","article-title":"Integrating polygenic risk scores in the prediction of type 2 diabetes risk and subtypes in British Pakistanis and Bangladeshis: A population-based cohort study","volume":"19","author":"Hodgson","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(23)00225-5_bib124","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S2213-8587(22)00047-X","article-title":"Obesity in children and adolescents: epidemiology, causes, assessment, and management","volume":"10","author":"Jebeile","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib125","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1111\/obr.12830","article-title":"Efficacy of very low-energy diet programs for weight loss: a systematic review with meta-analysis of intervention studies in children and adolescents with obesity","volume":"20","author":"Andela","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(23)00225-5_bib126","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2147\/DMSO.S238419","article-title":"Current perspectives on the role of very-low-energy diets in the treatment of obesity and type 2 diabetes in youth","volume":"14","author":"Gow","year":"2021","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/S2213-8587(23)00225-5_bib127","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2337\/dc19-1425","article-title":"Early outcomes from the English National Health Service Diabetes Prevention Programme","volume":"43","author":"Valabhji","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib128","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002736","article-title":"Uptake and impact of the English National Health Service digital diabetes prevention programme: observational study","volume":"10","author":"Ross","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(23)00225-5_bib129","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00225-5_bib130","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1016\/S2213-8587(23)00062-1","article-title":"Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population-based cohort study","volume":"11","author":"Bardugo","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00225-5_bib131","doi-asserted-by":"crossref","first-page":"4774","DOI":"10.1210\/jc.2008-0772","article-title":"Prevention of diabetes in women with a history of gestational diabetes: effects of metformin and lifestyle interventions","volume":"93","author":"Ratner","year":"2008","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002255?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002255?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:38Z","timestamp":1761991958000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723002255"}},"issued":{"date-parts":[[2023,10]]},"references-count":129,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2213858723002255"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00225-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Current insights and emerging trends in early-onset type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00225-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:31:26Z","timestamp":1794619886136,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"crossref","award":["(08\/0003594 and 08\/0003741)"],"award-info":[{"award-number":["(08\/0003594 and 08\/0003741)"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/s2213-8587(18)30038-x","type":"journal-article","created":{"date-parts":[[2018,10,24]],"date-time":"2018-10-24T18:51:14Z","timestamp":1540407074000},"page":"954-965","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":428,"title":["Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Francesco","family":"D'Aiuto","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikolaos","family":"Gkranias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Devina","family":"Bhowruth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tauseef","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Orlandi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Suvan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Masi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Georgios","family":"Tsakos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Hurel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroon D","family":"Hingorani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Donos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John E","family":"Deanfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alastair","family":"Lomax","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Attila","family":"Horvath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riccardo","family":"Zambon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shiefung","family":"Tay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikos","family":"Tatarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dave","family":"Spratt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Kingston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Parkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulpee","family":"Darbar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kalpesh","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Giedrys-Leeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Harrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Baynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Gable","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankeet","family":"Haria","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Lessani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna","family":"Moskal-Fitzpatrick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Chiara","family":"Curra'","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banbai","family":"Hirani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kasia","family":"Niziolek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiffany","family":"Mellor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30038-X_bib1","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(13)62219-9","article-title":"The many faces of diabetes: a disease with increasing heterogeneity","volume":"383","author":"Tuomi","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30038-X_bib2","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1038\/nri2925","article-title":"Type 2 diabetes as an inflammatory disease","volume":"11","author":"Donath","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/S2213-8587(18)30038-X_bib3","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1038\/nrendo.2011.106","article-title":"Diabetes mellitus and periodontitis: a tale of two common interrelated diseases","volume":"7","author":"Lalla","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(18)30038-X_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/j.1600-0757.2012.00450.x","article-title":"Periodontitis: a host-mediated disruption of microbial homeostasis. Unlearning learned concepts","volume":"62","author":"Bartold","year":"2013","journal-title":"Periodontol 2000"},{"key":"10.1016\/S2213-8587(18)30038-X_bib5","doi-asserted-by":"crossref","first-page":"e0128344","DOI":"10.1371\/journal.pone.0128344","article-title":"Periodontal therapy and systemic inflammation in type 2 diabetes mellitus: a meta-analysis","volume":"10","author":"Artese","year":"2015","journal-title":"PLoS One"},{"issue":"suppl 14","key":"10.1016\/S2213-8587(18)30038-X_bib6","first-page":"S135","article-title":"Effect of periodontal disease on diabetes: systematic review of epidemiologic observational evidence","volume":"40","author":"Borgnakke","year":"2013","journal-title":"J Clin Periodontol"},{"key":"10.1016\/S2213-8587(18)30038-X_bib7","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1056\/NEJMoa063186","article-title":"Treatment of periodontitis and endothelial function","volume":"356","author":"Tonetti","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30038-X_bib8","article-title":"Treatment of periodontal disease for glycaemic control in people with diabetes mellitus","volume":"11","author":"Simpson","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(18)30038-X_bib9","doi-asserted-by":"crossref","first-page":"e108412","DOI":"10.1371\/journal.pone.0108412","article-title":"The effect of periodontal treatment on hemoglobin A1c levels of diabetic patients: a systematic review and meta-analysis","volume":"9","author":"Wang","year":"2014","journal-title":"PLoS One"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30038-X_bib10","first-page":"S13","article-title":"2. Classification and diagnosis of diabetes","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30038-X_bib11","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1136\/bmj.330.7495.843","article-title":"Treatment allocation by minimisation","volume":"330","author":"Altman","year":"2005","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30038-X_bib12","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1902\/jop.1983.54.8.470","article-title":"Comparison of results following modified Widman flap surgery with and without surgical dressing","volume":"54","author":"Allen","year":"1983","journal-title":"J Periodontol"},{"issue":"suppl 6","key":"10.1016\/S2213-8587(18)30038-X_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1111\/j.1600-051X.2005.00822.x","article-title":"Advances in the progression of periodontitis and proposal of definitions of a periodontitis case and disease progression for use in risk factor research. Group C consensus report of the 5th European Workshop in Periodontology","volume":"32","author":"Tonetti","year":"2005","journal-title":"J Clin Periodontol"},{"key":"10.1016\/S2213-8587(18)30038-X_bib14","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1023\/A:1026485130100","article-title":"The development of an individualized questionnaire measure of perceived impact of diabetes on quality of life: the ADDQoL","volume":"8","author":"Bradley","year":"1999","journal-title":"Qual Life Res"},{"key":"10.1016\/S2213-8587(18)30038-X_bib15","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1056\/NEJMra054415","article-title":"Assessing kidney function\u2014measured and estimated glomerular filtration rate","volume":"354","author":"Stevens","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30038-X_bib16","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1093\/eurheartj\/ehq340","article-title":"Assessment of atherosclerosis: the role of flow-mediated dilatation","volume":"31","author":"Charakida","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(18)30038-X_bib17","series-title":"Applied multilevel analysis","author":"Hox","year":"1994"},{"key":"10.1016\/S2213-8587(18)30038-X_bib18","doi-asserted-by":"crossref","first-page":"165","DOI":"10.7326\/0003-4819-128-3-199802010-00001","article-title":"United Kingdom Prospective Diabetes Study 24: a 6-year, randomized, controlled trial comparing sulfonylurea, insulin, and metformin therapy in patients with newly diagnosed type 2 diabetes that could not be controlled with diet therapy","volume":"128","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(18)30038-X_bib19","doi-asserted-by":"crossref","first-page":"196","DOI":"10.1016\/j.diabres.2007.08.024","article-title":"Comparison of different drugs as add-on treatments to metformin in type 2 diabetes: a meta-analysis","volume":"79","author":"Monami","year":"2008","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30038-X_bib20","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.2169\/internalmedicine.50.5166","article-title":"Inflammatory cytokines, adiponectin, insulin resistance and metabolic control after periodontal intervention in patients with type 2 diabetes and chronic periodontitis","volume":"50","author":"Sun","year":"2011","journal-title":"Intern Med"},{"key":"10.1016\/S2213-8587(18)30038-X_bib21","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/j.1600-051X.2006.01002.x","article-title":"Does periodontal care improve glycemic control? The Department of Veterans Affairs Dental Diabetes Study","volume":"34","author":"Jones","year":"2007","journal-title":"J Clin Periodontol"},{"key":"10.1016\/S2213-8587(18)30038-X_bib22","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1902\/jop.2011.110327","article-title":"Effects of non-surgical periodontal treatment on clinical response, serum inflammatory parameters, and metabolic control in patients with type 2 diabetes: a randomized study","volume":"83","author":"Chen","year":"2012","journal-title":"J Periodontol"},{"key":"10.1016\/S2213-8587(18)30038-X_bib23","doi-asserted-by":"crossref","first-page":"2523","DOI":"10.1001\/jama.2013.282431","article-title":"The effect of nonsurgical periodontal therapy on hemoglobin A1c levels in persons with type 2 diabetes and chronic periodontitis: a randomized clinical trial","volume":"310","author":"Engebretson","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30038-X_bib24","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/cs1010671","article-title":"The UKPDS risk engine: a model for the risk of coronary heart disease in type II diabetes (UKPDS 56)","volume":"101","author":"Stevens","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/S2213-8587(18)30038-X_bib25","doi-asserted-by":"crossref","first-page":"27","DOI":"10.2337\/diacare.28.1.27","article-title":"Periodontal disease and mortality in type 2 diabetes","volume":"28","author":"Saremi","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30038-X_bib26","doi-asserted-by":"crossref","first-page":"717","DOI":"10.1038\/nrneph.2013.197","article-title":"The role of the glomerular endothelium in albumin handling","volume":"9","author":"Satchell","year":"2013","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S2213-8587(18)30038-X_bib27","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1002\/path.3964","article-title":"Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability","volume":"226","author":"Salmon","year":"2012","journal-title":"J Pathol"},{"key":"10.1016\/S2213-8587(18)30038-X_bib28","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(18)30038-X_bib29","doi-asserted-by":"crossref","first-page":"1793","DOI":"10.1172\/JCI29069","article-title":"Inflammation and insulin resistance","volume":"116","author":"Shoelson","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(18)30038-X_bib30","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/j.1600-051X.2006.01017.x","article-title":"Plasma levels of tumour necrosis factor-alpha in patients with chronic periodontitis and type 2 diabetes","volume":"34","author":"Engebretson","year":"2007","journal-title":"J Clin Periodontol"},{"key":"10.1016\/S2213-8587(18)30038-X_bib31","doi-asserted-by":"crossref","first-page":"543","DOI":"10.7326\/0003-4819-159-8-201310150-00007","article-title":"Lifestyle interventions for patients with and at risk for type 2 diabetes: a systematic review and meta-analysis","volume":"159","author":"Schellenberg","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(18)30038-X_bib32","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1373\/clinchem.2010.148833","article-title":"Therapeutic approaches to target inflammation in type 2 diabetes","volume":"57","author":"Goldfine","year":"2011","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(18)30038-X_bib33","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1056\/NEJMoa1707914","article-title":"Antiinflammatory therapy with canakinumab for atherosclerotic disease","volume":"377","author":"Ridker","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30038-X_bib34","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1038\/sj.bdj.2012.1088","article-title":"Adult Dental Health Survey 2009: common oral health conditions and their impact on the population","volume":"213","author":"White","year":"2012","journal-title":"Br Dent J"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871830038X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871830038X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T00:12:31Z","timestamp":1550535151000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871830038X"}},"issued":{"date-parts":[[2018,12]]},"references-count":34,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S221385871830038X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30038-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30038-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30032-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T16:50:27Z","timestamp":1794675027627,"version":"4.9.1"},"reference-count":150,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/s2213-8587(19)30254-2","type":"journal-article","created":{"date-parts":[[2019,10,14]],"date-time":"2019-10-14T18:39:48Z","timestamp":1571078388000},"page":"68-80","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Opioid-induced endocrinopathies"],"prefix":"10.1016","volume":"8","author":[{"given":"Athanasios","family":"Fountas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Van Uum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niki","family":"Karavitaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30254-2_bib1","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1177\/2049463712438493","article-title":"Basic opioid pharmacology: an update","volume":"6","author":"Pathan","year":"2012","journal-title":"Br J Pain"},{"key":"10.1016\/S2213-8587(19)30254-2_bib2","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1212\/WNL.0b013e3182662098","article-title":"Endogenous opioid systems: current concepts and clinical correlations","volume":"79","author":"Benarroch","year":"2012","journal-title":"Neurology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib3","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1146\/annurev-med-062613-093100","article-title":"Opioid receptors","volume":"67","author":"Stein","year":"2016","journal-title":"Annu Rev Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib4","doi-asserted-by":"crossref","first-page":"2514","DOI":"10.1038\/s41386-018-0225-3","article-title":"Untangling the complexity of opioid receptor function","volume":"43","author":"Valentino","year":"2018","journal-title":"Neuropsychopharmacology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib5","doi-asserted-by":"crossref","first-page":"7011","DOI":"10.1021\/acs.jmedchem.5b01499","article-title":"Nociceptin opioid receptor (NOP) as a therapeutic target: progress in translation from preclinical research to clinical utility","volume":"59","author":"Zaveri","year":"2016","journal-title":"J Med Chem"},{"key":"10.1016\/S2213-8587(19)30254-2_bib6","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.chest.2016.12.028","article-title":"Symptomatic treatment of cough among adult patients with lung cancer: CHEST guideline and expert panel report","volume":"151","author":"Molassiotis","year":"2017","journal-title":"Chest"},{"key":"10.1016\/S2213-8587(19)30254-2_bib7","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1016\/j.cgh.2017.05.014","article-title":"Opioids in gastroenterology: treating adverse effects and creating therapeutic benefits","volume":"15","author":"Camilleri","year":"2017","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib8","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30254-2_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/eurheartj\/ehx393","volume":"39","author":"Ibanez","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(19)30254-2_bib10","series-title":"2018 annual surveillance report of drug-related risks and outcomes\u2014United States","year":"2018"},{"key":"10.1016\/S2213-8587(19)30254-2_bib11","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1111\/imj.12966","article-title":"Prescription opioid analgesics for pain management in Australia: 20 years of dispensing","volume":"46","author":"Islam","year":"2016","journal-title":"Intern Med J"},{"key":"10.1016\/S2213-8587(19)30254-2_bib12","series-title":"National opioid pharmacotherapy statistics (NOPSAD) 2017","year":"2018"},{"key":"10.1016\/S2213-8587(19)30254-2_bib14","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.15585\/mmwr.mm6450a3","article-title":"Increases in drug and opioid overdose deaths\u2014United States, 2000\u20132014","volume":"64","author":"Rudd","year":"2016","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S2213-8587(19)30254-2_bib15","doi-asserted-by":"crossref","first-page":"349","DOI":"10.15585\/mmwr.mm6712a1","article-title":"Overdose deaths involving opioids, cocaine, and psychostimulants\u2014United States, 2015\u20132016","volume":"67","author":"Seth","year":"2018","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S2213-8587(19)30254-2_bib16","series-title":"Opioid harm in Australia and comparisons between Australia and Canada","year":"2018"},{"key":"10.1016\/S2213-8587(19)30254-2_bib17","series-title":"Deaths related to drug poisoning in England and Wales: 2017 registrations","year":"2018"},{"key":"10.1016\/S2213-8587(19)30254-2_bib18","article-title":"Overprescribing is major contributor to opioid crisis","volume":"359","author":"Makary","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30254-2_bib19","doi-asserted-by":"crossref","first-page":"221","DOI":"10.2105\/AJPH.2007.131714","article-title":"The promotion and marketing of oxycontin: commercial triumph, public health tragedy","volume":"99","author":"Van Zee","year":"2009","journal-title":"Am J Public Health"},{"key":"10.1016\/S2213-8587(19)30254-2_bib20","series-title":"Diagnostic and statistical manual of mental disorders","year":"2013"},{"key":"10.1016\/S2213-8587(19)30254-2_bib21","series-title":"National Drug Strategy Household Survey 2016: detailed findings","year":"2017"},{"key":"10.1016\/S2213-8587(19)30254-2_bib22","series-title":"Drug misuse: findings from the 2015\/16 Crime Survey for England and Wales","year":"2016"},{"key":"10.1016\/S2213-8587(19)30254-2_bib23","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1001\/jama.2016.7789","article-title":"Prescription of long-acting opioids and mortality in patients with chronic noncancer pain","volume":"315","author":"Ray","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30254-2_bib24","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/jcem-50-2-251","article-title":"Endocrine effects of naloxone-induced opiate receptor blockade","volume":"50","author":"Morley","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30254-2_bib25","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1159\/000123558","article-title":"Differential effects of opiate peptides and alkaloids on anterior pituitary hormone secretion","volume":"37","author":"Delitala","year":"1983","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib26","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1111\/papr.12731","article-title":"An internet-based survey to assess clinicians' knowledge and attitudes towards opioid-induced hypogonadism","volume":"19","author":"Hochberg","year":"2019","journal-title":"Pain Pract"},{"key":"10.1016\/S2213-8587(19)30254-2_bib27","doi-asserted-by":"crossref","DOI":"10.4158\/EP-2019-0177","article-title":"Current knowledge and practices of heath care professionals on opioid-induced adrenal insufficiency","author":"Saeed","year":"2019","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(19)30254-2_bib28","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1210\/er.2009-0009","article-title":"The effects of opioids and opioid analogs on animal and human endocrine systems","volume":"31","author":"Vuong","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(19)30254-2_bib29","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.fertnstert.2017.06.009","article-title":"Impact of the opioid system on the reproductive axis","volume":"108","author":"Bottcher","year":"2017","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(19)30254-2_bib30","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1677\/joe.0.0780299","article-title":"Failure of methadone-treated human testes to respond to the stimulatory effect of human chorionic gonadotrophin on testosterone biosynthesis in vitro","volume":"78","author":"Purohit","year":"1978","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib31","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.01.038","article-title":"Testosterone suppression in opioid users: a systematic review and meta-analysis","volume":"149","author":"Bawor","year":"2015","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/S2213-8587(19)30254-2_bib32","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S0022-3565(25)30047-9","article-title":"Plasma testosterone levels in heroin addiction and during methadone maintenance","volume":"192","author":"Mendelson","year":"1975","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S2213-8587(19)30254-2_bib33","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/0039-128X(73)90002-0","article-title":"Decreased serum testosterone concentration in male heroin and methadone addicts","volume":"22","author":"Azizi","year":"1973","journal-title":"Steroids"},{"key":"10.1016\/S2213-8587(19)30254-2_bib34","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.jsxm.2017.12.004","article-title":"Plasma testosterone and sexual function in Southeast Asian men receiving methadone and buprenorphine maintenance treatment","volume":"15","author":"Yee","year":"2018","journal-title":"J Sex Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib35","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1365-2605.2007.00824.x","article-title":"Hypogonadism in men receiving methadone and buprenorphine maintenance treatment","volume":"32","author":"Hallinan","year":"2009","journal-title":"Int J Androl"},{"key":"10.1016\/S2213-8587(19)30254-2_bib36","first-page":"35","article-title":"The effect of opium on serum LH, FSH and testosterone concentration in addicted men","volume":"5","author":"Hejazian","year":"2007","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.3923\/jms.2006.209.212","article-title":"Effects of opium dependency on hypothalamic pituitary gonadal axis","volume":"6","author":"Shahramian","year":"2006","journal-title":"J Med Sci"},{"key":"10.1016\/S2213-8587(19)30254-2_bib38","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1136\/postgradmedj-2016-134299","article-title":"The effects of opioids on the endocrine system: an overview","volume":"92","author":"Ali","year":"2016","journal-title":"Postgrad Med J"},{"key":"10.1016\/S2213-8587(19)30254-2_bib39","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1007\/s40618-018-0964-3","article-title":"Testosterone deficiency in non-cancer opioid-treated patients","volume":"41","author":"Coluzzi","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(19)30254-2_bib40","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1097\/j.pain.0000000000000691","article-title":"Comprehensive systematic review of long-term opioids in women with chronic noncancer pain and associated reproductive dysfunction (hypothalamic-pituitary-gonadal axis disruption)","volume":"158","author":"Wersocki","year":"2017","journal-title":"Pain"},{"key":"10.1016\/S2213-8587(19)30254-2_bib41","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1002\/ejp.1256","article-title":"Increased risk of reproductive dysfunction in women prescribed long-term opioids for musculoskeletal pain: a matched cohort study in the Clinical Practice Research Datalink","volume":"22","author":"Richardson","year":"2018","journal-title":"Eur J Pain"},{"key":"10.1016\/S2213-8587(19)30254-2_bib42","doi-asserted-by":"crossref","first-page":"2949","DOI":"10.1002\/cncr.22339","article-title":"The impact of hypogonadism and autonomic dysfunction on fatigue, emotional function, and sexual desire in male patients with advanced cancer: a pilot study","volume":"107","author":"Strasser","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(19)30254-2_bib43","doi-asserted-by":"crossref","first-page":"1819","DOI":"10.3892\/etm.2016.3156","article-title":"Opioid endocrinopathy: a clinical problem in patients with cancer pain","volume":"11","author":"Merdin","year":"2016","journal-title":"Exp Ther Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib44","first-page":"1699","article-title":"A systematic review of opioid effects on the hypogonadal axis of cancer patients","volume":"22","author":"McWilliams","year":"2014","journal-title":"Support Care Cancer"},{"key":"10.1016\/S2213-8587(19)30254-2_bib45","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1002\/cncr.20028","article-title":"Symptomatic hypogonadism in male survivors of cancer with chronic exposure to opioids","volume":"100","author":"Rajagopal","year":"2004","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(19)30254-2_bib46","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1210\/jcem.85.6.6615","article-title":"Endocrine consequences of long-term intrathecal administration of opioids","volume":"85","author":"Abs","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(19)30254-2_bib47","doi-asserted-by":"crossref","first-page":"S162","DOI":"10.1016\/j.psyneuen.2009.05.013","article-title":"Endocrine consequences of opioid therapy","volume":"34","author":"Aloisi","year":"2009","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib48","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1002\/cpt1975175529","article-title":"Plasma testosterone levels during chronic heroin use and protracted abstinence: a study of Hong Kong addicts","volume":"17","author":"Mendelson","year":"1975","journal-title":"Clin Pharmacol Ther"},{"key":"10.1016\/S2213-8587(19)30254-2_bib49","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1054\/jpai.2002.126790","article-title":"Hypogonadism in men consuming sustained-action oral opioids","volume":"3","author":"Daniell","year":"2002","journal-title":"J Pain"},{"key":"10.1016\/S2213-8587(19)30254-2_bib50","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1016\/j.amjmed.2014.07.015","article-title":"Elucidating risk factors for androgen deficiency associated with daily opioid use","volume":"127","author":"Rubinstein","year":"2014","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib51","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1093\/pm\/pnw182","article-title":"Association between commonly prescribed opioids and androgen deficiency in men: a retrospective cohort analysis","volume":"18","author":"Rubinstein","year":"2017","journal-title":"Pain Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib52","doi-asserted-by":"crossref","DOI":"10.1515\/hmbci-2017-0080","article-title":"Impact of opioid therapy on gonadal hormones: focus on buprenorphine","author":"Varma","year":"2018","journal-title":"Horm Mol Biol Clin Investig"},{"key":"10.1016\/S2213-8587(19)30254-2_bib53","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1177\/2049463716657363","article-title":"Is tapentadol different from classical opioids? A review of the evidence","volume":"10","author":"Langford","year":"2016","journal-title":"Br J Pain"},{"key":"10.1016\/S2213-8587(19)30254-2_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c4462","article-title":"Opioid induced hypogonadism","volume":"341","author":"Reddy","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30254-2_bib55","doi-asserted-by":"crossref","first-page":"R183","DOI":"10.1530\/EJE-18-0270","article-title":"Mechanisms of endocrinology: endocrinology of opioids","volume":"179","author":"Fountas","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib56","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jpain.2005.10.009","article-title":"Open-label pilot study of testosterone patch therapy in men with opioid-induced androgen deficiency","volume":"7","author":"Daniell","year":"2006","journal-title":"J Pain"},{"key":"10.1016\/S2213-8587(19)30254-2_bib57","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1097\/01.j.pain.0000460308.86819.aa","article-title":"Effects of testosterone replacement in men with opioid-induced androgen deficiency: a randomized controlled trial","volume":"156","author":"Basaria","year":"2015","journal-title":"Pain"},{"key":"10.1016\/S2213-8587(19)30254-2_bib58","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1111\/j.1526-4637.2012.01368.x","article-title":"Testosterone replacement therapy outcomes among opioid users: the Testim Registry in the United States (TRiUS)","volume":"13","author":"Blick","year":"2012","journal-title":"Pain Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib59","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/1477-7827-9-26","article-title":"Hormone replacement therapy in morphine-induced hypogonadic male chronic pain patients","volume":"9","author":"Aloisi","year":"2011","journal-title":"Reprod Biol Endocrinol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib60","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1177\/1557988316672396","article-title":"The role of testosterone supplemental therapy in opioid-induced hypogonadism: a retrospective pilot analysis","volume":"11","author":"Raheem","year":"2017","journal-title":"Am J Mens Health"},{"key":"10.1016\/S2213-8587(19)30254-2_bib61","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1007\/s11934-016-0634-y","article-title":"Opioid-induced androgen deficiency (OPIAD): diagnosis, management, and literature review","volume":"17","author":"O'Rourke","year":"2016","journal-title":"Curr Urol Rep"},{"key":"10.1016\/S2213-8587(19)30254-2_bib62","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.jpain.2007.08.005","article-title":"Opioid endocrinopathy in women consuming prescribed sustained-action opioids for control of nonmalignant pain","volume":"9","author":"Daniell","year":"2008","journal-title":"J Pain"},{"key":"10.1016\/S2213-8587(19)30254-2_bib63","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1097\/AJP.0b013e3181d1059d","article-title":"Opioid endocrinopathy: a clinical problem in patients with chronic pain and long-term oral opioid treatment","volume":"26","author":"Rhodin","year":"2010","journal-title":"Clin J Pain"},{"key":"10.1016\/S2213-8587(19)30254-2_bib64","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1016\/j.reprotox.2012.11.010","article-title":"The effects of opiate consumption on serum reproductive hormone levels, sperm parameters, seminal plasma antioxidant capacity and sperm DNA integrity","volume":"36","author":"Safarinejad","year":"2013","journal-title":"Reprod Toxicol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib65","doi-asserted-by":"crossref","DOI":"10.1111\/and.13026","article-title":"Tramadol (opioid) abuse is associated with a dose- and time-dependent poor sperm quality and hyperprolactinaemia in young men","volume":"50","author":"Farag","year":"2018","journal-title":"Andrologia"},{"key":"10.1016\/S2213-8587(19)30254-2_bib66","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000346110","article-title":"Atrial natriuretic peptide, arginine vasopressin peptide and cortisol serum levels in opiate-dependent patients","volume":"67","author":"Glahn","year":"2013","journal-title":"Neuropsychobiology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib67","first-page":"509","article-title":"Effect of oral morphine and naloxone on pituitary-adrenal response in man induced by human corticotropin-releasing hormone","volume":"114","author":"Allolio","year":"1987","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/S2213-8587(19)30254-2_bib68","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1210\/jcem-60-5-891","article-title":"Morphine inhibits the pituitary-adrenal response to ovine corticotropin-releasing hormone in normal subjects","volume":"60","author":"Rittmaster","year":"1985","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30254-2_bib69","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.regpep.2010.08.008","article-title":"Stimulatory effect of naloxone on plasma cortisol in human: possible direct stimulatory action at the adrenal cortex","volume":"166","author":"Coiro","year":"2011","journal-title":"Regul Pept"},{"key":"10.1016\/S2213-8587(19)30254-2_bib70","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1016\/j.psyneuen.2014.12.004","article-title":"Opioid partial agonist buprenorphine dampens responses to psychosocial stress in humans","volume":"52","author":"Bershad","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib71","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.yhbeh.2018.04.009","article-title":"Effects of opioid- and non-opioid analgesics on responses to psychosocial stress in humans","volume":"102","author":"Bershad","year":"2018","journal-title":"Horm Behav"},{"key":"10.1016\/S2213-8587(19)30254-2_bib72","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1007\/s00540-013-1738-x","article-title":"High-dose remifentanil suppresses stress response associated with pneumoperitoneum during laparoscopic colectomy","volume":"28","author":"Watanabe","year":"2014","journal-title":"J Anesth"},{"key":"10.1016\/S2213-8587(19)30254-2_bib73","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1111\/pme.12661","article-title":"Chronic spinal and oral morphine-induced neuroendocrine and metabolic changes in noncancer pain patients","volume":"16","author":"Valverde-Filho","year":"2015","journal-title":"Pain Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib74","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1111\/cen.13125","article-title":"Adrenal insufficiency in patients on long-term opioid analgesia","volume":"85","author":"Gibb","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(19)30254-2_bib75","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/EJE-18-0530","article-title":"Secondary adrenal insufficiency and pituitary dysfunction in oral\/transdermal opioid users with non-cancer pain","volume":"179","author":"Lamprecht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib76","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1111\/j.1365-2265.2007.02779.x","article-title":"Secondary adrenal failure and secondary amenorrhoea following hydromorphone treatment","volume":"66","author":"M\u00fcssig","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(19)30254-2_bib77","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00228-011-0992-9","article-title":"Tramadol-induced adrenal insufficiency","volume":"67","author":"Debono","year":"2011","journal-title":"Eur J Clin Pharmacol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib78","article-title":"Chronic heroin dependence leading to adrenal insufficiency","volume":"2014","author":"Das","year":"2014","journal-title":"Case Rep Endocrinol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib79","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2016-216384","article-title":"Loperamide-induced hypopituitarism","volume":"2016","author":"Napier","year":"2016","journal-title":"BMJ Case Rep"},{"key":"10.1016\/S2213-8587(19)30254-2_bib80","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1111\/j.1365-2796.2005.01483.x","article-title":"Chronic fentanyl application induces adrenocortical insufficiency","volume":"257","author":"Oltmanns","year":"2005","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib81","article-title":"Adrenal insufficiency in acute oral opiate therapy","volume":"2014","author":"Policola","year":"2014","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/S2213-8587(19)30254-2_bib82","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1159\/000334411","article-title":"The impact of diacetylmorphine on hypothalamic-pituitary-adrenal axis activity and heroin craving in heroin dependence","volume":"18","author":"Gerber","year":"2012","journal-title":"Eur Addict Res"},{"key":"10.1016\/S2213-8587(19)30254-2_bib83","first-page":"149","article-title":"Impaired circadian rhythmicity of \u03b2-lipotrophin, \u03b2-endorphin and ACTH in heroin addicts","volume":"105","author":"Facchinetti","year":"1984","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/S2213-8587(19)30254-2_bib84","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.psyneuen.2015.03.015","article-title":"Low-dose hydrocortisone replacement improves wellbeing and pain tolerance in chronic pain patients with opioid-induced hypocortisolemic responses. A pilot randomized, placebo-controlled trial","volume":"56","author":"Nenke","year":"2015","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib85","doi-asserted-by":"crossref","first-page":"1816","DOI":"10.2522\/ptj.20130597","article-title":"Chronic stress, cortisol dysfunction, and pain: a psychoneuroendocrine rationale for stress management in pain rehabilitation","volume":"94","author":"Hannibal","year":"2014","journal-title":"Phys Ther"},{"key":"10.1016\/S2213-8587(19)30254-2_bib86","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1159\/000124147","article-title":"Pituitary secretion of growth hormone in response to opioid peptides and opiates is mediated through growth hormone-releasing factor","volume":"41","author":"Wehrenberg","year":"1985","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib87","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1055\/s-2005-870230","article-title":"Effect of opiates on growth hormone secretion in acromegaly","volume":"37","author":"Bhansali","year":"2005","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(19)30254-2_bib88","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S0015-0282(16)46101-7","article-title":"Effect of morphine on the hypothalamic-pituitary axis in postmenopausal women","volume":"37","author":"Hemmings","year":"1982","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(19)30254-2_bib89","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1210\/jcem-41-4-797","article-title":"Effects of morphine on serum growth hormone, cortisol, prolactin and thyroid stimulating hormone in man","volume":"41","author":"Tolis","year":"1975","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30254-2_bib90","doi-asserted-by":"crossref","first-page":"2203","DOI":"10.1016\/S0140-6736(03)13775-0","article-title":"Patients with chronic pain and abnormal pituitary function require investigation","volume":"361","author":"Merza","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30254-2_bib91","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1210\/jcem-35-3-352","article-title":"Growth hormone in narcotic addiction","volume":"35","author":"Cushman","year":"1972","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30254-2_bib92","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1152\/physrev.2000.80.4.1523","article-title":"Prolactin: structure, function, and regulation of secretion","volume":"80","author":"Freeman","year":"2000","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(19)30254-2_bib93","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1210\/jcem-47-1-200","article-title":"Opiates, prolactin, and the dopamine receptor","volume":"47","author":"Tolis","year":"1978","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30254-2_bib94","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000180040","article-title":"Effects of dopamine receptor stimulation on opiate-induced modifications of pituitary-gonadal function","volume":"21","author":"Vescovi","year":"1985","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(19)30254-2_bib95","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1111\/j.1365-2265.1989.tb00441.x","article-title":"Effect of morphine on cortisol and prolactin secretion in anorexia nervosa and depression","volume":"30","author":"Zis","year":"1989","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(19)30254-2_bib96","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/0306-4530(87)90016-3","article-title":"Multiple hormonal responses to morphine: relationship to diagnosis and dexamethasone suppression","volume":"12","author":"Banki","year":"1987","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib97","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1016\/0306-4530(84)90050-7","article-title":"Morphine inhibits cortisol and stimulates prolactin secretion in man","volume":"9","author":"Zis","year":"1984","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib98","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/BF00718020","article-title":"Intraventricular morphine produces pain relief, hypothermia, hyperglycaemia and increased prolactin and growth hormone levels in patients with cancer pain","volume":"235","author":"Su","year":"1987","journal-title":"J Neurol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib99","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S0192-0561(96)00059-8","article-title":"Role of prolactin in the modulation of NK and LAK cell activity after short- or long-term morphine administration in neoplastic patients","volume":"18","author":"Provinciali","year":"1996","journal-title":"Int J Immunopharmacol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib100","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/00004714-198904000-00006","article-title":"Naloxone suppresses buprenorphine stimulation of plasma prolactin","volume":"9","author":"Mendelson","year":"1989","journal-title":"J Clin Psychopharmacol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib101","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/j.1600-0773.1989.tb01168.x","article-title":"Psychomotor, respiratory and neuroendocrinological effects of a \u03bc-opioid receptor agonist (oxycodone) in healthy volunteers","volume":"65","author":"Saarialho-Kere","year":"1989","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib102","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1016\/0306-4530(88)90046-7","article-title":"Human studies on the \u03bc opiate receptor agonist fentanyl: neuroendocrine and behavioral responses","volume":"13","author":"Hoehe","year":"1988","journal-title":"Psychoneuroendocrinology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib103","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1111\/j.1365-2265.1979.tb02115.x","article-title":"Effects of heroin addiction on thyrotrophin, thyroid hormones and prolactin secretion in men","volume":"10","author":"Chan","year":"1979","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(19)30254-2_bib104","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/13556210500351263","article-title":"Enhanced prolactin levels in opium smokers","volume":"10","author":"Moshtaghi-Kashanian","year":"2005","journal-title":"Addict Biol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib105","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1055\/s-0028-1093505","article-title":"The effect of methadone on hypophyseal and peripheral glandular hormones during withdrawal","volume":"9","author":"Kley","year":"1977","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(19)30254-2_bib106","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1210\/jc.2004-0929","article-title":"Plasma testosterone and sexual function in men receiving buprenorphine maintenance for opioid dependence","volume":"90","author":"Bliesener","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30254-2_bib107","first-page":"178","article-title":"Evaluation of the effects induced by four opiate drugs, with different affinities to opioid receptor subtypes, on anterior pituitary LH, TSH, PRL and GH secretion and on cortisol secretion in normal men","volume":"40","author":"Pende","year":"1986","journal-title":"Biomed Pharmacother"},{"key":"10.1016\/S2213-8587(19)30254-2_bib108","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1159\/000124091","article-title":"Morphine-induced TSH release in normal and hypothyroid subjects","volume":"40","author":"Devilla","year":"1985","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib109","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1055\/s-2007-1014693","article-title":"Effect of methadone on TSH and thyroid hormone secretion","volume":"16","author":"Vescovi","year":"1984","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(19)30254-2_bib110","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1007\/BF03348271","article-title":"Effects of chronic heroin addiction on pituitary-thyroid function in man","volume":"3","author":"Brambilla","year":"1980","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(19)30254-2_bib111","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/0376-8716(87)90034-2","article-title":"Prolactin and thyrotropin pituitary response to thyrotropin releasing hormone in young female heroin addicts","volume":"20","author":"Spagnolli","year":"1987","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/S2213-8587(19)30254-2_bib112","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1080\/13556210500351263","article-title":"Enhanced prolactin levels in opium smokers","volume":"10","author":"Moshtaghi-Kashanian","year":"2005","journal-title":"Addict Biol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib113","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/2251-6581-13-5","article-title":"The effect of opium addiction on thyroid function tests","volume":"13","author":"Gozashti","year":"2014","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/S2213-8587(19)30254-2_bib114","doi-asserted-by":"crossref","first-page":"71","DOI":"10.3346\/jkms.1989.4.2.71","article-title":"Responses of vasopressin release in patients with cardiopulmonary bypass anesthetized with enflurane and morphine","volume":"4","author":"Lee","year":"1989","journal-title":"J Korean Med Sci"},{"key":"10.1016\/S2213-8587(19)30254-2_bib115","first-page":"1169","article-title":"The comparison of epidural fentanyl, epidural lidocaine, and intravenous fentanyl in patients undergoing gastrectomy","volume":"81","author":"Harukuni","year":"1995","journal-title":"Anesth Analg"},{"key":"10.1016\/S2213-8587(19)30254-2_bib116","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/bjs.1800760110","article-title":"Plasma arginine vasopressin levels and arterial pressure during open heart surgery","volume":"76","author":"Woods","year":"1989","journal-title":"Br J Surg"},{"key":"10.1016\/S2213-8587(19)30254-2_bib117","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1016\/S0140-6736(80)92542-8","article-title":"Inhibition of vasopressin release in man by an opiate peptide","volume":"316","author":"Grossman","year":"1980","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30254-2_bib118","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1210\/jcem-51-6-1447","article-title":"Effects of the opiate antagonist naloxone and the enkephalin analog DAMME on the vasopressin response to a hypertonic stimulus in man","volume":"51","author":"Lightman","year":"1980","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30254-2_bib119","first-page":"304","article-title":"Inhibition of vasopressin secretion by a met-enkephalin (FK 33-824) in humans","volume":"94","author":"Brownell","year":"1980","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/S2213-8587(19)30254-2_bib120","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1046\/j.1365-2125.2000.00256.x","article-title":"Influence of asimadoline, a new \u03ba-opioid receptor agonist, on tubular water absorption and vasopressin secretion in man","volume":"50","author":"Kramer","year":"2000","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib121","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1111\/j.1365-2125.1991.tb03960.x","article-title":"Mechanism of diuretic action of spiradoline (U-62066E)\u2014a kappa opioid receptor agonist in the human","volume":"32","author":"Rimoy","year":"1991","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib122","doi-asserted-by":"crossref","first-page":"970","DOI":"10.1016\/S0022-3565(25)39200-1","article-title":"Effects of fentanyl on vasopressin secretion in human subjects","volume":"242","author":"Weiskopf","year":"1987","journal-title":"J Pharmacol Exp Ther"},{"key":"10.1016\/S2213-8587(19)30254-2_bib123","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1111\/j.1600-0773.1987.tb01823.x","article-title":"Meptazinol and pentazocine: effects on prolactin, growth hormone and vasopressin levels in plasma","volume":"61","author":"Manner","year":"1987","journal-title":"Pharmacol Toxicol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib124","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S0168-0102(99)00121-2","article-title":"Opioid modulation of magnocellular neurosecretory cell activity","volume":"36","author":"Brown","year":"2000","journal-title":"Neurosci Res"},{"key":"10.1016\/S2213-8587(19)30254-2_bib125","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1365-2265.1992.tb02337.x","article-title":"The effect of morphine and naloxone administration on plasma oxytocin concentrations in the first stage of labour","volume":"37","author":"Lindow","year":"1992","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(19)30254-2_bib126","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1053\/rapm.2001.27851","article-title":"Effects of intrathecal sufentanil on plasma oxytocin and cortisol concentrations in women during the first stage of labor","volume":"26","author":"Stocche","year":"2001","journal-title":"Reg Anesth Pain Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib127","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1159\/000010130","article-title":"Morphine suppresses the oxytocin response in breast-feeding women","volume":"48","author":"Lindow","year":"1999","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/S2213-8587(19)30254-2_bib128","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1111\/j.1365-2265.1993.tb02425.x","article-title":"The effect of morphine and naloxone administration on maternal oxytocin concentration in late pregnancy","volume":"39","author":"Lindow","year":"1993","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(19)30254-2_bib129","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1042\/cs1010415","article-title":"Effect of intrathecal fentanyl on oxytocin secretion in pregnant women not in labour","volume":"101","author":"Shibli","year":"2001","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/S2213-8587(19)30254-2_bib130","doi-asserted-by":"crossref","first-page":"515","DOI":"10.2147\/TCRM.S79409","article-title":"The unsolved case of \u201cbone-impairing analgesics\u201d: the endocrine effects of opioids on bone metabolism","volume":"11","author":"Coluzzi","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/S2213-8587(19)30254-2_bib131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1159\/000054586","article-title":"Expression of opioid receptors in osteoblast-like MG-63 cells, and effects of different opioid agonists on alkaline phosphatase and osteocalcin secretion by these cells","volume":"72","author":"P\u00e9rez-Castrill\u00f3n","year":"2000","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(19)30254-2_bib132","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1001\/archinte.164.3.338-a","article-title":"Opioid osteoporosis","volume":"164","author":"Daniell","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib133","first-page":"535","article-title":"The effect of opioid dependence on conventional and novel biochemical parameters of bone metabolism","volume":"41","author":"Balodimos","year":"2015","journal-title":"Am J Drug Alcohol Abuse"},{"key":"10.1016\/S2213-8587(19)30254-2_bib134","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1007\/s00774-015-0732-9","article-title":"Bone mineral density and its determinants in men with opioid dependence","volume":"35","author":"Gotthardt","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/S2213-8587(19)30254-2_bib135","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1111\/j.1360-0443.2010.03159.x","article-title":"Decreased bone density in men on methadone maintenance therapy","volume":"106","author":"Grey","year":"2011","journal-title":"Addiction"},{"key":"10.1016\/S2213-8587(19)30254-2_bib136","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-002856","article-title":"Hypogonadism and low bone mineral density in patients on long-term intrathecal opioid delivery therapy","volume":"3","author":"Duarte","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(19)30254-2_bib137","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1055\/s-2008-1076715","article-title":"Oral opioids for chronic non-cancer pain: higher prevalence of hypogonadism in men than in women","volume":"117","author":"Fraser","year":"2009","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/S2213-8587(19)30254-2_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjmed.2005.07.033","article-title":"Bone mineral density in subjects using central nervous system-active medications","volume":"118","author":"Kinjo","year":"2005","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib139","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1007\/s00198-011-1692-0","article-title":"Effects of paracetamol, non-steroidal anti-inflammatory drugs, acetylsalicylic acid, and opioids on bone mineral density and risk of fracture: results of the Danish Osteoporosis Prevention Study (DOPS)","volume":"23","author":"Vestergaard","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30254-2_bib140","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1016\/j.drugalcdep.2006.05.027","article-title":"Low bone density in patients receiving methadone maintenance treatment","volume":"85","author":"Kim","year":"2006","journal-title":"Drug Alcohol Depend"},{"key":"10.1016\/S2213-8587(19)30254-2_bib141","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/s00223-011-9510-4","article-title":"Bone mineral density in young women on methadone substitution","volume":"89","author":"Milos","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(19)30254-2_bib142","first-page":"42","article-title":"Effects of chronic heroin abuse on bone and mineral metabolism","volume":"129","author":"Pedrazzoni","year":"1993","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/S2213-8587(19)30254-2_bib143","doi-asserted-by":"crossref","first-page":"171","DOI":"10.2165\/00002018-200730020-00006","article-title":"Psychotropic medications and the risk of fracture: a meta-analysis","volume":"30","author":"Takkouche","year":"2007","journal-title":"Drug Saf"},{"key":"10.1016\/S2213-8587(19)30254-2_bib144","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0128232","article-title":"Opioids contribute to fracture risk: a meta-analysis of 8 cohort studies","volume":"10","author":"Teng","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30254-2_bib145","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00774-016-0755-x","article-title":"Opioids increase hip fracture risk: a meta-analysis","volume":"35","author":"Ping","year":"2017","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/S2213-8587(19)30254-2_bib146","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2796.2006.01667.x","article-title":"Fracture risk associated with the use of morphine and opiates","volume":"260","author":"Vestergaard","year":"2006","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib147","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/j.1532-5415.2011.03318.x","article-title":"Opioid analgesics and the risk of fractures in older adults with arthritis","volume":"59","author":"Miller","year":"2011","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(19)30254-2_bib148","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s11606-009-1218-z","article-title":"Relationship of opioid use and dosage levels to fractures in older chronic pain patients","volume":"25","author":"Saunders","year":"2010","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib149","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s11606-015-3579-9","article-title":"Association of opioids with falls, fractures, and physical performance among older men with persistent musculoskeletal pain","volume":"31","author":"Krebs","year":"2016","journal-title":"J Gen Intern Med"},{"key":"10.1016\/S2213-8587(19)30254-2_bib150","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/j.berh.2017.10.004","article-title":"Chronic musculoskeletal pain and its impact on older people","volume":"31","author":"Blyth","year":"2017","journal-title":"Best Pract Res Clin Rheumatol"},{"key":"10.1016\/S2213-8587(19)30254-2_bib151","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302542?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302542?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:26Z","timestamp":1761991646000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719302542"}},"issued":{"date-parts":[[2020,1]]},"references-count":150,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2213858719302542"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30254-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Opioid-induced endocrinopathies","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30254-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T16:54:44Z","timestamp":1648572884534},"reference-count":5,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/s2213-8587(18)30230-4","type":"journal-article","created":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T22:38:52Z","timestamp":1537915132000},"page":"765-766","source":"Crossref","is-referenced-by-count":1,"title":["Work stress and mortality in people with cardiometabolic disease"],"prefix":"10.1016","volume":"6","author":[{"given":"You","family":"Yang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yunzhao","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30230-4_bib1","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/S2213-8587(18)30140-2","article-title":"Work stress and risk of death in men and women with and without cardiometabolic disease: a multicohort study","volume":"6","author":"Kivim\u00e4ki","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30230-4_bib2","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1016\/S0140-6736(12)60994-5","article-title":"Job strain as a risk factor for coronary heart disease: a collaborative meta-analysis of individual participant data","volume":"380","author":"Kivim\u00e4ki","year":"2012","journal-title":"Lancet"},{"issue":"suppl","key":"10.1016\/S2213-8587(18)30230-4_bib3","doi-asserted-by":"crossref","first-page":"S41","DOI":"10.1007\/PL00014625","article-title":"Siegrist, Psychosocial work environment and the risk of coronary heart disease","volume":"73","author":"Peter","year":"2000","journal-title":"Int Arch Occup Environ Health"},{"key":"10.1016\/S2213-8587(18)30230-4_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.ejim.2015.08.005","article-title":"Perceived stress status and sympathetic nervous system activation in young male patients with coronary artery disease in China","volume":"26","author":"Yang","year":"2015","journal-title":"Eur J Intern Med"},{"key":"10.1016\/S2213-8587(18)30230-4_bib5","doi-asserted-by":"crossref","first-page":"e008073","DOI":"10.1161\/JAHA.117.008073","article-title":"Association between work-related stress and coronary heart disease: a review of prospective studies through the job strain, effort-reward balance, and organizational justice models","volume":"7","author":"Sara","year":"2018","journal-title":"J Am Heart Assoc"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302304?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302304?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T23:35:43Z","timestamp":1537918543000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302304"}},"issued":{"date-parts":[[2018,10]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2213858718302304"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30230-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,10]]}},{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T16:15:11Z","timestamp":1762272911096,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/s2213-8587(22)00164-4","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T18:38:41Z","timestamp":1653676721000},"page":"485","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Treating diabetes: combining tradition and science"],"prefix":"10.1016","volume":"10","author":[{"given":"Manjulika","family":"Das","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001644?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001644?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:06Z","timestamp":1761991866000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001644"}},"issued":{"date-parts":[[2022,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2213858722001644"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00164-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treating diabetes: combining tradition and science","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00164-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T23:02:07Z","timestamp":1649026927391},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/s2213-8587(14)70076-2","type":"journal-article","created":{"date-parts":[[2014,7,8]],"date-time":"2014-07-08T23:17:37Z","timestamp":1404861457000},"page":"e15","source":"Crossref","is-referenced-by-count":0,"title":["Correction for Lancet Diabetes Endocrinol 2014; published online June 16"],"prefix":"10.1016","volume":"2","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700762?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700762?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T08:36:25Z","timestamp":1548664585000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700762"}},"issued":{"date-parts":[[2014,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S2213858714700762"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70076-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,9]]}},{"indexed":{"date-parts":[[2023,9,24]],"date-time":"2023-09-24T13:28:33Z","timestamp":1695562113665},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2014,1,1]],"date-time":"2014-01-01T00:00:00Z","timestamp":1388534400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,1]]},"DOI":"10.1016\/s2213-8587(13)70116-5","type":"journal-article","created":{"date-parts":[[2013,10,8]],"date-time":"2013-10-08T02:45:17Z","timestamp":1381200317000},"page":"2-3","source":"Crossref","is-referenced-by-count":2,"title":["Risk prediction models in diabetes prevention"],"prefix":"10.1016","volume":"2","author":[{"given":"Richard","family":"Kahn","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70116-5_bib1","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70116-5_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70116-5_bib3","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1016\/S0140-6736(09)61457-4","article-title":"10-year follow-up of diabetes incidence and weight loss in the Diabetes Prevention Program Outcomes Study","volume":"374","year":"2009","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(13)70116-5_bib4","doi-asserted-by":"crossref","first-page":"S210","DOI":"10.2337\/dc11-s222","article-title":"Long-term benefits from lifestyle interventions for type 2 diabetes prevention","volume":"34","author":"Tuomilehto","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70116-5_bib5","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1377\/hlthaff.2011.1075","article-title":"Reducing the impact of diabetes: is prevention feasible today or should we aim for better treatment?","volume":"31","author":"Kahn","year":"2012","journal-title":"Health Aff"},{"key":"10.1016\/S2213-8587(13)70116-5_bib6","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"International Expert Committee report on the role of the A1c assay in the diagnosis of diabetes","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(13)70116-5_bib7","first-page":"S11","article-title":"Clinical practice recommendations","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70116-5_bib8","doi-asserted-by":"crossref","first-page":"e5900","DOI":"10.1136\/bmj.e5900","article-title":"Prediction models for risk of developing type 2 diabetes: systematic literature search and independent external validation study","volume":"345","author":"Abbasi","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70116-5_bib9","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1111\/j.1464-5491.2007.02157.x","article-title":"International Diabetes Federation: a consensus on type 2 diabetes prevention","volume":"24","author":"Alberti","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70116-5_bib10","article-title":"Non-invasive risk scores for prediction of type 2 diabetes (EPIC-InterAct): a validation of existing models","author":"Kengne","year":"2013","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701165?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701165?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T09:58:41Z","timestamp":1539338321000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701165"}},"issued":{"date-parts":[[2014,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2014,1]]}},"alternative-id":["S2213858713701165"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70116-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,1]]}},{"indexed":{"date-parts":[[2024,5,17]],"date-time":"2024-05-17T08:25:42Z","timestamp":1715934342636},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/s2213-8587(18)30319-x","type":"journal-article","created":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T17:29:13Z","timestamp":1542821353000},"page":"924","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Obesogens: accounting for environmental factors in obesity"],"prefix":"10.1016","volume":"6","author":[{"given":"Leonardo","family":"Trasande","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871830319X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871830319X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T05:12:18Z","timestamp":1550553138000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871830319X"}},"issued":{"date-parts":[[2018,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S221385871830319X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30319-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesogens: accounting for environmental factors in obesity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30319-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30275-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:44:13Z","timestamp":1648759453967},"reference-count":6,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30274-1","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T23:45:20Z","timestamp":1477439120000},"page":"888","source":"Crossref","is-referenced-by-count":0,"title":["Diabetic microvascular triopathy, smoking, and risk of cardiovascular events"],"prefix":"10.1016","volume":"4","author":[{"given":"Larry A","family":"Weinrauch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John A","family":"D'Elia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30274-1_bib1","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/S2213-8587(16)30057-2","article-title":"Microvascular disease and risk of cardiovascular events among individuals with type 2 diabetes: a population-level cohort study","volume":"4","author":"Brownrigg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30274-1_bib2","first-page":"661","article-title":"The triopathy of diabetics: diabetic neuropathies, malignant retinitis and diabetic nephropathy","volume":"70","author":"Root","year":"1953","journal-title":"AMA Arch Neurol Psychiatry"},{"key":"10.1016\/S2213-8587(16)30274-1_bib3","doi-asserted-by":"crossref","first-page":"785","DOI":"10.2337\/diacare.18.6.785","article-title":"The relationship between smoking and microvascular complications in the EURODIAB IDDM Complications Study","volume":"18","author":"Chaturverdi","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30274-1_bib4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","author":"Patel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30274-1_bib5","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/dc14-1844","article-title":"The hemoglobin glycation index identifies subpopulations with harms or benefits from intensive treatment in the ACCORD trial","volume":"38","author":"Hempe","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30274-1_bib6","doi-asserted-by":"crossref","first-page":"e000011","DOI":"10.1136\/bmjdrc-2013-000011","article-title":"Retinopathy and clinical outcomes in patients with type 2 diabetes mellitus, chronic kidney disease, and anemia","volume":"2","author":"Bello","year":"2014","journal-title":"BMJ Open Diabetes Res Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302741?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302741?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T07:54:07Z","timestamp":1536306847000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302741"}},"issued":{"date-parts":[[2016,11]]},"references-count":6,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2213858716302741"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30274-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T10:52:54Z","timestamp":1649155974155},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2017,7,1]],"date-time":"2017-07-01T00:00:00Z","timestamp":1498867200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,7]]},"DOI":"10.1016\/s2213-8587(17)30192-4","type":"journal-article","created":{"date-parts":[[2017,6,8]],"date-time":"2017-06-08T06:00:18Z","timestamp":1496901618000},"page":"497","source":"Crossref","is-referenced-by-count":0,"title":["Research digest: topical trials in thyroid disease"],"prefix":"10.1016","volume":"5","author":[{"given":"David","family":"Preiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Steve","family":"Cleland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,18]],"date-time":"2019-06-18T04:16:01Z","timestamp":1560831361000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301924"}},"issued":{"date-parts":[[2017,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2017,7]]}},"alternative-id":["S2213858717301924"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30192-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,7]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T21:05:36Z","timestamp":1649019936419},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2017,4,1]],"date-time":"2017-04-01T00:00:00Z","timestamp":1491004800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,4]]},"DOI":"10.1016\/s2213-8587(17)30069-4","type":"journal-article","created":{"date-parts":[[2017,3,7]],"date-time":"2017-03-07T02:31:07Z","timestamp":1488853867000},"page":"249","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"5","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T20:24:12Z","timestamp":1536006252000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300694"}},"issued":{"date-parts":[[2017,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2017,4]]}},"alternative-id":["S2213858717300694"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30069-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,4]]}},{"indexed":{"date-parts":[[2023,1,31]],"date-time":"2023-01-31T09:32:21Z","timestamp":1675157541917},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2013,11,1]],"date-time":"2013-11-01T00:00:00Z","timestamp":1383264000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1016\/s2213-8587(13)70101-3","type":"journal-article","created":{"date-parts":[[2013,9,10]],"date-time":"2013-09-10T23:31:31Z","timestamp":1378855891000},"page":"165-166","source":"Crossref","is-referenced-by-count":2,"title":["Text messaging to prevent onset of type 2 diabetes"],"prefix":"10.1016","volume":"1","author":[{"given":"Caroline","family":"Free","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70101-3_bib1","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(13)70101-3_bib2","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/bmj.39063.689375.55","article-title":"Pharmacological and lifestyle interventions to prevent or delay type 2 diabetes in people with impaired glucose tolerance: systematic review and meta-analysis","volume":"334","author":"Gillies","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70101-3_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003054.pub3","article-title":"Exercise or exercise and diet for preventing type 2 diabetes mellitus","volume":"3","author":"Orozco","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(13)70101-3_bib5","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1016\/S0140-6736(10)61997-6","article-title":"Effects of a mobile phone short message service on antiretroviral treatment adherence in Kenya (WelTel Kenya1): a randomised trial","volume":"376","author":"Lester","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70101-3_bib6","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1016\/S0140-6736(11)60701-0","article-title":"Smoking cessation support delivered via mobile phone text messaging (txt2stop): a single-blind, randomised trial","volume":"378","author":"Free","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70101-3_bib7","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S0140-6736(11)60783-6","article-title":"The effect of mobile phone text-message reminders on Kenyan health workers' adherence to malaria treatment guidelines: a cluster randomised trial","volume":"378","author":"Zurovac","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70101-3_bib8","doi-asserted-by":"crossref","first-page":"e1001362","DOI":"10.1371\/journal.pmed.1001362","article-title":"The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review","volume":"10","author":"Free","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(13)70101-3_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70067-6","article-title":"Effectiveness of mobile phone messaging in prevention of type 2 diabetes by lifestyle modification in men in India: a prospective, parallel-group, randomised controlled trial","author":"Ramachandran","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70101-3_bib10","series-title":"Global status report on NCDs","year":"2010"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T01:28:19Z","timestamp":1539394099000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701013"}},"issued":{"date-parts":[[2013,11]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2013,11]]}},"alternative-id":["S2213858713701013"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70101-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,11]]}},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T05:05:29Z","timestamp":1648703129205},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/s2213-8587(14)70092-0","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T01:30:35Z","timestamp":1398389435000},"page":"544","source":"Crossref","is-referenced-by-count":0,"title":["Health warnings about obesity: King's Festival of Food and Ideas"],"prefix":"10.1016","volume":"2","author":[{"given":"Natalie","family":"Harrison","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700920?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700920?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T16:52:29Z","timestamp":1538671949000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700920"}},"issued":{"date-parts":[[2014,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S2213858714700920"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70092-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,7]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T08:28:53Z","timestamp":1648974533666},"reference-count":4,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30294-7","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T19:45:29Z","timestamp":1477424729000},"page":"887-888","source":"Crossref","is-referenced-by-count":0,"title":["Looking deeper into POWeR+"],"prefix":"10.1016","volume":"4","author":[{"given":"Katherine J","family":"Bradbury","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Beth","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mary","family":"Steele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lucy","family":"Yardley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Little","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30294-7_bib1","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/S2213-8587(16)30115-2","article-title":"The POWeR of looking into the black box","volume":"4","author":"Brindal","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30294-7_bib2","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1016\/S2213-8587(16)30099-7","article-title":"An internet-based intervention with brief nurse support to manage obesity in primary care (POWeR+): a pragmatic, parallel-group, randomised controlled trial","volume":"4","author":"Little","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30294-7_bib3","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1111\/obr.12220","article-title":"Behavioural weight management programmes for adults assessed by trials conducted in everyday contexts: systematic review and meta-analysis","volume":"15","author":"Hartmann-Boyce","year":"2014","journal-title":"Obesity Rev"},{"key":"10.1016\/S2213-8587(16)30294-7_bib4","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1108660","article-title":"Comparative effectiveness of weight-loss interventions in clinical practice","volume":"365","author":"Appel","year":"2011","journal-title":"New Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302947?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302947?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T03:54:04Z","timestamp":1536292444000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302947"}},"issued":{"date-parts":[[2016,11]]},"references-count":4,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2213858716302947"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30294-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2024,3,15]],"date-time":"2024-03-15T10:29:47Z","timestamp":1710498587145},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70036-6","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T02:20:06Z","timestamp":1371090006000},"page":"2-3","source":"Crossref","is-referenced-by-count":2,"title":["Daglutril for treatment of renal damage in hypertensive patients with type 2 diabetes: disappointment or hope?"],"prefix":"10.1016","volume":"1","author":[{"given":"St\u00e9phane","family":"Laurent","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70036-6_bib1","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1097\/HJH.0b013e3281fc975a","article-title":"Guidelines for the Management of Arterial Hypertension. The Task Force for the Management of Arterial Hypertension of the European Society of Cardiology (ESC) and of the European Society of Hypertension (ESH)","volume":"25","author":"Mancia","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(13)70036-6_bib2","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1161\/CIRCULATIONAHA.105.563213","article-title":"Reciprocal relationships between insulin resistance and endothelial dysfunction: molecular and pathophysiological mechanisms","volume":"113","author":"Kim","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70036-6_bib3","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/S0140-6736(12)60825-3","article-title":"New drugs, procedure, and devices for hypertension","volume":"380","author":"Laurent","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70036-6_bib4","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1161\/hc4001.097191","article-title":"Vasopeptidase inhibitors: a new therapeutic concept in cardiovascular disease?","volume":"104","author":"Corti","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70036-6_bib5","doi-asserted-by":"crossref","first-page":"3606","DOI":"10.2174\/138161209789271889","article-title":"Inhibition of zinc metallopeptidases in cardiovascular disease\u2014from unity to trinity, or duality?","volume":"15","author":"Dive","year":"2009","journal-title":"Curr Pharm Des"},{"key":"10.1016\/S2213-8587(13)70036-6_bib6","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1097\/FJC.0b013e31813c6ca5","article-title":"Towards triple vasopeptidase inhibitors for the treatment of cardiovascular diseases","volume":"50","author":"Daull","year":"2007","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/S2213-8587(13)70036-6_bib7","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1161\/HYPERTENSIONAHA.110.163972","article-title":"Endothelin-converting enzyme\/neutral endopeptidase inhibitor SLV338 prevents hypertensive cardiac remodeling in a blood pressure-independent manner","volume":"57","author":"Kalk","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(13)70036-6_bib8","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1038\/nrd962","article-title":"New therapeutics that antagonize endothelin: promises and frustrations","volume":"1","author":"Remuzzi","year":"2002","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S2213-8587(13)70036-6_bib9","doi-asserted-by":"crossref","first-page":"F1114","DOI":"10.1152\/ajprenal.00122.2011","article-title":"Distinct cardiac and renal effects of ETA receptor antagonist and ACE inhibitor in experimental type 2 diabetes","volume":"301","author":"Zoja","year":"2011","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/S2213-8587(13)70036-6_bib10","author":"Parvanova","year":"2013","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T09:53:17Z","timestamp":1539597197000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700366"}},"issued":{"date-parts":[[2013,9]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2213858713700366"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70036-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T03:07:29Z","timestamp":1648609649637},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/s2213-8587(15)00100-x","type":"journal-article","created":{"date-parts":[[2015,4,15]],"date-time":"2015-04-15T15:30:28Z","timestamp":1429111828000},"page":"320","source":"Crossref","is-referenced-by-count":0,"title":["Elaine Rush: champion of physical activity and nutrition"],"prefix":"10.1016","volume":"3","author":[{"given":"Tony","family":"Kirby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500100X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500100X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T09:56:28Z","timestamp":1537696588000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871500100X"}},"issued":{"date-parts":[[2015,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S221385871500100X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00100-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,5]]}},{"indexed":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T12:40:06Z","timestamp":1746189606042,"version":"3.40.4"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK131584-04","T32DK108740-07","R01DK115408-04"],"award-info":[{"award-number":["R01DK131584-04","T32DK108740-07","R01DK115408-04"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/s2213-8587(25)00037-3","type":"journal-article","created":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T01:14:42Z","timestamp":1743556482000},"page":"360-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Comparative effectiveness research in bariatric surgery and the need for complementary study designs"],"prefix":"10.1016","volume":"13","author":[{"given":"Ryan","family":"Howard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Justin B","family":"Dimick","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00037-3_bib1","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1001\/jamasurg.2022.2229","article-title":"Effect of laparoscopic sleeve gastrectomy vs roux-en-y gastric bypass on weight loss, comorbidities, and reflux at 10 years in adult patients with obesity: the SLEEVEPASS randomized clinical trial","volume":"157","author":"Salminen","year":"2022","journal-title":"JAMA Surg"},{"key":"10.1016\/S2213-8587(25)00037-3_bib2","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1001\/jamasurg.2017.5025","article-title":"Seven-year weight trajectories and health outcomes in the longitudinal assessment of bariatric surgery (LABS) Study","volume":"153","author":"Courcoulas","year":"2018","journal-title":"JAMA Surg"},{"key":"10.1016\/S2213-8587(25)00037-3_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1056\/NEJMoa1506699","article-title":"Weight loss and health status 3 years after bariatric surgery in adolescents","volume":"374","author":"Inge","year":"2016","journal-title":"N Engl J Med"},{"journal-title":"Lancet Diabetes Endocrinol","article-title":"Roux-en-Y gastric bypass, adjustable gastric banding, or sleeve gastrectomy for severe obesity (By-Band-Sleeve): a multicentre, open label, three-group, randomised controlled trial","year":"2025","key":"10.1016\/S2213-8587(25)00037-3_bib4"},{"key":"10.1016\/S2213-8587(25)00037-3_bib5","doi-asserted-by":"crossref","first-page":"1160","DOI":"10.1001\/jamasurg.2021.4981","article-title":"Comparative safety of sleeve gastrectomy and gastric bypass up to 5 years after surgery in patients with severe obesity","volume":"156","author":"Howard","year":"2021","journal-title":"JAMA Surg"},{"key":"10.1016\/S2213-8587(25)00037-3_bib6","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.25964","article-title":"Association of insurance coverage with adoption of sleeve gastrectomy vs gastric bypass for patients undergoing bariatric surgery","volume":"5","author":"Howard","year":"2022","journal-title":"JAMA Network Open"},{"key":"10.1016\/S2213-8587(25)00037-3_bib7","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1001\/jama.2017.6584","article-title":"Monitoring medical devices: missed warning signs within existing data","volume":"318","author":"Ibrahim","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00037-3_bib8","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.57349","article-title":"Discontinuation and reinitiation of dual-labeled GLP-1 receptor agonists among us adults with overweight or obesity","volume":"8","author":"Rodriguez","year":"2025","journal-title":"JAMA Network Open"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000373?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000373?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T14:49:49Z","timestamp":1746110989000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000373"}},"issued":{"date-parts":[[2025,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2213858725000373"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00037-3","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative effectiveness research in bariatric surgery and the need for complementary study designs","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00037-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00025-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:48:12Z","timestamp":1767149292130,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(23)00253-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,11,22]],"date-time":"2023-11-22T00:00:00Z","timestamp":1700611200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["MC_PC_19056"],"award-info":[{"award-number":["MC_PC_19056"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["204765-112"],"award-info":[{"award-number":["204765-112"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["222406\/Z\/20\/Z"],"award-info":[{"award-number":["222406\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/s2213-8587(23)00360-1","type":"journal-article","created":{"date-parts":[[2023,11,28]],"date-time":"2023-11-28T18:59:47Z","timestamp":1701197987000},"page":"e1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2023; 11: 905\u201314"],"prefix":"10.1016","volume":"12","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003601?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003601?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T16:04:34Z","timestamp":1741190674000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003601"}},"issued":{"date-parts":[[2024,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213858723003601"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00360-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2023; 11: 905\u201314","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00360-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00253-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:45Z","timestamp":1761992205813,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/s2213-8587(22)00310-2","type":"journal-article","created":{"date-parts":[[2022,11,22]],"date-time":"2022-11-22T18:35:52Z","timestamp":1669142152000},"page":"841-842","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes \u2013 Authors' reply"],"prefix":"10.1016","volume":"10","author":[{"given":"Milad","family":"Nazarzadeh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amanda I","family":"Adler","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Chalmers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rury R","family":"Holman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kazem","family":"Rahimi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00310-2_bib1","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1016\/S2213-8587(22)00172-3","article-title":"Blood pressure-lowering treatment for prevention of major cardiovascular diseases in people with and without type 2 diabetes: an individual participant-level data meta-analysis","volume":"10","author":"Nazarzadeh","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00310-2_bib2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1097\/HJH.0000000000003107","article-title":"methodological clarifications of recent reports","volume":"40","author":"Nazarzadeh","year":"2022","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(22)00310-2_bib3","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1177\/1740774507085276","article-title":"A comparison of methods for fixed effects meta-analysis of individual patient data with time to event outcomes","volume":"4","author":"Tudur Smith","year":"2007","journal-title":"Clin Trials"},{"key":"10.1016\/S2213-8587(22)00310-2_bib4","doi-asserted-by":"crossref","first-page":"e1003599","DOI":"10.1371\/journal.pmed.1003599","article-title":"Blood pressure-lowering treatment for the prevention of cardiovascular events in patients with atrial fibrillation: An individual participant data meta-analysis","volume":"18","author":"Pinho-Gomes","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(22)00310-2_bib5","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S0140-6736(14)61171-5","article-title":"Effects of blood pressure lowering on cardiovascular risk according to baseline body-mass index: a meta-analysis of randomised trials","volume":"385","author":"Ying","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00310-2_bib6","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(21)01920-6","article-title":"Blood pressure lowering and risk of new-onset type 2 diabetes: an individual participant data meta-analysis","volume":"398","author":"Nazarzadeh","year":"2021","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003102?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003102?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:14Z","timestamp":1761991934000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003102"}},"issued":{"date-parts":[[2022,12]]},"references-count":6,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2213858722003102"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00310-2","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood pressure reduction and major cardiovascular events in people with and without type 2 diabetes \u2013 Authors' reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00310-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00312-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00311-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00172-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:09Z","timestamp":1761991929334,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/s2213-8587(20)30106-6","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:34:32Z","timestamp":1587580472000},"page":"367-368","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Type 1 diabetes\u2014origins and epidemiology"],"prefix":"10.1016","volume":"8","author":[{"given":"Sarah G","family":"Howard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert M","family":"Sargis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30106-6_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2213-8587(19)30412-7","article-title":"Type 1 diabetes\u2014early life origins and changing epidemiology","volume":"8","author":"Norris","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30106-6_bib2","doi-asserted-by":"crossref","first-page":"3353","DOI":"10.2337\/diabetes.51.12.3353","article-title":"The rise of childhood type 1 diabetes in the 20th century","volume":"51","author":"Gale","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30106-6_bib3","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.2337\/db11-0153","article-title":"The paradox of progress: environmental disruption of metabolism and the diabetes epidemic","volume":"60","author":"Neel","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30106-6_bib4","doi-asserted-by":"crossref","DOI":"10.1289\/ehp.1002727","article-title":"Environmental chemicals in pregnant women in the United States: NHANES 2003\u20132004","volume":"119","author":"Woodruff","year":"2011","journal-title":"Environ Health Perspect"},{"key":"10.1016\/S2213-8587(20)30106-6_bib5","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.1021\/acs.est.9b06379","article-title":"Toward a global understanding of chemical pollution: a first comprehensive analysis of national and regional chemical inventories","volume":"54","author":"Wang","year":"2020","journal-title":"Environ Sci Technol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301066?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301066?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:15Z","timestamp":1761991695000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301066"}},"issued":{"date-parts":[[2020,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213858720301066"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30106-6","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes\u2014origins and epidemiology","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30106-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30121-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30109-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30412-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T13:48:37Z","timestamp":1762004917936},"reference-count":12,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/s2213-8587(17)30202-4","type":"journal-article","created":{"date-parts":[[2017,8,25]],"date-time":"2017-08-25T21:32:30Z","timestamp":1503696750000},"page":"683-684","source":"Crossref","is-referenced-by-count":9,"title":["Issues with European guidelines for phenylketonuria \u2013 Authors' reply"],"prefix":"10.1016","volume":"5","author":[{"given":"Francjan J","family":"van Spronsen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annemiek M J","family":"van Wegberg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kirsten","family":"Ahring","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Amaya","family":"B\u00e9langer-Quintana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nenad","family":"Blau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Annet M","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jaime","family":"Campistol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Feillet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria","family":"Gi\u017cewska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephan C","family":"Huijbregts","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shauna","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vincenzo","family":"Leuzzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francois","family":"Maillot","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ania C","family":"Muntau","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fritz K","family":"Trefz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Margreet","family":"van Rijn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anita","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30202-4_bib1","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/S2213-8587(16)30320-5","article-title":"Key European guidelines for the diagnosis and management of patients with phenylketonuria","volume":"5","author":"van Spronsen","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30202-4_bib2","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1203\/00006450-200104000-00015","article-title":"Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia","volume":"49","author":"Weglage","year":"2001","journal-title":"Pediatr Res"},{"key":"10.1016\/S2213-8587(17)30202-4_bib3","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1007\/BF01954515","article-title":"Intelligence in mild atypical phenylketonuria","volume":"153","author":"Costello","year":"1994","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(17)30202-4_bib4","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/j.1651-2227.1994.tb13462.x","article-title":"Phenylalanine levels of 6\u201310 mg\/dL may not be as benign as once thought","volume":"407","author":"Diamond","year":"1994","journal-title":"Acta Paediatr Suppl"},{"key":"10.1016\/S2213-8587(17)30202-4_bib5","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1542\/peds.112.S4.1537","article-title":"Relation of prenatal phenylalanine exposure to infant and childhood cognitive outcomes: results from the International Maternal PKU Collaborative Study","volume":"112","author":"Widaman","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(17)30202-4_bib6","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neubiorev.2008.11.001","article-title":"Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis","volume":"33","author":"Albrecht","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/S2213-8587(17)30202-4_bib7","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-010-9253-9","article-title":"High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial","volume":"34","author":"ten Hoedt","year":"2011","journal-title":"J Inherit Metab Dis"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30202-4_bib8","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1016\/j.ymgme.2009.10.182","article-title":"Psychiatric symptoms and disorders in phenylketonuria","volume":"99","author":"Brumm","year":"2010","journal-title":"Mol Genet Metab"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(17)30202-4_bib9","doi-asserted-by":"crossref","first-page":"S415","DOI":"10.1007\/s10545-008-0978-7","article-title":"Quality of life in noncompliant adults with phenylketonuria after resumption of the diet","volume":"31","author":"Bik-Multanowski","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(17)30202-4_bib10","first-page":"773","article-title":"Intellectual development after relaxing the diet at the age of 5 years in typical phenylketonuria","volume":"49","author":"Abadie","year":"1992","journal-title":"Arch Fr Pediatr"},{"key":"10.1016\/S2213-8587(17)30202-4_bib11","first-page":"35","article-title":"Intellectual development in 12-year-old children treated for phenylketonuria","volume":"145","author":"Azen","year":"1991","journal-title":"Am J Dis Child"},{"key":"10.1016\/S2213-8587(17)30202-4_bib12","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1001\/jama.2016.19969","article-title":"Clinical practice guidelines: expanded use and misuse","volume":"317","author":"Greenfield","year":"2017","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T20:12:52Z","timestamp":1659384772000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717302024"}},"issued":{"date-parts":[[2017,9]]},"references-count":12,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2213858717302024"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30202-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,9]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:48Z","timestamp":1761991908536,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100019717","name":"AstraZeneca Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019717","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019718","name":"Boehringer Ingelheim Espa\u00f1a","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019718","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/s2213-8587(20)30029-2","type":"journal-article","created":{"date-parts":[[2020,2,4]],"date-time":"2020-02-04T18:32:26Z","timestamp":1580841146000},"page":"177-179","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Latent autoimmune diabetes of adulthood: time to take action"],"prefix":"10.1016","volume":"8","author":[{"given":"Didac","family":"Mauricio","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30029-2_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(20)30003-6","article-title":"Time-varying risk of microvascular complications in latent autoimmune diabetes of adulthood compared with type 2 diabetes in adults: a post-hoc analysis of the UK Prospective Diabetes Study 30-year follow-up data (UKPDS 86)","author":"Maddaloni","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30029-2_bib2","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1016\/S0140-6736(13)62219-9","article-title":"The many faces of diabetes: a disease with increasing heterogeneity","volume":"383","author":"Tuomi","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30029-2_bib3","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30029-2_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S0140-6736(77)91258-2","article-title":"Clinical and pathogenic significance of pancreatic-islet-cell antibodies in diabetics treated with oral hypoglycaemic agents","volume":"1","author":"Irvine","year":"1977","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30029-2_bib5","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1038\/nrendo.2017.99","article-title":"Adult-onset autoimmune diabetes: current knowledge and implications for management","volume":"13","author":"Buzzetti","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(20)30029-2_bib6","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1002\/dmrr.2411","article-title":"Latent autoimmune diabetes in adults is perched between type 1 and type 2: evidence from adults in one region of Spain","volume":"29","author":"Mollo","year":"2013","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(20)30029-2_bib7","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1111\/dom.13788","article-title":"Long-term risk of cardiovascular disease in individuals with latent autoimmune diabetes in adults (UKPDS 85)","volume":"21","author":"Maddaloni","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30029-2_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.endonu.2014.12.001","article-title":"Latent autoimmune diabetes in adults: are we paying sufficient attention?","volume":"62","author":"Hernandez","year":"2015","journal-title":"Endocrinol Nutr"},{"year":"2019","series-title":"Classification of diabetes mellitus","key":"10.1016\/S2213-8587(20)30029-2_bib9"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:29Z","timestamp":1761991649000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300292"}},"issued":{"date-parts":[[2020,3]]},"references-count":9,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2213858720300292"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30029-2","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Latent autoimmune diabetes of adulthood: time to take action","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30029-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30003-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:17:02Z","timestamp":1761992222511,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/s2213-8587(23)00265-6","type":"journal-article","created":{"date-parts":[[2023,9,26]],"date-time":"2023-09-26T18:30:12Z","timestamp":1695753012000},"page":"707","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["What's in a decade?"],"prefix":"10.1016","volume":"11","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:46Z","timestamp":1761991966000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723002656"}},"issued":{"date-parts":[[2023,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2213858723002656"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00265-6","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"What's in a decade?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00265-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T02:06:28Z","timestamp":1745546788103},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/s2213-8587(14)70104-4","type":"journal-article","created":{"date-parts":[[2014,6,2]],"date-time":"2014-06-02T05:46:06Z","timestamp":1401687966000},"page":"531-532","source":"Crossref","is-referenced-by-count":1,"title":["Cognitive impairment in ORIGIN: timing is everything"],"prefix":"10.1016","volume":"2","author":[{"given":"Rachel A","family":"Whitmer","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70104-4_bib1","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S2213-8587(13)70088-3","article-title":"Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions","volume":"2","author":"Biessels","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70104-4_bib2","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/S2213-8587(13)70048-2","article-title":"Risk score for prediction of 10 year dementia risk in individuals with type 2 diabetes: a cohort study","volume":"1","author":"Exalto","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70104-4_bib3","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/s40263-013-0076-8","article-title":"Intranasal insulin as a treatment for Alzheimer's disease: a review of basic research and clinical evidence","volume":"27","author":"Freiherr","year":"2013","journal-title":"CNS Drugs"},{"key":"10.1016\/S2213-8587(14)70104-4_bib4","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/dc13-1672","article-title":"Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes","volume":"37","author":"Novak","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70104-4_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70062-2","article-title":"Effects of basal insulin glargine and omega-3 fatty acid on cognitive decline and probable cognitive impairment in people with dysglycaemia: a substudy of the ORIGIN trial","author":"Cukierman-Yaffe","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70104-4_bib6","doi-asserted-by":"crossref","first-page":"1565","DOI":"10.1001\/jama.2009.460","article-title":"Hypoglycemic episodes and risk of dementia in older patients with type 2 diabetes mellitus","volume":"301","author":"Whitmer","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70104-4_bib7","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1001\/jamainternmed.2013.6176","article-title":"Association between hypoglycemia and dementia in a biracial cohort of older adults with diabetes mellitus","volume":"173","author":"Yaffe","year":"2013","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(14)70104-4_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1002\/ana.23944","article-title":"Mediterranean diet, stroke, cognitive impairment, and depression: a meta-analysis","volume":"74","author":"Psaltopoulou","year":"2013","journal-title":"Ann Neurol"},{"key":"10.1016\/S2213-8587(14)70104-4_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD005379.pub3","article-title":"Omega 3 fatty acid for the prevention of cognitive decline and dementia","volume":"6","author":"Sydenham","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(14)70104-4_bib10","doi-asserted-by":"crossref","first-page":"92","DOI":"10.3389\/fnagi.2013.00092","article-title":"Plasma omega-3 PUFA and white matter mediated executive decline in older adults","volume":"5","author":"Bowman","year":"2013","journal-title":"Front Aging Neurosci"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701044?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701044?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,3]],"date-time":"2018-10-03T19:24:38Z","timestamp":1538594678000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701044"}},"issued":{"date-parts":[[2014,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S2213858714701044"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70104-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,7]]}},{"indexed":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:20:44Z","timestamp":1736918444472,"version":"3.33.0"},"reference-count":3,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/s2213-8587(24)00228-6","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:43:01Z","timestamp":1724398981000},"page":"614-615","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Food additive emulsifiers and risk of type 2 diabetes"],"prefix":"10.1016","volume":"12","author":[{"given":"Ying","family":"Cui","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00228-6_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S2213-8587(24)00086-X","article-title":"Food additive emulsifiers and the risk of type 2 diabetes: analysis of data from the NutriNet-Sant\u00e9 prospective cohort study","volume":"12","author":"Salame","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00228-6_bib2","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1111\/1753-0407.13382","article-title":"Diabetes trends in youth","volume":"15","author":"Bloomgarden","year":"2023","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(24)00228-6_bib3","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2337\/diacare.23.5.589","article-title":"Consequences of a family history of type 1 and type 2 diabetes on the phenotype of patients with type 2 diabetes","volume":"23","author":"Li","year":"2000","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002286?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002286?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:09:15Z","timestamp":1736860155000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002286"}},"issued":{"date-parts":[[2024,9]]},"references-count":3,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213858724002286"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00228-6","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Food additive emulsifiers and risk of type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00228-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:56Z","timestamp":1761991916668,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/s2213-8587(20)30103-0","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:34:34Z","timestamp":1587580474000},"page":"352-353","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Skeletal protection in patients with primary hyperparathyroidism"],"prefix":"10.1016","volume":"8","author":[{"given":"Salvatore","family":"Minisola","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cristiana","family":"Cipriani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Pepe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30103-0_bib1","doi-asserted-by":"crossref","first-page":"3561","DOI":"10.1210\/jc.2014-1413","article-title":"Guidelines for the management of asymptomatic primary hyperparathyroidism: summary statement from the Fourth International Workshop","volume":"99","author":"Bilezikian","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30103-0_bib2","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1007\/s40618-018-0879-z","article-title":"Clinical presentation and management of patients with primary hyperparathyroidism in Italy","volume":"41","author":"Saponaro","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(20)30103-0_bib3","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/j.beem.2018.09.001","article-title":"Classical complications of primary hyperparathyroidism","volume":"32","author":"Minisola","year":"2018","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30103-0_bib4","doi-asserted-by":"crossref","first-page":"715","DOI":"10.7326\/M15-1232","article-title":"The relationship of parathyroidectomy and bisphosphonates with fracture risk in primary hyperparathyroidism: an observational study","volume":"164","author":"Yeh","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(20)30103-0_bib5","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S2213-8587(20)30063-2","article-title":"Denosumab and cinacalcet for primary hyperparathyroidism (DENOCINA): a randomised, double-blind, placebo-controlled phase 3 trial","volume":"8","author":"Leere","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30103-0_bib6","doi-asserted-by":"crossref","first-page":"2773","DOI":"10.1007\/s00198-015-3234-7","article-title":"The effect of 8 or 5 years of denosumab treatment in postmenopausal women with osteoporosis: results from the FREEDOM Extension study","volume":"26","author":"Papapoulos","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(20)30103-0_bib7","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1111\/jgs.15250","article-title":"Protective effect of denosumab on bone in older women with primary hyperparathyroidism","volume":"66","author":"Eller-Vainicher","year":"2018","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(20)30103-0_bib8","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbmr.2315","article-title":"Comparative effects of teriparatide, denosumab, and combination therapy on peripheral compartmental bone density, microarchitecture, and estimated strength: the DATA-HRpQCT Study","volume":"30","author":"Tsai","year":"2015","journal-title":"J Bone Miner Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301030?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301030?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:43Z","timestamp":1761991663000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301030"}},"issued":{"date-parts":[[2020,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213858720301030"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30103-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Skeletal protection in patients with primary hyperparathyroidism","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30103-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30063-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,29]],"date-time":"2026-04-29T18:10:45Z","timestamp":1777486245455,"version":"3.51.4"},"reference-count":24,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/s2213-8587(18)30289-4","type":"journal-article","created":{"date-parts":[[2018,11,6]],"date-time":"2018-11-06T18:40:34Z","timestamp":1541529634000},"page":"925-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":47,"title":["Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Dick","family":"de Zeeuw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronny W","family":"Renfurm","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"George","family":"Bakris","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fan Fan","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Masaomi","family":"Nangaku","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kumar","family":"Sharma","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiddo J L","family":"Heerspink","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alberto","family":"Garcia-Hernandez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tobias E","family":"Larsson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30289-4_bib1","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1053\/j.ajkd.2012.07.005","article-title":"KDOQI Clinical Practice Guideline for Diabetes and CKD: 2012 update","volume":"60","year":"2012","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(18)30289-4_bib2","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1016\/S2213-8587(16)30045-6","article-title":"Unmet need in diabetic nephropathy: failed drugs or trials?","volume":"4","author":"de Zeeuw","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30289-4_bib3","article-title":"Vascular adhesion protein-1: a cell surface amine oxidase in translation","author":"Salmi","year":"2017","journal-title":"Antioxid Redox Signal"},{"key":"10.1016\/S2213-8587(18)30289-4_bib4","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1182\/blood-2007-01-069674","article-title":"The oxidase activity of vascular adhesion protein-1 (VAP-1) induces endothelial E- and P-selectins and leukocyte binding","volume":"110","author":"Jalkanen","year":"2007","journal-title":"Blood"},{"key":"10.1016\/S2213-8587(18)30289-4_bib5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nri1705","article-title":"Cell-surface enzymes in control of leukocyte trafficking","volume":"5","author":"Salmi","year":"2005","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/S2213-8587(18)30289-4_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1172\/JCI73722","article-title":"Vascular adhesion protein-1 promotes liver inflammation and drives hepatic fibrosis","volume":"125","author":"Weston","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(18)30289-4_bib7","doi-asserted-by":"crossref","first-page":"3164","DOI":"10.4049\/jimmunol.0901794","article-title":"Small-molecule inhibitors of vascular adhesion protein-1 reduce the accumulation of myeloid cells into tumors and attenuate tumor growth in mice","volume":"184","author":"Marttila-Ichihara","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(18)30289-4_bib8","doi-asserted-by":"crossref","first-page":"4085","DOI":"10.1096\/fj.201700176R","article-title":"Inhibition of vascular adhesion protein-1 for treatment of graft-versus-host disease in mice","volume":"32","author":"Mukai","year":"2018","journal-title":"FASEB J"},{"key":"10.1016\/S2213-8587(18)30289-4_bib9","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1186\/s12974-018-1152-2","article-title":"Vascular adhesion protein-1 is actively involved in the development of inflammatory lesions in rat models of multiple sclerosis","volume":"15","author":"Elo","year":"2018","journal-title":"J Neuroinflammation"},{"key":"10.1016\/S2213-8587(18)30289-4_bib10","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/jcbfm.2010.167","article-title":"Vascular adhesion protein-1 inhibition provides antiinflammatory protection after an intracerebral hemorrhagic stroke in mice","volume":"31","author":"Ma","year":"2011","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/S2213-8587(18)30289-4_bib11","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1096\/fj.07-9377com","article-title":"Inhibition of vascular adhesion protein-1 suppresses endotoxin-induced uveitis","volume":"22","author":"Noda","year":"2008","journal-title":"FASEB J"},{"key":"10.1016\/S2213-8587(18)30289-4_bib12","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/j.trsl.2018.03.001","article-title":"Inhibition of semicarbazide-sensitive amine oxidase reduces atherosclerosis in apolipoprotein E-deficient mice","volume":"197","author":"Wang","year":"2018","journal-title":"Transl Res"},{"key":"10.1016\/S2213-8587(18)30289-4_bib13","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.kint.2017.01.014","article-title":"Vascular adhesion protein-1 enhances neutrophil infiltration by generation of hydrogen peroxide in renal ischemia\/reperfusion injury","volume":"92","author":"Tanaka","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(18)30289-4_bib14","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.cca.2009.03.041","article-title":"Serum vascular adhesion protein-1 is increased in acute and chronic hyperglycemia","volume":"404","author":"Li","year":"2009","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2213-8587(18)30289-4_bib15","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1016\/j.clinbiochem.2008.06.019","article-title":"Serum vascular adhesion protein-1 is higher in subjects with early stages of chronic kidney disease","volume":"41","author":"Lin","year":"2008","journal-title":"Clin Biochem"},{"key":"10.1016\/S2213-8587(18)30289-4_bib16","doi-asserted-by":"crossref","first-page":"993","DOI":"10.2337\/db10-0607","article-title":"Serum vascular adhesion protein-1 predicts 10-year cardiovascular and cancer mortality in individuals with type 2 diabetes","volume":"60","author":"Li","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30289-4_bib17","doi-asserted-by":"crossref","first-page":"e0147981","DOI":"10.1371\/journal.pone.0147981","article-title":"Serum vascular adhesion protein-1 predicts end-stage renal disease in patients with type 2 diabetes","volume":"11","author":"Li","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30289-4_bib18","first-page":"1","article-title":"KDIGO 2012 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/S2213-8587(18)30289-4_bib19","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jama.2015.0602","article-title":"Glomerular filtration rate and albuminuria for detection and staging of acute and chronic kidney disease in adults: a systematic review","volume":"313","author":"Levey","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30289-4_bib20","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.2215\/CJN.11511114","article-title":"Albuminuria is an appropriate therapeutic target in patients with CKD: the pro view","volume":"10","author":"Lambers Heerspink","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(18)30289-4_bib21","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ki.2011.79","article-title":"An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function","volume":"80","author":"Holtkamp","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(18)30289-4_bib22","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30289-4_bib23","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes mellitus: cardiovascular and kidney effects, potential mechanisms, and clinical applications","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30289-4_bib24","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/bcp.13217","article-title":"Variability in response to albuminuria-lowering drugs: true or random?","volume":"83","author":"Petrykiv","year":"2017","journal-title":"Br J Clin Pharmacol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302894?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302894?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:44Z","timestamp":1761991604000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302894"}},"issued":{"date-parts":[[2018,12]]},"references-count":24,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2213858718302894"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30289-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy of a novel inhibitor of vascular adhesion protein-1 in reducing albuminuria in patients with diabetic kidney disease (ALBUM): a randomised, placebo-controlled, phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30289-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30304-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,17]],"date-time":"2025-11-17T17:15:26Z","timestamp":1763399726022},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/s2213-8587(17)30180-8","type":"journal-article","created":{"date-parts":[[2017,5,31]],"date-time":"2017-05-31T21:09:15Z","timestamp":1496264955000},"page":"670-671","source":"Crossref","is-referenced-by-count":6,"title":["Rating the blood pressure outcome after adrenalectomy for unilateral primary aldosteronism"],"prefix":"10.1016","volume":"5","author":[{"given":"Olivier","family":"Steichen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30180-8_bib1","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled cross-sectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30180-8_bib2","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(17)30180-8_bib3","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.atherosclerosis.2011.12.003","article-title":"Adrenalectomy improves increased carotid intima-media thickness and arterial stiffness in patients with aldosterone producing adenoma","volume":"221","author":"Lin","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(17)30180-8_bib4","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1093\/ajh\/hpu154","article-title":"Adrenalectomy is comparable with medical treatment for reduction of left ventricular mass in primary aldosteronism: meta-analysis of long-term studies","volume":"28","author":"Marzano","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/S2213-8587(17)30180-8_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1055\/s-0031-1299681","article-title":"Outcomes of adrenalectomy in patients with unilateral primary aldosteronism: a review","volume":"44","author":"Steichen","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(17)30180-8_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30180-8_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1161\/HYPERTENSIONAHA.107.189011","article-title":"Call to action on use and reimbursement for home blood pressure monitoring: executive summary: a joint scientific statement from the American Heart Association, American Society Of Hypertension, and Preventive Cardiovascular Nurses Association","volume":"52","author":"Pickering","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30180-8_bib8","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.1097\/HJH.0b013e328363e964","article-title":"European Society of Hypertension position paper on ambulatory blood pressure monitoring","volume":"31","author":"O'Brien","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(17)30180-8_bib9","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/HJH.0b013e328350225d","article-title":"Blood pressure and medication changes following adrenalectomy for unilateral primary aldosteronism: a follow-up study","volume":"30","author":"van der Linden","year":"2012","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(17)30180-8_bib10","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301808?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301808?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,11,26]],"date-time":"2019-11-26T13:31:39Z","timestamp":1574775099000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301808"}},"issued":{"date-parts":[[2017,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2213858717301808"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30180-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,9]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T18:40:01Z","timestamp":1648665601459},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/s2213-8587(19)30140-8","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T23:43:14Z","timestamp":1555544594000},"page":"e18","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2019; 7: 34\u201343"],"prefix":"10.1016","volume":"7","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301408?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301408?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T21:03:56Z","timestamp":1560805436000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301408"}},"issued":{"date-parts":[[2019,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2213858719301408"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30140-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,6]]}},{"indexed":{"date-parts":[[2026,6,30]],"date-time":"2026-06-30T15:12:37Z","timestamp":1782832357253,"version":"3.54.5"},"reference-count":4,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/s2213-8587(18)30208-0","type":"journal-article","created":{"date-parts":[[2018,7,24]],"date-time":"2018-07-24T20:13:13Z","timestamp":1532463193000},"page":"599","source":"Crossref","is-referenced-by-count":3,"title":["Hyperglycaemia in pregnancy and the effect of diabetes on cardiovascular risk"],"prefix":"10.1016","volume":"6","author":[{"given":"Ravi","family":"Retnakaran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Sriram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chandrika N","family":"Wijeyaratne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Hod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anil","family":"Kapur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30208-0_bib1","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1016\/S2213-8587(18)30079-2","article-title":"Sex-specific relevance of diabetes to occlusive vascular and other mortality: a collaborative meta-analysis of individual data from 980\u2008793 adults from 68 prospective studies","volume":"6","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30208-0_bib2","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1016\/S0140-6736(07)60361-4","article-title":"Trends in diabetes prevalence, incidence, and mortality in Ontario, Canada 1995\u20132005: a population-based study","volume":"369","author":"Lipscombe","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30208-0_bib3","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type 2 diabetes after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30208-0_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/dc16-1400","article-title":"Role of type 2 diabetes in determining retinal, renal, and cardiovascular outcomes in women with previous gestational diabetes","volume":"40","author":"Retnakaran","year":"2017","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302080?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302080?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:04:39Z","timestamp":1534809879000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302080"}},"issued":{"date-parts":[[2018,8]]},"references-count":4,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S2213858718302080"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30208-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,8]]}},{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:52:19Z","timestamp":1760820739792},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/s2213-8587(15)00384-8","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T06:11:21Z","timestamp":1445494281000},"page":"827","source":"Crossref","is-referenced-by-count":7,"title":["Getting to the heart of the matter in type 2 diabetes"],"prefix":"10.1016","volume":"3","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003848?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003848?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T09:58:39Z","timestamp":1537264719000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003848"}},"issued":{"date-parts":[[2015,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S2213858715003848"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00384-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,11]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:50Z","timestamp":1761991970416,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011541","name":"National Cancer Institute Division of Cancer Epidemiology and Genetics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/s2213-8587(21)00073-5","type":"journal-article","created":{"date-parts":[[2021,3,23]],"date-time":"2021-03-23T19:40:53Z","timestamp":1616528453000},"page":"255-256","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Exposure to endocrine-disrupting chemicals in utero and thyroid cancer risk in offspring \u2013 Authors' reply"],"prefix":"10.1016","volume":"9","author":[{"given":"Cari M","family":"Kitahara","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tone","family":"Bj\u00f8rge","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tom","family":"Grotmol","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dagrun Sletteb\u00f8","family":"Daltveit","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Troisi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00073-5_bib1","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/S2213-8587(20)30399-5","article-title":"Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study","volume":"9","author":"Kitahara","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00073-5_bib2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3390\/toxics9010014","article-title":"Endocrine disrupting chemicals and thyroid cancer: an overview","volume":"9","author":"Alsen","year":"2021","journal-title":"Toxics"},{"key":"10.1016\/S2213-8587(21)00073-5_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/s12940-016-0199-8","article-title":"Brominated flame retardants in placental tissues: associations with infant sex and thyroid hormone endpoints","volume":"15","author":"Leonetti","year":"2016","journal-title":"Environ Health"},{"key":"10.1016\/S2213-8587(21)00073-5_bib4","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1210\/jc.2017-02599","article-title":"Benign thyroid diseases and risk of thyroid cancer: a nationwide cohort study","volume":"103","author":"Kitahara","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00073-5_bib5","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1158\/1055-9965.EPI-17-0329","article-title":"New evidence on the association between prediagnostic thyroid-stimulating hormone levels and thyroid cancer risk","volume":"26","author":"Kitahara","year":"2017","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(21)00073-5_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.envint.2017.06.021","article-title":"Exposure to flame retardant chemicals and occurrence and severity of papillary thyroid cancer: a case-control study","volume":"107","author":"Hoffman","year":"2017","journal-title":"Environ Int"},{"key":"10.1016\/S2213-8587(21)00073-5_bib7","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/joim.12747","article-title":"The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence","volume":"283","author":"Troisi","year":"2018","journal-title":"J Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:19Z","timestamp":1761991759000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000735"}},"issued":{"date-parts":[[2021,5]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2213858721000735"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00073-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exposure to endocrine-disrupting chemicals in utero and thyroid cancer risk in offspring \u2013 Authors' reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00073-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00052-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30399-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:51Z","timestamp":1761991971879,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/s2213-8587(21)00072-3","type":"journal-article","created":{"date-parts":[[2021,3,12]],"date-time":"2021-03-12T06:20:58Z","timestamp":1615530058000},"page":"261-263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["NICE guidance on dapagliflozin for chronic heart failure with reduced ejection fraction"],"prefix":"10.1016","volume":"9","author":[{"given":"Amanda I","family":"Adler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emma","family":"Douch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lorna","family":"Dunning","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nicole","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00072-3_bib4","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00072-3_bib7","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1056\/NEJMoa1409077","article-title":"Angiotensin\u2013neprilysin inhibition versus enalapril in heart failure","volume":"371","author":"McMurray","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00072-3_bib8","article-title":"Trends in survival after a diagnosis of heart failure in the United Kingdom 2000\u20132017: population based cohort study","volume":"364","author":"Taylor","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00072-3_bib9","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1056\/NEJMoa1812389","article-title":"Dapagliflozin and cardiovascular outcomes in type 2 diabetes","volume":"380","author":"Wiviott","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00072-3_bib10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1177\/0272989X11401031","article-title":"Catalogue of EQ-5D scores for the United Kingdom","volume":"31","author":"Sullivan","year":"2011","journal-title":"Med Decis Making"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000723?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000723?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:24Z","timestamp":1761991764000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000723"}},"issued":{"date-parts":[[2021,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2213858721000723"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00072-3","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NICE guidance on dapagliflozin for chronic heart failure with reduced ejection fraction","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00072-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:28Z","timestamp":1761992008676,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/s2213-8587(22)00038-9","type":"journal-article","created":{"date-parts":[[2022,2,4]],"date-time":"2022-02-04T19:08:55Z","timestamp":1644001735000},"page":"153-154","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Steps to redressing an imbalance: GLP-1 analogues for obesity in east Asia"],"prefix":"10.1016","volume":"10","author":[{"given":"Tricia M-M","family":"Tan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Bernard","family":"Khoo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2017","series-title":"The imminent obesity crisis in Asia and the Pacific: first cost estimates. Asian Development Bank Institute Working Paper 743","author":"Helble","key":"10.1016\/S2213-8587(22)00038-9_bib1"},{"key":"10.1016\/S2213-8587(22)00038-9_bib2","article-title":"Changes in the prevalence of obesity and hypertension and demographic risk factor profiles in China over 10 years: two national cross-sectional surveys","volume":"15","author":"Li","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/S2213-8587(22)00038-9_bib3","article-title":"Obesity and hypertension in Asia: current status and challenges","volume":"15","author":"Chu","year":"2021","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/S2213-8587(22)00038-9_bib4","first-page":"370","article-title":"How to define obesity? Evidence-based multiple action points for public awareness, screening, and treatment: an extension of Asian-Pacific recommendations","volume":"17","author":"Pan","year":"2008","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/S2213-8587(22)00038-9_bib5","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3945\/ajcn.112.035758","volume":"96","author":"Nazare","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(22)00038-9_bib6","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1056\/NEJMoa1411892","article-title":"A randomized, controlled trial of 3.0 mg of liraglutide in weight management","volume":"373","author":"Pi-Sunyer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00038-9_bib7","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00038-9_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(22)00008-0","article-title":"Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial","author":"Kadowaki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000389?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000389?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:48Z","timestamp":1761991848000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000389"}},"issued":{"date-parts":[[2022,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2213858722000389"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00038-9","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Steps to redressing an imbalance: GLP-1 analogues for obesity in east Asia","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00038-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00008-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T00:55:33Z","timestamp":1648860933401},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/s2213-8587(14)70093-2","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T01:30:46Z","timestamp":1398389446000},"page":"367","source":"Crossref","is-referenced-by-count":0,"title":["Giovanni Strippoli: finding the pleasures in nephrology"],"prefix":"10.1016","volume":"2","author":[{"given":"Talha Khan","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700932?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700932?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T16:52:27Z","timestamp":1538671947000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700932"}},"issued":{"date-parts":[[2014,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S2213858714700932"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70093-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,5]]}},{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T12:59:10Z","timestamp":1780491550222,"version":"3.54.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008871","name":"JDRF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008871","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/s2213-8587(23)00133-x","type":"journal-article","created":{"date-parts":[[2023,6,27]],"date-time":"2023-06-27T18:34:38Z","timestamp":1687890878000},"page":"530-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Islet autoimmunity and type 1 diabetes associated with enterovirus infections"],"prefix":"10.1016","volume":"11","author":[{"given":"Antonio","family":"Toniolo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00133-X_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(23)00122-5","article-title":"Enteroviruses and risk of islet autoimmunity or type 1 diabetes: systematic review and meta-analysis of controlled observational studies detecting viral nucleic acids and proteins","author":"Isaacs","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00133-X_bib3","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-022-05779-2","article-title":"Live enteroviruses, but not other viruses, detected in human pancreas at the onset of type 1 diabetes in the DiViD study","volume":"65","author":"Krogvold","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00133-X_bib4","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.gde.2018.01.006","article-title":"Genetics of type 1 diabetes","volume":"50","author":"Robertson","year":"2018","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/S2213-8587(23)00133-X_bib5","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(22)00159-0","article-title":"Type 1 diabetes in diverse ancestries and the use of genetic risk scores","volume":"10","author":"Redondo","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00133-X_bib6","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1126\/science.abi4742","article-title":"Preventing type 1 diabetes in childhood","volume":"373","author":"Dayan","year":"2021","journal-title":"Science"},{"key":"10.1016\/S2213-8587(23)00133-X_bib7","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s00705-017-3614-8","article-title":"Picornaviridae\u2014the ever-growing virus family","volume":"163","author":"Zell","year":"2018","journal-title":"Arch Virol"},{"key":"10.1016\/S2213-8587(23)00133-X_bib8","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/bs.aivir.2022.09.002","article-title":"Enteroviruses: the role of receptors in viral pathogenesis","volume":"113","author":"Heckenberg","year":"2022","journal-title":"Adv Virus Res"},{"key":"10.1016\/S2213-8587(23)00133-X_bib9","doi-asserted-by":"crossref","first-page":"2871","DOI":"10.2337\/db21-0193","article-title":"Coxsackievirus B vaccines prevent infection-accelerated diabetes in NOD mice and have no disease-inducing effect","volume":"70","author":"Stone","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00133-X_bib10","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.1016\/S1473-3099(18)30094-X","article-title":"Enterovirus D68 and acute flaccid myelitis\u2013evaluating the evidence for causality","volume":"18","author":"Messacar","year":"2018","journal-title":"Lancet Infect Dis"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872300133X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872300133X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:14Z","timestamp":1761991994000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872300133X"}},"issued":{"date-parts":[[2023,8]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S221385872300133X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00133-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Islet autoimmunity and type 1 diabetes associated with enterovirus infections","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00133-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00122-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,11]],"date-time":"2026-07-11T17:52:39Z","timestamp":1783792359981,"version":"3.55.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/s2213-8587(14)70196-2","type":"journal-article","created":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T22:13:10Z","timestamp":1416262390000},"page":"102","source":"Crossref","is-referenced-by-count":12,"title":["Chronic disease care crisis for Lebanon's Syrian refugees"],"prefix":"10.1016","volume":"3","author":[{"given":"David","family":"Holmes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701962?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701962?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,27]],"date-time":"2018-09-27T18:25:38Z","timestamp":1538072738000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701962"}},"issued":{"date-parts":[[2015,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S2213858714701962"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70196-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,2]]}},{"indexed":{"date-parts":[[2026,1,9]],"date-time":"2026-01-09T12:52:28Z","timestamp":1767963148034,"version":"3.49.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/s2213-8587(14)70231-1","type":"journal-article","created":{"date-parts":[[2014,12,31]],"date-time":"2014-12-31T00:15:56Z","timestamp":1419984956000},"page":"11","source":"Crossref","is-referenced-by-count":2,"title":["Association between 25-hydroxyvitamin D and type 2 diabetes"],"prefix":"10.1016","volume":"3","author":[{"given":"Edward D","family":"Gorham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Raphael E","family":"Cuomo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sharif B","family":"Mohr","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cedric F","family":"Garland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70231-1_bib1","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-8587(14)70184-6","article-title":"Association between circulating 25-hydroxyvitamin D and incident type 2 diabetes: a mendelian randomisation study","volume":"3","author":"Ye","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70231-1_bib2","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1016\/S2213-8587(14)70202-5","article-title":"Vitamin D for prevention of type 2 diabetes: a clouded forecast for the sunshine vitamin","volume":"3","author":"Buijsse","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(14)70231-1_bib3","first-page":"9","article-title":"How to avoid bias when comparing bone marrow transplantation with chemotherapy","volume":"7","author":"Gray","year":"1991","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S2213-8587(14)70231-1_bib4","first-page":"5078","article-title":"Apolioprotein E isoforms, serum cholesterol, and cancer","volume":"1","author":"Katan","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70231-1_bib5","first-page":"1341","article-title":"Comparison of oral 25-hydroxycholecalciferol, vitamin D, and ultraviolet light as determinants of circulating 25-hydroxyvitamin D","volume":"1","author":"Stamp","year":"1972","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70231-1_bib6","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1056\/NEJM198203253061206","article-title":"Vitamin D synthesis and metabolism after ultraviolet irradiation of normal and vitamin-D-deficient subjects","volume":"306","author":"Adams","year":"1982","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T16:20:58Z","timestamp":1537978858000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702311"}},"issued":{"date-parts":[[2015,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S2213858714702311"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70231-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,1]]}},{"indexed":{"date-parts":[[2025,11,4]],"date-time":"2025-11-04T23:15:19Z","timestamp":1762298119846},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,17]],"date-time":"2014-11-17T00:00:00Z","timestamp":1416182400000},"content-version":"vor","delay-in-days":108,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/s2213-8587(14)70103-2","type":"journal-article","created":{"date-parts":[[2014,5,20]],"date-time":"2014-05-20T23:15:48Z","timestamp":1400627748000},"page":"648-654","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":83,"title":["Lifelong patterns of BMI and cardiovascular phenotype in individuals aged 60\u201364 years in the 1946 British birth cohort study: an epidemiological study"],"prefix":"10.1016","volume":"2","author":[{"given":"Marietta","family":"Charakida","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tauseef","family":"Khan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nick","family":"Finer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Woodside","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Peter H","family":"Whincup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Diana","family":"Kuh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca","family":"Hardy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John","family":"Deanfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70103-2_bib1","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900\u2008000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"Whitlock","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70103-2_bib2","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1038\/ijo.2008.102","article-title":"Global burden of obesity in 2005 and projections to 2030","volume":"32","author":"Kelly","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(14)70103-2_bib3","doi-asserted-by":"crossref","first-page":"3063","DOI":"10.1093\/eurheartj\/ehq355","article-title":"Adiposity and cardiovascular risk factors in a large contemporary population of pre-pubertal children","volume":"31","author":"Falaschetti","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(14)70103-2_bib4","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1001\/archinte.163.15.1787","article-title":"Cardiovascular risk factors and increased carotid intima-media thickness in healthy young adults: the Atherosclerosis Risk in Young Adults (ARYA) Study","volume":"163","author":"Oren","year":"2003","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(14)70103-2_bib5","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1056\/NEJM199806043382302","article-title":"Association between multiple cardiovascular risk factors and atherosclerosis in children and young adults. The Bogalusa Heart Study","volume":"338","author":"Berenson","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70103-2_bib6","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1001\/jama.290.17.2277","article-title":"Cardiovascular risk factors in childhood and carotid artery intima-media thickness in adulthood: the Cardiovascular Risk in Young Finns Study","volume":"290","author":"Raitakari","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70103-2_bib7","doi-asserted-by":"crossref","first-page":"2815","DOI":"10.1161\/hc4601.099486","article-title":"Carotid intimal-medial thickness is related to cardiovascular risk factors measured from childhood through middle age: The Muscatine Study","volume":"104","author":"Davis","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(14)70103-2_bib8","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1161\/01.HYP.0000094221.86888.AE","article-title":"Influence of weight reduction on blood pressure: a meta-analysis of randomized controlled trials","volume":"42","author":"Neter","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(14)70103-2_bib9","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","article-title":"Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes","volume":"34","author":"Wing","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70103-2_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70103-2_bib11","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1093\/aje\/kwr378","article-title":"Weight cycling and mortality in a large prospective US study","volume":"175","author":"Stevens","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(14)70103-2_bib12","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1093\/ije\/dyq231","article-title":"Cohort profile: updating the cohort profile for the MRC National Survey of Health and Development: a new clinic-based data collection for ageing research","volume":"40","author":"Kuh","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(14)70103-2_bib13","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1093\/ije\/dys223","article-title":"Why representativeness should be avoided","volume":"42","author":"Rothman","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(14)70103-2_bib14","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1007\/s10433-013-0258-8","article-title":"Using a birth cohort to study ageing: representativeness and response rates in the National Survey of Health and Development","volume":"10","author":"Stafford","year":"2013","journal-title":"Eur J Ageing"},{"key":"10.1016\/S2213-8587(14)70103-2_bib15","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1016\/j.echo.2007.11.011","volume":"21","author":"Stein","year":"2008","journal-title":"J Am Soc Echocardiogr"},{"key":"10.1016\/S2213-8587(14)70103-2_bib16","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","article-title":"Establishing a standard definition for child overweight and obesity worldwide: international survey","volume":"320","author":"Cole","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70103-2_bib17","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1161\/01.ATV.0000116692.85043.ef","article-title":"Birth weight and lipids in a national birth cohort study","volume":"24","author":"Skidmore","year":"2004","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(14)70103-2_bib18","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1016\/j.amepre.2011.06.035","article-title":"Physical activity across adulthood and physical performance in midlife: findings from a British birth cohort","volume":"41","author":"Cooper","year":"2011","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(14)70103-2_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/ejcn.2009.139","article-title":"Body fat distribution and noncommunicable diseases in populations: overview of the 2008 WHO Expert Consultation on Waist Circumference and Waist-Hip Ratio","volume":"64","author":"Nishida","year":"2010","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70103-2_bib20","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1001\/archinte.167.16.1720","article-title":"Association of overweight with increased risk of coronary heart disease partly independent of blood pressure and cholesterol levels: a meta-analysis of 21 cohort studies including more than 300\u2008000 persons","volume":"167","author":"Bogers","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(14)70103-2_bib21","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJMoa1010112","article-title":"Childhood adiposity, adult adiposity, and cardiovascular risk factors","volume":"365","author":"Juonala","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70103-2_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1161\/CIRCULATIONAHA.106.628875","article-title":"Prediction of clinical cardiovascular events with carotid intima-media thickness: a systematic review and meta-analysis","volume":"115","author":"Lorenz","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(14)70103-2_bib23","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1111\/j.1467-789X.2008.00475.x","article-title":"Tracking of childhood overweight into adulthood: a systematic review of the literature","volume":"9","author":"Singh","year":"2008","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(14)70103-2_bib24","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/j.amjcard.2013.11.010","article-title":"Relation between self-reported physical activity level, fitness, and cardiometabolic risk","volume":"113","author":"Minder","year":"2014","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(14)70103-2_bib25","doi-asserted-by":"crossref","first-page":"1315","DOI":"10.1056\/NEJMoa1006992","article-title":"Adolescent BMI trajectory and risk of diabetes versus coronary disease","volume":"364","author":"Tirosh","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70103-2_bib26","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1038\/ijo.2013.165","article-title":"How do changes in body mass index in infancy and childhood associate with cardiometabolic profile in adulthood? Findings from the Northern Finland Birth Cohort 1966 Study","volume":"38","author":"Sovio","year":"2014","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(14)70103-2_bib27","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1136\/heartjnl-2012-301778","article-title":"Bariatric surgery and cardiovascular outcomes: a systematic review","volume":"98","author":"Vest","year":"2012","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(14)70103-2_bib28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1002\/oby.20431","article-title":"Lifestyle intervention and\/or statins for the reduction of C-reactive protein in type 2 diabetes: From the look AHEAD study","volume":"21","author":"Belalcazar","year":"2013","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(14)70103-2_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1038\/oby.2004.34","article-title":"Weight cycling and the risk of developing type 2 diabetes among adult women in the United States","volume":"12","author":"Field","year":"2004","journal-title":"Obes Res"},{"key":"10.1016\/S2213-8587(14)70103-2_bib30","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1007\/s11154-010-9134-4","article-title":"Endothelial dysfunction in diabetes mellitus: molecular mechanisms and clinical implications","volume":"11","author":"Tabit","year":"2010","journal-title":"Rev Endocr Metab Disord"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T02:25:35Z","timestamp":1538619935000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701032"}},"issued":{"date-parts":[[2014,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S2213858714701032"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70103-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lifelong patterns of BMI and cardiovascular phenotype in individuals aged 60\u201364 years in the 1946 British birth cohort study: an epidemiological study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70103-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70108-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:46:24Z","timestamp":1767149184265,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(21)00047-4","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,7]]},"DOI":"10.1016\/s2213-8587(21)00148-0","type":"journal-article","created":{"date-parts":[[2021,6,16]],"date-time":"2021-06-16T18:38:27Z","timestamp":1623868707000},"page":"e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2021; 9: 393\u2013405"],"prefix":"10.1016","volume":"9","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001480?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001480?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:37Z","timestamp":1761991777000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001480"}},"issued":{"date-parts":[[2021,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2021,7]]}},"alternative-id":["S2213858721001480"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00148-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2021; 9: 393\u2013405","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00148-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00047-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,30]],"date-time":"2026-04-30T07:15:47Z","timestamp":1777533347870,"version":"3.51.4"},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,10,15]],"date-time":"2015-10-15T00:00:00Z","timestamp":1444867200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/s2213-8587(15)00391-5","type":"journal-article","created":{"date-parts":[[2015,10,23]],"date-time":"2015-10-23T08:26:03Z","timestamp":1445588763000},"page":"90-92","source":"Crossref","is-referenced-by-count":10,"title":["Preventing new-onset diabetes in thiazide-treated patients"],"prefix":"10.1016","volume":"4","author":[{"given":"Giuseppe","family":"Mancia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00391-5_bib1","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1136\/bmj.326.7404.1427","article-title":"Value of low dose combination treatment with blood pressure lowering drugs: analysis of 354 randomised trials","volume":"326","author":"Law","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00391-5_bib2","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"The task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). 2013 ESH\/ESC Guidelines for the management of arterial hypertension","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(15)00391-5_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/01.hjh.0000194119.42722.21","article-title":"New-onset diabetes and antihypertensive drugs","volume":"24","author":"Mancia","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(15)00391-5_bib4","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1016\/S0140-6736(07)60108-1","article-title":"Incident diabetes in clinical trials of antihypertensive drugs: a network meta-analysis","volume":"369","author":"Elliott","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00391-5_bib5","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1136\/bmj.326.7391.681","article-title":"Increase in blood glucose concentration during antihypertensive treatment as a predictor of myocardial infarction: population based cohort study","volume":"326","author":"Dunder","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00391-5_bib6","series-title":"Hypertension: the clinical management of primary hypertension in adults: update of clinical guidelines 18 and 34","year":"2011"},{"key":"10.1016\/S2213-8587(15)00391-5_bib7","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1097\/HJH.0b013e328302f10d","article-title":"Long-term risk of diabetes, hypertension and left ventricular hypertrophy associated with the metabolic syndrome in a general population","volume":"26","author":"Mancia","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(15)00391-5_bib8","doi-asserted-by":"crossref","first-page":"2592","DOI":"10.2337\/dc06-1373","article-title":"Differences in glucose tolerance between fixed-dose antihypertensive drug combinations in people with metabolic syndrome","volume":"29","author":"Bakris","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00391-5_bib9","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1161\/01.HYP.0000231552.10054.aa","article-title":"Thiazide diuretics, potassium, and the development of diabetes: a quantitative review","volume":"48","author":"Zillich","year":"2006","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(15)00391-5_bib10","article-title":"Effect of amiloride, or amiloride plus hydrochlorothiazide, versus hydrochlorothiazide on glucose tolerance and blood pressure (PATHWAY-3): a parallel-group, double-blind randomised phase 4 trial","author":"Brown","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00391-5_bib11","doi-asserted-by":"crossref","first-page":"575","DOI":"10.7326\/0003-4819-136-8-200204160-00006","article-title":"Identification of persons at high risk for type 2 diabetes mellitus: do we need the oral glucose tolerance test?","volume":"136","author":"Stern","year":"2002","journal-title":"Ann Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003915?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003915?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T08:26:36Z","timestamp":1537259196000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003915"}},"issued":{"date-parts":[[2016,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2213858715003915"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00391-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,2]]}},{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:15:05Z","timestamp":1761513305388},"reference-count":66,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institute of Health Research","doi-asserted-by":"crossref","award":["OTG-88588"],"award-info":[{"award-number":["OTG-88588"]}],"id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Wellcome Trust through the Scottish Health Informatics Programme","award":["WT086113"],"award-info":[{"award-number":["WT086113"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/s2213-8587(13)70028-7","type":"journal-article","created":{"date-parts":[[2013,6,13]],"date-time":"2013-06-13T02:40:20Z","timestamp":1371091220000},"page":"132-139","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["Diabetes treatments and cancer risk: the importance of considering aspects of drug exposure"],"prefix":"10.1016","volume":"1","author":[{"given":"Jeremy J","family":"Walker","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeffrey A","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah H","family":"Wild","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70028-7_bib2","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1002\/ijc.22717","article-title":"Diabetes mellitus and risk of breast cancer: a meta-analysis","volume":"121","author":"Larsson","year":"2007","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(13)70028-7_bib3","doi-asserted-by":"crossref","first-page":"1365","DOI":"10.1007\/s00125-007-0681-5","article-title":"Diabetes mellitus and risk of endometrial cancer: a meta-analysis","volume":"50","author":"Friberg","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70028-7_bib4","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1007\/s00125-004-1415-6","article-title":"Diabetes mellitus and risk of prostate cancer: a meta analysis","volume":"47","author":"Bonovas","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70028-7_bib5","doi-asserted-by":"crossref","first-page":"2056","DOI":"10.1158\/1055-9965.EPI-06-0410","article-title":"A meta-analysis of diabetes mellitus and the risk of prostate cancer","volume":"15","author":"Kasper","year":"2006","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(13)70028-7_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.cgh.2005.12.007","article-title":"The association between diabetes and hepatocellular carcinoma: a systematic review of epidemiologic evidence","volume":"4","author":"El-Serag","year":"2006","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(13)70028-7_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1002\/dmrr.1291","article-title":"Diabetes mellitus and risk of hepatocellular carcinoma: a systematic review and meta-analysis","volume":"28","author":"Wang","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(13)70028-7_bib8","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1038\/sj.bjc.6602619","article-title":"Type-II diabetes and pancreatic cancer: a meta-analysis of 36 studies","volume":"92","author":"Huxley","year":"2005","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(13)70028-7_bib9","doi-asserted-by":"crossref","first-page":"1928","DOI":"10.1016\/j.ejca.2011.03.003","article-title":"Diabetes mellitus and risk of pancreatic cancer: a meta-analysis of cohort studies","volume":"47","author":"Ben","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2213-8587(13)70028-7_bib10","doi-asserted-by":"crossref","first-page":"2819","DOI":"10.1007\/s00125-006-0468-0","article-title":"Diabetes mellitus and risk of bladder cancer: a meta-analysis","volume":"49","author":"Larsson","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70028-7_bib11","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1093\/jnci\/dji375","article-title":"Diabetes mellitus and risk of colorectal cancer: a meta-analysis","volume":"97","author":"Larsson","year":"2005","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(13)70028-7_bib12","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1007\/s10620-012-2055-1","article-title":"Diabetes mellitus and the incidence of colorectal cancer: an updated systematic review and meta-analysis","volume":"57","author":"Deng","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S2213-8587(13)70028-7_bib13","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/j.jdiacomp.2011.11.003","article-title":"Diabetes and the risk for colorectal cancer","volume":"26","author":"Erbach","year":"2012","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(13)70028-7_bib14","doi-asserted-by":"crossref","first-page":"1586","DOI":"10.1007\/s10620-012-2059-x","article-title":"Diabetes mellitus is an independent risk factor for colorectal cancer","volume":"57","author":"Sun","year":"2012","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S2213-8587(13)70028-7_bib15","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1007\/s00125-011-2051-6","article-title":"Diabetes mellitus and incidence of kidney cancer: a meta-analysis of cohort studies","volume":"54","author":"Larsson","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70028-7_bib16","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.2337\/dc08-1034","article-title":"Diabetes and risk of non-Hodgkins lymphoma: a meta-analysis of observational studies","volume":"31","author":"Mitri","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70028-7_bib17","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endoc Relat Cancer"},{"key":"10.1016\/S2213-8587(13)70028-7_bib18","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70028-7_bib19","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1007\/s00592-010-0187-3","article-title":"Epidemiological aspects of neoplasms in diabetes","volume":"47","author":"Nicolucci","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(13)70028-7_bib20","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1007\/s10552-012-9971-4","article-title":"Diabetes and cancer II: role of diabetes drugs and influence of shared risk factors","volume":"23","author":"Onitilo","year":"2012","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(13)70028-7_bib21","doi-asserted-by":"crossref","first-page":"2507","DOI":"10.1007\/s00125-009-1568-4","article-title":"No evidence of increased risk of malignancies in patients with diabetes treated with insulin detemir: a meta-analysis","volume":"52","author":"Dejgaard","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70028-7_bib22","doi-asserted-by":"crossref","first-page":"2499","DOI":"10.1007\/s00125-009-1530-5","article-title":"Combined randomised controlled trial experience of malignancies in studies using insulin glargine","volume":"52","author":"Home","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70028-7_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1742-1241.2010.02354.x","article-title":"Insulin analogues and cancer risk: cause for concern or cause celebre?","volume":"64","author":"Pollak","year":"2010","journal-title":"Int J Clin Pract"},{"key":"10.1016\/S2213-8587(13)70028-7_bib24","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1093\/qjmed\/hcq149","article-title":"Diabetes and cancer","volume":"103","author":"Chowdhury","year":"2010","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(13)70028-7_bib25","doi-asserted-by":"crossref","first-page":"1766","DOI":"10.1007\/s00125-009-1440-6","article-title":"The influence of glucose-lowering therapies on cancer risk in type 2 diabetes","volume":"52","author":"Currie","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70028-7_bib26","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/diacare.29.02.06.dc05-1558","article-title":"Increased cancer-related mortality for patients with type 2 diabetes who use sulfonylureas or insulin","volume":"29","author":"Bowker","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70028-7_bib27","doi-asserted-by":"crossref","first-page":"299","DOI":"10.2337\/dc11-1313","article-title":"Mortality after incident cancer in people with and without type 2 diabetes: impact of metformin on survival","volume":"35","author":"Currie","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70028-7_bib28","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.2337\/dc12-0788","article-title":"Metformin and the risk of cancer","volume":"35","author":"Suissa","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70028-7_bib29","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1200\/JCO.2006.07.2777","article-title":"Thiazolidinediones and the risk of lung, prostate and colon cancer in patients with diabetes","volume":"25","author":"Govindarajan","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(13)70028-7_bib30","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1741-7015-5-17","article-title":"Association between cancer prevalence and use of thiazolidinediones: results from the Vermont Diabetes Information System","volume":"5","author":"Ramos-Nino","year":"2007","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(13)70028-7_bib31","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.2337\/dc07-2308","article-title":"Rosiglitazone and risk of cancer: a meta-analysis of randomized clinical trials","volume":"31","author":"Monami","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70028-7_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00592-008-0083-2","article-title":"Sulphonylureas and cancer: a case control study","volume":"46","author":"Monami","year":"2009","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(13)70028-7_bib33","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00125-011-2171-z","article-title":"Diabetes and risk of bladder cancer: a study using the National Health Insurance database in Taiwan","volume":"54","author":"Tseng","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70028-7_bib34","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1210\/en.2009-1272","article-title":"Glucagon-like peptide-1 receptor agonists activate rodent thyroid C-cells causing calcitonin release and C-cell proliferation","volume":"51","author":"Knudsen","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(13)70028-7_bib35","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1053\/j.gastro.2011.02.018","article-title":"Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1 based therapies","volume":"141","author":"Elashoff","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(13)70028-7_bib36","doi-asserted-by":"crossref","first-page":"1984","DOI":"10.1210\/en.2010-0115","article-title":"Minireview: update on incretin biology: focus on glucagon-like peptide-1","volume":"151","author":"Brubaker","year":"2010","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(13)70028-7_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00125-009-1591-5","article-title":"Glucagon-like peptide-1 therapy and the exocrine pancreas: innocent bystander or friendly fire?","volume":"53","author":"Butler","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70028-7_bib38","doi-asserted-by":"crossref","first-page":"428","DOI":"10.2337\/dc09-1499","article-title":"Incretin-based therapies for the treatment of type 2 diabetes: evaluation of the risks and benefits","volume":"33","author":"Drucker","year":"2010","journal-title":"Diabetes Care"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(13)70028-7_bib39","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1185\/03007995.2011.602964","article-title":"Safety of dipeptidyl peptidase-4 inhibitors: a meta-analysis of randomized clinical trials","volume":"27","author":"Monami","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/S2213-8587(13)70028-7_bib40","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1111\/j.1365-2710.2011.01323.x","article-title":"The efficacy and safety of vildagliptin in patients with type 2 diabetes: a meta-analysis of randomized clinical trials","volume":"37","author":"Cai","year":"2012","journal-title":"J Clin Pharm Ther"},{"key":"10.1016\/S2213-8587(13)70028-7_bib41","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1900\/RDS.2011.8.348","article-title":"SGLT-2 inhibitors in development for type 2 diabetes treatment","volume":"8","author":"Bhartia","year":"2011","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/S2213-8587(13)70028-7_bib43","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/dc08-0283","article-title":"Colesevelam HCl improves glycemic control and reduces LDL cholesterol in patients with inadequately controlled type 2 diabetes on sulfonylurea-based therapy","volume":"31","author":"Fonseca","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70028-7_bib44","doi-asserted-by":"crossref","first-page":"923","DOI":"10.2337\/dc10-1067","article-title":"Cohort study of pioglitazone and cancer incidence in patients with diabetes","volume":"34","author":"Ferrara","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70028-7_bib45","doi-asserted-by":"crossref","first-page":"1620","DOI":"10.2337\/dc08-2175","article-title":"New users of metformin are at low risk of incident cancer: a cohort study among people with type 2 diabetes","volume":"32","author":"Libby","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70028-7_bib46","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1002\/pds.1352","article-title":"Cancer risks in thiazolidinedione users compared to other anti diabetic agents","volume":"16","author":"Koro","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/S2213-8587(13)70028-7_bib47","doi-asserted-by":"crossref","first-page":"3297","DOI":"10.1200\/JCO.2009.19.6410","article-title":"Metformin and pathologic complete responses to neoadjuvant chemotherapy in diabetic patients with breast cancer","volume":"27","author":"Jiralerspong","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(13)70028-7_bib48","doi-asserted-by":"crossref","first-page":"322","DOI":"10.2337\/dc09-1380","article-title":"Metformin associated with lower cancer mortality in type 2 diabetes: ZODIAC-16","volume":"33","author":"Landman","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70028-7_bib49","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.diabres.2010.08.022","article-title":"Use of sulphonylurea and cancer in type 2 diabetes\u2014the Hong Kong Diabetes Registry","volume":"90","author":"Yang","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(13)70028-7_bib50","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1158\/1055-9965.EPI-10-0940","article-title":"Metformin and the incidence of prostate cancer in patients with type 2 diabetes","volume":"20","author":"Azoulay","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(13)70028-7_bib51","doi-asserted-by":"crossref","first-page":"1363","DOI":"10.1016\/j.metabol.2010.09.012","article-title":"Type 2 diabetes mellitus and medications for type 2 diabetes mellitus are associated with risk for and mortality from cancer in a German primary care cohort","volume":"60","author":"Baur","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(13)70028-7_bib52","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.ygyno.2011.06.038","article-title":"Use of metformin and the risk of ovarian cancer: a case-control analysis","volume":"123","author":"Bodmer","year":"2011","journal-title":"Gynecol Oncol"},{"key":"10.1016\/S2213-8587(13)70028-7_bib53","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1038\/ajg.2011.483","article-title":"Use of antidiabetic agents and the risk of pancreatic cancer: a case-control analysis","volume":"107","author":"Bodmer","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(13)70028-7_bib54","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1158\/1055-9965.EPI-11-0992-T","article-title":"Use of metformin is not associated with a decreased risk of colorectal cancer: a case-control analysis","volume":"21","author":"Bodmer","year":"2012","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(13)70028-7_bib55","first-page":"1771","article-title":"Metformin and thiazolidinediones are associated with improved breast cancer-specific survival of diabetic women with HER2+ breast cancer","volume":"23","author":"He","year":"2012","journal-title":"AnnOncol"},{"key":"10.1016\/S2213-8587(13)70028-7_bib57","doi-asserted-by":"crossref","first-page":"2721","DOI":"10.1016\/j.jacc.2010.03.017","article-title":"The ARBITER 6-HALTS Trial (arterial biology for the investigation of the treatment effects of reducing cholesterol 6-HDL and LDL treatment strategies in atherosclerosis): final results and the impact of medication adherence, dose, and treatment duration","volume":"55","author":"Villines","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(13)70028-7_bib58","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.1007\/s00125-010-1750-8","article-title":"Glucose-lowering agents and cancer mortality rates in type 2 diabetes: assessing effects of time-varying exposure","volume":"53","author":"Bowker","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70028-7_bib59","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/ajim.20377","article-title":"Assessing dose-response relationships by cumulative exposure in epidemiological studies","volume":"50","author":"Axelson","year":"2007","journal-title":"Am J Ind Med"},{"key":"10.1016\/S2213-8587(13)70028-7_bib60","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/0962280208092301","article-title":"Multi-state models for the analysis of time-to-event data","volume":"18","author":"Meira-Machado","year":"2009","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/S2213-8587(13)70028-7_bib61","doi-asserted-by":"crossref","first-page":"2542","DOI":"10.2337\/dc11-1199","article-title":"Risk of breast cancer after onset of type 2 diabetes: evidence of detection bias in postmenopausal women","volume":"34","author":"Bowker","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70028-7_bib62","doi-asserted-by":"crossref","first-page":"2263","DOI":"10.1007\/s00125-011-2242-1","article-title":"Time-varying incidence of cancer after the onset of type 2 diabetes: evidence of potential detection bias","volume":"54","author":"Johnson","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70028-7_bib63","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s00125-011-2381-4","article-title":"Cancer occurrence in Danish diabetic patients: duration and insulin effects","volume":"55","author":"Carstensen","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70028-7_bib64","doi-asserted-by":"crossref","first-page":"e000433","DOI":"10.1136\/bmjopen-2011-000433","article-title":"Risk of cancer in patients using glucose-lowering agents: a nationwide cohort study of 3\u00b76 million people","volume":"2","author":"Andersson","year":"2012","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(13)70028-7_bib65","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1002\/pds.1441","article-title":"Medical therapy for diabetes is associated with increased use of lower endoscopy","volume":"16","author":"Lewis","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/S2213-8587(13)70028-7_bib66","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1016\/j.thromres.2011.12.019","article-title":"Pioglitazone inhibits platelet function and potentiates the effects of aspirin: a prospective observation study","volume":"129","author":"Mongan","year":"2012","journal-title":"Thromb Res"},{"key":"10.1016\/S2213-8587(13)70028-7_bib67","doi-asserted-by":"crossref","first-page":"871","DOI":"10.2165\/00002018-200427120-00004","article-title":"The General Practice Research Database: role in pharmacovigilance","volume":"27","author":"Wood","year":"2004","journal-title":"Drug Saf"},{"key":"10.1016\/S2213-8587(13)70028-7_bib68","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.canep.2012.05.013","article-title":"Validity of cancer diagnosis in a primary care database compared with linked cancer registrations in England. Population-based cohort study","volume":"36","author":"Dregan","year":"2012","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/S2213-8587(13)70028-7_bib69","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2125.2009.03537.x","article-title":"Validation and validity of diagnoses in the general practice research database: a systematic review","volume":"69","author":"Herrett","year":"2010","journal-title":"Br J Clin Pharmacol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700287?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700287?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T09:53:13Z","timestamp":1539597193000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700287"}},"issued":{"date-parts":[[2013,10]]},"references-count":66,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S2213858713700287"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70028-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes treatments and cancer risk: the importance of considering aspects of drug exposure","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70028-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,6]],"date-time":"2026-04-06T14:53:35Z","timestamp":1775487215468,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/s2213-8587(24)00032-9","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T18:28:47Z","timestamp":1708453727000},"page":"155-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Living between two worlds: lessons for community involvement"],"prefix":"10.1016","volume":"12","author":[{"given":"Ashley H","family":"Ng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthew","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Benson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lauren","family":"Cusack","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Hicks","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ben","family":"Nash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Meaghan","family":"Read","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Renza","family":"Scibilia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cheryl","family":"Steele","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Leon","family":"Tribe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Holmes-Truscott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00032-9_bib1","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1186\/s40900-023-00439-0","article-title":"Understanding the identity of lived experience researchers and providers: a conceptual framework and systematic narrative review","volume":"9","author":"Gupta","year":"2023","journal-title":"Res Involv Engagem"},{"key":"10.1016\/S2213-8587(24)00032-9_bib2","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1111\/hex.12888","article-title":"Frameworks for supporting patient and public involvement in research: systematic review and co-design pilot","volume":"22","author":"Greenhalgh","year":"2019","journal-title":"Health Expect"},{"key":"10.1016\/S2213-8587(24)00032-9_bib3","doi-asserted-by":"crossref","DOI":"10.17061\/phrp3222211","article-title":"Co-creation, co-design, co-production for public health\u2014a perspective on definition and distinctions","volume":"32","author":"Vargas","year":"2022","journal-title":"Public Health Res Pract"},{"key":"10.1016\/S2213-8587(24)00032-9_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-051430","article-title":"A co-design study to develop supportive interventions to improve psychological and social adaptation among adults with new-onset type 1 diabetes in Denmark and the UK","volume":"11","author":"Due-Christensen","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(24)00032-9_bib7","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1111\/hex.12935","article-title":"How patient and community involvement in diabetes research influences health outcomes: a realist review","volume":"22","author":"Harris","year":"2019","journal-title":"Health Expect"},{"key":"10.1016\/S2213-8587(24)00032-9_bib8","article-title":"Our language matters: improving communication with and about people with diabetes. A position statement by Diabetes Australia","volume":"173","author":"Speight","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(24)00032-9_bib9","article-title":"Meaningful engagement of people living with noncommunicable diseases: challenges and opportunities","volume":"11","author":"Barone","year":"2024","journal-title":"J Patient Exp"},{"key":"10.1016\/S2213-8587(24)00032-9_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S2213-8587(23)00347-9","article-title":"Bringing an end to diabetes stigma and discrimination: an international consensus statement on evidence and recommendations","volume":"12","author":"Speight","year":"2024","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000329?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000329?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:43:20Z","timestamp":1766162600000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000329"}},"issued":{"date-parts":[[2024,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2213858724000329"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00032-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Living between two worlds: lessons for community involvement","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00032-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,26]],"date-time":"2025-10-26T21:22:49Z","timestamp":1761513769774},"reference-count":4,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/s2213-8587(16)00043-7","type":"journal-article","created":{"date-parts":[[2016,2,16]],"date-time":"2016-02-16T20:02:30Z","timestamp":1455652950000},"page":"303-304","source":"Crossref","is-referenced-by-count":8,"title":["Infection risk in elderly people with reduced glycaemic control"],"prefix":"10.1016","volume":"4","author":[{"given":"Andrew P","family":"McGovern","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia","family":"Hine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon","family":"de Lusignan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)00043-7_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/S2213-8587(15)00379-4","article-title":"Diabetes and infection: assessing the association with glycaemic control in population-based studies","volume":"4","author":"Pearson-Stuttard","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00043-7_bib2","doi-asserted-by":"crossref","first-page":"2342","DOI":"10.1111\/jgs.12035","article-title":"Diabetes in older adults: a consensus report","volume":"60","author":"Kirkman","year":"2012","journal-title":"J Am Geriatr Soc"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(16)00043-7_bib3","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1016\/S1262-3636(11)70962-4","article-title":"European Diabetes Working Party for Older People 2011 clinical guidelines for type 2 diabetes mellitus. Executive summary","volume":"37","author":"Sinclair","year":"2011","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(16)00043-7_bib4","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Seshasai","year":"2011","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000437?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000437?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T00:50:27Z","timestamp":1536972627000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716000437"}},"issued":{"date-parts":[[2016,4]]},"references-count":4,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S2213858716000437"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)00043-7","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2016,4]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:15Z","timestamp":1761991935026,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/s2213-8587(20)30066-8","type":"journal-article","created":{"date-parts":[[2020,2,24]],"date-time":"2020-02-24T19:49:34Z","timestamp":1582573774000},"page":"274-275","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["NICE guidance on sotagliflozin for type 1 diabetes"],"prefix":"10.1016","volume":"8","author":[{"given":"Amanda I","family":"Adler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jessica","family":"Cronshaw","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carl","family":"Prescott","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanjeev","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Donegan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jasdeep","family":"Hayre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"year":"2020","series-title":"NICE technology appraisal guidance TA622. Sotagliflozin with insulin for treating type 1 diabetes","key":"10.1016\/S2213-8587(20)30066-8_bib1"},{"year":"2011","series-title":"NICE quality standard QS6. Diabetes in adults","key":"10.1016\/S2213-8587(20)30066-8_bib2"},{"year":"2019","series-title":"NICE technology appraisal guidance TA597. Dapagliflozin with insulin for treating type 1 diabetes","key":"10.1016\/S2213-8587(20)30066-8_bib3"},{"year":"2015","series-title":"NICE guideline NG17. Type 1 diabetes in adults: diagnosis and management","key":"10.1016\/S2213-8587(20)30066-8_bib4"},{"key":"10.1016\/S2213-8587(20)30066-8_bib5","doi-asserted-by":"crossref","first-page":"1970","DOI":"10.2337\/dc18-0343","article-title":"Sotagliflozin in combination with optimized insulin therapy in adults with type 1 diabetes: the North American inTandem1 Study","volume":"41","author":"Buse","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30066-8_bib6","doi-asserted-by":"crossref","first-page":"1981","DOI":"10.2337\/dc18-0342","article-title":"HbA1c and hypoglycemia reductions at 24 and 52 weeks with sotagliflozin in combination with insulin in adults with type 1 diabetes: the European inTandem2 Study","volume":"41","author":"Danne","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30066-8_bib7","doi-asserted-by":"crossref","first-page":"3976","DOI":"10.2337\/db13-1093","article-title":"Diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: advances and contributions","volume":"62","author":"Nathan","year":"2013","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(20)30066-8_bib8","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1185\/030079904X1980","article-title":"The CORE Diabetes Model: projecting long-term clinical outcomes, costs and cost-effectiveness of interventions in diabetes mellitus (types 1 and 2) to support clinical and reimbursement decision-making","volume":"20","author":"Palmer","year":"2004","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/S2213-8587(20)30066-8_bib9","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/j.jval.2014.07.007","article-title":"Validation of the IMS CORE Diabetes Model","volume":"17","author":"McEwan","year":"2014","journal-title":"Value Health"},{"key":"10.1016\/S2213-8587(20)30066-8_bib10","doi-asserted-by":"crossref","first-page":"1747","DOI":"10.1007\/s00125-004-1527-z","article-title":"A model to estimate the lifetime health outcomes of patients with type 2 diabetes: the United Kingdom Prospective Diabetes Study (UKPDS) Outcomes Model (UKPDS no. 68)","volume":"47","author":"Clarke","year":"2004","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300668?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300668?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:23Z","timestamp":1761991703000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300668"}},"issued":{"date-parts":[[2020,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2213858720300668"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30066-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NICE guidance on sotagliflozin for type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30066-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T10:13:23Z","timestamp":1760523203117},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/s2213-8587(14)70147-0","type":"journal-article","created":{"date-parts":[[2014,7,28]],"date-time":"2014-07-28T07:00:12Z","timestamp":1406530812000},"page":"924-925","source":"Crossref","is-referenced-by-count":2,"title":["Young-onset type 2 diabetes: no room for complacency"],"prefix":"10.1016","volume":"2","author":[{"given":"Soon H","family":"Song","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70147-0_bib1","doi-asserted-by":"crossref","first-page":"1823","DOI":"10.1016\/S0140-6736(07)60821-6","article-title":"Acute and chronic complications in children and adolescents","volume":"369","author":"Pinhas-Hamiel","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70147-0_bib2","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1093\/qjmed\/hcp121","article-title":"Early-onset type 2 diabetes mellitus: a harbinger for complications in later years - clinical observation from a secondary care cohort","volume":"102","author":"Song","year":"2009","journal-title":"QJM"},{"key":"10.1016\/S2213-8587(14)70147-0_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.1111\/j.1464-5491.2011.03542.x","article-title":"Estimated morbidity and mortality in adolescents and young adults diagnosed with type 2 diabetes mellitus","volume":"29","author":"Rhodes","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(14)70147-0_bib4","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1136\/bmj.322.7299.1389","article-title":"Excess mortality in a population with diabetes and the impact of material deprivation: longitudinal, population based study","volume":"322","author":"Roper","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70147-0_bib5","doi-asserted-by":"crossref","first-page":"3863","DOI":"10.2337\/dc12-2455","article-title":"Long-term complications and mortality in young-onset diabetes: type 2 diabetes is more hazardous and lethal than type 1 diabetes","volume":"36","author":"Constantino","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70147-0_bib6","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1001\/jama.2009.726","article-title":"Diabetes in Asia: epidemiology, risk factors and pathophysiology","volume":"301","author":"Chan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70147-0_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70137-8","article-title":"Metabolic profiles and treatment gaps in young-onset type 2 diabetes in Asia (the JADE programme): a cross-sectional study of a prospective cohort","author":"Yeung","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70147-0_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/pedi.12147","article-title":"Care delivery in youth with type 2 diabetes - are we meeting clinical practice guidelines?","author":"Amed","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(14)70147-0_bib9","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/dc12-2393","article-title":"Effects of metformin, metformin plus rosiglitazone, and metformin plus lifestyle on insulin sensitivity and \u03b2-cell function in TODAY","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70147-0_bib10","doi-asserted-by":"crossref","first-page":"1876","DOI":"10.1056\/NEJMoa1010112","article-title":"Childhood adiposity, adult adiposity and cardiovascular risk factors","volume":"365","author":"Juonala","year":"2011","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T05:26:55Z","timestamp":1538371615000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701470"}},"issued":{"date-parts":[[2014,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S2213858714701470"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70147-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,12]]}},{"indexed":{"date-parts":[[2025,9,26]],"date-time":"2025-09-26T04:26:02Z","timestamp":1758860762475},"reference-count":11,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/s2213-8587(15)00456-8","type":"journal-article","created":{"date-parts":[[2015,11,27]],"date-time":"2015-11-27T00:30:20Z","timestamp":1448584220000},"page":"92-94","source":"Crossref","is-referenced-by-count":2,"title":["Taking action on sugar"],"prefix":"10.1016","volume":"4","author":[{"given":"W Philip T","family":"James","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00456-8_bib1","series-title":"Sugar reduction: the evidence for action","year":"2015"},{"key":"10.1016\/S2213-8587(15)00456-8_bib2","series-title":"Carbohydrates and health","year":"2015"},{"key":"10.1016\/S2213-8587(15)00456-8_bib3","series-title":"Guideline: sugars intake for adults and children","year":"2015"},{"key":"10.1016\/S2213-8587(15)00456-8_bib4","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1038\/482027a","article-title":"Public health: the toxic truth about sugar","volume":"482","author":"Lustig","year":"2012","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(15)00456-8_bib5","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00456-8_bib6","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1177\/0022034513490168","article-title":"Global burden of oral conditions in 1990\u20132010: a systematic analysis","volume":"92","author":"Marcenes","year":"2013","journal-title":"J Dent Res"},{"key":"10.1016\/S2213-8587(15)00456-8_bib7","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1161\/CIRCULATIONAHA.114.010636","article-title":"Estimated global, regional, and national disease burdens related to sugar-sweetened beverage consumption in 2010","volume":"132","author":"Singh","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(15)00456-8_bib9","author":"Hashem"},{"key":"10.1016\/S2213-8587(15)00456-8_bib10","series-title":"Subsidy Reform in the Middle East and North Africa: recent progress and challenges ahead","author":"Sdralevich","year":"2014"},{"key":"10.1016\/S2213-8587(15)00456-8_bib13","author":"Seale"},{"key":"10.1016\/S2213-8587(15)00456-8_bib14","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1186\/s12889-015-1781-7","article-title":"Are interventions to promote healthy eating equally effective for all? Systematic review of socioeconomic inequalities in impact","volume":"15","author":"McGill","year":"2015","journal-title":"BMC Public Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004568?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004568?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T11:54:27Z","timestamp":1537185267000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004568"}},"issued":{"date-parts":[[2016,2]]},"references-count":11,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2213858715004568"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00456-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,2]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:52Z","timestamp":1761991732239,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/s2213-8587(14)70044-0","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T21:17:56Z","timestamp":1396473476000},"page":"273-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Vitamin D status and ill health"],"prefix":"10.1016","volume":"2","author":[{"given":"Michael F","family":"Holick","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William B","family":"Grant","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70044-0_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S2213-8587(13)70165-7","article-title":"Vitamin D status and ill health: a systematic review","volume":"2","author":"Autier","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70044-0_bib2","doi-asserted-by":"crossref","first-page":"48054","DOI":"10.1111\/nure.12090","article-title":"Guidelines for optimizing design and analysis of clinical studies of nutrient effects","volume":"72","author":"Heaney","year":"2014","journal-title":"Nutr Rev"},{"key":"10.1016\/S2213-8587(14)70044-0_bib3","doi-asserted-by":"crossref","first-page":"3993","DOI":"10.3390\/nu5103993","article-title":"Molecular link between vitamin D and cancer prevention","volume":"5","author":"Moukayed","year":"2013","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(14)70044-0_bib4","doi-asserted-by":"crossref","first-page":"1912","DOI":"10.1056\/NEJMc0809996","article-title":"Vitamin D deficiency in critically ill patients","volume":"360","author":"Lee","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70044-0_bib5","doi-asserted-by":"crossref","first-page":"4623","DOI":"10.1210\/jc.2003-030358","article-title":"Bone turnover in prolonged critical illness: effect of vitamin D","volume":"88","author":"Van den Berghe","year":"2003","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700440?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700440?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:04Z","timestamp":1761991504000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700440"}},"issued":{"date-parts":[[2014,4]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S2213858714700440"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70044-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D status and ill health","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70044-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70165-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,29]],"date-time":"2025-12-29T18:37:01Z","timestamp":1767033421907,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/s2213-8587(20)30164-9","type":"journal-article","created":{"date-parts":[[2020,5,6]],"date-time":"2020-05-06T19:08:59Z","timestamp":1588792139000},"page":"457","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":18,"title":["COVID-19: underlying metabolic health in the spotlight"],"prefix":"10.1016","volume":"8","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301649?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301649?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:32Z","timestamp":1761991712000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301649"}},"issued":{"date-parts":[[2020,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2213858720301649"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30164-9","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COVID-19: underlying metabolic health in the spotlight","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30164-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T07:12:15Z","timestamp":1765609935193},"reference-count":2,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/s2213-8587(19)30261-x","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T22:41:17Z","timestamp":1566340877000},"page":"669-670","source":"Crossref","is-referenced-by-count":4,"title":["Lifestyle intervention and impaired glucose tolerance in the Da Qing study"],"prefix":"10.1016","volume":"7","author":[{"given":"Shen","family":"Tian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hao","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kai-nan","family":"Wu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling-quan","family":"Kong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30261-X_bib1","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/S2213-8587(19)30093-2","article-title":"Morbidity and mortality after lifestyle intervention for people with impaired glucose tolerance: 30-year results of the Da Qing Diabetes Prevention Outcome Study","volume":"7","author":"Gong","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30261-X_bib2","series-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation","year":"2006"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930261X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930261X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T23:31:39Z","timestamp":1566343899000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871930261X"}},"issued":{"date-parts":[[2019,9]]},"references-count":2,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S221385871930261X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30261-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,9]]}},{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T16:16:41Z","timestamp":1767889001052,"version":"3.49.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/s2213-8587(15)00429-5","type":"journal-article","created":{"date-parts":[[2015,11,10]],"date-time":"2015-11-10T01:35:02Z","timestamp":1447119302000},"page":"935-936","source":"Crossref","is-referenced-by-count":5,"title":["Turning big data into personalised diabetes care"],"prefix":"10.1016","volume":"3","author":[{"given":"Dara","family":"Mohammadi","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004295?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004295?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T22:54:23Z","timestamp":1537224863000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004295"}},"issued":{"date-parts":[[2015,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S2213858715004295"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00429-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,12]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:59Z","timestamp":1761991919733,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/s2213-8587(20)30109-1","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:34:36Z","timestamp":1587580476000},"page":"369-370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Type 1 diabetes\u2014origins and epidemiology \u2013 Authors' reply"],"prefix":"10.1016","volume":"8","author":[{"given":"Jill M","family":"Norris","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Randi K","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lars C","family":"Stene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30109-1_bib1","doi-asserted-by":"crossref","first-page":"226","DOI":"10.1016\/S2213-8587(19)30412-7","article-title":"Type 1 diabetes\u2014early life origins and changing epidemiology","volume":"8","author":"Norris","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30109-1_bib2","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.envint.2013.07.013","article-title":"Temporal trends of perfluoroalkyl acids in plasma samples of pregnant women in Hokkaido, Japan, 2003\u20132011","volume":"60","author":"Okada","year":"2013","journal-title":"Environ Int"},{"key":"10.1016\/S2213-8587(20)30109-1_bib3","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1016\/j.envint.2014.05.019","article-title":"Decline in perfluorooctane sulfonate and perfluorooctanoate serum concentrations in an Australian population from 2002 to 2011","volume":"71","author":"Toms","year":"2014","journal-title":"Environ Int"},{"key":"10.1016\/S2213-8587(20)30109-1_bib4","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.envres.2017.05.013","article-title":"Per- and polyfluoroalkyl substances (PFAS) in American Red Cross adult blood donors, 2000-2015","volume":"157","author":"Olsen","year":"2017","journal-title":"Environ Res"},{"key":"10.1016\/S2213-8587(20)30109-1_bib5","doi-asserted-by":"crossref","first-page":"9071","DOI":"10.1021\/es301168c","article-title":"Perfluorinated alkyl acids in blood serum from primiparous women in Sweden: serial sampling during pregnancy and nursing, and temporal trends 1996\u20132010","volume":"46","author":"Glynn","year":"2012","journal-title":"Environ Sci Technol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301091?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301091?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:51Z","timestamp":1761991671000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301091"}},"issued":{"date-parts":[[2020,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213858720301091"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30109-1","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes\u2014origins and epidemiology \u2013 Authors' reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30109-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30121-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30106-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30412-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,13]],"date-time":"2025-12-13T23:06:08Z","timestamp":1765667168821},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/s2213-8587(16)30331-x","type":"journal-article","created":{"date-parts":[[2016,11,4]],"date-time":"2016-11-04T20:16:16Z","timestamp":1478290576000},"page":"979-980","source":"Crossref","is-referenced-by-count":18,"title":["Country in Focus: confronting the challenge of NCDs in Nepal"],"prefix":"10.1016","volume":"4","author":[{"given":"Shiva Raj","family":"Mishra","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Per","family":"Kallestrup","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dinesh","family":"Neupane","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630331X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630331X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T19:57:45Z","timestamp":1536263865000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871630331X"}},"issued":{"date-parts":[[2016,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S221385871630331X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30331-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,12]]}},{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T19:15:11Z","timestamp":1768677311492,"version":"3.49.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/s2213-8587(15)00416-7","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T20:00:19Z","timestamp":1447876819000},"page":"932","source":"Crossref","is-referenced-by-count":8,"title":["Non-linear association between smoking cessation and incident type 2 diabetes"],"prefix":"10.1016","volume":"3","author":[{"given":"Ngoc Minh","family":"Pham","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chung Thanh","family":"Nguyen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin W","family":"Binns","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andy H","family":"Lee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00416-7_bib1","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1016\/S2213-8587(15)00316-2","article-title":"Relation of active, passive, and quitting smoking with incident type 2 diabetes: a systematic review and meta-analysis","volume":"3","author":"Pan","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00416-7_bib2","doi-asserted-by":"crossref","first-page":"e0132166","DOI":"10.1371\/journal.pone.0132166","article-title":"Smoking, smoking cessation, and the risk of type 2diabetes among Japanese adults: Japan Epidemiology Collaboration on Occupational Health Study","volume":"10","author":"Akter","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(15)00416-7_bib3","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1097\/00001648-199305000-00005","article-title":"Meta-analysis of epidemiologic dose-response data","volume":"4","author":"Berlin","year":"1993","journal-title":"Epidemiology"},{"key":"10.1016\/S2213-8587(15)00416-7_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1002\/sim.4780080504","article-title":"Flexible regression models with cubic splines","volume":"8","author":"Durrleman","year":"1989","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(15)00416-7_bib5","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1093\/oxfordjournals.aje.a116237","article-title":"Methods for trend estimation from summarized dose-response data, with applications to meta-analysis","volume":"135","author":"Greenland","year":"1992","journal-title":"Am J Epidemiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004167?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004167?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T12:22:09Z","timestamp":1537186929000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004167"}},"issued":{"date-parts":[[2015,12]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S2213858715004167"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00416-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,12]]}},{"indexed":{"date-parts":[[2026,7,15]],"date-time":"2026-07-15T19:15:08Z","timestamp":1784142908413,"version":"3.55.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100018562","name":"Steno Diabetes Center Copenhagen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018562","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/s2213-8587(20)30030-9","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T18:54:28Z","timestamp":1583175268000},"page":"313-324","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Nicklas J","family":"Johansen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas F","family":"Dejgaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asger","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilla","family":"Schl\u00fcntz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian S","family":"Frandsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie L","family":"Forman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai J","family":"Wewer Albrechtsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens J","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrik","family":"Pedersen-Bjergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sten","family":"Madsbad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Vilsb\u00f8ll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik U","family":"Andersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Filip K","family":"Knop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30030-9_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30030-9_bib2","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30030-9_bib3","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.diabres.2016.09.024","article-title":"Type 1 diabetes in older adults: Comparing treatments and chronic complications in the United States T1D Exchange and the German\/Austrian DPV registries","volume":"122","author":"Weinstock","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(20)30030-9_bib4","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.2337\/diacare.26.6.1902","article-title":"Hypoglycemia in diabetes","volume":"26","author":"Cryer","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30030-9_bib5","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2337\/diacare.24.10.1711","article-title":"Influence of intensive diabetes treatment on body weight and composition of adults with type 1 diabetes in the Diabetes Control and Complications Trial","volume":"24","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30030-9_bib6","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1161\/CIRCULATIONAHA.111.077487","volume":"127","author":"Purnell","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(20)30030-9_bib7","doi-asserted-by":"crossref","first-page":"626","DOI":"10.2337\/diab.44.6.626","article-title":"Glucagon-like peptide I reduces postprandial glycemic excursions in IDDM","volume":"44","author":"Dupre","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30030-9_bib8","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2337\/diacare.19.6.580","article-title":"Glucagonostatic actions and reduction of fasting hyperglycemia by exogenous glucagon-like peptide I(7\u201336) amide in type I diabetic patients","volume":"19","author":"Creutzfeldt","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30030-9_bib9","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.1152\/physrev.00034.2006","article-title":"The physiology of glucagon-like peptide 1","volume":"87","author":"Holst","year":"2007","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(20)30030-9_bib10","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2337\/dc16-0691","article-title":"Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE treat-to-target randomized trial","volume":"39","author":"Mathieu","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30030-9_bib11","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.2337\/dc16-0690","article-title":"Efficacy and safety of liraglutide added to capped insulin treatment in subjects with type 1 diabetes: the ADJUNCT TWO randomized trial","volume":"39","author":"Ahr\u00e9n","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30030-9_bib12","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(15)00436-2","article-title":"Efficacy and safety of liraglutide for overweight adult patients with type 1 diabetes and insufficient glycaemic control (Lira-1): a randomised, double-blind, placebo-controlled trial","volume":"4","author":"Dejgaard","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30030-9_bib13","article-title":"Liraglutide reduces hyperglycaemia and body weight in overweight, dysregulated insulin-pump-treated patients with type 1 diabetes: the Lira Pump trial\u2014a randomized, double-blinded, placebo-controlled trial","author":"Dejgaard","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30030-9_bib14","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/j.ejim.2014.03.005","article-title":"Glucagon-like peptide-1 receptor agonists for the treatment of type 2 diabetes: differences and similarities","volume":"25","author":"Lund","year":"2014","journal-title":"Eur J Intern Med"},{"key":"10.1016\/S2213-8587(20)30030-9_bib15","doi-asserted-by":"crossref","first-page":"1263","DOI":"10.2337\/dc14-1984","article-title":"Contrasting effects of lixisenatide and liraglutide on postprandial glycemic control, gastric emptying, and safety parameters in patients with type 2 diabetes on optimized insulin glargine with or without metformin: a randomized, open-label trial","volume":"38","author":"Meier","year":"2015","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(20)30030-9_bib16","first-page":"S61","article-title":"6. Glycemic targets: standards of medical care in diabetes\u20142019","volume":"42","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30030-9_bib17","doi-asserted-by":"crossref","first-page":"2251","DOI":"10.2337\/dc09-0773","article-title":"Effects of exenatide alone and in combination with daclizumab on \u03b2-cell function in long-standing type 1 diabetes","volume":"32","author":"Rother","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30030-9_bib18","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1097\/01.tp.0000251379.46596.2d","article-title":"Effect of exenatide on \u03b2 cell function after islet transplantation in type 1 diabetes","volume":"83","author":"Ghofaili","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/S2213-8587(20)30030-9_bib19","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1016\/j.diabres.2013.01.020","article-title":"Addition of exenatide or sitagliptin to insulin in new onset type 1 diabetes: a randomized, open label study","volume":"100","author":"Hari Kumar","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(20)30030-9_bib20","doi-asserted-by":"crossref","first-page":"666","DOI":"10.2337\/dc13-1473","article-title":"Exenatide treatment for 6 months improves insulin sensitivity in adults with type 1 diabetes","volume":"37","author":"Sarkar","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30030-9_bib21","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/dc13-1169","article-title":"Acute metabolic effects of exenatide in patients with type 1 diabetes with and without residual insulin to oral and intravenous glucose challenges","volume":"37","author":"Ghazi","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30030-9_bib22","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40618-017-0765-0","article-title":"The effects of add-on exenatide to insulin on glycemic variability and hypoglycemia in patients with type 1 diabetes mellitus","volume":"41","author":"Jiang","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(20)30030-9_bib23","doi-asserted-by":"crossref","first-page":"4143","DOI":"10.1210\/jc.2019-00087","article-title":"Effect of the GLP-1 receptor agonist exenatide on impaired awareness of hypoglycemia in type 1 diabetes: a randomized controlled trial","volume":"104","author":"van Meijel","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30030-9_bib24","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-021861","article-title":"Protocol for meal-time administration of exenatide for glycaemic control in type 1 diabetes cases (the MAG1C trial): a randomised, double-blinded, placebo-controlled trial","volume":"8","author":"Johansen","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(20)30030-9_bib25","series-title":"Applied longitudinal analysis","author":"Fitzmaurice","year":"2011"},{"key":"10.1016\/S2213-8587(20)30030-9_bib26","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J R Stat Soc B"},{"key":"10.1016\/S2213-8587(20)30030-9_bib27","doi-asserted-by":"crossref","first-page":"775","DOI":"10.2337\/diacare.24.4.775","article-title":"Postprandial blood glucose","volume":"24","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30030-9_bib28","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.2337\/diacare.28.5.1083","article-title":"Effects of exenatide (exendin-4) on glycemic control over 30 weeks in patients with type 2 diabetes treated with metformin and a sulfonylurea","volume":"28","author":"Kendall","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30030-9_bib29","doi-asserted-by":"crossref","first-page":"1092","DOI":"10.2337\/diacare.28.5.1092","article-title":"Effects of exenatide (exendin-4) on glycemic control and weight over 30 weeks in metformin-treated patients with type 2 diabetes","volume":"28","author":"DeFronzo","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30030-9_bib30","doi-asserted-by":"crossref","first-page":"2628","DOI":"10.2337\/diacare.27.11.2628","article-title":"Effects of exenatide (exendin-4) on glycemic control over 30 weeks in sulfonylurea-treated patients with type 2 diabetes","volume":"27","author":"Buse","year":"2004","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300309?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300309?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:13Z","timestamp":1761991693000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300309"}},"issued":{"date-parts":[[2020,4]]},"references-count":30,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2213858720300309"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30030-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of meal-time administration of short-acting exenatide for glycaemic control in type 1 diabetes (MAG1C): a randomised, double-blind, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30030-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30043-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T03:45:11Z","timestamp":1774928711138,"version":"3.50.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/s2213-8587(16)00049-8","type":"journal-article","created":{"date-parts":[[2016,3,22]],"date-time":"2016-03-22T23:45:18Z","timestamp":1458690318000},"page":"294-296","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Heart failure event definitions in drug trials in patients with type 2 diabetes"],"prefix":"10.1016","volume":"4","author":[{"given":"Abhinav","family":"Sharma","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gonzalo","family":"Calvo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nancy J","family":"Brown","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert J","family":"Mentz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)00049-8_bib1","series-title":"Guidance for industry: diabetes mellitus\u2014evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes","year":"2008"},{"key":"10.1016\/S2213-8587(16)00049-8_bib2","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S2213-8587(14)70031-2","article-title":"Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored","volume":"2","author":"McMurray","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00049-8_bib3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1161\/CIRCULATIONAHA.114.014796","article-title":"Impact of diabetes mellitus on hospitalization for heart failure, cardiovascular events, and death: outcomes at 4 years from the Reduction of Atherothrombosis for Continued Health (REACH) Registry","volume":"132","author":"Cavender","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)00049-8_bib4","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)00049-8_bib5","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1161\/CIRCULATIONAHA.114.010389","article-title":"Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial","volume":"130","author":"Scirica","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)00049-8_bib6","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1016\/j.ahj.2011.08.006","article-title":"The design and rationale of the saxagliptin assessment of vascular outcomes recorded in patients with diabetes mellitus-thrombolysis in myocardial infarction (SAVOR-TIMI) 53 study","volume":"162","author":"Scirica","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(16)00049-8_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2213-8587(15)00044-3","article-title":"Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials","volume":"3","author":"Udell","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00049-8_bib8","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1016\/j.jacc.2014.12.018","article-title":"2014 ACC\/AHA key data elements and definitions for cardiovascular endpoint events in clinical trials","volume":"66","author":"Hicks","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)00049-8_bib9","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00049-8_bib10","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/S0140-6736(07)60106-8","article-title":"Adjudication of serious heart failure in patients from PROactive","volume":"369","author":"Ryd\u00e9n","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)00049-8_bib11","first-page":"e240","article-title":"2013 ACCF\/AHA guideline for the management of heart failure","volume":"128","author":"Yancy","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)00049-8_bib12","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1093\/eurheartj\/ehm603","article-title":"Heart failure as an endpoint in heart failure and non-heart failure cardiovascular clinical trials: the need for a consensus definition","volume":"29","author":"Zannad","year":"2008","journal-title":"Eur Heart J"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000498?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000498?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T09:06:14Z","timestamp":1658307974000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716000498"}},"issued":{"date-parts":[[2016,4]]},"references-count":12,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S2213858716000498"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)00049-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heart failure event definitions in drug trials in patients with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)00049-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,2,25]],"date-time":"2026-02-25T06:12:58Z","timestamp":1771999978869,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,12,1]],"date-time":"2024-12-01T00:00:00Z","timestamp":1733011200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,12]]},"DOI":"10.1016\/s2213-8587(24)00307-3","type":"journal-article","created":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T22:32:47Z","timestamp":1728685967000},"page":"872-873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Lessons to learn from the 2024 NICE guideline on adrenal insufficiency"],"prefix":"10.1016","volume":"12","author":[{"given":"Jiawen","family":"Dong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy W","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00307-3_bib1","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad017","article-title":"The changing epidemiology of adrenal insufficiency: iatrogenic factors predominate","volume":"7","author":"Rushworth","year":"2023","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(24)00307-3_bib3","doi-asserted-by":"crossref","DOI":"10.1056\/EVIDoa2200182","article-title":"Home waking salivary cortisone to screen for adrenal insufficiency","volume":"2","author":"Debono","year":"2023","journal-title":"NEJM Evid"},{"key":"10.1016\/S2213-8587(24)00307-3_bib4","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1055\/s-0029-1225630","article-title":"Diagnosis of secondary adrenal insufficiency: unstimulated early morning cortisol in saliva and serum in comparison with the insulin tolerance test","volume":"41","author":"Deutschbein","year":"2009","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(24)00307-3_bib5","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1530\/EJE-15-0608","article-title":"Adrenal suppression in patients taking inhaled glucocorticoids is highly prevalent and management can be guided by morning cortisol","volume":"173","author":"Woods","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00307-3_bib6","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1111\/cen.13232","article-title":"Baseline morning cortisol level as a predictor of pituitary-adrenal reserve: a comparison across three assays","volume":"86","author":"Sbardella","year":"2017","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(24)00307-3_bib7","doi-asserted-by":"crossref","first-page":"G25","DOI":"10.1093\/ejendo\/lvae029","article-title":"European Society of Endocrinology and Endocrine Society Joint Clinical Guideline: diagnosis and therapy of glucocorticoid-induced adrenal insufficiency","volume":"190","author":"Beuschlein","year":"2024","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00307-3_bib8","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1210\/jc.2015-1218","article-title":"Adrenal insufficiency in corticosteroids use: systematic review and meta-analysis","volume":"100","author":"Broersen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00307-3_bib9","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/EJE-19-0305","article-title":"Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark","volume":"181","author":"Laugesen","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00307-3_bib10","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1093\/rheumatology\/ker017","article-title":"Prevalence of long-term oral glucocorticoid prescriptions in the UK over the past 20 years","volume":"50","author":"Fardet","year":"2011","journal-title":"Rheumatology"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003073?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003073?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,27]],"date-time":"2024-11-27T04:08:27Z","timestamp":1732680507000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003073"}},"issued":{"date-parts":[[2024,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2024,12]]}},"alternative-id":["S2213858724003073"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00307-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lessons to learn from the 2024 NICE guideline on adrenal insufficiency","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00307-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:58Z","timestamp":1761991978492,"version":"build-2065373602"},"reference-count":4,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,11,1]],"date-time":"2020-11-01T00:00:00Z","timestamp":1604188800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,11]]},"DOI":"10.1016\/s2213-8587(20)30341-7","type":"journal-article","created":{"date-parts":[[2020,10,13]],"date-time":"2020-10-13T19:04:35Z","timestamp":1602615875000},"page":"876-877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Urine metabolomic phenotyping for detection of adrenocortical carcinoma: still a long way to go"],"prefix":"10.1016","volume":"8","author":[{"given":"Panagiota","family":"Anyfanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Nikolaidou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugenia","family":"Gkaliagkousi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30341-7_bib1","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1016\/S2213-8587(20)30218-7","article-title":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study","volume":"8","author":"Bancos","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30341-7_bib2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S2213-8587(20)30224-2","article-title":"A multi-test strategy for adrenal tumours","volume":"8","author":"Turcu","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30341-7_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0214549","article-title":"Reference intervals for the urinary steroid metabolome: the impact of sex, age, day and night time on human adult steroidogenesis","volume":"14","author":"Ackermann","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(20)30341-7_bib4","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors","volume":"96","author":"Arlt","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303417?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303417?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:36Z","timestamp":1761991776000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303417"}},"issued":{"date-parts":[[2020,11]]},"references-count":4,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2020,11]]}},"alternative-id":["S2213858720303417"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30341-7","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine metabolomic phenotyping for detection of adrenocortical carcinoma: still a long way to go","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30341-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30345-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,3]],"date-time":"2026-06-03T14:02:43Z","timestamp":1780495363562,"version":"3.54.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/s2213-8587(19)30266-9","type":"journal-article","created":{"date-parts":[[2019,8,22]],"date-time":"2019-08-22T18:43:00Z","timestamp":1566499380000},"page":"739-741","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Personalising osteoporosis treatment for patients at high risk of fracture"],"prefix":"10.1016","volume":"7","author":[{"given":"Sundeep","family":"Khosla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30266-9_bib1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30266-9_bib2","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30266-9_bib3","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30266-9_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30255-4","article-title":"Combination denosumab and high dose teriparatide for postmenopausal osteoporosis (DATA-HD): a randomised, controlled phase 4 trial","author":"Tsai","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30266-9_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1016\/S0140-6736(13)60856-9","article-title":"Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial","volume":"382","author":"Tsai","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30266-9_bib6","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jbmr.3641","article-title":"Change in bone density and reduction in fracture risk: a meta-regression of published trials","volume":"34","author":"Bouxsein","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30266-9_bib7","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1001\/jama.2019.6077","article-title":"Drugs for postmenopausal osteoporosis","volume":"321","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30266-9_bib8","doi-asserted-by":"crossref","first-page":"145","DOI":"10.7326\/M16-1432","article-title":"High generic drug prices and market competition: a retrospective cohort study","volume":"167","author":"Dave","year":"2017","journal-title":"Ann Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302669?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302669?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:25Z","timestamp":1761991645000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719302669"}},"issued":{"date-parts":[[2019,10]]},"references-count":8,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2213858719302669"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30266-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Personalising osteoporosis treatment for patients at high risk of fracture","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30266-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30255-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:09:36Z","timestamp":1784070576895,"version":"3.55.0"},"update-to":[{"DOI":"10.1016\/s2213-8587(25)00394-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/s2213-8587(26)00139-7","type":"journal-article","created":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T22:40:58Z","timestamp":1780612858000},"page":"e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2026; 14: 259\u201374"],"prefix":"10.1016","volume":"14","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:48:18Z","timestamp":1784069298000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726001397"}},"issued":{"date-parts":[[2026,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2213858726001397"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00139-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2026; 14: 259\u201374","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00139-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00394-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T05:25:11Z","timestamp":1783488311345,"version":"3.55.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1050688"],"award-info":[{"award-number":["APP1050688"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1067066"],"award-info":[{"award-number":["APP1067066"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1021025"],"award-info":[{"award-number":["APP1021025"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["APP1054751"],"award-info":[{"award-number":["APP1054751"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/s2213-8587(16)30122-x","type":"journal-article","created":{"date-parts":[[2016,7,22]],"date-time":"2016-07-22T01:41:28Z","timestamp":1469151688000},"page":"756-765","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":97,"title":["Association between borderline neonatal thyroid-stimulating hormone concentrations and educational and developmental outcomes: a population-based record-linkage study"],"prefix":"10.1016","volume":"4","author":[{"given":"Samantha J","family":"Lain","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jason P","family":"Bentley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Veronica","family":"Wiley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine L","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Jack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget","family":"Wilcken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha","family":"Nassar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30122-X_bib1","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1210\/jc.2011-1850","article-title":"Increasing incidence of congenital hypothyroidism: some answers, more questions","volume":"96","author":"LaFranchi","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30122-X_bib2","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1046\/j.1365-2265.1999.00639.x","article-title":"Low maternal free thyroxine concentrations during early pregnancy are associated with impaired psychomotor development in infancy","volume":"50","author":"Pop","year":"1999","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(16)30122-X_bib3","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJM199908193410801","article-title":"Maternal thyroid deficiency during pregnancy and subsequent neuropsychological development of the child","volume":"341","author":"Haddow","year":"1999","journal-title":"New Engl J Med"},{"key":"10.1016\/S2213-8587(16)30122-X_bib4","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/jpc.12783","article-title":"Using record linkage to investigate perinatal factors and neonatal thyroid\u2013stimulating hormone","volume":"51","author":"Lain","year":"2015","journal-title":"J Paediatr Child Health"},{"key":"10.1016\/S2213-8587(16)30122-X_bib5","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1210\/jc.2011-2398","article-title":"Maternal early pregnancy and newborn thyroid hormone parameters: the generation R study","volume":"97","author":"Medici","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30122-X_bib6","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1016\/j.nutres.2015.09.002","article-title":"Neonatal thyroid-stimulating hormone level is influenced by neonatal, maternal, and pregnancy factors","volume":"35","author":"Trumpff","year":"2015","journal-title":"Nutrition Res"},{"key":"10.1016\/S2213-8587(16)30122-X_bib7","doi-asserted-by":"crossref","first-page":"206","DOI":"10.1210\/jc.2015-3559","article-title":"Maternal and birth characteristics are determinants of offspring thyroid function","volume":"101","author":"Korevaar","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30122-X_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/1750-1172-5-17","article-title":"Congenital hypothyroidism","volume":"5","author":"Rastogi","year":"2010","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(16)30122-X_bib9","series-title":"Endocrinology: adult and pediatric","first-page":"1282","article-title":"Thyroid-stimulating hormone: physiology and secretion","author":"Gordon","year":"2016"},{"key":"10.1016\/S2213-8587(16)30122-X_bib10","doi-asserted-by":"crossref","first-page":"R67","DOI":"10.1530\/EJE-14-0777","article-title":"Endocrinology and adolescence: congenital hypothyroidism: a clinical update of long-term outcome in young adults","volume":"172","author":"L\u00e9ger","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(16)30122-X_bib11","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1136\/adc.2010.190280","article-title":"Prevention of intellectual disability through screening for congenital hypothyroidism: how much and at what level?","volume":"96","author":"Grosse","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(16)30122-X_bib12","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1136\/adc.2008.147884","article-title":"Difficulties in selecting an appropriate neonatal thyroid stimulating hormone (TSH) screening threshold","volume":"95","author":"Korada","year":"2010","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(16)30122-X_bib13","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1136\/adc.2009.174466","article-title":"Treating patients not numbers: the benefit and burden of lowering TSH newborn screening cut-offs","volume":"96","author":"Krude","year":"2011","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(16)30122-X_bib14","doi-asserted-by":"crossref","first-page":"4499","DOI":"10.1210\/jc.2013-2175","article-title":"Cognitive development in congenital hypothyroidism: is overtreatment a greater threat than undertreatment?","volume":"98","author":"Bongers-Schokking","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30122-X_bib15","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s10545-011-9286-8","article-title":"Newborn screening for congenital hypothyroidism in very-low-birth-weight babies: the need for a second test","volume":"34","author":"Bijarnia","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30122-X_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1037\/cjbs2007001","article-title":"Development and psychometric properties of the Early Development Instrument (EDI): a measure of children's school readiness","volume":"39","author":"Janus","year":"2007","journal-title":"Can J Behav Sci"},{"key":"10.1016\/S2213-8587(16)30122-X_bib19","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1007\/s12187-013-9189-3","article-title":"Associations between the early development instrument at age 5, and reading and numeracy skills at ages 8, 10 and 12: a prospective linked data study","volume":"6","author":"Brinkman","year":"2013","journal-title":"Child Indic Res"},{"key":"10.1016\/S2213-8587(16)30122-X_bib21","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1210\/jc.2008-0936","article-title":"Neonatal thyroxine, maternal thyroid function, and child cognition","volume":"94","author":"Oken","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30122-X_bib23","doi-asserted-by":"crossref","first-page":"901","DOI":"10.1530\/EJE-10-0495","article-title":"Newborn TSH concentration and its association with cognitive development in healthy boys","volume":"163","author":"Freire","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(16)30122-X_bib24","doi-asserted-by":"crossref","first-page":"9018","DOI":"10.3390\/nu7115450","article-title":"Thyroid-stimulating hormone (TSH) concentration at birth in belgian neonates and cognitive development at preschool age","volume":"7","author":"Trumpff","year":"2015","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(16)30122-X_bib25","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1210\/jc.2012-3572","article-title":"Maternal and umbilical cord levels of T4, FT4, TSH, TPOAb, and TgAb in term infants and neurodevelopmental outcome at 5\u00b75 years","volume":"98","author":"Williams","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30122-X_bib26","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-8587(15)00327-7","article-title":"Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study","volume":"4","author":"Korevaar","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30122-X_bib27","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/j.jtemb.2013.01.002","article-title":"Mild iodine deficiency in pregnancy in Europe and its consequences for cognitive and psychomotor development of children: a review","volume":"27","author":"Trumpff","year":"2013","journal-title":"J Trace Elem Med Biol"},{"key":"10.1016\/S2213-8587(16)30122-X_bib28","doi-asserted-by":"crossref","first-page":"617","DOI":"10.5694\/j.1326-5377.2006.tb00417.x","article-title":"Iodine status in pregnant women and their newborns: are our babies at risk of iodine deficiency?","volume":"184","author":"Travers","year":"2006","journal-title":"Med J Aust"},{"key":"10.1016\/S2213-8587(16)30122-X_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/j.beem.2013.05.008","article-title":"Screening for congenital hypothyroidism: a worldwide view of strategies","volume":"28","author":"Ford","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30122-X_bib30","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1111\/j.1365-2265.2009.03568.x","article-title":"A 7-year experience with low blood TSH cutoff levels for neonatal screening reveals an unsuspected frequency of congenital hypothyroidism (CH)","volume":"71","author":"Corbetta","year":"2009","journal-title":"Clinical Endocrinol"},{"key":"10.1016\/S2213-8587(16)30122-X_bib31","doi-asserted-by":"crossref","first-page":"4283","DOI":"10.1210\/jc.2010-0057","article-title":"Screening for congenital hypothyroidism: the significance of threshold limit in false-negative results","volume":"95","author":"Mengreli","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30122-X_bib32","doi-asserted-by":"crossref","first-page":"3663","DOI":"10.1210\/jc.2013-1903","article-title":"Neurodevelopmental and body composition outcomes in children with congenital hypothyroidism treated with high-dose initial replacement and close monitoring","volume":"98","author":"Albert","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30122-X_bib33","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1542\/peds.105.3.515","article-title":"Psychoeducational outcome in children with early-treated congenital hypothyroidism","volume":"105","author":"Rovet","year":"2000","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)30122-X_bib34","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1542\/peds.112.4.923","article-title":"Congenital hypothyroidism: influence of disease severity and L-thyroxine treatment on intellectual, motor, and school-associated outcomes in young adults","volume":"112","author":"Oerbeck","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)30122-X_bib35","doi-asserted-by":"crossref","first-page":"1271","DOI":"10.1210\/jc.2004-2091","article-title":"Serum thyroid hormones in preterm infants and relationships to indices of severity of intercurrent illness","volume":"90","author":"Simpson","year":"2005","journal-title":"J Clin Endocrinol Metab"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(16)30241-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630122X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630122X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:16Z","timestamp":1761991576000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871630122X"}},"issued":{"date-parts":[[2016,9]]},"references-count":31,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S221385871630122X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30122-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between borderline neonatal thyroid-stimulating hormone concentrations and educational and developmental outcomes: a population-based record-linkage study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30122-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30152-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T18:28:42Z","timestamp":1786645722025,"version":"build-2736575974"},"reference-count":9,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,11,1]],"date-time":"2021-11-01T00:00:00Z","timestamp":1635724800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,11]]},"DOI":"10.1016\/s2213-8587(21)00265-5","type":"journal-article","created":{"date-parts":[[2021,10,5]],"date-time":"2021-10-05T21:03:21Z","timestamp":1633467801000},"page":"727-728","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Forecasting therapeutic responses by albuminuria and eGFR slope during the DAPA-CKD trial"],"prefix":"10.1016","volume":"9","author":[{"given":"Katherine R","family":"Tuttle","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00265-5_bib1","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00265-5_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2020.06.019","article-title":"Kidney Disease: Improving Global Outcomes (KDIGO) diabetes work group. KDIGO 2020 Clinical Practice Guideline for diabetes management in chronic kidney disease","volume":"98","author":"de Boer","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(21)00265-5_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00243-6","article-title":"Effect of dapagliflozin on urinary albumin excretion in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial","author":"Jongs","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00265-5_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00242-4","article-title":"Effect of dapagliflozin on the rate of decline in kidney function in patients with chronic kidney disease with and without type 2 diabetes: a prespecified analysis from the DAPA-CKD trial","author":"Heerspink","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00265-5_bib5","doi-asserted-by":"crossref","first-page":"2032","DOI":"10.2215\/CJN.11491116","article-title":"Diabetic kidney disease: challenges, progress, and possibilities","volume":"12","author":"Alicic","year":"2017","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(21)00265-5_bib6","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.kint.2020.08.039","article-title":"Rationale and design of the Kidney Precision Medicine Project","volume":"99","author":"de Boer","year":"2021","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(21)00265-5_bib7","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1056\/NEJMoa2025845","article-title":"Effect of finerenone on chronic kidney disease outcomes in type 2 diabetes","volume":"383","author":"Bakris","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00265-5_bib8","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2110956","article-title":"Cardiovascular events with finerenone in kidney disease and type 2 diabetes","author":"Pitt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00265-5_bib9","unstructured":"Filippato G. FIDELITY analysis. Finerenon in mild-to-severe chronic kidney disease and type 2 diabetes. European Society of Cardiology Congress 2021; virtual; Aug 27\u201330, 2021."}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002655?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002655?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:06Z","timestamp":1761991806000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002655"}},"issued":{"date-parts":[[2021,11]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2021,11]]}},"alternative-id":["S2213858721002655"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00265-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Forecasting therapeutic responses by albuminuria and eGFR slope during the DAPA-CKD trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00265-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00242-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00243-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:41:44Z","timestamp":1786999304575,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/s2213-8587(25)00323-7","type":"journal-article","created":{"date-parts":[[2026,1,29]],"date-time":"2026-01-29T23:57:10Z","timestamp":1769731030000},"page":"189-190","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["3 months of romosozumab: a pragmatic clinical solution"],"prefix":"10.1016","volume":"14","author":[{"given":"Sundeep","family":"Khosla","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00323-7_bib1","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00323-7_bib2","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1056\/NEJMoa1305224","article-title":"Romosozumab in postmenopausal women with low bone mineral density","volume":"370","author":"McClung","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00323-7_bib3","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1038\/nrrheum.2016.48","article-title":"The genetics of bone mass and susceptibility to bone diseases","volume":"12","author":"Karasik","year":"2016","journal-title":"Nat Rev Rheumatol"},{"key":"10.1016\/S2213-8587(25)00323-7_bib4","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1086\/318811","article-title":"Bone dysplasia sclerosteosis results from loss of the SOST gene product, a novel cystine knot-containing protein","volume":"68","author":"Brunkow","year":"2001","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(25)00323-7_bib5","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1136\/jmg.39.2.91","article-title":"Identification of a 52 kb deletion downstream of the SOST gene in patients with van Buchem disease","volume":"39","author":"Balemans","year":"2002","journal-title":"J Med Genet"},{"key":"10.1016\/S2213-8587(25)00323-7_bib6","doi-asserted-by":"crossref","first-page":"2882","DOI":"10.1210\/jc.2006-0190","article-title":"Effects of teriparatide, alendronate, or both on bone turnover in osteoporotic men","volume":"91","author":"Finkelstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00323-7_bib7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1001\/jama.2016.11136","article-title":"Effect of abaloparatide vs placebo on new vertebral fractures in postmenopausal women with osteoporosis: a randomized clinical trial","volume":"316","author":"Miller","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00323-7_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00319-5","article-title":"3 months vs 12 months of romosozumab for postmenopausal osteoporosis (LIDA): an open-label, non-inferiority, randomised controlled trial","author":"Leder","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00323-7_bib9","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1056\/NEJMoa1708322","article-title":"Romosozumab or alendronate for fracture prevention in women with osteoporosis","volume":"377","author":"Saag","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00323-7_bib10","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003237?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003237?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:29:49Z","timestamp":1780662589000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003237"}},"issued":{"date-parts":[[2026,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2213858725003237"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00323-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"3 months of romosozumab: a pragmatic clinical solution","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00323-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00319-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:47:24Z","timestamp":1787496444963,"version":"build-2736575974"},"reference-count":8,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100018484","name":"Institute for Healthcare Policy and Innovation, University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100018484","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["P30-DK092926"],"award-info":[{"award-number":["P30-DK092926"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005156","name":"Alexander von Humboldt-Stiftung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005156","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/s2213-8587(21)00328-4","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T18:42:26Z","timestamp":1641840146000},"page":"154-157","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Maximising use of population data on cardiometabolic diseases"],"prefix":"10.1016","volume":"10","author":[{"given":"David","family":"Flood","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Guwatudde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albertino","family":"Damasceno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Manne-Goehler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justine I","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00328-4_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(21)00340-5","article-title":"Estimated impact of increased diagnosis, treatment, and control of diabetes mellitus among low-and middle-income countries: a microsimulation model","volume":"9","author":"Basu","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(21)00328-4_bib2","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/S2213-8587(16)00037-1","article-title":"Liberating data: the crucial weapon in the fight against NCDs","volume":"4","author":"Davies","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00328-4_bib3","doi-asserted-by":"crossref","first-page":"1223","DOI":"10.1016\/S0140-6736(20)30752-2","article-title":"Global burden of 87 risk factors in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00328-4_bib4","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/S0140-6736(19)30955-9","article-title":"The state of hypertension care in 44 low-income and middle-income countries: a cross-sectional study of nationally representative individual-level data from 1\u00b71 million adults","volume":"394","author":"Geldsetzer","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00328-4_bib5","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S0140-6736(21)00844-8","article-title":"Body-mass index and diabetes risk in 57 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 685\u2009616 adults","volume":"398","author":"Teufel","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00328-4_bib7","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2213-8587(21)00111-X","article-title":"The WHO Global Diabetes Compact: a new initiative to support people living with diabetes","volume":"9","author":"Hunt","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00328-4_bib8","doi-asserted-by":"crossref","first-page":"390","DOI":"10.9745\/GHSP-D-20-00318","article-title":"The Demographic and Health Surveys Faculty Fellows Program: Successes, Challenges, and Lessons Learned","volume":"9","author":"Wang","year":"2021","journal-title":"Glob Health Sci Pract"},{"key":"10.1016\/S2213-8587(21)00328-4_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/S2214-109X(20)30298-9","article-title":"Oxygen availability in sub-Saharan African countries: a call for data to inform service delivery","volume":"8","author":"Mangipudi","year":"2020","journal-title":"Lancet Glob Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003284?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003284?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:54Z","timestamp":1761991854000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721003284"}},"issued":{"date-parts":[[2022,3]]},"references-count":8,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2213858721003284"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00328-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maximising use of population data on cardiometabolic diseases","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00328-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,23]],"date-time":"2026-08-23T14:56:51Z","timestamp":1787497011187,"version":"build-2736575974"},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/s2213-8587(17)30011-6","type":"journal-article","created":{"date-parts":[[2017,1,24]],"date-time":"2017-01-24T23:16:20Z","timestamp":1485299780000},"page":"92-93","source":"Crossref","is-referenced-by-count":15,"title":["Prediabetes definitions and clinical outcomes"],"prefix":"10.1016","volume":"5","author":[{"given":"Lu\u00eds Maur\u00edcio T R","family":"Lima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30011-6_bib1","doi-asserted-by":"publisher","first-page":"34","DOI":"10.1016\/S2213-8587(16)30321-7","article-title":"Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study","volume":"5","author":"Warren","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30011-6_bib2","first-page":"E214","article-title":"Glucose clamp technique: a method for quantifying insulin secretion and resistance","volume":"237","author":"DeFronzo","year":"1979","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(17)30011-6_bib3","doi-asserted-by":"publisher","first-page":"10","DOI":"10.1093\/labmed\/6.2.10","article-title":"Detection of diabetes mellitus in situ (occult diabetes)","volume":"6","author":"Kraft","year":"1975","journal-title":"Lab Med"},{"key":"10.1016\/S2213-8587(17)30011-6_bib4","doi-asserted-by":"publisher","first-page":"1462","DOI":"10.2337\/diacare.22.9.1462","article-title":"Insulin sensitivity indices obtained from oral glucose tolerance testing: comparison with the euglycemic insulin clamp","volume":"22","author":"Matsuda","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30011-6_bib5","doi-asserted-by":"publisher","first-page":"412","DOI":"10.1007\/BF00280883","article-title":"Homeostasis model assessment: insulin resistance and beta-cell function from fasting plasma glucose and insulin concentrations in man","volume":"28","author":"Matthews","year":"1985","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T18:20:29Z","timestamp":1536085229000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300116"}},"issued":{"date-parts":[[2017,2]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S2213858717300116"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30011-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,2]]}},{"indexed":{"date-parts":[[2026,9,2]],"date-time":"2026-09-02T20:09:48Z","timestamp":1788379788749,"version":"build-2803163510"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100011856","name":"Mauritius Research Council","doi-asserted-by":"publisher","award":["MC_UU_12015\/5"],"award-info":[{"award-number":["MC_UU_12015\/5"]}],"id":[{"id":"10.13039\/501100011856","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015250","name":"NIHR Bristol Biomedical Research Centre","doi-asserted-by":"publisher","award":["IS-BRC-1215-20014"],"award-info":[{"award-number":["IS-BRC-1215-20014"]}],"id":[{"id":"10.13039\/100015250","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/s2213-8587(20)30268-0","type":"journal-article","created":{"date-parts":[[2020,8,3]],"date-time":"2020-08-03T18:34:27Z","timestamp":1596479667000},"page":"735-736","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":161,"title":["Vitamin D for COVID-19: a case to answer?"],"prefix":"10.1016","volume":"8","author":[{"given":"Adrian R","family":"Martineau","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nita G","family":"Forouhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30268-0_bib1","article-title":"Vitamin D supplementation to prevent acute respiratory infections: systematic review and meta-analysis of aggregate data from randomised controlled trials","author":"Jolliffe","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(20)30268-0_bib2","article-title":"Calcitriol, the active form of vitamin D, is a promising candidate for COVID-19 prophylaxis","author":"Mok","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(20)30268-0_bib3","doi-asserted-by":"crossref","first-page":"7432","DOI":"10.3892\/mmr.2017.7546","article-title":"Vitamin D alleviates lipopolysaccharideinduced acute lung injury via regulation of the reninangiotensin system","volume":"16","author":"Xu","year":"2017","journal-title":"Mol Med Rep"},{"key":"10.1016\/S2213-8587(20)30268-0_bib4","first-page":"81","article-title":"Vitamin D and inflammation: potential implications for severity of COVID-19","volume":"113","author":"Laird","year":"2020","journal-title":"Ir Med J"},{"key":"10.1016\/S2213-8587(20)30268-0_bib5","doi-asserted-by":"crossref","first-page":"1195","DOI":"10.1007\/s40520-020-01570-8","article-title":"The role of vitamin D in the prevention of coronavirus disease 2019 infection and mortality","volume":"32","author":"Ilie","year":"2020","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/S2213-8587(20)30268-0_bib6","article-title":"25-hydroxyvitamin D concentrations are lower in patients with positive PCR for SARS-CoV-2","volume":"12","author":"D'Avolio","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(20)30268-0_bib7","article-title":"Low serum 25-hydroxyvitamin D (25[OH]D) levels in patients hospitalised with COVID-19 are associated with greater disease severity","author":"Panagiotou","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30268-0_bib8","doi-asserted-by":"crossref","DOI":"10.1164\/rccm.201909-1867OC","article-title":"Vitamin D metabolism is dysregulated in asthma and chronic obstructive pulmonary disease","author":"Jolliffe","year":"2020","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S2213-8587(20)30268-0_bib9","article-title":"Low plasma 25(OH) vitamin D level is associated with increased risk of COVID-19 infection: an Israeli population-based study","author":"Merzon","year":"2020","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(20)30268-0_bib10","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1016\/j.dsx.2020.04.050","article-title":"Vitamin D concentrations and COVID-19 infection in UK Biobank","volume":"14","author":"Hastie","year":"2020","journal-title":"Diabetes Metab Syndr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:24Z","timestamp":1761991704000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720302680"}},"issued":{"date-parts":[[2020,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2213858720302680"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30268-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D for COVID-19: a case to answer?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30268-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T04:57:37Z","timestamp":1789016257186,"version":"build-2803163510"},"reference-count":60,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T00:00:00Z","timestamp":1427846400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,4]]},"DOI":"10.1016\/s2213-8587(14)70256-6","type":"journal-article","created":{"date-parts":[[2015,2,6]],"date-time":"2015-02-06T01:57:41Z","timestamp":1423187861000},"page":"263-274","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":118,"title":["Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"3","author":[{"given":"Bin","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yue","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shi-Hua","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wen-Juan","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheng-Li","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yan-Gang","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70256-6_bib1","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70256-6_bib2","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70256-6_bib3","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1001\/jamaophthalmol.2014.859","article-title":"Sex- and age-specific prevalence and incidence rates of sight-threatening diabetic retinopathy in Taiwan","volume":"132","author":"Lin","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/S2213-8587(14)70256-6_bib4","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.2337\/dc13-2101","article-title":"Estimating the delay between onset and diagnosis of type 2 diabetes from the time course of retinopathy prevalence","volume":"37","author":"Porta","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70256-6_bib5","doi-asserted-by":"crossref","first-page":"556","DOI":"10.2337\/dc11-1909","article-title":"Global prevalence and major risk factors of diabetic retinopathy","volume":"35","author":"Yau","year":"2012","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70256-6_bib6","first-page":"S14","article-title":"Standards of medical care in diabetes\u20142014","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70256-6_bib7","doi-asserted-by":"crossref","first-page":"S137","DOI":"10.1016\/j.jcjd.2013.01.038","article-title":"Retinopathy","volume":"37","author":"Boyd","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(14)70256-6_bib8","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/dc12-0916","article-title":"Association of clinical symptomatic hypoglycemia with cardiovascular events and total mortality in type 2 diabetes: a nationwide population-based study","volume":"36","author":"Hsu","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70256-6_bib9","doi-asserted-by":"crossref","first-page":"246","DOI":"10.2337\/diacare.11.3.246","article-title":"Incidence of diabetic retinopathy and relationship to baseline plasma glucose and blood pressure","volume":"11","author":"Teuscher","year":"1988","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70256-6_bib10","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70256-6_bib11","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Chew","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70256-6_bib12","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00125-009-1457-x","article-title":"Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial","volume":"52","author":"Beulens","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70256-6_bib13","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1016\/j.ophtha.2014.07.019","article-title":"The effects of medical management on the progression of diabetic retinopathy in persons with type 2 diabetes: the Action to Control Cardiovascular Risk in Diabetes Eye Study","volume":"121","author":"Chew","year":"2014","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(14)70256-6_bib14","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1016\/S0140-6736(08)61411-7","article-title":"Effect of candesartan on progression and regression of retinopathy in type 2 diabetes (DIRECT-Protect 2): a randomised placebo-controlled trial","volume":"372","author":"Sjolie","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70256-6_bib15","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1046\/j.1523-1755.2002.00213.x","article-title":"Effects of aggressive blood pressure control in normotensive type 2 diabetic patients on albuminuria, retinopathy and strokes","volume":"61","author":"Schrier","year":"2002","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(14)70256-6_bib16","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0140-6736(97)06209-0","article-title":"Effect of lisinopril on progression of retinopathy in normotensive people with type 1 diabetes. The EUCLID Study Group. EURODIAB Controlled Trial of Lisinopril in Insulin-Dependent Diabetes Mellitus","volume":"351","author":"Chaturvedi","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70256-6_bib17","doi-asserted-by":"crossref","first-page":"577","DOI":"10.7326\/0003-4819-118-8-199304150-00001","article-title":"Long-term stabilizing effect of ACEinhibition on plasma creatinine and on proteinuria in normotensive type II diabetic patients","volume":"118","author":"Ravid","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(14)70256-6_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70256-6_bib19","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S0140-6736(99)12323-7","article-title":"Effects of ramipril on cardiovascular and microvascular outcomes in people with diabetes mellitus: results of the HOPE study and MICRO-HOPE substudy","volume":"355","year":"2000","journal-title":"Lancet"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(14)70256-6_bib20","first-page":"B54","article-title":"Effect of blood pressure control on diabetic microvascular complications in patients with hypertension and type 2 diabetes","volume":"23","author":"Estacio","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70256-6_bib21","doi-asserted-by":"crossref","first-page":"106384","DOI":"10.1155\/2010\/106384","article-title":"Effect of trandolapril on regression of retinopathy in hypertensive patients with type 2 diabetes: a prespecified analysis of the benedict trial","volume":"2010","author":"Ruggenenti","year":"2010","journal-title":"J Ophthalmol"},{"key":"10.1016\/S2213-8587(14)70256-6_bib22","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S0161-6420(13)38012-9","article-title":"Grading diabetic retinopathy from stereoscopic color fundus photographs--an extension of the modified Airlie House classification. ETDRS report number 10","volume":"98","year":"1991","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(14)70256-6_bib23","doi-asserted-by":"crossref","first-page":"d5928","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70256-6_bib24","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1136\/bmj.39489.470347.AD","article-title":"GRADE: an emerging consensus on rating quality of evidence and strength of recommendations","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70256-6_bib25","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2307\/3001666","article-title":"The combination of estimates from different experiments","volume":"10","author":"Cochran","year":"1954","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(14)70256-6_bib26","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70256-6_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/S2213-8587(14)70256-6_bib28","first-page":"719","article-title":"Statistical aspects of the analysis of data from retrospective studies of disease","volume":"22","author":"Mantel","year":"1959","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(14)70256-6_bib29","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70256-6_bib30","doi-asserted-by":"crossref","first-page":"4544","DOI":"10.1002\/sim.2889","article-title":"Performance of the trim and fill method in the presence of publication bias and between-study heterogeneity","volume":"26","author":"Peters","year":"2007","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(14)70256-6_bib31","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/sim.1201","article-title":"Network meta-analysis for indirect treatment comparisons","volume":"21","author":"Lumley","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(14)70256-6_bib32","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1177\/0962280207080643","article-title":"Evaluation of networks of randomized trials","volume":"17","author":"Salanti","year":"2008","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/S2213-8587(14)70256-6_bib33","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2165\/00019053-200624010-00001","article-title":"Bayesian methods for evidence synthesis in cost-effectiveness analysis","volume":"24","author":"Ades","year":"2006","journal-title":"Pharmacoeconomics"},{"key":"10.1016\/S2213-8587(14)70256-6_bib34","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.dss.2012.10.005","article-title":"ADDIS: a decision support system for evidence-based medicine","volume":"55","author":"van Valkenhoefa","year":"2013","journal-title":"Decis Support Syst"},{"key":"10.1016\/S2213-8587(14)70256-6_bib35","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/S0140-6736(08)61412-9","article-title":"Effect of candesartan on prevention (DIRECT-Prevent 1) and progression (DIRECT-Protect 1) of retinopathy in type 1 diabetes: randomised, placebo-controlled trials","volume":"372","author":"Chaturvedi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70256-6_bib36","first-page":"287","article-title":"Treatment effects of captopril on non-proliferative diabetic retinopathy","volume":"125","author":"Wang","year":"2012","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/S2213-8587(14)70256-6_bib37","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1161\/HYPERTENSIONAHA.111.174474","article-title":"Effects of manidipine and delapril in hypertensive patients with type 2 diabetes mellitus: the delapril and manidipine for nephroprotection in diabetes (DEMAND) randomized clinical trial","volume":"58","author":"Ruggenenti","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(14)70256-6_bib38","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1056\/NEJMoa0808400","article-title":"Renal and retinal effects of enalapril and losartan in type 1 diabetes","volume":"361","author":"Mauer","year":"2009","journal-title":"N Engl J Med"},{"issue":"12 pt 1","key":"10.1016\/S2213-8587(14)70256-6_bib39","doi-asserted-by":"crossref","first-page":"982","DOI":"10.7326\/0003-4819-128-12_Part_1-199806150-00004","article-title":"Use of enalapril to attenuate decline in renal function in normotensive, normoalbuminuric patients with type 2 diabetes mellitus. A randomized, controlled trial","volume":"128","author":"Ravid","year":"1998","journal-title":"Ann Intern Med"},{"issue":"12 suppl 1","key":"10.1016\/S2213-8587(14)70256-6_bib40","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/S0026-0495(98)90368-7","article-title":"Effect of ACEinhibition with perindopril and beta-blockade with atenolol on retinal blood flow in hypertensive diabetic subjects","volume":"47","author":"Patel","year":"1998","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(14)70256-6_bib41","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1046\/j.1523-1755.2001.00790.x","article-title":"Long-term beneficial effect of ACE inhibition on diabetic nephropathy in normotensive type 1 diabetic patients","volume":"60","author":"Parving","year":"2001","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(14)70256-6_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1365-2796.2003.01192.x","article-title":"Effects of losartan on diabetic maculopathy in type 2 diabetic patients: a randomized, double-masked study","volume":"254","author":"Knudsen","year":"2003","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(14)70256-6_bib43","doi-asserted-by":"crossref","first-page":"e000810","DOI":"10.1161\/JAHA.114.000810","article-title":"The Randomized Olmesartan and Diabetes Microalbuminuria Prevention (ROADMAP) observational follow-up study: benefits of RAS blockade with olmesartan treatment are sustained after study discontinuation","volume":"3","author":"Menne","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(14)70256-6_bib44","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1007\/BF00918480","article-title":"Protective effect of captopril on the blood-retina barrier in normotensive insulin-dependent diabetic patients with nephropathy and background retinopathy","volume":"228","author":"Larsen","year":"1990","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/S2213-8587(14)70256-6_bib45","first-page":"284","article-title":"ACEinhibitor treatment for young normotensive diabetic subjects: a two-year trial","volume":"25","author":"Chase","year":"1993","journal-title":"Ann Ophthalmol"},{"key":"10.1016\/S2213-8587(14)70256-6_bib46","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/j.amjhyper.2006.05.011","article-title":"Effect of intensive blood pressure control with valsartan on urinary albumin excretion in normotensive patients with type 2 diabetes","volume":"19","author":"Estacio","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/S2213-8587(14)70256-6_bib47","doi-asserted-by":"crossref","first-page":"566","DOI":"10.1007\/s00125-011-2398-8","article-title":"Reno-protective effects of RAS blockade in type 2 diabetic patients: a systematic review and network meta-analysis","volume":"55","author":"Vejakama","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70256-6_bib48","doi-asserted-by":"crossref","first-page":"f6008","DOI":"10.1136\/bmj.f6008","article-title":"Comparative effectiveness of RAS blockers and other antihypertensive drugs in patients with diabetes: systematic review and bayesian network meta-analysis","volume":"347","author":"Wu","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70256-6_bib49","doi-asserted-by":"crossref","first-page":"1058","DOI":"10.1161\/CIRCRESAHA.110.223545","article-title":"Oxidative stress and diabetic complications","volume":"107","author":"Giacco","year":"2010","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(14)70256-6_bib50","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.redox.2014.04.006","article-title":"Oxygen delivery, consumption, and conversion to reactive oxygen species in experimental models of diabetic retinopathy","volume":"2","author":"Eshaq","year":"2014","journal-title":"Redox Biol"},{"key":"10.1016\/S2213-8587(14)70256-6_bib51","doi-asserted-by":"crossref","first-page":"1752","DOI":"10.1016\/j.ajpath.2014.02.016","article-title":"Neuronal cell death in the inner retina and the influence of vascular endothelial growth factor inhibition in a diabetic rat model","volume":"184","author":"Park","year":"2014","journal-title":"Am J Pathol"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(14)70256-6_bib52","doi-asserted-by":"crossref","first-page":"S42","DOI":"10.1038\/sj.jhh.1001438","article-title":"The retinal RAS: implications for therapy in diabetic retinopathy","volume":"16","author":"Sjolie","year":"2002","journal-title":"J Hum Hypertens"},{"key":"10.1016\/S2213-8587(14)70256-6_bib53","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1007\/s001250051539","article-title":"Angiotensin converting enzyme inhibition reduces retinal overexpression of vascular endothelial growth factor and hyperpermeability in experimental diabetes","volume":"43","author":"Gilbert","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70256-6_bib54","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1161\/01.ATV.0000149377.90852.d8","article-title":"Dual effect of ACE inhibition on angiogenesis in type 1 diabetic mice","volume":"25","author":"Ebrahimian","year":"2005","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(14)70256-6_bib55","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.exer.2006.12.013","article-title":"Effects of ACE inhibitors and beta-adrenergic blockers on retinal vascular endothelial growth factor expression in rat diabetic retinopathy","volume":"84","author":"Zheng","year":"2007","journal-title":"Exp Eye Res"},{"key":"10.1016\/S2213-8587(14)70256-6_bib56","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.2337\/db10-0552","article-title":"Candesartan attenuates diabetic retinal vascular pathology by restoring glyoxalase-I function","volume":"59","author":"Miller","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(14)70256-6_bib57","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc10-2224","article-title":"Valsartan improves \u03b2-cell function and insulin sensitivity in subjects with impaired glucose metabolism: a randomized controlled trial","volume":"34","author":"van der Zijl","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70256-6_bib58","doi-asserted-by":"crossref","first-page":"5122","DOI":"10.1096\/fj.13-234104","article-title":"Losartan, an angiotensin II type 1 receptor blocker, protects human islets from glucotoxicity through the phospholipase C pathway","volume":"27","author":"Madec","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/S2213-8587(14)70256-6_bib59","doi-asserted-by":"crossref","first-page":"2799","DOI":"10.1161\/CIRCULATIONAHA.110.016337","article-title":"Blood pressure targets in subjects with type 2 diabetes mellitus\/impaired fasting glucose: observations from traditional and bayesian random-effects meta-analyses of randomized trials","volume":"123","author":"Bangalore","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(14)70256-6_bib60","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1001\/jamainternmed.2014.348","article-title":"Effect of ACE inhibitors and angiotensin II receptor blockers on all-cause mortality, cardiovascular deaths, and cardiovascular events in patients with diabetes mellitus: a meta-analysis","volume":"174","author":"Cheng","year":"2014","journal-title":"JAMA Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702566?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702566?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T17:41:14Z","timestamp":1566322874000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702566"}},"issued":{"date-parts":[[2015,4]]},"references-count":60,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2015,4]]}},"alternative-id":["S2213858714702566"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70256-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effects of RAS inhibitors on diabetic retinopathy: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70256-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)70006-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T22:21:30Z","timestamp":1790115690105,"version":"4.0.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/s2213-8587(13)70089-5","type":"journal-article","created":{"date-parts":[[2013,9,13]],"date-time":"2013-09-13T01:49:41Z","timestamp":1379036981000},"page":"317-328","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":189,"title":["Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials"],"prefix":"10.1016","volume":"1","author":[{"given":"Subodh","family":"Verma","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E","family":"Farkouh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bobby","family":"Yanagawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David H","family":"Fitchett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad R","family":"Ahsan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Ruel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachin","family":"Sud","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milan","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shantanu","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nandini","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asim N","family":"Cheema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul W M","family":"Fedak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hwee","family":"Teoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Latter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valentin","family":"Fuster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan O","family":"Friedrich","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70089-5_bib1","doi-asserted-by":"crossref","DOI":"10.1093\/eurheartj\/eht142","article-title":"Diabetes and vascular disease: pathophysiology, clinical consequences, and medical therapy: part II","author":"Beckman","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(13)70089-5_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1161\/JAHA.111.000059","article-title":"Mortality rates in trials of subjects with type 2 diabetes","volume":"1","author":"Barkoudah","year":"2012","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(13)70089-5_bib3","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1161\/CIRCULATIONAHA.112.147488","article-title":"Cost-effectiveness of percutaneous coronary intervention with drug eluting stents versus bypass surgery for patients with diabetes mellitus and multivessel coronary artery disease: results from the FREEDOM trial","volume":"127","author":"Magnuson","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70089-5_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2013-303820","article-title":"Multivessel coronary artery disease revascularisation strategies in patients with diabetes mellitus","author":"Bates","year":"2013","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(13)70089-5_bib5","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70089-5_bib6","doi-asserted-by":"crossref","first-page":"2115","DOI":"10.1161\/CIRCULATIONAHA.112.092973","article-title":"Clinical and angiographic risk stratification and differential impact on treatment outcomes in the Bypass Angioplasty Revascularization Investigation 2 Diabetes (BARI 2D) trial","volume":"126","author":"Brooks","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70089-5_bib7","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1161\/CIRCULATIONAHA.107.752147","article-title":"Long-term safety and efficacy of percutaneous coronary intervention with stenting and coronary artery bypass surgery for multivessel coronary artery disease: a meta-analysis with 5-year patient-level data from the ARTS, ERACI-II, MASS-II, and SoS trials","volume":"118","author":"Daemen","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70089-5_bib8","doi-asserted-by":"crossref","first-page":"2375","DOI":"10.1056\/NEJMoa1211585","article-title":"Strategies for multivessel revascularization in patients with diabetes","volume":"367","author":"Farkouh","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70089-5_bib9","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ejcts\/ezt017","article-title":"Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial","volume":"43","author":"Kappetein","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/S2213-8587(13)70089-5_bib10","unstructured":"Hall R. CARDia: coronary artery revascularisation in diabetes trial (5-year follow-up data). European Society of Cardiology Congress; Munich, Germany; 2012; Aug 25\u201329, 2012."},{"key":"10.1016\/S2213-8587(13)70089-5_bib11","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1016\/j.jacc.2012.11.044","article-title":"Percutaneous coronary intervention versus coronary bypass surgery in United States veterans with diabetes","volume":"61","author":"Kamalesh","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(13)70089-5_bib12","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/S2213-8587(13)70089-5_bib13","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70089-5_bib14","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70089-5_bib15","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1001\/jama.295.6.676","article-title":"Comparison of two methods to detect publication bias in meta-analysis","volume":"295","author":"Peters","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70089-5_bib16","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1016\/j.jacc.2009.10.014","article-title":"Randomized comparison of percutaneous coronary intervention with coronary artery bypass grafting in diabetic patients. 1-year results of the CARDia (Coronary Artery Revascularization in Diabetes) trial","volume":"55","author":"Kapur","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(13)70089-5_bib17","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1161\/hc3101.093700","article-title":"Clinical and economic impact of diabetes mellitus on percutaneous and surgical treatment of multivessel coronary disease patients: insights from the Arterial Revascularization Therapy Study (ARTS) trial","volume":"104","author":"Abizaid","year":"2001","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70089-5_bib18","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1056\/NEJM200104123441502","article-title":"Comparison of coronary-artery bypass surgery and stenting for the treatment of multivessel disease","volume":"344","author":"Serruys","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70089-5_bib19","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/j.jacc.2004.12.082","article-title":"Five-year outcomes after coronary stenting versus bypass surgery for the treatment of multivessel disease: the final analysis of the Arterial Revascularization Therapies Study (ARTS) randomized trial","volume":"46","author":"Serruys","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(13)70089-5_bib20","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S0735-1097(00)01052-4","article-title":"Argentine Randomized Study: Coronary Angioplasty with Stenting versus Coronary Bypass Surgery in patients with Multiple-Vessel Disease (ERACI II): 30-day and one-year follow-up results. ERACI II Investigators","volume":"37","author":"Rodriguez","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(13)70089-5_bib21","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1136\/heart.89.2.184","article-title":"Coronary stenting versus coronary bypass surgery in patients with multiple vessel disease and significant proximal LAD stenosis: results from the ERACI II study","volume":"89","author":"Rodriguez","year":"2003","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(13)70089-5_bib22","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/j.jacc.2004.12.081","article-title":"Five-year follow-up of the Argentine randomized trial of coronary angioplasty with stenting versus coronary bypass surgery in patients with multiple vessel disease (ERACI II)","volume":"46","author":"Rodriguez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(13)70089-5_bib23","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1161\/CIRCULATIONAHA.107.739144","article-title":"Randomized, controlled trial of coronary artery bypass surgery versus percutaneous coronary intervention in patients with multivessel coronary artery disease: six-year follow-up from the Stent or Surgery Trial (SoS)","volume":"118","author":"Booth","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70089-5_bib24","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/S0140-6736(02)11078-6","article-title":"Coronary artery bypass surgery versus percutaneous coronary intervention with stent implantation in patients with multivessel coronary artery disease (the Stent or Surgery trial): a randomised controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70089-5_bib25","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1136\/hrt.2003.015057","article-title":"One year comparison of costs of coronary surgery versus percutaneous coronary intervention in the stent or surgery trial","volume":"90","author":"Weintraub","year":"2004","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(13)70089-5_bib26","doi-asserted-by":"crossref","first-page":"1082","DOI":"10.1161\/CIRCULATIONAHA.106.625475","article-title":"Five-year follow-up of the Medicine, Angioplasty, or Surgery Study (MASS II): a randomized controlled clinical trial of 3 therapeutic strategies for multivessel coronary artery disease","volume":"115","author":"Hueb","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70089-5_bib27","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1016\/j.jacc.2003.08.065","article-title":"The medicine, angioplasty, or surgery study (MASS-II): a randomized, controlled clinical trial of three therapeutic strategies for multivessel coronary artery disease: one-year results","volume":"43","author":"Hueb","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(13)70089-5_bib28","doi-asserted-by":"crossref","first-page":"I420","DOI":"10.1161\/CIRCULATIONAHA.105.000679","article-title":"Coronary revascularization (surgical or percutaneous) decreases mortality after the first year in diabetic subjects but not in nondiabetic subjects with multivessel disease: an analysis from the Medicine, Angioplasty, or Surgery Study (MASS II)","volume":"114","author":"Soares","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70089-5_bib29","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1093\/eurheartj\/ehr213","article-title":"Comparison of coronary bypass surgery with drug-eluting stenting for the treatment of left main and\/or three-vessel disease: 3-year follow-up of the SYNTAX trial","volume":"32","author":"Kappetein","year":"2011","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(13)70089-5_bib30","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/j.athoracsur.2011.06.028","article-title":"Bypass versus drug-eluting stents at three years in SYNTAX patients with diabetes mellitus or metabolic syndrome","volume":"92","author":"Mack","year":"2011","journal-title":"Ann Thorac Surg"},{"key":"10.1016\/S2213-8587(13)70089-5_bib31","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1016\/j.jacc.2009.09.057","article-title":"Diabetic and nondiabetic patients with left main and\/or 3-vessel coronary artery disease: comparison of outcomes with cardiac surgery and paclitaxel-eluting stents","volume":"55","author":"Banning","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(13)70089-5_bib32","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0140-6736(09)60552-3","article-title":"Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials","volume":"373","author":"Hlatky","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70089-5_bib33","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(13)60258-5","article-title":"CABG or stents in coronary artery disease: end of the debate?","volume":"381","author":"Taggart","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70089-5_bib34","doi-asserted-by":"crossref","first-page":"e123","DOI":"10.1016\/j.jacc.2011.08.009","volume":"58","author":"Hillis","year":"2011","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(13)70089-5_bib35","doi-asserted-by":"crossref","first-page":"2451","DOI":"10.1093\/eurheartj\/ehs109","article-title":"Guidelines on the management of valvular heart disease (version 2012)","volume":"33","author":"Vahanian","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(13)70089-5_bib36","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700895?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700895?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T04:22:45Z","timestamp":1539404565000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700895"}},"issued":{"date-parts":[[2013,12]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2213858713700895"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70089-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70089-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70114-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T11:10:40Z","timestamp":1789989040089,"version":"4.0.1"},"reference-count":27,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute (NHLBI)","doi-asserted-by":"crossref","award":["contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C"],"award-info":[{"award-number":["contracts HHSN268201100005C, HHSN268201100006C, HHSN268201100007C, HHSN268201100008C, HHSN268201100009C, HHSN268201100010C, HHSN268201100011C, and HHSN268201100012C"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"crossref"}]},{"name":"National Institutes of Health (NIH)\/NHLBI","award":["grant T32HL007024"],"award-info":[{"award-number":["grant T32HL007024"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/s2213-8587(16)30321-7","type":"journal-article","created":{"date-parts":[[2016,11,16]],"date-time":"2016-11-16T08:01:58Z","timestamp":1479283318000},"page":"34-42","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":180,"title":["Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study"],"prefix":"10.1016","volume":"5","author":[{"given":"Bethany","family":"Warren","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James S","family":"Pankow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kunihiro","family":"Matsushita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naresh M","family":"Punjabi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie R","family":"Daya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morgan","family":"Grams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Woodward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Selvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30321-7_bib1","doi-asserted-by":"crossref","first-page":"517","DOI":"10.7326\/M13-2411","article-title":"Trends in prevalence and control of diabetes in the United States, 1988\u20131994 and 1999\u20132010","volume":"160","author":"Selvin","year":"2014","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)30321-7_bib2","series-title":"Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus: abbreviated report of a WHO consultation","year":"2011"},{"key":"10.1016\/S2213-8587(16)30321-7_bib3","series-title":"Global guideline for type 2 diabetes","year":"2012"},{"key":"10.1016\/S2213-8587(16)30321-7_bib4","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30321-7_bib5","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.2337\/dc09-9033","article-title":"International Expert Committee report on the role of the A1C assay in the diagnosis of diabetes","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)30321-7_bib6","first-page":"S1","article-title":"Standards of medical care in diabetes\u20142016","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30321-7_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30321-7_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(16)30321-7_bib9","doi-asserted-by":"crossref","first-page":"687","DOI":"10.1093\/oxfordjournals.aje.a115184","article-title":"The Atherosclerosis Risk in Communities (ARIC) study: design and objectives","volume":"129","year":"1989","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(16)30321-7_bib10","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1373\/clinchem.2015.238873","article-title":"Recalibration of blood analytes over 25 years in the Atherosclerosis Risk in Communities Study: impact of recalibration on chronic kidney disease prevalence and incidence","volume":"61","author":"Parrinello","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(16)30321-7_bib11","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/j.1753-0407.2010.00070.x","article-title":"Measurement of HbA1c from stored whole blood samples in the Atherosclerosis Risk in Communities study","volume":"2","author":"Selvin","year":"2010","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(16)30321-7_bib12","series-title":"Operations Manual no 7: blood collection and processing. Version 1.0","year":"1987"},{"key":"10.1016\/S2213-8587(16)30321-7_bib13","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0908359","article-title":"Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults","volume":"362","author":"Selvin","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30321-7_bib14","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1093\/aje\/kws156","article-title":"Validity and reliability of self-reported diabetes in the atherosclerosis risk in communities study","volume":"176","author":"Schneider","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(16)30321-7_bib15","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1053\/j.ajkd.2014.02.021","article-title":"Identification of incident CKD stage 3 in research studies","volume":"64","author":"Grams","year":"2014","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(16)30321-7_bib16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)30321-7_bib17","series-title":"Operations Manual no 2: cohort component procedures. Version 1.0","year":"1987"},{"key":"10.1016\/S2213-8587(16)30321-7_bib18","series-title":"Operations Manual no 11: sitting blood pressure. Version 1.0","year":"1987"},{"key":"10.1016\/S2213-8587(16)30321-7_bib19","series-title":"Operations Manual no 10: clinical chemistry determinations. Version 1.0","year":"1987"},{"key":"10.1016\/S2213-8587(16)30321-7_bib20","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1177\/1536867X0600600302","article-title":"Confidence intervals for rank statistics: Somers' D and extensions","volume":"6","author":"Newson","year":"2006","journal-title":"Stata J"},{"key":"10.1016\/S2213-8587(16)30321-7_bib21","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.2337\/dc15-1078","article-title":"Associations between prediabetes, by three different diagnostic criteria, and incident CVD differ in south Asians and Europeans","volume":"38","author":"Eastwood","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30321-7_bib22","doi-asserted-by":"crossref","first-page":"325","DOI":"10.2337\/dc06-1457","article-title":"Cardiometabolic risk in impaired fasting glucose and impaired glucose tolerance: the atherosclerosis risk in communities study","volume":"30","author":"Pankow","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30321-7_bib23","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.2014.1873","article-title":"Glycated hemoglobin measurement and prediction of cardiovascular disease","volume":"311","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30321-7_bib24","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1001\/archinte.161.3.397","article-title":"Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria","volume":"161","year":"2001","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(16)30321-7_bib25","doi-asserted-by":"crossref","first-page":"684","DOI":"10.3109\/07853890.2014.955051","article-title":"Associations of prediabetes with all-cause and cardiovascular mortality: a meta-analysis","volume":"46","author":"Huang","year":"2014","journal-title":"Ann Med"},{"key":"10.1016\/S2213-8587(16)30321-7_bib26","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1016\/j.jacc.2009.10.060","article-title":"Pre-diabetes and the risk for cardiovascular disease. A systematic review of the evidence","volume":"55","author":"Ford","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30321-7_bib27","first-page":"717","article-title":"Delayed diagnosis of incident type 2 diabetes mellitus in the ARIC study","volume":"12","author":"Samuels","year":"2006","journal-title":"Am J Manag Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T12:36:28Z","timestamp":1568550988000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303217"}},"issued":{"date-parts":[[2017,1]]},"references-count":27,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S2213858716303217"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30321-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Comparative prognostic performance of definitions of prediabetes: a prospective cohort analysis of the Atherosclerosis Risk in Communities (ARIC) study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30321-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30328-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T21:58:30Z","timestamp":1790805510631,"version":"4.1.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/s2213-8587(19)30257-8","type":"journal-article","created":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T18:41:15Z","timestamp":1566326475000},"page":"668-669","source":"Crossref","is-referenced-by-count":39,"title":["Clusters provide a better holistic view of type 2 diabetes than simple clinical features"],"prefix":"10.1016","volume":"7","author":[{"given":"Emma","family":"Ahlqvist","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tiinamaija","family":"Tuomi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leif","family":"Groop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30257-8_bib1","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30257-8_bib2","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1016\/S2213-8587(19)30087-7","article-title":"Disease progression and treatment response in data-driven subgroups of type 2 diabetes compared with models based on simple clinical features: an analysis using clinical trial data","volume":"7","author":"Dennis","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30257-8_bib3","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S2213-8587(19)30187-1","article-title":"Risk of diabetes-associated diseases in subgroups of patients with recent-onset diabetes: a 5-year follow-up study","volume":"7","author":"Zaharia","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30257-8_bib4","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30257-8_bib5","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","article-title":"Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial","volume":"373","author":"Home","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30257-8_bib6","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/S2213-8587(18)30316-4","article-title":"Novel subgroups of patients with adult onset diabetes in China and US populations","volume":"7","author":"Zou","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,20]],"date-time":"2019-08-20T19:31:41Z","timestamp":1566329501000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719302578"}},"issued":{"date-parts":[[2019,9]]},"references-count":6,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S2213858719302578"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30257-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,9]]}},{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T07:59:02Z","timestamp":1790755142723,"version":"4.1.0"},"reference-count":119,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2010JS3PMZ_002"],"award-info":[{"award-number":["2010JS3PMZ_002"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003407","name":"Ministero dell\u2019Istruzione, dell\u2019Universit\u00e0 e della Ricerca","doi-asserted-by":"publisher","award":["2010YK7Z5K_006"],"award-info":[{"award-number":["2010YK7Z5K_006"]}],"id":[{"id":"10.13039\/501100003407","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/s2213-8587(15)00097-2","type":"journal-article","created":{"date-parts":[[2015,6,6]],"date-time":"2015-06-06T16:50:25Z","timestamp":1433609425000},"page":"638-652","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":98,"title":["New forms of insulin and insulin therapies for the treatment of type 2 diabetes"],"prefix":"10.1016","volume":"3","author":[{"given":"Avivit","family":"Cahn","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Miccoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dardano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Del Prato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00097-2_bib1","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1016\/S0140-6736(13)62154-6","article-title":"Pathophysiology and treatment of type 2 diabetes: perspectives on the past, present, and future","volume":"383","author":"Kahn","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00097-2_bib2","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s00125-014-3460-0","article-title":"Management of hyperglycaemia in type 2 diabetes, 2015: a patient-centred approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"58","author":"Inzucchi","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00097-2_bib3","doi-asserted-by":"crossref","first-page":"327","DOI":"10.4158\/EP13176.CSUPPL","article-title":"AACE comprehensive diabetes management algorithm 2013","volume":"19","author":"Garber","year":"2013","journal-title":"Endocr Pract"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00097-2_bib4","first-page":"S1","article-title":"Canadian Diabetes Association 2013 clinical practice guidelines for the prevention and management of diabetes in Canada: methods","volume":"37","author":"Booth","year":"2013","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(15)00097-2_bib5","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2337\/dc08-9026","volume":"32","author":"Skyler","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib6","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00097-2_bib7","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00097-2_bib8","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00097-2_bib9","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.jdiacomp.2006.02.004","article-title":"Transition to insulin in Type 2 diabetes: family physicians' misconception of patients' fears contributes to existing barriers","volume":"21","author":"Nakar","year":"2007","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(15)00097-2_bib10","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(11)60698-3","article-title":"Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial","volume":"378","author":"Griffin","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00097-2_bib11","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1172\/JCI7231","article-title":"The natural history of insulin secretory dysfunction and insulin resistance in the pathogenesis of type 2 diabetes mellitus","volume":"104","author":"Weyer","year":"1999","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(15)00097-2_bib12","doi-asserted-by":"crossref","first-page":"330","DOI":"10.2337\/diacare.25.2.330","article-title":"Sulfonylurea inadequacy: efficacy of addition of insulin over 6 years in patients with type 2 diabetes in the U.K. Prospective Diabetes Study (UKPDS 57)","volume":"25","author":"Wright","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib13","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1016\/j.diabet.2009.11.006","article-title":"Time to insulin treatment and factors associated with insulin prescription in Swedish patients with type 2 diabetes","volume":"36","author":"Ringborg","year":"2010","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib14","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.diabres.2011.10.021","article-title":"An observational non-interventional study of people with diabetes beginning or changed to insulin analogue therapy in non-Western countries: the A1chieve study","volume":"94","author":"Home","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00097-2_bib15","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1186\/1758-5996-5-57","article-title":"Prevalence of diabetes complications in people with type 2 diabetes mellitus and its association with baseline characteristics in the multinational A1chieve study","volume":"5","author":"Litwak","year":"2013","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/S2213-8587(15)00097-2_bib16","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2337\/dc13-2743","article-title":"Insulin therapy in people with type 2 diabetes: opportunities and challenges?","volume":"37","author":"Home","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib17","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1463-1326.2011.01469.x","article-title":"The safety profile of exogenous insulin in people with type 2 diabetes: justification for concern","volume":"14","author":"Currie","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib18","doi-asserted-by":"crossref","first-page":"1990","DOI":"10.1007\/s00125-009-1468-7","article-title":"Optimal insulin regimens in type 2 diabetes mellitus: systematic review and meta-analyses","volume":"52","author":"Lasserson","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00097-2_bib19","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/dom.12412","article-title":"Glucose-lowering with exogenous insulin monotherapy in type 2 diabetes: dose association with all-cause mortality, cardiovascular events and cancer","volume":"17","author":"Holden","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib21","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib22","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib23","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.2337\/diab.44.2.165","article-title":"Bedtime insulin\/daytime glipizide. Effective therapy for sulfonylurea failures in NIDDM","volume":"44","author":"Shank","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(15)00097-2_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/13813450801900777","article-title":"Superiority of insulin analogues versus human insulin in the treatment of diabetes mellitus","volume":"114","author":"Rossetti","year":"2008","journal-title":"Arch Physiol Biochem"},{"key":"10.1016\/S2213-8587(15)00097-2_bib26","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s11095-012-0739-z","article-title":"Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin","volume":"29","author":"Jonassen","year":"2012","journal-title":"Pharm Res"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00097-2_bib27","first-page":"S388","article-title":"Insulin degludec, a new generation ultra-long acting basal insulin designed to maintain full metabolic effect while minimizing mitogenic potential","volume":"53","author":"Nishimura","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00097-2_bib28","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1463-1326.2012.01638.x","article-title":"Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes","volume":"14","author":"Heise","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib29","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/dom.12032","article-title":"Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials","volume":"15","author":"Ratner","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib30","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1111\/dom.12411","article-title":"Insulin degludec improves long-term glycaemic control similarly to insulin glargine but with fewer hypoglycaemic episodes in patients with advanced type 2 diabetes on basal-bolus insulin therapy","volume":"17","author":"Hollander","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib31","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1111\/dom.12250","article-title":"Cost-effectiveness of insulin degludec compared with insulin glargine for patients with type 2 diabetes treated with basal insulin\u2014from the UK health care cost perspective","volume":"16","author":"Evans","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/dom.12196","article-title":"PEGylated insulin Lispro, (LY2605541)\u2014a new basal insulin analogue","volume":"16","author":"Caparrotta","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib33","doi-asserted-by":"crossref","first-page":"522","DOI":"10.2337\/dc12-0067","article-title":"Better glycemic control and weight loss with the novel long-acting basal insulin LY2605541 compared with insulin glargine in type 1 diabetes: a randomized, crossover study","volume":"36","author":"Rosenstock","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib36","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.2337\/dc12-0060","article-title":"A randomized, controlled study of once-daily LY2605541, a novel long-acting basal insulin, versus insulin glargine in basal insulin-treated patients with type 2 diabetes","volume":"35","author":"Bergenstal","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib37","doi-asserted-by":"crossref","first-page":"3235","DOI":"10.2337\/dc14-0990","article-title":"New insulin glargine 300 units\/mL versus glargine 100 units\/mL in people with type 2 diabetes using oral agents and basal insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 2)","volume":"37","author":"Yki-J\u00e4rvinen","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib38","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.2337\/dc14-0991","article-title":"New insulin glargine 300 units\/mL versus glargine 100 units\/mL in people with type 2 diabetes using basal and mealtime insulin: glucose control and hypoglycemia in a 6-month randomized controlled trial (EDITION 1)","volume":"37","author":"Riddle","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib39","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1111\/j.1463-1326.2008.00934.x","article-title":"Short-acting insulin analogues vs. regular human insulin in type 2 diabetes: a meta-analysis","volume":"11","author":"Mannucci","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib40","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1111\/j.1463-1326.2011.01516.x","article-title":"U-100, pH-Neutral formulation of VIAject\u00ae : faster onset of action than insulin lispro in patients with type 1 diabetes","volume":"14","author":"Heinemann","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib41","doi-asserted-by":"crossref","first-page":"116","DOI":"10.2337\/dc09-0411","article-title":"Postprandial vascular effects of VIAject compared with insulin lispro and regular human insulin in patients with type 2 diabetes","volume":"33","author":"Forst","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib42","doi-asserted-by":"crossref","first-page":"273","DOI":"10.2337\/dc12-0808","article-title":"Comparative pharmacokinetics and insulin action for three rapid-acting insulin analogs injected subcutaneously with and without hyaluronidase","volume":"36","author":"Morrow","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib43","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1089\/dia.2011.0117","article-title":"Improved postprandial glycemic control in patients with type 2 diabetes from subcutaneous injection of insulin lispro with hyaluronidase","volume":"14","author":"Hompesch","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(15)00097-2_bib44","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1177\/193229681200600402","article-title":"Ultrafast-acting insulins: state of the art","volume":"6","author":"Heinemann","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(15)00097-2_bib48","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1089\/dia.2013.0187","article-title":"Faster in and faster out: accelerating insulin absorption and action by insulin infusion site warming","volume":"16","author":"Cengiz","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(15)00097-2_bib49","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1177\/193229681200600403","article-title":"Pharmacokinetics and postprandial glycemic excursions following insulin lispro delivered by intradermal microneedle or subcutaneous infusion","volume":"6","author":"McVey","year":"2012","journal-title":"J Diabetes Sci Tech"},{"key":"10.1016\/S2213-8587(15)00097-2_bib50","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.clinthera.2014.06.025","article-title":"Inhaled insulin: a breath of fresh air? A review of inhaled insulin","volume":"36","author":"Santos Cavaiola","year":"2014","journal-title":"Clin Ther"},{"key":"10.1016\/S2213-8587(15)00097-2_bib51","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1177\/1060028014554648","article-title":"Technosphere insulin (Afrezza): a new, inhaled prandial insulin","volume":"49","author":"Nuffer","year":"2015","journal-title":"Ann Pharmacother"},{"key":"10.1016\/S2213-8587(15)00097-2_bib52","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1089\/dia.2012.0101","article-title":"Technosphere insulin effectively controls postprandial glycemia in patients with type 2 diabetes mellitus","volume":"14","author":"Zisser","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(15)00097-2_bib53","doi-asserted-by":"crossref","first-page":"1201","DOI":"10.1089\/dia.2011.0037","article-title":"Patient-reported outcomes in adults with type 2 diabetes using mealtime inhaled technosphere insulin and basal insulin versus premixed insulin","volume":"13","author":"Peyrot","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(15)00097-2_bib54","doi-asserted-by":"crossref","first-page":"662","DOI":"10.1111\/j.1464-5491.2008.02438.x","volume":"25","author":"Del Prato","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2147\/DMSO.S3987","article-title":"Assessing the impact of a new delivery method of insulin on glycemic control using a novel trial design","volume":"2","author":"Strack","year":"2009","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/S2213-8587(15)00097-2_bib56","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1177\/193229681300700228","article-title":"Oral insulin delivery: how far are we?","volume":"7","author":"Fonte","year":"2013","journal-title":"J Diabetes Sci Tech"},{"key":"10.1016\/S2213-8587(15)00097-2_bib57","doi-asserted-by":"crossref","first-page":"29","DOI":"10.4155\/ppa.14.53","article-title":"Oral insulin-delivery system for diabetes mellitus","volume":"4","author":"Kanzarkar","year":"2015","journal-title":"Pharm Pat Anal"},{"key":"10.1016\/S2213-8587(15)00097-2_bib58","doi-asserted-by":"crossref","first-page":"1288","DOI":"10.2337\/dc09-1807","article-title":"Oral insulin: a comparison with subcutaneous regular human insulin in patients with type 2 diabetes","volume":"33","author":"Kapitza","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib59","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/j.1463-1326.2009.01146.x","article-title":"The glucose lowering effect of an oral insulin (Capsulin) during an isoglycaemic clamp study in persons with type 2 diabetes","volume":"12","author":"Luzio","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib60","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1111\/j.1742-1241.2011.02852.x","article-title":"New ways of insulin delivery","volume":"66","author":"Heinemann","year":"2012","journal-title":"Int J Clin Pract Suppl"},{"key":"10.1016\/S2213-8587(15)00097-2_bib61","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.2337\/diacare.28.6.1353","article-title":"Dose-response relationship of oral insulin spray in healthy subjects","volume":"28","author":"Cernea","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib62","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.2337\/dc11-0182","article-title":"Improved pharmacokinetic and pharmacodynamic profile of rapid-acting insulin using needle-free jet injection technology","volume":"34","author":"Engwerda","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib63","doi-asserted-by":"crossref","first-page":"6758","DOI":"10.1021\/nn401617u","article-title":"Glucose-responsive microgels integrated with enzyme nanocapsules for closed-loop insulin delivery","volume":"7","author":"Gu","year":"2013","journal-title":"ACS Nano"},{"key":"10.1016\/S2213-8587(15)00097-2_bib64","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/jc.2012-3042","article-title":"Mortality and other important diabetes-related outcomes with insulin vs other antihyperglycemic therapies in type 2 diabetes","volume":"98","author":"Currie","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib65","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/S0140-6736(09)61969-3","article-title":"Survival as a function of HbA(1c) in people with type 2 diabetes: a retrospective cohort study","volume":"375","author":"Currie","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00097-2_bib66","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1007\/s00125-011-2084-x","article-title":"Prognostic implications of glucose-lowering treatment in patients with acute myocardial infarction and diabetes: experiences from an extended follow-up of the Diabetes Mellitus Insulin-Glucose Infusion in Acute Myocardial Infarction (DIGAMI) 2 Study","volume":"54","author":"Mellbin","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00097-2_bib67","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1002\/pds.1630","article-title":"Association between serious ischemic cardiac outcomes and medications used to treat diabetes","volume":"17","author":"Margolis","year":"2008","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/S2213-8587(15)00097-2_bib68","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1007\/s00125-011-2381-4","article-title":"Cancer occurrence in Danish diabetic patients: duration and insulin effects","volume":"55","author":"Carstensen","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00097-2_bib69","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/s00125-010-1675-2","article-title":"Diabetes therapy and cancer risk: causal effects and other plausible explanations","volume":"53","author":"Hern\u00e1ndez-D\u00edaz","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00097-2_bib70","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1111\/j.1463-1326.2009.01125.x","article-title":"Insulin use and increased risk of mortality in type 2 diabetes: a cohort study","volume":"12","author":"Gamble","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib71","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1111\/dom.12349","article-title":"Optimizing clinical outcomes resulting from glucose-lowering therapies in type 2 diabetes: increased confidence about the DPP-4 inhibitors and continued concerns regarding sulphonylureas and exogenous insulin","volume":"16","author":"Currie","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib72","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1046\/j.1463-1326.2001.00160.x","article-title":"Long-term glycaemic improvement after addition of metformin to insulin in insulin-treated obese type 2 diabetes patients","volume":"3","author":"Hermann","year":"2001","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib73","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.2337\/diacare.25.12.2133","article-title":"Combination of insulin and metformin in the treatment of type 2 diabetes","volume":"25","author":"Wulffel\u00e9","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib74","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1111\/j.1464-5491.2005.01475.x","article-title":"Continuing metformin when starting insulin in patients with Type 2 diabetes: a double-blind randomized placebo-controlled trial","volume":"22","author":"Douek","year":"2005","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib75","doi-asserted-by":"crossref","first-page":"e1001204","DOI":"10.1371\/journal.pmed.1001204","article-title":"Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials","volume":"9","author":"Boussageon","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib76","doi-asserted-by":"crossref","first-page":"2163","DOI":"10.1210\/jc.2009-1974","article-title":"Pioglitazone use in combination with insulin in the prospective pioglitazone clinical trial in macrovascular events study (PROactive19)","volume":"95","author":"Charbonnel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib77","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1517\/14740338.2012.691963","article-title":"Thiazolidinedione safety","volume":"11","author":"Kung","year":"2012","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/S2213-8587(15)00097-2_bib78","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1016\/j.clinthera.2012.04.013","article-title":"Efficacy of GLP-1 receptor agonists and DPP-4 inhibitors: meta-analysis and systematic review","volume":"34","author":"Aroda","year":"2012","journal-title":"Clin Ther"},{"key":"10.1016\/S2213-8587(15)00097-2_bib79","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1111\/dom.12025","article-title":"Combination therapy with GLP-1 receptor agonists and basal insulin: a systematic review of the literature","volume":"15","author":"Balena","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib80","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s00125-007-0633-0","article-title":"Addition of vildagliptin to insulin improves glycaemic control in type 2 diabetes","volume":"50","author":"Fonseca","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00097-2_bib81","doi-asserted-by":"crossref","first-page":"21","DOI":"10.2147\/VHRM.S39300","article-title":"Efficacy of vildagliptin in combination with insulin in patients with type 2 diabetes and severe renal impairment","volume":"9","author":"Lukashevich","year":"2013","journal-title":"Vasc Health Risk Manag"},{"key":"10.1016\/S2213-8587(15)00097-2_bib82","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1111\/dom.12020","article-title":"Improved glycaemic control with vildagliptin added to insulin, with or without metformin, in patients with type 2 diabetes mellitus","volume":"15","author":"Kothny","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib83","doi-asserted-by":"crossref","first-page":"151","DOI":"10.4239\/wjd.v4.i4.151","article-title":"Vildagliptin-insulin combination improves glycemic control in Asians with type 2 diabetes","volume":"4","author":"Kozlovski","year":"2013","journal-title":"World J Diabetes"},{"key":"10.1016\/S2213-8587(15)00097-2_bib84","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1185\/03007995.2012.665046","article-title":"Effect of saxagliptin as add-on therapy in patients with poorly controlled type 2 diabetes on insulin alone or insulin combined with metformin","volume":"28","author":"Barnett","year":"2012","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/S2213-8587(15)00097-2_bib85","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1111\/j.1463-1326.2012.01600.x","article-title":"Comparison between sitagliptin as add-on therapy to insulin and insulin dose-increase therapy in uncontrolled Korean type 2 diabetes: CSI study","volume":"14","author":"Hong","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib86","doi-asserted-by":"crossref","first-page":"1509","DOI":"10.2337\/dc09-2191","article-title":"Further improvement in postprandial glucose control with addition of exenatide or sitagliptin to combination therapy with insulin glargine and metformin: a proof-of-concept study","volume":"33","author":"Arnolds","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib87","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1111\/j.1463-1326.2009.01173.x","article-title":"Efficacy and safety of sitagliptin when added to insulin therapy in patients with type 2 diabetes","volume":"12","author":"Vilsb\u00f8ll","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib88","doi-asserted-by":"crossref","first-page":"3875","DOI":"10.2337\/dc12-2718","article-title":"Effects of adding linagliptin to basal insulin regimen for inadequately controlled type 2 diabetes: a \u226552-week randomized, double-blind study","volume":"36","author":"Yki-J\u00e4rvinen","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib89","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1463-1326.2012.01628.x","article-title":"Combining GLP-1 receptor agonists with insulin: therapeutic rationales and clinical findings","volume":"15","author":"Holst","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib91","doi-asserted-by":"crossref","first-page":"910","DOI":"10.1111\/j.1463-1326.2012.01618.x","article-title":"Randomized, double-blind, placebo-controlled trial of the once-daily GLP-1 receptor agonist lixisenatide in Asian patients with type 2 diabetes insufficiently controlled on basal insulin with or without a sulfonylurea (GetGoal-L-Asia)","volume":"14","author":"Seino","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib92","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.2337\/dc12-2454","article-title":"Adding once-daily lixisenatide for type 2 diabetes inadequately controlled by established basal insulin: a 24-week, randomized, placebo-controlled comparison (GetGoal-L)","volume":"36","author":"Riddle","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib93","doi-asserted-by":"crossref","first-page":"2497","DOI":"10.2337\/dc12-2462","article-title":"Adding once-daily lixisenatide for type 2 diabetes inadequately controlled with newly initiated and continuously titrated basal insulin glargine: a 24-week, randomized, placebo-controlled study (GetGoal-Duo 1)","volume":"36","author":"Riddle","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib94","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.2337\/dc11-0291","article-title":"Effects of exenatide on measures of \u03b2-cell function after 3 years in metformin-treated patients with type 2 diabetes","volume":"34","author":"Bunck","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib95","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1016\/S2213-8587(14)70029-4","article-title":"Exenatide once weekly versus insulin glargine for type 2 diabetes (DURATION-3): 3-year results of an open-label randomised trial","volume":"2","author":"Diamant","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00097-2_bib96","doi-asserted-by":"crossref","first-page":"2046","DOI":"10.1007\/s00125-009-1472-y","article-title":"Liraglutide vs insulin glargine and placebo in combination with metformin and sulfonylurea therapy in type 2 diabetes mellitus (LEAD-5 met+SU): a randomised controlled trial","volume":"52","author":"Russell-Jones","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00097-2_bib97","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1111\/dom.12007","article-title":"A network meta-analysis to compare glycaemic control in patients with type 2 diabetes treated with exenatide once weekly or liraglutide once daily in comparison with insulin glargine, exenatide twice daily or placebo","volume":"15","author":"Scott","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib98","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1016\/S2213-8587(14)70174-3","volume":"2","author":"Gough","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00097-2_bib99","doi-asserted-by":"crossref","first-page":"2926","DOI":"10.2337\/dc14-0785","article-title":"Contribution of liraglutide in the fixed-ratio combination of insulin degludec and liraglutide (IDegLira)","volume":"37","author":"Buse","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib100","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1038\/nrendo.2011.243","article-title":"SGLT2 inhibition in diabetes mellitus: rationale and clinical prospects","volume":"8","author":"Ferrannini","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(15)00097-2_bib101","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1111\/dom.12187","article-title":"Dapagliflozin in patients with type 2 diabetes receiving high doses of insulin: efficacy and safety over 2 years","volume":"16","author":"Wilding","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib102","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.2337\/dc13-3055","article-title":"Improved glucose control with weight loss, lower insulin doses, and no increased hypoglycemia with empagliflozin added to titrated multiple daily injections of insulin in obese inadequately controlled type 2 diabetes","volume":"37","author":"Rosenstock","year":"2014","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00097-2_bib103","first-page":"A280","article-title":"Effects of Canagliflozin added on to basal insulin with or without other antihyperglycemic agents in type 2 diabetes","volume":"62","author":"Rosenstock","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(15)00097-2_bib105","doi-asserted-by":"crossref","first-page":"1716","DOI":"10.1056\/NEJMoa075392","article-title":"Addition of biphasic, prandial, or basal insulin to oral therapy in type 2 diabetes","volume":"357","author":"Holman","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib106","doi-asserted-by":"crossref","first-page":"3080","DOI":"10.2337\/diacare.26.11.3080","article-title":"The treat-to-target trial: randomized addition of glargine or human NPH insulin to oral therapy of type 2 diabetic patients","volume":"26","author":"Riddle","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib107","doi-asserted-by":"crossref","first-page":"1736","DOI":"10.1056\/NEJMoa0905479","article-title":"Three-year efficacy of complex insulin regimens in type 2 diabetes","volume":"361","author":"Holman","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib108","doi-asserted-by":"crossref","first-page":"1298","DOI":"10.1111\/dme.12303","article-title":"Comparison of insulin degludec with insulin glargine in insulin-naive subjects with Type 2 diabetes: a 2-year randomized, treat-to-target trial","volume":"30","author":"Rodbard","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib109","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1111\/jdi.12102","article-title":"Insulin degludec compared with insulin glargine in insulin-na\u00efve patients with type 2 diabetes: A 26-week, randomized, controlled, Pan-Asian, treat-to-target trial","volume":"4","author":"Onishi","year":"2013","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(15)00097-2_bib110","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1111\/dom.12225","article-title":"Randomized, 1-year comparison of three ways to initiate and advance insulin for type 2 diabetes: twice-daily premixed insulin versus basal insulin with either basal-plus one prandial insulin or basal-bolus up to three prandial injections","volume":"16","author":"Riddle","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib111","author":"Malek","year":"2014","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(15)00097-2_bib112","doi-asserted-by":"crossref","first-page":"e263","DOI":"10.1111\/j.1464-5491.2012.03722.x","article-title":"A study comparing insulin lispro mix 25 with glargine plus lispro therapy in patients with type 2 diabetes who have inadequate glycaemic control on oral anti-hyperglycaemic medication: results of the PARADIGM study","volume":"29","author":"Bowering","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib113","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1016\/j.diabres.2014.09.026","article-title":"Insulin degludec\/insulin aspart versus biphasic insulin aspart 30 in Asian patients with type 2 diabetes inadequately controlled on basal or pre-\/self-mixed insulin: a 26-week, randomised, treat-to-target trial","volume":"1","author":"Kaneko","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00097-2_bib114","doi-asserted-by":"crossref","first-page":"2084","DOI":"10.2337\/dc13-2908","article-title":"Comparison of insulin degludec\/insulin aspart and biphasic insulin aspart 30 in uncontrolled, insulin-treated type 2 diabetes: a phase 3a, randomized, treat-to-target trial","volume":"37","author":"Fulcher","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib115","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/dme.12019","article-title":"Stepwise intensification of insulin therapy in type 2 diabetes management\u2014exploring the concept of the basal-plus approach in clinical practice","volume":"30","author":"Owens","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib116","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.1016\/S0140-6736(14)61037-0","article-title":"Insulin pump treatment compared with multiple daily injections for treatment of type 2 diabetes (OpT2mise): a randomised open-label controlled trial","volume":"384","author":"Reznik","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00097-2_bib117","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00097-2_bib118","doi-asserted-by":"crossref","first-page":"1779","DOI":"10.2337\/dc13-0512","article-title":"Personalized management of hyperglycemia in type 2 diabetes: reflections from a Diabetes Care Editors' Expert Forum","volume":"36","author":"Raz","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib119","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta14360","article-title":"Newer agents for blood glucose control in type 2 diabetes: systematic review and economic evaluation","volume":"14","author":"Waugh","year":"2010","journal-title":"Health Technol Assess"},{"key":"10.1016\/S2213-8587(15)00097-2_bib120","doi-asserted-by":"crossref","first-page":"1767","DOI":"10.2337\/dc14-0031","article-title":"Insulin analogs-are they worth it? Yes!","volume":"37","author":"Grunberger","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib121","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.2337\/dc13-2915","article-title":"Insulin analogs\u2014is there a compelling case to use them? No!","volume":"37","author":"Davidson","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib122","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1007\/s11154-008-9101-5","article-title":"Beta-cell failure as a complication of diabetes","volume":"9","author":"Chang-Chen","year":"2008","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/S2213-8587(15)00097-2_bib123","doi-asserted-by":"crossref","first-page":"316","DOI":"10.2337\/dc14-0920","article-title":"Hypoglycemia and risk of cardiovascular disease and all-cause mortality in insulin-treated people with type 1 and type 2 diabetes: a cohort study","volume":"38","author":"Khunti","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00097-2_bib124","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1097\/SLA.0000000000001014","article-title":"Surgical versus medical treatment of type 2 diabetes mellitus in nonseverely obese patients: a systematic review and meta-analysis","volume":"261","author":"M\u00fcller-Stich","year":"2015","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(15)00097-2_bib125","series-title":"The treatment of diabetes mellitus","author":"Joslin","year":"1928"},{"key":"10.1016\/S2213-8587(15)00097-2_bib90","doi-asserted-by":"crossref","first-page":"103","DOI":"10.7326\/0003-4819-154-2-201101180-00300","article-title":"Use of twice-daily exenatide in Basal insulin-treated patients with type 2 diabetes: a randomized, controlled trial","volume":"154","author":"Buse","year":"2011","journal-title":"Ann Intern Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000972?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000972?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:12Z","timestamp":1761991572000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000972"}},"issued":{"date-parts":[[2015,8]]},"references-count":119,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S2213858715000972"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00097-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New forms of insulin and insulin therapies for the treatment of type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00097-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,28]],"date-time":"2026-09-28T15:53:57Z","timestamp":1790610837623,"version":"4.1.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/s2213-8587(25)00326-2","type":"journal-article","created":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T02:41:45Z","timestamp":1761187305000},"page":"1001-1002","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Obesity legally recognised as a chronic disease in Italy"],"prefix":"10.1016","volume":"13","author":[{"given":"Maurizio","family":"Bifulco","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina","family":"Pagano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erika","family":"Di Zazzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00326-2_bib1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00326-2_bib2","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0140-6736(24)01210-8","article-title":"Obesity in adults","volume":"404","author":"Lingvay","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00326-2_bib5","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00326-2_bib6","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1002\/ijc.34355","article-title":"Advances in \u201cadiponcosis\u201d: Insights in the inner mechanisms at the base of adipose and tumour tissues interplay","volume":"152","author":"Pagano","year":"2023","journal-title":"Int J Cancer"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003262?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003262?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T02:50:07Z","timestamp":1763088607000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003262"}},"issued":{"date-parts":[[2025,12]]},"references-count":4,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2213858725003262"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00326-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity legally recognised as a chronic disease in Italy","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00326-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T21:50:23Z","timestamp":1791323423056,"version":"4.3.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/s2213-8587(25)00255-4","type":"journal-article","created":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T07:43:55Z","timestamp":1759304635000},"page":"898-899","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Peripheral CB1 receptor blockade for treatment of obesity"],"prefix":"10.1016","volume":"13","author":[{"given":"Kishore M","family":"Gadde","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonanne","family":"Talebloo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniele","family":"Piomelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00255-4_bib1","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1038\/nn1457","article-title":"Endocannabinoid control of food intake and energy balance","volume":"8","author":"Di Marzo","year":"2005","journal-title":"Nat Neurosci"},{"key":"10.1016\/S2213-8587(25)00255-4_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.pharmthera.2020.107477","article-title":"The therapeutic potential of second and third generation CB1R antagonists","volume":"208","author":"Cinar","year":"2020","journal-title":"Pharmacol Ther"},{"key":"10.1016\/S2213-8587(25)00255-4_bib3","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1161\/CIRCULATIONAHA.105.596130","article-title":"Cannabinoid-1 receptor antagonist, rimonabant, for management of obesity and related risks","volume":"114","author":"Gadde","year":"2006","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(25)00255-4_bib4","article-title":"The peripheral cannabinoid receptor type 1 (CB1) as a molecular target for modulating body weight in man","volume":"26","author":"O'Sullivan","year":"2021","journal-title":"Molecules"},{"key":"10.1016\/S2213-8587(25)00255-4_bib5","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1021\/acsptsci.1c00048","article-title":"Functional selectivity of a biased cannabinoid-1 receptor (CB1R) antagonist","volume":"4","author":"Liu","year":"2021","journal-title":"ACS Pharmacol Transl Sci"},{"key":"10.1016\/S2213-8587(25)00255-4_bib6","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1111\/dom.15353","article-title":"Effects of CB1R inverse agonist, INV-202, in patients with features of metabolic syndrome. A randomized, placebo-controlled, double-blind phase 1b study","volume":"26","author":"Crater","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(25)00255-4_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00216-5","article-title":"Efficacy and safety of monlunabant in adults with obesity and metabolic syndrome in Canada: a double-blind, randomised, placebo-controlled, phase 2a trial","author":"Knop","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00255-4_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s00213-001-0946-5","article-title":"Involvement of CB1 cannabinoid receptors in emotional behaviour","volume":"159","author":"Martin","year":"2002","journal-title":"Psychopharmacology (Berl)"},{"key":"10.1016\/S2213-8587(25)00255-4_bib9","doi-asserted-by":"crossref","first-page":"63","DOI":"10.3389\/fnbeh.2011.00063","article-title":"Endocannabinoid system and psychiatry: in search of a neurobiological basis for detrimental and potential therapeutic effects","volume":"5","author":"Marco","year":"2011","journal-title":"Front Behav Neurosci"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:11:21Z","timestamp":1774987881000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002554"}},"issued":{"date-parts":[[2025,11]]},"references-count":9,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2213858725002554"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00255-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Peripheral CB1 receptor blockade for treatment of obesity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00255-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00216-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:51:58Z","timestamp":1791661918248,"version":"4.3.4"},"reference-count":5,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/s2213-8587(26)00252-4","type":"journal-article","created":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T22:44:00Z","timestamp":1791585840000},"update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Multidisciplinary care of pituitary adenomas"],"prefix":"10.1016","author":[{"given":"Zhaoyun","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nidan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yongfei","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongying","family":"Ye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yao","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00252-4_bib1","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1007\/s11102-017-0838-2","article-title":"Criteria for the definition of Pituitary Tumor Centers of Excellence (PTCOE): a Pituitary Society Statement","volume":"20","author":"Casanueva","year":"2017","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(26)00252-4_bib2","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1097\/JS9.0000000000001330","article-title":"Combined simultaneous transsphenoidal and transcranial regimen improves surgical outcomes in complex giant pituitary adenomas: a longitudinal retrospective cohort study","volume":"110","author":"Qiao","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/S2213-8587(26)00252-4_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.clineuro.2021.106781","article-title":"Comparative effectiveness of endoscopic versus microscopic transsphenoidal surgery for patients with growth hormone secreting pituitary adenoma: an emulated trial","volume":"207","author":"Qiao","year":"2021","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/S2213-8587(26)00252-4_bib4","doi-asserted-by":"crossref","first-page":"e7","DOI":"10.3171\/2020.3.FOCUS2067","article-title":"Surgical outcomes and multidisciplinary management strategy of Cushing's disease: a single-center experience in China","volume":"48","author":"Zhang","year":"2020","journal-title":"Neurosurg Focus"},{"key":"10.1016\/S2213-8587(26)00252-4_bib5","doi-asserted-by":"crossref","DOI":"10.1148\/radiol.233469","article-title":"Diagnostic accuracy and value of CXCR4-targeted PET\/MRI using 68Ga-pentixafor for tumor localization in Cushing disease","volume":"313","author":"Wu","year":"2024","journal-title":"Radiology"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002524?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002524?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T19:44:40Z","timestamp":1791661480000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726002524"}},"issued":{"date-parts":[[2026,10]]},"references-count":5,"alternative-id":["S2213858726002524"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00252-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidisciplinary care of pituitary adenomas","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00252-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T12:21:59Z","timestamp":1792153319446,"version":"4.4.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003130","name":"Fonds Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003130","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Javna Agencija za Raziskovalno Dejavnost RS","doi-asserted-by":"publisher","award":["J3\u20130343"],"award-info":[{"award-number":["J3\u20130343"]}],"id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/s2213-8587(23)00116-x","type":"journal-article","created":{"date-parts":[[2023,6,5]],"date-time":"2023-06-05T18:30:24Z","timestamp":1685989824000},"page":"490-508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets"],"prefix":"10.1016","volume":"11","author":[{"given":"Katrien","family":"Benhalima","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaat","family":"Beunen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah E","family":"Siegelaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Painter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen R","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denice S","family":"Feig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois E","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarit","family":"Polsky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Buschur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carol J","family":"Levy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogish C","family":"Kudva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lene","family":"Ringholm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth R","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00116-X_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib2","doi-asserted-by":"crossref","first-page":"3193","DOI":"10.1007\/s00125-012-2721-z","article-title":"HbA(1c) and birthweight in women with pre-conception type 1 and type 2 diabetes: a population-based cohort study","volume":"55","author":"Glinianaia","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00116-X_bib3","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.diabres.2018.02.014","article-title":"Diastolic blood pressure is a potentially modifiable risk factor for preeclampsia in women with pre-existing diabetes","volume":"138","author":"N\u00f8rgaard","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00116-X_bib4","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2337\/dc07-1596","article-title":"High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia","volume":"31","author":"Clausen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib5","doi-asserted-by":"crossref","first-page":"2005","DOI":"10.2337\/dc09-0656","article-title":"Obstetric and perinatal outcomes in type 1 diabetic pregnancies: a large, population-based study","volume":"32","author":"Persson","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib6","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1186\/s12884-016-0958-0","article-title":"Risk factors for large-for-gestational age infants in pregnant women with type 1 diabetes","volume":"16","author":"Morrens","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(23)00116-X_bib7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1136\/bmj.38043.583160.EE","article-title":"Risk of complications of pregnancy in women with type 1 diabetes: nationwide prospective study in the Netherlands","volume":"328","author":"Evers","year":"2004","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00116-X_bib8","doi-asserted-by":"crossref","first-page":"554","DOI":"10.2337\/diacare.25.3.554","article-title":"Risk indicators predictive for severe hypoglycemia during the first trimester of type 1 diabetic pregnancy","volume":"25","author":"Evers","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib9","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc07-1066","article-title":"Hypoglycemia in pregnant women with type 1 diabetes: predictors and role of metabolic control","volume":"31","author":"Nielsen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib10","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1007\/s00125-009-1633-z","article-title":"Insulin requirements throughout pregnancy in women with type 1 diabetes mellitus: three changes of direction","volume":"53","author":"Garc\u00eda-Patterson","year":"2010","journal-title":"Diabetologia"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00116-X_bib11","first-page":"S232","article-title":"15. Management of diabetes in pregnancy: standards of medical care in diabetes\u20142022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib12","doi-asserted-by":"crossref","first-page":"1668","DOI":"10.1007\/s00125-017-4314-3","article-title":"Improved pregnancy outcomes in women with type 1 and type 2 diabetes but substantial clinic-to-clinic variations: a prospective nationwide study","volume":"60","author":"Murphy","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00116-X_bib13","doi-asserted-by":"crossref","first-page":"2347","DOI":"10.1016\/S0140-6736(17)32400-5","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes (CONCEPTT): a multicentre international randomised controlled trial","volume":"390","author":"Feig","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00116-X_bib14","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00125-019-4850-0","article-title":"Continuous glucose monitoring in pregnant women with type 1 diabetes: an observational cohort study of 186 pregnancies","volume":"62","author":"Kristensen","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00116-X_bib15","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib16","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1111\/aogs.14039","article-title":"Glycemic, maternal and neonatal outcomes in women with type 1 diabetes using continuous glucose monitoring during pregnancy\u2014pump vs multiple daily injections, a secondary analysis of an observational cohort study","volume":"100","author":"Kj\u00f6lhede","year":"2021","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S2213-8587(23)00116-X_bib17","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1089\/dia.2021.0112","article-title":"Longitudinal observation of insulin use and glucose sensor metrics in pregnant women with type 1 diabetes using continuous glucose monitors and insulin pumps: the LOIS-P study","volume":"23","author":"O'Malley","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib18","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1089\/dia.2021.0073","article-title":"Continuous glucose monitoring time-in-range and HbA1c targets in pregnant women with type 1 diabetes","volume":"23","author":"Tundidor","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib19","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1089\/dia.2021.0521","article-title":"Feasibility of closed-loop insulin delivery with a pregnancy-specific zone model predictive control algorithm","volume":"24","author":"Ozaslan","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib20","doi-asserted-by":"crossref","first-page":"406","DOI":"10.2337\/dc10-1796","article-title":"Closed-loop insulin delivery during pregnancy complicated by type 1 diabetes","volume":"34","author":"Murphy","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib21","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.2337\/dc11-1430","article-title":"Safety and efficacy of 24-h closed-loop insulin delivery in well-controlled pregnant women with type 1 diabetes: a randomized crossover case series","volume":"34","author":"Murphy","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib22","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1602494","article-title":"Closed-loop insulin delivery during pregnancy in women with type 1 diabetes","volume":"375","author":"Stewart","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib23","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.2337\/dc17-2534","article-title":"Day-and-night closed-loop insulin delivery in a broad population of pregnant women with type 1 diabetes: a randomized controlled crossover trial","volume":"41","author":"Stewart","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib24","doi-asserted-by":"crossref","first-page":"2677","DOI":"10.2337\/dc14-0896","article-title":"Higher gestational weight gain is associated with increasing offspring birth weight independent of maternal glycemic control in women with type 1 diabetes","volume":"37","author":"Secher","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib25","doi-asserted-by":"crossref","DOI":"10.2337\/dc21-1182","article-title":"Unchanged Prevalence of Preeclampsia After Implementation of Prophylactic Aspirin for All Pregnant Women With Preexisting Diabetes: A Prospective Cohort Study","author":"Do","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib26","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1210\/jc.2015-4046","article-title":"A prepregnancy care program for women with diabetes: effective and cost saving","volume":"101","author":"Egan","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00116-X_bib27","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15014","article-title":"Attendance at pre-pregnancy care clinics for women with type 1 diabetes: a scoping review","volume":"40","author":"Ferry","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib28","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.diabres.2013.06.002","article-title":"The incidence of severe hypoglycaemia in pregnant women with type 1 diabetes mellitus can be reduced with unchanged HbA1c levels and pregnancy outcomes in a routine care setting","volume":"101","author":"Ringholm","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00116-X_bib29","doi-asserted-by":"crossref","first-page":"3137","DOI":"10.1210\/clinem\/dgac464","article-title":"Diabetic Ketoacidosis in Pregnancy: Clinical Risk Factors, Presentation, and Outcomes","volume":"107","author":"Dhanasekaran","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00116-X_bib30","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jamaophthalmol.2022.0050","article-title":"Global estimates of diabetic retinopathy prevalence and progression in pregnant women with preexisting diabetes: a systematic review and meta-analysis","volume":"140","author":"Widyaputri","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib31","doi-asserted-by":"crossref","first-page":"181","DOI":"10.2337\/dc20-0904","article-title":"Progression of diabetic retinopathy and predictors of its development and progression during pregnancy in patients with type 1 diabetes: a report of 499 pregnancies","volume":"44","author":"Bourry","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib32","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14819","article-title":"Prevalence and severity of diabetic retinopathy in pregnant women with diabetes-time to individualize photo screening frequency","volume":"39","author":"Pappot","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib33","doi-asserted-by":"crossref","first-page":"1739","DOI":"10.2337\/diacare.24.10.1739","article-title":"Pregnancy outcome in type 1 diabetic women with microalbuminuria","volume":"24","author":"Ekbom","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib34","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1900\/RDS.2013.10.6","article-title":"Type 1 diabetes, diabetic nephropathy, and pregnancy: a systematic review and meta-study","volume":"10","author":"Piccoli","year":"2013","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/S2213-8587(23)00116-X_bib35","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bmj.325.7367.746","article-title":"Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial","volume":"325","author":"Group","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00116-X_bib36","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.diabres.2016.12.012","article-title":"The influence of carbohydrate consumption on glycemic control in pregnant women with type 1 diabetes","volume":"127","author":"\u00c1sbj\u00f6rnsd\u00f3ttir","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00116-X_bib37","doi-asserted-by":"crossref","first-page":"1115","DOI":"10.1111\/jhn.13042","article-title":"Carbohydrate quantity is more closely associated with glycaemic control than weight in pregnant women with type 1 diabetes: insights from the Diabetes and Pre-eclampsia Intervention Trial (DAPIT)","volume":"35","author":"Hill","year":"2022","journal-title":"J Hum Nutr Diet"},{"key":"10.1016\/S2213-8587(23)00116-X_bib38","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/14767058.2014.906577","article-title":"Dietary advices on carbohydrate intake for pregnant women with type 1 diabetes","volume":"28","author":"Roskjaer","year":"2015","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib39","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1016\/S0002-8223(01)00080-3","article-title":"Dietary fiber intakes and insulin requirements in pregnant women with type 1 diabetes","volume":"101","author":"Kalkwarf","year":"2001","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/S2213-8587(23)00116-X_bib40","series-title":"Weight gain during pregnancy: reexamining the guidelines","year":"2009"},{"key":"10.1016\/S2213-8587(23)00116-X_bib41","doi-asserted-by":"crossref","first-page":"280","DOI":"10.2337\/dc20-2008","article-title":"Ketones in pregnancy: why is it considered necessary to avoid them and what is the evidence behind their perceived risk?","volume":"44","author":"Tanner","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib42","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.2337\/dc18-0551","article-title":"Large-for-gestational-age neonates in type 1 diabetes and pregnancy: contribution of factors beyond hyperglycemia","volume":"41","author":"McGrath","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib43","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(21)00246-1","article-title":"Obesity in people living with type 1 diabetes","volume":"9","author":"Van der Schueren","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib44","doi-asserted-by":"crossref","first-page":"753","DOI":"10.5114\/aoms.2016.58619","article-title":"Maternal lipids associated with large-for-gestational-age birth weight in women with type 1 diabetes: results from a prospective single-center study","volume":"13","author":"Gutaj","year":"2017","journal-title":"Arch Med Sci"},{"key":"10.1016\/S2213-8587(23)00116-X_bib45","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.2337\/dc10-0484","article-title":"Changes in serum lipid levels during pregnancy in type 1 and type 2 diabetic subjects","volume":"33","author":"G\u00f6bl","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib46","doi-asserted-by":"crossref","first-page":"2581","DOI":"10.1194\/jlr.M600236-JLR200","article-title":"Placental triglyceride accumulation in maternal type 1 diabetes is associated with increased lipase gene expression","volume":"47","author":"Lindegaard","year":"2006","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(23)00116-X_bib47","doi-asserted-by":"crossref","first-page":"e5","DOI":"10.2337\/dc19-1908","article-title":"Dietary patterns of insulin pump and multiple daily injection users during type 1 diabetes pregnancy","volume":"43","author":"Neoh","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib48","doi-asserted-by":"crossref","DOI":"10.3390\/nu14224867","article-title":"Dietary advice to support glycaemic control and weight management in women with type 1 diabetes during pregnancy and breastfeeding","volume":"14","author":"Ringholm","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(23)00116-X_bib49","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1111\/aogs.13180","article-title":"Vitamin D insufficiency, preterm delivery and preeclampsia in women with type 1 diabetes\u2014an observational study","volume":"96","author":"Vestgaard","year":"2017","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S2213-8587(23)00116-X_bib50","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.2337\/dc12-1567","article-title":"Physical activity energy expenditure and glucose control in pregnant women with type 1 diabetes: is 30 minutes of daily exercise enough?","volume":"36","author":"Kumareswaran","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib51","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s11892-019-1204-8","article-title":"Exercise in pregnant women with diabetes","volume":"19","author":"Peters","year":"2019","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(23)00116-X_bib52","doi-asserted-by":"crossref","first-page":"1359","DOI":"10.1016\/S0002-9378(87)80224-7","article-title":"Postprandial walking exercise in pregnant insulin-dependent (type I) diabetic women: reduction of plasma lipid levels but absence of a significant effect on glycemic control","volume":"157","author":"Hollingsworth","year":"1987","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib53","doi-asserted-by":"crossref","first-page":"713","DOI":"10.3389\/fendo.2018.00713","article-title":"Assessing the impact of excessive gestational weight gain among women with type 1 diabetes on overweight\/obesity in their adolescent and young adult offspring: a pilot study","volume":"9","author":"McWhorter","year":"2018","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib54","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1464-5491.2002.00729.x","article-title":"Hypertensive disorders of pregnancy in women with type 1 and type 2 diabetes","volume":"19","author":"Cundy","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib55","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1007\/s00125-021-05482-8","article-title":"Potentially modifiable risk factors of preterm delivery in women with type 1 and type 2 diabetes","volume":"64","author":"S\u00f8holm","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00116-X_bib56","doi-asserted-by":"crossref","first-page":"e3670","DOI":"10.1210\/clinem\/dgac392","article-title":"Home blood pressure for the prediction of preeclampsia in women with preexisting diabetes","volume":"107","author":"Do","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00116-X_bib57","doi-asserted-by":"crossref","first-page":"38","DOI":"10.2337\/dc08-1526","article-title":"Improved pregnancy outcome in type 1 diabetic women with microalbuminuria or diabetic nephropathy: effect of intensified antihypertensive therapy?","volume":"32","author":"Nielsen","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib58","doi-asserted-by":"crossref","first-page":"3489","DOI":"10.2337\/dc13-1031","article-title":"Diabetic nephropathy and microalbuminuria in pregnant women with type 1 and type 2 diabetes: prevalence, antihypertensive strategy, and pregnancy outcome","volume":"36","author":"Damm","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib59","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1111\/j.1464-5491.2006.01831.x","article-title":"Reduced prevalence of early preterm delivery in women with Type 1 diabetes and microalbuminuria\u2014possible effect of early antihypertensive treatment during pregnancy","volume":"23","author":"Nielsen","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib60","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3453","article-title":"Increased risk of major congenital malformations in early pregnancy use of angiotensin-converting-enzyme inhibitors and angiotensin-receptor-blockers: a meta-analysis","volume":"37","author":"Fu","year":"2021","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(23)00116-X_bib61","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/s41574-019-0197-3","article-title":"Improving pregnancy outcomes in women with diabetes mellitus: modern management","volume":"15","author":"Ringholm","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib62","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1056\/NEJMoa1704559","article-title":"Aspirin versus placebo in pregnancies at high risk for preterm preeclampsia","volume":"377","author":"Rolnik","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib63","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1111\/j.1471-0528.1996.tb09513.x","article-title":"ECPPA: randomised trial of low dose aspirin for the prevention of maternal and fetal complications in high risk pregnant women","volume":"103","year":"1996","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib64","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1056\/NEJM199803123381101","article-title":"Low-dose aspirin to prevent preeclampsia in women at high risk","volume":"338","author":"Caritis","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2019.100465","article-title":"Investigating the role of early low-dose aspirin in diabetes: a phase III multicentre double-blinded placebo-controlled randomised trial of aspirin therapy initiated in the first trimester of diabetes pregnancy","volume":"16","author":"Finnegan","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/S2213-8587(23)00116-X_bib66","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1038\/nrendo.2017.39","article-title":"Insulin analogues in type 1 diabetes mellitus: getting better all the time","volume":"13","author":"Mathieu","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib67","doi-asserted-by":"crossref","first-page":"907","DOI":"10.1089\/dia.2011.0032","article-title":"Glycemic control and pregnancy outcomes in women with type 1 diabetes mellitus using lispro versus regular insulin: a systematic review and meta-analysis","volume":"13","author":"Gonz\u00e1lez Blanco","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib68","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc06-1887","article-title":"Maternal glycemic control and hypoglycemia in type 1 diabetic pregnancy: a randomized trial of insulin aspart versus human insulin in 322 pregnant women","volume":"30","author":"Mathiesen","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib69","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s40262-017-0514-8","article-title":"A pooled analysis of clinical pharmacology trials investigating the pharmacokinetic and pharmacodynamic characteristics of fast-acting insulin aspart in adults with type 1 diabetes","volume":"56","author":"Heise","year":"2017","journal-title":"Clin Pharmacokinet"},{"key":"10.1016\/S2213-8587(23)00116-X_bib70","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1111\/dom.14461","article-title":"Ultra-rapid-acting insulins for adults with diabetes: a systematic review and meta-analysis","volume":"23","author":"Avgerinos","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00116-X_bib71","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-045650","article-title":"CopenFast trial: faster-acting insulin Fiasp versus insulin NovoRapid in the treatment of women with type 1 or type 2 diabetes during pregnancy and lactation\u2014a randomised controlled trial","volume":"11","author":"N\u00f8rgaard","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(23)00116-X_bib72","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1007\/s00125-011-2363-6","article-title":"Pathophysiology of postprandial hyperglycaemia in women with type 1 diabetes during pregnancy","volume":"55","author":"Murphy","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00116-X_bib73","doi-asserted-by":"crossref","first-page":"2012","DOI":"10.2337\/dc11-2264","article-title":"Maternal efficacy and safety outcomes in a randomized, controlled trial comparing insulin detemir with NPH insulin in 310 pregnant women with type 1 diabetes","volume":"35","author":"Mathiesen","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib74","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1111\/j.1464-5491.2008.02485.x","article-title":"Perinatal outcomes associated with the use of glargine during pregnancy","volume":"25","author":"Di Cianni","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib75","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1007\/s00592-021-01845-0","article-title":"Pregnancy outcomes in women with type 1 diabetes using insulin degludec","volume":"59","author":"Ringholm","year":"2022","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib76","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S2213-8587(22)00307-2","article-title":"Insulin degludec versus insulin detemir, both in combination with insulin aspart, in the treatment of pregnant women with type 1 diabetes (EXPECT): an openlabel, multinational, randomised, controlled, non-inferiority trial","volume":"11","author":"Mathiesen","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib77","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.2337\/dc19-1459","article-title":"Effects of continuous glucose monitoring on metrics of glycemic control in diabetes: a systematic review with meta-analysis of randomized controlled trials","volume":"43","author":"Maiorino","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib78","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1089\/dia.2022.0452","article-title":"Sustained impact of intermittently scanned continuous glucose monitoring on treatment satisfaction and severe hypoglycemia in adults with type 1 diabetes (FUTURE): an analysis in people with normal and impaired awareness of hypoglycemia","volume":"25","author":"Charleer","year":"2023","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib79","doi-asserted-by":"crossref","first-page":"11","DOI":"10.7573\/dic.2021-9-13","article-title":"Diabetes: the role of continuous glucose monitoring","volume":"11","author":"Kluemper","year":"2022","journal-title":"Drugs Context"},{"key":"10.1016\/S2213-8587(23)00116-X_bib80","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.a1680","article-title":"Effectiveness of continuous glucose monitoring in pregnant women with diabetes: randomised clinical trial","volume":"337","author":"Murphy","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00116-X_bib81","doi-asserted-by":"crossref","first-page":"1894","DOI":"10.1111\/dom.13310","article-title":"Continuous glucose monitoring during diabetic pregnancy (GlucoMOMS): a multicentre randomized controlled trial","volume":"20","author":"Voormolen","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00116-X_bib82","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.2337\/dc12-2360","article-title":"The effect of real-time continuous glucose monitoring in pregnant women with diabetes: a randomized controlled trial","volume":"36","author":"Secher","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib83","doi-asserted-by":"crossref","first-page":"1652","DOI":"10.1111\/dme.14046","article-title":"Modelling potential cost savings from use of real-time continuous glucose monitoring in pregnant women with type 1 diabetes","volume":"36","author":"Murphy","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib84","doi-asserted-by":"crossref","first-page":"E627","DOI":"10.9778\/cmajo.20200128","article-title":"The cost implications of continuous glucose monitoring in pregnant women with type 1 diabetes in 3 Canadian provinces: a posthoc cost analysis of the CONCEPTT trial","volume":"9","author":"Ahmed","year":"2021","journal-title":"CMAJ Open"},{"key":"10.1016\/S2213-8587(23)00116-X_bib87","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1089\/dia.2017.0386","article-title":"Accuracy, user acceptability, and safety evaluation for the freestyle libre flash glucose monitoring system when used by pregnant women with diabetes","volume":"20","author":"Scott","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib88","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.diabet.2019.08.001","article-title":"Disagreement between capillary blood glucose and flash glucose monitoring sensor can lead to inadequate treatment adjustments during pregnancy","volume":"46","author":"Sola-Gazagnes","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(23)00116-X_bib89","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1089\/dia.2021.0109","article-title":"Comparison of glycemic metrics measured simultaneously by intermittently scanned continuous glucose monitoring and real-time continuous glucose monitoring in pregnant women with type 1 diabetes","volume":"23","author":"N\u00f8rgaard","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib90","first-page":"768","article-title":"Exploratory analysis of glycemic control and variability over gestation among pregnant women with type 1 diabetes","volume":"23","author":"Buschur","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib91","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1089\/dia.2021.0093","article-title":"Relationship between time-in-range, HbA1c, and the glucose management indicator in pregnancies complicated by type 1 diabetes","volume":"23","author":"Shah","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib92","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1177\/1932296819890864","article-title":"Continuous glucose monitor use with remote monitoring reduces fear of hypoglycemia in pregnant women with type 1 diabetes: a pilot study","volume":"14","author":"Polsky","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib93","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1089\/dia.2020.0085","article-title":"Performance of the Dexcom G6 continuous glucose monitoring system in pregnant women with diabetes","volume":"22","author":"Castorino","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib94","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1186\/s12884-022-04543-z","article-title":"AiDAPT: automated insulin delivery amongst pregnant women with type 1 diabetes: a multicentre randomized controlled trial\u2014study protocol","volume":"22","author":"Lee","year":"2022","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(23)00116-X_bib95","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1186\/s12884-023-05481-0","article-title":"Closed-loop insulin delivery in pregnant women with type 1 diabetes (CRISTAL): a multicentre randomized controlled trial\u2014study protocol","volume":"23","author":"Beunen","year":"2023","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(23)00116-X_bib96","first-page":"177","article-title":"Commercialized hybrid closed-loop system (MiniMed Medtronic 670G) results during pregnancy","volume":"7","author":"Moreno-Fern\u00e1ndez","year":"2021","journal-title":"AACE Clin Case Rep"},{"key":"10.1016\/S2213-8587(23)00116-X_bib97","article-title":"The closed-loop system improved the control of a pregnant patient with type 1 diabetes mellitus","volume":"2021","author":"Guzm\u00e1n G\u00f3mez","year":"2021","journal-title":"Case Rep Endocrinol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib98","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3248","article-title":"Case series of a hybrid closed-loop system used in pregnancies in clinical practice","volume":"36","author":"Polsky","year":"2020","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(23)00116-X_bib99","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1089\/dia.2022.0043","article-title":"Management of pregnancy in a patient with highly unstable type 1 diabetes with DBL-hu closed-loop system","volume":"24","author":"Vambergue","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib100","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1007\/s00125-022-05717-2","article-title":"Addition of intermittently scanned continuous glucose monitoring to standard care in a cohort of pregnant women with type 1 diabetes: effect on glycaemic control and pregnancy outcomes","volume":"65","author":"Perea","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00116-X_bib101","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1932296820958754","article-title":"Accuracy of a 14-day factory-calibrated continuous glucose monitoring system with advanced algorithm in pediatric and adult population with diabetes","volume":"16","author":"Alva","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib102","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.2337\/dc22-0078","article-title":"Continuous glucose monitoring metrics and birth weight: informing management of type 1 diabetes throughout pregnancy","volume":"45","author":"Scott","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib103","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1089\/dia.2021.0194","article-title":"Novel continuous glucose monitoring metrics and large-for-gestational-age risk: an exploratory retrospective cohort study in pregnancies with type 1 diabetes","volume":"24","author":"Sibiak","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib104","doi-asserted-by":"crossref","first-page":"681","DOI":"10.2337\/dc20-2360","article-title":"Novel biochemical markers of glycemia to predict pregnancy outcomes in women with type 1 diabetes","volume":"44","author":"Meek","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib105","doi-asserted-by":"crossref","first-page":"e4309","DOI":"10.1210\/clinem\/dgab502","article-title":"Achieving the HbA1c target requires longer time in range in pregnant women with type 1 diabetes","volume":"106","author":"Ling","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00116-X_bib106","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1089\/dia.2021.0479","article-title":"Hypoglycemia in prospective multi-center study of pregnancies with pre-existing type 1 diabetes on sensor augmented pump therapy: the LOIS-P study","volume":"24","author":"Kaur","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib107","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14789","article-title":"Impaired awareness of hypoglycaemia in women with type 1 diabetes in pregnancy: hypoglycaemia fear, glycaemic and pregnancy outcomes","volume":"39","author":"Bahrami","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib108","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/j.jcjd.2021.02.007","article-title":"Use of virtual care for glycemic management in people with types 1 and 2 diabetes and diabetes in pregnancy: a rapid review","volume":"45","author":"Chan","year":"2021","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(23)00116-X_bib109","doi-asserted-by":"crossref","first-page":"349","DOI":"10.1089\/dia.2014.0223","article-title":"Web-based telemedicine system is useful for monitoring glucose control in pregnant women with diabetes","volume":"17","author":"Carral","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib110","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1016\/j.diabet.2011.02.002","article-title":"Type 1 diabetes control and pregnancy outcomes in women treated with continuous subcutaneous insulin infusion (CSII) or with insulin glargine and multiple daily injections of rapid-acting insulin analogues (glargine-MDI)","volume":"37","author":"Bruttomesso","year":"2011","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(23)00116-X_bib111","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1530\/EJE-17-0804","article-title":"Continuous subcutaneous insulin infusion vs multiple daily injections in pregnant women with type 1 diabetes mellitus: a systematic review and meta-analysis of randomised controlled trials and observational studies","volume":"178","author":"Rys","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108628","article-title":"Continuous subcutaneous insulin infusion does not correspond with pregnancy outcomes despite better glycemic control as compared to multiple daily injections in type 1 diabetes\u2014significance of pregnancy planning and prepregnancy HbA1c","volume":"172","author":"\u017burawska-Kli\u015b","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00116-X_bib113","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1177\/1932296820972123","article-title":"Changes in device uptake and glycemic control among pregnant women with type 1 diabetes: data from the T1D exchange","volume":"15","author":"Levy","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib114","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1111\/dme.13861","article-title":"Higher rates of large-for-gestational-age newborns mediated by excess maternal weight gain in pregnancies with type 1 diabetes and use of continuous subcutaneous insulin infusion vs multiple dose insulin injection","volume":"36","author":"Hauffe","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib115","doi-asserted-by":"crossref","first-page":"2471","DOI":"10.2337\/dc18-1437","article-title":"Pumps or multiple daily injections in pregnancy involving type 1 diabetes: a prespecified analysis of the CONCEPTT randomized trial","volume":"41","author":"Feig","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib116","doi-asserted-by":"crossref","first-page":"724","DOI":"10.3109\/14767058.2013.837444","article-title":"Changes in basal rates and bolus calculator settings in insulin pumps during pregnancy in women with type 1 diabetes","volume":"27","author":"Mathiesen","year":"2014","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib117","doi-asserted-by":"crossref","first-page":"303","DOI":"10.2337\/dc17-1604","article-title":"Reduction in hypoglycemia with the predictive low-glucose management system: a long-term randomized controlled trial in adolescents with type 1 diabetes","volume":"41","author":"Abraham","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib118","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2337\/dc16-2584","article-title":"Prevention of hypoglycemia with predictive low glucose insulin suspension in children with type 1 diabetes: a randomized controlled trial","volume":"40","author":"Battelino","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib119","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1111\/dom.12907","article-title":"Evaluation of subcutaneous glucose monitoring systems under routine environmental conditions in patients with type 1 diabetes","volume":"19","author":"Aberer","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00116-X_bib120","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1089\/dia.2016.0319","article-title":"Evaluation of a predictive low-glucose management system in-clinic","volume":"19","author":"Buckingham","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib121","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.2337\/dc18-0771","article-title":"Predictive low-glucose suspend reduces hypoglycemia in adults, adolescents, and children with type 1 diabetes in an at-home randomized crossover study: results of the PROLOG trial","volume":"41","author":"Forlenza","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib122","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1089\/dia.2017.0030","article-title":"Maternal-fetal outcomes in 34 pregnant women with type 1 diabetes in sensor-augmented insulin pump therapy","volume":"19","author":"G\u00f3mez","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib123","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1007\/s00125-021-05589-y","article-title":"Risk for ketonaemia in type 1 diabetes pregnancies with sensor-augmented pump therapy with predictive low glucose suspend compared with low glucose suspend: a crossover RCT","volume":"64","author":"Benhalima","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00116-X_bib124","doi-asserted-by":"crossref","first-page":"e2237","DOI":"10.1210\/clinem\/dgac159","article-title":"Falling insulin requirement in pregnant women with diabetes delivering preterm: prevalence, predictors, and consequences","volume":"107","author":"S\u00f8holm","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00116-X_bib125","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1055\/s-0038-1629903","article-title":"Management of diabetes in the intrapartum and postpartum patient","volume":"35","author":"Dude","year":"2018","journal-title":"Am J Perinatol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib126","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14744","article-title":"Managing hyperglycaemia during antenatal steroid administration, labour and birth in pregnant women with diabetes\u2014an updated guideline from the Joint British Diabetes Society for Inpatient Care","volume":"39","author":"Dashora","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib127","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1111\/dme.14137","article-title":"Severe neonatal hypoglycaemia and intrapartum glycaemic control in pregnancies complicated by type 1, type 2 and gestational diabetes","volume":"37","author":"Yamamoto","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib128","doi-asserted-by":"crossref","first-page":"1046","DOI":"10.1111\/dme.13988","article-title":"Maternal glycaemic control and risk of neonatal hypoglycaemia in type 1 diabetes pregnancy: a secondary analysis of the CONCEPTT trial","volume":"36","author":"Yamamoto","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib129","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/dme.13546","article-title":"Intrapartum glycaemic control and neonatal hypoglycaemia in pregnancies complicated by diabetes: a systematic review","volume":"35","author":"Yamamoto","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib130","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/dme.13106","article-title":"Insulin pump use compared with intravenous insulin during labour and delivery: the INSPIRED observational cohort study","volume":"33","author":"Drever","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib131","doi-asserted-by":"crossref","first-page":"8756","DOI":"10.1080\/14767058.2021.2004114","article-title":"Comparison of intrapartum glycemic management strategies in pregnant women with type 1 diabetes mellitus","volume":"35","author":"Wilkie","year":"2022","journal-title":"J Matern Fetal Neonatal Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib132","doi-asserted-by":"crossref","first-page":"187","DOI":"10.4158\/EP.15.3.187","article-title":"Breastfeeding and the basal insulin requirement in type 1 diabetic women","volume":"15","author":"Riviello","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(23)00116-X_bib133","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s00125-018-4794-9","article-title":"Breastfeeding at night is rarely followed by hypoglycaemia in women with type 1 diabetes using carbohydrate counting and flexible insulin therapy","volume":"62","author":"Ringholm","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00116-X_bib134","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/dia.2019.0280","article-title":"Insulin pump settings during breastfeeding in women with type 1 diabetes","volume":"22","author":"N\u00f8rgaard","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib135","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1007\/s11892-020-01315-x","article-title":"Diabetes management during breastfeeding in women with type 1 diabetes","volume":"20","author":"Ringholm","year":"2020","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(23)00116-X_bib136","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1210\/endrev\/bnac022","article-title":"Consensus recommendations for the use of automated insulin delivery (AID) technologies in clinical practice","volume":"44","author":"Phillip","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(23)00116-X_bib137","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1111\/dom.14273","article-title":"Hybrid closed-loop therapy: where are we in 2021?","volume":"23","author":"Leelarathna","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00116-X_bib138","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1007\/s00125-021-05391-w","article-title":"New closed-loop insulin systems","volume":"64","author":"Boughton","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00116-X_bib139","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1089\/dia.2018.0060","article-title":"Adaptability of closed loop during labor, delivery, and postpartum: a secondary analysis of data from two randomized crossover trials in type 1 diabetes pregnancy","volume":"20","author":"Stewart","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib140","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1177\/1932296818800065","article-title":"Women's experiences of day-and-night closed-loop insulin delivery during type 1 diabetes pregnancy","volume":"12","author":"Farrington","year":"2018","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib141","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1111\/dme.13406","article-title":"Experiences of closed-loop insulin delivery among pregnant women with type 1 diabetes","volume":"34","author":"Farrington","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib142","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.768639","article-title":"Zone-MPC automated insulin delivery algorithm tuned for pregnancy complicated by type 1 diabetes","volume":"12","author":"Ozaslan","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib143","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1089\/dia.2018.0278","article-title":"Design and clinical evaluation of the interoperable artificial pancreas system (iAPS) smartphone app: interoperable components with modular design for progressive artificial pancreas research and development","volume":"21","author":"Deshpande","year":"2019","journal-title":"Diabetes Technol Ther"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00116-X_bib144","first-page":"S83","article-title":"6. Glycemic targets: standards of medical care in diabetes-2022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib145","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1056\/NEJMoa1509351","article-title":"Home use of an artificial beta cell in type 1 diabetes","volume":"373","author":"Thabit","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib146","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S2213-8587(17)30001-3","article-title":"Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study","volume":"5","author":"Bally","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00116-X_bib147","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/dom.14355","article-title":"Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: a double-blind, multicentre, multinational, randomized, crossover study","volume":"23","author":"Boughton","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00116-X_bib148","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1089\/dia.2019.0011","article-title":"Successful at-home use of the tandem Control-IQ artificial pancreas system in young children during a randomized controlled trial","volume":"21","author":"Forlenza","year":"2019","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(23)00116-X_bib149","doi-asserted-by":"crossref","first-page":"844","DOI":"10.2337\/dc20-1809","article-title":"Diabeloop DBLG1 closed-loop system enables patients with type 1 diabetes to significantly improve their glycemic control in real-life situations without serious adverse events: 6-month follow-up","volume":"44","author":"Amadou","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00116-X_bib150","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S0140-6736(20)32514-9","article-title":"A comparison of two hybrid closed-loop systems in adolescents and young adults with type 1 diabetes (FLAIR): a multicentre, randomised, crossover trial","volume":"397","author":"Bergenstal","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00116-X_bib151","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15072","article-title":"Healthcare professionals' views about how pregnant women can benefit from using a closed-loop system: qualitative study","volume":"40","author":"Lawton","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00116-X_bib152","doi-asserted-by":"crossref","first-page":"118","DOI":"10.2337\/ds18-0035","article-title":"\u201cDiabetes just tends to take over everything\u201d: experiences of support and barriers to diabetes management for pregnancy in women with type 1 diabetes","volume":"32","author":"Singh","year":"2019","journal-title":"Diabetes Spectr"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(23)00230-9","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872300116X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872300116X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:20Z","timestamp":1761992000000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872300116X"}},"issued":{"date-parts":[[2023,7]]},"references-count":150,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S221385872300116X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00116-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of type 1 diabetes in pregnancy: update on lifestyle, pharmacological treatment, and novel technologies for achieving glycaemic targets","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00116-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T01:50:11Z","timestamp":1794361811468,"version":"4.9.0"},"reference-count":108,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013120","name":"European Medicines Agency","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013120","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000901","name":"Juvenile Diabetes Research Foundation International","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000901","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010376","name":"American Association of Clinical Endocrinologists","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010376","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004329","name":"Agencija za raziskovalno dejavnost Republike Slovenije","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004329","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007885","name":"European Association for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007885","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008644","name":"Japan Diabetes Society","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008644","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/s2213-8587(22)00319-9","type":"journal-article","created":{"date-parts":[[2022,12,6]],"date-time":"2022-12-06T08:01:40Z","timestamp":1670313700000},"page":"42-57","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":819,"title":["Continuous glucose monitoring and metrics for clinical trials: an international consensus statement"],"prefix":"10.1016","volume":"11","author":[{"given":"Tadej","family":"Battelino","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles M","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie A","family":"Amiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo","family":"Arreaza-Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy W","family":"Beck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M","family":"Bergenstal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce A","family":"Buckingham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Carroll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Chow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pratik","family":"Choudhary","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Close","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Danne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjoy","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Gabbay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satish","family":"Garg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Heverly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irl B","family":"Hirsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Kader","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Kovatchev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Laffel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Maahs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chantal","family":"Mathieu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00eddac","family":"Mauricio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Revital","family":"Nimri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rimei","family":"Nishimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mauro","family":"Scharf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Del Prato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Renard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Banshi","family":"Saboo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohjiro","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillermo E","family":"Umpierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart A","family":"Weinzimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Phillip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00319-9_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1136\/bmj.321.7258.405","article-title":"Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study","volume":"321","author":"Stratton","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00319-9_bib2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00319-9_bib3","doi-asserted-by":"crossref","first-page":"530","DOI":"10.2337\/diab.35.5.530","article-title":"The Diabetes Control and Complications Trial (DCCT). Design and methodologic considerations for the feasibility phase","volume":"35","year":"1986","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00319-9_bib4","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.2337\/dc17-1624","volume":"40","author":"Agiostratidou","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib5","doi-asserted-by":"crossref","first-page":"1631","DOI":"10.2337\/dc17-1600","article-title":"International consensus on use of continuous glucose monitoring","volume":"40","author":"Danne","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib6","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib7","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1111\/dom.14504","article-title":"Effect of insulin degludec versus insulin glargine U100 on time in range: SWITCH PRO, a crossover study of basal insulin-treated adults with type 2 diabetes and risk factors for hypoglycaemia","volume":"23","author":"Goldenberg","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(22)00319-9_bib8","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/S2213-8587(21)00245-X","article-title":"Glycaemic management in diabetes: old and new approaches","volume":"10","author":"Ceriello","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib9","doi-asserted-by":"crossref","first-page":"e3815","DOI":"10.1210\/clinem\/dgaa486","article-title":"Glycemic variability: the danger of a physiologically stable metric","volume":"105","author":"Battelino","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00319-9_bib10","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1001\/jama.2016.19976","article-title":"Continuous glucose monitoring vs conventional therapy for glycemic control in adults with type 1 diabetes treated with multiple daily insulin injections: the GOLD randomized clinical trial","volume":"317","author":"Lind","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00319-9_bib11","doi-asserted-by":"crossref","first-page":"538","DOI":"10.2337\/dc16-2482","article-title":"REPLACE-BG: a randomized trial comparing continuous glucose monitoring with and without routine blood glucose monitoring in adults with well-controlled type 1 diabetes","volume":"40","author":"Aleppo","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib12","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1001\/jama.2016.19975","article-title":"Effect of continuous glucose monitoring on glycemic control in adults with type 1 diabetes using insulin injections: the DIAMOND randomized clinical trial","volume":"317","author":"Beck","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00319-9_bib13","doi-asserted-by":"crossref","first-page":"37","DOI":"10.2337\/dc19-0888","article-title":"Glycemic outcomes in adults with t1d are impacted more by continuous glucose monitoring than by insulin delivery method: 3 years of follow-up from the COMISAIR study","volume":"43","author":"\u0160oupal","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib14","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/pedi.12735","article-title":"Outcomes of using flash glucose monitoring technology by children and young people with type 1 diabetes in a single arm study","volume":"19","author":"Campbell","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(22)00319-9_bib15","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1056\/NEJMoa2205650","article-title":"Intermittently scanned glucose monitoring for type 1 diabetes","volume":"387","author":"Leelarathna","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00319-9_bib16","doi-asserted-by":"crossref","first-page":"3155","DOI":"10.1007\/s00125-012-2708-9","article-title":"The use and efficacy of continuous glucose monitoring in type 1 diabetes treated with insulin pump therapy: a randomised controlled trial","volume":"55","author":"Battelino","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00319-9_bib17","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2337\/dc09-1502","article-title":"Effectiveness of continuous glucose monitoring in a clinical care environment: evidence from the Juvenile Diabetes Research Foundation continuous glucose monitoring (JDRF-CGM) trial","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib18","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1001\/jama.2021.7444","article-title":"Effect of continuous glucose monitoring on glycemic control in patients with type 2 diabetes treated with basal insulin: a randomized clinical trial","volume":"325","author":"Martens","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00319-9_bib19","doi-asserted-by":"crossref","first-page":"365","DOI":"10.7326\/M16-2855","article-title":"Continuous glucose monitoring versus usual care in patients with type 2 diabetes receiving multiple daily insulin injections: a randomized trial","volume":"167","author":"Beck","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(22)00319-9_bib20","doi-asserted-by":"crossref","first-page":"184","DOI":"10.2337\/ds20-0069","article-title":"Use of flash continuous glucose monitoring is associated with A1C reduction in people with type 2 diabetes treated with basal insulin or noninsulin therapy","volume":"34","author":"Wright","year":"2021","journal-title":"Diabetes Spectr"},{"key":"10.1016\/S2213-8587(22)00319-9_bib21","doi-asserted-by":"crossref","first-page":"e001115","DOI":"10.1136\/bmjdrc-2019-001115","article-title":"Flash glucose monitoring helps achieve better glycemic control than conventional self-monitoring of blood glucose in non-insulin-treated type 2 diabetes: a randomized controlled trial","volume":"8","author":"Wada","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib22","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(16)31535-5","article-title":"Novel glucose-sensing technology and hypoglycaemia in type 1 diabetes: a multicentre, non-masked, randomised controlled trial","volume":"388","author":"Bolinder","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00319-9_bib23","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1007\/s13300-016-0223-6","article-title":"Flash glucose-sensing technology as a replacement for blood glucose monitoring for the management of insulin-treated type 2 diabetes: a multicenter, open-label randomized controlled trial","volume":"8","author":"Haak","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib24","doi-asserted-by":"crossref","first-page":"947","DOI":"10.1007\/s13300-017-0281-4","article-title":"Hypoglycemic event frequency and the effect of continuous glucose monitoring in adults with type 1 diabetes using multiple daily insulin injections","volume":"8","author":"Riddlesworth","year":"2017","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib25","doi-asserted-by":"crossref","first-page":"108106","DOI":"10.1016\/j.jdiacomp.2021.108106","article-title":"Randomized comparison of self-monitored blood glucose (BGM) versus continuous glucose monitoring (CGM) data to optimize glucose control in type 2 diabetes","volume":"36","author":"Bergenstal","year":"2022","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(22)00319-9_bib26","doi-asserted-by":"crossref","first-page":"3123","DOI":"10.3390\/ijerph18063123","article-title":"Flash glucose monitoring and patient satisfaction: a meta-review of systematic reviews","volume":"18","author":"D\u00edez-Fern\u00e1ndez","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(22)00319-9_bib27","doi-asserted-by":"crossref","first-page":"S35","DOI":"10.1089\/dia.2020.0666","article-title":"Change in hemoglobin A1c and quality of life with real-time continuous glucose monitoring use by people with insulin-treated diabetes in the landmark study","volume":"23","author":"Gilbert","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib28","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/dc17-0133","article-title":"The impact of continuous glucose monitoring on markers of quality of life in adults with type 1 diabetes: further findings from the DIAMOND randomized clinical trial","volume":"40","author":"Polonsky","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib29","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1210\/jc.2017-02498","article-title":"Effect of continuous glucose monitoring on glycemic control, acute admissions, and quality of life: a real-world study","volume":"103","author":"Charleer","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00319-9_bib30","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc19-1610","article-title":"Quality of life and glucose control after 1 year of nationwide reimbursement of intermittently scanned continuous glucose monitoring in adults living with type 1 diabetes (FUTURE): a prospective observational real-world cohort study","volume":"43","author":"Charleer","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib31","doi-asserted-by":"crossref","first-page":"1368","DOI":"10.2337\/dc20-1690","article-title":"Important drop in rate of acute diabetes complications in people with type 1 or type 2 diabetes after initiation of flash glucose monitoring in France: the RELIEF study","volume":"44","author":"Roussel","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib32","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1089\/dia.2022.0085","article-title":"Reduced rate of acute diabetes events with flash glucose monitoring is sustained for two-years after initiation: extended outcomes from the RELIEF study","volume":"24","author":"Riveline","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib33","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/dia.2021.0374","article-title":"Continuous glucose monitoring for type 2 diabetes: how does it compare with type 1 diabetes?","volume":"24","author":"Beck","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib34","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00125-017-4463-4","article-title":"Improving the clinical value and utility of CGM systems: issues and recommendations: a joint statement of the European Association for the Study of Diabetes and the American Diabetes Association Diabetes Technology Working Group","volume":"60","author":"Petrie","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00319-9_bib35","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/dia.2017.0054","article-title":"Role of continuous glucose monitoring in clinical trials: recommendations on reporting","volume":"19","author":"Schnell","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib36","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1177\/1932296818812062","article-title":"Measures of accuracy for continuous glucose monitoring and blood glucose monitoring devices","volume":"13","author":"Freckmann","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib37","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1089\/dia.2014.0378","article-title":"The performance and usability of a factory-calibrated flash glucose monitoring system","volume":"17","author":"Bailey","year":"2015","journal-title":"Diabetes Technol Ther"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(22)00319-9_bib38","first-page":"S85","article-title":"Diabetes technology: standards of medical care in diabetes\u20142021","volume":"44","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib39","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1177\/1932296820958754","article-title":"Accuracy of a 14-day factory-calibrated continuous glucose monitoring system with advanced algorithm in pediatric and adult population with diabetes","volume":"16","author":"Alva","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib40","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1089\/dia.2018.0143","article-title":"Performance of a factory-calibrated real-time continuous glucose monitoring system utilizing an automated sensor applicator","volume":"20","author":"Shah","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib41","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1089\/dia.2017.0087","article-title":"Accuracy of a fourth-generation subcutaneous continuous glucose sensor","volume":"19","author":"Christiansen","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib42","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2337\/dc16-1525","article-title":"Accuracy and longevity of an implantable continuous glucose sensor in the PRECISE Study: a 180-day, prospective, multicenter, pivotal trial","volume":"40","author":"Kropff","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib43","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1089\/dia.2022.0011","article-title":"Accuracy and safety of Dexcom G7 continuous glucose monitoring in adults with diabetes","volume":"24","author":"Garg","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib44","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/dia.2021.0182","article-title":"Evaluation of accuracy and safety of the next-generation up to 180-day long-term implantable eversense continuous glucose monitoring system: the PROMISE study","volume":"24","author":"Garg","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib45","doi-asserted-by":"crossref","first-page":"395","DOI":"10.1089\/dia.2018.0150","article-title":"Accuracy of a factory-calibrated, real-time continuous glucose monitoring system during 10 days of use in youth and adults with diabetes","volume":"20","author":"Wadwa","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib46","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1089\/dia.2018.0028","article-title":"Interference assessment of various endogenous and exogenous substances on the performance of the Eversense long-term implantable continuous glucose monitoring system","volume":"20","author":"Lorenz","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib47","doi-asserted-by":"crossref","first-page":"e158","DOI":"10.2337\/dc15-1096","article-title":"Effect of acetaminophen on CGM glucose in an outpatient setting","volume":"38","author":"Maahs","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib48","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1177\/19322968211065065","article-title":"Interferences with CGM systems: practical relevance?","volume":"16","author":"Heinemann","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib49","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1089\/dia.2021.0014","article-title":"Sustainable use of a real-time continuous glucose monitoring system from 2018 to 2020","volume":"23","author":"van der Linden","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib50","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1177\/1932296820911919","article-title":"Review of the long-term implantable Senseonics continuous glucose monitoring system and other continuous glucose monitoring systems","volume":"15","author":"Joseph","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40200-015-0172-z","article-title":"Patient perspectives on self-monitoring of blood glucose: perceived recommendations, behaviors and barriers in a clinic sample of adults with type 2 diabetes","volume":"14","author":"Ward","year":"2015","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/S2213-8587(22)00319-9_bib52","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1373\/clinchem.2014.236760","article-title":"Performance of 10 systems for self-monitoring of blood glucose by trained healthcare professionals and in the hands of the users","volume":"61","author":"S\u00f8lvik","year":"2015","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(22)00319-9_bib53","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1089\/dia.2018.0142","article-title":"A new era in continuous glucose monitoring: Food and Drug Administration creates a new category of factory-calibrated nonadjunctive, interoperable class II medical devices","volume":"20","author":"Garg","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib54","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.1089\/dia.2021.0236","article-title":"Landscape of continuous glucose monitoring (CGM) and integrated CGM: accuracy considerations","volume":"23","author":"Bailey","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib55","article-title":"Consensus recommendations for the use of automated insulin delivery (AID) technologies in clinical practice","author":"Phillip","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(22)00319-9_bib56","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1177\/1479164118756240","article-title":"Accuracy of flash glucose monitoring and continuous glucose monitoring technologies: implications for clinical practice","volume":"15","author":"Ajjan","year":"2018","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/S2213-8587(22)00319-9_bib57","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1177\/1932296814539589","article-title":"The surveillance error grid","volume":"8","author":"Klonoff","year":"2014","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib58","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1177\/1932296819855670","article-title":"Benefits and limitations of MARD as a performance parameter for continuous glucose monitoring in the interstitial space","volume":"14","author":"Heinemann","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib59","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S2213-8587(17)30217-6","article-title":"Effect of initiating use of an insulin pump in adults with type 1 diabetes using multiple daily insulin injections and continuous glucose monitoring (DIAMOND): a multicentre, randomised controlled trial","volume":"5","author":"Beck","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib60","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1016\/j.jcjd.2022.02.003","article-title":"Randomized comparison of initiating the fixed-ratio combination of iGlarLixi or biosimilar insulin glargine together with gliclazide in participants of south Asian origin with type 2 diabetes: VARIATION 2 SA trial","volume":"46","author":"Bajaj","year":"2022","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(22)00319-9_bib61","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1111\/jdi.13327","article-title":"Effect of the FreeStyle Libre flash glucose monitoring system on glycemic control in individuals with type 2 diabetes treated with basal-bolus insulin therapy: an open label, prospective, multicenter trial in Japan","volume":"12","author":"Ogawa","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(22)00319-9_bib63","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1177\/1932296820948544","article-title":"Effect of repeated doses of acetaminophen on a continuous glucose monitoring system with permselective membrane","volume":"15","author":"Denham","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib64","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.diabres.2017.12.015","article-title":"Real-world flash glucose monitoring patterns and associations between self-monitoring frequency and glycaemic measures: a European analysis of over 60 million glucose tests","volume":"137","author":"Dunn","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(22)00319-9_bib65","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/j.eprac.2021.11.001","article-title":"Basal Insulin degludec and glycemic control compared to aspart via insulin pump in type 1 diabetes (BIGLEAP): a single-center, open-label, randomized, crossover trial","volume":"28","author":"Lane","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(22)00319-9_bib66","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1111\/dom.13482","article-title":"Closed-loop driven by control-to-range algorithm outperforms threshold-low-glucose-suspend insulin delivery on glucose control albeit not on nocturnal hypoglycaemia in prepubertal patients with type 1 diabetes in a supervised hotel setting","volume":"21","author":"Renard","year":"2019","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(22)00319-9_bib67","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.2337\/dc18-1581","article-title":"Glucose management indicator (GMI): a new term for estimating A1C from continuous glucose monitoring","volume":"41","author":"Bergenstal","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib68","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1089\/dia.2020.0501","article-title":"HbA1c and glucose management indicator discordance: a real-world analysis","volume":"23","author":"Perlman","year":"2021","journal-title":"Diabetes Technol Ther"},{"issue":"suppl 27","key":"10.1016\/S2213-8587(22)00319-9_bib69","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1111\/pedi.12737","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: glycemic control targets and glucose monitoring for children, adolescents, and young adults with diabetes","volume":"19","author":"DiMeglio","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(22)00319-9_bib70","doi-asserted-by":"crossref","first-page":"109784","DOI":"10.1016\/j.diabres.2022.109784","article-title":"Switching from predictive low glucose suspend to advanced hybrid closed loop control: effects on glucose control and patient reported outcomes","volume":"185","author":"Boscari","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(22)00319-9_bib71","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1016\/S2213-8587(22)00077-8","volume":"10","author":"Battelino","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib72","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/dia.2017.0455","article-title":"Optimal sampling duration for continuous glucose monitoring to determine long-term glycemic control","volume":"20","author":"Riddlesworth","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib73","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1089\/dia.2020.0011","article-title":"Baseline glucose variability and interweek variability affects the time to stability of continuous glucose monitoring-derived glycemic indices","volume":"22","author":"Rama Chandran","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib74","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1089\/dia.2020.0387","article-title":"Robust determination of the optimal continuous glucose monitoring length of intervention to evaluate long-term glycemic control","volume":"23","author":"Herrero","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib75","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/dme.13696","article-title":"Comparison of continuous and flash glucose monitoring in type 1 diabetes: methodological inconsistency precludes hypoglycaemia conclusions","volume":"35","author":"Seibold","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(22)00319-9_bib76","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.1111\/dme.13785","article-title":"Reply to Seibold and Schlaeger: comparison of continuous and flash glucose monitoring in type 1 diabetes: methodological inconsistency precludes hypoglycaemia conclusions","volume":"35","author":"Oliver","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(22)00319-9_bib77","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1089\/dia.2010.0156","article-title":"Optimal sampling intervals to assess long-term glycemic control using continuous glucose monitoring","volume":"13","author":"Xing","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib78","doi-asserted-by":"crossref","first-page":"2446","DOI":"10.1111\/dom.14483","article-title":"Design of clinical trials to assess diabetes treatment: minimum duration of continuous glucose monitoring data to estimate time-in-ranges with the desired precision","volume":"23","author":"Camerlingo","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(22)00319-9_bib79","doi-asserted-by":"crossref","first-page":"2609","DOI":"10.1007\/s00125-021-05568-3","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"64","author":"Holt","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00319-9_bib80","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1089\/dia.2022.0130","article-title":"Real-time continuous glucose monitoring can predict severe hypoglycemia in people with type 1 diabetes: combined analysis of the HypoDE and DIAMOND trials","volume":"24","author":"Hermanns","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib81","doi-asserted-by":"crossref","first-page":"4356","DOI":"10.1210\/jc.2018-02763","article-title":"Continuous glucose monitoring profiles in healthy nondiabetic participants: a multicenter prospective study","volume":"104","author":"Shah","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00319-9_bib82","doi-asserted-by":"crossref","first-page":"697","DOI":"10.2337\/diacare.17.7.697","article-title":"Frequency of severe hypoglycemia in patients with type I diabetes with impaired awareness of hypoglycemia","volume":"17","author":"Gold","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib83","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc09-9032","article-title":"Hyperglycemic crises in adult patients with diabetes","volume":"32","author":"Kitabchi","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib84","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2337\/dc18-1444","article-title":"Validation of time in range as an outcome measure for diabetes clinical trials","volume":"42","author":"Beck","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib85","doi-asserted-by":"crossref","first-page":"2370","DOI":"10.2337\/dc18-1131","article-title":"Association of time in range, as assessed by continuous glucose monitoring, with diabetic retinopathy in type 2 diabetes","volume":"41","author":"Lu","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib86","doi-asserted-by":"crossref","first-page":"108289","DOI":"10.1016\/j.diabres.2020.108289","article-title":"TIR generated by continuous glucose monitoring is associated with peripheral nerve function in type 2 diabetes","volume":"166","author":"Li","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(22)00319-9_bib87","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1111\/jdi.13394","article-title":"Association of time in range, as assessed by continuous glucose monitoring, with painful diabetic polyneuropathy","volume":"12","author":"Yang","year":"2021","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(22)00319-9_bib88","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1089\/dia.2019.0251","article-title":"Time in range is associated with carotid intima-media thickness in type 2 diabetes","volume":"22","author":"Lu","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib89","doi-asserted-by":"crossref","first-page":"549","DOI":"10.2337\/dc20-1862","article-title":"Time in range in relation to all-cause and cardiovascular mortality in patients with type 2 diabetes: a prospective cohort study","volume":"44","author":"Lu","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib90","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1089\/dia.2022.0104","article-title":"Essential continuous glucose monitoring metrics: the principal dimensions of glycemic control in diabetes","volume":"24","author":"Montaser","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib91","doi-asserted-by":"crossref","first-page":"2993","DOI":"10.1007\/s13300-021-01153-4","article-title":"Effectiveness and safety of insulin glargine 300 U\/ml in comparison with insulin degludec 100 U\/ml evaluated with continuous glucose monitoring in adults with type 1 diabetes and suboptimal glycemic control in routine clinical practice: the OneCARE study","volume":"12","author":"Conget","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib92","article-title":"CGM-based time-in-range using insulin glargine 300 Units\/mL versus insulin degludec 100 Units\/mL in type 1 diabetes: the head-to-head randomized controlled InRange trial","author":"Battelino","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(22)00319-9_bib93","doi-asserted-by":"crossref","first-page":"194","DOI":"10.2337\/dc21-1593","article-title":"A randomized crossover trial comparing glucose control during moderate-intensity, high-intensity, and resistance exercise with hybrid closed-loop insulin delivery while profiling potential additional signals in adults with type 1 diabetes","volume":"45","author":"Paldus","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib94","doi-asserted-by":"crossref","first-page":"381","DOI":"10.2337\/dc21-1667","article-title":"Closed-loop insulin delivery versus sensor-augmented pump therapy in older adults with type 1 diabetes (ORACL): a randomized, crossover trial","volume":"45","author":"McAuley","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib95","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1038\/nrendo.2017.3","article-title":"Metrics for glycaemic control\u2014from HbA1c to continuous glucose monitoring","volume":"13","author":"Kovatchev","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib96","article-title":"A Glycemia Risk Index (GRI) of hypoglycemia and hyperglycemia for continuous glucose monitoring validated by clinician ratings","author":"Klonoff","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib97","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1111\/dom.14638","article-title":"Understanding the clinical implications of differences between GMI and HbA1c","volume":"24","author":"Gomez-Peralta","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(22)00319-9_bib98","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/dc16-1769","article-title":"Toward defining the threshold between low and high glucose variability in diabetes","volume":"40","author":"Monnier","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib99","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2337\/diacare.10.1.111","article-title":"Ambulatory glucose profile: representation of verified self-monitored blood glucose data","volume":"10","author":"Mazze","year":"1987","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00319-9_bib100","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1089\/dia.2013.0051","article-title":"Recommendations for standardizing glucose reporting and analysis to optimize clinical decision making in diabetes: the Ambulatory Glucose Profile (AGP)","volume":"15","author":"Bergenstal","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib101","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1177\/1932296819883032","article-title":"Clinical recommendations for the use of the ambulatory glucose profile in diabetes care","volume":"14","author":"Kr\u00f6ger","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib102","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1177\/19322968211053341","article-title":"More green, less red: how color standardization may facilitate effective use of CGM data","volume":"16","author":"Bergenstal","year":"2022","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib103","doi-asserted-by":"crossref","DOI":"10.1089\/dia.2022.0274","article-title":"The optimal duration of a run-in period to initiate continuous glucose monitoring for a randomized trial","author":"Raghinaru","year":"2022","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00319-9_bib104","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1177\/193229681100500313","article-title":"Metabolic biofouling of glucose sensors in vivo: role of tissue microhemorrhages","volume":"5","author":"Klueh","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib105","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1177\/193229680800200504","article-title":"A review of the foreign-body response to subcutaneously-implanted devices: the role of macrophages and cytokines in biofouling and fibrosis","volume":"2","author":"Kenneth Ward","year":"2008","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib106","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/1097-4636(200101)54:1<69::AID-JBM8>3.0.CO;2-Q","article-title":"Influence of inflammatory cells and serum on the performance of implantable glucose sensors","volume":"54","author":"Gerritsen","year":"2001","journal-title":"J Biomed Mater Res"},{"key":"10.1016\/S2213-8587(22)00319-9_bib107","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1007\/s10544-018-0349-6","article-title":"Real-time intradermal continuous glucose monitoring using a minimally invasive microneedle-based system","volume":"20","author":"Ribet","year":"2018","journal-title":"Biomed Microdevices"},{"key":"10.1016\/S2213-8587(22)00319-9_bib108","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1177\/193229681100500318","article-title":"Biomechanics of the sensor-tissue interface-effects of motion, pressure, and design on sensor performance and foreign body response-part II: examples and application","volume":"5","author":"Helton","year":"2011","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(22)00319-9_bib109","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/0141-5425(89)90097-6","article-title":"Physiological preparation for studying the response of subcutaneously implanted glucose and oxygen sensors","volume":"11","author":"Ertefai","year":"1989","journal-title":"J Biomed Eng"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(24)00001-9","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003199?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003199?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:13Z","timestamp":1761991933000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003199"}},"issued":{"date-parts":[[2023,1]]},"references-count":108,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213858722003199"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00319-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Continuous glucose monitoring and metrics for clinical trials: an international consensus statement","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00319-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:19:41Z","timestamp":1794021581123,"version":"4.8.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2014,12,1]],"date-time":"2014-12-01T00:00:00Z","timestamp":1417392000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,12]]},"DOI":"10.1016\/s2213-8587(14)70200-1","type":"journal-article","created":{"date-parts":[[2014,10,15]],"date-time":"2014-10-15T19:30:38Z","timestamp":1413401438000},"page":"954-962","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":182,"title":["The effect of rate of weight loss on long-term weight management: a randomised controlled trial"],"prefix":"10.1016","volume":"2","author":[{"given":"Katrina","family":"Purcell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Sumithran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke A","family":"Prendergast","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Celestine J","family":"Bouniu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Delbridge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Proietto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70200-1_bib1","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1056\/NEJMoa055643","article-title":"Overweight, obesity, and mortality in a large prospective cohort of persons 50 to 71 years old","volume":"355","author":"Adams","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70200-1_bib2","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1038\/sj.ijo.0800495","article-title":"The treatment and prevention of obesity: a systematic review of the literature","volume":"21","author":"Glenny","year":"1997","journal-title":"Int J Obesity"},{"key":"10.1016\/S2213-8587(14)70200-1_bib3","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1046\/j.1467-789x.2000.00019.x","article-title":"Long-term efficacy of dietary treatment of obesity: a systematic review of studies published between 1931 and 1999","volume":"1","author":"Ayyad","year":"2000","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(14)70200-1_bib6","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1093\/ajcn\/68.4.899","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults: executive summary. Expert Panel on the Identification, Evaluation, and Treatment of Overweight in Adults","volume":"68","author":"Pi-Sunyer","year":"1998","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70200-1_bib7","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1056\/NEJMsa1208051","article-title":"Myths, presumptions, and facts about obesity","volume":"368","author":"Casazza","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70200-1_bib8","doi-asserted-by":"crossref","DOI":"10.1080\/10408398.2014.922044","article-title":"Weighing the evidence of common beliefs in obesity research","author":"Casazza","year":"2014","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/S2213-8587(14)70200-1_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/bmj.314.7073.29","article-title":"Randomised comparison of diets for maintaining obese subjects' weight after major weight loss: ad lib, low fat, high carbohydrate diet v fixed energy intake","volume":"314","author":"Toubro","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70200-1_bib10","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1007\/s12529-010-9092-y","article-title":"The association between rate of initial weight loss and long-term success in obesity treatment: does slow and steady win the race?","volume":"17","author":"Nackers","year":"2010","journal-title":"Int J Behav Med"},{"key":"10.1016\/S2213-8587(14)70200-1_bib11","series-title":"The Australian guide to healthy eating","author":"Smith","year":"1998"},{"key":"10.1016\/S2213-8587(14)70200-1_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1017\/S0007114500001719","article-title":"The use of visual analogue scales to assess motivation to eat in human subjects: a review of their reliability and validity with an evaluation of new hand-held computerized systems for temporal tracking of appetite ratings","volume":"84","author":"Stubbs","year":"2000","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(14)70200-1_bib13","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1111\/j.1467-789X.2008.00547.x","article-title":"Long-term effectiveness of diet-plus-exercise interventions vs diet-only interventions for weight loss: a meta-analysis","volume":"10","author":"Wu","year":"2009","journal-title":"Obesity Rev"},{"key":"10.1016\/S2213-8587(14)70200-1_bib14","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v045.i03","article-title":"MICE: Multivariate imputation by chained equations in R","volume":"45","author":"Buuren","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/S2213-8587(14)70200-1_bib15","series-title":"A language and environment for statisticial computing","year":"2013"},{"key":"10.1016\/S2213-8587(14)70200-1_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1136\/bmj.317.7171.1487","article-title":"Randomised controlled trial of novel, simple, and well supervised weight reducing diets in outpatients","volume":"317","author":"Summerbell","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70200-1_bib19","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S0140-6736(83)91560-X","article-title":"Effect of 3-hydroxybutyrate in obese subjects on very-low-energy diets and during therapeutic starvation","volume":"1","author":"Pawan","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70200-1_bib20","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1038\/oby.2007.516","article-title":"The effects of a low-carbohydrate ketogenic diet and a low-fat diet on mood, hunger, and other self-reported symptoms","volume":"15","author":"McClernon","year":"2007","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(14)70200-1_bib21","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1093\/ajcn\/87.1.44","article-title":"Effects of a high-protein ketogenic diet on hunger, appetite, and weight loss in obese men feeding ad libitum","volume":"87","author":"Johnstone","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70200-1_bib22","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1093\/ajcn\/87.5.1238","article-title":"Effect of weight loss and ketosis on postprandial cholecystokinin and free fatty acid concentrations","volume":"87","author":"Chearskul","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70200-1_bib23","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1038\/ejcn.2013.90","article-title":"Ketosis and appetite-mediating nutrients and hormones after weight loss","volume":"67","author":"Sumithran","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70200-1_bib24","first-page":"4406","article-title":"Relationship of plasma leptin to plasma insulin and adiposity in normal weight and overweight women: effects of dietary fat content and sustained weight loss","volume":"81","author":"Havel","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70200-1_bib25","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1056\/NEJMoa012908","article-title":"Plasma ghrelin levels after diet-induced weight loss or gastric bypass surgery","volume":"346","author":"Cummings","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70200-1_bib26","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1038\/sj.ijo.0801251","article-title":"Appetite after weight loss by energy restriction and a low-fat diet-exercise follow-up","volume":"24","author":"Doucet","year":"2000","journal-title":"Int J Obesity"},{"key":"10.1016\/S2213-8587(14)70200-1_bib27","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","article-title":"Long-term persistence of hormonal adaptations to weight loss","volume":"365","author":"Sumithran","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70200-1_bib28","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199503093321001","article-title":"Changes in energy expenditure resulting from altered body weight","volume":"332","author":"Leibel","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70200-1_bib29","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1038\/oby.2010.316","article-title":"Appetite and endocrine regulators of energy balance after 2 days of energy restriction: insulin, leptin, ghrelin, and DHEA-S","volume":"19","author":"Pasiakos","year":"2011","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(14)70200-1_bib30","doi-asserted-by":"crossref","first-page":"675","DOI":"10.7326\/0003-4819-99-5-675","article-title":"Very low calorie diets: their efficacy, safety, and future","volume":"99","author":"Wadden","year":"1983","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(14)70200-1_bib31","doi-asserted-by":"crossref","first-page":"1401","DOI":"10.1161\/01.CIR.60.6.1401","article-title":"Sudden unexpected death in avid dieters using the liquid-protein-fast diet. Observations in 17 patients and the role of prolonged QT interval","volume":"60","author":"Isner","year":"1979","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(14)70200-1_bib32","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1002\/j.1550-8528.1998.tb00380.x","article-title":"The effects of 46 weeks of very low calorie diet treatment on weight loss and cardiac function \u2013 a case report","volume":"6","author":"Rossner","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/S2213-8587(14)70200-1_bib33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.5694\/j.1326-5377.2008.tb01657.x","article-title":"Safe year-long use of a very-low-calorie diet for the treatment of severe obesity","volume":"188","author":"Sumithran","year":"2008","journal-title":"Med J Aust"},{"key":"10.1016\/S2213-8587(14)70200-1_bib34","first-page":"6","article-title":"Benefits and risks of an intensive very-low-calorie diet program for severe obesity","volume":"87","author":"Anderson","year":"1992","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(14)70200-1_bib35","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1093\/ajcn\/69.2.198","article-title":"Metabolic and weight-loss effects of a long-term dietary intervention in obese patients","volume":"69","author":"Ditschuneit","year":"1999","journal-title":"Am J Clin Nutr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702001?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702001?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,8,25]],"date-time":"2020-08-25T17:20:10Z","timestamp":1598376010000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702001"}},"issued":{"date-parts":[[2014,12]]},"references-count":31,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2014,12]]}},"alternative-id":["S2213858714702001"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70200-1","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725282319.793502542","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of rate of weight loss on long-term weight management: a randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70200-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70153-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T03:16:45Z","timestamp":1794021405261,"version":"4.8.0"},"reference-count":83,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2019,2,1]],"date-time":"2019-02-01T00:00:00Z","timestamp":1548979200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,2]]},"DOI":"10.1016\/s2213-8587(18)30074-3","type":"journal-article","created":{"date-parts":[[2018,7,30]],"date-time":"2018-07-30T18:43:22Z","timestamp":1532976202000},"page":"150-160","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":89,"title":["Blood glucose meters and test strips: global market and challenges to access in low-resource settings"],"prefix":"10.1016","volume":"7","author":[{"given":"Emma Louise","family":"Klatman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia Josephine","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Yakoob","family":"Ahmedani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham David","family":"Ogle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30074-3_bib1","series-title":"IDF Diabetes Atlas","year":"2017"},{"key":"10.1016\/S2213-8587(18)30074-3_bib3","author":"Mendosa"},{"key":"10.1016\/S2213-8587(18)30074-3_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.diabres.2012.10.001","article-title":"Global guideline for type 2 diabetes","volume":"104","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30074-3_bib5","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archinternmed.2009.193","volume":"169","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(18)30074-3_bib6","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/db15-1517","article-title":"Risk factors for cardiovascular disease in type 1 diabetes","volume":"65","year":"2016","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30074-3_bib7","first-page":"1","article-title":"Standards of medical care in diabetes\u20142017","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"issue":"suppl 20","key":"10.1016\/S2213-8587(18)30074-3_bib8","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1111\/pedi.12190","article-title":"Assessment and monitoring of glycemic control in children and adolescents with diabetes","volume":"15","author":"Rewers","year":"2014","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(18)30074-3_bib9","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.2337\/dc12-1770","article-title":"Evidence of a strong association between frequency of self-monitoring of blood glucose and hemoglobin A1c levels in T1D Exchange clinic registry participants","volume":"36","author":"Miller","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30074-3_bib10","doi-asserted-by":"crossref","first-page":"660","DOI":"10.1016\/j.jpeds.2003.12.042","article-title":"Predictors of control of diabetes: monitoring may be the key","volume":"144","author":"Haller","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(18)30074-3_bib11","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1111\/j.1399-5448.2010.00650.x","article-title":"Frequency of SMBG correlates with HbA1c and acute complications in children and adolescents with type 1 diabetes","volume":"12","author":"Ziegler","year":"2011","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(18)30074-3_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.7196\/SAMJ.7686","article-title":"Self-monitoring of blood glucose measurements and glycaemic control in a managed care paediatric type 1 diabetes practice","volume":"105","author":"Davey","year":"2015","journal-title":"S Afr Med J"},{"key":"10.1016\/S2213-8587(18)30074-3_bib13","doi-asserted-by":"crossref","first-page":"1255","DOI":"10.1111\/dme.12236","article-title":"Determinants of self-monitoring of blood glucose in patients with type 1 diabetes: a multi-centre study in Brazil","volume":"30","author":"Gomes","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30074-3_bib14","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1515\/JPEM.2008.21.12.1163","article-title":"Economic family burden of metabolic control in children and adolescents with type 1 diabetes mellitus","volume":"21","author":"Altamirano-Bustamante","year":"2008","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30074-3_bib15","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/s12902-016-0113-y","article-title":"Glycaemic control in type 1 diabetes mellitus among children and adolescents in a resource limited setting in Dar es Salaam\u2014Tanzania","volume":"16","author":"Noorani","year":"2016","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(18)30074-3_bib16","doi-asserted-by":"crossref","first-page":"136","DOI":"10.2337\/diaclin.33.3.136","article-title":"Dynamics, impact, and feasibility of self-monitoring of blood glucose in the rural, resource-constrained setting of western Kenya","volume":"33","author":"Pastakia","year":"2015","journal-title":"Clin Diabetes"},{"key":"10.1016\/S2213-8587(18)30074-3_bib17","doi-asserted-by":"crossref","first-page":"1002","DOI":"10.2337\/dc16-1990","article-title":"Factors associated with diabetes-specific health-related quality of life in youth with type 1 diabetes: the Global TEENs Study","volume":"40","author":"Anderson","year":"2017","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30074-3_bib18","doi-asserted-by":"crossref","first-page":"206","DOI":"10.2337\/db18-206-LB","article-title":"Establishing cost-effectiveness of \u201cacceptable\u201d T1D care in less-resourced countries","volume":"67","author":"Ogle","year":"2018","journal-title":"Diabetes"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30074-3_bib19","first-page":"1","article-title":"Standards of medical care in diabetes\u20142017","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30074-3_bib20","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S0002-9343(01)00742-2","article-title":"Self-monitoring of blood glucose levels and glycemic control: the Northern California Kaiser Permanente Diabetes registry","volume":"111","author":"Karter","year":"2001","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(18)30074-3_bib21","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1177\/1932296817719290","article-title":"Effects of structured versus unstructured self-monitoring of blood glucose on glucose control in patients with non-insulin-treated type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"12","author":"Mannucci","year":"2018","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib22","first-page":"798","article-title":"Glucose self-monitoring in non insulin-treated patients with type 2 diabetes in primary care settings","volume":"5","author":"Young","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(18)30074-3_bib23","article-title":"Self-monitoring of blood glucose in patients with type 2 diabetes mellitus who are not using insulin","volume":"1","author":"Malanda","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(18)30074-3_bib24","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1016\/j.clinthera.2016.02.011","article-title":"Opportunity cost and policy: a utilization review of self-monitoring of blood glucose in Manitoba, Canada","volume":"38","author":"Serwylo","year":"2016","journal-title":"Clin Ther"},{"key":"10.1016\/S2213-8587(18)30074-3_bib25","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1016\/j.diabres.2017.07.001","article-title":"Rational use of blood glucose test strips for self-monitoring in patients with diabetes mellitus: economic impact in the Portuguese healthcare system","volume":"134","author":"Risso","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30074-3_bib26","series-title":"ISO 15197:2013. In vitro diagnostic test systems\u2014requirements for blood-glucose monitoring systems for self-testing in managing diabetes mellitus","year":"2013"},{"key":"10.1016\/S2213-8587(18)30074-3_bib27","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.2337\/diacare.23.8.1143","article-title":"A new consensus error grid to evaluate the clinical significance of inaccuracies in the measurement of blood glucose","volume":"23","author":"Parkes","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30074-3_bib28","series-title":"Blood glucose monitoring test systems for prescription point-of-care use. Guidance for industry and Food and Drug Administration staff","year":"2016"},{"key":"10.1016\/S2213-8587(18)30074-3_bib29","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1177\/1932296815580160","article-title":"Analytical performance requirements for systems for self-monitoring of blood glucose with focus on system accuracy: relevant differences among ISO 15197:2003, ISO 15197:2013, and current FDA recommendations","volume":"9","author":"Freckmann","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib30","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1177\/193229681200600510","article-title":"System accuracy evaluation of 43 blood glucose monitoring systems for self-monitoring of blood glucose according to DIN EN ISO 15197","volume":"6","author":"Freckmann","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib31","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1177\/1932296815584797","article-title":"Performance of cleared blood glucose monitors","volume":"9","author":"Klonoff","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib32","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1177\/193229681300700213","article-title":"Clinical implications and economic impact of accuracy differences among commercially available blood glucose monitoring systems","volume":"7","author":"Budiman","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib33","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1177\/1932296815599551","article-title":"Economic value of improved accuracy for self-monitoring of blood glucose devices for type 1 diabetes in Canada","volume":"10","author":"McQueen","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib34","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1177\/193229681300700117","article-title":"Performance variability of seven commonly used self-monitoring of blood glucose systems: clinical considerations for patients and providers","volume":"7","author":"Brazg","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib35","doi-asserted-by":"crossref","first-page":"1076","DOI":"10.1177\/193229681200600511","article-title":"Lot-to-lot variability of test strips and accuracy assessment of systems for self-monitoring of blood glucose according to ISO 15197","volume":"6","author":"Baumstark","year":"2012","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib36","doi-asserted-by":"crossref","first-page":"1182","DOI":"10.1177\/1932296816644468","article-title":"The quantitative relationship between ISO 15197 accuracy criteria and mean absolute relative difference (MARD) in the evaluation of analytical performance of self-monitoring of blood glucose (SMBG) systems","volume":"10","author":"Pardo","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib37","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1089\/dia.2015.0043","article-title":"Accuracy evaluation of four blood glucose monitoring systems in unaltered blood samples in the low glycemic range and blood samples in the concentration range defined by ISO 15197","volume":"17","author":"Freckmann","year":"2015","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(18)30074-3_bib38","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1177\/1932296814547519","article-title":"Self-monitoring of blood glucose: impact of a time delay between capillary blood sampling and glucose measurement","volume":"8","author":"Freckmann","year":"2014","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib39","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1089\/dia.2016.0341","article-title":"Accuracy evaluation of four blood glucose monitoring systems in the hands of intended users and trained personnel based on ISO 15197 requirements","volume":"19","author":"Freckmann","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(18)30074-3_bib40","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1177\/1932296817693256","article-title":"If SMBG accuracy is critical to patient safety, why are inaccurate meters still on the market?","volume":"11","author":"Parkin","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib41","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1056\/NEJMp1109094","article-title":"Medical devices\u2014balancing regulation and innovation","volume":"365","author":"Curfman","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30074-3_bib42","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1373\/clinchem.2006.068114","article-title":"Results and feasibility of an external quality assessment scheme for self-monitoring of blood glucose","volume":"52","author":"Kristensen","year":"2006","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(18)30074-3_bib43","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1177\/193229681300700123","article-title":"Hematocrit interference of blood glucose meters for patient self-measurement","volume":"7","author":"Ramljak","year":"2013","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib44","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/dme.13194","article-title":"Insulin storage in hot climates without refrigeration: temperature reduction efficacy of clay pots and other techniques","volume":"33","author":"Ogle","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30074-3_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/dia.2006.0051","article-title":"Adverse impact of temperature and humidity on blood glucose monitoring reliability: a pilot study","volume":"9","author":"Haller","year":"2007","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(18)30074-3_bib49","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1089\/152091502320798259","article-title":"Effect of high altitude on blood glucose meter performance","volume":"4","author":"Fink","year":"2002","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(18)30074-3_bib50","first-page":"55","article-title":"Understanding the pharmaceutical value chain","volume":"18","author":"Aitken","year":"2016","journal-title":"Pharm Policy Law"},{"key":"10.1016\/S2213-8587(18)30074-3_bib51","series-title":"International comparison of medicines usage: quantitative analysis","author":"O'Neill","year":"2014"},{"key":"10.1016\/S2213-8587(18)30074-3_bib53","doi-asserted-by":"crossref","first-page":"1219","DOI":"10.1177\/193229680900300530","article-title":"The business of self-monitoring of blood glucose: a market profile","volume":"3","author":"Hughes","year":"2009","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib54","first-page":"90","article-title":"A glucose meter evaluation co-designed with both health professional and consumer input","volume":"126","author":"Thompson","year":"2013","journal-title":"N Z Med J"},{"key":"10.1016\/S2213-8587(18)30074-3_bib55","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2337\/dc15-1264","article-title":"Impact of CMS competitive bidding program on medicare beneficiary safety and access to diabetes testing supplies: a retrospective, longitudinal analysis","volume":"39","author":"Puckrein","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30074-3_bib56","first-page":"252","article-title":"Diabetes and Medicare competitive bidding: the \u2018perfect storm\u2019 for patient harm","volume":"22","author":"Davidson","year":"2016","journal-title":"Am J Manag Care"},{"key":"10.1016\/S2213-8587(18)30074-3_bib57","doi-asserted-by":"crossref","first-page":"1078","DOI":"10.2337\/dc16-0903","article-title":"Reevaluation of CMS' competitive bidding program","volume":"39","author":"Schatz","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30074-3_bib58","doi-asserted-by":"crossref","first-page":"2435","DOI":"10.1016\/j.bios.2004.11.012","article-title":"Home blood glucose sensors: a commercial perspective","volume":"20","author":"Newman","year":"2005","journal-title":"Biosens Bioelectron"},{"key":"10.1016\/S2213-8587(18)30074-3_bib59","first-page":"28","article-title":"Diabetes monitoring in developing countries","volume":"51","author":"Majikela-Dlangamandla","year":"2006","journal-title":"Diabetes Voice"},{"key":"10.1016\/S2213-8587(18)30074-3_bib60","doi-asserted-by":"crossref","first-page":"2317","DOI":"10.1056\/NEJMp1611475","article-title":"Breakthroughs for whom? Global diabetes care and equitable design","volume":"375","author":"Moran-Thomas","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30074-3_bib61","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/dme.12997","article-title":"Financial costs for families of children with type 1 diabetes in lower-income countries","volume":"33","author":"Ogle","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30074-3_bib63","author":"Nundy"},{"key":"10.1016\/S2213-8587(18)30074-3_bib65","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diabres.2010.03.029","article-title":"Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings","volume":"88","author":"Beran","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30074-3_bib66","series-title":"Assessing national capacity for the prevention and control of noncommunicable diseases. report of the 2015 global survey","year":"2016"},{"key":"10.1016\/S2213-8587(18)30074-3_bib68","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/pedi.12296","article-title":"The IDF Life for a Child Program Index of diabetes care for children and youth","volume":"17","author":"Ogle","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(18)30074-3_bib69","doi-asserted-by":"crossref","first-page":"434","DOI":"10.2471\/BLT.12.110387","article-title":"The cost of type 1 diabetes: a nationwide multicentre study in Brazil","volume":"91","author":"Cobas","year":"2013","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(18)30074-3_bib70","doi-asserted-by":"crossref","first-page":"e70567","DOI":"10.1371\/journal.pone.0070567","article-title":"Direct diabetes-related costs in young patients with early-onset, long-lasting type 1 diabetes","volume":"8","author":"B\u00e4chle","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30074-3_bib71","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s13300-012-0007-6","article-title":"Cost of self-monitoring of blood glucose in Canada among patients on an insulin regimen for diabetes","volume":"3","author":"Yeaw","year":"2012","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(18)30074-3_bib72","doi-asserted-by":"crossref","first-page":"21","DOI":"10.18553\/jmcp.2012.18.1.21","article-title":"Cost of self-monitoring of blood glucose in the United States among patients on an insulin regimen for diabetes","volume":"18","author":"Yeaw","year":"2012","journal-title":"J Manag Care Pharm"},{"key":"10.1016\/S2213-8587(18)30074-3_bib73","first-page":"4","article-title":"Universal health coverage and diabetes care affordable to all","volume":"63","author":"Klatman","year":"2017","journal-title":"Diabetes Voice"},{"key":"10.1016\/S2213-8587(18)30074-3_bib74","first-page":"39","article-title":"Structural barriers to coping with type 1 diabetes mellitus in Ghana: experiences of diabetic youth and their families","volume":"46","author":"Kratzer","year":"2012","journal-title":"Ghana Med J"},{"key":"10.1016\/S2213-8587(18)30074-3_bib75","first-page":"14","article-title":"Country report: access to insulin analogs in Bolivia","volume":"63","author":"Villarroel","year":"2017","journal-title":"Diabetes Voice"},{"key":"10.1016\/S2213-8587(18)30074-3_bib79","first-page":"64","article-title":"High direct costs of medical care in patients with type 1 diabetes attending a referral clinic in a government-funded hospital in northern India","volume":"29","author":"Katam","year":"2016","journal-title":"Natl Med J India"},{"key":"10.1016\/S2213-8587(18)30074-3_bib80","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.2337\/diacare.28.9.2136","article-title":"Access to care for patients with insulin-requiring diabetes in developing countries case studies of Mozambique and Zambia","volume":"28","author":"Beran","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30074-3_bib81","first-page":"13","article-title":"Factors associated with self-monitoring of glycaemic control among persons with diabetes in Benin City, Nigeria","volume":"19","author":"Eregie","year":"2011","journal-title":"African J Diabetes Med"},{"key":"10.1016\/S2213-8587(18)30074-3_bib82","author":"Kaplan"},{"key":"10.1016\/S2213-8587(18)30074-3_bib86","first-page":"24","article-title":"Cost and availability of insulin and other diabetes supplies: IDF survey 2002\u20132003","volume":"49","author":"Raab","year":"2004","journal-title":"Diabetes Voice"},{"key":"10.1016\/S2213-8587(18)30074-3_bib87","doi-asserted-by":"crossref","first-page":"477","DOI":"10.2337\/diacare.23.4.477","article-title":"Self-monitoring of blood glucose language and financial barriers in a managed care population with diabetes","volume":"23","author":"Karter","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30074-3_bib88","author":"Niba"},{"key":"10.1016\/S2213-8587(18)30074-3_bib89","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1016\/S2213-8587(13)70172-4","article-title":"Improving diabetes care in resource-poor countries: challenges and opportunities","volume":"1","author":"Atkinson","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(18)30074-3_bib93","first-page":"S3","article-title":"Continuous glucose monitoring: a review of successes, challenges, and opportunities","volume":"18","author":"Rodbard","year":"2016","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(18)30074-3_bib94","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(15)00521-5","article-title":"Constraints and challenges in access to insulin: a global perspective","volume":"4","author":"Beran","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib95","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1177\/1932296815589755","article-title":"A low-cost inkjet-printed glucose test strip system for resource-poor settings","volume":"9","author":"Wilson","year":"2015","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib96","article-title":"Using silk to measure blood sugar","author":"Phadnis","year":"2015","journal-title":"The Hindu"},{"key":"10.1016\/S2213-8587(18)30074-3_bib98","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1464-5491.2010.03053.x","article-title":"The Diabetes UK Mozambique Twinning Programme. Results of improvements in diabetes care in Mozambique: a reassessment 6 years later using the rapid assessment protocol for insulin access","volume":"27","author":"Beran","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30074-3_bib100","doi-asserted-by":"crossref","first-page":"1432","DOI":"10.2337\/db16-0766","article-title":"Type 2 diabetes: demystifying the global epidemic","volume":"66","author":"Unnikrishnan","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30074-3_bib101","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-8587(17)30181-X","article-title":"Diabetes in sub-Saharan Africa: from clinical care to health policy","volume":"5","author":"Atun","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30074-3_bib102","first-page":"1150","article-title":"BRIGHT guidelines on self-monitoring of blood glucose","volume":"30","author":"Basit","year":"2014","journal-title":"Pak J Med Sci"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300743?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300743?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,8,28]],"date-time":"2022-08-28T09:16:29Z","timestamp":1661678189000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300743"}},"issued":{"date-parts":[[2019,2]]},"references-count":83,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2019,2]]}},"alternative-id":["S2213858718300743"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30074-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Blood glucose meters and test strips: global market and challenges to access in low-resource settings","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30074-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T16:04:33Z","timestamp":1794413073596,"version":"4.9.1"},"reference-count":103,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2017,9,1]],"date-time":"2017-09-01T00:00:00Z","timestamp":1504224000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,9]]},"DOI":"10.1016\/s2213-8587(16)30320-5","type":"journal-article","created":{"date-parts":[[2017,1,10]],"date-time":"2017-01-10T01:15:16Z","timestamp":1484010916000},"page":"743-756","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":361,"title":["Key European guidelines for the diagnosis and management of patients with phenylketonuria"],"prefix":"10.1016","volume":"5","author":[{"given":"Francjan J","family":"van Spronsen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemiek MJ","family":"van Wegberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kirsten","family":"Ahring","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amaya","family":"B\u00e9langer-Quintana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nenad","family":"Blau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annet M","family":"Bosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto","family":"Burlina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaime","family":"Campistol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Feillet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Gi\u017cewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan C","family":"Huijbregts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shauna","family":"Kearney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincenzo","family":"Leuzzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francois","family":"Maillot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ania C","family":"Muntau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fritz K","family":"Trefz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Margreet","family":"van Rijn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John H","family":"Walter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30320-5_bib1","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1007\/s10545-007-0644-5","article-title":"Neonatal screening in Europe; the situation in 2004","volume":"30","author":"Loeber","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib2","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1016\/S0140-6736(10)60961-0","article-title":"Phenylketonuria","volume":"376","author":"Blau","year":"2010","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)30320-5_bib3","doi-asserted-by":"crossref","first-page":"S86","DOI":"10.1016\/j.ymgme.2009.10.016","article-title":"Pathogenesis of cognitive dysfunction in phenylketonuria: review of hypotheses","volume":"99","author":"de Groot","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib4","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1542\/peds.2009-3584","article-title":"Challenges and pitfalls in the management of phenylketonuria","volume":"126","author":"Feillet","year":"2010","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)30320-5_bib5","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.ymgme.2010.05.017","article-title":"Suboptimal outcomes in patients with PKU treated early with diet alone: revisiting the evidence","volume":"101","author":"Enns","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib6","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/j.clnu.2009.03.004","article-title":"Dietary management practices in phenylketonuria across European centres","volume":"28","author":"Ahring","year":"2009","journal-title":"Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30320-5_bib7","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.ymgme.2009.09.005","article-title":"Management of phenylketonuria in Europe: survey results from 19 countries","volume":"99","author":"Blau","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib8","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1186\/1750-1172-8-191","article-title":"Requirements for a minimum standard of care for phenylketonuria: the patients' perspective","volume":"8","author":"Hagedorn","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib9","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1007\/s10545-008-0918-6","article-title":"The truth of treating patients with phenylketonuria after childhood: the need for a new guideline","volume":"31","author":"van Spronsen","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib10","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1177\/0148607110375698","article-title":"The broader picture on guideline adherence","volume":"34","author":"Cabana","year":"2010","journal-title":"JPEN J Parenter Enteral Nutr"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(16)30320-5_bib11","doi-asserted-by":"crossref","first-page":"4S","DOI":"10.1378\/chest.118.2_suppl.4S","article-title":"Translating practice guidelines into patient care: guidelines at the bedside","volume":"118","author":"Weingarten","year":"2000","journal-title":"Chest"},{"key":"10.1016\/S2213-8587(16)30320-5_bib12","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/1750-1172-7-32","article-title":"Suggested guidelines for the diagnosis and management of urea cycle disorders","volume":"7","author":"Haberle","year":"2012","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib13","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1093\/oxfordjournals.pubmed.a024777","article-title":"A systematic review of evidence for the appropriateness of neonatal screening programmes for inborn errors of metabolism","volume":"20","author":"Thomason","year":"1998","journal-title":"J Public Health Med"},{"key":"10.1016\/S2213-8587(16)30320-5_bib14","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1136\/adc.65.5.472","article-title":"Intelligence and quality of dietary treatment in phenylketonuria","volume":"65","author":"Smith","year":"1990","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(16)30320-5_bib15","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1469-8749.2010.03869.x","article-title":"Neurocognitive function in mild hyperphenylalaninemia","volume":"53","author":"Campistol","year":"2011","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/S2213-8587(16)30320-5_bib16","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s10545-011-9283-y","article-title":"Mild hyperphenylalaninemia: to treat or not to treat","volume":"34","author":"van Spronsen","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib17","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1203\/00006450-200104000-00015","article-title":"Normal clinical outcome in untreated subjects with mild hyperphenylalaninemia","volume":"49","author":"Weglage","year":"2001","journal-title":"Pediatr Res"},{"key":"10.1016\/S2213-8587(16)30320-5_bib18","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ymgme.2007.05.006","article-title":"Phenylalanine blood levels and clinical outcomes in phenylketonuria: a systematic literature review and meta-analysis","volume":"92","author":"Waisbren","year":"2007","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib19","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1007\/s10545-012-9564-0","article-title":"Estimating the probability of IQ impairment from blood phenylalanine for phenylketonuria patients: a hierarchical meta-analysis","volume":"36","author":"Fonnesbeck","year":"2013","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib20","first-page":"35","article-title":"Intellectual development in 12-year-old children treated for phenylketonuria","volume":"145","author":"Azen","year":"1991","journal-title":"Am J Dis Child"},{"key":"10.1016\/S2213-8587(16)30320-5_bib21","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/BF00477051","article-title":"Termination of dietary treatment in phenylketonuria","volume":"126","author":"Cabalska","year":"1977","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(16)30320-5_bib22","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1023\/A:1020158631102","article-title":"Phenylketonuria in adulthood: a collaborative study","volume":"25","author":"Koch","year":"2002","journal-title":"J Inherit Metab Dis"},{"issue":"suppl","key":"10.1016\/S2213-8587(16)30320-5_bib23","doi-asserted-by":"crossref","first-page":"S44","DOI":"10.1016\/j.ymgme.2013.08.013","article-title":"Neurocognitive functioning in adults with phenylketonuria: results of a long term study","volume":"110","author":"Weglage","year":"2013","journal-title":"Mol Genet Metab"},{"issue":"suppl","key":"10.1016\/S2213-8587(16)30320-5_bib24","doi-asserted-by":"crossref","first-page":"S45","DOI":"10.1016\/j.ymgme.2011.09.036","article-title":"Cognitive, neurophysiological, neurological and psychosocial outcomes in early-treated PKU-patients: a start toward standardized outcome measurement across development","volume":"104","author":"van Spronsen","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib25","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neurol.2013.09.012","article-title":"Progressive neuropsychiatric manifestations of phenylketonuria in adulthood","volume":"170","author":"Daelman","year":"2014","journal-title":"Rev Neurol (Paris)"},{"key":"10.1016\/S2213-8587(16)30320-5_bib26","first-page":"2013","article-title":"Neurological improvement following reinstitution of a low phenylalanine diet after 20 years in established phenylketonuria","author":"Anwar","year":"2013","journal-title":"BMJ Case Rep"},{"key":"10.1016\/S2213-8587(16)30320-5_bib27","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/8904_2012_207","article-title":"Sight-threatening phenylketonuric encephalopathy in a young adult, reversed by diet","volume":"10","author":"Rubin","year":"2013","journal-title":"JIMD Rep"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(16)30320-5_bib28","doi-asserted-by":"crossref","first-page":"S415","DOI":"10.1007\/s10545-008-0978-7","article-title":"Quality of life in noncompliant adults with phenylketonuria after resumption of the diet","volume":"31","author":"Bik-Multanowski","year":"2008","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib29","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1111\/j.1651-2227.2003.tb00834.x","article-title":"Do adult patients with phenylketonuria improve their quality of life after introduction\/resumption of a phenylalanine-restricted diet?","volume":"92","author":"Gassio","year":"2003","journal-title":"Acta Paediatr"},{"key":"10.1016\/S2213-8587(16)30320-5_bib30","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1186\/s13023-015-0294-x","article-title":"Assessment of the impact of phenylketonuria and its treatment on quality of life of patients and parents from seven European countries","volume":"10","author":"Bosch","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1186\/s13023-015-0261-6","article-title":"Development and psychometric validation of measures to assess the impact of phenylketonuria and its dietary treatment on patients' and parents' quality of life: the phenylketonuria\u2014quality of life (PKU-QOL) questionnaires","volume":"10","author":"Regnault","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib32","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1016\/j.neubiorev.2008.11.001","article-title":"Neuropsychological speed tests and blood phenylalanine levels in patients with phenylketonuria: a meta-analysis","volume":"33","author":"Albrecht","year":"2009","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/S2213-8587(16)30320-5_bib33","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1007\/BF01957228","article-title":"White matter abnormalities in patients with treated hyperphenylalaninaemia: magnetic resonance relaxometry and proton spectroscopy findings","volume":"152","author":"Bick","year":"1993","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(16)30320-5_bib34","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1148\/radiol.2362040611","article-title":"Diffusion-weighted MR imaging in patients with phenylketonuria: relationship between serum phenylalanine levels and ADC values in cerebral white matter","volume":"236","author":"Kono","year":"2005","journal-title":"Radiology"},{"key":"10.1016\/S2213-8587(16)30320-5_bib35","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/S0140-6736(94)91281-5","article-title":"Magnetic resonance imaging of the brain in phenylketonuria","volume":"344","author":"Cleary","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30320-5_bib36","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1007\/s00234-009-0574-z","article-title":"Brain MRI diffusion-weighted imaging in patients with classical phenylketonuria","volume":"51","author":"Manara","year":"2009","journal-title":"Neuroradiology"},{"key":"10.1016\/S2213-8587(16)30320-5_bib37","doi-asserted-by":"crossref","first-page":"i","DOI":"10.2307\/1166208","article-title":"Prefrontal cortex cognitive deficits in children treated early and continuously for PKU","volume":"62","author":"Diamond","year":"1997","journal-title":"Monogr Soc Res Child Dev"},{"key":"10.1016\/S2213-8587(16)30320-5_bib38","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1023\/B:BOLI.0000028781.94251.1f","article-title":"Executive function impairment in early-treated PKU subjects with normal mental development","volume":"27","author":"Leuzzi","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib39","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0149-7634(02)00040-4","article-title":"The neuropsychological profile of early and continuously treated phenylketonuria: orienting, vigilance, and maintenance versus manipulation-functions of working memory","volume":"26","author":"Huijbregts","year":"2002","journal-title":"Neurosci Biobehav Rev"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)30320-5_bib40","doi-asserted-by":"crossref","first-page":"S82","DOI":"10.1007\/PL00014258","article-title":"Effects of concurrent phenylalanine levels on sustained attention and calculation speed in patients treated early for phenylketonuria","volume":"155","author":"Schmidt","year":"1996","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(16)30320-5_bib41","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1016\/j.jpeds.2013.12.015","article-title":"Neurocognitive evidence for revision of treatment targets and guidelines for phenylketonuria","volume":"164","author":"Jahja","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(16)30320-5_bib42","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1007\/s10545-010-9253-9","article-title":"High phenylalanine levels directly affect mood and sustained attention in adults with phenylketonuria: a randomised, double-blind, placebo-controlled, crossover trial","volume":"34","author":"ten Hoedt","year":"2011","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib43","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.ymgme.2008.12.019","article-title":"Phenylketonuria: high plasma phenylalanine decreases cerebral protein synthesis","volume":"96","author":"Hoeksma","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib44","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1016\/j.ymgme.2011.03.019","article-title":"Experimental evidence that phenylalanine is strongly associated to oxidative stress in adolescents and adults with phenylketonuria","volume":"103","author":"Sanayama","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib45","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/gim.2013.157","article-title":"Phenylalanine hydroxylase deficiency: diagnosis and management guideline","volume":"16","author":"Vockley","year":"2014","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(16)30320-5_bib46","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.clinbiochem.2014.09.014","article-title":"Comparison of tandem mass spectrometry and amino acid analyzer for phenylalanine and tyrosine monitoring\u2014implications for clinical management of patients with hyperphenylalaninemia","volume":"48","author":"Groselj","year":"2015","journal-title":"Clin Biochem"},{"key":"10.1016\/S2213-8587(16)30320-5_bib47","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1016\/j.clinbiochem.2013.05.047","article-title":"Simultaneous determination of phenylalanine and tyrosine in peripheral capillary blood by HPLC with ultraviolet detection","volume":"46","author":"Mo","year":"2013","journal-title":"Clin Biochem"},{"key":"10.1016\/S2213-8587(16)30320-5_bib48","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1097\/GIM.0b013e318159a355","article-title":"Blood phenylalanine monitoring for dietary compliance among patients with phenylketonuria: comparison of methods","volume":"9","author":"Gregory","year":"2007","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(16)30320-5_bib49","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1542\/peds.92.4.570","article-title":"Plasma phenylalanine and tyrosine responses to different nutritional conditions (fasting\/postprandial) in patients with phenylketonuria: effect of sample timing","volume":"92","author":"van Spronsen","year":"1993","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)30320-5_bib50","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1136\/adc.74.5.412","article-title":"Factors affecting the variation in plasma phenylalanine in patients with phenylketonuria on diet","volume":"74","author":"MacDonald","year":"1996","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(16)30320-5_bib51","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.ymgme.2008.06.014","article-title":"Stability of blood phenylalanine levels and IQ in children with phenylketonuria","volume":"95","author":"Anastasoaie","year":"2008","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib52","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1016\/j.ymgme.2014.01.012","article-title":"Variability in phenylalanine control predicts IQ and executive abilities in children with phenylketonuria","volume":"111","author":"Hood","year":"2014","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib53","first-page":"60","article-title":"Quality of dietary control in phenylketonuric patients and its relationship with general intelligence","volume":"25","author":"Vilaseca","year":"2010","journal-title":"Nutr Hosp"},{"key":"10.1016\/S2213-8587(16)30320-5_bib54","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1111\/1467-8624.00370","article-title":"Associations between phenylalanine-to-tyrosine ratios and performance on tests of neuropsychological function in adolescents treated early and continuously for phenylketonuria","volume":"72","author":"Luciana","year":"2001","journal-title":"Child Dev"},{"key":"10.1016\/S2213-8587(16)30320-5_bib55","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1080\/87565640903325725","article-title":"A preliminary investigation of the role of the phenylalanine:tyrosine ratio in children with early and continuously treated phenylketonuria: toward identification of \u201csafe\u201d levels","volume":"35","author":"Sharman","year":"2010","journal-title":"Dev Neuropsychol"},{"key":"10.1016\/S2213-8587(16)30320-5_bib56","doi-asserted-by":"crossref","first-page":"916","DOI":"10.1093\/ajcn\/64.6.916","article-title":"Large daily fluctuations in plasma tyrosine in treated patients with phenylketonuria","volume":"64","author":"van Spronsen","year":"1996","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30320-5_bib57","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1016\/j.ymgme.2009.07.016","article-title":"Reassessment of phenylalanine tolerance in adults with phenylketonuria is needed as body mass changes","volume":"98","author":"MacLeod","year":"2009","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib58","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1046\/j.1365-277X.1997.00050.x","article-title":"Abnormal feeding behaviours in phenylketonuria","volume":"10","author":"MacDonald","year":"1997","journal-title":"J Hum Nut Diet"},{"key":"10.1016\/S2213-8587(16)30320-5_bib59","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.ymgme.2012.09.021","article-title":"Long-term treatment with tetrahydrobiopterin in phenylketonuria: treatment strategies and prediction of long-term responders","volume":"107","author":"Hennermann","year":"2012","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib60","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1038\/ejcn.2011.205","article-title":"Unrestricted consumption of fruits and vegetables in phenylketonuria: no major impact on metabolic control","volume":"66","author":"Rohde","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30320-5_bib61","article-title":"Tyrosine supplementation for phenylketonuria","volume":"6","author":"Webster","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(16)30320-5_bib62","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1038\/sj.ejcn.1602866","article-title":"Direct and indirect cellular effects of aspartame on the brain","volume":"62","author":"Humphries","year":"2008","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30320-5_bib63","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1007\/BF00201660","article-title":"Neuropsychological and biochemical investigations in heterozygotes for phenylketonuria during ingestion of high dose aspartame (a sweetener containing phenylalanine)","volume":"93","author":"Trefz","year":"1994","journal-title":"Hum Genet"},{"key":"10.1016\/S2213-8587(16)30320-5_bib64","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1007\/s13197-011-0571-1","article-title":"Artificial sweeteners\u2014a review","volume":"51","author":"Chattopadhyay","year":"2014","journal-title":"J Food Sci Technol"},{"key":"10.1016\/S2213-8587(16)30320-5_bib65","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1007\/s10545-007-0605-z","article-title":"The response of patients with phenylketonuria and elevated serum phenylalanine to treatment with oral sapropterin dihydrochloride (6R-tetrahydrobiopterin): a phase II, multicentre, open-label, screening study","volume":"30","author":"Burton","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib66","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/8904_2012_168","article-title":"A systematic review of BH4 (Sapropterin) for the adjuvant treatment of phenylketonuria","volume":"8","author":"Lindegren","year":"2013","journal-title":"JIMD Rep"},{"key":"10.1016\/S2213-8587(16)30320-5_bib67","article-title":"Sapropterin dihydrochloride for phenylketonuria","volume":"3","author":"Somaraju","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(16)30320-5_bib68","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1750-1172-8-103","article-title":"Tetrahydrobiopterin responsiveness in phenylketonuria: prediction with the 48-hour loading test and genotype","volume":"8","author":"Anjema","year":"2013","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib69","first-page":"613","article-title":"Acute hair loss in phenylketonuria","volume":"23","author":"Donati","year":"2009","journal-title":"JEADV"},{"issue":"suppl","key":"10.1016\/S2213-8587(16)30320-5_bib70","doi-asserted-by":"crossref","first-page":"S66","DOI":"10.1016\/j.ymgme.2013.10.006","article-title":"Man made disease: clinical manifestations of low phenylalanine levels in an inadequately treated phenylketonuria patient and mouse study","volume":"110","author":"Pode-Shakked","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib71","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1159\/000363391","article-title":"The micronutrient status of patients with phenylketonuria on dietary treatment: an ongoing challenge","volume":"65","author":"Evans","year":"2014","journal-title":"Ann Nutr Metab"},{"issue":"suppl","key":"10.1016\/S2213-8587(16)30320-5_bib72","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ymgme.2013.08.008","article-title":"Main issues in micronutrient supplementation in phenylketonuria","volume":"110","author":"Lammardo","year":"2013","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib73","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/0140-6736(93)92047-W","article-title":"Vitamin B12 deficiency in adolescents and young adults with phenylketonuria","volume":"342","author":"Hanley","year":"1993","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30320-5_bib74","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0140-6736(98)10090-9","article-title":"Spastic paraparesis after anaesthesia","volume":"353","author":"Lee","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30320-5_bib75","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13023-015-0232-y","article-title":"Bone health in phenylketonuria: a systematic review and meta-analysis","volume":"10","author":"Demirdas","year":"2015","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib76","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s10545-014-9735-2","article-title":"A systematic review of bone mineral density and fractures in phenylketonuria","volume":"37","author":"Hansen","year":"2014","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib77","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s10571-010-9636-3","article-title":"Evidence that L-carnitine and selenium supplementation reduces oxidative stress in phenylketonuric patients","volume":"31","author":"Sitta","year":"2011","journal-title":"Cell Mol Neurobiol"},{"key":"10.1016\/S2213-8587(16)30320-5_bib78","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2337\/diacare.24.3.561","article-title":"Effectiveness of self-management training in type 2 diabetes: a systematic review of randomized controlled trials","volume":"24","author":"Norris","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30320-5_bib79","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1056\/NEJM198011203032104","article-title":"Maternal phenylketonuria and hyperphenylalaninemia. An international survey of the outcome of untreated and treated pregnancies","volume":"303","author":"Lenke","year":"1980","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30320-5_bib80","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1136\/adc.2003.037762","article-title":"Maternal phenylketonuria: report from the United Kingdom Registry 1978\u201397","volume":"90","author":"Lee","year":"2005","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(16)30320-5_bib81","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1203\/00006450-200105000-00005","article-title":"Congenital heart disease in maternal phenylketonuria: report from the Maternal PKU Collaborative Study","volume":"49","author":"Levy","year":"2001","journal-title":"Pediatr Res"},{"key":"10.1016\/S2213-8587(16)30320-5_bib82","doi-asserted-by":"crossref","first-page":"374","DOI":"10.3945\/ajcn.110.009456","article-title":"Maternal phenylketonuria and hyperphenylalaninemia in pregnancy: pregnancy complications and neonatal sequelae in untreated and treated pregnancies","volume":"95","author":"Prick","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30320-5_bib83","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.jpeds.2003.10.062","article-title":"Effect of high maternal blood phenylalanine on offspring congenital anomalies and developmental outcome at ages 4 and 6 years: the importance of strict dietary control preconception and throughout pregnancy","volume":"144","author":"Rouse","year":"2004","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(16)30320-5_bib84","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1111\/j.1467-8721.2009.01604.x","article-title":"Phenylketonuria in children and mothers: genes, environments, behavior","volume":"18","author":"Widaman","year":"2009","journal-title":"Curr Dir Psychol Sci"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)30320-5_bib85","doi-asserted-by":"crossref","first-page":"S68","DOI":"10.1016\/j.ymgme.2009.10.014","article-title":"Psychosocial issues and outcomes in maternal PKU","volume":"99","author":"Koch","year":"2010","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib86","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s10545-012-9491-0","article-title":"Maternal phenylketonuria: low phenylalaninemia might increase the risk of intra uterine growth retardation","volume":"35","author":"Teissier","year":"2012","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib87","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1016\/S0140-6736(94)90404-9","article-title":"Maternal mild hyperphenylalaninaemia: an international survey of offspring outcome","volume":"344","author":"Levy","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30320-5_bib88","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0002-9378(00)70219-5","article-title":"The international study of pregnancy outcome in women with maternal phenylketonuria: report of a 12-year study","volume":"182","author":"Platt","year":"2000","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(16)30320-5_bib89","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1542\/peds.112.S4.1544","article-title":"Cognitive and behavioral development in maternal phenylketonuria offspring","volume":"112","author":"Waisbren","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)30320-5_bib90","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1111\/j.1651-2227.1991.tb18150.x","article-title":"Management of inborn errors of metabolism during pregnancy","volume":"373","author":"Clark","year":"1991","journal-title":"Acta Paediatr Scand Suppl"},{"key":"10.1016\/S2213-8587(16)30320-5_bib91","doi-asserted-by":"crossref","first-page":"1534","DOI":"10.1542\/peds.112.S4.1534","article-title":"Role of nutrition in pregnancy with phenylketonuria and birth defects","volume":"112","author":"Matalon","year":"2003","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(16)30320-5_bib92","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1023\/B:BOLI.0000028785.20901.d9","article-title":"The resource mothers study of maternal phenylketonuria: preliminary findings","volume":"27","author":"Rohr","year":"2004","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib93","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1007\/s10545-007-0436-y","article-title":"A practical approach to maternal phenylketonuria management","volume":"30","author":"Maillot","year":"2007","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib94","first-page":"e184","article-title":"The management of nausea and vomiting of pregnancy and hyperemesis gravidarum\u2014a 2013 update","volume":"20","author":"Maltepe","year":"2013","journal-title":"J Popul Ther Clin Pharmacol"},{"key":"10.1016\/S2213-8587(16)30320-5_bib95","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1002\/ajmg.10075","article-title":"Late-treated phenylketonuria mimicking Angelman syndrome","volume":"104","author":"Dan","year":"2001","journal-title":"Am J Med Genet"},{"key":"10.1016\/S2213-8587(16)30320-5_bib96","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1016\/j.ymgme.2014.07.020","article-title":"Newborn screening in southeastern Europe","volume":"113","author":"Groselj","year":"2014","journal-title":"Mol Genet Metab"},{"issue":"suppl","key":"10.1016\/S2213-8587(16)30320-5_bib97","doi-asserted-by":"crossref","first-page":"S26","DOI":"10.1016\/j.ymgme.2011.08.025","article-title":"Adult phenylketonuria outcome and management","volume":"104","author":"Trefz","year":"2011","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib98","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1111\/j.1467-8624.2009.01389.x","article-title":"Late-treated phenylketonuria and partial reversibility of intellectual impairment","volume":"81","author":"Grosse","year":"2010","journal-title":"Child Dev"},{"key":"10.1016\/S2213-8587(16)30320-5_bib99","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1006\/mgme.1999.2863","article-title":"Long-term beneficial effects of the phenylalanine-restricted diet in late-diagnosed individuals with phenylketonuria","volume":"67","author":"Koch","year":"1999","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(16)30320-5_bib100","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0140-6736(13)61841-3","article-title":"Single-dose, subcutaneous recombinant phenylalanine ammonia lyase conjugated with polyethylene glycol in adult patients with phenylketonuria: an open-label, multicentre, phase 1 dose-escalation trial","volume":"384","author":"Longo","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30320-5_bib101","doi-asserted-by":"crossref","first-page":"e45165","DOI":"10.1371\/journal.pone.0045165","article-title":"Low bone strength is a manifestation of phenylketonuria in mice and is attenuated by a glycomacropeptide diet","volume":"7","author":"Solverson","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30320-5_bib102","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s10545-008-0952-4","article-title":"Nutritional management of PKU with glycomacropeptide from cheese whey","volume":"32","author":"Ney","year":"2009","journal-title":"J Inherit Metab Dis"},{"key":"10.1016\/S2213-8587(16)30320-5_bib103","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1007\/s10545-005-4478-8","article-title":"Living with phenylketonuria: perspectives of patients and their families","volume":"28","author":"Bilginsoy","year":"2005","journal-title":"J Inherit Metab Dis"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303205?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303205?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,21]],"date-time":"2022-07-21T02:56:19Z","timestamp":1658372179000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303205"}},"issued":{"date-parts":[[2017,9]]},"references-count":103,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2017,9]]}},"alternative-id":["S2213858716303205"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30320-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Key European guidelines for the diagnosis and management of patients with phenylketonuria","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30320-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T17:11:59Z","timestamp":1794503519026,"version":"4.9.1"},"reference-count":74,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008982","name":"Qatar National Research Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008982","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007458","name":"Qatar Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007458","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019460","name":"Weill Cornell Medicine - Qatar","doi-asserted-by":"publisher","award":["10-1208-160017"],"award-info":[{"award-number":["10-1208-160017"]}],"id":[{"id":"10.13039\/100019460","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/s2213-8587(24)00346-2","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T18:38:09Z","timestamp":1740595089000},"page":"294-306","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":62,"title":["Impact of bodyweight loss on type 2 diabetes remission: a systematic review and meta-regression analysis of randomised controlled trials"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3267-4419","authenticated-orcid":false,"given":"Sarah","family":"Kanbour","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rwedah A","family":"Ageeb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-7188-8903","authenticated-orcid":false,"given":"Rayaz A","family":"Malik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-0790-0506","authenticated-orcid":false,"given":"Laith J","family":"Abu-Raddad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00346-2_bib1","series-title":"IDF Diabetes Atlas","year":"2021"},{"key":"10.1016\/S2213-8587(24)00346-2_bib2","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00346-2_bib3","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00346-2_bib4","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.2020.0734","article-title":"US health care spending by payer and health condition, 1996\u20132016","volume":"323","author":"Dieleman","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00346-2_bib5","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00346-2_bib6","doi-asserted-by":"crossref","first-page":"1423","DOI":"10.2337\/dc17-1376","article-title":"Health care spending on diabetes in the US, 1996\u20132013","volume":"41","author":"Squires","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00346-2_bib7","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1186\/s12913-018-3772-8","article-title":"Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review","volume":"18","author":"Afroz","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(24)00346-2_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00346-2_bib9","first-page":"1066","article-title":"Prevalence of overweight and obesity among adults with diagnosed diabetes\u2014United States, 1988\u20131994 and 1999\u20132002","volume":"53","year":"2004","journal-title":"MMWR Morb Mortal Wkly Rep"},{"key":"10.1016\/S2213-8587(24)00346-2_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14669","article-title":"Consensus report: definition and interpretation of remission in type 2 diabetes","volume":"39","author":"Riddle","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00346-2_bib11","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00346-2_bib12","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1111\/dom.14863","article-title":"Semaglutide for the treatment of overweight and obesity: a review","volume":"25","author":"Bergmann","year":"2023","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00346-2_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155531","article-title":"Advances in physiology, design and development of novel medications changing the landscape of obesity pharmacotherapy","volume":"142","author":"Chakhtoura","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(24)00346-2_bib14","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00346-2_bib15","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13098-023-01001-4","article-title":"Metabolic surgery versus usual care effects on diabetes remission: a systematic review and meta-analysis","volume":"15","author":"Mirghani","year":"2023","journal-title":"Diabetol Metab Syndr"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00346-2_bib16","first-page":"S158","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00346-2_bib17","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1016\/S2213-8587(13)70070-6","article-title":"Preoperative prediction of type 2 diabetes remission after Roux-en-Y gastric bypass surgery: a retrospective cohort study","volume":"2","author":"Still","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00346-2_bib18","doi-asserted-by":"crossref","first-page":"2626","DOI":"10.2337\/dc21-0166","article-title":"Prognostic models for predicting remission of diabetes following bariatric surgery: a systematic review and meta-analysis","volume":"44","author":"Singh","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00346-2_bib19","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jama.299.3.316","article-title":"Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial","volume":"299","author":"Dixon","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00346-2_bib20","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1007\/s11695-017-2872-6","article-title":"Laparoscopic sleeve gastrectomy versus banded Roux-en-Y gastric bypass for diabetes and obesity: a prospective randomised double-blind trial","volume":"28","author":"Murphy","year":"2018","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(24)00346-2_bib21","article-title":"Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby)","volume":"9","author":"Sattar","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/S2213-8587(24)00346-2_bib22","series-title":"Cochrane handbook for systematic reviews of interventions","author":"Higgins","year":"2011"},{"key":"10.1016\/S2213-8587(24)00346-2_bib23","doi-asserted-by":"crossref","first-page":"n71","DOI":"10.1136\/bmj.n71","article-title":"The PRISMA 2020 statement: an updated guideline for reporting systematic reviews","volume":"372","author":"Page","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00346-2_bib24","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1001\/jama.2015.3656","article-title":"Preferred Reporting Items for Systematic Review and Meta-Analyses of individual participant data: the PRISMA-IPD Statement","volume":"313","author":"Stewart","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00346-2_bib25","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2021-068791","article-title":"Searching clinical trials registers: guide for systematic reviewers","volume":"377","author":"Hunter","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00346-2_bib26","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"Barba","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00346-2_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109900","article-title":"Roux-en-Y gastric bypass versus best medical treatment for type 2 diabetes mellitus in adults with body mass index between 27 and 32 kg\/m2: a 5-year randomized controlled trial","volume":"188","author":"Cheng","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(24)00346-2_bib28","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1016\/S0140-6736(18)32328-6","article-title":"Effect of lorcaserin on prevention and remission of type 2 diabetes in overweight and obese patients (CAMELLIA-TIMI 61): a randomised, placebo-controlled trial","volume":"392","author":"Bohula","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00346-2_bib29","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1016\/S2213-8587(19)30344-4","article-title":"Gastric bypass versus sleeve gastrectomy in patients with type 2 diabetes (Oseberg): a single-centre, triple-blind, randomised controlled trial","volume":"7","author":"Hofs\u00f8","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00346-2_bib30","doi-asserted-by":"crossref","first-page":"641","DOI":"10.1007\/s13300-021-01032-y","article-title":"What is diabetes remission?","volume":"12","author":"Holst","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(24)00346-2_bib31","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1200111","article-title":"Bariatric surgery versus conventional medical therapy for type 2 diabetes","volume":"366","author":"Mingrone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00346-2_bib32","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(14)70176-7","article-title":"Diabetes in older people: new insights and remaining challenges","volume":"3","author":"Sinclair","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00346-2_bib33","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","article-title":"Bariatric surgery versus intensive medical therapy in obese patients with diabetes","volume":"366","author":"Schauer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00346-2_bib34","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S2213-8587(15)00089-3","article-title":"Roux-en-Y gastric bypass for diabetes (the Diabetes Surgery Study): 2-year outcomes of a 5-year, randomised, controlled trial","volume":"3","author":"Ikramuddin","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00346-2_bib35","article-title":"Post metabolic bariatric surgery weight regain: the importance of GLP-1 levels","author":"\u00c7al\u0131k Ba\u015faran","year":"2024","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(24)00346-2_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00346-2_bib37","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00346-2_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1097\/XEB.0000000000000141","article-title":"A new improved graphical and quantitative method for detecting bias in meta-analysis","volume":"16","author":"Furuya-Kanamori","year":"2018","journal-title":"Int J Evid-Based Healthc"},{"key":"10.1016\/S2213-8587(24)00346-2_bib39","first-page":"40","article-title":"meta: an R package for meta-analysis","volume":"7","author":"Schwarzer","year":"2007","journal-title":"R News"},{"key":"10.1016\/S2213-8587(24)00346-2_bib40","series-title":"Introduction to meta-analysis","author":"Borenstein","year":"2009"},{"key":"10.1016\/S2213-8587(24)00346-2_bib41","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1214\/aoms\/1177729756","article-title":"Transformations related to the angular and the square root","volume":"21","author":"Freeman","year":"1950","journal-title":"Ann Math Stat"},{"key":"10.1016\/S2213-8587(24)00346-2_bib42","first-page":"138","article-title":"The Inverse of the Freeman\u2014Tukey double arcsine transformation","volume":"32","author":"Miller","year":"1978","journal-title":"Am Stat"},{"key":"10.1016\/S2213-8587(24)00346-2_bib43","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1002\/jrsm.1348","article-title":"Seriously misleading results using inverse of Freeman-Tukey double arcsine transformation in meta-analysis of single proportions","volume":"10","author":"Schwarzer","year":"2019","journal-title":"Res Synth Methods"},{"key":"10.1016\/S2213-8587(24)00346-2_bib44","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1177\/1536867X0800800403","article-title":"Meta-regression in Stata","volume":"8","author":"Harbord","year":"2008","journal-title":"Stata J"},{"key":"10.1016\/S2213-8587(24)00346-2_bib45","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1007\/s00125-016-3903-x","article-title":"Gastric bypass surgery vs intensive lifestyle and medical intervention for type 2 diabetes: the CROSSROADS randomised controlled trial","volume":"59","author":"Cummings","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00346-2_bib46","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.soard.2020.04.033","article-title":"Sleeve gastrectomy and Roux-en-Y gastric bypass in the treatment of type 2 diabetes. Two-year results from a Swedish multicenter randomized controlled trial","volume":"16","author":"Wallenius","year":"2020","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(24)00346-2_bib47","doi-asserted-by":"crossref","first-page":"1412","DOI":"10.1007\/s11695-022-05982-5","article-title":"Antrum preservation versus antrum resection in laparoscopic sleeve gastrectomy with effects on gastric emptying, body mass index, and type II diabetes remission in diabetic patients with body mass index 30\u201340 kg\/m2: a randomized controlled study","volume":"32","author":"Eskandaros","year":"2022","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(24)00346-2_bib48","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1007\/s11695-023-06515-4","article-title":"One Anastomosis Gastric Bypass (OAGB) vs Roux en Y Gastric Bypass (RYGB) for remission of T2DM in patients with morbid obesity: a randomized controlled trial","volume":"33","author":"Singh","year":"2023","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(24)00346-2_bib49","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1001\/archsurg.2010.326","article-title":"Gastric bypass vs sleeve gastrectomy for type 2 diabetes mellitus: a randomized controlled trial","volume":"146","author":"Lee","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/S2213-8587(24)00346-2_bib50","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1001\/jama.2012.67929","article-title":"Association of an intensive lifestyle intervention with remission of type 2 diabetes","volume":"308","author":"Gregg","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00346-2_bib51","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/S2213-8587(14)70066-X","article-title":"Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial","volume":"2","author":"Wentworth","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00346-2_bib52","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.2337\/dc13-2899","article-title":"The effects of a Mediterranean diet on the need for diabetes drugs and remission of newly diagnosed type 2 diabetes: follow-up of a randomized trial","volume":"37","author":"Esposito","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00346-2_bib53","doi-asserted-by":"crossref","first-page":"931","DOI":"10.1001\/jamasurg.2015.1534","article-title":"Three-year outcomes of bariatric surgery vs lifestyle intervention for type 2 diabetes mellitus treatment: a randomized clinical trial","volume":"150","author":"Courcoulas","year":"2015","journal-title":"JAMA Surg"},{"key":"10.1016\/S2213-8587(24)00346-2_bib54","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S2213-8587(19)30068-3","article-title":"Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial","volume":"7","author":"Lean","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00346-2_bib55","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2213-8587(20)30117-0","article-title":"Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial","volume":"8","author":"Taheri","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00346-2_bib56","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1186\/s12893-015-0074-5","article-title":"Long-term effects of laparoscopic sleeve gastrectomy versus roux-en-Y gastric bypass for the treatment of Chinese type 2 diabetes mellitus patients with body mass index 28-35 kg\/m2","volume":"15","author":"Yang","year":"2015","journal-title":"BMC Surg"},{"key":"10.1016\/S2213-8587(24)00346-2_bib57","doi-asserted-by":"crossref","first-page":"2235","DOI":"10.1007\/s11695-017-2669-7","article-title":"Predictive value of gut peptides in T2D remission: randomized controlled trial comparing metabolic gastric bypass, sleeve gastrectomy and greater curvature plication","volume":"27","author":"Casajoana","year":"2017","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(24)00346-2_bib58","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1016\/j.soard.2022.07.003","article-title":"Loop versus Roux-en-Y duodenojejunal bypass with sleeve gastrectomy for type 2 diabetes: short-term outcomes of a single-center randomized controlled trial","volume":"18","author":"Lin","year":"2022","journal-title":"Surg Obes Relat Dis"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00346-2_bib59","first-page":"S111","article-title":"Glycemic goals and hypoglycemia: standards of care in diabetes\u20142024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00346-2_bib60","doi-asserted-by":"crossref","first-page":"531","DOI":"10.2337\/dci23-0041","article-title":"Cardiovascular and kidney risks in individuals with type 2 diabetes: contemporary understanding with greater emphasis on excess adiposity","volume":"47","author":"Sattar","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00346-2_bib61","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1038\/s41574-022-00793-1","article-title":"Applying the WHO global targets for diabetes mellitus","volume":"19","author":"Cheng","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00346-2_bib62","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00346-2_bib63","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00346-2_bib64","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1916038","article-title":"A randomized, controlled trial of liraglutide for adolescents with obesity","volume":"382","author":"Kelly","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00346-2_bib65","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00346-2_bib66","doi-asserted-by":"crossref","first-page":"2049","DOI":"10.1038\/s41591-024-02996-7","article-title":"Long-term weight loss effects of semaglutide in obesity without diabetes in the SELECT trial","volume":"30","author":"Ryan","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00346-2_bib67","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1001\/jama.2024.0318","article-title":"Long-term outcomes of medical management vs bariatric surgery in type 2 diabetes","volume":"331","author":"Courcoulas","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00346-2_bib68","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1038\/s41574-021-00512-2","article-title":"Type 2 diabetes mellitus in older adults: clinical considerations and management","volume":"17","author":"Bellary","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00346-2_bib69","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.0055","article-title":"Body weight variability and risk of cardiovascular outcomes and death in the context of weight loss intervention among patients with type 2 diabetes","volume":"5","author":"Kaze","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(24)00346-2_bib70","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1001\/jama.2020.12567","article-title":"Benefits and risks of bariatric surgery in adults: a review","volume":"324","author":"Arterburn","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00346-2_bib71","article-title":"Bias caused by sampling error in meta-analysis with small sample sizes","volume":"13","author":"Lin","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(24)00346-2_bib72","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1471-2288-14-25","article-title":"The Hartung-Knapp-Sidik-Jonkman method for random effects meta-analysis is straightforward and considerably outperforms the standard DerSimonian-Laird method","volume":"14","author":"IntHout","year":"2014","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/S2213-8587(24)00346-2_bib73","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12874-015-0091-1","article-title":"Hartung-Knapp-Sidik-Jonkman approach and its modification for random-effects meta-analysis with few studies","volume":"15","author":"R\u00f6ver","year":"2015","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/S2213-8587(24)00346-2_bib74","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1002\/sim.6879","article-title":"Hartung-Knapp method is not always conservative compared with fixed-effect meta-analysis","volume":"35","author":"Wiksten","year":"2016","journal-title":"Stat Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:52Z","timestamp":1778858752000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003462"}},"issued":{"date-parts":[[2025,4]]},"references-count":74,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2213858724003462"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00346-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of bodyweight loss on type 2 diabetes remission: a systematic review and meta-regression analysis of randomised controlled trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00346-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00373-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T07:26:37Z","timestamp":1794468397164,"version":"4.9.1"},"reference-count":72,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,21]],"date-time":"2022-09-21T00:00:00Z","timestamp":1663718400000},"content-version":"am","delay-in-days":173,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100015015","name":"Government of South Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015015","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100017638","name":"Ministry of Health of the Russian Federation","doi-asserted-by":"publisher","award":["121031100288\u20135"],"award-info":[{"award-number":["121031100288\u20135"]}],"id":[{"id":"10.13039\/501100017638","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000382","name":"Society for Endocrinology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000382","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K08CA248972"],"award-info":[{"award-number":["K08CA248972"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 HD034568"],"award-info":[{"award-number":["R01 HD034568"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["UH3 OD 023286"],"award-info":[{"award-number":["UH3 OD 023286"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000884","name":"British Thyroid Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008231","name":"Arkansas Biosciences Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008231","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003246","name":"Nederlandse Organisatie voor Wetenschappelijk Onderzoek","doi-asserted-by":"publisher","award":["401\u00b716\u00b7020"],"award-info":[{"award-number":["401\u00b716\u00b7020"]}],"id":[{"id":"10.13039\/501100003246","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/s2213-8587(22)00007-9","type":"journal-article","created":{"date-parts":[[2022,3,4]],"date-time":"2022-03-04T18:29:21Z","timestamp":1646418561000},"page":"243-252","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":163,"title":["Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis"],"prefix":"10.1016","volume":"10","author":[{"given":"Freddy J K","family":"Toloza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arash","family":"Derakhshan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuija","family":"M\u00e4nnist\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofie","family":"Bliddal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Polina V","family":"Popova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Carty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liangmiao","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorena","family":"Mosso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Oken","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eila","family":"Suvanto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sachiko","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reiko","family":"Kishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judit","family":"Bassols","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juha","family":"Auvinen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abel","family":"L\u00f3pez-Bermejo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne J","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Boucai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aya","family":"Hisada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Yoshinaga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina","family":"Shilova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena N","family":"Grineva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tanja G M","family":"Vrijkotte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Sunyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Jim\u00e9nez-Zabala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isolina","family":"Ria\u00f1o-Galan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria-Jose","family":"Lopez-Espinosa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Larry J","family":"Prokop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naykky","family":"Singh Ospina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan P","family":"Brito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rene","family":"Rodriguez-Gutierrez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik K","family":"Alexander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Layal","family":"Chaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth N","family":"Pearce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin P","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulla","family":"Feldt-Rasmussen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M\u00f2nica","family":"Guxens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leda","family":"Chatzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Delles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeanine E","family":"Roeters van Lennep","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victor J M","family":"Pop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xuemian","family":"Lu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John P","family":"Walsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott M","family":"Nelson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim I M","family":"Korevaar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Spyridoula","family":"Maraka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00007-9_bib1","doi-asserted-by":"crossref","first-page":"e237","DOI":"10.1097\/AOG.0000000000003891","article-title":"Gestational Hypertension and Preeclampsia: ACOG Practice Bulletin, Number 222","volume":"135","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib2","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.1016\/S0140-6736(06)68397-9","article-title":"WHO analysis of causes of maternal death: a systematic review","volume":"367","author":"Khan","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00007-9_bib3","doi-asserted-by":"crossref","first-page":"e323","DOI":"10.1016\/S2214-109X(14)70227-X","article-title":"Global causes of maternal death: a WHO systematic analysis","volume":"2","author":"Say","year":"2014","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(22)00007-9_bib4","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.preghy.2014.02.001","article-title":"The classification, diagnosis and management of the hypertensive disorders of pregnancy: a revised statement from the ISSHP","volume":"4","author":"Tranquilli","year":"2014","journal-title":"Pregnancy Hypertens"},{"key":"10.1016\/S2213-8587(22)00007-9_bib5","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S1701-2163(16)30579-5","article-title":"Serious perinatal complications of non-proteinuric hypertension: an international, multicentre, retrospective cohort study","volume":"25","author":"Magee","year":"2003","journal-title":"J Obstet Gynaecol Can"},{"key":"10.1016\/S2213-8587(22)00007-9_bib6","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/j.bpobgyn.2011.01.006","article-title":"Epidemiology of pre-eclampsia and the other hypertensive disorders of pregnancy","volume":"25","author":"Hutcheon","year":"2011","journal-title":"Best Pract Res Clin Obstet Gynaecol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib7","doi-asserted-by":"crossref","first-page":"1590","DOI":"10.1016\/j.ajog.2004.03.050","article-title":"Maternal and perinatal outcomes during expectant management of 239 severe preeclamptic women between 24 and 33 weeks' gestation","volume":"190","author":"Haddad","year":"2004","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib8","doi-asserted-by":"crossref","first-page":"137","DOI":"10.3109\/10641955.2014.982329","article-title":"Maternal and fetal outcome in de novo preeclampsia in comparison to superimposed preeclampsia: a two-year observational study","volume":"34","author":"Rezk","year":"2015","journal-title":"Hypertens Pregnancy"},{"key":"10.1016\/S2213-8587(22)00007-9_bib9","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1053\/j.semperi.2011.09.011","article-title":"Maternal mortality from preeclampsia\/eclampsia","volume":"36","author":"Ghulmiyyah","year":"2012","journal-title":"Semin Perinatol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1093\/humupd\/dmr024","article-title":"Significance of (sub)clinical thyroid dysfunction and thyroid autoimmunity before conception and in early pregnancy: a systematic review","volume":"17","author":"van den Boogaard","year":"2011","journal-title":"Hum Reprod Update"},{"key":"10.1016\/S2213-8587(22)00007-9_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1016\/j.ecl.2019.05.010","article-title":"Hypothyroidism in Pregnancy","volume":"48","author":"Taylor","year":"2019","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(22)00007-9_bib12","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1038\/nrendo.2017.93","article-title":"Thyroid disease in pregnancy: new insights in diagnosis and clinical management","volume":"13","author":"Korevaar","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib13","first-page":"387","article-title":"Thyroid dysfunction and pregnancy outcomes","volume":"13","author":"Nazarpour","year":"2015","journal-title":"Iran J Reprod Med"},{"key":"10.1016\/S2213-8587(22)00007-9_bib14","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1007\/s00404-010-1362-z","article-title":"Outcomes of pregnancy complicated with hyperthyroidism: a cohort study","volume":"283","author":"Luewan","year":"2011","journal-title":"Arch Gynecol Obstet"},{"key":"10.1016\/S2213-8587(22)00007-9_bib15","doi-asserted-by":"crossref","first-page":"2725","DOI":"10.1210\/jc.2012-4233","article-title":"Thyroid diseases and adverse pregnancy outcomes in a contemporary US cohort","volume":"98","author":"M\u00e4nnist\u00f6","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00007-9_bib16","first-page":"8","article-title":"The interplay between thyroid hormones and the placenta: a comprehensive review","volume":"102","author":"Adu-Gyamfi","year":"2020","journal-title":"Biol Reprod"},{"key":"10.1016\/S2213-8587(22)00007-9_bib17","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1089\/105072501300042820","article-title":"Endothelial function in patients with hyperthyroidism before and after treatment with propranolol and thiamazol","volume":"11","author":"Burggraaf","year":"2001","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(22)00007-9_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.ecl.2014.02.005","article-title":"Thyroid disease and the cardiovascular system","volume":"43","author":"Danzi","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(22)00007-9_bib19","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/BF03347455","article-title":"Decreased number of circulating endothelial progenitor cells in patients with Graves' hyperthyroidism","volume":"34","author":"De Ciuceis","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(22)00007-9_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1056\/NEJM200102153440707","article-title":"Thyroid hormone and the cardiovascular system","volume":"344","author":"Klein","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00007-9_bib21","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1002\/pd.2566","article-title":"Maternal thyroid function at 11 to 13 weeks of gestation and subsequent development of preeclampsia","volume":"30","author":"Ashoor","year":"2010","journal-title":"Prenat Diagn"},{"key":"10.1016\/S2213-8587(22)00007-9_bib22","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1097\/AOG.0b013e318240de6a","article-title":"Subclinical thyroid disease and the incidence of hypertension in pregnancy","volume":"119","author":"Wilson","year":"2012","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib23","doi-asserted-by":"crossref","first-page":"E2591","DOI":"10.1210\/jc.2014-1505","article-title":"Maternal early-pregnancy thyroid function is associated with subsequent hypertensive disorders of pregnancy: the generation R study","volume":"99","author":"Medici","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00007-9_bib24","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1111\/cen.14282","article-title":"Maternal hyperthyroidism and pregnancy outcomes: A population-based cohort study","volume":"93","author":"Turunen","year":"2020","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(22)00007-9_bib25","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.580380","article-title":"Effects of maternal subclinical hypothyroidism in early pregnancy diagnosed by different criteria on adverse perinatal outcomes in Chinese women with negative TPOAb","volume":"11","author":"Li","year":"2020","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(22)00007-9_bib26","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1097\/AOG.0b013e3181788dd7","article-title":"Maternal thyroid hypofunction and pregnancy outcome","volume":"112","author":"Cleary-Goldman","year":"2008","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib27","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1097\/01.AOG.0000197991.64246.9a","article-title":"Subclinical hyperthyroidism and pregnancy outcomes","volume":"107","author":"Casey","year":"2006","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib28","doi-asserted-by":"crossref","first-page":"1084","DOI":"10.1210\/jc.2009-1904","article-title":"Thyroid dysfunction and autoantibodies during pregnancy as predictive factors of pregnancy complications and maternal morbidity in later life","volume":"95","author":"M\u00e4nnist\u00f6","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00007-9_bib29","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgz275","article-title":"Associations between maternal thyroid function in pregnancy and obstetric and perinatal outcomes","volume":"105","author":"Lee","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00007-9_bib30","doi-asserted-by":"crossref","first-page":"728","DOI":"10.1111\/cen.13575","article-title":"Impact of TSH during the first trimester of pregnancy on obstetric and foetal complications: usefulness of 2.5 mIU\/L cut-off value","volume":"88","author":"Hern\u00e1ndez","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(22)00007-9_bib31","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1159\/000452331","article-title":"An invitation to join the consortium on thyroid and pregnancy","volume":"5","author":"Korevaar","year":"2016","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(22)00007-9_bib32","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1097\/AOG.0000000000003642","article-title":"An invitation to collaborate in the consortium on thyroid and pregnancy","volume":"135","author":"Korevaar","year":"2020","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib33","author":"Wells"},{"key":"10.1016\/S2213-8587(22)00007-9_bib34","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/S2213-8587(22)00007-9_bib35","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1093\/aje\/kwx299","article-title":"Separation in logistic regression: causes, consequences, and control","volume":"187","author":"Mansournia","year":"2018","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib36","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00007-9_bib37","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1214\/18-STS646","article-title":"Multiple imputation for multilevel data with continuous and binary variables","volume":"33","author":"Audigier","year":"2018","journal-title":"Statistical Science"},{"key":"10.1016\/S2213-8587(22)00007-9_bib38","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1002\/sim.4780100410","article-title":"Multiple imputation in health-care databases: an overview and some applications","volume":"10","author":"Rubin","year":"1991","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(22)00007-9_bib39","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1136\/heart.84.4.455","article-title":"Thyroid disease and the heart","volume":"84","author":"Toft","year":"2000","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(22)00007-9_bib40","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1111\/j.1475-097X.1987.tb00172.x","article-title":"Increased sympathetic tone in forearm subcutaneous tissue in primary hypothyroidism","volume":"7","author":"Vagn Nielsen","year":"1987","journal-title":"Clin Physiol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib41","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1071\/RD11219","article-title":"Fetal growth restriction in hypothyroidism is associated with changes in proliferative activity, apoptosis and vascularisation of the placenta","volume":"24","author":"Silva","year":"2012","journal-title":"Reprod Fertil Dev"},{"key":"10.1016\/S2213-8587(22)00007-9_bib42","doi-asserted-by":"crossref","first-page":"803","DOI":"10.1530\/REP-13-0374","article-title":"Maternal thyroid dysfunction affects placental profile of inflammatory mediators and the intrauterine trophoblast migration kinetics","volume":"147","author":"Silva","year":"2014","journal-title":"Reproduction"},{"key":"10.1016\/S2213-8587(22)00007-9_bib43","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1093\/humrep\/deu046","article-title":"Triiodothyronine regulates angiogenic growth factor and cytokine secretion by isolated human decidual cells in a cell-type specific and gestational age-dependent manner","volume":"29","author":"Vasilopoulou","year":"2014","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(22)00007-9_bib44","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1056\/NEJMoa031884","article-title":"Circulating angiogenic factors and the risk of preeclampsia","volume":"350","author":"Levine","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00007-9_bib45","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b4336","article-title":"Pre-eclampsia, soluble fms-like tyrosine kinase 1, and the risk of reduced thyroid function: nested case-control and population based study","volume":"339","author":"Levine","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00007-9_bib46","doi-asserted-by":"crossref","first-page":"E1328","DOI":"10.1210\/jc.2015-2553","article-title":"Placental angiogenic factors are associated with maternal thyroid function and modify hCG-mediated FT4 stimulation","volume":"100","author":"Korevaar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00007-9_bib47","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1038\/sj.bjc.6603813","article-title":"Mechanisms of adverse effects of anti-VEGF therapy for cancer","volume":"96","author":"Kamba","year":"2007","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(22)00007-9_bib48","article-title":"Thyroid hormone treatment among pregnant women with subclinical hypothyroidism: US national assessment","volume":"356","author":"Maraka","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00007-9_bib49","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1056\/NEJMoa1606205","article-title":"Treatment of subclinical hypothyroidism or hypothyroxinemia in pregnancy","volume":"376","author":"Casey","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00007-9_bib50","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1056\/NEJMoa1106104","article-title":"Antenatal thyroid screening and childhood cognitive function","volume":"366","author":"Lazarus","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00007-9_bib51","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1210\/jc.2017-01850","article-title":"Effects of levothyroxine on pregnant women with subclinical hypothyroidism, negative for thyroid peroxidase antibodies","volume":"103","author":"Nazarpour","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00007-9_bib52","first-page":"946","article-title":"Low birth weight and preeclampsia in pregnancies complicated by hyperthyroidism","volume":"84","author":"Millar","year":"1994","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib53","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1159\/000357615","article-title":"Pregnancy outcome in hyperthyroidism: a case control study","volume":"77","author":"Aggarawal","year":"2014","journal-title":"Gynecol Obstet Invest"},{"key":"10.1016\/S2213-8587(22)00007-9_bib54","doi-asserted-by":"crossref","first-page":"4464","DOI":"10.1210\/jc.2012-2540","article-title":"Thyroid dysfunction and autoantibodies in early pregnancy are associated with increased risk of gestational diabetes and adverse birth outcomes","volume":"97","author":"Karakosta","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00007-9_bib55","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1089\/jwh.2018.7180","article-title":"Association of overt and subclinical hyperthyroidism during weeks 4-8 with adverse pregnancy outcomes","volume":"28","author":"Zhang","year":"2019","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/S2213-8587(22)00007-9_bib56","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1046\/j.1365-2362.1998.00381.x","article-title":"Impaired release of tissue plasminogen activator from the endothelium in Graves' disease\u2013indicator of endothelial dysfunction and reduced fibrinolytic capacity","volume":"28","author":"Li","year":"1998","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S2213-8587(22)00007-9_bib57","first-page":"653","article-title":"The association of maternal thyroid function with placental hemodynamics","volume":"32","author":"Barjaktarovic","year":"2017","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(22)00007-9_bib58","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/S2213-8587(13)70086-X","article-title":"Hyperthyroidism in pregnancy","volume":"1","author":"Cooper","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib59","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1210\/jcem-71-2-276","article-title":"Regulation of maternal thyroid during pregnancy","volume":"71","author":"Glinoer","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00007-9_bib60","doi-asserted-by":"crossref","first-page":"5037","DOI":"10.1210\/jc.2016-2397","article-title":"The risk of preeclampsia according to high thyroid function in pregnancy differs by hCG concentration","volume":"101","author":"Korevaar","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00007-9_bib61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1002\/uog.20256","article-title":"Human chorionic gonadotropin and risk of pre-eclampsia: prospective population-based cohort study","volume":"54","author":"Barjaktarovic","year":"2019","journal-title":"Ultrasound Obstet Gynecol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib62","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1016\/S2213-8587(19)30153-6","article-title":"Maternal thyroid function during pregnancy and child brain morphology: a time window-specific analysis of a prospective cohort","volume":"7","author":"Jansen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib63","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-8587(15)00327-7","article-title":"Association of maternal thyroid function during early pregnancy with offspring IQ and brain morphology in childhood: a population-based prospective cohort study","volume":"4","author":"Korevaar","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib64","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/S2213-8587(20)30061-9","article-title":"Association of maternal thyroid function with birthweight: a systematic review and individual-participant data meta-analysis","volume":"8","author":"Derakhshan","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib65","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1089\/thy.2019.0199","article-title":"The impact of thyroid disorders on clinical pregnancy outcomes in a real-world study setting","volume":"30","author":"Sitoris","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(22)00007-9_bib66","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/j.ajog.2017.09.001","article-title":"Thyroid-stimulating hormone, anti-thyroid antibodies, and pregnancy outcomes","volume":"217","author":"Plowden","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(22)00007-9_bib67","doi-asserted-by":"crossref","first-page":"139","DOI":"10.3109\/07435800.2014.966384","article-title":"Thyroid autoimmunity in pregnancy and its influences on maternal and fetal outcome in Iran (a prospective study)","volume":"40","author":"Saki","year":"2015","journal-title":"Endocr Res"},{"key":"10.1016\/S2213-8587(22)00007-9_bib68","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1001\/jama.2019.10931","article-title":"Association of thyroid function test abnormalities and thyroid autoimmunity with preterm birth: a systematic review and meta-analysis","volume":"322","author":"Korevaar","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00007-9_bib69","doi-asserted-by":"crossref","first-page":"1642","DOI":"10.1089\/thy.2014.0029","article-title":"Maternal subclinical hypothyroidism, thyroid autoimmunity, and the risk of miscarriage: a prospective cohort study","volume":"24","author":"Liu","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(22)00007-9_bib70","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1007\/s12020-016-1022-6","article-title":"Maternal TSH level and TPOAb status in early pregnancy and their relationship to the risk of gestational diabetes mellitus","volume":"54","author":"Ying","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(22)00007-9_bib71","article-title":"Pre-eclampsia: pathophysiology and clinical implications","volume":"366","author":"Burton","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00007-9_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2020.01864","article-title":"Mechanisms of key innate immune cells in early- and late-onset preeclampsia","volume":"11","author":"Aneman","year":"2020","journal-title":"Front Immunol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:19Z","timestamp":1761991819000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000079"}},"issued":{"date-parts":[[2022,4]]},"references-count":72,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2213858722000079"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00007-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between maternal thyroid function and risk of gestational hypertension and pre-eclampsia: a systematic review and individual-participant data meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00007-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00040-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:27:16Z","timestamp":1794482836465,"version":"4.9.1"},"reference-count":63,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,19]],"date-time":"2025-04-19T00:00:00Z","timestamp":1745020800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006389","name":"Universit\u00e9 de Gen\u00e8ve","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006389","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000054","name":"NIH NCI","doi-asserted-by":"publisher","award":["P30 CA008748"],"award-info":[{"award-number":["P30 CA008748"]}],"id":[{"id":"10.13039\/100000054","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/s2213-8587(25)00064-6","type":"journal-article","created":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T01:02:03Z","timestamp":1746061323000},"page":"516-527","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement"],"prefix":"10.1016","volume":"13","author":[{"given":"Sophie","family":"Leboulleux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Boucai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naifa","family":"Busaidy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cosimo","family":"Durante","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A","family":"Fagin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sasan","family":"Fazeli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew G","family":"Gianoukakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan R","family":"Haugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hyunseok","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhavana","family":"Konda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodore W","family":"Laetsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Locati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Spitzweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francis P","family":"Worden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00064-6_bib1","doi-asserted-by":"crossref","first-page":"2892","DOI":"10.1210\/jc.2005-2838","article-title":"Long-term outcome of 444 patients with distant metastases from papillary and follicular thyroid carcinoma: benefits and limits of radioiodine therapy","volume":"91","author":"Durante","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00064-6_bib2","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1038\/s41568-023-00598-y","article-title":"Pathogenesis of cancers derived from thyroid follicular cells","volume":"23","author":"Fagin","year":"2023","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/S2213-8587(25)00064-6_bib3","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1038\/s41574-023-00920-6","article-title":"Genomic alterations in thyroid cancer: biological and clinical insights","volume":"20","author":"Landa","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(25)00064-6_bib4","doi-asserted-by":"crossref","first-page":"R113","DOI":"10.1530\/ERC-19-0491","article-title":"Redifferentiation of radioiodine-refractory thyroid cancers","volume":"27","author":"Buffet","year":"2020","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(25)00064-6_bib5","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1530\/EJE-09-0702","article-title":"Beneficial effects of sorafenib on tumor progression, but not on radioiodine uptake, in patients with differentiated thyroid carcinoma","volume":"161","author":"Hoftijzer","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00064-6_bib6","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1089\/thy.2012.0393","article-title":"Evaluation of romidepsin for clinical activity and radioactive iodine reuptake in radioactive iodine-refractory thyroid carcinoma","volume":"23","author":"Sherman","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1007\/BF03346457","article-title":"Effectiveness of retinoic acid treatment for redifferentiation of thyroid cancer in relation to recovery of radioiodine uptake","volume":"32","author":"Fern\u00e1ndez","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(25)00064-6_bib8","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/1756-6614-2-8","article-title":"13-cis-retinoic acid re-differentiation therapy and recombinant human thyrotropin-aided radioiodine treatment of non-functional metastatic thyroid cancer: a single-center, 53-patient phase 2 study","volume":"2","author":"Handkiewicz-Junak","year":"2009","journal-title":"Thyroid Res"},{"key":"10.1016\/S2213-8587(25)00064-6_bib9","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1507\/endocrj.K08E-254","article-title":"Redifferentiation therapy with 13-cis retinoic acids in radioiodine-resistant thyroid cancer","volume":"56","author":"Kim","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/S2213-8587(25)00064-6_bib10","first-page":"912","article-title":"Lithium as a potential adjuvant to 131I therapy of metastatic, well differentiated thyroid carcinoma","volume":"84","author":"Koong","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00064-6_bib11","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1111\/cen.13806","article-title":"The effect of lithium on the progression-free and overall survival in patients with metastatic differentiated thyroid cancer undergoing radioactive iodine therapy","volume":"89","author":"Luo","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00064-6_bib12","doi-asserted-by":"crossref","first-page":"e240153","DOI":"10.1530\/ETJ-24-0153","article-title":"Digoxin treatment does not reinduce radioiodine uptake in radioiodine refractory non-medullary thyroid carcinoma","volume":"13","author":"van Houten","year":"2024","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(25)00064-6_bib13","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1056\/NEJMoa1209288","article-title":"Selumetinib-enhanced radioiodine uptake in advanced thyroid cancer","volume":"368","author":"Ho","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00064-6_bib14","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.1200\/JCO.21.00714","article-title":"Selumetinib plus adjuvant radioactive iodine in patients with high-risk differentiated thyroid cancer: a phase III, randomized, placebo-controlled trial (ASTRA)","volume":"40","author":"Ho","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(25)00064-6_bib15","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1210\/jc.2018-01478","article-title":"Vemurafenib redifferentiation of BRAF mutant, RAI-refractory thyroid cancers","volume":"104","author":"Dunn","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00064-6_bib16","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1089\/thy.2021.0565","article-title":"Enhancing radioiodine incorporation in BRAF-mutant, radioiodine-refractory thyroid cancers with vemurafenib and the Anti-ErbB3 monoclonal antibody CDX-3379: results of a pilot clinical trial","volume":"32","author":"Tchekmedyian","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib17","first-page":"1124","article-title":"MERAIODE: a phase II redifferentiation trial with trametinib and 131I in metastatic radioactive iodine refractory RAS mutated differentiated thyroid cancer","volume":"33","author":"Leboulleux","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib18","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1158\/1078-0432.CCR-23-0046","article-title":"A phase II redifferentiation trial with dabrafenib-trametinib and 131I in metastatic radioactive iodine refractory BRAF p.V600E-mutated differentiated thyroid cancer","volume":"29","author":"Leboulleux","year":"2023","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(25)00064-6_bib19","doi-asserted-by":"crossref","first-page":"1119","DOI":"10.1089\/thy.2022.0707","article-title":"Results of the SEL-I-METRY phase II trial on resensitization of advanced iodine refractory differentiated thyroid cancer to radioiodine therapy","volume":"33","author":"Wadsley","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib20","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1158\/1078-0432.CCR-14-2915","article-title":"Redifferentiation of iodine-refractory BRAF V600E-mutant metastatic papillary thyroid cancer with dabrafenib","volume":"21","author":"Rothenberg","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(25)00064-6_bib21","doi-asserted-by":"crossref","first-page":"4194","DOI":"10.1158\/1078-0432.CCR-22-0437","article-title":"Enhancing radioiodine incorporation into radioiodine-refractory thyroid cancer with MAPK inhibition (ERRITI): a single-center prospective two-arm study","volume":"28","author":"Weber","year":"2022","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(25)00064-6_bib22","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1016\/S2213-8587(13)70215-8","article-title":"Definition and management of radioactive iodine-refractory differentiated thyroid cancer","volume":"2","author":"Schlumberger","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00064-6_bib23","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/thy.2018.0597","volume":"29","author":"Tuttle","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib24","doi-asserted-by":"crossref","first-page":"832","DOI":"10.1089\/thy.2012.0081","article-title":"Postradioiodine treatment whole-body scan in the era of 18-fluorodeoxyglucose positron emission tomography for differentiated thyroid carcinoma with elevated serum thyroglobulin levels","volume":"22","author":"Leboulleux","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib25","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(25)00064-6_bib26","doi-asserted-by":"crossref","first-page":"4700","DOI":"10.1172\/JCI46382","article-title":"Small-molecule MAPK inhibitors restore radioiodine incorporation in mouse thyroid cancers with conditional BRAF activation","volume":"121","author":"Chakravarty","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(25)00064-6_bib27","doi-asserted-by":"crossref","first-page":"4119","DOI":"10.1172\/JCI89067","article-title":"Sustained ERK inhibition maximizes responses of BrafV600E thyroid cancers to radioiodine","volume":"126","author":"Nagarajah","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(25)00064-6_bib28","doi-asserted-by":"crossref","first-page":"6089","DOI":"10.1200\/JCO.2022.40.16_suppl.6089","article-title":"Phase 2 of trametinib plus radioiodine in RAS-mutant and wild-type, radioiodine-refractory thyroid cancer (ETCTN9446)","volume":"40","author":"Burman","year":"2022","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(25)00064-6_bib29","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1111\/j.1365-2265.2006.02626.x","article-title":"Comparison of iodine uptake in tumour and nontumour tissue under thyroid hormone deprivation and with recombinant human thyrotropin in thyroid cancer patients","volume":"65","author":"P\u00f6tzi","year":"2006","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00064-6_bib30","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1210\/jc.2011-0305","article-title":"Five-year survival is similar in thyroid cancer patients with distant metastases prepared for radioactive iodine therapy with either thyroid hormone withdrawal or recombinant human TSH","volume":"96","author":"Tala","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00064-6_bib31","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1089\/thy.2011.0235","article-title":"Radioiodine treatment of metastatic thyroid cancer: relative efficacy and side effect profile of preparation by thyroid hormone withdrawal versus recombinant human thyrotropin","volume":"22","author":"Klubo-Gwiezdzinska","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib32","doi-asserted-by":"crossref","first-page":"e3911","DOI":"10.1210\/clinem\/dgab436","article-title":"Avidity and Outcomes of Radioiodine Therapy for Distant Metastasis of Distinct Types of Differentiated Thyroid Cancer","volume":"106","author":"Sim\u00f5es-Pereira","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00064-6_bib33","doi-asserted-by":"crossref","first-page":"bvac032","DOI":"10.1210\/jendso\/bvac032","article-title":"Metastatic differentiated thyroid cancer survival is unaffected by mode of preparation for 131I administration","volume":"6","author":"Gomes-Lima","year":"2022","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(25)00064-6_bib34","doi-asserted-by":"crossref","first-page":"221","DOI":"10.3390\/diagnostics12010221","article-title":"Feasibility of recombinant human TSH as a preparation for radioiodine therapy in patients with distant metastases from papillary thyroid cancer: comparison of long-term survival outcomes with thyroid hormone withdrawal","volume":"12","author":"Tsai","year":"2022","journal-title":"Diagnostics"},{"key":"10.1016\/S2213-8587(25)00064-6_bib35","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1089\/thy.2018.0457","article-title":"Redifferentiation of a BRAFK601E-mutated poorly differentiated thyroid cancer patient with dabrafenib and trametinib treatment","volume":"29","author":"Leboulleux","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib36","doi-asserted-by":"crossref","first-page":"1327","DOI":"10.1089\/thy.2023.0228","article-title":"Pharmacokinetics\/pharmacodynamics of dabrafenib and trametinib for redifferentiation and treatment of radioactive iodine-resistant mutated advanced differentiated thyroid cancer","volume":"33","author":"Balakirouchenane","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib37","doi-asserted-by":"crossref","first-page":"1336","DOI":"10.2967\/jnumed.123.266955","article-title":"Paraplegic patient with metastatic papillary thyroid cancer: a multidisciplinary approach to radioactive iodine therapy safety and efficacy strategy","volume":"65","author":"Al-Naqeeb","year":"2024","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(25)00064-6_bib38","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1007\/s00259-024-06963-9","article-title":"EANM expert opinion: how can lessons from radiobiology be applied to the design of clinical trials? Part I: back to the basics of absorbed dose-response and threshold absorbed doses","volume":"52","author":"Pouget","year":"2025","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/S2213-8587(25)00064-6_bib39","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1056\/NEJM198310203091601","article-title":"Relation between effective radiation dose and outcome of radioiodine therapy for thyroid cancer","volume":"309","author":"Maxon","year":"1983","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00064-6_bib40","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s12149-021-01655-y","article-title":"I-124 PET\/CT image-based dosimetry in patients with differentiated thyroid cancer treated with I-131: correlation of patient-specific lesional dosimetry to treatment response","volume":"36","author":"Plyku","year":"2022","journal-title":"Ann Nucl Med"},{"key":"10.1016\/S2213-8587(25)00064-6_bib41","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2967\/jnumed.115.170571","article-title":"124I PET assessment of response of bone metastases to initial radioiodine treatment of differentiated thyroid cancer","volume":"57","author":"Jentzen","year":"2016","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(25)00064-6_bib42","first-page":"171","article-title":"The relation of radioiodine dosimetry to results and complications in the treatment of metastatic thyroid cancer","volume":"87","author":"Benua","year":"1962","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"10.1016\/S2213-8587(25)00064-6_bib43","doi-asserted-by":"crossref","first-page":"717","DOI":"10.2967\/jnumed.116.179606","article-title":"Comparison of empiric versus whole-body\/-blood clearance dosimetry-based approach to radioactive iodine treatment in patients with metastases from differentiated thyroid cancer","volume":"58","author":"Deandreis","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(25)00064-6_bib44","first-page":"1482","article-title":"A retrospective review of the effectiveness of recombinant human TSH as a preparation for radioiodine thyroid remnant ablation","volume":"43","author":"Robbins","year":"2002","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(25)00064-6_bib45","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.2967\/jnumed.122.264913","article-title":"The role of pretherapy quantitative imaging and dosimetry in radioiodine therapy for advanced thyroid cancer","volume":"64","author":"Taprogge","year":"2023","journal-title":"J Nucl Med"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(25)00064-6_bib46","doi-asserted-by":"crossref","first-page":"34S","DOI":"10.2967\/jnumed.116.186866","article-title":"Iodine symporter targeting with 124I\/131I theranostics","volume":"58","author":"Nagarajah","year":"2017","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(25)00064-6_bib47","doi-asserted-by":"crossref","first-page":"e230068","DOI":"10.1530\/ETJ-23-0068","article-title":"Use of lenvatinib in the treatment of radioiodine-refractory differentiated thyroid cancer: a multidisciplinary perspective for daily practice","volume":"12","author":"Capdevila","year":"2023","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(25)00064-6_bib48","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib49","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1016\/j.annonc.2022.04.009","article-title":"ESMO Clinical Practice Guideline update on the use of systemic therapy in advanced thyroid cancer","volume":"33","author":"Filetti","year":"2022","journal-title":"Ann Oncol"},{"key":"10.1016\/S2213-8587(25)00064-6_bib50","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1159\/000502229","article-title":"2019 European Thyroid Association guidelines for the treatment and follow-up of advanced radioiodine-refractory thyroid cancer","volume":"8","author":"Fugazzola","year":"2019","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(25)00064-6_bib51","doi-asserted-by":"crossref","first-page":"925","DOI":"10.6004\/jnccn.2022.0040","article-title":"Thyroid carcinoma, version 2.2022, NCCN clinical practice guidelines in oncology","volume":"20","author":"Haddad","year":"2022","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/S2213-8587(25)00064-6_bib52","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1089\/thy.2011.0429","article-title":"Clinical outcomes following empiric radioiodine therapy in patients with structurally identifiable metastatic follicular cell-derived thyroid carcinoma with negative diagnostic but positive post-therapy 131I whole-body scans","volume":"22","author":"Sabra","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib53","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1158\/2159-8290.CD-20-0735","article-title":"SWI\/SNF complex mutations promote thyroid tumor progression and insensitivity to redifferentiation therapies","volume":"11","author":"Saqcena","year":"2021","journal-title":"Cancer Discov"},{"key":"10.1016\/S2213-8587(25)00064-6_bib54","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/CCO.0000000000000693","article-title":"Multikinase inhibitors for the treatment of radioiodine refractory thyroid cancer: what have we learned from the \u2018real-world\u2019 experience?","volume":"33","author":"Costante","year":"2021","journal-title":"Curr Opin Oncol"},{"key":"10.1016\/S2213-8587(25)00064-6_bib55","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1089\/thy.2023.0456","article-title":"Clinical outcomes of radioactive iodine redifferentiation therapy in previously iodine refractory differentiated thyroid cancers","volume":"34","author":"Toro-Tobon","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib56","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1210\/jcem-36-6-1143","article-title":"The effect of 131 I therapy on survival of patients with metastatic papillary or follicular thyroid carcinoma","volume":"36","author":"Leeper","year":"1973","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00064-6_bib57","first-page":"1603","article-title":"Letter to the editor: selpercatinib-enhanced radioiodine uptake in RET-rearranged thyroid cancer","volume":"31","author":"Groussin","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00064-6_bib58","doi-asserted-by":"crossref","first-page":"e144847","DOI":"10.1172\/JCI144847","article-title":"NTRK and RET fusion-directed therapy in pediatric thyroid cancer yields a tumor response and radioiodine uptake","volume":"131","author":"Lee","year":"2021","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(25)00064-6_bib59","doi-asserted-by":"crossref","first-page":"3467","DOI":"10.1007\/s00259-024-06747-1","article-title":"Successful radioiodine redifferentiation with selpercatinib in RET fusion-positive papillary thyroid carcinoma","volume":"51","author":"Weiler","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/S2213-8587(25)00064-6_bib60","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of selpercatinib in RET-altered thyroid cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00064-6_bib61","doi-asserted-by":"crossref","first-page":"1686","DOI":"10.1056\/NEJMc2023094","article-title":"Larotrectinib-enhanced radioactive iodine uptake in advanced thyroid cancer","volume":"383","author":"Groussin","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00064-6_bib62","doi-asserted-by":"crossref","first-page":"e230227","DOI":"10.1530\/ETJ-23-0227","article-title":"Predictors of radioiodine (RAI)-avidity restoration for NTRK fusion-positive RAI-resistant metastatic thyroid cancers","volume":"13","author":"Syed","year":"2024","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(25)00064-6_bib63","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1089\/thy.2022.0533","article-title":"Inhibition of ALK-signaling overcomes strn-alk-induced downregulation of the sodium iodine symporter and restores radioiodine uptake in thyroid cells","volume":"33","author":"Nikitski","year":"2023","journal-title":"Thyroid"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,23]],"date-time":"2025-05-23T16:13:32Z","timestamp":1748016812000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000646"}},"issued":{"date-parts":[[2025,6]]},"references-count":63,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2213858725000646"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00064-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Redifferentiation therapy in unresectable or metastatic radioactive iodine refractory thyroid cancer: an International Thyroid Oncology Group statement","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00064-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:17:18Z","timestamp":1794316638387,"version":"4.9.0"},"reference-count":145,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/s2213-8587(26)00065-3","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T22:55:19Z","timestamp":1777071319000},"page":"498-511","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Burden and determinants of diabetes in sub-Saharan Africa"],"prefix":"10.1016","volume":"14","author":[{"given":"Charles","family":"Agyemang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Tetteh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma\u00efmouna Ndour","family":"Mbaye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberta","family":"Lamptey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Seidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre-Pascal","family":"Kengne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00065-3_bib1","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00065-3_bib2","article-title":"Trends in incidence of total or type 2 diabetes: systematic review","volume":"366","author":"Magliano","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(26)00065-3_bib4","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00065-3_bib5","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00065-3_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00065-3_bib7","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1016\/j.ophtha.2021.04.027","article-title":"Global prevalence of diabetic retinopathy and projection of burden through 2045: systematic review and meta-analysis","volume":"128","author":"Teo","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(26)00065-3_bib8","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1016\/S0140-6736(20)30925-9","article-title":"Global burden of 369 diseases and injuries in 204 countries and territories, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","volume":"396","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00065-3_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(26)00065-3_bib11","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1186\/s12913-018-3772-8","article-title":"Cost-of-illness of type 2 diabetes mellitus in low and lower-middle income countries: a systematic review","volume":"18","author":"Afroz","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(26)00065-3_bib12","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1001\/jama.2020.0734","article-title":"US health care spending by payer and health condition, 1996\u20132016","volume":"323","author":"Dieleman","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00065-3_bib14","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/S2213-8587(24)00161-X","article-title":"Alarming rise in young-onset type 2 diabetes","volume":"12","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib15","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00065-3_bib16","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1007\/s00125-021-05571-8","article-title":"Type 1 diabetes in 2017: global estimates of incident and prevalent cases in children and adults","volume":"64","author":"Green","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00065-3_bib17","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109050","article-title":"IDF Diabetes Atlas: estimation of global and regional gestational diabetes mellitus prevalence for 2021 by International Association of Diabetes in Pregnancy Study Group's criteria","volume":"183","author":"Wang","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(26)00065-3_bib18","article-title":"An insight into flatbush diabetes: a rare form of diabetes","volume":"14","author":"Shankar","year":"2022","journal-title":"Cureus"},{"key":"10.1016\/S2213-8587(26)00065-3_bib19","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11892-018-1075-4","article-title":"Ketosis-prone diabetes (flatbush diabetes): an emerging worldwide clinically important entity","volume":"18","author":"Lebovitz","year":"2018","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(26)00065-3_bib20","doi-asserted-by":"crossref","first-page":"589","DOI":"10.2217\/dmt.11.57","article-title":"Update on diagnosis, pathogenesis and management of ketosis-prone type 2 diabetes mellitus","volume":"1","author":"Smiley","year":"2011","journal-title":"Diabetes Manag"},{"key":"10.1016\/S2213-8587(26)00065-3_bib21","first-page":"231","article-title":"The first series of cases of ketosis-prone type 2 diabetes (flatbush diabetes) in Brazilian adults","volume":"65","author":"de Lima Ramaldes","year":"2021","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00065-3_bib22","doi-asserted-by":"crossref","first-page":"e340","DOI":"10.1016\/S2666-7568(21)00089-1","article-title":"The state of diabetes treatment coverage in 55 low-income and middle-income countries: a cross-sectional study of nationally representative, individual-level data in 680\u2008102 adults","volume":"2","author":"Flood","year":"2021","journal-title":"Lancet Healthy Longev"},{"key":"10.1016\/S2213-8587(26)00065-3_bib23","doi-asserted-by":"crossref","first-page":"e1909","DOI":"10.1210\/clinem\/dgaa938","article-title":"Casting a health equity lens on endocrinology and diabetes","volume":"106","author":"Golden","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00065-3_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.ijid.2024.107140","article-title":"Tuberculosis and diabetes mellitus: the complexity of the comorbid interactions","volume":"146","author":"Boadu","year":"2024","journal-title":"Int J Infect Dis"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(26)00065-3_bib25","doi-asserted-by":"crossref","first-page":"s30","DOI":"10.1016\/j.ijid.2023.02.009","article-title":"COVID-19, the escalation of diabetes mellitus and the repercussions on tuberculosis","volume":"130","author":"Thong","year":"2023","journal-title":"Int J Infect Dis"},{"key":"10.1016\/S2213-8587(26)00065-3_bib26","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/dci20-0053","article-title":"Social determinants of health and diabetes: a scientific review","volume":"44","author":"Hill-Briggs","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00065-3_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(26)00036-7","article-title":"Diabetes-related complications and multiple long-term conditions in sub-Saharan Africa: determinants and management strategies","author":"Ikhile","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(26)00035-5","article-title":"Strengthening diabetes care in sub-Saharan Africa: health systems, digital innovations, lifestyle interventions, and socioeconomic dimensions","author":"Cassambai","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib29","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-8587(19)30058-0","article-title":"Intermediate hyperglycaemia to predict progression to type 2 diabetes (ELSA-Brasil): an occupational cohort study in Brazil","volume":"7","author":"Schmidt","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib30","article-title":"Development of type 2 diabetes mellitus in people with intermediate hyperglycaemia","volume":"10","author":"Richter","year":"2018","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(26)00065-3_bib31","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/DMSO.S126314","article-title":"Diabetes in sub-Saharan Africa\u2014from policy to practice to progress: targeting the existing gaps for future care for diabetes","volume":"10","author":"Pastakia","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/S2213-8587(26)00065-3_bib32","first-page":"13","article-title":"Diabetes in sub-Saharan Africa\u2014overview of a looming health challenge","volume":"5","author":"Assah","year":"2009","journal-title":"Eur Endocrinol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib33","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-8587(17)30181-X","article-title":"Diabetes in sub-Saharan Africa: from clinical care to health policy","volume":"5","author":"Atun","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib34","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1080\/22201009.2011.10872264","article-title":"The epidemiology and pathogenesis of type 1 diabetes mellitus in Africa","volume":"16","author":"Padoa","year":"2011","journal-title":"J Endocrinol Metab Diabetes South Africa"},{"key":"10.1016\/S2213-8587(26)00065-3_bib35","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2023.1014626","article-title":"The phenotype of type 1 diabetes in sub-Saharan Africa","volume":"11","author":"Katte","year":"2023","journal-title":"Front Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib36","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/S2213-8587(25)00120-2","article-title":"Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study","volume":"13","author":"Katte","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib37","series-title":"Principles of medicine in Africa","first-page":"607","article-title":"Diabetes mellitus","author":"Mbanya","year":"2025"},{"key":"10.1016\/S2213-8587(26)00065-3_bib38","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13300-020-00958-z","article-title":"African cuisine-centered insulin therapy: expert opinion on the management of hyperglycaemia in adult patients with type 2 diabetes mellitus","volume":"12","author":"Mbanya","year":"2021","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(26)00065-3_bib39","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13690-019-0362-0","article-title":"Prevalence and determinants of gestational diabetes mellitus in Africa based on the updated international diagnostic criteria: a systematic review and meta-analysis","volume":"77","author":"Muche","year":"2019","journal-title":"Arch Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib40","doi-asserted-by":"crossref","first-page":"645","DOI":"10.2337\/diabetes.53.3.645","article-title":"Ketosis-prone type 2 diabetes in patients of sub-Saharan African origin: clinical pathophysiology and natural history of \u03b2-cell dysfunction and insulin resistance","volume":"53","author":"Mauvais-Jarvis","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(26)00065-3_bib41","doi-asserted-by":"crossref","first-page":"912","DOI":"10.2337\/db12-0624","article-title":"Pathogenesis of A\u2212\u03b2+ ketosis-prone diabetes","volume":"62","author":"Patel","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(26)00065-3_bib42","doi-asserted-by":"crossref","first-page":"5090","DOI":"10.1210\/jc.2003-030180","article-title":"Ketosis-prone diabetes: dissection of a heterogeneous syndrome using an immunogenetic and \u03b2-cell functional classification, prospective analysis, and clinical outcomes","volume":"88","author":"Maldonado","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00065-3_bib43","doi-asserted-by":"crossref","first-page":"350","DOI":"10.7326\/0003-4819-144-5-200603070-00011","article-title":"Narrative review: ketosis-prone type 2 diabetes mellitus","volume":"144","author":"Umpierrez","year":"2006","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(26)00065-3_bib44","doi-asserted-by":"crossref","first-page":"2575","DOI":"10.2337\/dc06-0749","article-title":"Accuracy and predictive value of classification schemes for ketosis-prone diabetes","volume":"29","author":"Balasubramanyam","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00065-3_bib45","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.4158\/EP15778.OR","article-title":"The clinical and metabolic characteristics of young-onset ketosis-prone type 2 diabetes in China","volume":"21","author":"Zhang","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(26)00065-3_bib46","doi-asserted-by":"crossref","first-page":"439","DOI":"10.3892\/br.2015.461","article-title":"Male predominance in ketosis-prone diabetes mellitus (Review)","volume":"3","author":"Wang","year":"2015","journal-title":"Biomed Rep"},{"key":"10.1016\/S2213-8587(26)00065-3_bib47","doi-asserted-by":"crossref","first-page":"2770","DOI":"10.1001\/jama.299.23.2770","article-title":"Ketosis-prone type 2 diabetes mellitus and human herpesvirus 8 infection in sub-Saharan Africans","volume":"299","author":"Sobngwi","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00065-3_bib48","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2025.2580758","article-title":"Prevalence of cardiometabolic diseases in sub-Saharan Africa: a systematic review and meta-analysis","volume":"18","author":"Cassambai","year":"2025","journal-title":"Glob Health Action"},{"key":"10.1016\/S2213-8587(26)00065-3_bib49","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18115868","article-title":"Prevalence of type 2 diabetes in South Africa: a systematic review and meta-analysis","volume":"18","author":"Pheiffer","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib50","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.1016\/S2214-109X(24)00520-5","article-title":"Incident type 2 diabetes and its risk factors in men and women aged 40\u201360 years from four sub-Saharan African countries: results from the AWI-Gen study","volume":"13","author":"Chikwati","year":"2025","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib51","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/j.diabres.2012.10.018","article-title":"Three-year's changes in glucose tolerance status in the Bellville South cohort: rates and phenotypes associated with progression","volume":"99","author":"Matsha","year":"2013","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(26)00065-3_bib52","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1016\/j.puhe.2009.07.009","article-title":"Prevalence and time trends in diabetes and physical inactivity among adult west African populations: the epidemic has arrived","volume":"123","author":"Abubakari","year":"2009","journal-title":"Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib53","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1186\/1471-2458-11-564","article-title":"Diabetes in sub-Saharan Africa 1999\u20132011: epidemiology and public health implications. A systematic review","volume":"11","author":"Hall","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib54","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063318","article-title":"Association between urban\u2013rural location and prevalence of type 2 diabetes and impaired fasting glucose in west Africa: a cross-sectional population-based epidemiological study","volume":"13","author":"Issaka","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00065-3_bib55","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1186\/s12916-016-0709-0","article-title":"Obesity and type 2 diabetes in sub-Saharan Africans\u2014is the burden in today's Africa similar to African migrants in Europe? The RODAM study","volume":"14","author":"Agyemang","year":"2016","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(26)00065-3_bib56","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2471\/BLT.12.113415","article-title":"Differences by sex in the prevalence of diabetes mellitus, impaired fasting glycaemia and impaired glucose tolerance in sub-Saharan Africa: a systematic review and meta-analysis","volume":"91","author":"Hilawe","year":"2013","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(26)00065-3_bib57","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091782","article-title":"Changing dietary habits: the impact of urbanization and rising socio-economic status in families from Burkina Faso in sub-Saharan Africa","volume":"14","author":"Casari","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(26)00065-3_bib58","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S2213-8587(17)30432-1","article-title":"Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi","volume":"6","author":"Price","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib59","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/S2213-8587(15)00363-0","article-title":"The prevalence of type 2 diabetes among older people in Africa: a systematic review","volume":"4","author":"Werfalli","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib60","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-18964-2","article-title":"Assessment of non-communicable disease risk factors, functional performance, and health-related quality of life in adults: a comparative analysis in low-resourced urban and rural areas of South Africa","volume":"24","author":"Ramalivhana","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib61","doi-asserted-by":"crossref","DOI":"10.1016\/j.jth.2022.101558","article-title":"Active travel and paratransit use in African cities: mixed-method systematic review and meta-ethnography","volume":"28","author":"Randall","year":"2023","journal-title":"J Transp Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib62","series-title":"Sedentary behaviour\u2014a contemporary view","article-title":"Lifestyle transition towards sedentary behavior among children and youth in sub-Saharan Africa: a narrative review","author":"Wachira","year":"2021"},{"key":"10.1016\/S2213-8587(26)00065-3_bib63","article-title":"Regional and sectorial distribution of cardiovascular risk factors among sub-Saharan Africa workforce: a systematic review","volume":"17","author":"Bamidele Adelowo","year":"2025","journal-title":"Cureus"},{"key":"10.1016\/S2213-8587(26)00065-3_bib64","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/S2352-4642(19)30323-2","article-title":"Global trends in insufficient physical activity among adolescents: a pooled analysis of 298 population-based surveys with 1\u00b76 million participants","volume":"4","author":"Guthold","year":"2020","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib65","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph21121707","article-title":"Knowledge, attitudes, and practice regarding physical exercise in type 2 diabetic and non-diabetic staff at a tertiary institution","volume":"21","author":"Sibazo","year":"2024","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib66","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/jep.14035","article-title":"Adherence to medication, dietary and physical activity recommendations: findings from a multicenter cross-sectional study among adults with diabetes in rural South Africa","volume":"30","author":"Owolabi","year":"2024","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/S2213-8587(26)00065-3_bib67","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1177\/17579759231205852","article-title":"Behavioural risk factors for non-communicable diseases among South African Durban-based refugees: a cross-sectional study","volume":"31","author":"Grace","year":"2024","journal-title":"Glob Health Promot"},{"key":"10.1016\/S2213-8587(26)00065-3_bib68","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/7948712","article-title":"Barriers and strategies to lifestyle and dietary pattern interventions for prevention and management of type-2 diabetes in Africa, systematic review","volume":"2020","author":"Bekele","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/S2213-8587(26)00065-3_bib69","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1016\/j.smhs.2022.12.001","article-title":"Benefits and barriers to physical activity among African women: a systematic review","volume":"5","author":"Obi","year":"2023","journal-title":"Sports Med Health Sci"},{"key":"10.1016\/S2213-8587(26)00065-3_bib70","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.pcad.2020.11.002","article-title":"Overcoming barriers to physical activity in underserved populations","volume":"64","author":"Bantham","year":"2021","journal-title":"Prog Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(26)00065-3_bib71","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.1016\/S0140-6736(10)60550-8","article-title":"Diabetes in sub-Saharan Africa","volume":"375","author":"Mbanya","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00065-3_bib72","doi-asserted-by":"crossref","first-page":"466","DOI":"10.1017\/S0029665114001669","article-title":"An overview of the nutrition transition in west Africa: implications for non-communicable diseases","volume":"74","author":"Bosu","year":"2015","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/S2213-8587(26)00065-3_bib73","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1017\/S0029665118002860","article-title":"Sugar-sweetened beverage consumption in the early years and implications for type-2 diabetes: a sub-Saharan Africa context","volume":"78","author":"Audain","year":"2019","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/S2213-8587(26)00065-3_bib75","doi-asserted-by":"crossref","first-page":"1948","DOI":"10.1017\/S1368980019004014","article-title":"Dietary behaviours in the context of nutrition transition: a systematic review and meta-analyses in two African countries","volume":"23","author":"Rousham","year":"2020","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(26)00065-3_bib76","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/07853890.2023.2182909","article-title":"Prevalence and associated factors of overweight and obesity among persons with type 2 diabetes in Africa: a systematic review and meta-analysis","volume":"55","author":"Ekpor","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/S2213-8587(26)00065-3_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.numecd.2023.06.011","article-title":"The association between body weight indices, behavioral factors, and type 2 diabetes mellitus in Africa: a systematic review and meta-analysis of population-based epidemiological studies","volume":"34","author":"Issaka","year":"2024","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(26)00065-3_bib78","doi-asserted-by":"crossref","DOI":"10.1155\/2024\/1240457","article-title":"Exploring the prevalence and components of metabolic syndrome in sub-Saharan African type 2 diabetes mellitus patients: a systematic review and meta-analysis","volume":"2024","author":"Musilanga","year":"2024","journal-title":"J Obes"},{"key":"10.1016\/S2213-8587(26)00065-3_bib79","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001931","article-title":"Regional prevalence of hypertension among people diagnosed with diabetes in Africa: a systematic review and meta-analysis","volume":"3","author":"Hinneh","year":"2023","journal-title":"PLoS Glob Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib80","doi-asserted-by":"crossref","first-page":"3468","DOI":"10.1097\/MS9.0000000000002122","article-title":"Prevalence of dyslipidemia among persons with type 2 diabetes in Africa: a systematic review and meta-analysis","volume":"86","author":"Ekpor","year":"2024","journal-title":"Ann Med Surg"},{"key":"10.1016\/S2213-8587(26)00065-3_bib81","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/ije\/dyx078","article-title":"Trends in obesity and diabetes across Africa from 1980 to 2014: an analysis of pooled population-based studies","volume":"46","year":"2017","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib82","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.09.020426","article-title":"Prevalence and determinants of type 2 diabetes among lean African migrants and non-migrants: the RODAM study","volume":"9","author":"Chilunga","year":"2019","journal-title":"J Glob Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib83","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1007\/s00125-021-05644-8","article-title":"Understanding the pathogenesis of lean non-autoimmune diabetes in an African population with newly diagnosed diabetes","volume":"65","author":"Kibirige","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00065-3_bib84","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1304501","article-title":"Body-mass index and mortality among adults with incident type 2 diabetes","volume":"370","author":"Tobias","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00065-3_bib85","series-title":"Endotext","article-title":"Lean non-autoimmune diabetes in adults in the Tropics. Jan 1, 2026","author":"Dasgupta","year":"2000"},{"key":"10.1016\/S2213-8587(26)00065-3_bib86","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1093\/ije\/dyr029","article-title":"Type 2 diabetes incidence and socio-economic position: a systematic review and meta-analysis","volume":"40","author":"Agardh","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib87","doi-asserted-by":"crossref","first-page":"767","DOI":"10.2337\/dc19-1782","article-title":"Diabetes prevalence and its relationship with education, wealth, and BMI in 29 low- and middle-income countries","volume":"43","author":"Seiglie","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00065-3_bib88","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1186\/s12889-023-15186-w","article-title":"Socioeconomic inequalities in diabetes prevalence: the case of South Africa between 2003 and 2016","volume":"23","author":"Sidahmed","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib89","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1136\/jech-2016-208322","article-title":"Association between socioeconomic position and the prevalence of type 2 diabetes in Ghanaians in different geographic locations: the RODAM study","volume":"71","author":"Addo","year":"2017","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib90","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1186\/s12902-024-01803-1","article-title":"Prevalence of diabetes and its associated factors in Cape Verde: an analysis of the 2020 WHO STEPS survey on non-communicable diseases risk factors","volume":"24","author":"Okyere","year":"2024","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(26)00065-3_bib91","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-47169-6","article-title":"Early-life factors are associated with waist circumference and type 2 diabetes among Ghanaian adults: the RODAM study","volume":"9","author":"Danquah","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(26)00065-3_bib92","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1744-8603-5-10","article-title":"An overview of cardiovascular risk factor burden in sub-Saharan African countries: a socio-cultural perspective","volume":"5","author":"BeLue","year":"2009","journal-title":"Global Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib93","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1186\/s12889-016-3028-7","article-title":"Perceptions of body size, obesity threat and the willingness to lose weight among Black South African adults: a qualitative study","volume":"16","author":"Okop","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib94","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1007\/s40519-013-0060-9","article-title":"Body size preference among Yoruba in three Nigerian communities","volume":"19","author":"Okoro","year":"2014","journal-title":"Eat Weight Disord"},{"key":"10.1016\/S2213-8587(26)00065-3_bib95","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1472-6823-9-5","article-title":"Diabetes mellitus: indigenous naming, indigenous diagnosis and self-management in an African setting: the example from Cameroon","volume":"9","author":"Awah","year":"2009","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(26)00065-3_bib96","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrendo.2017.64","article-title":"Type 2 diabetes mellitus and psychological stress\u2014a modifiable risk factor","volume":"13","author":"Hackett","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib97","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1146\/annurev-publhealth-031914-122921","article-title":"Stress and type 2 diabetes: a review of how stress contributes to the development of type 2 diabetes","volume":"36","author":"Kelly","year":"2015","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib98","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15006","article-title":"Associations of psychosocial stress with type 2 diabetes and glycaemic control among Ghanaians: the RODAM study","volume":"40","author":"Chilunga","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(26)00065-3_bib99","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph20105798","article-title":"Prevalence and psychosocial correlates of diabetes mellitus in South Africa: results from the South African National Health and Nutrition Examination Survey (SANHANES-1)","volume":"20","author":"Sifunda","year":"2023","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib100","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1177\/13591053251341786","article-title":"Psychosocial burden of diabetes in Africa: a systematic review and meta-analysis","volume":"31","author":"Boakye","year":"2026","journal-title":"J Health Psychol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib102","first-page":"810","article-title":"Malaria and diabetes","volume":"67","author":"Kalra","year":"2017","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/S2213-8587(26)00065-3_bib103","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1038\/nri3742","article-title":"Innate sensing of malaria parasites","volume":"14","author":"Gazzinelli","year":"2014","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib104","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2023.1028303","article-title":"Is TNF alpha a mediator in the co-existence of malaria and type 2 diabetes in a malaria endemic population?","volume":"14","author":"Ademola","year":"2023","journal-title":"Front Immunol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib105","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1007\/s11892-013-0375-y","article-title":"Diabetes mellitus and inflammation","volume":"13","author":"Lontchi-Yimagou","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(26)00065-3_bib106","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1186\/s40794-025-00248-1","article-title":"Current update on malaria in pregnancy: a systematic review","volume":"11","author":"Minwuyelet","year":"2025","journal-title":"Trop Dis Travel Med Vaccines"},{"key":"10.1016\/S2213-8587(26)00065-3_bib107","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002639","article-title":"Influence of placental and peripheral malaria exposure in fetal life on cardiometabolic traits in adult offspring","volume":"10","author":"Grunnet","year":"2022","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(26)00065-3_bib108","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/infdis\/jiae377","article-title":"Obesity, diabetes, plasmodium infection, and severe malaria in adults: a systematic review and meta-analysis","volume":"230","author":"Lee","year":"2024","journal-title":"J Infect Dis"},{"key":"10.1016\/S2213-8587(26)00065-3_bib109","doi-asserted-by":"crossref","first-page":"2480","DOI":"10.1038\/s41591-024-03089-1","article-title":"Adaptive selection at G6PD and disparities in diabetes complications","volume":"30","author":"Breeyear","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00065-3_bib111","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1080\/14656566.2025.2508904","article-title":"Clinical, metabolic, and immune interaction between tuberculosis and diabetes mellitus: implications and opportunities for therapies","volume":"26","author":"Magodoro","year":"2025","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/S2213-8587(26)00065-3_bib112","article-title":"Diabetes as a risk factor for tuberculosis disease","volume":"8","author":"Franco","year":"2024","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(26)00065-3_bib113","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40140","article-title":"Burden of active tuberculosis among patients with diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis","volume":"10","author":"Kassie","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/S2213-8587(26)00065-3_bib114","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-47285-4","article-title":"Burden and associated phenotypic characteristics of tuberculosis infection in adult Africans with diabetes: a systematic review","volume":"13","author":"Kibirige","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(26)00065-3_bib115","doi-asserted-by":"crossref","first-page":"e448","DOI":"10.1016\/S2214-109X(18)30487-X","article-title":"Global prevalence of diabetes in active tuberculosis: a systematic review and meta-analysis of data from 2\u00b73 million patients with tuberculosis","volume":"7","author":"Noubiap","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib116","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12879-019-3892-8","article-title":"Prevalence of diabetes mellitus among tuberculosis patients in sub-Saharan Africa: a systematic review and meta-analysis of observational studies","volume":"19","author":"Alebel","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/S2213-8587(26)00065-3_bib117","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1111\/tmi.13733","article-title":"Tuberculosis risk among people with diabetes mellitus in sub-Saharan Africa: a systematic review","volume":"27","author":"Obels","year":"2022","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib119","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0261246","article-title":"Diabetes mellitus and tuberculosis, a systematic review and meta-analysis with sensitivity analysis for studies comparable for confounders","volume":"16","author":"Foe-Essomba","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00065-3_bib120","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1186\/s12879-020-05512-7","article-title":"The epidemiology of tuberculosis-associated hyperglycemia in individuals newly screened for type 2 diabetes mellitus: systematic review and meta-analysis","volume":"20","author":"Menon","year":"2020","journal-title":"BMC Infect Dis"},{"key":"10.1016\/S2213-8587(26)00065-3_bib121","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2022.2114146","article-title":"Tuberculosis treatment and resulting abnormal blood glucose: a scoping review of studies from 1981 - 2021","volume":"15","author":"Williams","year":"2022","journal-title":"Glob Health Action"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(26)00065-3_bib123","doi-asserted-by":"crossref","first-page":"s5","DOI":"10.1097\/QAD.0000000000001888","article-title":"Noncommunicable diseases among HIV-infected persons in low-income and middle-income countries: a systematic review and meta-analysis","volume":"32","author":"Patel","year":"2018","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(26)00065-3_bib124","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.26059","article-title":"Prevalence and influences of diabetes and prediabetes among adults living with HIV in Africa: a systematic review and meta-analysis","volume":"26","author":"Peer","year":"2023","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/S2213-8587(26)00065-3_bib125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-013953","article-title":"Incidence and prevalence of type 2 diabetes mellitus with HIV infection in Africa: a systematic review and meta-analysis","volume":"7","author":"Prioreschi","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00065-3_bib126","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/j.ecl.2014.05.003","article-title":"Diabetes mellitus type 2 and abnormal glucose metabolism in the setting of human immunodeficiency virus","volume":"43","author":"Hadigan","year":"2014","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(26)00065-3_bib127","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1007\/s11892-018-1076-3","article-title":"Diabetes and HIV","volume":"18","author":"Noubissi","year":"2018","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(26)00065-3_bib128","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2022-003136","article-title":"Association between integrase strand transfer inhibitor use with insulin resistance and incident diabetes mellitus in persons living with HIV: a systematic review and meta-analysis","volume":"11","author":"Mulindwa","year":"2023","journal-title":"BMJ Open Diab Res Care"},{"key":"10.1016\/S2213-8587(26)00065-3_bib129","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41586-024-07019-6","article-title":"Genetic drivers of heterogeneity in type 2 diabetes pathophysiology","volume":"627","author":"Suzuki","year":"2024","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(26)00065-3_bib130","doi-asserted-by":"crossref","first-page":"838","DOI":"10.2337\/diabetes.53.3.838","article-title":"A genome-wide search for type 2 diabetes susceptibility genes in west Africans: the Africa America Diabetes Mellitus (AADM) Study","volume":"53","author":"Rotimi","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(26)00065-3_bib131","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.diabres.2007.04.010","article-title":"Genome-wide search for susceptibility genes to type 2 diabetes in west Africans: potential role of C-peptide","volume":"78","author":"Chen","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(26)00065-3_bib132","doi-asserted-by":"crossref","first-page":"1204","DOI":"10.1007\/s00125-019-4880-7","article-title":"Genome-wide association study of type 2 diabetes in Africa","volume":"62","author":"Chen","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00065-3_bib133","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00125-025-06395-6","article-title":"Genome-wide association study identifying novel risk variants associated with glycaemic traits in the continental African AWI-Gen cohort","volume":"68","author":"Chebii","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00065-3_bib134","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.diabres.2016.01.003","article-title":"Genetic risk of type 2 diabetes in populations of the African continent: a systematic review and meta-analyses","volume":"114","author":"Yako","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(26)00065-3_bib135","doi-asserted-by":"crossref","DOI":"10.1155\/2020\/3198671","article-title":"Heritability and genetics of type 2 diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis","volume":"2020","author":"Asamoah","year":"2020","journal-title":"J Diabetes Res"},{"key":"10.1016\/S2213-8587(26)00065-3_bib136","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2026.106265","article-title":"Insights into the genetic aetiology of diabetes in Africa","author":"Wade","year":"2026","journal-title":"eBioMedicine"},{"key":"10.1016\/S2213-8587(26)00065-3_bib137","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.clinbiochem.2015.11.021","article-title":"Differential DNA methylation of microRNAs within promoters, intergenic and intragenic regions of type 2 diabetic, pre-diabetic and non-diabetic individuals","volume":"49","author":"Pheiffer","year":"2016","journal-title":"Clin Biochem"},{"key":"10.1016\/S2213-8587(26)00065-3_bib138","doi-asserted-by":"crossref","DOI":"10.1155\/2016\/8738072","article-title":"Glucose tolerance, MTHFR C677T and NOS3 G894T polymorphisms, and global DNA methylation in mixed ancestry African individuals","volume":"2016","author":"Matsha","year":"2016","journal-title":"J Diabetes Res"},{"key":"10.1016\/S2213-8587(26)00065-3_bib139","doi-asserted-by":"crossref","DOI":"10.3389\/fgene.2021.702410","article-title":"Expression profiles of circulating microRNAs in South African type 2 diabetic individuals on treatment","volume":"12","author":"Weale","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/S2213-8587(26)00065-3_bib140","doi-asserted-by":"crossref","first-page":"30485","DOI":"10.18632\/oncotarget.25271","article-title":"MicroRNA profiling and their pathways in South African individuals with prediabetes and newly diagnosed type 2 diabetes mellitus","volume":"9","author":"Matsha","year":"2018","journal-title":"Oncotarget"},{"key":"10.1016\/S2213-8587(26)00065-3_bib141","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1093\/ije\/dyy171","article-title":"Epigenome-wide association study in whole blood on type 2 diabetes among sub-Saharan African individuals: findings from the RODAM study","volume":"48","author":"Meeks","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(26)00065-3_bib142","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/s13148-024-01758-z","article-title":"A comprehensive lifestyle index and its associations with DNA methylation and type 2 diabetes among Ghanaian adults: the RODAM study","volume":"16","author":"Abidha","year":"2024","journal-title":"Clin Epigenetics"},{"key":"10.1016\/S2213-8587(26)00065-3_bib143","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/s13148-024-01670-6","article-title":"DNA methylation and type 2 diabetes: a systematic review","volume":"16","author":"Nadiger","year":"2024","journal-title":"Clin Epigenetics"},{"key":"10.1016\/S2213-8587(26)00065-3_bib144","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4134937","article-title":"The burden of undiagnosed diabetes mellitus in adult African population: a systematic review and meta-analysis","volume":"2019","author":"Asmelash","year":"2019","journal-title":"J Diabetes Res"},{"key":"10.1016\/S2213-8587(26)00065-3_bib146","first-page":"110","article-title":"Socioeconomic factors and barriers to healthcare access for diabetes in west Africa","volume":"7","author":"Twamina","year":"2025","journal-title":"Eur Exp J Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib147","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00065-3_bib148","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00065-3_bib149","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","article-title":"The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study","volume":"371","author":"Li","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00065-3_bib150","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00065-3_bib151","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1186\/s12889-022-14884-1","article-title":"A study protocol for a cluster randomized controlled trial to test the applicability of the South African diabetes prevention program in the Eastern Cape Province of South Africa","volume":"23","author":"Hill","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib152","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13643-020-01377-8","article-title":"The effectiveness of peer and community health worker-led self-management support programs for improving diabetes health-related outcomes in adults in low- and-middle-income countries: a systematic review","volume":"9","author":"Werfalli","year":"2020","journal-title":"Syst Rev"},{"key":"10.1016\/S2213-8587(26)00065-3_bib153","doi-asserted-by":"crossref","first-page":"e170","DOI":"10.1016\/S2214-109X(20)30449-6","article-title":"Task-sharing interventions for improving control of diabetes in low-income and middle-income countries: a systematic review and meta-analysis","volume":"9","author":"Maria","year":"2021","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(26)00065-3_bib154","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-079776","article-title":"Public health surveillance through community health workers: a scoping review of evidence from 25 low-income and middle-income countries","volume":"14","author":"Alhassan","year":"2024","journal-title":"BMJ Open"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000653?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000653?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,4]],"date-time":"2026-07-04T08:59:57Z","timestamp":1783155597000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000653"}},"issued":{"date-parts":[[2026,6]]},"references-count":145,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2213858726000653"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00065-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Burden and determinants of diabetes in sub-Saharan Africa","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00065-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00036-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00035-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00099-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,9]],"date-time":"2026-11-09T17:55:09Z","timestamp":1794246909050,"version":"4.9.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,23]],"date-time":"2025-01-23T00:00:00Z","timestamp":1737590400000},"content-version":"am","delay-in-days":175,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100012729","name":"Case Western Reserve University Clinical and Translational Science Collaborative","doi-asserted-by":"publisher","award":["UM1TR004528"],"award-info":[{"award-number":["UM1TR004528"]}],"id":[{"id":"10.13039\/100012729","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01DK121619"],"award-info":[{"award-number":["R01DK121619"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/s2213-8587(24)00150-5","type":"journal-article","created":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T18:38:18Z","timestamp":1719859098000},"page":"523-534","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial"],"prefix":"10.1016","volume":"12","author":[{"given":"Allison Ross","family":"Eckard","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qian","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdus","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kianoush","family":"Ansari-Gilani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danielle","family":"Labbato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron A","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth O","family":"Adekunle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grace A","family":"McComsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00150-5_bib1","doi-asserted-by":"crossref","first-page":"1837","DOI":"10.1086\/430379","article-title":"Prevalence of, evolution of, and risk factors for fat atrophy and fat deposition in a cohort of HIV-infected men and women","volume":"40","author":"Jacobson","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(24)00150-5_bib2","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1097\/QAI.0000000000001606","article-title":"Abdominal fat depots and subclinical carotid artery atherosclerosis in women with and without HIV infection","volume":"77","author":"Glesby","year":"2018","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(24)00150-5_bib3","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1097\/QAI.0000000000002776","article-title":"Poorer muscle quality and quantity with ART initiation is associated with greater inflammation and immune activation","volume":"88","author":"Kousari","year":"2021","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(24)00150-5_bib4","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1097\/00126334-200001010-00005","article-title":"Hyperlipidemia and insulin resistance are induced by protease inhibitors independent of changes in body composition in patients with HIV infection","volume":"23","author":"Mulligan","year":"2000","journal-title":"J Acquir Immune Defic Syndr"},{"key":"10.1016\/S2213-8587(24)00150-5_bib5","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1210\/jc.2002-020795","article-title":"Hypoadiponectinemia is associated with insulin resistance, hypertriglyceridemia, and fat redistribution in human immunodeficiency virus-infected patients treated with highly active antiretroviral therapy","volume":"88","author":"Addy","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00150-5_bib6","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.1093\/cid\/cir627","article-title":"Premature age-related comorbidities among HIV-infected persons compared with the general population","volume":"53","author":"Guaraldi","year":"2011","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(24)00150-5_bib7","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1056\/NEJMoa030218","article-title":"Combination antiretroviral therapy and the risk of myocardial infarction","volume":"349","author":"Friis-M\u00f8ller","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00150-5_bib8","doi-asserted-by":"crossref","first-page":"1427","DOI":"10.1016\/j.amjcard.2017.07.019","article-title":"Effect of pericardial fat volume and density on markers of insulin resistance and inflammation in patients with human immunodeficiency virus infection","volume":"120","author":"Longenecker","year":"2017","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(24)00150-5_bib9","doi-asserted-by":"crossref","first-page":"1464","DOI":"10.1086\/383573","article-title":"Factors associated with severe impact of lipodystrophy on the quality of life of patients infected with HIV-1","volume":"38","author":"Blanch","year":"2004","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(24)00150-5_bib10","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1080\/09540121.2019.1687832","article-title":"Self-reported lipodystrophy, nutritional, lipemic profile and its impact on the body image of HIV-1-infected persons, with and without antiretroviral therapy","volume":"32","author":"Soares","year":"2020","journal-title":"AIDS Care"},{"key":"10.1016\/S2213-8587(24)00150-5_bib12","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1016\/S2213-8587(22)00008-0","article-title":"Semaglutide once a week in adults with overweight or obesity, with or without type 2 diabetes in an east Asian population (STEP 6): a randomised, double-blind, double-dummy, placebo-controlled, phase 3a trial","volume":"10","author":"Kadowaki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00150-5_bib13","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00150-5_bib14","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1001\/jama.2021.1831","article-title":"Effect of subcutaneous semaglutide vs placebo as an adjunct to intensive behavioral therapy on body weight in adults with overweight or obesity: the STEP 3 randomized clinical trial","volume":"325","author":"Wadden","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00150-5_bib15","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00150-5_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0289616","article-title":"The effects of GLP-1 receptor agonists on visceral fat and liver ectopic fat in an adult population with or without diabetes and nonalcoholic fatty liver disease: a systematic review and meta-analysis","volume":"18","author":"Liao","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(24)00150-5_bib17","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S2213-8587(17)30013-X","article-title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","volume":"5","author":"Sorli","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00150-5_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S2213-8587(17)30092-X","article-title":"Efficacy and safety of once-weekly semaglutide versus once-daily sitagliptin as an add-on to metformin, thiazolidinediones, or both, in patients with type 2 diabetes (SUSTAIN 2): a 56-week, double-blind, phase 3a, randomised trial","volume":"5","author":"Ahr\u00e9n","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00150-5_bib19","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1002\/cbf.3751","article-title":"Semaglutide (GLP-1 receptor agonist) stimulates browning on subcutaneous fat adipocytes and mitigates inflammation and endoplasmic reticulum stress in visceral fat adip0ocytes of obese mice","volume":"40","author":"Martins","year":"2022","journal-title":"Cell Biochem Funct"},{"key":"10.1016\/S2213-8587(24)00150-5_bib20","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvz042","article-title":"Effects of semaglutide versus dulaglutide on epicardial fat thickness in subjects with type 2 diabetes and obesity","volume":"4","author":"Iacobellis","year":"2020","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(24)00150-5_bib21","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00150-5_bib22","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1093\/cid\/ciw017","article-title":"Body composition changes after initiation of raltegravir or protease inhibitors: ACTG A5260s","volume":"62","author":"McComsey","year":"2016","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(24)00150-5_bib23","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1152\/jappl.2000.89.1.104","article-title":"Skeletal muscle attenuation determined by computed tomography is associated with skeletal muscle lipid content","volume":"89","author":"Goodpaster","year":"2000","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(24)00150-5_bib24","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0168-8278(97)80288-7","article-title":"Noninvasive in vivo quantitative assessment of fat content in human liver","volume":"27","author":"Ricci","year":"1997","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(24)00150-5_bib25","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.2214\/AJR.06.0992","article-title":"Comparison of CT methods for determining the fat content of the liver","volume":"188","author":"Kodama","year":"2007","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/S2213-8587(24)00150-5_bib26","article-title":"Central fatness and risk of all cause mortality: systematic review and dose-response meta-analysis of 72 prospective cohort studies","volume":"370","author":"Jayedi","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00150-5_bib27","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity","volume":"16","author":"Ross","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00150-5_bib28","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/dc09-1825","article-title":"Visceral Adiposity Index: a reliable indicator of visceral fat function associated with cardiometabolic risk","volume":"33","author":"Amato","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00150-5_bib29","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s00125-019-05065-8","article-title":"Effects of once-weekly semaglutide vs once-daily canagliflozin on body composition in type 2 diabetes: a substudy of the SUSTAIN 8 randomised controlled clinical trial","volume":"63","author":"McCrimmon","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00150-5_bib30","doi-asserted-by":"crossref","first-page":"4857","DOI":"10.1210\/jc.2018-02785","article-title":"CT fat density accurately reflects histologic fat quality in adults with HIV on and off antiretroviral therapy","volume":"104","author":"Lake","year":"2019","journal-title":"J Clin Endocrinol Metab"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(25)00051-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001505?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001505?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:59Z","timestamp":1778858759000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001505"}},"issued":{"date-parts":[[2024,8]]},"references-count":29,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2213858724001505"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00150-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Once-weekly semaglutide in people with HIV-associated lipohypertrophy: a randomised, double-blind, placebo-controlled phase 2b single-centre clinical trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00150-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00162-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T00:01:00Z","timestamp":1794441660490,"version":"4.9.1"},"reference-count":36,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009860","name":"Ramaciotti Foundations","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009860","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/s2213-8587(24)00155-4","type":"journal-article","created":{"date-parts":[[2024,7,8]],"date-time":"2024-07-08T18:34:29Z","timestamp":1720463669000},"page":"545-557","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":175,"title":["Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials"],"prefix":"10.1016","volume":"12","author":[{"given":"Ellen M","family":"Apperloo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendon L","family":"Neuen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Jongs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan D","family":"Anker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepak L","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Javed","family":"Butler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David Z I","family":"Cherney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William G","family":"Herrington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silvio E","family":"Inzucchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meg J","family":"Jardine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chih-Chin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth W","family":"Mahaffey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren K","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J V","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milton","family":"Packer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S","family":"Sabatine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Staplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Szarek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muthiah","family":"Vaduganathan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Wanner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David C","family":"Wheeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen D","family":"Wiviott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Faiez","family":"Zannad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiddo J L","family":"Heerspink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00155-4_bib1","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","year":"2022","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00155-4_bib2","first-page":"S179","article-title":"Cardiovascular disease and risk management: standards of care in diabetes-2024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00155-4_bib3","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1093\/eurheartj\/ehad192","article-title":"2023 ESC guidelines for the management of cardiovascular disease in patients with diabetes","volume":"44","author":"Marx","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(24)00155-4_bib4","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/j.kint.2023.10.016","article-title":"Executive summary of the KDIGO 2024 Clinical Practice Guideline for the Evaluation and Management of Chronic Kidney Disease: known knowns and known unknowns","volume":"105","author":"Levin","year":"2024","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(24)00155-4_bib5","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00155-4_bib6","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00155-4_bib7","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00155-4_bib8","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.kint.2022.06.008","article-title":"KDIGO 2022 clinical practice guideline for diabetes management in chronic kidney disease","volume":"102","author":"Rossing","year":"2022","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(24)00155-4_bib9","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1161\/CIRCULATIONAHA.124.069568","article-title":"Sodium glucose co-transporter 2 inhibitors and major adverse cardiovascular outcomes: a SMART-C collaborative meta-analysis","volume":"149","author":"Patel","year":"2024","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00155-4_bib10","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00155-4_bib11","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00155-4_bib12","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1056\/NEJMoa1911303","article-title":"Dapagliflozin in patients with heart failure and reduced ejection fraction","volume":"381","author":"McMurray","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00155-4_bib13","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00155-4_bib14","doi-asserted-by":"crossref","first-page":"1451","DOI":"10.1056\/NEJMoa2107038","article-title":"Empagliflozin in heart failure with a preserved ejection fraction","volume":"385","author":"Anker","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00155-4_bib15","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1056\/NEJMoa2206286","article-title":"Dapagliflozin in heart failure with mildly reduced or preserved ejection fraction","volume":"387","author":"Solomon","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00155-4_bib16","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2030183","article-title":"Sotagliflozin in patients with diabetes and recent worsening heart failure","volume":"384","author":"Bhatt","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00155-4_bib17","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00155-4_bib18","doi-asserted-by":"crossref","first-page":"1857","DOI":"10.1111\/dom.14108","article-title":"Glucagon-like peptide-1 receptor agonists and sodium-glucose co-transporter-2 inhibitors as combination therapy for type 2 diabetes: a systematic review and meta-analysis","volume":"22","author":"Mantsiou","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00155-4_bib19","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1111\/dom.15287","article-title":"Albuminuria-lowering effect of adding semaglutide on top of empagliflozin in individuals with type 2 diabetes: a randomized and placebo-controlled study","volume":"26","author":"Sivalingam","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00155-4_bib20","doi-asserted-by":"crossref","first-page":"1624","DOI":"10.1111\/dom.15464","article-title":"Separate and combined effects of empagliflozin and semaglutide on vascular function: a 32-week randomized trial","volume":"26","author":"Vernstr\u00f8m","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00155-4_bib21","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1111\/dom.14410","article-title":"Effect of exenatide twice daily and dapagliflozin, alone and in combination, on markers of kidney function in obese patients with type 2 diabetes: a prespecified secondary analysis of a randomized controlled clinical trial","volume":"23","author":"van Ruiten","year":"2021","journal-title":"Diabetes Obes Metab"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00155-4_bib22","first-page":"S179","article-title":"10. Cardiovascular disease and risk management: standards of care in diabetes-2024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00155-4_bib23","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00155-4_bib24","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1056\/NEJMoa2306963","article-title":"Semaglutide in patients with heart failure with preserved ejection fraction and obesity","volume":"389","author":"Kosiborod","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00155-4_bib25","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/S2213-8587(23)00321-2","article-title":"Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the Empa-kidney trial","volume":"12","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00155-4_bib26","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1016\/j.kint.2020.04.051","article-title":"Mediators of the effects of canagliflozin on kidney protection in patients with type 2 diabetes","volume":"98","author":"Li","year":"2020","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(24)00155-4_bib27","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00155-4_bib28","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1161\/CIRCULATIONAHA.118.037418","article-title":"Evaluation of glomerular hemodynamic function by empagliflozin in diabetic mice using in vivo imaging","volume":"140","author":"Kidokoro","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00155-4_bib29","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1161\/CIRCULATIONAHA.122.061732","article-title":"Critical reanalysis of the mechanisms underlying the cardiorenal benefits of SGLT2 inhibitors and reaffirmation of the nutrient deprivation signaling\/autophagy hypothesis","volume":"146","author":"Packer","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00155-4_bib30","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1007\/s00125-023-05906-7","article-title":"The expanding incretin universe: from basic biology to clinical translation","volume":"66","author":"Drucker","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00155-4_bib31","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00155-4_bib32","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1038\/s41591-023-02418-0","article-title":"A meta-analysis of GFR slope as a surrogate endpoint for kidney failure","volume":"29","author":"Inker","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00155-4_bib33","article-title":"Estimating the population-level impacts of improved uptake of SGLT2 inhibitors in patients with chronic kidney disease: a cross-sectional observational study using routinely collected Australian primary care data","volume":"43","author":"Neuen","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/S2213-8587(24)00155-4_bib34","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.2337\/dc22-0614","article-title":"Prescription patterns of cardiovascular- and kidney-protective therapies among patients with type 2 diabetes and chronic kidney disease","volume":"45","author":"Lamprea-Montealegre","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00155-4_bib35","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.1681\/ASN.2019010008","article-title":"Evaluating glomerular filtration rate slope as a surrogate end point for ESKD in clinical trials: an individual participant meta-analysis of observational data","volume":"30","author":"Grams","year":"2019","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(24)00155-4_bib36","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1016\/j.jacc.2023.05.048","article-title":"GLP-1 receptor agonist therapy with and without SGLT2 inhibitors in patients with type 2 diabetes","volume":"82","author":"Neves","year":"2023","journal-title":"J Am Coll Cardiol"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(26)00121-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000}},{"DOI":"10.1016\/s2213-8587(26)00121-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T00:00:00Z","timestamp":1782864000000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001554?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001554?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:26:43Z","timestamp":1778858803000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001554"}},"issued":{"date-parts":[[2024,8]]},"references-count":36,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2213858724001554"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00155-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of SGLT2 inhibitors with and without glucagon-like peptide 1 receptor agonists: a SMART-C collaborative meta-analysis of randomised controlled trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00155-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00183-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T17:44:25Z","timestamp":1793036665222,"version":"4.5.0"},"reference-count":40,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/s2213-8587(24)00341-3","type":"journal-article","created":{"date-parts":[[2025,2,7]],"date-time":"2025-02-07T18:33:33Z","timestamp":1738953213000},"page":"279-293","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy"],"prefix":"10.1016","volume":"13","author":[{"given":"Davide","family":"Catarinella","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raffaella","family":"Melzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessia","family":"Mercalli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Magistretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Tentori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chiara","family":"Gremizzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vera","family":"Paloschi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"De Cobelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Esposto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabrina","family":"Costa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Secchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossana","family":"Caldara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Maffi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rita","family":"Nano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorenzo","family":"Piemonti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00341-3_bib1","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1210\/er.2018-00154","article-title":"Pancreatic islet transplantation in humans: recent progress and future directions","volume":"40","author":"Rickels","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(24)00341-3_bib2","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1111\/ajt.16637","article-title":"Ten-year outcomes of islet transplantation in patients with type 1 diabetes: data from the Swiss-French GRAGIL network","volume":"21","author":"Lablanche","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(24)00341-3_bib3","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/ajt.13458","article-title":"Long-term follow-up of the Edmonton protocol of islet transplantation in the United States","volume":"16","author":"Brennan","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(24)00341-3_bib5","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2337\/dc19-0401","article-title":"Ten-year outcome of islet alone or islet after kidney transplantation in type 1 diabetes: a prospective parallel-arm cohort study","volume":"42","author":"Vantyghem","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00341-3_bib6","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.2337\/dc20-2458","article-title":"Survival after islet transplantation in subjects with type 1 diabetes: twenty-year follow-up","volume":"44","author":"Lemos","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00341-3_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jdi.13128","article-title":"Long-term outcome of islet transplantation on insulin-dependent diabetes mellitus: an observational cohort study","volume":"11","author":"Nakamura","year":"2020","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(24)00341-3_bib8","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1016\/S2213-8587(22)00114-0","article-title":"Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada","volume":"10","author":"Marfil-Garza","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00341-3_bib9","first-page":"e128","article-title":"25 years of the Ricordi automated method for islet isolation","volume":"1","author":"Piemonti","year":"2013","journal-title":"CellR4 Repair Replace Regen Reprogram"},{"key":"10.1016\/S2213-8587(24)00341-3_bib10","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1056\/NEJMoa061267","article-title":"International trial of the Edmonton protocol for islet transplantation","volume":"355","author":"Shapiro","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00341-3_bib11","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2022.10335","article-title":"Estimation of early graft function using the BETA-2 score following clinical islet transplantation","volume":"35","author":"Lam","year":"2022","journal-title":"Transpl Int"},{"key":"10.1016\/S2213-8587(24)00341-3_bib12","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00341-3_bib13","doi-asserted-by":"crossref","first-page":"964","DOI":"10.1007\/s00125-022-05659-9","article-title":"Mortality trends in type 1 diabetes: a multicountry analysis of six population-based cohorts","volume":"65","author":"Ruiz","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00341-3_bib14","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1097\/SLA.0000000000006415","article-title":"Evolution of pancreas transplantation at a single institution-50+ years and 2500 transplants","volume":"280","author":"Finger","year":"2024","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(24)00341-3_bib15","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s00125-022-05804-4","article-title":"Factors associated with favourable 5 year outcomes in islet transplant alone recipients with type 1 diabetes complicated by severe hypoglycaemia in the Collaborative Islet Transplant Registry","volume":"66","author":"Hering","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00341-3_bib16","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S2213-8587(23)00082-7","article-title":"Association between primary graft function and 5-year outcomes of islet allogeneic transplantation in type 1 diabetes: a retrospective, multicentre, observational cohort study in 1210 patients from the Collaborative Islet Transplant Registry","volume":"11","author":"Chetboun","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00341-3_bib17","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1600-6143.2011.03977.x","article-title":"Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes","volume":"12","author":"Bellin","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(24)00341-3_bib18","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2020.606332","article-title":"Innate immunity mediated inflammation and beta cell function: neighbors or enemies?","volume":"11","author":"Citro","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(24)00341-3_bib19","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.12320","article-title":"Peri-transplant inflammation and long-term diabetes outcomes were not impacted by either etanercept or alpha-1-antitrypsin treatment in islet autotransplant recipients","volume":"37","author":"Abdel-Karim","year":"2024","journal-title":"Transpl Int"},{"key":"10.1016\/S2213-8587(24)00341-3_bib20","doi-asserted-by":"crossref","first-page":"710","DOI":"10.2337\/dc19-1480","article-title":"Targeting CXCR1\/2 does not improve insulin secretion after pancreatic islet transplantation: a phase 3, double-blind, randomized, placebo-controlled trial in type 1 diabetes","volume":"43","author":"Maffi","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00341-3_bib21","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1111\/ajt.16695","article-title":"Targeting CXCR1\/2 in the first multicenter, double-blinded, randomized trial in autologous islet transplant recipients","volume":"21","author":"Witkowski","year":"2021","journal-title":"Am J Transplant"},{"issue":"10S2","key":"10.1016\/S2213-8587(24)00341-3_bib22","doi-asserted-by":"crossref","DOI":"10.1097\/01.tp.0000993940.30328.f8","article-title":"201\u00b75: TNF-alpha blockade during islet transplantation in immunosuppressed recipients: a study on in vitro, clinical, and CITR registry-derived data","volume":"107","author":"Landstra","year":"2023","journal-title":"Transplantation"},{"key":"10.1016\/S2213-8587(24)00341-3_bib23","doi-asserted-by":"crossref","DOI":"10.3390\/cancers15041347","article-title":"Variation in post-transplant cancer incidence among Italian kidney transplant recipients over a 25-year period","volume":"15","author":"Piselli","year":"2023","journal-title":"Cancers (Basel)"},{"key":"10.1016\/S2213-8587(24)00341-3_bib24","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1007\/s00125-016-3884-9","article-title":"Cancer incidence in persons with type 1 diabetes: a five-country study of 9,000 cancers in type 1 diabetic individuals","volume":"59","author":"Carstensen","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00341-3_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0060502","article-title":"Incidence and predictors of hospitalization for bacterial infection in community-based patients with type 2 diabetes: the fremantle diabetes study","volume":"8","author":"Hamilton","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(24)00341-3_bib26","doi-asserted-by":"crossref","first-page":"804","DOI":"10.4093\/dmj.2019.0071","article-title":"Diabetes and the risk of infection: a national cohort study","volume":"43","author":"Kim","year":"2019","journal-title":"Diabetes Metab J"},{"key":"10.1016\/S2213-8587(24)00341-3_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109862","article-title":"Proportions and trends of adult hospitalizations with diabetes, United States, 2000-2018","volume":"187","author":"Zhang","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(24)00341-3_bib28","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.111023","article-title":"A matched cohort study evaluating the risks of infections in people with type 1 diabetes and their associations with glycated haemoglobin","volume":"207","author":"Chaudhry","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(24)00341-3_bib29","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1097\/TP.0b013e3181d54bb9","article-title":"Epidemiology of infections requiring hospitalization during long-term follow-up of pancreas transplantation","volume":"89","author":"Rostambeigi","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/S2213-8587(24)00341-3_bib30","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2024.12235","article-title":"Infection-related hospitalizations after simultaneous pancreas-kidney transplantation compared to kidney transplantation alone","volume":"37","author":"Grasberger","year":"2024","journal-title":"Transpl Int"},{"key":"10.1016\/S2213-8587(24)00341-3_bib31","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1001321","article-title":"Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study","volume":"9","author":"Livingstone","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(24)00341-3_bib32","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.2337\/dc16-1162","article-title":"A contemporary estimate of total mortality and cardiovascular disease risk in young adults with type 1 diabetes: the Pittsburgh epidemiology of diabetes complications study","volume":"39","author":"Miller","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00341-3_bib33","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1111\/j.1600-6143.2006.01573.x","article-title":"Changes in renal function after clinical islet transplantation: four-year observational study","volume":"7","author":"Senior","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(24)00341-3_bib34","doi-asserted-by":"crossref","first-page":"2967","DOI":"10.2337\/dc21-2688","article-title":"Long-term outcomes with islet-alone and islet-after-kidney transplantation for type 1 diabetes in the clinical islet transplantation consortium: the CIT-08 study","volume":"45","author":"Rickels","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00341-3_bib35","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/TP.0000000000003627","article-title":"Treating type 1 diabetes by pancreas transplant alone: a cohort study on actual long-term (10 years) efficacy and safety","volume":"106","author":"Boggi","year":"2022","journal-title":"Transplantation"},{"key":"10.1016\/S2213-8587(24)00341-3_bib36","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1056\/NEJMoa1111732","article-title":"Intensive diabetes therapy and glomerular filtration rate in type 1 diabetes","volume":"365","author":"de Boer","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00341-3_bib37","doi-asserted-by":"crossref","first-page":"2311","DOI":"10.1111\/j.1600-6143.2007.01923.x","article-title":"High risk of sensitization after failed islet transplantation","volume":"7","author":"Campbell","year":"2007","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(24)00341-3_bib38","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1097\/01.tp.0000290388.70019.6e","article-title":"Allosensitization of islet allograft recipients","volume":"84","author":"Cardani","year":"2007","journal-title":"Transplantation"},{"key":"10.1016\/S2213-8587(24)00341-3_bib39","doi-asserted-by":"crossref","first-page":"901","DOI":"10.3727\/096368911X612468","article-title":"HLA class I sensitization in islet transplant recipients: report from the Collaborative Islet Transplant Registry","volume":"21","author":"Naziruddin","year":"2012","journal-title":"Cell Transplant"},{"key":"10.1016\/S2213-8587(24)00341-3_bib40","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11565","article-title":"Enhancing beta cell replacement therapies: exploring calcineurin inhibitor-sparing immunosuppressive regimens","volume":"36","author":"Caldara","year":"2023","journal-title":"Transpl Int"},{"key":"10.1016\/S2213-8587(24)00341-3_bib41","doi-asserted-by":"crossref","DOI":"10.3389\/ti.2023.11367","article-title":"A multi-modal approach to islet and pancreas transplantation with calcineurin-sparing immunosuppression maintains long-term insulin independence in patients with type i diabetes","volume":"36","author":"Wisel","year":"2023","journal-title":"Transpl Int"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,8]],"date-time":"2025-11-08T14:01:59Z","timestamp":1762610519000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003413"}},"issued":{"date-parts":[[2025,4]]},"references-count":40,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2213858724003413"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00341-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Long-term outcomes of pancreatic islet transplantation alone in type 1 diabetes: a 20-year single-centre study in Italy","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00341-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00003-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:47:29Z","timestamp":1793652449363,"version":"4.5.1"},"reference-count":13,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/s2213-8587(17)30100-6","type":"journal-article","created":{"date-parts":[[2017,4,27]],"date-time":"2017-04-27T00:00:15Z","timestamp":1493251215000},"page":"404-405","source":"Crossref","is-referenced-by-count":80,"title":["Global economic burden of diabetes and its implications"],"prefix":"10.1016","volume":"5","author":[{"given":"Ping","family":"Zhang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30100-6_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(17)30097-9","article-title":"The global economic burden of diabetes in adults aged 20\u201379: a cost-of-illiness study","author":"Bommer","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30100-6_bib2","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1001\/jama.2016.16885","article-title":"US Spending on personal health care and public health, 1996\u20132013","volume":"316","author":"Dieleman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30100-6_bib3","series-title":"IDF Diabetes Atlas","year":"2017"},{"key":"10.1016\/S2213-8587(17)30100-6_bib4","series-title":"IDF Diabetes Atlas","year":"2016"},{"key":"10.1016\/S2213-8587(17)30100-6_bib5","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/j.diabres.2010.01.026","article-title":"Global healthcare expenditure on diabetes for 2010 and 2030","volume":"87","author":"Zhang","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(17)30100-6_bib6","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.2337\/dc15-2308","article-title":"Age-specific trends from 2000\u20132011 in all-cause and cause-specific mortality in type 1 and type 2 diabetes: a cohort study of more than one million people","volume":"38","author":"Harding","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30100-6_bib7","doi-asserted-by":"crossref","first-page":"1252","DOI":"10.2337\/dc11-1162","article-title":"Trends in death rates among U.S. adults with and without diabetes between 1997 and 2006","volume":"35","author":"Gregg","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30100-6_bib8","doi-asserted-by":"crossref","first-page":"581","DOI":"10.2337\/dc14-1687","article-title":"Change in medical spending attributable to diabetes: national data from 1987 to 2011","volume":"38","author":"Zhuo","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30100-6_bib9","unstructured":"Medicines in Development for Diabetes 2016 Report, November 13, 2016 http:\/\/www.phrma.org\/report\/medicines-in-development-for-diabetes2 (accessed Feb 20, 2017)"},{"key":"10.1016\/S2213-8587(17)30100-6_bib10","series-title":"Disease control priorities in developing countries","first-page":"7","article-title":"Diabetes: An Update on the Pandemic and Potential Solutions","author":"Mohammed","year":"2017"},{"key":"10.1016\/S2213-8587(17)30100-6_bib11","doi-asserted-by":"crossref","first-page":"452","DOI":"10.7326\/M15-0469","article-title":"Economic evaluation of combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: a systematic review for the community preventive services task force","volume":"163","author":"Li","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30100-6_bib12","doi-asserted-by":"crossref","first-page":"1596","DOI":"10.1001\/jama.2009.519","article-title":"The public health response to diabetes\u2014two steps forward, one step back","volume":"301","author":"Gregg","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30100-6_bib13","doi-asserted-by":"crossref","first-page":"e1002080","DOI":"10.1371\/journal.pmed.1002080","article-title":"Population approaches to prevention of type 2 diabetes","volume":"13","author":"White","year":"2016","journal-title":"PLoS Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,27]],"date-time":"2022-07-27T23:44:29Z","timestamp":1658965469000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301006"}},"issued":{"date-parts":[[2017,6]]},"references-count":13,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2213858717301006"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30100-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,6]]}},{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T14:47:56Z","timestamp":1793717276707,"version":"4.6.1"},"reference-count":81,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"United States Public Health Service","award":["R24 NIDDK 092759"],"award-info":[{"award-number":["R24 NIDDK 092759"]}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/s2213-8587(14)70007-5","type":"journal-article","created":{"date-parts":[[2014,2,19]],"date-time":"2014-02-19T01:15:20Z","timestamp":1392772520000},"page":"141-147","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":236,"title":["The bone\u2013fat interface: basic and clinical implications of marrow adiposity"],"prefix":"10.1016","volume":"3","author":[{"given":"Maureen J","family":"Devlin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clifford J","family":"Rosen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70007-5_bib1","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jbmr.235","article-title":"BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS)","volume":"26","author":"Nielson","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib2","doi-asserted-by":"crossref","first-page":"2231","DOI":"10.1002\/jbmr.1759","article-title":"Type 2 diabetes and bone","volume":"27","author":"Leslie","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib3","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1002\/jcb.21573","article-title":"Understanding the pathology and mechanisms of type I diabetic bone loss","volume":"102","author":"McCabe","year":"2007","journal-title":"J Cell Biochem"},{"key":"10.1016\/S2213-8587(14)70007-5_bib4","doi-asserted-by":"crossref","first-page":"1057","DOI":"10.1089\/hum.2010.136","article-title":"\u201cMesenchymal\u201d stem cells in human bone marrow (skeletal stem cells): a critical discussion of their nature, identity, and significance in incurable skeletal disease","volume":"21","author":"Bianco","year":"2010","journal-title":"Hum Gene Ther"},{"key":"10.1016\/S2213-8587(14)70007-5_bib5","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/j.stem.2008.03.002","article-title":"Mesenchymal stem cells: revisiting history, concepts, and assays","volume":"2","author":"Bianco","year":"2008","journal-title":"Cell Stem Cell"},{"key":"10.1016\/S2213-8587(14)70007-5_bib6","doi-asserted-by":"crossref","first-page":"236","DOI":"10.1007\/s00018-008-8429-z","article-title":"Adipocyte differentiation of bone marrow-derived mesenchymal stem cells: cross talk with the osteoblastogenic program","volume":"66","author":"Muruganandan","year":"2009","journal-title":"Cell Mol Life Sci"},{"key":"10.1016\/S2213-8587(14)70007-5_bib7","doi-asserted-by":"crossref","unstructured":"DiGirolamo DJ, Clemens TL, Kousteni S. The skeleton as an endocrine organism. Nat Rev Rheumatol 8: 674\u201383.","DOI":"10.1038\/nrrheum.2012.157"},{"key":"10.1016\/S2213-8587(14)70007-5_bib8","doi-asserted-by":"crossref","first-page":"2687","DOI":"10.1210\/en.2012-2162","article-title":"Inducible brown adipose tissue, or beige fat, is anabolic for the skeleton","volume":"154","author":"Rahman","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(14)70007-5_bib9","first-page":"321","article-title":"The law of distribution of yellow and red marrow in the bones of the extremities","volume":"20","author":"Neumann","year":"1882","journal-title":"Cent J Med Sci"},{"key":"10.1016\/S2213-8587(14)70007-5_bib10","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1210\/jc.2012-3634","article-title":"Marrow fat and bone\u2014new perspectives","volume":"98","author":"Fazeli","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70007-5_bib11","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/j.bone.2011.06.016","article-title":"Bone marrow fat has brown adipose tissue characteristics, which are attenuated with aging and diabetes","volume":"50","author":"Krings","year":"2012","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(14)70007-5_bib12","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s11914-011-0051-6","article-title":"The role of bone marrow and visceral fat on bone metabolism","volume":"9","author":"Sheu","year":"2011","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/S2213-8587(14)70007-5_bib13","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1111\/j.1749-6632.2010.05806.x","article-title":"Bone and muscle loss after spinal cord injury: organ interactions","volume":"1211","author":"Qin","year":"2010","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(14)70007-5_bib14","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1148\/radiology.175.1.2315484","article-title":"Red and yellow marrow in the femur: age-related changes in appearance at MR imaging","volume":"175","author":"Moore","year":"1990","journal-title":"Radiology"},{"key":"10.1016\/S2213-8587(14)70007-5_bib15","doi-asserted-by":"crossref","first-page":"2129","DOI":"10.1210\/jc.2008-2532","article-title":"Increased bone marrow fat in anorexia nervosa","volume":"94","author":"Bredella","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70007-5_bib16","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1111\/j.1469-7580.2011.01423.x","article-title":"Changes in human bone marrow fat content associated with changes in hematopoietic stem cell numbers and cytokine levels with aging","volume":"219","author":"Tuljapurkar","year":"2011","journal-title":"J Anat"},{"key":"10.1016\/S2213-8587(14)70007-5_bib17","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1359\/jbmr.090805","article-title":"Bone marrow changes in adolescent girls with anorexia nervosa","volume":"25","author":"Ecklund","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib18","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1002\/jmri.22757","article-title":"Does vertebral bone marrow fat content correlate with abdominal adipose tissue, lumbar spine bone mineral density, and blood biomarkers in women with type 2 diabetes mellitus?","volume":"35","author":"Baum","year":"2012","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/S2213-8587(14)70007-5_bib19","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1210\/jc.2012-3949","article-title":"Vertebral bone marrow fat associated with lower trabecular BMD and prevalent vertebral fracture in older adults","volume":"98","author":"Schwartz","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70007-5_bib20","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1152\/japplphysiol.91530.2008","article-title":"Bone marrow fat accumulation after 60 days of bed rest persisted 1 year after activities were resumed along with hemopoietic stimulation: the Women International Space Simulation for Exploration study","volume":"107","author":"Trudel","year":"2009","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(14)70007-5_bib21","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1002\/jmri.20367","article-title":"Osteoporosis is associated with increased marrow fat content and decreased marrow fat unsaturation: a proton MR spectroscopy study","volume":"22","author":"Yeung","year":"2005","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/S2213-8587(14)70007-5_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/BF00361188","article-title":"Red-yellow marrow conversion: its effect on the location of some solitary bone lesions","volume":"14","author":"Kricun","year":"1985","journal-title":"Skeletal Radiol"},{"key":"10.1016\/S2213-8587(14)70007-5_bib23","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1309\/2Y7X-YDXK-006B-XLT2","article-title":"Bone marrow changes in anorexia nervosa are correlated with the amount of weight loss and not with other clinical findings","volume":"118","author":"Abella","year":"2002","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/S2213-8587(14)70007-5_bib24","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1002\/jbmr.1640","article-title":"Marrow fat and preadipocyte factor-1 levels decrease with recovery in women with anorexia nervosa","volume":"27","author":"Fazeli","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib25","doi-asserted-by":"crossref","first-page":"2782","DOI":"10.1210\/jc.2012-1477","article-title":"Increased marrow adiposity in premenopausal women with idiopathic osteoporosis","volume":"97","author":"Cohen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70007-5_bib26","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1007\/s00198-010-1353-8","article-title":"Effects of risedronate on bone marrow adipocytes in postmenopausal women","volume":"22","author":"Duque","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(14)70007-5_bib27","doi-asserted-by":"crossref","first-page":"387","DOI":"10.2522\/ptj.20070224","article-title":"Dose estimation and surveillance of mechanical loading interventions for bone loss after spinal cord injury","volume":"88","author":"Dudley-Javoroski","year":"2008","journal-title":"Phys Ther"},{"key":"10.1016\/S2213-8587(14)70007-5_bib28","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1007\/BF02405340","article-title":"Marrow changes in paraplegic patients","volume":"36","author":"Minaire","year":"1984","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(14)70007-5_bib29","doi-asserted-by":"crossref","first-page":"1884","DOI":"10.1359\/jbmr.080713","article-title":"IGF-1 and IGF-binding proteins and bone mass, geometry, and strength: relation to metabolic control in adolescent girls with type 1 diabetes","volume":"23","author":"Moyer-Mileur","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib30","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1615\/CritRevEukarGeneExpr.v21.i2.70","article-title":"Understanding the skeletal pathology of type 1 and 2 diabetes mellitus","volume":"21","author":"McCabe","year":"2011","journal-title":"Crit Rev Eukaryot Gene Expr"},{"key":"10.1016\/S2213-8587(14)70007-5_bib31","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/nature08099","article-title":"Bone-marrow adipocytes as negative regulators of the haematopoietic microenvironment","volume":"460","author":"Naveiras","year":"2009","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(14)70007-5_bib32","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1210\/en.2008-0936","article-title":"Strain-specific effects of rosiglitazone on bone mass, body composition, and serum insulin-like growth factor-I","volume":"150","author":"Ackert-Bicknell","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(14)70007-5_bib33","doi-asserted-by":"crossref","first-page":"534","DOI":"10.1016\/j.bone.2011.06.032","article-title":"Marrow fat metabolism is linked to the systemic energy metabolism","volume":"50","author":"Lecka-Czernik","year":"2012","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(14)70007-5_bib34","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1749-799X-6-30","article-title":"Effects of obesity on bone metabolism","volume":"6","author":"Cao","year":"2011","journal-title":"J Orthop Surg"},{"key":"10.1016\/S2213-8587(14)70007-5_bib35","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1016\/j.amjmed.2008.11.027","article-title":"Bone, fat, and body composition: evolving concepts in the pathogenesis of osteoporosis","volume":"122","author":"Rosen","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(14)70007-5_bib36","first-page":"205","article-title":"Regulatory pathways associated with bone loss and bone marrow adiposity caused by aging, chemotherapy, glucocorticoid therapy and radiotherapy","volume":"1","author":"Georgiou","year":"2012","journal-title":"Am J S Cell"},{"key":"10.1016\/S2213-8587(14)70007-5_bib37","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1016\/S0140-6736(10)60320-0","article-title":"Intracortical remodelling and porosity in the distal radius and post-mortem femurs of women: a cross-sectional study","volume":"375","author":"Zebaze","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70007-5_bib38","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1002\/jbmr.1763","article-title":"Increased cortical porosity in type 2 diabetic postmenopausal women with fragility fractures","volume":"28","author":"Patsch","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib39","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/bonekey.2013.49","article-title":"The relationships among total body fat, bone mineral content and bone marrow adipose tissue in early-pubertal girls","volume":"2","author":"Newton","year":"2013","journal-title":"Bonekey Rep"},{"key":"10.1016\/S2213-8587(14)70007-5_bib40","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1210\/jc.2009-2336","article-title":"Bone acquisition in healthy young females is reciprocally related to marrow adiposity","volume":"95","author":"Di Iorgi","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70007-5_bib41","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1210\/jc.2007-2691","article-title":"Reciprocal relation between marrow adiposity and the amount of bone in the axial and appendicular skeleton of young adults","volume":"93","author":"Di Iorgi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70007-5_bib42","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1210\/jc.2010-1922","article-title":"Bone marrow fat is inversely related to cortical bone in young and old subjects","volume":"96","author":"Wren","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70007-5_bib43","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/ejcn.2012.35","article-title":"MRI-measured pelvic bone marrow adipose tissue is inversely related to DXA-measured bone mineral in younger and older adults","volume":"66","author":"Shen","year":"2012","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70007-5_bib44","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2009-1152","article-title":"Preadipocyte factor-1 is associated with marrow adiposity and bone mineral density in women with anorexia nervosa","volume":"95","author":"Fazeli","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70007-5_bib45","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1210\/en.2007-1089","article-title":"Life-long caloric restriction reveals biphasic and dimorphic effects on bone metabolism in rodents","volume":"149","author":"Tatsumi","year":"2008","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(14)70007-5_bib46","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1359\/jbmr.080213","article-title":"Caloric restriction decreases cortical bone mass but spares trabecular bone in the mouse skeleton: implications for the regulation of bone mass by body weight","volume":"23","author":"Hamrick","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib47","doi-asserted-by":"crossref","first-page":"2078","DOI":"10.1002\/jbmr.82","article-title":"Caloric restriction leads to high marrow adiposity and low bone mass in growing mice","volume":"25","author":"Devlin","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib48","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1152\/japplphysiol.00187.2012","article-title":"Blocking \u03b2-adrenergic signaling attenuates reductions in circulating leptin, cancellous bone mass, and marrow adiposity seen with dietary energy restriction","volume":"113","author":"Baek","year":"2012","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(14)70007-5_bib49","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1359\/JBMR.050103","article-title":"Leptin treatment induces loss of bone marrow adipocytes and increases bone formation in leptin-deficient ob\/ob mice","volume":"20","author":"Hamrick","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib50","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1007\/s00441-006-0312-3","article-title":"Injections of leptin into rat ventromedial hypothalamus increase adipocyte apoptosis in peripheral fat and in bone marrow","volume":"327","author":"Hamrick","year":"2007","journal-title":"Cell Tissue Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib51","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2011.715","article-title":"Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes","volume":"305","author":"Schwartz","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70007-5_bib52","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1002\/jbmr.1950","article-title":"Bone marrow fat composition as a novel imaging biomarker in postmenopausal women with prevalent fragility fractures","volume":"28","author":"Patsch","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib53","doi-asserted-by":"crossref","first-page":"198","DOI":"10.1210\/en.2006-1006","article-title":"Bone loss and increased bone adiposity in spontaneous and pharmacologically induced diabetic mice","volume":"148","author":"Botolin","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(14)70007-5_bib54","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1210\/en.2004-1677","article-title":"Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice","volume":"146","author":"Botolin","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(14)70007-5_bib55","doi-asserted-by":"crossref","first-page":"967","DOI":"10.1002\/jcp.20804","article-title":"Inhibition of PPARgamma prevents type I diabetic bone marrow adiposity but not bone loss","volume":"209","author":"Botolin","year":"2006","journal-title":"J Cell Physiol"},{"key":"10.1016\/S2213-8587(14)70007-5_bib56","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1002\/jcp.21608","article-title":"Leptin treatment prevents type I diabetic marrow adiposity but not bone loss in mice","volume":"218","author":"Motyl","year":"2009","journal-title":"J Cell Physiol"},{"key":"10.1016\/S2213-8587(14)70007-5_bib57","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1002\/jbmr.1782","article-title":"Pharmacological inhibition of PPARgamma increases osteoblastogenesis and bone mass in male C57BL\/6 mice","volume":"28","author":"Duque","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib58","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1359\/jbmr.081207","article-title":"Diabetic patients have an increased risk of vertebral fractures independent of BMD or diabetic complications","volume":"24","author":"Yamamoto","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib59","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1210\/jc.2010-0226","article-title":"High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus","volume":"95","author":"Burghardt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70007-5_bib60","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1210\/en.2003-0746","article-title":"Bone is a target for the antidiabetic compound rosiglitazone","volume":"145","author":"Rzonca","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(14)70007-5_bib61","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1472-6823-9-10","article-title":"Different skeletal effects of the peroxisome proliferator activated receptor (PPAR)alpha agonist fenofibrate and the PPARgamma agonist pioglitazone","volume":"9","author":"Syversen","year":"2009","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(14)70007-5_bib62","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1210\/en.2006-1121","article-title":"Activation of peroxisome proliferator-activated receptor gamma (PPARgamma) by rosiglitazone suppresses components of the insulin-like growth factor regulatory system in vitro and in vivo","volume":"148","author":"Lecka-Czernik","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(14)70007-5_bib63","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1530\/EJE-11-1075","article-title":"Pioglitazone increases bone marrow fat in type 2 diabetes: results from a randomized controlled trial","volume":"166","author":"Grey","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70007-5_bib64","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1210\/jc.2010-2077","article-title":"Rosiglitazone decreases bone mass and bone marrow fat","volume":"96","author":"Harsl\u00f8f","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70007-5_bib65","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1152\/japplphysiol.00029.2012","article-title":"Resistive exercises, with or without whole body vibration, prevent vertebral marrow fat accumulation during 60 days of head-down tilt bed rest in men","volume":"112","author":"Trudel","year":"2012","journal-title":"J Appl Physiol (1985)"},{"issue":"suppl 6","key":"10.1016\/S2213-8587(14)70007-5_bib66","first-page":"79","article-title":"Cosmos 1129: spaceflight and bone changes","volume":"23","author":"Wronski","year":"1980","journal-title":"Physiologist"},{"key":"10.1016\/S2213-8587(14)70007-5_bib67","first-page":"R310","article-title":"Effects of spaceflight on trabecular bone in rats","volume":"244","author":"Jee","year":"1983","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(14)70007-5_bib68","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/0221-8747(82)90011-X","article-title":"Skeletal abnormalities in rats induced by simulated weightlessness","volume":"4","author":"Wronski","year":"1982","journal-title":"Metab Bone Dis Relat Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib69","first-page":"347","article-title":"Recovery of the rat skeleton from the adverse effects of simulated weightlessness","volume":"4","author":"Wronski","year":"1983","journal-title":"Metab Bone Dis Relat Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib70","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1359\/jbmr.2002.17.4.668","article-title":"Transforming growth factor beta2 inhibits adipocyte differentiation induced by skeletal unloading in rat bone marrow stroma","volume":"17","author":"Ahdjoudj","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib71","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.yexcr.2004.09.013","article-title":"Transforming growth factor-beta inhibits CCAAT\/enhancer-binding protein expression and PPARgamma activity in unloaded bone marrow stromal cells","volume":"303","author":"Ahdjoudj","year":"2005","journal-title":"Exp Cell Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib72","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1097\/00003086-197110000-00021","article-title":"Osteoporosis and the replacement of cell populations of the marrow by adipose tissue. A quantitative study of 84 iliac bone biopsies","volume":"80","author":"Meunier","year":"1971","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib73","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.exger.2008.10.004","article-title":"Age-related bone loss in the LOU\/c rat model of healthy ageing","volume":"44","author":"Duque","year":"2009","journal-title":"Exp Gerontol"},{"key":"10.1016\/S2213-8587(14)70007-5_bib74","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1359\/jbmr.070507","article-title":"Age-related changes in trabecular architecture differ in female and male C57BL\/6J mice","volume":"22","author":"Glatt","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib75","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.1210\/en.2006-1587","article-title":"Rosiglitazone induces decreases in bone mass and strength that are reminiscent of aged bone","volume":"148","author":"Lazarenko","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(14)70007-5_bib76","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00256-013-1659-7","article-title":"The temporal characterization of marrow lipids and adipocytes in a rabbit model of glucocorticoid-induced osteoporosis","volume":"42","author":"Li","year":"2013","journal-title":"Skeletal Radiol"},{"key":"10.1016\/S2213-8587(14)70007-5_bib77","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1016\/j.bone.2012.11.002","article-title":"Marrow adiposity recovery after early zoledronic acid treatment of glucocorticoid-induced bone loss in rabbits assessed by magnetic resonance spectroscopy","volume":"52","author":"Li","year":"2013","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(14)70007-5_bib78","doi-asserted-by":"crossref","first-page":"1607","DOI":"10.1359\/JBMR.040712","article-title":"Leptin, bone mass, and the thrifty phenotype","volume":"19","author":"Hamrick","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(14)70007-5_bib79","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1210\/en.2003-0899","article-title":"Ghrelin and des-octanoyl ghrelin promote adipogenesis directly in vivo by a mechanism independent of the type 1a growth hormone secretagogue receptor","volume":"145","author":"Thompson","year":"2004","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(14)70007-5_bib80","doi-asserted-by":"crossref","unstructured":"Scheller EL, Rosen CJ. What's the matter with MAT? \u2013 Marrow adipose tissue, metabolism and skeletal health. Ann N Y Acad Sci (in press).","DOI":"10.1111\/nyas.12327"},{"key":"10.1016\/S2213-8587(14)70007-5_bib81","doi-asserted-by":"crossref","first-page":"60","DOI":"10.3345\/kjp.2013.56.2.60","article-title":"Bone mineral density deficits in childhood cancer survivors: pathophysiology, prevalence, screening, and management","volume":"56","author":"Kang","year":"2013","journal-title":"Korean J Pediatr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700075?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700075?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,11]],"date-time":"2020-05-11T19:59:51Z","timestamp":1589227191000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700075"}},"issued":{"date-parts":[[2015,2]]},"references-count":81,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S2213858714700075"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70007-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The bone\u2013fat interface: basic and clinical implications of marrow adiposity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70007-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T10:13:24Z","timestamp":1793873604217,"version":"4.6.1"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/s2213-8587(13)70013-5","type":"journal-article","created":{"date-parts":[[2013,7,9]],"date-time":"2013-07-09T02:48:51Z","timestamp":1373338131000},"page":"123-131","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials"],"prefix":"10.1016","volume":"1","author":[{"given":"Bernard","family":"Zinman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Hans","family":"DeVries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce","family":"Bode","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Russell-Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alan","family":"Moses","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thue","family":"Johansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Ratner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70013-5_bib1","doi-asserted-by":"crossref","first-page":"2104","DOI":"10.1007\/s11095-012-0739-z","article-title":"Design of the novel protraction mechanism of insulin degludec, an ultra-long-acting basal insulin","volume":"29","author":"Jonassen","year":"2012","journal-title":"Pharm Res"},{"key":"10.1016\/S2213-8587(13)70013-5_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1463-1326.2012.01627.x","article-title":"Insulin degludec: four times lower pharmacodynamic variability than insulin glargine under steady-state conditions in type 1 diabetes","volume":"14","author":"Heise","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70013-5_bib3","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/j.1463-1326.2012.01638.x","article-title":"Ultra-long-acting insulin degludec has a flat and stable glucose-lowering effect in type 2 diabetes","volume":"14","author":"Heise","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70013-5_bib4","first-page":"S426","article-title":"Multi-hexamer formation is the underlying basis for the ultra-long glucose-lowering effect of insulin degludec","volume":"54","author":"Kurtzhals","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70013-5_bib5","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1016\/S0140-6736(12)60205-0","article-title":"Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 2 diabetes (BEGIN Basal-Bolus Type 2): a phase 3, randomised, open-label, treat-to-target non-inferiority trial","volume":"379","author":"Garber","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70013-5_bib6","doi-asserted-by":"crossref","first-page":"1489","DOI":"10.1016\/S0140-6736(12)60204-9","article-title":"Insulin degludec, an ultra-longacting basal insulin, versus insulin glargine in basal-bolus treatment with mealtime insulin aspart in type 1 diabetes (BEGIN Basal-Bolus Type 1): a phase 3, randomised, open-label, treat-to-target non-inferiority trial","volume":"379","author":"Heller","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70013-5_bib7","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.2337\/dc12-1205","article-title":"Insulin degludec versus insulin glargine in insulin-naive patients with type 2 diabetes: a 1-year, randomized, treat-to-target trial (BEGIN Once Long)","volume":"35","author":"Zinman","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70013-5_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/dom.12032","article-title":"Hypoglycaemia risk with insulin degludec compared with insulin glargine in type 2 and type 1 diabetes: a pre-planned meta-analysis of phase 3 trials","volume":"15","author":"Ratner","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70013-5_bib9","doi-asserted-by":"crossref","first-page":"924","DOI":"10.1016\/S0140-6736(10)62305-7","article-title":"Insulin degludec, an ultra-long-acting basal insulin, once a day or three times a week versus insulin glargine once a day in patients with type 2 diabetes: a 16-week, randomised, open-label, phase 2 trial","volume":"377","author":"Zinman","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70013-5_bib10","first-page":"403","article-title":"Declaration of Helsinki. ethical principles for medical research involving human subjects","volume":"107","year":"2009","journal-title":"J Indian Med Assoc"},{"key":"10.1016\/S2213-8587(13)70013-5_bib11","first-page":"199","article-title":"ICH harmonised tripartite guideline: guideline for Good Clinical Practice","volume":"47","year":"2001","journal-title":"J Postgrad Med"},{"key":"10.1016\/S2213-8587(13)70013-5_bib13","series-title":"Users manual for the SF-36v2 health survey","author":"Ware","year":"2007"},{"key":"10.1016\/S2213-8587(13)70013-5_bib15","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1111\/j.1463-1326.2009.01060.x","article-title":"Patient-directed titration for achieving glycaemic goals using a once-daily basal insulin analogue: an assessment of two different fasting plasma glucose targets\u2014the TITRATE study","volume":"11","author":"Blonde","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70013-5_bib16","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1111\/j.1463-1326.2007.00756.x","article-title":"Towards peakless, reproducible and long-acting insulins. An assessment of the basal analogues based on isoglycaemic clamp studies","volume":"9","author":"Heise","year":"2007","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70013-5_bib17","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1007\/s00125-012-2534-0","article-title":"Management of hyperglycaemia in type 2 diabetes: a patient-centered approach. Position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"55","author":"Inzucchi","year":"2012","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700135?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700135?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T18:27:44Z","timestamp":1539541664000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700135"}},"issued":{"date-parts":[[2013,10]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S2213858713700135"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70013-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of insulin degludec three times a week versus insulin glargine once a day in insulin-naive patients with type 2 diabetes: results of two phase 3, 26 week, randomised, open-label, treat-to-target, non-inferiority trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70013-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T07:04:43Z","timestamp":1793862283760,"version":"4.6.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/s2213-8587(17)30326-1","type":"journal-article","created":{"date-parts":[[2017,10,13]],"date-time":"2017-10-13T06:32:03Z","timestamp":1507876323000},"page":"17-26","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":150,"title":["Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Andr\u00e9","family":"Lacroix","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Feng","family":"Gu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wilson","family":"Gallardo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rosario","family":"Pivonello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yerong","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Przemys\u0142aw","family":"Witek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Boscaro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Salvatori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masanobu","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Libuse","family":"Tauchmanova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Roughton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoba","family":"Ravichandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Petersenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly M K","family":"Biller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Newell-Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giorgio","family":"Arnaldi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hesarghatta Shyamasunder","family":"Asha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar","family":"Bandgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariel","family":"Barkan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Biering","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Bex","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Bolanowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello Delano","family":"Bronstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Brue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dario","family":"Bruera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesco","family":"Cavagnini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdurrahman","family":"Comlekci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christophe","family":"De Block","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuncay","family":"Delibasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carmen","family":"Fajardo-Monta\u00f1ana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard Abraham","family":"Feelders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monica Roberto","family":"Gadelha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eliza Brevoort","family":"Geer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Heaney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ghislaine","family":"Houde","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsuhiro","family":"Ichihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syed Ali","family":"Imran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adriana","family":"Ioachimescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pinar","family":"Kadioglu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiming","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paola","family":"Loli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuru","family":"Nishiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liudmila","family":"Rozhinskaya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marek","family":"Ruchala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Youichi","family":"Saitoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Sch\u00f6fl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Schopohl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chikara","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thiti","family":"Snabboon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Snyder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyuki","family":"Suzaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susana Tara","family":"Britto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guy","family":"T'Sjoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie-Christine","family":"Vantyghem","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brigitte","family":"Velkeniers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Webb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shozo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30326-1_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S0140-6736(14)61375-1","article-title":"Cushing's syndrome","volume":"386","author":"Lacroix","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30326-1_bib2","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1210\/er.2013-1048","article-title":"The treatment of Cushing's disease","volume":"36","author":"Pivonello","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(17)30326-1_bib3","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30326-1_bib4","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1210\/jc.2012-3582","article-title":"Multisystem morbidity and mortality in Cushing's syndrome: a cohort study","volume":"98","author":"Dekkers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30326-1_bib5","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/j.ejim.2011.10.013","article-title":"Mortality in Cushing's syndrome: a systematic review and meta-analysis","volume":"23","author":"Graversen","year":"2012","journal-title":"Eur J Intern Med"},{"key":"10.1016\/S2213-8587(17)30326-1_bib6","doi-asserted-by":"crossref","first-page":"2807","DOI":"10.1210\/jc.2015-1818","article-title":"Treatment of Cushing's syndrome: an Endocrine Society clinical practice guideline","volume":"100","author":"Nieman","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30326-1_bib7","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1111\/j.1365-2265.1994.tb02486.x","article-title":"Morbidity and mortality in Cushing's disease: an epidemiological approach","volume":"40","author":"Etxabe","year":"1994","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(17)30326-1_bib8","first-page":"117","article-title":"Incidence and late prognosis of Cushing's syndrome: a population-based study","volume":"86","author":"Lindholm","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30326-1_bib9","first-page":"425","article-title":"Clinical use of pasireotide for Cushing's disease in adults","volume":"11","author":"Ceccato","year":"2015","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/S2213-8587(17)30326-1_bib10","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11154-008-9082-4","article-title":"Somatostatin and dopamine receptors as targets for medical treatment of Cushing's syndrome","volume":"10","author":"de Bruin","year":"2009","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/S2213-8587(17)30326-1_bib11","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1530\/EJE-11-0773","article-title":"Safety, tolerability and pharmacokinetics of a single dose of pasireotide long-acting release (LAR) in healthy volunteers: a single-center phase I study","volume":"166","author":"Dietrich","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(17)30326-1_bib12","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1210\/jc.2013-2480","article-title":"Pasireotide versus octreotide in acromegaly: a head-to-head superiority study","volume":"99","author":"Colao","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30326-1_bib13","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1016\/S2213-8587(14)70169-X","article-title":"Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial","volume":"2","author":"Gadelha","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30326-1_bib15","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1056\/NEJMoa1105743","article-title":"A 12-month phase 3 study of pasireotide in Cushing's disease","volume":"366","author":"Colao","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30326-1_bib16","doi-asserted-by":"crossref","first-page":"335","DOI":"10.4158\/EP09023OR","article-title":"Late-night salivary cortisol for the diagnosis of Cushing syndrome: a meta-analysis","volume":"15","author":"Carroll","year":"2009","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(17)30326-1_bib17","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1177\/0300060513498017","article-title":"Reassessing the reliability of the salivary cortisol assay for the diagnosis of Cushing syndrome","volume":"41","author":"Zhang","year":"2013","journal-title":"J Int Med Res"},{"key":"10.1016\/S2213-8587(17)30326-1_bib18","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1007\/s11102-013-0475-3","article-title":"Combination therapy for Cushing's disease: effectiveness of two schedules of treatment. Should we start with cabergoline or ketoconazole?","volume":"17","author":"Barbot","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(17)30326-1_bib19","doi-asserted-by":"crossref","first-page":"205","DOI":"10.4158\/EP14451.CO","article-title":"Evolution, global warming, smart phones, and late-night salivary cortisol","volume":"21","author":"Findling","year":"2015","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(17)30326-1_bib20","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1007\/s11102-014-0557-x","article-title":"Salivary cortisol is a useful tool to assess the early response to pasireotide in patients with Cushing's disease","volume":"18","author":"Trementino","year":"2015","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(17)30326-1_bib21","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11102-012-0452-2","article-title":"Cortisol diurnal rhythm and quality of life after successful medical treatment of Cushing's disease","volume":"16","author":"van der Pas","year":"2012","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(17)30326-1_bib22","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1097\/HJH.0b013e3283469976","article-title":"Effects of intensive blood pressure reduction on myocardial infarction and stroke in diabetes: a meta-analysis in 73,913 patients","volume":"29","author":"Reboldi","year":"2011","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(17)30326-1_bib23","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.2337\/dc10-2415","article-title":"Benefits of modest weight loss in improving cardiovascular risk factors in overweight and obese individuals with type 2 diabetes","volume":"34","author":"Wing","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30326-1_bib24","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1007\/s12020-015-0557-2","article-title":"The treatment with pasireotide in Cushing's disease: effects of long-term treatment on tumor mass in the experience of a single center","volume":"50","author":"Simeoli","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(17)30326-1_bib25","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1007\/BF03346419","article-title":"Somatostatin analogs and gallstones: a retrospective survey on a large series of acromegalic patients","volume":"31","author":"Attanasio","year":"2008","journal-title":"J Endocrinol Invest"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30326-1_bib26","first-page":"S14","article-title":"Standards of medical care in diabetes\u20142014","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30326-1_bib27","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,26]],"date-time":"2018-08-26T19:55:13Z","timestamp":1535313313000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303261"}},"issued":{"date-parts":[[2018,1]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2213858717303261"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30326-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of once-monthly pasireotide in Cushing's disease: a 12 month clinical trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30326-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30341-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T07:41:25Z","timestamp":1794555685675,"version":"4.9.1"},"update-to":[{"DOI":"10.1016\/s2213-8587(24)00316-4","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/s2213-8587(25)00006-3","type":"journal-article","created":{"date-parts":[[2025,2,25]],"date-time":"2025-02-25T23:33:45Z","timestamp":1740526425000},"page":"e6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Correction to Lancet Diabetes Endocrinol 2025; 13: 221\u201362"],"prefix":"10.1016","volume":"13","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000063?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000063?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,8]],"date-time":"2025-03-08T20:45:20Z","timestamp":1741466720000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000063"}},"issued":{"date-parts":[[2025,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2213858725000063"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00006-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2025; 13: 221\u201362","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00006-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00316-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T21:37:53Z","timestamp":1794605873972,"version":"4.9.1"},"reference-count":191,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["288034826"],"award-info":[{"award-number":["288034826"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["314061271"],"award-info":[{"award-number":["314061271"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/s2213-8587(23)00154-7","type":"journal-article","created":{"date-parts":[[2023,7,28]],"date-time":"2023-07-28T19:30:14Z","timestamp":1690572614000},"page":"675-693","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":43,"title":["Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases"],"prefix":"10.1016","volume":"11","author":[{"given":"Nikolaos","family":"Perakakis","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hani","family":"Harb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin G","family":"Hale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zsuzsanna","family":"Varga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Steenblock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Waldemar","family":"Kanczkowski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileia Ismini","family":"Alexaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Mirtschink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michele","family":"Solimena","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole","family":"Toepfner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Zeissig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuel","family":"Gado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene Alma","family":"Abela","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giatgen A","family":"Spinas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Cavelti-Weder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp A","family":"Gerber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Huber","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Trkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo A","family":"Puhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy Wei-Lynn","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Linkermann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viswanathan","family":"Mohan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Nawroth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Triantafyllos","family":"Chavakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geltrude","family":"Mingrone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Wolfrum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annelies S","family":"Zinkernagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00154-7_bib1","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1186\/1745-6150-1-29","article-title":"The ancient Virus World and evolution of cells","volume":"1","author":"Koonin","year":"2006","journal-title":"Biol Direct"},{"key":"10.1016\/S2213-8587(23)00154-7_bib2","doi-asserted-by":"crossref","first-page":"1049","DOI":"10.1098\/rstb.2004.1480","article-title":"Environmental and social influences on emerging infectious diseases: past, present and future","volume":"359","author":"McMichael","year":"2004","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"10.1016\/S2213-8587(23)00154-7_bib3","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1038\/s41586-022-04788-w","article-title":"Climate change increases cross-species viral transmission risk","volume":"607","author":"Carlson","year":"2022","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(23)00154-7_bib4","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2105482118","article-title":"Intensity and frequency of extreme novel epidemics","volume":"118","author":"Marani","year":"2021","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(23)00154-7_bib5","first-page":"195","article-title":"The effects of the COVID-19 pandemic on community respiratory virus activity","volume":"21","author":"Chow","year":"2023","journal-title":"Nat Rev Microbiol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib6","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.jinf.2022.04.006","article-title":"Acute respiratory infections in children, before and after the COVID-19 pandemic, a sentinel study","volume":"85","author":"Song","year":"2022","journal-title":"J Infect"},{"key":"10.1016\/S2213-8587(23)00154-7_bib7","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.46175","article-title":"Prevalence of common infectious diseases after COVID-19 vaccination and easing of pandemic restrictions in Israel","volume":"5","author":"Amar","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(23)00154-7_bib9","doi-asserted-by":"crossref","first-page":"107","DOI":"10.2991\/jegh.k.191028.001","article-title":"Epidemiology of type 2 diabetes \u2013 global burden of disease and forecasted trends","volume":"10","author":"Khan","year":"2020","journal-title":"J Epidemiol Glob Health"},{"key":"10.1016\/S2213-8587(23)00154-7_bib10","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1016\/S2468-1253(22)00165-0","article-title":"The prevalence and incidence of NAFLD worldwide: a systematic review and meta-analysis","volume":"7","author":"Riazi","year":"2022","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib11","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.2337\/dc21-0930","article-title":"Risks of and from SARS-CoV-2 infection and COVID-19 in people with diabetes: a systematic review of reviews","volume":"44","author":"Hartmann-Boyce","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00154-7_bib12","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1007\/s00125-022-05833-z","article-title":"Diabetes and the COVID-19 pandemic","volume":"66","author":"Khunti","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00154-7_bib13","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1146\/annurev-virology-091919-102416","article-title":"Viruses and metabolism: the effects of viral infections and viral insulins on host metabolism","volume":"8","author":"Girdhar","year":"2021","journal-title":"Annu Rev Virol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib14","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.virol.2015.02.038","article-title":"Viral activation of cellular metabolism","volume":"479-480","author":"Sanchez","year":"2015","journal-title":"Virology"},{"key":"10.1016\/S2213-8587(23)00154-7_bib15","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1002267","article-title":"Exposure to the viral by-product dsRNA or Coxsackievirus B5 triggers pancreatic beta cell apoptosis via a Bim \/ Mcl-1 imbalance","volume":"7","author":"Colli","year":"2011","journal-title":"PLoS Pathog"},{"key":"10.1016\/S2213-8587(23)00154-7_bib16","doi-asserted-by":"crossref","first-page":"3273","DOI":"10.1007\/s00125-012-2713-z","article-title":"Enterovirus-induced gene expression profile is critical for human pancreatic islet destruction","volume":"55","author":"Ylipaasto","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00154-7_bib17","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1038\/s42255-021-00347-1","article-title":"SARS-CoV-2 infects and replicates in cells of the human endocrine and exocrine pancreas","volume":"3","author":"M\u00fcller","year":"2021","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib18","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.97732","article-title":"Virus-like infection induces human \u03b2 cell dedifferentiation","volume":"3","author":"Oshima","year":"2018","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(23)00154-7_bib19","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1016\/j.cmet.2021.05.015","article-title":"SARS-CoV-2 infection induces beta cell transdifferentiation","volume":"33","author":"Tang","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib20","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1038\/nri3131","article-title":"Viral infection and the evolution of caspase 8-regulated apoptotic and necrotic death pathways","volume":"12","author":"Mocarski","year":"2011","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib21","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101121","article-title":"Characterization of viral insulins reveals white adipose tissue-specific effects in mice","volume":"44","author":"Chrudinov\u00e1","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib22","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1016\/j.jhep.2008.12.029","article-title":"HCV replication suppresses cellular glucose uptake through down-regulation of cell surface expression of glucose transporters","volume":"50","author":"Kasai","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib23","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1002\/j.2040-4603.2017.tb00775.x","article-title":"Adipose Tissue in HIV infection","volume":"7","author":"Koethe","year":"2017","journal-title":"Compr Physiol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib24","doi-asserted-by":"crossref","first-page":"66","DOI":"10.14218\/JCTH.2015.00051","article-title":"Hepatitis C virus, insulin resistance, and steatosis","volume":"4","author":"Kralj","year":"2016","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib25","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s11892-015-0654-x","article-title":"Mechanisms of beta cell dysfunction associated with viral infection","volume":"15","author":"Petzold","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(23)00154-7_bib26","doi-asserted-by":"crossref","first-page":"4092","DOI":"10.1128\/JVI.01653-14","article-title":"Hepatitis C virus attenuates mitochondrial lipid \u03b2-oxidation by downregulating mitochondrial trifunctional-protein expression","volume":"89","author":"Amako","year":"2015","journal-title":"J Virol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib27","first-page":"559","article-title":"Increased de novo hepatic lipogenesis in human immunodeficiency virus infection","volume":"76","author":"Hellerstein","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib28","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/nrendo.2016.30","article-title":"Viral infections in type 1 diabetes mellitus\u2013why the \u03b2 cells?","volume":"12","author":"Op de Beeck","year":"2016","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib29","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1097\/QAD.0000000000000599","article-title":"Human adipose tissue as a reservoir for memory CD4+ T cells and HIV","volume":"29","author":"Couturier","year":"2015","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(23)00154-7_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1005153","article-title":"Adipose tissue is a neglected viral reservoir and an inflammatory site during chronic HIV and SIV infection","volume":"11","author":"Damouche","year":"2015","journal-title":"PLoS Pathog"},{"key":"10.1016\/S2213-8587(23)00154-7_bib31","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/jcmm.13553","article-title":"Regulation of insulin resistance and type II diabetes by hepatitis C virus infection: a driver function of circulating miRNAs","volume":"22","author":"Singhal","year":"2018","journal-title":"J Cell Mol Med"},{"key":"10.1016\/S2213-8587(23)00154-7_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1002\/hep.23031","article-title":"Sites and mechanisms of insulin resistance in nonobese, nondiabetic patients with chronic hepatitis C","volume":"50","author":"Vanni","year":"2009","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(23)00154-7_bib33","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155265","article-title":"PCSK9 and ANGPTL3 levels correlate with hyperlipidemia in HIV-lipoatrophy, are regulated by fasting and are not affected by leptin administered in physiologic or pharmacologic doses","volume":"134","author":"Bouzoni","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(23)00154-7_bib34","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.immuni.2018.05.005","article-title":"Virus-induced interferon-\u03b3 causes insulin resistance in skeletal muscle and derails glycemic control in obesity","volume":"49","author":"\u0160estan","year":"2018","journal-title":"Immunity"},{"key":"10.1016\/S2213-8587(23)00154-7_bib35","doi-asserted-by":"crossref","first-page":"2461","DOI":"10.1073\/pnas.1721117115","article-title":"Viral insulin-like peptides activate human insulin and IGF-1 receptor signaling: a paradigm shift for host-microbe interactions","volume":"115","author":"Altindis","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(23)00154-7_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34391-6","article-title":"Interaction of a viral insulin-like peptide with the IGF-1 receptor produces a natural antagonist","volume":"13","author":"Moreau","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(23)00154-7_bib37","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S0198-8859(01)00223-3","article-title":"Molecular mimicry in type 1 diabetes mellitus revisited: T-cell clones to GAD65 peptides with sequence homology to Coxsackie or proinsulin peptides do not crossreact with homologous counterpart","volume":"62","author":"Schloot","year":"2001","journal-title":"Hum Immunol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib38","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2300320120","article-title":"vPIF-1 is an insulin-like antiferroptotic viral peptide","volume":"120","author":"Belavgeni","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(23)00154-7_bib39","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1038\/s41591-022-01810-6","article-title":"Unexplained post-acute infection syndromes","volume":"28","author":"Choutka","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(23)00154-7_bib40","doi-asserted-by":"crossref","DOI":"10.12659\/MSM.931447","article-title":"Historical insight into infections and disorders associated with neurological and psychiatric sequelae similar to long COVID","volume":"27","author":"Stefano","year":"2021","journal-title":"Med Sci Monit"},{"key":"10.1016\/S2213-8587(23)00154-7_bib41","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41586-021-03553-9","article-title":"High-dimensional characterization of post-acute sequelae of COVID-19","volume":"594","author":"Al-Aly","year":"2021","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(23)00154-7_bib42","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/S2213-8587(22)00044-4","article-title":"Risks and burdens of incident diabetes in long COVID: a cohort study","volume":"10","author":"Xie","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib43","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/S2213-8587(22)00355-2","article-title":"Risks and burdens of incident dyslipidaemia in long COVID: a cohort study","volume":"11","author":"Xu","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib44","doi-asserted-by":"crossref","first-page":"d35","DOI":"10.1136\/bmj.d35","article-title":"Enterovirus infection and type 1 diabetes mellitus: systematic review and meta-analysis of observational molecular studies","volume":"342","author":"Yeung","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00154-7_bib45","doi-asserted-by":"crossref","first-page":"e23","DOI":"10.1017\/S0950268821002442","article-title":"Association between enterovirus infection and clinical type 1 diabetes mellitus: systematic review and meta-analysis of observational studies","volume":"150","author":"Yang","year":"2021","journal-title":"Epidemiol Infect"},{"key":"10.1016\/S2213-8587(23)00154-7_bib46","article-title":"Association between enterovirus infection and type 1 diabetes risk: a meta-analysis of 38 case-control studies","volume":"12","author":"Wang","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(23)00154-7_bib47","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1007\/s00125-014-3400-z","article-title":"Enterovirus infection is associated with an increased risk of childhood type 1 diabetes in Taiwan: a nationwide population-based cohort study","volume":"58","author":"Lin","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00154-7_bib48","doi-asserted-by":"crossref","first-page":"655","DOI":"10.2337\/db13-0620","article-title":"Virus antibody survey in different European populations indicates risk association between coxsackievirus B1 and type 1 diabetes","volume":"63","author":"Oikarinen","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00154-7_bib49","doi-asserted-by":"crossref","first-page":"446","DOI":"10.2337\/db13-0619","article-title":"Coxsackievirus B1 is associated with induction of \u03b2-cell autoimmunity that portends type 1 diabetes","volume":"63","author":"Laitinen","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00154-7_bib50","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1007\/s00125-022-05704-7","article-title":"Health impact of seven herpesviruses on (pre)diabetes incidence and HbA1c: results from the KORA cohort","volume":"65","author":"Woelfle","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00154-7_bib51","article-title":"SC W. JY L. Epidemiologic implication of the association between herpes simplex virus infection and the risk of type 1 diabetes mellitus: a nationwide case-control study in Taiwan","volume":"19","author":"Wang","year":"2022","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(23)00154-7_bib52","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/j.jhep.2008.08.006","article-title":"Hepatitis C infection and risk of diabetes: a systematic review and meta-analysis","volume":"49","author":"White","year":"2008","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib53","doi-asserted-by":"crossref","first-page":"592","DOI":"10.7326\/0003-4819-133-8-200010170-00009","article-title":"Prevalence of type 2 diabetes mellitus among persons with hepatitis C virus infection in the United States","volume":"133","author":"Mehta","year":"2000","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(23)00154-7_bib54","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1053\/jhep.2003.50291","article-title":"Hepatitis C virus infection and incident type 2 diabetes","volume":"38","author":"Mehta","year":"2003","journal-title":"Hepatology"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00154-7_bib55","doi-asserted-by":"crossref","first-page":"S153","DOI":"10.1016\/j.dsx.2016.12.025","article-title":"Significant disparities in risks of diabetes mellitus and metabolic syndrome among chronic hepatitis C virus patients in the U.S","volume":"11","author":"Banks","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(23)00154-7_bib56","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s11154-017-9440-1","article-title":"Hepatitis C virus infection and development of type 2 diabetes mellitus: systematic review and meta-analysis of the literature","volume":"19","author":"Fabiani","year":"2018","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/S2213-8587(23)00154-7_bib57","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3892\/etm.2015.2537","article-title":"Association between hepatitis B virus infection and diabetes mellitus: a meta-analysis","volume":"10","author":"Cai","year":"2015","journal-title":"Exp Ther Med"},{"key":"10.1016\/S2213-8587(23)00154-7_bib58","doi-asserted-by":"crossref","first-page":"1100","DOI":"10.1111\/hepr.12481","article-title":"Hepatitis B virus infection status and risk of type 2 diabetes mellitus: a meta-analysis","volume":"45","author":"Zhang","year":"2015","journal-title":"Hepatol Res"},{"key":"10.1016\/S2213-8587(23)00154-7_bib59","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12876-015-0263-9","article-title":"Identifying patients with chronic hepatitis B at high risk of type 2 diabetes mellitus: a cross-sectional study with pair-matched controls","volume":"15","author":"Shen","year":"2015","journal-title":"BMC Gastroenterol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib60","doi-asserted-by":"crossref","first-page":"1708","DOI":"10.1016\/j.cgh.2023.01.001","article-title":"Prevalence and characteristics of nonalcoholic fatty liver disease and fibrosis in people living with HIV monoinfection: a systematic review and meta-analysis","volume":"21","author":"Kalligeros","year":"2023","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib61","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.1097\/QAD.0000000000001504","article-title":"Prevalence and risk factors of nonalcoholic fatty liver disease in HIV-monoinfection","volume":"31","author":"Maurice","year":"2017","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(23)00154-7_bib62","doi-asserted-by":"crossref","first-page":"250","DOI":"10.1086\/589294","article-title":"Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors","volume":"47","author":"Guaraldi","year":"2008","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(23)00154-7_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0087596","article-title":"Traditional but not HIV-related factors are associated with nonalcoholic fatty liver disease in Asian patients with HIV-1 infection","volume":"9","author":"Nishijima","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(23)00154-7_bib64","doi-asserted-by":"crossref","first-page":"2635","DOI":"10.1097\/QAD.0000000000001241","article-title":"Nonalcoholic fatty liver disease diagnosed by transient elastography with controlled attenuation parameter in unselected HIV monoinfected patients","volume":"30","author":"Vuille-Lessard","year":"2016","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(23)00154-7_bib65","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s13643-018-0927-y","article-title":"Prevalence of metabolic syndrome among HIV-positive and HIV-negative populations in sub-Saharan Africa-a systematic review and meta-analysis","volume":"8","author":"Todowede","year":"2019","journal-title":"Syst Rev"},{"key":"10.1016\/S2213-8587(23)00154-7_bib66","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0044575","article-title":"Risk of diabetes mellitus in persons with and without HIV: a Danish nationwide population-based cohort study","volume":"7","author":"Rasmussen","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(23)00154-7_bib67","doi-asserted-by":"crossref","first-page":"733","DOI":"10.4081\/jphr.2016.733","article-title":"Prevalence of diabetes in the 2009 influenza A (H1N1) and the Middle East respiratory syndrome coronavirus: a systematic review and meta-analysis","volume":"5","author":"Badawi","year":"2016","journal-title":"J Public Health Res"},{"key":"10.1016\/S2213-8587(23)00154-7_bib68","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1007\/s00125-022-05670-0","article-title":"Incidence of newly diagnosed diabetes after Covid-19","volume":"65","author":"Rathmann","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00154-7_bib69","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2337\/db11-1157","article-title":"Type 1 diabetes is associated with enterovirus infection in gut mucosa","volume":"61","author":"Oikarinen","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00154-7_bib70","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1089\/vim.2009.0072","article-title":"Detection of enterovirus RNA in peripheral blood mononuclear cells of type 1 diabetic patients beyond the stage of acute infection","volume":"23","author":"Schulte","year":"2010","journal-title":"Viral Immunol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib71","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00125-003-1297-z","article-title":"Enterovirus infection in human pancreatic islet cells, islet tropism in vivo and receptor involvement in cultured islet beta cells","volume":"47","author":"Ylipaasto","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00154-7_bib72","doi-asserted-by":"crossref","first-page":"1191","DOI":"10.1002\/oby.22843","article-title":"Is adipose tissue a reservoir for viral spread, immune activation, and cytokine amplification in coronavirus disease 2019?","volume":"28","author":"Ryan","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(23)00154-7_bib73","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1146\/annurev-physiol-052521-013627","article-title":"Inflammatory modulation of hematopoiesis: linking trained immunity and clonal hematopoiesis with chronic disorders","volume":"84","author":"Chavakis","year":"2022","journal-title":"Annu Rev Physiol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib74","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.1016\/j.cell.2022.03.043","article-title":"Maladaptive innate immune training of myelopoiesis links inflammatory comorbidities","volume":"185","author":"Li","year":"2022","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(23)00154-7_bib75","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.it.2018.11.002","article-title":"Immunometabolic crosstalk: an ancestral principle of trained immunity?","volume":"40","author":"Penkov","year":"2019","journal-title":"Trends Immunol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib76","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1038\/s41590-020-00845-6","article-title":"Trained immunity, tolerance, priming and differentiation: distinct immunological processes","volume":"22","author":"Divangahi","year":"2021","journal-title":"Nat Immunol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib77","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1038\/s41577-020-00488-6","article-title":"Local and systemic mechanisms linking periodontal disease and inflammatory comorbidities","volume":"21","author":"Hajishengallis","year":"2021","journal-title":"Nat Rev Immunol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib78","doi-asserted-by":"crossref","DOI":"10.1016\/j.coi.2022.102190","article-title":"Trained immunity: implications for vaccination","volume":"77","author":"Geckin","year":"2022","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib79","doi-asserted-by":"crossref","DOI":"10.3389\/fcimb.2020.596166","article-title":"Viral infections, the microbiome, and probiotics","volume":"10","author":"Harper","year":"2021","journal-title":"Front Cell Infect Microbiol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib80","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1016\/j.cmet.2022.09.017","article-title":"Gut-liver axis: Pathophysiological concepts and clinical implications","volume":"34","author":"Tilg","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib81","doi-asserted-by":"crossref","first-page":"E274","DOI":"10.1152\/ajpendo.00391.2001","article-title":"Intramyocellular lipid accumulation and reduced whole body lipid oxidation in HIV lipodystrophy","volume":"284","author":"Luzi","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib82","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155196","article-title":"Preadmission use of antidiabetic medications and mortality among patients with COVID-19 having type 2 diabetes: a meta-analysis","volume":"131","author":"Nguyen","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(23)00154-7_bib83","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.metabol.2019.05.001","article-title":"Fatty liver in lipodystrophy: a review with a focus on therapeutic perspectives of adiponectin and\/or leptin replacement","volume":"96","author":"Polyzos","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(23)00154-7_bib84","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.jaut.2016.05.013","article-title":"Infections as risk factor for autoimmune diseases \u2013 a nationwide study","volume":"74","author":"Nielsen","year":"2016","journal-title":"J Autoimmun"},{"key":"10.1016\/S2213-8587(23)00154-7_bib85","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnad007","article-title":"Coxsackievirus and type 1 diabetes: diabetogenic mechanisms and implications for prevention","author":"Carr\u00e9","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(23)00154-7_bib86","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.coph.2018.07.006","article-title":"Enteroviral infections in the pathogenesis of type 1 diabetes: new insights for therapeutic intervention","volume":"43","author":"Richardson","year":"2018","journal-title":"Curr Opin Pharmacol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib87","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/s41574-022-00688-1","article-title":"Persistent coxsackievirus B infection and pathogenesis of type 1 diabetes mellitus","volume":"18","author":"Nekoua","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib88","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(23)00122-5","article-title":"Enteroviruses and risk of islet autoimmunity or type 1 diabetes: systematic review and meta-analysis of controlled observational studies detecting viral nucleic acids and proteins","author":"Isaacs","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib89","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1007\/s00125-012-2745-4","article-title":"Expression of the enteroviral capsid protein VP1 in the islet cells of patients with type 1 diabetes is associated with induction of protein kinase R and downregulation of Mcl-1","volume":"56","author":"Richardson","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00154-7_bib90","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1007\/s00125-018-4704-1","article-title":"Unexpected subcellular distribution of a specific isoform of the Coxsackie and adenovirus receptor, CAR-SIV, in human pancreatic beta cells","volume":"61","author":"Ifie","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00154-7_bib91","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1016\/j.molmet.2014.05.002","article-title":"PTBP1 is required for glucose-stimulated cap-independent translation of insulin granule proteins and Coxsackieviruses in beta cells","volume":"3","author":"Knoch","year":"2014","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib92","doi-asserted-by":"crossref","first-page":"10153","DOI":"10.1128\/JVI.74.21.10153-10164.2000","article-title":"Persistent infection of human pancreatic islets by coxsackievirus B is associated with alpha interferon synthesis in beta cells","volume":"74","author":"Chehadeh","year":"2000","journal-title":"J Virol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib93","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/s41574-019-0254-y","article-title":"The heterogeneous pathogenesis of type 1 diabetes mellitus","volume":"15","author":"Ilonen","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib94","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1053\/j.gastro.2006.03.014","article-title":"Relationship between steatosis, inflammation, and fibrosis in chronic hepatitis C: a meta-analysis of individual patient data","volume":"130","author":"Leandro","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(23)00154-7_bib95","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1016\/S2468-1253(19)30227-4","article-title":"Global burden of atherosclerotic cardiovascular disease in people with hepatitis C virus infection: a systematic review, meta-analysis, and modelling study","volume":"4","author":"Lee","year":"2019","journal-title":"Lancet Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib96","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1093\/cid\/ciw809","article-title":"Hepatitis C infection and the risk of non-liver-related morbidity and mortality in HIV-infected persons in the Swiss HIV cohort study","volume":"64","author":"Kovari","year":"2017","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(23)00154-7_bib97","doi-asserted-by":"crossref","first-page":"134","DOI":"10.3389\/fendo.2015.00134","article-title":"Diabetes and hepatitis C: a two-way association","volume":"6","author":"Hammerstad","year":"2015","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(23)00154-7_bib98","doi-asserted-by":"crossref","first-page":"5523","DOI":"10.1128\/JVI.00585-12","article-title":"Regulation of hepatitis C virus replication by nuclear translocation of nonstructural 5A protein and transcriptional activation of host genes","volume":"87","author":"Maqbool","year":"2013","journal-title":"J Virol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib99","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1042\/CS20190900","article-title":"Chronic hepatitis C virus infection impairs insulin secretion by regulation of p38\u03b4 MAPK-dependent exocytosis in pancreatic \u03b2-cells","volume":"134","author":"Chen","year":"2020","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/S2213-8587(23)00154-7_bib100","article-title":"Hepatitis C virus induced a novel apoptosis-like death of pancreatic beta cells through a caspase 3-dependent pathway","volume":"7","author":"Wang","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(23)00154-7_bib101","doi-asserted-by":"crossref","DOI":"10.3390\/v13112249","article-title":"A review on extrahepatic manifestations of chronic hepatitis C virus infection and the impact of direct-acting antiviral therapy","volume":"13","author":"Mazzaro","year":"2021","journal-title":"Viruses"},{"key":"10.1016\/S2213-8587(23)00154-7_bib102","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.799382","article-title":"Virus elimination by direct-acting antiviral agents impacts glucose homeostasis in chronic hepatitis C patients","volume":"12","author":"Cheng","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(23)00154-7_bib103","doi-asserted-by":"crossref","first-page":"1940","DOI":"10.1007\/s10620-019-05918-7","article-title":"Different hepatitis C virus infection statuses show a significant risk of developing type 2 diabetes mellitus: a network meta-analysis","volume":"65","author":"Chen","year":"2020","journal-title":"Dig Dis Sci"},{"key":"10.1016\/S2213-8587(23)00154-7_bib104","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.jhep.2017.03.014","article-title":"Global epidemiology of HCV subtypes and resistance-associated substitutions evaluated by sequencing-based subtype analyses","volume":"67","author":"Welzel","year":"2017","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib105","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S0168-8278(00)80166-X","article-title":"Hepatocyte steatosis is a cytopathic effect of hepatitis C virus genotype 3","volume":"33","author":"Rubbia-Brandt","year":"2000","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib106","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines9101491","article-title":"The impact of steatosis on chronic hepatitis C progression and response to antiviral treatments","volume":"9","author":"Siphepho","year":"2021","journal-title":"Biomedicines"},{"key":"10.1016\/S2213-8587(23)00154-7_bib107","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1016\/j.cgh.2011.04.029","article-title":"Steatosis is an independent predictor of relapse following rapid virologic response in patients with HCV genotype 3","volume":"9","author":"Shah","year":"2011","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib108","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1097\/MEG.0000000000001106","article-title":"Changes in liver stiffness and steatosis among patients with hepatitis C virus infection who received direct-acting antiviral therapy and achieved sustained virological response","volume":"30","author":"Kobayashi","year":"2018","journal-title":"Eur J Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib109","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jceh.2018.06.009","article-title":"Therapy with oral directly acting agents in hepatitis C infection Is associated with reduction in fibrosis and increase in hepatic steatosis on transient elastography","volume":"9","author":"Rout","year":"2019","journal-title":"J Clin Exp Hepatol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib110","doi-asserted-by":"crossref","first-page":"1012","DOI":"10.1111\/apt.14554","article-title":"Viral eradication reduces both liver stiffness and steatosis in patients with chronic hepatitis C virus infection who received direct-acting anti-viral therapy","volume":"47","author":"Tada","year":"2018","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S2213-8587(23)00154-7_bib111","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.4254\/wjh.v14.i6.1053","article-title":"Impact of direct-acting antiviral regimens on hepatic and extrahepatic manifestations of hepatitis C virus infection","volume":"14","author":"Salama","year":"2022","journal-title":"World J Hepatol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib112","doi-asserted-by":"crossref","DOI":"10.14309\/ctg.0000000000000203","article-title":"Hepatitis C virus clearance by direct-acting antivirals agents improves endothelial dysfunction and subclinical atherosclerosis: HEPCAR study","volume":"11","author":"Mu\u00f1oz-Hern\u00e1ndez","year":"2020","journal-title":"Clin Transl Gastroenterol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib113","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10092093","article-title":"Effects of achieving sustained virologic response after direct-acting antiviral agents on long-term liver fibrosis in diabetics vs. in non-diabetic patients with chronic hepatitis C infection","volume":"10","author":"Popescu","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/S2213-8587(23)00154-7_bib114","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/jvh.13469","article-title":"Antiviral treatment for hepatitis C is associated with a reduced risk of atherosclerotic cardiovascular outcomes: A systematic review and meta-analysis","volume":"28","author":"Su","year":"2021","journal-title":"J Viral Hepat"},{"key":"10.1016\/S2213-8587(23)00154-7_bib115","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/j.virol.2017.06.007","article-title":"Ranaviruses and other members of the family Iridoviridae: their place in the virosphere","volume":"511","author":"Chinchar","year":"2017","journal-title":"Virology"},{"key":"10.1016\/S2213-8587(23)00154-7_bib116","doi-asserted-by":"crossref","first-page":"930","DOI":"10.2337\/dc14-2490","article-title":"Gut virome sequencing in children with early islet autoimmunity","volume":"38","author":"Kramn\u00e1","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00154-7_bib117","doi-asserted-by":"crossref","DOI":"10.1371\/journal.ppat.1000852","article-title":"Exposure to HIV-1 directly impairs mucosal epithelial barrier integrity allowing microbial translocation","volume":"6","author":"Nazli","year":"2010","journal-title":"PLoS Pathog"},{"key":"10.1016\/S2213-8587(23)00154-7_bib118","doi-asserted-by":"crossref","first-page":"538","DOI":"10.1128\/JVI.01449-07","article-title":"Rapid onset of intestinal epithelial barrier dysfunction in primary human immunodeficiency virus infection is driven by an imbalance between immune response and mucosal repair and regeneration","volume":"82","author":"Sankaran","year":"2008","journal-title":"J Virol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib119","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3803\/EnM.2018.33.1.33","article-title":"Association of adipokines with development and progression of nonalcoholic fatty liver disease","volume":"33","author":"Boutari","year":"2018","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/S2213-8587(23)00154-7_bib120","article-title":"Role of Kupffer cells in driving hepatic inflammation and fibrosis in HIV infection","volume":"11","author":"Zhang","year":"2020","journal-title":"Front Immunol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib121","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1001\/jama.2022.22246","article-title":"Antiretroviral drugs for treatment and prevention of HIV infection in adults: 2022 recommendations of the International Antiviral Society-USA panel","volume":"329","author":"Gandhi","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00154-7_bib122","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1097\/COH.0000000000000760","article-title":"Causes and outcomes of hepatic fibrosis in persons living with HIV","volume":"17","author":"Yen","year":"2022","journal-title":"Curr Opin HIV AIDS"},{"key":"10.1016\/S2213-8587(23)00154-7_bib123","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.110202","article-title":"The bidirectional association between diabetes and long-COVID-19 \u2013 a systematic review","volume":"195","author":"Harding","year":"2023","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00154-7_bib124","doi-asserted-by":"crossref","first-page":"938","DOI":"10.2337\/dc22-0670","article-title":"Comparative incidence of diabetes following hospital admission for COVID-19 and pneumonia: a cohort study","volume":"46","author":"Holman","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00154-7_bib125","doi-asserted-by":"crossref","first-page":"e1009","DOI":"10.1210\/clinem\/dgab792","article-title":"No evidence of long-term disruption of glycometabolic control after SARS-CoV-2 infection","volume":"107","author":"Laurenzi","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib126","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23886-3","article-title":"Viral infiltration of pancreatic islets in patients with COVID-19","volume":"12","author":"Steenblock","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(23)00154-7_bib127","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/s41586-022-05542-y","article-title":"SARS-CoV-2 infection and persistence in the human body and brain at autopsy","volume":"612","author":"Stein","year":"2022","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(23)00154-7_bib128","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-33218-8","article-title":"SARS-CoV-2 infects adipose tissue in a fat depot- and viral lineage-dependent manner","volume":"13","author":"Saccon","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(23)00154-7_bib129","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.cmet.2021.12.002","article-title":"Replication of SARS-CoV-2 in adipose tissue determines organ and systemic lipid metabolism in hamsters and humans","volume":"34","author":"Zickler","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib130","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1111\/jth.15806","article-title":"The suboptimal fibrinolytic response in COVID-19 is dictated by high PAI-1","volume":"20","author":"Whyte","year":"2022","journal-title":"J Thromb Haemost"},{"key":"10.1016\/S2213-8587(23)00154-7_bib131","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1038\/s42255-021-00508-2","article-title":"GP73 is a glucogenic hormone contributing to SARS-CoV-2-induced hyperglycemia","volume":"4","author":"Wan","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib132","article-title":"The epidemiological and clinical characteristics of the hospital-acquired influenza infections: a systematic review and meta-analysis","volume":"100","author":"Li","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S2213-8587(23)00154-7_bib133","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1086\/431587","article-title":"Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus","volume":"41","author":"Muller","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(23)00154-7_bib134","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/irv.12504","article-title":"Risk factors for serious outcomes associated with influenza illness in high- versus low- and middle-income countries: systematic literature review and meta-analysis","volume":"12","author":"Coleman","year":"2018","journal-title":"Influenza Other Respir Viruses"},{"key":"10.1016\/S2213-8587(23)00154-7_bib135","doi-asserted-by":"crossref","DOI":"10.2807\/ese.15.02.19463-en","article-title":"Severe hospitalised 2009 pandemic influenza A(H1N1) cases in France, 1 July-15 November 2009","volume":"15","author":"Fuhrman","year":"2010","journal-title":"Euro Surveill"},{"key":"10.1016\/S2213-8587(23)00154-7_bib136","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0009694","article-title":"Morbid obesity as a risk factor for hospitalization and death due to 2009 pandemic influenza A(H1N1) disease","volume":"5","author":"Morgan","year":"2010","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(23)00154-7_bib137","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.2337\/dc09-2215","article-title":"Diabetes and the severity of pandemic influenza A (H1N1) infection","volume":"33","author":"Allard","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00154-7_bib138","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154378","article-title":"Obesity in patients with COVID-19: a systematic review and meta-analysis","volume":"113","author":"Huang","year":"2020","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(23)00154-7_bib139","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1161\/CIRCULATIONAHA.120.051936","article-title":"Association of body mass index and age with morbidity and mortality in patients hospitalized with COVID-19: results from the American Heart Association COVID-19 cardiovascular disease registry","volume":"143","author":"Hendren","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00154-7_bib140","doi-asserted-by":"crossref","first-page":"21011","DOI":"10.1073\/pnas.2011086117","article-title":"Overweight, obesity, and risk of hospitalization for COVID-19: a community-based cohort study of adults in the United Kingdom","volume":"117","author":"Hamer","year":"2020","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(23)00154-7_bib141","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1007\/s00592-020-01546-0","article-title":"Diabetes increases the mortality of patients with COVID-19: a meta-analysis","volume":"58","author":"Wu","year":"2021","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib142","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/j.dsx.2020.04.044","article-title":"Is diabetes mellitus associated with mortality and severity of COVID-19? A meta-analysis","volume":"14","author":"Kumar","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(23)00154-7_bib143","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/j.ijid.2020.07.029","article-title":"Comorbidities and the risk of severe or fatal outcomes associated with coronavirus disease 2019: a systematic review and meta-analysis","volume":"99","author":"Zhou","year":"2020","journal-title":"Int J Infect Dis"},{"key":"10.1016\/S2213-8587(23)00154-7_bib144","doi-asserted-by":"crossref","first-page":"2345","DOI":"10.2337\/dc20-1380","article-title":"Hyperglycemia at hospital admission is associated with severity of the prognosis in patients hospitalized for COVID-19: the Pisa COVID-19 study","volume":"43","author":"Coppelli","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00154-7_bib145","doi-asserted-by":"crossref","first-page":"942","DOI":"10.4093\/dmj.2020.0266","article-title":"Independent impact of diabetes on the severity of coronavirus disease 2019 in 5,307 patients in South Korea: a nationwide cohort study (Diabetes Metab J 2020;44:737\u201346)","volume":"44","author":"Moon","year":"2020","journal-title":"Diabetes Metab J"},{"key":"10.1016\/S2213-8587(23)00154-7_bib146","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib147","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib148","article-title":"Factors associated with hospital admission and critical illness among 5279 people with coronavirus disease 2019 in New York City: prospective cohort study","volume":"369","author":"Petrilli","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00154-7_bib149","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/S2213-8587(20)30405-8","article-title":"Risks of and risk factors for COVID-19 disease in people with diabetes: a cohort study of the total population of Scotland","volume":"9","author":"McGurnaghan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib150","doi-asserted-by":"crossref","first-page":"1895","DOI":"10.1097\/CCM.0000000000005184","article-title":"Trends in 28-day mortality of critical care patients with coronavirus disease 2019 in the United Kingdom: a national cohort study, March 2020 to January 2021","volume":"49","author":"Dennis","year":"2021","journal-title":"Crit Care Med"},{"key":"10.1016\/S2213-8587(23)00154-7_bib151","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2020.100057","article-title":"The incidence of COVID-19 in patients with metabolic syndrome and non-alcoholic steatohepatitis: A population-based study","volume":"8","author":"Ghoneim","year":"2020","journal-title":"Metab Open"},{"key":"10.1016\/S2213-8587(23)00154-7_bib152","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-88598-6","article-title":"Non-autoimmune diabetes mellitus and the risk of virus infections: a systematic review and meta-analysis of case-control and cohort studies","volume":"11","author":"Lontchi-Yimagou","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(23)00154-7_bib153","doi-asserted-by":"crossref","DOI":"10.1038\/srep02981","article-title":"Type 2 diabetes mellitus and the risk of hepatitis C virus infection: a systematic review","volume":"3","author":"Guo","year":"2013","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(23)00154-7_bib154","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/MCG.0000000000000400","article-title":"Insulin resistance is associated with significant liver fibrosis in chronic hepatitis C patients: a systemic review and meta-analysis","volume":"50","author":"Patel","year":"2016","journal-title":"J Clin Gastroenterol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib155","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-052777","article-title":"Diabetes, hypertension, body mass index, smoking and COVID-19-related mortality: a systematic review and meta-analysis of observational studies","volume":"11","author":"Mahamat-Saleh","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(23)00154-7_bib156","article-title":"The incidence of herpes zoster in patients with diabetes mellitus: A meta-analysis of cohort studies","volume":"100","author":"Lai","year":"2021","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S2213-8587(23)00154-7_bib157","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1210\/clinem\/dgab675","article-title":"Association between diabetes mellitus and the risk of herpes zoster: a systematic review and meta-analysis","volume":"107","author":"Huang","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib158","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.1016\/S1473-3099(20)30601-0","article-title":"Risk predictors of progression to severe disease during the febrile phase of dengue: a systematic review and meta-analysis","volume":"21","author":"Sangkaew","year":"2021","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S2213-8587(23)00154-7_bib159","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1186\/s40249-021-00908-2","article-title":"Clinical predictors of severe dengue: a systematic review and meta-analysis","volume":"10","author":"Tsheten","year":"2021","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/S2213-8587(23)00154-7_bib160","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1111\/tmi.13797","article-title":"Risk factors for mortality in patients with dengue: a systematic review and meta-analysis","volume":"27","author":"Chagas","year":"2022","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(23)00154-7_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101044","article-title":"Diabetes, infection risk and COVID-19","volume":"39","author":"Erener","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib162","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/nature21363","article-title":"Inflammation, metaflammation and immunometabolic disorders","volume":"542","author":"Hotamisligil","year":"2017","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(23)00154-7_bib163","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/j.immuni.2017.08.009","article-title":"Foundations of immunometabolism and implications for metabolic health and disease","volume":"47","author":"Hotamisligil","year":"2017","journal-title":"Immunity"},{"key":"10.1016\/S2213-8587(23)00154-7_bib164","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1038\/s41586-019-1236-x","article-title":"Longitudinal multi-omics of host-microbe dynamics in prediabetes","volume":"569","author":"Zhou","year":"2019","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(23)00154-7_bib165","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2337\/db21-0209","article-title":"Hyperglycemia and not hyperinsulinemia mediates diabetes-induced memory CD8 T-cell dysfunction","volume":"71","author":"Kavazovi\u0107","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00154-7_bib166","doi-asserted-by":"crossref","first-page":"3127","DOI":"10.4049\/jimmunol.0903220","article-title":"Diet-induced obesity impairs the T cell memory response to influenza virus infection","volume":"184","author":"Karlsson","year":"2010","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib167","doi-asserted-by":"crossref","first-page":"4738","DOI":"10.4049\/jimmunol.1601031","article-title":"B cell activity is impaired in human and mouse obesity and is responsive to an essential fatty acid upon murine influenza infection","volume":"198","author":"Kosaraju","year":"2017","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib168","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1002\/oby.20383","article-title":"Overweight and obese adult humans have a defective cellular immune response to pandemic H1N1 influenza A virus","volume":"21","author":"Paich","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(23)00154-7_bib169","doi-asserted-by":"crossref","first-page":"e03341","DOI":"10.1128\/mBio.03341-19","article-title":"Obesity-related microenvironment promotes emergence of virulent influenza virus strains","volume":"11","author":"Honce","year":"2020","journal-title":"MBio"},{"key":"10.1016\/S2213-8587(23)00154-7_bib170","doi-asserted-by":"crossref","DOI":"10.3389\/fimmu.2021.649359","article-title":"COVID-19 severity in obesity: leptin and inflammatory cytokine interplay in the link between high morbidity and mortality","volume":"12","author":"Maurya","year":"2021","journal-title":"Front Immunol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib171","doi-asserted-by":"crossref","first-page":"221","DOI":"10.15403\/jgld-3404","article-title":"Fatty liver index as a simple and useful predictor for 10-year cardiovascular disease risks determined by Framingham risk score in the general Korean population","volume":"30","author":"Chung","year":"2021","journal-title":"J Gastrointestin Liver Dis"},{"key":"10.1016\/S2213-8587(23)00154-7_bib172","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.cmet.2020.07.015","article-title":"Elevated glucose levels favor SARS-CoV-2 infection and monocyte response through a HIF-1\u03b1\/glycolysis-dependent axis","volume":"32","author":"Codo","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.ebiom.2019.11.051","article-title":"Role of gut microbiota in type 2 diabetes pathophysiology","volume":"51","author":"Gurung","year":"2020","journal-title":"EBioMedicine"},{"key":"10.1016\/S2213-8587(23)00154-7_bib174","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1007\/s00535-019-01649-8","article-title":"Intestinal microbiome and NAFLD: molecular insights and therapeutic perspectives","volume":"55","author":"Hu","year":"2020","journal-title":"J Gastroenterol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib175","doi-asserted-by":"crossref","first-page":"3764","DOI":"10.1128\/IAI.00298-15","article-title":"Influenza and bacterial superinfection: illuminating the immunologic mechanisms of disease","volume":"83","author":"Rynda-Apple","year":"2015","journal-title":"Infect Immun"},{"key":"10.1016\/S2213-8587(23)00154-7_bib176","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1136\/gutjnl-2020-323020","article-title":"Gut microbiota composition reflects disease severity and dysfunctional immune responses in patients with COVID-19","volume":"70","author":"Yeoh","year":"2021","journal-title":"Gut"},{"key":"10.1016\/S2213-8587(23)00154-7_bib177","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/s42255-022-00567-z","article-title":"A glucose-like metabolite deficient in diabetes inhibits cellular entry of SARS-CoV-2","volume":"4","author":"Tong","year":"2022","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(23)00154-7_bib178","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1186\/s12933-018-0763-3","article-title":"Endothelial dysfunction and platelet hyperactivity in type 2 diabetes mellitus: molecular insights and therapeutic strategies","volume":"17","author":"Kaur","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib179","doi-asserted-by":"crossref","first-page":"980","DOI":"10.1016\/j.cell.2011.08.015","article-title":"Endothelial cells are central orchestrators of cytokine amplification during influenza virus infection","volume":"146","author":"Teijaro","year":"2011","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(23)00154-7_bib180","doi-asserted-by":"crossref","first-page":"9","DOI":"10.7554\/eLife.56907","article-title":"High glucose levels increase influenza-associated damage to the pulmonary epithelial-endothelial barrier","volume":"9","author":"Hulme","year":"2020","journal-title":"eLife"},{"key":"10.1016\/S2213-8587(23)00154-7_bib181","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1159\/000518914","article-title":"Autopsy-based pulmonary and vascular pathology: pulmonary endotheliitis and multi-organ involvement in COVID-19 associated deaths","volume":"101","author":"Haberecker","year":"2022","journal-title":"Respiration"},{"key":"10.1016\/S2213-8587(23)00154-7_bib182","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1111\/j.1464-5491.2010.03073.x","article-title":"Systematic review of the association between lung function and type 2 diabetes mellitus","volume":"27","author":"Klein","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00154-7_bib183","first-page":"1874","article-title":"Alveolar gas exchange and pulmonary functions in patients with type II diabetes mellitus","volume":"7","author":"Anandhalakshmi","year":"2013","journal-title":"J Clin Diagn Res"},{"key":"10.1016\/S2213-8587(23)00154-7_bib184","doi-asserted-by":"crossref","DOI":"10.1210\/endrev\/bnaa011","article-title":"Coronavirus infections and type 2 diabetes-shared pathways with therapeutic implications","volume":"41","author":"Drucker","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(23)00154-7_bib185","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S2213-8587(21)00180-7","article-title":"Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Kosiborod","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib186","doi-asserted-by":"crossref","first-page":"599","DOI":"10.1056\/NEJMoa2201662","article-title":"Randomized trial of metformin, ivermectin, and fluvoxamine for Covid-19","volume":"387","author":"Bramante","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00154-7_bib187","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14378","article-title":"Dexamethasone therapy in COVID-19 patients: implications and guidance for the management of blood glucose in people with and without diabetes","volume":"38","author":"Rayman","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00154-7_bib188","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/bs.apha.2019.01.003","article-title":"Drug-induced liver injury in obesity and nonalcoholic fatty liver disease","volume":"85","author":"Allard","year":"2019","journal-title":"Adv Pharmacol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib189","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1016\/S2213-8587(21)00244-8","article-title":"COVID-19 and metabolic disease: mechanisms and clinical management","volume":"9","author":"Steenblock","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib190","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/S2213-8587(18)30051-2","article-title":"Novel subgroups of adult-onset diabetes and their association with outcomes: a data-driven cluster analysis of six variables","volume":"6","author":"Ahlqvist","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00154-7_bib191","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1186\/s12916-022-02656-y","article-title":"Risk for newly diagnosed diabetes after COVID-19: a systematic review and meta-analysis","volume":"20","author":"Zhang","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(23)00154-7_bib192","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155330","article-title":"Risk of incident diabetes after COVID-19 infection: a systematic review and meta-analysis","volume":"137","author":"Lai","year":"2022","journal-title":"Metabolism"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001547?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001547?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:29Z","timestamp":1761992009000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001547"}},"issued":{"date-parts":[[2023,9]]},"references-count":191,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2213858723001547"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00154-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mechanisms and clinical relevance of the bidirectional relationship of viral infections with metabolic diseases","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00154-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:11:10Z","timestamp":1794651070729,"version":"4.9.1"},"reference-count":22,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,5,1]],"date-time":"2019-05-01T00:00:00Z","timestamp":1556668800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,3,28]],"date-time":"2019-03-28T00:00:00Z","timestamp":1553731200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/100008183","name":"Central Manchester University Hospitals NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008183","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001648","name":"European Foundation for the Study of Diabetes","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001648","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["100574\/Z\/12 \/Z"],"award-info":[{"award-number":["100574\/Z\/12 \/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012618","name":"National Institute for Health Research Biomedical Research Centre at Moorfields Eye Hospital NHS Foundation Trust and UCL Institute of Ophthalmology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012618","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","award":["14\/0004878"],"award-info":[{"award-number":["14\/0004878"]}],"id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["P1BEP3_165297"],"award-info":[{"award-number":["P1BEP3_165297"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009068","name":"Universit\u00e4t Bern","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009068","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1016\/s2213-8587(19)30061-0","type":"journal-article","created":{"date-parts":[[2019,3,29]],"date-time":"2019-03-29T19:35:33Z","timestamp":1553888133000},"page":"368-377","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial"],"prefix":"10.1016","volume":"7","author":[{"given":"Charlotte K","family":"Boughton","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Bally","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Martignoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sara","family":"Hartnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Herzig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria M","family":"Wertli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata E","family":"Wilinska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark L","family":"Evans","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony P","family":"Coll","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Stettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roman","family":"Hovorka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30061-0_bib1","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0261-5614(02)00215-7","article-title":"The impact of malnutrition on morbidity, mortality, length of hospital stay and costs evaluated through a multivariate model analysis","volume":"22","author":"Correia","year":"2003","journal-title":"Clin Nutr"},{"key":"10.1016\/S2213-8587(19)30061-0_bib2","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1177\/0884533609339069","article-title":"Hyperglycemic events in non-intensive care unit patients receiving parenteral nutrition","volume":"24","author":"Pleva","year":"2009","journal-title":"Nutr Clin Pract"},{"key":"10.1016\/S2213-8587(19)30061-0_bib3","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1046\/j.1365-2702.2001.00498.x","article-title":"Complications associated with enteral nutrition by nasogastric tube in an internal medicine unit","volume":"10","author":"Pancorbo-Hidalgo","year":"2001","journal-title":"J Clin Nurs"},{"key":"10.1016\/S2213-8587(19)30061-0_bib4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2337\/dc09-1748","article-title":"Hyperglycemia during total parenteral nutrition","volume":"33","author":"Pasquel","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30061-0_bib5","doi-asserted-by":"crossref","first-page":"2367","DOI":"10.2337\/diacare.28.10.2367","article-title":"Hyperglycemia is associated with adverse outcomes in patients receiving total parenteral nutrition","volume":"28","author":"Cheung","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30061-0_bib6","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.nut.2012.07.019","article-title":"Hyperglycemia and hypoalbuminemia as prognostic mortality factors in patients with enteral feeding","volume":"29","author":"Gonzalez Infantino","year":"2013","journal-title":"Nutrition"},{"key":"10.1016\/S2213-8587(19)30061-0_bib7","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.2337\/dc12-1379","article-title":"Parenteral nutrition-associated hyperglycemia in non-critically ill inpatients increases the risk of in-hospital mortality (multicenter study)","volume":"36","author":"Olveira","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30061-0_bib8","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S2213-8587(16)30280-7","article-title":"Closed-loop insulin delivery in inpatients with type 2 diabetes: a randomised, parallel-group trial","volume":"5","author":"Thabit","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30061-0_bib9","doi-asserted-by":"crossref","first-page":"R159","DOI":"10.1186\/cc12838","article-title":"Feasibility of fully automated closed-loop glucose control using continuous subcutaneous glucose measurements in critical illness: a randomized controlled trial","volume":"17","author":"Leelarathna","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/S2213-8587(19)30061-0_bib10","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1210\/jc.2011-2098","article-title":"Management of hyperglycemia in hospitalized patients in non-critical care setting: an endocrine society clinical practice guideline","volume":"97","author":"Umpierrez","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30061-0_bib11","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1056\/NEJMoa1805233","article-title":"Closed-loop insulin delivery for glycemic control in noncritical care","volume":"379","author":"Bally","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30061-0_bib12","author":"Evans"},{"key":"10.1016\/S2213-8587(19)30061-0_bib13","series-title":"National Diabetes Inpatient Audit (NaDIA) 2017\u2014National Report","year":"2017"},{"key":"10.1016\/S2213-8587(19)30061-0_bib14","doi-asserted-by":"crossref","first-page":"853","DOI":"10.4158\/EP11042.OR","article-title":"Update on inpatient glycemic control in hospitals in the United States","volume":"17","author":"Swanson","year":"2011","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(19)30061-0_bib15","doi-asserted-by":"crossref","first-page":"e2885","DOI":"10.1002\/dmrr.2885","article-title":"Efficacy of basal-bolus insulin regimens in the inpatient management of non-critically ill patients with type 2 diabetes: a systematic review and meta-analysis","volume":"33","author":"Christensen","year":"2017","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(19)30061-0_bib16","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1210\/jc.2011-2100","article-title":"Glycemic control in non-critically ill hospitalized patients: a systematic review and meta-analysis","volume":"97","author":"Murad","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30061-0_bib17","doi-asserted-by":"crossref","first-page":"e445","DOI":"10.1111\/dme.12002","article-title":"Hypoglycaemia is associated with increased length of stay and mortality in people with diabetes who are hospitalized","volume":"29","author":"Nirantharakumar","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30061-0_bib18","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4037\/ajcc2006.15.4.370","article-title":"Evaluation of nursing work effort and perceptions about blood glucose testing in tight glycemic control","volume":"15","author":"Aragon","year":"2006","journal-title":"Am J Crit Care"},{"key":"10.1016\/S2213-8587(19)30061-0_bib19","doi-asserted-by":"crossref","first-page":"5888","DOI":"10.1038\/s41598-018-24275-5","article-title":"Management of glycemic variation in diabetic patients receiving parenteral nutrition by continuous subcutaneous insulin infusion (CSII) therapy","volume":"8","author":"Li","year":"2018","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(19)30061-0_bib20","doi-asserted-by":"crossref","first-page":"846","DOI":"10.1177\/0148607117722750","article-title":"Addition of insulin to parenteral nutrition for control of hyperglycemia","volume":"42","author":"McCulloch","year":"2018","journal-title":"JPEN J Parenter Enteral Nutr"},{"key":"10.1016\/S2213-8587(19)30061-0_bib21","doi-asserted-by":"crossref","first-page":"41","DOI":"10.4158\/EP13131.OR","article-title":"Glucose variability is an independent predictor of mortality in hospitalized patients treated with total parenteral nutrition","volume":"20","author":"Farrokhi","year":"2014","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(19)30061-0_bib22","doi-asserted-by":"crossref","first-page":"1283","DOI":"10.1056\/NEJMoa0810625","article-title":"Intensive versus conventional glucose control in critically ill patients","volume":"360","year":"2009","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300610?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300610?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:03Z","timestamp":1761991623000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300610"}},"issued":{"date-parts":[[2019,5]]},"references-count":22,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["S2213858719300610"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30061-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30061-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30094-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:10:51Z","timestamp":1794661851264,"version":"4.9.1"},"reference-count":18,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002920","name":"Research Grants Council, University Grants Committee","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002920","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100030732","name":"MSD","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100030732","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/s2213-8587(25)00299-2","type":"journal-article","created":{"date-parts":[[2025,12,16]],"date-time":"2025-12-16T00:17:52Z","timestamp":1765844272000},"page":"149-156","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":683,"title":["11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050"],"prefix":"10.1016","volume":"14","author":[{"given":"Irini","family":"Genitsaridi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paraskevi","family":"Salpea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agus","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seyedeh Forough","family":"Sajjadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dunya","family":"Tomic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sathish","family":"Thirunavukkarasu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ayuba","family":"Issaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdul","family":"Basit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea O Y","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald C W","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Mbanya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ambady","family":"Ramachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bruce B","family":"Duncan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward J","family":"Boyko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna J","family":"Magliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00299-2_bib1","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00299-2_bib2","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00299-2_bib3","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1016\/j.diabres.2021.109118","article-title":"IDF diabetes Atlas: global estimates of undiagnosed diabetes in adults for 2021","volume":"183","author":"Ogurtsova","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00299-2_bib4","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00299-2_bib5","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00299-2_bib6","doi-asserted-by":"crossref","first-page":"2753","DOI":"10.2337\/dci22-0034","article-title":"Management of hyperglycemia in type 2 diabetes, 2022. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"45","author":"Davies","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00299-2_bib7","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S2213-8587(20)30402-2","article-title":"Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings","volume":"9","author":"Magliano","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00299-2_bib8","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.diabres.2011.10.040","article-title":"The International Diabetes Federation diabetes atlas methodology for estimating global and national prevalence of diabetes in adults","volume":"94","author":"Guariguata","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00299-2_bib9","doi-asserted-by":"crossref","first-page":"e19","DOI":"10.1016\/S0140-6736(16)30388-9","article-title":"Guidelines for Accurate and Transparent Health Estimates Reporting: the GATHER statement","volume":"388","author":"Stevens","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00299-2_bib10","series-title":"World population prospects: the 2022 revision","year":"2023"},{"key":"10.1016\/S2213-8587(25)00299-2_bib13","series-title":"Future directions for the demography of aging: proceedings of a workshop","year":"2018"},{"key":"10.1016\/S2213-8587(25)00299-2_bib14","doi-asserted-by":"crossref","first-page":"2327","DOI":"10.1007\/s00125-025-06478-4","article-title":"Variation in type 2 diabetes prevalence across different populations: the key drivers","volume":"68","author":"Gong","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00299-2_bib15","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 44 million participants","volume":"387","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00299-2_bib16","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00299-2_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.cca.2016.10.003","article-title":"Effect of iron deficiency anemia and iron supplementation on HbA1c levels\u2014implications for diagnosis of prediabetes and diabetes mellitus in Asian Indians","volume":"468","author":"Madhu","year":"2017","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2213-8587(25)00299-2_bib18","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1186\/s13045-021-01202-2","article-title":"Burden of anemia and its underlying causes in 204 countries and territories, 1990\u20132019: results from the Global Burden of Disease Study 2019","volume":"14","author":"Safiri","year":"2021","journal-title":"J Hematol Oncol"},{"key":"10.1016\/S2213-8587(25)00299-2_bib19","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1016\/S0140-6736(24)00476-8","volume":"403","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00299-2_bib20","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1001\/jama.2019.16932","article-title":"Life expectancy and mortality rates in the United States, 1959\u20132017","volume":"322","author":"Woolf","year":"2019","journal-title":"JAMA"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(26)00238-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T00:00:00Z","timestamp":1788912000000}},{"DOI":"10.1016\/s2213-8587(26)00238-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:50:01Z","timestamp":1789073401000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002992"}},"issued":{"date-parts":[[2026,2]]},"references-count":18,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2213858725002992"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00299-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"11th edition of the IDF Diabetes Atlas: global, regional, and national diabetes prevalence estimates for 2024 and projections for 2050","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00299-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00336-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,4,16]],"date-time":"2025-04-16T09:27:23Z","timestamp":1744795643313},"reference-count":4,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/s2213-8587(14)70221-9","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T00:15:30Z","timestamp":1414628130000},"page":"861-862","source":"Crossref","is-referenced-by-count":8,"title":["Risks and benefits of childhood physical activity"],"prefix":"10.1016","volume":"2","author":[{"given":"Patricia","family":"Longmuir","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rachel","family":"Colley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Valerie","family":"Wherley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Tremblay","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70221-9_bib1","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1016\/S2213-8587(14)70215-3","article-title":"Healthy lifestyle guidelines\u2014are they good enough?","volume":"2","year":"2014","journal-title":"Lancet Diabet Endocrinol"},{"key":"10.1016\/S2213-8587(14)70221-9_bib2","doi-asserted-by":"crossref","DOI":"10.1139\/apnm-2014-0074","article-title":"Canadian Society for Exercise Physiology position stand: benefit and risk for promoting childhood physical activity","author":"Longmuir","year":"2014","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/S2213-8587(14)70221-9_bib3","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-003086","article-title":"Associated of objectively assessed levels of physical activity, aerobic fitness and motor coordination with injury risk in school children aged 7-9 years: a cross-sectional study","volume":"3","author":"Martin-Diener","year":"2013","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(14)70221-9_bib4","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1249\/MSS.0000000000000152","article-title":"Injuries in children with extra physical education in primary schools","volume":"46","author":"Rexen","year":"2014","journal-title":"Med Sci Sports Exerc"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702219?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702219?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T04:51:14Z","timestamp":1538110274000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702219"}},"issued":{"date-parts":[[2014,11]]},"references-count":4,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S2213858714702219"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70221-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,11]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T16:10:40Z","timestamp":1648915840379},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/s2213-8587(17)30113-4","type":"journal-article","created":{"date-parts":[[2017,4,21]],"date-time":"2017-04-21T01:01:14Z","timestamp":1492736474000},"page":"328-329","source":"Crossref","is-referenced-by-count":0,"title":["Analysis of the MAVIDOS trial \u2013 Author's reply"],"prefix":"10.1016","volume":"5","author":[{"given":"Nicholas C","family":"Harvey","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rebecca J","family":"Moon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hazel M","family":"Inskip","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Keith M","family":"Godfrey","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cyrus","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30113-4_bib1","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S2213-8587(16)00044-9","article-title":"Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial","volume":"4","author":"Cooper","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30113-4_bib2","doi-asserted-by":"publisher","first-page":"13","DOI":"10.1186\/1745-6215-13-13","article-title":"MAVIDOS Maternal Vitamin D Osteoporosis Study: study protocol for a randomized controlled trial","volume":"13","author":"Harvey","year":"2012","journal-title":"Trials"},{"key":"10.1016\/S2213-8587(17)30113-4_bib3","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1016\/S2213-8587(17)30067-0","article-title":"Does fetal exposure to vitamin D programme childhood bone mass?","volume":"5","author":"Kovacs","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30113-4_bib4","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jocd.2014.01.003","article-title":"Dual-energy x-ray absorptiometry interpretation and reporting in children and adolescents: the revised 2013 ISCD Pediatric Official Positions","volume":"17","author":"Crabtree","year":"2014","journal-title":"J Clin Densitom"},{"key":"10.1016\/S2213-8587(17)30113-4_bib5","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1186\/s13063-016-1603-y","article-title":"Southampton pregnancy intervention for the next generation (SPRING): protocol for a randomised controlled trial","volume":"17","author":"Baird","year":"2016","journal-title":"Trials"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301134?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301134?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,2]],"date-time":"2018-09-02T14:54:17Z","timestamp":1535900057000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301134"}},"issued":{"date-parts":[[2017,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2213858717301134"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30113-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,5]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T20:13:23Z","timestamp":1648671203052},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/s2213-8587(16)30337-0","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T02:39:49Z","timestamp":1479868789000},"page":"e12","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2016; 4: 960\u201361"],"prefix":"10.1016","volume":"4","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T08:38:54Z","timestamp":1548664734000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303370"}},"issued":{"date-parts":[[2016,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2213858716303370"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30337-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,12]]}},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T06:24:12Z","timestamp":1649139852462},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/s2213-8587(14)70222-0","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T01:00:11Z","timestamp":1414630811000},"page":"e1","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2014; published online Aug 25"],"prefix":"10.1016","volume":"3","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702220?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702220?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T03:36:10Z","timestamp":1548646570000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702220"}},"issued":{"date-parts":[[2015,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S2213858714702220"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70222-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,1]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T00:29:44Z","timestamp":1649032184994},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/s2213-8587(16)00006-1","type":"journal-article","created":{"date-parts":[[2016,2,9]],"date-time":"2016-02-09T00:01:46Z","timestamp":1454976106000},"page":"e4","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2016; 4: 20\u201321"],"prefix":"10.1016","volume":"4","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T08:37:46Z","timestamp":1548664666000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716000061"}},"issued":{"date-parts":[[2016,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S2213858716000061"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)00006-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,4]]}},{"indexed":{"date-parts":[[2023,10,3]],"date-time":"2023-10-03T21:58:39Z","timestamp":1696370319894},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/s2213-8587(15)00053-4","type":"journal-article","created":{"date-parts":[[2015,3,13]],"date-time":"2015-03-13T00:49:52Z","timestamp":1426207792000},"page":"403-405","source":"Crossref","is-referenced-by-count":8,"title":["NICE draft type 2 diabetes guidelines: a cause for concern"],"prefix":"10.1016","volume":"3","author":[{"given":"Anthony H","family":"Barnett","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00053-4_bib1","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00053-4_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.15277\/bjdvd.2015.006","article-title":"The new NICE guidelines for type 2 diabetes\u2014a critical analysis","volume":"15","author":"O'Hare","year":"2015","journal-title":"Br J Diabetes Vasc Dis"},{"key":"10.1016\/S2213-8587(15)00053-4_bib4","author":"Price"},{"key":"10.1016\/S2213-8587(15)00053-4_bib6","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/1748-5908-7-60","article-title":"Developing clinical practice guidelines: target audiences, identifying topics for guidelines, guideline group composition and functioning and conflicts of interest","volume":"7","author":"Eccles","year":"2012","journal-title":"Implement Sci"},{"key":"10.1016\/S2213-8587(15)00053-4_bib7","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.2010.405","article-title":"Effect of noninsulin antidiabetic drugs added to metformin therapy on glycaemic control, weight gain, and hypoglycaemia in type 2 diabetes","volume":"303","author":"Phung","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00053-4_bib8","doi-asserted-by":"crossref","first-page":"759","DOI":"10.2337\/diacare.29.04.06.dc05-1967","article-title":"Efficacy, tolerability, and safety of a novel once-daily extended-release metformin in patients with type 2 diabetes","volume":"29","author":"Schwartz","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00053-4_bib10","doi-asserted-by":"crossref","first-page":"157201","DOI":"10.1155\/2015\/157201","article-title":"Effects of glucagon-like peptide-1 receptor agonists on weight loss in patients with type 2 diabetes: a systematic review and network meta-analysis","volume":"2015","author":"Sun","year":"2015","journal-title":"J Diabetes Res"},{"key":"10.1016\/S2213-8587(15)00053-4_bib11","doi-asserted-by":"crossref","DOI":"10.1177\/0272989X14565821","article-title":"Estimating cost-effectiveness in type 2 diabetes: the impact of treatment guidelines and therapy duration","author":"McEwan","year":"2015","journal-title":"Med Decis Making"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000534?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000534?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T11:54:24Z","timestamp":1537790064000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000534"}},"issued":{"date-parts":[[2015,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S2213858715000534"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00053-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,6]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T07:29:31Z","timestamp":1648625371155},"reference-count":5,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/s2213-8587(18)30043-3","type":"journal-article","created":{"date-parts":[[2018,2,20]],"date-time":"2018-02-20T19:34:17Z","timestamp":1519155257000},"page":"167-168","source":"Crossref","is-referenced-by-count":0,"title":["Treatment of cystic fibrosis-related diabetes \u2013 Authors' reply"],"prefix":"10.1016","volume":"6","author":[{"given":"Manfred","family":"Ballmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Reinhard W","family":"Holl","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30043-3_bib1","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S2213-8587(17)30400-X","article-title":"Repaglinide versus insulin for newly diagnosed diabetes in patients with cystic fibrosis: a multicentre, open-label, randomised trial","volume":"6","author":"Ballmann","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30043-3_bib2","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.2337\/dc09-0585","article-title":"Insulin therapy to improve BMI in cystic fibrosis-related diabetes without fasting hyperglycemia: results of the Cystic Fibrosis Related Diabetes Therapy Trial","volume":"32","author":"Moran","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30043-3_bib3","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1111\/dom.12501","article-title":"Plasma insulin profiles after subcutaneous injection: how close can we get to physiology in people with diabetes?","volume":"17","author":"Home","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30043-3_bib4","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1016\/j.jcf.2008.01.003","article-title":"Treatment compliance in children and adults with cystic fibrosis","volume":"7","author":"Arias Llorente","year":"2008","journal-title":"J Cyst Fibros"},{"key":"10.1016\/S2213-8587(18)30043-3_bib5","article-title":"Insulin and oral agents for managing cystic fibrosis-related diabetes","volume":"4","author":"Onady","year":"2016","journal-title":"Cochrane Database Syst Rev"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300433?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300433?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T19:54:03Z","timestamp":1535054043000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300433"}},"issued":{"date-parts":[[2018,3]]},"references-count":5,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["S2213858718300433"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30043-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,3]]}},{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T06:55:31Z","timestamp":1781765731781,"version":"3.54.5"},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/s2213-8587(15)00080-7","type":"journal-article","created":{"date-parts":[[2015,3,24]],"date-time":"2015-03-24T03:17:30Z","timestamp":1427167050000},"page":"319","source":"Crossref","is-referenced-by-count":6,"title":["Country in Focus: health disparities in Indigenous Canadians"],"prefix":"10.1016","volume":"3","author":[{"given":"Angela","family":"Pirisi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000807?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000807?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T06:22:35Z","timestamp":1537770155000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000807"}},"issued":{"date-parts":[[2015,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S2213858715000807"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00080-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,5]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T07:48:56Z","timestamp":1648972136804},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70016-0","type":"journal-article","created":{"date-parts":[[2013,4,18]],"date-time":"2013-04-18T10:24:42Z","timestamp":1366280682000},"page":"e5-e6","source":"Crossref","is-referenced-by-count":2,"title":["Cash for cutting calories: are financial incentives the way forward for weight loss?"],"prefix":"10.1016","volume":"1","author":[{"given":"Susan","family":"Mayor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,16]],"date-time":"2018-10-16T21:53:03Z","timestamp":1539726783000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700160"}},"issued":{"date-parts":[[2013,9]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2213858713700160"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70016-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]}},{"indexed":{"date-parts":[[2022,4,2]],"date-time":"2022-04-02T17:14:58Z","timestamp":1648919698310},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2016,4,1]],"date-time":"2016-04-01T00:00:00Z","timestamp":1459468800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,4]]},"DOI":"10.1016\/s2213-8587(15)00260-0","type":"journal-article","created":{"date-parts":[[2016,3,9]],"date-time":"2016-03-09T02:08:42Z","timestamp":1457489322000},"page":"305","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"4","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002600?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002600?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T13:27:19Z","timestamp":1536931639000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002600"}},"issued":{"date-parts":[[2016,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2016,4]]}},"alternative-id":["S2213858715002600"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00260-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,4]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T15:31:49Z","timestamp":1648999909012},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/s2213-8587(15)00433-7","type":"journal-article","created":{"date-parts":[[2015,11,18]],"date-time":"2015-11-18T20:00:45Z","timestamp":1447876845000},"page":"e11","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2015; 3: 855\u201365"],"prefix":"10.1016","volume":"3","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004337?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004337?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T03:37:26Z","timestamp":1548646646000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004337"}},"issued":{"date-parts":[[2015,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S2213858715004337"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00433-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,12]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T20:17:23Z","timestamp":1649017043336},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/s2213-8587(15)00375-7","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T10:14:47Z","timestamp":1445508887000},"page":"e10","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2015; 3: 503"],"prefix":"10.1016","volume":"3","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003757?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003757?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T08:37:14Z","timestamp":1548664634000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003757"}},"issued":{"date-parts":[[2015,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S2213858715003757"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00375-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,11]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T12:00:42Z","timestamp":1649073642646},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/s2213-8587(15)00077-7","type":"journal-article","created":{"date-parts":[[2015,3,19]],"date-time":"2015-03-19T14:03:56Z","timestamp":1426773836000},"page":"310-312","source":"Crossref","is-referenced-by-count":1,"title":["Glucose-lowering and heart failure: risks of errors"],"prefix":"10.1016","volume":"3","author":[{"given":"Iwan C C","family":"van der Horst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Frederik","family":"Keus","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00077-7_bib1","doi-asserted-by":"crossref","first-page":"d6898","DOI":"10.1136\/bmj.d6898","article-title":"Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials","volume":"343","author":"Hemmingsen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00077-7_bib2","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1016\/j.ahj.2011.07.030","article-title":"Intensive glycemic control has no impact on the risk of heart failure in type 2 diabetic patients: evidence from a 37,229 patient meta-analysis","volume":"162","author":"Castagno","year":"2011","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(15)00077-7_bib3","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S2213-8587(14)70031-2","article-title":"Heart failure: a cardiovascular outcome in diabetes that can no longer be ignored","volume":"2","author":"McMurray","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00077-7_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00044-3","article-title":"Glucose-lowering drugs or strategies and cardiovascular outcomes in patients with or at risk for type 2 diabetes: a meta-analysis of randomised controlled trials","author":"Udell","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00077-7_bib5","series-title":"Cochrane handbook for systematic reviews of interventions version 5.1.0","author":"Higgins","year":"2011"},{"key":"10.1016\/S2213-8587(15)00077-7_bib6","doi-asserted-by":"crossref","first-page":"3336","DOI":"10.1093\/eurheartj\/ehu424","article-title":"Systematic reviews and meta-analyses of randomized trials: principles and pitfalls","volume":"35","author":"da Costa","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(15)00077-7_bib7","doi-asserted-by":"crossref","first-page":"429","DOI":"10.7326\/0003-4819-157-6-201209180-00537","article-title":"Influence of reported study design characteristics on intervention effect estimates from randomized, controlled trials","volume":"157","author":"Savovi\u0107","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(15)00077-7_bib8","doi-asserted-by":"crossref","first-page":"e25491","DOI":"10.1371\/journal.pone.0025491","article-title":"The number of patients and events required to limit the risk of overestimation of intervention effects in meta-analysis\u2014a simulation study","volume":"6","author":"Thorlund","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(15)00077-7_bib9","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/j.jclinepi.2007.03.013","article-title":"Trial sequential analysis may establish when firm evidence is reached in cumulative meta-analysis","volume":"61","author":"Wetterslev","year":"2008","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(15)00077-7_bib10","doi-asserted-by":"crossref","first-page":"995","DOI":"10.1136\/bmj.39490.551019.BE","article-title":"What is \u201cquality of evidence\u201d and why is it important to clinicians?","volume":"336","author":"Guyatt","year":"2008","journal-title":"BMJ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,24]],"date-time":"2018-09-24T08:20:52Z","timestamp":1537777252000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000777"}},"issued":{"date-parts":[[2015,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S2213858715000777"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00077-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,5]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T04:35:27Z","timestamp":1648960527152},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/s2213-8587(14)70175-5","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T01:15:24Z","timestamp":1411521324000},"page":"855-856","source":"Crossref","is-referenced-by-count":1,"title":["The role of pasireotide in the treatment of acromegaly"],"prefix":"10.1016","volume":"2","author":[{"given":"Nicholas A","family":"Tritos","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70175-5_bib1","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrendo.2014.21","article-title":"Expert consensus document: a consensus on the medical treatment of acromegaly","volume":"10","author":"Giustina","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(14)70175-5_bib2","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1210\/jc.2011-3237","article-title":"Update on pituitary surgery","volume":"97","author":"Swearingen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70175-5_bib3","doi-asserted-by":"crossref","first-page":"1992","DOI":"10.1210\/jc.2011-0251","article-title":"Radiation therapy in the management of pituitary adenomas","volume":"96","author":"Loeffler","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70175-5_bib4","doi-asserted-by":"crossref","first-page":"R31","DOI":"10.1530\/EJE-13-0532","article-title":"Management of endocrine disease: GH excess: diagnosis and medical therapy","volume":"170","author":"Andersen","year":"2014","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70175-5_bib5","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/jc.2003-031052","article-title":"A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients","volume":"89","author":"van der Hoek","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70175-5_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70169-X","article-title":"Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial","author":"Gadelha","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70175-5_bib7","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1210\/jc.2013-2480","article-title":"Pasireotide versus octreotide in acromegaly: a head-to-head superiority study","volume":"99","author":"Colao","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70175-5_bib8","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1016\/j.tem.2012.11.007","article-title":"Novel pathway for somatostatin analogs in patients with acromegaly","volume":"24","author":"Gadelha","year":"2013","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70175-5_bib9","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1210\/jc.2013-1771","article-title":"Hyperglycemia associated with pasireotide: results from a mechanistic study in healthy volunteers","volume":"98","author":"Henry","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70175-5_bib10","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11102-013-0483-3","article-title":"Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations","volume":"17","author":"Colao","year":"2014","journal-title":"Pituitary"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701755?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701755?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T08:28:19Z","timestamp":1538209699000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701755"}},"issued":{"date-parts":[[2014,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S2213858714701755"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70175-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,11]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T01:54:11Z","timestamp":1649037251428},"reference-count":9,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/s2213-8587(16)30142-5","type":"journal-article","created":{"date-parts":[[2016,7,3]],"date-time":"2016-07-03T07:50:52Z","timestamp":1467532252000},"page":"632-633","source":"Crossref","is-referenced-by-count":2,"title":["Testosterone and the brain: the power of a negative study"],"prefix":"10.1016","volume":"4","author":[{"given":"Bradley D","family":"Anawalt","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephanie T","family":"Page","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30142-5_bib1","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.maturitas.2014.05.015","article-title":"Hormonal changes and their impact on cognition and mental health of ageing men","volume":"79","author":"Yeap","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(16)30142-5_bib2","doi-asserted-by":"crossref","first-page":"2223","DOI":"10.1210\/jc.2015-1016","article-title":"Longitudinal relationships between reproductive hormones and cognitive decline in older men: The Concord Health and Ageing in Men Project","volume":"100","author":"Hsu","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30142-5_bib3","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1212\/WNL.57.1.80","article-title":"Testosterone supplementation improves spatial and verbal memory in healthy older men","volume":"57","author":"Cherrier","year":"2001","journal-title":"Neurology"},{"key":"10.1016\/S2213-8587(16)30142-5_bib4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.2164\/jandrol.107.002931","article-title":"Exogenous testosterone alone or with finasteride does not improve measurements of cognition in healthy older men with low serum total testosterone","volume":"28","author":"Vaughan","year":"2007","journal-title":"J Androl"},{"key":"10.1016\/S2213-8587(16)30142-5_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)30102-4","article-title":"Effects of long-term testosterone administration on cognition in older men with low or low-to-normal testosterone concentrations: a prespecified secondary analysis of data from the randomised, double-blind, placebo-controlled TEAAM trial","author":"Huang","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30142-5_bib6","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1001\/jama.2015.8881","article-title":"Effects of Testosterone Administration for 3 Years on Subclinical Atherosclerosis Progression in Older Men With Low or Low-Normal Testosterone Levels: A Randomized Clinical Trial","volume":"314","author":"Basaria","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30142-5_bib7","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1111\/cen.12594","article-title":"Clinical practice patterns in the assessment and management of low testosterone in men: an international survey of endocrinologists","volume":"82","author":"Grossmann","year":"2015","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(16)30142-5_bib8","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1056\/NEJMoa0911101","article-title":"Identification of late-onset hypogonadism in middle-aged and elderly men","volume":"363","author":"Wu","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30142-5_bib9","doi-asserted-by":"crossref","first-page":"2021","DOI":"10.1200\/JCO.2014.60.1963","article-title":"Course and predictors of cognitive function in patients with prostate cancer receiving androgen-deprivation therapy: a controlled comparison","volume":"33","author":"Gonzalez","year":"2015","journal-title":"J Clin Oncol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T04:02:58Z","timestamp":1555387378000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301425"}},"issued":{"date-parts":[[2016,8]]},"references-count":9,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S2213858716301425"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30142-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,8]]}},{"indexed":{"date-parts":[[2023,8,23]],"date-time":"2023-08-23T12:08:56Z","timestamp":1692792536291},"reference-count":12,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/s2213-8587(14)70106-8","type":"journal-article","created":{"date-parts":[[2014,5,13]],"date-time":"2014-05-13T01:30:18Z","timestamp":1399944618000},"page":"603-604","source":"Crossref","is-referenced-by-count":2,"title":["DIGAMI 1: 20 years later"],"prefix":"10.1016","volume":"2","author":[{"given":"Denise E","family":"Bonds","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70106-8_bib1","doi-asserted-by":"crossref","first-page":"718","DOI":"10.1016\/S0002-9149(84)80196-4","article-title":"Prognosis of patients with diabetes mellitus after acute myocardial infarction","volume":"54","author":"Smith","year":"1984","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(14)70106-8_bib2","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1016\/S0140-6736(83)92586-2","article-title":"Prevention of deterioration of renal and sensory-nerve function by more intensive management of insulin-dependent diabetic patients. A two-year randomised prospective study","volume":"1","author":"Holman","year":"1983","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70106-8_bib3","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.2337\/diacare.17.12.1514","article-title":"Standards of care for diabetes","volume":"17","author":"Weir","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70106-8_bib4","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.1978.03290010041020","article-title":"Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. VII. Mortality and selected nonfatal events with insulin treatment","volume":"240","author":"Knatterud","year":"1978","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70106-8_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.2337\/diacare.17.9.1007","article-title":"Feasibility of insulin-glucose infusion in diabetic patients with acute myocardial infarction. A report from the multicenter trial: DIGAMI","volume":"17","author":"Malmberg","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70106-8_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70088-9","article-title":"Intensified insulin-based gylcaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial","author":"Ritsinger","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70106-8_bib7","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70106-8_bib8","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70106-8_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70106-8_bib10","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/eurheartj\/ehi199","article-title":"Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity","volume":"26","author":"Malmberg","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(14)70106-8_bib11","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/diacare.29.04.06.dc05-1894","article-title":"The hyperglycemia: intensive insulin infusion in infarction (hi-5) study: a randomized controlled trial of insulin infusion therapy for myocardial infarction","volume":"29","author":"Cheung","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70106-8_bib12","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0735-1097(95)00126-K","article-title":"Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year","volume":"26","author":"Malmberg","year":"1995","journal-title":"J Am Coll Cardiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T06:27:25Z","timestamp":1538634445000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701068"}},"issued":{"date-parts":[[2014,8]]},"references-count":12,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S2213858714701068"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70106-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,8]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T07:22:59Z","timestamp":1648624979879},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/s2213-8587(19)30141-x","type":"journal-article","created":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T19:43:13Z","timestamp":1555530193000},"page":"e18","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2019; 7: 339\u201341"],"prefix":"10.1016","volume":"7","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930141X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930141X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T17:03:59Z","timestamp":1560791039000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871930141X"}},"issued":{"date-parts":[[2019,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S221385871930141X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30141-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,6]]}},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T20:04:12Z","timestamp":1648757052294},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/s2213-8587(14)70105-6","type":"journal-article","created":{"date-parts":[[2014,5,2]],"date-time":"2014-05-02T00:46:33Z","timestamp":1398991593000},"page":"529-530","source":"Crossref","is-referenced-by-count":0,"title":["Insulin analogues for recurrent severe hypoglycaemia"],"prefix":"10.1016","volume":"2","author":[{"given":"Mikael","family":"Knip","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70105-6_bib1","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1002\/edn.91","article-title":"Concerns about hypoglycaemia and late complications in patients with insulin-treated diabetes","volume":"4","author":"Banck-Petersen","year":"2007","journal-title":"Eur Diabetes Nurs"},{"key":"10.1016\/S2213-8587(14)70105-6_bib2","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1002\/(SICI)1520-7560(199901\/02)15:1<42::AID-DMRR1>3.0.CO;2-B","article-title":"Hypoglycemia is the limiting factor in the management of diabetes","volume":"15","author":"Cryer","year":"1999","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(14)70105-6_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(14)70073-7","article-title":"Effect of insulin analogues on risk of severe hypoglycaemia in patients with type 1 diabetes prone to recurrent severe hypoglycaemia (HypoAna trial): a prospective, randomised, open-label, blinded-endpoint crossover trial","author":"Pedersen-Bjergaard","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70105-6_bib4","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1136\/pgmj.2008.068197","article-title":"Hypoglycaemia: current management and controversies","volume":"87","author":"Choudhary","year":"2011","journal-title":"Postgrad Med J"},{"key":"10.1016\/S2213-8587(14)70105-6_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD003287.pub4","article-title":"Short acting insulin analogues versus regular human insulin in patients with diabetes mellitus","volume":"2","author":"Siebenhofer","year":"2006","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(14)70105-6_bib6","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.2337\/diacare.21.11.1904","article-title":"Improved glycemic control with insulin aspart: a multicenter randomized double-blind crossover trial in type 1 diabetic patients","volume":"21","author":"Home","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70105-6_bib7","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.2337\/diacare.27.5.1081","article-title":"Insulin detemir offers improved glycemic control compared with NPH insulin in people with type 1 diabetes: a randomized clinical trial","volume":"27","author":"Home","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70105-6_bib8","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/j.1463-1326.2004.00363.x","article-title":"Insulin detemir used in basal-bolus therapy in people with type 1 diabetes is associated with a lower risk of nocturnal hypoglycaemia and less weight gain over 12 months in comparison to NPH insulin","volume":"7","author":"De Leeuw","year":"2005","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(14)70105-6_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1111\/j.1464-5491.2005.01781.x","article-title":"Improved glycaemic control with insulin glargine plus insulin lispro: a multicentre, randomized, cross-over trial in people with type 1 diabetes","volume":"23","author":"Ashwell","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(14)70105-6_bib10","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1111\/j.1463-1326.2008.00976.x","article-title":"Long-acting insulin analogues vs. NPH human insulin in type 1 diabetes: a meta-analysis","volume":"11","author":"Monami","year":"2009","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701056?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701056?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T13:27:14Z","timestamp":1538659634000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701056"}},"issued":{"date-parts":[[2014,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S2213858714701056"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70105-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,7]]}},{"indexed":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T20:02:09Z","timestamp":1762459329634},"reference-count":6,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/s2213-8587(15)00427-1","type":"journal-article","created":{"date-parts":[[2015,11,19]],"date-time":"2015-11-19T01:00:19Z","timestamp":1447894819000},"page":"930-931","source":"Crossref","is-referenced-by-count":8,"title":["Understanding EMPA-REG OUTCOME"],"prefix":"10.1016","volume":"3","author":[{"given":"Richard E","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim A","family":"Connelly","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00427-1_bib1","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/diacare.24.1.5","article-title":"Diastolic dysfunction in normotensive men with well-controlled type 2 diabetes: importance of maneuvers in echocardiographic screening for preclinical diabetic cardiomyopathy","volume":"24","author":"Poirier","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00427-1_bib2","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1016\/S0002-9149(99)00774-2","article-title":"Impact of left ventricular diastolic dysfunction on maximal treadmill performance in normotensive subjects with well-controlled type 2 diabetes mellitus","volume":"85","author":"Poirier","year":"2000","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(15)00427-1_bib3","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/eurheartj\/ehp604","article-title":"Heart failure events with rosiglitazone in type 2 diabetes: data from the RECORD clinical trial","volume":"31","author":"Komajda","year":"2010","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(15)00427-1_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00427-1_bib5","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1016\/S2213-8587(15)00384-8","article-title":"Getting to the heart of the matter in type 2 diabetes","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00427-1_bib6","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1007\/s00125-006-0359-4","article-title":"Plasma N-terminal pro-B-type natriuretic peptide and mortality in type 2 diabetes","volume":"49","author":"Tarnow","year":"2006","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004271?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004271?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T16:22:10Z","timestamp":1537201330000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004271"}},"issued":{"date-parts":[[2015,12]]},"references-count":6,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S2213858715004271"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00427-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,12]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:17:00Z","timestamp":1761992220417,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/s2213-8587(23)00255-3","type":"journal-article","created":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T18:29:44Z","timestamp":1694456984000},"page":"709-710","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Many years of life lost to young-onset type 2 diabetes"],"prefix":"10.1016","volume":"11","author":[{"given":"Bruce B","family":"Duncan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maria In\u00eas","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00255-3_bib1","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/S2213-8587(22)00252-2","article-title":"Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study","volume":"10","author":"Tomic","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"journal-title":"Lancet Diabetes Endocrinol","article-title":"Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation","year":"2023","key":"10.1016\/S2213-8587(23)00255-3_bib2"},{"key":"10.1016\/S2213-8587(23)00255-3_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S2213-8587(17)30186-9","article-title":"Type 2 diabetes in adolescents and young adults","volume":"6","author":"Lascar","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00255-3_bib4","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41574-020-0334-z","article-title":"Young-onset type 2 diabetes mellitus\u2014implications for morbidity and mortality","volume":"16","author":"Magliano","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00255-3_bib5","doi-asserted-by":"crossref","DOI":"10.7189\/jgh.11.04041","article-title":"Lifetime risk of developing diabetes and years of life lost among those with diabetes in Brazil","volume":"11","author":"Bracco","year":"2021","journal-title":"J Glob Health"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00255-3_bib6","article-title":"Ultraprocessed food consumption and dietary nutrient profiles associated with obesity: a multicountry study of children and adolescents","volume":"23","author":"Neri","year":"2022","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(23)00255-3_bib7","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.2337\/dc22-1993","article-title":"Ultra-processed food consumption and risk of type 2 diabetes: three large prospective U.S. cohort studies","volume":"46","author":"Chen","year":"2023","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002553?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002553?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:40Z","timestamp":1761991960000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723002553"}},"issued":{"date-parts":[[2023,10]]},"references-count":7,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2213858723002553"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00255-3","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Many years of life lost to young-onset type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00255-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00223-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:53Z","timestamp":1761992213062,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/s2213-8587(23)00024-4","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T23:23:48Z","timestamp":1677021828000},"page":"e3-e5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thank you to The Lancet Diabetes &amp; Endocrinology's statistical and peer reviewers in 2022"],"prefix":"10.1016","volume":"11","author":[{"family":"The Lancet Diabetes & Endocrinology Editors","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000244?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000244?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:25Z","timestamp":1761991945000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000244"}},"issued":{"date-parts":[[2023,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2213858723000244"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00024-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thank you to The Lancet Diabetes & Endocrinology's statistical and peer reviewers in 2022","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00024-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T16:10:00Z","timestamp":1769271000952,"version":"3.49.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,10,1]],"date-time":"2022-10-01T00:00:00Z","timestamp":1664582400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,10]]},"DOI":"10.1016\/s2213-8587(22)00242-x","type":"journal-article","created":{"date-parts":[[2022,8,26]],"date-time":"2022-08-26T18:32:05Z","timestamp":1661538725000},"page":"698-699","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Stigma in type 1 diabetes: a global problem"],"prefix":"10.1016","volume":"10","author":[{"given":"James S","family":"Hirsch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872200242X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872200242X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:02Z","timestamp":1761991862000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872200242X"}},"issued":{"date-parts":[[2022,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2022,10]]}},"alternative-id":["S221385872200242X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00242-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stigma in type 1 diabetes: a global problem","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00242-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:33:19Z","timestamp":1757629999299,"version":"3.44.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/s2213-8587(25)00257-8","type":"journal-article","created":{"date-parts":[[2025,8,20]],"date-time":"2025-08-20T01:11:32Z","timestamp":1755652292000},"page":"828","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A food system in crisis: battle lines for change"],"prefix":"10.1016","volume":"13","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002578?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002578?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T16:15:03Z","timestamp":1757520903000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002578"}},"issued":{"date-parts":[[2025,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2213858725002578"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00257-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A food system in crisis: battle lines for change","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00257-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:48Z","timestamp":1761991728609,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/s2213-8587(14)70043-9","type":"journal-article","created":{"date-parts":[[2014,4,2]],"date-time":"2014-04-02T21:17:45Z","timestamp":1396473465000},"page":"e8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["Vitamin D status and ill health"],"prefix":"10.1016","volume":"2","author":[{"given":"Martin","family":"Feelisch","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shelley","family":"Gorman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard B","family":"Weller","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70043-9_bib1","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1016\/S2213-8587(13)70165-7","article-title":"Vitamin D status and ill health: a systematic review","volume":"2","author":"Autier","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70043-9_bib2","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1158\/1055-9965.EPI-10-0982","article-title":"Ultraviolet exposure and mortality among women in Sweden","volume":"20","author":"Yang","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(14)70043-9_bib3","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/ije\/dyt168","article-title":"Skin cancer as a marker of sun exposure associates with myocardial infarction, hip fracture and death from any cause","volume":"42","author":"Brondum-Jacobsen","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(14)70043-9_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/jid.2014.27","article-title":"UVA irradiation of human skin vasodilates arterial vasculature and lowers blood pressure independently of nitric oxide synthase","author":"Liu","year":"2014","journal-title":"J Invest Dermatol"},{"key":"10.1016\/S2213-8587(14)70043-9_bib5","doi-asserted-by":"crossref","first-page":"e46006","DOI":"10.1371\/journal.pone.0046006","article-title":"Acute erythemal ultraviolet radiation causes systemic immunosuppression in the absence of increased 25-hydroxyvitamin D3 levels in male mice","volume":"7","author":"Gorman","year":"2012","journal-title":"PLoS One"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700439?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700439?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:01Z","timestamp":1761991501000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700439"}},"issued":{"date-parts":[[2014,4]]},"references-count":5,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S2213858714700439"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70043-9","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vitamin D status and ill health","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70043-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70165-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,21]],"date-time":"2025-10-21T03:27:05Z","timestamp":1761017225161},"reference-count":11,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/s2213-8587(18)30172-4","type":"journal-article","created":{"date-parts":[[2018,6,5]],"date-time":"2018-06-05T22:47:19Z","timestamp":1528238839000},"page":"676-678","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Stress at work in patients with cardiometabolic disease"],"prefix":"10.1016","volume":"6","author":[{"given":"Yulong","family":"Lian","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30172-4_bib1","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1080\/07853890.2016.1271957","article-title":"Cardiometabolic diseases of civilization: history and maturation of an evolving global threat. An update and call to action","volume":"49","author":"Kones","year":"2017","journal-title":"Ann Med"},{"key":"10.1016\/S2213-8587(18)30172-4_bib2","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1038\/nrcardio.2017.189","article-title":"Effects of stress on the development and progression of cardiovascular disease","volume":"15","author":"Kivim\u00e4ki","year":"2018","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(18)30172-4_bib3","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/dc17-0749","article-title":"Effect of changing work stressors and coping resources on the risk of type 2 diabetes: the OHSPIW cohort study","volume":"41","author":"Lian","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30172-4_bib4","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1161\/STROKEAHA.114.008019","article-title":"Job strain and the risk of stroke: an individual-participant data meta-analysis","volume":"46","author":"Fransson","year":"2015","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(18)30172-4_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30140-2","article-title":"Work stress and risk of death in adults with and without cardiometabolic disease: a multicohort study","author":"Kivim\u00e4ki","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30172-4_bib6","doi-asserted-by":"crossref","first-page":"1756","DOI":"10.1016\/j.jacc.2012.06.044","article-title":"Perceived stress in myocardial infarction: long-term mortality and health status outcomes","volume":"60","author":"Arnold","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(18)30172-4_bib7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1186\/1471-2458-14-588","article-title":"The associations between psychosocial working conditions and changes in common mental disorders: a follow-up study","volume":"14","author":"Laine","year":"2014","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(18)30172-4_bib8","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1136\/heartjnl-2016-311097","article-title":"Persistent psychological distress and mortality in patients with stable coronary artery disease","volume":"103","author":"Stewart","year":"2017","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(18)30172-4_bib9","doi-asserted-by":"crossref","first-page":"e260","DOI":"10.1016\/S2468-2667(17)30075-0","article-title":"Contribution of risk factors to excess mortality in isolated and lonely individuals: an analysis of data from the UK Biobank cohort study","volume":"2","author":"Elovainio","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(18)30172-4_bib10","doi-asserted-by":"crossref","first-page":"2824","DOI":"10.1016\/j.ijcard.2012.07.005","article-title":"Job insecurity and prognosis after myocardial infarction: the SHEEP Study","volume":"167","author":"L\u00e1szl\u00f3","year":"2013","journal-title":"Int J Cardiol"},{"key":"10.1016\/S2213-8587(18)30172-4_bib11","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.yfrne.2017.04.001","article-title":"Sex differences in cardiovascular disease\u2014impact on care and outcomes","volume":"46","author":"Humphries","year":"2017","journal-title":"Front Neuroendocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301724?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301724?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,22]],"date-time":"2018-08-22T03:20:25Z","timestamp":1534908025000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301724"}},"issued":{"date-parts":[[2018,9]]},"references-count":11,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2213858718301724"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30172-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Stress at work in patients with cardiometabolic disease","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30172-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30140-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:32:13Z","timestamp":1761895933403},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/s2213-8587(14)70217-7","type":"journal-article","created":{"date-parts":[[2014,10,22]],"date-time":"2014-10-22T23:30:23Z","timestamp":1414020623000},"page":"6-7","source":"Crossref","is-referenced-by-count":4,"title":["Does mortality risk vary among sulfonylureas?"],"prefix":"10.1016","volume":"3","author":[{"given":"Kevin M","family":"Pantalone","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 2","key":"10.1016\/S2213-8587(14)70217-7_bib1","first-page":"747","article-title":"A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes","volume":"19","year":"1970","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(14)70217-7_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70217-7_bib3","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc06-1789","article-title":"A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin","volume":"30","author":"Gangji","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70217-7_bib4","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1007\/s00125-003-1143-3","article-title":"Sulphonylurea action revisited: the post-cloning era","volume":"46","author":"Gribble","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70217-7_bib5","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1111\/j.1463-1326.2007.00833.x","article-title":"No differences in mortality between users of pancreatic-specific and non-pancreatic-specific sulphonylureas: a cohort analysis","volume":"10","author":"Evans","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(14)70217-7_bib6","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/euhj.1998.1242","article-title":"Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide","volume":"20","author":"Klepzig","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(14)70217-7_bib7","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1002\/dmrr.971","article-title":"Sulfonylureas and prognosis after myocardial infarction in patients with diabetes: a population-based follow-up study","volume":"25","author":"Horsdal","year":"2009","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(14)70217-7_bib8","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.2337\/dc10-0017","article-title":"The risk of overall mortality in patients with type 2 diabetes receiving glipizide, glyburide, or glimepiride monotherapy: a retrospective analysis","volume":"33","author":"Pantalone","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70217-7_bib9","doi-asserted-by":"crossref","first-page":"4993","DOI":"10.1210\/jc.2010-0449","article-title":"Impact of type of preadmission sulfonylureas on mortality and cardiovascular outcomes in diabetic patients with acute myocardial infarction","volume":"95","author":"Zeller","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70217-7_bib10","article-title":"Mortality risk among sulfonylureas: a systematic review and network meta-analysis","author":"Simpson","year":"2014","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702177?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702177?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T09:23:00Z","timestamp":1538126580000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702177"}},"issued":{"date-parts":[[2015,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S2213858714702177"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70217-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,1]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:48Z","timestamp":1761992208713,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/s2213-8587(22)00306-0","type":"journal-article","created":{"date-parts":[[2022,11,10]],"date-time":"2022-11-10T18:33:01Z","timestamp":1668105181000},"page":"828-829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Trending now: modelling global epidemiology of type 1 diabetes in children and adolescents"],"prefix":"10.1016","volume":"10","author":[{"given":"Lars C","family":"Stene","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aveni","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00306-0_bib1","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/j.1464-5491.2006.01925.x","article-title":"Incidence and trends of childhood type 1 diabetes worldwide 1990-1999","volume":"23","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(22)00306-0_bib2","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1007\/s00125-018-4763-3","article-title":"Trends and cyclical variation in the incidence of childhood type 1 diabetes in 26 European centres in the 25 year period 1989-2013: a multicentre prospective registration study","volume":"62","author":"Patterson","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00306-0_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109083","article-title":"Global estimates of incidence of type 1 diabetes in children and adolescents: results from the International Diabetes Federation Atlas, 10th edition","volume":"183","author":"Ogle","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(22)00306-0_bib4","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00306-0_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(22)00276-5","article-title":"Estimating the total incidence of type 1 diabetes in children and adolescents 0\u201319 from 1990 to 2050: a global simulation-based analysis","author":"Ward","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00306-0_bib6","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/pedi.13009","article-title":"Comparison of the incidence of diabetes in United States and Indian youth: an international harmonization of youth diabetes registries","volume":"22","author":"Jensen","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(22)00306-0_bib7","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/S2213-8587(18)30074-3","article-title":"Blood glucose meters and test strips: global market and challenges to access in low-resource settings","volume":"7","author":"Klatman","year":"2019","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003060?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003060?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:19Z","timestamp":1761991939000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003060"}},"issued":{"date-parts":[[2022,12]]},"references-count":7,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2213858722003060"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00306-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Trending now: modelling global epidemiology of type 1 diabetes in children and adolescents","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00306-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00276-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:34Z","timestamp":1761992014948,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/s2213-8587(22)00001-8","type":"journal-article","created":{"date-parts":[[2022,1,10]],"date-time":"2022-01-10T18:42:35Z","timestamp":1641840155000},"page":"87-88","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding decreasing mortality in people with diabetes"],"prefix":"10.1016","volume":"10","author":[{"given":"Jennifer","family":"Manne-Goehler","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Flood","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00001-8_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00327-2","article-title":"Trends in all-cause mortality among people with diagnosed diabetes in high-income settings: a multicountry analysis of aggregate data","author":"Magliano","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00001-8_bib2","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1016\/S0140-6736(12)61422-6","article-title":"Screening for type 2 diabetes and population mortality over 10 years (ADDITION-Cambridge): a cluster-randomised controlled trial","volume":"380","author":"Simmons","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00001-8_bib3","doi-asserted-by":"crossref","first-page":"1483","DOI":"10.1161\/CIRCULATIONAHA.113.004042","article-title":"Temporal trends in ischemic heart disease mortality in 21 world regions, 1980 to 2010: the Global Burden of Disease 2010 study","volume":"129","author":"Moran","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(22)00001-8_bib4","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1161\/CIRCULATIONAHA.120.046501","article-title":"Bending the curve in cardiovascular disease mortality: Bethesda + 40 and beyond","volume":"143","author":"Goff","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(22)00001-8_bib5","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1056\/NEJMsa053935","article-title":"Explaining the decrease in U.S. deaths from coronary disease, 1980\u20132000","volume":"356","author":"Ford","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00001-8_bib6","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1093\/ije\/dyz143","article-title":"Is the long-term decline in cardiovascular-disease mortality in high-income countries over? Evidence from national vital statistics","volume":"48","author":"Lopez","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(22)00001-8_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S2213-8587(20)30402-2","article-title":"Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings","volume":"9","author":"Magliano","year":"2021","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000018?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000018?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:50Z","timestamp":1761991850000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000018"}},"issued":{"date-parts":[[2022,2]]},"references-count":7,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2213858722000018"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00001-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding decreasing mortality in people with diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00001-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00327-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T16:59:09Z","timestamp":1761929949955},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2018,8,1]],"date-time":"2018-08-01T00:00:00Z","timestamp":1533081600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,8]]},"DOI":"10.1016\/s2213-8587(18)30179-7","type":"journal-article","created":{"date-parts":[[2018,6,7]],"date-time":"2018-06-07T18:39:57Z","timestamp":1528396797000},"page":"604","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["TV advertising and childhood obesity in the UK"],"prefix":"10.1016","volume":"6","author":[{"given":"Talha Khan","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301797?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301797?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T00:04:37Z","timestamp":1534809877000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301797"}},"issued":{"date-parts":[[2018,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2018,8]]}},"alternative-id":["S2213858718301797"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30179-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"TV advertising and childhood obesity in the UK","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30179-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,23]],"date-time":"2025-10-23T11:07:43Z","timestamp":1761217663569},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/s2213-8587(13)70136-0","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T16:46:35Z","timestamp":1379695595000},"page":"79","source":"Crossref","is-referenced-by-count":2,"title":["EDCs: negotiating the precautionary principle"],"prefix":"10.1016","volume":"1","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701360?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701360?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T17:52:10Z","timestamp":1539366730000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701360"}},"issued":{"date-parts":[[2013,10]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S2213858713701360"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70136-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,10]]}},{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T00:52:24Z","timestamp":1768265544872,"version":"3.49.0"},"update-to":[{"DOI":"10.1016\/s2213-8587(24)00157-8","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/s2213-8587(24)00244-4","type":"journal-article","created":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T22:47:16Z","timestamp":1722552436000},"page":"e18","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Correction to Lancet Diabetes Endocrinol 2024; published online July 19. https:\/\/doi.org\/10.1016\/S2213-8587(24)00157-8"],"prefix":"10.1016","volume":"12","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:09:30Z","timestamp":1736860170000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002444"}},"issued":{"date-parts":[[2024,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213858724002444"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00244-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2024; published online July 19. https:\/\/doi.org\/10.1016\/S2213-8587(24)00157-8","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00244-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00157-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T20:49:15Z","timestamp":1648586955177},"reference-count":0,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/s2213-8587(13)70047-0","type":"journal-article","created":{"date-parts":[[2013,10,27]],"date-time":"2013-10-27T20:15:48Z","timestamp":1382904948000},"page":"e17","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["An unusual case of hypopituitarism"],"prefix":"10.1016","volume":"1","author":[{"given":"Bradley","family":"Griffiths","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joanna","family":"Skelton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Patrick","family":"Semple","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ian","family":"Ross","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700470?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700470?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,11]],"date-time":"2018-10-11T04:55:38Z","timestamp":1539233738000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700470"}},"issued":{"date-parts":[[2013,12]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2213858713700470"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70047-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"An unusual case of hypopituitarism","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70047-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,27]],"date-time":"2026-06-27T05:05:49Z","timestamp":1782536749774,"version":"3.54.5"},"reference-count":5,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/s2213-8587(24)00217-1","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:42:51Z","timestamp":1724398971000},"page":"612-613","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Risk of new-onset diabetes with high-intensity statin use"],"prefix":"10.1016","volume":"12","author":[{"given":"David M","family":"Diamond","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin E","family":"Kip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00217-1_bib1","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1016\/S2213-8587(24)00040-8","article-title":"Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis","volume":"12","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00217-1_bib2","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1001\/jamainternmed.2022.0134","article-title":"Evaluating the association between low-density lipoprotein cholesterol reduction and relative and absolute effects of statin treatment: a systematic review and meta-analysis","volume":"182","author":"Byrne","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(24)00217-1_bib3","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00125-015-3528-5","article-title":"Increased risk of diabetes with statin treatment is associated with impaired insulin sensitivity and insulin secretion: a 6-year follow-up study of the METSIM cohort","volume":"58","author":"Cederberg","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00217-1_bib4","doi-asserted-by":"crossref","first-page":"2119","DOI":"10.1016\/j.jacc.2020.03.033","article-title":"Low-density lipoprotein cholesterol: lower Is totally better","volume":"75","author":"Cannon","year":"2020","journal-title":"J Am Coll Cardiology"},{"key":"10.1016\/S2213-8587(24)00217-1_bib5","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1097\/MED.0000000000000764","article-title":"Statin therapy is not warranted for a person with high LDL-cholesterol on a low-carbohydrate diet","volume":"29","author":"Diamond","year":"2022","journal-title":"Curr Opin Endocrinol Diabetes Obes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002171?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002171?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:09:15Z","timestamp":1736860155000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002171"}},"issued":{"date-parts":[[2024,9]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213858724002171"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00217-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Risk of new-onset diabetes with high-intensity statin use","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00217-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:14Z","timestamp":1761992174469,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,9,1]],"date-time":"2022-09-01T00:00:00Z","timestamp":1661990400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["214185\/Z\/18\/Z"],"award-info":[{"award-number":["214185\/Z\/18\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,9]]},"DOI":"10.1016\/s2213-8587(22)00196-6","type":"journal-article","created":{"date-parts":[[2022,7,15]],"date-time":"2022-07-15T18:48:54Z","timestamp":1657910934000},"page":"613-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["The burden of diabetes in the Americas"],"prefix":"10.1016","volume":"10","author":[{"given":"Antonio","family":"Bernabe-Ortiz","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rodrigo M","family":"Carrillo-Larco","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"journal-title":"Lancet Diabetes Endocrinol","article-title":"Burden of diabetes and hyperglycaemia in adults in the Americas, 1990\u20132019: a systematic analysis for the Global Burden of Disease Study 2019","year":"2022","key":"10.1016\/S2213-8587(22)00196-6_bib1"},{"key":"10.1016\/S2213-8587(22)00196-6_bib2","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3139","article-title":"The risk of mortality among people with type 2 diabetes in Latin America: a systematic review and meta-analysis of population-based cohort studies","volume":"35","author":"Carrillo-Larco","year":"2019","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(22)00196-6_bib3","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14805","article-title":"Health system responses for type 1 diabetes: a scoping review","volume":"39","author":"Zafra-Tanaka","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(22)00196-6_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.15276","article-title":"Outcomes following taxation of sugar-sweetened beverages: a systematic review and meta-analysis","volume":"5","author":"Andreyeva","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(22)00196-6_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/nu14091729","article-title":"Impact of nutrition and physical activity interventions provided by nutrition and exercise practitioners for the adult general population: a systematic review and meta-analysis","volume":"14","author":"Nitschke","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(22)00196-6_bib6","doi-asserted-by":"crossref","first-page":"455","DOI":"10.3389\/fendo.2019.00455","article-title":"Effects of lifestyle modification and anti-diabetic medicine on prediabetes progress: a systematic review and meta-analysis","volume":"10","author":"Sheng","year":"2019","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(22)00196-6_bib7","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/1741-7015-9-103","article-title":"Developing risk prediction models for type 2 diabetes: a systematic review of methodology and reporting","volume":"9","author":"Collins","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(22)00196-6_bib8","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1038\/s41574-022-00669-4","article-title":"Pathophysiology, phenotypes and management of type 2 diabetes mellitus in Indian and Chinese populations","volume":"18","author":"Ke","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(22)00196-6_bib9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S2213-8587(18)30233-X","article-title":"Availability and affordability of essential medicines for diabetes across high-income, middle-income, and low-income countries: a prospective epidemiological study","volume":"6","author":"Chow","year":"2018","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001966?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001966?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:21Z","timestamp":1761991881000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001966"}},"issued":{"date-parts":[[2022,9]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2022,9]]}},"alternative-id":["S2213858722001966"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00196-6","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden of diabetes in the Americas","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00196-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00186-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:56Z","timestamp":1761992216429,"version":"build-2065373602"},"reference-count":6,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,4,1]],"date-time":"2023-04-01T00:00:00Z","timestamp":1680307200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,4]]},"DOI":"10.1016\/s2213-8587(23)00037-2","type":"journal-article","created":{"date-parts":[[2023,2,28]],"date-time":"2023-02-28T18:31:29Z","timestamp":1677609089000},"page":"219-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["SEARCHing for answers to youth-onset type 2 diabetes"],"prefix":"10.1016","volume":"11","author":[{"given":"Jonathan E","family":"Shaw","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Dianna J","family":"Magliano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00037-2_bib1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012","volume":"376","author":"Mayer-Davis","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00037-2_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(23)00025-6","article-title":"Trends in incidence of youth-onset type 1 and type 2 diabetes in the USA, 2002\u201318: results from the population-based SEARCH for Diabetes in Youth study","author":"Wagenknecht","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00037-2_bib3","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00125-022-05722-5","article-title":"Obesity in late adolescence and incident type 1 diabetes in young adulthood","volume":"65","author":"Zucker","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00037-2_bib4","article-title":"Maternal diabetes during pregnancy and early onset of cardiovascular disease in offspring: population based cohort study with 40 years of follow-up","volume":"367","author":"Yu","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00037-2_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1038\/s41574-020-0334-z","article-title":"Young-onset type 2 diabetes mellitus\u2014implications for morbidity and mortality","volume":"16","author":"Magliano","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00037-2_bib6","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S2213-8587(20)30402-2","article-title":"Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings","volume":"9","author":"Magliano","year":"2021","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000372?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000372?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:31Z","timestamp":1761991951000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000372"}},"issued":{"date-parts":[[2023,4]]},"references-count":6,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2023,4]]}},"alternative-id":["S2213858723000372"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00037-2","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SEARCHing for answers to youth-onset type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00037-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00025-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:30:20Z","timestamp":1786491020324,"version":"build-2736575974"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,9,1]],"date-time":"2026-09-01T00:00:00Z","timestamp":1788220800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,9]]},"DOI":"10.1016\/s2213-8587(26)00128-2","type":"journal-article","created":{"date-parts":[[2026,7,6]],"date-time":"2026-07-06T23:09:00Z","timestamp":1783379340000},"page":"704-705","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Insulin and health systems in global low-resource settings"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-3449-0541","authenticated-orcid":false,"given":"Sze May","family":"Ng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00128-2_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(26)00097-5","article-title":"Human versus analogue insulin for children and young adults with type 1 diabetes in low-resource settings (HumAn-1): a multicentre, open-label, randomised controlled trial","author":"Luo","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00128-2_bib2","article-title":"(Ultra-)long-acting insulin analogues for people with type 1 diabetes mellitus","volume":"3","author":"Hemmingsen","year":"2021","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(26)00128-2_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.2337\/diacare.23.5.639","article-title":"Less hypoglycemia with insulin glargine in type 1 diabetes","volume":"23","author":"Ratner","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00128-2_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2022.109868","article-title":"Closing the type 1 diabetes gap in south-east Asia through government partnership working with non-government organisations","volume":"187","author":"Ng","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"issue":"suppl 23","key":"10.1016\/S2213-8587(26)00128-2_bib5","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1111\/pedi.12296","article-title":"The IDF Life for a Child Program Index of diabetes care for children and youth","volume":"17","author":"Ogle","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(26)00128-2_bib6","doi-asserted-by":"crossref","first-page":"P2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00128-2_bib7","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2213-8587(21)00323-5","article-title":"Diabetes and the WHO Model List of Essential Medicines","volume":"10","author":"Beran","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00128-2_bib8","doi-asserted-by":"crossref","first-page":"1593","DOI":"10.2337\/dci19-0028","article-title":"Clinical targets for continuous glucose monitoring data interpretation: recommendations from the international consensus on time in range","volume":"42","author":"Battelino","year":"2019","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(26)00128-2_bib9","first-page":"S1","article-title":"Standards of care in diabetes\u20142024","volume":"47","author":"ElSayed","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(26)00128-2_bib10","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2025-003924","article-title":"Voices from Laos: navigating the transition from a twice daily to multiple daily insulin regimen in a resource-limited setting","volume":"10","author":"Ng","year":"2026","journal-title":"BMJ Paediatr Open"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001282?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001282?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,11]],"date-time":"2026-08-11T23:06:59Z","timestamp":1786489619000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726001282"}},"issued":{"date-parts":[[2026,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2026,9]]}},"alternative-id":["S2213858726001282"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00128-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin and health systems in global low-resource settings","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00128-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00097-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Crown Copyright \u00a9 2026 Published by Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,24]],"date-time":"2026-07-24T18:32:04Z","timestamp":1784917924071,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/s2213-8587(24)00342-5","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T23:34:17Z","timestamp":1731713657000},"page":"77-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Associations of obesity with co-morbidities in early adult life"],"prefix":"10.1016","volume":"13","author":[{"given":"Thorkild I A","family":"S\u00f8rensen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00342-5_bib1","article-title":"Overweight and obesity among Israeli adolescence and the risk for serious morbidity in early young adulthood: a nationwide retrospective cohort study","author":"Zloof","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00342-5_bib2","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018546","article-title":"Morbidity, including fatal morbidity, throughout life in men entering adult life as obese","volume":"6","author":"Zimmermann","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(24)00342-5_bib3","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1038\/ijo.2010.274","article-title":"Lifelong doubling of mortality in men entering adult life as obese","volume":"35","author":"Zimmermann","year":"2011","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(24)00342-5_bib4","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1093\/oxfordjournals.aje.a114770","article-title":"Risk in childhood of development of severe adult obesity: retrospective, population-based case-cohort study","volume":"127","author":"S\u00f8rensen","year":"1988","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(24)00342-5_bib5","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1016\/j.bbalip.2009.12.006","article-title":"Adipose tissue expandability, lipotoxicity and the Metabolic Syndrome\u2013an allostatic perspective","volume":"1801","author":"Virtue","year":"2010","journal-title":"Biochim Biophys Acta"},{"key":"10.1016\/S2213-8587(24)00342-5_bib6","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1038\/s43586-021-00092-5","article-title":"Mendelian randomization","volume":"2","author":"Sanderson","year":"2022","journal-title":"Nat Rev Methods Primers"},{"key":"10.1016\/S2213-8587(24)00342-5_bib7","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13641","article-title":"A literature review of evidence for primary prevention of overweight and obesity in healthy weight children and adolescents: a report produced by a working group of the Danish Council on Health and Disease Prevention","volume":"25","author":"Olsen","year":"2024","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(24)00342-5_bib8","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1126\/science.adg2718","article-title":"Unanswered questions about the causes of obesity","volume":"381","author":"Speakman","year":"2023","journal-title":"Science"},{"key":"10.1016\/S2213-8587(24)00342-5_bib9","doi-asserted-by":"crossref","first-page":"1856","DOI":"10.1038\/s42255-024-01106-8","article-title":"On the pathogenesis of obesity: causal models and missing pieces of the puzzle","volume":"6","author":"Magkos","year":"2024","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(24)00342-5_bib10","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13795","article-title":"Trapped fat: obesity pathogenesis as an intrinsic disorder in metabolic fuel partitioning","volume":"25","author":"Friedman","year":"2024","journal-title":"Obes Rev"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:12:17Z","timestamp":1738703537000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003425"}},"issued":{"date-parts":[[2025,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2213858724003425"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00342-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations of obesity with co-morbidities in early adult life","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00342-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00287-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:41:46Z","timestamp":1786999306286,"version":"build-2736575974"},"reference-count":74,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/s2213-8587(17)30033-5","type":"journal-article","created":{"date-parts":[[2017,1,25]],"date-time":"2017-01-25T20:46:42Z","timestamp":1485377202000},"page":"391-402","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":63,"title":["Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes"],"prefix":"10.1016","volume":"5","author":[{"given":"Eberhard","family":"Standl","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oliver","family":"Schnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darren K","family":"McGuire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonio","family":"Ceriello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30033-5_bib1","doi-asserted-by":"publisher","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach: update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30033-5_bib2","doi-asserted-by":"publisher","first-page":"NP1","DOI":"10.1177\/2047487316653709","volume":"23","author":"Piepoli","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/S2213-8587(17)30033-5_bib3","doi-asserted-by":"publisher","first-page":"2129","DOI":"10.1093\/eurheartj\/ehw128","article-title":"2016 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"37","author":"Ponikowski","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(17)30033-5_bib4","doi-asserted-by":"publisher","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryden","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(17)30033-5_bib5","doi-asserted-by":"publisher","first-page":"1777","DOI":"10.2337\/dci15-0012","article-title":"Update on prevention of cardiovascular disease in adults with type 2 diabetes mellitus in light of recent evidence: a scientific statement from the American Heart Association and the American Diabetes Association","volume":"38","author":"Fox","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30033-5_bib6","doi-asserted-by":"publisher","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","article-title":"Excess mortality among persons with type 2 diabetes","volume":"373","author":"Tancredi","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib7","doi-asserted-by":"publisher","first-page":"537","DOI":"10.1016\/S2213-8587(16)30010-9","article-title":"The changing face of diabetes complications","volume":"4","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30033-5_bib8","doi-asserted-by":"publisher","first-page":"1771","DOI":"10.1161\/CIRCRESAHA.115.306884","article-title":"Vascular complications of diabetes","volume":"118","author":"Beckman","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(17)30033-5_bib9","doi-asserted-by":"publisher","first-page":"E176","DOI":"10.1016\/S0735-1097(13)60177-1","article-title":"Newly diagnosed diabetes and prediabetes in patients after acute myocardial infarction predicts adverse outcomes during a three-year follow-up: results of the SWEETHEART registry","volume":"61","author":"Gitt","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30033-5_bib10","series-title":"Swedeheart Annual Report 2015","year":"2015"},{"key":"10.1016\/S2213-8587(17)30033-5_bib11","doi-asserted-by":"publisher","first-page":"440","DOI":"10.1161\/CIRCULATIONAHA.107.704080","article-title":"New drugs for the treatment of diabetes mellitus: part I: thiazolidinediones and their evolving cardiovascular implications","volume":"117","author":"McGuire","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30033-5_bib12","doi-asserted-by":"publisher","first-page":"2581","DOI":"10.1001\/jama.294.20.joc50147","article-title":"Effect of muraglitazar on death and major adverse cardiovascular events in patients with type 2 diabetes mellitus","volume":"294","author":"Nissen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30033-5_bib13","doi-asserted-by":"publisher","first-page":"e32","DOI":"10.1161\/CIR.0000000000000426","article-title":"Drugs that may cause or exacerbate heart failure: a scientific statement from the American Heart Association","volume":"134","author":"Page","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30033-5_bib14","first-page":"88","article-title":"Guidelines on diabetes, pre-diabetes, and cardiovascular diseases: executive summary. The Task Force on Diabetes and Cardiovascular Diseases of the European Society of Cardiology (ESC) and of the European Association for the Study of Diabetes (EASD)","volume":"28","author":"Ryden","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(17)30033-5_bib15","doi-asserted-by":"publisher","first-page":"e147","DOI":"10.1016\/j.jacc.2013.05.019","article-title":"2013 ACCF\/antihyperglycaemic agent guideline for the management of heart failure: a report of the American College of Cardiology Foundation\/American Heart Association Task Force on Practice Guidelines","volume":"62","author":"Yancy","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30033-5_bib16","series-title":"Guidance for industry: diabetes mellitus\u2014evaluating cardiovascular risk in new antidiabetic therapies to treat type 2 diabetes","year":"2008"},{"key":"10.1016\/S2213-8587(17)30033-5_bib18","doi-asserted-by":"publisher","first-page":"2008","DOI":"10.1016\/S0140-6736(14)60794-7","article-title":"Cardiovascular outcome trials of glucose-lowering drugs or strategies in type 2 diabetes","volume":"383","author":"Holman","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30033-5_bib19","doi-asserted-by":"publisher","first-page":"1400","DOI":"10.1001\/jama.1971.03190220020005","article-title":"Effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. 3. Clinical implications of UGDP results","volume":"218","author":"Goldner","year":"1971","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30033-5_bib20","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1016\/S0140-6736(05)67528-9","article-title":"Secondary prevention of macrovascular events in patients with type 2 diabetes in the PROactive Study (PROspective pioglitAzone Clinical Trial In macroVascular Events): a randomised controlled trial","volume":"366","author":"Dormandy","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30033-5_bib21","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib22","doi-asserted-by":"publisher","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30033-5_bib23","doi-asserted-by":"publisher","first-page":"2125","DOI":"10.1016\/S0140-6736(09)60953-3","article-title":"Rosiglitazone evaluated for cardiovascular outcomes in oral agent combination therapy for type 2 diabetes (RECORD): a multicentre, randomised, open-label trial","volume":"373","author":"Home","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30033-5_bib24","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/0735-1097(95)00126-K","article-title":"Randomized trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on mortality at 1 year","volume":"26","author":"Malmberg","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30033-5_bib25","doi-asserted-by":"publisher","first-page":"650","DOI":"10.1093\/eurheartj\/ehi199","article-title":"Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity","volume":"26","author":"Malmberg","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(17)30033-5_bib26","doi-asserted-by":"publisher","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib27","doi-asserted-by":"publisher","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib28","doi-asserted-by":"publisher","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib29","doi-asserted-by":"publisher","first-page":"1489","DOI":"10.1056\/NEJMoa1501031","article-title":"Efficacy and safety of alirocumab in reducing lipids and cardiovascular events","volume":"372","author":"Robinson","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib30","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1056\/NEJMoa1500858","article-title":"Efficacy and safety of evolocumab in reducing lipids and cardiovascular events","volume":"372","author":"Sabatine","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib31","doi-asserted-by":"publisher","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib32","doi-asserted-by":"publisher","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib33","doi-asserted-by":"publisher","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib34","doi-asserted-by":"publisher","first-page":"203","DOI":"10.1111\/dom.12591","article-title":"Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"18","author":"Nauck","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(17)30033-5_bib35","doi-asserted-by":"publisher","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib36","doi-asserted-by":"publisher","first-page":"78","DOI":"10.1177\/1479164114561992","article-title":"Probing SGLT2 as a therapeutic target for diabetes: basic physiology and consequences","volume":"12","author":"Gallo","year":"2015","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/S2213-8587(17)30033-5_bib37","doi-asserted-by":"publisher","first-page":"3169","DOI":"10.2337\/dc13-0387","article-title":"Characterization of renal glucose reabsorption in response to dapagliflozin in healthy subjects and subjects with type 2 diabetes","volume":"36","author":"DeFronzo","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30033-5_bib38","doi-asserted-by":"publisher","first-page":"587","DOI":"10.1161\/CIRCULATIONAHA.113.005081","article-title":"Renal hemodynamic effect of sodium-glucose cotransporter 2 inhibition in patients with type 1 diabetes mellitus","volume":"129","author":"Cherney","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30033-5_bib39","doi-asserted-by":"publisher","first-page":"752","DOI":"10.1161\/CIRCULATIONAHA.116.021887","article-title":"Sodium glucose cotransporter 2 inhibitors in the treatment of diabetes: cardiovascular and kidney effects, potential mechanisms and clinical applications","volume":"134","author":"Heerspink","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30033-5_bib40","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1056\/NEJMoa1515920","article-title":"Empagliflozin and progression of kidney disease in type 2 diabetes","volume":"375","author":"Wanner","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib42","doi-asserted-by":"publisher","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib43","doi-asserted-by":"publisher","first-page":"12","DOI":"10.17925\/EE.2012.08.01.12","article-title":"Lixisenatide\u2014once-daily glucagon-like peptide-1 receptor agonist in the management of type 2 diabetes","volume":"8","author":"Quianzon","year":"2012","journal-title":"European Endocrinol"},{"key":"10.1016\/S2213-8587(17)30033-5_bib44","doi-asserted-by":"publisher","first-page":"500","DOI":"10.1001\/jama.2016.10260","article-title":"Effects of liraglutide on clinical stability among patients with advanced heart failure and reduced ejection fraction: a randomized clinical trial","volume":"316","author":"Margulies","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30033-5_bib45","doi-asserted-by":"publisher","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib46","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib47","doi-asserted-by":"publisher","first-page":"1327","DOI":"10.1056\/NEJMoa1305889","article-title":"Alogliptin after acute coronary syndrome in patients with type 2 diabetes","volume":"369","author":"White","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib48","doi-asserted-by":"publisher","first-page":"232","DOI":"10.1056\/NEJMoa1501352","article-title":"Effect of sitagliptin on cardiovascular outcomes in type 2 diabetes","volume":"373","author":"Green","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib49","doi-asserted-by":"publisher","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib50","doi-asserted-by":"publisher","first-page":"627","DOI":"10.1016\/S2213-8587(14)70088-9","article-title":"Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial","volume":"2","author":"Ritsinger","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30033-5_bib51","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1016\/j.numecd.2014.01.017","article-title":"Dipeptidyl peptidase-4 inhibitors and heart failure: a meta-analysis of randomized clinical trials","volume":"24","author":"Monami","year":"2014","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(17)30033-5_bib52","doi-asserted-by":"publisher","first-page":"1579","DOI":"10.1161\/CIRCULATIONAHA.114.010389","article-title":"Heart failure, saxagliptin, and diabetes mellitus: observations from the SAVOR-TIMI 53 randomized trial","volume":"130","author":"Scirica","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30033-5_bib53","doi-asserted-by":"publisher","first-page":"2067","DOI":"10.1016\/S0140-6736(14)62225-X","article-title":"Heart failure and mortality outcomes in patients with type 2 diabetes taking alogliptin versus placebo in EXAMINE: a multicentre, randomised, double-blind trial","volume":"385","author":"Zannad","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30033-5_bib54","doi-asserted-by":"publisher","first-page":"126","DOI":"10.1001\/jamacardio.2016.0103","article-title":"Association between sitagliptin use and heart failure hospitalization and related outcomes in type 2 diabetes mellitus: secondary analysis of a randomized clinical trial","volume":"1","author":"McGuire","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(17)30033-5_bib56","doi-asserted-by":"publisher","first-page":"990","DOI":"10.1111\/dom.12704","article-title":"Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register","volume":"18","author":"Ekstrom","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(17)30033-5_bib57","doi-asserted-by":"publisher","first-page":"2454","DOI":"10.1093\/eurheartj\/ehv301","article-title":"Risk of hospitalization for heart failure in patients with type 2 diabetes newly treated with DPP-4 inhibitors or other oral glucose-lowering medications: a retrospective registry study on 127,555 patients from the Nationwide OsMed Health-DB Database","volume":"36","author":"Fadini","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(17)30033-5_bib58","doi-asserted-by":"publisher","first-page":"1145","DOI":"10.1056\/NEJMoa1506115","article-title":"A multicenter observational study of incretin-based drugs and heart failure","volume":"374","author":"Filion","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib59","doi-asserted-by":"publisher","first-page":"99","DOI":"10.1177\/1479164112448876","article-title":"Statins and beyond: concurrent strategies for prevention of cardiovascular disease in patients with type 2 diabetes","volume":"10","author":"Standl","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/S2213-8587(17)30033-5_bib60","doi-asserted-by":"publisher","first-page":"1891","DOI":"10.1056\/NEJMoa1201832","article-title":"Atorvastatin with or without an antibody to PCSK9 in primary hypercholesterolemia","volume":"367","author":"Roth","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib61","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1016\/S0140-6736(12)60771-5","volume":"380","author":"Stein","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30033-5_bib62","doi-asserted-by":"publisher","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170\u2008000 participants in 26 randomised trials","volume":"376","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30033-5_bib63","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib64","doi-asserted-by":"publisher","first-page":"1333","DOI":"10.1007\/s00125-016-3956-x","article-title":"SGLT2 Inhibition and cardiovascular events: why did EMPA-REG outcomes surprise and what were the likely mechanisms?","volume":"59","author":"Sattar","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30033-5_bib65","doi-asserted-by":"publisher","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","author":"Wright","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib66","doi-asserted-by":"publisher","first-page":"808","DOI":"10.1161\/HYPERTENSIONAHA.116.07257","article-title":"Unattended blood pressure measurements in the Systolic Blood Pressure Intervention Trial: implications for entry and achieved blood pressure values compared with other trials","volume":"67","author":"Kjeldsen","year":"2016","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30033-5_bib67","doi-asserted-by":"publisher","first-page":"904","DOI":"10.1161\/CIRCULATIONAHA.116.022536","article-title":"The implications of blood pressure measurement methods on treatment targets for blood pressure","volume":"134","author":"Bakris","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30033-5_bib68","series-title":"International textbook of diabetes mellitus","first-page":"1064","article-title":"Clinical features and treatment of coronary heart disease in diabetes","author":"Standl","year":"2015"},{"key":"10.1016\/S2213-8587(17)30033-5_bib69","article-title":"Combined analysis of three large interventional trials with gliptins indicates increased incidence of acute pancreatitis in patients with type 2 diabetes","author":"Tkac","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30033-5_bib70","doi-asserted-by":"publisher","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone after ischemic stroke or transient ischemic attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib71","doi-asserted-by":"publisher","first-page":"92","DOI":"10.1016\/j.jacc.2016.03.519","volume":"68","author":"Writing","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30033-5_bib72","doi-asserted-by":"publisher","first-page":"2999","DOI":"10.1093\/eurheartj\/ehw272","volume":"37","author":"Catapano","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(17)30033-5_bib73","doi-asserted-by":"publisher","first-page":"1830","DOI":"10.1161\/CIRCRESAHA.116.306924","article-title":"Heart failure considerations of antihyperglycemic medications for type 2 diabetes","volume":"118","author":"Standl","year":"2016","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(17)30033-5_bib74","doi-asserted-by":"publisher","first-page":"129","DOI":"10.2147\/PGPM.S50288","article-title":"Personalized therapy algorithms for type 2 diabetes: a phenotype-based approach","volume":"7","author":"Ceriello","year":"2014","journal-title":"Pharmacogenomics Pers Med"},{"key":"10.1016\/S2213-8587(17)30033-5_bib75","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.2337\/dc14-1296","article-title":"Diabetic kidney disease: a report from an ADA Consensus Conference","volume":"37","author":"Tuttle","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30033-5_bib76","author":"McFarlane"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(17)30033-5_bib77","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1093\/ndt\/gfv100","article-title":"Clinical practice guideline on management of patients with diabetes and chronic kidney disease stage 3b or higher (eGFR <45 mL\/min)","volume":"30","year":"2015","journal-title":"Nephrol Dial Transplant"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300335?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300335?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T17:28:51Z","timestamp":1536082131000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300335"}},"issued":{"date-parts":[[2017,5]]},"references-count":74,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2213858717300335"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30033-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Integration of recent evidence into management of patients with atherosclerotic cardiovascular disease and type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30033-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,29]],"date-time":"2026-03-29T21:07:53Z","timestamp":1774818473441,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/s2213-8587(24)00373-5","type":"journal-article","created":{"date-parts":[[2025,2,26]],"date-time":"2025-02-26T23:38:10Z","timestamp":1740613090000},"page":"265-267","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Bodyweight loss and remission of type 2 diabetes"],"prefix":"10.1016","volume":"13","author":[{"given":"Andreas L","family":"Birkenfeld","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael","family":"Bergman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00373-5_bib1","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00373-5_bib2","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.2337\/dci21-0034","article-title":"Consensus report: definition and interpretation of remission in type 2 diabetes","volume":"44","author":"Riddle","year":"2021","journal-title":"Diabetes care"},{"key":"10.1016\/S2213-8587(24)00373-5_bib3","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.2337\/dc09-9036","article-title":"How do we define cure of diabetes?","volume":"32","author":"Buse","year":"2009","journal-title":"Diabetes care"},{"key":"10.1016\/S2213-8587(24)00373-5_bib4","article-title":"Impact of bodyweight loss on type 2 diabetes remission: a systematic review and meta-regression analysis of randomised controlled trials","author":"Kanbour","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00373-5_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2213-8587(23)00385-6","article-title":"5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study","volume":"12","author":"Lean","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00373-5_bib6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.cmet.2019.11.018","article-title":"Hepatic lipoprotein export and remission of human type 2 diabetes after weight loss","volume":"31","author":"Al-Mrabeh","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00373-5_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111589","article-title":"International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes","volume":"209","author":"Bergman","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(24)00373-5_bib8","doi-asserted-by":"crossref","first-page":"873","DOI":"10.1016\/S2213-8587(24)00320-6","article-title":"Staging schema for early diagnosis of prediabetes","volume":"12","author":"Bergman","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00373-5_bib9","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S2213-8587(23)00235-8","article-title":"Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)","volume":"11","author":"Sandforth","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00373-5_bib10","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1007\/s00125-024-06178-5","article-title":"Role of weight loss-induced prediabetes remission in the prevention of type 2 diabetes: time to improve diabetes prevention","volume":"67","author":"Jumpertz von Schwartzenberg","year":"2024","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003735?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003735?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T20:14:04Z","timestamp":1747426444000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003735"}},"issued":{"date-parts":[[2025,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2213858724003735"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00373-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bodyweight loss and remission of type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00373-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00346-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T06:36:12Z","timestamp":1785825372548,"version":"3.56.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/s2213-8587(21)00297-7","type":"journal-article","created":{"date-parts":[[2021,11,12]],"date-time":"2021-11-12T18:45:50Z","timestamp":1636742750000},"page":"799","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["World Diabetes Day 2021: a time of reckoning"],"prefix":"10.1016","volume":"9","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002977?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002977?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:55Z","timestamp":1761991795000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002977"}},"issued":{"date-parts":[[2021,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2213858721002977"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00297-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"World Diabetes Day 2021: a time of reckoning","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00297-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T13:19:38Z","timestamp":1787923178580,"version":"build-2784847793"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/s2213-8587(25)00167-6","type":"journal-article","created":{"date-parts":[[2025,7,21]],"date-time":"2025-07-21T22:40:46Z","timestamp":1753137646000},"page":"724-725","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Non-autoimmune, insulin-deficient diabetes in sub-Saharan Africa"],"prefix":"10.1016","volume":"13","author":[{"given":"Jannet","family":"Svensson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00167-6_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00120-2","article-title":"Non-autoimmune, insulin-deficient diabetes in children and young adults in Africa: evidence from the Young-Onset Diabetes in sub-Saharan Africa (YODA) cross-sectional study","author":"Katte","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00167-6_bib2","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1016\/S0140-6736(74)90140-8","article-title":"Islet-cell antibodies in diabetes mellitus with autoimmune polyendocrine deficiencies","volume":"2","author":"Bottazzo","year":"1974","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00167-6_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/ijms241210012","article-title":"Anti-islet autoantibodies in type 1 diabetes","volume":"24","author":"Kawasaki","year":"2023","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(25)00167-6_bib4","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2337\/dc17-0238","article-title":"Genetic and environmental interactions modify the risk of diabetes-related autoimmunity by 6 years of age: the TEDDY Study","volume":"40","author":"Krischer","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00167-6_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2025.112277","article-title":"Global type 1 diabetes prevalence, incidence, and mortality estimates 2025: results from the International Diabetes Federation Atlas, 11th edition, and the T1D Index version 3.0","volume":"225","author":"Ogle","year":"2025","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00167-6_bib6","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1111\/j.1399-5448.2011.00763.x","article-title":"Prospective evaluation of risk factors for the development of islet autoimmunity and type 1 diabetes during puberty\u2014TEENDIAB: study design","volume":"13","author":"Ziegler","year":"2012","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(25)00167-6_bib7","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1002\/ajmg.10343","article-title":"Humoral beta-cell autoimmunity in relation to HLA-defined disease susceptibility in preclinical and clinical type 1 diabetes","volume":"115","author":"Knip","year":"2002","journal-title":"Am J Med Genet"},{"key":"10.1016\/S2213-8587(25)00167-6_bib8","doi-asserted-by":"crossref","first-page":"2158","DOI":"10.1007\/s00125-020-05229-x","article-title":"Type 1 diabetes in Africa: an immunogenetic study in the Amhara of north-west Ethiopia","volume":"63","author":"Balcha","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00167-6_bib9","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1159\/000543035","article-title":"ISPAD Clinical Practice Consensus Guidelines 2024: screening, staging, and strategies to preserve beta-cell function in children and adolescents with type 1 diabetes","volume":"97","author":"Haller","year":"2024","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(25)00167-6_bib10","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S2213-8587(25)00029-4","article-title":"Type 1 diabetes screening: need for ethical, equity, and health systems perspective","volume":"13","author":"Beran","year":"2025","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001676?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001676?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T20:06:31Z","timestamp":1756757191000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725001676"}},"issued":{"date-parts":[[2025,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2213858725001676"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00167-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-autoimmune, insulin-deficient diabetes in sub-Saharan Africa","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00167-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00120-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,20]],"date-time":"2026-08-20T15:51:37Z","timestamp":1787241097971,"version":"build-2736575974"},"reference-count":35,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/s2213-8587(24)00068-8","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T19:34:36Z","timestamp":1711740876000},"page":"320-329","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Familial aggregation and heritability of childhood-onset and adult-onset type 1 diabetes: a Swedish register-based cohort study"],"prefix":"10.1016","volume":"12","author":[{"given":"Yuxia","family":"Wei","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengxin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomas","family":"Andersson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Feychting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralf","family":"Kuja-Halkola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00068-8_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00068-8_bib2","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.2337\/dc21-0770","article-title":"Adult-onset type 1 diabetes: current understanding and challenges","volume":"44","author":"Leslie","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00068-8_bib3","doi-asserted-by":"crossref","first-page":"2149","DOI":"10.1016\/S0140-6736(23)00223-4","article-title":"Type 1 diabetes","volume":"401","author":"Quattrin","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00068-8_bib4","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1530\/EJE-22-0025","article-title":"Shared etiology of type 1 diabetes and Hashimoto's thyroiditis: a population-based twin study","volume":"186","author":"Skov","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00068-8_bib5","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.2147\/CLEP.S172207","article-title":"Familial aggregation and heritability of type 1 diabetes mellitus and coaggregation of chronic diseases in affected families","volume":"10","author":"Kuo","year":"2018","journal-title":"Clin Epidemiol"},{"key":"10.1016\/S2213-8587(24)00068-8_bib6","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ng.3931","article-title":"Classification of common human diseases derived from shared genetic and environmental determinants","volume":"49","author":"Wang","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00068-8_bib7","doi-asserted-by":"crossref","first-page":"702","DOI":"10.1038\/ng.3285","article-title":"Meta-analysis of the heritability of human traits based on fifty years of twin studies","volume":"47","author":"Polderman","year":"2015","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00068-8_bib8","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","article-title":"Heterogeneity and endotypes in type 1 diabetes mellitus","volume":"19","author":"Redondo","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00068-8_bib9","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.2337\/diabetes.52.4.1052","article-title":"Genetic liability of type 1 diabetes and the onset age among 22,650 young Finnish twin pairs: a nationwide follow-up study","volume":"52","author":"Hyttinen","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00068-8_bib10","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/db09-0344","article-title":"Age at onset of type 1 diabetes in parents and recurrence risk in offspring","volume":"59","author":"Harjutsalo","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00068-8_bib11","doi-asserted-by":"crossref","first-page":"296","DOI":"10.2337\/diacare.28.2.296","article-title":"Secondary attack rate of type 1 diabetes in Colorado families","volume":"28","author":"Steck","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00068-8_bib12","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2337\/diabetes.54.2.563","article-title":"Cumulative incidence of type 1 diabetes in 10,168 siblings of Finnish young-onset type 1 diabetic patients","volume":"54","author":"Harjutsalo","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00068-8_bib13","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/diabetes.51.1.210","article-title":"High familial risk and genetic susceptibility in early onset childhood diabetes","volume":"51","author":"Gillespie","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00068-8_bib14","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1177\/140349489001800209","article-title":"A quality study of a medical birth registry","volume":"18","author":"Cnattingius","year":"1990","journal-title":"Scand J Soc Med"},{"key":"10.1016\/S2213-8587(24)00068-8_bib15","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1007\/978-1-59745-423-0_10","article-title":"The Swedish Multi-generation Register","volume":"675","author":"Ekbom","year":"2011","journal-title":"Methods Mol Biol"},{"key":"10.1016\/S2213-8587(24)00068-8_bib16","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.2337\/dc10-0398","article-title":"Glycemic control and cardiovascular disease in 7,454 patients with type 1 diabetes: an observational study from the Swedish National Diabetes Register (NDR)","volume":"33","author":"Eeg-Olofsson","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00068-8_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/1471-2458-11-450","article-title":"External review and validation of the Swedish national inpatient register","volume":"11","author":"Ludvigsson","year":"2011","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(24)00068-8_bib18","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1002\/pds.1294","article-title":"The new Swedish Prescribed Drug Register\u2014opportunities for pharmacoepidemiological research and experience from the first six months","volume":"16","author":"Wettermark","year":"2007","journal-title":"Pharmacoepidemiol Drug Saf"},{"key":"10.1016\/S2213-8587(24)00068-8_bib19","series-title":"Methodology for genetic studies of twins and families","author":"Neale","year":"1992"},{"key":"10.1016\/S2213-8587(24)00068-8_bib20","doi-asserted-by":"crossref","first-page":"1414","DOI":"10.2337\/dc18-2023","article-title":"Identification of novel T1D risk loci and their association with age and islet function at diagnosis in autoantibody-positive t1d individuals: based on a two-stage genome-wide association study","volume":"42","author":"Zhu","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00068-8_bib21","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00125-023-05927-2","article-title":"The countdown to type 1 diabetes: when, how and why does the clock start?","volume":"66","author":"Ziegler","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00068-8_bib22","doi-asserted-by":"crossref","first-page":"2473","DOI":"10.1001\/jama.2013.6285","article-title":"Seroconversion to multiple islet autoantibodies and risk of progression to diabetes in children","volume":"309","author":"Ziegler","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00068-8_bib23","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00125-022-05722-5","article-title":"Obesity in late adolescence and incident type 1 diabetes in young adulthood","volume":"65","author":"Zucker","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00068-8_bib24","article-title":"Prenatal and adult exposure to smoking and incidence of type 1 diabetes in children and adults-a nationwide cohort study with a family-based design","volume":"36","author":"Wei","year":"2023","journal-title":"Lancet Reg Health Eur"},{"key":"10.1016\/S2213-8587(24)00068-8_bib25","doi-asserted-by":"crossref","first-page":"914","DOI":"10.1007\/s001250100548","article-title":"The accelerator hypothesis: weight gain as the missing link between type I and type II diabetes","volume":"44","author":"Wilkin","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00068-8_bib26","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1038\/s41572-022-00390-6","article-title":"Adult-onset autoimmune diabetes","volume":"8","author":"Buzzetti","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(24)00068-8_bib27","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1136\/bmj.311.7010.913","article-title":"Concordance rates of insulin dependent diabetes mellitus: a population based study of young Danish twins","volume":"311","author":"Kyvik","year":"1995","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00068-8_bib28","doi-asserted-by":"crossref","first-page":"E1483","DOI":"10.1210\/jc.2011-3457","article-title":"Emerging effects of early environmental factors over genetic background for type 1 diabetes susceptibility: evidence from a nationwide Italian twin study","volume":"97","author":"Nistic\u00f2","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00068-8_bib29","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1375\/twin.11.1.28","article-title":"A study of diabetes mellitus within a large sample of Australian twins","volume":"11","author":"Condon","year":"2008","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/S2213-8587(24)00068-8_bib30","doi-asserted-by":"crossref","first-page":"192","DOI":"10.2337\/dc18-0288","article-title":"Identical and nonidentical twins: risk and factors involved in development of islet autoimmunity and type 1 diabetes","volume":"42","author":"Triolo","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00068-8_bib31","series-title":"Diabetes in America","article-title":"Risk factors for type 1 diabetes","author":"Stene","year":"2023"},{"key":"10.1016\/S2213-8587(24)00068-8_bib32","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2337\/dc19-0803","article-title":"Genetic variants predisposing most strongly to type 1 diabetes diagnosed under age 7 years lie near candidate genes that function in the immune system and in pancreatic \u03b2-cells","volume":"43","author":"Inshaw","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00068-8_bib33","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S2213-8587(23)00190-0","article-title":"Maternal type 1 diabetes and relative protection against offspring transmission","volume":"11","author":"Allen","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00068-8_bib34","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s001250050966","article-title":"Predictors of IDDM recurrence risk in offspring of Danish IDDM patients","volume":"41","author":"Lorenzen","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00068-8_bib35","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S2213-8587(22)00159-0","article-title":"Type 1 diabetes in diverse ancestries and the use of genetic risk scores","volume":"10","author":"Redondo","year":"2022","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000688?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000688?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T19:46:14Z","timestamp":1715024774000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000688"}},"issued":{"date-parts":[[2024,5]]},"references-count":35,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2213858724000688"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00068-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Familial aggregation and heritability of childhood-onset and adult-onset type 1 diabetes: a Swedish register-based cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00068-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00090-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,18]],"date-time":"2026-09-18T19:47:19Z","timestamp":1789760839497,"version":"4.0.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,7,1]],"date-time":"2024-07-01T00:00:00Z","timestamp":1719792000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,7]]},"DOI":"10.1016\/s2213-8587(24)00134-7","type":"journal-article","created":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T22:39:38Z","timestamp":1716417578000},"page":"437-439","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["Measuring serum testosterone in women"],"prefix":"10.1016","volume":"12","author":[{"given":"David J","family":"Handelsman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan R","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00134-7_bib1","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1210\/jc.2006-1864","article-title":"Position statement: utility, limitations, and pitfalls in measuring testosterone: an Endocrine Society position statement","volume":"92","author":"Rosner","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00134-7_bib2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1210\/er.2017-00025","article-title":"A reappraisal of testosterone's binding in circulation: physiological and clinical implications","volume":"38","author":"Goldman","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(24)00134-7_bib3","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/er.2017-00171","article-title":"Free testosterone: pumping up the tires or ending the free ride?","volume":"38","author":"Handelsman","year":"2017","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(24)00134-7_bib4","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.jsbmb.2019.04.008","article-title":"Assessment of free testosterone concentration","volume":"190","author":"Keevil","year":"2019","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S2213-8587(24)00134-7_bib5","doi-asserted-by":"crossref","first-page":"1026","DOI":"10.1210\/me.2014-1058","article-title":"Naturally occurring mutants inform SHBG structure and function","volume":"28","author":"Wu","year":"2014","journal-title":"Mol Endocrinol"},{"key":"10.1016\/S2213-8587(24)00134-7_bib6","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.steroids.2009.01.008","article-title":"A novel spreadsheet method for calculating the free serum concentrations of testosterone, dihydrotestosterone, estradiol, estrone and cortisol: with illustrative examples from male and female populations","volume":"74","author":"Mazer","year":"2009","journal-title":"Steroids"},{"key":"10.1016\/S2213-8587(24)00134-7_bib7","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1016\/j.mce.2014.09.001","article-title":"A multi-step, dynamic allosteric model of testosterone's binding to sex hormone binding globulin","volume":"399","author":"Zakharov","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(24)00134-7_bib8","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1111\/cen.13561","article-title":"The free androgen index is inaccurate in women when the SHBG concentration is low","volume":"88","author":"Keevil","year":"2018","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(24)00134-7_bib9","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1111\/j.1365-2265.2011.04301.x","article-title":"The relationships between insulin resistance, BMI, diastolic blood pressure and androgens, and SHBG levels is independent of circulating oestrogens and androgens in postmenopausal women","volume":"77","author":"Davis","year":"2012","journal-title":"Clin Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,19]],"date-time":"2024-06-19T07:19:20Z","timestamp":1718781560000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001347"}},"issued":{"date-parts":[[2024,7]]},"references-count":9,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2024,7]]}},"alternative-id":["S2213858724001347"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00134-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Measuring serum testosterone in women","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00134-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T17:57:04Z","timestamp":1761155824965},"reference-count":5,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/s2213-8587(14)70125-1","type":"journal-article","created":{"date-parts":[[2014,7,2]],"date-time":"2014-07-02T23:15:52Z","timestamp":1404342952000},"page":"540-541","source":"Crossref","is-referenced-by-count":2,"title":["Vitamin D and falls"],"prefix":"10.1016","volume":"2","author":[{"given":"J Stephen","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris D","family":"Poole","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70125-1_bib1","article-title":"Vitamin D supplementation and falls: a trial sequential meta-analysis","author":"Bolland","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70125-1_bib2","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1136\/jech.57.9.740","article-title":"Incidence and costs of unintentional falls in older people in the United Kingdom","volume":"57","author":"Scuffham","year":"2003","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(14)70125-1_bib3","author":"Bebbington"},{"key":"10.1016\/S2213-8587(14)70125-1_bib4","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S0895-4356(01)00414-0","article-title":"A comparison of summary patient-level covariates in meta-regression with individual patient data meta-analysis","volume":"55","author":"Lambert","year":"2002","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(14)70125-1_bib5","doi-asserted-by":"crossref","first-page":"1367","DOI":"10.1056\/NEJMc1209658","article-title":"Vitamin D dose requirements for fracture prevention","volume":"367","author":"Grey","year":"2012","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T23:27:43Z","timestamp":1538436463000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701251"}},"issued":{"date-parts":[[2014,7]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S2213858714701251"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70125-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,7]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:34Z","timestamp":1761991954936,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/s2213-8587(21)00085-1","type":"journal-article","created":{"date-parts":[[2021,3,26]],"date-time":"2021-03-26T22:20:20Z","timestamp":1616797220000},"page":"318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Pituitary acrogigantism and ectopic Cushing's syndrome"],"prefix":"10.1016","volume":"9","author":[{"given":"Hiya","family":"Boro","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Alam","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alpesh","family":"Goyal","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Shreya Datta","family":"Gupta","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nishikant","family":"Damle","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Devasenathipathy","family":"Kandasamy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rajesh","family":"Khadgawat","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nikhil","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:53Z","timestamp":1761991733000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000851"}},"issued":{"date-parts":[[2021,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2213858721000851"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00085-1","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pituitary acrogigantism and ectopic Cushing's syndrome","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00085-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,7,20]],"date-time":"2025-07-20T04:17:03Z","timestamp":1752985023603},"reference-count":14,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/s2213-8587(18)30134-7","type":"journal-article","created":{"date-parts":[[2018,4,21]],"date-time":"2018-04-21T06:56:38Z","timestamp":1524293798000},"page":"521-523","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Target blood pressure and kidney protection"],"prefix":"10.1016","volume":"6","author":[{"given":"Giuseppe","family":"Mancia","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30134-7_bib1","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1161\/CIRCULATIONAHA.110.008870","article-title":"Blood pressure targets recommended by guidelines and incidence of cardiovascular and renal events in the Ongoing Telmisartan Alone and in Combination With Ramipril Global Endpoint Trial (ONTARGET)","volume":"124","author":"Mancia","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(18)30134-7_bib2","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1161\/HYPERTENSIONAHA.113.01922","article-title":"Aggressive blood pressure lowering is dangerous: the J-curve","volume":"63","author":"Mancia","year":"2014","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(18)30134-7_bib3","doi-asserted-by":"crossref","first-page":"244","DOI":"10.7326\/0003-4819-139-4-200308190-00006","article-title":"Progression of chronic kidney disease: the role of blood pressure control, proteinuria, and angiotensin-converting enzyme inhibition: a patient-level meta-analysis","volume":"139","author":"Jafar","year":"2003","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(18)30134-7_bib4","doi-asserted-by":"crossref","first-page":"754","DOI":"10.7326\/0003-4819-123-10-199511150-00003","article-title":"Blood pressure control, proteinuria, and the progression of renal disease: the Modification of Diet in Renal Disease Study","volume":"123","author":"Peterson","year":"1995","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(18)30134-7_bib5","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(05)71082-5","article-title":"Blood-pressure control for renoprotection in patients with non-diabetic chronic renal disease (REIN-2): multicentre, randomised controlled trial","volume":"365","author":"Ruggenenti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30134-7_bib6","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1001\/jama.288.19.2421","article-title":"Effect of blood pressure lowering and antihypertensive drug class on progression of hypertensive kidney disease: results from the AASK trial","volume":"288","author":"Wright","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30134-7_bib7","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1016\/j.jacc.2014.04.065","article-title":"Impact of achieved blood pressures on mortality risk and end-stage renal disease among a large, diverse hypertension population","volume":"64","author":"Sim","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(18)30134-7_bib8","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30134-7_bib9","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1056\/NEJMoa1511939","article-title":"A randomized trial of intensive versus standard blood-pressure control","volume":"373","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30134-7_bib10","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1097\/01.hjh.0000431740.32696.cc","article-title":"2013 ESH\/ESC guidelines for the management of arterial hypertension: the task force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC)","volume":"31","author":"Mancia","year":"2013","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(18)30134-7_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30099-8","article-title":"Intensive systolic blood pressure control and incident chronic kidney disease in people with and without diabetes mellitus: secondary analyses of two randomised controlled trials","author":"Beddhu","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30134-7_bib12","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(15)01225-8","article-title":"Blood pressure lowering for prevention of cardiovascular disease and death: a systematic review and meta-analysis","volume":"387","author":"Ettehad","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30134-7_bib13","author":"Whelton","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(18)30134-7_bib14","doi-asserted-by":"crossref","first-page":"1741","DOI":"10.1097\/HJH.0000000000000253","article-title":"Blood pressure and low-density lipoprotein-cholesterol lowering for prevention of strokes and cognitive decline: a review of available trial evidence","volume":"32","author":"Zanchetti","year":"2014","journal-title":"J Hypertens"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301347?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301347?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T22:00:32Z","timestamp":1529445632000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301347"}},"issued":{"date-parts":[[2018,7]]},"references-count":14,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2213858718301347"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30134-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Target blood pressure and kidney protection","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30134-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30099-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T14:09:03Z","timestamp":1761919743120},"reference-count":9,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/s2213-8587(13)70114-1","type":"journal-article","created":{"date-parts":[[2013,9,12]],"date-time":"2013-09-12T21:48:37Z","timestamp":1379022517000},"page":"266-268","source":"Crossref","is-referenced-by-count":6,"title":["CABG or PCI for revascularisation in patients with diabetes?"],"prefix":"10.1016","volume":"1","author":[{"given":"Arie Pieter","family":"Kappetein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart J","family":"Head","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70114-1_bib1","doi-asserted-by":"crossref","first-page":"1190","DOI":"10.1016\/S0140-6736(09)60552-3","article-title":"Coronary artery bypass surgery compared with percutaneous coronary interventions for multivessel disease: a collaborative analysis of individual patient data from ten randomised trials","volume":"373","author":"Hlatky","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70114-1_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70089-5","article-title":"Comparison of coronary artery bypass surgery and percutaneous coronary intervention in patients with diabetes: a meta-analysis of randomised controlled trials","author":"Verma","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70114-1_bib3","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/j.jcin.2012.11.010","article-title":"Analysis of stroke occurring in the SYNTAX trial comparing coronary artery bypass surgery and percutaneous coronary intervention in the treatment of complex coronary artery disease","volume":"6","author":"Mack","year":"2013","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/S2213-8587(13)70114-1_bib4","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1016\/S0140-6736(13)60258-5","article-title":"CABG or stents in coronary artery disease: end of the debate?","volume":"381","author":"Taggart","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70114-1_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/heartjnl-2012-302482","article-title":"The SYNTAX score and its clinical implications","author":"Head","year":"2013","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(13)70114-1_bib6","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1093\/ejcts\/ezt017","article-title":"Treatment of complex coronary artery disease in patients with diabetes: 5-year results comparing outcomes of bypass surgery and percutaneous coronary intervention in the SYNTAX trial","volume":"43","author":"Kappetein","year":"2013","journal-title":"Eur J Cardiothorac Surg"},{"key":"10.1016\/S2213-8587(13)70114-1_bib7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1016\/j.jcin.2012.02.013","article-title":"Risk profile and 3-year outcomes from the SYNTAX percutaneous coronary intervention and coronary artery bypass grafting nested registries","volume":"5","author":"Head","year":"2012","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/S2213-8587(13)70114-1_bib8","doi-asserted-by":"crossref","first-page":"2529","DOI":"10.1161\/CIRCULATIONAHA.109.913111","article-title":"The Bypass Angioplasty Revascularization Investigation 2 Diabetes randomized trial of different treatment strategies in type 2 diabetes mellitus with stable ischemic heart disease: impact of treatment strategy on cardiac mortality and myocardial infarction","volume":"120","author":"Chaitman","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70114-1_bib9","doi-asserted-by":"crossref","first-page":"2510","DOI":"10.1093\/eurheartj\/eht059","article-title":"The rationale for Heart Team decision-making for patients with stable, complex coronary artery disease","volume":"34","author":"Head","year":"2013","journal-title":"Eur Heart J"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701141?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701141?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T00:22:46Z","timestamp":1539390166000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701141"}},"issued":{"date-parts":[[2013,12]]},"references-count":9,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2213858713701141"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70114-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,12]]}},{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:47:55Z","timestamp":1761896875024},"reference-count":5,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T00:00:00Z","timestamp":1535760000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,9]]},"DOI":"10.1016\/s2213-8587(18)30196-7","type":"journal-article","created":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T23:20:28Z","timestamp":1534893628000},"page":"684-685","source":"Crossref","is-referenced-by-count":10,"title":["Non-alcoholic fatty liver disease concerns with glucokinase activators"],"prefix":"10.1016","volume":"6","author":[{"given":"Leanne","family":"Hodson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Martijn C G J","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30196-7_bib1","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1016\/S2213-8587(18)30105-0","article-title":"Dorzagliatin monotherapy in Chinese patients with type 2 diabetes: a dose-ranging, randomised, double-blind, placebo-controlled, phase 2 study","volume":"6","author":"Zhu","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30196-7_bib2","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(18)30196-7_bib3","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.molmed.2015.08.004","article-title":"Modulation of glucokinase regulatory protein: a double-edged sword?","volume":"21","author":"Brouwers","year":"2015","journal-title":"Trends Mol Med"},{"key":"10.1016\/S2213-8587(18)30196-7_bib4","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(18)30196-7_bib5","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1016\/j.jhep.2012.11.021","article-title":"Non-invasive diagnosis of non-alcoholic fatty liver disease. A critical appraisal","volume":"58","author":"Machado","year":"2013","journal-title":"J Hepatol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301967?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301967?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,21]],"date-time":"2018-08-21T23:20:30Z","timestamp":1534893630000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301967"}},"issued":{"date-parts":[[2018,9]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2018,9]]}},"alternative-id":["S2213858718301967"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30196-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,9]]}},{"indexed":{"date-parts":[[2026,2,11]],"date-time":"2026-02-11T20:55:13Z","timestamp":1770843313440,"version":"3.50.1"},"reference-count":3,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30239-x","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T23:45:37Z","timestamp":1477439137000},"page":"884","source":"Crossref","is-referenced-by-count":4,"title":["Ayurveda for diabetes in India"],"prefix":"10.1016","volume":"4","author":[{"given":"Rajiv","family":"Vasudevan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zankhana","family":"Buch","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30239-X_bib1","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S2213-8587(15)00515-X","article-title":"Alternative medicines for diabetes in India: maximum hype, minimum science","volume":"4","author":"Misra","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30239-X_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.4103\/0973-7847.134229","article-title":"Polyherbal formulation: concept of Ayurveda","volume":"8","author":"Parasuraman","year":"2014","journal-title":"Pharmacogn Rev"},{"key":"10.1016\/S2213-8587(16)30239-X_bib3","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1017\/S0007114509992054","article-title":"Anti-diabetic and hypoglycaemic effects of Momordica charantia (bitter melon): a mini review","volume":"102","author":"Leung","year":"2009","journal-title":"Br J Nutr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630239X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871630239X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T07:54:02Z","timestamp":1536306842000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871630239X"}},"issued":{"date-parts":[[2016,11]]},"references-count":3,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S221385871630239X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30239-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:08Z","timestamp":1720746728857},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/s2213-8587(13)70011-1","type":"journal-article","created":{"date-parts":[[2013,3,14]],"date-time":"2013-03-14T14:05:05Z","timestamp":1363269905000},"page":"s22","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Correction to Lancet Diabetes Endocrinol 2013; published online Feb 26"],"prefix":"10.1016","volume":"1","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700111?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700111?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T03:36:08Z","timestamp":1548646568000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700111"}},"issued":{"date-parts":[[2013,8]]},"references-count":0,"alternative-id":["S2213858713700111"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70011-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,8]]}},{"indexed":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T22:34:26Z","timestamp":1761863666907},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30291-1","type":"journal-article","created":{"date-parts":[[2016,10,25]],"date-time":"2016-10-25T23:45:20Z","timestamp":1477439120000},"page":"873","source":"Crossref","is-referenced-by-count":6,"title":["Diabetes and NCD research: meeting the needs of the patient"],"prefix":"10.1016","volume":"4","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302911?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302911?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,7]],"date-time":"2018-09-07T07:54:06Z","timestamp":1536306846000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302911"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2213858716302911"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30291-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T13:37:14Z","timestamp":1761917834244},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/s2213-8587(17)30041-4","type":"journal-article","created":{"date-parts":[[2017,2,9]],"date-time":"2017-02-09T01:30:25Z","timestamp":1486603825000},"page":"158-159","source":"Crossref","is-referenced-by-count":25,"title":["Strategies to improve the affordability of insulin in the USA"],"prefix":"10.1016","volume":"5","author":[{"given":"Jing","family":"Luo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aaron S","family":"Kesselheim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jeremy","family":"Greene","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kasia J","family":"Lipska","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30041-4_bib1","doi-asserted-by":"publisher","first-page":"275","DOI":"10.1016\/S2213-8587(15)00521-5","article-title":"Constraints and challenges in access to insulin: a global perspective","volume":"4","author":"Beran","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30041-4_bib3","doi-asserted-by":"publisher","first-page":"2331","DOI":"10.1001\/jama.2014.6316","article-title":"Use and out-of-pocket costs of insulin for type 2 diabetes mellitus from 2000 through 2010","volume":"311","author":"Lipska","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30041-4_bib4","doi-asserted-by":"publisher","first-page":"483","DOI":"10.2337\/diacare.18.4.483","article-title":"Diabetes in urban African-Americans. I. Cessation of insulin therapy is the major precipitating cause of diabetic ketoacidosis","volume":"18","author":"Musey","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30041-4_bib5","series-title":"The discovery of insulin","author":"Bliss","year":"1982"},{"key":"10.1016\/S2213-8587(17)30041-4_bib6","doi-asserted-by":"publisher","first-page":"1171","DOI":"10.1056\/NEJMms1411398","article-title":"Why is there no generic insulin? Historical origins of a modern problem","volume":"372","author":"Greene","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30041-4_bib7","doi-asserted-by":"publisher","DOI":"10.1002\/14651858.CD005613.pub3","article-title":"Long-acting insulin analogues versus NPH insulin (human isophane insulin) for type 2 diabetes mellitus","volume":"2","author":"Horvath","year":"2007","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30041-4_bib8","author":"Johnson"},{"key":"10.1016\/S2213-8587(17)30041-4_bib9","author":"Tsai"},{"key":"10.1016\/S2213-8587(17)30041-4_bib10","doi-asserted-by":"publisher","first-page":"188","DOI":"10.1056\/NEJMp1301993","article-title":"Prescription-drug coupons\u2014no such thing as a free lunch","volume":"369","author":"Ross","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30041-4_bib12","unstructured":"Congress.gov. S.3335\u2014Fair Accountability and Innovative Research Drug Pricing Act of 2016. https:\/\/www.congress.gov\/bill\/114th-congress\/senate-bill\/3335 (accessed Feb 7, 2016)."}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300414?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300414?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,4]],"date-time":"2018-09-04T12:52:09Z","timestamp":1536065529000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300414"}},"issued":{"date-parts":[[2017,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2213858717300414"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30041-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,3]]}},{"indexed":{"date-parts":[[2026,5,16]],"date-time":"2026-05-16T00:59:58Z","timestamp":1778893198397,"version":"3.51.4"},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/s2213-8587(19)30160-3","type":"journal-article","created":{"date-parts":[[2019,5,15]],"date-time":"2019-05-15T20:53:07Z","timestamp":1557953587000},"page":"427","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Research digest: SGLT2 inhibition in kidney and liver disease"],"prefix":"10.1016","volume":"7","author":[{"given":"David","family":"Preiss","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301603?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301603?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:55Z","timestamp":1761991615000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301603"}},"issued":{"date-parts":[[2019,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2213858719301603"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30160-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Research digest: SGLT2 inhibition in kidney and liver disease","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30160-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:29Z","timestamp":1720746749974},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30368-0","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T06:33:08Z","timestamp":1479450788000},"page":"S13","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S1","title":["Incidence and temporal trends of type 1 diabetes in China: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"4","author":[{"given":"Bin","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianghong","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Qiuming","family":"Yao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ling","family":"Li","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ni","family":"Yan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ronghua","family":"Song","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaohong","family":"Shi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin-An","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303680?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303680?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T15:56:49Z","timestamp":1536249409000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303680"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"alternative-id":["S2213858716303680"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30368-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:41:08Z","timestamp":1762508468437,"version":"build-2065373602"},"reference-count":3,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/s2213-8587(21)00091-7","type":"journal-article","created":{"date-parts":[[2021,4,8]],"date-time":"2021-04-08T18:42:30Z","timestamp":1617907350000},"page":"332-333","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Diabetes in pregnancy: time to focus on women with type 2 diabetes"],"prefix":"10.1016","volume":"9","author":[{"given":"Jane Elizabeth","family":"Hirst","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Charlotte","family":"Frise","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gaya","family":"Thanabalasingham","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Katharine","family":"Owen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00091-7_bib1","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00091-7_bib2","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/j.1464-5491.1990.tb01405.x","article-title":"Diabetes care and research in Europe: the Saint Vincent declaration","volume":"7","year":"1990","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00091-7_bib4","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta21140","article-title":"Preconception care for women with type 1 or type 2 diabetes mellitus: a mixed-methods study exploring uptake of preconception care","volume":"21","author":"Earle","year":"2017","journal-title":"Health Technol Assess"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000917?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000917?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:28Z","timestamp":1761991768000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000917"}},"issued":{"date-parts":[[2021,6]]},"references-count":3,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213858721000917"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00091-7","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes in pregnancy: time to focus on women with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00091-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30406-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,17]],"date-time":"2026-03-17T09:30:04Z","timestamp":1773739804096,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T00:00:00Z","timestamp":1448928000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1016\/s2213-8587(15)00324-1","type":"journal-article","created":{"date-parts":[[2015,10,27]],"date-time":"2015-10-27T05:16:29Z","timestamp":1445922989000},"page":"917-918","source":"Crossref","is-referenced-by-count":14,"title":["Myostatin inhibition for treatment of sarcopenia"],"prefix":"10.1016","volume":"3","author":[{"given":"Gianni","family":"Parise","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tim","family":"Snijders","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00324-1_bib1","doi-asserted-by":"crossref","first-page":"12457","DOI":"10.1073\/pnas.94.23.12457","article-title":"Double muscling in cattle due to mutations in the myostatin gene","volume":"94","author":"McPherron","year":"1997","journal-title":"Proc Natl Acad Sci U S A"},{"key":"10.1016\/S2213-8587(15)00324-1_bib2","doi-asserted-by":"crossref","first-page":"2682","DOI":"10.1056\/NEJMoa040933","article-title":"Myostatin mutation associated with gross muscle hypertrophy in a child","volume":"350","author":"Schuelke","year":"2004","journal-title":"N Engl J Med"},{"issue":"10","key":"10.1016\/S2213-8587(15)00324-1_bib3","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.1016\/j.biocel.2013.05.019","article-title":"Myostatin\/activin pathway antagonism: molecular basis and therapeutic potential","volume":"45","author":"Han","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/S2213-8587(15)00324-1_bib4","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/j.jamda.2015.02.006","article-title":"Sarcopenia is associated with incident disability, institutionalization, and mortality in community-dwelling older men: the concord health and ageing in men project","volume":"16","author":"Hirani","year":"2015","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/S2213-8587(15)00324-1_bib5","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1532-5415.2004.52014.x","article-title":"The healthcare costs of sarcopenia in the United States","volume":"52","author":"Janssen","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(15)00324-1_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00298-3","article-title":"Myostatin antibody (LY2495655) in older weak fallers: a proof-of-concept, randomised, phase 2 trial","author":"Becker","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00324-1_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1002\/(SICI)1097-4652(199907)180:1<1::AID-JCP1>3.0.CO;2-V","article-title":"Myostatin, a transforming growth factor-beta superfamily member, is expressed in heart muscle and is upregulated in cardiomyocytes after infarct","volume":"180","author":"Sharma","year":"1999","journal-title":"J Cell Physiol"},{"key":"10.1016\/S2213-8587(15)00324-1_bib8","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1249\/MSS.0b013e3181eb6265","article-title":"Influence of resistance exercise on lean body mass in aging adults: a meta-analysis","volume":"43","author":"Peterson","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(15)00324-1_bib9","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.jamda.2012.05.020","article-title":"Protein supplementation increases muscle mass gain during prolonged resistance-type exercise training in frail elderly people: a randomized, double-blind, placebo-controlled trial","volume":"13","author":"Tieland","year":"2012","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/S2213-8587(15)00324-1_bib10","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.cger.2011.07.010","article-title":"Aging and exercise","volume":"27","author":"Allen","year":"2011","journal-title":"Clin Geriatr Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003241?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003241?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T02:57:01Z","timestamp":1537239421000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003241"}},"issued":{"date-parts":[[2015,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["S2213858715003241"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00324-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,12]]}},{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T16:09:24Z","timestamp":1765728564788},"reference-count":15,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/s2213-8587(15)00320-4","type":"journal-article","created":{"date-parts":[[2015,9,18]],"date-time":"2015-09-18T14:06:55Z","timestamp":1442585215000},"page":"829-831","source":"Crossref","is-referenced-by-count":2,"title":["Bariatric surgery: time to move beyond clinical outcomes"],"prefix":"10.1016","volume":"3","author":[{"given":"Ricardo","family":"Cohen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00320-4_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00290-9","article-title":"Health-care costs over 15 years after bariatric surgery for patients with different baseline glucose status: results from the Swedish Obese Subjects study","author":"Keating","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00320-4_bib2","doi-asserted-by":"crossref","first-page":"2002","DOI":"10.1056\/NEJMoa1401329","article-title":"Bariatric surgery versus intensive medical therapy for diabetes\u20143-year outcomes","volume":"370","author":"Schauer","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00320-4_bib3","doi-asserted-by":"crossref","first-page":"f5934","DOI":"10.1136\/bmj.f5934","article-title":"Bariatric surgery versus non-surgical treatment for obesity: a systematic review and meta-analysis of randomised controlled trials","volume":"347","author":"Gloy","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00320-4_bib4","doi-asserted-by":"crossref","first-page":"1420","DOI":"10.2337\/dc11-2289","article-title":"Effects of gastric bypass surgery in patients with type 2 diabetes and only mild obesity","volume":"35","author":"Cohen","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00320-4_bib5","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00320-4_bib6","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1056\/NEJMoa066603","article-title":"Long-term mortality after gastric bypass surgery","volume":"357","author":"Adams","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00320-4_bib7","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sj\u00f6str\u00f6m","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00320-4_bib8","doi-asserted-by":"crossref","first-page":"1448","DOI":"10.1007\/s00125-015-3591-y","article-title":"Incidence and remission of type 2 diabetes in relation to degree of obesity at baseline and 2 year weight change: the Swedish Obese Subjects (SOS) study","volume":"58","author":"Sj\u00f6holm","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00320-4_bib9","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1111\/j.1467-789X.2008.00472.x","article-title":"Indirect costs of obesity: a review of the current literature","volume":"9","author":"Trogdon","year":"2008","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(15)00320-4_bib10","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11695-012-0802-1","article-title":"A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass","volume":"23","author":"Arterburn","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(15)00320-4_bib11","doi-asserted-by":"crossref","first-page":"2297","DOI":"10.1001\/jama.2014.5988","article-title":"Association of bariatric surgery with long-term remission of type 2 diabetes and with microvascular and macrovascular complications","volume":"311","author":"Sj\u00f6str\u00f6m","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00320-4_bib12","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.2337\/dc11-2353","article-title":"Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes","volume":"35","author":"Miras","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00320-4_bib13","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1016\/j.soard.2006.07.004","article-title":"The ASBS Bariatric Surgery Centers of Excellence program: a blueprint for quality improvement","volume":"2","author":"Pratt","year":"2006","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(15)00320-4_bib14","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/S2213-8587(13)70198-0","article-title":"Beyond BMI: the need for new guidelines governing the use of bariatric and metabolic surgery","volume":"2","author":"Cummings","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00320-4_bib15","doi-asserted-by":"crossref","first-page":"g6608","DOI":"10.1136\/bmj.g6608","article-title":"Identification, assessment, and management of overweight and obesity: summary of updated NICE guidance","volume":"349","author":"Stegenga","year":"2014","journal-title":"BMJ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003204?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003204?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T09:50:45Z","timestamp":1537350645000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003204"}},"issued":{"date-parts":[[2015,11]]},"references-count":15,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S2213858715003204"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00320-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,11]]}},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T02:48:10Z","timestamp":1767149290418,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(21)00284-9","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/s2213-8587(22)00011-0","type":"journal-article","created":{"date-parts":[[2022,1,24]],"date-time":"2022-01-24T18:31:30Z","timestamp":1643049090000},"page":"e2","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2022; 10: 142\u201348"],"prefix":"10.1016","volume":"10","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000110?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000110?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:11Z","timestamp":1761991871000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000110"}},"issued":{"date-parts":[[2022,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2213858722000110"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00011-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2022; 10: 142\u201348","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00011-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00284-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,10]],"date-time":"2026-07-10T01:46:23Z","timestamp":1783647983027,"version":"3.55.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/s2213-8587(20)30041-3","type":"journal-article","created":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T18:36:58Z","timestamp":1581446218000},"page":"348","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Denosumab salvage therapy in a patient with a locally advanced and refractory sellar giant cell tumour of bone"],"prefix":"10.1016","volume":"8","author":[{"given":"Pedro","family":"Marques","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasha M","family":"Appelman-Dijkstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Gelderblom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark C","family":"Kruit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wouter R","family":"van Furth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M","family":"Pereira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nienke R","family":"Biermasz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300413?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300413?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:31Z","timestamp":1761991711000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300413"}},"issued":{"date-parts":[[2020,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2213858720300413"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30041-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Denosumab salvage therapy in a patient with a locally advanced and refractory sellar giant cell tumour of bone","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30041-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,8,28]],"date-time":"2025-08-28T12:05:11Z","timestamp":1756382711489},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/s2213-8587(15)00262-4","type":"journal-article","created":{"date-parts":[[2015,10,30]],"date-time":"2015-10-30T18:32:10Z","timestamp":1446229930000},"page":"630","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Cushing's conundrum: an unusual case of primary pigmented nodular adrenal disease in a 60-year-old woman"],"prefix":"10.1016","volume":"4","author":[{"given":"Jasna","family":"Aleksova","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Glenn","family":"Ward","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Taubman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jason","family":"Tan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stephen","family":"Farrell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stuart","family":"Galloway","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Richard J","family":"MacIsaac","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nirupa","family":"Sachithanandan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002624?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002624?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T01:20:43Z","timestamp":1537233643000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002624"}},"issued":{"date-parts":[[2016,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S2213858715002624"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00262-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cushing's conundrum: an unusual case of primary pigmented nodular adrenal disease in a 60-year-old woman","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00262-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:26Z","timestamp":1761992006816,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/s2213-8587(21)00147-9","type":"journal-article","created":{"date-parts":[[2022,6,9]],"date-time":"2022-06-09T13:11:02Z","timestamp":1654780262000},"page":"471","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Prioritising COVID-19 over everything: the unintended harm"],"prefix":"10.1016","volume":"10","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001479?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001479?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:44Z","timestamp":1761991844000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001479"}},"issued":{"date-parts":[[2022,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2213858721001479"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00147-9","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prioritising COVID-19 over everything: the unintended harm","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00147-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,1,15]],"date-time":"2025-01-15T05:20:26Z","timestamp":1736918426903,"version":"3.33.0"},"reference-count":3,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/s2213-8587(24)00227-4","type":"journal-article","created":{"date-parts":[[2024,8,23]],"date-time":"2024-08-23T07:43:00Z","timestamp":1724398980000},"page":"614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Food additive emulsifiers and risk of type 2 diabetes"],"prefix":"10.1016","volume":"12","author":[{"given":"Jieling","family":"Chen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Suilian","family":"Zheng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00227-4_bib1","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S2213-8587(24)00086-X","article-title":"Food additive emulsifiers and the risk of type 2 diabetes: analysis of data from the NutriNet-Sant\u00e9 prospective cohort study","volume":"12","author":"Salame","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00227-4_bib2","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S2213-8587(24)00091-3","article-title":"Environmental chemical obesogens, what can we do?","volume":"12","author":"Lobstein","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00227-4_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2023.110646","article-title":"Weight variability and diabetes complications","volume":"199","author":"Prattichizzo","year":"2023","journal-title":"Diabetes Res Clin Pract"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002274?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002274?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T13:09:15Z","timestamp":1736860155000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002274"}},"issued":{"date-parts":[[2024,9]]},"references-count":3,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213858724002274"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00227-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Food additive emulsifiers and risk of type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00227-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00086-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:46Z","timestamp":1761992206955,"version":"build-2065373602"},"reference-count":14,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,10,13]],"date-time":"2022-10-13T00:00:00Z","timestamp":1665619200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/s2213-8587(22)00305-9","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T19:58:45Z","timestamp":1666123125000},"page":"837-839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["COP27 Climate Change Conference: urgent action needed for Africa and the world"],"prefix":"10.1016","volume":"10","author":[{"given":"Lukoye","family":"Atwoli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gregory E","family":"Erhabor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Aiah A","family":"Gbakima","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abraham","family":"Haileamlak","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jean-Marie Kayembe","family":"Ntumba","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Kigera","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Laurie","family":"Laybourn-Langton","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Mash","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Joy","family":"Muhia","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fhumulani Mavis","family":"Mulaudzi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Ofori-Adjei","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Friday","family":"Okonofua","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arash","family":"Rashidian","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maha","family":"El-Adawy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siaka","family":"Sidib\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdelmadjid","family":"Snouber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"James","family":"Tumwine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mohammad Sahar","family":"Yassien","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Yonga","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lilia","family":"Zakhama","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chris","family":"Zielinski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00305-9_bib2","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(21)01915-2","article-title":"Call for emergency action to limit global temperature increases, restore biodiversity, and protect health","volume":"398","author":"Atwoli","year":"2021","journal-title":"Lancet"},{"year":"2016","series-title":"Strengthening health resilience to climate change","key":"10.1016\/S2213-8587(22)00305-9_bib5"},{"author":"Trisos","key":"10.1016\/S2213-8587(22)00305-9_bib6"},{"year":"2021","series-title":"Climate change adaptation and economic transformation in sub-Saharan Africa","key":"10.1016\/S2213-8587(22)00305-9_bib7"},{"key":"10.1016\/S2213-8587(22)00305-9_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph18094672","article-title":"Climate change and health preparedness in Africa: analysing trends in six African countries","volume":"18","author":"Opoku","year":"2021","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(22)00305-9_bib9","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/17579139211058299","article-title":"Climate change, health, and conflict in Africa's arc of instability","volume":"141","author":"Evans","year":"2021","journal-title":"Perspect Public Health"},{"key":"10.1016\/S2213-8587(22)00305-9_bib10","series-title":"Reflections on climate change and public health in Africa in an era of global pandemic. Contemporary developments and perspectives in international health security","volume":"vol 2","author":"Stawicki","year":"2021"},{"key":"10.1016\/S2213-8587(22)00305-9_bib13","doi-asserted-by":"crossref","DOI":"10.1192\/bji.2022.14","article-title":"Mental health and climate change in Africa","author":"Atwoli","year":"2022","journal-title":"BJPsych International"},{"year":"2020","series-title":"Climate vulnerable economies loss report","key":"10.1016\/S2213-8587(22)00305-9_bib14"},{"author":"Ritchie","key":"10.1016\/S2213-8587(22)00305-9_bib15"},{"year":"2022","series-title":"Paving the way for greener central banks: current trends and future developments around the globe","author":"Bilotta","key":"10.1016\/S2213-8587(22)00305-9_bib16"},{"year":"2021","series-title":"COP26 special report on climate change and health: the health argument for climate action","key":"10.1016\/S2213-8587(22)00305-9_bib17"},{"key":"10.1016\/S2213-8587(22)00305-9_bib18","doi-asserted-by":"crossref","first-page":"247","DOI":"10.26719\/2022.28.4.247","article-title":"\u201cOur planet, our health\u201d: saving lives, promoting health and attaining well-being by protecting the planet\u2014the Eastern Mediterranean perspectives","volume":"28","author":"Al-Mandhari","year":"2022","journal-title":"East Mediterr Health J"},{"author":"Evans","key":"10.1016\/S2213-8587(22)00305-9_bib19"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003059?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003059?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:16Z","timestamp":1761991936000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003059"}},"issued":{"date-parts":[[2022,12]]},"references-count":14,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2213858722003059"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00305-9","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"COP27 Climate Change Conference: urgent action needed for Africa and the world","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00305-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:28Z","timestamp":1761992188593,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,1]]},"DOI":"10.1016\/s2213-8587(22)00356-4","type":"journal-article","created":{"date-parts":[[2022,12,15]],"date-time":"2022-12-15T18:30:09Z","timestamp":1671129009000},"page":"17","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Silver Bahendeka: the obligation to hope"],"prefix":"10.1016","volume":"11","author":[{"given":"Carl","family":"Power","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003564?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003564?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:42Z","timestamp":1761991902000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003564"}},"issued":{"date-parts":[[2023,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2023,1]]}},"alternative-id":["S2213858722003564"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00356-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Silver Bahendeka: the obligation to hope","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00356-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,8]],"date-time":"2026-07-08T03:19:27Z","timestamp":1783480767164,"version":"3.55.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/s2213-8587(18)30107-4","type":"journal-article","created":{"date-parts":[[2018,5,15]],"date-time":"2018-05-15T22:34:19Z","timestamp":1526423659000},"page":"516-517","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Islet transplantation in type 1 diabetes: moving forward"],"prefix":"10.1016","volume":"6","author":[{"given":"Shareen","family":"Forbes","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Senior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M James","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30107-4_bib1","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30107-4_bib2","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2337\/dc12-0063","article-title":"Improvement in outcomes of clinical islet transplantation: 1999\u20132010","volume":"35","author":"Barton","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30107-4_bib3","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30107-4_bib4","author":"Lablanche"},{"key":"10.1016\/S2213-8587(18)30107-4_bib5","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","article-title":"Five-year follow-up after clinical islet transplantation","volume":"54","author":"Ryan","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30107-4_bib6","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00534-011-0441-2","article-title":"A comparison of islet autotransplantation with allotransplantation and factors elevating acute portal pressure in clinical islet transplantation","volume":"19","author":"Kawahara","year":"2012","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/S2213-8587(18)30107-4_bib7","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1111\/j.1600-6143.2005.01108.x","article-title":"Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution","volume":"5","author":"Villiger","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(18)30107-4_bib8","doi-asserted-by":"crossref","first-page":"343","DOI":"10.2337\/diacare.28.2.343","article-title":"\u03b2-score: an assessment of \u03b2-cell function after islet transplantation","volume":"28","author":"Ryan","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30107-4_bib9","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMc1613959","article-title":"Bioengineering of an intraabdominal endocrine pancreas","volume":"376","author":"Baidal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30107-4_bib10","doi-asserted-by":"crossref","first-page":"518","DOI":"10.1038\/nbt.3211","article-title":"A prevascularized subcutaneous device-less site for islet and cellular transplantation","volume":"33","author":"Pepper","year":"2015","journal-title":"Nat Biotechnol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T02:00:16Z","timestamp":1529460016000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301074"}},"issued":{"date-parts":[[2018,7]]},"references-count":10,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2213858718301074"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30107-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Islet transplantation in type 1 diabetes: moving forward","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30107-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30078-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T19:33:43Z","timestamp":1781206423476,"version":"3.54.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,2,1]],"date-time":"2023-02-01T00:00:00Z","timestamp":1675209600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,2]]},"DOI":"10.1016\/s2213-8587(23)00006-2","type":"journal-article","created":{"date-parts":[[2023,1,11]],"date-time":"2023-01-11T18:34:14Z","timestamp":1673462054000},"page":"82-84","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Hot topics on insulin access: pricing in the USA"],"prefix":"10.1016","volume":"11","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000062?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000062?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:10Z","timestamp":1761991930000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000062"}},"issued":{"date-parts":[[2023,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2023,2]]}},"alternative-id":["S2213858723000062"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00006-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hot topics on insulin access: pricing in the USA","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00006-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:19:15Z","timestamp":1767151155953,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(16)30085-7","type":"expression_of_concern","label":"Expression of concern","source":"retraction-watch","updated":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T00:00:00Z","timestamp":1533600000000},"record-id":"19006"}],"reference-count":5,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/s2213-8587(18)30236-5","type":"journal-article","created":{"date-parts":[[2018,8,7]],"date-time":"2018-08-07T18:43:50Z","timestamp":1533667430000},"page":"763","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Expression of concern\u2014Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial"],"prefix":"10.1016","volume":"6","author":[{"family":"The Editors of The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30236-5_bib1","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1016\/S2213-8587(16)30085-7","article-title":"Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial","volume":"4","author":"Estruch","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30236-5_bib2","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1111\/anae.13938","article-title":"Data fabrication and other reasons for non-random sampling in 5087 randomised, controlled trials in anaesthetic and general medical journals","volume":"72","author":"Carlisle","year":"2017","journal-title":"Anaesthesia"},{"key":"10.1016\/S2213-8587(18)30236-5_bib3","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1056\/NEJMoa1200303","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet","volume":"368","author":"Estruch","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30236-5_bib4","doi-asserted-by":"crossref","first-page":"2441","DOI":"10.1056\/NEJMc1806491","article-title":"Retraction and republication: primary prevention of cardiovascular disease with a Mediterranean diet. N Engl J Med 2013; 368: 1279\u201390","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30236-5_bib5","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(16)30085-7","type":"retraction","label":"Retraction","source":"publisher","updated":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302365?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302365?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T19:35:46Z","timestamp":1537904146000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302365"}},"issued":{"date-parts":[[2018,10]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2213858718302365"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30236-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Expression of concern\u2014Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30236-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30085-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:17:17Z","timestamp":1761992237802,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,7,1]],"date-time":"2023-07-01T00:00:00Z","timestamp":1688169600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,7]]},"DOI":"10.1016\/s2213-8587(23)00160-2","type":"journal-article","created":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T18:36:51Z","timestamp":1685644611000},"page":"452","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Vin Tangpricha: advocating evidence-based transgender care"],"prefix":"10.1016","volume":"11","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001602?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001602?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:23Z","timestamp":1761992003000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001602"}},"issued":{"date-parts":[[2023,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2023,7]]}},"alternative-id":["S2213858723001602"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00160-2","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Vin Tangpricha: advocating evidence-based transgender care","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00160-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,29]],"date-time":"2026-07-29T14:05:22Z","timestamp":1785333922780,"version":"3.55.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100024017","name":"Sheba Medical Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024017","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/s2213-8587(24)00287-0","type":"journal-article","created":{"date-parts":[[2024,11,15]],"date-time":"2024-11-15T23:34:04Z","timestamp":1731713644000},"page":"97-106","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Overweight and obesity among Israeli adolescents and the risk for serious morbidity in early young adulthood: a nationwide retrospective cohort study"],"prefix":"10.1016","volume":"13","author":[{"given":"Yair","family":"Zloof","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Nitecki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Simchoni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ofek","family":"Adar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avishai M","family":"Tsur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estela","family":"Derazne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorit","family":"Tzur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacob","family":"Rotschield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orit","family":"Pinhas-Hamiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Fliss Isakov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hadar","family":"Milloh-Raz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Nemet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dror","family":"Dicker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Moyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oded","family":"Scheuerman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zivan","family":"Beer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marius","family":"Braun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnon","family":"Afek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hertzel C","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George David","family":"Batty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel","family":"Chodick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilad","family":"Twig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00287-0_bib1","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-3459","article-title":"Prevalence of obesity and severe obesity in us children, 1999\u20132016","volume":"141","author":"Skinner","year":"2018","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(24)00287-0_bib2","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2021-053708","article-title":"Changes in the Incidence of Childhood Obesity","volume":"150","author":"Cunningham","year":"2022","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(24)00287-0_bib3","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S2213-8587(14)70229-3","article-title":"Years of life lost and healthy life-years lost from diabetes and cardiovascular disease in overweight and obese people: a modelling study","volume":"3","author":"Grover","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00287-0_bib4","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0140-6736(09)60318-4","article-title":"Body-mass index and cause-specific mortality in 900\u2008000 adults: collaborative analyses of 57 prospective studies","volume":"373","author":"Whitlock","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00287-0_bib5","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s13679-021-00439-9","article-title":"Adolescent and childhood obesity and excess morbidity and mortality in young adulthood\u2014 a systematic review","volume":"10","author":"Horesh","year":"2021","journal-title":"Curr Obes Rep"},{"key":"10.1016\/S2213-8587(24)00287-0_bib6","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/j.metabol.2018.12.001","article-title":"Childhood obesity: increased risk for cardiometabolic disease and cancer in adulthood","volume":"92","author":"Weihrauch-Bl\u00fcher","year":"2019","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(24)00287-0_bib7","doi-asserted-by":"crossref","first-page":"2423","DOI":"10.1016\/S0140-6736(16)00579-1","article-title":"Our future: a Lancet commission on adolescent health and wellbeing","volume":"387","author":"Patton","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00287-0_bib8","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1056\/NEJMoa1503840","article-title":"Body-mass index in 2\u00b73 million adolescents and cardiovascular death in adulthood","volume":"374","author":"Twig","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00287-0_bib9","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.1007\/s00125-022-05722-5","article-title":"Obesity in late adolescence and incident type 1 diabetes in young adulthood","volume":"65","author":"Zucker","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00287-0_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S2213-8587(20)30019-X","article-title":"Adolescent obesity and midlife cancer risk: a population-based cohort study of 2\u00b73 million adolescents in Israel","volume":"8","author":"Furer","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00287-0_bib11","doi-asserted-by":"crossref","first-page":"E108","DOI":"10.1542\/peds.108.6.e108","article-title":"Comparison of body weight and height of Israeli schoolchildren with the Tanner and Centers for Disease Control and Prevention growth charts","volume":"108","author":"Goldstein","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(24)00287-0_bib12","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1186\/s12933-018-0798-5","article-title":"Cognitive function in adolescence and the risk for premature diabetes and cardiovascular mortality in adulthood","volume":"17","author":"Twig","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(24)00287-0_bib13","doi-asserted-by":"crossref","first-page":"1391","DOI":"10.1038\/s41366-018-0213-z","article-title":"Severe obesity and cardio-metabolic comorbidities: a nationwide study of 2.8 million adolescents","volume":"43","author":"Twig","year":"2019","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(24)00287-0_bib14","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/dc19-1988","article-title":"Adolescent obesity and early-onset type 2 diabetes","volume":"43","author":"Twig","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00287-0_bib15","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1056\/NEJMoa1502821","article-title":"Cardiometabolic risks and severity of obesity in children and young adults","volume":"373","author":"Skinner","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00287-0_bib16","doi-asserted-by":"crossref","first-page":"2043","DOI":"10.1161\/STROKEAHA.120.033595","article-title":"Body mass index in 1\u00b79 million adolescents and stroke in young adulthood","volume":"52","author":"Bardugo","year":"2021","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(24)00287-0_bib18","doi-asserted-by":"crossref","first-page":"1350","DOI":"10.1056\/NEJM199211053271904","article-title":"Long-term morbidity and mortality of overweight adolescents. A follow-up of the Harvard Growth Study of 1922 to 1935","volume":"327","author":"Must","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00287-0_bib19","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1093\/aje\/kwn096","article-title":"Body mass index in adolescence in relation to cause-specific mortality: a follow-up of 230\u2008000 Norwegian adolescents","volume":"168","author":"Bj\u00f8rge","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(24)00287-0_bib20","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0018546","article-title":"Morbidity, including fatal morbidity, throughout life in men entering adult life as obese","volume":"6","author":"Zimmermann","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(24)00287-0_bib21","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1038\/ijo.2008.70","article-title":"Association between obesity status in young adulthood and disability pension","volume":"32","author":"Neovius","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(24)00287-0_bib22","doi-asserted-by":"crossref","first-page":"230","DOI":"10.7326\/M18-1861","article-title":"Fitness and body mass index during adolescence and disability later in life","volume":"170","author":"Henriksson","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(24)00287-0_bib23","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/resp.12645","article-title":"Association between asthma and body mass index and socioeconomic status: a cross-sectional study on 849\u2008659 adolescents","volume":"21","author":"Gordon","year":"2016","journal-title":"Respirology"},{"key":"10.1016\/S2213-8587(24)00287-0_bib24","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/S2213-8587(22)00033-X","article-title":"Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study","volume":"10","author":"Kivim\u00e4ki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00287-0_bib25","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa1703860","article-title":"Simulation of growth trajectories of childhood obesity into adulthood","volume":"377","author":"Ward","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00287-0_bib26","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected US state-level prevalence of adult obesity and severe obesity","volume":"381","author":"Ward","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00287-0_bib27","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1159\/000521913","article-title":"The global spread of severe obesity in toddlers, children, and adolescents: a systematic review and meta-analysis","volume":"15","author":"Pinhas-Hamiel","year":"2022","journal-title":"Obes Facts"},{"key":"10.1016\/S2213-8587(24)00287-0_bib28","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12916-021-02188-x","article-title":"Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of Mendelian randomization studies","volume":"19","author":"Larsson","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(24)00287-0_bib29","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.43947","article-title":"Genetic and environmental factors and cardiovascular disease risk in adolescents","volume":"6","author":"Ballin","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(24)00287-0_bib30","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1038\/nature09103","article-title":"The genome-wide structure of the Jewish people","volume":"466","author":"Behar","year":"2010","journal-title":"Nature"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002870?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002870?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:14:03Z","timestamp":1738703643000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002870"}},"issued":{"date-parts":[[2025,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2213858724002870"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00287-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overweight and obesity among Israeli adolescents and the risk for serious morbidity in early young adulthood: a nationwide retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00287-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00342-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,9]],"date-time":"2026-06-09T23:25:30Z","timestamp":1781047530462,"version":"3.54.1"},"reference-count":5,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/s2213-8587(20)30182-0","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T20:33:20Z","timestamp":1590006800000},"page":"564-565","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Health care and mental health challenges for transgender individuals during the COVID-19 pandemic"],"prefix":"10.1016","volume":"8","author":[{"given":"Yuanyuan","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bailin","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amanda","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jianjun","family":"Ou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Runsen","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30182-0_bib1","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1016\/S2213-8587(18)30144-X","article-title":"Transgender health: access to care under threat","volume":"6","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30182-0_bib2","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/S2213-8587(19)30079-8","article-title":"Health care and mental wellbeing in the transgender and gender-diverse Chinese population","volume":"7","author":"Zhu","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30182-0_bib3","doi-asserted-by":"crossref","DOI":"10.1007\/s10461-020-02889-z","article-title":"COVID-19 policies can perpetuate violence against transgender communities: insights from Peru","author":"Perez-Brumer","year":"2020","journal-title":"AIDS Behav"},{"key":"10.1016\/S2213-8587(20)30182-0_bib4","article-title":"Reduction in mental health treatment utilization among transgender individuals after gender-affirming surgeries: a total population study","author":"Br\u00e4nstr\u00f6m","year":"2019","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2213-8587(20)30182-0_bib5","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1016\/j.cps.2018.03.007","article-title":"Vaginoplasty complications","volume":"45","author":"Ferrando","year":"2018","journal-title":"Clin Plast Surg"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301820?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301820?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:59Z","timestamp":1761991739000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301820"}},"issued":{"date-parts":[[2020,7]]},"references-count":5,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2213858720301820"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30182-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Health care and mental health challenges for transgender individuals during the COVID-19 pandemic","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30182-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T01:55:36Z","timestamp":1792634136411,"version":"4.5.0"},"reference-count":89,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/s2213-8587(19)30351-1","type":"journal-article","created":{"date-parts":[[2019,11,20]],"date-time":"2019-11-20T19:15:27Z","timestamp":1574277327000},"page":"150-162","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":107,"title":["Physical activity and skeletal health in adults"],"prefix":"10.1016","volume":"8","author":[{"given":"Jane A","family":"Cauley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lora","family":"Giangregorio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30351-1_bib1","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1093\/gerona\/glt093","article-title":"Public health impact of osteoporosis","volume":"68","author":"Cauley","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(19)30351-1_bib2","series-title":"The breaking spine","author":"Bouxsein","year":"2010"},{"key":"10.1016\/S2213-8587(19)30351-1_bib3","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1007\/s00198-012-1964-3","article-title":"A systematic review of hip fracture incidence and probability of fracture worldwide","volume":"23","author":"Kanis","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib5","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1186\/s12877-016-0332-0","article-title":"A critical review of the long-term disability outcomes following hip fracture","volume":"16","author":"Dyer","year":"2016","journal-title":"BMC Geriatr"},{"key":"10.1016\/S2213-8587(19)30351-1_bib6","first-page":"126","article-title":"Physical activity, exercise, and physical fitness: definitions and distinctions for health-related research","volume":"100","author":"Caspersen","year":"1985","journal-title":"Public Health Rep"},{"key":"10.1016\/S2213-8587(19)30351-1_bib7","first-page":"326","article-title":"Adult participation in aerobic and muscle-strengthening physical activities\u2014United States, 2011","volume":"62","year":"2013","journal-title":"MMWR Morb Mortal Wkly"},{"key":"10.1016\/S2213-8587(19)30351-1_bib9","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1007\/s00198-009-0961-7","article-title":"Male risk factors for hip fracture: a 30-year follow-up study in 7,495 men","volume":"21","author":"Trimpou","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib10","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1016\/j.bone.2010.06.023","article-title":"The association between physical activity in different domains of life and risk of osteoporotic fractures","volume":"47","author":"Moayyeri","year":"2010","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(19)30351-1_bib11","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00223-010-9382-z","article-title":"Risk factors for cervical and trochanteric hip fractures in elderly women: a population-based 10-year follow-up study","volume":"87","author":"Jokinen","year":"2010","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib12","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1007\/s00198-010-1234-1","article-title":"Physical activity in middle-aged women and hip fracture risk: the UFO study","volume":"22","author":"Englund","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib13","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1093\/aje\/kwq405","article-title":"Usual physical activity and hip fracture in older men: an application of semiparametric methods to observational data","volume":"173","author":"Mackey","year":"2011","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(19)30351-1_bib14","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1016\/j.bone.2012.03.014","article-title":"Different effects of age, adiposity and physical activity on the risk of ankle, wrist and hip fractures in postmenopausal women","volume":"50","author":"Armstrong","year":"2012","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(19)30351-1_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s10654-012-9665-y","article-title":"Leisure time physical activity and risk of non-vertebral fracture in men and women aged 55 years and older: the Troms\u00f8 Study","volume":"27","author":"Morseth","year":"2012","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(19)30351-1_bib16","doi-asserted-by":"crossref","first-page":"2222","DOI":"10.1002\/jbmr.1963","article-title":"Prospective observational study of physical functioning, physical activity, and time outdoors and the risk of hip fracture: a population-based cohort study of 158,057 older adults in the 45 and up study","volume":"28","author":"Lai","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib17","doi-asserted-by":"crossref","first-page":"1810","DOI":"10.1002\/jbmr.2836","article-title":"Risk factors for hip fracture in older men: the Osteoporotic Fractures in Men Study (MrOS)","volume":"31","author":"Cauley","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib18","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1093\/ageing\/afq068","article-title":"The association between graded physical activity in postmenopausal British women, and the prevalence and incidence of hip and wrist fractures","volume":"39","author":"Gregson","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/S2213-8587(19)30351-1_bib19","doi-asserted-by":"crossref","first-page":"1947","DOI":"10.3899\/jrheum.080527","article-title":"Risk factors for the development of osteoporosis and osteoporotic fractures among older men","volume":"36","author":"Thomas-John","year":"2009","journal-title":"J Rheumatol"},{"key":"10.1016\/S2213-8587(19)30351-1_bib20","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1359\/jbmr.090722","article-title":"Clinical risk factors for osteoporotic fracture: a population-based prospective cohort study in Korea","volume":"25","author":"Lee","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib21","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1016\/j.bone.2011.11.024","article-title":"Independent predictors of all osteoporosis-related fractures among healthy Saudi postmenopausal women: the CEOR Study","volume":"50","author":"Rouzi","year":"2012","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(19)30351-1_bib22","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/jgs.12326","article-title":"Objective measures of physical activity, fractures and falls: the osteoporotic fractures in men study","volume":"61","author":"Cauley","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(19)30351-1_bib23","doi-asserted-by":"crossref","first-page":"1638","DOI":"10.1002\/jbmr.363","article-title":"Frequent walking, but not total physical activity, is associated with increased fracture incidence: a 5-year follow-up of an Australian population-based prospective study (AusDiab)","volume":"26","author":"Nikander","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib24","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11657-018-0459-z","article-title":"Sports participation and fracture in older Australian men","volume":"13","author":"Holloway-Kew","year":"2018","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(19)30351-1_bib25","doi-asserted-by":"crossref","first-page":"2332","DOI":"10.1002\/jbmr.143","article-title":"Physical activity slows femoral bone loss but promotes wrist fractures in postmenopausal women: a 15-year follow-up of the OSTPRE study","volume":"25","author":"Rikkonen","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib26","doi-asserted-by":"crossref","first-page":"2565","DOI":"10.1007\/s00198-014-2770-x","article-title":"Physical activity and 10-year incidence of self-reported vertebral fractures in Japanese women: the Japan Public Health Center-based Prospective Study","volume":"25","author":"Nakamura","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib27","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1046\/j.1532-5415.2002.50014.x","article-title":"Distal radius fractures in older women: a 10-year follow-up study of descriptive characteristics and risk factors: the study of osteoporotic fractures","volume":"50","author":"Vogt","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(19)30351-1_bib28","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1097\/01.GME.0000094210.15096.FD","article-title":"Validity of self-report for fractures among a multiethnic cohort of postmenopausal women: results from the Women's Health Initiative observational study and clinical trials","volume":"11","author":"Chen","year":"2004","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(19)30351-1_bib29","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1359\/JBMR.050314","article-title":"What proportion of incident radiographic vertebral deformities is clinically diagnosed and vice versa?","volume":"20","author":"Fink","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib30","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1002\/jbmr.5650070214","article-title":"Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985\u20131989","volume":"7","author":"Cooper","year":"1992","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib31","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12966-017-0636-2","article-title":"A systematic literature review of reviews on techniques for physical activity measurement in adults: a DEDIPAC study","volume":"15","author":"Dowd","year":"2018","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(19)30351-1_bib32","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1002\/jbmr.2017","article-title":"A meta-analysis of the association of fracture risk and body mass index in women","volume":"29","author":"Johansson","year":"2014","journal-title":"J Bone Miner Res"},{"issue":"suppl","key":"10.1016\/S2213-8587(19)30351-1_bib33","doi-asserted-by":"crossref","first-page":"S197","DOI":"10.1016\/8756-3282(95)00292-L","article-title":"Skeletal adaptations to mechanical usage: results from tibial loading studies in rats","volume":"17","author":"Forwood","year":"1995","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(19)30351-1_bib34","article-title":"Exercise for preventing and treating osteoporosis in postmenopausal women","volume":"7","author":"Howe","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(19)30351-1_bib36","article-title":"Exercise for preventing falls in older people living in the community","volume":"1","author":"Sherrington","year":"2019","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(19)30351-1_bib37","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1001\/jama.2017.15006","article-title":"Comparisons of interventions for preventing falls in older adults: a systematic review and meta-analysis","volume":"318","author":"Tricco","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30351-1_bib38","article-title":"The effect of fall prevention exercise programmes on fall induced injuries in community dwelling older adults: systematic review and meta-analysis of randomised controlled trials","volume":"347","author":"El-Khoury","year":"2013","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30351-1_bib39","article-title":"Interventions for preventing falls in older people living in the community","volume":"9","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(19)30351-1_bib40","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1071\/NB10056","article-title":"Exercise to prevent falls in older adults: an updated meta-analysis and best practice recommendations","volume":"22","author":"Sherrington","year":"2011","journal-title":"NSW Public Health Bull"},{"key":"10.1016\/S2213-8587(19)30351-1_bib41","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00198-011-1734-7","article-title":"The effect of exercise on pQCT parameters of bone structure and strength in postmenopausal women\u2014a systematic review and meta-analysis of randomized controlled trials","volume":"23","author":"Polidoulis","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib42","doi-asserted-by":"crossref","first-page":"623","DOI":"10.1007\/s00198-012-2000-3","article-title":"Does frequency of resistance training affect tibial cortical bone density in older women? A randomized controlled trial","volume":"24","author":"Ashe","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib43","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2165\/11597670-000000000-00000","article-title":"Effects of training on bone mass in older adults: a systematic review","volume":"42","author":"G\u00f3mez-Cabello","year":"2012","journal-title":"Sports Med"},{"key":"10.1016\/S2213-8587(19)30351-1_bib44","doi-asserted-by":"crossref","first-page":"2749","DOI":"10.1007\/s00198-013-2346-1","article-title":"The effect of physical exercise on bone density in middle-aged and older men: a systematic review","volume":"24","author":"Bolam","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib45","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1007\/s00198-018-4482-0","article-title":"Exercise effects on bone mineral density in older men: a systematic review with special emphasis on study interventions","volume":"29","author":"Kemmler","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib46","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1097\/GME.0000000000000872","article-title":"A systematic review of the exercise effect on bone health: the importance of assessing mechanical loading in perimenopausal and postmenopausal women","volume":"24","author":"Sa\u00f1udo","year":"2017","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(19)30351-1_bib47","doi-asserted-by":"crossref","first-page":"1605","DOI":"10.1007\/s00198-015-3034-0","article-title":"The effects of differing resistance training modes on the preservation of bone mineral density in postmenopausal women: a meta-analysis","volume":"26","author":"Zhao","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib48","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1097\/GME.0000000000000100","article-title":"Effects of walking on the preservation of bone mineral density in perimenopausal and postmenopausal women: a systematic review and meta-analysis","volume":"20","author":"Ma","year":"2013","journal-title":"Menopause"},{"key":"10.1016\/S2213-8587(19)30351-1_bib49","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2147\/OAJSM.S129182","article-title":"Effects of water-based exercise on bone health of middle-aged and older adults: a systematic review and meta-analysis","volume":"8","author":"Simas","year":"2017","journal-title":"Open Access J Sports Med"},{"key":"10.1016\/S2213-8587(19)30351-1_bib50","doi-asserted-by":"crossref","first-page":"2901","DOI":"10.1007\/s00198-016-3626-3","article-title":"Effects of tai chi exercise on bone health in perimenopausal and postmenopausal women: a systematic review and meta-analysis","volume":"27","author":"Sun","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib51","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/j.jcma.2016.06.010","article-title":"Effect of tai chi on bone mineral density in postmenopausal women: a systematic review and meta-analysis of randomized control trials","volume":"80","author":"Liu","year":"2017","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/S2213-8587(19)30351-1_bib52","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1093\/ageing\/afv055","article-title":"Randomised controlled trial of the effectiveness of community group and home-based falls prevention exercise programmes on bone health in older people: the ProAct65+ bone study","volume":"44","author":"Duckham","year":"2015","journal-title":"Age Ageing"},{"key":"10.1016\/S2213-8587(19)30351-1_bib53","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1186\/1471-2474-13-177","article-title":"Effects of ground and joint reaction force exercise on lumbar spine and femoral neck bone mineral density in postmenopausal women: a meta-analysis of randomized controlled trials","volume":"13","author":"Kelley","year":"2012","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/S2213-8587(19)30351-1_bib54","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jbmr.3284","article-title":"High-intensity resistance and impact training improves bone mineral density and physical function in postmenopausal women with osteopenia and osteoporosis: the LIFTMOR randomized controlled trial","volume":"33","author":"Watson","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib55","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1002\/jbmr.2014","article-title":"Effects of a targeted multimodal exercise program incorporating high-speed power training on falls and fracture risk factors in older adults: a community-based randomized controlled trial","volume":"29","author":"Gianoudis","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib56","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.bone.2012.11.031","article-title":"Exercise and bone mineral density in men: a meta-analysis of randomized controlled trials","volume":"53","author":"Kelley","year":"2013","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(19)30351-1_bib57","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bone.2012.12.045","article-title":"High impact exercise increased femoral neck bone mineral density in older men: a randomised unilateral intervention","volume":"53","author":"Allison","year":"2013","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(19)30351-1_bib58","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1016\/j.bone.2015.07.001","article-title":"Objectively measured physical activity is associated with parameters of bone in 70-year-old men and women","volume":"81","author":"Johansson","year":"2015","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(19)30351-1_bib59","doi-asserted-by":"crossref","first-page":"1859","DOI":"10.1002\/jbmr.2222","article-title":"Age-related impairment of bones' adaptive response to loading in mice is associated with sex-related deficiencies in osteoblasts but no change in osteocytes","volume":"29","author":"Meakin","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib60","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1002\/jbmr.2900","article-title":"Activation of Wnt signaling by mechanical loading is impaired in the bone of old mice","volume":"31","author":"Holguin","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib61","doi-asserted-by":"crossref","first-page":"9290","DOI":"10.1016\/j.biomaterials.2014.07.051","article-title":"The influence of age on adaptive bone formation and bone resorption","volume":"35","author":"Birkhold","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/S2213-8587(19)30351-1_bib62","doi-asserted-by":"crossref","first-page":"1693","DOI":"10.1007\/s40279-015-0385-9","article-title":"Dose-response relationships of resistance training in healthy old adults: a systematic review and meta-analysis","volume":"45","author":"Borde","year":"2015","journal-title":"Sports Med"},{"key":"10.1016\/S2213-8587(19)30351-1_bib63","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jsams.2011.08.007","article-title":"Effects of exercise on bone density and falls risk factors in post-menopausal women with osteopenia: a randomised controlled trial","volume":"15","author":"Bolton","year":"2012","journal-title":"J Sci Med Sport"},{"key":"10.1016\/S2213-8587(19)30351-1_bib64","article-title":"Exercise for improving outcomes after osteoporotic vertebral fracture","volume":"1","author":"Giangregorio","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(19)30351-1_bib65","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1007\/s00198-003-1423-2","article-title":"Efficacy of home-based exercise for improving quality of life among elderly women with symptomatic osteoporosis-related vertebral fractures","volume":"14","author":"Papaioannou","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib66","first-page":"512","article-title":"Effects of different treatments on patients with osteoporotic fracture after percutaneous kyphoplasty","volume":"28","author":"Wang","year":"2015","journal-title":"Zhongguo Gu Shang"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(19)30351-1_bib67","article-title":"Patient engagement in clinical guidelines development: input from >1000 members of the canadian osteoporosis patient network","volume":"32","author":"Funnel","year":"2018","journal-title":"J Bone Miner Res"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(19)30351-1_bib68","article-title":"Using behaviour change theory and user perspectives to design patient education materials to enhance uptake of Too Fit To Fracture recommendations","volume":"31","author":"Ziebart","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib69","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1007\/s00198-017-3975-6","article-title":"\u201cI do not have time. Is there a handout I can use?\u201d: combining physicians' needs and behavior change theory to put physical activity evidence into practice","volume":"28","author":"Clark","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib70","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1016\/j.apmr.2010.06.001","article-title":"Adverse events reported in progressive resistance strength training trials in older adults: 2 sides of a coin","volume":"91","author":"Liu","year":"2010","journal-title":"Arch Phys Med Rehabil"},{"key":"10.1016\/S2213-8587(19)30351-1_bib71","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1001\/jamainternmed.2018.5406","article-title":"Association of Long-term exercise training with risk of falls, fractures, hospitalizations, and mortality in older adults: a systematic review and meta-analysis","volume":"179","author":"de Souto Barreto","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(19)30351-1_bib72","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1139\/h11-037","article-title":"Evidence-based risk assessment and recommendations for physical activity: arthritis, osteoporosis, and low back pain","volume":"36","author":"Chilibeck","year":"2011","journal-title":"Appl Physiol Nutr Metab"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(19)30351-1_bib73","doi-asserted-by":"crossref","first-page":"S103","DOI":"10.1017\/S0007114512000748","article-title":"A pulse-based diet is effective for reducing total and LDL-cholesterol in older adults","volume":"108","author":"Abeysekara","year":"2012","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(19)30351-1_bib74","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1002\/jbmr.1815","article-title":"Effect of exercise training combined with isoflavone supplementation on bone and lipids in postmenopausal women: a randomized clinical trial","volume":"28","author":"Chilibeck","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib75","doi-asserted-by":"crossref","first-page":"1587","DOI":"10.1249\/MSS.0000000000000571","article-title":"Effects of creatine and resistance training on bone health in postmenopausal women","volume":"47","author":"Chilibeck","year":"2015","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(19)30351-1_bib76","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.bonr.2016.04.004","article-title":"Effects of low-dose ibuprofen supplementation and resistance training on bone and muscle in postmenopausal women: a randomized controlled trial","volume":"5","author":"Duff","year":"2016","journal-title":"Bone Rep"},{"key":"10.1016\/S2213-8587(19)30351-1_bib77","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1007\/s00198-018-4652-0","article-title":"Build better bones with exercise (B3E pilot trial): results of a feasibility study of a multicenter randomized controlled trial of 12 months of home exercise in older women with vertebral fracture","volume":"29","author":"Giangregorio","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib78","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1001\/jama.292.7.837","article-title":"Effects of extended outpatient rehabilitation after hip fracture: a randomized controlled trial","volume":"292","author":"Binder","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(19)30351-1_bib79","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1111\/j.1532-5415.2004.52409.x","article-title":"Group treatment improves trunk strength and psychological status in older women with vertebral fractures: results of a randomized, clinical trial","volume":"52","author":"Gold","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(19)30351-1_bib80","first-page":"1299","article-title":"Therapeutic approaches to non-erosive GERD\u2014comparison between the Western countries and Japan","volume":"63","author":"Hongo","year":"2005","journal-title":"Nihon Rinsho"},{"key":"10.1016\/S2213-8587(19)30351-1_bib81","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1007\/s00198-018-04829-z","article-title":"High-intensity exercise did not cause vertebral fractures and improves thoracic kyphosis in postmenopausal women with low to very low bone mass: the LIFTMOR trial","volume":"30","author":"Watson","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib88","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1007\/s00198-013-2523-2","article-title":"Too Fit To Fracture: exercise recommendations for individuals with osteoporosis or osteoporotic vertebral fracture","volume":"25","author":"Giangregorio","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib89","doi-asserted-by":"crossref","first-page":"438","DOI":"10.1016\/j.jsams.2016.10.001","article-title":"Exercise and Sports Science Australia (ESSA) position statement on exercise prescription for the prevention and management of osteoporosis","volume":"20","author":"Beck","year":"2017","journal-title":"J Sci Med Sport"},{"key":"10.1016\/S2213-8587(19)30351-1_bib90","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1007\/s00198-014-2881-4","article-title":"Too Fit To Fracture: outcomes of a Delphi consensus process on physical activity and exercise recommendations for adults with osteoporosis with or without vertebral fractures","volume":"26","author":"Giangregorio","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(19)30351-1_bib91","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1016\/j.ypmed.2012.10.001","article-title":"Prevalence and correlates of participation in fall prevention exercise\/physical activity by older adults","volume":"55","author":"Merom","year":"2012","journal-title":"Prev Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(19)30351-1_bib92","article-title":"Physical activity patterns and preferences in women with low bone mass","volume":"26","author":"Saccone","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib93","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1056\/NEJMp1103502","article-title":"Pragmatic trials\u2014guides to better patient care?","volume":"364","author":"Ware","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30351-1_bib94","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1016\/j.jamda.2013.05.021","article-title":"Evidence-based recommendations for optimal dietary protein intake in older people: a position paper from the PROT-AGE Study Group","volume":"14","author":"Bauer","year":"2013","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/S2213-8587(19)30351-1_bib95","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0083306","article-title":"When, where and how osteoporosis-associated fractures occur: an analysis from the Global Longitudinal Study of Osteoporosis in Women (GLOW)","volume":"8","author":"Costa","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30351-1_bib96","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1002\/jbmr.3641","article-title":"Change in bone density and reduction in fracture risk: a meta-regression of published trials","volume":"34","author":"Bouxsein","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(19)30351-1_bib97","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.jocd.2011.05.015","article-title":"Official positions for FRAX(R) clinical regarding international differences from Joint Official Positions Development Conference of the International Society for Clinical Densitometry and International Osteoporosis Foundation on FRAX(R)","volume":"14","author":"Cauley","year":"2011","journal-title":"J Clin Densitom"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303511?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303511?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:52Z","timestamp":1761991672000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719303511"}},"issued":{"date-parts":[[2020,2]]},"references-count":89,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2213858719303511"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30351-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Physical activity and skeletal health in adults","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30351-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T02:38:07Z","timestamp":1794278287444,"version":"4.9.0"},"reference-count":39,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/s2213-8587(24)00195-5","type":"journal-article","created":{"date-parts":[[2024,8,29]],"date-time":"2024-08-29T18:39:04Z","timestamp":1724956744000},"page":"704-715","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":46,"title":["Adiposity and metabolic health in Asian populations: an epidemiological study using dual-energy x-ray absorptiometry in Singapore"],"prefix":"10.1016","volume":"12","author":[{"given":"Theresia","family":"Mina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wubin","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dorrain Yanwen","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaoyan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin Chih Chiang","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nilanjana","family":"Sadhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hong Kiat","family":"Ng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nur-Azizah","family":"Aziz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terry Yoke Yin","family":"Tong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Swat Kim","family":"Kerk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wee Lin","family":"Choo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guo Liang","family":"Low","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Halimah","family":"Ibrahim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Shyong","family":"Tai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gervais","family":"Wansaicheong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rinkoo","family":"Dalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yik Weng","family":"Yew","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elio","family":"Riboli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie","family":"Loh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanne","family":"Ngeow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eng Sing","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jimmy","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00195-5_bib1","doi-asserted-by":"crossref","first-page":"1513","DOI":"10.1016\/S0140-6736(16)00618-8","article-title":"Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4\u00b74 million participants","volume":"387","author":"Zhou","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00195-5_bib2","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/s41586-020-2338-1","article-title":"Repositioning of the global epicentre of non-optimal cholesterol","volume":"582","author":"Taddei","year":"2020","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00195-5_bib3","doi-asserted-by":"crossref","first-page":"957","DOI":"10.1016\/S0140-6736(21)01330-1","article-title":"Worldwide trends in hypertension prevalence and progress in treatment and control from 1990 to 2019: a pooled analysis of 1201 population-representative studies with 104 million participants","volume":"398","author":"Zhou","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00195-5_bib4","series-title":"IDF Diabetes Atlas","year":"2021"},{"key":"10.1016\/S2213-8587(24)00195-5_bib5","series-title":"IDF Diabetes Atlas","year":"2019"},{"key":"10.1016\/S2213-8587(24)00195-5_bib7","doi-asserted-by":"crossref","first-page":"1621","DOI":"10.2337\/dc13-2656","article-title":"Understanding the high prevalence of diabetes in U.S. south Asians compared with four racial\/ethnic groups: the MASALA and MESA studies","volume":"37","author":"Kanaya","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00195-5_bib8","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1038\/s41588-021-00852-9","article-title":"The trans-ancestral genomic architecture of glycemic traits","volume":"53","author":"Chen","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00195-5_bib9","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-12026-7","article-title":"The transferability of lipid loci across African, Asian and European cohorts","volume":"10","author":"Kuchenbaecker","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00195-5_bib10","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41588-018-0303-9","article-title":"Trans-ethnic association study of blood pressure determinants in over 750,000 individuals","volume":"51","author":"Giri","year":"2019","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(24)00195-5_bib11","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41586-019-1171-x","article-title":"Rising rural body-mass index is the main driver of the global obesity epidemic in adults","volume":"569","year":"2019","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00195-5_bib12","article-title":"Anthropometric and adiposity indicators and risk of type 2 diabetes: systematic review and dose-response meta-analysis of cohort studies","volume":"376","author":"Jayedi","year":"2022","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00195-5_bib13","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41591-019-0563-7","article-title":"Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease","volume":"25","author":"Karlsson","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00195-5_bib14","series-title":"Prevalence of obesity among adults, BMI >= 30 (age-standardized estimate) (%)","year":"2016"},{"key":"10.1016\/S2213-8587(24)00195-5_bib15","article-title":"Adiposity impacts cognitive function in Asian populations: an epidemiological and Mendelian Randomization study","volume":"33","author":"Mina","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/S2213-8587(24)00195-5_bib16","article-title":"The Health for Life in Singapore (HELIOS) Study: delivering Precision Medicine research for Asian populations","author":"Wang","year":"2024","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(24)00195-5_bib17","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-34116-9","article-title":"Analysis of human disease variants from ancestrally diverse Asian genomes","volume":"13","author":"Chan","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00195-5_bib18","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00195-5_bib20","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1038\/oby.2011.367","article-title":"Dual-energy X-ray performs as well as clinical computed tomography for the measurement of visceral fat","volume":"20","author":"Micklesfield","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(24)00195-5_bib21","doi-asserted-by":"crossref","first-page":"e221","DOI":"10.1038\/nutd.2016.28","article-title":"Comparison of visceral fat mass measurement by dual-X-ray absorptiometry and magnetic resonance imaging in a multiethnic cohort: the Dallas Heart Study","volume":"6","author":"Neeland","year":"2016","journal-title":"Nutr Diabetes"},{"key":"10.1016\/S2213-8587(24)00195-5_bib23","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00195-5_bib24","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(24)00195-5_bib25","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0155478","article-title":"Investigation of genetic variation underlying central obesity amongst South Asians","volume":"11","author":"Scott","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(24)00195-5_bib26","doi-asserted-by":"crossref","first-page":"714","DOI":"10.3945\/ajcn.112.035758","volume":"96","author":"Nazare","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(24)00195-5_bib27","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2337\/dc12-0544","article-title":"Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall and Brent Revisited (SABRE) cohort","volume":"36","author":"Tillin","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00195-5_bib28","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00125-021-05580-7","article-title":"Type 2 diabetes risks and determinants in second-generation migrants and mixed ethnicity people of South Asian and African Caribbean descent in the UK","volume":"65","author":"Farmaki","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00195-5_bib29","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.2337\/db13-1483","article-title":"Body fat partitioning does not explain the interethnic variation in insulin sensitivity among Asian ethnicity: the Singapore Adults Metabolism Study","volume":"63","author":"Khoo","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00195-5_bib30","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.diabet.2015.07.003","article-title":"Impact of classical risk factors of type 2 diabetes among Asian Indian, Chinese and Japanese populations","volume":"41","author":"He","year":"2015","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(24)00195-5_bib31","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/1753-0407.12273","article-title":"Incidence of type 2 diabetes and number of events attributable to abdominal obesity in China: a cohort study","volume":"8","author":"Xue","year":"2016","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(24)00195-5_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/nrdp.2017.34","article-title":"Obesity","volume":"3","author":"Gonz\u00e1lez-Muniesa","year":"2017","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(24)00195-5_bib33","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrendo.2014.185","article-title":"Biology of upper-body and lower-body adipose tissue\u2014link to whole-body phenotypes","volume":"11","author":"Karpe","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00195-5_bib34","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/CIRCRESAHA.116.305697","article-title":"Obesity-induced hypertension: interaction of neurohumoral and renal mechanisms","volume":"116","author":"Hall","year":"2015","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(24)00195-5_bib35","doi-asserted-by":"crossref","first-page":"1086","DOI":"10.1038\/ijo.2011.185","article-title":"Can body fat distribution, adiponectin levels and inflammation explain differences in insulin resistance between ethnic Chinese, Malays and Asian Indians","volume":"36","author":"Gao","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(24)00195-5_bib36","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1007\/s00125-020-05132-5","article-title":"Why are South Asians prone to type 2 diabetes? A hypothesis based on underexplored pathways","volume":"63","author":"Narayan","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00195-5_bib37","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1007\/s00125-022-05803-5","article-title":"Liver, visceral and subcutaneous fat in men and women of South Asian and white European descent: a systematic review and meta-analysis of new and published data","volume":"66","author":"Iliodromiti","year":"2023","journal-title":"Diabetologia"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(24)00195-5_bib38","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1467-789X.2012.01034.x","article-title":"Ethnic variability in adiposity, thrifty phenotypes and cardiometabolic risk: addressing the full range of ethnicity, including those of mixed ethnicity","volume":"13","author":"Wells","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(24)00195-5_bib39","doi-asserted-by":"crossref","first-page":"1120","DOI":"10.2337\/dc10-2097","article-title":"Ethnicity modifies the relationships of insulin resistance, inflammation, and adiponectin with obesity in a multiethnic Asian population","volume":"34","author":"Khoo","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00195-5_bib40","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1093\/jn\/nxy016","article-title":"A healthy Asian a posteriori dietary pattern correlates with a priori dietary patterns and is associated with cardiovascular disease risk factors in a multiethnic Asian population","volume":"148","author":"Whitton","year":"2018","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(24)00195-5_bib41","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1186\/s12966-017-0626-4","article-title":"Correlates of occupational, leisure and total sitting time in working adults: results from the Singapore multi-ethnic cohort","volume":"14","author":"Uijtdewilligen","year":"2017","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(24)00195-5_bib42","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/ijo.2017.289","article-title":"Comparison of regional fat measurements by dual-energy X-ray absorptiometry and conventional anthropometry and their association with markers of diabetes and cardiovascular disease risk","volume":"42","author":"Vasan","year":"2018","journal-title":"Int J Obes (Lond)"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001955?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001955?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T19:24:37Z","timestamp":1727205877000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001955"}},"issued":{"date-parts":[[2024,10]]},"references-count":39,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2213858724001955"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00195-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adiposity and metabolic health in Asian populations: an epidemiological study using dual-energy x-ray absorptiometry in Singapore","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00195-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00268-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T23:21:52Z","timestamp":1794352912170,"version":"4.9.0"},"reference-count":128,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/s2213-8587(20)30110-8","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T18:50:29Z","timestamp":1592333429000},"page":"616-627","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":520,"title":["Causes, consequences, and treatment of metabolically unhealthy fat distribution"],"prefix":"10.1016","volume":"8","author":[{"given":"Norbert","family":"Stefan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30110-8_bib1","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1016\/S2213-8587(18)30288-2","article-title":"Association of BMI with overall and cause-specific mortality: a population-based cohort study of 3\u00b76 million adults in the UK","volume":"6","author":"Bhaskaran","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib2","doi-asserted-by":"crossref","first-page":"815","DOI":"10.1016\/S0140-6736(11)60814-3","article-title":"Health and economic burden of the projected obesity trends in the USA and the UK","volume":"378","author":"Wang","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30110-8_bib3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1016\/S2213-8587(14)70102-0","article-title":"Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment","volume":"2","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib4","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa0801891","article-title":"General and abdominal adiposity and risk of death in Europe","volume":"359","author":"Pischon","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib5","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib6","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","article-title":"Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications","volume":"1","author":"Stefan","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib7","doi-asserted-by":"crossref","first-page":"1205","DOI":"10.1111\/obr.12699","article-title":"Pathways and mechanisms linking dietary components to cardiometabolic disease: thinking beyond calories","volume":"19","author":"Stanhope","year":"2018","journal-title":"Obes Rev"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(20)30110-8_bib8","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/0026-0495(95)90201-5","article-title":"Regulation of nutrient metabolism and energy expenditure","volume":"44","author":"Felber","year":"1995","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(20)30110-8_bib9","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.cell.2013.12.012","article-title":"What we talk about when we talk about fat","volume":"156","author":"Rosen","year":"2014","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(20)30110-8_bib10","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.cmet.2013.03.008","article-title":"Mechanisms and metabolic implications of regional differences among fat depots","volume":"17","author":"Tchkonia","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib11","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1038\/79111","article-title":"Failure of adipocyte differentiation causes type II diabetes mellitus?","volume":"26","author":"Danforth","year":"2000","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(20)30110-8_bib12","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1038\/nature05488","article-title":"Abdominal obesity and metabolic syndrome","volume":"444","author":"Despr\u00e9s","year":"2006","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(20)30110-8_bib13","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1038\/nrendo.2014.185","article-title":"Biology of upper-body and lower-body adipose tissue\u2014link to whole-body phenotypes","volume":"11","author":"Karpe","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib14","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1038\/s41580-018-0093-z","article-title":"Adipogenesis and metabolic health","volume":"20","author":"Ghaben","year":"2019","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib15","doi-asserted-by":"crossref","first-page":"4022","DOI":"10.1172\/JCI129191","article-title":"Contribution of adipogenesis to healthy adipose tissue expansion in obesity","volume":"129","author":"Vishvanath","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(20)30110-8_bib16","doi-asserted-by":"crossref","first-page":"3990","DOI":"10.1172\/JCI129187","article-title":"Altered adipose tissue and adipocyte function in the pathogenesis of metabolic syndrome","volume":"129","author":"Kahn","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(20)30110-8_bib17","doi-asserted-by":"crossref","first-page":"4009","DOI":"10.1172\/JCI129190","article-title":"What lipodystrophies teach us about the metabolic syndrome","volume":"130","author":"Mann","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(20)30110-8_bib18","doi-asserted-by":"crossref","first-page":"1911","DOI":"10.1152\/physrev.00034.2017","article-title":"Impaired adipogenesis and dysfunctional adipose tissue in human hypertrophic obesity","volume":"98","author":"Hammarstedt","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(20)30110-8_bib19","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/db09-0942","article-title":"Adipocyte turnover: relevance to human adipose tissue morphology","volume":"59","author":"Arner","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30110-8_bib20","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1007\/s00125-018-4732-x","article-title":"Dynamics of adipose tissue turnover in human metabolic health and disease","volume":"62","author":"White","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30110-8_bib21","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1056\/NEJMra1011035","article-title":"Ectopic fat in insulin resistance, dyslipidemia, and cardiometabolic disease","volume":"371","author":"Shulman","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib22","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(18)30154-2","article-title":"Non-alcoholic fatty liver disease: causes, diagnosis, cardiometabolic consequences, and treatment strategies","volume":"7","author":"Stefan","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib23","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/j.jacc.2016.03.597","article-title":"Ectopic and visceral fat deposition in lean and obese patients with type 2 diabetes","volume":"68","author":"Levelt","year":"2016","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib24","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(20)30110-8_bib25","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1016\/j.jacc.2010.05.034","article-title":"The metabolic syndrome and cardiovascular risk a systematic review and meta-analysis","volume":"56","author":"Mottillo","year":"2010","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib26","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.1016\/S0140-6736(08)60602-9","article-title":"Can metabolic syndrome usefully predict cardiovascular disease and diabetes? Outcome data from two prospective studies","volume":"371","author":"Sattar","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30110-8_bib27","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s00125-009-1620-4","article-title":"The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation","volume":"53","author":"Simmons","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30110-8_bib28","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1038\/414799a","article-title":"Insulin signalling and the regulation of glucose and lipid metabolism","volume":"414","author":"Saltiel","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(20)30110-8_bib29","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0140-6736(09)61794-3","article-title":"The metabolic syndrome","volume":"375","author":"Eckel","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30110-8_bib30","doi-asserted-by":"crossref","first-page":"1166","DOI":"10.1172\/JCI119628","article-title":"Insulin resistance and hypersecretion in obesity","volume":"100","author":"Ferrannini","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(20)30110-8_bib31","doi-asserted-by":"crossref","first-page":"2569","DOI":"10.1210\/jc.2004-0165","article-title":"Metabolic and body composition factors in subgroups of obesity: what do we know?","volume":"89","author":"Karelis","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib32","doi-asserted-by":"crossref","first-page":"642","DOI":"10.1001\/archinte.167.7.642","article-title":"Heterogeneity in the prevalence of risk factors for cardiovascular disease and type 2 diabetes mellitus in obese individuals: effect of differences in insulin sensitivity","volume":"167","author":"McLaughlin","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib33","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.1001\/archinte.168.15.1609","article-title":"Identification and characterization of metabolically benign obesity in humans","volume":"168","author":"Stefan","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib34","doi-asserted-by":"crossref","first-page":"e506","DOI":"10.1152\/ajpendo.00586.2009","article-title":"Insulin-sensitive obesity","volume":"299","author":"Kl\u00f6ting","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib35","doi-asserted-by":"crossref","first-page":"758","DOI":"10.7326\/0003-4819-159-11-201312030-00008","article-title":"Are metabolically healthy overweight and obesity benign conditions?: a systematic review and meta-analysis","volume":"159","author":"Kramer","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib36","doi-asserted-by":"crossref","first-page":"2482","DOI":"10.1210\/jc.2011-3475","article-title":"Metabolically healthy obesity and risk of all-cause and cardiovascular disease mortality","volume":"97","author":"Hamer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib37","doi-asserted-by":"crossref","first-page":"956","DOI":"10.1177\/2047487315623884","article-title":"Metabolically healthy obesity and cardiovascular events: a systematic review and meta-analysis","volume":"23","author":"Eckel","year":"2016","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib38","doi-asserted-by":"crossref","first-page":"504","DOI":"10.1111\/obr.12157","article-title":"Metabolically healthy obesity and risk of incident type 2 diabetes: a meta-analysis of prospective cohort studies","volume":"15","author":"Bell","year":"2014","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(20)30110-8_bib39","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.1001\/archinte.168.15.1617","article-title":"Clustering and the normal weight with cardiometabolic risk factor clustering: prevalence and correlates of 2 phenotypes among the US population (NHANES 1999-2004)","volume":"168","author":"Wildman","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib40","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S2213-8587(17)30292-9","article-title":"Metabolically healthy obesity: the low-hanging fruit in obesity treatment?","volume":"6","author":"Stefan","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib41","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","article-title":"Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans","volume":"26","author":"Stefan","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib42","doi-asserted-by":"crossref","first-page":"3978","DOI":"10.1172\/JCI129186","article-title":"Metabolically healthy obesity: facts and fantasies","volume":"129","author":"Smith","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(20)30110-8_bib43","doi-asserted-by":"crossref","first-page":"1429","DOI":"10.1016\/j.jacc.2017.07.763","article-title":"Metabolically healthy obese and incident cardiovascular disease events among 3\u00b75 million men and women","volume":"70","author":"Caleyachetty","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib44","doi-asserted-by":"crossref","first-page":"714","DOI":"10.1016\/S2213-8587(18)30137-2","article-title":"Transition from metabolic healthy to unhealthy phenotypes and association with cardiovascular disease risk across BMI categories in 90\u2008257 women (the Nurses' Health Study): 30 year follow-up from a prospective cohort study","volume":"6","author":"Eckel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib45","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1093\/eurheartj\/ehx448","article-title":"Separate and combined associations of obesity and metabolic health with coronary heart disease: a pan-European case-cohort analysis","volume":"39","author":"Lassale","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(20)30110-8_bib46","article-title":"Factors associated with hospitalization and critical illness among 4,103 patients with COVID-19 disease in New York City","author":"Petrilli","year":"2020","journal-title":"MedRxiv"},{"key":"10.1016\/S2213-8587(20)30110-8_bib47","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(20)30160-1","article-title":"Prevalence of obesity among adult inpatients with COVID-19 in France","author":"Caussy","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.cmet.2020.04.021","article-title":"Association of blood glucose control and outcomes in patients with COVID-19 and pre-existing type 2 diabetes","author":"Zhu","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib49","doi-asserted-by":"crossref","DOI":"10.1002\/oby.22856","article-title":"The role of adipocytes and adipocyte-like cells in the severity of COVID-19 infections","author":"Kruglikov","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30110-8_bib50","doi-asserted-by":"crossref","DOI":"10.1038\/s41574-020-0364-6","article-title":"Obesity and impaired metabolic health in patients with COVID-19","author":"Stefan","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib51","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib52","doi-asserted-by":"crossref","first-page":"2849","DOI":"10.1093\/eurheartj\/ehz391","article-title":"Association between regional body fat and cardiovascular disease risk among postmenopausal women with normal body mass index","volume":"40","author":"Chen","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(20)30110-8_bib53","doi-asserted-by":"crossref","first-page":"2856","DOI":"10.1093\/eurheartj\/ehz411","article-title":"New concepts for body shape-related cardiovascular risk: role of fat distribution and adipose tissue function","volume":"40","author":"Bl\u00fcher","year":"2019","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(20)30110-8_bib54","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/0026-0495(87)90063-1","article-title":"Contribution of intra-abdominal fat accumulation to the impairment of glucose and lipid metabolism in human obesity","volume":"36","author":"Fujioka","year":"1987","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(20)30110-8_bib55","doi-asserted-by":"crossref","first-page":"497","DOI":"10.1161\/01.ATV.10.4.497","article-title":"Regional distribution of body fat, plasma lipoproteins, and cardiovascular disease","volume":"10","author":"Despr\u00e9s","year":"1990","journal-title":"Arteriosclerosis"},{"key":"10.1016\/S2213-8587(20)30110-8_bib56","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1161\/CIRCULATIONAHA.106.675355","article-title":"Abdominal visceral and subcutaneous adipose tissue compartments: association with metabolic risk factors in the Framingham Heart Study","volume":"116","author":"Fox","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(20)30110-8_bib57","doi-asserted-by":"crossref","first-page":"481","DOI":"10.2337\/dc08-1359","article-title":"Patterns of abdominal fat distribution: the Framingham Heart Study","volume":"32","author":"Pou","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30110-8_bib58","doi-asserted-by":"crossref","first-page":"e439","DOI":"10.1002\/oby.20135","article-title":"Associations of visceral and abdominal subcutaneous adipose tissue with markers of cardiac and metabolic risk in obese adults","volume":"21","author":"Neeland","year":"2013","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30110-8_bib59","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1001\/2012.jama.11132","article-title":"Dysfunctional adiposity and the risk of prediabetes and type 2 diabetes in obese adults","volume":"308","author":"Neeland","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30110-8_bib60","doi-asserted-by":"crossref","first-page":"82","DOI":"10.3109\/07853890.2010.526138","article-title":"Absolute value of visceral fat area measured on computed tomography scans and obesity-related cardiovascular risk factors in large-scale Japanese general population (the VACATION-J study)","volume":"44","author":"Hiuge-Shimizu","year":"2012","journal-title":"Ann Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib61","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2015.01.061","article-title":"Body fat distribution and incident cardiovascular disease in obese adults","volume":"65","author":"Neeland","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib62","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1210\/edrv.21.6.0415","article-title":"Subcutaneous and visceral adipose tissue: their relation to the metabolic syndrome","volume":"21","author":"Wajchenberg","year":"2000","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(20)30110-8_bib63","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(20)30110-8_bib64","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1038\/s41591-019-0563-7","article-title":"Contribution of genetics to visceral adiposity and its relation to cardiovascular and metabolic disease","volume":"25","author":"Karlsson","year":"2019","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib65","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2337\/dc13-1353","article-title":"Structural and functional properties of deep abdominal subcutaneous adipose tissue explain its association with insulin resistance and cardiovascular risk in men","volume":"37","author":"Marinou","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30110-8_bib66","doi-asserted-by":"crossref","first-page":"1785","DOI":"10.1002\/oby.22210","article-title":"Body composition profiling in the UK biobank imaging study","volume":"26","author":"Linge","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30110-8_bib67","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1161\/01.CIR.102.2.179","article-title":"Hypertriglyceridemic waist: a marker of the atherogenic metabolic triad (hyperinsulinemia; hyperapolipoprotein B; small, dense LDL) in men?","volume":"102","author":"Lemieux","year":"2000","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(20)30110-8_bib68","article-title":"Long-term risk of incident type 2 diabetes and measures of overall and regional obesity: the EPIC-InterAct case-cohort study","volume":"9","author":"Langenberg","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib69","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1467-789X.2012.01051.x","article-title":"A systematic review of the impact of including both waist and hip circumference in risk models for cardiovascular diseases, diabetes and mortality","volume":"14","author":"Cameron","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(20)30110-8_bib70","doi-asserted-by":"crossref","first-page":"2373","DOI":"10.1161\/CIRCULATIONAHA.116.026560","article-title":"Causal associations of adiposity and body fat distribution with coronary heart disease, stroke subtypes, and type 2 diabetes mellitus: a mendelian randomization analysis","volume":"135","author":"Dale","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(20)30110-8_bib71","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1001\/jama.2016.21042","article-title":"Genetic association of waist-to-hip ratio with cardiometabolic traits, type 2 diabetes, and coronary heart disease","volume":"317","author":"Emdin","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30110-8_bib72","article-title":"A joint view on genetic variants for adiposity differentiates subtypes with distinct metabolic implications","volume":"9","author":"Winkler","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(20)30110-8_bib73","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.gde.2018.02.009","article-title":"The genetics of adiposity","volume":"50","author":"Loos","year":"2018","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/S2213-8587(20)30110-8_bib74","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ng.2385","article-title":"Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways","volume":"44","author":"Scott","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(20)30110-8_bib75","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1038\/ng.2274","article-title":"A genome-wide approach accounting for body mass index identifies genetic variants influencing fasting glycemic traits and insulin resistance","volume":"44","author":"Manning","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(20)30110-8_bib76","doi-asserted-by":"crossref","first-page":"4378","DOI":"10.2337\/db14-0319","article-title":"Common genetic variants highlight the role of insulin resistance and body fat distribution in type 2 diabetes, independent of obesity","volume":"63","author":"Scott","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30110-8_bib77","doi-asserted-by":"crossref","first-page":"4369","DOI":"10.2337\/db14-0318","article-title":"Genetic evidence for a normal-weight \u201cmetabolically obese\u201d phenotype linking insulin resistance, hypertension, coronary artery disease, and type 2 diabetes","volume":"63","author":"Yaghootkar","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30110-8_bib78","doi-asserted-by":"crossref","first-page":"2448","DOI":"10.2337\/db15-1671","article-title":"Genetic evidence for a link between favorable adiposity and lower risk of type 2 diabetes, hypertension, and heart disease","volume":"65","author":"Yaghootkar","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30110-8_bib79","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ng.3714","article-title":"Integrative genomic analysis implicates limited peripheral adipose storage capacity in the pathogenesis of human insulin resistance","volume":"49","author":"Lotta","year":"2017","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(20)30110-8_bib80","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2337\/db18-0708","article-title":"Genome-wide and abdominal MRI data provide evidence that a genetically determined favorable adiposity phenotype is characterized by lower ectopic liver fat and lower risk of type 2 diabetes, heart disease, and hypertension","volume":"68","author":"Ji","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30110-8_bib81","doi-asserted-by":"crossref","first-page":"2553","DOI":"10.1001\/jama.2018.19329","article-title":"Association of genetic variants related to gluteofemoral vs abdominal fat distribution with type 2 diabetes, coronary disease, and cardiovascular risk factors","volume":"320","author":"Lotta","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30110-8_bib82","doi-asserted-by":"crossref","first-page":"e2029","DOI":"10.1210\/jc.2011-1576","article-title":"Reduced gluteal expression of adipogenic and lipogenic genes in black South African women is associated with obesity-related insulin resistance","volume":"96","author":"Goedecke","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib83","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1016\/j.celrep.2018.09.069","article-title":"Transforming growth factor-\u03b23 regulates adipocyte number in subcutaneous white adipose tissue","volume":"25","author":"Petrus","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/S2213-8587(20)30110-8_bib84","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.2337\/db15-1213","article-title":"Adipose cell size and regional fat deposition as predictors of metabolic response to overfeeding in insulin-resistant and insulin-sensitive humans","volume":"65","author":"McLaughlin","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30110-8_bib85","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1038\/nm.3324","article-title":"Tracking adipogenesis during white adipose tissue development, expansion and regeneration","volume":"19","author":"Wang","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib86","doi-asserted-by":"crossref","first-page":"18226","DOI":"10.1073\/pnas.1005259107","article-title":"Regional differences in cellular mechanisms of adipose tissue gain with overfeeding","volume":"107","author":"Tchoukalova","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(20)30110-8_bib87","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.metabol.2003.11.012","article-title":"Comparison of proliferation and differentiation capacity of human adipocyte precursor cells from the omental and subcutaneous adipose tissue depot of obese subjects","volume":"53","author":"Van Harmelen","year":"2004","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(20)30110-8_bib88","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1016\/j.mce.2014.11.029","article-title":"The sexual dimorphism of obesity","volume":"402","author":"Palmer","year":"2015","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib89","doi-asserted-by":"crossref","first-page":"1869","DOI":"10.1210\/jc.2003-031327","article-title":"Estrogen controls lipolysis by up-regulating alpha2A-adrenergic receptors directly in human adipose tissue through the estrogen receptor alpha. Implications for the female fat distribution","volume":"89","author":"Pedersen","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib90","doi-asserted-by":"crossref","first-page":"34797","DOI":"10.1074\/jbc.M005210200","article-title":"Expression of human alpha 2-adrenergic receptors in adipose tissue of beta 3-adrenergic receptor-deficient mice promotes diet-induced obesity","volume":"275","author":"Valet","year":"2000","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(20)30110-8_bib91","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1177\/153537020422901107","article-title":"Role of estrogens in adipocyte development and function","volume":"229","author":"Cooke","year":"2004","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/S2213-8587(20)30110-8_bib92","doi-asserted-by":"crossref","first-page":"C1645","DOI":"10.1152\/ajpcell.1998.274.6.C1645","article-title":"Androgen receptors in human preadipocytes and adipocytes: regional specificities and regulation by sex steroids","volume":"274","author":"Dieudonne","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib93","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1006\/bbrc.1995.1016","article-title":"Enhancement of the expression of the alpha 2-adrenoreceptor protein and mRNA by a direct effect of androgens in white adipocytes","volume":"206","author":"Pecquery","year":"1995","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(20)30110-8_bib94","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.mce.2008.10.035","article-title":"Androgen metabolism in adipose tissue: recent advances","volume":"301","author":"Blouin","year":"2009","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib95","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.mce.2008.08.019","article-title":"Effects of dihydrotestosterone on differentiation and proliferation of human mesenchymal stem cells and preadipocytes","volume":"296","author":"Gupta","year":"2008","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib96","doi-asserted-by":"crossref","first-page":"657","DOI":"10.1530\/eje.0.1430657","article-title":"Anthropometric, computed tomography and fat cell data in an obese population: relationship with insulin, leptin, tumor necrosis factor-alpha, sex hormone-binding globulin and sex hormones","volume":"143","author":"Garaulet","year":"2000","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib97","doi-asserted-by":"crossref","first-page":"861","DOI":"10.2337\/diacare.27.4.861","article-title":"Association of bioavailable, free, and total testosterone with insulin resistance: influence of sex hormone-binding globulin and body fat","volume":"27","author":"Tsai","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30110-8_bib98","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1080\/tam.6.1.1.7","article-title":"Testosterone supplementation in men with type 2 diabetes, visceral obesity and partial androgen deficiency","volume":"6","author":"Boyanov","year":"2003","journal-title":"Aging Male"},{"key":"10.1016\/S2213-8587(20)30110-8_bib99","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1038\/nrendo.2009.78","article-title":"The future of obesity reduction: beyond weight loss","volume":"5","author":"Ross","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib100","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cmet.2016.02.005","article-title":"Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity","volume":"23","author":"Magkos","year":"2016","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib101","doi-asserted-by":"crossref","first-page":"e34","DOI":"10.1056\/NEJMoa1800389","article-title":"Primary prevention of cardiovascular disease with a Mediterranean diet supplemented with extra-virgin olive oil or nuts","volume":"378","author":"Estruch","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib102","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S2213-8587(19)30074-9","article-title":"Effect of a high-fat Mediterranean diet on bodyweight and waist circumference: a prespecified secondary outcomes analysis of the PREDIMED randomised controlled trial","volume":"7","author":"Estruch","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib103","doi-asserted-by":"crossref","first-page":"3149","DOI":"10.1172\/JCI119870","article-title":"Activators of peroxisome proliferator-activated receptor gamma have depot-specific effects on human preadipocyte differentiation","volume":"100","author":"Adams","year":"1997","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(20)30110-8_bib104","doi-asserted-by":"crossref","first-page":"926","DOI":"10.1038\/oby.2009.380","article-title":"Pioglitazone increases the proportion of small cells in human abdominal subcutaneous adipose tissue","volume":"18","author":"McLaughlin","year":"2010","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30110-8_bib105","doi-asserted-by":"crossref","first-page":"770","DOI":"10.1097\/00002030-200303280-00022","article-title":"Glitazones in lipodystrophy syndrome induced by highly active antiretroviral therapy","volume":"17","author":"Calmy","year":"2003","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(20)30110-8_bib106","doi-asserted-by":"crossref","first-page":"1199","DOI":"10.1016\/j.metabol.2013.04.014","article-title":"Adipokines in the HIV\/HAART-associated lipodystrophy syndrome","volume":"62","author":"Paruthi","year":"2013","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(20)30110-8_bib107","first-page":"171","article-title":"Thiazolidinediones in the treatment of HIV\/HAART-associated lipodystrophy syndrome","volume":"15","author":"Edgeworth","year":"2013","journal-title":"AIDS Rev"},{"key":"10.1016\/S2213-8587(20)30110-8_bib108","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1016\/S0140-6736(04)15489-5","article-title":"No effect of rosiglitazone for treatment of HIV-1 lipoatrophy: randomised, double-blind, placebo-controlled trial","volume":"363","author":"Carr","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30110-8_bib109","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1086\/427697","article-title":"Improvement in highly active antiretroviral therapy-induced metabolic syndrome by treatment with pioglitazone but not with fenofibrate: a 2\u2008\u00d7\u20082 factorial, randomized, double-blinded, placebo-controlled trial","volume":"40","author":"Gavrila","year":"2005","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(20)30110-8_bib110","doi-asserted-by":"crossref","DOI":"10.7326\/L19-0635","article-title":"Lipodystrophic nonalcoholic fatty liver disease induced by immune checkpoint blockade","author":"Eigentler","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib111","doi-asserted-by":"crossref","first-page":"2784","DOI":"10.1210\/jcem.87.6.8567","article-title":"Effect of pioglitazone on abdominal fat distribution and insulin sensitivity in type 2 diabetic patients","volume":"87","author":"Miyazaki","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib112","doi-asserted-by":"crossref","first-page":"4438","DOI":"10.1210\/jc.2013-2920","article-title":"Effects of pioglitazone on visceral fat metabolic activity in impaired glucose tolerance or type 2 diabetes mellitus","volume":"98","author":"Kodama","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib113","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1016\/S2213-8587(19)30343-2","article-title":"Cushing's disease-from Minnie G to key issues in the early 21st century","volume":"7","author":"Kelsall","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib114","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1016\/S2213-8587(16)00086-3","article-title":"Complications of Cushing's syndrome: state of the art","volume":"4","author":"Pivonello","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib115","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1210\/jcem.86.3.7453","article-title":"Tissue-specific dysregulation of cortisol metabolism in human obesity","volume":"86","author":"Rask","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib116","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1055\/s-2002-38256","article-title":"Depot-specific hormonal characteristics of subcutaneous and visceral adipose tissue and their relation to the metabolic syndrome","volume":"34","author":"Wajchenberg","year":"2002","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(20)30110-8_bib117","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1210\/er.2012-1050","article-title":"11\u03b2-Hydroxysteroid dehydrogenase 1: translational and therapeutic aspects","volume":"34","author":"Gathercole","year":"2013","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(20)30110-8_bib118","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/S0140-6736(96)11222-8","article-title":"Does central obesity reflect \u201cCushing's disease of the omentum\u201d?","volume":"349","author":"Bujalska","year":"1997","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30110-8_bib119","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1210\/jcem-71-5-1215","article-title":"Steroid hormone receptors in human adipose tissues","volume":"71","author":"Rebuff\u00e9-Scrive","year":"1990","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30110-8_bib120","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1172\/JCI116821","article-title":"Lipoprotein lipase regulation by insulin and glucocorticoid in subcutaneous and omental adipose tissues of obese women and men","volume":"92","author":"Fried","year":"1993","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(20)30110-8_bib121","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1016\/S2213-8587(13)70170-0","article-title":"Inhibition of 11\u03b2-HSD1 with RO5093151 for non-alcoholic fatty liver disease: a multicentre, randomised, double-blind, placebo-controlled trial","volume":"2","author":"Stefan","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30110-8_bib122","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1001\/jama.292.2.210","article-title":"Growth hormone-releasing hormone in HIV-infected men with lipodystrophy: a randomized controlled trial","volume":"292","author":"Koutkia","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30110-8_bib123","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1097\/01.aids.0000180099.35146.30","article-title":"A placebo-controlled, dose-ranging study of a growth hormone releasing factor in HIV-infected patients with abdominal fat accumulation","volume":"19","author":"Falutz","year":"2005","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(20)30110-8_bib124","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1001\/jama.300.5.509","article-title":"Low-dose physiological growth hormone in patients with HIV and abdominal fat accumulation: a randomized controlled trial","volume":"300","author":"Lo","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30110-8_bib125","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1056\/NEJMoa072375","article-title":"Metabolic effects of a growth hormone-releasing factor in patients with HIV","volume":"357","author":"Falutz","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30110-8_bib126","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1001\/jama.2014.8334","article-title":"Effect of tesamorelin on visceral fat and liver fat in HIV-infected patients with abdominal fat accumulation: a randomized clinical trial","volume":"312","author":"Stanley","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30110-8_bib127","doi-asserted-by":"crossref","first-page":"e821","DOI":"10.1016\/S2352-3018(19)30338-8","article-title":"Effects of tesamorelin on non-alcoholic fatty liver disease in HIV: a randomised, double-blind, multicentre trial","volume":"6","author":"Stanley","year":"2019","journal-title":"Lancet HIV"},{"key":"10.1016\/S2213-8587(20)30110-8_bib128","doi-asserted-by":"crossref","first-page":"e808","DOI":"10.1016\/S2352-3018(19)30331-5","article-title":"Tesamorelin, liver fat, and NAFLD in the setting of HIV","volume":"6","author":"Audsley","year":"2019","journal-title":"Lancet HIV"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:51Z","timestamp":1761991731000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301108"}},"issued":{"date-parts":[[2020,7]]},"references-count":128,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2213858720301108"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30110-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Causes, consequences, and treatment of metabolically unhealthy fat distribution","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30110-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,20]],"date-time":"2026-10-20T19:30:03Z","timestamp":1792524603042,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/s2213-8587(15)00121-7","type":"journal-article","created":{"date-parts":[[2015,7,12]],"date-time":"2015-07-12T19:46:18Z","timestamp":1436730378000},"page":"615-623","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial"],"prefix":"10.1016","volume":"3","author":[{"given":"Saloua","family":"El Messaoudi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rianne","family":"Nederlof","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coert J","family":"Zuurbier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry A","family":"van Swieten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Pickkers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc","family":"Noyez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik-Jan","family":"Dieker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke J","family":"Coenen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Rogier T","family":"Donders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annemieke","family":"Vos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerard A","family":"Rongen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels P","family":"Riksen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00121-7_bib1","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1001\/jamainternmed.2013.12844","article-title":"Coronary artery bypass grafting vs percutaneous coronary intervention and long-term mortality and morbidity in multivessel disease: meta-analysis of randomized clinical trials of the arterial grafting and stenting era","volume":"174","author":"Sipahi","year":"2014","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(15)00121-7_bib2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1161\/CIRCULATIONAHA.113.007253","article-title":"Troponin T and B-type natriuretic peptide after on-pump cardiac surgery: prognostic impact on 12-month mortality and major cardiac events after adjustment for postoperative complications","volume":"130","author":"Lurati Buse","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(15)00121-7_bib3","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1001\/jama.2011.99","article-title":"Association of myocardial enzyme elevation and survival following coronary artery bypass graft surgery","volume":"305","author":"Domanski","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00121-7_bib4","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S0140-6736(12)60916-7","article-title":"Cardioprotection: chances and challenges of its translation to the clinic","volume":"381","author":"Heusch","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00121-7_bib5","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MOL.0b013e32834ae1a7","article-title":"The cardioprotective effects of metformin","volume":"22","author":"El Messaoudi","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(15)00121-7_bib6","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1007\/s10557-012-6425-x","article-title":"Chronic metformin associated cardioprotection against infarction: not just a glucose lowering phenomenon","volume":"27","author":"Whittington","year":"2013","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/S2213-8587(15)00121-7_bib7","doi-asserted-by":"crossref","first-page":"696","DOI":"10.2337\/db07-1098","article-title":"Acute metformin therapy confers cardioprotection against myocardial infarction via AMPK-eNOS-mediated signaling","volume":"57","author":"Calvert","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(15)00121-7_bib8","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1007\/s00395-007-0691-y","article-title":"Metformin protects the ischemic heart by the Akt-mediated inhibition of mitochondrial permeability transition pore opening","volume":"103","author":"Bhamra","year":"2008","journal-title":"Basic Res Cardiol"},{"key":"10.1016\/S2213-8587(15)00121-7_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/FJC.0b013e31819fd4e7","article-title":"Metformin prevents myocardial reperfusion injury by activating the adenosine receptor","volume":"53","author":"Paiva","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/S2213-8587(15)00121-7_bib10","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00121-7_bib11","doi-asserted-by":"crossref","first-page":"1304","DOI":"10.2337\/dc12-0719","article-title":"Effects of metformin versus glipizide on cardiovascular outcomes in patients with type 2 diabetes and coronary artery disease","volume":"36","author":"Hong","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00121-7_bib12","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1093\/bja\/aeu259","article-title":"Perioperative management of diabetic patients: new controversies","volume":"113","author":"Aldam","year":"2014","journal-title":"Br J Anaesth"},{"key":"10.1016\/S2213-8587(15)00121-7_bib13","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1213\/01.ane.0000242532.42656.e7","article-title":"Recent metformin ingestion does not increase in-hospital morbidity or mortality after cardiac surgery","volume":"104","author":"Duncan","year":"2007","journal-title":"Anesth Analg"},{"key":"10.1016\/S2213-8587(15)00121-7_bib14","doi-asserted-by":"crossref","first-page":"1085","DOI":"10.1093\/eurheartj\/ehm032","article-title":"Augmented hyperaemia and reduced tissue injury in response to ischaemia in subjects with the 34C > T variant of the AMPD1 gene","volume":"28","author":"Riksen","year":"2007","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(15)00121-7_bib15","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.2337\/diacare.27.6.1487","article-title":"Use and abuse of HOMA modeling","volume":"27","author":"Wallace","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00121-7_bib16","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1161\/01.RES.77.5.1030","article-title":"Does ischemic preconditioning in the human involve protein kinase C and the ATP-dependent K+ channel? Studies of contractile function after simulated ischemia in an atrial in vitro model","volume":"77","author":"Speechly-Dick","year":"1995","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(15)00121-7_bib17","doi-asserted-by":"crossref","first-page":"575","DOI":"10.1016\/S0140-6736(07)61296-3","article-title":"Effect of remote ischaemic preconditioning on myocardial injury in patients undergoing coronary artery bypass graft surgery: a randomised controlled trial","volume":"370","author":"Hausenloy","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00121-7_bib18","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1007\/s10557-013-6504-7","article-title":"Chronic metformin treatment is associated with reduced myocardial infarct size in diabetic patients with ST-segment elevation myocardial infarction","volume":"28","author":"Lexis","year":"2014","journal-title":"Cardiovasc Drugs Ther"},{"key":"10.1016\/S2213-8587(15)00121-7_bib19","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1159\/000355574","article-title":"Protective effect of metformin on myocardial injury in metabolic syndrome patients following percutaneous coronary intervention","volume":"127","author":"Li","year":"2014","journal-title":"Cardiology"},{"key":"10.1016\/S2213-8587(15)00121-7_bib20","doi-asserted-by":"crossref","first-page":"e96062","DOI":"10.1371\/journal.pone.0096062","article-title":"Impact of metformin on endothelial ischemia-reperfusion injury in humans in vivo: a prospective randomized open, blinded-endpoint study","volume":"9","author":"El Messaoudi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(15)00121-7_bib21","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S2213-8587(13)70152-9","article-title":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial","volume":"2","author":"Preiss","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00121-7_bib22","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1001\/jama.2014.3315","article-title":"Effect of metformin on left ventricular function after acute myocardial infarction in patients without diabetes: the GIPS-III randomized clinical trial","volume":"311","author":"Lexis","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(15)00121-7_bib23","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1124\/pr.113.008300","article-title":"Interaction of risk factors, comorbidities, and comedications with ischemia\/reperfusion injury and cardioprotection by preconditioning, postconditioning, and remote conditioning","volume":"66","author":"Ferdinandy","year":"2014","journal-title":"Pharmacol Rev"},{"key":"10.1016\/S2213-8587(15)00121-7_bib24","doi-asserted-by":"crossref","first-page":"845698","DOI":"10.1155\/2012\/845698","article-title":"The diabetic heart: too sweet for its own good?","volume":"2012","author":"Whittington","year":"2012","journal-title":"Cardiol Res Pract"},{"key":"10.1016\/S2213-8587(15)00121-7_bib25","doi-asserted-by":"crossref","first-page":"H1727","DOI":"10.1152\/ajpheart.00054.2013","article-title":"Aging attenuates the protective effect of ischemic preconditioning against endothelial ischemia-reperfusion injury in humans","volume":"304","author":"van den Munckhof","year":"2013","journal-title":"Am J Physiolog Heart Circ Physiol"},{"key":"10.1016\/S2213-8587(15)00121-7_bib26","doi-asserted-by":"crossref","first-page":"2067","DOI":"10.1111\/bph.12363","article-title":"Targeting hexokinase II to mitochondria to modulate energy metabolism and reduce ischaemia-reperfusion injury in heart","volume":"171","author":"Nederlof","year":"2014","journal-title":"Br J Pharmacol"},{"key":"10.1016\/S2213-8587(15)00121-7_bib27","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1161\/CIRCRESAHA.108.186429","article-title":"Ischemic postconditioning in pigs: no causal role for RISK activation","volume":"104","author":"Skyschally","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(15)00121-7_bib28","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1016\/S0735-1097(00)00850-0","article-title":"A common variant of the AMPD1 gene predicts improved cardiovascular survival in patients with coronary artery disease","volume":"36","author":"Anderson","year":"2000","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(15)00121-7_bib29","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.1365-2265.2010.03891.x","article-title":"Diabetes, metformin and lactic acidosis","volume":"74","author":"Scale","year":"2011","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(15)00121-7_bib30","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1053\/j.ajkd.2010.07.014","article-title":"Effect of remote ischemic preconditioning on acute kidney injury in nondiabetic patients undergoing coronary artery bypass graft surgery: a secondary analysis of 2 small randomized trials","volume":"56","author":"Venugopal","year":"2010","journal-title":"Am J Kidney Dis"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001217?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001217?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,7,17]],"date-time":"2019-07-17T00:07:14Z","timestamp":1563322034000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715001217"}},"issued":{"date-parts":[[2015,8]]},"references-count":30,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S2213858715001217"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00121-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725669310.793559015","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of metformin pretreatment on myocardial injury during coronary artery bypass surgery in patients without diabetes (MetCAB): a double-blind, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00121-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00209-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,16]],"date-time":"2026-10-16T21:06:49Z","timestamp":1792184809210,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/s2213-8587(15)00036-4","type":"journal-article","created":{"date-parts":[[2015,4,12]],"date-time":"2015-04-12T19:45:13Z","timestamp":1428867913000},"page":"307-308","source":"Crossref","is-referenced-by-count":9,"title":["Growth hormone replacement therapy and fracture risk"],"prefix":"10.1016","volume":"3","author":[{"given":"Andrea","family":"Giustina","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gherardo","family":"Mazziotti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00036-4_bib1","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1210\/er.2007-0036","article-title":"Growth hormone, insulin-like growth factors, and the skeleton","volume":"29","author":"Giustina","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(15)00036-4_bib2","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1210\/jc.2013-2394","article-title":"Cardiovascular risk in adult patients with growth hormone (GH) deficiency and following substitution with GH--an update","volume":"99","author":"Gazzaruso","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00036-4_bib3","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1359\/jbmr.070811","article-title":"Fracture incidence in GH-deficient patients on complete hormone replacement including GH","volume":"22","author":"Holmer","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(15)00036-4_bib4","doi-asserted-by":"crossref","first-page":"520","DOI":"10.1359\/jbmr.060112","article-title":"Increased prevalence of radiological spinal deformities in adult patients with GH deficiency: influence of GH replacement therapy","volume":"21","author":"Mazziotti","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(15)00036-4_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00098-4","article-title":"Fracture risk in adult patients treated with growth hormone replacement therapy for growth hormone deficiency: a prospective observational cohort study","author":"Mo","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00036-4_bib6","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/er.2001-9002","article-title":"Meta-analyses of therapies for postmenopausal osteoporosis. IX: Summary of meta-analyses of therapies for postmenopausal osteoporosis","volume":"23","author":"Cranney","year":"2002","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(15)00036-4_bib7","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1007\/s12020-011-9570-2","article-title":"New understanding and treatments for osteoporosis","volume":"41","author":"Mazziotti","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(15)00036-4_bib8","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1038\/ncpendmet0588","article-title":"Does growth hormone replacement therapy improve cardiac function?","volume":"3","author":"Giustina","year":"2007","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00036-4_bib9","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s12020-012-9691-2","article-title":"New advances in imaging osteoporosis and its complications","volume":"42","author":"Griffith","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(15)00036-4_bib10","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1530\/EJE-10-0125","article-title":"Glucocorticoid replacement therapy and vertebral fractures in hypopituitary adult males with GH deficiency","volume":"163","author":"Mazziotti","year":"2010","journal-title":"Eur J Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000364?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000364?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T10:53:00Z","timestamp":1537699980000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000364"}},"issued":{"date-parts":[[2015,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S2213858715000364"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00036-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,5]]}},{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:31Z","timestamp":1792097371663,"version":"4.4.0"},"reference-count":3,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100010874","name":"ASBMR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010874","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/s2213-8587(26)00246-9","type":"journal-article","created":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:50:10Z","timestamp":1791931810000},"page":"877","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Bone mineral density as a surrogate endpoint in osteoporosis trials"],"prefix":"10.1016","volume":"14","author":[{"given":"Richard","family":"Eastell","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L","family":"Bouxsein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis M","family":"Black","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00246-9_bib1","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/S2213-8587(26)00123-3","article-title":"Goal-directed osteoporosis treatment: are bone mineral density targets valid?","volume":"14","author":"Reid","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00246-9_bib2","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/j.jval.2016.10.011","article-title":"Time to review the role of surrogate end points in health policy: state of the art and the way forward","volume":"20","author":"Ciani","year":"2017","journal-title":"Value Health"},{"key":"10.1016\/S2213-8587(26)00246-9_bib3","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S2213-8587(20)30159-5","article-title":"Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials","volume":"8","author":"Black","year":"2020","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002469?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002469?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:17Z","timestamp":1792096877000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726002469"}},"issued":{"date-parts":[[2026,11]]},"references-count":3,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2213858726002469"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00246-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone mineral density as a surrogate endpoint in osteoporosis trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00246-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00123-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00247-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:49:43Z","timestamp":1792097383775,"version":"4.4.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004325","name":"AstraZeneca PLC","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/s2213-8587(26)00188-9","type":"journal-article","created":{"date-parts":[[2026,9,7]],"date-time":"2026-09-07T22:48:34Z","timestamp":1788821314000},"page":"927-951","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Hypoparathyroidism: translating science from the laboratory to the clinic"],"prefix":"10.1016","volume":"14","author":[{"given":"Maria Luisa","family":"Brandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hajar","family":"AbuAlrob","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wenhan","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart L","family":"Clarke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael T","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"DiMarchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Gardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Gorvin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diane","family":"Krause","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael A","family":"Levine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Mannstadt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francesca","family":"Marini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelly","family":"Roszko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heide","family":"Siggelkow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karen K","family":"Winer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hao","family":"Zuo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aliya A","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00188-9_bib1","doi-asserted-by":"crossref","first-page":"2568","DOI":"10.1002\/jbmr.4691","article-title":"Evaluation and management of hypoparathyroidism summary statement and guidelines from the second international workshop","volume":"37","author":"Khan","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib2","doi-asserted-by":"crossref","first-page":"2663","DOI":"10.1002\/jbmr.4716","article-title":"Management of hypoparathyroidism","volume":"37","author":"Khan","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156335","article-title":"Best practice recommendations for the diagnosis and management of hypoparathyroidism","volume":"171","author":"Khan","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(26)00188-9_bib4","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2024.55251","article-title":"Use of albumin-adjusted calcium measurements in clinical practice","volume":"8","author":"Desgagn\u00e9s","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(26)00188-9_bib5","doi-asserted-by":"crossref","first-page":"L3","DOI":"10.1093\/ejendo\/lvaf258","article-title":"\u201cAlbumin-adjusted\u201d calcemia: time to move on for chronic hypoparathyroidism patients?","volume":"194","author":"Bertocchio","year":"2026","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib6","doi-asserted-by":"crossref","first-page":"L6","DOI":"10.1093\/ejendo\/lvaf262","article-title":"Use of total calcium in hypoparathyroidism: a pragmatic approach but with limitations","volume":"194","author":"Pilz","year":"2026","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib7","doi-asserted-by":"crossref","first-page":"2615","DOI":"10.1002\/jbmr.4667","article-title":"Hypoparathyroidism: genetics and diagnosis","volume":"37","author":"Mannstadt","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib8","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1530\/EJE-17-0589","article-title":"Time to parathyroid function recovery in patients with protracted hypoparathyroidism after total thyroidectomy","volume":"178","author":"Villarroya-Marquina","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib9","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1089\/thy.2014.0500","article-title":"Recovery from permanent hypoparathyroidism after total thyroidectomy","volume":"25","author":"Kim","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(26)00188-9_bib10","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1055\/a-1608-1373","article-title":"Late recovery of parathyroid function after total thyroidectomy: a case-control study","volume":"53","author":"D\u00edez","year":"2021","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib11","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1007\/s12020-025-04330-8","article-title":"Late remission and \u201clate onset\u201d of hypoparathyroidism after total and completion thyroidectomy: a retrospective cohort study of 1060 patients from a tertiary referral center","volume":"90","author":"Michaelsen","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(26)00188-9_bib12","doi-asserted-by":"crossref","first-page":"2284","DOI":"10.1210\/jc.2015-3908","article-title":"Epidemiology and diagnosis of hypoparathyroidism","volume":"101","author":"Clarke","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib13","doi-asserted-by":"crossref","DOI":"10.1002\/ccr3.6288","article-title":"Hypoparathyroidism as one of the initial presentations of systemic lupus erythematosus","volume":"10","author":"Gadakchi","year":"2022","journal-title":"Clin Case Rep"},{"key":"10.1016\/S2213-8587(26)00188-9_bib14","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1210\/jc.2003-031054","article-title":"Activating antibodies to the calcium-sensing receptor in two patients with autoimmune hypoparathyroidism","volume":"89","author":"Kifor","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib15","doi-asserted-by":"crossref","first-page":"4749","DOI":"10.1210\/jc.2009-1080","article-title":"Activating autoantibodies against the calcium-sensing receptor detected in two patients with autoimmune polyendocrine syndrome type 1","volume":"94","author":"Kemp","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib16","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1056\/NEJMoa2312665","article-title":"The role of interferon-\u03b3 in autoimmune polyendocrine syndrome type 1","volume":"390","author":"Oikonomou","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00188-9_bib17","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.88782","article-title":"Redefined clinical features and diagnostic criteria in autoimmune polyendocrinopathy-candidiasis-ectodermal dystrophy","volume":"1","author":"Ferre","year":"2016","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(26)00188-9_bib18","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1056\/NEJMoa0706487","article-title":"Autoimmune polyendocrine syndrome type 1 and NALP5, a parathyroid autoantigen","volume":"358","author":"Alimohammadi","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00188-9_bib19","doi-asserted-by":"crossref","DOI":"10.1530\/EC-25-0337","article-title":"Point-of-care ionised calcium testing: lab validation and clinical feasibility study","volume":"14","author":"Garcia","year":"2025","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(26)00188-9_bib20","doi-asserted-by":"crossref","first-page":"297","DOI":"10.3390\/diagnostics13020297","article-title":"Analytical performances of the novel i-STAT alinity point-of-care analyzer","volume":"13","author":"Larcher","year":"2023","journal-title":"Diagnostics"},{"key":"10.1016\/S2213-8587(26)00188-9_bib21","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1007\/s12020-024-03807-2","article-title":"Quality of life in patients with hypoparathyroidism receiving standard treatment: an updated systematic review","volume":"85","author":"B\u00fcttner","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(26)00188-9_bib22","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1210\/jc.2017-01555","article-title":"PTH (1\u201334) for surgical hypoparathyroidism: a 2-year prospective, open-label investigation of efficacy and quality of life","volume":"103","author":"Palermo","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib23","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1007\/s00198-014-2677-6","article-title":"Effects of PTH(1-84) therapy on muscle function and quality of life in hypoparathyroidism: results from a randomized controlled trial","volume":"25","author":"Sikjaer","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(26)00188-9_bib24","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1210\/jc.2017-01471","article-title":"Recombinant human parathyroid hormone effect on health-related quality of life in adults with chronic hypoparathyroidism","volume":"103","author":"Vokes","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib25","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.1210\/jc.2018-02430","article-title":"Quality of life in hypoparathyroidism improves with rhPTH(1-84) throughout 8 years of therapy","volume":"104","author":"Tabacco","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib26","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1002\/jbmr.4726","article-title":"Efficacy and safety of parathyroid hormone replacement with TransCon PTH in hypoparathyroidism: 26-week results from the phase 3 Pathway trial","volume":"38","author":"Khan","year":"2023","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib27","doi-asserted-by":"crossref","first-page":"R33","DOI":"10.1530\/EJE-21-1044","article-title":"European Expert Consensus on Practical Management of Specific Aspects of Parathyroid Disorders in Adults and in Pregnancy: recommendations of the ESE Educational Program of Parathyroid Disorders","volume":"186","author":"Bollerslev","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib28","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41574-024-01075-8","article-title":"Hypoparathyroidism: diagnosis, management and emerging therapies","volume":"21","author":"Khan","year":"2025","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib30","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10368","article-title":"Quantification of symptom load by a disease-specific questionnaire HPQ 28 and analysis of associated biochemical parameters in patients with postsurgical hypoparathyroidism","volume":"4","author":"Wilde","year":"2020","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(26)00188-9_bib31","article-title":"The HPQ-development and first administration of a questionnaire for hypoparathyroid patients","volume":"4","author":"Wilde","year":"2019","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(26)00188-9_bib32","doi-asserted-by":"crossref","first-page":"1999","DOI":"10.1007\/s12325-019-00999-2","article-title":"Development of a patient-reported outcome measure for chronic hypoparathyroidism","volume":"36","author":"Martin","year":"2019","journal-title":"Adv Ther"},{"key":"10.1016\/S2213-8587(26)00188-9_bib33","doi-asserted-by":"crossref","first-page":"25","DOI":"10.2147\/PROM.S179310","article-title":"Psychometric evaluation of the hypoparathyroidism symptom diary","volume":"10","author":"Coles","year":"2019","journal-title":"Patient Relat Outcome Meas"},{"key":"10.1016\/S2213-8587(26)00188-9_bib34","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s40271-019-00388-5","article-title":"Assessing the patient experience of hypoparathyroidism symptoms: development of the hypoparathyroidism patient experience scale-symptom (HPES-Symptom)","volume":"13","author":"Brod","year":"2020","journal-title":"Patient"},{"key":"10.1016\/S2213-8587(26)00188-9_bib35","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1007\/s11136-020-02607-1","article-title":"Living with hypoparathyroidism: development of the Hypoparathyroidism Patient Experience Scale-Impact (HPES-Impact)","volume":"30","author":"Brod","year":"2021","journal-title":"Qual Life Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib36","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1093\/jbmr\/zjae063","article-title":"Hypoparathyroidism: changes in brain structure, cognitive impairment, and reduced quality of life","volume":"39","author":"Sikjaer","year":"2024","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib37","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziaf011","article-title":"Adaptation and validation of the French version of the Hypoparathyroid Patient Questionnaire 28 (HPQ28) in the Compare-Epi-Hypo e-cohort","volume":"9","author":"Bertocchio","year":"2025","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(26)00188-9_bib38","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10586","article-title":"The influence of conventional treatment on symptoms and complaints in patients with chronic postsurgical hypoparathyroidism","volume":"6","author":"Stamm","year":"2022","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(26)00188-9_bib39","doi-asserted-by":"crossref","first-page":"e22","DOI":"10.1093\/pm\/pnz252","article-title":"Potential unintended effects of standardized pain questionnaires: a qualitative study","volume":"21","author":"De Silva","year":"2020","journal-title":"Pain Med"},{"key":"10.1016\/S2213-8587(26)00188-9_bib40","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1038\/nrm1154","article-title":"Extracellular calcium sensing and signalling","volume":"4","author":"Hofer","year":"2003","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1016\/j.beem.2013.05.010","article-title":"Calcium-sensing receptor (CaSR): pharmacological properties and signaling pathways","volume":"27","author":"Conigrave","year":"2013","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib42","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.1002\/jbmr.4659","article-title":"Autosomal dominant hypocalcemia type 1: a systematic review","volume":"37","author":"Roszko","year":"2022","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib43","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1056\/NEJMc1300278","article-title":"Germline mutations affecting G\u03b111 in hypoparathyroidism","volume":"368","author":"Mannstadt","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00188-9_bib44","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1210\/clinem\/dgae769","article-title":"CASRdb: a publicly accessible comprehensive database for disease-associated calcium-sensing receptor variants","volume":"110","author":"Charoenngam","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib45","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1093\/jbmr\/zjae199","article-title":"An activating calcium-sensing receptor variant with biased signaling reveals a critical residue for G\u03b111 coupling","volume":"40","author":"Benson","year":"2025","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib46","doi-asserted-by":"crossref","first-page":"13566","DOI":"10.1073\/pnas.0405516101","article-title":"Activating calcium-sensing receptor mutation in the mouse is associated with cataracts and ectopic calcification","volume":"101","author":"Hough","year":"2004","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(26)00188-9_bib47","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1002\/jbmr.2551","article-title":"Calcilytic ameliorates abnormalities of mutant calcium-sensing receptor (CaSR) knock-in mice mimicking autosomal dominant hypocalcemia (ADH)","volume":"30","author":"Dong","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib48","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91103","article-title":"G\u03b111 mutation in mice causes hypocalcemia rectifiable by calcilytic therapy","volume":"2","author":"Gorvin","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(26)00188-9_bib49","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.91079","article-title":"Knockin mouse with mutant G\u03b111 mimics human inherited hypocalcemia and is rescued by pharmacologic inhibitors","volume":"2","author":"Roszko","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(26)00188-9_bib50","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10182","article-title":"Persistent activation of calcium-sensing receptor suppresses bone turnover, increases microcracks, and decreases bone strength","volume":"3","author":"Dong","year":"2019","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(26)00188-9_bib51","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/bs.pmch.2017.12.001","article-title":"Discovery and development of calcimimetic and calcilytic compounds","volume":"57","author":"Nemeth","year":"2018","journal-title":"Prog Med Chem"},{"key":"10.1016\/S2213-8587(26)00188-9_bib52","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa145","article-title":"A new therapeutic approach using a calcilytic (AXT914) for postsurgical hypoparathyroidism in female rats","volume":"161","author":"Lim","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(26)00188-9_bib53","doi-asserted-by":"crossref","first-page":"458","DOI":"10.3389\/fphys.2016.00458","article-title":"Autosomal dominant hypocalcemia (hypoparathyroidism) types 1 and 2","volume":"7","author":"Roszko","year":"2016","journal-title":"Front Physiol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib54","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0115178","article-title":"Amino alcohol- (NPS-2143) and quinazolinone-derived calcilytics (ATF936 and AXT914) differentially mitigate excessive signalling of calcium-sensing receptor mutants causing Bartter syndrome Type 5 and autosomal dominant hypocalcemia","volume":"9","author":"Letz","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00188-9_bib55","doi-asserted-by":"crossref","first-page":"3114","DOI":"10.1210\/en.2015-1269","article-title":"The Calcilytic agent NPS 2143 rectifies hypocalcemia in a mouse model with an activating calcium-sensing receptor (CaSR) mutation: relevance to autosomal dominant hypocalcemia type 1 (ADH1)","volume":"156","author":"Hannan","year":"2015","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(26)00188-9_bib56","doi-asserted-by":"crossref","first-page":"5387","DOI":"10.1016\/j.apsb.2025.07.044","article-title":"A novel chemoreactive calcilytic for the potential treatment of autosomal dominant hypocalcemia","volume":"15","author":"Dangerfield","year":"2025","journal-title":"Acta Pharm Sin B"},{"key":"10.1016\/S2213-8587(26)00188-9_bib57","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1056\/NEJMc2302708","article-title":"Efficacy and safety of encaleret in autosomal dominant hypocalcemia type 1","volume":"389","author":"Gafni","year":"2023","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(26)00188-9_bib58","article-title":"12\u2008520 preliminary findings from an ongoing open-label phase 2 study demonstrate that the calcilytic encaleret can improve the relationship between blood and urinary calcium in individuals with post-surgical hypoparathyroidism","volume":"8","author":"Hartley","year":"2024","journal-title":"J Endocr Soc"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(26)00188-9_bib59","article-title":"OR36-06 sustained normalization of mineral homeostasis in autosomal dominant hypocalcemia type 1: results from a phase 2 study over 42 months of encaleret (CLTX-305) treatment","volume":"9","author":"Gafni","year":"2025","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(26)00188-9_bib60","doi-asserted-by":"crossref","first-page":"e372","DOI":"10.1210\/clinem\/dgab577","article-title":"PaTH Forward: a randomized, double-blind, placebo-controlled phase 2 trial of TransCon PTH in adult hypoparathyroidism","volume":"107","author":"Khan","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib61","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1210\/clinem\/dgaf653","article-title":"Patient-reported outcomes in palopegteriparatide-treated adults with hypoparathyroidism: PaTH Forward trial extension","volume":"111","author":"Rubin","year":"2026","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.ando.2025.101912","article-title":"Efficacy and safety of palopegteriparatide treatment in adults with hypoparathyroidism: 3-year results from the phase 3 PaTHway trial","volume":"86","author":"Gagnon","year":"2025","journal-title":"Annales d'Endocrinologie"},{"key":"10.1016\/S2213-8587(26)00188-9_bib63","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.1007\/s12325-024-02843-8","article-title":"Palopegteriparatide treatment improves renal function in adults with chronic hypoparathyroidism: 1-year results from the phase 3 PaTHway trial","volume":"41","author":"Rejnmark","year":"2024","journal-title":"Adv Ther"},{"key":"10.1016\/S2213-8587(26)00188-9_bib64","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1210\/clinem\/dgae693","article-title":"Efficacy and safety of TransCon PTH in adults with hypoparathyroidism: 52-week results from the phase 3 PaTHway trial","volume":"110","author":"Clarke","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib65","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1210\/clinem\/dgae808","article-title":"MBX 2109, a once-weekly parathyroid hormone replacement therapy prodrug: phase 1, first-in-human, randomized trial","volume":"110","author":"Carney","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib66","author":"Hawryluk"},{"key":"10.1016\/S2213-8587(26)00188-9_bib67","doi-asserted-by":"crossref","DOI":"10.1530\/EC-24-0464","article-title":"Phase 1 clinical trial of eneboparatide, a novel PTH receptor 1 agonist","volume":"14","author":"Ovize","year":"2025","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(26)00188-9_bib68","doi-asserted-by":"crossref","first-page":"2199","DOI":"10.1210\/clinem\/dgae121","article-title":"An open-label phase 2 study of eneboparatide, a novel PTH receptor 1 agonist, in hypoparathyroidism","volume":"109","author":"Takacs","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib69","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1001\/jama.1996.03540080053029","article-title":"Synthetic human parathyroid hormone 1-34 vs calcitriol and calcium in the treatment of hypoparathyroidism","volume":"276","author":"Winer","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00188-9_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115977","article-title":"Therapy with PTH 1-34 or calcitriol and calcium in diverse etiologies of hypoparathyroidism over 27 years at a single tertiary care center","volume":"149","author":"Winer","year":"2021","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(26)00188-9_bib71","first-page":"391","article-title":"Synthetic human parathyroid hormone 1-34 replacement therapy: a randomized crossover trial comparing pump versus injections in the treatment of chronic hypoparathyroidism","volume":"97","author":"Winer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib72","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.jpeds.2014.04.060","article-title":"Effects of pump versus twice-daily injection delivery of synthetic parathyroid hormone 1-34 in children with severe congenital hypoparathyroidism","volume":"165","author":"Winer","year":"2014","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(26)00188-9_bib73","doi-asserted-by":"crossref","first-page":"4214","DOI":"10.1210\/jc.2002-021736","article-title":"Long-term treatment of hypoparathyroidism: a randomized controlled study comparing parathyroid hormone (1\u201334) versus calcitriol and calcium","volume":"88","author":"Winer","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib74","doi-asserted-by":"crossref","first-page":"2810","DOI":"10.1210\/clinem\/dgaf065","article-title":"Bone health and linear growth in children with familial hypoparathyroidism treated with human parathyroid hormone 1-34","volume":"110","author":"Winer","year":"2025","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00188-9_bib75","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvad043","article-title":"Long-term safety and efficacy of recombinant human parathyroid hormone (1-84) in adults with chronic hypoparathyroidism","volume":"7","author":"Watts","year":"2023","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(26)00188-9_bib76","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(13)70106-2","article-title":"Efficacy and safety of recombinant human parathyroid hormone (1-84) in hypoparathyroidism (REPLACE): a double-blind, placebo-controlled, randomised, phase 3 study","volume":"1","author":"Mannstadt","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib77","doi-asserted-by":"crossref","DOI":"10.1093\/jbmr\/zjag013","article-title":"Palopegteriparatide for adults with chronic hypoparathyroidism: skeletal dynamics through 3 years of the phase 2 PaTH Forward Trial","author":"Rubin","year":"2026","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib78","doi-asserted-by":"crossref","unstructured":"Brandi M. The safety and efficacy of eneboparatide, a parathyroid hormone 1 receptor agonist, in adults with chronic hypoparathyroidism: a phase 3, randomised, placebo-controlled study (CALYPSO). European Congress of Endocrinology; May 12, 2026.","DOI":"10.1093\/ejendo\/lvag096.144"},{"key":"10.1016\/S2213-8587(26)00188-9_bib79","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1002\/jbmr.4274","article-title":"Safety and efficacy of oral human parathyroid hormone (1\u201334) in hypoparathyroidism: an open-label study","volume":"36","author":"Ish-Shalom","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib80","article-title":"Long-term efficacy and safety of palopegteriparatide treatment in adults with chronic hypoparathyroidism: 4-year results from the phase 2 path forward trial","volume":"110","author":"Palermo","year":"2025","journal-title":"Endocrine Abstr"},{"key":"10.1016\/S2213-8587(26)00188-9_bib81","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1002\/jbmr.4016","article-title":"A randomized double-blind placebo-controlled first-in-human phase 1 trial of TransCon PTH in healthy adults","volume":"35","author":"Karpf","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib83","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10367","article-title":"Optimization of PTH\/PTHrP hybrid peptides to derive a long-acting PTH analog (LA-PTH)","volume":"4","author":"Noda","year":"2020","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(26)00188-9_bib84","doi-asserted-by":"crossref","DOI":"10.1016\/j.amjsurg.2025.116196","article-title":"Permanent hypoparathyroidism following total thyroidectomy\u2014incidence and preventative strategies without imaging adjuncts","volume":"243","author":"Niu","year":"2025","journal-title":"Am J Surg"},{"key":"10.1016\/S2213-8587(26)00188-9_bib85","doi-asserted-by":"crossref","DOI":"10.1016\/j.ejso.2025.110007","article-title":"Effectiveness of parathyroid autotransplantation during total thyroidectomy and functional recovery post-operation: a retrospective study","volume":"51","author":"Ge","year":"2025","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib86","doi-asserted-by":"crossref","first-page":"794","DOI":"10.1046\/j.1440-1622.1999.01697.x","article-title":"Routine autotransplantation of at least one parathyroid gland during total thyroidectomy may reduce permanent hypoparathyroidism to zero","volume":"69","author":"Zedenius","year":"1999","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/S2213-8587(26)00188-9_bib87","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1097\/00000658-198010000-00003","article-title":"Long-term evaluation of patients with primary parathyroid hyperplasia managed by total parathyroidectomy and heterotopic autotransplantation","volume":"192","author":"Wells","year":"1980","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(26)00188-9_bib88","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1056\/NEJM197607082950201","article-title":"Parathyroid autotransplantation in primary parathyroid hyperplasia","volume":"295","author":"Wells","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00188-9_bib89","doi-asserted-by":"crossref","first-page":"64","DOI":"10.4174\/astr.2025.108.1.64","article-title":"Investigation of the effect of perioperative parathyroid autotransplantation in incidental parathyroidectomy cases on the development of postoperative hypocalcemia: a retrospective observational study","volume":"108","author":"Bozkaya","year":"2025","journal-title":"Ann Surg Treat Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib90","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1177\/00034894241307530","article-title":"Outcome analysis of parathyroid gland auto-transplantation in pediatric patients: a retrospective review","volume":"134","author":"Lopez","year":"2025","journal-title":"Ann Otol Rhinol Laryngol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib91","doi-asserted-by":"crossref","first-page":"5047","DOI":"10.1097\/JS9.0000000000001475","article-title":"Risk factors of transient and permanent hypoparathyroidism after thyroidectomy: a systematic review and meta-analysis","volume":"110","author":"Ning","year":"2024","journal-title":"Int J Surg"},{"key":"10.1016\/S2213-8587(26)00188-9_bib92","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1186\/s12882-025-04335-5","article-title":"Subtotal versus total parathyroidectomy: retrospective patient-centric outcomes in a chronic dialysis population","volume":"26","author":"Lin","year":"2025","journal-title":"BMC Nephrol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib93","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1007\/s12020-024-04011-y","article-title":"The outcomes of parathyroid gland autotransplantation during thyroid surgery: a systematic review, meta-analysis and trial sequential analysis","volume":"87","author":"Koimtzis","year":"2025","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(26)00188-9_bib94","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1016\/j.surg.2009.10.010","article-title":"Results of cryopreserved parathyroid autografts: a retrospective multicenter study","volume":"147","author":"Borot","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(26)00188-9_bib95","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1007\/s00268-007-9437-0","article-title":"Viability of cryopreserved parathyroid tissue: when is continued storage versus disposal indicated?","volume":"32","author":"Guerrero","year":"2008","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(26)00188-9_bib96","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.1016\/j.surg.2005.09.029","article-title":"Long-term functionality of cryopreserved parathyroid autografts: a 13-year prospective analysis","volume":"138","author":"Cohen","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(26)00188-9_bib97","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1111\/j.1445-2197.2005.03435.x","article-title":"Recovery of parathyroid function after total thyroidectomy: long-term follow-up study","volume":"75","author":"Kihara","year":"2005","journal-title":"Aust N Z J Surg"},{"key":"10.1016\/S2213-8587(26)00188-9_bib98","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1007\/s00423-016-1548-3","article-title":"Failure of fragmented parathyroid gland autotransplantation to prevent permanent hypoparathyroidism after total thyroidectomy","volume":"402","author":"Lorente-Poch","year":"2017","journal-title":"Langenbecks Arch Surg"},{"key":"10.1016\/S2213-8587(26)00188-9_bib99","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1089\/thy.2016.0628","volume":"27","author":"Haugen","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(26)00188-9_bib100","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1007\/s12020-022-03292-5","article-title":"Is parathyroid allotransplantation a viable option in the treatment of permanent hypoparathyroidism? A review of the literature","volume":"80","author":"Gadelha","year":"2023","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(26)00188-9_bib101","doi-asserted-by":"crossref","first-page":"1504","DOI":"10.1093\/jimmun\/vkaf054","article-title":"Autoimmune regulator deficiency causes sterile epididymitis and impacts male fertility through disruption of inorganic physiology","volume":"214","author":"Ahn","year":"2025","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib102","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s00428-010-0953-1","article-title":"The birth of endocrine pathology: how Erdheim misunderstood parathyroids","volume":"457","author":"Vermeulen","year":"2010","journal-title":"Virchows Arch"},{"key":"10.1016\/S2213-8587(26)00188-9_bib103","doi-asserted-by":"crossref","first-page":"652","DOI":"10.1016\/j.amjsurg.2021.07.025","article-title":"Parathyroid allotransplantation for the treatment of permanent hypoparathyroidism: a systematic review","volume":"223","author":"Kim","year":"2022","journal-title":"Am J Surg"},{"key":"10.1016\/S2213-8587(26)00188-9_bib104","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1038\/nchembio.154","article-title":"A small molecule that directs differentiation of human ESCs into the pancreatic lineage","volume":"5","author":"Chen","year":"2009","journal-title":"Nat Chem Biol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib105","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-09404-6","article-title":"YAP inhibition enhances the differentiation of functional stem cell-derived insulin-producing \u03b2 cells","volume":"10","author":"Rosado-Olivieri","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(26)00188-9_bib106","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1038\/nm.4030","article-title":"Long-term glycemic control using polymer-encapsulated human stem cell-derived beta cells in immune-competent mice","volume":"22","author":"Vegas","year":"2016","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00188-9_bib107","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1056\/NEJMoa2506549","article-title":"Stem cell-derived, fully differentiated islets for type 1 diabetes","volume":"393","author":"Reichman","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00188-9_bib108","doi-asserted-by":"crossref","first-page":"2291","DOI":"10.1007\/s40618-022-01864-w","article-title":"Autotransplantation of parathyroid tissue into subcutaneous subclavicular area following total parathyroidectomy in secondary hyperparathyroidism","volume":"45","author":"Nasiri","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(26)00188-9_bib109","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/6065720","article-title":"Total parathyroidectomy with subcutaneous parathyroid forearm autotransplantation in the treatment of secondary hyperparathyroidism: a single-center experience","volume":"2018","author":"Casella","year":"2018","journal-title":"Int J Endocrinol"},{"key":"10.1016\/S2213-8587(26)00188-9_bib110","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqaa141","article-title":"Differentiation of PTH-expressing cells from human pluripotent stem cells","volume":"161","author":"Lawton","year":"2020","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(26)00188-9_bib111","doi-asserted-by":"crossref","first-page":"1071","DOI":"10.1089\/scd.2008.0337","article-title":"Differentiation of human embryonic stem cells to a parathyroid-like phenotype","volume":"18","author":"Bingham","year":"2009","journal-title":"Stem Cells Dev"},{"key":"10.1016\/S2213-8587(26)00188-9_bib112","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1089\/scd.2023.0130","article-title":"The induction of parathyroid cell differentiation from human induced pluripotent stem cells promoted via TGF-\u03b1\/EGFR signaling","volume":"32","author":"Nakatsuka","year":"2023","journal-title":"Stem Cells Dev"},{"key":"10.1016\/S2213-8587(26)00188-9_bib113","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1016\/j.scr.2013.06.007","article-title":"Generation of organized anterior foregut epithelia from pluripotent stem cells using small molecules","volume":"11","author":"Kearns","year":"2013","journal-title":"Stem Cell Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib114","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2216564120","article-title":"Functional calcium-responsive parathyroid glands generated using single-step blastocyst complementation","volume":"120","author":"Kano","year":"2023","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(26)00188-9_bib115","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1038\/35018111","article-title":"Genetic ablation of parathyroid glands reveals another source of parathyroid hormone","volume":"406","author":"G\u00fcnther","year":"2000","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(26)00188-9_bib116","doi-asserted-by":"crossref","first-page":"139","DOI":"10.21037\/gs-24-411","article-title":"Development and application of primary rat parathyroid cells for transplantation in hypoparathyroidism","volume":"14","author":"Ma","year":"2025","journal-title":"Gland Surg"},{"key":"10.1016\/S2213-8587(26)00188-9_bib117","doi-asserted-by":"crossref","DOI":"10.3389\/fvets.2023.1163903","article-title":"Challenges in establishing animal models for studying osteoimmunology of hypoparathyroidism","volume":"10","author":"Butylina","year":"2023","journal-title":"Front Vet Sci"},{"key":"10.1016\/S2213-8587(26)00188-9_bib118","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1002\/jbmr.2769","article-title":"Diphtheria toxin- and GFP-based mouse models of acquired hypoparathyroidism and treatment with a long-acting parathyroid hormone analog","volume":"31","author":"Bi","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(26)00188-9_bib119","doi-asserted-by":"crossref","DOI":"10.1093\/jbmrpl\/ziae045","article-title":"Preclinical development of EXT608, an investigational parathyroid hormone derivative with extended half-life for the treatment of hypoparathyroidism","volume":"8","author":"Hall","year":"2024","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(26)00188-9_bib120","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.97579","article-title":"Dimeric R25CPTH (1\u201334) activates the parathyroid hormone-1 receptor in vitro and stimulates bone formation in osteoporotic female mice","volume":"13","author":"Noh","year":"2025","journal-title":"eLife"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:08Z","timestamp":1792096868000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726001889"}},"issued":{"date-parts":[[2026,11]]},"references-count":118,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2213858726001889"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00188-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hypoparathyroidism: translating science from the laboratory to the clinic","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00188-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T01:01:25Z","timestamp":1794013285330,"version":"4.8.0"},"reference-count":64,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,27]],"date-time":"2016-07-27T00:00:00Z","timestamp":1469577600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007137","name":"Helse Nord RHF","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007137","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001030","name":"National Heart Foundation of Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","award":["BMBF01EO1004"],"award-info":[{"award-number":["BMBF01EO1004"]}],"id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004359","name":"Vetenskapsr\u00e5det","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004359","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100007051","name":"Uppsala Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100007051","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/s2213-8587(16)30156-5","type":"journal-article","created":{"date-parts":[[2016,7,29]],"date-time":"2016-07-29T20:11:03Z","timestamp":1469823063000},"page":"829-839","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":306,"title":["Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials"],"prefix":"10.1016","volume":"4","member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30156-5_bib1","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1185\/03007995.2013.833502","article-title":"Statins in patients with chronic kidney disease: an attempt at recommendations","volume":"29","year":"2013","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/S2213-8587(16)30156-5_bib2","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1056\/NEJMoa043545","article-title":"Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis","volume":"353","author":"Wanner","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib3","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1056\/NEJMoa0810177","article-title":"Rosuvastatin and cardiovascular events in patients undergoing hemodialysis","volume":"360","author":"Fellstr\u00f6m","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib4","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib5","doi-asserted-by":"crossref","first-page":"263","DOI":"10.7326\/0003-4819-157-4-201208210-00007","article-title":"Benefits and harms of statin therapy for persons with chronic kidney disease: a systematic review and meta-analysis","volume":"157","author":"Palmer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib6","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.3109\/0886022X.2015.1061871","article-title":"Meta-analysis of statin therapy in maintenance dialysis patients","volume":"37","author":"Sun","year":"2015","journal-title":"Ren Fail"},{"key":"10.1016\/S2213-8587(16)30156-5_bib7","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.phrs.2013.03.007","article-title":"Statins decrease all-cause mortality only in CKD patients not requiring dialysis therapy: a meta-analysis of 11 randomized controlled trials involving 21,295 participants","volume":"72","author":"Barylski","year":"2013","journal-title":"Pharmacol Res"},{"key":"10.1016\/S2213-8587(16)30156-5_bib8","article-title":"HMG CoA reductase inhibitors (statins) for dialysis patients","volume":"9","author":"Palmer","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(16)30156-5_bib9","doi-asserted-by":"crossref","first-page":"251","DOI":"10.7326\/0003-4819-157-4-201208210-00005","article-title":"Lipid-lowering therapy in persons with chronic kidney disease: a systematic review and meta-analysis","volume":"157","author":"Upadhyay","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib10","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1159\/000357676","article-title":"Meta-analysis of lipid-lowering therapy in maintenance dialysis patients","volume":"124","author":"Green","year":"2014","journal-title":"Nephron Clin Pract"},{"key":"10.1016\/S2213-8587(16)30156-5_bib11","doi-asserted-by":"crossref","first-page":"e006886","DOI":"10.1136\/bmjopen-2014-006886","article-title":"High-intensity statin therapy in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"5","author":"Yan","year":"2015","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(16)30156-5_bib12","doi-asserted-by":"crossref","first-page":"732","DOI":"10.2215\/CJN.07460714","article-title":"Statins and cardiovascular primary prevention in CKD: a meta-analysis","volume":"10","author":"Major","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(16)30156-5_bib13","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1093\/eurheartj\/eht065","article-title":"Effect of statin therapy on cardiovascular and renal outcomes in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"34","author":"Hou","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30156-5_bib14","article-title":"HMG CoA reductase inhibitors (statins) for people with chronic kidney disease not requiring dialysis","volume":"5","author":"Palmer","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(16)30156-5_bib15","first-page":"263","article-title":"KDIGO clinical practice guideline for lipid management in chronic kidney disease","volume":"3","year":"2013","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/S2213-8587(16)30156-5_bib16","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170\u2008000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib17","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1016\/S0140-6736(08)61240-4","article-title":"Effect of rosuvastatin in patients with chronic heart failure (the GISSI-HF trial): a randomised, double-blind, placebo-controlled trial","volume":"372","author":"Tavazzi","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib18","doi-asserted-by":"crossref","first-page":"2248","DOI":"10.1056\/NEJMoa0706201","article-title":"Rosuvastatin in older patients with systolic heart failure","volume":"357","author":"Kjekshus","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib19","doi-asserted-by":"crossref","first-page":"2024","DOI":"10.1016\/S0140-6736(03)13638-0","article-title":"Effect of fluvastatin on cardiac outcomes in renal transplant recipients: a multicentre, randomised, placebo-controlled trial","volume":"361","author":"Holdaas","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib20","doi-asserted-by":"crossref","first-page":"1267","DOI":"10.1016\/S0140-6736(05)67394-1","article-title":"Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90\u2008056 participants in 14 randomised trials of statins","volume":"366","author":"Baigent","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib21","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","author":"Mihaylova","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib22","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1016\/S0002-9149(99)80744-9","article-title":"Protocol for a prospective collaborative overview of all current and planned randomized trials of cholesterol treatment regimens","volume":"75","year":"1995","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(16)30156-5_bib23","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib24","doi-asserted-by":"crossref","first-page":"1301","DOI":"10.1056\/NEJM199511163332001","article-title":"Prevention of coronary heart disease with pravastatin in men with hypercholesterolemia","volume":"333","author":"Shepherd","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib25","first-page":"1383","article-title":"Randomised trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib26","doi-asserted-by":"crossref","first-page":"1001","DOI":"10.1056\/NEJM199610033351401","article-title":"The effect of pravastatin on coronary events after myocardial infarction in patients with average cholesterol levels","volume":"335","author":"Sacks","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib27","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1056\/NEJM199701163360301","article-title":"The effect of aggressive lowering of low-density lipoprotein cholesterol levels and low-dose anticoagulation on obstructive changes in saphenous-vein coronary-artery bypass grafts","volume":"336","year":"1997","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib28","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1056\/NEJM199811053391902","article-title":"Prevention of cardiovascular events and death with pravastatin in patients with coronary heart disease and a broad range of initial cholesterol levels","volume":"339","year":"1998","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib29","doi-asserted-by":"crossref","first-page":"1615","DOI":"10.1001\/jama.279.20.1615","article-title":"Primary prevention of acute coronary events with lovastatin in men and women with average cholesterol levels: results of AFCAPS\/TexCAPS\u2014Air Force\/Texas Coronary Atherosclerosis Prevention Study","volume":"279","author":"Downs","year":"1998","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30156-5_bib30","first-page":"810","article-title":"Results of the low-dose (20 mg) pravastatin GISSI Prevenzione trial in 4271 patients with recent myocardial infarction: do stopped trials contribute to overall knowledge?","volume":"1","year":"2000","journal-title":"Ital Heart J"},{"key":"10.1016\/S2213-8587(16)30156-5_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20\u2008536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib32","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1001\/jama.287.24.3215","article-title":"Fluvastatin for prevention of cardiac events following successful first percutaneous coronary intervention: a randomized controlled trial","volume":"287","author":"Serruys","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30156-5_bib33","doi-asserted-by":"crossref","first-page":"1623","DOI":"10.1016\/S0140-6736(02)11600-X","article-title":"Pravastatin in elderly individuals at risk of vascular disease (PROSPER): a randomised controlled trial","volume":"360","author":"Shepherd","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib34","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1111\/j.1524-6175.2003.03163.x","article-title":"Characteristics and lipid distribution of a large, high-risk, hypertensive population: the lipid-lowering component of the Antihypertensive and Lipid-Lowering Treatment to Prevent Heart Attack Trial (ALLHAT)","volume":"5","author":"Papademetriou","year":"2003","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/S2213-8587(16)30156-5_bib35","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1016\/S0140-6736(03)12948-0","volume":"361","author":"Sever","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib36","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib37","first-page":"1772","article-title":"Clinical outcomes in managed-care patients with coronary heart disease treated aggressively in lipid-lowering disease management clinics: the ALLIANCE study","volume":"44","author":"Koren","year":"2004","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30156-5_bib38","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.2337\/dc05-2415","article-title":"Efficacy and safety of atorvastatin in the prevention of cardiovascular end points in subjects with type 2 diabetes: the Atorvastatin Study for Prevention of Coronary Heart Disease Endpoints in non-insulin-dependent diabetes mellitus (ASPEN)","volume":"29","author":"Knopp","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30156-5_bib39","doi-asserted-by":"crossref","first-page":"1155","DOI":"10.1016\/S0140-6736(06)69472-5","article-title":"Primary prevention of cardiovascular disease with pravastatin in Japan (MEGA Study): a prospective randomised controlled trial","volume":"368","author":"Nakamura","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib40","doi-asserted-by":"crossref","first-page":"2195","DOI":"10.1056\/NEJMoa0807646","article-title":"Rosuvastatin to prevent vascular events in men and women with elevated C-reactive protein","volume":"359","author":"Ridker","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib41","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa040583","article-title":"Intensive versus moderate lipid lowering with statins after acute coronary syndromes","volume":"350","author":"Cannon","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib42","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/jama.292.11.1307","article-title":"Early intensive vs a delayed conservative simvastatin strategy in patients with acute coronary syndromes: phase Z of the A to Z trial","volume":"292","author":"de Lemos","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30156-5_bib43","doi-asserted-by":"crossref","first-page":"1425","DOI":"10.1056\/NEJMoa050461","article-title":"Intensive lipid lowering with atorvastatin in patients with stable coronary disease","volume":"352","author":"LaRosa","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib44","doi-asserted-by":"crossref","first-page":"2437","DOI":"10.1001\/jama.294.19.2437","article-title":"High-dose atorvastatin vs usual-dose simvastatin for secondary prevention after myocardial infarction: the IDEAL study: a randomized controlled trial","volume":"294","author":"Pedersen","year":"2005","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30156-5_bib45","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1016\/S0140-6736(10)60310-8","article-title":"Intensive lowering of LDL cholesterol with 80 mg versus 20 mg simvastatin daily in 12\u2008064 survivors of myocardial infarction: a double-blind randomised trial","volume":"376","author":"Armitage","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib46","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1056\/NEJMoa061894","article-title":"High-dose atorvastatin after stroke or transient ischemic attack","volume":"355","author":"Amarenco","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib47","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1185\/030079902125000787","article-title":"Treatment with atorvastatin to the National Cholesterol Educational Program goal versus \u2018usual\u2019 care in secondary coronary heart disease prevention: The GREek Atorvastatin and Coronary-heart-disease Evaluation (GREACE) study","volume":"18","author":"Athyros","year":"2002","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/S2213-8587(16)30156-5_bib48","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJMoa0804602","article-title":"Intensive lipid lowering with simvastatin and ezetimibe in aortic stenosis","volume":"359","author":"Rosseb\u00f8","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib49","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1093\/ndt\/gfl538","volume":"22","author":"Athyros","year":"2007","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(16)30156-5_bib50","doi-asserted-by":"crossref","first-page":"2974","DOI":"10.1161\/STROKEAHA.114.005832","article-title":"Effect of high-dose atorvastatin on renal function in subjects with stroke or transient ischemic attack in the SPARCL trial","volume":"45","author":"Amarenco","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(16)30156-5_bib51","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1681\/ASN.2012080870","article-title":"Association between LDL-C and risk of myocardial infarction in CKD","volume":"24","author":"Tonelli","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(16)30156-5_bib52","doi-asserted-by":"crossref","first-page":"2504","DOI":"10.1681\/ASN.2014070714","article-title":"Cause of death in patients with reduced kidney function","volume":"26","author":"Thompson","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(16)30156-5_bib53","doi-asserted-by":"crossref","first-page":"e001363","DOI":"10.1161\/JAHA.114.001363","article-title":"Effects of cinacalcet on atherosclerotic and nonatherosclerotic cardiovascular events in patients receiving hemodialysis: the EValuation Of Cinacalcet HCl Therapy to Lower CardioVascular Events (EVOLVE) trial","volume":"3","author":"Wheeler","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(16)30156-5_bib54","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1161\/CIRCULATIONAHA.107.696765","article-title":"Clinical characteristics of dialysis patients with acute myocardial infarction in the United States: a collaborative project of the United States Renal Data System and the National Registry of Myocardial Infarction","volume":"116","author":"Herzog","year":"2007","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)30156-5_bib55","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1525-139X.2012.01099.x","article-title":"The diagnostic utility of cardiac biomarkers in dialysis patients","volume":"25","author":"Wang","year":"2012","journal-title":"Semin Dial"},{"key":"10.1016\/S2213-8587(16)30156-5_bib56","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1093\/eurjhf\/hfp072","article-title":"Relationship between renal function and serum cardiac troponin T in patients with chronic heart failure","volume":"11","author":"Tsutamoto","year":"2009","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(16)30156-5_bib57","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib58","doi-asserted-by":"crossref","first-page":"e25920","DOI":"10.1371\/journal.pone.0025920","article-title":"Estimated glomerular filtration rate and the risk of major vascular events and all-cause mortality: a meta-analysis","volume":"6","author":"Mafham","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30156-5_bib59","doi-asserted-by":"crossref","first-page":"1662","DOI":"10.1016\/S0140-6736(12)61350-6","article-title":"Associations of kidney disease measures with mortality and end-stage renal disease in individuals with and without diabetes: a meta-analysis","volume":"380","author":"Fox","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30156-5_bib61","doi-asserted-by":"crossref","first-page":"1825","DOI":"10.1681\/ASN.2013090965","article-title":"Effects of lowering LDL cholesterol on progression of kidney disease","volume":"25","author":"Haynes","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(16)30156-5_bib62","doi-asserted-by":"crossref","first-page":"1246","DOI":"10.1681\/ASN.2006091006","article-title":"Lipoprotein metabolism and lipid management in chronic kidney disease","volume":"18","author":"Kwan","year":"2007","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(16)30156-5_bib63","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1056\/NEJMoa0801936","article-title":"SLCO1B1 variants and statin-induced myopathy: a genomewide study","volume":"359","author":"Link","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30156-5_bib65","doi-asserted-by":"crossref","first-page":"e29849","DOI":"10.1371\/journal.pone.0029849","article-title":"Lack of effect of lowering LDL cholesterol on cancer: meta-analysis of individual data from 175,000 people in 27 randomised trials of statin therapy","volume":"7","year":"2012","journal-title":"PLoS ONE"},{"key":"10.1016\/S2213-8587(16)30156-5_bib66","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.ahj.2016.01.016","article-title":"Protocol for analyses of adverse event data from randomized controlled trials of statin therapy","volume":"176","year":"2016","journal-title":"Am Heart J"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301565?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301565?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:11:44Z","timestamp":1781583104000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301565"}},"issued":{"date-parts":[[2016,10]]},"references-count":64,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2213858716301565"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30156-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30156-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30192-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:35:54Z","timestamp":1794062154537,"version":"4.8.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/s2213-8587(15)00389-7","type":"journal-article","created":{"date-parts":[[2015,11,12]],"date-time":"2015-11-12T01:00:40Z","timestamp":1447290040000},"page":"2-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":76,"title":["Type 2 diabetes via \u03b2-cell dysfunction in east Asian people"],"prefix":"10.1016","volume":"4","author":[{"given":"Daisuke","family":"Yabe","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Seino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00389-7_bib1","series-title":"IDF diabetes atlas. 2014 update","year":"2014"},{"key":"10.1016\/S2213-8587(15)00389-7_bib2","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1007\/s11892-015-0602-9","article-title":"\u03b2 cell dysfunction versus insulin resistance in the pathogenesis of type 2 diabetes in East Asians","volume":"15","author":"Yabe","year":"2015","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(15)00389-7_bib3","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1111\/nyas.12098","article-title":"Type 2 diabetes in East Asians: similarities and differences with populations in Europe and the United States","volume":"1281","author":"Ma","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(15)00389-7_bib4","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.2337\/dc12-1235","article-title":"Ethnic differences in the relationship between insulin sensitivity and insulin response: a systematic review and meta-analysis","volume":"36","author":"Kodama","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00389-7_bib5","doi-asserted-by":"crossref","first-page":"4273","DOI":"10.1210\/jc.2014-1724","article-title":"Ethnic differences in insulin sensitivity, \u03b2-cell function, and hepatic extraction between Japanese and Caucasians: a minimal model analysis","volume":"99","author":"Moller","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00389-7_bib6","doi-asserted-by":"crossref","first-page":"796","DOI":"10.2337\/dc13-0598","article-title":"Body composition is the main determinant for the difference in type 2 diabetes pathophysiology between Japanese and Caucasians","volume":"37","author":"Moller","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00389-7_bib7","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1136\/bmj.317.7155.371","article-title":"Will new diagnostic criteria for diabetes mellitus change phenotype of patients with diabetes? Reanalysis of European epidemiological data","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00389-7_bib8","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1007\/s001250051557","article-title":"Comparison of the fasting and the 2-h glucose criteria for diabetes in different Asian cohorts","volume":"43","author":"Qiao","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00389-7_bib9","article-title":"10-year trajectory of \u03b2-cell function and insulin sensitivity in the development of type 2 diabetes: a community-based prospective cohort study","author":"Ohn","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00389-7_bib10","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","article-title":"Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study","volume":"373","author":"Tabak","year":"2009","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003897?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003897?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,7,20]],"date-time":"2022-07-20T09:05:45Z","timestamp":1658307945000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003897"}},"issued":{"date-parts":[[2016,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S2213858715003897"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00389-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes via \u03b2-cell dysfunction in east Asian people","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00389-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00336-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T06:50:43Z","timestamp":1794379843493,"version":"4.9.0"},"reference-count":22,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/s2213-8587(14)70088-9","type":"journal-article","created":{"date-parts":[[2014,5,12]],"date-time":"2014-05-12T21:30:23Z","timestamp":1399930223000},"page":"627-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":78,"title":["Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial"],"prefix":"10.1016","volume":"2","author":[{"given":"Viveca","family":"Ritsinger","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klas","family":"Malmberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anton","family":"M\u00e5rtensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hans","family":"Wedel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Norhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70088-9_bib1","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70088-9_bib2","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70088-9_bib3","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70088-9_bib4","doi-asserted-by":"crossref","first-page":"d6898","DOI":"10.1136\/bmj.d6898","article-title":"Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials","volume":"343","author":"Hemmingsen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70088-9_bib5","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70088-9_bib6","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(14)70088-9_bib7","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70088-9_bib8","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70088-9_bib9","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70088-9_bib10","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"New Engl J Med"},{"key":"10.1016\/S2213-8587(14)70088-9_bib11","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/0735-1097(95)00126-K","article-title":"Randomised trial of insulin-glucose infusion followed by subcutaneous insulin treatment in diabetic patients with acute myocardial infarction (DIGAMI study): effects on one year mortality","volume":"26","author":"Malmberg","year":"1995","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(14)70088-9_bib12","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1136\/bmj.314.7093.1512","article-title":"Prospective randomised study of intensive insulin treatment on long term survival after acute myocardial infarction in patients with diabetes mellitus","volume":"314","author":"Malmberg","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70088-9_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.2337\/dc13-2116","article-title":"Update on cardiovascular outcomes at 30 years of the diabetes control and complications trial\/epidemiology of diabetes interventions and complications study","volume":"37","author":"Lachin","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70088-9_bib14","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1093\/eurheartj\/ehi199","article-title":"Intense metabolic control by means of insulin in patients with diabetes mellitus and acute myocardial infarction (DIGAMI 2): effects on mortality and morbidity","volume":"26","author":"Malmberg","year":"2005","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(14)70088-9_bib15","doi-asserted-by":"crossref","first-page":"765","DOI":"10.2337\/diacare.29.04.06.dc05-1894","article-title":"The hyperglycemia: Intensive insulin infusion in infarction (Hi-5) study: A randomized controlled trial of insulin infusion therapy for myocardial infarction","volume":"29","author":"Cheung","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70088-9_bib16","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70088-9_bib17","first-page":"1383","article-title":"Randomized trial of cholesterol lowering in 4444 patients with coronary heart disease: the Scandinavian Simvastatin Survival Study (4S)","volume":"344","year":"1994","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70088-9_bib18","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1042\/CS20000335","article-title":"The UKPDS risk engine: a model for the risk of coronary heart disease in Type II diabetes (UKPDS 56)","volume":"101","author":"Stevens","year":"2001","journal-title":"Clin Sci (Lond)."},{"key":"10.1016\/S2213-8587(14)70088-9_bib19","doi-asserted-by":"crossref","first-page":"S39","DOI":"10.2337\/diabetes.53.suppl_3.S39","article-title":"Intensive integrated therapy of type 2 diabetes: implications for long-term prognosis","volume":"53","author":"Gaede","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(14)70088-9_bib20","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1136\/hrt.2006.097956","volume":"93","author":"Norhammar","year":"2007","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(14)70088-9_bib21","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00125-013-3063-1","article-title":"Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study","volume":"56","author":"Lind","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70088-9_bib22","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1053\/euhj.1998.1098","article-title":"Long-term survival in severe heart failure in patients treated with enalapril. Ten year follow-up of CONSENSUS I","volume":"20","author":"Swedberg","year":"1999","journal-title":"Eur Heart J"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700889?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700889?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T02:27:23Z","timestamp":1538620043000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700889"}},"issued":{"date-parts":[[2014,8]]},"references-count":22,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S2213858714700889"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70088-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Intensified insulin-based glycaemic control after myocardial infarction: mortality during 20 year follow-up of the randomised Diabetes Mellitus Insulin Glucose Infusion in Acute Myocardial Infarction (DIGAMI 1) trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70088-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70106-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T06:19:33Z","timestamp":1790835573134,"version":"4.1.0"},"reference-count":36,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001774","name":"University of Sydney","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001774","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008415","name":"Diabetesliitto","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008415","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015268","name":"Solvay Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1037786"],"award-info":[{"award-number":["1037786"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/s2213-8587(18)30029-9","type":"journal-article","created":{"date-parts":[[2018,2,26]],"date-time":"2018-02-26T18:35:14Z","timestamp":1519670114000},"page":"310-318","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":60,"title":["Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study"],"prefix":"10.1016","volume":"6","author":[{"given":"Boris","family":"Waldman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean-Claude","family":"Ansquer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia J","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neil","family":"McGill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luke","family":"Buizen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timothy M E","family":"Davis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James D","family":"Best","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liping","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael D","family":"Feher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christelle","family":"Foucher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Y Antero","family":"Kesaniemi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Flack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"d'Emden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Russell S","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Hedley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Val","family":"Gebski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony C","family":"Keech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30029-9_bib1","doi-asserted-by":"crossref","first-page":"610","DOI":"10.1002\/art.10792","article-title":"Renal underexcretion of uric acid is present in patients with apparent high urinary uric acid output","volume":"47","author":"Perez-Ruiz","year":"2002","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(18)30029-9_bib2","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1111\/j.1445-5994.2012.02794.x","article-title":"Systematic review of the prevalence of gout and hyperuricaemia in Australia","volume":"42","author":"Robinson","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/S2213-8587(18)30029-9_bib3","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1002\/art.30520","article-title":"Prevalence of gout and hyperuricemia in the US general population: the National Health and Nutrition Examination Survey 2007\u20132008","volume":"63","author":"Zhu","year":"2011","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(18)30029-9_bib4","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1016\/S0140-6736(07)61607-9","article-title":"Effect of fenofibrate on the need for laser treatment for diabetic retinopathy (FIELD study): a randomised controlled trial","volume":"370","author":"Keech","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30029-9_bib5","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30029-9_bib6","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1055\/s-2007-982517","article-title":"Relationship between insulin resistance and low urinary pH in patients with gout, and effects of PPARalpha agonists on urine pH","volume":"39","author":"Takahashi","year":"2007","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(18)30029-9_bib7","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1007\/s10067-002-0658-1","article-title":"Long-term remission from gout associated with fenofibrate therapy","volume":"22","author":"Hepburn","year":"2003","journal-title":"Clin Rheumatol"},{"key":"10.1016\/S2213-8587(18)30029-9_bib8","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1002\/acr.21772","article-title":"2012 American College of Rheumatology guidelines for management of gout. Part 1: systematic nonpharmacologic and pharmacologic therapeutic approaches to hyperuricemia","volume":"64","author":"Khanna","year":"2012","journal-title":"Arthritis Care Res"},{"key":"10.1016\/S2213-8587(18)30029-9_bib9","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1136\/annrheumdis-2016-209707","article-title":"2016 updated EULAR evidence-based recommendations for the management of gout","volume":"76","author":"Richette","year":"2017","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S2213-8587(18)30029-9_bib10","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1475-2840-3-9","article-title":"The need for a large-scale trial of fibrate therapy in diabetes: the rationale and design of the Fenofibrate Intervention and Event Lowering in Diabetes (FIELD) study. [ISRCTN64783481]","volume":"3","year":"2004","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(18)30029-9_bib11","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.1016\/S0140-6736(05)67667-2","article-title":"Effects of long-term fenofibrate therapy on cardiovascular events in 9795 people with type 2 diabetes mellitus (the FIELD study): randomised controlled trial","volume":"366","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30029-9_bib12","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1002\/art.27338","article-title":"Epidemiology of gout in women: fifty-two-year followup of a prospective cohort","volume":"62","author":"Bhole","year":"2010","journal-title":"Arthritis Rheum"},{"key":"10.1016\/S2213-8587(18)30029-9_bib13","series-title":"Dictionary of pharmaceutical medicine","first-page":"193","article-title":"WHO-drug reference list (WHO-DRL)","year":"2009"},{"key":"10.1016\/S2213-8587(18)30029-9_bib14","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1186\/s12891-015-0762-4","article-title":"Factors influencing the crystallization of monosodium urate: a systematic literature review","volume":"16","author":"Chhana","year":"2015","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/S2213-8587(18)30029-9_bib15","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1016\/j.jbspin.2015.01.002","article-title":"Hyperuricemia starts at 360 micromoles (6 mg\/dL)","volume":"82","author":"Bardin","year":"2015","journal-title":"Joint Bone Spine"},{"key":"10.1016\/S2213-8587(18)30029-9_bib16","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1186\/1475-2840-10-102","article-title":"Impact of metabolic syndrome and its components on cardiovascular disease event rates in 4900 patients with type 2 diabetes assigned to placebo in the FIELD randomised trial","volume":"10","author":"Scott","year":"2011","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(18)30029-9_bib17","first-page":"1882","article-title":"Serum uric acid levels and risk for vascular diseases in patients with metabolic syndrome","volume":"34","author":"Hjortnaes","year":"2007","journal-title":"J Rheumatol"},{"key":"10.1016\/S2213-8587(18)30029-9_bib18","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1093\/rheumatology\/ken066","article-title":"Haemoglobin A1c, fasting glucose, serum C-peptide and insulin resistance in relation to serum uric acid levels\u2014the Third National Health and Nutrition Examination Survey","volume":"47","author":"Choi","year":"2008","journal-title":"Rheumatology"},{"key":"10.1016\/S2213-8587(18)30029-9_bib19","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/bdd.1909","article-title":"SGLT2 inhibitor lowers serum uric acid through alteration of uric acid transport activity in renal tubule by increased glycosuria","volume":"35","author":"Chino","year":"2014","journal-title":"Biopharm Drug Dispos"},{"key":"10.1016\/S2213-8587(18)30029-9_bib20","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1038\/ncomms1756","article-title":"Decreased extra-renal urate excretion is a common cause of hyperuricemia","volume":"3","author":"Ichida","year":"2012","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(18)30029-9_bib21","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1136\/bmj.39449.819271.BE","article-title":"Soft drinks, fructose consumption, and the risk of gout in men: prospective cohort study","volume":"336","author":"Choi","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30029-9_bib22","article-title":"Allopurinol for chronic gout","volume":"10","author":"Seth","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(18)30029-9_bib23","doi-asserted-by":"crossref","first-page":"89","DOI":"10.2169\/internalmedicine.49.2597","article-title":"Effect of fenofibrate on uric acid metabolism and urate transporter 1","volume":"49","author":"Uetake","year":"2010","journal-title":"Intern Med"},{"key":"10.1016\/S2213-8587(18)30029-9_bib24","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/ndt\/gfs574","article-title":"Functional cooperation of URAT1 (SLC22A12) and URATv1 (SLC2A9) in renal reabsorption of urate","volume":"28","author":"Nakanishi","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(18)30029-9_bib25","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.phrs.2015.09.012","article-title":"Plasma uric acid concentrations are reduced by fenofibrate: a systematic review and meta-analysis of randomized placebo-controlled trials","volume":"102","author":"Derosa","year":"2015","journal-title":"Pharmacol Res"},{"key":"10.1016\/S2213-8587(18)30029-9_bib26","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1093\/rheumatology\/keg103","article-title":"Fenofibrate enhances urate reduction in men treated with allopurinol for hyperuricaemia and gout","volume":"42","author":"Feher","year":"2003","journal-title":"Rheumatology"},{"key":"10.1016\/S2213-8587(18)30029-9_bib27","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1053\/j.ajkd.2008.01.014","article-title":"Effect of fenofibrate on kidney function: a 6-week randomized crossover trial in healthy people","volume":"51","author":"Ansquer","year":"2008","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(18)30029-9_bib28","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/0026-0495(88)90098-4","article-title":"Hypertriglyceridemia and hyperuricemia: effects of two fibric acid derivatives (bezafibrate and fenofibrate) in a double-blind, placebo-controlled trial","volume":"37","author":"Bastow","year":"1988","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(18)30029-9_bib29","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1016\/S0149-2918(02)80064-9","article-title":"Effects of fenofibrate on high-density lipoprotein particle size in patients with hyperlipidemia: a randomized, double-blind, placebo-controlled, multicenter, crossover study","volume":"24","author":"Sasaki","year":"2002","journal-title":"Clin Ther"},{"key":"10.1016\/S2213-8587(18)30029-9_bib30","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1016\/S0002-9149(02)02847-3","article-title":"Effect of fenofibrate on brachial artery flow-mediated dilatation in type 2 diabetes mellitus","volume":"90","author":"Playford","year":"2002","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(18)30029-9_bib31","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0011-393X(03)00127-9","article-title":"Effects of fenofibrate on albuminuria in patients with hypertriglyceridemia and\/or hyperuricemia: a multicenter, randomized, double-blind, placebo-controlled, crossover study","volume":"64","author":"Kazumi","year":"2003","journal-title":"Curr Ther Res Clin Exp"},{"key":"10.1016\/S2213-8587(18)30029-9_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.3904\/kjim.2006.21.2.89","article-title":"Effect of fenofibrate in combination with urate lowering agents in patients with gout","volume":"21","author":"Lee","year":"2006","journal-title":"Korean J Intern Med"},{"key":"10.1016\/S2213-8587(18)30029-9_bib33","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1161\/HYPERTENSIONAHA.111.171488","article-title":"Effect of a reduction in uric acid on renal outcomes during losartan treatment: a post hoc analysis of the reduction of endpoints in non-insulin-dependent diabetes mellitus with the Angiotensin II Antagonist Losartan Trial","volume":"58","author":"Miao","year":"2011","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(18)30029-9_bib34","first-page":"2294","article-title":"Effect of fenofibrate on plasma concentration and urinary excretion of purine bases and oxypurinol","volume":"28","author":"Yamamoto","year":"2001","journal-title":"J Rheumatol"},{"key":"10.1016\/S2213-8587(18)30029-9_bib35","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1136\/ard.2007.083071","article-title":"Efficacy and tolerability of urate-lowering drugs in gout: a randomised controlled trial of benzbromarone versus probenecid after failure of allopurinol","volume":"68","author":"Reinders","year":"2009","journal-title":"Ann Rheum Dis"},{"key":"10.1016\/S2213-8587(18)30029-9_bib36","doi-asserted-by":"crossref","first-page":"1789","DOI":"10.1136\/annrheumdis-2015-208237","article-title":"2015 gout classification criteria: an American College of Rheumatology\/European League Against Rheumatism collaborative initiative","volume":"74","author":"Neogi","year":"2015","journal-title":"Ann Rheum Dis"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300299?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300299?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:32Z","timestamp":1761991592000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300299"}},"issued":{"date-parts":[[2018,4]]},"references-count":36,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2213858718300299"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30029-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30029-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30022-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:11:29Z","timestamp":1790957489678,"version":"4.1.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/s2213-8587(26)00069-0","type":"journal-article","created":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T23:37:49Z","timestamp":1773877069000},"page":"374","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Viral medicine: social media and new expectations of obesity treatment"],"prefix":"10.1016","volume":"14","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2987-5922","authenticated-orcid":false,"given":"Cristina","family":"Tejera-P\u00e9rez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00069-0_bib1","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1016\/S0140-6736(24)01210-8","article-title":"Obesity in adults","volume":"404","author":"Lingvay","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00069-0_bib2","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00069-0_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00069-0_bib4","doi-asserted-by":"crossref","DOI":"10.2196\/73619","article-title":"Harnessing Facebook to investigate real-world mentions of adverse events of glucagon-like peptide-1 receptor agonist (GLP-1 RA) medications: observational study of Facebook posts from 2022 to 2024","volume":"5","author":"Alibilli","year":"2025","journal-title":"JMIR Infodemiology"},{"key":"10.1016\/S2213-8587(26)00069-0_bib5","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1097\/MS9.0000000000004254","article-title":"Emergence of \u201cOzempic face\u201d: addressing unintended consequences of rapid weight loss","volume":"88","author":"Jodat","year":"2025","journal-title":"Ann Med Surg (Lond)"},{"key":"10.1016\/S2213-8587(26)00069-0_bib6","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pdig.0000729","article-title":"Beyond the screen: exploring the dynamics of social media influencers, digital food marketing, and gendered influences on adolescent diets","volume":"4","author":"Amson","year":"2025","journal-title":"PLoS Digit Health"},{"key":"10.1016\/S2213-8587(26)00069-0_bib7","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1016\/j.puhe.2022.10.010","article-title":"TikTok: a far-reaching opportunity for health professionals to address weight loss","volume":"213","author":"Samuel","year":"2022","journal-title":"Public Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000690?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000690?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,4,14]],"date-time":"2026-04-14T22:44:28Z","timestamp":1776206668000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000690"}},"issued":{"date-parts":[[2026,5]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2213858726000690"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00069-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viral medicine: social media and new expectations of obesity treatment","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00069-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S0140-6736(24)01210-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T16:46:51Z","timestamp":1790959611522,"version":"4.1.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/s2213-8587(22)00165-6","type":"journal-article","created":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T18:34:19Z","timestamp":1654108459000},"page":"488","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Europe's obesity burden on the rise: WHO report"],"prefix":"10.1016","volume":"10","author":[{"given":"Vijay Shankar","family":"Balakrishnan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001656?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001656?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:06Z","timestamp":1761991866000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001656"}},"issued":{"date-parts":[[2022,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2213858722001656"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00165-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Europe's obesity burden on the rise: WHO report","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00165-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,14]],"date-time":"2026-09-14T22:55:29Z","timestamp":1789426529766,"version":"build-2803163510"},"reference-count":107,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/s2213-8587(26)00036-7","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T22:55:14Z","timestamp":1777071314000},"page":"512-522","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diabetes-related complications and multiple long-term conditions in sub-Saharan Africa: determinants and management strategies"],"prefix":"10.1016","volume":"14","author":[{"given":"Deborah","family":"Ikhile","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Seidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damilola","family":"Omodara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Katte","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaushik","family":"Ramaiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00036-7_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(26)00065-3","article-title":"Burden and determinants of diabetes in sub-Saharan Africa","author":"Agyemang","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00036-7_bib3","doi-asserted-by":"crossref","first-page":"219","DOI":"10.1038\/s41574-021-00613-y","article-title":"Type 2 diabetes mellitus in sub-Saharan Africa: challenges and opportunities","volume":"18","author":"Motala","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(26)00036-7_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-060786","article-title":"Indicators of optimal diabetes care and burden of diabetes complications in Africa: a systematic review and meta-analysis","volume":"12","author":"Kibirige","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00036-7_bib5","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/4134937","article-title":"The burden of undiagnosed diabetes mellitus in adult African population: a systematic review and meta-analysis","volume":"2019","author":"Asmelash","year":"2019","journal-title":"J Diabetes Res"},{"key":"10.1016\/S2213-8587(26)00036-7_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.eclinm.2019.09.001","article-title":"Type 2 diabetes complications and comorbidity in Sub-Saharan Africans","volume":"16","author":"Ekoru","year":"2019","journal-title":"eClinicalMedicine"},{"key":"10.1016\/S2213-8587(26)00036-7_bib7","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1186\/s12902-025-01866-8","article-title":"Burden of peripheral artery disease and risk factors among patients with diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis","volume":"25","author":"Haile","year":"2025","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(26)00036-7_bib8","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.1038\/s41433-023-02673-y","article-title":"Assessing the barriers and facilitators of access to diabetic retinopathy screening in sub-Saharan Africa: a literature review","volume":"38","author":"Achigbu","year":"2024","journal-title":"Eye"},{"key":"10.1016\/S2213-8587(26)00036-7_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-064275","article-title":"Multimorbidity of cardiometabolic diseases: a cross-sectional study of patterns, clusters and associated risk factors in sub-Saharan Africa","volume":"13","author":"Otieno","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00036-7_bib10","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1177\/13591053251341786","article-title":"Psychosocial burden of diabetes in Africa: a systematic review and meta-analysis","volume":"31","author":"Boakye","year":"2026","journal-title":"J Health Psychol"},{"key":"10.1016\/S2213-8587(26)00036-7_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2024.e40140","article-title":"Burden of active tuberculosis among patients with diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis","volume":"10","author":"Kassie","year":"2024","journal-title":"Heliyon"},{"key":"10.1016\/S2213-8587(26)00036-7_bib12","doi-asserted-by":"crossref","DOI":"10.1177\/26335565221112593","article-title":"Multimorbidity of communicable and non-communicable diseases in low- and middle-income countries: a systematic review","volume":"12","author":"Kaluvu","year":"2022","journal-title":"J Multimorb Comorb"},{"key":"10.1016\/S2213-8587(26)00036-7_bib13","article-title":"Chronic disease care integration into primary care services in sub-Saharan Africa: a \u2018best fit\u2019 framework synthesis and new conceptual model","volume":"10","author":"Harrison","year":"2022","journal-title":"Fam Med Community Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(26)00035-5","article-title":"Strengthening diabetes care in sub-Saharan Africa: health systems, digital innovations, lifestyle interventions, and socioeconomic dimensions","author":"Cassambai","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00036-7_bib15","doi-asserted-by":"crossref","first-page":"247","DOI":"10.2147\/DMSO.S126314","article-title":"Diabetes in sub-Saharan Africa\u2014from policy to practice to progress: targeting the existing gaps for future care for diabetes","volume":"10","author":"Pastakia","year":"2017","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/S2213-8587(26)00036-7_bib16","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1186\/s12884-019-2593-z","article-title":"Burden, risk factors and maternal and offspring outcomes of gestational diabetes mellitus (GDM) in sub-Saharan Africa (SSA): a systematic review and meta-analysis","volume":"19","author":"Natamba","year":"2019","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(26)00036-7_bib17","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/s12902-020-0534-5","article-title":"Prevalence of diabetic peripheral neuropathy in Africa: a systematic review and meta-analysis","volume":"20","author":"Shiferaw","year":"2020","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(26)00036-7_bib18","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12886-025-04589-5","article-title":"Diabetic retinopathy in sub-Saharan Africa: prevalence and regional variations from a systematic review and meta-analysis","volume":"26","author":"Ismail","year":"2026","journal-title":"BMC Ophthalmol"},{"key":"10.1016\/S2213-8587(26)00036-7_bib19","doi-asserted-by":"crossref","first-page":"43","DOI":"10.5334\/aogh.2669","article-title":"Diabetic microvascular complications among children and adolescents in northwestern Tanzania: a cross-sectional study","volume":"86","author":"Msanga","year":"2020","journal-title":"Ann Glob Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib20","first-page":"126","article-title":"Clinical presentation and factors associated with diabetic ketoacidosis at the onset of type-1 diabetes mellitus in children and adolescent at Muhimbili National Hospital, Tanzania: a cross section study","volume":"7","author":"Kipasika","year":"2020","journal-title":"Int J Diabetes Clin Res"},{"key":"10.1016\/S2213-8587(26)00036-7_bib21","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0000599","article-title":"Prevalence of microvascular and macrovascular complications of diabetes in newly diagnosed type 2 diabetes in low-and-middle-income countries: a systematic review and meta-analysis","volume":"2","author":"Aikaeli","year":"2022","journal-title":"PLoS Glob Public Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib22","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13098-022-00902-0","article-title":"Glycaemic control among type 2 diabetes patients in sub-Saharan Africa from 2012 to 2022: a systematic review and meta-analysis","volume":"14","author":"Fina Lubaki","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/S2213-8587(26)00036-7_bib23","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12913-023-10410-0","article-title":"Towards an integrated type 1 diabetes management in low-resource settings: barriers faced by patients and their caregivers in healthcare facilities in Ghana","volume":"24","author":"Owusu","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(26)00036-7_bib24","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2025.1551088","article-title":"Prevalence of nephropathy among patients with diabetes mellitus in Africa: a systematic review and meta-analysis","volume":"6","author":"Adebayo-Gege","year":"2025","journal-title":"Front Clin Diabetes Healthc"},{"key":"10.1016\/S2213-8587(26)00036-7_bib25","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/S2213-8587(17)30432-1","article-title":"Prevalence of obesity, hypertension, and diabetes, and cascade of care in sub-Saharan Africa: a cross-sectional, population-based study in rural and urban Malawi","volume":"6","author":"Price","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00036-7_bib26","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13643-022-02090-4","article-title":"Suboptimal blood pressure control and its associated factors among people living with diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis","volume":"11","author":"Akalu","year":"2022","journal-title":"Syst Rev"},{"key":"10.1016\/S2213-8587(26)00036-7_bib27","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.778891","article-title":"Determinants of dyslipidemia in Africa: a systematic review and meta-analysis","volume":"8","author":"Obsa","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/S2213-8587(26)00036-7_bib28","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1210\/clinem\/dgad599","article-title":"Sex-specific obesity and cardiometabolic disease risks in low-and middle-income countries: a meta-analysis involving 3\u2008916\u2008276 individuals","volume":"109","author":"Rocha","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00036-7_bib29","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/j.pcd.2022.01.011","article-title":"Contribution of diabetes to amputations in sub-Sahara Africa: a systematic review and meta-analysis","volume":"16","author":"Boateng","year":"2022","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/S2213-8587(26)00036-7_bib30","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/s13104-018-3670-5","article-title":"Diabetic nephropathy and hypertension in diabetes patients of sub-Saharan countries: a systematic review and meta-analysis","volume":"11","author":"Wagnew","year":"2018","journal-title":"BMC Res Notes"},{"key":"10.1016\/S2213-8587(26)00036-7_bib31","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-8587(17)30181-X","article-title":"Diabetes in sub-Saharan Africa: from clinical care to health policy","volume":"5","author":"Atun","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00036-7_bib32","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0001931","article-title":"Regional prevalence of hypertension among people diagnosed with diabetes in Africa: a systematic review and meta-analysis","volume":"3","author":"Hinneh","year":"2023","journal-title":"PLoS Glob Public Health"},{"issue":"1","key":"10.1016\/S2213-8587(26)00036-7_bib33","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12872-024-04272-5","article-title":"Pattern and outcome of the first manifestation of cardiovascular disease among patients with type 2 diabetes mellitus in Cameroon: a cross-sectional study","volume":"24","author":"Nkoke","year":"2024","journal-title":"BMC Cardiovascular Disorders"},{"key":"10.1016\/S2213-8587(26)00036-7_bib34","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2022.1008335","article-title":"Cardiovascular diseases in Africa in the twenty-first century: gaps and priorities going forward","volume":"9","author":"Minja","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/S2213-8587(26)00036-7_bib35","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0096688","article-title":"Acute myocardial infarction in sub-Saharan Africa: the need for data","volume":"9","author":"Hertz","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00036-7_bib36","article-title":"Fixing the broken care pathway for acute myocardial infraction care in sub-Saharan Africa","volume":"15","author":"Onuma","year":"2022","journal-title":"Circ Popul Health Outcomes"},{"key":"10.1016\/S2213-8587(26)00036-7_bib37","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000520909","article-title":"Heart failure in patients with diabetes and chronic kidney disease: challenges and opportunities","volume":"12","author":"Vijay","year":"2022","journal-title":"Cardiorenal Med"},{"key":"10.1016\/S2213-8587(26)00036-7_bib38","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1186\/s12933-023-01937-x","article-title":"The cardio\u2013renal\u2013metabolic connection: a review of the evidence","volume":"22","author":"Marassi","year":"2023","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(26)00036-7_bib39","article-title":"Social determinants of health for cardiovascular\u2013kidney\u2013metabolic syndrome among patients with diabetes","volume":"9","author":"Belay","year":"2025","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(26)00036-7_bib40","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063318","article-title":"Association between urban-rural location and prevalence of type 2 diabetes and impaired fasting glucose in west Africa: a cross-sectional population-based epidemiological study","volume":"13","author":"Issaka","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00036-7_bib41","doi-asserted-by":"crossref","DOI":"10.1002\/jia2.25364","article-title":"HIV, antiretroviral therapy and non-communicable diseases in sub-Saharan Africa: empirical evidence from 44 countries over the period 2000 to 2016","volume":"22","author":"Coetzee","year":"2019","journal-title":"J Int AIDS Soc"},{"key":"10.1016\/S2213-8587(26)00036-7_bib43","doi-asserted-by":"crossref","DOI":"10.4102\/phcfm.v12i1.2160","article-title":"Early detection, care and control of hypertension and diabetes in South Africa: a community-based approach","volume":"12","author":"Madela","year":"2020","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"10.1016\/S2213-8587(26)00036-7_bib44","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/584041","article-title":"Gaps in capacity in primary care in low-resource settings for implementation of essential noncommunicable disease interventions","volume":"2012","author":"Mendis","year":"2012","journal-title":"Int J Hypertens"},{"key":"10.1016\/S2213-8587(26)00036-7_bib45","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2022.895743","article-title":"Hyperglycemia first detected in pregnancy in South Africa: facts, gaps, and opportunities","volume":"3","author":"Coetzee","year":"2022","journal-title":"Frontiers in Clinical Diabetes and Healthcare"},{"key":"10.1016\/S2213-8587(26)00036-7_bib46","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1186\/s13690-019-0362-0","article-title":"Prevalence and determinants of gestational diabetes mellitus in Africa based on the updated international diagnostic criteria: a systematic review and meta-analysis","volume":"77","author":"Muche","year":"2019","journal-title":"Arch Public Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0237571","article-title":"Systematic review and meta-analysis of the effectiveness of pre-pregnancy care for women with diabetes for improving maternal and perinatal outcomes","volume":"15","author":"Wahabi","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00036-7_bib48","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00036-7_bib50","doi-asserted-by":"crossref","DOI":"10.3389\/fcdhc.2023.1241882","article-title":"Poor glycaemic control: prevalence, factors and implications for the care of patients with type 2 diabetes in Kinshasa, Democratic Republic of the Congo: a cross-sectional study","volume":"4","author":"Fina Lubaki","year":"2023","journal-title":"Front Clin Diabetes Healthc"},{"key":"10.1016\/S2213-8587(26)00036-7_bib51","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1080\/07853890.2023.2182909","article-title":"Prevalence and associated factors of overweight and obesity among persons with type 2 diabetes in Africa: a systematic review and meta-analysis","volume":"55","author":"Ekpor","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/S2213-8587(26)00036-7_bib52","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1093\/inthealth\/ihab054","article-title":"Barriers to screening, diagnosis and management of hyperglycaemia in pregnancy in Africa: a systematic review","volume":"14","author":"Hinneh","year":"2022","journal-title":"International Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib53","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0305860","article-title":"Diabetes self-care intervention strategies and their effectiveness in sub-Saharan Africa: a systematic review","volume":"19","author":"Ageru","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00036-7_bib54","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1007\/s13300-018-0384-6","article-title":"EADSG Guidelines: insulin therapy in diabetes","volume":"9","author":"Silver","year":"2018","journal-title":"Diabetes Ther"},{"key":"10.1016\/S2213-8587(26)00036-7_bib55","doi-asserted-by":"crossref","DOI":"10.1002\/edm2.135","article-title":"Continuous glucose monitoring assessment of metabolic control in east African children and young adults with type 1 diabetes: a pilot and feasibility study","volume":"3","author":"McClure Yauch","year":"2020","journal-title":"Endocrinol Diabetes Metab"},{"key":"10.1016\/S2213-8587(26)00036-7_bib56","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/pedi.13451","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: diabetes technologies: glucose monitoring","volume":"23","author":"Tauschmann","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(26)00036-7_bib57","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1186\/s12916-020-01530-z","article-title":"Pharmacotherapy for hypertension in sub-Saharan Africa: a systematic review and network meta-analysis","volume":"18","author":"Seeley","year":"2020","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(26)00036-7_bib58","first-page":"95","article-title":"Hypertension in sub-Saharan Africa: the current profile, recent advances, gaps, and priorities","volume":"39","author":"Gafane-Matemane","year":"2025","journal-title":"J Hum Hypertens"},{"key":"10.1016\/S2213-8587(26)00036-7_bib59","article-title":"Readiness of sub-Saharan Africa healthcare systems for the new pandemic, diabetes: a systematic review","volume":"2018","author":"Nuche-Berenguer","year":"2018","journal-title":"J Diabetes Res"},{"key":"10.1016\/S2213-8587(26)00036-7_bib60","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(23)01573-8","article-title":"Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial","volume":"402","author":"Kivuyo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00036-7_bib61","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-025-59123-4","article-title":"National evidence on glucose-lowering medication use for diabetes from 62 low- and middle-income countries","volume":"16","author":"Teufel","year":"2025","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(26)00036-7_bib63","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2021.e07085","article-title":"Meta-analysis of studies on depression prevalence among diabetes mellitus patients in Africa","volume":"7","author":"Ogunsakin","year":"2021","journal-title":"Heliyon"},{"key":"10.1016\/S2213-8587(26)00036-7_bib64","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1080\/20477724.2022.2046967","article-title":"Effect of tuberculosis (TB) and diabetes mellitus (DM) integrated healthcare on bidirectional screening and treatment outcomes among TB patients and people living with DM in developing countries: a systematic review","volume":"117","author":"Nyirenda","year":"2023","journal-title":"Pathog Glob Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib65","doi-asserted-by":"crossref","first-page":"395","DOI":"10.2147\/IJGM.S223882","article-title":"Identifying key challenges facing healthcare systems in Africa and potential solutions","volume":"12","author":"Oleribe","year":"2019","journal-title":"Int J Gen Med"},{"key":"10.1016\/S2213-8587(26)00036-7_bib66","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1186\/s12913-021-06957-5","article-title":"Using a theory of change to develop an integrated intervention for depression, diabetes and hypertension in Zimbabwe: lessons from the Friendship Bench project","volume":"21","author":"Kamvura","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(26)00036-7_bib67","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0043400","article-title":"Leveraging rapid community-based HIV testing campaigns for non-communicable diseases in rural Uganda","volume":"7","author":"Chamie","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00036-7_bib68","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5334\/ijic.5839","article-title":"Integrating care for diabetes and hypertension with HIV care in sub-Saharan Africa: a scoping review","volume":"22","author":"McCombe","year":"2022","journal-title":"Int J Integr Care"},{"key":"10.1016\/S2213-8587(26)00036-7_bib69","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13033-015-0013-y","article-title":"The Friendship Bench programme: a cluster randomised controlled trial of a brief psychological intervention for common mental disorders delivered by lay health workers in Zimbabwe","volume":"9","author":"Chibanda","year":"2015","journal-title":"Int J Ment Health Syst"},{"key":"10.1016\/S2213-8587(26)00036-7_bib70","doi-asserted-by":"crossref","DOI":"10.1016\/j.socscimed.2019.112760","article-title":"Explanatory models of depression in sub-Saharan Africa: synthesis of qualitative evidence","volume":"246","author":"Mayston","year":"2020","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(26)00036-7_bib71","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-023-48049-w","article-title":"Effects of family-based diabetes self-management education and support programme on support behaviour amongst adults with type 2 diabetes in western Ethiopia","volume":"13","author":"Diriba","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(26)00036-7_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.eujim.2025.102436","article-title":"Socioeconomic and cultural factors influencing traditional medicine (TM) use in Nigeria: a systematic mixed method review","volume":"74","author":"Abhadionmhen","year":"2025","journal-title":"Eur J Integr Med"},{"key":"10.1016\/S2213-8587(26)00036-7_bib73","doi-asserted-by":"crossref","first-page":"254","DOI":"10.1186\/s12879-019-3892-8","article-title":"Prevalence of diabetes mellitus among tuberculosis patients in sub-Saharan Africa: a systematic review and meta-analysis of observational studies","volume":"19","author":"Alebel","year":"2019","journal-title":"BMC Infect Dis"},{"key":"10.1016\/S2213-8587(26)00036-7_bib74","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1186\/s12879-024-09683-5","article-title":"Mortality and associated factors among patients with TB\u2013HIV co-infection in Ethiopia: a systematic review and meta-analysis","volume":"24","author":"Moges","year":"2024","journal-title":"BMC Infect Dis"},{"key":"10.1016\/S2213-8587(26)00036-7_bib75","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2022-003136","article-title":"Association between integrase strand transfer inhibitor use with insulin resistance and incident diabetes mellitus in persons living with HIV: a systematic review and meta-analysis","volume":"11","author":"Mulindwa","year":"2023","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(26)00036-7_bib76","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13033-020-00413-3","article-title":"Detection and prevalence of depression among adult type 2 diabetes mellitus patients attending non-communicable diseases clinics in Lilongwe, Malawi","volume":"14","author":"Udedi","year":"2020","journal-title":"Int J Ment Health Syst"},{"key":"10.1016\/S2213-8587(26)00036-7_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0240938","article-title":"Factors influencing self-management in relation to type 2 diabetes in Africa: a qualitative systematic review","volume":"15","author":"Suglo","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00036-7_bib78","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-073123","article-title":"Depression and glycaemic control among adult patients with type 2 diabetes: a cross-sectional study in a comprehensive specialised hospital, Jigjiga, Ethiopia","volume":"13","author":"Ali","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00036-7_bib79","article-title":"Prevalence and associated factors of depression among diabetic outpatients in Ethiopia","volume":"22","author":"Jarso","year":"2020","journal-title":"Prim Care Companion CNS Disord"},{"key":"10.1016\/S2213-8587(26)00036-7_bib80","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12888-022-04494-x","article-title":"Determinants of depression and anxiety among type 2 diabetes patients in governments' hospitals at Harari regional state, eastern Ethiopia: a multi-center cross-sectional study","volume":"23","author":"Nigussie","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/S2213-8587(26)00036-7_bib81","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1186\/s12888-023-04655-6","article-title":"Depression and determinants among diabetes mellitus patients in Ethiopia: a systematic review and meta-analysis","volume":"23","author":"Tegegne","year":"2023","journal-title":"BMC Psychiatry"},{"key":"10.1016\/S2213-8587(26)00036-7_bib82","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-077693","article-title":"Diabetes-related distress and its associated factors among people with type 2 diabetes in southeast Ethiopia: a cross-sectional study","volume":"14","author":"Adugnew","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00036-7_bib83","doi-asserted-by":"crossref","DOI":"10.1155\/2019\/2083196","article-title":"Prevalence of depression and associated factors among diabetic patients in an outpatient diabetes clinic","volume":"2019","author":"Khan","year":"2019","journal-title":"Psychiatry J"},{"key":"10.1016\/S2213-8587(26)00036-7_bib84","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-043997","article-title":"Quality of life among adult patients living with diabetes in Rwanda: a cross-sectional study in outpatient clinics","volume":"11","author":"Lygidakis","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00036-7_bib85","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/109019818801500401","article-title":"An ecological perspective on health promotion programs","volume":"15","author":"McLeroy","year":"1988","journal-title":"Health Educ Q"},{"key":"10.1016\/S2213-8587(26)00036-7_bib86","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-018-6050-0","article-title":"Self-management of diabetes in sub-Saharan Africa: a systematic review","volume":"18","author":"Stephani","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib87","doi-asserted-by":"crossref","first-page":"e104","DOI":"10.1017\/S1368980024000752","article-title":"Knowledge, perceptions and practices towards diabetes risk in sub-Saharan Africa: a mixed-methods scoping review","volume":"27","author":"Manyara","year":"2024","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(26)00036-7_bib88","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1007\/s13410-022-01045-8","article-title":"A systematic review of diabetes risk assessment tools in sub-Saharan Africa","volume":"42","author":"Ekure","year":"2022","journal-title":"Int J Diabetes Dev Ctries"},{"key":"10.1016\/S2213-8587(26)00036-7_bib89","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/tmi.13819","article-title":"Availability and affordability of essential medicines and diagnostic tests for diabetes mellitus in Africa","volume":"27","author":"Kibirige","year":"2022","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib90","doi-asserted-by":"crossref","DOI":"10.1177\/20420188241232280","article-title":"Insulin therapy among diabetic patients in rural communities of sub-Saharan Africa: a perspective review","volume":"15","author":"Kiconco","year":"2024","journal-title":"Ther Adv Endocrinol Metab"},{"key":"10.1016\/S2213-8587(26)00036-7_bib91","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/26350106241279809","article-title":"Patient-perceived challenges to type 2 diabetes self-management in sub-Saharan Africa: a qualitative exploratory study","volume":"50","author":"Desse","year":"2024","journal-title":"Sci Diabetes Self Manag Care"},{"key":"10.1016\/S2213-8587(26)00036-7_bib92","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s10943-024-02233-y","article-title":"The role of community organisation, religion, spirituality and cultural beliefs on diabetes social support and self-management in sub-Saharan Africa: integrative literature review","volume":"64","author":"Molla","year":"2025","journal-title":"J Relig Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003733","article-title":"Barriers and facilitators of primary care management of type II diabetes mellitus in the west African sub-region: a scoping review","volume":"5","author":"Abdul-Samed","year":"2025","journal-title":"PLoS Glob Public Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib95","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S2213-8587(22)00274-1","article-title":"Diabetes in sub-Saharan Africa: what are the next steps?","volume":"10","author":"Katte","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00036-7_bib96","doi-asserted-by":"crossref","DOI":"10.4102\/safp.v64i1.5447","article-title":"Coverage of diabetes complications screening in rural Eastern Cape, South Africa: a cross-sectional survey","volume":"64","author":"Owolabi","year":"2022","journal-title":"S Afr Fam Pract"},{"key":"10.1016\/S2213-8587(26)00036-7_bib97","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/pedi.13294","article-title":"Mortality amongst children and adolescents with type 1 diabetes in sub-Saharan Africa: the case study of the Changing Diabetes in Children program in Cameroon","volume":"23","author":"Katte","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(26)00036-7_bib98","doi-asserted-by":"crossref","first-page":"e411","DOI":"10.1016\/S2468-2667(17)30141-X","article-title":"Availability and affordability of blood pressure-lowering medicines and the effect on blood pressure control in high-income, middle-income, and low-income countries: an analysis of the PURE study data","volume":"2","author":"Attaei","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/j.jns.2020.116838","article-title":"Prevalence and predictors of statin utilization among patient populations at high vascular risk in Ghana","volume":"414","author":"Sarfo","year":"2020","journal-title":"J Neurol Sci"},{"key":"10.1016\/S2213-8587(26)00036-7_bib100","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1093\/inthealth\/ihad045","article-title":"Experience of stigma among persons with type 2 diabetes in Africa: a systematic review","volume":"16","author":"Akyirem","year":"2024","journal-title":"Int Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib101","doi-asserted-by":"crossref","DOI":"10.4102\/PHCFM.v17i1.5175","article-title":"Exploring diabetes-related stigma in adolescence: a critical review","volume":"17","author":"Janneke","year":"2025","journal-title":"Afr J Prim Health Care Fam Med"},{"key":"10.1016\/S2213-8587(26)00036-7_bib102","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-083004","article-title":"Traditional healing practices, factors influencing to access the practices and its complementary effect on mental health in sub-Saharan Africa: a systematic review","volume":"14","author":"Berhe","year":"2024","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00036-7_bib103","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1177\/17579759211065058","article-title":"Prevention of type 2 diabetes in sub-Saharan Africa, a review","volume":"29","author":"McCrory-Churchill","year":"2022","journal-title":"Glob Health Promot"},{"key":"10.1016\/S2213-8587(26)00036-7_bib104","doi-asserted-by":"crossref","DOI":"10.1186\/s12913-021-07073-0","article-title":"Integrating diabetes, hypertension and HIV care in sub-Saharan Africa: a Delphi consensus study on international best practice","volume":"21","author":"McCombe","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(26)00036-7_bib105","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2025.1658229","article-title":"HIV response financing challenges in sub-Saharan Africa: barriers to achieving the 95\u201395\u201395 UNAIDS targets","volume":"13","author":"Kulohoma","year":"2025","journal-title":"Front Public Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib106","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299904","article-title":"Integrated chronic care models for people with comorbid of HIV and non-communicable diseases in sub-Saharan Africa: a scoping review","volume":"19","author":"Chireshe","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00036-7_bib107","series-title":"Transforming social determinants to promote global health","first-page":"157","article-title":"Developing culturally salient assessment tools and interventions for underserved and high-risk populations in the United States and Africa","author":"Kariuki","year":"2024"},{"key":"10.1016\/S2213-8587(26)00036-7_bib108","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-049133","article-title":"Multimorbidity of non-communicable diseases in low-income and middle-income countries: a systematic review and meta-analysis","volume":"12","author":"Asogwa","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00036-7_bib109","article-title":"Cohort profile: Africa Wits-INDEPTH partnership for Genomic studies (AWI-Gen) in four sub-Saharan African countries","volume":"54","author":"Tluway","year":"2025","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(26)00036-7_bib110","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-067906","article-title":"Cohort profile: Research on Obesity and Diabetes among African Migrants in Europe and Africa Prospective (RODAM-Pros) cohort study","volume":"12","author":"Agyemang","year":"2022","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00036-7_bib111","doi-asserted-by":"crossref","first-page":"e1771","DOI":"10.1016\/S2214-109X(25)00263-3","article-title":"Classifying a distinct form of diabetes in lean individuals with a history of undernutrition: an international consensus statement","volume":"13","author":"Wadivkar","year":"2025","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(26)00036-7_bib112","doi-asserted-by":"crossref","first-page":"e459","DOI":"10.1016\/S2214-109X(24)00520-5","article-title":"Incident type 2 diabetes and its risk factors in men and women aged 40\u201360 years from four sub-Saharan African countries: results from the AWI-Gen study","volume":"13","author":"Chikwati","year":"2025","journal-title":"Lancet Glob Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000367?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000367?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T18:11:10Z","timestamp":1783102270000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000367"}},"issued":{"date-parts":[[2026,6]]},"references-count":107,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2213858726000367"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00036-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes-related complications and multiple long-term conditions in sub-Saharan Africa: determinants and management strategies","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00036-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00065-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00035-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00099-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T15:35:03Z","timestamp":1790264103614,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 ES013527"],"award-info":[{"award-number":["R01 ES013527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R56 ES013527"],"award-info":[{"award-number":["R56 ES013527"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/s2213-8587(19)30381-x","type":"journal-article","created":{"date-parts":[[2019,12,5]],"date-time":"2019-12-05T19:13:17Z","timestamp":1575573197000},"page":"11-13","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":75,"title":["BPA: have flawed analytical techniques compromised risk assessments?"],"prefix":"10.1016","volume":"8","author":[{"given":"Roy","family":"Gerona","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederick S","family":"vom Saal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia A","family":"Hunt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30381-X_bib1","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.reprotox.2016.10.001","article-title":"Metabolism disrupting chemicals and metabolic disorders","volume":"68","author":"Heindel","year":"2017","journal-title":"Reprod Toxicol"},{"key":"10.1016\/S2213-8587(19)30381-X_bib2","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1210\/er.2015-1010","article-title":"EDC-2: The Endocrine Society's second scientific statement on endocrine-disrupting chemicals","volume":"36","author":"Gore","year":"2015","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(19)30381-X_bib3","article-title":"Low dose effects of bisphenol A: an integrated review of in vitro, laboratory animal, and epidemiology studies","volume":"1","author":"Vandenberg","year":"2013","journal-title":"Endocr Disruptors (Austin)"},{"key":"10.1016\/S2213-8587(19)30381-X_bib4","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1038\/s41574-019-0173-y","article-title":"Endocrine disruptors and the future of toxicology testing\u2014lessons from CLARITY-BPA","volume":"15","author":"Vandenberg","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(19)30381-X_bib5","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1186\/s12940-016-0131-2","article-title":"Direct measurement of bisphenol A (BPA), BPA glucuronide and BPA sulfate in a diverse and low-income population of pregnant women reveals high exposure, with potential implications for previous exposure estimates: a cross-sectional study","volume":"15","author":"Gerona","year":"2016","journal-title":"Environ Health"},{"key":"10.1016\/S2213-8587(19)30381-X_bib6","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1186\/1476-069X-13-25","article-title":"A round robin approach to the analysis of bisphenol A (BPA) in human blood samples","volume":"13","author":"Vandenberg","year":"2014","journal-title":"Environ Health"},{"key":"10.1016\/S2213-8587(19)30381-X_bib7","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.taap.2010.07.009","article-title":"Pharmacokinetics of bisphenol A in neonatal and adult rhesus monkeys","volume":"248","author":"Doerge","year":"2010","journal-title":"Toxicol Appl Pharmacol"},{"key":"10.1016\/S2213-8587(19)30381-X_bib8","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.jchromb.2013.11.009","article-title":"Automated on-line column-switching high performance liquid chromatography isotope dilution tandem mass spectrometry method for the quantification of bisphenol A, bisphenol F, bisphenol S, and 11 other phenols in urine","volume":"944","author":"Zhou","year":"2014","journal-title":"J Chromatogr B Analyt Technol Biomed Life Sci"},{"key":"10.1016\/S2213-8587(19)30381-X_bib9","doi-asserted-by":"crossref","first-page":"12477","DOI":"10.1021\/es402764d","article-title":"Bisphenol-A (BPA), BPA glucuronide, and BPA sulfate in midgestation umbilical cord serum in a northern and central California population","volume":"47","author":"Gerona","year":"2013","journal-title":"Environ Sci Technol"},{"key":"10.1016\/S2213-8587(19)30381-X_bib10","doi-asserted-by":"crossref","first-page":"6523","DOI":"10.1021\/acsomega.8b00824","article-title":"Exposure to bisphenol A, bisphenol F, and bisphenol S in U.S. adults and children: the National Health and Nutrition Examination Survey 2013-2014","volume":"3","author":"Lehmler","year":"2018","journal-title":"ACS Omega"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930381X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930381X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:58Z","timestamp":1761991618000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871930381X"}},"issued":{"date-parts":[[2020,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S221385871930381X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30381-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"BPA: have flawed analytical techniques compromised risk assessments?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30381-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T11:05:45Z","timestamp":1791889545343,"version":"4.3.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2016,6,1]],"date-time":"2016-06-01T00:00:00Z","timestamp":1464739200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,6]]},"DOI":"10.1016\/s2213-8587(16)30007-9","type":"journal-article","created":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T02:33:55Z","timestamp":1462070035000},"page":"470-471","source":"Crossref","is-referenced-by-count":39,"title":["Curbing the obesity epidemic in China"],"prefix":"10.1016","volume":"4","author":[{"given":"Jieli","family":"Lu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yufang","family":"Bi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guang","family":"Ning","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30007-9_bib1","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30007-9_bib2","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1001\/jama.2013.168118","article-title":"Prevalence and control of diabetes in Chinese adults","volume":"310","author":"Xu","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30007-9_bib3","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1111\/1753-0407.12240","article-title":"Diabetes and cancer: findings from the REACTION study","volume":"7","author":"Ning","year":"2015","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(16)30007-9_bib4","first-page":"837","article-title":"The management of chronic non-communicable diseases is an uneasy long haul","volume":"31","author":"Chen","year":"2015","journal-title":"Chin J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30007-9_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)00081-4","article-title":"BMI, leisure-time physical activity, and physical fitness in adults in China: results from a series of national surveys, 2000\u201314","author":"Tian","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30007-9_bib7","doi-asserted-by":"crossref","first-page":"1013","DOI":"10.1016\/j.jacc.2014.12.044","article-title":"Status of cardiovascular health in Chinese adults","volume":"65","author":"Bi","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)30007-9_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1111\/j.1467-789X.2007.00433.x","article-title":"Overview of obesity in mainland China","volume":"9","author":"Chen","year":"2008","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(16)30007-9_bib9","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/ajcn\/80.5.1129","article-title":"Appropriate body mass index and waist circumference cutoffs for categorization of overweight and central adiposity among Chinese adults","volume":"80","author":"Wildman","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30007-9_bib10","first-page":"83","article-title":"Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2014study on optimal cut-off points of body mass index and waist circumference in Chinese adults","volume":"15","author":"Zhou","year":"2002","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/S2213-8587(16)30007-9_bib11","doi-asserted-by":"crossref","first-page":"e002562","DOI":"10.1161\/JAHA.115.002562","article-title":"Traditional Chinese exercise for cardiovascular diseases: systematic review and meta-analysis of randomized controlled trials","volume":"5","author":"Wang","year":"2016","journal-title":"J Am Heart Assoc"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716300079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,7]],"date-time":"2019-09-07T06:15:41Z","timestamp":1567836941000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716300079"}},"issued":{"date-parts":[[2016,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2016,6]]}},"alternative-id":["S2213858716300079"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30007-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,6]]}},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T22:20:00Z","timestamp":1791930000231,"version":"4.3.4"},"reference-count":47,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100022030","name":"Silence Therapeutics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100022030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/s2213-8587(23)00156-0","type":"journal-article","created":{"date-parts":[[2023,7,21]],"date-time":"2023-07-21T18:26:51Z","timestamp":1689964011000},"page":"667-674","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":42,"title":["Lipoprotein(a) and carotid intima-media thickness in children with familial hypercholesterolaemia in the Netherlands: a 20-year follow-up study"],"prefix":"10.1016","volume":"11","author":[{"given":"Lotte M","family":"de Boer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Wiegman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Kroon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotirios","family":"Tsimikas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Calvin","family":"Yeang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Merel C","family":"Peletier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alma","family":"Revers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J P","family":"Kastelein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aeilko H","family":"Zwinderman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara A","family":"Hutten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00156-0_bib1","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1194\/jlr.R067314","article-title":"Structure, function, and genetics of lipoprotein (a)","volume":"57","author":"Schmidt","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(23)00156-0_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.atherosclerosis.2022.04.015","article-title":"Lipoprotein(a) and cardiovascular and valvular diseases: a genetic epidemiological perspective","volume":"349","author":"Arsenault","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(23)00156-0_bib3","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1016\/S0140-6736(18)31652-0","article-title":"Baseline and on-statin treatment lipoprotein(a) levels for prediction of cardiovascular events: individual patient-data meta-analysis of statin outcome trials","volume":"392","author":"Willeit","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00156-0_bib4","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1161\/CIRCULATIONAHA.113.004406","article-title":"Lipoprotein(a) concentrations, rosuvastatin therapy, and residual vascular risk: an analysis from the JUPITER Trial (Justification for the Use of Statins in Prevention: an Intervention Trial Evaluating Rosuvastatin)","volume":"129","author":"Khera","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00156-0_bib5","doi-asserted-by":"crossref","first-page":"1601","DOI":"10.1080\/14656566.2022.2118522","article-title":"Pharmacotherapy for children with elevated levels of lipoprotein(a): future directions","volume":"23","author":"de Boer","year":"2022","journal-title":"Expert Opin Pharmacother"},{"key":"10.1016\/S2213-8587(23)00156-0_bib6","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/j.atherosclerosis.2022.04.003","article-title":"Lipoprotein(a) beyond the kringle IV repeat polymorphism: the complexity of genetic variation in the LPA gene","volume":"349","author":"Coassin","year":"2022","journal-title":"Atherosclerosis"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00156-0_bib7","first-page":"III33","article-title":"Measurement of arterial wall thickness as a surrogate marker for atherosclerosis","volume":"109","author":"de Groot","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00156-0_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1161\/CIRCULATIONAHA.120.046361","article-title":"Carotid intima-media thickness progression as surrogate marker for cardiovascular risk: meta-analysis of 119 clinical trials involving 100 667 patients","volume":"142","author":"Willeit","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00156-0_bib9","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1161\/CIRCRESAHA.114.301430","article-title":"Carotid intima-media thickness in children with familial hypercholesterolemia","volume":"114","author":"Kusters","year":"2014","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(23)00156-0_bib10","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1056\/NEJMoa1816454","article-title":"20-year follow-up of statins in children with familial hypercholesterolemia","volume":"381","author":"Luirink","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00156-0_bib11","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/S0140-6736(04)15467-6","article-title":"Arterial intima-media thickness in children heterozygous for familial hypercholesterolaemia","volume":"363","author":"Wiegman","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00156-0_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1001\/jama.292.3.331","article-title":"Efficacy and safety of statin therapy in children with familial hypercholesterolemia: a randomized controlled trial","volume":"292","author":"Wiegman","year":"2004","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00156-0_bib13","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-8587(16)30042-0","article-title":"High lipoprotein(a) as a possible cause of clinical familial hypercholesterolaemia: a prospective cohort study","volume":"4","author":"Langsted","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00156-0_bib14","doi-asserted-by":"crossref","first-page":"1982","DOI":"10.1016\/j.jacc.2014.01.063","article-title":"Lipoprotein(a) levels in familial hypercholesterolemia: an important predictor of cardiovascular disease independent of the type of LDL receptor mutation","volume":"63","author":"Alonso","year":"2014","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(23)00156-0_bib15","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1002\/clc.22880","article-title":"Elevated lipoprotein(a) and familial hypercholesterolemia in the coronary care unit: between Scylla and Charybdis","volume":"41","author":"Ellis","year":"2018","journal-title":"Clin Cardiol"},{"key":"10.1016\/S2213-8587(23)00156-0_bib16","doi-asserted-by":"crossref","first-page":"1029","DOI":"10.1016\/j.jacc.2018.12.037","article-title":"Value of measuring lipoprotein(a) during cascade testing for familial hypercholesterolemia","volume":"73","author":"Ellis","year":"2019","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(23)00156-0_bib17","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1093\/clinchem\/18.6.499","article-title":"Estimation of the concentration of low-density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge","volume":"18","author":"Friedewald","year":"1972","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(23)00156-0_bib18","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/j.jacc.2005.12.047","article-title":"Oxidized low-density lipoprotein in children with familial hypercholesterolemia and unaffected siblings: effect of pravastatin","volume":"47","author":"Rodenburg","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(23)00156-0_bib19","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1194\/jlr.R061648","article-title":"Lipoprotein (a) measurements for clinical application","volume":"57","author":"Marcovina","year":"2016","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(23)00156-0_bib20","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/j.cca.2011.05.036","article-title":"Lipoprotein(a)-cholesterol: a significant component of serum cholesterol","volume":"412","author":"Kinpara","year":"2011","journal-title":"Clin Chim Acta"},{"key":"10.1016\/S2213-8587(23)00156-0_bib21","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.016318","article-title":"Low-density lipoprotein cholesterol corrected for lipoprotein(a) cholesterol, risk thresholds, and cardiovascular events","volume":"9","author":"Willeit","year":"2020","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(23)00156-0_bib22","doi-asserted-by":"crossref","first-page":"e48","DOI":"10.1161\/ATV.0000000000000147","article-title":"Lipoprotein(a): a genetically determined, causal, and prevalent risk factor for atherosclerotic cardiovascular disease: a scientific statement from the American Heart Association","volume":"42","author":"Reyes-Soffer","year":"2022","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(23)00156-0_bib23","series-title":"Flexible imputation of missing data","author":"van Buuren","year":"2018"},{"key":"10.1016\/S2213-8587(23)00156-0_bib24","doi-asserted-by":"crossref","first-page":"1540","DOI":"10.1007\/s00246-018-1927-3","article-title":"Lipoprotein (a): examination of cardiovascular risk in a pediatric referral population","volume":"39","author":"Qayum","year":"2018","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/S2213-8587(23)00156-0_bib25","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1136\/hrt.76.4.321","article-title":"Carotid intima-media thickness in young patients with familial hypercholesterolaemia","volume":"76","author":"Lavrencic","year":"1996","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(23)00156-0_bib26","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jacl.2020.12.003","article-title":"The impact of dyslipidemia on early markers of endothelial and renal dysfunction in children","volume":"15","author":"Kosmeri","year":"2021","journal-title":"J Clin Lipidol"},{"key":"10.1016\/S2213-8587(23)00156-0_bib27","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1172\/JCI116983","article-title":"Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level","volume":"93","author":"Sorensen","year":"1994","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(23)00156-0_bib28","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1007\/s00246-013-0742-0","article-title":"Endothelial dysfunction, but not structural atherosclerosis, is evident early in children with heterozygous familial hypercholesterolemia","volume":"35","author":"Vlahos","year":"2014","journal-title":"Pediatr Cardiol"},{"key":"10.1016\/S2213-8587(23)00156-0_bib29","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1161\/CIRCULATIONAHA.116.024541","article-title":"Predicting cardiovascular events in familial hypercholesterolemia: the SAFEHEART registry (Spanish Familial Hypercholesterolemia Cohort Study)","volume":"135","author":"P\u00e9rez de Isla","year":"2017","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00156-0_bib30","doi-asserted-by":"crossref","first-page":"2632","DOI":"10.1161\/ATVBAHA.121.316106","article-title":"Familial hypercholesterolemia-risk-score: a new score predicting cardiovascular events and cardiovascular mortality in familial hypercholesterolemia","volume":"41","author":"Paquette","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(23)00156-0_bib31","doi-asserted-by":"crossref","first-page":"611","DOI":"10.1161\/CIRCULATIONAHA.116.020838","article-title":"Oxidized phospholipids on lipoprotein(a) elicit arterial wall inflammation and an inflammatory monocyte response in humans","volume":"134","author":"van der Valk","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00156-0_bib32","doi-asserted-by":"crossref","first-page":"1346","DOI":"10.1161\/CIRCRESAHA.119.316206","article-title":"Atherogenic lipoprotein(a) increases vascular glycolysis, thereby facilitating inflammation and leukocyte extravasation","volume":"126","author":"Schnitzler","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(23)00156-0_bib33","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/j.jacbts.2020.01.008","article-title":"Therapeutic antibody against phosphorylcholine preserves coronary function and attenuates vascular 18F-FDG uptake in atherosclerotic mice","volume":"5","author":"St\u00e5hle","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/S2213-8587(23)00156-0_bib34","doi-asserted-by":"crossref","first-page":"766","DOI":"10.1016\/S0735-1097(00)01180-3","article-title":"Improvement of coronary artery endothelial dysfunction with lipid-lowering therapy: heterogeneity of segmental response and correlation with plasma-oxidized low density lipoprotein","volume":"37","author":"Penny","year":"2001","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(23)00156-0_bib35","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1016\/j.jcmg.2018.05.001","article-title":"Lipoprotein apheresis acutely reverses coronary microvascular dysfunction in patients with severe hypercholesterolemia","volume":"12","author":"Wu","year":"2019","journal-title":"JACC Cardiovasc Imaging"},{"key":"10.1016\/S2213-8587(23)00156-0_bib36","doi-asserted-by":"crossref","first-page":"2219","DOI":"10.1016\/j.jacc.2006.03.001","article-title":"Oxidized phospholipids predict the presence and progression of carotid and femoral atherosclerosis and symptomatic cardiovascular disease: five-year prospective results from the Bruneck study","volume":"47","author":"Tsimikas","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(23)00156-0_bib37","doi-asserted-by":"crossref","DOI":"10.1016\/j.jlr.2021.100053","article-title":"Novel method for quantification of lipoprotein(a)-cholesterol: implications for improving accuracy of LDL-C measurements","volume":"62","author":"Yeang","year":"2021","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(23)00156-0_bib38","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1016\/j.atherosclerosis.2022.03.004","article-title":"Lipoprotein(a) levels from childhood to adulthood: data in nearly 3,000 children who visited a pediatric lipid clinic","volume":"349","author":"de Boer","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(23)00156-0_bib39","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1093\/eurheartj\/ehz310","article-title":"Statin therapy increases lipoprotein(a) levels","volume":"41","author":"Tsimikas","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(23)00156-0_bib40","first-page":"244","article-title":"Lipoprotein(a) reduction in persons with cardiovascular disease","volume":"382","author":"Tsimikas","year":"2020","journal-title":"xJ Med"},{"key":"10.1016\/S2213-8587(23)00156-0_bib41","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1001\/jama.2022.5050","article-title":"Single ascending dose study of a short interfering RNA targeting lipoprotein(a) production in individuals with elevated plasma lipoprotein(a) levels","volume":"327","author":"Nissen","year":"2022","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00156-0_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1097\/MED.0000000000000624","article-title":"Expert position statements: comparison of recommendations for the care of adults and youth with elevated lipoprotein(a)","volume":"28","author":"Wilson","year":"2021","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(23)00156-0_bib43","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1093\/eurheartj\/ehac660","article-title":"Lipoprotein(a) levels in children with suspected familial hypercholesterolaemia: a cross-sectional study","volume":"44","author":"de Boer","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(23)00156-0_bib44","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1016\/j.atherosclerosis.2022.04.008","article-title":"Lipoprotein(a) measurement issues: are we making a mountain out of a molehill?","volume":"349","author":"Kronenberg","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(23)00156-0_bib45","doi-asserted-by":"crossref","first-page":"3925","DOI":"10.1093\/eurheartj\/ehac361","article-title":"Lipoprotein(a) in atherosclerotic cardiovascular disease and aortic stenosis: a European Atherosclerosis Society consensus statement","volume":"43","author":"Kronenberg","year":"2022","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(23)00156-0_bib46","doi-asserted-by":"crossref","first-page":"1472","DOI":"10.1161\/CIRCULATIONAHA.118.034311","article-title":"Lipoprotein(a) levels and the risk of myocardial infarction among 7 ethnic groups","volume":"139","author":"Par\u00e9","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(23)00156-0_bib47","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1161\/ATVBAHA.120.315291","article-title":"Lp(a) (lipoprotein[a]) concentrations and incident atherosclerotic cardiovascular disease","volume":"41","author":"Patel","year":"2021","journal-title":"Arterioscler Thromb Vasc Biol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001560?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001560?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:23Z","timestamp":1761991943000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001560"}},"issued":{"date-parts":[[2023,9]]},"references-count":47,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2213858723001560"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00156-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lipoprotein(a) and carotid intima-media thickness in children with familial hypercholesterolaemia in the Netherlands: a 20-year follow-up study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00156-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00172-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T08:19:13Z","timestamp":1791965953855,"version":"4.3.4"},"reference-count":14,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00006\/1"],"award-info":[{"award-number":["MC_UU_00006\/1"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/s2213-8587(22)00131-0","type":"journal-article","created":{"date-parts":[[2022,5,27]],"date-time":"2022-05-27T18:38:24Z","timestamp":1653676704000},"page":"561-570","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["Associations between reductions in routine care delivery and non-COVID-19-related mortality in people with diabetes in England during the COVID-19 pandemic: a population-based parallel cohort study"],"prefix":"10.1016","volume":"10","author":[{"given":"Jonathan","family":"Valabhji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Gorton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Bakhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Partha","family":"Kar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bob","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naomi","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00131-0_bib3","article-title":"Impact of COVID-19 restrictions on diabetes health checks and prescribing for people with type 2 diabetes: a UK-wide cohort study involving 618\u2008161 people in primary care","author":"Carr","year":"2021","journal-title":"BMJ Qual Saf"},{"key":"10.1016\/S2213-8587(22)00131-0_bib4","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1016\/S2213-8587(21)00116-9","article-title":"Impact of COVID-19 on diagnoses, monitoring, and mortality in people with type 2 diabetes in the UK","volume":"9","author":"Carr","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00131-0_bib6","doi-asserted-by":"crossref","first-page":"2728","DOI":"10.1111\/dom.14528","article-title":"Completion of annual diabetes care processes and mortality: a cohort study using the National Diabetes Audit for England and Wales","volume":"23","author":"Holman","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(22)00131-0_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108746","article-title":"Associations between attainment of incentivised primary care diabetes indicators and mortality in an English cohort","volume":"174","author":"McKay","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(22)00131-0_bib8","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14616","article-title":"Cohort profile: national diabetes audit for England and Wales","volume":"38","author":"Holman","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(22)00131-0_bib9","author":"Gov"},{"key":"10.1016\/S2213-8587(22)00131-0_bib10","doi-asserted-by":"crossref","first-page":"e133","DOI":"10.2337\/dc20-2852","article-title":"Temporal trends in lower-limb major and minor amputation and revascularisation procedures in people with diabetes in England during the COVID-19 pandemic","volume":"44","author":"Valabhji","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00131-0_bib11","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S2213-8587(20)30272-2","article-title":"Associations of type 1 and type 2 diabetes with COVID-19-related mortality in England: a whole-population study","volume":"8","author":"Barron","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00131-0_bib12","doi-asserted-by":"crossref","first-page":"823","DOI":"10.1016\/S2213-8587(20)30271-0","article-title":"Risk factors for COVID-19-related mortality in people with type 1 and type 2 diabetes in England: a population-based cohort study","volume":"8","author":"Holman","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00131-0_bib13","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2337\/dc16-1616","article-title":"Life expectancy and cause-specific mortality in type 2 diabetes: a population-based cohort study quantifying relationships in ethnic subgroups","volume":"40","author":"Wright","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00131-0_bib14","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2021-050525","article-title":"Lockdown and non-COVID-19 deaths: cause-specific mortality during the first wave of the 2020 pandemic in Norway: a population-based register study","volume":"11","author":"Raknes","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(22)00131-0_bib15","doi-asserted-by":"crossref","DOI":"10.3389\/fpubh.2021.760795","article-title":"Accessibility to non-COVID health services in the world during the COVID-19 pandemic: review","volume":"9","author":"Tuczy\u0144ska","year":"2021","journal-title":"Front Public Health"},{"key":"10.1016\/S2213-8587(22)00131-0_bib16","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1016\/j.dsx.2020.06.042","article-title":"Impact of COVID-19 on routine care for chronic diseases: a global survey of views from healthcare professionals","volume":"14","author":"Chudasama","year":"2020","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(22)00131-0_bib17","article-title":"Indirect effects of the COVID-19 pandemic on people with type 2 diabetes: time to urgently move into a recovery phase","author":"Vamos","year":"2021","journal-title":"BMJ Qual Saf"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:00Z","timestamp":1761991860000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001310"}},"issued":{"date-parts":[[2022,8]]},"references-count":14,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2213858722001310"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00131-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Associations between reductions in routine care delivery and non-COVID-19-related mortality in people with diabetes in England during the COVID-19 pandemic: a population-based parallel cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00131-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00162-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T22:05:46Z","timestamp":1791497146954,"version":"4.3.4"},"reference-count":99,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2015,8,1]],"date-time":"2015-08-01T00:00:00Z","timestamp":1438387200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Fonds NutsOhra, the Netherlands","award":["grant 122047"],"award-info":[{"award-number":["grant 122047"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,8]]},"DOI":"10.1016\/s2213-8587(15)00136-9","type":"journal-article","created":{"date-parts":[[2015,7,14]],"date-time":"2015-07-14T01:40:29Z","timestamp":1436838029000},"page":"653-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":96,"title":["New ophthalmologic imaging techniques for detection and monitoring of neurodegenerative changes in diabetes: a systematic review"],"prefix":"10.1016","volume":"3","author":[{"given":"Eline E B","family":"De Clerck","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan S A G","family":"Schouten","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tos T J M","family":"Berendschot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alfons G H","family":"Kessels","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rudy M M A","family":"Nuijts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henny J M","family":"Beckers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miranda T","family":"Schram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen D A","family":"Stehouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carroll A B","family":"Webers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00136-9_bib1","doi-asserted-by":"crossref","first-page":"2619","DOI":"10.2337\/dc06-2479","article-title":"Challenges in design of multicenter trials: end points assessed longitudinally for change and monotonicity","volume":"30","author":"Dyck","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00136-9_bib2","doi-asserted-by":"crossref","first-page":"2699","DOI":"10.2174\/138161207781662920","article-title":"Neuronal and glial cell abnormality as predictors of progression of diabetic retinopathy","volume":"13","author":"Fletcher","year":"2007","journal-title":"Curr Pharm Des"},{"key":"10.1016\/S2213-8587(15)00136-9_bib3","doi-asserted-by":"crossref","first-page":"250","DOI":"10.2337\/diacare.24.2.250","article-title":"Simple screening tests for peripheral neuropathy in the diabetes clinic","volume":"24","author":"Perkins","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00136-9_bib4","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.2337\/dc09-1835","article-title":"Prediction of incident diabetic neuropathy using the monofilament examination: a 4-year prospective study","volume":"33","author":"Perkins","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00136-9_bib5","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1172\/JCI2425","article-title":"Neural apoptosis in the retina during experimental and human diabetes. Early onset and effect of insulin","volume":"102","author":"Barber","year":"1998","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(15)00136-9_bib6","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.2337\/dc07-0332","article-title":"Lower somatostatin expression is an early event in diabetic retinopathy and is associated with retinal neurodegeneration","volume":"30","author":"Carrasco","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00136-9_bib7","first-page":"1496","article-title":"Lowered cortistatin expression is an early event in the human diabetic retina and is associated with apoptosis and glial activation","volume":"14","author":"Carrasco","year":"2008","journal-title":"Mol Vis"},{"key":"10.1016\/S2213-8587(15)00136-9_bib8","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1007\/s00125-009-1548-8","article-title":"Interphotoreceptor retinoid-binding protein (IRBP) is downregulated at early stages of diabetic retinopathy","volume":"52","author":"Garcia-Ramirez","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00136-9_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1002\/(SICI)1520-6769(199707)21:1<13::AID-NRC203>3.0.CO;2-P","article-title":"The use of electrophysiology for the assessment of diabetic neuropathy","volume":"21","author":"Arezzo","year":"1997","journal-title":"Neurosci Res Commun"},{"key":"10.1016\/S2213-8587(15)00136-9_bib10","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1002\/mus.21661","article-title":"Signs and symptoms versus nerve conduction studies to diagnose diabetic sensorimotor polyneuropathy: Cl vs. NPhys trial","volume":"42","author":"Dyck","year":"2010","journal-title":"Muscle Nerve"},{"key":"10.1016\/S2213-8587(15)00136-9_bib11","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1212\/WNL.60.1.108","article-title":"The spectrum of neuropathy in diabetes and impaired glucose tolerance","volume":"60","author":"Sumner","year":"2003","journal-title":"Neurology"},{"key":"10.1016\/S2213-8587(15)00136-9_bib12","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1002\/mus.880170414","article-title":"Sensory thresholds in older adults: reproducibility and reference values","volume":"17","author":"de Neeling","year":"1994","journal-title":"Muscle Nerve"},{"key":"10.1016\/S2213-8587(15)00136-9_bib13","doi-asserted-by":"crossref","first-page":"6082","DOI":"10.1167\/iovs.14-14698","article-title":"Mosaicking the subbasal nerve plexus by guided eye movements","volume":"55","author":"Allgeier","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib14","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1001\/jamaophthalmol.2014.1698","article-title":"Reproducibility of spectral-domain optical coherence tomography retinal thickness measurements and conversion to equivalent time-domain metrics in diabetic macular edema","volume":"132","author":"Bressler","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib15","doi-asserted-by":"crossref","first-page":"e83","DOI":"10.1097\/ICO.0b013e3182749419","article-title":"Repeatability of in vivo corneal confocal microscopy to quantify corneal nerve morphology","volume":"32","author":"Petropoulos","year":"2013","journal-title":"Cornea"},{"key":"10.1016\/S2213-8587(15)00136-9_bib16","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1097\/ICL.0b013e3181eea915","article-title":"Repeatability of measuring corneal subbasal nerve fiber length in individuals with type 2 diabetes","volume":"36","author":"Efron","year":"2010","journal-title":"Eye Contact Lens"},{"key":"10.1016\/S2213-8587(15)00136-9_bib17","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1111\/j.1464-5491.2011.03299.x","article-title":"Reproducibility of in vivo corneal confocal microscopy as a novel screening test for early diabetic sensorimotor polyneuropathy","volume":"28","author":"Hertz","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00136-9_bib18","doi-asserted-by":"crossref","first-page":"33","DOI":"10.3928\/1542-8877-20030101-08","article-title":"Peripapillary nerve fiber layer thickness measurement reproducibility using optical coherence tomography","volume":"34","author":"Villain","year":"2003","journal-title":"Ophthalmic Surg Lasers Imaging"},{"key":"10.1016\/S2213-8587(15)00136-9_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1167\/tvst.3.1.1","article-title":"Optical coherence tomography (OCT) device independent intraretinal layer segmentation","volume":"3","author":"Ehnes","year":"2014","journal-title":"Transl Vis Sci Technol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib20","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1109\/TMI.2009.2016958","article-title":"Automated 3-D intraretinal layer segmentation of macular spectral-domain optical coherence tomography images","volume":"28","author":"Garvin","year":"2009","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/S2213-8587(15)00136-9_bib21","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1167\/iovs.13-13787","article-title":"Rapid automated diagnosis of diabetic peripheral neuropathy with in vivo corneal confocal microscopy","volume":"55","author":"Petropoulos","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib22","doi-asserted-by":"crossref","first-page":"4801","DOI":"10.1167\/iovs.08-2061","article-title":"Automatic recognition of corneal nerve structures in images from confocal microscopy","volume":"49","author":"Scarpa","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib23","doi-asserted-by":"crossref","first-page":"S125","DOI":"10.3928\/1081597X-20090115-09","article-title":"Confocal microscopy of corneal sub-basal nerve plexus: a quantitative and qualitative analysis in healthy and pathologic eyes","volume":"25","author":"Midena","year":"2009","journal-title":"J Refract Surg"},{"key":"10.1016\/S2213-8587(15)00136-9_bib24","first-page":"300","article-title":"Dual-model automatic detection of nerve-fibres in corneal confocal microscopy images","volume":"13","author":"Dabbah","year":"2010","journal-title":"Med Image Comput Comput Assist Interv"},{"key":"10.1016\/S2213-8587(15)00136-9_bib25","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1016\/j.media.2011.05.016","article-title":"Automatic analysis of diabetic peripheral neuropathy using multi-scale quantitative morphology of nerve fibres in corneal confocal microscopy imaging","volume":"15","author":"Dabbah","year":"2011","journal-title":"Med Image Anal"},{"key":"10.1016\/S2213-8587(15)00136-9_bib26","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1002\/cyto.a.20022","article-title":"Design and validation of a tool for neurite tracing and analysis in fluorescence microscopy images","volume":"58","author":"Meijering","year":"2004","journal-title":"Cytometry A"},{"key":"10.1016\/S2213-8587(15)00136-9_bib27","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1016\/j.visres.2010.08.024","article-title":"Association of visual function and ganglion cell layer thickness in patients with diabetes mellitus type 1 and no or minimal diabetic retinopathy","volume":"51","author":"van Dijk","year":"2011","journal-title":"Vision Res"},{"key":"10.1016\/S2213-8587(15)00136-9_bib28","doi-asserted-by":"crossref","first-page":"e7507","DOI":"10.1371\/journal.pone.0007507","article-title":"Noninvasive, in vivo assessment of mouse retinal structure using optical coherence tomography","volume":"4","author":"Fischer","year":"2009","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(15)00136-9_bib29","doi-asserted-by":"crossref","first-page":"2715","DOI":"10.1167\/iovs.11-8997","article-title":"Early neurodegeneration in the retina of type 2 diabetic patients","volume":"53","author":"van Dijk","year":"2012","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib30","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1167\/iovs.08-3143","article-title":"Selective loss of inner retinal layer thickness in type 1 diabetic patients with minimal diabetic retinopathy","volume":"50","author":"van Dijk","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib31","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.1167\/iovs.09-5041","article-title":"Decreased retinal ganglion cell layer thickness in patients with type 1 diabetes","volume":"51","author":"van Dijk","year":"2010","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib32","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1001\/jamaophthalmol.2014.1422","article-title":"Effect of doxycycline vs placebo on retinal function and diabetic retinopathy progression in mild to moderate nonproliferative diabetic retinopathy: a randomized proof-of-concept clinical trial","volume":"132","author":"Scott","year":"2014","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib33","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1136\/bjophthalmol-2012-302005","article-title":"Neurodegeneration is an early event in diabetic retinopathy: therapeutic implications","volume":"96","author":"Simo","year":"2012","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib34","doi-asserted-by":"crossref","first-page":"569215","DOI":"10.1155\/2010\/569215","article-title":"Retinal nerve fiber layer decrease during glycemic control in type 2 diabetes","volume":"2010","author":"Sugimoto","year":"2010","journal-title":"J Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1111\/j.1442-9071.2009.02016.x","article-title":"In vivo confocal microscopy, an inner vision of the cornea\u2014a major review","volume":"37","author":"Guthoff","year":"2009","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib36","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.clae.2013.07.002","article-title":"Non-contact laser-scanning confocal microscopy of the human cornea in vivo","volume":"37","author":"Pritchard","year":"2014","journal-title":"Cont Lens Anterior Eye"},{"key":"10.1016\/S2213-8587(15)00136-9_bib37","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1136\/bjo.87.2.225","article-title":"In vivo confocal microscopy of the human cornea","volume":"87","author":"Jalbert","year":"2003","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib38","first-page":"2915","article-title":"Corneal structure and sensitivity in type 1 diabetes mellitus","volume":"41","author":"Rosenberg","year":"2000","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib39","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1007\/s00125-003-1086-8","article-title":"Corneal confocal microscopy: a non-invasive surrogate of nerve fibre damage and repair in diabetic patients","volume":"46","author":"Malik","year":"2003","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00136-9_bib40","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1097\/OPX.0b013e3182171020","article-title":"The Glenn A. Fry award lecture 2010: Ophthalmic markers of diabetic neuropathy","volume":"88","author":"Efron","year":"2011","journal-title":"Optom Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib41","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1111\/j.1464-5491.2011.03372.x","article-title":"Corneal confocal microscopy detects improvement in corneal nerve morphology with an improvement in risk factors for diabetic neuropathy","volume":"28","author":"Tavakoli","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00136-9_bib42","doi-asserted-by":"crossref","first-page":"2608","DOI":"10.2337\/dc07-0870","article-title":"Corneal confocal microscopy detects early nerve regeneration after pancreas transplantation in patients with type 1 diabetes","volume":"30","author":"Mehra","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00136-9_bib43","doi-asserted-by":"crossref","first-page":"254","DOI":"10.2337\/db12-0574","article-title":"Corneal confocal microscopy detects early nerve regeneration in diabetic neuropathy after simultaneous pancreas and kidney transplantation","volume":"62","author":"Tavakoli","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(15)00136-9_bib44","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(15)00136-9_bib45","doi-asserted-by":"crossref","first-page":"e1000100","DOI":"10.1371\/journal.pmed.1000100","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate health care interventions: explanation and elaboration","volume":"6","author":"Liberati","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(15)00136-9_bib46","doi-asserted-by":"crossref","first-page":"884","DOI":"10.1038\/eye.2008.119","article-title":"Changes of macular and RNFL thicknesses measured by Stratus OCT in patients with early stage diabetes","volume":"23","author":"Oshitari","year":"2009","journal-title":"Eye (Lond)"},{"key":"10.1016\/S2213-8587(15)00136-9_bib47","doi-asserted-by":"crossref","first-page":"821","DOI":"10.2337\/dc11-1396","article-title":"Detection of diabetic sensorimotor polyneuropathy by corneal confocal microscopy in type 1 diabetes: a concurrent validity study","volume":"35","author":"Ahmed","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00136-9_bib48","doi-asserted-by":"crossref","first-page":"2454","DOI":"10.2337\/db13-1819","article-title":"Early detection of nerve fiber loss by corneal confocal microscopy and skin biopsy in recently diagnosed type 2 diabetes","volume":"63","author":"Ziegler","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(15)00136-9_bib49","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1016\/j.ajo.2006.04.033","article-title":"Decreased density of corneal basal epithelium and subbasal corneal nerve bundle changes in patients with diabetic retinopathy","volume":"142","author":"Chang","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1111\/j.2040-1124.2011.00157.x","article-title":"Corneal nerve fiber pathology in Japanese type 1 diabetic patients and its correlation with antecedent glycemic control and blood pressure","volume":"3","author":"Ishibashi","year":"2012","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(15)00136-9_bib51","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1111\/jdi.12171","article-title":"Correlation between sudomotor function, sweat gland duct size and corneal nerve fiber pathology in patients with type 2 diabetes mellitus","volume":"5","author":"Ishibashi","year":"2014","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(15)00136-9_bib52","doi-asserted-by":"crossref","first-page":"e106","DOI":"10.1111\/j.1464-5491.2012.03588.x","article-title":"Retinal nerve fibre layer thinning associated with diabetic peripheral neuropathy","volume":"29","author":"Shahidi","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00136-9_bib53","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1159\/000333220","article-title":"Does neuronal damage precede vascular damage in subjects with type 2 diabetes mellitus and having no clinical diabetic retinopathy?","volume":"47","author":"Verma","year":"2012","journal-title":"Ophthalmic Res"},{"key":"10.1016\/S2213-8587(15)00136-9_bib54","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s10633-012-9343-0","article-title":"Global flash multifocal electroretinogram: early detection of local functional changes and its correlations with optical coherence tomography and visual field tests in diabetic eyes","volume":"125","author":"Lung","year":"2012","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib55","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.1442-9071.2008.01769.x","article-title":"Macular thickness and systemic markers for diabetes in individuals with no or mild diabetic retinopathy","volume":"36","author":"Asefzadeh","year":"2008","journal-title":"Clin Experiment Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib56","doi-asserted-by":"crossref","first-page":"898","DOI":"10.3109\/02713683.2012.683507","article-title":"Correlation of diabetic retinopathy and corneal neuropathy using confocal microscopy","volume":"37","author":"Nitoda","year":"2012","journal-title":"Curr Eye Res"},{"key":"10.1016\/S2213-8587(15)00136-9_bib57","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1097\/01.ico.0000224640.58848.54","article-title":"Morphologic alterations of both the stromal and subbasal nerves in the corneas of patients with diabetes","volume":"25","author":"Mocan","year":"2006","journal-title":"Cornea"},{"key":"10.1016\/S2213-8587(15)00136-9_bib58","doi-asserted-by":"crossref","first-page":"658","DOI":"10.1016\/j.jdiacomp.2014.06.007","article-title":"Differential reduction in corneal nerve fiber length in patients with type 1 or type 2 diabetes mellitus","volume":"28","author":"Stem","year":"2014","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(15)00136-9_bib59","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1159\/000350593","article-title":"Macular thickness measured by stratus optical coherence tomography in patients with diabetes type 2 and mild nonproliferative retinopathy without clinical evidence of macular edema","volume":"229","author":"Pires","year":"2013","journal-title":"Ophthalmologica"},{"key":"10.1016\/S2213-8587(15)00136-9_bib60","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/dme.12324","article-title":"Corneal nerve fibre damage precedes diabetic retinopathy in patients with type 2 diabetes mellitus","volume":"31","author":"Bitirgen","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00136-9_bib61","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1159\/000088382","article-title":"Detection of early diabetic change with optical coherence tomography in type 2 diabetes mellitus patients without retinopathy","volume":"219","author":"Sugimoto","year":"2005","journal-title":"Ophthalmologica"},{"key":"10.1016\/S2213-8587(15)00136-9_bib62","doi-asserted-by":"crossref","first-page":"5155","DOI":"10.1167\/iovs.09-3384","article-title":"Corneal subbasal nerves changes in patients with diabetic retinopathy: an in vivo confocal study","volume":"50","author":"De Cilla","year":"2009","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib63","doi-asserted-by":"crossref","first-page":"1135","DOI":"10.1136\/bjo.2006.111534","article-title":"Decreased optical coherence tomography-measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy","volume":"91","author":"Biallosterski","year":"2007","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib64","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1007\/s10792-012-9610-9","article-title":"Optic disc topographic analysis in diabetic patients","volume":"32","author":"Toprak","year":"2012","journal-title":"Int Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib65","doi-asserted-by":"crossref","first-page":"7982","DOI":"10.1167\/iovs.14-15605","article-title":"Natural history of corneal nerve morphology in mild neuropathy associated with type 1 diabetes: development of a potential measure of diabetic peripheral neuropathy","volume":"55","author":"Dehghani","year":"2014","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib66","doi-asserted-by":"crossref","first-page":"2748","DOI":"10.2337\/dc12-2075","article-title":"Structure-function relationship between corneal nerves and conventional small-fiber tests in type 1 diabetes","volume":"36","author":"Sivaskandarajah","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00136-9_bib67","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.diabres.2014.02.011","article-title":"Longitudinal assessment of neuropathy in type 1 diabetes using novel ophthalmic markers (LANDMark): study design and baseline characteristics","volume":"104","author":"Pritchard","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00136-9_bib68","doi-asserted-by":"crossref","first-page":"464","DOI":"10.20452\/pamw.1411","article-title":"Neurodegeneration of the retina in type 1 diabetic patients","volume":"122","author":"Araszkiewicz","year":"2012","journal-title":"Pol Arch Med Wewn"},{"key":"10.1016\/S2213-8587(15)00136-9_bib69","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1007\/s00592-010-0193-5","article-title":"OCT is not useful for detection of minimal diabetic retinopathy in type 1 diabetes","volume":"47","author":"Ciresi","year":"2010","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib70","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1016\/S0895-4356(98)00131-0","article-title":"The Delphi list: a criteria list for quality assessment of randomized clinical trials for conducting systematic reviews developed by Delphi consensus","volume":"51","author":"Verhagen","year":"1998","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib71","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1038\/nn0901-877","article-title":"The fundamental plan of the retina","volume":"4","author":"Masland","year":"2001","journal-title":"Nat Neurosci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib72","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/414813a","article-title":"Biochemistry and molecular cell biology of diabetic complications","volume":"414","author":"Brownlee","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(15)00136-9_bib73","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1016\/S0889-8529(05)70324-8","article-title":"The cellular and molecular mechanisms of diabetic complications","volume":"25","author":"King","year":"1996","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(15)00136-9_bib74","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1016\/j.tem.2013.09.005","article-title":"Neurodegeneration in the diabetic eye: new insights and therapeutic perspectives","volume":"25","author":"Simo","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00136-9_bib75","doi-asserted-by":"crossref","first-page":"e97302","DOI":"10.1371\/journal.pone.0097302","article-title":"The db\/db mouse: a useful model for the study of diabetic retinal neurodegeneration","volume":"9","author":"Bogdanov","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(15)00136-9_bib76","doi-asserted-by":"crossref","first-page":"1051","DOI":"10.1258\/ebm.2011.010400","article-title":"Dietary wolfberry ameliorates retinal structure abnormalities in db\/db mice at the early stage of diabetes","volume":"23","author":"Tang","year":"2011","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/S2213-8587(15)00136-9_bib77","doi-asserted-by":"crossref","first-page":"4543","DOI":"10.1167\/iovs.04-0519","article-title":"Retinopathy in monkeys with spontaneous type 2 diabetes","volume":"45","author":"Kim","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib78","first-page":"1","article-title":"Diabetic retinopathy","volume":"11","author":"Bloodworth","year":"1962","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(15)00136-9_bib79","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1016\/0002-9394(61)91802-5","article-title":"Diabetic retinopathy","volume":"51","author":"Wolter","year":"1961","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib80","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00136-9_bib81","doi-asserted-by":"crossref","first-page":"1809","DOI":"10.1001\/archopht.122.12.1809","article-title":"Multifocal electroretinogram and short-wavelength automated perimetry measures in diabetic eyes with little or no retinopathy","volume":"122","author":"Han","year":"2004","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib82","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1016\/j.ophtha.2004.05.024","article-title":"Impact of diabetes on glaucoma screening using frequency-doubling perimetry","volume":"111","author":"Realini","year":"2004","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(15)00136-9_bib83","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1001\/archopht.1985.01050010055018","article-title":"Contrast sensitivity in diabetics with and without background retinopathy","volume":"103","author":"Sokol","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib84","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1136\/bjo.76.8.461","article-title":"Detection of colour vision abnormalities in uncomplicated type 1 diabetic patients with angiographically normal retinas","volume":"76","author":"Hardy","year":"1992","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib85","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/bjo.63.8.539","article-title":"Dark adaptation in diabetes mellitus","volume":"63","author":"Henson","year":"1979","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib86","doi-asserted-by":"crossref","first-page":"2620","DOI":"10.1167\/iovs.04-1254","article-title":"The multifocal ERG in diabetic patients without retinopathy during euglycemic clamping","volume":"46","author":"Klemp","year":"2005","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib87","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1001\/archopht.1986.01050190047037","article-title":"Diabetic retinopathy viewed as a neurosensory disorder","volume":"104","author":"Bresnick","year":"1986","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib88","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1097\/IAE.0b013e318183571e","article-title":"Retinal fixation impairment in diabetic macular edema","volume":"28","author":"Vujosevic","year":"2008","journal-title":"Retina"},{"key":"10.1016\/S2213-8587(15)00136-9_bib89","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1167\/iovs.03-1101","article-title":"Multifocal electroretinogram delays predict sites of subsequent diabetic retinopathy","volume":"45","author":"Han","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib90","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/j.preteyeres.2006.07.001","article-title":"A multifocal electroretinogram model predicting the development of diabetic retinopathy","volume":"25","author":"Bearse","year":"2006","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/S2213-8587(15)00136-9_bib91","doi-asserted-by":"crossref","first-page":"1622","DOI":"10.1167\/iovs.07-1157","article-title":"Local diabetic retinopathy prediction by multifocal ERG delays over 3 years","volume":"49","author":"Ng","year":"2008","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib92","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1167\/iovs.10-5931","article-title":"Multifocal electroretinograms predict onset of diabetic retinopathy in adult patients with diabetes","volume":"52","author":"Harrison","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(15)00136-9_bib93","doi-asserted-by":"crossref","first-page":"354783","DOI":"10.1155\/2012\/354783","article-title":"Comparison of time domain and spectral domain optical coherence tomography in measurement of macular thickness in macular edema secondary to diabetic retinopathy and retinal vein occlusion","volume":"2012","author":"Hatef","year":"2012","journal-title":"J Ophthalmol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib94","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1016\/S0161-6420(96)30410-7","article-title":"Reproducibility of nerve fiber layer thickness measurements using optical coherence tomography","volume":"103","author":"Schuman","year":"1996","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(15)00136-9_bib95","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.2337\/dc10-0253","article-title":"Corneal confocal microscopy: a novel noninvasive test to diagnose and stratify the severity of human diabetic neuropathy","volume":"33","author":"Tavakoli","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00136-9_bib96","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2337\/dc14-0279","article-title":"Corneal confocal microscopy detects neuropathy in subjects with impaired glucose tolerance","volume":"37","author":"Asghar","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00136-9_bib97","doi-asserted-by":"crossref","first-page":"671","DOI":"10.2337\/dc14-2114","article-title":"Corneal confocal microscopy predicts 4-year incident peripheral neuropathy in type 1 diabetes","volume":"38","author":"Pritchard","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00136-9_bib98","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1007\/s10654-014-9889-0","article-title":"The Maastricht Study: an extensive phenotyping study on determinants of type 2 diabetes, its complications and its comorbidities","volume":"29","author":"Schram","year":"2014","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00136-9_bib99","article-title":"CORNEAL confocal microscopy for the diagnosis of diabetic autonomic neuropathy","author":"Tavakoli","year":"2014","journal-title":"Muscle Nerve"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001369?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001369?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,29]],"date-time":"2025-05-29T04:53:23Z","timestamp":1748494403000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715001369"}},"issued":{"date-parts":[[2015,8]]},"references-count":99,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2015,8]]}},"alternative-id":["S2213858715001369"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00136-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"New ophthalmologic imaging techniques for detection and monitoring of neurodegenerative changes in diabetes: a systematic review","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00136-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,9]],"date-time":"2026-10-09T02:42:58Z","timestamp":1791513778329,"version":"4.3.4"},"reference-count":23,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,2,1]],"date-time":"2020-02-01T00:00:00Z","timestamp":1580515200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,2]]},"DOI":"10.1016\/s2213-8587(19)30423-1","type":"journal-article","created":{"date-parts":[[2020,1,7]],"date-time":"2020-01-07T20:58:14Z","timestamp":1578430694000},"page":"106-114","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Hertzel C","family":"Gerstein","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Hart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M","family":"Colhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Lakshmanan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fady T","family":"Botros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey","family":"Probstfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew C","family":"Riddle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles Messan","family":"Atisso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leanne","family":"Dyal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Hall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Avezum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Conget","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William C","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolae","family":"Hancu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markolf","family":"Hanefeld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Jansky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matyas","family":"Keltai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Lanas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lawrence A","family":"Leiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricio","family":"Lopez-Jaramillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ernesto Germ\u00e1n Cardona","family":"Mu\u00f1oz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nana","family":"Pogosova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Raubenheimer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne H-H","family":"Sheu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theodora","family":"Temelkova-Kurktschiev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30423-1_bib1","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1002\/dmrr.2810","article-title":"Efficacy and safety of dulaglutide in the treatment of type 2 diabetes: a comprehensive review of the dulaglutide clinical data focusing on the AWARD phase 3 clinical trial program","volume":"32","author":"Jendle","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(19)30423-1_bib2","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/dom.13162","article-title":"A review of GLP-1 receptor agonists: evolution and advancement, through the lens of randomised controlled trials","volume":"20","author":"Aroda","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30423-1_bib3","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30423-1_bib4","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/ene.13905","article-title":"Protection against stroke with glucagon-like peptide 1 receptor agonists: a systematic review and meta-analysis","volume":"26","author":"Barkas","year":"2019","journal-title":"Eur J Neurol"},{"key":"10.1016\/S2213-8587(19)30423-1_bib5","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30423-1_bib6","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1111\/dom.13028","article-title":"Design and baseline characteristics of participants in the researching cardiovascular events with a weekly incretin in diabetes (REWIND) trial of dulaglutide","volume":"20","author":"Gerstein","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30423-1_bib7","doi-asserted-by":"crossref","first-page":"356","DOI":"10.2337\/dc17-1096","article-title":"How does empagliflozin reduce cardiovascular mortality? Insights from a mediation analysis of the EMPA-REG OUTCOME trial","volume":"41","author":"Inzucchi","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30423-1_bib8","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(19)31150-X","article-title":"Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30423-1_bib9","doi-asserted-by":"crossref","first-page":"1692","DOI":"10.1007\/s00125-016-3971-y","article-title":"Incidence, prevalence and mortality of type 2 diabetes requiring glucose-lowering treatment, and associated risks of cardiovascular complications: a nationwide study in Sweden, 2006\u20132013","volume":"59","author":"Norhammar","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30423-1_bib10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone after ischemic stroke or transient ischemic attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30423-1_bib11","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1161\/STROKEAHA.118.023009","article-title":"Canagliflozin and stroke in type 2 diabetes mellitus","volume":"50","author":"Zhou","year":"2019","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(19)30423-1_bib12","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1161\/STROKEAHA.116.015756","article-title":"Empagliflozin and cerebrovascular events in patients with type 2 diabetes mellitus at high cardiovascular risk","volume":"48","author":"Zinman","year":"2017","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(19)30423-1_bib13","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1111\/dom.13850","article-title":"Diabetes drugs and stroke risk: intensive vs conventional glucose-lowering strategies, and implications of recent cardiovascular outcome trials","volume":"22","author":"Lim","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30423-1_bib14","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.119.012356","article-title":"Glycemic control, preexisting cardiovascular disease, and risk of major cardiovascular events in patients with type 2 diabetes mellitus: systematic review with meta-analysis of cardiovascular outcome trials and intensive glucose control trials","volume":"8","author":"Giugliano","year":"2019","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(19)30423-1_bib15","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1111\/dom.13033","article-title":"Prevention of cardiovascular disease through reduction of glycaemic exposure in type 2 diabetes: a perspective on glucose-lowering interventions","volume":"20","author":"Roussel","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30423-1_bib16","doi-asserted-by":"crossref","first-page":"1939","DOI":"10.1097\/HJH.0000000000002152","article-title":"Effects of glucose-lowering on outcome incidence in diabetes mellitus and the modulating role of blood pressure and other clinical variables: overview, meta-analysis of randomized trials","volume":"37","author":"Thomopoulos","year":"2019","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(19)30423-1_bib17","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.peptides.2018.09.002","article-title":"Glucagon-like peptide-1 receptor action in the vasculature","volume":"111","author":"Almutairi","year":"2019","journal-title":"Peptides"},{"key":"10.1016\/S2213-8587(19)30423-1_bib18","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.atherosclerosis.2018.09.011","article-title":"Incretin drugs as modulators of atherosclerosis","volume":"278","author":"Gallego-Colon","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(19)30423-1_bib19","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1111\/bcpt.12974","article-title":"Neuroprotective mechanisms of glucagon-like peptide-1-based therapies in ischaemic stroke: a systematic review based on pre-clinical studies","volume":"122","author":"Marlet","year":"2018","journal-title":"Basic Clin Pharmacol Toxicol"},{"key":"10.1016\/S2213-8587(19)30423-1_bib20","doi-asserted-by":"crossref","first-page":"745","DOI":"10.4103\/1673-5374.249217","article-title":"Repositioning of dipeptidyl peptidase-4 inhibitors and glucagon like peptide-1 agonists as potential neuroprotective agents","volume":"14","author":"Mousa","year":"2019","journal-title":"Neural Regen Res"},{"key":"10.1016\/S2213-8587(19)30423-1_bib21","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1016\/j.neuropharm.2017.08.022","article-title":"Glucagon-like receptor 1 agonists and DPP-4 inhibitors: anti-diabetic drugs with anti-stroke potential","volume":"136","author":"Darsalia","year":"2018","journal-title":"Neuropharmacology"},{"key":"10.1016\/S2213-8587(19)30423-1_bib22","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.3389\/fnins.2019.01112","article-title":"Glucagon-like peptide-1: a focus on neurodegenerative diseases","volume":"13","author":"Grieco","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/S2213-8587(19)30423-1_bib23","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/dom.13649","article-title":"Generalizability of glucagon-like peptide-1 receptor agonist cardiovascular outcome trials to the overall type 2 diabetes population in the United States","volume":"21","author":"Boye","year":"2019","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304231?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304231?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:40Z","timestamp":1761991660000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719304231"}},"issued":{"date-parts":[[2020,2]]},"references-count":23,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2020,2]]}},"alternative-id":["S2213858719304231"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30423-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of dulaglutide on stroke: an exploratory analysis of the REWIND trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30423-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30427-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:18:29Z","timestamp":1792801109608,"version":"4.5.0"},"update-to":[{"DOI":"10.1016\/s2213-8587(25)00119-6","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/s2213-8587(25)00293-1","type":"journal-article","created":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T06:01:18Z","timestamp":1758607278000},"page":"e14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Correction to Lancet Diabetes Endocrinol 2025; 13: 699\u2013721"],"prefix":"10.1016","volume":"13","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:11:19Z","timestamp":1774987879000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002931"}},"issued":{"date-parts":[[2025,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2213858725002931"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00293-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2025; 13: 699\u2013721","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00293-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00119-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:08:11Z","timestamp":1792818491824,"version":"4.5.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/s2213-8587(24)00163-3","type":"journal-article","created":{"date-parts":[[2024,7,22]],"date-time":"2024-07-22T22:32:11Z","timestamp":1721687531000},"page":"748-760","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":44,"title":["Bone health in adults with obesity before and after interventions to promote weight loss"],"prefix":"10.1016","volume":"12","author":[{"given":"Julien","family":"Paccou","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliet E","family":"Compston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00163-3_bib1","series-title":"Obesity and overweight","year":"2024"},{"key":"10.1016\/S2213-8587(24)00163-3_bib2","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1007\/s00198-005-1863-y","article-title":"Body mass index as a predictor of fracture risk: a meta-analysis","volume":"16","author":"De Laet","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(24)00163-3_bib3","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1359\/jbmr.091004","article-title":"Obesity and fractures in postmenopausal women","volume":"25","author":"Premaor","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib4","doi-asserted-by":"crossref","first-page":"1043","DOI":"10.1016\/j.amjmed.2011.06.013","article-title":"Obesity is not protective against fracture in postmenopausal women: GLOW","volume":"124","author":"Compston","year":"2011","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(24)00163-3_bib5","doi-asserted-by":"crossref","first-page":"2414","DOI":"10.1210\/jc.2011-0076","article-title":"Risk factors for nonvertebral fracture in obese older women","volume":"96","author":"Premaor","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib6","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1002\/jbmr.315","article-title":"Body mass index and physical activity in relation to the incidence of hip fracture in postmenopausal women","volume":"26","author":"Armstrong","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib7","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/jbmr.235","article-title":"BMI and fracture risk in older men: the osteoporotic fractures in men study (MrOS)","volume":"26","author":"Nielson","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib8","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/joim.12230","article-title":"Abdominal obesity increases the risk of hip fracture. A population-based study of 43,000 women and men aged 60\u201379 years followed for 8 years","volume":"277","author":"S\u00f8gaard","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(24)00163-3_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115546","article-title":"Incidence and predictors of fractures in older adults with and without obesity defined by body mass index versus body fat percentage","volume":"140","author":"Gandham","year":"2020","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(24)00163-3_bib10","first-page":"1198","article-title":"Waist circumference and the risk of lumbar and femur fractures: a nationwide population-based cohort study","volume":"25","author":"Park","year":"2021","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/S2213-8587(24)00163-3_bib11","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10730","article-title":"Relationships between obesity and incidence of fractures in a middle-aged population: a study from the CARTaGENE cohort","volume":"7","author":"Turcotte","year":"2023","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(24)00163-3_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1016\/j.ecl.2020.02.008","article-title":"Sex differences in adipose tissue function","volume":"49","author":"Gavin","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(24)00163-3_bib13","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.soard.2009.05.014","article-title":"Obesity in orthopedic patients","volume":"5","author":"Bergkvist","year":"2009","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(24)00163-3_bib14","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00774-009-0056-8","article-title":"Relationship of body mass index with main limb fragility fractures in postmenopausal women","volume":"27","author":"Gnudi","year":"2009","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib15","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1053\/j.jfas.2012.05.016","article-title":"Association between ankle fractures and obesity","volume":"51","author":"King","year":"2012","journal-title":"J Foot Ankle Surg"},{"key":"10.1016\/S2213-8587(24)00163-3_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1002\/jbmr.1466","article-title":"The association between fracture and obesity is site-dependent: a population-based study in postmenopausal women","volume":"27","author":"Prieto-Alhambra","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib17","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/j.bone.2013.11.024","article-title":"A United Kingdom perspective on the relationship between body mass index (BMI) and bone health: a cross sectional analysis of data from the Nottingham Fracture Liaison Service","volume":"59","author":"Ong","year":"2014","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(24)00163-3_bib18","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1002\/jbmr.2051","article-title":"Relationship of weight, height, and body mass index with fracture risk at different sites in postmenopausal women: the Global Longitudinal study of Osteoporosis in Women (GLOW)","volume":"29","author":"Compston","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib19","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1002\/jbmr.2826","article-title":"The effects of age, adiposity, and physical activity on the risk of seven site-specific fractures in postmenopausal women","volume":"31","author":"Lacombe","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib20","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1007\/s00774-009-0108-0","article-title":"High weight or body mass index increase the risk of vertebral fractures in postmenopausal osteoporotic women","volume":"28","author":"Pirro","year":"2010","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib21","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1007\/s00198-011-1741-8","article-title":"Excess body fat is associated with higher risk of vertebral deformities in older women but not in men: a cross-sectional study","volume":"23","author":"Laslett","year":"2012","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(24)00163-3_bib22","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1002\/jbmr.3085","article-title":"Total and visceral adiposity are associated with prevalent vertebral fracture in women but not men at age 62 Years: the Newcastle Thousand Families Study","volume":"32","author":"Hind","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib23","article-title":"Obesity and risk of fracture in postmenopausal women: a meta-analysis of cohort studies","volume":"55","author":"Liu","year":"2023","journal-title":"Ann Med"},{"key":"10.1016\/S2213-8587(24)00163-3_bib24","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1007\/s00223-013-9801-z","article-title":"Obesity, health-care utilization, and health-related quality of life after fracture in postmenopausal women: Global Longitudinal Study of Osteoporosis in Women (GLOW)","volume":"94","author":"Compston","year":"2014","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(24)00163-3_bib25","doi-asserted-by":"crossref","first-page":"1771","DOI":"10.1002\/jbmr.1878","article-title":"The association between fracture site and obesity in men: a population-based cohort study","volume":"28","author":"Premaor","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib26","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1186\/s12891-022-05247-3","article-title":"The effect of BMI on long-term outcomes after operatively treated ankle fractures: a study with up to 16 years of follow-up","volume":"23","author":"Cardoso","year":"2022","journal-title":"BMC Musculoskelet Disord"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(24)00163-3_bib27","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.1016\/j.injury.2020.11.029","article-title":"Fracture nonunion in long bones: a literature review of risk factors and surgical management","volume":"52","author":"Nicholson","year":"2021","journal-title":"Injury"},{"key":"10.1016\/S2213-8587(24)00163-3_bib28","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1002\/jbmr.2209","article-title":"Relationship between mortality and BMI after fracture: a population-based study of men and women aged \u226540 years","volume":"29","author":"Prieto-Alhambra","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib29","doi-asserted-by":"crossref","first-page":"185","DOI":"10.2340\/17453674.2021.1020","article-title":"The obesity paradox and mortality after pathological hip fractures: a Swedish registry study","volume":"93","author":"Ehne","year":"2022","journal-title":"Acta Orthop"},{"key":"10.1016\/S2213-8587(24)00163-3_bib30","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s10195-023-00715-5","article-title":"Facrots associated with mortality after proximal femoral fracture","volume":"24","author":"Walter","year":"2023","journal-title":"J Orthop Traumatol"},{"key":"10.1016\/S2213-8587(24)00163-3_bib31","doi-asserted-by":"crossref","first-page":"C375","DOI":"10.1152\/ajpcell.00379.2020","article-title":"Adipose tissue inflammation and metabolic dysfunction in obesity","volume":"320","author":"Kawai","year":"2021","journal-title":"Am J Physiol Cell Physiol"},{"key":"10.1016\/S2213-8587(24)00163-3_bib32","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1210\/jc.2015-3123","article-title":"Associations of body mass index with incident fractures and hip structural parameters in a large Canadian cohort","volume":"101","author":"Shen","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib33","doi-asserted-by":"crossref","first-page":"644","DOI":"10.3390\/biomedicines11020644","article-title":"Novel adipokines and their role in bone metabolism: a narrative review","volume":"11","author":"Deepika","year":"2023","journal-title":"Biomedicines"},{"key":"10.1016\/S2213-8587(24)00163-3_bib34","doi-asserted-by":"crossref","first-page":"3387","DOI":"10.1210\/jc.2008-2422","article-title":"Reciprocal relations of subcutaneous and visceral fat to bone structure and strength","volume":"94","author":"Gilsanz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib35","doi-asserted-by":"crossref","first-page":"4115","DOI":"10.1210\/jc.2012-2246","article-title":"Determinants of bone microarchitecture and mechanical properties in obese men","volume":"97","author":"Bredella","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib36","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph17113996","article-title":"Visceral fat is a negative determinant of bone health in obese postmenopausal women","volume":"17","author":"Sharma","year":"2020","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(24)00163-3_bib37","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1111\/joim.12718","article-title":"Clinical implications of bone marrow adiposity","volume":"283","author":"Veldhuis-Vlug","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(24)00163-3_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.981487","article-title":"The pathophysiology of osteoporosis in obesity and type 2 diabetes in aging women and men: the mechanisms and roles of increased bone marrow adiposity","volume":"13","author":"Ali","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(24)00163-3_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2023.155639","article-title":"Sarcopenic obesity: emerging mechanisms and therapeutic potential","volume":"146","author":"Axelrod","year":"2023","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(24)00163-3_bib40","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1002\/jbmr.506","article-title":"Simulated increases in body fat and errors in bone mineral density measurements by DXA and QCT","volume":"27","author":"Yu","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib41","doi-asserted-by":"crossref","DOI":"10.3390\/nu15214601","article-title":"The impact of interventional weight loss on bone marrow adipose tissue in people living with obesity and its connection to bone metabolism","volume":"15","author":"Tencerova","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(24)00163-3_bib42","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1530\/EJE-22-0530","article-title":"Fat, adipokines, bone structure and bone regulatory factors associations in obesity","volume":"187","author":"Vilaca","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00163-3_bib43","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1002\/jbmr.2407","article-title":"Bone density, microstructure and strength in obese and normal weight men and women in younger and older adulthood","volume":"30","author":"Evans","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib44","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1210\/jc.2012-4113","article-title":"Changes in bone resorption across the menopause transition: effects of reproductive hormones, body size, and ethnicity","volume":"98","author":"Sowers","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib45","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1007\/s00198-010-1305-3","article-title":"Obesity alters cortical and trabecular bone density and geometry in women","volume":"22","author":"Sukumar","year":"2011","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(24)00163-3_bib46","doi-asserted-by":"crossref","first-page":"1679","DOI":"10.1002\/jbmr.1880","article-title":"In obese postmenopausal women, bone microarchitecture and strength are not commensurate to greater body weight: the Os des Femmes de Lyon (OFELY) study","volume":"28","author":"Sornay-Rendu","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib47","doi-asserted-by":"crossref","first-page":"749","DOI":"10.1002\/jbmr.2747","article-title":"A high amount of local adipose tissue is associated with high cortical porosity and low bone material strength in older women","volume":"31","author":"Sundh","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib48","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11914-019-00538-6","article-title":"Effects of diabetes on bone material properties","volume":"17","author":"Lekkala","year":"2019","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/S2213-8587(24)00163-3_bib49","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41574-021-00555-5","article-title":"Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus","volume":"17","author":"Khosla","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00163-3_bib50","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/ijo.2011.119","article-title":"The link between obesity and low circulating 25-hydroxyvitamin D concentrations: considerations and implications","volume":"36","author":"Earthman","year":"2012","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(24)00163-3_bib51","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.1210\/jc.2010-2202","article-title":"Vitamin D and hyperparathyroidism in obesity","volume":"96","author":"Grethen","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib52","doi-asserted-by":"crossref","first-page":"2124","DOI":"10.1001\/archinte.166.19.2124","article-title":"Endogenous testosterone levels, physical performance, and fall risk in older men","volume":"166","author":"Orwoll","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(24)00163-3_bib53","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1093\/gerona\/glz272","article-title":"Does obesity increase the risk and severity of falls in people aged 60 years and older? A systematic review and meta-analysis of observational studies","volume":"75","author":"Neri","year":"2020","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(24)00163-3_bib54","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1177\/0898264316660412","article-title":"Obesity and falls in a prospective study of older men: the Osteoporotic Fractures in Men study","volume":"29","author":"Hooker","year":"2017","journal-title":"J Aging Health"},{"key":"10.1016\/S2213-8587(24)00163-3_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115433","article-title":"Comparison of clinical risk factors for incident fracture in obese and non-obese community-dwelling older men","volume":"137","author":"Scott","year":"2020","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(24)00163-3_bib56","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.maturitas.2017.12.011","article-title":"The risks of sarcopenia, falls and fractures in patients with type 2 diabetes mellitus","volume":"109","author":"Sarodnik","year":"2018","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(24)00163-3_bib57","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1038\/s41574-018-0062-9","article-title":"Sarcopenic obesity in older adults: aetiology, epidemiology and treatment strategies","volume":"14","author":"Batsis","year":"2018","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00163-3_bib58","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1159\/000521241","article-title":"Definition and diagnostic criteria for sarcopenic obesity: ESPEN and EASO Consensus Statement","volume":"15","author":"Donini","year":"2022","journal-title":"Obes Facts"},{"key":"10.1016\/S2213-8587(24)00163-3_bib59","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13187","article-title":"Falls, fractures, and areal bone mineral density in older adults with sarcopenic obesity: a systematic review and meta-analysis","volume":"22","author":"Gandham","year":"2021","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(24)00163-3_bib60","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1002\/oby.23609","article-title":"Reduced muscle strength (dynapenia) in women with obesity confers a greater risk of falls and fractures in the UK Biobank","volume":"31","author":"Dowling","year":"2023","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(24)00163-3_bib61","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s00198-014-2986-9","article-title":"Incident type 2 diabetes and hip fracture risk: a population-based matched cohort study","volume":"26","author":"Martinez-Laguna","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(24)00163-3_bib62","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1007\/s00198-020-05519-5","article-title":"Risk of fragility fractures in obesity and diabetes: a retrospective analysis on a nation-wide cohort","volume":"31","author":"Adami","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(24)00163-3_bib64","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1002\/jbmr.1729","article-title":"Predictive value of FRAX for fracture in obese older women","volume":"28","author":"Premaor","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib65","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/obr.12239","article-title":"Obesity and vitamin D deficiency: a systematic review and meta-analysis","volume":"16","author":"Pereira-Santos","year":"2015","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(24)00163-3_bib66","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1016\/j.jsbmb.2012.12.003","article-title":"The effect of vitamin D supplementation on serum 25(OH)D in thin and obese women","volume":"136","author":"Gallagher","year":"2013","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S2213-8587(24)00163-3_bib67","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S2213-8587(19)30378-X","article-title":"Reducing the treatment gap in osteoporosis","volume":"8","author":"Compston","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00163-3_bib68","doi-asserted-by":"crossref","first-page":"3215","DOI":"10.1210\/jc.2008-2765","article-title":"Effect of once-yearly zoledronic acid five milligrams on fracture risk and change in femoral neck bone mineral density","volume":"94","author":"Eastell","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib69","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1002\/jbmr.536","article-title":"Effect of denosumab treatment on the risk of fractures in subgroups of women with postmenopausal osteoporosis","volume":"27","author":"McClung","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib70","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1111\/joim.12901","article-title":"Anti-fracture efficacy of zoledronate in subgroups of osteopenic postmenopausal women: secondary analysis of a randomized controlled trial","volume":"286","author":"Reid","year":"2019","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(24)00163-3_bib71","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.jacc.2017.11.011","article-title":"Obesity: pathophysiology and management","volume":"71","author":"Gadde","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(24)00163-3_bib72","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-19-0893","article-title":"European Society of Endocrinology Clinical Practice Guideline: endocrine work-up in obesity","volume":"182","author":"Pasquali","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00163-3_bib73","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1159\/000500779","article-title":"Is weight loss harmful for skeletal health in obese older adults?","volume":"66","author":"Papageorgiou","year":"2020","journal-title":"Gerontology"},{"key":"10.1016\/S2213-8587(24)00163-3_bib74","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1210\/jc.2007-1473","article-title":"Effect of weight loss and exercise therapy on bone metabolism and mass in obese older adults: a one-year randomized controlled trial","volume":"93","author":"Villareal","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib75","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1007\/s00223-020-00798-w","article-title":"Bariatric surgery and osteoporosis","volume":"110","author":"Paccou","year":"2022","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(24)00163-3_bib76","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.1002\/jbmr.2564","article-title":"Does diet-induced weight loss lead to bone loss in overweight or obese adults? A systematic review and meta-analysis of clinical trials","volume":"30","author":"Zibellini","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib77","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jbmr.3905","article-title":"Effect of aerobic or resistance exercise, or both, on bone mineral density and bone metabolism in obese older adults while dieting: a randomized controlled trial","volume":"35","author":"Armamento-Villareal","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib78","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1007\/s00223-023-01150-8","article-title":"Narrative review of effects of glucagon-like peptide-1 receptor agonists on bone health in people living with obesity","volume":"114","author":"Herrou","year":"2024","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(24)00163-3_bib79","doi-asserted-by":"crossref","first-page":"1286","DOI":"10.1016\/j.bone.2009.10.013","article-title":"Three-month weight reduction does not compromise bone strength in obese premenopausal women","volume":"46","author":"Uusi-Rasi","year":"2010","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(24)00163-3_bib80","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1002\/jbmr.3555","article-title":"Effect of exercise modality during weight loss on bone health in older adults with obesity and cardiovascular disease or metabolic syndrome: a randomized controlled trial","volume":"33","author":"Beavers","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib81","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1007\/s40520-018-1010-1","article-title":"Prediction of lumbar vertebral body compressive strength of overweight and obese older adults using morphed subject-specific finite-element models to evaluate the effects of weight loss","volume":"31","author":"Schoell","year":"2019","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib82","doi-asserted-by":"crossref","first-page":"h25","DOI":"10.1136\/bmj.h25","article-title":"Postmenopausal weight change and incidence of fracture: post hoc findings from Women's Health Initiative Observational Study and Clinical Trials","volume":"350","author":"Crandall","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00163-3_bib83","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1046\/j.1532-5415.2003.51558.x","article-title":"Intentional and unintentional weight loss increase bone loss and hip fracture risk in older women","volume":"51","author":"Ensrud","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(24)00163-3_bib84","doi-asserted-by":"crossref","first-page":"2278","DOI":"10.1002\/jbmr.3214","article-title":"The effect of intentional weight loss on fracture risk in persons with diabetes: results from the Look AHEAD randomized clinical trial","volume":"32","author":"Johnson","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib85","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1002\/jbmr.1483","article-title":"Effect of 1 year of an intentional weight loss intervention on bone mineral density in type 2 diabetes: results from the Look AHEAD randomized trial","volume":"27","author":"Schwartz","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib86","doi-asserted-by":"crossref","first-page":"2822","DOI":"10.2337\/dc14-0762","article-title":"The Look AHEAD trial: bone loss at 4-year follow-up in type 2 diabetes","volume":"37","author":"Lipkin","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00163-3_bib87","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1210\/jc.2011-2165","article-title":"Diets higher in dairy foods and dietary protein support bone health during diet- and exercise-induced weight loss in overweight and obese premenopausal women","volume":"97","author":"Josse","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib88","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1210\/jc.2018-02084","article-title":"Obesity, bariatric surgery, and fractures","volume":"104","author":"Lespessailles","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib89","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1002\/jbm4.10048","article-title":"Bone health after bariatric surgery","volume":"2","author":"Gagnon","year":"2018","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(24)00163-3_bib90","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.116236","article-title":"Bariatric surgery and skeletal health: a narrative review and position statement for management by the European Calcified Tissue Society (ECTS)","volume":"154","author":"Paccou","year":"2022","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(24)00163-3_bib91","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.1007\/s11695-023-06503-8","article-title":"Changes in bone turnover markers after Roux-en-Y gastric bypass versus sleeve gastrectomy: a systematic review and meta-analysis","volume":"33","author":"Ebadinejad","year":"2023","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(24)00163-3_bib92","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/j.soard.2021.12.004","article-title":"A comparison of changes in bone turnover markers after gastric bypass and sleeve gastrectomy, and their association with markers of interest","volume":"18","author":"Paccou","year":"2022","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(24)00163-3_bib93","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1210\/clinem\/dgaa808","article-title":"Bone mineral density and turnover after sleeve gastrectomy and gastric bypass: a randomized controlled trial (Oseberg)","volume":"106","author":"Hofs\u00f8","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib94","doi-asserted-by":"crossref","first-page":"4104","DOI":"10.1210\/jc.2018-01496","article-title":"Longitudinal 5-year evaluation of bone density and microarchitecture after Roux-en-Y gastric bypass surgery","volume":"103","author":"Lindeman","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib95","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13479","article-title":"Changes in volumetric bone mineral density and bone quality after Roux-en-Y gastric bypass: a meta-analysis with meta-regression","volume":"23","author":"Hern\u00e1ndez-Mart\u00ednez","year":"2022","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(24)00163-3_bib96","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1002\/jbmr.3101","article-title":"Fracture risk after bariatric surgery: Roux-en-Y gastric bypass versus adjustable gastric banding","volume":"32","author":"Yu","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib97","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1001\/jamasurg.2019.1157","article-title":"Fracture risk after Roux-en-Y gastric bypass vs adjustable gastric banding among Medicare beneficiaries","volume":"154","author":"Yu","year":"2019","journal-title":"JAMA Surg"},{"key":"10.1016\/S2213-8587(24)00163-3_bib98","doi-asserted-by":"crossref","first-page":"2122","DOI":"10.1002\/jbmr.3553","article-title":"Fracture risk after gastric bypass surgery: a retrospective cohort study","volume":"33","author":"Axelsson","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib99","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2020.7419","article-title":"Association of bariatric surgery with risk of fracture in patients with severe obesity","volume":"3","author":"Khalid","year":"2020","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(24)00163-3_bib100","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1002\/jbmr.4012","article-title":"Gastric bypass but not sleeve gastrectomy increases risk of major osteoporotic fracture: French population-based cohort study","volume":"35","author":"Paccou","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib101","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1038\/s41366-018-0097-y","article-title":"Long-term incidence of serious fall-related injuries after bariatric surgery in Swedish obese subjects","volume":"43","author":"Carlsson","year":"2019","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(24)00163-3_bib102","doi-asserted-by":"crossref","first-page":"3830","DOI":"10.1007\/s11695-022-06335-y","article-title":"Body composition, sarcopenia and physical performance after bariatric surgery: differences between sleeve gastrectomy and Roux-En-Y gastric bypass","volume":"32","author":"Baad","year":"2022","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(24)00163-3_bib103","doi-asserted-by":"crossref","first-page":"256","DOI":"10.4158\/EP-2017-0072","article-title":"Increased bone turnover in type 2 diabetes patients randomized to bariatric surgery vs. medical therapy at least 5 years","volume":"24","author":"Crawford","year":"2018","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(24)00163-3_bib104","doi-asserted-by":"crossref","first-page":"3735","DOI":"10.1210\/jc.2008-0481","article-title":"The decline in hip bone density after gastric bypass surgery is associated with extent of weight loss","volume":"93","author":"Fleischer","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib105","doi-asserted-by":"crossref","first-page":"2344","DOI":"10.1002\/oby.21150","article-title":"Two-year outcomes on bone density and fracture incidence in patients with T2DM randomized to bariatric surgery versus intensive medical therapy","volume":"23","author":"Maghrabi","year":"2015","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(24)00163-3_bib106","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.soard.2020.09.031","article-title":"Metabolic bone changes after bariatric surgery: 2020 update, American Society for Metabolic and Bariatric Surgery Clinical Issues Committee position statement","volume":"17","author":"Kim","year":"2021","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(24)00163-3_bib107","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbspin.2022.105443","article-title":"French recommendations on the prevention and treatment of osteoporosis secondary to bariatric surgery","volume":"89","author":"Paccou","year":"2022","journal-title":"Joint Bone Spine"},{"key":"10.1016\/S2213-8587(24)00163-3_bib108","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1002\/jbmr.2707","article-title":"The impact of vitamin D, calcium, protein supplementation, and physical exercise on bone metabolism after bariatric surgery: the BABS study","volume":"31","author":"Muschitz","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib109","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1007\/s11154-023-09831-3","article-title":"Vitamin D status and supplementation before and after bariatric surgery: recommendations based on a systematic review and meta-analysis","volume":"24","author":"Giustina","year":"2023","journal-title":"Rev Endocr Metab Disord"},{"key":"10.1016\/S2213-8587(24)00163-3_bib110","article-title":"Fracture risk and management of discontinuation of denosumab therapy: a systematic review and position statement by ECTS","author":"Tsourdi","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib111","article-title":"Zoledronic acid for prevention of bone loss in patients receiving bariatric surgery","volume":"14","author":"Liu","year":"2021","journal-title":"Bone Rep"},{"key":"10.1016\/S2213-8587(24)00163-3_bib112","doi-asserted-by":"crossref","DOI":"10.1111\/cob.12487","article-title":"Risedronate use to attenuate bone loss following sleeve gastrectomy: results from a pilot randomized controlled trial","volume":"11","author":"Beavers","year":"2021","journal-title":"Clin Obes"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(24)00163-3_bib113","doi-asserted-by":"crossref","first-page":"S65","DOI":"10.1016\/S1262-3636(08)73397-4","article-title":"Physiology of incretins (GIP and GLP-1) and abnormalities in type 2 diabetes","volume":"34","author":"Gautier","year":"2008","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib114","doi-asserted-by":"crossref","DOI":"10.1172\/JCI167952","article-title":"Dual gut hormone receptor agonists for diabetes and obesity","volume":"133","author":"Bass","year":"2023","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(24)00163-3_bib115","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1038\/s41573-021-00337-8","article-title":"Anti-obesity drug discovery: advances and challenges","volume":"21","author":"M\u00fcller","year":"2022","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S2213-8587(24)00163-3_bib116","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.adh4453","article-title":"Seeking satiety: from signals to solutions","volume":"15","author":"Tsch\u00f6p","year":"2023","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(24)00163-3_bib117","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1056\/NEJMoa2032183","article-title":"Once-weekly semaglutide in adults with overweight or obesity","volume":"384","author":"Wilding","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00163-3_bib118","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/S0140-6736(21)00213-0","article-title":"Semaglutide 2\u00b74 mg once a week in adults with overweight or obesity, and type 2 diabetes (STEP 2): a randomised, double-blind, double-dummy, placebo-controlled, phase 3 trial","volume":"397","author":"Davies","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00163-3_bib119","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1056\/NEJMoa2206038","article-title":"Tirzepatide once weekly for the treatment of obesity","volume":"387","author":"Jastreboff","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00163-3_bib120","doi-asserted-by":"crossref","first-page":"514","DOI":"10.1056\/NEJMoa2301972","article-title":"Triple-hormone-receptor agonist retatrutide for obesity - a phase 2 trial","volume":"389","author":"Jastreboff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00163-3_bib121","doi-asserted-by":"crossref","DOI":"10.1145\/2818302","article-title":"Glucagon-like peptide-1 receptor agonist liraglutide has anabolic bone effects in ovariectomized rats without diabetes","volume":"10","author":"Lu","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(24)00163-3_bib122","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1016\/j.bone.2015.08.006","article-title":"Chronic administration of glucagon-like peptide-1 receptor agonists improves trabecular bone mass and architecture in ovariectomised mice","volume":"81","author":"Pereira","year":"2015","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(24)00163-3_bib123","doi-asserted-by":"crossref","first-page":"2909","DOI":"10.1210\/jc.2015-1176","article-title":"GLP-1 receptor agonist treatment increases bone formation and prevents bone loss in weight-reduced obese women","volume":"100","author":"Iepsen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib124","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102624","article-title":"Once-weekly semaglutide versus placebo in adults with increased fracture risk: a randomised, double-blinded, two-centre, phase 2 trial","volume":"72","author":"Hansen","year":"2024","journal-title":"eClinicalMedicine"},{"key":"10.1016\/S2213-8587(24)00163-3_bib125","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2019.115197","article-title":"Bone resorption is unchanged by liraglutide in type 2 diabetes patients: a randomised controlled trial","volume":"132","author":"Hygum","year":"2020","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(24)00163-3_bib126","doi-asserted-by":"crossref","DOI":"10.1155\/2021\/3361309","article-title":"Effects of GLP-1 receptor agonists on bone mineral density in patients with type 2 diabetes mellitus: a 52-week clinical study","volume":"2021","author":"Cai","year":"2021","journal-title":"BioMed Res Int"},{"key":"10.1016\/S2213-8587(24)00163-3_bib127","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1016\/j.bone.2006.09.025","article-title":"Disassociation of bone resorption and formation by GLP-2: a 14-day study in healthy postmenopausal women","volume":"40","author":"Henriksen","year":"2007","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(24)00163-3_bib128","doi-asserted-by":"crossref","first-page":"2180","DOI":"10.1359\/jbmr.2003.18.12.2180","article-title":"Role of gastrointestinal hormones in postprandial reduction of bone resorption","volume":"18","author":"Henriksen","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(24)00163-3_bib129","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1016\/j.bone.2009.07.008","article-title":"Four-month treatment with GLP-2 significantly increases hip BMD: a randomized, placebo-controlled, dose-ranging study in postmenopausal women with low BMD","volume":"45","author":"Henriksen","year":"2009","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(24)00163-3_bib130","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes \u2013 state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(24)00163-3_bib131","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/1753-0407.12102","article-title":"Use of glucagon-like peptide-1 receptor agonists and bone fractures: a meta-analysis of randomized clinical trials","volume":"6","author":"Mabilleau","year":"2014","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(24)00163-3_bib132","doi-asserted-by":"crossref","first-page":"2639","DOI":"10.1007\/s00198-018-4649-8","article-title":"Glucagon-like peptide-1 receptor agonists and fracture risk: a network meta-analysis of randomized clinical trials","volume":"29","author":"Zhang","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(24)00163-3_bib133","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2021.735824","article-title":"Effects of anti-diabetic drugs on fracture risk: a systematic review and network meta-analysis","volume":"12","author":"Zhang","year":"2021","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(24)00163-3_bib134","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3168","article-title":"Glucagon-like peptide-1 receptor agonists and risk of bone fracture in patients with type 2 diabetes: a meta-analysis of randomized controlled trials","volume":"35","author":"Cheng","year":"2019","journal-title":"Diabetes Metab Res Rev"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(24)00235-3","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001633?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001633?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,9,24]],"date-time":"2024-09-24T23:24:28Z","timestamp":1727220268000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001633"}},"issued":{"date-parts":[[2024,10]]},"references-count":133,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2213858724001633"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00163-3","relation":{"erratum":[{"id-type":"doi","id":"10.1016\/S2213-8587(24)00235-3","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone health in adults with obesity before and after interventions to promote weight loss","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00163-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T05:55:09Z","timestamp":1792821309134,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,11,21]],"date-time":"2018-11-21T00:00:00Z","timestamp":1542758400000},"content-version":"am","delay-in-days":355,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100016288","name":"Kissei","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016288","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002491","name":"Bristol-Myers Squibb","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002491","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100017346","name":"Boehringer Ingelheim Japan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100017346","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004324","name":"Astellas Pharma US","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004324","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012627","name":"Japan Diabetes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012627","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008792","name":"Novartis Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008792","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013170","name":"Ono Pharmaceutical","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013170","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004948","name":"Astellas Pharma","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004948","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007054","name":"Meso Scale Diagnostics","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007054","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006453","name":"Taisho Toyama Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006453","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012351","name":"Mitsubishi Tanabe Pharma Corporation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012351","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008373","name":"Takeda Pharmaceutical Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004095","name":"Kyowa Hakko Kirin","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004095","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/s2213-8587(17)30327-3","type":"journal-article","created":{"date-parts":[[2017,10,24]],"date-time":"2017-10-24T19:00:15Z","timestamp":1508871615000},"page":"951-964","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":271,"title":["Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial"],"prefix":"10.1016","volume":"5","author":[{"given":"Kohjiro","family":"Ueki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takayoshi","family":"Sasako","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukiko","family":"Okazaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sumie","family":"Okahata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisayuki","family":"Katsuyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikiko","family":"Haraguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ai","family":"Morita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ken","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Hara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Morise","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Izumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Ishizuka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ohashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhiko","family":"Noda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takashi","family":"Kadowaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masakazu","family":"Haneda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunori","family":"Iwashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiro","family":"Suda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Tamasawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Daimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriko","family":"Takebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Ishigaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Watanabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kikuo","family":"Kasai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshimasa","family":"Aso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shun","family":"Ishibashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigehiro","family":"Katayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"San-e","family":"Ishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kakei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Namai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naotake","family":"Hashimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshifumi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shunichiro","family":"Onishi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koutaro","family":"Yokote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Matsuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masahiro","family":"Masuzawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Satoshi","family":"Saito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norikazu","family":"Ogihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hisamitsu","family":"Ishihara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoko","family":"Tajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazunori","family":"Utsunomiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryuzo","family":"Kawamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirotaka","family":"Watada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michio","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasumichi","family":"Mori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruo","family":"Shiba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Isogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sakura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masato","family":"Odawara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuyuki","family":"Tobe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhisa","family":"Tsukamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshimasa","family":"Yamauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tamio","family":"Teramoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Hirata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isao","family":"Uchimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihiro","family":"Ogawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gen","family":"Yoshino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Hirose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kajio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshihito","family":"Atsumi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Shimada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoichi","family":"Oikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akio","family":"Ueki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ohno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masafumi","family":"Kitaoka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikuni","family":"Fujita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsumi","family":"Moriya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Taiki","family":"Tojo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayoshi","family":"Shichiri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daisuke","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masao","family":"Toyoda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kumiko","family":"Hamano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rieko","family":"Komi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Terauchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuaki","family":"Kuzuya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayo","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshinari","family":"Takamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuo","family":"Imura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhisa","family":"Kato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyasu","family":"Itoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Suzuki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikihiro","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takahisa","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eitaro","family":"Nakashima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuhiro","family":"Sumida","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yutaka","family":"Yano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuyoshi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuya","family":"Murata","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsunori","family":"Kashiwagi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Maegawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shigeo","family":"Kono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuya","family":"Inagaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keisuke","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuyuki","family":"Yasuda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasunao","family":"Yoshimasa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ichiro","family":"Kishimoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toshihiko","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masayuki","family":"Hosoi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoyuki","family":"Yamasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Munehide","family":"Matsuhisa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Iichiro","family":"Shimomura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ataru","family":"Taniguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akira","family":"Kuroe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Kurose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takeshi","family":"Ohara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuhiko","family":"Sakaguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuyoshi","family":"Namba","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kohei","family":"Kaku","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masazumi","family":"Fujiwara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ikki","family":"Shimizu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keizo","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osamu","family":"Ebisui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yukio","family":"Tanizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yosuke","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Natori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiko","family":"Kodera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoichi","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Makoto","family":"Ide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kentaro","family":"Yamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumio","family":"Umeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichi","family":"Natori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Eto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuo","family":"Mimura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinsuke","family":"Hiramatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Inoue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ryoko","family":"Takei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsushi","family":"Ogo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsumi","family":"Eguchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiji","family":"Kawasaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuji","family":"Koide","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eiichi","family":"Araki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideaki","family":"Jinnouchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroaki","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsutaka","family":"Motoyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Toru","family":"Hiyoshi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadahisa","family":"Momoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koichiro","family":"Sato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiko","family":"Yoneyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenichi","family":"Ito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Sobajima","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Ikegami","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masaki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroki","family":"Ikeda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenji","family":"Takahashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hirofumi","family":"Makino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasuo","family":"Ueda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Masamitsu","family":"Nakazato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30327-3_bib1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30327-3_bib2","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30327-3_bib3","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30327-3_bib4","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/0168-8227(95)01064-K","article-title":"Intensive insulin therapy prevents the progression of diabetic microvascular complications in Japanese patients with non-insulin-dependent diabetes mellitus: a randomized prospective 6-year study","volume":"28","author":"Ohkubo","year":"1995","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(17)30327-3_bib5","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30327-3_bib6","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30327-3_bib7","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose control and vascular complications in veterans with type 2 diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30327-3_bib8","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.2337\/dc09-2082","article-title":"Hypoglycemia, diabetes, and cardiovascular events","volume":"33","author":"Desouza","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30327-3_bib9","doi-asserted-by":"crossref","first-page":"217","DOI":"10.2337\/dc13-0701","article-title":"Vital signs, QT prolongation, and newly diagnosed cardiovascular disease during severe hypoglycemia in type 1 and type 2 diabetic patients","volume":"37","author":"Tsujimoto","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30327-3_bib10","doi-asserted-by":"crossref","first-page":"713","DOI":"10.1136\/bmj.317.7160.713","article-title":"Efficacy of atenolol and captopril in reducing risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 39","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30327-3_bib11","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S0140-6736(07)61303-8","article-title":"Effects of a fixed combination of perindopril and indapamide on macrovascular and microvascular outcomes in patients with type 2 diabetes mellitus (the ADVANCE trial): a randomised controlled trial","volume":"370","year":"2007","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30327-3_bib12","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1016\/S0140-6736(04)16895-5","article-title":"Primary prevention of cardiovascular disease with atorvastatin in type 2 diabetes in the Collaborative Atorvastatin Diabetes Study (CARDS): multicentre randomised placebo-controlled trial","volume":"364","author":"Colhoun","year":"2004","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30327-3_bib13","first-page":"S75","article-title":"Cardiovascular disease and risk management","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30327-3_bib14","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryd\u00e9n","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(17)30327-3_bib15","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30327-3_bib16","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1291\/hypres.30.677","article-title":"Influence of hypertension on the incidence of cardiovascular disease in two rural communities in Japan: the Tanno-Sobetsu study","volume":"30","author":"Obara","year":"2007","journal-title":"Hypertens Res"},{"key":"10.1016\/S2213-8587(17)30327-3_bib17","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1007\/s13340-015-0206-2","article-title":"Evidence-based practice guideline for the treatment for diabetes in Japan 2013","volume":"6","author":"Tajima","year":"2015","journal-title":"Diabetol Int"},{"key":"10.1016\/S2213-8587(17)30327-3_bib18","doi-asserted-by":"crossref","first-page":"3448","DOI":"10.1210\/jc.2011-0622","article-title":"Serum level of triglycerides is a potent risk factor comparable to LDL cholesterol for coronary heart disease in Japanese patients with type 2 diabetes: subanalysis of the Japan Diabetes Complications Study (JDCS)","volume":"96","author":"Sone","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30327-3_bib19","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1056\/NEJMoa021778","article-title":"Multifactorial intervention and cardiovascular disease in patients with type 2 diabetes","volume":"348","author":"G\u00e6de","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30327-3_bib20","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"G\u00e6de","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30327-3_bib21","doi-asserted-by":"crossref","first-page":"2298","DOI":"10.1007\/s00125-016-4065-6","article-title":"Years of life gained by multifactorial intervention in patients with type 2 diabetes mellitus and microalbuminuria: 21 years follow-up on the Steno-2 randomised trial","volume":"59","author":"G\u00e6de","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30327-3_bib22","doi-asserted-by":"crossref","first-page":"e000123","DOI":"10.1136\/bmjdrc-2015-000123","article-title":"Design of and rationale for the Japan Diabetes Optimal Integrated Treatment study for 3 major risk factors of cardiovascular diseases (J-DOIT3): a multicenter, open-label, randomized, parallel-group trial","volume":"4","author":"Ueki","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(17)30327-3_bib23","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1038\/nm0106-73","article-title":"Combating diabetes and obesity in Japan","volume":"12","author":"Yazaki","year":"2006","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(17)30327-3_bib24","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/2529712","article-title":"Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial","volume":"31","author":"Pocock","year":"1975","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(17)30327-3_bib25","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1056\/NEJMoa1310799","article-title":"Changes in diabetes-related complications in the United States, 1990\u20132010","volume":"370","author":"Gregg","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30327-3_bib26","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1001\/jama.2013.284427","article-title":"2014 evidence-based guideline for the management of high blood pressure in adults: report from the panel members appointed to the Eighth Joint National Committee (JNC 8)","volume":"311","author":"James","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30327-3_bib27","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30327-3_bib28","first-page":"S11","article-title":"Standards of medical care in diabetes\u20142013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30327-3_bib29","doi-asserted-by":"crossref","first-page":"1021","DOI":"10.1007\/s00125-012-2810-z","article-title":"Leisure-time physical activity is a significant predictor of stroke and total mortality in Japanese patients with type 2 diabetes: analysis from the Japan Diabetes Complications Study (JDCS)","volume":"56","author":"Sone","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30327-3_bib30","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone after ischemic stroke or transient ischemic attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30327-3_bib31","doi-asserted-by":"crossref","first-page":"517","DOI":"10.1038\/ki.2012.401","article-title":"Intensive glucose control improves kidney outcomes in patients with type 2 diabetes","volume":"83","author":"Perkovic","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30327-3_bib32","doi-asserted-by":"crossref","first-page":"883","DOI":"10.1681\/ASN.2008070667","article-title":"Lowering blood pressure reduces renal events in type 2 diabetes","volume":"20","author":"de Galan","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30327-3_bib33","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30327-3_bib34","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0140-6736(11)60698-3","article-title":"Effect of early intensive multifactorial therapy on 5-year cardiovascular outcomes in individuals with type 2 diabetes detected by screening (ADDITION-Europe): a cluster-randomised trial","volume":"378","author":"Griffin","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30327-3_bib35","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1111\/jdi.12645","article-title":"Causes of death in Japanese patients with diabetes based on the results of a survey of 45,708 cases during 2001\u20132010: report of the Committee on Causes of Death in Diabetes Mellitus","volume":"8","author":"Nakamura","year":"2017","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(17)30327-3_bib36","doi-asserted-by":"crossref","first-page":"d6898","DOI":"10.1136\/bmj.d6898","article-title":"Intensive glycaemic control for patients with type 2 diabetes: systematic review with meta-analysis and trial sequential analysis of randomised clinical trials","volume":"343","author":"Hemmingsen","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30327-3_bib37","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303273?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303273?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:47Z","timestamp":1761991547000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303273"}},"issued":{"date-parts":[[2017,12]]},"references-count":37,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2213858717303273"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30327-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of an intensified multifactorial intervention on cardiovascular outcomes and mortality in type 2 diabetes (J-DOIT3): an open-label, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30327-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30356-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,31]],"date-time":"2026-10-31T15:13:59Z","timestamp":1793459639532,"version":"4.5.0"},"reference-count":211,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100006041","name":"Innovate UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100006041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008664","name":"Juvenile Diabetes Research Foundation United Kingdom","doi-asserted-by":"publisher","award":["2-SRA-2020-775-S-B"],"award-info":[{"award-number":["2-SRA-2020-775-S-B"]}],"id":[{"id":"10.13039\/100008664","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100019326","name":"UK Regenerative Medicine Platform","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100019326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["200837"],"award-info":[{"award-number":["200837"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000041","name":"American Diabetes Association","doi-asserted-by":"publisher","award":["1-19-IBS-078"],"award-info":[{"award-number":["1-19-IBS-078"]}],"id":[{"id":"10.13039\/100000041","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["2-SRA-2021-1054-M-N"],"award-info":[{"award-number":["2-SRA-2021-1054-M-N"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["NIDDK-110276"],"award-info":[{"award-number":["NIDDK-110276"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01 DK121462"],"award-info":[{"award-number":["R01 DK121462"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/s2213-8587(21)00170-4","type":"journal-article","created":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T18:38:17Z","timestamp":1630521497000},"page":"708-724","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering"],"prefix":"10.1016","volume":"9","author":[{"given":"Nicole A J","family":"Krentz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lonnie D","family":"Shea","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark O","family":"Huising","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James A M","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00170-4_bib1","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1016\/j.ecl.2010.05.011","article-title":"Epidemiology of type 1 diabetes","volume":"39","author":"Maahs","year":"2010","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(21)00170-4_bib2","doi-asserted-by":"crossref","first-page":"1419","DOI":"10.1056\/NEJMoa1610187","article-title":"Incidence trends of type 1 and type 2 diabetes among youths, 2002\u20132012","volume":"376","author":"Mayer-Davis","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib3","series-title":"IDF Diabetes Atlas","year":"2019"},{"key":"10.1016\/S2213-8587(21)00170-4_bib4","series-title":"Endotext [Internet]","article-title":"Pathogenesis of type 2 diabetes mellitus. [Updated Feb 27, 2018]","author":"Cersosimo","year":"2000"},{"key":"10.1016\/S2213-8587(21)00170-4_bib5","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1056\/NEJM200007273430401","article-title":"Islet transplantation in seven patients with type 1 diabetes mellitus using a glucocorticoid-free immunosuppressive regimen","volume":"343","author":"Shapiro","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib6","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/S0140-6736(18)31320-5","article-title":"Type 1 diabetes","volume":"391","author":"DiMeglio","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00170-4_bib7","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2014.16425","article-title":"Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008-2010","volume":"313","author":"Livingstone","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00170-4_bib8","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00170-4_bib9","doi-asserted-by":"crossref","first-page":"1140","DOI":"10.1007\/s00125-007-0599-y","article-title":"Risk of hypoglycaemia in types 1 and 2 diabetes: effects of treatment modalities and their duration","volume":"50","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib10","article-title":"Artificial pancreas treatment for outpatients with type 1 diabetes: systematic review and meta-analysis","volume":"361","author":"Bekiari","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00170-4_bib11","doi-asserted-by":"crossref","first-page":"1389","DOI":"10.1111\/dom.14355","article-title":"Hybrid closed-loop glucose control with faster insulin aspart compared with standard insulin aspart in adults with type 1 diabetes: a double-blind, multicentre, multinational, randomized, crossover study","volume":"23","author":"Boughton","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib12","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1111\/dme.12706","article-title":"Psychosocial aspects of closed- and open-loop insulin delivery: closing the loop in adults with type 1 diabetes in the home setting","volume":"32","author":"Barnard","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib13","doi-asserted-by":"crossref","first-page":"1808","DOI":"10.1016\/S0140-6736(09)60609-7","article-title":"Pancreas transplantation","volume":"373","author":"White","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00170-4_bib14","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1111\/dme.14177","article-title":"\u03b2-cell and renal transplantation options for diabetes","volume":"37","author":"Flatt","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib15","series-title":"Islet transplantation and beta cell replacement therapy","first-page":"1","article-title":"A historical perspective on experimental and clinical islet transplantation","author":"Shapiro","year":"2007"},{"key":"10.1016\/S2213-8587(21)00170-4_bib16","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.2337\/dc08-1685","article-title":"Primary graft function, metabolic control, and graft survival after islet transplantation","volume":"32","author":"Vantyghem","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00170-4_bib17","doi-asserted-by":"crossref","first-page":"3236","DOI":"10.1111\/ajt.12469","article-title":"Attainment of metabolic goals in the integrated UK islet transplant program with locally isolated and transported preparations","volume":"13","author":"Brooks","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib18","doi-asserted-by":"crossref","first-page":"1230","DOI":"10.2337\/dc15-1988","article-title":"Phase 3 trial of transplantation of human islets in type 1 diabetes complicated by severe hypoglycemia","volume":"39","author":"Hering","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00170-4_bib19","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.2337\/dc12-0063","article-title":"Improvement in outcomes of clinical islet transplantation: 1999\u20132010","volume":"35","author":"Barton","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00170-4_bib20","doi-asserted-by":"crossref","DOI":"10.1155\/2014\/451035","article-title":"Inflammatory response in islet transplantation","volume":"2014","author":"Kanak","year":"2014","journal-title":"Int J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib21","doi-asserted-by":"crossref","first-page":"2816","DOI":"10.1111\/j.1600-6143.2009.02844.x","article-title":"Positron emission tomography in clinical islet transplantation","volume":"9","author":"Eriksson","year":"2009","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib22","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/352315","article-title":"Revascularization of transplanted pancreatic islets and role of the transplantation site","volume":"2013","author":"Pepper","year":"2013","journal-title":"Clin Dev Immunol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib23","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.3727\/096368912X658728","article-title":"A preexistent hypoxic gene signature predicts impaired islet graft function and glucose homeostasis","volume":"22","author":"Cantley","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib24","doi-asserted-by":"crossref","first-page":"750","DOI":"10.1111\/ajt.14521","article-title":"Loss of end-differentiated \u03b2-cell phenotype following pancreatic islet transplantation","volume":"18","author":"Anderson","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib25","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1111\/nyas.14572","article-title":"Pancreatic islet reserve in type 1 diabetes","volume":"1495","author":"Flatt","year":"2021","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(21)00170-4_bib26","doi-asserted-by":"crossref","first-page":"2890","DOI":"10.2337\/db12-1802","article-title":"Improvement in \u03b2-cell secretory capacity after human islet transplantation according to the CIT07 protocol","volume":"62","author":"Rickels","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib27","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1177\/1932296819868495","article-title":"Considerations for an alternative site of islet cell transplantation","volume":"14","author":"Addison","year":"2020","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib28","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/j.cmet.2018.01.015","article-title":"Paracrine interactions within the pancreatic islet determine the glycemic set point","volume":"27","author":"Rodriguez-Diaz","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.tem.2014.02.005","article-title":"Cellular communication and heterogeneity in pancreatic islet insulin secretion dynamics","volume":"25","author":"Benninger","year":"2014","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib30","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1369\/jhc.5C6684.2005","article-title":"Assessment of human pancreatic islet architecture and composition by laser scanning confocal microscopy","volume":"53","author":"Brissova","year":"2005","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/S2213-8587(21)00170-4_bib31","doi-asserted-by":"crossref","first-page":"135","DOI":"10.4161\/isl.2.3.11815","article-title":"Pancreatic islet plasticity: interspecies comparison of islet architecture and composition","volume":"2","author":"Steiner","year":"2010","journal-title":"Islets"},{"key":"10.1016\/S2213-8587(21)00170-4_bib32","doi-asserted-by":"crossref","first-page":"2334","DOI":"10.1073\/pnas.0510790103","article-title":"The unique cytoarchitecture of human pancreatic islets has implications for islet cell function","volume":"103","author":"Cabrera","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(21)00170-4_bib33","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1038\/labinvest.2010.124","article-title":"Quantitative analysis of cell composition and purity of human pancreatic islet preparations","volume":"90","author":"Pisania","year":"2010","journal-title":"Lab Invest"},{"key":"10.1016\/S2213-8587(21)00170-4_bib34","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1038\/s42255-019-0148-2","article-title":"Integrating the inputs that shape pancreatic islet hormone release","volume":"1","author":"Noguchi","year":"2019","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib35","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1007\/s00109-020-01887-x","article-title":"Paracrine signaling in islet function and survival","volume":"98","author":"Hartig","year":"2020","journal-title":"J Mol Med (Berl)"},{"key":"10.1016\/S2213-8587(21)00170-4_bib36","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1016\/j.celrep.2018.10.018","article-title":"Insulin secretion depends on intra-islet glucagon signaling","volume":"25","author":"Svendsen","year":"2018","journal-title":"Cell Rep"},{"key":"10.1016\/S2213-8587(21)00170-4_bib37","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.126742","article-title":"\u03b2 Cell tone is defined by proglucagon peptides through cAMP signaling","volume":"4","author":"Capozzi","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(21)00170-4_bib38","article-title":"Intra-islet glucagon signaling is critical for maintaining glucose homeostasis","volume":"5","author":"Zhu","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(21)00170-4_bib39","doi-asserted-by":"crossref","DOI":"10.1002\/bies.201800119","article-title":"Evidence for a neogenic niche at the periphery of pancreatic islets","volume":"40","author":"Huising","year":"2018","journal-title":"BioEssays"},{"key":"10.1016\/S2213-8587(21)00170-4_bib40","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1038\/nm.3872","article-title":"Urocortin3 mediates somatostatin-dependent negative feedback control of insulin secretion","volume":"21","author":"van der Meulen","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib41","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.2337\/db12-1523","article-title":"Amelioration of hypoglycemia via somatostatin receptor type 2 antagonism in recurrently hypoglycemic diabetic rats","volume":"62","author":"Yue","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101021","article-title":"Reduced somatostatin signalling leads to hypersecretion of glucagon in mice fed a high-fat diet","volume":"40","author":"Kellard","year":"2020","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib43","first-page":"74","article-title":"\u03b4-Cells: The neighborhood watch in the islet community","volume":"10","author":"Gao","year":"2021","journal-title":"Biology (Basel)"},{"key":"10.1016\/S2213-8587(21)00170-4_bib44","doi-asserted-by":"crossref","first-page":"16009","DOI":"10.1073\/pnas.1006639107","article-title":"Paracrinology of islets and the paracrinopathy of diabetes","volume":"107","author":"Unger","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(21)00170-4_bib45","doi-asserted-by":"crossref","first-page":"773","DOI":"10.2337\/dc13-1608","article-title":"Safety of nighttime 2-hour suspension of Basal insulin in pump-treated type 1 diabetes even in the absence of low glucose","volume":"37","author":"Sherr","year":"2014","journal-title":"Diabetes Care"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(21)00170-4_bib46","doi-asserted-by":"crossref","first-page":"S258","DOI":"10.2337\/dc11-s230","article-title":"Incretin effects on \u03b2-cell function, replication, and mass: the human perspective","volume":"34","author":"Garber","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00170-4_bib47","doi-asserted-by":"crossref","first-page":"799","DOI":"10.1002\/j.2040-4603.2019.tb00068.x","article-title":"Pancreatic blood flow with special emphasis on blood perfusion of the islets of Langerhans","volume":"9","author":"Jansson","year":"2019","journal-title":"Compr Physiol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib48","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2337\/db09-1177","article-title":"Unique arrangement of alpha- and beta-cells in human islets of Langerhans","volume":"59","author":"Bosco","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib49","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1007\/s00125-017-4524-8","article-title":"Extracellular matrix molecules and their potential contribution to the function of transplanted pancreatic islets","volume":"61","author":"Llacua","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib50","doi-asserted-by":"crossref","first-page":"2076","DOI":"10.1007\/s00125-020-05186-5","article-title":"Beta cell dysfunction in diabetes: the islet microenvironment as an unusual suspect","volume":"63","author":"Alma\u00e7a","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib51","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s00125-017-4409-x","article-title":"Human pancreatic neuro-insular network in health and fatty infiltration","volume":"61","author":"Tang","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib52","doi-asserted-by":"crossref","first-page":"875","DOI":"10.1053\/j.gastro.2020.10.034","article-title":"Pancreatic \u03b2-cells communicate with vagal sensory neurons","volume":"160","author":"Makhmutova","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(21)00170-4_bib53","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1016\/j.beem.2014.05.002","article-title":"Neural control of the endocrine pancreas","volume":"28","author":"Rodriguez-Diaz","year":"2014","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib54","doi-asserted-by":"crossref","first-page":"574","DOI":"10.1038\/nm1701","article-title":"Noninvasive in vivo imaging of pancreatic islet cell biology","volume":"14","author":"Speier","year":"2008","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib55","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1007\/s00125-019-4814-4","article-title":"Operational immune tolerance towards transplanted allogeneic pancreatic islets in mice and a non-human primate","volume":"62","author":"Abdulreda","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib56","doi-asserted-by":"crossref","first-page":"1360","DOI":"10.1056\/NEJM198605223142106","article-title":"Type 1 diabetes mellitus","volume":"314","author":"Eisenbarth","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib57","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00170-4_bib58","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/j.cmet.2018.11.014","article-title":"A map of human type 1 diabetes progression by imaging mass cytometry","volume":"29","author":"Damond","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib59","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1007\/s00125-007-0794-x","article-title":"Modestly increased beta cell apoptosis but no increased beta cell replication in recent-onset type 1 diabetic patients who died of diabetic ketoacidosis","volume":"50","author":"Butler","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib60","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1007\/s00125-019-4822-4","article-title":"Beta cells in type 1 diabetes: mass and function; sleeping or dead?","volume":"62","author":"Oram","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib61","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1369\/0022155415576543","article-title":"Heterogeneity and lobularity of pancreatic pathology in type 1 diabetes during the prediabetic phase","volume":"63","author":"Rodriguez-Calvo","year":"2015","journal-title":"J Histochem Cytochem"},{"key":"10.1016\/S2213-8587(21)00170-4_bib62","doi-asserted-by":"crossref","first-page":"3252","DOI":"10.1172\/JCI127397","article-title":"Residual \u03b2 cell function and monogenic variants in long-duration type 1 diabetes patients","volume":"129","author":"Yu","year":"2019","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(21)00170-4_bib63","doi-asserted-by":"crossref","first-page":"2846","DOI":"10.2337\/db10-0676","article-title":"Residual insulin production and pancreatic \u00df-cell turnover after 50 years of diabetes: Joslin Medalist Study","volume":"59","author":"Keenan","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib64","doi-asserted-by":"crossref","first-page":"719","DOI":"10.2337\/db15-0779","article-title":"Insulitis and \u03b2-cell mass in the natural history of type 1 diabetes","volume":"65","author":"Campbell-Thompson","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib65","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1210\/jc.2016-3806","article-title":"\u03b2 cells persist in T1D pancreata without evidence of ongoing \u03b2-cell turnover or neogenesis","volume":"102","author":"Lam","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib66","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.2337\/db15-1615","article-title":"Differential insulitic profiles determine the extent of \u03b2-cell destruction and the age at onset of type 1 diabetes","volume":"65","author":"Leete","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib67","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1007\/s00125-014-3166-3","article-title":"Non-invasive quantification of the beta cell mass by SPECT with (1)(1)(1)In-labelled exendin","volume":"57","author":"Brom","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib68","doi-asserted-by":"crossref","first-page":"966","DOI":"10.2337\/db20-0776","article-title":"Longitudinal assessment of 11C-5-hydroxytryptophan uptake in pancreas after debut of type 1 diabetes","volume":"70","author":"Espes","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib69","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00125-009-1562-x","article-title":"The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation","volume":"53","author":"Cnop","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib70","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.cmet.2019.05.010","article-title":"Age mosaicism across multiple scales in adult tissues","volume":"30","author":"Arrojo","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib71","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1038\/s41591-020-01182-9","article-title":"The distribution of cellular turnover in the human body","volume":"27","author":"Sender","year":"2021","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib72","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib73","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.cmet.2017.01.005","article-title":"\u03b2 cells that resist immunological attack develop during progression of autoimmune diabetes in NOD mice","volume":"25","author":"Rui","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib74","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11892-018-1084-3","article-title":"Pancreas pathology during the natural history of type 1 diabetes","volume":"18","author":"Rodriguez-Calvo","year":"2018","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(21)00170-4_bib75","doi-asserted-by":"crossref","first-page":"848","DOI":"10.2337\/db11-0955","article-title":"Preventing \u03b2-cell loss and diabetes with calcium channel blockers","volume":"61","author":"Xu","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib76","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1007\/s00125-021-05387-6","article-title":"Pancreatic beta cell autophagy is impaired in type 1 diabetes","volume":"64","author":"Muralidharan","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib77","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2337\/db16-1009","article-title":"Glucagon-like peptide 1 protects pancreatic \u03b2-cells from death by increasing autophagic flux and restoring lysosomal function","volume":"66","author":"Zummo","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib78","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.2337\/dc15-2849","article-title":"Elevations in the fasting serum proinsulin-to-C-Peptide ratio precede the onset of type 1 diabetes","volume":"39","author":"Sims","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00170-4_bib79","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.trsl.2015.08.010","article-title":"Proinsulin and heat shock protein 90 as biomarkers of beta-cell stress in the early period after onset of type 1 diabetes","volume":"168","author":"Watkins","year":"2016","journal-title":"Transl Res"},{"key":"10.1016\/S2213-8587(21)00170-4_bib80","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1210\/jc.2016-2773","article-title":"Measurement of pro-islet amyloid polypeptide (1-48) in diabetes and islet transplants","volume":"102","author":"Courtade","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib81","doi-asserted-by":"crossref","DOI":"10.1101\/cshperspect.a007765","article-title":"Do MHCII-presented neoantigens drive type 1 diabetes and other autoimmune diseases?","volume":"2","author":"Marrack","year":"2012","journal-title":"Cold Spring Harb Perspect Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib82","doi-asserted-by":"crossref","first-page":"739","DOI":"10.2337\/db13-0881","article-title":"Impact of C-peptide preservation on metabolic and clinical outcomes in the Diabetes Control and Complications Trial","volume":"63","author":"Lachin","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib83","doi-asserted-by":"crossref","first-page":"105","DOI":"10.2337\/dc14-1656","article-title":"Demonstration of an intrinsic relationship between endogenous C-peptide concentration and determinants of glycemic control in type 1 diabetes following islet transplantation","volume":"38","author":"Brooks","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00170-4_bib84","doi-asserted-by":"crossref","first-page":"1850","DOI":"10.1172\/JCI134057","article-title":"High residual C-peptide likely contributes to glycemic control in type 1 diabetes","volume":"130","author":"Rickels","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(21)00170-4_bib85","doi-asserted-by":"crossref","first-page":"2362","DOI":"10.2337\/dc20-0300","article-title":"Postexercise glycemic control in type 1 diabetes is associated with residual \u03b2-cell function","volume":"43","author":"Taylor","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00170-4_bib86","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00170-4_bib87","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.diabet.2019.06.004","article-title":"A low-carbohydrate high-fat diet initiated promptly after diagnosis provides clinical remission in three patients with type 1 diabetes","volume":"46","author":"Bouillet","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib88","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.1038\/s41591-018-0089-4","article-title":"Verapamil and beta cell function in adults with recent-onset type 1 diabetes","volume":"24","author":"Ovalle","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib89","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1089\/dia.2020.0305","article-title":"Comparing beta cell preservation across clinical trials in recent-onset type 1 diabetes","volume":"22","author":"Jacobsen","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(21)00170-4_bib90","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib91","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1016\/S2213-8587(21)00019-X","article-title":"Anti-interleukin-21 antibody and liraglutide for the preservation of \u03b2-cell function in adults with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled, phase 2 trial","volume":"9","author":"von Herrath","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib92","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1001\/jama.297.14.1568","article-title":"Autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"297","author":"Voltarelli","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00170-4_bib93","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2009.470","article-title":"C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"301","author":"Couri","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00170-4_bib94","doi-asserted-by":"crossref","first-page":"167","DOI":"10.3389\/fimmu.2017.00167","article-title":"Immunological balance is associated with clinical outcome after autologous hematopoietic stem cell transplantation in type 1 diabetes","volume":"8","author":"Malmegrim","year":"2017","journal-title":"Front Immunol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib95","doi-asserted-by":"crossref","first-page":"5","DOI":"10.2337\/dc19-0880","article-title":"Introducing the endotype concept to address the challenge of disease heterogeneity in type 1 diabetes","volume":"43","author":"Battaglia","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00170-4_bib96","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1038\/nature02520","article-title":"Adult pancreatic beta-cells are formed by self-duplication rather than stem-cell differentiation","volume":"429","author":"Dor","year":"2004","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(21)00170-4_bib97","doi-asserted-by":"crossref","first-page":"1584","DOI":"10.2337\/db07-1369","article-title":"Beta-cell replication is the primary mechanism subserving the postnatal expansion of beta-cell mass in humans","volume":"57","author":"Meier","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib98","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1530\/EJE-09-1053","article-title":"Beta-cell development and turnover during prenatal life in humans","volume":"162","author":"Meier","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib99","doi-asserted-by":"crossref","first-page":"E234","DOI":"10.1210\/jc.2010-0932","article-title":"Significant human beta-cell turnover is limited to the first three decades of life as determined by in vivo thymidine analog incorporation and radiocarbon dating","volume":"95","author":"Perl","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib100","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1111\/nyas.12031","article-title":"Islet \u03b2 cell mass in diabetes and how it relates to function, birth, and death","volume":"1281","author":"Weir","year":"2013","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(21)00170-4_bib101","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1007\/s00125-010-1809-6","article-title":"Adaptive changes in pancreatic beta cell fractional area and beta cell turnover in human pregnancy","volume":"53","author":"Butler","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib102","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1111\/j.1471-0528.1978.tb15835.x","article-title":"A morphological study of the endocrine pancreas in human pregnancy","volume":"85","author":"Van Assche","year":"1978","journal-title":"Br J Obstet Gynaecol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib103","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2337\/dc12-0421","article-title":"\u03b2-cell mass and turnover in humans: effects of obesity and aging","volume":"36","author":"Saisho","year":"2013","journal-title":"Diabetes Care"},{"issue":"suppl 4","key":"10.1016\/S2213-8587(21)00170-4_bib104","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1463-1326.2008.00969.x","article-title":"Pancreatic beta-cell mass in European subjects with type 2 diabetes","volume":"10","author":"Rahier","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib105","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1152\/physrev.00034.2016","article-title":"(Re)generating human beta cells: status, pitfalls, and perspectives","volume":"98","author":"Baeyens","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(21)00170-4_bib106","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/nm.3820","article-title":"A high-throughput chemical screen reveals that harmine-mediated inhibition of DYRK1A increases human pancreatic beta cell replication","volume":"21","author":"Wang","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib107","doi-asserted-by":"crossref","first-page":"1660","DOI":"10.2337\/db15-1127","article-title":"Inhibition of DYRK1A stimulates human \u03b2-cell proliferation","volume":"65","author":"Dirice","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib108","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms9372","article-title":"Inhibition of DYRK1A and GSK3B induces human \u03b2-cell proliferation","volume":"6","author":"Shen","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(21)00170-4_bib109","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaw9996","article-title":"GLP-1 receptor agonists synergize with DYRK1A inhibitors to potentiate functional human \u03b2 cell regeneration","volume":"12","author":"Ackeifi","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib110","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.132594","article-title":"Pharmacologic and genetic approaches define human pancreatic \u03b2 cell mitogenic targets of DYRK1A inhibitors","volume":"5","author":"Ackeifi","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(21)00170-4_bib111","doi-asserted-by":"crossref","DOI":"10.1016\/j.bmc.2019.115193","article-title":"Generation of highly potent DYRK1A-dependent inducers of human \u03b2-Cell replication via multi-dimensional compound optimization","volume":"28","author":"Allegretti","year":"2020","journal-title":"Bioorg Med Chem"},{"key":"10.1016\/S2213-8587(21)00170-4_bib112","doi-asserted-by":"crossref","first-page":"e163","DOI":"10.1371\/journal.pbio.0050163","article-title":"All beta cells contribute equally to islet growth and maintenance","volume":"5","author":"Brennand","year":"2007","journal-title":"PLoS Biol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib113","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1007\/s00125-016-3922-7","article-title":"Extreme obesity induces massive beta cell expansion in mice through self-renewal and does not alter the beta cell lineage","volume":"59","author":"Cox","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib114","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/j.cmet.2017.08.007","article-title":"Pancreatic \u03b2 cell regeneration as a possible therapy for diabetes","volume":"27","author":"Aguayo-Mazzucato","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib115","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/nature08894","article-title":"Conversion of adult pancreatic alpha-cells to beta-cells after extreme beta-cell loss","volume":"464","author":"Thorel","year":"2010","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(21)00170-4_bib116","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1038\/nature13633","article-title":"Diabetes recovery by age-dependent conversion of pancreatic \u03b4-cells into insulin producers","volume":"514","author":"Chera","year":"2014","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(21)00170-4_bib117","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1016\/j.cell.2016.11.002","article-title":"Long-term GABA administration induces alpha cell-mediated beta-like cell neogenesis","volume":"168","author":"Ben-Othman","year":"2017","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(21)00170-4_bib118","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.cell.2016.11.010","article-title":"Artemisinins target GABAA receptor signaling and impair \u03b1 cell identity","volume":"168","author":"Li","year":"2017","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(21)00170-4_bib119","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.cmet.2017.10.002","article-title":"Artemether does not turn \u03b1 cells into \u03b2 cells","volume":"27","author":"van der Meulen","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib120","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.cmet.2019.02.004","article-title":"Case reports of pre-clinical replication studies in metabolism and diabetes","volume":"29","author":"von Herrath","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib121","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1016\/j.cmet.2018.07.002","article-title":"GABA and artesunate do not induce pancreatic \u03b1-to-\u03b2 cell transdifferentiation in vivo","volume":"28","author":"Ackermann","year":"2018","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib122","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1016\/j.bbrc.2018.12.062","article-title":"Absence of spontaneous regeneration of endogenous pancreatic \u03b2-cells after chemical-induced diabetes and no effect of GABA on \u03b1-to-\u03b2 cell transdifferentiation in rhesus monkeys","volume":"508","author":"Shin","year":"2019","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(21)00170-4_bib123","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1126\/science.282.5391.1145","article-title":"Embryonic stem cell lines derived from human blastocysts","volume":"282","author":"Thomson","year":"1998","journal-title":"Science"},{"key":"10.1016\/S2213-8587(21)00170-4_bib124","doi-asserted-by":"crossref","first-page":"861","DOI":"10.1016\/j.cell.2007.11.019","article-title":"Induction of pluripotent stem cells from adult human fibroblasts by defined factors","volume":"131","author":"Takahashi","year":"2007","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(21)00170-4_bib125","doi-asserted-by":"crossref","first-page":"1392","DOI":"10.1038\/nbt1259","article-title":"Production of pancreatic hormone-expressing endocrine cells from human embryonic stem cells","volume":"24","author":"D'Amour","year":"2006","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib126","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/j.cmet.2021.03.021","article-title":"Human pluripotent stem cell-derived insulin-producing cells: A regenerative medicine perspective","volume":"33","author":"Migliorini","year":"2021","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00170-4_bib127","doi-asserted-by":"crossref","first-page":"2447","DOI":"10.1242\/dev.129.10.2447","article-title":"Direct evidence for the pancreatic lineage: NGN3+ cells are islet progenitors and are distinct from duct progenitors","volume":"129","author":"Gu","year":"2002","journal-title":"Development"},{"key":"10.1016\/S2213-8587(21)00170-4_bib128","doi-asserted-by":"crossref","first-page":"5533","DOI":"10.1242\/dev.127.24.5533","article-title":"Homeobox gene Nkx6.1 lies downstream of Nkx2.2 in the major pathway of beta-cell formation in the pancreas","volume":"127","author":"Sander","year":"2000","journal-title":"Development"},{"key":"10.1016\/S2213-8587(21)00170-4_bib129","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1038\/nbt1393","article-title":"Pancreatic endoderm derived from human embryonic stem cells generates glucose-responsive insulin-secreting cells in vivo","volume":"26","author":"Kroon","year":"2008","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib130","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.cell.2014.09.040","article-title":"Generation of functional human pancreatic \u03b2 cells in vitro","volume":"159","author":"Pagliuca","year":"2014","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(21)00170-4_bib131","doi-asserted-by":"crossref","first-page":"2016","DOI":"10.2337\/db11-1711","article-title":"Maturation of human embryonic stem cell-derived pancreatic progenitors into functional islets capable of treating pre-existing diabetes in mice","volume":"61","author":"Rezania","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib132","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1007\/s00125-013-2955-4","article-title":"Maturation and function of human embryonic stem cell-derived pancreatic progenitors in macroencapsulation devices following transplant into mice","volume":"56","author":"Bruin","year":"2013","journal-title":"Diabetologia"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00170-4_bib133","doi-asserted-by":"crossref","first-page":"138","DOI":"10.2337\/db18-138-OR","article-title":"Initial clinical evaluation of VC-01TM combination product\u2014a stem cell\u2013derived islet replacement for type 1 diabetes (T1D)","volume":"67","author":"Henry","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib134","doi-asserted-by":"crossref","first-page":"1581","DOI":"10.1111\/ajt.14954","article-title":"Stem cell-derived pancreatic progneitor cells have now been transplanted into patients: report from IPITA 2018","volume":"18","author":"Pullen","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib135","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1677\/joe.0.1810011","article-title":"Beta cell differentiation during early human pancreas development","volume":"181","author":"Piper","year":"2004","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib136","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1900\/RDS.2014.11.115","article-title":"Maturation of stem cell-derived beta-cells guided by the expression of urocortin 3","volume":"11","author":"van der Meulen","year":"2014","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/S2213-8587(21)00170-4_bib137","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/nbt.3033","article-title":"Reversal of diabetes with insulin-producing cells derived in vitro from human pluripotent stem cells","volume":"32","author":"Rezania","year":"2014","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib138","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.15252\/embj.201591058","article-title":"Controlled induction of human pancreatic progenitors produces functional beta-like cells in vitro","volume":"34","author":"Russ","year":"2015","journal-title":"EMBO J"},{"key":"10.1016\/S2213-8587(21)00170-4_bib139","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/j.stemcr.2018.12.012","article-title":"Acquisition of dynamic function in human stem cell-derived \u03b2 cells","volume":"12","author":"Velazco-Cruz","year":"2019","journal-title":"Stem Cell Reports"},{"key":"10.1016\/S2213-8587(21)00170-4_bib140","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1038\/s41556-018-0271-4","article-title":"Recapitulating endocrine cell clustering in culture promotes maturation of human stem-cell-derived \u03b2 cells","volume":"21","author":"Nair","year":"2019","journal-title":"Nat Cell Biol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib141","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1016\/j.bbrc.2006.02.003","article-title":"MIN6 beta-cell-beta-cell interactions influence insulin secretory responses to nutrients and non-nutrients","volume":"343","author":"Luther","year":"2006","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(21)00170-4_bib142","doi-asserted-by":"crossref","first-page":"1402","DOI":"10.2337\/diabetes.48.7.1402","article-title":"Pancreatic beta-cell-to-beta-cell interactions are required for integrated responses to nutrient stimuli: enhanced Ca2+ and insulin secretory responses of MIN6 pseudoislets","volume":"48","author":"Hauge-Evans","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib143","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1038\/s41587-020-0430-6","article-title":"Targeting the cytoskeleton to direct pancreatic differentiation of human pluripotent stem cells","volume":"38","author":"Hogrebe","year":"2020","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib144","doi-asserted-by":"crossref","first-page":"1030","DOI":"10.1007\/s00125-020-05367-2","article-title":"The promise of stem cell-derived islet replacement therapy","volume":"64","author":"Melton","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib145","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06176-3","article-title":"Lineage dynamics of murine pancreatic development at single-cell resolution","volume":"9","author":"Byrnes","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(21)00170-4_bib146","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-05740-1","article-title":"Endocrine lineage biases arise in temporally distinct endocrine progenitors during pancreatic morphogenesis","volume":"9","author":"Scavuzzo","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(21)00170-4_bib147","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1016\/j.stemcr.2018.11.008","article-title":"Single-cell transcriptome profiling of mouse and hESC-derived pancreatic progenitors","volume":"11","author":"Krentz","year":"2018","journal-title":"Stem Cell Reports"},{"key":"10.1016\/S2213-8587(21)00170-4_bib148","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1152\/physiolgenomics.00114.2016","article-title":"Single cell transcriptomic profiling of mouse pancreatic progenitors","volume":"49","author":"Stanescu","year":"2017","journal-title":"Physiol Genomics"},{"key":"10.1016\/S2213-8587(21)00170-4_bib149","doi-asserted-by":"crossref","DOI":"10.1242\/dev.173849","article-title":"Comprehensive single cell mRNA profiling reveals a detailed roadmap for pancreatic endocrinogenesis","volume":"146","author":"Bastidas-Ponce","year":"2019","journal-title":"Development"},{"key":"10.1016\/S2213-8587(21)00170-4_bib150","article-title":"Understanding human fetal pancreas development using subpopulation sorting, RNA sequencing and single-cell profiling","volume":"145","author":"Ramond","year":"2018","journal-title":"Development"},{"key":"10.1016\/S2213-8587(21)00170-4_bib151","doi-asserted-by":"crossref","DOI":"10.1126\/science.aba7721","article-title":"A human cell atlas of fetal gene expression","volume":"370","author":"Cao","year":"2020","journal-title":"Science"},{"key":"10.1016\/S2213-8587(21)00170-4_bib152","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1038\/nrd.2016.232","article-title":"Advances in islet encapsulation technologies","volume":"16","author":"Desai","year":"2017","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S2213-8587(21)00170-4_bib153","doi-asserted-by":"crossref","first-page":"2301","DOI":"10.1097\/TP.0000000000001371","article-title":"Progress in clinical encapsulated islet xenotransplantation","volume":"100","author":"Cooper","year":"2016","journal-title":"Transplantation"},{"key":"10.1016\/S2213-8587(21)00170-4_bib154","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/nbt.3462","article-title":"Combinatorial hydrogel library enables identification of materials that mitigate the foreign body response in primates","volume":"34","author":"Vegas","year":"2016","journal-title":"Nat Biotechnol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib155","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.stemcr.2019.11.004","article-title":"Conformal coating of stem cell-derived islets for \u03b2 cell replacement in type 1 diabetes","volume":"14","author":"Stock","year":"2020","journal-title":"Stem Cell Reports"},{"key":"10.1016\/S2213-8587(21)00170-4_bib156","doi-asserted-by":"crossref","first-page":"1463","DOI":"10.3727\/096368912X657341","article-title":"Enhanced oxygen supply improves islet viability in a new bioartificial pancreas","volume":"22","author":"Barkai","year":"2013","journal-title":"Cell Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib157","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1111\/ajt.14642","article-title":"Transplantation of macroencapsulated human islets within the bioartificial pancreas \u03b2Air to patients with type 1 diabetes mellitus","volume":"18","author":"Carlsson","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib158","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/j.biomaterials.2016.02.043","article-title":"Improvement of islet engrafts by enhanced angiogenesis and microparticle-mediated oxygenation","volume":"89","author":"Montazeri","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/S2213-8587(21)00170-4_bib159","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.biomaterials.2019.04.017","article-title":"Oxygen generating biomaterial improves the function and efficacy of beta cells within a macroencapsulation device","volume":"210","author":"Coronel","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/S2213-8587(21)00170-4_bib160","article-title":"A collagen based cryogel bioscaffold that generates oxygen for islet transplantation","volume":"30","author":"Razavi","year":"2020","journal-title":"Adv Funct Mater"},{"key":"10.1016\/S2213-8587(21)00170-4_bib161","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.1056\/NEJMc1613959","article-title":"Bioengineering of an intraabdominal endocrine pancreas","volume":"376","author":"Baidal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib162","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1007\/s00268-006-0719-8","article-title":"Islet vasculature as a regulator of endocrine pancreas function","volume":"31","author":"Ballian","year":"2007","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(21)00170-4_bib163","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/sctm.20-0466","article-title":"Protecting islet functional viability using mesenchymal stromal cells","volume":"10","author":"Hubber","year":"2021","journal-title":"Stem Cells Transl Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib164","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aan5907","article-title":"Human umbilical cord perivascular cells improve human pancreatic islet transplant function by increasing vascularization","volume":"12","author":"Forbes","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib165","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.1700184","article-title":"Vasculogenic hydrogel enhances islet survival, engraftment, and function in leading extrahepatic sites","volume":"3","author":"Weaver","year":"2017","journal-title":"Sci Adv"},{"key":"10.1016\/S2213-8587(21)00170-4_bib166","doi-asserted-by":"crossref","first-page":"1916","DOI":"10.1002\/bit.25589","article-title":"Fibrin gels engineered with pro-angiogenic growth factors promote engraftment of pancreatic islets in extrahepatic sites in mice","volume":"112","author":"Najjar","year":"2015","journal-title":"Biotechnol Bioeng"},{"key":"10.1016\/S2213-8587(21)00170-4_bib167","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1007\/s00125-018-4646-7","article-title":"Vegf-A mRNA transfection as a novel approach to improve mouse and human islet graft revascularisation","volume":"61","author":"Staels","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00170-4_bib168","doi-asserted-by":"crossref","first-page":"948","DOI":"10.1177\/0963689718759474","article-title":"Bioengineering with endothelial progenitor cells improves the vascular engraftment of transplanted human islets","volume":"27","author":"Grapensparr","year":"2018","journal-title":"Cell Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib169","doi-asserted-by":"crossref","DOI":"10.1016\/j.biomaterials.2019.119710","article-title":"Endothelialized collagen based pseudo-islets enables tuneable subcutaneous diabetes therapy","volume":"232","author":"Vlahos","year":"2020","journal-title":"Biomaterials"},{"key":"10.1016\/S2213-8587(21)00170-4_bib170","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.biomaterials.2019.01.035","article-title":"Biofabrication of a vascularized islet organ for type 1 diabetes","volume":"199","author":"Citro","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/S2213-8587(21)00170-4_bib171","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1111\/j.1600-6143.2011.03977.x","article-title":"Potent induction immunotherapy promotes long-term insulin independence after islet transplantation in type 1 diabetes","volume":"12","author":"Bellin","year":"2012","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib172","doi-asserted-by":"crossref","first-page":"2322","DOI":"10.1111\/ajt.14961","article-title":"Improved outcomes of islet autotransplant after total pancreatectomy by combined blockade of IL-1\u03b2 and TNF\u03b1","volume":"18","author":"Naziruddin","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib173","doi-asserted-by":"crossref","first-page":"1440","DOI":"10.1111\/ajt.16323","article-title":"Protective effect of a novel clinical-grade small molecule necrosis inhibitor against oxidative stress and inflammation during islet transplantation","volume":"21","author":"Kim","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib174","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-74786-3","article-title":"Inhibition of NLRP3 inflammasome by MCC950 improves the metabolic outcome of islet transplantation by suppressing IL-1\u03b2 and islet cellular death","volume":"10","author":"Matsuoka","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(21)00170-4_bib175","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1002\/dmrr.2714","article-title":"Essential phospholipids prevent islet damage induced by proinflammatory cytokines and hypoxic conditions","volume":"32","author":"Shahbazov","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(21)00170-4_bib176","series-title":"Oxford Textbook of Endocrinology and Diabetes","article-title":"Gene therapy in diabetes mellitus","author":"Shaw","year":"2011"},{"key":"10.1016\/S2213-8587(21)00170-4_bib177","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1111\/ajt.15740","article-title":"Novel cell-permeable p38-MAPK inhibitor efficiently prevents porcine islet apoptosis and improves islet graft function","volume":"20","author":"Noguchi","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib178","doi-asserted-by":"crossref","DOI":"10.1177\/0963689720958655","article-title":"Pax4 gene delivery improves islet transplantation efficacy by promoting \u03b2 cell survival and \u03b1-to-\u03b2 cell transdifferentiation","volume":"29","author":"Parajuli","year":"2020","journal-title":"Cell Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib179","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.131028","article-title":"A20 as an immune tolerance factor can determine islet transplant outcomes","volume":"4","author":"Zammit","year":"2019","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(21)00170-4_bib180","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.biomaterials.2016.11.004","article-title":"Local release of dexamethasone from macroporous scaffolds accelerates islet transplant engraftment by promotion of anti-inflammatory M2 macrophages","volume":"114","author":"Jiang","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/S2213-8587(21)00170-4_bib181","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/j.biomaterials.2017.03.002","article-title":"Islet encapsulation with polyphenol coatings decreases pro-inflammatory chemokine synthesis and T cell trafficking","volume":"128","author":"Pham-Hua","year":"2017","journal-title":"Biomaterials"},{"key":"10.1016\/S2213-8587(21)00170-4_bib182","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.biomaterials.2015.11.065","article-title":"Transforming growth factor-beta 1 delivery from microporous scaffolds decreases inflammation post-implant and enhances function of transplanted islets","volume":"80","author":"Liu","year":"2016","journal-title":"Biomaterials"},{"key":"10.1016\/S2213-8587(21)00170-4_bib183","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1111\/ajt.15308","article-title":"Alginate-microencapsulation of human stem cell-derived \u03b2 cells with CXCL12 prolongs their survival and function in immunocompetent mice without systemic immunosuppression","volume":"19","author":"Alagpulinsa","year":"2019","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib184","doi-asserted-by":"crossref","first-page":"3054","DOI":"10.4049\/jimmunol.1400567","article-title":"Cellular mechanisms of CCL22-mediated attenuation of autoimmune diabetes","volume":"194","author":"Bischoff","year":"2015","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib185","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1111\/ajt.12742","article-title":"Enhancing human islet transplantation by localized release of trophic factors from PLG scaffolds","volume":"14","author":"Hlavaty","year":"2014","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib186","first-page":"1770","article-title":"Microporous polymer scaffolds for the transplantation of embryonic stem cell derived pancreatic progenitors to a clinically translatable site for the treatment of type i diabetes","volume":"4","author":"Kasputis","year":"2018","journal-title":"ACS Biomater Sci Eng"},{"key":"10.1016\/S2213-8587(21)00170-4_bib187","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1056\/NEJM199609193351205","article-title":"Recurrence of autoimmune diabetes mellitus in recipients of cadaveric pancreatic grafts","volume":"335","author":"Tyd\u00e9n","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib188","doi-asserted-by":"crossref","first-page":"547","DOI":"10.3727\/000000002783985585","article-title":"Development of an immunoprivileged site to prolong islet allograft survival","volume":"11","author":"Kin","year":"2002","journal-title":"Cell Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib189","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/gt.2015.18","article-title":"\u03b2-Cell-targeted blockage of PD1 and CTLA4 pathways prevents development of autoimmune diabetes and acute allogeneic islets rejection","volume":"22","author":"El Khatib","year":"2015","journal-title":"Gene Ther"},{"key":"10.1016\/S2213-8587(21)00170-4_bib190","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.4049\/jimmunol.0900679","article-title":"Transgenic expression of single-chain anti-CTLA-4 Fv on beta cells protects nonobese diabetic mice from autoimmune diabetes","volume":"183","author":"Shieh","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(21)00170-4_bib191","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1111\/ajt.15747","article-title":"Pancreatic islets engineered with a FasL protein induce systemic tolerance at the induction phase that evolves into long-term graft-localized immune privilege","volume":"20","author":"Woodward","year":"2020","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib192","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1038\/s41563-018-0099-0","article-title":"Local immunomodulation Fas ligand-engineered biomaterials achieves allogeneic islet graft acceptance","volume":"17","author":"Headen","year":"2018","journal-title":"Nat Mater"},{"key":"10.1016\/S2213-8587(21)00170-4_bib193","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.biomaterials.2018.11.015","article-title":"Localized immune tolerance from FasL-functionalized PLG scaffolds","volume":"192","author":"Skoumal","year":"2019","journal-title":"Biomaterials"},{"key":"10.1016\/S2213-8587(21)00170-4_bib194","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.aba5573","article-title":"Immunotherapy via PD-L1-presenting biomaterials leads to long-term islet graft survival","volume":"6","author":"Coronel","year":"2020","journal-title":"Sci Adv"},{"key":"10.1016\/S2213-8587(21)00170-4_bib195","doi-asserted-by":"crossref","first-page":"3660","DOI":"10.2337\/db16-0320","article-title":"Biopatterned CTLA4\/Fc matrices facilitate local immunomodulation, engraftment, and glucose homeostasis after pancreatic islet transplantation","volume":"65","author":"Zhang","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00170-4_bib196","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0206449","article-title":"Improved islet recovery and efficacy through co-culture and co-transplantation of islets with human adipose-derived mesenchymal stem cells","volume":"13","author":"Gamble","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00170-4_bib197","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/j.bbrc.2018.10.070","article-title":"Mesenchymal stem cells in combination with low-dose rapamycin significantly prolong islet allograft survival through induction of regulatory T cells","volume":"506","author":"Duan","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(21)00170-4_bib198","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/S0140-6736(20)30167-7","article-title":"Regulatory cell therapy in kidney transplantation (The ONE Study): a harmonised design and analysis of seven non-randomised, single-arm, phase 1\/2A trials","volume":"395","author":"Sawitzki","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00170-4_bib199","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1089\/ten.tea.2012.0643","article-title":"PLG scaffold delivered antigen-specific regulatory T cells induce systemic tolerance in autoimmune diabetes","volume":"19","author":"Graham","year":"2013","journal-title":"Tissue Eng Part A"},{"key":"10.1016\/S2213-8587(21)00170-4_bib200","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2019.05.017","article-title":"Regulatory T cells engineered with a novel insulin-specific chimeric antigen receptor as a candidate immunotherapy for type 1 diabetes","volume":"103","author":"Tenspolde","year":"2019","journal-title":"J Autoimmun"},{"key":"10.1016\/S2213-8587(21)00170-4_bib201","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10991","article-title":"Type 1 diabetes vaccine candidates promote human Foxp3(+)Treg induction in humanized mice","volume":"7","author":"Serr","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(21)00170-4_bib202","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aaz3866","article-title":"Functional effects of chimeric antigen receptor co-receptor signaling domains in human regulatory T cells","volume":"12","author":"Dawson","year":"2020","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib203","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.stem.2020.09.008","article-title":"Solving the puzzle of immune tolerance for \u03b2-cell replacement therapy for type 1 diabetes","volume":"27","author":"Bluestone","year":"2020","journal-title":"Cell Stem Cell"},{"key":"10.1016\/S2213-8587(21)00170-4_bib204","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1053\/j.gastro.2021.03.014","article-title":"TAK-101 nanoparticles induce gluten-specific tolerance in celiac disease: a randomized, double-blind, placebo-controlled study","volume":"161","author":"Kelly","year":"2021","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(21)00170-4_bib205","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.3006168","article-title":"Antigen-specific tolerance by autologous myelin peptide-coupled cells: a phase 1 trial in multiple sclerosis","volume":"5","author":"Lutterotti","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(21)00170-4_bib206","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-019-11338-y","article-title":"Long-term tolerance of islet allografts in nonhuman primates induced by apoptotic donor leukocytes","volume":"10","author":"Singh","year":"2019","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(21)00170-4_bib207","doi-asserted-by":"crossref","first-page":"8887","DOI":"10.1016\/j.biomaterials.2014.06.044","article-title":"Nanoparticle delivery of donor antigens for transplant tolerance in allogeneic islet transplantation","volume":"35","author":"Bryant","year":"2014","journal-title":"Biomaterials"},{"key":"10.1016\/S2213-8587(21)00170-4_bib208","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1172\/JCI78142","article-title":"\u03b2 cell death and dysfunction during type 1 diabetes development in at-risk individuals","volume":"125","author":"Herold","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(21)00170-4_bib209","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1111\/ajt.14054","article-title":"Unmethylated insulin DNA is elevated after total pancreatectomy with islet autotransplantation: assessment of a novel beta cell marker","volume":"17","author":"Bellin","year":"2017","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(21)00170-4_bib210","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.136579","article-title":"Multiplexing DNA methylation markers to detect circulating cell-free DNA derived from human pancreatic \u03b2 cells","volume":"5","author":"Neiman","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(21)00170-4_bib211","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-020-17629-z","article-title":"Engineered immunological niches to monitor disease activity and treatment efficacy in relapsing multiple sclerosis","volume":"11","author":"Morris","year":"2020","journal-title":"Nat Commun"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001704?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001704?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:25Z","timestamp":1761991825000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001704"}},"issued":{"date-parts":[[2021,10]]},"references-count":211,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2213858721001704"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00170-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Restoring normal islet mass and function in type 1 diabetes through regenerative medicine and tissue engineering","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00170-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T11:49:50Z","timestamp":1793792990172,"version":"4.6.1"},"reference-count":7,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/s2213-8587(20)30119-4","type":"journal-article","created":{"date-parts":[[2020,4,22]],"date-time":"2020-04-22T18:34:36Z","timestamp":1587580476000},"page":"370","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":35,"title":["\u03b2-cell secretory dysfunction: a key cause of type 2 diabetes"],"prefix":"10.1016","volume":"8","author":[{"given":"Rury R","family":"Holman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"Clark","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patrik","family":"Rorsman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30119-4_bib1","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/S2213-8587(20)30022-X","article-title":"Inadequate \u03b2-cell mass is essential for the pathogenesis of type 2 diabetes","volume":"8","author":"Weir","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30119-4_bib2","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S0140-6736(82)91753-6","article-title":"Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes","volume":"1","author":"Turner","year":"1982","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30119-4_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1007\/s001250050664","article-title":"Near-normalisation of diurnal glucose concentrations by continuous administration of glucagon-like peptide-1 (GLP-1) in subjects with NIDDM","volume":"40","author":"Rachman","year":"1997","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30119-4_bib4","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1038\/oby.2007.9","article-title":"Restoration of acute insulin response in T2DM subjects 1 month after biliopancreatic diversion","volume":"16","author":"Briatore","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(20)30119-4_bib5","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1007\/s00125-009-1562-x","article-title":"The long lifespan and low turnover of human islet beta cells estimated by mathematical modelling of lipofuscin accumulation","volume":"53","author":"Cnop","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30119-4_bib6","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1146\/annurev-physiol-030212-183754","article-title":"Regulation of insulin secretion in human pancreatic islets","volume":"75","author":"Rorsman","year":"2013","journal-title":"Annu Rev Physiol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(20)30119-4_bib7","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.2337\/diabetes.51.2007.S117","article-title":"Is reduced first-phase insulin release the earliest detectable abnormality in individuals destined to develop type 2 diabetes?","volume":"51","author":"Gerich","year":"2002","journal-title":"Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:50Z","timestamp":1761991670000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301194"}},"issued":{"date-parts":[[2020,5]]},"references-count":7,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213858720301194"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30119-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u03b2-cell secretory dysfunction: a key cause of type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30119-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30120-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30022-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T07:47:37Z","timestamp":1793346457883,"version":"4.5.0"},"reference-count":43,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2017,3,1]],"date-time":"2017-03-01T00:00:00Z","timestamp":1488326400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,1,11]],"date-time":"2017-01-11T00:00:00Z","timestamp":1484092800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,3]]},"DOI":"10.1016\/s2213-8587(16)30419-3","type":"journal-article","created":{"date-parts":[[2017,1,12]],"date-time":"2017-01-12T20:01:50Z","timestamp":1484251310000},"page":"184-195","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":237,"title":["Objective assessment of dietary patterns by use of metabolic phenotyping: a randomised, controlled, crossover trial"],"prefix":"10.1016","volume":"5","author":[{"given":"Isabel","family":"Garcia-Perez","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joram M","family":"Posma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward S","family":"Chambers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tue H","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Vestergaard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manfred","family":"Beckmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluf","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Elliott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremiah","family":"Stamler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy K","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Draper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John C","family":"Mathers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elaine","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30419-3_bib1","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1093\/ajcn\/84.2.289","article-title":"Global nutrition dynamics: the world is shifting rapidly toward a diet linked with noncommunicable diseases","volume":"84","author":"Popkin","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib2","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1161\/CIRCULATIONAHA.108.771881","article-title":"Dietary patterns and risk of mortality from cardiovascular disease, cancer, and all causes in a prospective cohort of women","volume":"118","author":"Heidemann","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)30419-3_bib3","doi-asserted-by":"publisher","first-page":"954","DOI":"10.1056\/NEJMra1203528","article-title":"Behavioral and dietary risk factors for noncommunicable diseases","volume":"369","author":"Ezzati","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30419-3_bib4","doi-asserted-by":"publisher","first-page":"6342","DOI":"10.1038\/ncomms7342","article-title":"Fat, fibre and cancer risk in African Americans and rural Africans","volume":"6","author":"O'Keefe","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(16)30419-3_bib5","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1097\/00041433-200202000-00002","article-title":"Dietary pattern analysis: a new direction in nutritional epidemiology","volume":"13","author":"Hu","year":"2002","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(16)30419-3_bib6","series-title":"Global strategy on diet, physical activity and health","year":"2004"},{"key":"10.1016\/S2213-8587(16)30419-3_bib7","doi-asserted-by":"publisher","first-page":"243","DOI":"10.1006\/pmed.1996.0053","article-title":"Changes in diet in Finland from 1972 to 1992: impact on coronary heart disease risk","volume":"25","author":"Pietinen","year":"1996","journal-title":"Prev Med"},{"key":"10.1016\/S2213-8587(16)30419-3_bib8","doi-asserted-by":"publisher","first-page":"1169","DOI":"10.1017\/S0007114507433086","article-title":"Estimating under-reporting of energy intake in dietary surveys using an individualised method","volume":"97","author":"Rennie","year":"2007","journal-title":"Br J Nutr"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(16)30419-3_bib9","doi-asserted-by":"publisher","first-page":"S73","DOI":"10.1017\/S0007114509990602","article-title":"Misreporting of energy and micronutrient intake estimated by food records and 24 hour recalls, control and adjustment methods in practice","volume":"101","author":"Poslusna","year":"2009","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib10","doi-asserted-by":"publisher","first-page":"1500","DOI":"10.1038\/sj.ijo.0801392","article-title":"Does energy intake underreporting involve all kinds of food or only specific food items? Results from the Fleurbaix Laventie Ville Sant\u00e9 (FLVS) study","volume":"24","author":"Lafay","year":"2000","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(16)30419-3_bib11","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1093\/ajcn\/78.1.84","article-title":"Associations between diet and the metabolic syndrome vary with the validity of dietary intake data","volume":"78","author":"Rosell","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib12","doi-asserted-by":"publisher","first-page":"1109","DOI":"10.1038\/ijo.2014.199","article-title":"Energy balance measurement: when something is not better than nothing","volume":"39","author":"Dhurandhar","year":"2015","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(16)30419-3_bib13","doi-asserted-by":"publisher","first-page":"766","DOI":"10.1016\/S0140-6736(14)60460-8","article-title":"Global, regional, and national prevalence of overweight and obesity in children and adults during 1980\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","volume":"384","author":"Ng","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30419-3_bib14","doi-asserted-by":"publisher","first-page":"1322","DOI":"10.1079\/PHN2005750","article-title":"Can adverse effects of dietary fat intake be overestimated as a consequence of dietary fat underreporting?","volume":"8","author":"Heitmann","year":"2005","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1016\/0079-6565(89)80008-1","article-title":"High-resolution proton magnetic-resonance spectroscopy of biological-fluids","volume":"21","author":"Nicholson","year":"1989","journal-title":"Prog Nucleic Mag Res Sp"},{"key":"10.1016\/S2213-8587(16)30419-3_bib16","doi-asserted-by":"publisher","first-page":"314","DOI":"10.3945\/ajcn.110.000950","article-title":"Dietary intake patterns are reflected in metabolomic profiles: potential role in dietary assessment studies","volume":"93","author":"O'Sullivan","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib17","doi-asserted-by":"publisher","first-page":"208","DOI":"10.3945\/ajcn.113.078758","article-title":"Metabolomics in nutritional epidemiology: identifying metabolites associated with diet and quantifying their potential to uncover diet\u2013disease relations in populations","volume":"100","author":"Guertin","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib18","doi-asserted-by":"publisher","first-page":"776","DOI":"10.3945\/ajcn.116.135301","article-title":"Comparing metabolite profiles of habitual diet in serum and urine","volume":"104","author":"Playdon","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib19","doi-asserted-by":"crossref","first-page":"2776","DOI":"10.1002\/elps.201300066","article-title":"The role of metabonomics as a tool for augmenting nutritional information in epidemiological studies","volume":"34","author":"Ismail","year":"2013","journal-title":"Electrophoresis"},{"key":"10.1016\/S2213-8587(16)30419-3_bib20","doi-asserted-by":"publisher","first-page":"793","DOI":"10.1056\/NEJMp1500523","article-title":"A new initiative on precision medicine","volume":"372","author":"Collins","year":"2015","journal-title":"N Engl J Med"},{"issue":"1 suppl","key":"10.1016\/S2213-8587(16)30419-3_bib21","doi-asserted-by":"crossref","first-page":"230S","DOI":"10.1093\/ajcn\/81.1.230S","article-title":"Bioavailability and bioefficacy of polyphenols in humans. I. Review of 97 bioavailability studies","volume":"81","author":"Manach","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib22","doi-asserted-by":"publisher","first-page":"2423","DOI":"10.1021\/acs.jafc.5b05878","article-title":"An analytical pipeline for quantitative characterization of dietary intake: application to assess grape intake","volume":"64","author":"Garcia-Perez","year":"2016","journal-title":"J Agric Food Chem"},{"key":"10.1016\/S2213-8587(16)30419-3_bib23","doi-asserted-by":"publisher","first-page":"436","DOI":"10.3945\/ajcn.2010.29672","article-title":"Metabolic profiling strategy for discovery of nutritional biomarkers: proline betaine as a marker of citrus consumption","volume":"92","author":"Heinzmann","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib24","doi-asserted-by":"publisher","first-page":"643","DOI":"10.1021\/pr2005764","article-title":"Stability and robustness of human metabolic phenotypes in response to sequential food challenges","volume":"11","author":"Heinzmann","year":"2012","journal-title":"J Proteome Res"},{"key":"10.1016\/S2213-8587(16)30419-3_bib25","doi-asserted-by":"publisher","first-page":"974","DOI":"10.2337\/dc06-2188","article-title":"Dietary energy density is associated with obesity and the metabolic syndrome in US adults","volume":"30","author":"Mendoza","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30419-3_bib26","doi-asserted-by":"publisher","first-page":"9887","DOI":"10.1021\/ac5025039","article-title":"Precision high-throughput proton NMR spectroscopy of human urine, serum, and plasma for large-scale metabolic phenotyping","volume":"86","author":"Dona","year":"2014","journal-title":"Anal Chem"},{"key":"10.1016\/S2213-8587(16)30419-3_bib27","doi-asserted-by":"publisher","first-page":"812","DOI":"10.1017\/S0007114511001164","article-title":"Proline betaine and its biotransformation products in fasting urine samples are potential biomarkers of habitual citrus fruit consumption","volume":"106","author":"Lloyd","year":"2011","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib28","doi-asserted-by":"publisher","first-page":"981","DOI":"10.3945\/ajcn.111.017921","article-title":"Use of mass spectrometry fingerprinting to identify urinary metabolites after consumption of specific foods","volume":"94","author":"Lloyd","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib29","doi-asserted-by":"publisher","first-page":"10694","DOI":"10.1021\/ac302360v","article-title":"Subset optimization by reference matching (STORM): an optimized statistical approach for recovery of metabolic biomarker structural information from 1H NMR spectra of biofluids","volume":"84","author":"Posma","year":"2012","journal-title":"Anal Chem"},{"key":"10.1016\/S2213-8587(16)30419-3_bib30","doi-asserted-by":"publisher","first-page":"591","DOI":"10.1038\/sj.jhh.1001603","article-title":"INTERMAP: background, aims, design, methods, and descriptive statistics (nondietary)","volume":"17","author":"Stamler","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.1016\/S2213-8587(16)30419-3_bib31","doi-asserted-by":"publisher","first-page":"609","DOI":"10.1038\/sj.jhh.1001604","article-title":"INTERMAP: the dietary data\u2014process and quality control","volume":"17","author":"Dennis","year":"2003","journal-title":"J Hum Hypertens"},{"key":"10.1016\/S2213-8587(16)30419-3_bib32","doi-asserted-by":"publisher","first-page":"285ra62","DOI":"10.1126\/scitranslmed.aaa5680","article-title":"Urinary metabolic signatures of human adiposity","volume":"7","author":"Elliott","year":"2015","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(16)30419-3_bib33","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1001\/archinte.168.7.713","article-title":"Adherence to a DASH-style diet and risk of coronary heart disease and stroke in women","volume":"168","author":"Fung","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(16)30419-3_bib34","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1016\/j.jand.2014.12.009","article-title":"Diet quality as assessed by the Healthy Eating Index, the Alternate Healthy Eating Index, the Dietary Approaches To Stop Hypertension score, and health outcomes: a systematic review and meta-analysis of cohort studies","volume":"115","author":"Schwingshackl","year":"2015","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/S2213-8587(16)30419-3_bib35","doi-asserted-by":"publisher","first-page":"4281","DOI":"10.1021\/ac051632c","article-title":"Probabilistic quotient normalization as robust method to account for dilution of complex biological mixtures. Application in 1H NMR metabonomics","volume":"78","author":"Dieterle","year":"2006","journal-title":"Anal Chem"},{"key":"10.1016\/S2213-8587(16)30419-3_bib36","doi-asserted-by":"publisher","first-page":"588","DOI":"10.1079\/BJN20051543","article-title":"Attainment of precision in implementation of 24 h dietary recalls: INTERMAP UK","volume":"94","author":"Robertson","year":"2005","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib37","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1080\/15287399409531853","article-title":"Urinary-excretion of methylamines in men with varying intake of fish from the Baltic sea","volume":"41","author":"Svensson","year":"1994","journal-title":"J Toxicol Env Health"},{"key":"10.1016\/S2213-8587(16)30419-3_bib38","doi-asserted-by":"publisher","first-page":"1262","DOI":"10.1126\/science.1223813","article-title":"Host\u2013gut microbiota metabolic interactions","volume":"336","author":"Nicholson","year":"2012","journal-title":"Science"},{"key":"10.1016\/S2213-8587(16)30419-3_bib39","doi-asserted-by":"publisher","first-page":"1286","DOI":"10.3945\/ajcn.113.076133","article-title":"The food metabolome: a window over dietary exposure","volume":"99","author":"Scalbert","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib40","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1093\/ajcn\/76.6.1261","article-title":"Diet quality and major chronic disease risk in men and women: moving toward improved dietary guidance","volume":"76","author":"McCullough","year":"2002","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib41","doi-asserted-by":"publisher","first-page":"559","DOI":"10.1016\/j.numecd.2005.08.006","article-title":"Dietary patterns: a Mediterranean diet score and its relation to clinical and biological markers of cardiovascular disease risk","volume":"16","author":"Panagiotakos","year":"2006","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(16)30419-3_bib42","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1093\/ajcn\/82.1.163","article-title":"Diet-quality scores and plasma concentrations of markers of inflammation and endothelial dysfunction","volume":"82","author":"Fung","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30419-3_bib43","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1017\/S0007114514003341","article-title":"Effects of the Dietary Approach to Stop Hypertension (DASH) diet on cardiovascular risk factors: a systematic review and meta-analysis","volume":"113","author":"Siervo","year":"2015","journal-title":"Br J Nutr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716304193?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716304193?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,6,21]],"date-time":"2024-06-21T15:43:20Z","timestamp":1718984600000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716304193"}},"issued":{"date-parts":[[2017,3]]},"references-count":43,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2017,3]]}},"alternative-id":["S2213858716304193"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30419-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Objective assessment of dietary patterns by use of metabolic phenotyping: a randomised, controlled, crossover trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30419-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30007-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T17:41:59Z","timestamp":1793295719094,"version":"4.5.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/s2213-8587(23)00092-x","type":"journal-article","created":{"date-parts":[[2023,3,31]],"date-time":"2023-03-31T18:38:31Z","timestamp":1680287911000},"page":"303-304","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Defining gestational diabetes: not just about cutoffs"],"prefix":"10.1016","volume":"11","author":[{"given":"David","family":"Simmons","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianne","family":"Sweeting","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00092-X_bib1","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc09-1848","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00092-X_bib2","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00092-X_bib3","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1210\/endrev\/bnac003","article-title":"A clinical update on gestational diabetes mellitus","volume":"43","author":"Sweeting","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(23)00092-X_bib4","doi-asserted-by":"crossref","first-page":"1773","DOI":"10.1016\/S0140-6736(09)60731-5","article-title":"Type 2 diabetes mellitus after gestational diabetes: a systematic review and meta-analysis","volume":"373","author":"Bellamy","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00092-X_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108642","article-title":"Increasing prevalence of gestational diabetes mellitus when implementing the IADPSG criteria: a systematic review and meta-analysis","volume":"172","author":"Saeedi","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(23)00092-X_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(23)00062-1","article-title":"Glucose intolerance in pregnancy and risk of early-onset type 2 diabetes: a population based cohort study","author":"Bardugo","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00092-X_bib7","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/j.ajog.2016.04.040","article-title":"Single abnormal value on 3-hour oral glucose tolerance test during pregnancy is associated with adverse maternal and neonatal outcomes: a systematic review and meta-analysis","volume":"215","author":"Roeckner","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(23)00092-X_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/AOG.0000000000004453","article-title":"Gestational diabetes mellitus screening strategies: balancing short-term and long-term risks","volume":"138","author":"Carter","year":"2021","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(23)00092-X_bib9","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2337\/dc11-1641","article-title":"Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study","volume":"35","author":"Sacks","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00092-X_bib10","doi-asserted-by":"crossref","first-page":"405","DOI":"10.5694\/mja17.01129","article-title":"Hyperglycaemia in early pregnancy: the Treatment of Booking Gestational diabetes Mellitus (TOBOGM) study. A randomised controlled trial","volume":"209","author":"Simmons","year":"2018","journal-title":"Med J Aust"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872300092X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872300092X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:40Z","timestamp":1761991900000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872300092X"}},"issued":{"date-parts":[[2023,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S221385872300092X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00092-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Defining gestational diabetes: not just about cutoffs","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00092-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00062-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T06:46:29Z","timestamp":1793515589293,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/s2213-8587(25)00260-8","type":"journal-article","created":{"date-parts":[[2025,10,15]],"date-time":"2025-10-15T17:10:36Z","timestamp":1760548236000},"page":"980-986","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Managing adults with screen-detected islet autoantibody positivity: a pragmatic framework"],"prefix":"10.1016","volume":"13","author":[{"given":"Nicholas","family":"Thomas","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danijela","family":"Tatovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angus","family":"Jones","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Parth","family":"Narendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00260-8_bib1","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.abc8980","article-title":"Teplizumab improves and stabilizes beta cell function in antibody-positive high-risk individuals","volume":"13","author":"Sims","year":"2021","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(25)00260-8_bib2","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1016\/S2213-8587(23)00354-6","article-title":"Screening type 1 diabetes and celiac disease by law","volume":"12","author":"Bosi","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00260-8_bib3","first-page":"1276","article-title":"Consensus guidance for monitoring individuals with islet autoantibody-positive pre-stage 3 type 1 diabetes","volume":"47","author":"Phillip","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00260-8_bib4","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.2337\/dc15-1419","article-title":"Staging presymptomatic type 1 diabetes: a scientific statement of JDRF, the Endocrine Society, and the American Diabetes Association","volume":"38","author":"Insel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00260-8_bib5","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1007\/s00125-019-05047-w","article-title":"The risk of progression to type 1 diabetes is highly variable in individuals with multiple autoantibodies following screening","volume":"63","author":"Jacobsen","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00260-8_bib6","doi-asserted-by":"crossref","first-page":"1571","DOI":"10.2337\/dc25-0192","article-title":"Contrasting adult and pediatric populations in a cohort of at-risk relatives in the T1D TrialNet Pathway to Prevention study","volume":"48","author":"Templeman","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00260-8_bib7","first-page":"597","article-title":"Pediatric Endocrine Society statement on considerations for use of teplizumab (Tzield\u2122) in clinical practice","volume":"98","author":"Tonyushkina","year":"2025","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(25)00260-8_bib8","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1186\/s12916-021-02054-w","article-title":"Choice of HbA1c threshold for identifying individuals at high risk of type 2 diabetes and implications for diabetes prevention programmes: a cohort study","volume":"19","author":"Rodgers","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(25)00260-8_bib9","article-title":"Genetic risk targeted islet-autoantibody screening for presymptomatic type 1 diabetes in adults","author":"Thomas","year":"2024","journal-title":"SSRN"},{"key":"10.1016\/S2213-8587(25)00260-8_bib10","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.1007\/s00125-023-06004-4","article-title":"The challenges of identifying and studying type 1 diabetes in adults","volume":"66","author":"Thomas","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00260-8_bib11","doi-asserted-by":"crossref","first-page":"1156","DOI":"10.2337\/dc22-2159","article-title":"Age of diagnosis does not alter the presentation or progression of robustly defined adult-onset type 1 diabetes","volume":"46","author":"Thomas","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00260-8_bib12","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.2337\/dc20-2834","article-title":"Latent autoimmune diabetes of adults (LADA) is likely to represent a mixed population of autoimmune (type 1) and nonautoimmune (type 2) diabetes","volume":"44","author":"Jones","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00260-8_bib13","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1007\/s00125-023-05877-9","article-title":"Islet Autoantibody Standardization Program: interlaboratory comparison of insulin autoantibody assay performance in 2018 and 2020 workshops","volume":"66","author":"Marzinotto","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00260-8_bib14","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1007\/s00125-014-3412-8","article-title":"The time has come to test the beta cell preserving effects of exercise in patients with new onset type 1 diabetes","volume":"58","author":"Narendran","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00260-8_bib15","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1111\/dme.13439","article-title":"Exercise to preserve \u03b2-cell function in recent-onset type 1 diabetes mellitus (EXTOD)\u2014a randomized controlled pilot trial","volume":"34","author":"Narendran","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00260-8_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.3777","article-title":"Clinical care advice for monitoring of islet autoantibody positive individuals with presymptomatic type 1 diabetes","volume":"40","author":"Hendriks","year":"2024","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(25)00260-8_bib18","doi-asserted-by":"crossref","first-page":"1583","DOI":"10.2337\/db23-0980","article-title":"Autoantibodies to truncated GAD(96-585) antigen stratify risk of early insulin requirement in adult-onset diabetes","volume":"73","author":"Grace","year":"2024","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(25)00260-8_bib19","doi-asserted-by":"crossref","first-page":"2881","DOI":"10.1210\/jc.2017-00569","article-title":"Impact of age and antibody type on progression from single to multiple autoantibodies in type 1 diabetes relatives","volume":"102","author":"Bosi","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00260-8_bib20","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1007\/s00125-025-06382-x","article-title":"IA-2A positivity increases risk of progression within and across established stages of type 1 diabetes","volume":"68","author":"Sims","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00260-8_bib21","doi-asserted-by":"crossref","first-page":"1459","DOI":"10.2337\/diab.46.9.1459","article-title":"Prediction of type 1 diabetes postpartum in patients with gestational diabetes mellitus by combined islet cell autoantibody screening: a prospective multicenter study","volume":"46","author":"F\u00fcchtenbusch","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(25)00260-8_bib22","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.2337\/dci21-0043","article-title":"The management of type 1 diabetes in adults. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"44","author":"Holt","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00260-8_bib23","doi-asserted-by":"crossref","first-page":"e852","DOI":"10.3399\/bjgp15X687661","article-title":"Different type 2 diabetes risk assessments predict dissimilar numbers at \u2018high risk\u2019: a retrospective analysis of diabetes risk-assessment tools","volume":"65","author":"Gray","year":"2015","journal-title":"Br J Gen Pract"},{"key":"10.1016\/S2213-8587(25)00260-8_bib24","doi-asserted-by":"crossref","first-page":"610","DOI":"10.2337\/dbi20-0054","article-title":"Screening for type 1 diabetes in the general population: a status report and perspective","volume":"71","author":"Sims","year":"2022","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(25)00260-8_bib25","doi-asserted-by":"crossref","first-page":"913","DOI":"10.2337\/dc19-1731","article-title":"Autoantibody reversion: changing risk categories in multiple-autoantibody-positive individuals","volume":"43","author":"So","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00260-8_bib26","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2024-004480","article-title":"Presentation and characteristics of children with screen-detected type 1 diabetes: learnings from the ELSA general population pediatric screening study","volume":"12","author":"Quinn","year":"2024","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(25)00260-8_bib27","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.2337\/dbi20-0017","article-title":"Management of latent autoimmune diabetes in adults: a consensus statement from an international expert panel","volume":"69","author":"Buzzetti","year":"2020","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(25)00260-8_bib28","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1007\/s00125-022-05823-1","article-title":"The relationship between islet autoantibody status and the genetic risk of type 1 diabetes in adult-onset type 1 diabetes","volume":"66","author":"Thomas","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00260-8_bib29","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1038\/s41574-023-00837-0","article-title":"A perspective on treating type 1 diabetes mellitus before insulin is needed","volume":"19","author":"Tatovic","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(25)00260-8_bib31","article-title":"Diabetic ketoacidosis with SGLT2 inhibitors","volume":"371","author":"Musso","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00260-8_bib32","doi-asserted-by":"crossref","first-page":"1702","DOI":"10.2337\/dc16-0691","article-title":"Efficacy and safety of liraglutide added to insulin treatment in type 1 diabetes: the ADJUNCT ONE treat-to-target randomized trial","volume":"39","author":"Mathieu","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00260-8_bib33","doi-asserted-by":"crossref","first-page":"1384","DOI":"10.2337\/dc08-1987","article-title":"New definition for the partial remission period in children and adolescents with type 1 diabetes","volume":"32","author":"Mortensen","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00260-8_bib34","doi-asserted-by":"crossref","first-page":"1661","DOI":"10.1007\/s00125-004-1507-3","article-title":"Insulin resistance is a risk factor for progression to type 1 diabetes","volume":"47","author":"Fourlanos","year":"2004","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00260-8_bib35","doi-asserted-by":"crossref","first-page":"239","DOI":"10.4093\/dmj.2022.0013","article-title":"Links between thyroid disorders and glucose homeostasis","volume":"46","author":"Eom","year":"2022","journal-title":"Diabetes Metab J"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002608?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002608?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:10:49Z","timestamp":1774987849000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002608"}},"issued":{"date-parts":[[2025,11]]},"references-count":33,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2213858725002608"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00260-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Managing adults with screen-detected islet autoantibody positivity: a pragmatic framework","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00260-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:13:00Z","timestamp":1793329980604,"version":"4.5.0"},"reference-count":37,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T00:00:00Z","timestamp":1383696000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/3.0\/"}],"funder":[{"DOI":"10.13039\/501100000589","name":"Chief Scientist Office","doi-asserted-by":"publisher","award":["CZB\/4\/613"],"award-info":[{"award-number":["CZB\/4\/613"]}],"id":[{"id":"10.13039\/501100000589","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/s2213-8587(13)70152-9","type":"journal-article","created":{"date-parts":[[2013,11,6]],"date-time":"2013-11-06T21:00:16Z","timestamp":1383771616000},"page":"116-124","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":187,"title":["Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial"],"prefix":"10.1016","volume":"2","author":[{"given":"David","family":"Preiss","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Suzanne M","family":"Lloyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rury R","family":"Holman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Welsh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miles","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris J","family":"Packard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70152-9_bib1","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70152-9_bib2","doi-asserted-by":"crossref","first-page":"361","DOI":"10.2337\/dc08-0854","article-title":"Relationship of insulin resistance and related metabolic variables to coronary artery disease: a mathematical analysis","volume":"32","author":"Eddy","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70152-9_bib3","doi-asserted-by":"crossref","first-page":"952","DOI":"10.1056\/NEJM199604113341504","article-title":"Hyperinsulinemia as an independent risk factor for ischemic heart disease","volume":"334","author":"Despres","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70152-9_bib4","doi-asserted-by":"crossref","first-page":"2595","DOI":"10.1210\/jc.2004-0372","article-title":"Obesity, metabolic syndrome, and cardiovascular disease","volume":"89","author":"Grundy","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70152-9_bib5","doi-asserted-by":"crossref","first-page":"365","DOI":"10.3109\/09513590.2012.743007","article-title":"Polycystic ovary syndrome and combined oral contraceptive use: a comparison of clinical practice in the United States to treatment guidelines","volume":"29","author":"Bird","year":"2013","journal-title":"Gynecol Endocrinol"},{"key":"10.1016\/S2213-8587(13)70152-9_bib6","first-page":"27","article-title":"Effectiveness of metformin on weight loss in non-diabetic individuals with obesity","volume":"121","author":"Seifarth","year":"2013","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/S2213-8587(13)70152-9_bib7","doi-asserted-by":"crossref","first-page":"753","DOI":"10.2337\/dc07-9920","article-title":"Impaired fasting glucose and impaired glucose tolerance: implications for care","volume":"30","author":"Nathan","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70152-9_bib8","doi-asserted-by":"crossref","first-page":"920","DOI":"10.2337\/diacare.19.9.920","article-title":"The effect of metformin on the metabolic abnormalities associated with upper-body fat distribution. BIGPRO Study Group","volume":"19","author":"Fontbonne","year":"1996","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70152-9_bib9","doi-asserted-by":"crossref","first-page":"1967","DOI":"10.2337\/diacare.21.11.1967","article-title":"Effect of weight change and metformin on fibrinolysis and the von Willebrand factor in obese nondiabetic subjects: the BIGPRO1 Study. Biguanides and the Prevention of the Risk of Obesity","volume":"21","author":"Charles","year":"1998","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70152-9_bib10","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70152-9_bib11","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70152-9_bib12","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/archinternmed.2009.20","article-title":"Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus","volume":"169","author":"Kooy","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(13)70152-9_bib13","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70152-9_bib14","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/j.1464-5491.2006.01858.x","article-title":"Metabolic syndrome\u2014a new world-wide definition. A consensus statement from the International Diabetes Federation","volume":"23","author":"Alberti","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70152-9_bib15","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1161\/CIRCIMAGING.109.909655","article-title":"Carotid atherosclerosis progression in familial hypercholesterolemia patients: a pooled analysis of the ASAP, ENHANCE, RADIANCE 1, and CAPTIVATE studies","volume":"3","author":"Vergeer","year":"2010","journal-title":"Circ Cardiovasc Imaging"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(13)70152-9_bib16","first-page":"S11","article-title":"Standards of medical care in diabetes\u20142010","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70152-9_bib17","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1159\/000081812","article-title":"Mannheim intima-media thickness consensus","volume":"18","author":"Touboul","year":"2004","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/S2213-8587(13)70152-9_bib18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1109\/42.836372","article-title":"A multiscale dynamic programming procedure for boundary detection in ultrasonic artery images","volume":"19","author":"Liang","year":"2000","journal-title":"IEEE Trans Med Imaging"},{"key":"10.1016\/S2213-8587(13)70152-9_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1111\/j.1747-4949.2006.00068.x","article-title":"Measurement of intima-media thickness vs. carotid plaque: uses in patient care, genetic research and evaluation of new therapies","volume":"1","author":"Spence","year":"2006","journal-title":"Int J Stroke"},{"key":"10.1016\/S2213-8587(13)70152-9_bib20","doi-asserted-by":"crossref","first-page":"461","DOI":"10.7326\/0003-4819-130-6-199903160-00002","article-title":"A more accurate method to estimate glomerular filtration rate from serum creatinine: a new prediction equation. Modification of Diet in Renal Disease Study Group","volume":"130","author":"Levey","year":"1999","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(13)70152-9_bib21","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1111\/j.1440-1681.2008.04920.x","article-title":"Metformin, arterial function, intima-media thickness and nitroxidation in metabolic syndrome: the mefisto study","volume":"35","author":"Meaney","year":"2008","journal-title":"Clin Exp Pharmacol Physiol"},{"key":"10.1016\/S2213-8587(13)70152-9_bib22","doi-asserted-by":"crossref","first-page":"2055","DOI":"10.1161\/01.CIR.0000034508.55617.65","article-title":"ARBITER: Arterial Biology for the Investigation of the Treatment Effects of Reducing Cholesterol: a randomized trial comparing the effects of atorvastatin and pravastatin on carotid intima medial thickness","volume":"106","author":"Taylor","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70152-9_bib23","doi-asserted-by":"crossref","first-page":"2070","DOI":"10.1001\/archinte.168.19.2070","article-title":"Cardiovascular outcomes in trials of oral diabetes medications: a systematic review","volume":"168","author":"Selvin","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(13)70152-9_bib24","doi-asserted-by":"crossref","first-page":"e1001204","DOI":"10.1371\/journal.pmed.1001204","article-title":"Reappraisal of metformin efficacy in the treatment of type 2 diabetes: a meta-analysis of randomised controlled trials","volume":"9","author":"Boussageon","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(13)70152-9_bib25","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/S0140-6736(97)11509-4","article-title":"Randomised placebo-controlled trial of orlistat for weight loss and prevention of weight regain in obese patients","volume":"352","author":"Sj\u00f6str\u00f6m","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70152-9_bib26","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3310\/hta15380","article-title":"Insulin sensitisers in the treatment of non-alcoholic fatty liver disease: a systematic review","volume":"15","author":"Shyangdan","year":"2011","journal-title":"Health Technol Assess"},{"key":"10.1016\/S2213-8587(13)70152-9_bib27","doi-asserted-by":"crossref","first-page":"c2181","DOI":"10.1136\/bmj.c2181","article-title":"Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised placebo controlled trial","volume":"340","author":"de Jager","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70152-9_bib28","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1161\/01.STR.0000102044.27905.B5","article-title":"Carotid intima-media thickness measurements in intervention studies: design options, progression rates, and sample size considerations: a point of view","volume":"34","author":"Bots","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(13)70152-9_bib29","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa0907569","article-title":"Extended-release niacin or ezetimibe and carotid intima-media thickness","volume":"361","author":"Taylor","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70152-9_bib30","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1056\/NEJMoa1107579","article-title":"Niacin in patients with low HDL cholesterol levels receiving intensive statin therapy","volume":"365","author":"Boden","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70152-9_bib31","doi-asserted-by":"crossref","first-page":"108","DOI":"10.5551\/jat.14001","article-title":"Effect of statin therapy on the progression of common carotid artery intima-media thickness: an updated systematic review and meta-analysis of randomized controlled trials","volume":"20","author":"Huang","year":"2013","journal-title":"J Atheroscler Thromb"},{"key":"10.1016\/S2213-8587(13)70152-9_bib32","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1016\/S0140-6736(10)61350-5","article-title":"Efficacy and safety of more intensive lowering of LDL cholesterol: a meta-analysis of data from 170 000 participants in 26 randomised trials","volume":"376","author":"Baigent","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70152-9_bib33","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(12)60441-3","article-title":"Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data","volume":"379","author":"Lorenz","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70152-9_bib34","doi-asserted-by":"crossref","first-page":"2572","DOI":"10.1001\/jama.296.21.joc60158","article-title":"Effect of pioglitazone compared with glimepiride on carotid intima-media thickness in type 2 diabetes: a randomized trial","volume":"296","author":"Mazzone","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70152-9_bib35","doi-asserted-by":"crossref","first-page":"2113","DOI":"10.1056\/NEJMoa0907569","article-title":"Extended-release niacin or ezetimibe and carotid intima-media thickness","volume":"361","author":"Taylor","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70152-9_bib36","doi-asserted-by":"crossref","first-page":"2466","DOI":"10.2337\/dc12-2129","article-title":"Effect of insulin glargine and n-3FA on carotid intima-media thickness in people with dysglycemia at high risk for cardiovascular events: the glucose reduction and atherosclerosis continuing evaluation study (ORIGIN-GRACE)","volume":"36","author":"Lonn","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70152-9_bib37","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1007\/s10557-012-6413-1","article-title":"Metformin in non-diabetic patients presenting with ST elevation myocardial infarction: rationale and design of the glycometabolic intervention as adjunct to primary percutaneous intervention in ST elevation myocardial infarction (GIPS)-III trial","volume":"26","author":"Lexis","year":"2012","journal-title":"Cardiovasc Drugs Ther"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701529?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701529?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:04:55Z","timestamp":1761991495000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701529"}},"issued":{"date-parts":[[2014,2]]},"references-count":37,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S2213858713701529"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70152-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70152-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70171-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Preiss et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T21:29:54Z","timestamp":1793568594537,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001505","name":"Health Research Council of New Zealand","doi-asserted-by":"crossref","award":["grant 10\/400"],"award-info":[{"award-number":["grant 10\/400"]}],"id":[{"id":"10.13039\/501100001505","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/s2213-8587(17)30103-1","type":"journal-article","created":{"date-parts":[[2017,4,29]],"date-time":"2017-04-29T02:48:02Z","timestamp":1493434082000},"page":"438-447","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":179,"title":["Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial"],"prefix":"10.1016","volume":"5","author":[{"given":"Kay-Tee","family":"Khaw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alistair W","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie","family":"Waayer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlene M M","family":"Lawes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Les","family":"Toop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Carlos A","family":"Camargo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Scragg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30103-1_bib1","series-title":"Dietary reference intakes for calcium and vitamin D","author":"Ross","year":"2011"},{"key":"10.1016\/S2213-8587(17)30103-1_bib2","doi-asserted-by":"crossref","first-page":"2378","DOI":"10.1002\/jbmr.449","article-title":"Serum 25-hydroxyvitamin D and clinical fracture risk in a multiethnic cohort of women: the Women's Health Initiative (WHI)","volume":"26","author":"Cauley","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30103-1_bib3","doi-asserted-by":"crossref","first-page":"1361","DOI":"10.3945\/ajcn.114.086413","article-title":"Serum 25-hydroxyvitamin D, mortality, and incident cardiovascular disease, respiratory disease, cancers, and fractures: a 13-y prospective population study","volume":"100","author":"Khaw","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30103-1_bib4","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1056\/NEJM199212033272305","article-title":"Vitamin D3 and calcium to prevent hip fractures in elderly women","volume":"327","author":"Chapuy","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30103-1_bib5","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD000227.pub4","article-title":"Vitamin D and vitamin D analogues for preventing fractures in post-menopausal women and older men","volume":"4","author":"Avenell","year":"2014","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30103-1_bib6","doi-asserted-by":"crossref","first-page":"827","DOI":"10.7326\/0003-4819-155-12-201112200-00005","article-title":"Vitamin D with or without calcium supplementation for prevention of cancer and fractures: an updated meta-analysis for the US Preventive Services Task Force","volume":"155","author":"Chung","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30103-1_bib7","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1001\/jamainternmed.2015.7148","article-title":"Monthly high-dose vitamin D treatment for the prevention of functional decline: a randomized clinical trial","volume":"176","author":"Bischoff-Ferrari","year":"2016","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(17)30103-1_bib8","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007146.pub3","article-title":"Interventions for preventing falls in older people living in the community","volume":"9","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(17)30103-1_bib9","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1532-5415.2010.02949.x","article-title":"Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis","volume":"58","author":"Kalyani","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(17)30103-1_bib10","doi-asserted-by":"crossref","first-page":"197","DOI":"10.7326\/0003-4819-157-3-201208070-00462","article-title":"Prevention of falls in community-dwelling older adults: US Preventive Services Task Force recommendation statement","volume":"157","author":"Moyer","year":"2012","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30103-1_bib11","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1001\/jamainternmed.2015.0225","article-title":"Exercise and vitamin D in fall prevention among older women: a randomized clinical trial","volume":"175","author":"Uusi-Rasi","year":"2015","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(17)30103-1_bib12","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.jsbmb.2015.09.010","article-title":"The Vitamin D Assessment (ViDA) Study: design of a randomized controlled trial of vitamin D supplementation for the prevention of cardiovascular disease, acute respiratory infection, falls and non-vertebral fractures","volume":"164","author":"Scragg","year":"2016","journal-title":"J Steroid Biochem Mol Biol"},{"key":"10.1016\/S2213-8587(17)30103-1_bib13","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1093\/ajcn\/87.3.688","article-title":"Pharmacokinetics of a single, large dose of cholecalciferol","volume":"87","author":"Ilahi","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30103-1_bib14","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1093\/ajcn\/84.1.18","article-title":"Estimation of optimal serum concentrations of 25-hydroxyvitamin D for multiple health outcomes","volume":"84","author":"Bischoff-Ferrari","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30103-1_bib15","doi-asserted-by":"crossref","first-page":"1618","DOI":"10.1111\/j.1532-5415.2005.53455.x","article-title":"Development of a common outcome data set for fall injury prevention trials: the Prevention of Falls Network Europe consensus","volume":"53","author":"Lamb","year":"2005","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(17)30103-1_bib16","doi-asserted-by":"crossref","DOI":"10.1001\/jamacardio.2017.0175","article-title":"Effect of monthly high-dose vitamin D supplementation on cardiovascular disease in the vitamin D assessment study: a randomized clinical trial","author":"Scragg","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(17)30103-1_bib17","doi-asserted-by":"crossref","first-page":"e2423","DOI":"10.1371\/journal.pone.0002423","article-title":"Falls, depression and antidepressants in later life: a large primary care appraisal","volume":"3","author":"Kerse","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30103-1_bib18","doi-asserted-by":"crossref","first-page":"111","DOI":"10.2165\/11531500-000000000-00000","article-title":"Current and future economic burden of osteoporosis in New Zealand","volume":"9","author":"Brown","year":"2011","journal-title":"Appl Health Econ Health Policy"},{"key":"10.1016\/S2213-8587(17)30103-1_bib19","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.3945\/ajcn.112.054502","article-title":"Estimating mean annual 25-hydroxyvitamin D concentrations from single measurements: the Multi-Ethnic Study of Atherosclerosis","volume":"97","author":"Sachs","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30103-1_bib20","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1210\/jc.2011-2218","article-title":"IOM committee members respond to Endocrine Society vitamin D guideline","volume":"97","author":"Rosen","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30103-1_bib21","doi-asserted-by":"crossref","first-page":"1382","DOI":"10.1007\/s00198-006-0118-x","article-title":"Serum 25-hydroxyvitamin D concentrations of New Zealanders aged 15 years and older","volume":"17","author":"Rockell","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(17)30103-1_bib22","doi-asserted-by":"crossref","first-page":"g2035","DOI":"10.1136\/bmj.g2035","article-title":"Vitamin D and multiple health outcomes: umbrella review of systematic reviews and meta-analyses of observational studies and randomised trials","volume":"348","author":"Theodoratou","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30103-1_bib23","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/jgs.14679","article-title":"High-dose monthly vitamin D for prevention of acute respiratory infection in older long-term care residents: a randomized clinical trial","volume":"65","author":"Ginde","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(17)30103-1_bib24","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1001\/jama.2010.594","article-title":"Annual high-dose oral vitamin D and falls and fractures in older women: a randomized controlled trial","volume":"303","author":"Sanders","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30103-1_bib25","doi-asserted-by":"crossref","first-page":"4265","DOI":"10.1210\/jc.2014-2562","article-title":"Differences in overlapping meta-analyses of vitamin D supplements and falls","volume":"99","author":"Bolland","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30103-1_bib26","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1210\/jc.2011-1309","article-title":"Long-term follow-up for mortality and cancer in a randomized placebo-controlled trial of vitamin D(3) and\/or calcium (RECORD trial)","volume":"97","author":"Avenell","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30103-1_bib27","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1089\/jwh.2013.4270","article-title":"Calcium plus vitamin D supplementation and health outcomes five years after active intervention ended: the Women's Health Initiative","volume":"22","author":"Cauley","year":"2013","journal-title":"J Womens Health (Larchmt)"},{"key":"10.1016\/S2213-8587(17)30103-1_bib28","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1136\/bmj.326.7387.469","article-title":"Effect of four monthly oral vitamin D3 (cholecalciferol) supplementation on fractures and mortality in men and women living in the community: randomised double blind controlled trial","volume":"326","author":"Trivedi","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30103-1_bib29","doi-asserted-by":"crossref","first-page":"e0115850","DOI":"10.1371\/journal.pone.0115850","article-title":"A meta-analysis of high dose, intermittent vitamin D supplementation among older adults","volume":"10","author":"Zheng","year":"2015","journal-title":"PLoS One"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301031?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301031?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,22]],"date-time":"2019-09-22T12:40:52Z","timestamp":1569156052000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301031"}},"issued":{"date-parts":[[2017,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2213858717301031"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30103-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of monthly high-dose vitamin D supplementation on falls and non-vertebral fractures: secondary and post-hoc outcomes from the randomised, double-blind, placebo-controlled ViDA trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30103-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30140-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T01:55:46Z","timestamp":1794534946761,"version":"4.9.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/s2213-8587(26)00103-8","type":"journal-article","created":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:58:39Z","timestamp":1777597119000},"page":"437","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Diabetes-related complications: an evolving spectrum"],"prefix":"10.1016","volume":"14","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001038?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001038?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:53:52Z","timestamp":1778763232000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726001038"}},"issued":{"date-parts":[[2026,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2213858726001038"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00103-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes-related complications: an evolving spectrum","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00103-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00076-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00223-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00036-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00398-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00014-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T04:28:07Z","timestamp":1794544087715,"version":"4.9.1"},"reference-count":139,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"US National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["K23-DK093583, T32-DK062707"],"award-info":[{"award-number":["K23-DK093583, T32-DK062707"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Johns Hopkins Older Americans Independence Center","award":["P30-AG021334"],"award-info":[{"award-number":["P30-AG021334"]}]}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/s2213-8587(14)70034-8","type":"journal-article","created":{"date-parts":[[2014,3,6]],"date-time":"2014-03-06T14:15:41Z","timestamp":1394115341000},"page":"819-829","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":994,"title":["Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases"],"prefix":"10.1016","volume":"2","author":[{"given":"Rita Rastogi","family":"Kalyani","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Corriere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigi","family":"Ferrucci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70034-8_bib1","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1093\/gerona\/60.2.148","article-title":"Differences in size, strength, and power of upper and lower body muscle groups in young and older men","volume":"60","author":"Candow","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib2","doi-asserted-by":"crossref","first-page":"1851","DOI":"10.1152\/japplphysiol.00246.2003","article-title":"Age-associated changes in skeletal muscles and their effect on mobility: an operational diagnosis of sarcopenia","volume":"95","author":"Lauretani","year":"2003","journal-title":"J Appl Physiol (1985)"},{"issue":"suppl","key":"10.1016\/S2213-8587(14)70034-8_bib3","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1093\/jn\/127.5.990S","article-title":"Sarcopenia: origins and clinical relevance","volume":"127","author":"Rosenberg","year":"1997","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(14)70034-8_bib4","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/j.clnu.2007.03.008","article-title":"Loss of skeletal muscle mass in aging: examining the relationship of starvation, sarcopenia and cachexia","volume":"26","author":"Thomas","year":"2007","journal-title":"Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70034-8_bib5","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1093\/oxfordjournals.aje.a009520","article-title":"Epidemiology of sarcopenia among the elderly in New Mexico","volume":"147","author":"Baumgartner","year":"1998","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib6","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1046\/j.1532-5415.2002.50216.x","article-title":"Low relative skeletal muscle mass (sarcopenia) in older persons is associated with functional impairment and physical disability","volume":"50","author":"Janssen","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib7","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1046\/j.1532-5415.2003.51534.x","article-title":"Sarcopenia: alternative definitions and associations with lower extremity function","volume":"51","author":"Newman","year":"2003","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib8","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1093\/gerona\/63.8.829","article-title":"Sarcopenia =\/= dynapenia","volume":"63","author":"Clark","year":"2008","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib9","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1093\/ageing\/afq034","article-title":"Sarcopenia: European consensus on definition and diagnosis: report of the European Working Group on Sarcopenia in Older People","volume":"39","author":"Cruz-Jentoft","year":"2010","journal-title":"Age Ageing"},{"key":"10.1016\/S2213-8587(14)70034-8_bib10","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1016\/j.jamda.2011.01.003","article-title":"Sarcopenia: an undiagnosed condition in older adults. Current consensus definition: prevalence, etiology, and consequences. International working group on sarcopenia","volume":"12","author":"Fielding","year":"2011","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib11","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1007\/s13539-010-0014-2","article-title":"An overview of sarcopenia: facts and numbers on prevalence and clinical impact","volume":"1","author":"von Haehling","year":"2010","journal-title":"J Cachexia Sarcopenia Muscle"},{"key":"10.1016\/S2213-8587(14)70034-8_bib12","article-title":"Prevalence and clinical correlates of sarcopenia in community-dwelling older people: application of the EWGSOP definition and diagnostic algorithm","author":"Volpato","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib13","doi-asserted-by":"crossref","first-page":"324","DOI":"10.1093\/gerona\/60.3.324","article-title":"Muscle mass, muscle strength, and muscle fat infiltration as predictors of incident mobility limitations in well-functioning older persons","volume":"60","author":"Visser","year":"2005","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib14","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1111\/j.1532-5415.2004.52014.x","article-title":"The healthcare costs of sarcopenia in the United States","volume":"52","author":"Janssen","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib15","doi-asserted-by":"crossref","first-page":"E92","DOI":"10.1152\/ajpendo.00366.2003","article-title":"Age and aerobic exercise training effects on whole body and muscle protein metabolism","volume":"286","author":"Short","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70034-8_bib16","first-page":"11","article-title":"Human aging, muscle mass, and fiber type composition","volume":"50","author":"Lexell","year":"1995","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib17","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1136\/jnnp.36.2.174","article-title":"Physiological changes in ageing muscles","volume":"36","author":"Campbell","year":"1973","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S2213-8587(14)70034-8_bib18","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1093\/gerona\/61.10.1059","article-title":"The loss of skeletal muscle strength, mass, and quality in older adults: the health, aging and body composition study","volume":"61","author":"Goodpaster","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib19","doi-asserted-by":"crossref","first-page":"184","DOI":"10.7150\/ijms.6.184","article-title":"Comparison of skeletal muscle strength between cardiac patients and age-matched healthy controls","volume":"6","author":"Baum","year":"2009","journal-title":"Int J Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib20","doi-asserted-by":"crossref","DOI":"10.1111\/jgs.12653","article-title":"Difference in Muscle Quality over the Adult Life Span and Biological Correlates in the Baltimore Longitudinal Study of Aging","author":"Moore","year":"2014","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib21","doi-asserted-by":"crossref","first-page":"204164","DOI":"10.1155\/2013\/204164","article-title":"Sarcopenic obesity and endocrinal adaptation with age","volume":"2013","author":"Sakuma","year":"2013","journal-title":"Int J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib22","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1097\/MCO.0b013e3282f31744","article-title":"Individualizing recommendations for weight management in the elderly","volume":"11","author":"Chau","year":"2008","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1097\/01.NAJ.0000408184.21770.98","article-title":"Sarcopenic obesity: strategies for management","volume":"111","author":"Benton","year":"2011","journal-title":"Am J Nurs"},{"key":"10.1016\/S2213-8587(14)70034-8_bib24","doi-asserted-by":"crossref","first-page":"480","DOI":"10.1111\/j.1532-5415.2011.03833.x","article-title":"Protein intake and muscle strength in older persons: does inflammation matter?","volume":"60","author":"Bartali","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib25","first-page":"1","article-title":"Morphological and functional characteristics of the ageing skeletal muscle in man. A cross-sectional study","volume":"457","author":"Larsson","year":"1978","journal-title":"Acta Physiol Scand Suppl"},{"key":"10.1016\/S2213-8587(14)70034-8_bib26","doi-asserted-by":"crossref","first-page":"C638","DOI":"10.1152\/ajpcell.1997.272.2.C638","article-title":"Effects of aging on shortening velocity and myosin isoform composition in single human skeletal muscle cells","volume":"272","author":"Larsson","year":"1997","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib27","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1097\/01.mco.0000241664.38385.12","article-title":"Assessment of intramuscular triglycerides: contribution to metabolic abnormalities","volume":"9","author":"Dub\u00e9","year":"2006","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib28","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1093\/gerona\/glp179","article-title":"The effect of aging on human skeletal muscle mitochondrial and intramyocellular lipid ultrastructure","volume":"65","author":"Crane","year":"2010","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib29","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1093\/gerona\/gln050","article-title":"Skeletal muscle hypertrophy following resistance training is accompanied by a fiber type-specific increase in satellite cell content in elderly men","volume":"64","author":"Verdijk","year":"2009","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib30","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1016\/j.ydbio.2010.01.006","article-title":"The depletion of skeletal muscle satellite cells with age is concomitant with reduced capacity of single progenitors to produce reserve progeny","volume":"340","author":"Day","year":"2010","journal-title":"Dev Biol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib31","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1038\/nature03260","article-title":"Rejuvenation of aged progenitor cells by exposure to a young systemic environment","volume":"433","author":"Conboy","year":"2005","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(14)70034-8_bib32","doi-asserted-by":"crossref","first-page":"287","DOI":"10.2337\/dc08-1296","article-title":"Full accounting of diabetes and pre-diabetes in the U.S. population in 1988\u20131994 and 2005\u20132006","volume":"32","author":"Cowie","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib33","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1016\/j.diabres.2009.10.007","article-title":"Global estimates of the prevalence of diabetes for 2010 and 2030","volume":"87","author":"Shaw","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(14)70034-8_bib34","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.2337\/dc09-1597","article-title":"Association of diabetes, comorbidities, and A1C with functional disability in older adults: results from the National Health and Nutrition Examination Survey (NHANES), 1999-2006","volume":"33","author":"Kalyani","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib35","doi-asserted-by":"crossref","first-page":"1672","DOI":"10.2337\/dc11-2202","article-title":"Role of muscle mass and muscle quality in the association between diabetes and gait speed","volume":"35","author":"Volpato","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib36","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.2337\/dc09-0264","article-title":"Excessive loss of skeletal muscle mass in older adults with type 2 diabetes","volume":"32","author":"Park","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib37","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.2337\/dc06-2537","article-title":"Accelerated loss of skeletal muscle strength in older adults with type 2 diabetes: the health, aging, and body composition study","volume":"30","author":"Park","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib38","doi-asserted-by":"crossref","first-page":"2381","DOI":"10.2337\/dc11-1032","article-title":"Insulin sensitizers may attenuate lean mass loss in older men with diabetes","volume":"34","author":"Lee","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib39","doi-asserted-by":"crossref","first-page":"769","DOI":"10.1111\/jgs.12204","article-title":"Quadriceps strength, quadriceps power, and gait speed in older U.S. adults with diabetes mellitus: results from the National Health and Nutrition Examination Survey, 1999\u20132002","volume":"61","author":"Kalyani","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib40","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2337\/dc08-1781","article-title":"Insulin resistance is associated with decreased quadriceps muscle strength in nondiabetic adults aged >or=70 years","volume":"32","author":"Barzilay","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib41","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1471-2318-9-49","article-title":"Inverse association between insulin resistance and gait speed in nondiabetic older men: results from the U.S. National Health and Nutrition Examination Survey (NHANES) 1999\u20132002","volume":"9","author":"Kuo","year":"2009","journal-title":"BMC Geriatr"},{"key":"10.1016\/S2213-8587(14)70034-8_bib42","doi-asserted-by":"crossref","first-page":"262","DOI":"10.1093\/gerona\/61.3.262","article-title":"Phenotype of frailty: characterization in the women's health and aging studies","volume":"61","author":"Bandeen-Roche","year":"2006","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib43","doi-asserted-by":"crossref","first-page":"M146","DOI":"10.1093\/gerona\/56.3.M146","article-title":"Frailty in older adults: evidence for a phenotype","volume":"56","author":"Fried","year":"2001","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib44","doi-asserted-by":"crossref","first-page":"1701","DOI":"10.1111\/j.1532-5415.2012.04099.x","article-title":"Hyperglycemia and incidence of frailty and lower extremity mobility limitations in older women","volume":"60","author":"Kalyani","year":"2012","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib45","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1007\/s00125-009-1430-8","article-title":"Supraphysiological hyperinsulinaemia is necessary to stimulate skeletal muscle protein anabolism in older adults: evidence of a true age-related insulin resistance of muscle protein metabolism","volume":"52","author":"Fujita","year":"2009","journal-title":"Diabetologia"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(14)70034-8_bib46","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1463-1326.2010.01263.x","article-title":"Autophagic pathways and metabolic stress","volume":"12","author":"Kaushik","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(14)70034-8_bib47","doi-asserted-by":"crossref","first-page":"4160","DOI":"10.1210\/en.2006-0251","article-title":"Insulin resistance accelerates muscle protein degradation: Activation of the ubiquitin-proteasome pathway by defects in muscle cell signaling","volume":"147","author":"Wang","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(14)70034-8_bib48","doi-asserted-by":"crossref","first-page":"2944","DOI":"10.2337\/diabetes.51.10.2944","article-title":"Dysfunction of mitochondria in human skeletal muscle in type 2 diabetes","volume":"51","author":"Kelley","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(14)70034-8_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1212\/WNL.25.2.127","article-title":"Human muscle fiber fine structure: morphometric data on controls","volume":"25","author":"Jerusalem","year":"1975","journal-title":"Neurology"},{"key":"10.1016\/S2213-8587(14)70034-8_bib50","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.2337\/db06-0981","article-title":"Mitochondrial respiration is decreased in skeletal muscle of patients with type 2 diabetes","volume":"56","author":"Mogensen","year":"2007","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(14)70034-8_bib51","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1016\/j.physbeh.2008.01.020","article-title":"Type 2 diabetes mellitus and skeletal muscle metabolic function","volume":"94","author":"Phielix","year":"2008","journal-title":"Physiol Behav"},{"key":"10.1016\/S2213-8587(14)70034-8_bib52","doi-asserted-by":"crossref","first-page":"7996","DOI":"10.1073\/pnas.1332551100","article-title":"Effect of insulin on human skeletal muscle mitochondrial ATP production, protein synthesis, and mRNA transcripts","volume":"100","author":"Stump","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(14)70034-8_bib53","doi-asserted-by":"crossref","first-page":"16260","DOI":"10.1073\/pnas.0607795103","article-title":"PGC-1alpha protects skeletal muscle from atrophy by suppressing FoxO3 action and atrophy-specific gene transcription","volume":"103","author":"Sandri","year":"2006","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(14)70034-8_bib54","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1007\/s00125-007-0594-3","article-title":"Patients with type 2 diabetes have normal mitochondrial function in skeletal muscle","volume":"50","author":"Boushel","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70034-8_bib55","doi-asserted-by":"crossref","first-page":"8466","DOI":"10.1073\/pnas.1032913100","article-title":"Coordinated reduction of genes of oxidative metabolism in humans with insulin resistance and diabetes: Potential role of PGC1 and NRF1","volume":"100","author":"Patti","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(14)70034-8_bib56","doi-asserted-by":"crossref","first-page":"E145","DOI":"10.1152\/ajpendo.00755.2009","article-title":"PGC-1alpha regulation by exercise training and its influences on muscle function and insulin sensitivity","volume":"299","author":"Lira","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70034-8_bib57","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00125-006-0475-1","article-title":"Impaired in vivo mitochondrial function but similar intramyocellular lipid content in patients with type 2 diabetes mellitus and BMI-matched control subjects","volume":"50","author":"Schrauwen-Hinderling","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70034-8_bib58","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.cger.2011.03.007","article-title":"Sarcopenia and obesity","volume":"27","author":"Waters","year":"2011","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/S2213-8587(14)70034-8_bib59","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12603-009-0052-7","article-title":"Editorial: Obesity in the elderly: should we be using new diagnostic criteria?","volume":"13","author":"Ritz","year":"2009","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/S2213-8587(14)70034-8_bib60","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1467-789X.2006.00248.x","article-title":"Elevated body mass index and mortality risk in the elderly","volume":"8","author":"Janssen","year":"2007","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(14)70034-8_bib61","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1111\/j.1532-5415.2000.tb03895.x","article-title":"True osteoporosis and frailty-related osteopenia: two different clinical entities","volume":"48","author":"Russo","year":"2000","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib62","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1001\/jama.298.17.2020","article-title":"The changing relationship of obesity and disability, 1988\u20132004","volume":"298","author":"Alley","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70034-8_bib63","doi-asserted-by":"crossref","first-page":"172957","DOI":"10.1155\/2012\/172957","article-title":"Intermuscular adipose tissue is muscle specific and associated with poor functional performance","volume":"2012","author":"Tuttle","year":"2012","journal-title":"J Aging Res"},{"key":"10.1016\/S2213-8587(14)70034-8_bib64","doi-asserted-by":"crossref","first-page":"5559","DOI":"10.1113\/jphysiol.2009.179515","article-title":"The diseasome of physical inactivity--and the role of myokines in muscle-fat cross talk","volume":"587","author":"Pedersen","year":"2009","journal-title":"J Physiol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib65","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1093\/ajcn\/82.4.872","article-title":"Weight change and the conservation of lean mass in old age: the Health, Aging and Body Composition Study","volume":"82","author":"Newman","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70034-8_bib66","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1111\/j.1749-6632.2000.tb06498.x","article-title":"Body composition in healthy aging","volume":"904","author":"Baumgartner","year":"2000","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib67","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1046\/j.1532-5415.2002.50508.x","article-title":"Percentage of body fat and body mass index are associated with mobility limitations in people aged 70 and older from NHANES III","volume":"50","author":"Davison","year":"2002","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib68","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s12020-013-9992-0","article-title":"Sarcopenic obesity in aging population: current status and future directions for research","volume":"45","author":"Kohara","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(14)70034-8_bib69","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1111\/jgs.12260","article-title":"Variation in the prevalence of sarcopenia and sarcopenic obesity in older adults associated with different research definitions: dual-energy X-ray absorptiometry data from the National Health and Nutrition Examination Survey 1999\u20132004","volume":"61","author":"Batsis","year":"2013","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib70","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/ijo.2009.62","article-title":"The effect of obesity combined with low muscle strength on decline in mobility in older persons: results from the InCHIANTI study","volume":"33","author":"Stenholm","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(14)70034-8_bib71","doi-asserted-by":"crossref","first-page":"2082","DOI":"10.1038\/oby.2009.109","article-title":"Sarcopenic\/obesity and physical capacity in older men and women: data from the Nutrition as a Determinant of Successful Aging (NuAge)-the Quebec longitudinal Study","volume":"17","author":"Bouchard","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(14)70034-8_bib72","doi-asserted-by":"crossref","first-page":"1995","DOI":"10.1038\/oby.2004.250","article-title":"Sarcopenic obesity predicts instrumental activities of daily living disability in the elderly","volume":"12","author":"Baumgartner","year":"2004","journal-title":"Obes Res"},{"key":"10.1016\/S2213-8587(14)70034-8_bib73","doi-asserted-by":"crossref","first-page":"3905","DOI":"10.1096\/fj.12-224006","article-title":"Abnormal protein turnover and anabolic resistance to exercise in sarcopenic obesity","volume":"27","author":"Nilsson","year":"2013","journal-title":"FASEB J"},{"key":"10.1016\/S2213-8587(14)70034-8_bib74","doi-asserted-by":"crossref","first-page":"667","DOI":"10.1111\/j.1474-9726.2010.00608.x","article-title":"Fat tissue, aging, and cellular senescence","volume":"9","author":"Tchkonia","year":"2010","journal-title":"Aging Cell"},{"key":"10.1016\/S2213-8587(14)70034-8_bib75","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1172\/JCI37048","article-title":"Mitochondrial H2O2 emission and cellular redox state link excess fat intake to insulin resistance in both rodents and humans","volume":"119","author":"Anderson","year":"2009","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(14)70034-8_bib76","doi-asserted-by":"crossref","first-page":"1926","DOI":"10.2337\/diabetes.54.7.1926","article-title":"A high-fat diet coordinately downregulates genes required for mitochondrial oxidative phosphorylation in skeletal muscle","volume":"54","author":"Sparks","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(14)70034-8_bib77","doi-asserted-by":"crossref","first-page":"42","DOI":"10.3109\/13685538.2010.518179","article-title":"Gonadal status and physical performance in older men","volume":"14","author":"Maggio","year":"2011","journal-title":"Aging Male"},{"key":"10.1016\/S2213-8587(14)70034-8_bib78","doi-asserted-by":"crossref","first-page":"2396","DOI":"10.1210\/jcem.82.8.4160","article-title":"Marked decline in serum concentrations of adrenal C19 sex steroid precursors and conjugated androgen metabolites during aging","volume":"82","author":"Labrie","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70034-8_bib79","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1080\/13685530500361226","article-title":"The effect of 6 months of androgen deprivation therapy on muscle and fat mass in older men with localized prostate cancer","volume":"8","author":"Boxer","year":"2005","journal-title":"Aging Male"},{"key":"10.1016\/S2213-8587(14)70034-8_bib80","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1056\/NEJM199607043350101","article-title":"The effects of supraphysiologic doses of testosterone on muscle size and strength in normal men","volume":"335","author":"Bhasin","year":"1996","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70034-8_bib81","doi-asserted-by":"crossref","first-page":"2790","DOI":"10.1210\/jc.2009-2680","article-title":"Free testosterone levels are associated with mobility limitation and physical performance in community-dwelling men: the Framingham Offspring Study","volume":"95","author":"Krasnoff","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70034-8_bib82","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1093\/gerona\/glr100","article-title":"Clinical meaningfulness of the changes in muscle performance and physical function associated with testosterone administration in older men with mobility limitation","volume":"66","author":"Travison","year":"2011","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib83","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1001\/jama.2007.51","article-title":"Effect of testosterone supplementation on functional mobility, cognition, and other parameters in older men: a randomized controlled trial","volume":"299","author":"Emmelot-Vonk","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70034-8_bib84","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa1000485","article-title":"Adverse events associated with testosterone administration","volume":"363","author":"Basaria","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70034-8_bib85","doi-asserted-by":"crossref","first-page":"522","DOI":"10.1038\/bjp.2008.118","article-title":"Cellular and molecular mechanisms responsible for the action of testosterone on human skeletal muscle. A basis for illegal performance enhancement","volume":"154","author":"Kadi","year":"2008","journal-title":"Br J Pharmacol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib86","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1159\/000071310","article-title":"Activation of the somatotropic axis by testosterone in adult men: evidence for a role of hypothalamic growth hormone-releasing hormone","volume":"77","author":"Bondanelli","year":"2003","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(14)70034-8_bib87","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1210\/jc.2005-0957","article-title":"The effects of growth hormone and\/or testosterone in healthy elderly men: a randomized controlled trial","volume":"91","author":"Giannoulis","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70034-8_bib88","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1007\/s00421-011-2077-y","article-title":"Value of measuring muscle performance to assess changes in lean mass with testosterone and growth hormone supplementation","volume":"112","author":"Schroeder","year":"2012","journal-title":"Eur J Appl Physiol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib89","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.mad.2004.01.004","article-title":"Effects of testosterone on body composition of the aging male","volume":"125","author":"Mudali","year":"2004","journal-title":"Mech Ageing Dev"},{"key":"10.1016\/S2213-8587(14)70034-8_bib90","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1002\/path.2110","article-title":"The endocrine system and ageing","volume":"211","author":"Chahal","year":"2007","journal-title":"J Pathol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib91","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2174\/1874609811104030298","article-title":"The endocrine system and sarcopenia: potential therapeutic benefits","volume":"4","author":"McIntire","year":"2011","journal-title":"Curr Aging Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib92","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1007\/s10522-008-9131-0","article-title":"Cellular and molecular mechanisms underlying age-related skeletal muscle wasting and weakness","volume":"9","author":"Ryall","year":"2008","journal-title":"Biogerontology"},{"key":"10.1016\/S2213-8587(14)70034-8_bib93","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1677\/JOE-09-0431","article-title":"The GH\/IGF1 axis and signaling pathways in the muscle and bone: mechanisms underlying age-related skeletal muscle wasting and osteoporosis","volume":"205","author":"Perrini","year":"2010","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib94","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1016\/S1096-6374(02)00022-9","article-title":"Impact of the GH-cortisol ratio on the age-dependent changes in body composition","volume":"12","author":"Nass","year":"2002","journal-title":"Growth Horm IGF Res"},{"key":"10.1016\/S2213-8587(14)70034-8_bib95","doi-asserted-by":"crossref","first-page":"1797","DOI":"10.1056\/NEJM198912283212605","article-title":"The effects of treatment with recombinant human growth hormone on body composition and metabolism in adults with growth hormone deficiency","volume":"321","author":"Salomon","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70034-8_bib96","doi-asserted-by":"crossref","first-page":"104","DOI":"10.7326\/0003-4819-146-2-200701160-00005","article-title":"Systematic review: the safety and efficacy of growth hormone in the healthy elderly","volume":"146","author":"Liu","year":"2007","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(14)70034-8_bib97","doi-asserted-by":"crossref","first-page":"E1067","DOI":"10.1152\/ajpendo.00253.2004","article-title":"Whole body and forearm substrate metabolism in hyperthyroidism: evidence of increased basal muscle protein breakdown","volume":"288","author":"Riis","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70034-8_bib98","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1046\/j.1365-2265.1999.00861.x","article-title":"Muscle mass and function in thyrotoxic patients before and during medical treatment","volume":"51","author":"N\u00f8rrelund","year":"1999","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70034-8_bib99","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1677\/JOE-07-0606","article-title":"Mechanisms of glucocorticoid-induced myopathy","volume":"197","author":"Schakman","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib100","doi-asserted-by":"crossref","first-page":"913","DOI":"10.4103\/2230-8210.117215","article-title":"Glucocorticoid-induced myopathy: pathophysiology, diagnosis, and treatment","volume":"17","author":"Gupta","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70034-8_bib101","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1007\/s001980200012","article-title":"Vitamin D and muscle function","volume":"13","author":"Pfeifer","year":"2002","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(14)70034-8_bib102","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1111\/j.1532-5415.2010.02949.x","article-title":"Vitamin D treatment for the prevention of falls in older adults: systematic review and meta-analysis","volume":"58","author":"Kalyani","year":"2010","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib103","article-title":"Interaction between bone and muscle in older persons with mobility limitations","author":"Ferrucci","year":"2013","journal-title":"Curr Pharm Des"},{"key":"10.1016\/S2213-8587(14)70034-8_bib104","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1007\/s00198-012-1990-1","article-title":"Differential features of muscle fiber atrophy in osteoporosis and osteoarthritis","volume":"24","author":"Terracciano","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(14)70034-8_bib105","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1097\/MCO.0b013e328340c2c2","article-title":"Cachexia versus sarcopenia","volume":"14","author":"Rolland","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib106","doi-asserted-by":"crossref","first-page":"1421","DOI":"10.1177\/1535370213505961","article-title":"Muscle wasting in collagen-induced arthritis and disuse atrophy","volume":"238","author":"de Oliveira Nunes Teixeira","year":"2013","journal-title":"Exp Biol Med (Maywood)"},{"key":"10.1016\/S2213-8587(14)70034-8_bib107","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1111\/j.1532-5415.2004.52113.x","article-title":"Impairments of muscles and nerves associated with peripheral arterial disease and their relationship with lower extremity functioning: the InCHIANTI Study","volume":"52","author":"McDermott","year":"2004","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(14)70034-8_bib108","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1007\/s11357-011-9238-0","article-title":"Pulse wave velocity is associated with muscle mass decline: Health ABC study","volume":"34","author":"Abbatecola","year":"2012","journal-title":"Age (Dordr)"},{"key":"10.1016\/S2213-8587(14)70034-8_bib109","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1016\/j.arr.2010.04.004","article-title":"Models of accelerated sarcopenia: critical pieces for solving the puzzle of age-related muscle atrophy","volume":"9","author":"Buford","year":"2010","journal-title":"Ageing Res Rev"},{"key":"10.1016\/S2213-8587(14)70034-8_bib110","doi-asserted-by":"crossref","first-page":"1807","DOI":"10.1681\/ASN.2006010083","article-title":"Protein degradation by the ubiquitin-proteasome pathway in normal and disease states","volume":"17","author":"Lecker","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib111","doi-asserted-by":"crossref","first-page":"E591","DOI":"10.1152\/ajpendo.00073.2004","article-title":"IGF-I stimulates muscle growth by suppressing protein breakdown and expression of atrophy-related ubiquitin ligases, atrogin-1 and MuRF1","volume":"287","author":"Sacheck","year":"2004","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70034-8_bib112","doi-asserted-by":"crossref","first-page":"110","DOI":"10.5414\/CN107160","article-title":"Vitamin D and muscle strength, functional ability and balance in peritoneal dialysis patients with vitamin D deficiency","volume":"76","author":"Taskapan","year":"2011","journal-title":"Clin Nephrol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib113","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1097\/00075197-200301000-00012","article-title":"Protein metabolism in liver cirrhosis: from albumin to muscle myofibrils","volume":"6","author":"Tessari","year":"2003","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib114","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/lt.22472","article-title":"Exercise capacity and muscle strength in patients with cirrhosis","volume":"18","author":"Jones","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/S2213-8587(14)70034-8_bib115","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1146\/annurev-med-061509-131248","article-title":"Muscle wasting in cancer cachexia: clinical implications, diagnosis, and emerging treatment strategies","volume":"62","author":"Dodson","year":"2011","journal-title":"Annu Rev Med"},{"key":"10.1016\/S2213-8587(14)70034-8_bib116","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.clnu.2009.12.004","article-title":"Consensus definition of sarcopenia, cachexia and pre-cachexia: joint document elaborated by Special Interest Groups (SIG) \u201ccachexia-anorexia in chronic wasting diseases\u201d and \u201cnutrition in geriatrics\u201d","volume":"29","author":"Muscaritoli","year":"2010","journal-title":"Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70034-8_bib117","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1016\/j.critrevonc.2013.07.001","article-title":"Effect of physical exercise on muscle mass and strength in cancer patients during treatment\u2014a systematic review","volume":"88","author":"Stene","year":"2013","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib118","first-page":"4051","article-title":"Loss of lean body and muscle mass correlates with androgen levels in hypogonadal men with acquired immunodeficiency syndrome and wasting","volume":"81","author":"Grinspoon","year":"1996","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70034-8_bib119","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1590\/S1807-59322011000200014","article-title":"Effect of progressive resistance exercise on strength evolution of elderly patients living with HIV compared to healthy controls","volume":"66","author":"Souza","year":"2011","journal-title":"Clinics (Sao Paulo)"},{"key":"10.1016\/S2213-8587(14)70034-8_bib120","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1016\/j.jamcollsurg.2011.12.038","article-title":"Five-year outcomes after oxandrolone administration in severely burned children: a randomized clinical trial of safety and efficacy","volume":"214","author":"Porro","year":"2012","journal-title":"J Am Coll Surg"},{"key":"10.1016\/S2213-8587(14)70034-8_bib121","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s10354-009-0641-4","article-title":"Effects of progressive strength training on muscle mass in type 2 diabetes mellitus patients determined by computed tomography","volume":"159","author":"Cauza","year":"2009","journal-title":"Wien Med Wochenschr"},{"key":"10.1016\/S2213-8587(14)70034-8_bib122","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1001\/archinternmed.2008.558","article-title":"Effects of exercise modality on insulin resistance and functional limitation in older adults: a randomized controlled trial","volume":"169","author":"Davidson","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(14)70034-8_bib123","doi-asserted-by":"crossref","first-page":"1769","DOI":"10.1056\/NEJM199406233302501","article-title":"Exercise training and nutritional supplementation for physical frailty in very elderly people","volume":"330","author":"Fiatarone","year":"1994","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70034-8_bib124","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1016\/j.biocel.2013.06.024","article-title":"Mitochondrial dysfunction and sarcopenia of aging: from signaling pathways to clinical trials","volume":"45","author":"Marzetti","year":"2013","journal-title":"Int J Biochem Cell Biol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib125","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1001\/archinte.166.8.860","article-title":"Effect of weight loss and exercise on frailty in obese older adults","volume":"166","author":"Villareal","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(14)70034-8_bib126","doi-asserted-by":"crossref","first-page":"B347","DOI":"10.1093\/gerona\/55.7.B347","article-title":"Effects of high-intensity resistance training on untrained older men. II. Muscle fiber characteristics and nucleo-cytoplasmic relationships","volume":"55","author":"Hikida","year":"2000","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(14)70034-8_bib127","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1152\/japplphysiol.01474.2005","article-title":"Efficacy of 3 days\/wk resistance training on myofiber hypertrophy and myogenic mechanisms in young vs. older adults","volume":"101","author":"Kosek","year":"2006","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(14)70034-8_bib128","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/j.1600-0838.2006.00575.x","article-title":"Resistance training in the oldest old: consequences for muscle strength, fiber types, fiber size, and MHC isoforms","volume":"17","author":"Kryger","year":"2007","journal-title":"Scand J Med Sci Sports"},{"key":"10.1016\/S2213-8587(14)70034-8_bib129","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1097\/MCO.0b013e3283412260","article-title":"Sarcopenic obesity: satellite cells in the aging muscle","volume":"14","author":"Thornell","year":"2011","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib130","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1001\/jama.286.10.1218","article-title":"Effects of exercise on glycemic control and body mass in type 2 diabetes mellitus: a meta-analysis of controlled clinical trials","volume":"286","author":"Boul\u00e9","year":"2001","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70034-8_bib131","doi-asserted-by":"crossref","first-page":"969","DOI":"10.2337\/dc09-1974","article-title":"A high-protein diet with resistance exercise training improves weight loss and body composition in overweight and obese patients with type 2 diabetes","volume":"33","author":"Wycherley","year":"2010","journal-title":"Diabetes Care"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(14)70034-8_bib132","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1038\/oby.2009.383","article-title":"Improved insulin sensitivity after exercise: focus on insulin signaling","volume":"17","author":"Fr\u00f8sig","year":"2009","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(14)70034-8_bib133","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1073\/pnas.92.13.5817","article-title":"Contraction stimulates translocation of glucose transporter GLUT4 in skeletal muscle through a mechanism distinct from that of insulin","volume":"92","author":"Lund","year":"1995","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(14)70034-8_bib134","doi-asserted-by":"crossref","first-page":"E197","DOI":"10.1152\/ajpendo.2001.281.2.E197","article-title":"Timing of amino acid-carbohydrate ingestion alters anabolic response of muscle to resistance exercise","volume":"281","author":"Tipton","year":"2001","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70034-8_bib135","doi-asserted-by":"crossref","first-page":"69E","DOI":"10.1016\/j.amjcard.2008.03.004","article-title":"Nutritional supplements with oral amino acid mixtures increases whole-body lean mass and insulin sensitivity in elderly subjects with sarcopenia","volume":"101","author":"Solerte","year":"2008","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(14)70034-8_bib136","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1093\/ajcn\/84.5.1193","article-title":"Interrelations between fat distribution, muscle lipid content, adipocytokines, and insulin resistance: effect of moderate weight loss in older women","volume":"84","author":"Mazzali","year":"2006","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70034-8_bib137","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1097\/MCO.0b013e32831cef8b","article-title":"Dietary protein recommendations and the prevention of sarcopenia","volume":"12","author":"Paddon-Jones","year":"2009","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/S2213-8587(14)70034-8_bib138","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1093\/ajcn\/86.2.451","article-title":"Aging does not impair the anabolic response to a protein-rich meal","volume":"86","author":"Symons","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70034-8_bib139","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1093\/gerona\/glt064","article-title":"Lifestyle interventions and independence for elders study: recruitment and baseline characteristics","volume":"68","author":"Marsh","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700348?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700348?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,8]],"date-time":"2019-08-08T01:54:53Z","timestamp":1565229293000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700348"}},"issued":{"date-parts":[[2014,10]]},"references-count":139,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S2213858714700348"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70034-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Age-related and disease-related muscle loss: the effect of diabetes, obesity, and other diseases","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70034-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:31:20Z","timestamp":1794587480865,"version":"4.9.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,4]]},"DOI":"10.1016\/s2213-8587(25)00070-1","type":"journal-article","created":{"date-parts":[[2025,3,12]],"date-time":"2025-03-12T23:32:02Z","timestamp":1741822322000},"page":"263","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Kidney disease at the forefront of the global health agenda"],"prefix":"10.1016","volume":"13","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000701?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000701?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,16]],"date-time":"2025-05-16T20:14:32Z","timestamp":1747426472000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000701"}},"issued":{"date-parts":[[2025,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2025,4]]}},"alternative-id":["S2213858725000701"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00070-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Kidney disease at the forefront of the global health agenda","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00070-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T14:17:35Z","timestamp":1794579455735,"version":"4.9.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,5,1]],"date-time":"2020-05-01T00:00:00Z","timestamp":1588291200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100006108","name":"National Center for Advancing Translational Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006108","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014848","name":"Arnold Ventures","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014848","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["KL2TR001856"],"award-info":[{"award-number":["KL2TR001856"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,5]]},"DOI":"10.1016\/s2213-8587(20)30105-4","type":"journal-article","created":{"date-parts":[[2020,3,20]],"date-time":"2020-03-20T19:38:55Z","timestamp":1584733135000},"page":"360-362","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Insulin access and affordability in the USA: anticipating the first interchangeable insulin product"],"prefix":"10.1016","volume":"8","author":[{"given":"Jing","family":"Luo","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron S","family":"Kesselheim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ameet","family":"Sarpatwari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30105-4_bib1","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1001\/jamainternmed.2018.5008","article-title":"Cost-related insulin underuse among patients with diabetes","volume":"179","author":"Herkert","year":"2019","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(20)30105-4_bib2","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11892-020-1286-3","article-title":"Origins of the crisis in insulin affordability and practical advice for clinicians on using human insulin","volume":"20","author":"Luo","year":"2020","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(20)30105-4_bib5","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1056\/NEJMc1711899","article-title":"Prices of generic drugs associated with numbers of manufacturers","volume":"377","author":"Dave","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30105-4_bib6","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1001\/jama.2019.2990","article-title":"Trends in medicaid prices, market share, and spending on long-acting insulins, 2006\u20132018","volume":"321","author":"Hernandez","year":"2019","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30105-4_bib7","author":"Cauchi"},{"key":"10.1016\/S2213-8587(20)30105-4_bib8","author":"Rowland"},{"key":"10.1016\/S2213-8587(20)30105-4_bib9","first-page":"339","article-title":"Drug product life-cycle management as anticompetitive behavior: the case of memantine","volume":"22","author":"Capati","year":"2016","journal-title":"J Manag Care Spec Pharm"},{"key":"10.1016\/S2213-8587(20)30105-4_bib10","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2337\/dci18-0019","article-title":"Insulin access and affordability working group: conclusions and recommendations","volume":"41","author":"Cefalu","year":"2018","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301054?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301054?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:49Z","timestamp":1761991669000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301054"}},"issued":{"date-parts":[[2020,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2020,5]]}},"alternative-id":["S2213858720301054"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30105-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin access and affordability in the USA: anticipating the first interchangeable insulin product","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30105-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T09:20:04Z","timestamp":1794648004107,"version":"4.9.1"},"reference-count":115,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/s2213-8587(14)70032-4","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T23:54:34Z","timestamp":1396914874000},"page":"901-910","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1136,"title":["Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome"],"prefix":"10.1016","volume":"2","author":[{"given":"Hannele","family":"Yki-J\u00e4rvinen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70032-4_bib1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1007\/s00125-009-1620-4","article-title":"The metabolic syndrome: useful concept or clinical tool? Report of a WHO Expert Consultation","volume":"53","author":"Simmons","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70032-4_bib2","doi-asserted-by":"crossref","first-page":"1640","DOI":"10.1161\/CIRCULATIONAHA.109.192644","volume":"120","author":"Alberti","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(14)70032-4_bib3","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.2337\/diab.37.12.1595","article-title":"Banting lecture 1988. Role of insulin resistance in human disease","volume":"37","author":"Reaven","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(14)70032-4_bib4","doi-asserted-by":"crossref","first-page":"3490","DOI":"10.1210\/jc.2007-0482","article-title":"Liver fat in the metabolic syndrome","volume":"92","author":"Kotronen","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70032-4_bib5","doi-asserted-by":"crossref","first-page":"1592","DOI":"10.1053\/j.gastro.2012.04.001","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Gastroenterological Association, American Association for the Study of Liver Diseases, and American College of Gastroenterology","volume":"142","author":"Chalasani","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib6","doi-asserted-by":"crossref","first-page":"3023","DOI":"10.1210\/jcem.87.7.8638","article-title":"Fat accumulation in the liver is associated with defects in insulin suppression of glucose production and serum free fatty acids independent of obesity in normal men","volume":"87","author":"Sepp\u00e4l\u00e4-Lindroos","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70032-4_bib7","doi-asserted-by":"crossref","first-page":"2356","DOI":"10.1007\/s00125-007-0790-1","article-title":"Acute suppression of VLDL1 secretion rate by insulin is associated with hepatic fat content and insulin resistance","volume":"50","author":"Adiels","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70032-4_bib8","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1038\/nrgastro.2013.41","article-title":"Progression of NAFLD to diabetes mellitus, cardiovascular disease or cirrhosis","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib9","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1055\/s-0029-1222606","article-title":"Nonalcoholic fatty liver disease as a contributor to hypercoagulation and thrombophilia in the metabolic syndrome","volume":"35","author":"Targher","year":"2009","journal-title":"Semin Thromb Hemost"},{"key":"10.1016\/S2213-8587(14)70032-4_bib10","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1002\/hep.20466","article-title":"Prevalence of hepatic steatosis in an urban population in the United States: impact of ethnicity","volume":"40","author":"Browning","year":"2004","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib11","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1111\/j.1572-0241.2003.07486.x","article-title":"The prevalence and etiology of elevated aminotransferase levels in the United States","volume":"98","author":"Clark","year":"2003","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib12","doi-asserted-by":"crossref","first-page":"810","DOI":"10.1002\/hep.24127","article-title":"Nonalcoholic fatty liver disease (NAFLD) activity score and the histopathologic diagnosis in NAFLD: distinct clinicopathologic meanings","volume":"53","author":"Brunt","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib13","doi-asserted-by":"crossref","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","article-title":"Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults","volume":"34","author":"Vernon","year":"2011","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S2213-8587(14)70032-4_bib14","doi-asserted-by":"crossref","first-page":"1820","DOI":"10.1002\/hep.23594","article-title":"Nonalcoholic fatty liver disease and hepatocellular carcinoma: a weighty connection","volume":"51","author":"Starley","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib15","doi-asserted-by":"crossref","first-page":"1249","DOI":"10.1053\/j.gastro.2011.06.061","article-title":"Frequency and outcomes of liver transplantation for nonalcoholic steatohepatitis in the United States","volume":"141","author":"Charlton","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib16","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1055\/s-0032-1306424","article-title":"Nonalcoholic steatohepatitis and noncirrhotic hepatocellular carcinoma: fertile soil","volume":"32","author":"Torres","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/S2213-8587(14)70032-4_bib17","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.semcancer.2013.07.003","article-title":"Obesity, insulin resistance, NASH and hepatocellular carcinoma","volume":"23","author":"Yu","year":"2013","journal-title":"Semin Cancer Biol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib18","article-title":"Association between the PNPLA3 (rs738409 C>G) variant and hepatocellular carcinoma: evidence from a meta-analysis of individual participant data","author":"Tr\u00e9po","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib19","doi-asserted-by":"crossref","first-page":"E462","DOI":"10.1152\/ajpendo.00064.2004","article-title":"Magnetic resonance spectroscopy to measure hepatic triglyceride content: prevalence of hepatic steatosis in the general population","volume":"288","author":"Szczepaniak","year":"2005","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70032-4_bib20","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.jhep.2012.07.028","article-title":"Prevalence and risk factors of non-alcoholic fatty liver disease in the elderly: results from the Rotterdam study","volume":"57","author":"Koehler","year":"2012","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib21","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1093\/aje\/kws448","article-title":"Prevalence of nonalcoholic fatty liver disease in the United States: the third national health and nutrition examination survey, 1988-1994","volume":"178","author":"Lazo","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib22","doi-asserted-by":"crossref","first-page":"2093","DOI":"10.1038\/ajg.2010.152","article-title":"Association between metabolic syndrome and liver histology among children with nonalcoholic fatty liver disease","volume":"105","author":"Patton","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib23","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1016\/j.jhep.2009.03.019","article-title":"Systematic review of risk factors for fibrosis progression in non-alcoholic steatohepatitis","volume":"51","author":"Argo","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib24","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1038\/ajg.2009.587","article-title":"Predicting fibrosis worsening in obese patients with NASH through parenchymal fibronectin, HOMA-IR, and hypertension","volume":"105","author":"Sorrentino","year":"2010","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib25","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1016\/j.jhep.2013.04.027","article-title":"A systematic review of follow-up biopsies reveals disease progression in patients with non-alcoholic fatty liver","volume":"59","author":"Pais","year":"2013","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.arcmed.2013.01.007","article-title":"Increased risk of type 2 diabetes in subjects with both elevated liver enzymes and ultrasonographically diagnosed nonalcoholic fatty liver disease: a 4-year longitudinal study","volume":"44","author":"Choi","year":"2013","journal-title":"Arch Med Res"},{"key":"10.1016\/S2213-8587(14)70032-4_bib27","doi-asserted-by":"crossref","first-page":"1378","DOI":"10.1002\/hep.26183","article-title":"Clinical availability of nonalcoholic fatty liver disease as an early predictor of type 2 diabetes mellitus in Korean men: 5-year prospective cohort study","volume":"57","author":"Park","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib28","doi-asserted-by":"crossref","first-page":"1056","DOI":"10.1007\/s00125-009-1285-z","article-title":"A common variant in PNPLA3, which encodes adiponutrin, is associated with liver fat content in humans","volume":"52","author":"Kotronen","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70032-4_bib29","series-title":"Oxford Textbook of Endocrinology and Diabetes","first-page":"1740","article-title":"Pathophysiology of type 2 diabetes","author":"Yki-J\u00e4rvinen","year":"2011"},{"key":"10.1016\/S2213-8587(14)70032-4_bib30","doi-asserted-by":"crossref","first-page":"4215","DOI":"10.3748\/wjg.v18.i31.4215","article-title":"Metabolic syndrome and gallstone disease","volume":"18","author":"Chen","year":"2012","journal-title":"World J Gastroenterol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib31","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ajg.2013.84","article-title":"Cholecystectomy and NAFLD: does gallbladder removal have metabolic consequences?","volume":"108","author":"Nervi","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib32","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/j.jhep.2010.05.037","article-title":"Cholesterol synthesis is increased and absorption decreased in non-alcoholic fatty liver disease independent of obesity","volume":"54","author":"Simonen","year":"2011","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib33","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1016\/j.cmet.2012.04.004","article-title":"Increased hepatic synthesis and dysregulation of cholesterol metabolism is associated with the severity of nonalcoholic fatty liver disease","volume":"15","author":"Min","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(14)70032-4_bib34","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1053\/j.gastro.2007.04.068","article-title":"Relationship between hepatic\/visceral fat and hepatic insulin resistance in nondiabetic and type 2 diabetic subjects","volume":"133","author":"Gastaldelli","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib35","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1053\/j.gastro.2007.11.038","article-title":"Alterations in adipose tissue and hepatic lipid kinetics in obese men and women with nonalcoholic fatty liver disease","volume":"134","author":"Fabbrini","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib36","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1161\/ATVBAHA.107.160192","article-title":"Overproduction of very low-density lipoproteins is the hallmark of the dyslipidemia in the metabolic syndrome","volume":"28","author":"Adiels","year":"2008","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib37","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1053\/j.gastro.2008.03.021","article-title":"Increased liver fat, impaired insulin clearance, and hepatic and adipose tissue insulin resistance in type 2 diabetes","volume":"135","author":"Kotronen","year":"2008","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib38","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1152\/physrev.00033.2011","article-title":"Pathophysiology of human visceral obesity: an update","volume":"93","author":"Tchernof","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(14)70032-4_bib39","doi-asserted-by":"crossref","DOI":"10.1016\/j.jhep.2014.01.009","article-title":"Development of new fatty liver, or resolution of existing fatty liver, over five years of follow up, and risk of incident hypertension","author":"Sung","year":"2014","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib40","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1007\/s001250050023","article-title":"Cardiovascular risk factors clustering with endogenous hyperinsulinaemia predict death from coronary heart disease in patients with Type II diabetes","volume":"43","author":"Lehto","year":"2000","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70032-4_bib41","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","author":"Consultation","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70032-4_bib42","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.1038\/ajg.2013.104","article-title":"Prevalence and risk factors for the development of nonalcoholic fatty liver disease in a nonobese Chinese population: the Zhejiang Zhenhai Study","volume":"108","author":"Xu","year":"2013","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib43","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1159\/000282101","article-title":"The effect of lifestyle changes in non-alcoholic fatty liver disease","volume":"28","author":"Centis","year":"2010","journal-title":"Dig Dis"},{"key":"10.1016\/S2213-8587(14)70032-4_bib44","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1055\/s-0032-1306428","article-title":"The impact of bariatric surgery on nonalcoholic steatohepatitis","volume":"32","author":"Rabl","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/S2213-8587(14)70032-4_bib45","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1152\/physrev.00017.2012","article-title":"Hypoxia and adipose tissue function and dysfunction in obesity","volume":"93","author":"Trayhurn","year":"2013","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(14)70032-4_bib46","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(14)70032-4_bib47","doi-asserted-by":"crossref","first-page":"E982","DOI":"10.1210\/jc.2011-3305","article-title":"Adiponectin as an independent predictor of the presence and degree of hepatic steatosis in the Dallas Heart Study","volume":"97","author":"Turer","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70032-4_bib48","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1172\/JCI23621","article-title":"Sources of fatty acids stored in liver and secreted via lipoproteins in patients with nonalcoholic fatty liver disease","volume":"115","author":"Donnelly","year":"2005","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(14)70032-4_bib49","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1007\/s00125-012-2598-x","article-title":"Adiponectin: mechanistic insights and clinical implications","volume":"55","author":"Turer","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70032-4_bib50","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1016\/S1665-2681(19)31457-7","article-title":"Gut microbiota and nonalcoholic fatty liver disease","volume":"11","author":"Machado","year":"2012","journal-title":"Ann Hepatol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70032-4_bib51","doi-asserted-by":"crossref","first-page":"S71","DOI":"10.1017\/S0007114500000982","article-title":"Visceral fat and insulin resistance\u2014causative or correlative?","volume":"83","author":"Frayn","year":"2000","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(14)70032-4_bib52","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1038\/sj.ijo.0800467","article-title":"Visceral fat in relation to health: is it a major culprit or simply an innocent bystander?","volume":"21","author":"Seidell","year":"1997","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(14)70032-4_bib53","doi-asserted-by":"crossref","first-page":"15430","DOI":"10.1073\/pnas.0904944106","article-title":"Intrahepatic fat, not visceral fat, is linked with metabolic complications of obesity","volume":"106","author":"Fabbrini","year":"2009","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(14)70032-4_bib54","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1053\/j.gastro.2010.04.056","article-title":"Surgical removal of omental fat does not improve insulin sensitivity and cardiovascular risk factors in obese adults","volume":"139","author":"Fabbrini","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib55","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1093\/ajcn\/79.4.537","article-title":"Consumption of high-fructose corn syrup in beverages may play a role in the epidemic of obesity","volume":"79","author":"Bray","year":"2004","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70032-4_bib56","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1056\/NEJMoa1014296","article-title":"Changes in diet and lifestyle and long-term weight gain in women and men","volume":"364","author":"Mozaffarian","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70032-4_bib57","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1161\/CIRCULATIONAHA.111.067017","article-title":"Sweetened beverage consumption, incident coronary heart disease, and biomarkers of risk in men","volume":"125","author":"de Koning","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(14)70032-4_bib58","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.2337\/dc10-1079","article-title":"Sugar-sweetened beverages and risk of metabolic syndrome and type 2 diabetes: a meta-analysis","volume":"33","author":"Malik","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70032-4_bib59","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.3945\/ajcn.2008.27140","article-title":"Sweetened beverage consumption and risk of coronary heart disease in women","volume":"89","author":"Fung","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70032-4_bib60","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1002\/hep.23535","article-title":"Increased fructose consumption is associated with fibrosis severity in patients with nonalcoholic fatty liver disease","volume":"51","author":"Abdelmalek","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib61","article-title":"Increased de novo lipogenesis is a distinct characteristic of individuals with nonalcoholic fatty liver disease","author":"Lambert","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib62","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S0022-2275(20)32553-0","article-title":"Hepatic secretion of VLDL fatty acids during stimulated lipogenesis in men","volume":"39","author":"Aarsland","year":"1998","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(14)70032-4_bib63","doi-asserted-by":"crossref","first-page":"203","DOI":"10.2337\/db08-1074","article-title":"Hepatic stearoyl-CoA desaturase (SCD)-1 activity and diacylglycerol but not ceramide concentrations are increased in the nonalcoholic human fatty liver","volume":"58","author":"Kotronen","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(14)70032-4_bib64","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1053\/j.gastro.2010.06.064","article-title":"Splanchnic balance of free fatty acids, endocannabinoids, and lipids in subjects with nonalcoholic fatty liver disease","volume":"139","author":"Westerbacka","year":"2010","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib65","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1097\/MCO.0b013e328361c4d1","article-title":"Carbohydrate intake and nonalcoholic fatty liver disease","volume":"16","author":"Neuschwander-Tetri","year":"2013","journal-title":"Curr Opin Clin Nutr Metab Care"},{"key":"10.1016\/S2213-8587(14)70032-4_bib66","doi-asserted-by":"crossref","first-page":"727","DOI":"10.3945\/ajcn.112.038695","article-title":"Effect of short-term carbohydrate overfeeding and long-term weight loss on liver fat in overweight humans","volume":"96","author":"Sevastianova","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70032-4_bib67","doi-asserted-by":"crossref","first-page":"1146","DOI":"10.1093\/ajcn\/77.5.1146","article-title":"Effects of dietary fatty acids and carbohydrates on the ratio of serum total to HDL cholesterol and on serum lipids and apolipoproteins: a meta-analysis of 60 controlled trials","volume":"77","author":"Mensink","year":"2003","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70032-4_bib68","doi-asserted-by":"crossref","first-page":"1200","DOI":"10.1056\/NEJM197911293012203","article-title":"Increased insulin sensitivity and insulin binding to monocytes after physical training","volume":"301","author":"Soman","year":"1979","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70032-4_bib69","doi-asserted-by":"crossref","first-page":"e46819","DOI":"10.1371\/journal.pone.0046819","article-title":"Regular exercise is associated with a reduction in the risk of NAFLD and decreased liver enzymes in individuals with NAFLD independent of obesity in Korean adults","volume":"7","author":"Bae","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(14)70032-4_bib70","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1055\/s-0032-1306427","article-title":"Exercise and the liver: implications for therapy in fatty liver disorders","volume":"32","author":"Johnson","year":"2012","journal-title":"Semin Liver Dis"},{"key":"10.1016\/S2213-8587(14)70032-4_bib71","doi-asserted-by":"crossref","first-page":"1738","DOI":"10.1002\/hep.25548","article-title":"Randomized trial of exercise effect on intrahepatic triglyceride content and lipid kinetics in nonalcoholic fatty liver disease","volume":"55","author":"Sullivan","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib72","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1053\/j.gastro.2009.01.048","article-title":"Dietary fat and carbohydrates differentially alter insulin sensitivity during caloric restriction","volume":"136","author":"Kirk","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib73","doi-asserted-by":"crossref","first-page":"13705","DOI":"10.1073\/pnas.1110105108","article-title":"Reversal of muscle insulin resistance with exercise reduces postprandial hepatic de novo lipogenesis in insulin resistant individuals","volume":"108","author":"Rab\u00f8l","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(14)70032-4_bib74","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.1053\/j.gastro.2009.01.050","article-title":"Heritability of nonalcoholic fatty liver disease","volume":"136","author":"Schwimmer","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib75","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1016\/j.jhep.2008.12.025","article-title":"Genetic factors contribute to variation in serum alanine aminotransferase activity independent of obesity and alcohol: a study in monozygotic and dizygotic twins","volume":"50","author":"Makkonen","year":"2009","journal-title":"J Hepatol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib76","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1002\/hep.20554","article-title":"Racial and ethnic distribution of nonalcoholic fatty liver in persons with newly diagnosed chronic liver disease","volume":"41","author":"Weston","year":"2005","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib77","doi-asserted-by":"crossref","first-page":"685","DOI":"10.2337\/diacare.29.03.06.dc05-1796","article-title":"Geographic variations of the International Diabetes Federation and the National Cholesterol Education Program-Adult Treatment Panel III definitions of the metabolic syndrome in nondiabetic subjects","volume":"29","author":"Lorenzo","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70032-4_bib78","doi-asserted-by":"crossref","first-page":"e1001324","DOI":"10.1371\/journal.pgen.1001324","article-title":"Genome-wide association analysis identifies variants associated with nonalcoholic fatty liver disease that have distinct effects on metabolic traits","volume":"7","author":"Speliotes","year":"2011","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(14)70032-4_bib79","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1038\/ng.970","article-title":"Genome-wide association study identifies loci influencing concentrations of liver enzymes in plasma","volume":"43","author":"Chambers","year":"2011","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(14)70032-4_bib80","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1002\/hep.24806","article-title":"Variant in the glucokinase regulatory protein (GCKR) gene is associated with fatty liver in obese children and adolescents","volume":"55","author":"Santoro","year":"2012","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib81","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/j.cgh.2013.02.011","article-title":"Association between variants in or near PNPLA3, GCKR, and PPP1R3B with ultrasound-defined steatosis based on data from the third National Health and Nutrition Examination Survey","volume":"11","author":"Hernaez","year":"2013","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib82","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1002\/hep.26440","article-title":"Characterization of European ancestry nonalcoholic fatty liver disease-associated variants in individuals of African and Hispanic descent","volume":"58","author":"Palmer","year":"2013","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib83","doi-asserted-by":"crossref","first-page":"34","DOI":"10.1159\/000346195","article-title":"Genetic variation at NCAN locus is associated with inflammation and fibrosis in non-alcoholic fatty liver disease in morbid obesity","volume":"75","author":"Gorden","year":"2013","journal-title":"Hum Hered"},{"key":"10.1016\/S2213-8587(14)70032-4_bib84","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/ATVBAHA.112.255463","article-title":"Genetics of glucose homeostasis: implications for insulin resistance and metabolic syndrome","volume":"32","author":"Norris","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib85","doi-asserted-by":"crossref","first-page":"261","DOI":"10.5664\/jcsm.27191","article-title":"Obstructive sleep apnea and cardiovascular disease: role of the metabolic syndrome and its components","volume":"4","author":"Jean-Louis","year":"2008","journal-title":"J Clin Sleep Med"},{"key":"10.1016\/S2213-8587(14)70032-4_bib86","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1111\/obr.12020","article-title":"Association of obstructive sleep apnoea with the presence and severity of non-alcoholic fatty liver disease. A systematic review and meta-analysis","volume":"14","author":"Musso","year":"2013","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(14)70032-4_bib87","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1007\/s11695-013-0981-4","article-title":"Obstructive sleep apnea is associated with fatty liver and abnormal liver enzymes: a meta-analysis","volume":"23","author":"Sookoian","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(14)70032-4_bib88","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1016\/j.cmet.2013.06.016","article-title":"Fibrosis and adipose tissue dysfunction","volume":"18","author":"Sun","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(14)70032-4_bib89","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1097\/MED.0b013e32835a000e","article-title":"Clinical update on screening, diagnosis and management of metabolic disorders and cardiovascular risk factors associated with polycystic ovary syndrome","volume":"19","author":"Huang","year":"2012","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(14)70032-4_bib90","doi-asserted-by":"crossref","first-page":"3709","DOI":"10.1210\/jc.2012-1382","article-title":"Polycystic ovary syndrome with hyperandrogenism is characterized by an increased risk of hepatic steatosis compared to nonhyperandrogenic PCOS phenotypes and healthy controls, independent of obesity and insulin resistance","volume":"97","author":"Jones","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70032-4_bib91","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1038\/ng.257","article-title":"Genetic variation in PNPLA3 confers susceptibility to nonalcoholic fatty liver disease","volume":"40","author":"Romeo","year":"2008","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(14)70032-4_bib92","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1002\/hep.24283","article-title":"Meta-analysis of the influence of I148M variant of patatin-like phospholipase domain containing 3 gene (PNPLA3) on the susceptibility and histological severity of nonalcoholic fatty liver disease","volume":"53","author":"Sookoian","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib93","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1038\/nrgastro.2013.182","article-title":"The genetics of NAFLD","volume":"10","author":"Anstee","year":"2013","journal-title":"Nat Rev Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(14)70032-4_bib94","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1186\/1471-2350-13-113","article-title":"Genetic variant I148M in PNPLA3 is associated with the ultrasonography-determined steatosis degree in a Chinese population","volume":"13","author":"Li","year":"2012","journal-title":"BMC Med Genet"},{"key":"10.1016\/S2213-8587(14)70032-4_bib95","doi-asserted-by":"crossref","first-page":"e50256","DOI":"10.1371\/journal.pone.0050256","article-title":"Genetic variants in PNPLA3 and risk of non-alcoholic fatty liver disease in a Han Chinese population","volume":"7","author":"Peng","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(14)70032-4_bib96","doi-asserted-by":"crossref","first-page":"326","DOI":"10.3945\/ajcn.112.046417","article-title":"A common variant in the peroxisome proliferator-activated receptor-\u03b3 coactivator-1\u03b1 gene is associated with nonalcoholic fatty liver disease in obese children","volume":"97","author":"Lin","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70032-4_bib97","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.diabet.2011.05.001","article-title":"Association of PNPLA3 SNP rs738409 with liver density in African Americans with type 2 diabetes mellitus","volume":"37","author":"Cox","year":"2011","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(14)70032-4_bib98","doi-asserted-by":"crossref","first-page":"2616","DOI":"10.2337\/db09-0279","article-title":"Dissociation between fatty liver and insulin resistance in humans carrying a variant of the patatin-like phospholipase 3 gene","volume":"58","author":"Kantartzis","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(14)70032-4_bib99","doi-asserted-by":"crossref","first-page":"7892","DOI":"10.1073\/pnas.1003585107","article-title":"A feed-forward loop amplifies nutritional regulation of PNPLA3","volume":"107","author":"Huang","year":"2010","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(14)70032-4_bib100","doi-asserted-by":"crossref","first-page":"37085","DOI":"10.1074\/jbc.M111.290114","article-title":"Expression and characterization of a PNPLA3 protein isoform (I148M) associated with nonalcoholic fatty liver disease","volume":"286","author":"Huang","year":"2011","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(14)70032-4_bib101","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/j.cmet.2012.04.008","article-title":"Adiponutrin functions as a nutritionally regulated lysophosphatidic acid acyltransferase","volume":"15","author":"Kumari","year":"2012","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(14)70032-4_bib102","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1038\/ijo.2009.216","article-title":"Morbid obesity exposes the association between PNPLA3 I148M (rs738409) and indices of hepatic injury in individuals of European descent","volume":"34","author":"Romeo","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(14)70032-4_bib103","doi-asserted-by":"crossref","first-page":"E430","DOI":"10.1210\/jc.2010-0814","article-title":"Specifically PNPLA3-mediated accumulation of liver fat in obese patients with type 2 diabetes","volume":"95","author":"Petit","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70032-4_bib104","doi-asserted-by":"crossref","first-page":"2275","DOI":"10.1002\/hep.24567","article-title":"I148M variant of PNPLA3 confer increased risk for nonalcoholic fatty liver disease not only in European population, but also in Chinese population","volume":"54","author":"Li","year":"2011","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib105","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1194\/jlr.P900013-JLR200","article-title":"A nonsynonymous gene variant in the adiponutrin gene is associated with nonalcoholic fatty liver disease severity","volume":"50","author":"Sookoian","year":"2009","journal-title":"J Lipid Res"},{"key":"10.1016\/S2213-8587(14)70032-4_bib106","doi-asserted-by":"crossref","first-page":"1274","DOI":"10.1002\/hep.23823","article-title":"I148M patatin-like phospholipase domain-containing 3 gene variant and severity of pediatric nonalcoholic fatty liver disease","volume":"52","author":"Valenti","year":"2010","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib107","doi-asserted-by":"crossref","first-page":"e40376","DOI":"10.1371\/journal.pone.0040376","article-title":"The PNPLA3 rs738409 G-allele associates with reduced fasting serum triglyceride and serum cholesterol in Danes with impaired glucose regulation","volume":"7","author":"Krarup","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(14)70032-4_bib108","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1007\/s00439-013-1294-3","article-title":"Genome-wide scan revealed that polymorphisms in the PNPLA3, SAMM50, and PARVB genes are associated with development and progression of nonalcoholic fatty liver disease in Japan","volume":"132","author":"Kitamoto","year":"2013","journal-title":"Hum Genet"},{"key":"10.1016\/S2213-8587(14)70032-4_bib109","doi-asserted-by":"crossref","first-page":"e39362","DOI":"10.1371\/journal.pone.0039362","article-title":"Paradoxical lower serum triglyceride levels and higher type 2 diabetes mellitus susceptibility in obese individuals with the PNPLA3 148M variant","volume":"7","author":"Palmer","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(14)70032-4_bib110","doi-asserted-by":"crossref","first-page":"312","DOI":"10.2337\/db13-0774","article-title":"Circulating triacylglycerol signatures in nonalcoholic fatty liver disease associated with the I148M variant in PNPLA3 and with obesity","volume":"63","author":"Hyysalo","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(14)70032-4_bib111","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1007\/s00125-013-2829-9","article-title":"Adipose tissue is inflamed in NAFLD due to obesity but not in NAFLD due to genetic variation in PNPLA3","volume":"56","author":"Lallukka","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70032-4_bib112","doi-asserted-by":"crossref","first-page":"1326","DOI":"10.1111\/j.1478-3231.2011.02526.x","article-title":"The PNPLA3 I148M polymorphism is associated with insulin resistance and nonalcoholic fatty liver disease in a normoglycaemic population","volume":"31","author":"Wang","year":"2011","journal-title":"Liver Int"},{"key":"10.1016\/S2213-8587(14)70032-4_bib113","doi-asserted-by":"crossref","first-page":"104","DOI":"10.3945\/ajcn.111.012369","article-title":"Genetic variation in PNPLA3 (adiponutrin) confers sensitivity to weight loss-induced decrease in liver fat in humans","volume":"94","author":"Sevastianova","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70032-4_bib114","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1053\/jhep.2003.50161","article-title":"Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome","volume":"37","author":"Marchesini","year":"2003","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(14)70032-4_bib115","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1111\/j.1463-1326.2009.01191.x","article-title":"Decrease in hepatic very-low-density lipoprotein-triglyceride secretion after weight loss is inversely associated with changes in circulating leptin","volume":"12","author":"Magkos","year":"2010","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700324?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700324?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T02:03:55Z","timestamp":1648778635000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700324"}},"issued":{"date-parts":[[2014,11]]},"references-count":115,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S2213858714700324"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70032-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70032-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:16:26Z","timestamp":1794651386475,"version":"4.9.1"},"reference-count":19,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/s2213-8587(15)00261-2","type":"journal-article","created":{"date-parts":[[2015,8,9]],"date-time":"2015-08-09T19:45:16Z","timestamp":1439149516000},"page":"687-696","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":253,"title":["The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial"],"prefix":"10.1016","volume":"3","author":[{"given":"Dick","family":"de Zeeuw","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pirow","family":"Bekker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Henkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher","family":"Hasslacher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Gouni-Berthold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heidrun","family":"Mehling","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antonia","family":"Potarca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vladimir","family":"Tesar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiddo J Lambers","family":"Heerspink","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas J","family":"Schall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00261-2_bib1","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1111\/j.1523-1755.2004.00653.x","article-title":"Proteinuria, a target for renoprotection in patients with type 2 diabetic nephropathy: lessons from RENAAL","volume":"65","author":"de Zeeuw","year":"2004","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(15)00261-2_bib2","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1053\/j.ajkd.2004.10.019","article-title":"Proteinuria reduction and progression to renal failure in patients with type 2 diabetes mellitus and overt nephropathy","volume":"45","author":"Atkins","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(15)00261-2_bib3","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1038\/nrneph.2012.42","article-title":"Proteinuria should be used as a surrogate in CKD","volume":"8","author":"Cravedi","year":"2012","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S2213-8587(15)00261-2_bib4","first-page":"566","article-title":"Reduction in albuminuria translates to reduction in cardiovascular events in hypertensive patients with left ventricular hypertrophy and diabetes","volume":"21","author":"Ibsen","year":"2008","journal-title":"J Nephrol"},{"key":"10.1016\/S2213-8587(15)00261-2_bib5","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1681\/ASN.2010091001","article-title":"Changes in albuminuria predict mortality and morbidity in patients with vascular disease","volume":"22","author":"Schmieder","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(15)00261-2_bib6","doi-asserted-by":"crossref","first-page":"392","DOI":"10.1900\/RDS.2011.8.392","article-title":"The kidney in type 2 diabetes therapy","volume":"8","author":"Heerspink","year":"2011","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/S2213-8587(15)00261-2_bib7","doi-asserted-by":"crossref","first-page":"2204","DOI":"10.1056\/NEJMoa1208799","article-title":"Cardiorenal end points in a trial of aliskiren for type 2 diabetes","volume":"367","author":"Parving","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00261-2_bib8","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1056\/NEJMoa1303154","article-title":"Combined angiotensin inhibition for the treatment of diabetic nephropathy","volume":"369","author":"Fried","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00261-2_bib9","doi-asserted-by":"crossref","first-page":"7265","DOI":"10.1073\/pnas.1133870100","article-title":"Monocyte chemoattractant protein 1 in obesity and insulin resistance","volume":"100","author":"Sartipy","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(15)00261-2_bib10","doi-asserted-by":"crossref","first-page":"1494","DOI":"10.1172\/JCI26498","article-title":"MCP-1 contributes to macrophage infiltration into adipose tissue, insulin resistance, and hepatic steatosis in obesity","volume":"116","author":"Kanda","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(15)00261-2_bib11","doi-asserted-by":"crossref","first-page":"F697","DOI":"10.1152\/ajprenal.00016.2008","article-title":"MCP-1\/CCL2: a new diagnostic marker and therapeutic target for progressive renal injury in diabetic nephropathy","volume":"294","author":"Tesch","year":"2008","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/S2213-8587(15)00261-2_bib12","doi-asserted-by":"crossref","first-page":"2752","DOI":"10.1073\/pnas.91.7.2752","article-title":"Molecular cloning and functional expression of two monocyte chemoattractant protein 1 receptors reveals alternative splicing of the carboxyl-terminal tails","volume":"91","author":"Charo","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(15)00261-2_bib13","doi-asserted-by":"crossref","first-page":"F1288","DOI":"10.1152\/ajprenal.00316.2013","article-title":"CCR2 antagonist CCX140-B provides renal and glycemic benefits in diabetic transgenic human CCR2 knockin mice","volume":"305","author":"Sullivan","year":"2013","journal-title":"Am J Physiol Renal Physiol"},{"key":"10.1016\/S2213-8587(15)00261-2_bib14","doi-asserted-by":"crossref","first-page":"103","DOI":"10.2307\/2529712","article-title":"Sequential treatment assignment with balancing for prognostic factors in the controlled clinical trial","volume":"31","author":"Pocock","year":"1975","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(15)00261-2_bib15","doi-asserted-by":"crossref","first-page":"e0119803","DOI":"10.1371\/journal.pone.0119803","article-title":"Functional Interaction between Angiotensin II Receptor Type 1 and Chemokine (C-C Motif) Receptor 2 with Implications for Chronic Kidney Disease","volume":"10","author":"Ayoub","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(15)00261-2_bib16","doi-asserted-by":"crossref","first-page":"1700","DOI":"10.1093\/ndt\/gfs555","article-title":"Blockade of CCL2\/CCR2 signalling ameliorates diabetic nephropathy in db\/db mice","volume":"28","author":"Seok","year":"2013","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(15)00261-2_bib17","doi-asserted-by":"crossref","first-page":"225","DOI":"10.4172\/2155-6156.1000225","article-title":"Orally-administered chemokine receptor CCR2 antagonist CCX140-B in type 2 diabetes: a pilot double-blind, randomized clinical trial","volume":"3","author":"Hanefeld","year":"2012","journal-title":"J Diabetes Metab"},{"key":"10.1016\/S2213-8587(15)00261-2_bib18","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1038\/ki.2011.79","article-title":"An acute fall in estimated glomerular filtration rate during treatment with losartan predicts a slower decrease in long-term renal function","volume":"80","author":"Holtkamp","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(15)00261-2_bib19","article-title":"Drug-induced reduction in albuminuria is associated with subsequent renoprotection: a meta-analysis","author":"Lambers Heerspink","year":"2014","journal-title":"J Am Soc Nephrol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002612?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002612?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,11,19]],"date-time":"2022-11-19T00:53:12Z","timestamp":1668819192000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002612"}},"issued":{"date-parts":[[2015,9]]},"references-count":19,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S2213858715002612"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00261-2","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.725719377.793518345","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The effect of CCR2 inhibitor CCX140-B on residual albuminuria in patients with type 2 diabetes and nephropathy: a randomised trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00261-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00286-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:41:16Z","timestamp":1794667276622,"version":"4.9.1"},"reference-count":12,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2018,2,1]],"date-time":"2018-02-01T00:00:00Z","timestamp":1517443200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000062","name":"US National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"crossref","award":["P30DK072488"],"award-info":[{"award-number":["P30DK072488"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,2]]},"DOI":"10.1016\/s2213-8587(17)30413-8","type":"journal-article","created":{"date-parts":[[2017,12,5]],"date-time":"2017-12-05T22:12:39Z","timestamp":1512511959000},"page":"83-85","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":33,"title":["GLP-1 receptor agonists: differentiation within the class"],"prefix":"10.1016","volume":"6","author":[{"given":"Simeon I","family":"Taylor","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30413-8_bib1","first-page":"1151","article-title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","volume":"390","author":"Bethel","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30413-8_bib2","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30413-8_bib3","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30413-8_bib4","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30413-8_bib5","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30413-8_bib6","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1080\/00031305.2016.1154108","article-title":"The ASA's statement on p-values: context, process, and purpose","volume":"70","author":"Wasserstein","year":"2016","journal-title":"Am Stat"},{"key":"10.1016\/S2213-8587(17)30413-8_bib7","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.2337\/dc12-2709","article-title":"Efficacy and safety of lixisenatide once daily versus exenatide twice daily in type 2 diabetes inadequately controlled on metformin: a 24-week, randomized, open-label, active-controlled study (GetGoal-X)","volume":"36","author":"Rosenstock","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30413-8_bib8","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1016\/S0140-6736(08)61206-4","article-title":"Exenatide once weekly versus twice daily for the treatment of type 2 diabetes: a randomised, open-label, non-inferiority study","volume":"372","author":"Drucker","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30413-8_bib9","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/S0140-6736(12)61267-7","article-title":"Exenatide once weekly versus liraglutide once daily in patients with type 2 diabetes (DURATION-6): a randomised, open-label study","volume":"381","author":"Buse","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30413-8_bib11","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0140-6736(14)60976-4","article-title":"Once-weekly dulaglutide versus once-daily liraglutide in metformin-treated patients with type 2 diabetes (AWARD-6): a randomised, open-label, phase 3, non-inferiority trial","volume":"384","author":"Dungan","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30413-8_bib12","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S2213-8587(13)70214-6","article-title":"Once-weekly albiglutide versus once-daily liraglutide in patients with type 2 diabetes inadequately controlled on oral drugs (HARMONY 7): a randomised, open-label, multicentre, non-inferiority phase 3 study","volume":"2","author":"Pratley","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30413-8_bib13","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S0167-0115(03)00120-4","article-title":"The importance of the nine-amino acid C-terminal sequence of exendin-4 for binding to the GLP-1 receptor and for biological activity","volume":"114","author":"Doyle","year":"2003","journal-title":"Regul Pept"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304138?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717304138?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,3,19]],"date-time":"2019-03-19T04:30:32Z","timestamp":1552969832000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717304138"}},"issued":{"date-parts":[[2018,2]]},"references-count":12,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2018,2]]}},"alternative-id":["S2213858717304138"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30413-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonists: differentiation within the class","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30413-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30412-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,4]],"date-time":"2026-08-04T23:12:30Z","timestamp":1785885150732,"version":"3.56.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2017,1,1]],"date-time":"2017-01-01T00:00:00Z","timestamp":1483228800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,1]]},"DOI":"10.1016\/s2213-8587(16)30400-4","type":"journal-article","created":{"date-parts":[[2016,12,21]],"date-time":"2016-12-21T02:45:30Z","timestamp":1482288330000},"page":"11-12","source":"Crossref","is-referenced-by-count":17,"title":["Epigenetic inheritance and the responsibility for health in society"],"prefix":"10.1016","volume":"5","author":[{"given":"Mark","family":"Hanson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30400-4_bib1","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1016\/S2213-8587(16)30107-3","article-title":"Influence of maternal obesity on the long-term health of offspring","volume":"5","author":"Godfrey","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30400-4_bib2","series-title":"The epigenetics revolution: how modern biology is rewriting our understanding of genetics, disease and inheritance","author":"Carey","year":"2012"},{"key":"10.1016\/S2213-8587(16)30400-4_bib3","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1152\/physrev.00029.2013","article-title":"Early Developmental Conditioning of Later Health and Disease: Physiology or Pathophysiology?","volume":"94","author":"Hanson","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(16)30400-4_bib4","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S2213-8587(16)30217-0","article-title":"Preconceptional and maternal obesity: epidemiology and health consequences","volume":"4","author":"Poston","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30400-4_bib5","series-title":"Weighing in. Obesity, food justice, and the limits of capitalism","author":"Guthman","year":"2011"},{"key":"10.1016\/S2213-8587(16)30400-4_bib6","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1038\/512131a","article-title":"Don't blame the mothers","volume":"512","author":"Richardson","year":"2014","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)30400-4_bib7","doi-asserted-by":"crossref","DOI":"10.1057\/s41292-016-0002-7","article-title":"Of rats and women: narratives of motherhood in environmental epigenetics","author":"Kenney","year":"2016","journal-title":"BioSocieties"},{"key":"10.1016\/S2213-8587(16)30400-4_bib8","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1038\/507022a","article-title":"Epigenetics: The sins of the father","volume":"507","author":"Hughes","year":"2014","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)30400-4_bib9","series-title":"Eugenics, literature and culture in post-war Britain","author":"Hanson","year":"2012"},{"key":"10.1016\/S2213-8587(16)30400-4_bib10","series-title":"Race to the finish. Identity and governance in the age of genomics","author":"Reardon","year":"2005"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716304004?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716304004?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,5]],"date-time":"2018-09-05T18:52:24Z","timestamp":1536173544000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716304004"}},"issued":{"date-parts":[[2017,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2017,1]]}},"alternative-id":["S2213858716304004"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30400-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,1]]}},{"indexed":{"date-parts":[[2026,8,28]],"date-time":"2026-08-28T19:11:13Z","timestamp":1787944273198,"version":"build-2784847793"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/s2213-8587(24)00090-1","type":"journal-article","created":{"date-parts":[[2024,3,29]],"date-time":"2024-03-29T23:34:17Z","timestamp":1711755257000},"page":"287-289","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Type 1 diabetes: heterogeneity in heritability"],"prefix":"10.1016","volume":"12","author":[{"given":"Richard David","family":"Leslie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00090-1_bib1","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1016\/S2213-8587(23)00159-6","article-title":"Understanding diabetes heterogeneity: key steps towards precision medicine in diabetes","volume":"11","author":"Leslie","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00090-1_bib2","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.2337\/dc21-0770","article-title":"Adult-onset type 1 diabetes: current understanding and challenges","volume":"44","author":"Leslie","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00090-1_bib3","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1038\/s41574-023-00853-0","article-title":"Heterogeneity and endotypes in type 1 diabetes mellitus","volume":"19","author":"Redondo","year":"2023","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00090-1_bib4","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1007\/s00125-023-05927-2","article-title":"The countdown to type 1 diabetes: when, how and why does the clock start?","volume":"66","author":"Ziegler","year":"2023","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00090-1_bib5","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.2337\/dbi18-0034","article-title":"Etiology of autoimmune islet disease: timing is everything","volume":"70","author":"Lernmark","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00090-1_bib6","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1007\/s001250051626","article-title":"Heterogeneity of type I diabetes: analysis of monozygotic twins in Great Britain and the United States","volume":"44","author":"Redondo","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00090-1_bib7","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2337\/dc19-0803","article-title":"Genetic variants predisposing most strongly to type 1 diabetes diagnosed under age 7 years lie near candidate genes that function in the immune system and in pancreatic \u03b2-cells","volume":"43","author":"Inshaw","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00090-1_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00068-8","article-title":"Familial aggregation and heritability of childhood-onset and adult-onset type 1 diabetes: a genetically informative register-based cohort study","author":"Wei","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00090-1_bib9","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1016\/S2213-8587(23)00267-X","article-title":"C-peptide and metabolic outcomes in trials of disease modifying therapy in new-onset type 1 diabetes: an individual participant meta-analysis","volume":"11","author":"Taylor","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00090-1_bib10","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S2213-8587(23)00190-0","article-title":"Maternal type 1 diabetes and relative protection against offspring transmission","volume":"11","author":"Allen","year":"2023","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:46:13Z","timestamp":1715039173000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000901"}},"issued":{"date-parts":[[2024,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2213858724000901"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00090-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 1 diabetes: heterogeneity in heritability","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00090-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00068-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,29]],"date-time":"2026-08-29T17:18:57Z","timestamp":1788023937777,"version":"build-2784847793"},"reference-count":8,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T00:00:00Z","timestamp":1775001600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,4]]},"DOI":"10.1016\/s2213-8587(25)00369-9","type":"journal-article","created":{"date-parts":[[2026,2,20]],"date-time":"2026-02-20T23:40:52Z","timestamp":1771630852000},"page":"276-277","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Specific cortisol blockade in Cushing's syndrome"],"prefix":"10.1016","volume":"14","author":[{"given":"Ashley","family":"Grossman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00369-9_bib1","first-page":"137","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)","volume":"50","author":"Cushing","year":"1932","journal-title":"Bull Johns Hopkins Hosp"},{"key":"10.1016\/S2213-8587(25)00369-9_bib2","doi-asserted-by":"crossref","first-page":"847","DOI":"10.1016\/S2213-8587(21)00235-7","article-title":"Consensus on diagnosis and management of Cushing's disease: a guideline update","volume":"9","author":"Fleseriu","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00369-9_bib3","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1530\/EJE-12-0921","article-title":"Long-term remission and recurrence rates in Cushing's disease: predictive factors in a single-centre study","volume":"168","author":"Alexandraki","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00369-9_bib4","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.1210\/jc.2011-3350","article-title":"Mifepristone, a glucocorticoid receptor antagonist, produces clinical and metabolic benefits in patients with Cushing's syndrome","volume":"97","author":"Fleseriu","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00369-9_bib5","doi-asserted-by":"crossref","first-page":"408","DOI":"10.1002\/cpdd.389","article-title":"Assessment of safety, tolerability, pharmacokinetics, and pharmacological effect of orally administered CORT125134: an adaptive, double-blind, randomized, placebo-controlled phase 1 clinical study","volume":"7","author":"Hunt","year":"2018","journal-title":"Clin Pharmacol Drug Dev"},{"key":"10.1016\/S2213-8587(25)00369-9_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00362-6","article-title":"Efficacy and safety of relacorilant for the treatment of patients with Cushing's syndrome (GRACE): a multicentre, phase 3, double-blind, placebo-controlled, randomised-withdrawal study","author":"Pivonello","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00369-9_bib7","doi-asserted-by":"crossref","first-page":"M23","DOI":"10.1530\/EJE-15-0265","article-title":"A critical reappraisal of bilateral adrenalectomy for ACTH-dependent Cushing's syndrome","volume":"173","author":"Reincke","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00369-9_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1530\/EJE-20-1088","article-title":"Corticotroph tumor progression after bilateral adrenalectomy (Nelson's syndrome): systematic review and expert consensus recommendations","volume":"184","author":"Reincke","year":"2021","journal-title":"Eur J Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003699?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003699?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,18]],"date-time":"2026-03-18T08:47:01Z","timestamp":1773823621000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003699"}},"issued":{"date-parts":[[2026,4]]},"references-count":8,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2026,4]]}},"alternative-id":["S2213858725003699"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00369-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Specific cortisol blockade in Cushing's syndrome","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00369-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00362-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T06:33:58Z","timestamp":1791873238491,"version":"4.3.4"},"reference-count":69,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004339","name":"Sanofi","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004339","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000738","name":"University of Leicester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000738","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000857","name":"Loughborough University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000857","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009947","name":"Merck Sharp and Dohme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009947","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012358","name":"Collaboration for Leadership in Applied Health Research and Care - Greater Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100002429","name":"Amgen","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100002429","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100012151","name":"University Hospitals of Leicester NHS Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100012151","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/s2213-8587(18)30025-1","type":"journal-article","created":{"date-parts":[[2018,2,28]],"date-time":"2018-02-28T18:38:31Z","timestamp":1519843111000},"page":"821-832","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":106,"title":["Do sulphonylureas still have a place in clinical practice?"],"prefix":"10.1016","volume":"6","author":[{"given":"Kamlesh","family":"Khunti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudesna","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hertzel C","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophia","family":"Zoungas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie J","family":"Davies","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30025-1_bib1","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1007\/s11892-014-0473-5","article-title":"Sulfonylureas: a new look at old therapy","volume":"14","author":"Thule","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(18)30025-1_bib2","doi-asserted-by":"crossref","first-page":"140","DOI":"10.2337\/dc14-2441","article-title":"Management of hyperglycemia in type 2 diabetes, 2015: a patient-centered approach. Update to a position statement of the American Diabetes Association and the European Association for the Study of Diabetes","volume":"38","author":"Inzucchi","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30025-1_bib3","doi-asserted-by":"crossref","first-page":"523","DOI":"10.1111\/dom.12456","article-title":"Cardiovascular safety of sulphonylureas: over 40 years of continuous controversy without an answer","volume":"17","author":"Abdelmoneim","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30025-1_bib4","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30025-1_bib5","first-page":"891","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"376","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30025-1_bib6","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30025-1_bib8","doi-asserted-by":"crossref","first-page":"468","DOI":"10.2337\/dc16-0985","article-title":"Trends in drug utilization, glycemic control, and rates of severe hypoglycemia, 2006\u20132013","volume":"40","author":"Lipska","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30025-1_bib9","doi-asserted-by":"crossref","first-page":"e010210","DOI":"10.1136\/bmjopen-2015-010210","article-title":"Trends in incidence, prevalence and prescribing in type 2 diabetes mellitus between 2000 and 2013 in primary care: a retrospective cohort study","volume":"6","author":"Sharma","year":"2016","journal-title":"BMJ Open"},{"issue":"suppl","key":"10.1016\/S2213-8587(18)30025-1_bib10","first-page":"789","article-title":"A study of the effects of hypoglycemic agents on vascular complications in patients with adult-onset diabetes. II. Mortality results","volume":"19","author":"Meinert","year":"1970","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30025-1_bib11","doi-asserted-by":"crossref","first-page":"706","DOI":"10.2337\/dc16-1943","article-title":"Sulfonylureas and the risks of cardiovascular events and death: a methodological meta-regression analysis of the observational studies","volume":"40","author":"Azoulay","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30025-1_bib12","first-page":"21","article-title":"Accidents hypoglycemiques graves par un sulfamidothiodiazol (le VK 57 ou 2254 RP)","volume":"441","author":"Janbon","year":"1942","journal-title":"Montpellier Med"},{"key":"10.1016\/S2213-8587(18)30025-1_bib13","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33). UK Prospective Diabetes Study (UKPDS) Group","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30025-1_bib14","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30025-1_bib15","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1161\/CIRCRESAHA.107.165324","article-title":"The sulfonylurea receptor, an atypical ATP-binding cassette protein, and its regulation of the KATP channel","volume":"102","author":"Burke","year":"2008","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(18)30025-1_bib16","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1016\/j.biochi.2017.07.002","article-title":"Misunderstandings and controversies about the insulin-secreting properties of antidiabetic sulfonylureas","volume":"143","author":"Henquin","year":"2017","journal-title":"Biochimie"},{"key":"10.1016\/S2213-8587(18)30025-1_bib17","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1111\/j.1463-1326.2011.01496.x","article-title":"Variations in tissue selectivity amongst insulin secretagogues: a systematic review","volume":"14","author":"Abdelmoneim","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30025-1_bib18","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/0079-6107(89)90013-8","article-title":"Electrophysiology of the pancreatic beta-cell","volume":"54","author":"Ashcroft","year":"1989","journal-title":"Prog Biophys Mol Biol"},{"key":"10.1016\/S2213-8587(18)30025-1_bib19","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1053\/euhj.1998.1242","article-title":"Sulfonylureas and ischaemic preconditioning; a double-blind, placebo-controlled evaluation of glimepiride and glibenclamide","volume":"20","author":"Klepzig","year":"1999","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(18)30025-1_bib20","doi-asserted-by":"crossref","first-page":"e1001992","DOI":"10.1371\/journal.pmed.1001992","article-title":"The association between sulfonylurea use and all-cause and cardiovascular mortality: a meta-analysis with trial sequential analysis of randomized clinical trials","volume":"13","author":"Varvaki Rados","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(18)30025-1_bib21","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1007\/s00125-013-2856-6","article-title":"Estimating the effect of sulfonylurea on HbA1c in diabetes: a systematic review and meta-analysis","volume":"56","author":"Hirst","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30025-1_bib22","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1001\/jama.2010.405","article-title":"Effect of noninsulin antidiabetic drugs added to metformin therapy on glycemic control, weight gain, and hypoglycemia in type 2 diabetes","volume":"303","author":"Phung","year":"2010","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30025-1_bib23","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1002\/dmrr.2470","article-title":"The incidence of mild and severe hypoglycaemia in patients with type 2 diabetes mellitus treated with sulfonylureas: a systematic review and meta-analysis","volume":"30","author":"Schopman","year":"2014","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(18)30025-1_bib24","doi-asserted-by":"crossref","first-page":"389","DOI":"10.2337\/dc06-1789","article-title":"A systematic review and meta-analysis of hypoglycemia and cardiovascular events: a comparison of glyburide with other secretagogues and with insulin","volume":"30","author":"Gangji","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30025-1_bib25","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1001\/jama.2016.9400","article-title":"Comparison of clinical outcomes and adverse events associated with glucose-lowering drugs in patients with type 2 diabetes: a meta-analysis","volume":"316","author":"Palmer","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30025-1_bib26","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1111\/dom.12821","article-title":"Cardiovascular events and all-cause mortality associated with sulphonylureas compared with other antihyperglycaemic drugs: a Bayesian meta-analysis of survival data","volume":"19","author":"Bain","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30025-1_bib27","doi-asserted-by":"crossref","first-page":"938","DOI":"10.1111\/dom.12116","article-title":"Cardiovascular safety of sulfonylureas: a meta-analysis of randomized clinical trials","volume":"15","author":"Monami","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30025-1_bib28","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1056\/NEJMoa066224","article-title":"Glycemic durability of rosiglitazone, metformin, or glyburide monotherapy","volume":"355","author":"Kahn","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30025-1_bib29","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.2337\/dc07-0339","article-title":"Counterpoint: A Diabetes Outcome Progression Trial (ADOPT): good for sulfonylureas?","volume":"30","author":"Al-Ozairi","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30025-1_bib30","doi-asserted-by":"crossref","first-page":"475","DOI":"10.1016\/S0140-6736(12)60691-6","article-title":"2-year efficacy and safety of linagliptin compared with glimepiride in patients with type 2 diabetes inadequately controlled on metformin: a randomised, double-blind, non-inferiority trial","volume":"380","author":"Gallwitz","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30025-1_bib31","doi-asserted-by":"crossref","first-page":"2015","DOI":"10.2337\/dc11-0606","article-title":"Dapagliflozin versus glipizide as add-on therapy in patients with type 2 diabetes who have inadequate glycemic control with metformin: a randomized, 52-week, double-blind, active-controlled noninferiority trial","volume":"34","author":"Nauck","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30025-1_bib32","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/dom.12459","article-title":"Long-term glycaemic response and tolerability of dapagliflozin versus a sulphonylurea as add-on therapy to metformin in patients with type 2 diabetes: 4-year data","volume":"17","author":"Del Prato","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30025-1_bib33","doi-asserted-by":"crossref","first-page":"204","DOI":"10.1111\/dom.12012","article-title":"Long-term efficacy and safety comparison of liraglutide, glimepiride and placebo, all in combination with metformin in type 2 diabetes: 2-year results from the LEAD-2 study","volume":"15","author":"Nauck","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30025-1_bib34","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/j.diabres.2013.12.062","article-title":"Adding glimepiride to insulin+metformin in type 2 diabetes of more than 10 years duration - a randomised, double-blind, placebo-controlled, cross-over study","volume":"103","author":"Nyb\u00e4ck-Nakell","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30025-1_bib35","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1001\/jama.2014.4312","article-title":"Association between intensification of metformin treatment with insulin vs sulfonylureas and cardiovascular events and all-cause mortality among patients with diabetes","volume":"311","author":"Roumie","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30025-1_bib36","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30025-1_bib37","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1111\/j.1365-2362.2004.01381.x","article-title":"GUIDE study: double-blind comparison of once-daily gliclazide MR and glimepiride in type 2 diabetic patients","volume":"34","author":"Schernthaner","year":"2004","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S2213-8587(18)30025-1_bib38","doi-asserted-by":"crossref","first-page":"e0126427","DOI":"10.1371\/journal.pone.0126427","article-title":"Prevalence and incidence of hypoglycaemia in 532,542 people with type 2 diabetes on oral therapies and insulin: a systematic review and meta-analysis of population based studies","volume":"10","author":"Edridge","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30025-1_bib39","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/dmrr.235","article-title":"Lower incidence of severe hypoglycaemia in patients with type 2 diabetes treated with glimepiride versus glibenclamide","volume":"17","author":"Holstein","year":"2001","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(18)30025-1_bib40","doi-asserted-by":"crossref","first-page":"973","DOI":"10.1111\/dom.12700","article-title":"Addition of sulphonylurea to metformin does not relevantly change body weight: a prospective observational cohort study (ZODIAC-39)","volume":"18","author":"Schrijnders","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30025-1_bib41","doi-asserted-by":"crossref","first-page":"i3625","DOI":"10.1136\/bmj.i3625","article-title":"Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study","volume":"354","author":"van Dalem","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30025-1_bib42","article-title":"Sulfonylureas as initial treatment for type 2 diabetes and the risk of severe hypoglycemia","author":"Yu","year":"2017","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(18)30025-1_bib43","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1007\/s11892-017-0954-4","article-title":"The infamous, famous sulfonylureas and cardiovascular safety: much ado about nothing?","volume":"17","author":"Pop","year":"2017","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(18)30025-1_bib44","doi-asserted-by":"crossref","first-page":"2099","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30025-1_bib45","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1016\/S2213-8587(14)70213-X","article-title":"Mortality risk among sulfonylureas: a systematic review and network meta-analysis","volume":"3","author":"Simpson","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30025-1_bib46","doi-asserted-by":"crossref","first-page":"e7638","DOI":"10.1097\/MD.0000000000007638","article-title":"Combination therapy of metformin plus dipeptidyl peptidase-4 inhibitor versus metformin plus sulfonylurea and their association with a decreased risk of cardiovascular disease in type 2 diabetes mellitus patients","volume":"96","author":"Wang","year":"2017","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S2213-8587(18)30025-1_bib47","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30025-1_bib48","doi-asserted-by":"crossref","first-page":"887","DOI":"10.1016\/S2213-8587(17)30317-0","article-title":"Effects on the incidence of cardiovascular events of the addition of pioglitazone versus sulfonylureas in patients with type 2 diabetes inadequately controlled with metformin (TOSCA.IT): a randomised, multicentre trial","volume":"5","author":"Vaccaro","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30025-1_bib49","doi-asserted-by":"crossref","first-page":"531","DOI":"10.1210\/jc.2002-020904","article-title":"Impairment of myocardial protection in type 2 diabetic patients","volume":"88","author":"Lee","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30025-1_bib50","doi-asserted-by":"crossref","first-page":"663","DOI":"10.2337\/dc16-1972","article-title":"Cardiac effects of sulfonylurea-related hypoglycemia","volume":"40","author":"Middleton","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30025-1_bib51","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/dom.12704","article-title":"Cardiovascular safety of glucose-lowering agents as add-on medication to metformin treatment in type 2 diabetes: report from the Swedish National Diabetes Register","volume":"18","author":"Ekstrom","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30025-1_bib52","doi-asserted-by":"crossref","first-page":"50","DOI":"10.1007\/s00125-014-3372-z","article-title":"Sulfonylurea in combination with insulin is associated with increased mortality compared with a combination of insulin and metformin in a retrospective Danish nationwide study","volume":"58","author":"Mogensen","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30025-1_bib53","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.2337\/dc17-0595","article-title":"Pharmacologic differences of sulfonylureas and the risk of adverse cardiovascular and hypoglycemic events","volume":"40","author":"Douros","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30025-1_bib54","doi-asserted-by":"crossref","first-page":"1781","DOI":"10.2217\/pgs.09.96","article-title":"Presence of CYP2C9*3 allele increases risk for hypoglycemia in Type 2 diabetic patients treated with sulfonylureas","volume":"10","author":"Ragia","year":"2009","journal-title":"Pharmacogenomics"},{"key":"10.1016\/S2213-8587(18)30025-1_bib55","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1111\/dom.13046","article-title":"Interaction between variants in the CYP2C9 and POR genes and the risk of sulfonylurea-induced hypoglycaemia: a GoDARTS study","volume":"20","author":"Dujic","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30025-1_bib56","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.2337\/db17-0149","article-title":"Genetic variation at the sulfonylurea receptor, type 2 diabetes, and coronary heart disease","volume":"66","author":"Emdin","year":"2017","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(18)30025-1_bib57","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1463-1326.2009.01184.x","article-title":"Understanding the inter-relationship between improved glycaemic control, hypoglycaemia and weight change within a long-term economic model","volume":"12","author":"McEwan","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(18)30025-1_bib58","doi-asserted-by":"crossref","first-page":"E1213","DOI":"10.1503\/cmaj.110178","article-title":"Cost-effectiveness of second-line antihyperglycemic therapy in patients with type 2 diabetes mellitus inadequately controlled on metformin","volume":"183","author":"Klarenbach","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(18)30025-1_bib59","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1186\/1472-6963-12-213","article-title":"Group based diabetes self-management education compared to routine treatment for people with type 2 diabetes mellitus. A systematic review with meta-analysis","volume":"12","author":"Steinsbekk","year":"2012","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(18)30025-1_bib60","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1016\/j.diabres.2011.05.008","article-title":"Multifactorial intervention in individuals with type 2 diabetes and microalbuminuria: the Microalbuminuria Education and Medication Optimisation (MEMO) study","volume":"93","author":"Crasto","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30025-1_bib61","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S2213-8587(16)30048-1","article-title":"New drug treatments versus structured education programmes for type 2 diabetes: comparing cost-effectiveness","volume":"4","author":"Khunti","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30025-1_bib62","doi-asserted-by":"crossref","first-page":"279","DOI":"10.2471\/BLT.06.033647","article-title":"The availability and affordability of selected essential medicines for chronic diseases in six low- and middle-income countries","volume":"85","author":"Mendis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(18)30025-1_bib63","series-title":"The management of adult diabetes services in the NHS: progress review","year":"2015"},{"key":"10.1016\/S2213-8587(18)30025-1_bib64","doi-asserted-by":"crossref","first-page":"207","DOI":"10.4158\/EP161682.CS","article-title":"Consensus statement by the American Association of Clinical Endocrinologists and American College of Endocrinology on the comprehensive type 2 diabetes management algorithm\u20142017 executive summary","volume":"23","author":"Garber","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(18)30025-1_bib65","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30025-1_bib66","doi-asserted-by":"crossref","first-page":"588","DOI":"10.2337\/dc14-0599","article-title":"Tight glycemic control and use of hypoglycemic medications in older veterans with type 2 diabetes and comorbid dementia","volume":"38","author":"Thorpe","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30025-1_bib67","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.pcd.2017.01.007","article-title":"Clinical inertia-Time to reappraise the terminology?","volume":"11","author":"Khunti","year":"2017","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/S2213-8587(18)30025-1_bib68","doi-asserted-by":"crossref","first-page":"677","DOI":"10.1016\/S2213-8587(16)30091-2","article-title":"Trends in hospital admissions for hypoglycaemia in England: a retrospective, observational study","volume":"4","author":"Zaccardi","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30025-1_bib69","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1177\/1479164112475102","article-title":"Cardiovascular outcome trials in type 2 diabetes and the sulphonylurea controversy: rationale for the active-comparator CAROLINA trial","volume":"10","author":"Rosenstock","year":"2013","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/S2213-8587(18)30025-1_bib70","doi-asserted-by":"crossref","first-page":"2254","DOI":"10.2337\/dc13-0356","article-title":"Rationale and design of the glycemia reduction approaches in diabetes: a comparative effectiveness study (GRADE)","volume":"36","author":"Nathan","year":"2013","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:27Z","timestamp":1761991587000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300251"}},"issued":{"date-parts":[[2018,10]]},"references-count":69,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2213858718300251"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30025-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Do sulphonylureas still have a place in clinical practice?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30025-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:48:29Z","timestamp":1792097309026,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,11,1]],"date-time":"2026-11-01T00:00:00Z","timestamp":1793491200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,11]]},"DOI":"10.1016\/s2213-8587(26)00216-0","type":"journal-article","created":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T22:08:50Z","timestamp":1790719730000},"page":"872-873","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Petrelintide and the evolving role of amylin agonism in obesity"],"prefix":"10.1016","volume":"14","author":[{"given":"Sten","family":"Madsbad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jens J","family":"Holst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00216-0_bib1","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1080\/13543784.2025.2472408","article-title":"The promise of glucagon-like peptide 1 receptor agonists (GLP-1RA) for the treatment of obesity: a look at phase 2 and 3 pipelines","volume":"34","author":"Madsbad","year":"2025","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/S2213-8587(26)00216-0_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/dom.71146","article-title":"Amylin: A multi-functional pancreatic hormone\u2014a review","author":"Le Foll","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00216-0_bib3","doi-asserted-by":"crossref","first-page":"1883","DOI":"10.1111\/bph.13496","article-title":"Amylin structure-function relationships and receptor pharmacology: implications for amylin mimetic drug development","volume":"173","author":"Bower","year":"2016","journal-title":"Br J Pharmacol"},{"key":"10.1016\/S2213-8587(26)00216-0_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(26)00213-5","article-title":"Petrelintide, a human amylin analogue for the treatment of obesity: (ZUPREME 1): a randomised, double-blind, placebo-controlled, phase 2 trial","author":"Garvey","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00216-0_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/dom.71074","article-title":"Amylin analogs: the next major class of weight loss therapy: a review of experimental data and early-phase clinical trials","author":"Alhazmi","year":"2026","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(26)00216-0_bib6","doi-asserted-by":"crossref","first-page":"2160","DOI":"10.1016\/S0140-6736(21)01751-7","article-title":"Once-weekly cagrilintide for weight management in people with overweight and obesity: a multicentre, randomised, double-blind, placebo-controlled and active-controlled, dose-finding phase 2 trial","volume":"398","author":"Lau","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00216-0_bib7","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1056\/NEJMoa2502081","article-title":"Coadministered cagrilintide and semaglutide in adults with overweight or obesity","volume":"393","author":"Garvey","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(26)00216-0_bib8","doi-asserted-by":"crossref","first-page":"2631","DOI":"10.1016\/S0140-6736(25)02155-5","article-title":"Eloralintide, a selective amylin receptor agonist for the treatment of obesity: a 48-week phase 2, multicentre, double-blind, randomised, placebo-controlled trial","volume":"406","author":"Billings","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00216-0_bib9","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1016\/S0140-6736(26)01248-1","article-title":"Efficacy and safety of once-weekly subcutaneous zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial","volume":"408","author":"Mora","year":"2026","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00216-0_bib10","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0140-6736(26)01247-X","article-title":"Efficacy and safety of once-daily oral zenagamtide, a novel unimolecular GLP-1 and amylin receptor agonist, in adults with type 2 diabetes: a multicentre, randomised, parallel, double-blind, placebo-controlled, dose-finding, phase 2 trial","volume":"408","author":"Mora","year":"2026","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002160?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726002160?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,15]],"date-time":"2026-10-15T20:41:48Z","timestamp":1792096908000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726002160"}},"issued":{"date-parts":[[2026,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2026,11]]}},"alternative-id":["S2213858726002160"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00216-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Petrelintide and the evolving role of amylin agonism in obesity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00216-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00213-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T15:47:32Z","timestamp":1791474452742,"version":"4.3.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,15]],"date-time":"2024-07-15T00:00:00Z","timestamp":1721001600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002141","name":"Public Health England","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000865","name":"Bill and Melinda Gates Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000865","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004423","name":"World Health Organization","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004423","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000850","name":"National Heart and Lung Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000850","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014013","name":"UK Research and Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014013","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100024721","name":"Public Health Scotland","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100024721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001317","name":"Swansea University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001317","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","award":["MC_PC_19056"],"award-info":[{"award-number":["MC_PC_19056"]}],"id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["1OT2HL156812"],"award-info":[{"award-number":["1OT2HL156812"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["222406\/Z\/20\/Z"],"award-info":[{"award-number":["222406\/Z\/20\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_00004\/06"],"award-info":[{"award-number":["MC_UU_00004\/06"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["MC_UU_0002\/14"],"award-info":[{"award-number":["MC_UU_0002\/14"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020624","name":"NIHR Nottingham Biomedical Research Centre","doi-asserted-by":"publisher","award":["DARE-19"],"award-info":[{"award-number":["DARE-19"]}],"id":[{"id":"10.13039\/501100020624","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/s2213-8587(24)00219-5","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T19:07:29Z","timestamp":1725649649000},"page":"735-747","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Sodium\u2013glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials"],"prefix":"10.1016","volume":"12","author":[{"given":"Claire","family":"Vale","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Godolphin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter W","family":"Horby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mikhail N","family":"Kosiborod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith S","family":"Hochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katie","family":"Webster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julian P T","family":"Higgins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D","family":"Althouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Otavio","family":"Berwanger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Remo H M","family":"Furtado","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samvel B","family":"Gasparyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Haynes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary G","family":"Koch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Landray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Leifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Marshall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srinivas","family":"Murthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natalie","family":"Staplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Janet","family":"Diaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan A C","family":"Sterne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manu","family":"Shankar-Hari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00219-5_bib1","doi-asserted-by":"crossref","first-page":"1017","DOI":"10.1038\/s41591-020-0968-3","article-title":"Extrapulmonary manifestations of COVID-19","volume":"26","author":"Gupta","year":"2020","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00219-5_bib2","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1038\/s41591-021-01643-9","article-title":"A guide to immunotherapy for COVID-19","volume":"28","author":"van de Veerdonk","year":"2022","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(24)00219-5_bib3","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","author":"Herrington","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00219-5_bib4","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(24)00219-5_bib5","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S2213-8587(21)00180-7","article-title":"Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Kosiborod","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00219-5_bib6","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1038\/s41586-020-2521-4","article-title":"Factors associated with COVID-19-related death using OpenSAFELY","volume":"584","author":"Williamson","year":"2020","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00219-5_bib7","doi-asserted-by":"crossref","first-page":"1743","DOI":"10.1007\/s40200-021-00822-2","article-title":"Association between cardiometabolic risk factors and COVID-19 susceptibility, severity and mortality: a review","volume":"20","author":"Sharifi","year":"2021","journal-title":"J Diabetes Metab Disord"},{"key":"10.1016\/S2213-8587(24)00219-5_bib8","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.120.018451","article-title":"Chronic cardio-metabolic disease increases the risk of worse outcomes among hospitalized patients with COVID-19: a multicenter, retrospective, and real-world study","volume":"10","author":"Chen","year":"2021","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(24)00219-5_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003553","article-title":"Cardiometabolic risk factors for COVID-19 susceptibility and severity: a Mendelian randomization analysis","volume":"18","author":"Leong","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(24)00219-5_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.40568","article-title":"Metabolic syndrome and acute respiratory distress syndrome in hospitalized patients with COVID-19","volume":"4","author":"Denson","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(24)00219-5_bib11","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.m3379","article-title":"A living WHO guideline on drugs for covid-19","volume":"370","author":"Agarwal","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00219-5_bib12","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003629","article-title":"A framework for prospective, adaptive meta-analysis (FAME) of aggregate data from randomised trials","volume":"18","author":"Tierney","year":"2021","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(24)00219-5_bib13","doi-asserted-by":"crossref","first-page":"1330","DOI":"10.1001\/jama.2020.17023","article-title":"Association between administration of systemic corticosteroids and mortality among critically ill patients with COVID-19: a meta-analysis","volume":"324","author":"Sterne","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00219-5_bib14","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1001\/jama.2021.11330","article-title":"Association between administration of IL-6 antagonists and mortality among patients hospitalized for COVID-19: a Meta-analysis","volume":"326","author":"Shankar-Hari","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00219-5_bib15","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S2213-8587(23)00253-X","article-title":"Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"11","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00219-5_bib16","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00218-3","article-title":"Effect of sodium\u2013glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial","author":"Kosiborod","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00219-5_bib17","article-title":"RoB 2: a revised tool for assessing risk of bias in randomised trials","volume":"366","author":"Sterne","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00219-5_bib18","doi-asserted-by":"crossref","first-page":"j573","DOI":"10.1136\/bmj.j573","article-title":"Meta-analytical methods to identify who benefits most from treatments: daft, deluded, or deft approach?","volume":"356","author":"Fisher","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00219-5_bib19","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1002\/jrsm.1590","article-title":"Estimating interactions and subgroup-specific treatment effects in meta-analysis without aggregation bias: a within-trial framework","volume":"14","author":"Godolphin","year":"2023","journal-title":"Res Synth Methods"},{"key":"10.1016\/S2213-8587(24)00219-5_bib20","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1002\/sim.4780110202","article-title":"Meta-analysis for 2 x 2 tables: a Bayesian approach","volume":"11","author":"Carlin","year":"1992","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(24)00219-5_bib21","series-title":"Stata Statistical Software: Release 18","year":"2023"},{"key":"10.1016\/S2213-8587(24)00219-5_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/s12874-020-0899-1","article-title":"A systematic survey of randomised trials that stopped early for reasons of futility","volume":"20","author":"Walter","year":"2020","journal-title":"BMC Med Res Methodol"},{"key":"10.1016\/S2213-8587(24)00219-5_bib23","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.jacc.2023.04.034","article-title":"Effect of SGLT2 inhibitors on cardiovascular outcomes across various patient populations","volume":"81","author":"Usman","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(24)00219-5_bib24","doi-asserted-by":"crossref","first-page":"1788","DOI":"10.1016\/S0140-6736(22)02074-8","article-title":"Impact of diabetes on the effects of sodium glucose co-transporter-2 inhibitors on kidney outcomes: collaborative meta-analysis of large placebo-controlled trials","volume":"400","author":"Baigent","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00219-5_bib25","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/dom.14296","article-title":"Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: Design and rationale for the DARE-19 study","volume":"23","author":"Kosiborod","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00219-5_bib26","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2337\/dc15-2688","article-title":"Dapagliflozin enhances fat oxidation and ketone production in patients with type 2 diabetes","volume":"39","author":"Daniele","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00219-5_bib27","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12933-017-0621-8","article-title":"Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study","volume":"16","author":"Solini","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(24)00219-5_bib28","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13098-020-00545-z","article-title":"The extracellular volume status predicts body fluid response to SGLT2 inhibitor dapagliflozin in diabetic kidney disease","volume":"12","author":"Ohara","year":"2020","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/S2213-8587(24)00219-5_bib29","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10787-020-00732-4","article-title":"Empagliflozin suppresses inflammation and protects against acute septic renal injury","volume":"29","author":"Maayah","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/S2213-8587(24)00219-5_bib30","doi-asserted-by":"crossref","first-page":"853","DOI":"10.1111\/dom.12127","article-title":"Dapagliflozin a glucose-regulating drug with diuretic properties in subjects with type 2 diabetes","volume":"15","author":"Lambers Heerspink","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00219-5_bib31","article-title":"SGLT2 inhibition modulates NLRP3 inflammasome activity via ketones and insulin in diabetes with cardiovascular disease","volume":"11","author":"Kim","year":"2020","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(24)00219-5_bib32","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa057","article-title":"Dapagliflozin suppresses hepcidin and increases erythropoiesis","volume":"105","author":"Ghanim","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00219-5_bib33","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.diabet.2018.09.005","article-title":"Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: the potential contribution to diabetes complications and cardiovascular disease","volume":"44","author":"Bonnet","year":"2018","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(24)00219-5_bib34","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074068","article-title":"Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"381","author":"Shi","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00219-5_bib35","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.100933","article-title":"SGLT2 inhibitors decrease cardiovascular death and heart failure hospitalizations in patients with heart failure: a systematic review and meta-analysis","volume":"36","author":"Cardoso","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/S2213-8587(24)00219-5_bib36","doi-asserted-by":"crossref","first-page":"2071","DOI":"10.1111\/dom.14805","article-title":"Re-examining the widespread policy of stopping sodium-glucose cotransporter-2 inhibitors during acute illness: A perspective based on the updated evidence","volume":"24","author":"Khunti","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00219-5_bib37","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1007\/s40264-020-01010-6","article-title":"Potential safety issues with use of sodium-glucose cotransporter 2 inhibitors, particularly in people with type 2 diabetes and chronic kidney disease","volume":"43","author":"Milder","year":"2020","journal-title":"Drug Saf"},{"key":"10.1016\/S2213-8587(24)00219-5_bib38","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.diabet.2020.06.003","article-title":"SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?","volume":"46","author":"Scheen","year":"2020","journal-title":"Diabetes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002195?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002195?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:26:08Z","timestamp":1778858768000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002195"}},"issued":{"date-parts":[[2024,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2213858724002195"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00219-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Sodium\u2013glucose co-transporter-2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00219-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00218-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00230-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,7]],"date-time":"2026-10-07T16:06:30Z","timestamp":1791389190384,"version":"4.3.3"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/s2213-8587(25)00333-x","type":"journal-article","created":{"date-parts":[[2025,12,9]],"date-time":"2025-12-09T23:50:48Z","timestamp":1765324248000},"page":"8-10","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":12,"title":["Staging prediabetes and type 2 diabetes: the time to start is now"],"prefix":"10.1016","volume":"14","author":[{"given":"Viral N","family":"Shah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tadej","family":"Battelino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard M","family":"Bergenstal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Moshe","family":"Phillip","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00333-X_bib1","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus","volume":"34","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00333-X_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-021-05592-3","article-title":"Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies","volume":"65","author":"Schlesinger","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00333-X_bib3","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.70053","article-title":"Associations of prediabetes, diabetes and glucose-related markers with cognition and neuroimaging in a 2-year multidomain lifestyle randomised controlled trial","volume":"41","author":"Lorenzo","year":"2025","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(25)00333-X_bib4","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1016\/S2213-8587(24)00182-7","article-title":"Efficacy and safety of once-weekly semaglutide 2\u00b74 mg versus placebo in people with obesity and prediabetes (STEP 10): a randomised, double-blind, placebo-controlled, multicentre phase 3 trial","volume":"12","author":"McGowan","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00333-X_bib5","doi-asserted-by":"crossref","first-page":"958","DOI":"10.1056\/NEJMoa2410819","article-title":"Tirzepatide for obesity treatment and diabetes prevention","volume":"392","author":"Jastreboff","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00333-X_bib6","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S2213-8587(25)00034-8","article-title":"Prediabetes: much more than just a risk factor","volume":"13","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00333-X_bib7","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1001\/jama.2023.4406","article-title":"Prediabetes diagnosis and management","volume":"329","author":"Herman","year":"2023","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00333-X_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2024.111589","article-title":"International Diabetes Federation Position Statement on the 1-hour post-load plasma glucose for the diagnosis of intermediate hyperglycaemia and type 2 diabetes","volume":"209","author":"Bergman","year":"2024","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00333-X_bib9","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1001\/archinte.1993.00410020010002","article-title":"The fifth report of the Joint National Committee on Detection, Evaluation, and Treatment of High Blood Pressure (JNC V)","volume":"153","year":"1993","journal-title":"Arch Intern Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00333-X_bib10","first-page":"S13","article-title":"2. Classification and diagnosis of diabetes: Standards of Medical Care in Diabetes\u20142018","volume":"41","year":"2018","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872500333X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872500333X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:35:57Z","timestamp":1765326957000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872500333X"}},"issued":{"date-parts":[[2026,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S221385872500333X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00333-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Staging prediabetes and type 2 diabetes: the time to start is now","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00333-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T02:23:33Z","timestamp":1791426213708,"version":"4.3.3"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/s2213-8587(25)00366-3","type":"journal-article","created":{"date-parts":[[2025,12,12]],"date-time":"2025-12-12T23:35:25Z","timestamp":1765582525000},"page":"97-98","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Preventing cardiovascular risk in people with prediabetes"],"prefix":"10.1016","volume":"14","author":[{"given":"Linda","family":"Mellbin","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Ryd\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00366-3_bib1","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.2337\/diacare.26.12.3230","article-title":"The Finnish Diabetes Prevention Study (DPS): lifestyle intervention and 3-year results on diet and physical activity","volume":"26","author":"Lindstr\u00f6m","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00366-3_bib2","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1177\/1479164114551746","article-title":"Sustained prognostic implications of newly detected glucose abnormalities in patients with acute myocardial infarction: long-term follow-up of the Glucose Tolerance in Patients with Acute Myocardial Infarction cohort","volume":"12","author":"Ritsinger","year":"2015","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/S2213-8587(25)00366-3_bib3","doi-asserted-by":"crossref","first-page":"5117","DOI":"10.1093\/eurheartj\/ehae533","article-title":"Great debate: pre-diabetes is not an evidence-based treatment target for cardiovascular risk reduction","volume":"45","author":"Marx","year":"2024","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(25)00366-3_bib4","article-title":"Prediabetes remission and cardiovascular morbidity and mortality: a post-hoc analysis from the Diabetes Prevention Program Outcome study and the DaQing Diabetes Prevention Outcome study","author":"Vazquez Arreola","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00366-3_bib5","doi-asserted-by":"crossref","first-page":"659","DOI":"10.2337\/diacare.22.5.659","article-title":"Is glucose a continuous risk factor for cardiovascular mortality?","volume":"22","author":"Gerstein","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00366-3_bib6","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00366-3_bib7","first-page":"S20","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes 2024","volume":"47","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00366-3_bib8","series-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia: report of a WHO\/IDF consultation","year":"2006"},{"key":"10.1016\/S2213-8587(25)00366-3_bib9","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1016\/S2213-8587(24)00201-8","article-title":"Dysglycaemia screening and its prognostic impact in patients with coronary artery disease: experiences from the EUROASPIRE IV and V cohort studies","volume":"12","author":"Ferrannini","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00366-3_bib10","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12933-018-0665-4","volume":"17","author":"Shahim","year":"2018","journal-title":"Cardiovasc Diabetol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003663?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003663?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:50:03Z","timestamp":1789073403000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003663"}},"issued":{"date-parts":[[2026,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2213858725003663"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00366-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Preventing cardiovascular risk in people with prediabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00366-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00295-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T01:34:04Z","timestamp":1791250444301,"version":"4.1.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/s2213-8587(15)00102-3","type":"journal-article","created":{"date-parts":[[2015,4,22]],"date-time":"2015-04-22T19:30:50Z","timestamp":1429731050000},"page":"305","source":"Crossref","is-referenced-by-count":3,"title":["Sugar intake: lowering the bar"],"prefix":"10.1016","volume":"3","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001023?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001023?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,23]],"date-time":"2018-09-23T03:58:04Z","timestamp":1537675084000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715001023"}},"issued":{"date-parts":[[2015,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S2213858715001023"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00102-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,5]]}},{"indexed":{"date-parts":[[2022,12,2]],"date-time":"2022-12-02T10:58:43Z","timestamp":1669978723523},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70009-3","type":"journal-article","created":{"date-parts":[[2013,2,26]],"date-time":"2013-02-26T12:16:15Z","timestamp":1361880975000},"page":"4-5","source":"Crossref","is-referenced-by-count":2,"title":["Congenital adrenal hyperplasia: one hundred years of data"],"prefix":"10.1016","volume":"1","author":[{"given":"Bridget","family":"Wilcken","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70009-3_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70007-X","article-title":"One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study","author":"Gidl\u00f6f","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70009-3_bib2","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1038\/nrendo.2009.148","article-title":"Neonatal screening for congenital adrenal hyperplasia","volume":"5","author":"White","year":"2009","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(13)70009-3_bib3","article-title":"Establishment of the first newborn screening program in the People's Democratic Republic of Laos","author":"Hoehn","year":"2012","journal-title":"J Trop Pediatr"},{"key":"10.1016\/S2213-8587(13)70009-3_bib4","doi-asserted-by":"crossref","first-page":"101","DOI":"10.1136\/archdischild-2011-300234","article-title":"Incidence and clinical features of congenital adrenal hyperplasia in Great Britain","volume":"97","author":"Khalid","year":"2012","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(13)70009-3_bib5","doi-asserted-by":"crossref","first-page":"107","DOI":"10.5694\/j.1326-5377.2010.tb03432.x","article-title":"The case for newborn screening for congenital adrenal hyperplasia","volume":"192","author":"Warne","year":"2010","journal-title":"Med J Aust"},{"key":"10.1016\/S2213-8587(13)70009-3_bib6","doi-asserted-by":"crossref","first-page":"2371","DOI":"10.1001\/jama.2012.5281","article-title":"Cases of congenital adrenal hyperplasia missed by newborn screening in Minnesota","volume":"307","author":"Sarafoglou","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70009-3_bib7","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0889-8529(08)70025-2","article-title":"Cognitive function in congenital adrenal hyperplasia","volume":"30","author":"Berenbaum","year":"2001","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(13)70009-3_bib8","doi-asserted-by":"crossref","first-page":"853103","DOI":"10.1186\/1687-9856-2010-853103","article-title":"Normal intelligence in female and male patients with congenital adrenal hyperplasia","volume":"2010","author":"Berenbaum","year":"2010","journal-title":"Int J Pediatr Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,7,22]],"date-time":"2020-07-22T21:47:29Z","timestamp":1595454449000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700093"}},"issued":{"date-parts":[[2013,9]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2213858713700093"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70009-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]}},{"indexed":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T13:27:03Z","timestamp":1676986023956},"reference-count":5,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/s2213-8587(13)70207-9","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T13:45:41Z","timestamp":1391435141000},"page":"105-106","source":"Crossref","is-referenced-by-count":3,"title":["It takes more than one CAMERA to study cardiovascular protection by metformin"],"prefix":"10.1016","volume":"2","author":[{"given":"Niels P","family":"Riksen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Saloua","family":"el Messaoudi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gerard A","family":"Rongen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70207-9_bib1","article-title":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial","author":"Preiss","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70207-9_bib2","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1097\/MOL.0b013e32834ae1a7","article-title":"The cardioprotective effects of metformin","volume":"22","author":"El Messaoudi","year":"2011","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(13)70207-9_bib3","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1097\/FJC.0b013e31819fd4e7","article-title":"Metformin prevents myocardial reperfusion injury by activating the adenosine receptor","volume":"53","author":"Paiva","year":"2009","journal-title":"J Cardiovasc Pharmacol"},{"key":"10.1016\/S2213-8587(13)70207-9_bib4","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1161\/CIRCRESAHA.108.190918","article-title":"Activation of AMP-activated protein kinase by metformin improves left ventricular function and survival in heart failure","volume":"104","author":"Gundewar","year":"2009","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(13)70207-9_bib5","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1586\/ecp.12.8","article-title":"Targeting adenosine receptors in the development of cardiovascular therapeutics","volume":"5","author":"Riksen","year":"2012","journal-title":"Expert Rev Clin Pharmacol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713702079?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713702079?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T22:53:25Z","timestamp":1538866405000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713702079"}},"issued":{"date-parts":[[2014,2]]},"references-count":5,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S2213858713702079"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70207-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,2]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T00:44:30Z","timestamp":1648946670095},"reference-count":2,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/s2213-8587(15)00007-8","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T00:30:20Z","timestamp":1424305820000},"page":"168-169","source":"Crossref","is-referenced-by-count":0,"title":["The Lancet Diabetes &amp; Endocrinology needs a more rigorous conflict of interest policy \u2013 Editors' reply"],"prefix":"10.1016","volume":"3","author":[{"given":"Justine","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Linklater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00007-8_bib1","doi-asserted-by":"crossref","first-page":"992","DOI":"10.1016\/S2213-8587(14)70136-6","article-title":"Early therapy for type 2 diabetes in China","volume":"2","author":"Yang","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00007-8_bib2","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/S0140-6736(03)12184-8","article-title":"The Lancet's policy on conflicts of interest","volume":"361","author":"James","year":"2003","journal-title":"The Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000078?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000078?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T01:53:51Z","timestamp":1537840431000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000078"}},"issued":{"date-parts":[[2015,3]]},"references-count":2,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S2213858715000078"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00007-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,3]]}},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T22:43:20Z","timestamp":1648853000912},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/s2213-8587(15)00486-6","type":"journal-article","created":{"date-parts":[[2015,12,15]],"date-time":"2015-12-15T14:52:38Z","timestamp":1450191158000},"page":"22","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"4","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004866?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004866?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T00:58:46Z","timestamp":1537145926000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004866"}},"issued":{"date-parts":[[2016,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S2213858715004866"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00486-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,1]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T20:14:33Z","timestamp":1649016873563},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/s2213-8587(14)70090-7","type":"journal-article","created":{"date-parts":[[2014,4,25]],"date-time":"2014-04-25T01:30:38Z","timestamp":1398389438000},"page":"366","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"2","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700907?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700907?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T16:52:29Z","timestamp":1538671949000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700907"}},"issued":{"date-parts":[[2014,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S2213858714700907"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70090-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,5]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T07:35:50Z","timestamp":1648971350593},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/s2213-8587(17)30229-2","type":"journal-article","created":{"date-parts":[[2017,7,18]],"date-time":"2017-07-18T21:46:03Z","timestamp":1500414363000},"page":"e5","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2017; 5: 597\u2013609"],"prefix":"10.1016","volume":"5","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T03:39:16Z","timestamp":1548646756000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717302292"}},"issued":{"date-parts":[[2017,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S2213858717302292"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30229-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,8]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T12:22:58Z","timestamp":1648556578976},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2014,6,1]],"date-time":"2014-06-01T00:00:00Z","timestamp":1401580800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,6]]},"DOI":"10.1016\/s2213-8587(14)70039-7","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T19:15:24Z","timestamp":1400267724000},"page":"453","source":"Crossref","is-referenced-by-count":1,"title":["Research in brief"],"prefix":"10.1016","volume":"2","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700397?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700397?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T00:01:40Z","timestamp":1538611300000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700397"}},"issued":{"date-parts":[[2014,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2014,6]]}},"alternative-id":["S2213858714700397"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70039-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,6]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T11:51:09Z","timestamp":1648554669253},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/s2213-8587(17)30231-0","type":"journal-article","created":{"date-parts":[[2017,7,19]],"date-time":"2017-07-19T01:45:50Z","timestamp":1500428750000},"page":"584","source":"Crossref","is-referenced-by-count":0,"title":["Absorbing metabolic illness in India"],"prefix":"10.1016","volume":"5","author":[{"given":"Emily","family":"Yates-Doerr","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302310?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302310?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,30]],"date-time":"2018-08-30T04:52:14Z","timestamp":1535604734000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717302310"}},"issued":{"date-parts":[[2017,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S2213858717302310"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30231-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,8]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T17:22:35Z","timestamp":1649006555094},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2017,11,1]],"date-time":"2017-11-01T00:00:00Z","timestamp":1509494400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,11]]},"DOI":"10.1016\/s2213-8587(17)30333-9","type":"journal-article","created":{"date-parts":[[2017,10,26]],"date-time":"2017-10-26T12:15:25Z","timestamp":1509020125000},"page":"e7","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2017; 5: 887\u201397"],"prefix":"10.1016","volume":"5","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303339?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303339?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T04:03:32Z","timestamp":1555387412000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303339"}},"issued":{"date-parts":[[2017,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2017,11]]}},"alternative-id":["S2213858717303339"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30333-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,11]]}},{"indexed":{"date-parts":[[2023,9,11]],"date-time":"2023-09-11T02:21:42Z","timestamp":1694398902919},"reference-count":2,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/s2213-8587(16)30268-6","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T02:40:00Z","timestamp":1479868800000},"page":"973-974","source":"Crossref","is-referenced-by-count":2,"title":["Primary aldosteronism as a public health issue \u2013 Authors' reply"],"prefix":"10.1016","volume":"4","author":[{"given":"Morris J","family":"Brown","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William M","family":"Drake","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30268-6_bib1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30268-6_bib2","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/S2213-8587(16)30154-1","article-title":"Splitting atoms: the Endocrine Society guideline for the management of primary aldosteronism","volume":"4","author":"Brown","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302686?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302686?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T13:24:27Z","timestamp":1536240267000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302686"}},"issued":{"date-parts":[[2016,12]]},"references-count":2,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2213858716302686"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30268-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,12]]}},{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T22:05:11Z","timestamp":1774389911476,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/s2213-8587(20)30366-1","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T19:30:47Z","timestamp":1604086247000},"page":"933-935","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Setmelanotide: what does it mean for clinical care of patients with obesity?"],"prefix":"10.1016","volume":"8","author":[{"given":"Donna H","family":"Ryan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30366-1_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","author":"Cl\u00e9ment","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30366-1_bib2","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa1512693","article-title":"Proopiomelanocortin deficiency treated with a melanocortin-4receptor agonist","volume":"375","author":"K\u00fchnen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30366-1_bib3","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41591-018-0015-9","article-title":"MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency","volume":"24","author":"Clement","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(20)30366-1_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/dom.14133","article-title":"Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome","author":"Haws","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30366-1_bib5","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/jc.2018-00258","article-title":"Melanocortin 4 receptor pathway dysfunction in obesity: patient stratification aimed at MC4R agonist treatment","volume":"103","author":"Ayers","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30366-1_bib6","author":"Hales"},{"key":"10.1016\/S2213-8587(20)30366-1_bib8","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24101892","article-title":"Current mechanistic and pharmacodynamic understanding of melanocortin-4 receptor activation","volume":"24","author":"Sharma","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/S2213-8587(20)30366-1_bib9","doi-asserted-by":"crossref","first-page":"490","DOI":"10.2337\/db12-0598","article-title":"Chronic treatment with a melanocortin-4 receptor agonist causes weight loss, reduces insulin resistance, and improves cardiovascular function in diet-induced obese rhesus macaques","volume":"62","author":"Kievit","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30366-1_bib10","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.molmet.2017.06.015","article-title":"Evaluation of a melanocortin-4 receptor (MC4R) agonist (setmelanotide) in MC4R deficiency","volume":"6","author":"Collet","year":"2017","journal-title":"Mol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303661?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303661?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:52Z","timestamp":1761991732000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303661"}},"issued":{"date-parts":[[2020,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2213858720303661"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30366-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Setmelanotide: what does it mean for clinical care of patients with obesity?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30366-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30364-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,4,24]],"date-time":"2024-04-24T10:04:32Z","timestamp":1713953072055},"reference-count":0,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2018,7,1]],"date-time":"2018-07-01T00:00:00Z","timestamp":1530403200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,7]]},"DOI":"10.1016\/s2213-8587(18)30176-1","type":"journal-article","created":{"date-parts":[[2018,6,19]],"date-time":"2018-06-19T22:33:54Z","timestamp":1529447634000},"page":"515","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Food nutritional information: transparency and public health"],"prefix":"10.1016","volume":"6","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301761?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301761?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,6,20]],"date-time":"2018-06-20T02:00:17Z","timestamp":1529460017000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301761"}},"issued":{"date-parts":[[2018,7]]},"references-count":0,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2018,7]]}},"alternative-id":["S2213858718301761"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30176-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Food nutritional information: transparency and public health","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30176-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:19:53Z","timestamp":1762507193674},"reference-count":6,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/s2213-8587(17)30290-5","type":"journal-article","created":{"date-parts":[[2017,9,20]],"date-time":"2017-09-20T03:00:19Z","timestamp":1505876419000},"page":"769-770","source":"Crossref","is-referenced-by-count":2,"title":["Disentangling the association between diabetes and bone disease \u2013 Authors' reply"],"prefix":"10.1016","volume":"5","author":[{"given":"Vikram V","family":"Shanbhogue","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stinus","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Morten","family":"Frost","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kim","family":"Brixen","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne P","family":"Hermann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30290-5_bib1","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1007\/s00223-008-9195-5","article-title":"Diabetes and its complications and their relationship with risk of fractures in type 1 and 2 diabetes","volume":"84","author":"Vestergaard","year":"2009","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(17)30290-5_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(17)30134-1","article-title":"Bone disease in diabetes: another manifestation of microvascular disease?","author":"Shanbhogue","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30290-5_bib3","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/jbmr.2573","article-title":"Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with type 1 diabetes mellitus","volume":"30","author":"Shanbhogue","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30290-5_bib4","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-15-0860","article-title":"Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease","volume":"174","author":"Shanbhogue","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(17)30290-5_bib5","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1210\/jc.2015-3882","article-title":"Bone structure and predictors of fracture in type 1 and type 2 diabetes","volume":"101","author":"Starup-Linde","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30290-5_bib6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1016\/j.bone.2015.11.004","article-title":"Differences in biochemical bone markers by diabetes type and the impact of glucose","volume":"83","author":"Starup-Linde","year":"2016","journal-title":"Bone"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T13:41:02Z","timestamp":1539092462000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717302905"}},"issued":{"date-parts":[[2017,10]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2213858717302905"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30290-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,10]]}},{"indexed":{"date-parts":[[2026,1,17]],"date-time":"2026-01-17T07:59:18Z","timestamp":1768636758761,"version":"3.49.0"},"reference-count":19,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,5,1]],"date-time":"2023-05-01T00:00:00Z","timestamp":1682899200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,5]]},"DOI":"10.1016\/s2213-8587(23)00083-9","type":"journal-article","created":{"date-parts":[[2023,3,24]],"date-time":"2023-03-24T19:30:44Z","timestamp":1679686244000},"page":"304-307","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["The ISPAD Clinical Practice Consensus Guidelines 2022: how far we have come and the distance still to go"],"prefix":"10.1016","volume":"11","author":[{"given":"Brittany S","family":"Bruggeman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Desmond A","family":"Schatz","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00083-9_bib1","series-title":"Consensus Guidelines for the Management of Insulin-Dependent (Type 1) Diabetes (IDDM) in Childhood and Adolescence","author":"Laron","year":"1995"},{"key":"10.1016\/S2213-8587(23)00083-9_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1111\/pedi.13410","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: stages of type 1 diabetes in children and adolescents","volume":"23","author":"Besser","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib3","series-title":"ISPAD Clinical Practice Consensus Guidelines 2018","year":"2018"},{"key":"10.1016\/S2213-8587(23)00083-9_bib4","series-title":"ISPAD Clinical Practice Consensus Guidelines 2022","year":"2022"},{"key":"10.1016\/S2213-8587(23)00083-9_bib5","doi-asserted-by":"crossref","first-page":"1390","DOI":"10.1111\/pedi.13451","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: diabetes technologies: glucose monitoring","volume":"23","author":"Tauschmann","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib6","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1111\/pedi.13452","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: exercise in children and adolescents with diabetes","volume":"23","author":"Adolfsson","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib7","doi-asserted-by":"crossref","first-page":"1512","DOI":"10.1111\/pedi.13447","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: Ramadan and other religious fasting by young people with diabetes","volume":"23","author":"Deeb","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1111\/pedi.13429","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: nutritional management in children and adolescents with diabetes","volume":"23","author":"Annan","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib9","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/pedi.13455","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes","volume":"23","author":"de Bock","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib10","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1111\/pedi.13417","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: the delivery of ambulatory diabetes care to children and adolescents with diabetes","volume":"23","author":"Limbert","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib11","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.1111\/pedi.13453","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: management of cystic fibrosis-related diabetes in children and adolescents","volume":"23","author":"Ode","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib12","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/pedi.13421","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: diabetes technologies: insulin delivery","volume":"23","author":"Sherr","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib13","doi-asserted-by":"crossref","first-page":"1496","DOI":"10.1111\/pedi.13427","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: managing diabetes in preschoolers","volume":"23","author":"Sundberg","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib14","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/pedi.13418","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: diabetes education in children and adolescents","volume":"23","author":"Lindholm Olinder","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib15","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1111\/pedi.13409","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: type 2 diabetes in children and adolescents","volume":"23","author":"Shah","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib16","doi-asserted-by":"crossref","first-page":"857","DOI":"10.1111\/pedi.13408","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: diabetes in adolescence","volume":"23","author":"Gregory","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib17","doi-asserted-by":"crossref","first-page":"1277","DOI":"10.1111\/pedi.13442","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: insulin treatment in children and adolescents with diabetes","volume":"23","author":"Cengiz","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib18","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/pedi.13456","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: management of the child, adolescent, and young adult with diabetes in limited resource settings","volume":"23","author":"Virmani","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00083-9_bib20","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1111\/j.1440-1754.1995.tb00769.x","article-title":"ISPAD Declaration of Kos","volume":"31","author":"Weber","year":"1995","journal-title":"J Paediatr Child Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000839?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000839?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:43Z","timestamp":1761991903000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000839"}},"issued":{"date-parts":[[2023,5]]},"references-count":19,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2023,5]]}},"alternative-id":["S2213858723000839"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00083-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The ISPAD Clinical Practice Consensus Guidelines 2022: how far we have come and the distance still to go","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00083-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:17Z","timestamp":1761991937827,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/s2213-8587(20)30309-0","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T18:37:09Z","timestamp":1600195029000},"page":"868","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["A recurrent mass on the big toe"],"prefix":"10.1016","volume":"8","author":[{"given":"Salvatore L","family":"Renne","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Valeri","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Stefano","family":"Radaelli","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paola","family":"Collini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marta","family":"Barisella","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303090?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303090?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:26Z","timestamp":1761991706000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303090"}},"issued":{"date-parts":[[2020,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2213858720303090"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30309-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A recurrent mass on the big toe","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30309-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:47:52Z","timestamp":1766162872373,"version":"3.48.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,3,1]],"date-time":"2024-03-01T00:00:00Z","timestamp":1709251200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,3]]},"DOI":"10.1016\/s2213-8587(24)00030-5","type":"journal-article","created":{"date-parts":[[2024,2,20]],"date-time":"2024-02-20T18:28:45Z","timestamp":1708453725000},"page":"e13-e15","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thank you to The Lancet Diabetes &amp; Endocrinology's statistical and peer reviewers in 2023"],"prefix":"10.1016","volume":"12","author":[{"family":"The Lancet Diabetes & Endocrinology Editors","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000305?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000305?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T16:43:21Z","timestamp":1766162601000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000305"}},"issued":{"date-parts":[[2024,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2024,3]]}},"alternative-id":["S2213858724000305"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00030-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2024,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thank you to The Lancet Diabetes & Endocrinology's statistical and peer reviewers in 2023","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00030-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,9,24]],"date-time":"2025-09-24T00:20:29Z","timestamp":1758673229277,"version":"3.44.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,8,1]],"date-time":"2025-08-01T00:00:00Z","timestamp":1754006400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,8]]},"DOI":"10.1016\/s2213-8587(25)00199-8","type":"journal-article","created":{"date-parts":[[2025,7,3]],"date-time":"2025-07-03T19:46:00Z","timestamp":1751571960000},"page":"635","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Reassessing driving safety in diabetes"],"prefix":"10.1016","volume":"13","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001998?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001998?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,23]],"date-time":"2025-09-23T23:46:12Z","timestamp":1758671172000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725001998"}},"issued":{"date-parts":[[2025,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2025,8]]}},"alternative-id":["S2213858725001998"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00199-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2025,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reassessing driving safety in diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00199-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,26]],"date-time":"2026-04-26T08:57:59Z","timestamp":1777193879320,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/s2213-8587(19)30253-0","type":"journal-article","created":{"date-parts":[[2019,9,5]],"date-time":"2019-09-05T18:38:49Z","timestamp":1567708729000},"page":"820-821","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":4,"title":["Diabetic kidney disease 2.0: the treatment paradigm shifts"],"prefix":"10.1016","volume":"7","author":[{"given":"Richard E","family":"Gilbert","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30253-0_bib1","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30253-0_bib2","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30253-0_bib3","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30253-0_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30256-6","article-title":"SGLT2 inhibitors for the prevention of kidney failure in patients with type 2 diabetes: a systematic review and meta-analysis","author":"Neuen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30253-0_bib5","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1053\/j.ajkd.2015.02.338","article-title":"A meta-analysis of the association of estimated GFR, albuminuria, diabetes mellitus, and hypertension with acute kidney injury","volume":"66","author":"James","year":"2015","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(19)30253-0_bib6","doi-asserted-by":"crossref","first-page":"2333","DOI":"10.2337\/dc15-1222","article-title":"Acute kidney injury predicts major adverse outcomes in diabetes: synergic impact with low glomerular filtration rate and albuminuria","volume":"38","author":"Monseu","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30253-0_bib7","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1038\/ki.2011.379","article-title":"Chronic kidney disease after acute kidney injury: a systematic review and meta-analysis","volume":"81","author":"Coca","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(19)30253-0_bib8","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrneph.2016.159","article-title":"Acute kidney injury from SGLT2 inhibitors: potential mechanisms","volume":"12","author":"Hahn","year":"2016","journal-title":"Nat Rev Nephrol"},{"key":"10.1016\/S2213-8587(19)30253-0_bib9","series-title":"FDA strengthens kidney warnings for diabetes medicines canagliflozin (Invokana, Invokamet) and dapagliflozin (Farxiga, Xigduo XR)","year":"2016"},{"key":"10.1016\/S2213-8587(19)30253-0_bib10","doi-asserted-by":"crossref","first-page":"1996","DOI":"10.1111\/dom.13754","article-title":"Acute kidney injury with sodium-glucose co-transporter-2 inhibitors: a meta-analysis of cardiovascular outcome trials","volume":"21","author":"Gilbert","year":"2019","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302530?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302530?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:39Z","timestamp":1761991659000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719302530"}},"issued":{"date-parts":[[2019,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2213858719302530"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30253-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetic kidney disease 2.0: the treatment paradigm shifts","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30253-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30256-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:20Z","timestamp":1761991940527,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/s2213-8587(20)30429-0","type":"journal-article","created":{"date-parts":[[2020,12,8]],"date-time":"2020-12-08T19:48:48Z","timestamp":1607456928000},"page":"67","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Shahrad Taheri: putting patients' needs first"],"prefix":"10.1016","volume":"9","author":[{"given":"Fiona","family":"Mitchell","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Robert","family":"Stirrups","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720304290?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720304290?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:30Z","timestamp":1761991710000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720304290"}},"issued":{"date-parts":[[2021,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2213858720304290"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30429-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Shahrad Taheri: putting patients' needs first","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30429-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:12Z","timestamp":1761991992651,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/s2213-8587(21)00310-7","type":"journal-article","created":{"date-parts":[[2021,11,29]],"date-time":"2021-11-29T18:47:05Z","timestamp":1638211625000},"page":"2-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["SGLT-2 inhibitors: does it matter if they prevent type 2 diabetes"],"prefix":"10.1016","volume":"10","author":[{"given":"Alice Y Y","family":"Cheng","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00310-7_bib2","article-title":"Diabetes prevention in a U.S. healthcare system: a portrait of missed opportunities","author":"Mainous","year":"2021","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(21)00310-7_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00310-7_bib4","doi-asserted-by":"crossref","first-page":"2072","DOI":"10.1016\/S0140-6736(02)08905-5","article-title":"Acarbose for prevention of type 2 diabetes mellitus: the STOP-NIDDM randomised trial","volume":"359","author":"Chiasson","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00310-7_bib5","doi-asserted-by":"crossref","first-page":"1096","DOI":"10.1016\/S0140-6736(06)69420-8","article-title":"Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial","volume":"368","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00310-7_bib6","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1056\/NEJMoa1010949","article-title":"Pioglitazone for diabetes prevention in impaired glucose tolerance","volume":"364","author":"DeFronzo","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00310-7_bib7","doi-asserted-by":"crossref","first-page":"977","DOI":"10.2337\/diacare.26.4.977","article-title":"Effects of withdrawal from metformin on the development of diabetes in the Diabetes Prevention Program","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00310-7_bib8","doi-asserted-by":"crossref","first-page":"1265","DOI":"10.2337\/dc10-1567","article-title":"Incidence of diabetes following ramipril or rosiglitazone withdrawal","volume":"34","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00310-7_bib9","article-title":"Dapagliflozin and new-onset type 2 diabetes in patients with chronic kidney disease or heart failure: pooled analysis of the DAPA-CKD and DAPA-HF trials","author":"Rossing","year":"2021","journal-title":"Lancet Diabet Endocrinol"},{"key":"10.1016\/S2213-8587(21)00310-7_bib10","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1056\/NEJMoa2022190","article-title":"Cardiovascular and renal outcomes with empagliflozin in heart failure","volume":"383","author":"Packer","year":"2020","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003107?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003107?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:10Z","timestamp":1761991810000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721003107"}},"issued":{"date-parts":[[2022,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2213858721003107"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00310-7","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT-2 inhibitors: does it matter if they prevent type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00310-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00295-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T02:57:26Z","timestamp":1648954646280},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2015,9,1]],"date-time":"2015-09-01T00:00:00Z","timestamp":1441065600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,9]]},"DOI":"10.1016\/s2213-8587(15)00297-1","type":"journal-article","created":{"date-parts":[[2015,8,11]],"date-time":"2015-08-11T23:56:20Z","timestamp":1439337380000},"page":"677-678","source":"Crossref","is-referenced-by-count":0,"title":["Endocrinology in focus: photo competition 2015"],"prefix":"10.1016","volume":"3","author":[{"given":"Neil","family":"Bennet","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002971?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002971?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,11]],"date-time":"2019-02-11T00:23:25Z","timestamp":1549844605000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002971"}},"issued":{"date-parts":[[2015,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2015,9]]}},"alternative-id":["S2213858715002971"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00297-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,9]]}},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T23:11:32Z","timestamp":1649200292113},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/s2213-8587(17)30321-2","type":"journal-article","created":{"date-parts":[[2017,9,15]],"date-time":"2017-09-15T20:31:20Z","timestamp":1505507480000},"page":"926-927","source":"Crossref","is-referenced-by-count":1,"title":["PCSK9 inhibition and type 2 diabetes"],"prefix":"10.1016","volume":"5","author":[{"given":"Luca A","family":"Lotta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Simon J","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30321-2_bib1","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1001\/jama.2016.13985","article-title":"Association between lowering LDL-C and cardiovascular risk reduction among different therapeutic interventions: a systematic review and meta-analysis","volume":"316","author":"Silverman","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30321-2_bib2","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/S0140-6736(02)09327-3","article-title":"MRC\/BHF Heart Protection Study of cholesterol lowering with simvastatin in 20\u2008536 high-risk individuals: a randomised placebo-controlled trial","volume":"360","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30321-2_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(17)30313-3","article-title":"Cardiovascular safety and efficacy of the PCSK9 inhibitor evolocumab in patients with and without diabetes and the effect of evolocumab on glycaemia and risk of new-onset diabetes: a prespecified analysis of the FOURIER randomised controlled trial","author":"Sabatine","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30321-2_bib4","doi-asserted-by":"crossref","first-page":"1713","DOI":"10.1056\/NEJMoa1615664","article-title":"Evolocumab and clinical outcomes in patients with cardiovascular disease","volume":"376","author":"Sabatine","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30321-2_bib5","doi-asserted-by":"crossref","first-page":"2387","DOI":"10.1056\/NEJMoa1410489","article-title":"Ezetimibe added to statin therapy after acute coronary syndromes","volume":"372","author":"Cannon","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30321-2_bib6","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30321-2_bib7","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/S2213-8587(16)30396-5","article-title":"PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study","volume":"5","author":"Schmidt","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30321-2_bib8","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.2016.14568","article-title":"Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis","volume":"316","author":"Lotta","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30321-2_bib9","doi-asserted-by":"crossref","first-page":"748","DOI":"10.1001\/jama.2017.9924","article-title":"Updated cost-effectiveness analysis of PCSK9 inhibitors based on the results of the FOURIER trial","volume":"318","author":"Kazi","year":"2017","journal-title":"JAMA"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303212?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303212?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,27]],"date-time":"2018-08-27T17:20:26Z","timestamp":1535390426000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303212"}},"issued":{"date-parts":[[2017,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2213858717303212"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30321-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,12]]}},{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T14:08:02Z","timestamp":1781618882355,"version":"3.54.5"},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/s2213-8587(16)30161-9","type":"journal-article","created":{"date-parts":[[2016,7,9]],"date-time":"2016-07-09T12:49:49Z","timestamp":1468068589000},"page":"651","source":"Crossref","is-referenced-by-count":2,"title":["Research digest"],"prefix":"10.1016","volume":"4","author":[{"given":"Naveed","family":"Sattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Preiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301619?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301619?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T00:03:09Z","timestamp":1555372989000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301619"}},"issued":{"date-parts":[[2016,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S2213858716301619"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30161-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,8]]}},{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T13:24:46Z","timestamp":1781616286394,"version":"3.54.5"},"reference-count":5,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,12,1]],"date-time":"2025-12-01T00:00:00Z","timestamp":1764547200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,12]]},"DOI":"10.1016\/s2213-8587(25)00294-3","type":"journal-article","created":{"date-parts":[[2025,10,4]],"date-time":"2025-10-04T03:31:46Z","timestamp":1759548706000},"page":"998-999","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The evolutionary basis for type 2 diabetes prevalence in the Arabian Peninsula"],"prefix":"10.1016","volume":"13","author":[{"given":"Hamad","family":"Ali","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barrak","family":"Alahmad","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mohamed","family":"Abu-Farha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jehad","family":"Abubaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fahd","family":"Al-Mulla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00294-3_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(25)00294-3_bib2","first-page":"353","article-title":"Diabetes mellitus: a \u201cthrifty\u201d genotype rendered detrimental by \u201cprogress\u201d?","volume":"14","author":"Neel","year":"1962","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(25)00294-3_bib3","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1038\/s41366-021-00867-6","article-title":"Genetic polymorphisms associated with obesity in the Arab world: a systematic review","volume":"45","author":"Younes","year":"2021","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(25)00294-3_bib4","doi-asserted-by":"crossref","DOI":"10.1038\/s41576-025-00883-6","article-title":"Integrating the genome and exposome for precision health in Kuwait","author":"Ali","year":"2025","journal-title":"Nat Rev Genet"},{"key":"10.1016\/S2213-8587(25)00294-3_bib5","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1016\/S2213-8587(25)00125-1","article-title":"Should diabetes diagnostic thresholds be lowered? Insights from the Middle East","volume":"13","author":"Alahmad","year":"2025","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,14]],"date-time":"2025-11-14T02:50:11Z","timestamp":1763088611000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002943"}},"issued":{"date-parts":[[2025,12]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2025,12]]}},"alternative-id":["S2213858725002943"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00294-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The evolutionary basis for type 2 diabetes prevalence in the Arabian Peninsula","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00294-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:10:37Z","timestamp":1778861437671,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["KFO 114"],"award-info":[{"award-number":["KFO 114"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["STE 1096\/1\\u20133"],"award-info":[{"award-number":["STE 1096\/1\\u20133"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005972","name":"Deutsche Krebshilfe","doi-asserted-by":"publisher","award":["70\\u20132488-Ha I"],"award-info":[{"award-number":["70\\u20132488-Ha I"]}],"id":[{"id":"10.13039\/501100005972","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002347","name":"Bundesministerium f\u00fcr Bildung und Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002347","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100010767","name":"Innovative Medicines Initiative","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100010767","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["SOC 95201408 05F02"],"award-info":[{"award-number":["SOC 95201408 05F02"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["SOC 98200769 05F02"],"award-info":[{"award-number":["SOC 98200769 05F02"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/s2213-8587(24)00164-5","type":"journal-article","created":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T18:37:42Z","timestamp":1719945462000},"page":"514-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Impact of higher BMI on cardiometabolic risk: does height matter?"],"prefix":"10.1016","volume":"12","author":[{"given":"Norbert","family":"Stefan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Catarina","family":"Schiborn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J\u00fcrgen","family":"Machann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andreas L","family":"Birkenfeld","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Matthias B","family":"Schulze","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00164-5_bib1","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"Phelps","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00164-5_bib2","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.cmet.2021.12.012","article-title":"Why does obesity cause diabetes?","volume":"34","author":"Klein","year":"2022","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00164-5_bib3","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00164-5_bib4","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1038\/ijo.2012.201","article-title":"Optimal scaling of weight and waist circumference to height for maximal association with DXA-measured total body fat mass by sex, age and race\/ethnicity","volume":"37","author":"Heo","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(24)00164-5_bib5","doi-asserted-by":"crossref","first-page":"1511","DOI":"10.1016\/S0140-6736(20)31859-6","article-title":"Height and body-mass index trajectories of school-aged children and adolescents from 1985 to 2019 in 200 countries and territories: a pooled analysis of 2181 population-based studies with 65 million participants","volume":"396","author":"Rodriguez-Martinez","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00164-5_bib6","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1038\/s41586-023-05772-8","article-title":"Diminishing benefits of urban living for children and adolescents' growth and development","volume":"615","author":"Mishra","year":"2023","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(24)00164-5_bib7","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-8587(15)00474-X","article-title":"Divergent associations of height with cardiometabolic disease and cancer: epidemiology, pathophysiology, and global implications","volume":"4","author":"Stefan","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00164-5_bib8","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.cmet.2017.07.008","article-title":"Causes, characteristics, and consequences of metabolically unhealthy normal weight in humans","volume":"26","author":"Stefan","year":"2017","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00164-5_bib9","doi-asserted-by":"crossref","DOI":"10.1002\/ajhb.23252","article-title":"Scaling of adult human bone and skeletal muscle mass to height in the US population","volume":"31","author":"Heymsfield","year":"2019","journal-title":"Am J Hum Biol"},{"key":"10.1016\/S2213-8587(24)00164-5_bib10","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1007\/s00125-019-04978-8","article-title":"Associations of short stature and components of height with incidence of type 2 diabetes: mediating effects of cardiometabolic risk factors","volume":"62","author":"Wittenbecher","year":"2019","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001645?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001645?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:53Z","timestamp":1778858753000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001645"}},"issued":{"date-parts":[[2024,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S2213858724001645"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00164-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Impact of higher BMI on cardiometabolic risk: does height matter?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00164-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,27]],"date-time":"2026-03-27T11:48:24Z","timestamp":1774612104368,"version":"3.50.1"},"reference-count":4,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/s2213-8587(22)00316-3","type":"journal-article","created":{"date-parts":[[2022,11,4]],"date-time":"2022-11-04T20:09:50Z","timestamp":1667592590000},"page":"842-843","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Prequalification of insulin: what is missing?"],"prefix":"10.1016","volume":"10","author":[{"given":"David","family":"Beran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Giachino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christophe","family":"Perrin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C\u00e9cile","family":"Mac\u00e9","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00316-3_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(15)00521-5","article-title":"Constraints and challenges in access to insulin: a global perspective","volume":"4","author":"Beran","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00316-3_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1057\/jphp.2013.53","article-title":"A quiet revolution in global public health: the World Health Organization's Prequalification of Medicines Programme","volume":"35","author":"'t Hoen","year":"2014","journal-title":"J Public Health Policy"},{"key":"10.1016\/S2213-8587(22)00316-3_bib4","series-title":"Reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes","year":"2021"},{"key":"10.1016\/S2213-8587(22)00316-3_bib7","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2213-8587(17)30218-8","article-title":"The role of biosimilar manufacturers in improving access to insulin globally","volume":"5","author":"Perrin","year":"2017","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003163?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003163?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:17Z","timestamp":1761991937000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003163"}},"issued":{"date-parts":[[2022,12]]},"references-count":4,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2213858722003163"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00316-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Prequalification of insulin: what is missing?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00316-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T23:03:13Z","timestamp":1782946993002,"version":"3.54.5"},"reference-count":6,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/s2213-8587(24)00107-4","type":"journal-article","created":{"date-parts":[[2024,4,17]],"date-time":"2024-04-17T22:32:33Z","timestamp":1713393153000},"page":"378-379","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Improving support for university students with type 1 diabetes"],"prefix":"10.1016","volume":"12","author":[{"given":"Gijsbert","family":"Stoet","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emily","family":"Foster","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Kerr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingqing","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan-Ann","family":"Thornhill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarzyna","family":"Cyranka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart\u0142omiej","family":"Matejko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominika","family":"Sarna-Palacz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"P\u0142onka-St\u0119pie\u0144","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Klupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00107-4_bib1","first-page":"1387","article-title":"A retrospective epidemiological study of type 1 diabetes mellitus in Wales, UK between 2008 and 2018","volume":"6","author":"Rafferty","year":"2021","journal-title":"Int J Popul Data Sci"},{"key":"10.1016\/S2213-8587(24)00107-4_bib2","doi-asserted-by":"crossref","first-page":"e14943","DOI":"10.1111\/dme.14943","article-title":"The experiences and support needs of students with diabetes at university: an integrative literature review","volume":"40","author":"Hagger","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00107-4_bib3","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/j.tics.2004.12.005","article-title":"Cognitive and affective development in adolescence","volume":"9","author":"Steinberg","year":"2005","journal-title":"Trends Cogn Sci"},{"key":"10.1016\/S2213-8587(24)00107-4_bib4","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1136\/bmj.325.7367.746","article-title":"Training in flexible, intensive insulin management to enable dietary freedom in people with type 1 diabetes: dose adjustment for normal eating (DAFNE) randomised controlled trial","volume":"325","year":"2002","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00107-4_bib5","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1111\/dme.13656","article-title":"Young people's experiences of managing Type 1 diabetes at university: a national study of UK university students","volume":"35","author":"Kellett","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00107-4_bib6","author":"Stoet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001074?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001074?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,22]],"date-time":"2024-05-22T01:59:25Z","timestamp":1716343165000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001074"}},"issued":{"date-parts":[[2024,6]]},"references-count":6,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2213858724001074"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00107-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving support for university students with type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00107-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,21]],"date-time":"2026-07-21T22:59:05Z","timestamp":1784674745795,"version":"3.55.0"},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/s2213-8587(24)00315-2","type":"journal-article","created":{"date-parts":[[2024,11,25]],"date-time":"2024-11-25T23:36:16Z","timestamp":1732577776000},"page":"2-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["The promise and hope of GLP-1 receptor agonists"],"prefix":"10.1016","volume":"13","author":[{"given":"Priya","family":"Sumithran","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jamy","family":"Ard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00315-2_bib1","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/S2213-8587(21)00203-5","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","volume":"9","author":"Sattar","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00315-2_bib2","doi-asserted-by":"crossref","first-page":"2221","DOI":"10.1056\/NEJMoa2307563","article-title":"Semaglutide and cardiovascular outcomes in obesity without diabetes","volume":"389","author":"Lincoff","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00315-2_bib3","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","author":"Badve","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00315-2_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"Effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00315-2_bib5","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1038\/s41569-023-00849-3","article-title":"Glucagon-like peptide 1 receptor agonists: cardiovascular benefits and mechanisms of action","volume":"20","author":"Ussher","year":"2023","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(24)00315-2_bib6","series-title":"The top 10 causes of death","year":"2024"},{"key":"10.1016\/S2213-8587(24)00315-2_bib7","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.14725","article-title":"Weight regain and cardiometabolic effects after withdrawal of semaglutide: the STEP 1 trial extension","volume":"24","author":"Wilding","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00315-2_bib8","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1161\/CIR.0000000000001184","article-title":"cardiovascular-kidney-metabolic health: a presidential advisory from the American Heart Association","volume":"148","author":"Ndumele","year":"2023","journal-title":"Circulation"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:51:20Z","timestamp":1739839880000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003152"}},"issued":{"date-parts":[[2025,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2213858724003152"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00315-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The promise and hope of GLP-1 receptor agonists","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00315-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00271-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,18]],"date-time":"2026-06-18T07:39:46Z","timestamp":1781768386116,"version":"3.54.5"},"reference-count":19,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,3,24]],"date-time":"2025-03-24T00:00:00Z","timestamp":1742774400000},"content-version":"am","delay-in-days":174,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T00:00:00Z","timestamp":1727740800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"US Government National Institutes of Health","doi-asserted-by":"publisher","award":["1OT2HL156812"],"award-info":[{"award-number":["1OT2HL156812"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,10]]},"DOI":"10.1016\/s2213-8587(24)00218-3","type":"journal-article","created":{"date-parts":[[2024,9,6]],"date-time":"2024-09-06T23:07:20Z","timestamp":1725664040000},"page":"725-734","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Effect of sodium\u2013glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial"],"prefix":"10.1016","volume":"12","author":[{"given":"Mikhail N","family":"Kosiborod","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheryl L","family":"Windsor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Orly","family":"Vardeny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey S","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harmony R","family":"Reynolds","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stavroula","family":"Boumakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew D","family":"Althouse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Scott D","family":"Solomon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ankeet S","family":"Bhatt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Peikert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James F","family":"Luther","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric S","family":"Leifer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrei L","family":"Kindzelski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary","family":"Cushman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michelle","family":"Ng Gong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucy Z","family":"Kornblith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pooja","family":"Khatri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri S","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lisa","family":"Baumann Kreuziger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ali","family":"Javaheri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos","family":"Carpio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lana","family":"Wahid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Lopez-Sendon Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alvaro","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Minh Quang","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jose","family":"Lopez-Sendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey L","family":"Curtis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bridget-Anne","family":"Kirwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark W","family":"Geraci","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew D","family":"Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith S","family":"Hochman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"PR","family":"Avancini Caramori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Esteves Hernandes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Babudieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Contoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JR","family":"Gonzalez Juanatey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Iba\u00f1ez Estellez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Mateos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Tidswell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Akala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Pursley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Jathavedam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Markley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Gelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Ajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Mackay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Kunisaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Exline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Huggins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Nicholson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Aboudara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Sherwin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Torbati","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wilson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JG","family":"Latorre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Busch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Albertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Matthay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Gandotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Joseph","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Hudock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Iovine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Quigley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Hyzy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Kutcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Pandey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Sheehan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Solankhi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W","family":"Rodriguez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Khanna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Bochicchio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"McCarthy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Balasubraman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00218-3_bib1","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.0417","article-title":"Outcomes and mortality among adults hospitalized with COVID-19 at US medical centers","volume":"4","author":"Nguyen","year":"2021","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(24)00218-3_bib2","doi-asserted-by":"crossref","first-page":"n579","DOI":"10.1136\/bmj.n579","article-title":"Risk of mortality in patients infected with SARS-CoV-2 variant of concern 202012\/1: matched cohort study","volume":"372","author":"Challen","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00218-3_bib3","doi-asserted-by":"crossref","first-page":"2377","DOI":"10.1016\/j.jacc.2023.04.034","article-title":"Effect of SGLT2 inhibitors on cardiovascular outcomes across various patient populations","volume":"81","author":"Usman","year":"2023","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(24)00218-3_bib4","doi-asserted-by":"crossref","first-page":"2036","DOI":"10.2337\/dc15-2688","article-title":"Dapagliflozin enhances fat oxidation and ketone production in patients with type 2 diabetes","volume":"39","author":"Daniele","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00218-3_bib5","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1186\/s12933-017-0621-8","article-title":"Dapagliflozin acutely improves endothelial dysfunction, reduces aortic stiffness and renal resistive index in type 2 diabetic patients: a pilot study","volume":"16","author":"Solini","year":"2017","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(24)00218-3_bib6","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/j.diabet.2018.09.005","article-title":"Effects of SGLT2 inhibitors on systemic and tissue low-grade inflammation: the potential contribution to diabetes complications and cardiovascular disease","volume":"44","author":"Bonnet","year":"2018","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(24)00218-3_bib7","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1007\/s10787-020-00732-4","article-title":"Empagliflozin suppresses inflammation and protects against acute septic renal injury","volume":"29","author":"Maayah","year":"2021","journal-title":"Inflammopharmacology"},{"key":"10.1016\/S2213-8587(24)00218-3_bib8","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-93156-1","article-title":"Canagliflozin protects against sepsis capillary leak syndrome by activating endothelial \u03b11AMPK","volume":"11","author":"Ang\u00e9","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(24)00218-3_bib9","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa057","article-title":"Dapagliflozin suppresses hepcidin and increases erythropoiesis","volume":"105","author":"Ghanim","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00218-3_bib10","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1111\/dom.14296","article-title":"Effects of dapagliflozin on prevention of major clinical events and recovery in patients with respiratory failure because of COVID-19: design and rationale for the DARE-19 study","volume":"23","author":"Kosiborod","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00218-3_bib11","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1016\/S2213-8587(21)00180-7","article-title":"Dapagliflozin in patients with cardiometabolic risk factors hospitalised with COVID-19 (DARE-19): a randomised, double-blind, placebo-controlled, phase 3 trial","volume":"9","author":"Kosiborod","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00218-3_bib12","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1016\/S2213-8587(23)00253-X","article-title":"Empagliflozin in patients admitted to hospital with COVID-19 (RECOVERY): a randomised, controlled, open-label, platform trial","volume":"11","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00218-3_bib13","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1056\/NEJMoa2103417","article-title":"Therapeutic Anticoagulation with heparin in critically ill patients with COVID-19","volume":"385","author":"Goligher","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00218-3_bib14","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1056\/NEJMoa2105911","article-title":"Therapeutic anticoagulation with heparin in noncritically ill patients with Covid-19","volume":"385","author":"Lawler","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00218-3_bib15","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(24)00219-5","article-title":"Sodium\u2013glucose co-transporter 2 inhibitors for hospitalised patients with COVID-19: a prospective meta-analysis of randomised trials","author":"Vale","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00218-3_bib16","author":"Diabetes"},{"key":"10.1016\/S2213-8587(24)00218-3_bib17","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00218-3_bib18","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.diabet.2020.06.003","article-title":"SGLT2 inhibition during the COVID-19 epidemic: Friend or foe?","volume":"46","author":"Scheen","year":"2020","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(24)00218-3_bib19","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1161\/CIRCULATIONAHA.123.065748","article-title":"Blinded withdrawal of long-term randomized treatment with empagliflozin or placebo in patients with heart failure","volume":"148","author":"Packer","year":"2023","journal-title":"Circulation"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002183?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002183?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,11]],"date-time":"2024-10-11T01:22:08Z","timestamp":1728609728000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002183"}},"issued":{"date-parts":[[2024,10]]},"references-count":19,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2024,10]]}},"alternative-id":["S2213858724002183"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00218-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of sodium\u2013glucose co-transporter-2 inhibitors on survival free of organ support in patients hospitalised for COVID-19 (ACTIV-4a): a pragmatic, multicentre, open-label, randomised, controlled, platform trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00218-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00219-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00230-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T19:31:44Z","timestamp":1778873504051,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/s2213-8587(20)30307-7","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T18:37:10Z","timestamp":1600195030000},"page":"806-808","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":11,"title":["The oldest case of osteopetrosis in a human skeleton: exploring the history of rare diseases"],"prefix":"10.1016","volume":"8","author":[{"given":"Julia","family":"Gresky","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roman","family":"Sokiranski","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Florian","family":"Witzmann","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emmanuele","family":"Petiti","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30307-7_bib1","doi-asserted-by":"crossref","first-page":"721","DOI":"10.1016\/S1474-4422(18)30437-X","article-title":"Competing to raise awareness of rare diseases","volume":"18","author":"Polizzi","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(20)30307-7_bib2","doi-asserted-by":"crossref","first-page":"2869","DOI":"10.1002\/ajmg.a.37365","article-title":"Nosology and classification of genetic skeletal disorders: 2015 revision","volume":"167A","author":"Bonafe","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(20)30307-7_bib3","doi-asserted-by":"crossref","first-page":"R39","DOI":"10.1530\/EJE-13-0136","article-title":"Autosomal dominant osteopetrosis revisited: lessons from recent studies","volume":"169","author":"Bollerslev","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30307-7_bib4","unstructured":"Waldron T, Cox M, Molleson T. Osteopetrosis in an eighteenth century English family. Sixteenth Annual Meeting of the Paleopathology Association; San Diego, CA, USA; April 4\u20135, 1989."},{"key":"10.1016\/S2213-8587(20)30307-7_bib5","series-title":"The Spitalfields project. Volume 2\u2014the anthropology. The middling sort","author":"Molleson","year":"1993"},{"key":"10.1016\/S2213-8587(20)30307-7_bib6","unstructured":"Favia G, Scattarella V, Saponetti SS, Sivilli S, Lacaita MG, Radina F. Osteopetrosis tarda in an adult Neolithic skeleton from Palata 2-Ofanto River Valley (Canosa-South Italy): radiological, histological and confocal laser microscopy study. 18th European Meeting of the Paleopathology Association; Vienna, Austria; Aug 23\u201326, 2010."},{"key":"10.1016\/S2213-8587(20)30307-7_bib7","first-page":"125","article-title":"Malignant osteopetrosis in ancient Nubia. A case from the period 350-550 A.D","volume":"18","author":"Nielsen","year":"1971","journal-title":"Dan Med Bull"},{"key":"10.1016\/S2213-8587(20)30307-7_bib8","first-page":"410","article-title":"Le N\u00e9olithique ancien en Albanie","volume":"68","author":"Prendi","year":"1990","journal-title":"Germania"},{"key":"10.1016\/S2213-8587(20)30307-7_bib9","series-title":"Skeletterkrankungen: klinisch-radiologische Diagnose und Differentialdiagnose","author":"Freyschmidt","year":"2017"},{"key":"10.1016\/S2213-8587(20)30307-7_bib10","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1146\/annurev.pathmechdis.3.121806.151431","article-title":"The osteoclast: friend or foe?","volume":"3","author":"Novack","year":"2008","journal-title":"Annu Rev Pathol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303077?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303077?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:24Z","timestamp":1761991704000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303077"}},"issued":{"date-parts":[[2020,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2213858720303077"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30307-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The oldest case of osteopetrosis in a human skeleton: exploring the history of rare diseases","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30307-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S1474-4422(18)30437-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,4,9]],"date-time":"2025-04-09T08:51:57Z","timestamp":1744188717422},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T00:00:00Z","timestamp":1559347200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,6]]},"DOI":"10.1016\/s2213-8587(19)30139-1","type":"journal-article","created":{"date-parts":[[2019,4,18]],"date-time":"2019-04-18T19:21:07Z","timestamp":1555615267000},"page":"e18","source":"Crossref","is-referenced-by-count":4,"title":["Correction to Lancet Diabetes Endocrinol 2019; 7: 385\u201396"],"prefix":"10.1016","volume":"7","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301391?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719301391?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,6,17]],"date-time":"2019-06-17T17:03:57Z","timestamp":1560791037000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719301391"}},"issued":{"date-parts":[[2019,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2019,6]]}},"alternative-id":["S2213858719301391"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30139-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,6]]}},{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T23:28:21Z","timestamp":1793316501019,"version":"4.5.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,22]],"date-time":"2025-10-22T00:00:00Z","timestamp":1761091200000},"content-version":"am","delay-in-days":174,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,5,1]],"date-time":"2025-05-01T00:00:00Z","timestamp":1746057600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000049","name":"National Institute on Aging","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000049","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK114074"],"award-info":[{"award-number":["R01DK114074"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["R01DK120518"],"award-info":[{"award-number":["R01DK120518"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["K01DK132490"],"award-info":[{"award-number":["K01DK132490"]}],"id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000060","name":"National Institute of Allergy and Infectious Diseases","doi-asserted-by":"publisher","award":["K24AI144954"],"award-info":[{"award-number":["K24AI144954"]}],"id":[{"id":"10.13039\/100000060","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,5]]},"DOI":"10.1016\/s2213-8587(24)00371-1","type":"journal-article","created":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T18:33:48Z","timestamp":1741199628000},"page":"374-383","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":55,"title":["GLP-1 receptor agonists in kidney transplant recipients with pre-existing diabetes: a retrospective cohort study"],"prefix":"10.1016","volume":"13","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-6026-7135","authenticated-orcid":false,"given":"Babak J","family":"Orandi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6968-4664","authenticated-orcid":false,"given":"Yusi","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6279-5740","authenticated-orcid":false,"given":"Yiting","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9894-2386","authenticated-orcid":false,"given":"Garyn T","family":"Metoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krista L","family":"Lentine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Weintraub","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sunjae","family":"Bae","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole M","family":"Ali","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bonnie E","family":"Lonze","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine J","family":"Ren-Fielding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Lofton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akash","family":"Gujral","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-1924-4801","authenticated-orcid":false,"given":"Dorry L","family":"Segev","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3013-925X","authenticated-orcid":false,"given":"Mara","family":"McAdams-DeMarco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00371-1_bib1","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1016\/S2213-8587(17)30013-X","article-title":"Efficacy and safety of once-weekly semaglutide monotherapy versus placebo in patients with type 2 diabetes (SUSTAIN 1): a double-blind, randomised, placebo-controlled, parallel-group, multinational, multicentre phase 3a trial","volume":"5","author":"Sorli","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00371-1_bib2","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00371-1_bib3","first-page":"S125","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes\u20132022","volume":"45","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00371-1_bib4","doi-asserted-by":"crossref","first-page":"109","DOI":"10.1056\/NEJMoa2403347","article-title":"effects of semaglutide on chronic kidney disease in patients with type 2 diabetes","volume":"391","author":"Perkovic","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00371-1_bib5","doi-asserted-by":"crossref","first-page":"S117","DOI":"10.1016\/j.kint.2023.10.018","article-title":"KDIGO 2024 clinical practice guideline for the evaluation and management of chronic kidney disease","volume":"105","author":"Stevens","year":"2024","journal-title":"Kidney Int"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(24)00371-1_bib6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/ajt.16502","article-title":"OPTN\/SRTR 2019 annual data report: Kidney","volume":"21","author":"Hart","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(24)00371-1_bib7","series-title":"USRDS Annual Data Report: Epidemiology of kidney disease in the United States","year":"2023"},{"key":"10.1016\/S2213-8587(24)00371-1_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0222169","article-title":"Acute pancreatitis risk after kidney transplantation: Propensity score matching analysis of a national cohort","volume":"14","author":"Chuang","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(24)00371-1_bib9","doi-asserted-by":"crossref","first-page":"694","DOI":"10.1016\/j.amjsurg.2018.07.023","article-title":"Complications, length of stay, and cost of cholecystectomy in kidney transplant recipients","volume":"216","author":"DiBrito","year":"2018","journal-title":"Am J Surg"},{"key":"10.1016\/S2213-8587(24)00371-1_bib10","doi-asserted-by":"crossref","first-page":"232","DOI":"10.2337\/cd16-0052","article-title":"International Classification of Diseases, 10th Revision, Coding for Diabetes","volume":"35","author":"Dugan","year":"2017","journal-title":"Clin Diabetes"},{"key":"10.1016\/S2213-8587(24)00371-1_bib11","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1177\/1536867X20909696","article-title":"Conducting sensitivity analysis for unmeasured confounding in observational studies using E-values: the evalue package","volume":"20","author":"Linden","year":"2020","journal-title":"Stata J"},{"key":"10.1016\/S2213-8587(24)00371-1_bib12","doi-asserted-by":"crossref","first-page":"1260","DOI":"10.1111\/j.1464-5491.2012.03745.x","article-title":"Monotherapy with the once-weekly GLP-1 analogue dulaglutide for 12 weeks in patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomized, double-blind, placebo-controlled study","volume":"29","author":"Grunberger","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00371-1_bib13","doi-asserted-by":"crossref","first-page":"2168","DOI":"10.2337\/dc13-2759","article-title":"Efficacy and safety of dulaglutide monotherapy versus metformin in type 2 diabetes in a randomized controlled trial (AWARD-3)","volume":"37","author":"Umpierrez","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00371-1_bib14","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1507\/endocrj.EJ14-0147","article-title":"Monotherapy with the once weekly GLP-1 receptor agonist dulaglutide for 12 weeks in Japanese patients with type 2 diabetes: dose-dependent effects on glycaemic control in a randomised, double-blind, placebo-controlled study","volume":"61","author":"Terauchi","year":"2014","journal-title":"Endocr J"},{"key":"10.1016\/S2213-8587(24)00371-1_bib15","article-title":"Efficacy and safety of dulaglutide in patients with type 2 diabetes: a meta-analysis and systematic review","volume":"6","author":"Zhang","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(24)00371-1_bib16","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00371-1_bib17","doi-asserted-by":"crossref","first-page":"370","DOI":"10.3390\/jcm7100370","article-title":"Epidemiology and prognostic importance of atrial fibrillation in kidney transplant recipients: a meta-analysis","volume":"7","author":"Thongprayoon","year":"2018","journal-title":"J Clin Med"},{"key":"10.1016\/S2213-8587(24)00371-1_bib18","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1053\/j.ajkd.2005.06.019","article-title":"De novo congestive heart failure after kidney transplantation: a common condition with poor prognostic implications","volume":"46","author":"Lentine","year":"2005","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(24)00371-1_bib19","doi-asserted-by":"crossref","first-page":"3232","DOI":"10.1016\/j.transproceed.2018.08.028","article-title":"Impact of pre-existing comorbidities on long-term outcomes in kidney transplant recipients","volume":"50","author":"Kleinsteuber","year":"2018","journal-title":"Transplant Proc"},{"key":"10.1016\/S2213-8587(24)00371-1_bib20","doi-asserted-by":"crossref","first-page":"355","DOI":"10.2215\/CJN.0000000000000360","article-title":"Trends and specific causes of cardiovascular mortality after kidney transplantation in Finland","volume":"19","author":"Helve","year":"2024","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(24)00371-1_bib21","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.jdiacomp.2014.01.009","article-title":"Reductions in systolic blood pressure with liraglutide in patients with type 2 diabetes: insights from a patient-level pooled analysis of six randomized clinical trials","volume":"28","author":"Fonseca","year":"2014","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(24)00371-1_bib22","doi-asserted-by":"crossref","first-page":"2058","DOI":"10.1111\/dom.14443","article-title":"Potential kidney protection with liraglutide and semaglutide: exploratory mediation analysis","volume":"23","author":"Mann","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00371-1_bib23","doi-asserted-by":"crossref","first-page":"1501","DOI":"10.2337\/dc23-0261","article-title":"Effects of tirzepatide versus insulin glargine on cystatin C-based kidney function: a SURPASS-4 post hoc analysis","volume":"46","author":"Heerspink","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00371-1_bib24","doi-asserted-by":"crossref","DOI":"10.1111\/ctr.14633","article-title":"Effectiveness and safety of glucagon-like peptide-1 receptor agonist in a cohort of kidney transplant recipients","volume":"36","author":"Vigara","year":"2022","journal-title":"Clin Transplant"},{"key":"10.1016\/S2213-8587(24)00371-1_bib25","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1177\/15269248221122867","article-title":"Single-center evaluation of safety & efficacy of glucagon-like peptide-1 receptor agonists in solid organ transplantation","volume":"32","author":"Sweiss","year":"2022","journal-title":"Prog Transplant"},{"key":"10.1016\/S2213-8587(24)00371-1_bib26","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.1210\/clinem\/dgad177","article-title":"Possible advantage of glucagon-like peptide 1 receptor agonists for kidney transplant recipients with type 2 diabetes","volume":"108","author":"Sato","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00371-1_bib27","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1111\/dom.13964","article-title":"Comparison of the glucagon-like-peptide-1 receptor agonists dulaglutide and liraglutide for the management of diabetes in solid organ transplant: a retrospective study","volume":"22","author":"Singh","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00371-1_bib28","doi-asserted-by":"crossref","DOI":"10.1093\/ckj\/sfae018","article-title":"Safety and efficacy of glucagon-like peptide-1 receptor agonists among kidney transplant recipients: a systematic review and meta-analysis","volume":"17","author":"Krisanapan","year":"2024","journal-title":"Clin Kidney J"},{"key":"10.1016\/S2213-8587(24)00371-1_bib29","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jamainternmed.2022.0338","article-title":"Association of glucagon-like peptide-1 receptor agonist use with risk of gallbladder and biliary diseases: a systematic review and meta-analysis of randomized clinical trials","volume":"182","author":"He","year":"2022","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(24)00371-1_bib30","doi-asserted-by":"crossref","first-page":"290","DOI":"10.2337\/dc20-1815","article-title":"HbA1c change and diabetic retinopathy during GLP-1 receptor agonist cardiovascular outcome trials: a meta-analysis and meta-regression","volume":"44","author":"Bethel","year":"2021","journal-title":"Diabetes Care"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(25)00128-7","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003711?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003711?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,5,22]],"date-time":"2025-05-22T22:05:39Z","timestamp":1747951539000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003711"}},"issued":{"date-parts":[[2025,5]]},"references-count":30,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2025,5]]}},"alternative-id":["S2213858724003711"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00371-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonists in kidney transplant recipients with pre-existing diabetes: a retrospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00371-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00399-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T18:14:19Z","timestamp":1793297659674,"version":"4.5.0"},"reference-count":33,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014931","name":"Arrowhead Pharmaceuticals Inc","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014931","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/s2213-8587(25)00290-6","type":"journal-article","created":{"date-parts":[[2025,12,19]],"date-time":"2025-12-19T06:44:45Z","timestamp":1766126685000},"page":"123-136","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial"],"prefix":"10.1016","volume":"14","author":[{"given":"Frederick J","family":"Raal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean","family":"Bergeron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Gaudet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert S","family":"Rosenson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Sullivan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Traci","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert A","family":"Hegele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christie M","family":"Ballantyne","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua W","family":"Knowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Leeper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ira J","family":"Goldberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rong","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ma'an","family":"Muhsin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Hellawell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald F","family":"Watts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00290-6_bib1","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.1093\/eurheartj\/ehad197","article-title":"2023 Update on European Atherosclerosis Society Consensus Statement on Homozygous Familial Hypercholesterolaemia: new treatments and clinical guidance","volume":"44","author":"Cuchel","year":"2023","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(25)00290-6_bib2","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa2004215","article-title":"Evinacumab for homozygous familial hypercholesterolemia","volume":"383","author":"Raal","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00290-6_bib3","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1038\/s41569-019-0325-8","article-title":"Familial hypercholesterolaemia: evolving knowledge for designing adaptive models of care","volume":"17","author":"Watts","year":"2020","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(25)00290-6_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1016\/j.atherosclerosis.2016.10.017","article-title":"HEART UK statement on the management of homozygous familial hypercholesterolaemia in the United Kingdom","volume":"255","author":"France","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(25)00290-6_bib5","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.122.029175","article-title":"Contemporary homozygous familial hypercholesterolemia in the United States: insights from the CASCADE FH registry","volume":"12","author":"Cuchel","year":"2023","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(25)00290-6_bib6","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1161\/01.ATV.0000252827.51626.89","article-title":"Angiopoietin-like protein3 regulates plasma HDL cholesterol through suppression of endothelial lipase","volume":"27","author":"Shimamura","year":"2007","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(25)00290-6_bib7","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1097\/MOL.0000000000000898","article-title":"Angiopoietin-like 3 inhibition and the liver: less is more?","volume":"34","author":"Oostveen","year":"2023","journal-title":"Curr Opin Lipidol"},{"key":"10.1016\/S2213-8587(25)00290-6_bib8","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1056\/NEJMoa1612790","article-title":"Genetic and pharmacologic inactivation of ANGPTL3 and cardiovascular disease","volume":"377","author":"Dewey","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00290-6_bib9","doi-asserted-by":"crossref","first-page":"2054","DOI":"10.1016\/j.jacc.2017.02.030","article-title":"ANGPTL3 deficiency and protection against coronary artery disease","volume":"69","author":"Stitziel","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(25)00290-6_bib10","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1056\/NEJMoa2404147","article-title":"Zodasiran, an RNAi therapeutic targeting ANGPTL3, for mixed hyperlipidemia","volume":"391","author":"Rosenson","year":"2024","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00290-6_bib11","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1038\/s41591-023-02494-2","article-title":"RNA interference targeting ANGPTL3 for triglyceride and cholesterol lowering: phase 1 basket trial cohorts","volume":"29","author":"Watts","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00290-6_bib12","doi-asserted-by":"crossref","first-page":"2146","DOI":"10.1093\/eurheartj\/ehu274","article-title":"Homozygous familial hypercholesterolaemia: new insights and guidance for clinicians to improve detection and clinical management. A position paper from the Consensus Panel on Familial Hypercholesterolaemia of the European Atherosclerosis Society","volume":"35","author":"Cuchel","year":"2014","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(25)00290-6_bib13","series-title":"Manual of laboratory operations: lipid and lipoprotein analysis","first-page":"678","author":"Hainline","year":"1982"},{"key":"10.1016\/S2213-8587(25)00290-6_bib14","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.jacl.2015.02.003","article-title":"National lipid association recommendations for patient-centered management of dyslipidemia: part 1\u2014full report","volume":"9","author":"Jacobson","year":"2015","journal-title":"J Clin Lipidol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00290-6_bib15","article-title":"P1703. German lipoprotein apheresis registry\u2014more than 5 years on","volume":"39","author":"Schettler","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(25)00290-6_bib16","doi-asserted-by":"crossref","first-page":"483","DOI":"10.1016\/j.atherosclerosis.2018.06.859","article-title":"Familial hypercholesterolemia treatments: guidelines and new therapies","volume":"277","author":"Raal","year":"2018","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(25)00290-6_bib17","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1124\/dmd.122.001107","article-title":"Clinical pharmacology of RNA interference-based therapeutics: a summary based on Food and Drug Administration-approved small interfering RNAs","volume":"51","author":"Jing","year":"2023","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/S2213-8587(25)00290-6_bib18","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1038\/s41569-024-01039-5","article-title":"The LDL cumulative exposure hypothesis: evidence and practical applications","volume":"21","author":"Ference","year":"2024","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(25)00290-6_bib19","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/S0140-6736(12)61731-0","article-title":"Efficacy and safety of a microsomal triglyceride transfer protein inhibitor in patients with homozygous familial hypercholesterolaemia: a single-arm, open-label, phase 3 study","volume":"381","author":"Cuchel","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00290-6_bib20","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1016\/S0140-6736(21)02001-8","article-title":"Worldwide experience of homozygous familial hypercholesterolaemia: retrospective cohort study","volume":"399","author":"Tromp","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00290-6_bib21","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/liv.15497","article-title":"Long-term hepatic safety of lomitapide in homozygous familial hypercholesterolaemia","volume":"43","author":"Larrey","year":"2023","journal-title":"Liver Int"},{"key":"10.1016\/S2213-8587(25)00290-6_bib22","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1186\/s13023-024-03374-9","article-title":"Long-term effectiveness and safety of lomitapide in patients with homozygous familial hypercholesterolemia: an observational case series","volume":"19","author":"Suppressa","year":"2024","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(25)00290-6_bib23","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1016\/S2352-4642(24)00073-7","article-title":"Cardiovascular outcomes in patients with homozygous familial hypercholesterolaemia on lipoprotein apheresis initiated during childhood: long-term follow-up of an international cohort from two registries","volume":"8","author":"Reijman","year":"2024","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/S2213-8587(25)00290-6_bib24","doi-asserted-by":"crossref","first-page":"143","DOI":"10.2217\/fca-2021-0096","article-title":"Transcriptomic therapy for dyslipidemias utilizing nucleic acids targeted at ANGPTL3","volume":"18","author":"Watts","year":"2022","journal-title":"Future Cardiol"},{"key":"10.1016\/S2213-8587(25)00290-6_bib25","doi-asserted-by":"crossref","first-page":"2202","DOI":"10.1161\/CIRCULATIONAHA.111.042523","article-title":"Reduction in mortality in subjects with homozygous familial hypercholesterolemia associated with advances in lipid-lowering therapy","volume":"124","author":"Raal","year":"2011","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(25)00290-6_bib26","doi-asserted-by":"crossref","first-page":"1162","DOI":"10.1093\/eurheartj\/ehx317","article-title":"Survival in homozygous familial hypercholesterolaemia is determined by the on-treatment level of serum cholesterol","volume":"39","author":"Thompson","year":"2018","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(25)00290-6_bib27","doi-asserted-by":"crossref","first-page":"E1266","DOI":"10.1210\/jc.2012-1298","article-title":"Mutations in the ANGPTL3 gene and familial combined hypolipidemia: a clinical and biochemical characterization","volume":"97","author":"Minicocci","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00290-6_bib28","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1161\/01.CIR.100.11.1154","article-title":"Role of lipoprotein(a) and apolipoprotein(a) phenotype in atherogenesis: prospective results from the Bruneck study","volume":"100","author":"Kronenberg","year":"1999","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(25)00290-6_bib29","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.atherosclerosis.2022.04.002","article-title":"Recent advances in demystifying the metabolism of lipoprotein(a)","volume":"349","author":"Chemello","year":"2022","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(25)00290-6_bib30","doi-asserted-by":"crossref","first-page":"1377","DOI":"10.1161\/CIRCULATIONAHA.122.059266","article-title":"Effect of vupanorsen on non-high-density lipoprotein cholesterol levels in statin-treated patients with elevated cholesterol: TRANSLATE-TIMI 70","volume":"145","author":"Bergmark","year":"2022","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(25)00290-6_bib31","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1016\/S0140-6736(25)00507-0","article-title":"Durability and efficacy of solbinsiran, a GalNAc-conjugated siRNA targeting ANGPTL3, in adults with mixed dyslipidaemia (PROLONG-ANG3): a double-blind, randomised, placebo-controlled, phase 2 trial","volume":"405","author":"Ray","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00290-6_bib32","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1038\/s41591-023-02222-w","article-title":"Evinacumab in severe hypertriglyceridemia with or without lipoprotein lipase pathway mutations: a phase 2 randomized trial","volume":"29","author":"Rosenson","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00290-6_bib33","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1056\/NEJMoa061189","article-title":"Inhibition of microsomal triglyceride transfer protein in familial hypercholesterolemia","volume":"356","author":"Cuchel","year":"2007","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002906?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002906?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:49:36Z","timestamp":1789073376000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002906"}},"issued":{"date-parts":[[2026,2]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2213858725002906"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00290-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Zodasiran, an RNAi therapeutic targeting ANGPTL3, for treating patients with homozygous familial hypercholesterolaemia (GATEWAY): an open-label, randomised, phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00290-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00330-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,30]],"date-time":"2026-10-30T03:13:13Z","timestamp":1793329993033,"version":"4.5.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,8,1]],"date-time":"2017-08-01T00:00:00Z","timestamp":1501545600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,7,18]],"date-time":"2018-07-18T00:00:00Z","timestamp":1531872000000},"content-version":"am","delay-in-days":351,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,8]]},"DOI":"10.1016\/s2213-8587(17)30194-8","type":"journal-article","created":{"date-parts":[[2017,6,11]],"date-time":"2017-06-11T17:30:47Z","timestamp":1497202247000},"page":"597-609","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":319,"title":["Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial"],"prefix":"10.1016","volume":"5","author":[{"given":"John R","family":"Petrie","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nishi","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martijn C G J","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Greenlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Therese","family":"Tillin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irene","family":"Hramiak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alun D","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alicia J","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara E K","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teik C","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen D A","family":"Stehouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen M","family":"Colhoun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Nickerson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"O","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Dutta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Haw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Thomson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Gibb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Greenlaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Keech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Jenkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"March","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Coady","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Dreyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Jan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Sheffy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lusky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Peleg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Shore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Carty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Donnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Witham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Adler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Lonn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Rauchhaus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Lindsay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Brouwers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Van-Melckebeke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Hamill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Cuthbertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Jolly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Hair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Bell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Carmichael","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Douglas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Surtees","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Dinnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"McLaughlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Brindley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Smillie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Motherwell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"MacDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Ellis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Stuart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Travers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Brearley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Greig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Colman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Nankervis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Forulanos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"West","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Vaughan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Bjorasen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Donlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Vrazas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"O'Neal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Horsburgh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Pater","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Kent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Twigg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Fulcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Denner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Piotrowicz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Januszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Coy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"McDonald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Tereschyn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Weingert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Heard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Burke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TC","family":"Ooi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Lochnan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sorisky","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Keely","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Malcolm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Maranger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Favreau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Petherick","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Boles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Rossing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"TW","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Lund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Hemmingsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Thorogood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Green","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Abouglilia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Nayman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Warren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Aizawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Balasubramani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Toth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Harvey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Birch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Atkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Sathyapalan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"James","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Z","family":"Javed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Wilding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Martin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Birch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Wilcox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Watson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Oliver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Jugnee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Rutter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Turgut","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Shaju","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Yau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Subin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Wake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"C","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Millward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"P","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Hibbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N","family":"Schaper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Pinxt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"op het Roodt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sam","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Murray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Sleigh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Collier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"LE","family":"Sit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Allan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Cook","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Hodge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Leese","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Reekie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Jaap","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sudworth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"White","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"McKnight","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Steven","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Llano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G","family":"Currie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Lennon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Johnstone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Shields","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30194-8_bib1","doi-asserted-by":"crossref","first-page":"e1001321","DOI":"10.1371\/journal.pmed.1001321","article-title":"Risk of cardiovascular disease and total mortality in adults with type 1 diabetes: Scottish registry linkage study","volume":"9","author":"Livingstone","year":"2012","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30194-8_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2014.16425","article-title":"Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008\u20132010","volume":"313","author":"Livingstone","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30194-8_bib3","doi-asserted-by":"crossref","first-page":"686","DOI":"10.2337\/dc15-1990","article-title":"Intensive diabetes treatment and cardiovascular outcomes in type 1 diabetes: the DCCT\/EDIC study 30-year follow-up","volume":"39","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30194-8_bib4","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.1111\/dme.12676","article-title":"Glycaemic control of type 1 diabetes in clinical practice early in the 21st century: an international comparison","volume":"32","author":"McKnight","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(17)30194-8_bib5","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1038\/ijo.2009.75","article-title":"Adiposity and mortality in type 1 diabetes","volume":"33","author":"Conway","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(17)30194-8_bib6","unstructured":"UK National Institute for Health and Care Excellence, Type 1 diabetes in adults: diagnosis and management. https:\/\/www.nice.org.uk\/guidance\/ng17?unlid=43059219201639184149 (accessed May 7, 2017)."},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30194-8_bib7","first-page":"S1","article-title":"Standards of medical care in diabetes\u20142017","volume":"40","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30194-8_bib8","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s00125-009-1636-9","article-title":"The use of metformin in type 1 diabetes: a systematic review of efficacy","volume":"53","author":"Vella","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30194-8_bib9","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/S0140-6736(98)07037-8","article-title":"Effect of intensive blood-glucose control with metformin on complications in overweight patients with type 2 diabetes (UKPDS 34)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30194-8_bib10","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1001\/archinternmed.2009.20","article-title":"Long-term effects of metformin on metabolism and microvascular and macrovascular disease in patients with type 2 diabetes mellitus","volume":"169","author":"Kooy","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(17)30194-8_bib11","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1161\/CIRCIMAGING.112.978114","article-title":"Results from a carotid intima-media thickness trial as a decision tool for launching a large-scale morbidity and mortality trial","volume":"6","author":"Peters","year":"2013","journal-title":"Circ Cardiovasc Imaging"},{"key":"10.1016\/S2213-8587(17)30194-8_bib12","doi-asserted-by":"crossref","first-page":"2985","DOI":"10.1161\/01.STR.0000102044.27905.B5","article-title":"Carotid intima-media thickness measurements in intervention studies design options, progression rates, and sample size considerations","volume":"34","author":"Bots","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(17)30194-8_bib13","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1016\/S0140-6736(12)60441-3","article-title":"Carotid intima-media thickness progression to predict cardiovascular events in the general population (the PROG-IMT collaborative project): a meta-analysis of individual participant data","volume":"379","author":"Lorenz","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30194-8_bib14","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMoa022314","article-title":"Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus","volume":"348","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30194-8_bib15","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/dom.12840","article-title":"Metformin in adults with type 1 diabetes: design and methods of REducing with MetfOrmin Vascular Adverse Lesions (REMOVAL): an international multicentre trial","volume":"19","author":"Petrie","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(17)30194-8_bib16","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000343145","volume":"34","author":"Touboul","year":"2012","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/S2213-8587(17)30194-8_bib17","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1159\/000092129","article-title":"Mannheim consensus on carotid intima-media thickness: opposite and complementary points of view","volume":"21","author":"Meijer","year":"2006","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/S2213-8587(17)30194-8_bib18","doi-asserted-by":"crossref","first-page":"607","DOI":"10.2337\/db10-0296","article-title":"Progression of carotid artery intima-media thickness during 12 years in the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications (DCCT\/EDIC) study","volume":"60","author":"Polak","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30194-8_bib19","doi-asserted-by":"crossref","first-page":"e3363","DOI":"10.1371\/journal.pone.0003363","article-title":"Effect of adjunct metformin treatment in patients with type-1 diabetes and persistent inadequate glycaemic control. A randomized study","volume":"3","author":"Lund","year":"2008","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30194-8_bib20","doi-asserted-by":"crossref","first-page":"2241","DOI":"10.1001\/jama.2015.16174","article-title":"Effect of metformin added to insulin on glycemic control among overweight\/obese adolescents with type 1 diabetes: a randomized clinical trial","volume":"314","author":"Libman","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30194-8_bib21","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1111\/j.1463-1326.2009.01079.x","article-title":"Effect of adjunct metformin treatment on levels of plasma lipids in patients with type 1 diabetes","volume":"11","author":"Lund","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(17)30194-8_bib22","doi-asserted-by":"crossref","first-page":"2028","DOI":"10.2337\/db14-1225","article-title":"Metformin inhibits monocyte-to-macrophage differentiation via AMPK-mediated inhibition of STAT3 activation: potential role in atherosclerosis","volume":"64","author":"Vasamsetti","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(17)30194-8_bib23","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1111\/joim.12128","article-title":"Long-term effects of metformin on endothelial function in type 2 diabetes: a randomized controlled trial","volume":"275","author":"de Jager","year":"2014","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(17)30194-8_bib24","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1042\/BST20130275","article-title":"Methylglyoxal in diabetes: link to treatment, glycaemic control and biomarkers of complications","volume":"42","author":"Beisswenger","year":"2014","journal-title":"Biochem Soc Trans"},{"key":"10.1016\/S2213-8587(17)30194-8_bib25","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S2213-8587(13)70152-9","article-title":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial","volume":"2","author":"Preiss","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30194-8_bib26","doi-asserted-by":"crossref","first-page":"e000087","DOI":"10.1161\/JAHA.113.000087","article-title":"The value of carotid artery plaque and intima-media thickness for incident cardiovascular disease: the multi-ethnic study of atherosclerosis","volume":"2","author":"Polak","year":"2013","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(17)30194-8_bib27","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1111\/dom.12041","article-title":"Metformin improves endothelial function in type 1 diabetic subjects: a pilot, placebo-controlled randomized study","volume":"15","author":"Pitocco","year":"2013","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(17)30194-8_bib28","doi-asserted-by":"crossref","first-page":"2039","DOI":"10.2215\/CJN.02440314","article-title":"Handling of drugs, metabolites, and uremic toxins by kidney proximal tubule drug transporters","volume":"10","author":"Nigam","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30194-8_bib29","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s12882-017-0579-5","article-title":"Risk of acute kidney injury and survival in patients treated with metformin: an observational cohort study","volume":"18","author":"Bell","year":"2017","journal-title":"BMC Nephrol"},{"key":"10.1016\/S2213-8587(17)30194-8_bib30","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1111\/j.1463-1326.2008.00973.x","article-title":"Adherence in patients transferred from immediate release metformin to a sustained release formulation: a population-based study","volume":"11","author":"Donnelly","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(17)30194-8_bib31","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1210\/jc.2015-3754","article-title":"Long-term metformin use and vitamin B12 deficiency in the Diabetes Prevention Program Outcomes Study","volume":"101","author":"Aroda","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30194-8_bib32","doi-asserted-by":"crossref","first-page":"c2181","DOI":"10.1136\/bmj.c2181","article-title":"Long term treatment with metformin in patients with type 2 diabetes and risk of vitamin B-12 deficiency: randomised, placebo controlled trial","volume":"340","author":"de Jager","year":"2010","journal-title":"BMJ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301948?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301948?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:45Z","timestamp":1761991545000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301948"}},"issued":{"date-parts":[[2017,8]]},"references-count":32,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2017,8]]}},"alternative-id":["S2213858717301948"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30194-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular and metabolic effects of metformin in patients with type 1 diabetes (REMOVAL): a double-blind, randomised, placebo-controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30194-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30216-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T00:15:25Z","timestamp":1793924125672,"version":"4.8.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,2,1]],"date-time":"2021-02-01T00:00:00Z","timestamp":1612137600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100011541","name":"Division of Cancer Epidemiology and Genetics, National Cancer Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011541","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,2]]},"DOI":"10.1016\/s2213-8587(20)30399-5","type":"journal-article","created":{"date-parts":[[2020,12,18]],"date-time":"2020-12-18T18:41:11Z","timestamp":1608316871000},"page":"94-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study"],"prefix":"10.1016","volume":"9","author":[{"given":"Cari M","family":"Kitahara","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dagrun","family":"Sletteb\u00f8 Daltveit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Ekbom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anders","family":"Engeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Gissler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid","family":"Glimelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Grotmol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ylva","family":"Trolle Lagerros","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Madanat-Harjuoja","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tuija","family":"M\u00e4nnist\u00f6","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik Toft","family":"S\u00f8rensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rebecca","family":"Troisi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tone","family":"Bj\u00f8rge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30399-5_bib2","series-title":"Schottenfeld and Fraumeni Cancer Epidemiology and Prevention","article-title":"Thyroid Cancer","author":"Kitahara","year":"2018"},{"key":"10.1016\/S2213-8587(20)30399-5_bib3","series-title":"Global cancer observatory: cancer today","author":"Ferlay","year":"2018"},{"key":"10.1016\/S2213-8587(20)30399-5_bib4","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/joim.12747","article-title":"The role of pregnancy, perinatal factors and hormones in maternal cancer risk: a review of the evidence","volume":"283","author":"Troisi","year":"2018","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(20)30399-5_bib5","doi-asserted-by":"crossref","first-page":"259","DOI":"10.2307\/3579003","article-title":"Thyroid cancer after exposure to external radiation: a pooled analysis of seven studies","volume":"141","author":"Ron","year":"1995","journal-title":"Radiat Res"},{"key":"10.1016\/S2213-8587(20)30399-5_bib6","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1158\/0008-5472.CAN-13-2228","article-title":"Childhood height and body mass index were associated with risk of adult thyroid cancer in a large cohort study","volume":"74","author":"Kitahara","year":"2014","journal-title":"Cancer Res"},{"key":"10.1016\/S2213-8587(20)30399-5_bib7","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1210\/jc.2018-00847","article-title":"Thyroid cancer and benign nodules after exposure in utero to fallout from chernobyl","volume":"104","author":"Hatch","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30399-5_bib8","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1186\/s12885-015-1425-4","article-title":"Hyperemesis gravidarum and risk of cancer in offspring, a Scandinavian registry-based nested case-control study","volume":"15","author":"Vandraas","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/S2213-8587(20)30399-5_bib9","doi-asserted-by":"crossref","DOI":"10.1016\/j.canep.2019.07.003","article-title":"Birthweight and risk of thyroid cancer and its histological types: a large cohort study","volume":"62","author":"Aarestrup","year":"2019","journal-title":"Cancer Epidemiol"},{"key":"10.1016\/S2213-8587(20)30399-5_bib10","article-title":"Birth characteristics and risk of pediatric thyroid cancer: a population-based record-linkage study in California","author":"Deziel","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(20)30399-5_bib11","doi-asserted-by":"crossref","first-page":"563","DOI":"10.2147\/CLEP.S179083","article-title":"The Danish health care system and epidemiological research: from health care contacts to database records","volume":"11","author":"Schmidt","year":"2019","journal-title":"Clin Epidemiol"},{"key":"10.1016\/S2213-8587(20)30399-5_bib12","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1111\/aogs.12302","article-title":"The Nordic medical birth registers\u2014a potential goldmine for clinical research","volume":"93","author":"Langhoff-Roos","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S2213-8587(20)30399-5_bib13","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1080\/0284186X.2017.1407039","article-title":"Nordic cancer registries - an overview of their procedures and data comparability","volume":"57","author":"Pukkala","year":"2018","journal-title":"Acta Oncol"},{"key":"10.1016\/S2213-8587(20)30399-5_bib14","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1034\/j.1600-0412.2000.079006440.x","article-title":"Birthweight by gestational age in Norway","volume":"79","author":"Skj\u00e6rven","year":"2000","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S2213-8587(20)30399-5_bib15","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1210\/jc.2012-2028","article-title":"Maternal thyroid dysfunction during pregnancy and thyroid function of her child in adolescence","volume":"98","author":"Pakkila","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30399-5_bib16","doi-asserted-by":"crossref","first-page":"2216","DOI":"10.1210\/jc.2017-02599","article-title":"Benign thyroid diseases and risk of thyroid cancer: a nationwide cohort study","volume":"103","author":"Kitahara","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30399-5_bib17","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1038\/nrendo.2012.171","article-title":"Thyroid disorders in pregnancy","volume":"8","author":"Stagnaro-Green","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(20)30399-5_bib18","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/thy.2016.0457","article-title":"2017 Guidelines of the American Thyroid Association for the diagnosis and management of thyroid disease during pregnancy and the postpartum","volume":"27","author":"Alexander","year":"2017","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(20)30399-5_bib19","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1016\/S2213-8587(14)70225-6","article-title":"Iodine deficiency and thyroid disorders","volume":"3","author":"Zimmermann","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30399-5_bib20","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1186\/s13044-015-0020-8","article-title":"Iodine intake as a risk factor for thyroid cancer: a comprehensive review of animal and human studies","volume":"8","author":"Zimmermann","year":"2015","journal-title":"Thyroid Res"},{"key":"10.1016\/S2213-8587(20)30399-5_bib21","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1158\/1055-9965.EPI-13-1210-T","article-title":"Insulin-like growth factor-I and risk of differentiated thyroid carcinoma in the European prospective investigation into cancer and nutrition","volume":"23","author":"Schmidt","year":"2014","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(20)30399-5_bib22","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1093\/aje\/kwf183","article-title":"Accuracy of fetal growth indicators as surrogate measures of steroid hormone levels during pregnancy","volume":"157","author":"Peck","year":"2003","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(20)30399-5_bib23","first-page":"311","article-title":"Pregnancy estriol, estradiol, progesterone and prolactin in relation to birth weight and other birth size variables (United States)","volume":"14","author":"Mucci","year":"2003","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(20)30399-5_bib24","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.yhbeh.2004.06.010","article-title":"Relationships between sex hormones assessed in amniotic fluid, and maternal and umbilical cord serum: what is the best source of information to investigate the effects of fetal hormonal exposure?","volume":"46","author":"van de Beek","year":"2004","journal-title":"Horm Behav"},{"key":"10.1016\/S2213-8587(20)30399-5_bib25","doi-asserted-by":"crossref","first-page":"561","DOI":"10.1097\/AOG.0b013e31822a6c59","article-title":"Maternal obesity and risk of postpartum hemorrhage","volume":"118","author":"Blomberg","year":"2011","journal-title":"Obstet Gynecol"},{"key":"10.1016\/S2213-8587(20)30399-5_bib26","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1210\/jc.2008-0380","article-title":"Cigarette smoking during pregnancy is associated with alterations in maternal and fetal thyroid function","volume":"94","author":"Shields","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30399-5_bib27","doi-asserted-by":"crossref","DOI":"10.1289\/EHP6980","article-title":"Risk of bias assessments and evidence syntheses for observational epidemiologic studies of environmental and occupational exposures: strengths and limitations","volume":"128","author":"Steenland","year":"2020","journal-title":"Environ Health Perspect"},{"key":"10.1016\/S2213-8587(20)30399-5_bib28","article-title":"Breastfeeding, introduction of other foods and effects on health: a systematic literature review for the 5th Nordic nutrition recommendations","author":"H\u00f6rnell","year":"2013","journal-title":"Food Nutr Res"},{"key":"10.1016\/S2213-8587(20)30399-5_bib29","article-title":"Iodine status during pregnancy and at 6 weeks, 6, 12 and 18 months post-partum","author":"Aakre","year":"2020","journal-title":"Matern Child Nutr"},{"key":"10.1016\/S2213-8587(20)30399-5_bib30","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/S2213-8587(20)30115-7","article-title":"Global trends in thyroid cancer incidence and the impact of overdiagnosis","volume":"8","author":"Li","year":"2020","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303995?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303995?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:19Z","timestamp":1761991699000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303995"}},"issued":{"date-parts":[[2021,2]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,2]]}},"alternative-id":["S2213858720303995"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30399-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal health, in-utero, and perinatal exposures and risk of thyroid cancer in offspring: a Nordic population-based nested case-control study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30399-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30426-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:57:33Z","timestamp":1793977053483,"version":"4.8.0"},"reference-count":110,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/s2213-8587(22)00012-2","type":"journal-article","created":{"date-parts":[[2022,3,2]],"date-time":"2022-03-02T19:38:53Z","timestamp":1646249933000},"page":"273-283","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":207,"title":["Osteoporosis in men"],"prefix":"10.1016","volume":"10","author":[{"given":"Tatiane","family":"Vilaca","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Eastell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian","family":"Schini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00012-2_bib1","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.bone.2007.11.001","article-title":"A reference standard for the description of osteoporosis","volume":"42","author":"Kanis","year":"2008","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(22)00012-2_bib2","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s11657-020-0706-y","article-title":"Fragility fractures in Europe: burden, management and opportunities","volume":"15","author":"Borgstr\u00f6m","year":"2020","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(22)00012-2_bib3","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1007\/s00198-005-1970-9","article-title":"Bone mineral density predicts osteoporotic fractures in elderly men: the MINOS study","volume":"16","author":"Szulc","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib4","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005\u20132025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib5","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1007\/s11657-013-0136-1","article-title":"Osteoporosis in the European Union: medical management, epidemiology and economic burden. A report prepared in collaboration with the International Osteoporosis Foundation (IOF) and the European Federation of Pharmaceutical Industry Associations (EFPIA)","volume":"8","author":"Hernlund","year":"2013","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(22)00012-2_bib6","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1359\/JBMR.040109","article-title":"Incidence of hip and other osteoporotic fractures in elderly men and women: Dubbo Osteoporosis Epidemiology Study","volume":"19","author":"Chang","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib7","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1359\/jbmr.2002.17.4.716","article-title":"Incidence of vertebral fracture in europe: results from the European Prospective Osteoporosis Study (EPOS)","volume":"17","author":"Felsenberg","year":"2002","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib8","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1007\/s11657-020-00845-x","article-title":"Elderly men have much lower vertebral fracture risk than elderly women even at advanced age: the MrOS and MsOS (Hong Kong) year 14 follow-up radiology results","volume":"15","author":"W\u00e1ng","year":"2020","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(22)00012-2_bib9","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1359\/JBMR.041133","article-title":"Development and initial validation of a risk score for predicting in-hospital and 1-year mortality in patients with hip fractures","volume":"20","author":"Jiang","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib10","doi-asserted-by":"crossref","first-page":"380","DOI":"10.7326\/0003-4819-152-6-201003160-00008","article-title":"Meta-analysis: excess mortality after hip fracture among older women and men","volume":"152","author":"Haentjens","year":"2010","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1111\/joim.12586","article-title":"Excess mortality after hip fracture in elderly persons from Europe and the USA: the CHANCES project","volume":"281","author":"Katsoulis","year":"2017","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib12","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1001\/jama.2009.50","article-title":"Mortality risk associated with low-trauma osteoporotic fracture and subsequent fracture in men and women","volume":"301","author":"Bliuc","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00012-2_bib13","doi-asserted-by":"crossref","first-page":"2945","DOI":"10.1007\/s00198-016-3616-5","article-title":"Hip fracture, mortality risk, and cause of death over two decades","volume":"27","author":"von Friesendorff","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib14","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1359\/jbmr.090704","article-title":"Potential mediators of the mortality reduction with zoledronic acid after hip fracture","volume":"25","author":"Col\u00f3n-Emeric","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib15","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2009-0852","article-title":"Effect of osteoporosis treatment on mortality: a meta-analysis","volume":"95","author":"Bolland","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00012-2_bib16","doi-asserted-by":"crossref","first-page":"1491","DOI":"10.1001\/jamainternmed.2019.2779","article-title":"Association between drug treatments for patients with osteoporosis and overall mortality rates: a meta-analysis","volume":"179","author":"Cummings","year":"2019","journal-title":"JAMA Intern Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(22)00012-2_bib17","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/BF01623429","article-title":"Peak bone mass","volume":"4","author":"Bonjour","year":"1994","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib18","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1002\/jor.1100080418","article-title":"Differential effects of androgens on cortical bone histomorphometry in gonadectomized male and female rats","volume":"8","author":"Turner","year":"1990","journal-title":"J Orthop Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib19","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1359\/JBMR.041005","article-title":"Males have larger skeletal size and bone mass than females, despite comparable body size","volume":"20","author":"Nieves","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib20","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1359\/jbmr.040916","article-title":"Population-based study of age and sex differences in bone volumetric density, size, geometry, and structure at different skeletal sites","volume":"19","author":"Riggs","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib21","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1002\/jbmr.412","article-title":"Bone mineral accrual from 8 to 30 years of age: an estimation of peak bone mass","volume":"26","author":"Baxter-Jones","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib22","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s00198-008-0672-5","article-title":"Lumbar spine peak bone mass and bone turnover in men and women: a longitudinal study","volume":"20","author":"Walsh","year":"2009","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib23","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/j.bone.2018.03.016","article-title":"Bone turnover markers after the menopause: T-score approach","volume":"111","author":"Gossiel","year":"2018","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(22)00012-2_bib24","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1359\/jbmr.071020","article-title":"A population-based assessment of rates of bone loss at multiple skeletal sites: evidence for substantial trabecular bone loss in young adult women and men","volume":"23","author":"Riggs","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib25","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1016\/j.bone.2013.09.010","article-title":"Reference intervals for serum concentrations of three bone turnover markers for men and women","volume":"57","author":"Michelsen","year":"2013","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(22)00012-2_bib26","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/jbmr.124","article-title":"Association between bone turnover rate and bone microarchitecture in men: the STRAMBO study","volume":"25","author":"Chaitou","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib27","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1359\/JBMR.050916","article-title":"Effects of sex and age on bone microstructure at the ultradistal radius: a population-based noninvasive in vivo assessment","volume":"21","author":"Khosla","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib28","doi-asserted-by":"crossref","first-page":"1541","DOI":"10.1002\/jbmr.2817","article-title":"Age- and sex-related changes in bone microarchitecture and estimated strength: a three-year prospective study using HRpQCT","volume":"31","author":"Shanbhogue","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib29","doi-asserted-by":"crossref","first-page":"1630","DOI":"10.1002\/jbmr.3456","article-title":"Low muscle strength and mass is associated with the accelerated decline of bone microarchitecture at the distal radius in older men: the prospective STRAMBO study","volume":"33","author":"Wagner","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1097\/00003086-198702000-00038","article-title":"The microanatomy of trabecular bone loss in normal aging men and women","volume":"215","author":"Aaron","year":"1987","journal-title":"Clin Orthop Relat Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib31","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/S8756-3282(97)00100-2","article-title":"Modeling the mechanical behavior of vertebral trabecular bone: effects of age-related changes in microstructure","volume":"21","author":"Silva","year":"1997","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(22)00012-2_bib32","first-page":"e5180","article-title":"Bone microarchitecture decline and risk of fall and fracture in men with poor physical performance\u2014the STRAMBO Study","volume":"106","author":"Wagner","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00012-2_bib33","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.bone.2015.10.012","article-title":"Age-related changes in bone strength from HR-pQCT derived microarchitectural parameters with an emphasis on the role of cortical porosity","volume":"83","author":"Vilayphiou","year":"2016","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(22)00012-2_bib34","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1210\/jcem.87.2.8201","article-title":"Age trends in the level of serum testosterone and other hormones in middle-aged men: longitudinal results from the Massachusetts male aging study","volume":"87","author":"Feldman","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00012-2_bib35","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1359\/jbmr.080518","article-title":"Older men with low serum estradiol and high serum SHBG have an increased risk of fractures","volume":"23","author":"Mellstr\u00f6m","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib36","doi-asserted-by":"crossref","first-page":"2191","DOI":"10.1172\/JCI106185","article-title":"Conversion of blood androgens to estrogens in normal adult men and women","volume":"48","author":"Longcope","year":"1969","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(22)00012-2_bib37","doi-asserted-by":"crossref","first-page":"1833","DOI":"10.1359\/jbmr.1997.12.11.1833","article-title":"Endogenous sex steroids and bone mineral density in older women and men: the Rancho Bernardo Study","volume":"12","author":"Greendale","year":"1997","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib38","doi-asserted-by":"crossref","first-page":"576","DOI":"10.1016\/j.tem.2012.03.008","article-title":"Estrogen and the skeleton","volume":"23","author":"Khosla","year":"2012","journal-title":"Trends Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00012-2_bib39","doi-asserted-by":"crossref","first-page":"4314","DOI":"10.1210\/jc.2009-2635","article-title":"Sex steroid hormones in older men: longitudinal associations with 4\u00b75-year change in hip bone mineral density\u2014the osteoporotic fractures in men study","volume":"95","author":"Cauley","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00012-2_bib40","doi-asserted-by":"crossref","first-page":"3908","DOI":"10.1210\/jc.2006-0173","article-title":"Association of testosterone and estradiol deficiency with osteoporosis and rapid bone loss in older men","volume":"91","author":"Fink","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00012-2_bib41","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1172\/JCI10942","article-title":"Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men","volume":"106","author":"Falahati-Nini","year":"2000","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(22)00012-2_bib42","doi-asserted-by":"crossref","first-page":"1114","DOI":"10.1172\/JCI84137","article-title":"Gonadal steroid-dependent effects on bone turnover and bone mineral density in men","volume":"126","author":"Finkelstein","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(22)00012-2_bib43","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jbspin.2011.06.002","article-title":"Reduced levels of serum IGF-1 is related to the presence of osteoporotic fractures in male idiopathic osteoporosis","volume":"79","author":"Paccou","year":"2012","journal-title":"Joint Bone Spine"},{"key":"10.1016\/S2213-8587(22)00012-2_bib44","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/jbmr.281","article-title":"Older men with low serum IGF-1 have an increased risk of incident fractures: the MrOS Sweden study","volume":"26","author":"Ohlsson","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib45","doi-asserted-by":"crossref","first-page":"1864","DOI":"10.1503\/cmaj.100771","article-title":"2010 clinical practice guidelines for the diagnosis and management of osteoporosis in Canada: summary","volume":"182","author":"Papaioannou","year":"2010","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(22)00012-2_bib46","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1210\/jc.2011-3045","article-title":"Osteoporosis in men: an Endocrine Society clinical practice guideline","volume":"97","author":"Watts","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00012-2_bib47","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7326\/0003-4819-148-9-200805060-00008","article-title":"Screening for osteoporosis in men: a clinical practice guideline from the American College of Physicians","volume":"148","author":"Qaseem","year":"2008","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib48","doi-asserted-by":"crossref","first-page":"2521","DOI":"10.1001\/jama.2018.7498","article-title":"Screening for osteoporosis to prevent fractures: US Preventive Services Task Force recommendation statement","volume":"319","author":"Curry","year":"2018","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00012-2_bib49","doi-asserted-by":"crossref","first-page":"2359","DOI":"10.1007\/s00198-014-2794-2","article-title":"Clinician's guide to prevention and treatment of osteoporosis","volume":"25","author":"Cosman","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib50","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1111\/andr.12470","article-title":"EAA clinical guideline on management of bone health in the andrological outpatient clinic","volume":"6","author":"Rochira","year":"2018","journal-title":"Andrology"},{"key":"10.1016\/S2213-8587(22)00012-2_bib51","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1007\/s11657-017-0324-5","article-title":"UK clinical guideline for the prevention and treatment of osteoporosis","volume":"12","author":"Compston","year":"2017","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(22)00012-2_bib53","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1007\/s00198-021-05863-0","article-title":"Opportunistic CT screening predicts individuals at risk of major osteoporotic fracture","volume":"32","author":"Michalski","year":"2021","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib54","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s00198-007-0543-5","article-title":"FRAX and the assessment of fracture probability in men and women from the UK","volume":"19","author":"Kanis","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib55","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1007\/s00198-007-0362-8","article-title":"Development of a nomogram for individualizing hip fracture risk in men and women","volume":"18","author":"Nguyen","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib56","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.b4229","article-title":"Predicting risk of osteoporotic fracture in men and women in England and Wales: prospective derivation and validation of QFractureScores","volume":"339","author":"Hippisley-Cox","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00012-2_bib57","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1007\/s11657-017-0389-1","article-title":"Comparison of fracture risk assessment tools in older men without prior hip or spine fracture: the MrOS study","volume":"12","author":"Gourlay","year":"2017","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(22)00012-2_bib58","doi-asserted-by":"crossref","first-page":"174","DOI":"10.3109\/13685538.2013.875991","article-title":"FRAX calculator and Garvan nomogram in male osteoporotic population","volume":"17","author":"Pluskiewicz","year":"2014","journal-title":"Aging Male"},{"key":"10.1016\/S2213-8587(22)00012-2_bib59","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1007\/s00198-009-1026-7","article-title":"Prognosis of fracture: evaluation of predictive accuracy of the FRAX algorithm and Garvan nomogram","volume":"21","author":"Sandhu","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib60","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1210\/er.2008-0002","article-title":"Osteoporosis in men","volume":"29","author":"Khosla","year":"2008","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(22)00012-2_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/ijms221910834","article-title":"Identification of rare LRP5 variants in a cohort of males with impaired bone mass","volume":"22","author":"Rocca","year":"2021","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(22)00012-2_bib62","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1056\/NEJMoa1308223","article-title":"PLS3 mutations in X-linked osteoporosis with fractures","volume":"369","author":"van Dijk","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib63","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1007\/s00223-001-1049-3","article-title":"Genetics of male osteoporosis","volume":"69","author":"Gennari","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib64","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1056\/NEJMcp0707217","article-title":"Clinical practice. Osteoporosis in men","volume":"358","author":"Ebeling","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib65","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1210\/jc.2018-00229","article-title":"Testosterone therapy in men with hypogonadism: an Endocrine Society clinical practice guideline","volume":"103","author":"Bhasin","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00012-2_bib66","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbo.2020.100311","article-title":"Guidance for the assessment and management of prostate cancer treatment-induced bone loss. a consensus position statement from an expert group","volume":"25","author":"Brown","year":"2020","journal-title":"J Bone Oncol"},{"key":"10.1016\/S2213-8587(22)00012-2_bib67","doi-asserted-by":"crossref","first-page":"2361","DOI":"10.1016\/S0022-5347(05)64985-3","article-title":"Changes in bone mineral density, lean body mass and fat content as measured by dual energy x-ray absorptiometry in patients with prostate cancer without apparent bone metastases given androgen deprivation therapy","volume":"167","author":"Berruti","year":"2002","journal-title":"J Urol"},{"key":"10.1016\/S2213-8587(22)00012-2_bib68","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/S0022-5347(05)68000-7","article-title":"Progressive osteoporosis during androgen deprivation therapy for prostate cancer","volume":"163","author":"Daniell","year":"2000","journal-title":"J Urol"},{"key":"10.1016\/S2213-8587(22)00012-2_bib69","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1016\/j.bone.2008.05.003","article-title":"Incidence and risk factors for low trauma fractures in men with prostate cancer","volume":"43","author":"Ahlborg","year":"2008","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(22)00012-2_bib70","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1002\/jbmr.3653","article-title":"The efficacy and safety of vertebral augmentation: a second ASBMR Task Force report","volume":"34","author":"Ebeling","year":"2019","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib71","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1007\/s00198-019-04852-8","article-title":"Risk of imminent fracture following a previous fracture in a Swedish database study","volume":"30","author":"Banefelt","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib72","doi-asserted-by":"crossref","first-page":"775","DOI":"10.1007\/s00198-016-3868-0","article-title":"Imminent risk of fracture after fracture","volume":"28","author":"Johansson","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib73","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1007\/s11657-020-00784-7","article-title":"Predictors of imminent risk of fracture in Medicare-enrolled men and women","volume":"15","author":"Yusuf","year":"2020","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(22)00012-2_bib74","article-title":"Interventions for preventing falls in older people living in the community","volume":"2012","author":"Gillespie","year":"2012","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(22)00012-2_bib75","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1016\/j.bone.2012.12.045","article-title":"High impact exercise increased femoral neck bone mineral density in older men: a randomised unilateral intervention","volume":"53","author":"Allison","year":"2013","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(22)00012-2_bib76","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1093\/ageing\/afu093","article-title":"National Osteoporosis Society vitamin D guideline summary","volume":"43","author":"Aspray","year":"2014","journal-title":"Age Ageing"},{"key":"10.1016\/S2213-8587(22)00012-2_bib77","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00012-2_bib78","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1111\/joim.12394","article-title":"Calcium supplements: benefits and risks","volume":"278","author":"Reid","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib79","doi-asserted-by":"crossref","first-page":"856","DOI":"10.7326\/M16-1165","article-title":"Calcium intake and cardiovascular disease risk: an updated systematic review and meta-analysis","volume":"165","author":"Chung","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib80","doi-asserted-by":"crossref","first-page":"604","DOI":"10.1056\/NEJM200008313430902","article-title":"Alendronate for the treatment of osteoporosis in men","volume":"343","author":"Orwoll","year":"2000","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib81","doi-asserted-by":"crossref","first-page":"1535","DOI":"10.1016\/S0140-6736(96)07088-2","article-title":"Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures","volume":"348","author":"Black","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00012-2_bib82","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1359\/jbmr.081214","article-title":"Once-weekly risedronate in men with osteoporosis: results of a 2-year, placebo-controlled, double-blind, multicenter study","volume":"24","author":"Boonen","year":"2009","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib83","doi-asserted-by":"crossref","first-page":"1344","DOI":"10.1001\/jama.282.14.1344","article-title":"Effects of risedronate treatment on vertebral and nonvertebral fractures in women with postmenopausal osteoporosis: a randomized controlled trial","volume":"282","author":"Harris","year":"1999","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00012-2_bib84","doi-asserted-by":"crossref","first-page":"1714","DOI":"10.1056\/NEJMoa1204061","article-title":"Fracture risk and zoledronic acid therapy in men with osteoporosis","volume":"367","author":"Boonen","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib85","first-page":"S158-S","article-title":"Effect of once-yearly infusion of zoledronic acid 5 mg in postmenopausal women with osteoporosis","volume":"40","author":"Black","year":"2007","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(22)00012-2_bib86","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1359\/jbmr.2003.18.1.9","article-title":"The effect of teriparatide [human parathyroid hormone (1\u201334)] therapy on bone density in men with osteoporosis","volume":"18","author":"Orwoll","year":"2003","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib87","doi-asserted-by":"crossref","first-page":"1434","DOI":"10.1056\/NEJM200105103441904","article-title":"Effect of parathyroid hormone (1\u201334) on fractures and bone mineral density in postmenopausal women with osteoporosis","volume":"344","author":"Neer","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib88","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1210\/jc.2014-4079","article-title":"A 24-month study evaluating the efficacy and safety of denosumab for the treatment of men with low bone mineral density: results from the ADAMO trial","volume":"100","author":"Langdahl","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00012-2_bib89","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1056\/NEJMoa0809493","article-title":"Denosumab for prevention of fractures in postmenopausal women with osteoporosis","volume":"361","author":"Cummings","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib90","doi-asserted-by":"crossref","first-page":"3183","DOI":"10.1210\/jc.2017-02163","article-title":"A phase III randomized placebo-controlled trial to evaluate efficacy and safety of romosozumab in men with osteoporosis","volume":"103","author":"Lewiecki","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00012-2_bib91","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib92","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S2213-8587(20)30159-5","article-title":"Treatment-related changes in bone mineral density as a surrogate biomarker for fracture risk reduction: meta-regression analyses of individual patient data from multiple randomised controlled trials","volume":"8","author":"Black","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00012-2_bib93","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1056\/NEJMoa074941","article-title":"Zoledronic acid and clinical fractures and mortality after hip fracture","volume":"357","author":"Lyles","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib94","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1007\/s001980050093","article-title":"Updated data on proximal femur bone mineral levels of US adults","volume":"8","author":"Looker","year":"1998","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib95","doi-asserted-by":"crossref","first-page":"2239","DOI":"10.1002\/jbmr.119","article-title":"Efficacy and safety of a once-yearly i.v. Infusion of zoledronic acid 5 mg versus a once-weekly 70-mg oral alendronate in the treatment of male osteoporosis: a randomized, multicenter, double-blind, active-controlled study","volume":"25","author":"Orwoll","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib96","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1111\/jgs.14668","article-title":"Osteoporosis treatment efficacy for men: a systematic review and meta-analysis","volume":"65","author":"Nayak","year":"2017","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(22)00012-2_bib97","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1002\/jbmr.2708","article-title":"Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a Task Force of the American Society for Bone and Mineral Research","volume":"31","author":"Adler","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib98","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1056\/NEJMoa0809003","article-title":"Denosumab in men receiving androgen-deprivation therapy for prostate cancer","volume":"361","author":"Smith","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib99","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/jbmr.4305","article-title":"Treatment with zoledronate subsequent to denosumab in osteoporosis: a 2-year randomized study","volume":"36","author":"S\u00f8lling","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib100","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1007\/s00198-004-1713-3","article-title":"Teriparatide effects on vertebral fractures and bone mineral density in men with osteoporosis: treatment and discontinuation of therapy","volume":"16","author":"Kaufman","year":"2005","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib101","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.1056\/NEJMoa035725","article-title":"The effects of parathyroid hormone, alendronate, or both in men with osteoporosis","volume":"349","author":"Finkelstein","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib102","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1001\/jamainternmed.2016.9539","article-title":"Effect of testosterone treatment on volumetric bone density and strength in older men with low testosterone: a controlled clinical trial","volume":"177","author":"Snyder","year":"2017","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(22)00012-2_bib103","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1007\/s40520-021-01845-8","article-title":"Management of osteoporosis in older men","volume":"33","author":"Kaufman","year":"2021","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib104","doi-asserted-by":"crossref","first-page":"453","DOI":"10.3109\/13697137.2015.1016378","article-title":"Antiresorptives and anabolic therapy in sequence or combination for postmenopausal osteoporosis","volume":"18","author":"Palacios","year":"2015","journal-title":"Climacteric"},{"key":"10.1016\/S2213-8587(22)00012-2_bib105","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1002\/jbmr.3074","article-title":"Addressing the crisis in the treatment of osteoporosis: a path forward","volume":"32","author":"Khosla","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(22)00012-2_bib106","doi-asserted-by":"crossref","first-page":"3872","DOI":"10.1007\/s12325-021-01792-w","article-title":"Gender disparities in osteoporosis screening and management among older adults","volume":"38","author":"Ramachandran","year":"2021","journal-title":"Adv Ther"},{"key":"10.1016\/S2213-8587(22)00012-2_bib107","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.clinthera.2019.05.001","article-title":"Real-world adherence and persistence with bisphosphonate therapy in postmenopausal women: a systematic review","volume":"41","author":"Fardellone","year":"2019","journal-title":"Clin Ther"},{"key":"10.1016\/S2213-8587(22)00012-2_bib108","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1007\/s11657-021-00993-8","article-title":"Insufficient persistence to pharmacotherapy in Japanese patients with osteoporosis: an analysis of the National Database of Health Insurance Claims and Specific Health Checkups in Japan","volume":"16","author":"Nakatoh","year":"2021","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(22)00012-2_bib109","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1007\/s10067-018-4370-1","article-title":"Osteoporosis: a clinical and pharmacological update","volume":"38","author":"Vidal","year":"2019","journal-title":"Clin Rheumatol"},{"key":"10.1016\/S2213-8587(22)00012-2_bib110","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1007\/s00198-017-3906-6","article-title":"Recommendations for the screening of adherence to oral bisphosphonates","volume":"28","author":"Diez-Perez","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(22)00012-2_bib111","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1002\/jbmr.2023","article-title":"Risk factors for treatment failure with antiosteoporosis medication: the global longitudinal study of osteoporosis in women (GLOW)","volume":"29","author":"D\u00edez-P\u00e9rez","year":"2014","journal-title":"J Bone Miner Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000122?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000122?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:36Z","timestamp":1761991836000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000122"}},"issued":{"date-parts":[[2022,4]]},"references-count":110,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2213858722000122"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00012-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Osteoporosis in men","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00012-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,4]],"date-time":"2026-11-04T03:11:06Z","timestamp":1793761866647,"version":"4.6.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/s2213-8587(13)70111-6","type":"journal-article","created":{"date-parts":[[2013,9,23]],"date-time":"2013-09-23T01:18:57Z","timestamp":1379899137000},"page":"284-294","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":203,"title":["Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial"],"prefix":"10.1016","volume":"1","author":[{"given":"Mark R","family":"Rigby","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda A","family":"DiMeglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc S","family":"Rendell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric I","family":"Felner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean M","family":"Dostou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen E","family":"Gitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetanbabu M","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kurt J","family":"Griffin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eva","family":"Tsalikian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla J","family":"Greenbaum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole A","family":"Sherry","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne V","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roshanak","family":"Monzavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M","family":"Willi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Raskin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William E","family":"Russell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Pinckney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Keyes-Elstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Howell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeepta","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noha","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Phippard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gerald T","family":"Nepom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"McNamara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario R","family":"Ehlers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70111-6_bib1","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/nature08933","article-title":"Genetics, pathogenesis and clinical interventions in type 1 diabetes","volume":"464","author":"Bluestone","year":"2010","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(13)70111-6_bib2","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/diacare.26.3.832","article-title":"Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial","volume":"26","author":"Steffes","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70111-6_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(86)91943-4","article-title":"Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial","volume":"2","author":"Feutren","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70111-6_bib4","doi-asserted-by":"crossref","first-page":"779","DOI":"10.2337\/diab.38.6.779","article-title":"Double-blind controlled trial of azathioprine in children with newly diagnosed type I diabetes","volume":"38","author":"Cook","year":"1989","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70111-6_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1542\/peds.85.3.241","article-title":"Cyclosporine A for the treatment of new-onset insulin-dependent diabetes mellitus","volume":"85","author":"Chase","year":"1990","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(13)70111-6_bib6","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1016\/j.coi.2006.09.004","article-title":"Immune therapies of autoimmune diseases: are we approaching a real cure?","volume":"18","author":"Chatenoud","year":"2006","journal-title":"Curr Opin Immunol"},{"key":"10.1016\/S2213-8587(13)70111-6_bib7","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70111-6_bib8","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","article-title":"Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial","volume":"378","author":"Orban","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70111-6_bib9","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70111-6_bib10","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(11)60931-8","article-title":"Teplizumab for treatment of type 1 diabetes (Protege study): 1-year results from a randomised, placebo-controlled trial","volume":"378","author":"Sherry","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70111-6_bib11","doi-asserted-by":"crossref","DOI":"10.2337\/db13-0345","article-title":"Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: Metabolic and immunologic features at baseline identify a subgroup of responders","author":"Herold","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70111-6_bib12","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1016\/S0140-6736(13)60023-9","article-title":"Interleukin-1 antagonism in type 1 diabetes of recent onset: two multicentre, randomised, double-blind, placebo-controlled trials","volume":"381","author":"Moran","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70111-6_bib13","doi-asserted-by":"crossref","first-page":"746","DOI":"10.1038\/nm.1993","article-title":"Alefacept promotes co-stimulation blockade based allograft survival in nonhuman primates","volume":"15","author":"Weaver","year":"2009","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(13)70111-6_bib14","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/1479-5876-5-27","article-title":"Alefacept (anti-CD2) causes a selective reduction in circulating effector memory T cells (Tem) and relative preservation of central memory T cells (Tcm) in psoriasis","volume":"5","author":"Chamian","year":"2007","journal-title":"J Transl Med"},{"key":"10.1016\/S2213-8587(13)70111-6_bib15","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1517\/14712598.2.4.431","article-title":"Selective targeting of T cell subsets: focus on alefacept\u2014a remittive therapy for psoriasis","volume":"2","author":"Krueger","year":"2002","journal-title":"Expert Opin Biol Ther"},{"key":"10.1016\/S2213-8587(13)70111-6_bib16","first-page":"624","article-title":"Remittive effects of intramuscular alefacept in psoriasis","volume":"2","author":"Gordon","year":"2003","journal-title":"J Drugs Dermatol"},{"key":"10.1016\/S2213-8587(13)70111-6_bib17","doi-asserted-by":"crossref","first-page":"816","DOI":"10.1016\/S0190-9622(03)01836-X","article-title":"CD4+ T-cell-directed antibody responses are maintained in patients with psoriasis receiving alefacept: results of a randomized study","volume":"49","author":"Gottlieb","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S2213-8587(13)70111-6_bib18","doi-asserted-by":"crossref","first-page":"784","DOI":"10.1046\/j.1365-2133.2003.05239.x","article-title":"Alefacept therapy produces remission for patients with chronic plaque psoriasis","volume":"148","author":"Krueger","year":"2003","journal-title":"Br J Dermatol"},{"issue":"suppl","key":"10.1016\/S2213-8587(13)70111-6_bib19","doi-asserted-by":"crossref","first-page":"S87","DOI":"10.1016\/mjd.2003.552","article-title":"Development and use of alefacept to treat psoriasis","volume":"49","author":"Krueger","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"10.1016\/S2213-8587(13)70111-6_bib20","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1056\/NEJM200107263450403","article-title":"Treatment of chronic plaque psoriasis by selective targeting of memory effector T lymphocytes","volume":"345","author":"Ellis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70111-6_bib21","doi-asserted-by":"crossref","first-page":"2075","DOI":"10.1073\/pnas.0409569102","article-title":"Alefacept reduces infiltrating T cells, activated dendritic cells, and inflammatory genes in psoriasis vulgaris","volume":"102","author":"Chamian","year":"2005","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(13)70111-6_bib22","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1001\/archderm.139.12.1563","article-title":"Treatment of psoriasis with alefacept: correlation of clinical improvement with reductions of memory T-cell counts","volume":"139","author":"Gordon","year":"2003","journal-title":"Arch Dermatol"},{"key":"10.1016\/S2213-8587(13)70111-6_bib23","doi-asserted-by":"crossref","first-page":"e26471","DOI":"10.1371\/journal.pone.0026471","article-title":"Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes","volume":"6","author":"Lachin","year":"2011","journal-title":"PloS One"},{"key":"10.1016\/S2213-8587(13)70111-6_bib25","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2337\/diabetes.53.2.426","article-title":"Insulin secretion in type 1 diabetes","volume":"53","author":"Steele","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70111-6_bib26","doi-asserted-by":"crossref","first-page":"2066","DOI":"10.2337\/db11-1538","article-title":"Fall in C-peptide during first 2 years from diagnosis: evidence of at least two distinct phases from composite Type 1 Diabetes TrialNet data","volume":"61","author":"Greenbaum","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70111-6_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70065-2","article-title":"Antithymocyte globulin therapy for patients with recent-onset type 1 diabetes: a randomized double-blind phase 2 trial","author":"Gitelman","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70111-6_bib28","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1002\/(SICI)1099-0895(199607)12:2<103::AID-DMR157>3.0.CO;2-2","article-title":"The BB\/Wor rat and the balance hypothesis of autoimmunity","volume":"12","author":"Mordes","year":"1996","journal-title":"Diabetes Metab Rev"},{"key":"10.1016\/S2213-8587(13)70111-6_bib29","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/j.1600-065X.2009.00775.x","article-title":"Regulating the regulators: costimulatory signals control the homeostasis and function of regulatory T cells","volume":"229","author":"Bour-Jordan","year":"2009","journal-title":"Immunol Rev"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701116?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701116?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,6]],"date-time":"2022-03-06T16:27:59Z","timestamp":1646584079000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701116"}},"issued":{"date-parts":[[2013,12]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2213858713701116"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70111-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting of memory T cells with alefacept in new-onset type 1 diabetes (T1DAL study): 12 month results of a randomised, double-blind, placebo-controlled phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70111-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70123-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,29]],"date-time":"2026-10-29T05:04:16Z","timestamp":1793250256782,"version":"4.5.0"},"reference-count":138,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,12,1]],"date-time":"2018-12-01T00:00:00Z","timestamp":1543622400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001411","name":"Indian Council of Medical Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001411","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012358","name":"Collaboration for Leadership in Applied Health Research and Care - Greater Manchester","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100012358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001409","name":"Department of Science and Technology, Ministry of Science and Technology, India","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001409","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020013","name":"NIHR Leicester Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020013","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,12]]},"DOI":"10.1016\/s2213-8587(18)30199-2","type":"journal-article","created":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T19:03:30Z","timestamp":1538420610000},"page":"979-991","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":67,"title":["Clinical management of type 2 diabetes in south Asia"],"prefix":"10.1016","volume":"6","author":[{"given":"Anoop","family":"Misra","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nikhil","family":"Tandon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Usha","family":"Shrivastava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naval K","family":"Vikram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew P","family":"Hills","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"11 suppl 1","key":"10.1016\/S2213-8587(18)30199-2_bib1","doi-asserted-by":"crossref","first-page":"S9","DOI":"10.1210\/jc.2008-1595","article-title":"Obesity and the metabolic syndrome in developing countries","volume":"93","author":"Misra","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30199-2_bib2","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1038\/ijo.2010.135","article-title":"Obesity-related non-communicable diseases: south Asians vs white Caucasians","volume":"35","author":"Misra","year":"2011","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(18)30199-2_bib3","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1089\/dia.2012.0259","article-title":"Associations of \u03b2-cell function and insulin resistance with youth-onset type 2 diabetes and prediabetes among Asian Indians","volume":"15","author":"Mohan","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(18)30199-2_bib4","doi-asserted-by":"crossref","first-page":"j1420","DOI":"10.1136\/bmj.j1420","article-title":"Diabetes, cardiovascular disease, and chronic kidney disease in south Asia: current status and future directions","volume":"357","author":"Misra","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30199-2_bib5","doi-asserted-by":"crossref","first-page":"1153","DOI":"10.1111\/dme.12540","article-title":"Diabetes in south Asians","volume":"31","author":"Misra","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30204-3","article-title":"Epidemiology and determinants of type 2 diabetes in south Asia","author":"Hills","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30199-2_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30203-1","article-title":"Public health and health systems: implications for the prevention and management of type 2 diabetes in south Asia","author":"Hills","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30199-2_bib8","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1089\/dia.2014.0018","article-title":"Glycemic control among individuals with self-reported diabetes in India\u2014the ICMR\u2013INDIAB Study","volume":"16","author":"Unnikrishnan","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(18)30199-2_bib9","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1111\/nhs.12179","article-title":"Cross-sectional study of glycemic control among adults with type 2 diabetes","volume":"17","author":"Amarasekara","year":"2015","journal-title":"Nurs Health Sci"},{"key":"10.1016\/S2213-8587(18)30199-2_bib10","first-page":"8","article-title":"Association between diabetes-related knowledge and medication adherence: results from cross-sectional analysis","volume":"22","author":"Nazir","year":"2016","journal-title":"Altern Ther Health Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib11","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1016\/j.diabres.2016.07.030","article-title":"Association of good glycemic control and cost of diabetes care: experience from a tertiary care hospital in Bangladesh","volume":"120","author":"Afroz","year":"2016","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30199-2_bib12","first-page":"79","article-title":"Frequency of chronic complications of type II diabetes","volume":"14","author":"Basit","year":"2004","journal-title":"J Coll Physicians Surg Pak"},{"key":"10.1016\/S2213-8587(18)30199-2_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.4103\/2230-8210.129715","article-title":"Current status of management, control, complications and psychosocial aspects of patients with diabetes in India: results from the DiabCare India 2011 study","volume":"18","author":"Mohan","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30199-2_bib14","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1111\/1753-0407.12378","article-title":"Epidemiology of microvascular complications of diabetes in south Asians and comparison with other ethnicities","volume":"8","author":"Gupta","year":"2016","journal-title":"J Diabetes"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30199-2_bib15","doi-asserted-by":"crossref","first-page":"S329","DOI":"10.1016\/j.dsx.2017.03.010","article-title":"Frequency and pattern of chronic complications of diabetes and their association with glycemic control among adults with type 2 diabetes in Bangladesh","volume":"11","author":"Selim","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(18)30199-2_bib16","doi-asserted-by":"crossref","first-page":"31704","DOI":"10.3402\/gha.v9.31704","article-title":"Challenges in diabetes mellitus type 2 management in Nepal: a literature review","volume":"9","author":"Gyawali","year":"2016","journal-title":"Glob Health Action"},{"key":"10.1016\/S2213-8587(18)30199-2_bib17","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12913-015-1026-6","article-title":"A first country-wide review of diabetes mellitus care in Bhutan: time to do better","volume":"15","author":"Zam","year":"2015","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(18)30199-2_bib18","doi-asserted-by":"crossref","first-page":"10","DOI":"10.17987\/icfj.v8i0.285","article-title":"Epidemiology of macrovascular complications of diabetes in south Asians and comparison with other ethnicities","volume":"8","author":"Gupta","year":"2016","journal-title":"Int Cardiovasc Forum J"},{"key":"10.1016\/S2213-8587(18)30199-2_bib19","doi-asserted-by":"crossref","first-page":"585","DOI":"10.1016\/S2213-8587(17)30174-2","article-title":"Prevalence of diabetes and prediabetes in 15 states of India: results from the ICMR\u2013INDIAB population-based cross-sectional study","volume":"5","author":"Anjana","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30199-2_bib20","doi-asserted-by":"crossref","first-page":"e0149437","DOI":"10.1371\/journal.pone.0149437","article-title":"Disparities in prevalence of cardiometabolic risk factors in rural, urban-poor, and urban-middle class women in India","volume":"11","author":"Mohan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30199-2_bib21","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1111\/1753-0407.12316","article-title":"Socioeconomic factors relating to diabetes and its management in India","volume":"8","author":"Shrivastava","year":"2016","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(18)30199-2_bib22","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1111\/1753-0407.12547","article-title":"Diabetes and tuberculosis: an important relationship","volume":"9","author":"Bloomgarden","year":"2017","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(18)30199-2_bib23","first-page":"148","article-title":"Increased prevalence of type II diabetes mellitus in hepatitis C virus infection in western India","volume":"29","author":"Amarapurkar","year":"2008","journal-title":"Trop Gastroenterol"},{"key":"10.1016\/S2213-8587(18)30199-2_bib24","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jiph.2011.03.005","article-title":"Diabetes mellitus and HIV as co-morbidities in tuberculosis patients of rural south India","volume":"43","author":"Gupta","year":"2011","journal-title":"J Infect Public Health"},{"key":"10.1016\/S2213-8587(18)30199-2_bib25","first-page":"798","article-title":"Investigating the awareness level about diabetes mellitus and associated factors in Tarlai (rural Islamabad)","volume":"59","author":"Ulvi","year":"2009","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/S2213-8587(18)30199-2_bib26","doi-asserted-by":"crossref","first-page":"379","DOI":"10.4103\/2230-8210.131191","article-title":"Knowledge and awareness of diabetes in urban and rural India: the Indian Council of Medical Research India Diabetes Study (phase I): Indian Council of Medical Research India Diabetes 4","volume":"18","author":"Deepa","year":"2014","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30199-2_bib27","doi-asserted-by":"crossref","first-page":"e0118365","DOI":"10.1371\/journal.pone.0118365","article-title":"Awareness, treatment, and control of diabetes in Bangladesh: a nationwide population-based study","volume":"10","author":"Rahman","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30199-2_bib28","first-page":"347","article-title":"Identifying needs and barriers to diabetes education in patients with diabetes","volume":"56","author":"Rafique","year":"2006","journal-title":"J Pak Med Assoc"},{"key":"10.1016\/S2213-8587(18)30199-2_bib29","doi-asserted-by":"crossref","first-page":"e000048","DOI":"10.1136\/bmjdrc-2014-000048","article-title":"Prevalence of diabetes and cardiovascular risk factors in middle-class urban participants in India","volume":"2","author":"Gupta","year":"2014","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(18)30199-2_bib30","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1111\/1753-0407.12294","article-title":"Prediabetes, diagnosed and undiagnosed diabetes, their risk factors and association with knowledge of diabetes in rural Bangladesh: the Bangladesh Population-based Diabetes and Eye Study","volume":"8","author":"Islam","year":"2016","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(18)30199-2_bib31","doi-asserted-by":"crossref","first-page":"e46502","DOI":"10.1371\/journal.pone.0046502","article-title":"High diabetes prevalence among tuberculosis cases in Kerala, India","volume":"7","author":"Balakrishnan","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30199-2_bib32","doi-asserted-by":"crossref","first-page":"268","DOI":"10.4103\/2230-8210.85578","article-title":"Ramadan and diabetes: As-Saum (the fasting)","volume":"15","author":"Jaleel","year":"2011","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30199-2_bib33","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1038\/ejcn.2017.92","article-title":"Abdominal obesity and type 2 diabetes in Asian Indians: dietary strategies including edible oils, cooking practices and sugar intake","volume":"71","author":"Gulati","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(18)30199-2_bib34","doi-asserted-by":"crossref","first-page":"338","DOI":"10.2337\/dc16-1616","article-title":"Life expectancy and cause-specific mortality in type 2 diabetes: a population-based cohort study quantifying relationships in ethnic subgroups","volume":"40","author":"Wright","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30199-2_bib35","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.2337\/diacare.28.11.2673","article-title":"Resistance to insulin therapy among patients and providers: results of the cross-national Diabetes Attitudes, Wishes, and Needs (DAWN) study","volume":"28","author":"Peyrot","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30199-2_bib36","doi-asserted-by":"crossref","first-page":"329","DOI":"10.4103\/2230-8210.180000","article-title":"Adherence to diabetes care processes at general practices in the National Capital Region\u2013Delhi, India","volume":"20","author":"Shivashankar","year":"2016","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30199-2_bib37","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1016\/S2213-8587(16)30010-9","article-title":"The changing face of diabetes complications","volume":"4","author":"Gregg","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30199-2_bib38","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1111\/dme.12242","article-title":"Diabetes attitudes, wishes and needs second study (DAWN2): cross-national comparisons on barriers and resources for optimal care\u2014healthcare professional perspective","volume":"30","author":"Holt","year":"2013","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib39","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s00125-005-0048-8","article-title":"Patient and provider perceptions of care for diabetes: results of the cross-national DAWN study","volume":"49","author":"Peyrot","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30199-2_bib40","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.diabres.2014.11.004","article-title":"Quality of diabetes care in low- and middle-income Asian and Middle Eastern countries (1993\u20132012): 20-year systematic review","volume":"107","author":"Shivashankar","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30199-2_bib41","doi-asserted-by":"crossref","first-page":"e106522","DOI":"10.1371\/journal.pone.0106522","article-title":"Health system challenges in organizing quality diabetes care for urban poor in South India","volume":"9","author":"Bhojani","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30199-2_bib42","series-title":"National programme for prevention and control of cancer, diabetes, cardiovascular diseases and stroke (NPCDCS). Operational guidelines","year":"2013"},{"key":"10.1016\/S2213-8587(18)30199-2_bib43","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1089\/dia.2017.0286","article-title":"Rising costs of drug\/insulin treatment for diabetes: a perspective from India","volume":"19","author":"Misra","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(18)30199-2_bib44","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1111\/j.1464-5491.2012.03669.x","article-title":"Insulin initiation and management in people with type 2 diabetes in an ethnically diverse population: the healthcare provider perspective","volume":"29","author":"Patel","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib45","first-page":"166","article-title":"Effect of temperature on the potency & pharmacological action of insulin","volume":"130","author":"Vimalavathini","year":"2009","journal-title":"Indian J Med Res"},{"key":"10.1016\/S2213-8587(18)30199-2_bib46","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.1111\/dme.13194","article-title":"Insulin storage in hot climates without refrigeration: temperature reduction efficacy of clay pots and other techniques","volume":"33","author":"Ogle","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib47","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s40360-015-0043-8","article-title":"Availability of medicines in public sector health facilities of two North Indian States","volume":"16","author":"Prinja","year":"2015","journal-title":"BMC Pharmacol Toxicol"},{"key":"10.1016\/S2213-8587(18)30199-2_bib48","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1186\/s12913-016-1969-2","article-title":"Availability of essential medicines in selected public, primary and secondary health care institutions of a rural Sri Lankan district: a spot survey","volume":"17","author":"Rathish","year":"2017","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(18)30199-2_bib49","series-title":"Medicines in health care delivery Nepal","year":"2015"},{"key":"10.1016\/S2213-8587(18)30199-2_bib50","series-title":"Medicines in health care delivery Bangladesh","year":"2014"},{"key":"10.1016\/S2213-8587(18)30199-2_bib51","series-title":"Health for all: the journey of universal health coverage","article-title":"Primary health care reforms in Sri Lanka: aiming at preserving universal access to health","author":"Perera","year":"2015"},{"key":"10.1016\/S2213-8587(18)30199-2_bib52","doi-asserted-by":"crossref","first-page":"688","DOI":"10.1038\/ejcn.2013.70","article-title":"Overweight, obesity and related non-communicable diseases in Asian Indian girls and women","volume":"67","author":"Chopra","year":"2013","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(18)30199-2_bib53","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1093\/fampra\/cml066","article-title":"Promoting physical activity among south Asian women with coronary heart disease and diabetes: what might help?","volume":"24","author":"Sriskantharajah","year":"2007","journal-title":"Fam Pract"},{"key":"10.1016\/S2213-8587(18)30199-2_bib54","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/ppe.12209","article-title":"Racial\/ethnic differences in gestational diabetes prevalence and contribution of common risk factors","volume":"29","author":"Pu","year":"2015","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/S2213-8587(18)30199-2_bib55","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1016\/j.puhe.2006.04.010","article-title":"Knowledge, attitude and practice of complementary and alternative medicines for diabetes","volume":"120","author":"Kumar","year":"2006","journal-title":"Public Health"},{"key":"10.1016\/S2213-8587(18)30199-2_bib56","doi-asserted-by":"crossref","first-page":"374","DOI":"10.1186\/1472-6882-14-374","article-title":"Use of complementary and alternative medicines (CAMs) among type 2 diabetes patients in Sri Lanka: a cross sectional survey","volume":"14","author":"Medagama","year":"2014","journal-title":"BMC Complement Altern Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib57","first-page":"1178","article-title":"Alternative medicine; the tendency of using complimentary alternative medicine in patients of different hospitals of Lahore, Pakistan","volume":"21","author":"Khan","year":"2014","journal-title":"Prof Med J"},{"key":"10.1016\/S2213-8587(18)30199-2_bib58","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1016\/j.dsx.2018.04.008","article-title":"The benefits of yoga practice compared to physical exercise in the management of type 2 diabetes mellitus: a systematic review and meta-analysis","volume":"12","author":"Jayawardena","year":"2018","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(18)30199-2_bib59","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1016\/S2213-8587(15)00515-X","article-title":"Alternative medicines for diabetes in India: maximum hype, minimum science","volume":"4","author":"Misra","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30199-2_bib60","article-title":"Ayurvedic treatments for diabetes mellitus","volume":"12","author":"Sridharan","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(18)30199-2_bib61","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1089\/dia.2010.0198","article-title":"Consensus dietary guidelines for healthy living and prevention of obesity, the metabolic syndrome, diabetes, and related disorders in Asian Indians","volume":"13","author":"Misra","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(18)30199-2_bib62","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1089\/dia.2011.0111","article-title":"Consensus physical activity guidelines for Asian Indians","volume":"14","author":"Misra","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(18)30199-2_bib63","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30199-2_bib64","doi-asserted-by":"crossref","unstructured":"Gulati S, Misra A, Pandey RM. Effect of almond supplementation on glycemic and cardiovascular risk factors in Asian Indians in north India with type 2 diabetes mellitus: a 24-week prospective cohort study. Metab Syndr Relat Disord 15: 98\u2013105.","DOI":"10.1089\/met.2016.0066"},{"key":"10.1016\/S2213-8587(18)30199-2_bib65","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.nut.2013.08.005","article-title":"Effects of pistachio nuts on body composition, metabolic, inflammatory and oxidative stress parameters in Asian Indians with metabolic syndrome: a 24-wk, randomized control trial","volume":"30","author":"Gulati","year":"2014","journal-title":"Nutrition"},{"key":"10.1016\/S2213-8587(18)30199-2_bib66","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1017\/S0007114517001295","article-title":"Effect of high-protein meal replacement on weight and cardiometabolic profile in overweight\/obese Asian Indians in North India","volume":"117","author":"Gulati","year":"2017","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(18)30199-2_bib67","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1016\/j.foodchem.2016.06.021","article-title":"Effect of heating\/reheating of fats\/oils, as used by Asian Indians, on trans fatty acid formation","volume":"212","author":"Bhardwaj","year":"2016","journal-title":"Food Chem"},{"key":"10.1016\/S2213-8587(18)30199-2_bib68","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/dia.2013.0259","article-title":"Effect of brown rice, white rice, and brown rice with legumes on blood glucose and insulin responses in overweight Asian Indians: a randomized controlled trial","volume":"16","author":"Mohan","year":"2014","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(18)30199-2_bib69","first-page":"14","article-title":"Diabetes self-care activities: a community-based survey in urban southern India","volume":"25","author":"Gopichandran","year":"2012","journal-title":"Natl Med J India"},{"key":"10.1016\/S2213-8587(18)30199-2_bib70","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1111\/j.1467-789X.2009.00692.x","article-title":"Resistance training for obese, type 2 diabetic adults: a review of the evidence","volume":"11","author":"Hills","year":"2010","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(18)30199-2_bib71","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.2337\/dc07-2316","article-title":"Effect of supervised progressive resistance-exercise training protocol on insulin sensitivity, glycemia, lipids, and body composition in Asian Indians with type 2 diabetes","volume":"31","author":"Misra","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30199-2_bib72","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1136\/pgmj.2008.067975","article-title":"Causes of mortality in diabetes mellitus: data from a tertiary teaching hospital in India","volume":"85","author":"Zargar","year":"2009","journal-title":"Postgrad Med J"},{"issue":"1 suppl 1","key":"10.1016\/S2213-8587(18)30199-2_bib73","doi-asserted-by":"crossref","first-page":"S144","DOI":"10.1016\/j.dsx.2015.10.012","article-title":"Prevalence of hypoglycemia among diabetic old age home residents in South India","volume":"10","author":"Chandrakumar","year":"2016","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(18)30199-2_bib74","doi-asserted-by":"crossref","first-page":"1237","DOI":"10.1185\/03007995.2011.578245","article-title":"Hypoglycaemia in sulphonylurea-treated subjects with type 2 diabetes undergoing Ramadan fasting: a five-country observational study","volume":"27","author":"Aravind","year":"2011","journal-title":"Curr Med Res Opin"},{"key":"10.1016\/S2213-8587(18)30199-2_bib75","doi-asserted-by":"crossref","first-page":"11","DOI":"10.3329\/bmrcb.v37i1.7793","article-title":"Evaluation of management, control, complications and psychosocial aspects of diabetics in Bangladesh: DiabCare Bangladesh 2008","volume":"37","author":"Latif","year":"2011","journal-title":"Bangladesh Med Res Counc Bull"},{"key":"10.1016\/S2213-8587(18)30199-2_bib76","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1046\/j.1464-5491.2002.00833.x","article-title":"The status of diabetes control in Asia\u2014a cross-sectional survey of 24\u2008317 patients with diabetes mellitus in 1998","volume":"19","author":"Chuang","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib77","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.2337\/dc06-0003","article-title":"South-Asian type 2 diabetic patients have higher incidence and faster progression of renal disease compared with Dutch-European diabetic patients","volume":"29","author":"Chandie Shaw","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30199-2_bib78","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1093\/ndt\/16.2.286","article-title":"Variation in the progression of diabetic nephropathy according to racial origin","volume":"16","author":"Earle","year":"2001","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(18)30199-2_bib79","first-page":"154","article-title":"Ethnic differences among Chinese, Malay and Indian patients with type 2 diabetes mellitus in Singapore","volume":"45","author":"Hong","year":"2004","journal-title":"Singapore Med J"},{"key":"10.1016\/S2213-8587(18)30199-2_bib80","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/j.ajo.2005.08.063","article-title":"Diabetic retinopathy in a multi-ethnic cohort in the United States","volume":"141","author":"Wong","year":"2006","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S2213-8587(18)30199-2_bib81","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/j.diabet.2009.06.002","article-title":"Epidemiology of diabetic retinopathy: expected vs reported prevalence of cases in the French population","volume":"35","author":"Delcourt","year":"2009","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(18)30199-2_bib82","doi-asserted-by":"crossref","first-page":"e39608","DOI":"10.1371\/journal.pone.0039608","article-title":"Ethnic variation in the prevalence of visual impairment in people attending diabetic retinopathy screening in the United Kingdom (DRIVE UK)","volume":"7","author":"Sivaprasad","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30199-2_bib83","doi-asserted-by":"crossref","first-page":"410","DOI":"10.2337\/dc08-1422","article-title":"Higher prevalence of retinopathy in diabetic patients of south Asian ethnicity compared with white Europeans in the community: a cross-sectional study","volume":"32","author":"Raymond","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30199-2_bib84","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1038\/sj.eye.6700629","article-title":"Impact of age and duration on sight-threatening retinopathy in south Asians and Caucasians attending a diabetic clinic","volume":"18","author":"Pardhan","year":"2004","journal-title":"Eye (Lond)"},{"key":"10.1016\/S2213-8587(18)30199-2_bib85","doi-asserted-by":"crossref","first-page":"708","DOI":"10.2337\/dc07-1657","article-title":"Retinal vascular lesions in patients of Caucasian and Asian origin with type 2 diabetes: baseline results from the ADVANCE Retinal Measurements (AdRem) study","volume":"31","author":"Stolk","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30199-2_bib86","doi-asserted-by":"crossref","first-page":"7586","DOI":"10.1167\/iovs.11-7698","article-title":"Racial differences in the prevalence of diabetes but not diabetic retinopathy in a multi-ethnic Asian population","volume":"52","author":"Chiang","year":"2011","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(18)30199-2_bib87","first-page":"775","article-title":"Vitamin B12 deficiency and hyperhomocysteinemia in rural and urban Indians","volume":"54","author":"Yajnik","year":"2006","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(18)30199-2_bib88","doi-asserted-by":"crossref","first-page":"2500","DOI":"10.2337\/dc13-2966","article-title":"Ethnic-specific obesity cutoffs for diabetes risk: cross-sectional study of 490\u2008288 UK Biobank participants","volume":"37","author":"Ntuk","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30199-2_bib89","doi-asserted-by":"crossref","first-page":"286","DOI":"10.1001\/jama.297.3.286","article-title":"Risk factors for early myocardial infarction in south Asians compared with individuals in other countries","volume":"297","author":"Joshi","year":"2007","journal-title":"JAMA"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(18)30199-2_bib90","doi-asserted-by":"crossref","first-page":"S430","DOI":"10.4103\/2230-8210.104119","article-title":"Improving management practices and clinical outcomes in type 2 diabetes study: prevalence of complications in people with type 2 diabetes in India","volume":"16","author":"Das","year":"2012","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30199-2_bib91","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.jcin.2013.11.013","article-title":"Mortality in south Asians and Caucasians after percutaneous coronary intervention in the United Kingdom: an observational cohort study of 279,256 patients from the BCIS (British Cardiovascular Intervention Society) National Database","volume":"7","author":"Jones","year":"2014","journal-title":"JACC Cardiovasc Interv"},{"key":"10.1016\/S2213-8587(18)30199-2_bib92","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1016\/S2213-8587(15)00326-5","article-title":"Type 2 diabetes in migrant south Asians: mechanisms, mitigation, and management","volume":"3","author":"Sattar","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30199-2_bib93","doi-asserted-by":"crossref","first-page":"2866","DOI":"10.1007\/s00125-006-0469-z","article-title":"Ethnicity modifies the association between diabetes mellitus and ischaemic heart disease in Chinese, Malays and Asian Indians living in Singapore","volume":"49","author":"Yeo","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30199-2_bib94","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1177\/1358863X11400781","article-title":"Distribution of ankle\u2013brachial index and the risk factors of peripheral artery disease in a multi-ethnic Asian population","volume":"16","author":"Subramaniam","year":"2011","journal-title":"Vasc Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib95","doi-asserted-by":"crossref","first-page":"2532","DOI":"10.1016\/S0140-6736(16)31357-5","article-title":"Interpretation of the evidence for the efficacy and safety of statin therapy","volume":"388","author":"Collins","year":"2016","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30199-2_bib96","doi-asserted-by":"crossref","first-page":"818","DOI":"10.1056\/NEJMoa1311890","article-title":"Cardiovascular risk and events in 17 low-, middle-, and high-income countries","volume":"371","author":"Yusuf","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib97","first-page":"939","article-title":"2016 European Guidelines on cardiovascular disease prevention in clinical practice","volume":"69","author":"Piepoli","year":"2016","journal-title":"Rev Esp Cardiol (Engl Ed)"},{"key":"10.1016\/S2213-8587(18)30199-2_bib98","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1001\/jama.2014.18574","article-title":"Blood pressure lowering in type 2 diabetes: a systematic review and meta-analysis","volume":"313","author":"Emdin","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30199-2_bib99","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30002-0","article-title":"Personalised blood pressure ranges in type 2 diabetes?","author":"Rutter","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30199-2_bib100","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1136\/bmj.317.7160.703","article-title":"Tight blood pressure control and risk of macrovascular and microvascular complications in type 2 diabetes: UKPDS 38","volume":"317","year":"1998","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30199-2_bib101","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1111\/j.1464-5491.2006.01843.x","article-title":"Effect of pioglitazone on insulin sensitivity, vascular function and cardiovascular inflammatory markers in insulin-resistant non-diabetic Asian Indians","volume":"23","author":"Raji","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib102","doi-asserted-by":"crossref","first-page":"e32","DOI":"10.1016\/j.diabres.2015.05.030","article-title":"Effect of low dose pioglitazone on glycemic control and insulin resistance in type 2 diabetes: a randomized, double blind, clinical trial","volume":"109","author":"Rajagopalan","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30199-2_bib103","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1056\/NEJMoa1506930","article-title":"Pioglitazone after ischemic stroke or transient ischemic attack","volume":"374","author":"Kernan","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib104","doi-asserted-by":"crossref","first-page":"346","DOI":"10.1089\/dia.2015.0308","article-title":"A proposed India-specific algorithm for management of type 2 diabetes","volume":"18","year":"2016","journal-title":"Diabetes Technol Ther"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(18)30199-2_bib105","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s13410-018-0604-7","article-title":"RSSDI clinical practice recommendations for the management of type 2 diabetes mellitus 2017","volume":"38","author":"Bajaj","year":"2018","journal-title":"Int J Diabetes Dev Ctries"},{"key":"10.1016\/S2213-8587(18)30199-2_bib106","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib107","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 Diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib108","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1177\/1534734613486153","article-title":"Managing diabetic foot infection in India","volume":"12","author":"Viswanathan","year":"2013","journal-title":"Int J Low Extrem Wounds"},{"key":"10.1016\/S2213-8587(18)30199-2_bib109","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.2337\/dc17-1795","article-title":"Gaps in guidelines for the management of diabetes in low- and middle-income versus high-income countries\u2014a systematic review","volume":"41","author":"Owolabi","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30199-2_bib111","article-title":"80% of Indian population not covered under any health insurance","author":"Singh","year":"2016","journal-title":"Times of India"},{"key":"10.1016\/S2213-8587(18)30199-2_bib112","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.diabres.2008.11.027","article-title":"Cost of medical care among type 2 diabetic patients with a co-morbid condition\u2014hypertension in India","volume":"83","author":"Tharkar","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30199-2_bib113","series-title":"IDF Diabetes Atlas","year":"2017"},{"key":"10.1016\/S2213-8587(18)30199-2_bib114","first-page":"667","article-title":"Direct cost of ambulatory care of type 2 diabetes in the middle and high income group populace of Delhi: the DEDICOM survey","volume":"56","author":"Kumar","year":"2008","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(18)30199-2_bib115","doi-asserted-by":"crossref","first-page":"e000033","DOI":"10.1136\/bmjgh-2016-000033","article-title":"Healthcare use and expenditure for diabetes in Bangladesh","volume":"2","author":"Shariful Islam","year":"2017","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S2213-8587(18)30199-2_bib116","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1186\/1472-6963-7-189","article-title":"Cost of diabetes care in out-patient clinics of Karachi, Pakistan","volume":"7","author":"Khowaja","year":"2007","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(18)30199-2_bib117","doi-asserted-by":"crossref","first-page":"128","DOI":"10.5853\/jos.2013.15.3.128","article-title":"Stroke epidemiology and stroke care services in India","volume":"15","author":"Pandian","year":"2013","journal-title":"J Stroke"},{"issue":"1 suppl 1","key":"10.1016\/S2213-8587(18)30199-2_bib118","first-page":"S127","article-title":"Current status of end-stage renal disease care in south Asia","volume":"19","author":"Jha","year":"2009","journal-title":"Ethn Dis"},{"key":"10.1016\/S2213-8587(18)30199-2_bib119","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1093\/fampra\/cmi069","article-title":"Empowering patients with diabetes: a qualitative primary care study focusing on south Asians in Leicester, UK","volume":"22","author":"Stone","year":"2005","journal-title":"Fam Pract"},{"key":"10.1016\/S2213-8587(18)30199-2_bib120","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1111\/j.1464-5491.2008.02512.x","article-title":"Educational interventions for migrant south Asians with type 2 diabetes: a systematic review","volume":"25","author":"Khunti","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib121","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1017\/S0007114510000681","article-title":"Improvement in nutrition-related knowledge and behaviour of urban Asian Indian school children: findings from the \u2018Medical education for children\/Adolescents for Realistic prevention of obesity and diabetes and for healthy aGeing\u2019 (MARG) intervention study","volume":"104","author":"Shah","year":"2010","journal-title":"Br J Nutr"},{"key":"10.1016\/S2213-8587(18)30199-2_bib122","doi-asserted-by":"crossref","first-page":"94","DOI":"10.1111\/j.1464-5491.2005.01735.x","article-title":"A comparison of glycaemic and metabolic control over time among south Asian and European patients with type 2 diabetes: results from follow-up in a routine diabetes clinic","volume":"23","author":"Mukhopadhyay","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib123","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.1007\/s00125-013-2873-5","article-title":"The clinical characteristics at diagnosis of type 2 diabetes in a multi-ethnic population: the South London Diabetes cohort (SOUL-D)","volume":"56","author":"Winkley","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30199-2_bib124","doi-asserted-by":"crossref","first-page":"e000275","DOI":"10.1136\/bmjdrc-2016-000275","article-title":"Evaluation of statin prescriptions in type 2 diabetes: India Heart Watch-2","volume":"4","author":"Gupta","year":"2016","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(18)30199-2_bib125","first-page":"326","article-title":"Prevalence, awareness and control of hypertension in Chennai\u2014the Chennai Urban Rural Epidemiology Study (CURES-52)","volume":"55","author":"Mohan","year":"2007","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(18)30199-2_bib126","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/1471-2261-9-28","article-title":"Younger age of escalation of cardiovascular risk factors in Asian Indian subjects","volume":"9","author":"Gupta","year":"2009","journal-title":"BMC Cardiovasc Disord"},{"key":"10.1016\/S2213-8587(18)30199-2_bib127","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.2337\/dc09-2067","article-title":"Explanations for the lower rates of diabetic neuropathy in Indian Asians versus Europeans","volume":"33","author":"Abbott","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30199-2_bib128","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1046\/j.1464-5491.2002.00583.x","article-title":"Risk of diabetes-related amputation in south Asians vs Europeans in the UK","volume":"19","author":"Chaturvedi","year":"2002","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib129","first-page":"87","article-title":"Economic costs of diabetes care: the Bangalore Urban District Diabetes Study","volume":"19","author":"Rayappa","year":"1999","journal-title":"Int J Diab Dev Ctries"},{"key":"10.1016\/S2213-8587(18)30199-2_bib130","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/S0168-8227(99)00130-8","article-title":"Expenditure on health care incurred by diabetic subjects in a developing country\u2014a study from southern India","volume":"48","author":"Shobhana","year":"2000","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30199-2_bib131","first-page":"57","article-title":"Socio-economic inequalities in the financing of cardiovascular & diabetes inpatient treatment in India","volume":"133","author":"Rao","year":"2011","journal-title":"Indian J Med Res"},{"key":"10.1016\/S2213-8587(18)30199-2_bib132","doi-asserted-by":"crossref","first-page":"252","DOI":"10.2337\/dc06-0144","article-title":"Increasing expenditure on health care incurred by diabetic subjects in a developing country: a study from India","volume":"30","author":"Ramachandran","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30199-2_bib133","doi-asserted-by":"crossref","first-page":"1231","DOI":"10.1111\/j.1464-5491.2008.02529.x","article-title":"The personal cost of diabetic foot disease in the developing world\u2014a study from Pakistan","volume":"25","author":"Ali","year":"2008","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30199-2_bib134","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.diabres.2010.05.009","article-title":"The socioeconomics of diabetes from a developing country: a population based cost of illness study","volume":"89","author":"Tharkar","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30199-2_bib135","first-page":"102","article-title":"The costs of treating long-term diabetic complications in a developing country: a study from India","volume":"61","author":"Kumpatla","year":"2013","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(18)30199-2_bib137","doi-asserted-by":"crossref","first-page":"548","DOI":"10.4103\/2230-8210.113720","article-title":"South Asian women with diabetes: psychosocial challenges and management: consensus statement","volume":"17","author":"Bajaj","year":"2013","journal-title":"Indian J Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30199-2_bib139","doi-asserted-by":"crossref","first-page":"6965","DOI":"10.7314\/APJCP.2013.14.11.6965","article-title":"Socioeconomic inequality in the prevalence of smoking and smokeless tobacco use in India","volume":"14","author":"Thakur","year":"2013","journal-title":"Asian Pac J Cancer Prev"},{"key":"10.1016\/S2213-8587(18)30199-2_bib140","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1016\/j.aogh.2016.04.002","article-title":"Trends in coronary heart disease epidemiology in India","volume":"82","author":"Gupta","year":"2016","journal-title":"Ann Glob Health"},{"key":"10.1016\/S2213-8587(18)30199-2_bib141","doi-asserted-by":"crossref","first-page":"e13237","DOI":"10.1111\/ijcp.13237","article-title":"Sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes in North India: a 12-month prospective study in real-world setting","volume":"72","author":"Ghosh","year":"2018","journal-title":"Int J Clin Pract"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301992?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718301992?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:34Z","timestamp":1761991594000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718301992"}},"issued":{"date-parts":[[2018,12]]},"references-count":138,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2018,12]]}},"alternative-id":["S2213858718301992"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30199-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical management of type 2 diabetes in south Asia","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30199-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30203-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30204-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T14:58:27Z","timestamp":1793199507911,"version":"4.5.0"},"reference-count":69,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2014,9,1]],"date-time":"2014-09-01T00:00:00Z","timestamp":1409529600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,9]]},"DOI":"10.1016\/s2213-8587(14)70109-3","type":"journal-article","created":{"date-parts":[[2014,9,3]],"date-time":"2014-09-03T19:15:32Z","timestamp":1409771732000},"page":"730-739","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":196,"title":["Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice"],"prefix":"10.1016","volume":"2","author":[{"given":"Knut","family":"L\u00f6nnroth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gojka","family":"Roglic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony D","family":"Harries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70109-3_bib1","series-title":"Global tuberculosis report 2013. WHO\/HTM\/TB\/2013.11","year":"2013"},{"key":"10.1016\/S2213-8587(14)70109-3_bib2","first-page":"460","article-title":"Targets for global tuberculosis control","volume":"10","author":"Dye","year":"2006","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S2213-8587(14)70109-3_bib3","series-title":"The Global Plan to Stop TB 2006\u20132015. WHO\/HTM\/STB\/2006.35","year":"2006"},{"key":"10.1016\/S2213-8587(14)70109-3_bib4","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70109-3_bib5","doi-asserted-by":"crossref","first-page":"1814","DOI":"10.1016\/S0140-6736(10)60483-7","article-title":"Tuberculosis control and elimination 2010\u201350: cure, care, and social development","volume":"375","author":"L\u00f6nnroth","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70109-3_bib6","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1016\/S0140-6736(12)60727-2","article-title":"Scaling up interventions to achieve global tuberculosis control: progress and new developments","volume":"379","author":"Raviglione","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70109-3_bib7","doi-asserted-by":"crossref","first-page":"1050","DOI":"10.1056\/NEJMra0908076","article-title":"MDR tuberculosis\u2013critical steps for prevention and control","volume":"363","author":"Nathanson","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70109-3_bib8","series-title":"WHO Sixty-Seventh World Health Assembly (2014). Global strategy and targets for tuberculosis prevention, care and control after 2015. A67\/11","year":"2014"},{"key":"10.1016\/S2213-8587(14)70109-3_bib9","series-title":"WHO tuberculosis programme: framework for effective tuberculosis control. WHO\/TB\/94.179","year":"1994"},{"key":"10.1016\/S2213-8587(14)70109-3_bib10","series-title":"An expanded DOTS framework for effective tuberculosis control. WHO\/CDS\/TB\/2002.297","year":"2002"},{"key":"10.1016\/S2213-8587(14)70109-3_bib11","series-title":"The stop TB strategy. WHO\/HTM\/TB\/2006.368","year":"2006"},{"key":"10.1016\/S2213-8587(14)70109-3_bib12","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1183\/09031936.00084310","article-title":"Tuberculosis and non-communicable diseases: neglected links, missed opportunities","volume":"37","author":"Creswell","year":"2011","journal-title":"Eur Respir J"},{"key":"10.1016\/S2213-8587(14)70109-3_bib13","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1016\/S1473-3099(13)70015-X","article-title":"Tuberculosis co-morbidity with communicable and non-communicable diseases: integrating health services and control efforts","volume":"13","author":"Marais","year":"2013","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S2213-8587(14)70109-3_bib14","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.5588\/ijtld.11.0503","article-title":"The looming epidemic of diabetes-associated tuberculosis: learning lessons from HIV-associated tuberculosis","volume":"15","author":"Harries","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S2213-8587(14)70109-3_bib15","doi-asserted-by":"crossref","first-page":"S3","DOI":"10.5588\/pha.13.0024","article-title":"Epidemiology and interaction of diabetes mellitus and tuberculosis and the challenges for care: a review","volume":"3","author":"Harries","year":"2013","journal-title":"Public Health Action"},{"key":"10.1016\/S2213-8587(14)70109-3_bib16","doi-asserted-by":"crossref","first-page":"1300","DOI":"10.1111\/j.1365-3156.2010.02632.x","article-title":"Bi-directional screening for tuberculosis and diabetes: a systematic review","volume":"15","author":"Jeon","year":"2010","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(14)70109-3_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1177\/1742395307081502","article-title":"Diabetes and the risk of tuberculosis: a neglected threat to public health?","volume":"3","author":"Stevenson","year":"2007","journal-title":"Chronic Illn"},{"key":"10.1016\/S2213-8587(14)70109-3_bib18","doi-asserted-by":"crossref","first-page":"e152","DOI":"10.1371\/journal.pmed.0050152","article-title":"Diabetes mellitus increases the risk of active tuberculosis: a systematic review of 13 observational studies","volume":"5","author":"Jeon","year":"2008","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(14)70109-3_bib19","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1016\/S1473-3099(09)70282-8","article-title":"Tuberculosis and diabetes mellitus: convergence of two epidemics","volume":"9","author":"Dooley","year":"2009","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S2213-8587(14)70109-3_bib20","doi-asserted-by":"crossref","first-page":"1289","DOI":"10.1111\/j.1365-3156.2010.02625.x","article-title":"Implications of the global increase of diabetes for tuberculosis control and patient care","volume":"15","author":"Ruslami","year":"2010","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(14)70109-3_bib21","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1186\/1741-7015-9-81","article-title":"The impact of diabetes on tuberculosis treatment outcomes: a systematic review","volume":"9","author":"Baker","year":"2011","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(14)70109-3_bib22","series-title":"Diabetes Atlas IDF","year":"2000"},{"key":"10.1016\/S2213-8587(14)70109-3_bib23","series-title":"Diabetes Atlas IDF","year":"2006"},{"key":"10.1016\/S2213-8587(14)70109-3_bib24","series-title":"Diabetes Atlas IDF","year":"2013"},{"key":"10.1016\/S2213-8587(14)70109-3_bib25","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country-years and 2\u00b77 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70109-3_bib26","series-title":"134th session. Global strategy and targets for tuberculosis prevention, care and control after 2015. EB134.R4","year":"2014"},{"key":"10.1016\/S2213-8587(14)70109-3_bib27","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1183\/09031936.00193413","article-title":"Financial burden for tuberculosis patients in low- and middle-income countries\u2014a systematic review","volume":"43","author":"Tanimura","year":"2014","journal-title":"Eur Respir J"},{"key":"10.1016\/S2213-8587(14)70109-3_bib28","doi-asserted-by":"crossref","first-page":"e1001693","DOI":"10.1371\/journal.pmed.1001693","article-title":"Beyond UHC: monitoring health and social protection coverage in the context of tuberculosis care and prevention","volume":"11","author":"L\u00f6nnroth","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(14)70109-3_bib29","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1016\/j.socscimed.2009.03.041","article-title":"Drivers of tuberculosis epidemics: the role of risk factors and social determinants","volume":"68","author":"L\u00f6nnroth","year":"2009","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(14)70109-3_bib30","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1093\/ije\/dyq238","article-title":"Diabetes mellitus and tuberculosis in countries with high tuberculosis burdens: individual risks and social determinants","volume":"40","author":"Goldhaber-Fiebert","year":"2011","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(14)70109-3_bib31","doi-asserted-by":"crossref","first-page":"e21161","DOI":"10.1371\/journal.pone.0021161","article-title":"Nutrition, diabetes and tuberculosis in the epidemiological transition","volume":"6","author":"Dye","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(14)70109-3_bib32","doi-asserted-by":"crossref","first-page":"754","DOI":"10.1016\/S2213-8587(14)70164-0","article-title":"The effect of diabetes and undernutrition trrends on reaching 2035 global tuberculosis targets","volume":"2","author":"Odone","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70109-3_bib33","doi-asserted-by":"crossref","first-page":"1486","DOI":"10.1093\/aje\/kwn075","article-title":"Diabetic control and risk of tuberculosis: a cohort study","volume":"167","author":"Leung","year":"2008","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(14)70109-3_bib34","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1016\/j.diabres.2013.11.001","article-title":"Global estimates of undiagnosed diabetes in adults","volume":"103","author":"Beagley","year":"2014","journal-title":"Diab Res Clin Pract"},{"key":"10.1016\/S2213-8587(14)70109-3_bib35","article-title":"Isoniazid for preventing tuberculosis in non-HIV infected persons","volume":"2","author":"Smieja","year":"2000","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(14)70109-3_bib36","first-page":"167","article-title":"Isoniazid and recurrence of tuberculosis in diabetics","volume":"111","author":"Pfaffenberg","year":"1958","journal-title":"Z Tuberk"},{"key":"10.1016\/S2213-8587(14)70109-3_bib37","first-page":"1","article-title":"Experience with the chemoprophylaxis of pulmonary tuberculosis in diabetes mellitus patients","volume":"47","author":"Lesnichii","year":"1969","journal-title":"Probl Tuberk"},{"key":"10.1016\/S2213-8587(14)70109-3_bib38","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1056\/NEJMoa1104875","article-title":"Three months of rifapentine and isoniazid for latent tuberculosis infection","volume":"365","author":"Sterling","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70109-3_bib39","series-title":"Guidelines for intensified tuberculosis case-finding and isoniazid preventive therapy for people living with HIV in resource-constrained settings. WHO\/HTM\/TB\/2011.11","year":"2011"},{"key":"10.1016\/S2213-8587(14)70109-3_bib40","series-title":"Recommendations for investigating the contacts of persons with infectious tuberculosis in low- and middle-income countries. WHO\/HTM\/TB\/2012.9","year":"2012"},{"key":"10.1016\/S2213-8587(14)70109-3_bib41","doi-asserted-by":"crossref","first-page":"289","DOI":"10.5588\/ijtld.12.0797","article-title":"Systematic screening for active tuberculosis: rationale, definitions and key considerations","volume":"17","author":"L\u00f6nnroth","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S2213-8587(14)70109-3_bib42","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/1471-2458-8-15","article-title":"A systematic review of delay in the diagnosis and treatment of tuberculosis","volume":"8","author":"Storla","year":"2008","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(14)70109-3_bib43","author":"Shapiro"},{"key":"10.1016\/S2213-8587(14)70109-3_bib44","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1111\/j.1365-3156.2012.03069.x","article-title":"Screening patients with diabetes mellitus for tuberculosis in China","volume":"17","author":"Lin","year":"2012","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(14)70109-3_bib45","doi-asserted-by":"crossref","first-page":"646","DOI":"10.1111\/tmi.12083","article-title":"Screening of patients with diabetes mellitus for tuberculosis in India","volume":"18","year":"2013","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(14)70109-3_bib46","doi-asserted-by":"crossref","first-page":"432","DOI":"10.5588\/ijtld.12.0743","article-title":"The benefits to communities and individuals of screening for active tuberculosis disease: a systematic review","volume":"17","author":"Kranzer","year":"2013","journal-title":"Int J Tuberc Lung Dis"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(14)70109-3_bib47","doi-asserted-by":"crossref","first-page":"S50","DOI":"10.5588\/ijtld.10.0447","article-title":"The innovative socio-economic interventions against tuberculosis (ISIAT) project: an operational assessment","volume":"15","author":"Rocha","year":"2011","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S2213-8587(14)70109-3_bib48","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1136\/bmj.315.7120.1403","article-title":"Systematic review of randomised controlled trials of strategies to promote adherence to tuberculosis treatment","volume":"315","author":"Volmink","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(14)70109-3_bib49","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/2049-9957-1-9","article-title":"Providing financial incentives to rural-to-urban tuberculosis migrants in Shanghai: an intervention study","volume":"1","author":"Wei","year":"2012","journal-title":"Infect Dis Poverty"},{"key":"10.1016\/S2213-8587(14)70109-3_bib50","first-page":"1513","article-title":"Consultation meeting on tuberculosis and diabetes mellitus: meeting summary and recommendations","volume":"14","author":"Ottmani","year":"2010","journal-title":"Int J Tuberc Lung Dis"},{"key":"10.1016\/S2213-8587(14)70109-3_bib51","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1365-3156.2010.02523.x","article-title":"Defining the research agenda to reduce the joint burden of disease from diabetes mellitus and tuberculosis","volume":"15","author":"Harries","year":"2010","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(14)70109-3_bib52","series-title":"Collaborative framework for care and control of tuberculosis and diabetes. WHO\/HTM\/TB\/2011.15","year":"2011"},{"key":"10.1016\/S2213-8587(14)70109-3_bib53","series-title":"Systematic screening for active tuberculosis: principles and recommendations. WHO\/HTM\/TB.2013.04","year":"2013"},{"key":"10.1016\/S2213-8587(14)70109-3_bib54","doi-asserted-by":"crossref","first-page":"740","DOI":"10.1016\/S2213-8587(14)70110-X","article-title":"Clinical management of concurrent diabetes and tuberculosis and the implications for patient services","volume":"2","author":"Riza","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70109-3_bib55","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1111\/j.1365-3156.2012.03068.x","article-title":"Screening of patients with tuberculosis for diabetes mellitus in China","volume":"17","author":"Li","year":"2012","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(14)70109-3_bib56","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1111\/tmi.12084","article-title":"Screening of patients with tuberculosis for diabetes mellitus in India","volume":"18","year":"2013","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(14)70109-3_bib57","first-page":"875","article-title":"Manifest, chemical and latent chemical diabetes in pulmonary tuberculosis","volume":"21","author":"Kishore","year":"1973","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(14)70109-3_bib58","first-page":"191","article-title":"Study of the diabetic status in pulmonary tuberculosis","volume":"18","author":"Goyal","year":"1978","journal-title":"J Diabetes Assoc India"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70109-3_bib59","doi-asserted-by":"crossref","first-page":"S18","DOI":"10.5588\/pha.13.0032","article-title":"Tuberculosis-diabetes mellitus bidirectional screening at a tertiary care centre, south India","volume":"3","author":"Prakash","year":"2013","journal-title":"Public Health Action"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70109-3_bib60","doi-asserted-by":"crossref","first-page":"S29","DOI":"10.5588\/pha.13.0027","article-title":"Screening patients with tuberculosis for diabetes mellitus in Gujarat, India","volume":"3","author":"Dave","year":"2013","journal-title":"Public Health Action"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70109-3_bib61","doi-asserted-by":"crossref","first-page":"S34","DOI":"10.5588\/pha.13.0022","article-title":"Is screening for diabetes among tuberculosis patients feasible at the field level?","volume":"3","author":"Naik","year":"2013","journal-title":"Public Health Action"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70109-3_bib62","doi-asserted-by":"crossref","first-page":"S38","DOI":"10.5588\/pha.13.0037","article-title":"High prevalence of undiagnosed diabetes among tuberculosis patients in peripheral health facilities in Kerala","volume":"3","author":"Nair","year":"2013","journal-title":"Public Health Action"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70109-3_bib63","doi-asserted-by":"crossref","first-page":"S43","DOI":"10.5588\/pha.13.0033","article-title":"Screening tuberculosis patients for diabetes in a tribal area in south India","volume":"3","author":"Achanta","year":"2013","journal-title":"Public Health Action"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70109-3_bib64","doi-asserted-by":"crossref","first-page":"S23","DOI":"10.5588\/pha.13.0035","article-title":"Characteristics of patients with diabetes screened for tuberculosis in a tertiary care hospital in south India","volume":"3","author":"Kumpatla","year":"2013","journal-title":"Public Health Action"},{"key":"10.1016\/S2213-8587(14)70109-3_bib65","first-page":"118","article-title":"Impaired glucose tolerance in active pulmonary tuberculosis","volume":"31","author":"Singh","year":"1984","journal-title":"Indian J Tuberc"},{"key":"10.1016\/S2213-8587(14)70109-3_bib66","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/0041-3879(90)90010-6","article-title":"The significance of glucose intolerance in pulmonary tuberculosis","volume":"71","author":"Oluboyo","year":"1990","journal-title":"Tubercle"},{"key":"10.1016\/S2213-8587(14)70109-3_bib67","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"Prevalence of diabetes among men and women in China","volume":"362","author":"Yang","year":"2010","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70109-3_bib68","doi-asserted-by":"crossref","first-page":"S10","DOI":"10.5588\/pha.13.0036","article-title":"New screening technologies for type 2 diabetes mellitus appropriate for use in tuberculosis patients","volume":"3","author":"Adepoyibi","year":"2013","journal-title":"Public Health Action"},{"key":"10.1016\/S2213-8587(14)70109-3_bib70","series-title":"Contributing to health system strengthening\u2014guiding principles for national tuberculosis programmes. WHO\/HTM\/TB\/2008.400","year":"2008"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701093?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714701093?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T12:58:55Z","timestamp":1565787535000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714701093"}},"issued":{"date-parts":[[2014,9]]},"references-count":69,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2014,9]]}},"alternative-id":["S2213858714701093"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70109-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70109-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70192-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 World Health Organization. Published by Elsevier Ltd\/Inc\/BV. All rights reserved. Published by Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T00:20:30Z","timestamp":1793578830038,"version":"4.5.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/s2213-8587(21)00314-4","type":"journal-article","created":{"date-parts":[[2021,12,2]],"date-time":"2021-12-02T19:25:30Z","timestamp":1638473130000},"page":"1","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Childhood obesity: a growing pandemic"],"prefix":"10.1016","volume":"10","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003144?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003144?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:41Z","timestamp":1761991841000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721003144"}},"issued":{"date-parts":[[2022,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2213858721003144"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00314-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Childhood obesity: a growing pandemic","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00314-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00089-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T19:49:19Z","timestamp":1793735359073,"version":"4.6.1"},"reference-count":32,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,18]],"date-time":"2025-02-18T00:00:00Z","timestamp":1739836800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00f6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","award":["32473B162608"],"award-info":[{"award-number":["32473B162608"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008375","name":"Universit\u00e4t Basel","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008375","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100008485","name":"Schweizerische Akademie der Medizinischen Wissenschaften","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100008485","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,6]]},"DOI":"10.1016\/s2213-8587(25)00053-1","type":"journal-article","created":{"date-parts":[[2025,4,25]],"date-time":"2025-04-25T18:35:31Z","timestamp":1745606131000},"page":"505-515","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["A novel diagnostic score for diagnosing arginine vasopressin deficiency (central diabetes insipidus) or primary polydipsia with basal laboratory and clinical parameters: results from two international multicentre prospective diagnostic studies"],"prefix":"10.1016","volume":"13","author":[{"given":"Cihan","family":"Atila","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Chifu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana B","family":"Drummond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah R","family":"Vogt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uri","family":"Nahum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bettina","family":"Winzeler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Refardt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirjam","family":"Christ-Crain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00053-1_bib1","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/s41574-024-00985-x","article-title":"Arginine vasopressin deficiency: diagnosis, management and the relevance of oxytocin deficiency","volume":"20","author":"Atila","year":"2024","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(25)00053-1_bib2","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1159\/000505548","article-title":"Diabetes insipidus: new concepts for diagnosis","volume":"110","author":"Christ-Crain","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(25)00053-1_bib3","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1038\/s41572-019-0103-2","article-title":"Diabetes insipidus","volume":"5","author":"Christ-Crain","year":"2019","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(25)00053-1_bib4","doi-asserted-by":"crossref","first-page":"489","DOI":"10.1530\/EJE-22-0187","article-title":"Management of cranial diabetes insipidus: clinical outcomes and patient perception of care","volume":"187","author":"Dilrukshi","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00053-1_bib5","article-title":"Diabetes insipidus: pathogenesis, diagnosis, and clinical management","volume":"13","author":"Mutter","year":"2021","journal-title":"Cureus"},{"key":"10.1016\/S2213-8587(25)00053-1_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2020.101385","article-title":"Management of central diabetes insipidus","volume":"34","author":"Garrahy","year":"2020","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00053-1_bib7","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1530\/EJE-20-0759","article-title":"Simplified and improved fluid deprivation test for diagnosing diabetes insipidus","volume":"184","author":"Sj\u00f6str\u00f6m","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00053-1_bib8","doi-asserted-by":"crossref","first-page":"721","DOI":"10.7326\/0003-4819-73-5-721","article-title":"Recognition of partial defects in antidiuretic hormone secretion","volume":"73","author":"Miller","year":"1970","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00053-1_bib9","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1056\/NEJMoa1803760","article-title":"A copeptin-based approach in the diagnosis of diabetes insipidus","volume":"379","author":"Fenske","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00053-1_bib10","doi-asserted-by":"crossref","first-page":"1506","DOI":"10.1210\/jc.2010-2345","article-title":"Copeptin in the differential diagnosis of the polydipsia-polyuria syndrome\u2014revisiting the direct and indirect water deprivation tests","volume":"96","author":"Fenske","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00053-1_bib11","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1016\/j.eprac.2023.05.006","article-title":"Diagnostic accuracy of copeptin in the differential diagnosis of patients with diabetes insipidus: a systematic review and meta-analysis","volume":"29","author":"Mu","year":"2023","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(25)00053-1_bib12","doi-asserted-by":"crossref","first-page":"1877","DOI":"10.1056\/NEJMoa2306263","article-title":"Arginine or hypertonic saline-stimulated copeptin to diagnose AVP deficiency","volume":"389","author":"Refardt","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00053-1_bib13","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1530\/EJE-22-0033","article-title":"Glucagon-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a double-blind, randomized, placebo-controlled study","volume":"187","author":"Atila","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00053-1_bib14","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1016\/S0140-6736(19)31255-3","article-title":"Arginine-stimulated copeptin measurements in the differential diagnosis of diabetes insipidus: a prospective diagnostic study","volume":"394","author":"Winzeler","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00053-1_bib15","doi-asserted-by":"crossref","first-page":"2640","DOI":"10.1210\/jc.2006-2046","article-title":"Anterior and posterior pituitary function testing with simultaneous insulin tolerance test and a novel copeptin assay","volume":"92","author":"Katan","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00053-1_bib16","doi-asserted-by":"crossref","first-page":"2268","DOI":"10.1210\/jc.2014-4507","article-title":"Diagnostic accuracy of copeptin in the differential diagnosis of the polyuria-polydipsia syndrome: a prospective multicenter study","volume":"100","author":"Timper","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00053-1_bib17","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s13023-022-02191-2","article-title":"Challenges and improvement needs in the care of patients with central diabetes insipidus","volume":"17","author":"Teare","year":"2022","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(25)00053-1_bib18","doi-asserted-by":"crossref","first-page":"700","DOI":"10.1016\/S2213-8587(22)00219-4","article-title":"Central diabetes insipidus from a patient's perspective: management, psychological co-morbidities, and renaming of the condition: results from an international web-based survey","volume":"10","author":"Atila","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00053-1_bib19","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S2213-8587(14)70142-1","article-title":"Diagnosis and management of adrenal insufficiency","volume":"3","author":"Bancos","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00053-1_bib20","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1530\/EJE-22-0368","article-title":"Machine learning-based algorithm as an innovative approach for the differentiation between diabetes insipidus and primary polydipsia in clinical practice","volume":"187","author":"Nahum","year":"2022","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00053-1_bib21","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000336333","article-title":"Diabetes insipidus\u2014diagnosis and management","volume":"77","author":"Di Iorgi","year":"2012","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(25)00053-1_bib22","doi-asserted-by":"crossref","first-page":"3426","DOI":"10.1210\/jc.2012-1981","article-title":"Clinical review: current state and future perspectives in the diagnosis of diabetes insipidus: a clinical review","volume":"97","author":"Fenske","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00053-1_bib23","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1007\/s12020-015-0637-3","article-title":"Quality of life in the patients with central diabetes insipidus assessed by Nagasaki Diabetes Insipidus Questionnaire","volume":"51","author":"Nozaki","year":"2016","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(25)00053-1_bib24","first-page":"934","article-title":"Hypothalamic-pituitary-adrenal axis activation and stimulation of systemic vasopressin secretion by recombinant interleukin-6 in humans: potential implications for the syndrome of inappropriate vasopressin secretion","volume":"79","author":"Mastorakos","year":"1994","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00053-1_bib25","doi-asserted-by":"crossref","first-page":"414","DOI":"10.14310\/horm.2002.1762","article-title":"Diagnostic value of the water deprivation test in the polyuria-polydipsia syndrome","volume":"16","author":"Trimpou","year":"2017","journal-title":"Hormones (Athens)"},{"key":"10.1016\/S2213-8587(25)00053-1_bib26","doi-asserted-by":"crossref","first-page":"142","DOI":"10.3109\/02841859909177729","article-title":"High intensity signal of the posterior pituitary\u2014a study with horizontal direction of frequency-encoding and fat suppression MR techniques","volume":"40","author":"Arslan","year":"1999","journal-title":"Acta Radiol"},{"key":"10.1016\/S2213-8587(25)00053-1_bib27","doi-asserted-by":"crossref","first-page":"3108","DOI":"10.1210\/jc.2018-01871","article-title":"Nonneuroendocrine neoplasms of the pituitary region","volume":"104","author":"Kaltsas","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00053-1_bib28","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1210\/clinem\/dgab732","article-title":"Neoplastic etiology and natural course of pituitary stalk thickening","volume":"107","author":"Kim","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00053-1_bib29","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.1210\/jc.2002-020791","volume":"88","author":"Pivonello","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00053-1_bib30","first-page":"1273","article-title":"Use of T1-weighted MR imaging to differentiate between primary polydipsia and central diabetes insipidus","volume":"13","author":"Moses","year":"1992","journal-title":"AJNR Am J Neuroradiol"},{"key":"10.1016\/S2213-8587(25)00053-1_bib31","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1007\/s11102-018-0885-3","article-title":"Presence of the posterior pituitary bright spot sign on MRI in the general population: a comparison between 1.5 and 3T MRI and between 2D-T1 spin-echo- and 3D-T1 gradient-echo sequences","volume":"21","author":"Klyn","year":"2018","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(25)00053-1_bib32","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1111\/j.1365-2265.2008.03513.x","article-title":"Identification, characterization and rescue of a novel vasopressin-2 receptor mutation causing nephrogenic diabetes insipidus","volume":"71","author":"Ranadive","year":"2009","journal-title":"Clin Endocrinol (Oxf)"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(25)00133-0","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000}},{"DOI":"10.1016\/s2213-8587(25)00130-5","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,6,1]],"date-time":"2025-06-01T00:00:00Z","timestamp":1748736000000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000531?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725000531?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:26:04Z","timestamp":1778858764000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725000531"}},"issued":{"date-parts":[[2025,6]]},"references-count":32,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2025,6]]}},"alternative-id":["S2213858725000531"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00053-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"A novel diagnostic score for diagnosing arginine vasopressin deficiency (central diabetes insipidus) or primary polydipsia with basal laboratory and clinical parameters: results from two international multicentre prospective diagnostic studies","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00053-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00067-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T05:20:08Z","timestamp":1794547208024,"version":"4.9.1"},"reference-count":197,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,7,1]],"date-time":"2025-07-01T00:00:00Z","timestamp":1751328000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,7]]},"DOI":"10.1016\/s2213-8587(25)00066-x","type":"journal-article","created":{"date-parts":[[2025,5,2]],"date-time":"2025-05-02T18:37:48Z","timestamp":1746211068000},"page":"600-614","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":124,"title":["Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management"],"prefix":"10.1016","volume":"13","author":[{"given":"Wilmar M","family":"Wiersinga","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anja K","family":"Eckstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Milo\u0161","family":"\u017darkovi\u0107","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00066-X_bib1","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1089\/thy.2022.29143.wie","article-title":"Worldwide consensus on thyroid eye disease? What is in a name?","volume":"32","author":"Wiersinga","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib2","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.1083886","article-title":"Thyroid eye disease or Graves' orbitopathy: what name to use, and why it matters","volume":"13","author":"Wagner","year":"2022","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib3","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/01.iop.0000235499.34867.85","article-title":"VISA classification for Graves orbitopathy","volume":"22","author":"Dolman","year":"2006","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/S2213-8587(25)00066-X_bib4","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1530\/eje.1.02230","article-title":"Clinical assessment of patients with Graves' orbitopathy: the European Group on Graves' Orbitopathy recommendations to generalists, specialists and clinical researchers","volume":"155","author":"Wiersinga","year":"2006","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib5","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1046\/j.1365-2265.2001.01349.x","article-title":"Controversies in the clinical evaluation of active thyroid-associated orbitopathy: use of a detailed protocol with comparative photographs for objective assessment","volume":"55","author":"Dickinson","year":"2001","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib6","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1136\/bjo.73.8.639","article-title":"Clinical criteria for the assessment of disease activity in Graves' ophthalmopathy: a novel approach","volume":"73","author":"Mourits","year":"1989","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib7","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1046\/j.1365-2265.1997.2331047.x","article-title":"Clinical activity score as a guide in the management of patients with Graves' ophthalmopathy","volume":"47","author":"Mourits","year":"1997","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib8","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1111\/cen.13855","article-title":"Factors associated with the efficacy of intravenous methylprednisolone in moderate-to-severe and active thyroid-associated ophthalmopathy: a single-centre retrospective study","volume":"90","author":"Hu","year":"2019","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib9","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s12902-018-0240-8","article-title":"A single-center retrospective study of factors related to the effects of intravenous glucocorticoid therapy in moderate-to-severe and active thyroid-associated ophthalmopathy","volume":"18","author":"Wang","year":"2018","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(25)00066-X_bib10","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0109","article-title":"Predicting glucocorticoid effectiveness in thyroid eye disease: combined value from serological lipid metabolism and an orbital MRI parameter","volume":"13","author":"Zhang","year":"2024","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(25)00066-X_bib11","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/j.1365-2265.2005.02186.x","article-title":"Measuring disease activity to predict therapeutic outcome in Graves' ophthalmopathy","volume":"62","author":"Terwee","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib12","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1089\/thy.2023.0621","article-title":"A preliminary evaluation of the diagnostic performance of a smartphone-based machine learning-assisted system for evaluation of clinical activity score in digital images of thyroid-associated orbitopathy","volume":"34","author":"Shin","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib13","doi-asserted-by":"crossref","first-page":"S81","DOI":"10.1097\/IOP.0000000000002511","article-title":"Magnetic resonance imaging in the management of thyroid eye disease: a systematic review","volume":"39","author":"Vaishnav","year":"2023","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/S2213-8587(25)00066-X_bib14","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1038\/s41433-021-01504-2","article-title":"Evaluating the interreader agreement and intrareader reproducibility of visual field defects in thyroid eye disease- compressive optic neuropathy","volume":"36","author":"Garip Kuebler","year":"2022","journal-title":"Eye"},{"key":"10.1016\/S2213-8587(25)00066-X_bib15","doi-asserted-by":"crossref","first-page":"3421","DOI":"10.1007\/s00417-021-05227-8","article-title":"A pathological indicator for dysthyroid optic neuropathy: tritan color vision deficiency","volume":"259","author":"Garip Kuebler","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib16","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1159\/000490384","article-title":"2018 European Thyroid Association guideline for the management of Graves' hyperthyroidism","volume":"7","author":"Kahaly","year":"2018","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(25)00066-X_bib17","doi-asserted-by":"crossref","first-page":"3464","DOI":"10.1210\/jc.2005-2813","article-title":"Thyrotropin receptor autoantibodies are independent risk factors for Graves' ophthalmopathy and help to predict severity and outcome of the disease","volume":"91","author":"Eckstein","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib18","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/a-1525-2070","article-title":"Predicting the course of Graves' orbitopathy using serially measured TSH-receptor autoantibodies by automated binding immunoassays and the functional bioassay","volume":"53","author":"St\u00f6hr","year":"2021","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(25)00066-X_bib19","doi-asserted-by":"crossref","first-page":"933","DOI":"10.3389\/fendo.2019.00933","article-title":"Cholesterol serum levels and use of statins in Graves' orbitopathy: a new starting point for the therapy","volume":"10","author":"Lanzolla","year":"2020","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib20","doi-asserted-by":"crossref","first-page":"1740","DOI":"10.1080\/09273948.2021.1942498","article-title":"The role of TPOAb in thyroid-associated orbitopathy: a systematic review","volume":"30","author":"Kyriakos","year":"2022","journal-title":"Ocul Immunol Inflamm"},{"key":"10.1016\/S2213-8587(25)00066-X_bib21","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1136\/bjo.2007.137265","article-title":"Euthyroid and primarily hypothyroid patients develop milder and significantly more asymmetrical Graves ophthalmopathy","volume":"93","author":"Eckstein","year":"2009","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib22","doi-asserted-by":"crossref","first-page":"81","DOI":"10.1097\/IIO.0000000000000289","article-title":"A review of imaging modalities in thyroid-associated orbitopathy","volume":"59","author":"North","year":"2019","journal-title":"Int Ophthalmol Clin"},{"key":"10.1016\/S2213-8587(25)00066-X_bib23","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1002\/jmri.29114","article-title":"Application of quantitative MRI in thyroid eye disease: imaging techniques and clinical practices","volume":"60","author":"Zhang","year":"2024","journal-title":"J Magn Reson Imaging"},{"key":"10.1016\/S2213-8587(25)00066-X_bib24","doi-asserted-by":"crossref","first-page":"G43","DOI":"10.1530\/EJE-21-0479","article-title":"The 2021 European Group on Graves' Orbitopathy (EUGOGO) clinical practice guidelines for the medical management of Graves' orbitopathy","volume":"185","author":"Bartalena","year":"2021","journal-title":"Eur J Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00066-X_bib25","doi-asserted-by":"crossref","first-page":"S28","DOI":"10.1097\/IOP.0000000000001147","article-title":"Phenotypes of thyroid eye disease","volume":"34","author":"Uddin","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/S2213-8587(25)00066-X_bib26","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1186\/s13023-017-0625-1","article-title":"Graves' orbitopathy as a rare disease in Europe: a European Group on Graves' Orbitopathy (EUGOGO) position statement","volume":"12","author":"Perros","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(25)00066-X_bib27","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1530\/EJE-11-0548","article-title":"Incidence of hyperthyroidism in Sweden","volume":"165","author":"Abraham-Nordling","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib28","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1210\/jc.2012-1275","article-title":"Incidence and clinical presentation of moderate to severe graves' orbitopathy in a Danish population before and after iodine fortification of salt","volume":"97","author":"Laurberg","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib29","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S0002-9394(14)72666-2","article-title":"The incidence of Graves' ophthalmopathy in Olmsted County, Minnesota","volume":"120","author":"Bartley","year":"1995","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib30","doi-asserted-by":"crossref","first-page":"1522","DOI":"10.1089\/thy.2024.0304","article-title":"The epidemiology of thyroid eye disease in Olmsted County, Minnesota, 2005\u20132020","volume":"34","author":"Rachmasari","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib31","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/cen.14296","article-title":"Prevalence of thyroid eye disease in Graves' disease: a meta-analysis and systematic review","volume":"93","author":"Chin","year":"2020","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib32","doi-asserted-by":"crossref","first-page":"1443","DOI":"10.1210\/jc.2012-3873","article-title":"Prevalence and natural history of Graves' orbitopathy in a large series of patients with newly diagnosed graves' hyperthyroidism seen at a single center","volume":"98","author":"Tanda","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib33","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s40618-020-01479-z","article-title":"Change in newly diagnosed Graves' disease phenotype between the twentieth and the twenty-first centuries: meta-analysis and meta-regression","volume":"44","author":"Ippolito","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(25)00066-X_bib34","doi-asserted-by":"crossref","first-page":"1531","DOI":"10.1136\/bjophthalmol-2015-306733","article-title":"PREGO (presentation of Graves' orbitopathy) study: changes in referral patterns to European Group On Graves' Orbitopathy (EUGOGO) centres over the period from 2000 to 2012","volume":"99","author":"Perros","year":"2015","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib35","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1136\/bjo-2022-322442","article-title":"Presentation of Graves' orbitopathy within European Group On Graves' Orbitopathy (EUGOGO) centres from 2012 to 2019 (PREGO III)","volume":"108","author":"Schuh","year":"2024","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib36","first-page":"99","article-title":"Prevalence of Graves' ophthalmopathy in patients with Graves' disease presenting to a referral centre in north India","volume":"139","author":"Reddy","year":"2014","journal-title":"Indian J Med Res"},{"key":"10.1016\/S2213-8587(25)00066-X_bib37","doi-asserted-by":"crossref","first-page":"1629","DOI":"10.4103\/ijo.IJO_104_20","article-title":"Clinical profile of thyroid eye disease and factors predictive of disease severity","volume":"68","author":"Muralidhar","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib38","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1160172","article-title":"Influence of biological sex, age and smoking on Graves' orbitopathy \u2013 a ten-year tertiary referral center analysis","volume":"14","author":"Oeverhaus","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib39","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/OPX.0b013e3181ce5702","article-title":"Proptosis in dysthyroid ophthalmopathy: a case series of 10,931 Japanese cases","volume":"87","author":"Kozaki","year":"2010","journal-title":"Optom Vis Sci"},{"key":"10.1016\/S2213-8587(25)00066-X_bib40","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1089\/thy.2022.0280","article-title":"Predictive model for Graves' ophthalmopathy in patients with new-onset Graves' disease","volume":"32","author":"Ahn","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib41","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1111\/j.1365-2265.1993.tb00516.x","article-title":"Age and gender influence the severity of thyroid-associated ophthalmopathy: a study of 101 patients attending a combined thyroid-eye clinic","volume":"38","author":"Perros","year":"1993","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib42","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.eprac.2021.11.080","article-title":"Characteristics of diabetic and nondiabetic patients with thyroid eye disease in the United States: a claims-based analysis","volume":"28","author":"Patel","year":"2022","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(25)00066-X_bib43","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1177\/11206721231199868","article-title":"Predictive factors of development of dysthyroid optic neuropathy among individuals with thyroid-eye disease","volume":"34","author":"Kemchoknatee","year":"2024","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib44","article-title":"HbA1c: an independent risk factor for dysthyroid optic neuropathy","volume":"14","author":"Wang","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib45","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1001\/jamaophthalmol.2014.5103","article-title":"Risk factors for developing thyroid-associated ophthalmopathy among individuals with Graves disease","volume":"133","author":"Stein","year":"2015","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib46","doi-asserted-by":"crossref","first-page":"1417","DOI":"10.1007\/s40618-018-0915-z","article-title":"Relationship between serum cholesterol and Graves' orbitopathy (GO): a confirmatory study","volume":"41","author":"Lanzolla","year":"2018","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(25)00066-X_bib47","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1089\/thy.2015.0031","article-title":"Prevalence, phenotype, and psychosocial well-being in euthyroid\/hypothyroid thyroid-associated orbitopathy","volume":"25","author":"Ponto","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib48","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1089\/thy.2014.0475","article-title":"Role of the underlying thyroid disease on the phenotype of Graves' orbitopathy in a tertiary referral center","volume":"25","author":"Leo","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib49","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/archinte.1990.00390170124027","article-title":"Effect of abnormal thyroid function on the severity of Graves' ophthalmopathy","volume":"150","author":"Prummel","year":"1990","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib50","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1136\/bjo.88.1.72","article-title":"The relation of Graves' ophthalmopathy to circulating thyroid hormone status","volume":"88","author":"Kim","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib51","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1530\/EJE-18-0039","article-title":"Predictive score for the development or progression of Graves' orbitopathy in patients with newly diagnosed Graves' hyperthyroidism","volume":"178","author":"Wiersinga","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib52","doi-asserted-by":"crossref","first-page":"2123","DOI":"10.1210\/jc.2009-2470","article-title":"A novel thyroid stimulating immunoglobulin bioassay is a functional indicator of activity and severity of Graves' orbitopathy","volume":"95","author":"Lytton","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib53","doi-asserted-by":"crossref","first-page":"2309","DOI":"10.1007\/s40618-023-02085-5","article-title":"The phenotype of Graves' orbitopathy is associated with thyrotropin receptor antibody levels","volume":"46","author":"Sari\u0107 Matutinovi\u0107","year":"2023","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(25)00066-X_bib54","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1007\/s40618-020-01353-y","article-title":"Correlation between serum anti-TSH receptor autoantibodies (TRAbs) and the clinical feature of Graves' orbitopathy","volume":"44","author":"Nicol\u00ec","year":"2021","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(25)00066-X_bib55","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1089\/thy.1999.9.1175","article-title":"The combination of absent thyroid peroxidase antibodies and high thyroid-stimulating immunoglobulin levels in Graves' disease identifies a group at markedly increased risk of ophthalmopathy","volume":"9","author":"Khoo","year":"1999","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib56","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1055\/s-0033-1363193","article-title":"Increased TRAb and\/or low anti-TPO titers at diagnosis of graves' disease are associated with an increased risk of developing ophthalmopathy after onset","volume":"122","author":"Lantz","year":"2014","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/S2213-8587(25)00066-X_bib57","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1136\/bmj.295.6599.634","article-title":"Is endocrine ophthalmopathy related to smoking?","volume":"295","author":"H\u00e4gg","year":"1987","journal-title":"Br Med J"},{"key":"10.1016\/S2213-8587(25)00066-X_bib58","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1111\/cen.12222","article-title":"Smoking and thyroid","volume":"79","author":"Wiersinga","year":"2013","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib59","doi-asserted-by":"crossref","first-page":"4873","DOI":"10.1210\/jc.2006-1402","article-title":"Influences of age, gender, smoking, and family history on autoimmune thyroid disease phenotype","volume":"91","author":"Manji","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib60","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1046\/j.1365-2265.1996.8220832.x","article-title":"Smoking and endocrine ophthalmopathy: impact of smoking severity and current vs lifetime cigarette consumption","volume":"45","author":"Pfeilschifter","year":"1996","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib61","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1056\/NEJM199206253262603","article-title":"Occurrence of ophthalmopathy after treatment for Graves' hyperthyroidism","volume":"326","author":"Tallstedt","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib62","doi-asserted-by":"crossref","first-page":"632","DOI":"10.7326\/0003-4819-129-8-199810150-00010","article-title":"Cigarette smoking and treatment outcomes in Graves ophthalmopathy","volume":"129","author":"Bartalena","year":"1998","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib63","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S2213-8587(21)00238-2","article-title":"Statins for Graves' orbitopathy (STAGO): a phase 2, open-label, adaptive, single centre, randomised clinical trial","volume":"9","author":"Lanzolla","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib64","doi-asserted-by":"crossref","first-page":"3700","DOI":"10.1210\/jc.2009-0747","article-title":"Thyroid-associated ophthalmopathy after treatment for Graves' hyperthyroidism with antithyroid drugs or iodine-131","volume":"94","author":"Tr\u00e4isk","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib65","doi-asserted-by":"crossref","first-page":"1552","DOI":"10.1056\/NEJMra1510030","article-title":"Graves' disease","volume":"375","author":"Smith","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib66","doi-asserted-by":"crossref","first-page":"726","DOI":"10.1056\/NEJMra0905750","article-title":"Graves' ophthalmopathy","volume":"362","author":"Bahn","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib67","doi-asserted-by":"crossref","first-page":"745","DOI":"10.1055\/a-2161-5417","article-title":"Graves' orbitopathy models: valuable tools for exploring pathogenesis and treatment","volume":"55","author":"Wang","year":"2023","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(25)00066-X_bib68","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1159\/000488079","article-title":"Noninflammatory diffuse follicular hypertrophy\/hyperplasia of Graves disease: morphometric evaluation in an experimental mouse model","volume":"7","author":"Schl\u00fcter","year":"2018","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(25)00066-X_bib69","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1089\/thy.2021.0464","article-title":"An early wave of macrophage infiltration intertwined with antigen-specific proinflammatory T cells and browning of adipose tissue characterizes the onset of orbital inflammation in a mouse model of Graves' orbitopathy","volume":"32","author":"Philipp","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib70","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1089\/thy.2020.0088","article-title":"A promising mouse model of Graves' orbitopathy induced by adenovirus expressing thyrotropin receptor A subunit","volume":"31","author":"Zhang","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib71","doi-asserted-by":"crossref","first-page":"3771","DOI":"10.1210\/en.2016-1304","article-title":"Pathogenic phenotype of adipogenesis and hyaluronan in orbital fibroblasts from female Graves' orbitopathy mouse model","volume":"157","author":"G\u00f6rtz","year":"2016","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(25)00066-X_bib72","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac203","article-title":"Macrophage-orbital fibroblast interaction and hypoxia promote inflammation and adipogenesis in Graves' orbitopathy","volume":"164","author":"G\u00f6rtz","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(25)00066-X_bib73","doi-asserted-by":"crossref","first-page":"1465","DOI":"10.1089\/thy.2023.0309","article-title":"Yes-associated protein mediates the transition from inflammation to fibrosis in Graves' orbitopathy","volume":"33","author":"Ko","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib74","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1530\/JOE-11-0162","article-title":"Orbital fibrosis in a mouse model of Graves' disease induced by genetic immunization of thyrotropin receptor cDNA","volume":"210","author":"Zhao","year":"2011","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib75","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1210\/jc.2012-1771","article-title":"Autoantibodies to the IGF1 receptor in Graves' orbitopathy","volume":"98","author":"Minich","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib76","doi-asserted-by":"crossref","first-page":"1759","DOI":"10.1007\/s40618-020-01341-2","article-title":"Putative protective role of autoantibodies against the insulin-like growth factor-1 receptor in Graves' Disease: results of a pilot study","volume":"43","author":"Lanzolla","year":"2020","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(25)00066-X_bib77","doi-asserted-by":"crossref","first-page":"650","DOI":"10.1089\/thy.2018.0089","article-title":"Evidence that Graves' ophthalmopathy immunoglobulins do not directly activate IGF-1 receptors","volume":"28","author":"Marcus-Samuels","year":"2018","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib78","doi-asserted-by":"crossref","DOI":"10.3390\/ijms21186561","article-title":"Is there evidence for IGF1R-stimulating abs in Graves' orbitopathy pathogenesis?","volume":"21","author":"Krieger","year":"2020","journal-title":"Int J Mol Sci"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00066-X_bib79","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1159\/000511538","article-title":"Targeting TSH and IGF-1 receptors to treat thyroid eye disease","volume":"9","author":"Neumann","year":"2020","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(25)00066-X_bib80","doi-asserted-by":"crossref","first-page":"e1653","DOI":"10.1210\/clinem\/dgab824","article-title":"Inhibition of TSH\/IGF-1 receptor crosstalk by teprotumumab as a treatment modality of thyroid eye disease","volume":"107","author":"Krieger","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib81","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamaophthalmol.2018.0806","article-title":"Association of T and B cells infiltrating orbital tissues with clinical features of Graves orbitopathy","volume":"136","author":"Rotondo Dottore","year":"2018","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib82","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.1089\/thy.2022.0173","article-title":"A multicenter, single-blind, case-control, immunohistochemical study of orbital tissue in thyroid eye disease","volume":"32","author":"Hai","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib83","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/j.1365-2265.2007.02854.x","article-title":"Susceptibility genes in Graves' ophthalmopathy: searching for a needle in a haystack?","volume":"67","author":"Bednarczuk","year":"2007","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib84","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.1210\/clinem\/dgac645","article-title":"Insights into the role of DNA methylation and gene expression in Graves orbitopathy","volume":"108","author":"Rotondo Dottore","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib85","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.1210\/clinem\/dgad030","article-title":"Gut microbiome associated with Graves disease and Graves orbitopathy: the INDIGO multicenter European study","volume":"108","author":"Biscarini","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib86","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1186\/s40168-020-00952-4","article-title":"Modulating gut microbiota in a mouse model of Graves' orbitopathy and its impact on induced disease","volume":"9","author":"Moshkelgosha","year":"2021","journal-title":"Microbiome"},{"key":"10.1016\/S2213-8587(25)00066-X_bib87","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/clinem\/dgad501","article-title":"Increased risk of thyroid eye disease following Covid-19 vaccination","volume":"109","author":"Muller","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib88","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1210\/clinem\/dgac606","article-title":"New onset or deterioration of thyroid eye disease after mRNA SARS-CoV-2 vaccines: report of 2 cases and literature review","volume":"108","author":"Mohamed","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib89","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1210\/clinem\/dgad540","article-title":"Prevalence, risk factors, and clinical and biochemical characteristics of alemtuzumab-induced Graves disease","volume":"109","author":"Ueland","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib90","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1089\/thy.2022.0251","article-title":"Management of thyroid eye disease: a consensus statement by the American Thyroid Association and the European Thyroid Association","volume":"32","author":"Burch","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib91","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1089\/thy.2010.0181","article-title":"Outcome of very long-term treatment with antithyroid drugs in Graves' hyperthyroidism associated with Graves' orbitopathy","volume":"21","author":"Elbers","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib92","doi-asserted-by":"crossref","first-page":"40","DOI":"10.5603\/EP.2014.0006","article-title":"Radioactive iodine (RAI) treatment of hyperthyroidism is safe in patients with Graves' orbitopathy\u2013a prospective study","volume":"65","author":"Kr\u00f3l","year":"2014","journal-title":"Endokrynol Pol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib93","doi-asserted-by":"crossref","first-page":"5321","DOI":"10.1210\/jc.2005-0507","article-title":"A prospective study of the effects of radioiodine therapy for hyperthyroidism in patients with minimally active graves' ophthalmopathy","volume":"90","author":"Perros","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib94","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1530\/EJE-07-0450","article-title":"TSH-receptor autoimmunity in Graves' disease after therapy with anti-thyroid drugs, surgery, or radioiodine: a 5-year prospective randomized study","volume":"158","author":"Laurberg","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib95","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1007\/s40618-015-0255-1","article-title":"Total thyroid ablation in Graves' orbitopathy","volume":"38","author":"Menconi","year":"2015","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(25)00066-X_bib96","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1210\/jc.2013-3093","article-title":"Radioiodine ablation of postsurgical thyroid remnants after treatment with recombinant human TSH (rhTSH) in patients with moderate-to-severe graves' orbitopathy (GO): a prospective, randomized, single-blind clinical trial","volume":"99","author":"Moleti","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib97","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2967\/jnumed.122.264660","article-title":"Radioiodine ablation of thyroid remnants in patients with Graves' orbitopathy","volume":"64","author":"Oeverhaus","year":"2023","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib98","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1016\/j.eprac.2023.01.006","article-title":"Long-term follow-up of Graves orbitopathy after treatment with short- or long-term methimazole or radioactive iodine","volume":"29","author":"Azizi","year":"2023","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(25)00066-X_bib99","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1111\/cen.14721","article-title":"Audit of long-term treatment outcomes of thyrotoxicosis in a single-centre virtual clinic: the utility of long-term antithyroid drugs","volume":"97","author":"Levy","year":"2022","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib100","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1210\/clinem\/dgad538","article-title":"Outcomes of patients with Graves disease 25 years after initiating antithyroid drug therapy","volume":"109","author":"Meling Stokland","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib101","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1055\/a-1373-5523","article-title":"Predicting the relapse of hyperthyroidism in treated Graves' disease with orbitopathy by serial measurements of TSH-receptor autoantibodies","volume":"53","author":"St\u00f6hr","year":"2021","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(25)00066-X_bib102","doi-asserted-by":"crossref","first-page":"1670","DOI":"10.1136\/bjophthalmol-2011-300487","article-title":"Validity and reliability of the TED-QOL: a new three-item questionnaire to assess quality of life in thyroid eye disease","volume":"95","author":"Fayers","year":"2011","journal-title":"Br J Ophthalmol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00066-X_bib103","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1159\/000510700","article-title":"Proposal for standardization of primary and secondary outcomes in patients with active, moderate-to-severe Graves' orbitopathy","volume":"9","author":"Bartalena","year":"2020","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(25)00066-X_bib104","doi-asserted-by":"crossref","first-page":"1617","DOI":"10.4103\/ijo.IJO_2183_19","article-title":"Assessing the quality of life in Indian Graves' orbitopathy patients and validation of Hindi version of GO-QOL questionnaire","volume":"68","author":"Delampady","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib105","doi-asserted-by":"crossref","first-page":"2009","DOI":"10.1007\/s00417-021-05103-5","article-title":"Quality of life of patients with thyroid eye disease: 3-year follow-up in a multidisciplinary clinic in Israel","volume":"259","author":"Zloto","year":"2021","journal-title":"Graefes Arch Clin Exp Ophthalmol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00066-X_bib106","doi-asserted-by":"crossref","first-page":"S27","DOI":"10.1210\/clinem\/dgac230","article-title":"Measuring health-related quality of life in thyroid eye disease","volume":"107","author":"Sharma","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib107","doi-asserted-by":"crossref","first-page":"1609","DOI":"10.4103\/ijo.IJO_1918_19","article-title":"Thyroid eye disease survey: an anonymous web-based survey in the Indian subcontinent","volume":"68","author":"Pradhan","year":"2020","journal-title":"Indian J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib108","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0269","article-title":"A Chinese survey of clinical practice on the management of thyroid eye disease","volume":"13","author":"Chen","year":"2024","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(25)00066-X_bib109","doi-asserted-by":"crossref","first-page":"173","DOI":"10.7861\/clinmedicine.15-2-173","article-title":"Management of patients with Graves' orbitopathy: initial assessment, management outside specialised centres and referral pathways","volume":"15","author":"Perros","year":"2015","journal-title":"Clin Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib110","first-page":"57","article-title":"The relationship between Graves' ophthalmopathy and dry eye syndrome","volume":"9","author":"Selter","year":"2014","journal-title":"Clin Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib111","doi-asserted-by":"crossref","first-page":"1183","DOI":"10.1016\/S0161-6420(02)01041-2","article-title":"Treatment of upper eyelid retraction associated with thyroid eye disease with subconjunctival botulinum toxin injection","volume":"109","author":"Uddin","year":"2002","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(25)00066-X_bib112","doi-asserted-by":"crossref","first-page":"1380","DOI":"10.1136\/bjo.2004.046193","article-title":"Treatment of thyroid associated ophthalmopathy with periocular injections of triamcinolone","volume":"88","author":"Ebner","year":"2004","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib113","doi-asserted-by":"crossref","DOI":"10.5935\/0004-2749.20230063","article-title":"Adverse effects associated with peribulbar injection of triamcinolone for the treatment of thyroid eye disease: a retrospective case series","volume":"86","author":"Barlatay","year":"2023","journal-title":"Arq Bras Oftalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib114","doi-asserted-by":"crossref","first-page":"1920","DOI":"10.1056\/NEJMoa1012985","article-title":"Selenium and the course of mild Graves' orbitopathy","volume":"364","author":"Marcocci","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1038\/s41574-019-0311-6","article-title":"Selenium in thyroid disorders \u2013 essential knowledge for clinicians","volume":"16","author":"Winther","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib116","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1530\/EJE-07-0558","article-title":"Methylprednisolone pulse therapy for patients with moderately severe Graves' orbitopathy: a prospective, randomized, placebo-controlled study","volume":"158","author":"van Geest","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib117","doi-asserted-by":"crossref","first-page":"5234","DOI":"10.1210\/jc.2005-0148","article-title":"Randomized, single blind trial of intravenous versus oral steroid monotherapy in Graves' orbitopathy","volume":"90","author":"Kahaly","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib118","doi-asserted-by":"crossref","first-page":"4454","DOI":"10.1210\/jc.2012-2389","article-title":"Efficacy and safety of three different cumulative doses of intravenous methylprednisolone for moderate to severe and active Graves' orbitopathy","volume":"97","author":"Bartalena","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib119","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1210\/jc.2014-3014","article-title":"Efficacy of B-cell targeted therapy with rituximab in patients with active moderate to severe Graves' orbitopathy: a randomized controlled study","volume":"100","author":"Salvi","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib120","doi-asserted-by":"crossref","first-page":"287","DOI":"10.1016\/S2213-8587(18)30020-2","article-title":"Mycophenolate plus methylprednisolone versus methylprednisolone alone in active, moderate-to-severe Graves' orbitopathy (MINGO): a randomised, observer-masked, multicentre trial","volume":"6","author":"Kahaly","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib121","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1530\/EJE-11-0779","article-title":"Fatal and non-fatal adverse events of glucocorticoid therapy for Graves' orbitopathy: a questionnaire survey among members of the European Thyroid Association","volume":"166","author":"Marcocci","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib122","doi-asserted-by":"crossref","DOI":"10.1155\/2018\/4845894","article-title":"Corticosteroids for Graves' ophthalmopathy: systematic review and meta-analysis","volume":"2018","author":"Tu","year":"2018","journal-title":"BioMed Res Int"},{"key":"10.1016\/S2213-8587(25)00066-X_bib123","doi-asserted-by":"crossref","DOI":"10.1111\/ijcp.13608","article-title":"Comparison of efficacy and safety of parenteral versus parenteral and oral glucocorticoid therapy in Graves' orbitopathy","volume":"74","author":"Nedeljkovic Beleslin","year":"2020","journal-title":"Int J Clin Pract"},{"key":"10.1016\/S2213-8587(25)00066-X_bib124","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1001\/jamaophthalmol.2021.6284","article-title":"Proptosis and diplopia response with teprotumumab and placebo vs the recommended treatment regimen with intravenous methylprednisolone in moderate to severe thyroid eye disease: a meta-analysis and matching-adjusted indirect comparison","volume":"140","author":"Douglas","year":"2022","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib125","doi-asserted-by":"crossref","DOI":"10.1136\/bmjophth-2023-001515","article-title":"Graves' ophthalmopathy: the clinical and psychosocial outcomes of different medical interventions \u2013 a systematic review","volume":"9","author":"Bello","year":"2024","journal-title":"BMJ Open Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib126","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1210\/jc.2010-1962","article-title":"Clinical review: intravenous glucocorticoids for Graves' orbitopathy: efficacy and morbidity","volume":"96","author":"Zang","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib127","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1136\/bjophthalmol-2018-313697","article-title":"Treatment strategies for Graves' ophthalmopathy: a network meta-analysis","volume":"104","author":"Zhou","year":"2020","journal-title":"Br J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib128","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ophtha.2021.10.025","article-title":"Orbital radiation for thyroid eye disease: a report by the American Academy of Ophthalmology","volume":"129","author":"Sobel","year":"2022","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(25)00066-X_bib129","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/j.1365-2265.1987.tb00836.x","article-title":"Orbital cobalt irradiation combined with retrobulbar or systemic corticosteroids for Graves' ophthalmopathy: a comparative study","volume":"27","author":"Marcocci","year":"1987","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib130","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1056\/NEJMoa1910434","article-title":"Teprotumumab for the treatment of active thyroid eye disease","volume":"382","author":"Douglas","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib131","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1097\/IOP.0000000000002531","article-title":"Proptosis regression after teprotumumab treatment for thyroid eye disease","volume":"40","author":"Rosenblatt","year":"2024","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/S2213-8587(25)00066-X_bib132","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1097\/IOP.0000000000002564","article-title":"Teprotumumab for the treatment of recalcitrant thyroid eye disease","volume":"40","author":"Men","year":"2024","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/S2213-8587(25)00066-X_bib133","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1097\/IOP.0000000000002611","article-title":"Teprotumumab for thyroid eye disease-related strabismus","volume":"40","author":"Dallalzadeh","year":"2024","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/S2213-8587(25)00066-X_bib134","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1097\/WNO.0000000000002066","article-title":"Stability of ocular alignment after teprotumumab therapy in a cohort of patients with thyroid eye disease and baseline diplopia","volume":"44","author":"Davis","year":"2024","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib135","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1016\/j.ophtha.2021.04.024","article-title":"Teprotumumab: interpreting the clinical trials in the context of thyroid eye disease pathogenesis and current therapies","volume":"128","author":"Winn","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(25)00066-X_bib136","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/j.ajo.2023.12.001","article-title":"Reactivation after teprotumumab treatment for active thyroid eye disease","volume":"263","author":"Hwang","year":"2024","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib137","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1007\/s11096-023-01676-9","article-title":"Data mining and analysis of adverse event signals associated with teprotumumab using the Food and Drug Administration adverse event reporting system database","volume":"46","author":"Zhang","year":"2024","journal-title":"Int J Clin Pharm"},{"key":"10.1016\/S2213-8587(25)00066-X_bib138","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1016\/j.ophtha.2023.10.018","article-title":"Teprotumumab-related adverse events in thyroid eye disease: a multicenter study","volume":"131","author":"Shah","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(25)00066-X_bib139","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ophtha.2023.08.001","article-title":"Frequency and patterns of hearing dysfunction in patients treated with teprotumumab","volume":"131","author":"Keen","year":"2024","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(25)00066-X_bib140","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ajo.2022.02.015","article-title":"Hearing dysfunction after treatment with teprotumumab for thyroid eye disease","volume":"240","author":"Sears","year":"2022","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib141","doi-asserted-by":"crossref","first-page":"e654","DOI":"10.1210\/clinem\/dgad213","article-title":"The adverse effects profile of teprotumumab","volume":"108","author":"Stan","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib142","doi-asserted-by":"crossref","DOI":"10.1530\/ETJ-23-0043","article-title":"Teprotumumab in thyroid eye disease: wonder drug or great divider?","volume":"12","author":"Perros","year":"2023","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(25)00066-X_bib144","doi-asserted-by":"crossref","DOI":"10.3389\/fmed.2022.788228","article-title":"Mycophenolate mofetil (CellCept\u00ae) in combination with low dose prednisolone in moderate to severe Graves' orbitopathy","volume":"9","author":"Rajabi","year":"2022","journal-title":"Front Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib145","article-title":"Therapeutic outcomes of mycophenolate mofetil and glucocorticoid in thyroid-associated ophthalmopathy patients","volume":"14","author":"Li","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib146","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1097\/IOP.0000000000000037","article-title":"Treatment of active corticosteroid-resistant Graves' orbitopathy","volume":"30","author":"P\u00e9rez-Moreiras","year":"2014","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/S2213-8587(25)00066-X_bib147","doi-asserted-by":"crossref","DOI":"10.3390\/jcm9092816","article-title":"Anti-IL-6 receptor tocilizumab in refractory Graves' orbitopathy: national multicenter observational study of 48 patients","volume":"9","author":"S\u00e1nchez-Bilbao","year":"2020","journal-title":"J Clin Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib148","doi-asserted-by":"crossref","first-page":"706","DOI":"10.3390\/jcm10040706","article-title":"Steroid-resistant Graves' orbitopathy treated with tocilizumab in real-world clinical practice: a 9-year single-center experience","volume":"10","author":"P\u00e9rez-Moreiras","year":"2021","journal-title":"J Clin Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib149","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.ajo.2018.07.038","article-title":"Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant Graves orbitopathy: a randomized clinical trial","volume":"195","author":"Perez-Moreiras","year":"2018","journal-title":"Am J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib150","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10792-024-03117-6","article-title":"Efficacy of tocilizumab in patients with moderate-to-severe corticosteroid-resistant thyroid eye disease: a prospective study","volume":"44","author":"Lee","year":"2024","journal-title":"Int Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib151","doi-asserted-by":"crossref","first-page":"222","DOI":"10.1007\/s10792-024-03143-4","article-title":"Tocilizumab use for optic nerve compression in thyroid eye disease: a prospective longitudinal cohort","volume":"44","author":"Habroosh","year":"2024","journal-title":"Int Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib152","doi-asserted-by":"crossref","first-page":"2997","DOI":"10.1210\/clinem\/dgae526","article-title":"Effectiveness of different treatment modalities in initial and chronic phases of thyroid eye disease: a systematic review with meta-analysis","volume":"109","author":"Alves","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib153","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1097\/IOP.0000000000002573","article-title":"Efficiency and safety of tocilizumab for the treatment of thyroid eye disease: a systematic review","volume":"40","author":"Duarte","year":"2024","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/S2213-8587(25)00066-X_bib154","doi-asserted-by":"crossref","first-page":"432","DOI":"10.1210\/jc.2014-2572","article-title":"Randomized controlled trial of rituximab in patients with Graves' orbitopathy","volume":"100","author":"Stan","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib155","doi-asserted-by":"crossref","first-page":"R101","DOI":"10.1530\/EJE-16-0552","article-title":"Management of endocrine disease: rituximab therapy for Graves' orbitopathy \u2013 lessons from randomized control trials","volume":"176","author":"Stan","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib156","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1089\/thy.2020.0269","article-title":"Efficacy profile and safety of very low-dose rituximab in patients with Graves' orbitopathy","volume":"31","author":"Vannucchi","year":"2021","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib157","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1111\/j.0954-6820.1986.tb02749.x","article-title":"Treatment of Graves' ophthalmopathy with cyclosporin A","volume":"220","author":"Kvetny","year":"1986","journal-title":"Acta Med Scand"},{"key":"10.1016\/S2213-8587(25)00066-X_bib158","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1111\/j.1365-2362.1986.tb01016.x","article-title":"Ciclosporin and prednisone v. prednisone in treatment of Graves' ophthalmopathy: a controlled, randomized and prospective study","volume":"16","author":"Kahaly","year":"1986","journal-title":"Eur J Clin Invest"},{"key":"10.1016\/S2213-8587(25)00066-X_bib159","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1056\/NEJM198911163212002","article-title":"Prednisone and cyclosporine in the treatment of severe Graves' ophthalmopathy","volume":"321","author":"Prummel","year":"1989","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib160","series-title":"Goodman & Gilman's the pharmacological basis of therapeutics","year":"2018"},{"key":"10.1016\/S2213-8587(25)00066-X_bib161","first-page":"8","article-title":"Azathioprine in the treatment of thyroid-associated ophthalmopathy","volume":"122","author":"Perros","year":"1990","journal-title":"Acta Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib162","doi-asserted-by":"crossref","first-page":"953","DOI":"10.5301\/ejo.5000463","article-title":"Safety and efficacy of combined immunosuppression and orbital radiotherapy in thyroid-related restrictive myopathy: two-center experience","volume":"24","author":"Chalvatzis","year":"2014","journal-title":"Eur J Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib163","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1016\/S2213-8587(18)30021-4","article-title":"Combined immunosuppression and radiotherapy in thyroid eye disease (CIRTED): a multicentre, 2 \u00d7 2 factorial, double-blind, randomised controlled trial","volume":"6","author":"Rajendram","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib164","doi-asserted-by":"crossref","first-page":"2171","DOI":"10.1007\/s40618-022-01862-y","article-title":"Sirolimus as a second-line treatment for Graves' orbitopathy","volume":"45","author":"Lanzolla","year":"2022","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(25)00066-X_bib165","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1007\/s40618-024-02470-8","article-title":"Long-term outcome of Graves' orbitopathy following treatment with sirolimus","volume":"48","author":"Comi","year":"2025","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(25)00066-X_bib166","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/s41433-019-0340-3","article-title":"Sirolimus (rapamycin) for the targeted treatment of the fibrotic sequelae of Graves' orbitopathy","volume":"33","author":"Roos","year":"2019","journal-title":"Eye"},{"key":"10.1016\/S2213-8587(25)00066-X_bib167","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.160377","article-title":"Rapamycin improves Graves' orbitopathy by suppressing CD4+ cytotoxic T lymphocytes","volume":"8","author":"Zhang","year":"2023","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(25)00066-X_bib168","doi-asserted-by":"crossref","first-page":"222","DOI":"10.2174\/1570161116666180817155058","article-title":"The pleiotropic effects of statins \u2013 from coronary artery disease and stroke to atrial fibrillation and ventricular tachyarrhythmia","volume":"17","author":"Oesterle","year":"2019","journal-title":"Curr Vasc Pharmacol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib169","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12020-023-03680-5","article-title":"Statins and thyroid eye disease (TED): a systematic review","volume":"85","author":"Malboosbaf","year":"2024","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(25)00066-X_bib170","series-title":"Graves' orbitopathy: a multidisciplinary approach questions and answers","article-title":"Management of moderately severe Graves' orbitopathy","author":"Kahaly","year":"2017"},{"key":"10.1016\/S2213-8587(25)00066-X_bib171","doi-asserted-by":"crossref","first-page":"e1189","DOI":"10.1111\/aos.15074","article-title":"Comparative effectiveness of different treatment modalities for active, moderate-to-severe Graves' orbitopathy: a systematic review and network meta-analysis","volume":"100","author":"Li","year":"2022","journal-title":"Acta Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib172","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1089\/thy.2013.0445","article-title":"Therapeutic outcomes of high-dose intravenous steroids in the treatment of dysthyroid optic neuropathy","volume":"24","author":"Curr\u00f2","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib173","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1097\/WNO.0000000000001994","article-title":"Real-world experience with teprotumumab in patients with dysthyroid optic neuropathy","volume":"44","author":"Tamhankar","year":"2024","journal-title":"J Neuroophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib174","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1111\/j.1365-2265.2005.02345.x","article-title":"Surgical or medical decompression as a first-line treatment of optic neuropathy in Graves' ophthalmopathy? A randomized controlled trial","volume":"63","author":"Wakelkamp","year":"2005","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib175","doi-asserted-by":"crossref","DOI":"10.1016\/j.ophtha.2021.03.004","article-title":"Teprotumumab for asymmetric thyroid eye disease","volume":"128","author":"Ugradar","year":"2021","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(25)00066-X_bib176","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1210\/clinem\/dgad637","article-title":"Efficacy and safety of teprotumumab in patients with thyroid eye disease of long duration and low disease activity","volume":"109","author":"Douglas","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib177","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1016\/j.beem.2011.11.002","article-title":"Surgical treatment of Graves' ophthalmopathy","volume":"26","author":"Eckstein","year":"2012","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib178","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1097\/IOP.0000000000001949","article-title":"Risk factors for new onset diplopia after graduated orbital decompression","volume":"37","author":"St\u00e4hr","year":"2021","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/S2213-8587(25)00066-X_bib179","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1080\/01676830.2019.1600148","article-title":"Influence of surgical approach for decompression on lower eyelid position in thyroid eye disease","volume":"39","author":"Thorne","year":"2020","journal-title":"Orbit"},{"key":"10.1016\/S2213-8587(25)00066-X_bib180","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1089\/thy.2021.0411","article-title":"The effect of ophthalmic surgery for Graves' orbitopathy on quality of life: a systematic review and meta-analysis","volume":"32","author":"Woo","year":"2022","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib181","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.survophthal.2017.03.007","article-title":"Orbital decompression for thyroid eye disease","volume":"63","author":"Rootman","year":"2018","journal-title":"Surv Ophthalmol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib182","doi-asserted-by":"crossref","first-page":"2401","DOI":"10.1007\/s00405-021-07003-0","article-title":"Proposing a surgical algorithm for graduated orbital decompression in patients with Graves' orbitopathy","volume":"279","author":"St\u00e4hr","year":"2022","journal-title":"Eur Arch Otorhinolaryngol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib183","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1089\/thy.2022.0564","article-title":"Clinical and visual outcomes of dysthyroid optic neuropathy after surgical orbital decompression","volume":"33","author":"Curr\u00f2","year":"2023","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00066-X_bib184","doi-asserted-by":"crossref","first-page":"1004","DOI":"10.1177\/1120672119852322","article-title":"Orbital fat expansion in thyroid eye disease is related to age","volume":"30","author":"Ugradar","year":"2020","journal-title":"Eur J Ophthalmol"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(25)00066-X_bib185","first-page":"222","article-title":"Orbital fat decompression for Graves' orbitopathy: a literature review","volume":"7","author":"Boboridis","year":"2010","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/S2213-8587(25)00066-X_bib186","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1080\/09273972.2018.1450430","article-title":"Tendon elongation with bovine pericardium in patients with severe esotropia after decompression in Graves' orbitopathy-efficacy and long-term stability","volume":"26","author":"Oeverhaus","year":"2018","journal-title":"Strabismus"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00066-X_bib187","doi-asserted-by":"crossref","first-page":"S75","DOI":"10.1097\/IOP.0000000000001148","article-title":"Surgical treatment of diplopia in Graves orbitopathy patients","volume":"34","author":"Eckstein","year":"2018","journal-title":"Ophthalmic Plast Reconstr Surg"},{"key":"10.1016\/S2213-8587(25)00066-X_bib188","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/s13005-024-00423-3","article-title":"Long-term surgical outcome and impact on daily life activities of strabismus surgery in thyroid-associated ophthalmopathy with and without previous orbital decompression","volume":"20","author":"Roda","year":"2024","journal-title":"Head Face Med"},{"key":"10.1016\/S2213-8587(25)00066-X_bib189","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1055\/a-1325-9061","article-title":"Eyelid surgery in Graves' orbitopathy","volume":"238","author":"Hintschich","year":"2021","journal-title":"Klin Monbl Augenheilkd"},{"key":"10.1016\/S2213-8587(25)00066-X_bib190","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1111\/j.1365-2265.2010.03831.x","article-title":"Monoclonal autoantibodies to the TSH receptor, one with stimulating activity and one with blocking activity, obtained from the same blood sample","volume":"73","author":"Evans","year":"2010","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib191","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1111\/cen.14681","article-title":"TSH receptor specific monoclonal autoantibody K1-70TM targeting of the TSH receptor in subjects with Graves' disease and Graves' orbitopathy\u2013results from a phase I clinical trial","volume":"96","author":"Furmaniak","year":"2022","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib192","author":"Sun"},{"key":"10.1016\/S2213-8587(25)00066-X_bib193","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1089\/thy.2022.0694","article-title":"Thyrotropin receptor antagonism by a novel small molecule: preclinical in vitro observations","volume":"33","author":"Kahaly","year":"2023","journal-title":"Thyroid"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00066-X_bib194","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1159\/000511871","article-title":"Modulating TSH receptor signaling for therapeutic benefit","volume":"9","author":"Krause","year":"2020","journal-title":"Eur Thyroid J"},{"key":"10.1016\/S2213-8587(25)00066-X_bib196","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2023.1211473","article-title":"Linsitinib, an IGF-1R inhibitor, attenuates disease development and progression in a model of thyroid eye disease","volume":"14","author":"Gulbins","year":"2023","journal-title":"Front Endocrinol"},{"key":"10.1016\/S2213-8587(25)00066-X_bib197","doi-asserted-by":"crossref","first-page":"3122","DOI":"10.1210\/clinem\/dgad381","article-title":"Proof-of-concept and randomized, placebo-controlled trials of an FcRn inhibitor, batoclimab, for thyroid eye disease","volume":"108","author":"Kahaly","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib198","doi-asserted-by":"crossref","first-page":"e1938","DOI":"10.1210\/clinem\/dgad693","article-title":"The race for new treatments for Graves orbitopathy (thyroid eye disease)","volume":"109","author":"Dayan","year":"2024","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(25)00066-X_bib199","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1210\/clinem\/dgab763","article-title":"Adjuvant rituximab-exploratory trial in young people with Graves disease","volume":"107","author":"Cheetham","year":"2022","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872500066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872500066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,23]],"date-time":"2025-12-23T21:26:17Z","timestamp":1766525177000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872500066X"}},"issued":{"date-parts":[[2025,7]]},"references-count":197,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2025,7]]}},"alternative-id":["S221385872500066X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00066-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00066-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T23:08:35Z","timestamp":1784070515019,"version":"3.55.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/s2213-8587(26)00164-6","type":"journal-article","created":{"date-parts":[[2026,7,1]],"date-time":"2026-07-01T22:58:04Z","timestamp":1782946684000},"page":"617","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Out of touch medical care"],"prefix":"10.1016","volume":"14","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001646?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001646?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,7,14]],"date-time":"2026-07-14T22:48:50Z","timestamp":1784069330000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726001646"}},"issued":{"date-parts":[[2026,8]]},"references-count":0,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2026,8]]}},"alternative-id":["S2213858726001646"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00164-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Out of touch medical care","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00164-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T13:12:59Z","timestamp":1778764379759,"version":"3.51.4"},"update-to":[{"DOI":"10.1016\/s2213-8587(25)00225-6","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/s2213-8587(26)00078-1","type":"journal-article","created":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T22:44:32Z","timestamp":1774997072000},"page":"e9","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2025; 13: 935\u201348"],"prefix":"10.1016","volume":"14","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000781?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000781?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:52:44Z","timestamp":1778763164000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000781"}},"issued":{"date-parts":[[2026,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2213858726000781"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00078-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2025; 13: 935\u201348","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00078-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00225-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,31]],"date-time":"2025-10-31T07:30:18Z","timestamp":1761895818243},"reference-count":124,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/s2213-8587(13)70158-x","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T13:45:29Z","timestamp":1391435129000},"page":"141-151","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":31,"title":["Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health"],"prefix":"10.1016","volume":"2","author":[{"given":"Alexander D","family":"Miras","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Carel W","family":"le Roux","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70158-X_bib1","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1016\/S2213-8587(13)70062-7","article-title":"Metabolically healthy obesity: epidemiology, mechanisms, and clinical implications","volume":"1","author":"Stefan","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70158-X_bib2","doi-asserted-by":"crossref","first-page":"E1059","DOI":"10.1503\/cmaj.110387","article-title":"Using the Edmonton obesity staging system to predict mortality in a population-representative cohort of people with overweight and obesity","volume":"183","author":"Padwal","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(13)70158-X_bib3","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1093\/ajcn\/74.5.579","article-title":"Long-term weight-loss maintenance: a meta-analysis of US studies","volume":"74","author":"Anderson","year":"2001","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70158-X_bib4","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1056\/NEJMoa1105816","article-title":"Long-term persistence of hormonal adaptations to weight loss","volume":"365","author":"Sumithran","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib5","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199503093321001","article-title":"Changes in energy expenditure resulting from altered body weight","volume":"332","author":"Leibel","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib6","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1016\/j.neuroimage.2012.11.028","article-title":"Caloric deprivation increases responsivity of attention and reward brain regions to intake, anticipated intake, and images of palatable foods","volume":"67","author":"Stice","year":"2013","journal-title":"Neuroimage"},{"key":"10.1016\/S2213-8587(13)70158-X_bib7","doi-asserted-by":"crossref","first-page":"474","DOI":"10.1016\/j.physbeh.2008.02.014","article-title":"The effects of prolonged caloric restriction leading to weight-loss on food hedonics and reinforcement","volume":"94","author":"Cameron","year":"2008","journal-title":"Physiol Behav"},{"key":"10.1016\/S2213-8587(13)70158-X_bib8","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa061883","article-title":"A self-regulation program for maintenance of weight loss","volume":"355","author":"Wing","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib9","doi-asserted-by":"crossref","first-page":"2102","DOI":"10.1056\/NEJMoa1007137","article-title":"Diets with high or low protein content and glycemic index for weight-loss maintenance","volume":"363","author":"Larsen","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib10","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib11","doi-asserted-by":"crossref","first-page":"641","DOI":"10.5665\/sleep.2618","article-title":"Long-term effect of weight loss on obstructive sleep apnea severity in obese patients with type 2 diabetes","volume":"36","author":"Kuna","year":"2013","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(13)70158-X_bib12","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1001\/jama.2012.67929","article-title":"Association of an intensive lifestyle intervention with remission of type 2 diabetes","volume":"308","author":"Gregg","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70158-X_bib13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1056\/NEJMoa1110294","article-title":"Lifestyle change and mobility in obese adults with type 2 diabetes","volume":"366","author":"Rejeski","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib14","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1136\/bmj.39385.413113.25","article-title":"Long term pharmacotherapy for obesity and overweight: updated meta-analysis","volume":"335","author":"Rucker","year":"2007","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70158-X_bib15","doi-asserted-by":"crossref","first-page":"1426","DOI":"10.1038\/oby.2012.66","article-title":"Randomized placebo-controlled clinical trial of lorcaserin for weight loss in type 2 diabetes mellitus: the BLOOM-DM study","volume":"20","author":"O'Neil","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(13)70158-X_bib16","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1016\/S0140-6736(11)60205-5","article-title":"Effects of low-dose, controlled-release, phentermine plus topiramate combination on weight and associated comorbidities in overweight and obese adults (CONQUER): a randomised, placebo-controlled, phase 3 trial","volume":"377","author":"Gadde","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70158-X_bib17","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1056\/NEJMoa066254","article-title":"Effects of bariatric surgery on mortality in Swedish obese subjects","volume":"357","author":"Sj\u00f6str\u00f6m","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib18","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jama.299.3.316","article-title":"Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial","volume":"299","author":"Dixon","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70158-X_bib19","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","article-title":"Bariatric surgery versus intensive medical therapy in obese patients with diabetes","volume":"366","author":"Schauer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib20","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1200111","article-title":"Bariatric surgery versus conventional medical therapy for type 2 diabetes","volume":"366","author":"Mingrone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib21","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/jama.2013.5835","article-title":"Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial","volume":"309","author":"Ikramuddin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70158-X_bib22","doi-asserted-by":"crossref","first-page":"2613","DOI":"10.2337\/dc12-0193","article-title":"Cardiovascular events after bariatric surgery in obese subjects with type 2 diabetes","volume":"35","author":"Romeo","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70158-X_bib23","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1001\/jama.2011.1914","article-title":"Bariatric surgery and long-term cardiovascular events","volume":"307","author":"Sj\u00f6str\u00f6m","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70158-X_bib24","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJMoa0901836","article-title":"Perioperative safety in the longitudinal assessment of bariatric surgery","volume":"361","author":"Flum","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib25","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1038\/nrendo.2012.48","article-title":"Nutritional deficiencies after bariatric surgery","volume":"8","author":"Bal","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(13)70158-X_bib26","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/j.amjmed.2008.09.041","article-title":"Weight and type 2 diabetes after bariatric surgery: systematic review and meta-analysis","volume":"122","author":"Buchwald","year":"2009","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib27","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1381\/096089206778026316","article-title":"Systematic review of medium-term weight loss after bariatric operations","volume":"16","author":"O'Brien","year":"2006","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib28","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0039-6060(03)00392-1","article-title":"Laparoscopic adjustable gastric banding in the treatment of obesity: a systematic review","volume":"135","author":"Chapman","year":"2004","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(13)70158-X_bib29","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1016\/j.soard.2009.05.011","article-title":"Systematic review of sleeve gastrectomy as staging and primary bariatric procedure","volume":"5","author":"Brethauer","year":"2009","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(13)70158-X_bib30","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1530\/EJE-07-0145","article-title":"Surgical treatment of obesity","volume":"158","author":"Bult","year":"2008","journal-title":"European journal of endocrinology\/European Federation of Endocrine Societies"},{"key":"10.1016\/S2213-8587(13)70158-X_bib31","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1007\/s11695-008-9750-1","article-title":"Revisional bariatric surgery","volume":"19","author":"Lim","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib32","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/SLA.0b013e3181e90b31","article-title":"Long-term results of laparoscopic sleeve gastrectomy for obesity","volume":"252","author":"Himpens","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib33","doi-asserted-by":"crossref","first-page":"809","DOI":"10.1097\/00000658-200106000-00011","article-title":"High failure rate after laparoscopic adjustable silicone gastric banding for treatment of morbid obesity","volume":"233","author":"DeMaria","year":"2001","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib34","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.2337\/dc09-9036","article-title":"How do we define cure of diabetes?","volume":"32","author":"Buse","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70158-X_bib35","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1002\/bjs.7704","article-title":"Effect of the definition of type II diabetes remission in the evaluation of bariatric surgery for metabolic disorders","volume":"99","author":"Pournaras","year":"2012","journal-title":"Br J Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/S0140-6736(11)61027-1","article-title":"IDF's view of bariatric surgery in type 2 diabetes","volume":"378","author":"Zimmet","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70158-X_bib37","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1464-5491.2011.03306.x","article-title":"Bariatric surgery: an IDF statement for obese Type 2 diabetes","volume":"28","author":"Dixon","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib38","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/dom.12177","article-title":"Application of the International Diabetes Federation and American Diabetes Association criteria in the assessment of metabolic control after bariatric surgery","volume":"16","author":"Miras","year":"2014","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib39","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1210\/er.2011-1044","article-title":"All bariatric surgeries are not created equal: insights from mechanistic comparisons","volume":"33","author":"Stefater","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(13)70158-X_bib40","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1053\/j.gastro.2012.07.114","article-title":"Effects of bariatric surgery on glucose homeostasis and type 2 diabetes","volume":"143","author":"Bradley","year":"2012","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(13)70158-X_bib41","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1007\/s00125-012-2556-7","article-title":"Mechanisms of improved glycaemic control after Roux-en-Y gastric bypass","volume":"55","author":"Dirksen","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70158-X_bib42","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s11883-012-0284-6","article-title":"The effect of gastrointestinal surgery on insulin resistance and insulin secretion","volume":"14","author":"Castagneto","year":"2012","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/S2213-8587(13)70158-X_bib43","doi-asserted-by":"crossref","first-page":"966","DOI":"10.1097\/SLA.0b013e3181efc49a","article-title":"Remission of type 2 diabetes after gastric bypass and banding: mechanisms and 2 year outcomes","volume":"252","author":"Pournaras","year":"2010","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib44","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1038\/ijo.2009.254","article-title":"Acute effects of gastric bypass versus gastric restrictive surgery on beta-cell function and insulinotropic hormones in severely obese patients with type 2 diabetes","volume":"34","author":"Kashyap","year":"2010","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(13)70158-X_bib45","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1038\/oby.2007.83","article-title":"Effects of gastric bypass and gastric banding on glucose kinetics and gut hormone release","volume":"16","author":"Rodieux","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(13)70158-X_bib46","doi-asserted-by":"crossref","first-page":"2227","DOI":"10.1210\/jc.2010-2876","article-title":"Changes in glucose homeostasis after Roux-en-Y gastric bypass surgery for obesity at day three, two months, and one year after surgery: role of gut peptides","volume":"96","author":"Falk\u00e9n","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib47","doi-asserted-by":"crossref","first-page":"80re2","DOI":"10.1126\/scitranslmed.3002043","article-title":"Differential metabolic impact of gastric bypass surgery versus dietary intervention in obese diabetic subjects despite identical weight loss","volume":"3","author":"Laferrere","year":"2011","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib48","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1210\/jc.2007-2851","article-title":"Effect of weight loss by gastric bypass surgery versus hypocaloric diet on glucose and incretin levels in patients with type 2 diabetes","volume":"93","author":"Laferr\u00e8re","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib49","doi-asserted-by":"crossref","first-page":"786","DOI":"10.1038\/ijo.2009.79","article-title":"Prospective study of gut hormone and metabolic changes after adjustable gastric banding and Roux-en-Y gastric bypass","volume":"33","author":"Korner","year":"2009","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(13)70158-X_bib50","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1007\/s11695-011-0412-3","article-title":"Early improvement in glycemic control after bariatric surgery and its relationships with insulin, GLP-1, and glucagon secretion in type 2 diabetic patients","volume":"21","author":"Umeda","year":"2011","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib51","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1002\/bjs.5227","article-title":"Progressive rise in gut hormone levels after Roux-en-Y gastric bypass suggests gut adaptation and explains altered satiety","volume":"93","author":"Borg","year":"2006","journal-title":"Br J Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib52","doi-asserted-by":"crossref","first-page":"1709","DOI":"10.2337\/dc06-1549","article-title":"Incretin levels and effect are markedly enhanced 1 month after Roux-en-Y gastric bypass surgery in obese patients with type 2 diabetes","volume":"30","author":"Laferr\u00e8re","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70158-X_bib53","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1210\/jc.2004-1076","article-title":"Effects of Roux-en-Y gastric bypass surgery on fasting and postprandial concentrations of plasma ghrelin, peptide YY, and insulin","volume":"90","author":"Korner","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib54","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1530\/EJE-10-0804","article-title":"Beta cell function after weight loss: a clinical trial comparing gastric bypass surgery and intensive lifestyle intervention","volume":"164","author":"Hofs\u00f8","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(13)70158-X_bib55","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1177\/000313480907500608","article-title":"Dual mechanism for type-2 diabetes resolution after Roux-en-Y gastric bypass","volume":"75","author":"Lin","year":"2009","journal-title":"Am Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib56","doi-asserted-by":"crossref","first-page":"1179","DOI":"10.1381\/096089206778392383","article-title":"Morbidly obese individuals with impaired fasting glucose have a specific pattern of insulin secretion and sensitivity: effect of weight loss after bariatric surgery","volume":"16","author":"Garc\u00eda-Fuentes","year":"2006","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib57","doi-asserted-by":"crossref","first-page":"2525","DOI":"10.1210\/jc.2011-0165","article-title":"Roux-en-Y gastric bypass corrects hyperinsulinemia implications for the remission of type 2 diabetes","volume":"96","author":"Reed","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib58","doi-asserted-by":"crossref","first-page":"1594","DOI":"10.1381\/096089206779319338","article-title":"GLP-1 and changes in glucose tolerance following gastric bypass surgery in morbidly obese subjects","volume":"16","author":"Mor\u00ednigo","year":"2006","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib59","doi-asserted-by":"crossref","first-page":"E706","DOI":"10.1152\/ajpendo.00405.2010","article-title":"Improvement in \u03b2-cell function in patients with normal and hyperglycemia following Roux-en-Y gastric bypass surgery","volume":"299","author":"Lin","year":"2010","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib60","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2337\/dc09-2107","article-title":"The importance of caloric restriction in the early improvements in insulin sensitivity after Roux-en-Y gastric bypass surgery","volume":"33","author":"Isbell","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70158-X_bib61","doi-asserted-by":"crossref","first-page":"E1372","DOI":"10.1210\/jc.2011-0446","article-title":"The role of beta-cell function and insulin sensitivity in the remission of type 2 diabetes after gastric bypass surgery","volume":"96","author":"Nannipieri","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib62","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s11605-009-1060-y","article-title":"Improvement in peripheral glucose uptake after gastric bypass surgery is observed only after substantial weight loss has occurred and correlates with the magnitude of weight lost","volume":"14","author":"Campos","year":"2010","journal-title":"J Gastrointest Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib63","doi-asserted-by":"crossref","first-page":"4667","DOI":"10.1172\/JCI64895","article-title":"Gastric bypass and banding equally improve insulin sensitivity and \u03b2 cell function","volume":"122","author":"Bradley","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(13)70158-X_bib64","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1097\/SLA.0b013e3181ae32e3","article-title":"Improvement in glucose metabolism after bariatric surgery: comparison of laparoscopic Roux-en-Y gastric bypass and laparoscopic sleeve gastrectomy: a prospective randomized trial","volume":"250","author":"Peterli","year":"2009","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib65","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/j.surg.2009.10.059","article-title":"Laparoscopic sleeve gastrectomy for diabetes treatment in nonmorbidly obese patients: efficacy and change of insulin secretion","volume":"147","author":"Lee","year":"2010","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(13)70158-X_bib66","doi-asserted-by":"crossref","first-page":"3540","DOI":"10.1007\/s00464-011-1755-5","article-title":"First-phase insulin secretion, insulin sensitivity, ghrelin, GLP-1, and PYY changes 72 h after sleeve gastrectomy in obese diabetic patients: the gastric hypothesis","volume":"25","author":"Basso","year":"2011","journal-title":"Surg Endosc"},{"key":"10.1016\/S2213-8587(13)70158-X_bib67","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.2337\/diabetes.52.5.1098","article-title":"Restoration of euglycemia and normal acute insulin response to glucose in obese subjects with type 2 diabetes following bariatric surgery","volume":"52","author":"Polyzogopoulou","year":"2003","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70158-X_bib68","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.2337\/db06-0068","article-title":"Mechanisms of recovery from type 2 diabetes after malabsorptive bariatric surgery","volume":"55","author":"Guidone","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70158-X_bib69","doi-asserted-by":"crossref","first-page":"2136","DOI":"10.1007\/s00125-006-0337-x","article-title":"Restoration of normal glucose tolerance in severely obese patients after bilio-pancreatic diversion: role of insulin sensitivity and beta cell function","volume":"49","author":"Mari","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70158-X_bib70","doi-asserted-by":"crossref","first-page":"2308","DOI":"10.2337\/db11-0203","article-title":"Gastric bypass surgery enhances glucagon-like peptide 1-stimulated postprandial insulin secretion in humans","volume":"60","author":"Salehi","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70158-X_bib71","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1053\/j.gastro.2011.05.050","article-title":"Weight-independent changes in blood glucose homeostasis after gastric bypass or vertical sleeve gastrectomy in rats","volume":"141","author":"Chambers","year":"2011","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(13)70158-X_bib72","doi-asserted-by":"crossref","first-page":"976","DOI":"10.1097\/SLA.0b013e3182774522","article-title":"Alterations of global gastrointestinal motility after sleeve gastrectomy: a prospective study","volume":"258","author":"Melissas","year":"2013","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib73","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1007\/s00125-010-1798-5","article-title":"Nationwide cohort study of post-gastric bypass hypoglycaemia including 5040 patients undergoing surgery for obesity in 1986-2006 in Sweden","volume":"53","author":"Marsk","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70158-X_bib74","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1056\/NEJMoa043690","article-title":"Hyperinsulinemic hypoglycemia with nesidioblastosis after gastric-bypass surgery","volume":"353","author":"Service","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70158-X_bib75","doi-asserted-by":"crossref","first-page":"4678","DOI":"10.1210\/jc.2007-0918","article-title":"Patients with neuroglycopenia after gastric bypass surgery have exaggerated incretin and insulin secretory responses to a mixed meal","volume":"92","author":"Goldfine","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib76","first-page":"1","article-title":"Approach to the patient with postprandial hypoglycemia","volume":"18","author":"Galati","year":"2013","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(13)70158-X_bib77","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1007\/s11695-009-0026-1","article-title":"Urinary albumin excretion, HMW adiponectin, and insulin sensitivity in type 2 diabetic patients undergoing bariatric surgery","volume":"20","author":"Navaneethan","year":"2010","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib78","doi-asserted-by":"crossref","first-page":"561","DOI":"10.2337\/dc10-1761","article-title":"Effects of bilio-pancreatic diversion on diabetic complications: a 10-year follow-up","volume":"34","author":"Iaconelli","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70158-X_bib79","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.soard.2012.08.016","article-title":"Effects of bariatric surgery on diabetic nephropathy after 5 years of follow-up","volume":"9","author":"Heneghan","year":"2013","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(13)70158-X_bib80","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.2337\/dc11-2353","article-title":"Bariatric surgery does not exacerbate and may be beneficial for the microvascular complications of type 2 diabetes","volume":"35","author":"Miras","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70158-X_bib81","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/j.jamcollsurg.2012.12.019","article-title":"Bariatric surgery is associated with a reduction in major macrovascular and microvascular complications in moderately to severely obese patients with type 2 diabetes mellitus","volume":"216","author":"Johnson","year":"2013","journal-title":"J Am Coll Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib82","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1007\/s11695-012-0617-0","article-title":"Changes in renal function following Roux-en-Y gastric bypass: a prospective study","volume":"22","author":"Getty","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib83","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1053\/j.ackd.2005.02.001","article-title":"Predicting the development of diabetic nephropathy and its progression","volume":"12","author":"William","year":"2005","journal-title":"Adv Chronic Kidney Dis"},{"key":"10.1016\/S2213-8587(13)70158-X_bib84","doi-asserted-by":"crossref","first-page":"1167","DOI":"10.1097\/TP.0b013e31819e3f14","article-title":"Bariatric surgery among kidney transplant candidates and recipients: analysis of the United States renal data system and literature review","volume":"87","author":"Modanlou","year":"2009","journal-title":"Transplantation"},{"key":"10.1016\/S2213-8587(13)70158-X_bib85","doi-asserted-by":"crossref","first-page":"1838","DOI":"10.1002\/bjs.7264","article-title":"Renal cytokines improve early after bariatric surgery","volume":"97","author":"Bueter","year":"2010","journal-title":"Br J Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib86","doi-asserted-by":"crossref","first-page":"965","DOI":"10.1007\/s00125-010-2028-x","article-title":"Glucagon-like peptide-1 receptor agonist ameliorates renal injury through its anti-inflammatory action without lowering blood glucose level in a rat model of type 1 diabetes","volume":"54","author":"Kodera","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70158-X_bib87","doi-asserted-by":"crossref","first-page":"426","DOI":"10.2215\/CJN.03961106","article-title":"Acute kidney injury after gastric bypass surgery","volume":"2","author":"Thakar","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(13)70158-X_bib88","doi-asserted-by":"crossref","first-page":"826","DOI":"10.1016\/j.urology.2010.01.037","article-title":"The effect of restrictive bariatric surgery on urinary stone risk factors","volume":"76","author":"Semins","year":"2010","journal-title":"Urology"},{"key":"10.1016\/S2213-8587(13)70158-X_bib89","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1136\/bmj.290.6471.811","article-title":"Rapid tightening of blood glucose control leads to transient deterioration of retinopathy in insulin dependent diabetes mellitus: the Oslo study","volume":"290","author":"Dahl-J\u00f8rgensen","year":"1985","journal-title":"BMJ (Clin Res Ed)"},{"key":"10.1016\/S2213-8587(13)70158-X_bib90","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1007\/s11695-012-0600-9","article-title":"Bariatric surgery and diabetic retinopathy: a pilot analysis","volume":"22","author":"Varadhan","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib91","doi-asserted-by":"crossref","first-page":"2262","DOI":"10.1038\/oby.2012.122","article-title":"Improved arteriole-to-venule ratio of retinal vessels resulting from bariatric surgery","volume":"20","author":"Lammert","year":"2012","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(13)70158-X_bib92","doi-asserted-by":"crossref","first-page":"2977","DOI":"10.1007\/s00125-006-0463-5","article-title":"Pancreas transplant alone has beneficial effects on retinopathy in type 1 diabetic patients","volume":"49","author":"Giannarelli","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70158-X_bib93","doi-asserted-by":"crossref","first-page":"608534","DOI":"10.1155\/2012\/608534","article-title":"The Neurological Complications of Nutritional Deficiency following Bariatric Surgery","volume":"2012","author":"Becker","year":"2012","journal-title":"J Obes"},{"key":"10.1016\/S2213-8587(13)70158-X_bib94","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1097\/01.sla.0000089851.41115.1b","article-title":"Effect of laparoscopic Roux-en Y gastric bypass on type 2 diabetes mellitus","volume":"238","author":"Schauer","year":"2003","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib95","doi-asserted-by":"crossref","first-page":"2091","DOI":"10.1161\/CIRCULATIONAHA.107.721027","article-title":"Effects of bariatric surgery on cardiovascular function","volume":"118","author":"Ashrafian","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70158-X_bib96","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1136\/heartjnl-2012-301778","article-title":"Bariatric surgery and cardiovascular outcomes: a systematic review","volume":"98","author":"Vest","year":"2012","journal-title":"Heart"},{"key":"10.1016\/S2213-8587(13)70158-X_bib97","doi-asserted-by":"crossref","first-page":"188","DOI":"10.1038\/oby.2001.20","article-title":"Blood pressure and pulse pressure during long-term weight loss in the obese: the Swedish Obese Subjects (SOS) Intervention Study","volume":"9","author":"Sj\u00f6str\u00f6m","year":"2001","journal-title":"Obes Res"},{"key":"10.1016\/S2213-8587(13)70158-X_bib98","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1002\/lt.22435","article-title":"Excellent posttransplant survival for patients with nonalcoholic steatohepatitis in the United States","volume":"18","author":"Afzali","year":"2012","journal-title":"Liver Transpl"},{"key":"10.1016\/S2213-8587(13)70158-X_bib99","doi-asserted-by":"crossref","first-page":"811","DOI":"10.1038\/ajg.2012.128","article-title":"The diagnosis and management of non-alcoholic fatty liver disease: practice guideline by the American Association for the Study of Liver Diseases, American College of Gastroenterology, and the American Gastroenterological Association","volume":"107","author":"Chalasani","year":"2012","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(13)70158-X_bib100","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD007340.pub2","article-title":"Bariatric surgery for non-alcoholic steatohepatitis in obese patients","volume":"1","author":"Chavez-Tapia","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(13)70158-X_bib101","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1016\/j.cgh.2008.08.012","article-title":"Effect of bariatric surgery on nonalcoholic fatty liver disease: systematic review and meta-analysis","volume":"6","author":"Mummadi","year":"2008","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(13)70158-X_bib102","doi-asserted-by":"crossref","first-page":"532","DOI":"10.1053\/j.gastro.2009.04.052","article-title":"Prospective study of the long-term effects of bariatric surgery on liver injury in patients without advanced disease","volume":"137","author":"Mathurin","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(13)70158-X_bib103","doi-asserted-by":"crossref","first-page":"e60495","DOI":"10.1371\/journal.pone.0060495","article-title":"Long-term effect of bariatric surgery on liver enzymes in the Swedish Obese Subjects (SOS) study","volume":"8","author":"Burza","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70158-X_bib104","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1053\/j.gastro.2006.01.042","article-title":"Gastric bypass surgery improves metabolic and hepatic abnormalities associated with nonalcoholic fatty liver disease","volume":"130","author":"Klein","year":"2006","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(13)70158-X_bib105","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/humupd\/dmg024","article-title":"Obesity and reproductive disorders in women","volume":"9","author":"Pasquali","year":"2003","journal-title":"Hum Reprod Update"},{"key":"10.1016\/S2213-8587(13)70158-X_bib106","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1530\/REP-09-0568","article-title":"The adverse effects of obesity on conception and implantation","volume":"140","author":"Brewer","year":"2010","journal-title":"Reproduction"},{"key":"10.1016\/S2213-8587(13)70158-X_bib107","doi-asserted-by":"crossref","first-page":"2622","DOI":"10.1210\/jc.2003-031578","article-title":"Body size and ethnicity are associated with menstrual cycle alterations in women in the early menopausal transition: The Study of Women's Health across the Nation (SWAN) Daily Hormone Study","volume":"89","author":"Santoro","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib108","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.1210\/jc.2006-2274","article-title":"Pulsatile luteinizing hormone amplitude and progesterone metabolite excretion are reduced in obese women","volume":"92","author":"Jain","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib109","doi-asserted-by":"crossref","first-page":"4237","DOI":"10.1210\/jc.2006-0178","article-title":"Positions statement: criteria for defining polycystic ovary syndrome as a predominantly hyperandrogenic syndrome: an Androgen Excess Society guideline","volume":"91","author":"Azziz","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib110","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1111\/j.1467-789X.2007.00464.x","article-title":"Maternal obesity: pregnancy complications, gestational weight gain and nutrition","volume":"9","author":"Guelinckx","year":"2008","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(13)70158-X_bib111","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1159\/000008556","article-title":"Sex hormone changes in morbidly obese patients after vertical banded gastroplasty","volume":"30","author":"Bastounis","year":"1998","journal-title":"Eur Surg Res"},{"key":"10.1016\/S2213-8587(13)70158-X_bib112","doi-asserted-by":"crossref","first-page":"1410","DOI":"10.1016\/j.fertnstert.2008.08.025","article-title":"Partial recovery of luteal function after bariatric surgery in obese women","volume":"92","author":"Rochester","year":"2009","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(13)70158-X_bib113","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1381\/096089203765887697","article-title":"Contraceptive treatment after biliopancreatic diversion needs consensus","volume":"13","author":"Gerrits","year":"2003","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib114","doi-asserted-by":"crossref","first-page":"4540","DOI":"10.1210\/jc.2012-2205","article-title":"Effects of gastric bypass surgery on female reproductive function","volume":"97","author":"Legro","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib115","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1381\/096089201321209323","article-title":"Partnership, sexuality, and sexual disorders in morbidly obese women: consequences of weight loss after gastric banding","volume":"11","author":"Kinzl","year":"2001","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib116","doi-asserted-by":"crossref","first-page":"758","DOI":"10.1038\/sj.ijo.0803198","article-title":"Influence of weight reduction by sibutramine on female sexual function","volume":"30","author":"Kim","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(13)70158-X_bib117","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1381\/096089296765556700","article-title":"Impact of Bariatric Surgery on Body Image Perception and Sexuality in Morbidly Obese Patients and their Partners","volume":"6","author":"Camps","year":"1996","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70158-X_bib118","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/j.steroids.2011.12.004","article-title":"Surgical management of metabolic dysfunction in PCOS","volume":"77","author":"Escobar-Morreale","year":"2012","journal-title":"Steroids"},{"key":"10.1016\/S2213-8587(13)70158-X_bib119","doi-asserted-by":"crossref","first-page":"6364","DOI":"10.1210\/jc.2005-1490","article-title":"The polycystic ovary syndrome associated with morbid obesity may resolve after weight loss induced by bariatric surgery","volume":"90","author":"Escobar-Morreale","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1016\/j.soard.2005.02.008","article-title":"Effective treatment of polycystic ovarian syndrome with Roux-en-Y gastric bypass","volume":"1","author":"Eid","year":"2005","journal-title":"Surg Obes Relat Dis"},{"key":"10.1016\/S2213-8587(13)70158-X_bib121","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1001\/jama.2008.641","article-title":"Pregnancy and fertility following bariatric surgery: a systematic review","volume":"300","author":"Maggard","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70158-X_bib122","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1093\/humupd\/dmn057","article-title":"Reproductive outcome after bariatric surgery: a critical review","volume":"15","author":"Guelinckx","year":"2009","journal-title":"Hum Reprod Update"},{"key":"10.1016\/S2213-8587(13)70158-X_bib123","doi-asserted-by":"crossref","first-page":"1329","DOI":"10.1210\/jc.2008-1598","article-title":"Effect of Roux-en-Y gastric bypass surgery on the sex steroids and quality of life in obese men","volume":"94","author":"Hammoud","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70158-X_bib124","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1111\/j.1439-0272.2012.01300.x","article-title":"Dramatic reduction in sperm parameters following bariatric surgery: report of two cases","volume":"44","author":"Lazaros","year":"2012","journal-title":"Andrologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871370158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871370158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,3,25]],"date-time":"2022-03-25T04:42:56Z","timestamp":1648183376000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871370158X"}},"issued":{"date-parts":[[2014,2]]},"references-count":124,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S221385871370158X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70158-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Metabolic surgery: shifting the focus from glycaemia and weight to end-organ health","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70158-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70009-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70021-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70218-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,2,24]],"date-time":"2026-02-24T04:54:43Z","timestamp":1771908883670,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,5,1]],"date-time":"2024-05-01T00:00:00Z","timestamp":1714521600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,5]]},"DOI":"10.1016\/s2213-8587(24)00059-7","type":"journal-article","created":{"date-parts":[[2024,3,27]],"date-time":"2024-03-27T23:35:30Z","timestamp":1711582530000},"page":"286-287","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["How clinically relevant is statin-induced diabetes?"],"prefix":"10.1016","volume":"12","author":[{"given":"Hertzel C","family":"Gerstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marie","family":"Pigeyre","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00059-7_bib1","series-title":"IDF Diabetes Atlas","year":"2021"},{"key":"10.1016\/S2213-8587(24)00059-7_bib2","doi-asserted-by":"crossref","first-page":"1454","DOI":"10.1093\/eurheartj\/ehv083","article-title":"Mendelian randomization analysis supports the causal role of dysglycaemia and diabetes in the risk of coronary artery disease","volume":"36","author":"Ross","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(24)00059-7_bib3","doi-asserted-by":"crossref","first-page":"894","DOI":"10.2337\/dc19-1850","article-title":"Impact of glucose level on micro- and macrovascular disease in the general population: a mendelian randomization study","volume":"43","author":"Emanuelsson","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00059-7_bib4","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S2213-8587(23)00223-1","article-title":"Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation","volume":"11","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00059-7_bib5","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.2337\/dc24-S002","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20132024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00059-7_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/dc10-1206","article-title":"Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes","volume":"34","author":"Colagiuri","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00059-7_bib7","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1007\/s00125-021-05592-3","article-title":"Prediabetes and risk of mortality, diabetes-related complications and comorbidities: umbrella review of meta-analyses of prospective studies","volume":"65","author":"Schlesinger","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00059-7_bib8","article-title":"Effects of statin therapy on diagnoses of new-onset diabetes and worsening glycaemia in large-scale randomised blinded statin trials: an individual participant data meta-analysis","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00059-7_bib9","doi-asserted-by":"crossref","first-page":"1383","DOI":"10.1001\/jama.2016.14568","article-title":"Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis","volume":"316","author":"Lotta","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00059-7_bib10","doi-asserted-by":"crossref","first-page":"2144","DOI":"10.1056\/NEJMoa1604304","article-title":"Variation in PCSK9 and HMGCR and risk of cardiovascular disease and diabetes","volume":"375","author":"Ference","year":"2016","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000597?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000597?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,6]],"date-time":"2024-05-06T23:45:49Z","timestamp":1715039149000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000597"}},"issued":{"date-parts":[[2024,5]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,5]]}},"alternative-id":["S2213858724000597"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00059-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"How clinically relevant is statin-induced diabetes?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00059-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00040-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:17:32Z","timestamp":1761992252004,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/s2213-8587(23)00300-5","type":"journal-article","created":{"date-parts":[[2023,11,2]],"date-time":"2023-11-02T03:28:48Z","timestamp":1698895728000},"page":"884-886","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Balancing hormonal shifts: exploring the impact of ageing and dietary restriction"],"prefix":"10.1016","volume":"11","author":[{"given":"Stephen M","family":"Twigg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luigi","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00300-5_bib1","doi-asserted-by":"crossref","first-page":"1835","DOI":"10.1210\/clinem\/dgad225","article-title":"Hormones and aging: an endocrine society scientific statement","volume":"108","author":"Cappola","year":"2023","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00300-5_bib2","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1038\/s41580-021-00411-4","article-title":"Molecular mechanisms of dietary restriction promoting health and longevity","volume":"23","author":"Green","year":"2022","journal-title":"Nat Rev Mol Cell Biol"},{"key":"10.1016\/S2213-8587(23)00300-5_bib3","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.arr.2016.08.005","article-title":"Calorie restriction in humans: an update","volume":"39","author":"Most","year":"2017","journal-title":"Ageing Res Rev"},{"key":"10.1016\/S2213-8587(23)00300-5_bib4","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/acel.12400","article-title":"Effects of 2-year calorie restriction on circulating levels of IGF-1, IGF-binding proteins and cortisol in nonobese men and women: a randomized clinical trial","volume":"15","author":"Fontana","year":"2016","journal-title":"Aging Cell"},{"key":"10.1016\/S2213-8587(23)00300-5_bib5","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1007\/s00592-014-0635-6","article-title":"Insulin and GH-IGF-I axis: endocrine pacer or endocrine disruptor?","volume":"52","author":"Giustina","year":"2015","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(23)00300-5_bib6","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1152\/physrev.00063.2017","article-title":"Mechanisms of insulin action and insulin resistance","volume":"98","author":"Petersen","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(23)00300-5_bib7","doi-asserted-by":"crossref","first-page":"101557","DOI":"10.1016\/j.arr.2021.101557","article-title":"The hyperfunction theory: an emerging paradigm for the biology of aging","volume":"74","author":"Gems","year":"2022","journal-title":"Ageing Res Rev"},{"key":"10.1016\/S2213-8587(23)00300-5_bib8","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.1016\/j.cell.2013.05.039","article-title":"The hallmarks of aging","volume":"153","author":"L\u00f3pez-Ot\u00edn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(23)00300-5_bib9","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1093\/gerona\/glx059","article-title":"Caloric restriction and healthy life span: frail phenotype of nonhuman primates in the Wisconsin National Primate Research Center Caloric Restriction Study","volume":"73","author":"Yamada","year":"2018","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(23)00300-5_bib10","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1111\/acel.12068","article-title":"Identification of a metabolic signature for multidimensional impairment and mortality risk in hospitalized older patients","volume":"12","author":"Fontana","year":"2013","journal-title":"Aging Cell"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003005?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003005?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:55Z","timestamp":1761992035000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003005"}},"issued":{"date-parts":[[2023,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2213858723003005"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00300-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Balancing hormonal shifts: exploring the impact of ageing and dietary restriction","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00300-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:17Z","timestamp":1761991997648,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/s2213-8587(22)00041-9","type":"journal-article","created":{"date-parts":[[2022,2,2]],"date-time":"2022-02-02T19:22:37Z","timestamp":1643829757000},"page":"163","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Jennifer Manne-Goehler: at the crossroads of pandemics"],"prefix":"10.1016","volume":"10","author":[{"given":"Ray","family":"Cavanaugh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000419?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000419?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:24Z","timestamp":1761991824000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000419"}},"issued":{"date-parts":[[2022,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2213858722000419"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00041-9","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Jennifer Manne-Goehler: at the crossroads of pandemics","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00041-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,22]],"date-time":"2026-01-22T16:03:30Z","timestamp":1769097810663,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"Diabetes UK as a Strategic Research Initiative","award":["award number 13\/0004691"],"award-info":[{"award-number":["award number 13\/0004691"]}]},{"name":"Project Grant from Diabetes UK","award":["award number 17\/0005695"],"award-info":[{"award-number":["award number 17\/0005695"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/s2213-8587(18)30346-2","type":"journal-article","created":{"date-parts":[[2018,12,20]],"date-time":"2018-12-20T18:51:41Z","timestamp":1545331901000},"page":"169-172","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":27,"title":["Within-trial cost and 1-year cost-effectiveness of the DiRECT\/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes"],"prefix":"10.1016","volume":"7","author":[{"given":"Yiqiao","family":"Xin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Davies","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Louise","family":"McCombie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Andrew","family":"Briggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"C-Martina","family":"Messow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eleanor","family":"Grieve","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wilma S","family":"Leslie","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Roy","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Michael E J","family":"Lean","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30346-2_bib1","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1016\/j.diabres.2017.03.024","article-title":"IDF Diabetes Atlas: global estimates for the prevalence of diabetes for 2015 and 2040","volume":"128","author":"Ogurtsova","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(18)30346-2_bib2","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","article-title":"Excess mortality among persons with type 2 diabetes","volume":"373","author":"Tancredi","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30346-2_bib3","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1111\/1753-0407.12659","article-title":"Association between type 2 diabetes mellitus and disability: what is the contribution of diabetes risk factors and diabetes complications?","volume":"10","author":"Tabesh","year":"2018","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(18)30346-2_bib4","doi-asserted-by":"crossref","first-page":"917","DOI":"10.2337\/dci18-0007","article-title":"Economic costs of diabetes in the US in 2017","volume":"41","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30346-2_bib5","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1111\/j.1464-5491.2012.03698.x","article-title":"Estimating the current and future costs of type 1 and type 2 diabetes in the UK, including direct health costs and indirect societal and productivity costs","volume":"29","author":"Hex","year":"2012","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30346-2_bib6","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30346-2_bib7","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12875-016-0406-2","article-title":"The Diabetes Remission Clinical Trial (DiRECT): protocol for a cluster randomised trial","volume":"17","author":"Leslie","year":"2016","journal-title":"BMC Fam Pract"},{"key":"10.1016\/S2213-8587(18)30346-2_bib8","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30346-2_bib9","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1007\/s00125-017-4503-0","article-title":"Clinical and metabolic features of the randomised controlled Diabetes Remission Clinical Trial (DiRECT) cohort","volume":"61","author":"Taylor","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30346-2_bib10","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1001\/jama.2012.67929","article-title":"Association of an intensive lifestyle intervention with remission of type 2 diabetes","volume":"308","author":"Gregg","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30346-2_bib11","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1002\/osp4.92","article-title":"Cost of intervention delivery in a lifestyle weight loss trial in type 2 diabetes: results from the Look AHEAD clinical trial","volume":"3","author":"Rushing","year":"2017","journal-title":"Obes Sci Pract"},{"key":"10.1016\/S2213-8587(18)30346-2_bib12","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1478-7954-10-7","article-title":"Impact of diabetes mellitus on life expectancy and health-adjusted life expectancy in Canada","volume":"10","author":"Loukine","year":"2012","journal-title":"Popul Health Metr"},{"key":"10.1016\/S2213-8587(18)30346-2_bib13","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1111\/j.1464-5491.1990.tb01375.x","article-title":"Obesity, weight loss and prognosis in type 2 diabetes","volume":"7","author":"Lean","year":"1990","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(18)30346-2_bib14","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2337\/diacare.23.10.1499","article-title":"Intentional weight loss and mortality among overweight individuals with diabetes","volume":"23","author":"Williamson","year":"2000","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303462?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303462?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T18:52:32Z","timestamp":1550602352000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303462"}},"issued":{"date-parts":[[2019,3]]},"references-count":14,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2213858718303462"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30346-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Within-trial cost and 1-year cost-effectiveness of the DiRECT\/Counterweight-Plus weight-management programme to achieve remission of type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30346-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T05:27:06Z","timestamp":1767850026060,"version":"3.49.0"},"reference-count":5,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,9,1]],"date-time":"2016-09-01T00:00:00Z","timestamp":1472688000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001711","name":"Schweizerischer Nationalfonds zur F\u00c3\u00b6rderung der Wissenschaftlichen Forschung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,9]]},"DOI":"10.1016\/s2213-8587(16)30148-6","type":"journal-article","created":{"date-parts":[[2016,7,16]],"date-time":"2016-07-16T18:52:07Z","timestamp":1468695127000},"page":"731-732","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["The need to focus on primary health care for chronic diseases"],"prefix":"10.1016","volume":"4","author":[{"given":"David","family":"Beran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fran\u00e7ois","family":"Chappuis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sandro","family":"Cattacin","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Albertino","family":"Damasceno","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilambar","family":"Jha","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Claire","family":"Somerville","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"L Suzanne","family":"Suggs","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J Jaime","family":"Miranda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30148-6_bib1","doi-asserted-by":"crossref","first-page":"549","DOI":"10.1016\/S2213-8587(16)30110-3","article-title":"HIV and NCDs: the need to build stronger health systems","volume":"4","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30148-6_bib2","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1016\/S2213-8587(15)00388-5","article-title":"Pathophysiology and management of cardiovascular disease in patients with HIV","volume":"4","author":"Nou","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30148-6_bib3","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.1016\/S0140-6736(11)60393-0","article-title":"Priority actions for the non-communicable disease crisis","volume":"377","author":"Beaglehole","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30148-6_bib4","series-title":"Innovative care for chronic conditions: building blocks for action","year":"2002"},{"key":"10.1016\/S2213-8587(16)30148-6_bib5","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1136\/qshc.2004.010744","article-title":"Improving the quality of health care for chronic conditions","volume":"13","author":"Epping-Jordan","year":"2004","journal-title":"Qual Saf Health Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301486?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301486?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:52Z","timestamp":1761991552000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301486"}},"issued":{"date-parts":[[2016,9]]},"references-count":5,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2016,9]]}},"alternative-id":["S2213858716301486"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30148-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The need to focus on primary health care for chronic diseases","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30148-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30110-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,31]],"date-time":"2025-12-31T03:19:31Z","timestamp":1767151171416,"version":"build-2238731810"},"update-to":[{"DOI":"10.1016\/s2213-8587(23)00094-3","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000}}],"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/s2213-8587(23)00229-2","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T18:27:46Z","timestamp":1692728866000},"page":"e11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2023; 11: 402\u201313"],"prefix":"10.1016","volume":"11","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002292?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002292?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:15Z","timestamp":1761991935000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723002292"}},"issued":{"date-parts":[[2023,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2213858723002292"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00229-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Correction to Lancet Diabetes Endocrinol 2023; 11: 402\u201313","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00229-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00094-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,2,26]],"date-time":"2026-02-26T20:47:27Z","timestamp":1772138847670,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/s2213-8587(16)30263-7","type":"journal-article","created":{"date-parts":[[2016,9,16]],"date-time":"2016-09-16T19:34:15Z","timestamp":1474054455000},"page":"963-964","source":"Crossref","is-referenced-by-count":21,"title":["GLP-1 receptor agonists and SGLT2 inhibitors: a couple at last?"],"prefix":"10.1016","volume":"4","author":[{"given":"Michael A","family":"Nauck","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juris J","family":"Meier","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30263-7_bib1","author":"Frias","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30263-7_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1111\/dom.12591","article-title":"Incretin therapies: highlighting common features and differences in the modes of action of glucagon-like peptide-1 receptor agonists and dipeptidyl peptidase-4 inhibitors","volume":"18","author":"Nauck","year":"2016","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(16)30263-7_bib3","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1210\/er.2010-0029","article-title":"Role of sodium-glucose cotransporter 2 (SGLT 2) inhibitors in the treatment of type 2 diabetes","volume":"32","author":"Abdul-Ghani","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(16)30263-7_bib4","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1111\/j.1464-5491.2010.02941.x","article-title":"Relationship of baseline HbA1c and efficacy of current glucose-lowering therapies: a meta-analysis of randomized clinical trials","volume":"27","author":"DeFronzo","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(16)30263-7_bib5","doi-asserted-by":"crossref","first-page":"1730","DOI":"10.2337\/dc15-0355","article-title":"Energy balance after sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Ferrannini","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30263-7_bib6","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.2337\/dc15-0843","article-title":"Euglycemic diabetic ketoacidosis: a potential complication of treatment with sodium-glucose cotransporter 2 inhibition","volume":"38","author":"Peters","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30263-7_bib7","doi-asserted-by":"crossref","first-page":"1108","DOI":"10.2337\/dc16-0330","article-title":"CV protection in the EMPA-REG OUTCOME trial: a \u201cthrifty substrate\u201d hypothesis","volume":"39","author":"Ferrannini","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30263-7_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30263-7_bib9","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30263-7_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1038\/nrendo.2011.30","article-title":"Pharmacotherapy: GLP-1 analogues and insulin: sound the wedding bells?","volume":"7","author":"Nauck","year":"2011","journal-title":"Nat Rev Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302637?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302637?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,8]],"date-time":"2018-09-08T10:59:38Z","timestamp":1536404378000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302637"}},"issued":{"date-parts":[[2016,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2213858716302637"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30263-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,12]]}},{"indexed":{"date-parts":[[2026,1,13]],"date-time":"2026-01-13T14:50:26Z","timestamp":1768315826724,"version":"3.49.0"},"reference-count":14,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/s2213-8587(18)30337-1","type":"journal-article","created":{"date-parts":[[2018,12,4]],"date-time":"2018-12-04T23:35:03Z","timestamp":1543966503000},"page":"2-3","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Reassessing strategies to improve pregnancy outcomes in overweight and obese women"],"prefix":"10.1016","volume":"7","author":[{"given":"Patrick M","family":"Catalano","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30337-1_bib1","doi-asserted-by":"crossref","first-page":"2207","DOI":"10.1001\/jama.2017.3635","article-title":"Association of gestational weight gain with maternal and infant outcomes: a systematic review and meta-analysis","volume":"317","author":"Goldstein","year":"2007","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30337-1_bib2","first-page":"j3119","article-title":"Effect of diet and physical activity based interventions in pregnancy on gestational weight gain and pregnancy outcomes: meta-analysis of individual participant data from randomised trials","volume":"358","year":"2017","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30337-1_bib3","doi-asserted-by":"crossref","first-page":"778","DOI":"10.1016\/S2213-8587(15)00219-3","article-title":"Effect of metformin on maternal and fetal outcomes in obese pregnant women (EMPOWaR): a randomised, double-blind, placebo-controlled trial","volume":"3","author":"Chiswick","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30337-1_bib4","article-title":"Effect of metformin in addition to dietary and lifestyle advice for pregnant women who are overweight or obese: the GRoW randomised, double-blind, placebo-controlled trial","author":"Dodd","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30337-1_bib5","series-title":"Weight gain during pregnancy: reexamining the guidelines","year":"2009"},{"key":"10.1016\/S2213-8587(18)30337-1_bib6","doi-asserted-by":"crossref","first-page":"445.e1","DOI":"10.1016\/j.ajog.2017.05.054","article-title":"Variations in resting energy expenditure: impact on gestational weight gain","volume":"217","author":"Berggren","year":"2017","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(18)30337-1_bib7","doi-asserted-by":"crossref","first-page":"903","DOI":"10.1016\/S0002-9378(99)70662-9","article-title":"Longitudinal changes in glucose metabolism during pregnancy in obese women with normal glucose tolerance and gestational diabetes mellitus","volume":"180","author":"Catalano","year":"1999","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(18)30337-1_bib8","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1016\/j.ajog.2018.06.013","article-title":"A cautionary response to SMFM statement: pharmacological treatment of gestational diabetes","volume":"219","author":"Barbour","year":"2018","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(18)30337-1_bib9","doi-asserted-by":"crossref","first-page":"812","DOI":"10.1016\/S2352-4642(18)30273-6","article-title":"Influence of maternal obesity on the association between common pregnancy complications and risk of childhood obesity: an individual participant data meta-analysis","volume":"2","author":"Patro Golab","year":"2018","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/S2213-8587(18)30337-1_bib10","doi-asserted-by":"crossref","first-page":"205.e1","DOI":"10.1016\/j.ajog.2012.12.018","article-title":"The impact of interpregnancy weight change on birthweight in obese women","volume":"208","author":"Jain","year":"2013","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(18)30337-1_bib11","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1177\/107155769800500604","article-title":"Cord blood leptin reflects fetal fat mass","volume":"5","author":"Clapp","year":"1998","journal-title":"J Soc Gynecol Invest"},{"key":"10.1016\/S2213-8587(18)30337-1_bib12","doi-asserted-by":"crossref","first-page":"647.e1","DOI":"10.1016\/j.ajog.2015.02.026","article-title":"Identification of early transcriptome signatures in placenta exposed to insulin and obesity","volume":"212","author":"Lassance","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(18)30337-1_bib13","doi-asserted-by":"crossref","first-page":"11439","DOI":"10.1073\/pnas.1216959110","article-title":"Differential methylation in glucoregulatory genes of offspring born before vs after maternal gastrointestinal bypass surgery","volume":"110","author":"Gu\u00e9nard","year":"2013","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(18)30337-1_bib14","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1016\/j.cmet.2016.02.005","article-title":"Effects of moderate and subsequent progressive weight loss on metabolic function and adipose tissue biology in humans with obesity","volume":"23","author":"Magkos","year":"2016","journal-title":"Cell Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303371?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303371?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T20:26:59Z","timestamp":1555532819000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303371"}},"issued":{"date-parts":[[2019,1]]},"references-count":14,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2213858718303371"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30337-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Reassessing strategies to improve pregnancy outcomes in overweight and obese women","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30337-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30310-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,18]],"date-time":"2026-01-18T02:10:28Z","timestamp":1768702228336,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,8,1]],"date-time":"2014-08-01T00:00:00Z","timestamp":1406851200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,8]]},"DOI":"10.1016\/s2213-8587(14)70040-3","type":"journal-article","created":{"date-parts":[[2014,5,16]],"date-time":"2014-05-16T23:15:44Z","timestamp":1400282144000},"page":"604-606","source":"Crossref","is-referenced-by-count":8,"title":["The modifiable burden of worldwide mortality from cardiovascular diseases"],"prefix":"10.1016","volume":"2","author":[{"given":"Rachel R","family":"Huxley","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vlado","family":"Perkovic","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70040-3_bib1","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(11)60679-X","article-title":"National, regional, and global trends in fasting plasma glucose and diabetes prevalence since 1980: systematic analysis of health examination surveys and epidemiological studies with 370 country years and 2\u00b77 million participants","volume":"378","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70040-3_bib2","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1016\/S0140-6736(10)62037-5","article-title":"National, regional, and global trends in body-mass index since 1980: systematic analysis of health examination surveys and epidemiological studies with 960 country-years and 9\u00b71 million participants","volume":"377","author":"Finucane","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70040-3_bib3","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1016\/S0140-6736(10)62036-3","article-title":"National, regional, and global trends in systolic blood pressure since 1980: systematic analysis of health examination surveys and epidemiological studies with 786 country-years and 5\u00b74 million participants","volume":"377","author":"Danaei","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70040-3_bib4","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S0140-6736(10)62038-7","article-title":"National, regional, and global trends in serum total cholesterol since 1980: systematic analysis of health examination surveys and epidemiological studies with 321 country-years and 3\u00b70 million participants","volume":"377","author":"Farzadfar","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70040-3_bib5","article-title":"Cardiovascular disease, chronic kidney disease, and diabetes mortality burden of cardiometabolic risk factors from 1980 to 2010: a comparative risk assessment","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70040-3_bib6","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1161\/HYPERTENSIONAHA.107.095497","article-title":"The burden of blood pressure-related disease: a neglected priority for global health","volume":"50","author":"Perkovic","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(14)70040-3_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(14)60040-4","article-title":"Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775\u2008385 individuals and 12\u2008539 strokes","author":"Peters","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70040-3_bib8","doi-asserted-by":"crossref","first-page":"1297","DOI":"10.1016\/S0140-6736(11)60781-2","article-title":"Cigarette smoking as a risk factor for coronary heart disease in women compared with men: a systematic review and meta-analysis of prospective cohort studies","volume":"378","author":"Huxley","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70040-3_bib9","doi-asserted-by":"crossref","first-page":"2679","DOI":"10.1161\/CIRCULATIONAHA.108.788166","article-title":"Prevalence, awareness, treatment, and control of hypertension in China: data from the China National Nutrition and Health Survey 2002","volume":"118","author":"Wu","year":"2008","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(14)70040-3_bib10","doi-asserted-by":"crossref","first-page":"e60308","DOI":"10.1371\/journal.pone.0060308","article-title":"Prevalence, awareness, treatment, and control of hypertension in United States counties, 2001\u20132009","volume":"8","author":"Olives","year":"2013","journal-title":"PLoS One"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700403?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700403?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T04:01:36Z","timestamp":1538625696000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700403"}},"issued":{"date-parts":[[2014,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,8]]}},"alternative-id":["S2213858714700403"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70040-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,8]]}},{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T01:10:09Z","timestamp":1768871409260,"version":"3.49.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/s2213-8587(15)00323-x","type":"journal-article","created":{"date-parts":[[2015,9,3]],"date-time":"2015-09-03T04:28:21Z","timestamp":1441254501000},"page":"751-752","source":"Crossref","is-referenced-by-count":10,"title":["Prenatal famine and developmental origins of type 2 diabetes"],"prefix":"10.1016","volume":"3","author":[{"given":"Matthew W","family":"Gillman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00323-X_bib1","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF00400248","article-title":"Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis","volume":"35","author":"Hales","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00323-X_bib2","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1111\/aogs.12504","article-title":"Impact of fetal and neonatal environment on beta cell function and development of diabetes","volume":"93","author":"Nielsen","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S2213-8587(15)00323-X_bib3","series-title":"Maternal Obesity","first-page":"35","article-title":"Influences of maternal obesity on the health of the offspring: a review of animal models","author":"Poston","year":"2012"},{"key":"10.1016\/S2213-8587(15)00323-X_bib4","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1146\/annurev-publhealth-031210-101230","article-title":"Prenatal famine and adult health","volume":"32","author":"Lumey","year":"2011","journal-title":"Ann Rev Public Health"},{"key":"10.1016\/S2213-8587(15)00323-X_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00279-X","article-title":"Association between type 2 diabetes and prenatal exposure to the Ukraine famine of 1932\u201333: a retrospective cohort study","author":"Lumey","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00323-X_bib6","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1080\/00324720215934","article-title":"A new estimate of Ukrainian population losses during the crises of the 1930s and 1940s","volume":"56","author":"Vallin","year":"2002","journal-title":"Popul Stud"},{"key":"10.1016\/S2213-8587(15)00323-X_bib7","doi-asserted-by":"crossref","first-page":"536","DOI":"10.1007\/s11892-014-0536-7","article-title":"Famines in the last 100 years: implications for diabetes","volume":"14","author":"de Rooij","year":"2014","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(15)00323-X_bib8","doi-asserted-by":"crossref","first-page":"5592","DOI":"10.1038\/ncomms6592","article-title":"DNA methylation signatures link prenatal famine exposure to growth and metabolism","volume":"5","author":"Tobi","year":"2014","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(15)00323-X_bib9","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1016\/j.ajog.2014.12.038","article-title":"Association of trimester-specific gestational weight gain with fetal growth, offspring obesity, and cardiometabolic traits in early childhood","volume":"212","author":"Karachaliou","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(15)00323-X_bib10","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1016\/j.ajog.2014.11.012","article-title":"Associations of trimester-specific gestational weight gain with maternal adiposity and systolic blood pressure at 3 and 7 years postpartum","volume":"212","author":"Walter","year":"2015","journal-title":"Am J Obstet Gynecol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500323X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500323X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T15:28:05Z","timestamp":1537370885000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871500323X"}},"issued":{"date-parts":[[2015,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S221385871500323X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00323-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,10]]}},{"indexed":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T14:01:08Z","timestamp":1777644068976,"version":"3.51.4"},"reference-count":7,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/s2213-8587(21)00313-2","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T22:03:07Z","timestamp":1638309787000},"page":"5-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["The changing character of diabetes complications"],"prefix":"10.1016","volume":"10","author":[{"given":"Srikanth","family":"Bellary","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00313-2_bib1","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.1177\/1932296816645120","article-title":"Using large diabetes databases for research","volume":"10","author":"Wild","year":"2016","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(21)00313-2_bib2","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1016\/S0140-6736(18)30314-3","article-title":"Trends in cause-specific mortality among adults with and without diagnosed diabetes in the USA: an epidemiological analysis of linked national survey and vital statistics data","volume":"391","author":"Gregg","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00313-2_bib3","article-title":"Trends in leading causes of hospitalisation of adults with diabetes in England from 2003 to 2018: an epidemiological analysis of linked primary care records","author":"Pearson-Stuttard","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00313-2_bib4","doi-asserted-by":"crossref","first-page":"1407","DOI":"10.1056\/NEJMoa1608664","article-title":"Mortality and cardiovascular disease in type 1 and type 2 diabetes","volume":"376","author":"Rawshani","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00313-2_bib5","doi-asserted-by":"crossref","first-page":"152","DOI":"10.1186\/s12933-015-0315-z","article-title":"Temporal changes in the prevalence and associates of diabetes-related lower extremity amputations in patients with type 2 diabetes: the Fremantle Diabetes Study","volume":"14","author":"Baba","year":"2015","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(21)00313-2_bib6","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1001\/jama.1949.02900180003001","article-title":"Furtherance of treatment of diabetes mellitus","volume":"139","author":"Joslin","year":"1949","journal-title":"J Am Med Assoc"},{"key":"10.1016\/S2213-8587(21)00313-2_bib7","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00125-018-4711-2","article-title":"Global trends in diabetes complications: a review of current evidence","volume":"62","author":"Harding","year":"2019","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003132?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003132?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:46Z","timestamp":1761991846000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721003132"}},"issued":{"date-parts":[[2022,1]]},"references-count":7,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2213858721003132"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00313-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The changing character of diabetes complications","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00313-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00288-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,20]],"date-time":"2026-09-20T12:50:46Z","timestamp":1789908646141,"version":"4.0.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2015,2,1]],"date-time":"2015-02-01T00:00:00Z","timestamp":1422748800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,2]]},"DOI":"10.1016\/s2213-8587(14)70239-6","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T04:15:13Z","timestamp":1421900113000},"page":"98-100","source":"Crossref","is-referenced-by-count":12,"title":["The proliferation of irrational metformin fixed-dose combinations in India"],"prefix":"10.1016","volume":"3","author":[{"given":"Valerie","family":"Evans","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allyson M","family":"Pollock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70239-6_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(14)60059-3","article-title":"India should introduce a new Drugs Act","volume":"383","author":"Roderick","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70239-6_bib5","series-title":"List of drugs prohibited for manufacture and sale through gazette notifications under Section 26A of Drugs & Cosmetics Act 1940 by the Ministry of Health and Family Welfare","year":"2012"},{"key":"10.1016\/S2213-8587(14)70239-6_bib6","series-title":"Fixed dose combinations approved by DCGI since 1961 til February 2013","year":"2013"},{"key":"10.1016\/S2213-8587(14)70239-6_bib7","doi-asserted-by":"crossref","first-page":"S14","DOI":"10.1038\/485S14a","article-title":"Public health: India's diabetes time bomb","volume":"485","author":"Shetty","year":"2012","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(14)70239-6_bib9","series-title":"National list of essential medicines of India","year":"2011"},{"key":"10.1016\/S2213-8587(14)70239-6_bib10","series-title":"Global Guidelines for type 2 diabetes","year":"2005"},{"key":"10.1016\/S2213-8587(14)70239-6_bib11","author":"McGettigan"},{"key":"10.1016\/S2213-8587(14)70239-6_bib13","series-title":"Guidelines for registration of fixed-dose combination medicinal products - Annex 5. WHO Technical Report Series, No. 929","year":"2005"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702396?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702396?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T05:00:23Z","timestamp":1537938023000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702396"}},"issued":{"date-parts":[[2015,2]]},"references-count":8,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["S2213858714702396"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70239-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,2]]}},{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T05:05:39Z","timestamp":1790485539363,"version":"4.1.0"},"reference-count":99,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100015223","name":"Danish Diabetes Academy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015223","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","award":["1078477"],"award-info":[{"award-number":["1078477"]}],"id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009708","name":"Novo Nordisk Fonden","doi-asserted-by":"publisher","award":["NNF17SA0031406"],"award-info":[{"award-number":["NNF17SA0031406"]}],"id":[{"id":"10.13039\/501100009708","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/s2213-8587(19)30078-6","type":"journal-article","created":{"date-parts":[[2019,5,23]],"date-time":"2019-05-23T10:13:59Z","timestamp":1558606439000},"page":"796-806","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":64,"title":["Diabetes in pregnancy and epigenetic mechanisms\u2014how the first 9 months from conception might affect the child's epigenome and later risk of disease"],"prefix":"10.1016","volume":"7","author":[{"given":"Line","family":"Hjort","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Boris","family":"Novakovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise G","family":"Grunnet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louise","family":"Maple-Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Damm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gernot","family":"Desoye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Saffery","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30078-6_bib1","series-title":"IDF diabetes atlas","year":"2015"},{"key":"10.1016\/S2213-8587(19)30078-6_bib2","series-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation","year":"2006"},{"key":"10.1016\/S2213-8587(19)30078-6_bib3","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30078-6_bib4","doi-asserted-by":"crossref","first-page":"1396","DOI":"10.1007\/s00125-016-3985-5","article-title":"Gestational diabetes mellitus and long-term consequences for mother and offspring: a view from Denmark","volume":"59","author":"Damm","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30078-6_bib5","doi-asserted-by":"crossref","first-page":"4284","DOI":"10.1210\/jc.2009-1231","article-title":"Maternal and fetal outcome in women with type 2 versus type 1 diabetes mellitus: a systematic review and meta-analysis","volume":"94","author":"Balsells","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30078-6_bib6","doi-asserted-by":"crossref","first-page":"323","DOI":"10.2337\/diacare.28.2.323","article-title":"Poor pregnancy outcome in women with type 2 diabetes","volume":"28","author":"Clausen","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30078-6_bib7","doi-asserted-by":"crossref","first-page":"525.e1","DOI":"10.1016\/j.ajog.2007.11.017","article-title":"Gestational diabetes in the United States: temporal trends 1989 through 2004","volume":"198","author":"Getahun","year":"2008","journal-title":"Am J Obstet Gynecol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(19)30078-6_bib8","first-page":"s103","article-title":"Gestational diabetes mellitus","volume":"26","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30078-6_bib9","doi-asserted-by":"crossref","first-page":"e97","DOI":"10.2337\/dc10-0544","article-title":"International Association of Diabetes and Pregnancy Study Groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy: comment to the International Association of Diabetes and Pregnancy Study Groups consensus panel","volume":"33","author":"Weinert","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30078-6_bib10","series-title":"Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy","year":"2013"},{"key":"10.1016\/S2213-8587(19)30078-6_bib11","doi-asserted-by":"crossref","first-page":"526","DOI":"10.2337\/dc11-1641","article-title":"Frequency of gestational diabetes mellitus at collaborating centers based on IADPSG consensus panel-recommended criteria: the Hyperglycemia and Adverse Pregnancy Outcome (HAPO) study","volume":"35","author":"Sacks","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30078-6_bib12","first-page":"329","article-title":"Prevalence of gestational diabetes mellitus in south India (Tamil Nadu)\u2014a community based study","volume":"56","author":"Seshiah","year":"2008","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(19)30078-6_bib13","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1530\/EJE-14-0428","article-title":"Prevalence and risk factors of gestational diabetes in Punjab, north India: results from a population screening program","volume":"173","author":"Arora","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(19)30078-6_bib14","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1093\/ije\/dyy046","article-title":"Cohort profile: the pregnancy and neonatal diabetes outcomes in remote Australia (PANDORA) study","volume":"47","author":"Lee","year":"2018","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(19)30078-6_bib15","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1097\/MED.0b013e32834c800d","article-title":"Placental hormones and the control of maternal metabolism and fetal growth","volume":"18","author":"Newbern","year":"2011","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(19)30078-6_bib16","first-page":"78","article-title":"Hyperglycemia as the cause of characteristic features of the foetus and newborn of diabetic mothers","volume":"8","author":"Pedersen","year":"1961","journal-title":"Dan Med Bull"},{"key":"10.1016\/S2213-8587(19)30078-6_bib17","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1002\/dmrr.1304","article-title":"Major congenital malformations in women with gestational diabetes mellitus: a systematic review and meta-analysis","volume":"28","author":"Balsells","year":"2012","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(19)30078-6_bib18","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00125-016-3931-6","article-title":"The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy","volume":"59","author":"Desoye","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30078-6_bib19","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1007\/BF00400248","article-title":"Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis","volume":"35","author":"Hales","year":"1992","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30078-6_bib20","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1111\/aogs.12494","article-title":"Genetic, nongenetic and epigenetic risk determinants in developmental programming of type 2 diabetes","volume":"93","author":"Vaag","year":"2014","journal-title":"Acta Obstet Gynecol Scand"},{"key":"10.1016\/S2213-8587(19)30078-6_bib21","doi-asserted-by":"crossref","first-page":"17046","DOI":"10.1073\/pnas.0806560105","article-title":"Persistent epigenetic differences associated with prenatal exposure to famine in humans","volume":"105","author":"Heijmans","year":"2008","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(19)30078-6_bib22","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(97)07244-9","article-title":"Glucose tolerance in adults after prenatal exposure to famine","volume":"351","author":"Ravelli","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30078-6_bib23","doi-asserted-by":"crossref","first-page":"849","DOI":"10.1093\/aje\/kwk071","article-title":"Birth weight and subsequent risk of type 2 diabetes: a meta-analysis","volume":"165","author":"Harder","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(19)30078-6_bib24","doi-asserted-by":"crossref","first-page":"340","DOI":"10.2337\/dc07-1596","article-title":"High prevalence of type 2 diabetes and pre-diabetes in adult offspring of women with gestational diabetes mellitus or type 1 diabetes: the role of intrauterine hyperglycemia","volume":"31","author":"Clausen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30078-6_bib25","doi-asserted-by":"crossref","first-page":"2464","DOI":"10.1210\/jc.2009-0305","article-title":"Overweight and the metabolic syndrome in adult offspring of women with diet-treated gestational diabetes mellitus or type 1 diabetes","volume":"94","author":"Clausen","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30078-6_bib26","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2337\/diabetes.49.12.2208","article-title":"Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships","volume":"49","author":"Dabelea","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30078-6_bib27","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1111\/j.1464-5491.2006.01840.x","article-title":"Glucose tolerance of offspring of mother with gestational diabetes mellitus in a low-risk population","volume":"23","author":"Malcolm","year":"2006","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30078-6_bib28","doi-asserted-by":"crossref","first-page":"460","DOI":"10.2337\/diabetes.55.02.06.db05-0823","article-title":"Gestational glucose tolerance and risk of type 2 diabetes in young Pima Indian offspring","volume":"55","author":"Franks","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30078-6_bib29","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1007\/s00125-009-1560-z","article-title":"Association of existing diabetes, gestational diabetes and glycosuria in pregnancy with macrosomia and offspring body mass index, waist and fat mass in later childhood: findings from a prospective pregnancy cohort","volume":"53","author":"Lawlor","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30078-6_bib30","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2337\/dc10-0139","article-title":"Prevalence and predictors of overweight and insulin resistance in offspring of mothers with gestational diabetes mellitus","volume":"33","author":"Boerschmann","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30078-6_bib31","doi-asserted-by":"crossref","first-page":"63","DOI":"10.2337\/dc11-1633","article-title":"Associations of gestational diabetes, existing diabetes, and glycosuria with offspring obesity and cardiometabolic outcomes","volume":"35","author":"Patel","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30078-6_bib32","doi-asserted-by":"crossref","first-page":"1746","DOI":"10.2337\/dc17-0514","article-title":"Adiposity, dysmetabolic traits and earlier onset of female puberty in adolescent offspring of women with gestational diabetes mellitus: a clinical study within the Danish National Birth Cohort","volume":"40","author":"Grunnet","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30078-6_bib33","doi-asserted-by":"crossref","first-page":"210","DOI":"10.1007\/s00125-017-4458-1","article-title":"Differential effects of age and sex on insulin sensitivity and body composition in adolescent offspring of women with type 1 diabetes: results from the EPICOM study","volume":"61","author":"Lohse","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30078-6_bib34","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1111\/j.1749-6632.2010.05798.x","article-title":"Early life nutrition and metabolic programming","volume":"1212","author":"Fernandez-Twinn","year":"2010","journal-title":"Ann NY Acad Sci"},{"key":"10.1016\/S2213-8587(19)30078-6_bib35","doi-asserted-by":"crossref","first-page":"1861","DOI":"10.1016\/S0140-6736(03)13505-2","article-title":"Effect of a diabetic environment in utero on predisposition to type 2 diabetes","volume":"361","author":"Sobngwi","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30078-6_bib36","doi-asserted-by":"crossref","first-page":"274","DOI":"10.5582\/ddt.2015.01044","article-title":"Association between maternal diabetes mellitus and the risk of congenital malformations: a meta-analysis of cohort studies","volume":"9","author":"Zhao","year":"2015","journal-title":"Drug Discov Ther"},{"key":"10.1016\/S2213-8587(19)30078-6_bib37","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/S0304-3940(01)01495-1","article-title":"Pancreatic islet transplantation in diabetic pregnant rats prevents acquired malformation of the ventromedial hypothalamic nucleus in their offspring","volume":"299","author":"Harder","year":"2001","journal-title":"Neurosci Lett"},{"key":"10.1016\/S2213-8587(19)30078-6_bib38","doi-asserted-by":"crossref","first-page":"103","DOI":"10.3389\/fphar.2015.00103","article-title":"Health economic modeling to assess short-term costs of maternal overweight, gestational diabetes, and related macrosomia - a pilot evaluation","volume":"6","author":"Lenoir-Wijnkoop","year":"2015","journal-title":"Front Pharmacol"},{"key":"10.1016\/S2213-8587(19)30078-6_bib39","first-page":"903","article-title":"Effect of physical activity and\/or healthy eating on GDM risk: the DALI lifestyle study","volume":"102","author":"Simmons","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30078-6_bib40","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/35057062","article-title":"Initial sequencing and analysis of the human genome","volume":"409","author":"Lander","year":"2001","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(19)30078-6_bib41","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1016\/S0140-6736(18)30312-X","article-title":"Origins of lifetime health around the time of conception: causes and consequences","volume":"391","author":"Fleming","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30078-6_bib42","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/nature25759","article-title":"Adolescence and the next generation","volume":"554","author":"Patton","year":"2018","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(19)30078-6_bib43","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1038\/nature05913","article-title":"Perceptions of epigenetics","volume":"447","author":"Bird","year":"2007","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(19)30078-6_bib44","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1038\/nrg.2016.59","article-title":"The molecular hallmarks of epigenetic control","volume":"17","author":"Allis","year":"2016","journal-title":"Nat Rev Genet"},{"key":"10.1016\/S2213-8587(19)30078-6_bib45","doi-asserted-by":"crossref","first-page":"2709","DOI":"10.1093\/nar\/10.8.2709","article-title":"Amount and distribution of 5-methylcytosine in human DNA from different types of tissues of cells","volume":"10","author":"Ehrlich","year":"1982","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S2213-8587(19)30078-6_bib46","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1126\/science.3310230","article-title":"The inheritance of epigenetic defects","volume":"238","author":"Holliday","year":"1987","journal-title":"Science"},{"key":"10.1016\/S2213-8587(19)30078-6_bib47","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1002\/jcb.240200403","article-title":"DNA methylation, retroviruses, and embryogenesis","volume":"20","author":"Jaenisch","year":"1982","journal-title":"J Cell Biochem"},{"key":"10.1016\/S2213-8587(19)30078-6_bib48","doi-asserted-by":"crossref","first-page":"1395","DOI":"10.1101\/gr.136598.111","article-title":"Neonatal DNA methylation profile in human twins is specified by a complex interplay between intrauterine environmental and genetic factors, subject to tissue-specific influence","volume":"22","author":"Gordon","year":"2012","journal-title":"Genome Res"},{"key":"10.1016\/S2213-8587(19)30078-6_bib49","doi-asserted-by":"crossref","first-page":"e0157776","DOI":"10.1371\/journal.pone.0157776","article-title":"A genome-wide mQTL analysis in human adipose tissue identifies genetic variants associated with DNA methylation, gene expression and metabolic traits","volume":"11","author":"Volkov","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30078-6_bib50","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1186\/gm500","article-title":"Analysis of epigenetic changes in survivors of preterm birth reveals the effect of gestational age and evidence for a long term legacy","volume":"5","author":"Cruickshank","year":"2013","journal-title":"Genome Med"},{"key":"10.1016\/S2213-8587(19)30078-6_bib51","doi-asserted-by":"crossref","first-page":"680","DOI":"10.1016\/j.ajhg.2016.02.019","article-title":"DNA methylation in newborns and maternal smoking in pregnancy: genome-wide consortium meta-analysis","volume":"98","author":"Joubert","year":"2016","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(19)30078-6_bib52","doi-asserted-by":"crossref","first-page":"377","DOI":"10.4161\/epi.27248","article-title":"Postnatal stability, tissue, and time specific effects of AHRR methylation change in response to maternal smoking in pregnancy","volume":"9","author":"Novakovic","year":"2014","journal-title":"Epigenetics"},{"key":"10.1016\/S2213-8587(19)30078-6_bib53","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/hmg\/ddu739","article-title":"Prenatal exposure to maternal smoking and offspring DNA methylation across the lifecourse: findings from the Avon Longitudinal Study of Parents and Children (ALSPAC)","volume":"24","author":"Richmond","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(19)30078-6_bib54","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1093\/ije\/dyv048","article-title":"DNA methylation mediates the effect of maternal smoking during pregnancy on birthweight of the offspring","volume":"44","author":"K\u00fcpers","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(19)30078-6_bib55","doi-asserted-by":"crossref","first-page":"2900","DOI":"10.2337\/db16-0227","article-title":"Gene expression and DNA methylation of PPARGC1A in muscle and adipose tissue from adult offspring of women with diabetes in pregnancy","volume":"65","author":"Kelstrup","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30078-6_bib56","doi-asserted-by":"crossref","first-page":"1141","DOI":"10.1210\/jc.2016-3907","article-title":"Fetal hyperglycemia changes human preadipocyte function in adult life","volume":"102","author":"Hansen","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30078-6_bib57","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s13148-017-0338-2","article-title":"Differential adipokine DNA methylation and gene expression in subcutaneous adipose tissue from adult offspring of women with diabetes in pregnancy","volume":"9","author":"Houshmand-Oeregaard","year":"2017","journal-title":"Clin Epigenetics"},{"key":"10.1016\/S2213-8587(19)30078-6_bib58","doi-asserted-by":"crossref","first-page":"e0187038","DOI":"10.1371\/journal.pone.0187038","article-title":"DNA methylation and gene expression of TXNIP in adult offspring of women with diabetes in pregnancy","volume":"12","author":"Houshmand-Oeregaard","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30078-6_bib59","doi-asserted-by":"crossref","first-page":"1763","DOI":"10.1093\/hmg\/ddy085","article-title":"Increased expression of microRNA-15a and microRNA-15b in skeletal muscle from adult offspring of women with diabetes in pregnancy","volume":"27","author":"Houshmand-Oeregaard","year":"2018","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(19)30078-6_bib60","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.2337\/db10-0979","article-title":"Epigenetic gene promoter methylation at birth is associated with child's later adiposity","volume":"60","author":"Godfrey","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30078-6_bib61","doi-asserted-by":"crossref","first-page":"1272","DOI":"10.2337\/db11-1160","article-title":"Placental adiponectin gene DNA methylation levels are associated with mothers' blood glucose concentration","volume":"61","author":"Bouchard","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30078-6_bib62","doi-asserted-by":"crossref","first-page":"1320","DOI":"10.2337\/db12-0289","article-title":"Metabolic programming of MEST DNA methylation by intrauterine exposure to gestational diabetes mellitus","volume":"62","author":"El Hajj","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30078-6_bib63","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1186\/s12881-014-0108-3","article-title":"Increased methylation at differentially methylated region of GNAS in infants born to gestational diabetes","volume":"15","author":"Chen","year":"2014","journal-title":"BMC Med Genet"},{"key":"10.1016\/S2213-8587(19)30078-6_bib64","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1017\/S2040174414000038","article-title":"Placental lipoprotein lipase DNA methylation levels are associated with gestational diabetes mellitus and maternal and cord blood lipid profiles","volume":"5","author":"Houde","year":"2014","journal-title":"J Dev Orig Heal Dis"},{"key":"10.1016\/S2213-8587(19)30078-6_bib65","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1080\/15592294.2015.1029700","article-title":"Mendelian randomization supports causality between maternal hyperglycemia and epigenetic regulation of leptin gene in newborns","volume":"10","author":"Allard","year":"2015","journal-title":"Epigenetics"},{"key":"10.1016\/S2213-8587(19)30078-6_bib66","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1161\/ATVBAHA.114.304730","article-title":"Gestational diabetes mellitus impairs fetal endothelial cell functions through a mechanism involving microRNA-101 and histone methyltransferase enhancer of zester homolog-2","volume":"35","author":"Floris","year":"2015","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(19)30078-6_bib67","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1042\/CS20140688","article-title":"Placental DNA methylation of peroxisome-proliferator-activated receptor-\u03b3 co-activator-1\u03b1 promoter is associated with maternal gestational glucose level","volume":"129","author":"Xie","year":"2015","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/S2213-8587(19)30078-6_bib68","doi-asserted-by":"crossref","first-page":"e0148399","DOI":"10.1371\/journal.pone.0148399","article-title":"Alteration in expression and methylation of IGF2\/H19 in placenta and umbilical cord blood are associated with macrosomia exposed to intrauterine hyperglycemia","volume":"11","author":"Su","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30078-6_bib69","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1080\/15592294.2017.1322254","article-title":"Placental lipoprotein lipase DNA methylation alterations are associated with gestational diabetes and body composition at 5 years of age","volume":"12","author":"Gagn\u00e9-Ouellet","year":"2017","journal-title":"Epigenetics"},{"key":"10.1016\/S2213-8587(19)30078-6_bib70","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/j.bbrc.2018.05.010","article-title":"Altered expression of PGC-1\u03b1 and PDX1 and their methylation status are associated with fetal glucose metabolism in gestational diabetes mellitus","volume":"501","author":"Wang","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(19)30078-6_bib71","doi-asserted-by":"crossref","first-page":"935","DOI":"10.4161\/epi.25578","article-title":"Gestational diabetes mellitus epigenetically affects genes predominantly involved in metabolic diseases","volume":"8","author":"Ruchat","year":"2013","journal-title":"Epigenetics"},{"key":"10.1016\/S2213-8587(19)30078-6_bib72","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2478\/immun-2013-0001","article-title":"Exposure to maternal diabetes in utero and DNA methylation patterns in the offspring","volume":"1","author":"West","year":"2013","journal-title":"Immunometabolism"},{"key":"10.1016\/S2213-8587(19)30078-6_bib73","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1177\/1933719113492206","article-title":"Global methylation in the placenta and umbilical cord blood from pregnancies with maternal gestational diabetes, preeclampsia, and obesity","volume":"21","author":"Nomura","year":"2014","journal-title":"Reprod Sci"},{"key":"10.1016\/S2213-8587(19)30078-6_bib74","doi-asserted-by":"crossref","first-page":"4868","DOI":"10.1096\/fj.14-255240","article-title":"Impact on offspring methylation patterns of maternal gestational diabetes mellitus and intrauterine growth restraint suggest common genes and pathways linked to subsequent type 2 diabetes risk","volume":"28","author":"Quilter","year":"2014","journal-title":"FASEB J"},{"key":"10.1016\/S2213-8587(19)30078-6_bib75","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/s13148-015-0116-y","article-title":"Epigenome-wide and transcriptome-wide analyses reveal gestational diabetes is associated with alterations in the human leukocyte antigen complex","volume":"7","author":"Binder","year":"2015","journal-title":"Clin Epigenetics"},{"key":"10.1016\/S2213-8587(19)30078-6_bib76","doi-asserted-by":"crossref","first-page":"3021","DOI":"10.1093\/hmg\/ddv013","article-title":"Maternal gestational diabetes is associated with genome-wide DNA methylation variation in placenta and cord blood of exposed offspring","volume":"24","author":"Finer","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(19)30078-6_bib77","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1186\/s13148-017-0329-3","article-title":"Epigenetic signatures of gestational diabetes mellitus on cord blood methylation","volume":"9","author":"Haertle","year":"2017","journal-title":"Clin Epigenetics"},{"key":"10.1016\/S2213-8587(19)30078-6_bib78","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.1007\/s00125-018-4699-7","article-title":"Human fetoplacental arterial and venous endothelial cells are differentially programmed by gestational diabetes mellitus, resulting in cell-specific barrier function changes","volume":"61","author":"Cvitic","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30078-6_bib79","doi-asserted-by":"crossref","first-page":"e122572","DOI":"10.1172\/jci.insight.122572","article-title":"Gestational diabetes and maternal obesity are associated with epigenome-wide methylation changes in children","volume":"3","author":"Hjort","year":"2018","journal-title":"JCI insight"},{"key":"10.1016\/S2213-8587(19)30078-6_bib80","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.diabres.2018.03.016","article-title":"Genome-wide DNA methylation profiling in infants born to gestational diabetes mellitus","volume":"142","author":"Weng","year":"2018","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(19)30078-6_bib81","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1007\/s00125-016-4203-1","article-title":"Differential methylation of genes in individuals exposed to maternal diabetes in utero","volume":"60","author":"Chen","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30078-6_bib82","doi-asserted-by":"crossref","first-page":"1673","DOI":"10.2337\/db18-0123","article-title":"Placental DNA methylation adaptation to maternal glycemic response in pregnancy","volume":"67","author":"Cardenas","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30078-6_bib83","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1007\/s00125-016-4109-y","article-title":"Epigenetic markers to further understand insulin resistance","volume":"59","author":"Ling","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30078-6_bib84","doi-asserted-by":"crossref","first-page":"1032","DOI":"10.1038\/oby.2008.605","article-title":"Maternal pregestational BMI is associated with methylation of the PPARGC1A promoter in newborns","volume":"17","author":"Gemma","year":"2009","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(19)30078-6_bib85","doi-asserted-by":"crossref","first-page":"2528","DOI":"10.2337\/db13-0671","article-title":"PGC1\u03b1 promoter methylation in blood at 5\u20137 years predicts adiposity from 9 to 14 years (EarlyBird 50)","volume":"63","author":"Clarke-Harris","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30078-6_bib86","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1210\/er.2011-1050","article-title":"Hormones and endocrine-disrupting chemicals: low-dose effects and nonmonotonic dose responses","volume":"33","author":"Vandenberg","year":"2012","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(19)30078-6_bib87","first-page":"3792","article-title":"Impact of age, BMI and HbA1c levels on the genome-wide DNA methylation and mRNA expression patterns in human adipose tissue and identification of epigenetic biomarkers in blood","volume":"24","author":"R\u00f6nn","year":"2015","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(19)30078-6_bib88","doi-asserted-by":"crossref","first-page":"e0134654","DOI":"10.1371\/journal.pone.0134654","article-title":"Kidney dysfunction in adult offspring exposed in utero to type 1 diabetes is associated with alterations in genome-wide DNA methylation","volume":"10","author":"Gautier","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30078-6_bib89","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.2337\/db11-1314","article-title":"Transgenerational glucose intolerance with Igf2\/H19 epigenetic alterations in mouse islet induced by intrauterine hyperglycemia","volume":"61","author":"Ding","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30078-6_bib90","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1093\/hmg\/ddr472","article-title":"Genome-wide survey reveals predisposing diabetes type 2-related DNA methylation variations in human peripheral blood","volume":"21","author":"Toperoff","year":"2012","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(19)30078-6_bib91","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1289\/EHP333","article-title":"DNA methylation score as a biomarker in newborns for sustained maternal smoking during pregnancy","volume":"125","author":"Reese","year":"2017","journal-title":"Environ Health Perspect"},{"key":"10.1016\/S2213-8587(19)30078-6_bib92","doi-asserted-by":"crossref","first-page":"S182","DOI":"10.1016\/j.ajog.2015.07.011","article-title":"Epigenetic regulation of human placental function and pregnancy outcome: considerations for causal inference","volume":"213","author":"Januar","year":"2015","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(19)30078-6_bib93","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1186\/s12859-016-1140-4","article-title":"Reference-free deconvolution of DNA methylation data and mediation by cell composition effects","volume":"17","author":"Houseman","year":"2016","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/S2213-8587(19)30078-6_bib94","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1002\/ijc.31014","article-title":"Roadmap for investigating epigenome deregulation and environmental origins of cancer","volume":"142","author":"Herceg","year":"2018","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(19)30078-6_bib95","doi-asserted-by":"crossref","first-page":"11089","DOI":"10.1038\/ncomms11089","article-title":"Blood-based biomarkers of age-associated epigenetic changes in human islets associate with insulin secretion and diabetes","volume":"7","author":"Bacos","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(19)30078-6_bib96","doi-asserted-by":"crossref","first-page":"1553","DOI":"10.1111\/dom.13262","article-title":"Epigenetic effects of metformin: from molecular mechanisms to clinical implications","volume":"20","author":"Bridgeman","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(19)30078-6_bib97","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1093\/molehr\/gat020","article-title":"Epigenetics of gestational diabetes mellitus and offspring health: the time for action is in early stages of life","volume":"19","author":"Lehnen","year":"2013","journal-title":"Mol Hum Reprod"},{"key":"10.1016\/S2213-8587(19)30078-6_bib98","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1159\/000342552","article-title":"Non-imprinted epigenetics in fetal and postnatal development and growth","volume":"71","author":"Godfrey","year":"2013","journal-title":"Nestle Nutr Inst Workshop Ser"},{"key":"10.1016\/S2213-8587(19)30078-6_bib99","doi-asserted-by":"crossref","first-page":"e12262","DOI":"10.1111\/1755-5922.12262","article-title":"Epigenetic regulation in monocyte\/macrophage: A key player during atherosclerosis","volume":"35","author":"Jia","year":"2017","journal-title":"Cardiovasc Ther"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300786?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300786?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:03Z","timestamp":1761991683000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300786"}},"issued":{"date-parts":[[2019,10]]},"references-count":99,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2213858719300786"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30078-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Diabetes in pregnancy and epigenetic mechanisms\u2014how the first 9 months from conception might affect the child's epigenome and later risk of disease","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30078-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,23]],"date-time":"2026-09-23T21:33:08Z","timestamp":1790199188296,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2018,5,1]],"date-time":"2018-05-01T00:00:00Z","timestamp":1525132800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,2,23]],"date-time":"2018-02-23T00:00:00Z","timestamp":1519344000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,5]]},"DOI":"10.1016\/s2213-8587(18)30036-6","type":"journal-article","created":{"date-parts":[[2018,3,5]],"date-time":"2018-03-05T23:40:33Z","timestamp":1520293233000},"page":"382-391","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":29,"title":["Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial"],"prefix":"10.1016","volume":"6","author":[{"given":"Sobha","family":"Sivaprasad","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joana C","family":"Vasconcelos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A Toby","family":"Prevost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Helen","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philip","family":"Hykin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sheena","family":"George","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanna","family":"Kelly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geoffrey B","family":"Arden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank","family":"Ahfat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajay","family":"Bhatnagar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nirodhini","family":"Narendran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Randhir","family":"Chavan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abosede","family":"Cole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roxanne","family":"Crosby-Nwaobi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namritha","family":"Patrao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deepthy","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chris","family":"Hogg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gary","family":"Rubin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Leitch-Devlin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Egan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nisha","family":"Shah","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatiana","family":"Mansour","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tunde","family":"Peto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haralabos","family":"Eleftheriadis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joanathan","family":"Gibson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arevik","family":"Ghulakhszian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilli","family":"Vafidis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Afsar","family":"Jafree","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Geeta","family":"Menon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Priya","family":"Prakash","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Sandinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Scanlon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Chave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve","family":"Aldington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela","family":"Dale","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Hood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graham A","family":"Hitman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Crabb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alaistair","family":"Denniston","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Lewin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Grierson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Walker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Sturt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debendra","family":"Sahu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30036-6_bib1","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1016\/S2213-8587(16)30052-3","article-title":"Diabetic macular oedema","volume":"5","author":"Tan","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30036-6_bib2","doi-asserted-by":"crossref","first-page":"944","DOI":"10.1097\/IAE.0000000000000403","article-title":"Topical nepafenec in eyes with noncentral diabetic macular edema","volume":"35","author":"Friedman","year":"2015","journal-title":"Retina"},{"key":"10.1016\/S2213-8587(18)30036-6_bib3","article-title":"Anti-vascular endothelial growth factor for diabetic macular oedema: a network meta-analysis","volume":"6","author":"Virgili","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(18)30036-6_bib4","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1001\/archopht.1985.01050120030015","article-title":"Photocoagulation for diabetic macular edema: Early Treatment Diabetic Retinopathy Study report number 1","volume":"103","year":"1985","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S2213-8587(18)30036-6_bib5","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1001\/archopht.125.3.318","article-title":"Effect of ruboxistaurin in patients with diabetic macular edema: thirty-month results of the randomized PKC-DMES clinical trial","volume":"125","year":"2007","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S2213-8587(18)30036-6_bib6","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1085\/jgp.88.4.521","article-title":"Effects of light and darkness on oxygen distribution and consumption in the cat retina","volume":"88","author":"Linsenmeier","year":"1986","journal-title":"J Gen Physiol"},{"key":"10.1016\/S2213-8587(18)30036-6_bib7","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1038\/eye.2015.254","article-title":"Spare the rods and spoil the retina: revisited","volume":"30","author":"Sivaprasad","year":"2016","journal-title":"Eye (Lond)"},{"key":"10.1016\/S2213-8587(18)30036-6_bib8","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1167\/iovs.03-0557","article-title":"Supplemental oxygen improves diabetic macular edema: a pilot study","volume":"45","author":"Nguyen","year":"2004","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(18)30036-6_bib9","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/eye.2009.328","article-title":"A preliminary trial to determine whether prevention of dark adaptation affects the course of early diabetic retinopathy","volume":"24","author":"Arden","year":"2010","journal-title":"Eye (Lond)"},{"key":"10.1016\/S2213-8587(18)30036-6_bib10","doi-asserted-by":"crossref","first-page":"1546","DOI":"10.1038\/eye.2011.264","article-title":"Regression of early diabetic macular oedema is associated with prevention of dark adaptation","volume":"25","author":"Arden","year":"2011","journal-title":"Eye (Lond)"},{"key":"10.1016\/S2213-8587(18)30036-6_bib11","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1186\/1745-6215-15-458","volume":"15","author":"Sivaprasad","year":"2014","journal-title":"Trials"},{"key":"10.1016\/S2213-8587(18)30036-6_bib12","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1093\/sleep\/14.6.540","article-title":"A new method for measuring daytime sleepiness: the Epworth sleepiness scale","volume":"14","author":"Johns","year":"1991","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(18)30036-6_bib13","first-page":"A246","article-title":"Preliminary study of the test-retest reliability and concurrent validities of the Pittsburgh Insomnia Rating Scale (PIRS)","volume":"25","author":"Moul","year":"2002","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(18)30036-6_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1177\/009286150804200402","article-title":"Recommendations for the primary analysis of continuous endpoints in longitudinal clinical trials","volume":"42","author":"Mallinckrod","year":"2008","journal-title":"Drug Inf J"},{"key":"10.1016\/S2213-8587(18)30036-6_bib15","doi-asserted-by":"crossref","first-page":"d40","DOI":"10.1136\/bmj.d40","article-title":"Strategy for intention to treat analysis in randomised trials with missing outcome data","volume":"342","author":"White","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(18)30036-6_bib16","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1177\/1740774512450098","article-title":"Including all individuals is not enough: lessons for intention-to-treat analysis","volume":"9","author":"White","year":"2012","journal-title":"Clin Trials"},{"key":"10.1016\/S2213-8587(18)30036-6_bib17","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1002\/sim.1981","article-title":"Adjusting for partially missing baseline measurements in randomized trials","volume":"24","author":"White","year":"2005","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(18)30036-6_bib18","series-title":"Practical statistics for medical research","author":"Altman","year":"1990"},{"key":"10.1016\/S2213-8587(18)30036-6_bib19","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1192\/bjp.183.4.323","article-title":"Estimating psychological treatment effects from a randomised controlled trial with both non-compliance and loss to follow-up","volume":"183","author":"Dunn","year":"2003","journal-title":"Br J Psychiatry"},{"key":"10.1016\/S2213-8587(18)30036-6_bib20","article-title":"Investigating the Arden hypothesis: a pilot investigation of the prevention of dark adaptation as complementary therapy for diabetic retinopathy and macular edema","volume":"58","author":"Ramsey","year":"2017","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(18)30036-6_bib21","article-title":"Safety and acceptability of an organic light emitting diode (OLED) sleep mask for the treatment of retinal diseases: INSIGHT Study","volume":"56","author":"Czanner","year":"2015","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(18)30036-6_bib22","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1038\/eye.2016.259","article-title":"Safety and acceptability of an organic light-emitting diode sleep mask as a potential therapy for retinal disease","volume":"31","author":"Sahni","year":"2017","journal-title":"Eye (Lond)"},{"key":"10.1016\/S2213-8587(18)30036-6_bib23","first-page":"00253","article-title":"Patients with diabetic eye disease using a potentially therapeutic mask. Do sufficient patients wear the mask and for how long?","volume":"7","author":"Kuchynyka","year":"2017","journal-title":"Adv Ophthalmol Vis Syst"},{"key":"10.1016\/S2213-8587(18)30036-6_bib24","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1056\/NEJMra050100","article-title":"Adherence to medication","volume":"353","author":"Osterberg","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30036-6_bib25","series-title":"Adherence to long-term therapies. Evidence for action","year":"2003"},{"key":"10.1016\/S2213-8587(18)30036-6_bib26","doi-asserted-by":"crossref","first-page":"4272","DOI":"10.1167\/iovs.16-19415","article-title":"Photoreceptor cells influence retinal vascular degeneration in mouse models of retinal degeneration and diabetes","volume":"57","author":"Liu","year":"2016","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"10.1016\/S2213-8587(18)30036-6_bib27","doi-asserted-by":"crossref","first-page":"2111","DOI":"10.1007\/s00125-017-4381-5","article-title":"Photoreceptor cells produce inflammatory products that contribute to retinal vascular permeability in a mouse model of diabetes","volume":"60","author":"Tonade","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30036-6_bib28","first-page":"1647","article-title":"Retinal hypoxia in long-term diabetic cats","volume":"39","author":"Linsenmeier","year":"1998","journal-title":"Invest Ophthalmol Vis Sci"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300366?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300366?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,23]],"date-time":"2018-08-23T16:27:13Z","timestamp":1535041633000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300366"}},"issued":{"date-parts":[[2018,5]]},"references-count":28,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2018,5]]}},"alternative-id":["S2213858718300366"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30036-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Clinical efficacy and safety of a light mask for prevention of dark adaptation in treating and preventing progression of early diabetic macular oedema at 24 months (CLEOPATRA): a multicentre, phase 3, randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30036-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30068-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,21]],"date-time":"2026-09-21T20:14:49Z","timestamp":1790021689394,"version":"4.0.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2017,12,1]],"date-time":"2017-12-01T00:00:00Z","timestamp":1512086400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,12]]},"DOI":"10.1016\/s2213-8587(17)30220-6","type":"journal-article","created":{"date-parts":[[2017,8,7]],"date-time":"2017-08-07T20:30:10Z","timestamp":1502137810000},"page":"932-934","source":"Crossref","is-referenced-by-count":18,"title":["How to address non-communicable diseases in urban Africa"],"prefix":"10.1016","volume":"5","author":[{"given":"Jo","family":"Hunter-Adams","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaise Nguendo","family":"Yongsi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kafui","family":"Dzasi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Parnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jo Ivey","family":"Boufford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edgar","family":"Pieterse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tolu","family":"Oni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30220-6_bib1","series-title":"World urbanization prospects: 2014 revision, highlights (ST\/ESA\/SER.A\/352)","year":"2014"},{"key":"10.1016\/S2213-8587(17)30220-6_bib2","series-title":"The state of African cities, 2014. Re-imagining sustainable urban transitions","year":"2014"},{"key":"10.1016\/S2213-8587(17)30220-6_bib3","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1016\/j.diabres.2013.11.006","article-title":"Diabetes in the Africa region: an update","volume":"103","author":"Peer","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(17)30220-6_bib4","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1016\/S0140-6736(11)60879-9","article-title":"UN High-Level Meeting on Non-Communicable Diseases: addressing four questions","volume":"378","author":"Beaglehole","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30220-6_bib5","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3200\/BMED.32.3.77-86","article-title":"Urban stress and health in developing countries: development and validation of a neighborhood stress index for India","volume":"32","author":"Suchday","year":"2006","journal-title":"Behav Med"},{"key":"10.1016\/S2213-8587(17)30220-6_bib7","doi-asserted-by":"crossref","first-page":"722","DOI":"10.1007\/s11524-016-0050-0","article-title":"Urban health research in Africa: themes and priority research questions","volume":"93","author":"Oni","year":"2016","journal-title":"J Urban Health"},{"key":"10.1016\/S2213-8587(17)30220-6_bib9","doi-asserted-by":"crossref","first-page":"e0163463","DOI":"10.1371\/journal.pone.0163463","article-title":"Beverages sales in Mexico before and after implementation of a sugar sweetened beverage tax","volume":"11","author":"Colchero","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30220-6_bib10","series-title":"Health in all policies: framework for country action","year":"2014"},{"key":"10.1016\/S2213-8587(17)30220-6_bib12","doi-asserted-by":"crossref","first-page":"215","DOI":"10.2105\/AJPH.2015.302944","article-title":"Integrating systems science and community-based participatory research to achieve health equity","volume":"106","author":"Frerichs","year":"2016","journal-title":"Am J Public Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302206?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302206?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,8,29]],"date-time":"2018-08-29T13:57:55Z","timestamp":1535551075000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717302206"}},"issued":{"date-parts":[[2017,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2017,12]]}},"alternative-id":["S2213858717302206"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30220-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,12]]}},{"indexed":{"date-parts":[[2026,10,3]],"date-time":"2026-10-03T19:57:00Z","timestamp":1791057420940,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004312","name":"Eli Lilly and Company","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004312","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004374","name":"Medtronic","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004374","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005564","name":"Gilead Sciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005564","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004326","name":"Bayer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004326","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004191","name":"Novo Nordisk","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004191","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/s2213-8587(20)30114-5","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T20:32:57Z","timestamp":1590006777000},"page":"511-523","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial"],"prefix":"10.1016","volume":"8","author":[{"given":"Ronnie","family":"Aronson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aihua","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth E","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"McGaugh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30114-5_bib1","doi-asserted-by":"crossref","first-page":"1536","DOI":"10.2337\/dc15-0030","article-title":"Impact of physical activity on glycemic control and prevalence of cardiovascular risk factors in adults with type 1 diabetes: a cross-sectional multicenter study of 18,028 patients","volume":"38","author":"Bohn","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30114-5_bib2","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1007\/s40279-015-0302-2","article-title":"Quantifying the acute changes in glucose with exercise in type 1 diabetes: a systematic review and meta-analysis","volume":"45","author":"Garc\u00eda-Garc\u00eda","year":"2015","journal-title":"Sports Med"},{"key":"10.1016\/S2213-8587(20)30114-5_bib3","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2019.01.003","article-title":"Reproducibility in the cardiometabolic responses to high-intensity interval exercise in adults with type 1 diabetes","volume":"148","author":"Riddell","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(20)30114-5_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2018-000578","article-title":"Exercise modes and their association with hypoglycemia episodes in adults with type 1 diabetes mellitus: a systematic review","volume":"6","author":"Hasan","year":"2018","journal-title":"BMJ Open Diabetes Res Care"},{"issue":"suppl 27","key":"10.1016\/S2213-8587(20)30114-5_bib5","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/pedi.12755","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: exercise in children and adolescents with diabetes","volume":"19","author":"Adolfsson","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(20)30114-5_bib6","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S2213-8587(17)30014-1","article-title":"Exercise management in type 1 diabetes: a consensus statement","volume":"5","author":"Riddell","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30114-5_bib7","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2337\/dc16-1728","article-title":"Physical activity\/exercise and diabetes: a position statement of the American Diabetes Association","volume":"39","author":"Colberg","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30114-5_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/dia.2012.0168","article-title":"Insulin pump therapy is associated with less post-exercise hyperglycemia than multiple daily injections: an observational study of physically active type 1 diabetes patients","volume":"15","author":"Yardley","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(20)30114-5_bib9","doi-asserted-by":"crossref","first-page":"824","DOI":"10.2337\/dc18-2204","article-title":"Improved open-loop glucose control with basal insulin reduction 90 minutes before aerobic exercise in patients with type 1 diabetes on continuous subcutaneous insulin infusion","volume":"42","author":"Zaharieva","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30114-5_bib10","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1016\/j.diabet.2018.08.002","article-title":"Timing of insulin basal rate reduction to reduce hypoglycemia during late post-prandial exercise in adults with type 1 diabetes using insulin pump therapy: a randomized crossover trial","volume":"45","author":"Roy-Fleming","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(20)30114-5_bib11","doi-asserted-by":"crossref","first-page":"1636","DOI":"10.1007\/s00125-016-3981-9","article-title":"Insulin pump basal adjustment for exercise in type 1 diabetes: a randomised crossover study","volume":"59","author":"McAuley","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30114-5_bib12","doi-asserted-by":"crossref","first-page":"2200","DOI":"10.2337\/dc06-0495","article-title":"Prevention of hypoglycemia during exercise in children with type 1 diabetes by suspending basal insulin","volume":"29","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30114-5_bib13","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1111\/dom.12552","article-title":"Insulin-based strategies to prevent hypoglycaemia during and after exercise in adult patients with type 1 diabetes on pump therapy: the DIABRASPORT randomized study","volume":"17","author":"Franc","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30114-5_bib14","doi-asserted-by":"crossref","first-page":"e348","DOI":"10.1542\/peds.2004-2428","article-title":"Exercise with and without an insulin pump among children and adolescents with type 1 diabetes mellitus","volume":"116","author":"Admon","year":"2005","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(20)30114-5_bib15","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1089\/dia.2017.0010","article-title":"The effects of basal insulin suspension at the start of exercise on blood glucose levels during continuous versus circuit-based exercise in individuals with type 1 diabetes on continuous subcutaneous insulin infusion","volume":"19","author":"Zaharieva","year":"2017","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(20)30114-5_bib16","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1016\/j.jcjd.2016.04.010","article-title":"Techniques for exercise preparation and management in adults with type 1 diabetes","volume":"40","author":"Pinsker","year":"2016","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(20)30114-5_bib18","doi-asserted-by":"crossref","first-page":"65","DOI":"10.18544\/PEDM-21.02.0026","article-title":"Reasons for the discontinuation of therapy of personal insulin pump in children with type 1 diabetes","volume":"21","author":"Binek","year":"2016","journal-title":"Pediatr Endocrinol Diabetes Metab"},{"key":"10.1016\/S2213-8587(20)30114-5_bib19","doi-asserted-by":"crossref","first-page":"224","DOI":"10.1177\/1932296816663963","article-title":"Evaluation of pump discontinuation and associated factors in the T1D Exchange Clinic Registry","volume":"11","author":"Wong","year":"2017","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(20)30114-5_bib20","doi-asserted-by":"crossref","unstructured":"Edelmann E, Staudner V, Bachmann W, Walter H, Haas W, Mehnert H. Exercise-induced hypoglycaemia and subcutaneous insulin infusion. Diabet Med; 3: 526\u201331.","DOI":"10.1111\/j.1464-5491.1986.tb00808.x"},{"key":"10.1016\/S2213-8587(20)30114-5_bib21","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1007\/BF00400572","article-title":"Exercise in type 1 (insulin-dependent) diabetic patients treated with continuous subcutaneous insulin infusion. Prevention of exercise induced hypoglycaemia","volume":"33","author":"Sonnenberg","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30114-5_bib22","doi-asserted-by":"crossref","first-page":"519","DOI":"10.1007\/BF03346499","article-title":"Effects of moderate-severe exercise on blood glucose in type 1 diabetic adolescents treated with insulin pump or glargine insulin","volume":"32","author":"Delvecchio","year":"2009","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(20)30114-5_bib23","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1089\/dia.2011.0121","article-title":"Influence of physical activity on metabolic state within a 3-h interruption of continuous subcutaneous insulin infusion in patients with type 1 diabetes","volume":"13","author":"Jankovec","year":"2011","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(20)30114-5_bib24","author":"Edelman"},{"key":"10.1016\/S2213-8587(20)30114-5_bib25","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1249\/00005768-198205000-00012","article-title":"Psychophysical bases of perceived exertion","volume":"14","author":"Borg","year":"1982","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(20)30114-5_bib26","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1007\/BF00401150","article-title":"Partitioning the symptoms of hypoglycaemia using multi-sample confirmatory factor analysis","volume":"36","author":"Deary","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30114-5_bib27","doi-asserted-by":"crossref","first-page":"481","DOI":"10.1007\/s11136-005-1624-6","article-title":"Measuring the impact of diabetes through patient report of treatment satisfaction, productivity and symptom experience","volume":"15","author":"Brod","year":"2006","journal-title":"Qual Life Res"},{"key":"10.1016\/S2213-8587(20)30114-5_bib28","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1186\/1477-7525-7-83","article-title":"Understanding and assessing the impact of treatment in diabetes: the Treatment-Related Impact Measures for Diabetes and Devices (TRIM-Diabetes and TRIM-Diabetes Device)","volume":"7","author":"Brod","year":"2009","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/S2213-8587(20)30114-5_bib29","doi-asserted-by":"crossref","first-page":"801","DOI":"10.2337\/dc10-1343","article-title":"Psychometric properties of the hypoglycemia survey-ii for adults with type 1 diabetes","volume":"34","author":"Gonder-Frederick","year":"2011","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:31Z","timestamp":1761991651000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301145"}},"issued":{"date-parts":[[2020,6]]},"references-count":28,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2213858720301145"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30114-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Flexible insulin therapy with a hybrid regimen of insulin degludec and continuous subcutaneous insulin infusion with pump suspension before exercise in physically active adults with type 1 diabetes (FIT Untethered): a single-centre, open-label, proof-of-concept, randomised crossover trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30114-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T23:43:19Z","timestamp":1792712599749,"version":"4.5.0"},"reference-count":25,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,6,1]],"date-time":"2018-06-01T00:00:00Z","timestamp":1527811200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,2,12]],"date-time":"2018-02-12T00:00:00Z","timestamp":1518393600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000289","name":"Cancer Research UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000289","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["058299\/Z\/99,090532"],"award-info":[{"award-number":["058299\/Z\/99,090532"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["098381"],"award-info":[{"award-number":["098381"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003141","name":"Consejo Nacional de Ciencia y Tecnolog\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003141","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,6]]},"DOI":"10.1016\/s2213-8587(18)30050-0","type":"journal-article","created":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T19:39:14Z","timestamp":1521488354000},"page":"455-463","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":68,"title":["Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study"],"prefix":"10.1016","volume":"6","author":[{"given":"William G","family":"Herrington","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jesus","family":"Alegre-D\u00edaz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel","family":"Wade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Gnatiuc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ra\u00fal","family":"Ramirez-Reyes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Hill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Solano-S\u00e1nchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin","family":"Baigent","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Lewington","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rory","family":"Collins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roberto","family":"Tapia-Conyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Peto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Kuri-Morales","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan R","family":"Emberson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30050-0_bib1","series-title":"IDF Diabetes Atlas","year":"2017"},{"key":"10.1016\/S2213-8587(18)30050-0_bib2","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Rao Kondapally Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30050-0_bib3","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30050-0_bib4","doi-asserted-by":"crossref","first-page":"2465","DOI":"10.1007\/s00125-014-3369-7","article-title":"Impact of age, age at diagnosis and duration of diabetes on the risk of macrovascular and microvascular complications and death in type 2 diabetes","volume":"57","author":"Zoungas","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30050-0_bib5","doi-asserted-by":"crossref","first-page":"404","DOI":"10.1001\/archinternmed.2011.2","article-title":"Impact of diabetes on cardiovascular disease risk and all-cause mortality in older men: influence of age at onset, diabetes duration, and established and novel risk factors","volume":"171","author":"Wannamethee","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(18)30050-0_bib6","doi-asserted-by":"crossref","first-page":"704","DOI":"10.2337\/diacare.27.3.704","article-title":"The significant effect of diabetes duration on coronary heart disease mortality: the Framingham Heart Study","volume":"27","author":"Fox","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30050-0_bib7","doi-asserted-by":"crossref","first-page":"e0133958","DOI":"10.1371\/journal.pone.0133958","article-title":"Quality of diabetes care: the challenges of an increasing epidemic in Mexico. Results from two national health surveys (2006 and 2012)","volume":"10","author":"Flores-Hern\u00e1ndez","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(18)30050-0_bib8","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1056\/NEJMoa1605368","article-title":"Diabetes and cause-specific mortality in Mexico City","volume":"375","author":"Alegre-D\u00edaz","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30050-0_bib9","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1093\/ije\/dyl042","article-title":"Cohort profile: the Mexico City Prospective Study","volume":"35","author":"Tapia-Conyer","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(18)30050-0_bib10","doi-asserted-by":"crossref","first-page":"1627","DOI":"10.1093\/clinchem\/48.9.1627","article-title":"Reliable measurement of glycated hemoglobin in frozen blood samples: implications for epidemiologic studies","volume":"48","author":"Youngman","year":"2002","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(18)30050-0_bib12","series-title":"International statistical classification of diseases and related health problems: 10th revision (ICD-10)","volume":"Vol 2","year":"2004"},{"key":"10.1016\/S2213-8587(18)30050-0_bib13","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1002\/sim.1485","article-title":"Improved estimates of floating absolute risk","volume":"23","author":"Plummer","year":"2004","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(18)30050-0_bib14","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1056\/NEJMoa011303","article-title":"Renoprotective effect of the angiotensin-receptor antagonist irbesartan in patients with nephropathy due to type 2 diabetes","volume":"345","author":"Lewis","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(18)30050-0_bib15","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1001\/jama.2016.19720","article-title":"Association between diabetes and cause-specific mortality in rural and urban areas of China","volume":"317","author":"Bragg","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30050-0_bib16","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(14)60040-4","article-title":"Diabetes as a risk factor for stroke in women compared with men: a systematic review and meta-analysis of 64 cohorts, including 775\u2008385 individuals and 12\u2008539 strokes","volume":"383","author":"Peters","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(18)30050-0_bib17","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1001\/archinte.165.4.430","article-title":"Sex differences in the effect of diabetes duration on coronary heart disease mortality","volume":"165","author":"Natarajan","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(18)30050-0_bib18","doi-asserted-by":"crossref","first-page":"1299","DOI":"10.2337\/diacare.27.6.1299","article-title":"Mortality and predictors of mortality in a cohort of Brazilian type 2 diabetic patients","volume":"27","author":"Salles","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(18)30050-0_bib19","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(18)30050-0_bib20","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1016\/S2213-8587(17)30104-3","article-title":"Effects of intensive glucose control on microvascular outcomes in patients with type 2 diabetes: a meta-analysis of individual participant data from randomised controlled trials","volume":"5","author":"Zoungas","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30050-0_bib21","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.2014.1873","article-title":"Glycated hemoglobin measurement and prediction of cardiovascular disease","volume":"311","author":"Di Angelantonio","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30050-0_bib22","series-title":"Global report on diabetes","year":"2016"},{"key":"10.1016\/S2213-8587(18)30050-0_bib23","series-title":"Estrategia nacional para la prevenci\u00f3n y el control del sobrepeso, la obesidad y la diabetes","year":"2013"},{"key":"10.1016\/S2213-8587(18)30050-0_bib24","doi-asserted-by":"crossref","first-page":"393","DOI":"10.2471\/BLT.17.020617","article-title":"Quality of care is key to tackling Mexico's diabetes emergency","volume":"95","author":"Guthrie","year":"2017","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(18)30050-0_bib25","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1744-8603-9-3","article-title":"Diabetes in Mexico: cost and management of diabetes and its complications and challenges for health policy","volume":"9","author":"Barquera","year":"2013","journal-title":"Global Health"},{"key":"10.1016\/S2213-8587(18)30050-0_bib26","series-title":"The Mexican social protection system in health","author":"Bonilla-Chac\u00edn","year":"2013"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300500?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718300500?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:51Z","timestamp":1761991551000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718300500"}},"issued":{"date-parts":[[2018,6]]},"references-count":25,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2018,6]]}},"alternative-id":["S2213858718300500"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30050-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effect of diabetes duration and glycaemic control on 14-year cause-specific mortality in Mexican adults: a blood-based prospective cohort study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30050-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30098-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,25]],"date-time":"2026-10-25T00:18:09Z","timestamp":1792887489501,"version":"4.5.0"},"reference-count":34,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2015,9,7]],"date-time":"2015-09-07T00:00:00Z","timestamp":1441584000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"National Institute for Health Research, Health Technology Assessment programme","award":["project number 11\/99\/02"],"award-info":[{"award-number":["project number 11\/99\/02"]}]},{"name":"MRC","award":["MC_UU_12013\/5"],"award-info":[{"award-number":["MC_UU_12013\/5"]}]},{"name":"NIHR Senior Investigator","award":["NF-SI-0611-10196"],"award-info":[{"award-number":["NF-SI-0611-10196"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/s2213-8587(15)00255-7","type":"journal-article","created":{"date-parts":[[2015,9,6]],"date-time":"2015-09-06T19:30:30Z","timestamp":1441567830000},"page":"795-804","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":156,"title":["Association between hyperglycaemia and adverse perinatal outcomes in south Asian and white British women: analysis of data from the Born in Bradford cohort"],"prefix":"10.1016","volume":"3","author":[{"given":"Diane","family":"Farrar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lesley","family":"Fairley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gillian","family":"Santorelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Derek","family":"Tuffnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Trevor A","family":"Sheldon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lydia","family":"van Overveld","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debbie A","family":"Lawlor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00255-7_bib1","doi-asserted-by":"crossref","first-page":"123","DOI":"10.7326\/0003-4819-159-2-201307160-00661","article-title":"Benefits and harms of treating gestational diabetes mellitus: a systematic review and meta-analysis for the U.S. Preventive Services Task Force and the National Institutes of Health Office of Medical Applications of Research","volume":"159","author":"Hartling","year":"2013","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(15)00255-7_bib2","doi-asserted-by":"crossref","first-page":"676","DOI":"10.2337\/dc10-0719","article-title":"International association of diabetes and pregnancy study groups recommendations on the diagnosis and classification of hyperglycemia in pregnancy","volume":"33","author":"Metzger","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00255-7_bib3","series-title":"Diagnostic criteria and classification of hyperglycaemia first detected in pregnancy","year":"2013"},{"key":"10.1016\/S2213-8587(15)00255-7_bib4","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","author":"Metzger","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00255-7_bib5","series-title":"Definition, diagnosis and classification of diabetes mellitus and its complications. Report of a WHO consultation. Part 1: diagnosis and classification of diabetes mellitus","year":"1999"},{"key":"10.1016\/S2213-8587(15)00255-7_bib6","doi-asserted-by":"crossref","first-page":"2492","DOI":"10.1007\/s00125-014-3386-6","article-title":"Pregnancy glycaemia and cord-blood levels of insulin and leptin in Pakistani and white British mother-offspring pairs: findings from a prospective pregnancy cohort","volume":"57","author":"Lawlor","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00255-7_bib8","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1111\/dme.12357","article-title":"Diagnostic thresholds for gestational diabetes and their impact on pregnancy outcomes: a systematic review","volume":"31","author":"Hartling","year":"2014","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00255-7_bib9","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1530\/EJE-11-0866","article-title":"Impact of ethnicity on gestational diabetes identified with the WHO and the modified International Association of Diabetes and Pregnancy Study Groups criteria: a population-based cohort study","volume":"166","author":"Jenum","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(15)00255-7_bib10","doi-asserted-by":"crossref","first-page":"5575","DOI":"10.1210\/jc.2002-020434","article-title":"Adiposity and hyperinsulinemia in Indians are present at birth","volume":"87","author":"Yajnik","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00255-7_bib11","doi-asserted-by":"crossref","first-page":"544","DOI":"10.1136\/jech-2012-201891","article-title":"UK-born Pakistani-origin infants are relatively more adipose than white British infants: findings from 8704 mother-offspring pairs in the Born-in-Bradford prospective birth cohort","volume":"67","author":"West","year":"2013","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(15)00255-7_bib12","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1093\/ije\/dyt225","article-title":"Do ethnic differences in cord blood leptin levels differ by birthweight category? Findings from the Born in Bradford cohort study","volume":"43","author":"West","year":"2014","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00255-7_bib13","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1007\/s00125-007-0847-1","article-title":"Adiposity, inflammation and hyperglycaemia in rural and urban Indian men: Coronary Risk of Insulin Sensitivity in Indian Subjects (CRISIS) Study","volume":"51","author":"Yajnik","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00255-7_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1038\/sj.ijo.802219","article-title":"Neonatal anthropometry: the thin-fat Indian baby. The Pune Maternal Nutrition Study","volume":"27","author":"Yajnik","year":"2003","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(15)00255-7_bib15","first-page":"527","article-title":"Truncal adiposity is present at birth and in early childhood in South Indian children","volume":"42","author":"Krishnaveni","year":"2005","journal-title":"Indian Pediatr"},{"key":"10.1016\/S2213-8587(15)00255-7_bib16","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1097\/HJH.0b013e3282f3168e","article-title":"Effects of early growth on blood pressure of infants of British European and South Asian origin at one year of age: the Manchester children's growth and vascular health study","volume":"26","author":"Bansal","year":"2008","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(15)00255-7_bib17","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1093\/ije\/dys112","article-title":"Cohort profile: The Born in Bradford multi-ethnic family cohort study","volume":"42","author":"Wright","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00255-7_bib18","unstructured":"National Institute for Health and Care Excellence. Caesarean Section (update): Costing report. NICE clinical guideline 132. 2011."},{"key":"10.1016\/S2213-8587(15)00255-7_bib20","doi-asserted-by":"crossref","first-page":"c1140","DOI":"10.1136\/bmj.c1140","article-title":"Using the new UK-WHO growth charts","volume":"340","author":"Wright","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00255-7_bib21","doi-asserted-by":"crossref","first-page":"453","DOI":"10.2337\/db08-1112","article-title":"Hyperglycemia and Adverse Pregnancy Outcome (HAPO) Study: associations with neonatal anthropometrics","volume":"58","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(15)00255-7_bib22","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1111\/j.1365-3016.2010.01181.x","article-title":"Reliability of routine clinical measurements of neonatal circumferences and research measurements of neonatal skinfold thicknesses: findings from the Born in Bradford study","volume":"25","author":"West","year":"2011","journal-title":"Paediatr Perinat Epidemiol"},{"key":"10.1016\/S2213-8587(15)00255-7_bib23","doi-asserted-by":"crossref","first-page":"645","DOI":"10.1111\/j.0006-341X.2000.00645.x","article-title":"A note on robust variance estimation for cluster-correlated data","volume":"56","author":"Williams","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(15)00255-7_bib24","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: Issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(15)00255-7_bib25","doi-asserted-by":"crossref","first-page":"2148","DOI":"10.1007\/s00125-012-2549-6","article-title":"Impact of gestational diabetes on the risk of diabetes following pregnancy among Chinese and South Asian women","volume":"55","author":"Mukerji","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(15)00255-7_bib26","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1111\/j.1471-0528.2011.03156.x","article-title":"An analysis of the interrelationship between maternal age, body mass index and racial origin in the development of gestational diabetes mellitus","volume":"119","author":"Makgoba","year":"2012","journal-title":"BJOG"},{"key":"10.1016\/S2213-8587(15)00255-7_bib27","doi-asserted-by":"crossref","first-page":"820","DOI":"10.1111\/j.1464-5491.1992.tb01900.x","article-title":"High prevalence of gestational diabetes in women from ethnic minority groups","volume":"9","author":"Dornhorst","year":"1992","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00255-7_bib28","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1016\/j.diabres.2013.11.003","article-title":"Global estimates of the prevalence of hyperglycaemia in pregnancy","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(15)00255-7_bib29","doi-asserted-by":"crossref","first-page":"690","DOI":"10.2337\/dc09-2306","article-title":"New consensus criteria for GDM: problem solved or Pandora's box?","volume":"33","author":"Moses","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00255-7_bib30","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1111\/j.1464-5491.2011.03236.x","article-title":"The implications of the new International Association of Diabetes and Pregnancy Study Groups (IADPSG) diagnostic criteria for gestational diabetes","volume":"28","author":"Holt","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00255-7_bib31","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1093\/ije\/dys209","article-title":"The Society for Social Medicine John Pemberton Lecture 2011. Developmental overnutrition: an old hypothesis with new importance?","volume":"42","author":"Lawlor","year":"2013","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00255-7_bib32","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1038\/nrendo.2012.176","article-title":"Maternal adiposity: a determinant of perinatal and offspring outcomes?","volume":"8","author":"Lawlor","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(15)00255-7_bib33","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/dme.12625","article-title":"Does exposure to hyperglycaemia in utero increase the risk of obesity and diabetes in the offspring? A critical reappraisal","volume":"32","author":"Donovan","year":"2015","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(15)00255-7_bib34","doi-asserted-by":"crossref","first-page":"2477","DOI":"10.1056\/NEJMoa042973","article-title":"Effect of treatment of gestational diabetes mellitus on pregnancy outcomes","volume":"352","author":"Crowther","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00255-7_bib35","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1056\/NEJMoa0902430","article-title":"A multicenter, randomized trial of treatment for mild gestational diabetes","volume":"361","author":"Landon","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00255-7_bib36","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-015-3647-z","article-title":"Diagnosis of gestational diabetes mellitus: falling through the net","author":"Meek","year":"2015","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002557?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002557?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T13:27:09Z","timestamp":1537363629000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002557"}},"issued":{"date-parts":[[2015,10]]},"references-count":34,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2213858715002557"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00255-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association between hyperglycaemia and adverse perinatal outcomes in south Asian and white British women: analysis of data from the Born in Bradford cohort","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00255-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00282-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Farrar et al. Open Access article distributed under the terms of CC BY. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T23:31:32Z","timestamp":1794612692906,"version":"4.9.1"},"reference-count":194,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,3,1]],"date-time":"2022-03-01T00:00:00Z","timestamp":1646092800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010874","name":"American Society for Bone and Mineral Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010874","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004337","name":"Roche","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004337","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011110","name":"UCB","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011110","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004358","name":"Samsung","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004358","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011218","name":"Sandoz","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011218","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["860898"],"award-info":[{"award-number":["860898"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000038","name":"U.S. Food and Drug Administration","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000038","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000921","name":"European Cooperation in Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000921","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010665","name":"H2020 Marie Sk\u0142odowska-Curie Actions","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010665","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1016\/s2213-8587(21)00347-8","type":"journal-article","created":{"date-parts":[[2022,1,31]],"date-time":"2022-01-31T03:51:10Z","timestamp":1643601070000},"page":"207-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":463,"title":["Bone fragility in diabetes: novel concepts and clinical implications"],"prefix":"10.1016","volume":"10","author":[{"given":"Lorenz C","family":"Hofbauer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f6rn","family":"Busse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Eastell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morten","family":"Frost","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M","family":"Burden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando","family":"Rivadeneira","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Napoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martina","family":"Rauner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00347-8_bib1","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/nrendo.2011.233","article-title":"Bone, sweet bone\u2014osteoporotic fractures in diabetes mellitus","volume":"8","author":"Hamann","year":"2012","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib2","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1038\/nrendo.2016.153","article-title":"Mechanisms of diabetes mellitus-induced bone fragility","volume":"13","author":"Napoli","year":"2017","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib3","doi-asserted-by":"crossref","first-page":"1913","DOI":"10.2337\/dc15-0783","article-title":"Type 1 diabetes is associated with an increased risk of fracture across the life span: a population-based cohort study using The Health Improvement Network (THIN)","volume":"38","author":"Weber","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00347-8_bib4","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1002\/jbmr.3287","article-title":"Vertebral fracture risk in diabetic elderly men: the MrOS study","volume":"33","author":"Napoli","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib5","doi-asserted-by":"crossref","first-page":"685","DOI":"10.1038\/s41574-021-00555-5","article-title":"Update on the pathogenesis and treatment of skeletal fragility in type 2 diabetes mellitus","volume":"17","author":"Khosla","year":"2021","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib6","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jbmr.3240","article-title":"Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT study","volume":"33","author":"Samelson","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib7","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1016\/S2213-8587(17)30188-2","article-title":"Osteoporosis treatment: recent developments and ongoing challenges","volume":"5","author":"Khosla","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib8","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1093\/aje\/kwm106","article-title":"Systematic review of type 1 and type 2 diabetes mellitus and risk of fracture","volume":"166","author":"Janghorbani","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib9","article-title":"Diabetes mellitus and the risk of fractures at specific sites: a meta-analysis","volume":"9","author":"Wang","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(21)00347-8_bib10","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00198-019-05224-y","article-title":"Diabetes and fractures: new evidence of atypical femoral fractures?","volume":"31","author":"Rasmussen","year":"2020","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib11","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2147\/TCRM.S131945","article-title":"Fracture risk in patients with type 2 diabetes mellitus and possible risk factors: a systematic review and meta-analysis","volume":"13","author":"Moayeri","year":"2017","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/S2213-8587(21)00347-8_bib12","doi-asserted-by":"crossref","first-page":"1362","DOI":"10.1210\/clinem\/dgab061","article-title":"In men with obesity, T2DM is associated with poor trabecular microarchitecture and bone strength and low bone turnover","volume":"106","author":"Vigevano","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib13","doi-asserted-by":"crossref","first-page":"1185","DOI":"10.1359\/JBMR.050304","article-title":"Predictive value of BMD for hip and other fractures","volume":"20","author":"Johnell","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib14","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1016\/j.bone.2004.03.024","article-title":"A meta-analysis of previous fracture and subsequent fracture risk","volume":"35","author":"Kanis","year":"2004","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib15","doi-asserted-by":"crossref","first-page":"137","DOI":"10.2337\/dc19-0925","article-title":"Vertebral fractures in individuals with type 2 diabetes: more than skeletal complications alone","volume":"43","author":"Koromani","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00347-8_bib16","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0203533","article-title":"Fracture risk in type 2 diabetic patients: a clinical prediction tool based on a large population-based cohort","volume":"13","author":"Mart\u00ednez-Laguna","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00347-8_bib17","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1056\/NEJMcp1903252","article-title":"Prevention of Falls in Community-Dwelling Older Adults","volume":"382","author":"Ganz","year":"2020","journal-title":"N Engl J Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00347-8_bib18","doi-asserted-by":"crossref","first-page":"A280","DOI":"10.1210\/jendso\/bvab048.570","article-title":"Type 2 diabetes clusters indicate diabetes duration key in fracture risk","volume":"5","author":"Ghatan","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(21)00347-8_bib19","doi-asserted-by":"crossref","first-page":"1619","DOI":"10.2337\/dc12-1188","article-title":"High bone mineral density and fracture risk in type 2 diabetes as skeletal complications of inadequate glucose control: the Rotterdam Study","volume":"36","author":"Oei","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00347-8_bib20","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1016\/j.bone.2019.04.017","article-title":"Risk factors for fragility fractures in type 1 diabetes","volume":"125","author":"Leanza","year":"2019","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib21","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1007\/s00125-017-4269-4","article-title":"Diabetes, bone and glucose-lowering agents: basic biology","volume":"60","author":"Lecka-Czernik","year":"2017","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00347-8_bib22","doi-asserted-by":"crossref","first-page":"545","DOI":"10.1016\/8756-3282(96)00079-8","article-title":"Hyperinsulinemia and bone mineral density in an elderly population: The Rotterdam Study","volume":"18","author":"Stolk","year":"1996","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib23","doi-asserted-by":"crossref","first-page":"3303","DOI":"10.1210\/jc.2018-02539","article-title":"Effect of insulin resistance on BMD and fracture risk in older adults","volume":"104","author":"Napoli","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib24","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s00198-006-0253-4","article-title":"Discrepancies in bone mineral density and fracture risk in patients with type 1 and type 2 diabetes\u2014a meta-analysis","volume":"18","author":"Vestergaard","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib25","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1210\/jc.2006-0614","article-title":"Risk of fracture in women with type 2 diabetes: the Women's Health Initiative Observational Study","volume":"91","author":"Bonds","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib26","doi-asserted-by":"crossref","first-page":"2544","DOI":"10.2337\/dc19-2164","article-title":"Bone mass and density in youth with type 2 diabetes, obesity, and healthy weight","volume":"43","author":"Kindler","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00347-8_bib27","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1002\/jbmr.556","article-title":"FRAX underestimates fracture risk in patients with diabetes","volume":"27","author":"Giangregorio","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib28","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1210\/jc.2012-3118","article-title":"TBS (trabecular bone score) and diabetes-related fracture risk","volume":"98","author":"Leslie","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib29","doi-asserted-by":"crossref","first-page":"2184","DOI":"10.1001\/jama.2011.715","article-title":"Association of BMD and FRAX score with risk of fracture in older adults with type 2 diabetes","volume":"305","author":"Schwartz","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00347-8_bib30","doi-asserted-by":"crossref","first-page":"1923","DOI":"10.1002\/jbmr.3538","article-title":"Comparison of methods for improving fracture risk assessment in diabetes: the Manitoba BMD Registry","volume":"33","author":"Leslie","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib31","doi-asserted-by":"crossref","first-page":"1292","DOI":"10.1007\/s00125-005-1786-3","article-title":"Relative fracture risk in patients with diabetes mellitus, and the impact of insulin and oral antidiabetic medication on relative fracture risk","volume":"48","author":"Vestergaard","year":"2005","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00347-8_bib32","doi-asserted-by":"crossref","first-page":"1334","DOI":"10.1359\/jbmr.080323","article-title":"Fracture risk in type 2 diabetes: update of a population-based study","volume":"23","author":"Melton","year":"2008","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib33","doi-asserted-by":"crossref","first-page":"2792","DOI":"10.1210\/jc.2008-2157","article-title":"A cohort study of thiazolidinediones and fractures in older adults with diabetes","volume":"94","author":"Solomon","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib34","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1007\/s00774-010-0160-9","article-title":"Relationship between treatments with insulin and oral hypoglycemic agents versus the presence of vertebral fractures in type 2 diabetes mellitus","volume":"28","author":"Kanazawa","year":"2010","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib35","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1007\/s00774-014-0581-y","article-title":"Evaluation of the anti-osteoporotic effects of metformin and sitagliptin in postmenopausal diabetic women","volume":"33","author":"Hegazy","year":"2015","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib36","doi-asserted-by":"crossref","first-page":"2929","DOI":"10.1007\/s00125-012-2668-0","article-title":"Hospitalised hip fracture risk with rosiglitazone and pioglitazone use compared with other glucose-lowering drugs","volume":"55","author":"Colhoun","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00347-8_bib37","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1007\/s00125-014-3289-6","article-title":"Fracture risk in diabetic elderly men: the MrOS study","volume":"57","author":"Napoli","year":"2014","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00347-8_bib38","doi-asserted-by":"crossref","first-page":"506","DOI":"10.1007\/s00223-015-0037-y","article-title":"Use of glucagon-like-peptide 1 receptor agonists and risk of fracture as compared to use of other anti-hyperglycemic drugs","volume":"97","author":"Driessen","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib39","doi-asserted-by":"crossref","first-page":"406","DOI":"10.4158\/EP15758.OR","article-title":"Comparison of the long-term effects of liraglutide and glimepiride monotherapy on bone mineral density in patients with type 2 diabetes","volume":"22","author":"Gilbert","year":"2016","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(21)00347-8_bib40","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1007\/s00592-015-0792-2","article-title":"Effect of exenatide, insulin and pioglitazone on bone metabolism in patients with newly diagnosed type 2 diabetes","volume":"52","author":"Li","year":"2015","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib41","doi-asserted-by":"crossref","first-page":"1317","DOI":"10.1056\/NEJMoa1307684","article-title":"Saxagliptin and cardiovascular outcomes in patients with type 2 diabetes mellitus","volume":"369","author":"Scirica","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00347-8_bib42","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1111\/dom.13124","article-title":"Dapagliflozin in patients with type 2 diabetes mellitus: A pooled analysis of safety data from phase IIb\/III clinical trials","volume":"20","author":"Jabbour","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib43","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1111\/dom.13176","article-title":"Initiation of dapagliflozin and treatment-emergent fractures","volume":"20","author":"Toulis","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib44","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s12325-017-0573-0","article-title":"Safety and tolerability of empagliflozin in patients with type 2 diabetes: pooled analysis of phase i-iii clinical trials","volume":"34","author":"Kohler","year":"2017","journal-title":"Adv Ther"},{"key":"10.1016\/S2213-8587(21)00347-8_bib45","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1080\/00325481.2017.1256747","article-title":"Bone effects of canagliflozin, a sodium glucose co-transporter 2 inhibitor, in patients with type 2 diabetes mellitus","volume":"129","author":"Blevins","year":"2017","journal-title":"Postgrad Med"},{"key":"10.1016\/S2213-8587(21)00347-8_bib46","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1210\/jc.2015-1860","article-title":"Evaluation of bone mineral density and bone biomarkers in patients with type 2 diabetes treated with canagliflozin","volume":"101","author":"Bilezikian","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib47","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1210\/jc.2015-3167","article-title":"Effects of canagliflozin on fracture risk in patients with type 2 diabetes mellitus","volume":"101","author":"Watts","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib48","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00347-8_bib49","doi-asserted-by":"crossref","first-page":"644","DOI":"10.1056\/NEJMoa1611925","article-title":"Canagliflozin and cardiovascular and renal events in type 2 diabetes","volume":"377","author":"Neal","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00347-8_bib50","article-title":"Risk of hypoglycaemia in users of sulphonylureas compared with metformin in relation to renal function and sulphonylurea metabolite group: population based cohort study","volume":"354","author":"van Dalem","year":"2016","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00347-8_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1503\/cmaj.080486","article-title":"Long-term use of thiazolidinediones and fractures in type 2 diabetes: a meta-analysis","volume":"180","author":"Loke","year":"2009","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(21)00347-8_bib52","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1111\/j.1463-1326.2010.01225.x","article-title":"Rosiglitazone and pioglitazone increase fracture risk in women and men with type 2 diabetes","volume":"12","author":"Aubert","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib53","doi-asserted-by":"crossref","first-page":"845","DOI":"10.2337\/dc07-2270","article-title":"Rosiglitazone-associated fractures in type 2 diabetes: an analysis from A Diabetes Outcome Progression Trial (ADOPT)","volume":"31","author":"Kahn","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00347-8_bib54","doi-asserted-by":"crossref","first-page":"187","DOI":"10.2165\/00002018-200932030-00002","article-title":"Safety and tolerability of pioglitazone in high-risk patients with type 2 diabetes: an overview of data from PROactive","volume":"32","author":"Dormandy","year":"2009","journal-title":"Drug Saf"},{"key":"10.1016\/S2213-8587(21)00347-8_bib55","first-page":"914","article-title":"Pioglitazone and risk for bone fracture: safety data from a randomized clinical trial","volume":"102","author":"Viscoli","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib56","doi-asserted-by":"crossref","first-page":"4059","DOI":"10.1210\/jc.2015-1215","article-title":"Effects of TZD use and discontinuation on fracture rates in ACCORD bone study","volume":"100","author":"Schwartz","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib57","doi-asserted-by":"crossref","first-page":"199","DOI":"10.2337\/dc07-1736","article-title":"Bone fractures and hypoglycemic treatment in type 2 diabetic patients: a case-control study","volume":"31","author":"Monami","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00347-8_bib58","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115475","article-title":"The impact of thiazide diuretics on bone mineral density and the trabecular bone score: the Rotterdam Study","volume":"138","author":"van der Burgh","year":"2020","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib59","doi-asserted-by":"crossref","first-page":"1224","DOI":"10.1002\/jbmr.3989","article-title":"The effect of plasma lipids and lipid-lowering interventions on bone mineral density: a Mendelian randomization study","volume":"35","author":"Zheng","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib60","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1111\/jgs.15779","article-title":"Tricyclic antidepressant and\/or \u03b3-aminobutyric acid-analog use is associated with fall risk in diabetic peripheral neuropathy","volume":"67","author":"Randolph","year":"2019","journal-title":"J Am Geriatr Soc"},{"key":"10.1016\/S2213-8587(21)00347-8_bib61","doi-asserted-by":"crossref","first-page":"371.e1","DOI":"10.1016\/j.jamda.2017.12.013","article-title":"Fall-risk-increasing drugs: a systematic review and meta-analysis: I. cardiovascular drugs","volume":"19","author":"de Vries","year":"2018","journal-title":"J Am Med Dir Assoc"},{"key":"10.1016\/S2213-8587(21)00347-8_bib62","doi-asserted-by":"crossref","first-page":"2579","DOI":"10.1096\/fj.201902011RR","article-title":"Spatiotemporal characterization of microdamage accumulation and its targeted remodeling mechanisms in diabetic fatigued bone","volume":"34","author":"Liu","year":"2020","journal-title":"FASEB J"},{"key":"10.1016\/S2213-8587(21)00347-8_bib63","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-019-52224-3","article-title":"Elevated glucose acts directly on osteocytes to increase sclerostin expression in diabetes","volume":"9","author":"Pacicca","year":"2019","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(21)00347-8_bib64","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10483","article-title":"Skeletal response to insulin in the naturally occurring type 1 diabetes mellitus mouse model","volume":"5","author":"Dixit","year":"2021","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(21)00347-8_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2021.115913","article-title":"PPARG in osteocytes controls sclerostin expression, bone mass, marrow adiposity and mediates TZD-induced bone loss","volume":"147","author":"Baroi","year":"2021","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib66","doi-asserted-by":"crossref","first-page":"2415","DOI":"10.1002\/jbmr.4153","article-title":"Sclerostin regulation, microarchitecture, and advanced glycation end-products in the bone of elderly women with type 2 diabetes","volume":"35","author":"Piccoli","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib67","doi-asserted-by":"crossref","first-page":"592","DOI":"10.1016\/j.jdiacomp.2019.04.012","article-title":"Serum sclerostin level and its relation to subclinical atherosclerosis in subjects with type 2 diabetes","volume":"33","author":"Shalash","year":"2019","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(21)00347-8_bib68","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.bone.2018.08.007","article-title":"Sclerostin and its significance for children and adolescents with type 1 diabetes mellitus (T1D)","volume":"120","author":"W\u0119drychowicz","year":"2019","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib69","first-page":"470","article-title":"Upregulated serum sclerostin level in the T2DM patients with femur fracture inhibits the expression of bone formation\/remodeling-associated biomarkers via antagonizing Wnt signaling","volume":"21","author":"Wu","year":"2017","journal-title":"Eur Rev Med Pharmacol Sci"},{"key":"10.1016\/S2213-8587(21)00347-8_bib70","doi-asserted-by":"crossref","first-page":"4030","DOI":"10.1210\/jc.2013-2143","article-title":"Elevated sclerostin levels are associated with vertebral fractures in patients with type 2 diabetes mellitus","volume":"98","author":"Yamamoto","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib71","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1016\/j.bone.2013.06.029","article-title":"Increased serum sclerostin and decreased serum IGF-1 are associated with vertebral fractures among postmenopausal women with type-2 diabetes","volume":"56","author":"Ardawi","year":"2013","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib72","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1002\/jbmr.1803","article-title":"Sclerostin antibody treatment improves bone mass, bone strength, and bone defect regeneration in rats with type 2 diabetes mellitus","volume":"28","author":"Hamann","year":"2013","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib73","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.bone.2015.04.048","article-title":"Sclerostin antibody treatment improves fracture outcomes in a type I diabetic mouse model","volume":"82","author":"Yee","year":"2016","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib74","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1038\/s42003-019-0747-1","article-title":"Hyperglycemia compromises rat cortical bone by increasing osteocyte lacunar density and decreasing vascular canal volume","volume":"3","author":"Ay","year":"2020","journal-title":"Commun Biol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib75","doi-asserted-by":"crossref","first-page":"E951","DOI":"10.1152\/ajpendo.00655.2020","article-title":"Amelioration of bone fragility by pulsed electromagnetic fields in type 2 diabetic KK-Ay mice involving Wnt\/\u03b2-catenin signaling","volume":"320","author":"Shao","year":"2021","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib76","article-title":"Effects of forced swimming stress on expression and phosphorylation of PI3K\/Akt signal pathway in pancreas of type 2 diabetic rats","volume":"8","author":"Li","year":"2020","journal-title":"Ann Transl Med"},{"key":"10.1016\/S2213-8587(21)00347-8_bib77","first-page":"433","article-title":"Long-term wheel-running can prevent deterioration of bone properties in diabetes mellitus model rats","volume":"17","author":"Minematsu","year":"2017","journal-title":"J Musculoskelet Neuronal Interact"},{"key":"10.1016\/S2213-8587(21)00347-8_bib78","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.135236","article-title":"Accelerated osteocyte senescence and skeletal fragility in mice with type 2 diabetes","volume":"5","author":"Eckhardt","year":"2020","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(21)00347-8_bib79","doi-asserted-by":"crossref","first-page":"1576","DOI":"10.1016\/j.cell.2015.05.029","article-title":"Glucose uptake and runx2 synergize to orchestrate osteoblast differentiation and bone formation","volume":"161","author":"Wei","year":"2015","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(21)00347-8_bib80","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1007\/s13340-020-00463-5","article-title":"High glucose promotes mineralization via bone morphogenetic protein 4-Smad signals in early stage of osteoblast differentiation","volume":"12","author":"Takeno","year":"2020","journal-title":"Diabetol Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib81","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1111\/cen.14501","article-title":"Characteristics of bone metabolism in postmenopausal women with newly diagnosed type 2 diabetes mellitus","volume":"95","author":"Li","year":"2021","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(21)00347-8_bib82","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1210\/jc.2016-2371","article-title":"High sclerostin and dickkopf-1 (DKK-1) serum levels in children and adolescents with type 1 diabetes mellitus","volume":"102","author":"Faienza","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib83","doi-asserted-by":"crossref","first-page":"48","DOI":"10.1177\/1479164113510923","article-title":"The relationship between inhibitors of the Wnt signalling pathway (sclerostin and Dickkopf-1) and carotid intima-media thickness in postmenopausal women with type 2 diabetes mellitus","volume":"11","author":"Gaudio","year":"2014","journal-title":"Diab Vasc Dis Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib84","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-81543-7","article-title":"Role of osteogenic Dickkopf-1 in bone remodeling and bone healing in mice with type I diabetes mellitus","volume":"11","author":"Hildebrandt","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(21)00347-8_bib85","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms11505","article-title":"A bispecific antibody targeting sclerostin and DKK-1 promotes bone mass accrual and fracture repair","volume":"7","author":"Florio","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(21)00347-8_bib86","doi-asserted-by":"crossref","first-page":"1480","DOI":"10.1002\/jcp.29068","article-title":"Preactivation of \u03b2-catenin in osteoblasts improves the osteoanabolic effect of PTH in type 1 diabetic mice","volume":"235","author":"Chen","year":"2020","journal-title":"J Cell Physiol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib87","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s12276-018-0186-y","article-title":"Differential effects of type 1 diabetes mellitus and subsequent osteoblastic \u03b2-catenin activation on trabecular and cortical bone in a mouse model","volume":"50","author":"Chen","year":"2018","journal-title":"Exp Mol Med"},{"key":"10.1016\/S2213-8587(21)00347-8_bib88","article-title":"\u03b2-Catenin mediates glucose-dependent insulinotropic polypeptide increases in lysyl oxidase expression in osteoblasts","volume":"14","author":"Daley","year":"2021","journal-title":"Bone Rep"},{"key":"10.1016\/S2213-8587(21)00347-8_bib89","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1002\/jbmr.4303","article-title":"Gain-of-function Lrp5 mutation improves bone mass and strength and delays hyperglycemia in a mouse model of insulin-deficient diabetes","volume":"36","author":"Leanza","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib90","doi-asserted-by":"crossref","first-page":"12515","DOI":"10.1096\/fj.201802805RR","article-title":"Activation of ROS\/MAPKs\/NF-\u03baB\/NLRP3 and inhibition of efferocytosis in osteoclast-mediated diabetic osteoporosis","volume":"33","author":"An","year":"2019","journal-title":"FASEB J"},{"key":"10.1016\/S2213-8587(21)00347-8_bib91","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2353\/ajpath.2009.090148","article-title":"High levels of tumor necrosis factor-alpha contribute to accelerated loss of cartilage in diabetic fracture healing","volume":"175","author":"Alblowi","year":"2009","journal-title":"Am J Pathol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib92","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1016\/j.bbrc.2021.01.102","article-title":"TLR4 knockout ameliorates streptozotocin-induced osteoporosis in a mouse model of diabetes","volume":"546","author":"Cao","year":"2021","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(21)00347-8_bib93","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1016\/j.bbrc.2018.04.052","article-title":"High glucose downregulates the effects of autophagy on osteoclastogenesis via the AMPK\/mTOR\/ULK1 pathway","volume":"503","author":"Cai","year":"2018","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(21)00347-8_bib94","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.ejrad.2019.02.020","article-title":"Marrow adiposity as an indicator for insulin resistance in postmenopausal women with newly diagnosed type 2 diabetes - an investigation by chemical shift-encoded water-fat MRI","volume":"113","author":"Zhu","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib95","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1016\/j.bone.2018.07.015","article-title":"Differential effects of high-fat diet and exercise training on bone and energy metabolism","volume":"116","author":"Picke","year":"2018","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib96","doi-asserted-by":"crossref","first-page":"1154","DOI":"10.1002\/jbmr.3408","article-title":"High-fat diet-induced obesity promotes expansion of bone marrow adipose tissue and impairs skeletal stem cell functions in mice","volume":"33","author":"Tencerova","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib97","doi-asserted-by":"crossref","first-page":"3622","DOI":"10.1210\/en.2004-1677","article-title":"Increased bone adiposity and peroxisomal proliferator-activated receptor-gamma2 expression in type I diabetic mice","volume":"146","author":"Botolin","year":"2005","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(21)00347-8_bib98","doi-asserted-by":"crossref","first-page":"433","DOI":"10.1016\/j.bbrc.2020.02.079","article-title":"The increase in bone resorption in early-stage type I diabetic mice is induced by RANKL secreted by increased bone marrow adipocytes","volume":"525","author":"Yang","year":"2020","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(21)00347-8_bib99","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1016\/j.jbiosc.2021.02.007","article-title":"Exosomes from adipose derived mesenchymal stem cells alleviate diabetic osteoporosis in rats through suppressing NLRP3 inflammasome activation in osteoclasts","volume":"131","author":"Zhang","year":"2021","journal-title":"J Biosci Bioeng"},{"key":"10.1016\/S2213-8587(21)00347-8_bib100","doi-asserted-by":"crossref","first-page":"10","DOI":"10.7554\/eLife.69209","article-title":"Adipsin promotes bone marrow adiposity by priming mesenchymal stem cells","volume":"10","author":"Aaron","year":"2021","journal-title":"eLife"},{"key":"10.1016\/S2213-8587(21)00347-8_bib101","doi-asserted-by":"crossref","first-page":"e3592","DOI":"10.1210\/clinem\/dgab322","article-title":"Bone marrow adiposity in premenopausal women with type 2 diabetes with observations on peri-trabecular adipocytes","volume":"106","author":"Andrade","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib102","doi-asserted-by":"crossref","first-page":"1799","DOI":"10.1210\/js.2019-00160","article-title":"Advanced glycation end products (AGEs), receptor for AGEs, diabetes, and bone: review of the literature","volume":"3","author":"Asadipooya","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(21)00347-8_bib103","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1186\/s12944-016-0334-0","article-title":"Advanced glycation end products increase lipids accumulation in macrophages through upregulation of receptor of advanced glycation end products: increasing uptake, esterification and decreasing efflux of cholesterol","volume":"15","author":"Xu","year":"2016","journal-title":"Lipids Health Dis"},{"key":"10.1016\/S2213-8587(21)00347-8_bib104","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1002\/jbmr.4186","article-title":"Bone tissue composition in postmenopausal women varies with glycemic control from normal glucose tolerance to type 2 diabetes mellitus","volume":"36","author":"Hunt","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib105","doi-asserted-by":"crossref","first-page":"1514","DOI":"10.1007\/s00198-006-0155-5","article-title":"Role of collagen enzymatic and glycation induced cross-links as a determinant of bone quality in spontaneously diabetic WBN\/Kob rats","volume":"17","author":"Saito","year":"2006","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib106","doi-asserted-by":"crossref","first-page":"5691","DOI":"10.1074\/jbc.M610536200","article-title":"Non-enzymatic glycation of bone collagen modifies osteoclastic activity and differentiation","volume":"282","author":"Valcourt","year":"2007","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(21)00347-8_bib107","doi-asserted-by":"crossref","first-page":"e239","DOI":"10.3346\/jkms.2021.36.e239","article-title":"Effects of advanced glycation end products on differentiation and function of osteoblasts and osteoclasts","volume":"36","author":"Park","year":"2021","journal-title":"J Korean Med Sci"},{"key":"10.1016\/S2213-8587(21)00347-8_bib108","doi-asserted-by":"crossref","DOI":"10.1111\/cpr.12471","article-title":"Blockade of receptors of advanced glycation end products ameliorates diabetic osteogenesis of adipose-derived stem cells through DNA methylation and Wnt signalling pathway","volume":"51","author":"Zhang","year":"2018","journal-title":"Cell Prolif"},{"key":"10.1016\/S2213-8587(21)00347-8_bib109","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/j.lfs.2018.04.042","article-title":"Irbesartan attenuates advanced glycation end products-mediated damage in diabetes-associated osteoporosis through the AGEs\/RAGE pathway","volume":"205","author":"Cheng","year":"2018","journal-title":"Life Sci"},{"key":"10.1016\/S2213-8587(21)00347-8_bib110","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25235591","article-title":"The development of maillard reaction, and advanced glycation end product (AGE)-receptor for AGE (RAGE) signaling inhibitors as novel therapeutic strategies for patients with AGE-related diseases","volume":"25","author":"Shen","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/S2213-8587(21)00347-8_bib111","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1016\/j.bone.2017.01.015","article-title":"Assessment of collagen quality associated with non-enzymatic cross-links in human bone using Fourier-transform infrared imaging","volume":"97","author":"Schmidt","year":"2017","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib112","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115556","article-title":"Individuals with type 2 diabetes mellitus show dimorphic and heterogeneous patterns of loss in femoral bone quality","volume":"140","author":"W\u00f6lfel","year":"2020","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib113","doi-asserted-by":"crossref","first-page":"2380","DOI":"10.1210\/jc.2008-2498","article-title":"Pentosidine and increased fracture risk in older adults with type 2 diabetes","volume":"94","author":"Schwartz","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib114","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12891-016-1168-7","article-title":"Serum and bone pentosidine in patients with low impact hip fractures and in patients with advanced osteoarthritis","volume":"17","author":"Vacul\u00edk","year":"2016","journal-title":"BMC Musculoskelet Disord"},{"key":"10.1016\/S2213-8587(21)00347-8_bib115","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1016\/j.bone.2018.05.030","article-title":"Bone microarchitecture, biomechanical properties, and advanced glycation end-products in the proximal femur of adults with type 2 diabetes","volume":"114","author":"Karim","year":"2018","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib116","doi-asserted-by":"crossref","first-page":"691","DOI":"10.1016\/0021-9290(91)90333-I","article-title":"The underestimation of Young's modulus in compressive testing of cancellous bone specimens","volume":"24","author":"Odgaard","year":"1991","journal-title":"J Biomech"},{"key":"10.1016\/S2213-8587(21)00347-8_bib117","doi-asserted-by":"crossref","first-page":"954","DOI":"10.2106\/00004623-197759070-00021","article-title":"The compressive behavior of bone as a two-phase porous structure","volume":"59","author":"Carter","year":"1977","journal-title":"J Bone Joint Surg Am"},{"key":"10.1016\/S2213-8587(21)00347-8_bib118","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1016\/0021-9290(88)90008-5","article-title":"On the dependence of the elasticity and strength of cancellous bone on apparent density","volume":"21","author":"Rice","year":"1988","journal-title":"J Biomech"},{"key":"10.1016\/S2213-8587(21)00347-8_bib119","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1097\/00002142-200210000-00005","article-title":"Role of magnetic resonance for assessing structure and function of trabecular bone","volume":"13","author":"Wehrli","year":"2002","journal-title":"Top Magn Reson Imaging"},{"issue":"suppl 5","key":"10.1016\/S2213-8587(21)00347-8_bib120","doi-asserted-by":"crossref","first-page":"S118","DOI":"10.1007\/s00198-003-1489-x","article-title":"Bone quality: where do we go from here?","volume":"14","author":"Bouxsein","year":"2003","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib121","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.clinthera.2004.12.020","article-title":"The bone quality framework: determinants of bone strength and their interrelationships, and implications for osteoporosis management","volume":"27","author":"Felsenberg","year":"2005","journal-title":"Clin Ther"},{"key":"10.1016\/S2213-8587(21)00347-8_bib122","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality--the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00347-8_bib123","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1007\/BF02509542","article-title":"A microtomographic system for the nondestructive evaluation of bone architecture","volume":"58","author":"R\u00fcegsegger","year":"1996","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib124","doi-asserted-by":"crossref","first-page":"854","DOI":"10.1016\/j.bone.2006.04.017","article-title":"Monitoring individual morphological changes over time in ovariectomized rats by in vivo micro-computed tomography","volume":"39","author":"Boyd","year":"2006","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib125","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/jor.1100160105","article-title":"Relationships between bone morphology and bone elastic properties can be accurately quantified using high-resolution computer reconstructions","volume":"16","author":"Van Rietbergen","year":"1998","journal-title":"J Orthop Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib126","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1359\/jbmr.060102","article-title":"Importance of individual rods and plates in the assessment of bone quality and their contribution to bone stiffness","volume":"21","author":"Stauber","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib127","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.bone.2015.07.027","article-title":"Determinants of bone strength and quality in diabetes mellitus in humans","volume":"82","author":"Farr","year":"2016","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib128","doi-asserted-by":"crossref","first-page":"5045","DOI":"10.1210\/jc.2010-0226","article-title":"High-resolution peripheral quantitative computed tomographic imaging of cortical and trabecular bone microarchitecture in patients with type 2 diabetes mellitus","volume":"95","author":"Burghardt","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib129","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.1002\/jbmr.2573","article-title":"Bone geometry, volumetric density, microarchitecture, and estimated bone strength assessed by HR-pQCT in adult patients with type 1 diabetes mellitus","volume":"30","author":"Shanbhogue","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib130","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1002\/jbmr.4271","article-title":"The effects of type 1 diabetes and diabetic peripheral neuropathy on the musculoskeletal system: a case-control study","volume":"36","author":"Vilaca","year":"2021","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib131","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/jbmr.2106","article-title":"In vivo assessment of bone quality in postmenopausal women with type 2 diabetes","volume":"29","author":"Farr","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib132","doi-asserted-by":"crossref","first-page":"2502","DOI":"10.1210\/jc.2016-1437","article-title":"Advanced glycation endproducts and bone material strength in type 2 diabetes","volume":"101","author":"Furst","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib133","article-title":"In type 2 diabetes mellitus collagen fibril plasticity is altered along with higher glyco-oxydative damage and non-osteoporotic bone mineral density","volume":"13","author":"W\u00f6lfel","year":"2020","journal-title":"Bone Rep"},{"key":"10.1016\/S2213-8587(21)00347-8_bib134","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/bonekey.2015.112","article-title":"The fracture mechanics of human bone: influence of disease and treatment","volume":"4","author":"Zimmermann","year":"2015","journal-title":"Bonekey Rep"},{"key":"10.1016\/S2213-8587(21)00347-8_bib135","doi-asserted-by":"crossref","first-page":"e2271","DOI":"10.1210\/clinem\/dgab027","article-title":"Investigation of mechanical, material, and compositional determinants of human trabecular bone quality in type 2 diabetes","volume":"106","author":"Sihota","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib136","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1007\/s11914-019-00538-6","article-title":"Effects of diabetes on bone material properties","volume":"17","author":"Lekkala","year":"2019","journal-title":"Curr Osteoporos Rep"},{"key":"10.1016\/S2213-8587(21)00347-8_bib137","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2017-01922","article-title":"Diabetic microvascular disease: an Endocrine Society scientific statement","volume":"102","author":"Barrett","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib138","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1007\/BF01476763","article-title":"[Diabetic osteomyelopathy: histobioptic data of bone and bone marrow in diabetes mellitus (author's transl)]","volume":"56","author":"Bartl","year":"1978","journal-title":"Klin Wochenschr"},{"key":"10.1016\/S2213-8587(21)00347-8_bib139","doi-asserted-by":"crossref","first-page":"e3718","DOI":"10.1210\/clinem\/dgaa388","article-title":"Determinants of bone material strength and cortical porosity in patients with type 2 diabetes mellitus","volume":"105","author":"Samakkarnthai","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib140","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-15-0860","article-title":"Compromised cortical bone compartment in type 2 diabetes mellitus patients with microvascular disease","volume":"174","author":"Shanbhogue","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib141","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/jbmr.4171","article-title":"Bone vasculature and bone marrow vascular niches in health and disease","volume":"35","author":"Chen","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib142","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms13601","article-title":"Blood flow controls bone vascular function and osteogenesis","volume":"7","author":"Ramasamy","year":"2016","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(21)00347-8_bib143","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/JOE-14-0514","article-title":"Type 2 diabetes alters bone and marrow blood flow and vascular control mechanisms in the ZDF rat","volume":"225","author":"Stabley","year":"2015","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib144","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1007\/s00223-010-9415-7","article-title":"Three-dimensional cortical bone microstructure in a rat model of hypoxia-induced growth retardation","volume":"88","author":"Matsumoto","year":"2011","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib145","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115628","article-title":"Re-thinking the bone remodeling cycle mechanism and the origin of bone loss","volume":"141","author":"Delaisse","year":"2020","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib146","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1016\/j.bone.2007.02.021","article-title":"Biphasic fracture risk in diabetes: a population-based study","volume":"40","author":"Leslie","year":"2007","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib147","doi-asserted-by":"crossref","first-page":"2850","DOI":"10.2337\/diacare.28.12.2850","article-title":"Elevated hip fracture risk in type 1 diabetic patients: a population-based cohort study in Sweden","volume":"28","author":"Miao","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00347-8_bib148","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/dc06-0440","article-title":"Prospective study of diabetes and risk of hip fracture: the Nurses' Health Study","volume":"29","author":"Janghorbani","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00347-8_bib149","doi-asserted-by":"crossref","first-page":"1749","DOI":"10.2337\/diacare.25.10.1749","article-title":"Older women with diabetes have a higher risk of falls: a prospective study","volume":"25","author":"Schwartz","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00347-8_bib150","doi-asserted-by":"crossref","first-page":"2817","DOI":"10.1007\/s00198-014-2822-2","article-title":"Does diabetes modify the effect of FRAX risk factors for predicting major osteoporotic and hip fracture?","volume":"25","author":"Leslie","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib151","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1210\/jc.2018-01879","article-title":"Association between glycemic control and risk of fracture in diabetic patients: a nested case-control study","volume":"104","author":"Vavanikunnel","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib152","doi-asserted-by":"crossref","first-page":"1612","DOI":"10.1001\/archinte.165.14.1612","article-title":"Nontraumatic fracture risk with diabetes mellitus and impaired fasting glucose in older white and black adults: the health, aging, and body composition study","volume":"165","author":"Strotmeyer","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(21)00347-8_bib153","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1002\/jbmr.2462","article-title":"Glycated hemoglobin level and risk of hip fracture in older people with type 2 diabetes: a competing risk analysis of Taiwan diabetes cohort study","volume":"30","author":"Li","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib154","doi-asserted-by":"crossref","first-page":"1663","DOI":"10.1007\/s00198-019-05014-6","article-title":"Hypoglycaemia and type 1 diabetes are associated with an increased risk of fractures","volume":"30","author":"Jensen","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib155","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1530\/EJE-18-0458","article-title":"Hypoglycaemia is associated with increased risk of fractures in patients with type 2 diabetes mellitus: a cohort study","volume":"180","author":"Ntouva","year":"2019","journal-title":"Eur J Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00347-8_bib156","first-page":"S37","article-title":"4. Comprehensive medical evaluation and assessment of comorbidities: Standards of Medical Care in Diabetes\u20132020","volume":"43","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00347-8_bib157","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.4158\/EP171794.RA","article-title":"Aging, diabetes, and falls","volume":"23","author":"Vinik","year":"2017","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(21)00347-8_bib158","doi-asserted-by":"crossref","first-page":"2585","DOI":"10.1007\/s00198-018-4650-2","article-title":"Diagnosis and management of bone fragility in diabetes: an emerging challenge","volume":"29","author":"Ferrari","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib159","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1007\/s00592-017-0973-2","article-title":"Bone health in subjects with type 1 diabetes for more than 50 years","volume":"54","author":"Maddaloni","year":"2017","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(21)00347-8_bib160","doi-asserted-by":"crossref","first-page":"4511","DOI":"10.1210\/jc.2019-00035","article-title":"Poor glycemic control is associated with impaired bone accrual in the year following a diagnosis of type 1 diabetes","volume":"104","author":"Weber","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib161","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115614","article-title":"Fracture risk assessment (FRAX) without BMD and risk of major osteoporotic fractures in adults with type 1 diabetes","volume":"143","author":"Champakanath","year":"2021","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib162","doi-asserted-by":"crossref","first-page":"2363","DOI":"10.1002\/jbmr.4140","article-title":"Bone turnover markers do not predict fracture risk in type 2 diabetes","volume":"35","author":"Napoli","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib163","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1159\/000481825","article-title":"Practical recommendations of the Obesity Management Task Force of the European Association for the Study of Obesity for the post-bariatric surgery medical management","volume":"10","author":"Busetto","year":"2017","journal-title":"Obes Facts"},{"key":"10.1016\/S2213-8587(21)00347-8_bib164","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/ajcn\/85.5.1428","article-title":"Effects of dietary calcium compared with calcium supplements on estrogen metabolism and bone mineral density","volume":"85","author":"Napoli","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00347-8_bib165","doi-asserted-by":"crossref","first-page":"527","DOI":"10.1007\/s12603-016-0823-x","article-title":"Are dietary supplements and nutraceuticals effective for musculoskeletal health and cognitive function? a scoping review","volume":"21","author":"Iolascon","year":"2017","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/S2213-8587(21)00347-8_bib166","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1007\/s00198-018-4704-5","article-title":"European guidance for the diagnosis and management of osteoporosis in postmenopausal women","volume":"30","author":"Kanis","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib167","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.maturitas.2014.07.005","article-title":"The role of dietary protein and vitamin D in maintaining musculoskeletal health in postmenopausal women: a consensus statement from the European Society for Clinical and Economic Aspects of Osteoporosis and Osteoarthritis (ESCEO)","volume":"79","author":"Rizzoli","year":"2014","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(21)00347-8_bib168","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1093\/jn\/136.6.1453","article-title":"Bone, body weight, and weight reduction: what are the concerns?","volume":"136","author":"Shapses","year":"2006","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(21)00347-8_bib169","doi-asserted-by":"crossref","first-page":"1215","DOI":"10.1002\/jbmr.1560","article-title":"Weight loss in obese older adults increases serum sclerostin and impairs hip geometry but both are prevented by exercise training","volume":"27","author":"Armamento-Villareal","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib170","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1007\/s00198-013-2450-2","article-title":"Changes in thigh muscle volume predict bone mineral density response to lifestyle therapy in frail, obese older adults","volume":"25","author":"Armamento-Villareal","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib171","doi-asserted-by":"crossref","first-page":"430","DOI":"10.1002\/jbmr.3905","article-title":"Effect of aerobic or resistance exercise, or both, on bone mineral density and bone metabolism in obese older adults while dieting: a randomized controlled trial","volume":"35","author":"Armamento-Villareal","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib172","doi-asserted-by":"crossref","first-page":"1218","DOI":"10.1056\/NEJMoa1008234","article-title":"Weight loss, exercise, or both and physical function in obese older adults","volume":"364","author":"Villareal","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00347-8_bib173","doi-asserted-by":"crossref","first-page":"10","DOI":"10.14283\/jfa.2017.39","article-title":"An international position statement on the management of frailty in diabetes mellitus: summary of recommendations 2017","volume":"7","author":"Sinclair","year":"2018","journal-title":"J Frailty Aging"},{"key":"10.1016\/S2213-8587(21)00347-8_bib174","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1007\/s11357-013-9586-z","article-title":"Multicomponent exercises including muscle power training enhance muscle mass, power output, and functional outcomes in institutionalized frail nonagenarians","volume":"36","author":"Cadore","year":"2014","journal-title":"Age (Dordr)"},{"key":"10.1016\/S2213-8587(21)00347-8_bib175","doi-asserted-by":"crossref","DOI":"10.1155\/2012\/284635","article-title":"Resistance training and older adults with type 2 diabetes mellitus: strength of the evidence","volume":"2012","author":"Hovanec","year":"2012","journal-title":"J Aging Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib176","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1007\/s00198-016-3773-6","volume":"28","author":"Harvey","year":"2017","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib177","doi-asserted-by":"crossref","first-page":"333","DOI":"10.1210\/er.2018-00001","article-title":"Atypical femur fractures: review of epidemiology, relationship to bisphosphonates, prevention, and clinical management","volume":"40","author":"Black","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(21)00347-8_bib178","doi-asserted-by":"crossref","first-page":"1547","DOI":"10.2337\/diacare.27.7.1547","article-title":"Effect of alendronate on bone mineral density and biochemical markers of bone turnover in type 2 diabetic women: the fracture intervention trial","volume":"27","author":"Keegan","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00347-8_bib179","doi-asserted-by":"crossref","first-page":"764","DOI":"10.1359\/jbmr.040211","article-title":"Associations between baseline risk factors and vertebral fracture risk in the Multiple Outcomes of Raloxifene Evaluation (MORE) Study","volume":"19","author":"Johnell","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib180","doi-asserted-by":"crossref","DOI":"10.1016\/j.bone.2020.115268","article-title":"Denosumab in postmenopausal women with osteoporosis and diabetes: Subgroup analysis of FREEDOM and FREEDOM extension","volume":"134","author":"Ferrari","year":"2020","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib181","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.bone.2018.07.013","article-title":"Real-world effectiveness of teriparatide on fracture reduction in patients with osteoporosis and comorbidities or risk factors for fractures: integrated analysis of 4 prospective observational studies","volume":"116","author":"Langdahl","year":"2018","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib182","doi-asserted-by":"crossref","DOI":"10.1002\/jbm4.10346","article-title":"Abaloparatide in postmenopausal women with osteoporosis and type 2 diabetes: a post hoc analysis of the ACTIVE study","volume":"4","author":"Dhaliwal","year":"2020","journal-title":"JBMR Plus"},{"key":"10.1016\/S2213-8587(21)00347-8_bib183","doi-asserted-by":"crossref","first-page":"1532","DOI":"10.1056\/NEJMoa1607948","article-title":"Romosozumab treatment in postmenopausal women with osteoporosis","volume":"375","author":"Cosman","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00347-8_bib184","doi-asserted-by":"crossref","first-page":"1595","DOI":"10.1210\/jc.2019-00221","article-title":"Pharmacological management of osteoporosis in postmenopausal women: an Endocrine Society* clinical practice guideline","volume":"104","author":"Eastell","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00347-8_bib185","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/S0140-6736(15)61175-8","article-title":"More DATA to guide sequential osteoporosis therapy","volume":"386","author":"Hofbauer","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00347-8_bib186","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.1016\/S0140-6736(15)61120-5","article-title":"Denosumab and teriparatide transitions in postmenopausal osteoporosis (the DATA-Switch study): extension of a randomised controlled trial","volume":"386","author":"Leder","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00347-8_bib187","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1002\/jbmr.3877","article-title":"Secondary fracture prevention: consensus clinical recommendations from a multistakeholder coalition","volume":"35","author":"Conley","year":"2020","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(21)00347-8_bib188","doi-asserted-by":"crossref","first-page":"653","DOI":"10.3109\/17453674.2012.747054","article-title":"Patient-related risk factors for fracture-healing complications in the United Kingdom General Practice Research Database","volume":"83","author":"Hernandez","year":"2012","journal-title":"Acta Orthop"},{"key":"10.1016\/S2213-8587(21)00347-8_bib189","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1016\/j.injury.2011.03.021","article-title":"Diabetes mellitus and hip fracture: a study of 5966 cases","volume":"42","author":"Norris","year":"2011","journal-title":"Injury"},{"key":"10.1016\/S2213-8587(21)00347-8_bib190","doi-asserted-by":"crossref","first-page":"1757","DOI":"10.2337\/db16-0063","article-title":"Skeletal metabolism, fracture risk, and fracture outcomes in type 1 and type 2 diabetes","volume":"65","author":"Sellmeyer","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00347-8_bib191","doi-asserted-by":"crossref","first-page":"2407","DOI":"10.1007\/s00198-019-05122-3","article-title":"The association between type 2 diabetes mellitus, hip fracture, and post-hip fracture mortality: a multi-state cohort analysis","volume":"30","author":"Teb\u00e9","year":"2019","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(21)00347-8_bib192","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1210\/en.2013-1960","article-title":"Effects of parathyroid hormone on bone mass, bone strength, and bone regeneration in male rats with type 2 diabetes mellitus","volume":"155","author":"Hamann","year":"2014","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(21)00347-8_bib193","doi-asserted-by":"crossref","first-page":"108","DOI":"10.1016\/j.bone.2015.06.001","article-title":"Bone defect regeneration and cortical bone parameters of type 2 diabetic rats are improved by insulin therapy","volume":"82","author":"Picke","year":"2016","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(21)00347-8_bib194","doi-asserted-by":"crossref","DOI":"10.1016\/j.mad.2021.111565","article-title":"The role of senolytics in osteoporosis and other skeletal pathologies","volume":"199","author":"Doolittle","year":"2021","journal-title":"Mech Ageing Dev"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003478?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003478?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:21Z","timestamp":1761991821000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721003478"}},"issued":{"date-parts":[[2022,3]]},"references-count":194,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["S2213858721003478"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00347-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone fragility in diabetes: novel concepts and clinical implications","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00347-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T16:01:13Z","timestamp":1794585673622,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,9,1]],"date-time":"2019-09-01T00:00:00Z","timestamp":1567296000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1016\/s2213-8587(19)30155-x","type":"journal-article","created":{"date-parts":[[2019,7,31]],"date-time":"2019-07-31T18:33:43Z","timestamp":1564598023000},"page":"695-706","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial"],"prefix":"10.1016","volume":"7","author":[{"given":"Stefan","family":"Groeneweg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin P","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Athanasia","family":"Stoupa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7oise","family":"Auriol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Davide","family":"Tonduti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Dica","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Paone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Klara","family":"Rozenkova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jana","family":"Malikova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adri","family":"van der Walt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irenaeus F M","family":"de Coo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anne","family":"McGowan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Greta","family":"Lyons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Femke K","family":"Aarsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diana","family":"Barca","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ingrid M","family":"van Beynum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marieke M","family":"van der Knoop","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jurgen","family":"Jansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martien","family":"Manshande","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roelineke J","family":"Lunsing","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stan","family":"Nowak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corstiaan A","family":"den Uil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Carola","family":"Zillikens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank E","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Vrijmoeth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marie Claire Y","family":"de Wit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicole I","family":"Wolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angelique","family":"Zandstra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gautam","family":"Ambegaonkar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yogen","family":"Singh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yolanda B","family":"de Rijke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Medici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Enrico S","family":"Bertini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sylvia","family":"Depoorter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jan","family":"Lebl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marco","family":"Cappa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linda","family":"De Meirleir","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Krude","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Craiu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federica","family":"Zibordi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabelle","family":"Oliver Petit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michel","family":"Polak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Krishna","family":"Chatterjee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theo J","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W Edward","family":"Visser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30155-X_bib1","doi-asserted-by":"crossref","first-page":"40128","DOI":"10.1074\/jbc.M300909200","article-title":"Identification of monocarboxylate transporter 8 as a specific thyroid hormone transporter","volume":"278","author":"Friesema","year":"2003","journal-title":"J Biol Chem"},{"key":"10.1016\/S2213-8587(19)30155-X_bib2","doi-asserted-by":"crossref","first-page":"1435","DOI":"10.1016\/S0140-6736(04)17226-7","article-title":"Association between mutations in a thyroid hormone transporter and severe X-linked psychomotor retardation","volume":"364","author":"Friesema","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30155-X_bib3","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1086\/380999","article-title":"A novel syndrome combining thyroid and neurological abnormalities is associated with mutations in a monocarboxylate transporter gene","volume":"74","author":"Dumitrescu","year":"2004","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(19)30155-X_bib4","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1111\/cen.12023","article-title":"Identification, functional analysis, prevalence and treatment of monocarboxylate transporter 8 (MCT8) mutations in a cohort of adult patients with mental retardation","volume":"78","author":"Visser","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(19)30155-X_bib5","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/j.beem.2017.05.001","article-title":"Disorder of thyroid hormone transport into the tissues","volume":"31","author":"Groeneweg","year":"2017","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30155-X_bib7","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1056\/NEJMc0809750","article-title":"Ending propylthiouracil-induced liver failure in children","volume":"360","author":"Rivkees","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30155-X_bib8","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1089\/thy.2016.0229","article-title":"2016 American Thyroid Association guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis","volume":"26","author":"Ross","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(19)30155-X_bib9","doi-asserted-by":"crossref","first-page":"1961","DOI":"10.1210\/me.2014-1135","article-title":"In vitro and mouse studies supporting therapeutic utility of triiodothyroacetic acid in MCT8 deficiency","volume":"28","author":"Kersseboom","year":"2014","journal-title":"Mol Endocrinol"},{"key":"10.1016\/S2213-8587(19)30155-X_bib10","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0303-7207(00)00266-5","article-title":"Triac regulation of transcription is T3 receptor isoform- and response element-specific","volume":"165","author":"Messier","year":"2000","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(19)30155-X_bib11","doi-asserted-by":"crossref","first-page":"R99","DOI":"10.1530\/JOE-17-0113","article-title":"Triiodothyroacetic acid in health and disease","volume":"234","author":"Groeneweg","year":"2017","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(19)30155-X_bib12","first-page":"221","article-title":"Comparison of the metabolic and endocrine effects of 3,5,3\u2032-triiodothyroacetic acid and thyroxine","volume":"77","author":"Bracco","year":"1993","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30155-X_bib13","first-page":"455","article-title":"The effects of tetraiodothyroacetic and triiodothyroacetic acids on thyroid function in euthyroid and hyperthyroid subjects","volume":"92","author":"Burger","year":"1979","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/S2213-8587(19)30155-X_bib14","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1242\/dmm.027227","article-title":"Pharmacological treatment and BBB-targeted genetic therapy for MCT8-dependent hypomyelination in zebrafish","volume":"9","author":"Zada","year":"2016","journal-title":"Dis Model Mech"},{"key":"10.1016\/S2213-8587(19)30155-X_bib15","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2017-1904","article-title":"Clinical practice guideline for screening and management of high blood pressure in children and adolescents","volume":"140","author":"Flynn","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(19)30155-X_bib16","doi-asserted-by":"crossref","first-page":"1269","DOI":"10.1161\/HYP.0000000000000066","volume":"71","author":"Whelton","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(19)30155-X_bib17","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/S0140-6736(10)62226-X","article-title":"Normal ranges of heart rate and respiratory rate in children from birth to 18 years of age: a systematic review of observational studies","volume":"377","author":"Fleming","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30155-X_bib18","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1111\/j.1469-8749.1989.tb04003.x","article-title":"The gross motor function measure: a means to evaluate the effects of physical therapy","volume":"31","author":"Russell","year":"1989","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/S2213-8587(19)30155-X_bib19","doi-asserted-by":"crossref","first-page":"280","DOI":"10.1111\/j.1467-789X.2008.00546.x","article-title":"Effect of body mass index on the outcome of infections: a systematic review","volume":"10","author":"Falagas","year":"2009","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(19)30155-X_bib20","doi-asserted-by":"crossref","first-page":"930","DOI":"10.1016\/0002-9149(89)90142-2","article-title":"Cardiac arrhythmias and heart rate in hyperthyroidism","volume":"63","author":"von Olshausen","year":"1989","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(19)30155-X_bib21","doi-asserted-by":"crossref","first-page":"304","DOI":"10.1136\/hrt.44.3.304","article-title":"Results of 24 hour ambulatory monitoring of electrocardiogram in 131 healthy boys aged 10 to 13 years","volume":"44","author":"Scott","year":"1980","journal-title":"Br Heart J"},{"key":"10.1016\/S2213-8587(19)30155-X_bib22","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1161\/CIRCULATIONAHA.109.874982","article-title":"Excessive supraventricular ectopic activity and increased risk of atrial fibrillation and stroke","volume":"121","author":"Binici","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30155-X_bib23","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1056\/NEJMoa1105575","article-title":"Subclinical atrial fibrillation and the risk of stroke","volume":"366","author":"Healey","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30155-X_bib24","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/j.ahj.2009.08.002","article-title":"Electrocardiographic predictors of atrial fibrillation","volume":"158","author":"Perez","year":"2009","journal-title":"Am Heart J"},{"key":"10.1016\/S2213-8587(19)30155-X_bib25","doi-asserted-by":"crossref","first-page":"4515","DOI":"10.1210\/jc.2012-2556","article-title":"Diiodothyropropionic acid (DITPA) in the treatment of MCT8 deficiency","volume":"97","author":"Verge","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30155-X_bib26","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1111\/j.1365-2265.1991.tb03509.x","article-title":"TRIAC (3,5,3\u2032-triiodothyroacetic acid) has parallel effects at the pituitary and peripheral tissue levels in thyroid cancer patients treated with L-thyroxine","volume":"35","author":"Mechelany","year":"1991","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(19)30155-X_bib27","first-page":"2153","article-title":"Augmented hepatic and skeletal thyromimetic effects of tiratricol in comparison with levothyroxine","volume":"82","author":"Sherman","year":"1997","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30155-X_bib28","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1089\/thy.2015.0388","article-title":"Effect of triiodothyroacetic acid treatment in Mct8 deficiency: a word of caution","volume":"26","author":"B\u00e1rez-L\u00f3pez","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(19)30155-X_bib29","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1089\/thy.2016.0191","article-title":"Triiodothyroacetic acid treatment in MCT8 deficiency: a word of nuance","volume":"26","author":"Visser","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(19)30155-X_bib30","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1038\/nrendo.2015.66","article-title":"Thyroid hormone transporters\u2014functions and clinical implications","volume":"11","author":"Bernal","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(19)30155-X_bib31","doi-asserted-by":"crossref","first-page":"5287","DOI":"10.1210\/jc.2003-030095","article-title":"Comparative efficacy and side effects of the treatment of euthyroid goiter with levo-thyroxine or triiodothyroacetic acid","volume":"88","author":"Brenta","year":"2003","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930155X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930155X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:44Z","timestamp":1761991604000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871930155X"}},"issued":{"date-parts":[[2019,9]]},"references-count":30,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["S221385871930155X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30155-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Effectiveness and safety of the tri-iodothyronine analogue Triac in children and adults with MCT8 deficiency: an international, single-arm, open-label, phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30155-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30217-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T12:01:25Z","timestamp":1794571285174,"version":"4.9.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,6,1]],"date-time":"2020-06-01T00:00:00Z","timestamp":1590969600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,6]]},"DOI":"10.1016\/s2213-8587(20)30115-7","type":"journal-article","created":{"date-parts":[[2020,5,20]],"date-time":"2020-05-20T20:32:55Z","timestamp":1590006775000},"page":"468-470","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":402,"title":["Global trends in thyroid cancer incidence and the impact of overdiagnosis"],"prefix":"10.1016","volume":"8","author":[{"given":"Mengmeng","family":"Li","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luigino Dal","family":"Maso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salvatore","family":"Vaccarella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30115-7_bib1","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1056\/NEJMp1604412","article-title":"Worldwide thyroid cancer epidemic? The increasing impact of overdiagnosis","volume":"375","author":"Vaccarella","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30115-7_bib2","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1016\/j.ejca.2018.01.083","article-title":"The impact of overdiagnosis on thyroid cancer epidemic in Italy, 1998\u20132012","volume":"94","author":"Dal Maso","year":"2018","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2213-8587(20)30115-7_bib3","doi-asserted-by":"crossref","DOI":"10.1089\/thy.2019.0684","article-title":"Long term declines of thyroid cancer mortality: an international age-period-cohort analysis","author":"Li","year":"2020","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(20)30115-7_bib4","doi-asserted-by":"crossref","first-page":"2164","DOI":"10.1001\/jama.295.18.2164","article-title":"Increasing incidence of thyroid cancer in the United States, 1973\u20132002","volume":"295","author":"Davies","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30115-7_bib5","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1089\/thy.2013.0257","article-title":"The epidemic of thyroid cancer in the United States: the role of endocrinologists and ultrasounds","volume":"24","author":"Udelsman","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(20)30115-7_bib6","series-title":"World Cancer Report: cancer research for cancer prevention","first-page":"461","article-title":"Thyroid cancer: the challenge of overdiagnosis","author":"Francis","year":"2020"},{"key":"10.1016\/S2213-8587(20)30115-7_bib7","series-title":"Reducing social inequalities in cancer: evidence and priorities for research (IARC Scientific Publication No. 168)","first-page":"390","article-title":"The inverse care law: overutilization of health services and overdiagnosis","author":"Vaccarella","year":"2019"},{"key":"10.1016\/S2213-8587(20)30115-7_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: The American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(20)30115-7_bib9","doi-asserted-by":"crossref","first-page":"1280","DOI":"10.1016\/S1470-2045(18)30680-6","article-title":"Long-term strategies for thyroid health monitoring after nuclear accidents: recommendations from an Expert Group convened by IARC","volume":"19","author":"Togawa","year":"2018","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(20)30115-7_bib10","doi-asserted-by":"crossref","first-page":"2389","DOI":"10.1056\/NEJMc1507622","article-title":"South Korea's thyroid-cancer \u201cepidemic\u201d \u2013 turning the tide","volume":"373","author":"Ahn","year":"2015","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301157?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301157?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:57Z","timestamp":1761991677000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301157"}},"issued":{"date-parts":[[2020,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2020,6]]}},"alternative-id":["S2213858720301157"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30115-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Global trends in thyroid cancer incidence and the impact of overdiagnosis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30115-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T08:43:46Z","timestamp":1792572226571,"version":"4.5.0"},"reference-count":31,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000024","name":"Canadian Institutes of Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000024","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008986","name":"University of Guelph","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008986","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/s2213-8587(23)00004-9","type":"journal-article","created":{"date-parts":[[2023,2,3]],"date-time":"2023-02-03T18:38:14Z","timestamp":1675449494000},"page":"191-202","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":51,"title":["Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial"],"prefix":"10.1016","volume":"11","author":[{"given":"Denice S","family":"Feig","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J Johanna","family":"Sanchez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kellie E","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Asztalos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Zinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea M","family":"Haqq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I George","family":"Fantus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorraine","family":"Lipscombe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Armson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jon","family":"Barrett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lois","family":"Donovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Karanicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siobhan","family":"Tobin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Mangoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gail","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yidi","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"George","family":"Tomlinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill","family":"Hamilton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"DS","family":"Feig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Galper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Cleave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"Strom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Poolman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Fong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Viguiliouk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Legault","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Boutin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Ho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Virtanen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Zahedi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Szwiega","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Coolen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Dias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E","family":"Sellers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B","family":"Fletcher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"L","family":"Bourrier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Haqq","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H","family":"Rylance","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Hadjiyannakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Courtney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"McManus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I","family":"Halperin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K","family":"Coles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D","family":"Simmons","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Nema","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"SJ","family":"Weisnagel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"MC","family":"Dub\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"JP","family":"Chanoine","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Kwan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"HD","family":"McIntyre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Laurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"F","family":"Maguire","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J","family":"Soper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"T","family":"Bridger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R","family":"Houlden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Breen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M","family":"McLean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Duke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S","family":"Hendon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A","family":"Sigmund","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00004-9_bib1","first-page":"1081","article-title":"Diabetes and pregnancy: national trends over a 15 year period","volume":"61","author":"Mackin","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00004-9_bib2","doi-asserted-by":"crossref","first-page":"768","DOI":"10.2337\/dc09-1801","article-title":"Diabetes trends among delivery hospitalizations in the U.S., 1994\u20132004","volume":"33","author":"Albrecht","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00004-9_bib3","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1016\/S2213-8587(20)30406-X","article-title":"Characteristics and outcomes of pregnant women with type 1 or type 2 diabetes: a 5-year national population-based cohort study","volume":"9","author":"Murphy","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00004-9_bib4","doi-asserted-by":"crossref","first-page":"724","DOI":"10.1001\/jamapediatrics.2018.1201","article-title":"Association of gestational diabetes and type 2 diabetes exposure in utero with the development of type 2 diabetes in first nations and non-first nations offspring","volume":"172","author":"Wicklow","year":"2018","journal-title":"JAMA Pediatr"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(23)00004-9_bib5","doi-asserted-by":"crossref","first-page":"S169","DOI":"10.2337\/dc07-s211","article-title":"The predisposition to obesity and diabetes in offspring of diabetic mothers","volume":"30","author":"Dabelea","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00004-9_bib6","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1124\/dmd.109.031245","article-title":"Pharmacokinetics of metformin during pregnancy","volume":"38","author":"Eyal","year":"2010","journal-title":"Drug Metab Dispos"},{"key":"10.1016\/S2213-8587(23)00004-9_bib7","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2016-015557","article-title":"Treatments for gestational diabetes: a systematic review and meta-analysis","volume":"7","author":"Farrar","year":"2017","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(23)00004-9_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2017-000456","article-title":"Metformin in gestational diabetes: the offspring follow-up (MiG TOFU): body composition and metabolic outcomes at 7\u20139 years of age","volume":"6","author":"Rowan","year":"2018","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(23)00004-9_bib9","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1016\/S2352-4642(18)30385-7","article-title":"Intrauterine metformin exposure and offspring cardiometabolic risk factors (PedMet study): a 5\u201310 year follow-up of the PregMet randomised controlled trial","volume":"3","author":"Hanem","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/S2213-8587(23)00004-9_bib10","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1111\/dom.14589","article-title":"Metformin versus insulin therapy for gestational diabetes: effects on offspring anthropometrics and metabolism at the age of 9\u2008years: a follow-up study of two open-label, randomized controlled trials","volume":"24","author":"Paavilainen","year":"2022","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00004-9_bib11","doi-asserted-by":"crossref","first-page":"394","DOI":"10.1016\/j.ebiom.2018.08.047","article-title":"Metformin from mother to unborn child\u2014are there unwarranted effects?","volume":"35","author":"Nguyen","year":"2018","journal-title":"EBioMedicine"},{"key":"10.1016\/S2213-8587(23)00004-9_bib12","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1016\/j.clnu.2015.11.010","article-title":"The famine exposure in early life and metabolic syndrome in adulthood","volume":"36","author":"Wang","year":"2017","journal-title":"Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00004-9_bib13","doi-asserted-by":"crossref","first-page":"834","DOI":"10.1016\/S2213-8587(20)30310-7","article-title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): a multicentre, international, randomised, placebo-controlled trial","volume":"8","author":"Feig","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00004-9_bib14","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1186\/s12884-016-0954-4","article-title":"Metformin in women with type 2 diabetes in pregnancy (MiTy): a multi-center randomized, controlled trial","volume":"16","author":"Feig","year":"2016","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(23)00004-9_bib16","doi-asserted-by":"crossref","first-page":"E35","DOI":"10.1542\/peds.108.2.e35","article-title":"A new and improved population-based Canadian reference for birth weight for gestational age","volume":"108","author":"Kramer","year":"2001","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(23)00004-9_bib19","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1139\/apnm-2015-0048","article-title":"Development, reliability, and validity testing of Toddler NutriSTEP: a nutrition risk screening questionnaire for children 18\u201335 months of age","volume":"40","author":"Simpson","year":"2015","journal-title":"Appl Physiol Nutr Metab"},{"issue":"suppl","key":"10.1016\/S2213-8587(23)00004-9_bib20","first-page":"7","article-title":"Canadian Health Measures Survey: rationale, background and overview","volume":"18","author":"Tremblay","year":"2007","journal-title":"Health Rep"},{"key":"10.1016\/S2213-8587(23)00004-9_bib21","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1038\/sj.jhh.1002201","article-title":"Validity and reproducibility of HOMA-IR, 1\/HOMA-IR, QUICKI and McAuley's indices in patients with hypertension and type II diabetes","volume":"21","author":"Sarafidis","year":"2007","journal-title":"J Hum Hypertens"},{"key":"10.1016\/S2213-8587(23)00004-9_bib22","series-title":"Statistical power analysis","author":"C","year":"1988"},{"key":"10.1016\/S2213-8587(23)00004-9_bib23","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002848","article-title":"Neonatal, infant, and childhood growth following metformin versus insulin treatment for gestational diabetes: a systematic review and meta-analysis","volume":"16","author":"Tarry-Adkins","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(23)00004-9_bib24","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1001\/jamapediatrics.2018.4214","article-title":"Association of long-term child growth and developmental outcomes with metformin vs insulin treatment for gestational diabetes","volume":"173","author":"Landi","year":"2019","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(23)00004-9_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1017\/S0029665116000057","article-title":"The role of infant nutrition in the global epidemic of non-communicable disease","volume":"75","author":"Singhal","year":"2016","journal-title":"Proc Nutr Soc"},{"key":"10.1016\/S2213-8587(23)00004-9_bib26","doi-asserted-by":"crossref","first-page":"1527","DOI":"10.1210\/jc.2008-2489","article-title":"Infancy weight gain predicts childhood body fat and age at menarche in girls","volume":"94","author":"Ong","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00004-9_bib27","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/j.amepre.2015.11.012","article-title":"Risk factors for childhood obesity in the first 1,000 days: a systematic review","volume":"50","author":"Woo Baidal","year":"2016","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(23)00004-9_bib28","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1159\/000261899","article-title":"Early-life predictors of higher body mass index in healthy children","volume":"56","author":"Lamb","year":"2010","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/S2213-8587(23)00004-9_bib29","doi-asserted-by":"crossref","first-page":"3045","DOI":"10.2337\/dc13-0333","article-title":"Sex-specific associations of gestational glucose tolerance with childhood body composition","volume":"36","author":"Regnault","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00004-9_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0195531","article-title":"Sexual dimorphism in the association between gestational diabetes mellitus and overweight in offspring at 5\u20137 years: the OBEGEST cohort study","volume":"13","author":"Le Moullec","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(23)00004-9_bib31","doi-asserted-by":"crossref","first-page":"570","DOI":"10.3109\/00365513.2012.712319","article-title":"Growth, body composition and metabolic profile of 8-year-old children exposed to metformin in utero","volume":"72","author":"R\u00f8","year":"2012","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/S2213-8587(23)00004-9_bib32","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1111\/obr.12547","article-title":"Mediators of socioeconomic differences in adiposity among youth: a systematic review","volume":"18","author":"Gebremariam","year":"2017","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(23)00004-9_bib33","doi-asserted-by":"crossref","DOI":"10.1093\/sleep\/zsy018","article-title":"Sleep duration and incidence of obesity in infants, children, and adolescents: a systematic review and meta-analysis of prospective studies","volume":"41","author":"Miller","year":"2018","journal-title":"Sleep"},{"key":"10.1016\/S2213-8587(23)00004-9_bib34","doi-asserted-by":"crossref","first-page":"1037","DOI":"10.1007\/s00125-018-4584-4","article-title":"Long-term BMI and growth profiles in offspring of women with gestational diabetes","volume":"61","author":"Hammoud","year":"2018","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000049?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000049?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:31Z","timestamp":1761991951000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000049"}},"issued":{"date-parts":[[2023,3]]},"references-count":31,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2213858723000049"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00004-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes in children of women with type 2 diabetes exposed to metformin versus placebo during pregnancy (MiTy Kids): a 24-month follow-up of the MiTy randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00004-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00034-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T12:19:07Z","timestamp":1794485947291,"version":"4.9.1"},"reference-count":4,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/s2213-8587(20)30237-0","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T18:36:08Z","timestamp":1595356568000},"page":"664-665","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Back to normal? Building community resilience after COVID-19"],"prefix":"10.1016","volume":"8","author":[{"given":"Michael","family":"Penkler","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth","family":"M\u00fcller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martha","family":"Kenney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Hanson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30237-0_bib1","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2213-2600(20)30116-8","article-title":"Are patients with hypertension and diabetes mellitus at increased risk for COVID-19 infection?","volume":"8","author":"Fang","year":"2020","journal-title":"Lancet Respir Med"},{"key":"10.1016\/S2213-8587(20)30237-0_bib2","doi-asserted-by":"crossref","first-page":"814","DOI":"10.1007\/s11892-013-0421-9","article-title":"Race\/ethnic difference in diabetes and diabetic complications","volume":"13","author":"Spanakis","year":"2013","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(20)30237-0_bib3","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1017\/S2040174418000892","article-title":"DOHaD in science and society: emergent opportunities and novel responsibilities","volume":"10","author":"Penkler","year":"2019","journal-title":"J Dev Orig Health Dis"},{"key":"10.1016\/S2213-8587(20)30237-0_bib4","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1136\/jech.2004.024562","article-title":"Embodiment: a conceptual glossary for epidemiology","volume":"59","author":"Krieger","year":"2005","journal-title":"J Epidemiol Community Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:17Z","timestamp":1761991757000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720302370"}},"issued":{"date-parts":[[2020,8]]},"references-count":4,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2213858720302370"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30237-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Back to normal? Building community resilience after COVID-19","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30237-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:15:51Z","timestamp":1794492951918,"version":"4.9.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100000274","name":"British Heart Foundation","doi-asserted-by":"publisher","award":["RE\/18\/6\/34217"],"award-info":[{"award-number":["RE\/18\/6\/34217"]}],"id":[{"id":"10.13039\/501100000274","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000853","name":"University of Glasgow","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000853","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,10]]},"DOI":"10.1016\/s2213-8587(21)00203-5","type":"journal-article","created":{"date-parts":[[2021,8,20]],"date-time":"2021-08-20T18:42:01Z","timestamp":1629484921000},"page":"653-662","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1533,"title":["Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials"],"prefix":"10.1016","volume":"9","author":[{"given":"Naveed","family":"Sattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew M Y","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"S\u00f8ren L","family":"Kristensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kelley R H","family":"Branch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefano","family":"Del Prato","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nardev S","family":"Khurmi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carolyn S P","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renato D","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John J V","family":"McMurray","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard E","family":"Pratley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julio","family":"Rosenstock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hertzel C","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00203-5_bib1","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1016\/S2213-8587(15)00462-3","article-title":"Future glucose-lowering drugs for type 2 diabetes","volume":"4","author":"Bailey","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00203-5_bib2","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"7","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00203-5_bib3","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa2108269","article-title":"Cardiovascular and renal outcomes with efpeglenatide in type 2 diabetes","author":"Gerstein","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00203-5_bib4","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00203-5_bib5","doi-asserted-by":"crossref","first-page":"3200","DOI":"10.1016\/j.jacc.2018.09.020","volume":"72","author":"Das","year":"2018","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00203-5_bib6","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00203-5_bib7","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00203-5_bib8","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00203-5_bib9","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00203-5_bib10","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1016\/S0140-6736(18)32261-X","article-title":"Albiglutide and cardiovascular outcomes in patients with type 2 diabetes and cardiovascular disease (Harmony Outcomes): a double-blind, randomised placebo-controlled trial","volume":"392","author":"Hernandez","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00203-5_bib11","doi-asserted-by":"crossref","first-page":"1228","DOI":"10.1056\/NEJMoa1612917","article-title":"Effects of once-weekly exenatide on cardiovascular outcomes in type 2 diabetes","volume":"377","author":"Holman","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00203-5_bib12","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00203-5_bib13","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(19)31150-X","article-title":"Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00203-5_bib14","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1056\/NEJMoa1616011","article-title":"Liraglutide and Renal outcomes in type 2 diabetes","volume":"377","author":"Mann","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00203-5_bib15","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"381","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00203-5_bib16","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.d5928","article-title":"The Cochrane Collaboration's tool for assessing risk of bias in randomised trials","volume":"343","author":"Higgins","year":"2011","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00203-5_bib17","doi-asserted-by":"crossref","first-page":"1492","DOI":"10.1136\/bmj.319.7223.1492","article-title":"Calculating the number needed to treat for trials where the outcome is time to an event","volume":"319","author":"Altman","year":"1999","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00203-5_bib19","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S1473-3099(18)30602-9","article-title":"Interventions to improve oral vaccine performance: a systematic review and meta-analysis","volume":"19","author":"Church","year":"2019","journal-title":"Lancet Infect Dis"},{"key":"10.1016\/S2213-8587(21)00203-5_bib20","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/S2213-8587(17)30412-6","article-title":"Cardiovascular outcomes with glucagon-like peptide-1 receptor agonists in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"Bethel","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00203-5_bib21","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-8587(18)30268-7","article-title":"Lixisenatide and renal outcomes in patients with type 2 diabetes and acute coronary syndrome: an exploratory analysis of the ELIXA randomised, placebo-controlled trial","volume":"6","author":"Muskiet","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00203-5_bib22","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1016\/j.numecd.2020.03.013","article-title":"Major cardiovascular events, heart failure, and atrial fibrillation in patients treated with glucagon-like peptide-1 receptor agonists: an updated meta-analysis of randomized controlled trials","volume":"30","author":"Nreu","year":"2020","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(21)00203-5_bib23","doi-asserted-by":"crossref","first-page":"328","DOI":"10.2174\/1871530319666191014110414","article-title":"A review on the effects of new anti-diabetic drugs on platelet function","volume":"20","author":"Yaribeygi","year":"2020","journal-title":"Endocr Metab Immune Disord Drug Targets"},{"key":"10.1016\/S2213-8587(21)00203-5_bib24","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","article-title":"Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial","volume":"19","author":"Cukierman-Yaffe","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(21)00203-5_bib25","doi-asserted-by":"crossref","first-page":"322","DOI":"10.1159\/000492920","article-title":"Systematic review and meta-analysis of prevalence in post-stroke neurocognitive disorders in hospital-based studies","volume":"46","author":"Barbay","year":"2018","journal-title":"Dement Geriatr Cogn Disord"},{"key":"10.1016\/S2213-8587(21)00203-5_bib26","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1001\/jamacardio.2020.4511","article-title":"Association of SGLT2 inhibitors with cardiovascular and kidney outcomes in patients with type 2 diabetes: a meta-analysis","volume":"6","author":"McGuire","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(21)00203-5_bib27","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1161\/CIRCULATIONAHA.120.052186","article-title":"Effect of empagliflozin on left ventricular volumes in patients with type 2 diabetes, or prediabetes, and heart failure with reduced ejection fraction (SUGAR-DM-HF)","volume":"143","author":"Lee","year":"2021","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00203-5_bib28","doi-asserted-by":"crossref","first-page":"2108","DOI":"10.1007\/s00125-018-4670-7","article-title":"SGLT2 inhibitors and mechanisms of cardiovascular benefit: a state-of-the-art review","volume":"61","author":"Verma","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00203-5_bib29","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1093\/eurjpc\/zwaa081","article-title":"Cardiovascular effectiveness of human-based vs exendin-based glucagon like peptide-1 receptor agonists: a retrospective study in patients with type 2 diabetes","volume":"28","author":"Longato","year":"2021","journal-title":"Eur J Prev Cardiol"},{"key":"10.1016\/S2213-8587(21)00203-5_bib30","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(19)30267-0","article-title":"GLP-1 receptor agonists and cardiovascular outcomes: an updated synthesis","volume":"7","author":"Standl","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00203-5_bib31","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1080\/00325481.2020.1798099","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes: role and clinical experience to date","volume":"132","author":"Brunton","year":"2020","journal-title":"Postgrad Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002035?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002035?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:50Z","timestamp":1761991790000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002035"}},"issued":{"date-parts":[[2021,10]]},"references-count":30,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2021,10]]}},"alternative-id":["S2213858721002035"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00203-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of randomised trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00203-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00212-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T03:05:49Z","timestamp":1794279949410,"version":"4.9.0"},"reference-count":133,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1016\/s2213-8587(21)00002-4","type":"journal-article","created":{"date-parts":[[2021,2,26]],"date-time":"2021-02-26T18:43:06Z","timestamp":1614364986000},"page":"235-246","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":184,"title":["Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction"],"prefix":"10.1016","volume":"9","author":[{"given":"Maith\u00e9","family":"Tauber","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charlotte","family":"Hoybye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00002-4_bib1","first-page":"1260","article-title":"Ein Syndrom von Adipositas, Kleinwuchs, Kryptorchismus und Oligophrenie nach myatonieartigem Zustand im Neugeborenenalter","volume":"6","author":"Prader","year":"1956","journal-title":"Schweiz Med Wochenschr"},{"key":"10.1016\/S2213-8587(21)00002-4_bib2","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s13023-017-0673-6","article-title":"Early diagnosis and care is achieved but should be improved in infants with Prader-Willi syndrome","volume":"12","author":"Bar","year":"2017","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(21)00002-4_bib3","doi-asserted-by":"crossref","first-page":"1040","DOI":"10.1002\/ajmg.a.33951","article-title":"Nutritional phases in Prader-Willi syndrome","volume":"155A","author":"Miller","year":"2011","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(21)00002-4_bib4","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1038\/gim.0b013e31822bead0","article-title":"Prader-Willi syndrome","volume":"14","author":"Cassidy","year":"2012","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(21)00002-4_bib5","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1210\/edrv.22.6.0447","article-title":"Endocrine dysfunction in Prader-Willi syndrome: a review with special reference to GH","volume":"22","author":"Burman","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(21)00002-4_bib6","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa621","article-title":"Missed diagnoses and health problems in adults with Prader-Willi syndrome: recommendations for screening and treatment","volume":"105","author":"Pellikaan","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib7","doi-asserted-by":"crossref","first-page":"207","DOI":"10.2174\/1573396315666190716120925","article-title":"Prader-Willi syndrome\u2014clinical genetics, diagnosis and treatment approaches: an update","volume":"15","author":"Butler","year":"2019","journal-title":"Curr Pediatr Rev"},{"key":"10.1016\/S2213-8587(21)00002-4_bib8","doi-asserted-by":"crossref","first-page":"E260","DOI":"10.3390\/genes11030260","article-title":"Clinical observations and treatment approaches for scoliosis in Prader-Willi syndrome","volume":"11","author":"van Bosse","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/S2213-8587(21)00002-4_bib9","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00223-014-9949-1","article-title":"Adults with Prader-Willi syndrome have weaker bones: effect of treatment with GH and sex steroids","volume":"96","author":"Longhi","year":"2015","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(21)00002-4_bib10","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/j.numecd.2016.05.010","article-title":"Disorders of glucose metabolism in Prader-Willi syndrome: results of a multicenter Italian cohort study","volume":"26","author":"Fintini","year":"2016","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(21)00002-4_bib11","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1530\/EC-18-0089","article-title":"Impact of transitional care on endocrine and anthropometric parameters in Prader-Willi syndrome","volume":"7","author":"Paepegaey","year":"2018","journal-title":"Endocr Connect"},{"key":"10.1016\/S2213-8587(21)00002-4_bib12","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.1210\/jc.2008-0649","article-title":"Recommendations for the diagnosis and management of Prader-Willi syndrome","volume":"93","author":"Goldstone","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib13","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1002\/ajmg.a.38525","article-title":"A model to characterize psychopathological features in adults with Prader-Willi syndrome","volume":"176","author":"Thuilleaux","year":"2018","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(21)00002-4_bib14","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1136\/jmg.38.11.792","article-title":"Population prevalence and estimated birth incidence and mortality rate for people with Prader-Willi syndrome in one UK Health Region","volume":"38","author":"Whittington","year":"2001","journal-title":"J Med Genet"},{"key":"10.1016\/S2213-8587(21)00002-4_bib15","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1038\/gim.2016.178","article-title":"Causes of death in Prader-Willi syndrome: Prader-Willi Syndrome Association (USA) 40-year mortality survey","volume":"19","author":"Butler","year":"2017","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(21)00002-4_bib16","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1186\/s13023-019-1214-2","article-title":"Causes of death in Prader-Willi syndrome: lessons from 11 years' experience of a national reference center","volume":"14","author":"Pacoricona Alfaro","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(21)00002-4_bib17","doi-asserted-by":"crossref","DOI":"10.1002\/wrna.1417","article-title":"Box C\/D small nucleolar RNA genes and the Prader-Willi syndrome: a complex interplay","volume":"8","author":"Cavaill\u00e9","year":"2017","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"10.1016\/S2213-8587(21)00002-4_bib18","doi-asserted-by":"crossref","first-page":"154","DOI":"10.3389\/fped.2020.00154","article-title":"Chromosome 15 imprinting disorders: genetic laboratory methodology and approaches","volume":"8","author":"Butler","year":"2020","journal-title":"Front Pediatr"},{"key":"10.1016\/S2213-8587(21)00002-4_bib19","doi-asserted-by":"crossref","first-page":"3714","DOI":"10.1210\/jc.2018-00687","article-title":"Improved mental and motor development during 3 years of gh treatment in very young children with Prader-Willi syndrome","volume":"103","author":"Donze","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib20","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1136\/jmedgenet-2018-105301","article-title":"Molecular genetic classification in Prader-Willi syndrome: a multisite cohort study","volume":"56","author":"Butler","year":"2019","journal-title":"J Med Genet"},{"key":"10.1016\/S2213-8587(21)00002-4_bib21","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1002\/pd.5712","article-title":"Recognizing the unique prenatal phenotype of Prader-Willi syndrome (PWS) indicates the need for a diagnostic methylation test","volume":"40","author":"Srebnik","year":"2020","journal-title":"Prenat Diagn"},{"key":"10.1016\/S2213-8587(21)00002-4_bib22","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1111\/j.1365-2788.2009.01169.x","article-title":"Water intake and risk of hyponatraemia in Prader-Willi syndrome","volume":"53","author":"Akefeldt","year":"2009","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/S2213-8587(21)00002-4_bib23","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/ejhg.2014.103","article-title":"Highly restricted deletion of the SNORD116 region is implicated in Prader-Willi syndrome","volume":"23","author":"Bieth","year":"2015","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S2213-8587(21)00002-4_bib24","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1242\/jcs.054957","article-title":"Long nuclear-retained non-coding RNAs and allele-specific higher-order chromatin organization at imprinted snoRNA gene arrays","volume":"123","author":"Vitali","year":"2010","journal-title":"J Cell Sci"},{"key":"10.1016\/S2213-8587(21)00002-4_bib25","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1111\/cge.13005","article-title":"SNORD116 deletions cause Prader-Willi syndrome with a mild phenotype and macrocephaly","volume":"92","author":"Fontana","year":"2017","journal-title":"Clin Genet"},{"key":"10.1016\/S2213-8587(21)00002-4_bib26","doi-asserted-by":"crossref","first-page":"E128","DOI":"10.3390\/genes11020128","article-title":"Prader-Willi-like phenotype caused by an atypical 15q11.2 microdeletion","volume":"11","author":"Tan","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/S2213-8587(21)00002-4_bib27","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1016\/j.trsl.2019.02.012","article-title":"Epigenetic therapy of Prader-Willi syndrome","volume":"208","author":"Kim","year":"2019","journal-title":"Transl Res"},{"key":"10.1016\/S2213-8587(21)00002-4_bib28","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1038\/ng.2776","article-title":"Truncating mutations of MAGEL2 cause Prader-Willi phenotypes and autism","volume":"45","author":"Schaaf","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(21)00002-4_bib29","doi-asserted-by":"crossref","first-page":"E2","DOI":"10.3390\/diseases4010002","article-title":"Prader-Willi Syndrome and Schaaf-Yang syndrome: neurodevelopmental diseases intersecting at the MAGEL2 gene","volume":"4","author":"Fountain","year":"2016","journal-title":"Diseases"},{"key":"10.1016\/S2213-8587(21)00002-4_bib30","doi-asserted-by":"crossref","first-page":"2564","DOI":"10.1002\/ajmg.a.40650","article-title":"Schaaf-Yang syndrome overview: report of 78 individuals","volume":"176","author":"McCarthy","year":"2018","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(21)00002-4_bib31","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1302160","article-title":"Central precocious puberty caused by mutations in the imprinted gene MKRN3","volume":"368","author":"Abreu","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00002-4_bib32","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.ijdevneu.2012.05.005","article-title":"Hypothalamic expression of snoRNA Snord116 is consistent with a link to the hyperphagia and obesity symptoms of Prader-Willi syndrome","volume":"30","author":"Zhang","year":"2012","journal-title":"Int J Dev Neurosci"},{"key":"10.1016\/S2213-8587(21)00002-4_bib33","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1172\/JCI97007","article-title":"Hypothalamic loss of Snord116 recapitulates the hyperphagia of Prader-Willi syndrome","volume":"128","author":"Polex-Wolf","year":"2018","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(21)00002-4_bib34","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1172\/JCI88648","article-title":"Deficiency in prohormone convertase PC1 impairs prohormone processing in Prader-Willi syndrome","volume":"127","author":"Burnett","year":"2017","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(21)00002-4_bib35","doi-asserted-by":"crossref","first-page":"4318","DOI":"10.1093\/hmg\/ddt281","article-title":"A Prader-Willi locus lncRNA cloud modulates diurnal genes and energy expenditure","volume":"22","author":"Powell","year":"2013","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(21)00002-4_bib36","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1186\/s13023-019-1249-4","article-title":"Schaaf-Yang syndrome shows a Prader-Willi syndrome-like phenotype during infancy","volume":"14","author":"Negishi","year":"2019","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(21)00002-4_bib37","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1016\/j.nbd.2018.09.017","article-title":"Inactivation of Magel2 suppresses oxytocin neurons through synaptic excitation-inhibition imbalance","volume":"121","author":"Ates","year":"2019","journal-title":"Neurobiol Dis"},{"key":"10.1016\/S2213-8587(21)00002-4_bib38","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1093\/hmg\/ddq424","article-title":"A single postnatal injection of oxytocin rescues the lethal feeding behaviour in mouse newborns deficient for the imprinted Magel2 gene","volume":"19","author":"Schaller","year":"2010","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(21)00002-4_bib39","doi-asserted-by":"crossref","first-page":"3208","DOI":"10.1093\/hmg\/ddw169","article-title":"Loss of Magel2 impairs the development of hypothalamic anorexigenic circuits","volume":"25","author":"Maillard","year":"2016","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(21)00002-4_bib40","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1159\/000323442","article-title":"The GH\/IGF-I axis and pituitary function and size in adults with Prader-Willi syndrome","volume":"75","author":"van Nieuwpoort","year":"2011","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(21)00002-4_bib41","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s11689-017-9188-7","article-title":"Altered functional resting-state hypothalamic connectivity and abnormal pituitary morphology in children with Prader-Willi syndrome","volume":"9","author":"Lukoshe","year":"2017","journal-title":"J Neurodev Disord"},{"key":"10.1016\/S2213-8587(21)00002-4_bib42","doi-asserted-by":"crossref","DOI":"10.1016\/j.nicl.2019.101664","article-title":"Increased brain age in adults with Prader-Willi syndrome","volume":"21","author":"Azor","year":"2019","journal-title":"Neuroimage Clin"},{"key":"10.1016\/S2213-8587(21)00002-4_bib43","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194655","article-title":"High levels of caregiver burden in Prader-Willi syndrome","volume":"13","author":"Kayadjanian","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00002-4_bib44","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1038\/s41380-020-00917-x","article-title":"What can we learn from PWS and SNORD116 genes about the pathophysiology of addictive disorders?","volume":"26","author":"Salles","year":"2021","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S2213-8587(21)00002-4_bib45","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1210\/jc.2009-1389","article-title":"Long-term growth hormone therapy changes the natural history of body composition and motor function in children with prader-willi syndrome","volume":"95","author":"Carrel","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib46","first-page":"182","article-title":"Growth hormone treatment completely normalizes adult height and improves body composition in Prader-Willi syndrome: experience from KIGS (Pfizer International Growth Database)","volume":"70","author":"Lindgren","year":"2008","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(21)00002-4_bib47","doi-asserted-by":"crossref","first-page":"410","DOI":"10.1111\/j.1651-2227.2006.00051.x","article-title":"Five-years growth hormone (GH) treatment in adults with Prader-Willi syndrome","volume":"96","author":"H\u00f6ybye","year":"2007","journal-title":"Acta Paediatr"},{"key":"10.1016\/S2213-8587(21)00002-4_bib48","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.1210\/jc.2007-2212","article-title":"Growth hormone treatment of adults with Prader-Willi syndrome and growth hormone deficiency improves lean body mass, fractional body fat, and serum triiodothyronine without glucose impairment: results from the United States multicenter trial","volume":"93","author":"Mogul","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib49","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1111\/j.1365-2265.2011.04303.x","article-title":"Effects of recombinant human growth hormone therapy in adults with Prader-Willi syndrome: a meta-analysis","volume":"77","author":"Sanchez-Ortiga","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(21)00002-4_bib50","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s12020-011-9560-4","article-title":"Growth hormone treatment in adults with Prader-Willi syndrome: the Scandinavian study","volume":"41","author":"Sode-Carlsen","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(21)00002-4_bib51","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1038\/ijo.2012.228","article-title":"Comparison of body composition, basal metabolic rate and metabolic outcomes of adults with Prader Willi syndrome or lesional hypothalamic disease, with primary obesity","volume":"37","author":"Lloret-Linares","year":"2013","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(21)00002-4_bib52","doi-asserted-by":"crossref","first-page":"4330","DOI":"10.1210\/jcem.86.9.7814","article-title":"Visceral adipose tissue and metabolic complications of obesity are reduced in Prader-Willi syndrome female adults: evidence for novel influences on body fat distribution","volume":"86","author":"Goldstone","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib53","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1399-0004.2004.00392.x","article-title":"Insulin resistance and obesity-related factors in Prader-Willi syndrome: comparison with obese subjects","volume":"67","author":"Talebizadeh","year":"2005","journal-title":"Clin Genet"},{"key":"10.1016\/S2213-8587(21)00002-4_bib54","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1038\/sj.ijo.0803115","article-title":"Circulating adiponectin levels, body composition and obesity-related variables in Prader-Willi syndrome: comparison with obese subjects","volume":"30","author":"Kennedy","year":"2006","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(21)00002-4_bib55","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1210\/jc.2014-3127","article-title":"Metabolic and adipose tissue signatures in adults with Prader-Willi syndrome: a model of extreme adiposity","volume":"100","author":"Lacroix","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib56","doi-asserted-by":"crossref","first-page":"1134","DOI":"10.1016\/j.numecd.2012.11.006","article-title":"Metabolic syndrome in adult patients with Prader-Willi syndrome","volume":"23","author":"Grugni","year":"2013","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(21)00002-4_bib57","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1515\/JPEM.2007.20.4.491","article-title":"Nutrient intake and body composition variables in Prader-Willi syndrome\u2014effect of growth hormone supplementation and genetic subtype","volume":"20","author":"Galassetti","year":"2007","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib58","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1515\/jpem-2013-0180","article-title":"Effect of genetic subtypes and growth hormone treatment on bone mineral density in Prader-Willi syndrome","volume":"27","author":"Khare","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib59","doi-asserted-by":"crossref","first-page":"1685","DOI":"10.1038\/oby.2006.193","article-title":"Body composition and fatness patterns in Prader-Willi syndrome: comparison with simple obesity","volume":"14","author":"Theodoro","year":"2006","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00002-4_bib60","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1111\/jir.12140","article-title":"Medical, psychological and social features in a large cohort of adults with Prader-Willi syndrome: experience from a dedicated centre in France","volume":"59","author":"Laurier","year":"2015","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/S2213-8587(21)00002-4_bib61","doi-asserted-by":"crossref","first-page":"4895","DOI":"10.1210\/jc.2016-2163","article-title":"Effect of genotype and previous GH treatment on adiposity in adults with Prader-Willi syndrome","volume":"101","author":"Coupaye","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.npep.2020.102079","article-title":"The role of oxytocin and vasopressin dysfunction in cognitive impairment and mental disorders","volume":"83","author":"Abramova","year":"2020","journal-title":"Neuropeptides"},{"key":"10.1016\/S2213-8587(21)00002-4_bib63","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12805","article-title":"The role of oxytocin in regulation of appetitive behaviour, body weight and glucose homeostasis","volume":"32","author":"Lawson","year":"2020","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/S2213-8587(21)00002-4_bib64","first-page":"573","article-title":"Alterations in the hypothalamic paraventricular nucleus and its oxytocin neurons (putative satiety cells) in Prader-Willi syndrome: a study of five cases","volume":"80","author":"Swaab","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib65","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.1016\/S0006-3223(98)00190-5","article-title":"Cerebrospinal fluid levels of oxytocin in Prader-Willi syndrome: a preliminary report","volume":"44","author":"Martin","year":"1998","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2213-8587(21)00002-4_bib66","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1002\/ajmg.a.37488","article-title":"Elevated plasma oxytocin levels in children with Prader-Willi syndrome compared with healthy unrelated siblings","volume":"170","author":"Johnson","year":"2016","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(21)00002-4_bib67","doi-asserted-by":"crossref","first-page":"3101","DOI":"10.1093\/hmg\/9.20.3101","article-title":"Disruption of the mouse Necdin gene results in hypothalamic and behavioral alterations reminiscent of the human Prader-Willi syndrome","volume":"9","author":"Muscatelli","year":"2000","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(21)00002-4_bib68","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1016\/j.biopsych.2014.11.010","article-title":"An early postnatal oxytocin treatment prevents social and learning deficits in adult mice deficient for Magel2, a gene involved in Prader-Willi Syndrome and autism","volume":"78","author":"Meziane","year":"2015","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2213-8587(21)00002-4_bib69","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2016-2976","article-title":"The use of oxytocin to improve feeding and social skills in infants with Prader-Willi syndrome","volume":"139","author":"Tauber","year":"2017","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(21)00002-4_bib70","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1097\/YCO.0000000000000391","article-title":"A review of clinical trials of oxytocin in Prader-Willi syndrome","volume":"31","author":"Rice","year":"2018","journal-title":"Curr Opin Psychiatry"},{"key":"10.1016\/S2213-8587(21)00002-4_bib71","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.cell.2008.01.017","article-title":"Identification of the acyltransferase that octanoylates ghrelin, an appetite-stimulating peptide hormone","volume":"132","author":"Yang","year":"2008","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(21)00002-4_bib72","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1111\/jne.12236","article-title":"Ghrelin signalling on food reward: a salient link between the gut and the mesolimbic system","volume":"27","author":"Perello","year":"2015","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/S2213-8587(21)00002-4_bib73","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1172\/JCI29867","article-title":"Ghrelin modulates the activity and synaptic input organization of midbrain dopamine neurons while promoting appetite","volume":"116","author":"Abizaid","year":"2006","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(21)00002-4_bib74","doi-asserted-by":"crossref","first-page":"643","DOI":"10.1038\/nm0702-643","article-title":"Elevated plasma ghrelin levels in Prader Willi syndrome","volume":"8","author":"Cummings","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(21)00002-4_bib75","doi-asserted-by":"crossref","first-page":"2800","DOI":"10.1210\/jc.2007-2138","article-title":"Hyperghrelinemia precedes obesity in Prader-Willi syndrome","volume":"93","author":"Feigerlov\u00e1","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib76","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1002\/ajmg.a.36810","article-title":"Hyperghrelinemia in Prader-Willi syndrome begins in early infancy long before the onset of hyperphagia","volume":"167A","author":"Kweh","year":"2015","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(21)00002-4_bib77","doi-asserted-by":"crossref","first-page":"633","DOI":"10.1007\/s12020-015-0614-x","article-title":"Elevated ratio of acylated to unacylated ghrelin in children and young adults with Prader-Willi syndrome","volume":"50","author":"Kuppens","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(21)00002-4_bib78","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1186\/s13023-016-0440-0","article-title":"High unacylated ghrelin levels support the concept of anorexia in infants with prader-willi syndrome","volume":"11","author":"Beauloye","year":"2016","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(21)00002-4_bib79","doi-asserted-by":"crossref","DOI":"10.1111\/jne.12728","article-title":"Prader-Willi syndrome: a model for understanding the ghrelin system","volume":"31","author":"Tauber","year":"2019","journal-title":"J Neuroendocrinol"},{"key":"10.1016\/S2213-8587(21)00002-4_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0190849","article-title":"AZP-531, an unacylated ghrelin analog, improves food-related behavior in patients with Prader-Willi syndrome: a randomized placebo-controlled trial","volume":"13","author":"Allas","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00002-4_bib81","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148155","article-title":"Prader-Willi critical region, a non-translated, imprinted central regulator of bone mass: possible role in skeletal abnormalities in Prader-Willi syndrome","volume":"11","author":"Khor","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00002-4_bib82","doi-asserted-by":"crossref","first-page":"4006","DOI":"10.1210\/en.2018-00801","article-title":"Ghrelin receptor agonist rescues excess neonatal mortality in a Prader-Willi syndrome mouse model","volume":"159","author":"Rodriguez","year":"2018","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(21)00002-4_bib83","doi-asserted-by":"crossref","first-page":"90","DOI":"10.1016\/j.neuropharm.2018.12.022","article-title":"A ghrelin receptor and oxytocin receptor heterocomplex impairs oxytocin mediated signalling","volume":"152","author":"Wallace Fitzsimons","year":"2019","journal-title":"Neuropharmacology"},{"key":"10.1016\/S2213-8587(21)00002-4_bib84","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1038\/ijo.2011.274","article-title":"Appetite hormones and the transition to hyperphagia in children with Prader-Willi syndrome","volume":"36","author":"Goldstone","year":"2012","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(21)00002-4_bib85","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0163468","article-title":"Lack of postprandial peak in brain-derived neurotrophic factor in adults with Prader-Willi syndrome","volume":"11","author":"Bueno","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00002-4_bib86","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1016\/S0079-6123(06)53003-1","article-title":"The hypothalamus, hormones, and hunger: alterations in human obesity and illness","volume":"153","author":"Goldstone","year":"2006","journal-title":"Prog Brain Res"},{"key":"10.1016\/S2213-8587(21)00002-4_bib87","doi-asserted-by":"crossref","DOI":"10.1080\/16546628.2017.1297553","article-title":"Hedonic eating in Prader-Willi syndrome is associated with blunted PYY secretion","volume":"61","author":"Rigamonti","year":"2017","journal-title":"Food Nutr Res"},{"key":"10.1016\/S2213-8587(21)00002-4_bib88","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/j.npep.2011.06.001","article-title":"In adults with Prader-Willi syndrome, elevated ghrelin levels are more consistent with hyperphagia than high PYY and GLP-1 levels","volume":"45","author":"Purtell","year":"2011","journal-title":"Neuropeptides"},{"key":"10.1016\/S2213-8587(21)00002-4_bib89","doi-asserted-by":"crossref","DOI":"10.1111\/ijpo.12493","article-title":"Obestatin and adropin in Prader-Willi syndrome and nonsyndromic obesity: associations with weight, BMI-z, and HOMA-IR","volume":"14","author":"Orsso","year":"2019","journal-title":"Pediatr Obes"},{"issue":"suppl 5","key":"10.1016\/S2213-8587(21)00002-4_bib90","first-page":"48","article-title":"KIGS highlights: growth hormone treatment in Prader-Willi syndrome","volume":"68","author":"Tauber","year":"2007","journal-title":"Horm Res"},{"key":"10.1016\/S2213-8587(21)00002-4_bib91","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1159\/000356927","article-title":"Growth hormone response to standard provocative stimuli and combined tests in very young children with Prader-Willi syndrome","volume":"81","author":"Di Giorgio","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(21)00002-4_bib92","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1159\/000313377","article-title":"Endocrine disorders in children with Prader-Willi syndrome\u2014data from 142 children of the French database","volume":"74","author":"Diene","year":"2010","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(21)00002-4_bib93","doi-asserted-by":"crossref","first-page":"E1072","DOI":"10.1210\/jc.2012-3888","article-title":"GrowthHormone Research Society workshop summary: consensus guidelines for recombinant human growth hormone therapy in Prader-Willi syndrome","volume":"98","author":"Deal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib94","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/j.beem.2016.11.003","article-title":"Diagnosis and treatment of GH deficiency in Prader-Willi syndrome","volume":"30","author":"Grugni","year":"2016","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib95","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1111\/cen.13988","article-title":"Prevalence of growth hormone (GH) deficiency in previously GH-treated young adults with Prader-Willi syndrome","volume":"91","author":"Donze","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(21)00002-4_bib96","first-page":"493","article-title":"Growth hormone secretion among adult patients with Prader-Willi syndrome due to different genetic subtypes","volume":"34","author":"Grugni","year":"2011","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(21)00002-4_bib97","doi-asserted-by":"crossref","first-page":"1234","DOI":"10.1038\/ijo.2014.3","article-title":"Impairment of adipose tissue in Prader-Willi syndrome rescued by growth hormone treatment","volume":"38","author":"Cadoudal","year":"2014","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(21)00002-4_bib98","doi-asserted-by":"crossref","first-page":"4013","DOI":"10.1210\/jc.2013-2012","article-title":"Eight years of growth hormone treatment in children with Prader-Willi syndrome: maintaining the positive effects","volume":"98","author":"Bakker","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib99","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1111\/apa.12898","article-title":"Growth hormone treatment of Prader-Willi syndrome has long-term, positive effects on body composition","volume":"104","author":"H\u00f6ybye","year":"2015","journal-title":"Acta Paediatr"},{"key":"10.1016\/S2213-8587(21)00002-4_bib100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjpo-2019-000630","article-title":"Growth hormone treatment in Prader-Willi syndrome patients: systematic review and meta-analysis","volume":"4","author":"Passone","year":"2020","journal-title":"BMJ Paediatr Open"},{"key":"10.1016\/S2213-8587(21)00002-4_bib101","doi-asserted-by":"crossref","first-page":"4110","DOI":"10.1210\/jc.2016-2594","article-title":"Beneficial effects of GH in young adults with Prader-Willi syndrome: a 2-year crossover trial","volume":"101","author":"Kuppens","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib102","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1186\/s13023-020-01440-6","article-title":"Three years of growth hormone treatment in young adults with Prader-Willi syndrome: sustained positive effects on body composition","volume":"15","author":"Damen","year":"2020","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(21)00002-4_bib103","doi-asserted-by":"crossref","first-page":"873","DOI":"10.2147\/TCRM.S70068","article-title":"Growth hormone therapy for Prader-Willi syndrome: challenges and solutions","volume":"12","author":"Grugni","year":"2016","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/S2213-8587(21)00002-4_bib104","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1365-2788.2005.00641.x","article-title":"Cognitive, emotional, physical and social effects of growth hormone treatment in adults with Prader-Willi syndrome","volume":"49","author":"H\u00f6ybye","year":"2005","journal-title":"J Intellect Disabil Res"},{"key":"10.1016\/S2213-8587(21)00002-4_bib105","first-page":"138","article-title":"Sequelae of GH treatment in children with PWS","volume":"14","author":"Tauber","year":"2016","journal-title":"Pediatr Endocrinol Rev"},{"key":"10.1016\/S2213-8587(21)00002-4_bib106","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1067\/mpd.2003.81","article-title":"Myeloid leukemia in Prader-Willi syndrome","volume":"142","author":"Davies","year":"2003","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(21)00002-4_bib107","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s00431-002-1132-4","article-title":"Hypogonadism and pubertal development in Prader-Willi syndrome","volume":"162","author":"Crin\u00f2","year":"2003","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(21)00002-4_bib108","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1530\/EJE-09-0901","article-title":"Hypogonadism in females with Prader-Willi syndrome from infancy to adulthood: variable combinations of a primary gonadal defect and hypothalamic dysfunction","volume":"162","author":"Eldar-Geva","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00002-4_bib109","doi-asserted-by":"crossref","first-page":"2587","DOI":"10.1093\/humrep\/dev213","article-title":"Sexual dichotomy of gonadal function in Prader-Willi syndrome from early infancy through the fourth decade","volume":"30","author":"Hirsch","year":"2015","journal-title":"Hum Reprod"},{"key":"10.1016\/S2213-8587(21)00002-4_bib110","doi-asserted-by":"crossref","first-page":"874","DOI":"10.1016\/j.jpeds.2006.08.077","article-title":"Normal minipuberty of infancy in boys with Prader-Willi syndrome","volume":"149","author":"Fillion","year":"2006","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(21)00002-4_bib111","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1159\/000365047","article-title":"Characterization of minipuberty in infants with Prader-Willi syndrome","volume":"82","author":"Hirsch","year":"2014","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(21)00002-4_bib112","doi-asserted-by":"crossref","first-page":"72","DOI":"10.1111\/j.1365-2265.2011.04161.x","article-title":"Multiple forms of hypogonadism of central, peripheral or combined origin in males with Prader-Willi syndrome","volume":"76","author":"Radicioni","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(21)00002-4_bib113","doi-asserted-by":"crossref","first-page":"E1766","DOI":"10.1210\/jc.2012-1595","article-title":"Ovarian function and reproductive hormone levels in girls with Prader-Willi syndrome: a longitudinal study","volume":"97","author":"Siemensma","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib114","first-page":"1201","article-title":"Central precocious puberty in a girl with Prader-Willi syndrome","volume":"26","author":"Lee","year":"2013","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib115","first-page":"e352","article-title":"Central precocious puberty in two boys with Prader-Willi syndrome on growth hormone treatment","volume":"5","author":"Monai","year":"2019","journal-title":"AACE Clin Case Rep"},{"issue":"suppl","key":"10.1016\/S2213-8587(21)00002-4_bib116","doi-asserted-by":"crossref","first-page":"1800","DOI":"10.1016\/j.juro.2008.03.113","article-title":"Testicular histology in boys with Prader-Willi syndrome: fertile or infertile?","volume":"180","author":"Vogels","year":"2008","journal-title":"J Urol"},{"key":"10.1016\/S2213-8587(21)00002-4_bib117","doi-asserted-by":"crossref","first-page":"2167","DOI":"10.1002\/ajmg.a.36048","article-title":"Testosterone replacement therapy to improve secondary sexual characteristics and body composition without adverse behavioral problems in adult male patients with Prader-Willi syndrome: an observational study","volume":"161A","author":"Kido","year":"2013","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(21)00002-4_bib118","doi-asserted-by":"crossref","first-page":"789","DOI":"10.1017\/S0012162299221573","article-title":"\u2018A woman with Prader-Willi syndrome gives birth to a healthy baby girl\u2019","volume":"41","author":"Akefeldt","year":"1999","journal-title":"Dev Med Child Neurol"},{"key":"10.1016\/S2213-8587(21)00002-4_bib119","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1111\/j.1365-2265.2011.03989.x","article-title":"Pubarche and serum dehydroepiandrosterone sulphate levels in children with Prader-Willi syndrome","volume":"75","author":"Siemensma","year":"2011","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(21)00002-4_bib120","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1016\/j.jpeds.2013.03.058","article-title":"Thyroid function from birth to adolescence in Prader-Willi syndrome","volume":"163","author":"Sharkia","year":"2013","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(21)00002-4_bib121","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1515\/jpem-2018-0388","article-title":"Thyroid function in patients with Prader-Willi syndrome: an Italian multicenter study of 339 patients","volume":"32","author":"Iughetti","year":"2019","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib122","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1111\/j.1365-2265.2010.03840.x","article-title":"Thyroid axis dysfunction in patients with Prader-Willi syndrome during the first 2 years of life","volume":"73","author":"Vaiani","year":"2010","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(21)00002-4_bib123","doi-asserted-by":"crossref","first-page":"449","DOI":"10.1111\/j.1365-2265.2007.02910.x","article-title":"Thyroid hormone levels in children with Prader-Willi syndrome before and during growth hormone treatment","volume":"67","author":"Festen","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(21)00002-4_bib124","doi-asserted-by":"crossref","first-page":"1649","DOI":"10.1210\/jc.2007-2294","article-title":"High prevalence of central adrenal insufficiency in patients with Prader-Willi syndrome","volume":"93","author":"de Lind van Wijngaarden","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib125","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa168","article-title":"Central adrenal insufficiency is rare in adults with Prader-Willi syndrome","volume":"105","author":"Rosenberg","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib126","doi-asserted-by":"crossref","first-page":"1127","DOI":"10.1002\/ajmg.a.36405","article-title":"Hypoglycemia in Prader-Willi syndrome","volume":"164A","author":"Harrington","year":"2014","journal-title":"Am J Med Genet A"},{"key":"10.1016\/S2213-8587(21)00002-4_bib127","doi-asserted-by":"crossref","first-page":"E225","DOI":"10.1210\/jc.2010-1733","article-title":"The metabolic phenotype of Prader-Willi syndrome (PWS) in childhood: heightened insulin sensitivity relative to body mass index","volume":"96","author":"Haqq","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib128","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1515\/JPEM.2006.19.7.911","article-title":"Characterization of alterations in carbohydrate metabolism in children with Prader-Willi syndrome","volume":"19","author":"Krochik","year":"2006","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib129","doi-asserted-by":"crossref","first-page":"E328","DOI":"10.1210\/jc.2012-2881","article-title":"Growth hormone therapy for children and adolescents with Prader-Willi syndrome is associated with improved body composition and metabolic status in adulthood","volume":"98","author":"Coupaye","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib130","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1007\/s11892-020-1284-5","article-title":"Update on diabetes mellitus and glucose metabolism alterations in Prader-Willi syndrome","volume":"20","author":"Crin\u00f2","year":"2020","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(21)00002-4_bib131","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1515\/jpem-2013-0116","article-title":"Effects of metformin in children and adolescents with Prader-Willi syndrome and early-onset morbid obesity: a pilot study","volume":"27","author":"Miller","year":"2014","journal-title":"J Pediatr Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00002-4_bib132","doi-asserted-by":"crossref","first-page":"598","DOI":"10.1177\/014107689809101116","article-title":"Metformin therapy for diabetes in Prader-Willi syndrome","volume":"91","author":"Chan","year":"1998","journal-title":"J R Soc Med"},{"key":"10.1016\/S2213-8587(21)00002-4_bib133","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1515\/jpem-2019-0389","article-title":"Improvement in glycaemic parameters using SGLT-2 inhibitor and GLP-1 agonist in combination in an adolescent with diabetes mellitus and Prader-Willi syndrome: a case report","volume":"33","author":"Candler","year":"2020","journal-title":"J Pediatr Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000024?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000024?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:34Z","timestamp":1761991774000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000024"}},"issued":{"date-parts":[[2021,4]]},"references-count":133,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S2213858721000024"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00002-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Endocrine disorders in Prader-Willi syndrome: a model to understand and treat hypothalamic dysfunction","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00002-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:51:09Z","timestamp":1794297069314,"version":"4.9.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/s2213-8587(24)00273-0","type":"journal-article","created":{"date-parts":[[2024,11,13]],"date-time":"2024-11-13T18:34:43Z","timestamp":1731522883000},"page":"29-37","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":59,"title":["Setmelanotide in patients aged 2\u20135 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial"],"prefix":"10.1016","volume":"13","author":[{"given":"Jes\u00fas","family":"Argente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles F","family":"Verge","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uzoma","family":"Okorie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilene","family":"Fennoy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan M","family":"Kelsey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Casey","family":"Cokkinias","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Scimia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hak-Myung","family":"Lee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I Sadaf","family":"Farooqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00273-0_bib1","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1089\/chi.2021.0003","article-title":"Complexity and stigma of pediatric obesity","volume":"17","author":"Haqq","year":"2021","journal-title":"Child Obes"},{"key":"10.1016\/S2213-8587(24)00273-0_bib2","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1111\/joim.13547","article-title":"Pediatric obesity-long-term consequences and effect of weight loss","volume":"292","author":"Marcus","year":"2022","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(24)00273-0_bib3","doi-asserted-by":"crossref","first-page":"101187","DOI":"10.1016\/j.xcrm.2023.101187","article-title":"High morbidity and mortality in children with untreated congenital deficiency of leptin or its receptor","volume":"4","author":"Saeed","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/S2213-8587(24)00273-0_bib4","doi-asserted-by":"crossref","first-page":"1149","DOI":"10.1038\/sj.ijo.0803056","article-title":"New advances in the genetics of early onset obesity","volume":"29","author":"Farooqi","year":"2005","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(24)00273-0_bib5","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2016-2573","article-title":"Pediatric obesity-assessment, treatment, and prevention: an Endocrine Society clinical practice guideline","volume":"102","author":"Styne","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00273-0_bib6","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1038\/ncpendmet0966","article-title":"Mutations in ligands and receptors of the leptin-melanocortin pathway that lead to obesity","volume":"4","author":"Farooqi","year":"2008","journal-title":"Nat Clin Pract Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00273-0_bib7","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000445061","article-title":"Rare genetic forms of obesity: clinical approach and current treatments in 2016","volume":"9","author":"Huvenne","year":"2016","journal-title":"Obes Facts"},{"key":"10.1016\/S2213-8587(24)00273-0_bib8","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/JOE-18-0596","article-title":"The melanocortin pathway and control of appetite-progress and therapeutic implications","volume":"241","author":"Baldini","year":"2019","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00273-0_bib9","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/j.cell.2015.03.008","article-title":"The hunger genes: pathways to obesity","volume":"161","author":"van der Klaauw","year":"2015","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(24)00273-0_bib10","doi-asserted-by":"crossref","first-page":"1549","DOI":"10.1016\/j.jdiacomp.2017.04.026","article-title":"Genetics of non-syndromic childhood obesity and the use of high-throughput DNA sequencing technologies","volume":"31","author":"da Fonseca","year":"2017","journal-title":"J Diabetes Complications"},{"key":"10.1016\/S2213-8587(24)00273-0_bib11","doi-asserted-by":"crossref","first-page":"1323","DOI":"10.1093\/hmg\/ddp031","article-title":"Requirement of Bardet-Biedl syndrome proteins for leptin receptor signaling","volume":"18","author":"Seo","year":"2009","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(24)00273-0_bib12","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1136\/jmg.36.6.437","article-title":"New criteria for improved diagnosis of Bardet-Biedl syndrome: results of a population survey","volume":"36","author":"Beales","year":"1999","journal-title":"J Med Genet"},{"key":"10.1016\/S2213-8587(24)00273-0_bib13","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1038\/ejhg.2012.115","article-title":"Bardet-Biedl syndrome","volume":"21","author":"Forsythe","year":"2013","journal-title":"Eur J Hum Genet"},{"key":"10.1016\/S2213-8587(24)00273-0_bib14","doi-asserted-by":"crossref","first-page":"182","DOI":"10.1186\/s13023-023-02723-4","article-title":"Burden of hyperphagia and obesity in Bardet-Biedl syndrome: a multicountry survey","volume":"18","author":"Forsythe","year":"2023","journal-title":"Orphanet J Rare Dis"},{"key":"10.1016\/S2213-8587(24)00273-0_bib15","doi-asserted-by":"crossref","first-page":"bvac057","DOI":"10.1210\/jendso\/bvac057","article-title":"Natural history of obesity due to POMC, PCSK1, and LEPR deficiency and the impact of setmelanotide","volume":"6","author":"Wabitsch","year":"2022","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(24)00273-0_bib16","doi-asserted-by":"crossref","first-page":"1772","DOI":"10.1007\/s12325-022-02059-8","article-title":"Understanding the patient experience of hunger and improved quality of life with setmelanotide treatment in POMC and LEPR deficiencies","volume":"39","author":"Wabitsch","year":"2022","journal-title":"Adv Ther"},{"key":"10.1016\/S2213-8587(24)00273-0_bib17","doi-asserted-by":"crossref","first-page":"e12703","DOI":"10.1111\/ijpo.12703","article-title":"Bardet-Biedl syndrome: weight patterns and genetics in a rare obesity syndrome","volume":"16","author":"Pomeroy","year":"2021","journal-title":"Pediatr Obes"},{"key":"10.1016\/S2213-8587(24)00273-0_bib18","doi-asserted-by":"crossref","first-page":"1602","DOI":"10.1038\/s41366-018-0049-6","article-title":"Early childhood BMI trajectories in monogenic obesity due to leptin, leptin receptor, and melanocortin 4 receptor deficiency","volume":"42","author":"Kohlsdorf","year":"2018","journal-title":"Int J Obes (Lond)"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(24)00273-0_bib19","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1111\/dom.15555","article-title":"The melanocortin-4 receptor pathway and the emergence of precision medicine in obesity management","volume":"26","author":"Fansa","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00273-0_bib20","doi-asserted-by":"crossref","first-page":"113134","DOI":"10.1016\/j.physbeh.2020.113134","article-title":"Rare genetic forms of obesity: from gene to therapy","volume":"227","author":"Cl\u00e9ment","year":"2020","journal-title":"Physiol Behav"},{"key":"10.1016\/S2213-8587(24)00273-0_bib21","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/jc.2018-00258","article-title":"Melanocortin 4 receptor pathway dysfunction in obesity: patient stratification aimed at MC4R agonist treatment","volume":"103","author":"Ayers","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00273-0_bib22","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Cl\u00e9ment","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00273-0_bib23","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-8587(22)00277-7","article-title":"Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstr\u00f6m syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period","volume":"10","author":"Haqq","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00273-0_bib24","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1038\/gim.2015.30","article-title":"Standards and guidelines for the interpretation of sequence variants: a joint consensus recommendation of the American College of Medical Genetics and Genomics and the Association for Molecular Pathology","volume":"17","author":"Richards","year":"2015","journal-title":"Genet Med"},{"key":"10.1016\/S2213-8587(24)00273-0_bib25","doi-asserted-by":"crossref","first-page":"2417","DOI":"10.1001\/jama.2017.6803","article-title":"Screening for obesity in children and adolescents: US Preventive Services Task Force recommendation statement","volume":"317","author":"Grossman","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00273-0_bib26","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1080\/13607860500312142","article-title":"Assessing family caregiver's mental health using a statistically derived cut-off score for the Zarit Burden Interview","volume":"10","author":"Schreiner","year":"2006","journal-title":"Aging Ment Health"},{"key":"10.1016\/S2213-8587(24)00273-0_bib27","doi-asserted-by":"crossref","first-page":"e0248739","DOI":"10.1371\/journal.pone.0248739","article-title":"Characteristics and relationship between hyperphagia, anxiety, behavioral challenges and caregiver burden in Prader-Willi syndrome","volume":"16","author":"Kayadjanian","year":"2021","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(24)00273-0_bib28","first-page":"119","article-title":"Approximate is better than \u201cexact\u201d for interval estimation of binomial proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"Am Stat"},{"key":"10.1016\/S2213-8587(24)00273-0_bib29","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1016\/S2213-8587(24)00087-1","article-title":"Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial","volume":"12","author":"Roth","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00273-0_bib30","doi-asserted-by":"crossref","first-page":"2394","DOI":"10.1007\/s12325-023-02443-y","article-title":"Interview-based patient- and caregiver-reported experiences of hunger and improved quality of life with setmelanotide treatment in Bardet-Biedl syndrome","volume":"40","author":"Ervin","year":"2023","journal-title":"Adv Ther"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:51:30Z","timestamp":1739821890000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002730"}},"issued":{"date-parts":[[2025,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2213858724002730"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00273-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Setmelanotide in patients aged 2\u20135 years with rare MC4R pathway-associated obesity (VENTURE): a 1 year, open-label, multicenter, phase 3 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00273-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00312-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T01:53:37Z","timestamp":1794621217142,"version":"4.9.1"},"reference-count":25,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2020,6,25]],"date-time":"2020-06-25T00:00:00Z","timestamp":1593043200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011102","name":"Seventh Framework Programme","doi-asserted-by":"publisher","award":["259735"],"award-info":[{"award-number":["259735"]}],"id":[{"id":"10.13039\/100011102","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000855","name":"University of Birmingham","doi-asserted-by":"publisher","award":["BRC-1215-20009"],"award-info":[{"award-number":["BRC-1215-20009"]}],"id":[{"id":"10.13039\/501100000855","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013963","name":"University Hospitals Birmingham NHS Foundation Trust","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["K23DK121888"],"award-info":[{"award-number":["K23DK121888"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004963","name":"Seventh Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004963","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","award":["G0801473"],"award-info":[{"award-number":["G0801473"]}],"id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100018952","name":"Birmingham Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100018952","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000276","name":"Department of Health and Social Care","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000276","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["WT101671"],"award-info":[{"award-number":["WT101671"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007048","name":"Mayo Foundation for Medical Education and Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007048","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/s2213-8587(20)30218-7","type":"journal-article","created":{"date-parts":[[2020,7,23]],"date-time":"2020-07-23T18:35:14Z","timestamp":1595529314000},"page":"773-781","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":242,"title":["Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study"],"prefix":"10.1016","volume":"8","author":[{"given":"Irina","family":"Bancos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela E","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Chortis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice J","family":"Sitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Jenkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J","family":"Davidge-Pitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Tsagarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Macech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Riester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Deutschbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana D","family":"Pupovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Kienitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G","family":"Papathomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna C","family":"Gilligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Bancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Reimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Haissaguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljiljana","family":"Marina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne A","family":"Grytaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Sajwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Langton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E","family":"Ivison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric H L","family":"Shackleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Asia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiria","family":"Palimeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Kondracka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadni","family":"Spyroglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina L","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojana","family":"Simunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danae A","family":"Delivanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Tsirou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Bednarczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Burger-Stritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Feelders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Canu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm R","family":"Haak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Eisenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Conall","family":"Dennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grethe A","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miomira","family":"Ivovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Terzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Quinkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darko","family":"Kastelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Ambroziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra A","family":"Vassiliadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William F","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Biehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephan","family":"Gl\u00f6ckner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard O.","family":"Sinnott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony","family":"Stell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria C.","family":"Fragoso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darko","family":"Kastelan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ivana D.","family":"Pupovac","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bojana","family":"Simunov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah","family":"Cazenave","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magalie","family":"Haissaguerre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00e9r\u00f4me","family":"Bertherat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Lib\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tina","family":"Kienitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Quinkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Langton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Graeme","family":"Eisenhofer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Felix","family":"Beuschlein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina","family":"Brugger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Riester","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ariadni","family":"Spyroglou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Burger-Stritt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Timo","family":"Deutschbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Fassnacht","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthias","family":"Kroiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristina L.","family":"Ronchi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sotiria","family":"Palimeri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stylianos","family":"Tsagarakis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ioanna","family":"Tsirou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dimitra A.","family":"Vassiliadi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vittoria","family":"Basile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisa","family":"Ingargiola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Reimondo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Terzolo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Canu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Massimo","family":"Mannelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hester","family":"Ettaieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harm R.","family":"Haak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas M.","family":"Kerkhofs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Biehl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A.","family":"Feelders","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johannes","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leo J.","family":"Hofland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marianne A.","family":"Grytaas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eystein S.","family":"Husebye","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Grethe A.","family":"Ueland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Urszula","family":"Ambroziak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomasz","family":"Bednarczuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agnieszka","family":"Kondracka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Magdalena","family":"Macech","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Malgorzata","family":"Zawierucha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Isabel","family":"Paiva","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Conall","family":"Dennedy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ahmed","family":"Sajwani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark","family":"Sherlock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rachel K.","family":"Crowley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miomira","family":"Ivovic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ljiljana","family":"Marina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan J.","family":"Deeks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice J.","family":"Sitch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wiebke","family":"Arlt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irina","family":"Bancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vasileios","family":"Chortis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lorna C.","family":"Giligan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverly A.","family":"Hughes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katharina","family":"Lang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hannah E.","family":"Ivison","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carl","family":"Jenkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Konstantinos","family":"Manolopoulos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donna M.","family":"O'Neil","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael W.","family":"O'Reilly","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas G.","family":"Papathomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alessandro","family":"Prete","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cedric H.L.","family":"Shackleton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Angela E.","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Miriam","family":"Asia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert P.","family":"Sutcliffe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Guest","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kassiani","family":"Skordilis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cristian","family":"Bancos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alice","family":"Chang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline J.","family":"Davidge-Pitts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Danae A.","family":"Delivanis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dana","family":"Erickson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neena","family":"Natt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Todd B.","family":"Nippoldt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melinda","family":"Thomas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William F.","family":"Young Jr.","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30218-7_bib1","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.2214\/AJR.07.2799","article-title":"The incidental adrenal mass on CT: prevalence of adrenal disease in 1,049 consecutive adrenal masses in patients with no known malignancy","volume":"190","author":"Song","year":"2008","journal-title":"AJR Am J Roentgenol"},{"key":"10.1016\/S2213-8587(20)30218-7_bib2","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1007\/BF03344099","article-title":"Prevalence of adrenal incidentaloma in a contemporary computerized tomography series","volume":"29","author":"Bovio","year":"2006","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(20)30218-7_bib3","doi-asserted-by":"crossref","first-page":"851","DOI":"10.1530\/EJE-10-1147","article-title":"AME position statement on adrenal incidentaloma","volume":"164","author":"Terzolo","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30218-7_bib5","doi-asserted-by":"crossref","first-page":"4106","DOI":"10.1210\/jc.2010-0457","article-title":"Approach to the patient with an adrenal incidentaloma","volume":"95","author":"Nieman","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30218-7_bib6","doi-asserted-by":"crossref","first-page":"601","DOI":"10.1056\/NEJMcp065470","article-title":"The incidentally discovered adrenal mass","volume":"356","author":"Young","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30218-7_bib7","doi-asserted-by":"crossref","first-page":"1526","DOI":"10.1210\/jc.2008-0125","article-title":"The diagnosis of Cushing's syndrome: an Endocrine Society clinical practice guideline","volume":"93","author":"Nieman","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30218-7_bib8","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an Endocrine Society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30218-7_bib9","doi-asserted-by":"crossref","first-page":"1915","DOI":"10.1210\/jc.2014-1498","article-title":"Pheochromocytoma and paraganglioma: an Endocrine Society clinical practice guideline","volume":"99","author":"Lenders","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30218-7_bib10","first-page":"637","article-title":"A survey on adrenal incidentaloma in Italy","volume":"85","author":"Mantero","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30218-7_bib11","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.mayocpiqo.2017.11.002","article-title":"Clinical, biochemical, and radiological characteristics of a single-center retrospective cohort of 705 large adrenal tumors","volume":"2","author":"Iniguez-Ariza","year":"2018","journal-title":"Mayo Clin Proc Innov Qual Outcomes"},{"key":"10.1016\/S2213-8587(20)30218-7_bib12","first-page":"460","article-title":"Incidentally discovered adrenal masses","volume":"16","author":"Kloos","year":"1995","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(20)30218-7_bib13","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1210\/er.2013-1029","article-title":"Adrenocortical carcinoma","volume":"35","author":"Else","year":"2014","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(20)30218-7_bib14","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-18-0608","article-title":"European Society of Endocrinology clinical practice guidelines on the management of adrenocortical carcinoma in adults, in collaboration with the European Network for the Study of Adrenal Tumors","volume":"179","author":"Fassnacht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30218-7_bib15","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/EJE-16-0461","article-title":"Imaging for the diagnosis of malignancy in incidentally discovered adrenal masses: a systematic review and meta-analysis","volume":"175","author":"Dinnes","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30218-7_bib16","doi-asserted-by":"crossref","first-page":"G1","DOI":"10.1530\/EJE-16-0467","article-title":"Management of adrenal incidentalomas: European Society of Endocrinology clinical practice guideline in collaboration with the European Network for the Study of Adrenal Tumors","volume":"175","author":"Fassnacht","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30218-7_bib17","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1210\/jc.2004-1627","article-title":"Clinical utility of noncontrast computed tomography attenuation value (Hounsfield units) to differentiate adrenal adenomas\/hyperplasias from nonadenomas: Cleveland Clinic experience","volume":"90","author":"Hamrahian","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30218-7_bib18","doi-asserted-by":"crossref","first-page":"3775","DOI":"10.1210\/jc.2011-1565","article-title":"Urine steroid metabolomics as a biomarker tool for detecting malignancy in adrenal tumors","volume":"96","author":"Arlt","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30218-7_bib19","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1097\/MED.0000000000000333","article-title":"Diagnosis of a malignant adrenal mass: the role of urinary steroid metabolite profiling","volume":"24","author":"Bancos","year":"2017","journal-title":"Curr Opin Endocrinol Diabetes Obes"},{"key":"10.1016\/S2213-8587(20)30218-7_bib20","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1007\/s12672-015-0224-3","article-title":"Diagnostic value of urinary steroid profiling in the evaluation of adrenal tumors","volume":"6","author":"Kerkhofs","year":"2015","journal-title":"Horm Cancer"},{"key":"10.1016\/S2213-8587(20)30218-7_bib21","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1007\/s12672-016-0267-0","article-title":"Different types of urinary steroid profiling obtained by high-performance liquid chromatography and gas chromatography-mass spectrometry in patients with adrenocortical carcinoma","volume":"7","author":"Velikanova","year":"2016","journal-title":"Horm Cancer"},{"key":"10.1016\/S2213-8587(20)30218-7_bib22","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1210\/er.2002-0031","article-title":"The clinically inapparent adrenal mass: update in diagnosis and management","volume":"25","author":"Mansmann","year":"2004","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(20)30218-7_bib23","doi-asserted-by":"crossref","first-page":"1824","DOI":"10.1373\/clinchem.2017.271106","article-title":"High-resolution, accurate-mass (HRAM) mass spectrometry urine steroid profiling in the diagnosis of adrenal disorders","volume":"63","author":"Hines","year":"2017","journal-title":"Clin Chem"},{"key":"10.1016\/S2213-8587(20)30218-7_bib24","doi-asserted-by":"crossref","first-page":"R65","DOI":"10.1530\/EJE-16-0297","article-title":"The diagnostic performance of adrenal biopsy: a systematic review and meta-analysis","volume":"175","author":"Bancos","year":"2016","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30218-7_bib25","volume":"vol 10","year":"2017"},{"key":"10.1016\/S2213-8587(20)30218-7_bib26","series-title":"Carcinoma of the adrenal cortex histopathology reporting guide","author":"Giordano","year":"2019"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302187?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302187?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:21Z","timestamp":1761991701000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720302187"}},"issued":{"date-parts":[[2020,9]]},"references-count":25,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2213858720302187"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30218-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Urine steroid metabolomics for the differential diagnosis of adrenal incidentalomas in the EURINE-ACT study: a prospective test validation study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30218-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30224-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:17:03Z","timestamp":1794640623297,"version":"4.9.1"},"reference-count":264,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81930124"],"award-info":[{"award-number":["81930124"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003397","name":"Huazhong University of Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003397","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004912","name":"Sichuan University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004912","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012166","name":"National Key Research and Development Program of China","doi-asserted-by":"publisher","award":["2017YFC0907504"],"award-info":[{"award-number":["2017YFC0907504"]}],"id":[{"id":"10.13039\/501100012166","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/s2213-8587(21)00045-0","type":"journal-article","created":{"date-parts":[[2021,5,19]],"date-time":"2021-05-19T18:32:36Z","timestamp":1621449156000},"page":"373-392","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1461,"title":["Epidemiology and determinants of obesity in China"],"prefix":"10.1016","volume":"9","author":[{"given":"Xiong-Fei","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Limin","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00045-0_bib3","doi-asserted-by":"crossref","first-page":"1291","DOI":"10.1002\/hec.3217","article-title":"The medical cost attributable to obesity and overweight in China: estimation based on longitudinal surveys","volume":"25","author":"Qin","year":"2016","journal-title":"Health Econ"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00045-0_bib4","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1111\/obr.12120","article-title":"Synthesis and implications: China's nutrition transition in the context of changes across other low- and middle-income countries","volume":"15","author":"Popkin","year":"2014","journal-title":"Obes Rev"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00045-0_bib5","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1111\/obr.12122","article-title":"China in the period of transition from scarcity and extensive undernutrition to emerging nutrition-related non-communicable diseases, 1949\u20131992","volume":"15","author":"Du","year":"2014","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib6","doi-asserted-by":"crossref","first-page":"m997","DOI":"10.1136\/bmj.m997","article-title":"Prevalence of diabetes recorded in mainland China using 2018 diagnostic criteria from the American Diabetes Association: national cross sectional study","volume":"369","author":"Li","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00045-0_bib7","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1001\/jamacardio.2019.0295","article-title":"Burden of cardiovascular diseases in China, 1990\u20132016: findings from the 2016 Global Burden of Disease study","volume":"4","author":"Liu","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib8","first-page":"115","article-title":"Cancer statistics in China, 2015","volume":"66","author":"Chen","year":"2016","journal-title":"CA Cancer J Clin"},{"key":"10.1016\/S2213-8587(21)00045-0_bib9","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S2213-8587(21)00047-4","article-title":"Clinical management and treatment of obesity in China","volume":"9","author":"Zeng","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00118-2","article-title":"Health policy and public health implications of obesity in China","author":"Wang","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib11","series-title":"Obesity: preventing and managing the global epidemic","year":"2000"},{"key":"10.1016\/S2213-8587(21)00045-0_bib12","doi-asserted-by":"crossref","first-page":"1164","DOI":"10.1038\/sj.ijo.0800741","article-title":"Body mass index and percent body fat: a meta analysis among different ethnic groups","volume":"22","author":"Deurenberg","year":"1998","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(21)00045-0_bib13","article-title":"Ethnic differences in body composition and obesity related risk factors: study in Chinese and white males living in China","volume":"6","author":"Wang","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00045-0_bib14","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1038\/sj.ijo.0803220","article-title":"Validity of body mass index and waist circumference in the classification of obesity as compared to percent body fat in Chinese middle-aged women","volume":"30","author":"Chen","year":"2006","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib15","doi-asserted-by":"crossref","first-page":"66","DOI":"10.47102\/annals-acadmedsg.V38N1p66","article-title":"Rationale for redefining obesity in Asians","volume":"38","author":"Low","year":"2009","journal-title":"Ann Acad Med Singap"},{"key":"10.1016\/S2213-8587(21)00045-0_bib16","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1002\/oby.20995","article-title":"Lower BMI cutoffs to define overweight and obesity in China","volume":"23","author":"He","year":"2015","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib17","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0140-6736(03)15268-3","article-title":"Appropriate body-mass index for Asian populations and its implications for policy and intervention strategies","volume":"363","year":"2004","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib18","first-page":"83","article-title":"Predictive values of body mass index and waist circumference for risk factors of certain related diseases in Chinese adults\u2014study on optimal cut-off points of body mass index and waist circumference in Chinese adults","volume":"15","author":"Zhou","year":"2002","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/S2213-8587(21)00045-0_bib19","first-page":"1533","article-title":"The cut-off points of body mass index and waist circumference for predicting metabolic risk factors in Chinese adults","volume":"40","author":"Gao","year":"2019","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib20","first-page":"1541","article-title":"Association of body mass index and waist circumference with major chronic diseases in Chinese adults","volume":"40","author":"Li","year":"2019","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib21","series-title":"WHO child growth standards: length\/height-for-age, weight-for-age, weight-for-length, weight-for-height and body mass index-for-age: methods and development","year":"2006"},{"key":"10.1016\/S2213-8587(21)00045-0_bib22","doi-asserted-by":"crossref","first-page":"660","DOI":"10.2471\/BLT.07.043497","article-title":"Development of a WHO growth reference for school-aged children and adolescents","volume":"85","author":"de Onis","year":"2007","journal-title":"Bull World Health Organ"},{"key":"10.1016\/S2213-8587(21)00045-0_bib23","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.320.7244.1240","article-title":"Establishing a standard definition for child overweight and obesity worldwide: international survey","volume":"320","author":"Cole","year":"2000","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00045-0_bib24","first-page":"97","article-title":"Body mass index reference norm for screening overweight and obesity in Chinese children and adolescents","volume":"25","year":"2004","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib25","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1016\/S0140-6736(05)67402-8","article-title":"The metabolic syndrome\u2014a new worldwide definition","volume":"366","author":"Alberti","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib26","first-page":"447","article-title":"Guidelines for the prevention and treatment of type 2 diabetes in China (2013 edition)","volume":"6","year":"2014","journal-title":"Zhonghua Tang Niao Bing Za Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib27","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1016\/S2213-8587(19)30084-1","article-title":"Visceral and ectopic fat, atherosclerosis, and cardiometabolic disease: a position statement","volume":"7","author":"Neeland","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib28","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1161\/CIRCULATIONAHA.114.015000","article-title":"Association between visceral and subcutaneous adipose depots and incident cardiovascular disease risk factors","volume":"132","author":"Abraham","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00045-0_bib29","doi-asserted-by":"crossref","first-page":"2150","DOI":"10.1016\/j.jacc.2015.01.061","article-title":"Body fat distribution and incident cardiovascular disease in obese adults","volume":"65","author":"Neeland","year":"2015","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib30","doi-asserted-by":"crossref","first-page":"921","DOI":"10.1016\/j.jacc.2013.06.027","article-title":"Body fat distribution, incident cardiovascular disease, cancer, and all-cause mortality","volume":"62","author":"Britton","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib31","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1016\/j.jacc.2014.05.057","article-title":"The relationship of body mass and fat distribution with incident hypertension: observations from the Dallas Heart Study","volume":"64","author":"Chandra","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(21)00045-0_bib32","doi-asserted-by":"crossref","first-page":"S957","DOI":"10.1016\/j.dsx.2017.07.022","article-title":"Longitudinal changes in visceral and subcutaneous adipose tissue and metabolic syndrome: results from the Multicultural Community Health Assessment Trial (M-CHAT)","volume":"11","author":"Tu","year":"2017","journal-title":"Diabetes Metab Syndr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib33","doi-asserted-by":"crossref","first-page":"465","DOI":"10.2337\/diacare.23.4.465","article-title":"Visceral adiposity and risk of type 2 diabetes: a prospective study among Japanese Americans","volume":"23","author":"Boyko","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00045-0_bib34","doi-asserted-by":"crossref","first-page":"113","DOI":"10.2174\/1871529X11202020113","article-title":"A review of obesity and body fat distribution and its relationship to cardio-metabolic risk in men and women of Chinese origin","volume":"12","author":"Lear","year":"2012","journal-title":"Cardiovasc Hematol Disord Drug Targets"},{"key":"10.1016\/S2213-8587(21)00045-0_bib35","doi-asserted-by":"crossref","first-page":"738","DOI":"10.1136\/adc.2007.127589","article-title":"Adiposity measures and blood pressure in Chinese children and adolescents","volume":"93","author":"Wang","year":"2008","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(21)00045-0_bib36","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000824","article-title":"Abdominal visceral and subcutaneous adipose tissues in association with cardiometabolic risk in children and adolescents: the China Child and Adolescent Cardiovascular Health (CCACH) study","volume":"7","author":"Yan","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(21)00045-0_bib37","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/ijo.2011.222","article-title":"Contribution of visceral fat accumulation to carotid intima-media thickness in a Chinese population","volume":"36","author":"Wang","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib38","article-title":"Greater abdominal fat accumulation is associated with higher metabolic risk in Chinese than in white people: an ethnicity study","volume":"8","author":"He","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00045-0_bib39","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/s12933-018-0734-8","article-title":"Abdominal subcutaneous adipose tissue: a favorable adipose depot for diabetes?","volume":"17","author":"Chen","year":"2018","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib40","doi-asserted-by":"crossref","first-page":"1499","DOI":"10.2147\/TCRM.S168345","article-title":"Epicardial adipose tissue volume is associated with non-alcoholic fatty liver disease and cardiovascular risk factors in the general population","volume":"14","author":"Meng","year":"2018","journal-title":"Ther Clin Risk Manag"},{"key":"10.1016\/S2213-8587(21)00045-0_bib41","doi-asserted-by":"crossref","first-page":"1061","DOI":"10.1007\/s00592-019-01348-z","article-title":"Contribution of epicardial and abdominopelvic visceral adipose tissues in Chinese adults with impaired glucose regulation and diabetes","volume":"56","author":"Wang","year":"2019","journal-title":"Acta Diabetol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity","volume":"16","author":"Ross","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib43","doi-asserted-by":"crossref","first-page":"378","DOI":"10.1016\/j.atherosclerosis.2008.03.001","article-title":"Optimal waist circumference cutoffs for abdominal obesity in Chinese","volume":"201","author":"Bao","year":"2008","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(21)00045-0_bib44","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1093\/ije\/dyy289","article-title":"Data resource profile: China National Nutrition Surveys","volume":"48","author":"He","year":"2019","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib45","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41366-018-0129-7","article-title":"National trends in stunting, thinness and overweight among Chinese school-aged children, 1985\u20132014","volume":"43","author":"Song","year":"2019","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib46","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/S2352-4642(19)30302-5","article-title":"Trends in physical fitness, growth, and nutritional status of Chinese children and adolescents: a retrospective analysis of 1.5 million students from six successive national surveys between 1985 and 2014","volume":"3","author":"Dong","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib47","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/1478-7954-3-3","article-title":"Mortality registration and surveillance in China: history, current situation and challenges","volume":"3","author":"Yang","year":"2005","journal-title":"Popul Health Metr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib48","first-page":"239","article-title":"Adjustment and representativeness evaluation of national disease surveillance points system","volume":"25","author":"Zhou","year":"2010","journal-title":"Ji Bing Jian Ce"},{"key":"10.1016\/S2213-8587(21)00045-0_bib49","series-title":"Study on prevalence, secular trends and health risk of overweight and obesity among Chinese adults","author":"Jiang","year":"2013"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00045-0_bib50","doi-asserted-by":"crossref","first-page":"S77","DOI":"10.1016\/S0140-6736(15)00658-3","article-title":"Prevalence and trends in overweight and obesity among Chinese adults in 2004\u201310: data from three nationwide surveys in China","volume":"386","author":"Jiang","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib51","doi-asserted-by":"crossref","first-page":"291","DOI":"10.7326\/M19-0477","article-title":"Geographic variation in prevalence of adult obesity in China: results from the 2013\u20132014 national chronic disease and risk factor surveillance","volume":"172","author":"Zhang","year":"2019","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib52","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S2213-8587(16)00081-4","article-title":"BMI, leisure-time physical activity, and physical fitness in adults in China: results from a series of national surveys, 2000\u201314","volume":"4","author":"Tian","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00045-0_bib53","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1111\/obr.12119","article-title":"The China Health and Nutrition Survey, 1989\u20132011","volume":"15","author":"Zhang","year":"2014","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib54","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1186\/s12889-018-5483-9","article-title":"Prevalence and stabilizing trends in overweight and obesity among children and adolescents in China, 2011\u20132015","volume":"18","author":"Zhang","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib55","first-page":"311","article-title":"The prevalence of body overweight and obesity and its changes among Chinese people during 1992 to 2002","volume":"39","author":"Ma","year":"2005","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib56","series-title":"China blue paper on obesity prevention and control","author":"Wang","year":"2019"},{"key":"10.1016\/S2213-8587(21)00045-0_bib57","series-title":"Chinese National Nutrition and Health Survey (2002): comprehensive summary","author":"Wang","year":"2005"},{"key":"10.1016\/S2213-8587(21)00045-0_bib58","first-page":"315","article-title":"Changes in waist circumference and abdominal obesity among Chinese adults over a ten-year period","volume":"30","author":"Zhai","year":"2017","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/S2213-8587(21)00045-0_bib59","series-title":"Chinese national nutrition and health survey (2010\u20132013): comprehensive summary","author":"Chang","year":"2016"},{"key":"10.1016\/S2213-8587(21)00045-0_bib60","first-page":"710","article-title":"Prevalence and characteristics of overweight and obesity in Chinese children aged 0\u20135 years","volume":"39","author":"Yu","year":"2018","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib61","first-page":"776","article-title":"The trend analysis of overweight and obesity in Chinese students during 1985\u20132010","volume":"46","author":"Ma","year":"2012","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.ijcard.2008.07.003","article-title":"Epidemic increase in overweight and obesity in Chinese children from 1985 to 2005","volume":"132","author":"Ji","year":"2009","journal-title":"Int J Cardiol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib63","first-page":"300","article-title":"Trends in overweight and obesity among Chinese children of 7\u201318 years old during 1985\u20132014","volume":"51","author":"Wang","year":"2017","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib64","first-page":"529","article-title":"Changes of BMI distribution in Chinese adults from 1989 to 2011","volume":"36","author":"Ouyang","year":"2014","journal-title":"Acta Nutrimenta Sinica"},{"key":"10.1016\/S2213-8587(21)00045-0_bib65","first-page":"133","article-title":"Analysis on the trend of overweight and obesity of children and adolescents in 9 provinces of China from 1991 to 2015","volume":"54","author":"Ma","year":"2020","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib66","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1016\/j.amepre.2015.05.005","article-title":"Prevalence and secular trends in obesity among Chinese adults, 1991\u20132011","volume":"49","author":"Mi","year":"2015","journal-title":"Am J Prev Med"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00045-0_bib67","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1111\/obr.12121","article-title":"Overweight dynamics in Chinese children and adults","volume":"15","author":"Gordon-Larsen","year":"2014","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib68","first-page":"212","article-title":"Trends of the changes in waist circumference distribution of Chinese adults in nine provinces: from 1993 to 2011","volume":"36","author":"Yang","year":"2014","journal-title":"Acta Nutrimenta Sinica"},{"key":"10.1016\/S2213-8587(21)00045-0_bib69","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1161\/HYPERTENSIONAHA.118.11291","article-title":"Secular trends in blood pressure and overweight and obesity in Chinese boys and girls aged 7 to 17 years from 1995 to 2014","volume":"72","author":"Dong","year":"2018","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(21)00045-0_bib70","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1093\/ije\/30.3.427","article-title":"Sick individuals and sick populations","volume":"30","author":"Rose","year":"2001","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib71","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib72","first-page":"683","article-title":"Prevalence and characteristic of overweight and obesity among adults in China, 2010","volume":"46","author":"Li","year":"2012","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib73","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1007\/s12603-020-1332-5","article-title":"Sarcopenia, obesity and sarcopenia obesity in comparison: prevalence, metabolic profile, and key differences: results from WCHAT study","volume":"24","author":"Liu","year":"2020","journal-title":"J Nutr Health Aging"},{"key":"10.1016\/S2213-8587(21)00045-0_bib74","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-025559","article-title":"Geographical variation and urban-rural disparity of overweight and obesity in Chinese school-aged children between 2010 and 2014: two successive national cross-sectional surveys","volume":"9","author":"Dong","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(21)00045-0_bib75","doi-asserted-by":"crossref","first-page":"260","DOI":"10.1038\/s41586-019-1171-x","article-title":"Rising rural body-mass index is the main driver of the global obesity epidemic in adults","volume":"569","year":"2019","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(21)00045-0_bib76","doi-asserted-by":"crossref","first-page":"e160","DOI":"10.5888\/pcd16.190290","article-title":"Spatial and temporal changes in prevalence of obesity among Chinese children and adolescents, 1985\u20132005","volume":"16","author":"Jia","year":"2019","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/S2213-8587(21)00045-0_bib77","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.healthplace.2017.02.012","article-title":"Lifting the lid on geographic complexity in the relationship between body mass index and education in China","volume":"46","author":"Zhou","year":"2017","journal-title":"Health Place"},{"key":"10.1016\/S2213-8587(21)00045-0_bib78","article-title":"Prevalence of overweight and obesity in 15.8 million men aged 15\u201349 years in rural China from 2010 to 2014","volume":"7","author":"He","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(21)00045-0_bib79","doi-asserted-by":"crossref","DOI":"10.1038\/srep37491","article-title":"Prevalence of overweight and malnutrition among ethnic minority children and adolescents in China, 1991\u20132010","volume":"6","author":"Guo","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(21)00045-0_bib80","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.1093\/ije\/30.5.1129","article-title":"Cross-national comparison of childhood obesity: the epidemic and the relationship between obesity and socioeconomic status","volume":"30","author":"Wang","year":"2001","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib81","doi-asserted-by":"crossref","first-page":"e14","DOI":"10.2105\/AJPH.2013.301669","article-title":"An increasing socioeconomic gap in childhood overweight and obesity in China","volume":"104","author":"He","year":"2014","journal-title":"Am J Public Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib82","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1016\/S2213-8587(19)30075-0","article-title":"Economic development and the nutritional status of Chinese school-aged children and adolescents from 1995 to 2014: an analysis of five successive national surveys","volume":"7","author":"Dong","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib83","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1186\/1471-2458-13-355","article-title":"Association between socioeconomic status and obesity in a Chinese adult population","volume":"13","author":"Xiao","year":"2013","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib84","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S2095-3119(19)62691-2","article-title":"Low-income and overweight in China: evidence from a life-course utility model","volume":"18","author":"Ren","year":"2019","journal-title":"J Integr Agric"},{"key":"10.1016\/S2213-8587(21)00045-0_bib85","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-034288","article-title":"Income-related inequities of adult obesity and central obesity in China: evidence from the China Health and Nutrition Survey 1997\u20132011","volume":"10","author":"Zhou","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(21)00045-0_bib86","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1038\/ijo.2011.134","article-title":"Emerging disparities in overweight by educational attainment in Chinese adults (1989\u20132006)","volume":"36","author":"Jones-Smith","year":"2012","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib87","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1177\/0268580919832734","article-title":"The shifting burden of obesity: changes in the distribution of obesity in China, 2010\u20132015","volume":"34","author":"Zhou","year":"2019","journal-title":"Int Sociol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib88","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1016\/j.ehb.2014.02.001","article-title":"The income body weight gradients in the developing economy of China","volume":"16","author":"Tafreschi","year":"2015","journal-title":"Econ Hum Biol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib89","doi-asserted-by":"crossref","first-page":"1503","DOI":"10.1038\/ijo.2014.74","article-title":"Changes in waist circumference relative to body mass index in Chinese adults, 1993\u20132009","volume":"38","author":"Stern","year":"2014","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib90","first-page":"506","article-title":"Epidemiological characteristics of waist circumference and abdominal obesity among Chinese adults in 2010\u20132012","volume":"51","author":"Zhai","year":"2017","journal-title":"Zhonghua Yu Fang Yi Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib91","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1161\/STROKEAHA.108.539692","article-title":"General and abdominal adiposity and risk of stroke in Chinese women","volume":"40","author":"Zhang","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(21)00045-0_bib92","doi-asserted-by":"crossref","first-page":"886","DOI":"10.1001\/archinte.167.9.886","article-title":"Abdominal adiposity and mortality in Chinese women","volume":"167","author":"Zhang","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib93","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0138429","article-title":"Prospective cohort study of central adiposity and risk of death in middle aged and elderly Chinese","volume":"10","author":"Warren Andersen","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00045-0_bib94","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S0140-6736(08)60269-X","article-title":"Body-mass index and incidence of cancer: a systematic review and meta-analysis of prospective observational studies","volume":"371","author":"Renehan","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib95","doi-asserted-by":"crossref","first-page":"e277","DOI":"10.1016\/S2468-2667(17)30074-9","article-title":"Overweight, obesity, and risk of cardiometabolic multimorbidity: pooled analysis of individual-level data for 120\u2008813 adults from 16 cohort studies from the USA and Europe","volume":"2","author":"Kivim\u00e4ki","year":"2017","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib96","doi-asserted-by":"crossref","DOI":"10.1161\/JAHA.117.007153","article-title":"Association of body fat mass and fat distribution with the incidence of hypertension in a population-based Chinese cohort: a 22-year follow-up","volume":"7","author":"Chen","year":"2018","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(21)00045-0_bib97","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1159\/000506689","article-title":"Joint effects of body mass index and waist circumference on the incidence of hypertension in a community-based Chinese population","volume":"13","author":"Momin","year":"2020","journal-title":"Obes Facts"},{"key":"10.1016\/S2213-8587(21)00045-0_bib98","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1016\/j.diabres.2014.09.059","article-title":"Type 2 diabetes mellitus incidence in Chinese: contributions of overweight and obesity","volume":"107","author":"Wang","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(21)00045-0_bib99","doi-asserted-by":"crossref","first-page":"494","DOI":"10.2337\/dc17-1852","article-title":"Associations of general and central adiposity with incident diabetes in Chinese men and women","volume":"41","author":"Bragg","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00045-0_bib100","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2019-000879","article-title":"Long-term BMI change trajectories in Chinese adults and its association with the hazard of type 2 diabetes: evidence from a 20-year China Health and Nutrition Survey","volume":"8","author":"Mi","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(21)00045-0_bib101","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1046\/j.1467-789X.2002.00068.x","article-title":"Overweight is an independent risk factor for cardiovascular disease in Chinese populations","volume":"3","author":"Zhou","year":"2002","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib102","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1038\/sj.ijo.0802634","article-title":"Anthropometric predictors of coronary heart disease in Chinese women","volume":"28","author":"Zhang","year":"2004","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(21)00045-0_bib103","doi-asserted-by":"crossref","first-page":"e630","DOI":"10.1016\/S2214-109X(18)30216-X","article-title":"Adiposity and risk of ischaemic and haemorrhagic stroke in 0\u00b75 million Chinese men and women: a prospective cohort study","volume":"6","author":"Chen","year":"2018","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib104","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1038\/ijo.2012.152","article-title":"Body weight, fat distribution and colorectal cancer risk: a report from cohort studies of 134\u2008255 Chinese men and women","volume":"37","author":"Li","year":"2013","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib105","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1002\/ijc.30187","article-title":"Prospective cohort study of general and central obesity, weight change trajectory and risk of major cancers among Chinese women","volume":"139","author":"Liu","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(21)00045-0_bib106","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1038\/s41416-018-0124-8","article-title":"Adiposity and risks of colorectal and small intestine cancer in Chinese adults: a prospective study of 0.5 million people","volume":"119","author":"Pang","year":"2018","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(21)00045-0_bib107","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.1136\/jech-2017-208895","article-title":"Young adulthood and adulthood adiposity in relation to incidence of pancreatic cancer: a prospective study of 0.5 million Chinese adults and a meta-analysis","volume":"71","author":"Pang","year":"2017","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib108","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1093\/ije\/27.5.824","article-title":"Body weight and mortality: a prospective evaluation in a cohort of middle-aged men in Shanghai, China","volume":"27","author":"Yuan","year":"1998","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib109","doi-asserted-by":"crossref","first-page":"776","DOI":"10.1001\/jama.295.7.776","article-title":"Body weight and mortality among men and women in China","volume":"295","author":"Gu","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00045-0_bib110","doi-asserted-by":"crossref","first-page":"e329","DOI":"10.1503\/cmaj.100303","article-title":"Body mass index and all-cause mortality in a large Chinese cohort","volume":"183","author":"Lin","year":"2011","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(21)00045-0_bib111","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1093\/ije\/dyr208","article-title":"Body mass index and mortality in China: a 15-year prospective study of 220\u2008000 men","volume":"41","author":"Chen","year":"2012","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib112","article-title":"Adiposity and mortality in older Chinese: an 11-year follow-up of the Guangzhou Biobank Cohort Study","volume":"10","author":"Jiang","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(21)00045-0_bib113","doi-asserted-by":"crossref","first-page":"1498","DOI":"10.1001\/archinte.166.14.1498","article-title":"Obesity, physical activity, and mortality in a prospective Chinese elderly cohort","volume":"166","author":"Schooling","year":"2006","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib114","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1016\/j.diabet.2019.02.007","article-title":"Obesity paradox in associations between body mass index and diabetes-related hospitalization and mortality in patients with type 2 diabetes: retrospective cohort studies","volume":"45","author":"Lin","year":"2019","journal-title":"Diabetes Metab"},{"key":"10.1016\/S2213-8587(21)00045-0_bib115","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1304501","article-title":"Body-mass index and mortality among adults with incident type 2 diabetes","volume":"370","author":"Tobias","year":"2014","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib116","doi-asserted-by":"crossref","first-page":"190","DOI":"10.1111\/1753-0407.12273","article-title":"Incidence of type 2 diabetes and number of events attributable to abdominal obesity in China: a cohort study","volume":"8","author":"Xue","year":"2016","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(21)00045-0_bib117","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1002\/ijc.32148","article-title":"Central adiposity in relation to risk of liver cancer in Chinese adults: a prospective study of 0.5 million people","volume":"145","author":"Pang","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(21)00045-0_bib118","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1002\/oby.22638","article-title":"Waist circumference change is associated with blood pressure change independent of BMI change","volume":"28","author":"Wang","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib119","doi-asserted-by":"crossref","first-page":"351","DOI":"10.1177\/109019818801500401","article-title":"An ecological perspective on health promotion programs","volume":"15","author":"McLeroy","year":"1988","journal-title":"Health Educ Q"},{"key":"10.1016\/S2213-8587(21)00045-0_bib120","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S0140-6736(11)60813-1","article-title":"The global obesity pandemic: shaped by global drivers and local environments","volume":"378","author":"Swinburn","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib121","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/S0140-6736(11)61878-3","article-title":"Urbanisation and health in China","volume":"379","author":"Gong","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib122","series-title":"Tackling obesities: future choices\u2014building the obesity system map","author":"Vandenbroeck","year":"2007"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00045-0_bib124","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1111\/j.1728-4457.2011.00383.x","article-title":"The future of a demographic overachiever: long-term implications of the demographic transition in China","volume":"37","author":"Feng","year":"2011","journal-title":"Popul Dev Rev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib125","doi-asserted-by":"crossref","first-page":"1987","DOI":"10.1016\/S0140-6736(13)61097-1","article-title":"Rapid health transition in China, 1990\u20132010: findings from the Global Burden of Disease Study 2010","volume":"381","author":"Yang","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib126","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990\u20132017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib127","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s12992-019-0456-z","article-title":"Economic globalization, nutrition and health: a review of quantitative evidence","volume":"15","author":"Cuevas Garc\u00eda-Dorado","year":"2019","journal-title":"Global Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib128","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.foodpol.2014.05.001","article-title":"Nutrition, agriculture and the global food system in low and middle income countries","volume":"47","author":"Popkin","year":"2014","journal-title":"Food Policy"},{"key":"10.1016\/S2213-8587(21)00045-0_bib129","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph13111112","article-title":"A review of the growth of the fast food industry in China and its potential impact on obesity","volume":"13","author":"Wang","year":"2016","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib130","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/j.foodpol.2014.12.011","article-title":"Household composition, income, and food-away-from-home expenditure in urban China","volume":"51","author":"Liu","year":"2015","journal-title":"Food Policy"},{"key":"10.1016\/S2213-8587(21)00045-0_bib131","series-title":"Demand for food quantity and quality in China. Economic Research Report No 32","author":"Gale","year":"2007"},{"key":"10.1016\/S2213-8587(21)00045-0_bib132","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1016\/j.ehb.2009.08.001","article-title":"The growth of obesity and technological change","volume":"7","author":"Lakdawalla","year":"2009","journal-title":"Econ Hum Biol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib133","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12966-016-0364-z","article-title":"Age, period and cohort effects on adult physical activity levels from 1991 to 2011 in China","volume":"13","author":"Zang","year":"2016","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(21)00045-0_bib134","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1111\/j.1467-789X.2011.00982.x","article-title":"Time use and physical activity: a shift away from movement across the globe","volume":"13","author":"Ng","year":"2012","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib135","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/sj.ejcn.1602849","article-title":"Longitudinal relationships between occupational and domestic physical activity patterns and body weight in China","volume":"62","author":"Monda","year":"2008","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib136","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1086\/683055","article-title":"The effect of household technology on weight and health outcomes among Chinese adults: evidence from China's \u201cHome Appliances Going to the Countryside\u201d policy","volume":"9","author":"Chen","year":"2015","journal-title":"J Hum Cap"},{"key":"10.1016\/S2213-8587(21)00045-0_bib137","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1007\/s11113-015-9371-z","article-title":"The effects of household technology on body mass index among Chinese adults","volume":"34","author":"Huang","year":"2015","journal-title":"Popul Res Policy Rev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib138","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1016\/j.foodpol.2007.06.002","article-title":"Consumption and corpulence in China: A consumer segmentation study based on the food perspective","volume":"33","author":"Zhang","year":"2008","journal-title":"Food Policy"},{"key":"10.1016\/S2213-8587(21)00045-0_bib139","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.socscimed.2014.04.021","article-title":"Social class and body weight among Chinese urban adults: the role of the middle classes in the nutrition transition","volume":"112","author":"Bonnefond","year":"2014","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib140","doi-asserted-by":"crossref","first-page":"k94","DOI":"10.1136\/bmj.k94","article-title":"China: a return to the \u201ckingdom of bicycles\u201d?","volume":"360","author":"Hu","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00045-0_bib141","doi-asserted-by":"crossref","first-page":"2868","DOI":"10.1108\/BFJ-03-2018-0139","article-title":"Consumer adoption of online food shopping in China","volume":"120","author":"Wang","year":"2018","journal-title":"Br Food J"},{"key":"10.1016\/S2213-8587(21)00045-0_bib142","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1136\/bmj.333.7564.362","article-title":"Overweight and obesity in China","volume":"333","author":"Wu","year":"2006","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00045-0_bib143","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1186\/s12966-015-0251-z","article-title":"The role of grandparents in childhood obesity in China\u2014evidence from a mixed methods study","volume":"12","author":"Li","year":"2015","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(21)00045-0_bib144","doi-asserted-by":"crossref","first-page":"118","DOI":"10.1186\/s12966-016-0445-z","article-title":"Parent\u2013child associations for changes in diet, screen time, and physical activity across two decades in modernizing China: China Health and Nutrition Survey 1991\u20132009","volume":"13","author":"Dong","year":"2016","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(21)00045-0_bib145","first-page":"454","article-title":"Comparative analysis on self-evaluation of body weight and actual body mass index for residents aged 18\u201369 in China","volume":"18","author":"Gao","year":"2010","journal-title":"Zhongguo Man Xing Bing Yu Fang Yu Kong Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib146","doi-asserted-by":"crossref","first-page":"120","DOI":"10.1111\/apa.13640","article-title":"Excessive homework, inadequate sleep, physical inactivity and screen viewing time are major contributors to high paediatric obesity","volume":"106","author":"Ren","year":"2017","journal-title":"Acta Paediatr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib147","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.midw.2017.10.019","article-title":"Traditional beliefs and practices in pregnancy, childbirth and postpartum: a review of the evidence from Asian countries","volume":"56","author":"Withers","year":"2018","journal-title":"Midwifery"},{"key":"10.1016\/S2213-8587(21)00045-0_bib148","doi-asserted-by":"crossref","first-page":"1025","DOI":"10.1016\/S2213-8587(16)30217-0","article-title":"Preconceptional and maternal obesity: epidemiology and health consequences","volume":"4","author":"Poston","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib149","doi-asserted-by":"crossref","first-page":"1099","DOI":"10.1016\/j.jand.2014.05.005","article-title":"Position of the Academy of Nutrition and Dietetics: nutrition and lifestyle for a healthy pregnancy outcome","volume":"114","author":"Procter","year":"2014","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib150","series-title":"The guidelines for prevention and control of overweight and obesity in Chinese adults","year":"2003"},{"key":"10.1016\/S2213-8587(21)00045-0_bib151","series-title":"Guidelines for prevention and control of overweight and obesity among school-age children and adolescents in China","year":"2007"},{"key":"10.1016\/S2213-8587(21)00045-0_bib152","doi-asserted-by":"crossref","first-page":"2410","DOI":"10.1016\/S0140-6736(14)61745-1","article-title":"Smart food policies for obesity prevention","volume":"385","author":"Hawkes","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib153","series-title":"Tackling NCDs: \u2018best buys\u2019 and other recommended interventions for the prevention and control of noncommunicable diseases","year":"2017"},{"key":"10.1016\/S2213-8587(21)00045-0_bib154","doi-asserted-by":"crossref","first-page":"m545","DOI":"10.1136\/bmj.m545","article-title":"What role should the commercial food system play in promoting health through better diet?","volume":"368","author":"White","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(21)00045-0_bib155","first-page":"93","article-title":"Agricultural development, nutrition, and the policies behind China's success","volume":"7","author":"Huang","year":"2010","journal-title":"Asian J Agric Dev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib156","doi-asserted-by":"crossref","first-page":"2044","DOI":"10.1016\/S0140-6736(13)60776-X","article-title":"Food supply and food safety issues in China","volume":"381","author":"Lam","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib157","doi-asserted-by":"crossref","first-page":"994","DOI":"10.1093\/jn\/129.5.994","article-title":"Food price policy can favorably alter macronutrient intake in China","volume":"129","author":"Guo","year":"1999","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib158","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1038\/ijo.2017.2","article-title":"School environment and policies, child eating behavior and overweight\/obesity in urban China: the childhood obesity study in China megacities","volume":"41","author":"Jia","year":"2017","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib159","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ypmed.2017.04.031","article-title":"Pocket money, eating behaviors, and weight status among Chinese children: the Childhood Obesity Study in China mega-cities","volume":"100","author":"Li","year":"2017","journal-title":"Prev Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib160","doi-asserted-by":"crossref","first-page":"e447","DOI":"10.1016\/S2468-2667(19)30160-4","article-title":"Healthy China 2030: moving from blueprint to action with a new focus on public health","volume":"4","author":"Chen","year":"2019","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib161","doi-asserted-by":"crossref","first-page":"2140","DOI":"10.1016\/S0140-6736(18)30486-0","article-title":"The Tsinghua\u2013Lancet Commission on Healthy Cities in China: unlocking the power of cities for a healthy China","volume":"391","author":"Yang","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib162","doi-asserted-by":"crossref","first-page":"125","DOI":"10.1016\/S2213-8587(15)00366-6","article-title":"Diabetes-related metabolic risk factors in internal migrant workers in China: a national surveillance study","volume":"4","author":"Bi","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib163","doi-asserted-by":"crossref","first-page":"1305","DOI":"10.1016\/j.socscimed.2009.01.035","article-title":"Why have physical activity levels declined among Chinese adults? Findings from the 1991\u20132006 China Health and Nutrition Surveys","volume":"68","author":"Ng","year":"2009","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib164","first-page":"504","article-title":"The impact of urbanization on the community food environment in China","volume":"26","author":"Wu","year":"2017","journal-title":"Asia Pac J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib165","doi-asserted-by":"crossref","DOI":"10.3390\/nu12061597","article-title":"Longitudinal association between urbanicity and total dietary fat intake in adults in urbanizing China from 1991 to 2015: findings from the CHNS","volume":"12","author":"Su","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(21)00045-0_bib166","doi-asserted-by":"crossref","first-page":"92","DOI":"10.1016\/j.foodpol.2015.07.001","article-title":"The food retail revolution in China and its association with diet and health","volume":"55","author":"Zhou","year":"2015","journal-title":"Food Policy"},{"key":"10.1016\/S2213-8587(21)00045-0_bib167","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1016\/j.socscimed.2010.07.027","article-title":"Understanding community context and adult health changes in China: development of an urbanicity scale","volume":"71","author":"Jones-Smith","year":"2010","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib168","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1016\/j.healthplace.2012.12.009","article-title":"Overweight, obesity, and inactivity and urban design in rapidly growing Chinese cities","volume":"21","author":"Day","year":"2013","journal-title":"Health Place"},{"key":"10.1016\/S2213-8587(21)00045-0_bib169","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/j.pmedr.2016.03.007","article-title":"Built environmental correlates of physical activity in China: a review","volume":"3","author":"Day","year":"2016","journal-title":"Prev Med Rep"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00045-0_bib170","doi-asserted-by":"crossref","first-page":"S79","DOI":"10.1016\/j.ypmed.2014.10.002","article-title":"Walking, obesity and urban design in Chinese neighborhoods","volume":"69","author":"Alfonzo","year":"2014","journal-title":"Prev Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib171","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1038\/oby.2002.38","article-title":"The road to obesity or the path to prevention: motorized transportation and obesity in China","volume":"10","author":"Bell","year":"2002","journal-title":"Obes Res"},{"key":"10.1016\/S2213-8587(21)00045-0_bib172","doi-asserted-by":"crossref","first-page":"100","DOI":"10.1186\/s12955-019-1172-3","article-title":"Exploring the links between population density, lifestyle, and being overweight: secondary data analyses of middle-aged and older Chinese adults","volume":"17","author":"Wang","year":"2019","journal-title":"Health Qual Life Outcomes"},{"key":"10.1016\/S2213-8587(21)00045-0_bib173","doi-asserted-by":"crossref","DOI":"10.1016\/j.scitotenv.2019.135040","article-title":"Association between community greenness and obesity in urban-dwelling Chinese adults","volume":"702","author":"Huang","year":"2020","journal-title":"Sci Total Environ"},{"key":"10.1016\/S2213-8587(21)00045-0_bib174","doi-asserted-by":"crossref","first-page":"332","DOI":"10.3389\/fpubh.2020.00332","article-title":"Does green space really matter for residents' obesity? A new perspective from Baidu Street View","volume":"8","author":"Xiao","year":"2020","journal-title":"Front Public Health"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(21)00045-0_bib176","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1111\/obr.12860","article-title":"Global trends in ultraprocessed food and drink product sales and their association with adult body mass index trajectories","volume":"20","author":"Vandevijvere","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib177","first-page":"78","article-title":"Wet markets, supermarkets and alternative food sources: consumers' food access in Nanjing, China","volume":"40","author":"Si","year":"2019","journal-title":"Rev Can Etudes Dev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib178","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.jretconser.2015.12.006","article-title":"The modernization of fresh food retailing in China: the role of consumers","volume":"30","author":"Maruyama","year":"2016","journal-title":"J Retail Consum Serv"},{"key":"10.1016\/S2213-8587(21)00045-0_bib179","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1007\/s10460-019-09987-2","article-title":"Constructing freshness: the vitality of wet markets in urban China","volume":"37","author":"Zhong","year":"2020","journal-title":"Agric Human Values"},{"key":"10.1016\/S2213-8587(21)00045-0_bib180","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1017\/S1368980019002167","article-title":"Impact of neighbourhood food environment on diet and obesity in China: a systematic review","volume":"23","author":"An","year":"2020","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib181","article-title":"Obesogenic environmental factors of adult obesity in China: a nationally representative cross-sectional study","volume":"15","author":"Zhang","year":"2019","journal-title":"Environ Res Lett"},{"key":"10.1016\/S2213-8587(21)00045-0_bib182","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1186\/s12889-020-8257-0","article-title":"Association between convenience stores near schools and obesity among school-aged children in Beijing, China","volume":"20","author":"Zhou","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib183","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2013-004528","article-title":"Is density of neighbourhood restaurants associated with BMI in rural Chinese adults? A longitudinal study from the China Health and Nutrition Survey","volume":"4","author":"Du","year":"2014","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(21)00045-0_bib184","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1136\/jech-2012-201157","article-title":"Dynamic relations between fast-food restaurant and body weight status: a longitudinal and multilevel analysis of Chinese adults","volume":"67","author":"Xu","year":"2013","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib185","doi-asserted-by":"crossref","first-page":"792","DOI":"10.1186\/1471-2458-11-792","article-title":"School environment factors were associated with BMI among adolescents in Xi'an City, China","volume":"11","author":"Li","year":"2011","journal-title":"BMC Public Health"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00045-0_bib186","doi-asserted-by":"crossref","first-page":"16","DOI":"10.1111\/obr.12124","article-title":"Dynamics of the Chinese diet and the role of urbanicity, 1991\u20132011","volume":"15","author":"Zhai","year":"2014","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib187","doi-asserted-by":"crossref","first-page":"951","DOI":"10.3390\/nu10070951","article-title":"Eating out-of-home in adult residents in Shanghai and the nutritional differences among dining places","volume":"10","author":"Zang","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(21)00045-0_bib188","doi-asserted-by":"crossref","first-page":"168","DOI":"10.3945\/ajcn.116.146217","article-title":"Longitudinal associations of away-from-home eating, snacking, screen time, and physical activity behaviors with cardiometabolic risk factors among Chinese children and their parents","volume":"106","author":"Dong","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib189","series-title":"The 45th China Statistical Report on Internet Development","year":"2020"},{"key":"10.1016\/S2213-8587(21)00045-0_bib190","doi-asserted-by":"crossref","first-page":"1282","DOI":"10.1038\/s41430-018-0191-1","article-title":"How we eat determines what we become: opportunities and challenges brought by food delivery industry in a changing world in China","volume":"72","author":"Maimaiti","year":"2018","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib192","doi-asserted-by":"crossref","first-page":"158","DOI":"10.3390\/ijerph17010158","article-title":"Temporal trends and recent correlates in sedentary behaviors among Chinese adults from 2002 to 2010\u20132012","volume":"17","author":"Ding","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib193","first-page":"1366","article-title":"Changes on patterns of sleep duration: findings from China Health and Nutrition Survey in population in 9 provinces","volume":"37","author":"Jin","year":"2016","journal-title":"Zhonghua Liu Xing Bing Xue Za Zhi"},{"key":"10.1016\/S2213-8587(21)00045-0_bib194","doi-asserted-by":"crossref","first-page":"2392","DOI":"10.1056\/NEJMoa1014296","article-title":"Changes in diet and lifestyle and long-term weight gain in women and men","volume":"364","author":"Mozaffarian","year":"2011","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(21)00045-0_bib195","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1111\/obr.12879","article-title":"A comparison of the healthiness of packaged foods and beverages from 12 countries using the Health Star Rating nutrient profiling system, 2013\u20132018","volume":"20","author":"Dunford","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib196","doi-asserted-by":"crossref","first-page":"15","DOI":"10.3148\/75.1.2014.15","article-title":"Processed and ultra-processed food products: consumption trends in Canada from 1938 to 2011","volume":"75","author":"Moubarac","year":"2014","journal-title":"Can J Diet Pract Res"},{"key":"10.1016\/S2213-8587(21)00045-0_bib197","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2017-020574","article-title":"Consumption of ultra-processed foods and associated sociodemographic factors in the USA between 2007 and 2012: evidence from a nationally representative cross-sectional study","volume":"8","author":"Baraldi","year":"2018","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(21)00045-0_bib198","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1186\/s12966-015-0317-y","article-title":"Characterisation of UK diets according to degree of food processing and associations with socio-demographics and obesity: cross-sectional analysis of UK National Diet and Nutrition Survey (2008\u201312)","volume":"12","author":"Adams","year":"2015","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(21)00045-0_bib199","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-029544","article-title":"Ultra-processed foods and recommended intake levels of nutrients linked to non-communicable diseases in Australia: evidence from a nationally representative cross-sectional study","volume":"9","author":"Machado","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(21)00045-0_bib200","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.3945\/ajcn.116.135004","article-title":"Ultraprocessed food consumption and risk of overweight and obesity: the University of Navarra Follow-Up (SUN) cohort study","volume":"104","author":"Mendon\u00e7a","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib201","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003256","article-title":"Ultra-processed food intake in association with BMI change and risk of overweight and obesity: a prospective analysis of the French NutriNet-Sante cohort","volume":"17","author":"Beslay","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib202","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.cmet.2019.05.008","article-title":"Ultra-processed diets cause excess calorie intake and weight gain: an inpatient randomized controlled trial of ad libitum food intake","volume":"30","author":"Hall","year":"2019","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00045-0_bib203","doi-asserted-by":"crossref","DOI":"10.3390\/nu9121302","article-title":"Sugar-sweetened beverage consumption and risks of obesity and hypertension in Chinese children and adolescents: a national cross-sectional analysis","volume":"9","author":"Gui","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(21)00045-0_bib204","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1017\/S1368980016001373","article-title":"Consumption of sugar-sweetened beverages and its association with overweight among young children from China","volume":"19","author":"Yu","year":"2016","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib205","article-title":"The burden of ischemic heart disease and type 2 diabetes mellitus attributable to diet high in sugar-sweetened beverages in China: an analysis for the Global Burden of Disease Study 2017","author":"Li","year":"2020","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(21)00045-0_bib206","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1186\/s12937-018-0372-8","article-title":"Dietary pattern is associated with obesity in Chinese children and adolescents: data from China Health and Nutrition Survey (CHNS)","volume":"17","author":"Zhen","year":"2018","journal-title":"Nutr J"},{"key":"10.1016\/S2213-8587(21)00045-0_bib207","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1186\/s12889-016-3425-y","article-title":"Dietary pattern transitions, and the associations with BMI, waist circumference, weight and hypertension in a 7-year follow-up among the older Chinese population: a longitudinal study","volume":"16","author":"Xu","year":"2016","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib208","doi-asserted-by":"crossref","DOI":"10.3390\/nu12082245","article-title":"Trajectories of dietary patterns, sleep duration, and body mass index in China: a population-based longitudinal study from China Nutrition and Health Survey, 1991\u20132009","volume":"12","author":"Cao","year":"2020","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(21)00045-0_bib209","doi-asserted-by":"crossref","first-page":"723","DOI":"10.2337\/dc17-1626","article-title":"Long-term diet quality and risk of type 2 diabetes among urban Chinese adults","volume":"41","author":"Yu","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00045-0_bib210","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3945\/ajcn.113.079194","article-title":"Adherence to dietary guidelines and mortality: a report from prospective cohort studies of 134,000 Chinese adults in urban Shanghai","volume":"100","author":"Yu","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib211","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1038\/sj.ijo.0801651","article-title":"Weight gain and its predictors in Chinese adults","volume":"25","author":"Bell","year":"2001","journal-title":"Int J Obes Relat Metab Disord"},{"key":"10.1016\/S2213-8587(21)00045-0_bib212","doi-asserted-by":"crossref","first-page":"383","DOI":"10.1038\/ejcn.2016.262","article-title":"Longitudinal association of leisure time physical activity and sedentary behaviors with body weight among Chinese adults from China Health and Nutrition Survey 2004\u20132011","volume":"71","author":"Su","year":"2017","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib213","doi-asserted-by":"crossref","first-page":"2267","DOI":"10.1038\/s41366-020-00684-3","article-title":"Secular trends in sedentary behaviors and associations with weight indicators among Chinese reproductive-age women from 2004 to 2015: findings from the China Health and Nutrition Survey","volume":"44","author":"Wang","year":"2020","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib214","series-title":"Guidelines for physical activity in adults in China (tentative)","year":"2011"},{"key":"10.1016\/S2213-8587(21)00045-0_bib215","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1111\/j.1467-789X.2007.00452.x","article-title":"Leisure-time physical activity alone may not be a sufficient public health approach to prevent obesity \u2013 a focus on China","volume":"9","author":"Bauman","year":"2008","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(21)00045-0_bib216","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1186\/s12889-019-6515-9","article-title":"Physical activity, screen viewing time, and overweight\/obesity among Chinese children and adolescents: an update from the 2017 physical activity and fitness in China\u2014the youth study","volume":"19","author":"Zhu","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib217","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1186\/s12966-017-0598-4","article-title":"Trends in domain-specific physical activity and sedentary behaviors among Chinese school children, 2004\u20132011","volume":"14","author":"Dearth-Wesley","year":"2017","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(21)00045-0_bib218","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1479-5868-8-93","article-title":"Temporal trends and recent correlates in sedentary behaviours in Chinese children","volume":"8","author":"Cui","year":"2011","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(21)00045-0_bib219","doi-asserted-by":"crossref","first-page":"1042","DOI":"10.1038\/oby.2005.122","article-title":"Cluster analysis methods help to clarify the activity-BMI relationship of Chinese youth","volume":"13","author":"Monda","year":"2005","journal-title":"Obes Res"},{"key":"10.1016\/S2213-8587(21)00045-0_bib220","article-title":"A 3-year longitudinal study of the association of physical activity and sedentary behaviours with childhood obesity in China: the childhood obesity study in China mega-cities","author":"Sun","year":"2020","journal-title":"Pediatr Obes"},{"key":"10.1016\/S2213-8587(21)00045-0_bib221","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(21)00045-0_bib222","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1038\/ng.1087","article-title":"Meta-analysis identifies common variants associated with body mass index in east Asians","volume":"44","author":"Wen","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib223","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1038\/ng.1086","article-title":"Common variants at CDKAL1 and KLF9 are associated with body mass index in east Asian populations","volume":"44","author":"Okada","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib224","doi-asserted-by":"crossref","first-page":"5492","DOI":"10.1093\/hmg\/ddu248","article-title":"Meta-analysis of genome-wide association studies in East Asian-ancestry populations identifies four new loci for body mass index","volume":"23","author":"Wen","year":"2014","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib225","doi-asserted-by":"crossref","first-page":"AP460","DOI":"10.1161\/circ.141.suppl_1.P460","article-title":"Abstract P460: Genetic risk for obesity across the transition from young to older adulthood: a pathway based analysis","volume":"141","author":"Hou","year":"2020","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00045-0_bib226","doi-asserted-by":"crossref","first-page":"218","DOI":"10.1016\/j.atherosclerosis.2015.12.034","article-title":"Obesity and peripheral arterial disease: a mendelian randomization analysis","volume":"247","author":"Huang","year":"2016","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(21)00045-0_bib227","doi-asserted-by":"crossref","first-page":"934","DOI":"10.1002\/oby.22167","article-title":"Causal association of overall obesity and abdominal obesity with type 2 diabetes: a mendelian randomization analysis","volume":"26","author":"Wang","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib228","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2213-8587(17)30200-0","article-title":"Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications","volume":"6","author":"Goodarzi","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib229","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa1203039","article-title":"Sugar-sweetened beverages and genetic risk of obesity","volume":"367","author":"Qi","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib230","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1161\/CIRCULATIONAHA.112.098061","article-title":"Television watching, leisure time physical activity, and the genetic predisposition in relation to body mass inedex in women and men","volume":"126","author":"Qi","year":"2012","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00045-0_bib231","article-title":"Physical activity and sedentary behaviors modify the association between melanocortin 4 receptor gene variant and obesity in Chinese children and adolescents","volume":"12","author":"Song","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00045-0_bib232","article-title":"Associations of genetic risk score with obesity and related traits and the modifying effect of physical activity in a Chinese Han population","volume":"9","author":"Zhu","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00045-0_bib233","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgen.1008277","article-title":"Performing different kinds of physical exercise differentially attenuates the genetic effects on obesity measures: evidence from 18,424 Taiwan Biobank participants","volume":"15","author":"Lin","year":"2019","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib234","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1038\/s41366-019-0405-1","article-title":"Childhood sleep duration modifies the polygenic risk for obesity in youth through leptin pathway: the Beijing Child and Adolescent Metabolic Syndrome cohort study","volume":"43","author":"Fu","year":"2019","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib235","doi-asserted-by":"crossref","first-page":"59","DOI":"10.4103\/hm.hm_22_20","article-title":"Mental health challenges raised by rapid socioeconomic transformations in China: lessons learned and prevention strategies","volume":"4","author":"Sun","year":"2020","journal-title":"Heart Mind"},{"key":"10.1016\/S2213-8587(21)00045-0_bib236","doi-asserted-by":"crossref","first-page":"211","DOI":"10.1016\/S2215-0366(18)30511-X","article-title":"Prevalence of mental disorders in China: a cross-sectional epidemiological study","volume":"6","author":"Huang","year":"2019","journal-title":"Lancet Psychiatry"},{"key":"10.1016\/S2213-8587(21)00045-0_bib237","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1016\/S0140-6736(20)30059-3","article-title":"Eating disorders","volume":"395","author":"Treasure","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib238","article-title":"Secular trends in the incidence of eating disorders in China from 1990 to 2017: a joinpoint and age-period-cohort analysis","author":"Wu","year":"2020","journal-title":"Psychol Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib239","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1186\/1471-2458-10-314","article-title":"Associations between body mass index, weight control concerns and behaviors, and eating disorder symptoms among non-clinical Chinese adolescents","volume":"10","author":"Fan","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib240","first-page":"11","article-title":"Report on childhood obesity in China (5) body weight, body dissatisfaction, and depression symptoms of Chinese children aged 9\u201310 years","volume":"20","author":"Li","year":"2007","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/S2213-8587(21)00045-0_bib241","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.jpsychores.2007.08.015","article-title":"Predicting changes in eating disorder symptoms among Chinese adolescents: a 9-month prospective study","volume":"64","author":"Jackson","year":"2008","journal-title":"J Psychosom Res"},{"key":"10.1016\/S2213-8587(21)00045-0_bib242","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1007\/s10802-013-9823-z","article-title":"Risk factors for disordered eating during early and middle adolescence: a two year longitudinal study of mainland Chinese boys and girls","volume":"42","author":"Jackson","year":"2014","journal-title":"J Abnorm Child Psychol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib243","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.ypmed.2005.12.013","article-title":"Weight perception and weight-related sociocultural and behavioral factors in Chinese adolescents","volume":"42","author":"Xie","year":"2006","journal-title":"Prev Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib244","article-title":"Body weight and body dissatisfaction among Chinese adolescents: mediating and moderating roles of weight-related teasing","author":"Chen","year":"2019","journal-title":"Curr Psychol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib245","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1016\/j.numecd.2020.11.001","article-title":"Short duration of sleep and incidence of overweight or obesity in Chinese children and adolescents: a systematic review and meta-analysis of prospective studies","volume":"31","author":"Guo","year":"2021","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(21)00045-0_bib246","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1002\/oby.22713","article-title":"Association of sleep duration with weight gain and general and central obesity risk in Chinese adults: a prospective study","volume":"28","author":"Ning","year":"2020","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib247","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1038\/nrendo.2015.163","article-title":"Endocrine disruptors and obesity","volume":"11","author":"Heindel","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib248","article-title":"The association between bisphenol A exposure and obesity in children\u2014a systematic review with meta-analysis","volume":"16","author":"Kim","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib249","doi-asserted-by":"crossref","DOI":"10.1016\/j.envres.2019.108780","article-title":"Association between the exposure to phthalates and adiposity: a meta-analysis in children and adults","volume":"179","author":"Ribeiro","year":"2019","journal-title":"Environ Res"},{"key":"10.1016\/S2213-8587(21)00045-0_bib250","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1111\/1753-0407.12531","article-title":"Urinary bisphenol A concentration and the risk of central obesity in Chinese adults: a prospective study","volume":"10","author":"Hao","year":"2018","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(21)00045-0_bib251","doi-asserted-by":"crossref","first-page":"e223","DOI":"10.1210\/jc.2011-1989","article-title":"Urinary bisphenol A (BPA) concentration associates with obesity and insulin resistance","volume":"97","author":"Wang","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00045-0_bib252","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1476-069X-11-79","article-title":"Association between bisphenol A exposure and body mass index in Chinese school children: a cross-sectional study","volume":"11","author":"Wang","year":"2012","journal-title":"Environ Health"},{"key":"10.1016\/S2213-8587(21)00045-0_bib253","article-title":"Urine bisphenol-A level in relation to obesity and overweight in school-age children","volume":"8","author":"Li","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00045-0_bib254","article-title":"Age and sex-specific relationships between phthalate exposures and obesity in Chinese children at puberty","volume":"9","author":"Zhang","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00045-0_bib255","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.3945\/ajcn.110.008870","article-title":"Consumption of monosodium glutamate in relation to incidence of overweight in Chinese adults: China Health and Nutrition Survey (CHNS)","volume":"93","author":"He","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib256","doi-asserted-by":"crossref","first-page":"1875","DOI":"10.1038\/oby.2008.274","article-title":"Association of monosodium glutamate intake with overweight in Chinese adults: the INTERMAP Study","volume":"16","author":"He","year":"2008","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib257","doi-asserted-by":"crossref","first-page":"615","DOI":"10.1016\/j.scitotenv.2019.01.255","article-title":"Disease burden attributable to endocrine-disrupting chemicals exposure in China: a case study of phthalates","volume":"662","author":"Cao","year":"2019","journal-title":"Sci Total Environ"},{"key":"10.1016\/S2213-8587(21)00045-0_bib258","doi-asserted-by":"crossref","first-page":"1014","DOI":"10.2337\/dc10-2039","article-title":"Exposure to the Chinese famine in early life and the risk of metabolic syndrome in adulthood","volume":"34","author":"Li","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00045-0_bib259","doi-asserted-by":"crossref","first-page":"903","DOI":"10.3390\/nu11040903","article-title":"Exposure to famine during early life and abdominal obesity in adulthood: findings from the great Chinese famine during 1959\u20131961","volume":"11","author":"Liu","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(21)00045-0_bib260","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/sj.ijo.0803765","article-title":"Macrosomia is associated with high weight-for-height in children aged 1\u20133 years in Shanghai, China","volume":"32","author":"Yu","year":"2008","journal-title":"Int J Obes (Lond)"},{"key":"10.1016\/S2213-8587(21)00045-0_bib261","doi-asserted-by":"crossref","first-page":"153","DOI":"10.1007\/s12519-018-0218-7","article-title":"Association between fetal macrosomia and risk of obesity in children under 3 years in Western China: a cohort study","volume":"15","author":"Pan","year":"2019","journal-title":"World J Pediatr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib262","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1093\/ajcn\/72.4.1018","article-title":"Tracking of body mass index from childhood to adolescence: a 6-y follow-up study in China","volume":"72","author":"Wang","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00045-0_bib263","first-page":"162","article-title":"Childhood BMI and adult obesity in a Chinese sample: a 13-year follow-up study","volume":"32","author":"Liu","year":"2019","journal-title":"Biomed Environ Sci"},{"key":"10.1016\/S2213-8587(21)00045-0_bib264","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002744","article-title":"Maternal body mass index, gestational weight gain, and the risk of overweight and obesity across childhood: an individual participant data meta-analysis","volume":"16","author":"Voerman","year":"2019","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(21)00045-0_bib265","article-title":"Estimated global overweight and obesity burden in pregnant women based on panel data model","volume":"13","author":"Chen","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00045-0_bib266","doi-asserted-by":"crossref","first-page":"231","DOI":"10.1016\/S2213-8587(19)30026-9","article-title":"The obesity transition: stages of the global epidemic","volume":"7","author":"Jaacks","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00045-0_bib267","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1016\/S0140-6736(19)32497-3","article-title":"Dynamics of the double burden of malnutrition and the changing nutrition reality","volume":"395","author":"Popkin","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib268","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/S0140-6736(14)61214-9","article-title":"Can China diminish its burden of non-communicable diseases and injuries by promoting health in its policies, practices, and incentives?","volume":"384","author":"Huang","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00045-0_bib175","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.chieco.2006.10.001","article-title":"Consumer preferences for western-style convenience foods in China","volume":"18","author":"Curtis","year":"2007","journal-title":"China Econ Rev"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(21)00149-2","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,7,1]],"date-time":"2021-07-01T00:00:00Z","timestamp":1625097600000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000450?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000450?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:01Z","timestamp":1761991801000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000450"}},"issued":{"date-parts":[[2021,6]]},"references-count":264,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213858721000450"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00045-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Epidemiology and determinants of obesity in China","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00045-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T10:18:03Z","timestamp":1794651483150,"version":"4.9.1"},"reference-count":26,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70006-8","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T12:36:30Z","timestamp":1359981390000},"page":"28-34","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":228,"title":["Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"1","author":[{"given":"Caroline Kaercher","family":"Kramer","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernard","family":"Zinman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ravi","family":"Retnakaran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70006-8_bib1","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1007\/s00125-009-1321-z","article-title":"The beta cell lesion in type 2 diabetes: there has to be a primary functional abnormality","volume":"52","author":"Kahn","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70006-8_bib2","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/S0140-6736(11)60614-4","article-title":"Type 2 diabetes across generations: from pathophysiology to prevention and management","volume":"378","author":"Nolan","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70006-8_bib3","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1210\/10.1210\/er.2006-0038","article-title":"Beta-cell failure in diabetes and preservation by clinical treatment","volume":"28","author":"Wajchenberg","year":"2007","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(13)70006-8_bib4","doi-asserted-by":"crossref","first-page":"1364","DOI":"10.2337\/dc12-0413","article-title":"Management of hyperglycemia in type 2 diabetes: a patient-centered approach: position statement of the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"35","author":"Inzucchi","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70006-8_bib5","doi-asserted-by":"crossref","first-page":"1725","DOI":"10.1016\/S0140-6736(08)60736-9","article-title":"Intensive insulin therapy in newly diagnosed type 2 diabetes","volume":"371","author":"Retnakaran","year":"2008","journal-title":"Lancet"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(13)70006-8_bib6","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1111\/j.1463-1326.2012.01658.x","article-title":"Short-term intensified insulin treatment in type 2 diabetes: long-term effects on beta-cell function","volume":"14","author":"Retnakaran","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70006-8_bib7","doi-asserted-by":"crossref","first-page":"1927","DOI":"10.2337\/dc08-0075","article-title":"Beneficial effects of insulin on glycemic control and beta-cell function in newly diagnosed type 2 diabetes with severe hyperglycemia after short-term intensive insulin therapy","volume":"31","author":"Chen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70006-8_bib8","doi-asserted-by":"crossref","first-page":"1753","DOI":"10.1016\/S0140-6736(08)60762-X","article-title":"Effect of intensive insulin therapy on beta-cell function and glycaemic control in patients with newly diagnosed type 2 diabetes: a multicentre randomised parallel-group trial","volume":"371","author":"Weng","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70006-8_bib9","doi-asserted-by":"crossref","first-page":"264","DOI":"10.7326\/0003-4819-151-4-200908180-00135","article-title":"Preferred reporting items for systematic reviews and meta-analyses: the PRISMA statement","volume":"151","author":"Moher","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(13)70006-8_bib10","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(13)70006-8_bib11","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(13)70006-8_bib12","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(13)70006-8_bib13","doi-asserted-by":"crossref","first-page":"2597","DOI":"10.2337\/diacare.27.11.2597","article-title":"Induction of long-term glycemic control in newly diagnosed type 2 diabetic patients is associated with improvement of beta-cell function","volume":"27","author":"Li","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70006-8_bib14","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.diabres.2006.07.001","article-title":"The significance of tumor necrosis factor-alpha in newly diagnosed type 2 diabetic patients by transient intensive insulin treatment","volume":"75","author":"Chen","year":"2007","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(13)70006-8_bib15","first-page":"1878","article-title":"Effect of short-term intensive treatment with insulin pump on beta cell function and the mechanism of oxidative stress in newly diagnosed type 2 diabetic patients","volume":"27","author":"Zhao","year":"2007","journal-title":"Nan Fang Yi Ke Da Xue Xue Bao"},{"key":"10.1016\/S2213-8587(13)70006-8_bib16","doi-asserted-by":"crossref","first-page":"474","DOI":"10.2337\/dc11-1638","article-title":"Attitudes toward diabetes affect maintenance of drug-free remission in patients with newly diagnosed type 2 diabetes after short-term continuous subcutaneous insulin infusion treatment","volume":"35","author":"Chen","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70006-8_bib17","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1089\/dia.2012.0055","article-title":"Increased 1,5-anhydroglucitol predicts glycemic remission in patients with newly diagnosed type 2 diabetes treated with short-term intensive insulin therapy","volume":"14","author":"Liu","year":"2012","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(13)70006-8_bib18","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1016\/j.metabol.2011.01.018","article-title":"Insulin improves beta-cell function in glucose-intolerant rat models induced by feeding a high-fat diet","volume":"60","author":"Li","year":"2011","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(13)70006-8_bib19","first-page":"110","article-title":"Islet pathology and the pathogenesis of type 1 and type 2 diabetes mellitus revisited","volume":"4","author":"Kloppel","year":"1985","journal-title":"Surv Synth Pathol Res"},{"key":"10.1016\/S2213-8587(13)70006-8_bib20","doi-asserted-by":"crossref","first-page":"102","DOI":"10.2337\/diabetes.52.1.102","article-title":"Beta-cell deficit and increased beta-cell apoptosis in humans with type 2 diabetes","volume":"52","author":"Butler","year":"2003","journal-title":"Diabetes"},{"issue":"suppl 4","key":"10.1016\/S2213-8587(13)70006-8_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1111\/j.1463-1326.2008.00969.x","article-title":"Pancreatic beta-cell mass in European subjects with type 2 diabetes","volume":"10","author":"Rahier","year":"2008","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70006-8_bib22","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1111\/j.1365-2753.2010.01552.x","article-title":"Effect of short-term intensive insulin therapy on quality of life in type 2 diabetes","volume":"18","author":"Opsteen","year":"2012","journal-title":"J Eval Clin Pract"},{"key":"10.1016\/S2213-8587(13)70006-8_bib23","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1111\/j.1463-1326.2009.01129.x","article-title":"The response to short-term intensive insulin therapy in type 2 diabetes","volume":"12","author":"Retnakaran","year":"2010","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(13)70006-8_bib24","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.2337\/diacare.27.5.1028","article-title":"Short-term intensive insulin therapy in newly diagnosed type 2 diabetes","volume":"27","author":"Ryan","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70006-8_bib25","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.2337\/dc12-0212","article-title":"Pathophysiologic differences among Asians, native Hawaiians, and other Pacific Islanders and treatment implications","volume":"35","author":"Hsu","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70006-8_bib26","doi-asserted-by":"crossref","first-page":"909","DOI":"10.1111\/j.1463-1326.2010.01254.x","article-title":"Initial short-term intensive insulin therapy as a strategy for evaluating the preservation of beta-cell function with oral anti-diabetic medications: a pilot study with sitagliptin","volume":"12","author":"Retnakaran","year":"2010","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700068?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700068?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T21:25:25Z","timestamp":1539897925000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700068"}},"issued":{"date-parts":[[2013,9]]},"references-count":26,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2213858713700068"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70006-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Short-term intensive insulin therapy in type 2 diabetes mellitus: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70006-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70001-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:48:35Z","timestamp":1794664115216,"version":"4.9.1"},"reference-count":31,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,22]],"date-time":"2022-12-22T00:00:00Z","timestamp":1671667200000},"content-version":"am","delay-in-days":174,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,7,1]],"date-time":"2022-07-01T00:00:00Z","timestamp":1656633600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014247","name":"Immune Tolerance Network","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014247","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000190","name":"University of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000190","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000062","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000062","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001804","name":"Canada Research Chairs","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001804","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009881","name":"Juvenile Diabetes Research Foundation Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009881","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100020390","name":"Alberta Diabetes Foundation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020390","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013528","name":"Diabetes Canada","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013528","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100013200","name":"Government of Alberta","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100013200","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,7]]},"DOI":"10.1016\/s2213-8587(22)00114-0","type":"journal-article","created":{"date-parts":[[2022,5,16]],"date-time":"2022-05-16T19:13:23Z","timestamp":1652728403000},"page":"519-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":208,"title":["Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada"],"prefix":"10.1016","volume":"10","author":[{"given":"Braulio A","family":"Marfil-Garza","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sharleen","family":"Imes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kevin","family":"Verhoeff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua","family":"Hefler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Lam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Khaled","family":"Dajani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blaire","family":"Anderson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doug","family":"O'Gorman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tatsuya","family":"Kin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Bigam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Senior","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"A M James","family":"Shapiro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00114-0_bib1","doi-asserted-by":"crossref","first-page":"9","DOI":"10.2337\/dc13-2112","article-title":"The diabetes control and complications trial\/epidemiology of diabetes interventions and complications study at 30 years: overview","volume":"37","author":"Nathan","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00114-0_bib2","doi-asserted-by":"crossref","first-page":"2188","DOI":"10.2337\/db14-0059","article-title":"Glycemic goals in diabetes: trade-off between glycemic control and iatrogenic hypoglycemia","volume":"63","author":"Cryer","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00114-0_bib3","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1089\/dia.2019.0417","article-title":"The efficacy of technology in type 1 diabetes: a systematic review, network meta-analysis, and narrative synthesis","volume":"22","author":"Pease","year":"2020","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(22)00114-0_bib4","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1053\/j.ajkd.2021.02.339","article-title":"Transplant options for patients with diabetes and advanced kidney disease: a review","volume":"78","author":"Kukla","year":"2021","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(22)00114-0_bib5","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/ajt.13458","article-title":"Long-term follow-up of the edmonton protocol of islet transplantation in the United States","volume":"16","author":"Brennan","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(22)00114-0_bib6","doi-asserted-by":"crossref","first-page":"3725","DOI":"10.1111\/ajt.16637","article-title":"Ten-year outcomes of islet transplantation in patients with type 1 diabetes: data from the Swiss-French GRAGIL network","volume":"21","author":"Lablanche","year":"2021","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(22)00114-0_bib7","doi-asserted-by":"crossref","first-page":"752","DOI":"10.2337\/dc14-1686","article-title":"Glycemic control in simultaneous islet-kidney versus pancreas-kidney transplantation in type 1 diabetes: a prospective 13-year follow-up","volume":"38","author":"Lehmann","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00114-0_bib8","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.2337\/dc20-2458","article-title":"Survival after islet transplantation in subjects with type 1 diabetes: twenty-year follow-up","volume":"44","author":"Lemos","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00114-0_bib9","doi-asserted-by":"crossref","first-page":"2042","DOI":"10.2337\/dc19-0401","article-title":"Ten-year outcome of islet alone or islet after kidney transplantation in type 1 diabetes: a prospective parallel-arm cohort study","volume":"42","author":"Vantyghem","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00114-0_bib10","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/jdi.13128","article-title":"Long-term outcome of islet transplantation on insulin-dependent diabetes mellitus: an observational cohort study","volume":"11","author":"Nakamura","year":"2020","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(22)00114-0_bib11","doi-asserted-by":"crossref","first-page":"e67","DOI":"10.2337\/dc20-2458","article-title":"Survival after islet transplantation in subjects with type 1 diabetes: twenty-year follow-up","volume":"44","author":"Lemos","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00114-0_bib12","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1002\/jhbp.891","article-title":"Clinical islet transplantation: current progress and new frontiers","volume":"28","author":"Marfil-Garza","year":"2021","journal-title":"J Hepatobiliary Pancreat Sci"},{"key":"10.1016\/S2213-8587(22)00114-0_bib13","doi-asserted-by":"crossref","first-page":"2992","DOI":"10.1111\/j.1600-6143.2005.01108.x","article-title":"Prevention of bleeding after islet transplantation: lessons learned from a multivariate analysis of 132 cases at a single institution","volume":"5","author":"Villiger","year":"2005","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(22)00114-0_bib14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1097\/TP.0b013e3181c478fd","article-title":"Insulin-heparin infusions peritransplant substantially improve single-donor clinical islet transplant success","volume":"89","author":"Koh","year":"2010","journal-title":"Transplantation"},{"key":"10.1016\/S2213-8587(22)00114-0_bib16","doi-asserted-by":"crossref","first-page":"2060","DOI":"10.2337\/diabetes.54.7.2060","article-title":"Five-year follow-up after clinical islet transplantation","volume":"54","author":"Ryan","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00114-0_bib17","doi-asserted-by":"crossref","first-page":"955","DOI":"10.2337\/diabetes.53.4.955","article-title":"Assessment of the severity of hypoglycemia and glycemic lability in type 1 diabetic subjects undergoing islet transplantation","volume":"53","author":"Ryan","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00114-0_bib18","doi-asserted-by":"crossref","first-page":"517","DOI":"10.2337\/diacare.18.4.517","article-title":"Reduced awareness of hypoglycemia in adults with IDDM. A prospective study of hypoglycemic frequency and associated symptoms","volume":"18","author":"Clarke","year":"1995","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00114-0_bib19","doi-asserted-by":"crossref","first-page":"1868","DOI":"10.2337\/dc06-2556","article-title":"An evaluation of methods of assessing impaired awareness of hypoglycemia in type 1 diabetes","volume":"30","author":"Geddes","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00114-0_bib20","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1111\/ajt.13807","article-title":"Validation of the BETA-2 score: an improved tool to estimate beta cell function after clinical islet transplantation using a single fasting blood sample","volume":"16","author":"Forbes","year":"2016","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(22)00114-0_bib21","doi-asserted-by":"crossref","first-page":"1897","DOI":"10.2337\/dc11-2054","article-title":"Increased mortality of patients with diabetes reporting severe hypoglycemia","volume":"35","author":"McCoy","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00114-0_bib22","doi-asserted-by":"crossref","first-page":"1240","DOI":"10.1136\/bmj.302.6787.1240","article-title":"Course of brittle diabetes: 12 year follow up","volume":"302","author":"Tattersall","year":"1991","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00114-0_bib23","doi-asserted-by":"crossref","first-page":"e401","DOI":"10.1097\/TXD.0000000000000841","article-title":"Mortality in people with type 1 diabetes, severe hypoglycemia, and impaired awareness of hypoglycemia referred for islet transplantation","volume":"4","author":"Lee","year":"2018","journal-title":"Transplant Direct"},{"key":"10.1016\/S2213-8587(22)00114-0_bib24","doi-asserted-by":"crossref","first-page":"1129","DOI":"10.2337\/diacare.26.4.1129","article-title":"Long-term beneficial effect of islet transplantation on diabetic macro-\/microangiopathy in type 1 diabetic kidney-transplanted patients","volume":"26","author":"Fiorina","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00114-0_bib25","doi-asserted-by":"crossref","first-page":"352","DOI":"10.1016\/j.jpsychores.2014.02.009","article-title":"Suicide risk in type 1 diabetes mellitus: a systematic review","volume":"76","author":"Pompili","year":"2014","journal-title":"J Psychosom Res"},{"key":"10.1016\/S2213-8587(22)00114-0_bib26","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/ajt.16785","article-title":"The impact of islet mass, number of transplants, and time between transplants on graft function in a national islet transplant program","volume":"22","author":"Forbes","year":"2022","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(22)00114-0_bib27","doi-asserted-by":"crossref","first-page":"e973","DOI":"10.1210\/clinem\/dgab787","article-title":"Prolonged islet allograft function is associated with female sex in patients after islet transplantation","volume":"107","author":"Lemos","year":"2022","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00114-0_bib28","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1080\/19382014.2019.1601543","article-title":"Use of anti-inflammatory agents in clinical islet cell transplants: a qualitative systematic analysis","volume":"11","author":"Szempruch","year":"2019","journal-title":"Islets"},{"key":"10.1016\/S2213-8587(22)00114-0_bib29","doi-asserted-by":"crossref","first-page":"990","DOI":"10.1111\/ajt.14620","article-title":"Comparative evaluation of simple indices using a single fasting blood sample to estimate beta cell function after islet transplantation","volume":"18","author":"Go\u0142\u0119biewska","year":"2018","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(22)00114-0_bib30","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0147329","article-title":"The incidence of end-stage renal disease in the diabetic (compared to the non-diabetic) population: a systematic review","volume":"11","author":"Narres","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(22)00114-0_bib31","doi-asserted-by":"crossref","first-page":"2700","DOI":"10.1111\/j.1600-6143.2011.03717.x","article-title":"Portal vein thrombosis is a potentially preventable complication in clinical islet transplantation","volume":"11","author":"Kawahara","year":"2011","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(22)00114-0_bib32","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1111\/tri.13138","article-title":"Defining outcomes for \u03b2-cell replacement therapy in the treatment of diabetes: a consensus report on the Igls criteria from the IPITA\/EPITA opinion leaders workshop","volume":"31","author":"Rickels","year":"2018","journal-title":"Transpl Int"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001140?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001140?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:19Z","timestamp":1761991879000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001140"}},"issued":{"date-parts":[[2022,7]]},"references-count":31,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7]]}},"alternative-id":["S2213858722001140"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00114-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pancreatic islet transplantation in type 1 diabetes: 20-year experience from a single-centre cohort in Canada","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00114-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00138-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T14:26:28Z","timestamp":1794666388100,"version":"4.9.1"},"reference-count":142,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2018,4,1]],"date-time":"2018-04-01T00:00:00Z","timestamp":1522540800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,4]]},"DOI":"10.1016\/s2213-8587(17)30310-8","type":"journal-article","created":{"date-parts":[[2017,10,16]],"date-time":"2017-10-16T21:45:58Z","timestamp":1508190358000},"page":"319-331","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":146,"title":["Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population"],"prefix":"10.1016","volume":"6","author":[{"given":"Adrian","family":"Covic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Vervloet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ziad A","family":"Massy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo Ure\u00f1a","family":"Torres","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goldsmith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vincent","family":"Brandenburg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandro","family":"Mazzaferro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pieter","family":"Evenepoel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jordi","family":"Bover","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mugurel","family":"Apetrii","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario","family":"Cozzolino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30310-8_bib1","doi-asserted-by":"crossref","first-page":"e0158765","DOI":"10.1371\/journal.pone.0158765","article-title":"Global prevalence of chronic kidney disease\u2014a systematic review and meta-analysis","volume":"11","author":"Hill","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30310-8_bib2","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1681\/ASN.2009121311","article-title":"Klotho deficiency causes vascular calcification in chronic kidney disease","volume":"22","author":"Hu","year":"2011","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib3","doi-asserted-by":"crossref","first-page":"S20","DOI":"10.1038\/ki.2011.26","article-title":"Phosphate and klotho","volume":"79","author":"Kuro-o","year":"2011","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/S2213-8587(17)30310-8_bib4","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1681\/ASN.2013101033","article-title":"Klotho gene deficiency causes salt-sensitive hypertension via monocyte chemotactic protein-1\/CC chemokine receptor 2-mediated inflammation","volume":"26","author":"Zhou","year":"2015","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib5","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1016\/j.kint.2016.10.034","article-title":"Recombinant \u03b1-klotho may be prophylactic and therapeutic for acute to chronic kidney disease progression and uremic cardiomyopathy","volume":"91","author":"Hu","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib6","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","article-title":"Changing bone patterns with progression of chronic kidney disease","volume":"89","author":"Dr\u00fceke","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib7","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.4155\/fmc.12.134","article-title":"Small-molecule klotho enhancers as novel treatment of neurodegeneration","volume":"4","author":"Abraham","year":"2012","journal-title":"Future Med Chem"},{"key":"10.1016\/S2213-8587(17)30310-8_bib8","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1161\/01.CIR.0000031732.78052.81","article-title":"Urinary albumin excretion predicts cardiovascular and noncardiovascular mortality in general population","volume":"106","author":"Hillege","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30310-8_bib9","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1007\/BF02390833","article-title":"Bone loss and the progression of abdominal aortic calcification over a 25 year period: the Framingham Heart Study","volume":"68","author":"Kiel","year":"2001","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib10","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1007\/s00223-013-9712-z","article-title":"Vascular calcification: an update on mechanisms and challenges in treatment","volume":"93","author":"Wu","year":"2013","journal-title":"Calcif Tissue Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib11","doi-asserted-by":"crossref","first-page":"e0154740","DOI":"10.1371\/journal.pone.0154740","article-title":"Decreased bone mineral density is an independent predictor for the development of atherosclerosis: a systematic review and meta-analysis","volume":"11","author":"Ye","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30310-8_bib12","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1016\/j.ijcard.2016.11.099","article-title":"Arterial calcification: a new perspective?","volume":"228","author":"Nicoll","year":"2017","journal-title":"Int J Cardiol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib13","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1093\/gerona\/glt046","article-title":"The relevance of mouse models for investigating age-related bone loss in humans","volume":"68","author":"Jilka","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(17)30310-8_bib14","doi-asserted-by":"crossref","first-page":"2126","DOI":"10.1001\/jama.2016.17020","article-title":"Prevalence and prognostic implications of coronary artery calcification in low-risk women: a meta-analysis","volume":"316","author":"Kavousi","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30310-8_bib15","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1161\/HYPERTENSIONAHA.114.03618","article-title":"Matrix metalloproteinases promote arterial remodeling in aging, hypertension, and atherosclerosis","volume":"65","author":"Wang","year":"2015","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30310-8_bib16","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1053\/ajkd.1998.v31.pm9531176","article-title":"Association of serum phosphorus and calcium \u00d7 phosphate product with mortality risk in chronic hemodialysis patients: a national study","volume":"31","author":"Block","year":"1998","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(17)30310-8_bib17","doi-asserted-by":"crossref","first-page":"263","DOI":"10.1016\/j.atherosclerosis.2008.06.012","article-title":"Cardiorespiratory fitness and coronary artery calcification in young adults: the CARDIA Study","volume":"203","author":"Lee","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(17)30310-8_bib18","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1016\/j.jacc.2006.02.040","article-title":"Human degenerative valve disease is associated with up-regulation of low-density lipoprotein receptor-related protein 5 receptor-mediated bone formation","volume":"47","author":"Caira","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib19","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1001\/jamacardio.2017.0363","article-title":"Coronary artery calcification and risk of cardiovascular disease and death among patients with chronic kidney disease","volume":"2","author":"Chen","year":"2017","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib20","doi-asserted-by":"crossref","first-page":"2250","DOI":"10.1056\/NEJMra053077","article-title":"Bone quality\u2014the material and structural basis of bone strength and fragility","volume":"354","author":"Seeman","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30310-8_bib21","doi-asserted-by":"crossref","first-page":"66","DOI":"10.1016\/j.bone.2017.01.035","article-title":"Trabecular bone score (TBS): method and applications","volume":"104","author":"Martineau","year":"2017","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(17)30310-8_bib22","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1007\/s00198-013-2435-1","article-title":"Incidence and risk factors for hip fractures in dialysis patients","volume":"25","author":"Maravic","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib23","doi-asserted-by":"crossref","first-page":"1461","DOI":"10.1681\/ASN.2012090916","article-title":"Temporal trends in fracture rates and postdischarge outcomes among hemodialysis patients","volume":"24","author":"Beaubrun","year":"2013","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib24","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/j.bone.2014.04.017","article-title":"Epidemiology and mortality of hip fracture among patients on dialysis: Taiwan National Cohort Study","volume":"64","author":"Lin","year":"2014","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(17)30310-8_bib25","doi-asserted-by":"crossref","first-page":"672","DOI":"10.1016\/S0272-6386(04)00958-8","article-title":"Increased risk of mortality associated with hip fracture in the dialysis population","volume":"44","author":"Mittalhenkle","year":"2004","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(17)30310-8_bib26","doi-asserted-by":"crossref","first-page":"166","DOI":"10.1038\/ki.2013.279","article-title":"High rates of death and hospitalization follow bone fracture among hemodialysis patients","volume":"85","author":"Tentori","year":"2014","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib27","first-page":"317","article-title":"Fractures in chronic kidney disease: pursuing the best screening and management","volume":"24","author":"Goldenstein","year":"2015","journal-title":"Curr Opin Nephrol Hypertens"},{"key":"10.1016\/S2213-8587(17)30310-8_bib28","doi-asserted-by":"crossref","first-page":"1296","DOI":"10.1056\/NEJMoa041031","article-title":"Chronic kidney disease and the risks of death, cardiovascular events, and hospitalization","volume":"351","author":"Go","year":"2004","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30310-8_bib29","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1038\/ki.2010.483","article-title":"The definition, classification, and prognosis of chronic kidney disease: a KDIGO Controversies Conference report","volume":"80","author":"Levey","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib30","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/j.kint.2015.12.004","article-title":"Changing bone patterns with progression of chronic kidney disease","volume":"89","author":"Dr\u00fceke","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib31","doi-asserted-by":"crossref","first-page":"1952","DOI":"10.1016\/j.jacc.2017.01.064","article-title":"The aging cardiovascular system: understanding it at the cellular and clinical levels","volume":"69","author":"Paneni","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib32","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1161\/CIRCRESAHA.110.234914","article-title":"Arterial calcification in chronic kidney disease: key roles for calcium and phosphate","volume":"109","author":"Shanahan","year":"2011","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib33","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1038\/ki.1997.485","article-title":"Subtotal nephrectomy alters tubular function: effect of phosphorus restriction","volume":"52","author":"Laouari","year":"1997","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib34","doi-asserted-by":"crossref","first-page":"1815","DOI":"10.1111\/j.1523-1755.2005.00600.x","article-title":"Effects of sevelamer and calcium on coronary artery calcification in patients new to hemodialysis","volume":"68","author":"Block","year":"2005","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib35","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1038\/sj.ki.5002466","article-title":"Effects of sevelamer and calcium-based phosphate binders on mortality in hemodialysis patients","volume":"72","author":"Suki","year":"2007","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib36","doi-asserted-by":"crossref","first-page":"e74996","DOI":"10.1371\/journal.pone.0074996","article-title":"Serum phosphate as a risk factor for cardiovascular events in people with and without chronic kidney disease: a large community based cohort study","volume":"8","author":"McGovern","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(17)30310-8_bib37","doi-asserted-by":"crossref","first-page":"311","DOI":"10.3945\/ajcn.116.151654","article-title":"High dietary phosphorus density is a risk factor for incident chronic kidney disease development in diabetic subjects: a community-based prospective cohort study","volume":"106","author":"Yoon","year":"2017","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30310-8_bib38","doi-asserted-by":"crossref","first-page":"2627","DOI":"10.1161\/CIRCULATIONAHA.105.553198","article-title":"Relation between serum phosphate level and cardiovascular event rate in people with coronary disease","volume":"112","author":"Tonelli","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30310-8_bib39","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.2215\/CJN.11181012","article-title":"24-hour urine phosphorus excretion and mortality and cardiovascular events","volume":"8","author":"Palomino","year":"2013","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib40","doi-asserted-by":"crossref","first-page":"320","DOI":"10.3945\/ajcn.113.073148","article-title":"High dietary phosphorus intake is associated with all-cause mortality: results from NHANES III","volume":"99","author":"Chang","year":"2014","journal-title":"Am J Clin Nutr"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(17)30310-8_bib41","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1093\/ndt\/13.suppl_3.65","article-title":"Is it possible to control hyperphosphataemia with diet, without inducing protein malnutrition?","volume":"13","author":"Rufino","year":"1998","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(17)30310-8_bib42","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3-4 chronic kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib43","doi-asserted-by":"crossref","first-page":"1953","DOI":"10.1681\/ASN.2010020221","article-title":"Low socioeconomic status associates with higher serum phosphate irrespective of race","volume":"21","author":"Guti\u00e9rrez","year":"2010","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib44","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1001\/jama.2009.96","article-title":"Effect of food additives on hyperphosphatemia among patients with end-stage renal disease: a randomized controlled trial","volume":"301","author":"Sullivan","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30310-8_bib45","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1016\/j.pec.2015.05.005","article-title":"Effect of behavioral stage-based nutrition education on management of osteodystrophy among hemodialysis patients, Lebanon","volume":"98","author":"Karavetian","year":"2015","journal-title":"Patient Educ Couns"},{"key":"10.1016\/S2213-8587(17)30310-8_bib46","first-page":"476","article-title":"Dietary intervention focused on phosphate intake in hemodialysis patients with hyperphosphoremia","volume":"77","author":"Lou","year":"2012","journal-title":"Clin Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib47","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1525-139X.2007.00309.x","article-title":"Phosphorus homeostasis in normal health and in chronic kidney disease patients with special emphasis on dietary phosphorus intake","volume":"20","author":"Uribarri","year":"2007","journal-title":"Semin Dial"},{"key":"10.1016\/S2213-8587(17)30310-8_bib48","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1053\/j.ajkd.2012.11.051","article-title":"Chronic kidney disease: a clinical model of premature aging","volume":"62","author":"Stenvinkel","year":"2013","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(17)30310-8_bib49","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1053\/j.ajkd.2010.12.027","article-title":"Role of klotho in aging, phosphate metabolism, and CKD","volume":"58","author":"John","year":"2011","journal-title":"Am J Kidney Dis"},{"key":"10.1016\/S2213-8587(17)30310-8_bib50","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(17)30310-8_bib51","doi-asserted-by":"crossref","first-page":"e1003975","DOI":"10.1371\/journal.pgen.1003975","article-title":"Parathyroid-specific deletion of klotho unravels a novel calcineurin-dependent FGF23 signaling pathway that regulates PTH secretion","volume":"9","author":"Olauson","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(17)30310-8_bib52","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s40620-014-0142-4","article-title":"Phosphate balance in ESRD: diet, dialysis and binders against the low evident masked pool","volume":"28","author":"Galassi","year":"2015","journal-title":"J Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib53","doi-asserted-by":"crossref","first-page":"3438","DOI":"10.1096\/fj.10-154765","article-title":"Klotho: a novel phosphaturic substance acting as an autocrine enzyme in the renal proximal tubule","volume":"24","author":"Hu","year":"2010","journal-title":"FASEB J"},{"key":"10.1016\/S2213-8587(17)30310-8_bib54","doi-asserted-by":"crossref","first-page":"429","DOI":"10.1359\/JBMR.0301264","article-title":"FGF-23 is a potent regulator of vitamin D metabolism and phosphate homeostasis","volume":"19","author":"Shimada","year":"2004","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib55","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.1038\/ki.2011.47","article-title":"Fibroblast growth factor 23 is elevated before parathyroid hormone and phosphate in chronic kidney disease","volume":"79","author":"Isakova","year":"2011","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib56","doi-asserted-by":"crossref","first-page":"2650","DOI":"10.1093\/ndt\/gfs160","article-title":"The emerging role of klotho in clinical nephrology","volume":"27","author":"Hu","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(17)30310-8_bib57","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMoa0706130","article-title":"Fibroblast growth factor 23 and mortality among patients undergoing hemodialysis","volume":"359","author":"Guti\u00e9rrez","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30310-8_bib58","doi-asserted-by":"crossref","first-page":"2432","DOI":"10.1001\/jama.2011.826","article-title":"Fibroblast growth factor 23 and risks of mortality and end-stage renal disease in patients with chronic kidney disease","volume":"305","author":"Isakova","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30310-8_bib59","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1161\/CIRCULATIONAHA.114.013876","article-title":"Cinacalcet, fibroblast growth factor-23, and cardiovascular disease in hemodialysis: the Evaluation of Cinacalcet HCl Therapy to Lower Cardiovascular Events (EVOLVE) Trial","volume":"132","author":"Moe","year":"2015","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30310-8_bib60","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.jacc.2012.03.040","article-title":"Fibroblast growth factor-23 and death, heart failure, and cardiovascular events in community-living individuals: CHS (Cardiovascular Health Study)","volume":"60","author":"Ix","year":"2012","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib61","doi-asserted-by":"crossref","first-page":"e000936","DOI":"10.1161\/JAHA.114.000936","article-title":"Fibroblast growth factor-23 and incident coronary heart disease, heart failure, and cardiovascular mortality: the Atherosclerosis Risk in Communities study","volume":"3","author":"Lutsey","year":"2014","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(17)30310-8_bib62","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1038\/ki.2012.327","article-title":"Higher fibroblast growth factor-23 increases the risk of all-cause and cardiovascular mortality in the community","volume":"83","author":"\u00c4rnl\u00f6v","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib63","doi-asserted-by":"crossref","first-page":"409","DOI":"10.1161\/CIRCHEARTFAILURE.113.000952","article-title":"Fibroblast growth factor-23 and cardiovascular disease in the general population: the Multi-Ethnic Study of Atherosclerosis","volume":"7","author":"Kestenbaum","year":"2014","journal-title":"Circ Heart Fail"},{"key":"10.1016\/S2213-8587(17)30310-8_bib64","doi-asserted-by":"crossref","first-page":"3779","DOI":"10.1210\/jc.2016-2215","article-title":"Fibroblast growth factor 23 and cause-specific mortality in the general population: The Northern Manhattan Study","volume":"101","author":"Souma","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30310-8_bib65","doi-asserted-by":"crossref","first-page":"2169","DOI":"10.1681\/ASN.2013111209","article-title":"The kidney is the principal organ mediating klotho effects","volume":"25","author":"Lindberg","year":"2014","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib66","doi-asserted-by":"crossref","first-page":"e003486","DOI":"10.1161\/JAHA.116.003486","article-title":"Plasma fibroblast growth factor 23: clinical correlates and association with cardiovascular disease and mortality in the Framingham Heart Study","volume":"5","author":"Haring","year":"2016","journal-title":"J Am Heart Assoc"},{"key":"10.1016\/S2213-8587(17)30310-8_bib67","doi-asserted-by":"crossref","first-page":"2421","DOI":"10.1016\/j.jacc.2014.03.026","article-title":"Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart disease","volume":"63","author":"Udell","year":"2014","journal-title":"J Am Soc Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib68","doi-asserted-by":"crossref","first-page":"4393","DOI":"10.1172\/JCI46122","article-title":"FGF23 induces left ventricular hypertrophy","volume":"121","author":"Faul","year":"2011","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(17)30310-8_bib69","doi-asserted-by":"crossref","first-page":"3125","DOI":"10.1093\/ndt\/gfp205","article-title":"Relationship between circulating FGF23 and total body atherosclerosis in the community","volume":"24","author":"Mirza","year":"2009","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(17)30310-8_bib70","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/j.atherosclerosis.2009.01.001","article-title":"Circulating fibroblast growth factor-23 is associated with vascular dysfunction in the community","volume":"205","author":"Mirza","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(17)30310-8_bib71","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1681\/ASN.2008070783","article-title":"Initial FGF23-mediated signaling occurs in the distal convoluted tubule","volume":"20","author":"Farrow","year":"2009","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib72","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1002\/glia.20593","article-title":"Gene profile analysis implicates klotho as an important contributor to aging changes in brain white matter of the rhesus monkey","volume":"56","author":"Duce","year":"2008","journal-title":"Glia"},{"key":"10.1016\/S2213-8587(17)30310-8_bib73","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1007\/s11357-011-9315-4","article-title":"Promoter methylation and age-related downregulation of Klotho in rhesus monkey","volume":"34","author":"King","year":"2012","journal-title":"Age (Dordr)"},{"key":"10.1016\/S2213-8587(17)30310-8_bib74","doi-asserted-by":"crossref","first-page":"640","DOI":"10.1038\/ki.2011.445","article-title":"Suppression of klotho expression by protein-bound uremic toxins is associated with increased DNA methyltransferase expression and DNA hypermethylation","volume":"81","author":"Sun","year":"2012","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib75","doi-asserted-by":"crossref","first-page":"396","DOI":"10.1046\/j.1523-1755.2000.00178.x","article-title":"Increased risk of hip fracture among patients with end-stage renal disease","volume":"58","author":"Alem","year":"2000","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib76","doi-asserted-by":"crossref","first-page":"3014","DOI":"10.1001\/jama.288.23.3014","article-title":"Risk of hip fracture among dialysis and renal transplant recipients","volume":"288","author":"Ball","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30310-8_bib77","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1681\/ASN.2005111194","article-title":"Relationship between moderate to severe kidney disease and hip fracture in the United States","volume":"17","author":"Nickolas","year":"2006","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib78","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1007\/s00774-012-0411-z","article-title":"Increased risk of hip fracture among Japanese hemodialysis patients","volume":"31","author":"Wakasugi","year":"2013","journal-title":"J Bone Miner Metab"},{"key":"10.1016\/S2213-8587(17)30310-8_bib79","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1038\/sj.ki.5001754","article-title":"Incidence and risk factors for hip or other bone fractures among hemodialysis patients in the Dialysis Outcomes and Practice Patterns Study","volume":"70","author":"Jadoul","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib80","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1007\/s00198-003-1532-y","article-title":"Long-term fracture risk following renal transplantation: a population-based study","volume":"15","author":"Vautour","year":"2004","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib81","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1007\/s00198-015-3238-3","article-title":"The mortality and direct medical costs of osteoporotic fractures among postmenopausal women in Taiwan","volume":"27","author":"Chang","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib82","doi-asserted-by":"crossref","first-page":"878","DOI":"10.1016\/S0140-6736(98)09075-8","article-title":"Mortality after all major types of osteoporotic fracture in men and women: an observational study","volume":"353","author":"Center","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30310-8_bib83","doi-asserted-by":"crossref","first-page":"1161","DOI":"10.1007\/s00198-007-0539-1","article-title":"Progression of vascular calcifications is associated with greater bone loss and increased bone fractures","volume":"19","author":"Naves","year":"2008","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib84","doi-asserted-by":"crossref","first-page":"1945","DOI":"10.1038\/sj.ki.5000414","article-title":"Definition, evaluation, and classification of renal osteodystrophy: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO)","volume":"69","author":"Moe","year":"2006","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib85","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1038\/kisup.2013.93","article-title":"Uremic osteoporosis","volume":"3","author":"Kazama","year":"2013","journal-title":"Kidney Int Suppl (2011)"},{"key":"10.1016\/S2213-8587(17)30310-8_bib86","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.semnephrol.2014.09.004","article-title":"When, how, and why a bone biopsy should be performed in patients with chronic kidney disease","volume":"34","author":"Torres","year":"2014","journal-title":"Semin Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib87","first-page":"57","article-title":"Fractures and vertebral bone mineral density in patients with renal osteodystrophy","volume":"30","author":"Piraino","year":"1988","journal-title":"Clin Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib88","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2014a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(17)30310-8_bib89","doi-asserted-by":"crossref","first-page":"626","DOI":"10.1016\/j.semnephrol.2014.09.008","article-title":"Adynamic bone disease: from bone to vessels in chronic kidney disease","volume":"34","author":"Bover","year":"2014","journal-title":"Semin Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib90","first-page":"135","article-title":"Adynamic bone disease-bone and beyond","volume":"1","author":"Brandenburg","year":"2008","journal-title":"NDT Plus"},{"key":"10.1016\/S2213-8587(17)30310-8_bib91","doi-asserted-by":"crossref","first-page":"1184","DOI":"10.1016\/j.kint.2016.06.041","article-title":"Parathyroid hormone metabolism and signaling in health and chronic kidney disease","volume":"90","author":"Evenepoel","year":"2016","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib92","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1002\/jbmr.2702","article-title":"Adynamic bone decreases bone toughness during aging by affecting mineral and matrix","volume":"31","author":"Ng","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib93","doi-asserted-by":"crossref","first-page":"855","DOI":"10.1038\/ki.1994.342","article-title":"Evidence for abnormal calcium homeostasis in patients with adynamic bone disease","volume":"46","author":"Kurz","year":"1994","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib94","doi-asserted-by":"crossref","first-page":"1943","DOI":"10.1097\/01.ASN.0000129337.50739.48","article-title":"Arterial calcifications and bone histomorphometry in end-stage renal disease","volume":"15","author":"London","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib95","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.1210\/jc.2012-4188","article-title":"Mineral metabolism and cortical volumetric bone mineral density in childhood chronic kidney disease","volume":"98","author":"Denburg","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30310-8_bib96","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jbmr.2406","article-title":"Bone mineral density predicts fractures in chronic kidney disease","volume":"30","author":"West","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib97","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","article-title":"Bone mineral density and fracture risk in older individuals with CKD","volume":"7","author":"Yenchek","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib98","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1093\/ndt\/gfr317","article-title":"Diagnostic usefulness of bone mineral density and biochemical markers of bone turnover in predicting fracture in CKD stage 5D patients\u2014a single-center cohort study","volume":"27","author":"Iimori","year":"2012","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(17)30310-8_bib99","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2215\/CJN.06040614","article-title":"Comparison of fracture risk prediction among individuals with reduced and normal kidney function","volume":"10","author":"Naylor","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib100","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.kint.2017.04.006","article-title":"Executive summary of the 2017 KDIGO Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD\u2013MBD) Guideline Update: what's changed and why it matters","volume":"92","author":"Ketteler","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib101","doi-asserted-by":"crossref","first-page":"646","DOI":"10.2215\/CJN.06040614","article-title":"Comparison of fracture risk prediction among individuals with reduced and normal kidney function","volume":"10","author":"Naylor","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib102","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1002\/jbmr.2406","article-title":"Bone mineral density predicts fractures in chronic kidney disease","volume":"30","author":"West","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib103","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.2215\/CJN.12871211","article-title":"Bone mineral density and fracture risk in older individuals with CKD","volume":"7","author":"Yenchek","year":"2012","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib104","doi-asserted-by":"crossref","first-page":"2647","DOI":"10.1111\/j.1600-6143.2008.02423.x","article-title":"Can DXA predict fractures in renal transplant patients?","volume":"8","author":"Akaberi","year":"2008","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(17)30310-8_bib105","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1007\/s00198-013-2524-1","article-title":"The clinical utility of FRAX to discriminate fracture status in men and women with chronic kidney disease","volume":"25","author":"Jamal","year":"2014","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib106","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1097\/01.TP.0000438200.84154.1a","article-title":"FRAX predicts fracture risk in kidney transplant recipients","volume":"97","author":"Naylor","year":"2014","journal-title":"Transplantation"},{"key":"10.1016\/S2213-8587(17)30310-8_bib107","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.2215\/CJN.09470913","article-title":"Bone mineral density and serum biochemical predictors of bone loss in patients with CKD on dialysis","volume":"9","author":"Malluche","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib108","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1053\/j.ajkd.2014.09.023","article-title":"The future burden of CKD in the United States: a simulation model for the CDC CKD Initiative","volume":"65","author":"Hoerger","year":"2015","journal-title":"Am J Kindey Dis"},{"key":"10.1016\/S2213-8587(17)30310-8_bib109","doi-asserted-by":"crossref","first-page":"2520","DOI":"10.1002\/jbmr.2269","article-title":"The recent prevalence of osteoporosis and low bone mass in the United States based on bone mineral density at the femoral neck or lumbar spine","volume":"29","author":"Wright","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib110","doi-asserted-by":"crossref","first-page":"1537","DOI":"10.1056\/NEJMcp1210380","article-title":"Clinical practice. Calcium supplements and fracture prevention","volume":"369","author":"Bauer","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30310-8_bib111","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1056\/NEJMoa055218","article-title":"Calcium plus vitamin D supplementation and the risk of fractures","volume":"354","author":"Jackson","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30310-8_bib112","doi-asserted-by":"crossref","first-page":"h4580","DOI":"10.1136\/bmj.h4580","article-title":"Calcium intake and risk of fracture: systematic review","volume":"351","author":"Bolland","year":"2015","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30310-8_bib113","doi-asserted-by":"crossref","first-page":"1780","DOI":"10.1093\/ajcn\/86.5.1780","article-title":"Calcium intake and hip fracture risk in men and women: a meta-analysis of prospective cohort studies and randomized controlled trials","volume":"86","author":"Bischoff-Ferrari","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(17)30310-8_bib114","doi-asserted-by":"crossref","first-page":"c3691","DOI":"10.1136\/bmj.c3691","article-title":"Effect of calcium supplements on risk of myocardial infarction and cardiovascular events: meta-analysis","volume":"341","author":"Bolland","year":"2010","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30310-8_bib115","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1002\/jbmr.2311","article-title":"The effects of calcium supplementation on verified coronary heart disease hospitalization and death in postmenopausal women: a collaborative meta-analysis of randomized controlled trials","volume":"30","author":"Lewis","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib116","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1517\/14740338.2014.937423","article-title":"Cardiovascular complications of calcium supplementation in chronic kidney disease: are there arrhythmic risks?","volume":"13","author":"Genovesi","year":"2014","journal-title":"Expert Opin Drug Saf"},{"key":"10.1016\/S2213-8587(17)30310-8_bib117","doi-asserted-by":"crossref","first-page":"959","DOI":"10.1038\/ki.2012.403","article-title":"Oral calcium carbonate affects calcium but not phosphorus balance in stage 3\u20134 chronic kidney disease","volume":"83","author":"Hill","year":"2013","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib118","doi-asserted-by":"crossref","first-page":"1116","DOI":"10.1038\/ki.2011.490","article-title":"Calcium balance in normal individuals and in patients with chronic kidney disease on low- and high-calcium diets","volume":"81","author":"Spiegel","year":"2012","journal-title":"Kidney Int"},{"issue":"suppl 113","key":"10.1016\/S2213-8587(17)30310-8_bib119","first-page":"S1","article-title":"KDIGO clinical practice guideline for the diagnosis, evaluation, prevention, and treatment of Chronic Kidney Disease\u2013Mineral and Bone Disorder (CKD\u2013MBD)","volume":"76","author":"Moe","year":"2009","journal-title":"Kidney Int Suppl"},{"key":"10.1016\/S2213-8587(17)30310-8_bib120","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/S0140-6736(13)60439-0","article-title":"Evolving importance of kidney disease: from subspecialty to global health burden","volume":"382","author":"Eckardt","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30310-8_bib121","series-title":"Dietary reference intakes for calcium and vitamin D","first-page":"35","article-title":"Chapter 2","author":"Ross","year":"2011"},{"key":"10.1016\/S2213-8587(17)30310-8_bib122","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1038\/ki.2014.425","article-title":"Revisiting KDIGO clinical practice guideline on chronic kidney disease\u2013mineral and bone disorder: a commentary from a Kidney Disease: Improving Global Outcomes controversies conference","volume":"87","author":"Ketteler","year":"2015","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib123","doi-asserted-by":"crossref","first-page":"1430","DOI":"10.1681\/ASN.2007050555","article-title":"The effect of raloxifene treatment in postmenopausal women with CKD","volume":"19","author":"Ishani","year":"2008","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib124","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.070112","article-title":"Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial","volume":"22","author":"Jamal","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib125","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1359\/JBMR.050817","article-title":"Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib126","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1007\/s00198-006-0189-8","article-title":"Teriparatide in postmenopausal women with osteoporosis and mild or moderate renal impairment","volume":"18","author":"Miller","year":"2007","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib127","doi-asserted-by":"crossref","first-page":"2269","DOI":"10.1046\/j.1523-1755.2003.00005.x","article-title":"Effects of raloxifene on bone metabolism and serum lipids in postmenopausal women on chronic hemodialysis","volume":"63","author":"Hern\u00e1ndez","year":"2003","journal-title":"Kidney Int"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(17)30310-8_bib128","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1111\/j.1744-9987.2011.00929.x","article-title":"Effects of raloxifene on bone mineral metabolism in postmenopausal Japanese women on hemodialysis","volume":"15","author":"Tanaka","year":"2011","journal-title":"Ther Apher Dial"},{"key":"10.1016\/S2213-8587(17)30310-8_bib129","doi-asserted-by":"crossref","first-page":"450","DOI":"10.5301\/jn.5000188","article-title":"Bisphosphonate therapy in renal osteodystrophy\u2014a review","volume":"26","author":"Bergner","year":"2013","journal-title":"J Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib130","doi-asserted-by":"crossref","first-page":"649","DOI":"10.7326\/M16-2752","article-title":"Benefits and harms of osteoporosis medications in patients with chronic kidney disease: a systematic review and meta-analysis","volume":"166","author":"Wilson","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30310-8_bib131","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1359\/jbmr.070112","article-title":"Alendronate treatment in women with normal to severely impaired renal function: an analysis of the fracture intervention trial","volume":"22","author":"Jamal","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib132","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1359\/JBMR.050817","article-title":"Safety and efficacy of risedronate in patients with age-related reduced renal function as estimated by the Cockcroft and Gault method: a pooled analysis of nine clinical trials","volume":"20","author":"Miller","year":"2005","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib134","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1159\/000276666","article-title":"Bisphosphonate use in chronic kidney disease: association with adynamic bone disease in a bone histology series","volume":"29","author":"Amerling","year":"2010","journal-title":"Blood Purif"},{"key":"10.1016\/S2213-8587(17)30310-8_bib135","doi-asserted-by":"crossref","first-page":"43399","DOI":"10.1038\/srep43399","article-title":"Long-term effects of bisphosphonate therapy: perforations, microcracks and mechanical properties","volume":"7","author":"Ma","year":"2017","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(17)30310-8_bib136","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/joim.12361","article-title":"How to predict and treat increased fracture risk in chronic kidney disease","volume":"278","author":"West","year":"2015","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(17)30310-8_bib137","doi-asserted-by":"crossref","first-page":"1829","DOI":"10.1002\/jbmr.403","article-title":"Effects of denosumab on fracture and bone mineral density by level of kidney function","volume":"26","author":"Jamal","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib138","doi-asserted-by":"crossref","first-page":"1677","DOI":"10.1093\/annonc\/mdv136","article-title":"Renal effects of molecular targeted therapies in oncology: a review by the Cancer and the Kidney International Network (C-KIN)","volume":"26","author":"Launay-Vacher","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib139","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1002\/jbmr.1613","article-title":"A single-dose study of denosumab in patients with various degrees of renal impairment","volume":"27","author":"Block","year":"2012","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib140","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1159\/000316708","article-title":"Treatment of hemodialysis-associated adynamic bone disease with teriparatide (PTH1-34): a pilot study","volume":"33","author":"Cejka","year":"2010","journal-title":"Kidney Blood Press Res"},{"key":"10.1016\/S2213-8587(17)30310-8_bib141","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1007\/s00198-015-3377-6","article-title":"Once-weekly teriparatide in hemodialysis patients with hypoparathyroidism and low bone mass: a prospective study","volume":"27","author":"Sumida","year":"2016","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(17)30310-8_bib142","doi-asserted-by":"crossref","first-page":"411","DOI":"10.1097\/01.ASN.0000100125.21491.46","article-title":"The number, quality, and coverage of randomized controlled trials in nephrology","volume":"15","author":"Strippoli","year":"2004","journal-title":"J Am Soc Nephrol"},{"key":"10.1016\/S2213-8587(17)30310-8_bib143","doi-asserted-by":"crossref","first-page":"1929","DOI":"10.2215\/CJN.09500916","article-title":"Fractures in patients with CKD: time for action","volume":"11","author":"Moe","year":"2016","journal-title":"Clin J Am Soc Nephrol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:59Z","timestamp":1761991559000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303108"}},"issued":{"date-parts":[[2018,4]]},"references-count":142,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2018,4]]}},"alternative-id":["S2213858717303108"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30310-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Bone and mineral disorders in chronic kidney disease: implications for cardiovascular health and ageing in the general population","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30310-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:11:07Z","timestamp":1780665067727,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/s2213-8587(25)00355-9","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T23:39:15Z","timestamp":1769643555000},"page":"191-192","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Gene-environment interactions underlying temporal trends in type 2 diabetes prevalence"],"prefix":"10.1016","volume":"14","author":[{"given":"Tiange","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00355-9_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00355-9_bib2","doi-asserted-by":"crossref","first-page":"1530","DOI":"10.1016\/j.cell.2021.02.012","article-title":"Metabolic consequences of obesity and type 2 diabetes: balancing genes and environment for personalized care","volume":"184","author":"Pillon","year":"2021","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(25)00355-9_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00322-5","article-title":"Temporal changes and genetic susceptibility to type 2 diabetes (1984\u20132019; HUNT): a longitudinal, population-based study","author":"Bjark\u00f8","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00355-9_bib4","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1126\/science.aaf5094","article-title":"Exposing the exposures responsible for type 2 diabetes and obesity","volume":"354","author":"Franks","year":"2016","journal-title":"Science"},{"key":"10.1016\/S2213-8587(25)00355-9_bib5","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/em-2013-0005","article-title":"A tutorial on interaction","volume":"3","author":"VanderWeele","year":"2014","journal-title":"Epidemiol Methods"},{"key":"10.1016\/S2213-8587(25)00355-9_bib6","doi-asserted-by":"crossref","first-page":"3789","DOI":"10.1016\/j.cell.2024.06.029","article-title":"Diabetes mellitus\u2014progress and opportunities in the evolving epidemic","volume":"187","author":"Abel","year":"2024","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(25)00355-9_bib7","doi-asserted-by":"crossref","first-page":"258","DOI":"10.2337\/dci20-0053","article-title":"Social determinants of health and diabetes: a scientific review","volume":"44","author":"Hill-Briggs","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00355-9_bib8","doi-asserted-by":"crossref","first-page":"1387","DOI":"10.1056\/NEJMoa1203039","article-title":"Sugar-sweetened beverages and genetic risk of obesity","volume":"367","author":"Qi","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00355-9_bib9","article-title":"Improving adherence to healthy dietary patterns, genetic risk, and long term weight gain: gene-diet interaction analysis in two prospective cohort studies","volume":"360","author":"Wang","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00355-9_bib10","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1038\/s41576-018-0018-x","article-title":"The personal and clinical utility of polygenic risk scores","volume":"19","author":"Torkamani","year":"2018","journal-title":"Nat Rev Genet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003559?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003559?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:29:45Z","timestamp":1780662585000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003559"}},"issued":{"date-parts":[[2026,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2213858725003559"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00355-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gene-environment interactions underlying temporal trends in type 2 diabetes prevalence","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00355-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00322-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,2,13]],"date-time":"2026-02-13T17:16:12Z","timestamp":1771002972261,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2017,5,1]],"date-time":"2017-05-01T00:00:00Z","timestamp":1493596800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,5]]},"DOI":"10.1016\/s2213-8587(17)30067-0","type":"journal-article","created":{"date-parts":[[2017,3,2]],"date-time":"2017-03-02T06:17:01Z","timestamp":1488435421000},"page":"317-319","source":"Crossref","is-referenced-by-count":3,"title":["Does fetal exposure to vitamin D programme childhood bone mass?"],"prefix":"10.1016","volume":"5","author":[{"given":"Christopher S","family":"Kovacs","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30067-0_bib1","doi-asserted-by":"publisher","first-page":"1143","DOI":"10.1152\/physrev.00014.2014","article-title":"Bone development and mineral homeostasis in the fetus and neonate: roles of the calciotropic and phosphotropic hormones","volume":"94","author":"Kovacs","year":"2014","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(17)30067-0_bib2","doi-asserted-by":"publisher","first-page":"1803","DOI":"10.1172\/JCI45890","article-title":"Normocalcemia is maintained in mice under conditions of calcium malabsorption by vitamin D-induced inhibition of bone mineralization","volume":"122","author":"Lieben","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(17)30067-0_bib3","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1053\/j.gastro.2008.12.051","article-title":"Intestinal vitamin D receptor is required for normal calcium and bone metabolism in mice","volume":"136","author":"Xue","year":"2009","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(17)30067-0_bib4","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/S2213-8587(16)00044-9","article-title":"Maternal gestational vitamin D supplementation and offspring bone health (MAVIDOS): a multicentre, double-blind, randomised placebo-controlled trial","volume":"4","author":"Cooper","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30067-0_bib5","doi-asserted-by":"publisher","first-page":"36","DOI":"10.1016\/S0140-6736(06)67922-1","article-title":"Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study","volume":"367","author":"Javaid","year":"2006","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30067-0_bib6","doi-asserted-by":"publisher","first-page":"2176","DOI":"10.1016\/S0140-6736(12)62203-X","article-title":"Association of maternal vitamin D status during pregnancy with bone-mineral content in offspring: a prospective cohort study","volume":"381","author":"Lawlor","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30067-0_bib7","doi-asserted-by":"publisher","DOI":"10.1016\/S2213-8587(17)30064-5","article-title":"25-hydroxyvitamin D concentrations during fetal life and bone health in children aged 6 years: a population-based prospective cohort study","author":"Garcia","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30067-0_bib8","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1152\/physrev.00027.2015","article-title":"Maternal mineral and bone metabolism during pregnancy, lactation, and post-weaning recovery","volume":"96","author":"Kovacs","year":"2016","journal-title":"Physiol Rev"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717300670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,3]],"date-time":"2018-09-03T22:51:09Z","timestamp":1536015069000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717300670"}},"issued":{"date-parts":[[2017,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2017,5]]}},"alternative-id":["S2213858717300670"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30067-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,5]]}},{"indexed":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:52:59Z","timestamp":1781585579600,"version":"3.54.5"},"reference-count":13,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,10,1]],"date-time":"2016-10-01T00:00:00Z","timestamp":1475280000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2016,7,25]],"date-time":"2016-07-25T00:00:00Z","timestamp":1469404800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,10]]},"DOI":"10.1016\/s2213-8587(16)30115-2","type":"journal-article","created":{"date-parts":[[2016,7,28]],"date-time":"2016-07-28T00:00:34Z","timestamp":1469664034000},"page":"800-801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["The POWeR of looking into the black box"],"prefix":"10.1016","volume":"4","author":[{"given":"Emily","family":"Brindal","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30115-2_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)30099-7","article-title":"An internet-based intervention with brief nurse support to manage obesity in primary care (POWeR2): a pragmatic, parallel-group, randomised controlled trial","author":"Little","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30115-2_bib2","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1186\/1479-5868-11-67","article-title":"Randomised controlled feasibility trial of a web-based weight management intervention with nurse support for obese patients in primary care","volume":"11","author":"Yardley","year":"2014","journal-title":"Int J Behav Nutr Phys Act"},{"key":"10.1016\/S2213-8587(16)30115-2_bib3","doi-asserted-by":"crossref","first-page":"e30","DOI":"10.2196\/jmir.4055","article-title":"The person-based approach to intervention development: application to digital health-related behavior change interventions","volume":"17","author":"Yardley","year":"2015","journal-title":"J Med Internet Res"},{"key":"10.1016\/S2213-8587(16)30115-2_bib4","doi-asserted-by":"crossref","first-page":"1959","DOI":"10.1056\/NEJMoa1108660","article-title":"Comparative effectiveness of weight-loss interventions in clinical practice","volume":"365","author":"Appel","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30115-2_bib5","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1111\/j.1467-789X.2009.00646.x","article-title":"Effectiveness of web-based interventions in achieving weight loss and weight loss maintenance in overweight and obese adults: a systematic review with meta-analysis","volume":"11","author":"Neve","year":"2010","journal-title":"Obesity Rev"},{"key":"10.1016\/S2213-8587(16)30115-2_bib6","doi-asserted-by":"crossref","first-page":"e125","DOI":"10.2196\/jmir.1923","article-title":"CONSORT-EHEALTH: improving and standardizing evaluation reports of web-based and mobile health interventions","volume":"13","author":"Eysenbach","year":"2011","journal-title":"J Med Internet Res"},{"key":"10.1016\/S2213-8587(16)30115-2_bib7","doi-asserted-by":"crossref","first-page":"e11","DOI":"10.2196\/jmir.7.1.e11","article-title":"The law of attrition","volume":"7","author":"Eysenbach","year":"2005","journal-title":"J Med Internet Res"},{"key":"10.1016\/S2213-8587(16)30115-2_bib8","doi-asserted-by":"crossref","first-page":"17","DOI":"10.2196\/jmir.2104","article-title":"persuasive system design does matter: a systematic review of adherence to web-based interventions","volume":"14","author":"Kelders","year":"2012","journal-title":"J Med Internet Res"},{"key":"10.1016\/S2213-8587(16)30115-2_bib9","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.2196\/jmir.2156","article-title":"Features predicting weight loss in overweight or obese participants in a web-based intervention: randomized trial","volume":"14","author":"Brindal","year":"2012","journal-title":"J Med Internet Res"},{"key":"10.1016\/S2213-8587(16)30115-2_bib10","doi-asserted-by":"crossref","first-page":"e8","DOI":"10.2196\/humanfactors.4310","article-title":"A visualization tool to analyse usage of web-based interventions: the example of Positive Online Weight Reduction (POWeR)","volume":"2","author":"Arden-Close","year":"2015","journal-title":"JMIR Hum Factors"},{"issue":"1 suppl","key":"10.1016\/S2213-8587(16)30115-2_bib11","doi-asserted-by":"crossref","first-page":"222S","DOI":"10.1093\/ajcn\/82.1.222S","article-title":"Long-term weight loss maintenance","volume":"82","author":"Wing","year":"2005","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(16)30115-2_bib12","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1001\/jama.299.10.1139","article-title":"Comparison of strategies for sustaining weight loss: the weight loss maintenance randomized controlled trial","volume":"299","author":"Svetkey","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30115-2_bib13","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa061883","article-title":"A self-regulation program for maintenance of weight loss","volume":"355","author":"Wing","year":"2006","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301152?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301152?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T04:11:34Z","timestamp":1781583094000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301152"}},"issued":{"date-parts":[[2016,10]]},"references-count":13,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2016,10]]}},"alternative-id":["S2213858716301152"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30115-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The POWeR of looking into the black box","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30115-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30099-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T16:10:46Z","timestamp":1778861446615,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,8,1]],"date-time":"2024-08-01T00:00:00Z","timestamp":1722470400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,8]]},"DOI":"10.1016\/s2213-8587(24)00158-x","type":"journal-article","created":{"date-parts":[[2024,6,17]],"date-time":"2024-06-17T18:36:16Z","timestamp":1718649376000},"page":"510-513","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Call for effective therapies for preventing dementia in people with type 2 diabetes"],"prefix":"10.1016","volume":"12","author":[{"given":"Thomas T","family":"van Sloten","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jos\u00e9 A","family":"Luchsinger","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lenore J","family":"Launer","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mark","family":"Strachan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tali","family":"Cukierman-Yaffe","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hertzel C","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geert Jan","family":"Biessels","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00158-X_bib1","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.3233\/JAD-190427","article-title":"Diabetes-associated dementia risk and competing risk of death in the Three-City study","volume":"71","author":"Frison","year":"2019","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/S2213-8587(24)00158-X_bib2","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2022-074068","article-title":"Benefits and harms of drug treatment for type 2 diabetes: systematic review and network meta-analysis of randomised controlled trials","volume":"381","author":"Shi","year":"2023","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00158-X_bib3","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S2213-8587(20)30118-2","article-title":"Type 2 diabetes and cognitive dysfunction\u2014towards effective management of both comorbidities","volume":"8","author":"Srikanth","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00158-X_bib4","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/S1474-4422(20)30139-3","article-title":"Understanding multifactorial brain changes in type 2 diabetes: a biomarker perspective","volume":"19","author":"Biessels","year":"2020","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(24)00158-X_bib5","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(11)70188-0","article-title":"Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy","volume":"10","author":"Launer","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(24)00158-X_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/j.phrs.2022.106062","article-title":"Cognitive impairment and type 2 diabetes mellitus: focus of SGLT2 inhibitors treatment","volume":"176","author":"Rizzo","year":"2022","journal-title":"Pharmacol Res"},{"key":"10.1016\/S2213-8587(24)00158-X_bib7","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1038\/s41380-022-01792-4","article-title":"Incretin and insulin signaling as novel therapeutic targets for Alzheimer's and Parkinson's disease","volume":"28","author":"Nowell","year":"2023","journal-title":"Mol Psychiatry"},{"key":"10.1016\/S2213-8587(24)00158-X_bib8","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2337\/dc19-0783","article-title":"Effect of linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the CARMELINA randomized trial","volume":"42","author":"Biessels","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00158-X_bib9","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1007\/s00125-021-05393-8","article-title":"Effects of linagliptin vs glimepiride on cognitive performance in type 2 diabetes: results of the randomised double-blind, active-controlled CAROLINA-COGNITION study","volume":"64","author":"Biessels","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00158-X_bib10","doi-asserted-by":"crossref","first-page":"582","DOI":"10.1016\/S1474-4422(20)30173-3","article-title":"Effect of dulaglutide on cognitive impairment in type 2 diabetes: an exploratory analysis of the REWIND trial","volume":"19","author":"Cukierman-Yaffe","year":"2020","journal-title":"Lancet Neurol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872400158X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872400158X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:26:46Z","timestamp":1778858806000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872400158X"}},"issued":{"date-parts":[[2024,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2024,8]]}},"alternative-id":["S221385872400158X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00158-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Call for effective therapies for preventing dementia in people with type 2 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00158-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,7,28]],"date-time":"2026-07-28T02:54:34Z","timestamp":1785207274153,"version":"3.55.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/s2213-8587(21)00112-1","type":"journal-article","created":{"date-parts":[[2021,4,21]],"date-time":"2021-04-21T03:09:07Z","timestamp":1618974547000},"page":"406","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Petrifying: ears as hard as stone in adrenal insufficiency"],"prefix":"10.1016","volume":"9","author":[{"given":"Swantje","family":"Kannenberg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Svenja","family":"Meyh\u00f6fer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hendrik","family":"Lehnert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian M","family":"Schmid","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001121?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001121?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:35Z","timestamp":1761991775000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001121"}},"issued":{"date-parts":[[2021,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213858721001121"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00112-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Petrifying: ears as hard as stone in adrenal insufficiency","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00112-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,5,9]],"date-time":"2026-05-09T09:47:41Z","timestamp":1778320061522,"version":"3.51.4"},"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/s2213-8587(23)00042-6","type":"journal-article","created":{"date-parts":[[2023,2,21]],"date-time":"2023-02-21T23:23:59Z","timestamp":1677021839000},"page":"139","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Rare diseases: individually rare, collectively common"],"prefix":"10.1016","volume":"11","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000426?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723000426?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:36Z","timestamp":1761991956000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723000426"}},"issued":{"date-parts":[[2023,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2213858723000426"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00042-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Rare diseases: individually rare, collectively common","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00042-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,6,21]],"date-time":"2025-06-21T08:24:32Z","timestamp":1750494272961,"version":"3.38.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/s2213-8587(23)00355-8","type":"journal-article","created":{"date-parts":[[2023,12,4]],"date-time":"2023-12-04T23:33:51Z","timestamp":1701732831000},"page":"5-8","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Empagliflozin in chronic kidney disease: nephroprotection is independent of albuminuria, primary kidney disease, and baseline eGFR"],"prefix":"10.1016","volume":"12","author":[{"given":"Carmine","family":"Zoccali","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesca","family":"Mallamaci","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00355-8_bib1","doi-asserted-by":"crossref","first-page":"2017","DOI":"10.1093\/cvr\/cvad083","article-title":"Cardiovascular complications in chronic kidney disease: a review from the European Renal and Cardiovascular Medicine Working Group of the European Renal Association","volume":"119","author":"Zoccali","year":"2023","journal-title":"Cardiovasc Res"},{"key":"10.1016\/S2213-8587(23)00355-8_bib2","doi-asserted-by":"crossref","first-page":"ii194","DOI":"10.1093\/ndt\/gfw440","article-title":"Non-proteinuric rather than proteinuric renal diseases are the leading cause of end-stage kidney disease","volume":"32","author":"Bolignano","year":"2017","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(23)00355-8_bib3","doi-asserted-by":"crossref","first-page":"1436","DOI":"10.1056\/NEJMoa2024816","article-title":"Dapagliflozin in patients with chronic kidney disease","volume":"383","author":"Heerspink","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00355-8_bib4","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1056\/NEJMoa2204233","article-title":"Empagliflozin in patients with chronic kidney disease","volume":"388","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00355-8_bib5","doi-asserted-by":"crossref","first-page":"821","DOI":"10.1053\/j.ajkd.2014.07.030","article-title":"GFR decline as an end point for clinical trials in CKD: a scientific workshop sponsored by the National Kidney Foundation and the US Food and Drug Administration","volume":"64","author":"Levey","year":"2014","journal-title":"Am J Kidney Dis"},{"journal-title":"Lancet Diabetes Endocrinol","article-title":"Effects of empagliflozin on progression of chronic kidney disease: a prespecified secondary analysis from the EMPA-KIDNEY trial","year":"2023","key":"10.1016\/S2213-8587(23)00355-8_bib6"},{"journal-title":"Lancet Diabetes Endocrinol","article-title":"Impact of primary kidney disease on the effects of empagliflozin in patients with chronic kidney disease: secondary analyses of the EMPA-KIDNEY trial","year":"2023","key":"10.1016\/S2213-8587(23)00355-8_bib7"},{"key":"10.1016\/S2213-8587(23)00355-8_bib8","doi-asserted-by":"crossref","DOI":"10.1016\/j.conctc.2019.100486","article-title":"Choosing primary endpoints for clinical trials of health care interventions","volume":"16","author":"Mcleod","year":"2019","journal-title":"Contemp Clin Trials Commun"},{"key":"10.1016\/S2213-8587(23)00355-8_bib9","doi-asserted-by":"crossref","first-page":"1735","DOI":"10.1681\/ASN.2019010007","article-title":"GFR slope as a surrogate endpoint for kidney disease progression in clinical trials: a meta-analysis of treatment effects of randomised controlled trials","volume":"30","author":"Inker","year":"2019","journal-title":"J Am Soc Nephrol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003558?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003558?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T21:04:32Z","timestamp":1741208672000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003558"}},"issued":{"date-parts":[[2024,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213858723003558"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00355-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Empagliflozin in chronic kidney disease: nephroprotection is independent of albuminuria, primary kidney disease, and baseline eGFR","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00355-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00321-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00322-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T23:40:46Z","timestamp":1729640446692,"version":"3.28.0"},"reference-count":7,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/s2213-8587(24)00281-x","type":"journal-article","created":{"date-parts":[[2024,9,5]],"date-time":"2024-09-05T10:53:25Z","timestamp":1725533605000},"page":"787-788","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["International Day of Charity: what does charity mean for diabetes?"],"prefix":"10.1016","volume":"12","author":[{"given":"David","family":"Beran","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"St\u00e9phane","family":"Besan\u00e7on","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00281-X_bib1","series-title":"International Encyclopedia of Civil Society","first-page":"109","article-title":"Charity and religion","author":"O'Halloran","year":"2010"},{"year":"1984","series-title":"The discovery of insulin","author":"Bliss","key":"10.1016\/S2213-8587(24)00281-X_bib4"},{"key":"10.1016\/S2213-8587(24)00281-X_bib5","doi-asserted-by":"crossref","first-page":"253","DOI":"10.1057\/s41271-018-00159-w","article-title":"The importance of insulin donations for children in 43 low- and middle-income countries","volume":"40","author":"Hogerzeil","year":"2019","journal-title":"J Public Health Policy"},{"year":"2011","series-title":"Guidelines for medicine donations","key":"10.1016\/S2213-8587(24)00281-X_bib6"},{"key":"10.1016\/S2213-8587(24)00281-X_bib8","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1111\/pedi.13294","article-title":"Mortality amongst children and adolescents with type 1 diabetes in sub-Saharan Africa: the case study of the Changing Diabetes in Children Programme in Cameroon","volume":"23","author":"Katte","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00281-X_bib9","article-title":"Glycemic control and complications of type 1 diabetes among children in Tanzania","volume":"23","author":"Najem","year":"2021","journal-title":"J Clin Transl Endocrinol"},{"year":"2015","series-title":"Rebalancing society","author":"Mintzberg","key":"10.1016\/S2213-8587(24)00281-X_bib10"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872400281X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872400281X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T22:59:34Z","timestamp":1729637974000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872400281X"}},"issued":{"date-parts":[[2024,11]]},"references-count":7,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S221385872400281X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00281-x","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"International Day of Charity: what does charity mean for diabetes?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00281-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T17:05:47Z","timestamp":1648573547144},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2015,5,1]],"date-time":"2015-05-01T00:00:00Z","timestamp":1430438400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,5]]},"DOI":"10.1016\/s2213-8587(14)70269-4","type":"journal-article","created":{"date-parts":[[2015,1,22]],"date-time":"2015-01-22T04:17:25Z","timestamp":1421900245000},"page":"392","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["I'll have what they're having"],"prefix":"10.1016","volume":"3","author":[{"given":"Sharon","family":"Brownie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702694?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702694?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,26]],"date-time":"2018-09-26T04:59:54Z","timestamp":1537937994000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702694"}},"issued":{"date-parts":[[2015,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2015,5]]}},"alternative-id":["S2213858714702694"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70269-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"I'll have what they're having","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70269-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2015 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T15:37:01Z","timestamp":1648827421453},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/s2213-8587(15)00139-4","type":"journal-article","created":{"date-parts":[[2015,5,20]],"date-time":"2015-05-20T23:45:18Z","timestamp":1432165518000},"page":"411","source":"Crossref","is-referenced-by-count":0,"title":["Nigel Unwin: battling non-communicable diseases"],"prefix":"10.1016","volume":"3","author":[{"given":"Tony","family":"Kirby","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715001394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,22]],"date-time":"2018-09-22T13:20:23Z","timestamp":1537622423000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715001394"}},"issued":{"date-parts":[[2015,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S2213858715001394"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00139-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,6]]}},{"indexed":{"date-parts":[[2025,2,5]],"date-time":"2025-02-05T05:29:21Z","timestamp":1738733361619,"version":"3.37.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/s2213-8587(24)00395-4","type":"journal-article","created":{"date-parts":[[2024,12,19]],"date-time":"2024-12-19T23:37:53Z","timestamp":1734651473000},"page":"87","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Food for thought"],"prefix":"10.1016","volume":"13","author":[{"given":"Talha","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003954?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003954?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:14:00Z","timestamp":1738703640000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003954"}},"issued":{"date-parts":[[2025,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2213858724003954"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00395-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Food for thought","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00395-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T11:14:47Z","timestamp":1648811687488},"reference-count":2,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/s2213-8587(17)30144-4","type":"journal-article","created":{"date-parts":[[2017,5,23]],"date-time":"2017-05-23T21:00:16Z","timestamp":1495573216000},"page":"415-416","source":"Crossref","is-referenced-by-count":0,"title":["Bariatric surgery, glycaemic status, and microvascular complications"],"prefix":"10.1016","volume":"5","author":[{"given":"Pradeep","family":"Venkatesh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30144-4_bib1","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/S2213-8587(17)30061-X","article-title":"Long-term incidence of microvascular disease after bariatric surgery or usual care in patients with obesity, stratified by baseline glycaemic status: a post-hoc analysis of participants from the Swedish Obese Subjects study","volume":"5","author":"Carlsson","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30144-4_bib2","doi-asserted-by":"crossref","first-page":"1157","DOI":"10.1161\/CIRCULATIONAHA.111.039453","article-title":"Lifestyle modification for obesity","volume":"125","author":"Wadden","year":"2012","journal-title":"Circulation"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301444?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301444?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T10:21:39Z","timestamp":1535797299000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301444"}},"issued":{"date-parts":[[2017,6]]},"references-count":2,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2213858717301444"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30144-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,6]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T01:00:18Z","timestamp":1648602018465},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/s2213-8587(15)00464-7","type":"journal-article","created":{"date-parts":[[2015,11,26]],"date-time":"2015-11-26T00:15:34Z","timestamp":1448496934000},"page":"e1","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2015; 3: 931"],"prefix":"10.1016","volume":"4","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004647?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004647?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T08:38:32Z","timestamp":1548664712000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004647"}},"issued":{"date-parts":[[2016,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S2213858715004647"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00464-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,1]]}},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:08Z","timestamp":1720746728905},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/s2213-8587(13)70003-2","type":"journal-article","created":{"date-parts":[[2013,2,4]],"date-time":"2013-02-04T17:35:26Z","timestamp":1359999326000},"page":"s18","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Generation Me or generation me?"],"prefix":"10.1016","volume":"1","author":[{"given":"Glenn","family":"Matfin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700032?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700032?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,19]],"date-time":"2018-10-19T01:25:27Z","timestamp":1539912327000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700032"}},"issued":{"date-parts":[[2013,8]]},"references-count":0,"alternative-id":["S2213858713700032"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70003-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,8]]}},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:34Z","timestamp":1720746754148},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(16)30373-4","type":"journal-article","created":{"date-parts":[[2016,11,18]],"date-time":"2016-11-18T06:33:28Z","timestamp":1479450808000},"page":"S18","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Cardiovascular effects of incretin-based therapies in patients with type 2 diabetes: a systematic review and network meta-analysis"],"prefix":"10.1016","volume":"4","author":[{"given":"Shanshan","family":"Wu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ting","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yang","family":"Xu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zhirong","family":"Yang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sanbao","family":"Chai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Feng","family":"Sun","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Siyan","family":"Zhan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T15:56:43Z","timestamp":1536249403000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303734"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"alternative-id":["S2213858716303734"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30373-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]}},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T21:23:39Z","timestamp":1648761819220},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/s2213-8587(14)70223-2","type":"journal-article","created":{"date-parts":[[2014,10,30]],"date-time":"2014-10-30T00:15:36Z","timestamp":1414628136000},"page":"853","source":"Crossref","is-referenced-by-count":0,"title":["A time for reflection and thanks"],"prefix":"10.1016","volume":"2","author":[{"given":"Justine","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sarah","family":"Linklater","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Fiona","family":"Mitchell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702232?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702232?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,28]],"date-time":"2018-09-28T04:51:13Z","timestamp":1538110273000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702232"}},"issued":{"date-parts":[[2014,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S2213858714702232"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70223-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,11]]}},{"indexed":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:04:27Z","timestamp":1648771467034},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/s2213-8587(15)00455-6","type":"journal-article","created":{"date-parts":[[2015,12,1]],"date-time":"2015-12-01T03:03:25Z","timestamp":1448939005000},"page":"7-8","source":"Crossref","is-referenced-by-count":1,"title":["mHealth: only as good as the company it keeps"],"prefix":"10.1016","volume":"4","author":[{"given":"Gerald S","family":"Bloomfield","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00455-6_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S0140-6736(15)00128-2","article-title":"Global, regional, and national comparative risk assessment of 79 behavioural, environmental and occupational, and metabolic risks or clusters of risks in 188 countries, 1990\u20132013: a systematic analysis for the Global Burden of Disease Study 2013","author":"Forouzanfar","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00455-6_bib2","doi-asserted-by":"crossref","first-page":"181cm4","DOI":"10.1126\/scitranslmed.3005121","article-title":"Systems and capacity to address noncommunicable diseases in low- and middle-income countries","volume":"5","author":"Ali","year":"2013","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(15)00455-6_bib3","doi-asserted-by":"crossref","first-page":"e1001362","DOI":"10.1371\/journal.pmed.1001362","article-title":"The effectiveness of mobile-health technology-based health behaviour change or disease management interventions for health care consumers: a systematic review","volume":"10","author":"Free","year":"2013","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(15)00455-6_bib4","article-title":"Effectiveness of an mHealth intervention to improve the cardiometabolic profile of people with prehypertension in low-resource urban settings in Latin America: a randomised controlled trial","author":"Rubinstein","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00455-6_bib6","doi-asserted-by":"crossref","first-page":"160","DOI":"10.9745\/GHSP-D-13-00031","article-title":"mHealth innovations as health system strengthening tools: 12 common applications and a visual framework","volume":"1","author":"Labrique","year":"2013","journal-title":"Glob Health Sci Pract"},{"key":"10.1016\/S2213-8587(15)00455-6_bib7","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1186\/1744-8603-10-49","article-title":"Mobile health for non-communicable diseases in sub-Saharan Africa: a systematic review of the literature and strategic framework for research","volume":"10","author":"Bloomfield","year":"2014","journal-title":"Global Health"},{"key":"10.1016\/S2213-8587(15)00455-6_bib8","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1186\/1471-2458-10-627","article-title":"Estimation of the burden of cardiovascular disease attributable to modifiable risk factors and cost-effectiveness analysis of preventative interventions to reduce this burden in Argentina","volume":"10","author":"Rubinstein","year":"2010","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(15)00455-6_bib9","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1186\/1745-6215-15-93","article-title":"Launching a salt substitute to reduce blood pressure at the population level: a cluster randomized stepped wedge trial in Peru","volume":"15","author":"Bernabe-Ortiz","year":"2014","journal-title":"Trials"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004556?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004556?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T08:51:23Z","timestamp":1537174283000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004556"}},"issued":{"date-parts":[[2016,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S2213858715004556"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00455-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,1]]}},{"indexed":{"date-parts":[[2025,6,27]],"date-time":"2025-06-27T05:03:49Z","timestamp":1751000629111},"reference-count":4,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/s2213-8587(19)30030-0","type":"journal-article","created":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T23:36:46Z","timestamp":1550619406000},"page":"175-176","source":"Crossref","is-referenced-by-count":2,"title":["Intensive periodontal therapy and type 2 diabetes \u2013 Authors' reply"],"prefix":"10.1016","volume":"7","author":[{"given":"Francesco","family":"D'Aiuto","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"John E","family":"Deanfield","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 3","key":"10.1016\/S2213-8587(19)30030-0_bib1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1034\/j.1600-051X.29.s3.3.x","article-title":"A systematic review on the clinical efficacy of subgingival debridement in the treatment of chronic periodontitis","volume":"29","author":"Van der Weijden","year":"2002","journal-title":"J Clin Periodontol"},{"key":"10.1016\/S2213-8587(19)30030-0_bib2","doi-asserted-by":"crossref","first-page":"954","DOI":"10.1016\/S2213-8587(18)30038-X","article-title":"Systemic effects of periodontitis treatment in patients with type 2 diabetes: a 12 month, single-centre, investigator-masked, randomised trial","volume":"6","author":"D'Aiuto","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30030-0_bib3","series-title":"BHS five year forward view","year":"2014"},{"key":"10.1016\/S2213-8587(19)30030-0_bib4","series-title":"Introductory guide for commissioning dental specialties","year":"2015"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300300?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300300?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,2,19]],"date-time":"2019-02-19T23:52:52Z","timestamp":1550620372000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300300"}},"issued":{"date-parts":[[2019,3]]},"references-count":4,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S2213858719300300"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30030-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,3]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T07:07:55Z","timestamp":1649056075961},"reference-count":0,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2015,3,1]],"date-time":"2015-03-01T00:00:00Z","timestamp":1425168000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,3]]},"DOI":"10.1016\/s2213-8587(15)00014-5","type":"journal-article","created":{"date-parts":[[2015,2,19]],"date-time":"2015-02-19T00:30:20Z","timestamp":1424305820000},"page":"e2","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2015; 3: 15\u201316"],"prefix":"10.1016","volume":"3","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000145?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000145?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T08:36:45Z","timestamp":1548664605000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000145"}},"issued":{"date-parts":[[2015,3]]},"references-count":0,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2015,3]]}},"alternative-id":["S2213858715000145"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00014-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,3]]}},{"indexed":{"date-parts":[[2022,3,29]],"date-time":"2022-03-29T14:04:47Z","timestamp":1648562687437},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2015,11,1]],"date-time":"2015-11-01T00:00:00Z","timestamp":1446336000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,11]]},"DOI":"10.1016\/s2213-8587(15)00385-x","type":"journal-article","created":{"date-parts":[[2015,10,22]],"date-time":"2015-10-22T04:46:01Z","timestamp":1445489161000},"page":"843","source":"Crossref","is-referenced-by-count":0,"title":["Research in brief"],"prefix":"10.1016","volume":"3","author":[{"given":"Seema","family":"Kang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500385X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500385X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,18]],"date-time":"2018-09-18T14:21:41Z","timestamp":1537280501000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871500385X"}},"issued":{"date-parts":[[2015,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2015,11]]}},"alternative-id":["S221385871500385X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00385-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,11]]}},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T04:27:40Z","timestamp":1648960060238},"reference-count":10,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2016,8,1]],"date-time":"2016-08-01T00:00:00Z","timestamp":1470009600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,8]]},"DOI":"10.1016\/s2213-8587(16)30116-4","type":"journal-article","created":{"date-parts":[[2016,6,13]],"date-time":"2016-06-13T21:15:48Z","timestamp":1465852548000},"page":"637-638","source":"Crossref","is-referenced-by-count":5,"title":["Diabetes and compression of disability in the USA"],"prefix":"10.1016","volume":"4","author":[{"given":"Evelyn","family":"Wong","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30116-4_bib1","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/diacare.27.5.1047","article-title":"Global prevalence of diabetes: estimates for the year 2000 and projections for 2030","volume":"27","author":"Wild","year":"2004","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)30116-4_bib2","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2013.11.002","article-title":"Global estimates of diabetes prevalence for 2013 and projections for 2035","volume":"103","author":"Guariguata","year":"2014","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(16)30116-4_bib3","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2213-8587(13)70046-9","article-title":"Diabetes and risk of physical disability in adults: a systematic review and meta-analysis","volume":"1","author":"Wong","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30116-4_bib4","doi-asserted-by":"crossref","DOI":"10.1007\/s00125-016-3948-x","article-title":"Burden of diabetes in Australia: life expectancy and disability-free life expectancy in adults with diabetes","author":"Huo","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(16)30116-4_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(16)30090-0","article-title":"Compression of disability between two birth cohorts of US adults with diabetes, 1992\u20132012: a prospective longitudinal analysis","author":"Bardenheier","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30116-4_bib6","doi-asserted-by":"crossref","first-page":"369","DOI":"10.1093\/geronb\/gbn040","article-title":"Health and functioning among baby boomers approaching 60","volume":"64","author":"Martin","year":"2009","journal-title":"J Gerontol B Psychol Sci Soc Sci"},{"key":"10.1016\/S2213-8587(16)30116-4_bib7","doi-asserted-by":"crossref","first-page":"S4","DOI":"10.1016\/j.dhjo.2013.06.007","article-title":"Trends in disability and related chronic conditions among the forty-and-over population: 1997\u20132010","volume":"7","author":"Martin","year":"2014","journal-title":"Disabil Health J"},{"key":"10.1016\/S2213-8587(16)30116-4_bib8","doi-asserted-by":"crossref","first-page":"695","DOI":"10.1056\/NEJMsa044316","article-title":"Gradient of disability across the socioeconomic spectrum in the United States","volume":"355","author":"Minkler","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30116-4_bib9","doi-asserted-by":"crossref","first-page":"S186","DOI":"10.2105\/AJPH.2009.166082","article-title":"Socioeconomic disparities in health in the United States: what the patterns tell us","volume":"100","author":"Braveman","year":"2010","journal-title":"Am J Public Health"},{"key":"10.1016\/S2213-8587(16)30116-4_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1377\/hlthaff.19.3.191","article-title":"Population aging: a comparison among industrialized countries","volume":"19","author":"Anderson","year":"2000","journal-title":"Health Aff (Millwood)"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716301164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,16]],"date-time":"2019-04-16T04:02:56Z","timestamp":1555387376000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716301164"}},"issued":{"date-parts":[[2016,8]]},"references-count":10,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2016,8]]}},"alternative-id":["S2213858716301164"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30116-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,8]]}},{"indexed":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T23:28:45Z","timestamp":1697671725459},"reference-count":12,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/s2213-8587(18)30206-7","type":"journal-article","created":{"date-parts":[[2018,7,31]],"date-time":"2018-07-31T22:57:44Z","timestamp":1533077864000},"page":"754-755","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Mental health and sexual function in CAIS: context beyond sex hormones"],"prefix":"10.1016","volume":"6","author":[{"given":"David E","family":"Sandberg","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30206-7_bib1","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000442975","article-title":"Global disorders of sex development update since 2006: perceptions, approach and care","volume":"85","author":"Lee","year":"2016","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(18)30206-7_bib2","first-page":"44","article-title":"Emotionally and cognitively informed consent for clinical care for differences of sex development","volume":"5","author":"Tamar-Mattis","year":"2013","journal-title":"Psychol Sex"},{"key":"10.1016\/S2213-8587(18)30206-7_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1210\/er.2006-0005","article-title":"Germ cell tumors in the intersex gonad: Old paths, new directions, moving frontiers","volume":"27","author":"Cools","year":"2006","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(18)30206-7_bib5","doi-asserted-by":"crossref","first-page":"894","DOI":"10.1111\/j.1365-2265.2012.04330.x","article-title":"Timing of gonadectomy in adult women with complete androgen insensitivity syndrome (CAIS): patient preferences and clinical evidence","volume":"76","author":"Deans","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(18)30206-7_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(18)30197-9","article-title":"Oestrogen versus androgen in hormone-replacement therapy for complete androgen insensitivity syndrome: a multicentre, randomised, placebo-controlled, double-blind crossover trial","author":"Birnbaum","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(18)30206-7_bib7","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1111\/j.1471-0528.2009.02385.x","article-title":"Service users' experiences of obtaining and giving information about disorders of sex development","volume":"117","author":"Liao","year":"2010","journal-title":"BJOG"},{"key":"10.1016\/S2213-8587(18)30206-7_bib8","doi-asserted-by":"crossref","first-page":"609","DOI":"10.1016\/j.jpurol.2010.07.006","article-title":"Adolescent girls with disorders of sex development: A needs analysis of transitional care","volume":"6","author":"Liao","year":"2010","journal-title":"J Pediatr Urol"},{"key":"10.1016\/S2213-8587(18)30206-7_bib9","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1111\/j.1600-0047.2004.00325.x","article-title":"Prevalence of mental disorders in Europe: results from the European study of the epidemiology of mental disorders (ESEMeD) project","volume":"109","author":"Alonso","year":"2004","journal-title":"Acta Psychiatr Scand Suppl"},{"key":"10.1016\/S2213-8587(18)30206-7_bib10","doi-asserted-by":"crossref","first-page":"193","DOI":"10.1023\/A:1023420431760","article-title":"Distress about sex: a national survey of women in heterosexual relationships","volume":"32","author":"Bancroft","year":"2003","journal-title":"Arch Sex Behav"},{"key":"10.1016\/S2213-8587(18)30206-7_bib11","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1016\/S0015-0282(03)00501-6","article-title":"Sexual function in women with complete androgen insensitivity syndrome","volume":"80","author":"Minto","year":"2003","journal-title":"Fertil Steril"},{"key":"10.1016\/S2213-8587(18)30206-7_bib12","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/sj.ijir.3901334","article-title":"Testosterone therapy in women: a review","volume":"17","author":"Bolour","year":"2005","journal-title":"Int J Impot Res"},{"key":"10.1016\/S2213-8587(18)30206-7_bib13","doi-asserted-by":"crossref","first-page":"178","DOI":"10.1016\/j.yhbeh.2015.11.003","article-title":"Increasing women's sexual desire: the comparative effectiveness of estrogens and androgens","volume":"78","author":"Cappelletti","year":"2016","journal-title":"Horm Behav"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302067?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718302067?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,25]],"date-time":"2018-09-25T23:35:41Z","timestamp":1537918541000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718302067"}},"issued":{"date-parts":[[2018,10]]},"references-count":12,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["S2213858718302067"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30206-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Mental health and sexual function in CAIS: context beyond sex hormones","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30206-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30197-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,26]],"date-time":"2025-11-26T16:24:20Z","timestamp":1764174260829},"reference-count":0,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2016,11,1]],"date-time":"2016-11-01T00:00:00Z","timestamp":1477958400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,11]]},"DOI":"10.1016\/s2213-8587(15)00517-3","type":"journal-article","created":{"date-parts":[[2016,2,25]],"date-time":"2016-02-25T05:00:15Z","timestamp":1456376415000},"page":"957","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Childhood obesity and education"],"prefix":"10.1016","volume":"4","author":[{"given":"Gaetano","family":"Santulli","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715005173?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715005173?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,14]],"date-time":"2018-09-14T22:29:53Z","timestamp":1536964193000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715005173"}},"issued":{"date-parts":[[2016,11]]},"references-count":0,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2016,11]]}},"alternative-id":["S2213858715005173"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00517-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Childhood obesity and education","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00517-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,31]],"date-time":"2022-03-31T11:34:28Z","timestamp":1648726468492},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/s2213-8587(15)00332-0","type":"journal-article","created":{"date-parts":[[2015,9,4]],"date-time":"2015-09-04T04:05:37Z","timestamp":1441339537000},"page":"766","source":"Crossref","is-referenced-by-count":0,"title":["Sweet creature of bombast"],"prefix":"10.1016","volume":"3","author":[{"given":"Robert","family":"Stirrups","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003320?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003320?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T18:53:15Z","timestamp":1537383195000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003320"}},"issued":{"date-parts":[[2015,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2213858715003320"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00332-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,10]]}},{"indexed":{"date-parts":[[2022,4,5]],"date-time":"2022-04-05T13:11:22Z","timestamp":1649164282383},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/s2213-8587(17)30142-0","type":"journal-article","created":{"date-parts":[[2017,5,24]],"date-time":"2017-05-24T01:00:22Z","timestamp":1495587622000},"page":"403","source":"Crossref","is-referenced-by-count":0,"title":["Diabetes care: putting patients front and centre"],"prefix":"10.1016","volume":"5","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301420?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301420?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,1]],"date-time":"2018-09-01T14:21:38Z","timestamp":1535811698000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301420"}},"issued":{"date-parts":[[2017,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2213858717301420"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30142-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,6]]}},{"indexed":{"date-parts":[[2023,10,17]],"date-time":"2023-10-17T13:06:11Z","timestamp":1697547971316},"reference-count":10,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/s2213-8587(13)70193-1","type":"journal-article","created":{"date-parts":[[2013,12,4]],"date-time":"2013-12-04T04:45:14Z","timestamp":1386132314000},"page":"190-191","source":"Crossref","is-referenced-by-count":4,"title":["Reversing the obesity epidemic in young people: building up the physical activity side of energy balance"],"prefix":"10.1016","volume":"2","author":[{"given":"James F","family":"Sallis","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erica A","family":"Hinckson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70193-1_bib1","series-title":"Educating the student body: taking physical activity and physical education to school","year":"2013"},{"key":"10.1016\/S2213-8587(13)70193-1_bib2","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1016\/S0140-6736(12)60646-1","article-title":"Global physical activity levels: surveillance progress, pitfalls, and prospects","volume":"380","author":"Hallal","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70193-1_bib3","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.3945\/ajcn.2010.29786","article-title":"Global prevalence and trends of overweight and obesity among preschool children","volume":"92","author":"De Onis","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(13)70193-1_bib4","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1146\/annurev.publhealth.29.020907.090954","article-title":"Why is the developed world obese?","volume":"29","author":"Bleich","year":"2008","journal-title":"Ann Rev Public Health"},{"key":"10.1016\/S2213-8587(13)70193-1_bib5","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1249\/MSS.0b013e318064c8b0","article-title":"Fatness, fitness, and cardiovascular disease risk factors in children and adolescents","volume":"39","author":"Eisenmann","year":"2007","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(13)70193-1_bib6","doi-asserted-by":"crossref","first-page":"e3","DOI":"10.1016\/j.amepre.2013.03.012","article-title":"The caloric calculator: average caloric impact of childhood obesity interventions","volume":"45","author":"Wang","year":"2013","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(13)70193-1_bib7","doi-asserted-by":"crossref","first-page":"e57","DOI":"10.1016\/j.amepre.2012.02.008","article-title":"Obesogenic neighborhood environments, child and parent obesity: the Neighborhood Impact on Kids study","volume":"42","author":"Saelens","year":"2012","journal-title":"Am J Prev Med"},{"key":"10.1016\/S2213-8587(13)70193-1_bib8","series-title":"Accelerating progress in obesity prevention: solving the weight of the nation","year":"2012"},{"key":"10.1016\/S2213-8587(13)70193-1_bib9","series-title":"Physical Activity Guidelines for Americans Midcourse Report: strategies to increase physical activity among youth","year":"2012"},{"key":"10.1016\/S2213-8587(13)70193-1_bib10","doi-asserted-by":"crossref","first-page":"342","DOI":"10.3109\/17477166.2011.605895","article-title":"Evidence that the prevalence of childhood overweight is plateauing: data from nine countries","volume":"6","author":"Olds","year":"2011","journal-title":"Int J Pediatr Obes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701931?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701931?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,8]],"date-time":"2018-10-08T14:53:56Z","timestamp":1539010436000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701931"}},"issued":{"date-parts":[[2014,3]]},"references-count":10,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S2213858713701931"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70193-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,3]]}},{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T09:47:53Z","timestamp":1762508873851,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,12,1]],"date-time":"2022-12-01T00:00:00Z","timestamp":1669852800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,12]]},"DOI":"10.1016\/s2213-8587(22)00284-4","type":"journal-article","created":{"date-parts":[[2022,10,18]],"date-time":"2022-10-18T19:48:58Z","timestamp":1666122538000},"page":"846-847","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Gestational diabetes in Australia: navigating a tsunami"],"prefix":"10.1016","volume":"10","author":[{"given":"H David","family":"McIntyre","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Arianne","family":"Sweeting","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00284-4_bib2","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.2337\/dc12-2345","article-title":"Testing for gestational diabetes mellitus in Australia","volume":"36","author":"Nankervis","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00284-4_bib3","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1016\/j.diabres.2017.04.018","article-title":"Adopting the new World Health Organization diagnostic criteria for gestational diabetes: how the prevalence changes in a high-risk region in Australia","volume":"129","author":"Wong","year":"2017","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(22)00284-4_bib4","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1002\/dmrr.2715","article-title":"Type 2 diabetes after gestational diabetes: greater than fourfold risk among Indigenous compared with non-Indigenous Australian women","volume":"32","author":"Chamberlain","year":"2016","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(22)00284-4_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/ijerph16224488","article-title":"Real-world gestational diabetes screening: problems with the oral glucose tolerance test in rural and remote Australia","volume":"16","author":"Jamieson","year":"2019","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(22)00284-4_bib6","doi-asserted-by":"crossref","first-page":"1438","DOI":"10.2337\/dc20-0304","article-title":"Strict preanalytical oral glucose tolerance test blood sample handling is essential for diagnosing gestational diabetes mellitus","volume":"43","author":"Potter","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00284-4_bib7","article-title":"Oral glucose tolerance test to diagnose gestational diabetes mellitus: impact of variations in specimen handling","author":"Jamieson","year":"2022","journal-title":"Clin Biochem"},{"key":"10.1016\/S2213-8587(22)00284-4_bib8","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1111\/ajo.13144","article-title":"Antenatal models of care for women with gestational diabetes mellitus: vignettes from an international meeting","volume":"60","author":"Sina","year":"2020","journal-title":"Aust N Z J Obstet Gynaecol"},{"key":"10.1016\/S2213-8587(22)00284-4_bib9","doi-asserted-by":"crossref","first-page":"895","DOI":"10.1056\/NEJMoa2026028","article-title":"A pragmatic, randomized clinical trial of gestational diabetes screening","volume":"384","author":"Hillier","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00284-4_bib10","doi-asserted-by":"crossref","first-page":"587","DOI":"10.1056\/NEJMoa2204091","article-title":"Lower versus higher glycemic criteria for diagnosis of gestational diabetes","volume":"387","author":"Crowther","year":"2022","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002844?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002844?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:13Z","timestamp":1761991933000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722002844"}},"issued":{"date-parts":[[2022,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2022,12]]}},"alternative-id":["S2213858722002844"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00284-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Gestational diabetes in Australia: navigating a tsunami","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00284-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:29Z","timestamp":1761991949243,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004334","name":"Merck","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004334","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003769","name":"Eisai","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004628","name":"MedImmune","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004628","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007723","name":"Takeda Pharmaceuticals U.S.A.","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007723","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100015340","name":"Bayer Fund","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100015340","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004319","name":"Pfizer","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004319","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002973","name":"Daiichi-Sankyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002973","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019630","name":"Zora Biosciences","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019630","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/s2213-8587(20)30368-5","type":"journal-article","created":{"date-parts":[[2020,11,18]],"date-time":"2020-11-18T21:49:31Z","timestamp":1605736171000},"page":"932-933","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["EMPA-REG OUTCOME and beyond: the long game of cardiovascular risk reduction"],"prefix":"10.1016","volume":"8","author":[{"given":"Vanita R","family":"Aroda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marc S","family":"Sabatine","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30368-5_bib1","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30368-5_bib2","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. a consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(20)30368-5_bib3","doi-asserted-by":"crossref","first-page":"949","DOI":"10.1016\/S2213-8587(20)30344-2","article-title":"Effects of empagliflozin on first and recurrent clinical events in patients with type 2 diabetes and atherosclerotic cardiovascular disease: a secondary analysis of the EMPA-REG OUTCOME trial","volume":"8","author":"McGuire","year":"2020","journal-title":"Lancet Diabetets Endocrinol"},{"key":"10.1016\/S2213-8587(20)30368-5_bib4","doi-asserted-by":"crossref","first-page":"613","DOI":"10.1001\/jamacardio.2019.0886","article-title":"Effect of the PCSK9 inhibitor evolocumab on total cardiovascular events in patients with cardiovascular disease: a prespecified analysis from the FOURIER trial","volume":"4","author":"Murphy","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(20)30368-5_bib5","doi-asserted-by":"crossref","first-page":"760","DOI":"10.1002\/ejhf.1139","article-title":"Effect of sacubitril\/valsartan on recurrent events in the prospective comparison of ARNI with ACEI to determine impact on global mortality and morbidity in heart failure trial (PARADIGM-HF)","volume":"20","author":"Mogensen","year":"2018","journal-title":"Eur J Heart Fail"},{"key":"10.1016\/S2213-8587(20)30368-5_bib6","doi-asserted-by":"crossref","first-page":"1214","DOI":"10.1001\/jamacardio.2019.3080","article-title":"Occurrence of first and recurrent major adverse cardiovascular events with liraglutide treatment among patients with type 2 diabetes and high risk of cardiovascular events: a post hoc analysis of a randomized clinical trial","volume":"4","author":"Verma","year":"2019","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(20)30368-5_bib7","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1016\/j.jacbts.2020.02.004","article-title":"Mechanisms of cardiovascular benefits of sodium glucose co-transporter 2 (SGLT2) inhibitors: a state-of-the-art review","volume":"5","author":"Lopaschuk","year":"2020","journal-title":"JACC Basic Transl Sci"},{"key":"10.1016\/S2213-8587(20)30368-5_bib8","doi-asserted-by":"crossref","first-page":"1117","DOI":"10.1016\/j.jacc.2020.05.037","article-title":"2020 expert consensus decision pathway on novel therapies for cardiovascular risk reduction in patients with type 2 diabetes: a report of the American College of Cardiology solution set oversight committee","volume":"76","author":"Das","year":"2020","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(20)30368-5_bib9","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1093\/eurheartj\/ehz486","article-title":"2019 ESC Guidelines on diabetes, pre-diabetes, and cardiovascular diseases developed in collaboration with the EASD","volume":"41","author":"Cosentino","year":"2020","journal-title":"Eur Heart J"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303685?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303685?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:45Z","timestamp":1761991725000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303685"}},"issued":{"date-parts":[[2020,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2213858720303685"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30368-5","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"EMPA-REG OUTCOME and beyond: the long game of cardiovascular risk reduction","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30368-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30344-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:19Z","timestamp":1720746739107},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/s2213-8587(13)70132-3","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T08:31:13Z","timestamp":1379493073000},"page":"s11","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["Cholesterol test misses patients at risk of heart disease"],"prefix":"10.1016","volume":"1","author":[{"given":"Sanjay","family":"Tanday","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701323?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701323?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T20:50:56Z","timestamp":1539377456000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701323"}},"issued":{"date-parts":[[2013,8]]},"references-count":0,"alternative-id":["S2213858713701323"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70132-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,8]]}},{"indexed":{"date-parts":[[2026,4,23]],"date-time":"2026-04-23T14:33:04Z","timestamp":1776954784144,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,1,1]],"date-time":"2024-01-01T00:00:00Z","timestamp":1704067200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,1]]},"DOI":"10.1016\/s2213-8587(23)00328-5","type":"journal-article","created":{"date-parts":[[2023,11,17]],"date-time":"2023-11-17T23:30:20Z","timestamp":1700263820000},"page":"11-12","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Is a new discussion about diagnosis of gestational diabetes needed?"],"prefix":"10.1016","volume":"12","author":[{"given":"Gernot","family":"Desoye","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mireille","family":"van Poppel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00328-5_bib1","doi-asserted-by":"crossref","first-page":"1194","DOI":"10.2337\/dc20-2398","article-title":"Newborn adiposity and cord blood C-peptide as mediators of the maternal metabolic environment and childhood adiposity","volume":"44","author":"Josefson","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00328-5_bib2","doi-asserted-by":"crossref","first-page":"1089","DOI":"10.1007\/s00125-016-3931-6","article-title":"The fetal glucose steal: an underappreciated phenomenon in diabetic pregnancy","volume":"59","author":"Desoye","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00328-5_bib3","doi-asserted-by":"crossref","first-page":"1259","DOI":"10.2337\/diacare.24.7.1259","article-title":"Amniotic fluid insulin at 14\u201320 weeks' gestation: association with later maternal glucose intolerance and birth macrosomia","volume":"24","author":"Carpenter","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00328-5_bib4","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.2337\/dc22-2409","article-title":"Is the biphasic effect of diabetes and obesity on fetal growth a risk factor for childhood obesity?","volume":"46","author":"van Poppel","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00328-5_bib5","first-page":"903","article-title":"Effect of physical activity and\/or healthy eating on GDM risk: the DALI lifestyle study","volume":"102","author":"Simmons","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00328-5_bib6","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1056\/NEJMoa2214956","article-title":"Treatment of gestational diabetes mellitus diagnosed early in pregnancy","volume":"388","author":"Simmons","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00328-5_bib7","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1007\/s00125-019-4842-0","article-title":"A reduction in sedentary behaviour in obese women during pregnancy reduces neonatal adiposity: the DALI randomised controlled trial","volume":"62","author":"van Poppel","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00328-5_bib8","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.2337\/dc09-0688","article-title":"First-trimester fasting hyperglycemia and adverse pregnancy outcomes","volume":"32","author":"Riskin-Mashiah","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00328-5_bib9","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1016\/S2213-8587(20)30064-4","article-title":"Growing fat in utero: timing is everything","volume":"8","author":"van Poppel","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00328-5_bib10","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S2213-8587(23)00092-X","article-title":"Defining gestational diabetes: not just about cutoffs","volume":"11","author":"Simmons","year":"2023","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003285?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003285?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,5]],"date-time":"2025-03-05T21:04:24Z","timestamp":1741208664000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003285"}},"issued":{"date-parts":[[2024,1]]},"references-count":10,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2024,1]]}},"alternative-id":["S2213858723003285"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00328-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is a new discussion about diagnosis of gestational diabetes needed?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00328-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,24]],"date-time":"2026-01-24T04:41:36Z","timestamp":1769229696730,"version":"3.49.0"},"reference-count":15,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2016,2,1]],"date-time":"2016-02-01T00:00:00Z","timestamp":1454284800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,2]]},"DOI":"10.1016\/s2213-8587(15)00438-6","type":"journal-article","created":{"date-parts":[[2015,11,20]],"date-time":"2015-11-20T23:05:53Z","timestamp":1448060753000},"page":"89-90","source":"Crossref","is-referenced-by-count":25,"title":["Health and lifestyle changes among migrant workers in China: implications for the healthy migrant effect"],"prefix":"10.1016","volume":"4","author":[{"given":"Miguel A","family":"Salazar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiaojiang","family":"Hu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00438-6_bib1","doi-asserted-by":"crossref","first-page":"1717","DOI":"10.1016\/S0140-6736(08)61360-4","article-title":"Internal migration and health in China","volume":"372","author":"Hu","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00438-6_bib2","article-title":"Under-5 mortality in 2851 Chinese counties, 1996-2012: a subnational assessment of achieving MDG 4 goals in China","author":"Wang","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00438-6_bib3","article-title":"Cause-specific mortality for 240 causes in China during 1990\u20132013: a systematic subnational analysis for the Global Burden of Disease Study 2013","author":"Zhou","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00438-6_bib4","first-page":"A131","article-title":"An exploration into the determinants of noncommunicable diseases among rural-to-urban migrants in periurban South Africa","volume":"7","author":"Stern","year":"2010","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/S2213-8587(15)00438-6_bib5","doi-asserted-by":"crossref","first-page":"797","DOI":"10.1111\/j.1365-2036.2006.02805.x","article-title":"Diverticular disease and migration\u2014the influence of acculturation to a Western lifestyle on diverticular disease","volume":"23","author":"Hjern","year":"2006","journal-title":"Aliment Pharmacol Ther"},{"key":"10.1016\/S2213-8587(15)00438-6_bib6","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/00149831-200512000-00004","article-title":"Do immigrants have an increased prevalence of unhealthy behaviors and risk factors for coronary heart disease?","volume":"12","author":"Gadd","year":"2005","journal-title":"Eur J Cardiovasc Prev Rehabil"},{"key":"10.1016\/S2213-8587(15)00438-6_bib7","doi-asserted-by":"crossref","first-page":"8038","DOI":"10.3390\/ijerph110808038","article-title":"The longer you stay, the worse your health? A critical review of the negative acculturation theory among Asian immigrants","volume":"11","author":"Ro","year":"2014","journal-title":"Int J Environ Res Public Health"},{"key":"10.1016\/S2213-8587(15)00438-6_bib8","article-title":"Diabetes-related metabolic risk factors in internal migrant workers in China: a national surveillance study","author":"Bi","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00438-6_bib9","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1016\/j.atherosclerosis.2012.06.009","article-title":"Prevalence of dyslipidemia and associated factors in the Yi farmers and migrants of Southwestern China","volume":"223","author":"Wang","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(15)00438-6_bib10","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.socscimed.2011.02.016","article-title":"Internal migration and health: re-examining the healthy migrant phenomenon in China","volume":"72","author":"Chen","year":"2011","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(15)00438-6_bib11","doi-asserted-by":"crossref","first-page":"1892","DOI":"10.1194\/jlr.M400159-JLR200","article-title":"Are BMI and other anthropometric measures appropriate as indices for obesity? A study in an Asian population","volume":"45","author":"Goh","year":"2004","journal-title":"J Lipid Res"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00438-6_bib12","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1093\/eurpub\/cku112","article-title":"Why is the \u2018healthy immigrant effect\u2019 different between European countries?","volume":"24","author":"Moullan","year":"2014","journal-title":"Eur J Public Health"},{"key":"10.1016\/S2213-8587(15)00438-6_bib13","author":"Razum"},{"key":"10.1016\/S2213-8587(15)00438-6_bib14","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1007\/s10654-008-9247-1","article-title":"Low migrant mortality in Germany for men aged 65 and older: fact or artifact?","volume":"23","author":"Kibele","year":"2008","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(15)00438-6_bib15","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1080\/03670240701486719","article-title":"\u201cI don't make the soups anymore\u201d: pre- to post-migration dietary and lifestyle changes among Latinos living in west-central Florida","volume":"46","author":"Himmelgreen","year":"2007","journal-title":"Ecol Food Nutr"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004386?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715004386?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,17]],"date-time":"2018-09-17T15:23:24Z","timestamp":1537197804000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715004386"}},"issued":{"date-parts":[[2016,2]]},"references-count":15,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2016,2]]}},"alternative-id":["S2213858715004386"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00438-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,2]]}},{"indexed":{"date-parts":[[2026,3,16]],"date-time":"2026-03-16T06:02:39Z","timestamp":1773640959246,"version":"3.50.1"},"reference-count":9,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100000272","name":"National Institute for Health Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000361","name":"Diabetes UK","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000361","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000265","name":"Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000265","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000268","name":"Biotechnology and Biological Sciences Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000268","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/s2213-8587(21)00177-7","type":"journal-article","created":{"date-parts":[[2021,7,29]],"date-time":"2021-07-29T18:44:07Z","timestamp":1627584247000},"page":"556-559","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":26,"title":["Scientific medical conferences can be easily modified to improve female inclusion: a prospective study"],"prefix":"10.1016","volume":"9","author":[{"given":"Victoria","family":"Salem","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jordan","family":"McDonagh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Elizabeth","family":"Avis","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Pei Chia","family":"Eng","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sue","family":"Smith","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kevin G","family":"Murphy","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00177-7_bib1","doi-asserted-by":"crossref","first-page":"1045","DOI":"10.1097\/ACM.0000000000001273","article-title":"Women in academic medicine","volume":"91","author":"Thibault","year":"2016","journal-title":"Acad Med"},{"key":"10.1016\/S2213-8587(21)00177-7_bib2","series-title":"Focus on physicians: 2018\u201319 census (UK consultants and higher specialty trainees)","year":"2019"},{"key":"10.1016\/S2213-8587(21)00177-7_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0148528","article-title":"A theoretical model for the associative nature of conference participation","volume":"11","author":"Smiljani\u0107","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00177-7_bib4","doi-asserted-by":"crossref","first-page":"6.8","DOI":"10.1093\/astrogeo\/atu245","article-title":"Asking gender questions","volume":"55","author":"Pritchard","year":"2014","journal-title":"Astron Geophys"},{"key":"10.1016\/S2213-8587(21)00177-7_bib5","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0185534","article-title":"Men ask more questions than women at a scientific conference","volume":"12","author":"Hinsley","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00177-7_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1007\/s12147-011-9104-5","article-title":"Gender differences in STEM disciplines: from the aspects of informal professional networking and faculty career development","volume":"28","author":"Xu","year":"2011","journal-title":"Gend Issues"},{"key":"10.1016\/S2213-8587(21)00177-7_bib7","doi-asserted-by":"crossref","first-page":"e627","DOI":"10.7717\/peerj.627","article-title":"Gender differences in conference presentations: a consequence of self-selection?","volume":"2","author":"Jones","year":"2014","journal-title":"PeerJ"},{"key":"10.1016\/S2213-8587(21)00177-7_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-033480","article-title":"Factors impacting on retention, success and equitable participation in clinical academic careers: a scoping review and meta-thematic synthesis","volume":"10","author":"Vassie","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(21)00177-7_bib9","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2019-032232","article-title":"Women's leadership in academic medicine: a systematic review of extent, condition and interventions","volume":"10","author":"Alwazzan","year":"2020","journal-title":"BMJ Open"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:41Z","timestamp":1761991781000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001777"}},"issued":{"date-parts":[[2021,9]]},"references-count":9,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2213858721001777"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00177-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Scientific medical conferences can be easily modified to improve female inclusion: a prospective study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00177-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,4,3]],"date-time":"2022-04-03T21:23:11Z","timestamp":1649020991538},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70014-7","type":"journal-article","created":{"date-parts":[[2013,6,27]],"date-time":"2013-06-27T01:18:29Z","timestamp":1372295909000},"page":"e1-e2","source":"Crossref","is-referenced-by-count":0,"title":["95th annual meeting of the Endocrine Society"],"prefix":"10.1016","volume":"1","author":[{"given":"Sarah E","family":"Allan","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700147?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700147?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T01:24:30Z","timestamp":1539566670000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700147"}},"issued":{"date-parts":[[2013,9]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2213858713700147"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70014-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:12Z","timestamp":1761991992888,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,9,1]],"date-time":"2021-09-01T00:00:00Z","timestamp":1630454400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,9]]},"DOI":"10.1016\/s2213-8587(21)00171-6","type":"journal-article","created":{"date-parts":[[2021,6,17]],"date-time":"2021-06-17T23:19:05Z","timestamp":1623971945000},"page":"560","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Ashley Grossman: finding a calling in neuroendocrinology"],"prefix":"10.1016","volume":"9","author":[{"given":"Ray","family":"Cavanaugh","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001716?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001716?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:11Z","timestamp":1761991811000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001716"}},"issued":{"date-parts":[[2021,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2021,9]]}},"alternative-id":["S2213858721001716"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00171-6","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Ashley Grossman: finding a calling in neuroendocrinology","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00171-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T20:41:46Z","timestamp":1786999306354,"version":"build-2736575974"},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/s2213-8587(24)00306-1","type":"journal-article","created":{"date-parts":[[2024,11,22]],"date-time":"2024-11-22T19:19:11Z","timestamp":1732303151000},"page":"5-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["One step closer to the end of postoperative radioactive iodine thyroid remnant ablation"],"prefix":"10.1016","volume":"13","author":[{"given":"Frederik A","family":"Verburg","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bart","family":"de Keizer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00306-1_bib1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association Management Guidelines for Adult Patients with Thyroid Nodules and Differentiated Thyroid Cancer: The American Thyroid Association Guidelines Task Force on Thyroid Nodules and Differentiated Thyroid Cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(24)00306-1_bib2","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1089\/thy.2018.0597","volume":"29","author":"Tuttle","year":"2019","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(24)00306-1_bib3","doi-asserted-by":"crossref","first-page":"923","DOI":"10.1056\/NEJMoa2111953","article-title":"Thyroidectomy without radioiodine in patients with low-risk thyroid cancer","volume":"386","author":"Leboulleux","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00306-1_bib4","doi-asserted-by":"crossref","first-page":"159","DOI":"10.1016\/j.clon.2012.01.001","article-title":"Iodine or Not (IoN) for low-risk differentiated thyroid cancer: the next UK National Cancer Research Network randomised trial following HiLo","volume":"24","author":"Mallick","year":"2012","journal-title":"Clin Oncol (R Coll Radiol)"},{"key":"10.1016\/S2213-8587(24)00306-1_bib5","article-title":"Thyroidectomy without radioiodine in patients with low-risk thyroid cancer: 5 years of follow-up of the prospective randomised ESTIMABL2 trial","author":"Leboulleux","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00306-1_bib6","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1210\/jc.2012-2458","article-title":"Life expectancy is reduced in differentiated thyroid cancer patients \u226545 years old with extensive local tumor invasion, lateral lymph node, or distant metastases at diagnosis and normal in all other DTC patients","volume":"98","author":"Verburg","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00306-1_bib7","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1016\/j.ejrad.2019.01.006","article-title":"Meta-analysis of ultrasound for cervical lymph nodes in papillary thyroid cancer: diagnosis of central and lateral compartment nodal metastases","volume":"112","author":"Zhao","year":"2019","journal-title":"Eur J Radiol"},{"key":"10.1016\/S2213-8587(24)00306-1_bib8","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1007\/s00259-023-06449-0","article-title":"Sentinel lymph node detection in thyroid carcinoma using [68Ga]Ga-tilmanocept PET\/CT: a proof-of-concept study","volume":"51","author":"de Vries","year":"2024","journal-title":"Eur J Nucl Med Mol Imaging"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003061?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003061?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:51:18Z","timestamp":1739821878000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003061"}},"issued":{"date-parts":[[2025,1]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2213858724003061"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00306-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"One step closer to the end of postoperative radioactive iodine thyroid remnant ablation","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00306-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00276-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:53:02Z","timestamp":1791291182460,"version":"4.3.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/s2213-8587(26)00165-8","type":"journal-article","created":{"date-parts":[[2026,8,13]],"date-time":"2026-08-13T22:49:23Z","timestamp":1786661363000},"page":"795-797","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Type 2 diabetes management: weekly combination therapy comes of age?"],"prefix":"10.1016","volume":"14","author":[{"given":"Srikanth","family":"Bellary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Muhammad Ali","family":"Karamat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00165-8_bib1","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1210\/endrev\/bnaa015","article-title":"The evolution of insulin and how it informs therapy and treatment choices","volume":"41","author":"Hirsch","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(26)00165-8_bib2","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1210\/endrev\/bnad037","article-title":"The basis for weekly insulin therapy: evolving evidence with insulin icodec and insulin efsitora alfa","volume":"45","author":"Rosenstock","year":"2024","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(26)00165-8_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes - state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(26)00165-8_bib4","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15414","article-title":"Insulin icodec: a novel once-weekly treatment for diabetes","volume":"41","author":"Schaffner","year":"2024","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(26)00165-8_bib5","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines12081852","article-title":"Once-weekly insulin icodec in diabetes mellitus: a systematic review and meta-analysis of randomized clinical trials (ONWARDS clinical program)","volume":"12","author":"Lisco","year":"2024","journal-title":"Biomedicines"},{"key":"10.1016\/S2213-8587(26)00165-8_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(26)00136-1","article-title":"Once-weekly IcoSema versus once-daily insulin glargine U100 in type 2 diabetes management (COMBINE 4): an open-label, 3 multicentre, treat-to-target, randomised, phase 3b trial","author":"Ji","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00165-8_bib7","doi-asserted-by":"crossref","first-page":"898","DOI":"10.1001\/jama.2016.1252","article-title":"Effect of insulin glargine up-titration vs insulin degludec\/liraglutide on glycated hemoglobin levels in patients with uncontrolled type 2 diabetes: the DUAL V randomized clinical trial","volume":"315","author":"Lingvay","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00165-8_bib8","doi-asserted-by":"crossref","first-page":"379","DOI":"10.2337\/ds22-0084","article-title":"Therapeutic inertia and delays in insulin intensification in type 2 diabetes: a literature review","volume":"36","author":"Gavin","year":"2023","journal-title":"Diabetes Spectr"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(26)00165-8_bib9","first-page":"S181","article-title":"American Diabetes Association Professional Practice: pharmacologic approaches to glycemic treatment: standards of care in diabetes\u20132025","volume":"48","author":"El Sayed","year":"2025","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001658?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726001658?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,10,6]],"date-time":"2026-10-06T12:06:10Z","timestamp":1791288370000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726001658"}},"issued":{"date-parts":[[2026,10]]},"references-count":9,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2026,10]]}},"alternative-id":["S2213858726001658"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00165-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Type 2 diabetes management: weekly combination therapy comes of age?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00165-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00136-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T13:18:10Z","timestamp":1791897490471,"version":"4.3.4"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100003646","name":"National Health Insurance Service","doi-asserted-by":"publisher","award":["NHIS-2022-2-125"],"award-info":[{"award-number":["NHIS-2022-2-125"]}],"id":[{"id":"10.13039\/501100003646","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004721","name":"University of Tokyo","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004721","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000971","name":"Diabetes Australia","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000971","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001779","name":"Monash University","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001779","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["19FA1002"],"award-info":[{"award-number":["19FA1002"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["20FA1016"],"award-info":[{"award-number":["20FA1016"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Ministry of Health, Labour and Welfare","doi-asserted-by":"publisher","award":["22FA1018"],"award-info":[{"award-number":["22FA1018"]}],"id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,11]]},"DOI":"10.1016\/s2213-8587(22)00252-2","type":"journal-article","created":{"date-parts":[[2022,9,29]],"date-time":"2022-09-29T18:45:00Z","timestamp":1664477100000},"page":"795-803","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":84,"title":["Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study"],"prefix":"10.1016","volume":"10","author":[{"given":"Dunya","family":"Tomic","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jedidiah I","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lei","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Agus","family":"Salim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Edward W","family":"Gregg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meda E","family":"Pavkov","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martti","family":"Arffman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ran","family":"Balicer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Baviera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elise","family":"Boersma-van Dam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ralph","family":"Brinks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bendix","family":"Carstensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juliana C N","family":"Chan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yiling J","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Fosse-Edorh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonsoles","family":"Fuentes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H\u00e9l\u00e8ne","family":"Gardiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanne L","family":"Gulseth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Romualdas","family":"Gurevicius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kyoung Hwa","family":"Ha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annika","family":"Hoyer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gy\u00f6rgy","family":"Jermendy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexandra","family":"Kautzky-Willer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilmo","family":"Keskim\u00e4ki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dae Jung","family":"Kim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zolt\u00e1n","family":"Kiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Klimek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maya","family":"Leventer-Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chun-Yi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paz","family":"Lopez-Doriga Ruiz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea O Y","family":"Luk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manel","family":"Mata-Cases","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"D\u00eddac","family":"Mauricio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart","family":"McGurnaghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoaki","family":"Imamura","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjoy K","family":"Paul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Peeters","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Santa","family":"Pildava","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Avi","family":"Porath","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cynthia","family":"Robitaille","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Carla","family":"Roncaglioni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Takehiro","family":"Sugiyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kang-Ling","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarah H","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naama","family":"Yekutiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dianna J","family":"Magliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00252-2_bib1","doi-asserted-by":"crossref","first-page":"109119","DOI":"10.1016\/j.diabres.2021.109119","article-title":"IDF Diabetes Atlas: global, regional and country-level diabetes prevalence estimates for 2021 and projections for 2045","volume":"183","author":"Sun","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(22)00252-2_bib2","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1016\/S2213-8587(14)70161-5","article-title":"Trends in lifetime risk and years of life lost due to diabetes in the USA, 1985\u20132011: a modelling study","volume":"2","author":"Gregg","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00252-2_bib3","doi-asserted-by":"crossref","first-page":"2179","DOI":"10.1007\/s00125-008-1150-5","article-title":"Lifetime risk and projected population prevalence of diabetes","volume":"51","author":"Magliano","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00252-2_bib4","doi-asserted-by":"crossref","first-page":"e001065","DOI":"10.1136\/bmjdrc-2019-001065","article-title":"Lifetime risk and years lost to type 1 and type 2 diabetes in Denmark, 1996-2016","volume":"9","author":"Carstensen","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(22)00252-2_bib5","doi-asserted-by":"crossref","first-page":"04041","DOI":"10.7189\/jgh.11.04041","article-title":"Lifetime risk of developing diabetes and years of life lost among those with diabetes in Brazil","volume":"11","author":"Bracco","year":"2021","journal-title":"J Glob Health"},{"key":"10.1016\/S2213-8587(22)00252-2_bib6","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1186\/s12963-021-00266-z","article-title":"Diabetes free life expectancy and years of life lost associated with type 2 diabetes: projected trends in Germany between 2015 and 2040","volume":"19","author":"T\u00f6nnies","year":"2021","journal-title":"Popul Health Metr"},{"key":"10.1016\/S2213-8587(22)00252-2_bib7","doi-asserted-by":"crossref","first-page":"l5003","DOI":"10.1136\/bmj.l5003","article-title":"Trends in incidence of total or type 2 diabetes: systematic review","volume":"366","author":"Magliano","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00252-2_bib8","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S2213-8587(20)30402-2","article-title":"Trends in the incidence of diagnosed diabetes: a multicountry analysis of aggregate data from 22 million diagnoses in high-income and middle-income settings","volume":"9","author":"Magliano","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00252-2_bib9","doi-asserted-by":"crossref","first-page":"367","DOI":"10.1038\/nrd1723","article-title":"Type 2 diabetes market","volume":"4","author":"Gershell","year":"2005","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S2213-8587(22)00252-2_bib10","doi-asserted-by":"crossref","first-page":"e041508","DOI":"10.1136\/bmjopen-2020-041508","article-title":"Excess mortality in adults with documented diabetes in Germany: routine data analysis of all insurance claims in Germany 2013\u20132014","volume":"11","author":"Schmidt","year":"2021","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(22)00252-2_bib11","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1007\/s00125-013-3063-1","article-title":"Mortality trends in patients with and without diabetes in Ontario, Canada and the UK from 1996 to 2009: a population-based study","volume":"56","author":"Lind","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00252-2_bib12","first-page":"317","article-title":"Trends in mortality, cardiovascular complications, and risk factors in type 2 diabetes","volume":"77","author":"Heintjes","year":"2019","journal-title":"Neth J Med"},{"key":"10.1016\/S2213-8587(22)00252-2_bib13","first-page":"668","article-title":"\u00c9volution de la mortalit\u00e9 et de la surmortalit\u00e9 \u00e0 5 ans des personnes diab\u00e9tiques trait\u00e9es pharmacologiquement en France m\u00e9tropolitaine: comparaison des cohortes Entred 2001 et Entred 2007","volume":"37\u201338","author":"Mandereau-Bruno","year":"2016","journal-title":"Bull Epid\u00e9miol Hebd"},{"key":"10.1016\/S2213-8587(22)00252-2_bib14","series-title":"Demography: measuring and modeling population processes","author":"Preston","year":"2000"},{"key":"10.1016\/S2213-8587(22)00252-2_bib15","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1007\/s00125-020-05330-1","article-title":"Lifetime risk of diabetes in metropolitan cities in India","volume":"64","author":"Luhar","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(22)00252-2_bib16","doi-asserted-by":"crossref","first-page":"943","DOI":"10.1038\/bjc.2014.606","article-title":"Trends in the lifetime risk of developing cancer in Great Britain: comparison of risk for those born from 1930 to 1960","volume":"112","author":"Ahmad","year":"2015","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(22)00252-2_bib17","doi-asserted-by":"crossref","first-page":"1003","DOI":"10.1001\/jama.287.8.1003","article-title":"Residual lifetime risk for developing hypertension in middle-aged women and men: the Framingham Heart Study","volume":"287","author":"Vasan","year":"2002","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(22)00252-2_bib19","doi-asserted-by":"crossref","first-page":"696","DOI":"10.1186\/s12913-018-3445-7","article-title":"Evolution of public hospitals expenditure by healthcare area in the Spanish National Health System: the determinants to pay attention to","volume":"18","author":"Ridao-L\u00f3pez","year":"2018","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(22)00252-2_bib20","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1093\/eurpub\/14.1.32","article-title":"Association between health behaviour and self-reported health in Estonia, Finland, Latvia and Lithuania","volume":"14","author":"Kasmel","year":"2004","journal-title":"Eur J Public Health"},{"key":"10.1016\/S2213-8587(22)00252-2_bib21","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1186\/s12963-014-0032-y","article-title":"Towards a subsiding diabetes epidemic: trends from a large population-based study in Israel","volume":"12","author":"Karpati","year":"2014","journal-title":"Popul Health Metr"},{"key":"10.1016\/S2213-8587(22)00252-2_bib22","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1186\/s12889-020-08498-8","article-title":"Associations of health literacy with socioeconomic position, health risk behavior, and health status: a large national population-based survey among Danish adults","volume":"20","author":"Svendsen","year":"2020","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(22)00252-2_bib23","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1016\/j.kint.2017.01.030","article-title":"Diabetes with early kidney involvement may shorten life expectancy by 16 years","volume":"92","author":"Wen","year":"2017","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(22)00252-2_bib24","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1478-7954-10-7","article-title":"Impact of diabetes mellitus on life expectancy and health-adjusted life expectancy in Canada","volume":"10","author":"Loukine","year":"2012","journal-title":"Popul Health Metr"},{"key":"10.1016\/S2213-8587(22)00252-2_bib25","doi-asserted-by":"crossref","first-page":"e000657","DOI":"10.1136\/bmjdrc-2019-000657","article-title":"New directions in incidence and prevalence of diagnosed diabetes in the USA","volume":"7","author":"Benoit","year":"2019","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(22)00252-2_bib26","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/j.ecl.2021.05.001","article-title":"The changing nature of mortality and morbidity in patients with diabetes","volume":"50","author":"Pearson-Stuttard","year":"2021","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(22)00252-2_bib27","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2213-8587(15)00362-9","article-title":"Lifetime risk of developing impaired glucose metabolism and eventual progression from prediabetes to type 2 diabetes: a prospective cohort study","volume":"4","author":"Ligthart","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00252-2_bib28","doi-asserted-by":"crossref","first-page":"109118","DOI":"10.1016\/j.diabres.2021.109118","article-title":"IDF Diabetes Atlas: global estimates of undiagnosed diabetes in adults for 2021","volume":"183","author":"Ogurtsova","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(22)00252-2_bib29","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1097\/XCE.0000000000000210","article-title":"Estimating life years lost to diabetes: outcomes from analysis of National Diabetes Audit and Office of National Statistics data","volume":"9","author":"Heald","year":"2020","journal-title":"Cardiovasc Endocrinol Metab"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(22)00279-0","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2022,11,1]],"date-time":"2022-11-01T00:00:00Z","timestamp":1667260800000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002522?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722002522?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:06Z","timestamp":1761991866000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722002522"}},"issued":{"date-parts":[[2022,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2022,11]]}},"alternative-id":["S2213858722002522"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00252-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Lifetime risk, life expectancy, and years of life lost to type 2 diabetes in 23 high-income jurisdictions: a multinational, population-based study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00252-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00271-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,13]],"date-time":"2026-10-13T16:33:19Z","timestamp":1791909199853,"version":"4.3.4"},"reference-count":71,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,5,1]],"date-time":"2026-05-01T00:00:00Z","timestamp":1777593600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013076","name":"National Major Science and Technology Projects of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013076","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,5]]},"DOI":"10.1016\/s2213-8587(26)00010-0","type":"journal-article","created":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T23:52:58Z","timestamp":1774396378000},"page":"412-421","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Can artificial intelligence bridge the gaps for primary diabetes care in low-income and middle-income countries?"],"prefix":"10.1016","volume":"14","author":[{"given":"Zhouyu","family":"Guan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Huating","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sergio","family":"Hern\u00e1ndez-Jim\u00e9nez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kwesi N","family":"Amissah-Arthur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria In\u00eas","family":"Schmidt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saleha","family":"Masood","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dian","family":"Zeng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Weiping","family":"Jia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lee-Ling","family":"Lim","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00010-0_bib1","doi-asserted-by":"crossref","first-page":"2019","DOI":"10.1016\/S0140-6736(20)32374-6","article-title":"The Lancet Commission on diabetes: using data to transform diabetes care and patient lives","volume":"396","author":"Chan","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00010-0_bib2","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00010-0_bib3","doi-asserted-by":"crossref","first-page":"2077","DOI":"10.1016\/S0140-6736(24)02317-1","article-title":"Worldwide trends in diabetes prevalence and treatment from 1990 to 2022: a pooled analysis of 1108 population-representative studies with 141 million participants","volume":"404","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00010-0_bib4","doi-asserted-by":"crossref","first-page":"313","DOI":"10.1016\/S2213-8587(17)30116-X","article-title":"Urbanisation, inequality, and non-communicable disease risk","volume":"5","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00010-0_bib5","doi-asserted-by":"crossref","first-page":"e21","DOI":"10.1016\/S2214-109X(25)00393-6","article-title":"Attainment of global diabetes targets in 2021: a pooled analysis of individual-level data from national surveys in 100 low-income, middle-income, and high-income countries","volume":"14","year":"2026","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib6","doi-asserted-by":"crossref","first-page":"940","DOI":"10.1016\/S0140-6736(08)61404-X","article-title":"Improving the prevention and management of chronic disease in low-income and middle-income countries: a priority for primary health care","volume":"372","author":"Beaglehole","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00010-0_bib7","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1016\/S2213-8587(21)00240-0","article-title":"Expanding access to newer medicines for people with type 2 diabetes in low-income and middle-income countries: a cost-effectiveness and price target analysis","volume":"9","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00010-0_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1016\/S0140-6736(23)00909-1","article-title":"The role of structural racism and geographical inequity in diabetes outcomes","volume":"402","author":"Agarwal","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00010-0_bib9","doi-asserted-by":"crossref","first-page":"2886","DOI":"10.1038\/s41591-024-03139-8","article-title":"Integrated image-based deep learning and language models for primary diabetes care","volume":"30","author":"Li","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00010-0_bib10","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(24)00154-2","article-title":"Artificial intelligence for diabetes care: current and future prospects","volume":"12","author":"Sheng","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00010-0_bib11","first-page":"12","article-title":"A proposal for the Dartmouth summer research project on artificial intelligence\u2014August 31, 1955","volume":"27","author":"McCarthy","year":"2006","journal-title":"AI Mag"},{"key":"10.1016\/S2213-8587(26)00010-0_bib12","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1177\/1932296820949941","article-title":"Development and validation of a software linked to an internet portal that facilitates the medical treatment and empowerment of patients with type 2 diabetes, interaction with medical personnel, and the generation of a real-time registry","volume":"15","author":"Garc\u00eda-Ulloa","year":"2021","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(26)00010-0_bib13","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.pcd.2020.07.009","article-title":"Use of an electronic integral monitoring system for patients with diabetes to identify factors associated with an adequate glycemic goal and to measure quality of care","volume":"15","author":"Antonio-Villa","year":"2021","journal-title":"Prim Care Diabetes"},{"key":"10.1016\/S2213-8587(26)00010-0_bib14","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/s41551-021-00745-6","article-title":"Deep-learning models for the detection and incidence prediction of chronic kidney disease and type 2 diabetes from retinal fundus images","volume":"5","author":"Zhang","year":"2021","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/S2213-8587(26)00010-0_bib15","doi-asserted-by":"crossref","first-page":"2211","DOI":"10.1001\/jama.2017.18152","article-title":"Development and validation of a deep learning system for diabetic retinopathy and related eye diseases using retinal images from multiethnic populations with diabetes","volume":"318","author":"Ting","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00010-0_bib16","doi-asserted-by":"crossref","first-page":"2402","DOI":"10.1001\/jama.2016.17216","article-title":"Development and validation of a deep learning algorithm for detection of diabetic retinopathy in retinal fundus photographs","volume":"316","author":"Gulshan","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00010-0_bib17","article-title":"Non-invasive biopsy diagnosis of diabetic kidney disease via deep learning applied to retinal images: a population-based study","volume":"7","author":"Meng","year":"2025","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib18","doi-asserted-by":"crossref","first-page":"1907","DOI":"10.1038\/s41551-025-01413-9","article-title":"A deep learning system for detecting silent brain infarction and predicting stroke risk","volume":"9","author":"Jiang","year":"2025","journal-title":"Nat Biomed Eng"},{"key":"10.1016\/S2213-8587(26)00010-0_bib19","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-021-23458-5","article-title":"A deep learning system for detecting diabetic retinopathy across the disease spectrum","volume":"12","author":"Dai","year":"2021","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(26)00010-0_bib20","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1038\/s41591-023-02702-z","article-title":"A deep learning system for predicting time to progression of diabetic retinopathy","volume":"30","author":"Dai","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00010-0_bib21","doi-asserted-by":"crossref","first-page":"e10","DOI":"10.1016\/S2589-7500(20)30250-8","article-title":"Predicting the risk of developing diabetic retinopathy using deep learning","volume":"3","author":"Bora","year":"2021","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib22","doi-asserted-by":"crossref","DOI":"10.1093\/nsr\/nwaf039","article-title":"A pretrained transformer model for decoding individual glucose dynamics from continuous glucose monitoring data","volume":"12","author":"Lu","year":"2025","journal-title":"Natl Sci Rev"},{"key":"10.1016\/S2213-8587(26)00010-0_bib23","doi-asserted-by":"crossref","first-page":"2633","DOI":"10.1038\/s41591-023-02552-9","article-title":"Optimized glycemic control of type 2 diabetes with reinforcement learning: a proof-of-concept trial","volume":"29","author":"Wang","year":"2023","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00010-0_bib24","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s42255-020-0212-y","article-title":"An artificial intelligence decision support system for the management of type 1 diabetes","volume":"2","author":"Tyler","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(26)00010-0_bib25","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1016\/S0140-6736(19)30368-X","article-title":"Automated insulin dosing guidance to optimise insulin management in patients with type 2 diabetes: a multicentre, randomised controlled trial","volume":"393","author":"Bergenstal","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00010-0_bib26","doi-asserted-by":"crossref","first-page":"2079","DOI":"10.1001\/jama.2025.19563","article-title":"An AI-powered lifestyle intervention vs human coaching in the diabetes prevention program: a randomized clinical trial","volume":"334","author":"Mathioudakis","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00010-0_bib27","doi-asserted-by":"crossref","first-page":"3394","DOI":"10.1038\/s41591-025-03888-0","article-title":"A personal health large language model for sleep and fitness coaching","volume":"31","author":"Khasentino","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00010-0_bib28","doi-asserted-by":"crossref","first-page":"e615","DOI":"10.1016\/S2589-7500(22)00111-X","article-title":"Effectiveness of wearable activity trackers to increase physical activity and improve health: a systematic review of systematic reviews and meta-analyses","volume":"4","author":"Ferguson","year":"2022","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib29","article-title":"Artificial intelligence in diabetes management: advancements, opportunities, and challenges","volume":"4","author":"Guan","year":"2023","journal-title":"Cell Rep Med"},{"key":"10.1016\/S2213-8587(26)00010-0_bib30","doi-asserted-by":"crossref","first-page":"1006","DOI":"10.1001\/jamaophthalmol.2024.3707","article-title":"A Competition for the diagnosis of myopic maculopathy by artificial intelligence algorithms","volume":"142","author":"Qian","year":"2024","journal-title":"JAMA Ophthalmol"},{"key":"10.1016\/S2213-8587(26)00010-0_bib31","article-title":"Laying an equitable data foundation for foundation models","volume":"13","author":"Agrawal","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/S2213-8587(26)00010-0_bib32","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1016\/S2213-8587(24)00153-0","article-title":"The potential role for artificial intelligence in fracture risk prediction","volume":"12","author":"Hong","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00010-0_bib33","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/s41591-025-03724-5","article-title":"An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial","volume":"31","author":"Wang","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00010-0_bib34","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1016\/S0140-6736(22)00235-5","article-title":"Bridging the chasm between AI and clinical implementation","volume":"399","author":"Aristidou","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00010-0_bib35","doi-asserted-by":"crossref","first-page":"e599","DOI":"10.1016\/S2589-7500(21)00132-1","article-title":"Patient and general public attitudes towards clinical artificial intelligence: a mixed methods systematic review","volume":"3","author":"Young","year":"2021","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib36","doi-asserted-by":"crossref","first-page":"e376","DOI":"10.1016\/S2589-7500(20)30112-6","article-title":"The European artificial intelligence strategy: implications and challenges for digital health","volume":"2","author":"Cohen","year":"2020","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib37","doi-asserted-by":"crossref","first-page":"e35","DOI":"10.1016\/S2589-7500(19)30004-4","article-title":"Artificial intelligence using deep learning to screen for referable and vision-threatening diabetic retinopathy in Africa: a clinical validation study","volume":"1","author":"Bellemo","year":"2019","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib38","doi-asserted-by":"crossref","first-page":"e6","DOI":"10.1016\/S2589-7500(19)30009-3","article-title":"Artificial intelligence for diabetic retinopathy screening in Africa","volume":"1","author":"Mathenge","year":"2019","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib39","doi-asserted-by":"crossref","first-page":"e145","DOI":"10.1016\/S2214-109X(23)00488-6","article-title":"Inequalities in health system coverage and quality: a cross-sectional survey of four Latin American countries","volume":"12","author":"Roberti","year":"2024","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib40","article-title":"Importance of sample size on the quality and utility of AI-based prediction models for healthcare","volume":"7","author":"Riley","year":"2025","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib42","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1038\/s41746-024-01254-x","article-title":"Regulatory responses and approval status of artificial intelligence medical devices with a focus on China","volume":"7","author":"Liu","year":"2024","journal-title":"NPJ Digit Med"},{"key":"10.1016\/S2213-8587(26)00010-0_bib43","article-title":"Large-scale local deployment of DeepSeek-R1 in pilot hospitals in china: a nationwide cross-sectional survey","author":"Yuan","year":"2025","journal-title":"medRxiv"},{"key":"10.1016\/S2213-8587(26)00010-0_bib46","doi-asserted-by":"crossref","DOI":"10.1136\/bmj-2024-082568","article-title":"Transforming Chinese cohort studies through artificial intelligence: a new era of population health research","volume":"391","author":"Zeng","year":"2025","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(26)00010-0_bib49","doi-asserted-by":"crossref","DOI":"10.3389\/phrs.2022.1605025","article-title":"Nation-wide routinely collected health datasets in China: a scoping review","volume":"43","author":"Liu","year":"2022","journal-title":"Public Health Rev"},{"key":"10.1016\/S2213-8587(26)00010-0_bib51","doi-asserted-by":"crossref","DOI":"10.2196\/24813","article-title":"Adoption of electronic health records (EHRs) in China during the past 10 years: consecutive survey data analysis and comparison of Sino-American challenges and experiences","volume":"23","author":"Liang","year":"2021","journal-title":"J Med Internet Res"},{"key":"10.1016\/S2213-8587(26)00010-0_bib52","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1186\/s12889-024-18423-y","article-title":"The individuals' awareness and adoption of electronic health records in China: a questionnaire survey of 1\u2008337 individuals","volume":"24","author":"Xu","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib53","doi-asserted-by":"crossref","first-page":"1866","DOI":"10.1001\/jama.2025.6571","article-title":"DeepSeek's \u201clow-cost\u201d adoption across China's hospital systems: too fast, too soon?","volume":"333","author":"Zeng","year":"2025","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00010-0_bib54","doi-asserted-by":"crossref","first-page":"2727","DOI":"10.1038\/s41591-024-03257-3","article-title":"Improving primary healthcare with generative AI","volume":"30","author":"Yip","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00010-0_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2020.108078","article-title":"Diabetes and global ageing among 65\u201399-year-old adults: findings from the International Diabetes Federation Diabetes Atlas, 9th edition","volume":"162","author":"Sinclair","year":"2020","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(26)00010-0_bib56","doi-asserted-by":"crossref","first-page":"996","DOI":"10.1186\/s12889-022-13378-4","article-title":"Current status and influencing factors of digital health literacy among community-dwelling older adults in southwest China: a cross-sectional study","volume":"22","author":"Liu","year":"2022","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib57","article-title":"Smartphones and telemedicine for older people in China: opportunities and challenges","volume":"8","author":"Zhang","year":"2022","journal-title":"Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib59","article-title":"Supporting and retaining competent primary care workforce in low-resource settings: lessons learned from a prospective cohort study","volume":"11","author":"Li","year":"2023","journal-title":"Fam Med Community Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib60","doi-asserted-by":"crossref","first-page":"40","DOI":"10.1186\/s12960-025-01009-z","article-title":"Physician turnover in China, 2011\u20132021: a nationwide longitudinal study","volume":"23","author":"Wang","year":"2025","journal-title":"Hum Resour Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib61","article-title":"Prevalence, awareness, treatment, control of type 2 diabetes mellitus and risk factors in Chinese rural population: the RuralDiab study","volume":"6","author":"Liu","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(26)00010-0_bib62","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1001\/jama.2021.22208","article-title":"Prevalence and treatment of diabetes in China, 2013\u20132018","volume":"326","author":"Wang","year":"2021","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(26)00010-0_bib63","doi-asserted-by":"crossref","first-page":"348","DOI":"10.1186\/s12875-024-02600-4","article-title":"Diabetes knowledge, attitudes and practices among Chinese primary care physicians: a cross-sectional study","volume":"25","author":"Pi","year":"2024","journal-title":"BMC Prim Care"},{"key":"10.1016\/S2213-8587(26)00010-0_bib64","article-title":"Survey and analysis on the resource situation of primary health care institutions in rural China","volume":"12","author":"Zhang","year":"2024","journal-title":"Front Public Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib65","article-title":"Primary care quality and provider disparities in China: a standardized-patient-based study","volume":"50","author":"Huang","year":"2024","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/S2213-8587(26)00010-0_bib66","doi-asserted-by":"crossref","first-page":"e534","DOI":"10.1016\/S2589-7500(23)00092-4","article-title":"The global effect of digital health technologies on health workers' competencies and health workplace: an umbrella review of systematic reviews and lexical-based and sentence-based meta-analysis","volume":"5","author":"Borges do Nascimento","year":"2023","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib67","doi-asserted-by":"crossref","first-page":"e64","DOI":"10.1016\/S2589-7500(24)00224-3","article-title":"Tackling algorithmic bias and promoting transparency in health datasets: the STANDING Together consensus recommendations","volume":"7","author":"Alderman","year":"2025","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib68","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S0140-6736(20)30424-4","article-title":"Telemedicine 2020 and the next decade","volume":"395","author":"Dorsey","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00010-0_bib69","doi-asserted-by":"crossref","first-page":"583","DOI":"10.1016\/j.scib.2024.01.004","article-title":"Large language models for diabetes care: potentials and prospects","volume":"69","author":"Sheng","year":"2024","journal-title":"Sci Bull"},{"key":"10.1016\/S2213-8587(26)00010-0_bib70","doi-asserted-by":"crossref","first-page":"552","DOI":"10.1016\/S2213-8587(25)00142-1","article-title":"Artificial intelligence and diabetes: time for action and caution","volume":"13","author":"Bornstein","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00010-0_bib71","doi-asserted-by":"crossref","first-page":"e428","DOI":"10.1016\/S2468-2667(25)00036-2","article-title":"Artificial intelligence in public health: promises, challenges, and an agenda for policy makers and public health institutions","volume":"10","author":"Panteli","year":"2025","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib73","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1016\/S2213-8587(23)00174-2","article-title":"Diabetes care and AI: a looming threat or a necessary advancement?","volume":"11","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00010-0_bib75","doi-asserted-by":"crossref","first-page":"3404","DOI":"10.1038\/s41591-025-03900-7","article-title":"An eyecare foundation model for clinical assistance: a randomized controlled trial","volume":"31","author":"Wu","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00010-0_bib76","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1016\/S0140-6736(11)61349-4","article-title":"Effectiveness of diabetes and hypertension management by rural primary health-care workers (Behvarz workers) in Iran: a nationally representative observational study","volume":"379","author":"Farzadfar","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00010-0_bib77","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0103754","article-title":"Task shifting for non-communicable disease management in low and middle income countries\u2013a systematic review","volume":"9","author":"Joshi","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00010-0_bib78","article-title":"Digital twins, synthetic patient data, and in-silico trials: can they empower paediatric clinical trials?","volume":"7","author":"Pammi","year":"2025","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib79","doi-asserted-by":"crossref","first-page":"e281","DOI":"10.1016\/S2589-7500(24)00025-6","article-title":"Foresight-a generative pretrained transformer for modelling of patient timelines using electronic health records: a retrospective modelling study","volume":"6","author":"Kraljevic","year":"2024","journal-title":"Lancet Digit Health"},{"key":"10.1016\/S2213-8587(26)00010-0_bib80","article-title":"Can generative artificial intelligence empower target trial emulations?","volume":"8","author":"Guan","year":"2026","journal-title":"Lancet Digit Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000100?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000100?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:57Z","timestamp":1778858757000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000100"}},"issued":{"date-parts":[[2026,5]]},"references-count":71,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2026,5]]}},"alternative-id":["S2213858726000100"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00010-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Can artificial intelligence bridge the gaps for primary diabetes care in low-income and middle-income countries?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00010-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,2]],"date-time":"2026-04-02T15:01:02Z","timestamp":1775142062336,"version":"3.50.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/s2213-8587(20)30080-2","type":"journal-article","created":{"date-parts":[[2020,3,6]],"date-time":"2020-03-06T18:39:27Z","timestamp":1583519967000},"page":"257","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["NCD threat: falling on deaf ears"],"prefix":"10.1016","volume":"8","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720300802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:25Z","timestamp":1761991705000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720300802"}},"issued":{"date-parts":[[2020,4]]},"references-count":0,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S2213858720300802"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30080-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"NCD threat: falling on deaf ears","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30080-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,18]],"date-time":"2025-12-18T19:40:59Z","timestamp":1766086859213},"reference-count":1,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/s2213-8587(13)70188-8","type":"journal-article","created":{"date-parts":[[2013,11,7]],"date-time":"2013-11-07T21:32:35Z","timestamp":1383859955000},"page":"272","source":"Crossref","is-referenced-by-count":2,"title":["Diabetes\u2014a call for research papers"],"prefix":"10.1016","volume":"1","author":[{"given":"Justine","family":"Davies","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lin","family":"Guo","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70188-8_bib1","doi-asserted-by":"crossref","first-page":"62","DOI":"10.2165\/00003495-198428010-00004","article-title":"Oral hypoglycaemic agents. An update","volume":"28","author":"Asmal","year":"1984","journal-title":"Drugs"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701888?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701888?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,10]],"date-time":"2018-10-10T20:20:33Z","timestamp":1539202833000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701888"}},"issued":{"date-parts":[[2013,12]]},"references-count":1,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2213858713701888"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70188-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,12]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:51Z","timestamp":1761991971823,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/s2213-8587(20)30231-x","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T18:36:02Z","timestamp":1595356562000},"page":"666-667","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":8,"title":["Management of diabetes in patients with COVID-19"],"prefix":"10.1016","volume":"8","author":[{"given":"Jean-Daniel","family":"Lalau","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Abdallah","family":"Al-Salameh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30231-X_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30231-X_bib2","doi-asserted-by":"crossref","DOI":"10.1038\/s41586-020-2286-9","article-title":"A SARS-CoV-2 protein interaction map reveals targets for drug repurposing","author":"Gordon","year":"2020","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(20)30231-X_bib3","doi-asserted-by":"crossref","first-page":"1121","DOI":"10.1038\/s41591-018-0087-6","article-title":"Metformin reverses established lung fibrosis in a bleomycin model","volume":"24","author":"Rangarajan","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(20)30231-X_bib4","doi-asserted-by":"crossref","first-page":"R192","DOI":"10.1186\/cc12886","article-title":"Preadmission metformin use and mortality among intensive care patients with diabetes: a cohort study","volume":"17","author":"Christiansen","year":"2013","journal-title":"Crit Care"},{"key":"10.1016\/S2213-8587(20)30231-X_bib5","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1111\/dom.12974","article-title":"Metformin-associated lactic acidosis (MALA): moving towards a new paradigm","volume":"19","author":"Lalau","year":"2017","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872030231X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385872030231X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:24Z","timestamp":1761991764000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385872030231X"}},"issued":{"date-parts":[[2020,8]]},"references-count":5,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S221385872030231X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30231-x","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of diabetes in patients with COVID-19","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30231-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30223-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30227-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30152-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30226-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30234-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30235-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,26]],"date-time":"2026-03-26T19:13:31Z","timestamp":1774552411068,"version":"3.50.1"},"reference-count":6,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,3,1]],"date-time":"2020-03-01T00:00:00Z","timestamp":1583020800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,3]]},"DOI":"10.1016\/s2213-8587(19)30416-4","type":"journal-article","created":{"date-parts":[[2020,2,18]],"date-time":"2020-02-18T18:29:28Z","timestamp":1582050568000},"page":"183-185","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["DIY artificial pancreas systems: the clinician perspective"],"prefix":"10.1016","volume":"8","author":[{"given":"Emma G","family":"Wilmot","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Thomas","family":"Danne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30416-4_bib2","doi-asserted-by":"crossref","first-page":"790","DOI":"10.1177\/1932296818808307","article-title":"History and perspective on DIY closed looping","volume":"13","author":"Lewis","year":"2019","journal-title":"J Diabetes Sci Technol"},{"key":"10.1016\/S2213-8587(19)30416-4_bib4","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/S2213-8587(19)30417-6","article-title":"Health-care professional opinions of DIY artificial pancreas systems in the UK","volume":"8","author":"Crabtree","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30416-4_bib5","doi-asserted-by":"crossref","first-page":"744","DOI":"10.1089\/dia.2018.0214","article-title":"Excellent glycemic control maintained by open-source hybrid closed-loop AndroidAPS during and after sustained physical activity","volume":"20","author":"Petruzelkova","year":"2018","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(19)30416-4_bib7","author":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30416-4_bib9","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30416-4_bib10","first-page":"794","article-title":"Reduced burden of diabetes and improved quality of life: Experiences from unrestricted day-and-night hybrid closed-loop use in very young children with type 1 diabetes","volume":"20","author":"Musolino","year":"2019","journal-title":"Pediatr Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719304164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:44Z","timestamp":1761991664000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719304164"}},"issued":{"date-parts":[[2020,3]]},"references-count":6,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2020,3]]}},"alternative-id":["S2213858719304164"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30416-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"DIY artificial pancreas systems: the clinician perspective","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30416-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30417-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,10,18]],"date-time":"2025-10-18T20:52:01Z","timestamp":1760820721160},"reference-count":6,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2015,7,1]],"date-time":"2015-07-01T00:00:00Z","timestamp":1435708800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,7]]},"DOI":"10.1016\/s2213-8587(15)00211-9","type":"journal-article","created":{"date-parts":[[2015,6,29]],"date-time":"2015-06-29T23:38:30Z","timestamp":1435621110000},"page":"502","source":"Crossref","is-referenced-by-count":3,"title":["Diabetes prevention in England"],"prefix":"10.1016","volume":"3","author":[{"given":"John S","family":"Yudkin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher","family":"Millett","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00211-9_bib1","doi-asserted-by":"crossref","first-page":"312","DOI":"10.1016\/S2213-8587(15)00079-0","article-title":"Radically upgrading diabetes prevention in England","volume":"3","author":"Maruthappu","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00211-9_bib2","doi-asserted-by":"crossref","first-page":"160","DOI":"10.1016\/S2213-8587(15)70015-X","article-title":"Mind the gap: efficacy versus effectiveness of lifestyle interventions to prevent diabetes","volume":"3","author":"Wareham","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00211-9_bib3","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00211-9_bib4","doi-asserted-by":"crossref","first-page":"g4485","DOI":"10.1136\/bmj.g4485","article-title":"The epidemic of pre-diabetes: the medicine and the politics","volume":"349","author":"Yudkin","year":"2014","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(15)00211-9_bib5","doi-asserted-by":"crossref","first-page":"e81","DOI":"10.2337\/dc14-2910","article-title":"Comment on Cefalu et al. The alarming and rising costs of diabetes and prediabetes: a call for action!","volume":"38","author":"Yudkin","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00211-9_bib6","author":"Wanless"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715002119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,21]],"date-time":"2018-09-21T08:22:17Z","timestamp":1537518137000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715002119"}},"issued":{"date-parts":[[2015,7]]},"references-count":6,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2015,7]]}},"alternative-id":["S2213858715002119"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00211-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,7]]}},{"indexed":{"date-parts":[[2026,5,7]],"date-time":"2026-05-07T16:15:54Z","timestamp":1778170554975,"version":"3.51.4"},"reference-count":90,"publisher":"Elsevier BV","issue":"1","content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70025-1","type":"journal-article","created":{"date-parts":[[2013,8,20]],"date-time":"2013-08-20T14:30:23Z","timestamp":1377009023000},"page":"71-78","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":50,"title":["Dysglycaemia, vasculopenia, and the chronic consequences of diabetes"],"prefix":"10.1016","volume":"1","author":[{"given":"Hertzel C","family":"Gerstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoff H","family":"Werstuck","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70025-1_bib2","doi-asserted-by":"crossref","first-page":"1482","DOI":"10.2105\/AJPH.2011.300616","article-title":"Aging, diabetes, and the public health system in the United States","volume":"102","author":"Caspersen","year":"2012","journal-title":"Am J Public Health"},{"key":"10.1016\/S2213-8587(13)70025-1_bib3","doi-asserted-by":"crossref","first-page":"1090","DOI":"10.1056\/NEJMoa0908292","article-title":"Prevalence of diabetes among men and women in China","volume":"362","author":"Yang","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib4","doi-asserted-by":"crossref","first-page":"3022","DOI":"10.1007\/s00125-011-2291-5","article-title":"Prevalence of diabetes and prediabetes (impaired fasting glucose and\/or impaired glucose tolerance) in urban and rural India: phase I results of the Indian Council of Medical Research-INdia DIABetes (ICMR-INDIAB) study","volume":"54","author":"Anjana","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70025-1_bib5","doi-asserted-by":"crossref","first-page":"1033","DOI":"10.2337\/dc12-2625","article-title":"Economic costs of diabetes in the US in 2012","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib6","series-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation","year":"2006"},{"key":"10.1016\/S2213-8587(13)70025-1_bib7","series-title":"Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus (addenddum to: Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO\/IDF consultation)","year":"2011"},{"key":"10.1016\/S2213-8587(13)70025-1_bib8","first-page":"829","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"64","author":"Seshasai","year":"2011","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib9","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","author":"Sarwar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70025-1_bib10","doi-asserted-by":"crossref","first-page":"298","DOI":"10.2337\/db10-1198","article-title":"Glycated hemoglobin and the risk of kidney disease and retinopathy in adults with and without diabetes","volume":"60","author":"Selvin","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70025-1_bib11","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1056\/NEJMoa0908359","article-title":"Glycated hemoglobin, diabetes, and cardiovascular risk in nondiabetic adults","volume":"362","author":"Selvin","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib12","doi-asserted-by":"crossref","first-page":"e1000201","DOI":"10.1371\/journal.pmed.1000201","article-title":"Blood glucose and risk of incident and fatal cancer in the metabolic syndrome and cancer project (me-can): analysis of six prospective cohorts","volume":"6","author":"Stocks","year":"2009","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib13","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1158\/1055-9965.EPI-10-0230","article-title":"Metabolic syndrome and breast cancer in the me-can (metabolic syndrome and cancer) project","volume":"19","author":"Bjorge","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(13)70025-1_bib14","doi-asserted-by":"crossref","first-page":"2307","DOI":"10.1158\/1055-9965.EPI-10-0234","article-title":"Metabolic factors and the risk of pancreatic cancer: a prospective analysis of almost 580\u2008000 men and women in the Metabolic Syndrome and Cancer Project","volume":"19","author":"Johansen","year":"2010","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(13)70025-1_bib15","doi-asserted-by":"crossref","first-page":"892","DOI":"10.1093\/aje\/kwq006","article-title":"Metabolic syndrome and endometrial carcinoma","volume":"171","author":"Bjorge","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(13)70025-1_bib16","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1161\/CIRCULATIONAHA.108.834408","article-title":"Dysglycemia and cardiovascular risk in the general population","volume":"119","author":"Gerstein","year":"2009","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70025-1_bib17","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/j.diabres.2008.12.005","article-title":"Glucose intolerance and diabetes as risk factors for cognitive impairment in people at high cardiovascular risk: results from the ONTARGET\/TRANSCEND research programme","volume":"83","author":"Cukierman-Yaffe","year":"2009","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(13)70025-1_bib18","doi-asserted-by":"crossref","first-page":"1126","DOI":"10.1212\/WNL.0b013e31822f0435","article-title":"Glucose tolerance status and risk of dementia in the community: the Hisayama Study","volume":"77","author":"Ohara","year":"2011","journal-title":"Neurology"},{"key":"10.1016\/S2213-8587(13)70025-1_bib19","doi-asserted-by":"crossref","first-page":"26","DOI":"10.2337\/diacare.29.01.06.dc05-1405","article-title":"Relation between blood glucose and coronary mortality over 33 years in the Whitehall Study","volume":"29","author":"Brunner","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib20","doi-asserted-by":"crossref","first-page":"1633","DOI":"10.1161\/STROKEAHA.108.539650","article-title":"Hyperglycemia and incidence of ischemic and hemorrhagic stroke-comparison between fasting and 2-hour glucose criteria","volume":"40","author":"Hyvarinen","year":"2009","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(13)70025-1_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.2337\/diacare.22.2.233","article-title":"The relationship between glucose and incident cardiovascular events. A metaregression analysis of published data from 20 studies of 95,783 individuals followed for 12\u00b74 years","volume":"22","author":"Coutinho","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1136\/bmj.322.7277.15","article-title":"Glycated haemoglobin, diabetes, and mortality in men in Norfolk cohort of European Prospective Investigation of Cancer and Nutrition (EPIC-Norfolk)","volume":"322","author":"Khaw","year":"2001","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(13)70025-1_bib23","doi-asserted-by":"crossref","first-page":"413","DOI":"10.7326\/0003-4819-141-6-200409210-00006","article-title":"Association of hemoglobin A1c with cardiovascular disease and mortality in adults: the European prospective investigation into cancer in Norfolk","volume":"141","author":"Khaw","year":"2004","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib24","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1158\/1055-9965.915.13.6","article-title":"Preliminary communication: glycated hemoglobin, diabetes, and incident colorectal cancer in men and women: a prospective analysis from the European prospective investigation into cancer\u2014Norfolk study","volume":"13","author":"Khaw","year":"2004","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(13)70025-1_bib25","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/dc10-1206","article-title":"Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes","volume":"34","author":"Colagiuri","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib26","doi-asserted-by":"crossref","first-page":"877","DOI":"10.2337\/diacare.29.04.06.dc05-2018","article-title":"HbA1c and peripheral arterial disease in diabetes: the Atherosclerosis Risk in Communities study","volume":"29","author":"Selvin","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib27","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/S0140-6736(11)60471-6","article-title":"Glycaemic control and incidence of heart failure in 20,985 patients with type 1 diabetes: an observational study","volume":"378","author":"Lind","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70025-1_bib28","doi-asserted-by":"crossref","first-page":"1910","DOI":"10.1001\/archinte.165.16.1910","article-title":"Glycemic control and coronary heart disease risk in persons with and without diabetes: the atherosclerosis risk in communities study","volume":"165","author":"Selvin","year":"2005","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib29","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1111\/j.1464-5491.2007.02043.x","article-title":"The prevalence of retinopathy in impaired glucose tolerance and recent-onset diabetes in the Diabetes Prevention Program","volume":"24","year":"2007","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib30","doi-asserted-by":"crossref","first-page":"2509","DOI":"10.1007\/s00125-010-1871-0","article-title":"Dysglycaemia and the risk of acute myocardial infarction in multiple ethnic groups: an analysis of 15,780 patients from the INTERHEART study","volume":"53","author":"Gerstein","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70025-1_bib31","doi-asserted-by":"crossref","first-page":"1699","DOI":"10.1001\/archinte.168.15.1699","volume":"168","author":"Gerstein","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib32","doi-asserted-by":"crossref","first-page":"1993","DOI":"10.1001\/jama.2009.1619","article-title":"Major lipids, apolipoproteins, and risk of vascular disease","volume":"302","author":"Di","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70025-1_bib33","doi-asserted-by":"crossref","first-page":"1903","DOI":"10.1016\/S0140-6736(02)11911-8","article-title":"Age-specific relevance of usual blood pressure to vascular mortality: a meta-analysis of individual data for one million adults in 61 prospective studies","volume":"360","author":"Lewington","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70025-1_bib34","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib35","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1056\/NEJMoa052187","article-title":"Intensive diabetes treatment and cardiovascular disease in patients with type 1 diabetes","volume":"353","author":"Nathan","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib36","doi-asserted-by":"crossref","first-page":"1842","DOI":"10.1056\/NEJMoa066397","article-title":"Long-term effect of diabetes and its treatment on cognitive function","volume":"356","author":"Jacobson","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib37","doi-asserted-by":"crossref","first-page":"837","DOI":"10.1016\/S0140-6736(98)07019-6","article-title":"Intensive blood-glucose control with sulphonylureas or insulin compared with conventional treatment and risk of complications in patients with type 2 diabetes (UKPDS 33)","volume":"352","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70025-1_bib38","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","author":"Chew","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib39","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1016\/S0140-6736(10)60576-4","article-title":"Effect of intensive treatment of hyperglycaemia on microvascular outcomes in type 2 diabetes: an analysis of the ACCORD randomised trial","volume":"376","author":"Ismail-Beigi","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70025-1_bib40","doi-asserted-by":"crossref","first-page":"2560","DOI":"10.1056\/NEJMoa0802987","article-title":"Intensive blood glucose control and vascular outcomes in patients with type 2 diabetes","volume":"358","author":"Patel","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib41","doi-asserted-by":"crossref","first-page":"2288","DOI":"10.1007\/s00125-009-1470-0","article-title":"Intensive glucose control and macrovascular outcomes in type 2 diabetes","volume":"52","author":"Turnbull","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70025-1_bib42","doi-asserted-by":"crossref","first-page":"1608","DOI":"10.1007\/s00125-011-2104-x","article-title":"Intensive glucose control and risk of cancer in patients with type 2 diabetes","volume":"54","author":"Stefansdottir","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70025-1_bib43","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(11)70188-0","article-title":"Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy","volume":"10","author":"Launer","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(13)70025-1_bib44","doi-asserted-by":"crossref","first-page":"1525","DOI":"10.2337\/dc11-2184","article-title":"Intensive glycemic control is not associated with fractures or falls in the ACCORD randomized trial","volume":"35","author":"Schwartz","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib45","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","author":"Gerstein","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib46","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib47","doi-asserted-by":"crossref","first-page":"995","DOI":"10.2337\/db07-1618","article-title":"Effect of glycemic exposure on the risk of microvascular complications in the diabetes control and complications trial\u2014revisited","volume":"57","author":"Lachin","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70025-1_bib48","doi-asserted-by":"crossref","first-page":"1307","DOI":"10.1001\/archinternmed.2009.193","volume":"169","author":"Nathan","year":"2009","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib49","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1007\/s00125-009-1457-x","article-title":"Effects of blood pressure lowering and intensive glucose control on the incidence and progression of retinopathy in patients with type 2 diabetes mellitus: a randomised controlled trial","volume":"52","author":"Beulens","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70025-1_bib50","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1056\/NEJMoa0808431","article-title":"Glucose Control and Vascular Complications in Veterans with Type 2 Diabetes","volume":"360","author":"Duckworth","year":"2009","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(13)70025-1_bib51","first-page":"B21","article-title":"Long-term results of the Kumamoto Study on optimal diabetes control in type 2 diabetic patients","volume":"23","author":"Shichiri","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib52","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD008143.pub2","article-title":"Targeting intensive glycaemic control versus targeting conventional glycaemic control for type 2 diabetes mellitus","volume":"6","author":"Hemmingsen","year":"2011","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(13)70025-1_bib53","doi-asserted-by":"crossref","first-page":"1783","DOI":"10.1016\/S0140-6736(08)60766-7","article-title":"The long-term effect of lifestyle interventions to prevent diabetes in the China Da Qing Diabetes Prevention Study: a 20-year follow-up study","volume":"371","author":"Li","year":"2008","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70025-1_bib54","doi-asserted-by":"crossref","first-page":"2294","DOI":"10.1056\/NEJMoa022314","article-title":"Intensive diabetes therapy and carotid intima-media thickness in type 1 diabetes mellitus","volume":"348","author":"Nathan","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib55","doi-asserted-by":"crossref","first-page":"2503","DOI":"10.1056\/NEJMoa0805796","article-title":"A randomized trial of therapies for type 2 diabetes and coronary artery disease","volume":"360","author":"Frye","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib56","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1056\/NEJMoa1203858","article-title":"Basal insulin and cardiovascular and other outcomes in dysglycemia","volume":"367","author":"Gerstein","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib57","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib58","doi-asserted-by":"crossref","first-page":"1400","DOI":"10.1016\/j.ophtha.2009.10.047","article-title":"Retinal vascular fractals and microvascular and macrovascular complications in type 1 diabetes","volume":"117","author":"Grauslund","year":"2010","journal-title":"Ophthalmology"},{"key":"10.1016\/S2213-8587(13)70025-1_bib59","doi-asserted-by":"crossref","first-page":"124","DOI":"10.1016\/S0140-6736(09)62124-3","article-title":"Diabetic retinopathy","volume":"376","author":"Cheung","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70025-1_bib60","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1056\/NEJMra1005073","article-title":"Diabetic retinopathy","volume":"366","author":"Antonetti","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib61","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1007\/s10633-011-9305-y","article-title":"The pathogenesis of early retinal changes of diabetic retinopathy","volume":"124","author":"Arden","year":"2012","journal-title":"Doc Ophthalmol"},{"key":"10.1016\/S2213-8587(13)70025-1_bib62","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2013.02.011","article-title":"Microangiopathy of large artery wall: a neglected complication of diabetes mellitus","author":"Arcidiacono","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(13)70025-1_bib63","doi-asserted-by":"crossref","first-page":"1238","DOI":"10.2337\/dc11-0079","article-title":"Diabetic retinopathy predicts all-cause mortality and cardiovascular events in both type 1 and 2 diabetes: meta-analysis of observational studies","volume":"34","author":"Kramer","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib64","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1016\/j.jacc.2007.11.076","article-title":"Diabetic retinopathy and risk of heart failure","volume":"51","author":"Cheung","year":"2008","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(13)70025-1_bib65","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1001\/archinternmed.2011.16","article-title":"Long-term renal outcomes of patients with type 1 diabetes mellitus and microalbuminuria: an analysis of the Diabetes Control and Complications Trial\/Epidemiology of Diabetes Interventions and Complications cohort","volume":"171","author":"de Boer","year":"2011","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib66","doi-asserted-by":"crossref","first-page":"1832","DOI":"10.2337\/db05-1620","article-title":"Risk factors for renal dysfunction in type 2 diabetes: U.K. Prospective Diabetes Study 74","volume":"55","author":"Retnakaran","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70025-1_bib67","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.2337\/dc11-1341","article-title":"Early retinal arteriolar changes and peripheral neuropathy in diabetes","volume":"35","author":"Ding","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib68","doi-asserted-by":"crossref","first-page":"1133","DOI":"10.1016\/j.urology.2011.01.009","article-title":"Erectile dysfunction is associated with severe retinopathy in diabetic men","volume":"77","author":"Henis","year":"2011","journal-title":"Urology"},{"key":"10.1016\/S2213-8587(13)70025-1_bib69","doi-asserted-by":"crossref","first-page":"951","DOI":"10.2337\/diacare.22.6.951","article-title":"The 14-year incidence of lower-extremity amputations in a diabetic population. The Wisconsin epidemiologic study of diabetic retinopathy","volume":"22","author":"Moss","year":"1999","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib70","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.2337\/diacare.24.7.1198","article-title":"Diabetes and risk of fracture: the Blue Mountains Eye Study","volume":"24","author":"Ivers","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib71","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1007\/s00125-010-1720-1","article-title":"Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and retinopathy in type 1 diabetic patients","volume":"53","author":"Targher","year":"2010","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70025-1_bib72","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1007\/s00125-007-0897-4","article-title":"Non-alcoholic fatty liver disease is independently associated with an increased prevalence of chronic kidney disease and proliferative\/laser-treated retinopathy in type 2 diabetic patients","volume":"51","author":"Targher","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70025-1_bib73","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1111\/j.1464-5491.2010.02962.x","article-title":"The prevalence of retinopathy in men with type 2 diabetes and obstructive sleep apnoea","volume":"27","author":"West","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib74","first-page":"644","article-title":"Association of depression with complications of type 2 diabetes\u2013the Chennai Urban Rural Epidemiology Study (CURES-102)","volume":"59","author":"Poongothai","year":"2011","journal-title":"J Assoc Physicians India"},{"key":"10.1016\/S2213-8587(13)70025-1_bib75","article-title":"Diabetic retinopathy, its progression and incident cardiovascular events in the ACCORD Trial","author":"Gerstein","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib76","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2337\/diabetes.55.01.06.db05-0633","article-title":"Glucosamine-induced endoplasmic reticulum dysfunction is associated with accelerated atherosclerosis in a hyperglycemic mouse model","volume":"55","author":"Werstuck","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70025-1_bib77","doi-asserted-by":"crossref","DOI":"10.1016\/j.atherosclerosis.2013.01.018","article-title":"Hyperglycaemia is associated with impaired vasa vasorum neovascularization and accelerated atherosclerosis in apolipoprotein-E deficient mice","author":"Veerman","year":"2013","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(13)70025-1_bib78","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1161\/hc0302.102143","article-title":"Decreased cardiac expression of vascular endothelial growth factor and its receptors in insulin-resistant and diabetic States: a possible explanation for impaired collateral formation in cardiac tissue","volume":"105","author":"Chou","year":"2002","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(13)70025-1_bib79","first-page":"H781","article-title":"Role of vasa vasorum in nourishment of the aortic wall","volume":"240","author":"Heistad","year":"1981","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(13)70025-1_bib80","doi-asserted-by":"crossref","first-page":"1258","DOI":"10.1038\/2121258a0","article-title":"Vascular lesions due to obstruction of the vasa vasorum","volume":"212","author":"Nakata","year":"1966","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(13)70025-1_bib81","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.atherosclerosis.2009.03.010","article-title":"Low vasa vasorum densities correlate with inflammation and subintimal thickening: potential role in location\u2013determination of atherogenesis","volume":"206","author":"Gossl","year":"2009","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(13)70025-1_bib82","doi-asserted-by":"crossref","first-page":"H2346","DOI":"10.1152\/ajpheart.00066.2004","article-title":"Role of vasa vasorum in transendothelial solute transport in the coronary vessel wall: a study with cryostatic micro-CT","volume":"287","author":"Gossl","year":"2004","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/S2213-8587(13)70025-1_bib83","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.atherosclerosis.2012.09.003","article-title":"Hyperglycemia and arterial stiffness: the atherosclerosis risk in the communities study","volume":"225","author":"Rubin","year":"2012","journal-title":"Atherosclerosis"},{"key":"10.1016\/S2213-8587(13)70025-1_bib84","doi-asserted-by":"crossref","first-page":"1867","DOI":"10.1001\/archinternmed.2008.2","article-title":"Insulin therapy, hyperglycemia, and hypertension in type 1 diabetes mellitus","volume":"168","author":"de Boer","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib85","doi-asserted-by":"crossref","first-page":"2642","DOI":"10.2337\/db09-0618","article-title":"Intensive glucose-lowering therapy reduces cardiovascular disease events in veterans affairs diabetes trial participants with lower calcified coronary atherosclerosis","volume":"58","author":"Reaven","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70025-1_bib86","doi-asserted-by":"crossref","first-page":"1136","DOI":"10.1001\/archophthalmol.2012.1800","article-title":"Retinopathy and chronic kidney disease in the Chronic Renal Insufficiency Cohort (CRIC) study","volume":"130","author":"Grunwald","year":"2012","journal-title":"Arch Ophthalmol"},{"key":"10.1016\/S2213-8587(13)70025-1_bib88","doi-asserted-by":"crossref","first-page":"742976","DOI":"10.1155\/2012\/742976","article-title":"It is all in the blood: the multifaceted contribution of circulating progenitor cells in diabetic complications","volume":"2012","author":"Fadini","year":"2012","journal-title":"Exp Diabetes Res"},{"key":"10.1016\/S2213-8587(13)70025-1_bib89","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1002\/biof.1016","article-title":"Endothelial progenitor cells in diabetes mellitus","volume":"38","author":"Menegazzo","year":"2012","journal-title":"Biofactors"},{"key":"10.1016\/S2213-8587(13)70025-1_bib90","doi-asserted-by":"crossref","first-page":"943","DOI":"10.2337\/dc12-1084","article-title":"Diabetes impairs stem cell and proangiogenic cell mobilization in humans","volume":"36","author":"Fadini","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70025-1_bib91","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","author":"Ginsberg","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70025-1_bib87","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1016\/j.semnephrol.2012.02.006","article-title":"The endothelium in diabetic nephropathy","volume":"32","author":"Advani","year":"2012","journal-title":"Semin Nephrol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700251?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700251?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T23:36:56Z","timestamp":1688427416000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700251"}},"issued":{"date-parts":[[2013,9]]},"references-count":90,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S2213858713700251"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70025-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Dysglycaemia, vasculopenia, and the chronic consequences of diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70025-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,12]],"date-time":"2026-03-12T02:29:41Z","timestamp":1773282581432,"version":"3.50.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001826","name":"ZonMw","doi-asserted-by":"publisher","award":["543003109"],"award-info":[{"award-number":["543003109"]}],"id":[{"id":"10.13039\/501100001826","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002996","name":"Netherlands Heart Foundation","doi-asserted-by":"publisher","award":["2017T013"],"award-info":[{"award-number":["2017T013"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003092","name":"Diabetes Fonds","doi-asserted-by":"publisher","award":["2017.81.002"],"award-info":[{"award-number":["2017.81.002"]}],"id":[{"id":"10.13039\/501100003092","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/s2213-8587(21)00110-8","type":"journal-article","created":{"date-parts":[[2021,4,29]],"date-time":"2021-04-29T21:46:13Z","timestamp":1619732773000},"page":"320-321","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Tackling childhood obesity in low-socioeconomic status communities: what is the next step?"],"prefix":"10.1016","volume":"9","author":[{"given":"Romy","family":"Gaillard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00110-8_bib1","doi-asserted-by":"crossref","first-page":"1208","DOI":"10.1001\/jama.2020.14590","article-title":"Trends in obesity prevalence by race and Hispanic origin-1999\u20132000 to 2017\u20132018","volume":"324","author":"Ogden","year":"2020","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00110-8_bib2","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2019.2430","article-title":"Prevalence and trends of overweight and obesity in European children from 1999 to 2016: a systematic review and meta-analysis","volume":"173","author":"Garrido-Miguel","year":"2019","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(21)00110-8_bib3","doi-asserted-by":"crossref","first-page":"485","DOI":"10.1056\/NEJMoa0904130","article-title":"Childhood obesity, other cardiovascular risk factors, and premature death","volume":"362","author":"Franks","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00110-8_bib4","doi-asserted-by":"crossref","first-page":"2430","DOI":"10.1056\/NEJMoa1503840","article-title":"Body-mass index in 2.3 million adolescents and cardiovascular death in adulthood","volume":"374","author":"Twig","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00110-8_bib5","article-title":"Diet, physical activity and behavioural interventions for the treatment of overweight or obese children from the age of 6 to 11 years","volume":"6","author":"Mead","year":"2017","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(21)00110-8_bib6","doi-asserted-by":"crossref","first-page":"2427","DOI":"10.1001\/jama.2017.0332","article-title":"Screening for obesity and intervention for weight management in children and adolescents: evidence report and systematic review for the US Preventive services task force","volume":"317","author":"O'Connor","year":"2017","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(21)00110-8_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00084-X","article-title":"A Community-based, multi-level, multi-setting, multi-component intervention to reduce weight gain among low socioeconomic status Latinx children with overweight or obesity: the Stanford GOALS randomised controlled trial","author":"Robinson","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00110-8_bib8","doi-asserted-by":"crossref","first-page":"710","DOI":"10.1038\/pr.2015.29","article-title":"BMI, total and abdominal fat distribution, and cardiovascular risk factors in school-age children","volume":"77","author":"Gishti","year":"2015","journal-title":"Pediatr Res"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001108?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001108?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:33Z","timestamp":1761991773000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001108"}},"issued":{"date-parts":[[2021,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213858721001108"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00110-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tackling childhood obesity in low-socioeconomic status communities: what is the next step?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00110-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00084-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,8]],"date-time":"2026-01-08T06:45:36Z","timestamp":1767854736468,"version":"3.49.0"},"reference-count":0,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,2,1]],"date-time":"2014-02-01T00:00:00Z","timestamp":1391212800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,2]]},"DOI":"10.1016\/s2213-8587(14)70020-8","type":"journal-article","created":{"date-parts":[[2014,2,3]],"date-time":"2014-02-03T08:45:45Z","timestamp":1391417145000},"page":"91","source":"Crossref","is-referenced-by-count":10,"title":["Bariatric surgery: why only a last resort?"],"prefix":"10.1016","volume":"2","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700208?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700208?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T18:53:25Z","timestamp":1538852005000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700208"}},"issued":{"date-parts":[[2014,2]]},"references-count":0,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,2]]}},"alternative-id":["S2213858714700208"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70020-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,2]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:47Z","timestamp":1761992207890,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000030","name":"Centers for Disease Control and Prevention","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000030","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/s2213-8587(23)00226-7","type":"journal-article","created":{"date-parts":[[2023,8,22]],"date-time":"2023-08-22T18:27:44Z","timestamp":1692728864000},"page":"631-633","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Built environment and obesity prevention research: moving from niche to norm"],"prefix":"10.1016","volume":"11","author":[{"given":"Deborah","family":"Salvo","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Maura","family":"Kepper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ruth","family":"Hunter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Alejandra","family":"J\u00e1uregui","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00226-7_bib1","doi-asserted-by":"crossref","DOI":"10.1111\/obr.13171","article-title":"Associations between the built environment and dietary intake, physical activity, and obesity: a scoping review of reviews","volume":"22","author":"Dixon","year":"2021","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(23)00226-7_bib2","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1146\/annurev-publhealth-040218-043657","article-title":"Built environment, physical activity, and obesity: findings from the international physical activity and environment network (IPEN) adult study","volume":"41","author":"Sallis","year":"2020","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/S2213-8587(23)00226-7_bib3","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1093\/advances\/nmz031","article-title":"Food environment research in low-and middle-income countries: a systematic scoping review","volume":"11","author":"Turner","year":"2020","journal-title":"Adv Nutr"},{"key":"10.1016\/S2213-8587(23)00226-7_bib4","doi-asserted-by":"crossref","first-page":"e895","DOI":"10.1016\/S2214-109X(22)00068-7","article-title":"Determining thresholds for spatial urban design and transport features that support walking to create healthy and sustainable cities: findings from the IPEN Adult study","volume":"10","author":"Cerin","year":"2022","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(23)00226-7_bib5","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1016\/j.ypmed.2016.08.042","article-title":"Urban density, diversity and design: Is more always better for walking? A study from Hong Kong","volume":"103S","author":"Lu","year":"2017","journal-title":"Prev Med"},{"key":"10.1016\/S2213-8587(23)00226-7_bib6","doi-asserted-by":"crossref","first-page":"E147","DOI":"10.5888\/pcd11.140047","article-title":"Characteristics of the built environment in relation to objectively measured physical activity among Mexican adults, 2011","volume":"11","author":"Salvo","year":"2014","journal-title":"Prev Chronic Dis"},{"key":"10.1016\/S2213-8587(23)00226-7_bib7","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/j.jth.2018.11.008","article-title":"Pathways from built environment to health: a conceptual framework linking behavior and exposure-based impacts","volume":"12","author":"Frank","year":"2019","journal-title":"J Transp Health"},{"key":"10.1016\/S2213-8587(23)00226-7_bib8","doi-asserted-by":"crossref","first-page":"151","DOI":"10.1146\/annurev-publhealth-071321-042211","article-title":"When moving is the only option: the role of necessity versus choice for understanding and promoting physical activity in low-and middle-income countries","volume":"44","author":"Salvo","year":"2023","journal-title":"Annu Rev Public Health"},{"key":"10.1016\/S2213-8587(23)00226-7_bib9","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1123\/jpah.2021-0413","article-title":"Physical activity promotion and the United Nations sustainable development goals: building synergies to maximize impact","volume":"18","author":"Salvo","year":"2021","journal-title":"J Phys Act Health"},{"key":"10.1016\/S2213-8587(23)00226-7_bib10","doi-asserted-by":"crossref","DOI":"10.3389\/fdgth.2021.648777","article-title":"Development of a health information technology tool for behavior change to address obesity and prevent chronic disease among adolescents: designing for dissemination and sustainment using the ORBIT model","volume":"3","author":"Kepper","year":"2021","journal-title":"Front Digit Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002267?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002267?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:17Z","timestamp":1761991937000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723002267"}},"issued":{"date-parts":[[2023,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2213858723002267"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00226-7","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Built environment and obesity prevention research: moving from niche to norm","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00226-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,1]],"date-time":"2026-04-01T22:32:37Z","timestamp":1775082757019,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,6,1]],"date-time":"2022-06-01T00:00:00Z","timestamp":1654041600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,6]]},"DOI":"10.1016\/s2213-8587(22)00116-4","type":"journal-article","created":{"date-parts":[[2022,4,22]],"date-time":"2022-04-22T18:35:21Z","timestamp":1650652521000},"page":"377-378","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Add-on value of tirzepatide versus semaglutide"],"prefix":"10.1016","volume":"10","author":[{"given":"Andr\u00e9 J","family":"Scheen","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00116-4_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/j.molmet.2020.101102","article-title":"GLP-1 receptor agonists in the treatment of type 2 diabetes\u2014state-of-the-art","volume":"46","author":"Nauck","year":"2021","journal-title":"Mol Metab"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(22)00116-4_bib2","first-page":"S125","article-title":"9. Pharmacologic approaches to glycemic treatment: standards of medical care in diabetes\u20142022","volume":"45","author":"Draznin","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(22)00116-4_bib3","doi-asserted-by":"crossref","first-page":"2468","DOI":"10.2337\/dbi21-0026","article-title":"Treatment of type 2 diabetes and obesity on the basis of the incretin system: the 2021 Banting medal for scientific achievement award lecture","volume":"70","author":"Holst","year":"2021","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(22)00116-4_bib4","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00116-4_bib5","doi-asserted-by":"crossref","first-page":"388","DOI":"10.1210\/clinem\/dgaa863","article-title":"Dual GIP and GLP-1 receptor agonist tirzepatide improves beta-cell function and insulin sensitivity in type 2 diabetes","volume":"106","author":"Thomas","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00116-4_bib6","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(22)00085-7","article-title":"Effects of subcutaneous tirzepatide versus placebo or semaglutide on pancreatic islet function and insulin sensitivity in adults with type 2 diabetes: a multicentre, randomised, double-blind, parallel-arm, phase 1 clinical trial","author":"Heise","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00116-4_bib7","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(21)00205-9","article-title":"GLP-1 receptor agonists: which added value when increasing the dose?","volume":"9","author":"Scheen","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00116-4_bib8","doi-asserted-by":"crossref","DOI":"10.1126\/sciadv.abf1948","article-title":"GIP mediates the incretin effect and glucose tolerance by dual actions on \u03b1 cells and \u03b2 cells","volume":"7","author":"El","year":"2021","journal-title":"Sci Adv"},{"key":"10.1016\/S2213-8587(22)00116-4_bib9","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1016\/S2213-8587(14)70004-X","article-title":"Combating the dual burden: therapeutic targeting of common pathways in obesity and type 2 diabetes","volume":"2","author":"Scheen","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00116-4_bib10","doi-asserted-by":"crossref","DOI":"10.1172\/JCI146353","article-title":"GIPR agonism mediates weight-independent insulin sensitization by tirzepatide in obese mice","volume":"131","author":"Samms","year":"2021","journal-title":"J Clin Invest"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:39Z","timestamp":1761991899000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001164"}},"issued":{"date-parts":[[2022,6]]},"references-count":10,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2022,6]]}},"alternative-id":["S2213858722001164"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00116-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Add-on value of tirzepatide versus semaglutide","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00116-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00085-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,4,15]],"date-time":"2026-04-15T14:04:52Z","timestamp":1776261892899,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,10,1]],"date-time":"2020-10-01T00:00:00Z","timestamp":1601510400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100009945","name":"Merck KGaA","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009945","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100014860","name":"Australian Carbon Innovation","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014860","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008897","name":"Janssen Pharmaceuticals","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008897","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,10]]},"DOI":"10.1016\/s2213-8587(20)30311-9","type":"journal-article","created":{"date-parts":[[2020,9,15]],"date-time":"2020-09-15T18:37:10Z","timestamp":1600195030000},"page":"803-805","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["SGLT2 inhibitors and renal complications in type 1 diabetes"],"prefix":"10.1016","volume":"8","author":[{"given":"John R","family":"Petrie","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30311-9_bib1","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1016\/S2213-8587(17)30315-7","article-title":"SGLT2 inhibitors in type 1 diabetes: knocked down, but up again?","volume":"5","author":"Petrie","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30311-9_bib2","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1001\/jama.2014.16425","article-title":"Estimated life expectancy in a Scottish cohort with type 1 diabetes, 2008\u20132010","volume":"313","author":"Livingstone","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(20)30311-9_bib3","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000503919","article-title":"The effects of SGLT2 inhibitors on cardiovascular and renal outcomes in diabetic patients: a systematic review and meta-analysis","volume":"10","author":"Lo","year":"2020","journal-title":"Cardiorenal Med"},{"key":"10.1016\/S2213-8587(20)30311-9_bib4","doi-asserted-by":"crossref","first-page":"845","DOI":"10.1016\/S2213-8587(20)30280-1","article-title":"Effect of dapagliflozin as an adjunct to insulin over 52 weeks in individuals with type 1 diabetes: post-hoc renal analysis of the DEPICT randomised controlled trials","volume":"8","author":"Groop","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30311-9_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/dom.14144","article-title":"Benefit:risk profile of dapagliflozin 5 mg in the DEPICT-1 and -2 trials in individuals with type 1 diabetes and BMI \u226527 kg\/m2","author":"Mathieu","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(20)30311-9_bib6","doi-asserted-by":"crossref","first-page":"2295","DOI":"10.1056\/NEJMoa1811744","article-title":"Canagliflozin and renal outcomes in type 2 diabetes and nephropathy","volume":"380","author":"Perkovic","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30311-9_bib7","doi-asserted-by":"crossref","first-page":"1626","DOI":"10.1007\/s00125-020-05173-w","article-title":"Time trends in deaths before age 50 years in people with type 1 diabetes: a nationwide analysis from Scotland 2004-2017","volume":"63","author":"O'Reilly","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(20)30311-9_bib8","doi-asserted-by":"crossref","first-page":"1977","DOI":"10.1007\/s40265-019-01230-w","article-title":"Sotagliflozin: a review in type 1 diabetes","volume":"79","author":"Deeks","year":"2019","journal-title":"Drugs"},{"key":"10.1016\/S2213-8587(20)30311-9_bib9","series-title":"NICE recommends innovative treatment for type 1 diabetes","year":"2019"},{"key":"10.1016\/S2213-8587(20)30311-9_bib10","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1007\/s13300-019-00728-6","article-title":"Optimising the benefits of SGLT2 inhibitors for type 1 diabetes","volume":"11","author":"Evans","year":"2020","journal-title":"Diabetes Ther"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:41Z","timestamp":1761991721000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303119"}},"issued":{"date-parts":[[2020,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2020,10]]}},"alternative-id":["S2213858720303119"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30311-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"SGLT2 inhibitors and renal complications in type 1 diabetes","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30311-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30280-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T02:19:19Z","timestamp":1772763559299,"version":"3.50.1"},"reference-count":0,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/s2213-8587(20)30377-6","type":"journal-article","created":{"date-parts":[[2020,11,9]],"date-time":"2020-11-09T18:33:27Z","timestamp":1604946807000},"page":"931","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Nurses: at the heart of diabetes care"],"prefix":"10.1016","volume":"8","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303776?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303776?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:43Z","timestamp":1761991723000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303776"}},"issued":{"date-parts":[[2020,12]]},"references-count":0,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2213858720303776"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30377-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nurses: at the heart of diabetes care","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30377-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:24Z","timestamp":1761991944987,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,9,1]],"date-time":"2020-09-01T00:00:00Z","timestamp":1598918400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,9]]},"DOI":"10.1016\/s2213-8587(20)30273-4","type":"journal-article","created":{"date-parts":[[2020,8,7]],"date-time":"2020-08-07T18:36:20Z","timestamp":1596825380000},"page":"731","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Indigenous peoples: resilience in the face of adversity"],"prefix":"10.1016","volume":"8","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302734?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302734?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:40Z","timestamp":1761991720000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720302734"}},"issued":{"date-parts":[[2020,9]]},"references-count":0,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2020,9]]}},"alternative-id":["S2213858720302734"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30273-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Indigenous peoples: resilience in the face of adversity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30273-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,12,14]],"date-time":"2025-12-14T17:05:29Z","timestamp":1765731929077},"reference-count":12,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2016,7,1]],"date-time":"2016-07-01T00:00:00Z","timestamp":1467331200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,7]]},"DOI":"10.1016\/s2213-8587(16)00085-1","type":"journal-article","created":{"date-parts":[[2016,3,31]],"date-time":"2016-03-31T21:53:54Z","timestamp":1459461234000},"page":"560-562","source":"Crossref","is-referenced-by-count":20,"title":["Screening for diabetes in patients with cardiovascular disease: HbA1c trumps oral glucose tolerance testing"],"prefix":"10.1016","volume":"4","author":[{"given":"Naveed","family":"Sattar","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"David","family":"Preiss","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"suppl 1","key":"10.1016\/S2213-8587(16)00085-1_bib1","first-page":"S62","article-title":"Diagnosis and classification of diabetes mellitus","volume":"33","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00085-1_bib2","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1093\/eurheartj\/eht108","volume":"34","author":"Ryden","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)00085-1_bib3","doi-asserted-by":"crossref","first-page":"1171","DOI":"10.1093\/eurheartj\/ehv008","article-title":"Screening for dysglycaemia in patients with coronary artery disease as reflected by fasting glucose, oral glucose tolerance test, and HbA1c: a report from EUROASPIRE IV\u2014a survey from the European Society of Cardiology","volume":"36","author":"Gyberg","year":"2015","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)00085-1_bib4","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/dc10-1206","article-title":"Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes","volume":"34","author":"Colagiuri","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(16)00085-1_bib5","doi-asserted-by":"crossref","first-page":"1545","DOI":"10.1001\/archinte.167.14.1545","article-title":"Short-term variability in measures of glycemia and implications for the classification of diabetes","volume":"167","author":"Selvin","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(16)00085-1_bib6","doi-asserted-by":"crossref","first-page":"116","DOI":"10.1016\/S2213-8587(13)70152-9","article-title":"Metformin for non-diabetic patients with coronary heart disease (the CAMERA study): a randomised controlled trial","volume":"2","author":"Preiss","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)00085-1_bib7","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1001\/jama.2014.1873","article-title":"Glycated hemoglobin measurement and prediction of cardiovascular disease","volume":"311","author":"Di Angelantonio","year":"2014","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)00085-1_bib8","doi-asserted-by":"crossref","first-page":"1441","DOI":"10.1515\/cclm-2014-0860","article-title":"Comparing HbA1c, fasting and 2-h plasma glucose for screening for abnormal glucose regulation in patients undergoing coronary angiography","volume":"53","author":"Wang","year":"2015","journal-title":"Clin Chem Lab Med"},{"key":"10.1016\/S2213-8587(16)00085-1_bib9","doi-asserted-by":"crossref","first-page":"383","DOI":"10.4082\/kjfm.2011.32.7.383","article-title":"The utility of HbA1c as a diagnostic criterion of diabetes","volume":"32","author":"Kim","year":"2011","journal-title":"Korean J Fam Med"},{"key":"10.1016\/S2213-8587(16)00085-1_bib10","doi-asserted-by":"crossref","first-page":"366","DOI":"10.1055\/s-0030-1267183","article-title":"Comparison of HbA1c and OGTT criteria to diagnose diabetes among Chinese","volume":"119","author":"Dong","year":"2011","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/S2213-8587(16)00085-1_bib11","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1111\/j.1464-5491.2010.03034.x","article-title":"Comparing risk profiles of individuals diagnosed with diabetes by OGTT and HbA1c: the Danish Inter99 study","volume":"27","author":"Borg","year":"2010","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(16)00085-1_bib12","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1016\/S2213-8587(15)00129-1","article-title":"Effects of diabetes definition on global surveillance of diabetes prevalence and diagnosis: a pooled analysis of 96 population-based studies with 331\u2008288 participants","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000851?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000851?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,13]],"date-time":"2018-09-13T17:26:46Z","timestamp":1536859606000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716000851"}},"issued":{"date-parts":[[2016,7]]},"references-count":12,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2016,7]]}},"alternative-id":["S2213858716000851"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)00085-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,7]]}},{"indexed":{"date-parts":[[2026,4,27]],"date-time":"2026-04-27T14:12:13Z","timestamp":1777299133414,"version":"3.51.4"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,2,1]],"date-time":"2022-02-01T00:00:00Z","timestamp":1643673600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,2]]},"DOI":"10.1016\/s2213-8587(21)00325-9","type":"journal-article","created":{"date-parts":[[2021,12,20]],"date-time":"2021-12-20T18:40:31Z","timestamp":1640025631000},"page":"93-94","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":6,"title":["Nutrition-related health taxes: setting expectations"],"prefix":"10.1016","volume":"10","author":[{"given":"J Jaime","family":"Miranda","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Anne-Marie","family":"Thow","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Mar\u00eda Kathia","family":"C\u00e1rdenas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Camila","family":"Corval\u00e1n","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tonatiuh","family":"Barrientos-Guti\u00e9rrez","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jay S","family":"Kaufman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00325-9_bib1","doi-asserted-by":"crossref","first-page":"400","DOI":"10.2105\/AJPH.94.3.400","article-title":"Evidence-based public health: moving beyond randomized trials","volume":"94","author":"Victora","year":"2004","journal-title":"Am J Public Health"},{"key":"10.1016\/S2213-8587(21)00325-9_bib2","author":"Piper"},{"key":"10.1016\/S2213-8587(21)00325-9_bib3","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1186\/s12992-021-00767-4","article-title":"The future of human malnutrition: rebalancing agency for better nutritional health","volume":"17","author":"Wells","year":"2021","journal-title":"Global Health"},{"key":"10.1016\/S2213-8587(21)00325-9_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.ehb.2020.100854","article-title":"The macroeconomic impacts of diet-related fiscal policy for NCD prevention: A systematic review","volume":"37","author":"Mounsey","year":"2020","journal-title":"Econ Hum Biol"},{"key":"10.1016\/S2213-8587(21)00325-9_bib5","doi-asserted-by":"crossref","first-page":"339","DOI":"10.1186\/s12889-019-6663-y","article-title":"From intervention to interventional system: towards greater theorization in population health intervention research","volume":"19","author":"Cambon","year":"2019","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(21)00325-9_bib6","doi-asserted-by":"crossref","first-page":"2299","DOI":"10.1016\/j.socscimed.2012.08.032","article-title":"Realist randomised controlled trials: a new approach to evaluating complex public health interventions","volume":"75","author":"Bonell","year":"2012","journal-title":"Soc Sci Med"},{"key":"10.1016\/S2213-8587(21)00325-9_bib7","article-title":"Sugar-sweetened beverages tax and front-of-package labelling in Peru: two decades of history","author":"C\u00e1rdenas","year":"2021","journal-title":"SocArXiv"},{"key":"10.1016\/S2213-8587(21)00325-9_bib8","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/j.foodpol.2017.08.001","article-title":"Designing a food tax to impact food-related non-communicable diseases: the case of Chile","volume":"71","author":"Caro","year":"2017","journal-title":"Food Policy"},{"key":"10.1016\/S2213-8587(21)00325-9_bib9","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-021-11984-2","article-title":"How should we evaluate sweetened beverage tax policies? A review of worldwide experience","volume":"21","author":"Ng","year":"2021","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(21)00325-9_bib10","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1186\/s13063-019-3383-7","article-title":"Population health intervention research: the place of theories","volume":"20","author":"Moore","year":"2019","journal-title":"Trials"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003259?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003259?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:52Z","timestamp":1761991852000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721003259"}},"issued":{"date-parts":[[2022,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2022,2]]}},"alternative-id":["S2213858721003259"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00325-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Nutrition-related health taxes: setting expectations","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00325-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:16:19Z","timestamp":1761992179635,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,12,1]],"date-time":"2021-12-01T00:00:00Z","timestamp":1638316800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,12]]},"DOI":"10.1016\/s2213-8587(21)00237-0","type":"journal-article","created":{"date-parts":[[2021,10,13]],"date-time":"2021-10-13T22:02:40Z","timestamp":1634162560000},"page":"800-801","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Thought for food: a Cushing's syndrome enigma explained"],"prefix":"10.1016","volume":"9","author":[{"given":"Ashley","family":"Grossman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00237-0_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(21)00236-9","article-title":"Loss of KDM1A in GIP-dependent primary bilateral macronodular adrenal hyperplasia with Cushing's syndrome: a multicentre, retrospective, cohort study","author":"Chasseloup","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00237-0_bib2","first-page":"137","article-title":"The basophil adenomas of the pituitary body and their clinical manifestations (pituitary basophilism)","volume":"50","author":"Cushing","year":"1932","journal-title":"Bulletin Johns Hopkins Hospital"},{"key":"10.1016\/S2213-8587(21)00237-0_bib3","doi-asserted-by":"crossref","first-page":"2105","DOI":"10.1056\/NEJMoa1304603","article-title":"ARMC5 mutations in macronodular adrenal hyperplasia with Cushing's syndrome","volume":"369","author":"Assi\u00e9","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00237-0_bib4","doi-asserted-by":"crossref","first-page":"E1784","DOI":"10.1210\/jc.2014-1265","article-title":"ARMC5 mutations are common in familial bilateral macronodular adrenal hyperplasia","volume":"99","author":"Gagliardi","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00237-0_bib5","doi-asserted-by":"crossref","first-page":"974","DOI":"10.1056\/NEJM199210013271402","article-title":"Gastric inhibitory polypeptide-dependent cortisol hypersecretion--a new cause of Cushing's syndrome","volume":"327","author":"Lacroix","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00237-0_bib6","doi-asserted-by":"crossref","first-page":"3009","DOI":"10.1210\/jc.2004-0946","article-title":"The aberrant expression of the gastric inhibitory polypeptide (GIP) receptor in adrenal hyperplasia: does chronic adrenocorticotropin exposure stimulate up-regulation of GIP receptors in Cushing's disease?","volume":"90","author":"Swords","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00237-0_bib7","doi-asserted-by":"crossref","first-page":"K13","DOI":"10.1530\/EJE-17-0263","article-title":"Adrenal Cushing's syndrome during pregnancy","volume":"177","author":"Andreescu","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(21)00237-0_bib8","doi-asserted-by":"crossref","first-page":"1","DOI":"10.3389\/fgene.2021.680633","article-title":"Lysine demethylases: promising drug targets in melanoma and other cancers","volume":"12","author":"Punnia-Moorthy","year":"2021","journal-title":"Front Genet"},{"key":"10.1016\/S2213-8587(21)00237-0_bib9","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1186\/s12929-021-00737-3","article-title":"Roles of lysine-specific demethylase 1 (LSD1) in homeostasis and diseases","volume":"28","author":"Kim","year":"2021","journal-title":"J Biomed Sci"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002370?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721002370?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:31Z","timestamp":1761991891000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721002370"}},"issued":{"date-parts":[[2021,12]]},"references-count":9,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2021,12]]}},"alternative-id":["S2213858721002370"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00237-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thought for food: a Cushing's syndrome enigma explained","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00237-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00236-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,1,19]],"date-time":"2026-01-19T14:49:02Z","timestamp":1768834142555,"version":"3.49.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2015,1,1]],"date-time":"2015-01-01T00:00:00Z","timestamp":1420070400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,9,29]],"date-time":"2014-09-29T00:00:00Z","timestamp":1411948800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-sa\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,1]]},"DOI":"10.1016\/s2213-8587(14)70201-3","type":"journal-article","created":{"date-parts":[[2014,9,25]],"date-time":"2014-09-25T05:34:41Z","timestamp":1411623281000},"page":"3-4","source":"Crossref","is-referenced-by-count":4,"title":["Long working hours can be toxic"],"prefix":"10.1016","volume":"3","author":[{"given":"Orfeu M","family":"Buxton","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Cassandra A","family":"Okechukwu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70201-3_bib1","article-title":"Long working hours, socioeconomic status, and the risk of incident type 2 diabetes: a meta-analysis of published and unpublished data from 222\u2008120 individuals","author":"Kivim\u00e4ki","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70201-3_bib2","unstructured":"Jahoda M. Employment and unemployment: a social-psychological analysis. Volume 1: CUP Archive; 1982."},{"key":"10.1016\/S2213-8587(14)70201-3_bib3","doi-asserted-by":"crossref","first-page":"1023","DOI":"10.1177\/0003122412465331","article-title":"It's all about control worker control over schedule and hours in cross-national context","volume":"77","author":"Lyness","year":"2012","journal-title":"Am Sociol Rev"},{"key":"10.1016\/S2213-8587(14)70201-3_bib4","doi-asserted-by":"crossref","first-page":"588","DOI":"10.1136\/oem.2004.016667","article-title":"The impact of overtime and long work hours on occupational injuries and illnesses: new evidence from the United States","volume":"62","author":"Dembe","year":"2005","journal-title":"Occup Environ Med"},{"key":"10.1016\/S2213-8587(14)70201-3_bib5","doi-asserted-by":"crossref","first-page":"414","DOI":"10.2337\/dc09-1124","article-title":"Quantity and quality of sleep and incidence of type 2 diabetes: a systematic review and meta-analysis","volume":"33","author":"Cappuccio","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70201-3_bib6","doi-asserted-by":"crossref","first-page":"3557","DOI":"10.2337\/dc13-0777","article-title":"Association between sleep duration and diabetes in black and white adults","volume":"36","author":"Jackson","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70201-3_bib7","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1007\/978-3-642-25950-0_13","article-title":"Light and the human circadian clock","volume":"217","author":"Roenneberg","year":"2013","journal-title":"Handb Exp Pharmacol"},{"key":"10.1016\/S2213-8587(14)70201-3_bib8","doi-asserted-by":"crossref","first-page":"129ra43","DOI":"10.1126\/scitranslmed.3003200","article-title":"Adverse metabolic consequences in humans of prolonged sleep restriction combined with circadian disruption","volume":"4","author":"Buxton","year":"2012","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(14)70201-3_bib9","doi-asserted-by":"crossref","first-page":"1211","DOI":"10.1111\/j.1464-5491.2008.02566.x","article-title":"Psychosocial factors are independent risk factors for the development of type 2 diabetes in Japanese workers with impaired fasting glucose and\/or impaired glucose tolerance","volume":"25","author":"Toshihiro","year":"2008","journal-title":"Diabet Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702013?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714702013?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,29]],"date-time":"2018-09-29T12:22:38Z","timestamp":1538223758000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714702013"}},"issued":{"date-parts":[[2015,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,1]]}},"alternative-id":["S2213858714702013"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70201-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,1]]}},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:53Z","timestamp":1761991973750,"version":"build-2065373602"},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/s2213-8587(21)00080-2","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T11:23:39Z","timestamp":1618485819000},"page":"257-258","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Fluid volume regulation in patients with heart failure"],"prefix":"10.1016","volume":"9","author":[{"given":"Panagiota","family":"Anyfanti","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Erasmia","family":"Sampani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Apostolos","family":"Tsapas","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00080-2_bib1","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1016\/S2213-8587(20)30382-X","article-title":"Effects of empagliflozin on estimated extracellular volume, estimated plasma volume, and measured glomerular filtration rate in patients with heart failure (Empire HF Renal): a prespecified substudy of a double-blind, randomised, placebo-controlled trial","volume":"9","author":"Jensen","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00080-2_bib2","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00080-2_bib3","doi-asserted-by":"crossref","first-page":"278","DOI":"10.7326\/M20-0864","article-title":"Comparative effectiveness of glucose-lowering drugs for type 2 diabetes: a systematic review and network meta-analysis","volume":"173","author":"Tsapas","year":"2020","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(21)00080-2_bib4","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1016\/S0140-6736(09)61378-7","article-title":"Albuminuria in chronic heart failure: prevalence and prognostic importance","volume":"374","author":"Jackson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00080-2_bib5","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1038\/s41569-020-0406-8","article-title":"SGLT2 inhibitors: mechanisms of cardiovascular benefit beyond glycaemic control","volume":"17","author":"Cowie","year":"2020","journal-title":"Nat Rev Cardiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000802?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000802?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:28Z","timestamp":1761991768000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000802"}},"issued":{"date-parts":[[2021,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2213858721000802"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00080-2","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Fluid volume regulation in patients with heart failure","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00080-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00082-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00079-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30382-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:17:29Z","timestamp":1761992249818,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T00:00:00Z","timestamp":1693526400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,9]]},"DOI":"10.1016\/s2213-8587(23)00192-4","type":"journal-article","created":{"date-parts":[[2023,7,17]],"date-time":"2023-07-17T18:35:17Z","timestamp":1689618917000},"page":"628-629","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Increased cardiovascular morbidity and mortality in patients with resistance to thyroid hormone"],"prefix":"10.1016","volume":"11","author":[{"given":"Samuel","family":"Refetoff","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Luca","family":"Persani","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"W Edward","family":"Visser","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00192-4_bib1","doi-asserted-by":"crossref","first-page":"3035","DOI":"10.1172\/JCI60047","article-title":"Mechanisms of thyroid hormone action","volume":"122","author":"Brent","year":"2012","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(23)00192-4_bib2","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1111\/cen.14817","article-title":"Genetic disorders of thyroid development, hormone biosynthesis and signalling","volume":"97","author":"Moran","year":"2022","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(23)00192-4_bib3","first-page":"348","article-title":"The syndromes of resistance to thyroid hormone","volume":"14","author":"Refetoff","year":"1993","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(23)00192-4_bib4","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1210\/js.2017-00204","article-title":"Homozygous resistance to thyroid hormone \u03b2: can combined antithyroid drug and triiodothyroacetic acid treatment prevent cardiac failure?","volume":"1","author":"Moran","year":"2017","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(23)00192-4_bib5","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1210\/jc.2011-2642","article-title":"Homozygous thyroid hormone receptor \u03b2-gene mutations in resistance to thyroid hormone: three new cases and review of the literature","volume":"97","author":"Ferrara","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00192-4_bib6","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1016\/S2213-8587(19)30059-2","article-title":"Primary therapy of Graves' disease and cardiovascular morbidity and mortality: a linked-record cohort study","volume":"7","author":"Okosieme","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00192-4_bib7","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(23)00155-9","article-title":"Cardiovascular morbidity and mortality in patients in Wales, UK with resistance to thyroid hormone \u03b2 (RTH\u03b2): a linked-record cohort study","author":"Okosieme","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00192-4_bib8","doi-asserted-by":"crossref","first-page":"4612","DOI":"10.1021\/bi0482349","article-title":"Mutant-selective thyromimetics for the chemical rescue of thyroid hormone receptor mutants associated with resistance to thyroid hormone","volume":"44","author":"Shi","year":"2005","journal-title":"Biochemistry"},{"key":"10.1016\/S2213-8587(23)00192-4_bib9","first-page":"2033","article-title":"Triiodothyroacetic acid has unique potential for therapy of resistance to thyroid hormone","volume":"80","author":"Takeda","year":"1995","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00192-4_bib10","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.mce.2017.02.029","article-title":"Therapeutic applications of thyroid hormone analogues in resistance to thyroid hormone (RTH) syndromes","volume":"458","author":"Groeneweg","year":"2017","journal-title":"Mol Cell Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001924?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001924?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:47Z","timestamp":1761992027000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001924"}},"issued":{"date-parts":[[2023,9]]},"references-count":10,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2023,9]]}},"alternative-id":["S2213858723001924"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00192-4","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2023,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Increased cardiovascular morbidity and mortality in patients with resistance to thyroid hormone","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00192-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00155-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T22:29:00Z","timestamp":1788560940682,"version":"build-2803163510"},"reference-count":29,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2013,10,1]],"date-time":"2013-10-01T00:00:00Z","timestamp":1380585600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,16]],"date-time":"2014-04-16T00:00:00Z","timestamp":1397606400000},"content-version":"vor","delay-in-days":197,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100004201","name":"Oncosuisse","doi-asserted-by":"crossref","award":["OCS-02259-08-2008"],"award-info":[{"award-number":["OCS-02259-08-2008"]}],"id":[{"id":"10.13039\/501100004201","id-type":"DOI","asserted-by":"crossref"}]},{"DOI":"10.13039\/501100001711","name":"Swiss National Science Foundation","doi-asserted-by":"crossref","award":["PASMP3-123269 and 320030-109522"],"award-info":[{"award-number":["PASMP3-123269 and 320030-109522"]}],"id":[{"id":"10.13039\/501100001711","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,10]]},"DOI":"10.1016\/s2213-8587(13)70049-4","type":"journal-article","created":{"date-parts":[[2013,7,25]],"date-time":"2013-07-25T03:05:53Z","timestamp":1374721553000},"page":"115-122","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":162,"title":["Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study"],"prefix":"10.1016","volume":"1","author":[{"given":"Emanuel","family":"Christ","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damian","family":"Wild","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanne","family":"Ederer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"B\u00e9h\u00e9","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Nicolas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martyn E","family":"Caplin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Br\u00e4ndle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Clerici","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Fischli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Stettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Ell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jochen","family":"Seufert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beat","family":"Gloor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aurel","family":"Perren","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jean Claude","family":"Reubi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Flavio","family":"Forrer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70049-4_bib1","doi-asserted-by":"crossref","first-page":"783","DOI":"10.1016\/j.bpg.2005.05.008","article-title":"Insulinoma","volume":"19","author":"Grant","year":"2005","journal-title":"Best Pract Res Clin Gastroenterol"},{"key":"10.1016\/S2213-8587(13)70049-4_bib2","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S0899-7071(01)00290-X","article-title":"Imaging and localization of pancreatic insulinomas","volume":"25","author":"Chatziioannou","year":"2001","journal-title":"Clin Imaging"},{"key":"10.1016\/S2213-8587(13)70049-4_bib3","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1111\/j.1365-2265.2009.03527.x","article-title":"What should be done in an operating room when an insulinoma cannot be found?","volume":"70","author":"Rostambeigi","year":"2009","journal-title":"Clin Endocrinol"},{"key":"10.1016\/S2213-8587(13)70049-4_bib4","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.1056\/NEJM199206253262601","article-title":"Localization of pancreatic endocrine tumors by endoscopic ultrasonography","volume":"326","author":"Rosch","year":"1992","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70049-4_bib5","first-page":"884","article-title":"Preoperative localization of pancreatic insulinoma by selective intraarterial calcium injection and hepatic venous sampling","volume":"47","author":"Chatziioannou","year":"2000","journal-title":"Hepatogastroenterology"},{"key":"10.1016\/S2213-8587(13)70049-4_bib6","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1210\/jc.2008-2031","article-title":"Secular trends in the presentation and management of functioning insulinoma at the Mayo Clinic, 1987\u20132007","volume":"94","author":"Placzkowski","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70049-4_bib7","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1210\/jc.2008-1986","article-title":"Localization of insulinomas to regions of the pancreas by intraarterial calcium stimulation: the NIH experience","volume":"94","author":"Guettier","year":"2009","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/S2213-8587(13)70049-4_bib8","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1097\/01.RVI.0000140638.55375.1E","article-title":"Selective arterial calcium stimulation and hepatic venous sampling in the evaluation of hyperinsulinemic hypoglycemia: potential and limitations","volume":"15","author":"Wiesli","year":"2004","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/S2213-8587(13)70049-4_bib9","doi-asserted-by":"crossref","first-page":"781","DOI":"10.1007\/s00259-003-1184-3","article-title":"Concomitant expression of several peptide receptors in neuroendocrine tumours: molecular basis for in vivo multireceptor tumour targeting","volume":"30","author":"Reubi","year":"2003","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/S2213-8587(13)70049-4_bib10","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1210\/er.2002-0007","article-title":"Peptide receptors as molecular targets for cancer diagnosis and therapy","volume":"24","author":"Reubi","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(13)70049-4_bib11","doi-asserted-by":"crossref","first-page":"1654","DOI":"10.1111\/j.1742-1241.2006.01196.x","article-title":"Exenatide in type 2 diabetes: treatment effects in clinical studies and animal study data","volume":"60","author":"Gallwitz","year":"2006","journal-title":"Int J Clin Pract"},{"key":"10.1016\/S2213-8587(13)70049-4_bib12","doi-asserted-by":"crossref","first-page":"1731","DOI":"10.2174\/138161206776873671","article-title":"Glucagon and glucagon-like peptide receptors as drug targets","volume":"12","author":"Estall","year":"2006","journal-title":"Curr Pharm Des"},{"key":"10.1016\/S2213-8587(13)70049-4_bib13","first-page":"2025","article-title":"[Lys40(Ahx-DTPA-111In)NH2]exendin-4, a very promising ligand for glucagon-like peptide-1 (GLP-1) receptor targeting","volume":"47","author":"Wild","year":"2006","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(13)70049-4_bib14","doi-asserted-by":"crossref","first-page":"1059","DOI":"10.2967\/jnumed.110.074914","article-title":"Exendin-4-based radiopharmaceuticals for glucagonlike peptide-1 receptor PET\/CT and SPECT\/CT","volume":"51","author":"Wild","year":"2010","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(13)70049-4_bib15","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1007\/s00259-012-2299-1","article-title":"Glucagon-like peptide-1 receptor imaging with [Lys(40)(Ahx-HYNIC- (99m)Tc\/EDDA)NH 2]-exendin-4 for the detection of insulinoma","volume":"40","author":"Sowa-Staszczak","year":"2013","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/S2213-8587(13)70049-4_bib16","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.regpep.2006.07.005","article-title":"A new technique for in vivo imaging of specific GLP-1 binding sites: first results in small rodents","volume":"137","author":"Gotthardt","year":"2006","journal-title":"Regul Pept"},{"key":"10.1016\/S2213-8587(13)70049-4_bib17","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1007\/s00259-002-0761-1","article-title":"Use of the incretin hormone glucagon-like peptide-1 (GLP-1) for the detection of insulinomas: initial experimental results","volume":"29","author":"Gotthardt","year":"2002","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/S2213-8587(13)70049-4_bib18","doi-asserted-by":"crossref","first-page":"4398","DOI":"10.1210\/jc.2009-1082","article-title":"Glucagon-like peptide-1 receptor imaging for localization of insulinomas","volume":"94","author":"Christ","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70049-4_bib19","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1210\/jc.2008-1410","article-title":"Evaluation and management of adult hypoglycemic disorders: an Endocrine Society Clinical Practice Guideline","volume":"94","author":"Cryer","year":"2009","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70049-4_bib20","doi-asserted-by":"crossref","first-page":"1476","DOI":"10.1016\/S0140-6736(02)11475-9","article-title":"Glucose-induced hypoglycaemia","volume":"360","author":"Wiesli","year":"2002","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70049-4_bib21","first-page":"119","article-title":"Approximate is better than \u201cexact\u201d for interval estimation of binominal proportions","volume":"52","author":"Agresti","year":"1998","journal-title":"Am Stat"},{"key":"10.1016\/S2213-8587(13)70049-4_bib22","series-title":"Statistical methods in diagnostic medicine","author":"Zhou","year":"2011"},{"key":"10.1016\/S2213-8587(13)70049-4_bib23","doi-asserted-by":"crossref","first-page":"220","DOI":"10.2307\/3001552","article-title":"Some statistical problems in measuring the subjective response to drugs","volume":"8","author":"Mosteller","year":"1952","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(13)70049-4_bib24","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1111\/j.0006-341X.2000.00345.x","article-title":"Comparisons of predictive values of binary medical diagnostic tests for paired designs","volume":"56","author":"Leisenring","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(13)70049-4_bib25","doi-asserted-by":"crossref","first-page":"1073","DOI":"10.2967\/jnumed.110.085142","article-title":"Glucagon-like peptide-1 versus somatostatin receptor targeting reveals 2 distinct forms of malignant insulinomas","volume":"52","author":"Wild","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(13)70049-4_bib26","doi-asserted-by":"crossref","first-page":"736","DOI":"10.2967\/jnumed.106.038679","article-title":"GLP-1 receptor expression in human tumors and human normal tissues: potential for in vivo targeting","volume":"48","author":"Korner","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(13)70049-4_bib27","doi-asserted-by":"crossref","first-page":"2641","DOI":"10.1007\/s00125-010-1901-y","article-title":"Glucagon-like peptide-1 (GLP-1) receptors are not overexpressed in pancreatic islets from patients with severe hyperinsulinaemic hypoglycaemia following gastric bypass","volume":"53","author":"Reubi","year":"2010","journal-title":"Diabetologia"},{"issue":"suppl 4","key":"10.1016\/S2213-8587(13)70049-4_bib28","first-page":"iv1","article-title":"Guidelines for the management of gastroenteropancreatic neuroendocrine (including carcinoid) tumours","volume":"54","author":"Ramage","year":"2005","journal-title":"Gut"},{"key":"10.1016\/S2213-8587(13)70049-4_bib29","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1530\/EJE-10-0056","article-title":"Diagnosis and localisation of insulinoma: the value of modern magnetic resonance imaging in conjunction with calcium stimulation catheterisation","volume":"162","author":"Druce","year":"2010","journal-title":"Eur J Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700494?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700494?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,14]],"date-time":"2018-10-14T10:30:27Z","timestamp":1539513027000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700494"}},"issued":{"date-parts":[[2013,10]]},"references-count":29,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2013,10]]}},"alternative-id":["S2213858713700494"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70049-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glucagon-like peptide-1 receptor imaging for the localisation of insulinomas: a prospective multicentre imaging study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70049-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70060-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,15]],"date-time":"2026-09-15T11:01:30Z","timestamp":1789470090621,"version":"build-2803163510"},"reference-count":6,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,1,1]],"date-time":"2020-01-01T00:00:00Z","timestamp":1577836800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,1]]},"DOI":"10.1016\/s2213-8587(19)30382-1","type":"journal-article","created":{"date-parts":[[2019,12,2]],"date-time":"2019-12-02T18:35:04Z","timestamp":1575311704000},"page":"13-14","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":28,"title":["Exendin-based glucagon-like peptide-1 receptor agonists and anaphylactic reactions: a pharmacovigilance analysis"],"prefix":"10.1016","volume":"8","author":[{"given":"Richeek","family":"Pradhan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fran\u00e7ois","family":"Montastruc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Rousseau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabetta","family":"Patorno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurent","family":"Azoulay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30382-1_bib1","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30382-1_bib2","doi-asserted-by":"crossref","first-page":"202","DOI":"10.1900\/RDS.2014.11.202","article-title":"Adverse effects of GLP-1 receptor agonists","volume":"11","author":"Filippatos","year":"2014","journal-title":"Rev Diabet Stud RDS"},{"key":"10.1016\/S2213-8587(19)30382-1_bib3","doi-asserted-by":"crossref","DOI":"10.2337\/dc19-0720","article-title":"Allergic reaction to exenatide and lixisenatide but not to liraglutide: unveiling anaphylaxis to glucagon-like peptide 1 receptor agonists","author":"Shamriz","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30382-1_bib4","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/s10618-006-0052-8","article-title":"Duplicate detection in adverse drug reaction surveillance","volume":"14","author":"Noren","year":"2007","journal-title":"Data Min Knowl Discov"},{"key":"10.1016\/S2213-8587(19)30382-1_bib5","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1016\/j.therap.2019.01.006","article-title":"Case-non-case studies: Principle, methods, bias and interpretation","volume":"74","author":"Faillie","year":"2019","journal-title":"Therapie"},{"key":"10.1016\/S2213-8587(19)30382-1_bib6","doi-asserted-by":"crossref","first-page":"2159","DOI":"10.1111\/dom.13346","article-title":"Time trends and geographical variation in prescribing of drugs for diabetes in England from 1998 to 2017","volume":"20","author":"Curtis","year":"2018","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303821?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303821?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:09Z","timestamp":1761991689000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719303821"}},"issued":{"date-parts":[[2020,1]]},"references-count":6,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1]]}},"alternative-id":["S2213858719303821"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30382-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exendin-based glucagon-like peptide-1 receptor agonists and anaphylactic reactions: a pharmacovigilance analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30382-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T21:00:24Z","timestamp":1790456424506,"version":"4.1.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,6,1]],"date-time":"2023-06-01T00:00:00Z","timestamp":1685577600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,6]]},"DOI":"10.1016\/s2213-8587(23)00125-0","type":"journal-article","created":{"date-parts":[[2023,5,4]],"date-time":"2023-05-04T06:52:45Z","timestamp":1683183165000},"page":"379-380","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Insulin icodec: evolution or revolution in diabetes therapy?"],"prefix":"10.1016","volume":"11","author":[{"given":"Srikanth","family":"Bellary","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anthony H","family":"Barnett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00125-0_bib1","series-title":"The discovery of insulin","author":"Bliss","year":"1984"},{"key":"10.1016\/S2213-8587(23)00125-0_bib2","doi-asserted-by":"crossref","first-page":"613","DOI":"10.3389\/fendo.2018.00613","article-title":"The discovery of insulin: an important milestone in the history of medicine","volume":"9","author":"Vecchio","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(23)00125-0_bib3","doi-asserted-by":"crossref","first-page":"267","DOI":"10.2147\/JMDH.S64084","article-title":"Identifying and meeting the challenges of insulin therapy in type 2 diabetes","volume":"7","author":"Sorli","year":"2014","journal-title":"J Multidiscip Healthc"},{"key":"10.1016\/S2213-8587(23)00125-0_bib4","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2021-002301","article-title":"Molecular and pharmacological characterization of insulin icodec: a new basal insulin analog designed for once-weekly dosing","volume":"9","author":"Nishimura","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(23)00125-0_bib5","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(23)00093-1","article-title":"Switching to once-weekly insulin icodec versus once-daily insulin degludec in individuals with basal insulin-treated type 2 diabetes (ONWARDS 2): a phase 3a, randomised, open label, multicentre, treat-to-target trial","author":"Philis-Tsimikas","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00125-0_bib6","doi-asserted-by":"crossref","first-page":"1081","DOI":"10.1111\/j.1463-1326.2012.01636.x","article-title":"Factors associated with injection omission\/non-adherence in the Global Attitudes of Patients and Physicians in Insulin Therapy study","volume":"14","author":"Peyrot","year":"2012","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00125-0_bib7","doi-asserted-by":"crossref","first-page":"1370","DOI":"10.2337\/dc06-1386","article-title":"Prediction of severe hypoglycemia","volume":"30","author":"Cox","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00125-0_bib8","doi-asserted-by":"crossref","first-page":"915","DOI":"10.2337\/dc20-0876","article-title":"Glucose control, sulfonylureas, and insulin treatment in elderly people with type 2 diabetes and risk of severe hypoglycemia and death: an observational study","volume":"44","author":"Ling","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00125-0_bib9","doi-asserted-by":"crossref","first-page":"1080","DOI":"10.1111\/dom.14956","article-title":"Pharmacokinetic and pharmacodynamic properties of the novel basal insulin Fc (insulin efsitora alfa), an insulin fusion protein in development for once-weekly dosing for the treatment of patients with diabetes","volume":"25","author":"Heise","year":"2023","journal-title":"Diabetes Obes Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001250?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001250?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,26]],"date-time":"2026-09-26T20:29:20Z","timestamp":1790454560000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001250"}},"issued":{"date-parts":[[2023,6]]},"references-count":9,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2023,6]]}},"alternative-id":["S2213858723001250"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00125-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Insulin icodec: evolution or revolution in diabetes therapy?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00125-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00093-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,24]],"date-time":"2026-09-24T22:59:08Z","timestamp":1790290748579,"version":"4.1.0"},"reference-count":6,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T00:00:00Z","timestamp":1756684800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,9]]},"DOI":"10.1016\/s2213-8587(25)00218-9","type":"journal-article","created":{"date-parts":[[2025,8,12]],"date-time":"2025-08-12T22:35:26Z","timestamp":1755038126000},"page":"741-742","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Thyroid eye disease and the IGF-1 receptor"],"prefix":"10.1016","volume":"13","author":[{"given":"Terry J","family":"Smith","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00218-9_bib1","doi-asserted-by":"crossref","first-page":"600","DOI":"10.1016\/S2213-8587(25)00066-X","article-title":"Thyroid eye disease (Graves' orbitopathy): clinical presentation, epidemiology, pathogenesis, and management","volume":"13","author":"Wiersinga","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00218-9_bib2","doi-asserted-by":"crossref","first-page":"3008","DOI":"10.1210\/en.2013-1576","article-title":"Cutting edge: retrobulbar inflammation, adipogenesis, and acute orbital congestion in a preclinical female mouse model of Graves' orbitopathy induced by thyrotropin receptor plasmid-in vivo electroporation","volume":"154","author":"Moshkelgosha","year":"2013","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(25)00218-9_bib3","doi-asserted-by":"crossref","first-page":"6348","DOI":"10.4049\/jimmunol.170.12.6348","article-title":"Immunoglobulin activation of T cell chemoattractant expression in fibroblasts from patients with Graves' disease is mediated through the insulin-like growth factor I receptor pathway","volume":"170","author":"Pritchard","year":"2003","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(25)00218-9_bib4","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1016\/S2213-8587(21)00056-5","article-title":"Teprotumumab for patients with active thyroid eye disease: a pooled data analysis, subgroup analyses, and off-treatment follow-up results from two randomised, double-masked, placebo-controlled, multicentre trials","volume":"9","author":"Kahaly","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00218-9_bib5","doi-asserted-by":"crossref","first-page":"880","DOI":"10.1089\/thy.2023.0656","article-title":"Long-Term efficacy of teprotumumab in thyroid eye disease: follow-up outcomes in three clinical trials","volume":"34","author":"Kahaly","year":"2024","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(25)00218-9_bib6","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1089\/thy.2023.0466","article-title":"A prospective study examining audiometry outcomes following teprotumumab treatment for thyroid eye disease","volume":"34","author":"Douglas","year":"2024","journal-title":"Thyroid"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002189?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002189?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,1]],"date-time":"2025-09-01T20:06:36Z","timestamp":1756757196000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002189"}},"issued":{"date-parts":[[2025,9]]},"references-count":6,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2025,9]]}},"alternative-id":["S2213858725002189"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00218-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Thyroid eye disease and the IGF-1 receptor","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00218-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00066-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T08:56:20Z","timestamp":1790326580184,"version":"4.1.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/s2213-8587(25)00262-1","type":"journal-article","created":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T04:19:23Z","timestamp":1757909963000},"page":"901-903","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Semaglutide 7\u00b72 mg: another step towards tackling diseases mediated by obesity"],"prefix":"10.1016","volume":"13","author":[{"given":"Naveed","family":"Sattar","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael E J","family":"Lean","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00262-1_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00225-6","article-title":"Once-weekly semaglutide 7\u00b72 mg in adults with obesity and type 2 diabetes (STEP UP T2D): a randomised, controlled, phase 3b trial","author":"Lingvay","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00262-1_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00226-8","article-title":"Once-weekly semaglutide 7\u00b72 mg in adults with obesity (STEP UP): a randomised, controlled, phase 3b trial","author":"Wharton","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00262-1_bib3","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1016\/S2213-8587(24)00363-2","article-title":"Estimating direct tissue effects versus weight loss effects of incretin-based drugs for obesity on various chronic conditions","volume":"13","author":"Sattar","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00262-1_bib4","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1056\/NEJMoa2416394","article-title":"Tirzepatide as compared with semaglutide for the treatment of obesity","volume":"393","author":"Aronne","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00262-1_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/S2213-8587(24)00271-7","article-title":"Effects of GLP-1 receptor agonists on kidney and cardiovascular disease outcomes: a meta-analysis of randomised controlled trials","volume":"13","author":"Badve","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00262-1_bib6","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00262-1_bib7","article-title":"Doctor referral of overweight people to low energy total diet replacement treatment (DROPLET): pragmatic randomised controlled trial","volume":"362","author":"Astbury","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00262-1_bib8","unstructured":"Brosnahan N, Hankey C, Leeds A, et al. Diet strategies for maintaining substantial therapeutic weight loss: 78-week mixed methods randomised trial. Clin Nutr (in press)."},{"key":"10.1016\/S2213-8587(25)00262-1_bib9","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1038\/ijo.2016.175","article-title":"Weight losses with low-energy formula diets in obese patients with and without type 2 diabetes: systematic review and meta-analysis","volume":"41","author":"Leslie","year":"2017","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(25)00262-1_bib10","doi-asserted-by":"crossref","DOI":"10.2337\/dc25-1442","article-title":"Weight reduction with tirzepatide varied meaningfully by baseline HbA1c category in adults with overweight or obesity and Type 2 diabetes in SURMOUNT-2","author":"Sattar","year":"2025","journal-title":"Diabetes Care"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002621?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725002621?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,31]],"date-time":"2026-03-31T20:11:30Z","timestamp":1774987890000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725002621"}},"issued":{"date-parts":[[2025,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S2213858725002621"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00262-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Semaglutide 7\u00b72 mg: another step towards tackling diseases mediated by obesity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00262-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00226-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00225-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,22]],"date-time":"2026-09-22T12:20:07Z","timestamp":1790079607722,"version":"4.0.1"},"reference-count":68,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,8,1]],"date-time":"2019-08-01T00:00:00Z","timestamp":1564617600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002660","name":"National Institute of Diabetes and Digestive and Kidney Diseases","doi-asserted-by":"publisher","award":["T32DK007529"],"award-info":[{"award-number":["T32DK007529"]}],"id":[{"id":"10.13039\/501100002660","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,8]]},"DOI":"10.1016\/s2213-8587(19)30082-8","type":"journal-article","created":{"date-parts":[[2019,3,13]],"date-time":"2019-03-13T23:29:15Z","timestamp":1552519755000},"page":"638-647","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":69,"title":["The burden of diabetes and use of diabetes care in humanitarian crises in low-income and middle-income countries"],"prefix":"10.1016","volume":"7","author":[{"given":"Sylvia","family":"Kehlenbrink","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"\u00c9imh\u00edn","family":"Ansbro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniela C","family":"Fuhr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anson","family":"Cheung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruwan","family":"Ratnayake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippa","family":"Boulle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kiran","family":"Jobanputra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pablo","family":"Perel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bayard","family":"Roberts","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30082-8_bib4","series-title":"People affected by conflict 2013\u2014humanitarian needs in numbers","year":"2013"},{"key":"10.1016\/S2213-8587(19)30082-8_bib5","series-title":"The human cost of natural disasters 2015: a global perspective","year":"2015"},{"key":"10.1016\/S2213-8587(19)30082-8_bib6","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1016\/S0140-6736(16)31404-0","article-title":"Care of non-communicable diseases in emergencies","volume":"389","author":"Slama","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30082-8_bib7","doi-asserted-by":"crossref","first-page":"e1002180","DOI":"10.1371\/journal.pmed.1002180","article-title":"Three steps to improve management of noncommunicable diseases in humanitarian crises","volume":"13","author":"Jobanputra","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(19)30082-8_bib8","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S0140-6736(97)07244-9","article-title":"Glucose tolerance in adults after prenatal exposure to famine","volume":"351","author":"Ravelli","year":"1998","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30082-8_bib9","doi-asserted-by":"crossref","first-page":"2400","DOI":"10.2337\/db10-0385","article-title":"Exposure to the Chinese famine in early life and the risk of hyperglycemia and type 2 diabetes in adulthood","volume":"59","author":"Li","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30082-8_bib10","doi-asserted-by":"crossref","first-page":"e0138303","DOI":"10.1371\/journal.pone.0138303","article-title":"The effectiveness of interventions for non-communicable diseases in humanitarian crises: a systematic review","volume":"10","author":"Ruby","year":"2015","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30082-8_bib11","article-title":"Non-communicable diseases in emergencies: a call to action","volume":"5","author":"Demaio","year":"2013","journal-title":"PLoS Curr"},{"key":"10.1016\/S2213-8587(19)30082-8_bib12","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1016\/S0140-6736(09)61873-0","article-title":"Health-care needs of people affected by conflict: future trends and changing frameworks","volume":"375","author":"Spiegel","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30082-8_bib13","series-title":"Findings from the Global Burden of Disease Study 2017","year":"2018"},{"key":"10.1016\/S2213-8587(19)30082-8_bib14","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30083-X","article-title":"Challenges associated with providing diabetes care in humanitarian settings","author":"Boulle","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30082-8_bib15","series-title":"Multi-sector needs assessment of Syrian refugees residing in host communities: preliminary findings","year":"2014"},{"key":"10.1016\/S2213-8587(19)30082-8_bib16","series-title":"Multi-sector needs assessment of Syrian refugees residing in camps: preliminary findings","year":"2014"},{"key":"10.1016\/S2213-8587(19)30082-8_bib17","series-title":"Inter-agency regional response for Syrian refugees: health and nutrition bulletin: Iraq, Jordan, and Lebanon","year":"2013"},{"key":"10.1016\/S2213-8587(19)30082-8_bib18","series-title":"Health access and utilisation survey among non-camp Syrian refugees","year":"2014"},{"key":"10.1016\/S2213-8587(19)30082-8_bib19","series-title":"Syrian Refugee Access to Care Study Lebanon: medical service needs among post-emergency Syrian refugees in Bekaa Valley, Lebanon","year":"2014"},{"key":"10.1016\/S2213-8587(19)30082-8_bib20","series-title":"MSF health surveillance program: mid-Euphrates region follow-up assessment","year":"2016"},{"key":"10.1016\/S2213-8587(19)30082-8_bib21","doi-asserted-by":"crossref","first-page":"307","DOI":"10.26719\/2013.19.4.307","article-title":"Factors affecting the prevalence of chronic diseases in Palestinian people: an analysis of data from the Palestinian Central Bureau of Statistics","volume":"19","author":"Abukhdeir","year":"2013","journal-title":"East Mediterr Health J"},{"key":"10.1016\/S2213-8587(19)30082-8_bib22","doi-asserted-by":"crossref","first-page":"270","DOI":"10.4172\/2161-1017.1000270","article-title":"The effect of war on the control of diabetes in patients with type 2 diabetes mellitus in Yemen: a cross-sectional study","volume":"6","author":"Al-Sharafi","year":"2017","journal-title":"Endocrinol Metab Syndr"},{"key":"10.1016\/S2213-8587(19)30082-8_bib23","series-title":"Health status survey of Syrian refugees in Turkey: non-communicable disease risk factors surveillance among Syrian refugees living in Turkey","author":"Balcilar","year":"2016"},{"key":"10.1016\/S2213-8587(19)30082-8_bib24","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1007\/s10903-016-0381-7","article-title":"Diabetes among United States-bound adult refugees, 2009\u20132014","volume":"18","author":"Benoit","year":"2016","journal-title":"J Immigr Minor Health"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(19)30082-8_bib25","doi-asserted-by":"crossref","first-page":"B27","DOI":"10.1007\/PL00002949","article-title":"Incidence of childhood-onset type I diabetes in Slovenia and the Tuzia region (Bosnia and Herzegovina) in the period 1990\u20131998","volume":"44","author":"Bratina","year":"2001","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30082-8_bib26","doi-asserted-by":"crossref","DOI":"10.1186\/s13031-017-0106-0","article-title":"Prevalence of non-communicable diseases and access to healthcare and medications among Yazidis and other minority groups displaced by ISIS into the Kurdistan region of Iraq","volume":"11","author":"Cetorelli","year":"2017","journal-title":"Confl Health"},{"key":"10.1016\/S2213-8587(19)30082-8_bib27","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s13031-016-0088-3","article-title":"Prevalence, care-seeking, and health service utilization for non-communicable diseases among Syrian refugees and host communities in Lebanon","volume":"10","author":"Doocy","year":"2016","journal-title":"Confl Health"},{"key":"10.1016\/S2213-8587(19)30082-8_bib28","doi-asserted-by":"crossref","first-page":"1097","DOI":"10.1186\/s12889-015-2429-3","article-title":"Prevalence and care-seeking for chronic diseases among Syrian refugees in Jordan","volume":"15","author":"Doocy","year":"2015","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(19)30082-8_bib29","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1002\/hpm.2119","article-title":"Chronic disease and disability among Iraqi populations displaced in Jordan and Syria","volume":"28","author":"Doocy","year":"2013","journal-title":"Int J Health Plann Manage"},{"key":"10.1016\/S2213-8587(19)30082-8_bib30","first-page":"58","article-title":"Commonest diseases amongst Iraqi internally displaced after Islamic State expansion","volume":"5","author":"Dudova","year":"2015","journal-title":"Clinical Social Work and Health Intervention"},{"key":"10.1016\/S2213-8587(19)30082-8_bib31","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1186\/1471-2458-6-268","article-title":"Health-related quality of life in diabetic patients and controls without diabetes in refugee camps in the Gaza strip: a cross-sectional study","volume":"6","author":"Eljedi","year":"2006","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(19)30082-8_bib32","first-page":"17","article-title":"Communicable and non-communicable diseases in the Solomon Islands villages during recovery from a massive earthquake in April 2007","volume":"124","author":"Furusawa","year":"2011","journal-title":"NZ Med J"},{"key":"10.1016\/S2213-8587(19)30082-8_bib33","doi-asserted-by":"crossref","first-page":"23887","DOI":"10.3402\/gha.v7.23887","article-title":"Gestational diabetes mellitus prevalence in Maela refugee camp on the Thai-Myanmar border: a clinical report","volume":"7","author":"Gilder","year":"2014","journal-title":"Glob Health Action"},{"key":"10.1016\/S2213-8587(19)30082-8_bib34","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1161\/CIRCHEARTFAILURE.111.962431","article-title":"Feasibility of a heart failure disease management program in eastern Europe: Tbilisi, Georgia","volume":"4","author":"Hebert","year":"2011","journal-title":"Circ Heart Fail"},{"key":"10.1016\/S2213-8587(19)30082-8_bib35","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1002\/clc.20947","article-title":"Prognostic implication of earthquake-related loss and depressive symptoms in patients with heart failure following the 2008 earthquake in Sichuan","volume":"34","author":"Huang","year":"2011","journal-title":"Clin Cardiol"},{"key":"10.1016\/S2213-8587(19)30082-8_bib36","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.trstmh.2008.12.004","article-title":"Adult and paediatric mortality patterns in a referral hospital in Liberia 1 year after the end of the war","volume":"103","author":"Huerga","year":"2009","journal-title":"Trans R Soc Trop Med Hyg"},{"key":"10.1016\/S2213-8587(19)30082-8_bib37","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/j.ekir.2017.05.009","article-title":"The effect of war on Syrian refugees with end-stage renal disease","volume":"2","author":"Isreb","year":"2017","journal-title":"Kidney Int Rep"},{"key":"10.1016\/S2213-8587(19)30082-8_bib38","doi-asserted-by":"crossref","first-page":"259","DOI":"10.5588\/pha.13.0083","article-title":"Diabetes mellitus and treatment outcomes in Palestine refugees in UNRWA primary healthcare clinics in Jordan","volume":"3","author":"Khader","year":"2013","journal-title":"Public Health Action"},{"key":"10.1016\/S2213-8587(19)30082-8_bib39","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1111\/j.1365-3156.2012.03097.x","article-title":"Cohort monitoring of persons with diabetes mellitus in a primary healthcare clinic for Palestine refugees in Jordan","volume":"17","author":"Khader","year":"2012","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(19)30082-8_bib40","doi-asserted-by":"crossref","first-page":"1163","DOI":"10.1111\/j.1365-3156.2012.03048.x","article-title":"Cohort monitoring of persons with hypertension: an illustrated example from a primary healthcare clinic for Palestine refugees in Jordan","volume":"17","author":"Khader","year":"2012","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(19)30082-8_bib41","doi-asserted-by":"crossref","first-page":"1276","DOI":"10.1111\/tmi.12356","article-title":"Hypertension and treatment outcomes in Palestine refugees in United Nations Relief and Works Agency primary healthcare clinics in Jordan","volume":"19","author":"Khader","year":"2014","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(19)30082-8_bib42","doi-asserted-by":"crossref","first-page":"832","DOI":"10.4103\/1319-2442.113913","article-title":"Prevalence of patients with end-stage renal disease on dialysis in the West Bank, Palestine","volume":"24","author":"Khader","year":"2013","journal-title":"Saudi J Kidney Dis Transpl"},{"key":"10.1016\/S2213-8587(19)30082-8_bib43","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1093\/eurpub\/6.4.252","article-title":"The impact of war on Sarajevans with non-insulin-dependent diabetes mellitus","volume":"6","author":"Kulenovic","year":"1996","journal-title":"Eur J Public Health"},{"key":"10.1016\/S2213-8587(19)30082-8_bib44","article-title":"Needs of internally displaced women and children in Baghdad, Karbala, and Kirkuk, Iraq","volume":"8","author":"Lafta","year":"2016","journal-title":"PLoS Curr"},{"key":"10.1016\/S2213-8587(19)30082-8_bib45","doi-asserted-by":"crossref","first-page":"444","DOI":"10.2471\/BLT.11.097048","article-title":"Medical conditions among Iraqi refugees in Jordan: data from the United Nations refugee assistance information system","volume":"90","author":"Mateen","year":"2012","journal-title":"Bull World Health Org"},{"key":"10.1016\/S2213-8587(19)30082-8_bib46","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1007\/s00431-017-3057-y","article-title":"Impact of war on child health in northern Syria: the experience of M\u00e9decins Sans Fronti\u00e8res","volume":"177","author":"Meiqari","year":"2018","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(19)30082-8_bib47","first-page":"328","article-title":"Diabetes in time of armed conflict: the Croatian experience","volume":"45","author":"Metelko","year":"1992","journal-title":"World Health Stat Q"},{"key":"10.1016\/S2213-8587(19)30082-8_bib48","doi-asserted-by":"crossref","first-page":"460","DOI":"10.26719\/2010.16.6.609","article-title":"Hyperglycaemia, hypertension and their risk factors among Palestine refugees served by UNRWA","volume":"16","author":"Mousa","year":"2010","journal-title":"East Mediterr Health J"},{"key":"10.1016\/S2213-8587(19)30082-8_bib49","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1007\/BF00400723","article-title":"Incidence of IDDM during 1988\u20131992 in Zagreb, Croatia","volume":"38","author":"Roglic","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30082-8_bib50","doi-asserted-by":"crossref","first-page":"12","DOI":"10.4236\/jdm.2015.51002","article-title":"Clinical audit on the provision of diabetes care in the primary care setting by United Nations Relief and Works Agency for Palestine refugees in the near east (UNRWA)","volume":"5","author":"Shahin","year":"2015","journal-title":"J Diabetes Mellitus"},{"key":"10.1016\/S2213-8587(19)30082-8_bib51","series-title":"Prevalence, management and control of diabetes mellitus among Syrian refugees in Duhok governorate, Kurdistan region of Iraq\u2013a cross sectional study in the camp of Domiz 1","author":"Shamsi","year":"2017"},{"key":"10.1016\/S2213-8587(19)30082-8_bib52","first-page":"359","article-title":"Diabetes mellitus and its concomitant disorders in Afghan refugees residing in Peshawar, Pakistan","volume":"18","author":"Sofeh","year":"2004","journal-title":"JPMI"},{"key":"10.1016\/S2213-8587(19)30082-8_bib53","doi-asserted-by":"crossref","first-page":"12","DOI":"10.1186\/s13031-014-0029-y","article-title":"Health status and health needs of older refugees from Syria in Lebanon","volume":"9","author":"Strong","year":"2015","journal-title":"Confl Health"},{"key":"10.1016\/S2213-8587(19)30082-8_bib54","doi-asserted-by":"crossref","first-page":"e0182770","DOI":"10.1371\/journal.pone.0182770","article-title":"Diagnoses, infections and injuries in Northern Syrian children during the civil war: a cross-sectional study","volume":"12","author":"van Berlaer","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30082-8_bib55","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s10903-012-9578-6","article-title":"The health profile and chronic diseases comorbidities of US-bound Iraqi refugees screened by the International Organization for Migration in Jordan: 2007\u20132009","volume":"15","author":"Yanni","year":"2013","journal-title":"J Immigr Minor Health"},{"key":"10.1016\/S2213-8587(19)30082-8_bib56","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa0707943","article-title":"Hyperglycemia and adverse pregnancy outcomes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30082-8_bib57","series-title":"Essentials of epidemiology in public health","year":"2014"},{"key":"10.1016\/S2213-8587(19)30082-8_bib58","series-title":"IDF diabetes atlas","year":"2017"},{"key":"10.1016\/S2213-8587(19)30082-8_bib59","doi-asserted-by":"crossref","first-page":"2755","DOI":"10.2337\/dc06-1870","article-title":"Ketosis-prone type 2 diabetes: time to revise the classification of diabetes","volume":"29","author":"Umpierrez","year":"2006","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30082-8_bib60","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1007\/s00592-014-0685-9","article-title":"Fibrocalculous pancreatic diabetes (FCPD)","volume":"52","author":"Unnikrishnan","year":"2015","journal-title":"Acta Diabetologica"},{"key":"10.1016\/S2213-8587(19)30082-8_bib61","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1111\/j.1749-6632.2002.tb02955.x","article-title":"Clinicoepidemiological and biochemical profile of malnutrition-modulated diabetes mellitus","volume":"958","author":"Samal","year":"2002","journal-title":"Ann N Y Acad Sci"},{"key":"10.1016\/S2213-8587(19)30082-8_bib62","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-8587(17)30181-X","article-title":"Diabetes in sub-Saharan Africa: from clinical care to health policy","volume":"5","author":"Atun","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"issue":"suppl","key":"10.1016\/S2213-8587(19)30082-8_bib65","first-page":"S196","article-title":"Centers for Disease Control and Prevention public health response to humanitarian emergencies, 2007\u20132016","volume":"23","author":"Boyd","year":"2017","journal-title":"Emerg Infect Dis"},{"key":"10.1016\/S2213-8587(19)30082-8_bib66","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1186\/s13031-015-0042-9","article-title":"Diabetes in an emergency context: the Malian case study","volume":"9","author":"Besan\u00e7on","year":"2015","journal-title":"Confl Health"},{"key":"10.1016\/S2213-8587(19)30082-8_bib67","doi-asserted-by":"crossref","first-page":"939","DOI":"10.1016\/S0140-6736(13)60320-7","article-title":"Health services in Iraq","volume":"381","author":"Al Hilfi","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30082-8_bib68","doi-asserted-by":"crossref","first-page":"730","DOI":"10.1016\/S2213-8587(14)70109-3","article-title":"Improving tuberculosis prevention and care through addressing the global diabetes epidemic: from evidence to policy and practice","volume":"2","author":"Lonnroth","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30082-8_bib69","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1016\/S2213-8587(16)30081-X","article-title":"The global diabetes epidemic: what does it mean for infectious diseases in tropical countries?","volume":"5","author":"van Crevel","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30082-8_bib70","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1016\/j.diabres.2010.03.029","article-title":"Looking beyond the issue of access to insulin: what is needed for proper diabetes care in resource poor settings","volume":"88","author":"Beran","year":"2010","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(19)30082-8_bib71","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/S2213-8587(15)00521-5","article-title":"Constraints and challenges in access to insulin: a global perspective","volume":"4","author":"Beran","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30082-8_bib72","series-title":"Access to insulin: current challenges and constraints","author":"Beran","year":"2015"},{"key":"10.1016\/S2213-8587(19)30082-8_bib74","doi-asserted-by":"crossref","first-page":"e000128","DOI":"10.1136\/bmjgh-2016-000128","article-title":"Modifying the Interagency Emergency Health Kit to include treatment for non-communicable diseases in natural disasters and complex emergencies","volume":"1","author":"Tonelli","year":"2016","journal-title":"BMJ Glob Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300828?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719300828?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:43Z","timestamp":1761991603000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719300828"}},"issued":{"date-parts":[[2019,8]]},"references-count":68,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2019,8]]}},"alternative-id":["S2213858719300828"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30082-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The burden of diabetes and use of diabetes care in humanitarian crises in low-income and middle-income countries","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30082-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30083-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30197-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,29]],"date-time":"2026-09-29T09:45:52Z","timestamp":1790675152373,"version":"4.1.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2014,7,1]],"date-time":"2014-07-01T00:00:00Z","timestamp":1404172800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,7]]},"DOI":"10.1016\/s2213-8587(14)70066-x","type":"journal-article","created":{"date-parts":[[2014,4,7]],"date-time":"2014-04-07T23:55:18Z","timestamp":1396914918000},"page":"545-552","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":128,"title":["Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial"],"prefix":"10.1016","volume":"2","author":[{"given":"John M","family":"Wentworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Playfair","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cheryl","family":"Laurie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew E","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy A","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Burton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan E","family":"Shaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul E","family":"O'Brien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70066-X_bib1","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1038\/414782a","article-title":"Global and societal implications of the diabetes epidemic","volume":"414","author":"Zimmet","year":"2001","journal-title":"Nature"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70066-X_bib2","first-page":"S11","article-title":"Standards of medical care in diabetes\u20132013","volume":"36","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70066-X_bib3","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1001\/jama.2012.67929","article-title":"Association of an intensive lifestyle intervention with remission of type 2 diabetes","volume":"308","author":"Gregg","year":"2012","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70066-X_bib4","doi-asserted-by":"crossref","first-page":"316","DOI":"10.1001\/jama.299.3.316","article-title":"Adjustable gastric banding and conventional therapy for type 2 diabetes: a randomized controlled trial","volume":"299","author":"Dixon","year":"2008","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70066-X_bib5","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa1200111","article-title":"Bariatric surgery versus conventional medical therapy for type 2 diabetes","volume":"366","author":"Mingrone","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70066-X_bib6","doi-asserted-by":"crossref","first-page":"1567","DOI":"10.1056\/NEJMoa1200225","article-title":"Bariatric surgery versus intensive medical therapy in obese patients with diabetes","volume":"366","author":"Schauer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70066-X_bib7","doi-asserted-by":"crossref","first-page":"2240","DOI":"10.1001\/jama.2013.5835","article-title":"Roux-en-Y gastric bypass vs intensive medical management for the control of type 2 diabetes, hypertension, and hyperlipidemia: the Diabetes Surgery Study randomized clinical trial","volume":"309","author":"Ikramuddin","year":"2013","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(14)70066-X_bib8","doi-asserted-by":"crossref","first-page":"2765","DOI":"10.1210\/jc.2013-1476","article-title":"Biliopancreatic diversion in nonobese patients with type 2 diabetes: impact and mechanisms","volume":"98","author":"Astiarraga","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70066-X_bib9","doi-asserted-by":"crossref","first-page":"1313","DOI":"10.1007\/s00464-008-0156-x","article-title":"Laparoscopic ileal interposition associated to a diverted sleeve gastrectomy is an effective operation for the treatment of type 2 diabetes mellitus patients with BMI 21\u201329","volume":"23","author":"DePaula","year":"2009","journal-title":"Surg Endosc"},{"key":"10.1016\/S2213-8587(14)70066-X_bib10","doi-asserted-by":"crossref","first-page":"972","DOI":"10.1007\/s00268-009-9968-7","article-title":"Clinical improvement after duodenojejunal bypass for nonobese type 2 diabetes despite minimal improvement in glycemic homeostasis","volume":"33","author":"Ferzli","year":"2009","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(14)70066-X_bib11","doi-asserted-by":"crossref","first-page":"1077","DOI":"10.1007\/s11695-009-9844-4","article-title":"Surgery for nonobese type 2 diabetic patients: an interventional study with duodenal-jejunal exclusion","volume":"19","author":"Geloneze","year":"2009","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(14)70066-X_bib12","doi-asserted-by":"crossref","first-page":"1266","DOI":"10.1038\/oby.2011.377","article-title":"Moderate effect of duodenal\u2013jejunal bypass surgery on glucose homeostasis in patients with type 2 diabetes","volume":"20","author":"Klein","year":"2012","journal-title":"Obesity"},{"key":"10.1016\/S2213-8587(14)70066-X_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1056\/NEJMoa0901836","article-title":"Perioperative safety in the longitudinal assessment of bariatric surgery","volume":"361","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70066-X_bib14","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1007\/s11695-009-0065-7","article-title":"Laparoscopic gastric banding is safe in outpatient surgical centers","volume":"20","author":"Cobourn","year":"2010","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(14)70066-X_bib15","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1097\/SLA.0b013e31827b6c02","article-title":"Long term outcomes after bariatric surgery: Fifteen year follow up after gastric banding and a systematic review of the literature","volume":"257","author":"O'Brien","year":"2013","journal-title":"Ann Surg"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(14)70066-X_bib16","first-page":"S13","article-title":"Standards of medical care in diabetes\u20132009","volume":"32","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70066-X_bib17","series-title":"The lap-band solution. A partnership for weight loss","author":"O'Brien","year":"2011"},{"key":"10.1016\/S2213-8587(14)70066-X_bib18","doi-asserted-by":"crossref","first-page":"3130","DOI":"10.1097\/00007632-200012150-00008","article-title":"SF-36 health survey update","volume":"25","author":"Ware","year":"2000","journal-title":"Spine"},{"key":"10.1016\/S2213-8587(14)70066-X_bib19","doi-asserted-by":"crossref","first-page":"20","DOI":"10.2337\/dc12-0779","article-title":"Predicting the glycemic response to gastric bypass surgery in patients with type 2 diabetes","volume":"36","author":"Dixon","year":"2013","journal-title":"Diabetes care"},{"key":"10.1016\/S2213-8587(14)70066-X_bib20","doi-asserted-by":"crossref","first-page":"1521","DOI":"10.1007\/s11695-012-0676-2","article-title":"Improvement of type 2 diabetes mellitus (T2DM) after bariatric surgery\u2013who fails in the early postoperative course?","volume":"22","author":"Jurowich","year":"2012","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(14)70066-X_bib21","doi-asserted-by":"crossref","DOI":"10.1111\/1753-0407.12127","article-title":"Statistical models to predict type 2 diabetes remission after bariatric surgery","author":"Ramos-Levi","year":"2014","journal-title":"J Diabetes"},{"key":"10.1016\/S2213-8587(14)70066-X_bib22","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Look","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70066-X_bib23","doi-asserted-by":"crossref","first-page":"628","DOI":"10.1111\/j.1464-5491.2011.03306.x","article-title":"Bariatric surgery: an IDF statement for obese Type 2 diabetes","volume":"28","author":"Dixon","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(14)70066-X_bib24","doi-asserted-by":"crossref","first-page":"580","DOI":"10.1056\/NEJMoa0706245","article-title":"Effect of a multifactorial intervention on mortality in type 2 diabetes","volume":"358","author":"Gaede","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70066-X_bib25","unstructured":"Colagiuri S, Diabetes Australia, Eli Lilly Australia, Medical Technology Assessment Group (M\u2013TAG). DiabCo$t Australia: assessing the burden of type 2 diabetes in Australia: Australian Centre for Diabetes Strategies, 2002."},{"key":"10.1016\/S2213-8587(14)70066-X_bib26","doi-asserted-by":"crossref","first-page":"580","DOI":"10.2337\/dc08-1748","article-title":"Cost-efficacy of surgically induced weight loss for the management of type 2 diabetes: a randomized controlled trial","volume":"32","author":"Keating","year":"2009","journal-title":"Diabet Care"},{"key":"10.1016\/S2213-8587(14)70066-X_bib27","doi-asserted-by":"crossref","first-page":"567","DOI":"10.2337\/dc08-1749","article-title":"Cost-effectiveness of surgically induced weight loss for the management of type 2 diabetes: modeled lifetime analysis","volume":"32","author":"Keating","year":"2009","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(14)70066-X_bib28","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1001\/archsurg.2011.45","article-title":"Long-term outcomes of laparoscopic adjustable gastric banding","volume":"146","author":"Himpens","year":"2011","journal-title":"Arch Surg"},{"key":"10.1016\/S2213-8587(14)70066-X_bib29","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1007\/s11695-012-0864-0","article-title":"Metabolic\/bariatric surgery worldwide 2011","volume":"23","author":"Buchwald","year":"2013","journal-title":"Obes Surg"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871470066X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871470066X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,5]],"date-time":"2018-10-05T03:25:07Z","timestamp":1538709907000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871470066X"}},"issued":{"date-parts":[[2014,7]]},"references-count":29,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2014,7]]}},"alternative-id":["S221385871470066X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70066-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Multidisciplinary diabetes care with and without bariatric surgery in overweight people: a randomised controlled trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70066-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70019-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,9,27]],"date-time":"2026-09-27T14:04:44Z","timestamp":1790517884449,"version":"4.1.0"},"reference-count":28,"publisher":"Elsevier BV","issue":"4","content-domain":{"domain":["thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/s2213-8587(13)70065-2","type":"journal-article","created":{"date-parts":[[2013,8,28]],"date-time":"2013-08-28T01:45:15Z","timestamp":1377654315000},"page":"306-316","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":137,"title":["Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial"],"prefix":"10.1016","volume":"1","author":[{"given":"Stephen E","family":"Gitelman","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter A","family":"Gottlieb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mark R","family":"Rigby","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric I","family":"Felner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven M","family":"Willi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynda K","family":"Fisher","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoinette","family":"Moran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wayne V","family":"Moore","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley","family":"Pinckney","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lynette","family":"Keyes-Elstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sudeepta","family":"Aggarwal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Phippard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter H","family":"Sayre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Linna","family":"Ding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey A","family":"Bluestone","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mario R","family":"Ehlers","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70065-2_bib1","doi-asserted-by":"crossref","first-page":"2515","DOI":"10.2337\/dc12-0669","article-title":"Projections of type 1 and type 2 diabetes burden in the U.S. population aged <20 years through 2050: dynamic modeling of incidence, mortality, and population growth","volume":"35","author":"Imperatore","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70065-2_bib2","doi-asserted-by":"crossref","first-page":"2027","DOI":"10.1016\/S0140-6736(09)60568-7","article-title":"Incidence trends for childhood type 1 diabetes in Europe during 1989\u20132003 and predicted new cases 2005\u201320: a multicentre prospective registration study","volume":"373","author":"Patterson","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70065-2_bib3","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1038\/nature08933","article-title":"Genetics, pathogenesis and clinical interventions in type 1 diabetes","volume":"464","author":"Bluestone","year":"2010","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(13)70065-2_bib4","doi-asserted-by":"crossref","first-page":"832","DOI":"10.2337\/diacare.26.3.832","article-title":"Beta-cell function and the development of diabetes-related complications in the diabetes control and complications trial","volume":"26","author":"Steffes","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70065-2_bib5","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.2337\/diab.37.11.1574","article-title":"Cyclosporin-induced remission of IDDM after early intervention. Association of 1 yr of cyclosporin treatment with enhanced insulin secretion","volume":"37","year":"1988","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70065-2_bib6","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1016\/S0140-6736(86)91943-4","article-title":"Cyclosporin increases the rate and length of remissions in insulin-dependent diabetes of recent onset. Results of a multicentre double-blind trial","volume":"2","author":"Feutren","year":"1986","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70065-2_bib7","doi-asserted-by":"crossref","first-page":"412","DOI":"10.1016\/S0140-6736(11)60886-6","article-title":"Co-stimulation modulation with abatacept in patients with recent-onset type 1 diabetes: a randomised, double-blind, placebo-controlled trial","volume":"378","author":"Orban","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70065-2_bib8","doi-asserted-by":"crossref","first-page":"2598","DOI":"10.1056\/NEJMoa043980","article-title":"Insulin needs after CD3-antibody therapy in new-onset type 1 diabetes","volume":"352","author":"Keymeulen","year":"2005","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70065-2_bib9","doi-asserted-by":"crossref","first-page":"487","DOI":"10.1016\/S0140-6736(11)60931-8","article-title":"Teplizumab for treatment of type 1 diabetes (Prot\u00e9g\u00e9 study): 1-year results from a randomised, placebo-controlled trial","volume":"378","author":"Sherry","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70065-2_bib10","doi-asserted-by":"crossref","DOI":"10.2337\/db13-0345","article-title":"Teplizumab (anti-CD3 mAb) treatment preserves C-peptide responses in patients with new-onset type 1 diabetes in a randomized controlled trial: metabolic and immunologic features at baseline identify a subgroup of responders","author":"Herold","year":"2013","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70065-2_bib11","doi-asserted-by":"crossref","first-page":"691","DOI":"10.2165\/11315940-000000000-00000","article-title":"Rabbit antithymocyte globulin (thymoglobulin): 25 years and new frontiers in solid organ transplantation and haematology","volume":"70","author":"Gaber","year":"2010","journal-title":"Drugs"},{"key":"10.1016\/S2213-8587(13)70065-2_bib12","doi-asserted-by":"crossref","first-page":"405","DOI":"10.2337\/db06-1384","article-title":"Murine antithymocyte globulin therapy alters disease progression in NOD mice by a time-dependent induction of immunoregulation","volume":"57","author":"Simon","year":"2008","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70065-2_bib13","doi-asserted-by":"crossref","first-page":"1502","DOI":"10.1016\/S0140-6736(03)13175-3","article-title":"Tolerogenic immunosuppression for organ transplantation","volume":"361","author":"Starzl","year":"2003","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(13)70065-2_bib14","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1016\/S0037-1963(00)90031-3","article-title":"Treatment of acquired severe aplastic anemia: bone marrow transplantation compared with immunosuppressive therapy\u2013The European Group for Blood and Marrow Transplantation experience","volume":"37","author":"Bacigalupo","year":"2000","journal-title":"Semin Hematol"},{"key":"10.1016\/S2213-8587(13)70065-2_bib15","first-page":"271","article-title":"Anti-thymocyte globulin and prednisone immunotherapy of recent onset type 1 diabetes mellitus","volume":"2","author":"Eisenbarth","year":"1985","journal-title":"Diabetes Res"},{"key":"10.1016\/S2213-8587(13)70065-2_bib16","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1900\/RDS.2004.1.80","article-title":"Polyclonal anti-T-cell therapy for type 1 diabetes mellitus of recent onset","volume":"1","author":"Saudek","year":"2004","journal-title":"Rev Diabet Stud"},{"key":"10.1016\/S2213-8587(13)70065-2_bib17","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.1001\/jama.2009.470","article-title":"C-peptide levels and insulin independence following autologous nonmyeloablative hematopoietic stem cell transplantation in newly diagnosed type 1 diabetes mellitus","volume":"301","author":"Couri","year":"2009","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(13)70065-2_bib18","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.1210\/jc.2011-2188","article-title":"Autologous hematopoietic stem cell transplantation modulates immunocompetent cells and improves \u03b2-cell function in Chinese patients with new onset of type 1 diabetes","volume":"97","author":"Li","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(13)70065-2_bib19","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1038\/bmt.2010.147","article-title":"Independence of exogenous insulin following immunoablation and stem cell reconstitution in newly diagnosed diabetes type I","volume":"46","author":"Snarski","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"10.1016\/S2213-8587(13)70065-2_bib20","doi-asserted-by":"crossref","first-page":"2340","DOI":"10.2337\/db12-0049","article-title":"Rapamycin\/IL-2 combination therapy in patients with type 1 diabetes augments Tregs yet transiently impairs \u03b2-cell function","volume":"61","author":"Long","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70065-2_bib21","doi-asserted-by":"crossref","first-page":"e26471","DOI":"10.1371\/journal.pone.0026471","article-title":"Sample size requirements for studies of treatment effects on beta-cell function in newly diagnosed type 1 diabetes","volume":"6","author":"Lachin","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(13)70065-2_bib22","doi-asserted-by":"crossref","first-page":"2143","DOI":"10.1056\/NEJMoa0904452","article-title":"Rituximab, B-lymphocyte depletion, and preservation of beta-cell function","volume":"361","author":"Pescovitz","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70065-2_bib23","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1016\/j.cytogfr.2011.02.003","article-title":"IL-6 signaling in autoimmunity, chronic inflammation and inflammation-associated cancer","volume":"22","author":"Neurath","year":"2011","journal-title":"Cytokine Growth Factor Rev"},{"key":"10.1016\/S2213-8587(13)70065-2_bib24","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1097\/00007890-200102150-00021","article-title":"Mechanisms involved in antithymocyte globulin immunosuppressive activity in a nonhuman primate model","volume":"71","author":"Pr\u00e9ville","year":"2001","journal-title":"Transplantation"},{"key":"10.1016\/S2213-8587(13)70065-2_bib25","doi-asserted-by":"crossref","first-page":"2132","DOI":"10.1111\/j.1600-6143.2010.03210.x","article-title":"Immune reconstitution following rabbit antithymocyte globulin","volume":"10","author":"Gurkan","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(13)70065-2_bib26","doi-asserted-by":"crossref","first-page":"4608","DOI":"10.4049\/jimmunol.0713269","article-title":"Rabbit polyclonal mouse antithymocyte globulin administration alters dendritic cell profile and function in NOD mice to suppress diabetogenic responses","volume":"182","author":"Huang","year":"2009","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(13)70065-2_bib27","doi-asserted-by":"crossref","first-page":"647","DOI":"10.1002\/lt.21098","article-title":"Serum sickness following rabbit antithymocyte-globulin induction in a liver transplant recipient: case report and literature review","volume":"13","author":"Lundquist","year":"2007","journal-title":"Liver Transpl"},{"key":"10.1016\/S2213-8587(13)70065-2_bib28","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/db09-0557","article-title":"Immune depletion with cellular mobilization imparts immunoregulation and reverses autoimmune diabetes in nonobese diabetic mice","volume":"58","author":"Parker","year":"2009","journal-title":"Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700652?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700652?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,13]],"date-time":"2018-10-13T17:50:36Z","timestamp":1539453036000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700652"}},"issued":{"date-parts":[[2013,12]]},"references-count":28,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S2213858713700652"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70065-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Antithymocyte globulin treatment for patients with recent-onset type 1 diabetes: 12-month results of a randomised, placebo-controlled, phase 2 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70065-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70087-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T03:02:37Z","timestamp":1793070157132,"version":"4.5.0"},"reference-count":93,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,10,1]],"date-time":"2023-10-01T00:00:00Z","timestamp":1696118400000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust","doi-asserted-by":"publisher","award":["225446\/Z\/22\/Z"],"award-info":[{"award-number":["225446\/Z\/22\/Z"]}],"id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,10]]},"DOI":"10.1016\/s2213-8587(23)00190-0","type":"journal-article","created":{"date-parts":[[2023,9,1]],"date-time":"2023-09-01T18:28:17Z","timestamp":1693592897000},"page":"755-767","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Maternal type 1 diabetes and relative protection against offspring transmission"],"prefix":"10.1016","volume":"11","author":[{"given":"Lowri A","family":"Allen","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter N","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen M","family":"Gillespie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard A","family":"Oram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Colin M","family":"Dayan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00190-0_bib1","doi-asserted-by":"crossref","first-page":"962","DOI":"10.1038\/s41588-021-00880-5","article-title":"Fine-mapping, trans-ancestral and genomic analyses identify causal variants, cells, genes and drug targets for type 1 diabetes","volume":"53","author":"Robertson","year":"2021","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(23)00190-0_bib2","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1038\/ng.381","article-title":"Genome-wide association study and meta-analysis find that over 40 loci affect risk of type 1 diabetes","volume":"41","author":"Barrett","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(23)00190-0_bib3","doi-asserted-by":"crossref","first-page":"634","DOI":"10.1055\/s-2007-984443","article-title":"Familiality of diabetes mellitus","volume":"115","author":"Weires","year":"2007","journal-title":"Exp Clin Endocrinol Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib4","doi-asserted-by":"crossref","first-page":"348","DOI":"10.2337\/dc12-0445","article-title":"Extended family history of type 1 diabetes and phenotype and genotype of newly diagnosed children","volume":"36","author":"Parkkola","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00190-0_bib5","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1056\/NEJM198407193110304","article-title":"Differences in risk of insulin-dependent diabetes in offspring of diabetic mothers and diabetic fathers","volume":"311","author":"Warram","year":"1984","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00190-0_bib6","doi-asserted-by":"crossref","first-page":"93","DOI":"10.2337\/diab.36.1.93","article-title":"Age-corrected empirical genetic risk estimates for first-degree relatives of IDDM patients","volume":"36","author":"Tillil","year":"1987","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib7","doi-asserted-by":"crossref","first-page":"802","DOI":"10.1007\/BF00291068","article-title":"The epidemiology of diabetes in Swedish children 0-14 years\u2014a six-year prospective study","volume":"28","author":"Dahlquist","year":"1985","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib8","doi-asserted-by":"crossref","first-page":"870","DOI":"10.1007\/BF00400364","article-title":"A nationwide population-based study of the familial aggregation of type 1 (insulin-dependent) diabetes mellitus in Denmark","volume":"36","author":"Pociot","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib9","doi-asserted-by":"crossref","first-page":"1151","DOI":"10.1007\/s001250051044","article-title":"Familial risk of type I diabetes in European children","volume":"41","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib10","doi-asserted-by":"crossref","first-page":"2025","DOI":"10.1007\/s00125-019-4952-8","article-title":"Characteristics of familial type 1 diabetes: effects of the relationship to the affected family member on phenotype and genotype at diagnosis","volume":"62","author":"Turtinen","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib11","doi-asserted-by":"crossref","first-page":"1433","DOI":"10.2337\/diab.42.10.1433","article-title":"Decreased risk of type I diabetes in offspring of mothers who acquire diabetes during adrenarchy","volume":"42","author":"Bleich","year":"1993","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib12","doi-asserted-by":"crossref","first-page":"975","DOI":"10.1007\/BF00400588","article-title":"Evidence for importance of gender and birth cohort for risk of IDDM in offspring of IDDM parents","volume":"38","author":"Tuomilehto","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib13","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.2337\/db05-1296","article-title":"Differential transmission of type 1 diabetes from diabetic fathers and mothers to their offspring","volume":"55","author":"Harjutsalo","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib14","doi-asserted-by":"crossref","first-page":"1106","DOI":"10.1111\/obr.12858","article-title":"The influence of maternal body mass index, maternal diabetes mellitus, and maternal smoking during pregnancy on the risk of childhood-onset type 1 diabetes mellitus in the offspring: systematic review and meta-analysis of observational studies","volume":"20","author":"Hidayat","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(23)00190-0_bib15","doi-asserted-by":"crossref","first-page":"323","DOI":"10.1002\/gepi.10183","article-title":"Preferential transmission of type 1 diabetes from parents to offspring: fact or artifact?","volume":"23","author":"Guo","year":"2002","journal-title":"Genet Epidemiol"},{"key":"10.1016\/S2213-8587(23)00190-0_bib16","doi-asserted-by":"crossref","first-page":"535","DOI":"10.3389\/fgene.2018.00535","article-title":"Type 1 diabetes mellitus-associated genetic variants contribute to overlapping immune regulatory networks","volume":"9","author":"Nyaga","year":"2018","journal-title":"Front Genet"},{"key":"10.1016\/S2213-8587(23)00190-0_bib17","doi-asserted-by":"crossref","first-page":"3043","DOI":"10.4049\/jimmunol.1502056","article-title":"Systematic evaluation of genes and genetic variants associated with type 1 diabetes susceptibility","volume":"196","author":"Ram","year":"2016","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(23)00190-0_bib18","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.1007\/s00125-013-2929-6","article-title":"The prenatal environment and type 1 diabetes","volume":"56","author":"Stene","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib19","doi-asserted-by":"crossref","first-page":"372","DOI":"10.1016\/S0002-9378(84)80141-6","article-title":"Spontaneous abortion among insulin-dependent diabetic women","volume":"150","author":"Miodovnik","year":"1984","journal-title":"Am J Obstet Gynecol"},{"key":"10.1016\/S2213-8587(23)00190-0_bib20","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/diabetes.51.1.210","article-title":"High familial risk and genetic susceptibility in early onset childhood diabetes","volume":"51","author":"Gillespie","year":"2002","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib21","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1186\/1471-2393-6-30","article-title":"Poor glycated haemoglobin control and adverse pregnancy outcomes in type 1 and type 2 diabetes mellitus: systematic review of observational studies","volume":"6","author":"Inkster","year":"2006","journal-title":"BMC Pregnancy Childbirth"},{"key":"10.1016\/S2213-8587(23)00190-0_bib22","doi-asserted-by":"crossref","first-page":"334","DOI":"10.1016\/j.imbio.2019.02.003","article-title":"The role of autoimmunity in women with type 1 diabetes and adverse pregnancy outcome: a missing link","volume":"224","author":"Groen","year":"2019","journal-title":"Immunobiology"},{"key":"10.1016\/S2213-8587(23)00190-0_bib23","doi-asserted-by":"crossref","first-page":"337","DOI":"10.2337\/dc15-1111","article-title":"A type 1 diabetes genetic risk score can aid discrimination between type 1 and type 2 diabetes in young adults","volume":"39","author":"Oram","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00190-0_bib24","doi-asserted-by":"crossref","first-page":"1887","DOI":"10.2337\/dc18-0087","article-title":"A type 1 diabetes genetic risk score predicts progression of islet autoimmunity and development of type 1 diabetes in individuals at risk","volume":"41","author":"Redondo","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00190-0_bib25","doi-asserted-by":"crossref","first-page":"4037","DOI":"10.1210\/jc.2003-032084","article-title":"Absolute risk of childhood-onset type 1 diabetes defined by human leukocyte antigen class II genotype: a population-based study in the United Kingdom","volume":"89","author":"Lambert","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00190-0_bib26","doi-asserted-by":"crossref","first-page":"1314","DOI":"10.1056\/NEJM198611203152103","article-title":"Preferential transmission of diabetic alleles within the HLA gene complex","volume":"315","author":"Vadheim","year":"1986","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00190-0_bib27","doi-asserted-by":"crossref","first-page":"1462","DOI":"10.2337\/diab.43.12.1462","article-title":"Parental origin of diabetes-associated HLA types in sibling pairs with type I diabetes","volume":"43","author":"Bain","year":"1994","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib28","doi-asserted-by":"crossref","first-page":"279","DOI":"10.1007\/s10654-019-00502-9","article-title":"The Early Growth Genetics (EGG) and EArly Genetics and Lifecourse Epidemiology (EAGLE) consortia: design, results and future prospects","volume":"34","author":"Middeldorp","year":"2019","journal-title":"Eur J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00190-0_bib29","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/354155a0","article-title":"Insulin-IGF2 region on chromosome 11p encodes a gene implicated in HLA-DR4-dependent diabetes susceptibility","volume":"354","author":"Julier","year":"1991","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(23)00190-0_bib30","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1006\/jaut.1996.0057","article-title":"IDDM2-VNTR-encoded susceptibility to type 1 diabetes: dominant protection and parental transmission of alleles of the insulin gene-linked minisatellite locus","volume":"9","author":"Bennett","year":"1996","journal-title":"J Autoimmun"},{"key":"10.1016\/S2213-8587(23)00190-0_bib31","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1007\/BF00401845","article-title":"Parental imprinting effect at the INS-IGF2 diabetes susceptibility locus","volume":"38","author":"Polychronakos","year":"1995","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib32","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1038\/ng0395-284","article-title":"Susceptibility to human type 1 diabetes at IDDM2 is determined by tandem repeat variation at the insulin gene minisatellite locus","volume":"9","author":"Bennett","year":"1995","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(23)00190-0_bib33","doi-asserted-by":"crossref","first-page":"350","DOI":"10.1038\/ng1197-350","article-title":"Insulin VNTR allele-specific effect in type 1 diabetes depends on identity of untransmitted paternal allele","volume":"17","author":"Bennett","year":"1997","journal-title":"Nat Genet"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(23)00190-0_bib34","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1111\/j.1463-1326.2008.01006.x","article-title":"Analysis of maternal-offspring HLA compatibility, parent-of-origin and non-inherited maternal effects for the classical HLA loci in type 1 diabetes","volume":"11","author":"Bronson","year":"2009","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(23)00190-0_bib35","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1038\/ng.493","article-title":"The imprinted DLK1-MEG3 gene region on chromosome 14q32.2 alters susceptibility to type 1 diabetes","volume":"42","author":"Wallace","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(23)00190-0_bib36","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-020-68212-x","article-title":"Genomic imprinting analyses identify maternal effects as a cause of phenotypic variability in type 1 diabetes and rheumatoid arthritis","volume":"10","author":"Blunk","year":"2020","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(23)00190-0_bib37","doi-asserted-by":"crossref","first-page":"666","DOI":"10.1007\/s001250050966","article-title":"Predictors of IDDM recurrence risk in offspring of Danish IDDM patients","volume":"41","author":"Lorenzen","year":"1998","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib38","doi-asserted-by":"crossref","first-page":"210","DOI":"10.2337\/db09-0344","article-title":"Age at onset of type 1 diabetes in parents and recurrence risk in offspring","volume":"59","author":"Harjutsalo","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib39","doi-asserted-by":"crossref","first-page":"3718","DOI":"10.1210\/jc.2006-0624","article-title":"Consequences of fetal exposure to maternal diabetes in offspring","volume":"91","author":"Fetita","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00190-0_bib40","doi-asserted-by":"crossref","first-page":"2208","DOI":"10.2337\/diabetes.49.12.2208","article-title":"Intrauterine exposure to diabetes conveys risks for type 2 diabetes and obesity: a study of discordant sibships","volume":"49","author":"Dabelea","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib41","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.2337\/diabetes.49.12.2201","article-title":"Parental transmission of type 2 diabetes: the Framingham Offspring Study","volume":"49","author":"Meigs","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib42","doi-asserted-by":"crossref","first-page":"1245","DOI":"10.1007\/s00125-008-1022-z","article-title":"Maternal type 1 diabetes reduces the risk of islet autoantibodies: relationships with birthweight and maternal HbA(1c)","volume":"51","author":"Bonifacio","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib43","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1093\/bmb\/60.1.123","article-title":"Intra-uterine programming of the endocrine pancreas","volume":"60","author":"Fowden","year":"2001","journal-title":"Br Med Bull"},{"key":"10.1016\/S2213-8587(23)00190-0_bib44","doi-asserted-by":"crossref","first-page":"E410","DOI":"10.1503\/cmaj.181001","article-title":"Gestational diabetes associated with incident diabetes in childhood and youth: a retrospective cohort study","volume":"191","author":"Blotsky","year":"2019","journal-title":"CMAJ"},{"key":"10.1016\/S2213-8587(23)00190-0_bib45","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1002362","article-title":"Childhood adiposity and risk of type 1 diabetes: a mendelian randomization study","volume":"14","author":"Censin","year":"2017","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(23)00190-0_bib46","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-29932-y","article-title":"Childhood body size directly increases type 1 diabetes risk based on a lifecourse mendelian randomization approach","volume":"13","author":"Richardson","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(23)00190-0_bib47","doi-asserted-by":"crossref","first-page":"624","DOI":"10.1007\/s00335-009-9213-6","article-title":"Epigenetics: deciphering how environmental factors may modify autoimmune type 1 diabetes","volume":"20","author":"MacFarlane","year":"2009","journal-title":"Mamm Genome"},{"key":"10.1016\/S2213-8587(23)00190-0_bib48","doi-asserted-by":"crossref","first-page":"36","DOI":"10.3390\/ijms21010036","article-title":"Epigenetic regulation in etiology of type 1 diabetes mellitus","volume":"21","author":"Cerna","year":"2019","journal-title":"Int J Mol Sci"},{"key":"10.1016\/S2213-8587(23)00190-0_bib49","doi-asserted-by":"crossref","first-page":"338","DOI":"10.1186\/s12916-022-02514-x","article-title":"Epigenetic and transcriptomic alterations in offspring born to women with type 1 diabetes (the EPICOM study)","volume":"20","author":"Knorr","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(23)00190-0_bib50","doi-asserted-by":"crossref","first-page":"616","DOI":"10.1007\/s00125-017-4493-y","article-title":"Associations between birthweight, gestational age at birth and subsequent type 1 diabetes in children under 12: a retrospective cohort study in England, 1998-2012","volume":"61","author":"Goldacre","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib51","doi-asserted-by":"crossref","first-page":"1428","DOI":"10.1093\/aje\/kwp065","article-title":"Birth weight, early weight gain, and subsequent risk of type 1 diabetes: systematic review and meta-analysis","volume":"169","author":"Harder","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00190-0_bib52","doi-asserted-by":"crossref","first-page":"1484","DOI":"10.1007\/s00125-005-1813-4","article-title":"Diabetes-associated HLA genotypes affect birthweight in the general population","volume":"48","author":"Larsson","year":"2005","journal-title":"Diabetologia"},{"issue":"suppl 6","key":"10.1016\/S2213-8587(23)00190-0_bib53","doi-asserted-by":"crossref","first-page":"1821S","DOI":"10.3945\/ajcn.110.000646","article-title":"Early determinants of type 1 diabetes: experience from the BABYDIAB and BABYDIET studies","volume":"94","author":"Hummel","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00190-0_bib54","doi-asserted-by":"crossref","first-page":"196","DOI":"10.4239\/wjd.v2.i11.196","article-title":"Consequences of gestational and pregestational diabetes on placental function and birth weight","volume":"2","author":"Vambergue","year":"2011","journal-title":"World J Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib55","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1007\/s00125-019-05036-z","article-title":"A prospective study of associations between in utero exposure to gestational diabetes mellitus and metabolomic profiles during late childhood and adolescence","volume":"63","author":"Perng","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib56","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1007\/s11892-022-01449-0","article-title":"Metabolomics of type 1 and type 2 diabetes: insights into risk prediction and mechanisms","volume":"22","author":"Izundegui","year":"2022","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(23)00190-0_bib57","doi-asserted-by":"crossref","first-page":"4187","DOI":"10.4049\/jimmunol.167.8.4187","article-title":"Neonatal exposure to antigen primes the immune system to develop responses in various lymphoid organs and promotes bystander regulation of diverse T cell specificities","volume":"167","author":"Pack","year":"2001","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(23)00190-0_bib58","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.2337\/diabetes.49.10.1657","article-title":"Effect of cow's milk exposure and maternal type 1 diabetes on cellular and humoral immunization to dietary insulin in infants at genetic risk for type 1 diabetes","volume":"49","author":"Paronen","year":"2000","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib59","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2018-028578","article-title":"Oral insulin therapy for primary prevention of type 1 diabetes in infants with high genetic risk: the GPPAD-POInT (global platform for the prevention of autoimmune diabetes primary oral insulin trial) study protocol","volume":"9","author":"Ziegler","year":"2019","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(23)00190-0_bib60","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1007\/BF00402275","article-title":"On the appearance of islet associated autoimmunity in offspring of diabetic mothers: a prospective study from birth","volume":"36","author":"Ziegler","year":"1993","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib61","doi-asserted-by":"crossref","first-page":"967","DOI":"10.2337\/diab.45.7.967","article-title":"Perinatal autoimmunity in offspring of diabetic parents. The German Multicenter BABY-DIAB study: detection of humoral immune responses to islet antigens in early childhood","volume":"45","author":"Roll","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib62","doi-asserted-by":"crossref","first-page":"1","DOI":"10.2337\/diabetes.53.1.1","article-title":"Transmission of maternal islet antibodies and risk of autoimmune diabetes in offspring of mothers with type 1 diabetes","volume":"53","author":"Koczwara","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib63","first-page":"4249","article-title":"Postnatal elimination of transplacentally acquired disease-associated antibodies in infants born to families with type 1 diabetes. The Finnish TRIGR Study Group. Trial to reduce IDDM in the genetically at risk","volume":"85","author":"H\u00e4m\u00e4l\u00e4inen","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00190-0_bib64","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jcem.86.10.7931","article-title":"Prevalence, characteristics and diabetes risk associated with transient maternally acquired islet antibodies and persistent islet antibodies in offspring of parents with type 1 diabetes","volume":"86","author":"Naserke","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(23)00190-0_bib65","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1002\/dmrr.232","article-title":"Prevalence and fate of type 1 diabetes-associated autoantibodies in cord blood samples from newborn infants of non-diabetic mothers","volume":"18","author":"H\u00e4m\u00e4l\u00e4inen","year":"2002","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(23)00190-0_bib66","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/nm0402-399","article-title":"Elimination of maternally transmitted autoantibodies prevents diabetes in nonobese diabetic mice","volume":"8","author":"Greeley","year":"2002","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(23)00190-0_bib67","doi-asserted-by":"crossref","first-page":"926","DOI":"10.2337\/diab.45.7.926","article-title":"Prediction of type I diabetes in first-degree relatives using a combination of insulin, GAD, and ICA512bdc\/IA-2 autoantibodies","volume":"45","author":"Verge","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib68","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1007\/s00125-020-05287-1","article-title":"Association between family history, early growth and the risk of beta cell autoimmunity in children at risk for type 1 diabetes","volume":"64","author":"Pacaud","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib69","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/db18-0882","article-title":"Genetic contribution to the divergence in type 1 diabetes risk between children from the general population and children from affected families","volume":"68","author":"Hippich","year":"2019","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib70","doi-asserted-by":"crossref","first-page":"1447","DOI":"10.1111\/pedi.13122","article-title":"Extended family history of type 1 diabetes in HLA-predisposed children with and without islet autoantibodies","volume":"21","author":"Kuusela","year":"2020","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib71","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14979","article-title":"The measurement of autoantibodies to insulin informs diagnosis of diabetes in a childhood population negative for other autoantibodies","volume":"39","author":"Williams","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00190-0_bib72","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1007\/BF00275942","article-title":"Insulin immunogenicity in pregnancy: maternal and fetal studies","volume":"24","author":"Mylvaganam","year":"1983","journal-title":"Diabetologia"},{"issue":"suppl","key":"10.1016\/S2213-8587(23)00190-0_bib73","doi-asserted-by":"crossref","first-page":"83","DOI":"10.1007\/BF00275654","article-title":"Insulin-anti-insulin complexes in diabetic women and their neonates","volume":"27","author":"Di Mario","year":"1984","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib74","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1007\/s11892-002-0025-2","article-title":"Autoimmunity and familial risk of type 1 diabetes","volume":"2","author":"H\u00e4m\u00e4l\u00e4inen","year":"2002","journal-title":"Curr Diab Rep"},{"key":"10.1016\/S2213-8587(23)00190-0_bib75","doi-asserted-by":"crossref","first-page":"1706","DOI":"10.2337\/diab.45.12.1706","article-title":"Disease-associated antibodies in offspring of mothers with IDDM","volume":"45","author":"Martikainen","year":"1996","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib76","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1016\/S0022-3476(83)80599-X","article-title":"Relation of enteroinsular hormones at birth to macrosomia and neonatal hypoglycemia in infants of diabetic mothers","volume":"103","author":"Knip","year":"1983","journal-title":"J Pediatr"},{"key":"10.1016\/S2213-8587(23)00190-0_bib77","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1016\/S2213-8587(23)00122-5","article-title":"Enteroviruses and risk of islet autoimmunity or type 1 diabetes: systematic review and meta-analysis of controlled observational studies detecting viral nucleic acids and proteins","volume":"11","author":"Isaacs","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00190-0_bib78","doi-asserted-by":"crossref","first-page":"5115","DOI":"10.1073\/pnas.0700442104","article-title":"Coxsackie B4 virus infection of beta cells and natural killer cell insulitis in recent-onset type 1 diabetic patients","volume":"104","author":"Dotta","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(23)00190-0_bib79","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1007\/s00125-009-1276-0","article-title":"The prevalence of enteroviral capsid protein vp1 immunostaining in pancreatic islets in human type 1 diabetes","volume":"52","author":"Richardson","year":"2009","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib80","doi-asserted-by":"crossref","first-page":"687","DOI":"10.2337\/db11-1157","article-title":"Type 1 diabetes is associated with enterovirus infection in gut mucosa","volume":"61","author":"Oikarinen","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib81","doi-asserted-by":"crossref","first-page":"2479","DOI":"10.1007\/s00125-012-2591-4","article-title":"No evidence of enteroviruses in the intestine of patients with type 1 diabetes","volume":"55","author":"Mercalli","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib82","doi-asserted-by":"crossref","first-page":"941","DOI":"10.1542\/peds.2006-0780","article-title":"Maternal antibodies in breast milk protect the child from enterovirus infections","volume":"119","author":"Sadeharju","year":"2007","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(23)00190-0_bib83","doi-asserted-by":"crossref","first-page":"867","DOI":"10.1007\/s00125-013-2834-z","article-title":"Previous maternal infection protects offspring from enterovirus infection and prevents experimental diabetes development in mice","volume":"56","author":"Larsson","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(23)00190-0_bib84","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1126\/science.1164511","article-title":"Maternal alloantigens promote the development of tolerogenic fetal regulatory T cells in utero","volume":"322","author":"Mold","year":"2008","journal-title":"Science"},{"key":"10.1016\/S2213-8587(23)00190-0_bib85","doi-asserted-by":"crossref","first-page":"1637","DOI":"10.1073\/pnas.0606169104","article-title":"Maternal microchimerism in peripheral blood in type 1 diabetes and pancreatic islet beta cell microchimerism","volume":"104","author":"Nelson","year":"2007","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(23)00190-0_bib86","article-title":"Maternal microchimerism: increased in the insulin positive compartment of type 1 diabetes pancreas but not in infiltrating immune cells or replicating islet cells","volume":"9","author":"Ye","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(23)00190-0_bib87","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1111\/dme.14221","article-title":"Low prevalence of maternal microchimerism in peripheral blood of Japanese children with type 1 diabetes","volume":"37","author":"Ushijima","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(23)00190-0_bib88","first-page":"728","article-title":"Maternal microchimerism in cord blood and risk of childhood-onset type 1 diabetes","volume":"20","author":"Tapia","year":"2019","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib89","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1530\/EJE-11-0376","article-title":"Family history of diabetes and distribution of class II HLA genotypes in children with newly diagnosed type 1 diabetes: effect on diabetic ketoacidosis","volume":"165","author":"Hekkala","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(23)00190-0_bib90","doi-asserted-by":"crossref","first-page":"e1258","DOI":"10.1542\/peds.2007-1105","article-title":"Presence of diabetic ketoacidosis at diagnosis of diabetes mellitus in youth: the Search for Diabetes in Youth Study","volume":"121","author":"Rewers","year":"2008","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(23)00190-0_bib91","doi-asserted-by":"crossref","first-page":"2489","DOI":"10.1172\/JCI119067","article-title":"HLA-DQB1-defined genetic susceptibility, beta cell autoimmunity, and metabolic characteristics in familial and nonfamilial insulin-dependent diabetes mellitus. Childhood Diabetes in Finland (DiMe) Study Group","volume":"98","author":"Veijola","year":"1996","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(23)00190-0_bib92","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1111\/j.1399-5448.2009.00621.x","article-title":"Familial type 1 diabetes mellitus\u2014gender distribution and age at onset of diabetes distinguish between parent-offspring and sib-pair subgroups","volume":"11","author":"Lebenthal","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(23)00190-0_bib93","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/0168-8227(91)90019-A","article-title":"Familial and sporadic insulin-dependent diabetes: evidence for heterogeneous etiologies?","volume":"14","author":"O'Leary","year":"1991","journal-title":"Diabetes Res Clin Pract"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001900?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001900?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:03Z","timestamp":1761991983000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001900"}},"issued":{"date-parts":[[2023,10]]},"references-count":93,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2023,10]]}},"alternative-id":["S2213858723001900"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00190-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Maternal type 1 diabetes and relative protection against offspring transmission","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00190-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T03:21:53Z","timestamp":1793157713697,"version":"4.5.0"},"reference-count":77,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100014461","name":"NIHR","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100014461","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/s2213-8587(26)00035-5","type":"journal-article","created":{"date-parts":[[2026,4,24]],"date-time":"2026-04-24T22:55:13Z","timestamp":1777071313000},"page":"523-532","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Strengthening diabetes care in sub-Saharan Africa: health systems, digital innovations, lifestyle interventions, and socioeconomic dimensions"],"prefix":"10.1016","volume":"14","author":[{"given":"Shabana","family":"Cassambai","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pamela","family":"Godia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Silver","family":"Bahendeka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Damilola","family":"Omodara","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Deborah","family":"Ikhile","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel","family":"Seidu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kamlesh","family":"Khunti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(26)00035-5_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(26)00065-3","article-title":"Burden and determinants of diabetes in sub-Saharan Africa","author":"Agyemang","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00035-5_bib3","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-018-6050-0","article-title":"Self-management of diabetes in sub-Saharan Africa: a systematic review","volume":"18","author":"Stephani","year":"2018","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(26)00035-5_bib4","doi-asserted-by":"crossref","first-page":"622","DOI":"10.1016\/S2213-8587(17)30181-X","article-title":"Diabetes in sub-Saharan Africa: from clinical care to health policy","volume":"5","author":"Atun","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00035-5_bib5","doi-asserted-by":"crossref","first-page":"12378","DOI":"10.55248\/gengpi.6.0525.18157","article-title":"Exploring interdisciplinary family medicine approaches to improve chronic disease management and patient centered outcomes","volume":"6","author":"Olowomeye","year":"2025","journal-title":"Int J Res Publ Rev"},{"key":"10.1016\/S2213-8587(26)00035-5_bib6","first-page":"1","article-title":"Challenges facing primary health care services utilization and possible solutions","volume":"5","author":"Okunlola","year":"2025","journal-title":"Eur Glob Contemp Stud J"},{"key":"10.1016\/S2213-8587(26)00035-5_bib7","doi-asserted-by":"crossref","first-page":"409","DOI":"10.2147\/RMHP.S239074","article-title":"Strengthening primary health-care services to help prevent and control long-term (chronic) non-communicable diseases in low- and middle-income countries","volume":"13","author":"Haque","year":"2020","journal-title":"Risk Manag Healthc Policy"},{"key":"10.1016\/S2213-8587(26)00035-5_bib9","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pgph.0003733","article-title":"Barriers and facilitators of primary care management of type II diabetes mellitus in the west African sub-region: a scoping review","volume":"5","author":"Abdul-Samed","year":"2025","journal-title":"PLoS Glob Public Health"},{"key":"10.1016\/S2213-8587(26)00035-5_bib10","doi-asserted-by":"crossref","first-page":"942","DOI":"10.1111\/tmi.13819","article-title":"Availability and affordability of essential medicines and diagnostic tests for diabetes mellitus in Africa","volume":"27","author":"Kibirige","year":"2022","journal-title":"Trop Med Int Health"},{"key":"10.1016\/S2213-8587(26)00035-5_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(26)00036-7","article-title":"Diabetes-related complications and multiple long-term conditions in sub-Saharan Africa: determinants and management strategies","author":"Ikhile","year":"2026","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00035-5_bib12","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2022-063318","article-title":"Association between urban\u2013rural location and prevalence of type 2 diabetes and impaired fasting glucose in west Africa: a cross-sectional population-based epidemiological study","volume":"13","author":"Issaka","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00035-5_bib13","doi-asserted-by":"crossref","first-page":"2261","DOI":"10.2147\/DMSO.S207427","article-title":"Mitigating the burden of diabetes in sub-Saharan Africa through an integrated diagonal health systems approach","volume":"12","author":"Mercer","year":"2019","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/S2213-8587(26)00035-5_bib14","article-title":"Chronic disease care integration into primary care services in sub-Saharan Africa: a \u2018best fit\u2019 framework synthesis and new conceptual model","volume":"10","author":"Harrison","year":"2022","journal-title":"Fam Med Community Health"},{"key":"10.1016\/S2213-8587(26)00035-5_bib15","doi-asserted-by":"crossref","first-page":"463","DOI":"10.1007\/s40273-024-01353-3","article-title":"The burden of type 2 diabetes on the productivity and economy in sub-Saharan Africa: a life table modelling analysis from a South African perspective","volume":"42","author":"Hellebo","year":"2024","journal-title":"PharmacoEconomics"},{"key":"10.1016\/S2213-8587(26)00035-5_bib16","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/s13098-022-00902-0","article-title":"Glycaemic control among type 2 diabetes patients in sub-Saharan Africa from 2012 to 2022: a systematic review and meta-analysis","volume":"14","author":"Fina Lubaki","year":"2022","journal-title":"Diabetol Metab Syndr"},{"key":"10.1016\/S2213-8587(26)00035-5_bib17","doi-asserted-by":"crossref","DOI":"10.3390\/nu15122749","article-title":"Global impacts of western diet and its effects on metabolism and health: a narrative review","volume":"15","author":"Clemente-Su\u00e1rez","year":"2023","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(26)00035-5_bib18","doi-asserted-by":"crossref","first-page":"2296","DOI":"10.1111\/jocn.14835","article-title":"Barriers to diabetic self-care: a qualitative study of patients' and healthcare providers' perspectives","volume":"28","author":"Mogre","year":"2019","journal-title":"J Clin Nurs"},{"key":"10.1016\/S2213-8587(26)00035-5_bib19","doi-asserted-by":"crossref","first-page":"71","DOI":"10.4081\/aamr.2019.71","article-title":"Cigarette smoking, alcohol intake and the risk of diabetes mellitus in Gombe State, northeast Nigeria","volume":"2","author":"Bathna","year":"2019","journal-title":"Ann Afr Med Res"},{"key":"10.1016\/S2213-8587(26)00035-5_bib20","doi-asserted-by":"crossref","DOI":"10.1186\/s12889-024-20589-4","article-title":"Community beliefs and practices about diabetes and their implications for the prevention and management of diabetes in southeast Ghana","volume":"24","author":"Alor","year":"2024","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(26)00035-5_bib21","series-title":"Relationship among health literacy superstitious beliefs and self-care among diabetic patients in Warri, Nigeria","author":"Ukpabi","year":"2021"},{"key":"10.1016\/S2213-8587(26)00035-5_bib22","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/S0140-6736(24)02614-X","article-title":"Harnessing faith-based organisations for global health equity","volume":"405","author":"Ala","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00035-5_bib23","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/S0140-6736(15)60251-3","article-title":"Understanding the roles of faith-based health-care providers in Africa: review of the evidence with a focus on magnitude, reach, cost, and satisfaction","volume":"386","author":"Olivier","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00035-5_bib24","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1080\/13557858.2021.1881764","article-title":"Exploring the impact of cultural beliefs in the self-management of type 2 diabetes among Black sub-Saharan Africans in the UK\u2014a qualitative study informed by the PEN-3 cultural model","volume":"27","author":"Omodara","year":"2022","journal-title":"Ethn Health"},{"key":"10.1016\/S2213-8587(26)00035-5_bib25","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvae136","article-title":"Diabetes stigma and clinical outcomes: an international review","volume":"8","author":"Eitel","year":"2024","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(26)00035-5_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/j.metop.2025.100349","article-title":"Gender based difference in glycemic control and diabetes related chronic complications among type 2 diabetic patients in Debre Berhan city public hospitals","volume":"25","author":"Gebeyaw","year":"2025","journal-title":"Metab Open"},{"key":"10.1016\/S2213-8587(26)00035-5_bib27","doi-asserted-by":"crossref","first-page":"67","DOI":"10.53339\/aimdr.2024.10.4.9","article-title":"Gender-based disparities in glycemic control: insights from diabetes mellitus populations","volume":"10","author":"Eva","year":"2024","journal-title":"Ann Int Med Dent Res"},{"key":"10.1016\/S2213-8587(26)00035-5_bib28","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1186\/s12913-023-09151-x","article-title":"Implementation considerations for non-communicable disease-related integration in primary health care: a rapid review of qualitative evidence","volume":"23","author":"Leon","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(26)00035-5_bib29","doi-asserted-by":"crossref","first-page":"1353","DOI":"10.1007\/s40520-020-01533-z","article-title":"Integrated care for the management of ageing-related non-communicable diseases: current gaps and future directions","volume":"32","author":"Monaco","year":"2020","journal-title":"Aging Clin Exp Res"},{"key":"10.1016\/S2213-8587(26)00035-5_bib30","series-title":"The role of health services integration in healthcare system performance: a case of HIV\/AIDS and NCD services in Nakuru County, Kenya","author":"Kinyanjui","year":"2024"},{"key":"10.1016\/S2213-8587(26)00035-5_bib31","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2023-073652","article-title":"Effectiveness of integrated chronic care models for cardiometabolic multimorbidity in sub-Saharan Africa: a systematic review and meta-analysis","volume":"13","author":"Otieno","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(26)00035-5_bib32","doi-asserted-by":"crossref","first-page":"881","DOI":"10.1186\/s12889-023-15704-w","article-title":"Principles for task shifting hypertension and diabetes screening and referral: a qualitative study exploring patient, community health worker and healthcare professional perceptions in rural Uganda","volume":"23","author":"Ingenhoff","year":"2023","journal-title":"BMC Public Health"},{"key":"10.1016\/S2213-8587(26)00035-5_bib33","doi-asserted-by":"crossref","first-page":"194","DOI":"10.1097\/CEH.0000000000000517","article-title":"Health professions education strategies for enhancing capacity for task-shifting and task-sharing implementation in Africa: a scoping review","volume":"44","author":"Okoroafor","year":"2024","journal-title":"J Contin Educ Health Prof"},{"key":"10.1016\/S2213-8587(26)00035-5_bib34","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13063-021-05085-z","article-title":"Effect of a nurse-led lifestyle choice and coaching intervention on systolic blood pressure among type 2 diabetic patients with a high atherosclerotic cardiovascular risk: study protocol for a cluster-randomized trial","volume":"22","author":"Lumu","year":"2021","journal-title":"Trials"},{"key":"10.1016\/S2213-8587(26)00035-5_bib35","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12913-019-4367-8","article-title":"Effects of non-medical health coaching on multimorbid patients in primary care: a difference-in-differences analysis","volume":"19","author":"Shah","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(26)00035-5_bib36","doi-asserted-by":"crossref","DOI":"10.7189\/jogh.15.04148","article-title":"Self-management interventions for common long-term conditions in low-and middle-income countries: a synthesis of current evidence","volume":"15","author":"Akhal","year":"2025","journal-title":"J Glob Health"},{"key":"10.1016\/S2213-8587(26)00035-5_bib37","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1016\/S2213-8587(23)00117-1","article-title":"Implementing digital systems in diabetes care in low-income and middle-income countries: successes and challenges","volume":"11","author":"Bahendeka","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(26)00035-5_bib38","doi-asserted-by":"crossref","first-page":"8","DOI":"10.5334\/ijic.6962","article-title":"Scaling up integrated care for HIV and other chronic conditions in routine health care settings in sub-Saharan Africa: field notes from Uganda","volume":"23","author":"Moyo","year":"2023","journal-title":"Int J Integr Care"},{"key":"10.1016\/S2213-8587(26)00035-5_bib39","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299904","article-title":"Integrated chronic care models for people with comorbid of HIV and non-communicable diseases in sub-Saharan Africa: a scoping review","volume":"19","author":"Chireshe","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00035-5_bib40","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1016\/S0140-6736(23)01573-8","article-title":"Integrated management of HIV, diabetes, and hypertension in sub-Saharan Africa (INTE-AFRICA): a pragmatic cluster-randomised, controlled trial","volume":"402","author":"Kivuyo","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(26)00035-5_bib41","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1186\/s13643-020-01377-8","article-title":"The effectiveness of peer and community health worker-led self-management support programs for improving diabetes health-related outcomes in adults in low- and-middle-income countries: a systematic review","volume":"9","author":"Werfalli","year":"2020","journal-title":"Syst Rev"},{"key":"10.1016\/S2213-8587(26)00035-5_bib42","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0305860","article-title":"Diabetes self-care intervention strategies and their effectiveness in sub-Saharan Africa: a systematic review","volume":"19","author":"Ageru","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00035-5_bib43","doi-asserted-by":"crossref","first-page":"879","DOI":"10.1186\/s12982-025-01296-w","article-title":"Sustaining HIV gains towards the UNAIDS 95 95 95 targets amid a shifting funding landscape in sub-Saharan Africa","volume":"22","author":"Olpengs","year":"2025","journal-title":"Discov Public Health"},{"key":"10.1016\/S2213-8587(26)00035-5_bib45","doi-asserted-by":"crossref","first-page":"e346","DOI":"10.1016\/S2352-3018(25)00074-8","article-title":"Impact of an international HIV funding crisis on HIV infections and mortality in low-income and middle-income countries: a modelling study","volume":"12","author":"ten Brink","year":"2025","journal-title":"Lancet HIV"},{"key":"10.1016\/S2213-8587(26)00035-5_bib46","doi-asserted-by":"crossref","first-page":"6","DOI":"10.5334\/ijic.5839","article-title":"Integrating care for diabetes and hypertension with HIV care in sub-Saharan Africa: a scoping review","volume":"22","author":"McCombe","year":"2022","journal-title":"Int J Integr Care"},{"key":"10.1016\/S2213-8587(26)00035-5_bib47","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003150","article-title":"The impact of continuous quality improvement on coverage of antenatal HIV care tests in rural South Africa: results of a stepped-wedge cluster-randomised controlled implementation trial","volume":"17","author":"Yapa","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(26)00035-5_bib48","doi-asserted-by":"crossref","first-page":"382","DOI":"10.1186\/s12875-024-02620-0","article-title":"Hypertension and diabetes control: faith-based centres offer a promise for expanding screening services and linkage to care in Ghana","volume":"25","author":"Nonterah","year":"2024","journal-title":"BMC Prim Care"},{"key":"10.1016\/S2213-8587(26)00035-5_bib49","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2025.38101","article-title":"Faith-based lifestyle intervention for diabetes prevention among adults in Bangladesh: a cluster randomized clinical trial","volume":"8","author":"Bhowmik","year":"2025","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(26)00035-5_bib50","doi-asserted-by":"crossref","first-page":"456","DOI":"10.1177\/26350106241279809","article-title":"Patient-perceived challenges to type 2 diabetes self-management in sub-Saharan Africa: a qualitative exploratory study","volume":"50","author":"Desse","year":"2024","journal-title":"Sci Diabetes Self Manag Care"},{"key":"10.1016\/S2213-8587(26)00035-5_bib51","doi-asserted-by":"crossref","first-page":"32","DOI":"10.5334\/gh.1213","article-title":"Assessing the readiness to provide integrated management of cardiovascular diseases and type 2 diabetes in Kenya: results from a national survey","volume":"18","author":"Otieno","year":"2023","journal-title":"Glob Heart"},{"key":"10.1016\/S2213-8587(26)00035-5_bib52","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0213530","article-title":"Diabetes self-management in three different income settings: cross-learning of barriers and opportunities","volume":"14","author":"De Man","year":"2019","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00035-5_bib53","article-title":"Enhancing healthcare delivery through digital health interventions: a systematic review on telemedicine and mobile health applications in low and middle-income countries (LMICs)","author":"Jones-Esan","year":"2024","journal-title":"Research Square"},{"key":"10.1016\/S2213-8587(26)00035-5_bib55","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1186\/s12905-023-02825-y","article-title":"Effectiveness of mobile technology and utilization of maternal and neonatal healthcare in low and middle-income countries (LMICs): a systematic review","volume":"23","author":"De","year":"2023","journal-title":"BMC Women's Health"},{"key":"10.1016\/S2213-8587(26)00035-5_bib56","doi-asserted-by":"crossref","DOI":"10.7717\/peerj.18297","article-title":"Intention to use short messaging services for promoting drug adherence among individuals with diabetes in Addis Ababa, Ethiopia","volume":"12","author":"Alem","year":"2024","journal-title":"PeerJ"},{"key":"10.1016\/S2213-8587(26)00035-5_bib57","doi-asserted-by":"crossref","DOI":"10.4102\/sajim.v24i1.1550","article-title":"Digital health and self-management of chronic diseases in sub-Saharan Africa: a scoping review","volume":"24","author":"Achieng","year":"2022","journal-title":"S Afr J Inf Manag"},{"key":"10.1016\/S2213-8587(26)00035-5_bib58","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1002\/fsn3.3764","article-title":"Functional foods of sub-Saharan Africa and their implications in the management of type 2 diabetes: a review","volume":"12","author":"Matsinkou Soh","year":"2024","journal-title":"Food Sci Nutr"},{"key":"10.1016\/S2213-8587(26)00035-5_bib59","doi-asserted-by":"crossref","DOI":"10.1016\/j.hnm.2023.200236","article-title":"The effect of indigenous African diet on inflammatory markers linked to type 2 diabetic mellitus","volume":"35","author":"Malongane","year":"2024","journal-title":"Hum Nutr Metab"},{"key":"10.1016\/S2213-8587(26)00035-5_bib60","doi-asserted-by":"crossref","first-page":"1698","DOI":"10.1038\/s41591-025-03602-0","article-title":"Immune and metabolic effects of African heritage diets versus Western diets in men: a randomized controlled trial","volume":"31","author":"Temba","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(26)00035-5_bib61","doi-asserted-by":"crossref","DOI":"10.3390\/nu14235126","article-title":"A culturally sensitive and theory-based intervention on prevention and management of diabetes: a cluster randomized control trial","volume":"14","author":"Githinji","year":"2022","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(26)00035-5_bib62","doi-asserted-by":"crossref","DOI":"10.1080\/16549716.2023.2212952","article-title":"Cost-effectiveness of Lifestyle Africa: an adaptation of the diabetes prevention programme for delivery by community health workers in urban South Africa","volume":"16","author":"Whittington","year":"2023","journal-title":"Glob Health Action"},{"key":"10.1016\/S2213-8587(26)00035-5_bib63","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003964","article-title":"Evaluation of an adapted version of the Diabetes Prevention Program for low- and middle-income countries: a cluster randomized trial to evaluate \u201cLifestyle Africa\u201d in South Africa","volume":"19","author":"Catley","year":"2022","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(26)00035-5_bib64","first-page":"422","article-title":"Culturally tailored lifestyle interventions for the prevention and management of type 2 diabetes in adults of Black African ancestry: a systematic review of tailoring methods and their effectiveness","volume":"25","author":"Wadi","year":"2022","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(26)00035-5_bib65","doi-asserted-by":"crossref","DOI":"10.1002\/hsr2.70746","article-title":"Public\u2013private partnerships for universal health coverage in sub-Saharan Africa: a scoping review protocol","volume":"8","author":"Otchere","year":"2025","journal-title":"Health Sci Rep"},{"key":"10.1016\/S2213-8587(26)00035-5_bib66","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1186\/s12913-018-3744-z","article-title":"Role of public\u2013private partnerships in achieving UNAIDS HIV treatment targets","volume":"19","author":"Shrivastava","year":"2019","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(26)00035-5_bib67","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2018-001193","article-title":"Partnership with private for-profit sector for universal health coverage in sub-Saharan Africa: opportunities and caveats","volume":"4","author":"Nabyonga-Orem","year":"2019","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S2213-8587(26)00035-5_bib68","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1186\/s12913-020-05979-9","article-title":"Public\u2013private partnerships in primary health care: a scoping review","volume":"21","author":"Joudyian","year":"2021","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(26)00035-5_bib69","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1186\/s12913-023-09534-0","article-title":"Implementing integrated care clinics for HIV-infection, diabetes and hypertension in Uganda (INTE-AFRICA): process evaluation of a cluster randomised controlled trial","volume":"23","author":"Van Hout","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(26)00035-5_bib70","doi-asserted-by":"crossref","first-page":"3679","DOI":"10.2147\/DMSO.S391926","article-title":"A mixed methods multicenter study on the capabilities, barriers, and opportunities for diabetes screening and management in the public health system of southern Ethiopia","volume":"15","author":"Habebo","year":"2022","journal-title":"Diabetes Metab Syndr Obes"},{"key":"10.1016\/S2213-8587(26)00035-5_bib71","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s12913-023-10410-0","article-title":"Towards an integrated type 1 diabetes management in low-resource settings: barriers faced by patients and their caregivers in healthcare facilities in Ghana","volume":"24","author":"Owusu","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(26)00035-5_bib72","doi-asserted-by":"crossref","DOI":"10.3389\/fcvm.2021.778891","article-title":"Determinants of dyslipidemia in Africa: a systematic review and meta-analysis","volume":"8","author":"Obsa","year":"2022","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/S2213-8587(26)00035-5_bib73","doi-asserted-by":"crossref","first-page":"220","DOI":"10.1186\/s13643-022-02090-4","article-title":"Suboptimal blood pressure control and its associated factors among people living with diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis","volume":"11","author":"Akalu","year":"2022","journal-title":"Syst Rev"},{"key":"10.1016\/S2213-8587(26)00035-5_bib74","doi-asserted-by":"crossref","first-page":"e270","DOI":"10.1016\/S2214-109X(18)30450-9","article-title":"Implications of scaling up cardiovascular disease treatment in South Africa: a microsimulation and cost-effectiveness analysis","volume":"7","author":"Basu","year":"2019","journal-title":"Lancet Glob Health"},{"key":"10.1016\/S2213-8587(26)00035-5_bib75","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0299526","article-title":"Therapeutic patient education programs on diabetes in sub-Saharan Africa: a systematic review","volume":"19","author":"Iwelomen","year":"2024","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00035-5_bib76","author":"Petersen"},{"key":"10.1016\/S2213-8587(26)00035-5_bib77","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1186\/s12913-023-09188-y","article-title":"Change in glycaemic control with structured diabetes self-management education in urban low-resource settings: multicentre randomised trial of effectiveness","volume":"23","author":"Lamptey","year":"2023","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(26)00035-5_bib78","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.11124\/JBIES-23-00273","article-title":"Effectiveness and safety of self-management interventions for improving glycemic control and health-related quality of life among adults with type 2 diabetes mellitus in sub-Saharan Africa: a systematic review and meta-analysis","volume":"22","author":"Carter","year":"2024","journal-title":"JBI Evid Synth"},{"key":"10.1016\/S2213-8587(26)00035-5_bib79","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.1007\/s00125-025-06553-w","article-title":"Phenotype of insulin-dependent diabetes in chronic undernutrition: beta cell stress and immune dysfunction\u2014a rural sub-Saharan perspective on type 5 diabetes","volume":"68","author":"Trimble","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(26)00035-5_bib80","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0278353","article-title":"Community-based models of care for management of type 2 diabetes mellitus among non-pregnant adults in sub-Saharan Africa: a scoping review","volume":"18","author":"Firima","year":"2023","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(26)00035-5_bib81","author":"Arueyingho"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000355?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858726000355?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T12:53:14Z","timestamp":1778763194000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858726000355"}},"issued":{"date-parts":[[2026,6]]},"references-count":77,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S2213858726000355"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(26)00035-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Strengthening diabetes care in sub-Saharan Africa: health systems, digital innovations, lifestyle interventions, and socioeconomic dimensions","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00035-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00065-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00036-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(26)00099-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,28]],"date-time":"2026-10-28T00:34:04Z","timestamp":1793147644584,"version":"4.5.0"},"reference-count":1,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,8,1]],"date-time":"2022-08-01T00:00:00Z","timestamp":1659312000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100008349","name":"Boehringer Ingelheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008349","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100001316","name":"Abbott Laboratories","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100001316","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100004325","name":"AstraZeneca","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004325","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,8]]},"DOI":"10.1016\/s2213-8587(22)00190-5","type":"journal-article","created":{"date-parts":[[2022,7,19]],"date-time":"2022-07-19T19:29:59Z","timestamp":1658258999000},"page":"558","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Perceptions of alternative methods of insulin storage: an ethical dilemma"],"prefix":"10.1016","volume":"10","author":[{"given":"Arunkumar R","family":"Pande","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashwani Kumar","family":"Thakur","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00190-5_bib1","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1016\/S2213-8587(22)00140-1","article-title":"Hot topics on insulin access: the issue of thermostability","volume":"10","author":"Burki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001905?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722001905?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:53Z","timestamp":1761991853000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722001905"}},"issued":{"date-parts":[[2022,8]]},"references-count":1,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2022,8]]}},"alternative-id":["S2213858722001905"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00190-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Perceptions of alternative methods of insulin storage: an ethical dilemma","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00190-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00140-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,27]],"date-time":"2026-10-27T23:34:12Z","timestamp":1793144052052,"version":"4.5.0"},"reference-count":20,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,3,1]],"date-time":"2019-03-01T00:00:00Z","timestamp":1551398400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2019,8,19]],"date-time":"2019-08-19T00:00:00Z","timestamp":1566172800000},"content-version":"am","delay-in-days":171,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"name":"Polish National Center of Research and Development MILESTONE Project","award":["STRATEGMED2\/267398\/4\/NCBR\/2015"],"award-info":[{"award-number":["STRATEGMED2\/267398\/4\/NCBR\/2015"]}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,3]]},"DOI":"10.1016\/s2213-8587(18)30336-x","type":"journal-article","created":{"date-parts":[[2019,1,16]],"date-time":"2019-01-16T22:35:22Z","timestamp":1547678122000},"page":"213-220","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":134,"title":["Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study"],"prefix":"10.1016","volume":"7","author":[{"given":"Frederic","family":"Castinetti","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven G","family":"Waguespack","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreas","family":"Machens","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shinya","family":"Uchino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kornelia","family":"Hasse-Lazar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriella","family":"Sanso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tobias","family":"Else","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sarka","family":"Dvorakova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao Ping","family":"Qi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rossella","family":"Elisei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana Luisa","family":"Maia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Glod","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"Delmar Muniz","family":"Louren\u00e7o","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nuria","family":"Valdes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes","family":"Mathiesen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nelson","family":"Wohllk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tushar R","family":"Bandgar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Drui","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Korbonits","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maralyn R","family":"Druce","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caroline","family":"Brain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Kurzawinski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atila","family":"Patocs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Joao","family":"Bugalho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Caron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Fainstein-Day","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Francoise","family":"Borson Chazot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marc","family":"Klein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thera P","family":"Links","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Letizia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Fugazzola","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Olivier","family":"Chabre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Letizia","family":"Canu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Regis","family":"Cohen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Antoine","family":"Tabarin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anita","family":"Spehar Uroic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dominique","family":"Maiter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandrine","family":"Laboureau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Mian","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariola","family":"Peczkowska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frederic","family":"Sebag","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Brue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Delphine","family":"Mirebeau-Prunier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Leclerc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Birke","family":"Bausch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Amandine","family":"Berdelou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akihiro","family":"Sukurai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Petr","family":"Vlcek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jolanta","family":"Krajewska","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Barontini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carla","family":"Vaz Ferreira Vargas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laura","family":"Valerio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lucieli","family":"Ceolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Srivandana","family":"Akshintala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ana","family":"Hoff","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Godballe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara","family":"Jarzab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Camilo","family":"Jimenez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charis","family":"Eng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tsuneo","family":"Imai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schlumberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Grubbs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henning","family":"Dralle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hartmut P","family":"Neumann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric","family":"Baudin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30336-X_bib1","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1073\/pnas.91.4.1579","article-title":"Single missense mutation in the tyrosine kinase catalytic domain of the RET protooncogene is associated with multiple endocrine neoplasia type 2B","volume":"91","author":"Carlson","year":"1994","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(18)30336-X_bib2","doi-asserted-by":"crossref","DOI":"10.1530\/ERC-17-0122","article-title":"Incidence and prevalence of multiple endocrine neoplasia 2B in Denmark: a nationwide study","author":"Mathiesen","year":"2017","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(18)30336-X_bib3","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1093\/hmg\/3.2.237","article-title":"Point mutation within the tyrosine kinase domain of the RET proto-oncogene in multiple endocrine neoplasia type 2B and related sporadic tumours","volume":"3","author":"Eng","year":"1994","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(18)30336-X_bib4","series-title":"GeneReviews","article-title":"Multiple endocrine neoplasia type 2","author":"Marquard","year":"1993"},{"key":"10.1016\/S2213-8587(18)30336-X_bib5","doi-asserted-by":"crossref","first-page":"T29","DOI":"10.1530\/ERC-17-0209","article-title":"A comprehensive review on MEN2B","volume":"25","author":"Castinetti","year":"2018","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(18)30336-X_bib6","doi-asserted-by":"crossref","first-page":"596","DOI":"10.1038\/nrendo.2011.139","article-title":"Management of medullary thyroid carcinoma and MEN2 syndromes in childhood","volume":"7","author":"Waguespack","year":"2011","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(18)30336-X_bib7","first-page":"1017","article-title":"Medullary thyroid carcinoma in multiple endocrine neoplasia types 2A and 2B","volume":"116","author":"O'Riordain","year":"1994","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(18)30336-X_bib8","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1210\/jc.2017-01884","article-title":"Long-term survivorship in multiple endocrine neoplasia type 2b diagnosed before and in the new millennium","volume":"103","author":"Raue","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30336-X_bib9","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1002\/cncr.10205","article-title":"Medullary thyroid carcinoma as part of a multiple endocrine neoplasia type 2B syndrome: influence of the stage on the clinical course","volume":"94","author":"Leboulleux","year":"2002","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(18)30336-X_bib10","doi-asserted-by":"crossref","first-page":"800","DOI":"10.1097\/SLA.0b013e3182a6f43a","article-title":"Surgical curability of medullary thyroid cancer in multiple endocrine neoplasia 2B: a changing perspective","volume":"259","author":"Brauckhoff","year":"2014","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(18)30336-X_bib11","doi-asserted-by":"crossref","first-page":"1044","DOI":"10.1016\/j.surg.2008.08.028","article-title":"Premonitory symptoms preceding metastatic medullary thyroid cancer in MEN 2B: an exploratory analysis","volume":"144","author":"Brauckhoff","year":"2008","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(18)30336-X_bib12","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(18)30336-X_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1245\/s10434-007-9665-4","article-title":"Failure to recognize multiple endocrine neoplasia 2B: more common than we think?","volume":"15","author":"Wray","year":"2008","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/S2213-8587(18)30336-X_bib14","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1001\/jama.1996.03540190047028","article-title":"The relationship between specific RET proto-oncogene mutations and disease phenotype in multiple endocrine neoplasia type 2. International RET mutation consortium analysis","volume":"276","author":"Eng","year":"1996","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(18)30336-X_bib15","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1016\/S0039-6060(05)80097-2","article-title":"Multiple endocrine neoplasia type 2B: more than an endocrine disorder","volume":"118","author":"O'Riordain","year":"1995","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(18)30336-X_bib16","doi-asserted-by":"crossref","first-page":"E1813","DOI":"10.1210\/jc.2013-1653","article-title":"The characterization of pheochromocytoma and its impact on overall survival in multiple endocrine neoplasia type 2","volume":"98","author":"Thosani","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30336-X_bib17","doi-asserted-by":"crossref","first-page":"648","DOI":"10.1016\/S1470-2045(14)70154-8","article-title":"Outcomes of adrenal-sparing surgery or total adrenalectomy in phaeochromocytoma associated with multiple endocrine neoplasia type 2: an international retrospective population-based study","volume":"15","author":"Castinetti","year":"2014","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(18)30336-X_bib18","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1210\/jc.2018-00705","article-title":"Pheochromocytoma in children and adolescents with multiple endocrine neoplasia type 2B","volume":"104","author":"Makri","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30336-X_bib19","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1530\/EJE-12-1106","article-title":"High penetrance of pheochromocytoma in multiple endocrine neoplasia 2 caused by germ line RET codon 634 mutation in Japanese patients","volume":"168","author":"Imai","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(18)30336-X_bib20","doi-asserted-by":"crossref","first-page":"2069","DOI":"10.1210\/jc.2016-3640","article-title":"Risk profile of the RET A883F germline mutation: an international collaborative study","volume":"102","author":"Mathiesen","year":"2017","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871830336X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871830336X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:37Z","timestamp":1761991597000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871830336X"}},"issued":{"date-parts":[[2019,3]]},"references-count":20,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,3]]}},"alternative-id":["S221385871830336X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30336-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Natural history, treatment, and long-term follow up of patients with multiple endocrine neoplasia type 2B: an international, multicentre, retrospective study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30336-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30353-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,22]],"date-time":"2026-10-22T18:39:57Z","timestamp":1792694397618,"version":"4.5.0"},"reference-count":29,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,6,1]],"date-time":"2024-06-01T00:00:00Z","timestamp":1717200000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,6]]},"DOI":"10.1016\/s2213-8587(24)00087-1","type":"journal-article","created":{"date-parts":[[2024,4,30]],"date-time":"2024-04-30T04:05:56Z","timestamp":1714449956000},"page":"380-389","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":77,"title":["Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial"],"prefix":"10.1016","volume":"12","author":[{"given":"Christian L","family":"Roth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cecilia","family":"Scimia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ashley H","family":"Shoemaker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Gottschalk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sonali","family":"Malhotra","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Jennifer","family":"Abuzzahab","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00087-1_bib1","doi-asserted-by":"crossref","first-page":"2586","DOI":"10.1210\/jc.2002-030003","article-title":"Octreotide therapy of pediatric hypothalamic obesity: a double-blind, placebo-controlled trial","volume":"88","author":"Lustig","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00087-1_bib2","doi-asserted-by":"crossref","first-page":"1727","DOI":"10.1002\/oby.22315","article-title":"Hypothalamic obesity: 4 years of the International Registry of Hypothalamic Obesity Disorders","volume":"26","author":"Rose","year":"2018","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(24)00087-1_bib3","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1159\/000509616","article-title":"Diagnosis, background, and treatment of hypothalamic damage in craniopharyngioma","volume":"110","author":"Erfurth","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(24)00087-1_bib4","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1159\/000496564","article-title":"Hypothalamic obesity: prologue and promise","volume":"91","author":"Abuzzahab","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(24)00087-1_bib5","doi-asserted-by":"crossref","first-page":"24","DOI":"10.1038\/s41572-022-00351-z","article-title":"Hypothalamic syndrome","volume":"8","author":"M\u00fcller","year":"2022","journal-title":"Nat Rev Dis Primers"},{"key":"10.1016\/S2213-8587(24)00087-1_bib6","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.846880","article-title":"Treatment of acquired hypothalamic obesity: now and the future","volume":"13","author":"Dimitri","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(24)00087-1_bib7","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1111\/dom.14224","article-title":"A phase 3 randomized clinical trial using a once-weekly glucagon-like peptide-1 receptor agonist in adolescents and young adults with hypothalamic obesity","volume":"23","author":"Roth","year":"2021","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00087-1_bib8","doi-asserted-by":"crossref","first-page":"5227","DOI":"10.1210\/jc.2002-021797","article-title":"Obesity in patients with craniopharyngioma: assessment of food intake and movement counts indicating physical activity","volume":"88","author":"Harz","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00087-1_bib9","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1530\/eje.0.1380089","article-title":"Hyperphagia in children with craniopharyngioma is associated with hyperleptinaemia and a failure in the downregulation of appetite","volume":"138","author":"Roth","year":"1998","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00087-1_bib10","doi-asserted-by":"crossref","DOI":"10.1155\/2011\/417949","article-title":"Hypothalamic obesity following craniopharyngioma surgery: results of a pilot trial of combined diazoxide and metformin therapy","volume":"2011","author":"Hamilton","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.1016\/S2213-8587(24)00087-1_bib11","doi-asserted-by":"crossref","first-page":"697","DOI":"10.4158\/EP.14.6.697","article-title":"Treatment of hypothalamic obesity with caffeine and ephedrine","volume":"14","author":"Greenway","year":"2008","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(24)00087-1_bib12","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.molmed.2018.12.002","article-title":"Melanocortin-4 receptor signalling: importance for weight regulation and obesity treatment","volume":"25","author":"K\u00fchnen","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/S2213-8587(24)00087-1_bib13","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1016\/j.cell.2012.12.022","article-title":"Melanocortin 4 receptors reciprocally regulate sympathetic and parasympathetic preganglionic neurons","volume":"152","author":"Sohn","year":"2013","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(24)00087-1_bib14","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.7717\/peerj.856","article-title":"Obesity genetics in mouse and human: back and forth, and back again","volume":"3","author":"Yazdi","year":"2015","journal-title":"PeerJ"},{"key":"10.1016\/S2213-8587(24)00087-1_bib15","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1203\/pdr.0b013e3180332cd6","article-title":"Reduced sympathetic metabolites in urine of obese patients with craniopharyngioma","volume":"61","author":"Roth","year":"2007","journal-title":"Pediatr Res"},{"key":"10.1016\/S2213-8587(24)00087-1_bib16","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.metabol.2009.06.031","article-title":"Changes of peripheral alpha-melanocyte-stimulating hormone in childhood obesity","volume":"59","author":"Roth","year":"2010","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(24)00087-1_bib17","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1002\/oby.23087","article-title":"Alpha-melanocyte-stimulating hormone is elevated in hypothalamic obesity associated with childhood craniopharyngioma","volume":"29","author":"Emet","year":"2021","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(24)00087-1_bib18","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1016\/S2213-8587(22)00277-7","article-title":"Efficacy and safety of setmelanotide, a melanocortin-4 receptor agonist, in patients with Bardet-Biedl syndrome and Alstr\u00f6m syndrome: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial with an open-label period","volume":"10","author":"Haqq","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00087-1_bib19","doi-asserted-by":"crossref","first-page":"2133","DOI":"10.1111\/dom.14133","article-title":"Effect of setmelanotide, a melanocortin-4 receptor agonist, on obesity in Bardet-Biedl syndrome","volume":"22","author":"Haws","year":"2020","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(24)00087-1_bib20","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1021\/acschemneuro.8b00346","article-title":"Insights into the allosteric mechanism of setmelanotide (RM-493) as a potent and first-in-class melanocortin-4 receptor (MC4R) agonist to treat rare genetic disorders of obesity through an in silico approach","volume":"10","author":"Falls","year":"2019","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/S2213-8587(24)00087-1_bib21","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1016\/j.molmet.2017.06.015","article-title":"Evaluation of a melanocortin-4 receptor (MC4R) agonist (Setmelanotide) in MC4R deficiency","volume":"6","author":"Collet","year":"2017","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(24)00087-1_bib22","doi-asserted-by":"crossref","first-page":"960","DOI":"10.1016\/S2213-8587(20)30364-8","article-title":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","volume":"8","author":"Cl\u00e9ment","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00087-1_bib23","doi-asserted-by":"crossref","first-page":"1018","DOI":"10.1016\/j.cmet.2014.10.004","article-title":"The melanocortin-4 receptor is expressed in enteroendocrine L cells and regulates the release of peptide YY and glucagon-like peptide 1 in vivo","volume":"20","author":"Panaro","year":"2014","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(24)00087-1_bib24","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1210\/en.2006-1389","article-title":"Role of the central melanocortin circuitry in adaptive thermogenesis of brown adipose tissue","volume":"148","author":"Voss-Andreae","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(24)00087-1_bib25","doi-asserted-by":"crossref","first-page":"3171","DOI":"10.1210\/jc.2016-1885","article-title":"Which amount of BMI-SDS reduction is necessary to improve cardiovascular risk factors in overweight children?","volume":"101","author":"Reinehr","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00087-1_bib26","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1210\/jc.2014-3415","article-title":"Pharmacological management of obesity: an Endocrine Society clinical practice guideline","volume":"100","author":"Apovian","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00087-1_bib27","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27358","article-title":"Probability of 5% or greater weight loss or BMI reduction to healthy weight among adults with overweight or obesity","volume":"6","author":"Kompaniyets","year":"2023","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(24)00087-1_bib28","doi-asserted-by":"crossref","first-page":"4101","DOI":"10.1210\/jc.2007-0826","article-title":"Impact sibutramine therapy in children with hypothalamic obesity or obesity with aggravating syndromes","volume":"92","author":"Danielsson","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00087-1_bib29","article-title":"Semaglutide for treating obesity induced by craniopharyngioma resection: a successful case study","volume":"1","author":"Sciacovelli","year":"2023","journal-title":"JCEM Case Rep"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000871?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724000871?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,5,23]],"date-time":"2024-05-23T05:28:51Z","timestamp":1716442131000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724000871"}},"issued":{"date-parts":[[2024,6]]},"references-count":29,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2024,6]]}},"alternative-id":["S2213858724000871"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00087-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Setmelanotide for the treatment of acquired hypothalamic obesity: a phase 2, open-label, multicentre trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00087-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00109-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T03:04:24Z","timestamp":1792551864030,"version":"4.5.0"},"reference-count":4,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,8,1]],"date-time":"2023-08-01T00:00:00Z","timestamp":1690848000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,8]]},"DOI":"10.1016\/s2213-8587(23)00173-0","type":"journal-article","created":{"date-parts":[[2023,7,3]],"date-time":"2023-07-03T19:15:06Z","timestamp":1688411706000},"page":"527-529","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Patient-reported outcome measures after metabolic surgery"],"prefix":"10.1016","volume":"11","author":[{"given":"Geltrude","family":"Mingrone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lidia","family":"Castagneto-Gissey","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan R","family":"Bornstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00173-0_bib1","first-page":"1066","article-title":"Report CMaMW. Prevalence of overweight and obesity among adults with diagnosed diabetes\u2014United States, 1988\u20131994 and 1999\u20132002","volume":"53","year":"2004","journal-title":"Morb Mortal Wkly Rep"},{"key":"10.1016\/S2213-8587(23)00173-0_bib2","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1056\/NEJMoa2107519","article-title":"Tirzepatide versus semaglutide once weekly in patients with type 2 diabetes","volume":"385","author":"Fr\u00edas","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00173-0_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(23)00127-4","article-title":"Patient-reported outcomes, weight loss, and remission of type 2 diabetes 3 years after gastric bypass and sleeve gastrectomy (Oseberg); a single-centre, randomised controlled trial","author":"Svanevik","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00173-0_bib4","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/S0140-6736(23)00634-7","article-title":"Bariatric-metabolic surgery versus lifestyle intervention plus best medical care in non-alcoholic steatohepatitis (BRAVES): a multicentre, open-label, randomised trial","volume":"401","author":"Verrastro","year":"2023","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723001730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:13:07Z","timestamp":1761991987000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723001730"}},"issued":{"date-parts":[[2023,8]]},"references-count":4,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2023,8]]}},"alternative-id":["S2213858723001730"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00173-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Patient-reported outcome measures after metabolic surgery","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00173-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00127-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T11:42:24Z","timestamp":1791978144600,"version":"4.4.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,12,1]],"date-time":"2023-12-01T00:00:00Z","timestamp":1701388800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,12]]},"DOI":"10.1016\/s2213-8587(23)00286-3","type":"journal-article","created":{"date-parts":[[2023,10,19]],"date-time":"2023-10-19T18:30:00Z","timestamp":1697740200000},"page":"883-884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["Glycaemic fluctuations across the menstrual cycle: possible effect of the brain"],"prefix":"10.1016","volume":"11","author":[{"given":"Julia","family":"Hummel","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Kullmann","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R\u00f3bert","family":"Wagner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Heni","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00286-3_bib1","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1210\/er.2015-1137","article-title":"Sex and gender differences in risk, pathophysiology and complications of type 2 diabetes mellitus","volume":"37","author":"Kautzky-Willer","year":"2016","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(23)00286-3_bib2","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1038\/s41574-022-00708-0","article-title":"The interplay between diabetes mellitus and menopause: clinical implications","volume":"18","author":"Lambrinoudaki","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(23)00286-3_bib3","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1038\/s41746-023-00884-x","article-title":"Blood glucose variance measured by continuous glucose monitors across the menstrual cycle","volume":"6","author":"Lin","year":"2023","journal-title":"NPJ Digit Med"},{"key":"10.1016\/S2213-8587(23)00286-3_bib4","doi-asserted-by":"crossref","first-page":"524","DOI":"10.1016\/S2213-8587(20)30113-3","article-title":"Central nervous pathways of insulin action in the control of metabolism and food intake","volume":"8","author":"Kullmann","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(23)00286-3_bib5","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1159\/000504551","article-title":"Insulin action in the hypothalamus increases second-phase insulin secretion in humans","volume":"110","author":"Heni","year":"2020","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(23)00286-3_bib6","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1038\/s42255-023-00869-w","article-title":"Brain insulin action on peripheral insulin sensitivity in women depends on menstrual cycle phase","volume":"5","author":"Hummel","year":"2023","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(23)00286-3_bib7","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1001\/archinte.164.19.2147","article-title":"Is nondiabetic hyperglycemia a risk factor for cardiovascular disease? A meta-analysis of prospective studies","volume":"164","author":"Levitan","year":"2004","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(23)00286-3_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2020-002032","article-title":"Glycemic variability and cardiovascular disease in patients with type 2 diabetes","volume":"9","author":"Martinez","year":"2021","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(23)00286-3_bib9","doi-asserted-by":"crossref","first-page":"144","DOI":"10.1186\/s12933-020-01134-0","article-title":"Glucose variability and the risks of stroke, myocardial infarction, and all-cause mortality in individuals with diabetes: retrospective cohort study","volume":"19","author":"Lee","year":"2020","journal-title":"Cardiovasc Diabetol"},{"key":"10.1016\/S2213-8587(23)00286-3_bib10","doi-asserted-by":"crossref","first-page":"2793","DOI":"10.1210\/clinem\/dgac443","article-title":"Ambulatory glucose profile according to different phases of the menstrual cycle in women living with type 1 diabetes","volume":"107","author":"Tatulashvili","year":"2022","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002863?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723002863?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:14:08Z","timestamp":1761992048000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723002863"}},"issued":{"date-parts":[[2023,12]]},"references-count":10,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2023,12]]}},"alternative-id":["S2213858723002863"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00286-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Glycaemic fluctuations across the menstrual cycle: possible effect of the brain","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00286-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2023 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,14]],"date-time":"2026-10-14T12:53:52Z","timestamp":1791982432512,"version":"4.4.0"},"reference-count":150,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,5,1]],"date-time":"2021-05-01T00:00:00Z","timestamp":1619827200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,5]]},"DOI":"10.1016\/s2213-8587(21)00054-1","type":"journal-article","created":{"date-parts":[[2021,4,15]],"date-time":"2021-04-15T11:23:11Z","timestamp":1618485791000},"page":"304-317","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":25,"title":["Post-exercise recovery for the endurance athlete with type 1 diabetes: a consensus statement"],"prefix":"10.1016","volume":"9","author":[{"given":"Sam N","family":"Scott","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Federico Y","family":"Fontana","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matt","family":"Cocks","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James P","family":"Morton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Asker","family":"Jeukendrup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Radu","family":"Dragulin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen F P","family":"Wojtaszewski","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J\u00f8rgen","family":"Jensen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rafael","family":"Castol","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael C","family":"Riddell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christoph","family":"Stettler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00054-1_bib1","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1016\/S2213-8587(17)30014-1","article-title":"Exercise management in type 1 diabetes: a consensus statement","volume":"5","author":"Riddell","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib2","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.2337\/dc19-2302","article-title":"Evaluation of factors related to glycemic management in professional cyclists with type 1 diabetes over a 7-day stage race","volume":"43","author":"Scott","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib3","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1016\/j.wem.2017.04.005","article-title":"Glycemic control and muscle damage in 3 athletes with type 1 diabetes during a successful performance in a relay ultramarathon: a case report","volume":"28","author":"Belli","year":"2017","journal-title":"Wilderness Environ Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1123\/ijsnem.20.6.515","article-title":"Nutritional strategies to promote postexercise recovery","volume":"20","author":"Beelen","year":"2010","journal-title":"Int J Sport Nutr Exerc Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib5","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1007\/s00125-020-05183-8","article-title":"The competitive athlete with type 1 diabetes","volume":"63","author":"Riddell","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00054-1_bib6","doi-asserted-by":"crossref","first-page":"501","DOI":"10.1016\/j.jand.2015.12.006","article-title":"Position of the Academy of Nutrition and Dietetics, Dietitians of Canada, and the American College of Sports Medicine: nutrition and athletic performance","volume":"116","author":"Thomas","year":"2016","journal-title":"J Acad Nutr Diet"},{"key":"10.1016\/S2213-8587(21)00054-1_bib7","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1186\/s12970-017-0189-4","article-title":"International society of sports nutrition position stand: nutrient timing","volume":"14","author":"Kerksick","year":"2017","journal-title":"J Int Soc Sports Nutr"},{"key":"10.1016\/S2213-8587(21)00054-1_bib8","doi-asserted-by":"crossref","first-page":"1775","DOI":"10.2337\/diab.46.11.1775","article-title":"Insulin signaling in human skeletal muscle: time course and effect of exercise","volume":"46","author":"Wojtaszewski","year":"1997","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00054-1_bib9","doi-asserted-by":"crossref","first-page":"244","DOI":"10.4158\/EP09260.CR","article-title":"Confirmation of hypoglycemia in the \u201cdead-in-bed\u201d syndrome, as captured by a retrospective continuous glucose monitoring system","volume":"16","author":"Tanenberg","year":"2010","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(21)00054-1_bib10","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1123\/ijspp.2017-0759","article-title":"Recovery and performance in sport: consensus statement","volume":"13","author":"Kellmann","year":"2018","journal-title":"Int J Sports Physiol Perform"},{"key":"10.1016\/S2213-8587(21)00054-1_bib11","doi-asserted-by":"crossref","first-page":"584","DOI":"10.2337\/diacare.10.5.584","article-title":"Postexercise late-onset hypoglycemia in insulin-dependent diabetic patients","volume":"10","author":"MacDonald","year":"1987","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/j.jcjd.2020.09.007","article-title":"Fasting may alter blood glucose responses to high-intensity interval exercise in adults with type 1 diabetes: a randomized, acute crossover study","volume":"44","author":"Yardley","year":"2020","journal-title":"Can J Diabetes"},{"key":"10.1016\/S2213-8587(21)00054-1_bib13","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1089\/dia.2012.0168","article-title":"Insulin pump therapy is associated with less post-exercise hyperglycemia than multiple daily injections: an observational study of physically active type 1 diabetes patients","volume":"15","author":"Yardley","year":"2013","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(21)00054-1_bib14","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/S2213-8587(20)30114-5","volume":"8","author":"Aronson","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib15","doi-asserted-by":"crossref","first-page":"10","DOI":"10.2337\/dc18-1475","article-title":"Optimal insulin correction factor in post-high-intensity exercise hyperglycemia in adults with type 1 diabetes: the FIT study","volume":"42","author":"Aronson","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib16","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1111\/j.1469-7793.2001.00295.x","article-title":"The effects of increasing exercise intensity on muscle fuel utilisation in humans","volume":"536","author":"van Loon","year":"2001","journal-title":"J Physiol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib17","doi-asserted-by":"crossref","first-page":"1066","DOI":"10.2337\/diab.44.9.1066","article-title":"Lipid and carbohydrate metabolism in IDDM during moderate and intense exercise","volume":"44","author":"Raguso","year":"1995","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00054-1_bib18","doi-asserted-by":"crossref","first-page":"1457","DOI":"10.1007\/s00125-008-1045-5","article-title":"Fuel metabolism during exercise in euglycaemia and hyperglycaemia in patients with type 1 diabetes mellitus--a prospective single-blinded randomised crossover trial","volume":"51","author":"Jenni","year":"2008","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00054-1_bib19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1002\/dmrr.608","article-title":"Exercise capacity in subjects with type 1 diabetes mellitus in eu- and hyperglycaemia","volume":"22","author":"Stettler","year":"2006","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(21)00054-1_bib20","doi-asserted-by":"crossref","first-page":"414","DOI":"10.1007\/s00125-006-0520-0","article-title":"Exercise under hyperinsulinaemic conditions increases whole-body glucose disposal without affecting muscle glycogen utilisation in type 1 diabetes","volume":"50","author":"Chokkalingam","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00054-1_bib21","doi-asserted-by":"crossref","first-page":"1921","DOI":"10.1007\/s00125-007-0747-4","article-title":"Hyperinsulinaemia during exercise does not suppress hepatic glycogen concentrations in patients with type 1 diabetes: a magnetic resonance spectroscopy study","volume":"50","author":"Chokkalingam","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00054-1_bib22","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.2337\/dc20-0611","article-title":"Hyperglycemia but not hyperinsulinemia is favorable for exercise in type 1 diabetes: a pilot study","volume":"43","author":"Romeres","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib23","first-page":"e332","article-title":"Utilization of skeletal muscle triacylglycerol during postexercise recovery in humans","volume":"275","author":"Kiens","year":"1998","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib24","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1093\/ajcn\/42.1.69","article-title":"Energy metabolism during the postexercise recovery in man","volume":"42","author":"Bielinski","year":"1985","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00054-1_bib25","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1016\/j.cmet.2012.12.012","article-title":"Exercise metabolism and the molecular regulation of skeletal muscle adaptation","volume":"17","author":"Egan","year":"2013","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib26","doi-asserted-by":"crossref","first-page":"e65","DOI":"10.1152\/ajpendo.2000.278.1.E65","article-title":"Effect of carbohydrate ingestion on glycogen resynthesis in human liver and skeletal muscle, measured by (13)C MRS","volume":"278","author":"Casey","year":"2000","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib27","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1249\/MSS.0000000000000737","article-title":"Impact of muscle glycogen availability on the capacity for repeated exercise in man","volume":"48","author":"Alghannam","year":"2016","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(21)00054-1_bib28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3109\/00365516709090629","article-title":"A study of the glycogen metabolism during exercise in man","volume":"19","author":"Bergstr\u00f6m","year":"1967","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/S2213-8587(21)00054-1_bib29","doi-asserted-by":"crossref","first-page":"E1304","DOI":"10.1152\/ajpendo.00209.2003","article-title":"Effects of depletion exercise and light training on muscle glycogen supercompensation in men","volume":"285","author":"Goforth","year":"2003","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib30","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/00365517709092634","article-title":"Synthesis of muscle glycogen during recovery after prolonged severe exercise in diabetic and non-diabetic subjects","volume":"37","author":"Maehlum","year":"1977","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/S2213-8587(21)00054-1_bib31","first-page":"e509","article-title":"Role of insulin during exercise-induced glycogenesis in muscle: effect on cyclic AMP","volume":"233","author":"Ivy","year":"1977","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib32","doi-asserted-by":"crossref","first-page":"2187","DOI":"10.1152\/jappl.1995.78.6.2187","article-title":"Effect of coingestion of fat and protein with carbohydrate feedings on muscle glycogen storage","volume":"78","author":"Burke","year":"1995","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib33","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.1093\/ajcn\/34.9.1831","article-title":"The role of dietary carbohydrates in muscle glycogen resynthesis after strenuous running","volume":"34","author":"Costill","year":"1981","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00054-1_bib34","series-title":"The Encyclopaedia of Sports Medicine: an IOC Medical Commission Publication","first-page":"113","article-title":"The regulation and synthesis of muscle glycogen by means of nutrient intervention","author":"Ivy","year":"2013"},{"key":"10.1016\/S2213-8587(21)00054-1_bib35","doi-asserted-by":"crossref","first-page":"e298","DOI":"10.3390\/nu10030298","article-title":"Regulation of muscle glycogen metabolism during exercise: implications for endurance performance and training adaptations","volume":"10","author":"Hearris","year":"2018","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(21)00054-1_bib36","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1152\/japplphysiol.00817.2019","article-title":"Coingestion of protein and carbohydrate in the early recovery phase, compared with carbohydrate only, improves endurance performance despite similar glycogen degradation and AMPK phosphorylation","volume":"129","author":"Dahl","year":"2020","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib37","first-page":"97","article-title":"Optimization of glycogen stores","volume":"7","author":"Ivy","year":"2000","journal-title":"Nutrition in Sport"},{"key":"10.1016\/S2213-8587(21)00054-1_bib38","doi-asserted-by":"crossref","first-page":"117","DOI":"10.2165\/00007256-200333020-00004","article-title":"Determinants of post-exercise glycogen synthesis during short-term recovery","volume":"33","author":"Jentjens","year":"2003","journal-title":"Sports Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib39","first-page":"E197","article-title":"Exercise-induced increase in glucose transport, GLUT-4, and VAMP-2 in plasma membrane from human muscle","volume":"270","author":"Kristiansen","year":"1996","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib40","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.2337\/diabetes.48.5.1192","article-title":"Acute exercise induces GLUT4 translocation in skeletal muscle of normal human subjects and subjects with type 2 diabetes","volume":"48","author":"Kennedy","year":"1999","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00054-1_bib41","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1152\/jappl.1988.65.5.2018","article-title":"Muscle glycogen storage after different amounts of carbohydrate ingestion","volume":"65","author":"Ivy","year":"1988","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib42","doi-asserted-by":"crossref","first-page":"423","DOI":"10.1113\/jphysiol.1991.sp018478","article-title":"Substrates for muscle glycogen synthesis in recovery from intense exercise in man","volume":"434","author":"Bangsbo","year":"1991","journal-title":"J Physiol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib43","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1046\/j.1365-201X.1998.0302e.x","article-title":"Regulation of GLUT4 protein and glycogen synthase during muscle glycogen synthesis after exercise","volume":"162","author":"Ivy","year":"1998","journal-title":"Acta Physiol Scand"},{"key":"10.1016\/S2213-8587(21)00054-1_bib44","doi-asserted-by":"crossref","first-page":"349","DOI":"10.3109\/00365517809108433","article-title":"Muscle glycogen synthesis after a glucose infusion during post-exercise recovery in diabetic and non-diabetic subjects","volume":"38","author":"Maehlum","year":"1978","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/S2213-8587(21)00054-1_bib45","doi-asserted-by":"crossref","first-page":"35","DOI":"10.3109\/00365517809108400","article-title":"Synthesis of muscle glycogen during recovery after prolonged severe exercise in diabetic subjects. Effect of insulin deprivation","volume":"38","author":"Maehlum","year":"1978","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/S2213-8587(21)00054-1_bib46","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1152\/jappl.1994.76.1.104","article-title":"Human muscle glycogen resynthesis after exercise: insulin-dependent and -independent phases","volume":"76","author":"Price","year":"1994","journal-title":"J Appl Physiol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib47","doi-asserted-by":"crossref","first-page":"1107","DOI":"10.2337\/diabetes.47.7.1107","article-title":"Regulation of skeletal muscle hexokinase II by insulin in nondiabetic and NIDDM subjects","volume":"47","author":"Kruszynska","year":"1998","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00054-1_bib48","doi-asserted-by":"crossref","first-page":"847","DOI":"10.2337\/db08-1539","article-title":"Kinetics of GLUT4 trafficking in rat and human skeletal muscle","volume":"58","author":"Karlsson","year":"2009","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00054-1_bib49","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1172\/JCI113069","article-title":"Regulation of glycogen synthase and phosphorylase activities by glucose and insulin in human skeletal muscle","volume":"80","author":"Yki-J\u00e4rvinen","year":"1987","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(21)00054-1_bib50","doi-asserted-by":"crossref","first-page":"6","DOI":"10.2165\/00007256-199111010-00002","article-title":"Muscle glycogen synthesis before and after exercise","volume":"11","author":"Ivy","year":"1991","journal-title":"Sports Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib51","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2337\/diacare.26.4.1316","article-title":"Glucose response to intense aerobic exercise in type 1 diabetes: maintenance of near euglycemia despite a drastic decrease in insulin dose","volume":"26","author":"Mauvais-Jarvis","year":"2003","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib52","doi-asserted-by":"crossref","first-page":"309","DOI":"10.3109\/00365517709092634","article-title":"Synthesis of muscle glycogen during recovery after prolonged severe exercise in diabetic and non-diabetic subjects","volume":"37","author":"Maehlum","year":"1977","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/S2213-8587(21)00054-1_bib53","doi-asserted-by":"crossref","first-page":"77","DOI":"10.3109\/00365517209081094","article-title":"Muscle glycogen and glycogen synthetase in normal subjects and in patients with diabetes mellitus. Effect of intravenous glucose and insulin administration","volume":"30","author":"Roch-Norlund","year":"1972","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/S2213-8587(21)00054-1_bib54","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1038\/210309a0","article-title":"Muscle glycogen synthesis after exercise: an enhancing factor localized to the muscle cells in man","volume":"210","author":"Bergstr\u00f6m","year":"1966","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(21)00054-1_bib55","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1073\/pnas.86.5.1439","article-title":"Natural-abundance 13C NMR study of glycogen repletion in human liver and muscle","volume":"86","author":"Jue","year":"1989","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(21)00054-1_bib56","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1152\/japplphysiol.01023.2015","article-title":"Sucrose ingestion after exhaustive exercise accelerates liver, but not muscle glycogen repletion compared with glucose ingestion in trained athletes","volume":"120","author":"Fuchs","year":"2016","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib57","doi-asserted-by":"crossref","first-page":"1964","DOI":"10.1249\/MSS.0b013e318218ca5a","article-title":"Fructose and galactose enhance postexercise human liver glycogen synthesis","volume":"43","author":"D\u00e9combaz","year":"2011","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(21)00054-1_bib58","doi-asserted-by":"crossref","first-page":"e1","DOI":"10.1016\/j.diabres.2015.05.002","article-title":"Hepatic and intramyocellular glycogen stores in adults with type 1 diabetes and healthy controls","volume":"109","author":"Bally","year":"2015","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(21)00054-1_bib59","doi-asserted-by":"crossref","DOI":"10.3390\/nu11123017","article-title":"Carbohydrate intake in the context of exercise in people with type 1 diabetes","volume":"11","author":"Scott","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(21)00054-1_bib60","doi-asserted-by":"crossref","first-page":"674","DOI":"10.3389\/fendo.2018.00674","article-title":"Could age, sex and physical fitness affect blood glucose responses to exercise in type 1 diabetes?","volume":"9","author":"Yardley","year":"2018","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib61","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1080\/02640410500482727","article-title":"Promoting training adaptations through nutritional interventions","volume":"24","author":"Hawley","year":"2006","journal-title":"J Sports Sci"},{"key":"10.1016\/S2213-8587(21)00054-1_bib62","doi-asserted-by":"crossref","first-page":"2501","DOI":"10.1007\/s00125-020-05263-9","volume":"63","author":"Moser","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00054-1_bib65","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1249\/00005768-198710000-00012","article-title":"Effect of different post-exercise sugar diets on the rate of muscle glycogen synthesis","volume":"19","author":"Blom","year":"1987","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(21)00054-1_bib66","doi-asserted-by":"crossref","DOI":"10.3390\/nu11051022","article-title":"Carbohydrate restriction in type 1 diabetes: a realistic therapy for improved glycaemic control and athletic performance?","volume":"11","author":"Scott","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(21)00054-1_bib67","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1111\/j.1399-5448.2009.00558.x","article-title":"The effectiveness of glucose, sucrose, and fructose in treating hypoglycemia in children with type 1 diabetes","volume":"11","author":"Husband","year":"2010","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(21)00054-1_bib68","doi-asserted-by":"crossref","first-page":"e164","DOI":"10.3390\/nu9020164","article-title":"Metabolic effects of glucose-fructose co-ingestion compared to glucose alone during exercise in type 1 diabetes","volume":"9","author":"Bally","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(21)00054-1_bib69","doi-asserted-by":"crossref","first-page":"2010","DOI":"10.2337\/dc19-2250","article-title":"A single load of fructose attenuates the risk of exercise-induced hypoglycemia in adults with type 1 diabetes on ultra-long-acting basal insulin: a randomized, open-label, crossover proof-of-principle study","volume":"43","author":"Kosinski","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib70","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1093\/ajcn\/72.1.106","article-title":"Maximizing postexercise muscle glycogen synthesis: carbohydrate supplementation and the application of amino acid or protein hydrolysate mixtures","volume":"72","author":"van Loon","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(21)00054-1_bib71","doi-asserted-by":"crossref","first-page":"1394","DOI":"10.1152\/japplphysiol.90333.2008","article-title":"Coingestion of protein with carbohydrate during recovery from endurance exercise stimulates skeletal muscle protein synthesis in humans","volume":"106","author":"Howarth","year":"2009","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib72","doi-asserted-by":"crossref","first-page":"1337","DOI":"10.1152\/japplphysiol.00394.2002","article-title":"Early postexercise muscle glycogen recovery is enhanced with a carbohydrate-protein supplement","volume":"93","author":"Ivy","year":"2002","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib73","doi-asserted-by":"crossref","DOI":"10.1152\/japplphysiol.01132.2017","article-title":"Protein intake in the early recovery period after exhaustive exercise improves performance the following day","author":"Sollie","year":"2018","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib74","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0153229","article-title":"Intake of protein plus carbohydrate during the first two hours after exhaustive cycling improves performance the following day","volume":"11","author":"Rustad","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00054-1_bib75","doi-asserted-by":"crossref","first-page":"1087","DOI":"10.1007\/s00125-019-4858-5","article-title":"Impaired whole-body heat loss in type 1 diabetes during exercise in the heat: a cause for concern?","volume":"62","author":"Notley","year":"2019","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00054-1_bib76","doi-asserted-by":"crossref","first-page":"2224","DOI":"10.1249\/MSS.0000000000000350","article-title":"Impairments in local heat loss in type 1 diabetes during exercise in the heat","volume":"46","author":"Carter","year":"2014","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(21)00054-1_bib77","doi-asserted-by":"crossref","first-page":"1152","DOI":"10.1152\/jappl.1997.83.4.1152","article-title":"Restoration of fluid balance after exercise-induced dehydration: effects of alcohol consumption","volume":"83","author":"Shirreffs","year":"1997","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib78","doi-asserted-by":"crossref","first-page":"1888","DOI":"10.2337\/diacare.24.11.1888","article-title":"The effect of evening alcohol consumption on next-morning glucose control in type 1 diabetes","volume":"24","author":"Turner","year":"2001","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib79","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1002\/dmrr.482","article-title":"Severe hypoglycaemia in 1076 adult patients with type 1 diabetes: influence of risk markers and selection","volume":"20","author":"Pedersen-Bjergaard","year":"2004","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(21)00054-1_bib80","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.2337\/diabetes.50.10.2349","article-title":"Caffeine ingestion decreases glucose disposal during a hyperinsulinemic-euglycemic clamp in sedentary humans","volume":"50","author":"Greer","year":"2001","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00054-1_bib81","doi-asserted-by":"crossref","first-page":"488","DOI":"10.1111\/dme.12857","article-title":"Effects of acute caffeine supplementation on reducing exercise-associated hypoglycaemia in individuals with type 1 diabetes mellitus","volume":"33","author":"Zaharieva","year":"2016","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib82","doi-asserted-by":"crossref","first-page":"950","DOI":"10.1123\/ijspp.2014-0565","article-title":"Sleep and recovery in team sport: current sleep-related issues facing professional team-sport athletes","volume":"10","author":"Fullagar","year":"2015","journal-title":"Int J Sports Physiol Perform"},{"key":"10.1016\/S2213-8587(21)00054-1_bib83","doi-asserted-by":"crossref","first-page":"3897","DOI":"10.2337\/dc13-1195","article-title":"Both dietary protein and fat increase postprandial glucose excursions in children with type 1 diabetes, and the effect is additive","volume":"36","author":"Smart","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib84","doi-asserted-by":"crossref","first-page":"59","DOI":"10.2337\/dc19-0687","article-title":"Amount and type of dietary fat, postprandial glycemia, and insulin requirements in type 1 diabetes: a randomized within-subject trial","volume":"43","author":"Bell","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib85","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S2213-8587(17)30001-3","article-title":"Day-and-night glycaemic control with closed-loop insulin delivery versus conventional insulin pump therapy in free-living adults with well controlled type 1 diabetes: an open-label, randomised, crossover study","volume":"5","author":"Bally","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib86","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1152\/jappl.1989.66.2.720","article-title":"Muscle glycogen storage postexercise: effect of mode of carbohydrate administration","volume":"66","author":"Reed","year":"1989","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib87","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1152\/jappl.2000.88.5.1529","article-title":"Effect of different carbohydrate drinks on whole body carbohydrate storage after exhaustive exercise","volume":"88","author":"Bowtell","year":"2000","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib88","doi-asserted-by":"crossref","first-page":"e344","DOI":"10.3390\/nu9040344","article-title":"Glucose plus fructose ingestion for post-exercise recovery-greater than the sum of its parts?","volume":"9","author":"Gonzalez","year":"2017","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(21)00054-1_bib89","doi-asserted-by":"crossref","first-page":"e543","DOI":"10.1152\/ajpendo.00232.2016","article-title":"Liver glycogen metabolism during and after prolonged endurance-type exercise","volume":"311","author":"Gonzalez","year":"2016","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib90","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/s40279-013-0028-y","article-title":"What do athletes drink during competitive sporting activities?","volume":"43","author":"Garth","year":"2013","journal-title":"Sports Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib91","doi-asserted-by":"crossref","first-page":"1656","DOI":"10.1249\/MSS.0b013e31829002f3","article-title":"Whole-body heat loss during exercise in the heat is not impaired in type 1 diabetes","volume":"45","author":"Stapleton","year":"2013","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(21)00054-1_bib92","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0031-9384(83)90044-6","article-title":"Water intake, pleasure and water temperature in humans","volume":"30","author":"Boulze","year":"1983","journal-title":"Physiol Behav"},{"key":"10.1016\/S2213-8587(21)00054-1_bib93","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1159\/000489823","article-title":"Fluid intake habits in type 1 diabetes individuals during typical training bouts","volume":"73","author":"Buoite Stella","year":"2018","journal-title":"Ann Nutr Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib94","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/BF00252403","article-title":"Variations in renal threshold for glucose in type 1 (insulin-dependent) diabetes mellitus","volume":"26","author":"Johansen","year":"1984","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00054-1_bib95","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1172\/JCI105456","article-title":"Stimulation of insulin secretion by amino acids","volume":"45","author":"Floyd","year":"1966","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(21)00054-1_bib96","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1016\/S0140-6736(66)92767-X","article-title":"Patterns of hormonal release after glucose, protein, and glucose plus protein","volume":"2","author":"Rabinowitz","year":"1966","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00054-1_bib97","doi-asserted-by":"crossref","first-page":"109","DOI":"10.2337\/diab.19.2.109","article-title":"Synergistic effect of essential amino acids and glucose upon insulin secretion in man","volume":"19","author":"Floyd","year":"1970","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(21)00054-1_bib98","doi-asserted-by":"crossref","first-page":"1854","DOI":"10.1152\/jappl.1992.72.5.1854","article-title":"Carbohydrate-protein complex increases the rate of muscle glycogen storage after exercise","volume":"72","author":"Zawadzki","year":"1992","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib99","doi-asserted-by":"crossref","first-page":"839","DOI":"10.1152\/jappl.2001.91.2.839","article-title":"Addition of protein and amino acids to carbohydrates does not enhance postexercise muscle glycogen synthesis","volume":"91","author":"Jentjens","year":"2001","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib100","doi-asserted-by":"crossref","first-page":"559","DOI":"10.1139\/y01-026","article-title":"Caffeine ingestion elevates plasma insulin response in humans during an oral glucose tolerance test","volume":"79","author":"Graham","year":"2001","journal-title":"Can J Physiol Pharmacol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib101","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0161375","article-title":"The effects of caffeine supplementation on physiological responses to submaximal exercise in endurance-trained men","volume":"11","author":"Glaister","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00054-1_bib102","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1249\/MSS.0b013e3182967948","article-title":"Caffeine increases performance in cross-country double-poling time trial exercise","volume":"45","author":"Stadheim","year":"2013","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(21)00054-1_bib104","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1139\/apnm-2012-0471","article-title":"Caffeine and glucose homeostasis during rest and exercise in diabetes mellitus","volume":"38","author":"Zaharieva","year":"2013","journal-title":"Appl Physiol Nutr Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib105","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1016\/S0140-6736(96)91557-3","article-title":"Effect of caffeine on recognition of and physiological responses to hypoglycaemia in insulin-dependent diabetes","volume":"347","author":"Debrah","year":"1996","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00054-1_bib106","doi-asserted-by":"crossref","first-page":"455","DOI":"10.2337\/diacare.23.4.455","article-title":"Influence of caffeine on the frequency and perception of hypoglycemia in free-living patients with type 1 diabetes","volume":"23","author":"Watson","year":"2000","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib107","doi-asserted-by":"crossref","first-page":"799","DOI":"10.7326\/0003-4819-119-8-199310150-00005","article-title":"Effect of caffeine on the recognition of and responses to hypoglycemia in humans","volume":"119","author":"Kerr","year":"1993","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib108","doi-asserted-by":"crossref","first-page":"1316","DOI":"10.2337\/diacare.28.6.1316","article-title":"Influence of caffeine on frequency of hypoglycemia detected by continuous interstitial glucose monitoring system in patients with long-standing type 1 diabetes","volume":"28","author":"Richardson","year":"2005","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib109","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0088384","article-title":"Alcohol ingestion impairs maximal post-exercise rates of myofibrillar protein synthesis following a single bout of concurrent training","volume":"9","author":"Parr","year":"2014","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(21)00054-1_bib110","doi-asserted-by":"crossref","first-page":"97","DOI":"10.1016\/0026-0495(78)90128-2","article-title":"The influence of ethanol on splanchnic and skeletal muscle metabolism in man","volume":"27","author":"Jorfeldt","year":"1978","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(21)00054-1_bib111","first-page":"e195","article-title":"Influence of ethanol on splanchnic and skeletal muscle substrate turnover during prolonged exercise in man","volume":"233","author":"Juhlin-Dannfelt","year":"1977","journal-title":"Am J Physiol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib112","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1172\/JCI113428","article-title":"Ethanol causes acute inhibition of carbohydrate, fat, and protein oxidation and insulin resistance","volume":"81","author":"Shelmet","year":"1988","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(21)00054-1_bib113","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1042\/bj1120117","article-title":"Inhibition of hepatic gluconeogenesis by ethanol","volume":"112","author":"Krebs","year":"1969","journal-title":"Biochem J"},{"key":"10.1016\/S2213-8587(21)00054-1_bib114","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1007\/BF00404799","article-title":"Alcohol causes hypoglycaemic unawareness in healthy volunteers and patients with type 1 (insulin-dependent) diabetes","volume":"33","author":"Kerr","year":"1990","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00054-1_bib115","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1111\/j.1464-5491.2004.01154.x","article-title":"Influence of alcohol on cognitive performance during mild hypoglycaemia; implications for type 1 diabetes","volume":"21","author":"Cheyne","year":"2004","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib116","doi-asserted-by":"crossref","DOI":"10.1002\/dmrr.2965","article-title":"Effects of alcohol on plasma glucose and prevention of alcohol-induced hypoglycemia in type 1 diabetes-a systematic review with GRADE","volume":"34","author":"Tetzschner","year":"2018","journal-title":"Diabetes Metab Res Rev"},{"key":"10.1016\/S2213-8587(21)00054-1_bib117","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1007\/s40279-018-0916-2","article-title":"Do we need a cool-down after exercise? A narrative review of the psychophysiological effects and the effects on performance, injuries and the long-term adaptive response","volume":"48","author":"Van Hooren","year":"2018","journal-title":"Sports Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib118","doi-asserted-by":"crossref","first-page":"227","DOI":"10.1123\/ijspp.8.3.227","article-title":"Cooling and performance recovery of trained athletes: a meta-analytical review","volume":"8","author":"Poppendieck","year":"2013","journal-title":"Int J Sports Physiol Perform"},{"key":"10.1016\/S2213-8587(21)00054-1_bib119","doi-asserted-by":"crossref","first-page":"1890","DOI":"10.1152\/jappl.1994.77.4.1890","article-title":"Muscle lactate metabolism in recovery from intense exhaustive exercise: impact of light exercise","volume":"77","author":"Bangsbo","year":"1994","journal-title":"J Appl Physiol (1985)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib120","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1123\/pes.2013-0187","article-title":"Effects of active and passive recovery on blood lactate and blood pH after a repeated sprint protocol in children and adults","volume":"27","author":"Kappenstein","year":"2015","journal-title":"Pediatr Exerc Sci"},{"key":"10.1016\/S2213-8587(21)00054-1_bib121","doi-asserted-by":"crossref","first-page":"1335","DOI":"10.1113\/EP086283","article-title":"Cold water immersion: kill or cure?","volume":"102","author":"Tipton","year":"2017","journal-title":"Exp Physiol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib122","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1007\/s40279-015-0431-7","article-title":"Can water temperature and immersion time influence the effect of cold water immersion on muscle soreness? A systematic review and meta-analysis","volume":"46","author":"Machado","year":"2016","journal-title":"Sports Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib123","doi-asserted-by":"crossref","first-page":"403","DOI":"10.3389\/fphys.2018.00403","article-title":"An evidence-based approach for choosing post-exercise recovery techniques to reduce markers of muscle damage, soreness, fatigue, and inflammation: a systematic review with meta-analysis","volume":"9","author":"Dupuy","year":"2018","journal-title":"Front Physiol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib124","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1249\/MSS.0b013e3182814462","article-title":"Postexercise cold-water immersion does not attenuate muscle glycogen resynthesis","volume":"45","author":"Gregson","year":"2013","journal-title":"Med Sci Sports Exerc"},{"key":"10.1016\/S2213-8587(21)00054-1_bib125","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1016\/j.sleep.2016.03.019","article-title":"Sleep characteristics in type 1 diabetes and associations with glycemic control: systematic review and meta-analysis","volume":"23","author":"Reutrakul","year":"2016","journal-title":"Sleep Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib126","doi-asserted-by":"crossref","first-page":"1573","DOI":"10.2337\/dc09-2317","article-title":"Partial sleep restriction decreases insulin sensitivity in type 1 diabetes","volume":"33","author":"Donga","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib127","doi-asserted-by":"crossref","first-page":"2902","DOI":"10.2337\/dc12-2038","article-title":"Short sleep duration measured by wrist actimetry is associated with deteriorated glycemic control in type 1 diabetes","volume":"36","author":"Borel","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib128","doi-asserted-by":"crossref","first-page":"460","DOI":"10.1111\/jdi.12320","article-title":"Are late-night eating habits and sleep duration associated with glycemic control in adult type 1 diabetes patients treated with insulin pumps?","volume":"6","author":"Matejko","year":"2015","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(21)00054-1_bib129","doi-asserted-by":"crossref","first-page":"169","DOI":"10.1016\/j.ncl.2007.11.012","article-title":"Sleep, recovery, and performance: the new frontier in high-performance athletics","volume":"26","author":"Samuels","year":"2008","journal-title":"Neurol Clin"},{"key":"10.1016\/S2213-8587(21)00054-1_bib130","doi-asserted-by":"crossref","first-page":"963","DOI":"10.1210\/jc.2006-2263","article-title":"Glucose requirements to maintain euglycemia after moderate-intensity afternoon exercise in adolescents with type 1 diabetes are increased in a biphasic manner","volume":"92","author":"McMahon","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib131","doi-asserted-by":"crossref","first-page":"763","DOI":"10.1089\/dia.2010.0038","article-title":"Continuous glucose monitoring reveals delayed nocturnal hypoglycemia after intermittent high-intensity exercise in nontrained patients with type 1 diabetes","volume":"12","author":"Maran","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(21)00054-1_bib132","doi-asserted-by":"crossref","first-page":"824","DOI":"10.1111\/j.1464-5491.2011.03274.x","article-title":"Continuous moderate-intensity exercise with or without intermittent high-intensity work: effects on acute and late glycaemia in athletes with type 1 diabetes mellitus","volume":"28","author":"Iscoe","year":"2011","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib133","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1038\/nrendo.2014.170","article-title":"Hypoglycaemia in diabetes mellitus: epidemiology and clinical implications","volume":"10","author":"Frier","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib134","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1111\/dom.13065","article-title":"The effect of exercise on sleep in adults with type 1 diabetes","volume":"20","author":"Reddy","year":"2018","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib135","doi-asserted-by":"crossref","first-page":"2087","DOI":"10.1210\/jc.2005-2798","article-title":"Nocturnal hypoglycemia in type 1 diabetes: an assessment of preventive bedtime treatments","volume":"91","author":"Raju","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib136","doi-asserted-by":"crossref","first-page":"1845","DOI":"10.2337\/dc14-0186","article-title":"A low-glycemic index meal and bedtime snack prevents postprandial hyperglycemia and associated rises in inflammatory markers, providing protection from early but not late nocturnal hypoglycemia following evening exercise in type 1 diabetes","volume":"37","author":"Campbell","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib137","doi-asserted-by":"crossref","first-page":"553","DOI":"10.1111\/dom.12852","article-title":"MD-Logic overnight type 1 diabetes control in home settings: a multicentre, multinational, single blind randomized trial","volume":"19","author":"Nimri","year":"2017","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib138","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1111\/dom.12427","article-title":"Unsupervised home use of an overnight closed-loop system over 3-4 weeks: a pooled analysis of randomized controlled studies in adults and adolescents with type 1 diabetes","volume":"17","author":"Thabit","year":"2015","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib139","doi-asserted-by":"crossref","first-page":"119","DOI":"10.3810\/pgm.2009.09.2059","article-title":"The 600-step program for type 1 diabetes self-management in youth: the magnitude of the self-management task","volume":"121","author":"Coffen","year":"2009","journal-title":"Postgrad Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib140","doi-asserted-by":"crossref","first-page":"375","DOI":"10.1093\/her\/cyy028","article-title":"Physical activity and exercise in adults with type 1 diabetes: understanding their needs using a person-centered approach","volume":"33","author":"Kime","year":"2018","journal-title":"Health Educ Res"},{"key":"10.1016\/S2213-8587(21)00054-1_bib141","doi-asserted-by":"crossref","first-page":"368","DOI":"10.1016\/S2213-8587(19)30061-0","article-title":"Fully closed-loop insulin delivery in inpatients receiving nutritional support: a two-centre, open-label, randomised controlled trial","volume":"7","author":"Boughton","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib142","article-title":"New closed-loop insulin systems","author":"Boughton","year":"2021","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00054-1_bib143","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1056\/NEJMoa1907863","article-title":"Six-month randomized, multicenter trial of closed-loop control in type 1 diabetes","volume":"381","author":"Brown","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib144","doi-asserted-by":"crossref","first-page":"E73","DOI":"10.3390\/bios8030073","article-title":"Continuous glucose monitoring and exercise in type 1 diabetes: past, present and future","volume":"8","author":"Houlder","year":"2018","journal-title":"Biosensors (Basel)"},{"key":"10.1016\/S2213-8587(21)00054-1_bib145","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1038\/s42255-020-0212-y","article-title":"An artificial intelligence decision support system for the management of type 1 diabetes","volume":"2","author":"Tyler","year":"2020","journal-title":"Nat Metab"},{"key":"10.1016\/S2213-8587(21)00054-1_bib146","doi-asserted-by":"crossref","first-page":"2561","DOI":"10.1007\/s00125-016-4107-0","article-title":"Efficacy of single-hormone and dual-hormone artificial pancreas during continuous and interval exercise in adult patients with type 1 diabetes: randomised controlled crossover trial","volume":"59","author":"Taleb","year":"2016","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(21)00054-1_bib147","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1016\/S2213-8587(14)70226-8","article-title":"Comparison of dual-hormone artificial pancreas, single-hormone artificial pancreas, and conventional insulin pump therapy for glycaemic control in patients with type 1 diabetes: an open-label randomised controlled crossover trial","volume":"3","author":"Haidar","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00054-1_bib148","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1016\/j.ecl.2019.10.008","article-title":"Role of glucagon in automated insulin delivery","volume":"49","author":"Wilson","year":"2020","journal-title":"Endocrinol Metab Clin North Am"},{"key":"10.1016\/S2213-8587(21)00054-1_bib149","doi-asserted-by":"crossref","first-page":"1644","DOI":"10.2337\/dc17-0883","article-title":"Closed-loop control during intense prolonged outdoor exercise in adolescents with type 1 diabetes: the Artificial Pancreas Ski Study","volume":"40","author":"Breton","year":"2017","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib150","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1111\/dme.13567","article-title":"Psychosocial impacts of hybrid closed-loop systems in the management of diabetes: a review","volume":"35","author":"Farrington","year":"2018","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(21)00054-1_bib63","doi-asserted-by":"crossref","first-page":"137","DOI":"10.1016\/j.diabres.2019.01.003","article-title":"Reproducibility in the cardiometabolic responses to high-intensity interval exercise in adults with type 1 diabetes","volume":"148","author":"Riddell","year":"2019","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(21)00054-1_bib64","doi-asserted-by":"crossref","DOI":"10.1136\/bmjdrc-2015-000085","article-title":"Insulin therapy and dietary adjustments to normalize glycemia and prevent nocturnal hypoglycemia after evening exercise in type 1 diabetes: a randomized controlled trial","volume":"3","author":"Campbell","year":"2015","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(21)00054-1_bib103","doi-asserted-by":"crossref","first-page":"1787","DOI":"10.1249\/MSS.0000000000000288","article-title":"Caffeine and performance over consecutive days of simulated competition","volume":"46","author":"Stadheim","year":"2014","journal-title":"Med Sci Sports Exerc"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000541?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721000541?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:15Z","timestamp":1761991755000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721000541"}},"issued":{"date-parts":[[2021,5]]},"references-count":150,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2021,5]]}},"alternative-id":["S2213858721000541"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00054-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Post-exercise recovery for the endurance athlete with type 1 diabetes: a consensus statement","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00054-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T20:55:50Z","timestamp":1793652950589,"version":"4.5.1"},"reference-count":30,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,1,1]],"date-time":"2025-01-01T00:00:00Z","timestamp":1735689600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,1]]},"DOI":"10.1016\/s2213-8587(24)00279-1","type":"journal-article","created":{"date-parts":[[2024,11,29]],"date-time":"2024-11-29T18:33:28Z","timestamp":1732905208000},"page":"47-56","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":56,"title":["Treatment regimens and glycaemic outcomes in more than 100\u2009000 children with type 1 diabetes (2013\u201322): a longitudinal analysis of data from paediatric diabetes registries"],"prefix":"10.1016","volume":"13","author":[{"given":"Anthony T","family":"Zimmermann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Lanzinger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siv Janne","family":"Kummernes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicolai A","family":"Lund-Blix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Reinhard W","family":"Holl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elke","family":"Fr\u00f6hlich-Reiterer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David M","family":"Maahs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Osagie","family":"Ebekozien","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saketh","family":"Rompicherla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin T","family":"Warner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saira","family":"Pons Perez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Holly","family":"Robinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria E","family":"Craig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Johnson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Akesson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Thor\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katarina","family":"Eeg-Olofsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ajenthen G","family":"Ranjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mette","family":"Madsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Witsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Heiko","family":"Bratke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Todd","family":"Alonso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zdenek","family":"Sumnik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vit","family":"Neuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ondrej","family":"Cinek","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torild","family":"Skrivarhaug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jannet","family":"Svensson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00279-1_bib1","doi-asserted-by":"crossref","first-page":"741","DOI":"10.1016\/S2213-8587(22)00218-2","article-title":"Global incidence, prevalence, and mortality of type 1 diabetes in 2021 with projection to 2040: a modelling study","volume":"10","author":"Gregory","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00279-1_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.109083","article-title":"Global estimates of incidence of type 1 diabetes in children and adolescents: results from the International Diabetes Federation Atlas, 10th edition","volume":"183","author":"Ogle","year":"2022","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(24)00279-1_bib3","first-page":"70","article-title":"Advances in type 1 diabetes technology over the last decade","volume":"15","author":"Zimmerman","year":"2019","journal-title":"Eur Endocrinol"},{"key":"10.1016\/S2213-8587(24)00279-1_bib4","doi-asserted-by":"crossref","first-page":"1122","DOI":"10.2337\/dc24-0086","article-title":"Ten years of improving glycemic control in pediatric diabetes care: data from the Norwegian Childhood Diabetes Registry","volume":"47","author":"Bratke","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00279-1_bib5","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa2210834","article-title":"Trial of hybrid closed-loop control in young children with type 1 diabetes","volume":"388","author":"Wadwa","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00279-1_bib6","doi-asserted-by":"crossref","first-page":"1270","DOI":"10.1111\/pedi.13455","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: glycemic targets and glucose monitoring for children, adolescents, and young people with diabetes","volume":"23","author":"de Bock","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00279-1_bib7","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S0140-6736(18)31506-X","article-title":"Excess mortality and cardiovascular disease in young adults with type 1 diabetes in relation to age at onset: a nationwide, register-based cohort study","volume":"392","author":"Rawshani","year":"2018","journal-title":"Lancet"},{"issue":"suppl 23","key":"10.1016\/S2213-8587(24)00279-1_bib8","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1111\/pedi.12411","article-title":"The mission of SWEET: harmonize care to optimize outcomes of children with diabetes worldwide","volume":"17","author":"Danne","year":"2016","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00279-1_bib9","doi-asserted-by":"crossref","first-page":"627","DOI":"10.1111\/pedi.13362","article-title":"A collaborative comparison of international pediatric diabetes registries","volume":"23","author":"Lanzinger","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00279-1_bib10","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1111\/pedi.12929","article-title":"Five years of improving diabetes control in Czech children after the establishment of the population-based childhood diabetes register \u010cENDA","volume":"21","author":"\u0160umn\u00edk","year":"2020","journal-title":"Pediatr Diabetes"},{"issue":"suppl 27","key":"10.1016\/S2213-8587(24)00279-1_bib11","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1111\/pedi.12773","article-title":"ISPAD Clinical Practice Consensus Guidelines 2018: definition, epidemiology, and classification of diabetes in children and adolescents","volume":"19","author":"Mayer-Davis","year":"2018","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00279-1_bib12","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1002\/(SICI)1097-0258(20000215)19:3<335::AID-SIM336>3.0.CO;2-Z","article-title":"Permutation tests for joinpoint regression with applications to cancer rates","volume":"19","author":"Kim","year":"2000","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(24)00279-1_bib13","doi-asserted-by":"crossref","first-page":"977","DOI":"10.1056\/NEJM199309303291401","article-title":"The effect of intensive treatment of diabetes on the development and progression of long-term complications in insulin-dependent diabetes mellitus","volume":"329","author":"Nathan","year":"1993","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00279-1_bib14","doi-asserted-by":"crossref","DOI":"10.3389\/fphar.2023.1301931","article-title":"The effect of insulin analogs in people with type 1 diabetes at increased risk of severe hypoglycemia","volume":"14","author":"Broeng-Mikkelgaard","year":"2023","journal-title":"Front Pharmacol"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00279-1_bib15","doi-asserted-by":"crossref","first-page":"S59","DOI":"10.1089\/dia.2009.0161","article-title":"The use of insulin pumps in youth with type 1 diabetes","volume":"12","author":"Maahs","year":"2010","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(24)00279-1_bib16","doi-asserted-by":"crossref","first-page":"314","DOI":"10.1016\/S2213-8587(23)00061-X","article-title":"Continuous glucose monitoring versus blood glucose monitoring for risk of severe hypoglycaemia and diabetic ketoacidosis in children, adolescents, and young adults with type 1 diabetes: a population-based study","volume":"11","author":"Karges","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00279-1_bib17","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2337\/dc20-1978","article-title":"The evolution of hemoglobin A1c targets for youth with type 1 diabetes: rationale and supporting evidence","volume":"44","author":"Redondo","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00279-1_bib19","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1111\/pedi.13211","article-title":"A decade of improved glycemic control in young children with type 1 diabetes: a population-based cohort study","volume":"22","author":"Sundberg","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00279-1_bib20","doi-asserted-by":"crossref","DOI":"10.1542\/peds.2020-048942","article-title":"Hemoglobin A1c patterns of youth with type 1 diabetes 10 years post diagnosis from 3 continents","volume":"148","author":"Sherr","year":"2021","journal-title":"Pediatrics"},{"key":"10.1016\/S2213-8587(24)00279-1_bib21","doi-asserted-by":"crossref","first-page":"491","DOI":"10.1089\/dia.2020.0618","article-title":"The SWEET Project 10-year benchmarking in 19 countries worldwide is associated with improved HbA1c and increased use of diabetes technology in youth with type 1 diabetes","volume":"23","author":"Gerhardsson","year":"2021","journal-title":"Diabetes Technol Ther"},{"key":"10.1016\/S2213-8587(24)00279-1_bib22","unstructured":"Lal RA, Robinson H, Lanzinger S, et al. Temporal changes in hemoglobin A1c and diabetes technology use in DPV, NPDA, and T1DX pediatric cohorts from 2010 to 2018. Diabetes Technol Ther: 1398\u2013405."},{"key":"10.1016\/S2213-8587(24)00279-1_bib23","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1111\/pedi.13137","article-title":"Worldwide differences in childhood type 1 diabetes: the SWEET experience","volume":"22","author":"Saiyed","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00279-1_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2021.101186","article-title":"The impact of race and socioeconomic factors on paediatric diabetes","volume":"42","author":"Catherine","year":"2021","journal-title":"EClinicalMedicine"},{"key":"10.1016\/S2213-8587(24)00279-1_bib25","doi-asserted-by":"crossref","first-page":"1398","DOI":"10.2337\/dc19-0184","article-title":"Socioeconomic inequality in metabolic control among children with type 1 diabetes: a nationwide longitudinal study of 4,079 danish children","volume":"42","author":"Nielsen","year":"2019","journal-title":"Diabetes Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(24)00279-1_bib26","first-page":"S258","article-title":"14. Children and adolescents: standards of care in diabetes\u20132024","volume":"47","year":"2024","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00279-1_bib27","doi-asserted-by":"crossref","first-page":"391","DOI":"10.2337\/dc21-1666","article-title":"Universal subsidized continuous glucose monitoring funding for young people with type 1 diabetes: uptake and outcomes over 2 years, a population-based study","volume":"45","author":"Johnson","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00279-1_bib28","doi-asserted-by":"crossref","first-page":"439","DOI":"10.1111\/pedi.13184","article-title":"Use of continuous glucose monitoring and its association with type 1 diabetes control in children over the first 3 years of reimbursement approval: population data from the \u010cENDA registry","volume":"22","author":"\u0160umn\u00edk","year":"2021","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00279-1_bib29","doi-asserted-by":"crossref","first-page":"e40","DOI":"10.2337\/dc19-1358","article-title":"Reduction in diabetic ketoacidosis and severe hypoglycemia in pediatric type 1 diabetes during the first year of continuous glucose monitoring: a multicenter analysis of 3,553 subjects from the DPV registry","volume":"43","author":"Tauschmann","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00279-1_bib30","doi-asserted-by":"crossref","first-page":"73","DOI":"10.1111\/pedi.13284","article-title":"Center differences in diabetes treatment outcomes among children with type 1 diabetes: a nationwide study of 3866 Danish children","volume":"23","author":"Skipper","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00279-1_bib31","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1159\/000530833","article-title":"Glycemic control by treatment modalities: national registry-based population data in children and adolescents with type 1 diabetes","volume":"97","author":"\u0160umnik","year":"2024","journal-title":"Horm Res Paediatr"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(25)00032-4","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T00:00:00Z","timestamp":1743465600000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002791?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002791?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,17]],"date-time":"2025-02-17T19:51:33Z","timestamp":1739821893000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002791"}},"issued":{"date-parts":[[2025,1]]},"references-count":30,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,1]]}},"alternative-id":["S2213858724002791"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00279-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment regimens and glycaemic outcomes in more than 100\u2009000 children with type 1 diabetes (2013\u201322): a longitudinal analysis of data from paediatric diabetes registries","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00279-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00311-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T05:34:50Z","timestamp":1794461690519,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/100004336","name":"Novartis","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100004336","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/s2213-8587(14)70169-x","type":"journal-article","created":{"date-parts":[[2014,9,24]],"date-time":"2014-09-24T01:15:23Z","timestamp":1411521323000},"page":"875-884","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":349,"title":["Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial"],"prefix":"10.1016","volume":"2","author":[{"given":"M\u00f4nica R","family":"Gadelha","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcello D","family":"Bronstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Brue","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mihail","family":"Coculescu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Fleseriu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mirtha","family":"Guitelman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vyacheslav","family":"Pronin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G\u00e9rald","family":"Raverot","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilan","family":"Shimon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kayo Kodama","family":"Lievre","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juergen","family":"Fleck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mounir","family":"Aout","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alberto M","family":"Pedroncelli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annamaria","family":"Colao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70169-X_bib1","doi-asserted-by":"crossref","first-page":"2558","DOI":"10.1056\/NEJMra062453","article-title":"Medical progress: acromegaly","volume":"355","author":"Melmed","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(14)70169-X_bib2","doi-asserted-by":"crossref","first-page":"243","DOI":"10.1038\/nrendo.2014.21","article-title":"Expert consensus document: a consensus on the medical treatment of acromegaly","volume":"10","author":"Giustina","year":"2014","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(14)70169-X_bib3","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1365-2265.2008.03208.x","article-title":"Control of IGF-I levels with titrated dosing of lanreotide Autogel over 48 weeks in patients with acromegaly","volume":"69","author":"Chanson","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70169-X_bib4","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1111\/j.1365-2265.2008.03441.x","article-title":"Octreotide LAR vs. surgery in newly diagnosed patients with acromegaly: a randomized, open-label, multicentre study","volume":"70","author":"Colao","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70169-X_bib5","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1007\/s11102-009-0191-1","article-title":"Rapid and sustained reduction of serum growth hormone and insulin-like growth factor-1 in patients with acromegaly receiving lanreotide Autogel therapy: a randomized, placebo-controlled, multicenter study with a 52 week open extension","volume":"13","author":"Melmed","year":"2010","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(14)70169-X_bib6","doi-asserted-by":"crossref","first-page":"859","DOI":"10.1111\/j.1365-2265.2007.02825.x","article-title":"A prospective, multicentre study to investigate the efficacy, safety and tolerability of octreotide LAR (long-acting repeatable octreotide) in the primary therapy of patients with acromegaly","volume":"66","author":"Mercado","year":"2007","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70169-X_bib7","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1210\/er.2010-0002","article-title":"Resistance to somatostatin analogs in acromegaly","volume":"32","author":"Colao","year":"2011","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(14)70169-X_bib8","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1111\/j.1365-2265.2005.02317.x","article-title":"Treatment of acromegaly with octreotide-LAR: extensive experience in a Brazilian institution","volume":"63","author":"Jallad","year":"2005","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70169-X_bib9","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11102-009-0172-4","article-title":"Efficacy of long-term lanreotide treatment in patients with acromegaly","volume":"12","author":"Toledano","year":"2009","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(14)70169-X_bib10","doi-asserted-by":"crossref","first-page":"579","DOI":"10.1530\/EJE-07-0383","article-title":"Beneficial effect of dose escalation of Octreotide-LAR as first-line therapy in patients with acromegaly","volume":"157","author":"Colao","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70169-X_bib11","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1007\/s11102-010-0282-z","article-title":"Clinical efficacy and safety results for dose escalation of somatostatin receptor ligands in patients with acromegaly: a literature review","volume":"14","author":"Fleseriu","year":"2011","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(14)70169-X_bib12","doi-asserted-by":"crossref","first-page":"1589","DOI":"10.1210\/jc.2011-2508","article-title":"Long-term safety of pegvisomant in patients with acromegaly: comprehensive review of 1288 subjects in ACROSTUDY","volume":"97","author":"van der Lely","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70169-X_bib13","doi-asserted-by":"crossref","first-page":"1754","DOI":"10.1016\/S0140-6736(01)06844-1","article-title":"Long-term treatment of acromegaly with pegvisomant, a growth hormone receptor antagonist","volume":"358","author":"van der Lely","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70169-X_bib14","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1530\/eje.0.1460707","article-title":"SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile","volume":"146","author":"Bruns","year":"2002","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(14)70169-X_bib15","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1210\/jc.2013-2480","article-title":"Pasireotide versus octreotide in acromegaly: a head-to-head superiority study","volume":"99","author":"Colao","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70169-X_bib16","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1046\/j.1365-2265.2002.01597.x","article-title":"Acromegaly Quality of Life Questionnaire (ACROQOL) a new health-related quality of life questionnaire for patients with acromegaly: development and psychometric properties","volume":"57","author":"Webb","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70169-X_bib17","doi-asserted-by":"crossref","first-page":"1110","DOI":"10.1080\/01621459.1987.10478547","article-title":"Computing distributions for exact logistic regression","volume":"82","author":"Hirji","year":"1987","journal-title":"J Am Statist Assoc"},{"key":"10.1016\/S2213-8587(14)70169-X_bib18","doi-asserted-by":"crossref","first-page":"586","DOI":"10.1002\/sim.3495","article-title":"A graphical approach to sequentially rejective multiple test procedures","volume":"28","author":"Bretz","year":"2009","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(14)70169-X_bib19","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1198\/sbr.2010.10010","article-title":"Multiple and repeated testing of primary, coprimary and secondary hypotheses","volume":"3","author":"Maurer","year":"2011","journal-title":"Statist Biopharm Res"},{"key":"10.1016\/S2213-8587(14)70169-X_bib20","first-page":"38","article-title":"Low somatostatin receptor subtype 2, but not dopamine receptor subtype 2 expression predicts the lack of biochemical response of somatotropinomas to treatment with somatostatin analogs","volume":"36","author":"Wildemberg","year":"2013","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(14)70169-X_bib21","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1210\/jc.2003-031052","article-title":"A single-dose comparison of the acute effects between the new somatostatin analog SOM230 and octreotide in acromegalic patients","volume":"89","author":"Van Der Hoek","year":"2004","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70169-X_bib22","doi-asserted-by":"crossref","first-page":"3446","DOI":"10.1210\/jc.2013-1771","article-title":"Hyperglycemia associated with pasireotide: results from a mechanistic study in healthy volunteers","volume":"98","author":"Henry","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70169-X_bib23","doi-asserted-by":"crossref","first-page":"180","DOI":"10.1007\/s11102-013-0483-3","article-title":"Managing hyperglycemia in patients with Cushing's disease treated with pasireotide: medical expert recommendations","volume":"17","author":"Colao","year":"2014","journal-title":"Pituitary"},{"key":"10.1016\/S2213-8587(14)70169-X_bib24","doi-asserted-by":"crossref","first-page":"2781","DOI":"10.1210\/jc.2009-2272","article-title":"Pasireotide (SOM230) demonstrates efficacy and safety in patients with acromegaly: a randomized, multicenter, phase II trial","volume":"95","author":"Petersenn","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70169-X_bib25","unstructured":"Petersenn S, Bollerslev J, Arafat AM, et al. Pasireotide LAR shows efficacy in patients with acromegaly: interim results from a randomized, multicenter, pharmacokinetic, pharmacodynamic, phase I study. 90th Annual Meeting of The Endocrine Society; San Francisco, CA, USA; June 15\u201318, 2008. Abstr OR41-5."},{"key":"10.1016\/S2213-8587(14)70169-X_bib26","doi-asserted-by":"crossref","first-page":"3090","DOI":"10.1210\/jc.2003-030110","article-title":"Four-year treatment with octreotide-long-acting repeatable in 110 acromegalic patients: predictive value of short-term results?","volume":"88","author":"Cozzi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(14)70169-X_bib27","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1111\/j.1365-2265.2006.02450.x","article-title":"Effectiveness and tolerability of 3-year lanreotide Autogel treatment in patients with acromegaly","volume":"64","author":"Caron","year":"2006","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(14)70169-X_bib28","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1111\/j.1365-2265.2006.02467.x","article-title":"First-line octreotide-LAR therapy induces tumor shrinkage and controls hormone excess in patients with acromegaly: results from an open, prospective, multicentre trial","volume":"64","author":"Colao","year":"2006","journal-title":"Clin Endocrinol (Oxf)"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871470169X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871470169X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:18Z","timestamp":1761991518000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871470169X"}},"issued":{"date-parts":[[2014,11]]},"references-count":28,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S221385871470169X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70169-x","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.719747024.793511709","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pasireotide versus continued treatment with octreotide or lanreotide in patients with inadequately controlled acromegaly (PAOLA): a randomised, phase 3 trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70169-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70175-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T23:39:49Z","timestamp":1794440389373,"version":"4.9.1"},"reference-count":82,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,2,1]],"date-time":"2026-02-01T00:00:00Z","timestamp":1769904000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,2]]},"DOI":"10.1016\/s2213-8587(25)00357-2","type":"journal-article","created":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T23:51:45Z","timestamp":1765410705000},"page":"178-186","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":23,"title":["Obesity in China: current progress and future prospects"],"prefix":"10.1016","volume":"14","author":[{"given":"Xiong-Fei","family":"Pan","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhong-Ze","family":"Fang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lingli","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"An","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00357-2_bib1","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1016\/S2213-8587(21)00045-0","article-title":"Epidemiology and determinants of obesity in China","volume":"9","author":"Pan","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00357-2_bib2","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1016\/S2213-8587(21)00047-4","article-title":"Clinical management and treatment of obesity in China","volume":"9","author":"Zeng","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00357-2_bib3","doi-asserted-by":"crossref","first-page":"446","DOI":"10.1016\/S2213-8587(21)00118-2","article-title":"Health policy and public health implications of obesity in China","volume":"9","author":"Wang","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00357-2_bib4","doi-asserted-by":"crossref","first-page":"2057","DOI":"10.1016\/S0140-6736(24)00550-6","article-title":"Global fertility in 204 countries and territories, 1950\u20132021, with forecasts to 2100: a comprehensive demographic analysis for the Global Burden of Disease Study 2021","volume":"403","author":"Bhattacharjee","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00357-2_bib5","doi-asserted-by":"crossref","first-page":"530","DOI":"10.1016\/S2352-4642(25)00140-3","article-title":"Trends and predictions to 2030 in demographic structures and metabolic health for children and adolescents in China: analysis of national school health surveys from 2000 to 2019","volume":"9","author":"Song","year":"2025","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/S2213-8587(25)00357-2_bib6","doi-asserted-by":"crossref","first-page":"e915","DOI":"10.1016\/S2468-2667(22)00338-3","article-title":"Projections of future life expectancy in China up to 2035: a modelling study","volume":"8","author":"Bai","year":"2023","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(25)00357-2_bib7","doi-asserted-by":"crossref","first-page":"1724","DOI":"10.1002\/oby.23472","article-title":"Health consequences of obesity and projected future obesity health burden in China","volume":"30","author":"Sun","year":"2022","journal-title":"Obesity (Silver Spring)"},{"key":"10.1016\/S2213-8587(25)00357-2_bib8","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1016\/S0140-6736(21)00798-4","article-title":"Body-mass index and obesity in urban and rural China: findings from consecutive nationally representative surveys during 2004\u201318","volume":"398","author":"Wang","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00357-2_bib9","doi-asserted-by":"crossref","first-page":"e1025","DOI":"10.1016\/S2468-2667(24)00211-1","article-title":"Trends and inequalities in thinness and obesity among Chinese children and adolescents: evidence from seven national school surveys between 1985 and 2019","volume":"9","author":"Song","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(25)00357-2_bib10","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1097\/CM9.0000000000003123","article-title":"Secular trend and projection of overweight and obesity among Chinese children and adolescents aged 7-18 years from 1985 to 2019: rural areas are becoming the focus of investment","volume":"138","author":"Dang","year":"2025","journal-title":"Chin Med J (Engl)"},{"key":"10.1016\/S2213-8587(25)00357-2_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/nu16234008","article-title":"Trends in consumption of ultra-processed foods among adults in southern China: analysis of serial cross-sectional health survey data 2002-2022","volume":"16","author":"Li","year":"2024","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(25)00357-2_bib12","series-title":"Notice on issuing the implementation plan for the \u201cWeight Management Years\u201d activity","year":"2024"},{"key":"10.1016\/S2213-8587(25)00357-2_bib13","series-title":"Guidelines for the diagnosis and treatment of obesity (2024 version)","year":"2024"},{"key":"10.1016\/S2213-8587(25)00357-2_bib14","series-title":"Guidelines for weight management (2024 version)","year":"2024"},{"key":"10.1016\/S2213-8587(25)00357-2_bib15","series-title":"Technical guidelines for comprehensive prevention and control of overweight and obesity in primary and secondary school students","year":"2024"},{"key":"10.1016\/S2213-8587(25)00357-2_bib16","series-title":"Chinese Dietary Guidelines (2022 version)","year":"2022"},{"key":"10.1016\/S2213-8587(25)00357-2_bib17","series-title":"General Rules for Nutrition Labeling of Prepackaged Food (GB28050-2025)","year":"2025"},{"key":"10.1016\/S2213-8587(25)00357-2_bib18","article-title":"China's public health initiatives for climate change adaptation","volume":"40","author":"Ji","year":"2023","journal-title":"Lancet Reg Health West Pac"},{"key":"10.1016\/S2213-8587(25)00357-2_bib19","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-023-02869-9","article-title":"The effect of dietary carbohydrate and calorie restriction on weight and metabolic health in overweight\/obese individuals: a multi-center randomized controlled trial","volume":"21","author":"Sun","year":"2023","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(25)00357-2_bib20","article-title":"Effects of healthy low-carbohydrate diet and time-restricted eating on weight and gut microbiome in adults with overweight or obesity: feeding RCT","volume":"5","author":"Li","year":"2024","journal-title":"Cell Rep Med"},{"key":"10.1016\/S2213-8587(25)00357-2_bib21","article-title":"Time-restricted eating with or without low-carbohydrate diet reduces visceral fat and improves metabolic syndrome: a randomized trial","volume":"3","author":"He","year":"2022","journal-title":"Cell Rep Med"},{"key":"10.1016\/S2213-8587(25)00357-2_bib22","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1056\/NEJMoa2114833","article-title":"Calorie restriction with or without time-restricted eating in weight loss","volume":"386","author":"Liu","year":"2022","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00357-2_bib23","doi-asserted-by":"crossref","first-page":"1792","DOI":"10.1080\/10408398.2023.2300705","article-title":"Defining \u201clow-carb\u201d in the scientific literature: A scoping review of clinical studies","volume":"65","author":"Chac\u00f3n","year":"2025","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/S2213-8587(25)00357-2_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.nut.2014.06.011","article-title":"Dietary carbohydrate restriction as the first approach in diabetes management: critical review and evidence base","volume":"31","author":"Feinman","year":"2015","journal-title":"Nutrition"},{"key":"10.1016\/S2213-8587(25)00357-2_bib25","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2337\/dsi24-0001","article-title":"A guideline-directed approach to obesity treatment","volume":"37","author":"Chao","year":"2024","journal-title":"Diabetes Spectr"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00357-2_bib26","first-page":"S167","article-title":"8. Obesity and weight management for the prevention and treatment of type 2 diabetes: standards of care in diabetes\u20132025","volume":"48","author":"El Sayed","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00357-2_bib27","doi-asserted-by":"crossref","first-page":"e1115","DOI":"10.1016\/S2468-2667(24)00245-7","article-title":"Public health interventions against childhood obesity in China","volume":"9","author":"Yuan","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(25)00357-2_bib28","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2021.4375","article-title":"Effectiveness of a multifaceted intervention for prevention of obesity in primary school children in China: a cluster randomized clinical trial","volume":"176","author":"Liu","year":"2022","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(25)00357-2_bib29","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1038\/s41591-025-03724-5","article-title":"An adaptive AI-based virtual reality sports system for adolescents with excess body weight: a randomized controlled trial","volume":"31","author":"Wang","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00357-2_bib30","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1016\/S2213-8587(24)00154-2","article-title":"Artificial intelligence for diabetes care: current and future prospects","volume":"12","author":"Sheng","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00357-2_bib31","article-title":"Artificial intelligence and obesity management: an Obesity Medicine Association (OMA) Clinical Practice Statement (CPS) 2023","volume":"6","author":"Bays","year":"2023","journal-title":"Obes Pillars"},{"key":"10.1016\/S2213-8587(25)00357-2_bib32","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1111\/dom.15360","article-title":"Beinaglutide for weight management in Chinese individuals with overweight or obesity: a phase 3 randomized controlled clinical study","volume":"26","author":"Chen","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(25)00357-2_bib33","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1016\/S2213-8587(23)00388-1","article-title":"Efficacy and safety of once weekly semaglutide 2\u00b74 mg for weight management in a predominantly east Asian population with overweight or obesity (STEP 7): a double-blind, multicentre, randomised controlled trial","volume":"12","author":"Mu","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00357-2_bib34","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1001\/jama.2024.9217","article-title":"Tirzepatide for weight reduction in Chinese adults with obesity: the SURMOUNT-CN randomized clinical trial","volume":"332","author":"Zhao","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(25)00357-2_bib35","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1056\/NEJMoa2411528","article-title":"Once-weekly mazdutide in Chinese adults with obesity or overweight","volume":"392","author":"Ji","year":"2025","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00357-2_bib36","doi-asserted-by":"crossref","first-page":"777","DOI":"10.1016\/S2213-8587(25)00141-X","article-title":"Efficacy and safety of a biased GLP-1 receptor agonist ecnoglutide in adults with overweight or obesity: a multicentre, randomised, double-blind, placebo-controlled, phase 3 trial","volume":"13","author":"Ji","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00357-2_bib37","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1080\/01621459.1927.10502953","article-title":"Probable inference, the law of succession, and statistical inference","volume":"22","author":"Wilson","year":"1927","journal-title":"J Am Stat Assoc"},{"key":"10.1016\/S2213-8587(25)00357-2_bib38","first-page":"955","article-title":"Guideline for the prevention and treatment of metabolic dysfunction-associated fatty liver disease (Version 2024)","volume":"12","author":"Fan","year":"2024","journal-title":"J Clin Transl Hepatol"},{"key":"10.1016\/S2213-8587(25)00357-2_bib39","doi-asserted-by":"crossref","first-page":"e573","DOI":"10.1016\/j.cgh.2021.02.030","article-title":"Estimating global prevalence of metabolic dysfunction-associated fatty liver disease in overweight or obese adults","volume":"20","author":"Liu","year":"2022","journal-title":"Clin Gastroenterol Hepatol"},{"key":"10.1016\/S2213-8587(25)00357-2_bib40","series-title":"The selection and use of essential medicines, 2025: report of the 25th WHO Expert Committee on Selection and Use of Essential Medicines, executive summary","year":"2025"},{"key":"10.1016\/S2213-8587(25)00357-2_bib41","doi-asserted-by":"crossref","first-page":"315","DOI":"10.1038\/d41586-025-01987-z","article-title":"Obesity drugs made in China could power next wave of treatments","volume":"643","author":"Fieldhouse","year":"2025","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(25)00357-2_bib42","doi-asserted-by":"crossref","DOI":"10.1038\/d41573-025-00155-2","article-title":"The evolution of the obesity drug market","author":"Recasens-Alvarez","year":"2025","journal-title":"Nat Rev Drug Discov"},{"key":"10.1016\/S2213-8587(25)00357-2_bib43","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1016\/S0140-6736(25)00355-1","article-title":"Global, regional, and national prevalence of adult overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","author":"Ng","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00357-2_bib44","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2020.100521","article-title":"Prevalence and changes of BMI categories in China and related chronic diseases: Cross-sectional National Health Service Surveys (NHSSs) from 2013 to 2018","volume":"26","author":"Wang","year":"2020","journal-title":"EClinicalMedicine"},{"key":"10.1016\/S2213-8587(25)00357-2_bib45","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1016\/S0140-6736(23)02750-2","article-title":"Worldwide trends in underweight and obesity from 1990 to 2022: a pooled analysis of 3663 population-representative studies with 222 million children, adolescents, and adults","volume":"403","author":"Phelps","year":"2024","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00357-2_bib46","doi-asserted-by":"crossref","first-page":"1873","DOI":"10.1016\/S0140-6736(25)01637-X","volume":"406","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00357-2_bib47","doi-asserted-by":"crossref","first-page":"1145","DOI":"10.1016\/S0140-6736(19)30427-1","article-title":"Mortality, morbidity, and risk factors in China and its provinces, 1990-2017: a systematic analysis for the Global Burden of Disease Study 2017","volume":"394","author":"Zhou","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00357-2_bib48","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2024.102848","article-title":"Burden of disease attributable to high body mass index: an analysis of data from the Global Burden of Disease Study 2021","volume":"76","author":"Zhou","year":"2024","journal-title":"EClinicalMedicine"},{"key":"10.1016\/S2213-8587(25)00357-2_bib49","doi-asserted-by":"crossref","first-page":"e672","DOI":"10.1016\/S2468-2667(20)30191-2","article-title":"Cardiovascular risk factors in China: a nationwide population-based cohort study","volume":"5","author":"Li","year":"2020","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(25)00357-2_bib50","doi-asserted-by":"crossref","first-page":"1477","DOI":"10.1161\/CIRCRESAHA.120.316101","article-title":"Obesity phenotypes, diabetes, and cardiovascular diseases","volume":"126","author":"Pich\u00e9","year":"2020","journal-title":"Circ Res"},{"key":"10.1016\/S2213-8587(25)00357-2_bib51","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1038\/s41574-019-0310-7","article-title":"Waist circumference as a vital sign in clinical practice: a Consensus Statement from the IAS and ICCR Working Group on Visceral Obesity","volume":"16","author":"Ross","year":"2020","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(25)00357-2_bib52","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1016\/S2213-8587(24)00316-4","article-title":"Definition and diagnostic criteria of clinical obesity","volume":"13","author":"Rubino","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00357-2_bib53","doi-asserted-by":"crossref","first-page":"2395","DOI":"10.1038\/s41591-024-03095-3","article-title":"A new framework for the diagnosis, staging and management of obesity in adults","volume":"30","author":"Busetto","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00357-2_bib54","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1001\/jamainternmed.2023.7733","article-title":"Body composition in anti-obesity medication tials-beyond scales","volume":"184","author":"Agarwal","year":"2024","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(25)00357-2_bib55","series-title":"Obesity: missing the 2025 global targets","year":"2020"},{"key":"10.1016\/S2213-8587(25)00357-2_bib57","series-title":"Healthy China 2030 Plan","year":"2016"},{"key":"10.1016\/S2213-8587(25)00357-2_bib58","doi-asserted-by":"crossref","first-page":"785","DOI":"10.1016\/S0140-6736(25)00397-6","article-title":"Global, regional, and national prevalence of child and adolescent overweight and obesity, 1990\u20132021, with forecasts to 2050: a forecasting study for the Global Burden of Disease Study 2021","volume":"405","author":"Kerr","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00357-2_bib59","article-title":"Association between population mean and distribution of deviance in demographic surveys from 65 countries: cross sectional study","volume":"362","author":"Razak","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00357-2_bib60","doi-asserted-by":"crossref","first-page":"1031","DOI":"10.1136\/bmj.301.6759.1031","article-title":"The population mean predicts the number of deviant individuals","volume":"301","author":"Rose","year":"1990","journal-title":"BMJ"},{"issue":"Suppl 3","key":"10.1016\/S2213-8587(25)00357-2_bib61","doi-asserted-by":"crossref","first-page":"S213","DOI":"10.1097\/QAD.0000000000002355","article-title":"Global, regional and country-level 90-90-90 estimates for 2018: assessing progress towards the 2020 target","volume":"33","author":"Marsh","year":"2019","journal-title":"AIDS"},{"key":"10.1016\/S2213-8587(25)00357-2_bib62","doi-asserted-by":"crossref","first-page":"4694","DOI":"10.1111\/dom.15837","article-title":"Perceptions, attitudes and barriers to effective obesity care among people living with obesity and healthcare professionals in China: The ACTION-China study","volume":"26","author":"Ji","year":"2024","journal-title":"Diabetes Obes Metab"},{"key":"10.1016\/S2213-8587(25)00357-2_bib63","doi-asserted-by":"crossref","first-page":"255","DOI":"10.1001\/jamainternmed.2024.6450","article-title":"Lifestyle intervention requirements for novel antiobesity medications-necessary adjunct or harmful gatekeeper?","volume":"185","author":"Golovaty","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(25)00357-2_bib64","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1001\/jamainternmed.2024.3579","article-title":"GLP-1 receptor agonists and the path to sustainable obesity care","volume":"185","author":"Manne-Goehler","year":"2025","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(25)00357-2_bib65","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2025.103363","article-title":"The expanding role of GLP-1 receptor agonists: a narrative review of current evidence and future directions","volume":"86","author":"Moiz","year":"2025","journal-title":"EClinicalMedicine"},{"key":"10.1016\/S2213-8587(25)00357-2_bib66","doi-asserted-by":"crossref","first-page":"3317","DOI":"10.1038\/s41591-025-03978-z","article-title":"A systematic review and meta-analysis of the efficacy and safety of pharmacological treatments for obesity in adults","volume":"31","author":"McGowan","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00357-2_bib67","doi-asserted-by":"crossref","first-page":"3229","DOI":"10.1038\/s41591-025-03765-w","article-title":"Framework for the pharmacological treatment of obesity and its complications from the European Association for the Study of Obesity (EASO)","volume":"31","author":"McGowan","year":"2025","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00357-2_bib68","doi-asserted-by":"crossref","DOI":"10.1136\/bmjgh-2022-011535","article-title":"Improving access to medicines and beyond: the national volume-based procurement policy in China","volume":"8","author":"Zhu","year":"2023","journal-title":"BMJ Glob Health"},{"key":"10.1016\/S2213-8587(25)00357-2_bib69","series-title":"WHO global strategy on people-centred and integrated health services: interim report","year":"2015"},{"key":"10.1016\/S2213-8587(25)00357-2_bib70","doi-asserted-by":"crossref","first-page":"e1000","DOI":"10.1016\/S2468-2667(24)00271-8","article-title":"Obesity in China: what we know and what we can do","volume":"9","author":"Pan","year":"2024","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(25)00357-2_bib71","doi-asserted-by":"crossref","first-page":"1802","DOI":"10.1016\/S0140-6736(20)30122-7","article-title":"Quality of primary health care in China: challenges and recommendations","volume":"395","author":"Li","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00357-2_bib72","doi-asserted-by":"crossref","DOI":"10.1016\/j.eclinm.2022.101635","article-title":"Interventions to prevent obesity in school-aged children 6-18 years: An update of a Cochrane systematic review and meta-analysis including studies from 2015-2021","volume":"54","author":"Hodder","year":"2022","journal-title":"EClinicalMedicine"},{"key":"10.1016\/S2213-8587(25)00357-2_bib73","doi-asserted-by":"crossref","first-page":"332","DOI":"10.1016\/S2213-8587(17)30358-3","article-title":"Interventions to prevent global childhood overweight and obesity: a systematic review","volume":"6","author":"Bleich","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00357-2_bib74","series-title":"A primary health care approach to obesity prevention and management in children and adolescents: policy brief","year":"2023"},{"key":"10.1016\/S2213-8587(25)00357-2_bib75","doi-asserted-by":"crossref","first-page":"791","DOI":"10.1016\/S0140-6736(18)32822-8","article-title":"The global syndemic of obesity, undernutrition, and climate change: The Lancet Commission report","volume":"393","author":"Swinburn","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00357-2_bib76","doi-asserted-by":"crossref","DOI":"10.1016\/j.ecoenv.2025.118401","article-title":"Understanding the role of endocrine disrupting chemicals as environmental obesogens in the obesity epidemic: a comprehensive overview of epidemiological studies between 2014 and 2024","volume":"299","author":"Jaskulak","year":"2025","journal-title":"Ecotoxicol Environ Saf"},{"key":"10.1016\/S2213-8587(25)00357-2_bib77","doi-asserted-by":"crossref","first-page":"1625","DOI":"10.1016\/S0140-6736(25)01201-2","article-title":"The EAT-Lancet Commission on healthy, sustainable, and just food systems","volume":"406","author":"Rockstr\u00f6m","year":"2025","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00357-2_bib78","doi-asserted-by":"crossref","first-page":"1973","DOI":"10.1016\/S0140-6736(15)60901-1","article-title":"Safeguarding human health in the Anthropocene epoch: report of The Rockefeller Foundation-Lancet Commission on planetary health","volume":"386","author":"Whitmee","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00357-2_bib79","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2025.156373","article-title":"Mini-review of the EAT-Lancet planetary health diet and its role in cardiometabolic disease prevention","volume":"172","author":"Stubbendorff","year":"2025","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(25)00357-2_bib80","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/j.ajcnut.2025.06.013","article-title":"Prospective association of the EAT-Lancet reference diet with body weight changes and incidence of overweight and obesity in a French cohort","volume":"122","author":"Berthy","year":"2025","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(25)00357-2_bib81","doi-asserted-by":"crossref","first-page":"3407","DOI":"10.1016\/j.tjnut.2024.06.018","article-title":"The EAT-Lancet diet index is associated with lower obesity and incidence of type 2 diabetes in the multiethnic cohort","volume":"154","author":"Klapp","year":"2024","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(25)00357-2_bib82","series-title":"Songs of Chu: complete text, annotation, and translation of Chinese Classics","author":"Lin","year":"2015"},{"key":"10.1016\/S2213-8587(25)00357-2_bib56","series-title":"Implementation plan for obesity prevention and control in children and adolescents","year":"2020"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003572?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003572?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T20:50:43Z","timestamp":1789073443000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003572"}},"issued":{"date-parts":[[2026,2]]},"references-count":82,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2026,2]]}},"alternative-id":["S2213858725003572"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00357-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Obesity in China: current progress and future prospects","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00357-2","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,5]],"date-time":"2026-11-05T17:15:37Z","timestamp":1793898937636,"version":"4.8.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/s2213-8587(17)30221-8","type":"journal-article","created":{"date-parts":[[2017,8,11]],"date-time":"2017-08-11T00:00:12Z","timestamp":1502409612000},"page":"788-798","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":198,"title":["Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials"],"prefix":"10.1016","volume":"5","author":[{"given":"Sanjay","family":"Basu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeremy B","family":"Sussman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Seth A","family":"Berkowitz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rodney A","family":"Hayward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John S","family":"Yudkin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30221-8_bib1","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1001\/jamainternmed.2014.2894","article-title":"Effect of patients' risks and preferences on health gains with plasma glucose level lowering in type 2 diabetes mellitus","volume":"174","author":"Vijan","year":"2014","journal-title":"JAMA Intern Med"},{"issue":"25 suppl 2","key":"10.1016\/S2213-8587(17)30221-8_bib2","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1161\/01.cir.0000437738.63853.7a","article-title":"2013 ACC\/AHA guideline on the treatment of blood cholesterol to reduce atherosclerotic cardiovascular risk in adults: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines","volume":"129","author":"Stone","year":"2013","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30221-8_bib3","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S2213-8587(16)30270-4","article-title":"Comparative effectiveness and cost-effectiveness of treat-to-target versus benefit-based tailored treatment of type 2 diabetes in low-income and middle-income countries: a modelling analysis","volume":"4","author":"Basu","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30221-8_bib4","doi-asserted-by":"crossref","first-page":"e1001582","DOI":"10.1371\/journal.pmed.1001582","article-title":"Averting obesity and type 2 diabetes in India through sugar-sweetened beverage taxation: an economic-epidemiologic modeling study","volume":"11","author":"Basu","year":"2014","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib5","first-page":"680","article-title":"Detecting heterogeneous treatment effects to guide personalized blood pressure treatment: a modeling study of randomized clinical trials","volume":"154","author":"Basu","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib6","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1136\/bmj.39609.449676.25","article-title":"Predicting cardiovascular risk in England and Wales: prospective derivation and validation of QRISK2","volume":"336","author":"Hippisley-Cox","year":"2008","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30221-8_bib7","doi-asserted-by":"crossref","first-page":"S49","DOI":"10.1161\/01.cir.0000437741.48606.98","article-title":"2013 ACC\/AHA guideline on the assessment of cardiovascular risk","volume":"129","author":"Goff","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30221-8_bib8","doi-asserted-by":"crossref","first-page":"670","DOI":"10.1016\/j.jval.2013.01.002","article-title":"Computer modeling of diabetes and its complications: a report on the fifth mount hood challenge meeting","volume":"16","author":"Palmer","year":"2013","journal-title":"Value Health"},{"key":"10.1016\/S2213-8587(17)30221-8_bib9","doi-asserted-by":"crossref","first-page":"1925","DOI":"10.1007\/s00125-013-2940-y","article-title":"UKPDS outcomes model 2: a new version of a model to simulate lifetime health outcomes of patients with type 2 diabetes mellitus using data from the 30 year United Kingdom Prospective Diabetes Study: UKPDS 82","volume":"56","author":"Hayes","year":"2013","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(17)30221-8_bib10","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib11","doi-asserted-by":"crossref","first-page":"1563","DOI":"10.1056\/NEJMoa1001282","article-title":"Effects of combination lipid therapy in type 2 diabetes mellitus","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib12","doi-asserted-by":"crossref","first-page":"1575","DOI":"10.1056\/NEJMoa1001286","article-title":"Effects of intensive blood-pressure control in type 2 diabetes mellitus","volume":"362","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib13","doi-asserted-by":"crossref","first-page":"163","DOI":"10.1161\/CIRCOUTCOMES.113.000497","article-title":"Using internally developed risk models to assess heterogeneity in treatment effects in clinical trials","volume":"7","author":"Burke","year":"2014","journal-title":"Circ Cardiovasc Qual Outcomes"},{"key":"10.1016\/S2213-8587(17)30221-8_bib14","doi-asserted-by":"crossref","first-page":"866","DOI":"10.1016\/S2213-8587(15)00291-0","article-title":"Long-term effects of lifestyle intervention or metformin on diabetes development and microvascular complications over 15-year follow-up: the Diabetes Prevention Program Outcomes Study","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30221-8_bib15","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib16","doi-asserted-by":"crossref","first-page":"604","DOI":"10.7326\/0003-4819-150-9-200905050-00006","article-title":"A new equation to estimate glomerular filtration rate","volume":"150","author":"Levey","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib17","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.clineuro.2005.08.003","article-title":"Validation of Michigan neuropathy screening instrument for diabetic peripheral neuropathy","volume":"108","author":"Moghtaderi","year":"2006","journal-title":"Clin Neurol Neurosurg"},{"key":"10.1016\/S2213-8587(17)30221-8_bib18","doi-asserted-by":"crossref","first-page":"245","DOI":"10.1111\/j.1467-9868.2011.01004.x","article-title":"Strong rules for discarding predictors in lasso-type problems","volume":"74","author":"Tibshirani","year":"2012","journal-title":"J R Stat Soc Ser B Stat Methodol"},{"key":"10.1016\/S2213-8587(17)30221-8_bib19","doi-asserted-by":"crossref","first-page":"1","DOI":"10.18637\/jss.v039.i05","article-title":"Regularization paths for Cox's proportional hazards model via coordinate descent","volume":"39","author":"Simon","year":"2011","journal-title":"J Stat Softw"},{"key":"10.1016\/S2213-8587(17)30221-8_bib20","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1002\/sim.4067","article-title":"Multiple imputation using chained equations: issues and guidance for practice","volume":"30","author":"White","year":"2011","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib21","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1111\/j.0006-341X.2000.00337.x","article-title":"Time-dependent ROC curves for censored survival data and a diagnostic marker","volume":"56","author":"Heagerty","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(17)30221-8_bib22","series-title":"Targeted learning: causal inference for observational and experimental data","author":"van der Laan","year":"2011"},{"key":"10.1016\/S2213-8587(17)30221-8_bib23","doi-asserted-by":"crossref","first-page":"1659","DOI":"10.1002\/sim.6428","article-title":"Tests of calibration and goodness-of-fit in the survival setting","volume":"34","author":"Demler","year":"2015","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib24","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1097\/EDE.0000000000000018","article-title":"Net reclassification indices for evaluating risk prediction instruments: a critical review","volume":"25","author":"Kerr","year":"2014","journal-title":"Epidemiol Camb Mass"},{"key":"10.1016\/S2213-8587(17)30221-8_bib25","author":"Basu"},{"key":"10.1016\/S2213-8587(17)30221-8_bib26","doi-asserted-by":"crossref","first-page":"268","DOI":"10.1161\/CIRCULATIONAHA.113.007680","article-title":"Response to Comment on the reports of over-estimation of ASCVD risk using the 2013 AHA\/ACC risk equation","volume":"129","author":"Cook","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30221-8_bib27","doi-asserted-by":"crossref","first-page":"1762","DOI":"10.1016\/S0140-6736(13)62388-0","article-title":"Statins: new American guidelines for prevention of cardiovascular disease","volume":"382","author":"Ridker","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30221-8_bib28","doi-asserted-by":"crossref","first-page":"786","DOI":"10.7326\/M16-1739","article-title":"Calibration of the pooled cohort equations for atherosclerotic cardiovascular disease: an update","volume":"165","author":"Cook","year":"2016","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib29","doi-asserted-by":"crossref","first-page":"922","DOI":"10.1016\/S2213-8587(16)30270-4","article-title":"Comparative effectiveness and cost-effectiveness of treat-to-target versus benefit-based tailored treatment of type 2 diabetes in low-income and middle-income countries: a modelling analysis","volume":"4","author":"Basu","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30221-8_bib30","doi-asserted-by":"crossref","first-page":"326","DOI":"10.1186\/1471-2105-8-326","article-title":"Stratification bias in low signal microarray studies","volume":"8","author":"Parker","year":"2007","journal-title":"BMC Bioinformatics"},{"key":"10.1016\/S2213-8587(17)30221-8_bib31","doi-asserted-by":"crossref","first-page":"3474","DOI":"10.1002\/sim.2299","article-title":"Estimation of time-dependent area under the ROC curve for long-term risk prediction","volume":"25","author":"Chambless","year":"2006","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib32","doi-asserted-by":"crossref","first-page":"451","DOI":"10.1001\/archinte.168.5.451","article-title":"Development and validation of an all-cause mortality risk score in type 2 diabetes: the Hong Kong Diabetes Registry","volume":"168","author":"Yang","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib33","doi-asserted-by":"crossref","first-page":"359","DOI":"10.1093\/ndt\/gfu411","article-title":"Diabetic nephropathy: landmark clinical trials and tribulations","volume":"31","author":"Chan","year":"2016","journal-title":"Nephrol Dial Transplant"},{"key":"10.1016\/S2213-8587(17)30221-8_bib34","doi-asserted-by":"crossref","first-page":"706","DOI":"10.1016\/S2213-8587(15)00468-4","article-title":"Shared decision making in endocrinology: present and future directions","volume":"4","author":"Rodriguez-Gutierrez","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30221-8_bib35","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1056\/NEJMoa1603827","article-title":"Liraglutide and cardiovascular outcomes in type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib36","doi-asserted-by":"crossref","first-page":"1834","DOI":"10.1056\/NEJMoa1607141","article-title":"Semaglutide and cardiovascular outcomes in patients with type 2 diabetes","volume":"375","author":"Marso","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib37","doi-asserted-by":"crossref","first-page":"2117","DOI":"10.1056\/NEJMoa1504720","article-title":"Empagliflozin, cardiovascular outcomes, and mortality in type 2 diabetes","volume":"373","author":"Zinman","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30221-8_bib38","doi-asserted-by":"crossref","first-page":"380","DOI":"10.1056\/NEJMe1607413","article-title":"Cardiac and renovascular complications in type 2 diabetes\u2014is there hope?","volume":"375","author":"Ingelfinger","year":"2016","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302218?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717302218?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,9]],"date-time":"2018-10-09T13:40:48Z","timestamp":1539092448000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717302218"}},"issued":{"date-parts":[[2017,10]]},"references-count":38,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2213858717302218"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30221-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Development and validation of Risk Equations for Complications Of type 2 Diabetes (RECODe) using individual participant data from randomised trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30221-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30232-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,7]],"date-time":"2026-11-07T14:47:14Z","timestamp":1794062834189,"version":"4.8.0"},"reference-count":27,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2017,10,1]],"date-time":"2017-10-01T00:00:00Z","timestamp":1506816000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2018,3,19]],"date-time":"2018-03-19T00:00:00Z","timestamp":1521417600000},"content-version":"am","delay-in-days":169,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["DP2MD010478"],"award-info":[{"award-number":["DP2MD010478"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["U54MD010724"],"award-info":[{"award-number":["U54MD010724"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["F30MH106293"],"award-info":[{"award-number":["F30MH106293"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000025","name":"National Institute of Mental Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000025","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100006545","name":"National Institute on Minority Health and Health Disparities","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100006545","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000001","name":"National Science Foundation","doi-asserted-by":"publisher","award":["1464297"],"award-info":[{"award-number":["1464297"]}],"id":[{"id":"10.13039\/100000001","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000050","name":"National Heart, Lung, and Blood Institute","doi-asserted-by":"publisher","award":["K08HL121056"],"award-info":[{"award-number":["K08HL121056"]}],"id":[{"id":"10.13039\/100000050","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,10]]},"DOI":"10.1016\/s2213-8587(17)30176-6","type":"journal-article","created":{"date-parts":[[2017,7,13]],"date-time":"2017-07-13T05:02:44Z","timestamp":1499922164000},"page":"808-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":115,"title":["Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial"],"prefix":"10.1016","volume":"5","author":[{"given":"Aaron","family":"Baum","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseph","family":"Scarpa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emilie","family":"Bruzelius","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronald","family":"Tamler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanjay","family":"Basu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Faghmous","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30176-6_bib1","doi-asserted-by":"crossref","first-page":"1720","DOI":"10.1056\/NEJMoa1504347","article-title":"Excess mortality among persons with type 2 diabetes","volume":"373","author":"Tancredi","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30176-6_bib2","doi-asserted-by":"crossref","first-page":"1577","DOI":"10.1056\/NEJMoa0806470","article-title":"10-year follow-up of intensive glucose control in type 2 diabetes","volume":"359","author":"Holman","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30176-6_bib3","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1056\/NEJMoa1008862","article-title":"Diabetes mellitus, fasting glucose, and risk of cause-specific death","volume":"364","author":"Seshasai","year":"2011","journal-title":"N Engl J Med"},{"issue":"suppl 2","key":"10.1016\/S2213-8587(17)30176-6_bib4","first-page":"51S","article-title":"Clinical guidelines on the identification, evaluation, and treatment of overweight and obesity in adults\u2014the evidence report. National Institutes of Health","volume":"6","year":"1998","journal-title":"Obes Res"},{"key":"10.1016\/S2213-8587(17)30176-6_bib5","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1017\/S0954422409990035","article-title":"A review and meta-analysis of the effect of weight loss on all-cause mortality risk","volume":"22","author":"Harrington","year":"2009","journal-title":"Nutr Res Rev"},{"key":"10.1016\/S2213-8587(17)30176-6_bib6","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","author":"Wing","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30176-6_bib7","doi-asserted-by":"crossref","first-page":"354","DOI":"10.7326\/M16-1756","article-title":"Detecting heterogeneous treatment effects to guide personalized blood pressure treatment: a modeling study of randomized clinical trials","volume":"166","author":"Basu","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30176-6_bib8","doi-asserted-by":"crossref","first-page":"680","DOI":"10.7326\/0003-4819-154-10-201105170-00008","article-title":"Interpretation of subgroup analyses in randomized trials: heterogeneity versus secondary interventions","volume":"154","author":"VanderWeele","year":"2011","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30176-6_bib10","doi-asserted-by":"crossref","first-page":"7353","DOI":"10.1073\/pnas.1510489113","article-title":"Recursive partitioning for heterogeneous causal effects","volume":"113","author":"Athey","year":"2016","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(17)30176-6_bib11","doi-asserted-by":"crossref","first-page":"2366","DOI":"10.1001\/jama.2016.17563","article-title":"Artificial intelligence with deep learning technology looks into diabetic retinopathy screening","volume":"316","author":"Wong","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30176-6_bib12","doi-asserted-by":"crossref","DOI":"10.1016\/j.csbj.2016.12.005","article-title":"Machine learning and data mining methods in diabetes research","author":"Kavakiotis","year":"2017","journal-title":"Comput Struct Biotechnol J"},{"key":"10.1016\/S2213-8587(17)30176-6_bib13","doi-asserted-by":"crossref","first-page":"277","DOI":"10.1089\/big.2015.0020","article-title":"Population-level prediction of type 2 diabetes from claims data and analysis of risk factors","volume":"3","author":"Razavian","year":"2015","journal-title":"Big Data"},{"key":"10.1016\/S2213-8587(17)30176-6_bib14","author":"Wagner"},{"key":"10.1016\/S2213-8587(17)30176-6_bib15","author":"Athey"},{"key":"10.1016\/S2213-8587(17)30176-6_bib16","doi-asserted-by":"crossref","first-page":"735","DOI":"10.7326\/L15-5093-2","article-title":"Transparent Reporting of a multivariable prediction model for Individual Prognosis Or Diagnosis (TRIPOD)","volume":"162","author":"Collins","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30176-6_bib17","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1186\/1745-6215-11-85","article-title":"Assessing and reporting heterogeneity in treatment effects in clinical trials: a proposal","volume":"11","author":"Kent","year":"2010","journal-title":"Trials"},{"key":"10.1016\/S2213-8587(17)30176-6_bib18","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1097\/00005650-199206000-00002","article-title":"The MOS 36-item short-form health survey (SF-36). I. Conceptual framework and item selection","volume":"30","author":"Ware","year":"1992","journal-title":"Med Care"},{"key":"10.1016\/S2213-8587(17)30176-6_bib19","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30176-6_bib20","doi-asserted-by":"crossref","first-page":"2065","DOI":"10.2337\/dc16-1728","article-title":"Physical activity\/exercise and diabetes: A position statement of the American Diabetes Association","volume":"39","author":"Colberg","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30176-6_bib21","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1007\/s13668-014-0099-x","article-title":"The Look AHEAD rrial: a review and discussion of its outcomes","volume":"3","author":"Pi-Sunyer","year":"2014","journal-title":"Curr Nutr Rep"},{"key":"10.1016\/S2213-8587(17)30176-6_bib22","doi-asserted-by":"crossref","unstructured":"Bennett PH. The Look AHEAD study: a missed opportunity. Lancet Diabetes Endocrinol; 2: 775\u201376.","DOI":"10.1016\/S2213-8587(14)70203-7"},{"key":"10.1016\/S2213-8587(17)30176-6_bib23","doi-asserted-by":"crossref","first-page":"2398","DOI":"10.2337\/dc08-1341","article-title":"Depression and diabetes treatment nonadherence: a meta-analysis","volume":"31","author":"Gonzalez","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(17)30176-6_bib24","doi-asserted-by":"crossref","first-page":"698","DOI":"10.1016\/j.jada.2006.02.011","article-title":"Psychological predictors of physical activity in the diabetes prevention program","volume":"106","author":"Delahanty","year":"2006","journal-title":"J Am Diet Assoc"},{"key":"10.1016\/S2213-8587(17)30176-6_bib25","unstructured":"Association of the magnitude of weight loss and changes in physical fitness with long-term cardiovascular disease outcomes in overweight or obese people with type 2 diabetes: a post-hoc analysis of the Look AHEAD randomised clinical trial. Lancet Diabetes Endocrinol; 4: 91\u201321."},{"key":"10.1016\/S2213-8587(17)30176-6_bib26","doi-asserted-by":"crossref","first-page":"2152","DOI":"10.1056\/NEJMra1510057","article-title":"Integrating randomized comparative effectiveness research with patient care","volume":"374","author":"Fiore","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(17)30176-6_bib27","doi-asserted-by":"crossref","first-page":"e1001986","DOI":"10.1371\/journal.pmed.1001986","article-title":"Pragmatic trials for noncommunicable diseases: relieving constraints","volume":"13","author":"Patel","year":"2016","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(17)30176-6_bib28","doi-asserted-by":"crossref","first-page":"e55","DOI":"10.1136\/bmj.e55","article-title":"Pragmatic randomised trials using routine electronic health records: putting them to the test","volume":"344","author":"Staa","year":"2012","journal-title":"BMJ"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301766?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717301766?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,5,15]],"date-time":"2026-05-15T15:25:28Z","timestamp":1778858728000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717301766"}},"issued":{"date-parts":[[2017,10]]},"references-count":27,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2017,10]]}},"alternative-id":["S2213858717301766"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30176-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting weight loss interventions to reduce cardiovascular complications of type 2 diabetes: a machine learning-based post-hoc analysis of heterogeneous treatment effects in the Look AHEAD trial","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30176-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30238-3","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T13:17:29Z","timestamp":1794316649416,"version":"4.9.0"},"reference-count":100,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2023,3,1]],"date-time":"2023-03-01T00:00:00Z","timestamp":1677628800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100002924","name":"Federaci\u00f3n Espa\u00f1ola de Enfermedades Raras","doi-asserted-by":"publisher","award":["FIS-PI19\/00166"],"award-info":[{"award-number":["FIS-PI19\/00166"]}],"id":[{"id":"10.13039\/501100002924","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003751","name":"Ministerio de Sanidad, Servicios Sociales e Igualdad","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003751","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004587","name":"Instituto de Salud Carlos III","doi-asserted-by":"publisher","award":["PIE14-00005"],"award-info":[{"award-number":["PIE14-00005"]}],"id":[{"id":"10.13039\/501100004587","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100010661","name":"Horizon 2020 Framework Programme","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100010661","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["1R01HD084542"],"award-info":[{"award-number":["1R01HD084542"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["1R21AG061141"],"award-info":[{"award-number":["1R21AG061141"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["GAP-2014-655232"],"award-info":[{"award-number":["GAP-2014-655232"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["R01HD082314"],"award-info":[{"award-number":["R01HD082314"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000780","name":"European Commission","doi-asserted-by":"publisher","award":["R21HD098684"],"award-info":[{"award-number":["R21HD098684"]}],"id":[{"id":"10.13039\/501100000780","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012514","name":"Centro de Investigaci\u00f3n Biom\u00e9dica en Red-Fisiopatolog\u00eda de la Obesidad y Nutrici\u00f3n","doi-asserted-by":"publisher","award":["P12-FQM-01943"],"award-info":[{"award-number":["P12-FQM-01943"]}],"id":[{"id":"10.13039\/501100012514","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["8P51OD011092"],"award-info":[{"award-number":["8P51OD011092"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000009","name":"Foundation for the National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000009","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008143","name":"Oregon National Primate Research Center","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008143","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100006461","name":"Andalucia Innovation and Development Agency","doi-asserted-by":"publisher","award":["P18-RT-4093"],"award-info":[{"award-number":["P18-RT-4093"]}],"id":[{"id":"10.13039\/501100006461","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011011","name":"Junta de Andaluc\u00eda","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011011","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011033","name":"Agencia Estatal de Investigaci\u00f3n","doi-asserted-by":"publisher","award":["PID2020-118660GB-I00"],"award-info":[{"award-number":["PID2020-118660GB-I00"]}],"id":[{"id":"10.13039\/501100011033","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2023,3]]},"DOI":"10.1016\/s2213-8587(22)00339-4","type":"journal-article","created":{"date-parts":[[2023,1,5]],"date-time":"2023-01-05T18:39:56Z","timestamp":1672943996000},"page":"203-216","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":88,"title":["Molecular basis of normal and pathological puberty: from basic mechanisms to clinical implications"],"prefix":"10.1016","volume":"11","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5826-0276","authenticated-orcid":false,"given":"Jes\u00fas","family":"Argente","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4008-8521","authenticated-orcid":false,"given":"Leo","family":"Dunkel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8237-0704","authenticated-orcid":false,"given":"Ursula B","family":"Kaiser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-6782-693X","authenticated-orcid":false,"given":"Ana C","family":"Latronico","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4535-0103","authenticated-orcid":false,"given":"Alejandro","family":"Lomniczi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4268-8870","authenticated-orcid":false,"given":"Leandro","family":"Soriano-Guill\u00e9n","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-4741-5567","authenticated-orcid":false,"given":"Manuel","family":"Tena-Sempere","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00339-4_bib1","doi-asserted-by":"crossref","first-page":"668","DOI":"10.1210\/er.2002-0019","article-title":"The timing of normal puberty and the age limits of sexual precocity: variations around the world, secular trends, and changes after migration","volume":"24","author":"Parent","year":"2003","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(22)00339-4_bib2","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1093\/humupd\/dmx025","article-title":"Disentangling puberty: novel neuroendocrine pathways and mechanisms for the control of mammalian puberty","volume":"23","author":"Avenda\u00f1o","year":"2017","journal-title":"Hum Reprod Update"},{"key":"10.1016\/S2213-8587(22)00339-4_bib3","doi-asserted-by":"crossref","first-page":"291","DOI":"10.1136\/adc.44.235.291","article-title":"Variations in pattern of pubertal changes in girls","volume":"44","author":"Marshall","year":"1969","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(22)00339-4_bib4","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1136\/adc.45.239.13","article-title":"Variations in the pattern of pubertal changes in boys","volume":"45","author":"Marshall","year":"1970","journal-title":"Arch Dis Child"},{"key":"10.1016\/S2213-8587(22)00339-4_bib5","doi-asserted-by":"crossref","first-page":"4305","DOI":"10.1210\/jc.2010-1025","article-title":"Central precocious puberty in children living in Spain: incidence, prevalence, and influence of adoption and immigration","volume":"95","author":"Soriano-Guill\u00e9n","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib6","doi-asserted-by":"crossref","first-page":"1285","DOI":"10.1210\/er.2018-00248","article-title":"Delayed puberty-phenotypic diversity, molecular genetic mechanisms, and recent discoveries","volume":"40","author":"Howard","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(22)00339-4_bib7","article-title":"The congenital and acquired mechanisms implicated in the etiology of central precocious puberty","author":"Brito","year":"2022","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(22)00339-4_bib8","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1016\/S2352-4642(18)30306-7","article-title":"Is there a causal relationship between obesity and puberty?","volume":"3","author":"Reinehr","year":"2019","journal-title":"Lancet Child Adolesc Health"},{"key":"10.1016\/S2213-8587(22)00339-4_bib9","doi-asserted-by":"crossref","DOI":"10.1001\/jamapediatrics.2019.5881","article-title":"Worldwide secular trends in age at pubertal onset assessed by breast development among girls: a systematic review and meta-analysis","volume":"174","author":"Eckert-Lind","year":"2020","journal-title":"JAMA Pediatr"},{"key":"10.1016\/S2213-8587(22)00339-4_bib10","doi-asserted-by":"crossref","DOI":"10.1038\/srep11208","article-title":"Puberty timing associated with diabetes, cardiovascular disease and also diverse health outcomes in men and women: the UK Biobank study","volume":"5","author":"Day","year":"2015","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(22)00339-4_bib11","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1093\/humupd\/dmh001","article-title":"Neurobiological mechanisms of puberty in higher primates","volume":"10","author":"Plant","year":"2004","journal-title":"Hum Reprod Update"},{"key":"10.1016\/S2213-8587(22)00339-4_bib12","first-page":"111","article-title":"Neurobiological mechanisms of the onset of puberty in primates","volume":"22","author":"Terasawa","year":"2001","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(22)00339-4_bib13","doi-asserted-by":"crossref","DOI":"10.1016\/j.yfrne.2021.100977","article-title":"Kisspeptins and the neuroendocrine control of reproduction: Recent progress and new frontiers in kisspeptin research","volume":"65","author":"Sobrino","year":"2022","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/S2213-8587(22)00339-4_bib14","doi-asserted-by":"crossref","first-page":"3214","DOI":"10.1210\/en.2008-1733","article-title":"Postnatal development of an estradiol-kisspeptin positive feedback mechanism implicated in puberty onset","volume":"150","author":"Clarkson","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(22)00339-4_bib15","doi-asserted-by":"crossref","first-page":"10972","DOI":"10.1073\/pnas.1834399100","article-title":"Hypogonadotropic hypogonadism due to loss of function of the KiSS1-derived peptide receptor GPR54","volume":"100","author":"de Roux","year":"2003","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(22)00339-4_bib16","doi-asserted-by":"crossref","first-page":"1614","DOI":"10.1056\/NEJMoa035322","article-title":"The GPR54 gene as a regulator of puberty","volume":"349","author":"Seminara","year":"2003","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00339-4_bib17","doi-asserted-by":"crossref","first-page":"1235","DOI":"10.1152\/physrev.00037.2010","article-title":"Kisspeptins and reproduction: physiological roles and regulatory mechanisms","volume":"92","author":"Pinilla","year":"2012","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(22)00339-4_bib18","doi-asserted-by":"crossref","first-page":"5817","DOI":"10.1210\/en.2006-0787","article-title":"Postnatal development of kisspeptin neurons in mouse hypothalamus; sexual dimorphism and projections to gonadotropin-releasing hormone neurons","volume":"147","author":"Clarkson","year":"2006","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(22)00339-4_bib19","doi-asserted-by":"crossref","first-page":"275","DOI":"10.1016\/j.peptides.2009.11.017","article-title":"Maturation of kisspeptinergic neurons coincides with puberty onset in male rats","volume":"31","author":"Bentsen","year":"2010","journal-title":"Peptides"},{"key":"10.1016\/S2213-8587(22)00339-4_bib20","doi-asserted-by":"crossref","first-page":"E10216","DOI":"10.1073\/pnas.1713897114","article-title":"Definition of the hypothalamic GnRH pulse generator in mice","volume":"114","author":"Clarkson","year":"2017","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(22)00339-4_bib21","doi-asserted-by":"crossref","first-page":"521","DOI":"10.1038\/s41574-022-00703-5","article-title":"Origins of the \u2018KNDy hypothesis\u2019 of GnRH pulse generation","volume":"18","author":"Lehman","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(22)00339-4_bib22","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0183596","article-title":"Role of amygdala kisspeptin in pubertal timing in female rats","volume":"12","author":"Adekunbi","year":"2017","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(22)00339-4_bib23","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-022-32347-4","article-title":"Dicer ablation in KISS1 neurons impairs puberty and fertility preferentially in female mice","volume":"13","author":"Roa","year":"2022","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(22)00339-4_bib24","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1038\/nn.4298","article-title":"A microRNA switch regulates the rise in hypothalamic GnRH production before puberty","volume":"19","author":"Messina","year":"2016","journal-title":"Nat Neurosci"},{"key":"10.1016\/S2213-8587(22)00339-4_bib25","doi-asserted-by":"crossref","first-page":"354","DOI":"10.1038\/ng.306","article-title":"TAC3 and TACR3 mutations in familial hypogonadotropic hypogonadism reveal a key role for Neurokinin B in the central control of reproduction","volume":"41","author":"Topaloglu","year":"2009","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(22)00339-4_bib26","doi-asserted-by":"crossref","first-page":"2388","DOI":"10.1523\/JNEUROSCI.4288-11.2012","article-title":"Role of neurokinin B in the control of female puberty and its modulation by metabolic status","volume":"32","author":"Navarro","year":"2012","journal-title":"J Neurosci"},{"key":"10.1016\/S2213-8587(22)00339-4_bib27","doi-asserted-by":"crossref","first-page":"2319","DOI":"10.1210\/en.2016-1807","article-title":"TAC1 signaling is required for sexual maturation and responsiveness of GnRH neurons to kisspeptin in the male mouse","volume":"158","author":"Maguire","year":"2017","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(22)00339-4_bib28","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1016\/j.molmet.2016.08.003","article-title":"Defining a novel leptin-melanocortin-kisspeptin pathway involved in the metabolic control of puberty","volume":"5","author":"Manfredi-Lozano","year":"2016","journal-title":"Mol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib29","doi-asserted-by":"crossref","first-page":"436","DOI":"10.1038\/s41586-021-04088-9","article-title":"MC3R links nutritional state to childhood growth and the timing of puberty","volume":"599","author":"Lam","year":"2021","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(22)00339-4_bib30","doi-asserted-by":"crossref","DOI":"10.1210\/jendso\/bvab152","article-title":"Emerging roles of epigenetics in the control of reproductive function: focus on central neuroendocrine mechanisms","volume":"5","author":"Vazquez","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(22)00339-4_bib31","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1038\/nn.3319","article-title":"Epigenetic control of female puberty","volume":"16","author":"Lomniczi","year":"2013","journal-title":"Nat Neurosci"},{"key":"10.1016\/S2213-8587(22)00339-4_bib32","doi-asserted-by":"crossref","DOI":"10.1038\/s41598-021-81689-4","article-title":"Polycomb represses a gene network controlling puberty via modulation of histone demethylase Kdm6b expression","volume":"11","author":"Wright","year":"2021","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(22)00339-4_bib33","doi-asserted-by":"crossref","first-page":"57","DOI":"10.1038\/s41467-017-02512-1","article-title":"Trithorax dependent changes in chromatin landscape at enhancer and promoter regions drive female puberty","volume":"9","author":"Toro","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(22)00339-4_bib34","doi-asserted-by":"crossref","DOI":"10.1038\/ncomms10195","article-title":"Epigenetic regulation of puberty via Zinc finger protein-mediated transcriptional repression","volume":"6","author":"Lomniczi","year":"2015","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(22)00339-4_bib35","doi-asserted-by":"crossref","DOI":"10.1038\/s41467-018-06459-9","article-title":"SIRT1 mediates obesity- and nutrient-dependent perturbation of pubertal timing by epigenetically controlling Kiss1 expression","volume":"9","author":"Vazquez","year":"2018","journal-title":"Nat Commun"},{"key":"10.1016\/S2213-8587(22)00339-4_bib36","article-title":"Pubertal development in healthy children is mirrored by DNA methylation patterns in peripheral blood","volume":"6","author":"Almstrup","year":"2016","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(22)00339-4_bib37","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1186\/s13148-019-0780-4","article-title":"Changes in DNA methylation from pre- to post-adolescence are associated with pubertal exposures","volume":"11","author":"Han","year":"2019","journal-title":"Clin Epigenetics"},{"key":"10.1016\/S2213-8587(22)00339-4_bib38","doi-asserted-by":"crossref","DOI":"10.1093\/hropen\/hoaa006","article-title":"Age at onset of different pubertal signs in boys and girls and differential DNA methylation at age 10 and 18 years: an epigenome-wide follow-up study","volume":"2020","author":"Chen","year":"2020","journal-title":"Hum Reprod Open"},{"key":"10.1016\/S2213-8587(22)00339-4_bib39","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12864-020-06789-3","article-title":"Distinctions between sex and time in patterns of DNA methylation across puberty","volume":"21","author":"Moore","year":"2020","journal-title":"BMC Genomics"},{"key":"10.1016\/S2213-8587(22)00339-4_bib40","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1080\/15592294.2019.1640547","article-title":"Epigenome-wide association study of DNA methylation and microRNA expression highlights novel pathways for human complex traits","volume":"15","author":"Huan","year":"2020","journal-title":"Epigenetics"},{"key":"10.1016\/S2213-8587(22)00339-4_bib41","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1186\/s13148-018-0581-1","article-title":"Methylome profiling of healthy and central precocious puberty girls","volume":"10","author":"Bessa","year":"2018","journal-title":"Clin Epigenetics"},{"key":"10.1016\/S2213-8587(22)00339-4_bib42","doi-asserted-by":"crossref","first-page":"R51","DOI":"10.1530\/JOE-19-0223","article-title":"Novel mechanisms for the metabolic control of puberty: implications for pubertal alterations in early-onset obesity and malnutrition","volume":"242","author":"Vazquez","year":"2019","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(22)00339-4_bib43","first-page":"469","article-title":"Components of weight at menarche and the initiation of the adolescent growth spurt in girls: estimated total water, llean body weight and fat","volume":"45","author":"Frisch","year":"1973","journal-title":"Hum Biol"},{"key":"10.1016\/S2213-8587(22)00339-4_bib44","doi-asserted-by":"crossref","first-page":"2349","DOI":"10.1152\/physrev.00033.2017","article-title":"Neuroanatomical framework of the metabolic control of reproduction","volume":"98","author":"Hill","year":"2018","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(22)00339-4_bib45","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.mce.2009.12.017","article-title":"Metabolic signals in human puberty: effects of over and undernutrition","volume":"324","author":"Martos-Moreno","year":"2010","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(22)00339-4_bib46","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1111\/j.2047-6310.2013.00176.x","article-title":"Timing of puberty and physical growth in obese children: a longitudinal study in boys and girls","volume":"9","author":"De Leonibus","year":"2014","journal-title":"Pediatr Obes"},{"key":"10.1016\/S2213-8587(22)00339-4_bib47","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1159\/000346055","article-title":"Ghrelin, the gonadal axis and the onset of puberty","volume":"25","author":"Tena-Sempere","year":"2013","journal-title":"Endocr Dev"},{"key":"10.1016\/S2213-8587(22)00339-4_bib48","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/humupd\/dms024","article-title":"Female reproduction and type 1 diabetes: from mechanisms to clinical findings","volume":"18","author":"Codner","year":"2012","journal-title":"Hum Reprod Update"},{"key":"10.1016\/S2213-8587(22)00339-4_bib49","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1080\/10408398.2010.500245","article-title":"Cross-talk between AMPK and mTOR in regulating energy balance","volume":"52","author":"Xu","year":"2012","journal-title":"Crit Rev Food Sci Nutr"},{"key":"10.1016\/S2213-8587(22)00339-4_bib50","doi-asserted-by":"crossref","first-page":"5016","DOI":"10.1210\/en.2009-0096","article-title":"The mammalian target of rapamycin as novel central regulator of puberty onset via modulation of hypothalamic KISS1 system","volume":"150","author":"Roa","year":"2009","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(22)00339-4_bib51","doi-asserted-by":"crossref","first-page":"E10758","DOI":"10.1073\/pnas.1802053115","article-title":"Metabolic regulation of female puberty via hypothalamic AMPK-kisspeptin signaling","volume":"115","author":"Roa","year":"2018","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(22)00339-4_bib52","doi-asserted-by":"crossref","first-page":"951","DOI":"10.1016\/j.cmet.2020.10.001","article-title":"Central ceramide signaling mediates obesity-induced precocious puberty","volume":"32","author":"Heras","year":"2020","journal-title":"Cell Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib53","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/j.jchemneu.2014.05.005","article-title":"Chemical identity of hypothalamic neurons engaged by leptin in reproductive control","volume":"61-62","author":"Ratra","year":"2014","journal-title":"J Chem Neuroanat"},{"key":"10.1016\/S2213-8587(22)00339-4_bib54","doi-asserted-by":"crossref","DOI":"10.7554\/eLife.35960","article-title":"PACAP neurons in the ventral premammillary nucleus regulate reproductive function in the female mouse","volume":"7","author":"Ross","year":"2018","journal-title":"eLife"},{"key":"10.1016\/S2213-8587(22)00339-4_bib55","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2020.154460","article-title":"AMP-activated protein kinase (AMPK) signaling in GnRH neurons links energy status and reproduction","volume":"115","author":"Franssen","year":"2021","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(22)00339-4_bib56","doi-asserted-by":"crossref","DOI":"10.1016\/j.metabol.2022.155141","article-title":"Connecting nutritional deprivation and pubertal inhibition via GRK2-mediated repression of kisspeptin actions in GnRH neurons","volume":"129","author":"Perdices-Lopez","year":"2022","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(22)00339-4_bib57","doi-asserted-by":"crossref","first-page":"R107","DOI":"10.1530\/EJE-20-0103","article-title":"GENETICS IN ENDOCRINOLOGY: Genetic etiologies of central precocious puberty and the role of imprinted genes","volume":"183","author":"Roberts","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(22)00339-4_bib58","doi-asserted-by":"crossref","first-page":"709","DOI":"10.1056\/NEJMoa073443","article-title":"A GPR54-activating mutation in a patient with central precocious puberty","volume":"358","author":"Teles","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00339-4_bib59","doi-asserted-by":"crossref","first-page":"1616","DOI":"10.1210\/en.2010-0903","article-title":"KISS1R intracellular trafficking and degradation: effect of the Arg386Pro disease-associated mutation","volume":"152","author":"Bianco","year":"2011","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(22)00339-4_bib60","doi-asserted-by":"crossref","first-page":"2276","DOI":"10.1210\/jc.2009-2421","article-title":"Mutations of the KISS1 gene in disorders of puberty","volume":"95","author":"Silveira","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib61","doi-asserted-by":"crossref","first-page":"2467","DOI":"10.1056\/NEJMoa1302160","article-title":"Central precocious puberty caused by mutations in the imprinted gene MKRN3","volume":"368","author":"Abreu","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00339-4_bib62","doi-asserted-by":"crossref","first-page":"979","DOI":"10.1210\/js.2019-00041","article-title":"MKRN3 mutations in central precocious puberty: a systematic review and meta-analysis","volume":"3","author":"Valadares","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(22)00339-4_bib63","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1210\/clinem\/dgaa955","article-title":"Genotype-phenotype correlations in central precocious puberty caused by MKRN3 mutations","volume":"106","author":"Seraphim","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib64","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pbio.3000532","article-title":"Hypothalamic miR-30 regulates puberty onset via repression of the puberty-suppressing factor, MKRN3","volume":"17","author":"Heras","year":"2019","journal-title":"PLoS Biol"},{"key":"10.1016\/S2213-8587(22)00339-4_bib65","first-page":"4486","article-title":"MKRN3 inhibits the reproductive axis through actions in kisspeptin-expressing neurons","volume":"130","author":"Abreu","year":"2020","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(22)00339-4_bib66","doi-asserted-by":"crossref","first-page":"48","DOI":"10.3389\/fendo.2019.00048","article-title":"mkrn3 interacts with several proteins implicated in puberty timing but does not influence GNRH1 expression","volume":"10","author":"Yellapragada","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(22)00339-4_bib67","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/nsr\/nwaa023","article-title":"MKRN3 regulates the epigenetic switch of mammalian puberty via ubiquitination of MBD3","volume":"7","author":"Li","year":"2020","journal-title":"Natl Sci Rev"},{"key":"10.1016\/S2213-8587(22)00339-4_bib68","doi-asserted-by":"crossref","first-page":"3796","DOI":"10.1093\/nar\/gkab155","article-title":"MKRN3-mediated ubiquitination of Poly(A)-binding proteins modulates the stability and translation of GNRH1 mRNA in mammalian puberty","volume":"49","author":"Li","year":"2021","journal-title":"Nucleic Acids Res"},{"key":"10.1016\/S2213-8587(22)00339-4_bib69","doi-asserted-by":"crossref","DOI":"10.1210\/endocr\/bqac132","article-title":"Hypothalamic overexpression of makorin ring finger protein 3 results in delayed puberty in female mice","volume":"163","author":"Roberts","year":"2022","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(22)00339-4_bib70","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1210\/jc.2016-3677","article-title":"Paternally inherited dlk1 deletion associated with familial central precocious puberty","volume":"102","author":"Dauber","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib71","doi-asserted-by":"crossref","first-page":"2112","DOI":"10.1210\/jc.2018-02010","article-title":"DLK1 Is a novel link between reproduction and metabolism","volume":"104","author":"Gomes","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib72","doi-asserted-by":"crossref","DOI":"10.1210\/clinem\/dgaa461","article-title":"Novel genetic and biochemical findings of dlk1 in children with central precocious puberty: a Brazilian-Spanish study","volume":"105","author":"Montenegro","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib73","doi-asserted-by":"crossref","DOI":"10.3389\/fped.2022.968485","article-title":"Gonadotropin-releasing hormone analog therapies for children with central precocious puberty in the United States","volume":"10","author":"Popovic","year":"2022","journal-title":"Front Pediatr"},{"key":"10.1016\/S2213-8587(22)00339-4_bib74","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.01.003","article-title":"Central precocious puberty, functional and tumor-related","volume":"33","author":"Soriano-Guill\u00e9n","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib75","doi-asserted-by":"crossref","DOI":"10.1016\/j.beem.2019.04.007","article-title":"Peripheral precocious puberty including congenital adrenal hyperplasia: causes, consequences, management and outcomes","volume":"33","author":"Haddad","year":"2019","journal-title":"Best Pract Res Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib76","doi-asserted-by":"crossref","first-page":"1980","DOI":"10.1210\/jc.2015-3500","article-title":"The etiology and clinical features of non-CAH gonadotropin-independent precocious puberty: a multicenter study","volume":"101","author":"Atay","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib77","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1016\/S0140-6736(17)31431-9","article-title":"Congenital adrenal hyperplasia","volume":"390","author":"El-Maouche","year":"2017","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00339-4_bib78","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1056\/NEJMra1909786","article-title":"Congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"383","author":"Merke","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00339-4_bib79","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/endrev\/bnz011","article-title":"Fibrous dysplasia\/McCune-Albright syndrome: a rare, mosaic disease of G\u03b1s activation","volume":"41","author":"Boyce","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(22)00339-4_bib80","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1159\/000504802","article-title":"The clinical spectrum of McCune-Albright syndrome and its management","volume":"92","author":"Spencer","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(22)00339-4_bib81","doi-asserted-by":"crossref","first-page":"E1782","DOI":"10.1210\/jc.2012-1791","article-title":"Characterization and management of testicular pathology in McCune-Albright syndrome","volume":"97","author":"Boyce","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib82","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.906852","article-title":"Long-term treatment with letrozole in a boy with familial male-limited precocious puberty","volume":"13","author":"Yuan","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(22)00339-4_bib83","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1159\/000495189","article-title":"Gonadotropin- and adrenocorticotropic hormone-independent precocious puberty of gonadal origin in a patient with adrenal hypoplasia congenita due to DAX1 gene mutation\u2014a case report and review of the literature: implications for the pathomechanism","volume":"91","author":"Nagel","year":"2019","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(22)00339-4_bib84","doi-asserted-by":"crossref","first-page":"3073","DOI":"10.1007\/s00431-021-04022-1","article-title":"Diagnosis and management of precocious sexual maturation: an updated review","volume":"180","author":"Cheuiche","year":"2021","journal-title":"Eur J Pediatr"},{"key":"10.1016\/S2213-8587(22)00339-4_bib85","series-title":"Textbook Pediatric Endocrinology and Inborn Errors of Metabolism","first-page":"643","article-title":"Precocious puberty","author":"Soriano-Guill\u00e9n","year":"2017"},{"key":"10.1016\/S2213-8587(22)00339-4_bib86","article-title":"Precocious puberty","volume":"368","author":"Bradley","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(22)00339-4_bib87","doi-asserted-by":"crossref","first-page":"443","DOI":"10.1056\/NEJMcp1109290","article-title":"Clinical practice. Delayed puberty","volume":"366","author":"Palmert","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00339-4_bib88","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1210\/er.2018-00116","article-title":"Clinical management of congenital hypogonadotropic hypogonadism","volume":"40","author":"Young","year":"2019","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(22)00339-4_bib89","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1530\/eje.1.02315","article-title":"Treatment of gonadotropin-deficient boys with recombinant human FSH: long-term observation and outcome","volume":"156","author":"Raivio","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(22)00339-4_bib90","doi-asserted-by":"crossref","first-page":"R55","DOI":"10.1530\/EJE-17-0749","article-title":"Genetics in endocrinology: genetic counseling for congenital hypogonadotropic hypogonadism and Kallmann syndrome: new challenges in the era of oligogenism and next-generation sequencing","volume":"178","author":"Maione","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(22)00339-4_bib91","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1172\/JCI29884","article-title":"Digenic mutations account for variable phenotypes in idiopathic hypogonadotropic hypogonadism","volume":"117","author":"Pitteloud","year":"2007","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(22)00339-4_bib92","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1056\/NEJMoa066494","article-title":"Reversal of idiopathic hypogonadotropic hypogonadism","volume":"357","author":"Raivio","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00339-4_bib93","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1038\/nrendo.2015.112","article-title":"Expert consensus document: European Consensus Statement on congenital hypogonadotropic hypogonadism\u2014pathogenesis, diagnosis and treatment","volume":"11","author":"Boehm","year":"2015","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(22)00339-4_bib94","doi-asserted-by":"crossref","first-page":"723","DOI":"10.1210\/jc.2007-1786","article-title":"Patterns of inheritance of constitutional delay of growth and puberty in families of adolescent girls and boys referred to specialist pediatric care","volume":"93","author":"Wehkalampi","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib95","doi-asserted-by":"crossref","first-page":"617","DOI":"10.1530\/EJE-21-0387","article-title":"Genetic evaluation supports differential diagnosis in adolescent patients with delayed puberty","volume":"185","author":"Saengkaew","year":"2021","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(22)00339-4_bib96","doi-asserted-by":"crossref","first-page":"626","DOI":"10.15252\/emmm.201606250","article-title":"IGSF10 mutations dysregulate gonadotropin-releasing hormone neuronal migration resulting in delayed puberty","volume":"8","author":"Howard","year":"2016","journal-title":"EMBO Mol Med"},{"key":"10.1016\/S2213-8587(22)00339-4_bib97","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1093\/hmg\/ddy451","article-title":"EAP1 regulation of GnRH promoter activity is important for human pubertal timing","volume":"28","author":"Mancini","year":"2019","journal-title":"Hum Mol Genet"},{"key":"10.1016\/S2213-8587(22)00339-4_bib98","doi-asserted-by":"crossref","first-page":"649","DOI":"10.1210\/jc.2017-02147","article-title":"Contributions of function-altering variants in genes implicated in pubertal timing and body mass for self-limited delayed puberty","volume":"103","author":"Howard","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(22)00339-4_bib99","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1007\/s00439-020-02148-0","article-title":"Molecular genetic diagnostics of hypogonadotropic hypogonadism: from panel design towards result interpretation in clinical practice","volume":"140","author":"Butz","year":"2021","journal-title":"Hum Genet"},{"key":"10.1016\/S2213-8587(22)00339-4_bib100","doi-asserted-by":"crossref","first-page":"377","DOI":"10.1530\/EJE-17-0568","article-title":"Congenital hypogonadotropic hypogonadism and constitutional delay of growth and puberty have distinct genetic architectures","volume":"178","author":"Cassatella","year":"2018","journal-title":"Eur J Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722003394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:22Z","timestamp":1761991942000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722003394"}},"issued":{"date-parts":[[2023,3]]},"references-count":100,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2023,3]]}},"alternative-id":["S2213858722003394"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00339-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2023,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Molecular basis of normal and pathological puberty: from basic mechanisms to clinical implications","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00339-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T07:56:32Z","timestamp":1794297392252,"version":"4.9.0"},"reference-count":32,"publisher":"Elsevier BV","issue":"9","license":[{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,9,1]],"date-time":"2024-09-01T00:00:00Z","timestamp":1725148800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,2]],"date-time":"2024-07-02T00:00:00Z","timestamp":1719878400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100023233","name":"National Institute for Health and Care Research Applied Research Collaboration Oxford and Thames Valley","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100023233","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000272","name":"National Institute for Health and Care Research","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000272","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013342","name":"NIHR Imperial Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013342","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013373","name":"NIHR Oxford Biomedical Research Centre","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100013373","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,9]]},"DOI":"10.1016\/s2213-8587(24)00194-3","type":"journal-article","created":{"date-parts":[[2024,8,5]],"date-time":"2024-08-05T18:32:09Z","timestamp":1722882729000},"page":"653-663","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":74,"title":["Early findings from the NHS Type 2 Diabetes Path to Remission Programme: a prospective evaluation of real-world implementation"],"prefix":"10.1016","volume":"12","author":[{"given":"Jonathan","family":"Valabhji","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tessa","family":"Gorton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emma","family":"Barron","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soraya","family":"Safazadeh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiona","family":"Earnshaw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Clare","family":"Helm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Virr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Kernan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaun","family":"Crowe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Aveyard","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wilding","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tony","family":"Willis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Louisa","family":"Ells","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simon","family":"O'Neill","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Robertson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susan","family":"Jebb","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roy","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chirag","family":"Bakhai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00194-3_bib1","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1007\/s00125-011-2204-7","article-title":"Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol","volume":"54","author":"Lim","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00194-3_bib2","doi-asserted-by":"crossref","first-page":"808","DOI":"10.2337\/dc15-1942","article-title":"Very low-calorie diet and 6 months of weight stability in type 2 diabetes: pathophysiological changes in responders and nonresponders","volume":"39","author":"Steven","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00194-3_bib3","doi-asserted-by":"crossref","first-page":"1047","DOI":"10.2337\/dc12-1805","article-title":"Type 2 diabetes: etiology and reversibility","volume":"36","author":"Taylor","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00194-3_bib4","doi-asserted-by":"crossref","first-page":"541","DOI":"10.1016\/S0140-6736(17)33102-1","article-title":"Primary care-led weight management for remission of type 2 diabetes (DiRECT): an open-label, cluster-randomised trial","volume":"391","author":"Lean","year":"2018","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(24)00194-3_bib5","doi-asserted-by":"crossref","first-page":"k3760","DOI":"10.1136\/bmj.k3760","article-title":"Doctor referral of overweight people to low energy total diet replacement treatment (DROPLET): pragmatic randomised controlled trial","volume":"362","author":"Astbury","year":"2018","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(24)00194-3_bib6","doi-asserted-by":"crossref","first-page":"1554","DOI":"10.1111\/dme.13426","article-title":"Acceptability of a very low-energy diet in type 2 diabetes; patient experiences and behaviour regulation","volume":"34","author":"Rehackova","year":"2017","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00194-3_bib7","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/dme.14066","article-title":"Behaviour change during dietary type 2 diabetes remission: a longitudinal qualitative evaluation of an intervention using a very low energy diet","volume":"37","author":"Rehackova","year":"2020","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00194-3_bib8","unstructured":"Ells LJ, Brown TJ, Matu J, et al. Evaluation of the NHS England Low-Calorie Diet implementation pilot: a coproduced mixed method study. Health Soc Care Deliv Res (in press)."},{"key":"10.1016\/S2213-8587(24)00194-3_bib9","author":"NHS England"},{"key":"10.1016\/S2213-8587(24)00194-3_bib10","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/S2213-8587(24)00194-3_bib11","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/S2213-8587(24)00194-3_bib12","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/S2213-8587(24)00194-3_bib13","author":"National Institute for Health and Care Excellence"},{"key":"10.1016\/S2213-8587(24)00194-3_bib14","doi-asserted-by":"crossref","first-page":"e001703","DOI":"10.1136\/bmjdrc-2020-001703","article-title":"Experience of point-of-care HbA1c testing in the English National Health Service Diabetes Prevention Programme: an observational study","volume":"8","author":"Barron","year":"2020","journal-title":"BMJ Open Diabetes Res Care"},{"key":"10.1016\/S2213-8587(24)00194-3_bib15","doi-asserted-by":"crossref","first-page":"e14616","DOI":"10.1111\/dme.14616","article-title":"Cohort profile: National Diabetes Audit for England and Wales","volume":"38","author":"Holman","year":"2021","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00194-3_bib16","doi-asserted-by":"crossref","first-page":"2438","DOI":"10.2337\/dci21-0034","article-title":"Consensus report: definition and interpretation of remission in type 2 diabetes","volume":"44","author":"Riddle","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00194-3_bib17","author":"UK Government"},{"key":"10.1016\/S2213-8587(24)00194-3_bib18","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/obr.12366","article-title":"Clinical effectiveness of very-low-energy diets in the management of weight loss: a systematic review and meta-analysis of randomized controlled trials","volume":"17","author":"Parretti","year":"2016","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(24)00194-3_bib19","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/S2213-8587(20)30117-0","article-title":"Effect of intensive lifestyle intervention on bodyweight and glycaemia in early type 2 diabetes (DIADEM-I): an open-label, parallel-group, randomised controlled trial","volume":"8","author":"Taheri","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00194-3_bib20","doi-asserted-by":"crossref","first-page":"1415","DOI":"10.1210\/clinem\/dgac661","article-title":"Effect of an intermittent calorie-restricted diet on type 2 diabetes remission: a randomized controlled trial","volume":"108","author":"Yang","year":"2023","journal-title":"J Clin Endocrinol Metabol"},{"key":"10.1016\/S2213-8587(24)00194-3_bib21","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S2213-8587(23)00385-6","article-title":"5-year follow-up of the randomised Diabetes Remission Clinical Trial (DiRECT) of continued support for weight loss maintenance in the UK: an extension study","volume":"12","author":"Lean","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00194-3_bib22","doi-asserted-by":"crossref","first-page":"459","DOI":"10.1007\/s00125-023-06048-6","article-title":"Impact of remission from type 2 diabetes on long-term health outcomes: findings from the Look AHEAD study","volume":"67","author":"Gregg","year":"2024","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(24)00194-3_bib23","doi-asserted-by":"crossref","first-page":"344","DOI":"10.1016\/S2213-8587(19)30068-3","article-title":"Durability of a primary care-led weight-management intervention for remission of type 2 diabetes: 2-year results of the DiRECT open-label, cluster-randomised trial","volume":"7","author":"Lean","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00194-3_bib24","doi-asserted-by":"crossref","first-page":"53","DOI":"10.1186\/s12913-023-10501-y","article-title":"Commercial provider staff experiences of the NHS Low Calorie Diet Programme pilot: a qualitative exploration of key barriers and facilitators","volume":"24","author":"Jones","year":"2024","journal-title":"BMC Health Serv Res"},{"key":"10.1016\/S2213-8587(24)00194-3_bib25","doi-asserted-by":"crossref","first-page":"e079939","DOI":"10.1136\/bmjopen-2023-079939","article-title":"South Asian individuals\u2019 experiences on the NHS low-calorie diet programme: a qualitative study in community settings in England","volume":"13","author":"Dhir","year":"2023","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(24)00194-3_bib26","doi-asserted-by":"crossref","first-page":"152","DOI":"10.2337\/dc19-1425","article-title":"Early outcomes from the English National Health Service Diabetes Prevention Programme","volume":"43","author":"Valabhji","year":"2020","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00194-3_bib27","doi-asserted-by":"crossref","first-page":"100111","DOI":"10.1016\/j.lansea.2022.100111","article-title":"Dietary weight-management for type 2 diabetes remissions in South Asians: the South Asian diabetes remission randomised trial for proof-of-concept and feasibility (STANDby)","volume":"9","author":"Sattar","year":"2023","journal-title":"Lancet Reg Health Southeast Asia"},{"key":"10.1016\/S2213-8587(24)00194-3_bib28","doi-asserted-by":"crossref","first-page":"e15016","DOI":"10.1111\/dme.15016","article-title":"Care processes in people in remission from type 2 diabetes: a cohort study using the National Diabetes Audit","volume":"40","author":"Holman","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00194-3_bib29","doi-asserted-by":"crossref","first-page":"e173","DOI":"10.2196\/jmir.3332","article-title":"Longitudinal accuracy of web-based self-reported weights: results from the Hopkins POWER Trial","volume":"16","author":"Jerome","year":"2014","journal-title":"J Med Internet Res"},{"key":"10.1016\/S2213-8587(24)00194-3_bib30","doi-asserted-by":"crossref","first-page":"e0231229","DOI":"10.1371\/journal.pone.0231229","article-title":"Validation of self-reported height and weight in a large, nationwide cohort of U.S. adults","volume":"15","author":"Hodge","year":"2020","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(24)00194-3_bib31","doi-asserted-by":"crossref","first-page":"1333","DOI":"10.1042\/CS20230586","article-title":"Aetiology of type 2 diabetes in people with a 'normal\u2019 body mass index: testing the personal fat threshold hypothesis","volume":"137","author":"Taylor","year":"2023","journal-title":"Clin Sci (Lond)"},{"key":"10.1016\/S2213-8587(24)00194-3_bib32","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/S2213-8587(24)00067-6","article-title":"Bridging the worlds of research and policy making","volume":"12","author":"Valabhji","year":"2024","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001943?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724001943?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T08:09:19Z","timestamp":1736842159000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724001943"}},"issued":{"date-parts":[[2024,9]]},"references-count":32,"journal-issue":{"issue":"9","published-print":{"date-parts":[[2024,9]]}},"alternative-id":["S2213858724001943"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00194-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,9]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Early findings from the NHS Type 2 Diabetes Path to Remission Programme: a prospective evaluation of real-world implementation","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00194-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T03:13:01Z","timestamp":1794366781886,"version":"4.9.0"},"reference-count":118,"publisher":"Elsevier BV","issue":"7","license":[{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,7,1]],"date-time":"2020-07-01T00:00:00Z","timestamp":1593561600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,7]]},"DOI":"10.1016\/s2213-8587(20)30122-4","type":"journal-article","created":{"date-parts":[[2020,6,16]],"date-time":"2020-06-16T18:50:25Z","timestamp":1592333425000},"page":"628-639","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":48,"title":["Adrenal crises in older patients"],"prefix":"10.1016","volume":"8","author":[{"given":"Ruth L","family":"Rushworth","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David J","family":"Torpy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henrik","family":"Falhammar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30122-4_bib1","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1210\/jc.2014-3191","article-title":"High incidence of adrenal crisis in educated patients with chronic adrenal insufficiency: a prospective study","volume":"100","author":"Hahner","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib2","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1530\/EJE-08-0550","article-title":"Normal overall mortality rate in Addison's disease, but young patients are at risk of premature death","volume":"160","author":"Erichsen","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib3","doi-asserted-by":"crossref","first-page":"e2715","DOI":"10.1210\/jc.2014-2957","article-title":"Increased mortality in patients with congenital adrenal hyperplasia due to 21-hydroxylase deficiency","volume":"99","author":"Falhammar","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib4","doi-asserted-by":"crossref","first-page":"1466","DOI":"10.1210\/jc.2012-4059","article-title":"Deaths among adult patients with hypopituitarism: hypocortisolism during acute stress, and de novo malignant brain tumors contribute to an increased mortality","volume":"98","author":"Burman","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib5","doi-asserted-by":"crossref","first-page":"4849","DOI":"10.1210\/jc.2006-0076","article-title":"Premature mortality in patients with Addison's disease: a population-based study","volume":"91","author":"Bergthorsdottir","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib6","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1016\/S0140-6736(00)04006-X","article-title":"Association between premature mortality and hypopituitarism","volume":"357","author":"Tomlinson","year":"2001","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(20)30122-4_bib7","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1111\/j.1365-2265.2008.03340.x","article-title":"Increased death risk and altered cancer incidence pattern in patients with isolated or combined autoimmune primary adrenocortical insufficiency","volume":"69","author":"Bensing","year":"2008","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib8","doi-asserted-by":"crossref","first-page":"701","DOI":"10.1530\/EJE-19-0469","article-title":"Association of adrenal insufficiency with patient-oriented health-care outcomes in adult medical inpatients","volume":"181","author":"Ebrahimi","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib9","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1186\/1472-6823-14-79","article-title":"A descriptive study of adrenal crises in adults with adrenal insufficiency: increased risk with age and in those with bacterial infections","volume":"14","author":"Rushworth","year":"2014","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(20)30122-4_bib10","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1620\/tjem.221.281","article-title":"Adrenal insufficiency in the elderly: a nationwide study of hospitalizations in Taiwan","volume":"221","author":"Chen","year":"2010","journal-title":"Tohoku J Exp Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib11","doi-asserted-by":"crossref","first-page":"R115","DOI":"10.1530\/EJE-14-0824","article-title":"Extensive expertise in endocrinology. Adrenal crisis","volume":"172","author":"Allolio","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib12","doi-asserted-by":"crossref","first-page":"364","DOI":"10.1210\/jc.2015-1710","article-title":"Diagnosis and treatment of primary adrenal insufficiency: an Endocrine Society clinical practice guideline","volume":"101","author":"Bornstein","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib13","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1056\/NEJMra1807486","article-title":"Adrenal crisis","volume":"381","author":"Rushworth","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib14","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1055\/s-0034-1395680","article-title":"Adrenal insufficiency in Australia: is it possible that the use of lower dose, short-acting glucocorticoids has increased the risk of adrenal crises?","volume":"47","author":"Rushworth","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(20)30122-4_bib15","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1046\/j.1365-2265.2001.01406.x","article-title":"Prevalence and incidence of hypopituitarism in an adult Caucasian population in northwestern Spain","volume":"55","author":"Regal","year":"2001","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib16","doi-asserted-by":"crossref","first-page":"336","DOI":"10.1007\/s12020-016-1204-2","article-title":"Adrenal crises: perspectives and research directions","volume":"55","author":"Rushworth","year":"2017","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(20)30122-4_bib17","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1016\/S2213-8587(18)30155-4","article-title":"Advances in the medical treatment of Cushing's syndrome","volume":"7","author":"Feelders","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib18","doi-asserted-by":"crossref","first-page":"937","DOI":"10.1016\/j.mayocp.2018.04.010","article-title":"Opioid-induced adrenal insufficiency","volume":"93","author":"Donegan","year":"2018","journal-title":"Mayo Clin Proc"},{"key":"10.1016\/S2213-8587(20)30122-4_bib19","doi-asserted-by":"crossref","first-page":"2182","DOI":"10.1056\/NEJMra1807486","article-title":"Adrenal Crisis. Reply","volume":"381","author":"Rushworth","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib20","doi-asserted-by":"crossref","first-page":"98","DOI":"10.1210\/er.2009-0009","article-title":"The effects of opioids and opioid analogs on animal and human endocrine systems","volume":"31","author":"Vuong","year":"2010","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(20)30122-4_bib21","doi-asserted-by":"crossref","first-page":"353","DOI":"10.1530\/EJE-18-0530","article-title":"Secondary adrenal insufficiency and pituitary dysfunction in oral\/transdermal opioid users with non-cancer pain","volume":"179","author":"Lamprecht","year":"2018","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib22","doi-asserted-by":"crossref","first-page":"339.e1","DOI":"10.1016\/j.amjmed.2015.08.021","article-title":"Adrenal crisis: still a deadly event in the 21st century","volume":"129","author":"Puar","year":"2016","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib23","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1530\/EJE-12-0161","article-title":"Frequency and causes of adrenal crises over lifetime in patients with 21-hydroxylase deficiency","volume":"167","author":"Reisch","year":"2012","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib24","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1111\/cen.12865","article-title":"Incidence of adrenal crisis in patients with adrenal insufficiency","volume":"84","author":"Smans","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib25","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1111\/cen.13043","article-title":"Addison's disease with polyglandular autoimmunity carries a more than 2\u00b75-fold risk for adrenal crises: German Health insurance data 2010\u20132013","volume":"85","author":"Meyer","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib26","doi-asserted-by":"crossref","first-page":"115","DOI":"10.1530\/EJE-09-0559","article-title":"Adrenal crisis in treated Addison's disease: a predictable but under-managed event","volume":"162","author":"White","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib27","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1055\/s-0035-1548869","article-title":"Modern hydrocortisone replacement regimens in adrenal insufficiency patients and the risk of adrenal crisis","volume":"47","author":"Rushworth","year":"2015","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(20)30122-4_bib28","doi-asserted-by":"crossref","first-page":"2336","DOI":"10.1210\/jc.2018-00208","article-title":"Longitudinal assessment of illnesses, stress dosing, and illness sequelae in patients with congenital adrenal hyperplasia","volume":"103","author":"El-Maouche","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib29","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s12902-017-0208-0","article-title":"Clinical characteristics of adrenal crisis in adult population with and without predisposing chronic adrenal insufficiency: a retrospective cohort study","volume":"17","author":"Iwasaku","year":"2017","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(20)30122-4_bib30","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1530\/EJE-09-0884","article-title":"Epidemiology of adrenal crisis in chronic adrenal insufficiency: the need for new prevention strategies","volume":"162","author":"Hahner","year":"2010","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.4158\/EP-2017-0117","article-title":"Glucocorticoid-induced adrenal insufficiency: a study of the incidence in hospital patients and a review of peri-operative management","volume":"24","author":"Rushworth","year":"2018","journal-title":"Endocr Pract"},{"key":"10.1016\/S2213-8587(20)30122-4_bib32","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1016\/j.mce.2010.04.005","article-title":"The anti-inflammatory and immunosuppressive effects of glucocorticoids, recent developments and mechanistic insights","volume":"335","author":"Coutinho","year":"2011","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib33","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1046\/j.1365-2125.1998.00833.x","article-title":"Impaired pressor sensitivity to noradrenaline in septic shock patients with and without impaired adrenal function reserve","volume":"46","author":"Annane","year":"1998","journal-title":"Br J Clin Pharmacol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib34","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1677\/JOE-08-0054","article-title":"Glucocorticoids and fatty acid metabolism in humans: fuelling fat redistribution in the metabolic syndrome","volume":"197","author":"Macfarlane","year":"2008","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib35","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1016\/j.rdc.2015.08.002","article-title":"Corticosteroids: mechanisms of action in health and disease","volume":"42","author":"Ramamoorthy","year":"2016","journal-title":"Rheum Dis Clin North Am"},{"key":"10.1016\/S2213-8587(20)30122-4_bib36","doi-asserted-by":"crossref","first-page":"355","DOI":"10.1007\/s12020-011-9591-x","article-title":"Clinical outcomes in the management of congenital adrenal hyperplasia","volume":"41","author":"Falhammar","year":"2012","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(20)30122-4_bib37","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.ando.2018.04.015","article-title":"Acute adrenal crisis and mortality in adrenal insufficiency: Still a concern in 2018!","volume":"79","author":"Hahner","year":"2018","journal-title":"Ann Endocrinol (Paris)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib38","doi-asserted-by":"crossref","first-page":"512","DOI":"10.1164\/rccm.200205-446OC","article-title":"Immunologic and hemodynamic effects of \u201clow-dose\u201d hydrocortisone in septic shock: a double-blind, randomized, placebo-controlled, crossover study","volume":"167","author":"Keh","year":"2003","journal-title":"Am J Respir Crit Care Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib39","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1016\/j.metabol.2017.02.005","article-title":"Pharmacokinetics of oral hydrocortisone\u2014Results and implications from a randomized controlled trial","volume":"71","author":"Werumeus Buning","year":"2017","journal-title":"Metabolism"},{"key":"10.1016\/S2213-8587(20)30122-4_bib40","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1159\/000442985","article-title":"Hydrocortisone dose influences pain, depressive symptoms and perceived health in adrenal insufficiency: a randomized controlled trial","volume":"103","author":"Werumeus Buning","year":"2016","journal-title":"Neuroendocrinology"},{"key":"10.1016\/S2213-8587(20)30122-4_bib41","doi-asserted-by":"crossref","first-page":"54","DOI":"10.3389\/fendo.2019.00054","article-title":"Adrenal aging and its implications on stress responsiveness in humans","volume":"10","author":"Yiallouris","year":"2019","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib42","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1530\/EJE-12-1057","article-title":"Subcutaneous hydrocortisone administration for emergency use in adrenal insufficiency","volume":"169","author":"Hahner","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib43","doi-asserted-by":"crossref","first-page":"2194","DOI":"10.1210\/js.2019-00263","article-title":"Prehospital management of acute Addison disease: audit of patients attending a referral hospital in a regional area","volume":"3","author":"Goubar","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(20)30122-4_bib44","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1111\/cen.13985","article-title":"The use of medical identification jewellery in adults with adrenal insufficiency in Australia","volume":"91","author":"Rushworth","year":"2019","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib45","doi-asserted-by":"crossref","first-page":"4043","DOI":"10.1210\/jc.2018-01865","article-title":"Congenital adrenal hyperplasia due to steroid 21-hydroxylase deficiency: an Endocrine Society clinical practice guideline","volume":"103","author":"Speiser","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib46","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/S2213-8587(13)70007-X","article-title":"One hundred years of congenital adrenal hyperplasia in Sweden: a retrospective, population-based cohort study","volume":"1","author":"Gidl\u00f6f","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib47","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1046\/j.1365-2265.2002.t01-1-01552.x","article-title":"High prevalence and increasing incidence of Addison's disease in western Norway","volume":"56","author":"L\u00f8v\u00e5s","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib48","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1530\/EJE-19-0305","article-title":"Fifteen-year nationwide trends in systemic glucocorticoid drug use in Denmark","volume":"181","author":"Laugesen","year":"2019","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib49","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1001\/jamaoncol.2017.3064","article-title":"Incidence of endocrine dysfunction following the use of different immune checkpoint inhibitor regimens: a systematic review and meta-analysis","volume":"4","author":"Barroso-Sousa","year":"2018","journal-title":"JAMA Oncol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib50","doi-asserted-by":"crossref","first-page":"7503","DOI":"10.1002\/cam4.2661","article-title":"Immune checkpoint inhibitor-associated pituitary\u2013adrenal dysfunction: a systematic review and meta-analysis","volume":"8","author":"Lu","year":"2019","journal-title":"Cancer Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib51","doi-asserted-by":"crossref","DOI":"10.1016\/j.heliyon.2019.e01783","article-title":"Adrenal insufficiency due to bilateral adrenal metastases\u2014 a systematic review and meta-analysis","volume":"5","author":"Tallis","year":"2019","journal-title":"Heliyon"},{"key":"10.1016\/S2213-8587(20)30122-4_bib52","doi-asserted-by":"crossref","DOI":"10.1155\/2013\/482370","article-title":"Delay in diagnosis of adrenal insufficiency is a frequent cause of adrenal crisis","volume":"2013","author":"Papierska","year":"2013","journal-title":"Int J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib53","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1111\/cen.12373","article-title":"How good is a morning cortisol in predicting an adequate response to intramuscular synacthen stimulation?","volume":"81","author":"Yo","year":"2014","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib54","doi-asserted-by":"crossref","first-page":"418","DOI":"10.1111\/cen.13405","article-title":"A time-adjusted cortisol cut-off can reduce referral rate for Synacthen stimulation test whilst maintaining diagnostic performance","volume":"87","author":"Brown","year":"2017","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib55","doi-asserted-by":"crossref","first-page":"673","DOI":"10.1111\/cen.12039","article-title":"Method-specific serum cortisol responses to the adrenocorticotrophin test: comparison of gas chromatography\u2013mass spectrometry and five automated immunoassays","volume":"78","author":"El-Farhan","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib56","doi-asserted-by":"crossref","first-page":"201","DOI":"10.1177\/0310057X0503300208","article-title":"Evaluation of random plasma cortisol and the low dose corticotropin test as indicators of adrenal secretory capacity in critically ill patients: a prospective study","volume":"33","author":"Venkatesh","year":"2005","journal-title":"Anaesth Intensive Care"},{"key":"10.1016\/S2213-8587(20)30122-4_bib57","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1007\/s12020-017-1457-4","article-title":"Trends in surgery, hospital admissions and imaging for pituitary adenomas in Australia","volume":"59","author":"Crowther","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(20)30122-4_bib58","doi-asserted-by":"crossref","first-page":"140","DOI":"10.1016\/j.jcma.2012.11.001","article-title":"Epidemiology of adrenal insufficiency: a nationwide study of hospitalizations in Taiwan from 1996 to 2008","volume":"76","author":"Chen","year":"2013","journal-title":"J Chin Med Assoc"},{"key":"10.1016\/S2213-8587(20)30122-4_bib59","doi-asserted-by":"crossref","first-page":"329","DOI":"10.1530\/EJE-16-0803","article-title":"Clinical features and practice patterns of treatment for adrenal crisis: a nationwide cross-sectional study in Japan","volume":"176","author":"Ono","year":"2017","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib60","doi-asserted-by":"crossref","first-page":"4643","DOI":"10.1210\/jc.2007-0744","article-title":"Fractures and bone mineral density in adult women with 21-hydroxylase deficiency","volume":"92","author":"Falhammar","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib61","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/s12020-017-1501-4","article-title":"Skeletal fragility induced by overtreatment of adrenal insufficiency","volume":"59","author":"Falhammar","year":"2018","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(20)30122-4_bib62","doi-asserted-by":"crossref","first-page":"91","DOI":"10.1016\/j.yfrne.2018.02.001","article-title":"The effects of chronic stress on the human brain: From neurotoxicity, to vulnerability, to opportunity","volume":"49","author":"Lupien","year":"2018","journal-title":"Front Neuroendocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib63","doi-asserted-by":"crossref","first-page":"R1","DOI":"10.1530\/EJE-14-1101","article-title":"Mechanisms in endocrinology: Cushing's syndrome causes irreversible effects on the human brain: a systematic review of structural and functional magnetic resonance imaging studies","volume":"173","author":"Andela","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib64","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1210\/jc.2011-2231","article-title":"Verbal and visual memory performance and hippocampal volumes, measured by 3-Tesla magnetic resonance imaging, in patients with Cushing's syndrome","volume":"97","author":"Resmini","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib65","first-page":"1949","article-title":"Loss of brain volume in endogenous Cushing's syndrome and its reversibility after correction of hypercortisolism","volume":"87","author":"Bourdeau","year":"2002","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib66","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1159\/000029054","article-title":"Clinical correlates of major depression in Cushing's disease","volume":"31","author":"Sonino","year":"1998","journal-title":"Psychopathology"},{"key":"10.1016\/S2213-8587(20)30122-4_bib67","doi-asserted-by":"crossref","first-page":"284","DOI":"10.1210\/edrv-7-3-284","article-title":"The neuroendocrinology of stress and aging: the glucocorticoid cascade hypothesis","volume":"7","author":"Sapolsky","year":"1986","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(20)30122-4_bib68","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1210\/jcem-72-1-39","article-title":"Daily cortisol production rate in man determined by stable isotope dilution\/mass spectrometry","volume":"72","author":"Esteban","year":"1991","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib69","doi-asserted-by":"crossref","first-page":"3954","DOI":"10.1210\/jc.2006-0524","article-title":"The impact of glucocorticoid replacement regimens on metabolic outcome and comorbidity in hypopituitary patients","volume":"91","author":"Filipsson","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib70","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1530\/EJE-08-0880","article-title":"Glucocorticoid replacement therapy and pharmacogenetics in Addison's disease: effects on bone","volume":"160","author":"Lovas","year":"2009","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib71","doi-asserted-by":"crossref","first-page":"187","DOI":"10.1111\/j.1365-2796.2011.02352.x","article-title":"Risk of hip fracture in Addison's disease: a population-based cohort study","volume":"270","author":"Bj\u00f6rnsdottir","year":"2011","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib72","doi-asserted-by":"crossref","first-page":"3520","DOI":"10.1210\/JC.2015-2093","article-title":"Increased cardiovascular and metabolic morbidity in patients with 21-hydroxylase deficiency: a Swedish population-based national cohort study","volume":"100","author":"Falhammar","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib73","doi-asserted-by":"crossref","first-page":"376","DOI":"10.1210\/jc.2017-01928","article-title":"Primary adrenal insufficiency: managing mineralocorticoid replacement therapy","volume":"103","author":"Esposito","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib74","first-page":"259","article-title":"Diagnosis and therapy surveillance in Addison's disease: rapid adrenocorticotropin (ACTH) test and measurement of plasma ACTH, renin activity, and aldosterone","volume":"75","author":"Oelkers","year":"1992","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib75","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/j.amjmed.2017.07.025","article-title":"Differences in associations of antidepressants and hospitalization due to hyponatremia","volume":"131","author":"Farmand","year":"2018","journal-title":"Am J Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib76","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1016\/j.seizure.2018.04.025","article-title":"Differences in associations of antiepileptic drugs and hospitalization due to hyponatremia: a population-based case-control study","volume":"59","author":"Falhammar","year":"2018","journal-title":"Seizure"},{"key":"10.1016\/S2213-8587(20)30122-4_bib77","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.ejim.2018.11.011","article-title":"Antipsychotics and severe hyponatremia: a Swedish population-based case-control study","volume":"60","author":"Falhammar","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib78","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.ejim.2019.08.006","article-title":"Tramadol- and codeine-induced severe hyponatremia: a Swedish population-based case-control study","volume":"69","author":"Falhammar","year":"2019","journal-title":"Eur J Intern Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib79","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1111\/imj.12998","article-title":"Acute adrenal insufficiency: an aide-memoire of the critical importance of its recognition and prevention","volume":"46","author":"Gargya","year":"2016","journal-title":"Intern Med J"},{"key":"10.1016\/S2213-8587(20)30122-4_bib80","doi-asserted-by":"crossref","DOI":"10.1136\/bcr-2015-212216","article-title":"Budesonide-related adrenal insufficiency","volume":"2015","author":"Arntzenius","year":"2015","journal-title":"BMJ Case Rep"},{"key":"10.1016\/S2213-8587(20)30122-4_bib81","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1111\/cen.13609","article-title":"Mortality data from the European Adrenal Insufficiency Registry-Patient characterization and associations","volume":"89","author":"Quinkler","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib82","doi-asserted-by":"crossref","first-page":"3757","DOI":"10.1210\/jc.2019-00153","article-title":"Dose dependency of iatrogenic glucocorticoid excess and adrenal insufficiency and mortality: a cohort study in England","volume":"104","author":"Mebrahtu","year":"2019","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib83","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1111\/cen.13826","article-title":"Variations in the management of acute illness in children with congenital adrenal hyperplasia: An audit of three paediatric hospitals","volume":"89","author":"Chrisp","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib84","doi-asserted-by":"crossref","first-page":"341","DOI":"10.1159\/000481660","article-title":"Adrenal crises in children: perspectives and research directions","volume":"89","author":"Rushworth","year":"2018","journal-title":"Horm Res Paediatr"},{"key":"10.1016\/S2213-8587(20)30122-4_bib85","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1016\/S0749-0690(18)30929-7","article-title":"Abnormalities in blood pressure homeostasis that contribute to falls in the elderly","volume":"1","author":"Lipsitz","year":"1985","journal-title":"Clin Geriatr Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib86","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1186\/s12902-019-0459-z","article-title":"A retrospective analysis of adrenal crisis in steroid-dependent patients: causes, frequency and outcomes","volume":"19","author":"White","year":"2019","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(20)30122-4_bib87","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1530\/EJE-12-0865","article-title":"Bone mineral density, bone markers, and fractures in adult males with congenital adrenal hyperplasia","volume":"168","author":"Falhammar","year":"2013","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib88","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1210\/js.2019-00136","article-title":"Glucocorticoid regimens in the treatment of congenital adrenal hyperplasia: a systematic review and meta-analysis","volume":"3","author":"Whittle","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(20)30122-4_bib89","doi-asserted-by":"crossref","first-page":"2547","DOI":"10.1056\/NEJMcp1800214","article-title":"Glucocorticoid-induced osteoporosis","volume":"379","author":"Buckley","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib90","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1111\/cen.13608","article-title":"Management of adrenal emergencies in educated patients with adrenal insufficiency-a prospective study","volume":"89","author":"Burger-Stritt","year":"2018","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib91","doi-asserted-by":"crossref","first-page":"999","DOI":"10.1111\/cen.12825","article-title":"Interruptions to supply of high-dose hydrocortisone tablets and the incidence of adrenal crises","volume":"83","author":"Rushworth","year":"2015","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib92","doi-asserted-by":"crossref","first-page":"360","DOI":"10.1111\/imj.13720","article-title":"Routine vaccinations as a precipitant of adrenal crisis in adrenal insufficiency","volume":"48","author":"Major","year":"2018","journal-title":"Intern Med J"},{"key":"10.1016\/S2213-8587(20)30122-4_bib93","doi-asserted-by":"crossref","first-page":"1675","DOI":"10.1007\/s00198-018-4508-7","article-title":"Adrenal crisis after first infusion of zoledronic acid: a case report","volume":"29","author":"Smrecnik","year":"2018","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(20)30122-4_bib94","doi-asserted-by":"crossref","first-page":"7","DOI":"10.1186\/1756-6614-1-7","article-title":"New onset Graves' disease as a cause of an adrenal crisis in an individual with panhypopituitarism: brief report","volume":"1","author":"Lewandowski","year":"2008","journal-title":"Thyroid Res"},{"key":"10.1016\/S2213-8587(20)30122-4_bib95","article-title":"Thyrotoxicosis leading to adrenal crises reveals primary bilateral adrenal lymphoma","volume":"2017","author":"Roque","year":"2017","journal-title":"Endocrinol Diabetes Metab Case Rep"},{"key":"10.1016\/S2213-8587(20)30122-4_bib96","doi-asserted-by":"crossref","first-page":"1147","DOI":"10.2147\/DDDT.S149069","article-title":"The cytochrome P450 isoenzyme and some new opportunities for the prediction of negative drug interaction in vivo","volume":"12","author":"Sychev","year":"2018","journal-title":"Drug Des Devel Ther"},{"key":"10.1016\/S2213-8587(20)30122-4_bib97","doi-asserted-by":"crossref","first-page":"2328","DOI":"10.1056\/NEJMra0804635","article-title":"Predisposing factors for adrenal insufficiency","volume":"360","author":"Bornstein","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30122-4_bib98","doi-asserted-by":"crossref","first-page":"1197","DOI":"10.1210\/jcem-21-10-1197","article-title":"Adrenocortical function and cortisol metabolism in old age","volume":"21","author":"West","year":"1961","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30122-4_bib99","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/cen.12991","article-title":"Glucocorticoid therapy for adrenal insufficiency: nonadherence, concerns and dissatisfaction with information","volume":"84","author":"Chapman","year":"2016","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib100","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1186\/s12902-015-0058-6","article-title":"Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease\u2014favourable response to dietary management: a case report","volume":"15","author":"Petersen","year":"2015","journal-title":"BMC Endocr Disord"},{"key":"10.1016\/S2213-8587(20)30122-4_bib101","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/j.maturitas.2010.03.004","article-title":"Drug treatment in an ageing population: practical implications","volume":"66","author":"Wynne","year":"2010","journal-title":"Maturitas"},{"key":"10.1016\/S2213-8587(20)30122-4_bib102","doi-asserted-by":"crossref","first-page":"32","DOI":"10.1007\/s12020-015-0656-0","article-title":"Nonclassic congenital adrenal hyperplasia due to 21-hydroxylase deficiency: clinical presentation, diagnosis, treatment, and outcome","volume":"50","author":"Falhammar","year":"2015","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(20)30122-4_bib103","doi-asserted-by":"crossref","first-page":"1053","DOI":"10.1086\/516547","article-title":"Perspective: aging and infectious diseases: past, present, and future","volume":"176","author":"Yoshikawa","year":"1997","journal-title":"J Infect Dis"},{"key":"10.1016\/S2213-8587(20)30122-4_bib104","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1086\/313896","article-title":"Fever in the elderly","volume":"31","author":"Norman","year":"2000","journal-title":"Clin Infect Dis"},{"key":"10.1016\/S2213-8587(20)30122-4_bib105","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1093\/ageing\/15.4.230","article-title":"Pyrexia in infection in the elderly","volume":"15","author":"McAlpine","year":"1986","journal-title":"Age Ageing"},{"key":"10.1016\/S2213-8587(20)30122-4_bib106","doi-asserted-by":"crossref","DOI":"10.4414\/smw.2018.14586","article-title":"Evaluation of the frequency of adrenal crises and preventive measures in patients with primary and secondary adrenal insufficiency in Switzerland","volume":"148","author":"Notter","year":"2018","journal-title":"Swiss Med Wkly"},{"key":"10.1016\/S2213-8587(20)30122-4_bib107","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1007\/s11845-017-1607-y","article-title":"Patients treated with immunosuppressive steroids are less aware of sick day rules than those on endocrine replacement therapy, and may be at greater risk of adrenal crisis","volume":"187","author":"Salehmohamed","year":"2018","journal-title":"Ir J Med Sci"},{"key":"10.1016\/S2213-8587(20)30122-4_bib108","doi-asserted-by":"crossref","first-page":"1150","DOI":"10.1210\/js.2019-00046","article-title":"Modified-release hydrocortisone: is it time to change clinical practice?","volume":"3","author":"Stewart","year":"2019","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(20)30122-4_bib109","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/S2213-8587(17)30398-4","article-title":"Effect of once-daily, modified-release hydrocortisone versus standard glucocorticoid therapy on metabolism and innate immunity in patients with adrenal insufficiency (DREAM): a single-blind, randomised controlled trial","volume":"6","author":"Isidori","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib110","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1002\/j.2040-4603.2014.tb00585.x","article-title":"Hypothalamic-pituitary-adrenal (HPA) axis and aging","volume":"4","author":"Gupta","year":"2014","journal-title":"Compr Physiol"},{"key":"10.1016\/S2213-8587(20)30122-4_bib111","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1007\/s12020-013-0161-2","article-title":"Quality of life, social situation, and sexual satisfaction, in adult males with congenital adrenal hyperplasia","volume":"47","author":"Falhammar","year":"2014","journal-title":"Endocrine"},{"key":"10.1016\/S2213-8587(20)30122-4_bib112","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1111\/cen.12045","article-title":"Glucocorticoid treatment regimen and health outcomes in adults with congenital adrenal hyperplasia","volume":"78","author":"Han","year":"2013","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(20)30122-4_bib113","doi-asserted-by":"crossref","first-page":"2527","DOI":"10.1073\/pnas.1500242112","article-title":"Transplantation of bovine adrenocortical cells encapsulated in alginate","volume":"112","author":"Balyura","year":"2015","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(20)30122-4_bib114","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0194643","article-title":"Expression of progenitor markers is associated with the functionality of a bioartificial adrenal cortex","volume":"13","author":"Balyura","year":"2018","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(20)30122-4_bib115","doi-asserted-by":"crossref","first-page":"1905","DOI":"10.1111\/ajt.12296","article-title":"The first simultaneous kidney\u2013adrenal gland\u2013pancreas transplantation: outcome at 1 year","volume":"13","author":"Vouillarmet","year":"2013","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(20)30122-4_bib116","first-page":"1320","article-title":"Simultaneous adrenal gland and kidney allotransplantation after synchronous bilateral renal cell carcinoma: a case report","volume":"27","author":"Dubernard","year":"1995","journal-title":"Transplant Proc"},{"key":"10.1016\/S2213-8587(20)30122-4_bib117","doi-asserted-by":"crossref","first-page":"431","DOI":"10.1111\/j.1600-6143.2009.02929.x","article-title":"A case of human intramuscular adrenal gland transplantation as a cure for chronic adrenal insufficiency","volume":"10","author":"Grodstein","year":"2010","journal-title":"Am J Transplant"},{"key":"10.1016\/S2213-8587(20)30122-4_bib118","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1038\/npp.2015.235","article-title":"Gene\u2013stress\u2013epigenetic regulation of FKBP5: clinical and translational implications","volume":"41","author":"Zannas","year":"2016","journal-title":"Neuropsychopharmacology"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301224?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720301224?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:09Z","timestamp":1761991689000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720301224"}},"issued":{"date-parts":[[2020,7]]},"references-count":118,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2020,7]]}},"alternative-id":["S2213858720301224"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30122-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,7]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Adrenal crises in older patients","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30122-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T15:12:29Z","timestamp":1794582749742,"version":"4.9.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/s2213-8587(24)00272-9","type":"journal-article","created":{"date-parts":[[2024,9,9]],"date-time":"2024-09-09T18:35:21Z","timestamp":1725906921000},"page":"785-787","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":181,"title":["Muscle matters: the effects of medically induced weight loss on skeletal muscle"],"prefix":"10.1016","volume":"12","author":[{"given":"Carla M","family":"Prado","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stuart M","family":"Phillips","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Cristina","family":"Gonzalez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven B","family":"Heymsfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00272-9_bib1","doi-asserted-by":"crossref","DOI":"10.1038\/s41366-024-01511-9","article-title":"Advances in body composition: a 100-year journey","author":"Heymsfield","year":"2024","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(24)00272-9_bib2","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1001\/jama.2024.6586","article-title":"Is weight loss-induced muscle mass loss clinically relevant?","volume":"332","author":"Conte","year":"2024","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(24)00272-9_bib3","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/sj.ijo.0803483","article-title":"Changes in fat-free mass during significant weight loss: a systematic review","volume":"31","author":"Chaston","year":"2007","journal-title":"Int J Obes"},{"key":"10.1016\/S2213-8587(24)00272-9_bib4","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1186\/1471-2318-13-74","article-title":"Relationship between muscle mass and muscle strength, and the impact of comorbidities: a population-based, cross-sectional study of older adults in the United States","volume":"13","author":"Chen","year":"2013","journal-title":"BMC Geriatr"},{"key":"10.1016\/S2213-8587(24)00272-9_bib5","doi-asserted-by":"crossref","first-page":"3422","DOI":"10.1007\/s11695-023-06796-9","article-title":"Preserved muscle strength despite muscle mass loss after bariatric metabolic surgery: a systematic review and meta-analysis","volume":"33","author":"Jung","year":"2023","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(24)00272-9_bib6","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s41999-023-00760-7","article-title":"Sarcopenia\u2008\u2260\u2008low muscle mass","volume":"14","author":"Cruz-Jentoft","year":"2023","journal-title":"Eur Geriatr Med"},{"key":"10.1016\/S2213-8587(24)00272-9_bib7","doi-asserted-by":"crossref","first-page":"594","DOI":"10.1210\/endrev\/bnaa016","article-title":"Muscle-organ crosstalk: the emerging roles of myokines","volume":"41","author":"Severinsen","year":"2020","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(24)00272-9_bib8","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1080\/07853890.2018.1511918","article-title":"Implications of low muscle mass across the continuum of care: a narrative review","volume":"50","author":"Prado","year":"2018","journal-title":"Ann Med"},{"key":"10.1016\/S2213-8587(24)00272-9_bib9","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1016\/j.clnu.2019.11.024","article-title":"Critical appraisal of definitions and diagnostic criteria for sarcopenic obesity based on a systematic review","volume":"39","author":"Donini","year":"2020","journal-title":"Clin Nutr"},{"key":"10.1016\/S2213-8587(24)00272-9_bib10","doi-asserted-by":"crossref","first-page":"1068","DOI":"10.1002\/oby.22493","article-title":"Weight cycling as a risk factor for low muscle mass and strength in a population of males and females with obesity","volume":"27","author":"Rossi","year":"2019","journal-title":"Obesity"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002729?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724002729?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,10,22]],"date-time":"2024-10-22T18:59:26Z","timestamp":1729623566000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724002729"}},"issued":{"date-parts":[[2024,11]]},"references-count":10,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S2213858724002729"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00272-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Muscle matters: the effects of medically induced weight loss on skeletal muscle","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00272-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T13:00:40Z","timestamp":1794574840609,"version":"4.9.1"},"reference-count":35,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2019,1,1]],"date-time":"2019-01-01T00:00:00Z","timestamp":1546300800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"name":"National Institutes of Health (NIH) National Institute of Arthritis and Musculoskeletal and Skin Diseases","award":["R01AR061445"],"award-info":[{"award-number":["R01AR061445"]}],"id":[{"id":"https:\/\/ror.org\/006zn3t30","id-type":"ROR","asserted-by":"crossref"}]},{"name":"National Heart, Lung, and Blood Institute Framingham Heart Study","award":["N01-HC-25195, HHSN268201500001I"],"award-info":[{"award-number":["N01-HC-25195, HHSN268201500001I"]}],"id":[{"id":"https:\/\/ror.org\/012pb6c26","id-type":"ROR","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,1]]},"DOI":"10.1016\/s2213-8587(18)30308-5","type":"journal-article","created":{"date-parts":[[2018,11,28]],"date-time":"2018-11-28T19:59:30Z","timestamp":1543435170000},"page":"34-43","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":384,"title":["Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study"],"prefix":"10.1016","volume":"7","author":[{"given":"Elizabeth J","family":"Samelson","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerry E","family":"Broe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hanfei","family":"Xu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laiji","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steven","family":"Boyd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Emmanuel","family":"Biver","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pawel","family":"Szulc","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonathan","family":"Adachi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shreyasee","family":"Amin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Atkinson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudie","family":"Berger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lauren","family":"Burt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Roland","family":"Chapurlat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thierry","family":"Chevalley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serge","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Goltzman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David A","family":"Hanley","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marian T","family":"Hannan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sundeep","family":"Khosla","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ching-Ti","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mattias","family":"Lorentzon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Mellstrom","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Blandine","family":"Merle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Nethander","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ren\u00e9","family":"Rizzoli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Sornay-Rendu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bert","family":"Van Rietbergen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel","family":"Sundh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andy Kin On","family":"Wong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claes","family":"Ohlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Serkalem","family":"Demissie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas P","family":"Kiel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mary L","family":"Bouxsein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(18)30308-5_bib1","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1359\/jbmr.061113","article-title":"Incidence and economic burden of osteoporosis-related fractures in the United States, 2005-2025","volume":"22","author":"Burge","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib2","doi-asserted-by":"crossref","first-page":"1485","DOI":"10.1002\/jbmr.2888","article-title":"A crisis in the treatment of osteoporosis","volume":"31","author":"Khosla","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib3","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1016\/j.bone.2017.02.008","article-title":"Diagnostic accuracy of FRAX in predicting the 10-year risk of osteoporotic fractures using the USA treatment thresholds: a systematic review and meta-analysis","volume":"99","author":"Jiang","year":"2017","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(18)30308-5_bib4","doi-asserted-by":"crossref","first-page":"1568","DOI":"10.1002\/jbmr.3124","article-title":"Clinical utility of using lumbar spine trabecular bone score to adjust fracture probability: the Manitoba BMD Cohort","volume":"32","author":"Martineau","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib5","doi-asserted-by":"crossref","first-page":"1358","DOI":"10.1002\/jbmr.319","article-title":"Cross-sectional analysis of the association between fragility fractures and bone microarchitecture in older men: the STRAMBO study","volume":"26","author":"Szulc","year":"2011","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib6","doi-asserted-by":"crossref","first-page":"1158","DOI":"10.1002\/jbmr.2796","article-title":"Microarchitecture and peripheral BMD are impaired in postmenopausal white women with fracture independently of total hip T-score: an international multicenter study","volume":"31","author":"Boutroy","year":"2016","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib7","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1002\/jbmr.2144","article-title":"Skeletal structure in postmenopausal women with osteopenia and fractures is characterized by abnormal trabecular plates and cortical thinning","volume":"29","author":"Stein","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib8","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1002\/jbmr.2388","article-title":"Trabecular and cortical microstructure and fragility of the distal radius in women","volume":"30","author":"Bala","year":"2015","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib9","doi-asserted-by":"crossref","first-page":"2147","DOI":"10.1007\/s00198-015-3119-9","article-title":"Prior ankle fractures in postmenopausal women are associated with low areal bone mineral density and bone microstructure alterations","volume":"26","author":"Biver","year":"2015","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(18)30308-5_bib10","doi-asserted-by":"crossref","first-page":"496","DOI":"10.1111\/joim.12587","article-title":"Increased cortical porosity in women with hip fracture","volume":"281","author":"Sundh","year":"2017","journal-title":"J Intern Med"},{"key":"10.1016\/S2213-8587(18)30308-5_bib11","doi-asserted-by":"crossref","first-page":"516","DOI":"10.1210\/jc.2017-00536","article-title":"Cortical bone area predicts incident fractures independently of areal bone mineral density in older men","volume":"102","author":"Ohlsson","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30308-5_bib12","doi-asserted-by":"crossref","first-page":"1302","DOI":"10.1002\/jbmr.3433","article-title":"Volumetric bone mineral density and failure load of distal limbs predict incident clinical fracture independent of FRAX and clinical risk factors among older men","volume":"33","author":"Langsetmo","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib13","doi-asserted-by":"crossref","first-page":"1470","DOI":"10.1002\/jbmr.3451","article-title":"Prediction of fractures in men using bone microarchitectural parameters assessed by high-resolution peripheral quantitative computed tomography\u2014the Prospective STRAMBO study","volume":"33","author":"Szulc","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib14","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1002\/jbmr.3299","article-title":"Evaluation of radius microstructure and areal bone mineral density improves fracture prediction in postmenopausal women","volume":"33","author":"Biver","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib15","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1002\/jbmr.3105","article-title":"Bone microarchitecture assessed by HR-pQCT as predictor of fracture risk in postmenopausal women: the OFELY study","volume":"32","author":"Sornay-Rendu","year":"2017","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib16","doi-asserted-by":"crossref","first-page":"589","DOI":"10.1002\/jbmr.3347","article-title":"Lower bone density, impaired microarchitecture, and strength predict future fragility fracture in postmenopausal women: 5-year follow-up of the Calgary CaMos cohort","volume":"33","author":"Burt","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib17","doi-asserted-by":"crossref","first-page":"54","DOI":"10.1002\/jbmr.3240","article-title":"Diabetes and deficits in cortical bone density, microarchitecture, and bone size: Framingham HR-pQCT study","volume":"33","author":"Samelson","year":"2018","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib18","doi-asserted-by":"crossref","first-page":"129760","DOI":"10.1155\/2012\/129760","article-title":"Sex- and age-related differences in bone microarchitecture in men relative to women assessed by high-resolution peripheral quantitative computed tomography","volume":"2012","author":"Amin","year":"2012","journal-title":"J Osteoporos"},{"key":"10.1016\/S2213-8587(18)30308-5_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1007\/s11657-017-0412-6","article-title":"The QUALYOR (QUalit\u00e9 Osseuse LYon Orl\u00e9ans) study: a new cohort for non invasive evaluation of bone quality in postmenopausal osteoporosis. Rationale and study design","volume":"13","author":"Chapurlat","year":"2017","journal-title":"Arch Osteoporos"},{"key":"10.1016\/S2213-8587(18)30308-5_bib20","doi-asserted-by":"crossref","first-page":"2313","DOI":"10.1002\/jbmr.124","article-title":"Association between bone turnover rate and bone microarchitecture in men: the STRAMBO study","volume":"25","author":"Chaitou","year":"2010","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib21","doi-asserted-by":"crossref","first-page":"425","DOI":"10.1359\/jbmr.061206","article-title":"Alterations of cortical and trabecular architecture are associated with fractures in postmenopausal women, partially independent of decreased BMD measured by DXA: the OFELY study","volume":"22","author":"Sornay-Rendu","year":"2007","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib22","first-page":"40","article-title":"Within- and across-sex inheritance of bone microarchitecture","volume":"102","author":"Pepe","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30308-5_bib23","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1007\/s00198-012-2160-1","article-title":"Women with previous fragility fractures can be classified based on bone microarchitecture and finite element analysis measured with HR-pQCT","volume":"24","author":"Nishiyama","year":"2013","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(18)30308-5_bib24","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1359\/jbmr.060110","article-title":"Free testosterone is an independent predictor of BMD and prevalent fractures in elderly men: MrOS Sweden","volume":"21","author":"Mellstrom","year":"2006","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib25","doi-asserted-by":"crossref","first-page":"6508","DOI":"10.1210\/jc.2005-1258","article-title":"In vivo assessment of trabecular bone microarchitecture by high-resolution peripheral quantitative computed tomography","volume":"90","author":"Boutroy","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(18)30308-5_bib26","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1016\/j.bone.2011.10.003","article-title":"Visual grading of motion induced image degradation in high resolution peripheral computed tomography: impact of image quality on measures of bone density and micro-architecture","volume":"50","author":"Pialat","year":"2012","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(18)30308-5_bib27","doi-asserted-by":"crossref","first-page":"505","DOI":"10.1016\/j.bone.2007.07.007","article-title":"Automatic segmentation of cortical and trabecular compartments based on a dual threshold technique for in vivo micro-CT bone analysis","volume":"41","author":"Buie","year":"2007","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(18)30308-5_bib28","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1016\/S8756-3282(02)00736-6","article-title":"Estimation of distal radius failure load with micro-finite element analysis models based on three-dimensional peripheral quantitative computed tomography images","volume":"30","author":"Pistoia","year":"2002","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(18)30308-5_bib29","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1016\/j.jbiomech.2018.08.030","article-title":"Harmonizing finite element modelling for non-invasive strength estimation by high-resolution peripheral quantitative computed tomography","volume":"80","author":"Whittier","year":"2018","journal-title":"J Biomech"},{"key":"10.1016\/S2213-8587(18)30308-5_bib30","doi-asserted-by":"crossref","first-page":"1227","DOI":"10.1007\/s00198-009-1062-3","article-title":"Does standardized BMD still remove differences between Hologic and GE-Lunar state-of-the-art DXA systems?","volume":"21","author":"Fan","year":"2010","journal-title":"Osteoporos Int"},{"key":"10.1016\/S2213-8587(18)30308-5_bib31","doi-asserted-by":"crossref","first-page":"734","DOI":"10.1016\/j.bone.2009.01.373","article-title":"FRAX and its applications to clinical practice","volume":"44","author":"Kanis","year":"2009","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(18)30308-5_bib32","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1002\/sim.4780030207","article-title":"Regression modelling strategies for improved prognostic prediction","volume":"3","author":"Harrell","year":"1984","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(18)30308-5_bib33","doi-asserted-by":"crossref","first-page":"1356","DOI":"10.1002\/jbmr.2167","article-title":"Cortical porosity identifies women with osteopenia at increased risk for forearm fractures","volume":"29","author":"Bala","year":"2014","journal-title":"J Bone Miner Res"},{"key":"10.1016\/S2213-8587(18)30308-5_bib34","doi-asserted-by":"crossref","first-page":"8","DOI":"10.1016\/j.bone.2013.01.007","article-title":"A new method of segmentation of compact-appearing, transitional and trabecular compartments and quantification of cortical porosity from high resolution peripheral quantitative computed tomographic images","volume":"54","author":"Zebaze","year":"2013","journal-title":"Bone"},{"key":"10.1016\/S2213-8587(18)30308-5_bib35","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/j.bone.2014.11.023","article-title":"A comparison of methods for in vivo assessment of cortical porosity in the human appendicular skeleton","volume":"73","author":"Jorgenson","year":"2015","journal-title":"Bone"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858718303085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,4,17]],"date-time":"2019-04-17T16:26:50Z","timestamp":1555518410000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858718303085"}},"issued":{"date-parts":[[2019,1]]},"references-count":35,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2019,1]]}},"alternative-id":["S2213858718303085"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(18)30308-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cortical and trabecular bone microarchitecture as an independent predictor of incident fracture risk in older women and men in the Bone Microarchitecture International Consortium (BoMIC): a prospective study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30308-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(18)30333-4","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,13]],"date-time":"2026-11-13T20:08:44Z","timestamp":1794600524053,"version":"4.9.1"},"reference-count":100,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,4,1]],"date-time":"2020-04-01T00:00:00Z","timestamp":1585699200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100002996","name":"Dutch Heart Foundation","doi-asserted-by":"crossref","award":["2018T025"],"award-info":[{"award-number":["2018T025"]}],"id":[{"id":"10.13039\/501100002996","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,4]]},"DOI":"10.1016\/s2213-8587(19)30405-x","type":"journal-article","created":{"date-parts":[[2020,3,2]],"date-time":"2020-03-02T18:54:23Z","timestamp":1583175263000},"page":"325-336","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":684,"title":["Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression"],"prefix":"10.1016","volume":"8","author":[{"given":"Thomas T","family":"van Sloten","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sanaz","family":"Sedaghat","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mercedes R","family":"Carnethon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lenore J","family":"Launer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Coen D A","family":"Stehouwer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30405-X_bib1","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(10)60484-9","article-title":"Diabetes mellitus, fasting blood glucose concentration, and risk of vascular disease: a collaborative meta-analysis of 102 prospective studies","volume":"375","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30405-X_bib2","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1111\/j.1445-5994.2012.02758.x","article-title":"Diabetes as a risk factor for dementia and mild cognitive impairment: a meta-analysis of longitudinal studies","volume":"42","author":"Cheng","year":"2012","journal-title":"Intern Med J"},{"key":"10.1016\/S2213-8587(19)30405-X_bib3","doi-asserted-by":"crossref","first-page":"961","DOI":"10.1111\/dme.14042","article-title":"Prevalence of comorbid major depressive disorder in type 2 diabetes: a meta-analysis of comparative and epidemiological studies","volume":"36","author":"Wang","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30405-X_bib4","doi-asserted-by":"crossref","first-page":"540","DOI":"10.1056\/NEJMoa1215740","article-title":"Glucose levels and risk of dementia","volume":"369","author":"Crane","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30405-X_bib5","doi-asserted-by":"crossref","DOI":"10.1136\/bmj.e3564","article-title":"Effect of pre-diabetes on future risk of stroke: meta-analysis","volume":"344","author":"Lee","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(19)30405-X_bib6","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1001\/jamapsychiatry.2013.1965","article-title":"Association of depression with accelerated cognitive decline among patients with type 2 diabetes in the ACCORD-MIND trial","volume":"70","author":"Sullivan","year":"2013","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/S2213-8587(19)30405-X_bib7","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1016\/S1474-4422(18)30442-3","article-title":"Incidence and prevalence of dementia associated with transient ischaemic attack and stroke: analysis of the population-based Oxford Vascular Study","volume":"18","author":"Pendlebury","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib8","doi-asserted-by":"crossref","first-page":"101","DOI":"10.2337\/dc15-1174","article-title":"Consequences of comorbidity of elevated stress and\/or depressive symptoms and incident cardiovascular outcomes in diabetes: results from the reasons for geographic and racial differences in stroke (REGARDS) study","volume":"39","author":"Cummings","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30405-X_bib9","doi-asserted-by":"crossref","first-page":"1729","DOI":"10.2337\/dbi17-0044","article-title":"Microvascular dysfunction and hyperglycemia: a vicious cycle with widespread consequences","volume":"67","author":"Stehouwer","year":"2018","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30405-X_bib10","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1016\/S1474-4422(19)30079-1","article-title":"Small vessel disease: mechanisms and clinical implications","volume":"18","author":"Wardlaw","year":"2019","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1038\/nrneurol.2017.188","article-title":"Blood-brain barrier breakdown in Alzheimer disease and other neurodegenerative disorders","volume":"14","author":"Sweeney","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib12","doi-asserted-by":"crossref","first-page":"10237","DOI":"10.1073\/pnas.172399499","article-title":"Appraising the brain's energy budget","volume":"99","author":"Raichle","year":"2002","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(19)30405-X_bib13","doi-asserted-by":"crossref","first-page":"841","DOI":"10.1113\/jphysiol.2013.268953","article-title":"Integrative regulation of human brain blood flow","volume":"592","author":"Willie","year":"2014","journal-title":"J Physiol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib14","doi-asserted-by":"crossref","first-page":"686","DOI":"10.1038\/nrcardio.2010.161","article-title":"The relationship between blood pressure and cognitive function","volume":"7","author":"Novak","year":"2010","journal-title":"Nat Rev Cardiol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib15","doi-asserted-by":"crossref","first-page":"302","DOI":"10.1177\/0271678X15606723","article-title":"Cerebral small vessel disease: capillary pathways to stroke and cognitive decline","volume":"36","author":"\u00d8stergaard","year":"2016","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/S2213-8587(19)30405-X_bib16","doi-asserted-by":"crossref","DOI":"10.1126\/scitranslmed.aam9507","article-title":"Reversal of endothelial dysfunction reduces white matter vulnerability in cerebral small vessel disease in rats","volume":"10","author":"Rajani","year":"2018","journal-title":"Sci Transl Med"},{"key":"10.1016\/S2213-8587(19)30405-X_bib17","doi-asserted-by":"crossref","first-page":"1338","DOI":"10.1126\/science.1095505","article-title":"Endothelial cells stimulate self-renewal and expand neurogenesis of neural stem cells","volume":"304","author":"Shen","year":"2004","journal-title":"Science"},{"key":"10.1016\/S2213-8587(19)30405-X_bib18","doi-asserted-by":"crossref","first-page":"1902","DOI":"10.1007\/s00125-018-4692-1","article-title":"Neurodegeneration in diabetic retinopathy: does it really matter?","volume":"61","author":"Sim\u00f3","year":"2018","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30405-X_bib19","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1152\/physrev.00050.2017","article-title":"Blood-brain barrier: from physiology to disease and back","volume":"99","author":"Sweeney","year":"2019","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(19)30405-X_bib20","doi-asserted-by":"crossref","first-page":"4343","DOI":"10.1210\/jc.2017-01922","article-title":"Diabetic microvascular disease: an Endocrine Society Scientific Statement","volume":"102","author":"Barrett","year":"2017","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30405-X_bib21","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1038\/nrneurol.2017.185","article-title":"Brain insulin resistance in type 2 diabetes and Alzheimer disease: concepts and conundrums","volume":"14","author":"Arnold","year":"2018","journal-title":"Nat Rev Neurol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib22","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1007\/s11481-017-9752-7","article-title":"Blood brain barrier injury in diabetes: unrecognized effects on brain and cognition","volume":"12","author":"Bogush","year":"2017","journal-title":"J Neuroimmune Pharmacol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib23","first-page":"125","article-title":"Diabetes mellitus and blood-brain barrier dysfunction: an overview","volume":"2","author":"Prasad","year":"2014","journal-title":"J Pharmacovigil"},{"key":"10.1016\/S2213-8587(19)30405-X_bib24","doi-asserted-by":"crossref","first-page":"104","DOI":"10.1016\/j.neurobiolaging.2016.11.017","article-title":"Increased blood-brain barrier permeability is associated with dementia and diabetes but not amyloid pathology or APOE genotype","volume":"51","author":"Janelidze","year":"2017","journal-title":"Neurobiol Aging"},{"key":"10.1016\/S2213-8587(19)30405-X_bib25","doi-asserted-by":"crossref","first-page":"195","DOI":"10.1177\/1747493017730740","article-title":"Cerebrovascular reactivity measurement in cerebral small vessel disease: rationale and reproducibility of a protocol for MRI acquisition and image processing","volume":"13","author":"Thrippleton","year":"2018","journal-title":"Int J Stroke"},{"key":"10.1016\/S2213-8587(19)30405-X_bib26","doi-asserted-by":"crossref","first-page":"R1473","DOI":"10.1152\/ajpregu.91008.2008","article-title":"Integration of cerebrovascular CO2 reactivity and chemoreflex control of breathing: mechanisms of regulation, measurement, and interpretation","volume":"296","author":"Ainslie","year":"2009","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib27","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1016\/j.jalz.2019.01.013","article-title":"Quantifying blood-brain barrier leakage in small vessel disease: review and consensus recommendations","volume":"15","author":"Thrippleton","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/S2213-8587(19)30405-X_bib28","doi-asserted-by":"crossref","first-page":"1671","DOI":"10.1038\/jcbfm.2015.106","article-title":"Early disrupted neurovascular coupling and changed event level hemodynamic response function in type 2 diabetes: an fMRI study","volume":"35","author":"Duarte","year":"2015","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/S2213-8587(19)30405-X_bib29","doi-asserted-by":"crossref","first-page":"876","DOI":"10.2337\/dc14-2043","article-title":"On the interplay of microvasculature, parenchyma, and memory in type 2 diabetes","volume":"38","author":"van Bussel","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30405-X_bib30","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.2337\/dc06-2052","article-title":"Global and regional effects of type 2 diabetes on brain tissue volumes and cerebral vasoreactivity","volume":"30","author":"Last","year":"2007","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30405-X_bib31","doi-asserted-by":"crossref","first-page":"1248","DOI":"10.1007\/s11682-016-9583-9","article-title":"Cerebral perfusion alterations in type 2 diabetes and its relation to insulin resistance and cognitive dysfunction","volume":"11","author":"Cui","year":"2017","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/S2213-8587(19)30405-X_bib32","doi-asserted-by":"crossref","first-page":"36","DOI":"10.1016\/j.nicl.2014.05.020","article-title":"Combined effects of type 2 diabetes and hypertension associated with cortical thinning and impaired cerebrovascular reactivity relative to hypertension alone in older adults","volume":"5","author":"Tchistiakova","year":"2014","journal-title":"Neuroimage Clin"},{"key":"10.1016\/S2213-8587(19)30405-X_bib33","doi-asserted-by":"crossref","first-page":"822","DOI":"10.1016\/S1474-4422(13)70124-8","article-title":"Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration","volume":"12","author":"Wardlaw","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib34","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1016\/j.preteyeres.2017.01.001","article-title":"Imaging retina to study dementia and stroke","volume":"57","author":"Cheung","year":"2017","journal-title":"Prog Retin Eye Res"},{"key":"10.1016\/S2213-8587(19)30405-X_bib35","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1038\/jcbfm.2013.58","article-title":"Associations between retinal microvascular changes and dementia, cognitive functioning, and brain imaging abnormalities: a systematic review","volume":"33","author":"Heringa","year":"2013","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/S2213-8587(19)30405-X_bib36","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1007\/s00125-015-3511-1","article-title":"The clinical implications of recent studies on the structure and function of the retinal microvasculature in diabetes","volume":"58","author":"Cheung","year":"2015","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(19)30405-X_bib37","doi-asserted-by":"crossref","first-page":"2535","DOI":"10.2337\/dc18-1132","article-title":"Prediabetes is associated with structural brain abnormalities: the Maastricht study","volume":"41","author":"van Agtmaal","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30405-X_bib38","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1016\/j.jalz.2018.06.3060","article-title":"Prediabetes and diabetes accelerate cognitive decline and predict microvascular lesions: a population-based cohort study","volume":"15","author":"Marseglia","year":"2019","journal-title":"Alzheimers Dement"},{"key":"10.1016\/S2213-8587(19)30405-X_bib39","doi-asserted-by":"crossref","first-page":"544","DOI":"10.2337\/dc07-1528","article-title":"Relationship of retinal vascular caliber with diabetes and retinopathy: the Multi-Ethnic Study of Atherosclerosis (MESA)","volume":"31","author":"Nguyen","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30405-X_bib40","doi-asserted-by":"crossref","first-page":"1339","DOI":"10.1161\/CIRCULATIONAHA.116.023446","article-title":"Prediabetes and type 2 diabetes are associated with generalized microvascular dysfunction: the Maastricht study","volume":"134","author":"S\u00f6rensen","year":"2016","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30405-X_bib41","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1038\/s41574-019-0213-7","article-title":"The blood-brain barrier as an endocrine tissue","volume":"15","author":"Banks","year":"2019","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib42","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1016\/j.pneurobio.2009.01.001","article-title":"Inflammation in Alzheimer's disease: amyloid-\u03b2 oligomers trigger innate immunity defence via pattern recognition receptors","volume":"87","author":"Salminen","year":"2009","journal-title":"Prog Neurobiol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib43","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1093\/cvr\/cvx093","article-title":"The microcirculation: a key player in obesity-associated cardiovascular disease","volume":"113","author":"Sorop","year":"2017","journal-title":"Cardiovasc Res"},{"key":"10.1016\/S2213-8587(19)30405-X_bib44","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3389\/fnins.2019.00521","article-title":"Role of the blood-brain barrier in central nervous system insulin resistance","volume":"13","author":"Rhea","year":"2019","journal-title":"Front Neurosci"},{"key":"10.1016\/S2213-8587(19)30405-X_bib45","doi-asserted-by":"crossref","first-page":"1955","DOI":"10.1038\/jcbfm.2009.177","article-title":"Cerebrovascular responses to insulin in rats","volume":"29","author":"Katakam","year":"2009","journal-title":"J Cereb Blood Flow Metab"},{"key":"10.1016\/S2213-8587(19)30405-X_bib46","doi-asserted-by":"crossref","first-page":"E89","DOI":"10.1152\/ajpendo.00297.2016","article-title":"Long-term high-fat diet induces hippocampal microvascular insulin resistance and cognitive dysfunction","volume":"312","author":"Fu","year":"2017","journal-title":"Am J Physiol Endocrinol Metab"},{"key":"10.1016\/S2213-8587(19)30405-X_bib47","doi-asserted-by":"crossref","first-page":"1138","DOI":"10.1161\/HYPERTENSIONAHA.118.11769","article-title":"Macrovasculature and microvasculature at the crossroads between type 2 diabetes mellitus and hypertension","volume":"73","author":"Climie","year":"2019","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(19)30405-X_bib48","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/j.neubiorev.2015.03.011","article-title":"Association between arterial stiffness, cerebral small vessel disease and cognitive impairment: a systematic review and meta-analysis","volume":"53","author":"van Sloten","year":"2015","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/S2213-8587(19)30405-X_bib49","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1093\/ajh\/hpu246","article-title":"Association between arterial stiffness and skin microvascular function: the SUVIMAX2 Study and the Maastricht study","volume":"28","author":"van Sloten","year":"2015","journal-title":"Am J Hypertens"},{"key":"10.1016\/S2213-8587(19)30405-X_bib50","doi-asserted-by":"crossref","first-page":"261","DOI":"10.1016\/S1474-4422(12)70005-4","article-title":"Diabetes, hyperglycaemia, and acute ischaemic stroke","volume":"11","author":"Luitse","year":"2012","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib51","doi-asserted-by":"crossref","first-page":"1325","DOI":"10.1161\/STROKEAHA.117.020536","article-title":"Causal impact of type 2 diabetes mellitus on cerebral small vessel disease: a mendelian randomization analysis","volume":"49","author":"Liu","year":"2018","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(19)30405-X_bib52","doi-asserted-by":"crossref","first-page":"2689","DOI":"10.1161\/STROKEAHA.114.005018","article-title":"Lacunar strokes in patients with diabetes mellitus: risk factors, infarct location, and prognosis: the secondary prevention of small subcortical strokes study","volume":"45","author":"Palacio","year":"2014","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(19)30405-X_bib53","article-title":"Association of diabetes and prognosis of minor stroke and its subtypes: a prospective observational study","volume":"11","author":"Pan","year":"2016","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(19)30405-X_bib54","doi-asserted-by":"crossref","first-page":"164","DOI":"10.1016\/j.neubiorev.2018.04.003","article-title":"Cerebral small vessel disease and risk of incident stroke, dementia and depression, and all-cause mortality: a systematic review and meta-analysis","volume":"90","author":"Rensma","year":"2018","journal-title":"Neurosci Biobehav Rev"},{"key":"10.1016\/S2213-8587(19)30405-X_bib55","doi-asserted-by":"crossref","first-page":"281","DOI":"10.1136\/jnnp-2012-303365","article-title":"Rates and predictors of risk of stroke and its subtypes in diabetes: a prospective observational study","volume":"84","author":"Hankey","year":"2013","journal-title":"J Neurol Neurosurg Psychiatry"},{"key":"10.1016\/S2213-8587(19)30405-X_bib56","doi-asserted-by":"crossref","first-page":"49","DOI":"10.1159\/000444809","article-title":"Blood brain barrier disruption in diabetic stroke related to unfavorable outcome","volume":"42","author":"Yu","year":"2016","journal-title":"Cerebrovasc Dis"},{"key":"10.1016\/S2213-8587(19)30405-X_bib57","doi-asserted-by":"crossref","first-page":"246","DOI":"10.1016\/S2213-8587(13)70088-3","article-title":"Dementia and cognitive decline in type 2 diabetes and prediabetic stages: towards targeted interventions","volume":"2","author":"Biessels","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib58","doi-asserted-by":"crossref","first-page":"882","DOI":"10.1016\/j.jalz.2015.12.006","article-title":"Diabetes is associated with cerebrovascular but not Alzheimer's disease neuropathology","volume":"12","author":"Abner","year":"2016","journal-title":"Alzheimers Dement"},{"key":"10.1016\/S2213-8587(19)30405-X_bib59","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1002\/ana.24063","article-title":"Diabetes, markers of brain pathology and cognitive function: the Age, Gene\/Environment Susceptibility\u2013Reykjavik study","volume":"75","author":"Qiu","year":"2014","journal-title":"Ann Neurol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib60","doi-asserted-by":"crossref","first-page":"1253","DOI":"10.1016\/j.numecd.2018.07.008","article-title":"Brain imaging correlates of mild cognitive impairment and early dementia in patients with type 2 diabetes mellitus","volume":"28","author":"Groeneveld","year":"2018","journal-title":"Nutr Metab Cardiovasc Dis"},{"key":"10.1016\/S2213-8587(19)30405-X_bib61","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1016\/j.jalz.2018.10.002","article-title":"Retinal signs and risk of incident dementia in the Atherosclerosis Risk in Communities study","volume":"15","author":"Deal","year":"2019","journal-title":"Alzheimers Dement"},{"issue":"suppl 3","key":"10.1016\/S2213-8587(19)30405-X_bib62","doi-asserted-by":"crossref","first-page":"S109","DOI":"10.3233\/JAD-132570","article-title":"Severe diabetic retinal disease and dementia risk in type 2 diabetes","volume":"42","author":"Exalto","year":"2014","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/S2213-8587(19)30405-X_bib63","doi-asserted-by":"crossref","first-page":"2041","DOI":"10.1161\/STROKEAHA.107.483586","article-title":"Retinal microvascular signs, cognitive function, and dementia in older persons: the Cardiovascular Health Study","volume":"38","author":"Baker","year":"2007","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(19)30405-X_bib64","doi-asserted-by":"crossref","first-page":"1189","DOI":"10.1016\/S1474-4422(13)70144-3","article-title":"Assessment of system dysfunction in the brain through MRI-based connectomics","volume":"12","author":"Filippi","year":"2013","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib65","doi-asserted-by":"crossref","first-page":"2244","DOI":"10.2337\/db14-0348","article-title":"Brain changes underlying cognitive dysfunction in diabetes: what can we learn from MRI?","volume":"63","author":"Biessels","year":"2014","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30405-X_bib66","doi-asserted-by":"crossref","first-page":"405","DOI":"10.3233\/JAD-161166","article-title":"Neuroimaging and its relevance to understanding pathways linking diabetes and cognitive dysfunction","volume":"59","author":"Moran","year":"2017","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/S2213-8587(19)30405-X_bib67","doi-asserted-by":"crossref","DOI":"10.12688\/f1000research.13898.1","article-title":"Understanding depression in type 2 diabetes: a biological approach in observational studies","volume":"7","author":"van Sloten","year":"2018","journal-title":"F1000 Res"},{"key":"10.1016\/S2213-8587(19)30405-X_bib68","doi-asserted-by":"crossref","first-page":"612","DOI":"10.1001\/jamapsychiatry.2015.0082","article-title":"Effect of depression and diabetes mellitus on the risk for dementia: a national population-based cohort study","volume":"72","author":"Katon","year":"2015","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/S2213-8587(19)30405-X_bib69","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1016\/S2213-8587(15)00134-5","article-title":"The link between depression and diabetes: the search for shared mechanisms","volume":"3","author":"Moulton","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib70","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1176\/appi.ajp.2014.14050578","article-title":"Cerebral small vessel disease and association with higher incidence of depressive symptoms in a general elderly population: the AGES-Reykjavik Study","volume":"172","author":"van Sloten","year":"2015","journal-title":"Am J Psychiatry"},{"key":"10.1016\/S2213-8587(19)30405-X_bib71","doi-asserted-by":"crossref","first-page":"142","DOI":"10.1186\/1742-2094-10-142","article-title":"Neurovascular unit dysfunction with blood-brain barrier hyperpermeability contributes to major depressive disorder: a review of clinical and experimental evidence","volume":"10","author":"Najjar","year":"2013","journal-title":"J Neuroinflammation"},{"key":"10.1016\/S2213-8587(19)30405-X_bib72","doi-asserted-by":"crossref","first-page":"318","DOI":"10.1016\/j.biopsych.2012.01.019","article-title":"Cerebral hemodynamics and incident depression: the Rotterdam Study","volume":"72","author":"Direk","year":"2012","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2213-8587(19)30405-X_bib73","doi-asserted-by":"crossref","first-page":"729","DOI":"10.1001\/jamapsychiatry.2017.0984","article-title":"Association of microvascular dysfunction with late-life depression: a systematic review and meta-analysis","volume":"74","author":"van Agtmaal","year":"2017","journal-title":"JAMA Psychiatry"},{"key":"10.1016\/S2213-8587(19)30405-X_bib74","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1016\/j.biopsych.2018.09.018","article-title":"Carotid artery stiffness and incident depressive symptoms: the Paris prospective study III","volume":"85","author":"van Sloten","year":"2019","journal-title":"Biol Psychiatry"},{"key":"10.1016\/S2213-8587(19)30405-X_bib75","doi-asserted-by":"crossref","first-page":"162","DOI":"10.1503\/jpn.140334","article-title":"Associations between arterial stiffness, depressive symptoms and cerebral small vessel disease: cross-sectional findings from the AGES-Reykjavik Study","volume":"41","author":"van Sloten","year":"2016","journal-title":"J Psychiatry Neurosci"},{"key":"10.1016\/S2213-8587(19)30405-X_bib76","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1097\/PSY.0b013e3181da90f4","article-title":"Evidence of early retinal microvascular changes in patients with type 2 diabetes and depression","volume":"72","author":"Nguyen","year":"2010","journal-title":"Psychosom Med"},{"key":"10.1016\/S2213-8587(19)30405-X_bib77","doi-asserted-by":"crossref","first-page":"1562","DOI":"10.1111\/dme.14054","article-title":"Longitudinal associations between depression and diabetes complications: a systematic review and meta-analysis","volume":"36","author":"Nouwen","year":"2019","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(19)30405-X_bib78","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1007\/s11682-014-9348-2","article-title":"Meta-analyses of structural regional cerebral effects in type 1 and type 2 diabetes","volume":"9","author":"Moulton","year":"2015","journal-title":"Brain Imaging Behav"},{"key":"10.1016\/S2213-8587(19)30405-X_bib79","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1056\/NEJMoa1212914","article-title":"Cardiovascular effects of intensive lifestyle intervention in type 2 diabetes","volume":"369","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30405-X_bib80","doi-asserted-by":"crossref","first-page":"764","DOI":"10.2337\/dc15-2230","article-title":"Brain and white matter hyperintensity volumes after 10 years of random assignment to lifestyle intervention","volume":"39","author":"Espeland","year":"2016","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30405-X_bib81","doi-asserted-by":"crossref","first-page":"1544","DOI":"10.2337\/dc13-1928","article-title":"Impact of intensive lifestyle intervention on depression and health-related quality of life in type 2 diabetes: the look AHEAD trial","volume":"37","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30405-X_bib82","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/j.dadm.2017.09.002","article-title":"Long-term impact of intensive lifestyle intervention on cognitive function assessed with the National Institutes of Health toolbox: the Look AHEAD study","volume":"10","author":"Hayden","year":"2017","journal-title":"Alzheimers Dement (Amst)"},{"key":"10.1016\/S2213-8587(19)30405-X_bib83","doi-asserted-by":"crossref","first-page":"969","DOI":"10.1016\/S1474-4422(11)70188-0","article-title":"Effects of intensive glucose lowering on brain structure and function in people with type 2 diabetes (ACCORD MIND): a randomised open-label substudy","volume":"10","author":"Launer","year":"2011","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib84","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1056\/NEJMoa1001288","article-title":"Effects of medical therapies on retinopathy progression in type 2 diabetes","volume":"363","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30405-X_bib85","doi-asserted-by":"crossref","first-page":"2545","DOI":"10.1056\/NEJMoa0802743","article-title":"Effects of intensive glucose lowering in type 2 diabetes","volume":"358","year":"2008","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30405-X_bib86","doi-asserted-by":"crossref","first-page":"807","DOI":"10.2337\/dc10-1926","article-title":"Effect of intensive glycemic lowering on health-related quality of life in type 2 diabetes: ACCORD trial","volume":"34","author":"Anderson","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30405-X_bib87","doi-asserted-by":"crossref","first-page":"256","DOI":"10.1016\/S2213-8587(13)70125-6","article-title":"Diabetes drugs and neurological disorders: new views and therapeutic possibilities","volume":"2","author":"Patrone","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30405-X_bib88","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1111\/jdi.12420","article-title":"Potentials of incretin-based therapies in dementia and stroke in type 2 diabetes mellitus","volume":"7","author":"Groeneveld","year":"2016","journal-title":"J Diabetes Investig"},{"key":"10.1016\/S2213-8587(19)30405-X_bib89","doi-asserted-by":"crossref","first-page":"1930","DOI":"10.2337\/dc19-0783","article-title":"Effect of linagliptin on cognitive performance in patients with type 2 diabetes and cardiorenal comorbidities: the CARMELINA randomized trial","volume":"42","author":"Biessels","year":"2019","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30405-X_bib90","doi-asserted-by":"crossref","first-page":"e1168","DOI":"10.1212\/WNL.0000000000007093","article-title":"Blood pressure, glycemic control, and white matter hyperintensity progression in type 2 diabetics","volume":"92","author":"de Havenon","year":"2019","journal-title":"Neurology"},{"key":"10.1016\/S2213-8587(19)30405-X_bib91","doi-asserted-by":"crossref","first-page":"1479","DOI":"10.2337\/dc11-1868","article-title":"Effect of intensive versus standard blood pressure control on depression and health-related quality of life in type 2 diabetes: the ACCORD trial","volume":"35","author":"O'Connor","year":"2012","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30405-X_bib92","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1161\/HYPERTENSIONAHA.112.192401","article-title":"Peroxisome proliferator-activated receptor-\u03b3 activation with angiotensin II type 1 receptor blockade is pivotal for the prevention of blood-brain barrier impairment and cognitive decline in type 2 diabetic mice","volume":"59","author":"Min","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(19)30405-X_bib93","doi-asserted-by":"crossref","first-page":"2698","DOI":"10.1161\/01.STR.0000092121.62649.DC","article-title":"Enalapril prevents impaired nitric oxide synthase-dependent dilatation of cerebral arterioles in diabetic rats","volume":"34","author":"Trauernicht","year":"2003","journal-title":"Stroke"},{"key":"10.1016\/S2213-8587(19)30405-X_bib94","doi-asserted-by":"crossref","first-page":"407","DOI":"10.1152\/physrev.00001.2019","article-title":"Methylglyoxal, a highly reactive dicarbonyl compound, in diabetes, its vascular complications, and other age-related diseases","volume":"100","author":"Schalkwijk","year":"2020","journal-title":"Physiol Rev"},{"key":"10.1016\/S2213-8587(19)30405-X_bib95","doi-asserted-by":"crossref","first-page":"1689","DOI":"10.2337\/dc18-0159","article-title":"Higher plasma methylglyoxal levels are associated with incident cardiovascular disease and mortality in individuals with type 2 diabetes","volume":"41","author":"Hanssen","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30405-X_bib96","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1093\/gerona\/gls100","article-title":"Methylglyoxal, cognitive function and cerebral atrophy in older people","volume":"68","author":"Srikanth","year":"2013","journal-title":"J Gerontol A Biol Sci Med Sci"},{"key":"10.1016\/S2213-8587(19)30405-X_bib97","doi-asserted-by":"crossref","first-page":"956","DOI":"10.2337\/db15-1390","article-title":"Delayed intervention with pyridoxamine improves metabolic function and prevents adipose tissue inflammation and insulin resistance in high-fat diet-induced obese mice","volume":"65","author":"Maessen","year":"2016","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(19)30405-X_bib98","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1021\/cn3001679","article-title":"Restoration of glyoxalase enzyme activity precludes cognitive dysfunction in a mouse model of Alzheimer's disease","volume":"4","author":"More","year":"2013","journal-title":"ACS Chem Neurosci"},{"key":"10.1016\/S2213-8587(19)30405-X_bib99","doi-asserted-by":"crossref","first-page":"751","DOI":"10.2337\/dc13-1672","article-title":"Enhancement of vasoreactivity and cognition by intranasal insulin in type 2 diabetes","volume":"37","author":"Novak","year":"2014","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30405-X_bib100","doi-asserted-by":"crossref","first-page":"469","DOI":"10.1111\/ijs.12466","article-title":"Pharmacological treatment and prevention of cerebral small vessel disease: a review of potential interventions","volume":"10","author":"Bath","year":"2015","journal-title":"Int J Stroke"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930405X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930405X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:08:08Z","timestamp":1761991688000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871930405X"}},"issued":{"date-parts":[[2020,4]]},"references-count":100,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2020,4]]}},"alternative-id":["S221385871930405X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30405-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cerebral microvascular complications of type 2 diabetes: stroke, cognitive dysfunction, and depression","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30405-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:42:09Z","timestamp":1794663729126,"version":"4.9.1"},"reference-count":62,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2018,1,1]],"date-time":"2018-01-01T00:00:00Z","timestamp":1514764800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2018,1]]},"DOI":"10.1016\/s2213-8587(17)30319-4","type":"journal-article","created":{"date-parts":[[2017,11,9]],"date-time":"2017-11-09T19:46:22Z","timestamp":1510256782000},"page":"41-50","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1012,"title":["Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis"],"prefix":"10.1016","volume":"6","author":[{"given":"Silvia","family":"Monticone","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fabrizio","family":"D'Ascenzo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudio","family":"Moretti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Franco","family":"Veglio","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fiorenzo","family":"Gaita","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mulatero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(17)30319-4_bib1","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30319-4_bib2","doi-asserted-by":"crossref","first-page":"H1802","DOI":"10.1152\/ajpheart.01096.2001","article-title":"Aldosterone induces a vascular inflammatory phenotype in the rat heart","volume":"283","author":"Rocha","year":"2002","journal-title":"Am J Physiol Heart Circ Physiol"},{"key":"10.1016\/S2213-8587(17)30319-4_bib3","doi-asserted-by":"crossref","first-page":"420","DOI":"10.1161\/01.CIR.0000153800.09920.40","article-title":"Mineralocorticoid receptor inhibition ameliorates the transition to myocardial failure and decreases oxidative stress and inflammation in mice with chronic pressure overload","volume":"111","author":"Kuster","year":"2005","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30319-4_bib4","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1046\/j.1523-1755.2003.00929.x","article-title":"Aldosterone\/salt induces renal inflammation and fibrosis in hypertensive rats","volume":"63","author":"Blasi","year":"2003","journal-title":"Kidney Int"},{"key":"10.1016\/S2213-8587(17)30319-4_bib5","doi-asserted-by":"crossref","first-page":"776","DOI":"10.7326\/0003-4819-150-11-200906020-00005","article-title":"Narrative review: the emerging clinical implications of the role of aldosterone in the metabolic syndrome and resistant hypertension","volume":"150","author":"Sowers","year":"2009","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(17)30319-4_bib6","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1161\/01.HYP.25.1.30","article-title":"Relationships among plasma aldosterone, high-density lipoprotein cholesterol, and insulin in humans","volume":"25","author":"Goodfriend","year":"1995","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30319-4_bib7","doi-asserted-by":"crossref","first-page":"2125","DOI":"10.1097\/HJH.0b013e3282861fa4","article-title":"A possible association between primary aldosteronism and a lower beta cell function","volume":"25","author":"Mosso","year":"2007","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(17)30319-4_bib8","doi-asserted-by":"crossref","first-page":"751","DOI":"10.1530\/EJE-10-1074","article-title":"Association of plasma aldosterone with the metabolic syndrome in two German populations","volume":"164","author":"Hannemann","year":"2011","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(17)30319-4_bib9","doi-asserted-by":"crossref","first-page":"454","DOI":"10.1210\/jc.2005-1733","article-title":"Prevalence and characteristics of the metabolic syndrome in primary aldosteronism","volume":"91","author":"Fallo","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30319-4_bib10","doi-asserted-by":"crossref","first-page":"605","DOI":"10.1161\/HYPERTENSIONAHA.108.122002","article-title":"Fasting plasma glucose and serum lipids in patients with primary aldosteronism: a controlled cross-sectional study","volume":"53","author":"Matrozova","year":"2009","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30319-4_bib11","doi-asserted-by":"crossref","first-page":"625","DOI":"10.1038\/jhh.2010.65","article-title":"The prevalence of metabolic syndrome and its components in two main types of primary aldosteronism","volume":"24","author":"Soml\u00f3ov\u00e1","year":"2010","journal-title":"J Hum Hypertens"},{"key":"10.1016\/S2213-8587(17)30319-4_bib12","doi-asserted-by":"crossref","first-page":"331","DOI":"10.1161\/HYPERTENSIONAHA.113.01060","article-title":"Cardiovascular complications associated with primary aldosteronism: a controlled crosssectional study","volume":"62","author":"Savard","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30319-4_bib13","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1007\/BF03347840","article-title":"Vascular complications in patients with aldosterone producing adenoma in Japan: comparative study with essential hypertension. The Research Committee of Disorders of Adrenal Hormones in Japan","volume":"18","author":"Takeda","year":"1995","journal-title":"J Endocrinol Invest"},{"key":"10.1016\/S2213-8587(17)30319-4_bib14","doi-asserted-by":"crossref","first-page":"4826","DOI":"10.1210\/jc.2013-2805","article-title":"Long-term cardio- and cerebrovascular events in patients with primary aldosteronism","volume":"98","author":"Mulatero","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30319-4_bib15","doi-asserted-by":"crossref","first-page":"3266","DOI":"10.1210\/jc.2008-0104","article-title":"Case detection, diagnosis, and treatment of patients with primary aldosteronism: an endocrine society clinical practice guideline","volume":"93","author":"Funder","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30319-4_bib16","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1507\/endocrj.EJ11-0133","article-title":"Guidelines for the diagnosis and treatment of primary aldosteronism\u2014the Japan Endocrine Society 2009","volume":"58","author":"Nishikawa","year":"2011","journal-title":"Endocr J"},{"key":"10.1016\/S2213-8587(17)30319-4_bib17","doi-asserted-by":"crossref","first-page":"450","DOI":"10.1016\/0002-9149(86)90771-X","article-title":"Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings","volume":"57","author":"Devereux","year":"1986","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(17)30319-4_bib18","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(17)30319-4_bib19","doi-asserted-by":"crossref","first-page":"b2700","DOI":"10.1136\/bmj.b2700","article-title":"The PRISMA statement for reporting systematic reviews and meta-analyses of studies that evaluate healthcare interventions: explanation and elaboration","volume":"339","author":"Liberati","year":"2009","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(17)30319-4_bib20","doi-asserted-by":"crossref","first-page":"1896","DOI":"10.1016\/S0140-6736(99)04149-5","article-title":"Improving the quality of reports of meta-analyses of randomised controlled trials: the QUOROM statement. Quality of Reporting of Meta-analyses","volume":"354","author":"Moher","year":"1999","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(17)30319-4_bib21","doi-asserted-by":"crossref","first-page":"1811","DOI":"10.1016\/j.jacc.2017.01.052","article-title":"Prevalence and clinical manifestations of primary aldosteronism encountered in primary care practice","volume":"69","author":"Monticone","year":"2017","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30319-4_bib22","doi-asserted-by":"crossref","first-page":"1079","DOI":"10.1097\/HJH.0000000000001251","article-title":"Plasma aldosterone level within the normal range is less associated with cardiovascular and cerebrovascular risk in primary aldosteronism","volume":"35","author":"Murata","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(17)30319-4_bib23","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1001\/archinternmed.2007.33","article-title":"Cardiovascular outcomes in patients with primary aldosteronism after treatment","volume":"168","author":"Catena","year":"2008","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(17)30319-4_bib24","doi-asserted-by":"crossref","first-page":"1243","DOI":"10.1016\/j.jacc.2005.01.015","article-title":"Evidence for an increased rate of cardiovascular events in patients with primary aldosteronism","volume":"45","author":"Milliez","year":"2005","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30319-4_bib25","doi-asserted-by":"crossref","first-page":"618","DOI":"10.1161\/HYPERTENSIONAHA.112.197111","article-title":"German Conn's Registry-Else Kr\u00f6ner-Fresenius-Hyperaldosteronism Registry. Observational study mortality in treated primary aldosteronism: the German Conn's registry","volume":"60","author":"Reincke","year":"2012","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30319-4_bib26","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1161\/HYPERTENSIONAHA.113.01316","article-title":"Long-term control of arterial hypertension and regression of left ventricular hypertrophy with treatment of primary aldosteronism","volume":"62","author":"Rossi","year":"2013","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30319-4_bib27","doi-asserted-by":"crossref","first-page":"2391","DOI":"10.1210\/jc.2009-2204","article-title":"Adipokines and cardiometabolic profile in primary hyperaldosteronism","volume":"95","author":"Iacobellis","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30319-4_bib28","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.amjhyper.2005.05.013","article-title":"Role of aldosterone in left ventricular hypertrophy in hypertension","volume":"19","author":"Matsumura","year":"2006","journal-title":"Am J Hypertens"},{"key":"10.1016\/S2213-8587(17)30319-4_bib29","doi-asserted-by":"crossref","first-page":"2459","DOI":"10.1097\/01.hjh.0000251908.93298.a0","article-title":"QT interval in patients with primary aldosteronism and low-renin essential hypertension","volume":"24","author":"Maule","year":"2006","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(17)30319-4_bib30","doi-asserted-by":"crossref","first-page":"2813","DOI":"10.1210\/jc.2011-0354","article-title":"Cardiac dimensions are largely determined by dietary salt in patients with primary aldosteronism: results of a case-control study","volume":"96","author":"Pimenta","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30319-4_bib31","doi-asserted-by":"crossref","first-page":"340","DOI":"10.1016\/S0895-7061(01)02331-7","article-title":"Echocardiographic comparison of left ventricular structure and function in hypertensive patients with primary aldosteronism and essential hypertension","volume":"15","author":"Goldkorn","year":"2002","journal-title":"Am J Hypertens"},{"key":"10.1016\/S2213-8587(17)30319-4_bib32","doi-asserted-by":"crossref","first-page":"529","DOI":"10.1161\/HYPERTENSIONAHA.108.114140","article-title":"Inappropriate left ventricular mass in patients with primary aldosteronism","volume":"52","author":"Muiesan","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30319-4_bib33","doi-asserted-by":"crossref","first-page":"7","DOI":"10.3389\/fcvm.2014.00007","article-title":"Electrical and myocardial remodeling in primary aldosteronism","volume":"1","author":"Curione","year":"2014","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/S2213-8587(17)30319-4_bib34","doi-asserted-by":"crossref","first-page":"426","DOI":"10.1177\/1470320312446240","article-title":"Left ventricle remodeling in men with moderate to severe volume-dependent hypertension","volume":"13","author":"Indra","year":"2012","journal-title":"J Renin Angiotensin Aldosterone Syst"},{"key":"10.1016\/S2213-8587(17)30319-4_bib35","doi-asserted-by":"crossref","first-page":"911","DOI":"10.1161\/HYPERTENSIONAHA.107.095448","article-title":"Long-term cardiac effects of adrenalectomy or mineralocorticoid antagonists in patients with primary aldosteronism","volume":"50","author":"Catena","year":"2007","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30319-4_bib36","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1161\/01.HYP.0000052542.68896.2B","article-title":"Myocardial Ultrasonic Backscatter in Hypertension Relation to Aldosterone and Endothelin","volume":"41","author":"Koz\u00e0kov\u00e0","year":"2003","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30319-4_bib37","doi-asserted-by":"crossref","first-page":"985","DOI":"10.1016\/S0735-1097(98)00322-2","article-title":"Relations between cardiac and vascular structure in patients with primary and secondary hypertension","volume":"32","author":"Rizzoni","year":"1998","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30319-4_bib38","doi-asserted-by":"crossref","first-page":"85","DOI":"10.1291\/hypres.20.85","article-title":"Left ventricular hypertrophy is more prominent in patients with primary aldosteronism than in patients with other types of secondary hypertension","volume":"20","author":"Tanabe","year":"1997","journal-title":"Hypertens Res"},{"key":"10.1016\/S2213-8587(17)30319-4_bib39","doi-asserted-by":"crossref","first-page":"2513","DOI":"10.1210\/jc.2012-3934","article-title":"Aldosterone excess impairs first phase insulin secretion in primary aldosteronism","volume":"98","author":"Fischer","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(17)30319-4_bib40","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1055\/s-0029-1246189","article-title":"Is primary aldosteronism associated with diabetes mellitus? Results of the German Conn's Registry","volume":"42","author":"Reincke","year":"2010","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(17)30319-4_bib41","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.1097\/00004872-200207000-00032","article-title":"Structural changes in small resistance arteries and left ventricular geometry in patients with primary and secondary hypertension","volume":"20","author":"Muiesan","year":"2002","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(17)30319-4_bib42","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1530\/EJE-15-0450","article-title":"Increased prevalence of diabetes mellitus and the metabolic syndrome in patients with primary aldosteronism of the German Conn's Registry","volume":"173","author":"Hanslik","year":"2015","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(17)30319-4_bib43","doi-asserted-by":"crossref","first-page":"363","DOI":"10.5603\/EP.2013.0019","article-title":"Relationship between primary aldosteronism and obstructive sleep apnoea, metabolic abnormalities and cardiac structure in patients with resistant hypertension","volume":"64","author":"Prejbisz","year":"2013","journal-title":"Endokrynol Pol"},{"key":"10.1016\/S2213-8587(17)30319-4_bib44","doi-asserted-by":"crossref","first-page":"294594","DOI":"10.1155\/2013\/294594","article-title":"Twenty-four-hour urinary aldosterone predicts inappropriate left ventricular mass index in patients with primary aldosteronism","author":"Hung","year":"2013","journal-title":"Sci World J"},{"key":"10.1016\/S2213-8587(17)30319-4_bib45","doi-asserted-by":"crossref","first-page":"603","DOI":"10.33549\/physiolres.930123","article-title":"Can primary hyperaldosteronism be considered as a specific form of diabetes mellitus?","volume":"50","author":"Widimisky","year":"2001","journal-title":"Physiol Res"},{"key":"10.1016\/S2213-8587(17)30319-4_bib46","doi-asserted-by":"crossref","first-page":"4828","DOI":"10.1210\/en.2002-220120","article-title":"Selective aldosterone blockade prevents angiotensin II\/salt-induced vascular inflammation in the rat heart","volume":"143","author":"Rocha","year":"2002","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(17)30319-4_bib47","doi-asserted-by":"crossref","first-page":"75","DOI":"10.2174\/187152506775268776","article-title":"Mineralocorticoid receptor blockade in the protection of target organ damage","volume":"4","author":"Mulatero","year":"2006","journal-title":"Cardiovasc Hematol Agents Med Chem"},{"key":"10.1016\/S2213-8587(17)30319-4_bib48","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1161\/01.HYP.37.2.787","article-title":"Mineralocorticoid receptor affects AP-1 and nuclear factor-kappab activation in angiotensin II-induced cardiac injury","volume":"37","author":"Fiebeler","year":"2001","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30319-4_bib49","doi-asserted-by":"crossref","first-page":"2857","DOI":"10.1161\/01.CIR.0000129307.26791.8E","article-title":"Impaired endothelium-dependent flow-mediated vasodilation in hypertensive subjects with hyperaldosteronism","volume":"109","author":"Nishizaka","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30319-4_bib50","doi-asserted-by":"crossref","first-page":"2213","DOI":"10.1161\/01.CIR.0000127949.05756.9D","article-title":"Aldosterone administration to mice stimulates macrophage NADPH oxidase and increases atherosclerosis development: a possible role for angiotensin-converting enzyme and the receptors for angiotensin II and aldosterone","volume":"109","author":"Keidar","year":"2004","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(17)30319-4_bib51","doi-asserted-by":"crossref","first-page":"3871","DOI":"10.1210\/endo.141.10.7711","article-title":"Aldosterone: a mediator of myocardial necrosis and renal arteriopathy","volume":"141","author":"Rocha","year":"2000","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(17)30319-4_bib52","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1016\/j.mce.2003.10.047","article-title":"Aldosterone target organ protection by eplerenone","volume":"217","author":"Rudolph","year":"2004","journal-title":"Mol Cell Endocrinol"},{"key":"10.1016\/S2213-8587(17)30319-4_bib53","doi-asserted-by":"crossref","first-page":"2098","DOI":"10.1093\/eurheartj\/ehr266","article-title":"Aldosterone promotes atrial fibrillation","volume":"33","author":"Reil","year":"2012","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(17)30319-4_bib54","doi-asserted-by":"crossref","first-page":"221","DOI":"10.1161\/HYPERTENSIONAHA.109.146936","article-title":"Aldosterone, sodium, and hypertension: lessons from torcetrapib?","volume":"55","author":"Funder","year":"2010","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(17)30319-4_bib55","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.93136","article-title":"Steroid metabolome analysis reveals prevalent glucocorticoid excess in primary aldosteronism","volume":"2","author":"Arlt","year":"2017","journal-title":"JCI Insight"},{"key":"10.1016\/S2213-8587(17)30319-4_bib56","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1055\/s-0031-1295412","article-title":"Primary aldosteronism and metabolic syndrome","volume":"44","author":"Fallo","year":"2012","journal-title":"Horm Metab Res"},{"key":"10.1016\/S2213-8587(17)30319-4_bib57","doi-asserted-by":"crossref","first-page":"283","DOI":"10.1007\/s11845-013-1007-x","article-title":"Elevated prevalence of abnormal glucose metabolism in patients with primary aldosteronism: a meta-analysis","volume":"183","author":"Chen","year":"2014","journal-title":"Ir J Med Sci"},{"key":"10.1016\/S2213-8587(17)30319-4_bib58","doi-asserted-by":"crossref","first-page":"2293","DOI":"10.1016\/j.jacc.2006.07.059","article-title":"A prospective study of the prevalence of primary aldosteronism in 1,125 hypertensive patients","volume":"48","author":"Rossi","year":"2006","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(17)30319-4_bib59","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(17)30319-4_bib60","doi-asserted-by":"crossref","first-page":"2253","DOI":"10.1097\/HJH.0000000000001088","article-title":"Guidelines for primary aldosteronism: uptake by primary care physicians in Europe","volume":"34","author":"Mulatero","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(17)30319-4_bib61","doi-asserted-by":"crossref","first-page":"1691","DOI":"10.1097\/HJH.0000000000001384","article-title":"Diagnostic rate of primary aldosteronism in Emilia-Romagna, Northern Italy, during 16 years (2000\u20132015)","volume":"35","author":"Rossi","year":"2017","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(17)30319-4_bib62","doi-asserted-by":"crossref","first-page":"2665","DOI":"10.1016\/S0140-6736(16)31134-5","article-title":"A call to action and a lifecourse strategy to address the global burden of raised blood pressure on current and future generations: the Lancet Commission on hypertension","volume":"388","author":"Olsen","year":"2016","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303194?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858717303194?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,6,26]],"date-time":"2025-06-26T19:27:58Z","timestamp":1750966078000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858717303194"}},"issued":{"date-parts":[[2018,1]]},"references-count":62,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,1]]}},"alternative-id":["S2213858717303194"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(17)30319-4","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2018,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30319-4","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(17)30368-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2017 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T13:54:25Z","timestamp":1794664465483,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020884","name":"National Agency for Research and Development","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020884","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000925","name":"National Health and Medical Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003478","name":"Government of Japan Ministry of Health Labour and Welfare","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003478","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["444776998"],"award-info":[{"award-number":["444776998"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001659","name":"Deutsche Forschungsgemeinschaft","doi-asserted-by":"publisher","award":["WI 5359\/2-1"],"award-info":[{"award-number":["WI 5359\/2-1"]}],"id":[{"id":"10.13039\/501100001659","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004752","name":"State Government of Victoria","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004752","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100005890","name":"Hudson Institute","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100005890","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100009610","name":"Pontifical Catholic University of Chile","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100009610","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/s2213-8587(24)00308-5","type":"journal-article","created":{"date-parts":[[2025,1,14]],"date-time":"2025-01-14T18:37:16Z","timestamp":1736879836000},"page":"119-133","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":80,"title":["Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort"],"prefix":"10.1016","volume":"13","author":[{"given":"Jun","family":"Yang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jacopo","family":"Burrello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jessica","family":"Goi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Reincke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Adolf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evelyn","family":"Asbach","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Denise","family":"Br\u0171dgam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qifu","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Song","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinbo","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shumin","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fumitoshi","family":"Satoh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoshikiyo","family":"Ono","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Renata","family":"Libianto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Stowasser","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nanfang","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qing","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Namki","family":"Hong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Drishya","family":"Nayak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Troy H","family":"Puar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vin-Cent","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anand","family":"Vaidya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marta","family":"Araujo-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomaz","family":"Kocjan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Samuel Matthew","family":"O'Toole","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory L","family":"Hundemer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oskar","family":"Ragnarsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andr\u00e9","family":"Lacroix","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Larose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kazuki","family":"Nakai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuo","family":"Nishikawa","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daria","family":"Ladygina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adina F","family":"Turcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julieta","family":"Sholinyan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlos E","family":"Fardella","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Thomas","family":"Uslar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"Quinkler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paolo","family":"Mulatero","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Pintus","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gian Paolo","family":"Rossi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefanie","family":"Hahner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Laurence","family":"Amar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"William M","family":"Drake","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chetna","family":"Varsani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morris J","family":"Brown","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xilin","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jaap","family":"Deinum","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"E Marie","family":"Freel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Kline","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mitsuhide","family":"Naruse","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aleksander","family":"Prejbisz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"Jr","given":"William F","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tracy Ann","family":"Williams","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter J","family":"Fuller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00308-5_bib1","doi-asserted-by":"crossref","first-page":"665","DOI":"10.1038\/s41574-022-00730-2","article-title":"Primary aldosteronism\u2014a multidimensional syndrome","volume":"18","author":"Turcu","year":"2022","journal-title":"Nat Rev Endocrinol"},{"key":"10.1016\/S2213-8587(24)00308-5_bib2","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1016\/S2213-8587(17)30319-4","article-title":"Cardiovascular events and target organ damage in primary aldosteronism compared with essential hypertension: a systematic review and meta-analysis","volume":"6","author":"Monticone","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00308-5_bib3","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1097\/HJH.0000000000002216","article-title":"Renal damage in primary aldosteronism: a systematic review and meta-analysis","volume":"38","author":"Monticone","year":"2020","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(24)00308-5_bib4","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/S2213-8587(17)30367-4","article-title":"Cardiometabolic outcomes and mortality in medically treated primary aldosteronism: a retrospective cohort study","volume":"6","author":"Hundemer","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00308-5_bib5","doi-asserted-by":"crossref","first-page":"1899","DOI":"10.1161\/HYPERTENSIONAHA.122.17964","article-title":"Aldosterone as a mediator of cardiovascular damage","volume":"79","author":"Buffolo","year":"2022","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(24)00308-5_bib6","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1161\/HYPERTENSIONAHA.123.21895","article-title":"Mortality in patients with primary aldosteronism: a Swedish nationwide study","volume":"80","author":"Gkaniatsa","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(24)00308-5_bib7","doi-asserted-by":"crossref","first-page":"689","DOI":"10.1016\/S2213-8587(17)30135-3","article-title":"Outcomes after adrenalectomy for unilateral primary aldosteronism: an international consensus on outcome measures and analysis of remission rates in an international cohort","volume":"5","author":"Williams","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00308-5_bib8","doi-asserted-by":"crossref","first-page":"42","DOI":"10.1210\/clinem\/dgaa484","article-title":"International histopathology consensus for unilateral primary aldosteronism","volume":"106","author":"Williams","year":"2021","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00308-5_bib9","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1210\/endrev\/bnad024","article-title":"Biomarkers to guide medical therapy in primary aldosteronism","volume":"45","author":"Hundemer","year":"2023","journal-title":"Endocr Rev"},{"key":"10.1016\/S2213-8587(24)00308-5_bib10","doi-asserted-by":"crossref","first-page":"916744","DOI":"10.3389\/fendo.2022.916744","article-title":"Treatment of primary aldosteronism and reversal of renin suppression improves left ventricular systolic function","volume":"13","author":"Puar","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(24)00308-5_bib11","doi-asserted-by":"crossref","first-page":"1909","DOI":"10.1161\/HYPERTENSIONAHA.123.21096","article-title":"Association of reversal of renin suppression with long-term renal outcome in medically treated primary aldosteronism","volume":"80","author":"Katsuragawa","year":"2023","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(24)00308-5_bib12","doi-asserted-by":"crossref","first-page":"768","DOI":"10.1001\/jamacardio.2018.2003","article-title":"Incidence of atrial fibrillation and mineralocorticoid receptor activity in patients with medically and surgically treated primary aldosteronism","volume":"3","author":"Hundemer","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(24)00308-5_bib13","doi-asserted-by":"crossref","first-page":"1889","DOI":"10.1210\/jc.2015-4061","article-title":"The management of primary aldosteronism: case detection, diagnosis, and treatment: an Endocrine Society Clinical Practice Guideline","volume":"101","author":"Funder","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00308-5_bib14","doi-asserted-by":"crossref","first-page":"625457","DOI":"10.3389\/fendo.2021.625457","article-title":"Real-world effectiveness of mineralocorticoid receptor antagonists in primary aldosteronism","volume":"12","author":"Tezuka","year":"2021","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(24)00308-5_bib15","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1097\/HJH.0000000000000775","article-title":"A cross-sectional study of the effects of \u03b2-blocker therapy on the interpretation of the aldosterone\/renin ratio: can dosing regimen predict effect?","volume":"34","author":"Griffin","year":"2016","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(24)00308-5_bib16","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1046\/j.1365-2265.2002.01613.x","article-title":"Influence of antihypertensive medication on aldosterone and renin concentration in the differential diagnosis of essential hypertension and primary aldosteronism","volume":"57","author":"Seifarth","year":"2002","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(24)00308-5_bib17","doi-asserted-by":"crossref","first-page":"bvab144","DOI":"10.1210\/jendso\/bvab144","article-title":"Tolerability and efficacy of long-term medical therapy in primary aldosteronism","volume":"5","author":"Tang","year":"2021","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(24)00308-5_bib18","doi-asserted-by":"crossref","first-page":"2486","DOI":"10.1097\/HJH.0000000000003284","article-title":"Predictive model of hypertension resolution after adrenalectomy in primary aldosteronism: the SPAIN-ALDO score","volume":"40","author":"Araujo-Castro","year":"2022","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(24)00308-5_bib19","doi-asserted-by":"crossref","first-page":"1366","DOI":"10.1161\/HYPERTENSIONAHA.108.111369","article-title":"Vascular remodeling and duration of hypertension predict outcome of adrenalectomy in primary aldosteronism patients","volume":"51","author":"Rossi","year":"2008","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(24)00308-5_bib20","doi-asserted-by":"crossref","first-page":"e220249","DOI":"10.1530\/JOE-22-0249","article-title":"Mineralocorticoid receptor signalling in primary aldosteronism","volume":"259","author":"Yang","year":"2023","journal-title":"J Endocrinol"},{"key":"10.1016\/S2213-8587(24)00308-5_bib21","doi-asserted-by":"crossref","first-page":"1125","DOI":"10.1097\/SLA.0000000000003200","article-title":"The Primary Aldosteronism Surgical Outcome Score for the prediction of clinical outcomes after adrenalectomy for unilateral primary aldosteronism","volume":"272","author":"Burrello","year":"2020","journal-title":"Ann Surg"},{"key":"10.1016\/S2213-8587(24)00308-5_bib22","doi-asserted-by":"crossref","first-page":"369","DOI":"10.3803\/EnM.2022.1391","article-title":"Outcome-based decision-making algorithm for treating patients with primary aldosteronism","volume":"37","author":"Kim","year":"2022","journal-title":"Endocrinol Metab (Seoul)"},{"key":"10.1016\/S2213-8587(24)00308-5_bib23","doi-asserted-by":"crossref","first-page":"5781","DOI":"10.1038\/s41598-022-09706-8","article-title":"Machine learning-based models for predicting clinical outcomes after surgery in unilateral primary aldosteronism","volume":"12","author":"Kaneko","year":"2022","journal-title":"Sci Rep"},{"key":"10.1016\/S2213-8587(24)00308-5_bib24","doi-asserted-by":"crossref","first-page":"dgaa634","DOI":"10.1210\/clinem\/dgaa634","article-title":"Nomogram-based preoperative score for predicting clinical outcome in unilateral primary aldosteronism","volume":"105","author":"Yang","year":"2020","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(24)00308-5_bib25","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.1016\/j.cjca.2024.01.036","article-title":"Vascular aging in women","volume":"40","author":"Laporte","year":"2024","journal-title":"Can J Cardiol"},{"key":"10.1016\/S2213-8587(24)00308-5_bib26","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.1097\/HJH.0000000000002922","article-title":"Home blood pressure monitoring: methodology, clinical relevance, and practical application: a 2021 position paper by the Working Group on Blood Pressure Monitoring and Cardiovascular Variability of the European Society of Hypertension","volume":"39","author":"Parati","year":"2021","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(24)00308-5_bib27","doi-asserted-by":"crossref","first-page":"s6","DOI":"10.1017\/S136898002200218X","article-title":"Population-level salt intake in the WHO European Region in 2022: a systematic review","volume":"26","author":"Kwong","year":"2023","journal-title":"Public Health Nutr"},{"key":"10.1016\/S2213-8587(24)00308-5_bib28","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1016\/j.amjmed.2008.09.038","article-title":"Combination therapy versus monotherapy in reducing blood pressure: meta-analysis on 11\u2008000 participants from 42 trials","volume":"122","author":"Wald","year":"2009","journal-title":"Am J Med"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(25)00021-x","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003085?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003085?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T01:08:01Z","timestamp":1740791281000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003085"}},"issued":{"date-parts":[[2025,2]]},"references-count":28,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2213858724003085"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00308-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Outcomes after medical treatment for primary aldosteronism: an international consensus and analysis of treatment response in an international cohort","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00308-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00344-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:09Z","timestamp":1720746729993},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/s2213-8587(13)70033-0","type":"journal-article","created":{"date-parts":[[2013,5,22]],"date-time":"2013-05-22T21:26:12Z","timestamp":1369257972000},"page":"s12","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["TSH, blood pressure, and lipid levels"],"prefix":"10.1016","volume":"1","author":[{"given":"Talha Khan","family":"Burki","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700330?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713700330?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T17:22:26Z","timestamp":1539624146000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713700330"}},"issued":{"date-parts":[[2013,8]]},"references-count":0,"alternative-id":["S2213858713700330"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70033-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,8]]}},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:11Z","timestamp":1720746731290},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/s2213-8587(13)70041-x","type":"journal-article","created":{"date-parts":[[2013,6,12]],"date-time":"2013-06-12T22:19:27Z","timestamp":1371075567000},"page":"s15","source":"Crossref","is-referenced-by-count":1,"special_numbering":"S1","title":["MKRN3 and central precocious puberty"],"prefix":"10.1016","volume":"1","author":[{"given":"Farhat","family":"Yaqub","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871370041X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871370041X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,15]],"date-time":"2018-10-15T05:53:18Z","timestamp":1539582798000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871370041X"}},"issued":{"date-parts":[[2013,8]]},"references-count":0,"alternative-id":["S221385871370041X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70041-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,8]]}},{"indexed":{"date-parts":[[2024,7,12]],"date-time":"2024-07-12T01:12:18Z","timestamp":1720746738444},"reference-count":0,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2013,8,1]],"date-time":"2013-08-01T00:00:00Z","timestamp":1375315200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,8]]},"DOI":"10.1016\/s2213-8587(13)70131-1","type":"journal-article","created":{"date-parts":[[2013,9,18]],"date-time":"2013-09-18T08:31:13Z","timestamp":1379493073000},"page":"s10","source":"Crossref","is-referenced-by-count":0,"special_numbering":"S1","title":["A molecular handshake: insulin\u2013receptor interaction revealed"],"prefix":"10.1016","volume":"1","author":[{"given":"David","family":"Salman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701311?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713701311?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,12]],"date-time":"2018-10-12T20:50:56Z","timestamp":1539377456000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713701311"}},"issued":{"date-parts":[[2013,8]]},"references-count":0,"alternative-id":["S2213858713701311"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70131-1","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,8]]}},{"indexed":{"date-parts":[[2022,6,19]],"date-time":"2022-06-19T11:25:47Z","timestamp":1655637947551},"reference-count":5,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2014,5,1]],"date-time":"2014-05-01T00:00:00Z","timestamp":1398902400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,5]]},"DOI":"10.1016\/s2213-8587(14)70083-x","type":"journal-article","created":{"date-parts":[[2014,5,5]],"date-time":"2014-05-05T11:34:23Z","timestamp":1399289663000},"page":"361-362","source":"Crossref","is-referenced-by-count":2,"title":["Vitamin D, obesity, and risk of diabetes"],"prefix":"10.1016","volume":"2","author":[{"given":"Barbara","family":"Boucher","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70083-X_bib1","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1016\/S2213-8587(13)70200-6","article-title":"Vitamin D concentration, obesity, and risk of diabetes: a Mendelian randomisation study","volume":"2","author":"Afzal","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70083-X_bib2","doi-asserted-by":"crossref","first-page":"267","DOI":"10.1016\/S2213-8587(13)70220-1","article-title":"Vitamin D and prevention of diabetes: is lifelong endogenous vitamin D needed?","volume":"2","author":"Pilz","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70083-X_bib3","doi-asserted-by":"crossref","first-page":"61","DOI":"10.2174\/138945011793591653","article-title":"Vitamin D insufficiency and diabetes risks","volume":"12","author":"Boucher","year":"2011","journal-title":"Curr Drug Targets"},{"key":"10.1016\/S2213-8587(14)70083-X_bib4","doi-asserted-by":"crossref","first-page":"2173","DOI":"10.1007\/s00125-012-2544-y","article-title":"Circulating 25-hydroxyvitamin D concentration and the risk of type 2 diabetes: results from the European Prospective Investigation into Cancer (EPIC)-Norfolk cohort and updated meta-analysis of prospective studies","volume":"55","author":"Forouhi","year":"2012","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(14)70083-X_bib5","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1007\/BF00422375","article-title":"Glucose intolerance and impairment of insulin secretion in relation to vitamin D deficiency in East London Asians","volume":"38","author":"Boucher","year":"1995","journal-title":"Diabetologia"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871470083X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871470083X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,4]],"date-time":"2018-10-04T06:23:02Z","timestamp":1538634182000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871470083X"}},"issued":{"date-parts":[[2014,5]]},"references-count":5,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2014,5]]}},"alternative-id":["S221385871470083X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70083-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,5]]}},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T17:36:54Z","timestamp":1648661814938},"reference-count":8,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2013,9,1]],"date-time":"2013-09-01T00:00:00Z","timestamp":1377993600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2013,9]]},"DOI":"10.1016\/s2213-8587(13)70010-x","type":"journal-article","created":{"date-parts":[[2013,2,21]],"date-time":"2013-02-21T16:42:33Z","timestamp":1361464953000},"page":"6-7","source":"Crossref","is-referenced-by-count":0,"title":["Towards a personalised diagnosis of type 2 diabetes"],"prefix":"10.1016","volume":"1","author":[{"given":"Sarah H","family":"Wild","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Christopher D","family":"Byrne","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70010-X_bib1","series-title":"Definition and diagnosis of diabetes mellitus and intermediate hyperglycaemia","year":"2006"},{"key":"10.1016\/S2213-8587(13)70010-X_bib2","series-title":"Use of glycated haemoglobin (HbA1c) in the diagnosis of diabetes mellitus","year":"2011"},{"key":"10.1016\/S2213-8587(13)70010-X_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(13)70008-1","article-title":"Trajectories of cardiometabolic risk factors before diagnosis of three subtypes of type 2 diabetes: a post-hoc analysis of the longitudinal Whitehall II cohort study","author":"F\u00e6rch","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70010-X_bib4","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/s11695-012-0802-1","article-title":"A multisite study of long-term remission and relapse of type 2 diabetes mellitus following gastric bypass","volume":"23","author":"Arterburn","year":"2013","journal-title":"Obes Surg"},{"key":"10.1016\/S2213-8587(13)70010-X_bib5","doi-asserted-by":"crossref","first-page":"2506","DOI":"10.1007\/s00125-011-2204-7","article-title":"Reversal of type 2 diabetes: normalisation of beta cell function in association with decreased pancreas and liver triacylglycerol","volume":"54","author":"Lim","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70010-X_bib6","doi-asserted-by":"crossref","first-page":"981","DOI":"10.1038\/ng.2383","article-title":"Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes","volume":"44","author":"Morris","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(13)70010-X_bib7","doi-asserted-by":"crossref","first-page":"2131","DOI":"10.1053\/j.gastro.2007.03.054","article-title":"Biology of incretins: GLP-1 and GIP","volume":"132","author":"Baggio","year":"2007","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(13)70010-X_bib8","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","author":"Knowler","year":"2002","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871370010X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871370010X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,18]],"date-time":"2018-10-18T14:24:36Z","timestamp":1539872676000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871370010X"}},"issued":{"date-parts":[[2013,9]]},"references-count":8,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2013,9]]}},"alternative-id":["S221385871370010X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70010-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2013,9]]}},{"indexed":{"date-parts":[[2025,9,11]],"date-time":"2025-09-11T22:35:00Z","timestamp":1757630100357,"version":"3.44.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/s2213-8587(25)00190-1","type":"journal-article","created":{"date-parts":[[2025,8,11]],"date-time":"2025-08-11T22:36:59Z","timestamp":1754951819000},"page":"814-815","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Understanding the mechanism of prediabetes remission in young people"],"prefix":"10.1016","volume":"13","author":[{"given":"Roy","family":"Taylor","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00190-1_bib1","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s00125-024-06315-0","article-title":"Prediabetes is associated with elevated risk of clinical outcomes even without progression to diabetes","volume":"68","author":"Rooney","year":"2025","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00190-1_bib2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S2213-8587(23)00223-1","article-title":"Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation","volume":"11","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00190-1_bib3","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(25)00163-9","article-title":"The central role of recovery of \u03b2-cell function in the remission of prediabetes: a prospective cohort study in Canada","author":"Retnakaran","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00190-1_bib4","doi-asserted-by":"crossref","first-page":"2243","DOI":"10.1016\/S0140-6736(12)60525-X","article-title":"Effect of regression from prediabetes to normal glucose regulation on long-term reduction in diabetes risk: results from the Diabetes Prevention Program Outcomes Study","volume":"379","author":"Perreault","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00190-1_bib5","doi-asserted-by":"crossref","first-page":"2007","DOI":"10.1007\/s00125-020-05245-x","article-title":"Early beta cell dysfunction vs insulin hypersecretion as the primary event in the pathogenesis of dysglycaemia","volume":"63","author":"Esser","year":"2020","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00190-1_bib6","doi-asserted-by":"crossref","first-page":"798","DOI":"10.1016\/S2213-8587(23)00235-8","article-title":"Mechanisms of weight loss-induced remission in people with prediabetes: a post-hoc analysis of the randomised, controlled, multicentre Prediabetes Lifestyle Intervention Study (PLIS)","volume":"11","author":"Sandforth","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00190-1_bib7","doi-asserted-by":"crossref","first-page":"2215","DOI":"10.1016\/S0140-6736(09)60619-X","article-title":"Trajectories of glycaemia, insulin sensitivity, and insulin secretion before diagnosis of type 2 diabetes: an analysis from the Whitehall II study","volume":"373","author":"Tab\u00e1k","year":"2009","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00190-1_bib8","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1056\/NEJM197604012941401","article-title":"The syndromes of insulin resistance and acanthosis nigricans. Insulin-receptor disorders in man","volume":"294","author":"Kahn","year":"1976","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(25)00190-1_bib9","doi-asserted-by":"crossref","first-page":"778","DOI":"10.2337\/db12-0073","article-title":"Insulin resistance and type 2 diabetes","volume":"61","author":"Taylor","year":"2012","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(25)00190-1_bib10","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1016\/S2213-8587(24)00157-8","article-title":"Understanding the cause of type 2 diabetes","volume":"12","author":"Taylor","year":"2024","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001901?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725001901?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,10]],"date-time":"2025-09-10T16:15:00Z","timestamp":1757520900000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725001901"}},"issued":{"date-parts":[[2025,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2025,10]]}},"alternative-id":["S2213858725001901"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00190-1","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Understanding the mechanism of prediabetes remission in young people","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00190-1","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00163-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2022,3,30]],"date-time":"2022-03-30T09:38:00Z","timestamp":1648633080787},"reference-count":11,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2014,3,1]],"date-time":"2014-03-01T00:00:00Z","timestamp":1393632000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,1,20]],"date-time":"2014-01-20T00:00:00Z","timestamp":1390176000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/3.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,3]]},"DOI":"10.1016\/s2213-8587(13)70210-9","type":"journal-article","created":{"date-parts":[[2013,12,23]],"date-time":"2013-12-23T04:15:17Z","timestamp":1387772117000},"page":"186-188","source":"Crossref","is-referenced-by-count":2,"title":["Stemming the tide of type 2 diabetes and its consequences in south Asian individuals"],"prefix":"10.1016","volume":"2","author":[{"given":"Therese","family":"Tillin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nish","family":"Chaturvedi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(13)70210-9_bib1","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1016\/j.diabres.2011.10.029","article-title":"IDF diabetes atlas: global estimates of the prevalence of diabetes for 2011 and 2030","volume":"94","author":"Whiting","year":"2011","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(13)70210-9_bib2","doi-asserted-by":"crossref","first-page":"383","DOI":"10.2337\/dc12-0544","article-title":"Insulin resistance and truncal obesity as important determinants of the greater incidence of diabetes in Indian Asians and African Caribbeans compared with Europeans: the Southall And Brent REvisited (SABRE) cohort","volume":"36","author":"Tillin","year":"2013","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(13)70210-9_bib3","doi-asserted-by":"crossref","first-page":"1777","DOI":"10.1016\/j.jacc.2012.12.046","article-title":"The relationship between metabolic risk factors and incident cardiovascular disease in Europeans, south Asians, and African Caribbeans: SABRE (Southall and Brent revisited)\u2014a prospective population-based study","volume":"61","author":"Tillin","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(13)70210-9_bib4","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1007\/s00125-005-0097-z","article-title":"The Indian Diabetes Prevention Programme shows that lifestyle modification and metformin prevent type 2 diabetes in Asian Indian subjects with impaired glucose tolerance (IDPP-1)","volume":"49","author":"Ramachandran","year":"2006","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(13)70210-9_bib5","article-title":"Effect of a lifestyle intervention on weight change in south Asian individuals in the UK at high risk of type 2 diabetes: a family-cluster randomised controlled trial","author":"Bhopal","year":"2013","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(13)70210-9_bib6","doi-asserted-by":"crossref","first-page":"1343","DOI":"10.1056\/NEJM200105033441801","article-title":"Prevention of type 2 diabetes mellitus by changes in lifestyle among subjects with impaired glucose tolerance","volume":"344","author":"Tuomilehto","year":"2001","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70210-9_bib7","doi-asserted-by":"crossref","first-page":"393","DOI":"10.1056\/NEJMoa012512","article-title":"Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin","volume":"346","year":"2002","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(13)70210-9_bib8","doi-asserted-by":"crossref","first-page":"1849","DOI":"10.2337\/db11-0400","article-title":"Maternal environment and the transgenerational cycle of obesity and diabetes","volume":"60","author":"Dabelea","year":"2011","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(13)70210-9_bib9","series-title":"A life course approach to chronic disease epidemiology: tracing the origins of ill-health from early to adult life","author":"Kuh","year":"2004"},{"key":"10.1016\/S2213-8587(13)70210-9_bib10","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1093\/ije\/dyi309","article-title":"Treatment and prevention of obesity\u2014are there critical periods for intervention?","volume":"35","author":"Lawlor","year":"2006","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(13)70210-9_bib11","doi-asserted-by":"crossref","first-page":"2074","DOI":"10.1210\/jc.2006-0241","article-title":"Randomized, controlled trial of metformin for obesity and insulin resistance in children and adolescents: improvement in body composition and fasting insulin","volume":"91","author":"Srinivasan","year":"2006","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713702109?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858713702109?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,7]],"date-time":"2018-10-07T21:52:39Z","timestamp":1538949159000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858713702109"}},"issued":{"date-parts":[[2014,3]]},"references-count":11,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2014,3]]}},"alternative-id":["S2213858713702109"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(13)70210-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,3]]}},{"indexed":{"date-parts":[[2022,4,4]],"date-time":"2022-04-04T04:54:57Z","timestamp":1649048097428},"reference-count":5,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/s2213-8587(15)00321-6","type":"journal-article","created":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T16:05:57Z","timestamp":1442505957000},"page":"762","source":"Crossref","is-referenced-by-count":1,"title":["Postnatal testing following gestational diabetes \u2013 Authors' reply"],"prefix":"10.1016","volume":"3","author":[{"given":"Hema","family":"Venkataraman","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ponnusamy","family":"Saravanan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00321-6_bib1","doi-asserted-by":"crossref","first-page":"145","DOI":"10.2337\/dc10-1206","article-title":"Glycemic thresholds for diabetes-specific retinopathy: implications for diagnostic criteria for diabetes","volume":"34","author":"Colagiuri","year":"2011","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00321-6_bib2","doi-asserted-by":"crossref","first-page":"1349","DOI":"10.2337\/dc07-1707","article-title":"Longitudinal association of glucose metabolism with retinopathy: results from the Australian Diabetes Obesity and Lifestyle (AusDiab) study","volume":"31","author":"Tapp","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00321-6_bib3","doi-asserted-by":"crossref","first-page":"1564","DOI":"10.1007\/s00125-012-2510-8","article-title":"HbA1c in type 2 diabetes diagnostic criteria: addressing the right questions to move the field forwards","volume":"55","author":"Sattar","year":"2012","journal-title":"Diabetologia"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(15)00321-6_bib4","first-page":"S31","article-title":"Prevention or delay of type 2 diabetes","volume":"38","year":"2015","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(15)00321-6_bib6","doi-asserted-by":"crossref","first-page":"1646","DOI":"10.1210\/jc.2014-3761","article-title":"The effect of lifestyle intervention and metformin on preventing or delaying diabetes among women with and without gestational diabetes: the diabetes prevention program outcomes study 10-year follow-up","volume":"100","author":"Aroda","year":"2015","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003216?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003216?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T05:53:39Z","timestamp":1537336419000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003216"}},"issued":{"date-parts":[[2015,10]]},"references-count":5,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2213858715003216"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00321-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,10]]}},{"indexed":{"date-parts":[[2025,5,3]],"date-time":"2025-05-03T07:23:02Z","timestamp":1746256982501},"reference-count":5,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2016,12,1]],"date-time":"2016-12-01T00:00:00Z","timestamp":1480550400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,12]]},"DOI":"10.1016\/s2213-8587(16)30266-2","type":"journal-article","created":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T02:39:44Z","timestamp":1479868784000},"page":"971-972","source":"Crossref","is-referenced-by-count":7,"title":["Are statins useful in patients with advanced chronic kidney disease? \u2013 Authors' reply"],"prefix":"10.1016","volume":"4","author":[{"given":"William G","family":"Herrington","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jonathan","family":"Emberson","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Borislava","family":"Mihaylova","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rory","family":"Collins","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Colin","family":"Baigent","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30266-2_bib1","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1016\/S2213-8587(16)30156-5","article-title":"Impact of renal function on the effects of LDL cholesterol lowering with statin-based regimens: a meta-analysis of individual participant data from 28 randomised trials","volume":"4","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30266-2_bib2","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1016\/S0140-6736(12)60367-5","article-title":"The effects of lowering LDL cholesterol with statin therapy in people at low risk of vascular disease: meta-analysis of individual data from 27 randomised trials","volume":"380","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30266-2_bib3","doi-asserted-by":"crossref","first-page":"2181","DOI":"10.1016\/S0140-6736(11)60739-3","article-title":"The effects of lowering LDL cholesterol with simvastatin plus ezetimibe in patients with chronic kidney disease (Study of Heart and Renal Protection): a randomised placebo-controlled trial","volume":"377","author":"Baigent","year":"2011","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30266-2_bib4","doi-asserted-by":"crossref","first-page":"807","DOI":"10.1016\/S0140-6736(12)60572-8","article-title":"Risk of coronary events in people with chronic kidney disease compared with those with diabetes: a population-level cohort study","volume":"380","author":"Tonelli","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30266-2_bib5","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1016\/S2213-8587(16)30192-9","article-title":"Knowing what we do not know: statin therapy in advanced chronic kidney disease","volume":"4","author":"Wong","year":"2016","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302662?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302662?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,6]],"date-time":"2018-09-06T13:24:30Z","timestamp":1536240270000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302662"}},"issued":{"date-parts":[[2016,12]]},"references-count":5,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2016,12]]}},"alternative-id":["S2213858716302662"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30266-2","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,12]]}},{"indexed":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T01:03:25Z","timestamp":1765328605798,"version":"3.46.0"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,1,1]],"date-time":"2026-01-01T00:00:00Z","timestamp":1767225600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,1]]},"DOI":"10.1016\/s2213-8587(25)00332-8","type":"journal-article","created":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T00:48:17Z","timestamp":1763599697000},"page":"5-6","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Heterogeneity in type 2 diabetes trajectories: informing public health approaches"],"prefix":"10.1016","volume":"14","author":[{"given":"Jonathan","family":"Pearson-Stuttard","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Julia A","family":"Critchley","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00332-8_bib1","article-title":"Trajectories of type 2 diabetes and cancer in 330\u2008000 individuals with prediabetes: 20-year observational study in England","author":"Zaccardi","year":"2025","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00332-8_bib2","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S2213-8587(20)30431-9","article-title":"Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records","volume":"9","author":"Pearson-Stuttard","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00332-8_bib3","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1186\/s12916-019-1373-y","article-title":"The comorbidity burden of type 2 diabetes mellitus: patterns, clusters and predictions from a large English primary care cohort","volume":"17","author":"Nowakowska","year":"2019","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(25)00332-8_bib4","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1093\/ije\/dyv098","article-title":"Data resource profile: Clinical Practice Research Datalink (CPRD)","volume":"44","author":"Herrett","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00332-8_bib5","doi-asserted-by":"crossref","first-page":"684","DOI":"10.1093\/pubmed\/fdt116","article-title":"Completeness and usability of ethnicity data in UK-based primary care and hospital databases","volume":"36","author":"Mathur","year":"2014","journal-title":"J Public Health"},{"key":"10.1016\/S2213-8587(25)00332-8_bib6","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1186\/s12963-023-00302-0","article-title":"Completeness, agreement, and representativeness of ethnicity recording in the United Kingdom's Clinical Practice Research Datalink (CPRD) and linked Hospital Episode Statistics (HES)","volume":"21","author":"Shiekh","year":"2023","journal-title":"Popul Health Metr"},{"key":"10.1016\/S2213-8587(25)00332-8_bib7","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.2337\/dc22-2394","article-title":"Evaluating ethnic variations in the risk of infections in people with prediabetes and type 2 diabetes: a matched cohort study","volume":"46","author":"Carey","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00332-8_bib8","doi-asserted-by":"crossref","DOI":"10.1136\/bmjopen-2020-040201","article-title":"Epidemiology and determinants of non-diabetic hyperglycaemia and its conversion to type 2 diabetes mellitus, 2000-2015: cohort population study using UK electronic health records","volume":"10","author":"Ravindrarajah","year":"2020","journal-title":"BMJ Open"},{"key":"10.1016\/S2213-8587(25)00332-8_bib9","doi-asserted-by":"crossref","first-page":"86","DOI":"10.1016\/S1470-2045(23)00530-2","article-title":"Mortality from leading cancers in districts of England from 2002 to 2019: a population-based, spatiotemporal study","volume":"25","author":"Rashid","year":"2024","journal-title":"Lancet Oncol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003328?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003328?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,12,10]],"date-time":"2025-12-10T00:35:41Z","timestamp":1765326941000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003328"}},"issued":{"date-parts":[[2026,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2026,1]]}},"alternative-id":["S2213858725003328"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00332-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2026,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Heterogeneity in type 2 diabetes trajectories: informing public health approaches","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00332-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00285-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:11:34Z","timestamp":1761991894829,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/s2213-8587(19)30292-x","type":"journal-article","created":{"date-parts":[[2019,9,6]],"date-time":"2019-09-06T18:33:31Z","timestamp":1567794811000},"page":"737","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Tackling metabolic risk: opportunities and challenges"],"prefix":"10.1016","volume":"7","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930292X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871930292X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:06:59Z","timestamp":1761991619000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871930292X"}},"issued":{"date-parts":[[2019,10]]},"references-count":0,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S221385871930292X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30292-x","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Tackling metabolic risk: opportunities and challenges","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30292-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:40Z","timestamp":1761991960881,"version":"build-2065373602"},"reference-count":7,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,8,1]],"date-time":"2020-08-01T00:00:00Z","timestamp":1596240000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,8]]},"DOI":"10.1016\/s2213-8587(20)30223-0","type":"journal-article","created":{"date-parts":[[2020,7,21]],"date-time":"2020-07-21T18:36:02Z","timestamp":1595356562000},"page":"669-670","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Management of diabetes in patients with COVID-19 \u2013 Authors' reply"],"prefix":"10.1016","volume":"8","author":[{"given":"Stefan R","family":"Bornstein","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Paul","family":"Zimmet","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Francesco","family":"Rubino","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Barbara","family":"Ludwig","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30223-0_bib1","doi-asserted-by":"crossref","first-page":"546","DOI":"10.1016\/S2213-8587(20)30152-2","article-title":"Practical recommendations for the management of diabetes in patients with COVID-19","volume":"8","author":"Bornstein","year":"2020","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(20)30223-0_bib2","doi-asserted-by":"crossref","DOI":"10.3390\/molecules25092076","article-title":"Pharmacological (or synthetic) and nutritional agonists of PPAR-\u03b3 as candidates for cytokine storm modulation in COVID-19 disease","volume":"25","author":"Ciavarella","year":"2020","journal-title":"Molecules"},{"key":"10.1016\/S2213-8587(20)30223-0_bib3","doi-asserted-by":"crossref","first-page":"199","DOI":"10.20945\/2359-3997000000256","article-title":"Type 2 diabetes as a major risk factor for COVID-19 severity: a meta-analysis","volume":"64","author":"Pinto","year":"2020","journal-title":"Arch Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30223-0_bib4","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1038\/s41574-020-0353-9","article-title":"Endocrine and metabolic link to coronavirus infection","volume":"16","author":"Bornstein","year":"2020","journal-title":"Nat Rev Endocrinol"},{"author":"de Simone","key":"10.1016\/S2213-8587(20)30223-0_bib5"},{"key":"10.1016\/S2213-8587(20)30223-0_bib6","doi-asserted-by":"crossref","first-page":"669","DOI":"10.1097\/MCA.0000000000000036","article-title":"Newly diagnosed and previously known diabetes mellitus and short-term outcomes in patients with acute myocardial infarction","volume":"24","author":"Tian","year":"2013","journal-title":"Coron Artery Dis"},{"key":"10.1016\/S2213-8587(20)30223-0_bib7","article-title":"New-onset diabetes in COVID-19","author":"Rubino","year":"2020","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302230?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720302230?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:00Z","timestamp":1761991740000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720302230"}},"issued":{"date-parts":[[2020,8]]},"references-count":7,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2020,8]]}},"alternative-id":["S2213858720302230"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30223-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2020,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of diabetes in patients with COVID-19 \u2013 Authors' reply","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30223-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30227-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30152-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30226-6","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30234-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30235-7","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30231-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:43Z","timestamp":1761991963284,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,6,1]],"date-time":"2021-06-01T00:00:00Z","timestamp":1622505600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,6]]},"DOI":"10.1016\/s2213-8587(21)00123-6","type":"journal-article","created":{"date-parts":[[2021,5,7]],"date-time":"2021-05-07T19:18:24Z","timestamp":1620415104000},"page":"319","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":7,"title":["Food policies: in times of COVID-19 and beyond"],"prefix":"10.1016","volume":"9","author":[{"family":"The Lancet Diabetes & Endocrinology","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001236?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001236?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:05Z","timestamp":1761991745000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001236"}},"issued":{"date-parts":[[2021,6]]},"references-count":0,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2021,6]]}},"alternative-id":["S2213858721001236"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00123-6","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2021,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Food policies: in times of COVID-19 and beyond","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00123-6","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,20]],"date-time":"2025-11-20T18:40:56Z","timestamp":1763664056116,"version":"build-2065373602"},"reference-count":10,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2019,10,1]],"date-time":"2019-10-01T00:00:00Z","timestamp":1569888000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,10]]},"DOI":"10.1016\/s2213-8587(19)30267-0","type":"journal-article","created":{"date-parts":[[2019,8,14]],"date-time":"2019-08-14T18:36:50Z","timestamp":1565807810000},"page":"741-743","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":10,"title":["GLP-1 receptor agonists and cardiovascular outcomes: an updated synthesis"],"prefix":"10.1016","volume":"7","author":[{"given":"Eberhard","family":"Standl","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30267-0_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(19)30249-9","article-title":"Cardiovascular, mortality, and kidney outcomes with GLP-1 receptor agonists in patients with type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","author":"Kristensen","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30267-0_bib2","doi-asserted-by":"crossref","first-page":"121","DOI":"10.1016\/S0140-6736(19)31149-3","article-title":"Dulaglutide and cardiovascular outcomes in type 2 diabetes (REWIND): a double-blind, randomised placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30267-0_bib3","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0140-6736(19)31150-X","article-title":"Dulaglutide and renal outcomes in type 2 diabetes: an exploratory analysis of the REWIND randomised, placebo-controlled trial","volume":"394","author":"Gerstein","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30267-0_bib4","doi-asserted-by":"crossref","DOI":"10.1056\/NEJMoa1901118","article-title":"Oral semaglutide and cardiovascular outcomes in patients with type 2 diabetes","author":"Husain","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(19)30267-0_bib5","doi-asserted-by":"crossref","first-page":"2669","DOI":"10.2337\/dci18-0033","article-title":"Management of hyperglycemia in type 2 diabetes, 2018. A consensus report by the American Diabetes Association (ADA) and the European Association for the Study of Diabetes (EASD)","volume":"41","author":"Davies","year":"2018","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(19)30267-0_bib6","doi-asserted-by":"crossref","first-page":"2022","DOI":"10.1161\/CIRCULATIONAHA.118.038868","article-title":"Comparison of the effects of glucagon-like peptide receptor agonists and sodium-glucose cotransporter 2 inhibitors for prevention of major adverse cardiovascular and renal outcomes in type 2 diabetes mellitus","volume":"139","author":"Zelniker","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(19)30267-0_bib7","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/S0140-6736(18)32590-X","article-title":"SGLT2 inhibitors for primary and secondary prevention of cardiovascular and renal outcomes in type 2 diabetes: a systematic review and meta-analysis of cardiovascular outcome trials","volume":"393","author":"Zelniker","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(19)30267-0_bib8","doi-asserted-by":"crossref","first-page":"14","DOI":"10.3389\/fcvm.2019.00014","article-title":"Interpreting the findings from the recent PCSK9 monoclonal antibody cardiovascular outcomes trials","volume":"6","author":"Wong","year":"2019","journal-title":"Front Cardiovasc Med"},{"key":"10.1016\/S2213-8587(19)30267-0_bib9","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1016\/S2213-8587(17)30102-X","article-title":"Corrections needed to 2016 ESC guideline and AHA scientific statement on heart failure","volume":"5","author":"Ryd\u00e9n","year":"2017","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30267-0_bib10","doi-asserted-by":"crossref","first-page":"2247","DOI":"10.1056\/NEJMoa1509225","article-title":"Lixisenatide in patients with type 2 diabetes and acute coronary syndrome","volume":"373","author":"Pfeffer","year":"2015","journal-title":"N Engl J Med"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302670?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719302670?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:07:03Z","timestamp":1761991623000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719302670"}},"issued":{"date-parts":[[2019,10]]},"references-count":10,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2019,10]]}},"alternative-id":["S2213858719302670"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30267-0","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2019,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"GLP-1 receptor agonists and cardiovascular outcomes: an updated synthesis","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30267-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(19)30249-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2019 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:14:08Z","timestamp":1761992048086,"version":"build-2065373602"},"reference-count":9,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/s2213-8587(21)00311-9","type":"journal-article","created":{"date-parts":[[2021,11,30]],"date-time":"2021-11-30T22:02:55Z","timestamp":1638309775000},"page":"3-5","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Is the impact of add on heart failure therapy influenced by background therapy?"],"prefix":"10.1016","volume":"10","author":[{"given":"Lars","family":"Ryd\u00e9n","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Giulia","family":"Ferrannini","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00311-9_bib1","doi-asserted-by":"crossref","first-page":"3599","DOI":"10.1093\/eurheartj\/ehab368","article-title":"2021 ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure","volume":"42","author":"McDonagh","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00311-9_bib2","doi-asserted-by":"crossref","first-page":"194","DOI":"10.3810\/pgm.2011.09.2475","article-title":"Key concepts of clinical trials: a narrative review","volume":"123","author":"Umscheid","year":"2011","journal-title":"Postgrad Med"},{"key":"10.1016\/S2213-8587(21)00311-9_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/j.diabres.2021.108796","article-title":"Sodium-glucose transporter inhibition in heart failure: from an unexpected side effect to a novel treatment possibility","volume":"175","author":"Ferrannini","year":"2021","journal-title":"Diabetes Res Clin Pract"},{"key":"10.1016\/S2213-8587(21)00311-9_bib5","doi-asserted-by":"crossref","first-page":"819","DOI":"10.1016\/S0140-6736(20)31824-9","article-title":"SGLT2 inhibitors in patients with heart failure with reduced ejection fraction: a meta-analysis of the EMPEROR-Reduced and DAPA-HF trials","volume":"396","author":"Zannad","year":"2020","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00311-9_bib6","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1093\/eurheartj\/ehaa183","article-title":"Effects of dapagliflozin in DAPA-HF according to background heart failure therapy","volume":"41","author":"Docherty","year":"2020","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00311-9_bib7","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1093\/eurheartj\/ehaa968","article-title":"Influence of neprilysin inhibition on the efficacy and safety of empagliflozin in patients with chronic heart failure and a reduced ejection fraction: the EMPEROR-Reduced trial","volume":"42","author":"Packer","year":"2021","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(21)00311-9_bib8","article-title":"Empagliflozin in the treatment of heart failure with reduced ejection fraction in addition to background therapies and therapeutic combinations (EMPEROR-Reduced): a post-hoc analysis of a randomised, double-blind trial","author":"Verma","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(21)00311-9_bib9","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1161\/01.CIR.80.3.551","article-title":"Long-term beta-blockade in dilated cardiomyopathy. Effects of short- and long-term metoprolol treatment followed by withdrawal and readministration of metoprolol","volume":"80","author":"Waagstein","year":"1989","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(21)00311-9_bib10","doi-asserted-by":"crossref","first-page":"61","DOI":"10.1016\/S0140-6736(18)32484-X","article-title":"Withdrawal of pharmacological treatment for heart failure in patients with recovered dilated cardiomyopathy (TRED-HF): an open-label, pilot, randomised trial","volume":"393","author":"Halliday","year":"2019","journal-title":"Lancet"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003119?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003119?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:57Z","timestamp":1761991797000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721003119"}},"issued":{"date-parts":[[2022,1]]},"references-count":9,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2213858721003119"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00311-9","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Is the impact of add on heart failure therapy influenced by background therapy?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00311-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00292-8","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:14:21Z","timestamp":1761992061203,"version":"build-2065373602"},"reference-count":0,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,1,1]],"date-time":"2022-01-01T00:00:00Z","timestamp":1640995200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,1]]},"DOI":"10.1016\/s2213-8587(21)00316-8","type":"journal-article","created":{"date-parts":[[2021,12,14]],"date-time":"2021-12-14T18:31:48Z","timestamp":1639506708000},"page":"22","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["Viswanathan Mohan: a dynasty of diabetology"],"prefix":"10.1016","volume":"10","author":[{"given":"Carl","family":"Power","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003168?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721003168?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:31Z","timestamp":1761991831000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721003168"}},"issued":{"date-parts":[[2022,1]]},"references-count":0,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2022,1]]}},"alternative-id":["S2213858721003168"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00316-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2022,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Viswanathan Mohan: a dynasty of diabetology","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00316-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,5,11]],"date-time":"2025-05-11T22:22:19Z","timestamp":1747002139455,"version":"3.37.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2025,2,1]],"date-time":"2025-02-01T00:00:00Z","timestamp":1738368000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","clinicalkey.com.au","clinicalkey.es","clinicalkey.com","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2025,2]]},"DOI":"10.1016\/s2213-8587(24)00338-3","type":"journal-article","created":{"date-parts":[[2024,12,17]],"date-time":"2024-12-17T00:46:33Z","timestamp":1734396393000},"page":"76-77","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Technology for type 1 diabetes: what impact will it have?"],"prefix":"10.1016","volume":"13","author":[{"given":"Maria E","family":"Craig","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(24)00338-3_bib1","doi-asserted-by":"crossref","first-page":"720","DOI":"10.1016\/S2213-8587(22)00212-1","article-title":"Advanced hybrid closed loop therapy versus conventional treatment in adults with type 1 diabetes (ADAPT): a randomised controlled study","volume":"10","author":"Choudhary","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00338-3_bib2","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1056\/NEJMoa2210834","article-title":"Trial of hybrid closed-loop control in young children with type 1 diabetes","volume":"388","author":"Wadwa","year":"2023","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(24)00338-3_bib3","doi-asserted-by":"crossref","first-page":"1831","DOI":"10.2337\/dc23-0635","article-title":"Hybrid closed-loop therapy in adults with type 1 diabetes and above-target HbA1c: a real-world observational study","volume":"46","author":"Crabtree","year":"2023","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(24)00338-3_bib4","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1186\/s12916-024-03396-x","article-title":"Long-term assessment of the NHS hybrid closed-loop real-world study on glycaemic outcomes, time-in-range, and quality of life in children and young people with type 1 diabetes","volume":"22","author":"Ng","year":"2024","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(24)00338-3_bib5","doi-asserted-by":"crossref","DOI":"10.1111\/dme.15099","article-title":"A systematic review on the impact of commercially available hybrid closed loop systems on psychological outcomes in youths with type 1 diabetes and their parents","volume":"40","author":"Franceschi","year":"2023","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(24)00338-3_bib6","article-title":"Hybrid closed-loop insulin therapy and risk of severe hypoglycaemia and diabetic ketoacidosis in young people (aged 2\u201320 years) with type 1 diabetes: a population-based study","author":"Karges","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00338-3_bib7","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1111\/pedi.13418","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: diabetes education in children and adolescents","volume":"23","author":"Lindholm Olinder","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00338-3_bib8","doi-asserted-by":"crossref","first-page":"1406","DOI":"10.1111\/pedi.13421","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: diabetes technologies: insulin delivery","volume":"23","author":"Sherr","year":"2022","journal-title":"Pediatr Diabetes"},{"key":"10.1016\/S2213-8587(24)00338-3_bib9","doi-asserted-by":"crossref","first-page":"444","DOI":"10.1016\/S2213-8587(24)00156-6","article-title":"Lack of access to insulin: undermining the Rights of the Child","volume":"12","author":"Heller","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(24)00338-3_bib10","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1111\/pedi.13456","article-title":"ISPAD Clinical Practice Consensus Guidelines 2022: management of the child, adolescent, and young adult with diabetes in limited resource settings","volume":"23","author":"Virmani","year":"2022","journal-title":"Pediatr Diabetes"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003383?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858724003383?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,2,4]],"date-time":"2025-02-04T21:10:19Z","timestamp":1738703419000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858724003383"}},"issued":{"date-parts":[[2025,2]]},"references-count":10,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2025,2]]}},"alternative-id":["S2213858724003383"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(24)00338-3","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2025,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Technology for type 1 diabetes: what impact will it have?","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00338-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(24)00284-5","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:18:38Z","timestamp":1762543118539},"reference-count":5,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2019,11,1]],"date-time":"2019-11-01T00:00:00Z","timestamp":1572566400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2019,11]]},"DOI":"10.1016\/s2213-8587(19)30321-3","type":"journal-article","created":{"date-parts":[[2019,10,15]],"date-time":"2019-10-15T18:29:55Z","timestamp":1571164195000},"page":"829-830","source":"Crossref","is-referenced-by-count":2,"title":["Maternal pre-pregnancy obesity and preterm birth: more explorations needed \u2013 Authors' reply"],"prefix":"10.1016","volume":"7","author":[{"given":"Buyun","family":"Liu","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Wei","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(19)30321-3_bib1","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1016\/S2213-8587(19)30193-7","article-title":"Association between maternal pre-pregnancy obesity and preterm birth according to maternal age and race or ethnicity: a population-based study","volume":"7","author":"Liu","year":"2019","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(19)30321-3_bib2","doi-asserted-by":"crossref","DOI":"10.1111\/jre.12690","article-title":"Obesity and periodontitis are not associated in pregnant women","author":"Gomes-Filho","year":"2019","journal-title":"J Periodontal Res"},{"key":"10.1016\/S2213-8587(19)30321-3_bib3","doi-asserted-by":"crossref","first-page":"e224","DOI":"10.1902\/jop.2014.130578","article-title":"Association between obesity and periodontitis in pregnant females","volume":"85","author":"Lee","year":"2014","journal-title":"J Periodontol"},{"key":"10.1016\/S2213-8587(19)30321-3_bib4","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1093\/ije\/dyv075","article-title":"Using genetics to test the causal relationship of total adiposity and periodontitis: mendelian randomization analyses in the Gene-Lifestyle Interactions and Dental Endpoints (GLIDE) Consortium","volume":"44","author":"Shungin","year":"2015","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(19)30321-3_bib5","doi-asserted-by":"crossref","first-page":"569","DOI":"10.1007\/s00737-017-0739-4","article-title":"Antenatal and postnatal depression in women with obesity: a systematic review","volume":"20","author":"Steinig","year":"2017","journal-title":"Arch Womens Ment Health"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303213?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858719303213?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,10,25]],"date-time":"2019-10-25T16:21:42Z","timestamp":1572020502000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858719303213"}},"issued":{"date-parts":[[2019,11]]},"references-count":5,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2019,11]]}},"alternative-id":["S2213858719303213"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(19)30321-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2019,11]]}},{"indexed":{"date-parts":[[2025,9,9]],"date-time":"2025-09-09T20:44:13Z","timestamp":1757450653394},"reference-count":6,"publisher":"Elsevier BV","issue":"10","license":[{"start":{"date-parts":[[2015,10,1]],"date-time":"2015-10-01T00:00:00Z","timestamp":1443657600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,10]]},"DOI":"10.1016\/s2213-8587(15)00319-8","type":"journal-article","created":{"date-parts":[[2015,9,17]],"date-time":"2015-09-17T20:05:59Z","timestamp":1442520359000},"page":"763","source":"Crossref","is-referenced-by-count":8,"title":["Global health metrics and non-communicable diseases: the case of hypertension"],"prefix":"10.1016","volume":"3","author":[{"given":"Pedro","family":"Ordunez","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Norm","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00319-8_bib1","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1016\/S2213-8587(15)00231-4","article-title":"Global health metrics and NCDs: are our perceptions years behind the data?","volume":"3","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00319-8_bib2","series-title":"Draft comprehensive global monitoring framework and targets for the prevention and control of noncommunicable diseases (Document A66\/8). March 15, 2013","year":"2013"},{"key":"10.1016\/S2213-8587(15)00319-8_bib3","doi-asserted-by":"crossref","first-page":"2197","DOI":"10.1016\/S0140-6736(12)61689-4","article-title":"Disability-adjusted life years (DALYs) for 291 diseases and injuries in 21 regions, 1990\u20132010: a systematic analysis for the Global Burden of Disease Study 2010","volume":"380","author":"Murray","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(15)00319-8_bib4","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1111\/jch.12372","article-title":"High blood pressure: why prevention and control are urgent and important\u2014a 2014 fact sheet from the World Hypertension League and the International Society of Hypertension","volume":"16","author":"Campbell","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"},{"key":"10.1016\/S2213-8587(15)00319-8_bib5","doi-asserted-by":"crossref","first-page":"15","DOI":"10.1590\/S1020-49892012000700003","article-title":"Usefulness for surveillance of hypertension prevalence studies in Latin America and the Caribbean: the past 10 years","volume":"32","author":"Burroughs Pe\u00f1a","year":"2012","journal-title":"Pan Am J Public Health"},{"key":"10.1016\/S2213-8587(15)00319-8_bib6","doi-asserted-by":"crossref","first-page":"773","DOI":"10.1111\/jch.12387","article-title":"Standards for the uniform reporting of hypertension in adults using population survey data: recommendations from the World Hypertension League expert committee","volume":"16","author":"Gee","year":"2014","journal-title":"J Clin Hypertens (Greenwich)"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003198?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715003198?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,9,19]],"date-time":"2018-09-19T09:53:39Z","timestamp":1537350819000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715003198"}},"issued":{"date-parts":[[2015,10]]},"references-count":6,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2015,10]]}},"alternative-id":["S2213858715003198"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00319-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,10]]}},{"indexed":{"date-parts":[[2025,11,5]],"date-time":"2025-11-05T20:52:37Z","timestamp":1762375957873},"reference-count":8,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2015,6,1]],"date-time":"2015-06-01T00:00:00Z","timestamp":1433116800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2015,6]]},"DOI":"10.1016\/s2213-8587(15)00085-6","type":"journal-article","created":{"date-parts":[[2015,4,10]],"date-time":"2015-04-10T19:57:27Z","timestamp":1428695847000},"page":"397-398","source":"Crossref","is-referenced-by-count":21,"title":["BMI and dementia: feast or famine for the brain?"],"prefix":"10.1016","volume":"3","author":[{"given":"Deborah","family":"Gustafson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00085-6_bib1","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/S1474-4422(14)70085-7","article-title":"Adipokines and dementia","volume":"13","author":"Kiliaan","year":"2014","journal-title":"Lancet Neurol"},{"key":"10.1016\/S2213-8587(15)00085-6_bib2","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(15)00033-9","article-title":"BMI and risk of dementia in two million people over two decades: a retrospective cohort study","author":"Qizilbash","year":"2015","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(15)00085-6_bib3","first-page":"295","article-title":"The environment and disease: association or causation?","volume":"58","author":"Hill","year":"1965","journal-title":"Proc R Soc Med"},{"key":"10.1016\/S2213-8587(15)00085-6_bib4","doi-asserted-by":"crossref","first-page":"739","DOI":"10.3233\/JAD-141086","article-title":"2003\u20132013: a decade of body mass index, Alzheimer's disease and dementia","volume":"43","author":"Emerzaal","year":"2015","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/S2213-8587(15)00085-6_bib5","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1001\/archneur.62.1.55","article-title":"A 32-year prospective study of change in body weight and incident dementia: the Honolulu-Asia Aging Study","volume":"62","author":"Stewart","year":"2005","journal-title":"Arch Neurol"},{"key":"10.1016\/S2213-8587(15)00085-6_bib6","doi-asserted-by":"crossref","first-page":"1559","DOI":"10.1212\/WNL.0b013e3181c0d4b6","article-title":"Adiposity indicators and dementia over 32 years in Sweden","volume":"73","author":"Gustafson","year":"2009","journal-title":"Neurology"},{"key":"10.1016\/S2213-8587(15)00085-6_bib7","doi-asserted-by":"crossref","first-page":"163","DOI":"10.3233\/JAD-2011-110917","article-title":"37 years of body mass index and dementia: observations from the prospective population study of women in Gothenburg, Sweden","volume":"28","author":"Gustafson","year":"2012","journal-title":"J Alzheimers Dis"},{"key":"10.1016\/S2213-8587(15)00085-6_bib8","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/j.neurobiolaging.2010.03.025","article-title":"The genetic architecture of Alzheimer's disease: beyond APP, PSENs and APOE","volume":"33","author":"Guerreiro","year":"2012","journal-title":"Neurobiol Aging"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000856?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858715000856?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,8,23]],"date-time":"2019-08-23T07:07:43Z","timestamp":1566544063000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858715000856"}},"issued":{"date-parts":[[2015,6]]},"references-count":8,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2015,6]]}},"alternative-id":["S2213858715000856"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00085-6","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2015,6]]}},{"indexed":{"date-parts":[[2025,5,9]],"date-time":"2025-05-09T15:58:31Z","timestamp":1746806311662,"version":"3.40.5"},"reference-count":0,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2016,5,1]],"date-time":"2016-05-01T00:00:00Z","timestamp":1462060800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,5]]},"DOI":"10.1016\/s2213-8587(16)00083-8","type":"journal-article","created":{"date-parts":[[2016,3,5]],"date-time":"2016-03-05T09:23:49Z","timestamp":1457169829000},"page":"e5","source":"Crossref","is-referenced-by-count":0,"title":["Correction to Lancet Diabetes Endocrinol 2016; published online March 1. http:\/\/dx.doi.org\/10.1016\/S2213-8587(16)00079-6"],"prefix":"10.1016","volume":"4","member":"78","container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000838?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716000838?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,1,28]],"date-time":"2019-01-28T03:38:19Z","timestamp":1548646699000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716000838"}},"issued":{"date-parts":[[2016,5]]},"references-count":0,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2016,5]]}},"alternative-id":["S2213858716000838"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)00083-8","ISSN":["2213-8587"],"issn-type":[{"type":"print","value":"2213-8587"}],"published":{"date-parts":[[2016,5]]}},{"indexed":{"date-parts":[[2026,2,19]],"date-time":"2026-02-19T04:25:00Z","timestamp":1771475100893,"version":"3.50.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,4,1]],"date-time":"2014-04-01T00:00:00Z","timestamp":1396310400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2014,4]]},"DOI":"10.1016\/s2213-8587(14)70008-7","type":"journal-article","created":{"date-parts":[[2014,1,24]],"date-time":"2014-01-24T02:30:31Z","timestamp":1390530631000},"page":"269-270","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":9,"title":["The puzzling world of vitamin D insufficiency"],"prefix":"10.1016","volume":"2","author":[{"given":"Karl","family":"Micha\u00eblsson","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(14)70008-7_bib1","doi-asserted-by":"crossref","first-page":"266","DOI":"10.1056\/NEJMra070553","article-title":"Vitamin D deficiency","volume":"357","author":"Holick","year":"2007","journal-title":"NEJM"},{"key":"10.1016\/S2213-8587(14)70008-7_bib2","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1146\/annurev-nutr-071812-161249","article-title":"Vitamin D biology revealed through the study of knockout and transgenic mouse models","volume":"33","author":"Christakos","year":"2013","journal-title":"Annual review of nutrition"},{"key":"10.1016\/S2213-8587(14)70008-7_bib3","doi-asserted-by":"crossref","unstructured":"Ross AC, Manson JE, Abrams SA, et al. The 2011 report on dietary reference intakes for calcium and vitamin d from the institute of medicine: what clinicians need to know. J Clin Endocrinol Metab; 96: 53\u201358.","DOI":"10.1016\/j.jada.2011.01.004"},{"key":"10.1016\/S2213-8587(14)70008-7_bib4","doi-asserted-by":"crossref","first-page":"468","DOI":"10.1016\/j.annepidem.2009.03.021","article-title":"Vitamin D for cancer prevention: global perspective","volume":"19","author":"Garland","year":"2009","journal-title":"Ann Epidemiol"},{"key":"10.1016\/S2213-8587(14)70008-7_bib5","doi-asserted-by":"crossref","first-page":"841","DOI":"10.3945\/ajcn.2010.29749","article-title":"Plasma vitamin D and mortality in older men: a community-based prospective cohort study","volume":"92","author":"Michaelsson","year":"2010","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(14)70008-7_bib6","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa1306357","article-title":"Vitamin D-binding protein and vitamin D status of black Americans and white Americans","volume":"369","author":"Powe","year":"2013","journal-title":"NEJM"},{"issue":"supp 36","key":"10.1016\/S2213-8587(14)70008-7_bib7","first-page":"1","article-title":"Calcium requirement and adaptation in adult men","volume":"10","author":"Malm","year":"1958","journal-title":"Scand J Clin Lab Invest"},{"key":"10.1016\/S2213-8587(14)70008-7_bib8","article-title":"TThe effect of vitamin D supplementation on skeletal, vascular, or cancer outcomes: a trial sequential meta-analysis","author":"Bolland","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(14)70008-7_bib9","article-title":"Effects of vitamin D supplements on bone mineral density: a systematic review and meta-analysis","author":"Reid","year":"2013","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(14)70008-7_bib10","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1007\/s00223-012-9679-1","article-title":"Is high dose vitamin D harmful?","volume":"92","author":"Sanders","year":"2013","journal-title":"Calcified tissue international"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700087?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858714700087?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:05:04Z","timestamp":1761991504000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858714700087"}},"issued":{"date-parts":[[2014,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2014,4]]}},"alternative-id":["S2213858714700087"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(14)70008-7","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2014,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The puzzling world of vitamin D insufficiency","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(14)70008-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(13)70212-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,2]],"date-time":"2026-06-02T07:13:56Z","timestamp":1780384436484,"version":"3.54.1"},"reference-count":10,"publisher":"Elsevier BV","issue":"4","license":[{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T00:00:00Z","timestamp":1648771200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,4]]},"DOI":"10.1016\/s2213-8587(22)00073-0","type":"journal-article","created":{"date-parts":[[2022,3,3]],"date-time":"2022-03-03T18:29:59Z","timestamp":1646332199000},"page":"233-234","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":30,"title":["The actual burden of obesity\u2014accounting for multimorbidity"],"prefix":"10.1016","volume":"10","author":[{"given":"Avishai M","family":"Tsur","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilad","family":"Twig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00073-0_bib1","doi-asserted-by":"crossref","first-page":"2440","DOI":"10.1056\/NEJMsa1909301","article-title":"Projected U.S. state-level prevalence of adult obesity and severe obesity","volume":"381","author":"Ward","year":"2019","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00073-0_bib2","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1186\/s12916-021-02188-x","article-title":"Causal role of high body mass index in multiple chronic diseases: a systematic review and meta-analysis of Mendelian randomization studies","volume":"19","author":"Larsson","year":"2021","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(22)00073-0_bib3","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003198","article-title":"The global burden of disease attributable to high body mass index in 195 countries and territories, 1990\u20132017: an analysis of the Global Burden of Disease Study","volume":"17","author":"Dai","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(22)00073-0_bib4","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(22)00033-X","article-title":"Body-mass index and risk of obesity-related complex multimorbidity: an observational multicohort study","author":"Kivim\u00e4ki","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00073-0_bib5","doi-asserted-by":"crossref","first-page":"2145","DOI":"10.1056\/NEJMoa1703860","article-title":"Simulation of growth trajectories of childhood obesity into adulthood","volume":"377","author":"Ward","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00073-0_bib6","doi-asserted-by":"crossref","first-page":"681","DOI":"10.1016\/S2213-8587(21)00207-2","article-title":"Identifying adults at high-risk for change in weight and BMI in England: a longitudinal, large-scale, population-based cohort study using electronic health records","volume":"9","author":"Katsoulis","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00073-0_bib7","doi-asserted-by":"crossref","first-page":"e587","DOI":"10.1016\/S2468-2667(21)00107-9","article-title":"Examining variation in the measurement of multimorbidity in research: a systematic review of 566 studies","volume":"6","author":"Ho","year":"2021","journal-title":"Lancet Public Health"},{"key":"10.1016\/S2213-8587(22)00073-0_bib8","series-title":"Absence of excess body fatness","volume":"vol 16","year":"2018"},{"key":"10.1016\/S2213-8587(22)00073-0_bib9","doi-asserted-by":"crossref","first-page":"755","DOI":"10.1016\/S0140-6736(14)60892-8","article-title":"Body-mass index and risk of 22 specific cancers: a population-based cohort study of 5\u00b724 million UK adults","volume":"384","author":"Bhaskaran","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(22)00073-0_bib10","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1016\/S2213-8587(20)30019-X","article-title":"Adolescent obesity and midlife cancer risk: a population-based cohort study of 2\u00b73 million adolescents in Israel","volume":"8","author":"Furer","year":"2020","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000730?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000730?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:39Z","timestamp":1761991839000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000730"}},"issued":{"date-parts":[[2022,4]]},"references-count":10,"journal-issue":{"issue":"4","published-print":{"date-parts":[[2022,4]]}},"alternative-id":["S2213858722000730"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00073-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"The actual burden of obesity\u2014accounting for multimorbidity","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00073-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00033-X","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T13:09:58Z","timestamp":1780664998593,"version":"3.54.1"},"reference-count":33,"publisher":"Elsevier BV","issue":"3","license":[{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,3,1]],"date-time":"2026-03-01T00:00:00Z","timestamp":1772323200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100021078","name":"Norwegian Institute of Public Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100021078","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100011769","name":"St. Olavs Hospital Universitetssykehuset i Trondheim","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100011769","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007270","name":"University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007270","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004590","name":"Central Norway Regional Health Authority","doi-asserted-by":"publisher","award":["2019\/38881"],"award-info":[{"award-number":["2019\/38881"]}],"id":[{"id":"10.13039\/501100004590","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100019902","name":"Fakultet for medisin og helsevitenskap, Norges Teknisk-Naturvitenskapelige Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100019902","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100011631","name":"School of Public Health, University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100011631","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100008455","name":"Medical School, University of Michigan","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100008455","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009123","name":"Norges Teknisk-Naturvitenskapelige Universitet","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100009123","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005416","name":"Norges Forskningsr\u00e5d","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100005416","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2026,3]]},"DOI":"10.1016\/s2213-8587(25)00322-5","type":"journal-article","created":{"date-parts":[[2026,1,28]],"date-time":"2026-01-28T23:39:14Z","timestamp":1769643554000},"page":"223-232","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["Temporal changes and genetic susceptibility to type 2 diabetes (1984\u20132019; HUNT): a longitudinal, population-based study"],"prefix":"10.1016","volume":"14","author":[{"given":"Vera Vik","family":"Bjark\u00f8","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brooke N","family":"Wolford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eirin B","family":"Haug","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars C","family":"Stene","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Carlsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arnulf","family":"Langhammer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"K\u00e5re I","family":"Birkeland","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tore Julsrud","family":"Berg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elin Pettersen","family":"S\u00f8rgjerd","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Valeriya","family":"Lyssenko","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ben M","family":"Brumpton","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gunnhild \u00c5berge","family":"Vie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bj\u00f8rn Olav","family":"\u00c5svold","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(25)00322-5_bib1","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/S0140-6736(23)01301-6","article-title":"Global, regional, and national burden of diabetes from 1990 to 2021, with projections of prevalence to 2050: a systematic analysis for the Global Burden of Disease Study 2021","volume":"402","author":"Ong","year":"2023","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00322-5_bib2","doi-asserted-by":"crossref","first-page":"731","DOI":"10.1016\/S2213-8587(23)00223-1","article-title":"Life expectancy associated with different ages at diagnosis of type 2 diabetes in high-income countries: 23 million person-years of observation","volume":"11","author":"Kaptoge","year":"2023","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00322-5_bib3","doi-asserted-by":"crossref","first-page":"904","DOI":"10.1016\/S2213-8587(24)00242-0","article-title":"Younger-onset compared with later-onset type 2 diabetes: an analysis of the UK Prospective Diabetes Study (UKPDS) with up to 30 years of follow-up (UKPDS 92)","volume":"12","author":"Lin","year":"2024","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00322-5_bib4","doi-asserted-by":"crossref","first-page":"1803","DOI":"10.1016\/S0140-6736(22)01655-5","article-title":"Type 2 diabetes","volume":"400","author":"Ahmad","year":"2022","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(25)00322-5_bib5","doi-asserted-by":"crossref","first-page":"2811","DOI":"10.1007\/s00125-011-2267-5","article-title":"Heritability and familiality of type 2 diabetes and related quantitative traits in the Botnia Study","volume":"54","author":"Almgren","year":"2011","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00322-5_bib6","doi-asserted-by":"crossref","first-page":"762","DOI":"10.1017\/thg.2015.83","article-title":"The concordance and heritability of type 2 diabetes in 34,166 twin pairs from international twin registers: the Discordant Twin (DISCOTWIN) consortium","volume":"18","author":"Willemsen","year":"2015","journal-title":"Twin Res Hum Genet"},{"key":"10.1016\/S2213-8587(25)00322-5_bib7","doi-asserted-by":"crossref","first-page":"223","DOI":"10.1016\/S2213-8587(17)30200-0","article-title":"Genetics of obesity: what genetic association studies have taught us about the biology of obesity and its complications","volume":"6","author":"Goodarzi","year":"2018","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00322-5_bib8","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pmed.1003452","article-title":"Genetic associations with temporal shifts in obesity and severe obesity during the obesity epidemic in Norway: a longitudinal population-based cohort (the HUNT Study)","volume":"17","author":"Brandkvist","year":"2020","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(25)00322-5_bib9","doi-asserted-by":"crossref","first-page":"1804","DOI":"10.1007\/s00125-021-05639-5","article-title":"Do gene-environment interactions have implications for the precision prevention of type 2 diabetes?","volume":"65","author":"S\u00f8rensen","year":"2022","journal-title":"Diabetologia"},{"key":"10.1016\/S2213-8587(25)00322-5_bib10","doi-asserted-by":"crossref","first-page":"35","DOI":"10.1016\/j.gde.2018.02.001","article-title":"Gene-lifestyle interplay in type 2 diabetes","volume":"50","author":"Franks","year":"2018","journal-title":"Curr Opin Genet Dev"},{"key":"10.1016\/S2213-8587(25)00322-5_bib11","doi-asserted-by":"crossref","first-page":"1557","DOI":"10.1111\/obr.12921","article-title":"Gene-lifestyle interaction on risk of type 2 diabetes: a systematic review","volume":"20","author":"Dietrich","year":"2019","journal-title":"Obes Rev"},{"key":"10.1016\/S2213-8587(25)00322-5_bib12","doi-asserted-by":"crossref","first-page":"63","DOI":"10.1186\/s13073-024-01337-0","article-title":"Polygenic scores for longitudinal prediction of incident type 2 diabetes in an ancestrally and medically diverse primary care physician network: a patient cohort study","volume":"16","author":"Mandla","year":"2024","journal-title":"Genome Med"},{"key":"10.1016\/S2213-8587(25)00322-5_bib13","doi-asserted-by":"crossref","first-page":"e80","DOI":"10.1093\/ije\/dyac095","article-title":"Cohort profile update: the HUNT study, Norway","volume":"52","author":"\u00c5svold","year":"2023","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00322-5_bib14","doi-asserted-by":"crossref","DOI":"10.1093\/ije\/dyae073","article-title":"Data resource profile: the HUNT biobank","volume":"53","author":"N\u00e6ss","year":"2024","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(25)00322-5_bib15","article-title":"The HUNT study: a population-based cohort for genetic research","volume":"2","author":"Brumpton","year":"2022","journal-title":"Cell Genom"},{"key":"10.1016\/S2213-8587(25)00322-5_bib16","doi-asserted-by":"crossref","first-page":"1279","DOI":"10.1038\/ng.3643","article-title":"A reference panel of 64\u2008976 haplotypes for genotype imputation","volume":"48","author":"McCarthy","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(25)00322-5_bib17","doi-asserted-by":"crossref","first-page":"1284","DOI":"10.1038\/ng.3656","article-title":"Next-generation genotype imputation service and methods","volume":"48","author":"Das","year":"2016","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(25)00322-5_bib18","doi-asserted-by":"crossref","first-page":"1989","DOI":"10.1038\/s41588-024-01937-x","article-title":"Enhancing the Polygenic Score Catalog with tools for score calculation and ancestry normalization","volume":"56","author":"Lambert","year":"2024","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(25)00322-5_bib19","article-title":"[How many people have diabetes in Norway in 2020?]","volume":"140","author":"Stene","year":"2020","journal-title":"Tidsskr Nor Laegeforen"},{"key":"10.1016\/S2213-8587(25)00322-5_bib20","doi-asserted-by":"crossref","DOI":"10.3389\/fendo.2022.917850","article-title":"Lifestyle or environmental influences and their interaction with genetic susceptibility on the risk of LADA","volume":"13","author":"Carlsson","year":"2022","journal-title":"Front Endocrinol (Lausanne)"},{"key":"10.1016\/S2213-8587(25)00322-5_bib21","doi-asserted-by":"crossref","first-page":"1065","DOI":"10.1038\/s41591-024-02865-3","article-title":"Multi-ancestry polygenic mechanisms of type 2 diabetes","volume":"30","author":"Smith","year":"2024","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(25)00322-5_bib22","doi-asserted-by":"crossref","first-page":"1431","DOI":"10.1016\/j.ajhg.2024.06.003","article-title":"Evaluation of polygenic scoring methods in five biobanks shows larger variation between biobanks than methods and finds benefits of ensemble learning","volume":"111","author":"Monti","year":"2024","journal-title":"Am J Hum Genet"},{"key":"10.1016\/S2213-8587(25)00322-5_bib23","article-title":"Trends in incidence of total or type 2 diabetes: systematic review","volume":"366","author":"Magliano","year":"2019","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(25)00322-5_bib24","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S2213-8587(20)30431-9","article-title":"Trends in predominant causes of death in individuals with and without diabetes in England from 2001 to 2018: an epidemiological analysis of linked primary care records","volume":"9","author":"Pearson-Stuttard","year":"2021","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(25)00322-5_bib25","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1515\/em-2013-0005","article-title":"A tutorial on interaction","volume":"3","author":"VanderWeele","year":"2014","journal-title":"Epidemiol Methods"},{"key":"10.1016\/S2213-8587(25)00322-5_bib26","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.2337\/diacare.17.9.1067","article-title":"Effects of a traditional lifestyle on obesity in Pima Indians","volume":"17","author":"Ravussin","year":"1994","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00322-5_bib27","unstructured":"Hindenes LB, Ruiz PL-D, Tapia G, et al. Type 2 diabetes in Norway 2009\u20132021: Have declining incidence rates continued? Diabet Med (in press)."},{"key":"10.1016\/S2213-8587(25)00322-5_bib28","doi-asserted-by":"crossref","first-page":"693","DOI":"10.1001\/jamacardio.2018.1717","article-title":"Associations of combined genetic and lifestyle risks with incident cardiovascular disease and diabetes in the UK Biobank study","volume":"3","author":"Said","year":"2018","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(25)00322-5_bib29","doi-asserted-by":"crossref","DOI":"10.1111\/dme.14829","article-title":"Undiagnosed diabetes: prevalence and cardiovascular risk profile in a population-based study of 52,856 individuals. The HUNT Study, Norway","volume":"39","author":"Bjark\u00f8","year":"2022","journal-title":"Diabet Med"},{"key":"10.1016\/S2213-8587(25)00322-5_bib30","doi-asserted-by":"crossref","first-page":"229","DOI":"10.3109\/02813439508996766","article-title":"Prevalence of known and previously unknown diabetes mellitus and impaired glucose tolerance in an adult Norwegian population. Indications of an increasing diabetes prevalence. The Nord-Tr\u00f8ndelag Diabetes Study","volume":"13","author":"Midthjell","year":"1995","journal-title":"Scand J Prim Health Care"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(25)00322-5_bib31","first-page":"S27","article-title":"2. Diagnosis and classification of diabetes: standards of care in diabetes\u20132025","volume":"48","author":"ElSayed","year":"2025","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(25)00322-5_bib32","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1136\/jech.46.5.537","article-title":"Is questionnaire information valid in the study of a chronic disease such as diabetes? The Nord-Tr\u00f8ndelag diabetes study","volume":"46","author":"Midthjell","year":"1992","journal-title":"J Epidemiol Community Health"},{"key":"10.1016\/S2213-8587(25)00322-5_bib33","doi-asserted-by":"crossref","first-page":"143","DOI":"10.1186\/1471-2288-12-143","article-title":"The HUNT study: participation is associated with survival and depends on socioeconomic status, diseases and symptoms","volume":"12","author":"Langhammer","year":"2012","journal-title":"BMC Med Res Methodol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003225?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858725003225?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,6,5]],"date-time":"2026-06-05T12:30:12Z","timestamp":1780662612000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858725003225"}},"issued":{"date-parts":[[2026,3]]},"references-count":33,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2026,3]]}},"alternative-id":["S2213858725003225"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(25)00322-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2026,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Temporal changes and genetic susceptibility to type 2 diabetes (1984\u20132019; HUNT): a longitudinal, population-based study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00322-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(25)00355-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 Elsevier Ltd. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T04:40:30Z","timestamp":1780548030128,"version":"3.54.1"},"reference-count":8,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2022,5,1]],"date-time":"2022-05-01T00:00:00Z","timestamp":1651363200000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2022,5]]},"DOI":"10.1016\/s2213-8587(22)00086-9","type":"journal-article","created":{"date-parts":[[2022,4,1]],"date-time":"2022-04-01T18:40:45Z","timestamp":1648838445000},"page":"301-303","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Targeting PCSK9 inhibitors to those who will benefit most"],"prefix":"10.1016","volume":"10","author":[{"given":"Traci A","family":"Turner","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Evan A","family":"Stein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(22)00086-9_bib1","doi-asserted-by":"crossref","DOI":"10.1016\/S2213-8587(22)00043-2","article-title":"Metabolic risk factors and effect of alirocumab on cardiovascular events after acute coronary syndrome: a post-hoc analysis of the ODYSSEY OUTCOMES randomised controlled trial","author":"Ostadal","year":"2022","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(22)00086-9_bib2","doi-asserted-by":"crossref","first-page":"1405","DOI":"10.1016\/j.amjcard.2006.06.039","article-title":"Identifying patients for aggressive cholesterol lowering: the risk curve concept","volume":"98","author":"Robinson","year":"2006","journal-title":"Am J Cardiol"},{"key":"10.1016\/S2213-8587(22)00086-9_bib3","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1001\/jamacardio.2020.3151","article-title":"Efficacy and Safety of PCSK9 Inhibition With Evolocumab in Reducing Cardiovascular Events in Patients With Metabolic Syndrome Receiving Statin Therapy: Secondary Analysis From the FOURIER Randomized Clinical Trial","volume":"6","author":"Deedwania","year":"2021","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(22)00086-9_bib4","doi-asserted-by":"crossref","first-page":"2097","DOI":"10.1056\/NEJMoa1801174","article-title":"Alirocumab and cardiovascular outcomes after acute coronary syndrome","volume":"379","author":"Schwartz","year":"2018","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(22)00086-9_bib5","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1093\/eurheartj\/ehz455","article-title":"2019 ESC\/EAS Guidelines for the management of dyslipidaemias: lipid modification to reduce cardiovascular risk","volume":"41","author":"Mach","year":"2020","journal-title":"Eur Heart J"},{"issue":"Suppl 2","key":"10.1016\/S2213-8587(22)00086-9_bib6","first-page":"S1","volume":"129","author":"Stone","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(22)00086-9_bib7","first-page":"e1082","article-title":"2018 AHA\/ACC\/AACVPR\/AAPA\/ABC\/ACPM\/ADA\/AGS\/APhA\/ASPC\/NLA\/PCNA guideline on the management of blood cholesterol: a report of the American College of Cardiology\/American Heart Association task force on clinical practice guidelines","volume":"139","author":"Grundy","year":"2019","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(22)00086-9_bib8","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1177\/2047487318816495","article-title":"Effects of high-density lipoprotein targeting treatments on cardiovascular outcomes: a systematic review and meta-analysis","volume":"26","author":"Riaz","year":"2019","journal-title":"Eur J Prev Cardiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000869?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858722000869?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:10:52Z","timestamp":1761991852000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858722000869"}},"issued":{"date-parts":[[2022,5]]},"references-count":8,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2022,5]]}},"alternative-id":["S2213858722000869"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(22)00086-9","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2022,5]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Targeting PCSK9 inhibitors to those who will benefit most","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00086-9","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(22)00043-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"simple-article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2022 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T07:49:02Z","timestamp":1794383342019,"version":"4.9.0"},"reference-count":41,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2017,2,1]],"date-time":"2017-02-01T00:00:00Z","timestamp":1485907200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2016,11,23]],"date-time":"2016-11-23T00:00:00Z","timestamp":1479859200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"name":"British Heart Foundation Programme Grant","award":["RG\/10\/12\/28456"],"award-info":[{"award-number":["RG\/10\/12\/28456"]}]}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,2]]},"DOI":"10.1016\/s2213-8587(16)30396-5","type":"journal-article","created":{"date-parts":[[2016,11,28]],"date-time":"2016-11-28T19:45:14Z","timestamp":1480362314000},"page":"97-105","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":349,"title":["PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study"],"prefix":"10.1016","volume":"5","author":[{"given":"Amand F","family":"Schmidt","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I","family":"Swerdlow","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael V","family":"Holmes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Riyaz S","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zammy","family":"Fairhurst-Hunter","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Donald M","family":"Lyall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fernando Pires","family":"Hartwig","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bernardo Lessa","family":"Horta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elina","family":"Hypp\u00f6nen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Power","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Max","family":"Moldovan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"van Iperen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"G Kees","family":"Hovingh","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ilja","family":"Demuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristina","family":"Norman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elisabeth","family":"Steinhagen-Thiessen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juri","family":"Demuth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Bertram","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tian","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Coassin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Johann","family":"Willeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Kiechl","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karin","family":"Willeit","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan","family":"Mason","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Wright","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Richard","family":"Morris","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goya","family":"Wanamethee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"Whincup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yoav","family":"Ben-Shlomo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stela","family":"McLachlan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie F","family":"Price","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mika","family":"Kivimaki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine","family":"Welch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Adelaida","family":"Sanchez-Galvez","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pedro","family":"Marques-Vidal","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Nicolaides","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrie G","family":"Panayiotou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N Charlotte","family":"Onland-Moret","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne T","family":"van der Schouw","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Matullo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giovanni","family":"Fiorito","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simonetta","family":"Guarrera","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carlotta","family":"Sacerdote","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicholas J","family":"Wareham","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Claudia","family":"Langenberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robert","family":"Scott","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian'an","family":"Luan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bobak","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sofia","family":"Malyutina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrzej","family":"Paj\u0105k","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruzena","family":"Kubinova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abdonas","family":"Tamosiunas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hynek","family":"Pikhart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lise Lotte Nystrup","family":"Husemoen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niels","family":"Grarup","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oluf","family":"Pedersen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Torben","family":"Hansen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allan","family":"Linneberg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kenneth Starup","family":"Simonsen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jackie","family":"Cooper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Steve E","family":"Humphries","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Brilliant","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Terrie","family":"Kitchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hakon","family":"Hakonarson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David S","family":"Carrell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Catherine A","family":"McCarty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"H Lester","family":"Kirchner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Eric B","family":"Larson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David R","family":"Crosslin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariza","family":"de Andrade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dan M","family":"Roden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joshua C","family":"Denny","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cara","family":"Carty","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen","family":"Hancock","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John","family":"Attia","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elizabeth","family":"Holliday","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"O'Donnell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michael","family":"Chong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guillaume","family":"Pare","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pim","family":"van der Harst","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M Abdullah","family":"Said","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruben N","family":"Eppinga","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Niek","family":"Verweij","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Harold","family":"Snieder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tim","family":"Christen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dennis O","family":"Mook-Kanamori","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stefan","family":"Gustafsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lars","family":"Lind","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erik","family":"Ingelsson","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Raha","family":"Pazoki","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Oscar","family":"Franco","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Albert","family":"Hofman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andre","family":"Uitterlinden","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Abbas","family":"Dehghan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alexander","family":"Teumer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebastian","family":"Baumeister","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcus","family":"D\u00f6rr","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Markus M","family":"Lerch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Uwe","family":"V\u00f6lker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Henry","family":"V\u00f6lzke","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joey","family":"Ward","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jill P","family":"Pell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel J","family":"Smith","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tom","family":"Meade","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anke H","family":"Maitland-van der Zee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ekaterina V","family":"Baranova","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Robin","family":"Young","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ian","family":"Ford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Archie","family":"Campbell","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandosh","family":"Padmanabhan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Michiel L","family":"Bots","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Diederick E","family":"Grobbee","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philippe","family":"Froguel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Doroth\u00e9e","family":"Thuillier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Beverley","family":"Balkau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Am\u00e9lie","family":"Bonnefond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bertrand","family":"Cariou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Smart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanchun","family":"Bao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meena","family":"Kumari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anubha","family":"Mahajan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul M","family":"Ridker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel I","family":"Chasman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex P","family":"Reiner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Leslie A","family":"Lange","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marylyn D","family":"Ritchie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Folkert W","family":"Asselbergs","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan-Pablo","family":"Casas","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Brendan J","family":"Keating","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"David","family":"Preiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aroon D","family":"Hingorani","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naveed","family":"Sattar","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30396-5_bib1","doi-asserted-by":"publisher","first-page":"735","DOI":"10.1016\/S0140-6736(09)61965-6","article-title":"Statins and risk of incident diabetes: a collaborative meta-analysis of randomised statin trials","volume":"375","author":"Sattar","year":"2010","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib2","doi-asserted-by":"publisher","first-page":"2556","DOI":"10.1001\/jama.2011.860","article-title":"Risk of incident diabetes with intensive-dose compared with moderate-dose statin therapy: a meta-analysis","volume":"305","author":"Preiss","year":"2011","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30396-5_bib3","doi-asserted-by":"publisher","first-page":"351","DOI":"10.1016\/S0140-6736(14)61183-1","article-title":"HMG-coenzyme A reductase inhibition, type 2 diabetes, and bodyweight: evidence from genetic analysis and randomised trials","volume":"385","author":"Swerdlow","year":"2015","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib4","doi-asserted-by":"publisher","first-page":"2676","DOI":"10.2337\/db14-1710","article-title":"Using genetic variants to assess the relationship between circulating lipids and type 2 diabetes","volume":"64","author":"Fall","year":"2015","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)30396-5_bib5","doi-asserted-by":"publisher","first-page":"692","DOI":"10.1001\/jamacardio.2016.1884","article-title":"Association of lipid fractions with risks for coronary artery disease and diabetes","volume":"1","author":"White","year":"2016","journal-title":"JAMA Cardiol"},{"key":"10.1016\/S2213-8587(16)30396-5_bib6","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1001\/jama.2015.1206","article-title":"Association between familial hypercholesterolemia and prevalence of type 2 diabetes mellitus","volume":"313","author":"Besseling","year":"2015","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30396-5_bib7","doi-asserted-by":"publisher","first-page":"154","DOI":"10.1038\/ng1161","article-title":"Mutations in PCSK9 cause autosomal dominant hypercholesterolemia","volume":"34","author":"Abifadel","year":"2003","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib8","doi-asserted-by":"publisher","first-page":"1264","DOI":"10.1056\/NEJMoa054013","article-title":"Sequence variations in PCSK9, low LDL, and protection against coronary heart disease","volume":"354","author":"Cohen","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30396-5_bib9","doi-asserted-by":"publisher","first-page":"40","DOI":"10.7326\/M14-2957","article-title":"Effects of proprotein convertase subtilisin\/kexin type 9 antibodies in adults with hypercholesterolemia: a systematic review and meta-analysis","volume":"163","author":"Navarese","year":"2015","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(16)30396-5_bib10","doi-asserted-by":"publisher","first-page":"1108","DOI":"10.1056\/NEJMoa1105803","article-title":"Effect of a monoclonal antibody to PCSK9 on LDL cholesterol","volume":"366","author":"Stein","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30396-5_bib11","doi-asserted-by":"publisher","first-page":"1906","DOI":"10.1016\/S0140-6736(05)67767-7","article-title":"Nature's randomised trials","volume":"366","author":"Hingorani","year":"2005","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib12","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1161\/CIRCULATIONAHA.109.865444","article-title":"Separating the mechanism-based and off-target actions of cholesteryl ester transfer protein inhibitors with CETP gene polymorphisms","volume":"121","author":"Sofat","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/S2213-8587(16)30396-5_bib13","doi-asserted-by":"publisher","first-page":"1383","DOI":"10.1001\/jama.2016.14568","article-title":"Association between low-density lipoprotein cholesterol-lowering genetic variants and risk of type 2 diabetes: a meta-analysis","volume":"316","author":"Lotta","year":"2016","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(16)30396-5_bib14","doi-asserted-by":"publisher","first-page":"1274","DOI":"10.1038\/ng.2797","article-title":"Discovery and refinement of loci associated with lipid levels","volume":"45","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib15","doi-asserted-by":"publisher","first-page":"310","DOI":"10.1038\/ng.2892","article-title":"A general framework for estimating the relative pathogenicity of human genetic variants","volume":"46","author":"Kircher","year":"2014","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib16","doi-asserted-by":"publisher","first-page":"25","DOI":"10.1038\/ng.2480","article-title":"Large-scale association analysis identifies new risk loci for coronary artery disease","volume":"45","author":"Deloukas","year":"2013","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib17","doi-asserted-by":"publisher","first-page":"991","DOI":"10.1038\/ng.2385","article-title":"Large-scale association analyses identify new loci influencing glycemic traits and provide insight into the underlying biological pathways","volume":"44","author":"Scott","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib18","doi-asserted-by":"publisher","first-page":"3229","DOI":"10.2337\/db10-0502","article-title":"Common variants at 10 genomic loci influence hemoglobin A1c levels via glycemic and nonglycemic pathways","volume":"59","author":"Soranzo","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(16)30396-5_bib19","doi-asserted-by":"publisher","first-page":"105","DOI":"10.1038\/ng.520","article-title":"New genetic loci implicated in fasting glucose homeostasis and their impact on type 2 diabetes risk","volume":"42","author":"Dupuis","year":"2010","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib20","doi-asserted-by":"publisher","first-page":"e1003500","DOI":"10.1371\/journal.pgen.1003500","article-title":"Sex-stratified genome-wide association studies including 270,000 individuals show sexual dimorphism in genetic loci for anthropometric traits","volume":"9","author":"Randall","year":"2013","journal-title":"PLoS Genet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib21","doi-asserted-by":"publisher","first-page":"197","DOI":"10.1038\/nature14177","article-title":"Genetic studies of body mass index yield new insights for obesity biology","volume":"518","author":"Locke","year":"2015","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)30396-5_bib22","doi-asserted-by":"publisher","first-page":"981","DOI":"10.1038\/ng.2383","article-title":"Large-scale association analysis provides insights into the genetic architecture and pathophysiology of type 2 diabetes","volume":"44","author":"Morris","year":"2012","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib23","doi-asserted-by":"publisher","first-page":"41","DOI":"10.1038\/nature18642","article-title":"The genetic architecture of type 2 diabetes","volume":"536","author":"Fuchsberger","year":"2016","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)30396-5_bib24","doi-asserted-by":"publisher","first-page":"e1001779","DOI":"10.1371\/journal.pmed.1001779","article-title":"UK Biobank: an open access resource for identifying the causes of a wide range of complex diseases of middle and old age","volume":"12","author":"Sudlow","year":"2015","journal-title":"PLoS Med"},{"key":"10.1016\/S2213-8587(16)30396-5_bib25","doi-asserted-by":"publisher","first-page":"557","DOI":"10.1136\/bmj.327.7414.557","article-title":"Measuring inconsistency in meta-analyses","volume":"327","author":"Higgins","year":"2003","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)30396-5_bib26","unstructured":"Johnson T. Efficient calculation for multi-SNP genetic risk scores. American Society of Human Genetics Annual Meeting; San Francisco, CA; Nov 6\u201310, 2012."},{"key":"10.1016\/S2213-8587(16)30396-5_bib27","doi-asserted-by":"publisher","first-page":"210","DOI":"10.1093\/aje\/kwr302","article-title":"Dealing with missing outcome data in randomized trials and observational studies","volume":"175","author":"Groenwold","year":"2012","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(16)30396-5_bib28","series-title":"Statistical analysis with missing data","author":"Little","year":"2002"},{"key":"10.1016\/S2213-8587(16)30396-5_bib29","series-title":"Statistical methods for research workers","author":"Fisher","year":"1934"},{"key":"10.1016\/S2213-8587(16)30396-5_bib30","doi-asserted-by":"publisher","first-page":"e7325","DOI":"10.1136\/bmj.e7325","article-title":"Use of Mendelian randomisation to assess potential benefit of clinical intervention","volume":"345","author":"Burgess","year":"2012","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(16)30396-5_bib31","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD009217.pub2","article-title":"Statins for the primary prevention of cardiovascular disease","volume":"1","author":"Taylor","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"key":"10.1016\/S2213-8587(16)30396-5_bib32","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1016\/S0140-6736(12)61190-8","article-title":"Cardiovascular benefits and diabetes risks of statin therapy in primary prevention: an analysis from the JUPITER trial","volume":"380","author":"Ridker","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib33","doi-asserted-by":"publisher","first-page":"2981","DOI":"10.1093\/eurheartj\/ehw292","article-title":"No effect of PCSK9 inhibitor alirocumab on the incidence of diabetes in a pooled analysis from 10 ODYSSEY phase 3 studies","volume":"37","author":"Colhoun","year":"2016","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30396-5_bib34","doi-asserted-by":"publisher","first-page":"972","DOI":"10.1093\/eurheartj\/ehs243","article-title":"Influence of common genetic variation on blood lipid levels, cardiovascular risk, and coronary events in two British prospective cohort studies","volume":"34","author":"Shah","year":"2013","journal-title":"Eur Heart J"},{"key":"10.1016\/S2213-8587(16)30396-5_bib35","doi-asserted-by":"publisher","first-page":"550","DOI":"10.1097\/00001648-200009000-00011","article-title":"Marginal structural models and causal inference in epidemiology","volume":"11","author":"Robins","year":"2000","journal-title":"Epidemiology"},{"key":"10.1016\/S2213-8587(16)30396-5_bib36","doi-asserted-by":"publisher","first-page":"1966","DOI":"10.1016\/j.jacc.2013.06.044","article-title":"Secretory phospholipase A2-IIA and cardiovascular disease: a mendelian randomization study","volume":"62","author":"Holmes","year":"2013","journal-title":"J Am Coll Cardiol"},{"key":"10.1016\/S2213-8587(16)30396-5_bib37","doi-asserted-by":"publisher","first-page":"1214","DOI":"10.1016\/S0140-6736(12)60110-X","article-title":"The interleukin-6 receptor as a target for prevention of coronary heart disease: a mendelian randomisation analysis","volume":"379","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30396-5_bib38","doi-asserted-by":"publisher","first-page":"701","DOI":"10.1016\/j.febslet.2009.12.018","article-title":"PCSK9-deficient mice exhibit impaired glucose tolerance and pancreatic islet abnormalities","volume":"584","author":"Mbikay","year":"2010","journal-title":"FEBS Lett"},{"key":"10.1016\/S2213-8587(16)30396-5_bib39","doi-asserted-by":"publisher","first-page":"1288","DOI":"10.1016\/j.bbrc.2009.10.138","article-title":"PCSK9 is expressed in pancreatic delta-cells and does not alter insulin secretion","volume":"390","author":"Langhi","year":"2009","journal-title":"Biochem Biophys Res Commun"},{"key":"10.1016\/S2213-8587(16)30396-5_bib40","doi-asserted-by":"publisher","first-page":"1526","DOI":"10.1161\/ATVBAHA.111.240549","article-title":"Common and low-frequency genetic variants in the PCSK9 locus influence circulating PCSK9 levels","volume":"32","author":"Chernogubova","year":"2012","journal-title":"Arterioscler Thromb Vasc Biol"},{"key":"10.1016\/S2213-8587(16)30396-5_bib41","doi-asserted-by":"publisher","first-page":"2833","DOI":"10.1016\/j.jacc.2010.02.044","article-title":"PCSK9 R46L, low-density lipoprotein cholesterol levels, and risk of ischemic heart disease: 3 independent studies and meta-analyses","volume":"55","author":"Benn","year":"2010","journal-title":"J Am Coll Cardiol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303965?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716303965?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2019,9,15]],"date-time":"2019-09-15T21:35:52Z","timestamp":1568583352000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716303965"}},"issued":{"date-parts":[[2017,2]]},"references-count":41,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2017,2]]}},"alternative-id":["S2213858716303965"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30396-5","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PCSK9 genetic variants and risk of type 2 diabetes: a mendelian randomisation study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30396-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30398-9","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 The Author(s). Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,10]],"date-time":"2026-11-10T14:15:57Z","timestamp":1794320157621,"version":"4.9.0"},"reference-count":30,"publisher":"Elsevier BV","issue":"12","license":[{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2020,12,1]],"date-time":"2020-12-01T00:00:00Z","timestamp":1606780800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2020,12]]},"DOI":"10.1016\/s2213-8587(20)30364-8","type":"journal-article","created":{"date-parts":[[2020,10,30]],"date-time":"2020-10-30T19:30:42Z","timestamp":1604086242000},"page":"960-970","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":477,"title":["Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials"],"prefix":"10.1016","volume":"8","author":[{"given":"Karine","family":"Cl\u00e9ment","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica","family":"van den Akker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Argente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison","family":"Bahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy K","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillori","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"De Waele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"I Sadaf","family":"Farooqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gonneau-Lejeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Kohlsdorf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Poitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Puder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Guojun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wabitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"K\u00fchnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Patricia","family":"Pigeon-Kherchiche","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Anna","family":"Flaus-Furmaniuk","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Bald","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christian","family":"Denzer","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"von Schnurbein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ozair","family":"Abawi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ulrike","family":"Blume-Peytavi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Philipp","family":"Krabusch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Knut","family":"Mai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Dirk","family":"Schnabel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Susanna","family":"Wiegand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christa E","family":"Fl\u00fcck","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Esther","family":"Schulz","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Egbert","family":"Voss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Natasa","family":"Bratina","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katja","family":"Weiss","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gabriel \u00c1","family":"Martos-Moreno","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alban","family":"Danset","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Paul","family":"Gougis","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"B\u00e9atrice","family":"Dubern","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Karine","family":"Cl\u00e9ment","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erica L.T.","family":"van den Akker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jes\u00fas","family":"Argente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Allison L","family":"Bahm","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wendy K","family":"Chung","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hillori S","family":"Connors","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathleen","family":"De Waele","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ismaa Sadaf","family":"Farooqi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julie","family":"Gonneau-Lejeune","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gregory A","family":"Gordon","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Poitou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lia","family":"Puder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"James M","family":"Swain","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Murray W","family":"Stewart","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Goujun","family":"Yuan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Wabitsch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Peter","family":"K\u00fchnen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(20)30364-8_bib1","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1056\/NEJMoa1614362","article-title":"Health effects of overweight and obesity in 195 countries over 25 years","volume":"377","author":"Afshin","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30364-8_bib2","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1159\/000445061","article-title":"Rare genetic forms of obesity: clinical approach and current treatments in 2016","volume":"9","author":"Huvenne","year":"2016","journal-title":"Obes Facts"},{"key":"10.1016\/S2213-8587(20)30364-8_bib3","doi-asserted-by":"crossref","first-page":"136","DOI":"10.1016\/j.molmed.2018.12.002","article-title":"Melanocortin-4 receptor signalling: importance for weight regulation and obesity treatment","volume":"25","author":"K\u00fchnen","year":"2019","journal-title":"Trends Mol Med"},{"key":"10.1016\/S2213-8587(20)30364-8_bib4","doi-asserted-by":"crossref","first-page":"e856","DOI":"10.7717\/peerj.856","article-title":"Obesity genetics in mouse and human: back and forth, and back again","volume":"3","author":"Yazdi","year":"2015","journal-title":"PeerJ"},{"key":"10.1016\/S2213-8587(20)30364-8_bib5","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1016\/S0092-8674(00)81865-6","article-title":"Targeted disruption of the melanocortin-4 receptor results in obesity in mice","volume":"88","author":"Huszar","year":"1997","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(20)30364-8_bib6","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/32911","article-title":"A mutation in the human leptin receptor gene causes obesity and pituitary dysfunction","volume":"392","author":"Cl\u00e9ment","year":"1998","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(20)30364-8_bib7","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1038\/509","article-title":"Severe early-onset obesity, adrenal insufficiency and red hair pigmentation caused by POMC mutations in humans","volume":"19","author":"Krude","year":"1998","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(20)30364-8_bib8","doi-asserted-by":"crossref","first-page":"51","DOI":"10.1016\/j.ymgme.2017.03.007","article-title":"Next-generation sequencing of the monogenic obesity genes LEP, LEPR, MC4R, PCSK1 and POMC in a Norwegian cohort of patients with morbid obesity and normal weight controls","volume":"121","author":"Nordang","year":"2017","journal-title":"Mol Genet Metab"},{"key":"10.1016\/S2213-8587(20)30364-8_bib9","doi-asserted-by":"crossref","first-page":"2601","DOI":"10.1210\/jc.2018-00258","article-title":"Melanocortin 4 receptor pathway dysfunction in obesity: patient stratification aimed at MC4R agonist treatment","volume":"103","author":"Ayers","year":"2018","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30364-8_bib10","doi-asserted-by":"crossref","first-page":"4633","DOI":"10.1210\/jc.2003-030502","article-title":"Obesity due to proopiomelanocortin deficiency: three new cases and treatment trials with thyroid hormone and ACTH4-10","volume":"88","author":"Krude","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30364-8_bib11","doi-asserted-by":"crossref","first-page":"2549","DOI":"10.2337\/db06-0214","article-title":"Heterozygosity for a POMC-null mutation and increased obesity risk in humans","volume":"55","author":"Farooqi","year":"2006","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(20)30364-8_bib12","doi-asserted-by":"crossref","first-page":"4955","DOI":"10.1210\/jc.2008-1164","article-title":"Unexpected endocrine features and normal pigmentation in a young adult patient carrying a novel homozygous mutation in the POMC gene","volume":"93","author":"Cl\u00e9ment","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30364-8_bib13","doi-asserted-by":"crossref","first-page":"5","DOI":"10.1186\/1687-9856-2011-5","article-title":"Early onset obesity and adrenal insufficiency associated with a homozygous POMC mutation","volume":"2011","author":"Mendiratta","year":"2011","journal-title":"Int J Pediatr Endocrinol"},{"key":"10.1016\/S2213-8587(20)30364-8_bib14","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1038\/ng0797-303","article-title":"Obesity and impaired prohormone processing associated with mutations in the human prohormone convertase 1 gene","volume":"16","author":"Jackson","year":"1997","journal-title":"Nat Genet"},{"key":"10.1016\/S2213-8587(20)30364-8_bib15","doi-asserted-by":"crossref","first-page":"1550","DOI":"10.1172\/JCI200318784","article-title":"Small-intestinal dysfunction accompanies the complex endocrinopathy of human proprotein convertase 1 deficiency","volume":"112","author":"Jackson","year":"2003","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(20)30364-8_bib16","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1053\/j.gastro.2013.03.048","article-title":"Congenital proprotein convertase 1\/3 deficiency causes malabsorptive diarrhea and other endocrinopathies in a pediatric cohort","volume":"145","author":"Mart\u00edn","year":"2013","journal-title":"Gastroenterology"},{"key":"10.1016\/S2213-8587(20)30364-8_bib17","doi-asserted-by":"crossref","first-page":"237","DOI":"10.1056\/NEJMoa063988","article-title":"Clinical and molecular genetic spectrum of congenital deficiency of the leptin receptor","volume":"356","author":"Farooqi","year":"2007","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30364-8_bib18","doi-asserted-by":"crossref","first-page":"6036","DOI":"10.1523\/JNEUROSCI.4875-09.2010","article-title":"CNS leptin action modulates immune response and survival in sepsis","volume":"30","author":"Tsch\u00f6p","year":"2010","journal-title":"J Neurosci"},{"key":"10.1016\/S2213-8587(20)30364-8_bib19","doi-asserted-by":"crossref","first-page":"E757","DOI":"10.1210\/jc.2015-1036","article-title":"Seven novel deleterious LEPR mutations found in early-onset obesity: a \u0394Exon6-8 shared by subjects from Reunion Island, France, suggests a founder effect","volume":"100","author":"Huvenne","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30364-8_bib20","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1210\/js.2018-00123","article-title":"Functional and phenotypic characteristics of human leptin receptor mutations","volume":"3","author":"Nunziata","year":"2018","journal-title":"J Endocr Soc"},{"key":"10.1016\/S2213-8587(20)30364-8_bib21","doi-asserted-by":"crossref","first-page":"47","DOI":"10.1530\/EJE-19-0678","article-title":"Leptin receptor deficiency: a systematic literature review and prevalence estimation based on population genetics","volume":"182","author":"Kleinendorst","year":"2020","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(20)30364-8_bib22","doi-asserted-by":"crossref","first-page":"240","DOI":"10.1056\/NEJMoa1512693","article-title":"Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist","volume":"375","author":"K\u00fchnen","year":"2016","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30364-8_bib23","doi-asserted-by":"crossref","first-page":"551","DOI":"10.1038\/s41591-018-0015-9","article-title":"MC4R agonism promotes durable weight loss in patients with leptin receptor deficiency","volume":"24","author":"Cl\u00e9ment","year":"2018","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(20)30364-8_bib24","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neuron.2017.06.014","article-title":"Toward a wiring diagram understanding of appetite control","volume":"95","author":"Andermann","year":"2017","journal-title":"Neuron"},{"key":"10.1016\/S2213-8587(20)30364-8_bib25","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJM199503093321001","article-title":"Changes in energy expenditure resulting from altered body weight","volume":"332","author":"Leibel","year":"1995","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30364-8_bib26","doi-asserted-by":"crossref","first-page":"1639","DOI":"10.1210\/jc.2014-4024","article-title":"RM-493, a melanocortin-4 receptor (MC4R) agonist, increases resting energy expenditure in obese individuals","volume":"100","author":"Chen","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(20)30364-8_bib27","doi-asserted-by":"crossref","first-page":"R444","DOI":"10.1152\/ajpregu.2001.281.2.R444","article-title":"Central melanocortin system modulates energy intake and expenditure of obese and lean Zucker rats","volume":"281","author":"Hwa","year":"2001","journal-title":"Am J Physiol Regul Integr Comp Physiol"},{"key":"10.1016\/S2213-8587(20)30364-8_bib28","doi-asserted-by":"crossref","first-page":"44","DOI":"10.1056\/NEJMoa0803085","article-title":"Modulation of blood pressure by central melanocortinergic pathways","volume":"360","author":"Greenfield","year":"2009","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(20)30364-8_bib29","doi-asserted-by":"crossref","first-page":"370","DOI":"10.1161\/01.HYP.0000111836.54204.93","article-title":"Role of adrenergic activity in pressor responses to chronic melanocortin receptor activation","volume":"43","author":"Kuo","year":"2004","journal-title":"Hypertension"},{"key":"10.1016\/S2213-8587(20)30364-8_bib30","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1177\/0883073813495959","article-title":"Clinical trials in rare disease: challenges and opportunities","volume":"28","author":"Augustine","year":"2013","journal-title":"J Child Neurol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303648?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858720303648?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,16]],"date-time":"2026-08-16T11:35:05Z","timestamp":1786880105000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858720303648"}},"issued":{"date-parts":[[2020,12]]},"references-count":30,"journal-issue":{"issue":"12","published-print":{"date-parts":[[2020,12]]}},"alternative-id":["S2213858720303648"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(20)30364-8","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2020,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Efficacy and safety of setmelanotide, an MC4R agonist, in individuals with severe obesity due to LEPR or POMC deficiency: single-arm, open-label, multicentre, phase 3 trials","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30364-8","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(20)30366-1","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2020 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:31:58Z","timestamp":1792801918482,"version":"4.5.0"},"reference-count":70,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2016,1,1]],"date-time":"2016-01-01T00:00:00Z","timestamp":1451606400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2016,1]]},"DOI":"10.1016\/s2213-8587(15)00337-x","type":"journal-article","created":{"date-parts":[[2015,10,25]],"date-time":"2015-10-25T15:09:44Z","timestamp":1445785784000},"page":"64-71","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":116,"title":["Management of advanced medullary thyroid cancer"],"prefix":"10.1016","volume":"4","author":[{"given":"Julien","family":"Hadoux","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Furio","family":"Pacini","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R Michael","family":"Tuttle","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schlumberger","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(15)00337-X_bib1","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(15)00337-X_bib2","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jc.2007-1714","article-title":"Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study","volume":"93","author":"Elisei","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib3","doi-asserted-by":"crossref","first-page":"E863","DOI":"10.1210\/jc.2010-1921","article-title":"High prevalence of RAS mutations in RET-negative sporadic medullary thyroid carcinomas","volume":"96","author":"Moura","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib4","doi-asserted-by":"crossref","first-page":"E2031","DOI":"10.1210\/jc.2012-2092","article-title":"Somatic RAS mutations occur in a large proportion of sporadic RET-negative medullary thyroid carcinomas and extend to a previously unidentified exon","volume":"97","author":"Boichard","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib5","doi-asserted-by":"crossref","first-page":"E364","DOI":"10.1210\/jc.2012-2703","article-title":"Exomic sequencing of medullary thyroid cancer reveals dominant and mutually exclusive oncogenic mutations in RET and RAS","volume":"98","author":"Agrawal","year":"2013","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib6","doi-asserted-by":"crossref","first-page":"132","DOI":"10.1002\/(SICI)1097-0142(19970101)79:1<132::AID-CNCR19>3.0.CO;2-5","article-title":"Long-term follow-up of patients with medullary carcinoma of the thyroid","volume":"79","author":"Bergholm","year":"1997","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00337-X_bib7","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1210\/jc.2013-2942","article-title":"The effect of extent of surgery and number of lymph node metastases on overall survival in patients with medullary thyroid cancer","volume":"99","author":"Esfandiari","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib8","doi-asserted-by":"crossref","first-page":"1139","DOI":"10.1002\/(SICI)1097-0142(20000301)88:5<1139::AID-CNCR26>3.0.CO;2-Z","article-title":"Medullary thyroid carcinoma: clinical characteristics, treatment, prognostic factors, and a comparison of staging systems","volume":"88","author":"Kebebew","year":"2000","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00337-X_bib9","doi-asserted-by":"crossref","first-page":"1273","DOI":"10.1007\/s00268-011-1086-7","article-title":"Medullary thyroid cancer: clinico-pathological profile and outcome in a tertiary care center in North India","volume":"35","author":"Mehrotra","year":"2011","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(15)00337-X_bib10","doi-asserted-by":"crossref","first-page":"265","DOI":"10.1046\/j.1365-2265.1998.00392.x","article-title":"Prognostic factors for survival and for biochemical cure in medullary thyroid carcinoma: results in 899 patients. The GETC Study Group. Groupe d'\u00e9tude des tumeurs \u00e0 calcitonine","volume":"48","author":"Modigliani","year":"1998","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(15)00337-X_bib11","doi-asserted-by":"crossref","first-page":"493","DOI":"10.1016\/j.ejso.2006.10.021","article-title":"Natural history, diagnosis, treatment and outcome of medullary thyroid cancer: 37 years experience on 157 patients","volume":"33","author":"Pelizzo","year":"2007","journal-title":"Eur J Surg Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib12","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1097\/00005792-198411000-00001","article-title":"Medullary carcinoma of the thyroid. A study of the clinical features and prognostic factors in 161 patients","volume":"63","author":"Saad","year":"1984","journal-title":"Medicine (Baltimore)"},{"key":"10.1016\/S2213-8587(15)00337-X_bib13","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s10147-013-0588-8","article-title":"Predictive factors that influence the course of medullary thyroid carcinoma","volume":"19","author":"Pazaitou-Panayiotou","year":"2014","journal-title":"Int J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib14","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1530\/EJE-07-0667","article-title":"Progression of medullary thyroid carcinoma: assessment with calcitonin and carcinoembryonic antigen doubling times","volume":"158","author":"Laure Giraudet","year":"2008","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib15","doi-asserted-by":"crossref","first-page":"6077","DOI":"10.1210\/jc.2005-0044","article-title":"Prognostic impact of serum calcitonin and carcinoembryonic antigen doubling-times in patients with medullary thyroid carcinoma","volume":"90","author":"Barbet","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib16","doi-asserted-by":"crossref","first-page":"294","DOI":"10.1089\/thy.2012.0236","article-title":"Prevalence and clinical spectrum of nonsecretory medullary thyroid carcinoma in a series of 839 patients with sporadic medullary thyroid carcinoma","volume":"23","author":"Frank-Raue","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(15)00337-X_bib17","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/j.ejca.2008.10.026","article-title":"New response evaluation criteria in solid tumours: revised RECIST guideline (version 1.1)","volume":"45","author":"Eisenhauer","year":"2009","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2213-8587(15)00337-X_bib18","doi-asserted-by":"crossref","first-page":"2029","DOI":"10.1210\/jc.2004-1836","article-title":"Prospects of remission in medullary thyroid carcinoma according to basal calcitonin level","volume":"90","author":"Machens","year":"2005","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib19","doi-asserted-by":"crossref","first-page":"4185","DOI":"10.1210\/jc.2007-1211","article-title":"Imaging medullary thyroid carcinoma with persistent elevated calcitonin levels","volume":"92","author":"Giraudet","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib20","doi-asserted-by":"crossref","first-page":"501","DOI":"10.2967\/jnumed.106.036681","article-title":"Diagnostic accuracy of 18F-FDG PET in restaging patients with medullary thyroid carcinoma and elevated calcitonin levels","volume":"48","author":"Ong","year":"2007","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(15)00337-X_bib21","doi-asserted-by":"crossref","first-page":"1855","DOI":"10.2967\/jnumed.111.094771","article-title":"Complementary roles of 18F-DOPA PET\/CT and 18F-FDG PET\/CT in medullary thyroid cancer","volume":"52","author":"Kauhanen","year":"2011","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(15)00337-X_bib22","doi-asserted-by":"crossref","first-page":"1863","DOI":"10.2967\/jnumed.112.105940","article-title":"Clinical relevance of 18F-FDG PET and 18F-DOPA PET in recurrent medullary thyroid carcinoma","volume":"53","author":"Verbeek","year":"2012","journal-title":"J Nucl Med"},{"key":"10.1016\/S2213-8587(15)00337-X_bib23","doi-asserted-by":"crossref","first-page":"6956","DOI":"10.1158\/0008-5472.CAN-06-4605","article-title":"The RET kinase inhibitor NVP-AST487 blocks growth and calcitonin gene expression through distinct mechanisms in medullary thyroid cancer cells","volume":"67","author":"Akeno-Stuart","year":"2007","journal-title":"Cancer Res"},{"key":"10.1016\/S2213-8587(15)00337-X_bib24","doi-asserted-by":"crossref","first-page":"2256","DOI":"10.1093\/annonc\/mdt177","article-title":"Tumor marker and measurement fluctuations may not reflect treatment efficacy in patients with medullary thyroid carcinoma on long-term RET inhibitor therapy","volume":"24","author":"Kurzrock","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib25","doi-asserted-by":"crossref","first-page":"2201","DOI":"10.1093\/annonc\/mdt331","article-title":"Tumour markers fluctuations in patients with medullary thyroid carcinoma receiving long-term RET inhibitor therapy: ordinary lapping or alarming waves foreshadowing disease progression?","volume":"24","author":"Postel-Vinay","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib26","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1111\/j.1440-1843.2008.01309.x","article-title":"Airway stenting for the treatment of laryngotracheal stenosis secondary to thyroid cancer","volume":"13","author":"Tsutsui","year":"2008","journal-title":"Respirology"},{"key":"10.1016\/S2213-8587(15)00337-X_bib27","first-page":"983","article-title":"Slow release lanreotide in combination with interferon-alpha2b in the treatment of symptomatic advanced medullary thyroid carcinoma","volume":"85","author":"Vitale","year":"2000","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib28","doi-asserted-by":"crossref","first-page":"2796","DOI":"10.1210\/jc.2011-0536","article-title":"Mitotane, metyrapone, and ketoconazole combination therapy as an alternative to rescue adrenalectomy for severe ACTH-dependent Cushing's syndrome","volume":"96","author":"Kamenick\u00fd","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib29","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1056\/NEJMc1301428","article-title":"Reversal of Cushing's syndrome by vandetanib in medullary thyroid carcinoma","volume":"369","author":"Baudry","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(15)00337-X_bib30","doi-asserted-by":"crossref","first-page":"3082","DOI":"10.1016\/j.ejca.2012.08.002","article-title":"Superiority of denosumab to zoledronic acid for prevention of skeletal-related events: a combined analysis of 3 pivotal, randomised, phase 3 trials","volume":"48","author":"Lipton","year":"2012","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2213-8587(15)00337-X_bib31","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1634\/theoncologist.2014-0328","article-title":"Systematic literature review and network meta-analysis comparing bone-targeted agents for the prevention of skeletal-related events in cancer patients with bone metastasis","volume":"20","author":"Wang","year":"2015","journal-title":"Oncologist"},{"issue":"suppl","key":"10.1016\/S2213-8587(15)00337-X_bib32","doi-asserted-by":"crossref","first-page":"2062","DOI":"10.1002\/1097-0142(19850501)55:9+<2062::AID-CNCR2820551406>3.0.CO;2-O","article-title":"External radiotherapy in thyroid cancers","volume":"55","author":"Tubiana","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00337-X_bib33","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1007\/s11060-010-0175-z","article-title":"Stereotactic radiosurgery in the management of brain metastases from primary thyroid cancers","volume":"98","author":"Bernad","year":"2010","journal-title":"J Neurooncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib34","doi-asserted-by":"crossref","first-page":"2496","DOI":"10.1210\/jc.2005-2401","article-title":"Chemoembolization for liver metastases from medullary thyroid carcinoma","volume":"91","author":"Fromigu\u00e9","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib35","doi-asserted-by":"crossref","first-page":"986","DOI":"10.1016\/j.surg.2005.09.020","article-title":"Selective arterial chemoembolization for hepatic metastases from medullary thyroid carcinoma","volume":"138","author":"Lorenz","year":"2005","journal-title":"Surgery"},{"key":"10.1016\/S2213-8587(15)00337-X_bib36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1093\/annonc\/mdv037","article-title":"Radiofrequency ablation is a valid treatment option for lung metastases: experience in 566 patients with 1037 metastases","volume":"26","author":"de Ba\u00e8re","year":"2015","journal-title":"Ann Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib37","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1016\/j.diii.2014.04.004","article-title":"Percutaneous ablation of bone tumors","volume":"95","author":"Deschamps","year":"2014","journal-title":"Diagn Interv Imaging"},{"key":"10.1016\/S2213-8587(15)00337-X_bib38","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1016\/j.jvir.2014.12.009","article-title":"Radiofrequency ablation for neuroendocrine liver metastases: a systematic review","volume":"26","author":"Mohan","year":"2015","journal-title":"J Vasc Interv Radiol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib39","doi-asserted-by":"crossref","first-page":"1105","DOI":"10.1089\/thy.2008.0080","article-title":"Radiofrequency ablation of hepatic metastases from thyroid carcinoma","volume":"18","author":"Wertenbroek","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(15)00337-X_bib40","doi-asserted-by":"crossref","first-page":"386","DOI":"10.1089\/thy.2014.0361","article-title":"Vandetanib for the treatment of advanced medullary thyroid cancer outside a clinical trial: results from a French cohort","volume":"25","author":"Chougnet","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(15)00337-X_bib41","doi-asserted-by":"crossref","first-page":"6696","DOI":"10.1158\/1078-0432.CCR-07-0935","article-title":"Response to [90Yttrium-DOTA]-TOC treatment is associated with long-term survival benefit in metastasized medullary thyroid cancer: a phase II clinical trial","volume":"13","author":"Iten","year":"2007","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(15)00337-X_bib42","doi-asserted-by":"crossref","first-page":"3","DOI":"10.3747\/co.v16i5.464","article-title":"Pretargeted radioimmunotherapy in the treatment of metastatic medullary thyroid cancer","volume":"16","author":"Kraeber-Bod\u00e9r\u00e9","year":"2009","journal-title":"Curr Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib43","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.1002\/1097-0142(19851101)56:9<2155::AID-CNCR2820560903>3.0.CO;2-E","article-title":"A randomized trial of doxorubicin versus doxorubicin plus cisplatin in patients with advanced thyroid carcinoma","volume":"56","author":"Shimaoka","year":"1985","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(15)00337-X_bib44","first-page":"405","article-title":"Phase II evaluation of doxorubicin plus cisplatin in advanced thyroid cancer: a Southeastern Cancer Study Group Trial","volume":"70","author":"Williams","year":"1986","journal-title":"Cancer Treat Rep"},{"key":"10.1016\/S2213-8587(15)00337-X_bib45","doi-asserted-by":"crossref","first-page":"715","DOI":"10.1054\/bjoc.2000.1314","article-title":"Treatment of advanced medullary thyroid cancer with an alternating combination of doxorubicin-streptozocin and 5 FU-dacarbazine. Groupe d'Etude des Tumeurs \u00e0 Calcitonine (GETC)","volume":"83","author":"Nocera","year":"2000","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(15)00337-X_bib46","doi-asserted-by":"crossref","first-page":"363","DOI":"10.1038\/bjc.1995.73","article-title":"Treatment of advanced medullary thyroid cancer with an alternating combination of 5 FU-streptozocin and 5 FU-dacarbazine. The Groupe d'Etude des Tumeurs a Calcitonine (GETC)","volume":"71","author":"Schlumberger","year":"1995","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(15)00337-X_bib47","doi-asserted-by":"crossref","first-page":"863","DOI":"10.1089\/thy.2009.0417","article-title":"Increased expression of vascular endothelial growth factor and its receptors, VEGFR-1 and VEGFR-2, in medullary thyroid carcinoma","volume":"20","author":"Capp","year":"2010","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(15)00337-X_bib48","doi-asserted-by":"crossref","first-page":"19","DOI":"10.1385\/EP:11:1:19","article-title":"Expression of hepatocyte growth factor (HGF) and its receptor (MET) in medullary carcinoma of the thyroid","volume":"11","author":"Papotti","year":"2000","journal-title":"Endocr Pathol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib49","doi-asserted-by":"crossref","first-page":"767","DOI":"10.1200\/JCO.2009.23.6604","article-title":"Vandetanib for the treatment of patients with locally advanced or metastatic hereditary medullary thyroid cancer","volume":"28","author":"Wells","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib50","doi-asserted-by":"crossref","first-page":"2323","DOI":"10.1200\/JCO.2009.25.0068","article-title":"Phase II clinical trial of sorafenib in metastatic medullary thyroid cancer","volume":"28","author":"Lam","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib51","doi-asserted-by":"crossref","first-page":"3794","DOI":"10.1200\/JCO.2008.18.7815","article-title":"Phase II study of safety and efficacy of motesanib in patients with progressive or symptomatic, advanced or metastatic medullary thyroid cancer","volume":"27","author":"Schlumberger","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib52","doi-asserted-by":"crossref","first-page":"4708","DOI":"10.1200\/JCO.2007.15.9566","article-title":"Axitinib is an active treatment for all histologic subtypes of advanced thyroid cancer: results from a phase II study","volume":"26","author":"Cohen","year":"2008","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib53","doi-asserted-by":"crossref","first-page":"5260","DOI":"10.1158\/1078-0432.CCR-10-0994","article-title":"Phase II study of daily sunitinib in FDG-PET-positive, iodine-refractory differentiated thyroid cancer and metastatic medullary carcinoma of the thyroid with functional imaging correlation","volume":"16","author":"Carr","year":"2010","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(15)00337-X_bib54","article-title":"A phase II trial of the multitargeted kinase inhibitor lenvatinib (E7080) in advanced medullary thyroid cancer (MTC)","author":"Schlumberger","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(15)00337-X_bib55","doi-asserted-by":"crossref","first-page":"2660","DOI":"10.1200\/JCO.2010.32.4145","article-title":"Activity of XL184 (Cabozantinib), an oral tyrosine kinase inhibitor, in patients with medullary thyroid cancer","volume":"29","author":"Kurzrock","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib56","doi-asserted-by":"crossref","first-page":"1687","DOI":"10.1210\/jc.2013-3713","article-title":"A multicenter phase 2 trial of pazopanib in metastatic and progressive medullary thyroid carcinoma: MC057H","volume":"99","author":"Bible","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib57","doi-asserted-by":"crossref","first-page":"317","DOI":"10.1089\/thy.2007.0120","article-title":"A phase II study of gefitinib in patients with advanced thyroid cancer","volume":"18","author":"Pennell","year":"2008","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(15)00337-X_bib58","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1530\/EJE-06-0695","article-title":"Efficacy of imatinib mesylate in advanced medullary thyroid carcinoma","volume":"157","author":"Frank-Raue","year":"2007","journal-title":"Eur J Endocrinol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib59","doi-asserted-by":"crossref","first-page":"3466","DOI":"10.1210\/jc.2007-0649","article-title":"A phase II trial of imatinib therapy for metastatic medullary thyroid carcinoma","volume":"92","author":"de Groot","year":"2007","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib60","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial","volume":"30","author":"Wells","year":"2012","journal-title":"J Clin Oncol"},{"issue":"suppl 5","key":"10.1016\/S2213-8587(15)00337-X_bib61","article-title":"Final overall survival analysis of EXAM, an international, double-blind, randomized, placebo-controlled phase III trial of cabozantinib (Cabo) in medullary thyroid carcinoma (MTC) patients with documented RECIST progression at baseline","volume":"33","author":"Schlumberger","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib62","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in progressive medullary thyroid cancer","volume":"31","author":"Elisei","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib63","doi-asserted-by":"crossref","first-page":"2664","DOI":"10.1210\/jc.2009-2461","article-title":"Vandetanib (100 mg) in patients with locally advanced or metastatic hereditary medullary thyroid cancer","volume":"95","author":"Robinson","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib64","doi-asserted-by":"crossref","first-page":"4239","DOI":"10.1158\/1078-0432.CCR-13-0071","article-title":"Vandetanib in children and adolescents with multiple endocrine neoplasia type 2B associated medullary thyroid carcinoma","volume":"19","author":"Fox","year":"2013","journal-title":"Clin Cancer Res"},{"issue":"suppl","key":"10.1016\/S2213-8587(15)00337-X_bib65","article-title":"Efficacy of cabozantinib (Cabo) in medullary thyroid cancer (MTC) patients with RAS or RET mutations: results from a phase III study","volume":"31","author":"Sherman","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib66","doi-asserted-by":"crossref","first-page":"1418","DOI":"10.1001\/2013.jamadermatol.192","article-title":"A new spectrum of skin toxic effects associated with the multikinase inhibitor vandetanib","volume":"148","author":"Giacchero","year":"2012","journal-title":"Arch Dermatol"},{"key":"10.1016\/S2213-8587(15)00337-X_bib67","doi-asserted-by":"crossref","first-page":"2741","DOI":"10.1210\/jc.2010-2771","article-title":"Endocrine effects of the tyrosine kinase inhibitor vandetanib in patients treated for thyroid cancer","volume":"96","author":"Brassard","year":"2011","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib68","doi-asserted-by":"crossref","first-page":"4390","DOI":"10.1210\/jc.2014-2811","article-title":"Medullary thyroid cancer in the era of tyrosine kinase inhibitors: to treat or not to treat\u2014and with which drug\u2014those are the questions","volume":"99","author":"Cabanillas","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(15)00337-X_bib69","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1038\/sj.onc.1207810","article-title":"Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors","volume":"23","author":"Carlomagno","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/S2213-8587(15)00337-X_bib70","doi-asserted-by":"crossref","first-page":"997","DOI":"10.1210\/jc.2010-1899","article-title":"Inhibition of the Ras\/Raf\/MEK\/ERK and RET kinase pathways with the combination of the multikinase inhibitor sorafenib and the farnesyltransferase inhibitor tipifarnib in medullary and differentiated thyroid malignancies","volume":"96","author":"Hong","year":"2011","journal-title":"J Clin Endocrinol Metab"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500337X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221385871500337X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2022,5,24]],"date-time":"2022-05-24T04:34:44Z","timestamp":1653366884000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221385871500337X"}},"issued":{"date-parts":[[2016,1]]},"references-count":70,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2016,1]]}},"alternative-id":["S221385871500337X"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(15)00337-x","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2016,1]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Management of advanced medullary thyroid cancer","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(15)00337-X","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,10,24]],"date-time":"2026-10-24T00:31:43Z","timestamp":1792801903980,"version":"4.5.0"},"reference-count":140,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2017,6,1]],"date-time":"2017-06-01T00:00:00Z","timestamp":1496275200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.fr","clinicalkey.com.au","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2017,6]]},"DOI":"10.1016\/s2213-8587(16)30277-7","type":"journal-article","created":{"date-parts":[[2016,10,20]],"date-time":"2016-10-20T20:34:30Z","timestamp":1476995670000},"page":"469-481","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":65,"title":["Leveraging the immune system to treat advanced thyroid cancers"],"prefix":"10.1016","volume":"5","author":[{"given":"Jena D","family":"French","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keith","family":"Bible","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christine","family":"Spitzweg","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bryan R","family":"Haugen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mabel","family":"Ryder","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(16)30277-7_bib1","doi-asserted-by":"crossref","first-page":"3801","DOI":"10.1002\/cncr.24416","article-title":"Increasing incidence of differentiated thyroid cancer in the United States, 1988\u20132005","volume":"115","author":"Chen","year":"2009","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib2","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1634\/theoncologist.12-1-20","article-title":"Cancer statistics, trends, and multiple primary cancer analyses from the Surveillance, Epidemiology, and End Results (SEER) Program","volume":"12","author":"Hayat","year":"2007","journal-title":"Oncologist"},{"key":"10.1016\/S2213-8587(16)30277-7_bib3","series-title":"Surveillance Epidemiology and End Results (SEER): cancer statistics review 1975\u20132013","year":"2016"},{"key":"10.1016\/S2213-8587(16)30277-7_bib5","series-title":"Surveillance Epidemiology and End Results (SEER): cancer statistics review 1975\u20132008","year":"2011"},{"key":"10.1016\/S2213-8587(16)30277-7_bib6","doi-asserted-by":"crossref","first-page":"64","DOI":"10.1016\/S2213-8587(15)00337-X","article-title":"Management of advanced medullary thyroid cancer","volume":"4","author":"Hadoux","year":"2016","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib7","doi-asserted-by":"crossref","first-page":"R71","DOI":"10.1530\/ERC-15-0194","article-title":"Effectiveness of chemotherapy in advanced differentiated thyroid cancer: a systematic review","volume":"23","author":"Albero","year":"2016","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib8","doi-asserted-by":"crossref","first-page":"1357","DOI":"10.1517\/13543784.2011.614230","article-title":"Emerging therapeutics for advanced thyroid malignancies: rationale and targeted approaches","volume":"20","author":"Harris","year":"2011","journal-title":"Expert Opin Investig Drugs"},{"key":"10.1016\/S2213-8587(16)30277-7_bib9","doi-asserted-by":"crossref","first-page":"184","DOI":"10.1038\/nrc3431","article-title":"Molecular pathogenesis and mechanisms of thyroid cancer","volume":"13","author":"Xing","year":"2013","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib10","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30277-7_bib11","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in progressive medullary thyroid cancer","volume":"31","author":"Elisei","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib12","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30277-7_bib13","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomized, double-blind phase III trial","volume":"30","author":"Wells","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib14","doi-asserted-by":"crossref","first-page":"e2058","DOI":"10.1038\/cddis.2015.275","article-title":"Potential of apoptotic pathway-targeted cancer therapeutic research: where do we stand?","volume":"7","author":"Baig","year":"2016","journal-title":"Cell Death Dis"},{"key":"10.1016\/S2213-8587(16)30277-7_bib15","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/j.critrevonc.2013.12.012","article-title":"Cancer therapeutics: targeting the apoptotic pathway","volume":"90","author":"Khan","year":"2014","journal-title":"Crit Rev Oncol Hematol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib16","doi-asserted-by":"crossref","first-page":"427","DOI":"10.1038\/bjc.2016.5","article-title":"Survivin and XIAP: two valuable biomarkers in medullary thyroid carcinoma","volume":"114","author":"Werner","year":"2016","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib17","doi-asserted-by":"crossref","first-page":"27","DOI":"10.1186\/s12935-016-0303-8","article-title":"The BH3 mimetic drug ABT-737 induces apoptosis and acts synergistically with chemotherapeutic drugs in thyroid carcinoma cells","volume":"16","author":"Broecker-Preuss","year":"2016","journal-title":"Cancer Cell Int"},{"key":"10.1016\/S2213-8587(16)30277-7_bib18","doi-asserted-by":"crossref","first-page":"E974","DOI":"10.1210\/jc.2014-4356","article-title":"Role of X-Linked inhibitor of apoptosis as a prognostic marker and therapeutic target in papillary thyroid carcinoma","volume":"100","author":"Hussain","year":"2015","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30277-7_bib19","doi-asserted-by":"crossref","first-page":"830","DOI":"10.1016\/S2213-8587(14)70051-8","article-title":"Advanced radioiodine-refractory differentiated thyroid cancer: the sodium iodide symporter and other emerging therapeutic targets","volume":"2","author":"Spitzweg","year":"2014","journal-title":"Lancet Diabetes Endocrinol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib20","doi-asserted-by":"crossref","first-page":"25","DOI":"10.1089\/thy.2010.0220","article-title":"Enhanced survival in locoregionally confined anaplastic thyroid carcinoma: a single-institution experience using aggressive multimodal therapy","volume":"21","author":"Foote","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30277-7_bib21","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1089\/thy.2015.0020","article-title":"2015 American Thyroid Association management guidelines for adult patients with thyroid nodules and differentiated thyroid cancer: the American Thyroid Association guidelines task force on thyroid nodules and differentiated thyroid cancer","volume":"26","author":"Haugen","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30277-7_bib22","doi-asserted-by":"crossref","first-page":"1104","DOI":"10.1089\/thy.2012.0302","article-title":"American Thyroid Association guidelines for management of patients with anaplastic thyroid cancer","volume":"22","author":"Smallridge","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30277-7_bib23","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30277-7_bib24","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1159\/000386035","article-title":"The concept of immunological surveillance","volume":"13","author":"Burnet","year":"1970","journal-title":"Prog Exp Tumor Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib25","doi-asserted-by":"crossref","first-page":"991","DOI":"10.1038\/ni1102-991","article-title":"Cancer immunoediting: from immunosurveillance to tumor escape","volume":"3","author":"Dunn","year":"2002","journal-title":"Nat Immunol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib26","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1007\/s00268-006-0211-5","article-title":"Clinical significance of lymph node metastasis of thyroid papillary carcinoma located in one lobe","volume":"30","author":"Ito","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(16)30277-7_bib27","doi-asserted-by":"crossref","first-page":"759","DOI":"10.1507\/endocrj.K09E-025","article-title":"Prognosis of patients with papillary thyroid carcinoma having clinically apparent metastasis to the lateral compartment","volume":"56","author":"Ito","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/S2213-8587(16)30277-7_bib28","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1507\/endocrj.K08E-297","article-title":"Clinical significance of extrathyroid extension to the parathyroid gland of papillary thyroid carcinoma","volume":"56","author":"Ito","year":"2009","journal-title":"Endocr J"},{"key":"10.1016\/S2213-8587(16)30277-7_bib29","doi-asserted-by":"crossref","first-page":"780","DOI":"10.1007\/s00268-005-0270-z","article-title":"Prognostic significance of extrathyroid extension of papillary thyroid carcinoma: massive but not minimal extension affects the relapse-free survival","volume":"30","author":"Ito","year":"2006","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(16)30277-7_bib30","doi-asserted-by":"crossref","first-page":"676","DOI":"10.1016\/j.cell.2014.09.050","article-title":"Integrated genomic characterization of papillary thyroid carcinoma","volume":"159","year":"2014","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(16)30277-7_bib31","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(16)30277-7_bib32","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1016\/j.cell.2010.03.014","article-title":"Macrophage diversity enhances tumor progression and metastasis","volume":"141","author":"Qian","year":"2010","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(16)30277-7_bib33","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1016\/j.ccr.2012.02.022","article-title":"Accessories to the crime: functions of cells recruited to the tumor microenvironment","volume":"21","author":"Hanahan","year":"2012","journal-title":"Cancer Cell"},{"key":"10.1016\/S2213-8587(16)30277-7_bib34","doi-asserted-by":"crossref","first-page":"252","DOI":"10.1038\/nrc3239","article-title":"The blockade of immune checkpoints in cancer immunotherapy","volume":"12","author":"Pardoll","year":"2012","journal-title":"Nat Rev Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib35","doi-asserted-by":"crossref","first-page":"3356","DOI":"10.1172\/JCI80005","article-title":"Myeloid-derived suppressor cells in the tumor microenvironment: expect the unexpected","volume":"125","author":"Marvel","year":"2015","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(16)30277-7_bib36","doi-asserted-by":"crossref","first-page":"2155","DOI":"10.4049\/jimmunol.178.4.2155","article-title":"Natural regulatory T cells and de novo-induced regulatory T cells contribute independently to tumor-specific tolerance","volume":"178","author":"Zhou","year":"2007","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib37","doi-asserted-by":"crossref","first-page":"6203","DOI":"10.1038\/onc.2010.348","article-title":"Mast cells have a protumorigenic role in human thyroid cancer","volume":"29","author":"Melillo","year":"2010","journal-title":"Oncogene"},{"key":"10.1016\/S2213-8587(16)30277-7_bib38","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1089\/thy.2011.0059","article-title":"Higher intratumoral expression of CD1a, tryptase, and CD68 in a follicular variant of papillary thyroid carcinoma compared to adenomas: correlation with clinical and pathological parameters","volume":"21","author":"Proietti","year":"2011","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30277-7_bib39","doi-asserted-by":"crossref","first-page":"5175","DOI":"10.1038\/onc.2014.441","article-title":"Mast cells induce epithelial-to-mesenchymal transition and stem cell features in human thyroid cancer cells through an IL-8-Akt-Slug pathway","volume":"34","author":"Visciano","year":"2015","journal-title":"Oncogene"},{"key":"10.1016\/S2213-8587(16)30277-7_bib40","doi-asserted-by":"crossref","first-page":"1474","DOI":"10.1210\/jc.2011-1838","article-title":"Phenotypical analysis of lymphocytes with suppressive and regulatory properties (Tregs) and NK cells in the papillary carcinoma of thyroid","volume":"97","author":"Gogali","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30277-7_bib41","doi-asserted-by":"crossref","first-page":"4418","DOI":"10.1210\/jc.2003-030342","article-title":"Papillary thyroid carcinomas from young adults and children contain a mixture of lymphocytes","volume":"88","author":"Modi","year":"2003","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30277-7_bib42","first-page":"189","article-title":"Natural killer activity in thyroid cancer patients","volume":"20","author":"Boros","year":"1987","journal-title":"Haematologia (Budap)"},{"key":"10.1016\/S2213-8587(16)30277-7_bib43","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1038\/labinvest.2015.126","article-title":"IL-12 immunotherapy of Braf(V600E)-induced papillary thyroid cancer in a mouse model","volume":"96","author":"Parhar","year":"2016","journal-title":"Lab Invest"},{"key":"10.1016\/S2213-8587(16)30277-7_bib44","doi-asserted-by":"crossref","first-page":"2704","DOI":"10.1210\/jc.2006-0492","article-title":"Clinicopathological significance of major histocompatibility complex class I-related chain a and B expression in thyroid cancer","volume":"91","author":"Xu","year":"2006","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30277-7_bib45","doi-asserted-by":"crossref","first-page":"6034","DOI":"10.1158\/1078-0432.CCR-14-0879","article-title":"MHC class I loss is a frequent mechanism of immune escape in papillary thyroid cancer that is reversed by interferon and selumetinib treatment in vitro","volume":"20","author":"Angell","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib46","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1158\/1078-0432.CCR-14-0291","article-title":"Human anaplastic thyroid carcinoma cells are sensitive to NK cell-mediated lysis via ULBP2\/5\/6 and chemoattract NK cells","volume":"20","author":"Wennerberg","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib47","doi-asserted-by":"crossref","first-page":"905","DOI":"10.1089\/thy.2011.0452","article-title":"Density of tumor-associated macrophages correlates with lymph node metastasis in papillary thyroid carcinoma","volume":"22","author":"Qing","year":"2012","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30277-7_bib48","doi-asserted-by":"crossref","first-page":"1069","DOI":"10.1677\/ERC-08-0036","article-title":"Increased density of tumor-associated macrophages is associated with decreased survival in advanced thyroid cancer","volume":"15","author":"Ryder","year":"2008","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib49","doi-asserted-by":"crossref","first-page":"e22567","DOI":"10.1371\/journal.pone.0022567","article-title":"Tumor-associated macrophages (TAMs) form an interconnected cellular supportive network in anaplastic thyroid carcinoma","volume":"6","author":"Caillou","year":"2011","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30277-7_bib50","doi-asserted-by":"crossref","first-page":"111","DOI":"10.1385\/EP:13:2:111","article-title":"S-100 protein+ dendritic cells and CD34+ dendritic interstitial cells in thyroid lesions","volume":"13","author":"Batistatou","year":"2002","journal-title":"Endocr Pathol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib51","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1089\/thy.2006.0306","article-title":"Lymphocyte and immature dendritic cell infiltrates in differentiated, poorly differentiated, and undifferentiated thyroid carcinoma","volume":"17","author":"Ugolini","year":"2007","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30277-7_bib52","doi-asserted-by":"crossref","first-page":"831","DOI":"10.1016\/S0002-9440(10)64951-6","article-title":"Papillary carcinoma of the thyroid: hepatocyte growth factor (HGF) stimulates tumor cells to release chemokines active in recruiting dendritic cells","volume":"156","author":"Scarpino","year":"2000","journal-title":"Am J Pathol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib53","doi-asserted-by":"crossref","first-page":"1500","DOI":"10.18632\/oncotarget.6430","article-title":"The oncolytic virus dl922-947 reduces IL-8\/CXCL8 and MCP-1\/CCL2 expression and impairs angiogenesis and macrophage infiltration in anaplastic thyroid carcinoma","volume":"7","author":"Passaro","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/S2213-8587(16)30277-7_bib54","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1089\/thy.2015.0289","article-title":"Circulating myeloid-derived suppressor cells predict differentiated thyroid cancer diagnosis and extent","volume":"26","author":"Angell","year":"2016","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30277-7_bib55","doi-asserted-by":"crossref","first-page":"959","DOI":"10.3892\/mco.2013.170","article-title":"Immunosuppression involving increased myeloid-derived suppressor cell levels, systemic inflammation and hypoalbuminemia are present in patients with anaplastic thyroid cancer","volume":"1","author":"Suzuki","year":"2013","journal-title":"Mol Clin Oncol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib56","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1002\/cyto.b.21206","article-title":"Complexity and challenges in defining myeloid-derived suppressor cells","volume":"88","author":"Damuzzo","year":"2015","journal-title":"Cytometry B Clin Cytom"},{"key":"10.1016\/S2213-8587(16)30277-7_bib57","doi-asserted-by":"crossref","first-page":"918","DOI":"10.1111\/j.1365-2265.2012.04482.x","article-title":"Infiltration of a mixture of immune cells may be related to good prognosis in patients with differentiated thyroid carcinoma","volume":"77","author":"Cunha","year":"2012","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(16)30277-7_bib58","doi-asserted-by":"crossref","first-page":"2325","DOI":"10.1210\/jc.2009-2564","article-title":"Tumor-associated lymphocytes and increased FoxP3+ regulatory T cell frequency correlate with more aggressive papillary thyroid cancer","volume":"95","author":"French","year":"2010","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30277-7_bib59","doi-asserted-by":"crossref","first-page":"199","DOI":"10.1089\/thy.1994.4.199","article-title":"Significance of antithyroglobulin autoantibodies in differentiated thyroid carcinoma","volume":"4","author":"Kumar","year":"1994","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30277-7_bib60","doi-asserted-by":"crossref","first-page":"373","DOI":"10.1530\/acta.0.1190373","article-title":"Thyroid autoantibodies in thyroid cancer: incidence and relationship with tumour outcome","volume":"119","author":"Pacini","year":"1988","journal-title":"Acta Endocrinol (Copenh)"},{"key":"10.1016\/S2213-8587(16)30277-7_bib61","first-page":"1121","article-title":"Serum thyroglobulin autoantibodies: prevalence, influence on serum thyroglobulin measurement, and prognostic significance in patients with differentiated thyroid carcinoma","volume":"83","author":"Spencer","year":"1998","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30277-7_bib62","doi-asserted-by":"crossref","first-page":"2863","DOI":"10.1210\/jc.2015-4227","article-title":"Tumor-infiltrating T cells and the PD-1 checkpoint pathway in advanced differentiated and anaplastic thyroid cancer","volume":"101","author":"Bastman","year":"2016","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30277-7_bib63","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1038\/ni.2035","article-title":"T cell exhaustion","volume":"12","author":"Wherry","year":"2011","journal-title":"Nat Immunol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib64","doi-asserted-by":"crossref","first-page":"E934","DOI":"10.1210\/jc.2011-3428","article-title":"Programmed death-1+ T cells and regulatory T cells are enriched in tumor-involved lymph nodes and associated with aggressive features in papillary thyroid cancer","volume":"97","author":"French","year":"2012","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30277-7_bib65","doi-asserted-by":"crossref","first-page":"620","DOI":"10.1158\/2326-6066.CIR-14-0201","article-title":"PD-1+Tim-3+ CD8+ T lymphocytes display varied degrees of functional exhaustion in patients with regionally metastatic differentiated thyroid cancer","volume":"3","author":"Severson","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib66","doi-asserted-by":"crossref","first-page":"2175","DOI":"10.1084\/jem.20100637","article-title":"Upregulation of Tim-3 and PD-1 expression is associated with tumor antigen-specific CD8+ T cell dysfunction in melanoma patients","volume":"207","author":"Fourcade","year":"2010","journal-title":"J Exp Med"},{"key":"10.1016\/S2213-8587(16)30277-7_bib67","doi-asserted-by":"crossref","first-page":"e54302","DOI":"10.1371\/journal.pone.0054302","article-title":"Genetic and pharmacological targeting of CSF-1\/CSF-1R inhibits tumor-associated macrophages and impairs BRAF-induced thyroid cancer progression","volume":"8","author":"Ryder","year":"2013","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30277-7_bib68","doi-asserted-by":"crossref","first-page":"1264","DOI":"10.1038\/nm.3337","article-title":"CSF-1R inhibition alters macrophage polarization and blocks glioma progression","volume":"19","author":"Pyonteck","year":"2013","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(16)30277-7_bib69","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1038\/nature12213","article-title":"Mutational heterogeneity in cancer and the search for new cancer-associated genes","volume":"499","author":"Lawrence","year":"2013","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)30277-7_bib70","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1186\/s12885-015-1377-8","article-title":"Inhibition of colony stimulating factor-1 receptor improves antitumor efficacy of BRAF inhibition","volume":"15","author":"Mok","year":"2015","journal-title":"BMC Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib71","unstructured":"Withers S, Bornschlegl S, Bulur P, et al. Targeting tumor-associated monocytes\/macrophages (TAMs) through the CSF-1\/CSF-1R pathway restores sensitivity of advanced thyroid cancers to cytotoxic chemotherapy. Endocrine Society Annual Meeting; Boston, MA; April 1\u20134, 2016. OR45-6."},{"key":"10.1016\/S2213-8587(16)30277-7_bib72","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1016\/j.cell.2009.05.046","article-title":"CD47 is upregulated on circulating hematopoietic stem cells and leukemia cells to avoid phagocytosis","volume":"138","author":"Jaiswal","year":"2009","journal-title":"Cell"},{"key":"10.1016\/S2213-8587(16)30277-7_bib73","doi-asserted-by":"crossref","first-page":"6662","DOI":"10.1073\/pnas.1121623109","article-title":"The CD47-signal regulatory protein alpha (SIRPa) interaction is a therapeutic target for human solid tumors","volume":"109","author":"Willingham","year":"2012","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(16)30277-7_bib74","doi-asserted-by":"crossref","first-page":"18342","DOI":"10.1073\/pnas.1106550108","article-title":"CD47-signal regulatory protein-alpha (SIRPalpha) interactions form a barrier for antibody-mediated tumor cell destruction","volume":"108","author":"Zhao","year":"2011","journal-title":"Proc Natl Acad Sci USA"},{"key":"10.1016\/S2213-8587(16)30277-7_bib75","doi-asserted-by":"crossref","first-page":"e41154","DOI":"10.1371\/journal.pone.0041154","article-title":"Novel process of intrathymic tumor-immune tolerance through CCR2-mediated recruitment of Sirpalpha+ dendritic cells: a murine model","volume":"7","author":"Baba","year":"2012","journal-title":"PLoS One"},{"key":"10.1016\/S2213-8587(16)30277-7_bib76","doi-asserted-by":"crossref","first-page":"41","DOI":"10.1126\/science.1241716","article-title":"Immunology. Making macrophages eat cancer","volume":"341","author":"Kershaw","year":"2013","journal-title":"Science"},{"key":"10.1016\/S2213-8587(16)30277-7_bib77","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1038\/nm.3931","article-title":"CD47 blockade triggers T cell-mediated destruction of immunogenic tumors","volume":"21","author":"Liu","year":"2015","journal-title":"Nat Med"},{"key":"10.1016\/S2213-8587(16)30277-7_bib78","doi-asserted-by":"crossref","first-page":"921864","DOI":"10.1155\/2014\/921864","article-title":"CD8+ TIL recruitment may revert the association of MAGE A3 with aggressive features in thyroid tumors","volume":"2014","author":"Martins","year":"2014","journal-title":"J Immunol Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib79","doi-asserted-by":"crossref","first-page":"45","DOI":"10.1385\/EP:17:1:45","article-title":"Expression of MAGE tumor-associated antigen in thyroid carcinomas","volume":"17","author":"Milkovic","year":"2006","journal-title":"Endocr Pathol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib80","doi-asserted-by":"crossref","first-page":"725","DOI":"10.1089\/thy.1997.7.725","article-title":"MUC1 mucin gene, transcripts, and protein in adenomas and papillary carcinomas of the thyroid","volume":"7","author":"Bieche","year":"1997","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30277-7_bib81","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1046\/j.1365-2265.2000.01124.x","article-title":"Over-expression of hepatocyte growth factor\/scatter factor (HGF\/SF) and the HGF\/SF receptor (cMET) are associated with a high risk of metastasis and recurrence for children and young adults with papillary thyroid carcinoma","volume":"53","author":"Ramirez","year":"2000","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(16)30277-7_bib82","doi-asserted-by":"crossref","first-page":"1052","DOI":"10.1172\/JCI85271","article-title":"Genomic and transcriptomic hallmarks of poorly differentiated and anaplastic thyroid cancers","volume":"126","author":"Landa","year":"2016","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(16)30277-7_bib83","doi-asserted-by":"crossref","first-page":"2326","DOI":"10.1158\/1078-0432.CCR-11-2515","article-title":"BRAF(V600) inhibitor GSK2118436 targeted inhibition of mutant BRAF in cancer patients does not impair overall immune competency","volume":"18","author":"Hong","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib84","doi-asserted-by":"crossref","first-page":"3167","DOI":"10.1200\/JCO.2009.26.7609","article-title":"Phase I study of single-agent anti-programmed death-1 (MDX-1106) in refractory solid tumors: safety, clinical activity, pharmacodynamics, and immunologic correlates","volume":"28","author":"Brahmer","year":"2010","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib85","doi-asserted-by":"crossref","first-page":"2455","DOI":"10.1056\/NEJMoa1200694","article-title":"Safety and activity of anti-PD-L1 antibody in patients with advanced cancer","volume":"366","author":"Brahmer","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30277-7_bib86","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1056\/NEJMoa1305133","article-title":"Safety and tumor responses with lambrolizumab (anti-PD-1) in melanoma","volume":"369","author":"Hamid","year":"2013","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30277-7_bib87","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1016\/S1470-2045(15)70054-9","article-title":"Activity and safety of nivolumab, an anti-PD-1 immune checkpoint inhibitor, for patients with advanced, refractory squamous non-small-cell lung cancer (CheckMate 063): a phase 2, single-arm trial","volume":"16","author":"Rizvi","year":"2015","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib88","doi-asserted-by":"crossref","first-page":"1109","DOI":"10.1016\/S0140-6736(14)60958-2","article-title":"Anti-programmed-death-receptor-1 treatment with pembrolizumab in ipilimumab-refractory advanced melanoma: a randomised dose-comparison cohort of a phase 1 trial","volume":"384","author":"Robert","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(16)30277-7_bib89","doi-asserted-by":"crossref","first-page":"2443","DOI":"10.1056\/NEJMoa1200690","article-title":"Safety, activity, and immune correlates of anti-PD-1 antibody in cancer","volume":"366","author":"Topalian","year":"2012","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30277-7_bib90","doi-asserted-by":"crossref","first-page":"711","DOI":"10.1056\/NEJMoa1003466","article-title":"Improved survival with ipilimumab in patients with metastatic melanoma","volume":"363","author":"Hodi","year":"2010","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30277-7_bib91","unstructured":"Mehnert JM, Varga A, Brose M, et al. Pembrolizumab for advanced papillary or follicular thyroid cancer: preliminary results from the phase 1b KEYNOTE-028 study. 2016 ASCO Annual Meeting; Chicago, IL; June 3\u20137, 2016. 6091."},{"key":"10.1016\/S2213-8587(16)30277-7_bib92","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1056\/NEJM197704142961502","article-title":"Cellular immune responses in familial medullary thyroid carcinoma","volume":"296","author":"Rocklin","year":"1977","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(16)30277-7_bib93","doi-asserted-by":"crossref","first-page":"1658","DOI":"10.1002\/1097-0142(197511)36:5<1658::AID-CNCR2820360519>3.0.CO;2-0","article-title":"Medullary carcinoma of the thyroid. Cellular immune response to tumor antigen in a heritable human cancer","volume":"36","author":"George","year":"1975","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib94","doi-asserted-by":"crossref","first-page":"1481","DOI":"10.1007\/s00268-010-0484-6","article-title":"Regulatory T cells in peripheral blood, lymph node, and thyroid tissue in patients with medullary thyroid carcinoma","volume":"34","author":"Muller","year":"2010","journal-title":"World J Surg"},{"key":"10.1016\/S2213-8587(16)30277-7_bib95","doi-asserted-by":"crossref","first-page":"1585","DOI":"10.3892\/or_00000391","article-title":"Pilot trial of autologous dendritic cells loaded with tumor lysate(s) from allogeneic tumor cell lines in patients with metastatic medullary thyroid carcinoma","volume":"21","author":"Bachleitner-Hofmann","year":"2009","journal-title":"Oncol Rep"},{"key":"10.1016\/S2213-8587(16)30277-7_bib96","doi-asserted-by":"crossref","first-page":"663","DOI":"10.1007\/s00262-002-0325-z","article-title":"Calcitonin-specific antitumor immunity in medullary thyroid carcinoma following dendritic cell vaccination","volume":"51","author":"Schott","year":"2002","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/S2213-8587(16)30277-7_bib97","doi-asserted-by":"crossref","first-page":"4965","DOI":"10.1210\/jcem.86.10.7949","article-title":"Immunotherapy for medullary thyroid carcinoma by dendritic cell vaccination","volume":"86","author":"Schott","year":"2001","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30277-7_bib98","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1093\/ajcp\/95.3.300","article-title":"Medullary thyroid cancer. An immunohistochemical and humoral study using six separate antigens","volume":"95","author":"Pacini","year":"1991","journal-title":"Am J Clin Pathol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib99","doi-asserted-by":"crossref","first-page":"1705","DOI":"10.1200\/JCO.2005.04.4917","article-title":"Survival improvement in patients with medullary thyroid carcinoma who undergo pretargeted anti-carcinoembryonic-antigen radioimmunotherapy: a collaborative study with the French Endocrine Tumor Group","volume":"24","author":"Chatal","year":"2006","journal-title":"J Clin Oncol"},{"issue":"suppl 10","key":"10.1016\/S2213-8587(16)30277-7_bib100","first-page":"3190s","article-title":"Radioimmunotherapy in medullary thyroid cancer using bispecific antibody and iodine 131-labeled bivalent hapten: preliminary results of a phase I\/II clinical trial","volume":"5","author":"Kraeber-Bodere","year":"1999","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib101","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1007\/s00262-013-1505-8","article-title":"Phase I trial of a recombinant yeast-CEA vaccine (GI-6207) in adults with metastatic CEA-expressing carcinoma","volume":"63","author":"Bilusic","year":"2014","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/S2213-8587(16)30277-7_bib102","doi-asserted-by":"crossref","first-page":"597","DOI":"10.1016\/S0076-6879(05)07047-3","article-title":"Sorafenib (BAY 43-9006, Nexavar), a dual-action inhibitor that targets RAF\/MEK\/ERK pathway in tumor cells and tyrosine kinases VEGFR\/PDGFR in tumor vasculature","volume":"407","author":"Adnane","year":"2006","journal-title":"Methods Enzymol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib103","doi-asserted-by":"crossref","first-page":"638747","DOI":"10.1155\/2014\/638747","article-title":"Antitumor activity of lenvatinib (e7080): an angiogenesis inhibitor that targets multiple receptor tyrosine kinases in preclinical human thyroid cancer models","volume":"2014","author":"Tohyama","year":"2014","journal-title":"J Thyroid Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib104","doi-asserted-by":"crossref","first-page":"403","DOI":"10.1038\/nrclinonc.2016.19","article-title":"Evolving molecularly targeted therapies for advanced-stage thyroid cancers","volume":"13","author":"Bible","year":"2016","journal-title":"Nat Rev Clin Oncol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib105","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1038\/sj.bjc.6604965","article-title":"Influence of bevacizumab, sunitinib and sorafenib as single agents or in combination on the inhibitory effects of VEGF on human dendritic cell differentiation from monocytes","volume":"100","author":"Alfaro","year":"2009","journal-title":"Br J Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib106","first-page":"1755","article-title":"Clinical significance of defective dendritic cell differentiation in cancer","volume":"6","author":"Almand","year":"2000","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib107","doi-asserted-by":"crossref","first-page":"215","DOI":"10.4049\/jimmunol.174.1.215","article-title":"Differential roles of vascular endothelial growth factor receptors 1 and 2 in dendritic cell differentiation","volume":"174","author":"Dikov","year":"2005","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib108","doi-asserted-by":"crossref","first-page":"4150","DOI":"10.1182\/blood.V92.11.4150","article-title":"Vascular endothelial growth factor inhibits the development of dendritic cells and dramatically affects the differentiation of multiple hematopoietic lineages in vivo","volume":"92","author":"Gabrilovich","year":"1998","journal-title":"Blood"},{"key":"10.1016\/S2213-8587(16)30277-7_bib109","doi-asserted-by":"crossref","first-page":"70","DOI":"10.3389\/fonc.2014.00070","article-title":"Control of the immune response by pro-angiogenic factors","volume":"4","author":"Voron","year":"2014","journal-title":"Front Oncol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib110","doi-asserted-by":"crossref","first-page":"4183","DOI":"10.4049\/jimmunol.1002802","article-title":"Angiopoietin 2 stimulates TIE2-expressing monocytes to suppress T cell activation and to promote regulatory T cell expansion","volume":"186","author":"Coffelt","year":"2011","journal-title":"J Immunol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib111","doi-asserted-by":"crossref","first-page":"919","DOI":"10.1084\/jem.20050463","article-title":"Tumor cells convert immature myeloid dendritic cells into TGF-beta-secreting cells inducing CD4+CD25+ regulatory T cell proliferation","volume":"202","author":"Ghiringhelli","year":"2005","journal-title":"J Exp Med"},{"key":"10.1016\/S2213-8587(16)30277-7_bib112","doi-asserted-by":"crossref","first-page":"1123","DOI":"10.1158\/0008-5472.CAN-05-1299","article-title":"Gr-1+CD115+ immature myeloid suppressor cells mediate the development of tumor-induced T regulatory cells and T-cell anergy in tumor-bearing host","volume":"66","author":"Huang","year":"2006","journal-title":"Cancer Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib113","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1158\/0008-5472.CAN-12-2325","article-title":"VEGFA-VEGFR pathway blockade inhibits tumor-induced regulatory T-cell proliferation in colorectal cancer","volume":"73","author":"Terme","year":"2013","journal-title":"Cancer Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib114","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1007\/s00262-012-1380-8","article-title":"Immune modulation of effector CD4+ and regulatory T cell function by sorafenib in patients with hepatocellular carcinoma","volume":"62","author":"Cabrera","year":"2013","journal-title":"Cancer Immunol Immunother"},{"key":"10.1016\/S2213-8587(16)30277-7_bib115","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ijc.28362","article-title":"Sorafenib relieves cell-intrinsic and cell-extrinsic inhibitions of effector T cells in tumor microenvironment to augment antitumor immunity","volume":"134","author":"Chen","year":"2014","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib116","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1016\/j.ejca.2010.11.021","article-title":"Immunomodulatory effects of sorafenib on peripheral immune effector cells in metastatic renal cell carcinoma","volume":"47","author":"Busse","year":"2011","journal-title":"Eur J Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib117","doi-asserted-by":"crossref","first-page":"298","DOI":"10.1097\/CAD.0b013e32834ee2b1","article-title":"Sorafenib, but not sunitinib, induces regulatory T cells in the peripheral blood of patients with metastatic renal cell carcinoma","volume":"23","author":"Florcken","year":"2012","journal-title":"Anticancer Drugs"},{"key":"10.1016\/S2213-8587(16)30277-7_bib118","doi-asserted-by":"crossref","first-page":"556","DOI":"10.1007\/s12032-013-0556-1","article-title":"Changes in peripheral blood immune cells: their prognostic significance in metastatic renal cell carcinoma patients treated with molecular targeted therapy","volume":"30","author":"Kobayashi","year":"2013","journal-title":"Med Oncol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib119","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1084\/jem.20140559","article-title":"VEGF-A modulates expression of inhibitory checkpoints on CD8+ T cells in tumors","volume":"212","author":"Voron","year":"2015","journal-title":"J Exp Med"},{"key":"10.1016\/S2213-8587(16)30277-7_bib120","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1089\/thy.2014.0134","article-title":"BRAF V600E in papillary thyroid carcinoma is associated with increased programmed death ligand 1 expression and suppressive immune cell infiltration","volume":"24","author":"Angell","year":"2014","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30277-7_bib121","doi-asserted-by":"crossref","first-page":"5329","DOI":"10.1158\/1078-0432.CCR-12-1632","article-title":"Oncogenic BRAF(V600E) promotes stromal cell-mediated immunosuppression via induction of interleukin-1 in melanoma","volume":"18","author":"Khalili","year":"2012","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib122","doi-asserted-by":"crossref","first-page":"5213","DOI":"10.1158\/0008-5472.CAN-10-0118","article-title":"Selective BRAFV600E inhibition enhances T-cell recognition of melanoma without affecting lymphocyte function","volume":"70","author":"Boni","year":"2010","journal-title":"Cancer Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib123","doi-asserted-by":"crossref","first-page":"602","DOI":"10.1158\/2326-6066.CIR-15-0030","article-title":"BRAFV600E co-opts a conserved MHC Class I internalization pathway to diminish antigen presentation and CD8+ T-cell recognition of melanoma","volume":"3","author":"Bradley","year":"2015","journal-title":"Cancer Immunol Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib124","doi-asserted-by":"crossref","first-page":"1225","DOI":"10.1158\/1078-0432.CCR-12-1630","article-title":"BRAF inhibition is associated with enhanced melanoma antigen expression and a more favorable tumor microenvironment in patients with metastatic melanoma","volume":"19","author":"Frederick","year":"2013","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib125","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1172\/JCI66236","article-title":"Host immunity contributes to the anti-melanoma activity of BRAF inhibitors","volume":"123","author":"Knight","year":"2013","journal-title":"J Clin Invest"},{"key":"10.1016\/S2213-8587(16)30277-7_bib126","doi-asserted-by":"crossref","first-page":"3996","DOI":"10.18632\/oncotarget.2130","article-title":"Combined BRAF(V600E)- and SRC-inhibition induces apoptosis, evokes an immune response and reduces tumor growth in an immunocompetent orthotopic mouse model of anaplastic thyroid cancer","volume":"5","author":"Vanden Borre","year":"2014","journal-title":"Oncotarget"},{"key":"10.1016\/S2213-8587(16)30277-7_bib127","doi-asserted-by":"crossref","first-page":"17194","DOI":"10.18632\/oncotarget.7839","article-title":"Combining BRAF inhibitor and anti PD-L1 antibody dramatically improves tumor regression and anti tumor immunity in an immunocompetent murine model of anaplastic thyroid cancer","volume":"7","author":"Brauner","year":"2016","journal-title":"Oncotarget"},{"key":"10.1016\/S2213-8587(16)30277-7_bib128","doi-asserted-by":"crossref","first-page":"5064","DOI":"10.1158\/1078-0432.CCR-13-3271","article-title":"Association of PD-1, PD-1 ligands, and other features of the tumor immune microenvironment with response to anti-PD-1 therapy","volume":"20","author":"Taube","year":"2014","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib129","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1038\/nature13954","article-title":"PD-1 blockade induces responses by inhibiting adaptive immune resistance","volume":"515","author":"Tumeh","year":"2014","journal-title":"Nature"},{"key":"10.1016\/S2213-8587(16)30277-7_bib130","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.jaut.2015.07.009","article-title":"Immunogenetics of autoimmune thyroid diseases: a comprehensive review","volume":"64","author":"Lee","year":"2015","journal-title":"J Autoimmun"},{"key":"10.1016\/S2213-8587(16)30277-7_bib131","doi-asserted-by":"crossref","first-page":"197","DOI":"10.1089\/thy.1998.8.197","article-title":"Chronic thyroiditis as a favorable prognostic factor in papillary thyroid carcinoma","volume":"8","author":"Kashima","year":"1998","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(16)30277-7_bib132","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1111\/j.1365-2265.2009.03537.x","article-title":"Coexistence of chronic lymphocytic thyroiditis is associated with lower recurrence rates in patients with papillary thyroid carcinoma","volume":"71","author":"Kim","year":"2009","journal-title":"Clin Endocrinol (Oxf)"},{"key":"10.1016\/S2213-8587(16)30277-7_bib133","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1210\/jcem.84.2.5443","article-title":"Influence of lymphocytic thyroiditis on the prognostic outcome of patients with papillary thyroid carcinoma","volume":"84","author":"Loh","year":"1999","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30277-7_bib134","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1210\/jc.2013-2201","article-title":"Alemtuzumab-related thyroid dysfunction in a phase 2 trial of patients with relapsing-remitting multiple sclerosis","volume":"99","author":"Daniels","year":"2014","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(16)30277-7_bib135","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1002\/ajh.22008","article-title":"Thyroid abnormalities in patients treated with lenalidomide for hematological malignancies: results of a retrospective case review","volume":"86","author":"Figaro","year":"2011","journal-title":"Am J Hematol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib136","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1097\/00002371-199511000-00008","article-title":"Thyroid dysfunction in 281 patients with metastatic melanoma or renal carcinoma treated with interleukin-2 alone","volume":"18","author":"Krouse","year":"1995","journal-title":"J Immunother Emphasis Tumor Immunol"},{"key":"10.1016\/S2213-8587(16)30277-7_bib137","doi-asserted-by":"crossref","first-page":"661","DOI":"10.1002\/hep.21146","article-title":"The clinical and physiological spectrum of interferon-alpha induced thyroiditis: toward a new classification","volume":"43","author":"Mandac","year":"2006","journal-title":"Hepatology"},{"key":"10.1016\/S2213-8587(16)30277-7_bib138","doi-asserted-by":"crossref","first-page":"371","DOI":"10.1530\/ERC-13-0499","article-title":"Endocrine-related adverse events following ipilimumab in patients with advanced melanoma: a comprehensive retrospective review from a single institution","volume":"21","author":"Ryder","year":"2014","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib139","doi-asserted-by":"crossref","first-page":"18","DOI":"10.1186\/2051-1426-2-18","article-title":"Strategies for improving the reporting of human immunophenotypes by flow cytometry","volume":"2","author":"Gustafson","year":"2014","journal-title":"J Immunother Cancer"},{"key":"10.1016\/S2213-8587(16)30277-7_bib140","doi-asserted-by":"crossref","first-page":"4224","DOI":"10.1158\/1078-0432.CCR-15-0260","article-title":"Intratumoral CD14+ cells and circulating CD14+HLA-DRlo\/neg monocytes correlate with decreased survival in patients with clear cell renal cell carcinoma","volume":"21","author":"Gustafson","year":"2015","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(16)30277-7_bib141","doi-asserted-by":"crossref","first-page":"147","DOI":"10.3389\/fimmu.2014.00147","article-title":"Cancer vaccines in the world of immune suppressive monocytes (CD14(+)HLA-DR(lo\/neg) cells): the gateway to improved responses","volume":"5","author":"Laborde","year":"2014","journal-title":"Front Immunol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302777?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858716302777?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,9,26]],"date-time":"2020-09-26T16:48:23Z","timestamp":1601138903000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858716302777"}},"issued":{"date-parts":[[2017,6]]},"references-count":140,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2017,6]]}},"alternative-id":["S2213858716302777"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(16)30277-7","relation":{"has-review":[{"id-type":"doi","id":"10.3410\/f.726881202.793541198","asserted-by":"object"}]},"ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2017,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Leveraging the immune system to treat advanced thyroid cancers","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(16)30277-7","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2016 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T14:16:38Z","timestamp":1794492998535,"version":"4.9.1"},"reference-count":110,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2024,2,1]],"date-time":"2024-02-01T00:00:00Z","timestamp":1706745600000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/501100020895","name":"University of Toronto Temerty Faculty of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100020895","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2024,2]]},"DOI":"10.1016\/s2213-8587(23)00344-3","type":"journal-article","created":{"date-parts":[[2024,1,23]],"date-time":"2024-01-23T18:28:01Z","timestamp":1706034481000},"page":"107-118","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":127,"title":["Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100\u2008000 participants"],"prefix":"10.1016","volume":"12","author":[{"given":"David J A","family":"Jenkins","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Walter C","family":"Willett","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Salim","family":"Yusuf","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Frank B","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrea J","family":"Glenn","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Simin","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Mente","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Victoria","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shrikant I","family":"Bangdiwala","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hertzel C","family":"Gerstein","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sabina","family":"Sieri","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Pietro","family":"Ferrari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alpa V","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marjorie L","family":"McCullough","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lo\u00efc","family":"Le Marchand","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Neal D","family":"Freedman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Erikka","family":"Loftfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Rashmi","family":"Sinha","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiao-Ou","family":"Shu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mathilde","family":"Touvier","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Norie","family":"Sawada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shoichiro","family":"Tsugane","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Piet A","family":"van den Brandt","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kerem","family":"Shuval","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tauseef Ahmad","family":"Khan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melanie","family":"Paquette","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sandhya","family":"Sahye-Pudaruth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Darshna","family":"Patel","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teenie Fei Yi","family":"Siu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Korbua","family":"Srichaikul","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Cyril W C","family":"Kendall","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"John L","family":"Sievenpiper","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bashyam","family":"Balachandran","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andreea","family":"Zurbau","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xunan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Fred","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanning","family":"Yang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(23)00344-3_bib1","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0140-6736(18)31809-9","article-title":"Carbohydrate quality and human health: a series of systematic reviews and meta-analyses","volume":"393","author":"Reynolds","year":"2019","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(23)00344-3_bib2","series-title":"Carbohydrate intake for adults and children: WHO guideline","year":"2023"},{"key":"10.1016\/S2213-8587(23)00344-3_bib3","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1093\/ajcn\/34.3.362","article-title":"Glycemic index of foods: a physiological basis for carbohydrate exchange","volume":"34","author":"Jenkins","year":"1981","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib4","doi-asserted-by":"crossref","first-page":"381","DOI":"10.1007\/s11883-013-0381-1","article-title":"The role of glycemic index and glycemic load in cardiovascular disease and its risk factors: a review of the recent literature","volume":"16","author":"Mirrahimi","year":"2014","journal-title":"Curr Atheroscler Rep"},{"key":"10.1016\/S2213-8587(23)00344-3_bib5","doi-asserted-by":"crossref","first-page":"141","DOI":"10.1007\/s11886-022-01635-2","article-title":"Associations of glycemic index and glycemic load with cardiovascular disease: updated evidence from meta-analysis and cohort Studies","volume":"24","author":"Dwivedi","year":"2022","journal-title":"Curr Cardiol Rep"},{"key":"10.1016\/S2213-8587(23)00344-3_bib6","series-title":"The Newcastle\u2013Ottawa Scale (NOS) for assessing the quality of nonrandomised studies in meta-analyses","author":"Wells","year":"2021"},{"key":"10.1016\/S2213-8587(23)00344-3_bib7","series-title":"Cochrane handbook for systematic reviews of interventions","year":"2019"},{"key":"10.1016\/S2213-8587(23)00344-3_bib8","doi-asserted-by":"crossref","first-page":"2008","DOI":"10.1001\/jama.283.15.2008","article-title":"Meta-analysis of observational studies in epidemiology: a proposal for reporting. Meta-analysis Of Observational Studies in Epidemiology (MOOSE) group","volume":"283","author":"Stroup","year":"2000","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00344-3_bib9","doi-asserted-by":"crossref","first-page":"1103","DOI":"10.1677\/ERC-09-0087","article-title":"Diabetes and cancer","volume":"16","author":"Vigneri","year":"2009","journal-title":"Endocr Relat Cancer"},{"key":"10.1016\/S2213-8587(23)00344-3_bib10","doi-asserted-by":"crossref","first-page":"1674","DOI":"10.2337\/dc10-0666","article-title":"Diabetes and cancer: a consensus report","volume":"33","author":"Giovannucci","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00344-3_bib11","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.2337\/dc08-1239","article-title":"International tables of glycemic index and glycemic load values: 2008","volume":"31","author":"Atkinson","year":"2008","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00344-3_bib12","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1111\/rssa.12275","article-title":"A re-evaluation of fixed effect (s) meta-analysis","volume":"181","author":"Rice","year":"2018","journal-title":"J R Stat Soc Ser A Stat Soc"},{"key":"10.1016\/S2213-8587(23)00344-3_bib13","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/0197-2456(86)90046-2","article-title":"Meta-analysis in clinical trials","volume":"7","author":"DerSimonian","year":"1986","journal-title":"Control Clin Trials"},{"key":"10.1016\/S2213-8587(23)00344-3_bib14","doi-asserted-by":"crossref","first-page":"3153","DOI":"10.1002\/sim.1262","article-title":"A simple confidence interval for meta-analysis","volume":"21","author":"Sidik","year":"2002","journal-title":"Stat Med"},{"key":"10.1016\/S2213-8587(23)00344-3_bib15","doi-asserted-by":"crossref","first-page":"1294","DOI":"10.1016\/j.jclinepi.2011.03.017","article-title":"GRADE guidelines: 7. Rating the quality of evidence\u2013inconsistency","volume":"64","author":"Guyatt","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib16","doi-asserted-by":"crossref","first-page":"268","DOI":"10.7326\/M16-2607","article-title":"Sensitivity analysis in observational research: introducing the E-value","volume":"167","author":"VanderWeele","year":"2017","journal-title":"Ann Intern Med"},{"key":"10.1016\/S2213-8587(23)00344-3_bib17","doi-asserted-by":"crossref","first-page":"1309S","DOI":"10.1093\/ajcn\/69.6.1309S","article-title":"Causal criteria in nutritional epidemiology","volume":"69","author":"Potischman","year":"1999","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib18","doi-asserted-by":"crossref","first-page":"1088","DOI":"10.2307\/2533446","article-title":"Operating characteristics of a rank correlation test for publication bias","volume":"50","author":"Begg","year":"1994","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(23)00344-3_bib19","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00344-3_bib20","doi-asserted-by":"crossref","first-page":"455","DOI":"10.1111\/j.0006-341X.2000.00455.x","article-title":"Trim and fill: a simple funnel-plot-based method of testing and adjusting for publication bias in meta-analysis","volume":"56","author":"Duval","year":"2000","journal-title":"Biometrics"},{"key":"10.1016\/S2213-8587(23)00344-3_bib21","doi-asserted-by":"crossref","first-page":"1579","DOI":"10.1177\/0962280218773122","article-title":"One-stage dose-response meta-analysis for aggregated data","volume":"28","author":"Crippa","year":"2019","journal-title":"Stat Methods Med Res"},{"key":"10.1016\/S2213-8587(23)00344-3_bib22","series-title":"Regression modeling strategies: with applications to linear models, logistic regression, and survival analysis","author":"Harrell","year":"2001"},{"key":"10.1016\/S2213-8587(23)00344-3_bib23","doi-asserted-by":"crossref","first-page":"994","DOI":"10.3945\/an.116.013052","article-title":"Perspective: NutriGrade: a scoring system to assess and judge the meta-evidence of randomized controlled trials and cohort studies in nutrition research","volume":"7","author":"Schwingshackl","year":"2016","journal-title":"Adv Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib24","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/j.jclinepi.2010.07.015","article-title":"GRADE guidelines: 3. Rating the quality of evidence","volume":"64","author":"Balshem","year":"2011","journal-title":"J Clin Epidemiol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib25","author":"Sch\u00fcnemann"},{"key":"10.1016\/S2213-8587(23)00344-3_bib26","doi-asserted-by":"crossref","first-page":"1385","DOI":"10.1093\/ajcn\/nqab124","article-title":"Grading nutrition evidence: where to go from here?","volume":"113","author":"Tobias","year":"2021","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib27","first-page":"583","article-title":"Glycemic index and glycemic load and risk of colorectal cancer: a population-based cohort study (JPHC Study)","volume":"27","author":"Abe","year":"2016","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(23)00344-3_bib28","doi-asserted-by":"crossref","first-page":"218","DOI":"10.3945\/ajcn.113.079533","article-title":"Glycemic index, glycemic load, and risk of type 2 diabetes: results from 3 large US cohorts and an updated meta-analysis","volume":"100","author":"Bhupathiraju","year":"2014","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib29","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1093\/aje\/kwt222","article-title":"Dietary carbohydrate intake, glycemic index, and glycemic load and endometrial cancer risk: a prospective cohort study","volume":"179","author":"Coleman","year":"2014","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib30","doi-asserted-by":"crossref","first-page":"978","DOI":"10.1158\/1055-9965.EPI-10-1089","article-title":"Dietary fat, fiber, and carbohydrate intake in relation to risk of endometrial cancer","volume":"20","author":"Cui","year":"2011","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(23)00344-3_bib31","doi-asserted-by":"crossref","first-page":"912","DOI":"10.1093\/aje\/kwm161","article-title":"Dietary carbohydrates, glycemic index, glycemic load, and endometrial cancer risk within the European Prospective Investigation into Cancer and Nutrition cohort","volume":"166","author":"Cust","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib32","doi-asserted-by":"crossref","first-page":"1111","DOI":"10.1158\/1055-9965.EPI-14-1401","article-title":"Adolescent and early adulthood dietary carbohydrate quantity and quality in relation to breast cancer risk","volume":"24","author":"Farvid","year":"2015","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(23)00344-3_bib33","doi-asserted-by":"crossref","first-page":"543","DOI":"10.1093\/annonc\/mds434","article-title":"Glycemic index, glycemic load, dietary carbohydrate, and dietary fiber intake and risk of liver and biliary tract cancers in Western Europeans","volume":"24","author":"Fedirko","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib34","doi-asserted-by":"crossref","first-page":"462","DOI":"10.1093\/aje\/kwn347","article-title":"Dietary glycemic index, glycemic load, and risk of cancer: a prospective cohort study","volume":"169","author":"George","year":"2009","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib35","doi-asserted-by":"crossref","first-page":"1991","DOI":"10.1056\/NEJMoa055317","article-title":"Low-carbohydrate-diet score and the risk of coronary heart disease in women","volume":"355","author":"Halton","year":"2006","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00344-3_bib36","doi-asserted-by":"crossref","first-page":"113","DOI":"10.1158\/1055-9965.EPI-17-0964","article-title":"Dietary energy density, glycemic load, glycemic index, and risk for endometrial cancer in the CPS-II nutrition cohort","volume":"27","author":"Hartman","year":"2018","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(23)00344-3_bib37","doi-asserted-by":"crossref","first-page":"732","DOI":"10.1093\/aje\/kwh112","article-title":"Dietary carbohydrates, fiber, and breast cancer risk","volume":"159","author":"Holmes","year":"2004","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib38","doi-asserted-by":"crossref","first-page":"68","DOI":"10.3945\/jn.109.112441","article-title":"Dietary fiber, magnesium, and glycemic load alter risk of type 2 diabetes in a multiethnic cohort in Hawaii","volume":"140","author":"Hopping","year":"2010","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib39","doi-asserted-by":"crossref","first-page":"4607","DOI":"10.1007\/s00394-021-02621-0","article-title":"Dietary glycemic index, glycemic load and mortality: Japan Public Health Center-based prospective study","volume":"60","author":"Huang","year":"2021","journal-title":"Eur J Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib40","doi-asserted-by":"crossref","first-page":"1312","DOI":"10.1056\/NEJMoa2007123","article-title":"Glycemic index, glycemic load, and cardiovascular disease and mortality","volume":"384","author":"Jenkins","year":"2021","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(23)00344-3_bib41","doi-asserted-by":"crossref","first-page":"1144","DOI":"10.1158\/1055-9965.EPI-08-1135","article-title":"Glycemic index, carbohydrates, glycemic load, and the risk of pancreatic cancer in a prospective cohort study","volume":"18","author":"Jiao","year":"2009","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(23)00344-3_bib42","doi-asserted-by":"crossref","first-page":"1229","DOI":"10.1158\/1055-9965.EPI-20-1478","article-title":"Dietary patterns of insulinemia, inflammation and glycemia, and pancreatic cancer risk: findings from the Women's Health Initiative","volume":"30","author":"Jin","year":"2021","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(23)00344-3_bib43","doi-asserted-by":"crossref","first-page":"707","DOI":"10.2337\/dc20-2216","article-title":"Insulinemic and inflammatory dietary patterns show enhanced predictive potential for type 2 diabetes risk in postmenopausal women","volume":"44","author":"Jin","year":"2021","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00344-3_bib44","first-page":"573","article-title":"Dietary glycemic index, glycemic load, and risk of incident breast cancer in postmenopausal women","volume":"12","author":"Jonas","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(23)00344-3_bib45","first-page":"1291","article-title":"Dietary carbohydrate, glycemic index, and glycemic load in relation to colorectal cancer risk in the Women's Health Initiative","volume":"19","author":"Kabat","year":"2008","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(23)00344-3_bib46","doi-asserted-by":"crossref","first-page":"101","DOI":"10.3945\/ajcn.110.003053","article-title":"Dietary glycemic load and risk of colorectal cancer in Chinese women","volume":"93","author":"Li","year":"2011","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib47","doi-asserted-by":"crossref","first-page":"1455","DOI":"10.1093\/ajcn\/71.6.1455","article-title":"A prospective study of dietary glycemic load, carbohydrate intake, and risk of coronary heart disease in US women","volume":"71","author":"Liu","year":"2000","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib48","doi-asserted-by":"crossref","first-page":"1870","DOI":"10.14309\/ajg.0000000000000450","article-title":"Type 2 diabetes prevention diet and hepatocellular carcinoma risk in US men and women","volume":"114","author":"Luo","year":"2019","journal-title":"Am J Gastroenterol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib49","doi-asserted-by":"crossref","first-page":"1174","DOI":"10.1093\/aje\/kwq061","article-title":"Available carbohydrates, glycemic load, and pancreatic cancer: is there a link?","volume":"171","author":"Meinhold","year":"2010","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib50","doi-asserted-by":"crossref","first-page":"1293","DOI":"10.1093\/jnci\/94.17.1293","article-title":"Dietary sugar, glycemic load, and pancreatic cancer risk in a prospective study","volume":"94","author":"Michaud","year":"2002","journal-title":"J Natl Cancer Inst"},{"key":"10.1016\/S2213-8587(23)00344-3_bib51","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1158\/1055-9965.138.14.1","article-title":"Dietary glycemic load, carbohydrate, sugar, and colorectal cancer risk in men and women","volume":"14","author":"Michaud","year":"2005","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(23)00344-3_bib52","doi-asserted-by":"crossref","first-page":"1597","DOI":"10.1093\/jn\/nxab011","article-title":"Glycemic index, glycemic load, and risk of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort","volume":"151","author":"Mongiovi","year":"2021","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib53","first-page":"51","article-title":"Dietary glycemic index, glycemic load, insulin index, fiber and whole-grain intake in relation to risk of prostate cancer","volume":"22","author":"Nimptsch","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(23)00344-3_bib54","doi-asserted-by":"crossref","first-page":"1495","DOI":"10.1093\/ajcn\/86.5.1495","article-title":"Dietary glycemic load, added sugars, and carbohydrates as risk factors for pancreatic cancer: the Multiethnic Cohort Study","volume":"86","author":"N\u00f6thlings","year":"2007","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib55","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1186\/1475-2891-12-165","article-title":"Dietary glycemic index, glycemic load and incidence of type 2 diabetes in Japanese men and women: the Japan Public Health Center-based Prospective Study","volume":"12","author":"Oba","year":"2013","journal-title":"Nutr J"},{"key":"10.1016\/S2213-8587(23)00344-3_bib56","first-page":"287","article-title":"Glycemic load, glycemic index, and carbohydrate intake in relation to pancreatic cancer risk in a large US cohort","volume":"18","author":"Patel","year":"2007","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(23)00344-3_bib57","doi-asserted-by":"crossref","DOI":"10.3389\/fnut.2023.1073373","article-title":"Dietary glycemic index, glycemic load, and renal cancer risk: findings from prostate, lung, colorectal, and ovarian cancer trial","volume":"10","author":"Qi","year":"2023","journal-title":"Front Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib58","doi-asserted-by":"crossref","first-page":"345","DOI":"10.3945\/ajcn.111.026724","article-title":"Dietary glycemic index and glycemic load and breast cancer risk in the European Prospective Investigation into Cancer and Nutrition (EPIC)","volume":"96","author":"Romieu","year":"2012","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib59","first-page":"995","article-title":"Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort","volume":"22","author":"Shikany","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(23)00344-3_bib60","doi-asserted-by":"crossref","first-page":"899","DOI":"10.1080\/01635581.2011.587227","article-title":"Dietary glycemic load, glycemic index, and carbohydrate and risk of breast cancer in the Women's Health Initiative","volume":"63","author":"Shikany","year":"2011","journal-title":"Nutr Cancer"},{"key":"10.1016\/S2213-8587(23)00344-3_bib61","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1093\/ajcn\/nqaa157","article-title":"Glycemic index, glycemic load, and risk of coronary heart disease: a pan-European cohort study","volume":"112","author":"Sieri","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib62","doi-asserted-by":"crossref","first-page":"671","DOI":"10.1080\/01635581.2018.1460675","article-title":"Dietary glycemic load, glycemic index, and carbohydrate intake on the risk of lung cancer among men and women in Shanghai","volume":"70","author":"Sun","year":"2018","journal-title":"Nutr Cancer"},{"key":"10.1016\/S2213-8587(23)00344-3_bib63","doi-asserted-by":"crossref","first-page":"87","DOI":"10.1016\/j.lungcan.2021.03.009","article-title":"Role of dietary carbohydrates on risk of lung cancer","volume":"155","author":"Tao","year":"2021","journal-title":"Lung Cancer"},{"key":"10.1016\/S2213-8587(23)00344-3_bib64","doi-asserted-by":"crossref","first-page":"2310","DOI":"10.1001\/archinte.167.21.2310","article-title":"Prospective study of dietary carbohydrates, glycemic index, glycemic load, and incidence of type 2 diabetes mellitus in middle-aged Chinese women","volume":"167","author":"Villegas","year":"2007","journal-title":"Arch Intern Med"},{"key":"10.1016\/S2213-8587(23)00344-3_bib65","doi-asserted-by":"crossref","first-page":"238","DOI":"10.1093\/annonc\/mds287","article-title":"Dietary glycemic load, glycemic index, and carbohydrates on the risk of primary liver cancer among Chinese women and men","volume":"24","author":"Vogtmann","year":"2013","journal-title":"Ann Oncol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib66","doi-asserted-by":"crossref","first-page":"3682","DOI":"10.1111\/cas.14997","article-title":"Dietary glycemic index, glycemic load, and endometrial cancer risk: The Japan Public Health Center-based Prospective Study","volume":"112","author":"Watanabe","year":"2021","journal-title":"Cancer Sci"},{"key":"10.1016\/S2213-8587(23)00344-3_bib67","doi-asserted-by":"crossref","first-page":"283","DOI":"10.3945\/ajcn.2008.26356","article-title":"Dietary carbohydrates, fiber, and breast cancer risk in Chinese women","volume":"89","author":"Wen","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib68","doi-asserted-by":"crossref","first-page":"1041","DOI":"10.1007\/s00394-020-02313-1","article-title":"Dietary glycemic index, glycemic load and risk of bladder cancer: a prospective study","volume":"60","author":"Xu","year":"2021","journal-title":"Eur J Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib69","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.3945\/ajcn.115.129379","article-title":"Dietary glycemic index, glycemic load, and refined carbohydrates are associated with risk of stroke: a prospective cohort study in urban Chinese women","volume":"104","author":"Yu","year":"2016","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib70","doi-asserted-by":"crossref","first-page":"1542","DOI":"10.1093\/aje\/kwt178","article-title":"Dietary carbohydrates, refined grains, glycemic load, and risk of coronary heart disease in Chinese adults","volume":"178","author":"Yu","year":"2013","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib71","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1002\/ijc.29693","article-title":"Energy and macronutrient intake and risk of differentiated thyroid carcinoma in the European Prospective Investigation into Cancer and Nutrition study","volume":"138","author":"Zamora-Ros","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(23)00344-3_bib72","doi-asserted-by":"crossref","first-page":"1142","DOI":"10.1038\/s41430-022-01083-9","article-title":"Dietary glycemic index, glycemic load, and cause-specific mortality: two population-based prospective cohort studies","volume":"76","author":"Zhao","year":"2022","journal-title":"Eur J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib73","doi-asserted-by":"crossref","first-page":"1074","DOI":"10.1093\/ajcn\/88.4.1074","article-title":"The association of glycemic load and carbohydrate intake with colorectal cancer risk in the Multiethnic Cohort Study","volume":"88","author":"Howarth","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib74","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1093\/aje\/kwi026","article-title":"Carbohydrate intake, glycemic index, glycemic load, and dietary fiber in relation to risk of stroke in women","volume":"161","author":"Oh","year":"2005","journal-title":"Am J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib75","doi-asserted-by":"crossref","first-page":"257","DOI":"10.1093\/ajcn\/nqx060","article-title":"Carbohydrate quality and quantity and risk of coronary heart disease among US women and men","volume":"107","author":"AlEssa","year":"2018","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib76","doi-asserted-by":"crossref","first-page":"1543","DOI":"10.3945\/ajcn.115.116558","article-title":"Carbohydrate quality and quantity and risk of type 2 diabetes in US women","volume":"102","author":"AlEssa","year":"2015","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib77","first-page":"1153","article-title":"Premenopausal dietary carbohydrate, glycemic index, glycemic load, and fiber in relation to risk of breast cancer","volume":"12","author":"Cho","year":"2003","journal-title":"Cancer Epidemiol Biomarkers Prev"},{"key":"10.1016\/S2213-8587(23)00344-3_bib78","doi-asserted-by":"crossref","first-page":"1036","DOI":"10.3945\/ajcn.112.045351","article-title":"Intake of fiber and fiber-rich plant foods is associated with a lower risk of renal cell carcinoma in a large US cohort","volume":"97","author":"Daniel","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib79","doi-asserted-by":"crossref","first-page":"335","DOI":"10.1007\/s10549-016-3910-0","article-title":"Lifetime grain consumption and breast cancer risk","volume":"159","author":"Farvid","year":"2016","journal-title":"Breast Cancer Res Treat"},{"key":"10.1016\/S2213-8587(23)00344-3_bib80","doi-asserted-by":"crossref","first-page":"344","DOI":"10.3945\/ajcn.112.034025","article-title":"Dietary fiber intake and risk of hormonal receptor-defined breast cancer in the European Prospective Investigation into Cancer and Nutrition study","volume":"97","author":"Ferrari","year":"2013","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib81","doi-asserted-by":"crossref","first-page":"3040","DOI":"10.1002\/ijc.32382","article-title":"Dietary intake of fiber, whole grains and risk of colorectal cancer: an updated analysis according to food sources, tumor location and molecular subtypes in two large US cohorts","volume":"145","author":"He","year":"2019","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(23)00344-3_bib82","article-title":"Intake of whole grain foods and risk of type 2 diabetes: results from three prospective cohort studies","volume":"370","author":"Hu","year":"2020","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00344-3_bib83","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12916-022-02396-z","article-title":"Intake of whole grain foods and risk of coronary heart disease in US men and women","volume":"20","author":"Hu","year":"2022","journal-title":"BMC Med"},{"key":"10.1016\/S2213-8587(23)00344-3_bib84","doi-asserted-by":"crossref","first-page":"603","DOI":"10.1093\/ajcn\/nqaa161","article-title":"Whole grain and dietary fiber intake and risk of colorectal cancer in the NIH-AARP Diet and Health Study cohort","volume":"112","author":"Hullings","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib85","doi-asserted-by":"crossref","first-page":"1027","DOI":"10.1093\/ajcn\/nqaa002","article-title":"Dietary fiber intake and total and cause-specific mortality: the Japan Public Health Center-based prospective study","volume":"111","author":"Katagiri","year":"2020","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib86","first-page":"1405","article-title":"Dietary fiber and grain consumption in relation to head and neck cancer in the NIH-AARP Diet and Health Study","volume":"22","author":"Lam","year":"2011","journal-title":"Cancer Causes Control"},{"key":"10.1016\/S2213-8587(23)00344-3_bib87","doi-asserted-by":"crossref","first-page":"3223","DOI":"10.1093\/jn\/nxab241","article-title":"Adolescent plant product intake in relation to later prostate cancer risk and mortality in the NIH-AARP diet and health study","volume":"151","author":"Lan","year":"2021","journal-title":"J Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib88","doi-asserted-by":"crossref","first-page":"1742","DOI":"10.2337\/dc22-0368","article-title":"Dietary protein sources, mediating biomarkers, and incidence of type 2 diabetes: findings from the Women's Health Initiative and the UK Biobank","volume":"45","author":"Li","year":"2022","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00344-3_bib89","doi-asserted-by":"crossref","first-page":"478","DOI":"10.1093\/carcin\/bgz187","article-title":"Dietary fiber intake and the risk of bladder cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cohort","volume":"41","author":"Luo","year":"2020","journal-title":"Carcinogenesis"},{"key":"10.1016\/S2213-8587(23)00344-3_bib90","doi-asserted-by":"crossref","first-page":"779","DOI":"10.3390\/nu8120779","article-title":"The interaction between dietary fiber and fat and risk of colorectal cancer in the Women's Health Initiative","volume":"8","author":"Navarro","year":"2016","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(23)00344-3_bib91","doi-asserted-by":"crossref","first-page":"1475","DOI":"10.1002\/ijc.22007","article-title":"Dietary fiber intake and subsequent risk of colorectal cancer: the Japan Public Health Center-based prospective study","volume":"119","author":"Otani","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(23)00344-3_bib92","doi-asserted-by":"crossref","first-page":"1241","DOI":"10.1002\/ijc.30172","article-title":"Inverse associations of dietary fiber and menopausal hormone therapy with colorectal cancer risk in the Multiethnic Cohort Study","volume":"139","author":"Park","year":"2016","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(23)00344-3_bib93","doi-asserted-by":"crossref","first-page":"212","DOI":"10.1093\/ije\/dyaa155","article-title":"Plant foods, dietary fibre and risk of ischaemic heart disease in the European Prospective Investigation into Cancer and Nutrition (EPIC) cohort","volume":"50","author":"Perez-Cornago","year":"2021","journal-title":"Int J Epidemiol"},{"key":"10.1016\/S2213-8587(23)00344-3_bib94","doi-asserted-by":"crossref","first-page":"2938","DOI":"10.1002\/ijc.22196","article-title":"Dietary intake of calcium, fiber and other micronutrients in relation to colorectal cancer risk: results from the Shanghai Women's Health Study","volume":"119","author":"Shin","year":"2006","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(23)00344-3_bib95","article-title":"Associations of cereal grains intake with cardiovascular disease and mortality across 21 countries in Prospective Urban and Rural Epidemiology study: prospective cohort study","volume":"372","author":"Swaminathan","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00344-3_bib96","doi-asserted-by":"crossref","first-page":"2037","DOI":"10.1001\/jama.1992.03490150089030","article-title":"Dietary fat and fiber in relation to risk of breast cancer. An 8-year follow-up","volume":"268","author":"Willett","year":"1992","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00344-3_bib97","doi-asserted-by":"crossref","first-page":"664","DOI":"10.3945\/ajcn.2009.27758","article-title":"Dietary fiber intake and risk of breast cancer in postmenopausal women: the National Institutes of Health-AARP Diet and Health Study","volume":"90","author":"Park","year":"2009","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib98","doi-asserted-by":"crossref","first-page":"701","DOI":"10.2337\/diabetes.53.3.701","article-title":"Effect of postprandial hypertriglyceridemia and hyperglycemia on circulating adhesion molecules and oxidative stress generation and the possible role of simvastatin treatment","volume":"53","author":"Ceriello","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/S2213-8587(23)00344-3_bib99","doi-asserted-by":"crossref","first-page":"1098","DOI":"10.1001\/jamainternmed.2018.2933","article-title":"The carbohydrate-insulin model of obesity: beyond \u201ccalories in, calories out\u201d","volume":"178","author":"Ludwig","year":"2018","journal-title":"JAMA Intern Med"},{"key":"10.1016\/S2213-8587(23)00344-3_bib100","doi-asserted-by":"crossref","first-page":"1439","DOI":"10.2337\/diacare.25.8.1439","article-title":"Role of hyperglycemia in nitrotyrosine postprandial generation","volume":"25","author":"Ceriello","year":"2002","journal-title":"Diabetes Care"},{"key":"10.1016\/S2213-8587(23)00344-3_bib101","doi-asserted-by":"crossref","first-page":"1681","DOI":"10.1001\/jama.295.14.1681","article-title":"Activation of oxidative stress by acute glucose fluctuations compared with sustained chronic hyperglycemia in patients with type 2 diabetes","volume":"295","author":"Monnier","year":"2006","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00344-3_bib102","doi-asserted-by":"crossref","first-page":"655","DOI":"10.1097\/00004872-200018060-00002","article-title":"Role of oxidative stress in cardiovascular diseases","volume":"18","author":"Dhalla","year":"2000","journal-title":"J Hypertens"},{"key":"10.1016\/S2213-8587(23)00344-3_bib103","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1093\/ajcn\/87.1.114","article-title":"The Canadian Trial of Carbohydrates in Diabetes (CCD), a 1-y controlled trial of low-glycemic-index dietary carbohydrate in type 2 diabetes: no effect on glycated hemoglobin but reduction in C-reactive protein","volume":"87","author":"Wolever","year":"2008","journal-title":"Am J Clin Nutr"},{"key":"10.1016\/S2213-8587(23)00344-3_bib104","doi-asserted-by":"crossref","first-page":"1603","DOI":"10.1016\/j.freeradbiomed.2010.09.006","article-title":"Oxidative stress, inflammation, and cancer: how are they linked?","volume":"49","author":"Reuter","year":"2010","journal-title":"Free Radic Biol Med"},{"key":"10.1016\/S2213-8587(23)00344-3_bib105","doi-asserted-by":"crossref","first-page":"472","DOI":"10.1001\/jama.1997.03540300040031","article-title":"Dietary fiber, glycemic load, and risk of non-insulin-dependent diabetes mellitus in women","volume":"277","author":"Salmer\u00f3n","year":"1997","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00344-3_bib106","article-title":"Dietary glycemic index and load and the risk of type 2 diabetes: a systematic review and updated meta-analyses of prospective cohort studies","volume":"11","author":"Livesey","year":"2019","journal-title":"Nutrients"},{"key":"10.1016\/S2213-8587(23)00344-3_bib107","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2021.46705","article-title":"Evaluation of the quality of evidence of the association of foods and nutrients with cardiovascular disease and diabetes: a systematic review","volume":"5","author":"Miller","year":"2022","journal-title":"JAMA Netw Open"},{"key":"10.1016\/S2213-8587(23)00344-3_bib108","article-title":"Effect of low glycaemic index or load dietary patterns on glycaemic control and cardiometabolic risk factors in diabetes: systematic review and meta-analysis of randomised controlled trials","volume":"374","author":"Chiavaroli","year":"2021","journal-title":"BMJ"},{"key":"10.1016\/S2213-8587(23)00344-3_bib109","doi-asserted-by":"crossref","first-page":"486","DOI":"10.1001\/jama.290.4.486","article-title":"Acarbose treatment and the risk of cardiovascular disease and hypertension in patients with impaired glucose tolerance: the STOP-NIDDM trial","volume":"290","author":"Chiasson","year":"2003","journal-title":"JAMA"},{"key":"10.1016\/S2213-8587(23)00344-3_bib110","doi-asserted-by":"crossref","first-page":"877","DOI":"10.1016\/S2213-8587(17)30309-1","article-title":"Effects of acarbose on cardiovascular and diabetes outcomes in patients with coronary heart disease and impaired glucose tolerance (ACE): a randomised, double-blind, placebo-controlled trial","volume":"5","author":"Holman","year":"2017","journal-title":"Lancet Diabetes Endocrinol"}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003443?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858723003443?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:12:58Z","timestamp":1761991978000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858723003443"}},"issued":{"date-parts":[[2024,2]]},"references-count":110,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2024,2]]}},"alternative-id":["S2213858723003443"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(23)00344-3","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2024,2]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Association of glycaemic index and glycaemic load with type 2 diabetes, cardiovascular disease, cancer, and all-cause mortality: a meta-analysis of mega cohorts of more than 100\u2008000 participants","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00344-3","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(23)00365-0","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]},{"indexed":{"date-parts":[[2026,11,14]],"date-time":"2026-11-14T07:35:03Z","timestamp":1794641703653,"version":"4.9.1"},"reference-count":28,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2021,8,1]],"date-time":"2021-08-01T00:00:00Z","timestamp":1627776000000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100000002","name":"National Institutes of Health","doi-asserted-by":"publisher","award":["R01CA242845"],"award-info":[{"award-number":["R01CA242845"]}],"id":[{"id":"10.13039\/100000002","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100007313","name":"University of Texas MD Anderson Cancer Center","doi-asserted-by":"publisher","award":["P30 CA016672"],"award-info":[{"award-number":["P30 CA016672"]}],"id":[{"id":"10.13039\/100007313","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","thelancet.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["The Lancet Diabetes &amp; Endocrinology"],"published-print":{"date-parts":[[2021,8]]},"DOI":"10.1016\/s2213-8587(21)00120-0","type":"journal-article","created":{"date-parts":[[2021,6,9]],"date-time":"2021-06-09T18:40:29Z","timestamp":1623264029000},"page":"491-501","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":351,"title":["Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1\/2 study"],"prefix":"10.1016","volume":"9","author":[{"given":"Vivek","family":"Subbiah","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mimi I","family":"Hu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lori J","family":"Wirth","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Schuler","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Aaron S","family":"Mansfield","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Giuseppe","family":"Curigliano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Marcia S","family":"Brose","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Viola W","family":"Zhu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sophie","family":"Leboulleux","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daniel W","family":"Bowles","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christina S","family":"Baik","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Douglas","family":"Adkins","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bhumsuk","family":"Keam","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ignacio","family":"Matos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elena","family":"Garralda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Justin F","family":"Gainor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Gilberto","family":"Lopes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Chi","family":"Lin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yann","family":"Godbert","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Debashis","family":"Sarker","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephen G","family":"Miller","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Corinne","family":"Clifford","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hui","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christopher D","family":"Turner","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthew H","family":"Taylor","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/S2213-8587(21)00120-0_bib1","doi-asserted-by":"crossref","first-page":"49","DOI":"10.3892\/ol.2010.223","article-title":"Medullary thyroid carcinoma: The third most common thyroid cancer reviewed","volume":"2","author":"Stamatakos","year":"2011","journal-title":"Oncol Lett"},{"key":"10.1016\/S2213-8587(21)00120-0_bib2","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1016\/j.cancergen.2018.11.002","article-title":"Novel rearrangements involving the RET gene in papillary thyroid carcinoma","volume":"230","author":"Staubitz","year":"2019","journal-title":"Cancer Genet"},{"key":"10.1016\/S2213-8587(21)00120-0_bib3","doi-asserted-by":"crossref","first-page":"567","DOI":"10.1089\/thy.2014.0335","article-title":"Revised American Thyroid Association guidelines for the management of medullary thyroid carcinoma","volume":"25","author":"Wells","year":"2015","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00120-0_bib4","doi-asserted-by":"crossref","first-page":"2134","DOI":"10.1002\/cncr.22244","article-title":"Prognosis of medullary thyroid carcinoma: demographic, clinical, and pathologic predictors of survival in 1252 cases","volume":"107","author":"Roman","year":"2006","journal-title":"Cancer"},{"key":"10.1016\/S2213-8587(21)00120-0_bib5","doi-asserted-by":"crossref","first-page":"1988","DOI":"10.1158\/1078-0432.CCR-16-1679","article-title":"RET aberrations in diverse cancers: next-generation sequencing of 4,871 patients","volume":"23","author":"Kato","year":"2017","journal-title":"Clin Cancer Res"},{"key":"10.1016\/S2213-8587(21)00120-0_bib6","doi-asserted-by":"crossref","first-page":"936","DOI":"10.1210\/en.2006-0921","article-title":"RET\/PTC rearrangements and BRAF mutations in thyroid tumorigenesis","volume":"148","author":"Ciampi","year":"2007","journal-title":"Endocrinology"},{"key":"10.1016\/S2213-8587(21)00120-0_bib7","doi-asserted-by":"crossref","first-page":"618","DOI":"10.2174\/138920211798120835","article-title":"Genetic alterations in medullary thyroid cancer: diagnostic and prognostic markers","volume":"12","author":"Taccaliti","year":"2011","journal-title":"Curr Genomics"},{"key":"10.1016\/S2213-8587(21)00120-0_bib8","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1158\/2159-8290.CD-18-0338","article-title":"Precision targeted therapy with BLU-667 for RET-driven cancers","volume":"8","author":"Subbiah","year":"2018","journal-title":"Cancer Discov"},{"issue":"suppl 1","key":"10.1016\/S2213-8587(21)00120-0_bib9","doi-asserted-by":"crossref","first-page":"77","DOI":"10.6061\/clinics\/2012(Sup01)14","article-title":"Molecular mechanisms of RET receptor-mediated oncogenesis in multiple endocrine neoplasia 2","volume":"67","author":"Wagner","year":"2012","journal-title":"Clinics (S\u00e3o Paulo)"},{"key":"10.1016\/S2213-8587(21)00120-0_bib10","doi-asserted-by":"crossref","first-page":"498","DOI":"10.1158\/2159-8290.CD-19-1116","article-title":"Advances in targeting RET-dependent cancers","volume":"10","author":"Subbiah","year":"2020","journal-title":"Cancer Discov"},{"key":"10.1016\/S2213-8587(21)00120-0_bib11","doi-asserted-by":"crossref","first-page":"62","DOI":"10.1002\/1097-0215(20010120)95:1<62::AID-IJC1011>3.0.CO;2-1","article-title":"Prognostic value of codon 918 (ATG\u2013>ACG) RET proto-oncogene mutations in sporadic medullary thyroid carcinoma","volume":"95","author":"Schilling","year":"2001","journal-title":"Int J Cancer"},{"key":"10.1016\/S2213-8587(21)00120-0_bib12","doi-asserted-by":"crossref","first-page":"682","DOI":"10.1210\/jc.2007-1714","article-title":"Prognostic significance of somatic RET oncogene mutations in sporadic medullary thyroid cancer: a 10-year follow-up study","volume":"93","author":"Elisei","year":"2008","journal-title":"J Clin Endocrinol Metab"},{"key":"10.1016\/S2213-8587(21)00120-0_bib13","doi-asserted-by":"crossref","first-page":"E424","DOI":"10.3390\/genes11040424","article-title":"RET Gene Fusions in Malignancies of the Thyroid and Other Tissues","volume":"11","author":"Santoro","year":"2020","journal-title":"Genes (Basel)"},{"key":"10.1016\/S2213-8587(21)00120-0_bib14","doi-asserted-by":"crossref","first-page":"833","DOI":"10.1111\/j.1365-2559.2012.04276.x","article-title":"RET\/PTC rearrangement is prevalent in follicular H\u00fcrthle cell carcinomas","volume":"61","author":"de Vries","year":"2012","journal-title":"Histopathology"},{"key":"10.1016\/S2213-8587(21)00120-0_bib15","doi-asserted-by":"crossref","first-page":"1209","DOI":"10.1200\/JCO.19.02551","article-title":"State-of-the-art strategies for targeting RET-dependent cancers","volume":"38","author":"Subbiah","year":"2020","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(21)00120-0_bib17","doi-asserted-by":"crossref","first-page":"3639","DOI":"10.1200\/JCO.2012.48.4659","article-title":"Cabozantinib in progressive medullary thyroid cancer","volume":"31","author":"Elisei","year":"2013","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(21)00120-0_bib18","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1200\/JCO.2011.35.5040","article-title":"Vandetanib in patients with locally advanced or metastatic medullary thyroid cancer: a randomed, double-blind phase III trial","volume":"30","author":"Wells","year":"2012","journal-title":"J Clin Oncol"},{"key":"10.1016\/S2213-8587(21)00120-0_bib19","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1056\/NEJMoa1406470","article-title":"Lenvatinib versus placebo in radioiodine-refractory thyroid cancer","volume":"372","author":"Schlumberger","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00120-0_bib20","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1016\/S0140-6736(14)60421-9","article-title":"Sorafenib in radioactive iodine-refractory, locally advanced or metastatic differentiated thyroid cancer: a randomised, double-blind, phase 3 trial","volume":"384","author":"Brose","year":"2014","journal-title":"Lancet"},{"key":"10.1016\/S2213-8587(21)00120-0_bib21","doi-asserted-by":"crossref","first-page":"172","DOI":"10.1016\/j.ejcsup.2013.07.016","article-title":"Understanding and managing toxicities of vascular endothelial growth factor (VEGF) inhibitors","volume":"11","author":"Schmidinger","year":"2013","journal-title":"EJC Suppl"},{"key":"10.1016\/S2213-8587(21)00120-0_bib22","doi-asserted-by":"crossref","first-page":"6056","DOI":"10.1038\/sj.onc.1207810","article-title":"Disease associated mutations at valine 804 in the RET receptor tyrosine kinase confer resistance to selective kinase inhibitors","volume":"23","author":"Carlomagno","year":"2004","journal-title":"Oncogene"},{"key":"10.1016\/S2213-8587(21)00120-0_bib23","doi-asserted-by":"crossref","first-page":"1569","DOI":"10.1089\/thy.2013.0137","article-title":"In vitro and in vivo activity of cabozantinib (XL184), an inhibitor of RET, MET, and VEGFR2, in a model of medullary thyroid cancer","volume":"23","author":"Bentzien","year":"2013","journal-title":"Thyroid"},{"key":"10.1016\/S2213-8587(21)00120-0_bib25","doi-asserted-by":"crossref","unstructured":"Subbiah V, Taylor M, Lin J, et al. Highly potent and selective RET inhibitor, BLU-667, achieves proof of concept in ARROW, a phase 1 study of advanced, RET-altered solid tumors. Annual Meeting of the American Association for Cancer Research; Chicago, IL; April 14\u201318, 2018.","DOI":"10.1158\/1538-7445.AM2018-CT043"},{"key":"10.1016\/S2213-8587(21)00120-0_bib26","doi-asserted-by":"crossref","DOI":"10.1016\/S1470-2045(21)00247-3","article-title":"Pralsetinib for RET fusion-positive non-small-cell lung cancer (ARROW): a multi-cohort, open-label, phase 1\/2 study","author":"Gainor","year":"2021","journal-title":"Lancet Oncol"},{"key":"10.1016\/S2213-8587(21)00120-0_bib27","author":"Lilly"},{"key":"10.1016\/S2213-8587(21)00120-0_bib28","doi-asserted-by":"crossref","first-page":"825","DOI":"10.1056\/NEJMoa2005651","article-title":"Efficacy of selpercatinib in RET-altered thyroid cancers","volume":"383","author":"Wirth","year":"2020","journal-title":"N Engl J Med"},{"key":"10.1016\/S2213-8587(21)00120-0_bib29","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/s11912-012-0242-z","article-title":"VEGF inhibition, hypertension, and renal toxicity","volume":"14","author":"Hayman","year":"2012","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/S2213-8587(21)00120-0_bib30","doi-asserted-by":"crossref","first-page":"2684","DOI":"10.1158\/1078-0432.CCR-14-2329","article-title":"Targeting FGFR Signaling in Cancer","volume":"21","author":"Touat","year":"2015","journal-title":"Clin Cancer Res"}],"updated-by":[{"DOI":"10.1016\/s2213-8587(21)00247-3","type":"erratum","label":"Erratum","source":"publisher","updated":{"date-parts":[[2021,10,1]],"date-time":"2021-10-01T00:00:00Z","timestamp":1633046400000}}],"container-title":["The Lancet Diabetes &amp; Endocrinology"],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001200?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2213858721001200?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T10:09:47Z","timestamp":1761991787000},"score":0.0,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2213858721001200"}},"issued":{"date-parts":[[2021,8]]},"references-count":28,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2021,8]]}},"alternative-id":["S2213858721001200"],"URL":"https:\/\/doi.org\/10.1016\/s2213-8587(21)00120-0","ISSN":["2213-8587"],"issn-type":[{"value":"2213-8587","type":"print"}],"published":{"date-parts":[[2021,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Pralsetinib for patients with advanced or metastatic RET-altered thyroid cancer (ARROW): a multi-cohort, open-label, registrational, phase 1\/2 study","name":"articletitle","label":"Article Title"},{"value":"The Lancet Diabetes & Endocrinology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00120-0","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"https:\/\/doi.org\/10.1016\/S2213-8587(21)00152-2","name":"associatedlink","label":"CrossRef DOI link to the associated document"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2021 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}],"items-per-page":1000,"query":{"start-index":0,"search-terms":null}}}